100.0%	7	7	478	Mendelian_Lipoprotein_deficiency	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
100.0%	7	7	46	Mendelian_Lipoprotein_deficiency	REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT
100.0%	7	7	28	Mendelian_Lipoprotein_deficiency	REACTOME_LIPOPROTEIN_METABOLISM
100.0%	6	6	200	Mendelian_Disorders_of_Urea_Cycle_Metabolism	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
100.0%	28	28	28	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_G1_PATHWAY
100.0%	26	26	26	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_WNT_PATHWAY
100.0%	23	23	23	Diabetes_McGill_Mtor_pathway	BIOCARTA_MTOR_PATHWAY
100.0%	124	124	128	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_CELL_CYCLE
100.0%	10	10	429	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MOOTHA_HUMAN_MITODB_6_2002
96.4285714286%	27	28	128	Diabetes_McGill_Cell_cycle_G1	KEGG_CELL_CYCLE
96.1538461538%	25	26	920	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_SIGNALING_BY_GPCR
96.1538461538%	25	26	408	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_GPCR_LIGAND_BINDING
95.7142857143%	67	70	67	Diabetes_McGill_Adipocytokine_signallin	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
92.3076923077%	24	26	805	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_GPCR_DOWNSTREAM_SIGNALING
90.9090909091%	10	11	88	Mendelian_Diamond-Blackfan_Anemia	KEGG_RIBOSOME
90.9090909091%	10	11	518	Mendelian_Diamond-Blackfan_Anemia	REACTOME_METABOLISM_OF_PROTEINS
90.9090909091%	10	11	330	Mendelian_Diamond-Blackfan_Anemia	REACTOME_METABOLISM_OF_RNA
90.9090909091%	10	11	284	Mendelian_Diamond-Blackfan_Anemia	REACTOME_METABOLISM_OF_MRNA
90.9090909091%	10	11	222	Mendelian_Diamond-Blackfan_Anemia	REACTOME_TRANSLATION
90.9090909091%	10	11	203	Mendelian_Diamond-Blackfan_Anemia	REACTOME_INFLUENZA_LIFE_CYCLE
90.9090909091%	10	11	179	Mendelian_Diamond-Blackfan_Anemia	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE
90.9090909091%	10	11	176	Mendelian_Diamond-Blackfan_Anemia	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX
90.9090909091%	10	11	176	Mendelian_Diamond-Blackfan_Anemia	REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION
90.9090909091%	10	11	169	Mendelian_Diamond-Blackfan_Anemia	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION
90.9090909091%	10	11	153	Mendelian_Diamond-Blackfan_Anemia	REACTOME_PEPTIDE_CHAIN_ELONGATION
90.0%	9	10	447	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MOOTHA_MITOCHONDRIA
84.6153846154%	22	26	151	Diabetes_McGill_Set_Wnt_pathway	KEGG_WNT_SIGNALING_PATHWAY
83.3333333333%	5	6	80	Diabetes_McGill_Insulin_synthesis_and_ER_stres	REACTOME_UNFOLDED_PROTEIN_RESPONSE
83.3333333333%	5	6	54	Mendelian_Disorders_of_Urea_Cycle_Metabolism	KEGG_ARGININE_AND_PROLINE_METABOLISM
83.3333333333%	5	6	133	Diabetes_McGill_Insulin_synthesis_and_ER_stres	REACTOME_DIABETES_PATHWAYS
82.3529411765%	14	17	35	Mendelian_Severe_Combined_Immunodeficiency	KEGG_PRIMARY_IMMUNODEFICIENCY
80.7692307692%	21	26	46	Diabetes_McGill_Set_Wnt_pathway	PID_PS1PATHWAY
78.5714285714%	22	28	328	Diabetes_McGill_Cell_cycle_G1	KEGG_PATHWAYS_IN_CANCER
76.9230769231%	20	26	89	Diabetes_McGill_Set_Wnt_pathway	WNT_SIGNALING
76.9230769231%	20	26	305	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
76.9230769231%	20	26	272	Diabetes_McGill_GPCRs_expressed_in_beta_cell	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
75.0%	21	28	421	Diabetes_McGill_Cell_cycle_G1	REACTOME_CELL_CYCLE
74.0740740741%	20	27	48	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE
74.0740740741%	20	27	429	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MOOTHA_HUMAN_MITODB_6_2002
74.0740740741%	20	27	32	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_CITRATE_CYCLE_TCA_CYCLE
74.0740740741%	20	27	141	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
73.3870967742%	91	124	421	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_CELL_CYCLE
71.4285714286%	5	7	16	Mendelian_Lipoprotein_deficiency	REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT
70.8333333333%	17	24	58	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_HIVNEF_PATHWAY
70.0%	7	10	152	Mendelian_Disorders_of_Fatty_Acid_Oxidation	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
69.5652173913%	16	23	24	Diabetes_McGill_Mtor_pathway	BIOCARTA_EIF4_PATHWAY
67.7419354839%	84	124	325	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_CELL_CYCLE_MITOTIC
66.6666666667%	4	6	266	Mendelian_Disorders_of_Urea_Cycle_Metabolism	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
66.6666666667%	4	6	244	Mendelian_Disorders_of_Urea_Cycle_Metabolism	HSIAO_LIVER_SPECIFIC_GENES
66.6666666667%	16	24	35	Diabetes_McGill_TNF_alpha_signalin	PID_HIVNEFPATHWAY
64.2857142857%	18	28	325	Diabetes_McGill_Cell_cycle_G1	REACTOME_CELL_CYCLE_MITOTIC
64.2857142857%	18	28	137	Diabetes_McGill_Cell_cycle_G1	REACTOME_MITOTIC_G1_G1_S_PHASES
63.6363636364%	7	11	68	Mendelian_Diamond-Blackfan_Anemia	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES
63.6363636364%	7	11	389	Mendelian_Diamond-Blackfan_Anemia	HSIAO_HOUSEKEEPING_GENES
62.962962963%	17	27	447	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MOOTHA_MITOCHONDRIA
62.5%	5	8	200	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
61.5384615385%	8	13	133	Diabetes_McGill_Insulin	REACTOME_DIABETES_PATHWAYS
60.8695652174%	14	23	933	Diabetes_McGill_Mtor_pathway	REACTOME_IMMUNE_SYSTEM
60.4838709677%	75	124	1652	Diabetes_McGill_Cell_cycle_All_Gene	PUJANA_BRCA1_PCC_NETWORK
60.0%	6	10	882	Mendelian_Disorders_of_Fatty_Acid_Oxidation	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
60.0%	6	10	478	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
60.0%	6	10	42	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KEGG_FATTY_ACID_METABOLISM
60.0%	6	10	22	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MOOTHA_FFA_OXYDATION
60.0%	6	10	168	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
59.2592592593%	16	27	535	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	STEIN_ESRRA_TARGETS
59.2592592593%	16	27	388	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	STEIN_ESRRA_TARGETS_UP
58.9743589744%	23	39	933	Diabetes_McGill_IL6	REACTOME_IMMUNE_SYSTEM
58.8235294118%	10	17	88	Mendelian_Blood_Desease	KEGG_RIBOSOME
58.8235294118%	10	17	518	Mendelian_Blood_Desease	REACTOME_METABOLISM_OF_PROTEINS
58.8235294118%	10	17	330	Mendelian_Blood_Desease	REACTOME_METABOLISM_OF_RNA
58.8235294118%	10	17	284	Mendelian_Blood_Desease	REACTOME_METABOLISM_OF_MRNA
58.8235294118%	10	17	222	Mendelian_Blood_Desease	REACTOME_TRANSLATION
58.8235294118%	10	17	203	Mendelian_Blood_Desease	REACTOME_INFLUENZA_LIFE_CYCLE
58.8235294118%	10	17	179	Mendelian_Blood_Desease	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE
58.8235294118%	10	17	176	Mendelian_Blood_Desease	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX
58.8235294118%	10	17	176	Mendelian_Blood_Desease	REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION
58.8235294118%	10	17	169	Mendelian_Blood_Desease	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION
58.8235294118%	10	17	153	Mendelian_Blood_Desease	REACTOME_PEPTIDE_CHAIN_ELONGATION
58.3333333333%	7	12	267	Diabetes_McGill_Adipocytokines	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
58.3333333333%	14	24	88	Diabetes_McGill_TNF_alpha_signalin	KEGG_APOPTOSIS
58.3333333333%	14	24	52	Diabetes_McGill_TNF_alpha_signalin	PID_CASPASE_PATHWAY
58.3333333333%	14	24	48	Diabetes_McGill_TNF_alpha_signalin	PID_CERAMIDE_PATHWAY
58.064516129%	18	31	155	Diabetes_McGill_IL10	KEGG_JAK_STAT_SIGNALING_PATHWAY
57.6923076923%	15	26	328	Diabetes_McGill_Set_Wnt_pathway	KEGG_PATHWAYS_IN_CANCER
57.1428571429%	4	7	93	Diabetes_McGill_Insulin_exocytosi	REACTOME_REGULATION_OF_INSULIN_SECRETION
57.1428571429%	4	7	504	Mendelian_Lipoprotein_deficiency	PILON_KLF1_TARGETS_UP
57.1428571429%	4	7	38	Diabetes_McGill_Insulin_exocytosi	KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT
57.1428571429%	4	7	279	Diabetes_McGill_Insulin_exocytosi	REACTOME_NEURONAL_SYSTEM
57.1428571429%	4	7	244	Mendelian_Lipoprotein_deficiency	HSIAO_LIVER_SPECIFIC_GENES
57.1428571429%	4	7	19	Diabetes_McGill_Insulin_exocytosi	REACTOME_BOTULINUM_NEUROTOXICITY
57.1428571429%	4	7	17	Diabetes_McGill_Insulin_exocytosi	REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS
57.1428571429%	4	7	1305	Diabetes_McGill_Insulin_exocytosi	YOSHIMURA_MAPK8_TARGETS_UP
57.1428571429%	4	7	1237	Diabetes_McGill_Insulin_exocytosi	BLALOCK_ALZHEIMERS_DISEASE_DN
57.1428571429%	4	7	120	Diabetes_McGill_Insulin_exocytosi	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
57.1428571429%	16	28	73	Diabetes_McGill_Cell_cycle_G1	KEGG_CHRONIC_MYELOID_LEUKEMIA
56.4102564103%	22	39	155	Diabetes_McGill_IL6	KEGG_JAK_STAT_SIGNALING_PATHWAY
55.5555555556%	5	9	933	Mendelian_Immune	REACTOME_IMMUNE_SYSTEM
55.5555555556%	5	9	539	Mendelian_Immune	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
55.5555555556%	5	9	118	Mendelian_Immune	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
55.5555555556%	15	27	26	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE
54.5454545455%	6	11	871	Mendelian_Diamond-Blackfan_Anemia	GRADE_COLON_CANCER_UP
54.5454545455%	6	11	841	Mendelian_Diamond-Blackfan_Anemia	MARTENS_TRETINOIN_RESPONSE_DN
54.5454545455%	6	11	84	Mendelian_Diamond-Blackfan_Anemia	REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S
54.5454545455%	6	11	74	Mendelian_Diamond-Blackfan_Anemia	REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX
54.5454545455%	6	11	1652	Mendelian_Diamond-Blackfan_Anemia	PUJANA_BRCA1_PCC_NETWORK
54.1666666667%	13	24	148	Diabetes_McGill_TNF_alpha_signalin	REACTOME_APOPTOSIS
53.5714285714%	15	28	65	Diabetes_McGill_Cell_cycle_G1	PID_RB_1PATHWAY
53.5714285714%	15	28	23	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_CELLCYCLE_PATHWAY
53.5714285714%	15	28	1652	Diabetes_McGill_Cell_cycle_G1	PUJANA_BRCA1_PCC_NETWORK
53.3333333333%	8	15	247	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	REACTOME_METABOLISM_OF_CARBOHYDRATES
52.1739130435%	12	23	87	Diabetes_McGill_Mtor_pathway	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
52.1739130435%	12	23	71	Diabetes_McGill_Mtor_pathway	REACTOME_PI3K_CASCADE
52.1739130435%	12	23	52	Diabetes_McGill_Mtor_pathway	KEGG_MTOR_SIGNALING_PATHWAY
52.1739130435%	12	23	20	Diabetes_McGill_Mtor_pathway	BIOCARTA_IGF1MTOR_PATHWAY
52.1739130435%	12	23	137	Diabetes_McGill_Mtor_pathway	KEGG_INSULIN_SIGNALING_PATHWAY
52.1739130435%	12	23	118	Diabetes_McGill_Mtor_pathway	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
52.1739130435%	12	23	108	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
51.8518518519%	14	27	1382	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
51.8518518519%	14	27	1237	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BLALOCK_ALZHEIMERS_DISEASE_DN
50.0%	6	12	1037	Diabetes_McGill_Adipocytokines	NUYTTEN_EZH2_TARGETS_UP
50.0%	5	10	535	Mendelian_Disorders_of_Fatty_Acid_Oxidation	STEIN_ESRRA_TARGETS
50.0%	5	10	388	Mendelian_Disorders_of_Fatty_Acid_Oxidation	STEIN_ESRRA_TARGETS_UP
50.0%	4	8	546	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
50.0%	4	8	435	Mendelian_Long_QT_syndrome	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
50.0%	4	8	31	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM
50.0%	4	8	267	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CAIRO_HEPATOBLASTOMA_DN
50.0%	3	6	988	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BENPORATH_NANOG_TARGETS
50.0%	3	6	811	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
50.0%	3	6	32	Mendelian_Disorders_of_Urea_Cycle_Metabolism	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM
50.0%	3	6	29	Diabetes_McGill_Insulin_synthesis_and_ER_stres	REACTOME_PERK_REGULATED_GENE_EXPRESSION
50.0%	3	6	267	Mendelian_Disorders_of_Urea_Cycle_Metabolism	CAIRO_HEPATOBLASTOMA_DN
50.0%	3	6	245	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BLUM_RESPONSE_TO_SALIRASIB_UP
50.0%	3	6	1972	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PILON_KLF1_TARGETS_DN
50.0%	3	6	1781	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
50.0%	3	6	169	Diabetes_McGill_Insulin_synthesis_and_ER_stres	KEGG_ALZHEIMERS_DISEASE
50.0%	3	6	13	Diabetes_McGill_Insulin_synthesis_and_ER_stres	REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6_ALPHA
50.0%	3	6	1229	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
50.0%	3	6	11	Diabetes_McGill_Insulin_synthesis_and_ER_stres	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA
50.0%	16	32	1305	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	YOSHIMURA_MAPK8_TARGETS_UP
50.0%	14	28	101	Diabetes_McGill_Cell_cycle_G1	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
50.0%	12	24	33	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_DEATH_PATHWAY
50.0%	12	24	29	Diabetes_McGill_TNF_alpha_signalin	ST_TUMOR_NECROSIS_FACTOR_PATHWAY
50.0%	12	24	29	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_TNFR1_PATHWAY
48.1481481481%	13	27	420	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MOOTHA_PGC
47.8260869565%	11	23	1103	Diabetes_McGill_Mtor_pathway	DANG_BOUND_BY_MYC
47.0588235294%	8	17	1103	Mendelian_Blood_Desease	DANG_BOUND_BY_MYC
46.875%	15	32	279	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_NEURONAL_SYSTEM
46.6666666667%	7	15	69	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	REACTOME_GLUCOSE_METABOLISM
46.6666666667%	7	15	121	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KEGG_LYSOSOME
46.4285714286%	13	28	74	Diabetes_McGill_Cell_cycle_G1	PID_E2F_PATHWAY
46.4285714286%	13	28	1103	Diabetes_McGill_Cell_cycle_G1	DANG_BOUND_BY_MYC
45.8333333333%	11	24	46	Diabetes_McGill_TNF_alpha_signalin	PID_TNFPATHWAY
45.8333333333%	11	24	169	Diabetes_McGill_TNF_alpha_signalin	KEGG_ALZHEIMERS_DISEASE
45.4545454545%	5	11	957	Mendelian_Diamond-Blackfan_Anemia	LOPEZ_MBD_TARGETS
45.4545454545%	5	11	682	Mendelian_Diamond-Blackfan_Anemia	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
45.4545454545%	5	11	55	Mendelian_Diamond-Blackfan_Anemia	TIEN_INTESTINE_PROBIOTICS_6HR_UP
45.4545454545%	5	11	406	Mendelian_Diamond-Blackfan_Anemia	OSMAN_BLADDER_CANCER_DN
45.4545454545%	5	11	146	Mendelian_Diamond-Blackfan_Anemia	PECE_MAMMARY_STEM_CELL_DN
45.4545454545%	5	11	1442	Mendelian_Diamond-Blackfan_Anemia	PUJANA_ATM_PCC_NETWORK
45.4545454545%	5	11	1103	Mendelian_Diamond-Blackfan_Anemia	DANG_BOUND_BY_MYC
44.4444444444%	4	9	76	Mendelian_Immune	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION
44.4444444444%	4	9	72	Mendelian_Immune	KEGG_LEISHMANIA_INFECTION
44.4444444444%	4	9	54	Mendelian_Immune	PID_RAC1_PATHWAY
44.4444444444%	4	9	33	Mendelian_Immune	REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS
44.4444444444%	4	9	282	Mendelian_Immune	HELLER_SILENCED_BY_METHYLATION_UP
44.4444444444%	4	9	253	Mendelian_Immune	MCLACHLAN_DENTAL_CARIES_UP
44.4444444444%	4	9	251	Mendelian_Immune	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
44.4444444444%	4	9	245	Mendelian_Immune	MCLACHLAN_DENTAL_CARIES_DN
44.4444444444%	4	9	1210	Mendelian_Immune	CHEN_METABOLIC_SYNDROM_NETWORK
44.4444444444%	12	27	16	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MOOTHA_TCA
43.75%	14	32	98	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_POTASSIUM_CHANNELS
43.5897435897%	17	39	328	Diabetes_McGill_IL6	KEGG_PATHWAYS_IN_CANCER
43.5483870968%	54	124	137	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_MITOTIC_G1_G1_S_PHASES
43.4782608696%	10	23	69	Diabetes_McGill_Mtor_pathway	PID_MTOR_4PATHWAY
42.8571428571%	3	7	93	Mendelian_Lipoprotein_deficiency	CADWELL_ATG16L1_TARGETS_UP
42.8571428571%	3	7	540	Mendelian_Lipoprotein_deficiency	ACEVEDO_LIVER_CANCER_DN
42.8571428571%	3	7	514	Mendelian_Lipoprotein_deficiency	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
42.8571428571%	3	7	34	Diabetes_McGill_Insulin_exocytosi	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE
42.8571428571%	3	7	21	Diabetes_McGill_Insulin_exocytosi	REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING
42.8571428571%	3	7	186	Diabetes_McGill_Insulin_exocytosi	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
42.8571428571%	3	7	17	Diabetes_McGill_Insulin_exocytosi	REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION
42.8571428571%	3	7	15	Mendelian_Lipoprotein_deficiency	REACTOME_HDL_MEDIATED_LIPID_TRANSPORT
42.8571428571%	3	7	15	Diabetes_McGill_Insulin_exocytosi	REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE
42.8571428571%	3	7	133	Diabetes_McGill_Insulin_exocytosi	REACTOME_DIABETES_PATHWAYS
42.8571428571%	3	7	1305	Mendelian_Lipoprotein_deficiency	YOSHIMURA_MAPK8_TARGETS_UP
42.8571428571%	3	7	11	Diabetes_McGill_Insulin_exocytosi	REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE
42.8571428571%	3	7	10	Diabetes_McGill_Insulin_exocytosi	REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE
42.8571428571%	3	7	10	Diabetes_McGill_Insulin_exocytosi	REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE
42.8571428571%	12	28	70	Diabetes_McGill_Cell_cycle_G1	KEGG_PANCREATIC_CANCER
42.8571428571%	12	28	112	Diabetes_McGill_Cell_cycle_G1	REACTOME_G1_S_TRANSITION
42.3076923077%	11	26	855	Diabetes_McGill_Set_Wnt_pathway	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
41.6666666667%	5	12	811	Diabetes_McGill_Adipocytokines	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
41.6666666667%	5	12	544	Diabetes_McGill_Adipocytokines	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
41.6666666667%	5	12	457	Diabetes_McGill_Adipocytokines	SENESE_HDAC1_TARGETS_UP
41.6666666667%	10	24	933	Diabetes_McGill_TNF_alpha_signalin	REACTOME_IMMUNE_SYSTEM
41.6666666667%	10	24	328	Diabetes_McGill_TNF_alpha_signalin	KEGG_PATHWAYS_IN_CANCER
41.6666666667%	10	24	279	Diabetes_McGill_TNF_alpha_signalin	REACTOME_INNATE_IMMUNE_SYSTEM
41.1764705882%	7	17	933	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_IMMUNE_SYSTEM
41.1764705882%	7	17	68	Mendelian_Blood_Desease	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES
41.1764705882%	7	17	389	Mendelian_Blood_Desease	HSIAO_HOUSEKEEPING_GENES
41.1290322581%	51	124	779	Diabetes_McGill_Cell_cycle_All_Gene	PUJANA_CHEK2_PCC_NETWORK
40.0%	6	15	18	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS
40.0%	4	10	420	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MOOTHA_PGC
40.0%	4	10	364	Mendelian_Disorders_of_Fatty_Acid_Oxidation	YANG_BCL3_TARGETS_UP
40.0%	4	10	1382	Mendelian_Disorders_of_Fatty_Acid_Oxidation	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
40.0%	4	10	1142	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
39.5161290323%	49	124	1375	Diabetes_McGill_Cell_cycle_All_Gene	DODD_NASOPHARYNGEAL_CARCINOMA_DN
39.5161290323%	49	124	124	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_CELL_CYCLE_CHECKPOINTS
39.2857142857%	11	28	84	Diabetes_McGill_Cell_cycle_G1	KEGG_SMALL_CELL_LUNG_CANCER
39.2857142857%	11	28	69	Diabetes_McGill_Cell_cycle_G1	KEGG_P53_SIGNALING_PATHWAY
39.2857142857%	11	28	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_HNF3BPATHWAY
39.2857142857%	11	28	396	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_DEVELOPMENTAL_BIOLOGY
39.2857142857%	11	28	38	Diabetes_McGill_Cell_cycle_G1	REACTOME_G1_PHASE
39.2857142857%	11	28	1442	Diabetes_McGill_Cell_cycle_G1	PUJANA_ATM_PCC_NETWORK
39.2857142857%	11	28	128	Diabetes_McGill_Cell_cycle_G1	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
39.1304347826%	9	23	29	Diabetes_McGill_Mtor_pathway	REACTOME_PKB_MEDIATED_EVENTS
39.1304347826%	9	23	127	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
39.1304347826%	9	23	112	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALING_BY_FGFR
38.7096774194%	48	124	1278	Diabetes_McGill_Cell_cycle_All_Gene	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
38.4615384615%	5	13	80	Diabetes_McGill_Insulin	REACTOME_UNFOLDED_PROTEIN_RESPONSE
38.4615384615%	5	13	1305	Diabetes_McGill_Insulin	YOSHIMURA_MAPK8_TARGETS_UP
38.4615384615%	15	39	270	Diabetes_McGill_IL6	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
38.4615384615%	10	26	27	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_GSK3_PATHWAY
38.4615384615%	10	26	1691	Diabetes_McGill_Set_Wnt_pathway	BLALOCK_ALZHEIMERS_DISEASE_UP
38.4615384615%	10	26	15	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_PITX2_PATHWAY
38.4615384615%	10	26	1305	Diabetes_McGill_GPCRs_expressed_in_beta_cell	YOSHIMURA_MAPK8_TARGETS_UP
37.5%	9	24	46	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_KERATINOCYTE_PATHWAY
37.5%	9	24	22	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_CERAMIDE_PATHWAY
37.5%	9	24	1972	Diabetes_McGill_TNF_alpha_signalin	PILON_KLF1_TARGETS_DN
37.5%	9	24	10	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_SODD_PATHWAY
37.5%	3	8	605	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CAIRO_HEPATOBLASTOMA_CLASSES_UP
37.5%	3	8	354	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
37.5%	3	8	341	Mendelian_Long_QT_syndrome	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
37.5%	3	8	261	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
37.5%	3	8	222	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CAIRO_LIVER_DEVELOPMENT_DN
37.5%	3	8	179	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
37.5%	3	8	1375	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	DODD_NASOPHARYNGEAL_CARCINOMA_DN
37.5%	3	8	1305	Mendelian_Long_QT_syndrome	YOSHIMURA_MAPK8_TARGETS_UP
37.5%	3	8	1210	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CHEN_METABOLIC_SYNDROM_NETWORK
37.5%	3	8	1174	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	PEREZ_TP53_TARGETS
37.5%	3	8	1069	Mendelian_Long_QT_syndrome	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
37.1428571429%	26	70	137	Diabetes_McGill_Adipocytokine_signallin	KEGG_INSULIN_SIGNALING_PATHWAY
37.037037037%	10	27	546	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
37.037037037%	10	27	217	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WONG_MITOCHONDRIA_GENE_MODULE
37.037037037%	10	27	189	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BURTON_ADIPOGENESIS_6
36.3636363636%	4	11	863	Mendelian_Diamond-Blackfan_Anemia	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
36.3636363636%	4	11	775	Mendelian_Diamond-Blackfan_Anemia	BENPORATH_MYC_MAX_TARGETS
36.3636363636%	4	11	756	Mendelian_Diamond-Blackfan_Anemia	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
36.3636363636%	4	11	593	Mendelian_Diamond-Blackfan_Anemia	MARTINEZ_TP53_TARGETS_DN
36.3636363636%	4	11	591	Mendelian_Diamond-Blackfan_Anemia	MARTINEZ_RB1_AND_TP53_TARGETS_DN
36.3636363636%	4	11	543	Mendelian_Diamond-Blackfan_Anemia	MARTINEZ_RB1_TARGETS_DN
36.3636363636%	4	11	43	Mendelian_Diamond-Blackfan_Anemia	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
36.3636363636%	4	11	214	Mendelian_Diamond-Blackfan_Anemia	TIEN_INTESTINE_PROBIOTICS_24HR_DN
36.3636363636%	4	11	181	Mendelian_Diamond-Blackfan_Anemia	JISON_SICKLE_CELL_DISEASE_DN
36.3636363636%	4	11	143	Mendelian_Diamond-Blackfan_Anemia	DANG_MYC_TARGETS_UP
36.3636363636%	12	33	80	Diabetes_McGill_ER_Stress	REACTOME_UNFOLDED_PROTEIN_RESPONSE
36.3636363636%	12	33	133	Diabetes_McGill_ER_Stress	REACTOME_DIABETES_PATHWAYS
36.2903225806%	45	124	423	Diabetes_McGill_Cell_cycle_All_Gene	PUJANA_BRCA2_PCC_NETWORK
35.8974358974%	14	39	67	Diabetes_McGill_IL6	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
35.8974358974%	14	39	1691	Diabetes_McGill_IL6	BLALOCK_ALZHEIMERS_DISEASE_UP
35.8974358974%	14	39	126	Diabetes_McGill_IL6	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
35.8974358974%	14	39	105	Diabetes_McGill_IL6	PID_ERBB1_DOWNSTREAM_PATHWAY
35.7142857143%	10	28	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
35.7142857143%	10	28	26	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_RACCYCD_PATHWAY
35.7142857143%	10	28	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG
35.7142857143%	10	28	1972	Diabetes_McGill_Cell_cycle_G1	PILON_KLF1_TARGETS_DN
35.7142857143%	10	28	1118	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BENPORATH_ES_WITH_H3K27ME3
35.7142857143%	10	28	109	Diabetes_McGill_Cell_cycle_G1	REACTOME_S_PHASE
35.7142857143%	10	28	1062	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BENPORATH_EED_TARGETS
35.4838709677%	44	124	648	Diabetes_McGill_Cell_cycle_All_Gene	BENPORATH_CYCLING_GENES
35.4838709677%	11	31	933	Diabetes_McGill_IL10	REACTOME_IMMUNE_SYSTEM
35.4838709677%	11	31	328	Diabetes_McGill_IL10	KEGG_PATHWAYS_IN_CANCER
35.2941176471%	6	17	871	Mendelian_Blood_Desease	GRADE_COLON_CANCER_UP
35.2941176471%	6	17	841	Mendelian_Blood_Desease	MARTENS_TRETINOIN_RESPONSE_DN
35.2941176471%	6	17	84	Mendelian_Blood_Desease	REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S
35.2941176471%	6	17	74	Mendelian_Blood_Desease	REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX
35.2941176471%	6	17	476	Mendelian_Severe_Combined_Immunodeficiency	SMID_BREAST_CANCER_NORMAL_LIKE_UP
35.2941176471%	6	17	423	Mendelian_Severe_Combined_Immunodeficiency	PUJANA_BRCA2_PCC_NETWORK
35.2941176471%	6	17	1652	Mendelian_Blood_Desease	PUJANA_BRCA1_PCC_NETWORK
35.2941176471%	6	17	1229	Mendelian_Severe_Combined_Immunodeficiency	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
34.7826086957%	8	23	84	Diabetes_McGill_Mtor_pathway	REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S
34.7826086957%	8	23	539	Diabetes_McGill_Mtor_pathway	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
34.7826086957%	8	23	518	Diabetes_McGill_Mtor_pathway	REACTOME_METABOLISM_OF_PROTEINS
34.7826086957%	8	23	330	Diabetes_McGill_Mtor_pathway	REACTOME_METABOLISM_OF_RNA
34.7826086957%	8	23	284	Diabetes_McGill_Mtor_pathway	REACTOME_METABOLISM_OF_MRNA
34.7826086957%	8	23	270	Diabetes_McGill_Mtor_pathway	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
34.7826086957%	8	23	222	Diabetes_McGill_Mtor_pathway	REACTOME_TRANSLATION
34.7826086957%	8	23	217	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALLING_BY_NGF
34.7826086957%	8	23	1972	Diabetes_McGill_Mtor_pathway	PILON_KLF1_TARGETS_DN
34.7826086957%	8	23	1382	Diabetes_McGill_Mtor_pathway	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
34.7826086957%	8	23	137	Diabetes_McGill_Mtor_pathway	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
34.6153846154%	9	26	37	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_ALK_PATHWAY
34.6153846154%	9	26	205	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
34.6153846154%	9	26	195	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
34.6153846154%	9	26	184	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
33.3333333333%	8	24	267	Diabetes_McGill_TNF_alpha_signalin	KEGG_MAPK_SIGNALING_PATHWAY
33.3333333333%	8	24	25	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_STRESS_PATHWAY
33.3333333333%	8	24	1691	Diabetes_McGill_TNF_alpha_signalin	BLALOCK_ALZHEIMERS_DISEASE_UP
33.3333333333%	8	24	1382	Diabetes_McGill_TNF_alpha_signalin	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
33.3333333333%	8	24	102	Diabetes_McGill_TNF_alpha_signalin	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
33.3333333333%	5	15	21	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MOOTHA_GLYCOGEN_METABOLISM
33.3333333333%	5	15	1972	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PILON_KLF1_TARGETS_DN
33.3333333333%	5	15	137	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KEGG_INSULIN_SIGNALING_PATHWAY
33.3333333333%	4	12	953	Diabetes_McGill_Adipocytokines	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
33.3333333333%	4	12	848	Diabetes_McGill_Adipocytokines	NUYTTEN_NIPP1_TARGETS_DN
33.3333333333%	4	12	783	Diabetes_McGill_Adipocytokines	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
33.3333333333%	4	12	66	Diabetes_McGill_Adipocytokines	TENEDINI_MEGAKARYOCYTE_MARKERS
33.3333333333%	4	12	58	Diabetes_McGill_Adipocytokines	PID_SHP2_PATHWAY
33.3333333333%	4	12	572	Diabetes_McGill_Adipocytokines	CHICAS_RB1_TARGETS_SENESCENT
33.3333333333%	4	12	51	Diabetes_McGill_Adipocytokines	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
33.3333333333%	4	12	326	Diabetes_McGill_Adipocytokines	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
33.3333333333%	4	12	24	Diabetes_McGill_Adipocytokines	KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM
33.3333333333%	4	12	238	Diabetes_McGill_Adipocytokines	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
33.3333333333%	4	12	1691	Diabetes_McGill_Adipocytokines	BLALOCK_ALZHEIMERS_DISEASE_UP
33.3333333333%	4	12	165	Diabetes_McGill_Adipocytokines	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
33.3333333333%	4	12	160	Diabetes_McGill_Adipocytokines	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
33.3333333333%	4	12	1103	Mendelian_Etc	DANG_BOUND_BY_MYC
33.3333333333%	3	9	546	Mendelian_Immune	WEST_ADRENOCORTICAL_TUMOR_DN
33.3333333333%	3	9	53	Mendelian_Immune	KEGG_AUTOIMMUNE_THYROID_DISEASE
33.3333333333%	3	9	443	Mendelian_Immune	DELYS_THYROID_CANCER_UP
33.3333333333%	3	9	41	Mendelian_Immune	CROONQUIST_NRAS_SIGNALING_UP
33.3333333333%	3	9	38	Mendelian_Immune	KEGG_ALLOGRAFT_REJECTION
33.3333333333%	3	9	346	Mendelian_Immune	GOLDRATH_ANTIGEN_RESPONSE
33.3333333333%	3	9	267	Mendelian_Immune	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
33.3333333333%	3	9	1442	Mendelian_Immune	PUJANA_ATM_PCC_NETWORK
33.3333333333%	3	9	131	Mendelian_Immune	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
33.3333333333%	3	9	12	Mendelian_Immune	BIOCARTA_ASBCELL_PATHWAY
33.3333333333%	2	6	957	Diabetes_McGill_Insulin_synthesis_and_ER_stres	LOPEZ_MBD_TARGETS
33.3333333333%	2	6	841	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MARTENS_TRETINOIN_RESPONSE_DN
33.3333333333%	2	6	80	Mendelian_Disorders_of_Urea_Cycle_Metabolism	WOO_LIVER_CANCER_RECURRENCE_DN
33.3333333333%	2	6	775	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BENPORATH_MYC_MAX_TARGETS
33.3333333333%	2	6	770	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
33.3333333333%	2	6	634	Mendelian_Disorders_of_Urea_Cycle_Metabolism	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
33.3333333333%	2	6	584	Diabetes_McGill_Insulin_synthesis_and_ER_stres	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
33.3333333333%	2	6	552	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
33.3333333333%	2	6	55	Mendelian_Disorders_of_Urea_Cycle_Metabolism	SU_LIVER
33.3333333333%	2	6	536	Mendelian_Disorders_of_Urea_Cycle_Metabolism	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
33.3333333333%	2	6	530	Diabetes_McGill_Insulin_synthesis_and_ER_stres	ENK_UV_RESPONSE_KERATINOCYTE_UP
33.3333333333%	2	6	51	Mendelian_Disorders_of_Urea_Cycle_Metabolism	TSUNODA_CISPLATIN_RESISTANCE_DN
33.3333333333%	2	6	508	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ENK_UV_RESPONSE_EPIDERMIS_DN
33.3333333333%	2	6	508	Diabetes_McGill_Insulin_synthesis_and_ER_stres	ENK_UV_RESPONSE_EPIDERMIS_DN
33.3333333333%	2	6	459	Diabetes_McGill_Insulin_synthesis_and_ER_stres	KIM_WT1_TARGETS_DN
33.3333333333%	2	6	447	Mendelian_Disorders_of_Urea_Cycle_Metabolism	MOOTHA_MITOCHONDRIA
33.3333333333%	2	6	442	Diabetes_McGill_Insulin_synthesis_and_ER_stres	HAN_SATB1_TARGETS_DN
33.3333333333%	2	6	429	Mendelian_Disorders_of_Urea_Cycle_Metabolism	MOOTHA_HUMAN_MITODB_6_2002
33.3333333333%	2	6	389	Diabetes_McGill_Insulin_synthesis_and_ER_stres	HSIAO_HOUSEKEEPING_GENES
33.3333333333%	2	6	292	Diabetes_McGill_Insulin_synthesis_and_ER_stres	HELLER_HDAC_TARGETS_DN
33.3333333333%	2	6	281	Diabetes_McGill_Insulin_synthesis_and_ER_stres	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
33.3333333333%	2	6	271	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
33.3333333333%	2	6	26	Diabetes_McGill_Insulin_synthesis_and_ER_stres	REACTOME_ACTIVATION_OF_GENES_BY_ATF4
33.3333333333%	2	6	244	Diabetes_McGill_Insulin_synthesis_and_ER_stres	DAZARD_RESPONSE_TO_UV_NHEK_UP
33.3333333333%	2	6	23	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5
33.3333333333%	2	6	222	Mendelian_Disorders_of_Urea_Cycle_Metabolism	CAIRO_LIVER_DEVELOPMENT_DN
33.3333333333%	2	6	217	Diabetes_McGill_Insulin_synthesis_and_ER_stres	SANSOM_APC_MYC_TARGETS
33.3333333333%	2	6	199	Mendelian_Disorders_of_Urea_Cycle_Metabolism	PLASARI_TGFB1_TARGETS_10HR_UP
33.3333333333%	2	6	1821	Mendelian_Disorders_of_Urea_Cycle_Metabolism	DODD_NASOPHARYNGEAL_CARCINOMA_UP
33.3333333333%	2	6	17	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
33.3333333333%	2	6	156	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GROSS_HYPOXIA_VIA_ELK3_DN
33.3333333333%	2	6	147	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
33.3333333333%	2	6	1382	Mendelian_Disorders_of_Urea_Cycle_Metabolism	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
33.3333333333%	2	6	1305	Mendelian_Disorders_of_Urea_Cycle_Metabolism	YOSHIMURA_MAPK8_TARGETS_UP
33.3333333333%	2	6	1103	Diabetes_McGill_Insulin_synthesis_and_ER_stres	DANG_BOUND_BY_MYC
33.3333333333%	2	6	1022	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MARSON_BOUND_BY_FOXP3_STIMULATED
33.3333333333%	13	39	47	Diabetes_McGill_IL6	PID_IL6_7PATHWAY
33.3333333333%	13	39	37	Diabetes_McGill_IL6	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
33.3333333333%	13	39	129	Diabetes_McGill_IL6	PID_PDGFRBPATHWAY
33.3333333333%	11	33	200	Mendelian_Metabolism	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
33.064516129%	41	124	570	Diabetes_McGill_Cell_cycle_All_Gene	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
32.4324324324%	12	37	396	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_DEVELOPMENTAL_BIOLOGY
32.2580645161%	40	124	1442	Diabetes_McGill_Cell_cycle_All_Gene	PUJANA_ATM_PCC_NETWORK
32.2580645161%	40	124	114	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_OOCYTE_MEIOSIS
32.2580645161%	10	31	60	Diabetes_McGill_IL10	KEGG_ACUTE_MYELOID_LEUKEMIA
32.2580645161%	10	31	1305	Diabetes_McGill_IL10	YOSHIMURA_MAPK8_TARGETS_UP
32.1428571429%	9	28	89	Diabetes_McGill_Cell_cycle_G1	KEGG_PROSTATE_CANCER
32.1428571429%	9	28	779	Diabetes_McGill_Cell_cycle_G1	PUJANA_CHEK2_PCC_NETWORK
32.1428571429%	9	28	652	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BENPORATH_PRC2_TARGETS
32.1428571429%	9	28	323	Diabetes_McGill_Cell_cycle_G1	GRESHOCK_CANCER_COPY_NUMBER_UP
32.1428571429%	9	28	1691	Diabetes_McGill_Cell_cycle_G1	BLALOCK_ALZHEIMERS_DISEASE_UP
32.1428571429%	9	28	16	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_P53_PATHWAY
32.1428571429%	9	28	1278	Diabetes_McGill_Cell_cycle_G1	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
32.1428571429%	9	28	124	Diabetes_McGill_Cell_cycle_G1	REACTOME_CELL_CYCLE_CHECKPOINTS
32.1428571429%	9	28	1038	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BENPORATH_SUZ12_TARGETS
31.7073170732%	13	41	396	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_DEVELOPMENTAL_BIOLOGY
31.4285714286%	22	70	933	Diabetes_McGill_Adipocytokine_signallin	REACTOME_IMMUNE_SYSTEM
30.7692307692%	8	26	84	Diabetes_McGill_Set_Wnt_pathway	PID_CMYB_PATHWAY
30.7692307692%	8	26	80	Diabetes_McGill_Set_Wnt_pathway	PID_BETACATENIN_NUC_PATHWAY
30.7692307692%	8	26	62	Diabetes_McGill_Set_Wnt_pathway	KEGG_COLORECTAL_CANCER
30.7692307692%	8	26	55	Diabetes_McGill_Set_Wnt_pathway	KEGG_BASAL_CELL_CARCINOMA
30.7692307692%	8	26	34	Diabetes_McGill_Set_Wnt_pathway	ST_WNT_BETA_CATENIN_PATHWAY
30.7692307692%	8	26	14	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_PS1_PATHWAY
30.7692307692%	8	26	1382	Diabetes_McGill_Set_Wnt_pathway	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
30.7692307692%	4	13	93	Diabetes_McGill_Insulin	REACTOME_REGULATION_OF_INSULIN_SECRETION
30.7692307692%	4	13	811	Diabetes_McGill_Insulin	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
30.7692307692%	4	13	38	Diabetes_McGill_Insulin	KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT
30.7692307692%	4	13	279	Diabetes_McGill_Insulin	REACTOME_NEURONAL_SYSTEM
30.7692307692%	4	13	1972	Diabetes_McGill_Insulin	PILON_KLF1_TARGETS_DN
30.7692307692%	4	13	19	Diabetes_McGill_Insulin	REACTOME_BOTULINUM_NEUROTOXICITY
30.7692307692%	4	13	1781	Diabetes_McGill_Insulin	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
30.7692307692%	4	13	17	Diabetes_McGill_Insulin	REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS
30.7692307692%	4	13	1237	Diabetes_McGill_Insulin	BLALOCK_ALZHEIMERS_DISEASE_DN
30.7692307692%	4	13	1229	Diabetes_McGill_Insulin	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
30.7692307692%	4	13	120	Diabetes_McGill_Insulin	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
30.7692307692%	12	39	51	Diabetes_McGill_IL6	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
30.7692307692%	12	39	466	Diabetes_McGill_IL6	REACTOME_HEMOSTASIS
30.7692307692%	12	39	22	Diabetes_McGill_IL6	BIOCARTA_IL6_PATHWAY
30.7692307692%	12	39	137	Diabetes_McGill_IL6	KEGG_INSULIN_SIGNALING_PATHWAY
30.7692307692%	12	39	107	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_ILS
30.6451612903%	38	124	192	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_DNA_REPLICATION
30.6451612903%	38	124	112	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_G1_S_TRANSITION
30.4347826087%	7	23	95	Diabetes_McGill_Mtor_pathway	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
30.4347826087%	7	23	90	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALING_BY_ERBB4
30.4347826087%	7	23	80	Diabetes_McGill_Mtor_pathway	PID_MET_PATHWAY
30.4347826087%	7	23	78	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALING_BY_SCF_KIT
30.4347826087%	7	23	775	Diabetes_McGill_Mtor_pathway	BENPORATH_MYC_MAX_TARGETS
30.4347826087%	7	23	722	Diabetes_McGill_Mtor_pathway	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
30.4347826087%	7	23	67	Diabetes_McGill_Mtor_pathway	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
30.4347826087%	7	23	56	Diabetes_McGill_Mtor_pathway	REACTOME_PI_3K_CASCADE
30.4347826087%	7	23	44	Diabetes_McGill_Mtor_pathway	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
30.4347826087%	7	23	38	Diabetes_McGill_Mtor_pathway	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
30.4347826087%	7	23	38	Diabetes_McGill_Mtor_pathway	REACTOME_PI3K_AKT_ACTIVATION
30.4347826087%	7	23	38	Diabetes_McGill_Mtor_pathway	REACTOME_GAB1_SIGNALOSOME
30.4347826087%	7	23	34	Diabetes_McGill_Mtor_pathway	PID_IL2_PI3KPATHWAY
30.4347826087%	7	23	176	Diabetes_McGill_Mtor_pathway	REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION
30.4347826087%	7	23	16	Diabetes_McGill_Mtor_pathway	BIOCARTA_EIF_PATHWAY
30.4347826087%	7	23	122	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALING_BY_PDGF
30.4347826087%	7	23	11	Diabetes_McGill_Mtor_pathway	REACTOME_MTORC1_MEDIATED_SIGNALLING
30.4347826087%	7	23	109	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
30.4347826087%	7	23	105	Diabetes_McGill_Mtor_pathway	PID_ERBB1_DOWNSTREAM_PATHWAY
30.4347826087%	7	23	101	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALING_BY_ERBB2
30.4347826087%	7	23	100	Diabetes_McGill_Mtor_pathway	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
30.0%	3	10	98	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
30.0%	3	10	79	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT
30.0%	3	10	720	Mendelian_Disorders_of_Fatty_Acid_Oxidation	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
30.0%	3	10	69	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KEGG_PPAR_SIGNALING_PATHWAY
30.0%	3	10	663	Mendelian_Disorders_of_Fatty_Acid_Oxidation	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
30.0%	3	10	58	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LUCAS_HNF4A_TARGETS_UP
30.0%	3	10	546	Mendelian_Disorders_of_Fatty_Acid_Oxidation	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
30.0%	3	10	540	Mendelian_Disorders_of_Fatty_Acid_Oxidation	ACEVEDO_LIVER_CANCER_DN
30.0%	3	10	45	Mendelian_Disorders_of_Fatty_Acid_Oxidation	PID_HNF3BPATHWAY
30.0%	3	10	44	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
30.0%	3	10	326	Mendelian_Disorders_of_Fatty_Acid_Oxidation	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
30.0%	3	10	267	Mendelian_Disorders_of_Fatty_Acid_Oxidation	CAIRO_HEPATOBLASTOMA_DN
30.0%	3	10	266	Mendelian_Disorders_of_Fatty_Acid_Oxidation	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
30.0%	3	10	261	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
30.0%	3	10	19	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE
30.0%	3	10	1652	Mendelian_Disorders_of_Fatty_Acid_Oxidation	PUJANA_BRCA1_PCC_NETWORK
30.0%	3	10	15	Mendelian_Disorders_of_Fatty_Acid_Oxidation	SANDERSON_PPARA_TARGETS
30.0%	3	10	141	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
30.0%	3	10	14	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION
30.0%	3	10	1305	Mendelian_Disorders_of_Fatty_Acid_Oxidation	YOSHIMURA_MAPK8_TARGETS_UP
30.0%	3	10	126	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BURTON_ADIPOGENESIS_5
30.0%	3	10	104	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
29.8387096774%	37	124	342	Diabetes_McGill_Cell_cycle_All_Gene	BLUM_RESPONSE_TO_SALIRASIB_DN
29.6296296296%	8	27	8	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BIOCARTA_KREB_PATHWAY
29.6296296296%	8	27	40	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_PYRUVATE_METABOLISM
29.6296296296%	8	27	261	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
29.6296296296%	8	27	1652	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PUJANA_BRCA1_PCC_NETWORK
29.4117647059%	5	17	957	Mendelian_Blood_Desease	LOPEZ_MBD_TARGETS
29.4117647059%	5	17	682	Mendelian_Blood_Desease	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
29.4117647059%	5	17	564	Mendelian_Severe_Combined_Immunodeficiency	SMID_BREAST_CANCER_LUMINAL_B_DN
29.4117647059%	5	17	55	Mendelian_Blood_Desease	TIEN_INTESTINE_PROBIOTICS_6HR_UP
29.4117647059%	5	17	543	Mendelian_Blood_Desease	MARTINEZ_RB1_TARGETS_DN
29.4117647059%	5	17	406	Mendelian_Blood_Desease	OSMAN_BLADDER_CANCER_DN
29.4117647059%	5	17	299	Mendelian_Severe_Combined_Immunodeficiency	WALLACE_PROSTATE_CANCER_RACE_UP
29.4117647059%	5	17	259	Mendelian_Severe_Combined_Immunodeficiency	QI_PLASMACYTOMA_UP
29.4117647059%	5	17	237	Mendelian_Severe_Combined_Immunodeficiency	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
29.4117647059%	5	17	1972	Mendelian_Severe_Combined_Immunodeficiency	PILON_KLF1_TARGETS_DN
29.4117647059%	5	17	1652	Mendelian_Severe_Combined_Immunodeficiency	PUJANA_BRCA1_PCC_NETWORK
29.4117647059%	5	17	146	Mendelian_Blood_Desease	PECE_MAMMARY_STEM_CELL_DN
29.4117647059%	5	17	1442	Mendelian_Blood_Desease	PUJANA_ATM_PCC_NETWORK
29.1666666667%	7	24	87	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_MAPK_PATHWAY
29.1666666667%	7	24	71	Diabetes_McGill_TNF_alpha_signalin	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
29.1666666667%	7	24	65	Diabetes_McGill_TNF_alpha_signalin	ST_FAS_SIGNALING_PATHWAY
29.1666666667%	7	24	567	Diabetes_McGill_TNF_alpha_signalin	PARENT_MTOR_SIGNALING_UP
29.1666666667%	7	24	53	Diabetes_McGill_TNF_alpha_signalin	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
29.1666666667%	7	24	30	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_FAS_PATHWAY
29.1666666667%	7	24	28	Diabetes_McGill_TNF_alpha_signalin	PID_TRAIL_PATHWAY
29.1666666667%	7	24	23	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_NFKB_PATHWAY
29.1666666667%	7	24	21	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_MITOCHONDRIA_PATHWAY
29.1666666667%	7	24	16	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_RELA_PATHWAY
29.1666666667%	7	24	13	Diabetes_McGill_TNF_alpha_signalin	REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS
29.1666666667%	7	24	128	Diabetes_McGill_TNF_alpha_signalin	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
29.0322580645%	9	31	87	Diabetes_McGill_IL10	KEGG_ERBB_SIGNALING_PATHWAY
29.0322580645%	9	31	73	Diabetes_McGill_IL10	KEGG_CHRONIC_MYELOID_LEUKEMIA
29.0322580645%	9	31	70	Diabetes_McGill_IL10	KEGG_PANCREATIC_CANCER
29.0322580645%	9	31	47	Diabetes_McGill_IL10	PID_IL6_7PATHWAY
29.0322580645%	9	31	409	Diabetes_McGill_IL10	FOSTER_TOLERANT_MACROPHAGE_DN
29.0322580645%	9	31	201	Diabetes_McGill_IL10	KEGG_FOCAL_ADHESION
29.0322580645%	9	31	1691	Diabetes_McGill_IL10	BLALOCK_ALZHEIMERS_DISEASE_UP
29.0322580645%	9	31	115	Diabetes_McGill_IL10	MARZEC_IL2_SIGNALING_UP
29.0322580645%	36	124	1972	Diabetes_McGill_Cell_cycle_All_Gene	PILON_KLF1_TARGETS_DN
28.5714285714%	8	28	855	Diabetes_McGill_Cell_cycle_G1	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
28.5714285714%	8	28	82	Diabetes_McGill_Cell_cycle_G1	PID_SMAD2_3NUCLEARPATHWAY
28.5714285714%	8	28	71	Diabetes_McGill_Cell_cycle_G1	KEGG_MELANOMA
28.5714285714%	8	28	68	Diabetes_McGill_Cell_cycle_G1	PID_TELOMERASEPATHWAY
28.5714285714%	8	28	65	Diabetes_McGill_Cell_cycle_G1	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
28.5714285714%	8	28	65	Diabetes_McGill_Cell_cycle_G1	KEGG_GLIOMA
28.5714285714%	8	28	637	Diabetes_McGill_Cell_cycle_G1	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
28.5714285714%	8	28	62	Diabetes_McGill_Cell_cycle_G1	KEGG_COLORECTAL_CANCER
28.5714285714%	8	28	59	Diabetes_McGill_Cell_cycle_G1	PID_P53REGULATIONPATHWAY
28.5714285714%	8	28	40	Diabetes_McGill_Cell_cycle_G1	PID_FOXM1PATHWAY
28.5714285714%	8	28	35	Diabetes_McGill_Cell_cycle_G1	REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION
28.5714285714%	8	28	342	Diabetes_McGill_Cell_cycle_G1	BLUM_RESPONSE_TO_SALIRASIB_DN
28.5714285714%	8	28	25	Diabetes_McGill_Cell_cycle_G1	REACTOME_G0_AND_EARLY_G1
28.5714285714%	8	28	1781	Diabetes_McGill_Cell_cycle_G1	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
28.5714285714%	8	28	15	Diabetes_McGill_Cell_cycle_G1	SA_G1_AND_S_PHASES
28.5714285714%	8	28	1305	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	YOSHIMURA_MAPK8_TARGETS_UP
28.5714285714%	8	28	13	Diabetes_McGill_Cell_cycle_G1	SA_REG_CASCADE_OF_CYCLIN_EXPR
28.5714285714%	2	7	79	Diabetes_McGill_Insulin_exocytosi	MCCLUNG_COCAINE_REWARD_5D
28.5714285714%	2	7	745	Mendelian_Lipoprotein_deficiency	LEE_BMP2_TARGETS_UP
28.5714285714%	2	7	74	Mendelian_Lipoprotein_deficiency	URS_ADIPOCYTE_DIFFERENTIATION_UP
28.5714285714%	2	7	69	Mendelian_Lipoprotein_deficiency	KEGG_PPAR_SIGNALING_PATHWAY
28.5714285714%	2	7	682	Mendelian_Lipoprotein_deficiency	FEVR_CTNNB1_TARGETS_UP
28.5714285714%	2	7	652	Mendelian_Disorders_of_Phosphorous_Metabolism	BENPORATH_PRC2_TARGETS
28.5714285714%	2	7	590	Diabetes_McGill_Insulin_exocytosi	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
28.5714285714%	2	7	58	Mendelian_Lipoprotein_deficiency	BIOCARTA_PPARA_PATHWAY
28.5714285714%	2	7	578	Mendelian_Lipoprotein_deficiency	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
28.5714285714%	2	7	548	Diabetes_McGill_Insulin_exocytosi	KIM_ALL_DISORDERS_CALB1_CORR_UP
28.5714285714%	2	7	466	Mendelian_Lipoprotein_deficiency	REACTOME_HEMOSTASIS
28.5714285714%	2	7	425	Mendelian_Lipoprotein_deficiency	BOCHKIS_FOXA2_TARGETS
28.5714285714%	2	7	367	Mendelian_Lipoprotein_deficiency	VECCHI_GASTRIC_CANCER_EARLY_DN
28.5714285714%	2	7	276	Mendelian_Disorders_of_Phosphorous_Metabolism	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
28.5714285714%	2	7	274	Mendelian_Lipoprotein_deficiency	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
28.5714285714%	2	7	266	Mendelian_Lipoprotein_deficiency	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
28.5714285714%	2	7	261	Mendelian_Lipoprotein_deficiency	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
28.5714285714%	2	7	222	Mendelian_Lipoprotein_deficiency	CAIRO_LIVER_DEVELOPMENT_DN
28.5714285714%	2	7	189	Mendelian_Lipoprotein_deficiency	BURTON_ADIPOGENESIS_6
28.5714285714%	2	7	1839	Mendelian_Disorders_of_Phosphorous_Metabolism	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
28.5714285714%	2	7	1725	Diabetes_McGill_Insulin_exocytosi	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
28.5714285714%	2	7	1691	Mendelian_Lipoprotein_deficiency	BLALOCK_ALZHEIMERS_DISEASE_UP
28.5714285714%	2	7	168	Mendelian_Lipoprotein_deficiency	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
28.5714285714%	2	7	158	Mendelian_Lipoprotein_deficiency	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
28.5714285714%	2	7	126	Mendelian_Lipoprotein_deficiency	GERY_CEBP_TARGETS
28.5714285714%	2	7	1118	Mendelian_Disorders_of_Phosphorous_Metabolism	BENPORATH_ES_WITH_H3K27ME3
28.5714285714%	2	7	1118	Diabetes_McGill_Insulin_exocytosi	BENPORATH_ES_WITH_H3K27ME3
28.5714285714%	2	7	1062	Mendelian_Disorders_of_Phosphorous_Metabolism	BENPORATH_EED_TARGETS
28.5714285714%	2	7	104	Mendelian_Lipoprotein_deficiency	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
28.5714285714%	2	7	1038	Mendelian_Disorders_of_Phosphorous_Metabolism	BENPORATH_SUZ12_TARGETS
28.5714285714%	2	7	1011	Mendelian_Lipoprotein_deficiency	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
28.2051282051%	11	39	78	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_SCF_KIT
28.2051282051%	11	39	73	Diabetes_McGill_IL6	KEGG_CHRONIC_MYELOID_LEUKEMIA
28.2051282051%	11	39	539	Diabetes_McGill_IL6	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
28.2051282051%	11	39	36	Diabetes_McGill_IL6	PID_PI3KPLCTRKPATHWAY
28.2051282051%	11	39	35	Diabetes_McGill_IL6	PID_PI3KCIAKTPATHWAY
28.2051282051%	11	39	217	Diabetes_McGill_IL6	REACTOME_SIGNALLING_BY_NGF
28.2051282051%	11	39	208	Diabetes_McGill_IL6	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
28.125%	9	32	178	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_CALCIUM_SIGNALING_PATHWAY
28.125%	9	32	1118	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BENPORATH_ES_WITH_H3K27ME3
27.4193548387%	34	124	456	Diabetes_McGill_Cell_cycle_All_Gene	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
27.4193548387%	34	124	109	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_S_PHASE
27.2727272727%	9	33	244	Mendelian_Metabolism	HSIAO_LIVER_SPECIFIC_GENES
27.2727272727%	3	11	90	Mendelian_Diamond-Blackfan_Anemia	HILLION_HMGA1_TARGETS
27.2727272727%	3	11	668	Mendelian_Diamond-Blackfan_Anemia	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
27.2727272727%	3	11	59	Mendelian_Diamond-Blackfan_Anemia	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
27.2727272727%	3	11	53	Mendelian_Diamond-Blackfan_Anemia	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP
27.2727272727%	3	11	526	Mendelian_Diamond-Blackfan_Anemia	ONKEN_UVEAL_MELANOMA_DN
27.2727272727%	3	11	52	Mendelian_Diamond-Blackfan_Anemia	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP
27.2727272727%	3	11	517	Mendelian_Diamond-Blackfan_Anemia	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
27.2727272727%	3	11	487	Mendelian_Diamond-Blackfan_Anemia	RODWELL_AGING_KIDNEY_UP
27.2727272727%	3	11	236	Mendelian_Diamond-Blackfan_Anemia	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
27.2727272727%	3	11	203	Mendelian_Diamond-Blackfan_Anemia	GRUETZMANN_PANCREATIC_CANCER_DN
27.2727272727%	3	11	1691	Mendelian_Diamond-Blackfan_Anemia	BLALOCK_ALZHEIMERS_DISEASE_UP
27.2727272727%	3	11	1375	Mendelian_Diamond-Blackfan_Anemia	DODD_NASOPHARYNGEAL_CARCINOMA_DN
27.1428571429%	19	70	328	Diabetes_McGill_Adipocytokine_signallin	KEGG_PATHWAYS_IN_CANCER
27.027027027%	10	37	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_HNF3BPATHWAY
27.027027027%	10	37	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
27.027027027%	10	37	1118	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BENPORATH_ES_WITH_H3K27ME3
27.027027027%	10	37	1062	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BENPORATH_EED_TARGETS
26.9230769231%	7	26	75	Diabetes_McGill_Set_Wnt_pathway	KEGG_ADHERENS_JUNCTION
26.9230769231%	7	26	65	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SIGNALING_BY_WNT
26.9230769231%	7	26	52	Diabetes_McGill_Set_Wnt_pathway	KEGG_ENDOMETRIAL_CANCER
26.9230769231%	7	26	38	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS
26.9230769231%	7	26	1972	Diabetes_McGill_Set_Wnt_pathway	PILON_KLF1_TARGETS_DN
26.9230769231%	7	26	18	Diabetes_McGill_Set_Wnt_pathway	PID_BETACATENIN_DEG_PATHWAY
26.9230769231%	7	26	1781	Diabetes_McGill_Set_Wnt_pathway	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
26.9230769231%	7	26	121	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS
26.9230769231%	7	26	120	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
26.9230769231%	7	26	1118	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BENPORATH_ES_WITH_H3K27ME3
26.9230769231%	7	26	1062	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BENPORATH_EED_TARGETS
26.9230769231%	7	26	1038	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BENPORATH_SUZ12_TARGETS
26.9230769231%	7	26	102	Diabetes_McGill_Set_Wnt_pathway	KEGG_MELANOGENESIS
26.8774703557%	68	253	1691	Diabetes_McGill_CREBBP_coTF	BLALOCK_ALZHEIMERS_DISEASE_UP
26.8292682927%	11	41	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_HNF3BPATHWAY
26.8292682927%	11	41	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
26.6666666667%	8	30	1382	Mendelian_Hereditary_Sensory_Neuropathy	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
26.6666666667%	4	15	668	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
26.6666666667%	4	15	394	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BERENJENO_TRANSFORMED_BY_RHOA_DN
26.6666666667%	4	15	356	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
26.6666666667%	4	15	178	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KEGG_CALCIUM_SIGNALING_PATHWAY
26.6129032258%	33	124	605	Diabetes_McGill_Cell_cycle_All_Gene	CAIRO_HEPATOBLASTOMA_CLASSES_UP
26.6129032258%	33	124	553	Diabetes_McGill_Cell_cycle_All_Gene	FEVR_CTNNB1_TARGETS_DN
26.6129032258%	33	124	1103	Diabetes_McGill_Cell_cycle_All_Gene	DANG_BOUND_BY_MYC
26.0869565217%	6	23	89	Diabetes_McGill_Mtor_pathway	KEGG_PROSTATE_CANCER
26.0869565217%	6	23	87	Diabetes_McGill_Mtor_pathway	KEGG_ERBB_SIGNALING_PATHWAY
26.0869565217%	6	23	66	Diabetes_McGill_Mtor_pathway	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES
26.0869565217%	6	23	63	Diabetes_McGill_Mtor_pathway	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
26.0869565217%	6	23	60	Diabetes_McGill_Mtor_pathway	KEGG_ACUTE_MYELOID_LEUKEMIA
26.0869565217%	6	23	526	Diabetes_McGill_Mtor_pathway	ONKEN_UVEAL_MELANOMA_DN
26.0869565217%	6	23	52	Diabetes_McGill_Mtor_pathway	PID_KITPATHWAY
26.0869565217%	6	23	45	Diabetes_McGill_Mtor_pathway	PID_INSULIN_PATHWAY
26.0869565217%	6	23	23	Diabetes_McGill_Mtor_pathway	BIOCARTA_CTCF_PATHWAY
26.0869565217%	6	23	18	Diabetes_McGill_Mtor_pathway	BIOCARTA_PTEN_PATHWAY
26.0869565217%	6	23	159	Diabetes_McGill_Mtor_pathway	REACTOME_INTERFERON_SIGNALING
26.0869565217%	6	23	126	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
26.0869565217%	6	23	102	Diabetes_McGill_Mtor_pathway	PID_CXCR4_PATHWAY
25.9259259259%	7	27	62	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
25.9259259259%	7	27	247	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_METABOLISM_OF_CARBOHYDRATES
25.8064516129%	8	31	84	Diabetes_McGill_IL10	KEGG_SMALL_CELL_LUNG_CANCER
25.8064516129%	8	31	79	Diabetes_McGill_IL10	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
25.8064516129%	8	31	270	Diabetes_McGill_IL10	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
25.8064516129%	8	31	137	Diabetes_McGill_IL10	KEGG_INSULIN_SIGNALING_PATHWAY
25.8064516129%	8	31	129	Diabetes_McGill_IL10	PID_PDGFRBPATHWAY
25.8064516129%	8	31	108	Diabetes_McGill_IL10	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
25.8064516129%	8	31	107	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_ILS
25.8064516129%	8	31	102	Diabetes_McGill_IL10	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
25.8064516129%	32	124	728	Diabetes_McGill_Cell_cycle_All_Gene	MARSON_BOUND_BY_E2F4_UNSTIMULATED
25.8064516129%	32	124	328	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_PATHWAYS_IN_CANCER
25.8064516129%	32	124	1781	Diabetes_McGill_Cell_cycle_All_Gene	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
25.8064516129%	32	124	172	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_MITOTIC_M_M_G1_PHASES
25.8064516129%	32	124	1382	Diabetes_McGill_Cell_cycle_All_Gene	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
25.641025641%	10	39	65	Diabetes_McGill_IL6	PID_IL4_2PATHWAY
25.641025641%	10	39	38	Diabetes_McGill_IL6	BIOCARTA_IL2RB_PATHWAY
25.641025641%	10	39	27	Diabetes_McGill_IL6	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
25.641025641%	10	39	267	Diabetes_McGill_IL6	KEGG_MAPK_SIGNALING_PATHWAY
25.641025641%	10	39	1972	Diabetes_McGill_IL6	PILON_KLF1_TARGETS_DN
25.641025641%	10	39	1781	Diabetes_McGill_IL6	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
25.641025641%	10	39	137	Diabetes_McGill_IL6	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
25.641025641%	10	39	1037	Diabetes_McGill_IL6	NUYTTEN_EZH2_TARGETS_UP
25.0%	8	32	590	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
25.0%	8	32	1038	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BENPORATH_SUZ12_TARGETS
25.0%	7	28	957	Diabetes_McGill_Cell_cycle_G1	LOPEZ_MBD_TARGETS
25.0%	7	28	86	Diabetes_McGill_Cell_cycle_G1	KEGG_TGF_BETA_SIGNALING_PATHWAY
25.0%	7	28	673	Diabetes_McGill_Cell_cycle_G1	MARTINEZ_RB1_TARGETS_UP
25.0%	7	28	648	Diabetes_McGill_Cell_cycle_G1	SMID_BREAST_CANCER_BASAL_UP
25.0%	7	28	63	Diabetes_McGill_Cell_cycle_G1	PID_MYC_REPRESSPATHWAY
25.0%	7	28	593	Diabetes_McGill_Cell_cycle_G1	MARTINEZ_TP53_TARGETS_DN
25.0%	7	28	570	Diabetes_McGill_Cell_cycle_G1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
25.0%	7	28	54	Diabetes_McGill_Cell_cycle_G1	KEGG_NON_SMALL_CELL_LUNG_CANCER
25.0%	7	28	536	Diabetes_McGill_Cell_cycle_G1	BERENJENO_TRANSFORMED_BY_RHOA_UP
25.0%	7	28	505	Diabetes_McGill_Cell_cycle_G1	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
25.0%	7	28	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_TYPE_II_DIABETES_MELLITUS
25.0%	7	28	466	Diabetes_McGill_Cell_cycle_G1	REACTOME_HEMOSTASIS
25.0%	7	28	423	Diabetes_McGill_Cell_cycle_G1	PUJANA_BRCA2_PCC_NETWORK
25.0%	7	28	42	Diabetes_McGill_Cell_cycle_G1	KEGG_BLADDER_CANCER
25.0%	7	28	251	Diabetes_McGill_Cell_cycle_G1	KOBAYASHI_EGFR_SIGNALING_24HR_DN
25.0%	7	28	242	Diabetes_McGill_Cell_cycle_G1	WINTER_HYPOXIA_METAGENE
25.0%	7	28	23	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_CTCF_PATHWAY
25.0%	7	28	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
25.0%	7	28	19	Diabetes_McGill_Cell_cycle_G1	REACTOME_G1_S_SPECIFIC_TRANSCRIPTION
25.0%	7	28	1375	Diabetes_McGill_Cell_cycle_G1	DODD_NASOPHARYNGEAL_CARCINOMA_DN
25.0%	7	28	13	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_P27_PATHWAY
25.0%	7	28	117	Diabetes_McGill_Cell_cycle_G1	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
25.0%	7	28	1069	Diabetes_McGill_Cell_cycle_G1	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
25.0%	7	28	10	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_SKP2E2F_PATHWAY
25.0%	6	24	74	Diabetes_McGill_TNF_alpha_signalin	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
25.0%	6	24	67	Diabetes_McGill_TNF_alpha_signalin	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
25.0%	6	24	62	Diabetes_McGill_TNF_alpha_signalin	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
25.0%	6	24	30	Diabetes_McGill_TNF_alpha_signalin	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
25.0%	6	24	23	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_CASPASE_PATHWAY
25.0%	6	24	225	Diabetes_McGill_TNF_alpha_signalin	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
25.0%	6	24	22	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_CHEMICAL_PATHWAY
25.0%	6	24	1442	Diabetes_McGill_TNF_alpha_signalin	PUJANA_ATM_PCC_NETWORK
25.0%	6	24	117	Diabetes_McGill_TNF_alpha_signalin	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
25.0%	6	24	1103	Diabetes_McGill_TNF_alpha_signalin	DANG_BOUND_BY_MYC
25.0%	31	124	747	Diabetes_McGill_Cell_cycle_All_Gene	PATIL_LIVER_CANCER
25.0%	31	124	536	Diabetes_McGill_Cell_cycle_All_Gene	BERENJENO_TRANSFORMED_BY_RHOA_UP
25.0%	31	124	335	Diabetes_McGill_Cell_cycle_All_Gene	WONG_EMBRYONIC_STEM_CELL_CORE
25.0%	31	124	1691	Diabetes_McGill_Cell_cycle_All_Gene	BLALOCK_ALZHEIMERS_DISEASE_UP
25.0%	31	124	1024	Diabetes_McGill_Cell_cycle_All_Gene	NUYTTEN_EZH2_TARGETS_DN
25.0%	3	12	933	Diabetes_McGill_Adipocytokines	REACTOME_IMMUNE_SYSTEM
25.0%	3	12	920	Diabetes_McGill_Adipocytokines	REACTOME_SIGNALING_BY_GPCR
25.0%	3	12	91	Diabetes_McGill_Adipocytokines	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
25.0%	3	12	84	Diabetes_McGill_Adipocytokines	HINATA_NFKB_TARGETS_FIBROBLAST_UP
25.0%	3	12	81	Diabetes_McGill_Adipocytokines	HARRIS_HYPOXIA
25.0%	3	12	805	Diabetes_McGill_Adipocytokines	REACTOME_GPCR_DOWNSTREAM_SIGNALING
25.0%	3	12	77	Diabetes_McGill_Adipocytokines	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
25.0%	3	12	69	Mendelian_Etc	REACTOME_SPHINGOLIPID_METABOLISM
25.0%	3	12	68	Diabetes_McGill_Adipocytokines	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
25.0%	3	12	658	Diabetes_McGill_Adipocytokines	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
25.0%	3	12	634	Diabetes_McGill_Adipocytokines	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
25.0%	3	12	61	Diabetes_McGill_Adipocytokines	BROWNE_HCMV_INFECTION_1HR_UP
25.0%	3	12	57	Diabetes_McGill_Adipocytokines	REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
25.0%	3	12	516	Diabetes_McGill_Adipocytokines	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
25.0%	3	12	508	Diabetes_McGill_Adipocytokines	ENK_UV_RESPONSE_EPIDERMIS_DN
25.0%	3	12	501	Diabetes_McGill_Adipocytokines	SENESE_HDAC3_TARGETS_UP
25.0%	3	12	485	Diabetes_McGill_Adipocytokines	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
25.0%	3	12	478	Mendelian_Etc	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
25.0%	3	12	47	Diabetes_McGill_Adipocytokines	PID_IL6_7PATHWAY
25.0%	3	12	44	Diabetes_McGill_Adipocytokines	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS
25.0%	3	12	425	Diabetes_McGill_Adipocytokines	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
25.0%	3	12	425	Diabetes_McGill_Adipocytokines	BOCHKIS_FOXA2_TARGETS
25.0%	3	12	408	Diabetes_McGill_Adipocytokines	REACTOME_GPCR_LIGAND_BINDING
25.0%	3	12	38	Mendelian_Etc	REACTOME_GLYCOSPHINGOLIPID_METABOLISM
25.0%	3	12	366	Diabetes_McGill_Adipocytokines	YOSHIMURA_MAPK8_TARGETS_DN
25.0%	3	12	328	Diabetes_McGill_Adipocytokines	KEGG_PATHWAYS_IN_CANCER
25.0%	3	12	305	Diabetes_McGill_Adipocytokines	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
25.0%	3	12	29	Diabetes_McGill_Adipocytokines	KRIGE_AMINO_ACID_DEPRIVATION
25.0%	3	12	270	Diabetes_McGill_Adipocytokines	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
25.0%	3	12	261	Diabetes_McGill_Adipocytokines	BILD_HRAS_ONCOGENIC_SIGNATURE
25.0%	3	12	253	Diabetes_McGill_Adipocytokines	MCLACHLAN_DENTAL_CARIES_UP
25.0%	3	12	242	Diabetes_McGill_Adipocytokines	WINTER_HYPOXIA_METAGENE
25.0%	3	12	225	Mendelian_Etc	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
25.0%	3	12	22	Diabetes_McGill_Adipocytokines	BIOCARTA_IL6_PATHWAY
25.0%	3	12	22	Diabetes_McGill_Adipocytokines	BIOCARTA_HER2_PATHWAY
25.0%	3	12	198	Mendelian_Etc	REACTOME_PHOSPHOLIPID_METABOLISM
25.0%	3	12	195	Diabetes_McGill_Adipocytokines	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
25.0%	3	12	190	Diabetes_McGill_Adipocytokines	KEGG_CHEMOKINE_SIGNALING_PATHWAY
25.0%	3	12	188	Diabetes_McGill_Adipocytokines	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
25.0%	3	12	1839	Mendelian_Etc	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
25.0%	3	12	1725	Diabetes_McGill_Adipocytokines	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
25.0%	3	12	158	Diabetes_McGill_Adipocytokines	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
25.0%	3	12	155	Diabetes_McGill_Adipocytokines	KEGG_JAK_STAT_SIGNALING_PATHWAY
25.0%	3	12	1382	Mendelian_Etc	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
25.0%	3	12	138	Diabetes_McGill_Adipocytokines	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
25.0%	3	12	1305	Mendelian_Etc	YOSHIMURA_MAPK8_TARGETS_UP
25.0%	3	12	13	Diabetes_McGill_Adipocytokines	MARTINELLI_IMMATURE_NEUTROPHIL_DN
25.0%	3	12	128	Diabetes_McGill_Adipocytokines	LENAOUR_DENDRITIC_CELL_MATURATION_DN
25.0%	3	12	128	Diabetes_McGill_Adipocytokines	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
25.0%	3	12	121	Mendelian_Etc	KEGG_LYSOSOME
25.0%	3	12	117	Diabetes_McGill_Adipocytokines	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
25.0%	3	12	1142	Diabetes_McGill_Adipocytokines	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
25.0%	3	12	114	Diabetes_McGill_Adipocytokines	SENESE_HDAC2_TARGETS_UP
25.0%	3	12	110	Diabetes_McGill_Adipocytokines	GHANDHI_DIRECT_IRRADIATION_UP
25.0%	3	12	11	Diabetes_McGill_Adipocytokines	REACTOME_IL_6_SIGNALING
25.0%	3	12	107	Diabetes_McGill_Adipocytokines	REACTOME_SIGNALING_BY_ILS
25.0%	2	8	98	Mendelian_Long_QT_syndrome	REACTOME_POTASSIUM_CHANNELS
25.0%	2	8	957	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	LOPEZ_MBD_TARGETS
25.0%	2	8	898	Mendelian_Long_QT_syndrome	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
25.0%	2	8	898	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
25.0%	2	8	863	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
25.0%	2	8	80	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	WOO_LIVER_CANCER_RECURRENCE_DN
25.0%	2	8	74	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	LEE_LIVER_CANCER_DENA_DN
25.0%	2	8	70	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	REACTOME_PHASE_II_CONJUGATION
25.0%	2	8	682	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
25.0%	2	8	682	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	FEVR_CTNNB1_TARGETS_UP
25.0%	2	8	590	Mendelian_Long_QT_syndrome	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
25.0%	2	8	584	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
25.0%	2	8	567	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	PARENT_MTOR_SIGNALING_UP
25.0%	2	8	540	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	ACEVEDO_LIVER_CANCER_DN
25.0%	2	8	539	Mendelian_Long_QT_syndrome	LIAO_METASTASIS
25.0%	2	8	536	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
25.0%	2	8	510	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
25.0%	2	8	51	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
25.0%	2	8	46	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KRASNOSELSKAYA_ILF3_TARGETS_DN
25.0%	2	8	447	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MOOTHA_MITOCHONDRIA
25.0%	2	8	43	Mendelian_Long_QT_syndrome	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS
25.0%	2	8	429	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MOOTHA_HUMAN_MITODB_6_2002
25.0%	2	8	425	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BOCHKIS_FOXA2_TARGETS
25.0%	2	8	349	Mendelian_Long_QT_syndrome	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
25.0%	2	8	34	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KEGG_CYSTEINE_AND_METHIONINE_METABOLISM
25.0%	2	8	315	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
25.0%	2	8	309	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
25.0%	2	8	279	Mendelian_Long_QT_syndrome	REACTOME_NEURONAL_SYSTEM
25.0%	2	8	267	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	HOLLMANN_APOPTOSIS_VIA_CD40_DN
25.0%	2	8	26	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KEGG_SELENOAMINO_ACID_METABOLISM
25.0%	2	8	24	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	REACTOME_SULFUR_AMINO_ACID_METABOLISM
25.0%	2	8	234	Mendelian_Long_QT_syndrome	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
25.0%	2	8	214	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
25.0%	2	8	203	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	GRUETZMANN_PANCREATIC_CANCER_DN
25.0%	2	8	185	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
25.0%	2	8	1821	Mendelian_Long_QT_syndrome	DODD_NASOPHARYNGEAL_CARCINOMA_UP
25.0%	2	8	1821	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	DODD_NASOPHARYNGEAL_CARCINOMA_UP
25.0%	2	8	1725	Mendelian_Long_QT_syndrome	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
25.0%	2	8	142	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	PENG_LEUCINE_DEPRIVATION_UP
25.0%	2	8	139	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	REACTOME_BIOLOGICAL_OXIDATIONS
25.0%	2	8	1305	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	YOSHIMURA_MAPK8_TARGETS_UP
25.0%	2	8	129	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BROWN_MYELOID_CELL_DEVELOPMENT_DN
25.0%	2	8	1137	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BRUINS_UVC_RESPONSE_LATE
25.0%	2	8	1118	Mendelian_Long_QT_syndrome	BENPORATH_ES_WITH_H3K27ME3
25.0%	2	8	1062	Mendelian_Long_QT_syndrome	BENPORATH_EED_TARGETS
24.3902439024%	10	41	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG
24.3902439024%	10	41	1118	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BENPORATH_ES_WITH_H3K27ME3
24.3902439024%	10	41	1062	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BENPORATH_EED_TARGETS
24.3243243243%	9	37	652	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BENPORATH_PRC2_TARGETS
24.3243243243%	9	37	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_TYPE_II_DIABETES_MELLITUS
24.3243243243%	9	37	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG
24.3243243243%	9	37	1038	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BENPORATH_SUZ12_TARGETS
24.2424242424%	8	33	933	Diabetes_McGill_ER_Stress	REACTOME_IMMUNE_SYSTEM
24.2424242424%	8	33	478	Mendelian_Metabolism	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
24.2424242424%	8	33	267	Mendelian_Metabolism	CAIRO_HEPATOBLASTOMA_DN
24.2424242424%	8	33	1305	Mendelian_Metabolism	YOSHIMURA_MAPK8_TARGETS_UP
24.1935483871%	30	124	251	Diabetes_McGill_Cell_cycle_All_Gene	KOBAYASHI_EGFR_SIGNALING_24HR_DN
24.1935483871%	30	124	101	Diabetes_McGill_Cell_cycle_All_Gene	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
23.8095238095%	10	42	1972	Diabetes_McGill_RAS	PILON_KLF1_TARGETS_DN
23.5294117647%	4	17	89	Mendelian_Severe_Combined_Immunodeficiency	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION
23.5294117647%	4	17	863	Mendelian_Blood_Desease	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
23.5294117647%	4	17	775	Mendelian_Blood_Desease	BENPORATH_MYC_MAX_TARGETS
23.5294117647%	4	17	756	Mendelian_Blood_Desease	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
23.5294117647%	4	17	658	Mendelian_Severe_Combined_Immunodeficiency	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
23.5294117647%	4	17	593	Mendelian_Blood_Desease	MARTINEZ_TP53_TARGETS_DN
23.5294117647%	4	17	591	Mendelian_Blood_Desease	MARTINEZ_RB1_AND_TP53_TARGETS_DN
23.5294117647%	4	17	526	Mendelian_Blood_Desease	ONKEN_UVEAL_MELANOMA_DN
23.5294117647%	4	17	52	Mendelian_Severe_Combined_Immunodeficiency	VILIMAS_NOTCH1_TARGETS_UP
23.5294117647%	4	17	487	Mendelian_Blood_Desease	RODWELL_AGING_KIDNEY_UP
23.5294117647%	4	17	45	Mendelian_Severe_Combined_Immunodeficiency	KLEIN_TARGETS_OF_BCR_ABL1_FUSION
23.5294117647%	4	17	43	Mendelian_Blood_Desease	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
23.5294117647%	4	17	392	Mendelian_Severe_Combined_Immunodeficiency	LINDGREN_BLADDER_CANCER_CLUSTER_2B
23.5294117647%	4	17	368	Mendelian_Severe_Combined_Immunodeficiency	YAGI_AML_WITH_T_8_21_TRANSLOCATION
23.5294117647%	4	17	366	Mendelian_Severe_Combined_Immunodeficiency	SANSOM_APC_TARGETS_DN
23.5294117647%	4	17	351	Mendelian_Severe_Combined_Immunodeficiency	YAGI_AML_WITH_11Q23_REARRANGED
23.5294117647%	4	17	293	Mendelian_Severe_Combined_Immunodeficiency	HADDAD_B_LYMPHOCYTE_PROGENITOR
23.5294117647%	4	17	270	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
23.5294117647%	4	17	226	Mendelian_Severe_Combined_Immunodeficiency	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
23.5294117647%	4	17	214	Mendelian_Blood_Desease	TIEN_INTESTINE_PROBIOTICS_24HR_DN
23.5294117647%	4	17	200	Mendelian_Severe_Combined_Immunodeficiency	LEE_DIFFERENTIATING_T_LYMPHOCYTE
23.5294117647%	4	17	181	Mendelian_Blood_Desease	JISON_SICKLE_CELL_DISEASE_DN
23.5294117647%	4	17	1691	Mendelian_Severe_Combined_Immunodeficiency	BLALOCK_ALZHEIMERS_DISEASE_UP
23.5294117647%	4	17	1691	Mendelian_Blood_Desease	BLALOCK_ALZHEIMERS_DISEASE_UP
23.5294117647%	4	17	1442	Mendelian_Severe_Combined_Immunodeficiency	PUJANA_ATM_PCC_NETWORK
23.5294117647%	4	17	143	Mendelian_Blood_Desease	DANG_MYC_TARGETS_UP
23.5294117647%	4	17	1305	Mendelian_Severe_Combined_Immunodeficiency	YOSHIMURA_MAPK8_TARGETS_UP
23.5294117647%	4	17	1142	Mendelian_Severe_Combined_Immunodeficiency	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
23.5294117647%	4	17	1022	Mendelian_Severe_Combined_Immunodeficiency	MARSON_BOUND_BY_FOXP3_STIMULATED
23.3870967742%	29	124	74	Diabetes_McGill_Cell_cycle_All_Gene	PID_E2F_PATHWAY
23.3870967742%	29	124	299	Diabetes_McGill_Cell_cycle_All_Gene	MUELLER_PLURINET
23.3201581028%	59	253	1652	Diabetes_McGill_CREBBP_coTF	PUJANA_BRCA1_PCC_NETWORK
23.0769230769%	9	39	90	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_ERBB4
23.0769230769%	9	39	84	Diabetes_McGill_IL6	KEGG_SMALL_CELL_LUNG_CANCER
23.0769230769%	9	39	70	Diabetes_McGill_IL6	KEGG_PANCREATIC_CANCER
23.0769230769%	9	39	55	Diabetes_McGill_IL6	PID_IL2_1PATHWAY
23.0769230769%	9	39	54	Diabetes_McGill_IL6	PID_NFAT_3PATHWAY
23.0769230769%	9	39	52	Diabetes_McGill_IL6	PID_KITPATHWAY
23.0769230769%	9	39	46	Diabetes_McGill_IL6	PID_A6B1_A6B4_INTEGRIN_PATHWAY
23.0769230769%	9	39	201	Diabetes_McGill_IL6	KEGG_FOCAL_ADHESION
23.0769230769%	9	39	190	Diabetes_McGill_IL6	KEGG_CHEMOKINE_SIGNALING_PATHWAY
23.0769230769%	9	39	128	Diabetes_McGill_IL6	KEGG_CELL_CYCLE
23.0769230769%	9	39	127	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
23.0769230769%	6	26	940	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
23.0769230769%	6	26	93	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_REGULATION_OF_INSULIN_SECRETION
23.0769230769%	6	26	811	Diabetes_McGill_Set_Wnt_pathway	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
23.0769230769%	6	26	770	Diabetes_McGill_Set_Wnt_pathway	KRIEG_HYPOXIA_NOT_VIA_KDM3A
23.0769230769%	6	26	652	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BENPORATH_PRC2_TARGETS
23.0769230769%	6	26	55	Diabetes_McGill_Set_Wnt_pathway	PID_TGFBRPATHWAY
23.0769230769%	6	26	421	Diabetes_McGill_Set_Wnt_pathway	REACTOME_CELL_CYCLE
23.0769230769%	6	26	325	Diabetes_McGill_Set_Wnt_pathway	REACTOME_CELL_CYCLE_MITOTIC
23.0769230769%	6	26	323	Diabetes_McGill_Set_Wnt_pathway	GRESHOCK_CANCER_COPY_NUMBER_UP
23.0769230769%	6	26	16	Diabetes_McGill_Set_Wnt_pathway	REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE
23.0769230769%	6	26	128	Diabetes_McGill_Set_Wnt_pathway	KEGG_CELL_CYCLE
23.0769230769%	6	26	1069	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
23.0769230769%	6	26	101	Diabetes_McGill_Set_Wnt_pathway	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
23.0769230769%	3	13	988	Diabetes_McGill_Insulin	BENPORATH_NANOG_TARGETS
23.0769230769%	3	13	770	Diabetes_McGill_Insulin	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
23.0769230769%	3	13	552	Diabetes_McGill_Insulin	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
23.0769230769%	3	13	34	Diabetes_McGill_Insulin	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE
23.0769230769%	3	13	29	Diabetes_McGill_Insulin	REACTOME_PERK_REGULATED_GENE_EXPRESSION
23.0769230769%	3	13	245	Diabetes_McGill_Insulin	BLUM_RESPONSE_TO_SALIRASIB_UP
23.0769230769%	3	13	21	Diabetes_McGill_Insulin	REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING
23.0769230769%	3	13	186	Diabetes_McGill_Insulin	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
23.0769230769%	3	13	17	Diabetes_McGill_Insulin	REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION
23.0769230769%	3	13	169	Diabetes_McGill_Insulin	KEGG_ALZHEIMERS_DISEASE
23.0769230769%	3	13	15	Diabetes_McGill_Insulin	REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE
23.0769230769%	3	13	13	Diabetes_McGill_Insulin	REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6_ALPHA
23.0769230769%	3	13	1103	Diabetes_McGill_Insulin	DANG_BOUND_BY_MYC
23.0769230769%	3	13	11	Diabetes_McGill_Insulin	REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE
23.0769230769%	3	13	11	Diabetes_McGill_Insulin	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA
23.0769230769%	3	13	1022	Diabetes_McGill_Insulin	MARSON_BOUND_BY_FOXP3_STIMULATED
23.0769230769%	3	13	10	Diabetes_McGill_Insulin	REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE
23.0769230769%	3	13	10	Diabetes_McGill_Insulin	REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE
22.8571428571%	16	70	69	Diabetes_McGill_Adipocytokine_signallin	KEGG_PPAR_SIGNALING_PATHWAY
22.8571428571%	16	70	478	Diabetes_McGill_Adipocytokine_signallin	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
22.8571428571%	16	70	126	Diabetes_McGill_Adipocytokine_signallin	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
22.5806451613%	7	31	88	Diabetes_McGill_IL10	KEGG_APOPTOSIS
22.5806451613%	7	31	86	Diabetes_McGill_IL10	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
22.5806451613%	7	31	76	Diabetes_McGill_IL10	KEGG_VEGF_SIGNALING_PATHWAY
22.5806451613%	7	31	65	Diabetes_McGill_IL10	PID_IL4_2PATHWAY
22.5806451613%	7	31	65	Diabetes_McGill_IL10	KEGG_GLIOMA
22.5806451613%	7	31	62	Diabetes_McGill_IL10	KEGG_COLORECTAL_CANCER
22.5806451613%	7	31	52	Diabetes_McGill_IL10	KEGG_ENDOMETRIAL_CANCER
22.5806451613%	7	31	504	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_48HR_DN
22.5806451613%	7	31	466	Diabetes_McGill_IL10	REACTOME_HEMOSTASIS
22.5806451613%	7	31	459	Diabetes_McGill_IL10	KIM_WT1_TARGETS_DN
22.5806451613%	7	31	368	Diabetes_McGill_IL10	YAGI_AML_WITH_T_8_21_TRANSLOCATION
22.5806451613%	7	31	30	Diabetes_McGill_IL10	PID_IL2_STAT5PATHWAY
22.5806451613%	7	31	208	Diabetes_McGill_IL10	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
22.5806451613%	7	31	190	Diabetes_McGill_IL10	KEGG_CHEMOKINE_SIGNALING_PATHWAY
22.5806451613%	7	31	17	Diabetes_McGill_IL10	BIOCARTA_IL10_PATHWAY
22.5806451613%	7	31	1652	Diabetes_McGill_IL10	PUJANA_BRCA1_PCC_NETWORK
22.5806451613%	7	31	16	Diabetes_McGill_IL10	BAKER_HEMATOPOIESIS_STAT3_TARGETS
22.5806451613%	7	31	1442	Diabetes_McGill_IL10	PUJANA_ATM_PCC_NETWORK
22.5806451613%	7	31	1375	Diabetes_McGill_IL10	DODD_NASOPHARYNGEAL_CARCINOMA_DN
22.5806451613%	7	31	126	Diabetes_McGill_IL10	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
22.5806451613%	7	31	105	Diabetes_McGill_IL10	PID_ERBB1_DOWNSTREAM_PATHWAY
22.5806451613%	7	31	102	Diabetes_McGill_IL10	PID_CXCR4_PATHWAY
22.5806451613%	28	124	882	Diabetes_McGill_Cell_cycle_All_Gene	LEE_BMP2_TARGETS_DN
22.5806451613%	28	124	86	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
22.5806451613%	28	124	633	Diabetes_McGill_Cell_cycle_All_Gene	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
22.2222222222%	6	27	485	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ENK_UV_RESPONSE_KERATINOCYTE_DN
22.2222222222%	6	27	335	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WONG_EMBRYONIC_STEM_CELL_CORE
22.2222222222%	6	27	19	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_PYRUVATE_METABOLISM
22.2222222222%	6	27	13	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX
22.2222222222%	2	9	98	Mendelian_Immune	HAHTOLA_SEZARY_SYNDROM_UP
22.2222222222%	2	9	953	Mendelian_Immune	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
22.2222222222%	2	9	9	Mendelian_Immune	SA_FAS_SIGNALING
22.2222222222%	2	9	88	Mendelian_Immune	KEGG_APOPTOSIS
22.2222222222%	2	9	88	Mendelian_Immune	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
22.2222222222%	2	9	857	Mendelian_Immune	MARTENS_TRETINOIN_RESPONSE_UP
22.2222222222%	2	9	71	Mendelian_Immune	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
22.2222222222%	2	9	58	Mendelian_Immune	BIOCARTA_HIVNEF_PATHWAY
22.2222222222%	2	9	564	Mendelian_Immune	SMID_BREAST_CANCER_LUMINAL_B_DN
22.2222222222%	2	9	491	Mendelian_Immune	ZHENG_BOUND_BY_FOXP3
22.2222222222%	2	9	476	Mendelian_Immune	SMID_BREAST_CANCER_NORMAL_LIKE_UP
22.2222222222%	2	9	47	Mendelian_Immune	PID_NFAT_TFPATHWAY
22.2222222222%	2	9	46	Mendelian_Immune	BIOCARTA_KERATINOCYTE_PATHWAY
22.2222222222%	2	9	447	Mendelian_Immune	MOOTHA_MITOCHONDRIA
22.2222222222%	2	9	44	Mendelian_Immune	KEGG_TYPE_I_DIABETES_MELLITUS
22.2222222222%	2	9	429	Mendelian_Immune	MOOTHA_HUMAN_MITODB_6_2002
22.2222222222%	2	9	42	Mendelian_Immune	KEGG_GRAFT_VERSUS_HOST_DISEASE
22.2222222222%	2	9	41	Mendelian_Immune	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
22.2222222222%	2	9	397	Mendelian_Immune	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
22.2222222222%	2	9	387	Mendelian_Immune	CHYLA_CBFA2T3_TARGETS_UP
22.2222222222%	2	9	38	Mendelian_Immune	PID_FASPATHWAY
22.2222222222%	2	9	38	Mendelian_Immune	BIOCARTA_IL2RB_PATHWAY
22.2222222222%	2	9	36	Mendelian_Immune	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
22.2222222222%	2	9	35	Mendelian_Immune	PID_HIVNEFPATHWAY
22.2222222222%	2	9	35	Mendelian_Immune	KEGG_PRIMARY_IMMUNODEFICIENCY
22.2222222222%	2	9	33	Mendelian_Immune	DUTTA_APOPTOSIS_VIA_NFKB
22.2222222222%	2	9	328	Mendelian_Immune	KEGG_PATHWAYS_IN_CANCER
22.2222222222%	2	9	30	Mendelian_Immune	BIOCARTA_FAS_PATHWAY
22.2222222222%	2	9	29	Mendelian_Immune	WILENSKY_RESPONSE_TO_DARAPLADIB
22.2222222222%	2	9	29	Mendelian_Immune	PID_TCRCALCIUMPATHWAY
22.2222222222%	2	9	267	Mendelian_Immune	KEGG_MAPK_SIGNALING_PATHWAY
22.2222222222%	2	9	240	Mendelian_Immune	VANTVEER_BREAST_CANCER_ESR1_DN
22.2222222222%	2	9	237	Mendelian_Immune	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
22.2222222222%	2	9	23	Mendelian_Immune	MARKS_HDAC_TARGETS_UP
22.2222222222%	2	9	228	Mendelian_Immune	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
22.2222222222%	2	9	226	Mendelian_Immune	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
22.2222222222%	2	9	22	Mendelian_Immune	GAVIN_PDE3B_TARGETS
22.2222222222%	2	9	215	Mendelian_Immune	MARKEY_RB1_ACUTE_LOF_UP
22.2222222222%	2	9	210	Mendelian_Immune	VERHAAK_GLIOBLASTOMA_NEURAL
22.2222222222%	2	9	205	Mendelian_Immune	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
22.2222222222%	2	9	20	Mendelian_Immune	VILIMAS_NOTCH1_TARGETS_DN
22.2222222222%	2	9	19	Mendelian_Immune	SA_CASPASE_CASCADE
22.2222222222%	2	9	187	Mendelian_Immune	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
22.2222222222%	2	9	17	Mendelian_Immune	BIOCARTA_PML_PATHWAY
22.2222222222%	2	9	169	Mendelian_Immune	KATSANOU_ELAVL1_TARGETS_UP
22.2222222222%	2	9	15	Mendelian_Immune	BIOCARTA_HSP27_PATHWAY
22.2222222222%	2	9	15	Mendelian_Immune	BIOCARTA_CTL_PATHWAY
22.2222222222%	2	9	148	Mendelian_Immune	REACTOME_APOPTOSIS
22.2222222222%	2	9	1382	Mendelian_Immune	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
22.2222222222%	2	9	1375	Mendelian_Immune	DODD_NASOPHARYNGEAL_CARCINOMA_DN
22.2222222222%	2	9	137	Mendelian_Immune	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
22.2222222222%	2	9	13	Mendelian_Immune	REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS
22.2222222222%	2	9	11	Mendelian_Immune	BIOCARTA_TCAPOPTOSIS_PATHWAY
22.2222222222%	2	9	107	Mendelian_Immune	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
22.2222222222%	2	9	1037	Mendelian_Immune	NUYTTEN_EZH2_TARGETS_UP
22.1343873518%	56	253	1442	Diabetes_McGill_CREBBP_coTF	PUJANA_ATM_PCC_NETWORK
21.9512195122%	9	41	652	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BENPORATH_PRC2_TARGETS
21.9512195122%	9	41	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_TYPE_II_DIABETES_MELLITUS
21.9512195122%	9	41	1305	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YOSHIMURA_MAPK8_TARGETS_UP
21.9512195122%	9	41	1038	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BENPORATH_SUZ12_TARGETS
21.875%	7	32	701	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SMID_BREAST_CANCER_BASAL_DN
21.875%	7	32	435	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
21.875%	7	32	31	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_INWARDLY_RECTIFYING_K_CHANNELS
21.875%	7	32	1062	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BENPORATH_EED_TARGETS
21.7741935484%	27	124	918	Diabetes_McGill_Cell_cycle_All_Gene	JOHNSTONE_PARVB_TARGETS_3_DN
21.7741935484%	27	124	45	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_G2_M_CHECKPOINTS
21.7741935484%	27	124	324	Diabetes_McGill_Cell_cycle_All_Gene	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
21.7741935484%	27	124	28	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_G1_PATHWAY
21.7391304348%	55	253	1781	Diabetes_McGill_CREBBP_coTF	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
21.7391304348%	5	23	97	Diabetes_McGill_Mtor_pathway	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
21.7391304348%	5	23	920	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALING_BY_GPCR
21.7391304348%	5	23	855	Diabetes_McGill_Mtor_pathway	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
21.7391304348%	5	23	65	Diabetes_McGill_Mtor_pathway	PID_IL4_2PATHWAY
21.7391304348%	5	23	65	Diabetes_McGill_Mtor_pathway	PID_BCR_5PATHWAY
21.7391304348%	5	23	65	Diabetes_McGill_Mtor_pathway	KEGG_GLIOMA
21.7391304348%	5	23	56	Diabetes_McGill_Mtor_pathway	BIOCARTA_NFAT_PATHWAY
21.7391304348%	5	23	553	Diabetes_McGill_Mtor_pathway	FEVR_CTNNB1_TARGETS_DN
21.7391304348%	5	23	52	Diabetes_McGill_Mtor_pathway	KEGG_ENDOMETRIAL_CANCER
21.7391304348%	5	23	51	Diabetes_McGill_Mtor_pathway	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
21.7391304348%	5	23	48	Diabetes_McGill_Mtor_pathway	REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY
21.7391304348%	5	23	466	Diabetes_McGill_Mtor_pathway	REACTOME_HEMOSTASIS
21.7391304348%	5	23	43	Diabetes_McGill_Mtor_pathway	PID_CXCR3PATHWAY
21.7391304348%	5	23	389	Diabetes_McGill_Mtor_pathway	HSIAO_HOUSEKEEPING_GENES
21.7391304348%	5	23	328	Diabetes_McGill_Mtor_pathway	KEGG_PATHWAYS_IN_CANCER
21.7391304348%	5	23	323	Diabetes_McGill_Mtor_pathway	GRESHOCK_CANCER_COPY_NUMBER_UP
21.7391304348%	5	23	32	Diabetes_McGill_Mtor_pathway	REACTOME_CD28_CO_STIMULATION
21.7391304348%	5	23	30	Diabetes_McGill_Mtor_pathway	PID_IGF1_PATHWAY
21.7391304348%	5	23	29	Diabetes_McGill_Mtor_pathway	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
21.7391304348%	5	23	27	Diabetes_McGill_Mtor_pathway	BIOCARTA_GSK3_PATHWAY
21.7391304348%	5	23	230	Diabetes_McGill_Mtor_pathway	BENPORATH_MYC_TARGETS_WITH_EBOX
21.7391304348%	5	23	22	Diabetes_McGill_Mtor_pathway	REACTOME_DEADENYLATION_OF_MRNA
21.7391304348%	5	23	22	Diabetes_McGill_Mtor_pathway	REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING
21.7391304348%	5	23	22	Diabetes_McGill_Mtor_pathway	BIOCARTA_AKT_PATHWAY
21.7391304348%	5	23	201	Diabetes_McGill_Mtor_pathway	KEGG_FOCAL_ADHESION
21.7391304348%	5	23	1781	Diabetes_McGill_Mtor_pathway	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
21.7391304348%	5	23	1652	Diabetes_McGill_Mtor_pathway	PUJANA_BRCA1_PCC_NETWORK
21.6216216216%	8	37	1305	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YOSHIMURA_MAPK8_TARGETS_UP
21.4285714286%	9	42	830	Diabetes_McGill_RAS	CUI_TCF21_TARGETS_2_DN
21.4285714286%	6	28	882	Diabetes_McGill_Cell_cycle_G1	LEE_BMP2_TARGETS_DN
21.4285714286%	6	28	84	Diabetes_McGill_Cell_cycle_G1	PID_CMYB_PATHWAY
21.4285714286%	6	28	79	Diabetes_McGill_Cell_cycle_G1	PID_P73PATHWAY
21.4285714286%	6	28	75	Diabetes_McGill_Cell_cycle_G1	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
21.4285714286%	6	28	747	Diabetes_McGill_Cell_cycle_G1	PATIL_LIVER_CANCER
21.4285714286%	6	28	728	Diabetes_McGill_Cell_cycle_G1	MARSON_BOUND_BY_E2F4_UNSTIMULATED
21.4285714286%	6	28	722	Diabetes_McGill_Cell_cycle_G1	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
21.4285714286%	6	28	70	Diabetes_McGill_Cell_cycle_G1	PID_AP1_PATHWAY
21.4285714286%	6	28	682	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FEVR_CTNNB1_TARGETS_UP
21.4285714286%	6	28	66	Diabetes_McGill_Cell_cycle_G1	TENEDINI_MEGAKARYOCYTE_MARKERS
21.4285714286%	6	28	648	Diabetes_McGill_Cell_cycle_G1	BENPORATH_CYCLING_GENES
21.4285714286%	6	28	63	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
21.4285714286%	6	28	57	Diabetes_McGill_Cell_cycle_G1	REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE
21.4285714286%	6	28	56	Diabetes_McGill_Cell_cycle_G1	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21
21.4285714286%	6	28	485	Diabetes_McGill_Cell_cycle_G1	ENK_UV_RESPONSE_KERATINOCYTE_DN
21.4285714286%	6	28	460	Diabetes_McGill_Cell_cycle_G1	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
21.4285714286%	6	28	44	Diabetes_McGill_Cell_cycle_G1	WHITFIELD_CELL_CYCLE_LITERATURE
21.4285714286%	6	28	435	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
21.4285714286%	6	28	430	Diabetes_McGill_Cell_cycle_G1	VECCHI_GASTRIC_CANCER_EARLY_UP
21.4285714286%	6	28	396	Diabetes_McGill_Cell_cycle_G1	REACTOME_DEVELOPMENTAL_BIOLOGY
21.4285714286%	6	28	299	Diabetes_McGill_Cell_cycle_G1	MUELLER_PLURINET
21.4285714286%	6	28	269	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
21.4285714286%	6	28	253	Diabetes_McGill_Cell_cycle_G1	DANG_REGULATED_BY_MYC_DN
21.4285714286%	6	28	24	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_G2_PATHWAY
21.4285714286%	6	28	230	Diabetes_McGill_Cell_cycle_G1	BENPORATH_MYC_TARGETS_WITH_EBOX
21.4285714286%	6	28	192	Diabetes_McGill_Cell_cycle_G1	REACTOME_DNA_REPLICATION
21.4285714286%	6	28	180	Diabetes_McGill_Cell_cycle_G1	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
21.4285714286%	6	28	168	Diabetes_McGill_Cell_cycle_G1	PUJANA_XPRSS_INT_NETWORK
21.4285714286%	6	28	1382	Diabetes_McGill_Cell_cycle_G1	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
21.4285714286%	6	28	13	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_RB_PATHWAY
21.4285714286%	6	28	1229	Diabetes_McGill_Cell_cycle_G1	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
21.4285714286%	6	28	117	Diabetes_McGill_Cell_cycle_G1	PUJANA_BRCA_CENTERED_NETWORK
21.4285714286%	6	28	116	Diabetes_McGill_Cell_cycle_G1	WHITEFORD_PEDIATRIC_CANCER_MARKERS
21.4285714286%	15	70	168	Diabetes_McGill_Adipocytokine_signallin	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
21.2121212121%	7	33	682	Diabetes_McGill_ER_Stress	FEVR_CTNNB1_TARGETS_UP
21.2121212121%	7	33	668	Diabetes_McGill_ER_Stress	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
21.2121212121%	7	33	46	Mendelian_Metabolism	REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT
21.2121212121%	7	33	447	Mendelian_Metabolism	MOOTHA_MITOCHONDRIA
21.2121212121%	7	33	28	Mendelian_Metabolism	REACTOME_LIPOPROTEIN_METABOLISM
21.2121212121%	7	33	245	Diabetes_McGill_ER_Stress	BLUM_RESPONSE_TO_SALIRASIB_UP
21.2121212121%	7	33	244	Diabetes_McGill_ER_Stress	DAZARD_RESPONSE_TO_UV_NHEK_UP
21.2121212121%	7	33	222	Mendelian_Metabolism	CAIRO_LIVER_DEVELOPMENT_DN
21.2121212121%	7	33	1781	Diabetes_McGill_ER_Stress	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
21.2121212121%	7	33	1375	Diabetes_McGill_ER_Stress	DODD_NASOPHARYNGEAL_CARCINOMA_DN
21.2121212121%	7	33	13	Diabetes_McGill_ER_Stress	REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6_ALPHA
20.987654321%	17	81	1305	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YOSHIMURA_MAPK8_TARGETS_UP
20.9677419355%	26	124	85	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE
20.9677419355%	26	124	648	Diabetes_McGill_Cell_cycle_All_Gene	SMID_BREAST_CANCER_BASAL_UP
20.9677419355%	26	124	228	Diabetes_McGill_Cell_cycle_All_Gene	MARKEY_RB1_ACUTE_LOF_DN
20.8333333333%	5	24	93	Diabetes_McGill_TNF_alpha_signalin	REACTOME_ACTIVATED_TLR4_SIGNALLING
20.8333333333%	5	24	882	Diabetes_McGill_TNF_alpha_signalin	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
20.8333333333%	5	24	72	Diabetes_McGill_TNF_alpha_signalin	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
20.8333333333%	5	24	72	Diabetes_McGill_TNF_alpha_signalin	KEGG_LEISHMANIA_INFECTION
20.8333333333%	5	24	71	Diabetes_McGill_TNF_alpha_signalin	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
20.8333333333%	5	24	69	Diabetes_McGill_TNF_alpha_signalin	PID_P75NTRPATHWAY
20.8333333333%	5	24	69	Diabetes_McGill_TNF_alpha_signalin	KEGG_P53_SIGNALING_PATHWAY
20.8333333333%	5	24	62	Diabetes_McGill_TNF_alpha_signalin	KEGG_COLORECTAL_CANCER
20.8333333333%	5	24	544	Diabetes_McGill_TNF_alpha_signalin	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
20.8333333333%	5	24	38	Diabetes_McGill_TNF_alpha_signalin	PID_FASPATHWAY
20.8333333333%	5	24	337	Diabetes_McGill_TNF_alpha_signalin	PHONG_TNF_RESPONSE_NOT_VIA_P38
20.8333333333%	5	24	312	Diabetes_McGill_TNF_alpha_signalin	GENTILE_UV_HIGH_DOSE_DN
20.8333333333%	5	24	259	Diabetes_McGill_TNF_alpha_signalin	QI_PLASMACYTOMA_UP
20.8333333333%	5	24	217	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNALLING_BY_NGF
20.8333333333%	5	24	19	Diabetes_McGill_TNF_alpha_signalin	SA_CASPASE_CASCADE
20.8333333333%	5	24	1821	Diabetes_McGill_TNF_alpha_signalin	DODD_NASOPHARYNGEAL_CARCINOMA_UP
20.8333333333%	5	24	1781	Diabetes_McGill_TNF_alpha_signalin	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
20.8333333333%	5	24	16	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_CDMAC_PATHWAY
20.8333333333%	5	24	137	Diabetes_McGill_TNF_alpha_signalin	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
20.8333333333%	5	24	1305	Diabetes_McGill_TNF_alpha_signalin	YOSHIMURA_MAPK8_TARGETS_UP
20.8333333333%	5	24	13	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_D4GDI_PATHWAY
20.8333333333%	5	24	126	Diabetes_McGill_TNF_alpha_signalin	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
20.8333333333%	5	24	118	Diabetes_McGill_TNF_alpha_signalin	REACTOME_TOLL_RECEPTOR_CASCADES
20.8333333333%	5	24	108	Diabetes_McGill_TNF_alpha_signalin	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
20.8333333333%	5	24	1038	Diabetes_McGill_TNF_alpha_signalin	BENPORATH_SUZ12_TARGETS
20.5128205128%	8	39	95	Diabetes_McGill_IL6	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
20.5128205128%	8	39	87	Diabetes_McGill_IL6	KEGG_ERBB_SIGNALING_PATHWAY
20.5128205128%	8	39	770	Diabetes_McGill_IL6	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
20.5128205128%	8	39	70	Diabetes_McGill_IL6	KEGG_RENAL_CELL_CARCINOMA
20.5128205128%	8	39	62	Diabetes_McGill_IL6	KEGG_COLORECTAL_CANCER
20.5128205128%	8	39	58	Diabetes_McGill_IL6	PID_SHP2_PATHWAY
20.5128205128%	8	39	516	Diabetes_McGill_IL6	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
20.5128205128%	8	39	46	Diabetes_McGill_IL6	SIG_BCR_SIGNALING_PATHWAY
20.5128205128%	8	39	409	Diabetes_McGill_IL6	FOSTER_TOLERANT_MACROPHAGE_DN
20.5128205128%	8	39	396	Diabetes_McGill_IL6	REACTOME_DEVELOPMENTAL_BIOLOGY
20.5128205128%	8	39	26	Diabetes_McGill_IL6	ST_INTERLEUKIN_4_PATHWAY
20.5128205128%	8	39	26	Diabetes_McGill_IL6	PID_INSULIN_GLUCOSE_PATHWAY
20.5128205128%	8	39	1237	Diabetes_McGill_IL6	BLALOCK_ALZHEIMERS_DISEASE_DN
20.5128205128%	8	39	122	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_PDGF
20.5128205128%	8	39	112	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_FGFR
20.5128205128%	8	39	1103	Diabetes_McGill_IL6	DANG_BOUND_BY_MYC
20.5128205128%	8	39	109	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
20.5128205128%	8	39	101	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_ERBB2
20.5128205128%	8	39	100	Diabetes_McGill_IL6	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
20.1612903226%	25	124	933	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_IMMUNE_SYSTEM
20.1612903226%	25	124	855	Diabetes_McGill_Cell_cycle_All_Gene	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
20.1612903226%	25	124	38	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_G1_PHASE
20.1612903226%	25	124	180	Diabetes_McGill_Cell_cycle_All_Gene	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
20.1612903226%	25	124	1229	Diabetes_McGill_Cell_cycle_All_Gene	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
20.1581027668%	51	253	1972	Diabetes_McGill_CREBBP_coTF	PILON_KLF1_TARGETS_DN
20.0%	3	15	718	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MIKKELSEN_ES_ICP_WITH_H3K4ME3
20.0%	3	15	69	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	REACTOME_SPHINGOLIPID_METABOLISM
20.0%	3	15	555	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
20.0%	3	15	546	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
20.0%	3	15	530	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ENK_UV_RESPONSE_KERATINOCYTE_UP
20.0%	3	15	52	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KEGG_STARCH_AND_SUCROSE_METABOLISM
20.0%	3	15	478	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
20.0%	3	15	457	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
20.0%	3	15	418	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	RUTELLA_RESPONSE_TO_HGF_UP
20.0%	3	15	418	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MULLIGHAN_MLL_SIGNATURE_2_UP
20.0%	3	15	414	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MOHANKUMAR_TLX1_TARGETS_UP
20.0%	3	15	408	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
20.0%	3	15	40	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KEGG_SPHINGOLIPID_METABOLISM
20.0%	3	15	397	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
20.0%	3	15	38	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	REACTOME_GLYCOSPHINGOLIPID_METABOLISM
20.0%	3	15	302	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
20.0%	3	15	253	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DANG_REGULATED_BY_MYC_DN
20.0%	3	15	239	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ALFANO_MYC_TARGETS
20.0%	3	15	207	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KARLSSON_TGFB1_TARGETS_DN
20.0%	3	15	198	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	REACTOME_PHOSPHOLIPID_METABOLISM
20.0%	3	15	160	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
20.0%	3	15	1382	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
20.0%	3	15	1305	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	YOSHIMURA_MAPK8_TARGETS_UP
20.0%	3	15	1210	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	CHEN_METABOLIC_SYNDROM_NETWORK
20.0%	2	10	988	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BENPORATH_NANOG_TARGETS
20.0%	2	10	957	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LOPEZ_MBD_TARGETS
20.0%	2	10	84	Mendelian_Disorders_of_Fatty_Acid_Oxidation	RUAN_RESPONSE_TO_TNF_DN
20.0%	2	10	779	Mendelian_Disorders_of_Fatty_Acid_Oxidation	PUJANA_CHEK2_PCC_NETWORK
20.0%	2	10	756	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
20.0%	2	10	74	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LEE_LIVER_CANCER_DENA_DN
20.0%	2	10	682	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
20.0%	2	10	658	Mendelian_Disorders_of_Fatty_Acid_Oxidation	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
20.0%	2	10	637	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
20.0%	2	10	612	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
20.0%	2	10	567	Mendelian_Disorders_of_Fatty_Acid_Oxidation	PARENT_MTOR_SIGNALING_UP
20.0%	2	10	555	Mendelian_Disorders_of_Fatty_Acid_Oxidation	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
20.0%	2	10	55	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN
20.0%	2	10	51	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
20.0%	2	10	49	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GERHOLD_ADIPOGENESIS_UP
20.0%	2	10	485	Mendelian_Disorders_of_Fatty_Acid_Oxidation	ENK_UV_RESPONSE_KERATINOCYTE_DN
20.0%	2	10	414	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MOHANKUMAR_TLX1_TARGETS_UP
20.0%	2	10	408	Mendelian_Disorders_of_Fatty_Acid_Oxidation	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
20.0%	2	10	394	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BERENJENO_TRANSFORMED_BY_RHOA_DN
20.0%	2	10	362	Mendelian_Disorders_of_Fatty_Acid_Oxidation	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
20.0%	2	10	330	Mendelian_Disorders_of_Fatty_Acid_Oxidation	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
20.0%	2	10	33	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KEGG_PROPANOATE_METABOLISM
20.0%	2	10	315	Mendelian_Disorders_of_Fatty_Acid_Oxidation	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
20.0%	2	10	274	Mendelian_Disorders_of_Fatty_Acid_Oxidation	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
20.0%	2	10	235	Mendelian_Disorders_of_Fatty_Acid_Oxidation	RUTELLA_RESPONSE_TO_HGF_DN
20.0%	2	10	222	Mendelian_Disorders_of_Fatty_Acid_Oxidation	CAIRO_LIVER_DEVELOPMENT_DN
20.0%	2	10	222	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BROWNE_HCMV_INFECTION_1HR_DN
20.0%	2	10	22	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KEGG_BETA_ALANINE_METABOLISM
20.0%	2	10	217	Mendelian_Disorders_of_Fatty_Acid_Oxidation	WONG_MITOCHONDRIA_GENE_MODULE
20.0%	2	10	209	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GROSS_HYPOXIA_VIA_ELK3_UP
20.0%	2	10	206	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
20.0%	2	10	196	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
20.0%	2	10	1839	Mendelian_Disorders_of_Fatty_Acid_Oxidation	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
20.0%	2	10	179	Mendelian_Disorders_of_Fatty_Acid_Oxidation	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
20.0%	2	10	1691	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BLALOCK_ALZHEIMERS_DISEASE_UP
20.0%	2	10	149	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LANDIS_ERBB2_BREAST_TUMORS_324_DN
20.0%	2	10	145	Mendelian_Disorders_of_Fatty_Acid_Oxidation	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
20.0%	2	10	1442	Mendelian_Disorders_of_Fatty_Acid_Oxidation	PUJANA_ATM_PCC_NETWORK
20.0%	2	10	1229	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
20.0%	2	10	1137	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BRUINS_UVC_RESPONSE_LATE
20.0%	2	10	1103	Mendelian_Disorders_of_Fatty_Acid_Oxidation	DANG_BOUND_BY_MYC
20.0%	2	10	1024	Mendelian_Disorders_of_Fatty_Acid_Oxidation	NUYTTEN_EZH2_TARGETS_DN
20.0%	14	70	539	Diabetes_McGill_Adipocytokine_signallin	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
20.0%	14	70	396	Diabetes_McGill_Adipocytokine_signallin	REACTOME_DEVELOPMENTAL_BIOLOGY
20.0%	14	70	267	Diabetes_McGill_Adipocytokine_signallin	KEGG_MAPK_SIGNALING_PATHWAY
20.0%	14	70	1382	Diabetes_McGill_Adipocytokine_signallin	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
20.0%	14	70	1305	Diabetes_McGill_Adipocytokine_signallin	YOSHIMURA_MAPK8_TARGETS_UP
20.0%	14	70	108	Diabetes_McGill_Adipocytokine_signallin	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
19.7628458498%	50	253	1382	Diabetes_McGill_CREBBP_coTF	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
19.512195122%	8	41	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
19.3548387097%	6	31	988	Diabetes_McGill_IL10	BENPORATH_NANOG_TARGETS
19.3548387097%	6	31	97	Diabetes_McGill_IL10	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
19.3548387097%	6	31	920	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_GPCR
19.3548387097%	6	31	89	Diabetes_McGill_IL10	KEGG_PROSTATE_CANCER
19.3548387097%	6	31	805	Diabetes_McGill_IL10	REACTOME_GPCR_DOWNSTREAM_SIGNALING
19.3548387097%	6	31	78	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_SCF_KIT
19.3548387097%	6	31	734	Diabetes_McGill_IL10	BENPORATH_SOX2_TARGETS
19.3548387097%	6	31	71	Diabetes_McGill_IL10	KEGG_MELANOMA
19.3548387097%	6	31	55	Diabetes_McGill_IL10	PID_IL2_1PATHWAY
19.3548387097%	6	31	54	Diabetes_McGill_IL10	KEGG_NON_SMALL_CELL_LUNG_CANCER
19.3548387097%	6	31	52	Diabetes_McGill_IL10	KEGG_MTOR_SIGNALING_PATHWAY
19.3548387097%	6	31	501	Diabetes_McGill_IL10	SENESE_HDAC3_TARGETS_UP
19.3548387097%	6	31	47	Diabetes_McGill_IL10	KEGG_TYPE_II_DIABETES_MELLITUS
19.3548387097%	6	31	421	Diabetes_McGill_IL10	REACTOME_CELL_CYCLE
19.3548387097%	6	31	38	Diabetes_McGill_IL10	BIOCARTA_IL2RB_PATHWAY
19.3548387097%	6	31	338	Diabetes_McGill_IL10	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
19.3548387097%	6	31	325	Diabetes_McGill_IL10	REACTOME_CELL_CYCLE_MITOTIC
19.3548387097%	6	31	323	Diabetes_McGill_IL10	GRESHOCK_CANCER_COPY_NUMBER_UP
19.3548387097%	6	31	31	Diabetes_McGill_IL10	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
19.3548387097%	6	31	217	Diabetes_McGill_IL10	REACTOME_SIGNALLING_BY_NGF
19.3548387097%	6	31	137	Diabetes_McGill_IL10	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
19.3548387097%	6	31	137	Diabetes_McGill_IL10	REACTOME_MITOTIC_G1_G1_S_PHASES
19.3548387097%	6	31	137	Diabetes_McGill_IL10	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
19.3548387097%	6	31	128	Diabetes_McGill_IL10	KEGG_CELL_CYCLE
19.3548387097%	6	31	1229	Diabetes_McGill_IL10	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
19.3548387097%	6	31	118	Diabetes_McGill_IL10	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
19.3548387097%	6	31	1103	Diabetes_McGill_IL10	DANG_BOUND_BY_MYC
19.3548387097%	6	31	1022	Diabetes_McGill_IL10	MARSON_BOUND_BY_FOXP3_STIMULATED
19.3548387097%	24	124	722	Diabetes_McGill_Cell_cycle_All_Gene	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
19.3548387097%	24	124	69	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_P53_SIGNALING_PATHWAY
19.3548387097%	24	124	663	Diabetes_McGill_Cell_cycle_All_Gene	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
19.3548387097%	24	124	65	Diabetes_McGill_Cell_cycle_All_Gene	PID_RB_1PATHWAY
19.3548387097%	24	124	329	Diabetes_McGill_Cell_cycle_All_Gene	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
19.3548387097%	24	124	290	Diabetes_McGill_Cell_cycle_All_Gene	BASAKI_YBX1_TARGETS_UP
19.3548387097%	24	124	277	Diabetes_McGill_Cell_cycle_All_Gene	ZHANG_TLX_TARGETS_60HR_DN
19.2307692308%	5	26	933	Diabetes_McGill_Set_Wnt_pathway	REACTOME_IMMUNE_SYSTEM
19.2307692308%	5	26	89	Diabetes_McGill_Set_Wnt_pathway	KEGG_PROSTATE_CANCER
19.2307692308%	5	26	882	Diabetes_McGill_Set_Wnt_pathway	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
19.2307692308%	5	26	88	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS
19.2307692308%	5	26	82	Diabetes_McGill_Set_Wnt_pathway	PID_SMAD2_3NUCLEARPATHWAY
19.2307692308%	5	26	73	Diabetes_McGill_Set_Wnt_pathway	KEGG_CHRONIC_MYELOID_LEUKEMIA
19.2307692308%	5	26	65	Diabetes_McGill_Set_Wnt_pathway	PID_RB_1PATHWAY
19.2307692308%	5	26	637	Diabetes_McGill_Set_Wnt_pathway	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
19.2307692308%	5	26	59	Diabetes_McGill_Set_Wnt_pathway	PID_P53REGULATIONPATHWAY
19.2307692308%	5	26	584	Diabetes_McGill_Set_Wnt_pathway	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
19.2307692308%	5	26	58	Diabetes_McGill_Set_Wnt_pathway	SANSOM_WNT_PATHWAY_REQUIRE_MYC
19.2307692308%	5	26	56	Diabetes_McGill_Set_Wnt_pathway	KEGG_HEDGEHOG_SIGNALING_PATHWAY
19.2307692308%	5	26	483	Diabetes_McGill_Set_Wnt_pathway	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
19.2307692308%	5	26	48	Diabetes_McGill_Set_Wnt_pathway	PID_HEDGEHOG_GLIPATHWAY
19.2307692308%	5	26	396	Diabetes_McGill_Set_Wnt_pathway	REACTOME_DEVELOPMENTAL_BIOLOGY
19.2307692308%	5	26	352	Diabetes_McGill_Set_Wnt_pathway	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
19.2307692308%	5	26	33	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS
19.2307692308%	5	26	32	Diabetes_McGill_Set_Wnt_pathway	PID_WNT_NONCANONICAL_PATHWAY
19.2307692308%	5	26	20	Diabetes_McGill_Set_Wnt_pathway	PID_WNT_CANONICAL_PATHWAY
19.2307692308%	5	26	195	Diabetes_McGill_Set_Wnt_pathway	KYNG_DNA_DAMAGE_DN
19.2307692308%	5	26	19	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_TGFB_PATHWAY
19.2307692308%	5	26	188	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
19.2307692308%	5	26	178	Diabetes_McGill_GPCRs_expressed_in_beta_cell	KEGG_CALCIUM_SIGNALING_PATHWAY
19.2307692308%	5	26	1725	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
19.2307692308%	5	26	1442	Diabetes_McGill_Set_Wnt_pathway	PUJANA_ATM_PCC_NETWORK
19.2307692308%	5	26	1305	Diabetes_McGill_Set_Wnt_pathway	YOSHIMURA_MAPK8_TARGETS_UP
19.2307692308%	5	26	103	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SIGNALING_BY_NOTCH
19.0476190476%	8	42	267	Diabetes_McGill_RAS	KEGG_MAPK_SIGNALING_PATHWAY
19.0476190476%	8	42	1382	Diabetes_McGill_RAS	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
18.9189189189%	7	37	553	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FEVR_CTNNB1_TARGETS_DN
18.9189189189%	7	37	478	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
18.9189189189%	7	37	466	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_HEMOSTASIS
18.9189189189%	7	37	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
18.9189189189%	7	37	137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_INSULIN_SIGNALING_PATHWAY
18.75%	6	32	93	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_REGULATION_OF_INSULIN_SECRETION
18.75%	6	32	47	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_TYPE_II_DIABETES_MELLITUS
18.75%	6	32	186	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
18.75%	6	32	1725	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
18.75%	6	32	120	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
18.75%	6	32	115	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
18.5770750988%	47	253	396	Diabetes_McGill_CREBBP_coTF	REACTOME_DEVELOPMENTAL_BIOLOGY
18.5714285714%	13	70	88	Diabetes_McGill_Adipocytokine_signallin	KEGG_APOPTOSIS
18.5714285714%	13	70	84	Diabetes_McGill_Adipocytokine_signallin	KEGG_SMALL_CELL_LUNG_CANCER
18.5714285714%	13	70	71	Diabetes_McGill_Adipocytokine_signallin	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
18.5714285714%	13	70	1691	Diabetes_McGill_Adipocytokine_signallin	BLALOCK_ALZHEIMERS_DISEASE_UP
18.5714285714%	13	70	102	Diabetes_McGill_Adipocytokine_signallin	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
18.5483870968%	23	124	98	Diabetes_McGill_Cell_cycle_All_Gene	CROONQUIST_IL6_DEPRIVATION_DN
18.5483870968%	23	124	374	Diabetes_McGill_Cell_cycle_All_Gene	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
18.5483870968%	23	124	305	Diabetes_McGill_Cell_cycle_All_Gene	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
18.5483870968%	23	124	23	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_CELLCYCLE_PATHWAY
18.5483870968%	23	124	168	Diabetes_McGill_Cell_cycle_All_Gene	PUJANA_XPRSS_INT_NETWORK
18.5483870968%	23	124	151	Diabetes_McGill_Cell_cycle_All_Gene	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
18.5185185185%	5	27	882	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
18.5185185185%	5	27	756	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
18.5185185185%	5	27	567	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PARENT_MTOR_SIGNALING_UP
18.5185185185%	5	27	548	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KIM_ALL_DISORDERS_CALB1_CORR_UP
18.5185185185%	5	27	424	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SHEN_SMARCA2_TARGETS_UP
18.5185185185%	5	27	371	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WANG_SMARCE1_TARGETS_DN
18.5185185185%	5	27	266	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
18.5185185185%	5	27	16	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM
18.5185185185%	5	27	1103	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DANG_BOUND_BY_MYC
18.5185185185%	15	81	396	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_DEVELOPMENTAL_BIOLOGY
18.1818181818%	6	33	712	Diabetes_McGill_ER_Stress	SCHLOSSER_SERUM_RESPONSE_DN
18.1818181818%	6	33	540	Mendelian_Metabolism	ACEVEDO_LIVER_CANCER_DN
18.1818181818%	6	33	54	Mendelian_Metabolism	KEGG_ARGININE_AND_PROLINE_METABOLISM
18.1818181818%	6	33	457	Diabetes_McGill_ER_Stress	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
18.1818181818%	6	33	292	Diabetes_McGill_ER_Stress	HELLER_HDAC_TARGETS_DN
18.1818181818%	6	33	29	Diabetes_McGill_ER_Stress	REACTOME_PERK_REGULATED_GENE_EXPRESSION
18.1818181818%	6	33	281	Diabetes_McGill_ER_Stress	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
18.1818181818%	6	33	266	Mendelian_Metabolism	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
18.1818181818%	6	33	1972	Diabetes_McGill_ER_Stress	PILON_KLF1_TARGETS_DN
18.1818181818%	6	33	1691	Diabetes_McGill_ER_Stress	BLALOCK_ALZHEIMERS_DISEASE_UP
18.1818181818%	6	33	1237	Diabetes_McGill_ER_Stress	BLALOCK_ALZHEIMERS_DISEASE_DN
18.1818181818%	6	33	1229	Diabetes_McGill_ER_Stress	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
18.1818181818%	6	33	1210	Mendelian_Metabolism	CHEN_METABOLIC_SYNDROM_NETWORK
18.1818181818%	6	33	1142	Diabetes_McGill_ER_Stress	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
18.1818181818%	6	33	1037	Diabetes_McGill_ER_Stress	NUYTTEN_EZH2_TARGETS_UP
18.1818181818%	2	11	92	Mendelian_Diamond-Blackfan_Anemia	HILLION_HMGA1B_TARGETS
18.1818181818%	2	11	73	Mendelian_Diamond-Blackfan_Anemia	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
18.1818181818%	2	11	605	Mendelian_Diamond-Blackfan_Anemia	CAIRO_HEPATOBLASTOMA_CLASSES_UP
18.1818181818%	2	11	59	Mendelian_Diamond-Blackfan_Anemia	PID_P53REGULATIONPATHWAY
18.1818181818%	2	11	57	Mendelian_Diamond-Blackfan_Anemia	TONG_INTERACT_WITH_PTTG1
18.1818181818%	2	11	53	Mendelian_Diamond-Blackfan_Anemia	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP
18.1818181818%	2	11	457	Mendelian_Diamond-Blackfan_Anemia	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
18.1818181818%	2	11	37	Mendelian_Diamond-Blackfan_Anemia	BILANGES_SERUM_RESPONSE_TRANSLATION
18.1818181818%	2	11	36	Mendelian_Diamond-Blackfan_Anemia	JIANG_AGING_CEREBRAL_CORTEX_UP
18.1818181818%	2	11	352	Mendelian_Diamond-Blackfan_Anemia	WANG_LMO4_TARGETS_DN
18.1818181818%	2	11	271	Mendelian_Diamond-Blackfan_Anemia	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
18.1818181818%	2	11	26	Mendelian_Diamond-Blackfan_Anemia	HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP
18.1818181818%	2	11	222	Mendelian_Diamond-Blackfan_Anemia	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
18.1818181818%	2	11	201	Mendelian_Diamond-Blackfan_Anemia	KIM_MYC_AMPLIFICATION_TARGETS_UP
18.1818181818%	2	11	198	Mendelian_Diamond-Blackfan_Anemia	ALONSO_METASTASIS_UP
18.1818181818%	2	11	178	Mendelian_Diamond-Blackfan_Anemia	LI_AMPLIFIED_IN_LUNG_CANCER
18.1818181818%	2	11	127	Mendelian_Diamond-Blackfan_Anemia	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
18.1818181818%	2	11	1237	Mendelian_Diamond-Blackfan_Anemia	BLALOCK_ALZHEIMERS_DISEASE_DN
18.1818181818%	2	11	116	Mendelian_Diamond-Blackfan_Anemia	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
18.1818181818%	2	11	115	Mendelian_Diamond-Blackfan_Anemia	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
18.1818181818%	2	11	1024	Mendelian_Diamond-Blackfan_Anemia	NUYTTEN_EZH2_TARGETS_DN
18.1818181818%	2	11	1011	Mendelian_Diamond-Blackfan_Anemia	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
17.9487179487%	7	39	920	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_GPCR
17.9487179487%	7	39	898	Diabetes_McGill_IL6	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
17.9487179487%	7	39	89	Diabetes_McGill_IL6	KEGG_PROSTATE_CANCER
17.9487179487%	7	39	69	Diabetes_McGill_IL6	PID_MTOR_4PATHWAY
17.9487179487%	7	39	66	Diabetes_McGill_IL6	TENEDINI_MEGAKARYOCYTE_MARKERS
17.9487179487%	7	39	658	Diabetes_McGill_IL6	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
17.9487179487%	7	39	60	Diabetes_McGill_IL6	KEGG_ACUTE_MYELOID_LEUKEMIA
17.9487179487%	7	39	55	Diabetes_McGill_IL6	PID_TGFBRPATHWAY
17.9487179487%	7	39	52	Diabetes_McGill_IL6	KEGG_ENDOMETRIAL_CANCER
17.9487179487%	7	39	49	Diabetes_McGill_IL6	PID_FOXOPATHWAY
17.9487179487%	7	39	44	Diabetes_McGill_IL6	PID_ERBB2ERBB3PATHWAY
17.9487179487%	7	39	40	Diabetes_McGill_IL6	ST_B_CELL_ANTIGEN_RECEPTOR
17.9487179487%	7	39	40	Diabetes_McGill_IL6	PID_IFNGPATHWAY
17.9487179487%	7	39	35	Diabetes_McGill_IL6	ST_G_ALPHA_I_PATHWAY
17.9487179487%	7	39	34	Diabetes_McGill_IL6	PID_IL2_PI3KPATHWAY
17.9487179487%	7	39	34	Diabetes_McGill_IL6	PID_EPOPATHWAY
17.9487179487%	7	39	30	Diabetes_McGill_IL6	PID_IGF1_PATHWAY
17.9487179487%	7	39	27	Diabetes_McGill_IL6	PID_IL3_PATHWAY
17.9487179487%	7	39	22	Diabetes_McGill_IL6	BIOCARTA_HER2_PATHWAY
17.9487179487%	7	39	21	Diabetes_McGill_IL6	PID_P38_MK2PATHWAY
17.9487179487%	7	39	17	Diabetes_McGill_IL6	SA_TRKA_RECEPTOR
17.9487179487%	7	39	1442	Diabetes_McGill_IL6	PUJANA_ATM_PCC_NETWORK
17.9487179487%	7	39	1375	Diabetes_McGill_IL6	DODD_NASOPHARYNGEAL_CARCINOMA_DN
17.9487179487%	7	39	126	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
17.9487179487%	7	39	1229	Diabetes_McGill_IL6	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
17.9487179487%	7	39	1137	Diabetes_McGill_IL6	BRUINS_UVC_RESPONSE_LATE
17.8571428571%	5	28	93	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_REGULATION_OF_INSULIN_SECRETION
17.8571428571%	5	28	92	Diabetes_McGill_Cell_cycle_G1	REACTOME_SYNTHESIS_OF_DNA
17.8571428571%	5	28	918	Diabetes_McGill_Cell_cycle_G1	JOHNSTONE_PARVB_TARGETS_3_DN
17.8571428571%	5	28	81	Diabetes_McGill_Cell_cycle_G1	REACTOME_MITOTIC_G2_G2_M_PHASES
17.8571428571%	5	28	795	Diabetes_McGill_Cell_cycle_G1	WEI_MYCN_TARGETS_WITH_E_BOX
17.8571428571%	5	28	79	Diabetes_McGill_Cell_cycle_G1	PID_MYC_ACTIVPATHWAY
17.8571428571%	5	28	783	Diabetes_McGill_Cell_cycle_G1	ONKEN_UVEAL_MELANOMA_UP
17.8571428571%	5	28	775	Diabetes_McGill_Cell_cycle_G1	BENPORATH_MYC_MAX_TARGETS
17.8571428571%	5	28	77	Diabetes_McGill_Cell_cycle_G1	FRIDMAN_SENESCENCE_UP
17.8571428571%	5	28	77	Diabetes_McGill_Cell_cycle_G1	CARD_MIR302A_TARGETS
17.8571428571%	5	28	734	Diabetes_McGill_Cell_cycle_G1	BENPORATH_SOX2_TARGETS
17.8571428571%	5	28	70	Diabetes_McGill_Cell_cycle_G1	VERNELL_RETINOBLASTOMA_PATHWAY_UP
17.8571428571%	5	28	67	Diabetes_McGill_Cell_cycle_G1	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN
17.8571428571%	5	28	633	Diabetes_McGill_Cell_cycle_G1	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
17.8571428571%	5	28	612	Diabetes_McGill_Cell_cycle_G1	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
17.8571428571%	5	28	61	Diabetes_McGill_Cell_cycle_G1	REN_BOUND_BY_E2F
17.8571428571%	5	28	605	Diabetes_McGill_Cell_cycle_G1	CAIRO_HEPATOBLASTOMA_CLASSES_UP
17.8571428571%	5	28	601	Diabetes_McGill_Cell_cycle_G1	MARTINEZ_RB1_AND_TP53_TARGETS_UP
17.8571428571%	5	28	591	Diabetes_McGill_Cell_cycle_G1	MARTINEZ_RB1_AND_TP53_TARGETS_DN
17.8571428571%	5	28	590	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
17.8571428571%	5	28	572	Diabetes_McGill_Cell_cycle_G1	CHICAS_RB1_TARGETS_SENESCENT
17.8571428571%	5	28	553	Diabetes_McGill_Cell_cycle_G1	FEVR_CTNNB1_TARGETS_DN
17.8571428571%	5	28	55	Diabetes_McGill_Cell_cycle_G1	PID_TGFBRPATHWAY
17.8571428571%	5	28	483	Diabetes_McGill_Cell_cycle_G1	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
17.8571428571%	5	28	463	Diabetes_McGill_Cell_cycle_G1	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
17.8571428571%	5	28	459	Diabetes_McGill_Cell_cycle_G1	KIM_WT1_TARGETS_DN
17.8571428571%	5	28	456	Diabetes_McGill_Cell_cycle_G1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
17.8571428571%	5	28	45	Diabetes_McGill_Cell_cycle_G1	REACTOME_G2_M_CHECKPOINTS
17.8571428571%	5	28	38	Diabetes_McGill_Cell_cycle_G1	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER
17.8571428571%	5	28	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ROLEF_GLIS3_TARGETS
17.8571428571%	5	28	37	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_ALK_PATHWAY
17.8571428571%	5	28	352	Diabetes_McGill_Cell_cycle_G1	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
17.8571428571%	5	28	335	Diabetes_McGill_Cell_cycle_G1	WONG_EMBRYONIC_STEM_CELL_CORE
17.8571428571%	5	28	329	Diabetes_McGill_Cell_cycle_G1	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
17.8571428571%	5	28	324	Diabetes_McGill_Cell_cycle_G1	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
17.8571428571%	5	28	309	Diabetes_McGill_Cell_cycle_G1	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
17.8571428571%	5	28	294	Diabetes_McGill_Cell_cycle_G1	WEST_ADRENOCORTICAL_TUMOR_UP
17.8571428571%	5	28	29	Diabetes_McGill_Cell_cycle_G1	PID_BARD1PATHWAY
17.8571428571%	5	28	289	Diabetes_McGill_Cell_cycle_G1	MANALO_HYPOXIA_DN
17.8571428571%	5	28	277	Diabetes_McGill_Cell_cycle_G1	ZHANG_TLX_TARGETS_60HR_DN
17.8571428571%	5	28	277	Diabetes_McGill_Cell_cycle_G1	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
17.8571428571%	5	28	27	Diabetes_McGill_Cell_cycle_G1	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION
17.8571428571%	5	28	241	Diabetes_McGill_Cell_cycle_G1	DOANE_RESPONSE_TO_ANDROGEN_DN
17.8571428571%	5	28	230	Diabetes_McGill_Cell_cycle_G1	KAUFFMANN_DNA_REPAIR_GENES
17.8571428571%	5	28	21	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_TOB1_PATHWAY
17.8571428571%	5	28	19	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_TGFB_PATHWAY
17.8571428571%	5	28	182	Diabetes_McGill_Cell_cycle_G1	FERNANDEZ_BOUND_BY_MYC
17.8571428571%	5	28	18	Diabetes_McGill_Cell_cycle_G1	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
17.8571428571%	5	28	176	Diabetes_McGill_Cell_cycle_G1	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
17.8571428571%	5	28	1725	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
17.8571428571%	5	28	17	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_ARF_PATHWAY
17.8571428571%	5	28	16	Diabetes_McGill_Cell_cycle_G1	HE_PTEN_TARGETS_UP
17.8571428571%	5	28	151	Diabetes_McGill_Cell_cycle_G1	KEGG_WNT_SIGNALING_PATHWAY
17.8571428571%	5	28	149	Diabetes_McGill_Cell_cycle_G1	TSAI_RESPONSE_TO_IONIZING_RADIATION
17.8571428571%	5	28	1442	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PUJANA_ATM_PCC_NETWORK
17.8571428571%	5	28	142	Diabetes_McGill_Cell_cycle_G1	RUIZ_TNC_TARGETS_DN
17.8571428571%	5	28	14	Diabetes_McGill_Cell_cycle_G1	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
17.8571428571%	5	28	137	Diabetes_McGill_Cell_cycle_G1	PID_P53DOWNSTREAMPATHWAY
17.8571428571%	5	28	1305	Diabetes_McGill_Cell_cycle_G1	YOSHIMURA_MAPK8_TARGETS_UP
17.8571428571%	5	28	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
17.8571428571%	5	28	1142	Diabetes_McGill_Cell_cycle_G1	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
17.8571428571%	5	28	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ZHOU_PANCREATIC_EXOCRINE_PROGENITOR
17.8571428571%	5	28	103	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALING_BY_NOTCH
17.8571428571%	5	28	1024	Diabetes_McGill_Cell_cycle_G1	NUYTTEN_EZH2_TARGETS_DN
17.8571428571%	5	28	1022	Diabetes_McGill_Cell_cycle_G1	MARSON_BOUND_BY_FOXP3_STIMULATED
17.8571428571%	5	28	1011	Diabetes_McGill_Cell_cycle_G1	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
17.7419354839%	22	124	61	Diabetes_McGill_Cell_cycle_All_Gene	REN_BOUND_BY_E2F
17.7419354839%	22	124	539	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
17.7419354839%	22	124	44	Diabetes_McGill_Cell_cycle_All_Gene	WHITFIELD_CELL_CYCLE_LITERATURE
17.7419354839%	22	124	430	Diabetes_McGill_Cell_cycle_All_Gene	VECCHI_GASTRIC_CANCER_EARLY_UP
17.7419354839%	22	124	117	Diabetes_McGill_Cell_cycle_All_Gene	PUJANA_BRCA_CENTERED_NETWORK
17.6470588235%	3	17	90	Mendelian_Blood_Desease	HILLION_HMGA1_TARGETS
17.6470588235%	3	17	75	Mendelian_Severe_Combined_Immunodeficiency	MORI_MATURE_B_LYMPHOCYTE_DN
17.6470588235%	3	17	72	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_METABOLISM_OF_NUCLEOTIDES
17.6470588235%	3	17	668	Mendelian_Blood_Desease	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
17.6470588235%	3	17	66	Mendelian_Severe_Combined_Immunodeficiency	PID_TCR_PATHWAY
17.6470588235%	3	17	59	Mendelian_Blood_Desease	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
17.6470588235%	3	17	579	Mendelian_Severe_Combined_Immunodeficiency	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
17.6470588235%	3	17	553	Mendelian_Blood_Desease	FEVR_CTNNB1_TARGETS_DN
17.6470588235%	3	17	552	Mendelian_Severe_Combined_Immunodeficiency	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
17.6470588235%	3	17	54	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_TCR_SIGNALING
17.6470588235%	3	17	539	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
17.6470588235%	3	17	53	Mendelian_Severe_Combined_Immunodeficiency	PID_CD8TCRPATHWAY
17.6470588235%	3	17	53	Mendelian_Blood_Desease	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP
17.6470588235%	3	17	52	Mendelian_Blood_Desease	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP
17.6470588235%	3	17	517	Mendelian_Blood_Desease	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
17.6470588235%	3	17	50	Mendelian_Severe_Combined_Immunodeficiency	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
17.6470588235%	3	17	491	Mendelian_Severe_Combined_Immunodeficiency	ZHENG_BOUND_BY_FOXP3
17.6470588235%	3	17	463	Mendelian_Severe_Combined_Immunodeficiency	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
17.6470588235%	3	17	456	Mendelian_Blood_Desease	MARTENS_BOUND_BY_PML_RARA_FUSION
17.6470588235%	3	17	45	Mendelian_Severe_Combined_Immunodeficiency	ST_T_CELL_SIGNAL_TRANSDUCTION
17.6470588235%	3	17	442	Mendelian_Severe_Combined_Immunodeficiency	HAN_SATB1_TARGETS_DN
17.6470588235%	3	17	405	Mendelian_Severe_Combined_Immunodeficiency	KUMAR_TARGETS_OF_MLL_AF9_FUSION
17.6470588235%	3	17	374	Mendelian_Severe_Combined_Immunodeficiency	WANG_TUMOR_INVASIVENESS_UP
17.6470588235%	3	17	356	Mendelian_Severe_Combined_Immunodeficiency	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
17.6470588235%	3	17	320	Mendelian_Severe_Combined_Immunodeficiency	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
17.6470588235%	3	17	288	Mendelian_Severe_Combined_Immunodeficiency	POOLA_INVASIVE_BREAST_CANCER_UP
17.6470588235%	3	17	276	Mendelian_Severe_Combined_Immunodeficiency	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
17.6470588235%	3	17	246	Mendelian_Severe_Combined_Immunodeficiency	VERHAAK_AML_WITH_NPM1_MUTATED_DN
17.6470588235%	3	17	24	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_CSK_PATHWAY
17.6470588235%	3	17	236	Mendelian_Blood_Desease	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
17.6470588235%	3	17	230	Mendelian_Blood_Desease	BENPORATH_MYC_TARGETS_WITH_EBOX
17.6470588235%	3	17	215	Mendelian_Severe_Combined_Immunodeficiency	MARKEY_RB1_ACUTE_LOF_UP
17.6470588235%	3	17	203	Mendelian_Blood_Desease	GRUETZMANN_PANCREATIC_CANCER_DN
17.6470588235%	3	17	1725	Mendelian_Severe_Combined_Immunodeficiency	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
17.6470588235%	3	17	17	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_IL7_PATHWAY
17.6470588235%	3	17	159	Mendelian_Severe_Combined_Immunodeficiency	KEGG_PURINE_METABOLISM
17.6470588235%	3	17	155	Mendelian_Severe_Combined_Immunodeficiency	KEGG_JAK_STAT_SIGNALING_PATHWAY
17.6470588235%	3	17	1382	Mendelian_Severe_Combined_Immunodeficiency	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
17.6470588235%	3	17	1375	Mendelian_Blood_Desease	DODD_NASOPHARYNGEAL_CARCINOMA_DN
17.6470588235%	3	17	13	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_TCRA_PATHWAY
17.6470588235%	3	17	13	Mendelian_Blood_Desease	BIOCARTA_AHSP_PATHWAY
17.6470588235%	3	17	1237	Mendelian_Blood_Desease	BLALOCK_ALZHEIMERS_DISEASE_DN
17.6470588235%	3	17	11	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_IL_7_SIGNALING
17.6470588235%	3	17	108	Mendelian_Severe_Combined_Immunodeficiency	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
17.6470588235%	3	17	107	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_SIGNALING_BY_ILS
17.3913043478%	44	253	1103	Diabetes_McGill_CREBBP_coTF	DANG_BOUND_BY_MYC
17.3913043478%	4	23	97	Diabetes_McGill_Mtor_pathway	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
17.3913043478%	4	23	957	Diabetes_McGill_Mtor_pathway	LOPEZ_MBD_TARGETS
17.3913043478%	4	23	882	Diabetes_McGill_Mtor_pathway	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
17.3913043478%	4	23	84	Diabetes_McGill_Mtor_pathway	KEGG_SMALL_CELL_LUNG_CANCER
17.3913043478%	4	23	805	Diabetes_McGill_Mtor_pathway	REACTOME_GPCR_DOWNSTREAM_SIGNALING
17.3913043478%	4	23	800	Diabetes_McGill_Mtor_pathway	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
17.3913043478%	4	23	75	Diabetes_McGill_Mtor_pathway	PID_AVB3_INTEGRIN_PATHWAY
17.3913043478%	4	23	71	Diabetes_McGill_Mtor_pathway	KEGG_MELANOMA
17.3913043478%	4	23	70	Diabetes_McGill_Mtor_pathway	PID_CDC42_PATHWAY
17.3913043478%	4	23	69	Diabetes_McGill_Mtor_pathway	PID_VEGFR1_2_PATHWAY
17.3913043478%	4	23	682	Diabetes_McGill_Mtor_pathway	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
17.3913043478%	4	23	673	Diabetes_McGill_Mtor_pathway	MARTINEZ_RB1_TARGETS_UP
17.3913043478%	4	23	605	Diabetes_McGill_Mtor_pathway	CAIRO_HEPATOBLASTOMA_CLASSES_UP
17.3913043478%	4	23	584	Diabetes_McGill_Mtor_pathway	HAMAI_APOPTOSIS_VIA_TRAIL_UP
17.3913043478%	4	23	567	Diabetes_McGill_Mtor_pathway	PARENT_MTOR_SIGNALING_UP
17.3913043478%	4	23	55	Diabetes_McGill_Mtor_pathway	PID_TGFBRPATHWAY
17.3913043478%	4	23	55	Diabetes_McGill_Mtor_pathway	PID_FGF_PATHWAY
17.3913043478%	4	23	54	Diabetes_McGill_Mtor_pathway	REACTOME_TCR_SIGNALING
17.3913043478%	4	23	54	Diabetes_McGill_Mtor_pathway	KEGG_NON_SMALL_CELL_LUNG_CANCER
17.3913043478%	4	23	514	Diabetes_McGill_Mtor_pathway	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
17.3913043478%	4	23	51	Diabetes_McGill_Mtor_pathway	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
17.3913043478%	4	23	508	Diabetes_McGill_Mtor_pathway	ENK_UV_RESPONSE_EPIDERMIS_DN
17.3913043478%	4	23	50	Diabetes_McGill_Mtor_pathway	PID_ANGIOPOIETINRECEPTOR_PATHWAY
17.3913043478%	4	23	49	Diabetes_McGill_Mtor_pathway	PID_PI3KCIPATHWAY
17.3913043478%	4	23	46	Diabetes_McGill_Mtor_pathway	PID_A6B1_A6B4_INTEGRIN_PATHWAY
17.3913043478%	4	23	45	Diabetes_McGill_Mtor_pathway	SIG_CHEMOTAXIS
17.3913043478%	4	23	44	Diabetes_McGill_Mtor_pathway	PID_ERBB2ERBB3PATHWAY
17.3913043478%	4	23	406	Diabetes_McGill_Mtor_pathway	OSMAN_BLADDER_CANCER_DN
17.3913043478%	4	23	40	Diabetes_McGill_Mtor_pathway	PID_IFNGPATHWAY
17.3913043478%	4	23	38	Diabetes_McGill_Mtor_pathway	PID_FASPATHWAY
17.3913043478%	4	23	38	Diabetes_McGill_Mtor_pathway	BIOCARTA_IL2RB_PATHWAY
17.3913043478%	4	23	374	Diabetes_McGill_Mtor_pathway	WANG_TUMOR_INVASIVENESS_UP
17.3913043478%	4	23	37	Diabetes_McGill_Mtor_pathway	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
17.3913043478%	4	23	37	Diabetes_McGill_Mtor_pathway	REACTOME_DOWNSTREAM_TCR_SIGNALING
17.3913043478%	4	23	368	Diabetes_McGill_Mtor_pathway	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
17.3913043478%	4	23	36	Diabetes_McGill_Mtor_pathway	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
17.3913043478%	4	23	36	Diabetes_McGill_Mtor_pathway	PID_PI3KPLCTRKPATHWAY
17.3913043478%	4	23	335	Diabetes_McGill_Mtor_pathway	WONG_EMBRYONIC_STEM_CELL_CORE
17.3913043478%	4	23	31	Diabetes_McGill_Mtor_pathway	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
17.3913043478%	4	23	26	Diabetes_McGill_Mtor_pathway	PID_VEGFR1_PATHWAY
17.3913043478%	4	23	208	Diabetes_McGill_Mtor_pathway	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
17.3913043478%	4	23	197	Diabetes_McGill_Mtor_pathway	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
17.3913043478%	4	23	1839	Diabetes_McGill_Mtor_pathway	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
17.3913043478%	4	23	182	Diabetes_McGill_Mtor_pathway	FERNANDEZ_BOUND_BY_MYC
17.3913043478%	4	23	181	Diabetes_McGill_Mtor_pathway	JISON_SICKLE_CELL_DISEASE_DN
17.3913043478%	4	23	16	Diabetes_McGill_Mtor_pathway	BIOCARTA_BCELLSURVIVAL_PATHWAY
17.3913043478%	4	23	1442	Diabetes_McGill_Mtor_pathway	PUJANA_ATM_PCC_NETWORK
17.3913043478%	4	23	129	Diabetes_McGill_Mtor_pathway	PID_PDGFRBPATHWAY
17.1428571429%	12	70	87	Diabetes_McGill_Adipocytokine_signallin	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
17.1428571429%	12	70	71	Diabetes_McGill_Adipocytokine_signallin	REACTOME_PI3K_CASCADE
17.1428571429%	12	70	70	Diabetes_McGill_Adipocytokine_signallin	KEGG_PANCREATIC_CANCER
17.1428571429%	12	70	47	Diabetes_McGill_Adipocytokine_signallin	KEGG_TYPE_II_DIABETES_MELLITUS
17.1428571429%	12	70	217	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SIGNALLING_BY_NGF
17.1428571429%	12	70	190	Diabetes_McGill_Adipocytokine_signallin	KEGG_CHEMOKINE_SIGNALING_PATHWAY
17.1428571429%	12	70	19	Diabetes_McGill_Adipocytokine_signallin	REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE
17.1428571429%	12	70	108	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
17.0731707317%	7	41	553	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FEVR_CTNNB1_TARGETS_DN
17.0731707317%	7	41	510	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
17.0731707317%	7	41	478	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
17.0731707317%	7	41	466	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_HEMOSTASIS
17.0731707317%	7	41	323	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GRESHOCK_CANCER_COPY_NUMBER_UP
17.0731707317%	7	41	1442	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PUJANA_ATM_PCC_NETWORK
17.0731707317%	7	41	137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_INSULIN_SIGNALING_PATHWAY
16.9960474308%	43	253	328	Diabetes_McGill_CREBBP_coTF	KEGG_PATHWAYS_IN_CANCER
16.935483871%	21	124	92	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SYNTHESIS_OF_DNA
16.935483871%	21	124	73	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_CHRONIC_MYELOID_LEUKEMIA
16.935483871%	21	124	557	Diabetes_McGill_Cell_cycle_All_Gene	TIEN_INTESTINE_PROBIOTICS_24HR_UP
16.935483871%	21	124	459	Diabetes_McGill_Cell_cycle_All_Gene	KIM_WT1_TARGETS_DN
16.935483871%	21	124	38	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS
16.935483871%	21	124	346	Diabetes_McGill_Cell_cycle_All_Gene	GOLDRATH_ANTIGEN_RESPONSE
16.935483871%	21	124	230	Diabetes_McGill_Cell_cycle_All_Gene	KAUFFMANN_DNA_REPAIR_GENES
16.935483871%	21	124	147	Diabetes_McGill_Cell_cycle_All_Gene	KAUFFMANN_DNA_REPLICATION_GENES
16.935483871%	21	124	140	Diabetes_McGill_Cell_cycle_All_Gene	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
16.6666666667%	7	42	328	Diabetes_McGill_RAS	KEGG_PATHWAYS_IN_CANCER
16.6666666667%	5	30	830	Mendelian_Hereditary_Sensory_Neuropathy	CUI_TCF21_TARGETS_2_DN
16.6666666667%	5	30	567	Mendelian_Hereditary_Sensory_Neuropathy	CHICAS_RB1_TARGETS_CONFLUENT
16.6666666667%	5	30	548	Mendelian_Hereditary_Sensory_Neuropathy	KIM_ALL_DISORDERS_CALB1_CORR_UP
16.6666666667%	5	30	508	Mendelian_Hereditary_Sensory_Neuropathy	ENK_UV_RESPONSE_EPIDERMIS_DN
16.6666666667%	5	30	1781	Mendelian_Hereditary_Sensory_Neuropathy	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
16.6666666667%	5	30	1237	Mendelian_Hereditary_Sensory_Neuropathy	BLALOCK_ALZHEIMERS_DISEASE_DN
16.6666666667%	5	30	1210	Mendelian_Hereditary_Sensory_Neuropathy	CHEN_METABOLIC_SYNDROM_NETWORK
16.6666666667%	5	30	1118	Mendelian_Hereditary_Sensory_Neuropathy	BENPORATH_ES_WITH_H3K27ME3
16.6666666667%	5	30	108	Mendelian_Hereditary_Sensory_Neuropathy	LE_EGR2_TARGETS_DN
16.6666666667%	5	30	1038	Mendelian_Hereditary_Sensory_Neuropathy	BENPORATH_SUZ12_TARGETS
16.6666666667%	4	24	89	Diabetes_McGill_TNF_alpha_signalin	KEGG_PROSTATE_CANCER
16.6666666667%	4	24	882	Diabetes_McGill_TNF_alpha_signalin	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
16.6666666667%	4	24	855	Diabetes_McGill_TNF_alpha_signalin	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
16.6666666667%	4	24	84	Diabetes_McGill_TNF_alpha_signalin	KEGG_SMALL_CELL_LUNG_CANCER
16.6666666667%	4	24	83	Diabetes_McGill_TNF_alpha_signalin	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
16.6666666667%	4	24	82	Diabetes_McGill_TNF_alpha_signalin	PID_REG_GR_PATHWAY
16.6666666667%	4	24	770	Diabetes_McGill_TNF_alpha_signalin	KRIEG_HYPOXIA_NOT_VIA_KDM3A
16.6666666667%	4	24	77	Diabetes_McGill_TNF_alpha_signalin	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
16.6666666667%	4	24	75	Diabetes_McGill_TNF_alpha_signalin	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
16.6666666667%	4	24	73	Diabetes_McGill_TNF_alpha_signalin	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
16.6666666667%	4	24	73	Diabetes_McGill_TNF_alpha_signalin	KEGG_VIRAL_MYOCARDITIS
16.6666666667%	4	24	70	Diabetes_McGill_TNF_alpha_signalin	KEGG_PANCREATIC_CANCER
16.6666666667%	4	24	682	Diabetes_McGill_TNF_alpha_signalin	FEVR_CTNNB1_TARGETS_UP
16.6666666667%	4	24	68	Diabetes_McGill_TNF_alpha_signalin	PID_TELOMERASEPATHWAY
16.6666666667%	4	24	65	Diabetes_McGill_TNF_alpha_signalin	PID_CD8TCRDOWNSTREAMPATHWAY
16.6666666667%	4	24	65	Diabetes_McGill_TNF_alpha_signalin	PID_BCR_5PATHWAY
16.6666666667%	4	24	62	Diabetes_McGill_TNF_alpha_signalin	PID_FCER1PATHWAY
16.6666666667%	4	24	584	Diabetes_McGill_TNF_alpha_signalin	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
16.6666666667%	4	24	58	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_PPARA_PATHWAY
16.6666666667%	4	24	55	Diabetes_McGill_TNF_alpha_signalin	LAU_APOPTOSIS_CDKN2A_UP
16.6666666667%	4	24	54	Diabetes_McGill_TNF_alpha_signalin	REACTOME_APOPTOTIC_EXECUTION_PHASE
16.6666666667%	4	24	50	Diabetes_McGill_TNF_alpha_signalin	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
16.6666666667%	4	24	50	Diabetes_McGill_TNF_alpha_signalin	PID_ANGIOPOIETINRECEPTOR_PATHWAY
16.6666666667%	4	24	409	Diabetes_McGill_TNF_alpha_signalin	FOSTER_TOLERANT_MACROPHAGE_DN
16.6666666667%	4	24	40	Diabetes_McGill_TNF_alpha_signalin	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
16.6666666667%	4	24	39	Diabetes_McGill_TNF_alpha_signalin	HOFMANN_CELL_LYMPHOMA_DN
16.6666666667%	4	24	34	Diabetes_McGill_TNF_alpha_signalin	SIG_CD40PATHWAYMAP
16.6666666667%	4	24	31	Diabetes_McGill_TNF_alpha_signalin	PID_AVB3_OPN_PATHWAY
16.6666666667%	4	24	23	Diabetes_McGill_TNF_alpha_signalin	PID_NFKAPPABCANONICALPATHWAY
16.6666666667%	4	24	23	Diabetes_McGill_TNF_alpha_signalin	MARKS_HDAC_TARGETS_UP
16.6666666667%	4	24	21	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_TFF_PATHWAY
16.6666666667%	4	24	19	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_TID_PATHWAY
16.6666666667%	4	24	185	Diabetes_McGill_TNF_alpha_signalin	KEGG_HUNTINGTONS_DISEASE
16.6666666667%	4	24	18	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_TNFR2_PATHWAY
16.6666666667%	4	24	15	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_HSP27_PATHWAY
16.6666666667%	4	24	137	Diabetes_McGill_TNF_alpha_signalin	PID_P53DOWNSTREAMPATHWAY
16.6666666667%	4	24	13	Diabetes_McGill_TNF_alpha_signalin	REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS
16.6666666667%	4	24	1229	Diabetes_McGill_TNF_alpha_signalin	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
16.6666666667%	4	24	1174	Diabetes_McGill_TNF_alpha_signalin	PEREZ_TP53_TARGETS
16.6666666667%	4	24	1118	Diabetes_McGill_TNF_alpha_signalin	BENPORATH_ES_WITH_H3K27ME3
16.6666666667%	4	24	1037	Diabetes_McGill_TNF_alpha_signalin	NUYTTEN_EZH2_TARGETS_UP
16.6666666667%	2	12	98	Diabetes_McGill_Adipocytokines	MENSE_HYPOXIA_UP
16.6666666667%	2	12	953	Mendelian_Etc	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
16.6666666667%	2	12	933	Mendelian_Etc	REACTOME_IMMUNE_SYSTEM
16.6666666667%	2	12	92	Diabetes_McGill_Adipocytokines	WINTER_HYPOXIA_UP
16.6666666667%	2	12	911	Mendelian_Etc	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
16.6666666667%	2	12	9	Diabetes_McGill_Adipocytokines	ZERBINI_RESPONSE_TO_SULINDAC_UP
16.6666666667%	2	12	9	Diabetes_McGill_Adipocytokines	SIMBULAN_UV_RESPONSE_NORMAL_UP
16.6666666667%	2	12	882	Mendelian_Etc	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
16.6666666667%	2	12	882	Diabetes_McGill_Adipocytokines	LEE_BMP2_TARGETS_DN
16.6666666667%	2	12	88	Diabetes_McGill_Adipocytokines	KEGG_HEMATOPOIETIC_CELL_LINEAGE
16.6666666667%	2	12	86	Diabetes_McGill_Adipocytokines	GHANDHI_BYSTANDER_IRRADIATION_UP
16.6666666667%	2	12	85	Mendelian_Etc	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
16.6666666667%	2	12	830	Diabetes_McGill_Adipocytokines	CUI_TCF21_TARGETS_2_DN
16.6666666667%	2	12	83	Diabetes_McGill_Adipocytokines	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
16.6666666667%	2	12	82	Diabetes_McGill_Adipocytokines	PID_REG_GR_PATHWAY
16.6666666667%	2	12	81	Diabetes_McGill_Adipocytokines	MAHAJAN_RESPONSE_TO_IL1A_UP
16.6666666667%	2	12	80	Diabetes_McGill_Adipocytokines	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
16.6666666667%	2	12	80	Diabetes_McGill_Adipocytokines	FALVELLA_SMOKERS_WITH_LUNG_CANCER
16.6666666667%	2	12	8	Diabetes_McGill_Adipocytokines	KONDO_HYPOXIA
16.6666666667%	2	12	795	Diabetes_McGill_Adipocytokines	WEI_MYCN_TARGETS_WITH_E_BOX
16.6666666667%	2	12	783	Mendelian_Etc	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
16.6666666667%	2	12	781	Mendelian_Etc	GOZGIT_ESR1_TARGETS_DN
16.6666666667%	2	12	756	Mendelian_Etc	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
16.6666666667%	2	12	722	Diabetes_McGill_Adipocytokines	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
16.6666666667%	2	12	720	Diabetes_McGill_Adipocytokines	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
16.6666666667%	2	12	712	Diabetes_McGill_Adipocytokines	SCHLOSSER_SERUM_RESPONSE_DN
16.6666666667%	2	12	701	Mendelian_Etc	SMID_BREAST_CANCER_BASAL_DN
16.6666666667%	2	12	70	Diabetes_McGill_Adipocytokines	PID_AP1_PATHWAY
16.6666666667%	2	12	673	Diabetes_McGill_Adipocytokines	MARTINEZ_RB1_TARGETS_UP
16.6666666667%	2	12	67	Diabetes_McGill_Adipocytokines	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
16.6666666667%	2	12	67	Diabetes_McGill_Adipocytokines	LINDSTEDT_DENDRITIC_CELL_MATURATION_A
16.6666666667%	2	12	668	Mendelian_Etc	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
16.6666666667%	2	12	66	Diabetes_McGill_Adipocytokines	PID_LYSOPHOSPHOLIPID_PATHWAY
16.6666666667%	2	12	648	Diabetes_McGill_Adipocytokines	SMID_BREAST_CANCER_BASAL_UP
16.6666666667%	2	12	64	Diabetes_McGill_Adipocytokines	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
16.6666666667%	2	12	633	Diabetes_McGill_Adipocytokines	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
16.6666666667%	2	12	63	Diabetes_McGill_Adipocytokines	PHONG_TNF_TARGETS_UP
16.6666666667%	2	12	63	Diabetes_McGill_Adipocytokines	CROMER_TUMORIGENESIS_UP
16.6666666667%	2	12	62	Diabetes_McGill_Adipocytokines	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
16.6666666667%	2	12	612	Diabetes_McGill_Adipocytokines	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
16.6666666667%	2	12	602	Diabetes_McGill_Adipocytokines	MARTINEZ_TP53_TARGETS_UP
16.6666666667%	2	12	601	Diabetes_McGill_Adipocytokines	MARTINEZ_RB1_AND_TP53_TARGETS_UP
16.6666666667%	2	12	6	Diabetes_McGill_Adipocytokines	MIZUKAMI_HYPOXIA_DN
16.6666666667%	2	12	59	Diabetes_McGill_Adipocytokines	PID_ATF2_PATHWAY
16.6666666667%	2	12	59	Diabetes_McGill_Adipocytokines	DASU_IL6_SIGNALING_UP
16.6666666667%	2	12	584	Mendelian_Etc	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
16.6666666667%	2	12	579	Diabetes_McGill_Adipocytokines	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
16.6666666667%	2	12	566	Diabetes_McGill_Adipocytokines	DOUGLAS_BMI1_TARGETS_UP
16.6666666667%	2	12	564	Diabetes_McGill_Adipocytokines	SMID_BREAST_CANCER_LUMINAL_B_DN
16.6666666667%	2	12	555	Diabetes_McGill_Adipocytokines	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
16.6666666667%	2	12	552	Mendelian_Etc	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
16.6666666667%	2	12	518	Mendelian_Etc	REACTOME_METABOLISM_OF_PROTEINS
16.6666666667%	2	12	514	Mendelian_Etc	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
16.6666666667%	2	12	51	Diabetes_McGill_Adipocytokines	BURTON_ADIPOGENESIS_PEAK_AT_2HR
16.6666666667%	2	12	504	Mendelian_Etc	BROWNE_HCMV_INFECTION_48HR_DN
16.6666666667%	2	12	504	Diabetes_McGill_Adipocytokines	BROWNE_HCMV_INFECTION_48HR_DN
16.6666666667%	2	12	493	Mendelian_Etc	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
16.6666666667%	2	12	489	Diabetes_McGill_Adipocytokines	LIM_MAMMARY_STEM_CELL_UP
16.6666666667%	2	12	476	Diabetes_McGill_Adipocytokines	SMID_BREAST_CANCER_NORMAL_LIKE_UP
16.6666666667%	2	12	47	Diabetes_McGill_Adipocytokines	ZHU_CMV_8_HR_UP
16.6666666667%	2	12	460	Diabetes_McGill_Adipocytokines	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
16.6666666667%	2	12	457	Mendelian_Etc	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
16.6666666667%	2	12	456	Mendelian_Etc	MARTENS_BOUND_BY_PML_RARA_FUSION
16.6666666667%	2	12	448	Mendelian_Etc	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
16.6666666667%	2	12	442	Diabetes_McGill_Adipocytokines	HAN_SATB1_TARGETS_DN
16.6666666667%	2	12	435	Diabetes_McGill_Adipocytokines	SWEET_LUNG_CANCER_KRAS_DN
16.6666666667%	2	12	434	Diabetes_McGill_Adipocytokines	BAELDE_DIABETIC_NEPHROPATHY_DN
16.6666666667%	2	12	431	Diabetes_McGill_Adipocytokines	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
16.6666666667%	2	12	428	Mendelian_Etc	CUI_TCF21_TARGETS_2_UP
16.6666666667%	2	12	423	Diabetes_McGill_Adipocytokines	THUM_SYSTOLIC_HEART_FAILURE_UP
16.6666666667%	2	12	42	Diabetes_McGill_Adipocytokines	KEGG_BLADDER_CANCER
16.6666666667%	2	12	418	Diabetes_McGill_Adipocytokines	MULLIGHAN_MLL_SIGNATURE_2_UP
16.6666666667%	2	12	41	Diabetes_McGill_Adipocytokines	WEINMANN_ADAPTATION_TO_HYPOXIA_DN
16.6666666667%	2	12	409	Diabetes_McGill_Adipocytokines	FOSTER_TOLERANT_MACROPHAGE_DN
16.6666666667%	2	12	408	Diabetes_McGill_Adipocytokines	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
16.6666666667%	2	12	40	Mendelian_Etc	KEGG_SPHINGOLIPID_METABOLISM
16.6666666667%	2	12	398	Diabetes_McGill_Adipocytokines	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
16.6666666667%	2	12	397	Mendelian_Etc	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
16.6666666667%	2	12	394	Mendelian_Etc	BERENJENO_TRANSFORMED_BY_RHOA_DN
16.6666666667%	2	12	390	Diabetes_McGill_Adipocytokines	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
16.6666666667%	2	12	39	Diabetes_McGill_Adipocytokines	AMIT_EGF_RESPONSE_60_MCF10A
16.6666666667%	2	12	384	Diabetes_McGill_Adipocytokines	BASAKI_YBX1_TARGETS_DN
16.6666666667%	2	12	380	Diabetes_McGill_Adipocytokines	MULLIGHAN_MLL_SIGNATURE_1_UP
16.6666666667%	2	12	37	Mendelian_Etc	HOWLIN_CITED1_TARGETS_1_DN
16.6666666667%	2	12	37	Diabetes_McGill_Adipocytokines	PID_FRA_PATHWAY
16.6666666667%	2	12	366	Mendelian_Etc	YOSHIMURA_MAPK8_TARGETS_DN
16.6666666667%	2	12	364	Diabetes_McGill_Adipocytokines	YANG_BCL3_TARGETS_UP
16.6666666667%	2	12	352	Mendelian_Etc	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
16.6666666667%	2	12	34	Diabetes_McGill_Adipocytokines	PID_IL8CXCR2_PATHWAY
16.6666666667%	2	12	330	Mendelian_Etc	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
16.6666666667%	2	12	330	Diabetes_McGill_Adipocytokines	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
16.6666666667%	2	12	33	Diabetes_McGill_Adipocytokines	BURTON_ADIPOGENESIS_1
16.6666666667%	2	12	328	Mendelian_Etc	KEGG_PATHWAYS_IN_CANCER
16.6666666667%	2	12	323	Mendelian_Etc	GRESHOCK_CANCER_COPY_NUMBER_UP
16.6666666667%	2	12	32	Diabetes_McGill_Adipocytokines	TSAI_RESPONSE_TO_RADIATION_THERAPY
16.6666666667%	2	12	318	Diabetes_McGill_Adipocytokines	LEI_MYB_TARGETS
16.6666666667%	2	12	315	Diabetes_McGill_Adipocytokines	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
16.6666666667%	2	12	293	Mendelian_Etc	ENK_UV_RESPONSE_EPIDERMIS_UP
16.6666666667%	2	12	293	Diabetes_McGill_Adipocytokines	ENK_UV_RESPONSE_EPIDERMIS_UP
16.6666666667%	2	12	29	Diabetes_McGill_Adipocytokines	BIOCARTA_INFLAM_PATHWAY
16.6666666667%	2	12	281	Diabetes_McGill_Adipocytokines	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
16.6666666667%	2	12	28	Diabetes_McGill_Adipocytokines	TIAN_TNF_SIGNALING_VIA_NFKB
16.6666666667%	2	12	28	Diabetes_McGill_Adipocytokines	PID_IL8CXCR1_PATHWAY
16.6666666667%	2	12	279	Mendelian_Etc	REACTOME_INNATE_IMMUNE_SYSTEM
16.6666666667%	2	12	279	Diabetes_McGill_Adipocytokines	FORTSCHEGGER_PHF8_TARGETS_UP
16.6666666667%	2	12	26	Diabetes_McGill_Adipocytokines	PID_IL27PATHWAY
16.6666666667%	2	12	25	Diabetes_McGill_Adipocytokines	KIM_HYPOXIA
16.6666666667%	2	12	246	Diabetes_McGill_Adipocytokines	VERHAAK_AML_WITH_NPM1_MUTATED_DN
16.6666666667%	2	12	245	Diabetes_McGill_Adipocytokines	MCLACHLAN_DENTAL_CARIES_DN
16.6666666667%	2	12	245	Diabetes_McGill_Adipocytokines	KONDO_EZH2_TARGETS
16.6666666667%	2	12	245	Diabetes_McGill_Adipocytokines	BLUM_RESPONSE_TO_SALIRASIB_UP
16.6666666667%	2	12	244	Mendelian_Etc	KAYO_AGING_MUSCLE_UP
16.6666666667%	2	12	244	Diabetes_McGill_Adipocytokines	HSIAO_LIVER_SPECIFIC_GENES
16.6666666667%	2	12	244	Diabetes_McGill_Adipocytokines	DAZARD_RESPONSE_TO_UV_NHEK_UP
16.6666666667%	2	12	242	Diabetes_McGill_Adipocytokines	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
16.6666666667%	2	12	24	Diabetes_McGill_Adipocytokines	DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
16.6666666667%	2	12	233	Diabetes_McGill_Adipocytokines	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
16.6666666667%	2	12	229	Diabetes_McGill_Adipocytokines	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
16.6666666667%	2	12	225	Diabetes_McGill_Adipocytokines	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
16.6666666667%	2	12	223	Diabetes_McGill_Adipocytokines	CHEN_HOXA5_TARGETS_9HR_UP
16.6666666667%	2	12	222	Diabetes_McGill_Adipocytokines	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
16.6666666667%	2	12	220	Diabetes_McGill_Adipocytokines	RIGGINS_TAMOXIFEN_RESISTANCE_DN
16.6666666667%	2	12	22	Diabetes_McGill_Adipocytokines	BIOCARTA_CYTOKINE_PATHWAY
16.6666666667%	2	12	217	Diabetes_McGill_Adipocytokines	AMUNDSON_RESPONSE_TO_ARSENITE
16.6666666667%	2	12	214	Mendelian_Etc	ZWANG_EGF_INTERVAL_DN
16.6666666667%	2	12	21	Diabetes_McGill_Adipocytokines	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD
16.6666666667%	2	12	203	Mendelian_Etc	GRUETZMANN_PANCREATIC_CANCER_DN
16.6666666667%	2	12	199	Diabetes_McGill_Adipocytokines	PLASARI_TGFB1_TARGETS_10HR_UP
16.6666666667%	2	12	197	Diabetes_McGill_Adipocytokines	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
16.6666666667%	2	12	1839	Diabetes_McGill_Adipocytokines	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
16.6666666667%	2	12	183	Diabetes_McGill_Adipocytokines	VERHAAK_AML_WITH_NPM1_MUTATED_UP
16.6666666667%	2	12	183	Diabetes_McGill_Adipocytokines	KEGG_ENDOCYTOSIS
16.6666666667%	2	12	182	Mendelian_Etc	FERNANDEZ_BOUND_BY_MYC
16.6666666667%	2	12	176	Diabetes_McGill_Adipocytokines	NAGASHIMA_NRG1_SIGNALING_UP
16.6666666667%	2	12	17	Diabetes_McGill_Adipocytokines	BIOCARTA_LAIR_PATHWAY
16.6666666667%	2	12	17	Diabetes_McGill_Adipocytokines	BIOCARTA_IL17_PATHWAY
16.6666666667%	2	12	169	Diabetes_McGill_Adipocytokines	ONDER_CDH1_TARGETS_1_DN
16.6666666667%	2	12	1652	Mendelian_Etc	PUJANA_BRCA1_PCC_NETWORK
16.6666666667%	2	12	162	Diabetes_McGill_Adipocytokines	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
16.6666666667%	2	12	16	Diabetes_McGill_Adipocytokines	BAKER_HEMATOPOIESIS_STAT3_TARGETS
16.6666666667%	2	12	156	Diabetes_McGill_Adipocytokines	GROSS_HYPOXIA_VIA_ELK3_DN
16.6666666667%	2	12	15	Diabetes_McGill_Adipocytokines	MARKS_HDAC_TARGETS_DN
16.6666666667%	2	12	15	Diabetes_McGill_Adipocytokines	BIOCARTA_STEM_PATHWAY
16.6666666667%	2	12	144	Diabetes_McGill_Adipocytokines	BROCKE_APOPTOSIS_REVERSED_BY_IL6
16.6666666667%	2	12	137	Diabetes_McGill_Adipocytokines	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
16.6666666667%	2	12	1305	Diabetes_McGill_Adipocytokines	YOSHIMURA_MAPK8_TARGETS_UP
16.6666666667%	2	12	1237	Diabetes_McGill_Adipocytokines	BLALOCK_ALZHEIMERS_DISEASE_DN
16.6666666667%	2	12	123	Diabetes_McGill_Adipocytokines	DAZARD_RESPONSE_TO_UV_SCC_UP
16.6666666667%	2	12	1210	Mendelian_Etc	CHEN_METABOLIC_SYNDROM_NETWORK
16.6666666667%	2	12	120	Diabetes_McGill_Adipocytokines	ZHU_CMV_ALL_UP
16.6666666667%	2	12	12	Diabetes_McGill_Adipocytokines	MIZUKAMI_HYPOXIA_UP
16.6666666667%	2	12	115	Diabetes_McGill_Adipocytokines	MARZEC_IL2_SIGNALING_UP
16.6666666667%	2	12	114	Mendelian_Etc	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN
16.6666666667%	2	12	112	Mendelian_Etc	DOANE_BREAST_CANCER_ESR1_UP
16.6666666667%	2	12	11	Diabetes_McGill_Adipocytokines	ST_STAT3_PATHWAY
16.6666666667%	2	12	1080	Mendelian_Etc	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
16.6666666667%	2	12	107	Diabetes_McGill_Adipocytokines	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
16.6666666667%	2	12	102	Diabetes_McGill_Adipocytokines	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
16.6666666667%	2	12	100	Diabetes_McGill_Adipocytokines	WINZEN_DEGRADED_VIA_KHSRP
16.6666666667%	1	6	98	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GUO_TARGETS_OF_IRS1_AND_IRS2
16.6666666667%	1	6	973	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ACEVEDO_LIVER_CANCER_UP
16.6666666667%	1	6	973	Diabetes_McGill_Insulin_synthesis_and_ER_stres	ACEVEDO_LIVER_CANCER_UP
16.6666666667%	1	6	97	Mendelian_Disorders_of_Urea_Cycle_Metabolism	LABBE_WNT3A_TARGETS_DN
16.6666666667%	1	6	953	Mendelian_Disorders_of_Urea_Cycle_Metabolism	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
16.6666666667%	1	6	95	Mendelian_Disorders_of_Urea_Cycle_Metabolism	HECKER_IFNB1_TARGETS
16.6666666667%	1	6	940	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
16.6666666667%	1	6	94	Diabetes_McGill_Insulin_synthesis_and_ER_stres	LU_IL4_SIGNALING
16.6666666667%	1	6	94	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GAVIN_FOXP3_TARGETS_CLUSTER_T4
16.6666666667%	1	6	91	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GAVIN_FOXP3_TARGETS_CLUSTER_P6
16.6666666667%	1	6	90	Mendelian_Disorders_of_Urea_Cycle_Metabolism	BILANGES_SERUM_SENSITIVE_GENES
16.6666666667%	1	6	90	Diabetes_McGill_Insulin_synthesis_and_ER_stres	IGARASHI_ATF4_TARGETS_DN
16.6666666667%	1	6	898	Mendelian_Disorders_of_Urea_Cycle_Metabolism	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
16.6666666667%	1	6	893	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GEORGES_TARGETS_OF_MIR192_AND_MIR215
16.6666666667%	1	6	89	Mendelian_Disorders_of_Urea_Cycle_Metabolism	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
16.6666666667%	1	6	89	Diabetes_McGill_Insulin_synthesis_and_ER_stres	KEGG_PROSTATE_CANCER
16.6666666667%	1	6	882	Mendelian_Disorders_of_Urea_Cycle_Metabolism	LEE_BMP2_TARGETS_DN
16.6666666667%	1	6	882	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
16.6666666667%	1	6	88	Diabetes_McGill_Insulin_synthesis_and_ER_stres	UEDA_CENTRAL_CLOCK
16.6666666667%	1	6	871	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GRADE_COLON_CANCER_UP
16.6666666667%	1	6	87	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
16.6666666667%	1	6	863	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
16.6666666667%	1	6	863	Diabetes_McGill_Insulin_synthesis_and_ER_stres	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
16.6666666667%	1	6	86	Mendelian_Disorders_of_Urea_Cycle_Metabolism	NGUYEN_NOTCH1_TARGETS_DN
16.6666666667%	1	6	86	Mendelian_Disorders_of_Urea_Cycle_Metabolism	BAELDE_DIABETIC_NEPHROPATHY_UP
16.6666666667%	1	6	86	Diabetes_McGill_Insulin_synthesis_and_ER_stres	NGUYEN_NOTCH1_TARGETS_DN
16.6666666667%	1	6	84	Mendelian_Disorders_of_Urea_Cycle_Metabolism	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
16.6666666667%	1	6	84	Diabetes_McGill_Insulin_synthesis_and_ER_stres	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
16.6666666667%	1	6	83	Diabetes_McGill_Insulin_synthesis_and_ER_stres	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
16.6666666667%	1	6	83	Diabetes_McGill_Insulin_synthesis_and_ER_stres	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
16.6666666667%	1	6	811	Mendelian_Disorders_of_Urea_Cycle_Metabolism	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
16.6666666667%	1	6	81	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MUNSHI_MULTIPLE_MYELOMA_UP
16.6666666667%	1	6	80	Mendelian_Disorders_of_Urea_Cycle_Metabolism	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
16.6666666667%	1	6	80	Diabetes_McGill_Insulin_synthesis_and_ER_stres	LEE_AGING_NEOCORTEX_DN
16.6666666667%	1	6	79	Mendelian_Disorders_of_Urea_Cycle_Metabolism	TOOKER_GEMCITABINE_RESISTANCE_UP
16.6666666667%	1	6	784	Mendelian_Disorders_of_Urea_Cycle_Metabolism	FORTSCHEGGER_PHF8_TARGETS_DN
16.6666666667%	1	6	783	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ONKEN_UVEAL_MELANOMA_UP
16.6666666667%	1	6	783	Mendelian_Disorders_of_Urea_Cycle_Metabolism	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
16.6666666667%	1	6	781	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GOZGIT_ESR1_TARGETS_DN
16.6666666667%	1	6	78	Mendelian_Disorders_of_Urea_Cycle_Metabolism	LINDVALL_IMMORTALIZED_BY_TERT_UP
16.6666666667%	1	6	78	Mendelian_Disorders_of_Urea_Cycle_Metabolism	COATES_MACROPHAGE_M1_VS_M2_DN
16.6666666667%	1	6	756	Mendelian_Disorders_of_Urea_Cycle_Metabolism	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
16.6666666667%	1	6	75	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BAE_BRCA1_TARGETS_UP
16.6666666667%	1	6	745	Diabetes_McGill_Insulin_synthesis_and_ER_stres	LEE_BMP2_TARGETS_UP
16.6666666667%	1	6	74	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
16.6666666667%	1	6	734	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BENPORATH_SOX2_TARGETS
16.6666666667%	1	6	73	Mendelian_Disorders_of_Urea_Cycle_Metabolism	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
16.6666666667%	1	6	720	Diabetes_McGill_Insulin_synthesis_and_ER_stres	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
16.6666666667%	1	6	72	Diabetes_McGill_Insulin_synthesis_and_ER_stres	DOANE_BREAST_CANCER_CLASSES_UP
16.6666666667%	1	6	712	Mendelian_Disorders_of_Urea_Cycle_Metabolism	SCHLOSSER_SERUM_RESPONSE_DN
16.6666666667%	1	6	712	Diabetes_McGill_Insulin_synthesis_and_ER_stres	SCHLOSSER_SERUM_RESPONSE_DN
16.6666666667%	1	6	71	Mendelian_Disorders_of_Urea_Cycle_Metabolism	KUMAR_AUTOPHAGY_NETWORK
16.6666666667%	1	6	701	Diabetes_McGill_Insulin_synthesis_and_ER_stres	SMID_BREAST_CANCER_BASAL_DN
16.6666666667%	1	6	70	Diabetes_McGill_Insulin_synthesis_and_ER_stres	KEGG_LONG_TERM_POTENTIATION
16.6666666667%	1	6	7	Diabetes_McGill_Insulin_synthesis_and_ER_stres	ZHAN_EARLY_DIFFERENTIATION_GENES_UP
16.6666666667%	1	6	69	Mendelian_Disorders_of_Urea_Cycle_Metabolism	HUANG_DASATINIB_RESISTANCE_DN
16.6666666667%	1	6	682	Mendelian_Disorders_of_Urea_Cycle_Metabolism	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
16.6666666667%	1	6	682	Diabetes_McGill_Insulin_synthesis_and_ER_stres	FEVR_CTNNB1_TARGETS_UP
16.6666666667%	1	6	68	Mendelian_Disorders_of_Urea_Cycle_Metabolism	SESTO_RESPONSE_TO_UV_C7
16.6666666667%	1	6	68	Diabetes_McGill_Insulin_synthesis_and_ER_stres	SESTO_RESPONSE_TO_UV_C7
16.6666666667%	1	6	67	Diabetes_McGill_Insulin_synthesis_and_ER_stres	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
16.6666666667%	1	6	668	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
16.6666666667%	1	6	663	Mendelian_Disorders_of_Urea_Cycle_Metabolism	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
16.6666666667%	1	6	66	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
16.6666666667%	1	6	652	Mendelian_Disorders_of_Urea_Cycle_Metabolism	BENPORATH_PRC2_TARGETS
16.6666666667%	1	6	65	Mendelian_Disorders_of_Urea_Cycle_Metabolism	PID_IL4_2PATHWAY
16.6666666667%	1	6	65	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PID_ERA_GENOMIC_PATHWAY
16.6666666667%	1	6	64	Mendelian_Disorders_of_Urea_Cycle_Metabolism	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
16.6666666667%	1	6	612	Mendelian_Disorders_of_Urea_Cycle_Metabolism	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
16.6666666667%	1	6	61	Mendelian_Disorders_of_Urea_Cycle_Metabolism	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
16.6666666667%	1	6	61	Mendelian_Disorders_of_Urea_Cycle_Metabolism	BAKKER_FOXO3_TARGETS_UP
16.6666666667%	1	6	60	Diabetes_McGill_Insulin_synthesis_and_ER_stres	CUI_GLUCOSE_DEPRIVATION
16.6666666667%	1	6	590	Mendelian_Disorders_of_Urea_Cycle_Metabolism	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
16.6666666667%	1	6	59	Mendelian_Disorders_of_Urea_Cycle_Metabolism	PID_ATF2_PATHWAY
16.6666666667%	1	6	59	Mendelian_Disorders_of_Urea_Cycle_Metabolism	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
16.6666666667%	1	6	584	Diabetes_McGill_Insulin_synthesis_and_ER_stres	HAMAI_APOPTOSIS_VIA_TRAIL_UP
16.6666666667%	1	6	57	Diabetes_McGill_Insulin_synthesis_and_ER_stres	AMIT_SERUM_RESPONSE_240_MCF10A
16.6666666667%	1	6	567	Mendelian_Disorders_of_Urea_Cycle_Metabolism	CHICAS_RB1_TARGETS_CONFLUENT
16.6666666667%	1	6	564	Mendelian_Disorders_of_Urea_Cycle_Metabolism	SMID_BREAST_CANCER_LUMINAL_B_DN
16.6666666667%	1	6	56	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ZHENG_IL22_SIGNALING_UP
16.6666666667%	1	6	56	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GALE_APL_WITH_FLT3_MUTATED_UP
16.6666666667%	1	6	553	Diabetes_McGill_Insulin_synthesis_and_ER_stres	FEVR_CTNNB1_TARGETS_DN
16.6666666667%	1	6	55	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PID_TGFBRPATHWAY
16.6666666667%	1	6	548	Mendelian_Disorders_of_Urea_Cycle_Metabolism	KIM_ALL_DISORDERS_CALB1_CORR_UP
16.6666666667%	1	6	546	Mendelian_Disorders_of_Urea_Cycle_Metabolism	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
16.6666666667%	1	6	544	Diabetes_McGill_Insulin_synthesis_and_ER_stres	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
16.6666666667%	1	6	540	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ACEVEDO_LIVER_CANCER_DN
16.6666666667%	1	6	54	Diabetes_McGill_Insulin_synthesis_and_ER_stres	ZHOU_TNF_SIGNALING_30MIN
16.6666666667%	1	6	537	Mendelian_Disorders_of_Urea_Cycle_Metabolism	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
16.6666666667%	1	6	532	Mendelian_Disorders_of_Urea_Cycle_Metabolism	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
16.6666666667%	1	6	530	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ENK_UV_RESPONSE_KERATINOCYTE_UP
16.6666666667%	1	6	526	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ONKEN_UVEAL_MELANOMA_DN
16.6666666667%	1	6	518	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
16.6666666667%	1	6	510	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
16.6666666667%	1	6	51	Mendelian_Disorders_of_Urea_Cycle_Metabolism	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
16.6666666667%	1	6	51	Diabetes_McGill_Insulin_synthesis_and_ER_stres	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP
16.6666666667%	1	6	501	Mendelian_Disorders_of_Urea_Cycle_Metabolism	SENESE_HDAC3_TARGETS_UP
16.6666666667%	1	6	50	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MARTINEZ_RESPONSE_TO_TRABECTEDIN
16.6666666667%	1	6	493	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
16.6666666667%	1	6	491	Mendelian_Disorders_of_Urea_Cycle_Metabolism	SWEET_LUNG_CANCER_KRAS_UP
16.6666666667%	1	6	491	Diabetes_McGill_Insulin_synthesis_and_ER_stres	SWEET_LUNG_CANCER_KRAS_UP
16.6666666667%	1	6	49	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
16.6666666667%	1	6	48	Mendelian_Disorders_of_Urea_Cycle_Metabolism	TAVOR_CEBPA_TARGETS_UP
16.6666666667%	1	6	48	Mendelian_Disorders_of_Urea_Cycle_Metabolism	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
16.6666666667%	1	6	48	Mendelian_Disorders_of_Urea_Cycle_Metabolism	DOANE_BREAST_CANCER_ESR1_DN
16.6666666667%	1	6	48	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PID_CERAMIDE_PATHWAY
16.6666666667%	1	6	48	Diabetes_McGill_Insulin_synthesis_and_ER_stres	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN
16.6666666667%	1	6	48	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
16.6666666667%	1	6	473	Mendelian_Disorders_of_Urea_Cycle_Metabolism	GARY_CD5_TARGETS_UP
16.6666666667%	1	6	473	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GARY_CD5_TARGETS_UP
16.6666666667%	1	6	47	Mendelian_Disorders_of_Urea_Cycle_Metabolism	POTTI_DOCETAXEL_SENSITIVITY
16.6666666667%	1	6	47	Mendelian_Disorders_of_Urea_Cycle_Metabolism	IRITANI_MAD1_TARGETS_DN
16.6666666667%	1	6	47	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP
16.6666666667%	1	6	467	Diabetes_McGill_Insulin_synthesis_and_ER_stres	RATTENBACHER_BOUND_BY_CELF1
16.6666666667%	1	6	462	Mendelian_Disorders_of_Urea_Cycle_Metabolism	DELACROIX_RAR_BOUND_ES
16.6666666667%	1	6	46	Diabetes_McGill_Insulin_synthesis_and_ER_stres	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
16.6666666667%	1	6	46	Diabetes_McGill_Insulin_synthesis_and_ER_stres	HEIDENBLAD_AMPLICON_8Q24_DN
16.6666666667%	1	6	46	Diabetes_McGill_Insulin_synthesis_and_ER_stres	ABBUD_LIF_SIGNALING_1_UP
16.6666666667%	1	6	457	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
16.6666666667%	1	6	456	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ODONNELL_TFRC_TARGETS_UP
16.6666666667%	1	6	456	Diabetes_McGill_Insulin_synthesis_and_ER_stres	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
16.6666666667%	1	6	450	Diabetes_McGill_Insulin_synthesis_and_ER_stres	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
16.6666666667%	1	6	442	Mendelian_Disorders_of_Urea_Cycle_Metabolism	HAN_SATB1_TARGETS_DN
16.6666666667%	1	6	44	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PID_HNF3APATHWAY
16.6666666667%	1	6	44	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MA_MYELOID_DIFFERENTIATION_DN
16.6666666667%	1	6	44	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MARTIN_INTERACT_WITH_HDAC
16.6666666667%	1	6	44	Diabetes_McGill_Insulin_synthesis_and_ER_stres	LANDIS_BREAST_CANCER_PROGRESSION_UP
16.6666666667%	1	6	439	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MITSIADES_RESPONSE_TO_APLIDIN_UP
16.6666666667%	1	6	434	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BAELDE_DIABETIC_NEPHROPATHY_DN
16.6666666667%	1	6	431	Diabetes_McGill_Insulin_synthesis_and_ER_stres	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
16.6666666667%	1	6	430	Mendelian_Disorders_of_Urea_Cycle_Metabolism	VECCHI_GASTRIC_CANCER_EARLY_UP
16.6666666667%	1	6	43	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PID_TCPTP_PATHWAY
16.6666666667%	1	6	43	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MILI_PSEUDOPODIA
16.6666666667%	1	6	43	Diabetes_McGill_Insulin_synthesis_and_ER_stres	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
16.6666666667%	1	6	425	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BOCHKIS_FOXA2_TARGETS
16.6666666667%	1	6	422	Mendelian_Disorders_of_Urea_Cycle_Metabolism	YAGI_AML_WITH_INV_16_TRANSLOCATION
16.6666666667%	1	6	412	Mendelian_Disorders_of_Urea_Cycle_Metabolism	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
16.6666666667%	1	6	403	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
16.6666666667%	1	6	40	Mendelian_Disorders_of_Urea_Cycle_Metabolism	BURTON_ADIPOGENESIS_PEAK_AT_16HR
16.6666666667%	1	6	40	Diabetes_McGill_Insulin_synthesis_and_ER_stres	VARELA_ZMPSTE24_TARGETS_UP
16.6666666667%	1	6	394	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BERENJENO_TRANSFORMED_BY_RHOA_DN
16.6666666667%	1	6	393	Mendelian_Disorders_of_Urea_Cycle_Metabolism	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
16.6666666667%	1	6	390	Mendelian_Disorders_of_Urea_Cycle_Metabolism	HATADA_METHYLATED_IN_LUNG_CANCER_UP
16.6666666667%	1	6	39	Mendelian_Disorders_of_Urea_Cycle_Metabolism	AIYAR_COBRA1_TARGETS_UP
16.6666666667%	1	6	39	Diabetes_McGill_Insulin_synthesis_and_ER_stres	SESTO_RESPONSE_TO_UV_C6
16.6666666667%	1	6	387	Mendelian_Disorders_of_Urea_Cycle_Metabolism	CHYLA_CBFA2T3_TARGETS_UP
16.6666666667%	1	6	387	Diabetes_McGill_Insulin_synthesis_and_ER_stres	CHYLA_CBFA2T3_TARGETS_UP
16.6666666667%	1	6	384	Mendelian_Disorders_of_Urea_Cycle_Metabolism	BASAKI_YBX1_TARGETS_DN
16.6666666667%	1	6	380	Diabetes_McGill_Insulin_synthesis_and_ER_stres	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
16.6666666667%	1	6	38	Mendelian_Disorders_of_Urea_Cycle_Metabolism	CERVERA_SDHB_TARGETS_1_DN
16.6666666667%	1	6	38	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PID_P38ALPHABETADOWNSTREAMPATHWAY
16.6666666667%	1	6	378	Diabetes_McGill_Insulin_synthesis_and_ER_stres	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
16.6666666667%	1	6	374	Diabetes_McGill_Insulin_synthesis_and_ER_stres	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
16.6666666667%	1	6	373	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
16.6666666667%	1	6	37	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PID_FRA_PATHWAY
16.6666666667%	1	6	366	Mendelian_Disorders_of_Urea_Cycle_Metabolism	YOSHIMURA_MAPK8_TARGETS_DN
16.6666666667%	1	6	36	Mendelian_Disorders_of_Urea_Cycle_Metabolism	VALK_AML_CLUSTER_11
16.6666666667%	1	6	36	Diabetes_McGill_Insulin_synthesis_and_ER_stres	YANG_BREAST_CANCER_ESR1_UP
16.6666666667%	1	6	36	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MMS_MOUSE_LYMPH_HIGH_4HRS_UP
16.6666666667%	1	6	355	Mendelian_Disorders_of_Urea_Cycle_Metabolism	PEREZ_TP63_TARGETS
16.6666666667%	1	6	354	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
16.6666666667%	1	6	351	Diabetes_McGill_Insulin_synthesis_and_ER_stres	YAGI_AML_WITH_11Q23_REARRANGED
16.6666666667%	1	6	35	Mendelian_Disorders_of_Urea_Cycle_Metabolism	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
16.6666666667%	1	6	35	Diabetes_McGill_Insulin_synthesis_and_ER_stres	HU_GENOTOXIC_DAMAGE_24HR
16.6666666667%	1	6	349	Mendelian_Disorders_of_Urea_Cycle_Metabolism	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
16.6666666667%	1	6	342	Mendelian_Disorders_of_Urea_Cycle_Metabolism	BLUM_RESPONSE_TO_SALIRASIB_DN
16.6666666667%	1	6	34	Diabetes_McGill_Insulin_synthesis_and_ER_stres	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP
16.6666666667%	1	6	337	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PENG_GLUTAMINE_DEPRIVATION_DN
16.6666666667%	1	6	335	Diabetes_McGill_Insulin_synthesis_and_ER_stres	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
16.6666666667%	1	6	332	Mendelian_Disorders_of_Urea_Cycle_Metabolism	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
16.6666666667%	1	6	330	Diabetes_McGill_Insulin_synthesis_and_ER_stres	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
16.6666666667%	1	6	330	Diabetes_McGill_Insulin_synthesis_and_ER_stres	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
16.6666666667%	1	6	33	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP
16.6666666667%	1	6	33	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP
16.6666666667%	1	6	33	Diabetes_McGill_Insulin_synthesis_and_ER_stres	CHO_NR4A1_TARGETS
16.6666666667%	1	6	329	Mendelian_Disorders_of_Urea_Cycle_Metabolism	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
16.6666666667%	1	6	326	Mendelian_Disorders_of_Urea_Cycle_Metabolism	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
16.6666666667%	1	6	324	Diabetes_McGill_Insulin_synthesis_and_ER_stres	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
16.6666666667%	1	6	32	Diabetes_McGill_Insulin_synthesis_and_ER_stres	TRACEY_RESISTANCE_TO_IFNA2_DN
16.6666666667%	1	6	318	Diabetes_McGill_Insulin_synthesis_and_ER_stres	LEI_MYB_TARGETS
16.6666666667%	1	6	317	Diabetes_McGill_Insulin_synthesis_and_ER_stres	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
16.6666666667%	1	6	314	Diabetes_McGill_Insulin_synthesis_and_ER_stres	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
16.6666666667%	1	6	309	Mendelian_Disorders_of_Urea_Cycle_Metabolism	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
16.6666666667%	1	6	309	Diabetes_McGill_Insulin_synthesis_and_ER_stres	LIU_SOX4_TARGETS_DN
16.6666666667%	1	6	307	Mendelian_Disorders_of_Urea_Cycle_Metabolism	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
16.6666666667%	1	6	307	Diabetes_McGill_Insulin_synthesis_and_ER_stres	LI_INDUCED_T_TO_NATURAL_KILLER_UP
16.6666666667%	1	6	30	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
16.6666666667%	1	6	30	Diabetes_McGill_Insulin_synthesis_and_ER_stres	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
16.6666666667%	1	6	30	Diabetes_McGill_Insulin_synthesis_and_ER_stres	DAZARD_UV_RESPONSE_CLUSTER_G2
16.6666666667%	1	6	298	Mendelian_Disorders_of_Urea_Cycle_Metabolism	BROWNE_HCMV_INFECTION_14HR_DN
16.6666666667%	1	6	298	Mendelian_Disorders_of_Urea_Cycle_Metabolism	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
16.6666666667%	1	6	293	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ENK_UV_RESPONSE_EPIDERMIS_UP
16.6666666667%	1	6	293	Diabetes_McGill_Insulin_synthesis_and_ER_stres	HADDAD_B_LYMPHOCYTE_PROGENITOR
16.6666666667%	1	6	29	Mendelian_Disorders_of_Urea_Cycle_Metabolism	KRIGE_AMINO_ACID_DEPRIVATION
16.6666666667%	1	6	29	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MAYBURD_RESPONSE_TO_L663536_UP
16.6666666667%	1	6	29	Diabetes_McGill_Insulin_synthesis_and_ER_stres	DORN_ADENOVIRUS_INFECTION_12HR_UP
16.6666666667%	1	6	289	Mendelian_Disorders_of_Urea_Cycle_Metabolism	MANALO_HYPOXIA_DN
16.6666666667%	1	6	289	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
16.6666666667%	1	6	289	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GABRIELY_MIR21_TARGETS
16.6666666667%	1	6	284	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
16.6666666667%	1	6	283	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
16.6666666667%	1	6	281	Mendelian_Disorders_of_Urea_Cycle_Metabolism	MULLIGHAN_MLL_SIGNATURE_2_DN
16.6666666667%	1	6	281	Mendelian_Disorders_of_Urea_Cycle_Metabolism	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
16.6666666667%	1	6	281	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BHAT_ESR1_TARGETS_VIA_AKT1_UP
16.6666666667%	1	6	279	Diabetes_McGill_Insulin_synthesis_and_ER_stres	FORTSCHEGGER_PHF8_TARGETS_UP
16.6666666667%	1	6	276	Diabetes_McGill_Insulin_synthesis_and_ER_stres	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
16.6666666667%	1	6	275	Mendelian_Disorders_of_Urea_Cycle_Metabolism	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
16.6666666667%	1	6	275	Mendelian_Disorders_of_Urea_Cycle_Metabolism	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
16.6666666667%	1	6	274	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
16.6666666667%	1	6	27	Mendelian_Disorders_of_Urea_Cycle_Metabolism	GROSS_ELK3_TARGETS_UP
16.6666666667%	1	6	269	Mendelian_Disorders_of_Urea_Cycle_Metabolism	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
16.6666666667%	1	6	268	Diabetes_McGill_Insulin_synthesis_and_ER_stres	XU_GH1_AUTOCRINE_TARGETS_UP
16.6666666667%	1	6	267	Diabetes_McGill_Insulin_synthesis_and_ER_stres	KEGG_MAPK_SIGNALING_PATHWAY
16.6666666667%	1	6	267	Diabetes_McGill_Insulin_synthesis_and_ER_stres	HOLLMANN_APOPTOSIS_VIA_CD40_DN
16.6666666667%	1	6	261	Mendelian_Disorders_of_Urea_Cycle_Metabolism	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
16.6666666667%	1	6	261	Mendelian_Disorders_of_Urea_Cycle_Metabolism	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
16.6666666667%	1	6	260	Mendelian_Disorders_of_Urea_Cycle_Metabolism	SENESE_HDAC1_TARGETS_DN
16.6666666667%	1	6	258	Mendelian_Disorders_of_Urea_Cycle_Metabolism	JAEGER_METASTASIS_DN
16.6666666667%	1	6	255	Mendelian_Disorders_of_Urea_Cycle_Metabolism	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
16.6666666667%	1	6	250	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
16.6666666667%	1	6	25	Mendelian_Disorders_of_Urea_Cycle_Metabolism	COLLER_MYC_TARGETS_UP
16.6666666667%	1	6	246	Mendelian_Disorders_of_Urea_Cycle_Metabolism	VERHAAK_AML_WITH_NPM1_MUTATED_DN
16.6666666667%	1	6	245	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PENG_RAPAMYCIN_RESPONSE_DN
16.6666666667%	1	6	242	Mendelian_Disorders_of_Urea_Cycle_Metabolism	CHYLA_CBFA2T3_TARGETS_DN
16.6666666667%	1	6	240	Mendelian_Disorders_of_Urea_Cycle_Metabolism	VANTVEER_BREAST_CANCER_ESR1_DN
16.6666666667%	1	6	240	Diabetes_McGill_Insulin_synthesis_and_ER_stres	UDAYAKUMAR_MED1_TARGETS_DN
16.6666666667%	1	6	24	Mendelian_Disorders_of_Urea_Cycle_Metabolism	MAEKAWA_ATF2_TARGETS
16.6666666667%	1	6	24	Mendelian_Disorders_of_Urea_Cycle_Metabolism	JIANG_TIP30_TARGETS_DN
16.6666666667%	1	6	238	Diabetes_McGill_Insulin_synthesis_and_ER_stres	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
16.6666666667%	1	6	234	Mendelian_Disorders_of_Urea_Cycle_Metabolism	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
16.6666666667%	1	6	234	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
16.6666666667%	1	6	232	Mendelian_Disorders_of_Urea_Cycle_Metabolism	DELYS_THYROID_CANCER_DN
16.6666666667%	1	6	230	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BENPORATH_MYC_TARGETS_WITH_EBOX
16.6666666667%	1	6	23	Mendelian_Disorders_of_Urea_Cycle_Metabolism	KEGG_NITROGEN_METABOLISM
16.6666666667%	1	6	23	Diabetes_McGill_Insulin_synthesis_and_ER_stres	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
16.6666666667%	1	6	23	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BARIS_THYROID_CANCER_UP
16.6666666667%	1	6	229	Mendelian_Disorders_of_Urea_Cycle_Metabolism	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
16.6666666667%	1	6	229	Diabetes_McGill_Insulin_synthesis_and_ER_stres	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
16.6666666667%	1	6	229	Diabetes_McGill_Insulin_synthesis_and_ER_stres	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
16.6666666667%	1	6	226	Mendelian_Disorders_of_Urea_Cycle_Metabolism	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
16.6666666667%	1	6	222	Diabetes_McGill_Insulin_synthesis_and_ER_stres	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
16.6666666667%	1	6	221	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PEDRIOLI_MIR31_TARGETS_UP
16.6666666667%	1	6	22	Diabetes_McGill_Insulin_synthesis_and_ER_stres	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP
16.6666666667%	1	6	22	Diabetes_McGill_Insulin_synthesis_and_ER_stres	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
16.6666666667%	1	6	211	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
16.6666666667%	1	6	210	Mendelian_Disorders_of_Urea_Cycle_Metabolism	VERHAAK_GLIOBLASTOMA_PRONEURAL
16.6666666667%	1	6	210	Diabetes_McGill_Insulin_synthesis_and_ER_stres	WANG_TUMOR_INVASIVENESS_DN
16.6666666667%	1	6	21	Diabetes_McGill_Insulin_synthesis_and_ER_stres	DAZARD_UV_RESPONSE_CLUSTER_G4
16.6666666667%	1	6	208	Diabetes_McGill_Insulin_synthesis_and_ER_stres	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
16.6666666667%	1	6	205	Mendelian_Disorders_of_Urea_Cycle_Metabolism	SHEPARD_BMYB_MORPHOLINO_UP
16.6666666667%	1	6	203	Mendelian_Disorders_of_Urea_Cycle_Metabolism	PENG_RAPAMYCIN_RESPONSE_UP
16.6666666667%	1	6	203	Diabetes_McGill_Insulin_synthesis_and_ER_stres	GRUETZMANN_PANCREATIC_CANCER_DN
16.6666666667%	1	6	202	Diabetes_McGill_Insulin_synthesis_and_ER_stres	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
16.6666666667%	1	6	19	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MELLMAN_TUT1_TARGETS_UP
16.6666666667%	1	6	185	Mendelian_Disorders_of_Urea_Cycle_Metabolism	DARWICHE_SKIN_TUMOR_PROMOTER_DN
16.6666666667%	1	6	1839	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
16.6666666667%	1	6	182	Diabetes_McGill_Insulin_synthesis_and_ER_stres	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
16.6666666667%	1	6	182	Diabetes_McGill_Insulin_synthesis_and_ER_stres	FERNANDEZ_BOUND_BY_MYC
16.6666666667%	1	6	181	Mendelian_Disorders_of_Urea_Cycle_Metabolism	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
16.6666666667%	1	6	18	Mendelian_Disorders_of_Urea_Cycle_Metabolism	NIELSEN_SCHWANNOMA_DN
16.6666666667%	1	6	179	Mendelian_Disorders_of_Urea_Cycle_Metabolism	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
16.6666666667%	1	6	178	Mendelian_Disorders_of_Urea_Cycle_Metabolism	BROWNE_HCMV_INFECTION_18HR_DN
16.6666666667%	1	6	178	Diabetes_McGill_Insulin_synthesis_and_ER_stres	LI_AMPLIFIED_IN_LUNG_CANCER
16.6666666667%	1	6	177	Diabetes_McGill_Insulin_synthesis_and_ER_stres	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
16.6666666667%	1	6	176	Mendelian_Disorders_of_Urea_Cycle_Metabolism	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
16.6666666667%	1	6	176	Mendelian_Disorders_of_Urea_Cycle_Metabolism	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
16.6666666667%	1	6	175	Mendelian_Disorders_of_Urea_Cycle_Metabolism	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
16.6666666667%	1	6	17	Mendelian_Disorders_of_Urea_Cycle_Metabolism	LEI_HOXC8_TARGETS_DN
16.6666666667%	1	6	1691	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BLALOCK_ALZHEIMERS_DISEASE_UP
16.6666666667%	1	6	169	Mendelian_Disorders_of_Urea_Cycle_Metabolism	UEDA_PERIFERAL_CLOCK
16.6666666667%	1	6	167	Diabetes_McGill_Insulin_synthesis_and_ER_stres	VANTVEER_BREAST_CANCER_ESR1_UP
16.6666666667%	1	6	1652	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PUJANA_BRCA1_PCC_NETWORK
16.6666666667%	1	6	165	Mendelian_Disorders_of_Urea_Cycle_Metabolism	LIU_CMYB_TARGETS_UP
16.6666666667%	1	6	163	Mendelian_Disorders_of_Urea_Cycle_Metabolism	SERVITJA_ISLET_HNF1A_TARGETS_UP
16.6666666667%	1	6	162	Mendelian_Disorders_of_Urea_Cycle_Metabolism	DARWICHE_PAPILLOMA_RISK_LOW_UP
16.6666666667%	1	6	16	Diabetes_McGill_Insulin_synthesis_and_ER_stres	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8
16.6666666667%	1	6	156	Mendelian_Disorders_of_Urea_Cycle_Metabolism	FOSTER_TOLERANT_MACROPHAGE_UP
16.6666666667%	1	6	153	Diabetes_McGill_Insulin_synthesis_and_ER_stres	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
16.6666666667%	1	6	151	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
16.6666666667%	1	6	150	Diabetes_McGill_Insulin_synthesis_and_ER_stres	LANDIS_ERBB2_BREAST_TUMORS_324_UP
16.6666666667%	1	6	148	Mendelian_Disorders_of_Urea_Cycle_Metabolism	BROWNE_HCMV_INFECTION_24HR_DN
16.6666666667%	1	6	147	Mendelian_Disorders_of_Urea_Cycle_Metabolism	SMID_BREAST_CANCER_ERBB2_UP
16.6666666667%	1	6	147	Mendelian_Disorders_of_Urea_Cycle_Metabolism	DARWICHE_PAPILLOMA_RISK_HIGH_UP
16.6666666667%	1	6	147	Diabetes_McGill_Insulin_synthesis_and_ER_stres	WHITFIELD_CELL_CYCLE_G1_S
16.6666666667%	1	6	146	Mendelian_Disorders_of_Urea_Cycle_Metabolism	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
16.6666666667%	1	6	145	Diabetes_McGill_Insulin_synthesis_and_ER_stres	SMITH_TERT_TARGETS_UP
16.6666666667%	1	6	143	Mendelian_Disorders_of_Urea_Cycle_Metabolism	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
16.6666666667%	1	6	143	Mendelian_Disorders_of_Urea_Cycle_Metabolism	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
16.6666666667%	1	6	142	Mendelian_Disorders_of_Urea_Cycle_Metabolism	PENG_LEUCINE_DEPRIVATION_UP
16.6666666667%	1	6	142	Diabetes_McGill_Insulin_synthesis_and_ER_stres	PENG_LEUCINE_DEPRIVATION_UP
16.6666666667%	1	6	141	Mendelian_Disorders_of_Urea_Cycle_Metabolism	SABATES_COLORECTAL_ADENOMA_UP
16.6666666667%	1	6	140	Mendelian_Disorders_of_Urea_Cycle_Metabolism	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
16.6666666667%	1	6	14	Diabetes_McGill_Insulin_synthesis_and_ER_stres	ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS
16.6666666667%	1	6	14	Diabetes_McGill_Insulin_synthesis_and_ER_stres	DORN_ADENOVIRUS_INFECTION_48HR_UP
16.6666666667%	1	6	138	Mendelian_Disorders_of_Urea_Cycle_Metabolism	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
16.6666666667%	1	6	1375	Diabetes_McGill_Insulin_synthesis_and_ER_stres	DODD_NASOPHARYNGEAL_CARCINOMA_DN
16.6666666667%	1	6	1305	Diabetes_McGill_Insulin_synthesis_and_ER_stres	YOSHIMURA_MAPK8_TARGETS_UP
16.6666666667%	1	6	1278	Diabetes_McGill_Insulin_synthesis_and_ER_stres	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
16.6666666667%	1	6	127	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
16.6666666667%	1	6	126	Diabetes_McGill_Insulin_synthesis_and_ER_stres	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
16.6666666667%	1	6	126	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BURTON_ADIPOGENESIS_5
16.6666666667%	1	6	1229	Mendelian_Disorders_of_Urea_Cycle_Metabolism	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
16.6666666667%	1	6	1210	Mendelian_Disorders_of_Urea_Cycle_Metabolism	CHEN_METABOLIC_SYNDROM_NETWORK
16.6666666667%	1	6	121	Mendelian_Disorders_of_Urea_Cycle_Metabolism	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
16.6666666667%	1	6	121	Diabetes_McGill_Insulin_synthesis_and_ER_stres	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
16.6666666667%	1	6	120	Mendelian_Disorders_of_Urea_Cycle_Metabolism	XU_GH1_EXOGENOUS_TARGETS_DN
16.6666666667%	1	6	12	Mendelian_Disorders_of_Urea_Cycle_Metabolism	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN
16.6666666667%	1	6	12	Diabetes_McGill_Insulin_synthesis_and_ER_stres	DORN_ADENOVIRUS_INFECTION_24HR_UP
16.6666666667%	1	6	118	Diabetes_McGill_Insulin_synthesis_and_ER_stres	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
16.6666666667%	1	6	116	Mendelian_Disorders_of_Urea_Cycle_Metabolism	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
16.6666666667%	1	6	116	Diabetes_McGill_Insulin_synthesis_and_ER_stres	LIM_MAMMARY_LUMINAL_MATURE_UP
16.6666666667%	1	6	115	Mendelian_Disorders_of_Urea_Cycle_Metabolism	MARKEY_RB1_CHRONIC_LOF_UP
16.6666666667%	1	6	1142	Mendelian_Disorders_of_Urea_Cycle_Metabolism	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
16.6666666667%	1	6	114	Diabetes_McGill_Insulin_synthesis_and_ER_stres	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN
16.6666666667%	1	6	112	Mendelian_Disorders_of_Urea_Cycle_Metabolism	PASINI_SUZ12_TARGETS_UP
16.6666666667%	1	6	112	Diabetes_McGill_Insulin_synthesis_and_ER_stres	DOANE_BREAST_CANCER_ESR1_UP
16.6666666667%	1	6	1118	Mendelian_Disorders_of_Urea_Cycle_Metabolism	BENPORATH_ES_WITH_H3K27ME3
16.6666666667%	1	6	111	Mendelian_Disorders_of_Urea_Cycle_Metabolism	WANG_HCP_PROSTATE_CANCER
16.6666666667%	1	6	111	Mendelian_Disorders_of_Urea_Cycle_Metabolism	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
16.6666666667%	1	6	111	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
16.6666666667%	1	6	110	Mendelian_Disorders_of_Urea_Cycle_Metabolism	WOOD_EBV_EBNA1_TARGETS_UP
16.6666666667%	1	6	110	Mendelian_Disorders_of_Urea_Cycle_Metabolism	SUNG_METASTASIS_STROMA_UP
16.6666666667%	1	6	110	Mendelian_Disorders_of_Urea_Cycle_Metabolism	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
16.6666666667%	1	6	11	Diabetes_McGill_Insulin_synthesis_and_ER_stres	DORN_ADENOVIRUS_INFECTION_32HR_UP
16.6666666667%	1	6	11	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BIOCARTA_EIF2_PATHWAY
16.6666666667%	1	6	108	Diabetes_McGill_Insulin_synthesis_and_ER_stres	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
16.6666666667%	1	6	1069	Mendelian_Disorders_of_Urea_Cycle_Metabolism	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
16.6666666667%	1	6	1062	Mendelian_Disorders_of_Urea_Cycle_Metabolism	BENPORATH_EED_TARGETS
16.6666666667%	1	6	106	Mendelian_Disorders_of_Urea_Cycle_Metabolism	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
16.6666666667%	1	6	105	Diabetes_McGill_Insulin_synthesis_and_ER_stres	HELLER_SILENCED_BY_METHYLATION_DN
16.6666666667%	1	6	1038	Mendelian_Disorders_of_Urea_Cycle_Metabolism	BENPORATH_SUZ12_TARGETS
16.6666666667%	1	6	1024	Mendelian_Disorders_of_Urea_Cycle_Metabolism	NUYTTEN_EZH2_TARGETS_DN
16.6666666667%	1	6	1022	Mendelian_Disorders_of_Urea_Cycle_Metabolism	MARSON_BOUND_BY_FOXP3_STIMULATED
16.6666666667%	1	6	102	Mendelian_Disorders_of_Urea_Cycle_Metabolism	LABBE_TGFB1_TARGETS_UP
16.6666666667%	1	6	102	Diabetes_McGill_Insulin_synthesis_and_ER_stres	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
16.6666666667%	1	6	101	Mendelian_Disorders_of_Urea_Cycle_Metabolism	KOBAYASHI_EGFR_SIGNALING_24HR_UP
16.6666666667%	1	6	101	Diabetes_McGill_Insulin_synthesis_and_ER_stres	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
16.6666666667%	1	6	101	Diabetes_McGill_Insulin_synthesis_and_ER_stres	KEGG_GNRH_SIGNALING_PATHWAY
16.6666666667%	1	6	100	Diabetes_McGill_Insulin_synthesis_and_ER_stres	QI_PLASMACYTOMA_DN
16.6666666667%	1	6	100	Diabetes_McGill_Insulin_synthesis_and_ER_stres	BENPORATH_ES_CORE_NINE_CORRELATED
16.2162162162%	6	37	882	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
16.2162162162%	6	37	510	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
16.2162162162%	6	37	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_INSULIN_PATHWAY
16.2162162162%	6	37	435	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
16.2162162162%	6	37	269	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
16.2162162162%	6	37	1442	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PUJANA_ATM_PCC_NETWORK
16.1290322581%	5	31	91	Diabetes_McGill_IL10	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
16.1290322581%	5	31	855	Diabetes_McGill_IL10	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
16.1290322581%	5	31	75	Diabetes_McGill_IL10	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
16.1290322581%	5	31	70	Diabetes_McGill_IL10	KEGG_RENAL_CELL_CARCINOMA
16.1290322581%	5	31	7	Diabetes_McGill_IL10	BAKER_HEMATOPOESIS_STAT5_TARGETS
16.1290322581%	5	31	67	Diabetes_McGill_IL10	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
16.1290322581%	5	31	65	Diabetes_McGill_IL10	PID_RB_1PATHWAY
16.1290322581%	5	31	637	Diabetes_McGill_IL10	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
16.1290322581%	5	31	59	Diabetes_McGill_IL10	PID_ATF2_PATHWAY
16.1290322581%	5	31	539	Diabetes_McGill_IL10	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
16.1290322581%	5	31	514	Diabetes_McGill_IL10	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
16.1290322581%	5	31	49	Diabetes_McGill_IL10	PID_PI3KCIPATHWAY
16.1290322581%	5	31	48	Diabetes_McGill_IL10	REACTOME_PI_METABOLISM
16.1290322581%	5	31	478	Diabetes_McGill_IL10	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
16.1290322581%	5	31	457	Diabetes_McGill_IL10	SENESE_HDAC1_TARGETS_UP
16.1290322581%	5	31	43	Diabetes_McGill_IL10	PID_TCPTP_PATHWAY
16.1290322581%	5	31	418	Diabetes_McGill_IL10	RUTELLA_RESPONSE_TO_HGF_UP
16.1290322581%	5	31	37	Diabetes_McGill_IL10	PID_IL23PATHWAY
16.1290322581%	5	31	34	Diabetes_McGill_IL10	PID_IL2_PI3KPATHWAY
16.1290322581%	5	31	318	Diabetes_McGill_IL10	LEI_MYB_TARGETS
16.1290322581%	5	31	31	Diabetes_McGill_IL10	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE
16.1290322581%	5	31	292	Diabetes_McGill_IL10	HELLER_HDAC_TARGETS_DN
16.1290322581%	5	31	29	Diabetes_McGill_IL10	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
16.1290322581%	5	31	281	Diabetes_McGill_IL10	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
16.1290322581%	5	31	267	Diabetes_McGill_IL10	KEGG_MAPK_SIGNALING_PATHWAY
16.1290322581%	5	31	225	Diabetes_McGill_IL10	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
16.1290322581%	5	31	198	Diabetes_McGill_IL10	REACTOME_PHOSPHOLIPID_METABOLISM
16.1290322581%	5	31	16	Diabetes_McGill_IL10	BIOCARTA_IL22BP_PATHWAY
16.1290322581%	5	31	1382	Diabetes_McGill_IL10	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
16.1290322581%	20	124	957	Diabetes_McGill_Cell_cycle_All_Gene	LOPEZ_MBD_TARGETS
16.1290322581%	20	124	81	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_M_G1_TRANSITION
16.1290322581%	20	124	379	Diabetes_McGill_Cell_cycle_All_Gene	BENPORATH_ES_1
16.1290322581%	20	124	309	Diabetes_McGill_Cell_cycle_All_Gene	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
16.1290322581%	20	124	24	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_G2_PATHWAY
16.049382716%	13	81	1118	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BENPORATH_ES_WITH_H3K27ME3
16.049382716%	13	81	1062	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BENPORATH_EED_TARGETS
16.049382716%	13	81	1038	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BENPORATH_SUZ12_TARGETS
15.8102766798%	40	253	811	Diabetes_McGill_CREBBP_coTF	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
15.7142857143%	11	70	97	Diabetes_McGill_Adipocytokine_signallin	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
15.7142857143%	11	70	882	Diabetes_McGill_Adipocytokine_signallin	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
15.7142857143%	11	70	75	Diabetes_McGill_Adipocytokine_signallin	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
15.7142857143%	11	70	62	Diabetes_McGill_Adipocytokine_signallin	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
15.7142857143%	11	70	46	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_KERATINOCYTE_PATHWAY
15.7142857143%	11	70	25	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_STRESS_PATHWAY
15.7142857143%	11	70	1442	Diabetes_McGill_Adipocytokine_signallin	PUJANA_ATM_PCC_NETWORK
15.7142857143%	11	70	126	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
15.625%	5	32	898	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
15.625%	5	32	652	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BENPORATH_PRC2_TARGETS
15.625%	5	32	52	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_GABA_RECEPTOR_ACTIVATION
15.625%	5	32	38	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_GABA_B_RECEPTOR_ACTIVATION
15.625%	5	32	267	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_MAPK_SIGNALING_PATHWAY
15.625%	5	32	25	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS
15.625%	5	32	169	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_ALZHEIMERS_DISEASE
15.625%	5	32	137	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
15.625%	5	32	101	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_GNRH_SIGNALING_PATHWAY
15.4150197628%	39	253	933	Diabetes_McGill_CREBBP_coTF	REACTOME_IMMUNE_SYSTEM
15.4150197628%	39	253	352	Diabetes_McGill_CREBBP_coTF	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
15.3846153846%	6	39	88	Diabetes_McGill_IL6	KEGG_APOPTOSIS
15.3846153846%	6	39	87	Diabetes_McGill_IL6	BIOCARTA_MAPK_PATHWAY
15.3846153846%	6	39	82	Diabetes_McGill_IL6	ST_INTEGRIN_SIGNALING_PATHWAY
15.3846153846%	6	39	811	Diabetes_McGill_IL6	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
15.3846153846%	6	39	80	Diabetes_McGill_IL6	PID_MET_PATHWAY
15.3846153846%	6	39	80	Diabetes_McGill_IL6	PID_BETACATENIN_NUC_PATHWAY
15.3846153846%	6	39	784	Diabetes_McGill_IL6	FORTSCHEGGER_PHF8_TARGETS_DN
15.3846153846%	6	39	67	Diabetes_McGill_IL6	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
15.3846153846%	6	39	65	Diabetes_McGill_IL6	KEGG_GLIOMA
15.3846153846%	6	39	54	Diabetes_McGill_IL6	KEGG_NON_SMALL_CELL_LUNG_CANCER
15.3846153846%	6	39	52	Diabetes_McGill_IL6	PID_PTP1BPATHWAY
15.3846153846%	6	39	47	Diabetes_McGill_IL6	PID_LKB1_PATHWAY
15.3846153846%	6	39	43	Diabetes_McGill_IL6	REACTOME_IL_3_5_AND_GM_CSF_SIGNALING
15.3846153846%	6	39	43	Diabetes_McGill_IL6	PID_TCPTP_PATHWAY
15.3846153846%	6	39	42	Diabetes_McGill_IL6	BIOCARTA_CHREBP2_PATHWAY
15.3846153846%	6	39	41	Diabetes_McGill_IL6	REACTOME_IL_2_SIGNALING
15.3846153846%	6	39	40	Diabetes_McGill_IL6	BIOCARTA_P38MAPK_PATHWAY
15.3846153846%	6	39	37	Diabetes_McGill_IL6	PID_GMCSF_PATHWAY
15.3846153846%	6	39	368	Diabetes_McGill_IL6	YAGI_AML_WITH_T_8_21_TRANSLOCATION
15.3846153846%	6	39	366	Diabetes_McGill_IL6	YOSHIMURA_MAPK8_TARGETS_DN
15.3846153846%	6	39	32	Diabetes_McGill_IL6	BIOCARTA_PDGF_PATHWAY
15.3846153846%	6	39	31	Diabetes_McGill_IL6	BIOCARTA_EGF_PATHWAY
15.3846153846%	6	39	30	Diabetes_McGill_IL6	PID_IL2_STAT5PATHWAY
15.3846153846%	6	39	28	Diabetes_McGill_IL6	BIOCARTA_GH_PATHWAY
15.3846153846%	6	39	267	Diabetes_McGill_IL6	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
15.3846153846%	6	39	26	Diabetes_McGill_IL6	DEN_INTERACT_WITH_LCA5
15.3846153846%	6	39	23	Diabetes_McGill_IL6	BIOCARTA_IGF1R_PATHWAY
15.3846153846%	6	39	182	Diabetes_McGill_IL6	FERNANDEZ_BOUND_BY_MYC
15.3846153846%	6	39	17	Diabetes_McGill_IL6	SA_PTEN_PATHWAY
15.3846153846%	6	39	144	Diabetes_McGill_IL6	BROCKE_APOPTOSIS_REVERSED_BY_IL6
15.3846153846%	6	39	1382	Diabetes_McGill_IL6	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
15.3846153846%	6	39	138	Diabetes_McGill_IL6	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
15.3846153846%	6	39	132	Diabetes_McGill_IL6	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
15.3846153846%	6	39	115	Diabetes_McGill_IL6	MARZEC_IL2_SIGNALING_UP
15.3846153846%	6	39	114	Diabetes_McGill_IL6	KEGG_OOCYTE_MEIOSIS
15.3846153846%	6	39	11	Diabetes_McGill_IL6	ST_STAT3_PATHWAY
15.3846153846%	6	39	11	Diabetes_McGill_IL6	REACTOME_IL_6_SIGNALING
15.3846153846%	4	26	86	Diabetes_McGill_Set_Wnt_pathway	KEGG_TGF_BETA_SIGNALING_PATHWAY
15.3846153846%	4	26	841	Diabetes_McGill_Set_Wnt_pathway	MARTENS_TRETINOIN_RESPONSE_DN
15.3846153846%	4	26	800	Diabetes_McGill_Set_Wnt_pathway	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
15.3846153846%	4	26	779	Diabetes_McGill_Set_Wnt_pathway	PUJANA_CHEK2_PCC_NETWORK
15.3846153846%	4	26	734	Diabetes_McGill_Set_Wnt_pathway	BENPORATH_SOX2_TARGETS
15.3846153846%	4	26	722	Diabetes_McGill_Set_Wnt_pathway	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
15.3846153846%	4	26	71	Diabetes_McGill_Set_Wnt_pathway	GU_PDEF_TARGETS_UP
15.3846153846%	4	26	701	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SMID_BREAST_CANCER_BASAL_DN
15.3846153846%	4	26	70	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SIGNALING_BY_NOTCH1
15.3846153846%	4	26	65	Diabetes_McGill_Set_Wnt_pathway	PID_ERA_GENOMIC_PATHWAY
15.3846153846%	4	26	63	Diabetes_McGill_Set_Wnt_pathway	PID_MYC_REPRESSPATHWAY
15.3846153846%	4	26	60	Diabetes_McGill_Set_Wnt_pathway	KEGG_ACUTE_MYELOID_LEUKEMIA
15.3846153846%	4	26	59	Diabetes_McGill_Set_Wnt_pathway	PID_NOTCH_PATHWAY
15.3846153846%	4	26	567	Diabetes_McGill_Set_Wnt_pathway	PARENT_MTOR_SIGNALING_UP
15.3846153846%	4	26	553	Diabetes_McGill_Set_Wnt_pathway	FEVR_CTNNB1_TARGETS_DN
15.3846153846%	4	26	54	Diabetes_McGill_Set_Wnt_pathway	PID_NFAT_3PATHWAY
15.3846153846%	4	26	514	Diabetes_McGill_Set_Wnt_pathway	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
15.3846153846%	4	26	508	Diabetes_McGill_Set_Wnt_pathway	ENK_UV_RESPONSE_EPIDERMIS_DN
15.3846153846%	4	26	49	Diabetes_McGill_Set_Wnt_pathway	PID_FOXOPATHWAY
15.3846153846%	4	26	485	Diabetes_McGill_Set_Wnt_pathway	ENK_UV_RESPONSE_KERATINOCYTE_DN
15.3846153846%	4	26	48	Diabetes_McGill_Set_Wnt_pathway	PID_HES_HEYPATHWAY
15.3846153846%	4	26	47	Diabetes_McGill_Set_Wnt_pathway	KEGG_NOTCH_SIGNALING_PATHWAY
15.3846153846%	4	26	46	Diabetes_McGill_Set_Wnt_pathway	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION
15.3846153846%	4	26	42	Diabetes_McGill_Set_Wnt_pathway	PID_BMPPATHWAY
15.3846153846%	4	26	29	Diabetes_McGill_Set_Wnt_pathway	KEGG_THYROID_CANCER
15.3846153846%	4	26	28	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_G1_PATHWAY
15.3846153846%	4	26	279	Diabetes_McGill_Set_Wnt_pathway	REACTOME_INNATE_IMMUNE_SYSTEM
15.3846153846%	4	26	271	Diabetes_McGill_Set_Wnt_pathway	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
15.3846153846%	4	26	267	Diabetes_McGill_Set_Wnt_pathway	KEGG_MAPK_SIGNALING_PATHWAY
15.3846153846%	4	26	25	Diabetes_McGill_Set_Wnt_pathway	PID_MYC_PATHWAY
15.3846153846%	4	26	210	Diabetes_McGill_Set_Wnt_pathway	RIZKI_TUMOR_INVASIVENESS_3D_UP
15.3846153846%	4	26	163	Diabetes_McGill_Set_Wnt_pathway	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
15.3846153846%	4	26	137	Diabetes_McGill_Set_Wnt_pathway	REACTOME_MITOTIC_G1_G1_S_PHASES
15.3846153846%	4	26	1278	Diabetes_McGill_Set_Wnt_pathway	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
15.3846153846%	4	26	1237	Diabetes_McGill_Set_Wnt_pathway	BLALOCK_ALZHEIMERS_DISEASE_DN
15.3846153846%	4	26	1137	Diabetes_McGill_Set_Wnt_pathway	BRUINS_UVC_RESPONSE_LATE
15.3846153846%	4	26	1118	Diabetes_McGill_Set_Wnt_pathway	BENPORATH_ES_WITH_H3K27ME3
15.3846153846%	4	26	1103	Diabetes_McGill_Set_Wnt_pathway	DANG_BOUND_BY_MYC
15.3846153846%	4	26	11	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_P35ALZHEIMERS_PATHWAY
15.3846153846%	4	26	1069	Diabetes_McGill_Set_Wnt_pathway	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
15.3846153846%	4	26	102	Diabetes_McGill_GPCRs_expressed_in_beta_cell	KANG_IMMORTALIZED_BY_TERT_DN
15.3846153846%	2	13	957	Diabetes_McGill_Insulin	LOPEZ_MBD_TARGETS
15.3846153846%	2	13	893	Diabetes_McGill_Insulin	GEORGES_TARGETS_OF_MIR192_AND_MIR215
15.3846153846%	2	13	841	Diabetes_McGill_Insulin	MARTENS_TRETINOIN_RESPONSE_DN
15.3846153846%	2	13	79	Diabetes_McGill_Insulin	MCCLUNG_COCAINE_REWARD_5D
15.3846153846%	2	13	775	Diabetes_McGill_Insulin	BENPORATH_MYC_MAX_TARGETS
15.3846153846%	2	13	682	Diabetes_McGill_Insulin	FEVR_CTNNB1_TARGETS_UP
15.3846153846%	2	13	590	Diabetes_McGill_Insulin	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
15.3846153846%	2	13	584	Diabetes_McGill_Insulin	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
15.3846153846%	2	13	584	Diabetes_McGill_Insulin	HAMAI_APOPTOSIS_VIA_TRAIL_UP
15.3846153846%	2	13	548	Diabetes_McGill_Insulin	KIM_ALL_DISORDERS_CALB1_CORR_UP
15.3846153846%	2	13	530	Diabetes_McGill_Insulin	ENK_UV_RESPONSE_KERATINOCYTE_UP
15.3846153846%	2	13	508	Diabetes_McGill_Insulin	ENK_UV_RESPONSE_EPIDERMIS_DN
15.3846153846%	2	13	491	Diabetes_McGill_Insulin	SWEET_LUNG_CANCER_KRAS_UP
15.3846153846%	2	13	473	Diabetes_McGill_Insulin	GARY_CD5_TARGETS_UP
15.3846153846%	2	13	467	Diabetes_McGill_Insulin	RATTENBACHER_BOUND_BY_CELF1
15.3846153846%	2	13	459	Diabetes_McGill_Insulin	KIM_WT1_TARGETS_DN
15.3846153846%	2	13	450	Diabetes_McGill_Insulin	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
15.3846153846%	2	13	442	Diabetes_McGill_Insulin	HAN_SATB1_TARGETS_DN
15.3846153846%	2	13	439	Diabetes_McGill_Insulin	MITSIADES_RESPONSE_TO_APLIDIN_UP
15.3846153846%	2	13	389	Diabetes_McGill_Insulin	HSIAO_HOUSEKEEPING_GENES
15.3846153846%	2	13	292	Diabetes_McGill_Insulin	HELLER_HDAC_TARGETS_DN
15.3846153846%	2	13	281	Diabetes_McGill_Insulin	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
15.3846153846%	2	13	281	Diabetes_McGill_Insulin	BHAT_ESR1_TARGETS_VIA_AKT1_UP
15.3846153846%	2	13	276	Diabetes_McGill_Insulin	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
15.3846153846%	2	13	271	Diabetes_McGill_Insulin	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
15.3846153846%	2	13	26	Diabetes_McGill_Insulin	REACTOME_ACTIVATION_OF_GENES_BY_ATF4
15.3846153846%	2	13	244	Diabetes_McGill_Insulin	DAZARD_RESPONSE_TO_UV_NHEK_UP
15.3846153846%	2	13	240	Diabetes_McGill_Insulin	UDAYAKUMAR_MED1_TARGETS_DN
15.3846153846%	2	13	230	Diabetes_McGill_Insulin	BENPORATH_MYC_TARGETS_WITH_EBOX
15.3846153846%	2	13	23	Diabetes_McGill_Insulin	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5
15.3846153846%	2	13	217	Diabetes_McGill_Insulin	SANSOM_APC_MYC_TARGETS
15.3846153846%	2	13	182	Diabetes_McGill_Insulin	FERNANDEZ_BOUND_BY_MYC
15.3846153846%	2	13	1725	Diabetes_McGill_Insulin	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
15.3846153846%	2	13	17	Diabetes_McGill_Insulin	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
15.3846153846%	2	13	156	Diabetes_McGill_Insulin	GROSS_HYPOXIA_VIA_ELK3_DN
15.3846153846%	2	13	147	Diabetes_McGill_Insulin	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
15.3846153846%	2	13	1375	Diabetes_McGill_Insulin	DODD_NASOPHARYNGEAL_CARCINOMA_DN
15.3846153846%	2	13	1118	Diabetes_McGill_Insulin	BENPORATH_ES_WITH_H3K27ME3
15.3846153846%	2	13	102	Diabetes_McGill_Insulin	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
15.3225806452%	19	124	795	Diabetes_McGill_Cell_cycle_All_Gene	WEI_MYCN_TARGETS_WITH_E_BOX
15.3225806452%	19	124	67	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN
15.3225806452%	19	124	378	Diabetes_McGill_Cell_cycle_All_Gene	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
15.3225806452%	19	124	277	Diabetes_McGill_Cell_cycle_All_Gene	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
15.3225806452%	19	124	181	Diabetes_McGill_Cell_cycle_All_Gene	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
15.3225806452%	19	124	138	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
15.3225806452%	19	124	1237	Diabetes_McGill_Cell_cycle_All_Gene	BLALOCK_ALZHEIMERS_DISEASE_DN
15.3225806452%	19	124	116	Diabetes_McGill_Cell_cycle_All_Gene	WHITEFORD_PEDIATRIC_CANCER_MARKERS
15.3225806452%	19	124	1137	Diabetes_McGill_Cell_cycle_All_Gene	BRUINS_UVC_RESPONSE_LATE
15.3225806452%	19	124	101	Diabetes_McGill_Cell_cycle_All_Gene	BURTON_ADIPOGENESIS_3
15.1515151515%	5	33	957	Diabetes_McGill_ER_Stress	LOPEZ_MBD_TARGETS
15.1515151515%	5	33	953	Mendelian_Metabolism	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
15.1515151515%	5	33	841	Diabetes_McGill_ER_Stress	MARTENS_TRETINOIN_RESPONSE_DN
15.1515151515%	5	33	811	Diabetes_McGill_ER_Stress	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
15.1515151515%	5	33	80	Mendelian_Metabolism	WOO_LIVER_CANCER_RECURRENCE_DN
15.1515151515%	5	33	775	Diabetes_McGill_ER_Stress	BENPORATH_MYC_MAX_TARGETS
15.1515151515%	5	33	546	Mendelian_Metabolism	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
15.1515151515%	5	33	540	Diabetes_McGill_ER_Stress	ACEVEDO_LIVER_CANCER_DN
15.1515151515%	5	33	539	Diabetes_McGill_ER_Stress	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
15.1515151515%	5	33	536	Mendelian_Metabolism	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
15.1515151515%	5	33	518	Diabetes_McGill_ER_Stress	REACTOME_METABOLISM_OF_PROTEINS
15.1515151515%	5	33	514	Mendelian_Metabolism	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
15.1515151515%	5	33	508	Diabetes_McGill_ER_Stress	ENK_UV_RESPONSE_EPIDERMIS_DN
15.1515151515%	5	33	504	Mendelian_Metabolism	PILON_KLF1_TARGETS_UP
15.1515151515%	5	33	439	Diabetes_McGill_ER_Stress	MITSIADES_RESPONSE_TO_APLIDIN_UP
15.1515151515%	5	33	429	Mendelian_Metabolism	MOOTHA_HUMAN_MITODB_6_2002
15.1515151515%	5	33	337	Diabetes_McGill_ER_Stress	PENG_GLUTAMINE_DEPRIVATION_DN
15.1515151515%	5	33	326	Mendelian_Metabolism	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
15.1515151515%	5	33	314	Diabetes_McGill_ER_Stress	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
15.1515151515%	5	33	251	Diabetes_McGill_ER_Stress	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
15.1515151515%	5	33	245	Diabetes_McGill_ER_Stress	PENG_RAPAMYCIN_RESPONSE_DN
15.1515151515%	5	33	24	Diabetes_McGill_ER_Stress	KEGG_PROTEIN_EXPORT
15.1515151515%	5	33	222	Diabetes_McGill_ER_Stress	REACTOME_TRANSLATION
15.1515151515%	5	33	1821	Mendelian_Metabolism	DODD_NASOPHARYNGEAL_CARCINOMA_UP
15.1515151515%	5	33	179	Mendelian_Metabolism	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
15.1515151515%	5	33	1652	Diabetes_McGill_ER_Stress	PUJANA_BRCA1_PCC_NETWORK
15.1515151515%	5	33	16	Mendelian_Metabolism	REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT
15.1515151515%	5	33	156	Diabetes_McGill_ER_Stress	GROSS_HYPOXIA_VIA_ELK3_DN
15.1515151515%	5	33	1375	Mendelian_Metabolism	DODD_NASOPHARYNGEAL_CARCINOMA_DN
15.1515151515%	5	33	1305	Diabetes_McGill_ER_Stress	YOSHIMURA_MAPK8_TARGETS_UP
15.1515151515%	5	33	1137	Mendelian_Metabolism	BRUINS_UVC_RESPONSE_LATE
15.1515151515%	5	33	1103	Diabetes_McGill_ER_Stress	DANG_BOUND_BY_MYC
15.1515151515%	5	33	11	Diabetes_McGill_ER_Stress	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA
15.1515151515%	5	33	11	Diabetes_McGill_ER_Stress	BIOCARTA_EIF2_PATHWAY
15.1515151515%	5	33	1038	Mendelian_Metabolism	BENPORATH_SUZ12_TARGETS
15.0197628458%	38	253	855	Diabetes_McGill_CREBBP_coTF	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
15.0197628458%	38	253	82	Diabetes_McGill_CREBBP_coTF	PID_SMAD2_3NUCLEARPATHWAY
15.0197628458%	38	253	323	Diabetes_McGill_CREBBP_coTF	GRESHOCK_CANCER_COPY_NUMBER_UP
15.0197628458%	38	253	1118	Diabetes_McGill_CREBBP_coTF	BENPORATH_ES_WITH_H3K27ME3
14.8148148148%	4	27	988	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BENPORATH_NANOG_TARGETS
14.8148148148%	4	27	98	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
14.8148148148%	4	27	957	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LOPEZ_MBD_TARGETS
14.8148148148%	4	27	871	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GRADE_COLON_CANCER_UP
14.8148148148%	4	27	87	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MOOTHA_VOXPHOS
14.8148148148%	4	27	8	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MOOTHA_PYR
14.8148148148%	4	27	79	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT
14.8148148148%	4	27	783	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ONKEN_UVEAL_MELANOMA_UP
14.8148148148%	4	27	712	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SCHLOSSER_SERUM_RESPONSE_DN
14.8148148148%	4	27	69	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_GLUCOSE_METABOLISM
14.8148148148%	4	27	682	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
14.8148148148%	4	27	566	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DOUGLAS_BMI1_TARGETS_UP
14.8148148148%	4	27	557	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	TIEN_INTESTINE_PROBIOTICS_24HR_UP
14.8148148148%	4	27	532	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
14.8148148148%	4	27	425	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZHANG_BREAST_CANCER_PROGENITORS_UP
14.8148148148%	4	27	358	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GRUETZMANN_PANCREATIC_CANCER_UP
14.8148148148%	4	27	323	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GRESHOCK_CANCER_COPY_NUMBER_UP
14.8148148148%	4	27	185	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_HUNTINGTONS_DISEASE
14.8148148148%	4	27	169	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_ALZHEIMERS_DISEASE
14.8148148148%	4	27	135	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_OXIDATIVE_PHOSPHORYLATION
14.8148148148%	4	27	133	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_PARKINSONS_DISEASE
14.8148148148%	4	27	1278	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
14.8148148148%	4	27	123	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KAYO_AGING_MUSCLE_DN
14.8148148148%	4	27	12	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BIOCARTA_ETC_PATHWAY
14.8148148148%	12	81	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
14.8148148148%	12	81	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG
14.6341463415%	6	41	882	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
14.6341463415%	6	41	682	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FEVR_CTNNB1_TARGETS_UP
14.6341463415%	6	41	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_INSULIN_PATHWAY
14.6341463415%	6	41	435	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
14.6341463415%	6	41	269	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
14.6341463415%	6	41	1691	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BLALOCK_ALZHEIMERS_DISEASE_UP
14.6341463415%	6	41	1375	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DODD_NASOPHARYNGEAL_CARCINOMA_DN
14.5161290323%	18	124	87	Diabetes_McGill_Cell_cycle_All_Gene	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
14.5161290323%	18	124	86	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_TGF_BETA_SIGNALING_PATHWAY
14.5161290323%	18	124	81	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_MITOTIC_G2_G2_M_PHASES
14.5161290323%	18	124	73	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
14.5161290323%	18	124	72	Diabetes_McGill_Cell_cycle_All_Gene	CROONQUIST_NRAS_SIGNALING_DN
14.5161290323%	18	124	572	Diabetes_McGill_Cell_cycle_All_Gene	CHICAS_RB1_TARGETS_SENESCENT
14.5161290323%	18	124	202	Diabetes_McGill_Cell_cycle_All_Gene	FUJII_YBX1_TARGETS_DN
14.5161290323%	18	124	128	Diabetes_McGill_Cell_cycle_All_Gene	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
14.2857142857%	6	42	770	Diabetes_McGill_RAS	KRIEG_HYPOXIA_NOT_VIA_KDM3A
14.2857142857%	6	42	40	Diabetes_McGill_RAS	PID_EPHBFWDPATHWAY
14.2857142857%	6	42	36	Diabetes_McGill_RAS	REACTOME_SIGNALLING_TO_ERKS
14.2857142857%	6	42	217	Diabetes_McGill_RAS	REACTOME_SIGNALLING_BY_NGF
14.2857142857%	6	42	216	Diabetes_McGill_RAS	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
14.2857142857%	6	42	1442	Diabetes_McGill_RAS	PUJANA_ATM_PCC_NETWORK
14.2857142857%	6	42	137	Diabetes_McGill_RAS	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
14.2857142857%	6	42	134	Diabetes_McGill_RAS	KEGG_TIGHT_JUNCTION
14.2857142857%	6	42	1069	Diabetes_McGill_RAS	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
14.2857142857%	4	28	98	Diabetes_McGill_Cell_cycle_G1	CROONQUIST_IL6_DEPRIVATION_DN
14.2857142857%	4	28	933	Diabetes_McGill_Cell_cycle_G1	REACTOME_IMMUNE_SYSTEM
14.2857142857%	4	28	893	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GEORGES_TARGETS_OF_MIR192_AND_MIR215
14.2857142857%	4	28	893	Diabetes_McGill_Cell_cycle_G1	GEORGES_TARGETS_OF_MIR192_AND_MIR215
14.2857142857%	4	28	882	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
14.2857142857%	4	28	882	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
14.2857142857%	4	28	87	Diabetes_McGill_Cell_cycle_G1	KEGG_ERBB_SIGNALING_PATHWAY
14.2857142857%	4	28	87	Diabetes_McGill_Cell_cycle_G1	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
14.2857142857%	4	28	86	Diabetes_McGill_Cell_cycle_G1	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
14.2857142857%	4	28	85	Diabetes_McGill_Cell_cycle_G1	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE
14.2857142857%	4	28	848	Diabetes_McGill_Cell_cycle_G1	NUYTTEN_NIPP1_TARGETS_DN
14.2857142857%	4	28	82	Diabetes_McGill_Cell_cycle_G1	PID_REG_GR_PATHWAY
14.2857142857%	4	28	811	Diabetes_McGill_Cell_cycle_G1	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
14.2857142857%	4	28	81	Diabetes_McGill_Cell_cycle_G1	HARRIS_HYPOXIA
14.2857142857%	4	28	8	Diabetes_McGill_Cell_cycle_G1	REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS
14.2857142857%	4	28	770	Diabetes_McGill_Cell_cycle_G1	KRIEG_HYPOXIA_NOT_VIA_KDM3A
14.2857142857%	4	28	71	Diabetes_McGill_Cell_cycle_G1	GU_PDEF_TARGETS_UP
14.2857142857%	4	28	67	Diabetes_McGill_Cell_cycle_G1	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
14.2857142857%	4	28	60	Diabetes_McGill_Cell_cycle_G1	SONG_TARGETS_OF_IE86_CMV_PROTEIN
14.2857142857%	4	28	59	Diabetes_McGill_Cell_cycle_G1	PID_NOTCH_PATHWAY
14.2857142857%	4	28	59	Diabetes_McGill_Cell_cycle_G1	PID_ATF2_PATHWAY
14.2857142857%	4	28	553	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FEVR_CTNNB1_TARGETS_DN
14.2857142857%	4	28	552	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
14.2857142857%	4	28	55	Diabetes_McGill_Cell_cycle_G1	LAU_APOPTOSIS_CDKN2A_UP
14.2857142857%	4	28	540	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ACEVEDO_LIVER_CANCER_DN
14.2857142857%	4	28	539	Diabetes_McGill_Cell_cycle_G1	LIAO_METASTASIS
14.2857142857%	4	28	536	Diabetes_McGill_Cell_cycle_G1	SENESE_HDAC3_TARGETS_DN
14.2857142857%	4	28	530	Diabetes_McGill_Cell_cycle_G1	ENK_UV_RESPONSE_KERATINOCYTE_UP
14.2857142857%	4	28	53	Diabetes_McGill_Cell_cycle_G1	ISHIDA_E2F_TARGETS
14.2857142857%	4	28	516	Diabetes_McGill_Cell_cycle_G1	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
14.2857142857%	4	28	514	Diabetes_McGill_Cell_cycle_G1	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
14.2857142857%	4	28	504	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PILON_KLF1_TARGETS_UP
14.2857142857%	4	28	501	Diabetes_McGill_Cell_cycle_G1	SENESE_HDAC3_TARGETS_UP
14.2857142857%	4	28	50	Diabetes_McGill_Cell_cycle_G1	HOFMANN_CELL_LYMPHOMA_UP
14.2857142857%	4	28	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_HES_HEYPATHWAY
14.2857142857%	4	28	48	Diabetes_McGill_Cell_cycle_G1	PID_HES_HEYPATHWAY
14.2857142857%	4	28	48	Diabetes_McGill_Cell_cycle_G1	OXFORD_RALA_OR_RALB_TARGETS_UP
14.2857142857%	4	28	473	Diabetes_McGill_Cell_cycle_G1	GARY_CD5_TARGETS_UP
14.2857142857%	4	28	47	Diabetes_McGill_Cell_cycle_G1	KHETCHOUMIAN_TRIM24_TARGETS_UP
14.2857142857%	4	28	457	Diabetes_McGill_Cell_cycle_G1	SENESE_HDAC1_TARGETS_UP
14.2857142857%	4	28	447	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MOOTHA_MITOCHONDRIA
14.2857142857%	4	28	44	Diabetes_McGill_Cell_cycle_G1	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
14.2857142857%	4	28	429	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MOOTHA_HUMAN_MITODB_6_2002
14.2857142857%	4	28	428	Diabetes_McGill_Cell_cycle_G1	CUI_TCF21_TARGETS_2_UP
14.2857142857%	4	28	414	Diabetes_McGill_Cell_cycle_G1	MOHANKUMAR_TLX1_TARGETS_UP
14.2857142857%	4	28	395	Diabetes_McGill_Cell_cycle_G1	HAN_SATB1_TARGETS_UP
14.2857142857%	4	28	378	Diabetes_McGill_Cell_cycle_G1	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
14.2857142857%	4	28	374	Diabetes_McGill_Cell_cycle_G1	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
14.2857142857%	4	28	364	Diabetes_McGill_Cell_cycle_G1	YANG_BCL3_TARGETS_UP
14.2857142857%	4	28	362	Diabetes_McGill_Cell_cycle_G1	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
14.2857142857%	4	28	36	Diabetes_McGill_Cell_cycle_G1	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2
14.2857142857%	4	28	34	Diabetes_McGill_Cell_cycle_G1	FRIDMAN_IMMORTALIZATION_DN
14.2857142857%	4	28	337	Diabetes_McGill_Cell_cycle_G1	PENG_GLUTAMINE_DEPRIVATION_DN
14.2857142857%	4	28	330	Diabetes_McGill_Cell_cycle_G1	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
14.2857142857%	4	28	318	Diabetes_McGill_Cell_cycle_G1	LEI_MYB_TARGETS
14.2857142857%	4	28	315	Diabetes_McGill_Cell_cycle_G1	PASINI_SUZ12_TARGETS_DN
14.2857142857%	4	28	309	Diabetes_McGill_Cell_cycle_G1	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
14.2857142857%	4	28	305	Diabetes_McGill_Cell_cycle_G1	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
14.2857142857%	4	28	293	Diabetes_McGill_Cell_cycle_G1	HADDAD_B_LYMPHOCYTE_PROGENITOR
14.2857142857%	4	28	29	Diabetes_McGill_Cell_cycle_G1	REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION
14.2857142857%	4	28	29	Diabetes_McGill_Cell_cycle_G1	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
14.2857142857%	4	28	267	Diabetes_McGill_Cell_cycle_G1	KEGG_MAPK_SIGNALING_PATHWAY
14.2857142857%	4	28	26	Diabetes_McGill_Cell_cycle_G1	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
14.2857142857%	4	28	26	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_WNT_PATHWAY
14.2857142857%	4	28	228	Diabetes_McGill_Cell_cycle_G1	MARKEY_RB1_ACUTE_LOF_DN
14.2857142857%	4	28	217	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALLING_BY_NGF
14.2857142857%	4	28	206	Diabetes_McGill_Cell_cycle_G1	LINSLEY_MIR16_TARGETS
14.2857142857%	4	28	202	Diabetes_McGill_Cell_cycle_G1	FUJII_YBX1_TARGETS_DN
14.2857142857%	4	28	20	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_ATM_PATHWAY
14.2857142857%	4	28	1839	Diabetes_McGill_Cell_cycle_G1	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
14.2857142857%	4	28	1821	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	DODD_NASOPHARYNGEAL_CARCINOMA_UP
14.2857142857%	4	28	176	Diabetes_McGill_Cell_cycle_G1	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
14.2857142857%	4	28	1691	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BLALOCK_ALZHEIMERS_DISEASE_UP
14.2857142857%	4	28	151	Diabetes_McGill_Cell_cycle_G1	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
14.2857142857%	4	28	148	Diabetes_McGill_Cell_cycle_G1	CHANG_CYCLING_GENES
14.2857142857%	4	28	147	Diabetes_McGill_Cell_cycle_G1	WHITFIELD_CELL_CYCLE_G1_S
14.2857142857%	4	28	143	Diabetes_McGill_Cell_cycle_G1	DANG_MYC_TARGETS_UP
14.2857142857%	4	28	140	Diabetes_McGill_Cell_cycle_G1	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
14.2857142857%	4	28	133	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_DIABETES_PATHWAYS
14.2857142857%	4	28	132	Diabetes_McGill_Cell_cycle_G1	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
14.2857142857%	4	28	1210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHEN_METABOLIC_SYNDROM_NETWORK
14.2857142857%	4	28	1174	Diabetes_McGill_Cell_cycle_G1	PEREZ_TP53_TARGETS
14.2857142857%	4	28	116	Diabetes_McGill_Cell_cycle_G1	REACTOME_MEIOSIS
14.2857142857%	4	28	115	Diabetes_McGill_Cell_cycle_G1	MARZEC_IL2_SIGNALING_UP
14.2857142857%	4	28	1137	Diabetes_McGill_Cell_cycle_G1	BRUINS_UVC_RESPONSE_LATE
14.2857142857%	4	28	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ZHOU_PANCREATIC_BETA_CELL
14.2857142857%	4	28	1069	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
14.2857142857%	4	28	1022	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARSON_BOUND_BY_FOXP3_STIMULATED
14.2857142857%	10	70	89	Diabetes_McGill_Adipocytokine_signallin	KEGG_PROSTATE_CANCER
14.2857142857%	10	70	882	Diabetes_McGill_Adipocytokine_signallin	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
14.2857142857%	10	70	87	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_MAPK_PATHWAY
14.2857142857%	10	70	73	Diabetes_McGill_Adipocytokine_signallin	KEGG_CHRONIC_MYELOID_LEUKEMIA
14.2857142857%	10	70	72	Diabetes_McGill_Adipocytokine_signallin	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
14.2857142857%	10	70	68	Diabetes_McGill_Adipocytokine_signallin	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
14.2857142857%	10	70	60	Diabetes_McGill_Adipocytokine_signallin	KEGG_ACUTE_MYELOID_LEUKEMIA
14.2857142857%	10	70	58	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_HIVNEF_PATHWAY
14.2857142857%	10	70	46	Diabetes_McGill_Adipocytokine_signallin	PID_TNFPATHWAY
14.2857142857%	10	70	29	Diabetes_McGill_Adipocytokine_signallin	ST_TUMOR_NECROSIS_FACTOR_PATHWAY
14.2857142857%	10	70	29	Diabetes_McGill_Adipocytokine_signallin	REACTOME_PKB_MEDIATED_EVENTS
14.2857142857%	10	70	279	Diabetes_McGill_Adipocytokine_signallin	REACTOME_INNATE_IMMUNE_SYSTEM
14.2857142857%	10	70	23	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_NFKB_PATHWAY
14.2857142857%	10	70	1972	Diabetes_McGill_Adipocytokine_signallin	PILON_KLF1_TARGETS_DN
14.2857142857%	10	70	1781	Diabetes_McGill_Adipocytokine_signallin	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
14.2857142857%	10	70	16	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_RELA_PATHWAY
14.2857142857%	10	70	11	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_LEPTIN_PATHWAY
14.2857142857%	1	7	99	Mendelian_Lipoprotein_deficiency	LIM_MAMMARY_LUMINAL_MATURE_DN
14.2857142857%	1	7	988	Mendelian_Lipoprotein_deficiency	BENPORATH_NANOG_TARGETS
14.2857142857%	1	7	98	Mendelian_Disorders_of_Phosphorous_Metabolism	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
14.2857142857%	1	7	97	Mendelian_Lipoprotein_deficiency	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP
14.2857142857%	1	7	97	Mendelian_Disorders_of_Phosphorous_Metabolism	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP
14.2857142857%	1	7	97	Diabetes_McGill_Insulin_exocytosi	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
14.2857142857%	1	7	96	Mendelian_Lipoprotein_deficiency	ZAMORA_NOS2_TARGETS_DN
14.2857142857%	1	7	953	Mendelian_Lipoprotein_deficiency	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
14.2857142857%	1	7	95	Mendelian_Lipoprotein_deficiency	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
14.2857142857%	1	7	95	Mendelian_Lipoprotein_deficiency	HOEBEKE_LYMPHOID_STEM_CELL_UP
14.2857142857%	1	7	940	Mendelian_Lipoprotein_deficiency	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
14.2857142857%	1	7	940	Mendelian_Disorders_of_Phosphorous_Metabolism	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
14.2857142857%	1	7	94	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES
14.2857142857%	1	7	933	Mendelian_Lipoprotein_deficiency	REACTOME_IMMUNE_SYSTEM
14.2857142857%	1	7	93	Mendelian_Lipoprotein_deficiency	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
14.2857142857%	1	7	911	Mendelian_Lipoprotein_deficiency	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
14.2857142857%	1	7	91	Mendelian_Lipoprotein_deficiency	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION
14.2857142857%	1	7	91	Mendelian_Lipoprotein_deficiency	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
14.2857142857%	1	7	91	Mendelian_Disorders_of_Phosphorous_Metabolism	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
14.2857142857%	1	7	90	Mendelian_Lipoprotein_deficiency	MORI_MATURE_B_LYMPHOCYTE_UP
14.2857142857%	1	7	90	Mendelian_Disorders_of_Phosphorous_Metabolism	GAVIN_FOXP3_TARGETS_CLUSTER_P7
14.2857142857%	1	7	898	Mendelian_Disorders_of_Phosphorous_Metabolism	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
14.2857142857%	1	7	898	Diabetes_McGill_Insulin_exocytosi	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
14.2857142857%	1	7	893	Diabetes_McGill_Insulin_exocytosi	GEORGES_TARGETS_OF_MIR192_AND_MIR215
14.2857142857%	1	7	89	Mendelian_Lipoprotein_deficiency	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
14.2857142857%	1	7	89	Mendelian_Lipoprotein_deficiency	LEE_AGING_NEOCORTEX_UP
14.2857142857%	1	7	882	Mendelian_Lipoprotein_deficiency	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
14.2857142857%	1	7	88	Mendelian_Lipoprotein_deficiency	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
14.2857142857%	1	7	88	Mendelian_Disorders_of_Phosphorous_Metabolism	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
14.2857142857%	1	7	88	Mendelian_Disorders_of_Phosphorous_Metabolism	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
14.2857142857%	1	7	87	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
14.2857142857%	1	7	86	Mendelian_Disorders_of_Phosphorous_Metabolism	GHANDHI_BYSTANDER_IRRADIATION_UP
14.2857142857%	1	7	86	Diabetes_McGill_Insulin_exocytosi	NELSON_RESPONSE_TO_ANDROGEN_UP
14.2857142857%	1	7	857	Diabetes_McGill_Insulin_exocytosi	MARTENS_TRETINOIN_RESPONSE_UP
14.2857142857%	1	7	85	Diabetes_McGill_Insulin_exocytosi	XU_GH1_EXOGENOUS_TARGETS_UP
14.2857142857%	1	7	85	Diabetes_McGill_Insulin_exocytosi	STEIN_ESR1_TARGETS
14.2857142857%	1	7	848	Mendelian_Lipoprotein_deficiency	NUYTTEN_NIPP1_TARGETS_DN
14.2857142857%	1	7	841	Mendelian_Disorders_of_Phosphorous_Metabolism	MARTENS_TRETINOIN_RESPONSE_DN
14.2857142857%	1	7	84	Mendelian_Lipoprotein_deficiency	RUAN_RESPONSE_TO_TNF_DN
14.2857142857%	1	7	84	Mendelian_Lipoprotein_deficiency	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
14.2857142857%	1	7	84	Mendelian_Disorders_of_Phosphorous_Metabolism	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
14.2857142857%	1	7	83	Mendelian_Lipoprotein_deficiency	REACTOME_AMYLOIDS
14.2857142857%	1	7	83	Diabetes_McGill_Insulin_exocytosi	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
14.2857142857%	1	7	811	Mendelian_Lipoprotein_deficiency	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
14.2857142857%	1	7	811	Diabetes_McGill_Insulin_exocytosi	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
14.2857142857%	1	7	81	Mendelian_Lipoprotein_deficiency	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION
14.2857142857%	1	7	800	Diabetes_McGill_Insulin_exocytosi	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
14.2857142857%	1	7	80	Mendelian_Lipoprotein_deficiency	WOO_LIVER_CANCER_RECURRENCE_DN
14.2857142857%	1	7	80	Mendelian_Lipoprotein_deficiency	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
14.2857142857%	1	7	8	Mendelian_Lipoprotein_deficiency	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN
14.2857142857%	1	7	783	Mendelian_Lipoprotein_deficiency	ONKEN_UVEAL_MELANOMA_UP
14.2857142857%	1	7	781	Mendelian_Disorders_of_Phosphorous_Metabolism	GOZGIT_ESR1_TARGETS_DN
14.2857142857%	1	7	78	Mendelian_Lipoprotein_deficiency	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
14.2857142857%	1	7	78	Mendelian_Lipoprotein_deficiency	REACTOME_PLATELET_HOMEOSTASIS
14.2857142857%	1	7	770	Diabetes_McGill_Insulin_exocytosi	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
14.2857142857%	1	7	77	Mendelian_Lipoprotein_deficiency	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM
14.2857142857%	1	7	77	Mendelian_Lipoprotein_deficiency	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
14.2857142857%	1	7	77	Mendelian_Disorders_of_Phosphorous_Metabolism	CHEBOTAEV_GR_TARGETS_UP
14.2857142857%	1	7	769	Mendelian_Disorders_of_Phosphorous_Metabolism	NUYTTEN_NIPP1_TARGETS_UP
14.2857142857%	1	7	76	Mendelian_Lipoprotein_deficiency	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
14.2857142857%	1	7	76	Mendelian_Lipoprotein_deficiency	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
14.2857142857%	1	7	756	Diabetes_McGill_Insulin_exocytosi	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
14.2857142857%	1	7	75	Mendelian_Lipoprotein_deficiency	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
14.2857142857%	1	7	75	Mendelian_Disorders_of_Phosphorous_Metabolism	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
14.2857142857%	1	7	74	Mendelian_Lipoprotein_deficiency	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN
14.2857142857%	1	7	74	Mendelian_Lipoprotein_deficiency	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
14.2857142857%	1	7	73	Mendelian_Disorders_of_Phosphorous_Metabolism	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
14.2857142857%	1	7	73	Diabetes_McGill_Insulin_exocytosi	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
14.2857142857%	1	7	728	Diabetes_McGill_Insulin_exocytosi	MARSON_BOUND_BY_E2F4_UNSTIMULATED
14.2857142857%	1	7	722	Diabetes_McGill_Insulin_exocytosi	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
14.2857142857%	1	7	721	Mendelian_Lipoprotein_deficiency	WONG_ADULT_TISSUE_STEM_MODULE
14.2857142857%	1	7	720	Mendelian_Lipoprotein_deficiency	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
14.2857142857%	1	7	72	Mendelian_Lipoprotein_deficiency	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
14.2857142857%	1	7	72	Mendelian_Lipoprotein_deficiency	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
14.2857142857%	1	7	718	Mendelian_Disorders_of_Phosphorous_Metabolism	MIKKELSEN_ES_ICP_WITH_H3K4ME3
14.2857142857%	1	7	718	Diabetes_McGill_Insulin_exocytosi	MIKKELSEN_ES_ICP_WITH_H3K4ME3
14.2857142857%	1	7	71	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_PI3K_CASCADE
14.2857142857%	1	7	71	Mendelian_Disorders_of_Phosphorous_Metabolism	KUMAR_AUTOPHAGY_NETWORK
14.2857142857%	1	7	71	Mendelian_Disorders_of_Phosphorous_Metabolism	KEGG_MELANOMA
14.2857142857%	1	7	701	Mendelian_Disorders_of_Phosphorous_Metabolism	SMID_BREAST_CANCER_BASAL_DN
14.2857142857%	1	7	70	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS
14.2857142857%	1	7	70	Mendelian_Disorders_of_Phosphorous_Metabolism	PID_AP1_PATHWAY
14.2857142857%	1	7	70	Mendelian_Disorders_of_Phosphorous_Metabolism	MIKKELSEN_MEF_LCP_WITH_H3K27ME3
14.2857142857%	1	7	7	Mendelian_Disorders_of_Phosphorous_Metabolism	HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER
14.2857142857%	1	7	69	Mendelian_Lipoprotein_deficiency	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
14.2857142857%	1	7	69	Mendelian_Disorders_of_Phosphorous_Metabolism	RIZKI_TUMOR_INVASIVENESS_2D_UP
14.2857142857%	1	7	69	Mendelian_Disorders_of_Phosphorous_Metabolism	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
14.2857142857%	1	7	69	Diabetes_McGill_Insulin_exocytosi	LEIN_NEURON_MARKERS
14.2857142857%	1	7	682	Diabetes_McGill_Insulin_exocytosi	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
14.2857142857%	1	7	682	Diabetes_McGill_Insulin_exocytosi	FEVR_CTNNB1_TARGETS_UP
14.2857142857%	1	7	681	Mendelian_Lipoprotein_deficiency	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
14.2857142857%	1	7	673	Mendelian_Lipoprotein_deficiency	MARTINEZ_RB1_TARGETS_UP
14.2857142857%	1	7	67	Mendelian_Lipoprotein_deficiency	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
14.2857142857%	1	7	66	Mendelian_Lipoprotein_deficiency	NAKAMURA_ADIPOGENESIS_EARLY_UP
14.2857142857%	1	7	652	Mendelian_Lipoprotein_deficiency	BENPORATH_PRC2_TARGETS
14.2857142857%	1	7	65	Mendelian_Lipoprotein_deficiency	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN
14.2857142857%	1	7	65	Mendelian_Lipoprotein_deficiency	GUO_HEX_TARGETS_DN
14.2857142857%	1	7	64	Mendelian_Lipoprotein_deficiency	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
14.2857142857%	1	7	64	Mendelian_Lipoprotein_deficiency	LEE_LIVER_CANCER_ACOX1_UP
14.2857142857%	1	7	64	Mendelian_Lipoprotein_deficiency	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
14.2857142857%	1	7	633	Mendelian_Lipoprotein_deficiency	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
14.2857142857%	1	7	63	Mendelian_Lipoprotein_deficiency	BURTON_ADIPOGENESIS_PEAK_AT_0HR
14.2857142857%	1	7	63	Mendelian_Lipoprotein_deficiency	BILBAN_B_CLL_LPL_UP
14.2857142857%	1	7	63	Diabetes_McGill_Insulin_exocytosi	MODY_HIPPOCAMPUS_POSTNATAL
14.2857142857%	1	7	62	Mendelian_Lipoprotein_deficiency	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
14.2857142857%	1	7	62	Mendelian_Lipoprotein_deficiency	LEE_LIVER_CANCER_E2F1_UP
14.2857142857%	1	7	62	Mendelian_Lipoprotein_deficiency	KORKOLA_YOLK_SAC_TUMOR
14.2857142857%	1	7	61	Mendelian_Lipoprotein_deficiency	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
14.2857142857%	1	7	61	Mendelian_Lipoprotein_deficiency	LEE_LIVER_CANCER_MYC_TGFA_UP
14.2857142857%	1	7	602	Mendelian_Lipoprotein_deficiency	MARTINEZ_TP53_TARGETS_UP
14.2857142857%	1	7	601	Mendelian_Lipoprotein_deficiency	MARTINEZ_RB1_AND_TP53_TARGETS_UP
14.2857142857%	1	7	60	Mendelian_Lipoprotein_deficiency	WIERENGA_STAT5A_TARGETS_GROUP2
14.2857142857%	1	7	60	Mendelian_Lipoprotein_deficiency	LEE_LIVER_CANCER_DENA_UP
14.2857142857%	1	7	60	Mendelian_Lipoprotein_deficiency	LEE_LIVER_CANCER_CIPROFIBRATE_UP
14.2857142857%	1	7	60	Mendelian_Lipoprotein_deficiency	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
14.2857142857%	1	7	60	Diabetes_McGill_Insulin_exocytosi	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING
14.2857142857%	1	7	590	Mendelian_Disorders_of_Phosphorous_Metabolism	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
14.2857142857%	1	7	584	Diabetes_McGill_Insulin_exocytosi	HAMAI_APOPTOSIS_VIA_TRAIL_UP
14.2857142857%	1	7	58	Mendelian_Lipoprotein_deficiency	KANNAN_TP53_TARGETS_UP
14.2857142857%	1	7	579	Mendelian_Lipoprotein_deficiency	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
14.2857142857%	1	7	578	Diabetes_McGill_Insulin_exocytosi	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
14.2857142857%	1	7	57	Mendelian_Lipoprotein_deficiency	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
14.2857142857%	1	7	57	Mendelian_Lipoprotein_deficiency	BORLAK_LIVER_CANCER_EGF_UP
14.2857142857%	1	7	566	Mendelian_Lipoprotein_deficiency	DOUGLAS_BMI1_TARGETS_UP
14.2857142857%	1	7	566	Mendelian_Disorders_of_Phosphorous_Metabolism	DOUGLAS_BMI1_TARGETS_UP
14.2857142857%	1	7	564	Mendelian_Lipoprotein_deficiency	SMID_BREAST_CANCER_LUMINAL_B_DN
14.2857142857%	1	7	56	Mendelian_Lipoprotein_deficiency	LEE_LIVER_CANCER_MYC_E2F1_UP
14.2857142857%	1	7	56	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_PI_3K_CASCADE
14.2857142857%	1	7	552	Mendelian_Disorders_of_Phosphorous_Metabolism	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
14.2857142857%	1	7	552	Diabetes_McGill_Insulin_exocytosi	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
14.2857142857%	1	7	55	Mendelian_Lipoprotein_deficiency	YU_MYC_TARGETS_DN
14.2857142857%	1	7	55	Mendelian_Lipoprotein_deficiency	SU_LIVER
14.2857142857%	1	7	55	Mendelian_Disorders_of_Phosphorous_Metabolism	PID_FGF_PATHWAY
14.2857142857%	1	7	549	Mendelian_Lipoprotein_deficiency	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
14.2857142857%	1	7	546	Mendelian_Lipoprotein_deficiency	WEST_ADRENOCORTICAL_TUMOR_DN
14.2857142857%	1	7	546	Diabetes_McGill_Insulin_exocytosi	WEST_ADRENOCORTICAL_TUMOR_DN
14.2857142857%	1	7	54	Mendelian_Lipoprotein_deficiency	LEE_LIVER_CANCER_MYC_UP
14.2857142857%	1	7	54	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE
14.2857142857%	1	7	539	Mendelian_Lipoprotein_deficiency	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
14.2857142857%	1	7	539	Diabetes_McGill_Insulin_exocytosi	LIAO_METASTASIS
14.2857142857%	1	7	537	Mendelian_Disorders_of_Phosphorous_Metabolism	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
14.2857142857%	1	7	536	Mendelian_Lipoprotein_deficiency	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
14.2857142857%	1	7	535	Mendelian_Disorders_of_Phosphorous_Metabolism	STEIN_ESRRA_TARGETS
14.2857142857%	1	7	53	Diabetes_McGill_Insulin_exocytosi	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
14.2857142857%	1	7	53	Diabetes_McGill_Insulin_exocytosi	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS
14.2857142857%	1	7	53	Diabetes_McGill_Insulin_exocytosi	PID_AR_TF_PATHWAY
14.2857142857%	1	7	52	Mendelian_Disorders_of_Phosphorous_Metabolism	KEGG_STARCH_AND_SUCROSE_METABOLISM
14.2857142857%	1	7	518	Mendelian_Lipoprotein_deficiency	REACTOME_METABOLISM_OF_PROTEINS
14.2857142857%	1	7	517	Mendelian_Lipoprotein_deficiency	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
14.2857142857%	1	7	514	Mendelian_Disorders_of_Phosphorous_Metabolism	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
14.2857142857%	1	7	51	Mendelian_Lipoprotein_deficiency	GUILLAUMOND_KLF10_TARGETS_UP
14.2857142857%	1	7	51	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
14.2857142857%	1	7	51	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE
14.2857142857%	1	7	508	Mendelian_Disorders_of_Phosphorous_Metabolism	ENK_UV_RESPONSE_EPIDERMIS_DN
14.2857142857%	1	7	505	Mendelian_Lipoprotein_deficiency	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
14.2857142857%	1	7	504	Mendelian_Disorders_of_Phosphorous_Metabolism	PILON_KLF1_TARGETS_UP
14.2857142857%	1	7	504	Mendelian_Disorders_of_Phosphorous_Metabolism	BROWNE_HCMV_INFECTION_48HR_DN
14.2857142857%	1	7	501	Mendelian_Disorders_of_Phosphorous_Metabolism	SENESE_HDAC3_TARGETS_UP
14.2857142857%	1	7	501	Diabetes_McGill_Insulin_exocytosi	SENESE_HDAC3_TARGETS_UP
14.2857142857%	1	7	50	Diabetes_McGill_Insulin_exocytosi	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
14.2857142857%	1	7	491	Mendelian_Disorders_of_Phosphorous_Metabolism	ZHENG_BOUND_BY_FOXP3
14.2857142857%	1	7	491	Mendelian_Disorders_of_Phosphorous_Metabolism	SWEET_LUNG_CANCER_KRAS_UP
14.2857142857%	1	7	491	Diabetes_McGill_Insulin_exocytosi	SWEET_LUNG_CANCER_KRAS_UP
14.2857142857%	1	7	49	Mendelian_Lipoprotein_deficiency	OLSSON_E2F3_TARGETS_DN
14.2857142857%	1	7	49	Mendelian_Lipoprotein_deficiency	LEE_LIVER_CANCER
14.2857142857%	1	7	49	Mendelian_Lipoprotein_deficiency	KEGG_GLYCEROLIPID_METABOLISM
14.2857142857%	1	7	49	Mendelian_Lipoprotein_deficiency	DAUER_STAT3_TARGETS_UP
14.2857142857%	1	7	489	Mendelian_Lipoprotein_deficiency	LIM_MAMMARY_STEM_CELL_UP
14.2857142857%	1	7	487	Mendelian_Lipoprotein_deficiency	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
14.2857142857%	1	7	485	Mendelian_Lipoprotein_deficiency	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
14.2857142857%	1	7	482	Mendelian_Lipoprotein_deficiency	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
14.2857142857%	1	7	482	Mendelian_Disorders_of_Phosphorous_Metabolism	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
14.2857142857%	1	7	481	Mendelian_Lipoprotein_deficiency	LIU_PROSTATE_CANCER_DN
14.2857142857%	1	7	48	Mendelian_Lipoprotein_deficiency	CHANGOLKAR_H2AFY_TARGETS_UP
14.2857142857%	1	7	48	Mendelian_Disorders_of_Phosphorous_Metabolism	DELACROIX_RAR_TARGETS_UP
14.2857142857%	1	7	479	Diabetes_McGill_Insulin_exocytosi	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
14.2857142857%	1	7	478	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
14.2857142857%	1	7	476	Mendelian_Lipoprotein_deficiency	SMID_BREAST_CANCER_NORMAL_LIKE_UP
14.2857142857%	1	7	475	Diabetes_McGill_Insulin_exocytosi	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
14.2857142857%	1	7	473	Diabetes_McGill_Insulin_exocytosi	GARY_CD5_TARGETS_UP
14.2857142857%	1	7	469	Diabetes_McGill_Insulin_exocytosi	MCCABE_BOUND_BY_HOXC6
14.2857142857%	1	7	467	Mendelian_Disorders_of_Phosphorous_Metabolism	RATTENBACHER_BOUND_BY_CELF1
14.2857142857%	1	7	467	Diabetes_McGill_Insulin_exocytosi	RATTENBACHER_BOUND_BY_CELF1
14.2857142857%	1	7	464	Mendelian_Disorders_of_Phosphorous_Metabolism	ONDER_CDH1_TARGETS_2_DN
14.2857142857%	1	7	462	Diabetes_McGill_Insulin_exocytosi	DELACROIX_RAR_BOUND_ES
14.2857142857%	1	7	461	Diabetes_McGill_Insulin_exocytosi	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
14.2857142857%	1	7	46	Mendelian_Disorders_of_Phosphorous_Metabolism	TSENG_ADIPOGENIC_POTENTIAL_DN
14.2857142857%	1	7	46	Mendelian_Disorders_of_Phosphorous_Metabolism	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON
14.2857142857%	1	7	46	Mendelian_Disorders_of_Phosphorous_Metabolism	KUNINGER_IGF1_VS_PDGFB_TARGETS_DN
14.2857142857%	1	7	46	Mendelian_Disorders_of_Phosphorous_Metabolism	JIANG_TIP30_TARGETS_UP
14.2857142857%	1	7	456	Mendelian_Disorders_of_Phosphorous_Metabolism	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
14.2857142857%	1	7	450	Diabetes_McGill_Insulin_exocytosi	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
14.2857142857%	1	7	45	Mendelian_Lipoprotein_deficiency	SHIPP_DLBCL_CURED_VS_FATAL_DN
14.2857142857%	1	7	45	Mendelian_Lipoprotein_deficiency	PID_HNF3BPATHWAY
14.2857142857%	1	7	45	Mendelian_Disorders_of_Phosphorous_Metabolism	WANG_TARGETS_OF_MLL_CBP_FUSION_DN
14.2857142857%	1	7	45	Mendelian_Disorders_of_Phosphorous_Metabolism	HUANG_FOXA2_TARGETS_UP
14.2857142857%	1	7	448	Diabetes_McGill_Insulin_exocytosi	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
14.2857142857%	1	7	447	Mendelian_Lipoprotein_deficiency	MOOTHA_MITOCHONDRIA
14.2857142857%	1	7	447	Mendelian_Disorders_of_Phosphorous_Metabolism	MOOTHA_MITOCHONDRIA
14.2857142857%	1	7	445	Mendelian_Disorders_of_Phosphorous_Metabolism	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
14.2857142857%	1	7	443	Mendelian_Lipoprotein_deficiency	DELYS_THYROID_CANCER_UP
14.2857142857%	1	7	442	Mendelian_Lipoprotein_deficiency	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
14.2857142857%	1	7	44	Mendelian_Lipoprotein_deficiency	PID_HNF3APATHWAY
14.2857142857%	1	7	44	Mendelian_Lipoprotein_deficiency	KEGG_ABC_TRANSPORTERS
14.2857142857%	1	7	44	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_SIGNALING_BY_FGFR_MUTANTS
14.2857142857%	1	7	44	Mendelian_Disorders_of_Phosphorous_Metabolism	JAEGER_METASTASIS_UP
14.2857142857%	1	7	44	Diabetes_McGill_Insulin_exocytosi	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION
14.2857142857%	1	7	44	Diabetes_McGill_Insulin_exocytosi	JAEGER_METASTASIS_UP
14.2857142857%	1	7	439	Diabetes_McGill_Insulin_exocytosi	MITSIADES_RESPONSE_TO_APLIDIN_UP
14.2857142857%	1	7	435	Mendelian_Lipoprotein_deficiency	SWEET_LUNG_CANCER_KRAS_DN
14.2857142857%	1	7	434	Mendelian_Lipoprotein_deficiency	BAELDE_DIABETIC_NEPHROPATHY_DN
14.2857142857%	1	7	430	Mendelian_Lipoprotein_deficiency	RIGGI_EWING_SARCOMA_PROGENITOR_UP
14.2857142857%	1	7	430	Mendelian_Lipoprotein_deficiency	JOHNSTONE_PARVB_TARGETS_3_UP
14.2857142857%	1	7	430	Mendelian_Disorders_of_Phosphorous_Metabolism	RIGGI_EWING_SARCOMA_PROGENITOR_UP
14.2857142857%	1	7	43	Mendelian_Disorders_of_Phosphorous_Metabolism	AMIT_EGF_RESPONSE_480_MCF10A
14.2857142857%	1	7	429	Mendelian_Disorders_of_Phosphorous_Metabolism	MOOTHA_HUMAN_MITODB_6_2002
14.2857142857%	1	7	428	Mendelian_Disorders_of_Phosphorous_Metabolism	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
14.2857142857%	1	7	425	Mendelian_Lipoprotein_deficiency	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
14.2857142857%	1	7	422	Mendelian_Lipoprotein_deficiency	YAGI_AML_WITH_INV_16_TRANSLOCATION
14.2857142857%	1	7	420	Mendelian_Lipoprotein_deficiency	MOOTHA_PGC
14.2857142857%	1	7	42	Mendelian_Lipoprotein_deficiency	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
14.2857142857%	1	7	419	Diabetes_McGill_Insulin_exocytosi	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
14.2857142857%	1	7	418	Mendelian_Disorders_of_Phosphorous_Metabolism	RUTELLA_RESPONSE_TO_HGF_UP
14.2857142857%	1	7	413	Mendelian_Lipoprotein_deficiency	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
14.2857142857%	1	7	413	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
14.2857142857%	1	7	411	Diabetes_McGill_Insulin_exocytosi	KOYAMA_SEMA3B_TARGETS_DN
14.2857142857%	1	7	41	Mendelian_Lipoprotein_deficiency	WENG_POR_TARGETS_LIVER_UP
14.2857142857%	1	7	41	Mendelian_Lipoprotein_deficiency	WEINMANN_ADAPTATION_TO_HYPOXIA_DN
14.2857142857%	1	7	41	Mendelian_Lipoprotein_deficiency	PID_AMB2_NEUTROPHILS_PATHWAY
14.2857142857%	1	7	408	Mendelian_Lipoprotein_deficiency	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
14.2857142857%	1	7	408	Mendelian_Disorders_of_Phosphorous_Metabolism	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
14.2857142857%	1	7	406	Diabetes_McGill_Insulin_exocytosi	OSMAN_BLADDER_CANCER_DN
14.2857142857%	1	7	40	Mendelian_Lipoprotein_deficiency	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
14.2857142857%	1	7	398	Diabetes_McGill_Insulin_exocytosi	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
14.2857142857%	1	7	396	Mendelian_Lipoprotein_deficiency	REACTOME_DEVELOPMENTAL_BIOLOGY
14.2857142857%	1	7	395	Mendelian_Disorders_of_Phosphorous_Metabolism	HAN_SATB1_TARGETS_UP
14.2857142857%	1	7	390	Mendelian_Lipoprotein_deficiency	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
14.2857142857%	1	7	39	Mendelian_Lipoprotein_deficiency	HAN_JNK_SINGALING_DN
14.2857142857%	1	7	39	Mendelian_Lipoprotein_deficiency	BEIER_GLIOMA_STEM_CELL_UP
14.2857142857%	1	7	39	Diabetes_McGill_Insulin_exocytosi	WANG_LSD1_TARGETS_DN
14.2857142857%	1	7	388	Mendelian_Disorders_of_Phosphorous_Metabolism	STEIN_ESRRA_TARGETS_UP
14.2857142857%	1	7	382	Mendelian_Lipoprotein_deficiency	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
14.2857142857%	1	7	380	Mendelian_Disorders_of_Phosphorous_Metabolism	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
14.2857142857%	1	7	38	Mendelian_Disorders_of_Phosphorous_Metabolism	PIONTEK_PKD1_TARGETS_UP
14.2857142857%	1	7	373	Mendelian_Disorders_of_Phosphorous_Metabolism	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
14.2857142857%	1	7	372	Diabetes_McGill_Insulin_exocytosi	WANG_LMO4_TARGETS_UP
14.2857142857%	1	7	37	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING
14.2857142857%	1	7	368	Mendelian_Lipoprotein_deficiency	YAGI_AML_WITH_T_8_21_TRANSLOCATION
14.2857142857%	1	7	368	Mendelian_Disorders_of_Phosphorous_Metabolism	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
14.2857142857%	1	7	367	Mendelian_Disorders_of_Phosphorous_Metabolism	DELACROIX_RARG_BOUND_MEF
14.2857142857%	1	7	366	Mendelian_Lipoprotein_deficiency	SANSOM_APC_TARGETS_DN
14.2857142857%	1	7	366	Mendelian_Disorders_of_Phosphorous_Metabolism	SANSOM_APC_TARGETS_DN
14.2857142857%	1	7	364	Mendelian_Lipoprotein_deficiency	YANG_BCL3_TARGETS_UP
14.2857142857%	1	7	36	Mendelian_Lipoprotein_deficiency	STEARMAN_TUMOR_FIELD_EFFECT_UP
14.2857142857%	1	7	36	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_FRS2_MEDIATED_CASCADE
14.2857142857%	1	7	36	Mendelian_Disorders_of_Phosphorous_Metabolism	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP
14.2857142857%	1	7	357	Mendelian_Disorders_of_Phosphorous_Metabolism	SHEN_SMARCA2_TARGETS_DN
14.2857142857%	1	7	353	Mendelian_Disorders_of_Phosphorous_Metabolism	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
14.2857142857%	1	7	35	Mendelian_Lipoprotein_deficiency	WEIGEL_OXIDATIVE_STRESS_RESPONSE
14.2857142857%	1	7	35	Mendelian_Lipoprotein_deficiency	MODY_HIPPOCAMPUS_NEONATAL
14.2857142857%	1	7	35	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D
14.2857142857%	1	7	35	Mendelian_Disorders_of_Phosphorous_Metabolism	HOWLIN_CITED1_TARGETS_1_UP
14.2857142857%	1	7	344	Mendelian_Lipoprotein_deficiency	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
14.2857142857%	1	7	344	Diabetes_McGill_Insulin_exocytosi	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
14.2857142857%	1	7	34	Mendelian_Lipoprotein_deficiency	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT
14.2857142857%	1	7	34	Mendelian_Lipoprotein_deficiency	PETRETTO_CARDIAC_HYPERTROPHY
14.2857142857%	1	7	338	Mendelian_Disorders_of_Phosphorous_Metabolism	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
14.2857142857%	1	7	337	Mendelian_Lipoprotein_deficiency	PHONG_TNF_RESPONSE_NOT_VIA_P38
14.2857142857%	1	7	336	Mendelian_Disorders_of_Phosphorous_Metabolism	JOHNSTONE_PARVB_TARGETS_2_DN
14.2857142857%	1	7	332	Mendelian_Disorders_of_Phosphorous_Metabolism	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
14.2857142857%	1	7	330	Mendelian_Lipoprotein_deficiency	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
14.2857142857%	1	7	33	Mendelian_Lipoprotein_deficiency	TANG_SENESCENCE_TP53_TARGETS_UP
14.2857142857%	1	7	33	Mendelian_Lipoprotein_deficiency	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION
14.2857142857%	1	7	33	Mendelian_Lipoprotein_deficiency	JEPSEN_SMRT_TARGETS
14.2857142857%	1	7	33	Mendelian_Lipoprotein_deficiency	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN
14.2857142857%	1	7	329	Mendelian_Lipoprotein_deficiency	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
14.2857142857%	1	7	328	Mendelian_Disorders_of_Phosphorous_Metabolism	KEGG_PATHWAYS_IN_CANCER
14.2857142857%	1	7	326	Mendelian_Lipoprotein_deficiency	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
14.2857142857%	1	7	321	Mendelian_Disorders_of_Phosphorous_Metabolism	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
14.2857142857%	1	7	314	Mendelian_Disorders_of_Phosphorous_Metabolism	DOUGLAS_BMI1_TARGETS_DN
14.2857142857%	1	7	306	Mendelian_Lipoprotein_deficiency	HORIUCHI_WTAP_TARGETS_UP
14.2857142857%	1	7	302	Diabetes_McGill_Insulin_exocytosi	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
14.2857142857%	1	7	30	Mendelian_Lipoprotein_deficiency	BURTON_ADIPOGENESIS_10
14.2857142857%	1	7	30	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
14.2857142857%	1	7	298	Diabetes_McGill_Insulin_exocytosi	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
14.2857142857%	1	7	296	Mendelian_Lipoprotein_deficiency	DURAND_STROMA_MAX_UP
14.2857142857%	1	7	293	Mendelian_Disorders_of_Phosphorous_Metabolism	ENK_UV_RESPONSE_EPIDERMIS_UP
14.2857142857%	1	7	292	Diabetes_McGill_Insulin_exocytosi	KOYAMA_SEMA3B_TARGETS_UP
14.2857142857%	1	7	290	Mendelian_Lipoprotein_deficiency	BASAKI_YBX1_TARGETS_UP
14.2857142857%	1	7	29	Mendelian_Lipoprotein_deficiency	WEINMANN_ADAPTATION_TO_HYPOXIA_UP
14.2857142857%	1	7	29	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_STEROID_HORMONES
14.2857142857%	1	7	289	Mendelian_Lipoprotein_deficiency	MANALO_HYPOXIA_DN
14.2857142857%	1	7	289	Mendelian_Disorders_of_Phosphorous_Metabolism	WANG_MLL_TARGETS
14.2857142857%	1	7	289	Mendelian_Disorders_of_Phosphorous_Metabolism	MANALO_HYPOXIA_DN
14.2857142857%	1	7	289	Mendelian_Disorders_of_Phosphorous_Metabolism	GABRIELY_MIR21_TARGETS
14.2857142857%	1	7	289	Mendelian_Disorders_of_Phosphorous_Metabolism	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
14.2857142857%	1	7	285	Mendelian_Lipoprotein_deficiency	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
14.2857142857%	1	7	283	Mendelian_Lipoprotein_deficiency	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
14.2857142857%	1	7	283	Mendelian_Disorders_of_Phosphorous_Metabolism	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
14.2857142857%	1	7	281	Diabetes_McGill_Insulin_exocytosi	BHAT_ESR1_TARGETS_VIA_AKT1_UP
14.2857142857%	1	7	280	Mendelian_Lipoprotein_deficiency	WANG_SMARCE1_TARGETS_UP
14.2857142857%	1	7	28	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_SHC_MEDIATED_CASCADE
14.2857142857%	1	7	276	Mendelian_Lipoprotein_deficiency	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
14.2857142857%	1	7	276	Diabetes_McGill_Insulin_exocytosi	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
14.2857142857%	1	7	275	Mendelian_Disorders_of_Phosphorous_Metabolism	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
14.2857142857%	1	7	275	Diabetes_McGill_Insulin_exocytosi	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
14.2857142857%	1	7	271	Mendelian_Lipoprotein_deficiency	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
14.2857142857%	1	7	27	Diabetes_McGill_Insulin_exocytosi	HOEGERKORP_CD44_TARGETS_DIRECT_UP
14.2857142857%	1	7	267	Mendelian_Lipoprotein_deficiency	CAIRO_HEPATOBLASTOMA_DN
14.2857142857%	1	7	267	Mendelian_Disorders_of_Phosphorous_Metabolism	KEGG_MAPK_SIGNALING_PATHWAY
14.2857142857%	1	7	266	Mendelian_Lipoprotein_deficiency	FOSTER_KDM1A_TARGETS_UP
14.2857142857%	1	7	266	Mendelian_Disorders_of_Phosphorous_Metabolism	ROZANOV_MMP14_TARGETS_UP
14.2857142857%	1	7	266	Diabetes_McGill_Insulin_exocytosi	ROZANOV_MMP14_TARGETS_UP
14.2857142857%	1	7	266	Diabetes_McGill_Insulin_exocytosi	FOSTER_KDM1A_TARGETS_UP
14.2857142857%	1	7	264	Diabetes_McGill_Insulin_exocytosi	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
14.2857142857%	1	7	261	Mendelian_Lipoprotein_deficiency	BILD_HRAS_ONCOGENIC_SIGNATURE
14.2857142857%	1	7	261	Mendelian_Disorders_of_Phosphorous_Metabolism	BILD_HRAS_ONCOGENIC_SIGNATURE
14.2857142857%	1	7	261	Diabetes_McGill_Insulin_exocytosi	BILD_HRAS_ONCOGENIC_SIGNATURE
14.2857142857%	1	7	26	Mendelian_Lipoprotein_deficiency	PID_RXR_VDR_PATHWAY
14.2857142857%	1	7	26	Mendelian_Disorders_of_Phosphorous_Metabolism	NAKAMURA_CANCER_MICROENVIRONMENT_UP
14.2857142857%	1	7	26	Mendelian_Disorders_of_Phosphorous_Metabolism	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP
14.2857142857%	1	7	26	Diabetes_McGill_Insulin_exocytosi	PID_INSULIN_GLUCOSE_PATHWAY
14.2857142857%	1	7	256	Mendelian_Disorders_of_Phosphorous_Metabolism	ONDER_CDH1_TARGETS_2_UP
14.2857142857%	1	7	254	Diabetes_McGill_Insulin_exocytosi	IVANOVA_HEMATOPOIESIS_STEM_CELL
14.2857142857%	1	7	253	Mendelian_Lipoprotein_deficiency	MCLACHLAN_DENTAL_CARIES_UP
14.2857142857%	1	7	252	Mendelian_Disorders_of_Phosphorous_Metabolism	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
14.2857142857%	1	7	251	Mendelian_Lipoprotein_deficiency	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
14.2857142857%	1	7	245	Mendelian_Lipoprotein_deficiency	MCLACHLAN_DENTAL_CARIES_DN
14.2857142857%	1	7	244	Mendelian_Lipoprotein_deficiency	PLASARI_TGFB1_TARGETS_10HR_DN
14.2857142857%	1	7	244	Diabetes_McGill_Insulin_exocytosi	KAYO_AGING_MUSCLE_UP
14.2857142857%	1	7	242	Mendelian_Lipoprotein_deficiency	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
14.2857142857%	1	7	242	Mendelian_Lipoprotein_deficiency	CHYLA_CBFA2T3_TARGETS_DN
14.2857142857%	1	7	242	Diabetes_McGill_Insulin_exocytosi	WINTER_HYPOXIA_METAGENE
14.2857142857%	1	7	241	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
14.2857142857%	1	7	240	Mendelian_Disorders_of_Phosphorous_Metabolism	UDAYAKUMAR_MED1_TARGETS_DN
14.2857142857%	1	7	240	Diabetes_McGill_Insulin_exocytosi	UDAYAKUMAR_MED1_TARGETS_DN
14.2857142857%	1	7	24	Mendelian_Disorders_of_Phosphorous_Metabolism	KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM
14.2857142857%	1	7	238	Mendelian_Disorders_of_Phosphorous_Metabolism	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
14.2857142857%	1	7	232	Mendelian_Disorders_of_Phosphorous_Metabolism	DELYS_THYROID_CANCER_DN
14.2857142857%	1	7	230	Diabetes_McGill_Insulin_exocytosi	BENPORATH_MYC_TARGETS_WITH_EBOX
14.2857142857%	1	7	23	Diabetes_McGill_Insulin_exocytosi	REACTOME_LYSOSOME_VESICLE_BIOGENESIS
14.2857142857%	1	7	229	Mendelian_Lipoprotein_deficiency	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
14.2857142857%	1	7	229	Mendelian_Lipoprotein_deficiency	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
14.2857142857%	1	7	229	Mendelian_Disorders_of_Phosphorous_Metabolism	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
14.2857142857%	1	7	228	Mendelian_Lipoprotein_deficiency	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
14.2857142857%	1	7	225	Mendelian_Disorders_of_Phosphorous_Metabolism	BROWNE_HCMV_INFECTION_16HR_UP
14.2857142857%	1	7	221	Diabetes_McGill_Insulin_exocytosi	ZHANG_TLX_TARGETS_36HR_UP
14.2857142857%	1	7	220	Mendelian_Disorders_of_Phosphorous_Metabolism	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
14.2857142857%	1	7	22	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION
14.2857142857%	1	7	217	Mendelian_Lipoprotein_deficiency	WIERENGA_STAT5A_TARGETS_UP
14.2857142857%	1	7	216	Mendelian_Disorders_of_Phosphorous_Metabolism	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
14.2857142857%	1	7	215	Mendelian_Lipoprotein_deficiency	MARKEY_RB1_ACUTE_LOF_UP
14.2857142857%	1	7	214	Mendelian_Lipoprotein_deficiency	AFFAR_YY1_TARGETS_UP
14.2857142857%	1	7	213	Diabetes_McGill_Insulin_exocytosi	WIERENGA_STAT5A_TARGETS_DN
14.2857142857%	1	7	212	Mendelian_Lipoprotein_deficiency	CHANG_CORE_SERUM_RESPONSE_UP
14.2857142857%	1	7	212	Mendelian_Disorders_of_Phosphorous_Metabolism	SANSOM_APC_TARGETS
14.2857142857%	1	7	211	Mendelian_Disorders_of_Phosphorous_Metabolism	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
14.2857142857%	1	7	211	Diabetes_McGill_Insulin_exocytosi	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
14.2857142857%	1	7	210	Diabetes_McGill_Insulin_exocytosi	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
14.2857142857%	1	7	21	Mendelian_Lipoprotein_deficiency	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN
14.2857142857%	1	7	21	Mendelian_Lipoprotein_deficiency	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC
14.2857142857%	1	7	21	Mendelian_Lipoprotein_deficiency	HU_ANGIOGENESIS_UP
14.2857142857%	1	7	208	Mendelian_Lipoprotein_deficiency	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
14.2857142857%	1	7	207	Mendelian_Lipoprotein_deficiency	MANALO_HYPOXIA_UP
14.2857142857%	1	7	207	Mendelian_Disorders_of_Phosphorous_Metabolism	MANALO_HYPOXIA_UP
14.2857142857%	1	7	206	Mendelian_Disorders_of_Phosphorous_Metabolism	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
14.2857142857%	1	7	204	Mendelian_Lipoprotein_deficiency	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
14.2857142857%	1	7	199	Mendelian_Disorders_of_Phosphorous_Metabolism	PLASARI_TGFB1_TARGETS_10HR_UP
14.2857142857%	1	7	1972	Diabetes_McGill_Insulin_exocytosi	PILON_KLF1_TARGETS_DN
14.2857142857%	1	7	197	Mendelian_Disorders_of_Phosphorous_Metabolism	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
14.2857142857%	1	7	196	Mendelian_Lipoprotein_deficiency	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
14.2857142857%	1	7	196	Mendelian_Disorders_of_Phosphorous_Metabolism	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
14.2857142857%	1	7	19	Mendelian_Lipoprotein_deficiency	VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP
14.2857142857%	1	7	19	Mendelian_Disorders_of_Phosphorous_Metabolism	TRAYNOR_RETT_SYNDROM_DN
14.2857142857%	1	7	19	Mendelian_Disorders_of_Phosphorous_Metabolism	KANG_AR_TARGETS_DN
14.2857142857%	1	7	188	Mendelian_Lipoprotein_deficiency	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
14.2857142857%	1	7	185	Mendelian_Lipoprotein_deficiency	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
14.2857142857%	1	7	1839	Mendelian_Lipoprotein_deficiency	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
14.2857142857%	1	7	1821	Mendelian_Disorders_of_Phosphorous_Metabolism	DODD_NASOPHARYNGEAL_CARCINOMA_UP
14.2857142857%	1	7	182	Mendelian_Lipoprotein_deficiency	RAO_BOUND_BY_SALL4_ISOFORM_A
14.2857142857%	1	7	182	Diabetes_McGill_Insulin_exocytosi	RAO_BOUND_BY_SALL4_ISOFORM_A
14.2857142857%	1	7	182	Diabetes_McGill_Insulin_exocytosi	FERNANDEZ_BOUND_BY_MYC
14.2857142857%	1	7	18	Mendelian_Lipoprotein_deficiency	REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS
14.2857142857%	1	7	18	Mendelian_Lipoprotein_deficiency	NIELSEN_LIPOSARCOMA_UP
14.2857142857%	1	7	18	Mendelian_Lipoprotein_deficiency	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES
14.2857142857%	1	7	18	Diabetes_McGill_Insulin_exocytosi	LE_NEURONAL_DIFFERENTIATION_UP
14.2857142857%	1	7	179	Mendelian_Lipoprotein_deficiency	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
14.2857142857%	1	7	1781	Mendelian_Disorders_of_Phosphorous_Metabolism	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
14.2857142857%	1	7	1781	Diabetes_McGill_Insulin_exocytosi	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
14.2857142857%	1	7	177	Mendelian_Lipoprotein_deficiency	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
14.2857142857%	1	7	175	Mendelian_Lipoprotein_deficiency	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
14.2857142857%	1	7	175	Diabetes_McGill_Insulin_exocytosi	FIRESTEIN_PROLIFERATION
14.2857142857%	1	7	1725	Mendelian_Lipoprotein_deficiency	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
14.2857142857%	1	7	172	Mendelian_Disorders_of_Phosphorous_Metabolism	SMID_BREAST_CANCER_LUMINAL_B_UP
14.2857142857%	1	7	170	Mendelian_Disorders_of_Phosphorous_Metabolism	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
14.2857142857%	1	7	17	Mendelian_Lipoprotein_deficiency	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP
14.2857142857%	1	7	17	Mendelian_Lipoprotein_deficiency	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP
14.2857142857%	1	7	17	Mendelian_Disorders_of_Phosphorous_Metabolism	KEGG_STEROID_BIOSYNTHESIS
14.2857142857%	1	7	17	Mendelian_Disorders_of_Phosphorous_Metabolism	KANG_AR_TARGETS_UP
14.2857142857%	1	7	17	Diabetes_McGill_Insulin_exocytosi	ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN
14.2857142857%	1	7	169	Mendelian_Lipoprotein_deficiency	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
14.2857142857%	1	7	169	Mendelian_Lipoprotein_deficiency	KEGG_ALZHEIMERS_DISEASE
14.2857142857%	1	7	169	Mendelian_Disorders_of_Phosphorous_Metabolism	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
14.2857142857%	1	7	167	Mendelian_Disorders_of_Phosphorous_Metabolism	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
14.2857142857%	1	7	167	Diabetes_McGill_Insulin_exocytosi	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
14.2857142857%	1	7	163	Mendelian_Lipoprotein_deficiency	LIN_NPAS4_TARGETS_UP
14.2857142857%	1	7	163	Mendelian_Disorders_of_Phosphorous_Metabolism	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
14.2857142857%	1	7	161	Diabetes_McGill_Insulin_exocytosi	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
14.2857142857%	1	7	16	Mendelian_Lipoprotein_deficiency	WANG_RECURRENT_LIVER_CANCER_DN
14.2857142857%	1	7	16	Mendelian_Lipoprotein_deficiency	REACTOME_PLATELET_SENSITIZATION_BY_LDL
14.2857142857%	1	7	16	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2
14.2857142857%	1	7	16	Mendelian_Disorders_of_Phosphorous_Metabolism	KEGG_RIBOFLAVIN_METABOLISM
14.2857142857%	1	7	16	Mendelian_Disorders_of_Phosphorous_Metabolism	KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS
14.2857142857%	1	7	159	Mendelian_Disorders_of_Phosphorous_Metabolism	KEGG_PURINE_METABOLISM
14.2857142857%	1	7	158	Diabetes_McGill_Insulin_exocytosi	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON
14.2857142857%	1	7	157	Mendelian_Lipoprotein_deficiency	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
14.2857142857%	1	7	156	Mendelian_Disorders_of_Phosphorous_Metabolism	GROSS_HYPOXIA_VIA_ELK3_DN
14.2857142857%	1	7	153	Mendelian_Lipoprotein_deficiency	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
14.2857142857%	1	7	153	Diabetes_McGill_Insulin_exocytosi	RUIZ_TNC_TARGETS_UP
14.2857142857%	1	7	152	Mendelian_Lipoprotein_deficiency	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
14.2857142857%	1	7	151	Mendelian_Lipoprotein_deficiency	IGLESIAS_E2F_TARGETS_UP
14.2857142857%	1	7	150	Mendelian_Lipoprotein_deficiency	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
14.2857142857%	1	7	15	Mendelian_Disorders_of_Phosphorous_Metabolism	SU_KIDNEY
14.2857142857%	1	7	15	Diabetes_McGill_Insulin_exocytosi	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP
14.2857142857%	1	7	149	Mendelian_Lipoprotein_deficiency	OHGUCHI_LIVER_HNF4A_TARGETS_DN
14.2857142857%	1	7	149	Mendelian_Disorders_of_Phosphorous_Metabolism	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
14.2857142857%	1	7	147	Diabetes_McGill_Insulin_exocytosi	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
14.2857142857%	1	7	146	Diabetes_McGill_Insulin_exocytosi	LEE_NEURAL_CREST_STEM_CELL_UP
14.2857142857%	1	7	145	Mendelian_Lipoprotein_deficiency	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
14.2857142857%	1	7	145	Mendelian_Lipoprotein_deficiency	RODWELL_AGING_KIDNEY_DN
14.2857142857%	1	7	142	Mendelian_Lipoprotein_deficiency	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
14.2857142857%	1	7	142	Mendelian_Disorders_of_Phosphorous_Metabolism	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
14.2857142857%	1	7	141	Mendelian_Lipoprotein_deficiency	SABATES_COLORECTAL_ADENOMA_UP
14.2857142857%	1	7	14	Mendelian_Lipoprotein_deficiency	MATZUK_POST-IMPLANTATION_AND_POST-PARTUM
14.2857142857%	1	7	14	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION
14.2857142857%	1	7	14	Diabetes_McGill_Insulin_exocytosi	VICENT_METASTASIS_UP
14.2857142857%	1	7	139	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_BIOLOGICAL_OXIDATIONS
14.2857142857%	1	7	139	Mendelian_Disorders_of_Phosphorous_Metabolism	HOELZEL_NF1_TARGETS_UP
14.2857142857%	1	7	138	Mendelian_Disorders_of_Phosphorous_Metabolism	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
14.2857142857%	1	7	1375	Diabetes_McGill_Insulin_exocytosi	DODD_NASOPHARYNGEAL_CARCINOMA_DN
14.2857142857%	1	7	137	Mendelian_Lipoprotein_deficiency	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
14.2857142857%	1	7	135	Mendelian_Lipoprotein_deficiency	SERVITJA_LIVER_HNF1A_TARGETS_UP
14.2857142857%	1	7	135	Mendelian_Disorders_of_Phosphorous_Metabolism	TSENG_IRS1_TARGETS_DN
14.2857142857%	1	7	134	Mendelian_Lipoprotein_deficiency	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
14.2857142857%	1	7	131	Mendelian_Lipoprotein_deficiency	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
14.2857142857%	1	7	1305	Mendelian_Disorders_of_Phosphorous_Metabolism	YOSHIMURA_MAPK8_TARGETS_UP
14.2857142857%	1	7	129	Mendelian_Lipoprotein_deficiency	REACTOME_MEMBRANE_TRAFFICKING
14.2857142857%	1	7	129	Mendelian_Disorders_of_Phosphorous_Metabolism	YAGI_AML_SURVIVAL
14.2857142857%	1	7	129	Diabetes_McGill_Insulin_exocytosi	REACTOME_MEMBRANE_TRAFFICKING
14.2857142857%	1	7	127	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
14.2857142857%	1	7	127	Mendelian_Disorders_of_Phosphorous_Metabolism	INGRAM_SHH_TARGETS_UP
14.2857142857%	1	7	126	Mendelian_Disorders_of_Phosphorous_Metabolism	SANSOM_APC_TARGETS_UP
14.2857142857%	1	7	123	Mendelian_Disorders_of_Phosphorous_Metabolism	HOOI_ST7_TARGETS_DN
14.2857142857%	1	7	1229	Diabetes_McGill_Insulin_exocytosi	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
14.2857142857%	1	7	1210	Mendelian_Lipoprotein_deficiency	CHEN_METABOLIC_SYNDROM_NETWORK
14.2857142857%	1	7	1210	Mendelian_Disorders_of_Phosphorous_Metabolism	CHEN_METABOLIC_SYNDROM_NETWORK
14.2857142857%	1	7	121	Diabetes_McGill_Insulin_exocytosi	VANTVEER_BREAST_CANCER_METASTASIS_DN
14.2857142857%	1	7	12	Mendelian_Lipoprotein_deficiency	RUAN_RESPONSE_TO_TNF_UP
14.2857142857%	1	7	12	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION
14.2857142857%	1	7	12	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION
14.2857142857%	1	7	119	Mendelian_Disorders_of_Phosphorous_Metabolism	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
14.2857142857%	1	7	1174	Mendelian_Lipoprotein_deficiency	PEREZ_TP53_TARGETS
14.2857142857%	1	7	116	Mendelian_Lipoprotein_deficiency	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
14.2857142857%	1	7	115	Mendelian_Disorders_of_Phosphorous_Metabolism	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
14.2857142857%	1	7	114	Mendelian_Lipoprotein_deficiency	MATZUK_SPERMATOZOA
14.2857142857%	1	7	114	Mendelian_Lipoprotein_deficiency	LENAOUR_DENDRITIC_CELL_MATURATION_UP
14.2857142857%	1	7	114	Mendelian_Lipoprotein_deficiency	CERVERA_SDHB_TARGETS_2
14.2857142857%	1	7	1137	Mendelian_Disorders_of_Phosphorous_Metabolism	BRUINS_UVC_RESPONSE_LATE
14.2857142857%	1	7	113	Mendelian_Disorders_of_Phosphorous_Metabolism	RICKMAN_HEAD_AND_NECK_CANCER_C
14.2857142857%	1	7	112	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_SIGNALING_BY_FGFR
14.2857142857%	1	7	1118	Mendelian_Lipoprotein_deficiency	BENPORATH_ES_WITH_H3K27ME3
14.2857142857%	1	7	1103	Diabetes_McGill_Insulin_exocytosi	DANG_BOUND_BY_MYC
14.2857142857%	1	7	110	Mendelian_Disorders_of_Phosphorous_Metabolism	GROSS_HYPOXIA_VIA_HIF1A_DN
14.2857142857%	1	7	11	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_SIGNALING_BY_FGFR3_MUTANTS
14.2857142857%	1	7	11	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1
14.2857142857%	1	7	11	Diabetes_McGill_Insulin_exocytosi	AMIT_EGF_RESPONSE_20_HELA
14.2857142857%	1	7	109	Diabetes_McGill_Insulin_exocytosi	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
14.2857142857%	1	7	108	Mendelian_Lipoprotein_deficiency	LE_EGR2_TARGETS_DN
14.2857142857%	1	7	108	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
14.2857142857%	1	7	107	Mendelian_Lipoprotein_deficiency	ROESSLER_LIVER_CANCER_METASTASIS_UP
14.2857142857%	1	7	1069	Mendelian_Lipoprotein_deficiency	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
14.2857142857%	1	7	1069	Mendelian_Disorders_of_Phosphorous_Metabolism	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
14.2857142857%	1	7	1062	Mendelian_Lipoprotein_deficiency	BENPORATH_EED_TARGETS
14.2857142857%	1	7	104	Mendelian_Lipoprotein_deficiency	NAKAMURA_ADIPOGENESIS_LATE_UP
14.2857142857%	1	7	104	Mendelian_Lipoprotein_deficiency	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
14.2857142857%	1	7	1038	Mendelian_Lipoprotein_deficiency	BENPORATH_SUZ12_TARGETS
14.2857142857%	1	7	103	Mendelian_Disorders_of_Phosphorous_Metabolism	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
14.2857142857%	1	7	1022	Diabetes_McGill_Insulin_exocytosi	MARSON_BOUND_BY_FOXP3_STIMULATED
14.2857142857%	1	7	102	Diabetes_McGill_Insulin_exocytosi	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
14.2857142857%	1	7	101	Mendelian_Lipoprotein_deficiency	BURTON_ADIPOGENESIS_3
14.2857142857%	1	7	100	Mendelian_Disorders_of_Phosphorous_Metabolism	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
14.2857142857%	1	7	100	Diabetes_McGill_Insulin_exocytosi	MCCLUNG_CREB1_TARGETS_UP
14.2292490119%	36	253	1038	Diabetes_McGill_CREBBP_coTF	BENPORATH_SUZ12_TARGETS
14.0324214792%	277	1974	1305	Mendelian_Nancy_Cox	YOSHIMURA_MAPK8_TARGETS_UP
13.7096774194%	17	124	82	Diabetes_McGill_Cell_cycle_All_Gene	PID_SMAD2_3NUCLEARPATHWAY
13.7096774194%	17	124	79	Diabetes_McGill_Cell_cycle_All_Gene	PID_P73PATHWAY
13.7096774194%	17	124	775	Diabetes_McGill_Cell_cycle_All_Gene	BENPORATH_MYC_MAX_TARGETS
13.7096774194%	17	124	65	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
13.7096774194%	17	124	637	Diabetes_McGill_Cell_cycle_All_Gene	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
13.7096774194%	17	124	40	Diabetes_McGill_Cell_cycle_All_Gene	PID_FOXM1PATHWAY
13.7096774194%	17	124	362	Diabetes_McGill_Cell_cycle_All_Gene	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
13.7096774194%	17	124	35	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION
13.7096774194%	17	124	310	Diabetes_McGill_Cell_cycle_All_Gene	HORIUCHI_WTAP_TARGETS_DN
13.7096774194%	17	124	31	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX
13.7096774194%	17	124	294	Diabetes_McGill_Cell_cycle_All_Gene	WEST_ADRENOCORTICAL_TUMOR_UP
13.7096774194%	17	124	289	Diabetes_McGill_Cell_cycle_All_Gene	MANALO_HYPOXIA_DN
13.7096774194%	17	124	251	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
13.7096774194%	17	124	250	Diabetes_McGill_Cell_cycle_All_Gene	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
13.7096774194%	17	124	243	Diabetes_McGill_Cell_cycle_All_Gene	CHICAS_RB1_TARGETS_GROWING
13.7096774194%	17	124	212	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
13.7096774194%	17	124	148	Diabetes_McGill_Cell_cycle_All_Gene	CHANG_CYCLING_GENES
13.7096774194%	17	124	142	Diabetes_McGill_Cell_cycle_All_Gene	RUIZ_TNC_TARGETS_DN
13.5802469136%	11	81	882	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
13.5802469136%	11	81	652	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BENPORATH_PRC2_TARGETS
13.5802469136%	11	81	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_HNF3BPATHWAY
13.5135135135%	5	37	93	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_REGULATION_OF_INSULIN_SECRETION
13.5135135135%	5	37	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_PROSTATE_CANCER
13.5135135135%	5	37	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
13.5135135135%	5	37	848	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NUYTTEN_NIPP1_TARGETS_DN
13.5135135135%	5	37	71	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_PI3K_CASCADE
13.5135135135%	5	37	590	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
13.5135135135%	5	37	567	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHICAS_RB1_TARGETS_CONFLUENT
13.5135135135%	5	37	526	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ONKEN_UVEAL_MELANOMA_DN
13.5135135135%	5	37	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_PTP1BPATHWAY
13.5135135135%	5	37	514	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
13.5135135135%	5	37	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ROLEF_GLIS3_TARGETS
13.5135135135%	5	37	328	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_PATHWAYS_IN_CANCER
13.5135135135%	5	37	323	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GRESHOCK_CANCER_COPY_NUMBER_UP
13.5135135135%	5	37	201	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_FOCAL_ADHESION
13.5135135135%	5	37	1781	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
13.5135135135%	5	37	1725	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
13.5135135135%	5	37	1691	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BLALOCK_ALZHEIMERS_DISEASE_UP
13.5135135135%	5	37	1375	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DODD_NASOPHARYNGEAL_CARCINOMA_DN
13.5135135135%	5	37	1237	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BLALOCK_ALZHEIMERS_DISEASE_DN
13.5135135135%	5	37	1210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHEN_METABOLIC_SYNDROM_NETWORK
13.5135135135%	5	37	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
13.5135135135%	5	37	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHOU_PANCREATIC_EXOCRINE_PROGENITOR
13.5135135135%	5	37	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
13.5135135135%	5	37	1069	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
13.4387351779%	34	253	882	Diabetes_McGill_CREBBP_coTF	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
13.3333333333%	4	30	988	Mendelian_Hereditary_Sensory_Neuropathy	BENPORATH_NANOG_TARGETS
13.3333333333%	4	30	682	Mendelian_Hereditary_Sensory_Neuropathy	FEVR_CTNNB1_TARGETS_UP
13.3333333333%	4	30	663	Mendelian_Hereditary_Sensory_Neuropathy	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
13.3333333333%	4	30	485	Mendelian_Hereditary_Sensory_Neuropathy	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
13.3333333333%	4	30	422	Mendelian_Hereditary_Sensory_Neuropathy	YAGI_AML_WITH_INV_16_TRANSLOCATION
13.3333333333%	4	30	389	Mendelian_Hereditary_Sensory_Neuropathy	HSIAO_HOUSEKEEPING_GENES
13.3333333333%	4	30	366	Mendelian_Hereditary_Sensory_Neuropathy	YOSHIMURA_MAPK8_TARGETS_DN
13.3333333333%	4	30	355	Mendelian_Hereditary_Sensory_Neuropathy	PEREZ_TP63_TARGETS
13.3333333333%	4	30	296	Mendelian_Hereditary_Sensory_Neuropathy	DURAND_STROMA_MAX_UP
13.3333333333%	4	30	239	Mendelian_Hereditary_Sensory_Neuropathy	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
13.3333333333%	4	30	1839	Mendelian_Hereditary_Sensory_Neuropathy	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
13.3333333333%	4	30	1725	Mendelian_Hereditary_Sensory_Neuropathy	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
13.3333333333%	4	30	1691	Mendelian_Hereditary_Sensory_Neuropathy	BLALOCK_ALZHEIMERS_DISEASE_UP
13.3333333333%	4	30	1652	Mendelian_Hereditary_Sensory_Neuropathy	PUJANA_BRCA1_PCC_NETWORK
13.3333333333%	4	30	160	Mendelian_Hereditary_Sensory_Neuropathy	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
13.3333333333%	4	30	1375	Mendelian_Hereditary_Sensory_Neuropathy	DODD_NASOPHARYNGEAL_CARCINOMA_DN
13.3333333333%	4	30	1305	Mendelian_Hereditary_Sensory_Neuropathy	YOSHIMURA_MAPK8_TARGETS_UP
13.3333333333%	4	30	1069	Mendelian_Hereditary_Sensory_Neuropathy	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
13.3333333333%	4	30	101	Mendelian_Hereditary_Sensory_Neuropathy	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
13.3333333333%	2	15	973	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ACEVEDO_LIVER_CANCER_UP
13.3333333333%	2	15	911	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
13.3333333333%	2	15	863	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
13.3333333333%	2	15	86	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BURTON_ADIPOGENESIS_8
13.3333333333%	2	15	848	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	NUYTTEN_NIPP1_TARGETS_DN
13.3333333333%	2	15	841	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MARTENS_TRETINOIN_RESPONSE_DN
13.3333333333%	2	15	82	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
13.3333333333%	2	15	77	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
13.3333333333%	2	15	75	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BAE_BRCA1_TARGETS_UP
13.3333333333%	2	15	747	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PATIL_LIVER_CANCER
13.3333333333%	2	15	634	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
13.3333333333%	2	15	567	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PARENT_MTOR_SIGNALING_UP
13.3333333333%	2	15	549	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
13.3333333333%	2	15	528	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
13.3333333333%	2	15	485	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ENK_UV_RESPONSE_KERATINOCYTE_DN
13.3333333333%	2	15	479	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
13.3333333333%	2	15	473	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GARY_CD5_TARGETS_UP
13.3333333333%	2	15	445	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
13.3333333333%	2	15	430	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	JOHNSTONE_PARVB_TARGETS_3_UP
13.3333333333%	2	15	420	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MOOTHA_PGC
13.3333333333%	2	15	398	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
13.3333333333%	2	15	395	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HAN_SATB1_TARGETS_UP
13.3333333333%	2	15	364	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	YANG_BCL3_TARGETS_UP
13.3333333333%	2	15	36	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
13.3333333333%	2	15	338	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
13.3333333333%	2	15	33	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	APPEL_IMATINIB_RESPONSE
13.3333333333%	2	15	307	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
13.3333333333%	2	15	293	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ZHANG_TLX_TARGETS_60HR_UP
13.3333333333%	2	15	280	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
13.3333333333%	2	15	267	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	CAIRO_HEPATOBLASTOMA_DN
13.3333333333%	2	15	262	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LU_AGING_BRAIN_UP
13.3333333333%	2	15	26	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KEGG_GALACTOSE_METABOLISM
13.3333333333%	2	15	258	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
13.3333333333%	2	15	239	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
13.3333333333%	2	15	225	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
13.3333333333%	2	15	207	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
13.3333333333%	2	15	201	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KIM_MYC_AMPLIFICATION_TARGETS_UP
13.3333333333%	2	15	182	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
13.3333333333%	2	15	181	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
13.3333333333%	2	15	1781	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
13.3333333333%	2	15	1725	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
13.3333333333%	2	15	1691	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BLALOCK_ALZHEIMERS_DISEASE_UP
13.3333333333%	2	15	169	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	UEDA_PERIFERAL_CLOCK
13.3333333333%	2	15	151	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
13.3333333333%	2	15	1375	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DODD_NASOPHARYNGEAL_CARCINOMA_DN
13.3333333333%	2	15	132	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
13.3333333333%	2	15	130	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	YAGI_AML_WITH_T_9_11_TRANSLOCATION
13.3333333333%	2	15	123	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DAZARD_RESPONSE_TO_UV_SCC_UP
13.3333333333%	2	15	1137	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BRUINS_UVC_RESPONSE_LATE
13.3333333333%	2	15	1080	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
13.3333333333%	2	15	1024	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	NUYTTEN_EZH2_TARGETS_DN
13.3333333333%	2	15	1011	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
13.3333333333%	2	15	101	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
13.3333333333%	2	15	100	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
13.0434782609%	33	253	779	Diabetes_McGill_CREBBP_coTF	PUJANA_CHEK2_PCC_NETWORK
13.0434782609%	33	253	1305	Diabetes_McGill_CREBBP_coTF	YOSHIMURA_MAPK8_TARGETS_UP
13.0434782609%	3	23	882	Diabetes_McGill_Mtor_pathway	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
13.0434782609%	3	23	88	Diabetes_McGill_Mtor_pathway	KEGG_APOPTOSIS
13.0434782609%	3	23	871	Diabetes_McGill_Mtor_pathway	GRADE_COLON_CANCER_UP
13.0434782609%	3	23	86	Diabetes_McGill_Mtor_pathway	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
13.0434782609%	3	23	824	Diabetes_McGill_Mtor_pathway	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
13.0434782609%	3	23	82	Diabetes_McGill_Mtor_pathway	ST_INTEGRIN_SIGNALING_PATHWAY
13.0434782609%	3	23	811	Diabetes_McGill_Mtor_pathway	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
13.0434782609%	3	23	8	Diabetes_McGill_Mtor_pathway	TCGA_GLIOBLASTOMA_MUTATED
13.0434782609%	3	23	79	Diabetes_McGill_Mtor_pathway	PID_MYC_ACTIVPATHWAY
13.0434782609%	3	23	79	Diabetes_McGill_Mtor_pathway	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
13.0434782609%	3	23	770	Diabetes_McGill_Mtor_pathway	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
13.0434782609%	3	23	76	Diabetes_McGill_Mtor_pathway	KEGG_VEGF_SIGNALING_PATHWAY
13.0434782609%	3	23	76	Diabetes_McGill_Mtor_pathway	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
13.0434782609%	3	23	756	Diabetes_McGill_Mtor_pathway	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
13.0434782609%	3	23	75	Diabetes_McGill_Mtor_pathway	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
13.0434782609%	3	23	73	Diabetes_McGill_Mtor_pathway	KEGG_VIRAL_MYOCARDITIS
13.0434782609%	3	23	73	Diabetes_McGill_Mtor_pathway	KEGG_CHRONIC_MYELOID_LEUKEMIA
13.0434782609%	3	23	73	Diabetes_McGill_Mtor_pathway	DITTMER_PTHLH_TARGETS_DN
13.0434782609%	3	23	70	Diabetes_McGill_Mtor_pathway	KEGG_RENAL_CELL_CARCINOMA
13.0434782609%	3	23	70	Diabetes_McGill_Mtor_pathway	KEGG_PANCREATIC_CANCER
13.0434782609%	3	23	69	Diabetes_McGill_Mtor_pathway	PID_P75NTRPATHWAY
13.0434782609%	3	23	68	Diabetes_McGill_Mtor_pathway	PID_TELOMERASEPATHWAY
13.0434782609%	3	23	66	Diabetes_McGill_Mtor_pathway	PID_TCR_PATHWAY
13.0434782609%	3	23	648	Diabetes_McGill_Mtor_pathway	BENPORATH_CYCLING_GENES
13.0434782609%	3	23	634	Diabetes_McGill_Mtor_pathway	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
13.0434782609%	3	23	62	Diabetes_McGill_Mtor_pathway	PID_FCER1PATHWAY
13.0434782609%	3	23	62	Diabetes_McGill_Mtor_pathway	KEGG_COLORECTAL_CANCER
13.0434782609%	3	23	602	Diabetes_McGill_Mtor_pathway	MARTINEZ_TP53_TARGETS_UP
13.0434782609%	3	23	601	Diabetes_McGill_Mtor_pathway	MARTINEZ_RB1_AND_TP53_TARGETS_UP
13.0434782609%	3	23	52	Diabetes_McGill_Mtor_pathway	PID_PTP1BPATHWAY
13.0434782609%	3	23	514	Diabetes_McGill_Mtor_pathway	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
13.0434782609%	3	23	483	Diabetes_McGill_Mtor_pathway	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
13.0434782609%	3	23	48	Diabetes_McGill_Mtor_pathway	REACTOME_PI_METABOLISM
13.0434782609%	3	23	479	Diabetes_McGill_Mtor_pathway	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
13.0434782609%	3	23	478	Diabetes_McGill_Mtor_pathway	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
13.0434782609%	3	23	47	Diabetes_McGill_Mtor_pathway	PID_LKB1_PATHWAY
13.0434782609%	3	23	47	Diabetes_McGill_Mtor_pathway	PID_IL6_7PATHWAY
13.0434782609%	3	23	47	Diabetes_McGill_Mtor_pathway	KEGG_TYPE_II_DIABETES_MELLITUS
13.0434782609%	3	23	46	Diabetes_McGill_Mtor_pathway	SIG_BCR_SIGNALING_PATHWAY
13.0434782609%	3	23	45	Diabetes_McGill_Mtor_pathway	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
13.0434782609%	3	23	442	Diabetes_McGill_Mtor_pathway	HAN_SATB1_TARGETS_DN
13.0434782609%	3	23	420	Diabetes_McGill_Mtor_pathway	MOOTHA_PGC
13.0434782609%	3	23	42	Diabetes_McGill_Mtor_pathway	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
13.0434782609%	3	23	41	Diabetes_McGill_Mtor_pathway	PID_ER_NONGENOMIC_PATHWAY
13.0434782609%	3	23	40	Diabetes_McGill_Mtor_pathway	ST_B_CELL_ANTIGEN_RECEPTOR
13.0434782609%	3	23	39	Diabetes_McGill_Mtor_pathway	PID_ECADHERIN_NASCENTAJ_PATHWAY
13.0434782609%	3	23	38	Diabetes_McGill_Mtor_pathway	PID_P38ALPHABETADOWNSTREAMPATHWAY
13.0434782609%	3	23	371	Diabetes_McGill_Mtor_pathway	WANG_SMARCE1_TARGETS_DN
13.0434782609%	3	23	37	Diabetes_McGill_Mtor_pathway	ST_P38_MAPK_PATHWAY
13.0434782609%	3	23	37	Diabetes_McGill_Mtor_pathway	BIOCARTA_MET_PATHWAY
13.0434782609%	3	23	366	Diabetes_McGill_Mtor_pathway	YOSHIMURA_MAPK8_TARGETS_DN
13.0434782609%	3	23	36	Diabetes_McGill_Mtor_pathway	ST_ADRENERGIC
13.0434782609%	3	23	35	Diabetes_McGill_Mtor_pathway	PID_PI3KCIAKTPATHWAY
13.0434782609%	3	23	34	Diabetes_McGill_Mtor_pathway	PID_IL8CXCR2_PATHWAY
13.0434782609%	3	23	32	Diabetes_McGill_Mtor_pathway	BIOCARTA_HDAC_PATHWAY
13.0434782609%	3	23	31	Diabetes_McGill_Mtor_pathway	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE
13.0434782609%	3	23	31	Diabetes_McGill_Mtor_pathway	PID_NEPHRIN_NEPH1_PATHWAY
13.0434782609%	3	23	31	Diabetes_McGill_Mtor_pathway	PID_AR_NONGENOMIC_PATHWAY
13.0434782609%	3	23	29	Diabetes_McGill_Mtor_pathway	PID_REELINPATHWAY
13.0434782609%	3	23	28	Diabetes_McGill_Mtor_pathway	DAIRKEE_CANCER_PRONE_RESPONSE_E2
13.0434782609%	3	23	27	Diabetes_McGill_Mtor_pathway	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
13.0434782609%	3	23	27	Diabetes_McGill_Mtor_pathway	BIOCARTA_EDG1_PATHWAY
13.0434782609%	3	23	27	Diabetes_McGill_Mtor_pathway	BIOCARTA_CREB_PATHWAY
13.0434782609%	3	23	26	Diabetes_McGill_Mtor_pathway	ST_INTERLEUKIN_4_PATHWAY
13.0434782609%	3	23	26	Diabetes_McGill_Mtor_pathway	BIOCARTA_RACCYCD_PATHWAY
13.0434782609%	3	23	26	Diabetes_McGill_Mtor_pathway	BIOCARTA_BAD_PATHWAY
13.0434782609%	3	23	25	Diabetes_McGill_Mtor_pathway	PID_LYMPHANGIOGENESIS_PATHWAY
13.0434782609%	3	23	249	Diabetes_McGill_Mtor_pathway	MITSIADES_RESPONSE_TO_APLIDIN_DN
13.0434782609%	3	23	238	Diabetes_McGill_Mtor_pathway	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
13.0434782609%	3	23	23	Diabetes_McGill_Mtor_pathway	BIOCARTA_RAS_PATHWAY
13.0434782609%	3	23	23	Diabetes_McGill_Mtor_pathway	BIOCARTA_RAC1_PATHWAY
13.0434782609%	3	23	23	Diabetes_McGill_Mtor_pathway	BIOCARTA_PTDINS_PATHWAY
13.0434782609%	3	23	23	Diabetes_McGill_Mtor_pathway	BIOCARTA_IGF1R_PATHWAY
13.0434782609%	3	23	23	Diabetes_McGill_Mtor_pathway	BIOCARTA_GLEEVEC_PATHWAY
13.0434782609%	3	23	225	Diabetes_McGill_Mtor_pathway	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
13.0434782609%	3	23	22	Diabetes_McGill_Mtor_pathway	PID_HEDGEHOG_2PATHWAY
13.0434782609%	3	23	22	Diabetes_McGill_Mtor_pathway	BIOCARTA_GCR_PATHWAY
13.0434782609%	3	23	214	Diabetes_McGill_Mtor_pathway	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
13.0434782609%	3	23	21	Diabetes_McGill_Mtor_pathway	REACTOME_CTLA4_INHIBITORY_SIGNALING
13.0434782609%	3	23	21	Diabetes_McGill_Mtor_pathway	PID_ECADHERIN_KERATINOCYTE_PATHWAY
13.0434782609%	3	23	21	Diabetes_McGill_Mtor_pathway	BIOCARTA_TFF_PATHWAY
13.0434782609%	3	23	198	Diabetes_McGill_Mtor_pathway	REACTOME_PHOSPHOLIPID_METABOLISM
13.0434782609%	3	23	190	Diabetes_McGill_Mtor_pathway	KEGG_CHEMOKINE_SIGNALING_PATHWAY
13.0434782609%	3	23	18	Diabetes_McGill_Mtor_pathway	BIOCARTA_ERK5_PATHWAY
13.0434782609%	3	23	176	Diabetes_McGill_Mtor_pathway	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX
13.0434782609%	3	23	17	Diabetes_McGill_Mtor_pathway	SA_PTEN_PATHWAY
13.0434782609%	3	23	17	Diabetes_McGill_Mtor_pathway	BIOCARTA_HCMV_PATHWAY
13.0434782609%	3	23	16	Diabetes_McGill_Mtor_pathway	BIOCARTA_ACH_PATHWAY
13.0434782609%	3	23	155	Diabetes_McGill_Mtor_pathway	KEGG_JAK_STAT_SIGNALING_PATHWAY
13.0434782609%	3	23	15	Diabetes_McGill_Mtor_pathway	BIOCARTA_LONGEVITY_PATHWAY
13.0434782609%	3	23	143	Diabetes_McGill_Mtor_pathway	DANG_MYC_TARGETS_UP
13.0434782609%	3	23	1375	Diabetes_McGill_Mtor_pathway	DODD_NASOPHARYNGEAL_CARCINOMA_DN
13.0434782609%	3	23	134	Diabetes_McGill_Mtor_pathway	KEGG_TIGHT_JUNCTION
13.0434782609%	3	23	126	Diabetes_McGill_Mtor_pathway	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
13.0434782609%	3	23	12	Diabetes_McGill_Mtor_pathway	BIOCARTA_TRKA_PATHWAY
13.0434782609%	3	23	1137	Diabetes_McGill_Mtor_pathway	BRUINS_UVC_RESPONSE_LATE
13.0434782609%	3	23	108	Diabetes_McGill_Mtor_pathway	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
13.0434782609%	3	23	1037	Diabetes_McGill_Mtor_pathway	NUYTTEN_EZH2_TARGETS_UP
13.0434782609%	3	23	102	Diabetes_McGill_Mtor_pathway	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
12.9032258065%	4	31	95	Diabetes_McGill_IL10	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
12.9032258065%	4	31	89	Diabetes_McGill_IL10	WNT_SIGNALING
12.9032258065%	4	31	88	Diabetes_McGill_IL10	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
12.9032258065%	4	31	88	Diabetes_McGill_IL10	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
12.9032258065%	4	31	87	Diabetes_McGill_IL10	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
12.9032258065%	4	31	87	Diabetes_McGill_IL10	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
12.9032258065%	4	31	87	Diabetes_McGill_IL10	BIOCARTA_MAPK_PATHWAY
12.9032258065%	4	31	80	Diabetes_McGill_IL10	PID_BETACATENIN_NUC_PATHWAY
12.9032258065%	4	31	79	Diabetes_McGill_IL10	PID_P73PATHWAY
12.9032258065%	4	31	79	Diabetes_McGill_IL10	PID_MYC_ACTIVPATHWAY
12.9032258065%	4	31	770	Diabetes_McGill_IL10	KRIEG_HYPOXIA_NOT_VIA_KDM3A
12.9032258065%	4	31	76	Diabetes_McGill_IL10	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
12.9032258065%	4	31	722	Diabetes_McGill_IL10	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
12.9032258065%	4	31	721	Diabetes_McGill_IL10	WONG_ADULT_TISSUE_STEM_MODULE
12.9032258065%	4	31	72	Diabetes_McGill_IL10	KEGG_LEISHMANIA_INFECTION
12.9032258065%	4	31	70	Diabetes_McGill_IL10	PID_CDC42_PATHWAY
12.9032258065%	4	31	70	Diabetes_McGill_IL10	PID_AP1_PATHWAY
12.9032258065%	4	31	682	Diabetes_McGill_IL10	FEVR_CTNNB1_TARGETS_UP
12.9032258065%	4	31	673	Diabetes_McGill_IL10	MARTINEZ_RB1_TARGETS_UP
12.9032258065%	4	31	67	Diabetes_McGill_IL10	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
12.9032258065%	4	31	663	Diabetes_McGill_IL10	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
12.9032258065%	4	31	66	Diabetes_McGill_IL10	TENEDINI_MEGAKARYOCYTE_MARKERS
12.9032258065%	4	31	63	Diabetes_McGill_IL10	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
12.9032258065%	4	31	62	Diabetes_McGill_IL10	PID_TRKRPATHWAY
12.9032258065%	4	31	591	Diabetes_McGill_IL10	MARTINEZ_RB1_AND_TP53_TARGETS_DN
12.9032258065%	4	31	58	Diabetes_McGill_IL10	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
12.9032258065%	4	31	553	Diabetes_McGill_IL10	FEVR_CTNNB1_TARGETS_DN
12.9032258065%	4	31	52	Diabetes_McGill_IL10	PID_PTP1BPATHWAY
12.9032258065%	4	31	516	Diabetes_McGill_IL10	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
12.9032258065%	4	31	510	Diabetes_McGill_IL10	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
12.9032258065%	4	31	50	Diabetes_McGill_IL10	PID_ANGIOPOIETINRECEPTOR_PATHWAY
12.9032258065%	4	31	487	Diabetes_McGill_IL10	RODWELL_AGING_KIDNEY_UP
12.9032258065%	4	31	463	Diabetes_McGill_IL10	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
12.9032258065%	4	31	456	Diabetes_McGill_IL10	MARTENS_BOUND_BY_PML_RARA_FUSION
12.9032258065%	4	31	443	Diabetes_McGill_IL10	DELYS_THYROID_CANCER_UP
12.9032258065%	4	31	44	Diabetes_McGill_IL10	PID_ERBB2ERBB3PATHWAY
12.9032258065%	4	31	430	Diabetes_McGill_IL10	RIGGI_EWING_SARCOMA_PROGENITOR_UP
12.9032258065%	4	31	43	Diabetes_McGill_IL10	REACTOME_IL_3_5_AND_GM_CSF_SIGNALING
12.9032258065%	4	31	43	Diabetes_McGill_IL10	PID_CXCR3PATHWAY
12.9032258065%	4	31	423	Diabetes_McGill_IL10	PUJANA_BRCA2_PCC_NETWORK
12.9032258065%	4	31	42	Diabetes_McGill_IL10	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
12.9032258065%	4	31	412	Diabetes_McGill_IL10	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
12.9032258065%	4	31	41	Diabetes_McGill_IL10	REACTOME_IL_2_SIGNALING
12.9032258065%	4	31	408	Diabetes_McGill_IL10	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
12.9032258065%	4	31	396	Diabetes_McGill_IL10	REACTOME_DEVELOPMENTAL_BIOLOGY
12.9032258065%	4	31	389	Diabetes_McGill_IL10	HSIAO_HOUSEKEEPING_GENES
12.9032258065%	4	31	38	Diabetes_McGill_IL10	REACTOME_G1_PHASE
12.9032258065%	4	31	38	Diabetes_McGill_IL10	PID_FASPATHWAY
12.9032258065%	4	31	374	Diabetes_McGill_IL10	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
12.9032258065%	4	31	37	Diabetes_McGill_IL10	PID_FRA_PATHWAY
12.9032258065%	4	31	367	Diabetes_McGill_IL10	DELACROIX_RARG_BOUND_MEF
12.9032258065%	4	31	351	Diabetes_McGill_IL10	YAGI_AML_WITH_11Q23_REARRANGED
12.9032258065%	4	31	35	Diabetes_McGill_IL10	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
12.9032258065%	4	31	342	Diabetes_McGill_IL10	BLUM_RESPONSE_TO_SALIRASIB_DN
12.9032258065%	4	31	34	Diabetes_McGill_IL10	PID_EPOPATHWAY
12.9032258065%	4	31	335	Diabetes_McGill_IL10	WONG_EMBRYONIC_STEM_CELL_CORE
12.9032258065%	4	31	32	Diabetes_McGill_IL10	REACTOME_CD28_CO_STIMULATION
12.9032258065%	4	31	32	Diabetes_McGill_IL10	BIOCARTA_PDGF_PATHWAY
12.9032258065%	4	31	31	Diabetes_McGill_IL10	PID_NEPHRIN_NEPH1_PATHWAY
12.9032258065%	4	31	31	Diabetes_McGill_IL10	PID_CD40_PATHWAY
12.9032258065%	4	31	31	Diabetes_McGill_IL10	BIOCARTA_EGF_PATHWAY
12.9032258065%	4	31	28	Diabetes_McGill_IL10	PID_TRAIL_PATHWAY
12.9032258065%	4	31	271	Diabetes_McGill_IL10	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
12.9032258065%	4	31	27	Diabetes_McGill_IL10	REACTOME_IL_RECEPTOR_SHC_SIGNALING
12.9032258065%	4	31	267	Diabetes_McGill_IL10	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
12.9032258065%	4	31	26	Diabetes_McGill_IL10	ST_INTERLEUKIN_4_PATHWAY
12.9032258065%	4	31	26	Diabetes_McGill_IL10	PID_IL27PATHWAY
12.9032258065%	4	31	253	Diabetes_McGill_IL10	DANG_REGULATED_BY_MYC_DN
12.9032258065%	4	31	242	Diabetes_McGill_IL10	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
12.9032258065%	4	31	23	Diabetes_McGill_IL10	BIOCARTA_CELLCYCLE_PATHWAY
12.9032258065%	4	31	226	Diabetes_McGill_IL10	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
12.9032258065%	4	31	22	Diabetes_McGill_IL10	REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING
12.9032258065%	4	31	216	Diabetes_McGill_IL10	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
12.9032258065%	4	31	1972	Diabetes_McGill_IL10	PILON_KLF1_TARGETS_DN
12.9032258065%	4	31	195	Diabetes_McGill_IL10	KYNG_DNA_DAMAGE_DN
12.9032258065%	4	31	1839	Diabetes_McGill_IL10	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
12.9032258065%	4	31	165	Diabetes_McGill_IL10	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
12.9032258065%	4	31	151	Diabetes_McGill_IL10	KEGG_WNT_SIGNALING_PATHWAY
12.9032258065%	4	31	15	Diabetes_McGill_IL10	MARKS_HDAC_TARGETS_DN
12.9032258065%	4	31	144	Diabetes_McGill_IL10	BROCKE_APOPTOSIS_REVERSED_BY_IL6
12.9032258065%	4	31	1237	Diabetes_McGill_IL10	BLALOCK_ALZHEIMERS_DISEASE_DN
12.9032258065%	4	31	122	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_PDGF
12.9032258065%	4	31	1210	Diabetes_McGill_IL10	CHEN_METABOLIC_SYNDROM_NETWORK
12.9032258065%	4	31	116	Diabetes_McGill_IL10	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
12.9032258065%	4	31	11	Diabetes_McGill_IL10	REACTOME_IL_7_SIGNALING
12.9032258065%	4	31	11	Diabetes_McGill_IL10	REACTOME_IL_6_SIGNALING
12.9032258065%	4	31	1080	Diabetes_McGill_IL10	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
12.9032258065%	4	31	108	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
12.9032258065%	4	31	101	Diabetes_McGill_IL10	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
12.9032258065%	16	124	90	Diabetes_McGill_Cell_cycle_All_Gene	MORI_IMMATURE_B_LYMPHOCYTE_DN
12.9032258065%	16	124	893	Diabetes_McGill_Cell_cycle_All_Gene	GEORGES_TARGETS_OF_MIR192_AND_MIR215
12.9032258065%	16	124	86	Diabetes_McGill_Cell_cycle_All_Gene	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
12.9032258065%	16	124	80	Diabetes_McGill_Cell_cycle_All_Gene	PID_BETACATENIN_NUC_PATHWAY
12.9032258065%	16	124	783	Diabetes_McGill_Cell_cycle_All_Gene	ONKEN_UVEAL_MELANOMA_UP
12.9032258065%	16	124	65	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX
12.9032258065%	16	124	49	Diabetes_McGill_Cell_cycle_All_Gene	PID_FOXOPATHWAY
12.9032258065%	16	124	463	Diabetes_McGill_Cell_cycle_All_Gene	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
12.9032258065%	16	124	425	Diabetes_McGill_Cell_cycle_All_Gene	ZHANG_BREAST_CANCER_PROGENITORS_UP
12.9032258065%	16	124	323	Diabetes_McGill_Cell_cycle_All_Gene	GRESHOCK_CANCER_COPY_NUMBER_UP
12.9032258065%	16	124	285	Diabetes_McGill_Cell_cycle_All_Gene	GRADE_COLON_AND_RECTAL_CANCER_UP
12.9032258065%	16	124	271	Diabetes_McGill_Cell_cycle_All_Gene	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
12.9032258065%	16	124	25	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_G0_AND_EARLY_G1
12.9032258065%	16	124	249	Diabetes_McGill_Cell_cycle_All_Gene	MITSIADES_RESPONSE_TO_APLIDIN_DN
12.9032258065%	16	124	244	Diabetes_McGill_Cell_cycle_All_Gene	GAL_LEUKEMIC_STEM_CELL_DN
12.9032258065%	16	124	18	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_MCM_PATHWAY
12.9032258065%	16	124	163	Diabetes_McGill_Cell_cycle_All_Gene	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
12.9032258065%	16	124	163	Diabetes_McGill_Cell_cycle_All_Gene	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
12.9032258065%	16	124	128	Diabetes_McGill_Cell_cycle_All_Gene	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
12.9032258065%	16	124	108	Diabetes_McGill_Cell_cycle_All_Gene	LE_EGR2_TARGETS_UP
12.9032258065%	16	124	1022	Diabetes_McGill_Cell_cycle_All_Gene	MARSON_BOUND_BY_FOXP3_STIMULATED
12.8571428571%	9	70	93	Diabetes_McGill_Adipocytokine_signallin	REACTOME_ACTIVATED_TLR4_SIGNALLING
12.8571428571%	9	70	83	Diabetes_McGill_Adipocytokine_signallin	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
12.8571428571%	9	70	77	Diabetes_McGill_Adipocytokine_signallin	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
12.8571428571%	9	70	74	Diabetes_McGill_Adipocytokine_signallin	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
12.8571428571%	9	70	72	Diabetes_McGill_Adipocytokine_signallin	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
12.8571428571%	9	70	701	Diabetes_McGill_Adipocytokine_signallin	SMID_BREAST_CANCER_BASAL_DN
12.8571428571%	9	70	673	Diabetes_McGill_Adipocytokine_signallin	MARTINEZ_RB1_TARGETS_UP
12.8571428571%	9	70	65	Diabetes_McGill_Adipocytokine_signallin	PID_BCR_5PATHWAY
12.8571428571%	9	70	540	Diabetes_McGill_Adipocytokine_signallin	ACEVEDO_LIVER_CANCER_DN
12.8571428571%	9	70	48	Diabetes_McGill_Adipocytokine_signallin	PID_CERAMIDE_PATHWAY
12.8571428571%	9	70	37	Diabetes_McGill_Adipocytokine_signallin	ST_GA13_PATHWAY
12.8571428571%	9	70	35	Diabetes_McGill_Adipocytokine_signallin	PID_HIVNEFPATHWAY
12.8571428571%	9	70	34	Diabetes_McGill_Adipocytokine_signallin	SIG_CD40PATHWAYMAP
12.8571428571%	9	70	270	Diabetes_McGill_Adipocytokine_signallin	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
12.8571428571%	9	70	155	Diabetes_McGill_Adipocytokine_signallin	KEGG_JAK_STAT_SIGNALING_PATHWAY
12.8571428571%	9	70	118	Diabetes_McGill_Adipocytokine_signallin	REACTOME_TOLL_RECEPTOR_CASCADES
12.8571428571%	9	70	1080	Diabetes_McGill_Adipocytokine_signallin	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
12.8205128205%	5	39	957	Diabetes_McGill_IL6	LOPEZ_MBD_TARGETS
12.8205128205%	5	39	882	Diabetes_McGill_IL6	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
12.8205128205%	5	39	87	Diabetes_McGill_IL6	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
12.8205128205%	5	39	855	Diabetes_McGill_IL6	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
12.8205128205%	5	39	848	Diabetes_McGill_IL6	NUYTTEN_NIPP1_TARGETS_DN
12.8205128205%	5	39	805	Diabetes_McGill_IL6	REACTOME_GPCR_DOWNSTREAM_SIGNALING
12.8205128205%	5	39	79	Diabetes_McGill_IL6	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
12.8205128205%	5	39	783	Diabetes_McGill_IL6	ONKEN_UVEAL_MELANOMA_UP
12.8205128205%	5	39	75	Diabetes_McGill_IL6	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
12.8205128205%	5	39	721	Diabetes_McGill_IL6	WONG_ADULT_TISSUE_STEM_MODULE
12.8205128205%	5	39	72	Diabetes_McGill_IL6	KEGG_LEISHMANIA_INFECTION
12.8205128205%	5	39	69	Diabetes_McGill_IL6	PID_P75NTRPATHWAY
12.8205128205%	5	39	682	Diabetes_McGill_IL6	FEVR_CTNNB1_TARGETS_UP
12.8205128205%	5	39	65	Diabetes_McGill_IL6	PID_BCR_5PATHWAY
12.8205128205%	5	39	61	Diabetes_McGill_IL6	PID_AR_PATHWAY
12.8205128205%	5	39	59	Diabetes_McGill_IL6	PID_ATF2_PATHWAY
12.8205128205%	5	39	566	Diabetes_McGill_IL6	DOUGLAS_BMI1_TARGETS_UP
12.8205128205%	5	39	56	Diabetes_McGill_IL6	REACTOME_PI_3K_CASCADE
12.8205128205%	5	39	552	Diabetes_McGill_IL6	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
12.8205128205%	5	39	473	Diabetes_McGill_IL6	GARY_CD5_TARGETS_UP
12.8205128205%	5	39	460	Diabetes_McGill_IL6	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
12.8205128205%	5	39	457	Diabetes_McGill_IL6	SENESE_HDAC1_TARGETS_UP
12.8205128205%	5	39	45	Diabetes_McGill_IL6	PID_INSULIN_PATHWAY
12.8205128205%	5	39	45	Diabetes_McGill_IL6	BIOCARTA_BIOPEPTIDES_PATHWAY
12.8205128205%	5	39	44	Diabetes_McGill_IL6	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
12.8205128205%	5	39	423	Diabetes_McGill_IL6	THUM_SYSTOLIC_HEART_FAILURE_UP
12.8205128205%	5	39	404	Diabetes_McGill_IL6	OSMAN_BLADDER_CANCER_UP
12.8205128205%	5	39	389	Diabetes_McGill_IL6	HSIAO_HOUSEKEEPING_GENES
12.8205128205%	5	39	38	Diabetes_McGill_IL6	REACTOME_GAB1_SIGNALOSOME
12.8205128205%	5	39	37	Diabetes_McGill_IL6	ST_GA13_PATHWAY
12.8205128205%	5	39	305	Diabetes_McGill_IL6	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
12.8205128205%	5	39	30	Diabetes_McGill_IL6	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
12.8205128205%	5	39	28	Diabetes_McGill_IL6	BIOCARTA_ERK_PATHWAY
12.8205128205%	5	39	27	Diabetes_McGill_IL6	REACTOME_IL_RECEPTOR_SHC_SIGNALING
12.8205128205%	5	39	26	Diabetes_McGill_IL6	PID_IL27PATHWAY
12.8205128205%	5	39	26	Diabetes_McGill_IL6	BIOCARTA_BAD_PATHWAY
12.8205128205%	5	39	259	Diabetes_McGill_IL6	QI_PLASMACYTOMA_UP
12.8205128205%	5	39	24	Diabetes_McGill_IL6	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING
12.8205128205%	5	39	24	Diabetes_McGill_IL6	BIOCARTA_TPO_PATHWAY
12.8205128205%	5	39	230	Diabetes_McGill_IL6	BENPORATH_MYC_TARGETS_WITH_EBOX
12.8205128205%	5	39	23	Diabetes_McGill_IL6	BIOCARTA_GLEEVEC_PATHWAY
12.8205128205%	5	39	22	Diabetes_McGill_IL6	PID_PDGFRAPATHWAY
12.8205128205%	5	39	22	Diabetes_McGill_IL6	BIOCARTA_INSULIN_PATHWAY
12.8205128205%	5	39	22	Diabetes_McGill_IL6	BIOCARTA_IL2_PATHWAY
12.8205128205%	5	39	21	Diabetes_McGill_IL6	BIOCARTA_TFF_PATHWAY
12.8205128205%	5	39	21	Diabetes_McGill_IL6	BIOCARTA_IGF1_PATHWAY
12.8205128205%	5	39	197	Diabetes_McGill_IL6	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
12.8205128205%	5	39	194	Diabetes_McGill_IL6	KASLER_HDAC7_TARGETS_1_UP
12.8205128205%	5	39	19	Diabetes_McGill_IL6	BIOCARTA_EPO_PATHWAY
12.8205128205%	5	39	176	Diabetes_McGill_IL6	NAGASHIMA_NRG1_SIGNALING_UP
12.8205128205%	5	39	1652	Diabetes_McGill_IL6	PUJANA_BRCA1_PCC_NETWORK
12.8205128205%	5	39	165	Diabetes_McGill_IL6	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
12.8205128205%	5	39	148	Diabetes_McGill_IL6	REACTOME_APOPTOSIS
12.8205128205%	5	39	141	Diabetes_McGill_IL6	KAAB_FAILED_HEART_ATRIUM_DN
12.8205128205%	5	39	128	Diabetes_McGill_IL6	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
12.8205128205%	5	39	117	Diabetes_McGill_IL6	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
12.8205128205%	5	39	1142	Diabetes_McGill_IL6	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
12.8205128205%	5	39	1080	Diabetes_McGill_IL6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
12.8205128205%	5	39	108	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
12.8205128205%	5	39	108	Diabetes_McGill_IL6	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
12.8166160081%	253	1974	1691	Mendelian_Nancy_Cox	BLALOCK_ALZHEIMERS_DISEASE_UP
12.6482213439%	32	253	1278	Diabetes_McGill_CREBBP_coTF	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
12.6482213439%	32	253	1229	Diabetes_McGill_CREBBP_coTF	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
12.5%	4	32	920	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_SIGNALING_BY_GPCR
12.5%	4	32	857	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MARTENS_TRETINOIN_RESPONSE_UP
12.5%	4	32	805	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_GPCR_DOWNSTREAM_SIGNALING
12.5%	4	32	70	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_LONG_TERM_POTENTIATION
12.5%	4	32	70	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_LONG_TERM_DEPRESSION
12.5%	4	32	578	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
12.5%	4	32	567	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CHICAS_RB1_TARGETS_CONFLUENT
12.5%	4	32	43	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS
12.5%	4	32	396	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_DEVELOPMENTAL_BIOLOGY
12.5%	4	32	36	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ST_ADRENERGIC
12.5%	4	32	35	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ST_G_ALPHA_I_PATHWAY
12.5%	4	32	27	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ST_MYOCYTE_AD_PATHWAY
12.5%	4	32	251	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_AXON_GUIDANCE
12.5%	4	32	1821	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DODD_NASOPHARYNGEAL_CARCINOMA_UP
12.5%	4	32	172	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SMID_BREAST_CANCER_LUMINAL_B_UP
12.5%	4	32	1174	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PEREZ_TP53_TARGETS
12.5%	4	32	1069	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
12.5%	3	24	988	Diabetes_McGill_TNF_alpha_signalin	BENPORATH_NANOG_TARGETS
12.5%	3	24	957	Diabetes_McGill_TNF_alpha_signalin	LOPEZ_MBD_TARGETS
12.5%	3	24	953	Diabetes_McGill_TNF_alpha_signalin	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
12.5%	3	24	95	Diabetes_McGill_TNF_alpha_signalin	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
12.5%	3	24	90	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNALING_BY_ERBB4
12.5%	3	24	88	Diabetes_McGill_TNF_alpha_signalin	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
12.5%	3	24	87	Diabetes_McGill_TNF_alpha_signalin	KEGG_ERBB_SIGNALING_PATHWAY
12.5%	3	24	86	Diabetes_McGill_TNF_alpha_signalin	KEGG_TGF_BETA_SIGNALING_PATHWAY
12.5%	3	24	824	Diabetes_McGill_TNF_alpha_signalin	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
12.5%	3	24	800	Diabetes_McGill_TNF_alpha_signalin	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
12.5%	3	24	80	Diabetes_McGill_TNF_alpha_signalin	PID_MET_PATHWAY
12.5%	3	24	795	Diabetes_McGill_TNF_alpha_signalin	WEI_MYCN_TARGETS_WITH_E_BOX
12.5%	3	24	79	Diabetes_McGill_TNF_alpha_signalin	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
12.5%	3	24	783	Diabetes_McGill_TNF_alpha_signalin	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
12.5%	3	24	78	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNALING_BY_SCF_KIT
12.5%	3	24	775	Diabetes_McGill_TNF_alpha_signalin	BENPORATH_MYC_MAX_TARGETS
12.5%	3	24	770	Diabetes_McGill_TNF_alpha_signalin	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
12.5%	3	24	77	Diabetes_McGill_TNF_alpha_signalin	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
12.5%	3	24	76	Diabetes_McGill_TNF_alpha_signalin	KEGG_VEGF_SIGNALING_PATHWAY
12.5%	3	24	75	Diabetes_McGill_TNF_alpha_signalin	PID_AVB3_INTEGRIN_PATHWAY
12.5%	3	24	73	Diabetes_McGill_TNF_alpha_signalin	KEGG_CHRONIC_MYELOID_LEUKEMIA
12.5%	3	24	70	Diabetes_McGill_TNF_alpha_signalin	PID_CDC42_PATHWAY
12.5%	3	24	70	Diabetes_McGill_TNF_alpha_signalin	KEGG_RENAL_CELL_CARCINOMA
12.5%	3	24	68	Diabetes_McGill_TNF_alpha_signalin	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
12.5%	3	24	67	Diabetes_McGill_TNF_alpha_signalin	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70
12.5%	3	24	66	Diabetes_McGill_TNF_alpha_signalin	TENEDINI_MEGAKARYOCYTE_MARKERS
12.5%	3	24	66	Diabetes_McGill_TNF_alpha_signalin	PID_LYSOPHOSPHOLIPID_PATHWAY
12.5%	3	24	66	Diabetes_McGill_TNF_alpha_signalin	PID_HDAC_CLASSI_PATHWAY
12.5%	3	24	658	Diabetes_McGill_TNF_alpha_signalin	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
12.5%	3	24	652	Diabetes_McGill_TNF_alpha_signalin	BENPORATH_PRC2_TARGETS
12.5%	3	24	63	Diabetes_McGill_TNF_alpha_signalin	PID_ENDOTHELINPATHWAY
12.5%	3	24	602	Diabetes_McGill_TNF_alpha_signalin	MARTINEZ_TP53_TARGETS_UP
12.5%	3	24	601	Diabetes_McGill_TNF_alpha_signalin	MARTINEZ_RB1_AND_TP53_TARGETS_UP
12.5%	3	24	60	Diabetes_McGill_TNF_alpha_signalin	KEGG_ACUTE_MYELOID_LEUKEMIA
12.5%	3	24	59	Diabetes_McGill_TNF_alpha_signalin	PID_ATF2_PATHWAY
12.5%	3	24	58	Diabetes_McGill_TNF_alpha_signalin	SCHEIDEREIT_IKK_INTERACTING_PROTEINS
12.5%	3	24	579	Diabetes_McGill_TNF_alpha_signalin	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
12.5%	3	24	56	Diabetes_McGill_TNF_alpha_signalin	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
12.5%	3	24	55	Diabetes_McGill_TNF_alpha_signalin	PID_IL2_1PATHWAY
12.5%	3	24	55	Diabetes_McGill_TNF_alpha_signalin	PID_FGF_PATHWAY
12.5%	3	24	54	Diabetes_McGill_TNF_alpha_signalin	KEGG_NON_SMALL_CELL_LUNG_CANCER
12.5%	3	24	532	Diabetes_McGill_TNF_alpha_signalin	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
12.5%	3	24	52	Diabetes_McGill_TNF_alpha_signalin	KEGG_ENDOMETRIAL_CANCER
12.5%	3	24	49	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_TCR_PATHWAY
12.5%	3	24	485	Diabetes_McGill_TNF_alpha_signalin	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
12.5%	3	24	483	Diabetes_McGill_TNF_alpha_signalin	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
12.5%	3	24	47	Diabetes_McGill_TNF_alpha_signalin	PID_NFAT_TFPATHWAY
12.5%	3	24	47	Diabetes_McGill_TNF_alpha_signalin	KEGG_TYPE_II_DIABETES_MELLITUS
12.5%	3	24	46	Diabetes_McGill_TNF_alpha_signalin	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
12.5%	3	24	46	Diabetes_McGill_TNF_alpha_signalin	PID_PS1PATHWAY
12.5%	3	24	45	Diabetes_McGill_TNF_alpha_signalin	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
12.5%	3	24	447	Diabetes_McGill_TNF_alpha_signalin	MOOTHA_MITOCHONDRIA
12.5%	3	24	44	Diabetes_McGill_TNF_alpha_signalin	PID_ERBB2ERBB3PATHWAY
12.5%	3	24	431	Diabetes_McGill_TNF_alpha_signalin	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
12.5%	3	24	429	Diabetes_McGill_TNF_alpha_signalin	MOOTHA_HUMAN_MITODB_6_2002
12.5%	3	24	412	Diabetes_McGill_TNF_alpha_signalin	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
12.5%	3	24	41	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_FCER1_PATHWAY
12.5%	3	24	40	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_P38MAPK_PATHWAY
12.5%	3	24	396	Diabetes_McGill_TNF_alpha_signalin	REACTOME_DEVELOPMENTAL_BIOLOGY
12.5%	3	24	39	Diabetes_McGill_TNF_alpha_signalin	PID_RET_PATHWAY
12.5%	3	24	39	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_FMLP_PATHWAY
12.5%	3	24	38	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_INTEGRIN_PATHWAY
12.5%	3	24	37	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_MET_PATHWAY
12.5%	3	24	366	Diabetes_McGill_TNF_alpha_signalin	SANSOM_APC_TARGETS_DN
12.5%	3	24	36	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_AT1R_PATHWAY
12.5%	3	24	36	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_AGR_PATHWAY
12.5%	3	24	356	Diabetes_McGill_TNF_alpha_signalin	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
12.5%	3	24	33	Diabetes_McGill_TNF_alpha_signalin	PID_SYNDECAN_2_PATHWAY
12.5%	3	24	33	Diabetes_McGill_TNF_alpha_signalin	DUTTA_APOPTOSIS_VIA_NFKB
12.5%	3	24	33	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_IL1R_PATHWAY
12.5%	3	24	32	Diabetes_McGill_TNF_alpha_signalin	ST_ERK1_ERK2_MAPK_PATHWAY
12.5%	3	24	314	Diabetes_McGill_TNF_alpha_signalin	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
12.5%	3	24	31	Diabetes_McGill_TNF_alpha_signalin	PID_CD40_PATHWAY
12.5%	3	24	31	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_PYK2_PATHWAY
12.5%	3	24	309	Diabetes_McGill_TNF_alpha_signalin	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
12.5%	3	24	30	Diabetes_McGill_TNF_alpha_signalin	REACTOME_NOD1_2_SIGNALING_PATHWAY
12.5%	3	24	30	Diabetes_McGill_TNF_alpha_signalin	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES
12.5%	3	24	29	Diabetes_McGill_TNF_alpha_signalin	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
12.5%	3	24	270	Diabetes_McGill_TNF_alpha_signalin	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
12.5%	3	24	27	Diabetes_McGill_TNF_alpha_signalin	ST_GRANULE_CELL_SURVIVAL_PATHWAY
12.5%	3	24	267	Diabetes_McGill_TNF_alpha_signalin	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
12.5%	3	24	26	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_RACCYCD_PATHWAY
12.5%	3	24	26	Diabetes_McGill_TNF_alpha_signalin	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
12.5%	3	24	24	Diabetes_McGill_TNF_alpha_signalin	SA_B_CELL_RECEPTOR_COMPLEXES
12.5%	3	24	24	Diabetes_McGill_TNF_alpha_signalin	PID_S1P_S1P2_PATHWAY
12.5%	3	24	24	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_CXCR4_PATHWAY
12.5%	3	24	234	Diabetes_McGill_TNF_alpha_signalin	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
12.5%	3	24	233	Diabetes_McGill_TNF_alpha_signalin	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
12.5%	3	24	23	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_RAS_PATHWAY
12.5%	3	24	223	Diabetes_McGill_TNF_alpha_signalin	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
12.5%	3	24	223	Diabetes_McGill_TNF_alpha_signalin	CHEN_HOXA5_TARGETS_9HR_UP
12.5%	3	24	222	Diabetes_McGill_TNF_alpha_signalin	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
12.5%	3	24	201	Diabetes_McGill_TNF_alpha_signalin	KEGG_FOCAL_ADHESION
12.5%	3	24	190	Diabetes_McGill_TNF_alpha_signalin	KEGG_CHEMOKINE_SIGNALING_PATHWAY
12.5%	3	24	182	Diabetes_McGill_TNF_alpha_signalin	FERNANDEZ_BOUND_BY_MYC
12.5%	3	24	17	Diabetes_McGill_TNF_alpha_signalin	PID_ANTHRAXPATHWAY
12.5%	3	24	17	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_PML_PATHWAY
12.5%	3	24	17	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_HCMV_PATHWAY
12.5%	3	24	17	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_41BB_PATHWAY
12.5%	3	24	1652	Diabetes_McGill_TNF_alpha_signalin	PUJANA_BRCA1_PCC_NETWORK
12.5%	3	24	165	Diabetes_McGill_TNF_alpha_signalin	BROWN_MYELOID_CELL_DEVELOPMENT_UP
12.5%	3	24	160	Diabetes_McGill_TNF_alpha_signalin	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
12.5%	3	24	15	Diabetes_McGill_TNF_alpha_signalin	SA_MMP_CYTOKINE_CONNECTION
12.5%	3	24	1375	Diabetes_McGill_TNF_alpha_signalin	DODD_NASOPHARYNGEAL_CARCINOMA_DN
12.5%	3	24	137	Diabetes_McGill_TNF_alpha_signalin	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
12.5%	3	24	133	Diabetes_McGill_TNF_alpha_signalin	KEGG_PARKINSONS_DISEASE
12.5%	3	24	129	Diabetes_McGill_TNF_alpha_signalin	PID_PDGFRBPATHWAY
12.5%	3	24	127	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
12.5%	3	24	123	Diabetes_McGill_TNF_alpha_signalin	DAZARD_RESPONSE_TO_UV_SCC_DN
12.5%	3	24	122	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNALING_BY_PDGF
12.5%	3	24	1210	Diabetes_McGill_TNF_alpha_signalin	CHEN_METABOLIC_SYNDROM_NETWORK
12.5%	3	24	12	Diabetes_McGill_TNF_alpha_signalin	SA_PROGRAMMED_CELL_DEATH
12.5%	3	24	12	Diabetes_McGill_TNF_alpha_signalin	REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10
12.5%	3	24	112	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNALING_BY_FGFR
12.5%	3	24	109	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
12.5%	3	24	107	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNALING_BY_ILS
12.5%	3	24	1062	Diabetes_McGill_TNF_alpha_signalin	BENPORATH_EED_TARGETS
12.5%	3	24	105	Diabetes_McGill_TNF_alpha_signalin	PID_ERBB1_DOWNSTREAM_PATHWAY
12.5%	3	24	1022	Diabetes_McGill_TNF_alpha_signalin	MARSON_BOUND_BY_FOXP3_STIMULATED
12.5%	3	24	101	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNALING_BY_ERBB2
12.5%	3	24	101	Diabetes_McGill_TNF_alpha_signalin	KEGG_GNRH_SIGNALING_PATHWAY
12.5%	3	24	100	Diabetes_McGill_TNF_alpha_signalin	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
12.5%	3	24	10	Diabetes_McGill_TNF_alpha_signalin	REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS
12.5%	1	8	953	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
12.5%	1	8	94	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	GAVIN_FOXP3_TARGETS_CLUSTER_T4
12.5%	1	8	92	Mendelian_Long_QT_syndrome	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
12.5%	1	8	92	Mendelian_Long_QT_syndrome	KEGG_DILATED_CARDIOMYOPATHY
12.5%	1	8	92	Mendelian_Long_QT_syndrome	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
12.5%	1	8	92	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
12.5%	1	8	90	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BILANGES_SERUM_SENSITIVE_GENES
12.5%	1	8	893	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	GEORGES_TARGETS_OF_MIR192_AND_MIR215
12.5%	1	8	89	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	LI_DCP2_BOUND_MRNA
12.5%	1	8	882	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	LEE_BMP2_TARGETS_DN
12.5%	1	8	882	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
12.5%	1	8	88	Mendelian_Long_QT_syndrome	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
12.5%	1	8	88	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
12.5%	1	8	87	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SMITH_TERT_TARGETS_DN
12.5%	1	8	86	Mendelian_Long_QT_syndrome	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
12.5%	1	8	86	Mendelian_Long_QT_syndrome	REACTOME_L1CAM_INTERACTIONS
12.5%	1	8	857	Mendelian_Long_QT_syndrome	MARTENS_TRETINOIN_RESPONSE_UP
12.5%	1	8	85	Mendelian_Long_QT_syndrome	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
12.5%	1	8	848	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	NUYTTEN_NIPP1_TARGETS_DN
12.5%	1	8	84	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
12.5%	1	8	82	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
12.5%	1	8	811	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
12.5%	1	8	81	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
12.5%	1	8	81	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	COATES_MACROPHAGE_M1_VS_M2_UP
12.5%	1	8	805	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
12.5%	1	8	80	Mendelian_Long_QT_syndrome	KEGG_CARDIAC_MUSCLE_CONTRACTION
12.5%	1	8	80	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SCHUHMACHER_MYC_TARGETS_UP
12.5%	1	8	79	Mendelian_Long_QT_syndrome	MEISSNER_NPC_HCP_WITH_H3K27ME3
12.5%	1	8	79	Mendelian_Long_QT_syndrome	DUAN_PRDM5_TARGETS
12.5%	1	8	79	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
12.5%	1	8	784	Mendelian_Long_QT_syndrome	FORTSCHEGGER_PHF8_TARGETS_DN
12.5%	1	8	783	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
12.5%	1	8	77	Mendelian_Long_QT_syndrome	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN
12.5%	1	8	77	Mendelian_Long_QT_syndrome	LIN_APC_TARGETS
12.5%	1	8	77	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	JACKSON_DNMT1_TARGETS_UP
12.5%	1	8	77	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CHEBOTAEV_GR_TARGETS_UP
12.5%	1	8	76	Mendelian_Long_QT_syndrome	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
12.5%	1	8	756	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
12.5%	1	8	75	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	JAIN_NFKB_SIGNALING
12.5%	1	8	747	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	PATIL_LIVER_CANCER
12.5%	1	8	74	Mendelian_Long_QT_syndrome	URS_ADIPOCYTE_DIFFERENTIATION_UP
12.5%	1	8	74	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	LEIN_OLIGODENDROCYTE_MARKERS
12.5%	1	8	74	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CORRE_MULTIPLE_MYELOMA_UP
12.5%	1	8	73	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
12.5%	1	8	722	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
12.5%	1	8	721	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	WONG_ADULT_TISSUE_STEM_MODULE
12.5%	1	8	718	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MIKKELSEN_ES_ICP_WITH_H3K4ME3
12.5%	1	8	701	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SMID_BREAST_CANCER_BASAL_DN
12.5%	1	8	70	Mendelian_Long_QT_syndrome	KEGG_LONG_TERM_POTENTIATION
12.5%	1	8	7	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER
12.5%	1	8	69	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
12.5%	1	8	681	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
12.5%	1	8	68	Mendelian_Long_QT_syndrome	ROSS_AML_OF_FAB_M7_TYPE
12.5%	1	8	68	Mendelian_Long_QT_syndrome	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN
12.5%	1	8	68	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
12.5%	1	8	673	Mendelian_Long_QT_syndrome	MARTINEZ_RB1_TARGETS_UP
12.5%	1	8	663	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
12.5%	1	8	652	Mendelian_Long_QT_syndrome	BENPORATH_PRC2_TARGETS
12.5%	1	8	65	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
12.5%	1	8	648	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SMID_BREAST_CANCER_BASAL_UP
12.5%	1	8	64	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	RHODES_CANCER_META_SIGNATURE
12.5%	1	8	64	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	LEE_LIVER_CANCER_MYC_E2F1_DN
12.5%	1	8	64	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
12.5%	1	8	634	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
12.5%	1	8	633	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
12.5%	1	8	63	Mendelian_Long_QT_syndrome	BRIDEAU_IMPRINTED_GENES
12.5%	1	8	63	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BRIDEAU_IMPRINTED_GENES
12.5%	1	8	61	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
12.5%	1	8	61	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	LEE_LIVER_CANCER_MYC_TGFA_UP
12.5%	1	8	602	Mendelian_Long_QT_syndrome	MARTINEZ_TP53_TARGETS_UP
12.5%	1	8	601	Mendelian_Long_QT_syndrome	MARTINEZ_RB1_AND_TP53_TARGETS_UP
12.5%	1	8	60	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	LEE_LIVER_CANCER_DENA_UP
12.5%	1	8	60	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	LEE_LIVER_CANCER_CIPROFIBRATE_UP
12.5%	1	8	593	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MARTINEZ_TP53_TARGETS_DN
12.5%	1	8	591	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MARTINEZ_RB1_AND_TP53_TARGETS_DN
12.5%	1	8	59	Mendelian_Long_QT_syndrome	MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3
12.5%	1	8	58	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
12.5%	1	8	58	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
12.5%	1	8	58	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BERNARD_PPAPDC1B_TARGETS_DN
12.5%	1	8	567	Mendelian_Long_QT_syndrome	CHICAS_RB1_TARGETS_CONFLUENT
12.5%	1	8	567	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CHICAS_RB1_TARGETS_CONFLUENT
12.5%	1	8	56	Mendelian_Long_QT_syndrome	KEGG_VIBRIO_CHOLERAE_INFECTION
12.5%	1	8	56	Mendelian_Long_QT_syndrome	BROWNE_HCMV_INFECTION_30MIN_UP
12.5%	1	8	557	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	TIEN_INTESTINE_PROBIOTICS_24HR_UP
12.5%	1	8	553	Mendelian_Long_QT_syndrome	FEVR_CTNNB1_TARGETS_DN
12.5%	1	8	553	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	FEVR_CTNNB1_TARGETS_DN
12.5%	1	8	55	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
12.5%	1	8	548	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KIM_ALL_DISORDERS_CALB1_CORR_UP
12.5%	1	8	546	Mendelian_Long_QT_syndrome	WEST_ADRENOCORTICAL_TUMOR_DN
12.5%	1	8	543	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MARTINEZ_RB1_TARGETS_DN
12.5%	1	8	54	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KEGG_ARGININE_AND_PROLINE_METABOLISM
12.5%	1	8	536	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BERENJENO_TRANSFORMED_BY_RHOA_UP
12.5%	1	8	532	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
12.5%	1	8	53	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP
12.5%	1	8	528	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
12.5%	1	8	516	Mendelian_Long_QT_syndrome	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
12.5%	1	8	510	Mendelian_Long_QT_syndrome	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
12.5%	1	8	51	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
12.5%	1	8	51	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
12.5%	1	8	508	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	ENK_UV_RESPONSE_EPIDERMIS_DN
12.5%	1	8	504	Mendelian_Long_QT_syndrome	BROWNE_HCMV_INFECTION_48HR_DN
12.5%	1	8	504	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BROWNE_HCMV_INFECTION_48HR_DN
12.5%	1	8	493	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
12.5%	1	8	49	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MANTOVANI_VIRAL_GPCR_SIGNALING_DN
12.5%	1	8	49	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BROWNE_HCMV_INFECTION_2HR_DN
12.5%	1	8	489	Mendelian_Long_QT_syndrome	LIM_MAMMARY_STEM_CELL_UP
12.5%	1	8	487	Mendelian_Long_QT_syndrome	RODWELL_AGING_KIDNEY_UP
12.5%	1	8	485	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	ENK_UV_RESPONSE_KERATINOCYTE_DN
12.5%	1	8	481	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	LIU_PROSTATE_CANCER_DN
12.5%	1	8	479	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
12.5%	1	8	473	Mendelian_Long_QT_syndrome	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
12.5%	1	8	473	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	GARY_CD5_TARGETS_UP
12.5%	1	8	47	Mendelian_Long_QT_syndrome	KEGG_TYPE_II_DIABETES_MELLITUS
12.5%	1	8	47	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	IRITANI_MAD1_TARGETS_DN
12.5%	1	8	47	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP
12.5%	1	8	467	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	RATTENBACHER_BOUND_BY_CELF1
12.5%	1	8	463	Mendelian_Long_QT_syndrome	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
12.5%	1	8	463	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
12.5%	1	8	461	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
12.5%	1	8	46	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	NAKAMURA_CANCER_MICROENVIRONMENT_DN
12.5%	1	8	459	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KIM_WT1_TARGETS_DN
12.5%	1	8	456	Mendelian_Long_QT_syndrome	MARTENS_BOUND_BY_PML_RARA_FUSION
12.5%	1	8	45	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	ZHAN_MULTIPLE_MYELOMA_CD2_UP
12.5%	1	8	45	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	ZHAN_MULTIPLE_MYELOMA_CD1_DN
12.5%	1	8	445	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
12.5%	1	8	442	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
12.5%	1	8	44	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KEGG_LYSINE_DEGRADATION
12.5%	1	8	435	Mendelian_Long_QT_syndrome	SWEET_LUNG_CANCER_KRAS_DN
12.5%	1	8	435	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
12.5%	1	8	43	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	ZUCCHI_METASTASIS_UP
12.5%	1	8	425	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	ZHANG_BREAST_CANCER_PROGENITORS_UP
12.5%	1	8	420	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MOOTHA_PGC
12.5%	1	8	42	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	LEIN_ASTROCYTE_MARKERS
12.5%	1	8	42	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KEGG_FATTY_ACID_METABOLISM
12.5%	1	8	419	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
12.5%	1	8	418	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	PEDRIOLI_MIR31_TARGETS_DN
12.5%	1	8	414	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MOHANKUMAR_TLX1_TARGETS_UP
12.5%	1	8	412	Mendelian_Long_QT_syndrome	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
12.5%	1	8	41	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	ZHAN_MULTIPLE_MYELOMA_DN
12.5%	1	8	41	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KAMMINGA_EZH2_TARGETS
12.5%	1	8	41	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
12.5%	1	8	41	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CROONQUIST_NRAS_SIGNALING_UP
12.5%	1	8	408	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
12.5%	1	8	40	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	TOMLINS_PROSTATE_CANCER_DN
12.5%	1	8	40	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KEGG_TRYPTOPHAN_METABOLISM
12.5%	1	8	398	Mendelian_Long_QT_syndrome	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
12.5%	1	8	396	Mendelian_Long_QT_syndrome	REACTOME_DEVELOPMENTAL_BIOLOGY
12.5%	1	8	393	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
12.5%	1	8	391	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
12.5%	1	8	390	Mendelian_Long_QT_syndrome	HATADA_METHYLATED_IN_LUNG_CANCER_UP
12.5%	1	8	39	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	POTTI_PACLITAXEL_SENSITIVITY
12.5%	1	8	379	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BENPORATH_ES_1
12.5%	1	8	374	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	WANG_TUMOR_INVASIVENESS_UP
12.5%	1	8	372	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	WANG_LMO4_TARGETS_UP
12.5%	1	8	37	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	HU_ANGIOGENESIS_DN
12.5%	1	8	368	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
12.5%	1	8	367	Mendelian_Long_QT_syndrome	VECCHI_GASTRIC_CANCER_EARLY_DN
12.5%	1	8	364	Mendelian_Long_QT_syndrome	YANG_BCL3_TARGETS_UP
12.5%	1	8	364	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	YANG_BCL3_TARGETS_UP
12.5%	1	8	362	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
12.5%	1	8	357	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SHEN_SMARCA2_TARGETS_DN
12.5%	1	8	355	Mendelian_Long_QT_syndrome	PEREZ_TP63_TARGETS
12.5%	1	8	35	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
12.5%	1	8	349	Mendelian_Long_QT_syndrome	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
12.5%	1	8	337	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	PENG_GLUTAMINE_DEPRIVATION_DN
12.5%	1	8	335	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	WONG_EMBRYONIC_STEM_CELL_CORE
12.5%	1	8	330	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
12.5%	1	8	33	Mendelian_Long_QT_syndrome	VALK_AML_CLUSTER_5
12.5%	1	8	326	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
12.5%	1	8	324	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
12.5%	1	8	316	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
12.5%	1	8	309	Mendelian_Long_QT_syndrome	LIU_SOX4_TARGETS_DN
12.5%	1	8	309	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	LIU_SOX4_TARGETS_DN
12.5%	1	8	308	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
12.5%	1	8	307	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
12.5%	1	8	305	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
12.5%	1	8	30	Mendelian_Long_QT_syndrome	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
12.5%	1	8	30	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN
12.5%	1	8	30	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY
12.5%	1	8	299	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	WALLACE_PROSTATE_CANCER_RACE_UP
12.5%	1	8	296	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	DURAND_STROMA_MAX_UP
12.5%	1	8	292	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	HELLER_HDAC_TARGETS_DN
12.5%	1	8	290	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BENPORATH_OCT4_TARGETS
12.5%	1	8	287	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
12.5%	1	8	285	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	GRADE_COLON_AND_RECTAL_CANCER_UP
12.5%	1	8	28	Mendelian_Long_QT_syndrome	VALK_AML_CLUSTER_7
12.5%	1	8	276	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
12.5%	1	8	271	Mendelian_Long_QT_syndrome	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
12.5%	1	8	27	Mendelian_Long_QT_syndrome	ST_MYOCYTE_AD_PATHWAY
12.5%	1	8	269	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
12.5%	1	8	267	Mendelian_Long_QT_syndrome	KEGG_MAPK_SIGNALING_PATHWAY
12.5%	1	8	265	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
12.5%	1	8	264	Mendelian_Long_QT_syndrome	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
12.5%	1	8	262	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	LU_AGING_BRAIN_UP
12.5%	1	8	261	Mendelian_Long_QT_syndrome	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
12.5%	1	8	255	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
12.5%	1	8	254	Mendelian_Long_QT_syndrome	BROWNE_HCMV_INFECTION_4HR_DN
12.5%	1	8	252	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
12.5%	1	8	251	Mendelian_Long_QT_syndrome	REACTOME_AXON_GUIDANCE
12.5%	1	8	25	Mendelian_Long_QT_syndrome	WANG_NFKB_TARGETS
12.5%	1	8	25	Mendelian_Long_QT_syndrome	VANDESLUIS_NORMAL_EMBRYOS_DN
12.5%	1	8	25	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	COLLER_MYC_TARGETS_UP
12.5%	1	8	25	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN
12.5%	1	8	249	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MITSIADES_RESPONSE_TO_APLIDIN_DN
12.5%	1	8	246	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	VERHAAK_AML_WITH_NPM1_MUTATED_DN
12.5%	1	8	245	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	PENG_RAPAMYCIN_RESPONSE_DN
12.5%	1	8	244	Mendelian_Long_QT_syndrome	THUM_SYSTOLIC_HEART_FAILURE_DN
12.5%	1	8	244	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	HSIAO_LIVER_SPECIFIC_GENES
12.5%	1	8	243	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CHICAS_RB1_TARGETS_GROWING
12.5%	1	8	242	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CHYLA_CBFA2T3_TARGETS_DN
12.5%	1	8	240	Mendelian_Long_QT_syndrome	BROWNE_HCMV_INFECTION_20HR_UP
12.5%	1	8	239	Mendelian_Long_QT_syndrome	ALFANO_MYC_TARGETS
12.5%	1	8	239	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	ALFANO_MYC_TARGETS
12.5%	1	8	232	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	DELYS_THYROID_CANCER_DN
12.5%	1	8	23	Mendelian_Long_QT_syndrome	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS
12.5%	1	8	229	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
12.5%	1	8	228	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
12.5%	1	8	228	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MARKEY_RB1_ACUTE_LOF_DN
12.5%	1	8	226	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KYNG_DNA_DAMAGE_UP
12.5%	1	8	225	Mendelian_Long_QT_syndrome	BROWNE_HCMV_INFECTION_16HR_UP
12.5%	1	8	225	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BROWNE_HCMV_INFECTION_16HR_UP
12.5%	1	8	222	Mendelian_Long_QT_syndrome	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
12.5%	1	8	221	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	PEDRIOLI_MIR31_TARGETS_UP
12.5%	1	8	220	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
12.5%	1	8	22	Mendelian_Long_QT_syndrome	PID_PDGFRAPATHWAY
12.5%	1	8	22	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP
12.5%	1	8	217	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	WONG_MITOCHONDRIA_GENE_MODULE
12.5%	1	8	215	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MARKEY_RB1_ACUTE_LOF_UP
12.5%	1	8	214	Mendelian_Long_QT_syndrome	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
12.5%	1	8	210	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CAIRO_HEPATOBLASTOMA_CLASSES_DN
12.5%	1	8	21	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP
12.5%	1	8	209	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CHANG_CORE_SERUM_RESPONSE_DN
12.5%	1	8	206	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
12.5%	1	8	203	Mendelian_Long_QT_syndrome	PENG_RAPAMYCIN_RESPONSE_UP
12.5%	1	8	203	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	PENG_RAPAMYCIN_RESPONSE_UP
12.5%	1	8	203	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	PAL_PRMT5_TARGETS_UP
12.5%	1	8	202	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
12.5%	1	8	201	Mendelian_Long_QT_syndrome	KEGG_FOCAL_ADHESION
12.5%	1	8	201	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KIM_MYC_AMPLIFICATION_TARGETS_UP
12.5%	1	8	20	Mendelian_Long_QT_syndrome	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN
12.5%	1	8	20	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	WALLACE_PROSTATE_CANCER_UP
12.5%	1	8	199	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	PLASARI_TGFB1_TARGETS_10HR_UP
12.5%	1	8	198	Mendelian_Long_QT_syndrome	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
12.5%	1	8	198	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
12.5%	1	8	194	Mendelian_Long_QT_syndrome	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
12.5%	1	8	194	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
12.5%	1	8	19	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	TERAMOTO_OPN_TARGETS_CLUSTER_7
12.5%	1	8	187	Mendelian_Long_QT_syndrome	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
12.5%	1	8	187	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	PENG_LEUCINE_DEPRIVATION_DN
12.5%	1	8	187	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BAKKER_FOXO3_TARGETS_DN
12.5%	1	8	184	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	DOANE_RESPONSE_TO_ANDROGEN_UP
12.5%	1	8	1839	Mendelian_Long_QT_syndrome	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
12.5%	1	8	180	Mendelian_Long_QT_syndrome	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
12.5%	1	8	180	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
12.5%	1	8	18	Mendelian_Long_QT_syndrome	ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE
12.5%	1	8	178	Mendelian_Long_QT_syndrome	KEGG_CALCIUM_SIGNALING_PATHWAY
12.5%	1	8	175	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	YAMAZAKI_TCEB3_TARGETS_UP
12.5%	1	8	170	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
12.5%	1	8	17	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION
12.5%	1	8	169	Mendelian_Long_QT_syndrome	KEGG_ALZHEIMERS_DISEASE
12.5%	1	8	169	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	UEDA_PERIFERAL_CLOCK
12.5%	1	8	169	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	PENG_GLUCOSE_DEPRIVATION_DN
12.5%	1	8	169	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KATSANOU_ELAVL1_TARGETS_UP
12.5%	1	8	1652	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	PUJANA_BRCA1_PCC_NETWORK
12.5%	1	8	162	Mendelian_Long_QT_syndrome	MULLIGHAN_NPM1_SIGNATURE_3_DN
12.5%	1	8	161	Mendelian_Long_QT_syndrome	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
12.5%	1	8	161	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
12.5%	1	8	16	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	IGLESIAS_E2F_TARGETS_DN
12.5%	1	8	158	Mendelian_Long_QT_syndrome	RODRIGUES_NTN1_TARGETS_DN
12.5%	1	8	150	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
12.5%	1	8	149	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
12.5%	1	8	149	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	GOZGIT_ESR1_TARGETS_UP
12.5%	1	8	1442	Mendelian_Long_QT_syndrome	PUJANA_ATM_PCC_NETWORK
12.5%	1	8	144	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BROCKE_APOPTOSIS_REVERSED_BY_IL6
12.5%	1	8	1382	Mendelian_Long_QT_syndrome	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
12.5%	1	8	1382	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
12.5%	1	8	135	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	UDAYAKUMAR_MED1_TARGETS_UP
12.5%	1	8	134	Mendelian_Long_QT_syndrome	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
12.5%	1	8	133	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SENESE_HDAC2_TARGETS_DN
12.5%	1	8	13	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER
12.5%	1	8	13	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CROONQUIST_STROMAL_STIMULATION_DN
12.5%	1	8	129	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	KIM_WT1_TARGETS_8HR_DN
12.5%	1	8	128	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS
12.5%	1	8	126	Mendelian_Long_QT_syndrome	SANSOM_APC_TARGETS_UP
12.5%	1	8	126	Mendelian_Long_QT_syndrome	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
12.5%	1	8	126	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
12.5%	1	8	120	Mendelian_Long_QT_syndrome	XU_GH1_EXOGENOUS_TARGETS_DN
12.5%	1	8	118	Mendelian_Long_QT_syndrome	CERVERA_SDHB_TARGETS_1_UP
12.5%	1	8	118	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	LEE_NEURAL_CREST_STEM_CELL_DN
12.5%	1	8	118	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
12.5%	1	8	1174	Mendelian_Long_QT_syndrome	PEREZ_TP53_TARGETS
12.5%	1	8	116	Mendelian_Long_QT_syndrome	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
12.5%	1	8	116	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	LI_INDUCED_T_TO_NATURAL_KILLER_DN
12.5%	1	8	115	Mendelian_Long_QT_syndrome	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
12.5%	1	8	115	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MARKEY_RB1_CHRONIC_LOF_UP
12.5%	1	8	115	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
12.5%	1	8	1142	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
12.5%	1	8	114	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	LENAOUR_DENDRITIC_CELL_MATURATION_UP
12.5%	1	8	1137	Mendelian_Long_QT_syndrome	BRUINS_UVC_RESPONSE_LATE
12.5%	1	8	113	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	RICKMAN_HEAD_AND_NECK_CANCER_C
12.5%	1	8	112	Mendelian_Long_QT_syndrome	LABBE_WNT3A_TARGETS_UP
12.5%	1	8	110	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
12.5%	1	8	109	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SERVITJA_ISLET_HNF1A_TARGETS_DN
12.5%	1	8	109	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
12.5%	1	8	109	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
12.5%	1	8	1080	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
12.5%	1	8	108	Mendelian_Long_QT_syndrome	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
12.5%	1	8	108	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	TAVAZOIE_METASTASIS
12.5%	1	8	107	Mendelian_Long_QT_syndrome	ROESSLER_LIVER_CANCER_METASTASIS_UP
12.5%	1	8	1069	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
12.5%	1	8	104	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
12.5%	1	8	1038	Mendelian_Long_QT_syndrome	BENPORATH_SUZ12_TARGETS
12.5%	1	8	1038	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	BENPORATH_SUZ12_TARGETS
12.5%	1	8	1037	Mendelian_Long_QT_syndrome	NUYTTEN_EZH2_TARGETS_UP
12.5%	1	8	103	Mendelian_Long_QT_syndrome	LEIN_CHOROID_PLEXUS_MARKERS
12.5%	1	8	1024	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	NUYTTEN_EZH2_TARGETS_DN
12.5%	1	8	101	Mendelian_Long_QT_syndrome	KEGG_GNRH_SIGNALING_PATHWAY
12.5%	1	8	101	Mendelian_Disorders_of_Straight_Chain_Amino_Acid_Metabolism	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
12.3456790123%	10	81	1972	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PILON_KLF1_TARGETS_DN
12.3456790123%	10	81	1691	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BLALOCK_ALZHEIMERS_DISEASE_UP
12.3456790123%	10	81	1442	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PUJANA_ATM_PCC_NETWORK
12.2529644269%	31	253	1062	Diabetes_McGill_CREBBP_coTF	BENPORATH_EED_TARGETS
12.1951219512%	5	41	988	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BENPORATH_NANOG_TARGETS
12.1951219512%	5	41	93	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_REGULATION_OF_INSULIN_SECRETION
12.1951219512%	5	41	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_PROSTATE_CANCER
12.1951219512%	5	41	882	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
12.1951219512%	5	41	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
12.1951219512%	5	41	848	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NUYTTEN_NIPP1_TARGETS_DN
12.1951219512%	5	41	811	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
12.1951219512%	5	41	71	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_PI3K_CASCADE
12.1951219512%	5	41	590	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
12.1951219512%	5	41	567	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHICAS_RB1_TARGETS_CONFLUENT
12.1951219512%	5	41	526	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ONKEN_UVEAL_MELANOMA_DN
12.1951219512%	5	41	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_PTP1BPATHWAY
12.1951219512%	5	41	514	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
12.1951219512%	5	41	504	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BROWNE_HCMV_INFECTION_48HR_DN
12.1951219512%	5	41	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ROLEF_GLIS3_TARGETS
12.1951219512%	5	41	328	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_PATHWAYS_IN_CANCER
12.1951219512%	5	41	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_GH_PATHWAY
12.1951219512%	5	41	201	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_FOCAL_ADHESION
12.1951219512%	5	41	1972	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PILON_KLF1_TARGETS_DN
12.1951219512%	5	41	1781	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
12.1951219512%	5	41	1725	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
12.1951219512%	5	41	1652	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PUJANA_BRCA1_PCC_NETWORK
12.1951219512%	5	41	1382	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
12.1951219512%	5	41	1237	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BLALOCK_ALZHEIMERS_DISEASE_DN
12.1951219512%	5	41	1210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHEN_METABOLIC_SYNDROM_NETWORK
12.1951219512%	5	41	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
12.1951219512%	5	41	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHOU_PANCREATIC_EXOCRINE_PROGENITOR
12.1951219512%	5	41	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
12.1951219512%	5	41	1069	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
12.1212121212%	4	33	988	Diabetes_McGill_ER_Stress	BENPORATH_NANOG_TARGETS
12.1212121212%	4	33	957	Mendelian_Metabolism	LOPEZ_MBD_TARGETS
12.1212121212%	4	33	898	Mendelian_Metabolism	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
12.1212121212%	4	33	871	Diabetes_McGill_ER_Stress	GRADE_COLON_CANCER_UP
12.1212121212%	4	33	863	Mendelian_Metabolism	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
12.1212121212%	4	33	824	Diabetes_McGill_ER_Stress	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
12.1212121212%	4	33	76	Diabetes_McGill_ER_Stress	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION
12.1212121212%	4	33	682	Mendelian_Metabolism	FEVR_CTNNB1_TARGETS_UP
12.1212121212%	4	33	652	Mendelian_Metabolism	BENPORATH_PRC2_TARGETS
12.1212121212%	4	33	64	Diabetes_McGill_ER_Stress	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
12.1212121212%	4	33	61	Diabetes_McGill_ER_Stress	REACTOME_ER_PHAGOSOME_PATHWAY
12.1212121212%	4	33	605	Mendelian_Metabolism	CAIRO_HEPATOBLASTOMA_CLASSES_UP
12.1212121212%	4	33	584	Diabetes_McGill_ER_Stress	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
12.1212121212%	4	33	56	Diabetes_McGill_ER_Stress	KEGG_VIBRIO_CHOLERAE_INFECTION
12.1212121212%	4	33	555	Diabetes_McGill_ER_Stress	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
12.1212121212%	4	33	548	Diabetes_McGill_ER_Stress	KIM_ALL_DISORDERS_CALB1_CORR_UP
12.1212121212%	4	33	528	Diabetes_McGill_ER_Stress	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
12.1212121212%	4	33	508	Mendelian_Metabolism	ENK_UV_RESPONSE_EPIDERMIS_DN
12.1212121212%	4	33	491	Mendelian_Metabolism	SWEET_LUNG_CANCER_KRAS_UP
12.1212121212%	4	33	434	Diabetes_McGill_ER_Stress	BAELDE_DIABETIC_NEPHROPATHY_DN
12.1212121212%	4	33	425	Mendelian_Metabolism	BOCHKIS_FOXA2_TARGETS
12.1212121212%	4	33	420	Diabetes_McGill_ER_Stress	MOOTHA_PGC
12.1212121212%	4	33	396	Diabetes_McGill_ER_Stress	REACTOME_DEVELOPMENTAL_BIOLOGY
12.1212121212%	4	33	354	Mendelian_Metabolism	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
12.1212121212%	4	33	354	Diabetes_McGill_ER_Stress	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
12.1212121212%	4	33	330	Mendelian_Metabolism	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
12.1212121212%	4	33	317	Diabetes_McGill_ER_Stress	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
12.1212121212%	4	33	312	Diabetes_McGill_ER_Stress	GENTILE_UV_HIGH_DOSE_DN
12.1212121212%	4	33	31	Mendelian_Metabolism	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM
12.1212121212%	4	33	289	Mendelian_Metabolism	MANALO_HYPOXIA_DN
12.1212121212%	4	33	283	Diabetes_McGill_ER_Stress	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
12.1212121212%	4	33	281	Diabetes_McGill_ER_Stress	BHAT_ESR1_TARGETS_VIA_AKT1_UP
12.1212121212%	4	33	276	Mendelian_Metabolism	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
12.1212121212%	4	33	274	Diabetes_McGill_ER_Stress	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
12.1212121212%	4	33	261	Mendelian_Metabolism	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
12.1212121212%	4	33	261	Mendelian_Metabolism	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
12.1212121212%	4	33	199	Mendelian_Metabolism	PLASARI_TGFB1_TARGETS_10HR_UP
12.1212121212%	4	33	1839	Mendelian_Metabolism	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
12.1212121212%	4	33	179	Diabetes_McGill_ER_Stress	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE
12.1212121212%	4	33	169	Diabetes_McGill_ER_Stress	KEGG_ALZHEIMERS_DISEASE
12.1212121212%	4	33	147	Diabetes_McGill_ER_Stress	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
12.1212121212%	4	33	1382	Mendelian_Metabolism	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
12.1212121212%	4	33	1174	Mendelian_Metabolism	PEREZ_TP53_TARGETS
12.1212121212%	4	33	1118	Mendelian_Metabolism	BENPORATH_ES_WITH_H3K27ME3
12.1212121212%	4	33	1069	Mendelian_Metabolism	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
12.1212121212%	4	33	1062	Mendelian_Metabolism	BENPORATH_EED_TARGETS
12.1212121212%	4	33	1024	Mendelian_Metabolism	NUYTTEN_EZH2_TARGETS_DN
12.0967741935%	15	124	988	Diabetes_McGill_Cell_cycle_All_Gene	BENPORATH_NANOG_TARGETS
12.0967741935%	15	124	89	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_PROSTATE_CANCER
12.0967741935%	15	124	84	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_SMALL_CELL_LUNG_CANCER
12.0967741935%	15	124	734	Diabetes_McGill_Cell_cycle_All_Gene	BENPORATH_SOX2_TARGETS
12.0967741935%	15	124	72	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1
12.0967741935%	15	124	70	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_PANCREATIC_CANCER
12.0967741935%	15	124	61	Diabetes_McGill_Cell_cycle_All_Gene	KAUFFMANN_MELANOMA_RELAPSE_UP
12.0967741935%	15	124	53	Diabetes_McGill_Cell_cycle_All_Gene	ISHIDA_E2F_TARGETS
12.0967741935%	15	124	518	Diabetes_McGill_Cell_cycle_All_Gene	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
12.0967741935%	15	124	485	Diabetes_McGill_Cell_cycle_All_Gene	ENK_UV_RESPONSE_KERATINOCYTE_DN
12.0967741935%	15	124	483	Diabetes_McGill_Cell_cycle_All_Gene	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
12.0967741935%	15	124	428	Diabetes_McGill_Cell_cycle_All_Gene	CUI_TCF21_TARGETS_2_UP
12.0967741935%	15	124	414	Diabetes_McGill_Cell_cycle_All_Gene	MOHANKUMAR_TLX1_TARGETS_UP
12.0967741935%	15	124	40	Diabetes_McGill_Cell_cycle_All_Gene	AMUNDSON_GAMMA_RADIATION_RESPONSE
12.0967741935%	15	124	28	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A
12.0967741935%	15	124	24	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS
12.0967741935%	15	124	178	Diabetes_McGill_Cell_cycle_All_Gene	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
12.0967741935%	15	124	137	Diabetes_McGill_Cell_cycle_All_Gene	PID_P53DOWNSTREAMPATHWAY
11.9047619048%	5	42	933	Diabetes_McGill_RAS	REACTOME_IMMUNE_SYSTEM
11.9047619048%	5	42	857	Diabetes_McGill_RAS	MARTENS_TRETINOIN_RESPONSE_UP
11.9047619048%	5	42	841	Diabetes_McGill_RAS	MARTENS_TRETINOIN_RESPONSE_DN
11.9047619048%	5	42	811	Diabetes_McGill_RAS	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
11.9047619048%	5	42	784	Diabetes_McGill_RAS	FORTSCHEGGER_PHF8_TARGETS_DN
11.9047619048%	5	42	721	Diabetes_McGill_RAS	WONG_ADULT_TISSUE_STEM_MODULE
11.9047619048%	5	42	70	Diabetes_McGill_RAS	KEGG_RENAL_CELL_CARCINOMA
11.9047619048%	5	42	70	Diabetes_McGill_RAS	KEGG_LONG_TERM_POTENTIATION
11.9047619048%	5	42	66	Diabetes_McGill_RAS	PID_TCR_PATHWAY
11.9047619048%	5	42	62	Diabetes_McGill_RAS	PID_TRKRPATHWAY
11.9047619048%	5	42	572	Diabetes_McGill_RAS	CHICAS_RB1_TARGETS_SENESCENT
11.9047619048%	5	42	54	Diabetes_McGill_RAS	KEGG_NON_SMALL_CELL_LUNG_CANCER
11.9047619048%	5	42	539	Diabetes_McGill_RAS	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
11.9047619048%	5	42	53	Diabetes_McGill_RAS	PID_CD8TCRPATHWAY
11.9047619048%	5	42	466	Diabetes_McGill_RAS	REACTOME_HEMOSTASIS
11.9047619048%	5	42	34	Diabetes_McGill_RAS	PID_MAPKTRKPATHWAY
11.9047619048%	5	42	27	Diabetes_McGill_RAS	REACTOME_SIGNALLING_TO_RAS
11.9047619048%	5	42	190	Diabetes_McGill_RAS	KEGG_CHEMOKINE_SIGNALING_PATHWAY
11.9047619048%	5	42	1781	Diabetes_McGill_RAS	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
11.9047619048%	5	42	1691	Diabetes_McGill_RAS	BLALOCK_ALZHEIMERS_DISEASE_UP
11.9047619048%	5	42	1652	Diabetes_McGill_RAS	PUJANA_BRCA1_PCC_NETWORK
11.9047619048%	5	42	13	Diabetes_McGill_RAS	REACTOME_P38MAPK_EVENTS
11.9047619048%	5	42	129	Diabetes_McGill_RAS	PID_PDGFRBPATHWAY
11.9047619048%	5	42	126	Diabetes_McGill_RAS	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
11.9047619048%	5	42	1210	Diabetes_McGill_RAS	CHEN_METABOLIC_SYNDROM_NETWORK
11.9047619048%	5	42	1137	Diabetes_McGill_RAS	BRUINS_UVC_RESPONSE_LATE
11.8577075099%	30	253	101	Diabetes_McGill_CREBBP_coTF	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
11.7647058824%	2	17	988	Mendelian_Severe_Combined_Immunodeficiency	BENPORATH_NANOG_TARGETS
11.7647058824%	2	17	95	Mendelian_Severe_Combined_Immunodeficiency	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
11.7647058824%	2	17	940	Mendelian_Severe_Combined_Immunodeficiency	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
11.7647058824%	2	17	93	Mendelian_Severe_Combined_Immunodeficiency	ZHU_CMV_24_HR_UP
11.7647058824%	2	17	92	Mendelian_Blood_Desease	HILLION_HMGA1B_TARGETS
11.7647058824%	2	17	911	Mendelian_Severe_Combined_Immunodeficiency	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
11.7647058824%	2	17	90	Mendelian_Severe_Combined_Immunodeficiency	MORI_MATURE_B_LYMPHOCYTE_UP
11.7647058824%	2	17	882	Mendelian_Severe_Combined_Immunodeficiency	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
11.7647058824%	2	17	88	Mendelian_Severe_Combined_Immunodeficiency	KEGG_HEMATOPOIETIC_CELL_LINEAGE
11.7647058824%	2	17	87	Mendelian_Severe_Combined_Immunodeficiency	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
11.7647058824%	2	17	841	Mendelian_Severe_Combined_Immunodeficiency	MARTENS_TRETINOIN_RESPONSE_DN
11.7647058824%	2	17	84	Mendelian_Severe_Combined_Immunodeficiency	PID_CMYB_PATHWAY
11.7647058824%	2	17	830	Mendelian_Severe_Combined_Immunodeficiency	CUI_TCF21_TARGETS_2_DN
11.7647058824%	2	17	78	Mendelian_Severe_Combined_Immunodeficiency	ROSS_LEUKEMIA_WITH_MLL_FUSIONS
11.7647058824%	2	17	779	Mendelian_Severe_Combined_Immunodeficiency	PUJANA_CHEK2_PCC_NETWORK
11.7647058824%	2	17	75	Mendelian_Severe_Combined_Immunodeficiency	MCCLUNG_COCAIN_REWARD_4WK
11.7647058824%	2	17	74	Mendelian_Severe_Combined_Immunodeficiency	RAMALHO_STEMNESS_DN
11.7647058824%	2	17	74	Mendelian_Blood_Desease	RAMALHO_STEMNESS_DN
11.7647058824%	2	17	73	Mendelian_Blood_Desease	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
11.7647058824%	2	17	718	Mendelian_Severe_Combined_Immunodeficiency	MIKKELSEN_ES_ICP_WITH_H3K4ME3
11.7647058824%	2	17	69	Mendelian_Severe_Combined_Immunodeficiency	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
11.7647058824%	2	17	652	Mendelian_Blood_Desease	BENPORATH_PRC2_TARGETS
11.7647058824%	2	17	65	Mendelian_Severe_Combined_Immunodeficiency	PID_IL4_2PATHWAY
11.7647058824%	2	17	65	Mendelian_Severe_Combined_Immunodeficiency	PID_CD8TCRDOWNSTREAMPATHWAY
11.7647058824%	2	17	633	Mendelian_Severe_Combined_Immunodeficiency	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
11.7647058824%	2	17	63	Mendelian_Severe_Combined_Immunodeficiency	PID_IL12_2PATHWAY
11.7647058824%	2	17	61	Mendelian_Severe_Combined_Immunodeficiency	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
11.7647058824%	2	17	605	Mendelian_Blood_Desease	CAIRO_HEPATOBLASTOMA_CLASSES_UP
11.7647058824%	2	17	59	Mendelian_Blood_Desease	PID_P53REGULATIONPATHWAY
11.7647058824%	2	17	584	Mendelian_Severe_Combined_Immunodeficiency	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
11.7647058824%	2	17	58	Mendelian_Severe_Combined_Immunodeficiency	PID_SHP2_PATHWAY
11.7647058824%	2	17	58	Mendelian_Severe_Combined_Immunodeficiency	MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
11.7647058824%	2	17	57	Mendelian_Blood_Desease	TONG_INTERACT_WITH_PTTG1
11.7647058824%	2	17	566	Mendelian_Severe_Combined_Immunodeficiency	DOUGLAS_BMI1_TARGETS_UP
11.7647058824%	2	17	56	Mendelian_Severe_Combined_Immunodeficiency	WORSCHECH_TUMOR_REJECTION_UP
11.7647058824%	2	17	555	Mendelian_Severe_Combined_Immunodeficiency	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
11.7647058824%	2	17	55	Mendelian_Severe_Combined_Immunodeficiency	YU_MYC_TARGETS_DN
11.7647058824%	2	17	55	Mendelian_Severe_Combined_Immunodeficiency	PID_IL2_1PATHWAY
11.7647058824%	2	17	55	Mendelian_Blood_Desease	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
11.7647058824%	2	17	544	Mendelian_Severe_Combined_Immunodeficiency	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
11.7647058824%	2	17	53	Mendelian_Blood_Desease	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP
11.7647058824%	2	17	504	Mendelian_Blood_Desease	BROWNE_HCMV_INFECTION_48HR_DN
11.7647058824%	2	17	49	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_TCR_PATHWAY
11.7647058824%	2	17	47	Mendelian_Blood_Desease	JIANG_AGING_HYPOTHALAMUS_UP
11.7647058824%	2	17	466	Mendelian_Blood_Desease	REACTOME_HEMOSTASIS
11.7647058824%	2	17	463	Mendelian_Severe_Combined_Immunodeficiency	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
11.7647058824%	2	17	461	Mendelian_Blood_Desease	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
11.7647058824%	2	17	457	Mendelian_Severe_Combined_Immunodeficiency	SENESE_HDAC1_TARGETS_UP
11.7647058824%	2	17	457	Mendelian_Blood_Desease	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
11.7647058824%	2	17	455	Mendelian_Severe_Combined_Immunodeficiency	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
11.7647058824%	2	17	445	Mendelian_Severe_Combined_Immunodeficiency	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
11.7647058824%	2	17	435	Mendelian_Severe_Combined_Immunodeficiency	SWEET_LUNG_CANCER_KRAS_DN
11.7647058824%	2	17	43	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_IL_3_5_AND_GM_CSF_SIGNALING
11.7647058824%	2	17	423	Mendelian_Severe_Combined_Immunodeficiency	THUM_SYSTOLIC_HEART_FAILURE_UP
11.7647058824%	2	17	41	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_IL_2_SIGNALING
11.7647058824%	2	17	404	Mendelian_Severe_Combined_Immunodeficiency	OSMAN_BLADDER_CANCER_UP
11.7647058824%	2	17	398	Mendelian_Severe_Combined_Immunodeficiency	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
11.7647058824%	2	17	390	Mendelian_Severe_Combined_Immunodeficiency	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
11.7647058824%	2	17	390	Mendelian_Blood_Desease	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
11.7647058824%	2	17	384	Mendelian_Severe_Combined_Immunodeficiency	BASAKI_YBX1_TARGETS_DN
11.7647058824%	2	17	38	Mendelian_Severe_Combined_Immunodeficiency	FIGUEROA_AML_METHYLATION_CLUSTER_6_DN
11.7647058824%	2	17	38	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_IL2RB_PATHWAY
11.7647058824%	2	17	374	Mendelian_Blood_Desease	WANG_TUMOR_INVASIVENESS_UP
11.7647058824%	2	17	37	Mendelian_Blood_Desease	BILANGES_SERUM_RESPONSE_TRANSLATION
11.7647058824%	2	17	362	Mendelian_Severe_Combined_Immunodeficiency	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
11.7647058824%	2	17	36	Mendelian_Blood_Desease	JIANG_AGING_CEREBRAL_CORTEX_UP
11.7647058824%	2	17	358	Mendelian_Severe_Combined_Immunodeficiency	GRUETZMANN_PANCREATIC_CANCER_UP
11.7647058824%	2	17	358	Mendelian_Blood_Desease	GRUETZMANN_PANCREATIC_CANCER_UP
11.7647058824%	2	17	353	Mendelian_Severe_Combined_Immunodeficiency	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
11.7647058824%	2	17	352	Mendelian_Blood_Desease	WANG_LMO4_TARGETS_DN
11.7647058824%	2	17	34	Mendelian_Severe_Combined_Immunodeficiency	PID_IL2_PI3KPATHWAY
11.7647058824%	2	17	337	Mendelian_Severe_Combined_Immunodeficiency	PENG_GLUTAMINE_DEPRIVATION_DN
11.7647058824%	2	17	33	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_PURINE_METABOLISM
11.7647058824%	2	17	317	Mendelian_Blood_Desease	HELLER_HDAC_TARGETS_UP
11.7647058824%	2	17	309	Mendelian_Severe_Combined_Immunodeficiency	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
11.7647058824%	2	17	307	Mendelian_Severe_Combined_Immunodeficiency	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
11.7647058824%	2	17	30	Mendelian_Severe_Combined_Immunodeficiency	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP
11.7647058824%	2	17	30	Mendelian_Severe_Combined_Immunodeficiency	PID_IL2_STAT5PATHWAY
11.7647058824%	2	17	292	Mendelian_Severe_Combined_Immunodeficiency	HELLER_HDAC_TARGETS_DN
11.7647058824%	2	17	292	Mendelian_Blood_Desease	HELLER_HDAC_TARGETS_DN
11.7647058824%	2	17	285	Mendelian_Severe_Combined_Immunodeficiency	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
11.7647058824%	2	17	271	Mendelian_Blood_Desease	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
11.7647058824%	2	17	27	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_IL_RECEPTOR_SHC_SIGNALING
11.7647058824%	2	17	27	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES
11.7647058824%	2	17	267	Mendelian_Severe_Combined_Immunodeficiency	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
11.7647058824%	2	17	267	Mendelian_Severe_Combined_Immunodeficiency	HOLLMANN_APOPTOSIS_VIA_CD40_DN
11.7647058824%	2	17	26	Mendelian_Severe_Combined_Immunodeficiency	ST_INTERLEUKIN_4_PATHWAY
11.7647058824%	2	17	26	Mendelian_Blood_Desease	HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP
11.7647058824%	2	17	253	Mendelian_Severe_Combined_Immunodeficiency	MCLACHLAN_DENTAL_CARIES_UP
11.7647058824%	2	17	253	Mendelian_Blood_Desease	MCLACHLAN_DENTAL_CARIES_UP
11.7647058824%	2	17	252	Mendelian_Severe_Combined_Immunodeficiency	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
11.7647058824%	2	17	245	Mendelian_Severe_Combined_Immunodeficiency	PENG_RAPAMYCIN_RESPONSE_DN
11.7647058824%	2	17	245	Mendelian_Severe_Combined_Immunodeficiency	MCLACHLAN_DENTAL_CARIES_DN
11.7647058824%	2	17	245	Mendelian_Blood_Desease	PENG_RAPAMYCIN_RESPONSE_DN
11.7647058824%	2	17	245	Mendelian_Blood_Desease	MCLACHLAN_DENTAL_CARIES_DN
11.7647058824%	2	17	244	Mendelian_Severe_Combined_Immunodeficiency	KAYO_AGING_MUSCLE_UP
11.7647058824%	2	17	242	Mendelian_Severe_Combined_Immunodeficiency	WINTER_HYPOXIA_METAGENE
11.7647058824%	2	17	240	Mendelian_Blood_Desease	VANTVEER_BREAST_CANCER_ESR1_DN
11.7647058824%	2	17	24	Mendelian_Severe_Combined_Immunodeficiency	GOLUB_ALL_VS_AML_UP
11.7647058824%	2	17	232	Mendelian_Blood_Desease	DELYS_THYROID_CANCER_DN
11.7647058824%	2	17	228	Mendelian_Severe_Combined_Immunodeficiency	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
11.7647058824%	2	17	227	Mendelian_Severe_Combined_Immunodeficiency	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
11.7647058824%	2	17	226	Mendelian_Blood_Desease	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
11.7647058824%	2	17	223	Mendelian_Severe_Combined_Immunodeficiency	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
11.7647058824%	2	17	222	Mendelian_Blood_Desease	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
11.7647058824%	2	17	22	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_IL2_PATHWAY
11.7647058824%	2	17	215	Mendelian_Blood_Desease	MARKEY_RB1_ACUTE_LOF_UP
11.7647058824%	2	17	210	Mendelian_Severe_Combined_Immunodeficiency	VERHAAK_GLIOBLASTOMA_NEURAL
11.7647058824%	2	17	206	Mendelian_Severe_Combined_Immunodeficiency	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
11.7647058824%	2	17	203	Mendelian_Severe_Combined_Immunodeficiency	PENG_RAPAMYCIN_RESPONSE_UP
11.7647058824%	2	17	201	Mendelian_Blood_Desease	KIM_MYC_AMPLIFICATION_TARGETS_UP
11.7647058824%	2	17	198	Mendelian_Blood_Desease	ALONSO_METASTASIS_UP
11.7647058824%	2	17	1972	Mendelian_Blood_Desease	PILON_KLF1_TARGETS_DN
11.7647058824%	2	17	194	Mendelian_Severe_Combined_Immunodeficiency	KASLER_HDAC7_TARGETS_1_UP
11.7647058824%	2	17	184	Mendelian_Severe_Combined_Immunodeficiency	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
11.7647058824%	2	17	18	Mendelian_Severe_Combined_Immunodeficiency	SHIN_B_CELL_LYMPHOMA_CLUSTER_5
11.7647058824%	2	17	178	Mendelian_Blood_Desease	LI_AMPLIFIED_IN_LUNG_CANCER
11.7647058824%	2	17	176	Mendelian_Severe_Combined_Immunodeficiency	SASAKI_ADULT_T_CELL_LEUKEMIA
11.7647058824%	2	17	169	Mendelian_Severe_Combined_Immunodeficiency	UEDA_PERIFERAL_CLOCK
11.7647058824%	2	17	165	Mendelian_Blood_Desease	BROWN_MYELOID_CELL_DEVELOPMENT_UP
11.7647058824%	2	17	16	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS
11.7647058824%	2	17	16	Mendelian_Severe_Combined_Immunodeficiency	PID_DNAPK_PATHWAY
11.7647058824%	2	17	16	Mendelian_Severe_Combined_Immunodeficiency	FINETTI_BREAST_CANCER_KINOME_GREEN
11.7647058824%	2	17	142	Mendelian_Severe_Combined_Immunodeficiency	RUIZ_TNC_TARGETS_DN
11.7647058824%	2	17	14	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE
11.7647058824%	2	17	14	Mendelian_Severe_Combined_Immunodeficiency	KEGG_NON_HOMOLOGOUS_END_JOINING
11.7647058824%	2	17	14	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_THELPER_PATHWAY
11.7647058824%	2	17	14	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_TCYTOTOXIC_PATHWAY
11.7647058824%	2	17	1375	Mendelian_Severe_Combined_Immunodeficiency	DODD_NASOPHARYNGEAL_CARCINOMA_DN
11.7647058824%	2	17	134	Mendelian_Severe_Combined_Immunodeficiency	SCHLOSSER_SERUM_RESPONSE_UP
11.7647058824%	2	17	13	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_PURINE_SALVAGE
11.7647058824%	2	17	127	Mendelian_Blood_Desease	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
11.7647058824%	2	17	1210	Mendelian_Blood_Desease	CHEN_METABOLIC_SYNDROM_NETWORK
11.7647058824%	2	17	120	Mendelian_Severe_Combined_Immunodeficiency	ZHU_CMV_ALL_UP
11.7647058824%	2	17	120	Mendelian_Blood_Desease	NIKOLSKY_BREAST_CANCER_16P13_AMPLICON
11.7647058824%	2	17	116	Mendelian_Severe_Combined_Immunodeficiency	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
11.7647058824%	2	17	116	Mendelian_Blood_Desease	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
11.7647058824%	2	17	115	Mendelian_Blood_Desease	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
11.7647058824%	2	17	1118	Mendelian_Blood_Desease	BENPORATH_ES_WITH_H3K27ME3
11.7647058824%	2	17	11	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_IL4_PATHWAY
11.7647058824%	2	17	108	Mendelian_Severe_Combined_Immunodeficiency	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
11.7647058824%	2	17	107	Mendelian_Severe_Combined_Immunodeficiency	LEE_EARLY_T_LYMPHOCYTE_UP
11.7647058824%	2	17	1062	Mendelian_Blood_Desease	BENPORATH_EED_TARGETS
11.7647058824%	2	17	105	Mendelian_Blood_Desease	HELLER_SILENCED_BY_METHYLATION_DN
11.7647058824%	2	17	1038	Mendelian_Blood_Desease	BENPORATH_SUZ12_TARGETS
11.7647058824%	2	17	1024	Mendelian_Blood_Desease	NUYTTEN_EZH2_TARGETS_DN
11.7647058824%	2	17	102	Mendelian_Severe_Combined_Immunodeficiency	PID_CXCR4_PATHWAY
11.7647058824%	2	17	1011	Mendelian_Blood_Desease	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
11.7647058824%	2	17	101	Mendelian_Severe_Combined_Immunodeficiency	WIELAND_UP_BY_HBV_INFECTION
11.7647058824%	2	17	10	Mendelian_Severe_Combined_Immunodeficiency	SHANK_TAL1_TARGETS_DN
11.6514690983%	230	1974	1781	Mendelian_Nancy_Cox	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
11.5384615385%	3	26	957	Diabetes_McGill_Set_Wnt_pathway	LOPEZ_MBD_TARGETS
11.5384615385%	3	26	93	Diabetes_McGill_Set_Wnt_pathway	REACTOME_ACTIVATED_TLR4_SIGNALLING
11.5384615385%	3	26	920	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SIGNALING_BY_GPCR
11.5384615385%	3	26	893	Diabetes_McGill_Set_Wnt_pathway	GEORGES_TARGETS_OF_MIR192_AND_MIR215
11.5384615385%	3	26	882	Diabetes_McGill_Set_Wnt_pathway	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
11.5384615385%	3	26	88	Diabetes_McGill_Set_Wnt_pathway	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
11.5384615385%	3	26	871	Diabetes_McGill_Set_Wnt_pathway	GRADE_COLON_CANCER_UP
11.5384615385%	3	26	87	Diabetes_McGill_Set_Wnt_pathway	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
11.5384615385%	3	26	83	Diabetes_McGill_Set_Wnt_pathway	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
11.5384615385%	3	26	82	Diabetes_McGill_Set_Wnt_pathway	PID_REG_GR_PATHWAY
11.5384615385%	3	26	80	Diabetes_McGill_GPCRs_expressed_in_beta_cell	LEE_AGING_NEOCORTEX_DN
11.5384615385%	3	26	79	Diabetes_McGill_Set_Wnt_pathway	PID_MYC_ACTIVPATHWAY
11.5384615385%	3	26	770	Diabetes_McGill_Set_Wnt_pathway	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
11.5384615385%	3	26	77	Diabetes_McGill_Set_Wnt_pathway	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
11.5384615385%	3	26	75	Diabetes_McGill_Set_Wnt_pathway	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
11.5384615385%	3	26	74	Diabetes_McGill_Set_Wnt_pathway	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
11.5384615385%	3	26	74	Diabetes_McGill_Set_Wnt_pathway	PID_E2F_PATHWAY
11.5384615385%	3	26	72	Diabetes_McGill_Set_Wnt_pathway	SESTO_RESPONSE_TO_UV_C1
11.5384615385%	3	26	72	Diabetes_McGill_Set_Wnt_pathway	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
11.5384615385%	3	26	70	Diabetes_McGill_Set_Wnt_pathway	PID_CDC42_PATHWAY
11.5384615385%	3	26	70	Diabetes_McGill_Set_Wnt_pathway	PID_AP1_PATHWAY
11.5384615385%	3	26	68	Diabetes_McGill_Set_Wnt_pathway	PID_TELOMERASEPATHWAY
11.5384615385%	3	26	673	Diabetes_McGill_Set_Wnt_pathway	MARTINEZ_RB1_TARGETS_UP
11.5384615385%	3	26	64	Diabetes_McGill_Set_Wnt_pathway	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
11.5384615385%	3	26	63	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
11.5384615385%	3	26	601	Diabetes_McGill_Set_Wnt_pathway	MARTINEZ_RB1_AND_TP53_TARGETS_UP
11.5384615385%	3	26	593	Diabetes_McGill_Set_Wnt_pathway	MARTINEZ_TP53_TARGETS_DN
11.5384615385%	3	26	590	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
11.5384615385%	3	26	58	Diabetes_McGill_Set_Wnt_pathway	SCHEIDEREIT_IKK_INTERACTING_PROTEINS
11.5384615385%	3	26	56	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_NFAT_PATHWAY
11.5384615385%	3	26	546	Diabetes_McGill_Set_Wnt_pathway	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
11.5384615385%	3	26	546	Diabetes_McGill_GPCRs_expressed_in_beta_cell	WEST_ADRENOCORTICAL_TUMOR_DN
11.5384615385%	3	26	544	Diabetes_McGill_Set_Wnt_pathway	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
11.5384615385%	3	26	539	Diabetes_McGill_Set_Wnt_pathway	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
11.5384615385%	3	26	53	Diabetes_McGill_Set_Wnt_pathway	REACTOME_CIRCADIAN_CLOCK
11.5384615385%	3	26	53	Diabetes_McGill_Set_Wnt_pathway	PID_AR_TF_PATHWAY
11.5384615385%	3	26	504	Diabetes_McGill_Set_Wnt_pathway	PILON_KLF1_TARGETS_UP
11.5384615385%	3	26	50	Diabetes_McGill_Set_Wnt_pathway	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
11.5384615385%	3	26	47	Diabetes_McGill_Set_Wnt_pathway	PID_LKB1_PATHWAY
11.5384615385%	3	26	466	Diabetes_McGill_Set_Wnt_pathway	REACTOME_HEMOSTASIS
11.5384615385%	3	26	466	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_HEMOSTASIS
11.5384615385%	3	26	45	Diabetes_McGill_Set_Wnt_pathway	PID_ILK_PATHWAY
11.5384615385%	3	26	431	Diabetes_McGill_Set_Wnt_pathway	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
11.5384615385%	3	26	431	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
11.5384615385%	3	26	423	Diabetes_McGill_Set_Wnt_pathway	PUJANA_BRCA2_PCC_NETWORK
11.5384615385%	3	26	40	Diabetes_McGill_Set_Wnt_pathway	PID_FOXM1PATHWAY
11.5384615385%	3	26	39	Diabetes_McGill_Set_Wnt_pathway	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2
11.5384615385%	3	26	39	Diabetes_McGill_Set_Wnt_pathway	REACTOME_IL1_SIGNALING
11.5384615385%	3	26	39	Diabetes_McGill_Set_Wnt_pathway	PID_ECADHERIN_NASCENTAJ_PATHWAY
11.5384615385%	3	26	380	Diabetes_McGill_Set_Wnt_pathway	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
11.5384615385%	3	26	38	Diabetes_McGill_Set_Wnt_pathway	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER
11.5384615385%	3	26	368	Diabetes_McGill_Set_Wnt_pathway	YAGI_AML_WITH_T_8_21_TRANSLOCATION
11.5384615385%	3	26	364	Diabetes_McGill_GPCRs_expressed_in_beta_cell	YANG_BCL3_TARGETS_UP
11.5384615385%	3	26	357	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SHEN_SMARCA2_TARGETS_DN
11.5384615385%	3	26	35	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_CARM_ER_PATHWAY
11.5384615385%	3	26	335	Diabetes_McGill_Set_Wnt_pathway	WONG_EMBRYONIC_STEM_CELL_CORE
11.5384615385%	3	26	332	Diabetes_McGill_GPCRs_expressed_in_beta_cell	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
11.5384615385%	3	26	305	Diabetes_McGill_Set_Wnt_pathway	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
11.5384615385%	3	26	299	Diabetes_McGill_Set_Wnt_pathway	MUELLER_PLURINET
11.5384615385%	3	26	28	Diabetes_McGill_Set_Wnt_pathway	PID_WNT_SIGNALING_PATHWAY
11.5384615385%	3	26	270	Diabetes_McGill_Set_Wnt_pathway	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
11.5384615385%	3	26	27	Diabetes_McGill_Set_Wnt_pathway	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
11.5384615385%	3	26	27	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION
11.5384615385%	3	26	253	Diabetes_McGill_Set_Wnt_pathway	DANG_REGULATED_BY_MYC_DN
11.5384615385%	3	26	24	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_NTHI_PATHWAY
11.5384615385%	3	26	230	Diabetes_McGill_Set_Wnt_pathway	BENPORATH_MYC_TARGETS_WITH_EBOX
11.5384615385%	3	26	23	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_CTCF_PATHWAY
11.5384615385%	3	26	22	Diabetes_McGill_Set_Wnt_pathway	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER
11.5384615385%	3	26	22	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
11.5384615385%	3	26	217	Diabetes_McGill_Set_Wnt_pathway	SANSOM_APC_MYC_TARGETS
11.5384615385%	3	26	214	Diabetes_McGill_Set_Wnt_pathway	KIM_WT1_TARGETS_UP
11.5384615385%	3	26	208	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
11.5384615385%	3	26	206	Diabetes_McGill_Set_Wnt_pathway	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
11.5384615385%	3	26	201	Diabetes_McGill_Set_Wnt_pathway	KEGG_FOCAL_ADHESION
11.5384615385%	3	26	19	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1
11.5384615385%	3	26	1839	Diabetes_McGill_Set_Wnt_pathway	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
11.5384615385%	3	26	1725	Diabetes_McGill_Set_Wnt_pathway	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
11.5384615385%	3	26	1652	Diabetes_McGill_Set_Wnt_pathway	PUJANA_BRCA1_PCC_NETWORK
11.5384615385%	3	26	155	Diabetes_McGill_Set_Wnt_pathway	KEGG_JAK_STAT_SIGNALING_PATHWAY
11.5384615385%	3	26	147	Diabetes_McGill_Set_Wnt_pathway	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
11.5384615385%	3	26	134	Diabetes_McGill_Set_Wnt_pathway	KEGG_TIGHT_JUNCTION
11.5384615385%	3	26	128	Diabetes_McGill_Set_Wnt_pathway	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
11.5384615385%	3	26	118	Diabetes_McGill_Set_Wnt_pathway	REACTOME_TOLL_RECEPTOR_CASCADES
11.5384615385%	3	26	1174	Diabetes_McGill_GPCRs_expressed_in_beta_cell	PEREZ_TP53_TARGETS
11.5384615385%	3	26	117	Diabetes_McGill_Set_Wnt_pathway	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
11.5384615385%	3	26	107	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SIGNALING_BY_ILS
11.4624505929%	29	253	712	Diabetes_McGill_CREBBP_coTF	SCHLOSSER_SERUM_RESPONSE_DN
11.4624505929%	29	253	1375	Diabetes_McGill_CREBBP_coTF	DODD_NASOPHARYNGEAL_CARCINOMA_DN
11.4624505929%	29	253	1142	Diabetes_McGill_CREBBP_coTF	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
11.4488348531%	226	1974	1652	Mendelian_Nancy_Cox	PUJANA_BRCA1_PCC_NETWORK
11.4285714286%	8	70	85	Diabetes_McGill_Adipocytokine_signallin	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
11.4285714286%	8	70	824	Diabetes_McGill_Adipocytokine_signallin	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
11.4285714286%	8	70	82	Diabetes_McGill_Adipocytokine_signallin	PID_REG_GR_PATHWAY
11.4285714286%	8	70	682	Diabetes_McGill_Adipocytokine_signallin	FEVR_CTNNB1_TARGETS_UP
11.4285714286%	8	70	67	Diabetes_McGill_Adipocytokine_signallin	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
11.4285714286%	8	70	65	Diabetes_McGill_Adipocytokine_signallin	ST_FAS_SIGNALING_PATHWAY
11.4285714286%	8	70	62	Diabetes_McGill_Adipocytokine_signallin	PID_FCER1PATHWAY
11.4285714286%	8	70	58	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_PPARA_PATHWAY
11.4285714286%	8	70	567	Diabetes_McGill_Adipocytokine_signallin	PARENT_MTOR_SIGNALING_UP
11.4285714286%	8	70	44	Diabetes_McGill_Adipocytokine_signallin	PID_ERBB2ERBB3PATHWAY
11.4285714286%	8	70	429	Diabetes_McGill_Adipocytokine_signallin	MOOTHA_HUMAN_MITODB_6_2002
11.4285714286%	8	70	42	Diabetes_McGill_Adipocytokine_signallin	KEGG_FATTY_ACID_METABOLISM
11.4285714286%	8	70	37	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_TOLL_PATHWAY
11.4285714286%	8	70	31	Diabetes_McGill_Adipocytokine_signallin	PID_CD40_PATHWAY
11.4285714286%	8	70	28	Diabetes_McGill_Adipocytokine_signallin	ST_GAQ_PATHWAY
11.4285714286%	8	70	23	Diabetes_McGill_Adipocytokine_signallin	PID_NFKAPPABCANONICALPATHWAY
11.4285714286%	8	70	19	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_TID_PATHWAY
11.4285714286%	8	70	18	Diabetes_McGill_Adipocytokine_signallin	REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK
11.4285714286%	8	70	18	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_TNFR2_PATHWAY
11.4285714286%	8	70	15	Diabetes_McGill_Adipocytokine_signallin	REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1
11.4285714286%	8	70	14	Diabetes_McGill_Adipocytokine_signallin	GILMORE_CORE_NFKB_PATHWAY
11.4285714286%	8	70	137	Diabetes_McGill_Adipocytokine_signallin	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
11.2903225806%	14	124	973	Diabetes_McGill_Cell_cycle_All_Gene	ACEVEDO_LIVER_CANCER_UP
11.2903225806%	14	124	712	Diabetes_McGill_Cell_cycle_All_Gene	SCHLOSSER_SERUM_RESPONSE_DN
11.2903225806%	14	124	59	Diabetes_McGill_Cell_cycle_All_Gene	PID_P53REGULATIONPATHWAY
11.2903225806%	14	124	364	Diabetes_McGill_Cell_cycle_All_Gene	YANG_BCL3_TARGETS_UP
11.2903225806%	14	124	318	Diabetes_McGill_Cell_cycle_All_Gene	DAZARD_RESPONSE_TO_UV_NHEK_DN
11.2903225806%	14	124	309	Diabetes_McGill_Cell_cycle_All_Gene	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
11.2903225806%	14	124	294	Diabetes_McGill_Cell_cycle_All_Gene	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
11.2903225806%	14	124	29	Diabetes_McGill_Cell_cycle_All_Gene	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
11.2903225806%	14	124	26	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B
11.2903225806%	14	124	23	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_PHOSPHORYLATION_OF_THE_APC_C
11.2903225806%	14	124	229	Diabetes_McGill_Cell_cycle_All_Gene	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
11.2903225806%	14	124	214	Diabetes_McGill_Cell_cycle_All_Gene	BIDUS_METASTASIS_UP
11.2903225806%	14	124	175	Diabetes_McGill_Cell_cycle_All_Gene	LEE_LIVER_CANCER_SURVIVAL_DN
11.2903225806%	14	124	151	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_WNT_SIGNALING_PATHWAY
11.2903225806%	14	124	1210	Diabetes_McGill_Cell_cycle_All_Gene	CHEN_METABOLIC_SYNDROM_NETWORK
11.1955420466%	221	1974	1382	Mendelian_Nancy_Cox	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
11.1951588502%	74	661	1691	T2D_GENES_TANYA_GLYCEMIC	BLALOCK_ALZHEIMERS_DISEASE_UP
11.1111111111%	9	81	93	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_REGULATION_OF_INSULIN_SECRETION
11.1111111111%	9	81	510	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
11.1111111111%	9	81	478	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
11.1111111111%	9	81	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_TYPE_II_DIABETES_MELLITUS
11.1111111111%	9	81	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
11.1111111111%	9	81	1821	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DODD_NASOPHARYNGEAL_CARCINOMA_UP
11.1111111111%	9	81	1781	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
11.1111111111%	9	81	1237	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BLALOCK_ALZHEIMERS_DISEASE_DN
11.1111111111%	9	81	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
11.1111111111%	3	27	882	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
11.1111111111%	3	27	87	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
11.1111111111%	3	27	81	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HARRIS_HYPOXIA
11.1111111111%	3	27	800	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
11.1111111111%	3	27	779	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PUJANA_CHEK2_PCC_NETWORK
11.1111111111%	3	27	775	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BENPORATH_MYC_MAX_TARGETS
11.1111111111%	3	27	682	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FEVR_CTNNB1_TARGETS_UP
11.1111111111%	3	27	663	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
11.1111111111%	3	27	66	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PID_HIF1_TFPATHWAY
11.1111111111%	3	27	63	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MODY_HIPPOCAMPUS_POSTNATAL
11.1111111111%	3	27	584	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
11.1111111111%	3	27	555	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
11.1111111111%	3	27	517	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
11.1111111111%	3	27	501	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SENESE_HDAC3_TARGETS_UP
11.1111111111%	3	27	473	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GARY_CD5_TARGETS_UP
11.1111111111%	3	27	47	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_TYPE_II_DIABETES_MELLITUS
11.1111111111%	3	27	413	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
11.1111111111%	3	27	408	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
11.1111111111%	3	27	380	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MULLIGHAN_MLL_SIGNATURE_1_UP
11.1111111111%	3	27	38	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_GLUCOSE_TRANSPORT
11.1111111111%	3	27	362	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
11.1111111111%	3	27	36	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SEMENZA_HIF1_TARGETS
11.1111111111%	3	27	351	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	YAGI_AML_WITH_11Q23_REARRANGED
11.1111111111%	3	27	33	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_PROPANOATE_METABOLISM
11.1111111111%	3	27	311	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	JIANG_HYPOXIA_NORMAL
11.1111111111%	3	27	309	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
11.1111111111%	3	27	261	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RICKMAN_METASTASIS_DN
11.1111111111%	3	27	261	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BILD_HRAS_ONCOGENIC_SIGNATURE
11.1111111111%	3	27	242	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WINTER_HYPOXIA_METAGENE
11.1111111111%	3	27	241	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
11.1111111111%	3	27	200	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
11.1111111111%	3	27	1972	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PILON_KLF1_TARGETS_DN
11.1111111111%	3	27	196	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
11.1111111111%	3	27	1781	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
11.1111111111%	3	27	178	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LI_AMPLIFIED_IN_LUNG_CANCER
11.1111111111%	3	27	1691	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BLALOCK_ALZHEIMERS_DISEASE_UP
11.1111111111%	3	27	165	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
11.1111111111%	3	27	1442	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PUJANA_ATM_PCC_NETWORK
11.1111111111%	3	27	126	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BURTON_ADIPOGENESIS_5
11.1111111111%	3	27	117	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
11.1111111111%	3	27	113	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
11.1111111111%	3	27	102	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
11.1111111111%	1	9	99	Mendelian_Immune	LIM_MAMMARY_LUMINAL_MATURE_DN
11.1111111111%	1	9	98	Mendelian_Immune	GAVIN_FOXP3_TARGETS_CLUSTER_T7
11.1111111111%	1	9	97	Mendelian_Immune	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
11.1111111111%	1	9	957	Mendelian_Immune	LOPEZ_MBD_TARGETS
11.1111111111%	1	9	95	Mendelian_Immune	KAYO_CALORIE_RESTRICTION_MUSCLE_UP
11.1111111111%	1	9	940	Mendelian_Immune	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
11.1111111111%	1	9	94	Mendelian_Immune	LU_IL4_SIGNALING
11.1111111111%	1	9	92	Mendelian_Immune	DE_YY1_TARGETS_DN
11.1111111111%	1	9	90	Mendelian_Immune	MORI_MATURE_B_LYMPHOCYTE_UP
11.1111111111%	1	9	90	Mendelian_Immune	GAVIN_FOXP3_TARGETS_CLUSTER_P7
11.1111111111%	1	9	9	Mendelian_Immune	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN
11.1111111111%	1	9	89	Mendelian_Immune	VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP
11.1111111111%	1	9	89	Mendelian_Immune	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
11.1111111111%	1	9	88	Mendelian_Immune	ALCALA_APOPTOSIS
11.1111111111%	1	9	871	Mendelian_Immune	GRADE_COLON_CANCER_UP
11.1111111111%	1	9	87	Mendelian_Immune	SAFFORD_T_LYMPHOCYTE_ANERGY
11.1111111111%	1	9	84	Mendelian_Immune	SWEET_KRAS_TARGETS_UP
11.1111111111%	1	9	84	Mendelian_Immune	RASHI_RESPONSE_TO_IONIZING_RADIATION_6
11.1111111111%	1	9	830	Mendelian_Immune	CUI_TCF21_TARGETS_2_DN
11.1111111111%	1	9	83	Mendelian_Immune	WARTERS_RESPONSE_TO_IR_SKIN
11.1111111111%	1	9	811	Mendelian_Immune	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
11.1111111111%	1	9	81	Mendelian_Immune	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
11.1111111111%	1	9	79	Mendelian_Immune	PID_P73PATHWAY
11.1111111111%	1	9	784	Mendelian_Immune	FORTSCHEGGER_PHF8_TARGETS_DN
11.1111111111%	1	9	783	Mendelian_Immune	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
11.1111111111%	1	9	78	Mendelian_Immune	BOYLAN_MULTIPLE_MYELOMA_D_DN
11.1111111111%	1	9	775	Mendelian_Immune	BENPORATH_MYC_MAX_TARGETS
11.1111111111%	1	9	770	Mendelian_Immune	KRIEG_HYPOXIA_NOT_VIA_KDM3A
11.1111111111%	1	9	77	Mendelian_Immune	SEKI_INFLAMMATORY_RESPONSE_LPS_UP
11.1111111111%	1	9	77	Mendelian_Immune	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
11.1111111111%	1	9	76	Mendelian_Immune	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
11.1111111111%	1	9	74	Mendelian_Immune	POTTI_ADRIAMYCIN_SENSITIVITY
11.1111111111%	1	9	74	Mendelian_Immune	DER_IFN_ALPHA_RESPONSE_UP
11.1111111111%	1	9	73	Mendelian_Immune	KEGG_VIRAL_MYOCARDITIS
11.1111111111%	1	9	722	Mendelian_Immune	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
11.1111111111%	1	9	712	Mendelian_Immune	SCHLOSSER_SERUM_RESPONSE_DN
11.1111111111%	1	9	71	Mendelian_Immune	DER_IFN_GAMMA_RESPONSE_UP
11.1111111111%	1	9	70	Mendelian_Immune	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
11.1111111111%	1	9	70	Mendelian_Immune	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
11.1111111111%	1	9	69	Mendelian_Immune	KEGG_P53_SIGNALING_PATHWAY
11.1111111111%	1	9	68	Mendelian_Immune	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
11.1111111111%	1	9	68	Mendelian_Immune	BASSO_CD40_SIGNALING_DN
11.1111111111%	1	9	673	Mendelian_Immune	MARTINEZ_RB1_TARGETS_UP
11.1111111111%	1	9	67	Mendelian_Immune	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
11.1111111111%	1	9	66	Mendelian_Immune	MARSON_FOXP3_TARGETS_UP
11.1111111111%	1	9	65	Mendelian_Immune	ST_FAS_SIGNALING_PATHWAY
11.1111111111%	1	9	65	Mendelian_Immune	PID_IL4_2PATHWAY
11.1111111111%	1	9	65	Mendelian_Immune	PID_CD8TCRDOWNSTREAMPATHWAY
11.1111111111%	1	9	64	Mendelian_Immune	BYSTROEM_CORRELATED_WITH_IL5_DN
11.1111111111%	1	9	63	Mendelian_Immune	PID_IL12_2PATHWAY
11.1111111111%	1	9	612	Mendelian_Immune	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
11.1111111111%	1	9	602	Mendelian_Immune	MARTINEZ_TP53_TARGETS_UP
11.1111111111%	1	9	601	Mendelian_Immune	MARTINEZ_RB1_AND_TP53_TARGETS_UP
11.1111111111%	1	9	59	Mendelian_Immune	BARIS_THYROID_CANCER_DN
11.1111111111%	1	9	584	Mendelian_Immune	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
11.1111111111%	1	9	58	Mendelian_Immune	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
11.1111111111%	1	9	58	Mendelian_Immune	KANNAN_TP53_TARGETS_UP
11.1111111111%	1	9	579	Mendelian_Immune	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
11.1111111111%	1	9	578	Mendelian_Immune	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
11.1111111111%	1	9	56	Mendelian_Immune	WORSCHECH_TUMOR_REJECTION_UP
11.1111111111%	1	9	552	Mendelian_Immune	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
11.1111111111%	1	9	55	Mendelian_Immune	LAU_APOPTOSIS_CDKN2A_UP
11.1111111111%	1	9	549	Mendelian_Immune	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
11.1111111111%	1	9	544	Mendelian_Immune	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
11.1111111111%	1	9	54	Mendelian_Immune	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP
11.1111111111%	1	9	54	Mendelian_Immune	PID_TAP63PATHWAY
11.1111111111%	1	9	536	Mendelian_Immune	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
11.1111111111%	1	9	530	Mendelian_Immune	ENK_UV_RESPONSE_KERATINOCYTE_UP
11.1111111111%	1	9	53	Mendelian_Immune	SMIRNOV_RESPONSE_TO_IR_2HR_UP
11.1111111111%	1	9	53	Mendelian_Immune	NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON
11.1111111111%	1	9	52	Mendelian_Immune	ROSS_AML_WITH_CBFB_MYH11_FUSION
11.1111111111%	1	9	52	Mendelian_Immune	HALMOS_CEBPA_TARGETS_UP
11.1111111111%	1	9	51	Mendelian_Immune	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
11.1111111111%	1	9	51	Mendelian_Immune	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
11.1111111111%	1	9	51	Mendelian_Immune	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
11.1111111111%	1	9	51	Mendelian_Immune	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
11.1111111111%	1	9	505	Mendelian_Immune	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
11.1111111111%	1	9	501	Mendelian_Immune	SENESE_HDAC3_TARGETS_UP
11.1111111111%	1	9	50	Mendelian_Immune	PARK_APL_PATHOGENESIS_DN
11.1111111111%	1	9	50	Mendelian_Immune	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
11.1111111111%	1	9	5	Mendelian_Immune	CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP
11.1111111111%	1	9	491	Mendelian_Immune	SWEET_LUNG_CANCER_KRAS_UP
11.1111111111%	1	9	49	Mendelian_Immune	PID_FOXOPATHWAY
11.1111111111%	1	9	49	Mendelian_Immune	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
11.1111111111%	1	9	489	Mendelian_Immune	LIM_MAMMARY_STEM_CELL_UP
11.1111111111%	1	9	487	Mendelian_Immune	RODWELL_AGING_KIDNEY_UP
11.1111111111%	1	9	48	Mendelian_Immune	KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
11.1111111111%	1	9	48	Mendelian_Immune	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
11.1111111111%	1	9	475	Mendelian_Immune	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
11.1111111111%	1	9	47	Mendelian_Immune	WARTERS_IR_RESPONSE_5GY
11.1111111111%	1	9	47	Mendelian_Immune	KHETCHOUMIAN_TRIM24_TARGETS_UP
11.1111111111%	1	9	464	Mendelian_Immune	ONDER_CDH1_TARGETS_2_DN
11.1111111111%	1	9	463	Mendelian_Immune	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
11.1111111111%	1	9	460	Mendelian_Immune	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
11.1111111111%	1	9	457	Mendelian_Immune	SENESE_HDAC1_TARGETS_UP
11.1111111111%	1	9	456	Mendelian_Immune	ODONNELL_TFRC_TARGETS_UP
11.1111111111%	1	9	455	Mendelian_Immune	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
11.1111111111%	1	9	45	Mendelian_Immune	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN
11.1111111111%	1	9	45	Mendelian_Immune	KLEIN_TARGETS_OF_BCR_ABL1_FUSION
11.1111111111%	1	9	445	Mendelian_Immune	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
11.1111111111%	1	9	44	Mendelian_Immune	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS
11.1111111111%	1	9	44	Mendelian_Immune	KERLEY_RESPONSE_TO_CISPLATIN_UP
11.1111111111%	1	9	435	Mendelian_Immune	SWEET_LUNG_CANCER_KRAS_DN
11.1111111111%	1	9	435	Mendelian_Immune	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
11.1111111111%	1	9	431	Mendelian_Immune	GARY_CD5_TARGETS_DN
11.1111111111%	1	9	43	Mendelian_Immune	FUJII_YBX1_TARGETS_UP
11.1111111111%	1	9	428	Mendelian_Immune	CUI_TCF21_TARGETS_2_UP
11.1111111111%	1	9	423	Mendelian_Immune	THUM_SYSTOLIC_HEART_FAILURE_UP
11.1111111111%	1	9	42	Mendelian_Immune	ONO_FOXP3_TARGETS_DN
11.1111111111%	1	9	42	Mendelian_Immune	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP
11.1111111111%	1	9	418	Mendelian_Immune	RUTELLA_RESPONSE_TO_HGF_UP
11.1111111111%	1	9	418	Mendelian_Immune	PEDRIOLI_MIR31_TARGETS_DN
11.1111111111%	1	9	418	Mendelian_Immune	MULLIGHAN_MLL_SIGNATURE_2_UP
11.1111111111%	1	9	411	Mendelian_Immune	KOYAMA_SEMA3B_TARGETS_DN
11.1111111111%	1	9	41	Mendelian_Immune	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN
11.1111111111%	1	9	409	Mendelian_Immune	FOSTER_TOLERANT_MACROPHAGE_DN
11.1111111111%	1	9	408	Mendelian_Immune	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
11.1111111111%	1	9	404	Mendelian_Immune	OSMAN_BLADDER_CANCER_UP
11.1111111111%	1	9	40	Mendelian_Immune	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP
11.1111111111%	1	9	398	Mendelian_Immune	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
11.1111111111%	1	9	392	Mendelian_Immune	LINDGREN_BLADDER_CANCER_CLUSTER_2B
11.1111111111%	1	9	39	Mendelian_Immune	HAN_JNK_SINGALING_DN
11.1111111111%	1	9	39	Mendelian_Immune	BIOCARTA_FMLP_PATHWAY
11.1111111111%	1	9	389	Mendelian_Immune	HSIAO_HOUSEKEEPING_GENES
11.1111111111%	1	9	380	Mendelian_Immune	MULLIGHAN_MLL_SIGNATURE_1_UP
11.1111111111%	1	9	38	Mendelian_Immune	ONGUSAHA_TP53_TARGETS
11.1111111111%	1	9	38	Mendelian_Immune	CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN
11.1111111111%	1	9	374	Mendelian_Immune	WANG_TUMOR_INVASIVENESS_UP
11.1111111111%	1	9	374	Mendelian_Immune	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
11.1111111111%	1	9	366	Mendelian_Immune	SANSOM_APC_TARGETS_DN
11.1111111111%	1	9	36	Mendelian_Immune	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
11.1111111111%	1	9	36	Mendelian_Immune	MARZEC_IL2_SIGNALING_DN
11.1111111111%	1	9	357	Mendelian_Immune	SHEN_SMARCA2_TARGETS_DN
11.1111111111%	1	9	351	Mendelian_Immune	YAGI_AML_WITH_11Q23_REARRANGED
11.1111111111%	1	9	351	Mendelian_Immune	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
11.1111111111%	1	9	35	Mendelian_Immune	SCHRAETS_MLL_TARGETS_UP
11.1111111111%	1	9	335	Mendelian_Immune	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
11.1111111111%	1	9	323	Mendelian_Immune	GRESHOCK_CANCER_COPY_NUMBER_UP
11.1111111111%	1	9	321	Mendelian_Immune	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
11.1111111111%	1	9	320	Mendelian_Immune	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
11.1111111111%	1	9	32	Mendelian_Immune	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP
11.1111111111%	1	9	317	Mendelian_Immune	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
11.1111111111%	1	9	315	Mendelian_Immune	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
11.1111111111%	1	9	315	Mendelian_Immune	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
11.1111111111%	1	9	31	Mendelian_Immune	PID_CD40_PATHWAY
11.1111111111%	1	9	309	Mendelian_Immune	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
11.1111111111%	1	9	307	Mendelian_Immune	LI_INDUCED_T_TO_NATURAL_KILLER_UP
11.1111111111%	1	9	30	Mendelian_Immune	PID_IL2_STAT5PATHWAY
11.1111111111%	1	9	30	Mendelian_Immune	KEGG_ASTHMA
11.1111111111%	1	9	298	Mendelian_Immune	BROWNE_HCMV_INFECTION_14HR_DN
11.1111111111%	1	9	294	Mendelian_Immune	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
11.1111111111%	1	9	293	Mendelian_Immune	IVANOVA_HEMATOPOIESIS_MATURE_CELL
11.1111111111%	1	9	292	Mendelian_Immune	HELLER_HDAC_TARGETS_DN
11.1111111111%	1	9	29	Mendelian_Immune	WATANABE_COLON_CANCER_MSI_VS_MSS_UP
11.1111111111%	1	9	29	Mendelian_Immune	WANG_RESPONSE_TO_BEXAROTENE_DN
11.1111111111%	1	9	29	Mendelian_Immune	PID_INTEGRIN2_PATHWAY
11.1111111111%	1	9	29	Mendelian_Immune	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
11.1111111111%	1	9	29	Mendelian_Immune	BIOCARTA_NKT_PATHWAY
11.1111111111%	1	9	289	Mendelian_Immune	WANG_MLL_TARGETS
11.1111111111%	1	9	288	Mendelian_Immune	POOLA_INVASIVE_BREAST_CANCER_UP
11.1111111111%	1	9	281	Mendelian_Immune	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
11.1111111111%	1	9	28	Mendelian_Immune	KAMIKUBO_MYELOID_CEBPA_NETWORK
11.1111111111%	1	9	28	Mendelian_Immune	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
11.1111111111%	1	9	276	Mendelian_Immune	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
11.1111111111%	1	9	27	Mendelian_Immune	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
11.1111111111%	1	9	27	Mendelian_Immune	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN
11.1111111111%	1	9	266	Mendelian_Immune	ROZANOV_MMP14_TARGETS_UP
11.1111111111%	1	9	261	Mendelian_Immune	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
11.1111111111%	1	9	26	Mendelian_Immune	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
11.1111111111%	1	9	26	Mendelian_Immune	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
11.1111111111%	1	9	259	Mendelian_Immune	QI_PLASMACYTOMA_UP
11.1111111111%	1	9	259	Mendelian_Immune	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
11.1111111111%	1	9	253	Mendelian_Immune	DANG_REGULATED_BY_MYC_DN
11.1111111111%	1	9	25	Mendelian_Immune	LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS
11.1111111111%	1	9	25	Mendelian_Immune	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP
11.1111111111%	1	9	245	Mendelian_Immune	KONDO_EZH2_TARGETS
11.1111111111%	1	9	244	Mendelian_Immune	KAYO_AGING_MUSCLE_UP
11.1111111111%	1	9	244	Mendelian_Immune	GAL_LEUKEMIC_STEM_CELL_DN
11.1111111111%	1	9	244	Mendelian_Immune	DAZARD_RESPONSE_TO_UV_NHEK_UP
11.1111111111%	1	9	240	Mendelian_Immune	UDAYAKUMAR_MED1_TARGETS_DN
11.1111111111%	1	9	24	Mendelian_Immune	YIH_RESPONSE_TO_ARSENITE_C1
11.1111111111%	1	9	24	Mendelian_Immune	ONO_AML1_TARGETS_UP
11.1111111111%	1	9	24	Mendelian_Immune	JEON_SMAD6_TARGETS_UP
11.1111111111%	1	9	239	Mendelian_Immune	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
11.1111111111%	1	9	23	Mendelian_Immune	WU_HBX_TARGETS_2_UP
11.1111111111%	1	9	23	Mendelian_Immune	BIOCARTA_RAC1_PATHWAY
11.1111111111%	1	9	228	Mendelian_Immune	MARKEY_RB1_ACUTE_LOF_DN
11.1111111111%	1	9	226	Mendelian_Immune	KYNG_DNA_DAMAGE_UP
11.1111111111%	1	9	225	Mendelian_Immune	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
11.1111111111%	1	9	222	Mendelian_Immune	CAIRO_LIVER_DEVELOPMENT_DN
11.1111111111%	1	9	22	Mendelian_Immune	BIOCARTA_AKT_PATHWAY
11.1111111111%	1	9	217	Mendelian_Immune	WIERENGA_STAT5A_TARGETS_UP
11.1111111111%	1	9	215	Mendelian_Immune	YAMAZAKI_TCEB3_TARGETS_DN
11.1111111111%	1	9	214	Mendelian_Immune	AFFAR_YY1_TARGETS_UP
11.1111111111%	1	9	211	Mendelian_Immune	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
11.1111111111%	1	9	210	Mendelian_Immune	CAIRO_HEPATOBLASTOMA_CLASSES_DN
11.1111111111%	1	9	21	Mendelian_Immune	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD
11.1111111111%	1	9	21	Mendelian_Immune	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN
11.1111111111%	1	9	209	Mendelian_Immune	GROSS_HYPOXIA_VIA_ELK3_UP
11.1111111111%	1	9	206	Mendelian_Immune	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
11.1111111111%	1	9	203	Mendelian_Immune	GRUETZMANN_PANCREATIC_CANCER_DN
11.1111111111%	1	9	20	Mendelian_Immune	NIELSEN_SYNOVIAL_SARCOMA_DN
11.1111111111%	1	9	20	Mendelian_Immune	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN
11.1111111111%	1	9	20	Mendelian_Immune	CROONQUIST_IL6_DEPRIVATION_UP
11.1111111111%	1	9	198	Mendelian_Immune	WELCSH_BRCA1_TARGETS_UP
11.1111111111%	1	9	1972	Mendelian_Immune	PILON_KLF1_TARGETS_DN
11.1111111111%	1	9	196	Mendelian_Immune	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
11.1111111111%	1	9	190	Mendelian_Immune	KEGG_CHEMOKINE_SIGNALING_PATHWAY
11.1111111111%	1	9	19	Mendelian_Immune	BIOCARTA_TH1TH2_PATHWAY
11.1111111111%	1	9	186	Mendelian_Immune	WANG_CLIM2_TARGETS_DN
11.1111111111%	1	9	186	Mendelian_Immune	HAMAI_APOPTOSIS_VIA_TRAIL_DN
11.1111111111%	1	9	185	Mendelian_Immune	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
11.1111111111%	1	9	1821	Mendelian_Immune	DODD_NASOPHARYNGEAL_CARCINOMA_UP
11.1111111111%	1	9	180	Mendelian_Immune	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
11.1111111111%	1	9	18	Mendelian_Immune	WU_HBX_TARGETS_3_UP
11.1111111111%	1	9	18	Mendelian_Immune	DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP
11.1111111111%	1	9	18	Mendelian_Immune	BIOCARTA_PTEN_PATHWAY
11.1111111111%	1	9	178	Mendelian_Immune	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
11.1111111111%	1	9	178	Mendelian_Immune	BROWNE_HCMV_INFECTION_18HR_UP
11.1111111111%	1	9	176	Mendelian_Immune	SASAKI_ADULT_T_CELL_LEUKEMIA
11.1111111111%	1	9	176	Mendelian_Immune	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
11.1111111111%	1	9	172	Mendelian_Immune	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
11.1111111111%	1	9	170	Mendelian_Immune	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
11.1111111111%	1	9	17	Mendelian_Immune	MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN
11.1111111111%	1	9	17	Mendelian_Immune	INGA_TP53_TARGETS
11.1111111111%	1	9	169	Mendelian_Immune	KEGG_ALZHEIMERS_DISEASE
11.1111111111%	1	9	166	Mendelian_Immune	SMIRNOV_RESPONSE_TO_IR_6HR_UP
11.1111111111%	1	9	1652	Mendelian_Immune	PUJANA_BRCA1_PCC_NETWORK
11.1111111111%	1	9	165	Mendelian_Immune	BROWN_MYELOID_CELL_DEVELOPMENT_UP
11.1111111111%	1	9	163	Mendelian_Immune	SERVITJA_ISLET_HNF1A_TARGETS_UP
11.1111111111%	1	9	160	Mendelian_Immune	GAVIN_FOXP3_TARGETS_CLUSTER_P3
11.1111111111%	1	9	16	Mendelian_Immune	WU_HBX_TARGETS_1_UP
11.1111111111%	1	9	16	Mendelian_Immune	SCHAVOLT_TARGETS_OF_TP53_AND_TP63
11.1111111111%	1	9	16	Mendelian_Immune	BIOCARTA_ACH_PATHWAY
11.1111111111%	1	9	16	Mendelian_Immune	BAKER_HEMATOPOIESIS_STAT3_TARGETS
11.1111111111%	1	9	158	Mendelian_Immune	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
11.1111111111%	1	9	15	Mendelian_Immune	BIOCARTA_CD40_PATHWAY
11.1111111111%	1	9	149	Mendelian_Immune	TSAI_RESPONSE_TO_IONIZING_RADIATION
11.1111111111%	1	9	147	Mendelian_Immune	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
11.1111111111%	1	9	141	Mendelian_Immune	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
11.1111111111%	1	9	140	Mendelian_Immune	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
11.1111111111%	1	9	139	Mendelian_Immune	HOELZEL_NF1_TARGETS_UP
11.1111111111%	1	9	138	Mendelian_Immune	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
11.1111111111%	1	9	137	Mendelian_Immune	PID_P53DOWNSTREAMPATHWAY
11.1111111111%	1	9	136	Mendelian_Immune	WIERENGA_STAT5A_TARGETS_GROUP1
11.1111111111%	1	9	134	Mendelian_Immune	SCHLOSSER_SERUM_RESPONSE_UP
11.1111111111%	1	9	134	Mendelian_Immune	KEGG_CELL_ADHESION_MOLECULES_CAMS
11.1111111111%	1	9	1305	Mendelian_Immune	YOSHIMURA_MAPK8_TARGETS_UP
11.1111111111%	1	9	13	Mendelian_Immune	MARTINELLI_IMMATURE_NEUTROPHIL_DN
11.1111111111%	1	9	13	Mendelian_Immune	HOEGERKORP_CD44_TARGETS_TEMPORAL_UP
11.1111111111%	1	9	13	Mendelian_Immune	CROONQUIST_STROMAL_STIMULATION_DN
11.1111111111%	1	9	128	Mendelian_Immune	LENAOUR_DENDRITIC_CELL_MATURATION_DN
11.1111111111%	1	9	128	Mendelian_Immune	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
11.1111111111%	1	9	128	Mendelian_Immune	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
11.1111111111%	1	9	1278	Mendelian_Immune	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
11.1111111111%	1	9	126	Mendelian_Immune	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
11.1111111111%	1	9	120	Mendelian_Immune	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN
11.1111111111%	1	9	12	Mendelian_Immune	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
11.1111111111%	1	9	12	Mendelian_Immune	CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL
11.1111111111%	1	9	117	Mendelian_Immune	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
11.1111111111%	1	9	115	Mendelian_Immune	MARZEC_IL2_SIGNALING_UP
11.1111111111%	1	9	1142	Mendelian_Immune	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
11.1111111111%	1	9	114	Mendelian_Immune	SMIRNOV_RESPONSE_TO_IR_6HR_DN
11.1111111111%	1	9	113	Mendelian_Immune	TSENG_IRS1_TARGETS_UP
11.1111111111%	1	9	112	Mendelian_Immune	PASINI_SUZ12_TARGETS_UP
11.1111111111%	1	9	1103	Mendelian_Immune	DANG_BOUND_BY_MYC
11.1111111111%	1	9	110	Mendelian_Immune	GHANDHI_DIRECT_IRRADIATION_UP
11.1111111111%	1	9	11	Mendelian_Immune	MARTINELLI_IMMATURE_NEUTROPHIL_UP
11.1111111111%	1	9	108	Mendelian_Immune	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
11.1111111111%	1	9	106	Mendelian_Immune	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
11.1111111111%	1	9	103	Mendelian_Immune	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
11.1111111111%	1	9	1022	Mendelian_Immune	MARSON_BOUND_BY_FOXP3_STIMULATED
11.1111111111%	1	9	102	Mendelian_Immune	LABBE_TGFB1_TARGETS_UP
11.1111111111%	1	9	1011	Mendelian_Immune	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
11.1111111111%	1	9	101	Mendelian_Immune	BROWNE_HCMV_INFECTION_10HR_UP
11.1111111111%	1	9	101	Mendelian_Immune	BASSO_CD40_SIGNALING_UP
11.1111111111%	1	9	100	Mendelian_Immune	GAVIN_FOXP3_TARGETS_CLUSTER_P4
10.8108108108%	4	37	988	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BENPORATH_NANOG_TARGETS
10.8108108108%	4	37	95	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
10.8108108108%	4	37	933	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_IMMUNE_SYSTEM
10.8108108108%	4	37	91	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
10.8108108108%	4	37	90	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SIGNALING_BY_ERBB4
10.8108108108%	4	37	86	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
10.8108108108%	4	37	857	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARTENS_TRETINOIN_RESPONSE_UP
10.8108108108%	4	37	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_SMALL_CELL_LUNG_CANCER
10.8108108108%	4	37	82	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ST_INTEGRIN_SIGNALING_PATHWAY
10.8108108108%	4	37	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WOO_LIVER_CANCER_RECURRENCE_DN
10.8108108108%	4	37	78	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SIGNALING_BY_SCF_KIT
10.8108108108%	4	37	71	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_MELANOMA
10.8108108108%	4	37	682	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FEVR_CTNNB1_TARGETS_UP
10.8108108108%	4	37	663	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
10.8108108108%	4	37	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_GLIOMA
10.8108108108%	4	37	637	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
10.8108108108%	4	37	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_PI_3K_CASCADE
10.8108108108%	4	37	552	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
10.8108108108%	4	37	540	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ACEVEDO_LIVER_CANCER_DN
10.8108108108%	4	37	539	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
10.8108108108%	4	37	536	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SENESE_HDAC3_TARGETS_DN
10.8108108108%	4	37	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_MTOR_SIGNALING_PATHWAY
10.8108108108%	4	37	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_ENDOMETRIAL_CANCER
10.8108108108%	4	37	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
10.8108108108%	4	37	504	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PILON_KLF1_TARGETS_UP
10.8108108108%	4	37	504	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BROWNE_HCMV_INFECTION_48HR_DN
10.8108108108%	4	37	481	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LIU_PROSTATE_CANCER_DN
10.8108108108%	4	37	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_HES_HEYPATHWAY
10.8108108108%	4	37	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SIG_CHEMOTAXIS
10.8108108108%	4	37	447	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MOOTHA_MITOCHONDRIA
10.8108108108%	4	37	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
10.8108108108%	4	37	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_TCPTP_PATHWAY
10.8108108108%	4	37	429	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MOOTHA_HUMAN_MITODB_6_2002
10.8108108108%	4	37	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
10.8108108108%	4	37	413	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
10.8108108108%	4	37	403	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
10.8108108108%	4	37	395	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HAN_SATB1_TARGETS_UP
10.8108108108%	4	37	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
10.8108108108%	4	37	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_PI3K_AKT_ACTIVATION
10.8108108108%	4	37	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_GAB1_SIGNALOSOME
10.8108108108%	4	37	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_HDAC_PATHWAY
10.8108108108%	4	37	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_GH_PATHWAY
10.8108108108%	4	37	266	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
10.8108108108%	4	37	262	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LU_AGING_BRAIN_UP
10.8108108108%	4	37	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_INSULIN_GLUCOSE_PATHWAY
10.8108108108%	4	37	253	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DANG_REGULATED_BY_MYC_DN
10.8108108108%	4	37	230	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BENPORATH_MYC_TARGETS_WITH_EBOX
10.8108108108%	4	37	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_INSULIN_PATHWAY
10.8108108108%	4	37	217	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SIGNALLING_BY_NGF
10.8108108108%	4	37	1972	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PILON_KLF1_TARGETS_DN
10.8108108108%	4	37	197	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
10.8108108108%	4	37	1821	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DODD_NASOPHARYNGEAL_CARCINOMA_UP
10.8108108108%	4	37	1382	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
10.8108108108%	4	37	137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
10.8108108108%	4	37	127	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
10.8108108108%	4	37	122	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SIGNALING_BY_PDGF
10.8108108108%	4	37	112	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SIGNALING_BY_FGFR
10.8108108108%	4	37	1103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DANG_BOUND_BY_MYC
10.8108108108%	4	37	109	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
10.8108108108%	4	37	1022	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARSON_BOUND_BY_FOXP3_STIMULATED
10.8108108108%	4	37	101	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SIGNALING_BY_ERBB2
10.8108108108%	4	37	100	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
10.7142857143%	3	28	988	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BENPORATH_NANOG_TARGETS
10.7142857143%	3	28	988	Diabetes_McGill_Cell_cycle_G1	BENPORATH_NANOG_TARGETS
10.7142857143%	3	28	953	Diabetes_McGill_Cell_cycle_G1	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
10.7142857143%	3	28	95	Diabetes_McGill_Cell_cycle_G1	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
10.7142857143%	3	28	92	Diabetes_McGill_Cell_cycle_G1	KEGG_DILATED_CARDIOMYOPATHY
10.7142857143%	3	28	92	Diabetes_McGill_Cell_cycle_G1	DE_YY1_TARGETS_DN
10.7142857143%	3	28	92	Diabetes_McGill_Cell_cycle_G1	BURTON_ADIPOGENESIS_9
10.7142857143%	3	28	911	Diabetes_McGill_Cell_cycle_G1	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
10.7142857143%	3	28	91	Diabetes_McGill_Cell_cycle_G1	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
10.7142857143%	3	28	91	Diabetes_McGill_Cell_cycle_G1	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
10.7142857143%	3	28	90	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALING_BY_ERBB4
10.7142857143%	3	28	898	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
10.7142857143%	3	28	89	Diabetes_McGill_Cell_cycle_G1	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
10.7142857143%	3	28	88	Diabetes_McGill_Cell_cycle_G1	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
10.7142857143%	3	28	87	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_MAPK_PATHWAY
10.7142857143%	3	28	86	Diabetes_McGill_Cell_cycle_G1	REACTOME_MEIOTIC_RECOMBINATION
10.7142857143%	3	28	857	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARTENS_TRETINOIN_RESPONSE_UP
10.7142857143%	3	28	85	Diabetes_McGill_Cell_cycle_G1	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
10.7142857143%	3	28	824	Diabetes_McGill_Cell_cycle_G1	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
10.7142857143%	3	28	82	Diabetes_McGill_Cell_cycle_G1	FRASOR_RESPONSE_TO_ESTRADIOL_DN
10.7142857143%	3	28	811	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
10.7142857143%	3	28	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WOO_LIVER_CANCER_RECURRENCE_DN
10.7142857143%	3	28	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_UNFOLDED_PROTEIN_RESPONSE
10.7142857143%	3	28	80	Diabetes_McGill_Cell_cycle_G1	PID_BETACATENIN_NUC_PATHWAY
10.7142857143%	3	28	8	Diabetes_McGill_Cell_cycle_G1	SA_G2_AND_M_PHASES
10.7142857143%	3	28	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MEISSNER_NPC_HCP_WITH_H3K27ME3
10.7142857143%	3	28	781	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GOZGIT_ESR1_TARGETS_DN
10.7142857143%	3	28	781	Diabetes_McGill_Cell_cycle_G1	GOZGIT_ESR1_TARGETS_DN
10.7142857143%	3	28	78	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALING_BY_SCF_KIT
10.7142857143%	3	28	721	Diabetes_McGill_Cell_cycle_G1	WONG_ADULT_TISSUE_STEM_MODULE
10.7142857143%	3	28	72	Diabetes_McGill_Cell_cycle_G1	MATZUK_SPERMATOCYTE
10.7142857143%	3	28	72	Diabetes_McGill_Cell_cycle_G1	KEGG_LEISHMANIA_INFECTION
10.7142857143%	3	28	70	Diabetes_McGill_Cell_cycle_G1	KEGG_RENAL_CELL_CARCINOMA
10.7142857143%	3	28	663	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
10.7142857143%	3	28	663	Diabetes_McGill_Cell_cycle_G1	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
10.7142857143%	3	28	65	Diabetes_McGill_Cell_cycle_G1	PID_ERA_GENOMIC_PATHWAY
10.7142857143%	3	28	648	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BENPORATH_CYCLING_GENES
10.7142857143%	3	28	637	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
10.7142857143%	3	28	61	Diabetes_McGill_Cell_cycle_G1	PID_AR_PATHWAY
10.7142857143%	3	28	602	Diabetes_McGill_Cell_cycle_G1	MARTINEZ_TP53_TARGETS_UP
10.7142857143%	3	28	59	Diabetes_McGill_Cell_cycle_G1	BARIS_THYROID_CANCER_DN
10.7142857143%	3	28	58	Diabetes_McGill_Cell_cycle_G1	SCHEIDEREIT_IKK_INTERACTING_PROTEINS
10.7142857143%	3	28	58	Diabetes_McGill_Cell_cycle_G1	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
10.7142857143%	3	28	578	Diabetes_McGill_Cell_cycle_G1	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
10.7142857143%	3	28	572	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHICAS_RB1_TARGETS_SENESCENT
10.7142857143%	3	28	567	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHICAS_RB1_TARGETS_CONFLUENT
10.7142857143%	3	28	56	Diabetes_McGill_Cell_cycle_G1	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP
10.7142857143%	3	28	557	Diabetes_McGill_Cell_cycle_G1	TIEN_INTESTINE_PROBIOTICS_24HR_UP
10.7142857143%	3	28	544	Diabetes_McGill_Cell_cycle_G1	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
10.7142857143%	3	28	543	Diabetes_McGill_Cell_cycle_G1	MARTINEZ_RB1_TARGETS_DN
10.7142857143%	3	28	54	Diabetes_McGill_Cell_cycle_G1	PID_TAP63PATHWAY
10.7142857143%	3	28	539	Diabetes_McGill_Cell_cycle_G1	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
10.7142857143%	3	28	536	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SENESE_HDAC3_TARGETS_DN
10.7142857143%	3	28	528	Diabetes_McGill_Cell_cycle_G1	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
10.7142857143%	3	28	52	Diabetes_McGill_Cell_cycle_G1	KEGG_ENDOMETRIAL_CANCER
10.7142857143%	3	28	517	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	RAO_BOUND_BY_SALL4_ISOFORM_B
10.7142857143%	3	28	514	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
10.7142857143%	3	28	510	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
10.7142857143%	3	28	504	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BROWNE_HCMV_INFECTION_48HR_DN
10.7142857143%	3	28	491	Diabetes_McGill_Cell_cycle_G1	ZHENG_BOUND_BY_FOXP3
10.7142857143%	3	28	49	Diabetes_McGill_Cell_cycle_G1	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
10.7142857143%	3	28	49	Diabetes_McGill_Cell_cycle_G1	PID_FOXOPATHWAY
10.7142857143%	3	28	47	Diabetes_McGill_Cell_cycle_G1	PID_LKB1_PATHWAY
10.7142857143%	3	28	47	Diabetes_McGill_Cell_cycle_G1	PID_DELTANP63PATHWAY
10.7142857143%	3	28	46	Diabetes_McGill_Cell_cycle_G1	PID_PS1PATHWAY
10.7142857143%	3	28	455	Diabetes_McGill_Cell_cycle_G1	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
10.7142857143%	3	28	431	Diabetes_McGill_Cell_cycle_G1	GARY_CD5_TARGETS_DN
10.7142857143%	3	28	430	Diabetes_McGill_Cell_cycle_G1	JOHNSTONE_PARVB_TARGETS_3_UP
10.7142857143%	3	28	43	Diabetes_McGill_Cell_cycle_G1	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
10.7142857143%	3	28	425	Diabetes_McGill_Cell_cycle_G1	ZHANG_BREAST_CANCER_PROGENITORS_UP
10.7142857143%	3	28	424	Diabetes_McGill_Cell_cycle_G1	SHEN_SMARCA2_TARGETS_UP
10.7142857143%	3	28	42	Diabetes_McGill_Cell_cycle_G1	ONO_FOXP3_TARGETS_DN
10.7142857143%	3	28	42	Diabetes_McGill_Cell_cycle_G1	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP
10.7142857143%	3	28	414	Diabetes_McGill_Cell_cycle_G1	LU_EZH2_TARGETS_DN
10.7142857143%	3	28	413	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
10.7142857143%	3	28	408	Diabetes_McGill_Cell_cycle_G1	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
10.7142857143%	3	28	403	Diabetes_McGill_Cell_cycle_G1	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
10.7142857143%	3	28	40	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_P38MAPK_PATHWAY
10.7142857143%	3	28	395	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HAN_SATB1_TARGETS_UP
10.7142857143%	3	28	39	Diabetes_McGill_Cell_cycle_G1	PID_ATR_PATHWAY
10.7142857143%	3	28	38	Diabetes_McGill_Cell_cycle_G1	REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS
10.7142857143%	3	28	379	Diabetes_McGill_Cell_cycle_G1	BENPORATH_ES_1
10.7142857143%	3	28	371	Diabetes_McGill_Cell_cycle_G1	WANG_SMARCE1_TARGETS_DN
10.7142857143%	3	28	37	Diabetes_McGill_Cell_cycle_G1	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
10.7142857143%	3	28	366	Diabetes_McGill_Cell_cycle_G1	SANSOM_APC_TARGETS_DN
10.7142857143%	3	28	36	Diabetes_McGill_Cell_cycle_G1	YIH_RESPONSE_TO_ARSENITE_C3
10.7142857143%	3	28	35	Diabetes_McGill_Cell_cycle_G1	PID_PI3KCIAKTPATHWAY
10.7142857143%	3	28	341	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
10.7142857143%	3	28	341	Diabetes_McGill_Cell_cycle_G1	MULLIGHAN_NPM1_SIGNATURE_3_UP
10.7142857143%	3	28	34	Diabetes_McGill_Cell_cycle_G1	PID_ATM_PATHWAY
10.7142857143%	3	28	33	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_IL1R_PATHWAY
10.7142857143%	3	28	323	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GRESHOCK_CANCER_COPY_NUMBER_UP
10.7142857143%	3	28	318	Diabetes_McGill_Cell_cycle_G1	DAZARD_RESPONSE_TO_UV_NHEK_DN
10.7142857143%	3	28	31	Diabetes_McGill_Cell_cycle_G1	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN
10.7142857143%	3	28	31	Diabetes_McGill_Cell_cycle_G1	DANG_MYC_TARGETS_DN
10.7142857143%	3	28	307	Diabetes_McGill_Cell_cycle_G1	LI_INDUCED_T_TO_NATURAL_KILLER_UP
10.7142857143%	3	28	30	Diabetes_McGill_Cell_cycle_G1	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
10.7142857143%	3	28	298	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BROWNE_HCMV_INFECTION_14HR_DN
10.7142857143%	3	28	290	Diabetes_McGill_Cell_cycle_G1	BASAKI_YBX1_TARGETS_UP
10.7142857143%	3	28	29	Diabetes_McGill_Cell_cycle_G1	YU_BAP1_TARGETS
10.7142857143%	3	28	29	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_NKT_PATHWAY
10.7142857143%	3	28	29	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_INFLAM_PATHWAY
10.7142857143%	3	28	289	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WANG_MLL_TARGETS
10.7142857143%	3	28	289	Diabetes_McGill_Cell_cycle_G1	GABRIELY_MIR21_TARGETS
10.7142857143%	3	28	281	Diabetes_McGill_Cell_cycle_G1	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
10.7142857143%	3	28	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BIOCARTA_GH_PATHWAY
10.7142857143%	3	28	276	Diabetes_McGill_Cell_cycle_G1	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
10.7142857143%	3	28	27	Diabetes_McGill_Cell_cycle_G1	PID_GLYPICAN_1PATHWAY
10.7142857143%	3	28	27	Diabetes_McGill_Cell_cycle_G1	OHM_METHYLATED_IN_ADULT_CANCERS
10.7142857143%	3	28	267	Diabetes_McGill_Cell_cycle_G1	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
10.7142857143%	3	28	267	Diabetes_McGill_Cell_cycle_G1	HOLLMANN_APOPTOSIS_VIA_CD40_DN
10.7142857143%	3	28	266	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
10.7142857143%	3	28	261	Diabetes_McGill_Cell_cycle_G1	BILD_HRAS_ONCOGENIC_SIGNATURE
10.7142857143%	3	28	26	Diabetes_McGill_Cell_cycle_G1	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS
10.7142857143%	3	28	26	Diabetes_McGill_Cell_cycle_G1	PID_ALK1PATHWAY
10.7142857143%	3	28	26	Diabetes_McGill_Cell_cycle_G1	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
10.7142857143%	3	28	25	Diabetes_McGill_Cell_cycle_G1	PID_MYC_PATHWAY
10.7142857143%	3	28	249	Diabetes_McGill_Cell_cycle_G1	MITSIADES_RESPONSE_TO_APLIDIN_DN
10.7142857143%	3	28	246	Diabetes_McGill_Cell_cycle_G1	BILD_E2F3_ONCOGENIC_SIGNATURE
10.7142857143%	3	28	244	Diabetes_McGill_Cell_cycle_G1	GAL_LEUKEMIC_STEM_CELL_DN
10.7142857143%	3	28	230	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BENPORATH_MYC_TARGETS_WITH_EBOX
10.7142857143%	3	28	23	Diabetes_McGill_Cell_cycle_G1	PID_PRLSIGNALINGEVENTSPATHWAY
10.7142857143%	3	28	23	Diabetes_McGill_Cell_cycle_G1	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
10.7142857143%	3	28	23	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_P53HYPOXIA_PATHWAY
10.7142857143%	3	28	227	Diabetes_McGill_Cell_cycle_G1	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
10.7142857143%	3	28	222	Diabetes_McGill_Cell_cycle_G1	BROWNE_HCMV_INFECTION_1HR_DN
10.7142857143%	3	28	221	Diabetes_McGill_Cell_cycle_G1	ZHANG_TLX_TARGETS_36HR_UP
10.7142857143%	3	28	217	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SANSOM_APC_MYC_TARGETS
10.7142857143%	3	28	214	Diabetes_McGill_Cell_cycle_G1	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
10.7142857143%	3	28	214	Diabetes_McGill_Cell_cycle_G1	BIDUS_METASTASIS_UP
10.7142857143%	3	28	21	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_ATRBRCA_PATHWAY
10.7142857143%	3	28	208	Diabetes_McGill_Cell_cycle_G1	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
10.7142857143%	3	28	206	Diabetes_McGill_Cell_cycle_G1	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
10.7142857143%	3	28	200	Diabetes_McGill_Cell_cycle_G1	SHEPARD_BMYB_MORPHOLINO_DN
10.7142857143%	3	28	20	Diabetes_McGill_Cell_cycle_G1	REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY
10.7142857143%	3	28	198	Diabetes_McGill_Cell_cycle_G1	WELCSH_BRCA1_TARGETS_UP
10.7142857143%	3	28	195	Diabetes_McGill_Cell_cycle_G1	KYNG_DNA_DAMAGE_DN
10.7142857143%	3	28	193	Diabetes_McGill_Cell_cycle_G1	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP
10.7142857143%	3	28	181	Diabetes_McGill_Cell_cycle_G1	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
10.7142857143%	3	28	18	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_MCM_PATHWAY
10.7142857143%	3	28	179	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
10.7142857143%	3	28	17	Diabetes_McGill_Cell_cycle_G1	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS
10.7142857143%	3	28	169	Diabetes_McGill_Cell_cycle_G1	PENG_GLUCOSE_DEPRIVATION_DN
10.7142857143%	3	28	163	Diabetes_McGill_Cell_cycle_G1	SERVITJA_ISLET_HNF1A_TARGETS_UP
10.7142857143%	3	28	163	Diabetes_McGill_Cell_cycle_G1	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
10.7142857143%	3	28	163	Diabetes_McGill_Cell_cycle_G1	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
10.7142857143%	3	28	160	Diabetes_McGill_Cell_cycle_G1	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
10.7142857143%	3	28	156	Diabetes_McGill_Cell_cycle_G1	BROWNE_HCMV_INFECTION_14HR_UP
10.7142857143%	3	28	153	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	DURAND_STROMA_MAX_DN
10.7142857143%	3	28	15	Diabetes_McGill_Cell_cycle_G1	REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION
10.7142857143%	3	28	15	Diabetes_McGill_Cell_cycle_G1	MARKS_ACETYLATED_NON_HISTONE_PROTEINS
10.7142857143%	3	28	15	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_ERYTH_PATHWAY
10.7142857143%	3	28	148	Diabetes_McGill_Cell_cycle_G1	REACTOME_APOPTOSIS
10.7142857143%	3	28	145	Diabetes_McGill_Cell_cycle_G1	SMITH_TERT_TARGETS_UP
10.7142857143%	3	28	141	Diabetes_McGill_Cell_cycle_G1	WELCSH_BRCA1_TARGETS_DN
10.7142857143%	3	28	140	Diabetes_McGill_Cell_cycle_G1	ONDER_CDH1_TARGETS_1_UP
10.7142857143%	3	28	140	Diabetes_McGill_Cell_cycle_G1	JOHNSTONE_PARVB_TARGETS_2_UP
10.7142857143%	3	28	137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_INSULIN_SIGNALING_PATHWAY
10.7142857143%	3	28	137	Diabetes_McGill_Cell_cycle_G1	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
10.7142857143%	3	28	13	Diabetes_McGill_Cell_cycle_G1	REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1
10.7142857143%	3	28	128	Diabetes_McGill_Cell_cycle_G1	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
10.7142857143%	3	28	127	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
10.7142857143%	3	28	126	Diabetes_McGill_Cell_cycle_G1	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
10.7142857143%	3	28	1237	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BLALOCK_ALZHEIMERS_DISEASE_DN
10.7142857143%	3	28	1237	Diabetes_McGill_Cell_cycle_G1	BLALOCK_ALZHEIMERS_DISEASE_DN
10.7142857143%	3	28	122	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALING_BY_PDGF
10.7142857143%	3	28	12	Diabetes_McGill_Cell_cycle_G1	TURJANSKI_MAPK1_AND_MAPK2_TARGETS
10.7142857143%	3	28	12	Diabetes_McGill_Cell_cycle_G1	REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT
10.7142857143%	3	28	114	Diabetes_McGill_Cell_cycle_G1	KEGG_OOCYTE_MEIOSIS
10.7142857143%	3	28	112	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALING_BY_FGFR
10.7142857143%	3	28	112	Diabetes_McGill_Cell_cycle_G1	LABBE_WNT3A_TARGETS_UP
10.7142857143%	3	28	1103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	DANG_BOUND_BY_MYC
10.7142857143%	3	28	109	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
10.7142857143%	3	28	1080	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
10.7142857143%	3	28	101	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALING_BY_ERBB2
10.7142857143%	3	28	100	Diabetes_McGill_Cell_cycle_G1	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
10.7142857143%	3	28	10	Diabetes_McGill_Cell_cycle_G1	MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY
10.6719367589%	27	253	783	Diabetes_McGill_CREBBP_coTF	ONKEN_UVEAL_MELANOMA_UP
10.6719367589%	27	253	648	Diabetes_McGill_CREBBP_coTF	BENPORATH_CYCLING_GENES
10.4838709677%	13	124	97	Diabetes_McGill_Cell_cycle_All_Gene	KONG_E2F3_TARGETS
10.4838709677%	13	124	871	Diabetes_McGill_Cell_cycle_All_Gene	GRADE_COLON_CANCER_UP
10.4838709677%	13	124	841	Diabetes_McGill_Cell_cycle_All_Gene	MARTENS_TRETINOIN_RESPONSE_DN
10.4838709677%	13	124	76	Diabetes_McGill_Cell_cycle_All_Gene	PEART_HDAC_PROLIFERATION_CLUSTER_DN
10.4838709677%	13	124	67	Diabetes_McGill_Cell_cycle_All_Gene	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
10.4838709677%	13	124	63	Diabetes_McGill_Cell_cycle_All_Gene	PID_MYC_REPRESSPATHWAY
10.4838709677%	13	124	50	Diabetes_McGill_Cell_cycle_All_Gene	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN
10.4838709677%	13	124	460	Diabetes_McGill_Cell_cycle_All_Gene	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
10.4838709677%	13	124	39	Diabetes_McGill_Cell_cycle_All_Gene	PID_ATR_PATHWAY
10.4838709677%	13	124	330	Diabetes_McGill_Cell_cycle_All_Gene	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
10.4838709677%	13	124	318	Diabetes_McGill_Cell_cycle_All_Gene	LEI_MYB_TARGETS
10.4838709677%	13	124	234	Diabetes_McGill_Cell_cycle_All_Gene	AFFAR_YY1_TARGETS_DN
10.4838709677%	13	124	230	Diabetes_McGill_Cell_cycle_All_Gene	BENPORATH_MYC_TARGETS_WITH_EBOX
10.4838709677%	13	124	22	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE
10.4838709677%	13	124	216	Diabetes_McGill_Cell_cycle_All_Gene	WHITFIELD_CELL_CYCLE_G2_M
10.4838709677%	13	124	200	Diabetes_McGill_Cell_cycle_All_Gene	SHEPARD_BMYB_MORPHOLINO_DN
10.4838709677%	13	124	185	Diabetes_McGill_Cell_cycle_All_Gene	ZHANG_TLX_TARGETS_36HR_DN
10.4838709677%	13	124	184	Diabetes_McGill_Cell_cycle_All_Gene	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
10.4838709677%	13	124	1839	Diabetes_McGill_Cell_cycle_All_Gene	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
10.4838709677%	13	124	15	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION
10.4838709677%	13	124	149	Diabetes_McGill_Cell_cycle_All_Gene	TSAI_RESPONSE_TO_IONIZING_RADIATION
10.4838709677%	13	124	147	Diabetes_McGill_Cell_cycle_All_Gene	WHITFIELD_CELL_CYCLE_G1_S
10.4838709677%	13	124	147	Diabetes_McGill_Cell_cycle_All_Gene	BENPORATH_PROLIFERATION
10.4838709677%	13	124	1305	Diabetes_McGill_Cell_cycle_All_Gene	YOSHIMURA_MAPK8_TARGETS_UP
10.4838709677%	13	124	1069	Diabetes_McGill_Cell_cycle_All_Gene	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
10.4838709677%	13	124	103	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_NOTCH
10.4387291982%	69	661	1229	T2D_GENES_TANYA_GLYCEMIC	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
10.4356636272%	206	1974	1442	Mendelian_Nancy_Cox	PUJANA_ATM_PCC_NETWORK
10.2575896964%	223	2174	1691	T2D_GENES_TANYA_LIPIDS	BLALOCK_ALZHEIMERS_DISEASE_UP
10.2564102564%	4	39	97	Diabetes_McGill_IL6	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
10.2564102564%	4	39	9	Diabetes_McGill_IL6	ST_JAK_STAT_PATHWAY
10.2564102564%	4	39	89	Diabetes_McGill_IL6	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
10.2564102564%	4	39	85	Diabetes_McGill_IL6	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
10.2564102564%	4	39	82	Diabetes_McGill_IL6	PID_SMAD2_3NUCLEARPATHWAY
10.2564102564%	4	39	805	Diabetes_McGill_IL6	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
10.2564102564%	4	39	79	Diabetes_McGill_IL6	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
10.2564102564%	4	39	76	Diabetes_McGill_IL6	KEGG_VEGF_SIGNALING_PATHWAY
10.2564102564%	4	39	747	Diabetes_McGill_IL6	PATIL_LIVER_CANCER
10.2564102564%	4	39	71	Diabetes_McGill_IL6	KEGG_MELANOMA
10.2564102564%	4	39	66	Diabetes_McGill_IL6	PID_TCR_PATHWAY
10.2564102564%	4	39	637	Diabetes_McGill_IL6	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
10.2564102564%	4	39	634	Diabetes_McGill_IL6	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
10.2564102564%	4	39	63	Diabetes_McGill_IL6	REACTOME_INTERFERON_GAMMA_SIGNALING
10.2564102564%	4	39	63	Diabetes_McGill_IL6	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
10.2564102564%	4	39	62	Diabetes_McGill_IL6	PID_TRKRPATHWAY
10.2564102564%	4	39	62	Diabetes_McGill_IL6	PID_FCER1PATHWAY
10.2564102564%	4	39	612	Diabetes_McGill_IL6	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
10.2564102564%	4	39	602	Diabetes_McGill_IL6	MARTINEZ_TP53_TARGETS_UP
10.2564102564%	4	39	60	Diabetes_McGill_IL6	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
10.2564102564%	4	39	584	Diabetes_McGill_IL6	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
10.2564102564%	4	39	555	Diabetes_McGill_IL6	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
10.2564102564%	4	39	55	Diabetes_McGill_IL6	PID_FGF_PATHWAY
10.2564102564%	4	39	548	Diabetes_McGill_IL6	KIM_ALL_DISORDERS_CALB1_CORR_UP
10.2564102564%	4	39	53	Diabetes_McGill_IL6	PID_CD8TCRPATHWAY
10.2564102564%	4	39	514	Diabetes_McGill_IL6	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
10.2564102564%	4	39	501	Diabetes_McGill_IL6	SENESE_HDAC3_TARGETS_UP
10.2564102564%	4	39	50	Diabetes_McGill_IL6	PID_ANGIOPOIETINRECEPTOR_PATHWAY
10.2564102564%	4	39	491	Diabetes_McGill_IL6	ZHENG_BOUND_BY_FOXP3
10.2564102564%	4	39	49	Diabetes_McGill_IL6	BIOCARTA_TCR_PATHWAY
10.2564102564%	4	39	47	Diabetes_McGill_IL6	KEGG_TYPE_II_DIABETES_MELLITUS
10.2564102564%	4	39	447	Diabetes_McGill_IL6	MOOTHA_MITOCHONDRIA
10.2564102564%	4	39	43	Diabetes_McGill_IL6	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
10.2564102564%	4	39	425	Diabetes_McGill_IL6	BOCHKIS_FOXA2_TARGETS
10.2564102564%	4	39	41	Diabetes_McGill_IL6	PID_ER_NONGENOMIC_PATHWAY
10.2564102564%	4	39	41	Diabetes_McGill_IL6	BIOCARTA_FCER1_PATHWAY
10.2564102564%	4	39	395	Diabetes_McGill_IL6	HAN_SATB1_TARGETS_UP
10.2564102564%	4	39	394	Diabetes_McGill_IL6	BERENJENO_TRANSFORMED_BY_RHOA_DN
10.2564102564%	4	39	392	Diabetes_McGill_IL6	LINDGREN_BLADDER_CANCER_CLUSTER_2B
10.2564102564%	4	39	38	Diabetes_McGill_IL6	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
10.2564102564%	4	39	38	Diabetes_McGill_IL6	REACTOME_PI3K_AKT_ACTIVATION
10.2564102564%	4	39	37	Diabetes_McGill_IL6	PID_IL23PATHWAY
10.2564102564%	4	39	37	Diabetes_McGill_IL6	BIOCARTA_MET_PATHWAY
10.2564102564%	4	39	37	Diabetes_McGill_IL6	BIOCARTA_BCR_PATHWAY
10.2564102564%	4	39	364	Diabetes_McGill_IL6	YANG_BCL3_TARGETS_UP
10.2564102564%	4	39	36	Diabetes_McGill_IL6	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
10.2564102564%	4	39	36	Diabetes_McGill_IL6	REACTOME_SIGNALLING_TO_ERKS
10.2564102564%	4	39	36	Diabetes_McGill_IL6	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
10.2564102564%	4	39	36	Diabetes_McGill_IL6	BIOCARTA_AT1R_PATHWAY
10.2564102564%	4	39	358	Diabetes_McGill_IL6	GRUETZMANN_PANCREATIC_CANCER_UP
10.2564102564%	4	39	351	Diabetes_McGill_IL6	YAGI_AML_WITH_11Q23_REARRANGED
10.2564102564%	4	39	35	Diabetes_McGill_IL6	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
10.2564102564%	4	39	330	Diabetes_McGill_IL6	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
10.2564102564%	4	39	33	Diabetes_McGill_IL6	BIOCARTA_IL1R_PATHWAY
10.2564102564%	4	39	32	Diabetes_McGill_IL6	ST_ERK1_ERK2_MAPK_PATHWAY
10.2564102564%	4	39	32	Diabetes_McGill_IL6	REACTOME_CD28_CO_STIMULATION
10.2564102564%	4	39	315	Diabetes_McGill_IL6	PASINI_SUZ12_TARGETS_DN
10.2564102564%	4	39	294	Diabetes_McGill_IL6	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
10.2564102564%	4	39	292	Diabetes_McGill_IL6	HELLER_HDAC_TARGETS_DN
10.2564102564%	4	39	29	Diabetes_McGill_IL6	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
10.2564102564%	4	39	29	Diabetes_McGill_IL6	BIOCARTA_INFLAM_PATHWAY
10.2564102564%	4	39	281	Diabetes_McGill_IL6	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
10.2564102564%	4	39	280	Diabetes_McGill_IL6	WANG_SMARCE1_TARGETS_UP
10.2564102564%	4	39	279	Diabetes_McGill_IL6	REACTOME_INNATE_IMMUNE_SYSTEM
10.2564102564%	4	39	27	Diabetes_McGill_IL6	REACTOME_SIGNALLING_TO_RAS
10.2564102564%	4	39	27	Diabetes_McGill_IL6	REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING
10.2564102564%	4	39	27	Diabetes_McGill_IL6	PID_GLYPICAN_1PATHWAY
10.2564102564%	4	39	253	Diabetes_McGill_IL6	DANG_REGULATED_BY_MYC_DN
10.2564102564%	4	39	25	Diabetes_McGill_IL6	PID_LYMPHANGIOGENESIS_PATHWAY
10.2564102564%	4	39	242	Diabetes_McGill_IL6	WINTER_HYPOXIA_METAGENE
10.2564102564%	4	39	242	Diabetes_McGill_IL6	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
10.2564102564%	4	39	24	Diabetes_McGill_IL6	SA_B_CELL_RECEPTOR_COMPLEXES
10.2564102564%	4	39	23	Diabetes_McGill_IL6	WU_HBX_TARGETS_1_DN
10.2564102564%	4	39	23	Diabetes_McGill_IL6	BIOCARTA_RAS_PATHWAY
10.2564102564%	4	39	22	Diabetes_McGill_IL6	BIOCARTA_CHEMICAL_PATHWAY
10.2564102564%	4	39	205	Diabetes_McGill_IL6	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
10.2564102564%	4	39	20	Diabetes_McGill_IL6	REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING
10.2564102564%	4	39	18	Diabetes_McGill_IL6	BIOCARTA_PTEN_PATHWAY
10.2564102564%	4	39	18	Diabetes_McGill_IL6	BIOCARTA_NGF_PATHWAY
10.2564102564%	4	39	17	Diabetes_McGill_IL6	REACTOME_SHC_RELATED_EVENTS
10.2564102564%	4	39	17	Diabetes_McGill_IL6	REACTOME_REGULATION_OF_KIT_SIGNALING
10.2564102564%	4	39	17	Diabetes_McGill_IL6	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS
10.2564102564%	4	39	160	Diabetes_McGill_IL6	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
10.2564102564%	4	39	16	Diabetes_McGill_IL6	BIOCARTA_IL22BP_PATHWAY
10.2564102564%	4	39	159	Diabetes_McGill_IL6	REACTOME_INTERFERON_SIGNALING
10.2564102564%	4	39	151	Diabetes_McGill_IL6	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
10.2564102564%	4	39	15	Diabetes_McGill_IL6	REACTOME_SHC_MEDIATED_SIGNALLING
10.2564102564%	4	39	15	Diabetes_McGill_IL6	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING
10.2564102564%	4	39	15	Diabetes_McGill_IL6	BIOCARTA_IL3_PATHWAY
10.2564102564%	4	39	15	Diabetes_McGill_IL6	BIOCARTA_ERYTH_PATHWAY
10.2564102564%	4	39	14	Diabetes_McGill_IL6	REACTOME_REGULATION_OF_IFNG_SIGNALING
10.2564102564%	4	39	137	Diabetes_McGill_IL6	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
10.2564102564%	4	39	1305	Diabetes_McGill_IL6	YOSHIMURA_MAPK8_TARGETS_UP
10.2564102564%	4	39	1278	Diabetes_McGill_IL6	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
10.2564102564%	4	39	12	Diabetes_McGill_IL6	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
10.2564102564%	4	39	12	Diabetes_McGill_IL6	BIOCARTA_TRKA_PATHWAY
10.2564102564%	4	39	11	Diabetes_McGill_IL6	BIOCARTA_IL4_PATHWAY
10.2564102564%	4	39	105	Diabetes_McGill_IL6	WOO_LIVER_CANCER_RECURRENCE_UP
10.2564102564%	4	39	102	Diabetes_McGill_IL6	PID_CXCR4_PATHWAY
10.2564102564%	4	39	102	Diabetes_McGill_IL6	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
10.208444682%	191	1871	1972	T2D_GENES_TANYA_HEIGHT	PILON_KLF1_TARGETS_DN
10.1317122594%	200	1974	1972	Mendelian_Nancy_Cox	PILON_KLF1_TARGETS_DN
10.1098901099%	46	455	1229	T2D_GENES_TANYA_BLOODPRESSURE	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
10.0%	7	70	87	Diabetes_McGill_Adipocytokine_signallin	KEGG_ERBB_SIGNALING_PATHWAY
10.0%	7	70	79	Diabetes_McGill_Adipocytokine_signallin	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
10.0%	7	70	78	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SIGNALING_BY_SCF_KIT
10.0%	7	70	775	Diabetes_McGill_Adipocytokine_signallin	BENPORATH_MYC_MAX_TARGETS
10.0%	7	70	73	Diabetes_McGill_Adipocytokine_signallin	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
10.0%	7	70	69	Diabetes_McGill_Adipocytokine_signallin	PID_VEGFR1_2_PATHWAY
10.0%	7	70	69	Diabetes_McGill_Adipocytokine_signallin	PID_P75NTRPATHWAY
10.0%	7	70	64	Diabetes_McGill_Adipocytokine_signallin	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS
10.0%	7	70	601	Diabetes_McGill_Adipocytokine_signallin	MARTINEZ_RB1_AND_TP53_TARGETS_UP
10.0%	7	70	584	Diabetes_McGill_Adipocytokine_signallin	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
10.0%	7	70	56	Diabetes_McGill_Adipocytokine_signallin	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
10.0%	7	70	55	Diabetes_McGill_Adipocytokine_signallin	PID_IL2_1PATHWAY
10.0%	7	70	52	Diabetes_McGill_Adipocytokine_signallin	PID_PTP1BPATHWAY
10.0%	7	70	52	Diabetes_McGill_Adipocytokine_signallin	KEGG_MTOR_SIGNALING_PATHWAY
10.0%	7	70	51	Diabetes_McGill_Adipocytokine_signallin	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
10.0%	7	70	49	Diabetes_McGill_Adipocytokine_signallin	PID_FOXOPATHWAY
10.0%	7	70	42	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_CHREBP2_PATHWAY
10.0%	7	70	40	Diabetes_McGill_Adipocytokine_signallin	ST_B_CELL_ANTIGEN_RECEPTOR
10.0%	7	70	38	Diabetes_McGill_Adipocytokine_signallin	REACTOME_PI3K_AKT_ACTIVATION
10.0%	7	70	38	Diabetes_McGill_Adipocytokine_signallin	PID_FASPATHWAY
10.0%	7	70	37	Diabetes_McGill_Adipocytokine_signallin	PID_IL23PATHWAY
10.0%	7	70	364	Diabetes_McGill_Adipocytokine_signallin	YANG_BCL3_TARGETS_UP
10.0%	7	70	33	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_IL1R_PATHWAY
10.0%	7	70	26	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_RACCYCD_PATHWAY
10.0%	7	70	247	Diabetes_McGill_Adipocytokine_signallin	REACTOME_METABOLISM_OF_CARBOHYDRATES
10.0%	7	70	22	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_AKT_PATHWAY
10.0%	7	70	21	Diabetes_McGill_Adipocytokine_signallin	REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION
10.0%	7	70	185	Diabetes_McGill_Adipocytokine_signallin	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
10.0%	7	70	17	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_41BB_PATHWAY
10.0%	7	70	148	Diabetes_McGill_Adipocytokine_signallin	REACTOME_APOPTOSIS
10.0%	7	70	1237	Diabetes_McGill_Adipocytokine_signallin	BLALOCK_ALZHEIMERS_DISEASE_DN
10.0%	7	70	120	Diabetes_McGill_Adipocytokine_signallin	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
10.0%	7	70	1103	Diabetes_McGill_Adipocytokine_signallin	DANG_BOUND_BY_MYC
10.0%	7	70	107	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SIGNALING_BY_ILS
10.0%	7	70	1022	Diabetes_McGill_Adipocytokine_signallin	MARSON_BOUND_BY_FOXP3_STIMULATED
10.0%	7	70	10	Diabetes_McGill_Adipocytokine_signallin	REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK
10.0%	3	30	953	Mendelian_Hereditary_Sensory_Neuropathy	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
10.0%	3	30	911	Mendelian_Hereditary_Sensory_Neuropathy	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
10.0%	3	30	898	Mendelian_Hereditary_Sensory_Neuropathy	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
10.0%	3	30	882	Mendelian_Hereditary_Sensory_Neuropathy	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
10.0%	3	30	824	Mendelian_Hereditary_Sensory_Neuropathy	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
10.0%	3	30	82	Mendelian_Hereditary_Sensory_Neuropathy	FRASOR_RESPONSE_TO_ESTRADIOL_DN
10.0%	3	30	811	Mendelian_Hereditary_Sensory_Neuropathy	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
10.0%	3	30	81	Mendelian_Hereditary_Sensory_Neuropathy	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
10.0%	3	30	800	Mendelian_Hereditary_Sensory_Neuropathy	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
10.0%	3	30	784	Mendelian_Hereditary_Sensory_Neuropathy	FORTSCHEGGER_PHF8_TARGETS_DN
10.0%	3	30	783	Mendelian_Hereditary_Sensory_Neuropathy	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
10.0%	3	30	770	Mendelian_Hereditary_Sensory_Neuropathy	KRIEG_HYPOXIA_NOT_VIA_KDM3A
10.0%	3	30	77	Mendelian_Hereditary_Sensory_Neuropathy	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
10.0%	3	30	756	Mendelian_Hereditary_Sensory_Neuropathy	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
10.0%	3	30	734	Mendelian_Hereditary_Sensory_Neuropathy	BENPORATH_SOX2_TARGETS
10.0%	3	30	721	Mendelian_Hereditary_Sensory_Neuropathy	WONG_ADULT_TISSUE_STEM_MODULE
10.0%	3	30	652	Mendelian_Hereditary_Sensory_Neuropathy	BENPORATH_PRC2_TARGETS
10.0%	3	30	602	Mendelian_Hereditary_Sensory_Neuropathy	MARTINEZ_TP53_TARGETS_UP
10.0%	3	30	601	Mendelian_Hereditary_Sensory_Neuropathy	MARTINEZ_RB1_AND_TP53_TARGETS_UP
10.0%	3	30	584	Mendelian_Hereditary_Sensory_Neuropathy	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
10.0%	3	30	578	Mendelian_Hereditary_Sensory_Neuropathy	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
10.0%	3	30	549	Mendelian_Hereditary_Sensory_Neuropathy	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
10.0%	3	30	546	Mendelian_Hereditary_Sensory_Neuropathy	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
10.0%	3	30	544	Mendelian_Hereditary_Sensory_Neuropathy	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
10.0%	3	30	544	Mendelian_Hereditary_Sensory_Neuropathy	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
10.0%	3	30	543	Mendelian_Hereditary_Sensory_Neuropathy	MARTINEZ_RB1_TARGETS_DN
10.0%	3	30	517	Mendelian_Hereditary_Sensory_Neuropathy	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
10.0%	3	30	481	Mendelian_Hereditary_Sensory_Neuropathy	LIU_PROSTATE_CANCER_DN
10.0%	3	30	478	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
10.0%	3	30	431	Mendelian_Hereditary_Sensory_Neuropathy	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
10.0%	3	30	430	Mendelian_Hereditary_Sensory_Neuropathy	RIGGI_EWING_SARCOMA_PROGENITOR_UP
10.0%	3	30	42	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_TRNA_AMINOACYLATION
10.0%	3	30	418	Mendelian_Hereditary_Sensory_Neuropathy	RUTELLA_RESPONSE_TO_HGF_UP
10.0%	3	30	418	Mendelian_Hereditary_Sensory_Neuropathy	PEDRIOLI_MIR31_TARGETS_DN
10.0%	3	30	414	Mendelian_Hereditary_Sensory_Neuropathy	MOHANKUMAR_TLX1_TARGETS_UP
10.0%	3	30	412	Mendelian_Hereditary_Sensory_Neuropathy	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
10.0%	3	30	41	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS
10.0%	3	30	396	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_DEVELOPMENTAL_BIOLOGY
10.0%	3	30	352	Mendelian_Hereditary_Sensory_Neuropathy	WANG_LMO4_TARGETS_DN
10.0%	3	30	342	Mendelian_Hereditary_Sensory_Neuropathy	BLUM_RESPONSE_TO_SALIRASIB_DN
10.0%	3	30	338	Mendelian_Hereditary_Sensory_Neuropathy	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
10.0%	3	30	337	Mendelian_Hereditary_Sensory_Neuropathy	PENG_GLUTAMINE_DEPRIVATION_DN
10.0%	3	30	307	Mendelian_Hereditary_Sensory_Neuropathy	LI_INDUCED_T_TO_NATURAL_KILLER_UP
10.0%	3	30	290	Mendelian_Hereditary_Sensory_Neuropathy	BENPORATH_OCT4_TARGETS
10.0%	3	30	289	Mendelian_Hereditary_Sensory_Neuropathy	MANALO_HYPOXIA_DN
10.0%	3	30	262	Mendelian_Hereditary_Sensory_Neuropathy	LU_AGING_BRAIN_UP
10.0%	3	30	261	Mendelian_Hereditary_Sensory_Neuropathy	RICKMAN_METASTASIS_DN
10.0%	3	30	253	Mendelian_Hereditary_Sensory_Neuropathy	DANG_REGULATED_BY_MYC_DN
10.0%	3	30	240	Mendelian_Hereditary_Sensory_Neuropathy	VANTVEER_BREAST_CANCER_ESR1_DN
10.0%	3	30	24	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION
10.0%	3	30	217	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_SIGNALLING_BY_NGF
10.0%	3	30	201	Mendelian_Hereditary_Sensory_Neuropathy	KIM_MYC_AMPLIFICATION_TARGETS_UP
10.0%	3	30	199	Mendelian_Hereditary_Sensory_Neuropathy	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
10.0%	3	30	195	Mendelian_Hereditary_Sensory_Neuropathy	KYNG_DNA_DAMAGE_DN
10.0%	3	30	163	Mendelian_Hereditary_Sensory_Neuropathy	SERVITJA_ISLET_HNF1A_TARGETS_UP
10.0%	3	30	159	Mendelian_Hereditary_Sensory_Neuropathy	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
10.0%	3	30	146	Mendelian_Hereditary_Sensory_Neuropathy	LEE_NEURAL_CREST_STEM_CELL_UP
10.0%	3	30	143	Mendelian_Hereditary_Sensory_Neuropathy	BASSO_B_LYMPHOCYTE_NETWORK
10.0%	3	30	142	Mendelian_Hereditary_Sensory_Neuropathy	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
10.0%	3	30	1229	Mendelian_Hereditary_Sensory_Neuropathy	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
10.0%	3	30	1174	Mendelian_Hereditary_Sensory_Neuropathy	PEREZ_TP53_TARGETS
10.0%	3	30	1142	Mendelian_Hereditary_Sensory_Neuropathy	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
10.0%	3	30	1103	Mendelian_Hereditary_Sensory_Neuropathy	DANG_BOUND_BY_MYC
10.0%	3	30	110	Mendelian_Hereditary_Sensory_Neuropathy	CHENG_IMPRINTED_BY_ESTRADIOL
10.0%	3	30	1062	Mendelian_Hereditary_Sensory_Neuropathy	BENPORATH_EED_TARGETS
10.0%	3	30	1037	Mendelian_Hereditary_Sensory_Neuropathy	NUYTTEN_EZH2_TARGETS_UP
10.0%	3	30	1011	Mendelian_Hereditary_Sensory_Neuropathy	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
10.0%	1	10	98	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GUO_TARGETS_OF_IRS1_AND_IRS2
10.0%	1	10	97	Mendelian_Disorders_of_Fatty_Acid_Oxidation	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP
10.0%	1	10	92	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KIM_MYCN_AMPLIFICATION_TARGETS_UP
10.0%	1	10	92	Mendelian_Disorders_of_Fatty_Acid_Oxidation	HILLION_HMGA1B_TARGETS
10.0%	1	10	911	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
10.0%	1	10	893	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GEORGES_TARGETS_OF_MIR192_AND_MIR215
10.0%	1	10	89	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LI_DCP2_BOUND_MRNA
10.0%	1	10	88	Mendelian_Disorders_of_Fatty_Acid_Oxidation	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
10.0%	1	10	88	Mendelian_Disorders_of_Fatty_Acid_Oxidation	ALCALA_APOPTOSIS
10.0%	1	10	86	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BROWNE_HCMV_INFECTION_16HR_DN
10.0%	1	10	85	Mendelian_Disorders_of_Fatty_Acid_Oxidation	XU_GH1_EXOGENOUS_TARGETS_UP
10.0%	1	10	848	Mendelian_Disorders_of_Fatty_Acid_Oxidation	NUYTTEN_NIPP1_TARGETS_DN
10.0%	1	10	841	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MARTENS_TRETINOIN_RESPONSE_DN
10.0%	1	10	84	Mendelian_Disorders_of_Fatty_Acid_Oxidation	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
10.0%	1	10	84	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LEE_AGING_CEREBELLUM_UP
10.0%	1	10	824	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
10.0%	1	10	82	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS
10.0%	1	10	811	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
10.0%	1	10	80	Mendelian_Disorders_of_Fatty_Acid_Oxidation	WOO_LIVER_CANCER_RECURRENCE_DN
10.0%	1	10	80	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REACTOME_UNFOLDED_PROTEIN_RESPONSE
10.0%	1	10	795	Mendelian_Disorders_of_Fatty_Acid_Oxidation	WEI_MYCN_TARGETS_WITH_E_BOX
10.0%	1	10	783	Mendelian_Disorders_of_Fatty_Acid_Oxidation	ONKEN_UVEAL_MELANOMA_UP
10.0%	1	10	781	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GOZGIT_ESR1_TARGETS_DN
10.0%	1	10	775	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BENPORATH_MYC_MAX_TARGETS
10.0%	1	10	77	Mendelian_Disorders_of_Fatty_Acid_Oxidation	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
10.0%	1	10	769	Mendelian_Disorders_of_Fatty_Acid_Oxidation	NUYTTEN_NIPP1_TARGETS_UP
10.0%	1	10	76	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
10.0%	1	10	76	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MAHAJAN_RESPONSE_TO_IL1A_DN
10.0%	1	10	734	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BENPORATH_SOX2_TARGETS
10.0%	1	10	712	Mendelian_Disorders_of_Fatty_Acid_Oxidation	SCHLOSSER_SERUM_RESPONSE_DN
10.0%	1	10	701	Mendelian_Disorders_of_Fatty_Acid_Oxidation	SMID_BREAST_CANCER_BASAL_DN
10.0%	1	10	70	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LANDIS_BREAST_CANCER_PROGRESSION_DN
10.0%	1	10	69	Mendelian_Disorders_of_Fatty_Acid_Oxidation	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
10.0%	1	10	69	Mendelian_Disorders_of_Fatty_Acid_Oxidation	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
10.0%	1	10	68	Mendelian_Disorders_of_Fatty_Acid_Oxidation	CASTELLANO_NRAS_TARGETS_UP
10.0%	1	10	673	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MARTINEZ_RB1_TARGETS_UP
10.0%	1	10	67	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
10.0%	1	10	66	Mendelian_Disorders_of_Fatty_Acid_Oxidation	RIGGINS_TAMOXIFEN_RESISTANCE_UP
10.0%	1	10	66	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LEE_LIVER_CANCER_CIPROFIBRATE_DN
10.0%	1	10	65	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LEE_LIVER_CANCER_MYC_TGFA_DN
10.0%	1	10	63	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BILBAN_B_CLL_LPL_UP
10.0%	1	10	61	Mendelian_Disorders_of_Fatty_Acid_Oxidation	RAMASWAMY_METASTASIS_DN
10.0%	1	10	61	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GENTILE_RESPONSE_CLUSTER_D3
10.0%	1	10	61	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BAKKER_FOXO3_TARGETS_UP
10.0%	1	10	602	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MARTINEZ_TP53_TARGETS_UP
10.0%	1	10	601	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MARTINEZ_RB1_AND_TP53_TARGETS_UP
10.0%	1	10	593	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MARTINEZ_TP53_TARGETS_DN
10.0%	1	10	591	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MARTINEZ_RB1_AND_TP53_TARGETS_DN
10.0%	1	10	584	Mendelian_Disorders_of_Fatty_Acid_Oxidation	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
10.0%	1	10	584	Mendelian_Disorders_of_Fatty_Acid_Oxidation	HAMAI_APOPTOSIS_VIA_TRAIL_UP
10.0%	1	10	572	Mendelian_Disorders_of_Fatty_Acid_Oxidation	CHICAS_RB1_TARGETS_SENESCENT
10.0%	1	10	553	Mendelian_Disorders_of_Fatty_Acid_Oxidation	FEVR_CTNNB1_TARGETS_DN
10.0%	1	10	55	Mendelian_Disorders_of_Fatty_Acid_Oxidation	SU_LIVER
10.0%	1	10	546	Mendelian_Disorders_of_Fatty_Acid_Oxidation	WEST_ADRENOCORTICAL_TUMOR_DN
10.0%	1	10	543	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MARTINEZ_RB1_TARGETS_DN
10.0%	1	10	530	Mendelian_Disorders_of_Fatty_Acid_Oxidation	ENK_UV_RESPONSE_KERATINOCYTE_UP
10.0%	1	10	53	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REACTOME_CIRCADIAN_CLOCK
10.0%	1	10	526	Mendelian_Disorders_of_Fatty_Acid_Oxidation	ONKEN_UVEAL_MELANOMA_DN
10.0%	1	10	52	Mendelian_Disorders_of_Fatty_Acid_Oxidation	WINTER_HYPOXIA_DN
10.0%	1	10	517	Mendelian_Disorders_of_Fatty_Acid_Oxidation	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
10.0%	1	10	51	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GUILLAUMOND_KLF10_TARGETS_UP
10.0%	1	10	51	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
10.0%	1	10	505	Mendelian_Disorders_of_Fatty_Acid_Oxidation	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
10.0%	1	10	504	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BROWNE_HCMV_INFECTION_48HR_DN
10.0%	1	10	50	Mendelian_Disorders_of_Fatty_Acid_Oxidation	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
10.0%	1	10	50	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KOHOUTEK_CCNT1_TARGETS
10.0%	1	10	50	Mendelian_Disorders_of_Fatty_Acid_Oxidation	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC
10.0%	1	10	493	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
10.0%	1	10	482	Mendelian_Disorders_of_Fatty_Acid_Oxidation	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
10.0%	1	10	47	Mendelian_Disorders_of_Fatty_Acid_Oxidation	ZHAN_MULTIPLE_MYELOMA_MF_UP
10.0%	1	10	47	Mendelian_Disorders_of_Fatty_Acid_Oxidation	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP
10.0%	1	10	461	Mendelian_Disorders_of_Fatty_Acid_Oxidation	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
10.0%	1	10	46	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
10.0%	1	10	456	Mendelian_Disorders_of_Fatty_Acid_Oxidation	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
10.0%	1	10	45	Mendelian_Disorders_of_Fatty_Acid_Oxidation	SHIPP_DLBCL_CURED_VS_FATAL_DN
10.0%	1	10	44	Mendelian_Disorders_of_Fatty_Acid_Oxidation	VANTVEER_BREAST_CANCER_BRCA1_DN
10.0%	1	10	44	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KEGG_LYSINE_DEGRADATION
10.0%	1	10	434	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BAELDE_DIABETIC_NEPHROPATHY_DN
10.0%	1	10	430	Mendelian_Disorders_of_Fatty_Acid_Oxidation	JOHNSTONE_PARVB_TARGETS_3_UP
10.0%	1	10	43	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
10.0%	1	10	428	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LIM_MAMMARY_STEM_CELL_DN
10.0%	1	10	425	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BOCHKIS_FOXA2_TARGETS
10.0%	1	10	42	Mendelian_Disorders_of_Fatty_Acid_Oxidation	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
10.0%	1	10	42	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LUI_THYROID_CANCER_CLUSTER_2
10.0%	1	10	41	Mendelian_Disorders_of_Fatty_Acid_Oxidation	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
10.0%	1	10	408	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
10.0%	1	10	40	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KEGG_TRYPTOPHAN_METABOLISM
10.0%	1	10	397	Mendelian_Disorders_of_Fatty_Acid_Oxidation	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
10.0%	1	10	390	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
10.0%	1	10	38	Mendelian_Disorders_of_Fatty_Acid_Oxidation	VARELA_ZMPSTE24_TARGETS_DN
10.0%	1	10	38	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP
10.0%	1	10	38	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN
10.0%	1	10	38	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN
10.0%	1	10	373	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
10.0%	1	10	37	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LANDIS_ERBB2_BREAST_TUMORS_65_DN
10.0%	1	10	368	Mendelian_Disorders_of_Fatty_Acid_Oxidation	YAGI_AML_WITH_T_8_21_TRANSLOCATION
10.0%	1	10	367	Mendelian_Disorders_of_Fatty_Acid_Oxidation	DELACROIX_RARG_BOUND_MEF
10.0%	1	10	366	Mendelian_Disorders_of_Fatty_Acid_Oxidation	SANSOM_APC_TARGETS_DN
10.0%	1	10	358	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GRUETZMANN_PANCREATIC_CANCER_UP
10.0%	1	10	356	Mendelian_Disorders_of_Fatty_Acid_Oxidation	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
10.0%	1	10	354	Mendelian_Disorders_of_Fatty_Acid_Oxidation	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
10.0%	1	10	346	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GOLDRATH_ANTIGEN_RESPONSE
10.0%	1	10	341	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MULLIGHAN_NPM1_SIGNATURE_3_UP
10.0%	1	10	34	Mendelian_Disorders_of_Fatty_Acid_Oxidation	YANG_BREAST_CANCER_ESR1_LASER_UP
10.0%	1	10	34	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KEGG_BUTANOATE_METABOLISM
10.0%	1	10	335	Mendelian_Disorders_of_Fatty_Acid_Oxidation	WONG_EMBRYONIC_STEM_CELL_CORE
10.0%	1	10	330	Mendelian_Disorders_of_Fatty_Acid_Oxidation	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
10.0%	1	10	33	Mendelian_Disorders_of_Fatty_Acid_Oxidation	SCHRAETS_MLL_TARGETS_DN
10.0%	1	10	329	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
10.0%	1	10	32	Mendelian_Disorders_of_Fatty_Acid_Oxidation	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN
10.0%	1	10	316	Mendelian_Disorders_of_Fatty_Acid_Oxidation	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
10.0%	1	10	312	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GENTILE_UV_HIGH_DOSE_DN
10.0%	1	10	309	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LIU_SOX4_TARGETS_DN
10.0%	1	10	302	Mendelian_Disorders_of_Fatty_Acid_Oxidation	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
10.0%	1	10	30	Mendelian_Disorders_of_Fatty_Acid_Oxidation	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN
10.0%	1	10	298	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BROWNE_HCMV_INFECTION_14HR_DN
10.0%	1	10	295	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LU_EZH2_TARGETS_UP
10.0%	1	10	290	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BENPORATH_OCT4_TARGETS
10.0%	1	10	28	Mendelian_Disorders_of_Fatty_Acid_Oxidation	DAIRKEE_CANCER_PRONE_RESPONSE_E2
10.0%	1	10	276	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
10.0%	1	10	276	Mendelian_Disorders_of_Fatty_Acid_Oxidation	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
10.0%	1	10	271	Mendelian_Disorders_of_Fatty_Acid_Oxidation	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
10.0%	1	10	271	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
10.0%	1	10	265	Mendelian_Disorders_of_Fatty_Acid_Oxidation	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
10.0%	1	10	261	Mendelian_Disorders_of_Fatty_Acid_Oxidation	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
10.0%	1	10	254	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BROWNE_HCMV_INFECTION_4HR_DN
10.0%	1	10	25	Mendelian_Disorders_of_Fatty_Acid_Oxidation	RUAN_RESPONSE_TO_TROGLITAZONE_UP
10.0%	1	10	245	Mendelian_Disorders_of_Fatty_Acid_Oxidation	PENG_RAPAMYCIN_RESPONSE_DN
10.0%	1	10	244	Mendelian_Disorders_of_Fatty_Acid_Oxidation	PLASARI_TGFB1_TARGETS_10HR_DN
10.0%	1	10	244	Mendelian_Disorders_of_Fatty_Acid_Oxidation	HSIAO_LIVER_SPECIFIC_GENES
10.0%	1	10	240	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BROWNE_HCMV_INFECTION_20HR_UP
10.0%	1	10	24	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION
10.0%	1	10	24	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GOLUB_ALL_VS_AML_UP
10.0%	1	10	239	Mendelian_Disorders_of_Fatty_Acid_Oxidation	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
10.0%	1	10	230	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BENPORATH_MYC_TARGETS_WITH_EBOX
10.0%	1	10	229	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
10.0%	1	10	228	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MARKEY_RB1_ACUTE_LOF_DN
10.0%	1	10	225	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BROWNE_HCMV_INFECTION_16HR_UP
10.0%	1	10	220	Mendelian_Disorders_of_Fatty_Acid_Oxidation	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
10.0%	1	10	220	Mendelian_Disorders_of_Fatty_Acid_Oxidation	RIGGINS_TAMOXIFEN_RESISTANCE_DN
10.0%	1	10	22	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS
10.0%	1	10	214	Mendelian_Disorders_of_Fatty_Acid_Oxidation	ZWANG_EGF_INTERVAL_DN
10.0%	1	10	206	Mendelian_Disorders_of_Fatty_Acid_Oxidation	RAMALHO_STEMNESS_UP
10.0%	1	10	203	Mendelian_Disorders_of_Fatty_Acid_Oxidation	PENG_RAPAMYCIN_RESPONSE_UP
10.0%	1	10	203	Mendelian_Disorders_of_Fatty_Acid_Oxidation	PAL_PRMT5_TARGETS_UP
10.0%	1	10	203	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GRUETZMANN_PANCREATIC_CANCER_DN
10.0%	1	10	201	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KIM_MYC_AMPLIFICATION_TARGETS_UP
10.0%	1	10	200	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
10.0%	1	10	198	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REACTOME_PHOSPHOLIPID_METABOLISM
10.0%	1	10	198	Mendelian_Disorders_of_Fatty_Acid_Oxidation	ALONSO_METASTASIS_UP
10.0%	1	10	1972	Mendelian_Disorders_of_Fatty_Acid_Oxidation	PILON_KLF1_TARGETS_DN
10.0%	1	10	19	Mendelian_Disorders_of_Fatty_Acid_Oxidation	ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE
10.0%	1	10	189	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BURTON_ADIPOGENESIS_6
10.0%	1	10	185	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LEE_LIVER_CANCER_SURVIVAL_UP
10.0%	1	10	182	Mendelian_Disorders_of_Fatty_Acid_Oxidation	FERNANDEZ_BOUND_BY_MYC
10.0%	1	10	181	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
10.0%	1	10	180	Mendelian_Disorders_of_Fatty_Acid_Oxidation	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
10.0%	1	10	179	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BENPORATH_NOS_TARGETS
10.0%	1	10	176	Mendelian_Disorders_of_Fatty_Acid_Oxidation	SASAKI_ADULT_T_CELL_LEUKEMIA
10.0%	1	10	172	Mendelian_Disorders_of_Fatty_Acid_Oxidation	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
10.0%	1	10	172	Mendelian_Disorders_of_Fatty_Acid_Oxidation	SMID_BREAST_CANCER_LUMINAL_B_UP
10.0%	1	10	170	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
10.0%	1	10	17	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM
10.0%	1	10	169	Mendelian_Disorders_of_Fatty_Acid_Oxidation	UEDA_PERIFERAL_CLOCK
10.0%	1	10	169	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
10.0%	1	10	167	Mendelian_Disorders_of_Fatty_Acid_Oxidation	VANTVEER_BREAST_CANCER_ESR1_UP
10.0%	1	10	165	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LIU_CMYB_TARGETS_UP
10.0%	1	10	163	Mendelian_Disorders_of_Fatty_Acid_Oxidation	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
10.0%	1	10	161	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BIDUS_METASTASIS_DN
10.0%	1	10	159	Mendelian_Disorders_of_Fatty_Acid_Oxidation	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
10.0%	1	10	158	Mendelian_Disorders_of_Fatty_Acid_Oxidation	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON
10.0%	1	10	151	Mendelian_Disorders_of_Fatty_Acid_Oxidation	IGLESIAS_E2F_TARGETS_UP
10.0%	1	10	149	Mendelian_Disorders_of_Fatty_Acid_Oxidation	HUANG_GATA2_TARGETS_UP
10.0%	1	10	146	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KIM_ALL_DISORDERS_DURATION_CORR_DN
10.0%	1	10	14	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP
10.0%	1	10	137	Mendelian_Disorders_of_Fatty_Acid_Oxidation	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
10.0%	1	10	134	Mendelian_Disorders_of_Fatty_Acid_Oxidation	POOLA_INVASIVE_BREAST_CANCER_DN
10.0%	1	10	134	Mendelian_Disorders_of_Fatty_Acid_Oxidation	CHUNG_BLISTER_CYTOTOXICITY_UP
10.0%	1	10	133	Mendelian_Disorders_of_Fatty_Acid_Oxidation	REACTOME_DIABETES_PATHWAYS
10.0%	1	10	133	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GAL_LEUKEMIC_STEM_CELL_UP
10.0%	1	10	13	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LUI_THYROID_CANCER_CLUSTER_5
10.0%	1	10	13	Mendelian_Disorders_of_Fatty_Acid_Oxidation	CAFFAREL_RESPONSE_TO_THC_24HR_3_DN
10.0%	1	10	128	Mendelian_Disorders_of_Fatty_Acid_Oxidation	POTTI_TOPOTECAN_SENSITIVITY
10.0%	1	10	127	Mendelian_Disorders_of_Fatty_Acid_Oxidation	LIU_VMYB_TARGETS_UP
10.0%	1	10	1237	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BLALOCK_ALZHEIMERS_DISEASE_DN
10.0%	1	10	123	Mendelian_Disorders_of_Fatty_Acid_Oxidation	DAZARD_RESPONSE_TO_UV_SCC_UP
10.0%	1	10	1210	Mendelian_Disorders_of_Fatty_Acid_Oxidation	CHEN_METABOLIC_SYNDROM_NETWORK
10.0%	1	10	120	Mendelian_Disorders_of_Fatty_Acid_Oxidation	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
10.0%	1	10	115	Mendelian_Disorders_of_Fatty_Acid_Oxidation	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
10.0%	1	10	113	Mendelian_Disorders_of_Fatty_Acid_Oxidation	RICKMAN_HEAD_AND_NECK_CANCER_C
10.0%	1	10	112	Mendelian_Disorders_of_Fatty_Acid_Oxidation	PASINI_SUZ12_TARGETS_UP
10.0%	1	10	112	Mendelian_Disorders_of_Fatty_Acid_Oxidation	DOANE_BREAST_CANCER_ESR1_UP
10.0%	1	10	112	Mendelian_Disorders_of_Fatty_Acid_Oxidation	DITTMER_PTHLH_TARGETS_UP
10.0%	1	10	11	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BIOCARTA_LEPTIN_PATHWAY
10.0%	1	10	109	Mendelian_Disorders_of_Fatty_Acid_Oxidation	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
10.0%	1	10	1080	Mendelian_Disorders_of_Fatty_Acid_Oxidation	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
10.0%	1	10	1069	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
10.0%	1	10	1038	Mendelian_Disorders_of_Fatty_Acid_Oxidation	BENPORATH_SUZ12_TARGETS
10.0%	1	10	103	Mendelian_Disorders_of_Fatty_Acid_Oxidation	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
10.0%	1	10	1022	Mendelian_Disorders_of_Fatty_Acid_Oxidation	MARSON_BOUND_BY_FOXP3_STIMULATED
10.0%	1	10	1011	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
10.0%	1	10	100	Mendelian_Disorders_of_Fatty_Acid_Oxidation	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
10.0%	1	10	10	Mendelian_Disorders_of_Fatty_Acid_Oxidation	KEGG_LIMONENE_AND_PINENE_DEGRADATION
9.88776055585%	185	1871	1781	T2D_GENES_TANYA_HEIGHT	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
9.88776055585%	185	1871	1691	T2D_GENES_TANYA_HEIGHT	BLALOCK_ALZHEIMERS_DISEASE_UP
9.8814229249%	25	253	72	Diabetes_McGill_CREBBP_coTF	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
9.8814229249%	25	253	483	Diabetes_McGill_CREBBP_coTF	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
9.8814229249%	25	253	1839	Diabetes_McGill_CREBBP_coTF	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
9.87654320988%	8	81	553	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FEVR_CTNNB1_TARGETS_DN
9.87654320988%	8	81	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_PTP1BPATHWAY
9.87654320988%	8	81	466	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_HEMOSTASIS
9.87654320988%	8	81	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ROLEF_GLIS3_TARGETS
9.87654320988%	8	81	1725	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
9.87654320988%	8	81	1069	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
9.78792822186%	60	613	1972	T2D_GENES_TANYA_BIOMARKER	PILON_KLF1_TARGETS_DN
9.77859778598%	53	542	1781	T2D_GENES_TANYA_ANTHROPOMETRIC	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
9.77859778598%	53	542	1691	T2D_GENES_TANYA_ANTHROPOMETRIC	BLALOCK_ALZHEIMERS_DISEASE_UP
9.75609756098%	4	41	95	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
9.75609756098%	4	41	933	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_IMMUNE_SYSTEM
9.75609756098%	4	41	91	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
9.75609756098%	4	41	90	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SIGNALING_BY_ERBB4
9.75609756098%	4	41	898	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
9.75609756098%	4	41	893	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GEORGES_TARGETS_OF_MIR192_AND_MIR215
9.75609756098%	4	41	86	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
9.75609756098%	4	41	857	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARTENS_TRETINOIN_RESPONSE_UP
9.75609756098%	4	41	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_SMALL_CELL_LUNG_CANCER
9.75609756098%	4	41	82	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ST_INTEGRIN_SIGNALING_PATHWAY
9.75609756098%	4	41	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WOO_LIVER_CANCER_RECURRENCE_DN
9.75609756098%	4	41	78	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SIGNALING_BY_SCF_KIT
9.75609756098%	4	41	71	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_MELANOMA
9.75609756098%	4	41	663	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
9.75609756098%	4	41	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_GLIOMA
9.75609756098%	4	41	637	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
9.75609756098%	4	41	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_PI_3K_CASCADE
9.75609756098%	4	41	552	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
9.75609756098%	4	41	540	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ACEVEDO_LIVER_CANCER_DN
9.75609756098%	4	41	539	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
9.75609756098%	4	41	536	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SENESE_HDAC3_TARGETS_DN
9.75609756098%	4	41	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_MTOR_SIGNALING_PATHWAY
9.75609756098%	4	41	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_ENDOMETRIAL_CANCER
9.75609756098%	4	41	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
9.75609756098%	4	41	504	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PILON_KLF1_TARGETS_UP
9.75609756098%	4	41	481	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LIU_PROSTATE_CANCER_DN
9.75609756098%	4	41	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_HES_HEYPATHWAY
9.75609756098%	4	41	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SIG_CHEMOTAXIS
9.75609756098%	4	41	447	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MOOTHA_MITOCHONDRIA
9.75609756098%	4	41	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
9.75609756098%	4	41	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_TCPTP_PATHWAY
9.75609756098%	4	41	429	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MOOTHA_HUMAN_MITODB_6_2002
9.75609756098%	4	41	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
9.75609756098%	4	41	413	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
9.75609756098%	4	41	403	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
9.75609756098%	4	41	395	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HAN_SATB1_TARGETS_UP
9.75609756098%	4	41	394	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BERENJENO_TRANSFORMED_BY_RHOA_DN
9.75609756098%	4	41	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
9.75609756098%	4	41	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_PI3K_AKT_ACTIVATION
9.75609756098%	4	41	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_GAB1_SIGNALOSOME
9.75609756098%	4	41	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_HDAC_PATHWAY
9.75609756098%	4	41	266	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
9.75609756098%	4	41	262	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LU_AGING_BRAIN_UP
9.75609756098%	4	41	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_INSULIN_GLUCOSE_PATHWAY
9.75609756098%	4	41	253	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DANG_REGULATED_BY_MYC_DN
9.75609756098%	4	41	230	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BENPORATH_MYC_TARGETS_WITH_EBOX
9.75609756098%	4	41	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_INSULIN_PATHWAY
9.75609756098%	4	41	217	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SIGNALLING_BY_NGF
9.75609756098%	4	41	197	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
9.75609756098%	4	41	1821	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DODD_NASOPHARYNGEAL_CARCINOMA_UP
9.75609756098%	4	41	137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
9.75609756098%	4	41	133	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_DIABETES_PATHWAYS
9.75609756098%	4	41	127	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
9.75609756098%	4	41	122	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SIGNALING_BY_PDGF
9.75609756098%	4	41	112	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SIGNALING_BY_FGFR
9.75609756098%	4	41	1103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DANG_BOUND_BY_MYC
9.75609756098%	4	41	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHOU_PANCREATIC_BETA_CELL
9.75609756098%	4	41	109	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
9.75609756098%	4	41	1080	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
9.75609756098%	4	41	1022	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARSON_BOUND_BY_FOXP3_STIMULATED
9.75609756098%	4	41	101	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SIGNALING_BY_ERBB2
9.75609756098%	4	41	100	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
9.67741935484%	3	31	918	Diabetes_McGill_IL10	JOHNSTONE_PARVB_TARGETS_3_DN
9.67741935484%	3	31	893	Diabetes_McGill_IL10	GEORGES_TARGETS_OF_MIR192_AND_MIR215
9.67741935484%	3	31	89	Diabetes_McGill_IL10	BOYLAN_MULTIPLE_MYELOMA_D_UP
9.67741935484%	3	31	882	Diabetes_McGill_IL10	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
9.67741935484%	3	31	88	Diabetes_McGill_IL10	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
9.67741935484%	3	31	86	Diabetes_McGill_IL10	KEGG_TGF_BETA_SIGNALING_PATHWAY
9.67741935484%	3	31	85	Diabetes_McGill_IL10	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
9.67741935484%	3	31	848	Diabetes_McGill_IL10	NUYTTEN_NIPP1_TARGETS_DN
9.67741935484%	3	31	841	Diabetes_McGill_IL10	MARTENS_TRETINOIN_RESPONSE_DN
9.67741935484%	3	31	84	Diabetes_McGill_IL10	PID_CMYB_PATHWAY
9.67741935484%	3	31	824	Diabetes_McGill_IL10	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
9.67741935484%	3	31	811	Diabetes_McGill_IL10	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
9.67741935484%	3	31	81	Diabetes_McGill_IL10	GRABARCZYK_BCL11B_TARGETS_UP
9.67741935484%	3	31	783	Diabetes_McGill_IL10	ONKEN_UVEAL_MELANOMA_UP
9.67741935484%	3	31	77	Diabetes_McGill_IL10	JACKSON_DNMT1_TARGETS_UP
9.67741935484%	3	31	77	Diabetes_McGill_IL10	CARD_MIR302A_TARGETS
9.67741935484%	3	31	74	Diabetes_McGill_IL10	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS
9.67741935484%	3	31	74	Diabetes_McGill_IL10	PID_E2F_PATHWAY
9.67741935484%	3	31	71	Diabetes_McGill_IL10	REACTOME_PI3K_CASCADE
9.67741935484%	3	31	71	Diabetes_McGill_IL10	KYNG_RESPONSE_TO_H2O2
9.67741935484%	3	31	69	Diabetes_McGill_IL10	KEGG_P53_SIGNALING_PATHWAY
9.67741935484%	3	31	68	Diabetes_McGill_IL10	PID_TELOMERASEPATHWAY
9.67741935484%	3	31	66	Diabetes_McGill_IL10	NAKAMURA_ADIPOGENESIS_EARLY_UP
9.67741935484%	3	31	66	Diabetes_McGill_IL10	DIRMEIER_LMP1_RESPONSE_EARLY
9.67741935484%	3	31	648	Diabetes_McGill_IL10	SMID_BREAST_CANCER_BASAL_UP
9.67741935484%	3	31	648	Diabetes_McGill_IL10	BENPORATH_CYCLING_GENES
9.67741935484%	3	31	64	Diabetes_McGill_IL10	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
9.67741935484%	3	31	634	Diabetes_McGill_IL10	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
9.67741935484%	3	31	63	Diabetes_McGill_IL10	PID_IL12_2PATHWAY
9.67741935484%	3	31	602	Diabetes_McGill_IL10	MARTINEZ_TP53_TARGETS_UP
9.67741935484%	3	31	593	Diabetes_McGill_IL10	MARTINEZ_TP53_TARGETS_DN
9.67741935484%	3	31	59	Diabetes_McGill_IL10	PID_FAK_PATHWAY
9.67741935484%	3	31	584	Diabetes_McGill_IL10	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
9.67741935484%	3	31	58	Diabetes_McGill_IL10	BIOCARTA_PPARA_PATHWAY
9.67741935484%	3	31	570	Diabetes_McGill_IL10	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
9.67741935484%	3	31	57	Diabetes_McGill_IL10	PID_TXA2PATHWAY
9.67741935484%	3	31	56	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_30MIN_UP
9.67741935484%	3	31	56	Diabetes_McGill_IL10	BIOCARTA_NFAT_PATHWAY
9.67741935484%	3	31	54	Diabetes_McGill_IL10	PID_RAC1_PATHWAY
9.67741935484%	3	31	54	Diabetes_McGill_IL10	PID_NFAT_3PATHWAY
9.67741935484%	3	31	536	Diabetes_McGill_IL10	BERENJENO_TRANSFORMED_BY_RHOA_UP
9.67741935484%	3	31	53	Diabetes_McGill_IL10	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
9.67741935484%	3	31	52	Diabetes_McGill_IL10	PID_KITPATHWAY
9.67741935484%	3	31	51	Diabetes_McGill_IL10	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
9.67741935484%	3	31	51	Diabetes_McGill_IL10	BURTON_ADIPOGENESIS_PEAK_AT_2HR
9.67741935484%	3	31	508	Diabetes_McGill_IL10	ENK_UV_RESPONSE_EPIDERMIS_DN
9.67741935484%	3	31	504	Diabetes_McGill_IL10	PILON_KLF1_TARGETS_UP
9.67741935484%	3	31	491	Diabetes_McGill_IL10	ZHENG_BOUND_BY_FOXP3
9.67741935484%	3	31	49	Diabetes_McGill_IL10	DAUER_STAT3_TARGETS_UP
9.67741935484%	3	31	489	Diabetes_McGill_IL10	LIM_MAMMARY_STEM_CELL_UP
9.67741935484%	3	31	485	Diabetes_McGill_IL10	ENK_UV_RESPONSE_KERATINOCYTE_DN
9.67741935484%	3	31	48	Diabetes_McGill_IL10	PID_CERAMIDE_PATHWAY
9.67741935484%	3	31	460	Diabetes_McGill_IL10	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
9.67741935484%	3	31	46	Diabetes_McGill_IL10	BIOCARTA_KERATINOCYTE_PATHWAY
9.67741935484%	3	31	457	Diabetes_McGill_IL10	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
9.67741935484%	3	31	45	Diabetes_McGill_IL10	SIG_CHEMOTAXIS
9.67741935484%	3	31	430	Diabetes_McGill_IL10	JOHNSTONE_PARVB_TARGETS_3_UP
9.67741935484%	3	31	425	Diabetes_McGill_IL10	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
9.67741935484%	3	31	42	Diabetes_McGill_IL10	KEGG_BLADDER_CANCER
9.67741935484%	3	31	41	Diabetes_McGill_IL10	PID_ERBB1_INTERNALIZATION_PATHWAY
9.67741935484%	3	31	408	Diabetes_McGill_IL10	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
9.67741935484%	3	31	40	Diabetes_McGill_IL10	PID_IFNGPATHWAY
9.67741935484%	3	31	40	Diabetes_McGill_IL10	PID_FOXM1PATHWAY
9.67741935484%	3	31	40	Diabetes_McGill_IL10	BIOCARTA_P38MAPK_PATHWAY
9.67741935484%	3	31	397	Diabetes_McGill_IL10	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
9.67741935484%	3	31	38	Diabetes_McGill_IL10	REACTOME_PI3K_AKT_ACTIVATION
9.67741935484%	3	31	38	Diabetes_McGill_IL10	PID_ERBB4_PATHWAY
9.67741935484%	3	31	37	Diabetes_McGill_IL10	PID_GMCSF_PATHWAY
9.67741935484%	3	31	366	Diabetes_McGill_IL10	YOSHIMURA_MAPK8_TARGETS_DN
9.67741935484%	3	31	364	Diabetes_McGill_IL10	YANG_BCL3_TARGETS_UP
9.67741935484%	3	31	36	Diabetes_McGill_IL10	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
9.67741935484%	3	31	351	Diabetes_McGill_IL10	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
9.67741935484%	3	31	34	Diabetes_McGill_IL10	SIG_CD40PATHWAYMAP
9.67741935484%	3	31	337	Diabetes_McGill_IL10	PENG_GLUTAMINE_DEPRIVATION_DN
9.67741935484%	3	31	314	Diabetes_McGill_IL10	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
9.67741935484%	3	31	311	Diabetes_McGill_IL10	JIANG_HYPOXIA_NORMAL
9.67741935484%	3	31	31	Diabetes_McGill_IL10	SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN
9.67741935484%	3	31	299	Diabetes_McGill_IL10	WALLACE_PROSTATE_CANCER_RACE_UP
9.67741935484%	3	31	299	Diabetes_McGill_IL10	MUELLER_PLURINET
9.67741935484%	3	31	294	Diabetes_McGill_IL10	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
9.67741935484%	3	31	289	Diabetes_McGill_IL10	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
9.67741935484%	3	31	28	Diabetes_McGill_IL10	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING
9.67741935484%	3	31	279	Diabetes_McGill_IL10	REACTOME_INNATE_IMMUNE_SYSTEM
9.67741935484%	3	31	27	Diabetes_McGill_IL10	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
9.67741935484%	3	31	27	Diabetes_McGill_IL10	PID_IL3_PATHWAY
9.67741935484%	3	31	261	Diabetes_McGill_IL10	BILD_HRAS_ONCOGENIC_SIGNATURE
9.67741935484%	3	31	254	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_4HR_DN
9.67741935484%	3	31	253	Diabetes_McGill_IL10	MCLACHLAN_DENTAL_CARIES_UP
9.67741935484%	3	31	251	Diabetes_McGill_IL10	KOBAYASHI_EGFR_SIGNALING_24HR_DN
9.67741935484%	3	31	250	Diabetes_McGill_IL10	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
9.67741935484%	3	31	25	Diabetes_McGill_IL10	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
9.67741935484%	3	31	25	Diabetes_McGill_IL10	PID_LYMPHANGIOGENESIS_PATHWAY
9.67741935484%	3	31	25	Diabetes_McGill_IL10	BIOCARTA_STRESS_PATHWAY
9.67741935484%	3	31	249	Diabetes_McGill_IL10	MITSIADES_RESPONSE_TO_APLIDIN_DN
9.67741935484%	3	31	245	Diabetes_McGill_IL10	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
9.67741935484%	3	31	242	Diabetes_McGill_IL10	WINTER_HYPOXIA_METAGENE
9.67741935484%	3	31	240	Diabetes_McGill_IL10	UDAYAKUMAR_MED1_TARGETS_DN
9.67741935484%	3	31	24	Diabetes_McGill_IL10	REACTOME_REGULATION_OF_IFNA_SIGNALING
9.67741935484%	3	31	24	Diabetes_McGill_IL10	BIOCARTA_EIF4_PATHWAY
9.67741935484%	3	31	238	Diabetes_McGill_IL10	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
9.67741935484%	3	31	23	Diabetes_McGill_IL10	BIOCARTA_GLEEVEC_PATHWAY
9.67741935484%	3	31	23	Diabetes_McGill_IL10	BIOCARTA_CTCF_PATHWAY
9.67741935484%	3	31	22	Diabetes_McGill_IL10	BIOCARTA_IL6_PATHWAY
9.67741935484%	3	31	217	Diabetes_McGill_IL10	SANSOM_APC_MYC_TARGETS
9.67741935484%	3	31	210	Diabetes_McGill_IL10	RIZKI_TUMOR_INVASIVENESS_3D_UP
9.67741935484%	3	31	209	Diabetes_McGill_IL10	GROSS_HYPOXIA_VIA_ELK3_UP
9.67741935484%	3	31	205	Diabetes_McGill_IL10	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
9.67741935484%	3	31	197	Diabetes_McGill_IL10	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
9.67741935484%	3	31	187	Diabetes_McGill_IL10	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
9.67741935484%	3	31	187	Diabetes_McGill_IL10	PENG_LEUCINE_DEPRIVATION_DN
9.67741935484%	3	31	184	Diabetes_McGill_IL10	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
9.67741935484%	3	31	181	Diabetes_McGill_IL10	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
9.67741935484%	3	31	18	Diabetes_McGill_IL10	REACTOME_REGULATION_OF_SIGNALING_BY_CBL
9.67741935484%	3	31	1781	Diabetes_McGill_IL10	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
9.67741935484%	3	31	176	Diabetes_McGill_IL10	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
9.67741935484%	3	31	175	Diabetes_McGill_IL10	FIRESTEIN_PROLIFERATION
9.67741935484%	3	31	1725	Diabetes_McGill_IL10	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
9.67741935484%	3	31	171	Diabetes_McGill_IL10	GOLDRATH_HOMEOSTATIC_PROLIFERATION
9.67741935484%	3	31	164	Diabetes_McGill_IL10	AMIT_EGF_RESPONSE_480_HELA
9.67741935484%	3	31	159	Diabetes_McGill_IL10	REACTOME_INTERFERON_SIGNALING
9.67741935484%	3	31	14	Diabetes_McGill_IL10	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN
9.67741935484%	3	31	129	Diabetes_McGill_IL10	YAGI_AML_SURVIVAL
9.67741935484%	3	31	127	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
9.67741935484%	3	31	120	Diabetes_McGill_IL10	REACTOME_CELL_CELL_COMMUNICATION
9.67741935484%	3	31	114	Diabetes_McGill_IL10	SMIRNOV_RESPONSE_TO_IR_6HR_DN
9.67741935484%	3	31	109	Diabetes_McGill_IL10	REACTOME_S_PHASE
9.67741935484%	3	31	1069	Diabetes_McGill_IL10	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
9.67741935484%	12	124	87	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_MITOTIC_PROMETAPHASE
9.67741935484%	12	124	84	Diabetes_McGill_Cell_cycle_All_Gene	PID_CMYB_PATHWAY
9.67741935484%	12	124	673	Diabetes_McGill_Cell_cycle_All_Gene	MARTINEZ_RB1_TARGETS_UP
9.67741935484%	12	124	55	Diabetes_McGill_Cell_cycle_All_Gene	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53
9.67741935484%	12	124	466	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_HEMOSTASIS
9.67741935484%	12	124	46	Diabetes_McGill_Cell_cycle_All_Gene	PID_PLK1_PATHWAY
9.67741935484%	12	124	457	Diabetes_McGill_Cell_cycle_All_Gene	SENESE_HDAC1_TARGETS_UP
9.67741935484%	12	124	253	Diabetes_McGill_Cell_cycle_All_Gene	DANG_REGULATED_BY_MYC_DN
9.67741935484%	12	124	185	Diabetes_McGill_Cell_cycle_All_Gene	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
9.67741935484%	12	124	176	Diabetes_McGill_Cell_cycle_All_Gene	SASAKI_ADULT_T_CELL_LEUKEMIA
9.67741935484%	12	124	162	Diabetes_McGill_Cell_cycle_All_Gene	WINNEPENNINCKX_MELANOMA_METASTASIS_UP
9.67741935484%	12	124	16	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_P53_PATHWAY
9.67741935484%	12	124	131	Diabetes_McGill_Cell_cycle_All_Gene	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
9.67741935484%	12	124	13	Diabetes_McGill_Cell_cycle_All_Gene	SA_REG_CASCADE_OF_CYCLIN_EXPR
9.67741935484%	12	124	122	Diabetes_McGill_Cell_cycle_All_Gene	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
9.67741935484%	12	124	117	Diabetes_McGill_Cell_cycle_All_Gene	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
9.67741935484%	12	124	107	Diabetes_McGill_Cell_cycle_All_Gene	LEE_EARLY_T_LYMPHOCYTE_UP
9.67741935484%	12	124	1011	Diabetes_McGill_Cell_cycle_All_Gene	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
9.67032967033%	44	455	1839	T2D_GENES_TANYA_BLOODPRESSURE	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
9.59409594096%	52	542	1652	T2D_GENES_TANYA_ANTHROPOMETRIC	PUJANA_BRCA1_PCC_NETWORK
9.52380952381%	4	42	957	Diabetes_McGill_RAS	LOPEZ_MBD_TARGETS
9.52380952381%	4	42	940	Diabetes_McGill_RAS	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
9.52380952381%	4	42	781	Diabetes_McGill_RAS	GOZGIT_ESR1_TARGETS_DN
9.52380952381%	4	42	673	Diabetes_McGill_RAS	MARTINEZ_RB1_TARGETS_UP
9.52380952381%	4	42	612	Diabetes_McGill_RAS	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
9.52380952381%	4	42	593	Diabetes_McGill_RAS	MARTINEZ_TP53_TARGETS_DN
9.52380952381%	4	42	591	Diabetes_McGill_RAS	MARTINEZ_RB1_AND_TP53_TARGETS_DN
9.52380952381%	4	42	566	Diabetes_McGill_RAS	DOUGLAS_BMI1_TARGETS_UP
9.52380952381%	4	42	536	Diabetes_McGill_RAS	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
9.52380952381%	4	42	518	Diabetes_McGill_RAS	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
9.52380952381%	4	42	49	Diabetes_McGill_RAS	PID_PI3KCIPATHWAY
9.52380952381%	4	42	435	Diabetes_McGill_RAS	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
9.52380952381%	4	42	42	Diabetes_McGill_RAS	KEGG_BLADDER_CANCER
9.52380952381%	4	42	418	Diabetes_McGill_RAS	MULLIGHAN_MLL_SIGNATURE_2_UP
9.52380952381%	4	42	396	Diabetes_McGill_RAS	REACTOME_DEVELOPMENTAL_BIOLOGY
9.52380952381%	4	42	306	Diabetes_McGill_RAS	CHANDRAN_METASTASIS_DN
9.52380952381%	4	42	30	Diabetes_McGill_RAS	PID_RAS_PATHWAY
9.52380952381%	4	42	270	Diabetes_McGill_RAS	RIZKI_TUMOR_INVASIVENESS_3D_DN
9.52380952381%	4	42	259	Diabetes_McGill_RAS	QI_PLASMACYTOMA_UP
9.52380952381%	4	42	251	Diabetes_McGill_RAS	REACTOME_AXON_GUIDANCE
9.52380952381%	4	42	19	Diabetes_McGill_RAS	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS
9.52380952381%	4	42	17	Diabetes_McGill_RAS	REACTOME_ARMS_MEDIATED_ACTIVATION
9.52380952381%	4	42	1142	Diabetes_McGill_RAS	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
9.52380952381%	4	42	105	Diabetes_McGill_RAS	PID_ERBB1_DOWNSTREAM_PATHWAY
9.52380952381%	4	42	1037	Diabetes_McGill_RAS	NUYTTEN_EZH2_TARGETS_UP
9.48616600791%	24	253	775	Diabetes_McGill_CREBBP_coTF	BENPORATH_MYC_MAX_TARGETS
9.48616600791%	24	253	566	Diabetes_McGill_CREBBP_coTF	DOUGLAS_BMI1_TARGETS_UP
9.48616600791%	24	253	552	Diabetes_McGill_CREBBP_coTF	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
9.48616600791%	24	253	478	Diabetes_McGill_CREBBP_coTF	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
9.48616600791%	24	253	168	Diabetes_McGill_CREBBP_coTF	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
9.48616600791%	24	253	104	Diabetes_McGill_CREBBP_coTF	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
9.47562097516%	206	2174	1972	T2D_GENES_TANYA_LIPIDS	PILON_KLF1_TARGETS_DN
9.45054945055%	43	455	1305	T2D_GENES_TANYA_BLOODPRESSURE	YOSHIMURA_MAPK8_TARGETS_UP
9.45054945055%	43	455	1062	T2D_GENES_TANYA_BLOODPRESSURE	BENPORATH_EED_TARGETS
9.42249240122%	186	1974	1237	Mendelian_Nancy_Cox	BLALOCK_ALZHEIMERS_DISEASE_DN
9.37972768533%	62	661	1022	T2D_GENES_TANYA_GLYCEMIC	MARSON_BOUND_BY_FOXP3_STIMULATED
9.375%	3	32	92	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_DILATED_CARDIOMYOPATHY
9.375%	3	32	90	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_GAP_JUNCTION
9.375%	3	32	882	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
9.375%	3	32	86	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_L1CAM_INTERACTIONS
9.375%	3	32	85	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
9.375%	3	32	80	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_CARDIAC_MUSCLE_CONTRACTION
9.375%	3	32	76	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
9.375%	3	32	76	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
9.375%	3	32	721	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	WONG_ADULT_TISSUE_STEM_MODULE
9.375%	3	32	552	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
9.375%	3	32	548	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KIM_ALL_DISORDERS_CALB1_CORR_UP
9.375%	3	32	539	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LIAO_METASTASIS
9.375%	3	32	530	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ENK_UV_RESPONSE_KERATINOCYTE_UP
9.375%	3	32	52	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_TASTE_TRANSDUCTION
9.375%	3	32	504	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BROWNE_HCMV_INFECTION_48HR_DN
9.375%	3	32	491	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MEISSNER_NPC_HCP_WITH_H3K4ME2
9.375%	3	32	469	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MCCABE_BOUND_BY_HOXC6
9.375%	3	32	46	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SIG_BCR_SIGNALING_PATHWAY
9.375%	3	32	456	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MARTENS_BOUND_BY_PML_RARA_FUSION
9.375%	3	32	45	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SIG_CHEMOTAXIS
9.375%	3	32	443	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DELYS_THYROID_CANCER_UP
9.375%	3	32	43	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1
9.375%	3	32	420	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MOOTHA_PGC
9.375%	3	32	412	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
9.375%	3	32	398	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
9.375%	3	32	36	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
9.375%	3	32	353	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
9.375%	3	32	317	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
9.375%	3	32	292	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KOYAMA_SEMA3B_TARGETS_UP
9.375%	3	32	28	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ST_GAQ_PATHWAY
9.375%	3	32	264	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
9.375%	3	32	254	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BROWNE_HCMV_INFECTION_4HR_DN
9.375%	3	32	23	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS
9.375%	3	32	229	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
9.375%	3	32	20	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ST_WNT_CA2_CYCLIC_GMP_PATHWAY
9.375%	3	32	1972	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PILON_KLF1_TARGETS_DN
9.375%	3	32	1691	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BLALOCK_ALZHEIMERS_DISEASE_UP
9.375%	3	32	1382	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
9.375%	3	32	1237	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BLALOCK_ALZHEIMERS_DISEASE_DN
9.375%	3	32	1210	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CHEN_METABOLIC_SYNDROM_NETWORK
9.375%	3	32	114	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_OOCYTE_MEIOSIS
9.29853181077%	57	613	1839	T2D_GENES_TANYA_BIOMARKER	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
9.27051671733%	183	1974	1118	Mendelian_Nancy_Cox	BENPORATH_ES_WITH_H3K27ME3
9.16919959473%	181	1974	1375	Mendelian_Nancy_Cox	DODD_NASOPHARYNGEAL_CARCINOMA_DN
9.15363385465%	199	2174	1821	T2D_GENES_TANYA_LIPIDS	DODD_NASOPHARYNGEAL_CARCINOMA_UP
9.13539967374%	56	613	1725	T2D_GENES_TANYA_BIOMARKER	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
9.09090909091%	3	33	940	Mendelian_Metabolism	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
9.09090909091%	3	33	93	Mendelian_Metabolism	CADWELL_ATG16L1_TARGETS_UP
9.09090909091%	3	33	882	Mendelian_Metabolism	LEE_BMP2_TARGETS_DN
9.09090909091%	3	33	882	Diabetes_McGill_ER_Stress	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
9.09090909091%	3	33	88	Diabetes_McGill_ER_Stress	WALLACE_PROSTATE_CANCER_RACE_DN
9.09090909091%	3	33	863	Diabetes_McGill_ER_Stress	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
9.09090909091%	3	33	848	Mendelian_Metabolism	NUYTTEN_NIPP1_TARGETS_DN
9.09090909091%	3	33	848	Diabetes_McGill_ER_Stress	NUYTTEN_NIPP1_TARGETS_DN
9.09090909091%	3	33	841	Mendelian_Metabolism	MARTENS_TRETINOIN_RESPONSE_DN
9.09090909091%	3	33	811	Mendelian_Metabolism	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
9.09090909091%	3	33	783	Mendelian_Metabolism	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
9.09090909091%	3	33	721	Diabetes_McGill_ER_Stress	WONG_ADULT_TISSUE_STEM_MODULE
9.09090909091%	3	33	72	Mendelian_Metabolism	REACTOME_METABOLISM_OF_NUCLEOTIDES
9.09090909091%	3	33	682	Mendelian_Metabolism	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
9.09090909091%	3	33	682	Diabetes_McGill_ER_Stress	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
9.09090909091%	3	33	681	Mendelian_Metabolism	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
9.09090909091%	3	33	637	Diabetes_McGill_ER_Stress	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
9.09090909091%	3	33	634	Mendelian_Metabolism	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
9.09090909091%	3	33	633	Diabetes_McGill_ER_Stress	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
9.09090909091%	3	33	59	Diabetes_McGill_ER_Stress	PID_ATF2_PATHWAY
9.09090909091%	3	33	567	Mendelian_Metabolism	CHICAS_RB1_TARGETS_CONFLUENT
9.09090909091%	3	33	557	Mendelian_Metabolism	TIEN_INTESTINE_PROBIOTICS_24HR_UP
9.09090909091%	3	33	552	Diabetes_McGill_ER_Stress	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
9.09090909091%	3	33	55	Mendelian_Metabolism	SU_LIVER
9.09090909091%	3	33	548	Mendelian_Metabolism	KIM_ALL_DISORDERS_CALB1_CORR_UP
9.09090909091%	3	33	532	Mendelian_Metabolism	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
9.09090909091%	3	33	530	Diabetes_McGill_ER_Stress	ENK_UV_RESPONSE_KERATINOCYTE_UP
9.09090909091%	3	33	51	Mendelian_Metabolism	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
9.09090909091%	3	33	504	Mendelian_Metabolism	BROWNE_HCMV_INFECTION_48HR_DN
9.09090909091%	3	33	491	Diabetes_McGill_ER_Stress	SWEET_LUNG_CANCER_KRAS_UP
9.09090909091%	3	33	48	Diabetes_McGill_ER_Stress	PID_CERAMIDE_PATHWAY
9.09090909091%	3	33	47	Diabetes_McGill_ER_Stress	KEGG_TYPE_II_DIABETES_MELLITUS
9.09090909091%	3	33	462	Diabetes_McGill_ER_Stress	DELACROIX_RAR_BOUND_ES
9.09090909091%	3	33	46	Diabetes_McGill_ER_Stress	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
9.09090909091%	3	33	459	Diabetes_McGill_ER_Stress	KIM_WT1_TARGETS_DN
9.09090909091%	3	33	425	Diabetes_McGill_ER_Stress	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
9.09090909091%	3	33	413	Mendelian_Metabolism	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
9.09090909091%	3	33	394	Diabetes_McGill_ER_Stress	BERENJENO_TRANSFORMED_BY_RHOA_DN
9.09090909091%	3	33	393	Mendelian_Metabolism	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
9.09090909091%	3	33	389	Diabetes_McGill_ER_Stress	HSIAO_HOUSEKEEPING_GENES
9.09090909091%	3	33	373	Diabetes_McGill_ER_Stress	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
9.09090909091%	3	33	368	Mendelian_Metabolism	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
9.09090909091%	3	33	351	Diabetes_McGill_ER_Stress	YAGI_AML_WITH_11Q23_REARRANGED
9.09090909091%	3	33	337	Mendelian_Metabolism	PENG_GLUTAMINE_DEPRIVATION_DN
9.09090909091%	3	33	332	Mendelian_Metabolism	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
9.09090909091%	3	33	330	Diabetes_McGill_ER_Stress	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
9.09090909091%	3	33	33	Diabetes_McGill_ER_Stress	CHO_NR4A1_TARGETS
9.09090909091%	3	33	324	Mendelian_Metabolism	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
9.09090909091%	3	33	324	Diabetes_McGill_ER_Stress	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
9.09090909091%	3	33	32	Mendelian_Metabolism	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM
9.09090909091%	3	33	309	Mendelian_Metabolism	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
9.09090909091%	3	33	307	Mendelian_Metabolism	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
9.09090909091%	3	33	293	Diabetes_McGill_ER_Stress	HADDAD_B_LYMPHOCYTE_PROGENITOR
9.09090909091%	3	33	29	Diabetes_McGill_ER_Stress	KRIGE_AMINO_ACID_DEPRIVATION
9.09090909091%	3	33	287	Diabetes_McGill_ER_Stress	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
9.09090909091%	3	33	276	Diabetes_McGill_ER_Stress	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
9.09090909091%	3	33	274	Mendelian_Metabolism	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
9.09090909091%	3	33	267	Diabetes_McGill_ER_Stress	KEGG_MAPK_SIGNALING_PATHWAY
9.09090909091%	3	33	26	Diabetes_McGill_ER_Stress	REACTOME_ACTIVATION_OF_GENES_BY_ATF4
9.09090909091%	3	33	253	Diabetes_McGill_ER_Stress	DANG_REGULATED_BY_MYC_DN
9.09090909091%	3	33	25	Diabetes_McGill_ER_Stress	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP
9.09090909091%	3	33	242	Mendelian_Metabolism	CHYLA_CBFA2T3_TARGETS_DN
9.09090909091%	3	33	242	Diabetes_McGill_ER_Stress	WINTER_HYPOXIA_METAGENE
9.09090909091%	3	33	232	Mendelian_Metabolism	DELYS_THYROID_CANCER_DN
9.09090909091%	3	33	229	Mendelian_Metabolism	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
9.09090909091%	3	33	217	Diabetes_McGill_ER_Stress	SANSOM_APC_MYC_TARGETS
9.09090909091%	3	33	211	Diabetes_McGill_ER_Stress	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
9.09090909091%	3	33	1972	Mendelian_Metabolism	PILON_KLF1_TARGETS_DN
9.09090909091%	3	33	197	Diabetes_McGill_ER_Stress	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
9.09090909091%	3	33	194	Diabetes_McGill_ER_Stress	KASLER_HDAC7_TARGETS_1_UP
9.09090909091%	3	33	187	Mendelian_Metabolism	PENG_LEUCINE_DEPRIVATION_DN
9.09090909091%	3	33	187	Diabetes_McGill_ER_Stress	PENG_LEUCINE_DEPRIVATION_DN
9.09090909091%	3	33	185	Mendelian_Metabolism	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
9.09090909091%	3	33	178	Diabetes_McGill_ER_Stress	LI_AMPLIFIED_IN_LUNG_CANCER
9.09090909091%	3	33	1691	Mendelian_Metabolism	BLALOCK_ALZHEIMERS_DISEASE_UP
9.09090909091%	3	33	169	Diabetes_McGill_ER_Stress	PENG_GLUCOSE_DEPRIVATION_DN
9.09090909091%	3	33	159	Mendelian_Metabolism	KEGG_PURINE_METABOLISM
9.09090909091%	3	33	153	Diabetes_McGill_ER_Stress	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
9.09090909091%	3	33	15	Mendelian_Metabolism	REACTOME_HDL_MEDIATED_LIPID_TRANSPORT
9.09090909091%	3	33	145	Diabetes_McGill_ER_Stress	SMITH_TERT_TARGETS_UP
9.09090909091%	3	33	1442	Diabetes_McGill_ER_Stress	PUJANA_ATM_PCC_NETWORK
9.09090909091%	3	33	143	Diabetes_McGill_ER_Stress	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
9.09090909091%	3	33	142	Mendelian_Metabolism	PENG_LEUCINE_DEPRIVATION_UP
9.09090909091%	3	33	139	Mendelian_Metabolism	REACTOME_BIOLOGICAL_OXIDATIONS
9.09090909091%	3	33	1382	Diabetes_McGill_ER_Stress	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
9.09090909091%	3	33	137	Diabetes_McGill_ER_Stress	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
9.09090909091%	3	33	126	Diabetes_McGill_ER_Stress	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
9.09090909091%	3	33	118	Diabetes_McGill_ER_Stress	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
9.09090909091%	3	33	105	Diabetes_McGill_ER_Stress	HELLER_SILENCED_BY_METHYLATION_DN
9.09090909091%	3	33	1022	Diabetes_McGill_ER_Stress	MARSON_BOUND_BY_FOXP3_STIMULATED
9.09090909091%	3	33	1011	Mendelian_Metabolism	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
9.09090909091%	23	253	957	Diabetes_McGill_CREBBP_coTF	LOPEZ_MBD_TARGETS
9.09090909091%	23	253	871	Diabetes_McGill_CREBBP_coTF	GRADE_COLON_CANCER_UP
9.09090909091%	23	253	652	Diabetes_McGill_CREBBP_coTF	BENPORATH_PRC2_TARGETS
9.09090909091%	23	253	593	Diabetes_McGill_CREBBP_coTF	MARTINEZ_TP53_TARGETS_DN
9.09090909091%	23	253	267	Diabetes_McGill_CREBBP_coTF	KEGG_MAPK_SIGNALING_PATHWAY
9.09090909091%	1	11	988	Mendelian_Diamond-Blackfan_Anemia	BENPORATH_NANOG_TARGETS
9.09090909091%	1	11	98	Mendelian_Diamond-Blackfan_Anemia	GAVIN_FOXP3_TARGETS_CLUSTER_T7
9.09090909091%	1	11	973	Mendelian_Diamond-Blackfan_Anemia	ACEVEDO_LIVER_CANCER_UP
9.09090909091%	1	11	953	Mendelian_Diamond-Blackfan_Anemia	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
9.09090909091%	1	11	94	Mendelian_Diamond-Blackfan_Anemia	LU_IL4_SIGNALING
9.09090909091%	1	11	918	Mendelian_Diamond-Blackfan_Anemia	JOHNSTONE_PARVB_TARGETS_3_DN
9.09090909091%	1	11	911	Mendelian_Diamond-Blackfan_Anemia	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
9.09090909091%	1	11	9	Mendelian_Diamond-Blackfan_Anemia	NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON
9.09090909091%	1	11	9	Mendelian_Diamond-Blackfan_Anemia	CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN
9.09090909091%	1	11	89	Mendelian_Diamond-Blackfan_Anemia	KANG_IMMORTALIZED_BY_TERT_UP
9.09090909091%	1	11	89	Mendelian_Diamond-Blackfan_Anemia	BHATTACHARYA_EMBRYONIC_STEM_CELL
9.09090909091%	1	11	882	Mendelian_Diamond-Blackfan_Anemia	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
9.09090909091%	1	11	882	Mendelian_Diamond-Blackfan_Anemia	LEE_BMP2_TARGETS_DN
9.09090909091%	1	11	87	Mendelian_Diamond-Blackfan_Anemia	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
9.09090909091%	1	11	82	Mendelian_Diamond-Blackfan_Anemia	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
9.09090909091%	1	11	82	Mendelian_Diamond-Blackfan_Anemia	BILD_CTNNB1_ONCOGENIC_SIGNATURE
9.09090909091%	1	11	79	Mendelian_Diamond-Blackfan_Anemia	PID_MYC_ACTIVPATHWAY
9.09090909091%	1	11	79	Mendelian_Diamond-Blackfan_Anemia	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
9.09090909091%	1	11	79	Mendelian_Diamond-Blackfan_Anemia	LIU_COMMON_CANCER_GENES
9.09090909091%	1	11	779	Mendelian_Diamond-Blackfan_Anemia	PUJANA_CHEK2_PCC_NETWORK
9.09090909091%	1	11	77	Mendelian_Diamond-Blackfan_Anemia	GROSS_HYPOXIA_VIA_HIF1A_UP
9.09090909091%	1	11	747	Mendelian_Diamond-Blackfan_Anemia	PATIL_LIVER_CANCER
9.09090909091%	1	11	734	Mendelian_Diamond-Blackfan_Anemia	BENPORATH_SOX2_TARGETS
9.09090909091%	1	11	71	Mendelian_Diamond-Blackfan_Anemia	KYNG_RESPONSE_TO_H2O2
9.09090909091%	1	11	69	Mendelian_Diamond-Blackfan_Anemia	AMIT_EGF_RESPONSE_120_HELA
9.09090909091%	1	11	67	Mendelian_Diamond-Blackfan_Anemia	DAZARD_UV_RESPONSE_CLUSTER_G1
9.09090909091%	1	11	66	Mendelian_Diamond-Blackfan_Anemia	DIRMEIER_LMP1_RESPONSE_EARLY
9.09090909091%	1	11	62	Mendelian_Diamond-Blackfan_Anemia	BILD_SRC_ONCOGENIC_SIGNATURE
9.09090909091%	1	11	61	Mendelian_Diamond-Blackfan_Anemia	LEE_LIVER_CANCER_MYC_TGFA_UP
9.09090909091%	1	11	553	Mendelian_Diamond-Blackfan_Anemia	FEVR_CTNNB1_TARGETS_DN
9.09090909091%	1	11	546	Mendelian_Diamond-Blackfan_Anemia	WEST_ADRENOCORTICAL_TUMOR_DN
9.09090909091%	1	11	54	Mendelian_Diamond-Blackfan_Anemia	LEE_LIVER_CANCER_MYC_UP
9.09090909091%	1	11	530	Mendelian_Diamond-Blackfan_Anemia	ENK_UV_RESPONSE_KERATINOCYTE_UP
9.09090909091%	1	11	53	Mendelian_Diamond-Blackfan_Anemia	MENSSEN_MYC_TARGETS
9.09090909091%	1	11	514	Mendelian_Diamond-Blackfan_Anemia	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
9.09090909091%	1	11	51	Mendelian_Diamond-Blackfan_Anemia	ZHANG_PROLIFERATING_VS_QUIESCENT
9.09090909091%	1	11	51	Mendelian_Diamond-Blackfan_Anemia	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
9.09090909091%	1	11	50	Mendelian_Diamond-Blackfan_Anemia	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS
9.09090909091%	1	11	49	Mendelian_Diamond-Blackfan_Anemia	ZHAN_MULTIPLE_MYELOMA_HP_UP
9.09090909091%	1	11	479	Mendelian_Diamond-Blackfan_Anemia	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
9.09090909091%	1	11	47	Mendelian_Diamond-Blackfan_Anemia	IRITANI_MAD1_TARGETS_DN
9.09090909091%	1	11	467	Mendelian_Diamond-Blackfan_Anemia	RATTENBACHER_BOUND_BY_CELF1
9.09090909091%	1	11	456	Mendelian_Diamond-Blackfan_Anemia	MARTENS_BOUND_BY_PML_RARA_FUSION
9.09090909091%	1	11	448	Mendelian_Diamond-Blackfan_Anemia	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
9.09090909091%	1	11	422	Mendelian_Diamond-Blackfan_Anemia	YAGI_AML_WITH_INV_16_TRANSLOCATION
9.09090909091%	1	11	42	Mendelian_Diamond-Blackfan_Anemia	MODY_HIPPOCAMPUS_PRENATAL
9.09090909091%	1	11	411	Mendelian_Diamond-Blackfan_Anemia	KOYAMA_SEMA3B_TARGETS_DN
9.09090909091%	1	11	403	Mendelian_Diamond-Blackfan_Anemia	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
9.09090909091%	1	11	390	Mendelian_Diamond-Blackfan_Anemia	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
9.09090909091%	1	11	39	Mendelian_Diamond-Blackfan_Anemia	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
9.09090909091%	1	11	39	Mendelian_Diamond-Blackfan_Anemia	BILANGES_RAPAMYCIN_SENSITIVE_GENES
9.09090909091%	1	11	380	Mendelian_Diamond-Blackfan_Anemia	DAIRKEE_TERT_TARGETS_UP
9.09090909091%	1	11	379	Mendelian_Diamond-Blackfan_Anemia	BENPORATH_ES_1
9.09090909091%	1	11	374	Mendelian_Diamond-Blackfan_Anemia	WANG_TUMOR_INVASIVENESS_UP
9.09090909091%	1	11	337	Mendelian_Diamond-Blackfan_Anemia	PENG_GLUTAMINE_DEPRIVATION_DN
9.09090909091%	1	11	335	Mendelian_Diamond-Blackfan_Anemia	WONG_EMBRYONIC_STEM_CELL_CORE
9.09090909091%	1	11	32	Mendelian_Diamond-Blackfan_Anemia	KIM_TIAL1_TARGETS
9.09090909091%	1	11	32	Mendelian_Diamond-Blackfan_Anemia	DIRMEIER_LMP1_RESPONSE_LATE_DN
9.09090909091%	1	11	317	Mendelian_Diamond-Blackfan_Anemia	BRUINS_UVC_RESPONSE_EARLY_LATE
9.09090909091%	1	11	30	Mendelian_Diamond-Blackfan_Anemia	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP
9.09090909091%	1	11	293	Mendelian_Diamond-Blackfan_Anemia	HADDAD_B_LYMPHOCYTE_PROGENITOR
9.09090909091%	1	11	292	Mendelian_Diamond-Blackfan_Anemia	KOYAMA_SEMA3B_TARGETS_UP
9.09090909091%	1	11	292	Mendelian_Diamond-Blackfan_Anemia	HELLER_HDAC_TARGETS_DN
9.09090909091%	1	11	27	Mendelian_Diamond-Blackfan_Anemia	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN
9.09090909091%	1	11	245	Mendelian_Diamond-Blackfan_Anemia	PENG_RAPAMYCIN_RESPONSE_DN
9.09090909091%	1	11	244	Mendelian_Diamond-Blackfan_Anemia	DAZARD_RESPONSE_TO_UV_NHEK_UP
9.09090909091%	1	11	24	Mendelian_Diamond-Blackfan_Anemia	ODONNELL_METASTASIS_DN
9.09090909091%	1	11	230	Mendelian_Diamond-Blackfan_Anemia	BENPORATH_MYC_TARGETS_WITH_EBOX
9.09090909091%	1	11	227	Mendelian_Diamond-Blackfan_Anemia	LEE_RECENT_THYMIC_EMIGRANT
9.09090909091%	1	11	220	Mendelian_Diamond-Blackfan_Anemia	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
9.09090909091%	1	11	22	Mendelian_Diamond-Blackfan_Anemia	SPIRA_SMOKERS_LUNG_CANCER_DN
9.09090909091%	1	11	22	Mendelian_Diamond-Blackfan_Anemia	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP
9.09090909091%	1	11	210	Mendelian_Diamond-Blackfan_Anemia	SANSOM_APC_TARGETS_REQUIRE_MYC
9.09090909091%	1	11	21	Mendelian_Diamond-Blackfan_Anemia	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN
9.09090909091%	1	11	208	Mendelian_Diamond-Blackfan_Anemia	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
9.09090909091%	1	11	1972	Mendelian_Diamond-Blackfan_Anemia	PILON_KLF1_TARGETS_DN
9.09090909091%	1	11	196	Mendelian_Diamond-Blackfan_Anemia	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
9.09090909091%	1	11	19	Mendelian_Diamond-Blackfan_Anemia	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN
9.09090909091%	1	11	19	Mendelian_Diamond-Blackfan_Anemia	GRANDVAUX_IRF3_TARGETS_DN
9.09090909091%	1	11	185	Mendelian_Diamond-Blackfan_Anemia	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
9.09090909091%	1	11	1781	Mendelian_Diamond-Blackfan_Anemia	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
9.09090909091%	1	11	177	Mendelian_Diamond-Blackfan_Anemia	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
9.09090909091%	1	11	176	Mendelian_Diamond-Blackfan_Anemia	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
9.09090909091%	1	11	175	Mendelian_Diamond-Blackfan_Anemia	LEE_LIVER_CANCER_SURVIVAL_DN
9.09090909091%	1	11	167	Mendelian_Diamond-Blackfan_Anemia	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
9.09090909091%	1	11	165	Mendelian_Diamond-Blackfan_Anemia	BROWN_MYELOID_CELL_DEVELOPMENT_UP
9.09090909091%	1	11	151	Mendelian_Diamond-Blackfan_Anemia	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
9.09090909091%	1	11	151	Mendelian_Diamond-Blackfan_Anemia	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
9.09090909091%	1	11	145	Mendelian_Diamond-Blackfan_Anemia	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
9.09090909091%	1	11	143	Mendelian_Diamond-Blackfan_Anemia	BASSO_B_LYMPHOCYTE_NETWORK
9.09090909091%	1	11	140	Mendelian_Diamond-Blackfan_Anemia	JOHNSTONE_PARVB_TARGETS_2_UP
9.09090909091%	1	11	14	Mendelian_Diamond-Blackfan_Anemia	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION
9.09090909091%	1	11	136	Mendelian_Diamond-Blackfan_Anemia	PROVENZANI_METASTASIS_DN
9.09090909091%	1	11	1305	Mendelian_Diamond-Blackfan_Anemia	YOSHIMURA_MAPK8_TARGETS_UP
9.09090909091%	1	11	13	Mendelian_Diamond-Blackfan_Anemia	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS
9.09090909091%	1	11	124	Mendelian_Diamond-Blackfan_Anemia	DAIRKEE_TERT_TARGETS_DN
9.09090909091%	1	11	123	Mendelian_Diamond-Blackfan_Anemia	KAYO_AGING_MUSCLE_DN
9.09090909091%	1	11	1229	Mendelian_Diamond-Blackfan_Anemia	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
9.09090909091%	1	11	121	Mendelian_Diamond-Blackfan_Anemia	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
9.09090909091%	1	11	116	Mendelian_Diamond-Blackfan_Anemia	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
9.09090909091%	1	11	113	Mendelian_Diamond-Blackfan_Anemia	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
9.09090909091%	1	11	111	Mendelian_Diamond-Blackfan_Anemia	BOUDOUKHA_BOUND_BY_IGF2BP2
9.09090909091%	1	11	105	Mendelian_Diamond-Blackfan_Anemia	HELLER_SILENCED_BY_METHYLATION_DN
9.09090909091%	1	11	1022	Mendelian_Diamond-Blackfan_Anemia	MARSON_BOUND_BY_FOXP3_STIMULATED
9.01098901099%	41	455	728	T2D_GENES_TANYA_BLOODPRESSURE	MARSON_BOUND_BY_E2F4_UNSTIMULATED
9.01098901099%	41	455	1022	T2D_GENES_TANYA_BLOODPRESSURE	MARSON_BOUND_BY_FOXP3_STIMULATED
8.9722675367%	55	613	1821	T2D_GENES_TANYA_BIOMARKER	DODD_NASOPHARYNGEAL_CARCINOMA_UP
8.9258698941%	59	661	1652	T2D_GENES_TANYA_GLYCEMIC	PUJANA_BRCA1_PCC_NETWORK
8.8776448942%	193	2174	1781	T2D_GENES_TANYA_LIPIDS	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
8.87226082309%	166	1871	1229	T2D_GENES_TANYA_HEIGHT	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
8.87096774194%	11	124	99	Diabetes_McGill_Cell_cycle_All_Gene	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
8.87096774194%	11	124	882	Diabetes_McGill_Cell_cycle_All_Gene	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
8.87096774194%	11	124	848	Diabetes_McGill_Cell_cycle_All_Gene	NUYTTEN_NIPP1_TARGETS_DN
8.87096774194%	11	124	824	Diabetes_McGill_Cell_cycle_All_Gene	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
8.87096774194%	11	124	811	Diabetes_McGill_Cell_cycle_All_Gene	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
8.87096774194%	11	124	79	Diabetes_McGill_Cell_cycle_All_Gene	PID_MYC_ACTIVPATHWAY
8.87096774194%	11	124	770	Diabetes_McGill_Cell_cycle_All_Gene	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
8.87096774194%	11	124	71	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_MELANOMA
8.87096774194%	11	124	69	Diabetes_McGill_Cell_cycle_All_Gene	RHODES_UNDIFFERENTIATED_CANCER
8.87096774194%	11	124	68	Diabetes_McGill_Cell_cycle_All_Gene	PID_TELOMERASEPATHWAY
8.87096774194%	11	124	65	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_GLIOMA
8.87096774194%	11	124	64	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C
8.87096774194%	11	124	63	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
8.87096774194%	11	124	601	Diabetes_McGill_Cell_cycle_All_Gene	MARTINEZ_RB1_AND_TP53_TARGETS_UP
8.87096774194%	11	124	60	Diabetes_McGill_Cell_cycle_All_Gene	SONG_TARGETS_OF_IE86_CMV_PROTEIN
8.87096774194%	11	124	584	Diabetes_McGill_Cell_cycle_All_Gene	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
8.87096774194%	11	124	584	Diabetes_McGill_Cell_cycle_All_Gene	HAMAI_APOPTOSIS_VIA_TRAIL_UP
8.87096774194%	11	124	530	Diabetes_McGill_Cell_cycle_All_Gene	ENK_UV_RESPONSE_KERATINOCYTE_UP
8.87096774194%	11	124	501	Diabetes_McGill_Cell_cycle_All_Gene	SENESE_HDAC3_TARGETS_UP
8.87096774194%	11	124	48	Diabetes_McGill_Cell_cycle_All_Gene	OXFORD_RALA_OR_RALB_TARGETS_UP
8.87096774194%	11	124	479	Diabetes_McGill_Cell_cycle_All_Gene	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
8.87096774194%	11	124	47	Diabetes_McGill_Cell_cycle_All_Gene	PID_LKB1_PATHWAY
8.87096774194%	11	124	424	Diabetes_McGill_Cell_cycle_All_Gene	SHEN_SMARCA2_TARGETS_UP
8.87096774194%	11	124	42	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_BLADDER_CANCER
8.87096774194%	11	124	396	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_DEVELOPMENTAL_BIOLOGY
8.87096774194%	11	124	352	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
8.87096774194%	11	124	35	Diabetes_McGill_Cell_cycle_All_Gene	PID_PI3KCIAKTPATHWAY
8.87096774194%	11	124	182	Diabetes_McGill_Cell_cycle_All_Gene	WHITFIELD_CELL_CYCLE_G2
8.87096774194%	11	124	163	Diabetes_McGill_Cell_cycle_All_Gene	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
8.87096774194%	11	124	13	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_RB_PATHWAY
8.86524822695%	175	1974	1103	Mendelian_Nancy_Cox	DANG_BOUND_BY_MYC
8.81458966565%	174	1974	1210	Mendelian_Nancy_Cox	CHEN_METABOLIC_SYNDROM_NETWORK
8.81458966565%	174	1974	1137	Mendelian_Nancy_Cox	BRUINS_UVC_RESPONSE_LATE
8.77458396369%	58	661	1781	T2D_GENES_TANYA_GLYCEMIC	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
8.71327254306%	172	1974	1038	Mendelian_Nancy_Cox	BENPORATH_SUZ12_TARGETS
8.71191876002%	163	1871	1652	T2D_GENES_TANYA_HEIGHT	PUJANA_BRCA1_PCC_NETWORK
8.69565217391%	22	253	770	Diabetes_McGill_CREBBP_coTF	KRIEG_HYPOXIA_NOT_VIA_KDM3A
8.69565217391%	22	253	770	Diabetes_McGill_CREBBP_coTF	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
8.69565217391%	22	253	553	Diabetes_McGill_CREBBP_coTF	FEVR_CTNNB1_TARGETS_DN
8.69565217391%	22	253	337	Diabetes_McGill_CREBBP_coTF	PHONG_TNF_RESPONSE_NOT_VIA_P38
8.69565217391%	22	253	1069	Diabetes_McGill_CREBBP_coTF	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
8.69565217391%	22	253	1037	Diabetes_McGill_CREBBP_coTF	NUYTTEN_EZH2_TARGETS_UP
8.69565217391%	22	253	103	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_NOTCH
8.69565217391%	2	23	988	Diabetes_McGill_Mtor_pathway	BENPORATH_NANOG_TARGETS
8.69565217391%	2	23	94	Diabetes_McGill_Mtor_pathway	LU_IL4_SIGNALING
8.69565217391%	2	23	93	Diabetes_McGill_Mtor_pathway	ZHU_CMV_24_HR_UP
8.69565217391%	2	23	93	Diabetes_McGill_Mtor_pathway	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
8.69565217391%	2	23	92	Diabetes_McGill_Mtor_pathway	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
8.69565217391%	2	23	918	Diabetes_McGill_Mtor_pathway	JOHNSTONE_PARVB_TARGETS_3_DN
8.69565217391%	2	23	911	Diabetes_McGill_Mtor_pathway	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
8.69565217391%	2	23	91	Diabetes_McGill_Mtor_pathway	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
8.69565217391%	2	23	9	Diabetes_McGill_Mtor_pathway	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK
8.69565217391%	2	23	898	Diabetes_McGill_Mtor_pathway	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
8.69565217391%	2	23	882	Diabetes_McGill_Mtor_pathway	LEE_BMP2_TARGETS_DN
8.69565217391%	2	23	88	Diabetes_McGill_Mtor_pathway	WALLACE_PROSTATE_CANCER_RACE_DN
8.69565217391%	2	23	88	Diabetes_McGill_Mtor_pathway	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
8.69565217391%	2	23	87	Diabetes_McGill_Mtor_pathway	BIOCARTA_MAPK_PATHWAY
8.69565217391%	2	23	86	Diabetes_McGill_Mtor_pathway	KEGG_TGF_BETA_SIGNALING_PATHWAY
8.69565217391%	2	23	848	Diabetes_McGill_Mtor_pathway	NUYTTEN_NIPP1_TARGETS_DN
8.69565217391%	2	23	841	Diabetes_McGill_Mtor_pathway	MARTENS_TRETINOIN_RESPONSE_DN
8.69565217391%	2	23	84	Diabetes_McGill_Mtor_pathway	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
8.69565217391%	2	23	82	Diabetes_McGill_Mtor_pathway	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
8.69565217391%	2	23	805	Diabetes_McGill_Mtor_pathway	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
8.69565217391%	2	23	8	Diabetes_McGill_Mtor_pathway	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7
8.69565217391%	2	23	79	Diabetes_McGill_Mtor_pathway	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
8.69565217391%	2	23	784	Diabetes_McGill_Mtor_pathway	FORTSCHEGGER_PHF8_TARGETS_DN
8.69565217391%	2	23	783	Diabetes_McGill_Mtor_pathway	ONKEN_UVEAL_MELANOMA_UP
8.69565217391%	2	23	779	Diabetes_McGill_Mtor_pathway	PUJANA_CHEK2_PCC_NETWORK
8.69565217391%	2	23	770	Diabetes_McGill_Mtor_pathway	KRIEG_HYPOXIA_NOT_VIA_KDM3A
8.69565217391%	2	23	745	Diabetes_McGill_Mtor_pathway	LEE_BMP2_TARGETS_UP
8.69565217391%	2	23	74	Diabetes_McGill_Mtor_pathway	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS
8.69565217391%	2	23	74	Diabetes_McGill_Mtor_pathway	REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX
8.69565217391%	2	23	69	Diabetes_McGill_Mtor_pathway	KEGG_P53_SIGNALING_PATHWAY
8.69565217391%	2	23	681	Diabetes_McGill_Mtor_pathway	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
8.69565217391%	2	23	68	Diabetes_McGill_Mtor_pathway	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES
8.69565217391%	2	23	67	Diabetes_McGill_Mtor_pathway	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
8.69565217391%	2	23	66	Diabetes_McGill_Mtor_pathway	PID_LYSOPHOSPHOLIPID_PATHWAY
8.69565217391%	2	23	64	Diabetes_McGill_Mtor_pathway	BYSTROEM_CORRELATED_WITH_IL5_DN
8.69565217391%	2	23	633	Diabetes_McGill_Mtor_pathway	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
8.69565217391%	2	23	62	Diabetes_McGill_Mtor_pathway	PID_TRKRPATHWAY
8.69565217391%	2	23	6	Diabetes_McGill_Mtor_pathway	COURTOIS_SENESCENCE_TRIGGERS
8.69565217391%	2	23	59	Diabetes_McGill_Mtor_pathway	PID_P53REGULATIONPATHWAY
8.69565217391%	2	23	59	Diabetes_McGill_Mtor_pathway	PID_FAK_PATHWAY
8.69565217391%	2	23	58	Diabetes_McGill_Mtor_pathway	PID_SHP2_PATHWAY
8.69565217391%	2	23	58	Diabetes_McGill_Mtor_pathway	BIOCARTA_PPARA_PATHWAY
8.69565217391%	2	23	55	Diabetes_McGill_Mtor_pathway	TIEN_INTESTINE_PROBIOTICS_6HR_UP
8.69565217391%	2	23	55	Diabetes_McGill_Mtor_pathway	PID_IL2_1PATHWAY
8.69565217391%	2	23	548	Diabetes_McGill_Mtor_pathway	KIM_ALL_DISORDERS_CALB1_CORR_UP
8.69565217391%	2	23	546	Diabetes_McGill_Mtor_pathway	WEST_ADRENOCORTICAL_TUMOR_DN
8.69565217391%	2	23	54	Diabetes_McGill_Mtor_pathway	KEGG_INOSITOL_PHOSPHATE_METABOLISM
8.69565217391%	2	23	54	Diabetes_McGill_Mtor_pathway	JIANG_AGING_CEREBRAL_CORTEX_DN
8.69565217391%	2	23	53	Diabetes_McGill_Mtor_pathway	PID_CD8TCRPATHWAY
8.69565217391%	2	23	53	Diabetes_McGill_Mtor_pathway	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP
8.69565217391%	2	23	52	Diabetes_McGill_Mtor_pathway	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP
8.69565217391%	2	23	517	Diabetes_McGill_Mtor_pathway	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
8.69565217391%	2	23	491	Diabetes_McGill_Mtor_pathway	SWEET_LUNG_CANCER_KRAS_UP
8.69565217391%	2	23	49	Diabetes_McGill_Mtor_pathway	BIOCARTA_TCR_PATHWAY
8.69565217391%	2	23	456	Diabetes_McGill_Mtor_pathway	MARTENS_BOUND_BY_PML_RARA_FUSION
8.69565217391%	2	23	45	Diabetes_McGill_Mtor_pathway	ZHAN_V2_LATE_DIFFERENTIATION_GENES
8.69565217391%	2	23	442	Diabetes_McGill_Mtor_pathway	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
8.69565217391%	2	23	44	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALING_BY_FGFR_MUTANTS
8.69565217391%	2	23	43	Diabetes_McGill_Mtor_pathway	REACTOME_IL_3_5_AND_GM_CSF_SIGNALING
8.69565217391%	2	23	43	Diabetes_McGill_Mtor_pathway	PID_THROMBIN_PAR1_PATHWAY
8.69565217391%	2	23	43	Diabetes_McGill_Mtor_pathway	PID_TCPTP_PATHWAY
8.69565217391%	2	23	43	Diabetes_McGill_Mtor_pathway	IKEDA_MIR133_TARGETS_UP
8.69565217391%	2	23	425	Diabetes_McGill_Mtor_pathway	BOCHKIS_FOXA2_TARGETS
8.69565217391%	2	23	41	Diabetes_McGill_Mtor_pathway	REACTOME_IL_2_SIGNALING
8.69565217391%	2	23	41	Diabetes_McGill_Mtor_pathway	PID_ERBB1_INTERNALIZATION_PATHWAY
8.69565217391%	2	23	41	Diabetes_McGill_Mtor_pathway	BIOCARTA_FCER1_PATHWAY
8.69565217391%	2	23	404	Diabetes_McGill_Mtor_pathway	OSMAN_BLADDER_CANCER_UP
8.69565217391%	2	23	40	Diabetes_McGill_Mtor_pathway	PID_EPHBFWDPATHWAY
8.69565217391%	2	23	395	Diabetes_McGill_Mtor_pathway	HAN_SATB1_TARGETS_UP
8.69565217391%	2	23	394	Diabetes_McGill_Mtor_pathway	BERENJENO_TRANSFORMED_BY_RHOA_DN
8.69565217391%	2	23	393	Diabetes_McGill_Mtor_pathway	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
8.69565217391%	2	23	39	Diabetes_McGill_Mtor_pathway	PID_RET_PATHWAY
8.69565217391%	2	23	38	Diabetes_McGill_Mtor_pathway	PID_ERBB4_PATHWAY
8.69565217391%	2	23	37	Diabetes_McGill_Mtor_pathway	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING
8.69565217391%	2	23	37	Diabetes_McGill_Mtor_pathway	PID_IL23PATHWAY
8.69565217391%	2	23	37	Diabetes_McGill_Mtor_pathway	PID_GMCSF_PATHWAY
8.69565217391%	2	23	37	Diabetes_McGill_Mtor_pathway	BIOCARTA_PAR1_PATHWAY
8.69565217391%	2	23	368	Diabetes_McGill_Mtor_pathway	YAGI_AML_WITH_T_8_21_TRANSLOCATION
8.69565217391%	2	23	36	Diabetes_McGill_Mtor_pathway	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
8.69565217391%	2	23	357	Diabetes_McGill_Mtor_pathway	SHEN_SMARCA2_TARGETS_DN
8.69565217391%	2	23	353	Diabetes_McGill_Mtor_pathway	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
8.69565217391%	2	23	352	Diabetes_McGill_Mtor_pathway	WANG_LMO4_TARGETS_DN
8.69565217391%	2	23	35	Diabetes_McGill_Mtor_pathway	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
8.69565217391%	2	23	34	Diabetes_McGill_Mtor_pathway	SIG_CD40PATHWAYMAP
8.69565217391%	2	23	34	Diabetes_McGill_Mtor_pathway	PID_IL1PATHWAY
8.69565217391%	2	23	337	Diabetes_McGill_Mtor_pathway	PENG_GLUTAMINE_DEPRIVATION_DN
8.69565217391%	2	23	335	Diabetes_McGill_Mtor_pathway	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
8.69565217391%	2	23	335	Diabetes_McGill_Mtor_pathway	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
8.69565217391%	2	23	33	Diabetes_McGill_Mtor_pathway	PID_NCADHERINPATHWAY
8.69565217391%	2	23	32	Diabetes_McGill_Mtor_pathway	ST_ERK1_ERK2_MAPK_PATHWAY
8.69565217391%	2	23	32	Diabetes_McGill_Mtor_pathway	PID_NETRIN_PATHWAY
8.69565217391%	2	23	32	Diabetes_McGill_Mtor_pathway	BIOCARTA_PDGF_PATHWAY
8.69565217391%	2	23	31	Diabetes_McGill_Mtor_pathway	PID_AVB3_OPN_PATHWAY
8.69565217391%	2	23	31	Diabetes_McGill_Mtor_pathway	BIOCARTA_EGF_PATHWAY
8.69565217391%	2	23	309	Diabetes_McGill_Mtor_pathway	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
8.69565217391%	2	23	30	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
8.69565217391%	2	23	30	Diabetes_McGill_Mtor_pathway	PID_NECTIN_PATHWAY
8.69565217391%	2	23	30	Diabetes_McGill_Mtor_pathway	PID_IL2_STAT5PATHWAY
8.69565217391%	2	23	30	Diabetes_McGill_Mtor_pathway	PID_EPHRINBREVPATHWAY
8.69565217391%	2	23	29	Diabetes_McGill_Mtor_pathway	BIOCARTA_VEGF_PATHWAY
8.69565217391%	2	23	285	Diabetes_McGill_Mtor_pathway	GRADE_COLON_AND_RECTAL_CANCER_UP
8.69565217391%	2	23	28	Diabetes_McGill_Mtor_pathway	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING
8.69565217391%	2	23	28	Diabetes_McGill_Mtor_pathway	PID_TRAIL_PATHWAY
8.69565217391%	2	23	28	Diabetes_McGill_Mtor_pathway	PID_IL8CXCR1_PATHWAY
8.69565217391%	2	23	28	Diabetes_McGill_Mtor_pathway	BIOCARTA_GH_PATHWAY
8.69565217391%	2	23	28	Diabetes_McGill_Mtor_pathway	BIOCARTA_ERK_PATHWAY
8.69565217391%	2	23	277	Diabetes_McGill_Mtor_pathway	ZHANG_TLX_TARGETS_60HR_DN
8.69565217391%	2	23	271	Diabetes_McGill_Mtor_pathway	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
8.69565217391%	2	23	27	Diabetes_McGill_Mtor_pathway	REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING
8.69565217391%	2	23	27	Diabetes_McGill_Mtor_pathway	REACTOME_IL_RECEPTOR_SHC_SIGNALING
8.69565217391%	2	23	27	Diabetes_McGill_Mtor_pathway	PID_IL3_PATHWAY
8.69565217391%	2	23	267	Diabetes_McGill_Mtor_pathway	KEGG_MAPK_SIGNALING_PATHWAY
8.69565217391%	2	23	25	Diabetes_McGill_Mtor_pathway	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
8.69565217391%	2	23	246	Diabetes_McGill_Mtor_pathway	BILD_E2F3_ONCOGENIC_SIGNATURE
8.69565217391%	2	23	245	Diabetes_McGill_Mtor_pathway	PENG_RAPAMYCIN_RESPONSE_DN
8.69565217391%	2	23	244	Diabetes_McGill_Mtor_pathway	PLASARI_TGFB1_TARGETS_10HR_DN
8.69565217391%	2	23	24	Diabetes_McGill_Mtor_pathway	BIOCARTA_TPO_PATHWAY
8.69565217391%	2	23	24	Diabetes_McGill_Mtor_pathway	BIOCARTA_ECM_PATHWAY
8.69565217391%	2	23	24	Diabetes_McGill_Mtor_pathway	BIOCARTA_CXCR4_PATHWAY
8.69565217391%	2	23	228	Diabetes_McGill_Mtor_pathway	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
8.69565217391%	2	23	226	Diabetes_McGill_Mtor_pathway	KYNG_DNA_DAMAGE_UP
8.69565217391%	2	23	22	Diabetes_McGill_Mtor_pathway	PID_PDGFRAPATHWAY
8.69565217391%	2	23	22	Diabetes_McGill_Mtor_pathway	BIOCARTA_INSULIN_PATHWAY
8.69565217391%	2	23	22	Diabetes_McGill_Mtor_pathway	BIOCARTA_HER2_PATHWAY
8.69565217391%	2	23	217	Diabetes_McGill_Mtor_pathway	AMUNDSON_RESPONSE_TO_ARSENITE
8.69565217391%	2	23	216	Diabetes_McGill_Mtor_pathway	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
8.69565217391%	2	23	214	Diabetes_McGill_Mtor_pathway	TIEN_INTESTINE_PROBIOTICS_24HR_DN
8.69565217391%	2	23	214	Diabetes_McGill_Mtor_pathway	BIDUS_METASTASIS_UP
8.69565217391%	2	23	212	Diabetes_McGill_Mtor_pathway	CHANG_CORE_SERUM_RESPONSE_UP
8.69565217391%	2	23	21	Diabetes_McGill_Mtor_pathway	BIOCARTA_IGF1_PATHWAY
8.69565217391%	2	23	21	Diabetes_McGill_Mtor_pathway	BIOCARTA_CTLA4_PATHWAY
8.69565217391%	2	23	209	Diabetes_McGill_Mtor_pathway	KIM_WT1_TARGETS_12HR_DN
8.69565217391%	2	23	206	Diabetes_McGill_Mtor_pathway	RAMALHO_STEMNESS_UP
8.69565217391%	2	23	205	Diabetes_McGill_Mtor_pathway	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
8.69565217391%	2	23	203	Diabetes_McGill_Mtor_pathway	GRUETZMANN_PANCREATIC_CANCER_DN
8.69565217391%	2	23	20	Diabetes_McGill_Mtor_pathway	REACTOME_NEPHRIN_INTERACTIONS
8.69565217391%	2	23	20	Diabetes_McGill_Mtor_pathway	BIOCARTA_NKCELLS_PATHWAY
8.69565217391%	2	23	198	Diabetes_McGill_Mtor_pathway	WELCSH_BRCA1_TARGETS_UP
8.69565217391%	2	23	196	Diabetes_McGill_Mtor_pathway	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
8.69565217391%	2	23	195	Diabetes_McGill_Mtor_pathway	KYNG_DNA_DAMAGE_DN
8.69565217391%	2	23	19	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS
8.69565217391%	2	23	19	Diabetes_McGill_Mtor_pathway	PID_EPHA2_FWDPATHWAY
8.69565217391%	2	23	187	Diabetes_McGill_Mtor_pathway	PENG_LEUCINE_DEPRIVATION_DN
8.69565217391%	2	23	184	Diabetes_McGill_Mtor_pathway	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
8.69565217391%	2	23	181	Diabetes_McGill_Mtor_pathway	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
8.69565217391%	2	23	18	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR
8.69565217391%	2	23	18	Diabetes_McGill_Mtor_pathway	REACTOME_REGULATION_OF_SIGNALING_BY_CBL
8.69565217391%	2	23	18	Diabetes_McGill_Mtor_pathway	REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK
8.69565217391%	2	23	18	Diabetes_McGill_Mtor_pathway	BIOCARTA_TEL_PATHWAY
8.69565217391%	2	23	18	Diabetes_McGill_Mtor_pathway	BIOCARTA_NGF_PATHWAY
8.69565217391%	2	23	176	Diabetes_McGill_Mtor_pathway	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
8.69565217391%	2	23	17	Diabetes_McGill_Mtor_pathway	SA_TRKA_RECEPTOR
8.69565217391%	2	23	17	Diabetes_McGill_Mtor_pathway	REACTOME_TIE2_SIGNALING
8.69565217391%	2	23	17	Diabetes_McGill_Mtor_pathway	PID_NFKAPPABATYPICALPATHWAY
8.69565217391%	2	23	17	Diabetes_McGill_Mtor_pathway	BIOCARTA_IL7_PATHWAY
8.69565217391%	2	23	17	Diabetes_McGill_Mtor_pathway	BIOCARTA_ARF_PATHWAY
8.69565217391%	2	23	160	Diabetes_McGill_Mtor_pathway	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
8.69565217391%	2	23	16	Diabetes_McGill_Mtor_pathway	BIOCARTA_CDC42RAC_PATHWAY
8.69565217391%	2	23	159	Diabetes_McGill_Mtor_pathway	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
8.69565217391%	2	23	154	Diabetes_McGill_Mtor_pathway	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
8.69565217391%	2	23	153	Diabetes_McGill_Mtor_pathway	LU_AGING_BRAIN_DN
8.69565217391%	2	23	15	Diabetes_McGill_Mtor_pathway	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN
8.69565217391%	2	23	148	Diabetes_McGill_Mtor_pathway	WHITFIELD_CELL_CYCLE_M_G1
8.69565217391%	2	23	142	Diabetes_McGill_Mtor_pathway	XU_GH1_AUTOCRINE_TARGETS_DN
8.69565217391%	2	23	14	Diabetes_McGill_Mtor_pathway	ZHANG_ADIPOGENESIS_BY_BMP7
8.69565217391%	2	23	14	Diabetes_McGill_Mtor_pathway	REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING
8.69565217391%	2	23	14	Diabetes_McGill_Mtor_pathway	PID_IL5_PATHWAY
8.69565217391%	2	23	137	Diabetes_McGill_Mtor_pathway	PID_P53DOWNSTREAMPATHWAY
8.69565217391%	2	23	137	Diabetes_McGill_Mtor_pathway	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
8.69565217391%	2	23	137	Diabetes_McGill_Mtor_pathway	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
8.69565217391%	2	23	136	Diabetes_McGill_Mtor_pathway	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
8.69565217391%	2	23	135	Diabetes_McGill_Mtor_pathway	UDAYAKUMAR_MED1_TARGETS_UP
8.69565217391%	2	23	127	Diabetes_McGill_Mtor_pathway	KARLSSON_TGFB1_TARGETS_UP
8.69565217391%	2	23	1237	Diabetes_McGill_Mtor_pathway	BLALOCK_ALZHEIMERS_DISEASE_DN
8.69565217391%	2	23	1229	Diabetes_McGill_Mtor_pathway	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
8.69565217391%	2	23	120	Diabetes_McGill_Mtor_pathway	ZHU_CMV_ALL_UP
8.69565217391%	2	23	120	Diabetes_McGill_Mtor_pathway	REACTOME_CELL_CELL_COMMUNICATION
8.69565217391%	2	23	12	Diabetes_McGill_Mtor_pathway	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
8.69565217391%	2	23	118	Diabetes_McGill_Mtor_pathway	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
8.69565217391%	2	23	116	Diabetes_McGill_Mtor_pathway	WHITEFORD_PEDIATRIC_CANCER_MARKERS
8.69565217391%	2	23	115	Diabetes_McGill_Mtor_pathway	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
8.69565217391%	2	23	1142	Diabetes_McGill_Mtor_pathway	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
8.69565217391%	2	23	11	Diabetes_McGill_Mtor_pathway	BIOCARTA_IL4_PATHWAY
8.69565217391%	2	23	107	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALING_BY_ILS
8.69565217391%	2	23	1024	Diabetes_McGill_Mtor_pathway	NUYTTEN_EZH2_TARGETS_DN
8.69565217391%	2	23	1022	Diabetes_McGill_Mtor_pathway	MARSON_BOUND_BY_FOXP3_STIMULATED
8.69565217391%	2	23	1011	Diabetes_McGill_Mtor_pathway	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
8.69565217391%	2	23	10	Diabetes_McGill_Mtor_pathway	REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK
8.64197530864%	7	81	933	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_IMMUNE_SYSTEM
8.64197530864%	7	81	898	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
8.64197530864%	7	81	893	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GEORGES_TARGETS_OF_MIR192_AND_MIR215
8.64197530864%	7	81	857	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARTENS_TRETINOIN_RESPONSE_UP
8.64197530864%	7	81	811	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
8.64197530864%	7	81	682	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FEVR_CTNNB1_TARGETS_UP
8.64197530864%	7	81	526	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ONKEN_UVEAL_MELANOMA_DN
8.64197530864%	7	81	435	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
8.64197530864%	7	81	323	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GRESHOCK_CANCER_COPY_NUMBER_UP
8.64197530864%	7	81	1652	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PUJANA_BRCA1_PCC_NETWORK
8.64197530864%	7	81	1382	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
8.64197530864%	7	81	1375	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DODD_NASOPHARYNGEAL_CARCINOMA_DN
8.64197530864%	7	81	137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_INSULIN_SIGNALING_PATHWAY
8.64197530864%	7	81	1210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHEN_METABOLIC_SYNDROM_NETWORK
8.64197530864%	7	81	1142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
8.64197530864%	7	81	1022	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARSON_BOUND_BY_FOXP3_STIMULATED
8.57142857143%	6	70	957	Diabetes_McGill_Adipocytokine_signallin	LOPEZ_MBD_TARGETS
8.57142857143%	6	70	95	Diabetes_McGill_Adipocytokine_signallin	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
8.57142857143%	6	70	920	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SIGNALING_BY_GPCR
8.57142857143%	6	70	90	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SIGNALING_BY_ERBB4
8.57142857143%	6	70	88	Diabetes_McGill_Adipocytokine_signallin	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
8.57142857143%	6	70	86	Diabetes_McGill_Adipocytokine_signallin	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
8.57142857143%	6	70	857	Diabetes_McGill_Adipocytokine_signallin	MARTENS_TRETINOIN_RESPONSE_UP
8.57142857143%	6	70	82	Diabetes_McGill_Adipocytokine_signallin	ST_INTEGRIN_SIGNALING_PATHWAY
8.57142857143%	6	70	805	Diabetes_McGill_Adipocytokine_signallin	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
8.57142857143%	6	70	805	Diabetes_McGill_Adipocytokine_signallin	REACTOME_GPCR_DOWNSTREAM_SIGNALING
8.57142857143%	6	70	745	Diabetes_McGill_Adipocytokine_signallin	LEE_BMP2_TARGETS_UP
8.57142857143%	6	70	72	Diabetes_McGill_Adipocytokine_signallin	KEGG_LEISHMANIA_INFECTION
8.57142857143%	6	70	66	Diabetes_McGill_Adipocytokine_signallin	PID_TCR_PATHWAY
8.57142857143%	6	70	66	Diabetes_McGill_Adipocytokine_signallin	PID_HDAC_CLASSI_PATHWAY
8.57142857143%	6	70	65	Diabetes_McGill_Adipocytokine_signallin	PID_IL4_2PATHWAY
8.57142857143%	6	70	62	Diabetes_McGill_Adipocytokine_signallin	KEGG_COLORECTAL_CANCER
8.57142857143%	6	70	593	Diabetes_McGill_Adipocytokine_signallin	MARTINEZ_TP53_TARGETS_DN
8.57142857143%	6	70	54	Diabetes_McGill_Adipocytokine_signallin	REACTOME_TCR_SIGNALING
8.57142857143%	6	70	54	Diabetes_McGill_Adipocytokine_signallin	KEGG_NON_SMALL_CELL_LUNG_CANCER
8.57142857143%	6	70	504	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_48HR_DN
8.57142857143%	6	70	50	Diabetes_McGill_Adipocytokine_signallin	PID_ANGIOPOIETINRECEPTOR_PATHWAY
8.57142857143%	6	70	47	Diabetes_McGill_Adipocytokine_signallin	PID_LKB1_PATHWAY
8.57142857143%	6	70	466	Diabetes_McGill_Adipocytokine_signallin	REACTOME_HEMOSTASIS
8.57142857143%	6	70	45	Diabetes_McGill_Adipocytokine_signallin	PID_HNF3BPATHWAY
8.57142857143%	6	70	425	Diabetes_McGill_Adipocytokine_signallin	BOCHKIS_FOXA2_TARGETS
8.57142857143%	6	70	420	Diabetes_McGill_Adipocytokine_signallin	MOOTHA_PGC
8.57142857143%	6	70	37	Diabetes_McGill_Adipocytokine_signallin	REACTOME_DOWNSTREAM_TCR_SIGNALING
8.57142857143%	6	70	35	Diabetes_McGill_Adipocytokine_signallin	PID_PI3KCIAKTPATHWAY
8.57142857143%	6	70	34	Diabetes_McGill_Adipocytokine_signallin	PID_IL1PATHWAY
8.57142857143%	6	70	34	Diabetes_McGill_Adipocytokine_signallin	PID_EPOPATHWAY
8.57142857143%	6	70	33	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_DEATH_PATHWAY
8.57142857143%	6	70	28	Diabetes_McGill_Adipocytokine_signallin	PID_TRAIL_PATHWAY
8.57142857143%	6	70	267	Diabetes_McGill_Adipocytokine_signallin	CAIRO_HEPATOBLASTOMA_DN
8.57142857143%	6	70	24	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_NTHI_PATHWAY
8.57142857143%	6	70	23	Diabetes_McGill_Adipocytokine_signallin	REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX
8.57142857143%	6	70	22	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_CERAMIDE_PATHWAY
8.57142857143%	6	70	207	Diabetes_McGill_Adipocytokine_signallin	VERHAAK_GLIOBLASTOMA_CLASSICAL
8.57142857143%	6	70	201	Diabetes_McGill_Adipocytokine_signallin	KEGG_FOCAL_ADHESION
8.57142857143%	6	70	18	Diabetes_McGill_Adipocytokine_signallin	REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI
8.57142857143%	6	70	15	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_CD40_PATHWAY
8.57142857143%	6	70	149	Diabetes_McGill_Adipocytokine_signallin	TSAI_RESPONSE_TO_IONIZING_RADIATION
8.57142857143%	6	70	129	Diabetes_McGill_Adipocytokine_signallin	PID_PDGFRBPATHWAY
8.57142857143%	6	70	127	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
8.57142857143%	6	70	1229	Diabetes_McGill_Adipocytokine_signallin	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
8.57142857143%	6	70	122	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SIGNALING_BY_PDGF
8.57142857143%	6	70	1142	Diabetes_McGill_Adipocytokine_signallin	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
8.57142857143%	6	70	104	Diabetes_McGill_Adipocytokine_signallin	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
8.57142857143%	6	70	1037	Diabetes_McGill_Adipocytokine_signallin	NUYTTEN_EZH2_TARGETS_UP
8.57142857143%	39	455	800	T2D_GENES_TANYA_BLOODPRESSURE	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
8.57142857143%	39	455	1691	T2D_GENES_TANYA_BLOODPRESSURE	BLALOCK_ALZHEIMERS_DISEASE_UP
8.57142857143%	39	455	1103	T2D_GENES_TANYA_BLOODPRESSURE	DANG_BOUND_BY_MYC
8.56129685917%	169	1974	1069	Mendelian_Nancy_Cox	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
8.55565777369%	186	2174	1652	T2D_GENES_TANYA_LIPIDS	PUJANA_BRCA1_PCC_NETWORK
8.4981293426%	159	1871	1839	T2D_GENES_TANYA_HEIGHT	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
8.48708487085%	46	542	1839	T2D_GENES_TANYA_ANTHROPOMETRIC	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
8.48708487085%	46	542	1725	T2D_GENES_TANYA_ANTHROPOMETRIC	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
8.48708487085%	46	542	1118	T2D_GENES_TANYA_ANTHROPOMETRIC	BENPORATH_ES_WITH_H3K27ME3
8.48287112561%	52	613	1142	T2D_GENES_TANYA_BIOMARKER	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
8.45997973658%	167	1974	1839	Mendelian_Nancy_Cox	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
8.37166513339%	182	2174	1839	T2D_GENES_TANYA_LIPIDS	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
8.35164835165%	38	455	1972	T2D_GENES_TANYA_BLOODPRESSURE	PILON_KLF1_TARGETS_DN
8.35164835165%	38	455	1652	T2D_GENES_TANYA_BLOODPRESSURE	PUJANA_BRCA1_PCC_NETWORK
8.33333333333%	2	24	98	Diabetes_McGill_TNF_alpha_signalin	GUO_TARGETS_OF_IRS1_AND_IRS2
8.33333333333%	2	24	973	Diabetes_McGill_TNF_alpha_signalin	ACEVEDO_LIVER_CANCER_UP
8.33333333333%	2	24	97	Diabetes_McGill_TNF_alpha_signalin	LABBE_WNT3A_TARGETS_DN
8.33333333333%	2	24	97	Diabetes_McGill_TNF_alpha_signalin	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
8.33333333333%	2	24	96	Diabetes_McGill_TNF_alpha_signalin	ZAMORA_NOS2_TARGETS_DN
8.33333333333%	2	24	920	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNALING_BY_GPCR
8.33333333333%	2	24	918	Diabetes_McGill_TNF_alpha_signalin	JOHNSTONE_PARVB_TARGETS_3_DN
8.33333333333%	2	24	911	Diabetes_McGill_TNF_alpha_signalin	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
8.33333333333%	2	24	91	Diabetes_McGill_TNF_alpha_signalin	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
8.33333333333%	2	24	90	Diabetes_McGill_TNF_alpha_signalin	KEGG_GAP_JUNCTION
8.33333333333%	2	24	9	Diabetes_McGill_TNF_alpha_signalin	SA_FAS_SIGNALING
8.33333333333%	2	24	88	Diabetes_McGill_TNF_alpha_signalin	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
8.33333333333%	2	24	88	Diabetes_McGill_TNF_alpha_signalin	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
8.33333333333%	2	24	87	Diabetes_McGill_TNF_alpha_signalin	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
8.33333333333%	2	24	87	Diabetes_McGill_TNF_alpha_signalin	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
8.33333333333%	2	24	86	Diabetes_McGill_TNF_alpha_signalin	REACTOME_L1CAM_INTERACTIONS
8.33333333333%	2	24	86	Diabetes_McGill_TNF_alpha_signalin	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
8.33333333333%	2	24	857	Diabetes_McGill_TNF_alpha_signalin	MARTENS_TRETINOIN_RESPONSE_UP
8.33333333333%	2	24	85	Diabetes_McGill_TNF_alpha_signalin	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
8.33333333333%	2	24	848	Diabetes_McGill_TNF_alpha_signalin	NUYTTEN_NIPP1_TARGETS_DN
8.33333333333%	2	24	841	Diabetes_McGill_TNF_alpha_signalin	MARTENS_TRETINOIN_RESPONSE_DN
8.33333333333%	2	24	83	Diabetes_McGill_TNF_alpha_signalin	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
8.33333333333%	2	24	81	Diabetes_McGill_TNF_alpha_signalin	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
8.33333333333%	2	24	81	Diabetes_McGill_TNF_alpha_signalin	HARRIS_HYPOXIA
8.33333333333%	2	24	805	Diabetes_McGill_TNF_alpha_signalin	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
8.33333333333%	2	24	784	Diabetes_McGill_TNF_alpha_signalin	FORTSCHEGGER_PHF8_TARGETS_DN
8.33333333333%	2	24	77	Diabetes_McGill_TNF_alpha_signalin	MORI_PRE_BI_LYMPHOCYTE_DN
8.33333333333%	2	24	769	Diabetes_McGill_TNF_alpha_signalin	NUYTTEN_NIPP1_TARGETS_UP
8.33333333333%	2	24	756	Diabetes_McGill_TNF_alpha_signalin	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
8.33333333333%	2	24	75	Diabetes_McGill_TNF_alpha_signalin	KEGG_ADHERENS_JUNCTION
8.33333333333%	2	24	74	Diabetes_McGill_TNF_alpha_signalin	PID_E2F_PATHWAY
8.33333333333%	2	24	74	Diabetes_McGill_TNF_alpha_signalin	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
8.33333333333%	2	24	734	Diabetes_McGill_TNF_alpha_signalin	BENPORATH_SOX2_TARGETS
8.33333333333%	2	24	73	Diabetes_McGill_TNF_alpha_signalin	GAURNIER_PSMD4_TARGETS
8.33333333333%	2	24	728	Diabetes_McGill_TNF_alpha_signalin	MARSON_BOUND_BY_E2F4_UNSTIMULATED
8.33333333333%	2	24	722	Diabetes_McGill_TNF_alpha_signalin	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
8.33333333333%	2	24	720	Diabetes_McGill_TNF_alpha_signalin	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
8.33333333333%	2	24	71	Diabetes_McGill_TNF_alpha_signalin	KEGG_MELANOMA
8.33333333333%	2	24	70	Diabetes_McGill_TNF_alpha_signalin	KEGG_LONG_TERM_POTENTIATION
8.33333333333%	2	24	70	Diabetes_McGill_TNF_alpha_signalin	KEGG_LONG_TERM_DEPRESSION
8.33333333333%	2	24	69	Diabetes_McGill_TNF_alpha_signalin	PID_VEGFR1_2_PATHWAY
8.33333333333%	2	24	69	Diabetes_McGill_TNF_alpha_signalin	PID_MTOR_4PATHWAY
8.33333333333%	2	24	69	Diabetes_McGill_TNF_alpha_signalin	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
8.33333333333%	2	24	681	Diabetes_McGill_TNF_alpha_signalin	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
8.33333333333%	2	24	673	Diabetes_McGill_TNF_alpha_signalin	MARTINEZ_RB1_TARGETS_UP
8.33333333333%	2	24	66	Diabetes_McGill_TNF_alpha_signalin	DIRMEIER_LMP1_RESPONSE_EARLY
8.33333333333%	2	24	65	Diabetes_McGill_TNF_alpha_signalin	KEGG_GLIOMA
8.33333333333%	2	24	648	Diabetes_McGill_TNF_alpha_signalin	BENPORATH_CYCLING_GENES
8.33333333333%	2	24	64	Diabetes_McGill_TNF_alpha_signalin	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
8.33333333333%	2	24	64	Diabetes_McGill_TNF_alpha_signalin	GERHOLD_ADIPOGENESIS_DN
8.33333333333%	2	24	63	Diabetes_McGill_TNF_alpha_signalin	PID_IL12_2PATHWAY
8.33333333333%	2	24	62	Diabetes_McGill_TNF_alpha_signalin	PID_TRKRPATHWAY
8.33333333333%	2	24	612	Diabetes_McGill_TNF_alpha_signalin	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
8.33333333333%	2	24	61	Diabetes_McGill_TNF_alpha_signalin	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
8.33333333333%	2	24	59	Diabetes_McGill_TNF_alpha_signalin	PID_FAK_PATHWAY
8.33333333333%	2	24	58	Diabetes_McGill_TNF_alpha_signalin	REACTOME_REGULATION_OF_APOPTOSIS
8.33333333333%	2	24	572	Diabetes_McGill_TNF_alpha_signalin	CHICAS_RB1_TARGETS_SENESCENT
8.33333333333%	2	24	570	Diabetes_McGill_TNF_alpha_signalin	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
8.33333333333%	2	24	57	Diabetes_McGill_TNF_alpha_signalin	DIRMEIER_LMP1_RESPONSE_LATE_UP
8.33333333333%	2	24	566	Diabetes_McGill_TNF_alpha_signalin	DOUGLAS_BMI1_TARGETS_UP
8.33333333333%	2	24	56	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_NFAT_PATHWAY
8.33333333333%	2	24	548	Diabetes_McGill_TNF_alpha_signalin	KIM_ALL_DISORDERS_CALB1_CORR_UP
8.33333333333%	2	24	543	Diabetes_McGill_TNF_alpha_signalin	MARTINEZ_RB1_TARGETS_DN
8.33333333333%	2	24	540	Diabetes_McGill_TNF_alpha_signalin	ACEVEDO_LIVER_CANCER_DN
8.33333333333%	2	24	54	Diabetes_McGill_TNF_alpha_signalin	PID_NFAT_3PATHWAY
8.33333333333%	2	24	539	Diabetes_McGill_TNF_alpha_signalin	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
8.33333333333%	2	24	536	Diabetes_McGill_TNF_alpha_signalin	BERENJENO_TRANSFORMED_BY_RHOA_UP
8.33333333333%	2	24	530	Diabetes_McGill_TNF_alpha_signalin	ENK_UV_RESPONSE_KERATINOCYTE_UP
8.33333333333%	2	24	53	Diabetes_McGill_TNF_alpha_signalin	LINDSTEDT_DENDRITIC_CELL_MATURATION_B
8.33333333333%	2	24	52	Diabetes_McGill_TNF_alpha_signalin	RADAEVA_RESPONSE_TO_IFNA1_UP
8.33333333333%	2	24	52	Diabetes_McGill_TNF_alpha_signalin	KEGG_MTOR_SIGNALING_PATHWAY
8.33333333333%	2	24	51	Diabetes_McGill_TNF_alpha_signalin	ZHANG_PROLIFERATING_VS_QUIESCENT
8.33333333333%	2	24	51	Diabetes_McGill_TNF_alpha_signalin	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
8.33333333333%	2	24	51	Diabetes_McGill_TNF_alpha_signalin	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
8.33333333333%	2	24	505	Diabetes_McGill_TNF_alpha_signalin	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
8.33333333333%	2	24	485	Diabetes_McGill_TNF_alpha_signalin	ENK_UV_RESPONSE_KERATINOCYTE_DN
8.33333333333%	2	24	475	Diabetes_McGill_TNF_alpha_signalin	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
8.33333333333%	2	24	466	Diabetes_McGill_TNF_alpha_signalin	REACTOME_HEMOSTASIS
8.33333333333%	2	24	463	Diabetes_McGill_TNF_alpha_signalin	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
8.33333333333%	2	24	46	Diabetes_McGill_TNF_alpha_signalin	SIG_BCR_SIGNALING_PATHWAY
8.33333333333%	2	24	46	Diabetes_McGill_TNF_alpha_signalin	PID_SYNDECAN_1_PATHWAY
8.33333333333%	2	24	456	Diabetes_McGill_TNF_alpha_signalin	ODONNELL_TFRC_TARGETS_UP
8.33333333333%	2	24	45	Diabetes_McGill_TNF_alpha_signalin	ST_T_CELL_SIGNAL_TRANSDUCTION
8.33333333333%	2	24	45	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_BIOPEPTIDES_PATHWAY
8.33333333333%	2	24	448	Diabetes_McGill_TNF_alpha_signalin	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
8.33333333333%	2	24	443	Diabetes_McGill_TNF_alpha_signalin	DELYS_THYROID_CANCER_UP
8.33333333333%	2	24	44	Diabetes_McGill_TNF_alpha_signalin	MARTIN_INTERACT_WITH_HDAC
8.33333333333%	2	24	44	Diabetes_McGill_TNF_alpha_signalin	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS
8.33333333333%	2	24	439	Diabetes_McGill_TNF_alpha_signalin	MITSIADES_RESPONSE_TO_APLIDIN_UP
8.33333333333%	2	24	43	Diabetes_McGill_TNF_alpha_signalin	PID_CXCR3PATHWAY
8.33333333333%	2	24	43	Diabetes_McGill_TNF_alpha_signalin	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
8.33333333333%	2	24	428	Diabetes_McGill_TNF_alpha_signalin	LIM_MAMMARY_STEM_CELL_DN
8.33333333333%	2	24	42	Diabetes_McGill_TNF_alpha_signalin	KEGG_BLADDER_CANCER
8.33333333333%	2	24	42	Diabetes_McGill_TNF_alpha_signalin	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
8.33333333333%	2	24	418	Diabetes_McGill_TNF_alpha_signalin	MULLIGHAN_MLL_SIGNATURE_2_UP
8.33333333333%	2	24	41	Diabetes_McGill_TNF_alpha_signalin	REACTOME_IL_2_SIGNALING
8.33333333333%	2	24	41	Diabetes_McGill_TNF_alpha_signalin	PID_AMB2_NEUTROPHILS_PATHWAY
8.33333333333%	2	24	40	Diabetes_McGill_TNF_alpha_signalin	ST_B_CELL_ANTIGEN_RECEPTOR
8.33333333333%	2	24	40	Diabetes_McGill_TNF_alpha_signalin	PID_IFNGPATHWAY
8.33333333333%	2	24	40	Diabetes_McGill_TNF_alpha_signalin	PID_EPHBFWDPATHWAY
8.33333333333%	2	24	40	Diabetes_McGill_TNF_alpha_signalin	GENTILE_UV_RESPONSE_CLUSTER_D7
8.33333333333%	2	24	380	Diabetes_McGill_TNF_alpha_signalin	MULLIGHAN_MLL_SIGNATURE_1_UP
8.33333333333%	2	24	38	Diabetes_McGill_TNF_alpha_signalin	PID_ERBB4_PATHWAY
8.33333333333%	2	24	38	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_IL2RB_PATHWAY
8.33333333333%	2	24	378	Diabetes_McGill_TNF_alpha_signalin	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
8.33333333333%	2	24	373	Diabetes_McGill_TNF_alpha_signalin	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
8.33333333333%	2	24	37	Diabetes_McGill_TNF_alpha_signalin	ST_P38_MAPK_PATHWAY
8.33333333333%	2	24	37	Diabetes_McGill_TNF_alpha_signalin	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING
8.33333333333%	2	24	37	Diabetes_McGill_TNF_alpha_signalin	PID_IL23PATHWAY
8.33333333333%	2	24	37	Diabetes_McGill_TNF_alpha_signalin	PID_GMCSF_PATHWAY
8.33333333333%	2	24	37	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_TOLL_PATHWAY
8.33333333333%	2	24	37	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_GPCR_PATHWAY
8.33333333333%	2	24	37	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_BCR_PATHWAY
8.33333333333%	2	24	368	Diabetes_McGill_TNF_alpha_signalin	YAGI_AML_WITH_T_8_21_TRANSLOCATION
8.33333333333%	2	24	36	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNALLING_TO_ERKS
8.33333333333%	2	24	36	Diabetes_McGill_TNF_alpha_signalin	REACTOME_FRS2_MEDIATED_CASCADE
8.33333333333%	2	24	354	Diabetes_McGill_TNF_alpha_signalin	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
8.33333333333%	2	24	35	Diabetes_McGill_TNF_alpha_signalin	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
8.33333333333%	2	24	35	Diabetes_McGill_TNF_alpha_signalin	KEGG_PRION_DISEASES
8.33333333333%	2	24	341	Diabetes_McGill_TNF_alpha_signalin	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
8.33333333333%	2	24	34	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNAL_TRANSDUCTION_BY_L1
8.33333333333%	2	24	34	Diabetes_McGill_TNF_alpha_signalin	PID_MAPKTRKPATHWAY
8.33333333333%	2	24	34	Diabetes_McGill_TNF_alpha_signalin	PID_IL1PATHWAY
8.33333333333%	2	24	34	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_MPR_PATHWAY
8.33333333333%	2	24	338	Diabetes_McGill_TNF_alpha_signalin	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
8.33333333333%	2	24	33	Diabetes_McGill_TNF_alpha_signalin	PID_ALPHASYNUCLEIN_PATHWAY
8.33333333333%	2	24	32	Diabetes_McGill_TNF_alpha_signalin	REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS
8.33333333333%	2	24	32	Diabetes_McGill_TNF_alpha_signalin	PID_NETRIN_PATHWAY
8.33333333333%	2	24	32	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_PDGF_PATHWAY
8.33333333333%	2	24	318	Diabetes_McGill_TNF_alpha_signalin	DAZARD_RESPONSE_TO_UV_NHEK_DN
8.33333333333%	2	24	317	Diabetes_McGill_TNF_alpha_signalin	BRUINS_UVC_RESPONSE_EARLY_LATE
8.33333333333%	2	24	314	Diabetes_McGill_TNF_alpha_signalin	DOUGLAS_BMI1_TARGETS_DN
8.33333333333%	2	24	311	Diabetes_McGill_TNF_alpha_signalin	JIANG_HYPOXIA_NORMAL
8.33333333333%	2	24	31	Diabetes_McGill_TNF_alpha_signalin	PID_AR_NONGENOMIC_PATHWAY
8.33333333333%	2	24	31	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_EGF_PATHWAY
8.33333333333%	2	24	307	Diabetes_McGill_TNF_alpha_signalin	LI_INDUCED_T_TO_NATURAL_KILLER_UP
8.33333333333%	2	24	30	Diabetes_McGill_TNF_alpha_signalin	PID_RETINOIC_ACID_PATHWAY
8.33333333333%	2	24	299	Diabetes_McGill_TNF_alpha_signalin	MUELLER_PLURINET
8.33333333333%	2	24	29	Diabetes_McGill_TNF_alpha_signalin	PID_S1P_S1P3_PATHWAY
8.33333333333%	2	24	29	Diabetes_McGill_TNF_alpha_signalin	KEGG_THYROID_CANCER
8.33333333333%	2	24	28	Diabetes_McGill_TNF_alpha_signalin	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
8.33333333333%	2	24	28	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_GH_PATHWAY
8.33333333333%	2	24	28	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_ERK_PATHWAY
8.33333333333%	2	24	275	Diabetes_McGill_TNF_alpha_signalin	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
8.33333333333%	2	24	271	Diabetes_McGill_TNF_alpha_signalin	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
8.33333333333%	2	24	271	Diabetes_McGill_TNF_alpha_signalin	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
8.33333333333%	2	24	27	Diabetes_McGill_TNF_alpha_signalin	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
8.33333333333%	2	24	27	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNALLING_TO_RAS
8.33333333333%	2	24	27	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_EDG1_PATHWAY
8.33333333333%	2	24	27	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_CREB_PATHWAY
8.33333333333%	2	24	267	Diabetes_McGill_TNF_alpha_signalin	HOLLMANN_APOPTOSIS_VIA_CD40_DN
8.33333333333%	2	24	264	Diabetes_McGill_TNF_alpha_signalin	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
8.33333333333%	2	24	26	Diabetes_McGill_TNF_alpha_signalin	PID_VEGFR1_PATHWAY
8.33333333333%	2	24	26	Diabetes_McGill_TNF_alpha_signalin	PID_ALK1PATHWAY
8.33333333333%	2	24	26	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_BAD_PATHWAY
8.33333333333%	2	24	253	Diabetes_McGill_TNF_alpha_signalin	DANG_REGULATED_BY_MYC_DN
8.33333333333%	2	24	251	Diabetes_McGill_TNF_alpha_signalin	REACTOME_AXON_GUIDANCE
8.33333333333%	2	24	25	Diabetes_McGill_TNF_alpha_signalin	PID_LYMPHANGIOGENESIS_PATHWAY
8.33333333333%	2	24	25	Diabetes_McGill_TNF_alpha_signalin	KEGG_DORSO_VENTRAL_AXIS_FORMATION
8.33333333333%	2	24	25	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_MCALPAIN_PATHWAY
8.33333333333%	2	24	245	Diabetes_McGill_TNF_alpha_signalin	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
8.33333333333%	2	24	244	Diabetes_McGill_TNF_alpha_signalin	DAZARD_RESPONSE_TO_UV_NHEK_UP
8.33333333333%	2	24	242	Diabetes_McGill_TNF_alpha_signalin	WINTER_HYPOXIA_METAGENE
8.33333333333%	2	24	241	Diabetes_McGill_TNF_alpha_signalin	DOANE_RESPONSE_TO_ANDROGEN_DN
8.33333333333%	2	24	24	Diabetes_McGill_TNF_alpha_signalin	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION
8.33333333333%	2	24	24	Diabetes_McGill_TNF_alpha_signalin	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING
8.33333333333%	2	24	24	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_TPO_PATHWAY
8.33333333333%	2	24	24	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_NTHI_PATHWAY
8.33333333333%	2	24	24	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_EIF4_PATHWAY
8.33333333333%	2	24	24	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_ECM_PATHWAY
8.33333333333%	2	24	239	Diabetes_McGill_TNF_alpha_signalin	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
8.33333333333%	2	24	234	Diabetes_McGill_TNF_alpha_signalin	AFFAR_YY1_TARGETS_DN
8.33333333333%	2	24	230	Diabetes_McGill_TNF_alpha_signalin	BENPORATH_MYC_TARGETS_WITH_EBOX
8.33333333333%	2	24	23	Diabetes_McGill_TNF_alpha_signalin	ST_GA12_PATHWAY
8.33333333333%	2	24	23	Diabetes_McGill_TNF_alpha_signalin	PID_PRLSIGNALINGEVENTSPATHWAY
8.33333333333%	2	24	23	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_IGF1R_PATHWAY
8.33333333333%	2	24	23	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_GLEEVEC_PATHWAY
8.33333333333%	2	24	23	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_CCR3_PATHWAY
8.33333333333%	2	24	228	Diabetes_McGill_TNF_alpha_signalin	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
8.33333333333%	2	24	22	Diabetes_McGill_TNF_alpha_signalin	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING
8.33333333333%	2	24	22	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_SPPA_PATHWAY
8.33333333333%	2	24	22	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_INSULIN_PATHWAY
8.33333333333%	2	24	22	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_IL6_PATHWAY
8.33333333333%	2	24	22	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_IL2_PATHWAY
8.33333333333%	2	24	22	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_HER2_PATHWAY
8.33333333333%	2	24	22	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_AKT_PATHWAY
8.33333333333%	2	24	216	Diabetes_McGill_TNF_alpha_signalin	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
8.33333333333%	2	24	214	Diabetes_McGill_TNF_alpha_signalin	ZWANG_EGF_INTERVAL_DN
8.33333333333%	2	24	210	Diabetes_McGill_TNF_alpha_signalin	VERHAAK_GLIOBLASTOMA_PRONEURAL
8.33333333333%	2	24	210	Diabetes_McGill_TNF_alpha_signalin	VERHAAK_GLIOBLASTOMA_NEURAL
8.33333333333%	2	24	21	Diabetes_McGill_TNF_alpha_signalin	REACTOME_ERK_MAPK_TARGETS
8.33333333333%	2	24	21	Diabetes_McGill_TNF_alpha_signalin	PID_S1P_S1P1_PATHWAY
8.33333333333%	2	24	21	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_IGF1_PATHWAY
8.33333333333%	2	24	208	Diabetes_McGill_TNF_alpha_signalin	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
8.33333333333%	2	24	206	Diabetes_McGill_TNF_alpha_signalin	LINSLEY_MIR16_TARGETS
8.33333333333%	2	24	205	Diabetes_McGill_TNF_alpha_signalin	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
8.33333333333%	2	24	20	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING
8.33333333333%	2	24	20	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_ATM_PATHWAY
8.33333333333%	2	24	197	Diabetes_McGill_TNF_alpha_signalin	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
8.33333333333%	2	24	19	Diabetes_McGill_TNF_alpha_signalin	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS
8.33333333333%	2	24	19	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_MAL_PATHWAY
8.33333333333%	2	24	19	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_EPO_PATHWAY
8.33333333333%	2	24	182	Diabetes_McGill_TNF_alpha_signalin	WHITFIELD_CELL_CYCLE_G2
8.33333333333%	2	24	181	Diabetes_McGill_TNF_alpha_signalin	JISON_SICKLE_CELL_DISEASE_UP
8.33333333333%	2	24	18	Diabetes_McGill_TNF_alpha_signalin	YIH_RESPONSE_TO_ARSENITE_C4
8.33333333333%	2	24	18	Diabetes_McGill_TNF_alpha_signalin	REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI
8.33333333333%	2	24	18	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_SPRY_PATHWAY
8.33333333333%	2	24	18	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_PTEN_PATHWAY
8.33333333333%	2	24	18	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_NGF_PATHWAY
8.33333333333%	2	24	18	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_ERK5_PATHWAY
8.33333333333%	2	24	18	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_CARDIACEGF_PATHWAY
8.33333333333%	2	24	176	Diabetes_McGill_TNF_alpha_signalin	NAGASHIMA_NRG1_SIGNALING_UP
8.33333333333%	2	24	17	Diabetes_McGill_TNF_alpha_signalin	SA_PTEN_PATHWAY
8.33333333333%	2	24	17	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SHC_RELATED_EVENTS
8.33333333333%	2	24	17	Diabetes_McGill_TNF_alpha_signalin	REACTOME_ARMS_MEDIATED_ACTIVATION
8.33333333333%	2	24	17	Diabetes_McGill_TNF_alpha_signalin	PID_SMAD2_3PATHWAY
8.33333333333%	2	24	165	Diabetes_McGill_TNF_alpha_signalin	LIU_CMYB_TARGETS_UP
8.33333333333%	2	24	160	Diabetes_McGill_TNF_alpha_signalin	BROWNE_HCMV_INFECTION_6HR_DN
8.33333333333%	2	24	16	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_BCELLSURVIVAL_PATHWAY
8.33333333333%	2	24	158	Diabetes_McGill_TNF_alpha_signalin	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
8.33333333333%	2	24	157	Diabetes_McGill_TNF_alpha_signalin	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
8.33333333333%	2	24	153	Diabetes_McGill_TNF_alpha_signalin	DAZARD_UV_RESPONSE_CLUSTER_G6
8.33333333333%	2	24	150	Diabetes_McGill_TNF_alpha_signalin	BROWNE_HCMV_INFECTION_30MIN_DN
8.33333333333%	2	24	15	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN
8.33333333333%	2	24	15	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SHC_MEDIATED_SIGNALLING
8.33333333333%	2	24	15	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING
8.33333333333%	2	24	15	Diabetes_McGill_TNF_alpha_signalin	PID_ARF6DOWNSTREAMPATHWAY
8.33333333333%	2	24	15	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_TALL1_PATHWAY
8.33333333333%	2	24	15	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_BARRESTIN_SRC_PATHWAY
8.33333333333%	2	24	149	Diabetes_McGill_TNF_alpha_signalin	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
8.33333333333%	2	24	147	Diabetes_McGill_TNF_alpha_signalin	DARWICHE_PAPILLOMA_RISK_HIGH_UP
8.33333333333%	2	24	146	Diabetes_McGill_TNF_alpha_signalin	KIM_ALL_DISORDERS_DURATION_CORR_DN
8.33333333333%	2	24	14	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING
8.33333333333%	2	24	14	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SOS_MEDIATED_SIGNALLING
8.33333333333%	2	24	14	Diabetes_McGill_TNF_alpha_signalin	PID_TCRRASPATHWAY
8.33333333333%	2	24	14	Diabetes_McGill_TNF_alpha_signalin	PID_S1P_S1P4_PATHWAY
8.33333333333%	2	24	14	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_DREAM_PATHWAY
8.33333333333%	2	24	137	Diabetes_McGill_TNF_alpha_signalin	KEGG_INSULIN_SIGNALING_PATHWAY
8.33333333333%	2	24	13	Diabetes_McGill_TNF_alpha_signalin	REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING
8.33333333333%	2	24	13	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_ARENRF2_PATHWAY
8.33333333333%	2	24	129	Diabetes_McGill_TNF_alpha_signalin	KEGG_AXON_GUIDANCE
8.33333333333%	2	24	128	Diabetes_McGill_TNF_alpha_signalin	LENAOUR_DENDRITIC_CELL_MATURATION_DN
8.33333333333%	2	24	121	Diabetes_McGill_TNF_alpha_signalin	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
8.33333333333%	2	24	120	Diabetes_McGill_TNF_alpha_signalin	ZHU_CMV_ALL_UP
8.33333333333%	2	24	12	Diabetes_McGill_TNF_alpha_signalin	REACTOME_ERKS_ARE_INACTIVATED
8.33333333333%	2	24	12	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_BARR_MAPK_PATHWAY
8.33333333333%	2	24	115	Diabetes_McGill_TNF_alpha_signalin	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
8.33333333333%	2	24	1142	Diabetes_McGill_TNF_alpha_signalin	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
8.33333333333%	2	24	114	Diabetes_McGill_TNF_alpha_signalin	KEGG_OOCYTE_MEIOSIS
8.33333333333%	2	24	11	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_CDK5_PATHWAY
8.33333333333%	2	24	1080	Diabetes_McGill_TNF_alpha_signalin	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
8.33333333333%	2	24	108	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
8.33333333333%	2	24	1024	Diabetes_McGill_TNF_alpha_signalin	NUYTTEN_EZH2_TARGETS_DN
8.33333333333%	2	24	102	Diabetes_McGill_TNF_alpha_signalin	KEGG_MELANOGENESIS
8.33333333333%	2	24	10	Diabetes_McGill_TNF_alpha_signalin	REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS
8.33333333333%	2	24	10	Diabetes_McGill_TNF_alpha_signalin	REACTOME_RAF_MAP_KINASE_CASCADE
8.33333333333%	2	24	10	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_FREE_PATHWAY
8.33333333333%	2	24	10	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_DNAFRAGMENT_PATHWAY
8.33333333333%	2	24	10	Diabetes_McGill_TNF_alpha_signalin	BAKER_HEMATOPOESIS_STAT1_TARGETS
8.33333333333%	1	12	99	Mendelian_Etc	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
8.33333333333%	1	12	99	Diabetes_McGill_Adipocytokines	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
8.33333333333%	1	12	98	Diabetes_McGill_Adipocytokines	GUO_TARGETS_OF_IRS1_AND_IRS2
8.33333333333%	1	12	957	Mendelian_Etc	LOPEZ_MBD_TARGETS
8.33333333333%	1	12	95	Diabetes_McGill_Adipocytokines	HECKER_IFNB1_TARGETS
8.33333333333%	1	12	95	Diabetes_McGill_Adipocytokines	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
8.33333333333%	1	12	95	Diabetes_McGill_Adipocytokines	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
8.33333333333%	1	12	940	Diabetes_McGill_Adipocytokines	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
8.33333333333%	1	12	94	Diabetes_McGill_Adipocytokines	LU_IL4_SIGNALING
8.33333333333%	1	12	94	Diabetes_McGill_Adipocytokines	HOOI_ST7_TARGETS_UP
8.33333333333%	1	12	93	Mendelian_Etc	REACTOME_ACTIVATED_TLR4_SIGNALLING
8.33333333333%	1	12	93	Mendelian_Etc	CADWELL_ATG16L1_TARGETS_UP
8.33333333333%	1	12	93	Diabetes_McGill_Adipocytokines	ZHU_CMV_24_HR_UP
8.33333333333%	1	12	920	Mendelian_Etc	REACTOME_SIGNALING_BY_GPCR
8.33333333333%	1	12	92	Diabetes_McGill_Adipocytokines	KIM_MYCN_AMPLIFICATION_TARGETS_UP
8.33333333333%	1	12	911	Diabetes_McGill_Adipocytokines	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
8.33333333333%	1	12	91	Mendelian_Etc	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
8.33333333333%	1	12	91	Mendelian_Etc	GAVIN_FOXP3_TARGETS_CLUSTER_P6
8.33333333333%	1	12	90	Mendelian_Etc	REACTOME_SIGNALING_BY_ERBB4
8.33333333333%	1	12	90	Diabetes_McGill_Adipocytokines	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN
8.33333333333%	1	12	9	Diabetes_McGill_Adipocytokines	SASSON_FSH_RESPONSE
8.33333333333%	1	12	9	Diabetes_McGill_Adipocytokines	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
8.33333333333%	1	12	893	Mendelian_Etc	GEORGES_TARGETS_OF_MIR192_AND_MIR215
8.33333333333%	1	12	893	Diabetes_McGill_Adipocytokines	GEORGES_TARGETS_OF_MIR192_AND_MIR215
8.33333333333%	1	12	89	Mendelian_Etc	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
8.33333333333%	1	12	89	Mendelian_Etc	LEIN_PONS_MARKERS
8.33333333333%	1	12	89	Mendelian_Etc	LEE_AGING_NEOCORTEX_UP
8.33333333333%	1	12	89	Mendelian_Etc	KEGG_PROSTATE_CANCER
8.33333333333%	1	12	89	Diabetes_McGill_Adipocytokines	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
8.33333333333%	1	12	89	Diabetes_McGill_Adipocytokines	LEE_AGING_NEOCORTEX_UP
8.33333333333%	1	12	882	Diabetes_McGill_Adipocytokines	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
8.33333333333%	1	12	88	Mendelian_Etc	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
8.33333333333%	1	12	88	Mendelian_Etc	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
8.33333333333%	1	12	88	Diabetes_McGill_Adipocytokines	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
8.33333333333%	1	12	871	Mendelian_Etc	GRADE_COLON_CANCER_UP
8.33333333333%	1	12	87	Mendelian_Etc	SMITH_TERT_TARGETS_DN
8.33333333333%	1	12	863	Mendelian_Etc	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
8.33333333333%	1	12	86	Mendelian_Etc	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
8.33333333333%	1	12	86	Mendelian_Etc	BURTON_ADIPOGENESIS_8
8.33333333333%	1	12	86	Mendelian_Etc	BROWNE_HCMV_INFECTION_16HR_DN
8.33333333333%	1	12	86	Diabetes_McGill_Adipocytokines	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
8.33333333333%	1	12	857	Diabetes_McGill_Adipocytokines	MARTENS_TRETINOIN_RESPONSE_UP
8.33333333333%	1	12	855	Diabetes_McGill_Adipocytokines	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
8.33333333333%	1	12	85	Mendelian_Etc	STEIN_ESR1_TARGETS
8.33333333333%	1	12	85	Diabetes_McGill_Adipocytokines	XU_GH1_EXOGENOUS_TARGETS_UP
8.33333333333%	1	12	85	Diabetes_McGill_Adipocytokines	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
8.33333333333%	1	12	85	Diabetes_McGill_Adipocytokines	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
8.33333333333%	1	12	85	Diabetes_McGill_Adipocytokines	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
8.33333333333%	1	12	85	Diabetes_McGill_Adipocytokines	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
8.33333333333%	1	12	848	Mendelian_Etc	NUYTTEN_NIPP1_TARGETS_DN
8.33333333333%	1	12	841	Diabetes_McGill_Adipocytokines	MARTENS_TRETINOIN_RESPONSE_DN
8.33333333333%	1	12	84	Mendelian_Etc	LEE_AGING_CEREBELLUM_UP
8.33333333333%	1	12	84	Diabetes_McGill_Adipocytokines	RUAN_RESPONSE_TO_TNF_DN
8.33333333333%	1	12	84	Diabetes_McGill_Adipocytokines	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
8.33333333333%	1	12	830	Mendelian_Etc	CUI_TCF21_TARGETS_2_DN
8.33333333333%	1	12	83	Mendelian_Etc	WARTERS_RESPONSE_TO_IR_SKIN
8.33333333333%	1	12	83	Mendelian_Etc	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
8.33333333333%	1	12	83	Mendelian_Etc	REACTOME_AMYLOIDS
8.33333333333%	1	12	83	Diabetes_McGill_Adipocytokines	SANA_TNF_SIGNALING_UP
8.33333333333%	1	12	83	Diabetes_McGill_Adipocytokines	ONDER_CDH1_SIGNALING_VIA_CTNNB1
8.33333333333%	1	12	82	Mendelian_Etc	PID_SMAD2_3NUCLEARPATHWAY
8.33333333333%	1	12	81	Mendelian_Etc	MAHAJAN_RESPONSE_TO_IL1A_UP
8.33333333333%	1	12	81	Mendelian_Etc	LEIN_MEDULLA_MARKERS
8.33333333333%	1	12	81	Mendelian_Etc	GUO_HEX_TARGETS_UP
8.33333333333%	1	12	81	Diabetes_McGill_Adipocytokines	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
8.33333333333%	1	12	81	Diabetes_McGill_Adipocytokines	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
8.33333333333%	1	12	81	Diabetes_McGill_Adipocytokines	GUO_HEX_TARGETS_UP
8.33333333333%	1	12	805	Mendelian_Etc	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
8.33333333333%	1	12	805	Mendelian_Etc	REACTOME_GPCR_DOWNSTREAM_SIGNALING
8.33333333333%	1	12	805	Diabetes_McGill_Adipocytokines	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
8.33333333333%	1	12	800	Diabetes_McGill_Adipocytokines	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
8.33333333333%	1	12	80	Mendelian_Etc	SCHUHMACHER_MYC_TARGETS_UP
8.33333333333%	1	12	80	Mendelian_Etc	PID_BETACATENIN_NUC_PATHWAY
8.33333333333%	1	12	80	Mendelian_Etc	LEE_AGING_NEOCORTEX_DN
8.33333333333%	1	12	80	Mendelian_Etc	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
8.33333333333%	1	12	80	Diabetes_McGill_Adipocytokines	SCHUHMACHER_MYC_TARGETS_UP
8.33333333333%	1	12	80	Diabetes_McGill_Adipocytokines	REACTOME_UNFOLDED_PROTEIN_RESPONSE
8.33333333333%	1	12	80	Diabetes_McGill_Adipocytokines	PID_BETACATENIN_NUC_PATHWAY
8.33333333333%	1	12	80	Diabetes_McGill_Adipocytokines	LINDVALL_IMMORTALIZED_BY_TERT_DN
8.33333333333%	1	12	8	Mendelian_Etc	KHETCHOUMIAN_TRIM24_TARGETS_DN
8.33333333333%	1	12	8	Diabetes_McGill_Adipocytokines	RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN
8.33333333333%	1	12	79	Diabetes_McGill_Adipocytokines	DUAN_PRDM5_TARGETS
8.33333333333%	1	12	79	Diabetes_McGill_Adipocytokines	CROMER_METASTASIS_UP
8.33333333333%	1	12	784	Diabetes_McGill_Adipocytokines	FORTSCHEGGER_PHF8_TARGETS_DN
8.33333333333%	1	12	783	Mendelian_Etc	ONKEN_UVEAL_MELANOMA_UP
8.33333333333%	1	12	78	Diabetes_McGill_Adipocytokines	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
8.33333333333%	1	12	78	Diabetes_McGill_Adipocytokines	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
8.33333333333%	1	12	78	Diabetes_McGill_Adipocytokines	RADMACHER_AML_PROGNOSIS
8.33333333333%	1	12	78	Diabetes_McGill_Adipocytokines	COATES_MACROPHAGE_M1_VS_M2_DN
8.33333333333%	1	12	779	Mendelian_Etc	PUJANA_CHEK2_PCC_NETWORK
8.33333333333%	1	12	775	Mendelian_Etc	BENPORATH_MYC_MAX_TARGETS
8.33333333333%	1	12	770	Mendelian_Etc	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
8.33333333333%	1	12	770	Diabetes_McGill_Adipocytokines	KRIEG_HYPOXIA_NOT_VIA_KDM3A
8.33333333333%	1	12	770	Diabetes_McGill_Adipocytokines	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
8.33333333333%	1	12	77	Mendelian_Etc	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
8.33333333333%	1	12	77	Mendelian_Etc	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
8.33333333333%	1	12	77	Diabetes_McGill_Adipocytokines	RODRIGUES_THYROID_CARCINOMA_DN
8.33333333333%	1	12	77	Diabetes_McGill_Adipocytokines	CARD_MIR302A_TARGETS
8.33333333333%	1	12	769	Mendelian_Etc	NUYTTEN_NIPP1_TARGETS_UP
8.33333333333%	1	12	769	Diabetes_McGill_Adipocytokines	NUYTTEN_NIPP1_TARGETS_UP
8.33333333333%	1	12	76	Mendelian_Etc	MAHAJAN_RESPONSE_TO_IL1A_DN
8.33333333333%	1	12	76	Diabetes_McGill_Adipocytokines	PEART_HDAC_PROLIFERATION_CLUSTER_DN
8.33333333333%	1	12	76	Diabetes_McGill_Adipocytokines	KEGG_VEGF_SIGNALING_PATHWAY
8.33333333333%	1	12	756	Diabetes_McGill_Adipocytokines	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
8.33333333333%	1	12	75	Diabetes_McGill_Adipocytokines	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
8.33333333333%	1	12	75	Diabetes_McGill_Adipocytokines	PID_AVB3_INTEGRIN_PATHWAY
8.33333333333%	1	12	75	Diabetes_McGill_Adipocytokines	JAIN_NFKB_SIGNALING
8.33333333333%	1	12	75	Diabetes_McGill_Adipocytokines	BAE_BRCA1_TARGETS_UP
8.33333333333%	1	12	747	Diabetes_McGill_Adipocytokines	PATIL_LIVER_CANCER
8.33333333333%	1	12	745	Mendelian_Etc	LEE_BMP2_TARGETS_UP
8.33333333333%	1	12	74	Mendelian_Etc	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
8.33333333333%	1	12	74	Mendelian_Etc	POTTI_ADRIAMYCIN_SENSITIVITY
8.33333333333%	1	12	74	Mendelian_Etc	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
8.33333333333%	1	12	74	Mendelian_Etc	LIAN_LIPA_TARGETS_6M
8.33333333333%	1	12	74	Mendelian_Etc	FURUKAWA_DUSP6_TARGETS_PCI35_UP
8.33333333333%	1	12	74	Diabetes_McGill_Adipocytokines	LIAN_LIPA_TARGETS_6M
8.33333333333%	1	12	74	Diabetes_McGill_Adipocytokines	DER_IFN_ALPHA_RESPONSE_UP
8.33333333333%	1	12	73	Mendelian_Etc	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP
8.33333333333%	1	12	73	Mendelian_Etc	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
8.33333333333%	1	12	73	Diabetes_McGill_Adipocytokines	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
8.33333333333%	1	12	73	Diabetes_McGill_Adipocytokines	GAURNIER_PSMD4_TARGETS
8.33333333333%	1	12	73	Diabetes_McGill_Adipocytokines	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
8.33333333333%	1	12	721	Diabetes_McGill_Adipocytokines	WONG_ADULT_TISSUE_STEM_MODULE
8.33333333333%	1	12	72	Mendelian_Etc	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
8.33333333333%	1	12	72	Mendelian_Etc	DOANE_BREAST_CANCER_CLASSES_UP
8.33333333333%	1	12	72	Diabetes_McGill_Adipocytokines	SESTO_RESPONSE_TO_UV_C8
8.33333333333%	1	12	72	Diabetes_McGill_Adipocytokines	SESTO_RESPONSE_TO_UV_C1
8.33333333333%	1	12	718	Mendelian_Etc	MIKKELSEN_ES_ICP_WITH_H3K4ME3
8.33333333333%	1	12	71	Diabetes_McGill_Adipocytokines	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
8.33333333333%	1	12	71	Diabetes_McGill_Adipocytokines	GU_PDEF_TARGETS_UP
8.33333333333%	1	12	71	Diabetes_McGill_Adipocytokines	GEORGANTAS_HSC_MARKERS
8.33333333333%	1	12	71	Diabetes_McGill_Adipocytokines	DER_IFN_GAMMA_RESPONSE_UP
8.33333333333%	1	12	701	Diabetes_McGill_Adipocytokines	SMID_BREAST_CANCER_BASAL_DN
8.33333333333%	1	12	70	Diabetes_McGill_Adipocytokines	KEGG_RENAL_CELL_CARCINOMA
8.33333333333%	1	12	70	Diabetes_McGill_Adipocytokines	KEGG_PANCREATIC_CANCER
8.33333333333%	1	12	7	Diabetes_McGill_Adipocytokines	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP
8.33333333333%	1	12	7	Diabetes_McGill_Adipocytokines	HE_PTEN_TARGETS_DN
8.33333333333%	1	12	7	Diabetes_McGill_Adipocytokines	FARDIN_HYPOXIA_9
8.33333333333%	1	12	69	Diabetes_McGill_Adipocytokines	PID_VEGFR1_2_PATHWAY
8.33333333333%	1	12	69	Diabetes_McGill_Adipocytokines	AMIT_EGF_RESPONSE_120_HELA
8.33333333333%	1	12	682	Mendelian_Etc	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
8.33333333333%	1	12	682	Diabetes_McGill_Adipocytokines	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
8.33333333333%	1	12	681	Mendelian_Etc	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
8.33333333333%	1	12	673	Mendelian_Etc	MARTINEZ_RB1_TARGETS_UP
8.33333333333%	1	12	67	Diabetes_McGill_Adipocytokines	VANHARANTA_UTERINE_FIBROID_DN
8.33333333333%	1	12	67	Diabetes_McGill_Adipocytokines	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
8.33333333333%	1	12	67	Diabetes_McGill_Adipocytokines	DAZARD_UV_RESPONSE_CLUSTER_G1
8.33333333333%	1	12	668	Diabetes_McGill_Adipocytokines	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
8.33333333333%	1	12	66	Mendelian_Etc	RIGGINS_TAMOXIFEN_RESISTANCE_UP
8.33333333333%	1	12	66	Diabetes_McGill_Adipocytokines	PID_INTEGRIN1_PATHWAY
8.33333333333%	1	12	66	Diabetes_McGill_Adipocytokines	PID_HIF1_TFPATHWAY
8.33333333333%	1	12	658	Mendelian_Etc	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
8.33333333333%	1	12	65	Mendelian_Etc	GUO_HEX_TARGETS_DN
8.33333333333%	1	12	65	Mendelian_Etc	CHANG_IMMORTALIZED_BY_HPV31_DN
8.33333333333%	1	12	65	Diabetes_McGill_Adipocytokines	ST_FAS_SIGNALING_PATHWAY
8.33333333333%	1	12	64	Mendelian_Etc	INGRAM_SHH_TARGETS_DN
8.33333333333%	1	12	64	Diabetes_McGill_Adipocytokines	PETROVA_PROX1_TARGETS_DN
8.33333333333%	1	12	64	Diabetes_McGill_Adipocytokines	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
8.33333333333%	1	12	64	Diabetes_McGill_Adipocytokines	BYSTROEM_CORRELATED_WITH_IL5_DN
8.33333333333%	1	12	634	Mendelian_Etc	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
8.33333333333%	1	12	633	Mendelian_Etc	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
8.33333333333%	1	12	63	Mendelian_Etc	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
8.33333333333%	1	12	63	Diabetes_McGill_Adipocytokines	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
8.33333333333%	1	12	62	Mendelian_Etc	KYNG_DNA_DAMAGE_BY_UV
8.33333333333%	1	12	62	Mendelian_Etc	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
8.33333333333%	1	12	61	Mendelian_Etc	RAMASWAMY_METASTASIS_DN
8.33333333333%	1	12	61	Mendelian_Etc	PID_AR_PATHWAY
8.33333333333%	1	12	61	Mendelian_Etc	NADLER_OBESITY_UP
8.33333333333%	1	12	61	Mendelian_Etc	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
8.33333333333%	1	12	61	Mendelian_Etc	BROWNE_HCMV_INFECTION_1HR_UP
8.33333333333%	1	12	605	Mendelian_Etc	CAIRO_HEPATOBLASTOMA_CLASSES_UP
8.33333333333%	1	12	602	Mendelian_Etc	MARTINEZ_TP53_TARGETS_UP
8.33333333333%	1	12	601	Mendelian_Etc	MARTINEZ_RB1_AND_TP53_TARGETS_UP
8.33333333333%	1	12	60	Mendelian_Etc	WIERENGA_STAT5A_TARGETS_GROUP2
8.33333333333%	1	12	60	Mendelian_Etc	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
8.33333333333%	1	12	60	Mendelian_Etc	CUI_GLUCOSE_DEPRIVATION
8.33333333333%	1	12	60	Diabetes_McGill_Adipocytokines	WIERENGA_STAT5A_TARGETS_GROUP2
8.33333333333%	1	12	60	Diabetes_McGill_Adipocytokines	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
8.33333333333%	1	12	60	Diabetes_McGill_Adipocytokines	CROONQUIST_STROMAL_STIMULATION_UP
8.33333333333%	1	12	6	Mendelian_Etc	ELVIDGE_HIF2A_TARGETS_UP
8.33333333333%	1	12	59	Mendelian_Etc	ELVIDGE_HYPOXIA_BY_DMOG_DN
8.33333333333%	1	12	59	Diabetes_McGill_Adipocytokines	ONDER_CDH1_TARGETS_3_DN
8.33333333333%	1	12	59	Diabetes_McGill_Adipocytokines	LIAN_LIPA_TARGETS_3M
8.33333333333%	1	12	58	Mendelian_Etc	SCHEIDEREIT_IKK_INTERACTING_PROTEINS
8.33333333333%	1	12	58	Mendelian_Etc	SANSOM_WNT_PATHWAY_REQUIRE_MYC
8.33333333333%	1	12	58	Mendelian_Etc	REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT
8.33333333333%	1	12	58	Diabetes_McGill_Adipocytokines	BERNARD_PPAPDC1B_TARGETS_DN
8.33333333333%	1	12	578	Mendelian_Etc	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
8.33333333333%	1	12	57	Diabetes_McGill_Adipocytokines	LEE_EARLY_T_LYMPHOCYTE_DN
8.33333333333%	1	12	57	Diabetes_McGill_Adipocytokines	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
8.33333333333%	1	12	57	Diabetes_McGill_Adipocytokines	AMIT_SERUM_RESPONSE_60_MCF10A
8.33333333333%	1	12	567	Mendelian_Etc	CHICAS_RB1_TARGETS_CONFLUENT
8.33333333333%	1	12	56	Mendelian_Etc	HOQUE_METHYLATED_IN_CANCER
8.33333333333%	1	12	56	Diabetes_McGill_Adipocytokines	LY_AGING_OLD_DN
8.33333333333%	1	12	56	Diabetes_McGill_Adipocytokines	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
8.33333333333%	1	12	555	Mendelian_Etc	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
8.33333333333%	1	12	552	Diabetes_McGill_Adipocytokines	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
8.33333333333%	1	12	55	Mendelian_Etc	DEMAGALHAES_AGING_UP
8.33333333333%	1	12	55	Diabetes_McGill_Adipocytokines	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53
8.33333333333%	1	12	55	Diabetes_McGill_Adipocytokines	BROWNE_HCMV_INFECTION_4HR_UP
8.33333333333%	1	12	549	Diabetes_McGill_Adipocytokines	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
8.33333333333%	1	12	548	Mendelian_Etc	KIM_ALL_DISORDERS_CALB1_CORR_UP
8.33333333333%	1	12	548	Diabetes_McGill_Adipocytokines	KIM_ALL_DISORDERS_CALB1_CORR_UP
8.33333333333%	1	12	546	Diabetes_McGill_Adipocytokines	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
8.33333333333%	1	12	54	Diabetes_McGill_Adipocytokines	ZHOU_TNF_SIGNALING_30MIN
8.33333333333%	1	12	536	Diabetes_McGill_Adipocytokines	BERENJENO_TRANSFORMED_BY_RHOA_UP
8.33333333333%	1	12	535	Diabetes_McGill_Adipocytokines	STEIN_ESRRA_TARGETS
8.33333333333%	1	12	53	Mendelian_Etc	ZHU_CMV_8_HR_DN
8.33333333333%	1	12	53	Mendelian_Etc	PID_AR_TF_PATHWAY
8.33333333333%	1	12	53	Diabetes_McGill_Adipocytokines	ZHU_CMV_8_HR_DN
8.33333333333%	1	12	53	Diabetes_McGill_Adipocytokines	REACTOME_CIRCADIAN_CLOCK
8.33333333333%	1	12	53	Diabetes_McGill_Adipocytokines	LIANG_SILENCED_BY_METHYLATION_2
8.33333333333%	1	12	526	Mendelian_Etc	ONKEN_UVEAL_MELANOMA_DN
8.33333333333%	1	12	52	Diabetes_McGill_Adipocytokines	PRAMOONJAGO_SOX4_TARGETS_UP
8.33333333333%	1	12	52	Diabetes_McGill_Adipocytokines	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
8.33333333333%	1	12	52	Diabetes_McGill_Adipocytokines	KENNY_CTNNB1_TARGETS_DN
8.33333333333%	1	12	52	Diabetes_McGill_Adipocytokines	KEGG_MTOR_SIGNALING_PATHWAY
8.33333333333%	1	12	52	Diabetes_McGill_Adipocytokines	HALMOS_CEBPA_TARGETS_UP
8.33333333333%	1	12	52	Diabetes_McGill_Adipocytokines	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP
8.33333333333%	1	12	52	Diabetes_McGill_Adipocytokines	BECKER_TAMOXIFEN_RESISTANCE_DN
8.33333333333%	1	12	518	Diabetes_McGill_Adipocytokines	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
8.33333333333%	1	12	514	Mendelian_Etc	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
8.33333333333%	1	12	514	Diabetes_McGill_Adipocytokines	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
8.33333333333%	1	12	510	Diabetes_McGill_Adipocytokines	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
8.33333333333%	1	12	51	Mendelian_Etc	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN
8.33333333333%	1	12	51	Mendelian_Etc	GUILLAUMOND_KLF10_TARGETS_UP
8.33333333333%	1	12	51	Diabetes_McGill_Adipocytokines	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
8.33333333333%	1	12	51	Diabetes_McGill_Adipocytokines	ZHANG_PROLIFERATING_VS_QUIESCENT
8.33333333333%	1	12	51	Diabetes_McGill_Adipocytokines	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN
8.33333333333%	1	12	51	Diabetes_McGill_Adipocytokines	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
8.33333333333%	1	12	51	Diabetes_McGill_Adipocytokines	BURTON_ADIPOGENESIS_7
8.33333333333%	1	12	508	Mendelian_Etc	ENK_UV_RESPONSE_EPIDERMIS_DN
8.33333333333%	1	12	505	Diabetes_McGill_Adipocytokines	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
8.33333333333%	1	12	501	Mendelian_Etc	SENESE_HDAC3_TARGETS_UP
8.33333333333%	1	12	50	Mendelian_Etc	STOSSI_RESPONSE_TO_ESTRADIOL
8.33333333333%	1	12	50	Diabetes_McGill_Adipocytokines	STOSSI_RESPONSE_TO_ESTRADIOL
8.33333333333%	1	12	50	Diabetes_McGill_Adipocytokines	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
8.33333333333%	1	12	50	Diabetes_McGill_Adipocytokines	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
8.33333333333%	1	12	50	Diabetes_McGill_Adipocytokines	PARK_APL_PATHOGENESIS_DN
8.33333333333%	1	12	50	Diabetes_McGill_Adipocytokines	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
8.33333333333%	1	12	50	Diabetes_McGill_Adipocytokines	HOFMANN_CELL_LYMPHOMA_UP
8.33333333333%	1	12	50	Diabetes_McGill_Adipocytokines	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
8.33333333333%	1	12	5	Mendelian_Etc	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_11
8.33333333333%	1	12	5	Diabetes_McGill_Adipocytokines	REN_MIF_TARGETS_DN
8.33333333333%	1	12	5	Diabetes_McGill_Adipocytokines	KANG_GIST_WITH_PDGFRA_DN
8.33333333333%	1	12	491	Mendelian_Etc	SWEET_LUNG_CANCER_KRAS_UP
8.33333333333%	1	12	491	Diabetes_McGill_Adipocytokines	ZHENG_BOUND_BY_FOXP3
8.33333333333%	1	12	49	Mendelian_Etc	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
8.33333333333%	1	12	49	Mendelian_Etc	MANTOVANI_VIRAL_GPCR_SIGNALING_DN
8.33333333333%	1	12	49	Diabetes_McGill_Adipocytokines	GERHOLD_ADIPOGENESIS_UP
8.33333333333%	1	12	49	Diabetes_McGill_Adipocytokines	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
8.33333333333%	1	12	487	Diabetes_McGill_Adipocytokines	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
8.33333333333%	1	12	481	Diabetes_McGill_Adipocytokines	LIU_PROSTATE_CANCER_DN
8.33333333333%	1	12	48	Mendelian_Etc	RASHI_RESPONSE_TO_IONIZING_RADIATION_3
8.33333333333%	1	12	48	Mendelian_Etc	PID_HES_HEYPATHWAY
8.33333333333%	1	12	48	Mendelian_Etc	PID_AJDISS_2PATHWAY
8.33333333333%	1	12	48	Diabetes_McGill_Adipocytokines	ZHAN_MULTIPLE_MYELOMA_LB_UP
8.33333333333%	1	12	48	Diabetes_McGill_Adipocytokines	KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
8.33333333333%	1	12	48	Diabetes_McGill_Adipocytokines	DOANE_BREAST_CANCER_ESR1_DN
8.33333333333%	1	12	479	Mendelian_Etc	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
8.33333333333%	1	12	473	Diabetes_McGill_Adipocytokines	GARY_CD5_TARGETS_UP
8.33333333333%	1	12	47	Mendelian_Etc	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
8.33333333333%	1	12	47	Mendelian_Etc	MCCLUNG_DELTA_FOSB_TARGETS_8WK
8.33333333333%	1	12	47	Diabetes_McGill_Adipocytokines	PID_NFAT_TFPATHWAY
8.33333333333%	1	12	47	Diabetes_McGill_Adipocytokines	LEONARD_HYPOXIA
8.33333333333%	1	12	469	Mendelian_Etc	MCCABE_BOUND_BY_HOXC6
8.33333333333%	1	12	467	Mendelian_Etc	RATTENBACHER_BOUND_BY_CELF1
8.33333333333%	1	12	466	Mendelian_Etc	REACTOME_HEMOSTASIS
8.33333333333%	1	12	466	Diabetes_McGill_Adipocytokines	REACTOME_HEMOSTASIS
8.33333333333%	1	12	464	Diabetes_McGill_Adipocytokines	ONDER_CDH1_TARGETS_2_DN
8.33333333333%	1	12	463	Diabetes_McGill_Adipocytokines	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
8.33333333333%	1	12	462	Mendelian_Etc	DELACROIX_RAR_BOUND_ES
8.33333333333%	1	12	461	Mendelian_Etc	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
8.33333333333%	1	12	46	Mendelian_Etc	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
8.33333333333%	1	12	46	Mendelian_Etc	OSADA_ASCL1_TARGETS_UP
8.33333333333%	1	12	46	Diabetes_McGill_Adipocytokines	TSENG_ADIPOGENIC_POTENTIAL_DN
8.33333333333%	1	12	46	Diabetes_McGill_Adipocytokines	SAGIV_CD24_TARGETS_DN
8.33333333333%	1	12	46	Diabetes_McGill_Adipocytokines	PARENT_MTOR_SIGNALING_DN
8.33333333333%	1	12	46	Diabetes_McGill_Adipocytokines	LEE_AGING_MUSCLE_DN
8.33333333333%	1	12	46	Diabetes_McGill_Adipocytokines	KRASNOSELSKAYA_ILF3_TARGETS_DN
8.33333333333%	1	12	46	Diabetes_McGill_Adipocytokines	AMIT_EGF_RESPONSE_60_HELA
8.33333333333%	1	12	457	Mendelian_Etc	SENESE_HDAC1_TARGETS_UP
8.33333333333%	1	12	457	Diabetes_McGill_Adipocytokines	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
8.33333333333%	1	12	456	Diabetes_McGill_Adipocytokines	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
8.33333333333%	1	12	455	Diabetes_McGill_Adipocytokines	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
8.33333333333%	1	12	45	Diabetes_McGill_Adipocytokines	TRAYNOR_RETT_SYNDROM_UP
8.33333333333%	1	12	45	Diabetes_McGill_Adipocytokines	SMITH_LIVER_CANCER
8.33333333333%	1	12	45	Diabetes_McGill_Adipocytokines	SHIPP_DLBCL_CURED_VS_FATAL_DN
8.33333333333%	1	12	45	Diabetes_McGill_Adipocytokines	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
8.33333333333%	1	12	45	Diabetes_McGill_Adipocytokines	LEE_AGING_MUSCLE_UP
8.33333333333%	1	12	45	Diabetes_McGill_Adipocytokines	GRADE_METASTASIS_DN
8.33333333333%	1	12	45	Diabetes_McGill_Adipocytokines	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
8.33333333333%	1	12	447	Mendelian_Etc	MOOTHA_MITOCHONDRIA
8.33333333333%	1	12	443	Diabetes_McGill_Adipocytokines	DELYS_THYROID_CANCER_UP
8.33333333333%	1	12	44	Mendelian_Etc	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP
8.33333333333%	1	12	44	Mendelian_Etc	PID_HNF3APATHWAY
8.33333333333%	1	12	44	Diabetes_McGill_Adipocytokines	ZUCCHI_METASTASIS_DN
8.33333333333%	1	12	44	Diabetes_McGill_Adipocytokines	STREICHER_LSM1_TARGETS_UP
8.33333333333%	1	12	439	Diabetes_McGill_Adipocytokines	MITSIADES_RESPONSE_TO_APLIDIN_UP
8.33333333333%	1	12	434	Mendelian_Etc	BAELDE_DIABETIC_NEPHROPATHY_DN
8.33333333333%	1	12	431	Mendelian_Etc	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
8.33333333333%	1	12	430	Mendelian_Etc	JOHNSTONE_PARVB_TARGETS_3_UP
8.33333333333%	1	12	430	Diabetes_McGill_Adipocytokines	VECCHI_GASTRIC_CANCER_EARLY_UP
8.33333333333%	1	12	43	Mendelian_Etc	RIZ_ERYTHROID_DIFFERENTIATION_12HR
8.33333333333%	1	12	43	Mendelian_Etc	MANTOVANI_NFKB_TARGETS_UP
8.33333333333%	1	12	43	Diabetes_McGill_Adipocytokines	PID_TCPTP_PATHWAY
8.33333333333%	1	12	43	Diabetes_McGill_Adipocytokines	PID_INTEGRIN3_PATHWAY
8.33333333333%	1	12	43	Diabetes_McGill_Adipocytokines	MANTOVANI_NFKB_TARGETS_UP
8.33333333333%	1	12	43	Diabetes_McGill_Adipocytokines	LIU_TARGETS_OF_VMYB_VS_CMYB_DN
8.33333333333%	1	12	43	Diabetes_McGill_Adipocytokines	DORN_ADENOVIRUS_INFECTION_24HR_DN
8.33333333333%	1	12	43	Diabetes_McGill_Adipocytokines	AMIT_EGF_RESPONSE_480_MCF10A
8.33333333333%	1	12	429	Mendelian_Etc	MOOTHA_HUMAN_MITODB_6_2002
8.33333333333%	1	12	428	Mendelian_Etc	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
8.33333333333%	1	12	422	Mendelian_Etc	YAGI_AML_WITH_INV_16_TRANSLOCATION
8.33333333333%	1	12	420	Diabetes_McGill_Adipocytokines	MOOTHA_PGC
8.33333333333%	1	12	42	Mendelian_Etc	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP
8.33333333333%	1	12	42	Mendelian_Etc	LEIN_ASTROCYTE_MARKERS
8.33333333333%	1	12	42	Diabetes_McGill_Adipocytokines	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
8.33333333333%	1	12	42	Diabetes_McGill_Adipocytokines	KEGG_GRAFT_VERSUS_HOST_DISEASE
8.33333333333%	1	12	42	Diabetes_McGill_Adipocytokines	AMIT_EGF_RESPONSE_40_HELA
8.33333333333%	1	12	418	Diabetes_McGill_Adipocytokines	RUTELLA_RESPONSE_TO_HGF_UP
8.33333333333%	1	12	418	Diabetes_McGill_Adipocytokines	PEDRIOLI_MIR31_TARGETS_DN
8.33333333333%	1	12	414	Mendelian_Etc	MOHANKUMAR_TLX1_TARGETS_UP
8.33333333333%	1	12	411	Diabetes_McGill_Adipocytokines	KOYAMA_SEMA3B_TARGETS_DN
8.33333333333%	1	12	41	Mendelian_Etc	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
8.33333333333%	1	12	41	Diabetes_McGill_Adipocytokines	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
8.33333333333%	1	12	41	Diabetes_McGill_Adipocytokines	PID_AMB2_NEUTROPHILS_PATHWAY
8.33333333333%	1	12	41	Diabetes_McGill_Adipocytokines	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN
8.33333333333%	1	12	41	Diabetes_McGill_Adipocytokines	GENTILE_UV_RESPONSE_CLUSTER_D2
8.33333333333%	1	12	41	Diabetes_McGill_Adipocytokines	DELPUECH_FOXO3_TARGETS_DN
8.33333333333%	1	12	408	Mendelian_Etc	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
8.33333333333%	1	12	408	Mendelian_Etc	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
8.33333333333%	1	12	408	Mendelian_Etc	REACTOME_GPCR_LIGAND_BINDING
8.33333333333%	1	12	408	Diabetes_McGill_Adipocytokines	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
8.33333333333%	1	12	406	Diabetes_McGill_Adipocytokines	OSMAN_BLADDER_CANCER_DN
8.33333333333%	1	12	405	Diabetes_McGill_Adipocytokines	KUMAR_TARGETS_OF_MLL_AF9_FUSION
8.33333333333%	1	12	403	Mendelian_Etc	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
8.33333333333%	1	12	40	Mendelian_Etc	CHANGOLKAR_H2AFY_TARGETS_DN
8.33333333333%	1	12	40	Diabetes_McGill_Adipocytokines	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
8.33333333333%	1	12	40	Diabetes_McGill_Adipocytokines	DORN_ADENOVIRUS_INFECTION_48HR_DN
8.33333333333%	1	12	398	Mendelian_Etc	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
8.33333333333%	1	12	397	Diabetes_McGill_Adipocytokines	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
8.33333333333%	1	12	395	Diabetes_McGill_Adipocytokines	HAN_SATB1_TARGETS_UP
8.33333333333%	1	12	394	Diabetes_McGill_Adipocytokines	BERENJENO_TRANSFORMED_BY_RHOA_DN
8.33333333333%	1	12	391	Mendelian_Etc	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
8.33333333333%	1	12	39	Mendelian_Etc	POTTI_PACLITAXEL_SENSITIVITY
8.33333333333%	1	12	39	Mendelian_Etc	PID_RET_PATHWAY
8.33333333333%	1	12	39	Mendelian_Etc	CONRAD_STEM_CELL
8.33333333333%	1	12	39	Diabetes_McGill_Adipocytokines	HOFMANN_CELL_LYMPHOMA_DN
8.33333333333%	1	12	39	Diabetes_McGill_Adipocytokines	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
8.33333333333%	1	12	39	Diabetes_McGill_Adipocytokines	BROWNE_HCMV_INFECTION_2HR_UP
8.33333333333%	1	12	389	Mendelian_Etc	HSIAO_HOUSEKEEPING_GENES
8.33333333333%	1	12	388	Diabetes_McGill_Adipocytokines	STEIN_ESRRA_TARGETS_UP
8.33333333333%	1	12	387	Mendelian_Etc	CHYLA_CBFA2T3_TARGETS_UP
8.33333333333%	1	12	384	Diabetes_McGill_Adipocytokines	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
8.33333333333%	1	12	380	Mendelian_Etc	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
8.33333333333%	1	12	38	Mendelian_Etc	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER
8.33333333333%	1	12	38	Mendelian_Etc	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4
8.33333333333%	1	12	38	Mendelian_Etc	HATADA_METHYLATED_IN_LUNG_CANCER_DN
8.33333333333%	1	12	38	Mendelian_Etc	CHANDRAN_METASTASIS_TOP50_UP
8.33333333333%	1	12	38	Diabetes_McGill_Adipocytokines	YOKOE_CANCER_TESTIS_ANTIGENS
8.33333333333%	1	12	38	Diabetes_McGill_Adipocytokines	SPIRA_SMOKERS_LUNG_CANCER_UP
8.33333333333%	1	12	38	Diabetes_McGill_Adipocytokines	NAKAMURA_ADIPOGENESIS_LATE_DN
8.33333333333%	1	12	38	Diabetes_McGill_Adipocytokines	NAKAMURA_ADIPOGENESIS_EARLY_DN
8.33333333333%	1	12	38	Diabetes_McGill_Adipocytokines	KRASNOSELSKAYA_ILF3_TARGETS_UP
8.33333333333%	1	12	372	Mendelian_Etc	WANG_LMO4_TARGETS_UP
8.33333333333%	1	12	371	Diabetes_McGill_Adipocytokines	WANG_SMARCE1_TARGETS_DN
8.33333333333%	1	12	37	Mendelian_Etc	VALK_AML_WITH_CEBPA
8.33333333333%	1	12	37	Mendelian_Etc	FRASOR_RESPONSE_TO_ESTRADIOL_UP
8.33333333333%	1	12	37	Diabetes_McGill_Adipocytokines	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
8.33333333333%	1	12	37	Diabetes_McGill_Adipocytokines	PID_IL23PATHWAY
8.33333333333%	1	12	367	Mendelian_Etc	DELACROIX_RARG_BOUND_MEF
8.33333333333%	1	12	367	Diabetes_McGill_Adipocytokines	VECCHI_GASTRIC_CANCER_EARLY_DN
8.33333333333%	1	12	367	Diabetes_McGill_Adipocytokines	DELACROIX_RARG_BOUND_MEF
8.33333333333%	1	12	366	Mendelian_Etc	SANSOM_APC_TARGETS_DN
8.33333333333%	1	12	36	Mendelian_Etc	SUBTIL_PROGESTIN_TARGETS
8.33333333333%	1	12	36	Mendelian_Etc	ST_ADRENERGIC
8.33333333333%	1	12	36	Diabetes_McGill_Adipocytokines	VALK_AML_CLUSTER_11
8.33333333333%	1	12	36	Diabetes_McGill_Adipocytokines	SUBTIL_PROGESTIN_TARGETS
8.33333333333%	1	12	36	Diabetes_McGill_Adipocytokines	SEMENZA_HIF1_TARGETS
8.33333333333%	1	12	36	Diabetes_McGill_Adipocytokines	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION
8.33333333333%	1	12	36	Diabetes_McGill_Adipocytokines	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
8.33333333333%	1	12	356	Diabetes_McGill_Adipocytokines	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
8.33333333333%	1	12	355	Mendelian_Etc	PEREZ_TP63_TARGETS
8.33333333333%	1	12	352	Mendelian_Etc	WANG_LMO4_TARGETS_DN
8.33333333333%	1	12	351	Mendelian_Etc	YAGI_AML_WITH_11Q23_REARRANGED
8.33333333333%	1	12	351	Diabetes_McGill_Adipocytokines	YAGI_AML_WITH_11Q23_REARRANGED
8.33333333333%	1	12	35	Mendelian_Etc	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
8.33333333333%	1	12	35	Mendelian_Etc	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP
8.33333333333%	1	12	35	Diabetes_McGill_Adipocytokines	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
8.33333333333%	1	12	35	Diabetes_McGill_Adipocytokines	KEGG_PRION_DISEASES
8.33333333333%	1	12	35	Diabetes_McGill_Adipocytokines	HOWLIN_CITED1_TARGETS_1_UP
8.33333333333%	1	12	349	Mendelian_Etc	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
8.33333333333%	1	12	344	Mendelian_Etc	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
8.33333333333%	1	12	34	Mendelian_Etc	YANG_BREAST_CANCER_ESR1_LASER_UP
8.33333333333%	1	12	34	Mendelian_Etc	PID_HIF2PATHWAY
8.33333333333%	1	12	34	Diabetes_McGill_Adipocytokines	SCHOEN_NFKB_SIGNALING
8.33333333333%	1	12	34	Diabetes_McGill_Adipocytokines	PLASARI_TGFB1_TARGETS_1HR_UP
8.33333333333%	1	12	34	Diabetes_McGill_Adipocytokines	PID_HIF2PATHWAY
8.33333333333%	1	12	34	Diabetes_McGill_Adipocytokines	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP
8.33333333333%	1	12	338	Diabetes_McGill_Adipocytokines	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
8.33333333333%	1	12	337	Mendelian_Etc	PHONG_TNF_RESPONSE_NOT_VIA_P38
8.33333333333%	1	12	337	Diabetes_McGill_Adipocytokines	PHONG_TNF_RESPONSE_NOT_VIA_P38
8.33333333333%	1	12	330	Mendelian_Etc	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
8.33333333333%	1	12	33	Mendelian_Etc	VALK_AML_CLUSTER_5
8.33333333333%	1	12	33	Mendelian_Etc	VALK_AML_CLUSTER_3
8.33333333333%	1	12	33	Diabetes_McGill_Adipocytokines	VALK_AML_CLUSTER_3
8.33333333333%	1	12	33	Diabetes_McGill_Adipocytokines	SIMBULAN_UV_RESPONSE_NORMAL_DN
8.33333333333%	1	12	33	Diabetes_McGill_Adipocytokines	PID_SYNDECAN_2_PATHWAY
8.33333333333%	1	12	33	Diabetes_McGill_Adipocytokines	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
8.33333333333%	1	12	33	Diabetes_McGill_Adipocytokines	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP
8.33333333333%	1	12	33	Diabetes_McGill_Adipocytokines	DORN_ADENOVIRUS_INFECTION_12HR_DN
8.33333333333%	1	12	33	Diabetes_McGill_Adipocytokines	CAFFAREL_RESPONSE_TO_THC_UP
8.33333333333%	1	12	33	Diabetes_McGill_Adipocytokines	BIOCARTA_NO1_PATHWAY
8.33333333333%	1	12	33	Diabetes_McGill_Adipocytokines	BIOCARTA_IL1R_PATHWAY
8.33333333333%	1	12	329	Mendelian_Etc	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
8.33333333333%	1	12	326	Mendelian_Etc	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
8.33333333333%	1	12	324	Mendelian_Etc	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
8.33333333333%	1	12	32	Mendelian_Etc	DIRMEIER_LMP1_RESPONSE_LATE_DN
8.33333333333%	1	12	32	Diabetes_McGill_Adipocytokines	TRACEY_RESISTANCE_TO_IFNA2_DN
8.33333333333%	1	12	32	Diabetes_McGill_Adipocytokines	KASLER_HDAC7_TARGETS_2_DN
8.33333333333%	1	12	32	Diabetes_McGill_Adipocytokines	GROSS_ELK3_TARGETS_DN
8.33333333333%	1	12	32	Diabetes_McGill_Adipocytokines	FARDIN_HYPOXIA_11
8.33333333333%	1	12	32	Diabetes_McGill_Adipocytokines	AMIT_SERUM_RESPONSE_40_MCF10A
8.33333333333%	1	12	318	Mendelian_Etc	LEI_MYB_TARGETS
8.33333333333%	1	12	317	Diabetes_McGill_Adipocytokines	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
8.33333333333%	1	12	317	Diabetes_McGill_Adipocytokines	BRUINS_UVC_RESPONSE_EARLY_LATE
8.33333333333%	1	12	316	Mendelian_Etc	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
8.33333333333%	1	12	315	Mendelian_Etc	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
8.33333333333%	1	12	315	Diabetes_McGill_Adipocytokines	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
8.33333333333%	1	12	314	Diabetes_McGill_Adipocytokines	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
8.33333333333%	1	12	312	Diabetes_McGill_Adipocytokines	GENTILE_UV_HIGH_DOSE_DN
8.33333333333%	1	12	31	Mendelian_Etc	PID_AR_NONGENOMIC_PATHWAY
8.33333333333%	1	12	31	Mendelian_Etc	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP
8.33333333333%	1	12	31	Mendelian_Etc	CUI_TCF21_TARGETS_DN
8.33333333333%	1	12	31	Diabetes_McGill_Adipocytokines	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
8.33333333333%	1	12	309	Mendelian_Etc	LIU_SOX4_TARGETS_DN
8.33333333333%	1	12	309	Diabetes_McGill_Adipocytokines	LIU_SOX4_TARGETS_DN
8.33333333333%	1	12	305	Mendelian_Etc	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
8.33333333333%	1	12	30	Mendelian_Etc	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
8.33333333333%	1	12	30	Mendelian_Etc	LI_PROSTATE_CANCER_EPIGENETIC
8.33333333333%	1	12	30	Diabetes_McGill_Adipocytokines	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
8.33333333333%	1	12	30	Diabetes_McGill_Adipocytokines	YANAGIHARA_ESX1_TARGETS
8.33333333333%	1	12	30	Diabetes_McGill_Adipocytokines	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP
8.33333333333%	1	12	30	Diabetes_McGill_Adipocytokines	LY_AGING_PREMATURE_DN
8.33333333333%	1	12	30	Diabetes_McGill_Adipocytokines	DAZARD_UV_RESPONSE_CLUSTER_G2
8.33333333333%	1	12	30	Diabetes_McGill_Adipocytokines	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY
8.33333333333%	1	12	30	Diabetes_McGill_Adipocytokines	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP
8.33333333333%	1	12	295	Diabetes_McGill_Adipocytokines	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
8.33333333333%	1	12	292	Mendelian_Etc	KOYAMA_SEMA3B_TARGETS_UP
8.33333333333%	1	12	292	Diabetes_McGill_Adipocytokines	HELLER_HDAC_TARGETS_DN
8.33333333333%	1	12	291	Mendelian_Etc	SABATES_COLORECTAL_ADENOMA_DN
8.33333333333%	1	12	291	Diabetes_McGill_Adipocytokines	SABATES_COLORECTAL_ADENOMA_DN
8.33333333333%	1	12	29	Mendelian_Etc	KEGG_THYROID_CANCER
8.33333333333%	1	12	29	Diabetes_McGill_Adipocytokines	REACTOME_PERK_REGULATED_GENE_EXPRESSION
8.33333333333%	1	12	29	Diabetes_McGill_Adipocytokines	PID_S1P_S1P3_PATHWAY
8.33333333333%	1	12	29	Diabetes_McGill_Adipocytokines	MIKKELSEN_MCV6_LCP_WITH_H3K27ME3
8.33333333333%	1	12	29	Diabetes_McGill_Adipocytokines	BIOCARTA_VEGF_PATHWAY
8.33333333333%	1	12	289	Mendelian_Etc	WANG_MLL_TARGETS
8.33333333333%	1	12	289	Mendelian_Etc	MANALO_HYPOXIA_DN
8.33333333333%	1	12	289	Diabetes_McGill_Adipocytokines	WANG_MLL_TARGETS
8.33333333333%	1	12	289	Diabetes_McGill_Adipocytokines	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
8.33333333333%	1	12	288	Mendelian_Etc	POOLA_INVASIVE_BREAST_CANCER_UP
8.33333333333%	1	12	287	Mendelian_Etc	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
8.33333333333%	1	12	285	Diabetes_McGill_Adipocytokines	GRADE_COLON_AND_RECTAL_CANCER_UP
8.33333333333%	1	12	283	Diabetes_McGill_Adipocytokines	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
8.33333333333%	1	12	282	Diabetes_McGill_Adipocytokines	HELLER_SILENCED_BY_METHYLATION_UP
8.33333333333%	1	12	281	Mendelian_Etc	BHAT_ESR1_TARGETS_VIA_AKT1_UP
8.33333333333%	1	12	281	Diabetes_McGill_Adipocytokines	MULLIGHAN_MLL_SIGNATURE_2_DN
8.33333333333%	1	12	28	Mendelian_Etc	MATZUK_MALE_REPRODUCTION_SERTOLI
8.33333333333%	1	12	28	Mendelian_Etc	CHEN_LUNG_CANCER_SURVIVAL
8.33333333333%	1	12	276	Diabetes_McGill_Adipocytokines	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
8.33333333333%	1	12	275	Mendelian_Etc	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
8.33333333333%	1	12	271	Mendelian_Etc	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
8.33333333333%	1	12	271	Diabetes_McGill_Adipocytokines	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
8.33333333333%	1	12	271	Diabetes_McGill_Adipocytokines	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
8.33333333333%	1	12	27	Mendelian_Etc	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION
8.33333333333%	1	12	27	Mendelian_Etc	REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION
8.33333333333%	1	12	27	Diabetes_McGill_Adipocytokines	ST_GRANULE_CELL_SURVIVAL_PATHWAY
8.33333333333%	1	12	27	Diabetes_McGill_Adipocytokines	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
8.33333333333%	1	12	27	Diabetes_McGill_Adipocytokines	PID_GLYPICAN_1PATHWAY
8.33333333333%	1	12	27	Diabetes_McGill_Adipocytokines	HOEGERKORP_CD44_TARGETS_DIRECT_UP
8.33333333333%	1	12	267	Diabetes_McGill_Adipocytokines	CAIRO_HEPATOBLASTOMA_DN
8.33333333333%	1	12	266	Mendelian_Etc	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
8.33333333333%	1	12	266	Diabetes_McGill_Adipocytokines	ROZANOV_MMP14_TARGETS_UP
8.33333333333%	1	12	266	Diabetes_McGill_Adipocytokines	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
8.33333333333%	1	12	262	Mendelian_Etc	LU_AGING_BRAIN_UP
8.33333333333%	1	12	262	Diabetes_McGill_Adipocytokines	LU_AGING_BRAIN_UP
8.33333333333%	1	12	26	Mendelian_Etc	VALK_AML_CLUSTER_16
8.33333333333%	1	12	26	Mendelian_Etc	NAKAMURA_CANCER_MICROENVIRONMENT_UP
8.33333333333%	1	12	26	Diabetes_McGill_Adipocytokines	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
8.33333333333%	1	12	26	Diabetes_McGill_Adipocytokines	WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG
8.33333333333%	1	12	26	Diabetes_McGill_Adipocytokines	REACTOME_ACTIVATION_OF_GENES_BY_ATF4
8.33333333333%	1	12	26	Diabetes_McGill_Adipocytokines	PID_VEGFR1_PATHWAY
8.33333333333%	1	12	26	Diabetes_McGill_Adipocytokines	NEWMAN_ERCC6_TARGETS_UP
8.33333333333%	1	12	26	Diabetes_McGill_Adipocytokines	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
8.33333333333%	1	12	254	Mendelian_Etc	BROWNE_HCMV_INFECTION_4HR_DN
8.33333333333%	1	12	254	Diabetes_McGill_Adipocytokines	BROWNE_HCMV_INFECTION_4HR_DN
8.33333333333%	1	12	253	Diabetes_McGill_Adipocytokines	DANG_REGULATED_BY_MYC_DN
8.33333333333%	1	12	25	Mendelian_Etc	PID_TOLL_ENDOGENOUS_PATHWAY
8.33333333333%	1	12	25	Mendelian_Etc	HOEGERKORP_CD44_TARGETS_TEMPORAL_DN
8.33333333333%	1	12	25	Diabetes_McGill_Adipocytokines	REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN
8.33333333333%	1	12	25	Diabetes_McGill_Adipocytokines	PID_INTEGRIN_A9B1_PATHWAY
8.33333333333%	1	12	25	Diabetes_McGill_Adipocytokines	LU_TUMOR_ANGIOGENESIS_UP
8.33333333333%	1	12	25	Diabetes_McGill_Adipocytokines	COLLER_MYC_TARGETS_UP
8.33333333333%	1	12	249	Diabetes_McGill_Adipocytokines	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
8.33333333333%	1	12	246	Mendelian_Etc	VERHAAK_AML_WITH_NPM1_MUTATED_DN
8.33333333333%	1	12	245	Diabetes_McGill_Adipocytokines	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
8.33333333333%	1	12	244	Mendelian_Etc	HSIAO_LIVER_SPECIFIC_GENES
8.33333333333%	1	12	244	Diabetes_McGill_Adipocytokines	PLASARI_TGFB1_TARGETS_10HR_DN
8.33333333333%	1	12	244	Diabetes_McGill_Adipocytokines	KAYO_AGING_MUSCLE_UP
8.33333333333%	1	12	242	Diabetes_McGill_Adipocytokines	MULLIGHAN_MLL_SIGNATURE_1_DN
8.33333333333%	1	12	240	Mendelian_Etc	BROWNE_HCMV_INFECTION_20HR_UP
8.33333333333%	1	12	240	Diabetes_McGill_Adipocytokines	BROWNE_HCMV_INFECTION_20HR_UP
8.33333333333%	1	12	24	Mendelian_Etc	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23
8.33333333333%	1	12	24	Diabetes_McGill_Adipocytokines	WANG_TNF_TARGETS
8.33333333333%	1	12	24	Diabetes_McGill_Adipocytokines	OXFORD_RALA_OR_RALB_TARGETS_DN
8.33333333333%	1	12	24	Diabetes_McGill_Adipocytokines	JEON_SMAD6_TARGETS_UP
8.33333333333%	1	12	24	Diabetes_McGill_Adipocytokines	GOLUB_ALL_VS_AML_DN
8.33333333333%	1	12	24	Diabetes_McGill_Adipocytokines	BIOCARTA_NTHI_PATHWAY
8.33333333333%	1	12	239	Diabetes_McGill_Adipocytokines	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
8.33333333333%	1	12	235	Mendelian_Etc	RUTELLA_RESPONSE_TO_HGF_DN
8.33333333333%	1	12	235	Diabetes_McGill_Adipocytokines	RUTELLA_RESPONSE_TO_HGF_DN
8.33333333333%	1	12	234	Diabetes_McGill_Adipocytokines	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
8.33333333333%	1	12	230	Mendelian_Etc	BENPORATH_MYC_TARGETS_WITH_EBOX
8.33333333333%	1	12	23	Mendelian_Etc	REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX
8.33333333333%	1	12	23	Diabetes_McGill_Adipocytokines	UROSEVIC_RESPONSE_TO_IMIQUIMOD
8.33333333333%	1	12	23	Diabetes_McGill_Adipocytokines	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
8.33333333333%	1	12	23	Diabetes_McGill_Adipocytokines	CHIBA_RESPONSE_TO_TSA_DN
8.33333333333%	1	12	229	Mendelian_Etc	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
8.33333333333%	1	12	228	Mendelian_Etc	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
8.33333333333%	1	12	227	Mendelian_Etc	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
8.33333333333%	1	12	227	Diabetes_McGill_Adipocytokines	RAO_BOUND_BY_SALL4
8.33333333333%	1	12	227	Diabetes_McGill_Adipocytokines	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
8.33333333333%	1	12	226	Mendelian_Etc	KYNG_DNA_DAMAGE_UP
8.33333333333%	1	12	226	Mendelian_Etc	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
8.33333333333%	1	12	225	Diabetes_McGill_Adipocytokines	BROWNE_HCMV_INFECTION_16HR_UP
8.33333333333%	1	12	223	Diabetes_McGill_Adipocytokines	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
8.33333333333%	1	12	222	Mendelian_Etc	CAIRO_LIVER_DEVELOPMENT_DN
8.33333333333%	1	12	222	Diabetes_McGill_Adipocytokines	BROWNE_HCMV_INFECTION_1HR_DN
8.33333333333%	1	12	221	Mendelian_Etc	CHANDRAN_METASTASIS_UP
8.33333333333%	1	12	221	Diabetes_McGill_Adipocytokines	CHANDRAN_METASTASIS_UP
8.33333333333%	1	12	22	Mendelian_Etc	VALK_AML_WITH_11Q23_REARRANGED
8.33333333333%	1	12	217	Mendelian_Etc	WIERENGA_STAT5A_TARGETS_UP
8.33333333333%	1	12	217	Mendelian_Etc	SANSOM_APC_MYC_TARGETS
8.33333333333%	1	12	217	Diabetes_McGill_Adipocytokines	WIERENGA_STAT5A_TARGETS_UP
8.33333333333%	1	12	215	Diabetes_McGill_Adipocytokines	MARKEY_RB1_ACUTE_LOF_UP
8.33333333333%	1	12	214	Mendelian_Etc	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
8.33333333333%	1	12	214	Diabetes_McGill_Adipocytokines	ZWANG_EGF_INTERVAL_DN
8.33333333333%	1	12	214	Diabetes_McGill_Adipocytokines	TIEN_INTESTINE_PROBIOTICS_24HR_DN
8.33333333333%	1	12	214	Diabetes_McGill_Adipocytokines	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
8.33333333333%	1	12	214	Diabetes_McGill_Adipocytokines	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
8.33333333333%	1	12	214	Diabetes_McGill_Adipocytokines	KIM_WT1_TARGETS_UP
8.33333333333%	1	12	211	Mendelian_Etc	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
8.33333333333%	1	12	211	Diabetes_McGill_Adipocytokines	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
8.33333333333%	1	12	210	Mendelian_Etc	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
8.33333333333%	1	12	210	Mendelian_Etc	CAIRO_HEPATOBLASTOMA_CLASSES_DN
8.33333333333%	1	12	210	Diabetes_McGill_Adipocytokines	RIZKI_TUMOR_INVASIVENESS_3D_UP
8.33333333333%	1	12	210	Diabetes_McGill_Adipocytokines	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
8.33333333333%	1	12	210	Diabetes_McGill_Adipocytokines	CAIRO_HEPATOBLASTOMA_CLASSES_DN
8.33333333333%	1	12	21	Mendelian_Etc	REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION
8.33333333333%	1	12	21	Mendelian_Etc	FINETTI_BREAST_CANCERS_KINOME_BLUE
8.33333333333%	1	12	21	Diabetes_McGill_Adipocytokines	STEGER_ADIPOGENESIS_UP
8.33333333333%	1	12	21	Diabetes_McGill_Adipocytokines	SCHURINGA_STAT5A_TARGETS_UP
8.33333333333%	1	12	21	Diabetes_McGill_Adipocytokines	PID_S1P_S1P1_PATHWAY
8.33333333333%	1	12	21	Diabetes_McGill_Adipocytokines	MURAKAMI_UV_RESPONSE_6HR_DN
8.33333333333%	1	12	21	Diabetes_McGill_Adipocytokines	FERRANDO_TAL1_NEIGHBORS
8.33333333333%	1	12	209	Mendelian_Etc	KIM_WT1_TARGETS_12HR_DN
8.33333333333%	1	12	209	Diabetes_McGill_Adipocytokines	CHANG_CORE_SERUM_RESPONSE_DN
8.33333333333%	1	12	208	Mendelian_Etc	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
8.33333333333%	1	12	208	Mendelian_Etc	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
8.33333333333%	1	12	208	Diabetes_McGill_Adipocytokines	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
8.33333333333%	1	12	207	Diabetes_McGill_Adipocytokines	MANALO_HYPOXIA_UP
8.33333333333%	1	12	206	Mendelian_Etc	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
8.33333333333%	1	12	206	Mendelian_Etc	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
8.33333333333%	1	12	205	Mendelian_Etc	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
8.33333333333%	1	12	205	Mendelian_Etc	PEREZ_TP53_AND_TP63_TARGETS
8.33333333333%	1	12	203	Diabetes_McGill_Adipocytokines	GRUETZMANN_PANCREATIC_CANCER_DN
8.33333333333%	1	12	201	Diabetes_McGill_Adipocytokines	KIM_MYC_AMPLIFICATION_TARGETS_UP
8.33333333333%	1	12	201	Diabetes_McGill_Adipocytokines	KEGG_FOCAL_ADHESION
8.33333333333%	1	12	200	Mendelian_Etc	SHEPARD_BMYB_MORPHOLINO_DN
8.33333333333%	1	12	20	Mendelian_Etc	FARMER_BREAST_CANCER_CLUSTER_7
8.33333333333%	1	12	20	Diabetes_McGill_Adipocytokines	ZHU_SKIL_TARGETS_UP
8.33333333333%	1	12	20	Diabetes_McGill_Adipocytokines	SESTO_RESPONSE_TO_UV_C3
8.33333333333%	1	12	20	Diabetes_McGill_Adipocytokines	MURAKAMI_UV_RESPONSE_24HR
8.33333333333%	1	12	20	Diabetes_McGill_Adipocytokines	MAHADEVAN_RESPONSE_TO_MP470_UP
8.33333333333%	1	12	20	Diabetes_McGill_Adipocytokines	DAZARD_UV_RESPONSE_CLUSTER_G28
8.33333333333%	1	12	20	Diabetes_McGill_Adipocytokines	CHEN_ETV5_TARGETS_SERTOLI
8.33333333333%	1	12	1972	Diabetes_McGill_Adipocytokines	PILON_KLF1_TARGETS_DN
8.33333333333%	1	12	196	Diabetes_McGill_Adipocytokines	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
8.33333333333%	1	12	196	Diabetes_McGill_Adipocytokines	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
8.33333333333%	1	12	195	Mendelian_Etc	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
8.33333333333%	1	12	195	Mendelian_Etc	KYNG_DNA_DAMAGE_DN
8.33333333333%	1	12	194	Mendelian_Etc	KASLER_HDAC7_TARGETS_1_UP
8.33333333333%	1	12	191	Diabetes_McGill_Adipocytokines	RIGGI_EWING_SARCOMA_PROGENITOR_DN
8.33333333333%	1	12	19	Mendelian_Etc	OUYANG_PROSTATE_CANCER_MARKERS
8.33333333333%	1	12	19	Mendelian_Etc	LI_WILMS_TUMOR_ANAPLASTIC_UP
8.33333333333%	1	12	19	Diabetes_McGill_Adipocytokines	ZHANG_RESPONSE_TO_CANTHARIDIN_UP
8.33333333333%	1	12	19	Diabetes_McGill_Adipocytokines	VERNOCHET_ADIPOGENESIS
8.33333333333%	1	12	19	Diabetes_McGill_Adipocytokines	STREICHER_LSM1_TARGETS_DN
8.33333333333%	1	12	19	Diabetes_McGill_Adipocytokines	LEE_NAIVE_T_LYMPHOCYTE
8.33333333333%	1	12	19	Diabetes_McGill_Adipocytokines	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN
8.33333333333%	1	12	19	Diabetes_McGill_Adipocytokines	KANG_AR_TARGETS_DN
8.33333333333%	1	12	19	Diabetes_McGill_Adipocytokines	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
8.33333333333%	1	12	189	Mendelian_Etc	BURTON_ADIPOGENESIS_6
8.33333333333%	1	12	189	Diabetes_McGill_Adipocytokines	BURTON_ADIPOGENESIS_6
8.33333333333%	1	12	188	Mendelian_Etc	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
8.33333333333%	1	12	188	Mendelian_Etc	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
8.33333333333%	1	12	187	Diabetes_McGill_Adipocytokines	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
8.33333333333%	1	12	186	Mendelian_Etc	HAMAI_APOPTOSIS_VIA_TRAIL_DN
8.33333333333%	1	12	185	Mendelian_Etc	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
8.33333333333%	1	12	185	Mendelian_Etc	LEE_LIVER_CANCER_SURVIVAL_UP
8.33333333333%	1	12	185	Mendelian_Etc	KEGG_HUNTINGTONS_DISEASE
8.33333333333%	1	12	185	Diabetes_McGill_Adipocytokines	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
8.33333333333%	1	12	185	Diabetes_McGill_Adipocytokines	LEE_LIVER_CANCER_SURVIVAL_UP
8.33333333333%	1	12	184	Mendelian_Etc	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
8.33333333333%	1	12	184	Mendelian_Etc	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
8.33333333333%	1	12	184	Diabetes_McGill_Adipocytokines	DOANE_RESPONSE_TO_ANDROGEN_UP
8.33333333333%	1	12	184	Diabetes_McGill_Adipocytokines	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
8.33333333333%	1	12	183	Mendelian_Etc	OKUMURA_INFLAMMATORY_RESPONSE_LPS
8.33333333333%	1	12	183	Mendelian_Etc	KEGG_ENDOCYTOSIS
8.33333333333%	1	12	183	Diabetes_McGill_Adipocytokines	OKUMURA_INFLAMMATORY_RESPONSE_LPS
8.33333333333%	1	12	1821	Mendelian_Etc	DODD_NASOPHARYNGEAL_CARCINOMA_UP
8.33333333333%	1	12	182	Mendelian_Etc	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
8.33333333333%	1	12	182	Diabetes_McGill_Adipocytokines	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
8.33333333333%	1	12	181	Mendelian_Etc	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
8.33333333333%	1	12	180	Mendelian_Etc	BROWNE_HCMV_INFECTION_48HR_UP
8.33333333333%	1	12	18	Mendelian_Etc	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA
8.33333333333%	1	12	18	Mendelian_Etc	REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI
8.33333333333%	1	12	18	Mendelian_Etc	NIELSEN_SCHWANNOMA_UP
8.33333333333%	1	12	18	Diabetes_McGill_Adipocytokines	YIH_RESPONSE_TO_ARSENITE_C4
8.33333333333%	1	12	18	Diabetes_McGill_Adipocytokines	SHIN_B_CELL_LYMPHOMA_CLUSTER_5
8.33333333333%	1	12	18	Diabetes_McGill_Adipocytokines	MAINA_VHL_TARGETS_DN
8.33333333333%	1	12	18	Diabetes_McGill_Adipocytokines	KOBAYASHI_EGFR_SIGNALING_6HR_DN
8.33333333333%	1	12	179	Mendelian_Etc	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
8.33333333333%	1	12	1781	Mendelian_Etc	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
8.33333333333%	1	12	1781	Diabetes_McGill_Adipocytokines	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
8.33333333333%	1	12	178	Diabetes_McGill_Adipocytokines	LI_AMPLIFIED_IN_LUNG_CANCER
8.33333333333%	1	12	178	Diabetes_McGill_Adipocytokines	BROWNE_HCMV_INFECTION_18HR_UP
8.33333333333%	1	12	176	Mendelian_Etc	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
8.33333333333%	1	12	176	Mendelian_Etc	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
8.33333333333%	1	12	176	Diabetes_McGill_Adipocytokines	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
8.33333333333%	1	12	175	Mendelian_Etc	YAMAZAKI_TCEB3_TARGETS_UP
8.33333333333%	1	12	175	Diabetes_McGill_Adipocytokines	YAMAZAKI_TCEB3_TARGETS_UP
8.33333333333%	1	12	175	Diabetes_McGill_Adipocytokines	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
8.33333333333%	1	12	175	Diabetes_McGill_Adipocytokines	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
8.33333333333%	1	12	1725	Mendelian_Etc	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
8.33333333333%	1	12	172	Mendelian_Etc	SMID_BREAST_CANCER_LUMINAL_B_UP
8.33333333333%	1	12	172	Diabetes_McGill_Adipocytokines	SMID_BREAST_CANCER_LUMINAL_B_UP
8.33333333333%	1	12	171	Diabetes_McGill_Adipocytokines	ELVIDGE_HYPOXIA_UP
8.33333333333%	1	12	17	Mendelian_Etc	REACTOME_INFLAMMASOMES
8.33333333333%	1	12	17	Mendelian_Etc	HOWLIN_CITED1_TARGETS_2_DN
8.33333333333%	1	12	17	Diabetes_McGill_Adipocytokines	ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN
8.33333333333%	1	12	17	Diabetes_McGill_Adipocytokines	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
8.33333333333%	1	12	17	Diabetes_McGill_Adipocytokines	PID_SYNDECAN_3_PATHWAY
8.33333333333%	1	12	17	Diabetes_McGill_Adipocytokines	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
8.33333333333%	1	12	17	Diabetes_McGill_Adipocytokines	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
8.33333333333%	1	12	17	Diabetes_McGill_Adipocytokines	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
8.33333333333%	1	12	17	Diabetes_McGill_Adipocytokines	DORMOY_ELAVL1_TARGETS
8.33333333333%	1	12	17	Diabetes_McGill_Adipocytokines	BIOCARTA_IL10_PATHWAY
8.33333333333%	1	12	1691	Mendelian_Etc	BLALOCK_ALZHEIMERS_DISEASE_UP
8.33333333333%	1	12	169	Mendelian_Etc	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
8.33333333333%	1	12	169	Diabetes_McGill_Adipocytokines	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
8.33333333333%	1	12	167	Mendelian_Etc	VANTVEER_BREAST_CANCER_ESR1_UP
8.33333333333%	1	12	167	Diabetes_McGill_Adipocytokines	VANTVEER_BREAST_CANCER_ESR1_UP
8.33333333333%	1	12	167	Diabetes_McGill_Adipocytokines	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
8.33333333333%	1	12	164	Diabetes_McGill_Adipocytokines	KIM_WT1_TARGETS_8HR_UP
8.33333333333%	1	12	163	Mendelian_Etc	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
8.33333333333%	1	12	163	Diabetes_McGill_Adipocytokines	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
8.33333333333%	1	12	162	Diabetes_McGill_Adipocytokines	MULLIGHAN_NPM1_SIGNATURE_3_DN
8.33333333333%	1	12	161	Mendelian_Etc	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
8.33333333333%	1	12	16	Diabetes_McGill_Adipocytokines	WU_HBX_TARGETS_2_DN
8.33333333333%	1	12	16	Diabetes_McGill_Adipocytokines	WU_HBX_TARGETS_1_UP
8.33333333333%	1	12	16	Diabetes_McGill_Adipocytokines	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA
8.33333333333%	1	12	16	Diabetes_McGill_Adipocytokines	LEE_LIVER_CANCER_HEPATOBLAST
8.33333333333%	1	12	16	Diabetes_McGill_Adipocytokines	FARMER_BREAST_CANCER_CLUSTER_4
8.33333333333%	1	12	16	Diabetes_McGill_Adipocytokines	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP
8.33333333333%	1	12	158	Diabetes_McGill_Adipocytokines	RODRIGUES_NTN1_TARGETS_DN
8.33333333333%	1	12	157	Mendelian_Etc	SERVITJA_LIVER_HNF1A_TARGETS_DN
8.33333333333%	1	12	154	Mendelian_Etc	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
8.33333333333%	1	12	153	Mendelian_Etc	RUIZ_TNC_TARGETS_UP
8.33333333333%	1	12	151	Mendelian_Etc	IGLESIAS_E2F_TARGETS_UP
8.33333333333%	1	12	15	Diabetes_McGill_Adipocytokines	VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP
8.33333333333%	1	12	15	Diabetes_McGill_Adipocytokines	SA_MMP_CYTOKINE_CONNECTION
8.33333333333%	1	12	15	Diabetes_McGill_Adipocytokines	BIOCARTA_HIF_PATHWAY
8.33333333333%	1	12	15	Diabetes_McGill_Adipocytokines	BIOCARTA_ERYTH_PATHWAY
8.33333333333%	1	12	149	Mendelian_Etc	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
8.33333333333%	1	12	149	Diabetes_McGill_Adipocytokines	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
8.33333333333%	1	12	148	Diabetes_McGill_Adipocytokines	KATSANOU_ELAVL1_TARGETS_DN
8.33333333333%	1	12	148	Diabetes_McGill_Adipocytokines	BROWNE_HCMV_INFECTION_24HR_UP
8.33333333333%	1	12	148	Diabetes_McGill_Adipocytokines	BROWNE_HCMV_INFECTION_24HR_DN
8.33333333333%	1	12	147	Mendelian_Etc	SMID_BREAST_CANCER_ERBB2_UP
8.33333333333%	1	12	147	Diabetes_McGill_Adipocytokines	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
8.33333333333%	1	12	147	Diabetes_McGill_Adipocytokines	KAUFFMANN_DNA_REPLICATION_GENES
8.33333333333%	1	12	146	Mendelian_Etc	ELVIDGE_HYPOXIA_DN
8.33333333333%	1	12	145	Diabetes_McGill_Adipocytokines	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
8.33333333333%	1	12	1442	Mendelian_Etc	PUJANA_ATM_PCC_NETWORK
8.33333333333%	1	12	143	Mendelian_Etc	DANG_MYC_TARGETS_UP
8.33333333333%	1	12	142	Mendelian_Etc	PENG_LEUCINE_DEPRIVATION_UP
8.33333333333%	1	12	142	Diabetes_McGill_Adipocytokines	RUIZ_TNC_TARGETS_DN
8.33333333333%	1	12	142	Diabetes_McGill_Adipocytokines	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
8.33333333333%	1	12	142	Diabetes_McGill_Adipocytokines	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
8.33333333333%	1	12	142	Diabetes_McGill_Adipocytokines	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
8.33333333333%	1	12	141	Diabetes_McGill_Adipocytokines	SABATES_COLORECTAL_ADENOMA_UP
8.33333333333%	1	12	140	Mendelian_Etc	JOHNSTONE_PARVB_TARGETS_2_UP
8.33333333333%	1	12	140	Diabetes_McGill_Adipocytokines	QI_HYPOXIA
8.33333333333%	1	12	14	Diabetes_McGill_Adipocytokines	MATZUK_OVULATION
8.33333333333%	1	12	14	Diabetes_McGill_Adipocytokines	LY_AGING_MIDDLE_UP
8.33333333333%	1	12	14	Diabetes_McGill_Adipocytokines	BIOCARTA_GRANULOCYTES_PATHWAY
8.33333333333%	1	12	139	Mendelian_Etc	HOELZEL_NF1_TARGETS_UP
8.33333333333%	1	12	1382	Diabetes_McGill_Adipocytokines	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
8.33333333333%	1	12	1375	Mendelian_Etc	DODD_NASOPHARYNGEAL_CARCINOMA_DN
8.33333333333%	1	12	137	Mendelian_Etc	PID_P53DOWNSTREAMPATHWAY
8.33333333333%	1	12	137	Diabetes_McGill_Adipocytokines	LIU_SOX4_TARGETS_UP
8.33333333333%	1	12	136	Diabetes_McGill_Adipocytokines	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
8.33333333333%	1	12	136	Diabetes_McGill_Adipocytokines	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
8.33333333333%	1	12	135	Diabetes_McGill_Adipocytokines	TSENG_IRS1_TARGETS_DN
8.33333333333%	1	12	134	Mendelian_Etc	SCHLOSSER_SERUM_RESPONSE_UP
8.33333333333%	1	12	134	Mendelian_Etc	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
8.33333333333%	1	12	133	Diabetes_McGill_Adipocytokines	REACTOME_DIABETES_PATHWAYS
8.33333333333%	1	12	131	Diabetes_McGill_Adipocytokines	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
8.33333333333%	1	12	130	Diabetes_McGill_Adipocytokines	ELVIDGE_HYPOXIA_BY_DMOG_UP
8.33333333333%	1	12	13	Mendelian_Etc	REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING
8.33333333333%	1	12	13	Diabetes_McGill_Adipocytokines	WU_HBX_TARGETS_3_DN
8.33333333333%	1	12	13	Diabetes_McGill_Adipocytokines	WACKER_HYPOXIA_TARGETS_OF_VHL
8.33333333333%	1	12	13	Diabetes_McGill_Adipocytokines	RAY_ALZHEIMERS_DISEASE
8.33333333333%	1	12	13	Diabetes_McGill_Adipocytokines	HASINA_NOL7_TARGETS_DN
8.33333333333%	1	12	129	Mendelian_Etc	YAGI_AML_SURVIVAL
8.33333333333%	1	12	129	Mendelian_Etc	KIM_WT1_TARGETS_8HR_DN
8.33333333333%	1	12	128	Mendelian_Etc	ZHU_CMV_ALL_DN
8.33333333333%	1	12	128	Mendelian_Etc	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
8.33333333333%	1	12	128	Diabetes_McGill_Adipocytokines	ZHU_CMV_ALL_DN
8.33333333333%	1	12	128	Diabetes_McGill_Adipocytokines	POTTI_TOPOTECAN_SENSITIVITY
8.33333333333%	1	12	128	Diabetes_McGill_Adipocytokines	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
8.33333333333%	1	12	1278	Diabetes_McGill_Adipocytokines	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
8.33333333333%	1	12	127	Mendelian_Etc	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
8.33333333333%	1	12	126	Mendelian_Etc	MISSIAGLIA_REGULATED_BY_METHYLATION_UP
8.33333333333%	1	12	126	Diabetes_McGill_Adipocytokines	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
8.33333333333%	1	12	126	Diabetes_McGill_Adipocytokines	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
8.33333333333%	1	12	125	Mendelian_Etc	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
8.33333333333%	1	12	1237	Mendelian_Etc	BLALOCK_ALZHEIMERS_DISEASE_DN
8.33333333333%	1	12	123	Diabetes_McGill_Adipocytokines	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
8.33333333333%	1	12	121	Diabetes_McGill_Adipocytokines	VANTVEER_BREAST_CANCER_METASTASIS_DN
8.33333333333%	1	12	120	Mendelian_Etc	CHEBOTAEV_GR_TARGETS_DN
8.33333333333%	1	12	120	Diabetes_McGill_Adipocytokines	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
8.33333333333%	1	12	12	Mendelian_Etc	REACTOME_THE_NLRP3_INFLAMMASOME
8.33333333333%	1	12	12	Mendelian_Etc	REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES
8.33333333333%	1	12	12	Diabetes_McGill_Adipocytokines	HEDVAT_ELF4_TARGETS_UP
8.33333333333%	1	12	118	Mendelian_Etc	REACTOME_TOLL_RECEPTOR_CASCADES
8.33333333333%	1	12	118	Diabetes_McGill_Adipocytokines	MARKEY_RB1_CHRONIC_LOF_DN
8.33333333333%	1	12	116	Diabetes_McGill_Adipocytokines	MATTIOLI_MGUS_VS_PCL
8.33333333333%	1	12	116	Diabetes_McGill_Adipocytokines	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
8.33333333333%	1	12	114	Mendelian_Etc	KEGG_OOCYTE_MEIOSIS
8.33333333333%	1	12	114	Diabetes_McGill_Adipocytokines	CERVERA_SDHB_TARGETS_2
8.33333333333%	1	12	113	Mendelian_Etc	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
8.33333333333%	1	12	112	Diabetes_McGill_Adipocytokines	LAIHO_COLORECTAL_CANCER_SERRATED_UP
8.33333333333%	1	12	112	Diabetes_McGill_Adipocytokines	LABBE_WNT3A_TARGETS_UP
8.33333333333%	1	12	111	Diabetes_McGill_Adipocytokines	WANG_HCP_PROSTATE_CANCER
8.33333333333%	1	12	111	Diabetes_McGill_Adipocytokines	BROWNE_HCMV_INFECTION_12HR_UP
8.33333333333%	1	12	110	Diabetes_McGill_Adipocytokines	GROSS_HYPOXIA_VIA_HIF1A_DN
8.33333333333%	1	12	11	Mendelian_Etc	HASEGAWA_TUMORIGENESIS_BY_RET_C634R
8.33333333333%	1	12	11	Diabetes_McGill_Adipocytokines	SEIKE_LUNG_CANCER_POOR_SURVIVAL
8.33333333333%	1	12	11	Diabetes_McGill_Adipocytokines	LOPEZ_MESOTHELIOMA_SURVIVAL_UP
8.33333333333%	1	12	11	Diabetes_McGill_Adipocytokines	BIOCARTA_LYM_PATHWAY
8.33333333333%	1	12	108	Mendelian_Etc	LABBE_TGFB1_TARGETS_DN
8.33333333333%	1	12	108	Mendelian_Etc	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
8.33333333333%	1	12	108	Mendelian_Etc	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN
8.33333333333%	1	12	108	Diabetes_McGill_Adipocytokines	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
8.33333333333%	1	12	107	Mendelian_Etc	SESTO_RESPONSE_TO_UV_C0
8.33333333333%	1	12	1069	Mendelian_Etc	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
8.33333333333%	1	12	105	Diabetes_McGill_Adipocytokines	WOO_LIVER_CANCER_RECURRENCE_UP
8.33333333333%	1	12	104	Diabetes_McGill_Adipocytokines	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
8.33333333333%	1	12	1037	Mendelian_Etc	NUYTTEN_EZH2_TARGETS_UP
8.33333333333%	1	12	1022	Mendelian_Etc	MARSON_BOUND_BY_FOXP3_STIMULATED
8.33333333333%	1	12	102	Diabetes_McGill_Adipocytokines	DER_IFN_BETA_RESPONSE_UP
8.33333333333%	1	12	1011	Mendelian_Etc	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
8.33333333333%	1	12	1011	Diabetes_McGill_Adipocytokines	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
8.33333333333%	1	12	101	Mendelian_Etc	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
8.33333333333%	1	12	101	Diabetes_McGill_Adipocytokines	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
8.33333333333%	1	12	101	Diabetes_McGill_Adipocytokines	BROWNE_HCMV_INFECTION_10HR_UP
8.33333333333%	1	12	100	Diabetes_McGill_Adipocytokines	ROVERSI_GLIOMA_COPY_NUMBER_UP
8.33333333333%	1	12	100	Diabetes_McGill_Adipocytokines	QI_PLASMACYTOMA_DN
8.33333333333%	1	12	10	Diabetes_McGill_Adipocytokines	REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS
8.33333333333%	1	12	10	Diabetes_McGill_Adipocytokines	PID_VEGF_VEGFR_PATHWAY
8.33333333333%	1	12	10	Diabetes_McGill_Adipocytokines	OSAWA_TNF_TARGETS
8.33333333333%	1	12	10	Diabetes_McGill_Adipocytokines	MURAKAMI_UV_RESPONSE_1HR_DN
8.33333333333%	1	12	10	Diabetes_McGill_Adipocytokines	GOUYER_TATI_TARGETS_UP
8.33333333333%	1	12	10	Diabetes_McGill_Adipocytokines	CHEN_HOXA5_TARGETS_6HR_UP
8.33333333333%	1	12	10	Diabetes_McGill_Adipocytokines	BUDHU_LIVER_CANCER_METASTASIS_UP
8.33333333333%	1	12	10	Diabetes_McGill_Adipocytokines	BIOCARTA_IL5_PATHWAY
8.33333333333%	1	12	10	Diabetes_McGill_Adipocytokines	BIOCARTA_FREE_PATHWAY
8.33333333333%	1	12	10	Diabetes_McGill_Adipocytokines	AGARWAL_AKT_PATHWAY_TARGETS
8.31024930748%	30	361	1972	T2D_GENES_TANYA_T2D_RSQ05_02CM	PILON_KLF1_TARGETS_DN
8.30258302583%	45	542	1442	T2D_GENES_TANYA_ANTHROPOMETRIC	PUJANA_ATM_PCC_NETWORK
8.30039525692%	21	253	973	Diabetes_McGill_CREBBP_coTF	ACEVEDO_LIVER_CANCER_UP
8.30039525692%	21	253	82	Diabetes_McGill_CREBBP_coTF	PID_REG_GR_PATHWAY
8.30039525692%	21	253	721	Diabetes_McGill_CREBBP_coTF	WONG_ADULT_TISSUE_STEM_MODULE
8.30039525692%	21	253	673	Diabetes_McGill_CREBBP_coTF	MARTINEZ_RB1_TARGETS_UP
8.30039525692%	21	253	591	Diabetes_McGill_CREBBP_coTF	MARTINEZ_RB1_AND_TP53_TARGETS_DN
8.30039525692%	21	253	530	Diabetes_McGill_CREBBP_coTF	ENK_UV_RESPONSE_KERATINOCYTE_UP
8.1876724931%	178	2174	1305	T2D_GENES_TANYA_LIPIDS	YOSHIMURA_MAPK8_TARGETS_UP
8.1876724931%	178	2174	1229	T2D_GENES_TANYA_LIPIDS	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
8.16944024206%	54	661	1821	T2D_GENES_TANYA_GLYCEMIC	DODD_NASOPHARYNGEAL_CARCINOMA_UP
8.15660685155%	50	613	1652	T2D_GENES_TANYA_BIOMARKER	PUJANA_BRCA1_PCC_NETWORK
8.15660685155%	50	613	1022	T2D_GENES_TANYA_BIOMARKER	MARSON_BOUND_BY_FOXP3_STIMULATED
8.15602836879%	161	1974	1062	Mendelian_Nancy_Cox	BENPORATH_EED_TARGETS
8.13186813187%	37	455	1781	T2D_GENES_TANYA_BLOODPRESSURE	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
8.12399786211%	152	1871	1821	T2D_GENES_TANYA_HEIGHT	DODD_NASOPHARYNGEAL_CARCINOMA_UP
8.10810810811%	3	37	97	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
8.10810810811%	3	37	920	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SIGNALING_BY_GPCR
8.10810810811%	3	37	918	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	JOHNSTONE_PARVB_TARGETS_3_DN
8.10810810811%	3	37	911	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
8.10810810811%	3	37	898	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
8.10810810811%	3	37	893	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GEORGES_TARGETS_OF_MIR192_AND_MIR215
8.10810810811%	3	37	882	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
8.10810810811%	3	37	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_APOPTOSIS
8.10810810811%	3	37	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_ERBB_SIGNALING_PATHWAY
8.10810810811%	3	37	811	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
8.10810810811%	3	37	805	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
8.10810810811%	3	37	805	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_GPCR_DOWNSTREAM_SIGNALING
8.10810810811%	3	37	800	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
8.10810810811%	3	37	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_MET_PATHWAY
8.10810810811%	3	37	8	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	TCGA_GLIOBLASTOMA_MUTATED
8.10810810811%	3	37	795	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WEI_MYCN_TARGETS_WITH_E_BOX
8.10810810811%	3	37	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MEISSNER_NPC_HCP_WITH_H3K27ME3
8.10810810811%	3	37	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
8.10810810811%	3	37	781	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GOZGIT_ESR1_TARGETS_DN
8.10810810811%	3	37	770	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KRIEG_HYPOXIA_NOT_VIA_KDM3A
8.10810810811%	3	37	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_VEGF_SIGNALING_PATHWAY
8.10810810811%	3	37	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
8.10810810811%	3	37	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
8.10810810811%	3	37	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	URS_ADIPOCYTE_DIFFERENTIATION_UP
8.10810810811%	3	37	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_CHRONIC_MYELOID_LEUKEMIA
8.10810810811%	3	37	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DITTMER_PTHLH_TARGETS_DN
8.10810810811%	3	37	701	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SMID_BREAST_CANCER_BASAL_DN
8.10810810811%	3	37	70	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_RENAL_CELL_CARCINOMA
8.10810810811%	3	37	70	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_PANCREATIC_CANCER
8.10810810811%	3	37	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_VEGFR1_2_PATHWAY
8.10810810811%	3	37	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
8.10810810811%	3	37	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_BCR_5PATHWAY
8.10810810811%	3	37	648	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BENPORATH_CYCLING_GENES
8.10810810811%	3	37	63	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
8.10810810811%	3	37	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_COLORECTAL_CANCER
8.10810810811%	3	37	60	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_ACUTE_MYELOID_LEUKEMIA
8.10810810811%	3	37	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_PPARA_PATHWAY
8.10810810811%	3	37	572	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHICAS_RB1_TARGETS_SENESCENT
8.10810810811%	3	37	564	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SMID_BREAST_CANCER_LUMINAL_B_DN
8.10810810811%	3	37	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_NFAT_PATHWAY
8.10810810811%	3	37	546	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WEST_ADRENOCORTICAL_TUMOR_DN
8.10810810811%	3	37	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_TCR_SIGNALING
8.10810810811%	3	37	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_NON_SMALL_CELL_LUNG_CANCER
8.10810810811%	3	37	537	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
8.10810810811%	3	37	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_KITPATHWAY
8.10810810811%	3	37	517	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RAO_BOUND_BY_SALL4_ISOFORM_B
8.10810810811%	3	37	491	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SWEET_LUNG_CANCER_KRAS_UP
8.10810810811%	3	37	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_PI3KCIPATHWAY
8.10810810811%	3	37	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_PI_METABOLISM
8.10810810811%	3	37	460	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
8.10810810811%	3	37	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SIG_BCR_SIGNALING_PATHWAY
8.10810810811%	3	37	455	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
8.10810810811%	3	37	435	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SWEET_LUNG_CANCER_KRAS_DN
8.10810810811%	3	37	421	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_CELL_CYCLE
8.10810810811%	3	37	409	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FOSTER_TOLERANT_MACROPHAGE_DN
8.10810810811%	3	37	408	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
8.10810810811%	3	37	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ST_B_CELL_ANTIGEN_RECEPTOR
8.10810810811%	3	37	394	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BERENJENO_TRANSFORMED_BY_RHOA_DN
8.10810810811%	3	37	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
8.10810810811%	3	37	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_DOWNSTREAM_TCR_SIGNALING
8.10810810811%	3	37	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_MET_PATHWAY
8.10810810811%	3	37	36	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
8.10810810811%	3	37	341	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
8.10810810811%	3	37	336	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	JOHNSTONE_PARVB_TARGETS_2_DN
8.10810810811%	3	37	335	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WONG_EMBRYONIC_STEM_CELL_CORE
8.10810810811%	3	37	330	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
8.10810810811%	3	37	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_CD28_CO_STIMULATION
8.10810810811%	3	37	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE
8.10810810811%	3	37	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
8.10810810811%	3	37	298	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BROWNE_HCMV_INFECTION_14HR_DN
8.10810810811%	3	37	289	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WANG_MLL_TARGETS
8.10810810811%	3	37	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
8.10810810811%	3	37	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_VEGFR1_PATHWAY
8.10810810811%	3	37	243	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHICAS_RB1_TARGETS_GROWING
8.10810810811%	3	37	241	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
8.10810810811%	3	37	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_EIF4_PATHWAY
8.10810810811%	3	37	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_MTOR_PATHWAY
8.10810810811%	3	37	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_CTCF_PATHWAY
8.10810810811%	3	37	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING
8.10810810811%	3	37	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_PDGFRAPATHWAY
8.10810810811%	3	37	216	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
8.10810810811%	3	37	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_ECADHERIN_KERATINOCYTE_PATHWAY
8.10810810811%	3	37	208	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
8.10810810811%	3	37	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KARLSSON_TGFB1_TARGETS_DN
8.10810810811%	3	37	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_IGF1MTOR_PATHWAY
8.10810810811%	3	37	198	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_PHOSPHOLIPID_METABOLISM
8.10810810811%	3	37	190	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_CHEMOKINE_SIGNALING_PATHWAY
8.10810810811%	3	37	182	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FERNANDEZ_BOUND_BY_MYC
8.10810810811%	3	37	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_PTEN_PATHWAY
8.10810810811%	3	37	179	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
8.10810810811%	3	37	170	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
8.10810810811%	3	37	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SA_PTEN_PATHWAY
8.10810810811%	3	37	1652	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PUJANA_BRCA1_PCC_NETWORK
8.10810810811%	3	37	157	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
8.10810810811%	3	37	155	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_JAK_STAT_SIGNALING_PATHWAY
8.10810810811%	3	37	153	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DURAND_STROMA_MAX_DN
8.10810810811%	3	37	137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
8.10810810811%	3	37	133	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_DIABETES_PATHWAYS
8.10810810811%	3	37	129	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_PDGFRBPATHWAY
8.10810810811%	3	37	1278	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
8.10810810811%	3	37	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
8.10810810811%	3	37	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
8.10810810811%	3	37	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	XU_GH1_EXOGENOUS_TARGETS_DN
8.10810810811%	3	37	1142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
8.10810810811%	3	37	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHOU_PANCREATIC_BETA_CELL
8.10810810811%	3	37	1080	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
8.10810810811%	3	37	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
8.10810810811%	3	37	1037	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NUYTTEN_EZH2_TARGETS_UP
8.10810810811%	3	37	1024	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NUYTTEN_EZH2_TARGETS_DN
8.10810810811%	3	37	102	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_CXCR4_PATHWAY
8.10810810811%	3	37	102	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
8.10810810811%	3	37	1011	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
8.07174887892%	36	446	1652	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PUJANA_BRCA1_PCC_NETWORK
8.06451612903%	10	124	85	Diabetes_McGill_Cell_cycle_All_Gene	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
8.06451612903%	10	124	82	Diabetes_McGill_Cell_cycle_All_Gene	PID_REG_GR_PATHWAY
8.06451612903%	10	124	75	Diabetes_McGill_Cell_cycle_All_Gene	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
8.06451612903%	10	124	69	Diabetes_McGill_Cell_cycle_All_Gene	ZAMORA_NOS2_TARGETS_UP
8.06451612903%	10	124	66	Diabetes_McGill_Cell_cycle_All_Gene	TENEDINI_MEGAKARYOCYTE_MARKERS
8.06451612903%	10	124	62	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_COLORECTAL_CANCER
8.06451612903%	10	124	593	Diabetes_McGill_Cell_cycle_All_Gene	MARTINEZ_TP53_TARGETS_DN
8.06451612903%	10	124	56	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21
8.06451612903%	10	124	56	Diabetes_McGill_Cell_cycle_All_Gene	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP
8.06451612903%	10	124	56	Diabetes_McGill_Cell_cycle_All_Gene	LY_AGING_OLD_DN
8.06451612903%	10	124	54	Diabetes_McGill_Cell_cycle_All_Gene	PID_NFAT_3PATHWAY
8.06451612903%	10	124	528	Diabetes_McGill_Cell_cycle_All_Gene	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
8.06451612903%	10	124	38	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER
8.06451612903%	10	124	358	Diabetes_McGill_Cell_cycle_All_Gene	GRUETZMANN_PANCREATIC_CANCER_UP
8.06451612903%	10	124	356	Diabetes_McGill_Cell_cycle_All_Gene	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
8.06451612903%	10	124	312	Diabetes_McGill_Cell_cycle_All_Gene	GENTILE_UV_HIGH_DOSE_DN
8.06451612903%	10	124	29	Diabetes_McGill_Cell_cycle_All_Gene	YU_BAP1_TARGETS
8.06451612903%	10	124	27	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION
8.06451612903%	10	124	26	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_RACCYCD_PATHWAY
8.06451612903%	10	124	23	Diabetes_McGill_Cell_cycle_All_Gene	EGUCHI_CELL_CYCLE_RB1_TARGETS
8.06451612903%	10	124	203	Diabetes_McGill_Cell_cycle_All_Gene	PAL_PRMT5_TARGETS_UP
8.06451612903%	10	124	19	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_G1_S_SPECIFIC_TRANSCRIPTION
8.06451612903%	10	124	169	Diabetes_McGill_Cell_cycle_All_Gene	PENG_GLUCOSE_DEPRIVATION_DN
8.06451612903%	10	124	15	Diabetes_McGill_Cell_cycle_All_Gene	SA_G1_AND_S_PHASES
8.06451612903%	10	124	146	Diabetes_McGill_Cell_cycle_All_Gene	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
8.06451612903%	10	124	139	Diabetes_McGill_Cell_cycle_All_Gene	ODONNELL_TFRC_TARGETS_DN
8.06451612903%	10	124	135	Diabetes_McGill_Cell_cycle_All_Gene	SERVITJA_LIVER_HNF1A_TARGETS_UP
8.06451612903%	10	124	13	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_P27_PATHWAY
8.06451612903%	10	124	116	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_MEIOSIS
8.06451612903%	10	124	115	Diabetes_McGill_Cell_cycle_All_Gene	MARZEC_IL2_SIGNALING_UP
8.06451612903%	10	124	11	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX
8.0547112462%	159	1974	1821	Mendelian_Nancy_Cox	DODD_NASOPHARYNGEAL_CARCINOMA_UP
8.01815431165%	53	661	1839	T2D_GENES_TANYA_GLYCEMIC	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
8.0040526849%	158	1974	1725	Mendelian_Nancy_Cox	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
7.99347471452%	49	613	1691	T2D_GENES_TANYA_BIOMARKER	BLALOCK_ALZHEIMERS_DISEASE_UP
7.90513833992%	20	253	953	Diabetes_McGill_CREBBP_coTF	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
7.90513833992%	20	253	893	Diabetes_McGill_CREBBP_coTF	GEORGES_TARGETS_OF_MIR192_AND_MIR215
7.90513833992%	20	253	848	Diabetes_McGill_CREBBP_coTF	NUYTTEN_NIPP1_TARGETS_DN
7.90513833992%	20	253	783	Diabetes_McGill_CREBBP_coTF	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
7.90513833992%	20	253	747	Diabetes_McGill_CREBBP_coTF	PATIL_LIVER_CANCER
7.90513833992%	20	253	70	Diabetes_McGill_CREBBP_coTF	PID_AP1_PATHWAY
7.90513833992%	20	253	65	Diabetes_McGill_CREBBP_coTF	PID_RB_1PATHWAY
7.90513833992%	20	253	648	Diabetes_McGill_CREBBP_coTF	SMID_BREAST_CANCER_BASAL_UP
7.90513833992%	20	253	584	Diabetes_McGill_CREBBP_coTF	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
7.90513833992%	20	253	555	Diabetes_McGill_CREBBP_coTF	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
7.90513833992%	20	253	546	Diabetes_McGill_CREBBP_coTF	WEST_ADRENOCORTICAL_TUMOR_DN
7.90513833992%	20	253	312	Diabetes_McGill_CREBBP_coTF	GENTILE_UV_HIGH_DOSE_DN
7.90513833992%	20	253	269	Diabetes_McGill_CREBBP_coTF	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
7.90513833992%	20	253	217	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALLING_BY_NGF
7.90513833992%	20	253	1821	Diabetes_McGill_CREBBP_coTF	DODD_NASOPHARYNGEAL_CARCINOMA_UP
7.90513833992%	20	253	1210	Diabetes_McGill_CREBBP_coTF	CHEN_METABOLIC_SYNDROM_NETWORK
7.90513833992%	20	253	1080	Diabetes_McGill_CREBBP_coTF	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
7.86686838124%	52	661	1442	T2D_GENES_TANYA_GLYCEMIC	PUJANA_ATM_PCC_NETWORK
7.86686838124%	52	661	1305	T2D_GENES_TANYA_GLYCEMIC	YOSHIMURA_MAPK8_TARGETS_UP
7.80141843972%	154	1974	882	Mendelian_Nancy_Cox	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
7.80141843972%	154	1974	1142	Mendelian_Nancy_Cox	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
7.74907749077%	42	542	1821	T2D_GENES_TANYA_ANTHROPOMETRIC	DODD_NASOPHARYNGEAL_CARCINOMA_UP
7.69230769231%	35	455	1821	T2D_GENES_TANYA_BLOODPRESSURE	DODD_NASOPHARYNGEAL_CARCINOMA_UP
7.69230769231%	3	39	97	Diabetes_McGill_IL6	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
7.69230769231%	3	39	96	Diabetes_McGill_IL6	ZAMORA_NOS2_TARGETS_DN
7.69230769231%	3	39	92	Diabetes_McGill_IL6	KEGG_DILATED_CARDIOMYOPATHY
7.69230769231%	3	39	911	Diabetes_McGill_IL6	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
7.69230769231%	3	39	91	Diabetes_McGill_IL6	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
7.69230769231%	3	39	90	Diabetes_McGill_IL6	HILLION_HMGA1_TARGETS
7.69230769231%	3	39	9	Diabetes_McGill_IL6	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK
7.69230769231%	3	39	89	Diabetes_McGill_IL6	KANG_IMMORTALIZED_BY_TERT_UP
7.69230769231%	3	39	882	Diabetes_McGill_IL6	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
7.69230769231%	3	39	86	Diabetes_McGill_IL6	KEGG_TGF_BETA_SIGNALING_PATHWAY
7.69230769231%	3	39	86	Diabetes_McGill_IL6	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
7.69230769231%	3	39	84	Diabetes_McGill_IL6	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
7.69230769231%	3	39	84	Diabetes_McGill_IL6	PID_CMYB_PATHWAY
7.69230769231%	3	39	82	Diabetes_McGill_IL6	PID_REG_GR_PATHWAY
7.69230769231%	3	39	81	Diabetes_McGill_IL6	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
7.69230769231%	3	39	81	Diabetes_McGill_IL6	HARRIS_HYPOXIA
7.69230769231%	3	39	79	Diabetes_McGill_IL6	DUAN_PRDM5_TARGETS
7.69230769231%	3	39	779	Diabetes_McGill_IL6	PUJANA_CHEK2_PCC_NETWORK
7.69230769231%	3	39	775	Diabetes_McGill_IL6	BENPORATH_MYC_MAX_TARGETS
7.69230769231%	3	39	770	Diabetes_McGill_IL6	KRIEG_HYPOXIA_NOT_VIA_KDM3A
7.69230769231%	3	39	722	Diabetes_McGill_IL6	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
7.69230769231%	3	39	720	Diabetes_McGill_IL6	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
7.69230769231%	3	39	712	Diabetes_McGill_IL6	SCHLOSSER_SERUM_RESPONSE_DN
7.69230769231%	3	39	701	Diabetes_McGill_IL6	SMID_BREAST_CANCER_BASAL_DN
7.69230769231%	3	39	69	Diabetes_McGill_IL6	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
7.69230769231%	3	39	68	Diabetes_McGill_IL6	PID_TELOMERASEPATHWAY
7.69230769231%	3	39	673	Diabetes_McGill_IL6	MARTINEZ_RB1_TARGETS_UP
7.69230769231%	3	39	668	Diabetes_McGill_IL6	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
7.69230769231%	3	39	66	Diabetes_McGill_IL6	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM
7.69230769231%	3	39	648	Diabetes_McGill_IL6	SMID_BREAST_CANCER_BASAL_UP
7.69230769231%	3	39	648	Diabetes_McGill_IL6	BENPORATH_CYCLING_GENES
7.69230769231%	3	39	64	Diabetes_McGill_IL6	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
7.69230769231%	3	39	633	Diabetes_McGill_IL6	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
7.69230769231%	3	39	63	Diabetes_McGill_IL6	PID_IL12_2PATHWAY
7.69230769231%	3	39	601	Diabetes_McGill_IL6	MARTINEZ_RB1_AND_TP53_TARGETS_UP
7.69230769231%	3	39	60	Diabetes_McGill_IL6	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE
7.69230769231%	3	39	59	Diabetes_McGill_IL6	DASU_IL6_SIGNALING_UP
7.69230769231%	3	39	549	Diabetes_McGill_IL6	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
7.69230769231%	3	39	544	Diabetes_McGill_IL6	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
7.69230769231%	3	39	543	Diabetes_McGill_IL6	MARTINEZ_RB1_TARGETS_DN
7.69230769231%	3	39	539	Diabetes_McGill_IL6	LIAO_METASTASIS
7.69230769231%	3	39	532	Diabetes_McGill_IL6	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
7.69230769231%	3	39	530	Diabetes_McGill_IL6	ENK_UV_RESPONSE_KERATINOCYTE_UP
7.69230769231%	3	39	53	Diabetes_McGill_IL6	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
7.69230769231%	3	39	52	Diabetes_McGill_IL6	RADAEVA_RESPONSE_TO_IFNA1_UP
7.69230769231%	3	39	52	Diabetes_McGill_IL6	KEGG_MTOR_SIGNALING_PATHWAY
7.69230769231%	3	39	514	Diabetes_McGill_IL6	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
7.69230769231%	3	39	510	Diabetes_McGill_IL6	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
7.69230769231%	3	39	505	Diabetes_McGill_IL6	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
7.69230769231%	3	39	50	Diabetes_McGill_IL6	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
7.69230769231%	3	39	491	Diabetes_McGill_IL6	SWEET_LUNG_CANCER_KRAS_UP
7.69230769231%	3	39	489	Diabetes_McGill_IL6	LIM_MAMMARY_STEM_CELL_UP
7.69230769231%	3	39	487	Diabetes_McGill_IL6	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
7.69230769231%	3	39	483	Diabetes_McGill_IL6	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
7.69230769231%	3	39	481	Diabetes_McGill_IL6	LIU_PROSTATE_CANCER_DN
7.69230769231%	3	39	48	Diabetes_McGill_IL6	PID_CERAMIDE_PATHWAY
7.69230769231%	3	39	479	Diabetes_McGill_IL6	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
7.69230769231%	3	39	467	Diabetes_McGill_IL6	RATTENBACHER_BOUND_BY_CELF1
7.69230769231%	3	39	46	Diabetes_McGill_IL6	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
7.69230769231%	3	39	46	Diabetes_McGill_IL6	ABBUD_LIF_SIGNALING_1_UP
7.69230769231%	3	39	459	Diabetes_McGill_IL6	KIM_WT1_TARGETS_DN
7.69230769231%	3	39	457	Diabetes_McGill_IL6	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
7.69230769231%	3	39	45	Diabetes_McGill_IL6	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
7.69230769231%	3	39	45	Diabetes_McGill_IL6	SIG_CHEMOTAXIS
7.69230769231%	3	39	442	Diabetes_McGill_IL6	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
7.69230769231%	3	39	442	Diabetes_McGill_IL6	HAN_SATB1_TARGETS_DN
7.69230769231%	3	39	44	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_FGFR_MUTANTS
7.69230769231%	3	39	431	Diabetes_McGill_IL6	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
7.69230769231%	3	39	429	Diabetes_McGill_IL6	MOOTHA_HUMAN_MITODB_6_2002
7.69230769231%	3	39	42	Diabetes_McGill_IL6	AMIT_EGF_RESPONSE_40_HELA
7.69230769231%	3	39	418	Diabetes_McGill_IL6	RUTELLA_RESPONSE_TO_HGF_UP
7.69230769231%	3	39	418	Diabetes_McGill_IL6	MULLIGHAN_MLL_SIGNATURE_2_UP
7.69230769231%	3	39	41	Diabetes_McGill_IL6	PID_ERBB1_INTERNALIZATION_PATHWAY
7.69230769231%	3	39	406	Diabetes_McGill_IL6	OSMAN_BLADDER_CANCER_DN
7.69230769231%	3	39	390	Diabetes_McGill_IL6	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
7.69230769231%	3	39	39	Diabetes_McGill_IL6	PID_RET_PATHWAY
7.69230769231%	3	39	387	Diabetes_McGill_IL6	CHYLA_CBFA2T3_TARGETS_UP
7.69230769231%	3	39	384	Diabetes_McGill_IL6	BASAKI_YBX1_TARGETS_DN
7.69230769231%	3	39	380	Diabetes_McGill_IL6	MULLIGHAN_MLL_SIGNATURE_1_UP
7.69230769231%	3	39	38	Diabetes_McGill_IL6	PID_ERBB4_PATHWAY
7.69230769231%	3	39	38	Diabetes_McGill_IL6	BIOCARTA_INTEGRIN_PATHWAY
7.69230769231%	3	39	373	Diabetes_McGill_IL6	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
7.69230769231%	3	39	37	Diabetes_McGill_IL6	ST_P38_MAPK_PATHWAY
7.69230769231%	3	39	37	Diabetes_McGill_IL6	BIOCARTA_ALK_PATHWAY
7.69230769231%	3	39	367	Diabetes_McGill_IL6	DELACROIX_RARG_BOUND_MEF
7.69230769231%	3	39	36	Diabetes_McGill_IL6	SUBTIL_PROGESTIN_TARGETS
7.69230769231%	3	39	36	Diabetes_McGill_IL6	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
7.69230769231%	3	39	36	Diabetes_McGill_IL6	REACTOME_FRS2_MEDIATED_CASCADE
7.69230769231%	3	39	34	Diabetes_McGill_IL6	ST_WNT_BETA_CATENIN_PATHWAY
7.69230769231%	3	39	34	Diabetes_McGill_IL6	PID_HDAC_CLASSII_PATHWAY
7.69230769231%	3	39	338	Diabetes_McGill_IL6	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
7.69230769231%	3	39	330	Diabetes_McGill_IL6	REACTOME_METABOLISM_OF_RNA
7.69230769231%	3	39	33	Diabetes_McGill_IL6	PID_IL12_STAT4PATHWAY
7.69230769231%	3	39	323	Diabetes_McGill_IL6	GRESHOCK_CANCER_COPY_NUMBER_UP
7.69230769231%	3	39	316	Diabetes_McGill_IL6	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
7.69230769231%	3	39	31	Diabetes_McGill_IL6	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
7.69230769231%	3	39	31	Diabetes_McGill_IL6	PID_NEPHRIN_NEPH1_PATHWAY
7.69230769231%	3	39	31	Diabetes_McGill_IL6	PID_CD40_PATHWAY
7.69230769231%	3	39	31	Diabetes_McGill_IL6	BIOCARTA_PYK2_PATHWAY
7.69230769231%	3	39	30	Diabetes_McGill_IL6	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP
7.69230769231%	3	39	30	Diabetes_McGill_IL6	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
7.69230769231%	3	39	299	Diabetes_McGill_IL6	MUELLER_PLURINET
7.69230769231%	3	39	293	Diabetes_McGill_IL6	ENK_UV_RESPONSE_EPIDERMIS_UP
7.69230769231%	3	39	29	Diabetes_McGill_IL6	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
7.69230769231%	3	39	29	Diabetes_McGill_IL6	PID_S1P_S1P3_PATHWAY
7.69230769231%	3	39	29	Diabetes_McGill_IL6	BIOCARTA_NKT_PATHWAY
7.69230769231%	3	39	284	Diabetes_McGill_IL6	REACTOME_METABOLISM_OF_MRNA
7.69230769231%	3	39	282	Diabetes_McGill_IL6	HELLER_SILENCED_BY_METHYLATION_UP
7.69230769231%	3	39	28	Diabetes_McGill_IL6	ST_GAQ_PATHWAY
7.69230769231%	3	39	28	Diabetes_McGill_IL6	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
7.69230769231%	3	39	28	Diabetes_McGill_IL6	REACTOME_SHC_MEDIATED_CASCADE
7.69230769231%	3	39	28	Diabetes_McGill_IL6	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING
7.69230769231%	3	39	28	Diabetes_McGill_IL6	BIOCARTA_G1_PATHWAY
7.69230769231%	3	39	27	Diabetes_McGill_IL6	BIOCARTA_CREB_PATHWAY
7.69230769231%	3	39	261	Diabetes_McGill_IL6	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
7.69230769231%	3	39	261	Diabetes_McGill_IL6	BILD_HRAS_ONCOGENIC_SIGNATURE
7.69230769231%	3	39	254	Diabetes_McGill_IL6	BROWNE_HCMV_INFECTION_4HR_DN
7.69230769231%	3	39	251	Diabetes_McGill_IL6	REACTOME_AXON_GUIDANCE
7.69230769231%	3	39	25	Diabetes_McGill_IL6	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
7.69230769231%	3	39	249	Diabetes_McGill_IL6	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
7.69230769231%	3	39	244	Diabetes_McGill_IL6	DAZARD_RESPONSE_TO_UV_NHEK_UP
7.69230769231%	3	39	238	Diabetes_McGill_IL6	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
7.69230769231%	3	39	238	Diabetes_McGill_IL6	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
7.69230769231%	3	39	23	Diabetes_McGill_IL6	WU_HBX_TARGETS_2_UP
7.69230769231%	3	39	23	Diabetes_McGill_IL6	BIOCARTA_CTCF_PATHWAY
7.69230769231%	3	39	221	Diabetes_McGill_IL6	ZHANG_TLX_TARGETS_36HR_UP
7.69230769231%	3	39	22	Diabetes_McGill_IL6	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING
7.69230769231%	3	39	22	Diabetes_McGill_IL6	REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING
7.69230769231%	3	39	22	Diabetes_McGill_IL6	GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION
7.69230769231%	3	39	22	Diabetes_McGill_IL6	BIOCARTA_AKT_PATHWAY
7.69230769231%	3	39	217	Diabetes_McGill_IL6	SANSOM_APC_MYC_TARGETS
7.69230769231%	3	39	214	Diabetes_McGill_IL6	AFFAR_YY1_TARGETS_UP
7.69230769231%	3	39	210	Diabetes_McGill_IL6	VERHAAK_GLIOBLASTOMA_NEURAL
7.69230769231%	3	39	21	Diabetes_McGill_IL6	REACTOME_CTLA4_INHIBITORY_SIGNALING
7.69230769231%	3	39	21	Diabetes_McGill_IL6	MURAKAMI_UV_RESPONSE_6HR_DN
7.69230769231%	3	39	21	Diabetes_McGill_IL6	BIOCARTA_TOB1_PATHWAY
7.69230769231%	3	39	206	Diabetes_McGill_IL6	RAMALHO_STEMNESS_UP
7.69230769231%	3	39	206	Diabetes_McGill_IL6	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
7.69230769231%	3	39	20	Diabetes_McGill_IL6	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
7.69230769231%	3	39	199	Diabetes_McGill_IL6	PLASARI_TGFB1_TARGETS_10HR_UP
7.69230769231%	3	39	196	Diabetes_McGill_IL6	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
7.69230769231%	3	39	19	Diabetes_McGill_IL6	BIOCARTA_TGFB_PATHWAY
7.69230769231%	3	39	187	Diabetes_McGill_IL6	PENG_LEUCINE_DEPRIVATION_DN
7.69230769231%	3	39	180	Diabetes_McGill_IL6	DARWICHE_PAPILLOMA_RISK_HIGH_DN
7.69230769231%	3	39	18	Diabetes_McGill_IL6	SHIN_B_CELL_LYMPHOMA_CLUSTER_5
7.69230769231%	3	39	18	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR
7.69230769231%	3	39	18	Diabetes_McGill_IL6	BIOCARTA_SPRY_PATHWAY
7.69230769231%	3	39	18	Diabetes_McGill_IL6	BIOCARTA_ERK5_PATHWAY
7.69230769231%	3	39	175	Diabetes_McGill_IL6	LEE_LIVER_CANCER_SURVIVAL_DN
7.69230769231%	3	39	171	Diabetes_McGill_IL6	GOLDRATH_HOMEOSTATIC_PROLIFERATION
7.69230769231%	3	39	17	Diabetes_McGill_IL6	REACTOME_TIE2_SIGNALING
7.69230769231%	3	39	17	Diabetes_McGill_IL6	REACTOME_INFLAMMASOMES
7.69230769231%	3	39	169	Diabetes_McGill_IL6	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
7.69230769231%	3	39	166	Diabetes_McGill_IL6	CAIRO_LIVER_DEVELOPMENT_UP
7.69230769231%	3	39	161	Diabetes_McGill_IL6	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
7.69230769231%	3	39	16	Diabetes_McGill_IL6	BIOCARTA_ACH_PATHWAY
7.69230769231%	3	39	158	Diabetes_McGill_IL6	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
7.69230769231%	3	39	15	Diabetes_McGill_IL6	SA_MMP_CYTOKINE_CONNECTION
7.69230769231%	3	39	15	Diabetes_McGill_IL6	MARKS_HDAC_TARGETS_DN
7.69230769231%	3	39	142	Diabetes_McGill_IL6	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
7.69230769231%	3	39	140	Diabetes_McGill_IL6	JOHNSTONE_PARVB_TARGETS_2_UP
7.69230769231%	3	39	14	Diabetes_McGill_IL6	ZHANG_ADIPOGENESIS_BY_BMP7
7.69230769231%	3	39	14	Diabetes_McGill_IL6	REACTOME_SOS_MEDIATED_SIGNALLING
7.69230769231%	3	39	14	Diabetes_McGill_IL6	REACTOME_SIGNAL_ATTENUATION
7.69230769231%	3	39	137	Diabetes_McGill_IL6	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
7.69230769231%	3	39	134	Diabetes_McGill_IL6	KEGG_TIGHT_JUNCTION
7.69230769231%	3	39	127	Diabetes_McGill_IL6	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
7.69230769231%	3	39	12	Diabetes_McGill_IL6	SA_PROGRAMMED_CELL_DEATH
7.69230769231%	3	39	12	Diabetes_McGill_IL6	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING
7.69230769231%	3	39	116	Diabetes_McGill_IL6	IKEDA_MIR30_TARGETS_UP
7.69230769231%	3	39	116	Diabetes_McGill_IL6	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
7.69230769231%	3	39	1024	Diabetes_McGill_IL6	NUYTTEN_EZH2_TARGETS_DN
7.69230769231%	3	39	1022	Diabetes_McGill_IL6	MARSON_BOUND_BY_FOXP3_STIMULATED
7.69230769231%	3	39	1011	Diabetes_McGill_IL6	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
7.69230769231%	3	39	101	Diabetes_McGill_IL6	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
7.69230769231%	3	39	101	Diabetes_McGill_IL6	KEGG_GNRH_SIGNALING_PATHWAY
7.69230769231%	2	26	97	Diabetes_McGill_Set_Wnt_pathway	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
7.69230769231%	2	26	97	Diabetes_McGill_Set_Wnt_pathway	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
7.69230769231%	2	26	940	Diabetes_McGill_Set_Wnt_pathway	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
7.69230769231%	2	26	92	Diabetes_McGill_Set_Wnt_pathway	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
7.69230769231%	2	26	918	Diabetes_McGill_Set_Wnt_pathway	JOHNSTONE_PARVB_TARGETS_3_DN
7.69230769231%	2	26	911	Diabetes_McGill_Set_Wnt_pathway	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
7.69230769231%	2	26	91	Diabetes_McGill_Set_Wnt_pathway	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
7.69230769231%	2	26	91	Diabetes_McGill_Set_Wnt_pathway	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
7.69230769231%	2	26	90	Diabetes_McGill_Set_Wnt_pathway	SASSON_RESPONSE_TO_FORSKOLIN_UP
7.69230769231%	2	26	90	Diabetes_McGill_GPCRs_expressed_in_beta_cell	KEGG_GAP_JUNCTION
7.69230769231%	2	26	9	Diabetes_McGill_Set_Wnt_pathway	REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION
7.69230769231%	2	26	898	Diabetes_McGill_Set_Wnt_pathway	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
7.69230769231%	2	26	89	Diabetes_McGill_Set_Wnt_pathway	SWEET_KRAS_ONCOGENIC_SIGNATURE
7.69230769231%	2	26	89	Diabetes_McGill_Set_Wnt_pathway	LEE_AGING_NEOCORTEX_UP
7.69230769231%	2	26	89	Diabetes_McGill_Set_Wnt_pathway	BOYLAN_MULTIPLE_MYELOMA_D_UP
7.69230769231%	2	26	882	Diabetes_McGill_Set_Wnt_pathway	LEE_BMP2_TARGETS_DN
7.69230769231%	2	26	88	Diabetes_McGill_Set_Wnt_pathway	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
7.69230769231%	2	26	88	Diabetes_McGill_Set_Wnt_pathway	REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS
7.69230769231%	2	26	88	Diabetes_McGill_Set_Wnt_pathway	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
7.69230769231%	2	26	88	Diabetes_McGill_Set_Wnt_pathway	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
7.69230769231%	2	26	87	Diabetes_McGill_Set_Wnt_pathway	KEGG_ERBB_SIGNALING_PATHWAY
7.69230769231%	2	26	87	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_MAPK_PATHWAY
7.69230769231%	2	26	86	Diabetes_McGill_Set_Wnt_pathway	BAELDE_DIABETIC_NEPHROPATHY_UP
7.69230769231%	2	26	86	Diabetes_McGill_GPCRs_expressed_in_beta_cell	LEE_AGING_CEREBELLUM_DN
7.69230769231%	2	26	857	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MARTENS_TRETINOIN_RESPONSE_UP
7.69230769231%	2	26	848	Diabetes_McGill_GPCRs_expressed_in_beta_cell	NUYTTEN_NIPP1_TARGETS_DN
7.69230769231%	2	26	84	Diabetes_McGill_Set_Wnt_pathway	KEGG_SMALL_CELL_LUNG_CANCER
7.69230769231%	2	26	830	Diabetes_McGill_Set_Wnt_pathway	CUI_TCF21_TARGETS_2_DN
7.69230769231%	2	26	824	Diabetes_McGill_Set_Wnt_pathway	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
7.69230769231%	2	26	81	Diabetes_McGill_Set_Wnt_pathway	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
7.69230769231%	2	26	805	Diabetes_McGill_Set_Wnt_pathway	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
7.69230769231%	2	26	80	Diabetes_McGill_Set_Wnt_pathway	PID_MET_PATHWAY
7.69230769231%	2	26	80	Diabetes_McGill_Set_Wnt_pathway	LEE_AGING_NEOCORTEX_DN
7.69230769231%	2	26	76	Diabetes_McGill_Set_Wnt_pathway	PEART_HDAC_PROLIFERATION_CLUSTER_DN
7.69230769231%	2	26	76	Diabetes_McGill_Set_Wnt_pathway	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
7.69230769231%	2	26	74	Diabetes_McGill_Set_Wnt_pathway	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
7.69230769231%	2	26	73	Diabetes_McGill_Set_Wnt_pathway	LIN_MELANOMA_COPY_NUMBER_UP
7.69230769231%	2	26	728	Diabetes_McGill_Set_Wnt_pathway	MARSON_BOUND_BY_E2F4_UNSTIMULATED
7.69230769231%	2	26	721	Diabetes_McGill_Set_Wnt_pathway	WONG_ADULT_TISSUE_STEM_MODULE
7.69230769231%	2	26	72	Diabetes_McGill_Set_Wnt_pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
7.69230769231%	2	26	72	Diabetes_McGill_Set_Wnt_pathway	KEGG_LEISHMANIA_INFECTION
7.69230769231%	2	26	712	Diabetes_McGill_Set_Wnt_pathway	SCHLOSSER_SERUM_RESPONSE_DN
7.69230769231%	2	26	70	Diabetes_McGill_Set_Wnt_pathway	KEGG_PANCREATIC_CANCER
7.69230769231%	2	26	7	Diabetes_McGill_Set_Wnt_pathway	BAKER_HEMATOPOESIS_STAT5_TARGETS
7.69230769231%	2	26	67	Diabetes_McGill_Set_Wnt_pathway	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
7.69230769231%	2	26	67	Diabetes_McGill_Set_Wnt_pathway	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
7.69230769231%	2	26	66	Diabetes_McGill_Set_Wnt_pathway	PID_HIF1_TFPATHWAY
7.69230769231%	2	26	66	Diabetes_McGill_Set_Wnt_pathway	PID_HDAC_CLASSI_PATHWAY
7.69230769231%	2	26	66	Diabetes_McGill_Set_Wnt_pathway	NAKAMURA_ADIPOGENESIS_EARLY_UP
7.69230769231%	2	26	658	Diabetes_McGill_Set_Wnt_pathway	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
7.69230769231%	2	26	65	Diabetes_McGill_Set_Wnt_pathway	PID_BCR_5PATHWAY
7.69230769231%	2	26	648	Diabetes_McGill_Set_Wnt_pathway	SMID_BREAST_CANCER_BASAL_UP
7.69230769231%	2	26	648	Diabetes_McGill_Set_Wnt_pathway	BENPORATH_CYCLING_GENES
7.69230769231%	2	26	64	Diabetes_McGill_Set_Wnt_pathway	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS
7.69230769231%	2	26	633	Diabetes_McGill_Set_Wnt_pathway	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
7.69230769231%	2	26	62	Diabetes_McGill_Set_Wnt_pathway	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
7.69230769231%	2	26	61	Diabetes_McGill_Set_Wnt_pathway	PID_AR_PATHWAY
7.69230769231%	2	26	602	Diabetes_McGill_Set_Wnt_pathway	MARTINEZ_TP53_TARGETS_UP
7.69230769231%	2	26	591	Diabetes_McGill_Set_Wnt_pathway	MARTINEZ_RB1_AND_TP53_TARGETS_DN
7.69230769231%	2	26	58	Diabetes_McGill_Set_Wnt_pathway	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
7.69230769231%	2	26	58	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_PPARA_PATHWAY
7.69230769231%	2	26	544	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
7.69230769231%	2	26	543	Diabetes_McGill_Set_Wnt_pathway	MARTINEZ_RB1_TARGETS_DN
7.69230769231%	2	26	54	Diabetes_McGill_Set_Wnt_pathway	REACTOME_APOPTOTIC_EXECUTION_PHASE
7.69230769231%	2	26	54	Diabetes_McGill_Set_Wnt_pathway	JIANG_AGING_CEREBRAL_CORTEX_DN
7.69230769231%	2	26	537	Diabetes_McGill_Set_Wnt_pathway	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
7.69230769231%	2	26	536	Diabetes_McGill_Set_Wnt_pathway	SENESE_HDAC3_TARGETS_DN
7.69230769231%	2	26	536	Diabetes_McGill_Set_Wnt_pathway	BERENJENO_TRANSFORMED_BY_RHOA_UP
7.69230769231%	2	26	530	Diabetes_McGill_Set_Wnt_pathway	ENK_UV_RESPONSE_KERATINOCYTE_UP
7.69230769231%	2	26	526	Diabetes_McGill_Set_Wnt_pathway	ONKEN_UVEAL_MELANOMA_DN
7.69230769231%	2	26	52	Diabetes_McGill_Set_Wnt_pathway	PID_KITPATHWAY
7.69230769231%	2	26	517	Diabetes_McGill_Set_Wnt_pathway	RAO_BOUND_BY_SALL4_ISOFORM_B
7.69230769231%	2	26	516	Diabetes_McGill_Set_Wnt_pathway	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
7.69230769231%	2	26	516	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
7.69230769231%	2	26	514	Diabetes_McGill_Set_Wnt_pathway	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
7.69230769231%	2	26	510	Diabetes_McGill_Set_Wnt_pathway	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
7.69230769231%	2	26	51	Diabetes_McGill_Set_Wnt_pathway	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN
7.69230769231%	2	26	50	Diabetes_McGill_Set_Wnt_pathway	HOFMANN_CELL_LYMPHOMA_UP
7.69230769231%	2	26	491	Diabetes_McGill_Set_Wnt_pathway	SWEET_LUNG_CANCER_KRAS_UP
7.69230769231%	2	26	491	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MEISSNER_NPC_HCP_WITH_H3K4ME2
7.69230769231%	2	26	49	Diabetes_McGill_Set_Wnt_pathway	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8
7.69230769231%	2	26	489	Diabetes_McGill_Set_Wnt_pathway	LIM_MAMMARY_STEM_CELL_UP
7.69230769231%	2	26	487	Diabetes_McGill_Set_Wnt_pathway	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
7.69230769231%	2	26	485	Diabetes_McGill_Set_Wnt_pathway	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
7.69230769231%	2	26	485	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
7.69230769231%	2	26	48	Diabetes_McGill_Set_Wnt_pathway	PID_AJDISS_2PATHWAY
7.69230769231%	2	26	48	Diabetes_McGill_GPCRs_expressed_in_beta_cell	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN
7.69230769231%	2	26	479	Diabetes_McGill_Set_Wnt_pathway	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
7.69230769231%	2	26	476	Diabetes_McGill_Set_Wnt_pathway	SMID_BREAST_CANCER_NORMAL_LIKE_UP
7.69230769231%	2	26	475	Diabetes_McGill_Set_Wnt_pathway	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
7.69230769231%	2	26	473	Diabetes_McGill_Set_Wnt_pathway	GARY_CD5_TARGETS_UP
7.69230769231%	2	26	462	Diabetes_McGill_Set_Wnt_pathway	DELACROIX_RAR_BOUND_ES
7.69230769231%	2	26	46	Diabetes_McGill_Set_Wnt_pathway	SESTO_RESPONSE_TO_UV_C5
7.69230769231%	2	26	46	Diabetes_McGill_Set_Wnt_pathway	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
7.69230769231%	2	26	46	Diabetes_McGill_Set_Wnt_pathway	PID_TNFPATHWAY
7.69230769231%	2	26	457	Diabetes_McGill_Set_Wnt_pathway	SENESE_HDAC1_TARGETS_UP
7.69230769231%	2	26	457	Diabetes_McGill_Set_Wnt_pathway	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
7.69230769231%	2	26	456	Diabetes_McGill_Set_Wnt_pathway	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
7.69230769231%	2	26	45	Diabetes_McGill_Set_Wnt_pathway	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN
7.69230769231%	2	26	44	Diabetes_McGill_Set_Wnt_pathway	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
7.69230769231%	2	26	44	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS
7.69230769231%	2	26	435	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SWEET_LUNG_CANCER_KRAS_DN
7.69230769231%	2	26	424	Diabetes_McGill_Set_Wnt_pathway	SHEN_SMARCA2_TARGETS_UP
7.69230769231%	2	26	42	Diabetes_McGill_Set_Wnt_pathway	KEGG_BLADDER_CANCER
7.69230769231%	2	26	418	Diabetes_McGill_Set_Wnt_pathway	RUTELLA_RESPONSE_TO_HGF_UP
7.69230769231%	2	26	412	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
7.69230769231%	2	26	408	Diabetes_McGill_Set_Wnt_pathway	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
7.69230769231%	2	26	408	Diabetes_McGill_Set_Wnt_pathway	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
7.69230769231%	2	26	408	Diabetes_McGill_Set_Wnt_pathway	REACTOME_GPCR_LIGAND_BINDING
7.69230769231%	2	26	408	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
7.69230769231%	2	26	405	Diabetes_McGill_Set_Wnt_pathway	KUMAR_TARGETS_OF_MLL_AF9_FUSION
7.69230769231%	2	26	40	Diabetes_McGill_Set_Wnt_pathway	VARELA_ZMPSTE24_TARGETS_UP
7.69230769231%	2	26	40	Diabetes_McGill_Set_Wnt_pathway	ST_JNK_MAPK_PATHWAY
7.69230769231%	2	26	40	Diabetes_McGill_Set_Wnt_pathway	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
7.69230769231%	2	26	40	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_P38MAPK_PATHWAY
7.69230769231%	2	26	395	Diabetes_McGill_Set_Wnt_pathway	HAN_SATB1_TARGETS_UP
7.69230769231%	2	26	393	Diabetes_McGill_Set_Wnt_pathway	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
7.69230769231%	2	26	390	Diabetes_McGill_Set_Wnt_pathway	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
7.69230769231%	2	26	389	Diabetes_McGill_Set_Wnt_pathway	HSIAO_HOUSEKEEPING_GENES
7.69230769231%	2	26	387	Diabetes_McGill_GPCRs_expressed_in_beta_cell	CHYLA_CBFA2T3_TARGETS_UP
7.69230769231%	2	26	382	Diabetes_McGill_Set_Wnt_pathway	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
7.69230769231%	2	26	38	Diabetes_McGill_Set_Wnt_pathway	REACTOME_G1_PHASE
7.69230769231%	2	26	374	Diabetes_McGill_Set_Wnt_pathway	WANG_TUMOR_INVASIVENESS_UP
7.69230769231%	2	26	372	Diabetes_McGill_Set_Wnt_pathway	WANG_LMO4_TARGETS_UP
7.69230769231%	2	26	37	Diabetes_McGill_Set_Wnt_pathway	ST_P38_MAPK_PATHWAY
7.69230769231%	2	26	37	Diabetes_McGill_Set_Wnt_pathway	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
7.69230769231%	2	26	37	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_TOLL_PATHWAY
7.69230769231%	2	26	367	Diabetes_McGill_Set_Wnt_pathway	DELACROIX_RARG_BOUND_MEF
7.69230769231%	2	26	367	Diabetes_McGill_GPCRs_expressed_in_beta_cell	VECCHI_GASTRIC_CANCER_EARLY_DN
7.69230769231%	2	26	36	Diabetes_McGill_Set_Wnt_pathway	PID_PI3KPLCTRKPATHWAY
7.69230769231%	2	26	36	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
7.69230769231%	2	26	355	Diabetes_McGill_Set_Wnt_pathway	PEREZ_TP63_TARGETS
7.69230769231%	2	26	349	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
7.69230769231%	2	26	342	Diabetes_McGill_Set_Wnt_pathway	BLUM_RESPONSE_TO_SALIRASIB_DN
7.69230769231%	2	26	341	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
7.69230769231%	2	26	34	Diabetes_McGill_Set_Wnt_pathway	PID_IL1PATHWAY
7.69230769231%	2	26	338	Diabetes_McGill_Set_Wnt_pathway	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
7.69230769231%	2	26	336	Diabetes_McGill_Set_Wnt_pathway	JOHNSTONE_PARVB_TARGETS_2_DN
7.69230769231%	2	26	33	Diabetes_McGill_Set_Wnt_pathway	PID_NCADHERINPATHWAY
7.69230769231%	2	26	33	Diabetes_McGill_Set_Wnt_pathway	DORN_ADENOVIRUS_INFECTION_12HR_DN
7.69230769231%	2	26	33	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_IL1R_PATHWAY
7.69230769231%	2	26	318	Diabetes_McGill_Set_Wnt_pathway	LEI_MYB_TARGETS
7.69230769231%	2	26	318	Diabetes_McGill_Set_Wnt_pathway	DAZARD_RESPONSE_TO_UV_NHEK_DN
7.69230769231%	2	26	317	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
7.69230769231%	2	26	31	Diabetes_McGill_Set_Wnt_pathway	SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN
7.69230769231%	2	26	30	Diabetes_McGill_Set_Wnt_pathway	REACTOME_NOD1_2_SIGNALING_PATHWAY
7.69230769231%	2	26	30	Diabetes_McGill_Set_Wnt_pathway	PID_RETINOIC_ACID_PATHWAY
7.69230769231%	2	26	299	Diabetes_McGill_Set_Wnt_pathway	WALLACE_PROSTATE_CANCER_RACE_UP
7.69230769231%	2	26	295	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
7.69230769231%	2	26	293	Diabetes_McGill_Set_Wnt_pathway	HADDAD_B_LYMPHOCYTE_PROGENITOR
7.69230769231%	2	26	293	Diabetes_McGill_Set_Wnt_pathway	ENK_UV_RESPONSE_EPIDERMIS_UP
7.69230769231%	2	26	292	Diabetes_McGill_Set_Wnt_pathway	HELLER_HDAC_TARGETS_DN
7.69230769231%	2	26	29	Diabetes_McGill_Set_Wnt_pathway	REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION
7.69230769231%	2	26	287	Diabetes_McGill_Set_Wnt_pathway	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
7.69230769231%	2	26	285	Diabetes_McGill_Set_Wnt_pathway	GRADE_COLON_AND_RECTAL_CANCER_UP
7.69230769231%	2	26	281	Diabetes_McGill_Set_Wnt_pathway	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
7.69230769231%	2	26	281	Diabetes_McGill_Set_Wnt_pathway	BHAT_ESR1_TARGETS_VIA_AKT1_UP
7.69230769231%	2	26	28	Diabetes_McGill_Set_Wnt_pathway	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
7.69230769231%	2	26	28	Diabetes_McGill_Set_Wnt_pathway	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN
7.69230769231%	2	26	28	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_ERK_PATHWAY
7.69230769231%	2	26	277	Diabetes_McGill_Set_Wnt_pathway	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
7.69230769231%	2	26	276	Diabetes_McGill_Set_Wnt_pathway	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
7.69230769231%	2	26	275	Diabetes_McGill_Set_Wnt_pathway	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
7.69230769231%	2	26	27	Diabetes_McGill_Set_Wnt_pathway	CHIN_BREAST_CANCER_COPY_NUMBER_UP
7.69230769231%	2	26	269	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
7.69230769231%	2	26	265	Diabetes_McGill_Set_Wnt_pathway	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
7.69230769231%	2	26	264	Diabetes_McGill_Set_Wnt_pathway	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
7.69230769231%	2	26	26	Diabetes_McGill_Set_Wnt_pathway	PID_P38_MKK3_6PATHWAY
7.69230769231%	2	26	26	Diabetes_McGill_Set_Wnt_pathway	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
7.69230769231%	2	26	258	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
7.69230769231%	2	26	250	Diabetes_McGill_Set_Wnt_pathway	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
7.69230769231%	2	26	249	Diabetes_McGill_Set_Wnt_pathway	MITSIADES_RESPONSE_TO_APLIDIN_DN
7.69230769231%	2	26	246	Diabetes_McGill_Set_Wnt_pathway	BILD_E2F3_ONCOGENIC_SIGNATURE
7.69230769231%	2	26	244	Diabetes_McGill_Set_Wnt_pathway	THUM_SYSTOLIC_HEART_FAILURE_DN
7.69230769231%	2	26	24	Diabetes_McGill_Set_Wnt_pathway	WILLERT_WNT_SIGNALING
7.69230769231%	2	26	23	Diabetes_McGill_Set_Wnt_pathway	REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX
7.69230769231%	2	26	23	Diabetes_McGill_Set_Wnt_pathway	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP
7.69230769231%	2	26	23	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_P53HYPOXIA_PATHWAY
7.69230769231%	2	26	23	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_NFKB_PATHWAY
7.69230769231%	2	26	229	Diabetes_McGill_Set_Wnt_pathway	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
7.69230769231%	2	26	228	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
7.69230769231%	2	26	225	Diabetes_McGill_Set_Wnt_pathway	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
7.69230769231%	2	26	220	Diabetes_McGill_GPCRs_expressed_in_beta_cell	RIGGINS_TAMOXIFEN_RESISTANCE_DN
7.69230769231%	2	26	217	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SIGNALLING_BY_NGF
7.69230769231%	2	26	211	Diabetes_McGill_Set_Wnt_pathway	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
7.69230769231%	2	26	210	Diabetes_McGill_Set_Wnt_pathway	WANG_TUMOR_INVASIVENESS_DN
7.69230769231%	2	26	210	Diabetes_McGill_Set_Wnt_pathway	SANSOM_APC_TARGETS_REQUIRE_MYC
7.69230769231%	2	26	209	Diabetes_McGill_Set_Wnt_pathway	KIM_WT1_TARGETS_12HR_DN
7.69230769231%	2	26	206	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
7.69230769231%	2	26	203	Diabetes_McGill_Set_Wnt_pathway	GRUETZMANN_PANCREATIC_CANCER_DN
7.69230769231%	2	26	201	Diabetes_McGill_Set_Wnt_pathway	HOLLMANN_APOPTOSIS_VIA_CD40_UP
7.69230769231%	2	26	20	Diabetes_McGill_Set_Wnt_pathway	REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY
7.69230769231%	2	26	20	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_IGF1MTOR_PATHWAY
7.69230769231%	2	26	198	Diabetes_McGill_Set_Wnt_pathway	WELCSH_BRCA1_TARGETS_UP
7.69230769231%	2	26	195	Diabetes_McGill_Set_Wnt_pathway	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
7.69230769231%	2	26	19	Diabetes_McGill_Set_Wnt_pathway	NELSON_RESPONSE_TO_ANDROGEN_DN
7.69230769231%	2	26	19	Diabetes_McGill_GPCRs_expressed_in_beta_cell	VERNOCHET_ADIPOGENESIS
7.69230769231%	2	26	186	Diabetes_McGill_GPCRs_expressed_in_beta_cell	HAMAI_APOPTOSIS_VIA_TRAIL_DN
7.69230769231%	2	26	185	Diabetes_McGill_Set_Wnt_pathway	KEGG_HUNTINGTONS_DISEASE
7.69230769231%	2	26	183	Diabetes_McGill_GPCRs_expressed_in_beta_cell	KEGG_ENDOCYTOSIS
7.69230769231%	2	26	1821	Diabetes_McGill_Set_Wnt_pathway	DODD_NASOPHARYNGEAL_CARCINOMA_UP
7.69230769231%	2	26	1821	Diabetes_McGill_GPCRs_expressed_in_beta_cell	DODD_NASOPHARYNGEAL_CARCINOMA_UP
7.69230769231%	2	26	182	Diabetes_McGill_Set_Wnt_pathway	FERNANDEZ_BOUND_BY_MYC
7.69230769231%	2	26	18	Diabetes_McGill_Set_Wnt_pathway	SCHEIDEREIT_IKK_TARGETS
7.69230769231%	2	26	18	Diabetes_McGill_Set_Wnt_pathway	REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION
7.69230769231%	2	26	18	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_TEL_PATHWAY
7.69230769231%	2	26	176	Diabetes_McGill_Set_Wnt_pathway	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
7.69230769231%	2	26	176	Diabetes_McGill_Set_Wnt_pathway	NAGASHIMA_NRG1_SIGNALING_UP
7.69230769231%	2	26	176	Diabetes_McGill_Set_Wnt_pathway	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
7.69230769231%	2	26	176	Diabetes_McGill_GPCRs_expressed_in_beta_cell	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
7.69230769231%	2	26	172	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SMID_BREAST_CANCER_LUMINAL_B_UP
7.69230769231%	2	26	171	Diabetes_McGill_Set_Wnt_pathway	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
7.69230769231%	2	26	170	Diabetes_McGill_Set_Wnt_pathway	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
7.69230769231%	2	26	17	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_CK1_PATHWAY
7.69230769231%	2	26	165	Diabetes_McGill_Set_Wnt_pathway	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
7.69230769231%	2	26	164	Diabetes_McGill_Set_Wnt_pathway	AMIT_EGF_RESPONSE_480_HELA
7.69230769231%	2	26	163	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SERVITJA_ISLET_HNF1A_TARGETS_UP
7.69230769231%	2	26	16	Diabetes_McGill_Set_Wnt_pathway	REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1
7.69230769231%	2	26	16	Diabetes_McGill_Set_Wnt_pathway	BAKER_HEMATOPOIESIS_STAT3_TARGETS
7.69230769231%	2	26	153	Diabetes_McGill_GPCRs_expressed_in_beta_cell	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN
7.69230769231%	2	26	148	Diabetes_McGill_Set_Wnt_pathway	REACTOME_APOPTOSIS
7.69230769231%	2	26	147	Diabetes_McGill_Set_Wnt_pathway	KAUFFMANN_DNA_REPLICATION_GENES
7.69230769231%	2	26	145	Diabetes_McGill_Set_Wnt_pathway	SMITH_TERT_TARGETS_UP
7.69230769231%	2	26	145	Diabetes_McGill_Set_Wnt_pathway	RODWELL_AGING_KIDNEY_DN
7.69230769231%	2	26	142	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
7.69230769231%	2	26	141	Diabetes_McGill_Set_Wnt_pathway	WELCSH_BRCA1_TARGETS_DN
7.69230769231%	2	26	14	Diabetes_McGill_Set_Wnt_pathway	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX
7.69230769231%	2	26	14	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP
7.69230769231%	2	26	139	Diabetes_McGill_GPCRs_expressed_in_beta_cell	HOELZEL_NF1_TARGETS_UP
7.69230769231%	2	26	138	Diabetes_McGill_Set_Wnt_pathway	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
7.69230769231%	2	26	1375	Diabetes_McGill_Set_Wnt_pathway	DODD_NASOPHARYNGEAL_CARCINOMA_DN
7.69230769231%	2	26	137	Diabetes_McGill_Set_Wnt_pathway	PID_P53DOWNSTREAMPATHWAY
7.69230769231%	2	26	137	Diabetes_McGill_Set_Wnt_pathway	LIU_SOX4_TARGETS_UP
7.69230769231%	2	26	135	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SERVITJA_LIVER_HNF1A_TARGETS_UP
7.69230769231%	2	26	132	Diabetes_McGill_Set_Wnt_pathway	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
7.69230769231%	2	26	129	Diabetes_McGill_Set_Wnt_pathway	PID_PDGFRBPATHWAY
7.69230769231%	2	26	126	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
7.69230769231%	2	26	1229	Diabetes_McGill_Set_Wnt_pathway	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
7.69230769231%	2	26	1210	Diabetes_McGill_GPCRs_expressed_in_beta_cell	CHEN_METABOLIC_SYNDROM_NETWORK
7.69230769231%	2	26	120	Diabetes_McGill_Set_Wnt_pathway	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
7.69230769231%	2	26	12	Diabetes_McGill_Set_Wnt_pathway	TURJANSKI_MAPK1_AND_MAPK2_TARGETS
7.69230769231%	2	26	12	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_VDR_PATHWAY
7.69230769231%	2	26	12	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_SEROTONIN_RECEPTORS
7.69230769231%	2	26	118	Diabetes_McGill_Set_Wnt_pathway	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
7.69230769231%	2	26	116	Diabetes_McGill_Set_Wnt_pathway	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
7.69230769231%	2	26	115	Diabetes_McGill_Set_Wnt_pathway	MARZEC_IL2_SIGNALING_UP
7.69230769231%	2	26	115	Diabetes_McGill_Set_Wnt_pathway	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
7.69230769231%	2	26	114	Diabetes_McGill_Set_Wnt_pathway	KEGG_OOCYTE_MEIOSIS
7.69230769231%	2	26	114	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BOSCO_TH1_CYTOTOXIC_MODULE
7.69230769231%	2	26	113	Diabetes_McGill_GPCRs_expressed_in_beta_cell	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
7.69230769231%	2	26	112	Diabetes_McGill_Set_Wnt_pathway	REACTOME_G1_S_TRANSITION
7.69230769231%	2	26	109	Diabetes_McGill_Set_Wnt_pathway	REACTOME_S_PHASE
7.69230769231%	2	26	109	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SERVITJA_ISLET_HNF1A_TARGETS_DN
7.69230769231%	2	26	1080	Diabetes_McGill_Set_Wnt_pathway	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
7.69230769231%	2	26	108	Diabetes_McGill_Set_Wnt_pathway	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
7.69230769231%	2	26	1062	Diabetes_McGill_Set_Wnt_pathway	BENPORATH_EED_TARGETS
7.69230769231%	2	26	104	Diabetes_McGill_Set_Wnt_pathway	NAKAMURA_ADIPOGENESIS_LATE_UP
7.69230769231%	2	26	1038	Diabetes_McGill_Set_Wnt_pathway	BENPORATH_SUZ12_TARGETS
7.69230769231%	2	26	102	Diabetes_McGill_Set_Wnt_pathway	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
7.69230769231%	2	26	1011	Diabetes_McGill_Set_Wnt_pathway	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
7.69230769231%	2	26	100	Diabetes_McGill_Set_Wnt_pathway	BENPORATH_ES_CORE_NINE_CORRELATED
7.69230769231%	1	13	98	Diabetes_McGill_Insulin	GUO_TARGETS_OF_IRS1_AND_IRS2
7.69230769231%	1	13	973	Diabetes_McGill_Insulin	ACEVEDO_LIVER_CANCER_UP
7.69230769231%	1	13	97	Diabetes_McGill_Insulin	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
7.69230769231%	1	13	94	Diabetes_McGill_Insulin	LU_IL4_SIGNALING
7.69230769231%	1	13	94	Diabetes_McGill_Insulin	GAVIN_FOXP3_TARGETS_CLUSTER_T4
7.69230769231%	1	13	91	Diabetes_McGill_Insulin	GAVIN_FOXP3_TARGETS_CLUSTER_P6
7.69230769231%	1	13	90	Diabetes_McGill_Insulin	IGARASHI_ATF4_TARGETS_DN
7.69230769231%	1	13	898	Diabetes_McGill_Insulin	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
7.69230769231%	1	13	89	Diabetes_McGill_Insulin	KEGG_PROSTATE_CANCER
7.69230769231%	1	13	882	Diabetes_McGill_Insulin	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
7.69230769231%	1	13	88	Diabetes_McGill_Insulin	UEDA_CENTRAL_CLOCK
7.69230769231%	1	13	871	Diabetes_McGill_Insulin	GRADE_COLON_CANCER_UP
7.69230769231%	1	13	87	Diabetes_McGill_Insulin	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
7.69230769231%	1	13	863	Diabetes_McGill_Insulin	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
7.69230769231%	1	13	86	Diabetes_McGill_Insulin	NGUYEN_NOTCH1_TARGETS_DN
7.69230769231%	1	13	86	Diabetes_McGill_Insulin	NELSON_RESPONSE_TO_ANDROGEN_UP
7.69230769231%	1	13	857	Diabetes_McGill_Insulin	MARTENS_TRETINOIN_RESPONSE_UP
7.69230769231%	1	13	85	Diabetes_McGill_Insulin	XU_GH1_EXOGENOUS_TARGETS_UP
7.69230769231%	1	13	85	Diabetes_McGill_Insulin	STEIN_ESR1_TARGETS
7.69230769231%	1	13	84	Diabetes_McGill_Insulin	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
7.69230769231%	1	13	83	Diabetes_McGill_Insulin	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
7.69230769231%	1	13	83	Diabetes_McGill_Insulin	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
7.69230769231%	1	13	83	Diabetes_McGill_Insulin	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
7.69230769231%	1	13	81	Diabetes_McGill_Insulin	MUNSHI_MULTIPLE_MYELOMA_UP
7.69230769231%	1	13	800	Diabetes_McGill_Insulin	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
7.69230769231%	1	13	80	Diabetes_McGill_Insulin	LEE_AGING_NEOCORTEX_DN
7.69230769231%	1	13	781	Diabetes_McGill_Insulin	GOZGIT_ESR1_TARGETS_DN
7.69230769231%	1	13	756	Diabetes_McGill_Insulin	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
7.69230769231%	1	13	75	Diabetes_McGill_Insulin	BAE_BRCA1_TARGETS_UP
7.69230769231%	1	13	745	Diabetes_McGill_Insulin	LEE_BMP2_TARGETS_UP
7.69230769231%	1	13	74	Diabetes_McGill_Insulin	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
7.69230769231%	1	13	734	Diabetes_McGill_Insulin	BENPORATH_SOX2_TARGETS
7.69230769231%	1	13	73	Diabetes_McGill_Insulin	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
7.69230769231%	1	13	728	Diabetes_McGill_Insulin	MARSON_BOUND_BY_E2F4_UNSTIMULATED
7.69230769231%	1	13	722	Diabetes_McGill_Insulin	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
7.69230769231%	1	13	720	Diabetes_McGill_Insulin	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
7.69230769231%	1	13	72	Diabetes_McGill_Insulin	DOANE_BREAST_CANCER_CLASSES_UP
7.69230769231%	1	13	718	Diabetes_McGill_Insulin	MIKKELSEN_ES_ICP_WITH_H3K4ME3
7.69230769231%	1	13	712	Diabetes_McGill_Insulin	SCHLOSSER_SERUM_RESPONSE_DN
7.69230769231%	1	13	701	Diabetes_McGill_Insulin	SMID_BREAST_CANCER_BASAL_DN
7.69230769231%	1	13	70	Diabetes_McGill_Insulin	KEGG_LONG_TERM_POTENTIATION
7.69230769231%	1	13	7	Diabetes_McGill_Insulin	ZHAN_EARLY_DIFFERENTIATION_GENES_UP
7.69230769231%	1	13	69	Diabetes_McGill_Insulin	LEIN_NEURON_MARKERS
7.69230769231%	1	13	682	Diabetes_McGill_Insulin	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
7.69230769231%	1	13	68	Diabetes_McGill_Insulin	SESTO_RESPONSE_TO_UV_C7
7.69230769231%	1	13	67	Diabetes_McGill_Insulin	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
7.69230769231%	1	13	668	Diabetes_McGill_Insulin	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
7.69230769231%	1	13	65	Diabetes_McGill_Insulin	PID_ERA_GENOMIC_PATHWAY
7.69230769231%	1	13	63	Diabetes_McGill_Insulin	MODY_HIPPOCAMPUS_POSTNATAL
7.69230769231%	1	13	60	Diabetes_McGill_Insulin	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING
7.69230769231%	1	13	60	Diabetes_McGill_Insulin	CUI_GLUCOSE_DEPRIVATION
7.69230769231%	1	13	578	Diabetes_McGill_Insulin	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
7.69230769231%	1	13	57	Diabetes_McGill_Insulin	AMIT_SERUM_RESPONSE_240_MCF10A
7.69230769231%	1	13	56	Diabetes_McGill_Insulin	GALE_APL_WITH_FLT3_MUTATED_UP
7.69230769231%	1	13	553	Diabetes_McGill_Insulin	FEVR_CTNNB1_TARGETS_DN
7.69230769231%	1	13	55	Diabetes_McGill_Insulin	PID_TGFBRPATHWAY
7.69230769231%	1	13	546	Diabetes_McGill_Insulin	WEST_ADRENOCORTICAL_TUMOR_DN
7.69230769231%	1	13	544	Diabetes_McGill_Insulin	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
7.69230769231%	1	13	54	Diabetes_McGill_Insulin	ZHOU_TNF_SIGNALING_30MIN
7.69230769231%	1	13	539	Diabetes_McGill_Insulin	LIAO_METASTASIS
7.69230769231%	1	13	53	Diabetes_McGill_Insulin	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
7.69230769231%	1	13	53	Diabetes_McGill_Insulin	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS
7.69230769231%	1	13	53	Diabetes_McGill_Insulin	PID_AR_TF_PATHWAY
7.69230769231%	1	13	518	Diabetes_McGill_Insulin	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
7.69230769231%	1	13	510	Diabetes_McGill_Insulin	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
7.69230769231%	1	13	51	Diabetes_McGill_Insulin	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP
7.69230769231%	1	13	501	Diabetes_McGill_Insulin	SENESE_HDAC3_TARGETS_UP
7.69230769231%	1	13	50	Diabetes_McGill_Insulin	MARTINEZ_RESPONSE_TO_TRABECTEDIN
7.69230769231%	1	13	50	Diabetes_McGill_Insulin	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
7.69230769231%	1	13	493	Diabetes_McGill_Insulin	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
7.69230769231%	1	13	49	Diabetes_McGill_Insulin	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
7.69230769231%	1	13	48	Diabetes_McGill_Insulin	PID_CERAMIDE_PATHWAY
7.69230769231%	1	13	48	Diabetes_McGill_Insulin	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN
7.69230769231%	1	13	48	Diabetes_McGill_Insulin	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
7.69230769231%	1	13	479	Diabetes_McGill_Insulin	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
7.69230769231%	1	13	475	Diabetes_McGill_Insulin	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
7.69230769231%	1	13	47	Diabetes_McGill_Insulin	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP
7.69230769231%	1	13	469	Diabetes_McGill_Insulin	MCCABE_BOUND_BY_HOXC6
7.69230769231%	1	13	462	Diabetes_McGill_Insulin	DELACROIX_RAR_BOUND_ES
7.69230769231%	1	13	461	Diabetes_McGill_Insulin	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
7.69230769231%	1	13	46	Diabetes_McGill_Insulin	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
7.69230769231%	1	13	46	Diabetes_McGill_Insulin	HEIDENBLAD_AMPLICON_8Q24_DN
7.69230769231%	1	13	46	Diabetes_McGill_Insulin	ABBUD_LIF_SIGNALING_1_UP
7.69230769231%	1	13	457	Diabetes_McGill_Insulin	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
7.69230769231%	1	13	456	Diabetes_McGill_Insulin	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
7.69230769231%	1	13	448	Diabetes_McGill_Insulin	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
7.69230769231%	1	13	44	Diabetes_McGill_Insulin	PID_HNF3APATHWAY
7.69230769231%	1	13	44	Diabetes_McGill_Insulin	MA_MYELOID_DIFFERENTIATION_DN
7.69230769231%	1	13	44	Diabetes_McGill_Insulin	MARTIN_INTERACT_WITH_HDAC
7.69230769231%	1	13	44	Diabetes_McGill_Insulin	LANDIS_BREAST_CANCER_PROGRESSION_UP
7.69230769231%	1	13	44	Diabetes_McGill_Insulin	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION
7.69230769231%	1	13	44	Diabetes_McGill_Insulin	JAEGER_METASTASIS_UP
7.69230769231%	1	13	434	Diabetes_McGill_Insulin	BAELDE_DIABETIC_NEPHROPATHY_DN
7.69230769231%	1	13	431	Diabetes_McGill_Insulin	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
7.69230769231%	1	13	43	Diabetes_McGill_Insulin	PID_TCPTP_PATHWAY
7.69230769231%	1	13	43	Diabetes_McGill_Insulin	MILI_PSEUDOPODIA
7.69230769231%	1	13	43	Diabetes_McGill_Insulin	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
7.69230769231%	1	13	425	Diabetes_McGill_Insulin	BOCHKIS_FOXA2_TARGETS
7.69230769231%	1	13	419	Diabetes_McGill_Insulin	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
7.69230769231%	1	13	411	Diabetes_McGill_Insulin	KOYAMA_SEMA3B_TARGETS_DN
7.69230769231%	1	13	406	Diabetes_McGill_Insulin	OSMAN_BLADDER_CANCER_DN
7.69230769231%	1	13	403	Diabetes_McGill_Insulin	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
7.69230769231%	1	13	40	Diabetes_McGill_Insulin	VARELA_ZMPSTE24_TARGETS_UP
7.69230769231%	1	13	398	Diabetes_McGill_Insulin	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
7.69230769231%	1	13	394	Diabetes_McGill_Insulin	BERENJENO_TRANSFORMED_BY_RHOA_DN
7.69230769231%	1	13	39	Diabetes_McGill_Insulin	WANG_LSD1_TARGETS_DN
7.69230769231%	1	13	39	Diabetes_McGill_Insulin	SESTO_RESPONSE_TO_UV_C6
7.69230769231%	1	13	387	Diabetes_McGill_Insulin	CHYLA_CBFA2T3_TARGETS_UP
7.69230769231%	1	13	380	Diabetes_McGill_Insulin	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
7.69230769231%	1	13	38	Diabetes_McGill_Insulin	PID_P38ALPHABETADOWNSTREAMPATHWAY
7.69230769231%	1	13	378	Diabetes_McGill_Insulin	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
7.69230769231%	1	13	374	Diabetes_McGill_Insulin	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
7.69230769231%	1	13	373	Diabetes_McGill_Insulin	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
7.69230769231%	1	13	372	Diabetes_McGill_Insulin	WANG_LMO4_TARGETS_UP
7.69230769231%	1	13	37	Diabetes_McGill_Insulin	PID_FRA_PATHWAY
7.69230769231%	1	13	36	Diabetes_McGill_Insulin	YANG_BREAST_CANCER_ESR1_UP
7.69230769231%	1	13	36	Diabetes_McGill_Insulin	MMS_MOUSE_LYMPH_HIGH_4HRS_UP
7.69230769231%	1	13	351	Diabetes_McGill_Insulin	YAGI_AML_WITH_11Q23_REARRANGED
7.69230769231%	1	13	35	Diabetes_McGill_Insulin	HU_GENOTOXIC_DAMAGE_24HR
7.69230769231%	1	13	344	Diabetes_McGill_Insulin	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
7.69230769231%	1	13	34	Diabetes_McGill_Insulin	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP
7.69230769231%	1	13	337	Diabetes_McGill_Insulin	PENG_GLUTAMINE_DEPRIVATION_DN
7.69230769231%	1	13	335	Diabetes_McGill_Insulin	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
7.69230769231%	1	13	330	Diabetes_McGill_Insulin	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
7.69230769231%	1	13	330	Diabetes_McGill_Insulin	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
7.69230769231%	1	13	33	Diabetes_McGill_Insulin	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP
7.69230769231%	1	13	33	Diabetes_McGill_Insulin	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP
7.69230769231%	1	13	33	Diabetes_McGill_Insulin	CHO_NR4A1_TARGETS
7.69230769231%	1	13	324	Diabetes_McGill_Insulin	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
7.69230769231%	1	13	32	Diabetes_McGill_Insulin	TRACEY_RESISTANCE_TO_IFNA2_DN
7.69230769231%	1	13	318	Diabetes_McGill_Insulin	LEI_MYB_TARGETS
7.69230769231%	1	13	317	Diabetes_McGill_Insulin	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
7.69230769231%	1	13	314	Diabetes_McGill_Insulin	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
7.69230769231%	1	13	309	Diabetes_McGill_Insulin	LIU_SOX4_TARGETS_DN
7.69230769231%	1	13	307	Diabetes_McGill_Insulin	LI_INDUCED_T_TO_NATURAL_KILLER_UP
7.69230769231%	1	13	302	Diabetes_McGill_Insulin	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
7.69230769231%	1	13	30	Diabetes_McGill_Insulin	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
7.69230769231%	1	13	30	Diabetes_McGill_Insulin	DAZARD_UV_RESPONSE_CLUSTER_G2
7.69230769231%	1	13	298	Diabetes_McGill_Insulin	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
7.69230769231%	1	13	293	Diabetes_McGill_Insulin	HADDAD_B_LYMPHOCYTE_PROGENITOR
7.69230769231%	1	13	292	Diabetes_McGill_Insulin	KOYAMA_SEMA3B_TARGETS_UP
7.69230769231%	1	13	29	Diabetes_McGill_Insulin	MAYBURD_RESPONSE_TO_L663536_UP
7.69230769231%	1	13	29	Diabetes_McGill_Insulin	DORN_ADENOVIRUS_INFECTION_12HR_UP
7.69230769231%	1	13	289	Diabetes_McGill_Insulin	GABRIELY_MIR21_TARGETS
7.69230769231%	1	13	283	Diabetes_McGill_Insulin	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
7.69230769231%	1	13	279	Diabetes_McGill_Insulin	FORTSCHEGGER_PHF8_TARGETS_UP
7.69230769231%	1	13	275	Diabetes_McGill_Insulin	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
7.69230769231%	1	13	27	Diabetes_McGill_Insulin	HOEGERKORP_CD44_TARGETS_DIRECT_UP
7.69230769231%	1	13	268	Diabetes_McGill_Insulin	XU_GH1_AUTOCRINE_TARGETS_UP
7.69230769231%	1	13	267	Diabetes_McGill_Insulin	KEGG_MAPK_SIGNALING_PATHWAY
7.69230769231%	1	13	267	Diabetes_McGill_Insulin	HOLLMANN_APOPTOSIS_VIA_CD40_DN
7.69230769231%	1	13	266	Diabetes_McGill_Insulin	ROZANOV_MMP14_TARGETS_UP
7.69230769231%	1	13	266	Diabetes_McGill_Insulin	FOSTER_KDM1A_TARGETS_UP
7.69230769231%	1	13	264	Diabetes_McGill_Insulin	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
7.69230769231%	1	13	261	Diabetes_McGill_Insulin	BILD_HRAS_ONCOGENIC_SIGNATURE
7.69230769231%	1	13	26	Diabetes_McGill_Insulin	PID_INSULIN_GLUCOSE_PATHWAY
7.69230769231%	1	13	254	Diabetes_McGill_Insulin	IVANOVA_HEMATOPOIESIS_STEM_CELL
7.69230769231%	1	13	245	Diabetes_McGill_Insulin	PENG_RAPAMYCIN_RESPONSE_DN
7.69230769231%	1	13	244	Diabetes_McGill_Insulin	KAYO_AGING_MUSCLE_UP
7.69230769231%	1	13	242	Diabetes_McGill_Insulin	WINTER_HYPOXIA_METAGENE
7.69230769231%	1	13	238	Diabetes_McGill_Insulin	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
7.69230769231%	1	13	234	Diabetes_McGill_Insulin	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
7.69230769231%	1	13	23	Diabetes_McGill_Insulin	REACTOME_LYSOSOME_VESICLE_BIOGENESIS
7.69230769231%	1	13	23	Diabetes_McGill_Insulin	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
7.69230769231%	1	13	23	Diabetes_McGill_Insulin	BARIS_THYROID_CANCER_UP
7.69230769231%	1	13	229	Diabetes_McGill_Insulin	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
7.69230769231%	1	13	229	Diabetes_McGill_Insulin	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
7.69230769231%	1	13	222	Diabetes_McGill_Insulin	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
7.69230769231%	1	13	221	Diabetes_McGill_Insulin	ZHANG_TLX_TARGETS_36HR_UP
7.69230769231%	1	13	221	Diabetes_McGill_Insulin	PEDRIOLI_MIR31_TARGETS_UP
7.69230769231%	1	13	22	Diabetes_McGill_Insulin	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP
7.69230769231%	1	13	22	Diabetes_McGill_Insulin	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
7.69230769231%	1	13	213	Diabetes_McGill_Insulin	WIERENGA_STAT5A_TARGETS_DN
7.69230769231%	1	13	211	Diabetes_McGill_Insulin	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
7.69230769231%	1	13	211	Diabetes_McGill_Insulin	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
7.69230769231%	1	13	210	Diabetes_McGill_Insulin	WANG_TUMOR_INVASIVENESS_DN
7.69230769231%	1	13	210	Diabetes_McGill_Insulin	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
7.69230769231%	1	13	21	Diabetes_McGill_Insulin	DAZARD_UV_RESPONSE_CLUSTER_G4
7.69230769231%	1	13	208	Diabetes_McGill_Insulin	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
7.69230769231%	1	13	203	Diabetes_McGill_Insulin	GRUETZMANN_PANCREATIC_CANCER_DN
7.69230769231%	1	13	202	Diabetes_McGill_Insulin	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
7.69230769231%	1	13	19	Diabetes_McGill_Insulin	MELLMAN_TUT1_TARGETS_UP
7.69230769231%	1	13	182	Diabetes_McGill_Insulin	RAO_BOUND_BY_SALL4_ISOFORM_A
7.69230769231%	1	13	182	Diabetes_McGill_Insulin	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
7.69230769231%	1	13	18	Diabetes_McGill_Insulin	LE_NEURONAL_DIFFERENTIATION_UP
7.69230769231%	1	13	178	Diabetes_McGill_Insulin	LI_AMPLIFIED_IN_LUNG_CANCER
7.69230769231%	1	13	177	Diabetes_McGill_Insulin	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
7.69230769231%	1	13	175	Diabetes_McGill_Insulin	FIRESTEIN_PROLIFERATION
7.69230769231%	1	13	17	Diabetes_McGill_Insulin	ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN
7.69230769231%	1	13	1691	Diabetes_McGill_Insulin	BLALOCK_ALZHEIMERS_DISEASE_UP
7.69230769231%	1	13	167	Diabetes_McGill_Insulin	VANTVEER_BREAST_CANCER_ESR1_UP
7.69230769231%	1	13	167	Diabetes_McGill_Insulin	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
7.69230769231%	1	13	1652	Diabetes_McGill_Insulin	PUJANA_BRCA1_PCC_NETWORK
7.69230769231%	1	13	161	Diabetes_McGill_Insulin	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
7.69230769231%	1	13	16	Diabetes_McGill_Insulin	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8
7.69230769231%	1	13	158	Diabetes_McGill_Insulin	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON
7.69230769231%	1	13	153	Diabetes_McGill_Insulin	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
7.69230769231%	1	13	153	Diabetes_McGill_Insulin	RUIZ_TNC_TARGETS_UP
7.69230769231%	1	13	151	Diabetes_McGill_Insulin	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
7.69230769231%	1	13	150	Diabetes_McGill_Insulin	LANDIS_ERBB2_BREAST_TUMORS_324_UP
7.69230769231%	1	13	15	Diabetes_McGill_Insulin	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP
7.69230769231%	1	13	147	Diabetes_McGill_Insulin	WHITFIELD_CELL_CYCLE_G1_S
7.69230769231%	1	13	147	Diabetes_McGill_Insulin	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
7.69230769231%	1	13	146	Diabetes_McGill_Insulin	LEE_NEURAL_CREST_STEM_CELL_UP
7.69230769231%	1	13	145	Diabetes_McGill_Insulin	SMITH_TERT_TARGETS_UP
7.69230769231%	1	13	142	Diabetes_McGill_Insulin	PENG_LEUCINE_DEPRIVATION_UP
7.69230769231%	1	13	14	Diabetes_McGill_Insulin	ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS
7.69230769231%	1	13	14	Diabetes_McGill_Insulin	VICENT_METASTASIS_UP
7.69230769231%	1	13	14	Diabetes_McGill_Insulin	DORN_ADENOVIRUS_INFECTION_48HR_UP
7.69230769231%	1	13	129	Diabetes_McGill_Insulin	REACTOME_MEMBRANE_TRAFFICKING
7.69230769231%	1	13	1278	Diabetes_McGill_Insulin	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
7.69230769231%	1	13	127	Diabetes_McGill_Insulin	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
7.69230769231%	1	13	126	Diabetes_McGill_Insulin	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
7.69230769231%	1	13	126	Diabetes_McGill_Insulin	BURTON_ADIPOGENESIS_5
7.69230769231%	1	13	121	Diabetes_McGill_Insulin	VANTVEER_BREAST_CANCER_METASTASIS_DN
7.69230769231%	1	13	121	Diabetes_McGill_Insulin	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
7.69230769231%	1	13	12	Diabetes_McGill_Insulin	DORN_ADENOVIRUS_INFECTION_24HR_UP
7.69230769231%	1	13	118	Diabetes_McGill_Insulin	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
7.69230769231%	1	13	116	Diabetes_McGill_Insulin	LIM_MAMMARY_LUMINAL_MATURE_UP
7.69230769231%	1	13	114	Diabetes_McGill_Insulin	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN
7.69230769231%	1	13	112	Diabetes_McGill_Insulin	DOANE_BREAST_CANCER_ESR1_UP
7.69230769231%	1	13	111	Diabetes_McGill_Insulin	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
7.69230769231%	1	13	11	Diabetes_McGill_Insulin	DORN_ADENOVIRUS_INFECTION_32HR_UP
7.69230769231%	1	13	11	Diabetes_McGill_Insulin	BIOCARTA_EIF2_PATHWAY
7.69230769231%	1	13	11	Diabetes_McGill_Insulin	AMIT_EGF_RESPONSE_20_HELA
7.69230769231%	1	13	109	Diabetes_McGill_Insulin	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
7.69230769231%	1	13	108	Diabetes_McGill_Insulin	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
7.69230769231%	1	13	105	Diabetes_McGill_Insulin	HELLER_SILENCED_BY_METHYLATION_DN
7.69230769231%	1	13	101	Diabetes_McGill_Insulin	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
7.69230769231%	1	13	101	Diabetes_McGill_Insulin	KEGG_GNRH_SIGNALING_PATHWAY
7.69230769231%	1	13	100	Diabetes_McGill_Insulin	QI_PLASMACYTOMA_DN
7.69230769231%	1	13	100	Diabetes_McGill_Insulin	MCCLUNG_CREB1_TARGETS_UP
7.69230769231%	1	13	100	Diabetes_McGill_Insulin	BENPORATH_ES_CORE_NINE_CORRELATED
7.56429652042%	50	661	1972	T2D_GENES_TANYA_GLYCEMIC	PILON_KLF1_TARGETS_DN
7.54812563323%	149	1974	1174	Mendelian_Nancy_Cox	PEREZ_TP53_TARGETS
7.52780153978%	88	1169	1691	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BLALOCK_ALZHEIMERS_DISEASE_UP
7.50988142292%	19	253	988	Diabetes_McGill_CREBBP_coTF	BENPORATH_NANOG_TARGETS
7.50988142292%	19	253	728	Diabetes_McGill_CREBBP_coTF	MARSON_BOUND_BY_E2F4_UNSTIMULATED
7.50988142292%	19	253	508	Diabetes_McGill_CREBBP_coTF	ENK_UV_RESPONSE_EPIDERMIS_DN
7.50988142292%	19	253	456	Diabetes_McGill_CREBBP_coTF	MARTENS_BOUND_BY_PML_RARA_FUSION
7.50988142292%	19	253	439	Diabetes_McGill_CREBBP_coTF	MITSIADES_RESPONSE_TO_APLIDIN_UP
7.50988142292%	19	253	423	Diabetes_McGill_CREBBP_coTF	PUJANA_BRCA2_PCC_NETWORK
7.50988142292%	19	253	318	Diabetes_McGill_CREBBP_coTF	DAZARD_RESPONSE_TO_UV_NHEK_DN
7.50988142292%	19	253	314	Diabetes_McGill_CREBBP_coTF	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
7.50988142292%	19	253	1137	Diabetes_McGill_CREBBP_coTF	BRUINS_UVC_RESPONSE_LATE
7.50988142292%	19	253	1022	Diabetes_McGill_CREBBP_coTF	MARSON_BOUND_BY_FOXP3_STIMULATED
7.50988142292%	19	253	100	Diabetes_McGill_CREBBP_coTF	BENPORATH_ES_CORE_NINE_CORRELATED
7.47252747253%	34	455	1725	T2D_GENES_TANYA_BLOODPRESSURE	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
7.47252747253%	34	455	1118	T2D_GENES_TANYA_BLOODPRESSURE	BENPORATH_ES_WITH_H3K27ME3
7.47252747253%	34	455	1069	T2D_GENES_TANYA_BLOODPRESSURE	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
7.45170193192%	162	2174	1022	T2D_GENES_TANYA_LIPIDS	MARSON_BOUND_BY_FOXP3_STIMULATED
7.41301059002%	49	661	728	T2D_GENES_TANYA_GLYCEMIC	MARSON_BOUND_BY_E2F4_UNSTIMULATED
7.40740740741%	6	81	988	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BENPORATH_NANOG_TARGETS
7.40740740741%	6	81	882	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
7.40740740741%	6	81	848	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NUYTTEN_NIPP1_TARGETS_DN
7.40740740741%	6	81	701	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SMID_BREAST_CANCER_BASAL_DN
7.40740740741%	6	81	564	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SMID_BREAST_CANCER_LUMINAL_B_DN
7.40740740741%	6	81	546	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WEST_ADRENOCORTICAL_TUMOR_DN
7.40740740741%	6	81	539	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
7.40740740741%	6	81	514	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
7.40740740741%	6	81	504	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PILON_KLF1_TARGETS_UP
7.40740740741%	6	81	504	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BROWNE_HCMV_INFECTION_48HR_DN
7.40740740741%	6	81	481	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LIU_PROSTATE_CANCER_DN
7.40740740741%	6	81	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_INSULIN_PATHWAY
7.40740740741%	6	81	403	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
7.40740740741%	6	81	330	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
7.40740740741%	6	81	269	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
7.40740740741%	6	81	230	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BENPORATH_MYC_TARGETS_WITH_EBOX
7.40740740741%	6	81	1839	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
7.40740740741%	6	81	133	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_DIABETES_PATHWAYS
7.40740740741%	6	81	1103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DANG_BOUND_BY_MYC
7.40740740741%	6	81	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHOU_PANCREATIC_BETA_CELL
7.40740740741%	6	81	1037	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NUYTTEN_EZH2_TARGETS_UP
7.40740740741%	2	27	918	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	JOHNSTONE_PARVB_TARGETS_3_DN
7.40740740741%	2	27	911	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
7.40740740741%	2	27	89	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
7.40740740741%	2	27	882	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LEE_BMP2_TARGETS_DN
7.40740740741%	2	27	830	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CUI_TCF21_TARGETS_2_DN
7.40740740741%	2	27	770	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KRIEG_HYPOXIA_NOT_VIA_KDM3A
7.40740740741%	2	27	77	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
7.40740740741%	2	27	76	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MAHAJAN_RESPONSE_TO_IL1A_DN
7.40740740741%	2	27	734	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BENPORATH_SOX2_TARGETS
7.40740740741%	2	27	72	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SESTO_RESPONSE_TO_UV_C8
7.40740740741%	2	27	72	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HUANG_GATA2_TARGETS_DN
7.40740740741%	2	27	70	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_RENAL_CELL_CARCINOMA
7.40740740741%	2	27	70	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
7.40740740741%	2	27	658	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
7.40740740741%	2	27	648	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SMID_BREAST_CANCER_BASAL_UP
7.40740740741%	2	27	633	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
7.40740740741%	2	27	58	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT
7.40740740741%	2	27	572	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHICAS_RB1_TARGETS_SENESCENT
7.40740740741%	2	27	567	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHICAS_RB1_TARGETS_CONFLUENT
7.40740740741%	2	27	552	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
7.40740740741%	2	27	540	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ACEVEDO_LIVER_CANCER_DN
7.40740740741%	2	27	54	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	JIANG_AGING_CEREBRAL_CORTEX_DN
7.40740740741%	2	27	539	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LIAO_METASTASIS
7.40740740741%	2	27	52	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KENNY_CTNNB1_TARGETS_DN
7.40740740741%	2	27	518	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_METABOLISM_OF_PROTEINS
7.40740740741%	2	27	510	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
7.40740740741%	2	27	51	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
7.40740740741%	2	27	51	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	APPIERTO_RESPONSE_TO_FENRETINIDE_DN
7.40740740741%	2	27	482	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
7.40740740741%	2	27	47	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LEONARD_HYPOXIA
7.40740740741%	2	27	462	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DELACROIX_RAR_BOUND_ES
7.40740740741%	2	27	455	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
7.40740740741%	2	27	45	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP
7.40740740741%	2	27	45	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PID_HNF3BPATHWAY
7.40740740741%	2	27	442	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HAN_SATB1_TARGETS_DN
7.40740740741%	2	27	44	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_LYSINE_DEGRADATION
7.40740740741%	2	27	425	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BOCHKIS_FOXA2_TARGETS
7.40740740741%	2	27	42	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BIOCARTA_CHREBP2_PATHWAY
7.40740740741%	2	27	418	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RUTELLA_RESPONSE_TO_HGF_UP
7.40740740741%	2	27	418	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MULLIGHAN_MLL_SIGNATURE_2_UP
7.40740740741%	2	27	414	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MOHANKUMAR_TLX1_TARGETS_UP
7.40740740741%	2	27	414	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LU_EZH2_TARGETS_DN
7.40740740741%	2	27	404	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	OSMAN_BLADDER_CANCER_UP
7.40740740741%	2	27	40	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ST_JNK_MAPK_PATHWAY
7.40740740741%	2	27	40	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	JIANG_AGING_HYPOTHALAMUS_DN
7.40740740741%	2	27	396	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_DEVELOPMENTAL_BIOLOGY
7.40740740741%	2	27	39	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
7.40740740741%	2	27	380	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DAIRKEE_TERT_TARGETS_UP
7.40740740741%	2	27	38	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP
7.40740740741%	2	27	374	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WANG_TUMOR_INVASIVENESS_UP
7.40740740741%	2	27	374	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
7.40740740741%	2	27	372	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WANG_LMO4_TARGETS_UP
7.40740740741%	2	27	346	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GOLDRATH_ANTIGEN_RESPONSE
7.40740740741%	2	27	341	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MULLIGHAN_NPM1_SIGNATURE_3_UP
7.40740740741%	2	27	34	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_GLUCONEOGENESIS
7.40740740741%	2	27	34	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_BUTANOATE_METABOLISM
7.40740740741%	2	27	338	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
7.40740740741%	2	27	329	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
7.40740740741%	2	27	328	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_PATHWAYS_IN_CANCER
7.40740740741%	2	27	32	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MOOTHA_GLUCONEOGENESIS
7.40740740741%	2	27	315	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
7.40740740741%	2	27	305	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
7.40740740741%	2	27	30	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
7.40740740741%	2	27	298	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
7.40740740741%	2	27	295	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LU_EZH2_TARGETS_UP
7.40740740741%	2	27	293	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ENK_UV_RESPONSE_EPIDERMIS_UP
7.40740740741%	2	27	29	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_GLYCOLYSIS
7.40740740741%	2	27	279	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FORTSCHEGGER_PHF8_TARGETS_UP
7.40740740741%	2	27	276	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
7.40740740741%	2	27	27	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	AKL_HTLV1_INFECTION_UP
7.40740740741%	2	27	267	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CAIRO_HEPATOBLASTOMA_DN
7.40740740741%	2	27	261	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
7.40740740741%	2	27	25	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17
7.40740740741%	2	27	25	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG
7.40740740741%	2	27	244	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DAZARD_RESPONSE_TO_UV_NHEK_UP
7.40740740741%	2	27	242	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
7.40740740741%	2	27	230	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BENPORATH_MYC_TARGETS_WITH_EBOX
7.40740740741%	2	27	222	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
7.40740740741%	2	27	207	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MANALO_HYPOXIA_UP
7.40740740741%	2	27	204	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
7.40740740741%	2	27	202	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
7.40740740741%	2	27	201	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KIM_MYC_AMPLIFICATION_TARGETS_UP
7.40740740741%	2	27	20	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
7.40740740741%	2	27	198	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WELCSH_BRCA1_TARGETS_UP
7.40740740741%	2	27	198	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ALONSO_METASTASIS_UP
7.40740740741%	2	27	19	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP
7.40740740741%	2	27	182	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FERNANDEZ_BOUND_BY_MYC
7.40740740741%	2	27	181	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
7.40740740741%	2	27	181	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
7.40740740741%	2	27	176	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
7.40740740741%	2	27	175	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FIRESTEIN_PROLIFERATION
7.40740740741%	2	27	174	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
7.40740740741%	2	27	17	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED
7.40740740741%	2	27	169	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
7.40740740741%	2	27	159	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_PURINE_METABOLISM
7.40740740741%	2	27	157	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
7.40740740741%	2	27	149	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LANDIS_ERBB2_BREAST_TUMORS_324_DN
7.40740740741%	2	27	148	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BROWNE_HCMV_INFECTION_24HR_DN
7.40740740741%	2	27	143	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
7.40740740741%	2	27	140	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	JOHNSTONE_PARVB_TARGETS_2_UP
7.40740740741%	2	27	139	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
7.40740740741%	2	27	1375	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DODD_NASOPHARYNGEAL_CARCINOMA_DN
7.40740740741%	2	27	137	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_INSULIN_SIGNALING_PATHWAY
7.40740740741%	2	27	136	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PROVENZANI_METASTASIS_DN
7.40740740741%	2	27	132	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
7.40740740741%	2	27	1305	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	YOSHIMURA_MAPK8_TARGETS_UP
7.40740740741%	2	27	128	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	POTTI_TOPOTECAN_SENSITIVITY
7.40740740741%	2	27	1229	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
7.40740740741%	2	27	120	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
7.40740740741%	2	27	12	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS
7.40740740741%	2	27	11	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP
7.40740740741%	2	27	11	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS
7.40740740741%	2	27	11	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BIOCARTA_VITCB_PATHWAY
7.40740740741%	2	27	109	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SERVITJA_ISLET_HNF1A_TARGETS_DN
7.40740740741%	2	27	1037	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	NUYTTEN_EZH2_TARGETS_UP
7.40740740741%	2	27	1022	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MARSON_BOUND_BY_FOXP3_STIMULATED
7.40740740741%	2	27	1011	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
7.39910313901%	33	446	1022	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARSON_BOUND_BY_FOXP3_STIMULATED
7.39614994934%	146	1974	933	Mendelian_Nancy_Cox	REACTOME_IMMUNE_SYSTEM
7.38007380074%	40	542	1972	T2D_GENES_TANYA_ANTHROPOMETRIC	PILON_KLF1_TARGETS_DN
7.38007380074%	40	542	1062	T2D_GENES_TANYA_ANTHROPOMETRIC	BENPORATH_EED_TARGETS
7.34094616639%	45	613	1229	T2D_GENES_TANYA_BIOMARKER	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
7.31707317073%	3	41	97	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
7.31707317073%	3	41	920	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SIGNALING_BY_GPCR
7.31707317073%	3	41	918	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	JOHNSTONE_PARVB_TARGETS_3_DN
7.31707317073%	3	41	911	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
7.31707317073%	3	41	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_APOPTOSIS
7.31707317073%	3	41	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_ERBB_SIGNALING_PATHWAY
7.31707317073%	3	41	805	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
7.31707317073%	3	41	805	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_GPCR_DOWNSTREAM_SIGNALING
7.31707317073%	3	41	800	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
7.31707317073%	3	41	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_UNFOLDED_PROTEIN_RESPONSE
7.31707317073%	3	41	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_MET_PATHWAY
7.31707317073%	3	41	8	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	TCGA_GLIOBLASTOMA_MUTATED
7.31707317073%	3	41	795	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WEI_MYCN_TARGETS_WITH_E_BOX
7.31707317073%	3	41	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MEISSNER_NPC_HCP_WITH_H3K27ME3
7.31707317073%	3	41	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
7.31707317073%	3	41	781	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GOZGIT_ESR1_TARGETS_DN
7.31707317073%	3	41	770	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KRIEG_HYPOXIA_NOT_VIA_KDM3A
7.31707317073%	3	41	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_VEGF_SIGNALING_PATHWAY
7.31707317073%	3	41	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
7.31707317073%	3	41	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
7.31707317073%	3	41	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	URS_ADIPOCYTE_DIFFERENTIATION_UP
7.31707317073%	3	41	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_CHRONIC_MYELOID_LEUKEMIA
7.31707317073%	3	41	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DITTMER_PTHLH_TARGETS_DN
7.31707317073%	3	41	720	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
7.31707317073%	3	41	701	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SMID_BREAST_CANCER_BASAL_DN
7.31707317073%	3	41	70	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_RENAL_CELL_CARCINOMA
7.31707317073%	3	41	70	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_PANCREATIC_CANCER
7.31707317073%	3	41	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_VEGFR1_2_PATHWAY
7.31707317073%	3	41	673	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARTINEZ_RB1_TARGETS_UP
7.31707317073%	3	41	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
7.31707317073%	3	41	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_BCR_5PATHWAY
7.31707317073%	3	41	648	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BENPORATH_CYCLING_GENES
7.31707317073%	3	41	63	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
7.31707317073%	3	41	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_COLORECTAL_CANCER
7.31707317073%	3	41	60	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_ACUTE_MYELOID_LEUKEMIA
7.31707317073%	3	41	584	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HAMAI_APOPTOSIS_VIA_TRAIL_UP
7.31707317073%	3	41	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_PPARA_PATHWAY
7.31707317073%	3	41	572	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHICAS_RB1_TARGETS_SENESCENT
7.31707317073%	3	41	564	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SMID_BREAST_CANCER_LUMINAL_B_DN
7.31707317073%	3	41	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_NFAT_PATHWAY
7.31707317073%	3	41	546	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WEST_ADRENOCORTICAL_TUMOR_DN
7.31707317073%	3	41	544	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
7.31707317073%	3	41	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_TCR_SIGNALING
7.31707317073%	3	41	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_NON_SMALL_CELL_LUNG_CANCER
7.31707317073%	3	41	537	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
7.31707317073%	3	41	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_KITPATHWAY
7.31707317073%	3	41	517	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RAO_BOUND_BY_SALL4_ISOFORM_B
7.31707317073%	3	41	491	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SWEET_LUNG_CANCER_KRAS_UP
7.31707317073%	3	41	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_PI3KCIPATHWAY
7.31707317073%	3	41	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_PI_METABOLISM
7.31707317073%	3	41	460	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
7.31707317073%	3	41	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SIG_BCR_SIGNALING_PATHWAY
7.31707317073%	3	41	455	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
7.31707317073%	3	41	442	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HAN_SATB1_TARGETS_DN
7.31707317073%	3	41	435	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SWEET_LUNG_CANCER_KRAS_DN
7.31707317073%	3	41	421	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_CELL_CYCLE
7.31707317073%	3	41	409	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FOSTER_TOLERANT_MACROPHAGE_DN
7.31707317073%	3	41	408	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
7.31707317073%	3	41	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ST_B_CELL_ANTIGEN_RECEPTOR
7.31707317073%	3	41	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
7.31707317073%	3	41	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_DOWNSTREAM_TCR_SIGNALING
7.31707317073%	3	41	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_MET_PATHWAY
7.31707317073%	3	41	36	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
7.31707317073%	3	41	341	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
7.31707317073%	3	41	336	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	JOHNSTONE_PARVB_TARGETS_2_DN
7.31707317073%	3	41	335	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WONG_EMBRYONIC_STEM_CELL_CORE
7.31707317073%	3	41	330	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
7.31707317073%	3	41	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_CD28_CO_STIMULATION
7.31707317073%	3	41	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE
7.31707317073%	3	41	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
7.31707317073%	3	41	298	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BROWNE_HCMV_INFECTION_14HR_DN
7.31707317073%	3	41	293	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HADDAD_B_LYMPHOCYTE_PROGENITOR
7.31707317073%	3	41	289	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WANG_MLL_TARGETS
7.31707317073%	3	41	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
7.31707317073%	3	41	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_VEGFR1_PATHWAY
7.31707317073%	3	41	243	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHICAS_RB1_TARGETS_GROWING
7.31707317073%	3	41	241	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
7.31707317073%	3	41	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_EIF4_PATHWAY
7.31707317073%	3	41	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_MTOR_PATHWAY
7.31707317073%	3	41	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_CTCF_PATHWAY
7.31707317073%	3	41	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING
7.31707317073%	3	41	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_PDGFRAPATHWAY
7.31707317073%	3	41	217	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SANSOM_APC_MYC_TARGETS
7.31707317073%	3	41	216	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
7.31707317073%	3	41	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_ECADHERIN_KERATINOCYTE_PATHWAY
7.31707317073%	3	41	208	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
7.31707317073%	3	41	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KARLSSON_TGFB1_TARGETS_DN
7.31707317073%	3	41	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_IGF1MTOR_PATHWAY
7.31707317073%	3	41	198	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_PHOSPHOLIPID_METABOLISM
7.31707317073%	3	41	190	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_CHEMOKINE_SIGNALING_PATHWAY
7.31707317073%	3	41	182	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FERNANDEZ_BOUND_BY_MYC
7.31707317073%	3	41	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_PTEN_PATHWAY
7.31707317073%	3	41	179	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
7.31707317073%	3	41	170	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
7.31707317073%	3	41	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SA_PTEN_PATHWAY
7.31707317073%	3	41	161	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
7.31707317073%	3	41	159	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
7.31707317073%	3	41	157	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
7.31707317073%	3	41	155	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_JAK_STAT_SIGNALING_PATHWAY
7.31707317073%	3	41	153	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DURAND_STROMA_MAX_DN
7.31707317073%	3	41	137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
7.31707317073%	3	41	129	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_PDGFRBPATHWAY
7.31707317073%	3	41	1278	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
7.31707317073%	3	41	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
7.31707317073%	3	41	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
7.31707317073%	3	41	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	XU_GH1_EXOGENOUS_TARGETS_DN
7.31707317073%	3	41	1142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
7.31707317073%	3	41	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
7.31707317073%	3	41	1037	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NUYTTEN_EZH2_TARGETS_UP
7.31707317073%	3	41	1024	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NUYTTEN_EZH2_TARGETS_DN
7.31707317073%	3	41	102	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_CXCR4_PATHWAY
7.31707317073%	3	41	102	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
7.31707317073%	3	41	1011	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
7.3137074517%	159	2174	1442	T2D_GENES_TANYA_LIPIDS	PUJANA_ATM_PCC_NETWORK
7.26884019241%	136	1871	1103	T2D_GENES_TANYA_HEIGHT	DANG_BOUND_BY_MYC
7.26172465961%	48	661	1382	T2D_GENES_TANYA_GLYCEMIC	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
7.25806451613%	9	124	911	Diabetes_McGill_Cell_cycle_All_Gene	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
7.25806451613%	9	124	89	Diabetes_McGill_Cell_cycle_All_Gene	ZHANG_TLX_TARGETS_UP
7.25806451613%	9	124	85	Diabetes_McGill_Cell_cycle_All_Gene	STEIN_ESR1_TARGETS
7.25806451613%	9	124	770	Diabetes_McGill_Cell_cycle_All_Gene	KRIEG_HYPOXIA_NOT_VIA_KDM3A
7.25806451613%	9	124	77	Diabetes_McGill_Cell_cycle_All_Gene	RIZ_ERYTHROID_DIFFERENTIATION
7.25806451613%	9	124	77	Diabetes_McGill_Cell_cycle_All_Gene	FRIDMAN_SENESCENCE_UP
7.25806451613%	9	124	77	Diabetes_McGill_Cell_cycle_All_Gene	CARD_MIR302A_TARGETS
7.25806451613%	9	124	70	Diabetes_McGill_Cell_cycle_All_Gene	VERNELL_RETINOBLASTOMA_PATHWAY_UP
7.25806451613%	9	124	69	Diabetes_McGill_Cell_cycle_All_Gene	PID_MTOR_4PATHWAY
7.25806451613%	9	124	602	Diabetes_McGill_Cell_cycle_All_Gene	MARTINEZ_TP53_TARGETS_UP
7.25806451613%	9	124	58	Diabetes_McGill_Cell_cycle_All_Gene	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
7.25806451613%	9	124	57	Diabetes_McGill_Cell_cycle_All_Gene	TANG_SENESCENCE_TP53_TARGETS_DN
7.25806451613%	9	124	544	Diabetes_McGill_Cell_cycle_All_Gene	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
7.25806451613%	9	124	54	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_NON_SMALL_CELL_LUNG_CANCER
7.25806451613%	9	124	514	Diabetes_McGill_Cell_cycle_All_Gene	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
7.25806451613%	9	124	51	Diabetes_McGill_Cell_cycle_All_Gene	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
7.25806451613%	9	124	41	Diabetes_McGill_Cell_cycle_All_Gene	KAMMINGA_EZH2_TARGETS
7.25806451613%	9	124	390	Diabetes_McGill_Cell_cycle_All_Gene	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
7.25806451613%	9	124	37	Diabetes_McGill_Cell_cycle_All_Gene	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
7.25806451613%	9	124	36	Diabetes_McGill_Cell_cycle_All_Gene	PID_PI3KPLCTRKPATHWAY
7.25806451613%	9	124	34	Diabetes_McGill_Cell_cycle_All_Gene	PID_ATM_PATHWAY
7.25806451613%	9	124	293	Diabetes_McGill_Cell_cycle_All_Gene	HADDAD_B_LYMPHOCYTE_PROGENITOR
7.25806451613%	9	124	288	Diabetes_McGill_Cell_cycle_All_Gene	POOLA_INVASIVE_BREAST_CANCER_UP
7.25806451613%	9	124	281	Diabetes_McGill_Cell_cycle_All_Gene	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
7.25806451613%	9	124	267	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_MAPK_SIGNALING_PATHWAY
7.25806451613%	9	124	241	Diabetes_McGill_Cell_cycle_All_Gene	DOANE_RESPONSE_TO_ANDROGEN_DN
7.25806451613%	9	124	23	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_CTCF_PATHWAY
7.25806451613%	9	124	22	Diabetes_McGill_Cell_cycle_All_Gene	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN
7.25806451613%	9	124	195	Diabetes_McGill_Cell_cycle_All_Gene	KYNG_DNA_DAMAGE_DN
7.25806451613%	9	124	172	Diabetes_McGill_Cell_cycle_All_Gene	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
7.25806451613%	9	124	172	Diabetes_McGill_Cell_cycle_All_Gene	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
7.25806451613%	9	124	153	Diabetes_McGill_Cell_cycle_All_Gene	DAZARD_UV_RESPONSE_CLUSTER_G6
7.25806451613%	9	124	151	Diabetes_McGill_Cell_cycle_All_Gene	IGLESIAS_E2F_TARGETS_UP
7.25806451613%	9	124	143	Diabetes_McGill_Cell_cycle_All_Gene	DANG_MYC_TARGETS_UP
7.25806451613%	9	124	14	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX
7.25806451613%	9	124	129	Diabetes_McGill_Cell_cycle_All_Gene	PID_PDGFRBPATHWAY
7.25806451613%	9	124	126	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
7.25806451613%	9	124	12	Diabetes_McGill_Cell_cycle_All_Gene	WAESCH_ANAPHASE_PROMOTING_COMPLEX
7.25806451613%	9	124	1174	Diabetes_McGill_Cell_cycle_All_Gene	PEREZ_TP53_TARGETS
7.25806451613%	9	124	1142	Diabetes_McGill_Cell_cycle_All_Gene	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
7.25806451613%	9	124	112	Diabetes_McGill_Cell_cycle_All_Gene	LABBE_WNT3A_TARGETS_UP
7.25806451613%	9	124	105	Diabetes_McGill_Cell_cycle_All_Gene	AMUNDSON_GENOTOXIC_SIGNATURE
7.25806451613%	9	124	10	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION
7.25806451613%	9	124	10	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_SKP2E2F_PATHWAY
7.25274725275%	33	455	988	T2D_GENES_TANYA_BLOODPRESSURE	BENPORATH_NANOG_TARGETS
7.25274725275%	33	455	1442	T2D_GENES_TANYA_BLOODPRESSURE	PUJANA_ATM_PCC_NETWORK
7.25274725275%	33	455	140	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
7.19557195572%	39	542	1305	T2D_GENES_TANYA_ANTHROPOMETRIC	YOSHIMURA_MAPK8_TARGETS_UP
7.19351570415%	142	1974	957	Mendelian_Nancy_Cox	LOPEZ_MBD_TARGETS
7.17781402936%	44	613	1781	T2D_GENES_TANYA_BIOMARKER	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
7.17781402936%	44	613	1305	T2D_GENES_TANYA_BIOMARKER	YOSHIMURA_MAPK8_TARGETS_UP
7.1619454837%	134	1871	1725	T2D_GENES_TANYA_HEIGHT	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
7.14285714286%	5	70	98	Diabetes_McGill_Adipocytokine_signallin	GUO_TARGETS_OF_IRS1_AND_IRS2
7.14285714286%	5	70	940	Diabetes_McGill_Adipocytokine_signallin	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
7.14285714286%	5	70	911	Diabetes_McGill_Adipocytokine_signallin	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
7.14285714286%	5	70	91	Diabetes_McGill_Adipocytokine_signallin	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
7.14285714286%	5	70	90	Diabetes_McGill_Adipocytokine_signallin	HILLION_HMGA1_TARGETS
7.14285714286%	5	70	855	Diabetes_McGill_Adipocytokine_signallin	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
7.14285714286%	5	70	830	Diabetes_McGill_Adipocytokine_signallin	CUI_TCF21_TARGETS_2_DN
7.14285714286%	5	70	80	Diabetes_McGill_Adipocytokine_signallin	PID_MET_PATHWAY
7.14285714286%	5	70	78	Diabetes_McGill_Adipocytokine_signallin	KEGG_PEROXISOME
7.14285714286%	5	70	76	Diabetes_McGill_Adipocytokine_signallin	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
7.14285714286%	5	70	720	Diabetes_McGill_Adipocytokine_signallin	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
7.14285714286%	5	70	70	Diabetes_McGill_Adipocytokine_signallin	KEGG_RENAL_CELL_CARCINOMA
7.14285714286%	5	70	69	Diabetes_McGill_Adipocytokine_signallin	PID_MTOR_4PATHWAY
7.14285714286%	5	70	658	Diabetes_McGill_Adipocytokine_signallin	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
7.14285714286%	5	70	634	Diabetes_McGill_Adipocytokine_signallin	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
7.14285714286%	5	70	63	Diabetes_McGill_Adipocytokine_signallin	PID_IL12_2PATHWAY
7.14285714286%	5	70	602	Diabetes_McGill_Adipocytokine_signallin	MARTINEZ_TP53_TARGETS_UP
7.14285714286%	5	70	56	Diabetes_McGill_Adipocytokine_signallin	REACTOME_PI_3K_CASCADE
7.14285714286%	5	70	544	Diabetes_McGill_Adipocytokine_signallin	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
7.14285714286%	5	70	53	Diabetes_McGill_Adipocytokine_signallin	PID_CD8TCRPATHWAY
7.14285714286%	5	70	52	Diabetes_McGill_Adipocytokine_signallin	PID_KITPATHWAY
7.14285714286%	5	70	510	Diabetes_McGill_Adipocytokine_signallin	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
7.14285714286%	5	70	491	Diabetes_McGill_Adipocytokine_signallin	SWEET_LUNG_CANCER_KRAS_UP
7.14285714286%	5	70	485	Diabetes_McGill_Adipocytokine_signallin	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
7.14285714286%	5	70	485	Diabetes_McGill_Adipocytokine_signallin	ENK_UV_RESPONSE_KERATINOCYTE_DN
7.14285714286%	5	70	473	Diabetes_McGill_Adipocytokine_signallin	GARY_CD5_TARGETS_UP
7.14285714286%	5	70	47	Diabetes_McGill_Adipocytokine_signallin	PID_IL6_7PATHWAY
7.14285714286%	5	70	45	Diabetes_McGill_Adipocytokine_signallin	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
7.14285714286%	5	70	44	Diabetes_McGill_Adipocytokine_signallin	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
7.14285714286%	5	70	435	Diabetes_McGill_Adipocytokine_signallin	SWEET_LUNG_CANCER_KRAS_DN
7.14285714286%	5	70	434	Diabetes_McGill_Adipocytokine_signallin	BAELDE_DIABETIC_NEPHROPATHY_DN
7.14285714286%	5	70	430	Diabetes_McGill_Adipocytokine_signallin	JOHNSTONE_PARVB_TARGETS_3_UP
7.14285714286%	5	70	413	Diabetes_McGill_Adipocytokine_signallin	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
7.14285714286%	5	70	409	Diabetes_McGill_Adipocytokine_signallin	FOSTER_TOLERANT_MACROPHAGE_DN
7.14285714286%	5	70	40	Diabetes_McGill_Adipocytokine_signallin	PID_IFNGPATHWAY
7.14285714286%	5	70	38	Diabetes_McGill_Adipocytokine_signallin	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS
7.14285714286%	5	70	38	Diabetes_McGill_Adipocytokine_signallin	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
7.14285714286%	5	70	38	Diabetes_McGill_Adipocytokine_signallin	REACTOME_GLUCOSE_TRANSPORT
7.14285714286%	5	70	38	Diabetes_McGill_Adipocytokine_signallin	REACTOME_GAB1_SIGNALOSOME
7.14285714286%	5	70	366	Diabetes_McGill_Adipocytokine_signallin	YOSHIMURA_MAPK8_TARGETS_DN
7.14285714286%	5	70	36	Diabetes_McGill_Adipocytokine_signallin	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
7.14285714286%	5	70	34	Diabetes_McGill_Adipocytokine_signallin	PID_IL2_PI3KPATHWAY
7.14285714286%	5	70	323	Diabetes_McGill_Adipocytokine_signallin	GRESHOCK_CANCER_COPY_NUMBER_UP
7.14285714286%	5	70	31	Diabetes_McGill_Adipocytokine_signallin	PID_AVB3_OPN_PATHWAY
7.14285714286%	5	70	30	Diabetes_McGill_Adipocytokine_signallin	PID_RETINOIC_ACID_PATHWAY
7.14285714286%	5	70	293	Diabetes_McGill_Adipocytokine_signallin	ENK_UV_RESPONSE_EPIDERMIS_UP
7.14285714286%	5	70	29	Diabetes_McGill_Adipocytokine_signallin	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
7.14285714286%	5	70	29	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_TNFR1_PATHWAY
7.14285714286%	5	70	27	Diabetes_McGill_Adipocytokine_signallin	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
7.14285714286%	5	70	267	Diabetes_McGill_Adipocytokine_signallin	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
7.14285714286%	5	70	26	Diabetes_McGill_Adipocytokine_signallin	PID_RXR_VDR_PATHWAY
7.14285714286%	5	70	242	Diabetes_McGill_Adipocytokine_signallin	WINTER_HYPOXIA_METAGENE
7.14285714286%	5	70	241	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
7.14285714286%	5	70	24	Diabetes_McGill_Adipocytokine_signallin	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING
7.14285714286%	5	70	233	Diabetes_McGill_Adipocytokine_signallin	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
7.14285714286%	5	70	222	Diabetes_McGill_Adipocytokine_signallin	CAIRO_LIVER_DEVELOPMENT_DN
7.14285714286%	5	70	221	Diabetes_McGill_Adipocytokine_signallin	ZHANG_TLX_TARGETS_36HR_UP
7.14285714286%	5	70	208	Diabetes_McGill_Adipocytokine_signallin	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
7.14285714286%	5	70	1821	Diabetes_McGill_Adipocytokine_signallin	DODD_NASOPHARYNGEAL_CARCINOMA_UP
7.14285714286%	5	70	18	Diabetes_McGill_Adipocytokine_signallin	SCHEIDEREIT_IKK_TARGETS
7.14285714286%	5	70	18	Diabetes_McGill_Adipocytokine_signallin	REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS
7.14285714286%	5	70	1652	Diabetes_McGill_Adipocytokine_signallin	PUJANA_BRCA1_PCC_NETWORK
7.14285714286%	5	70	15	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_TALL1_PATHWAY
7.14285714286%	5	70	14	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS
7.14285714286%	5	70	1375	Diabetes_McGill_Adipocytokine_signallin	DODD_NASOPHARYNGEAL_CARCINOMA_DN
7.14285714286%	5	70	1210	Diabetes_McGill_Adipocytokine_signallin	CHEN_METABOLIC_SYNDROM_NETWORK
7.14285714286%	5	70	112	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SIGNALING_BY_FGFR
7.14285714286%	5	70	1118	Diabetes_McGill_Adipocytokine_signallin	BENPORATH_ES_WITH_H3K27ME3
7.14285714286%	5	70	109	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
7.14285714286%	5	70	1069	Diabetes_McGill_Adipocytokine_signallin	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
7.14285714286%	5	70	105	Diabetes_McGill_Adipocytokine_signallin	PID_ERBB1_DOWNSTREAM_PATHWAY
7.14285714286%	5	70	1038	Diabetes_McGill_Adipocytokine_signallin	BENPORATH_SUZ12_TARGETS
7.14285714286%	5	70	102	Diabetes_McGill_Adipocytokine_signallin	PID_CXCR4_PATHWAY
7.14285714286%	5	70	101	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SIGNALING_BY_ERBB2
7.14285714286%	5	70	100	Diabetes_McGill_Adipocytokine_signallin	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
7.14285714286%	5	70	10	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_SODD_PATHWAY
7.14285714286%	3	42	97	Diabetes_McGill_RAS	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
7.14285714286%	3	42	95	Diabetes_McGill_RAS	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
7.14285714286%	3	42	920	Diabetes_McGill_RAS	REACTOME_SIGNALING_BY_GPCR
7.14285714286%	3	42	92	Diabetes_McGill_RAS	CAMPS_COLON_CANCER_COPY_NUMBER_UP
7.14285714286%	3	42	91	Diabetes_McGill_RAS	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
7.14285714286%	3	42	90	Diabetes_McGill_RAS	REACTOME_SIGNALING_BY_ERBB4
7.14285714286%	3	42	90	Diabetes_McGill_RAS	KEGG_GAP_JUNCTION
7.14285714286%	3	42	89	Diabetes_McGill_RAS	KEGG_PROSTATE_CANCER
7.14285714286%	3	42	882	Diabetes_McGill_RAS	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
7.14285714286%	3	42	87	Diabetes_McGill_RAS	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
7.14285714286%	3	42	87	Diabetes_McGill_RAS	KEGG_ERBB_SIGNALING_PATHWAY
7.14285714286%	3	42	855	Diabetes_McGill_RAS	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
7.14285714286%	3	42	84	Diabetes_McGill_RAS	PID_CMYB_PATHWAY
7.14285714286%	3	42	80	Diabetes_McGill_RAS	PID_MET_PATHWAY
7.14285714286%	3	42	79	Diabetes_McGill_RAS	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
7.14285714286%	3	42	78	Diabetes_McGill_RAS	REACTOME_SIGNALING_BY_SCF_KIT
7.14285714286%	3	42	775	Diabetes_McGill_RAS	BENPORATH_MYC_MAX_TARGETS
7.14285714286%	3	42	76	Diabetes_McGill_RAS	KEGG_VEGF_SIGNALING_PATHWAY
7.14285714286%	3	42	756	Diabetes_McGill_RAS	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
7.14285714286%	3	42	75	Diabetes_McGill_RAS	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
7.14285714286%	3	42	745	Diabetes_McGill_RAS	LEE_BMP2_TARGETS_UP
7.14285714286%	3	42	73	Diabetes_McGill_RAS	KEGG_CHRONIC_MYELOID_LEUKEMIA
7.14285714286%	3	42	71	Diabetes_McGill_RAS	KEGG_MELANOMA
7.14285714286%	3	42	70	Diabetes_McGill_RAS	KEGG_PANCREATIC_CANCER
7.14285714286%	3	42	70	Diabetes_McGill_RAS	KEGG_LONG_TERM_DEPRESSION
7.14285714286%	3	42	69	Diabetes_McGill_RAS	PID_MTOR_4PATHWAY
7.14285714286%	3	42	65	Diabetes_McGill_RAS	PID_CD8TCRDOWNSTREAMPATHWAY
7.14285714286%	3	42	65	Diabetes_McGill_RAS	KEGG_GLIOMA
7.14285714286%	3	42	64	Diabetes_McGill_RAS	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
7.14285714286%	3	42	60	Diabetes_McGill_RAS	KEGG_ACUTE_MYELOID_LEUKEMIA
7.14285714286%	3	42	59	Diabetes_McGill_RAS	PID_FAK_PATHWAY
7.14285714286%	3	42	58	Diabetes_McGill_RAS	PID_SHP2_PATHWAY
7.14285714286%	3	42	578	Diabetes_McGill_RAS	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
7.14285714286%	3	42	567	Diabetes_McGill_RAS	CHICAS_RB1_TARGETS_CONFLUENT
7.14285714286%	3	42	564	Diabetes_McGill_RAS	SMID_BREAST_CANCER_LUMINAL_B_DN
7.14285714286%	3	42	55	Diabetes_McGill_RAS	PID_IL2_1PATHWAY
7.14285714286%	3	42	549	Diabetes_McGill_RAS	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
7.14285714286%	3	42	546	Diabetes_McGill_RAS	WEST_ADRENOCORTICAL_TUMOR_DN
7.14285714286%	3	42	52	Diabetes_McGill_RAS	KEGG_ENDOMETRIAL_CANCER
7.14285714286%	3	42	516	Diabetes_McGill_RAS	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
7.14285714286%	3	42	504	Diabetes_McGill_RAS	BROWNE_HCMV_INFECTION_48HR_DN
7.14285714286%	3	42	489	Diabetes_McGill_RAS	LIM_MAMMARY_STEM_CELL_UP
7.14285714286%	3	42	487	Diabetes_McGill_RAS	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
7.14285714286%	3	42	482	Diabetes_McGill_RAS	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
7.14285714286%	3	42	481	Diabetes_McGill_RAS	LIU_PROSTATE_CANCER_DN
7.14285714286%	3	42	44	Diabetes_McGill_RAS	REACTOME_SIGNALING_BY_FGFR_MUTANTS
7.14285714286%	3	42	44	Diabetes_McGill_RAS	PID_ERBB2ERBB3PATHWAY
7.14285714286%	3	42	43	Diabetes_McGill_RAS	PID_CXCR3PATHWAY
7.14285714286%	3	42	428	Diabetes_McGill_RAS	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
7.14285714286%	3	42	425	Diabetes_McGill_RAS	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
7.14285714286%	3	42	423	Diabetes_McGill_RAS	THUM_SYSTOLIC_HEART_FAILURE_UP
7.14285714286%	3	42	418	Diabetes_McGill_RAS	PEDRIOLI_MIR31_TARGETS_DN
7.14285714286%	3	42	411	Diabetes_McGill_RAS	KOYAMA_SEMA3B_TARGETS_DN
7.14285714286%	3	42	41	Diabetes_McGill_RAS	REACTOME_IL_2_SIGNALING
7.14285714286%	3	42	41	Diabetes_McGill_RAS	PID_ER_NONGENOMIC_PATHWAY
7.14285714286%	3	42	41	Diabetes_McGill_RAS	PID_ERBB1_INTERNALIZATION_PATHWAY
7.14285714286%	3	42	408	Diabetes_McGill_RAS	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
7.14285714286%	3	42	403	Diabetes_McGill_RAS	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
7.14285714286%	3	42	380	Diabetes_McGill_RAS	MULLIGHAN_MLL_SIGNATURE_1_UP
7.14285714286%	3	42	378	Diabetes_McGill_RAS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
7.14285714286%	3	42	37	Diabetes_McGill_RAS	PID_GMCSF_PATHWAY
7.14285714286%	3	42	37	Diabetes_McGill_RAS	BIOCARTA_MET_PATHWAY
7.14285714286%	3	42	36	Diabetes_McGill_RAS	REACTOME_FRS2_MEDIATED_CASCADE
7.14285714286%	3	42	36	Diabetes_McGill_RAS	PID_PI3KPLCTRKPATHWAY
7.14285714286%	3	42	35	Diabetes_McGill_RAS	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
7.14285714286%	3	42	344	Diabetes_McGill_RAS	RICKMAN_METASTASIS_UP
7.14285714286%	3	42	336	Diabetes_McGill_RAS	JOHNSTONE_PARVB_TARGETS_2_DN
7.14285714286%	3	42	323	Diabetes_McGill_RAS	GRESHOCK_CANCER_COPY_NUMBER_UP
7.14285714286%	3	42	314	Diabetes_McGill_RAS	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
7.14285714286%	3	42	312	Diabetes_McGill_RAS	GENTILE_UV_HIGH_DOSE_DN
7.14285714286%	3	42	305	Diabetes_McGill_RAS	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
7.14285714286%	3	42	29	Diabetes_McGill_RAS	KEGG_THYROID_CANCER
7.14285714286%	3	42	28	Diabetes_McGill_RAS	REACTOME_SHC_MEDIATED_CASCADE
7.14285714286%	3	42	279	Diabetes_McGill_RAS	FORTSCHEGGER_PHF8_TARGETS_UP
7.14285714286%	3	42	270	Diabetes_McGill_RAS	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
7.14285714286%	3	42	244	Diabetes_McGill_RAS	DAZARD_RESPONSE_TO_UV_NHEK_UP
7.14285714286%	3	42	22	Diabetes_McGill_RAS	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING
7.14285714286%	3	42	205	Diabetes_McGill_RAS	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
7.14285714286%	3	42	201	Diabetes_McGill_RAS	KEGG_FOCAL_ADHESION
7.14285714286%	3	42	20	Diabetes_McGill_RAS	REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING
7.14285714286%	3	42	1839	Diabetes_McGill_RAS	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
7.14285714286%	3	42	18	Diabetes_McGill_RAS	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR
7.14285714286%	3	42	1725	Diabetes_McGill_RAS	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
7.14285714286%	3	42	17	Diabetes_McGill_RAS	REACTOME_TIE2_SIGNALING
7.14285714286%	3	42	17	Diabetes_McGill_RAS	REACTOME_SHC_RELATED_EVENTS
7.14285714286%	3	42	166	Diabetes_McGill_RAS	SMIRNOV_RESPONSE_TO_IR_6HR_UP
7.14285714286%	3	42	151	Diabetes_McGill_RAS	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
7.14285714286%	3	42	15	Diabetes_McGill_RAS	REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN
7.14285714286%	3	42	15	Diabetes_McGill_RAS	REACTOME_SHC_MEDIATED_SIGNALLING
7.14285714286%	3	42	15	Diabetes_McGill_RAS	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING
7.14285714286%	3	42	14	Diabetes_McGill_RAS	REACTOME_SOS_MEDIATED_SIGNALLING
7.14285714286%	3	42	14	Diabetes_McGill_RAS	PID_TCRRASPATHWAY
7.14285714286%	3	42	137	Diabetes_McGill_RAS	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
7.14285714286%	3	42	137	Diabetes_McGill_RAS	KEGG_INSULIN_SIGNALING_PATHWAY
7.14285714286%	3	42	1305	Diabetes_McGill_RAS	YOSHIMURA_MAPK8_TARGETS_UP
7.14285714286%	3	42	129	Diabetes_McGill_RAS	KEGG_AXON_GUIDANCE
7.14285714286%	3	42	127	Diabetes_McGill_RAS	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
7.14285714286%	3	42	126	Diabetes_McGill_RAS	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
7.14285714286%	3	42	1237	Diabetes_McGill_RAS	BLALOCK_ALZHEIMERS_DISEASE_DN
7.14285714286%	3	42	122	Diabetes_McGill_RAS	REACTOME_SIGNALING_BY_PDGF
7.14285714286%	3	42	118	Diabetes_McGill_RAS	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
7.14285714286%	3	42	116	Diabetes_McGill_RAS	IKEDA_MIR30_TARGETS_UP
7.14285714286%	3	42	112	Diabetes_McGill_RAS	REACTOME_SIGNALING_BY_FGFR
7.14285714286%	3	42	1103	Diabetes_McGill_RAS	DANG_BOUND_BY_MYC
7.14285714286%	3	42	109	Diabetes_McGill_RAS	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
7.14285714286%	3	42	108	Diabetes_McGill_RAS	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
7.14285714286%	3	42	108	Diabetes_McGill_RAS	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
7.14285714286%	3	42	107	Diabetes_McGill_RAS	REACTOME_SIGNALING_BY_ILS
7.14285714286%	3	42	1024	Diabetes_McGill_RAS	NUYTTEN_EZH2_TARGETS_DN
7.14285714286%	3	42	102	Diabetes_McGill_RAS	KEGG_MELANOGENESIS
7.14285714286%	3	42	101	Diabetes_McGill_RAS	REACTOME_SIGNALING_BY_ERBB2
7.14285714286%	3	42	101	Diabetes_McGill_RAS	KEGG_GNRH_SIGNALING_PATHWAY
7.14285714286%	3	42	100	Diabetes_McGill_RAS	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
7.14285714286%	3	42	10	Diabetes_McGill_RAS	REACTOME_RAF_MAP_KINASE_CASCADE
7.14285714286%	2	28	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_POTASSIUM_CHANNELS
7.14285714286%	2	28	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GUO_TARGETS_OF_IRS1_AND_IRS2
7.14285714286%	2	28	98	Diabetes_McGill_Cell_cycle_G1	PYEON_HPV_POSITIVE_TUMORS_UP
7.14285714286%	2	28	97	Diabetes_McGill_Cell_cycle_G1	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
7.14285714286%	2	28	97	Diabetes_McGill_Cell_cycle_G1	KONG_E2F3_TARGETS
7.14285714286%	2	28	95	Diabetes_McGill_Cell_cycle_G1	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
7.14285714286%	2	28	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KIM_MYCN_AMPLIFICATION_TARGETS_UP
7.14285714286%	2	28	92	Diabetes_McGill_Cell_cycle_G1	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
7.14285714286%	2	28	918	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	JOHNSTONE_PARVB_TARGETS_3_DN
7.14285714286%	2	28	91	Diabetes_McGill_Cell_cycle_G1	ZHU_CMV_24_HR_DN
7.14285714286%	2	28	90	Diabetes_McGill_Cell_cycle_G1	MORI_IMMATURE_B_LYMPHOCYTE_DN
7.14285714286%	2	28	90	Diabetes_McGill_Cell_cycle_G1	IVANOVSKA_MIR106B_TARGETS
7.14285714286%	2	28	9	Diabetes_McGill_Cell_cycle_G1	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP
7.14285714286%	2	28	89	Diabetes_McGill_Cell_cycle_G1	WNT_SIGNALING
7.14285714286%	2	28	89	Diabetes_McGill_Cell_cycle_G1	SWEET_KRAS_ONCOGENIC_SIGNATURE
7.14285714286%	2	28	89	Diabetes_McGill_Cell_cycle_G1	KANG_IMMORTALIZED_BY_TERT_UP
7.14285714286%	2	28	89	Diabetes_McGill_Cell_cycle_G1	DELASERNA_MYOD_TARGETS_UP
7.14285714286%	2	28	882	Diabetes_McGill_Cell_cycle_G1	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
7.14285714286%	2	28	882	Diabetes_McGill_Cell_cycle_G1	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
7.14285714286%	2	28	88	Diabetes_McGill_Cell_cycle_G1	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
7.14285714286%	2	28	88	Diabetes_McGill_Cell_cycle_G1	KEGG_APOPTOSIS
7.14285714286%	2	28	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
7.14285714286%	2	28	87	Diabetes_McGill_Cell_cycle_G1	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
7.14285714286%	2	28	86	Diabetes_McGill_Cell_cycle_G1	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
7.14285714286%	2	28	85	Diabetes_McGill_Cell_cycle_G1	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
7.14285714286%	2	28	85	Diabetes_McGill_Cell_cycle_G1	STEIN_ESR1_TARGETS
7.14285714286%	2	28	848	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	NUYTTEN_NIPP1_TARGETS_DN
7.14285714286%	2	28	841	Diabetes_McGill_Cell_cycle_G1	MARTENS_TRETINOIN_RESPONSE_DN
7.14285714286%	2	28	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHANG_IMMORTALIZED_BY_HPV31_UP
7.14285714286%	2	28	84	Diabetes_McGill_Cell_cycle_G1	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
7.14285714286%	2	28	84	Diabetes_McGill_Cell_cycle_G1	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
7.14285714286%	2	28	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
7.14285714286%	2	28	82	Diabetes_McGill_Cell_cycle_G1	ST_INTEGRIN_SIGNALING_PATHWAY
7.14285714286%	2	28	82	Diabetes_McGill_Cell_cycle_G1	BHAT_ESR1_TARGETS_VIA_AKT1_DN
7.14285714286%	2	28	81	Diabetes_McGill_Cell_cycle_G1	REACTOME_M_G1_TRANSITION
7.14285714286%	2	28	800	Diabetes_McGill_Cell_cycle_G1	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
7.14285714286%	2	28	80	Diabetes_McGill_Cell_cycle_G1	MORI_PRE_BI_LYMPHOCYTE_UP
7.14285714286%	2	28	80	Diabetes_McGill_Cell_cycle_G1	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
7.14285714286%	2	28	80	Diabetes_McGill_Cell_cycle_G1	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
7.14285714286%	2	28	8	Diabetes_McGill_Cell_cycle_G1	TCGA_GLIOBLASTOMA_MUTATED
7.14285714286%	2	28	8	Diabetes_McGill_Cell_cycle_G1	OHM_EMBRYONIC_CARCINOMA_DN
7.14285714286%	2	28	8	Diabetes_McGill_Cell_cycle_G1	MATZUK_LUTEAL_GENES
7.14285714286%	2	28	770	Diabetes_McGill_Cell_cycle_G1	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
7.14285714286%	2	28	77	Diabetes_McGill_Cell_cycle_G1	RIZ_ERYTHROID_DIFFERENTIATION
7.14285714286%	2	28	77	Diabetes_McGill_Cell_cycle_G1	JACKSON_DNMT1_TARGETS_UP
7.14285714286%	2	28	769	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	NUYTTEN_NIPP1_TARGETS_UP
7.14285714286%	2	28	76	Diabetes_McGill_Cell_cycle_G1	PEART_HDAC_PROLIFERATION_CLUSTER_DN
7.14285714286%	2	28	75	Diabetes_McGill_Cell_cycle_G1	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
7.14285714286%	2	28	75	Diabetes_McGill_Cell_cycle_G1	KEGG_ADHERENS_JUNCTION
7.14285714286%	2	28	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	URS_ADIPOCYTE_DIFFERENTIATION_UP
7.14285714286%	2	28	73	Diabetes_McGill_Cell_cycle_G1	KEGG_VIRAL_MYOCARDITIS
7.14285714286%	2	28	720	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
7.14285714286%	2	28	72	Diabetes_McGill_Cell_cycle_G1	SESTO_RESPONSE_TO_UV_C1
7.14285714286%	2	28	72	Diabetes_McGill_Cell_cycle_G1	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
7.14285714286%	2	28	72	Diabetes_McGill_Cell_cycle_G1	DANG_REGULATED_BY_MYC_UP
7.14285714286%	2	28	712	Diabetes_McGill_Cell_cycle_G1	SCHLOSSER_SERUM_RESPONSE_DN
7.14285714286%	2	28	71	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_PI3K_CASCADE
7.14285714286%	2	28	701	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SMID_BREAST_CANCER_BASAL_DN
7.14285714286%	2	28	70	Diabetes_McGill_Cell_cycle_G1	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
7.14285714286%	2	28	7	Diabetes_McGill_Cell_cycle_G1	BUSA_SAM68_TARGETS_UP
7.14285714286%	2	28	7	Diabetes_McGill_Cell_cycle_G1	BAKER_HEMATOPOESIS_STAT5_TARGETS
7.14285714286%	2	28	69	Diabetes_McGill_Cell_cycle_G1	ZAMORA_NOS2_TARGETS_UP
7.14285714286%	2	28	69	Diabetes_McGill_Cell_cycle_G1	PID_P75NTRPATHWAY
7.14285714286%	2	28	69	Diabetes_McGill_Cell_cycle_G1	PID_MTOR_4PATHWAY
7.14285714286%	2	28	682	Diabetes_McGill_Cell_cycle_G1	FEVR_CTNNB1_TARGETS_UP
7.14285714286%	2	28	673	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARTINEZ_RB1_TARGETS_UP
7.14285714286%	2	28	67	Diabetes_McGill_Cell_cycle_G1	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
7.14285714286%	2	28	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_HIF1_TFPATHWAY
7.14285714286%	2	28	66	Diabetes_McGill_Cell_cycle_G1	PID_HIF1_TFPATHWAY
7.14285714286%	2	28	658	Diabetes_McGill_Cell_cycle_G1	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
7.14285714286%	2	28	64	Diabetes_McGill_Cell_cycle_G1	ZHAN_MULTIPLE_MYELOMA_UP
7.14285714286%	2	28	64	Diabetes_McGill_Cell_cycle_G1	RHODES_CANCER_META_SIGNATURE
7.14285714286%	2	28	64	Diabetes_McGill_Cell_cycle_G1	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
7.14285714286%	2	28	64	Diabetes_McGill_Cell_cycle_G1	GERHOLD_ADIPOGENESIS_DN
7.14285714286%	2	28	63	Diabetes_McGill_Cell_cycle_G1	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
7.14285714286%	2	28	62	Diabetes_McGill_Cell_cycle_G1	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP
7.14285714286%	2	28	62	Diabetes_McGill_Cell_cycle_G1	PID_TRKRPATHWAY
7.14285714286%	2	28	60	Diabetes_McGill_Cell_cycle_G1	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
7.14285714286%	2	28	60	Diabetes_McGill_Cell_cycle_G1	KEGG_ACUTE_MYELOID_LEUKEMIA
7.14285714286%	2	28	6	Diabetes_McGill_Cell_cycle_G1	ZERBINI_RESPONSE_TO_SULINDAC_DN
7.14285714286%	2	28	59	Diabetes_McGill_Cell_cycle_G1	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
7.14285714286%	2	28	584	Diabetes_McGill_Cell_cycle_G1	HAMAI_APOPTOSIS_VIA_TRAIL_UP
7.14285714286%	2	28	58	Diabetes_McGill_Cell_cycle_G1	SANSOM_WNT_PATHWAY_REQUIRE_MYC
7.14285714286%	2	28	58	Diabetes_McGill_Cell_cycle_G1	JI_RESPONSE_TO_FSH_DN
7.14285714286%	2	28	58	Diabetes_McGill_Cell_cycle_G1	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
7.14285714286%	2	28	57	Diabetes_McGill_Cell_cycle_G1	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
7.14285714286%	2	28	57	Diabetes_McGill_Cell_cycle_G1	TANG_SENESCENCE_TP53_TARGETS_DN
7.14285714286%	2	28	57	Diabetes_McGill_Cell_cycle_G1	PEART_HDAC_PROLIFERATION_CLUSTER_UP
7.14285714286%	2	28	57	Diabetes_McGill_Cell_cycle_G1	BORLAK_LIVER_CANCER_EGF_UP
7.14285714286%	2	28	567	Diabetes_McGill_Cell_cycle_G1	CHICAS_RB1_TARGETS_CONFLUENT
7.14285714286%	2	28	56	Diabetes_McGill_Cell_cycle_G1	REACTOME_PI_3K_CASCADE
7.14285714286%	2	28	56	Diabetes_McGill_Cell_cycle_G1	LY_AGING_OLD_DN
7.14285714286%	2	28	56	Diabetes_McGill_Cell_cycle_G1	HOQUE_METHYLATED_IN_CANCER
7.14285714286%	2	28	55	Diabetes_McGill_Cell_cycle_G1	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53
7.14285714286%	2	28	55	Diabetes_McGill_Cell_cycle_G1	KEGG_BASAL_CELL_CARCINOMA
7.14285714286%	2	28	546	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WEST_ADRENOCORTICAL_TUMOR_DN
7.14285714286%	2	28	537	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
7.14285714286%	2	28	532	Diabetes_McGill_Cell_cycle_G1	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
7.14285714286%	2	28	53	Diabetes_McGill_Cell_cycle_G1	SMIRNOV_RESPONSE_TO_IR_2HR_UP
7.14285714286%	2	28	53	Diabetes_McGill_Cell_cycle_G1	PID_AR_TF_PATHWAY
7.14285714286%	2	28	53	Diabetes_McGill_Cell_cycle_G1	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
7.14285714286%	2	28	526	Diabetes_McGill_Cell_cycle_G1	ONKEN_UVEAL_MELANOMA_DN
7.14285714286%	2	28	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_PTP1BPATHWAY
7.14285714286%	2	28	510	Diabetes_McGill_Cell_cycle_G1	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
7.14285714286%	2	28	51	Diabetes_McGill_Cell_cycle_G1	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
7.14285714286%	2	28	51	Diabetes_McGill_Cell_cycle_G1	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
7.14285714286%	2	28	51	Diabetes_McGill_Cell_cycle_G1	REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT
7.14285714286%	2	28	51	Diabetes_McGill_Cell_cycle_G1	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1
7.14285714286%	2	28	508	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ENK_UV_RESPONSE_EPIDERMIS_DN
7.14285714286%	2	28	505	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
7.14285714286%	2	28	504	Diabetes_McGill_Cell_cycle_G1	BROWNE_HCMV_INFECTION_48HR_DN
7.14285714286%	2	28	50	Diabetes_McGill_Cell_cycle_G1	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN
7.14285714286%	2	28	491	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SWEET_LUNG_CANCER_KRAS_UP
7.14285714286%	2	28	491	Diabetes_McGill_Cell_cycle_G1	SWEET_LUNG_CANCER_KRAS_UP
7.14285714286%	2	28	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
7.14285714286%	2	28	485	Diabetes_McGill_Cell_cycle_G1	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
7.14285714286%	2	28	481	Diabetes_McGill_Cell_cycle_G1	LIU_PROSTATE_CANCER_DN
7.14285714286%	2	28	48	Diabetes_McGill_Cell_cycle_G1	RICKMAN_HEAD_AND_NECK_CANCER_B
7.14285714286%	2	28	48	Diabetes_McGill_Cell_cycle_G1	PID_HEDGEHOG_GLIPATHWAY
7.14285714286%	2	28	479	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
7.14285714286%	2	28	479	Diabetes_McGill_Cell_cycle_G1	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
7.14285714286%	2	28	478	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
7.14285714286%	2	28	47	Diabetes_McGill_Cell_cycle_G1	PID_NFAT_TFPATHWAY
7.14285714286%	2	28	47	Diabetes_McGill_Cell_cycle_G1	PID_FANCONI_PATHWAY
7.14285714286%	2	28	466	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_HEMOSTASIS
7.14285714286%	2	28	462	Diabetes_McGill_Cell_cycle_G1	DELACROIX_RAR_BOUND_ES
7.14285714286%	2	28	461	Diabetes_McGill_Cell_cycle_G1	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
7.14285714286%	2	28	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
7.14285714286%	2	28	459	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KIM_WT1_TARGETS_DN
7.14285714286%	2	28	456	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ODONNELL_TFRC_TARGETS_UP
7.14285714286%	2	28	456	Diabetes_McGill_Cell_cycle_G1	MARTENS_BOUND_BY_PML_RARA_FUSION
7.14285714286%	2	28	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_INSULIN_PATHWAY
7.14285714286%	2	28	45	Diabetes_McGill_Cell_cycle_G1	PID_ILK_PATHWAY
7.14285714286%	2	28	443	Diabetes_McGill_Cell_cycle_G1	DELYS_THYROID_CANCER_UP
7.14285714286%	2	28	442	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HAN_SATB1_TARGETS_DN
7.14285714286%	2	28	442	Diabetes_McGill_Cell_cycle_G1	HAN_SATB1_TARGETS_DN
7.14285714286%	2	28	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MA_MYELOID_DIFFERENTIATION_DN
7.14285714286%	2	28	44	Diabetes_McGill_Cell_cycle_G1	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
7.14285714286%	2	28	439	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MITSIADES_RESPONSE_TO_APLIDIN_UP
7.14285714286%	2	28	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_TCPTP_PATHWAY
7.14285714286%	2	28	425	Diabetes_McGill_Cell_cycle_G1	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
7.14285714286%	2	28	421	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_CELL_CYCLE
7.14285714286%	2	28	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LUI_THYROID_CANCER_CLUSTER_2
7.14285714286%	2	28	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
7.14285714286%	2	28	42	Diabetes_McGill_Cell_cycle_G1	YU_MYC_TARGETS_UP
7.14285714286%	2	28	42	Diabetes_McGill_Cell_cycle_G1	PID_BMPPATHWAY
7.14285714286%	2	28	42	Diabetes_McGill_Cell_cycle_G1	MODY_HIPPOCAMPUS_PRENATAL
7.14285714286%	2	28	419	Diabetes_McGill_Cell_cycle_G1	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
7.14285714286%	2	28	41	Diabetes_McGill_Cell_cycle_G1	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN
7.14285714286%	2	28	408	Diabetes_McGill_Cell_cycle_G1	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
7.14285714286%	2	28	408	Diabetes_McGill_Cell_cycle_G1	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
7.14285714286%	2	28	405	Diabetes_McGill_Cell_cycle_G1	KUMAR_TARGETS_OF_MLL_AF9_FUSION
7.14285714286%	2	28	404	Diabetes_McGill_Cell_cycle_G1	OSMAN_BLADDER_CANCER_UP
7.14285714286%	2	28	403	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
7.14285714286%	2	28	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	RIZ_ERYTHROID_DIFFERENTIATION_6HR
7.14285714286%	2	28	40	Diabetes_McGill_Cell_cycle_G1	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
7.14285714286%	2	28	40	Diabetes_McGill_Cell_cycle_G1	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
7.14285714286%	2	28	391	Diabetes_McGill_Cell_cycle_G1	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
7.14285714286%	2	28	39	Diabetes_McGill_Cell_cycle_G1	MA_MYELOID_DIFFERENTIATION_UP
7.14285714286%	2	28	39	Diabetes_McGill_Cell_cycle_G1	MATZUK_MEIOTIC_AND_DNA_REPAIR
7.14285714286%	2	28	380	Diabetes_McGill_Cell_cycle_G1	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
7.14285714286%	2	28	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_GLUCOSE_TRANSPORT
7.14285714286%	2	28	38	Diabetes_McGill_Cell_cycle_G1	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
7.14285714286%	2	28	38	Diabetes_McGill_Cell_cycle_G1	REACTOME_PI3K_AKT_ACTIVATION
7.14285714286%	2	28	38	Diabetes_McGill_Cell_cycle_G1	REACTOME_GAB1_SIGNALOSOME
7.14285714286%	2	28	38	Diabetes_McGill_Cell_cycle_G1	ONGUSAHA_TP53_TARGETS
7.14285714286%	2	28	38	Diabetes_McGill_Cell_cycle_G1	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN
7.14285714286%	2	28	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BIOCARTA_ALK_PATHWAY
7.14285714286%	2	28	37	Diabetes_McGill_Cell_cycle_G1	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
7.14285714286%	2	28	37	Diabetes_McGill_Cell_cycle_G1	PID_FRA_PATHWAY
7.14285714286%	2	28	368	Diabetes_McGill_Cell_cycle_G1	YAGI_AML_WITH_T_8_21_TRANSLOCATION
7.14285714286%	2	28	367	Diabetes_McGill_Cell_cycle_G1	DELACROIX_RARG_BOUND_MEF
7.14285714286%	2	28	366	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SANSOM_APC_TARGETS_DN
7.14285714286%	2	28	36	Diabetes_McGill_Cell_cycle_G1	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
7.14285714286%	2	28	36	Diabetes_McGill_Cell_cycle_G1	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
7.14285714286%	2	28	36	Diabetes_McGill_Cell_cycle_G1	SEMENZA_HIF1_TARGETS
7.14285714286%	2	28	36	Diabetes_McGill_Cell_cycle_G1	PID_PI3KPLCTRKPATHWAY
7.14285714286%	2	28	36	Diabetes_McGill_Cell_cycle_G1	MARZEC_IL2_SIGNALING_DN
7.14285714286%	2	28	356	Diabetes_McGill_Cell_cycle_G1	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
7.14285714286%	2	28	355	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PEREZ_TP63_TARGETS
7.14285714286%	2	28	354	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
7.14285714286%	2	28	352	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
7.14285714286%	2	28	351	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	YAGI_AML_WITH_11Q23_REARRANGED
7.14285714286%	2	28	351	Diabetes_McGill_Cell_cycle_G1	YAGI_AML_WITH_11Q23_REARRANGED
7.14285714286%	2	28	35	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_CARM_ER_PATHWAY
7.14285714286%	2	28	349	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
7.14285714286%	2	28	346	Diabetes_McGill_Cell_cycle_G1	GOLDRATH_ANTIGEN_RESPONSE
7.14285714286%	2	28	344	Diabetes_McGill_Cell_cycle_G1	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
7.14285714286%	2	28	338	Diabetes_McGill_Cell_cycle_G1	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
7.14285714286%	2	28	337	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PHONG_TNF_RESPONSE_NOT_VIA_P38
7.14285714286%	2	28	337	Diabetes_McGill_Cell_cycle_G1	PHONG_TNF_RESPONSE_NOT_VIA_P38
7.14285714286%	2	28	336	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	JOHNSTONE_PARVB_TARGETS_2_DN
7.14285714286%	2	28	336	Diabetes_McGill_Cell_cycle_G1	JOHNSTONE_PARVB_TARGETS_2_DN
7.14285714286%	2	28	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SCHRAETS_MLL_TARGETS_DN
7.14285714286%	2	28	33	Diabetes_McGill_Cell_cycle_G1	CAFFAREL_RESPONSE_TO_THC_UP
7.14285714286%	2	28	326	Diabetes_McGill_Cell_cycle_G1	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
7.14285714286%	2	28	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BIOCARTA_HDAC_PATHWAY
7.14285714286%	2	28	32	Diabetes_McGill_Cell_cycle_G1	TSAI_RESPONSE_TO_RADIATION_THERAPY
7.14285714286%	2	28	316	Diabetes_McGill_Cell_cycle_G1	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
7.14285714286%	2	28	315	Diabetes_McGill_Cell_cycle_G1	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
7.14285714286%	2	28	310	Diabetes_McGill_Cell_cycle_G1	HORIUCHI_WTAP_TARGETS_DN
7.14285714286%	2	28	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_INWARDLY_RECTIFYING_K_CHANNELS
7.14285714286%	2	28	31	Diabetes_McGill_Cell_cycle_G1	SIMBULAN_PARP1_TARGETS_UP
7.14285714286%	2	28	31	Diabetes_McGill_Cell_cycle_G1	PID_AURORA_A_PATHWAY
7.14285714286%	2	28	31	Diabetes_McGill_Cell_cycle_G1	CAFFAREL_RESPONSE_TO_THC_DN
7.14285714286%	2	28	309	Diabetes_McGill_Cell_cycle_G1	LIU_SOX4_TARGETS_DN
7.14285714286%	2	28	307	Diabetes_McGill_Cell_cycle_G1	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
7.14285714286%	2	28	30	Diabetes_McGill_Cell_cycle_G1	PID_RETINOIC_ACID_PATHWAY
7.14285714286%	2	28	298	Diabetes_McGill_Cell_cycle_G1	BROWNE_HCMV_INFECTION_14HR_DN
7.14285714286%	2	28	293	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HADDAD_B_LYMPHOCYTE_PROGENITOR
7.14285714286%	2	28	293	Diabetes_McGill_Cell_cycle_G1	ZHANG_TLX_TARGETS_60HR_UP
7.14285714286%	2	28	292	Diabetes_McGill_Cell_cycle_G1	HELLER_HDAC_TARGETS_DN
7.14285714286%	2	28	291	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SABATES_COLORECTAL_ADENOMA_DN
7.14285714286%	2	28	29	Diabetes_McGill_Cell_cycle_G1	TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN
7.14285714286%	2	28	29	Diabetes_McGill_Cell_cycle_G1	STANELLE_E2F1_TARGETS
7.14285714286%	2	28	29	Diabetes_McGill_Cell_cycle_G1	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
7.14285714286%	2	28	29	Diabetes_McGill_Cell_cycle_G1	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
7.14285714286%	2	28	29	Diabetes_McGill_Cell_cycle_G1	KEGG_THYROID_CANCER
7.14285714286%	2	28	289	Diabetes_McGill_Cell_cycle_G1	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
7.14285714286%	2	28	287	Diabetes_McGill_Cell_cycle_G1	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
7.14285714286%	2	28	285	Diabetes_McGill_Cell_cycle_G1	GRADE_COLON_AND_RECTAL_CANCER_UP
7.14285714286%	2	28	280	Diabetes_McGill_Cell_cycle_G1	WANG_SMARCE1_TARGETS_UP
7.14285714286%	2	28	28	Diabetes_McGill_Cell_cycle_G1	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
7.14285714286%	2	28	28	Diabetes_McGill_Cell_cycle_G1	MOREIRA_RESPONSE_TO_TSA_UP
7.14285714286%	2	28	279	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_NEURONAL_SYSTEM
7.14285714286%	2	28	275	Diabetes_McGill_Cell_cycle_G1	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
7.14285714286%	2	28	27	Diabetes_McGill_Cell_cycle_G1	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
7.14285714286%	2	28	27	Diabetes_McGill_Cell_cycle_G1	GENTILE_UV_LOW_DOSE_UP
7.14285714286%	2	28	27	Diabetes_McGill_Cell_cycle_G1	CHIN_BREAST_CANCER_COPY_NUMBER_UP
7.14285714286%	2	28	27	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_GSK3_PATHWAY
7.14285714286%	2	28	265	Diabetes_McGill_Cell_cycle_G1	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
7.14285714286%	2	28	262	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LU_AGING_BRAIN_UP
7.14285714286%	2	28	260	Diabetes_McGill_Cell_cycle_G1	SENESE_HDAC1_TARGETS_DN
7.14285714286%	2	28	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_INSULIN_GLUCOSE_PATHWAY
7.14285714286%	2	28	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN
7.14285714286%	2	28	259	Diabetes_McGill_Cell_cycle_G1	QI_PLASMACYTOMA_UP
7.14285714286%	2	28	253	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	DANG_REGULATED_BY_MYC_DN
7.14285714286%	2	28	251	Diabetes_McGill_Cell_cycle_G1	REACTOME_AXON_GUIDANCE
7.14285714286%	2	28	250	Diabetes_McGill_Cell_cycle_G1	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
7.14285714286%	2	28	25	Diabetes_McGill_Cell_cycle_G1	REACTOME_FANCONI_ANEMIA_PATHWAY
7.14285714286%	2	28	25	Diabetes_McGill_Cell_cycle_G1	PID_HDAC_CLASSIII_PATHWAY
7.14285714286%	2	28	249	Diabetes_McGill_Cell_cycle_G1	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
7.14285714286%	2	28	247	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_METABOLISM_OF_CARBOHYDRATES
7.14285714286%	2	28	245	Diabetes_McGill_Cell_cycle_G1	PENG_RAPAMYCIN_RESPONSE_DN
7.14285714286%	2	28	245	Diabetes_McGill_Cell_cycle_G1	BLUM_RESPONSE_TO_SALIRASIB_UP
7.14285714286%	2	28	244	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HSIAO_LIVER_SPECIFIC_GENES
7.14285714286%	2	28	244	Diabetes_McGill_Cell_cycle_G1	KAYO_AGING_MUSCLE_UP
7.14285714286%	2	28	244	Diabetes_McGill_Cell_cycle_G1	DAZARD_RESPONSE_TO_UV_NHEK_UP
7.14285714286%	2	28	241	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
7.14285714286%	2	28	24	Diabetes_McGill_Cell_cycle_G1	WANG_LSD1_TARGETS_UP
7.14285714286%	2	28	24	Diabetes_McGill_Cell_cycle_G1	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23
7.14285714286%	2	28	24	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_NTHI_PATHWAY
7.14285714286%	2	28	239	Diabetes_McGill_Cell_cycle_G1	ALFANO_MYC_TARGETS
7.14285714286%	2	28	235	Diabetes_McGill_Cell_cycle_G1	RUTELLA_RESPONSE_TO_HGF_DN
7.14285714286%	2	28	233	Diabetes_McGill_Cell_cycle_G1	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
7.14285714286%	2	28	232	Diabetes_McGill_Cell_cycle_G1	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
7.14285714286%	2	28	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_INSULIN_RECEPTOR_RECYCLING
7.14285714286%	2	28	23	Diabetes_McGill_Cell_cycle_G1	WU_HBX_TARGETS_1_DN
7.14285714286%	2	28	23	Diabetes_McGill_Cell_cycle_G1	REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING
7.14285714286%	2	28	23	Diabetes_McGill_Cell_cycle_G1	MARKS_HDAC_TARGETS_UP
7.14285714286%	2	28	229	Diabetes_McGill_Cell_cycle_G1	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
7.14285714286%	2	28	227	Diabetes_McGill_Cell_cycle_G1	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
7.14285714286%	2	28	225	Diabetes_McGill_Cell_cycle_G1	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
7.14285714286%	2	28	223	Diabetes_McGill_Cell_cycle_G1	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
7.14285714286%	2	28	222	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
7.14285714286%	2	28	221	Diabetes_McGill_Cell_cycle_G1	CHANDRAN_METASTASIS_UP
7.14285714286%	2	28	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BIOCARTA_INSULIN_PATHWAY
7.14285714286%	2	28	22	Diabetes_McGill_Cell_cycle_G1	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER
7.14285714286%	2	28	22	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_CHEMICAL_PATHWAY
7.14285714286%	2	28	217	Diabetes_McGill_Cell_cycle_G1	SANSOM_APC_MYC_TARGETS
7.14285714286%	2	28	215	Diabetes_McGill_Cell_cycle_G1	YAMAZAKI_TCEB3_TARGETS_DN
7.14285714286%	2	28	214	Diabetes_McGill_Cell_cycle_G1	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
7.14285714286%	2	28	214	Diabetes_McGill_Cell_cycle_G1	AFFAR_YY1_TARGETS_UP
7.14285714286%	2	28	212	Diabetes_McGill_Cell_cycle_G1	CHANG_CORE_SERUM_RESPONSE_UP
7.14285714286%	2	28	211	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
7.14285714286%	2	28	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
7.14285714286%	2	28	210	Diabetes_McGill_Cell_cycle_G1	VERHAAK_GLIOBLASTOMA_PRONEURAL
7.14285714286%	2	28	210	Diabetes_McGill_Cell_cycle_G1	SANSOM_APC_TARGETS_REQUIRE_MYC
7.14285714286%	2	28	210	Diabetes_McGill_Cell_cycle_G1	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
7.14285714286%	2	28	21	Diabetes_McGill_Cell_cycle_G1	MURAKAMI_UV_RESPONSE_6HR_DN
7.14285714286%	2	28	21	Diabetes_McGill_Cell_cycle_G1	MACLACHLAN_BRCA1_TARGETS_UP
7.14285714286%	2	28	209	Diabetes_McGill_Cell_cycle_G1	GROSS_HYPOXIA_VIA_ELK3_UP
7.14285714286%	2	28	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MANALO_HYPOXIA_UP
7.14285714286%	2	28	207	Diabetes_McGill_Cell_cycle_G1	CAIRO_HEPATOBLASTOMA_UP
7.14285714286%	2	28	206	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
7.14285714286%	2	28	206	Diabetes_McGill_Cell_cycle_G1	RAMALHO_STEMNESS_UP
7.14285714286%	2	28	206	Diabetes_McGill_Cell_cycle_G1	BILD_MYC_ONCOGENIC_SIGNATURE
7.14285714286%	2	28	205	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SHEPARD_BMYB_MORPHOLINO_UP
7.14285714286%	2	28	203	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GRUETZMANN_PANCREATIC_CANCER_DN
7.14285714286%	2	28	201	Diabetes_McGill_Cell_cycle_G1	KEGG_FOCAL_ADHESION
7.14285714286%	2	28	201	Diabetes_McGill_Cell_cycle_G1	HOLLMANN_APOPTOSIS_VIA_CD40_UP
7.14285714286%	2	28	200	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LEE_DIFFERENTIATING_T_LYMPHOCYTE
7.14285714286%	2	28	20	Diabetes_McGill_Cell_cycle_G1	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
7.14285714286%	2	28	1972	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PILON_KLF1_TARGETS_DN
7.14285714286%	2	28	194	Diabetes_McGill_Cell_cycle_G1	PROVENZANI_METASTASIS_UP
7.14285714286%	2	28	194	Diabetes_McGill_Cell_cycle_G1	KASLER_HDAC7_TARGETS_1_UP
7.14285714286%	2	28	193	Diabetes_McGill_Cell_cycle_G1	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
7.14285714286%	2	28	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHEN_PDGF_TARGETS
7.14285714286%	2	28	19	Diabetes_McGill_Cell_cycle_G1	PID_HIF1APATHWAY
7.14285714286%	2	28	19	Diabetes_McGill_Cell_cycle_G1	OUYANG_PROSTATE_CANCER_MARKERS
7.14285714286%	2	28	19	Diabetes_McGill_Cell_cycle_G1	LI_WILMS_TUMOR_ANAPLASTIC_UP
7.14285714286%	2	28	19	Diabetes_McGill_Cell_cycle_G1	LAMB_CCND1_TARGETS
7.14285714286%	2	28	19	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_TID_PATHWAY
7.14285714286%	2	28	19	Diabetes_McGill_Cell_cycle_G1	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
7.14285714286%	2	28	187	Diabetes_McGill_Cell_cycle_G1	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
7.14285714286%	2	28	185	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LEE_LIVER_CANCER_SURVIVAL_UP
7.14285714286%	2	28	185	Diabetes_McGill_Cell_cycle_G1	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
7.14285714286%	2	28	185	Diabetes_McGill_Cell_cycle_G1	KEGG_HUNTINGTONS_DISEASE
7.14285714286%	2	28	184	Diabetes_McGill_Cell_cycle_G1	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
7.14285714286%	2	28	182	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FERNANDEZ_BOUND_BY_MYC
7.14285714286%	2	28	182	Diabetes_McGill_Cell_cycle_G1	WHITFIELD_CELL_CYCLE_G2
7.14285714286%	2	28	181	Diabetes_McGill_Cell_cycle_G1	JISON_SICKLE_CELL_DISEASE_DN
7.14285714286%	2	28	18	Diabetes_McGill_Cell_cycle_G1	YIH_RESPONSE_TO_ARSENITE_C2
7.14285714286%	2	28	18	Diabetes_McGill_Cell_cycle_G1	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN
7.14285714286%	2	28	18	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALING_BY_NODAL
7.14285714286%	2	28	18	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_TEL_PATHWAY
7.14285714286%	2	28	1781	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
7.14285714286%	2	28	178	Diabetes_McGill_Cell_cycle_G1	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
7.14285714286%	2	28	176	Diabetes_McGill_Cell_cycle_G1	SASAKI_ADULT_T_CELL_LEUKEMIA
7.14285714286%	2	28	175	Diabetes_McGill_Cell_cycle_G1	FIRESTEIN_PROLIFERATION
7.14285714286%	2	28	172	Diabetes_McGill_Cell_cycle_G1	REACTOME_MITOTIC_M_M_G1_PHASES
7.14285714286%	2	28	172	Diabetes_McGill_Cell_cycle_G1	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
7.14285714286%	2	28	170	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
7.14285714286%	2	28	170	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
7.14285714286%	2	28	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_SHC_RELATED_EVENTS
7.14285714286%	2	28	17	Diabetes_McGill_Cell_cycle_G1	PID_SMAD2_3PATHWAY
7.14285714286%	2	28	17	Diabetes_McGill_Cell_cycle_G1	KANG_AR_TARGETS_UP
7.14285714286%	2	28	17	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_PML_PATHWAY
7.14285714286%	2	28	169	Diabetes_McGill_Cell_cycle_G1	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
7.14285714286%	2	28	168	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
7.14285714286%	2	28	1652	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PUJANA_BRCA1_PCC_NETWORK
7.14285714286%	2	28	165	Diabetes_McGill_Cell_cycle_G1	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
7.14285714286%	2	28	163	Diabetes_McGill_Cell_cycle_G1	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
7.14285714286%	2	28	162	Diabetes_McGill_Cell_cycle_G1	WINNEPENNINCKX_MELANOMA_METASTASIS_UP
7.14285714286%	2	28	162	Diabetes_McGill_Cell_cycle_G1	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
7.14285714286%	2	28	161	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
7.14285714286%	2	28	160	Diabetes_McGill_Cell_cycle_G1	BROWNE_HCMV_INFECTION_6HR_DN
7.14285714286%	2	28	158	Diabetes_McGill_Cell_cycle_G1	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
7.14285714286%	2	28	157	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
7.14285714286%	2	28	157	Diabetes_McGill_Cell_cycle_G1	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
7.14285714286%	2	28	153	Diabetes_McGill_Cell_cycle_G1	DAZARD_UV_RESPONSE_CLUSTER_G6
7.14285714286%	2	28	150	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BROWNE_HCMV_INFECTION_30MIN_DN
7.14285714286%	2	28	150	Diabetes_McGill_Cell_cycle_G1	LANDIS_ERBB2_BREAST_TUMORS_324_UP
7.14285714286%	2	28	150	Diabetes_McGill_Cell_cycle_G1	BROWNE_HCMV_INFECTION_30MIN_DN
7.14285714286%	2	28	15	Diabetes_McGill_Cell_cycle_G1	SA_MMP_CYTOKINE_CONNECTION
7.14285714286%	2	28	15	Diabetes_McGill_Cell_cycle_G1	SANCHEZ_MDM2_TARGETS
7.14285714286%	2	28	15	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_PITX2_PATHWAY
7.14285714286%	2	28	149	Diabetes_McGill_Cell_cycle_G1	HUANG_GATA2_TARGETS_UP
7.14285714286%	2	28	148	Diabetes_McGill_Cell_cycle_G1	WEI_MIR34A_TARGETS
7.14285714286%	2	28	147	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WHITFIELD_CELL_CYCLE_G1_S
7.14285714286%	2	28	145	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
7.14285714286%	2	28	143	Diabetes_McGill_Cell_cycle_G1	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
7.14285714286%	2	28	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR
7.14285714286%	2	28	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_SIGNAL_ATTENUATION
7.14285714286%	2	28	1382	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
7.14285714286%	2	28	138	Diabetes_McGill_Cell_cycle_G1	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
7.14285714286%	2	28	1375	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	DODD_NASOPHARYNGEAL_CARCINOMA_DN
7.14285714286%	2	28	135	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SERVITJA_LIVER_HNF1A_TARGETS_UP
7.14285714286%	2	28	132	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
7.14285714286%	2	28	13	Diabetes_McGill_Cell_cycle_G1	WU_HBX_TARGETS_3_DN
7.14285714286%	2	28	13	Diabetes_McGill_Cell_cycle_G1	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
7.14285714286%	2	28	129	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	YAGI_AML_SURVIVAL
7.14285714286%	2	28	129	Diabetes_McGill_Cell_cycle_G1	KIM_WT1_TARGETS_8HR_DN
7.14285714286%	2	28	129	Diabetes_McGill_Cell_cycle_G1	KEGG_AXON_GUIDANCE
7.14285714286%	2	28	128	Diabetes_McGill_Cell_cycle_G1	ZHU_CMV_ALL_DN
7.14285714286%	2	28	127	Diabetes_McGill_Cell_cycle_G1	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
7.14285714286%	2	28	126	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
7.14285714286%	2	28	126	Diabetes_McGill_Cell_cycle_G1	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
7.14285714286%	2	28	122	Diabetes_McGill_Cell_cycle_G1	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
7.14285714286%	2	28	1210	Diabetes_McGill_Cell_cycle_G1	CHEN_METABOLIC_SYNDROM_NETWORK
7.14285714286%	2	28	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	XU_GH1_EXOGENOUS_TARGETS_DN
7.14285714286%	2	28	12	Diabetes_McGill_Cell_cycle_G1	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
7.14285714286%	2	28	12	Diabetes_McGill_Cell_cycle_G1	DING_LUNG_CANCER_MUTATED_FREQUENTLY
7.14285714286%	2	28	118	Diabetes_McGill_Cell_cycle_G1	MARKEY_RB1_CHRONIC_LOF_DN
7.14285714286%	2	28	1174	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PEREZ_TP53_TARGETS
7.14285714286%	2	28	116	Diabetes_McGill_Cell_cycle_G1	IKEDA_MIR30_TARGETS_UP
7.14285714286%	2	28	115	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
7.14285714286%	2	28	115	Diabetes_McGill_Cell_cycle_G1	MARKEY_RB1_CHRONIC_LOF_UP
7.14285714286%	2	28	115	Diabetes_McGill_Cell_cycle_G1	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
7.14285714286%	2	28	1142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
7.14285714286%	2	28	114	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ROPERO_HDAC2_TARGETS
7.14285714286%	2	28	114	Diabetes_McGill_Cell_cycle_G1	SENESE_HDAC2_TARGETS_UP
7.14285714286%	2	28	112	Diabetes_McGill_Cell_cycle_G1	REACTOME_DNA_REPAIR
7.14285714286%	2	28	111	Diabetes_McGill_Cell_cycle_G1	WANG_HCP_PROSTATE_CANCER
7.14285714286%	2	28	11	Diabetes_McGill_Cell_cycle_G1	REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY
7.14285714286%	2	28	11	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_SRCRPTP_PATHWAY
7.14285714286%	2	28	11	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_PTC1_PATHWAY
7.14285714286%	2	28	109	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SERVITJA_ISLET_HNF1A_TARGETS_DN
7.14285714286%	2	28	1080	Diabetes_McGill_Cell_cycle_G1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
7.14285714286%	2	28	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
7.14285714286%	2	28	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
7.14285714286%	2	28	108	Diabetes_McGill_Cell_cycle_G1	ZHANG_TLX_TARGETS_DN
7.14285714286%	2	28	108	Diabetes_McGill_Cell_cycle_G1	LE_EGR2_TARGETS_UP
7.14285714286%	2	28	108	Diabetes_McGill_Cell_cycle_G1	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
7.14285714286%	2	28	107	Diabetes_McGill_Cell_cycle_G1	LEE_EARLY_T_LYMPHOCYTE_UP
7.14285714286%	2	28	105	Diabetes_McGill_Cell_cycle_G1	WOO_LIVER_CANCER_RECURRENCE_UP
7.14285714286%	2	28	105	Diabetes_McGill_Cell_cycle_G1	BROWNE_HCMV_INFECTION_8HR_UP
7.14285714286%	2	28	104	Diabetes_McGill_Cell_cycle_G1	NAKAMURA_ADIPOGENESIS_LATE_UP
7.14285714286%	2	28	1037	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	NUYTTEN_EZH2_TARGETS_UP
7.14285714286%	2	28	1037	Diabetes_McGill_Cell_cycle_G1	NUYTTEN_EZH2_TARGETS_UP
7.14285714286%	2	28	103	Diabetes_McGill_Cell_cycle_G1	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
7.14285714286%	2	28	1024	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	NUYTTEN_EZH2_TARGETS_DN
7.14285714286%	2	28	101	Diabetes_McGill_Cell_cycle_G1	BURTON_ADIPOGENESIS_3
7.14285714286%	2	28	100	Diabetes_McGill_Cell_cycle_G1	BENPORATH_ES_CORE_NINE_CORRELATED
7.14285714286%	2	28	10	Diabetes_McGill_Cell_cycle_G1	REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION
7.11462450593%	18	253	89	Diabetes_McGill_CREBBP_coTF	KEGG_PROSTATE_CANCER
7.11462450593%	18	253	824	Diabetes_McGill_CREBBP_coTF	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
7.11462450593%	18	253	805	Diabetes_McGill_CREBBP_coTF	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
7.11462450593%	18	253	73	Diabetes_McGill_CREBBP_coTF	KEGG_CHRONIC_MYELOID_LEUKEMIA
7.11462450593%	18	253	543	Diabetes_McGill_CREBBP_coTF	MARTINEZ_RB1_TARGETS_DN
7.11462450593%	18	253	53	Diabetes_McGill_CREBBP_coTF	REACTOME_CIRCADIAN_CLOCK
7.11462450593%	18	253	479	Diabetes_McGill_CREBBP_coTF	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
7.11462450593%	18	253	390	Diabetes_McGill_CREBBP_coTF	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
7.11462450593%	18	253	279	Diabetes_McGill_CREBBP_coTF	REACTOME_INNATE_IMMUNE_SYSTEM
7.11462450593%	18	253	270	Diabetes_McGill_CREBBP_coTF	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
7.11462450593%	18	253	1725	Diabetes_McGill_CREBBP_coTF	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
7.11462450593%	18	253	137	Diabetes_McGill_CREBBP_coTF	PID_P53DOWNSTREAMPATHWAY
7.10849812934%	133	1871	1142	T2D_GENES_TANYA_HEIGHT	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
7.05505077499%	132	1871	1305	T2D_GENES_TANYA_HEIGHT	YOSHIMURA_MAPK8_TARGETS_UP
7.04154002026%	139	1974	323	Mendelian_Nancy_Cox	GRESHOCK_CANCER_COPY_NUMBER_UP
7.0110701107%	38	542	1278	T2D_GENES_TANYA_ANTHROPOMETRIC	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
7.0110701107%	38	542	1103	T2D_GENES_TANYA_ANTHROPOMETRIC	DANG_BOUND_BY_MYC
7.00160342063%	131	1871	1442	T2D_GENES_TANYA_HEIGHT	PUJANA_ATM_PCC_NETWORK
6.99172033119%	152	2174	1142	T2D_GENES_TANYA_LIPIDS	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
6.94572217111%	151	2174	1725	T2D_GENES_TANYA_LIPIDS	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
6.94022289767%	137	1974	1229	Mendelian_Nancy_Cox	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
6.8515497553%	42	613	1103	T2D_GENES_TANYA_BIOMARKER	DANG_BOUND_BY_MYC
6.83890577508%	135	1974	546	Mendelian_Nancy_Cox	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
6.82656826568%	37	542	882	T2D_GENES_TANYA_ANTHROPOMETRIC	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
6.82656826568%	37	542	1375	T2D_GENES_TANYA_ANTHROPOMETRIC	DODD_NASOPHARYNGEAL_CARCINOMA_DN
6.81318681319%	31	455	882	T2D_GENES_TANYA_BLOODPRESSURE	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
6.81318681319%	31	455	210	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRANSCRIPTION
6.75791274594%	79	1169	1652	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PUJANA_BRCA1_PCC_NETWORK
6.7264573991%	30	446	1691	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BLALOCK_ALZHEIMERS_DISEASE_UP
6.71936758893%	17	253	918	Diabetes_McGill_CREBBP_coTF	JOHNSTONE_PARVB_TARGETS_3_DN
6.71936758893%	17	253	882	Diabetes_McGill_CREBBP_coTF	LEE_BMP2_TARGETS_DN
6.71936758893%	17	253	84	Diabetes_McGill_CREBBP_coTF	PID_CMYB_PATHWAY
6.71936758893%	17	253	795	Diabetes_McGill_CREBBP_coTF	WEI_MYCN_TARGETS_WITH_E_BOX
6.71936758893%	17	253	781	Diabetes_McGill_CREBBP_coTF	GOZGIT_ESR1_TARGETS_DN
6.71936758893%	17	253	601	Diabetes_McGill_CREBBP_coTF	MARTINEZ_RB1_AND_TP53_TARGETS_UP
6.71936758893%	17	253	53	Diabetes_McGill_CREBBP_coTF	PID_AR_TF_PATHWAY
6.71936758893%	17	253	514	Diabetes_McGill_CREBBP_coTF	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
6.71936758893%	17	253	504	Diabetes_McGill_CREBBP_coTF	PILON_KLF1_TARGETS_UP
6.71936758893%	17	253	48	Diabetes_McGill_CREBBP_coTF	PID_HES_HEYPATHWAY
6.71936758893%	17	253	473	Diabetes_McGill_CREBBP_coTF	GARY_CD5_TARGETS_UP
6.71936758893%	17	253	425	Diabetes_McGill_CREBBP_coTF	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
6.71936758893%	17	253	421	Diabetes_McGill_CREBBP_coTF	REACTOME_CELL_CYCLE
6.71936758893%	17	253	409	Diabetes_McGill_CREBBP_coTF	FOSTER_TOLERANT_MACROPHAGE_DN
6.71936758893%	17	253	341	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
6.71936758893%	17	253	230	Diabetes_McGill_CREBBP_coTF	BENPORATH_MYC_TARGETS_WITH_EBOX
6.71936758893%	17	253	182	Diabetes_McGill_CREBBP_coTF	FERNANDEZ_BOUND_BY_MYC
6.71936758893%	17	253	128	Diabetes_McGill_CREBBP_coTF	KEGG_CELL_CYCLE
6.71936758893%	17	253	1174	Diabetes_McGill_CREBBP_coTF	PEREZ_TP53_TARGETS
6.68841761827%	41	613	1237	T2D_GENES_TANYA_BIOMARKER	BLALOCK_ALZHEIMERS_DISEASE_DN
6.68841761827%	41	613	1137	T2D_GENES_TANYA_BIOMARKER	BRUINS_UVC_RESPONSE_LATE
6.68841761827%	41	613	1024	T2D_GENES_TANYA_BIOMARKER	NUYTTEN_EZH2_TARGETS_DN
6.68091929449%	125	1871	1382	T2D_GENES_TANYA_HEIGHT	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
6.67236954662%	78	1169	1972	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PILON_KLF1_TARGETS_DN
6.66666666667%	2	30	96	Mendelian_Hereditary_Sensory_Neuropathy	ZAMORA_NOS2_TARGETS_DN
6.66666666667%	2	30	957	Mendelian_Hereditary_Sensory_Neuropathy	LOPEZ_MBD_TARGETS
6.66666666667%	2	30	933	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_IMMUNE_SYSTEM
6.66666666667%	2	30	93	Mendelian_Hereditary_Sensory_Neuropathy	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
6.66666666667%	2	30	92	Mendelian_Hereditary_Sensory_Neuropathy	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
6.66666666667%	2	30	91	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION
6.66666666667%	2	30	90	Mendelian_Hereditary_Sensory_Neuropathy	HILLION_HMGA1_TARGETS
6.66666666667%	2	30	89	Mendelian_Hereditary_Sensory_Neuropathy	LEIN_PONS_MARKERS
6.66666666667%	2	30	882	Mendelian_Hereditary_Sensory_Neuropathy	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
6.66666666667%	2	30	88	Mendelian_Hereditary_Sensory_Neuropathy	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
6.66666666667%	2	30	87	Mendelian_Hereditary_Sensory_Neuropathy	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
6.66666666667%	2	30	87	Mendelian_Hereditary_Sensory_Neuropathy	SAFFORD_T_LYMPHOCYTE_ANERGY
6.66666666667%	2	30	848	Mendelian_Hereditary_Sensory_Neuropathy	NUYTTEN_NIPP1_TARGETS_DN
6.66666666667%	2	30	79	Mendelian_Hereditary_Sensory_Neuropathy	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
6.66666666667%	2	30	783	Mendelian_Hereditary_Sensory_Neuropathy	ONKEN_UVEAL_MELANOMA_UP
6.66666666667%	2	30	779	Mendelian_Hereditary_Sensory_Neuropathy	PUJANA_CHEK2_PCC_NETWORK
6.66666666667%	2	30	77	Mendelian_Hereditary_Sensory_Neuropathy	LIN_APC_TARGETS
6.66666666667%	2	30	75	Mendelian_Hereditary_Sensory_Neuropathy	MORI_MATURE_B_LYMPHOCYTE_DN
6.66666666667%	2	30	747	Mendelian_Hereditary_Sensory_Neuropathy	PATIL_LIVER_CANCER
6.66666666667%	2	30	74	Mendelian_Hereditary_Sensory_Neuropathy	LEIN_OLIGODENDROCYTE_MARKERS
6.66666666667%	2	30	72	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
6.66666666667%	2	30	72	Mendelian_Hereditary_Sensory_Neuropathy	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
6.66666666667%	2	30	718	Mendelian_Hereditary_Sensory_Neuropathy	MIKKELSEN_ES_ICP_WITH_H3K4ME3
6.66666666667%	2	30	701	Mendelian_Hereditary_Sensory_Neuropathy	SMID_BREAST_CANCER_BASAL_DN
6.66666666667%	2	30	682	Mendelian_Hereditary_Sensory_Neuropathy	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
6.66666666667%	2	30	67	Mendelian_Hereditary_Sensory_Neuropathy	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
6.66666666667%	2	30	648	Mendelian_Hereditary_Sensory_Neuropathy	SMID_BREAST_CANCER_BASAL_UP
6.66666666667%	2	30	648	Mendelian_Hereditary_Sensory_Neuropathy	BENPORATH_CYCLING_GENES
6.66666666667%	2	30	634	Mendelian_Hereditary_Sensory_Neuropathy	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
6.66666666667%	2	30	633	Mendelian_Hereditary_Sensory_Neuropathy	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
6.66666666667%	2	30	612	Mendelian_Hereditary_Sensory_Neuropathy	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
6.66666666667%	2	30	579	Mendelian_Hereditary_Sensory_Neuropathy	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
6.66666666667%	2	30	57	Mendelian_Hereditary_Sensory_Neuropathy	DIRMEIER_LMP1_RESPONSE_LATE_UP
6.66666666667%	2	30	55	Mendelian_Hereditary_Sensory_Neuropathy	DEMAGALHAES_AGING_UP
6.66666666667%	2	30	540	Mendelian_Hereditary_Sensory_Neuropathy	ACEVEDO_LIVER_CANCER_DN
6.66666666667%	2	30	539	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
6.66666666667%	2	30	539	Mendelian_Hereditary_Sensory_Neuropathy	LIAO_METASTASIS
6.66666666667%	2	30	536	Mendelian_Hereditary_Sensory_Neuropathy	SENESE_HDAC3_TARGETS_DN
6.66666666667%	2	30	535	Mendelian_Hereditary_Sensory_Neuropathy	STEIN_ESRRA_TARGETS
6.66666666667%	2	30	528	Mendelian_Hereditary_Sensory_Neuropathy	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
6.66666666667%	2	30	526	Mendelian_Hereditary_Sensory_Neuropathy	ONKEN_UVEAL_MELANOMA_DN
6.66666666667%	2	30	514	Mendelian_Hereditary_Sensory_Neuropathy	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
6.66666666667%	2	30	514	Mendelian_Hereditary_Sensory_Neuropathy	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
6.66666666667%	2	30	51	Mendelian_Hereditary_Sensory_Neuropathy	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP
6.66666666667%	2	30	501	Mendelian_Hereditary_Sensory_Neuropathy	SENESE_HDAC3_TARGETS_UP
6.66666666667%	2	30	493	Mendelian_Hereditary_Sensory_Neuropathy	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
6.66666666667%	2	30	491	Mendelian_Hereditary_Sensory_Neuropathy	SWEET_LUNG_CANCER_KRAS_UP
6.66666666667%	2	30	489	Mendelian_Hereditary_Sensory_Neuropathy	LIM_MAMMARY_STEM_CELL_UP
6.66666666667%	2	30	482	Mendelian_Hereditary_Sensory_Neuropathy	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
6.66666666667%	2	30	48	Mendelian_Hereditary_Sensory_Neuropathy	TAVOR_CEBPA_TARGETS_UP
6.66666666667%	2	30	48	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_PI_METABOLISM
6.66666666667%	2	30	48	Mendelian_Hereditary_Sensory_Neuropathy	PID_AJDISS_2PATHWAY
6.66666666667%	2	30	48	Mendelian_Hereditary_Sensory_Neuropathy	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
6.66666666667%	2	30	461	Mendelian_Hereditary_Sensory_Neuropathy	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
6.66666666667%	2	30	460	Mendelian_Hereditary_Sensory_Neuropathy	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
6.66666666667%	2	30	456	Mendelian_Hereditary_Sensory_Neuropathy	MARTENS_BOUND_BY_PML_RARA_FUSION
6.66666666667%	2	30	455	Mendelian_Hereditary_Sensory_Neuropathy	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
6.66666666667%	2	30	45	Mendelian_Hereditary_Sensory_Neuropathy	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
6.66666666667%	2	30	442	Mendelian_Hereditary_Sensory_Neuropathy	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
6.66666666667%	2	30	442	Mendelian_Hereditary_Sensory_Neuropathy	HAN_SATB1_TARGETS_DN
6.66666666667%	2	30	44	Mendelian_Hereditary_Sensory_Neuropathy	KERLEY_RESPONSE_TO_CISPLATIN_UP
6.66666666667%	2	30	435	Mendelian_Hereditary_Sensory_Neuropathy	SWEET_LUNG_CANCER_KRAS_DN
6.66666666667%	2	30	434	Mendelian_Hereditary_Sensory_Neuropathy	BAELDE_DIABETIC_NEPHROPATHY_DN
6.66666666667%	2	30	430	Mendelian_Hereditary_Sensory_Neuropathy	JOHNSTONE_PARVB_TARGETS_3_UP
6.66666666667%	2	30	428	Mendelian_Hereditary_Sensory_Neuropathy	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
6.66666666667%	2	30	425	Mendelian_Hereditary_Sensory_Neuropathy	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
6.66666666667%	2	30	423	Mendelian_Hereditary_Sensory_Neuropathy	THUM_SYSTOLIC_HEART_FAILURE_UP
6.66666666667%	2	30	398	Mendelian_Hereditary_Sensory_Neuropathy	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
6.66666666667%	2	30	395	Mendelian_Hereditary_Sensory_Neuropathy	HAN_SATB1_TARGETS_UP
6.66666666667%	2	30	390	Mendelian_Hereditary_Sensory_Neuropathy	HATADA_METHYLATED_IN_LUNG_CANCER_UP
6.66666666667%	2	30	384	Mendelian_Hereditary_Sensory_Neuropathy	BASAKI_YBX1_TARGETS_DN
6.66666666667%	2	30	374	Mendelian_Hereditary_Sensory_Neuropathy	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
6.66666666667%	2	30	372	Mendelian_Hereditary_Sensory_Neuropathy	WANG_LMO4_TARGETS_UP
6.66666666667%	2	30	37	Mendelian_Hereditary_Sensory_Neuropathy	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
6.66666666667%	2	30	367	Mendelian_Hereditary_Sensory_Neuropathy	DELACROIX_RARG_BOUND_MEF
6.66666666667%	2	30	358	Mendelian_Hereditary_Sensory_Neuropathy	GRUETZMANN_PANCREATIC_CANCER_UP
6.66666666667%	2	30	357	Mendelian_Hereditary_Sensory_Neuropathy	SHEN_SMARCA2_TARGETS_DN
6.66666666667%	2	30	346	Mendelian_Hereditary_Sensory_Neuropathy	GOLDRATH_ANTIGEN_RESPONSE
6.66666666667%	2	30	344	Mendelian_Hereditary_Sensory_Neuropathy	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
6.66666666667%	2	30	337	Mendelian_Hereditary_Sensory_Neuropathy	PHONG_TNF_RESPONSE_NOT_VIA_P38
6.66666666667%	2	30	335	Mendelian_Hereditary_Sensory_Neuropathy	WONG_EMBRYONIC_STEM_CELL_CORE
6.66666666667%	2	30	330	Mendelian_Hereditary_Sensory_Neuropathy	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
6.66666666667%	2	30	318	Mendelian_Hereditary_Sensory_Neuropathy	LEI_MYB_TARGETS
6.66666666667%	2	30	317	Mendelian_Hereditary_Sensory_Neuropathy	HELLER_HDAC_TARGETS_UP
6.66666666667%	2	30	315	Mendelian_Hereditary_Sensory_Neuropathy	PASINI_SUZ12_TARGETS_DN
6.66666666667%	2	30	311	Mendelian_Hereditary_Sensory_Neuropathy	JIANG_HYPOXIA_NORMAL
6.66666666667%	2	30	309	Mendelian_Hereditary_Sensory_Neuropathy	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
6.66666666667%	2	30	306	Mendelian_Hereditary_Sensory_Neuropathy	HORIUCHI_WTAP_TARGETS_UP
6.66666666667%	2	30	306	Mendelian_Hereditary_Sensory_Neuropathy	CHANDRAN_METASTASIS_DN
6.66666666667%	2	30	30	Mendelian_Hereditary_Sensory_Neuropathy	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
6.66666666667%	2	30	298	Mendelian_Hereditary_Sensory_Neuropathy	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
6.66666666667%	2	30	29	Mendelian_Hereditary_Sensory_Neuropathy	MAYBURD_RESPONSE_TO_L663536_UP
6.66666666667%	2	30	29	Mendelian_Hereditary_Sensory_Neuropathy	AIYAR_COBRA1_TARGETS_DN
6.66666666667%	2	30	285	Mendelian_Hereditary_Sensory_Neuropathy	GRADE_COLON_AND_RECTAL_CANCER_UP
6.66666666667%	2	30	27	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_GAP_JUNCTION_TRAFFICKING
6.66666666667%	2	30	267	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_MAPK_SIGNALING_PATHWAY
6.66666666667%	2	30	267	Mendelian_Hereditary_Sensory_Neuropathy	HOLLMANN_APOPTOSIS_VIA_CD40_DN
6.66666666667%	2	30	266	Mendelian_Hereditary_Sensory_Neuropathy	ROZANOV_MMP14_TARGETS_UP
6.66666666667%	2	30	266	Mendelian_Hereditary_Sensory_Neuropathy	FOSTER_KDM1A_TARGETS_UP
6.66666666667%	2	30	261	Mendelian_Hereditary_Sensory_Neuropathy	BILD_HRAS_ONCOGENIC_SIGNATURE
6.66666666667%	2	30	245	Mendelian_Hereditary_Sensory_Neuropathy	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
6.66666666667%	2	30	242	Mendelian_Hereditary_Sensory_Neuropathy	CHYLA_CBFA2T3_TARGETS_DN
6.66666666667%	2	30	240	Mendelian_Hereditary_Sensory_Neuropathy	UDAYAKUMAR_MED1_TARGETS_DN
6.66666666667%	2	30	238	Mendelian_Hereditary_Sensory_Neuropathy	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
6.66666666667%	2	30	237	Mendelian_Hereditary_Sensory_Neuropathy	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
6.66666666667%	2	30	234	Mendelian_Hereditary_Sensory_Neuropathy	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
6.66666666667%	2	30	229	Mendelian_Hereditary_Sensory_Neuropathy	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
6.66666666667%	2	30	227	Mendelian_Hereditary_Sensory_Neuropathy	RAO_BOUND_BY_SALL4
6.66666666667%	2	30	227	Mendelian_Hereditary_Sensory_Neuropathy	LEE_RECENT_THYMIC_EMIGRANT
6.66666666667%	2	30	222	Mendelian_Hereditary_Sensory_Neuropathy	CAIRO_LIVER_DEVELOPMENT_DN
6.66666666667%	2	30	221	Mendelian_Hereditary_Sensory_Neuropathy	ZHANG_TLX_TARGETS_36HR_UP
6.66666666667%	2	30	217	Mendelian_Hereditary_Sensory_Neuropathy	WIERENGA_STAT5A_TARGETS_UP
6.66666666667%	2	30	214	Mendelian_Hereditary_Sensory_Neuropathy	TIEN_INTESTINE_PROBIOTICS_24HR_DN
6.66666666667%	2	30	214	Mendelian_Hereditary_Sensory_Neuropathy	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
6.66666666667%	2	30	214	Mendelian_Hereditary_Sensory_Neuropathy	BIDUS_METASTASIS_UP
6.66666666667%	2	30	210	Mendelian_Hereditary_Sensory_Neuropathy	WANG_TUMOR_INVASIVENESS_DN
6.66666666667%	2	30	210	Mendelian_Hereditary_Sensory_Neuropathy	RIZKI_TUMOR_INVASIVENESS_3D_UP
6.66666666667%	2	30	210	Mendelian_Hereditary_Sensory_Neuropathy	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
6.66666666667%	2	30	21	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION
6.66666666667%	2	30	205	Mendelian_Hereditary_Sensory_Neuropathy	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
6.66666666667%	2	30	205	Mendelian_Hereditary_Sensory_Neuropathy	PEREZ_TP53_AND_TP63_TARGETS
6.66666666667%	2	30	198	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_PHOSPHOLIPID_METABOLISM
6.66666666667%	2	30	198	Mendelian_Hereditary_Sensory_Neuropathy	ALONSO_METASTASIS_UP
6.66666666667%	2	30	196	Mendelian_Hereditary_Sensory_Neuropathy	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
6.66666666667%	2	30	188	Mendelian_Hereditary_Sensory_Neuropathy	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
6.66666666667%	2	30	185	Mendelian_Hereditary_Sensory_Neuropathy	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
6.66666666667%	2	30	183	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_ENDOCYTOSIS
6.66666666667%	2	30	1821	Mendelian_Hereditary_Sensory_Neuropathy	DODD_NASOPHARYNGEAL_CARCINOMA_UP
6.66666666667%	2	30	181	Mendelian_Hereditary_Sensory_Neuropathy	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
6.66666666667%	2	30	181	Mendelian_Hereditary_Sensory_Neuropathy	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
6.66666666667%	2	30	174	Mendelian_Hereditary_Sensory_Neuropathy	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
6.66666666667%	2	30	170	Mendelian_Hereditary_Sensory_Neuropathy	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
6.66666666667%	2	30	169	Mendelian_Hereditary_Sensory_Neuropathy	UEDA_PERIFERAL_CLOCK
6.66666666667%	2	30	169	Mendelian_Hereditary_Sensory_Neuropathy	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
6.66666666667%	2	30	167	Mendelian_Hereditary_Sensory_Neuropathy	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
6.66666666667%	2	30	164	Mendelian_Hereditary_Sensory_Neuropathy	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
6.66666666667%	2	30	163	Mendelian_Hereditary_Sensory_Neuropathy	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
6.66666666667%	2	30	162	Mendelian_Hereditary_Sensory_Neuropathy	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
6.66666666667%	2	30	158	Mendelian_Hereditary_Sensory_Neuropathy	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
6.66666666667%	2	30	157	Mendelian_Hereditary_Sensory_Neuropathy	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
6.66666666667%	2	30	151	Mendelian_Hereditary_Sensory_Neuropathy	IGLESIAS_E2F_TARGETS_UP
6.66666666667%	2	30	147	Mendelian_Hereditary_Sensory_Neuropathy	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
6.66666666667%	2	30	145	Mendelian_Hereditary_Sensory_Neuropathy	ZHANG_BREAST_CANCER_PROGENITORS_DN
6.66666666667%	2	30	137	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
6.66666666667%	2	30	136	Mendelian_Hereditary_Sensory_Neuropathy	WIERENGA_STAT5A_TARGETS_GROUP1
6.66666666667%	2	30	136	Mendelian_Hereditary_Sensory_Neuropathy	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
6.66666666667%	2	30	13	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING
6.66666666667%	2	30	129	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_MEMBRANE_TRAFFICKING
6.66666666667%	2	30	128	Mendelian_Hereditary_Sensory_Neuropathy	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
6.66666666667%	2	30	1278	Mendelian_Hereditary_Sensory_Neuropathy	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
6.66666666667%	2	30	122	Mendelian_Hereditary_Sensory_Neuropathy	TOOKER_GEMCITABINE_RESISTANCE_DN
6.66666666667%	2	30	121	Mendelian_Hereditary_Sensory_Neuropathy	VANTVEER_BREAST_CANCER_METASTASIS_DN
6.66666666667%	2	30	12	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE
6.66666666667%	2	30	117	Mendelian_Hereditary_Sensory_Neuropathy	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
6.66666666667%	2	30	1080	Mendelian_Hereditary_Sensory_Neuropathy	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
6.66666666667%	2	30	106	Mendelian_Hereditary_Sensory_Neuropathy	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
6.66666666667%	2	30	10	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE
6.66666666667%	1	15	988	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BENPORATH_NANOG_TARGETS
6.66666666667%	1	15	97	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LABBE_WNT3A_TARGETS_DN
6.66666666667%	1	15	957	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LOPEZ_MBD_TARGETS
6.66666666667%	1	15	953	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
6.66666666667%	1	15	94	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP
6.66666666667%	1	15	92	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KIM_MYCN_AMPLIFICATION_TARGETS_UP
6.66666666667%	1	15	918	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	JOHNSTONE_PARVB_TARGETS_3_DN
6.66666666667%	1	15	91	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
6.66666666667%	1	15	90	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SASSON_RESPONSE_TO_FORSKOLIN_UP
6.66666666667%	1	15	90	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SANA_TNF_SIGNALING_DN
6.66666666667%	1	15	9	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BIOCARTA_FEEDER_PATHWAY
6.66666666667%	1	15	898	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
6.66666666667%	1	15	893	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GEORGES_TARGETS_OF_MIR192_AND_MIR215
6.66666666667%	1	15	89	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SWEET_KRAS_ONCOGENIC_SIGNATURE
6.66666666667%	1	15	89	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
6.66666666667%	1	15	882	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
6.66666666667%	1	15	882	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LEE_BMP2_TARGETS_DN
6.66666666667%	1	15	882	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
6.66666666667%	1	15	88	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	UEDA_CENTRAL_CLOCK
6.66666666667%	1	15	88	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SASSON_RESPONSE_TO_FORSKOLIN_DN
6.66666666667%	1	15	88	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
6.66666666667%	1	15	871	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GRADE_COLON_CANCER_UP
6.66666666667%	1	15	87	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SMITH_TERT_TARGETS_DN
6.66666666667%	1	15	87	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
6.66666666667%	1	15	86	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LAIHO_COLORECTAL_CANCER_SERRATED_DN
6.66666666667%	1	15	85	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	STEIN_ESR1_TARGETS
6.66666666667%	1	15	85	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SANA_RESPONSE_TO_IFNG_DN
6.66666666667%	1	15	85	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LEIN_CEREBELLUM_MARKERS
6.66666666667%	1	15	84	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SWEET_KRAS_TARGETS_UP
6.66666666667%	1	15	824	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
6.66666666667%	1	15	82	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	FRASOR_RESPONSE_TO_ESTRADIOL_DN
6.66666666667%	1	15	811	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
6.66666666667%	1	15	800	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
6.66666666667%	1	15	80	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
6.66666666667%	1	15	8	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2
6.66666666667%	1	15	8	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GROSS_HYPOXIA_VIA_HIF1A_ONLY
6.66666666667%	1	15	79	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16
6.66666666667%	1	15	79	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GAVIN_FOXP3_TARGETS_CLUSTER_P2
6.66666666667%	1	15	783	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ONKEN_UVEAL_MELANOMA_UP
6.66666666667%	1	15	781	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GOZGIT_ESR1_TARGETS_DN
6.66666666667%	1	15	78	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ROSS_AML_WITH_MLL_FUSIONS
6.66666666667%	1	15	78	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BOYLAN_MULTIPLE_MYELOMA_D_DN
6.66666666667%	1	15	779	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PUJANA_CHEK2_PCC_NETWORK
6.66666666667%	1	15	770	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
6.66666666667%	1	15	77	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	FRIDMAN_SENESCENCE_UP
6.66666666667%	1	15	76	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SU_TESTIS
6.66666666667%	1	15	756	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
6.66666666667%	1	15	75	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	JAIN_NFKB_SIGNALING
6.66666666667%	1	15	75	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
6.66666666667%	1	15	745	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LEE_BMP2_TARGETS_UP
6.66666666667%	1	15	74	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LEIN_OLIGODENDROCYTE_MARKERS
6.66666666667%	1	15	73	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HOSHIDA_LIVER_CANCER_SURVIVAL_UP
6.66666666667%	1	15	721	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	WONG_ADULT_TISSUE_STEM_MODULE
6.66666666667%	1	15	720	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
6.66666666667%	1	15	712	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SCHLOSSER_SERUM_RESPONSE_DN
6.66666666667%	1	15	701	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SMID_BREAST_CANCER_BASAL_DN
6.66666666667%	1	15	70	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	RAGHAVACHARI_PLATELET_SPECIFIC_GENES
6.66666666667%	1	15	69	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
6.66666666667%	1	15	682	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
6.66666666667%	1	15	682	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	FEVR_CTNNB1_TARGETS_UP
6.66666666667%	1	15	67	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GENTILE_UV_LOW_DOSE_DN
6.66666666667%	1	15	66	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LEE_LIVER_CANCER_CIPROFIBRATE_DN
6.66666666667%	1	15	66	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
6.66666666667%	1	15	65	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ST_FAS_SIGNALING_PATHWAY
6.66666666667%	1	15	65	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LEE_LIVER_CANCER_ACOX1_DN
6.66666666667%	1	15	64	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ZHAN_MULTIPLE_MYELOMA_UP
6.66666666667%	1	15	64	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
6.66666666667%	1	15	637	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
6.66666666667%	1	15	63	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MODY_HIPPOCAMPUS_POSTNATAL
6.66666666667%	1	15	63	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LEE_LIVER_CANCER_MYC_DN
6.66666666667%	1	15	62	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
6.66666666667%	1	15	612	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
6.66666666667%	1	15	61	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MASSARWEH_RESPONSE_TO_ESTRADIOL
6.66666666667%	1	15	59	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ASTIER_INTEGRIN_SIGNALING
6.66666666667%	1	15	578	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
6.66666666667%	1	15	567	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	CHICAS_RB1_TARGETS_CONFLUENT
6.66666666667%	1	15	566	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DOUGLAS_BMI1_TARGETS_UP
6.66666666667%	1	15	55	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	YU_MYC_TARGETS_DN
6.66666666667%	1	15	55	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN
6.66666666667%	1	15	55	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DEMAGALHAES_AGING_UP
6.66666666667%	1	15	540	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ACEVEDO_LIVER_CANCER_DN
6.66666666667%	1	15	54	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SUNG_METASTASIS_STROMA_DN
6.66666666667%	1	15	535	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	STEIN_ESRRA_TARGETS
6.66666666667%	1	15	52	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
6.66666666667%	1	15	514	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
6.66666666667%	1	15	51	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MORI_PLASMA_CELL_UP
6.66666666667%	1	15	493	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
6.66666666667%	1	15	491	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SWEET_LUNG_CANCER_KRAS_UP
6.66666666667%	1	15	49	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KEGG_GLYCEROLIPID_METABOLISM
6.66666666667%	1	15	49	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	FAELT_B_CLL_WITH_VH3_21_DN
6.66666666667%	1	15	49	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DAUER_STAT3_TARGETS_UP
6.66666666667%	1	15	487	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
6.66666666667%	1	15	48	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PID_HES_HEYPATHWAY
6.66666666667%	1	15	48	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PID_CERAMIDE_PATHWAY
6.66666666667%	1	15	48	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
6.66666666667%	1	15	466	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	REACTOME_HEMOSTASIS
6.66666666667%	1	15	46	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	TSENG_ADIPOGENIC_POTENTIAL_DN
6.66666666667%	1	15	46	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PID_TNFPATHWAY
6.66666666667%	1	15	46	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	NUTT_GBM_VS_AO_GLIOMA_UP
6.66666666667%	1	15	46	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	NAKAJIMA_MAST_CELL
6.66666666667%	1	15	456	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MARTENS_BOUND_BY_PML_RARA_FUSION
6.66666666667%	1	15	448	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
6.66666666667%	1	15	443	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DELYS_THYROID_CANCER_UP
6.66666666667%	1	15	442	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HAN_SATB1_TARGETS_DN
6.66666666667%	1	15	44	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP
6.66666666667%	1	15	439	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MITSIADES_RESPONSE_TO_APLIDIN_UP
6.66666666667%	1	15	425	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BOCHKIS_FOXA2_TARGETS
6.66666666667%	1	15	424	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SHEN_SMARCA2_TARGETS_UP
6.66666666667%	1	15	419	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
6.66666666667%	1	15	414	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LU_EZH2_TARGETS_DN
6.66666666667%	1	15	413	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
6.66666666667%	1	15	408	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
6.66666666667%	1	15	40	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN
6.66666666667%	1	15	40	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BERNARD_PPAPDC1B_TARGETS_UP
6.66666666667%	1	15	389	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HSIAO_HOUSEKEEPING_GENES
6.66666666667%	1	15	384	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BASAKI_YBX1_TARGETS_DN
6.66666666667%	1	15	380	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MULLIGHAN_MLL_SIGNATURE_1_UP
6.66666666667%	1	15	38	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	REACTOME_GLUCOSE_TRANSPORT
6.66666666667%	1	15	38	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PID_FASPATHWAY
6.66666666667%	1	15	38	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON
6.66666666667%	1	15	38	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN
6.66666666667%	1	15	371	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	WANG_SMARCE1_TARGETS_DN
6.66666666667%	1	15	37	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ST_GA13_PATHWAY
6.66666666667%	1	15	36	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN
6.66666666667%	1	15	36	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ST_ADRENERGIC
6.66666666667%	1	15	358	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GRUETZMANN_PANCREATIC_CANCER_UP
6.66666666667%	1	15	351	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	YAGI_AML_WITH_11Q23_REARRANGED
6.66666666667%	1	15	35	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15
6.66666666667%	1	15	35	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	YAGI_AML_RELAPSE_PROGNOSIS
6.66666666667%	1	15	34	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	REACTOME_GLUCONEOGENESIS
6.66666666667%	1	15	34	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PID_IL2_PI3KPATHWAY
6.66666666667%	1	15	335	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
6.66666666667%	1	15	332	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
6.66666666667%	1	15	330	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
6.66666666667%	1	15	329	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
6.66666666667%	1	15	326	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
6.66666666667%	1	15	324	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
6.66666666667%	1	15	32	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MOOTHA_GLUCONEOGENESIS
6.66666666667%	1	15	32	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP
6.66666666667%	1	15	318	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LEI_MYB_TARGETS
6.66666666667%	1	15	315	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
6.66666666667%	1	15	314	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DOUGLAS_BMI1_TARGETS_DN
6.66666666667%	1	15	310	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HORIUCHI_WTAP_TARGETS_DN
6.66666666667%	1	15	31	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP
6.66666666667%	1	15	309	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LIU_SOX4_TARGETS_DN
6.66666666667%	1	15	309	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
6.66666666667%	1	15	308	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
6.66666666667%	1	15	305	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
6.66666666667%	1	15	298	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
6.66666666667%	1	15	293	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	IVANOVA_HEMATOPOIESIS_MATURE_CELL
6.66666666667%	1	15	292	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HELLER_HDAC_TARGETS_DN
6.66666666667%	1	15	29	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	REACTOME_GLYCOLYSIS
6.66666666667%	1	15	287	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
6.66666666667%	1	15	283	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
6.66666666667%	1	15	281	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BHAT_ESR1_TARGETS_VIA_AKT1_UP
6.66666666667%	1	15	28	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ST_GAQ_PATHWAY
6.66666666667%	1	15	28	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PID_TRAIL_PATHWAY
6.66666666667%	1	15	28	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN
6.66666666667%	1	15	28	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN
6.66666666667%	1	15	276	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
6.66666666667%	1	15	274	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
6.66666666667%	1	15	270	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	RIZKI_TUMOR_INVASIVENESS_3D_DN
6.66666666667%	1	15	27	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BIOCARTA_EDG1_PATHWAY
6.66666666667%	1	15	267	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HOLLMANN_APOPTOSIS_VIA_CD40_DN
6.66666666667%	1	15	266	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
6.66666666667%	1	15	264	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
6.66666666667%	1	15	264	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
6.66666666667%	1	15	261	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
6.66666666667%	1	15	261	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
6.66666666667%	1	15	260	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BOQUEST_STEM_CELL_UP
6.66666666667%	1	15	26	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN
6.66666666667%	1	15	26	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
6.66666666667%	1	15	259	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
6.66666666667%	1	15	254	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	IVANOVA_HEMATOPOIESIS_STEM_CELL
6.66666666667%	1	15	254	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BROWNE_HCMV_INFECTION_4HR_DN
6.66666666667%	1	15	25	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP
6.66666666667%	1	15	249	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MITSIADES_RESPONSE_TO_APLIDIN_DN
6.66666666667%	1	15	246	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
6.66666666667%	1	15	245	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BLUM_RESPONSE_TO_SALIRASIB_UP
6.66666666667%	1	15	244	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KAYO_AGING_MUSCLE_UP
6.66666666667%	1	15	244	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HSIAO_LIVER_SPECIFIC_GENES
6.66666666667%	1	15	244	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DAZARD_RESPONSE_TO_UV_NHEK_UP
6.66666666667%	1	15	242	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
6.66666666667%	1	15	241	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
6.66666666667%	1	15	237	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
6.66666666667%	1	15	236	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
6.66666666667%	1	15	230	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BENPORATH_MYC_TARGETS_WITH_EBOX
6.66666666667%	1	15	23	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SABATES_COLORECTAL_ADENOMA_SIZE_UP
6.66666666667%	1	15	23	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5
6.66666666667%	1	15	229	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
6.66666666667%	1	15	225	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
6.66666666667%	1	15	222	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
6.66666666667%	1	15	222	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	CAIRO_LIVER_DEVELOPMENT_DN
6.66666666667%	1	15	222	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BROWNE_HCMV_INFECTION_1HR_DN
6.66666666667%	1	15	221	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ZHANG_TLX_TARGETS_36HR_UP
6.66666666667%	1	15	220	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
6.66666666667%	1	15	220	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	RIGGINS_TAMOXIFEN_RESISTANCE_DN
6.66666666667%	1	15	22	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BIOCARTA_CERAMIDE_PATHWAY
6.66666666667%	1	15	217	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	AMUNDSON_RESPONSE_TO_ARSENITE
6.66666666667%	1	15	215	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MARKEY_RB1_ACUTE_LOF_UP
6.66666666667%	1	15	214	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KIM_WT1_TARGETS_UP
6.66666666667%	1	15	210	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	VERHAAK_GLIOBLASTOMA_NEURAL
6.66666666667%	1	15	21	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP
6.66666666667%	1	15	21	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MOOTHA_GLYCOLYSIS
6.66666666667%	1	15	208	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
6.66666666667%	1	15	205	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SHEPARD_BMYB_MORPHOLINO_UP
6.66666666667%	1	15	203	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GRUETZMANN_PANCREATIC_CANCER_DN
6.66666666667%	1	15	202	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
6.66666666667%	1	15	202	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	FUJII_YBX1_TARGETS_DN
6.66666666667%	1	15	200	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SHEPARD_BMYB_MORPHOLINO_DN
6.66666666667%	1	15	20	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3
6.66666666667%	1	15	198	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	WELCSH_BRCA1_TARGETS_UP
6.66666666667%	1	15	198	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ALONSO_METASTASIS_UP
6.66666666667%	1	15	195	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
6.66666666667%	1	15	194	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KASLER_HDAC7_TARGETS_1_UP
6.66666666667%	1	15	191	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
6.66666666667%	1	15	188	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
6.66666666667%	1	15	186	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HAMAI_APOPTOSIS_VIA_TRAIL_DN
6.66666666667%	1	15	185	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LEE_LIVER_CANCER_SURVIVAL_UP
6.66666666667%	1	15	184	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DOANE_RESPONSE_TO_ANDROGEN_UP
6.66666666667%	1	15	183	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	VERHAAK_AML_WITH_NPM1_MUTATED_UP
6.66666666667%	1	15	182	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	RAO_BOUND_BY_SALL4_ISOFORM_A
6.66666666667%	1	15	181	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	JISON_SICKLE_CELL_DISEASE_UP
6.66666666667%	1	15	181	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
6.66666666667%	1	15	180	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
6.66666666667%	1	15	180	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DARWICHE_PAPILLOMA_RISK_HIGH_DN
6.66666666667%	1	15	176	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
6.66666666667%	1	15	176	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	NAGASHIMA_NRG1_SIGNALING_UP
6.66666666667%	1	15	175	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	FIRESTEIN_PROLIFERATION
6.66666666667%	1	15	172	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SMID_BREAST_CANCER_LUMINAL_B_UP
6.66666666667%	1	15	17	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
6.66666666667%	1	15	17	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
6.66666666667%	1	15	169	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PENG_GLUCOSE_DEPRIVATION_DN
6.66666666667%	1	15	165	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BROWN_MYELOID_CELL_DEVELOPMENT_UP
6.66666666667%	1	15	162	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
6.66666666667%	1	15	162	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DARWICHE_PAPILLOMA_RISK_LOW_UP
6.66666666667%	1	15	16	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KEGG_OTHER_GLYCAN_DEGRADATION
6.66666666667%	1	15	158	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	RODRIGUES_NTN1_TARGETS_DN
6.66666666667%	1	15	157	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SERVITJA_LIVER_HNF1A_TARGETS_DN
6.66666666667%	1	15	157	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
6.66666666667%	1	15	156	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GROSS_HYPOXIA_VIA_ELK3_DN
6.66666666667%	1	15	156	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BROWNE_HCMV_INFECTION_14HR_UP
6.66666666667%	1	15	149	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LANDIS_ERBB2_BREAST_TUMORS_324_DN
6.66666666667%	1	15	149	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
6.66666666667%	1	15	148	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BROWNE_HCMV_INFECTION_24HR_UP
6.66666666667%	1	15	147	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
6.66666666667%	1	15	145	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SMITH_TERT_TARGETS_UP
6.66666666667%	1	15	142	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
6.66666666667%	1	15	142	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DARWICHE_SKIN_TUMOR_PROMOTER_UP
6.66666666667%	1	15	141	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	WELCSH_BRCA1_TARGETS_DN
6.66666666667%	1	15	14	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES
6.66666666667%	1	15	14	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HOEGERKORP_CD44_TARGETS_DIRECT_DN
6.66666666667%	1	15	136	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
6.66666666667%	1	15	135	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	TSENG_IRS1_TARGETS_DN
6.66666666667%	1	15	129	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	YAGI_AML_SURVIVAL
6.66666666667%	1	15	128	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LENAOUR_DENDRITIC_CELL_MATURATION_DN
6.66666666667%	1	15	1278	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
6.66666666667%	1	15	126	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SANSOM_APC_TARGETS_UP
6.66666666667%	1	15	126	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GERY_CEBP_TARGETS
6.66666666667%	1	15	1237	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	BLALOCK_ALZHEIMERS_DISEASE_DN
6.66666666667%	1	15	1229	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
6.66666666667%	1	15	122	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	TOOKER_GEMCITABINE_RESISTANCE_DN
6.66666666667%	1	15	120	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	XU_GH1_EXOGENOUS_TARGETS_DN
6.66666666667%	1	15	120	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
6.66666666667%	1	15	118	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
6.66666666667%	1	15	1174	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	PEREZ_TP53_TARGETS
6.66666666667%	1	15	116	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
6.66666666667%	1	15	116	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LIM_MAMMARY_LUMINAL_MATURE_UP
6.66666666667%	1	15	115	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
6.66666666667%	1	15	115	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
6.66666666667%	1	15	1142	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
6.66666666667%	1	15	114	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MATZUK_SPERMATOZOA
6.66666666667%	1	15	113	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
6.66666666667%	1	15	111	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
6.66666666667%	1	15	1103	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	DANG_BOUND_BY_MYC
6.66666666667%	1	15	110	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SUNG_METASTASIS_STROMA_UP
6.66666666667%	1	15	109	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	SERVITJA_ISLET_HNF1A_TARGETS_DN
6.66666666667%	1	15	108	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	ZHANG_TLX_TARGETS_DN
6.66666666667%	1	15	105	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	STEIN_ESRRA_TARGETS_DN
6.66666666667%	1	15	104	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	NAKAMURA_ADIPOGENESIS_LATE_UP
6.66666666667%	1	15	1037	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	NUYTTEN_EZH2_TARGETS_UP
6.66666666667%	1	15	1022	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MARSON_BOUND_BY_FOXP3_STIMULATED
6.66666666667%	1	15	102	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
6.66666666667%	1	15	10	Mendelian_Cerebral_Degeneration_Due_to_Generalized_Lipidoses	MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP
6.65658093797%	44	661	882	T2D_GENES_TANYA_GLYCEMIC	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
6.64819944598%	24	361	1781	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
6.64819944598%	24	361	1691	T2D_GENES_TANYA_T2D_RSQ05_02CM	BLALOCK_ALZHEIMERS_DISEASE_UP
6.63627152989%	131	1974	429	Mendelian_Nancy_Cox	MOOTHA_HUMAN_MITODB_6_2002
6.59340659341%	30	455	1382	T2D_GENES_TANYA_BLOODPRESSURE	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
6.59340659341%	30	455	1237	T2D_GENES_TANYA_BLOODPRESSURE	BLALOCK_ALZHEIMERS_DISEASE_DN
6.58561296859%	130	1974	447	Mendelian_Nancy_Cox	MOOTHA_MITOCHONDRIA
6.53173873045%	142	2174	1103	T2D_GENES_TANYA_LIPIDS	DANG_BOUND_BY_MYC
6.52528548124%	40	613	1442	T2D_GENES_TANYA_BIOMARKER	PUJANA_ATM_PCC_NETWORK
6.52057723143%	122	1871	1022	T2D_GENES_TANYA_HEIGHT	MARSON_BOUND_BY_FOXP3_STIMULATED
6.50529500756%	43	661	1103	T2D_GENES_TANYA_GLYCEMIC	DANG_BOUND_BY_MYC
6.50529500756%	43	661	1062	T2D_GENES_TANYA_GLYCEMIC	BENPORATH_EED_TARGETS
6.45756457565%	35	542	1142	T2D_GENES_TANYA_ANTHROPOMETRIC	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
6.45756457565%	35	542	1038	T2D_GENES_TANYA_ANTHROPOMETRIC	BENPORATH_SUZ12_TARGETS
6.45161290323%	8	124	92	Diabetes_McGill_Cell_cycle_All_Gene	DE_YY1_TARGETS_DN
6.45161290323%	8	124	91	Diabetes_McGill_Cell_cycle_All_Gene	GAVIN_FOXP3_TARGETS_CLUSTER_P6
6.45161290323%	8	124	90	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_ERBB4
6.45161290323%	8	124	87	Diabetes_McGill_Cell_cycle_All_Gene	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
6.45161290323%	8	124	863	Diabetes_McGill_Cell_cycle_All_Gene	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
6.45161290323%	8	124	80	Diabetes_McGill_Cell_cycle_All_Gene	MORI_PRE_BI_LYMPHOCYTE_UP
6.45161290323%	8	124	8	Diabetes_McGill_Cell_cycle_All_Gene	REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS
6.45161290323%	8	124	70	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_NOTCH1
6.45161290323%	8	124	70	Diabetes_McGill_Cell_cycle_All_Gene	PID_AP1_PATHWAY
6.45161290323%	8	124	658	Diabetes_McGill_Cell_cycle_All_Gene	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
6.45161290323%	8	124	591	Diabetes_McGill_Cell_cycle_All_Gene	MARTINEZ_RB1_AND_TP53_TARGETS_DN
6.45161290323%	8	124	59	Diabetes_McGill_Cell_cycle_All_Gene	PID_NOTCH_PATHWAY
6.45161290323%	8	124	57	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE
6.45161290323%	8	124	55	Diabetes_McGill_Cell_cycle_All_Gene	LAU_APOPTOSIS_CDKN2A_UP
6.45161290323%	8	124	54	Diabetes_McGill_Cell_cycle_All_Gene	PID_TAP63PATHWAY
6.45161290323%	8	124	54	Diabetes_McGill_Cell_cycle_All_Gene	KANG_DOXORUBICIN_RESISTANCE_UP
6.45161290323%	8	124	510	Diabetes_McGill_Cell_cycle_All_Gene	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
6.45161290323%	8	124	505	Diabetes_McGill_Cell_cycle_All_Gene	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
6.45161290323%	8	124	50	Diabetes_McGill_Cell_cycle_All_Gene	HOFMANN_CELL_LYMPHOMA_UP
6.45161290323%	8	124	46	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION
6.45161290323%	8	124	45	Diabetes_McGill_Cell_cycle_All_Gene	ABRAMSON_INTERACT_WITH_AIRE
6.45161290323%	8	124	431	Diabetes_McGill_Cell_cycle_All_Gene	GARY_CD5_TARGETS_DN
6.45161290323%	8	124	41	Diabetes_McGill_Cell_cycle_All_Gene	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN
6.45161290323%	8	124	368	Diabetes_McGill_Cell_cycle_All_Gene	YAGI_AML_WITH_T_8_21_TRANSLOCATION
6.45161290323%	8	124	368	Diabetes_McGill_Cell_cycle_All_Gene	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
6.45161290323%	8	124	33	Diabetes_McGill_Cell_cycle_All_Gene	FARMER_BREAST_CANCER_CLUSTER_2
6.45161290323%	8	124	30	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_DNA_STRAND_ELONGATION
6.45161290323%	8	124	292	Diabetes_McGill_Cell_cycle_All_Gene	HELLER_HDAC_TARGETS_DN
6.45161290323%	8	124	289	Diabetes_McGill_Cell_cycle_All_Gene	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
6.45161290323%	8	124	26	Diabetes_McGill_Cell_cycle_All_Gene	PID_INSULIN_GLUCOSE_PATHWAY
6.45161290323%	8	124	246	Diabetes_McGill_Cell_cycle_All_Gene	BILD_E2F3_ONCOGENIC_SIGNATURE
6.45161290323%	8	124	217	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALLING_BY_NGF
6.45161290323%	8	124	21	Diabetes_McGill_Cell_cycle_All_Gene	PID_P38_MK2PATHWAY
6.45161290323%	8	124	206	Diabetes_McGill_Cell_cycle_All_Gene	LINSLEY_MIR16_TARGETS
6.45161290323%	8	124	20	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_ATM_PATHWAY
6.45161290323%	8	124	193	Diabetes_McGill_Cell_cycle_All_Gene	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP
6.45161290323%	8	124	19	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_TGFB_PATHWAY
6.45161290323%	8	124	188	Diabetes_McGill_Cell_cycle_All_Gene	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
6.45161290323%	8	124	182	Diabetes_McGill_Cell_cycle_All_Gene	FERNANDEZ_BOUND_BY_MYC
6.45161290323%	8	124	18	Diabetes_McGill_Cell_cycle_All_Gene	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
6.45161290323%	8	124	143	Diabetes_McGill_Cell_cycle_All_Gene	BASSO_B_LYMPHOCYTE_NETWORK
6.45161290323%	8	124	132	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
6.45161290323%	8	124	122	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_CHROMOSOME_MAINTENANCE
6.45161290323%	8	124	121	Diabetes_McGill_Cell_cycle_All_Gene	VANTVEER_BREAST_CANCER_METASTASIS_DN
6.45161290323%	8	124	12	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT
6.45161290323%	2	31	98	Diabetes_McGill_IL10	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
6.45161290323%	2	31	98	Diabetes_McGill_IL10	PYEON_HPV_POSITIVE_TUMORS_UP
6.45161290323%	2	31	98	Diabetes_McGill_IL10	HAHTOLA_SEZARY_SYNDROM_UP
6.45161290323%	2	31	957	Diabetes_McGill_IL10	LOPEZ_MBD_TARGETS
6.45161290323%	2	31	95	Diabetes_McGill_IL10	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
6.45161290323%	2	31	93	Diabetes_McGill_IL10	REACTOME_ACTIVATED_TLR4_SIGNALLING
6.45161290323%	2	31	93	Diabetes_McGill_IL10	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
6.45161290323%	2	31	92	Diabetes_McGill_IL10	HILLION_HMGA1B_TARGETS
6.45161290323%	2	31	911	Diabetes_McGill_IL10	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
6.45161290323%	2	31	91	Diabetes_McGill_IL10	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
6.45161290323%	2	31	91	Diabetes_McGill_IL10	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
6.45161290323%	2	31	90	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_ERBB4
6.45161290323%	2	31	90	Diabetes_McGill_IL10	MORI_MATURE_B_LYMPHOCYTE_UP
6.45161290323%	2	31	90	Diabetes_McGill_IL10	MORI_IMMATURE_B_LYMPHOCYTE_DN
6.45161290323%	2	31	90	Diabetes_McGill_IL10	IVANOVSKA_MIR106B_TARGETS
6.45161290323%	2	31	9	Diabetes_McGill_IL10	ZHU_SKIL_TARGETS_DN
6.45161290323%	2	31	9	Diabetes_McGill_IL10	ST_TYPE_I_INTERFERON_PATHWAY
6.45161290323%	2	31	898	Diabetes_McGill_IL10	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
6.45161290323%	2	31	882	Diabetes_McGill_IL10	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
6.45161290323%	2	31	882	Diabetes_McGill_IL10	LEE_BMP2_TARGETS_DN
6.45161290323%	2	31	88	Diabetes_McGill_IL10	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
6.45161290323%	2	31	871	Diabetes_McGill_IL10	GRADE_COLON_CANCER_UP
6.45161290323%	2	31	863	Diabetes_McGill_IL10	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
6.45161290323%	2	31	86	Diabetes_McGill_IL10	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
6.45161290323%	2	31	86	Diabetes_McGill_IL10	BAELDE_DIABETIC_NEPHROPATHY_UP
6.45161290323%	2	31	857	Diabetes_McGill_IL10	MARTENS_TRETINOIN_RESPONSE_UP
6.45161290323%	2	31	84	Diabetes_McGill_IL10	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
6.45161290323%	2	31	830	Diabetes_McGill_IL10	CUI_TCF21_TARGETS_2_DN
6.45161290323%	2	31	83	Diabetes_McGill_IL10	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
6.45161290323%	2	31	83	Diabetes_McGill_IL10	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
6.45161290323%	2	31	83	Diabetes_McGill_IL10	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
6.45161290323%	2	31	82	Diabetes_McGill_IL10	ST_INTEGRIN_SIGNALING_PATHWAY
6.45161290323%	2	31	82	Diabetes_McGill_IL10	PID_SMAD2_3NUCLEARPATHWAY
6.45161290323%	2	31	81	Diabetes_McGill_IL10	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
6.45161290323%	2	31	800	Diabetes_McGill_IL10	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
6.45161290323%	2	31	80	Diabetes_McGill_IL10	PID_MET_PATHWAY
6.45161290323%	2	31	80	Diabetes_McGill_IL10	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
6.45161290323%	2	31	8	Diabetes_McGill_IL10	REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS
6.45161290323%	2	31	79	Diabetes_McGill_IL10	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
6.45161290323%	2	31	79	Diabetes_McGill_IL10	DUAN_PRDM5_TARGETS
6.45161290323%	2	31	784	Diabetes_McGill_IL10	FORTSCHEGGER_PHF8_TARGETS_DN
6.45161290323%	2	31	779	Diabetes_McGill_IL10	PUJANA_CHEK2_PCC_NETWORK
6.45161290323%	2	31	775	Diabetes_McGill_IL10	BENPORATH_MYC_MAX_TARGETS
6.45161290323%	2	31	770	Diabetes_McGill_IL10	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
6.45161290323%	2	31	77	Diabetes_McGill_IL10	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
6.45161290323%	2	31	77	Diabetes_McGill_IL10	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
6.45161290323%	2	31	77	Diabetes_McGill_IL10	MORI_PRE_BI_LYMPHOCYTE_DN
6.45161290323%	2	31	77	Diabetes_McGill_IL10	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
6.45161290323%	2	31	77	Diabetes_McGill_IL10	FRIDMAN_SENESCENCE_UP
6.45161290323%	2	31	75	Diabetes_McGill_IL10	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
6.45161290323%	2	31	75	Diabetes_McGill_IL10	PID_AVB3_INTEGRIN_PATHWAY
6.45161290323%	2	31	75	Diabetes_McGill_IL10	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
6.45161290323%	2	31	75	Diabetes_McGill_IL10	CHESLER_BRAIN_QTL_CIS
6.45161290323%	2	31	747	Diabetes_McGill_IL10	PATIL_LIVER_CANCER
6.45161290323%	2	31	745	Diabetes_McGill_IL10	LEE_BMP2_TARGETS_UP
6.45161290323%	2	31	74	Diabetes_McGill_IL10	VANASSE_BCL2_TARGETS_DN
6.45161290323%	2	31	74	Diabetes_McGill_IL10	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
6.45161290323%	2	31	73	Diabetes_McGill_IL10	LIN_MELANOMA_COPY_NUMBER_UP
6.45161290323%	2	31	73	Diabetes_McGill_IL10	GAURNIER_PSMD4_TARGETS
6.45161290323%	2	31	728	Diabetes_McGill_IL10	MARSON_BOUND_BY_E2F4_UNSTIMULATED
6.45161290323%	2	31	72	Diabetes_McGill_IL10	SESTO_RESPONSE_TO_UV_C8
6.45161290323%	2	31	72	Diabetes_McGill_IL10	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
6.45161290323%	2	31	72	Diabetes_McGill_IL10	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
6.45161290323%	2	31	712	Diabetes_McGill_IL10	SCHLOSSER_SERUM_RESPONSE_DN
6.45161290323%	2	31	71	Diabetes_McGill_IL10	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
6.45161290323%	2	31	7	Diabetes_McGill_IL10	ST_INTERLEUKIN_13_PATHWAY
6.45161290323%	2	31	7	Diabetes_McGill_IL10	ST_IL_13_PATHWAY
6.45161290323%	2	31	69	Diabetes_McGill_IL10	PID_VEGFR1_2_PATHWAY
6.45161290323%	2	31	69	Diabetes_McGill_IL10	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
6.45161290323%	2	31	681	Diabetes_McGill_IL10	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
6.45161290323%	2	31	68	Diabetes_McGill_IL10	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
6.45161290323%	2	31	66	Diabetes_McGill_IL10	PID_LYSOPHOSPHOLIPID_PATHWAY
6.45161290323%	2	31	66	Diabetes_McGill_IL10	PID_HDAC_CLASSI_PATHWAY
6.45161290323%	2	31	65	Diabetes_McGill_IL10	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
6.45161290323%	2	31	65	Diabetes_McGill_IL10	PID_ERA_GENOMIC_PATHWAY
6.45161290323%	2	31	65	Diabetes_McGill_IL10	PID_BCR_5PATHWAY
6.45161290323%	2	31	65	Diabetes_McGill_IL10	GOLDRATH_IMMUNE_MEMORY
6.45161290323%	2	31	64	Diabetes_McGill_IL10	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
6.45161290323%	2	31	64	Diabetes_McGill_IL10	GERHOLD_ADIPOGENESIS_DN
6.45161290323%	2	31	64	Diabetes_McGill_IL10	BYSTROEM_CORRELATED_WITH_IL5_DN
6.45161290323%	2	31	63	Diabetes_McGill_IL10	REACTOME_INTERFERON_GAMMA_SIGNALING
6.45161290323%	2	31	63	Diabetes_McGill_IL10	PID_MYC_REPRESSPATHWAY
6.45161290323%	2	31	62	Diabetes_McGill_IL10	PID_FCER1PATHWAY
6.45161290323%	2	31	62	Diabetes_McGill_IL10	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
6.45161290323%	2	31	61	Diabetes_McGill_IL10	PID_AR_PATHWAY
6.45161290323%	2	31	605	Diabetes_McGill_IL10	CAIRO_HEPATOBLASTOMA_CLASSES_UP
6.45161290323%	2	31	601	Diabetes_McGill_IL10	MARTINEZ_RB1_AND_TP53_TARGETS_UP
6.45161290323%	2	31	6	Diabetes_McGill_IL10	GERHOLD_RESPONSE_TO_TZD_UP
6.45161290323%	2	31	590	Diabetes_McGill_IL10	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
6.45161290323%	2	31	59	Diabetes_McGill_IL10	PID_P53REGULATIONPATHWAY
6.45161290323%	2	31	59	Diabetes_McGill_IL10	PID_NOTCH_PATHWAY
6.45161290323%	2	31	59	Diabetes_McGill_IL10	ELVIDGE_HYPOXIA_BY_DMOG_DN
6.45161290323%	2	31	59	Diabetes_McGill_IL10	BARIS_THYROID_CANCER_DN
6.45161290323%	2	31	58	Diabetes_McGill_IL10	SANSOM_WNT_PATHWAY_REQUIRE_MYC
6.45161290323%	2	31	58	Diabetes_McGill_IL10	PID_SHP2_PATHWAY
6.45161290323%	2	31	58	Diabetes_McGill_IL10	NAGASHIMA_EGF_SIGNALING_UP
6.45161290323%	2	31	578	Diabetes_McGill_IL10	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
6.45161290323%	2	31	567	Diabetes_McGill_IL10	CHICAS_RB1_TARGETS_CONFLUENT
6.45161290323%	2	31	56	Diabetes_McGill_IL10	REACTOME_PI_3K_CASCADE
6.45161290323%	2	31	56	Diabetes_McGill_IL10	HOQUE_METHYLATED_IN_CANCER
6.45161290323%	2	31	557	Diabetes_McGill_IL10	TIEN_INTESTINE_PROBIOTICS_24HR_UP
6.45161290323%	2	31	555	Diabetes_McGill_IL10	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
6.45161290323%	2	31	55	Diabetes_McGill_IL10	PID_FGF_PATHWAY
6.45161290323%	2	31	55	Diabetes_McGill_IL10	LAU_APOPTOSIS_CDKN2A_UP
6.45161290323%	2	31	549	Diabetes_McGill_IL10	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
6.45161290323%	2	31	546	Diabetes_McGill_IL10	WEST_ADRENOCORTICAL_TUMOR_DN
6.45161290323%	2	31	544	Diabetes_McGill_IL10	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
6.45161290323%	2	31	540	Diabetes_McGill_IL10	ACEVEDO_LIVER_CANCER_DN
6.45161290323%	2	31	54	Diabetes_McGill_IL10	REACTOME_TCR_SIGNALING
6.45161290323%	2	31	53	Diabetes_McGill_IL10	PID_AR_TF_PATHWAY
6.45161290323%	2	31	53	Diabetes_McGill_IL10	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
6.45161290323%	2	31	528	Diabetes_McGill_IL10	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
6.45161290323%	2	31	526	Diabetes_McGill_IL10	ONKEN_UVEAL_MELANOMA_DN
6.45161290323%	2	31	518	Diabetes_McGill_IL10	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
6.45161290323%	2	31	51	Diabetes_McGill_IL10	ZHANG_PROLIFERATING_VS_QUIESCENT
6.45161290323%	2	31	51	Diabetes_McGill_IL10	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
6.45161290323%	2	31	51	Diabetes_McGill_IL10	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
6.45161290323%	2	31	50	Diabetes_McGill_IL10	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
6.45161290323%	2	31	50	Diabetes_McGill_IL10	PARK_HSC_AND_MULTIPOTENT_PROGENITORS
6.45161290323%	2	31	50	Diabetes_McGill_IL10	HOFMANN_CELL_LYMPHOMA_UP
6.45161290323%	2	31	50	Diabetes_McGill_IL10	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN
6.45161290323%	2	31	493	Diabetes_McGill_IL10	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
6.45161290323%	2	31	491	Diabetes_McGill_IL10	SWEET_LUNG_CANCER_KRAS_UP
6.45161290323%	2	31	49	Diabetes_McGill_IL10	BIOCARTA_TCR_PATHWAY
6.45161290323%	2	31	485	Diabetes_McGill_IL10	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
6.45161290323%	2	31	483	Diabetes_McGill_IL10	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
6.45161290323%	2	31	482	Diabetes_McGill_IL10	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
6.45161290323%	2	31	481	Diabetes_McGill_IL10	LIU_PROSTATE_CANCER_DN
6.45161290323%	2	31	48	Diabetes_McGill_IL10	TAVOR_CEBPA_TARGETS_UP
6.45161290323%	2	31	479	Diabetes_McGill_IL10	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
6.45161290323%	2	31	473	Diabetes_McGill_IL10	GARY_CD5_TARGETS_UP
6.45161290323%	2	31	473	Diabetes_McGill_IL10	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
6.45161290323%	2	31	47	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_8HR_DN
6.45161290323%	2	31	467	Diabetes_McGill_IL10	RATTENBACHER_BOUND_BY_CELF1
6.45161290323%	2	31	464	Diabetes_McGill_IL10	ONDER_CDH1_TARGETS_2_DN
6.45161290323%	2	31	462	Diabetes_McGill_IL10	DELACROIX_RAR_BOUND_ES
6.45161290323%	2	31	46	Diabetes_McGill_IL10	SIG_BCR_SIGNALING_PATHWAY
6.45161290323%	2	31	46	Diabetes_McGill_IL10	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
6.45161290323%	2	31	46	Diabetes_McGill_IL10	PID_PS1PATHWAY
6.45161290323%	2	31	46	Diabetes_McGill_IL10	PID_A6B1_A6B4_INTEGRIN_PATHWAY
6.45161290323%	2	31	46	Diabetes_McGill_IL10	ABBUD_LIF_SIGNALING_1_UP
6.45161290323%	2	31	456	Diabetes_McGill_IL10	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
6.45161290323%	2	31	455	Diabetes_McGill_IL10	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
6.45161290323%	2	31	45	Diabetes_McGill_IL10	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
6.45161290323%	2	31	45	Diabetes_McGill_IL10	PID_INSULIN_PATHWAY
6.45161290323%	2	31	45	Diabetes_McGill_IL10	MCDOWELL_ACUTE_LUNG_INJURY_UP
6.45161290323%	2	31	45	Diabetes_McGill_IL10	BIOCARTA_BIOPEPTIDES_PATHWAY
6.45161290323%	2	31	45	Diabetes_McGill_IL10	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
6.45161290323%	2	31	44	Diabetes_McGill_IL10	WHITFIELD_CELL_CYCLE_LITERATURE
6.45161290323%	2	31	44	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_FGFR_MUTANTS
6.45161290323%	2	31	44	Diabetes_McGill_IL10	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
6.45161290323%	2	31	44	Diabetes_McGill_IL10	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS
6.45161290323%	2	31	431	Diabetes_McGill_IL10	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
6.45161290323%	2	31	43	Diabetes_McGill_IL10	MANTOVANI_NFKB_TARGETS_UP
6.45161290323%	2	31	428	Diabetes_McGill_IL10	LIM_MAMMARY_STEM_CELL_DN
6.45161290323%	2	31	428	Diabetes_McGill_IL10	CUI_TCF21_TARGETS_2_UP
6.45161290323%	2	31	422	Diabetes_McGill_IL10	YAGI_AML_WITH_INV_16_TRANSLOCATION
6.45161290323%	2	31	42	Diabetes_McGill_IL10	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
6.45161290323%	2	31	419	Diabetes_McGill_IL10	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
6.45161290323%	2	31	418	Diabetes_McGill_IL10	MULLIGHAN_MLL_SIGNATURE_2_UP
6.45161290323%	2	31	41	Diabetes_McGill_IL10	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
6.45161290323%	2	31	41	Diabetes_McGill_IL10	PID_ER_NONGENOMIC_PATHWAY
6.45161290323%	2	31	41	Diabetes_McGill_IL10	PID_AMB2_NEUTROPHILS_PATHWAY
6.45161290323%	2	31	41	Diabetes_McGill_IL10	ONO_AML1_TARGETS_DN
6.45161290323%	2	31	41	Diabetes_McGill_IL10	BIOCARTA_FCER1_PATHWAY
6.45161290323%	2	31	404	Diabetes_McGill_IL10	OSMAN_BLADDER_CANCER_UP
6.45161290323%	2	31	40	Diabetes_McGill_IL10	VARELA_ZMPSTE24_TARGETS_UP
6.45161290323%	2	31	40	Diabetes_McGill_IL10	ST_B_CELL_ANTIGEN_RECEPTOR
6.45161290323%	2	31	40	Diabetes_McGill_IL10	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN
6.45161290323%	2	31	398	Diabetes_McGill_IL10	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
6.45161290323%	2	31	394	Diabetes_McGill_IL10	BERENJENO_TRANSFORMED_BY_RHOA_DN
6.45161290323%	2	31	393	Diabetes_McGill_IL10	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
6.45161290323%	2	31	392	Diabetes_McGill_IL10	LINDGREN_BLADDER_CANCER_CLUSTER_2B
6.45161290323%	2	31	390	Diabetes_McGill_IL10	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
6.45161290323%	2	31	39	Diabetes_McGill_IL10	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2
6.45161290323%	2	31	39	Diabetes_McGill_IL10	PID_ECADHERIN_NASCENTAJ_PATHWAY
6.45161290323%	2	31	39	Diabetes_McGill_IL10	CONRAD_STEM_CELL
6.45161290323%	2	31	384	Diabetes_McGill_IL10	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
6.45161290323%	2	31	380	Diabetes_McGill_IL10	MULLIGHAN_MLL_SIGNATURE_1_UP
6.45161290323%	2	31	38	Diabetes_McGill_IL10	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
6.45161290323%	2	31	38	Diabetes_McGill_IL10	REACTOME_GAB1_SIGNALOSOME
6.45161290323%	2	31	38	Diabetes_McGill_IL10	KEGG_ALLOGRAFT_REJECTION
6.45161290323%	2	31	379	Diabetes_McGill_IL10	BENPORATH_ES_1
6.45161290323%	2	31	373	Diabetes_McGill_IL10	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
6.45161290323%	2	31	37	Diabetes_McGill_IL10	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
6.45161290323%	2	31	37	Diabetes_McGill_IL10	ST_P38_MAPK_PATHWAY
6.45161290323%	2	31	37	Diabetes_McGill_IL10	ST_GA13_PATHWAY
6.45161290323%	2	31	37	Diabetes_McGill_IL10	REACTOME_DOWNSTREAM_TCR_SIGNALING
6.45161290323%	2	31	37	Diabetes_McGill_IL10	BIOCARTA_TOLL_PATHWAY
6.45161290323%	2	31	37	Diabetes_McGill_IL10	BIOCARTA_MET_PATHWAY
6.45161290323%	2	31	36	Diabetes_McGill_IL10	ST_ADRENERGIC
6.45161290323%	2	31	36	Diabetes_McGill_IL10	REACTOME_SIGNALLING_TO_ERKS
6.45161290323%	2	31	36	Diabetes_McGill_IL10	PID_PI3KPLCTRKPATHWAY
6.45161290323%	2	31	36	Diabetes_McGill_IL10	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
6.45161290323%	2	31	358	Diabetes_McGill_IL10	GRUETZMANN_PANCREATIC_CANCER_UP
6.45161290323%	2	31	356	Diabetes_McGill_IL10	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
6.45161290323%	2	31	35	Diabetes_McGill_IL10	WEIGEL_OXIDATIVE_STRESS_RESPONSE
6.45161290323%	2	31	35	Diabetes_McGill_IL10	ST_G_ALPHA_I_PATHWAY
6.45161290323%	2	31	35	Diabetes_McGill_IL10	PID_PI3KCIAKTPATHWAY
6.45161290323%	2	31	346	Diabetes_McGill_IL10	GOLDRATH_ANTIGEN_RESPONSE
6.45161290323%	2	31	34	Diabetes_McGill_IL10	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP
6.45161290323%	2	31	34	Diabetes_McGill_IL10	PID_EPHA_FWDPATHWAY
6.45161290323%	2	31	337	Diabetes_McGill_IL10	PHONG_TNF_RESPONSE_NOT_VIA_P38
6.45161290323%	2	31	335	Diabetes_McGill_IL10	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
6.45161290323%	2	31	330	Diabetes_McGill_IL10	REACTOME_METABOLISM_OF_RNA
6.45161290323%	2	31	330	Diabetes_McGill_IL10	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
6.45161290323%	2	31	33	Diabetes_McGill_IL10	STAEGE_EWING_FAMILY_TUMOR
6.45161290323%	2	31	33	Diabetes_McGill_IL10	DUTTA_APOPTOSIS_VIA_NFKB
6.45161290323%	2	31	33	Diabetes_McGill_IL10	DORN_ADENOVIRUS_INFECTION_12HR_DN
6.45161290323%	2	31	33	Diabetes_McGill_IL10	BIOCARTA_IL1R_PATHWAY
6.45161290323%	2	31	329	Diabetes_McGill_IL10	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
6.45161290323%	2	31	320	Diabetes_McGill_IL10	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
6.45161290323%	2	31	32	Diabetes_McGill_IL10	TRACEY_RESISTANCE_TO_IFNA2_DN
6.45161290323%	2	31	32	Diabetes_McGill_IL10	BIOCARTA_HDAC_PATHWAY
6.45161290323%	2	31	317	Diabetes_McGill_IL10	HELLER_HDAC_TARGETS_UP
6.45161290323%	2	31	315	Diabetes_McGill_IL10	PASINI_SUZ12_TARGETS_DN
6.45161290323%	2	31	31	Diabetes_McGill_IL10	SIMBULAN_PARP1_TARGETS_UP
6.45161290323%	2	31	31	Diabetes_McGill_IL10	PID_P38ALPHABETAPATHWAY
6.45161290323%	2	31	31	Diabetes_McGill_IL10	PID_AVB3_OPN_PATHWAY
6.45161290323%	2	31	31	Diabetes_McGill_IL10	DANG_MYC_TARGETS_DN
6.45161290323%	2	31	31	Diabetes_McGill_IL10	BIOCARTA_PYK2_PATHWAY
6.45161290323%	2	31	309	Diabetes_McGill_IL10	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
6.45161290323%	2	31	309	Diabetes_McGill_IL10	LIU_SOX4_TARGETS_DN
6.45161290323%	2	31	309	Diabetes_McGill_IL10	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
6.45161290323%	2	31	308	Diabetes_McGill_IL10	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
6.45161290323%	2	31	307	Diabetes_McGill_IL10	LI_INDUCED_T_TO_NATURAL_KILLER_UP
6.45161290323%	2	31	307	Diabetes_McGill_IL10	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
6.45161290323%	2	31	30	Diabetes_McGill_IL10	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
6.45161290323%	2	31	30	Diabetes_McGill_IL10	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
6.45161290323%	2	31	30	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
6.45161290323%	2	31	30	Diabetes_McGill_IL10	PID_IGF1_PATHWAY
6.45161290323%	2	31	30	Diabetes_McGill_IL10	PID_EPHRINBREVPATHWAY
6.45161290323%	2	31	30	Diabetes_McGill_IL10	KEGG_ASTHMA
6.45161290323%	2	31	298	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_14HR_DN
6.45161290323%	2	31	293	Diabetes_McGill_IL10	IVANOVA_HEMATOPOIESIS_MATURE_CELL
6.45161290323%	2	31	293	Diabetes_McGill_IL10	ENK_UV_RESPONSE_EPIDERMIS_UP
6.45161290323%	2	31	290	Diabetes_McGill_IL10	BASAKI_YBX1_TARGETS_UP
6.45161290323%	2	31	29	Diabetes_McGill_IL10	WILENSKY_RESPONSE_TO_DARAPLADIB
6.45161290323%	2	31	29	Diabetes_McGill_IL10	ST_TUMOR_NECROSIS_FACTOR_PATHWAY
6.45161290323%	2	31	29	Diabetes_McGill_IL10	KEGG_THYROID_CANCER
6.45161290323%	2	31	29	Diabetes_McGill_IL10	BIOCARTA_TNFR1_PATHWAY
6.45161290323%	2	31	29	Diabetes_McGill_IL10	BIOCARTA_INFLAM_PATHWAY
6.45161290323%	2	31	289	Diabetes_McGill_IL10	GABRIELY_MIR21_TARGETS
6.45161290323%	2	31	288	Diabetes_McGill_IL10	POOLA_INVASIVE_BREAST_CANCER_UP
6.45161290323%	2	31	287	Diabetes_McGill_IL10	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
6.45161290323%	2	31	284	Diabetes_McGill_IL10	REACTOME_METABOLISM_OF_MRNA
6.45161290323%	2	31	282	Diabetes_McGill_IL10	HELLER_SILENCED_BY_METHYLATION_UP
6.45161290323%	2	31	28	Diabetes_McGill_IL10	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
6.45161290323%	2	31	28	Diabetes_McGill_IL10	BIOCARTA_ERK_PATHWAY
6.45161290323%	2	31	27	Diabetes_McGill_IL10	REACTOME_SIGNALLING_TO_RAS
6.45161290323%	2	31	27	Diabetes_McGill_IL10	CHIN_BREAST_CANCER_COPY_NUMBER_UP
6.45161290323%	2	31	27	Diabetes_McGill_IL10	BIOCARTA_GSK3_PATHWAY
6.45161290323%	2	31	27	Diabetes_McGill_IL10	BIOCARTA_CREB_PATHWAY
6.45161290323%	2	31	26	Diabetes_McGill_IL10	PID_VEGFR1_PATHWAY
6.45161290323%	2	31	26	Diabetes_McGill_IL10	PID_RXR_VDR_PATHWAY
6.45161290323%	2	31	26	Diabetes_McGill_IL10	BIOCARTA_WNT_PATHWAY
6.45161290323%	2	31	26	Diabetes_McGill_IL10	BIOCARTA_RACCYCD_PATHWAY
6.45161290323%	2	31	26	Diabetes_McGill_IL10	BIOCARTA_BAD_PATHWAY
6.45161290323%	2	31	26	Diabetes_McGill_IL10	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
6.45161290323%	2	31	259	Diabetes_McGill_IL10	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
6.45161290323%	2	31	255	Diabetes_McGill_IL10	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
6.45161290323%	2	31	252	Diabetes_McGill_IL10	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
6.45161290323%	2	31	25	Diabetes_McGill_IL10	NOJIMA_SFRP2_TARGETS_DN
6.45161290323%	2	31	25	Diabetes_McGill_IL10	LU_TUMOR_ANGIOGENESIS_UP
6.45161290323%	2	31	246	Diabetes_McGill_IL10	VERHAAK_AML_WITH_NPM1_MUTATED_DN
6.45161290323%	2	31	245	Diabetes_McGill_IL10	MCLACHLAN_DENTAL_CARIES_DN
6.45161290323%	2	31	244	Diabetes_McGill_IL10	PLASARI_TGFB1_TARGETS_10HR_DN
6.45161290323%	2	31	244	Diabetes_McGill_IL10	GAL_LEUKEMIC_STEM_CELL_DN
6.45161290323%	2	31	244	Diabetes_McGill_IL10	DAZARD_RESPONSE_TO_UV_NHEK_UP
6.45161290323%	2	31	242	Diabetes_McGill_IL10	CHYLA_CBFA2T3_TARGETS_DN
6.45161290323%	2	31	240	Diabetes_McGill_IL10	VANTVEER_BREAST_CANCER_ESR1_DN
6.45161290323%	2	31	240	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_20HR_UP
6.45161290323%	2	31	24	Diabetes_McGill_IL10	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING
6.45161290323%	2	31	24	Diabetes_McGill_IL10	BIOCARTA_TPO_PATHWAY
6.45161290323%	2	31	24	Diabetes_McGill_IL10	BIOCARTA_NTHI_PATHWAY
6.45161290323%	2	31	239	Diabetes_McGill_IL10	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
6.45161290323%	2	31	237	Diabetes_McGill_IL10	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
6.45161290323%	2	31	235	Diabetes_McGill_IL10	RUTELLA_RESPONSE_TO_HGF_DN
6.45161290323%	2	31	234	Diabetes_McGill_IL10	AFFAR_YY1_TARGETS_DN
6.45161290323%	2	31	233	Diabetes_McGill_IL10	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
6.45161290323%	2	31	230	Diabetes_McGill_IL10	BENPORATH_MYC_TARGETS_WITH_EBOX
6.45161290323%	2	31	23	Diabetes_McGill_IL10	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP
6.45161290323%	2	31	23	Diabetes_McGill_IL10	BIOCARTA_RAS_PATHWAY
6.45161290323%	2	31	23	Diabetes_McGill_IL10	BIOCARTA_RAC1_PATHWAY
6.45161290323%	2	31	23	Diabetes_McGill_IL10	BIOCARTA_MTOR_PATHWAY
6.45161290323%	2	31	23	Diabetes_McGill_IL10	BIOCARTA_IL12_PATHWAY
6.45161290323%	2	31	229	Diabetes_McGill_IL10	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
6.45161290323%	2	31	226	Diabetes_McGill_IL10	KYNG_DNA_DAMAGE_UP
6.45161290323%	2	31	221	Diabetes_McGill_IL10	PEDRIOLI_MIR31_TARGETS_UP
6.45161290323%	2	31	22	Diabetes_McGill_IL10	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN
6.45161290323%	2	31	22	Diabetes_McGill_IL10	PID_PDGFRAPATHWAY
6.45161290323%	2	31	22	Diabetes_McGill_IL10	GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION
6.45161290323%	2	31	22	Diabetes_McGill_IL10	BIOCARTA_HER2_PATHWAY
6.45161290323%	2	31	22	Diabetes_McGill_IL10	BIOCARTA_CYTOKINE_PATHWAY
6.45161290323%	2	31	217	Diabetes_McGill_IL10	WIERENGA_STAT5A_TARGETS_UP
6.45161290323%	2	31	216	Diabetes_McGill_IL10	WHITFIELD_CELL_CYCLE_G2_M
6.45161290323%	2	31	214	Diabetes_McGill_IL10	ZWANG_EGF_INTERVAL_DN
6.45161290323%	2	31	212	Diabetes_McGill_IL10	SANSOM_APC_TARGETS
6.45161290323%	2	31	211	Diabetes_McGill_IL10	FOSTER_KDM1A_TARGETS_DN
6.45161290323%	2	31	21	Diabetes_McGill_IL10	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD
6.45161290323%	2	31	209	Diabetes_McGill_IL10	KIM_WT1_TARGETS_12HR_DN
6.45161290323%	2	31	207	Diabetes_McGill_IL10	KARLSSON_TGFB1_TARGETS_DN
6.45161290323%	2	31	206	Diabetes_McGill_IL10	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
6.45161290323%	2	31	206	Diabetes_McGill_IL10	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
6.45161290323%	2	31	205	Diabetes_McGill_IL10	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
6.45161290323%	2	31	203	Diabetes_McGill_IL10	PENG_RAPAMYCIN_RESPONSE_UP
6.45161290323%	2	31	203	Diabetes_McGill_IL10	GRUETZMANN_PANCREATIC_CANCER_DN
6.45161290323%	2	31	20	Diabetes_McGill_IL10	REACTOME_NEPHRIN_INTERACTIONS
6.45161290323%	2	31	20	Diabetes_McGill_IL10	OUYANG_PROSTATE_CANCER_PROGRESSION_UP
6.45161290323%	2	31	20	Diabetes_McGill_IL10	BIOCARTA_IGF1MTOR_PATHWAY
6.45161290323%	2	31	198	Diabetes_McGill_IL10	WELCSH_BRCA1_TARGETS_UP
6.45161290323%	2	31	197	Diabetes_McGill_IL10	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
6.45161290323%	2	31	195	Diabetes_McGill_IL10	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
6.45161290323%	2	31	19	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS
6.45161290323%	2	31	19	Diabetes_McGill_IL10	NELSON_RESPONSE_TO_ANDROGEN_DN
6.45161290323%	2	31	185	Diabetes_McGill_IL10	ZHANG_TLX_TARGETS_36HR_DN
6.45161290323%	2	31	183	Diabetes_McGill_IL10	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
6.45161290323%	2	31	183	Diabetes_McGill_IL10	VERHAAK_AML_WITH_NPM1_MUTATED_UP
6.45161290323%	2	31	181	Diabetes_McGill_IL10	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
6.45161290323%	2	31	180	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_48HR_UP
6.45161290323%	2	31	18	Diabetes_McGill_IL10	ZHENG_RESPONSE_TO_ARSENITE_DN
6.45161290323%	2	31	18	Diabetes_McGill_IL10	SHIN_B_CELL_LYMPHOMA_CLUSTER_5
6.45161290323%	2	31	18	Diabetes_McGill_IL10	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
6.45161290323%	2	31	178	Diabetes_McGill_IL10	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
6.45161290323%	2	31	176	Diabetes_McGill_IL10	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
6.45161290323%	2	31	176	Diabetes_McGill_IL10	NAGASHIMA_NRG1_SIGNALING_UP
6.45161290323%	2	31	175	Diabetes_McGill_IL10	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
6.45161290323%	2	31	172	Diabetes_McGill_IL10	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
6.45161290323%	2	31	171	Diabetes_McGill_IL10	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
6.45161290323%	2	31	170	Diabetes_McGill_IL10	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
6.45161290323%	2	31	170	Diabetes_McGill_IL10	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
6.45161290323%	2	31	17	Diabetes_McGill_IL10	REACTOME_TIE2_SIGNALING
6.45161290323%	2	31	17	Diabetes_McGill_IL10	PID_NFKAPPABATYPICALPATHWAY
6.45161290323%	2	31	17	Diabetes_McGill_IL10	PID_ANTHRAXPATHWAY
6.45161290323%	2	31	17	Diabetes_McGill_IL10	DORMOY_ELAVL1_TARGETS
6.45161290323%	2	31	17	Diabetes_McGill_IL10	BIOCARTA_IL7_PATHWAY
6.45161290323%	2	31	17	Diabetes_McGill_IL10	BIOCARTA_HCMV_PATHWAY
6.45161290323%	2	31	17	Diabetes_McGill_IL10	BIOCARTA_ARF_PATHWAY
6.45161290323%	2	31	165	Diabetes_McGill_IL10	BROWN_MYELOID_CELL_DEVELOPMENT_UP
6.45161290323%	2	31	163	Diabetes_McGill_IL10	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
6.45161290323%	2	31	163	Diabetes_McGill_IL10	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
6.45161290323%	2	31	162	Diabetes_McGill_IL10	KIM_WT1_TARGETS_12HR_UP
6.45161290323%	2	31	160	Diabetes_McGill_IL10	GAVIN_FOXP3_TARGETS_CLUSTER_P3
6.45161290323%	2	31	16	Diabetes_McGill_IL10	SUZUKI_AMPLIFIED_IN_ORAL_CANCER
6.45161290323%	2	31	16	Diabetes_McGill_IL10	BIOCARTA_CDMAC_PATHWAY
6.45161290323%	2	31	156	Diabetes_McGill_IL10	GROSS_HYPOXIA_VIA_ELK3_DN
6.45161290323%	2	31	148	Diabetes_McGill_IL10	REACTOME_APOPTOSIS
6.45161290323%	2	31	146	Diabetes_McGill_IL10	PECE_MAMMARY_STEM_CELL_UP
6.45161290323%	2	31	146	Diabetes_McGill_IL10	ELVIDGE_HYPOXIA_DN
6.45161290323%	2	31	145	Diabetes_McGill_IL10	SMITH_TERT_TARGETS_UP
6.45161290323%	2	31	143	Diabetes_McGill_IL10	BASSO_B_LYMPHOCYTE_NETWORK
6.45161290323%	2	31	142	Diabetes_McGill_IL10	XU_GH1_AUTOCRINE_TARGETS_DN
6.45161290323%	2	31	141	Diabetes_McGill_IL10	WELCSH_BRCA1_TARGETS_DN
6.45161290323%	2	31	140	Diabetes_McGill_IL10	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
6.45161290323%	2	31	14	Diabetes_McGill_IL10	REACTOME_REGULATION_OF_IFNG_SIGNALING
6.45161290323%	2	31	14	Diabetes_McGill_IL10	PID_IL5_PATHWAY
6.45161290323%	2	31	137	Diabetes_McGill_IL10	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
6.45161290323%	2	31	136	Diabetes_McGill_IL10	PROVENZANI_METASTASIS_DN
6.45161290323%	2	31	134	Diabetes_McGill_IL10	SCHLOSSER_SERUM_RESPONSE_UP
6.45161290323%	2	31	13	Diabetes_McGill_IL10	SA_REG_CASCADE_OF_CYCLIN_EXPR
6.45161290323%	2	31	13	Diabetes_McGill_IL10	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15
6.45161290323%	2	31	128	Diabetes_McGill_IL10	ZHU_CMV_ALL_DN
6.45161290323%	2	31	128	Diabetes_McGill_IL10	LENAOUR_DENDRITIC_CELL_MATURATION_DN
6.45161290323%	2	31	126	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
6.45161290323%	2	31	126	Diabetes_McGill_IL10	GERY_CEBP_TARGETS
6.45161290323%	2	31	121	Diabetes_McGill_IL10	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
6.45161290323%	2	31	121	Diabetes_McGill_IL10	RODRIGUES_DCC_TARGETS_DN
6.45161290323%	2	31	118	Diabetes_McGill_IL10	REACTOME_TOLL_RECEPTOR_CASCADES
6.45161290323%	2	31	115	Diabetes_McGill_IL10	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
6.45161290323%	2	31	1142	Diabetes_McGill_IL10	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
6.45161290323%	2	31	114	Diabetes_McGill_IL10	SENESE_HDAC2_TARGETS_UP
6.45161290323%	2	31	112	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_FGFR
6.45161290323%	2	31	112	Diabetes_McGill_IL10	REACTOME_G1_S_TRANSITION
6.45161290323%	2	31	112	Diabetes_McGill_IL10	LABBE_WNT3A_TARGETS_UP
6.45161290323%	2	31	111	Diabetes_McGill_IL10	BOUDOUKHA_BOUND_BY_IGF2BP2
6.45161290323%	2	31	11	Diabetes_McGill_IL10	ST_STAT3_PATHWAY
6.45161290323%	2	31	11	Diabetes_McGill_IL10	SEIKE_LUNG_CANCER_POOR_SURVIVAL
6.45161290323%	2	31	11	Diabetes_McGill_IL10	BIOCARTA_IL4_PATHWAY
6.45161290323%	2	31	109	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
6.45161290323%	2	31	109	Diabetes_McGill_IL10	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
6.45161290323%	2	31	108	Diabetes_McGill_IL10	LE_EGR2_TARGETS_UP
6.45161290323%	2	31	107	Diabetes_McGill_IL10	SESTO_RESPONSE_TO_UV_C0
6.45161290323%	2	31	106	Diabetes_McGill_IL10	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
6.45161290323%	2	31	105	Diabetes_McGill_IL10	WOO_LIVER_CANCER_RECURRENCE_UP
6.45161290323%	2	31	105	Diabetes_McGill_IL10	HELLER_SILENCED_BY_METHYLATION_DN
6.45161290323%	2	31	105	Diabetes_McGill_IL10	AMUNDSON_GENOTOXIC_SIGNATURE
6.45161290323%	2	31	103	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_NOTCH
6.45161290323%	2	31	103	Diabetes_McGill_IL10	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
6.45161290323%	2	31	1024	Diabetes_McGill_IL10	NUYTTEN_EZH2_TARGETS_DN
6.45161290323%	2	31	1011	Diabetes_McGill_IL10	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
6.45161290323%	2	31	101	Diabetes_McGill_IL10	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
6.45161290323%	2	31	101	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_ERBB2
6.45161290323%	2	31	101	Diabetes_McGill_IL10	KOBAYASHI_EGFR_SIGNALING_24HR_UP
6.45161290323%	2	31	101	Diabetes_McGill_IL10	KEGG_GNRH_SIGNALING_PATHWAY
6.45161290323%	2	31	100	Diabetes_McGill_IL10	WINZEN_DEGRADED_VIA_KHSRP
6.45161290323%	2	31	100	Diabetes_McGill_IL10	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
6.45161290323%	2	31	10	Diabetes_McGill_IL10	BAKER_HEMATOPOESIS_STAT1_TARGETS
6.41368252272%	120	1871	1375	T2D_GENES_TANYA_HEIGHT	DODD_NASOPHARYNGEAL_CARCINOMA_DN
6.41368252272%	120	1871	1137	T2D_GENES_TANYA_HEIGHT	BRUINS_UVC_RESPONSE_LATE
6.41368252272%	120	1871	1062	T2D_GENES_TANYA_HEIGHT	BENPORATH_EED_TARGETS
6.3829787234%	126	1974	1037	Mendelian_Nancy_Cox	NUYTTEN_EZH2_TARGETS_UP
6.37362637363%	29	455	86	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MEIOTIC_RECOMBINATION
6.37362637363%	29	455	116	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MEIOSIS
6.37362637363%	29	455	1037	T2D_GENES_TANYA_BLOODPRESSURE	NUYTTEN_EZH2_TARGETS_UP
6.36023516836%	119	1871	957	T2D_GENES_TANYA_HEIGHT	LOPEZ_MBD_TARGETS
6.35400907716%	42	661	1725	T2D_GENES_TANYA_GLYCEMIC	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
6.34774609016%	138	2174	1382	T2D_GENES_TANYA_LIPIDS	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
6.33232016211%	125	1974	1278	Mendelian_Nancy_Cox	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
6.32411067194%	16	253	93	Diabetes_McGill_CREBBP_coTF	REACTOME_ACTIVATED_TLR4_SIGNALLING
6.32411067194%	16	253	882	Diabetes_McGill_CREBBP_coTF	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
6.32411067194%	16	253	841	Diabetes_McGill_CREBBP_coTF	MARTENS_TRETINOIN_RESPONSE_DN
6.32411067194%	16	253	77	Diabetes_McGill_CREBBP_coTF	RIZ_ERYTHROID_DIFFERENTIATION
6.32411067194%	16	253	74	Diabetes_McGill_CREBBP_coTF	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
6.32411067194%	16	253	602	Diabetes_McGill_CREBBP_coTF	MARTINEZ_TP53_TARGETS_UP
6.32411067194%	16	253	536	Diabetes_McGill_CREBBP_coTF	BERENJENO_TRANSFORMED_BY_RHOA_UP
6.32411067194%	16	253	514	Diabetes_McGill_CREBBP_coTF	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
6.32411067194%	16	253	462	Diabetes_McGill_CREBBP_coTF	DELACROIX_RAR_BOUND_ES
6.32411067194%	16	253	44	Diabetes_McGill_CREBBP_coTF	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
6.32411067194%	16	253	341	Diabetes_McGill_CREBBP_coTF	MULLIGHAN_NPM1_SIGNATURE_3_UP
6.32411067194%	16	253	29	Diabetes_McGill_CREBBP_coTF	REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION
6.32411067194%	16	253	227	Diabetes_McGill_CREBBP_coTF	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
6.32411067194%	16	253	151	Diabetes_McGill_CREBBP_coTF	KEGG_WNT_SIGNALING_PATHWAY
6.32411067194%	16	253	137	Diabetes_McGill_CREBBP_coTF	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
6.32411067194%	16	253	118	Diabetes_McGill_CREBBP_coTF	REACTOME_TOLL_RECEPTOR_CASCADES
6.32411067194%	16	253	1024	Diabetes_McGill_CREBBP_coTF	NUYTTEN_EZH2_TARGETS_DN
6.306787814%	118	1871	1278	T2D_GENES_TANYA_HEIGHT	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
6.30174793008%	137	2174	841	T2D_GENES_TANYA_LIPIDS	MARTENS_TRETINOIN_RESPONSE_DN
6.28166160081%	124	1974	988	Mendelian_Nancy_Cox	BENPORATH_NANOG_TARGETS
6.28166160081%	124	1974	1080	Mendelian_Nancy_Cox	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
6.25%	2	32	98	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
6.25%	2	32	953	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
6.25%	2	32	95	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
6.25%	2	32	933	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_IMMUNE_SYSTEM
6.25%	2	32	871	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GRADE_COLON_CANCER_UP
6.25%	2	32	85	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
6.25%	2	32	83	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ONDER_CDH1_SIGNALING_VIA_CTNNB1
6.25%	2	32	784	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	FORTSCHEGGER_PHF8_TARGETS_DN
6.25%	2	32	783	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
6.25%	2	32	78	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_PLATELET_HOMEOSTASIS
6.25%	2	32	78	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_OPIOID_SIGNALLING
6.25%	2	32	756	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
6.25%	2	32	681	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
6.25%	2	32	68	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN
6.25%	2	32	67	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
6.25%	2	32	668	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
6.25%	2	32	648	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SMID_BREAST_CANCER_BASAL_UP
6.25%	2	32	648	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BENPORATH_CYCLING_GENES
6.25%	2	32	63	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MODY_HIPPOCAMPUS_POSTNATAL
6.25%	2	32	593	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MARTINEZ_TP53_TARGETS_DN
6.25%	2	32	591	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MARTINEZ_RB1_AND_TP53_TARGETS_DN
6.25%	2	32	584	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
6.25%	2	32	584	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HAMAI_APOPTOSIS_VIA_TRAIL_UP
6.25%	2	32	579	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
6.25%	2	32	57	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
6.25%	2	32	553	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	FEVR_CTNNB1_TARGETS_DN
6.25%	2	32	543	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MARTINEZ_RB1_TARGETS_DN
6.25%	2	32	54	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE
6.25%	2	32	539	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
6.25%	2	32	536	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
6.25%	2	32	535	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	STEIN_ESRRA_TARGETS
6.25%	2	32	52	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6
6.25%	2	32	505	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
6.25%	2	32	504	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PILON_KLF1_TARGETS_UP
6.25%	2	32	491	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZHENG_BOUND_BY_FOXP3
6.25%	2	32	491	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SWEET_LUNG_CANCER_KRAS_UP
6.25%	2	32	481	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LIU_PROSTATE_CANCER_DN
6.25%	2	32	466	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_HEMOSTASIS
6.25%	2	32	464	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ONDER_CDH1_TARGETS_2_DN
6.25%	2	32	45	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PID_HNF3BPATHWAY
6.25%	2	32	43	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_PLC_BETA_MEDIATED_EVENTS
6.25%	2	32	418	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RUTELLA_RESPONSE_TO_HGF_UP
6.25%	2	32	408	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
6.25%	2	32	408	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_GPCR_LIGAND_BINDING
6.25%	2	32	394	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BERENJENO_TRANSFORMED_BY_RHOA_DN
6.25%	2	32	390	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HATADA_METHYLATED_IN_LUNG_CANCER_UP
6.25%	2	32	388	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	STEIN_ESRRA_TARGETS_UP
6.25%	2	32	387	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CHYLA_CBFA2T3_TARGETS_UP
6.25%	2	32	366	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	YOSHIMURA_MAPK8_TARGETS_DN
6.25%	2	32	355	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PEREZ_TP63_TARGETS
6.25%	2	32	341	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
6.25%	2	32	332	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
6.25%	2	32	32	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_DAG_AND_IP3_SIGNALING
6.25%	2	32	306	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HORIUCHI_WTAP_TARGETS_UP
6.25%	2	32	305	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
6.25%	2	32	29	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
6.25%	2	32	289	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	WANG_MLL_TARGETS
6.25%	2	32	289	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
6.25%	2	32	287	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
6.25%	2	32	283	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
6.25%	2	32	280	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
6.25%	2	32	28	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	VALK_AML_CLUSTER_7
6.25%	2	32	272	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
6.25%	2	32	270	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RIZKI_TUMOR_INVASIVENESS_3D_DN
6.25%	2	32	261	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BILD_HRAS_ONCOGENIC_SIGNATURE
6.25%	2	32	256	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ONDER_CDH1_TARGETS_2_UP
6.25%	2	32	255	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
6.25%	2	32	25	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS
6.25%	2	32	249	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
6.25%	2	32	241	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DOANE_RESPONSE_TO_ANDROGEN_DN
6.25%	2	32	239	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ALFANO_MYC_TARGETS
6.25%	2	32	232	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DELYS_THYROID_CANCER_DN
6.25%	2	32	228	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
6.25%	2	32	222	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BROWNE_HCMV_INFECTION_1HR_DN
6.25%	2	32	217	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_SIGNALLING_BY_NGF
6.25%	2	32	210	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
6.25%	2	32	208	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
6.25%	2	32	206	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
6.25%	2	32	205	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
6.25%	2	32	203	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PENG_RAPAMYCIN_RESPONSE_UP
6.25%	2	32	203	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GRUETZMANN_PANCREATIC_CANCER_DN
6.25%	2	32	202	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	FUJII_YBX1_TARGETS_DN
6.25%	2	32	195	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
6.25%	2	32	191	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RIGGI_EWING_SARCOMA_PROGENITOR_DN
6.25%	2	32	188	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
6.25%	2	32	186	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HAMAI_APOPTOSIS_VIA_TRAIL_DN
6.25%	2	32	185	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DARWICHE_SKIN_TUMOR_PROMOTER_DN
6.25%	2	32	184	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
6.25%	2	32	1839	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
6.25%	2	32	181	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
6.25%	2	32	180	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DARWICHE_PAPILLOMA_RISK_HIGH_DN
6.25%	2	32	180	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BROWNE_HCMV_INFECTION_48HR_UP
6.25%	2	32	18	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS
6.25%	2	32	1781	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
6.25%	2	32	176	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SASAKI_ADULT_T_CELL_LEUKEMIA
6.25%	2	32	1652	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PUJANA_BRCA1_PCC_NETWORK
6.25%	2	32	162	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DARWICHE_PAPILLOMA_RISK_LOW_UP
6.25%	2	32	150	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LANDIS_ERBB2_BREAST_TUMORS_324_UP
6.25%	2	32	149	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
6.25%	2	32	143	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BASSO_B_LYMPHOCYTE_NETWORK
6.25%	2	32	142	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
6.25%	2	32	1375	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DODD_NASOPHARYNGEAL_CARCINOMA_DN
6.25%	2	32	137	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
6.25%	2	32	134	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SCHLOSSER_SERUM_RESPONSE_UP
6.25%	2	32	134	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	POOLA_INVASIVE_BREAST_CANCER_DN
6.25%	2	32	127	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
6.25%	2	32	126	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
6.25%	2	32	122	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_SIGNALING_BY_PDGF
6.25%	2	32	1137	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BRUINS_UVC_RESPONSE_LATE
6.25%	2	32	112	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_SIGNALING_BY_FGFR
6.25%	2	32	109	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
6.25%	2	32	1080	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
6.25%	2	32	1037	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	NUYTTEN_EZH2_TARGETS_UP
6.25%	2	32	101	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_SIGNALING_BY_ERBB2
6.25%	2	32	100	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
6.25%	2	32	100	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MCCLUNG_CREB1_TARGETS_UP
6.25%	2	32	10	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS
6.22159090909%	219	3520	1691	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BLALOCK_ALZHEIMERS_DISEASE_UP
6.19902120718%	38	613	1210	T2D_GENES_TANYA_BIOMARKER	CHEN_METABOLIC_SYNDROM_NETWORK
6.18034447822%	122	1974	898	Mendelian_Nancy_Cox	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
6.17283950617%	5	81	920	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SIGNALING_BY_GPCR
6.17283950617%	5	81	918	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	JOHNSTONE_PARVB_TARGETS_3_DN
6.17283950617%	5	81	90	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SIGNALING_BY_ERBB4
6.17283950617%	5	81	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_PROSTATE_CANCER
6.17283950617%	5	81	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
6.17283950617%	5	81	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SMID_BREAST_CANCER_LUMINAL_A_UP
6.17283950617%	5	81	805	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
6.17283950617%	5	81	805	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_GPCR_DOWNSTREAM_SIGNALING
6.17283950617%	5	81	800	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
6.17283950617%	5	81	781	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GOZGIT_ESR1_TARGETS_DN
6.17283950617%	5	81	769	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NUYTTEN_NIPP1_TARGETS_UP
6.17283950617%	5	81	71	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PI3K_CASCADE
6.17283950617%	5	81	673	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARTINEZ_RB1_TARGETS_UP
6.17283950617%	5	81	634	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
6.17283950617%	5	81	590	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
6.17283950617%	5	81	584	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HAMAI_APOPTOSIS_VIA_TRAIL_UP
6.17283950617%	5	81	572	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHICAS_RB1_TARGETS_SENESCENT
6.17283950617%	5	81	567	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHICAS_RB1_TARGETS_CONFLUENT
6.17283950617%	5	81	552	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
6.17283950617%	5	81	540	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ACEVEDO_LIVER_CANCER_DN
6.17283950617%	5	81	537	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
6.17283950617%	5	81	517	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RAO_BOUND_BY_SALL4_ISOFORM_B
6.17283950617%	5	81	516	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
6.17283950617%	5	81	508	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ENK_UV_RESPONSE_EPIDERMIS_DN
6.17283950617%	5	81	435	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SWEET_LUNG_CANCER_KRAS_DN
6.17283950617%	5	81	421	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_CELL_CYCLE
6.17283950617%	5	81	413	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
6.17283950617%	5	81	328	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_PATHWAYS_IN_CANCER
6.17283950617%	5	81	298	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BROWNE_HCMV_INFECTION_14HR_DN
6.17283950617%	5	81	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_GH_PATHWAY
6.17283950617%	5	81	279	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FORTSCHEGGER_PHF8_TARGETS_UP
6.17283950617%	5	81	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
6.17283950617%	5	81	201	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_FOCAL_ADHESION
6.17283950617%	5	81	155	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_JAK_STAT_SIGNALING_PATHWAY
6.17283950617%	5	81	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR
6.17283950617%	5	81	1229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
6.17283950617%	5	81	114	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MATZUK_SPERMATOZOA
6.17283950617%	5	81	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHOU_PANCREATIC_EXOCRINE_PROGENITOR
6.17283950617%	5	81	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
6.15911035073%	72	1169	1305	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YOSHIMURA_MAPK8_TARGETS_UP
6.15384615385%	28	455	89	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_RNA_POL_I_TRANSCRIPTION
6.15384615385%	28	455	83	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_AMYLOIDS
6.15384615385%	28	455	122	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
6.15384615385%	28	455	1137	T2D_GENES_TANYA_BLOODPRESSURE	BRUINS_UVC_RESPONSE_LATE
6.14644575094%	115	1871	1080	T2D_GENES_TANYA_HEIGHT	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
6.12968591692%	121	1974	478	Mendelian_Nancy_Cox	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
6.11775528979%	133	2174	882	T2D_GENES_TANYA_LIPIDS	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
6.08856088561%	33	542	841	T2D_GENES_TANYA_ANTHROPOMETRIC	MARTENS_TRETINOIN_RESPONSE_DN
6.08856088561%	33	542	1237	T2D_GENES_TANYA_ANTHROPOMETRIC	BLALOCK_ALZHEIMERS_DISEASE_DN
6.08856088561%	33	542	1137	T2D_GENES_TANYA_ANTHROPOMETRIC	BRUINS_UVC_RESPONSE_LATE
6.07902735562%	120	1974	882	Mendelian_Nancy_Cox	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
6.07902735562%	120	1974	855	Mendelian_Nancy_Cox	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
6.06776989756%	77	1269	1691	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BLALOCK_ALZHEIMERS_DISEASE_UP
6.06060606061%	2	33	973	Diabetes_McGill_ER_Stress	ACEVEDO_LIVER_CANCER_UP
6.06060606061%	2	33	97	Mendelian_Metabolism	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP
6.06060606061%	2	33	96	Diabetes_McGill_ER_Stress	LIU_PROSTATE_CANCER_UP
6.06060606061%	2	33	953	Diabetes_McGill_ER_Stress	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
6.06060606061%	2	33	94	Diabetes_McGill_ER_Stress	LU_IL4_SIGNALING
6.06060606061%	2	33	911	Mendelian_Metabolism	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
6.06060606061%	2	33	90	Mendelian_Metabolism	BILANGES_SERUM_SENSITIVE_GENES
6.06060606061%	2	33	893	Diabetes_McGill_ER_Stress	GEORGES_TARGETS_OF_MIR192_AND_MIR215
6.06060606061%	2	33	89	Mendelian_Metabolism	LI_DCP2_BOUND_MRNA
6.06060606061%	2	33	89	Diabetes_McGill_ER_Stress	KEGG_PROSTATE_CANCER
6.06060606061%	2	33	882	Mendelian_Metabolism	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
6.06060606061%	2	33	882	Diabetes_McGill_ER_Stress	LEE_BMP2_TARGETS_DN
6.06060606061%	2	33	88	Diabetes_McGill_ER_Stress	UEDA_CENTRAL_CLOCK
6.06060606061%	2	33	88	Diabetes_McGill_ER_Stress	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
6.06060606061%	2	33	87	Diabetes_McGill_ER_Stress	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
6.06060606061%	2	33	87	Diabetes_McGill_ER_Stress	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
6.06060606061%	2	33	84	Mendelian_Metabolism	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
6.06060606061%	2	33	84	Diabetes_McGill_ER_Stress	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
6.06060606061%	2	33	83	Diabetes_McGill_ER_Stress	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
6.06060606061%	2	33	81	Diabetes_McGill_ER_Stress	MUNSHI_MULTIPLE_MYELOMA_UP
6.06060606061%	2	33	8	Diabetes_McGill_ER_Stress	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN
6.06060606061%	2	33	795	Mendelian_Metabolism	WEI_MYCN_TARGETS_WITH_E_BOX
6.06060606061%	2	33	795	Diabetes_McGill_ER_Stress	WEI_MYCN_TARGETS_WITH_E_BOX
6.06060606061%	2	33	79	Diabetes_McGill_ER_Stress	GAVIN_FOXP3_TARGETS_CLUSTER_P2
6.06060606061%	2	33	783	Mendelian_Metabolism	ONKEN_UVEAL_MELANOMA_UP
6.06060606061%	2	33	783	Diabetes_McGill_ER_Stress	ONKEN_UVEAL_MELANOMA_UP
6.06060606061%	2	33	783	Diabetes_McGill_ER_Stress	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
6.06060606061%	2	33	78	Diabetes_McGill_ER_Stress	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
6.06060606061%	2	33	779	Diabetes_McGill_ER_Stress	PUJANA_CHEK2_PCC_NETWORK
6.06060606061%	2	33	770	Diabetes_McGill_ER_Stress	KRIEG_HYPOXIA_NOT_VIA_KDM3A
6.06060606061%	2	33	770	Diabetes_McGill_ER_Stress	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
6.06060606061%	2	33	77	Mendelian_Metabolism	CHEBOTAEV_GR_TARGETS_UP
6.06060606061%	2	33	769	Mendelian_Metabolism	NUYTTEN_NIPP1_TARGETS_UP
6.06060606061%	2	33	769	Diabetes_McGill_ER_Stress	NUYTTEN_NIPP1_TARGETS_UP
6.06060606061%	2	33	76	Diabetes_McGill_ER_Stress	PEART_HDAC_PROLIFERATION_CLUSTER_DN
6.06060606061%	2	33	76	Diabetes_McGill_ER_Stress	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
6.06060606061%	2	33	756	Mendelian_Metabolism	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
6.06060606061%	2	33	756	Diabetes_McGill_ER_Stress	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
6.06060606061%	2	33	75	Mendelian_Metabolism	JAIN_NFKB_SIGNALING
6.06060606061%	2	33	745	Mendelian_Metabolism	LEE_BMP2_TARGETS_UP
6.06060606061%	2	33	745	Diabetes_McGill_ER_Stress	LEE_BMP2_TARGETS_UP
6.06060606061%	2	33	74	Mendelian_Metabolism	URS_ADIPOCYTE_DIFFERENTIATION_UP
6.06060606061%	2	33	74	Mendelian_Metabolism	LEE_LIVER_CANCER_DENA_DN
6.06060606061%	2	33	734	Diabetes_McGill_ER_Stress	BENPORATH_SOX2_TARGETS
6.06060606061%	2	33	73	Mendelian_Metabolism	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
6.06060606061%	2	33	73	Diabetes_McGill_ER_Stress	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
6.06060606061%	2	33	721	Mendelian_Metabolism	WONG_ADULT_TISSUE_STEM_MODULE
6.06060606061%	2	33	72	Diabetes_McGill_ER_Stress	MATZUK_SPERMATOCYTE
6.06060606061%	2	33	718	Mendelian_Metabolism	MIKKELSEN_ES_ICP_WITH_H3K4ME3
6.06060606061%	2	33	71	Mendelian_Metabolism	KUMAR_AUTOPHAGY_NETWORK
6.06060606061%	2	33	71	Diabetes_McGill_ER_Stress	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
6.06060606061%	2	33	71	Diabetes_McGill_ER_Stress	BROWNE_HCMV_INFECTION_6HR_UP
6.06060606061%	2	33	701	Mendelian_Metabolism	SMID_BREAST_CANCER_BASAL_DN
6.06060606061%	2	33	701	Diabetes_McGill_ER_Stress	SMID_BREAST_CANCER_BASAL_DN
6.06060606061%	2	33	70	Mendelian_Metabolism	REACTOME_PHASE_II_CONJUGATION
6.06060606061%	2	33	7	Mendelian_Metabolism	HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER
6.06060606061%	2	33	69	Mendelian_Metabolism	KEGG_PPAR_SIGNALING_PATHWAY
6.06060606061%	2	33	69	Mendelian_Metabolism	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
6.06060606061%	2	33	681	Diabetes_McGill_ER_Stress	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
6.06060606061%	2	33	68	Diabetes_McGill_ER_Stress	SESTO_RESPONSE_TO_UV_C7
6.06060606061%	2	33	673	Mendelian_Metabolism	MARTINEZ_RB1_TARGETS_UP
6.06060606061%	2	33	673	Diabetes_McGill_ER_Stress	MARTINEZ_RB1_TARGETS_UP
6.06060606061%	2	33	67	Diabetes_McGill_ER_Stress	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
6.06060606061%	2	33	67	Diabetes_McGill_ER_Stress	DAZARD_UV_RESPONSE_CLUSTER_G1
6.06060606061%	2	33	663	Mendelian_Metabolism	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
6.06060606061%	2	33	66	Diabetes_McGill_ER_Stress	DIRMEIER_LMP1_RESPONSE_EARLY
6.06060606061%	2	33	658	Diabetes_McGill_ER_Stress	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
6.06060606061%	2	33	652	Diabetes_McGill_ER_Stress	BENPORATH_PRC2_TARGETS
6.06060606061%	2	33	65	Diabetes_McGill_ER_Stress	ST_FAS_SIGNALING_PATHWAY
6.06060606061%	2	33	65	Diabetes_McGill_ER_Stress	PID_ERA_GENOMIC_PATHWAY
6.06060606061%	2	33	648	Diabetes_McGill_ER_Stress	SMID_BREAST_CANCER_BASAL_UP
6.06060606061%	2	33	64	Mendelian_Metabolism	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
6.06060606061%	2	33	64	Diabetes_McGill_ER_Stress	BYSTROEM_CORRELATED_WITH_IL5_DN
6.06060606061%	2	33	633	Mendelian_Metabolism	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
6.06060606061%	2	33	63	Diabetes_McGill_ER_Stress	PID_MYC_REPRESSPATHWAY
6.06060606061%	2	33	62	Diabetes_McGill_ER_Stress	KEGG_COLORECTAL_CANCER
6.06060606061%	2	33	61	Mendelian_Metabolism	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
6.06060606061%	2	33	61	Mendelian_Metabolism	LEE_LIVER_CANCER_MYC_TGFA_UP
6.06060606061%	2	33	601	Diabetes_McGill_ER_Stress	MARTINEZ_RB1_AND_TP53_TARGETS_UP
6.06060606061%	2	33	60	Mendelian_Metabolism	LEE_LIVER_CANCER_DENA_UP
6.06060606061%	2	33	60	Mendelian_Metabolism	LEE_LIVER_CANCER_CIPROFIBRATE_UP
6.06060606061%	2	33	593	Mendelian_Metabolism	MARTINEZ_TP53_TARGETS_DN
6.06060606061%	2	33	593	Diabetes_McGill_ER_Stress	MARTINEZ_TP53_TARGETS_DN
6.06060606061%	2	33	591	Mendelian_Metabolism	MARTINEZ_RB1_AND_TP53_TARGETS_DN
6.06060606061%	2	33	590	Mendelian_Metabolism	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
6.06060606061%	2	33	59	Diabetes_McGill_ER_Stress	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
6.06060606061%	2	33	584	Mendelian_Metabolism	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
6.06060606061%	2	33	58	Mendelian_Metabolism	BIOCARTA_PPARA_PATHWAY
6.06060606061%	2	33	58	Diabetes_McGill_ER_Stress	BIOCARTA_HIVNEF_PATHWAY
6.06060606061%	2	33	579	Mendelian_Metabolism	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
6.06060606061%	2	33	578	Mendelian_Metabolism	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
6.06060606061%	2	33	567	Mendelian_Metabolism	PARENT_MTOR_SIGNALING_UP
6.06060606061%	2	33	566	Mendelian_Metabolism	DOUGLAS_BMI1_TARGETS_UP
6.06060606061%	2	33	564	Mendelian_Metabolism	SMID_BREAST_CANCER_LUMINAL_B_DN
6.06060606061%	2	33	553	Diabetes_McGill_ER_Stress	FEVR_CTNNB1_TARGETS_DN
6.06060606061%	2	33	55	Diabetes_McGill_ER_Stress	PID_IL2_1PATHWAY
6.06060606061%	2	33	55	Diabetes_McGill_ER_Stress	GENTILE_UV_RESPONSE_CLUSTER_D4
6.06060606061%	2	33	544	Diabetes_McGill_ER_Stress	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
6.06060606061%	2	33	54	Mendelian_Metabolism	LEE_LIVER_CANCER_MYC_UP
6.06060606061%	2	33	54	Diabetes_McGill_ER_Stress	PID_NFAT_3PATHWAY
6.06060606061%	2	33	537	Mendelian_Metabolism	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
6.06060606061%	2	33	537	Diabetes_McGill_ER_Stress	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
6.06060606061%	2	33	536	Mendelian_Metabolism	BERENJENO_TRANSFORMED_BY_RHOA_UP
6.06060606061%	2	33	532	Diabetes_McGill_ER_Stress	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
6.06060606061%	2	33	530	Mendelian_Metabolism	ENK_UV_RESPONSE_KERATINOCYTE_UP
6.06060606061%	2	33	53	Diabetes_McGill_ER_Stress	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
6.06060606061%	2	33	528	Mendelian_Metabolism	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
6.06060606061%	2	33	526	Mendelian_Metabolism	ONKEN_UVEAL_MELANOMA_DN
6.06060606061%	2	33	52	Diabetes_McGill_ER_Stress	RADAEVA_RESPONSE_TO_IFNA1_UP
6.06060606061%	2	33	52	Diabetes_McGill_ER_Stress	PID_KITPATHWAY
6.06060606061%	2	33	517	Diabetes_McGill_ER_Stress	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
6.06060606061%	2	33	510	Mendelian_Metabolism	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
6.06060606061%	2	33	510	Diabetes_McGill_ER_Stress	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
6.06060606061%	2	33	51	Mendelian_Metabolism	TSUNODA_CISPLATIN_RESISTANCE_DN
6.06060606061%	2	33	51	Mendelian_Metabolism	KEGG_DRUG_METABOLISM_OTHER_ENZYMES
6.06060606061%	2	33	504	Diabetes_McGill_ER_Stress	BROWNE_HCMV_INFECTION_48HR_DN
6.06060606061%	2	33	501	Mendelian_Metabolism	SENESE_HDAC3_TARGETS_UP
6.06060606061%	2	33	493	Diabetes_McGill_ER_Stress	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
6.06060606061%	2	33	49	Diabetes_McGill_ER_Stress	WONG_PROTEASOME_GENE_MODULE
6.06060606061%	2	33	49	Diabetes_McGill_ER_Stress	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
6.06060606061%	2	33	489	Diabetes_McGill_ER_Stress	LIM_MAMMARY_STEM_CELL_UP
6.06060606061%	2	33	485	Mendelian_Metabolism	ENK_UV_RESPONSE_KERATINOCYTE_DN
6.06060606061%	2	33	485	Diabetes_McGill_ER_Stress	ENK_UV_RESPONSE_KERATINOCYTE_DN
6.06060606061%	2	33	482	Mendelian_Metabolism	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
6.06060606061%	2	33	481	Mendelian_Metabolism	LIU_PROSTATE_CANCER_DN
6.06060606061%	2	33	481	Diabetes_McGill_ER_Stress	LIU_PROSTATE_CANCER_DN
6.06060606061%	2	33	48	Diabetes_McGill_ER_Stress	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
6.06060606061%	2	33	479	Mendelian_Metabolism	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
6.06060606061%	2	33	473	Mendelian_Metabolism	GARY_CD5_TARGETS_UP
6.06060606061%	2	33	473	Diabetes_McGill_ER_Stress	GARY_CD5_TARGETS_UP
6.06060606061%	2	33	47	Mendelian_Metabolism	IRITANI_MAD1_TARGETS_DN
6.06060606061%	2	33	47	Diabetes_McGill_ER_Stress	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP
6.06060606061%	2	33	467	Mendelian_Metabolism	RATTENBACHER_BOUND_BY_CELF1
6.06060606061%	2	33	467	Diabetes_McGill_ER_Stress	RATTENBACHER_BOUND_BY_CELF1
6.06060606061%	2	33	466	Mendelian_Metabolism	REACTOME_HEMOSTASIS
6.06060606061%	2	33	466	Diabetes_McGill_ER_Stress	REACTOME_HEMOSTASIS
6.06060606061%	2	33	461	Mendelian_Metabolism	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
6.06060606061%	2	33	46	Mendelian_Metabolism	KRASNOSELSKAYA_ILF3_TARGETS_DN
6.06060606061%	2	33	46	Diabetes_McGill_ER_Stress	SIG_BCR_SIGNALING_PATHWAY
6.06060606061%	2	33	46	Diabetes_McGill_ER_Stress	BIOCARTA_KERATINOCYTE_PATHWAY
6.06060606061%	2	33	450	Diabetes_McGill_ER_Stress	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
6.06060606061%	2	33	45	Mendelian_Metabolism	WANG_TARGETS_OF_MLL_CBP_FUSION_DN
6.06060606061%	2	33	445	Mendelian_Metabolism	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
6.06060606061%	2	33	442	Mendelian_Metabolism	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
6.06060606061%	2	33	442	Diabetes_McGill_ER_Stress	HAN_SATB1_TARGETS_DN
6.06060606061%	2	33	44	Diabetes_McGill_ER_Stress	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP
6.06060606061%	2	33	44	Diabetes_McGill_ER_Stress	MA_MYELOID_DIFFERENTIATION_DN
6.06060606061%	2	33	435	Diabetes_McGill_ER_Stress	SWEET_LUNG_CANCER_KRAS_DN
6.06060606061%	2	33	431	Diabetes_McGill_ER_Stress	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
6.06060606061%	2	33	431	Diabetes_McGill_ER_Stress	GARY_CD5_TARGETS_DN
6.06060606061%	2	33	430	Mendelian_Metabolism	RIGGI_EWING_SARCOMA_PROGENITOR_UP
6.06060606061%	2	33	43	Diabetes_McGill_ER_Stress	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
6.06060606061%	2	33	43	Diabetes_McGill_ER_Stress	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
6.06060606061%	2	33	425	Mendelian_Metabolism	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
6.06060606061%	2	33	425	Diabetes_McGill_ER_Stress	BOCHKIS_FOXA2_TARGETS
6.06060606061%	2	33	423	Diabetes_McGill_ER_Stress	THUM_SYSTOLIC_HEART_FAILURE_UP
6.06060606061%	2	33	422	Mendelian_Metabolism	YAGI_AML_WITH_INV_16_TRANSLOCATION
6.06060606061%	2	33	420	Mendelian_Metabolism	MOOTHA_PGC
6.06060606061%	2	33	414	Mendelian_Metabolism	MOHANKUMAR_TLX1_TARGETS_UP
6.06060606061%	2	33	414	Diabetes_McGill_ER_Stress	MOHANKUMAR_TLX1_TARGETS_UP
6.06060606061%	2	33	412	Diabetes_McGill_ER_Stress	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
6.06060606061%	2	33	41	Diabetes_McGill_ER_Stress	REACTOME_NETRIN1_SIGNALING
6.06060606061%	2	33	408	Mendelian_Metabolism	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
6.06060606061%	2	33	408	Diabetes_McGill_ER_Stress	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
6.06060606061%	2	33	380	Diabetes_McGill_ER_Stress	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
6.06060606061%	2	33	38	Diabetes_McGill_ER_Stress	PID_P38ALPHABETADOWNSTREAMPATHWAY
6.06060606061%	2	33	374	Diabetes_McGill_ER_Stress	WANG_TUMOR_INVASIVENESS_UP
6.06060606061%	2	33	37	Diabetes_McGill_ER_Stress	ST_GA13_PATHWAY
6.06060606061%	2	33	37	Diabetes_McGill_ER_Stress	BIOCARTA_TOLL_PATHWAY
6.06060606061%	2	33	367	Mendelian_Metabolism	VECCHI_GASTRIC_CANCER_EARLY_DN
6.06060606061%	2	33	367	Mendelian_Metabolism	DELACROIX_RARG_BOUND_MEF
6.06060606061%	2	33	366	Mendelian_Metabolism	SANSOM_APC_TARGETS_DN
6.06060606061%	2	33	364	Mendelian_Metabolism	YANG_BCL3_TARGETS_UP
6.06060606061%	2	33	362	Mendelian_Metabolism	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
6.06060606061%	2	33	36	Diabetes_McGill_ER_Stress	YANG_BREAST_CANCER_ESR1_UP
6.06060606061%	2	33	357	Mendelian_Metabolism	SHEN_SMARCA2_TARGETS_DN
6.06060606061%	2	33	35	Mendelian_Metabolism	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
6.06060606061%	2	33	35	Diabetes_McGill_ER_Stress	PID_HIVNEFPATHWAY
6.06060606061%	2	33	344	Mendelian_Metabolism	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
6.06060606061%	2	33	34	Mendelian_Metabolism	KEGG_CYSTEINE_AND_METHIONINE_METABOLISM
6.06060606061%	2	33	34	Diabetes_McGill_ER_Stress	PID_EPOPATHWAY
6.06060606061%	2	33	337	Diabetes_McGill_ER_Stress	PHONG_TNF_RESPONSE_NOT_VIA_P38
6.06060606061%	2	33	335	Diabetes_McGill_ER_Stress	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
6.06060606061%	2	33	33	Mendelian_Metabolism	REACTOME_PURINE_METABOLISM
6.06060606061%	2	33	33	Diabetes_McGill_ER_Stress	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP
6.06060606061%	2	33	328	Diabetes_McGill_ER_Stress	KEGG_PATHWAYS_IN_CANCER
6.06060606061%	2	33	326	Diabetes_McGill_ER_Stress	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
6.06060606061%	2	33	323	Diabetes_McGill_ER_Stress	GRESHOCK_CANCER_COPY_NUMBER_UP
6.06060606061%	2	33	32	Diabetes_McGill_ER_Stress	TRACEY_RESISTANCE_TO_IFNA2_DN
6.06060606061%	2	33	315	Mendelian_Metabolism	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
6.06060606061%	2	33	315	Diabetes_McGill_ER_Stress	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
6.06060606061%	2	33	311	Diabetes_McGill_ER_Stress	JIANG_HYPOXIA_NORMAL
6.06060606061%	2	33	31	Diabetes_McGill_ER_Stress	NOJIMA_SFRP2_TARGETS_UP
6.06060606061%	2	33	307	Diabetes_McGill_ER_Stress	LI_INDUCED_T_TO_NATURAL_KILLER_UP
6.06060606061%	2	33	307	Diabetes_McGill_ER_Stress	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
6.06060606061%	2	33	305	Mendelian_Metabolism	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
6.06060606061%	2	33	305	Diabetes_McGill_ER_Stress	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
6.06060606061%	2	33	30	Diabetes_McGill_ER_Stress	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
6.06060606061%	2	33	30	Diabetes_McGill_ER_Stress	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
6.06060606061%	2	33	296	Mendelian_Metabolism	DURAND_STROMA_MAX_UP
6.06060606061%	2	33	295	Diabetes_McGill_ER_Stress	LU_EZH2_TARGETS_UP
6.06060606061%	2	33	293	Mendelian_Metabolism	ENK_UV_RESPONSE_EPIDERMIS_UP
6.06060606061%	2	33	289	Mendelian_Metabolism	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
6.06060606061%	2	33	285	Diabetes_McGill_ER_Stress	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
6.06060606061%	2	33	283	Mendelian_Metabolism	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
6.06060606061%	2	33	281	Diabetes_McGill_ER_Stress	MULLIGHAN_MLL_SIGNATURE_2_DN
6.06060606061%	2	33	279	Diabetes_McGill_ER_Stress	REACTOME_INNATE_IMMUNE_SYSTEM
6.06060606061%	2	33	279	Diabetes_McGill_ER_Stress	FORTSCHEGGER_PHF8_TARGETS_UP
6.06060606061%	2	33	275	Mendelian_Metabolism	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
6.06060606061%	2	33	269	Mendelian_Metabolism	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
6.06060606061%	2	33	269	Diabetes_McGill_ER_Stress	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
6.06060606061%	2	33	267	Mendelian_Metabolism	HOLLMANN_APOPTOSIS_VIA_CD40_DN
6.06060606061%	2	33	262	Diabetes_McGill_ER_Stress	LU_AGING_BRAIN_UP
6.06060606061%	2	33	261	Mendelian_Metabolism	BILD_HRAS_ONCOGENIC_SIGNATURE
6.06060606061%	2	33	26	Mendelian_Metabolism	KEGG_SELENOAMINO_ACID_METABOLISM
6.06060606061%	2	33	258	Diabetes_McGill_ER_Stress	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
6.06060606061%	2	33	255	Mendelian_Metabolism	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
6.06060606061%	2	33	252	Mendelian_Metabolism	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
6.06060606061%	2	33	251	Diabetes_McGill_ER_Stress	REACTOME_AXON_GUIDANCE
6.06060606061%	2	33	25	Mendelian_Metabolism	COLLER_MYC_TARGETS_UP
6.06060606061%	2	33	25	Diabetes_McGill_ER_Stress	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG
6.06060606061%	2	33	25	Diabetes_McGill_ER_Stress	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN
6.06060606061%	2	33	249	Diabetes_McGill_ER_Stress	MITSIADES_RESPONSE_TO_APLIDIN_DN
6.06060606061%	2	33	246	Mendelian_Metabolism	VERHAAK_AML_WITH_NPM1_MUTATED_DN
6.06060606061%	2	33	246	Diabetes_McGill_ER_Stress	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
6.06060606061%	2	33	244	Diabetes_McGill_ER_Stress	KAYO_AGING_MUSCLE_UP
6.06060606061%	2	33	243	Mendelian_Metabolism	CHICAS_RB1_TARGETS_GROWING
6.06060606061%	2	33	241	Mendelian_Metabolism	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
6.06060606061%	2	33	240	Diabetes_McGill_ER_Stress	UDAYAKUMAR_MED1_TARGETS_DN
6.06060606061%	2	33	24	Mendelian_Metabolism	REACTOME_SULFUR_AMINO_ACID_METABOLISM
6.06060606061%	2	33	24	Diabetes_McGill_ER_Stress	YAN_ESCAPE_FROM_ANOIKIS
6.06060606061%	2	33	24	Diabetes_McGill_ER_Stress	SHI_SPARC_TARGETS_UP
6.06060606061%	2	33	239	Diabetes_McGill_ER_Stress	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
6.06060606061%	2	33	238	Diabetes_McGill_ER_Stress	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
6.06060606061%	2	33	232	Diabetes_McGill_ER_Stress	DELYS_THYROID_CANCER_DN
6.06060606061%	2	33	230	Diabetes_McGill_ER_Stress	BENPORATH_MYC_TARGETS_WITH_EBOX
6.06060606061%	2	33	23	Diabetes_McGill_ER_Stress	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5
6.06060606061%	2	33	227	Diabetes_McGill_ER_Stress	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
6.06060606061%	2	33	225	Mendelian_Metabolism	BROWNE_HCMV_INFECTION_16HR_UP
6.06060606061%	2	33	222	Diabetes_McGill_ER_Stress	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
6.06060606061%	2	33	221	Diabetes_McGill_ER_Stress	ZHANG_TLX_TARGETS_36HR_UP
6.06060606061%	2	33	221	Diabetes_McGill_ER_Stress	PEDRIOLI_MIR31_TARGETS_UP
6.06060606061%	2	33	220	Mendelian_Metabolism	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
6.06060606061%	2	33	22	Diabetes_McGill_ER_Stress	BIOCARTA_CHEMICAL_PATHWAY
6.06060606061%	2	33	22	Diabetes_McGill_ER_Stress	BIOCARTA_CERAMIDE_PATHWAY
6.06060606061%	2	33	217	Diabetes_McGill_ER_Stress	WONG_MITOCHONDRIA_GENE_MODULE
6.06060606061%	2	33	217	Diabetes_McGill_ER_Stress	AMUNDSON_RESPONSE_TO_ARSENITE
6.06060606061%	2	33	215	Mendelian_Metabolism	MARKEY_RB1_ACUTE_LOF_UP
6.06060606061%	2	33	214	Mendelian_Metabolism	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
6.06060606061%	2	33	214	Diabetes_McGill_ER_Stress	TIEN_INTESTINE_PROBIOTICS_24HR_DN
6.06060606061%	2	33	214	Diabetes_McGill_ER_Stress	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
6.06060606061%	2	33	214	Diabetes_McGill_ER_Stress	AFFAR_YY1_TARGETS_UP
6.06060606061%	2	33	212	Mendelian_Metabolism	CHANG_CORE_SERUM_RESPONSE_UP
6.06060606061%	2	33	210	Diabetes_McGill_ER_Stress	WANG_TUMOR_INVASIVENESS_DN
6.06060606061%	2	33	208	Mendelian_Metabolism	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
6.06060606061%	2	33	207	Mendelian_Metabolism	MANALO_HYPOXIA_UP
6.06060606061%	2	33	206	Mendelian_Metabolism	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
6.06060606061%	2	33	204	Diabetes_McGill_ER_Stress	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
6.06060606061%	2	33	203	Mendelian_Metabolism	PENG_RAPAMYCIN_RESPONSE_UP
6.06060606061%	2	33	203	Mendelian_Metabolism	GRUETZMANN_PANCREATIC_CANCER_DN
6.06060606061%	2	33	203	Diabetes_McGill_ER_Stress	GRUETZMANN_PANCREATIC_CANCER_DN
6.06060606061%	2	33	202	Diabetes_McGill_ER_Stress	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
6.06060606061%	2	33	201	Mendelian_Metabolism	KIM_MYC_AMPLIFICATION_TARGETS_UP
6.06060606061%	2	33	201	Diabetes_McGill_ER_Stress	KEGG_FOCAL_ADHESION
6.06060606061%	2	33	20	Diabetes_McGill_ER_Stress	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
6.06060606061%	2	33	199	Diabetes_McGill_ER_Stress	PLASARI_TGFB1_TARGETS_10HR_UP
6.06060606061%	2	33	19	Diabetes_McGill_ER_Stress	SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP
6.06060606061%	2	33	19	Diabetes_McGill_ER_Stress	MAHADEVAN_RESPONSE_TO_MP470_DN
6.06060606061%	2	33	189	Mendelian_Metabolism	BURTON_ADIPOGENESIS_6
6.06060606061%	2	33	188	Diabetes_McGill_ER_Stress	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
6.06060606061%	2	33	187	Mendelian_Metabolism	BAKKER_FOXO3_TARGETS_DN
6.06060606061%	2	33	182	Diabetes_McGill_ER_Stress	FERNANDEZ_BOUND_BY_MYC
6.06060606061%	2	33	178	Mendelian_Metabolism	BROWNE_HCMV_INFECTION_18HR_DN
6.06060606061%	2	33	176	Diabetes_McGill_ER_Stress	NAGASHIMA_NRG1_SIGNALING_UP
6.06060606061%	2	33	174	Diabetes_McGill_ER_Stress	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
6.06060606061%	2	33	17	Diabetes_McGill_ER_Stress	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS
6.06060606061%	2	33	17	Diabetes_McGill_ER_Stress	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN
6.06060606061%	2	33	17	Diabetes_McGill_ER_Stress	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
6.06060606061%	2	33	169	Mendelian_Metabolism	UEDA_PERIFERAL_CLOCK
6.06060606061%	2	33	169	Diabetes_McGill_ER_Stress	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
6.06060606061%	2	33	168	Mendelian_Metabolism	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
6.06060606061%	2	33	167	Diabetes_McGill_ER_Stress	VANTVEER_BREAST_CANCER_ESR1_UP
6.06060606061%	2	33	166	Diabetes_McGill_ER_Stress	SMIRNOV_RESPONSE_TO_IR_6HR_UP
6.06060606061%	2	33	1652	Mendelian_Metabolism	PUJANA_BRCA1_PCC_NETWORK
6.06060606061%	2	33	165	Diabetes_McGill_ER_Stress	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
6.06060606061%	2	33	16	Diabetes_McGill_ER_Stress	ABDELMOHSEN_ELAVL4_TARGETS
6.06060606061%	2	33	158	Mendelian_Metabolism	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
6.06060606061%	2	33	157	Diabetes_McGill_ER_Stress	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
6.06060606061%	2	33	151	Diabetes_McGill_ER_Stress	KEGG_WNT_SIGNALING_PATHWAY
6.06060606061%	2	33	151	Diabetes_McGill_ER_Stress	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
6.06060606061%	2	33	150	Mendelian_Metabolism	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
6.06060606061%	2	33	149	Diabetes_McGill_ER_Stress	TSAI_RESPONSE_TO_IONIZING_RADIATION
6.06060606061%	2	33	148	Diabetes_McGill_ER_Stress	REACTOME_APOPTOSIS
6.06060606061%	2	33	147	Mendelian_Metabolism	SMID_BREAST_CANCER_ERBB2_UP
6.06060606061%	2	33	146	Diabetes_McGill_ER_Stress	PECE_MAMMARY_STEM_CELL_DN
6.06060606061%	2	33	143	Diabetes_McGill_ER_Stress	DANG_MYC_TARGETS_UP
6.06060606061%	2	33	143	Diabetes_McGill_ER_Stress	BASSO_B_LYMPHOCYTE_NETWORK
6.06060606061%	2	33	142	Diabetes_McGill_ER_Stress	PENG_LEUCINE_DEPRIVATION_UP
6.06060606061%	2	33	141	Mendelian_Metabolism	SABATES_COLORECTAL_ADENOMA_UP
6.06060606061%	2	33	14	Diabetes_McGill_ER_Stress	BIOCARTA_RANKL_PATHWAY
6.06060606061%	2	33	138	Diabetes_McGill_ER_Stress	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
6.06060606061%	2	33	136	Diabetes_McGill_ER_Stress	PROVENZANI_METASTASIS_DN
6.06060606061%	2	33	135	Mendelian_Metabolism	SERVITJA_LIVER_HNF1A_TARGETS_UP
6.06060606061%	2	33	13	Mendelian_Metabolism	REACTOME_PURINE_SALVAGE
6.06060606061%	2	33	129	Mendelian_Metabolism	BROWN_MYELOID_CELL_DEVELOPMENT_DN
6.06060606061%	2	33	129	Diabetes_McGill_ER_Stress	PID_PDGFRBPATHWAY
6.06060606061%	2	33	1278	Diabetes_McGill_ER_Stress	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
6.06060606061%	2	33	127	Diabetes_McGill_ER_Stress	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
6.06060606061%	2	33	126	Mendelian_Metabolism	GERY_CEBP_TARGETS
6.06060606061%	2	33	126	Mendelian_Metabolism	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
6.06060606061%	2	33	126	Diabetes_McGill_ER_Stress	GERY_CEBP_TARGETS
6.06060606061%	2	33	125	Diabetes_McGill_ER_Stress	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
6.06060606061%	2	33	123	Diabetes_McGill_ER_Stress	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
6.06060606061%	2	33	123	Diabetes_McGill_ER_Stress	DAZARD_RESPONSE_TO_UV_SCC_DN
6.06060606061%	2	33	1229	Mendelian_Metabolism	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
6.06060606061%	2	33	121	Diabetes_McGill_ER_Stress	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
6.06060606061%	2	33	120	Diabetes_McGill_ER_Stress	XU_GH1_EXOGENOUS_TARGETS_DN
6.06060606061%	2	33	115	Mendelian_Metabolism	MARKEY_RB1_CHRONIC_LOF_UP
6.06060606061%	2	33	115	Mendelian_Metabolism	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
6.06060606061%	2	33	1142	Mendelian_Metabolism	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
6.06060606061%	2	33	114	Mendelian_Metabolism	LENAOUR_DENDRITIC_CELL_MATURATION_UP
6.06060606061%	2	33	114	Diabetes_McGill_ER_Stress	BOSCO_TH1_CYTOTOXIC_MODULE
6.06060606061%	2	33	1137	Diabetes_McGill_ER_Stress	BRUINS_UVC_RESPONSE_LATE
6.06060606061%	2	33	113	Mendelian_Metabolism	RICKMAN_HEAD_AND_NECK_CANCER_C
6.06060606061%	2	33	112	Mendelian_Metabolism	PASINI_SUZ12_TARGETS_UP
6.06060606061%	2	33	112	Diabetes_McGill_ER_Stress	DOANE_BREAST_CANCER_ESR1_UP
6.06060606061%	2	33	1118	Diabetes_McGill_ER_Stress	BENPORATH_ES_WITH_H3K27ME3
6.06060606061%	2	33	110	Mendelian_Metabolism	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
6.06060606061%	2	33	11	Diabetes_McGill_ER_Stress	ZHOU_PANCREATIC_BETA_CELL
6.06060606061%	2	33	108	Diabetes_McGill_ER_Stress	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
6.06060606061%	2	33	1062	Diabetes_McGill_ER_Stress	BENPORATH_EED_TARGETS
6.06060606061%	2	33	105	Diabetes_McGill_ER_Stress	WOO_LIVER_CANCER_RECURRENCE_UP
6.06060606061%	2	33	104	Mendelian_Metabolism	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
6.06060606061%	2	33	1038	Diabetes_McGill_ER_Stress	BENPORATH_SUZ12_TARGETS
6.06060606061%	2	33	1024	Diabetes_McGill_ER_Stress	NUYTTEN_EZH2_TARGETS_DN
6.06060606061%	2	33	102	Diabetes_McGill_ER_Stress	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
6.06060606061%	2	33	101	Diabetes_McGill_ER_Stress	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
6.06060606061%	2	33	101	Diabetes_McGill_ER_Stress	KEGG_GNRH_SIGNALING_PATHWAY
6.06060606061%	2	33	100	Diabetes_McGill_ER_Stress	RICKMAN_HEAD_AND_NECK_CANCER_A
6.06060606061%	2	33	100	Diabetes_McGill_ER_Stress	QI_PLASMACYTOMA_DN
6.06060606061%	2	33	100	Diabetes_McGill_ER_Stress	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
6.06060606061%	2	33	10	Diabetes_McGill_ER_Stress	BIOCARTA_RNA_PATHWAY
6.05381165919%	27	446	1442	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PUJANA_ATM_PCC_NETWORK
6.05143721634%	40	661	920	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_GPCR
6.05143721634%	40	661	1080	T2D_GENES_TANYA_GLYCEMIC	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
6.03588907015%	37	613	973	T2D_GENES_TANYA_BIOMARKER	ACEVEDO_LIVER_CANCER_UP
5.98610368787%	112	1871	841	T2D_GENES_TANYA_HEIGHT	MARTENS_TRETINOIN_RESPONSE_DN
5.97771023303%	118	1974	721	Mendelian_Nancy_Cox	WONG_ADULT_TISSUE_STEM_MODULE
5.93406593407%	27	455	62	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_RNA_POL_I_PROMOTER_OPENING
5.93406593407%	27	455	421	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CELL_CYCLE
5.93406593407%	27	455	1375	T2D_GENES_TANYA_BLOODPRESSURE	DODD_NASOPHARYNGEAL_CARCINOMA_DN
5.93406593407%	27	455	1038	T2D_GENES_TANYA_BLOODPRESSURE	BENPORATH_SUZ12_TARGETS
5.92885375494%	15	253	87	Diabetes_McGill_CREBBP_coTF	BIOCARTA_MAPK_PATHWAY
5.92885375494%	15	253	79	Diabetes_McGill_CREBBP_coTF	DUAN_PRDM5_TARGETS
5.92885375494%	15	253	734	Diabetes_McGill_CREBBP_coTF	BENPORATH_SOX2_TARGETS
5.92885375494%	15	253	701	Diabetes_McGill_CREBBP_coTF	SMID_BREAST_CANCER_BASAL_DN
5.92885375494%	15	253	70	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_NOTCH1
5.92885375494%	15	253	65	Diabetes_McGill_CREBBP_coTF	PID_ERA_GENOMIC_PATHWAY
5.92885375494%	15	253	634	Diabetes_McGill_CREBBP_coTF	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
5.92885375494%	15	253	570	Diabetes_McGill_CREBBP_coTF	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
5.92885375494%	15	253	505	Diabetes_McGill_CREBBP_coTF	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
5.92885375494%	15	253	475	Diabetes_McGill_CREBBP_coTF	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
5.92885375494%	15	253	47	Diabetes_McGill_CREBBP_coTF	KEGG_NOTCH_SIGNALING_PATHWAY
5.92885375494%	15	253	466	Diabetes_McGill_CREBBP_coTF	REACTOME_HEMOSTASIS
5.92885375494%	15	253	46	Diabetes_McGill_CREBBP_coTF	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION
5.92885375494%	15	253	374	Diabetes_McGill_CREBBP_coTF	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
5.92885375494%	15	253	366	Diabetes_McGill_CREBBP_coTF	YOSHIMURA_MAPK8_TARGETS_DN
5.92885375494%	15	253	342	Diabetes_McGill_CREBBP_coTF	BLUM_RESPONSE_TO_SALIRASIB_DN
5.92885375494%	15	253	299	Diabetes_McGill_CREBBP_coTF	MUELLER_PLURINET
5.92885375494%	15	253	1237	Diabetes_McGill_CREBBP_coTF	BLALOCK_ALZHEIMERS_DISEASE_DN
5.92885375494%	15	253	105	Diabetes_McGill_CREBBP_coTF	PID_ERBB1_DOWNSTREAM_PATHWAY
5.92705167173%	117	1974	953	Mendelian_Nancy_Cox	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
5.92705167173%	117	1974	745	Mendelian_Nancy_Cox	LEE_BMP2_TARGETS_UP
5.92705167173%	117	1974	328	Mendelian_Nancy_Cox	KEGG_PATHWAYS_IN_CANCER
5.90405904059%	32	542	953	T2D_GENES_TANYA_ANTHROPOMETRIC	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
5.90405904059%	32	542	756	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
5.90248075278%	69	1169	1781	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
5.90248075278%	69	1169	1442	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PUJANA_ATM_PCC_NETWORK
5.90015128593%	39	661	421	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CELL_CYCLE
5.88235294118%	1	17	988	Mendelian_Blood_Desease	BENPORATH_NANOG_TARGETS
5.88235294118%	1	17	98	Mendelian_Severe_Combined_Immunodeficiency	KEGG_PYRIMIDINE_METABOLISM
5.88235294118%	1	17	98	Mendelian_Severe_Combined_Immunodeficiency	HAHTOLA_SEZARY_SYNDROM_UP
5.88235294118%	1	17	98	Mendelian_Severe_Combined_Immunodeficiency	GAVIN_FOXP3_TARGETS_CLUSTER_T7
5.88235294118%	1	17	98	Mendelian_Severe_Combined_Immunodeficiency	CROONQUIST_IL6_DEPRIVATION_DN
5.88235294118%	1	17	98	Mendelian_Severe_Combined_Immunodeficiency	BRUINS_UVC_RESPONSE_MIDDLE
5.88235294118%	1	17	98	Mendelian_Blood_Desease	HAHTOLA_SEZARY_SYNDROM_UP
5.88235294118%	1	17	98	Mendelian_Blood_Desease	GAVIN_FOXP3_TARGETS_CLUSTER_T7
5.88235294118%	1	17	973	Mendelian_Severe_Combined_Immunodeficiency	ACEVEDO_LIVER_CANCER_UP
5.88235294118%	1	17	973	Mendelian_Blood_Desease	ACEVEDO_LIVER_CANCER_UP
5.88235294118%	1	17	97	Mendelian_Severe_Combined_Immunodeficiency	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
5.88235294118%	1	17	957	Mendelian_Severe_Combined_Immunodeficiency	LOPEZ_MBD_TARGETS
5.88235294118%	1	17	953	Mendelian_Severe_Combined_Immunodeficiency	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
5.88235294118%	1	17	953	Mendelian_Blood_Desease	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
5.88235294118%	1	17	95	Mendelian_Severe_Combined_Immunodeficiency	HOEBEKE_LYMPHOID_STEM_CELL_UP
5.88235294118%	1	17	95	Mendelian_Severe_Combined_Immunodeficiency	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
5.88235294118%	1	17	94	Mendelian_Severe_Combined_Immunodeficiency	HOOI_ST7_TARGETS_UP
5.88235294118%	1	17	94	Mendelian_Blood_Desease	LU_IL4_SIGNALING
5.88235294118%	1	17	933	Mendelian_Blood_Desease	REACTOME_IMMUNE_SYSTEM
5.88235294118%	1	17	92	Mendelian_Blood_Desease	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
5.88235294118%	1	17	918	Mendelian_Severe_Combined_Immunodeficiency	JOHNSTONE_PARVB_TARGETS_3_DN
5.88235294118%	1	17	918	Mendelian_Blood_Desease	JOHNSTONE_PARVB_TARGETS_3_DN
5.88235294118%	1	17	911	Mendelian_Blood_Desease	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
5.88235294118%	1	17	91	Mendelian_Severe_Combined_Immunodeficiency	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
5.88235294118%	1	17	91	Mendelian_Blood_Desease	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
5.88235294118%	1	17	90	Mendelian_Severe_Combined_Immunodeficiency	MORI_IMMATURE_B_LYMPHOCYTE_DN
5.88235294118%	1	17	9	Mendelian_Severe_Combined_Immunodeficiency	ST_JAK_STAT_PATHWAY
5.88235294118%	1	17	9	Mendelian_Severe_Combined_Immunodeficiency	FIGUEROA_AML_METHYLATION_CLUSTER_2_DN
5.88235294118%	1	17	9	Mendelian_Blood_Desease	YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN
5.88235294118%	1	17	9	Mendelian_Blood_Desease	NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON
5.88235294118%	1	17	9	Mendelian_Blood_Desease	FIGUEROA_AML_METHYLATION_CLUSTER_2_DN
5.88235294118%	1	17	9	Mendelian_Blood_Desease	CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN
5.88235294118%	1	17	898	Mendelian_Severe_Combined_Immunodeficiency	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
5.88235294118%	1	17	89	Mendelian_Severe_Combined_Immunodeficiency	VANLOO_SP3_TARGETS_DN
5.88235294118%	1	17	89	Mendelian_Severe_Combined_Immunodeficiency	LI_DCP2_BOUND_MRNA
5.88235294118%	1	17	89	Mendelian_Blood_Desease	SWEET_KRAS_ONCOGENIC_SIGNATURE
5.88235294118%	1	17	89	Mendelian_Blood_Desease	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
5.88235294118%	1	17	89	Mendelian_Blood_Desease	KANG_IMMORTALIZED_BY_TERT_UP
5.88235294118%	1	17	89	Mendelian_Blood_Desease	BHATTACHARYA_EMBRYONIC_STEM_CELL
5.88235294118%	1	17	882	Mendelian_Severe_Combined_Immunodeficiency	LEE_BMP2_TARGETS_DN
5.88235294118%	1	17	882	Mendelian_Blood_Desease	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
5.88235294118%	1	17	882	Mendelian_Blood_Desease	LEE_BMP2_TARGETS_DN
5.88235294118%	1	17	88	Mendelian_Severe_Combined_Immunodeficiency	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
5.88235294118%	1	17	88	Mendelian_Blood_Desease	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
5.88235294118%	1	17	87	Mendelian_Severe_Combined_Immunodeficiency	SMITH_TERT_TARGETS_DN
5.88235294118%	1	17	87	Mendelian_Severe_Combined_Immunodeficiency	SAFFORD_T_LYMPHOCYTE_ANERGY
5.88235294118%	1	17	87	Mendelian_Severe_Combined_Immunodeficiency	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
5.88235294118%	1	17	87	Mendelian_Blood_Desease	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
5.88235294118%	1	17	87	Mendelian_Blood_Desease	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
5.88235294118%	1	17	87	Mendelian_Blood_Desease	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
5.88235294118%	1	17	87	Mendelian_Blood_Desease	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
5.88235294118%	1	17	863	Mendelian_Severe_Combined_Immunodeficiency	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
5.88235294118%	1	17	86	Mendelian_Severe_Combined_Immunodeficiency	GHANDHI_BYSTANDER_IRRADIATION_UP
5.88235294118%	1	17	86	Mendelian_Blood_Desease	BAELDE_DIABETIC_NEPHROPATHY_UP
5.88235294118%	1	17	857	Mendelian_Blood_Desease	MARTENS_TRETINOIN_RESPONSE_UP
5.88235294118%	1	17	855	Mendelian_Severe_Combined_Immunodeficiency	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
5.88235294118%	1	17	85	Mendelian_Severe_Combined_Immunodeficiency	XU_GH1_EXOGENOUS_TARGETS_UP
5.88235294118%	1	17	85	Mendelian_Severe_Combined_Immunodeficiency	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
5.88235294118%	1	17	84	Mendelian_Severe_Combined_Immunodeficiency	RUAN_RESPONSE_TO_TNF_DN
5.88235294118%	1	17	84	Mendelian_Severe_Combined_Immunodeficiency	RASHI_RESPONSE_TO_IONIZING_RADIATION_6
5.88235294118%	1	17	84	Mendelian_Blood_Desease	SMID_BREAST_CANCER_LUMINAL_A_UP
5.88235294118%	1	17	84	Mendelian_Blood_Desease	RASHI_RESPONSE_TO_IONIZING_RADIATION_6
5.88235294118%	1	17	83	Mendelian_Severe_Combined_Immunodeficiency	SANA_TNF_SIGNALING_UP
5.88235294118%	1	17	83	Mendelian_Severe_Combined_Immunodeficiency	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
5.88235294118%	1	17	824	Mendelian_Severe_Combined_Immunodeficiency	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
5.88235294118%	1	17	82	Mendelian_Severe_Combined_Immunodeficiency	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
5.88235294118%	1	17	82	Mendelian_Blood_Desease	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
5.88235294118%	1	17	82	Mendelian_Blood_Desease	BILD_CTNNB1_ONCOGENIC_SIGNATURE
5.88235294118%	1	17	81	Mendelian_Severe_Combined_Immunodeficiency	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
5.88235294118%	1	17	81	Mendelian_Severe_Combined_Immunodeficiency	MAHAJAN_RESPONSE_TO_IL1A_UP
5.88235294118%	1	17	81	Mendelian_Severe_Combined_Immunodeficiency	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
5.88235294118%	1	17	81	Mendelian_Severe_Combined_Immunodeficiency	COATES_MACROPHAGE_M1_VS_M2_UP
5.88235294118%	1	17	805	Mendelian_Severe_Combined_Immunodeficiency	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
5.88235294118%	1	17	805	Mendelian_Blood_Desease	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
5.88235294118%	1	17	800	Mendelian_Severe_Combined_Immunodeficiency	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
5.88235294118%	1	17	80	Mendelian_Severe_Combined_Immunodeficiency	WOO_LIVER_CANCER_RECURRENCE_DN
5.88235294118%	1	17	80	Mendelian_Severe_Combined_Immunodeficiency	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
5.88235294118%	1	17	80	Mendelian_Blood_Desease	BASSO_HAIRY_CELL_LEUKEMIA_DN
5.88235294118%	1	17	8	Mendelian_Blood_Desease	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN
5.88235294118%	1	17	8	Mendelian_Blood_Desease	NEBEN_AML_WITH_FLT3_OR_NRAS_UP
5.88235294118%	1	17	795	Mendelian_Severe_Combined_Immunodeficiency	WEI_MYCN_TARGETS_WITH_E_BOX
5.88235294118%	1	17	79	Mendelian_Severe_Combined_Immunodeficiency	PID_P73PATHWAY
5.88235294118%	1	17	79	Mendelian_Blood_Desease	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
5.88235294118%	1	17	79	Mendelian_Blood_Desease	PID_MYC_ACTIVPATHWAY
5.88235294118%	1	17	79	Mendelian_Blood_Desease	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
5.88235294118%	1	17	79	Mendelian_Blood_Desease	LIU_COMMON_CANCER_GENES
5.88235294118%	1	17	784	Mendelian_Severe_Combined_Immunodeficiency	FORTSCHEGGER_PHF8_TARGETS_DN
5.88235294118%	1	17	783	Mendelian_Severe_Combined_Immunodeficiency	ONKEN_UVEAL_MELANOMA_UP
5.88235294118%	1	17	783	Mendelian_Severe_Combined_Immunodeficiency	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
5.88235294118%	1	17	78	Mendelian_Severe_Combined_Immunodeficiency	ROSS_AML_WITH_MLL_FUSIONS
5.88235294118%	1	17	78	Mendelian_Severe_Combined_Immunodeficiency	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
5.88235294118%	1	17	78	Mendelian_Severe_Combined_Immunodeficiency	RADMACHER_AML_PROGNOSIS
5.88235294118%	1	17	78	Mendelian_Severe_Combined_Immunodeficiency	BOYLAN_MULTIPLE_MYELOMA_D_DN
5.88235294118%	1	17	779	Mendelian_Blood_Desease	PUJANA_CHEK2_PCC_NETWORK
5.88235294118%	1	17	775	Mendelian_Severe_Combined_Immunodeficiency	BENPORATH_MYC_MAX_TARGETS
5.88235294118%	1	17	770	Mendelian_Severe_Combined_Immunodeficiency	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
5.88235294118%	1	17	770	Mendelian_Blood_Desease	KRIEG_HYPOXIA_NOT_VIA_KDM3A
5.88235294118%	1	17	77	Mendelian_Severe_Combined_Immunodeficiency	SEKI_INFLAMMATORY_RESPONSE_LPS_UP
5.88235294118%	1	17	77	Mendelian_Severe_Combined_Immunodeficiency	MORI_PRE_BI_LYMPHOCYTE_DN
5.88235294118%	1	17	77	Mendelian_Blood_Desease	GROSS_HYPOXIA_VIA_HIF1A_UP
5.88235294118%	1	17	76	Mendelian_Severe_Combined_Immunodeficiency	ROSS_AML_WITH_AML1_ETO_FUSION
5.88235294118%	1	17	76	Mendelian_Severe_Combined_Immunodeficiency	PEART_HDAC_PROLIFERATION_CLUSTER_DN
5.88235294118%	1	17	75	Mendelian_Severe_Combined_Immunodeficiency	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
5.88235294118%	1	17	75	Mendelian_Severe_Combined_Immunodeficiency	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
5.88235294118%	1	17	747	Mendelian_Severe_Combined_Immunodeficiency	PATIL_LIVER_CANCER
5.88235294118%	1	17	747	Mendelian_Blood_Desease	PATIL_LIVER_CANCER
5.88235294118%	1	17	745	Mendelian_Severe_Combined_Immunodeficiency	LEE_BMP2_TARGETS_UP
5.88235294118%	1	17	74	Mendelian_Severe_Combined_Immunodeficiency	WESTON_VEGFA_TARGETS_3HR
5.88235294118%	1	17	734	Mendelian_Severe_Combined_Immunodeficiency	BENPORATH_SOX2_TARGETS
5.88235294118%	1	17	734	Mendelian_Blood_Desease	BENPORATH_SOX2_TARGETS
5.88235294118%	1	17	73	Mendelian_Severe_Combined_Immunodeficiency	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP
5.88235294118%	1	17	73	Mendelian_Severe_Combined_Immunodeficiency	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
5.88235294118%	1	17	73	Mendelian_Severe_Combined_Immunodeficiency	LIN_MELANOMA_COPY_NUMBER_UP
5.88235294118%	1	17	73	Mendelian_Severe_Combined_Immunodeficiency	GAURNIER_PSMD4_TARGETS
5.88235294118%	1	17	73	Mendelian_Blood_Desease	KEGG_VIRAL_MYOCARDITIS
5.88235294118%	1	17	73	Mendelian_Blood_Desease	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
5.88235294118%	1	17	728	Mendelian_Severe_Combined_Immunodeficiency	MARSON_BOUND_BY_E2F4_UNSTIMULATED
5.88235294118%	1	17	72	Mendelian_Severe_Combined_Immunodeficiency	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
5.88235294118%	1	17	72	Mendelian_Blood_Desease	KEGG_LEISHMANIA_INFECTION
5.88235294118%	1	17	712	Mendelian_Severe_Combined_Immunodeficiency	SCHLOSSER_SERUM_RESPONSE_DN
5.88235294118%	1	17	71	Mendelian_Severe_Combined_Immunodeficiency	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
5.88235294118%	1	17	71	Mendelian_Severe_Combined_Immunodeficiency	BROWNE_HCMV_INFECTION_6HR_UP
5.88235294118%	1	17	71	Mendelian_Blood_Desease	KYNG_RESPONSE_TO_H2O2
5.88235294118%	1	17	70	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
5.88235294118%	1	17	70	Mendelian_Blood_Desease	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
5.88235294118%	1	17	70	Mendelian_Blood_Desease	RAGHAVACHARI_PLATELET_SPECIFIC_GENES
5.88235294118%	1	17	70	Mendelian_Blood_Desease	ENGELMANN_CANCER_PROGENITORS_DN
5.88235294118%	1	17	69	Mendelian_Severe_Combined_Immunodeficiency	ZAMORA_NOS2_TARGETS_UP
5.88235294118%	1	17	69	Mendelian_Blood_Desease	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10
5.88235294118%	1	17	69	Mendelian_Blood_Desease	AMIT_EGF_RESPONSE_120_HELA
5.88235294118%	1	17	682	Mendelian_Severe_Combined_Immunodeficiency	FEVR_CTNNB1_TARGETS_UP
5.88235294118%	1	17	681	Mendelian_Severe_Combined_Immunodeficiency	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
5.88235294118%	1	17	68	Mendelian_Severe_Combined_Immunodeficiency	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
5.88235294118%	1	17	68	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_SEMAPHORIN_INTERACTIONS
5.88235294118%	1	17	68	Mendelian_Severe_Combined_Immunodeficiency	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
5.88235294118%	1	17	68	Mendelian_Blood_Desease	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
5.88235294118%	1	17	673	Mendelian_Severe_Combined_Immunodeficiency	MARTINEZ_RB1_TARGETS_UP
5.88235294118%	1	17	67	Mendelian_Severe_Combined_Immunodeficiency	LINDSTEDT_DENDRITIC_CELL_MATURATION_A
5.88235294118%	1	17	67	Mendelian_Severe_Combined_Immunodeficiency	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70
5.88235294118%	1	17	67	Mendelian_Blood_Desease	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
5.88235294118%	1	17	67	Mendelian_Blood_Desease	ELVIDGE_HIF1A_TARGETS_UP
5.88235294118%	1	17	67	Mendelian_Blood_Desease	DAZARD_UV_RESPONSE_CLUSTER_G1
5.88235294118%	1	17	66	Mendelian_Severe_Combined_Immunodeficiency	MARSON_FOXP3_TARGETS_UP
5.88235294118%	1	17	66	Mendelian_Severe_Combined_Immunodeficiency	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
5.88235294118%	1	17	66	Mendelian_Blood_Desease	PID_HIF1_TFPATHWAY
5.88235294118%	1	17	66	Mendelian_Blood_Desease	DIRMEIER_LMP1_RESPONSE_EARLY
5.88235294118%	1	17	65	Mendelian_Severe_Combined_Immunodeficiency	PID_BCR_5PATHWAY
5.88235294118%	1	17	65	Mendelian_Blood_Desease	GUO_HEX_TARGETS_DN
5.88235294118%	1	17	65	Mendelian_Blood_Desease	CHANG_IMMORTALIZED_BY_HPV31_DN
5.88235294118%	1	17	648	Mendelian_Severe_Combined_Immunodeficiency	SMID_BREAST_CANCER_BASAL_UP
5.88235294118%	1	17	64	Mendelian_Severe_Combined_Immunodeficiency	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
5.88235294118%	1	17	637	Mendelian_Severe_Combined_Immunodeficiency	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
5.88235294118%	1	17	63	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_INTERFERON_GAMMA_SIGNALING
5.88235294118%	1	17	63	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
5.88235294118%	1	17	63	Mendelian_Severe_Combined_Immunodeficiency	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
5.88235294118%	1	17	62	Mendelian_Severe_Combined_Immunodeficiency	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
5.88235294118%	1	17	62	Mendelian_Severe_Combined_Immunodeficiency	BILD_SRC_ONCOGENIC_SIGNATURE
5.88235294118%	1	17	62	Mendelian_Blood_Desease	BILD_SRC_ONCOGENIC_SIGNATURE
5.88235294118%	1	17	612	Mendelian_Severe_Combined_Immunodeficiency	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
5.88235294118%	1	17	61	Mendelian_Blood_Desease	LEE_LIVER_CANCER_MYC_TGFA_UP
5.88235294118%	1	17	605	Mendelian_Severe_Combined_Immunodeficiency	CAIRO_HEPATOBLASTOMA_CLASSES_UP
5.88235294118%	1	17	602	Mendelian_Severe_Combined_Immunodeficiency	MARTINEZ_TP53_TARGETS_UP
5.88235294118%	1	17	602	Mendelian_Blood_Desease	MARTINEZ_TP53_TARGETS_UP
5.88235294118%	1	17	601	Mendelian_Severe_Combined_Immunodeficiency	MARTINEZ_RB1_AND_TP53_TARGETS_UP
5.88235294118%	1	17	601	Mendelian_Blood_Desease	MARTINEZ_RB1_AND_TP53_TARGETS_UP
5.88235294118%	1	17	60	Mendelian_Severe_Combined_Immunodeficiency	WIERENGA_STAT5A_TARGETS_GROUP2
5.88235294118%	1	17	60	Mendelian_Severe_Combined_Immunodeficiency	SONG_TARGETS_OF_IE86_CMV_PROTEIN
5.88235294118%	1	17	60	Mendelian_Severe_Combined_Immunodeficiency	CUI_GLUCOSE_DEPRIVATION
5.88235294118%	1	17	60	Mendelian_Severe_Combined_Immunodeficiency	AMIT_EGF_RESPONSE_240_HELA
5.88235294118%	1	17	59	Mendelian_Blood_Desease	ELVIDGE_HYPOXIA_BY_DMOG_DN
5.88235294118%	1	17	584	Mendelian_Severe_Combined_Immunodeficiency	HAMAI_APOPTOSIS_VIA_TRAIL_UP
5.88235294118%	1	17	58	Mendelian_Blood_Desease	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
5.88235294118%	1	17	57	Mendelian_Severe_Combined_Immunodeficiency	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
5.88235294118%	1	17	57	Mendelian_Blood_Desease	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
5.88235294118%	1	17	567	Mendelian_Severe_Combined_Immunodeficiency	PARENT_MTOR_SIGNALING_UP
5.88235294118%	1	17	564	Mendelian_Blood_Desease	SMID_BREAST_CANCER_LUMINAL_B_DN
5.88235294118%	1	17	56	Mendelian_Blood_Desease	ZHENG_IL22_SIGNALING_UP
5.88235294118%	1	17	555	Mendelian_Blood_Desease	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
5.88235294118%	1	17	553	Mendelian_Severe_Combined_Immunodeficiency	FEVR_CTNNB1_TARGETS_DN
5.88235294118%	1	17	55	Mendelian_Severe_Combined_Immunodeficiency	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
5.88235294118%	1	17	55	Mendelian_Blood_Desease	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
5.88235294118%	1	17	55	Mendelian_Blood_Desease	DEMAGALHAES_AGING_UP
5.88235294118%	1	17	549	Mendelian_Severe_Combined_Immunodeficiency	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
5.88235294118%	1	17	546	Mendelian_Severe_Combined_Immunodeficiency	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
5.88235294118%	1	17	546	Mendelian_Blood_Desease	WEST_ADRENOCORTICAL_TUMOR_DN
5.88235294118%	1	17	544	Mendelian_Severe_Combined_Immunodeficiency	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
5.88235294118%	1	17	540	Mendelian_Blood_Desease	ACEVEDO_LIVER_CANCER_DN
5.88235294118%	1	17	54	Mendelian_Severe_Combined_Immunodeficiency	SUNG_METASTASIS_STROMA_DN
5.88235294118%	1	17	54	Mendelian_Severe_Combined_Immunodeficiency	PID_TAP63PATHWAY
5.88235294118%	1	17	54	Mendelian_Severe_Combined_Immunodeficiency	MARSON_FOXP3_TARGETS_DN
5.88235294118%	1	17	54	Mendelian_Blood_Desease	ZHOU_TNF_SIGNALING_4HR
5.88235294118%	1	17	54	Mendelian_Blood_Desease	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
5.88235294118%	1	17	54	Mendelian_Blood_Desease	LEE_LIVER_CANCER_MYC_UP
5.88235294118%	1	17	539	Mendelian_Blood_Desease	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
5.88235294118%	1	17	535	Mendelian_Severe_Combined_Immunodeficiency	STEIN_ESRRA_TARGETS
5.88235294118%	1	17	532	Mendelian_Severe_Combined_Immunodeficiency	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
5.88235294118%	1	17	530	Mendelian_Severe_Combined_Immunodeficiency	ENK_UV_RESPONSE_KERATINOCYTE_UP
5.88235294118%	1	17	530	Mendelian_Blood_Desease	ENK_UV_RESPONSE_KERATINOCYTE_UP
5.88235294118%	1	17	53	Mendelian_Severe_Combined_Immunodeficiency	MORI_IMMATURE_B_LYMPHOCYTE_UP
5.88235294118%	1	17	53	Mendelian_Severe_Combined_Immunodeficiency	LINDSTEDT_DENDRITIC_CELL_MATURATION_B
5.88235294118%	1	17	53	Mendelian_Blood_Desease	MENSSEN_MYC_TARGETS
5.88235294118%	1	17	52	Mendelian_Severe_Combined_Immunodeficiency	WINTER_HYPOXIA_DN
5.88235294118%	1	17	514	Mendelian_Blood_Desease	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
5.88235294118%	1	17	510	Mendelian_Blood_Desease	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
5.88235294118%	1	17	51	Mendelian_Severe_Combined_Immunodeficiency	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
5.88235294118%	1	17	51	Mendelian_Severe_Combined_Immunodeficiency	LEE_CALORIE_RESTRICTION_MUSCLE_DN
5.88235294118%	1	17	51	Mendelian_Severe_Combined_Immunodeficiency	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
5.88235294118%	1	17	51	Mendelian_Severe_Combined_Immunodeficiency	BURTON_ADIPOGENESIS_7
5.88235294118%	1	17	51	Mendelian_Blood_Desease	ZHANG_PROLIFERATING_VS_QUIESCENT
5.88235294118%	1	17	51	Mendelian_Blood_Desease	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
5.88235294118%	1	17	508	Mendelian_Severe_Combined_Immunodeficiency	ENK_UV_RESPONSE_EPIDERMIS_DN
5.88235294118%	1	17	504	Mendelian_Severe_Combined_Immunodeficiency	BROWNE_HCMV_INFECTION_48HR_DN
5.88235294118%	1	17	501	Mendelian_Severe_Combined_Immunodeficiency	SENESE_HDAC3_TARGETS_UP
5.88235294118%	1	17	50	Mendelian_Severe_Combined_Immunodeficiency	YANG_BREAST_CANCER_ESR1_LASER_DN
5.88235294118%	1	17	50	Mendelian_Severe_Combined_Immunodeficiency	FIGUEROA_AML_METHYLATION_CLUSTER_5_DN
5.88235294118%	1	17	50	Mendelian_Blood_Desease	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
5.88235294118%	1	17	50	Mendelian_Blood_Desease	FIGUEROA_AML_METHYLATION_CLUSTER_5_DN
5.88235294118%	1	17	50	Mendelian_Blood_Desease	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS
5.88235294118%	1	17	493	Mendelian_Severe_Combined_Immunodeficiency	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
5.88235294118%	1	17	491	Mendelian_Severe_Combined_Immunodeficiency	MEISSNER_NPC_HCP_WITH_H3K4ME2
5.88235294118%	1	17	491	Mendelian_Blood_Desease	SWEET_LUNG_CANCER_KRAS_UP
5.88235294118%	1	17	49	Mendelian_Severe_Combined_Immunodeficiency	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
5.88235294118%	1	17	49	Mendelian_Severe_Combined_Immunodeficiency	PID_PI3KCIPATHWAY
5.88235294118%	1	17	49	Mendelian_Severe_Combined_Immunodeficiency	LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE
5.88235294118%	1	17	49	Mendelian_Blood_Desease	ZHAN_MULTIPLE_MYELOMA_HP_UP
5.88235294118%	1	17	487	Mendelian_Severe_Combined_Immunodeficiency	RODWELL_AGING_KIDNEY_UP
5.88235294118%	1	17	485	Mendelian_Severe_Combined_Immunodeficiency	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
5.88235294118%	1	17	483	Mendelian_Severe_Combined_Immunodeficiency	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
5.88235294118%	1	17	48	Mendelian_Severe_Combined_Immunodeficiency	TAVOR_CEBPA_TARGETS_UP
5.88235294118%	1	17	48	Mendelian_Severe_Combined_Immunodeficiency	PENG_GLUCOSE_DEPRIVATION_UP
5.88235294118%	1	17	48	Mendelian_Blood_Desease	MCDOWELL_ACUTE_LUNG_INJURY_DN
5.88235294118%	1	17	48	Mendelian_Blood_Desease	GNATENKO_PLATELET_SIGNATURE
5.88235294118%	1	17	479	Mendelian_Severe_Combined_Immunodeficiency	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
5.88235294118%	1	17	479	Mendelian_Blood_Desease	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
5.88235294118%	1	17	476	Mendelian_Blood_Desease	SMID_BREAST_CANCER_NORMAL_LIKE_UP
5.88235294118%	1	17	475	Mendelian_Severe_Combined_Immunodeficiency	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
5.88235294118%	1	17	473	Mendelian_Severe_Combined_Immunodeficiency	GARY_CD5_TARGETS_UP
5.88235294118%	1	17	47	Mendelian_Severe_Combined_Immunodeficiency	PID_DELTANP63PATHWAY
5.88235294118%	1	17	47	Mendelian_Blood_Desease	IRITANI_MAD1_TARGETS_DN
5.88235294118%	1	17	467	Mendelian_Blood_Desease	RATTENBACHER_BOUND_BY_CELF1
5.88235294118%	1	17	460	Mendelian_Severe_Combined_Immunodeficiency	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
5.88235294118%	1	17	46	Mendelian_Severe_Combined_Immunodeficiency	ZHAN_MULTIPLE_MYELOMA_CD2_DN
5.88235294118%	1	17	46	Mendelian_Severe_Combined_Immunodeficiency	SIG_BCR_SIGNALING_PATHWAY
5.88235294118%	1	17	456	Mendelian_Severe_Combined_Immunodeficiency	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
5.88235294118%	1	17	456	Mendelian_Severe_Combined_Immunodeficiency	ODONNELL_TFRC_TARGETS_UP
5.88235294118%	1	17	45	Mendelian_Severe_Combined_Immunodeficiency	ZHAN_V2_LATE_DIFFERENTIATION_GENES
5.88235294118%	1	17	45	Mendelian_Severe_Combined_Immunodeficiency	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN
5.88235294118%	1	17	45	Mendelian_Severe_Combined_Immunodeficiency	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
5.88235294118%	1	17	45	Mendelian_Blood_Desease	LEE_AGING_MUSCLE_UP
5.88235294118%	1	17	448	Mendelian_Severe_Combined_Immunodeficiency	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
5.88235294118%	1	17	448	Mendelian_Blood_Desease	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
5.88235294118%	1	17	447	Mendelian_Severe_Combined_Immunodeficiency	MOOTHA_MITOCHONDRIA
5.88235294118%	1	17	443	Mendelian_Severe_Combined_Immunodeficiency	DELYS_THYROID_CANCER_UP
5.88235294118%	1	17	442	Mendelian_Blood_Desease	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
5.88235294118%	1	17	44	Mendelian_Severe_Combined_Immunodeficiency	XU_CREBBP_TARGETS_DN
5.88235294118%	1	17	44	Mendelian_Severe_Combined_Immunodeficiency	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP
5.88235294118%	1	17	44	Mendelian_Severe_Combined_Immunodeficiency	MARTIN_INTERACT_WITH_HDAC
5.88235294118%	1	17	44	Mendelian_Severe_Combined_Immunodeficiency	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS
5.88235294118%	1	17	44	Mendelian_Severe_Combined_Immunodeficiency	FARMER_BREAST_CANCER_CLUSTER_1
5.88235294118%	1	17	44	Mendelian_Blood_Desease	WANG_TARGETS_OF_MLL_CBP_FUSION_UP
5.88235294118%	1	17	435	Mendelian_Blood_Desease	SWEET_LUNG_CANCER_KRAS_DN
5.88235294118%	1	17	431	Mendelian_Severe_Combined_Immunodeficiency	GARY_CD5_TARGETS_DN
5.88235294118%	1	17	430	Mendelian_Severe_Combined_Immunodeficiency	RIGGI_EWING_SARCOMA_PROGENITOR_UP
5.88235294118%	1	17	430	Mendelian_Blood_Desease	RIGGI_EWING_SARCOMA_PROGENITOR_UP
5.88235294118%	1	17	43	Mendelian_Severe_Combined_Immunodeficiency	PID_TCPTP_PATHWAY
5.88235294118%	1	17	43	Mendelian_Severe_Combined_Immunodeficiency	LEE_CALORIE_RESTRICTION_MUSCLE_UP
5.88235294118%	1	17	43	Mendelian_Severe_Combined_Immunodeficiency	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
5.88235294118%	1	17	43	Mendelian_Blood_Desease	PID_CXCR3PATHWAY
5.88235294118%	1	17	429	Mendelian_Severe_Combined_Immunodeficiency	MOOTHA_HUMAN_MITODB_6_2002
5.88235294118%	1	17	428	Mendelian_Severe_Combined_Immunodeficiency	LIM_MAMMARY_STEM_CELL_DN
5.88235294118%	1	17	423	Mendelian_Blood_Desease	THUM_SYSTOLIC_HEART_FAILURE_UP
5.88235294118%	1	17	422	Mendelian_Blood_Desease	YAGI_AML_WITH_INV_16_TRANSLOCATION
5.88235294118%	1	17	420	Mendelian_Blood_Desease	MOOTHA_PGC
5.88235294118%	1	17	42	Mendelian_Severe_Combined_Immunodeficiency	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
5.88235294118%	1	17	42	Mendelian_Blood_Desease	PID_UPA_UPAR_PATHWAY
5.88235294118%	1	17	42	Mendelian_Blood_Desease	MODY_HIPPOCAMPUS_PRENATAL
5.88235294118%	1	17	42	Mendelian_Blood_Desease	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
5.88235294118%	1	17	419	Mendelian_Severe_Combined_Immunodeficiency	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
5.88235294118%	1	17	418	Mendelian_Severe_Combined_Immunodeficiency	MULLIGHAN_MLL_SIGNATURE_2_UP
5.88235294118%	1	17	418	Mendelian_Blood_Desease	PEDRIOLI_MIR31_TARGETS_DN
5.88235294118%	1	17	418	Mendelian_Blood_Desease	MULLIGHAN_MLL_SIGNATURE_2_UP
5.88235294118%	1	17	413	Mendelian_Blood_Desease	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
5.88235294118%	1	17	411	Mendelian_Severe_Combined_Immunodeficiency	KOYAMA_SEMA3B_TARGETS_DN
5.88235294118%	1	17	411	Mendelian_Blood_Desease	KOYAMA_SEMA3B_TARGETS_DN
5.88235294118%	1	17	41	Mendelian_Severe_Combined_Immunodeficiency	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
5.88235294118%	1	17	41	Mendelian_Blood_Desease	ZHAN_MULTIPLE_MYELOMA_DN
5.88235294118%	1	17	41	Mendelian_Blood_Desease	PID_AMB2_NEUTROPHILS_PATHWAY
5.88235294118%	1	17	41	Mendelian_Blood_Desease	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
5.88235294118%	1	17	408	Mendelian_Severe_Combined_Immunodeficiency	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
5.88235294118%	1	17	408	Mendelian_Severe_Combined_Immunodeficiency	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
5.88235294118%	1	17	405	Mendelian_Blood_Desease	KUMAR_TARGETS_OF_MLL_AF9_FUSION
5.88235294118%	1	17	404	Mendelian_Blood_Desease	OSMAN_BLADDER_CANCER_UP
5.88235294118%	1	17	403	Mendelian_Severe_Combined_Immunodeficiency	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
5.88235294118%	1	17	403	Mendelian_Blood_Desease	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
5.88235294118%	1	17	40	Mendelian_Severe_Combined_Immunodeficiency	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP
5.88235294118%	1	17	40	Mendelian_Severe_Combined_Immunodeficiency	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN
5.88235294118%	1	17	40	Mendelian_Severe_Combined_Immunodeficiency	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
5.88235294118%	1	17	40	Mendelian_Blood_Desease	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN
5.88235294118%	1	17	397	Mendelian_Severe_Combined_Immunodeficiency	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
5.88235294118%	1	17	396	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_DEVELOPMENTAL_BIOLOGY
5.88235294118%	1	17	395	Mendelian_Severe_Combined_Immunodeficiency	HAN_SATB1_TARGETS_UP
5.88235294118%	1	17	394	Mendelian_Severe_Combined_Immunodeficiency	BERENJENO_TRANSFORMED_BY_RHOA_DN
5.88235294118%	1	17	392	Mendelian_Blood_Desease	LINDGREN_BLADDER_CANCER_CLUSTER_2B
5.88235294118%	1	17	39	Mendelian_Severe_Combined_Immunodeficiency	MA_MYELOID_DIFFERENTIATION_UP
5.88235294118%	1	17	39	Mendelian_Blood_Desease	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
5.88235294118%	1	17	39	Mendelian_Blood_Desease	BILANGES_RAPAMYCIN_SENSITIVE_GENES
5.88235294118%	1	17	387	Mendelian_Severe_Combined_Immunodeficiency	CHYLA_CBFA2T3_TARGETS_UP
5.88235294118%	1	17	382	Mendelian_Severe_Combined_Immunodeficiency	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
5.88235294118%	1	17	380	Mendelian_Severe_Combined_Immunodeficiency	MULLIGHAN_MLL_SIGNATURE_1_UP
5.88235294118%	1	17	380	Mendelian_Severe_Combined_Immunodeficiency	DAIRKEE_TERT_TARGETS_UP
5.88235294118%	1	17	380	Mendelian_Blood_Desease	MULLIGHAN_MLL_SIGNATURE_1_UP
5.88235294118%	1	17	380	Mendelian_Blood_Desease	DAIRKEE_TERT_TARGETS_UP
5.88235294118%	1	17	38	Mendelian_Severe_Combined_Immunodeficiency	VARELA_ZMPSTE24_TARGETS_DN
5.88235294118%	1	17	38	Mendelian_Severe_Combined_Immunodeficiency	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
5.88235294118%	1	17	38	Mendelian_Severe_Combined_Immunodeficiency	PENG_GLUTAMINE_DEPRIVATION_UP
5.88235294118%	1	17	38	Mendelian_Severe_Combined_Immunodeficiency	HATADA_METHYLATED_IN_LUNG_CANCER_DN
5.88235294118%	1	17	38	Mendelian_Severe_Combined_Immunodeficiency	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN
5.88235294118%	1	17	38	Mendelian_Severe_Combined_Immunodeficiency	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
5.88235294118%	1	17	379	Mendelian_Blood_Desease	BENPORATH_ES_1
5.88235294118%	1	17	378	Mendelian_Severe_Combined_Immunodeficiency	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
5.88235294118%	1	17	378	Mendelian_Blood_Desease	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
5.88235294118%	1	17	373	Mendelian_Severe_Combined_Immunodeficiency	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
5.88235294118%	1	17	371	Mendelian_Severe_Combined_Immunodeficiency	WANG_SMARCE1_TARGETS_DN
5.88235294118%	1	17	37	Mendelian_Severe_Combined_Immunodeficiency	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN
5.88235294118%	1	17	37	Mendelian_Severe_Combined_Immunodeficiency	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
5.88235294118%	1	17	37	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_DOWNSTREAM_TCR_SIGNALING
5.88235294118%	1	17	367	Mendelian_Severe_Combined_Immunodeficiency	VECCHI_GASTRIC_CANCER_EARLY_DN
5.88235294118%	1	17	366	Mendelian_Blood_Desease	SANSOM_APC_TARGETS_DN
5.88235294118%	1	17	36	Mendelian_Severe_Combined_Immunodeficiency	VALK_AML_CLUSTER_11
5.88235294118%	1	17	36	Mendelian_Severe_Combined_Immunodeficiency	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
5.88235294118%	1	17	36	Mendelian_Severe_Combined_Immunodeficiency	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
5.88235294118%	1	17	36	Mendelian_Severe_Combined_Immunodeficiency	MARZEC_IL2_SIGNALING_DN
5.88235294118%	1	17	36	Mendelian_Blood_Desease	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP
5.88235294118%	1	17	354	Mendelian_Severe_Combined_Immunodeficiency	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
5.88235294118%	1	17	351	Mendelian_Severe_Combined_Immunodeficiency	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
5.88235294118%	1	17	35	Mendelian_Severe_Combined_Immunodeficiency	BALDWIN_PRKCI_TARGETS_UP
5.88235294118%	1	17	346	Mendelian_Blood_Desease	GOLDRATH_ANTIGEN_RESPONSE
5.88235294118%	1	17	342	Mendelian_Severe_Combined_Immunodeficiency	BLUM_RESPONSE_TO_SALIRASIB_DN
5.88235294118%	1	17	341	Mendelian_Severe_Combined_Immunodeficiency	MULLIGHAN_NPM1_SIGNATURE_3_UP
5.88235294118%	1	17	34	Mendelian_Severe_Combined_Immunodeficiency	PID_HDAC_CLASSII_PATHWAY
5.88235294118%	1	17	34	Mendelian_Severe_Combined_Immunodeficiency	PID_ATM_PATHWAY
5.88235294118%	1	17	34	Mendelian_Severe_Combined_Immunodeficiency	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP
5.88235294118%	1	17	337	Mendelian_Severe_Combined_Immunodeficiency	PHONG_TNF_RESPONSE_NOT_VIA_P38
5.88235294118%	1	17	337	Mendelian_Blood_Desease	PENG_GLUTAMINE_DEPRIVATION_DN
5.88235294118%	1	17	336	Mendelian_Severe_Combined_Immunodeficiency	JOHNSTONE_PARVB_TARGETS_2_DN
5.88235294118%	1	17	335	Mendelian_Severe_Combined_Immunodeficiency	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
5.88235294118%	1	17	335	Mendelian_Blood_Desease	WONG_EMBRYONIC_STEM_CELL_CORE
5.88235294118%	1	17	33	Mendelian_Severe_Combined_Immunodeficiency	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP
5.88235294118%	1	17	33	Mendelian_Severe_Combined_Immunodeficiency	PID_IL12_STAT4PATHWAY
5.88235294118%	1	17	33	Mendelian_Severe_Combined_Immunodeficiency	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN
5.88235294118%	1	17	33	Mendelian_Severe_Combined_Immunodeficiency	HEIDENBLAD_AMPLICON_12P11_12_UP
5.88235294118%	1	17	329	Mendelian_Severe_Combined_Immunodeficiency	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
5.88235294118%	1	17	326	Mendelian_Severe_Combined_Immunodeficiency	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
5.88235294118%	1	17	323	Mendelian_Severe_Combined_Immunodeficiency	GRESHOCK_CANCER_COPY_NUMBER_UP
5.88235294118%	1	17	321	Mendelian_Severe_Combined_Immunodeficiency	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
5.88235294118%	1	17	32	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING
5.88235294118%	1	17	32	Mendelian_Severe_Combined_Immunodeficiency	BAUS_TFF2_TARGETS_UP
5.88235294118%	1	17	32	Mendelian_Blood_Desease	TSAI_RESPONSE_TO_RADIATION_THERAPY
5.88235294118%	1	17	32	Mendelian_Blood_Desease	KIM_TIAL1_TARGETS
5.88235294118%	1	17	32	Mendelian_Blood_Desease	DIRMEIER_LMP1_RESPONSE_LATE_DN
5.88235294118%	1	17	318	Mendelian_Severe_Combined_Immunodeficiency	LEI_MYB_TARGETS
5.88235294118%	1	17	317	Mendelian_Blood_Desease	BRUINS_UVC_RESPONSE_EARLY_LATE
5.88235294118%	1	17	315	Mendelian_Severe_Combined_Immunodeficiency	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
5.88235294118%	1	17	314	Mendelian_Severe_Combined_Immunodeficiency	DOUGLAS_BMI1_TARGETS_DN
5.88235294118%	1	17	314	Mendelian_Severe_Combined_Immunodeficiency	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
5.88235294118%	1	17	311	Mendelian_Severe_Combined_Immunodeficiency	JIANG_HYPOXIA_NORMAL
5.88235294118%	1	17	31	Mendelian_Severe_Combined_Immunodeficiency	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
5.88235294118%	1	17	31	Mendelian_Severe_Combined_Immunodeficiency	PID_CD40_PATHWAY
5.88235294118%	1	17	31	Mendelian_Severe_Combined_Immunodeficiency	CAFFAREL_RESPONSE_TO_THC_DN
5.88235294118%	1	17	31	Mendelian_Blood_Desease	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES
5.88235294118%	1	17	309	Mendelian_Severe_Combined_Immunodeficiency	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
5.88235294118%	1	17	309	Mendelian_Severe_Combined_Immunodeficiency	LIU_SOX4_TARGETS_DN
5.88235294118%	1	17	306	Mendelian_Severe_Combined_Immunodeficiency	HORIUCHI_WTAP_TARGETS_UP
5.88235294118%	1	17	30	Mendelian_Severe_Combined_Immunodeficiency	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY
5.88235294118%	1	17	30	Mendelian_Blood_Desease	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP
5.88235294118%	1	17	299	Mendelian_Severe_Combined_Immunodeficiency	MUELLER_PLURINET
5.88235294118%	1	17	299	Mendelian_Blood_Desease	WALLACE_PROSTATE_CANCER_RACE_UP
5.88235294118%	1	17	298	Mendelian_Severe_Combined_Immunodeficiency	BROWNE_HCMV_INFECTION_14HR_DN
5.88235294118%	1	17	293	Mendelian_Severe_Combined_Immunodeficiency	ZWANG_DOWN_BY_2ND_EGF_PULSE
5.88235294118%	1	17	293	Mendelian_Severe_Combined_Immunodeficiency	ZHANG_TLX_TARGETS_60HR_UP
5.88235294118%	1	17	293	Mendelian_Blood_Desease	IVANOVA_HEMATOPOIESIS_MATURE_CELL
5.88235294118%	1	17	293	Mendelian_Blood_Desease	HADDAD_B_LYMPHOCYTE_PROGENITOR
5.88235294118%	1	17	292	Mendelian_Blood_Desease	KOYAMA_SEMA3B_TARGETS_UP
5.88235294118%	1	17	29	Mendelian_Severe_Combined_Immunodeficiency	MARSON_FOXP3_TARGETS_STIMULATED_UP
5.88235294118%	1	17	29	Mendelian_Blood_Desease	WANG_RESPONSE_TO_BEXAROTENE_DN
5.88235294118%	1	17	29	Mendelian_Blood_Desease	VALK_AML_CLUSTER_2
5.88235294118%	1	17	29	Mendelian_Blood_Desease	PID_INTEGRIN2_PATHWAY
5.88235294118%	1	17	29	Mendelian_Blood_Desease	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6
5.88235294118%	1	17	288	Mendelian_Blood_Desease	POOLA_INVASIVE_BREAST_CANCER_UP
5.88235294118%	1	17	283	Mendelian_Severe_Combined_Immunodeficiency	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
5.88235294118%	1	17	282	Mendelian_Severe_Combined_Immunodeficiency	HELLER_SILENCED_BY_METHYLATION_UP
5.88235294118%	1	17	281	Mendelian_Severe_Combined_Immunodeficiency	MULLIGHAN_MLL_SIGNATURE_2_DN
5.88235294118%	1	17	281	Mendelian_Severe_Combined_Immunodeficiency	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
5.88235294118%	1	17	281	Mendelian_Blood_Desease	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
5.88235294118%	1	17	28	Mendelian_Severe_Combined_Immunodeficiency	TIAN_TNF_SIGNALING_VIA_NFKB
5.88235294118%	1	17	28	Mendelian_Blood_Desease	SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER
5.88235294118%	1	17	276	Mendelian_Severe_Combined_Immunodeficiency	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
5.88235294118%	1	17	275	Mendelian_Severe_Combined_Immunodeficiency	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
5.88235294118%	1	17	271	Mendelian_Blood_Desease	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
5.88235294118%	1	17	270	Mendelian_Severe_Combined_Immunodeficiency	RIZKI_TUMOR_INVASIVENESS_3D_DN
5.88235294118%	1	17	27	Mendelian_Severe_Combined_Immunodeficiency	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
5.88235294118%	1	17	27	Mendelian_Blood_Desease	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN
5.88235294118%	1	17	268	Mendelian_Severe_Combined_Immunodeficiency	XU_GH1_AUTOCRINE_TARGETS_UP
5.88235294118%	1	17	266	Mendelian_Severe_Combined_Immunodeficiency	ROZANOV_MMP14_TARGETS_UP
5.88235294118%	1	17	266	Mendelian_Severe_Combined_Immunodeficiency	FOSTER_KDM1A_TARGETS_UP
5.88235294118%	1	17	264	Mendelian_Blood_Desease	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
5.88235294118%	1	17	262	Mendelian_Blood_Desease	LU_AGING_BRAIN_UP
5.88235294118%	1	17	261	Mendelian_Severe_Combined_Immunodeficiency	RICKMAN_METASTASIS_DN
5.88235294118%	1	17	26	Mendelian_Severe_Combined_Immunodeficiency	VALK_AML_CLUSTER_16
5.88235294118%	1	17	26	Mendelian_Blood_Desease	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN
5.88235294118%	1	17	26	Mendelian_Blood_Desease	PID_INTEGRIN_CS_PATHWAY
5.88235294118%	1	17	26	Mendelian_Blood_Desease	BRACHAT_RESPONSE_TO_METHOTREXATE_UP
5.88235294118%	1	17	259	Mendelian_Blood_Desease	QI_PLASMACYTOMA_UP
5.88235294118%	1	17	259	Mendelian_Blood_Desease	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
5.88235294118%	1	17	251	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_AXON_GUIDANCE
5.88235294118%	1	17	25	Mendelian_Severe_Combined_Immunodeficiency	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP
5.88235294118%	1	17	25	Mendelian_Blood_Desease	VERRECCHIA_RESPONSE_TO_TGFB1_C2
5.88235294118%	1	17	25	Mendelian_Blood_Desease	VANDESLUIS_NORMAL_EMBRYOS_DN
5.88235294118%	1	17	25	Mendelian_Blood_Desease	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP
5.88235294118%	1	17	25	Mendelian_Blood_Desease	LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS
5.88235294118%	1	17	244	Mendelian_Blood_Desease	DAZARD_RESPONSE_TO_UV_NHEK_UP
5.88235294118%	1	17	242	Mendelian_Severe_Combined_Immunodeficiency	MULLIGHAN_MLL_SIGNATURE_1_DN
5.88235294118%	1	17	242	Mendelian_Severe_Combined_Immunodeficiency	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
5.88235294118%	1	17	241	Mendelian_Blood_Desease	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
5.88235294118%	1	17	24	Mendelian_Severe_Combined_Immunodeficiency	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN
5.88235294118%	1	17	24	Mendelian_Severe_Combined_Immunodeficiency	KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM
5.88235294118%	1	17	24	Mendelian_Blood_Desease	ODONNELL_METASTASIS_DN
5.88235294118%	1	17	24	Mendelian_Blood_Desease	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
5.88235294118%	1	17	239	Mendelian_Severe_Combined_Immunodeficiency	ALFANO_MYC_TARGETS
5.88235294118%	1	17	238	Mendelian_Severe_Combined_Immunodeficiency	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
5.88235294118%	1	17	238	Mendelian_Severe_Combined_Immunodeficiency	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
5.88235294118%	1	17	237	Mendelian_Blood_Desease	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
5.88235294118%	1	17	235	Mendelian_Severe_Combined_Immunodeficiency	RUTELLA_RESPONSE_TO_HGF_DN
5.88235294118%	1	17	230	Mendelian_Severe_Combined_Immunodeficiency	KAUFFMANN_DNA_REPAIR_GENES
5.88235294118%	1	17	23	Mendelian_Severe_Combined_Immunodeficiency	FERRANDO_HOX11_NEIGHBORS
5.88235294118%	1	17	23	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_IL12_PATHWAY
5.88235294118%	1	17	23	Mendelian_Severe_Combined_Immunodeficiency	BARIS_THYROID_CANCER_UP
5.88235294118%	1	17	229	Mendelian_Severe_Combined_Immunodeficiency	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
5.88235294118%	1	17	228	Mendelian_Severe_Combined_Immunodeficiency	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
5.88235294118%	1	17	227	Mendelian_Blood_Desease	LEE_RECENT_THYMIC_EMIGRANT
5.88235294118%	1	17	225	Mendelian_Severe_Combined_Immunodeficiency	BROWNE_HCMV_INFECTION_16HR_UP
5.88235294118%	1	17	225	Mendelian_Blood_Desease	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
5.88235294118%	1	17	223	Mendelian_Severe_Combined_Immunodeficiency	CHEN_HOXA5_TARGETS_9HR_UP
5.88235294118%	1	17	221	Mendelian_Blood_Desease	CHANDRAN_METASTASIS_UP
5.88235294118%	1	17	220	Mendelian_Blood_Desease	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
5.88235294118%	1	17	22	Mendelian_Severe_Combined_Immunodeficiency	SPIRA_SMOKERS_LUNG_CANCER_DN
5.88235294118%	1	17	22	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_IL6_PATHWAY
5.88235294118%	1	17	22	Mendelian_Blood_Desease	SPIRA_SMOKERS_LUNG_CANCER_DN
5.88235294118%	1	17	22	Mendelian_Blood_Desease	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP
5.88235294118%	1	17	22	Mendelian_Blood_Desease	BRACHAT_RESPONSE_TO_CISPLATIN
5.88235294118%	1	17	217	Mendelian_Severe_Combined_Immunodeficiency	WONG_MITOCHONDRIA_GENE_MODULE
5.88235294118%	1	17	217	Mendelian_Severe_Combined_Immunodeficiency	WIERENGA_STAT5A_TARGETS_UP
5.88235294118%	1	17	216	Mendelian_Severe_Combined_Immunodeficiency	BOQUEST_STEM_CELL_DN
5.88235294118%	1	17	216	Mendelian_Blood_Desease	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
5.88235294118%	1	17	214	Mendelian_Severe_Combined_Immunodeficiency	AFFAR_YY1_TARGETS_UP
5.88235294118%	1	17	213	Mendelian_Blood_Desease	WIERENGA_STAT5A_TARGETS_DN
5.88235294118%	1	17	212	Mendelian_Severe_Combined_Immunodeficiency	CHANG_CORE_SERUM_RESPONSE_UP
5.88235294118%	1	17	211	Mendelian_Severe_Combined_Immunodeficiency	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
5.88235294118%	1	17	210	Mendelian_Blood_Desease	SANSOM_APC_TARGETS_REQUIRE_MYC
5.88235294118%	1	17	21	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_TOB1_PATHWAY
5.88235294118%	1	17	21	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_CTLA4_PATHWAY
5.88235294118%	1	17	21	Mendelian_Blood_Desease	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP
5.88235294118%	1	17	21	Mendelian_Blood_Desease	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN
5.88235294118%	1	17	21	Mendelian_Blood_Desease	FERRANDO_TAL1_NEIGHBORS
5.88235294118%	1	17	209	Mendelian_Severe_Combined_Immunodeficiency	KIM_WT1_TARGETS_12HR_DN
5.88235294118%	1	17	208	Mendelian_Severe_Combined_Immunodeficiency	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
5.88235294118%	1	17	208	Mendelian_Blood_Desease	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
5.88235294118%	1	17	206	Mendelian_Severe_Combined_Immunodeficiency	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
5.88235294118%	1	17	205	Mendelian_Severe_Combined_Immunodeficiency	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
5.88235294118%	1	17	204	Mendelian_Severe_Combined_Immunodeficiency	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
5.88235294118%	1	17	203	Mendelian_Severe_Combined_Immunodeficiency	PAL_PRMT5_TARGETS_UP
5.88235294118%	1	17	201	Mendelian_Severe_Combined_Immunodeficiency	KIM_MYC_AMPLIFICATION_TARGETS_UP
5.88235294118%	1	17	201	Mendelian_Severe_Combined_Immunodeficiency	HOLLMANN_APOPTOSIS_VIA_CD40_UP
5.88235294118%	1	17	200	Mendelian_Blood_Desease	LEE_DIFFERENTIATING_T_LYMPHOCYTE
5.88235294118%	1	17	20	Mendelian_Severe_Combined_Immunodeficiency	COLLIS_PRKDC_SUBSTRATES
5.88235294118%	1	17	20	Mendelian_Blood_Desease	NIELSEN_SYNOVIAL_SARCOMA_DN
5.88235294118%	1	17	20	Mendelian_Blood_Desease	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN
5.88235294118%	1	17	199	Mendelian_Blood_Desease	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
5.88235294118%	1	17	196	Mendelian_Severe_Combined_Immunodeficiency	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
5.88235294118%	1	17	196	Mendelian_Blood_Desease	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
5.88235294118%	1	17	194	Mendelian_Severe_Combined_Immunodeficiency	PROVENZANI_METASTASIS_UP
5.88235294118%	1	17	194	Mendelian_Blood_Desease	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
5.88235294118%	1	17	191	Mendelian_Severe_Combined_Immunodeficiency	YAGI_AML_FAB_MARKERS
5.88235294118%	1	17	190	Mendelian_Severe_Combined_Immunodeficiency	KEGG_CHEMOKINE_SIGNALING_PATHWAY
5.88235294118%	1	17	19	Mendelian_Severe_Combined_Immunodeficiency	RUAN_RESPONSE_TO_TROGLITAZONE_DN
5.88235294118%	1	17	19	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES
5.88235294118%	1	17	19	Mendelian_Severe_Combined_Immunodeficiency	NAGY_TFTC_COMPONENTS_HUMAN
5.88235294118%	1	17	19	Mendelian_Severe_Combined_Immunodeficiency	MARSON_FOXP3_CORE_DIRECT_TARGETS
5.88235294118%	1	17	19	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_STATHMIN_PATHWAY
5.88235294118%	1	17	19	Mendelian_Blood_Desease	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN
5.88235294118%	1	17	19	Mendelian_Blood_Desease	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN
5.88235294118%	1	17	19	Mendelian_Blood_Desease	GRANDVAUX_IRF3_TARGETS_DN
5.88235294118%	1	17	187	Mendelian_Severe_Combined_Immunodeficiency	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
5.88235294118%	1	17	187	Mendelian_Severe_Combined_Immunodeficiency	PENG_LEUCINE_DEPRIVATION_DN
5.88235294118%	1	17	187	Mendelian_Severe_Combined_Immunodeficiency	BAKKER_FOXO3_TARGETS_DN
5.88235294118%	1	17	187	Mendelian_Blood_Desease	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
5.88235294118%	1	17	186	Mendelian_Severe_Combined_Immunodeficiency	HAMAI_APOPTOSIS_VIA_TRAIL_DN
5.88235294118%	1	17	185	Mendelian_Blood_Desease	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
5.88235294118%	1	17	1839	Mendelian_Severe_Combined_Immunodeficiency	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
5.88235294118%	1	17	183	Mendelian_Severe_Combined_Immunodeficiency	KEGG_ENDOCYTOSIS
5.88235294118%	1	17	1821	Mendelian_Blood_Desease	DODD_NASOPHARYNGEAL_CARCINOMA_UP
5.88235294118%	1	17	182	Mendelian_Severe_Combined_Immunodeficiency	WHITFIELD_CELL_CYCLE_G2
5.88235294118%	1	17	182	Mendelian_Severe_Combined_Immunodeficiency	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
5.88235294118%	1	17	181	Mendelian_Blood_Desease	JISON_SICKLE_CELL_DISEASE_UP
5.88235294118%	1	17	181	Mendelian_Blood_Desease	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
5.88235294118%	1	17	180	Mendelian_Severe_Combined_Immunodeficiency	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
5.88235294118%	1	17	18	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_PD1_SIGNALING
5.88235294118%	1	17	18	Mendelian_Severe_Combined_Immunodeficiency	MOREIRA_RESPONSE_TO_TSA_DN
5.88235294118%	1	17	18	Mendelian_Severe_Combined_Immunodeficiency	LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK
5.88235294118%	1	17	1781	Mendelian_Blood_Desease	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
5.88235294118%	1	17	177	Mendelian_Severe_Combined_Immunodeficiency	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
5.88235294118%	1	17	177	Mendelian_Severe_Combined_Immunodeficiency	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
5.88235294118%	1	17	177	Mendelian_Blood_Desease	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
5.88235294118%	1	17	176	Mendelian_Blood_Desease	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
5.88235294118%	1	17	175	Mendelian_Severe_Combined_Immunodeficiency	LEE_LIVER_CANCER_SURVIVAL_DN
5.88235294118%	1	17	175	Mendelian_Blood_Desease	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
5.88235294118%	1	17	175	Mendelian_Blood_Desease	LEE_LIVER_CANCER_SURVIVAL_DN
5.88235294118%	1	17	171	Mendelian_Severe_Combined_Immunodeficiency	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
5.88235294118%	1	17	170	Mendelian_Severe_Combined_Immunodeficiency	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
5.88235294118%	1	17	17	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_NO2IL12_PATHWAY
5.88235294118%	1	17	17	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_IL17_PATHWAY
5.88235294118%	1	17	17	Mendelian_Blood_Desease	BIOCARTA_LAIR_PATHWAY
5.88235294118%	1	17	169	Mendelian_Severe_Combined_Immunodeficiency	ONDER_CDH1_TARGETS_1_DN
5.88235294118%	1	17	169	Mendelian_Severe_Combined_Immunodeficiency	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
5.88235294118%	1	17	169	Mendelian_Severe_Combined_Immunodeficiency	KATSANOU_ELAVL1_TARGETS_UP
5.88235294118%	1	17	167	Mendelian_Blood_Desease	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
5.88235294118%	1	17	163	Mendelian_Blood_Desease	SERVITJA_ISLET_HNF1A_TARGETS_UP
5.88235294118%	1	17	162	Mendelian_Severe_Combined_Immunodeficiency	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
5.88235294118%	1	17	16	Mendelian_Severe_Combined_Immunodeficiency	ZHAN_LATE_DIFFERENTIATION_GENES_DN
5.88235294118%	1	17	16	Mendelian_Severe_Combined_Immunodeficiency	HAHTOLA_CTCL_PATHOGENESIS
5.88235294118%	1	17	16	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_IL22BP_PATHWAY
5.88235294118%	1	17	159	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_INTERFERON_SIGNALING
5.88235294118%	1	17	159	Mendelian_Severe_Combined_Immunodeficiency	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
5.88235294118%	1	17	157	Mendelian_Blood_Desease	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
5.88235294118%	1	17	152	Mendelian_Blood_Desease	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
5.88235294118%	1	17	151	Mendelian_Severe_Combined_Immunodeficiency	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
5.88235294118%	1	17	151	Mendelian_Blood_Desease	IGLESIAS_E2F_TARGETS_UP
5.88235294118%	1	17	151	Mendelian_Blood_Desease	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
5.88235294118%	1	17	151	Mendelian_Blood_Desease	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
5.88235294118%	1	17	150	Mendelian_Severe_Combined_Immunodeficiency	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
5.88235294118%	1	17	150	Mendelian_Severe_Combined_Immunodeficiency	BROWNE_HCMV_INFECTION_30MIN_DN
5.88235294118%	1	17	150	Mendelian_Blood_Desease	BROWNE_HCMV_INFECTION_30MIN_DN
5.88235294118%	1	17	15	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_CTL_PATHWAY
5.88235294118%	1	17	15	Mendelian_Blood_Desease	BIOCARTA_CTL_PATHWAY
5.88235294118%	1	17	149	Mendelian_Severe_Combined_Immunodeficiency	TSAI_RESPONSE_TO_IONIZING_RADIATION
5.88235294118%	1	17	148	Mendelian_Severe_Combined_Immunodeficiency	WEI_MIR34A_TARGETS
5.88235294118%	1	17	148	Mendelian_Severe_Combined_Immunodeficiency	CHANG_CYCLING_GENES
5.88235294118%	1	17	146	Mendelian_Severe_Combined_Immunodeficiency	PECE_MAMMARY_STEM_CELL_UP
5.88235294118%	1	17	146	Mendelian_Blood_Desease	ELVIDGE_HYPOXIA_DN
5.88235294118%	1	17	145	Mendelian_Severe_Combined_Immunodeficiency	RODWELL_AGING_KIDNEY_DN
5.88235294118%	1	17	145	Mendelian_Blood_Desease	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
5.88235294118%	1	17	143	Mendelian_Blood_Desease	BASSO_B_LYMPHOCYTE_NETWORK
5.88235294118%	1	17	142	Mendelian_Severe_Combined_Immunodeficiency	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
5.88235294118%	1	17	142	Mendelian_Severe_Combined_Immunodeficiency	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
5.88235294118%	1	17	140	Mendelian_Blood_Desease	JOHNSTONE_PARVB_TARGETS_2_UP
5.88235294118%	1	17	14	Mendelian_Blood_Desease	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION
5.88235294118%	1	17	14	Mendelian_Blood_Desease	BIOCARTA_THELPER_PATHWAY
5.88235294118%	1	17	14	Mendelian_Blood_Desease	BIOCARTA_TCYTOTOXIC_PATHWAY
5.88235294118%	1	17	14	Mendelian_Blood_Desease	BIOCARTA_GRANULOCYTES_PATHWAY
5.88235294118%	1	17	1382	Mendelian_Blood_Desease	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
5.88235294118%	1	17	138	Mendelian_Blood_Desease	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
5.88235294118%	1	17	138	Mendelian_Blood_Desease	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
5.88235294118%	1	17	137	Mendelian_Severe_Combined_Immunodeficiency	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
5.88235294118%	1	17	137	Mendelian_Severe_Combined_Immunodeficiency	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
5.88235294118%	1	17	137	Mendelian_Blood_Desease	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
5.88235294118%	1	17	136	Mendelian_Severe_Combined_Immunodeficiency	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
5.88235294118%	1	17	136	Mendelian_Blood_Desease	PROVENZANI_METASTASIS_DN
5.88235294118%	1	17	134	Mendelian_Severe_Combined_Immunodeficiency	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
5.88235294118%	1	17	134	Mendelian_Severe_Combined_Immunodeficiency	KEGG_CELL_ADHESION_MOLECULES_CAMS
5.88235294118%	1	17	134	Mendelian_Severe_Combined_Immunodeficiency	CHUNG_BLISTER_CYTOTOXICITY_UP
5.88235294118%	1	17	134	Mendelian_Blood_Desease	POOLA_INVASIVE_BREAST_CANCER_DN
5.88235294118%	1	17	134	Mendelian_Blood_Desease	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
5.88235294118%	1	17	134	Mendelian_Blood_Desease	KEGG_CELL_ADHESION_MOLECULES_CAMS
5.88235294118%	1	17	132	Mendelian_Severe_Combined_Immunodeficiency	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
5.88235294118%	1	17	132	Mendelian_Blood_Desease	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
5.88235294118%	1	17	131	Mendelian_Severe_Combined_Immunodeficiency	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
5.88235294118%	1	17	131	Mendelian_Severe_Combined_Immunodeficiency	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
5.88235294118%	1	17	131	Mendelian_Blood_Desease	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
5.88235294118%	1	17	1305	Mendelian_Blood_Desease	YOSHIMURA_MAPK8_TARGETS_UP
5.88235294118%	1	17	130	Mendelian_Severe_Combined_Immunodeficiency	YAGI_AML_WITH_T_9_11_TRANSLOCATION
5.88235294118%	1	17	13	Mendelian_Blood_Desease	SHI_SPARC_TARGETS_DN
5.88235294118%	1	17	13	Mendelian_Blood_Desease	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS
5.88235294118%	1	17	129	Mendelian_Severe_Combined_Immunodeficiency	KIM_WT1_TARGETS_8HR_DN
5.88235294118%	1	17	128	Mendelian_Severe_Combined_Immunodeficiency	LENAOUR_DENDRITIC_CELL_MATURATION_DN
5.88235294118%	1	17	128	Mendelian_Severe_Combined_Immunodeficiency	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
5.88235294118%	1	17	1278	Mendelian_Severe_Combined_Immunodeficiency	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
5.88235294118%	1	17	126	Mendelian_Severe_Combined_Immunodeficiency	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
5.88235294118%	1	17	126	Mendelian_Severe_Combined_Immunodeficiency	BURTON_ADIPOGENESIS_5
5.88235294118%	1	17	124	Mendelian_Blood_Desease	DAIRKEE_TERT_TARGETS_DN
5.88235294118%	1	17	1237	Mendelian_Severe_Combined_Immunodeficiency	BLALOCK_ALZHEIMERS_DISEASE_DN
5.88235294118%	1	17	123	Mendelian_Severe_Combined_Immunodeficiency	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
5.88235294118%	1	17	123	Mendelian_Blood_Desease	KAYO_AGING_MUSCLE_DN
5.88235294118%	1	17	1229	Mendelian_Blood_Desease	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
5.88235294118%	1	17	1210	Mendelian_Severe_Combined_Immunodeficiency	CHEN_METABOLIC_SYNDROM_NETWORK
5.88235294118%	1	17	121	Mendelian_Blood_Desease	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
5.88235294118%	1	17	120	Mendelian_Severe_Combined_Immunodeficiency	CHEBOTAEV_GR_TARGETS_DN
5.88235294118%	1	17	118	Mendelian_Severe_Combined_Immunodeficiency	MARKEY_RB1_CHRONIC_LOF_DN
5.88235294118%	1	17	118	Mendelian_Blood_Desease	MARKEY_RB1_CHRONIC_LOF_DN
5.88235294118%	1	17	118	Mendelian_Blood_Desease	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
5.88235294118%	1	17	1174	Mendelian_Severe_Combined_Immunodeficiency	PEREZ_TP53_TARGETS
5.88235294118%	1	17	116	Mendelian_Severe_Combined_Immunodeficiency	LI_INDUCED_T_TO_NATURAL_KILLER_DN
5.88235294118%	1	17	116	Mendelian_Severe_Combined_Immunodeficiency	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
5.88235294118%	1	17	116	Mendelian_Blood_Desease	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
5.88235294118%	1	17	116	Mendelian_Blood_Desease	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
5.88235294118%	1	17	115	Mendelian_Severe_Combined_Immunodeficiency	MARZEC_IL2_SIGNALING_UP
5.88235294118%	1	17	115	Mendelian_Blood_Desease	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
5.88235294118%	1	17	114	Mendelian_Severe_Combined_Immunodeficiency	SMIRNOV_RESPONSE_TO_IR_6HR_DN
5.88235294118%	1	17	114	Mendelian_Severe_Combined_Immunodeficiency	SENESE_HDAC2_TARGETS_UP
5.88235294118%	1	17	113	Mendelian_Blood_Desease	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
5.88235294118%	1	17	112	Mendelian_Severe_Combined_Immunodeficiency	LABBE_WNT3A_TARGETS_UP
5.88235294118%	1	17	111	Mendelian_Severe_Combined_Immunodeficiency	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
5.88235294118%	1	17	111	Mendelian_Blood_Desease	BOUDOUKHA_BOUND_BY_IGF2BP2
5.88235294118%	1	17	1103	Mendelian_Severe_Combined_Immunodeficiency	DANG_BOUND_BY_MYC
5.88235294118%	1	17	110	Mendelian_Severe_Combined_Immunodeficiency	SUNG_METASTASIS_STROMA_UP
5.88235294118%	1	17	11	Mendelian_Severe_Combined_Immunodeficiency	ST_STAT3_PATHWAY
5.88235294118%	1	17	11	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_TCAPOPTOSIS_PATHWAY
5.88235294118%	1	17	11	Mendelian_Severe_Combined_Immunodeficiency	BIOCARTA_BLYMPHOCYTE_PATHWAY
5.88235294118%	1	17	11	Mendelian_Blood_Desease	BIOCARTA_MONOCYTE_PATHWAY
5.88235294118%	1	17	11	Mendelian_Blood_Desease	BIOCARTA_LYM_PATHWAY
5.88235294118%	1	17	11	Mendelian_Blood_Desease	BIOCARTA_BLYMPHOCYTE_PATHWAY
5.88235294118%	1	17	1080	Mendelian_Severe_Combined_Immunodeficiency	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
5.88235294118%	1	17	108	Mendelian_Severe_Combined_Immunodeficiency	WESTON_VEGFA_TARGETS
5.88235294118%	1	17	108	Mendelian_Severe_Combined_Immunodeficiency	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
5.88235294118%	1	17	107	Mendelian_Severe_Combined_Immunodeficiency	SESTO_RESPONSE_TO_UV_C0
5.88235294118%	1	17	1069	Mendelian_Severe_Combined_Immunodeficiency	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
5.88235294118%	1	17	105	Mendelian_Severe_Combined_Immunodeficiency	STEIN_ESRRA_TARGETS_DN
5.88235294118%	1	17	105	Mendelian_Severe_Combined_Immunodeficiency	HELLER_SILENCED_BY_METHYLATION_DN
5.88235294118%	1	17	104	Mendelian_Severe_Combined_Immunodeficiency	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
5.88235294118%	1	17	1022	Mendelian_Blood_Desease	MARSON_BOUND_BY_FOXP3_STIMULATED
5.88235294118%	1	17	102	Mendelian_Severe_Combined_Immunodeficiency	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
5.88235294118%	1	17	1011	Mendelian_Severe_Combined_Immunodeficiency	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
5.88235294118%	1	17	101	Mendelian_Severe_Combined_Immunodeficiency	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
5.88235294118%	1	17	101	Mendelian_Severe_Combined_Immunodeficiency	BURTON_ADIPOGENESIS_3
5.88235294118%	1	17	101	Mendelian_Severe_Combined_Immunodeficiency	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
5.88235294118%	1	17	100	Mendelian_Blood_Desease	ROVERSI_GLIOMA_COPY_NUMBER_UP
5.88235294118%	1	17	10	Mendelian_Severe_Combined_Immunodeficiency	WONG_ENDOMETRIAL_CANCER_LATE
5.88235294118%	1	17	10	Mendelian_Severe_Combined_Immunodeficiency	REACTOME_PURINE_CATABOLISM
5.88235294118%	1	17	10	Mendelian_Severe_Combined_Immunodeficiency	BAKER_HEMATOPOESIS_STAT1_TARGETS
5.87920897916%	110	1871	973	T2D_GENES_TANYA_HEIGHT	ACEVEDO_LIVER_CANCER_UP
5.87639311044%	116	1974	783	Mendelian_Nancy_Cox	ONKEN_UVEAL_MELANOMA_UP
5.87275693312%	36	613	841	T2D_GENES_TANYA_BIOMARKER	MARTENS_TRETINOIN_RESPONSE_DN
5.87275693312%	36	613	1278	T2D_GENES_TANYA_BIOMARKER	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
5.87275693312%	36	613	1174	T2D_GENES_TANYA_BIOMARKER	PEREZ_TP53_TARGETS
5.87275693312%	36	613	1118	T2D_GENES_TANYA_BIOMARKER	BENPORATH_ES_WITH_H3K27ME3
5.87275693312%	36	613	1080	T2D_GENES_TANYA_BIOMARKER	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
5.8257616248%	109	1871	728	T2D_GENES_TANYA_HEIGHT	MARSON_BOUND_BY_E2F4_UNSTIMULATED
5.8257616248%	109	1871	1174	T2D_GENES_TANYA_HEIGHT	PEREZ_TP53_TARGETS
5.82573454914%	115	1974	1011	Mendelian_Nancy_Cox	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
5.81717451524%	21	361	1652	T2D_GENES_TANYA_T2D_RSQ05_02CM	PUJANA_BRCA1_PCC_NETWORK
5.77231427044%	108	1871	1069	T2D_GENES_TANYA_HEIGHT	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
5.74886535552%	38	661	973	T2D_GENES_TANYA_GLYCEMIC	ACEVEDO_LIVER_CANCER_UP
5.74886535552%	38	661	805	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GPCR_DOWNSTREAM_SIGNALING
5.74886535552%	38	661	1069	T2D_GENES_TANYA_GLYCEMIC	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
5.74886535552%	38	661	1024	T2D_GENES_TANYA_GLYCEMIC	NUYTTEN_EZH2_TARGETS_DN
5.71955719557%	31	542	1382	T2D_GENES_TANYA_ANTHROPOMETRIC	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
5.71955719557%	31	542	1080	T2D_GENES_TANYA_ANTHROPOMETRIC	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
5.71428571429%	4	70	988	Diabetes_McGill_Adipocytokine_signallin	BENPORATH_NANOG_TARGETS
5.71428571429%	4	70	973	Diabetes_McGill_Adipocytokine_signallin	ACEVEDO_LIVER_CANCER_UP
5.71428571429%	4	70	93	Diabetes_McGill_Adipocytokine_signallin	CADWELL_ATG16L1_TARGETS_UP
5.71428571429%	4	70	90	Diabetes_McGill_Adipocytokine_signallin	IGARASHI_ATF4_TARGETS_DN
5.71428571429%	4	70	89	Diabetes_McGill_Adipocytokine_signallin	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
5.71428571429%	4	70	85	Diabetes_McGill_Adipocytokine_signallin	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
5.71428571429%	4	70	84	Diabetes_McGill_Adipocytokine_signallin	RUAN_RESPONSE_TO_TNF_DN
5.71428571429%	4	70	84	Diabetes_McGill_Adipocytokine_signallin	HINATA_NFKB_TARGETS_FIBROBLAST_UP
5.71428571429%	4	70	81	Diabetes_McGill_Adipocytokine_signallin	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
5.71428571429%	4	70	80	Diabetes_McGill_Adipocytokine_signallin	WOO_LIVER_CANCER_RECURRENCE_DN
5.71428571429%	4	70	80	Diabetes_McGill_Adipocytokine_signallin	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
5.71428571429%	4	70	781	Diabetes_McGill_Adipocytokine_signallin	GOZGIT_ESR1_TARGETS_DN
5.71428571429%	4	70	770	Diabetes_McGill_Adipocytokine_signallin	KRIEG_HYPOXIA_NOT_VIA_KDM3A
5.71428571429%	4	70	74	Diabetes_McGill_Adipocytokine_signallin	URS_ADIPOCYTE_DIFFERENTIATION_UP
5.71428571429%	4	70	721	Diabetes_McGill_Adipocytokine_signallin	WONG_ADULT_TISSUE_STEM_MODULE
5.71428571429%	4	70	718	Diabetes_McGill_Adipocytokine_signallin	MIKKELSEN_ES_ICP_WITH_H3K4ME3
5.71428571429%	4	70	71	Diabetes_McGill_Adipocytokine_signallin	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
5.71428571429%	4	70	681	Diabetes_McGill_Adipocytokine_signallin	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
5.71428571429%	4	70	668	Diabetes_McGill_Adipocytokine_signallin	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
5.71428571429%	4	70	66	Diabetes_McGill_Adipocytokine_signallin	PID_LYSOPHOSPHOLIPID_PATHWAY
5.71428571429%	4	70	65	Diabetes_McGill_Adipocytokine_signallin	PID_CD8TCRDOWNSTREAMPATHWAY
5.71428571429%	4	70	65	Diabetes_McGill_Adipocytokine_signallin	KEGG_GLIOMA
5.71428571429%	4	70	64	Diabetes_McGill_Adipocytokine_signallin	LEE_LIVER_CANCER_MYC_E2F1_DN
5.71428571429%	4	70	63	Diabetes_McGill_Adipocytokine_signallin	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
5.71428571429%	4	70	63	Diabetes_McGill_Adipocytokine_signallin	PID_ENDOTHELINPATHWAY
5.71428571429%	4	70	62	Diabetes_McGill_Adipocytokine_signallin	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
5.71428571429%	4	70	591	Diabetes_McGill_Adipocytokine_signallin	MARTINEZ_RB1_AND_TP53_TARGETS_DN
5.71428571429%	4	70	59	Diabetes_McGill_Adipocytokine_signallin	PID_ATF2_PATHWAY
5.71428571429%	4	70	555	Diabetes_McGill_Adipocytokine_signallin	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
5.71428571429%	4	70	543	Diabetes_McGill_Adipocytokine_signallin	MARTINEZ_RB1_TARGETS_DN
5.71428571429%	4	70	53	Diabetes_McGill_Adipocytokine_signallin	REACTOME_CIRCADIAN_CLOCK
5.71428571429%	4	70	53	Diabetes_McGill_Adipocytokine_signallin	PID_AR_TF_PATHWAY
5.71428571429%	4	70	52	Diabetes_McGill_Adipocytokine_signallin	PID_CASPASE_PATHWAY
5.71428571429%	4	70	501	Diabetes_McGill_Adipocytokine_signallin	SENESE_HDAC3_TARGETS_UP
5.71428571429%	4	70	50	Diabetes_McGill_Adipocytokine_signallin	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
5.71428571429%	4	70	49	Diabetes_McGill_Adipocytokine_signallin	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
5.71428571429%	4	70	49	Diabetes_McGill_Adipocytokine_signallin	GERHOLD_ADIPOGENESIS_UP
5.71428571429%	4	70	49	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_TCR_PATHWAY
5.71428571429%	4	70	476	Diabetes_McGill_Adipocytokine_signallin	SMID_BREAST_CANCER_NORMAL_LIKE_UP
5.71428571429%	4	70	475	Diabetes_McGill_Adipocytokine_signallin	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
5.71428571429%	4	70	462	Diabetes_McGill_Adipocytokine_signallin	DELACROIX_RAR_BOUND_ES
5.71428571429%	4	70	46	Diabetes_McGill_Adipocytokine_signallin	PID_A6B1_A6B4_INTEGRIN_PATHWAY
5.71428571429%	4	70	46	Diabetes_McGill_Adipocytokine_signallin	ABBUD_LIF_SIGNALING_1_UP
5.71428571429%	4	70	456	Diabetes_McGill_Adipocytokine_signallin	ODONNELL_TFRC_TARGETS_UP
5.71428571429%	4	70	45	Diabetes_McGill_Adipocytokine_signallin	ST_T_CELL_SIGNAL_TRANSDUCTION
5.71428571429%	4	70	45	Diabetes_McGill_Adipocytokine_signallin	PID_INSULIN_PATHWAY
5.71428571429%	4	70	445	Diabetes_McGill_Adipocytokine_signallin	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
5.71428571429%	4	70	431	Diabetes_McGill_Adipocytokine_signallin	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
5.71428571429%	4	70	418	Diabetes_McGill_Adipocytokine_signallin	RUTELLA_RESPONSE_TO_HGF_UP
5.71428571429%	4	70	418	Diabetes_McGill_Adipocytokine_signallin	MULLIGHAN_MLL_SIGNATURE_2_UP
5.71428571429%	4	70	412	Diabetes_McGill_Adipocytokine_signallin	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
5.71428571429%	4	70	40	Diabetes_McGill_Adipocytokine_signallin	ST_JNK_MAPK_PATHWAY
5.71428571429%	4	70	393	Diabetes_McGill_Adipocytokine_signallin	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
5.71428571429%	4	70	39	Diabetes_McGill_Adipocytokine_signallin	PID_RET_PATHWAY
5.71428571429%	4	70	374	Diabetes_McGill_Adipocytokine_signallin	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
5.71428571429%	4	70	373	Diabetes_McGill_Adipocytokine_signallin	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
5.71428571429%	4	70	37	Diabetes_McGill_Adipocytokine_signallin	PID_GMCSF_PATHWAY
5.71428571429%	4	70	366	Diabetes_McGill_Adipocytokine_signallin	SANSOM_APC_TARGETS_DN
5.71428571429%	4	70	354	Diabetes_McGill_Adipocytokine_signallin	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
5.71428571429%	4	70	352	Diabetes_McGill_Adipocytokine_signallin	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
5.71428571429%	4	70	35	Diabetes_McGill_Adipocytokine_signallin	ST_G_ALPHA_I_PATHWAY
5.71428571429%	4	70	337	Diabetes_McGill_Adipocytokine_signallin	PHONG_TNF_RESPONSE_NOT_VIA_P38
5.71428571429%	4	70	326	Diabetes_McGill_Adipocytokine_signallin	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
5.71428571429%	4	70	32	Diabetes_McGill_Adipocytokine_signallin	REACTOME_CD28_CO_STIMULATION
5.71428571429%	4	70	315	Diabetes_McGill_Adipocytokine_signallin	PASINI_SUZ12_TARGETS_DN
5.71428571429%	4	70	31	Diabetes_McGill_Adipocytokine_signallin	PID_NEPHRIN_NEPH1_PATHWAY
5.71428571429%	4	70	30	Diabetes_McGill_Adipocytokine_signallin	PID_IGF1_PATHWAY
5.71428571429%	4	70	291	Diabetes_McGill_Adipocytokine_signallin	SABATES_COLORECTAL_ADENOMA_DN
5.71428571429%	4	70	29	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_VIP_PATHWAY
5.71428571429%	4	70	266	Diabetes_McGill_Adipocytokine_signallin	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
5.71428571429%	4	70	26	Diabetes_McGill_Adipocytokine_signallin	ST_INTERLEUKIN_4_PATHWAY
5.71428571429%	4	70	254	Diabetes_McGill_Adipocytokine_signallin	IVANOVA_HEMATOPOIESIS_STEM_CELL
5.71428571429%	4	70	244	Diabetes_McGill_Adipocytokine_signallin	HSIAO_LIVER_SPECIFIC_GENES
5.71428571429%	4	70	24	Diabetes_McGill_Adipocytokine_signallin	REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION
5.71428571429%	4	70	23	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_RAS_PATHWAY
5.71428571429%	4	70	223	Diabetes_McGill_Adipocytokine_signallin	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
5.71428571429%	4	70	22	Diabetes_McGill_Adipocytokine_signallin	REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING
5.71428571429%	4	70	22	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_INSULIN_PATHWAY
5.71428571429%	4	70	210	Diabetes_McGill_Adipocytokine_signallin	CAIRO_HEPATOBLASTOMA_CLASSES_DN
5.71428571429%	4	70	21	Diabetes_McGill_Adipocytokine_signallin	STEGER_ADIPOGENESIS_UP
5.71428571429%	4	70	207	Diabetes_McGill_Adipocytokine_signallin	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
5.71428571429%	4	70	206	Diabetes_McGill_Adipocytokine_signallin	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
5.71428571429%	4	70	20	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_ATM_PATHWAY
5.71428571429%	4	70	197	Diabetes_McGill_Adipocytokine_signallin	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
5.71428571429%	4	70	196	Diabetes_McGill_Adipocytokine_signallin	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
5.71428571429%	4	70	195	Diabetes_McGill_Adipocytokine_signallin	KYNG_DNA_DAMAGE_DN
5.71428571429%	4	70	185	Diabetes_McGill_Adipocytokine_signallin	LEE_LIVER_CANCER_SURVIVAL_UP
5.71428571429%	4	70	183	Diabetes_McGill_Adipocytokine_signallin	VERHAAK_AML_WITH_NPM1_MUTATED_UP
5.71428571429%	4	70	183	Diabetes_McGill_Adipocytokine_signallin	OKUMURA_INFLAMMATORY_RESPONSE_LPS
5.71428571429%	4	70	176	Diabetes_McGill_Adipocytokine_signallin	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
5.71428571429%	4	70	175	Diabetes_McGill_Adipocytokine_signallin	FIRESTEIN_PROLIFERATION
5.71428571429%	4	70	170	Diabetes_McGill_Adipocytokine_signallin	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
5.71428571429%	4	70	17	Diabetes_McGill_Adipocytokine_signallin	PID_NFKAPPABATYPICALPATHWAY
5.71428571429%	4	70	161	Diabetes_McGill_Adipocytokine_signallin	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
5.71428571429%	4	70	160	Diabetes_McGill_Adipocytokine_signallin	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
5.71428571429%	4	70	16	Diabetes_McGill_Adipocytokine_signallin	REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1
5.71428571429%	4	70	16	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_CDMAC_PATHWAY
5.71428571429%	4	70	156	Diabetes_McGill_Adipocytokine_signallin	GROSS_HYPOXIA_VIA_ELK3_DN
5.71428571429%	4	70	144	Diabetes_McGill_Adipocytokine_signallin	BROCKE_APOPTOSIS_REVERSED_BY_IL6
5.71428571429%	4	70	134	Diabetes_McGill_Adipocytokine_signallin	KEGG_TIGHT_JUNCTION
5.71428571429%	4	70	13	Diabetes_McGill_Adipocytokine_signallin	REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS
5.71428571429%	4	70	1278	Diabetes_McGill_Adipocytokine_signallin	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
5.71428571429%	4	70	127	Diabetes_McGill_Adipocytokine_signallin	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
5.71428571429%	4	70	12	Diabetes_McGill_Adipocytokine_signallin	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
5.71428571429%	4	70	1137	Diabetes_McGill_Adipocytokine_signallin	BRUINS_UVC_RESPONSE_LATE
5.71428571429%	4	70	11	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_EPONFKB_PATHWAY
5.71428571429%	4	70	109	Diabetes_McGill_Adipocytokine_signallin	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
5.71428571429%	4	70	108	Diabetes_McGill_Adipocytokine_signallin	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
5.71428571429%	4	70	104	Diabetes_McGill_Adipocytokine_signallin	NAKAMURA_ADIPOGENESIS_LATE_UP
5.71428571429%	4	70	1011	Diabetes_McGill_Adipocytokine_signallin	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
5.71428571429%	4	70	101	Diabetes_McGill_Adipocytokine_signallin	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
5.71428571429%	4	70	101	Diabetes_McGill_Adipocytokine_signallin	BASSO_CD40_SIGNALING_UP
5.71428571429%	4	70	10	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_RNA_PATHWAY
5.71428571429%	26	455	973	T2D_GENES_TANYA_BLOODPRESSURE	ACEVEDO_LIVER_CANCER_UP
5.71428571429%	26	455	863	T2D_GENES_TANYA_BLOODPRESSURE	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
5.71428571429%	26	455	830	T2D_GENES_TANYA_BLOODPRESSURE	CUI_TCF21_TARGETS_2_DN
5.71428571429%	26	455	461	T2D_GENES_TANYA_BLOODPRESSURE	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
5.70962479608%	35	613	988	T2D_GENES_TANYA_BIOMARKER	BENPORATH_NANOG_TARGETS
5.70962479608%	35	613	882	T2D_GENES_TANYA_BIOMARKER	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
5.70962479608%	35	613	1038	T2D_GENES_TANYA_BIOMARKER	BENPORATH_SUZ12_TARGETS
5.70377184913%	124	2174	1210	T2D_GENES_TANYA_LIPIDS	CHEN_METABOLIC_SYNDROM_NETWORK
5.66541956173%	106	1871	1118	T2D_GENES_TANYA_HEIGHT	BENPORATH_ES_WITH_H3K27ME3
5.65777368905%	123	2174	1137	T2D_GENES_TANYA_LIPIDS	BRUINS_UVC_RESPONSE_LATE
5.64585115483%	66	1169	1839	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
5.64516129032%	7	124	882	Diabetes_McGill_Cell_cycle_All_Gene	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
5.64516129032%	7	124	87	Diabetes_McGill_Cell_cycle_All_Gene	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
5.64516129032%	7	124	84	Diabetes_McGill_Cell_cycle_All_Gene	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
5.64516129032%	7	124	8	Diabetes_McGill_Cell_cycle_All_Gene	SA_G2_AND_M_PHASES
5.64516129032%	7	124	76	Diabetes_McGill_Cell_cycle_All_Gene	SU_TESTIS
5.64516129032%	7	124	74	Diabetes_McGill_Cell_cycle_All_Gene	FURUKAWA_DUSP6_TARGETS_PCI35_DN
5.64516129032%	7	124	73	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_MEIOTIC_SYNAPSIS
5.64516129032%	7	124	62	Diabetes_McGill_Cell_cycle_All_Gene	GEORGES_CELL_CYCLE_MIR192_TARGETS
5.64516129032%	7	124	612	Diabetes_McGill_Cell_cycle_All_Gene	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
5.64516129032%	7	124	59	Diabetes_McGill_Cell_cycle_All_Gene	PID_ATF2_PATHWAY
5.64516129032%	7	124	567	Diabetes_McGill_Cell_cycle_All_Gene	CHICAS_RB1_TARGETS_CONFLUENT
5.64516129032%	7	124	56	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX
5.64516129032%	7	124	555	Diabetes_McGill_Cell_cycle_All_Gene	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
5.64516129032%	7	124	55	Diabetes_McGill_Cell_cycle_All_Gene	PID_TGFBRPATHWAY
5.64516129032%	7	124	54	Diabetes_McGill_Cell_cycle_All_Gene	SUNG_METASTASIS_STROMA_DN
5.64516129032%	7	124	539	Diabetes_McGill_Cell_cycle_All_Gene	LIAO_METASTASIS
5.64516129032%	7	124	536	Diabetes_McGill_Cell_cycle_All_Gene	SENESE_HDAC3_TARGETS_DN
5.64516129032%	7	124	53	Diabetes_McGill_Cell_cycle_All_Gene	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN
5.64516129032%	7	124	52	Diabetes_McGill_Cell_cycle_All_Gene	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
5.64516129032%	7	124	516	Diabetes_McGill_Cell_cycle_All_Gene	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
5.64516129032%	7	124	49	Diabetes_McGill_Cell_cycle_All_Gene	OLSSON_E2F3_TARGETS_DN
5.64516129032%	7	124	475	Diabetes_McGill_Cell_cycle_All_Gene	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
5.64516129032%	7	124	46	Diabetes_McGill_Cell_cycle_All_Gene	PID_A6B1_A6B4_INTEGRIN_PATHWAY
5.64516129032%	7	124	45	Diabetes_McGill_Cell_cycle_All_Gene	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN
5.64516129032%	7	124	44	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
5.64516129032%	7	124	434	Diabetes_McGill_Cell_cycle_All_Gene	BAELDE_DIABETIC_NEPHROPATHY_DN
5.64516129032%	7	124	43	Diabetes_McGill_Cell_cycle_All_Gene	BURTON_ADIPOGENESIS_PEAK_AT_24HR
5.64516129032%	7	124	425	Diabetes_McGill_Cell_cycle_All_Gene	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
5.64516129032%	7	124	42	Diabetes_McGill_Cell_cycle_All_Gene	YU_MYC_TARGETS_UP
5.64516129032%	7	124	371	Diabetes_McGill_Cell_cycle_All_Gene	WANG_SMARCE1_TARGETS_DN
5.64516129032%	7	124	366	Diabetes_McGill_Cell_cycle_All_Gene	YOSHIMURA_MAPK8_TARGETS_DN
5.64516129032%	7	124	36	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_DNA_REPLICATION
5.64516129032%	7	124	344	Diabetes_McGill_Cell_cycle_All_Gene	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
5.64516129032%	7	124	336	Diabetes_McGill_Cell_cycle_All_Gene	JOHNSTONE_PARVB_TARGETS_2_DN
5.64516129032%	7	124	33	Diabetes_McGill_Cell_cycle_All_Gene	GREENBAUM_E2A_TARGETS_UP
5.64516129032%	7	124	314	Diabetes_McGill_Cell_cycle_All_Gene	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
5.64516129032%	7	124	309	Diabetes_McGill_Cell_cycle_All_Gene	LIU_SOX4_TARGETS_DN
5.64516129032%	7	124	290	Diabetes_McGill_Cell_cycle_All_Gene	BENPORATH_OCT4_TARGETS
5.64516129032%	7	124	29	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION
5.64516129032%	7	124	29	Diabetes_McGill_Cell_cycle_All_Gene	PID_BARD1PATHWAY
5.64516129032%	7	124	270	Diabetes_McGill_Cell_cycle_All_Gene	RIZKI_TUMOR_INVASIVENESS_3D_DN
5.64516129032%	7	124	242	Diabetes_McGill_Cell_cycle_All_Gene	WINTER_HYPOXIA_METAGENE
5.64516129032%	7	124	221	Diabetes_McGill_Cell_cycle_All_Gene	ZHANG_TLX_TARGETS_36HR_UP
5.64516129032%	7	124	209	Diabetes_McGill_Cell_cycle_All_Gene	GROSS_HYPOXIA_VIA_ELK3_UP
5.64516129032%	7	124	193	Diabetes_McGill_Cell_cycle_All_Gene	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
5.64516129032%	7	124	176	Diabetes_McGill_Cell_cycle_All_Gene	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
5.64516129032%	7	124	175	Diabetes_McGill_Cell_cycle_All_Gene	FIRESTEIN_PROLIFERATION
5.64516129032%	7	124	17	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_ARF_PATHWAY
5.64516129032%	7	124	167	Diabetes_McGill_Cell_cycle_All_Gene	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
5.64516129032%	7	124	16	Diabetes_McGill_Cell_cycle_All_Gene	FINETTI_BREAST_CANCER_KINOME_RED
5.64516129032%	7	124	152	Diabetes_McGill_Cell_cycle_All_Gene	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
5.64516129032%	7	124	126	Diabetes_McGill_Cell_cycle_All_Gene	SANSOM_APC_TARGETS_UP
5.64516129032%	7	124	125	Diabetes_McGill_Cell_cycle_All_Gene	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
5.64516129032%	7	124	116	Diabetes_McGill_Cell_cycle_All_Gene	MATTIOLI_MGUS_VS_PCL
5.64516129032%	7	124	115	Diabetes_McGill_Cell_cycle_All_Gene	MARKEY_RB1_CHRONIC_LOF_UP
5.64516129032%	7	124	112	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_DNA_REPAIR
5.64516129032%	7	124	11	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_UNWINDING_OF_DNA
5.64516129032%	7	124	11	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_PTC1_PATHWAY
5.64516129032%	7	124	105	Diabetes_McGill_Cell_cycle_All_Gene	PID_ERBB1_DOWNSTREAM_PATHWAY
5.64516129032%	7	124	100	Diabetes_McGill_Cell_cycle_All_Gene	BENPORATH_ES_CORE_NINE_CORRELATED
5.62310030395%	111	1974	652	Mendelian_Nancy_Cox	BENPORATH_PRC2_TARGETS
5.62310030395%	111	1974	567	Mendelian_Nancy_Cox	PARENT_MTOR_SIGNALING_UP
5.61197220738%	105	1871	1210	T2D_GENES_TANYA_HEIGHT	CHEN_METABOLIC_SYNDROM_NETWORK
5.59757942511%	37	661	756	T2D_GENES_TANYA_GLYCEMIC	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
5.59757942511%	37	661	1278	T2D_GENES_TANYA_GLYCEMIC	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
5.59757942511%	37	661	1237	T2D_GENES_TANYA_GLYCEMIC	BLALOCK_ALZHEIMERS_DISEASE_DN
5.57244174265%	110	1974	893	Mendelian_Nancy_Cox	GEORGES_TARGETS_OF_MIR192_AND_MIR215
5.57244174265%	110	1974	848	Mendelian_Nancy_Cox	NUYTTEN_NIPP1_TARGETS_DN
5.57244174265%	110	1974	805	Mendelian_Nancy_Cox	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
5.56818181818%	196	3520	1972	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PILON_KLF1_TARGETS_DN
5.56818181818%	196	3520	1821	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DODD_NASOPHARYNGEAL_CARCINOMA_UP
5.54649265905%	34	613	756	T2D_GENES_TANYA_BIOMARKER	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
5.54649265905%	34	613	1382	T2D_GENES_TANYA_BIOMARKER	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
5.54649265905%	34	613	1375	T2D_GENES_TANYA_BIOMARKER	DODD_NASOPHARYNGEAL_CARCINOMA_DN
5.54649265905%	34	613	1062	T2D_GENES_TANYA_BIOMARKER	BENPORATH_EED_TARGETS
5.54016620499%	20	361	1375	T2D_GENES_TANYA_T2D_RSQ05_02CM	DODD_NASOPHARYNGEAL_CARCINOMA_DN
5.53505535055%	30	542	898	T2D_GENES_TANYA_ANTHROPOMETRIC	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
5.53505535055%	30	542	871	T2D_GENES_TANYA_ANTHROPOMETRIC	GRADE_COLON_CANCER_UP
5.53505535055%	30	542	1210	T2D_GENES_TANYA_ANTHROPOMETRIC	CHEN_METABOLIC_SYNDROM_NETWORK
5.53505535055%	30	542	1022	T2D_GENES_TANYA_ANTHROPOMETRIC	MARSON_BOUND_BY_FOXP3_STIMULATED
5.53359683794%	14	253	83	Diabetes_McGill_CREBBP_coTF	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
5.53359683794%	14	253	80	Diabetes_McGill_CREBBP_coTF	PID_BETACATENIN_NUC_PATHWAY
5.53359683794%	14	253	77	Diabetes_McGill_CREBBP_coTF	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
5.53359683794%	14	253	769	Diabetes_McGill_CREBBP_coTF	NUYTTEN_NIPP1_TARGETS_UP
5.53359683794%	14	253	745	Diabetes_McGill_CREBBP_coTF	LEE_BMP2_TARGETS_UP
5.53359683794%	14	253	74	Diabetes_McGill_CREBBP_coTF	PID_E2F_PATHWAY
5.53359683794%	14	253	72	Diabetes_McGill_CREBBP_coTF	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
5.53359683794%	14	253	663	Diabetes_McGill_CREBBP_coTF	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
5.53359683794%	14	253	66	Diabetes_McGill_CREBBP_coTF	PID_HIF1_TFPATHWAY
5.53359683794%	14	253	539	Diabetes_McGill_CREBBP_coTF	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
5.53359683794%	14	253	536	Diabetes_McGill_CREBBP_coTF	SENESE_HDAC3_TARGETS_DN
5.53359683794%	14	253	455	Diabetes_McGill_CREBBP_coTF	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
5.53359683794%	14	253	434	Diabetes_McGill_CREBBP_coTF	BAELDE_DIABETIC_NEPHROPATHY_DN
5.53359683794%	14	253	405	Diabetes_McGill_CREBBP_coTF	KUMAR_TARGETS_OF_MLL_AF9_FUSION
5.53359683794%	14	253	368	Diabetes_McGill_CREBBP_coTF	YAGI_AML_WITH_T_8_21_TRANSLOCATION
5.53359683794%	14	253	36	Diabetes_McGill_CREBBP_coTF	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION
5.53359683794%	14	253	335	Diabetes_McGill_CREBBP_coTF	WONG_EMBRYONIC_STEM_CELL_CORE
5.53359683794%	14	253	255	Diabetes_McGill_CREBBP_coTF	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
5.53359683794%	14	253	242	Diabetes_McGill_CREBBP_coTF	WINTER_HYPOXIA_METAGENE
5.53359683794%	14	253	24	Diabetes_McGill_CREBBP_coTF	REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION
5.53359683794%	14	253	214	Diabetes_McGill_CREBBP_coTF	KIM_WT1_TARGETS_UP
5.53359683794%	14	253	206	Diabetes_McGill_CREBBP_coTF	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
5.53359683794%	14	253	155	Diabetes_McGill_CREBBP_coTF	KEGG_JAK_STAT_SIGNALING_PATHWAY
5.53359683794%	14	253	149	Diabetes_McGill_CREBBP_coTF	TSAI_RESPONSE_TO_IONIZING_RADIATION
5.53359683794%	14	253	129	Diabetes_McGill_CREBBP_coTF	PID_PDGFRBPATHWAY
5.53359683794%	14	253	127	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
5.53359683794%	14	253	126	Diabetes_McGill_CREBBP_coTF	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
5.52178318136%	109	1974	779	Mendelian_Nancy_Cox	PUJANA_CHEK2_PCC_NETWORK
5.51977920883%	120	2174	1024	T2D_GENES_TANYA_LIPIDS	NUYTTEN_EZH2_TARGETS_DN
5.49450549451%	25	455	882	T2D_GENES_TANYA_BLOODPRESSURE	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
5.49450549451%	25	455	745	T2D_GENES_TANYA_BLOODPRESSURE	LEE_BMP2_TARGETS_UP
5.49450549451%	25	455	1024	T2D_GENES_TANYA_BLOODPRESSURE	NUYTTEN_EZH2_TARGETS_DN
5.47378104876%	119	2174	1237	T2D_GENES_TANYA_LIPIDS	BLALOCK_ALZHEIMERS_DISEASE_DN
5.47112462006%	108	1974	701	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_BASAL_DN
5.45163014431%	102	1871	882	T2D_GENES_TANYA_HEIGHT	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
5.44896392939%	71	1303	1691	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BLALOCK_ALZHEIMERS_DISEASE_UP
5.4462934947%	36	661	841	T2D_GENES_TANYA_GLYCEMIC	MARTENS_TRETINOIN_RESPONSE_DN
5.4462934947%	36	661	1174	T2D_GENES_TANYA_GLYCEMIC	PEREZ_TP53_TARGETS
5.4462934947%	36	661	1118	T2D_GENES_TANYA_GLYCEMIC	BENPORATH_ES_WITH_H3K27ME3
5.43735224586%	69	1269	1229	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
5.42778288868%	118	2174	1080	T2D_GENES_TANYA_LIPIDS	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
5.42046605876%	107	1974	673	Mendelian_Nancy_Cox	MARTINEZ_RB1_TARGETS_UP
5.42046605876%	107	1974	658	Mendelian_Nancy_Cox	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
5.40540540541%	2	37	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_POTASSIUM_CHANNELS
5.40540540541%	2	37	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GUO_TARGETS_OF_IRS1_AND_IRS2
5.40540540541%	2	37	97	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
5.40540540541%	2	37	953	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
5.40540540541%	2	37	93	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
5.40540540541%	2	37	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KIM_MYCN_AMPLIFICATION_TARGETS_UP
5.40540540541%	2	37	91	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ELVIDGE_HIF1A_TARGETS_DN
5.40540540541%	2	37	9	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK
5.40540540541%	2	37	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
5.40540540541%	2	37	863	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
5.40540540541%	2	37	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SMID_BREAST_CANCER_LUMINAL_A_UP
5.40540540541%	2	37	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHANG_IMMORTALIZED_BY_HPV31_UP
5.40540540541%	2	37	830	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CUI_TCF21_TARGETS_2_DN
5.40540540541%	2	37	824	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
5.40540540541%	2	37	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HUANG_DASATINIB_RESISTANCE_UP
5.40540540541%	2	37	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CROMER_METASTASIS_DN
5.40540540541%	2	37	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_UNFOLDED_PROTEIN_RESPONSE
5.40540540541%	2	37	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
5.40540540541%	2	37	783	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
5.40540540541%	2	37	77	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
5.40540540541%	2	37	769	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NUYTTEN_NIPP1_TARGETS_UP
5.40540540541%	2	37	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MAHAJAN_RESPONSE_TO_IL1A_DN
5.40540540541%	2	37	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_AVB3_INTEGRIN_PATHWAY
5.40540540541%	2	37	747	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PATIL_LIVER_CANCER
5.40540540541%	2	37	745	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LEE_BMP2_TARGETS_UP
5.40540540541%	2	37	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS
5.40540540541%	2	37	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
5.40540540541%	2	37	722	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
5.40540540541%	2	37	721	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WONG_ADULT_TISSUE_STEM_MODULE
5.40540540541%	2	37	720	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
5.40540540541%	2	37	72	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
5.40540540541%	2	37	70	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_CDC42_PATHWAY
5.40540540541%	2	37	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_P75NTRPATHWAY
5.40540540541%	2	37	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_PPAR_SIGNALING_PATHWAY
5.40540540541%	2	37	68	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DELPUECH_FOXO3_TARGETS_UP
5.40540540541%	2	37	673	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARTINEZ_RB1_TARGETS_UP
5.40540540541%	2	37	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_HIF1_TFPATHWAY
5.40540540541%	2	37	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_IL4_2PATHWAY
5.40540540541%	2	37	648	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SMID_BREAST_CANCER_BASAL_UP
5.40540540541%	2	37	634	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
5.40540540541%	2	37	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_TRKRPATHWAY
5.40540540541%	2	37	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_FCER1PATHWAY
5.40540540541%	2	37	60	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LEE_LIVER_CANCER_CIPROFIBRATE_UP
5.40540540541%	2	37	59	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_FAK_PATHWAY
5.40540540541%	2	37	584	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HAMAI_APOPTOSIS_VIA_TRAIL_UP
5.40540540541%	2	37	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_SHP2_PATHWAY
5.40540540541%	2	37	555	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
5.40540540541%	2	37	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_IL2_1PATHWAY
5.40540540541%	2	37	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_FGF_PATHWAY
5.40540540541%	2	37	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER
5.40540540541%	2	37	546	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
5.40540540541%	2	37	544	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
5.40540540541%	2	37	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_INOSITOL_PHOSPHATE_METABOLISM
5.40540540541%	2	37	536	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
5.40540540541%	2	37	528	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
5.40540540541%	2	37	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PRAMOONJAGO_SOX4_TARGETS_DN
5.40540540541%	2	37	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
5.40540540541%	2	37	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
5.40540540541%	2	37	505	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
5.40540540541%	2	37	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_ANGIOPOIETINRECEPTOR_PATHWAY
5.40540540541%	2	37	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NADERI_BREAST_CANCER_PROGNOSIS_UP
5.40540540541%	2	37	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
5.40540540541%	2	37	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_TCR_PATHWAY
5.40540540541%	2	37	479	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
5.40540540541%	2	37	476	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SMID_BREAST_CANCER_NORMAL_LIKE_UP
5.40540540541%	2	37	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_IL6_7PATHWAY
5.40540540541%	2	37	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	IRITANI_MAD1_TARGETS_DN
5.40540540541%	2	37	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT
5.40540540541%	2	37	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
5.40540540541%	2	37	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_A6B1_A6B4_INTEGRIN_PATHWAY
5.40540540541%	2	37	456	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ODONNELL_TFRC_TARGETS_UP
5.40540540541%	2	37	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
5.40540540541%	2	37	448	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
5.40540540541%	2	37	442	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
5.40540540541%	2	37	442	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HAN_SATB1_TARGETS_DN
5.40540540541%	2	37	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SIGNALING_BY_FGFR_MUTANTS
5.40540540541%	2	37	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_ERBB2ERBB3PATHWAY
5.40540540541%	2	37	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KERLEY_RESPONSE_TO_CISPLATIN_UP
5.40540540541%	2	37	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RIZ_ERYTHROID_DIFFERENTIATION_12HR
5.40540540541%	2	37	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_IL_3_5_AND_GM_CSF_SIGNALING
5.40540540541%	2	37	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_THROMBIN_PAR1_PATHWAY
5.40540540541%	2	37	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_CXCR3PATHWAY
5.40540540541%	2	37	428	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
5.40540540541%	2	37	428	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CUI_TCF21_TARGETS_2_UP
5.40540540541%	2	37	425	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
5.40540540541%	2	37	422	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YAGI_AML_WITH_INV_16_TRANSLOCATION
5.40540540541%	2	37	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LUI_THYROID_CANCER_CLUSTER_2
5.40540540541%	2	37	414	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MOHANKUMAR_TLX1_TARGETS_UP
5.40540540541%	2	37	412	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
5.40540540541%	2	37	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_IL_2_SIGNALING
5.40540540541%	2	37	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_ER_NONGENOMIC_PATHWAY
5.40540540541%	2	37	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_ERBB1_INTERNALIZATION_PATHWAY
5.40540540541%	2	37	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_FCER1_PATHWAY
5.40540540541%	2	37	404	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	OSMAN_BLADDER_CANCER_UP
5.40540540541%	2	37	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RIZ_ERYTHROID_DIFFERENTIATION_6HR
5.40540540541%	2	37	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_IFNGPATHWAY
5.40540540541%	2	37	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_EPHBFWDPATHWAY
5.40540540541%	2	37	393	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
5.40540540541%	2	37	392	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LINDGREN_BLADDER_CANCER_CLUSTER_2B
5.40540540541%	2	37	390	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HATADA_METHYLATED_IN_LUNG_CANCER_UP
5.40540540541%	2	37	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_RET_PATHWAY
5.40540540541%	2	37	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_ECADHERIN_NASCENTAJ_PATHWAY
5.40540540541%	2	37	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BURTON_ADIPOGENESIS_PEAK_AT_8HR
5.40540540541%	2	37	384	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BASAKI_YBX1_TARGETS_DN
5.40540540541%	2	37	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_GLUCOSE_TRANSPORT
5.40540540541%	2	37	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_FASPATHWAY
5.40540540541%	2	37	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_ERBB4_PATHWAY
5.40540540541%	2	37	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KAAB_FAILED_HEART_ATRIUM_UP
5.40540540541%	2	37	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_IL2RB_PATHWAY
5.40540540541%	2	37	371	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WANG_SMARCE1_TARGETS_DN
5.40540540541%	2	37	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_IL23PATHWAY
5.40540540541%	2	37	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_GMCSF_PATHWAY
5.40540540541%	2	37	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_PAR1_PATHWAY
5.40540540541%	2	37	368	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YAGI_AML_WITH_T_8_21_TRANSLOCATION
5.40540540541%	2	37	367	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	VECCHI_GASTRIC_CANCER_EARLY_DN
5.40540540541%	2	37	366	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YOSHIMURA_MAPK8_TARGETS_DN
5.40540540541%	2	37	366	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SANSOM_APC_TARGETS_DN
5.40540540541%	2	37	36	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ST_ADRENERGIC
5.40540540541%	2	37	36	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_PI3KPLCTRKPATHWAY
5.40540540541%	2	37	358	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GRUETZMANN_PANCREATIC_CANCER_UP
5.40540540541%	2	37	355	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PEREZ_TP63_TARGETS
5.40540540541%	2	37	354	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
5.40540540541%	2	37	352	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
5.40540540541%	2	37	351	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YAGI_AML_WITH_11Q23_REARRANGED
5.40540540541%	2	37	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WANG_METHYLATED_IN_BREAST_CANCER
5.40540540541%	2	37	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
5.40540540541%	2	37	349	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
5.40540540541%	2	37	344	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
5.40540540541%	2	37	342	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BLUM_RESPONSE_TO_SALIRASIB_DN
5.40540540541%	2	37	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SIG_CD40PATHWAYMAP
5.40540540541%	2	37	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_IL2_PI3KPATHWAY
5.40540540541%	2	37	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_IL1PATHWAY
5.40540540541%	2	37	337	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PHONG_TNF_RESPONSE_NOT_VIA_P38
5.40540540541%	2	37	330	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
5.40540540541%	2	37	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SCHRAETS_MLL_TARGETS_DN
5.40540540541%	2	37	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_NCADHERINPATHWAY
5.40540540541%	2	37	325	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_CELL_CYCLE_MITOTIC
5.40540540541%	2	37	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_NETRIN_PATHWAY
5.40540540541%	2	37	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_PDGF_PATHWAY
5.40540540541%	2	37	315	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PASINI_SUZ12_TARGETS_DN
5.40540540541%	2	37	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_INWARDLY_RECTIFYING_K_CHANNELS
5.40540540541%	2	37	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_NEPHRIN_NEPH1_PATHWAY
5.40540540541%	2	37	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_AVB3_OPN_PATHWAY
5.40540540541%	2	37	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_AR_NONGENOMIC_PATHWAY
5.40540540541%	2	37	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_EGF_PATHWAY
5.40540540541%	2	37	307	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LI_INDUCED_T_TO_NATURAL_KILLER_UP
5.40540540541%	2	37	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
5.40540540541%	2	37	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_BASIGIN_INTERACTIONS
5.40540540541%	2	37	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_NECTIN_PATHWAY
5.40540540541%	2	37	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_IL2_STAT5PATHWAY
5.40540540541%	2	37	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_IGF1_PATHWAY
5.40540540541%	2	37	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_EPHRINBREVPATHWAY
5.40540540541%	2	37	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KYNG_NORMAL_AGING_DN
5.40540540541%	2	37	294	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WEST_ADRENOCORTICAL_TUMOR_UP
5.40540540541%	2	37	293	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HADDAD_B_LYMPHOCYTE_PROGENITOR
5.40540540541%	2	37	293	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ENK_UV_RESPONSE_EPIDERMIS_UP
5.40540540541%	2	37	292	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KOYAMA_SEMA3B_TARGETS_UP
5.40540540541%	2	37	291	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SABATES_COLORECTAL_ADENOMA_DN
5.40540540541%	2	37	290	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BENPORATH_OCT4_TARGETS
5.40540540541%	2	37	290	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BASAKI_YBX1_TARGETS_UP
5.40540540541%	2	37	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
5.40540540541%	2	37	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_REELINPATHWAY
5.40540540541%	2	37	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_VEGF_PATHWAY
5.40540540541%	2	37	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_TRAIL_PATHWAY
5.40540540541%	2	37	279	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_NEURONAL_SYSTEM
5.40540540541%	2	37	279	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FORTSCHEGGER_PHF8_TARGETS_UP
5.40540540541%	2	37	270	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
5.40540540541%	2	37	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_IL_RECEPTOR_SHC_SIGNALING
5.40540540541%	2	37	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_IL3_PATHWAY
5.40540540541%	2	37	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_GSK3_PATHWAY
5.40540540541%	2	37	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_EDG1_PATHWAY
5.40540540541%	2	37	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_CREB_PATHWAY
5.40540540541%	2	37	261	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
5.40540540541%	2	37	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ST_INTERLEUKIN_4_PATHWAY
5.40540540541%	2	37	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN
5.40540540541%	2	37	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_RACCYCD_PATHWAY
5.40540540541%	2	37	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_BAD_PATHWAY
5.40540540541%	2	37	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_LYMPHANGIOGENESIS_PATHWAY
5.40540540541%	2	37	247	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_METABOLISM_OF_CARBOHYDRATES
5.40540540541%	2	37	246	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	VERHAAK_AML_WITH_NPM1_MUTATED_DN
5.40540540541%	2	37	244	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PLASARI_TGFB1_TARGETS_10HR_DN
5.40540540541%	2	37	244	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HSIAO_LIVER_SPECIFIC_GENES
5.40540540541%	2	37	242	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MULLIGHAN_MLL_SIGNATURE_1_DN
5.40540540541%	2	37	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_TPO_PATHWAY
5.40540540541%	2	37	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_ECM_PATHWAY
5.40540540541%	2	37	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_CXCR4_PATHWAY
5.40540540541%	2	37	239	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
5.40540540541%	2	37	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_INSULIN_RECEPTOR_RECYCLING
5.40540540541%	2	37	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_RAS_PATHWAY
5.40540540541%	2	37	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_RAC1_PATHWAY
5.40540540541%	2	37	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_IGF1R_PATHWAY
5.40540540541%	2	37	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_GLEEVEC_PATHWAY
5.40540540541%	2	37	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_HEDGEHOG_2PATHWAY
5.40540540541%	2	37	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_HER2_PATHWAY
5.40540540541%	2	37	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_GCR_PATHWAY
5.40540540541%	2	37	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_AKT_PATHWAY
5.40540540541%	2	37	217	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SANSOM_APC_MYC_TARGETS
5.40540540541%	2	37	211	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
5.40540540541%	2	37	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
5.40540540541%	2	37	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_TFF_PATHWAY
5.40540540541%	2	37	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_IGF1_PATHWAY
5.40540540541%	2	37	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_CTLA4_PATHWAY
5.40540540541%	2	37	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	VERHAAK_GLIOBLASTOMA_CLASSICAL
5.40540540541%	2	37	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MANALO_HYPOXIA_UP
5.40540540541%	2	37	206	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
5.40540540541%	2	37	205	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SHEPARD_BMYB_MORPHOLINO_UP
5.40540540541%	2	37	205	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
5.40540540541%	2	37	204	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
5.40540540541%	2	37	203	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GRUETZMANN_PANCREATIC_CANCER_DN
5.40540540541%	2	37	200	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LEE_DIFFERENTIATING_T_LYMPHOCYTE
5.40540540541%	2	37	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_NEPHRIN_INTERACTIONS
5.40540540541%	2	37	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_NKCELLS_PATHWAY
5.40540540541%	2	37	196	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
5.40540540541%	2	37	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS
5.40540540541%	2	37	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_EPHA2_FWDPATHWAY
5.40540540541%	2	37	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHEN_PDGF_TARGETS
5.40540540541%	2	37	185	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
5.40540540541%	2	37	185	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LEE_LIVER_CANCER_SURVIVAL_UP
5.40540540541%	2	37	184	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
5.40540540541%	2	37	184	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
5.40540540541%	2	37	1839	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
5.40540540541%	2	37	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR
5.40540540541%	2	37	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_REGULATION_OF_SIGNALING_BY_CBL
5.40540540541%	2	37	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_NGF_PATHWAY
5.40540540541%	2	37	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_ERK5_PATHWAY
5.40540540541%	2	37	178	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BROWNE_HCMV_INFECTION_18HR_DN
5.40540540541%	2	37	176	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
5.40540540541%	2	37	175	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YAMAZAKI_TCEB3_TARGETS_UP
5.40540540541%	2	37	175	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FIRESTEIN_PROLIFERATION
5.40540540541%	2	37	171	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ELVIDGE_HYPOXIA_UP
5.40540540541%	2	37	171	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
5.40540540541%	2	37	170	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
5.40540540541%	2	37	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SA_TRKA_RECEPTOR
5.40540540541%	2	37	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_TIE2_SIGNALING
5.40540540541%	2	37	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SHC_RELATED_EVENTS
5.40540540541%	2	37	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_NFKAPPABATYPICALPATHWAY
5.40540540541%	2	37	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_IL7_PATHWAY
5.40540540541%	2	37	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_HCMV_PATHWAY
5.40540540541%	2	37	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_ARF_PATHWAY
5.40540540541%	2	37	169	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ONDER_CDH1_TARGETS_1_DN
5.40540540541%	2	37	169	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
5.40540540541%	2	37	168	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
5.40540540541%	2	37	161	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
5.40540540541%	2	37	160	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BROWNE_HCMV_INFECTION_6HR_DN
5.40540540541%	2	37	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_CDC42RAC_PATHWAY
5.40540540541%	2	37	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_BCELLSURVIVAL_PATHWAY
5.40540540541%	2	37	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_ACH_PATHWAY
5.40540540541%	2	37	159	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
5.40540540541%	2	37	154	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
5.40540540541%	2	37	152	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
5.40540540541%	2	37	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_LONGEVITY_PATHWAY
5.40540540541%	2	37	148	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BROWNE_HCMV_INFECTION_24HR_DN
5.40540540541%	2	37	147	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WHITFIELD_CELL_CYCLE_G1_S
5.40540540541%	2	37	145	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
5.40540540541%	2	37	141	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
5.40540540541%	2	37	140	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	JOHNSTONE_PARVB_TARGETS_2_UP
5.40540540541%	2	37	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR
5.40540540541%	2	37	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHANG_ADIPOGENESIS_BY_BMP7
5.40540540541%	2	37	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SIGNAL_ATTENUATION
5.40540540541%	2	37	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_IL5_PATHWAY
5.40540540541%	2	37	137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_P53DOWNSTREAMPATHWAY
5.40540540541%	2	37	137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
5.40540540541%	2	37	135	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SERVITJA_LIVER_HNF1A_TARGETS_UP
5.40540540541%	2	37	134	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_TIGHT_JUNCTION
5.40540540541%	2	37	132	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
5.40540540541%	2	37	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS
5.40540540541%	2	37	129	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YAGI_AML_SURVIVAL
5.40540540541%	2	37	128	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	POTTI_TOPOTECAN_SENSITIVITY
5.40540540541%	2	37	128	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
5.40540540541%	2	37	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BURTON_ADIPOGENESIS_5
5.40540540541%	2	37	122	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_CHROMOSOME_MAINTENANCE
5.40540540541%	2	37	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_CELL_CELL_COMMUNICATION
5.40540540541%	2	37	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
5.40540540541%	2	37	12	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_TRKA_PATHWAY
5.40540540541%	2	37	118	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
5.40540540541%	2	37	117	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
5.40540540541%	2	37	115	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
5.40540540541%	2	37	114	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ROPERO_HDAC2_TARGETS
5.40540540541%	2	37	1137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BRUINS_UVC_RESPONSE_LATE
5.40540540541%	2	37	109	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SERVITJA_ISLET_HNF1A_TARGETS_DN
5.40540540541%	2	37	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LABBE_TGFB1_TARGETS_DN
5.40540540541%	2	37	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
5.40540540541%	2	37	107	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SIGNALING_BY_ILS
5.40540540541%	2	37	105	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_ERBB1_DOWNSTREAM_PATHWAY
5.40540540541%	2	37	104	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
5.40540540541%	2	37	103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
5.40540540541%	2	37	103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
5.39818278995%	101	1871	848	T2D_GENES_TANYA_HEIGHT	NUYTTEN_NIPP1_TARGETS_DN
5.39818278995%	101	1871	1237	T2D_GENES_TANYA_HEIGHT	BLALOCK_ALZHEIMERS_DISEASE_DN
5.38922155689%	63	1169	1229	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
5.38336052202%	33	613	957	T2D_GENES_TANYA_BIOMARKER	LOPEZ_MBD_TARGETS
5.38178472861%	117	2174	871	T2D_GENES_TANYA_LIPIDS	GRADE_COLON_CANCER_UP
5.38116591928%	24	446	1229	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
5.36980749747%	106	1974	775	Mendelian_Nancy_Cox	BENPORATH_MYC_MAX_TARGETS
5.35055350554%	29	542	918	T2D_GENES_TANYA_ANTHROPOMETRIC	JOHNSTONE_PARVB_TARGETS_3_DN
5.33578656854%	116	2174	973	T2D_GENES_TANYA_LIPIDS	ACEVEDO_LIVER_CANCER_UP
5.31914893617%	105	1974	863	Mendelian_Nancy_Cox	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
5.2950075643%	35	661	784	T2D_GENES_TANYA_GLYCEMIC	FORTSCHEGGER_PHF8_TARGETS_DN
5.27472527473%	24	455	720	T2D_GENES_TANYA_BLOODPRESSURE	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
5.27472527473%	24	455	658	T2D_GENES_TANYA_BLOODPRESSURE	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
5.27472527473%	24	455	493	T2D_GENES_TANYA_BLOODPRESSURE	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
5.26849037487%	104	1974	973	Mendelian_Nancy_Cox	ACEVEDO_LIVER_CANCER_UP
5.26849037487%	104	1974	911	Mendelian_Nancy_Cox	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
5.26849037487%	104	1974	824	Mendelian_Nancy_Cox	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
5.26849037487%	104	1974	682	Mendelian_Nancy_Cox	FEVR_CTNNB1_TARGETS_UP
5.26849037487%	104	1974	668	Mendelian_Nancy_Cox	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
5.26315789474%	19	361	1839	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
5.26315789474%	19	361	1725	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
5.26315789474%	19	361	1305	T2D_GENES_TANYA_T2D_RSQ05_02CM	YOSHIMURA_MAPK8_TARGETS_UP
5.26315789474%	19	361	1142	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
5.24379024839%	114	2174	957	T2D_GENES_TANYA_LIPIDS	LOPEZ_MBD_TARGETS
5.22022838499%	32	613	1069	T2D_GENES_TANYA_BIOMARKER	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
5.21783181358%	103	1974	857	Mendelian_Nancy_Cox	MARTENS_TRETINOIN_RESPONSE_UP
5.18439337253%	97	1871	933	T2D_GENES_TANYA_HEIGHT	REACTOME_IMMUNE_SYSTEM
5.18439337253%	97	1871	871	T2D_GENES_TANYA_HEIGHT	GRADE_COLON_CANCER_UP
5.18439337253%	97	1871	1024	T2D_GENES_TANYA_HEIGHT	NUYTTEN_EZH2_TARGETS_DN
5.16717325228%	102	1974	504	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_48HR_DN
5.16605166052%	28	542	933	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_IMMUNE_SYSTEM
5.16605166052%	28	542	1011	T2D_GENES_TANYA_ANTHROPOMETRIC	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
5.15695067265%	23	446	1781	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
5.15179392824%	112	2174	756	T2D_GENES_TANYA_LIPIDS	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
5.15179392824%	112	2174	1011	T2D_GENES_TANYA_LIPIDS	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
5.14372163389%	34	661	957	T2D_GENES_TANYA_GLYCEMIC	LOPEZ_MBD_TARGETS
5.14372163389%	34	661	940	T2D_GENES_TANYA_GLYCEMIC	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
5.14372163389%	34	661	855	T2D_GENES_TANYA_GLYCEMIC	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
5.14372163389%	34	661	770	T2D_GENES_TANYA_GLYCEMIC	KRIEG_HYPOXIA_NOT_VIA_KDM3A
5.14372163389%	34	661	1210	T2D_GENES_TANYA_GLYCEMIC	CHEN_METABOLIC_SYNDROM_NETWORK
5.14372163389%	34	661	1011	T2D_GENES_TANYA_GLYCEMIC	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
5.13833992095%	13	253	95	Diabetes_McGill_CREBBP_coTF	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
5.13833992095%	13	253	863	Diabetes_McGill_CREBBP_coTF	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
5.13833992095%	13	253	830	Diabetes_McGill_CREBBP_coTF	CUI_TCF21_TARGETS_2_DN
5.13833992095%	13	253	800	Diabetes_McGill_CREBBP_coTF	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
5.13833992095%	13	253	79	Diabetes_McGill_CREBBP_coTF	PID_MYC_ACTIVPATHWAY
5.13833992095%	13	253	77	Diabetes_McGill_CREBBP_coTF	JACKSON_DNMT1_TARGETS_UP
5.13833992095%	13	253	682	Diabetes_McGill_CREBBP_coTF	FEVR_CTNNB1_TARGETS_UP
5.13833992095%	13	253	668	Diabetes_McGill_CREBBP_coTF	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
5.13833992095%	13	253	66	Diabetes_McGill_CREBBP_coTF	PID_HDAC_CLASSI_PATHWAY
5.13833992095%	13	253	612	Diabetes_McGill_CREBBP_coTF	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
5.13833992095%	13	253	61	Diabetes_McGill_CREBBP_coTF	PID_AR_PATHWAY
5.13833992095%	13	253	605	Diabetes_McGill_CREBBP_coTF	CAIRO_HEPATOBLASTOMA_CLASSES_UP
5.13833992095%	13	253	60	Diabetes_McGill_CREBBP_coTF	KEGG_ACUTE_MYELOID_LEUKEMIA
5.13833992095%	13	253	58	Diabetes_McGill_CREBBP_coTF	BIOCARTA_PPARA_PATHWAY
5.13833992095%	13	253	578	Diabetes_McGill_CREBBP_coTF	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
5.13833992095%	13	253	539	Diabetes_McGill_CREBBP_coTF	LIAO_METASTASIS
5.13833992095%	13	253	518	Diabetes_McGill_CREBBP_coTF	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
5.13833992095%	13	253	491	Diabetes_McGill_CREBBP_coTF	ZHENG_BOUND_BY_FOXP3
5.13833992095%	13	253	485	Diabetes_McGill_CREBBP_coTF	ENK_UV_RESPONSE_KERATINOCYTE_DN
5.13833992095%	13	253	463	Diabetes_McGill_CREBBP_coTF	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
5.13833992095%	13	253	459	Diabetes_McGill_CREBBP_coTF	KIM_WT1_TARGETS_DN
5.13833992095%	13	253	457	Diabetes_McGill_CREBBP_coTF	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
5.13833992095%	13	253	430	Diabetes_McGill_CREBBP_coTF	VECCHI_GASTRIC_CANCER_EARLY_UP
5.13833992095%	13	253	430	Diabetes_McGill_CREBBP_coTF	JOHNSTONE_PARVB_TARGETS_3_UP
5.13833992095%	13	253	362	Diabetes_McGill_CREBBP_coTF	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
5.13833992095%	13	253	293	Diabetes_McGill_CREBBP_coTF	HADDAD_B_LYMPHOCYTE_PROGENITOR
5.13833992095%	13	253	289	Diabetes_McGill_CREBBP_coTF	WANG_MLL_TARGETS
5.13833992095%	13	253	281	Diabetes_McGill_CREBBP_coTF	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
5.13833992095%	13	253	276	Diabetes_McGill_CREBBP_coTF	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
5.13833992095%	13	253	233	Diabetes_McGill_CREBBP_coTF	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
5.13833992095%	13	253	230	Diabetes_McGill_CREBBP_coTF	KAUFFMANN_DNA_REPAIR_GENES
5.13833992095%	13	253	23	Diabetes_McGill_CREBBP_coTF	REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA
5.13833992095%	13	253	225	Diabetes_McGill_CREBBP_coTF	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
5.13833992095%	13	253	176	Diabetes_McGill_CREBBP_coTF	SASAKI_ADULT_T_CELL_LEUKEMIA
5.13833992095%	13	253	163	Diabetes_McGill_CREBBP_coTF	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
5.13833992095%	13	253	132	Diabetes_McGill_CREBBP_coTF	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
5.13833992095%	13	253	122	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_PDGF
5.13094601817%	96	1871	863	T2D_GENES_TANYA_HEIGHT	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
5.13094601817%	96	1871	1037	T2D_GENES_TANYA_HEIGHT	NUYTTEN_EZH2_TARGETS_UP
5.12820512821%	2	39	98	Diabetes_McGill_IL6	GUO_TARGETS_OF_IRS1_AND_IRS2
5.12820512821%	2	39	973	Diabetes_McGill_IL6	ACEVEDO_LIVER_CANCER_UP
5.12820512821%	2	39	94	Diabetes_McGill_IL6	LU_IL4_SIGNALING
5.12820512821%	2	39	94	Diabetes_McGill_IL6	GAVIN_FOXP3_TARGETS_CLUSTER_T4
5.12820512821%	2	39	93	Diabetes_McGill_IL6	REACTOME_ACTIVATED_TLR4_SIGNALLING
5.12820512821%	2	39	92	Diabetes_McGill_IL6	DE_YY1_TARGETS_DN
5.12820512821%	2	39	918	Diabetes_McGill_IL6	JOHNSTONE_PARVB_TARGETS_3_DN
5.12820512821%	2	39	91	Diabetes_McGill_IL6	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
5.12820512821%	2	39	91	Diabetes_McGill_IL6	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
5.12820512821%	2	39	90	Diabetes_McGill_IL6	KEGG_GAP_JUNCTION
5.12820512821%	2	39	90	Diabetes_McGill_IL6	GAVIN_FOXP3_TARGETS_CLUSTER_P7
5.12820512821%	2	39	9	Diabetes_McGill_IL6	ZERBINI_RESPONSE_TO_SULINDAC_UP
5.12820512821%	2	39	893	Diabetes_McGill_IL6	GEORGES_TARGETS_OF_MIR192_AND_MIR215
5.12820512821%	2	39	88	Diabetes_McGill_IL6	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
5.12820512821%	2	39	88	Diabetes_McGill_IL6	KEGG_HEMATOPOIETIC_CELL_LINEAGE
5.12820512821%	2	39	88	Diabetes_McGill_IL6	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
5.12820512821%	2	39	88	Diabetes_McGill_IL6	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
5.12820512821%	2	39	871	Diabetes_McGill_IL6	GRADE_COLON_CANCER_UP
5.12820512821%	2	39	87	Diabetes_McGill_IL6	SAFFORD_T_LYMPHOCYTE_ANERGY
5.12820512821%	2	39	86	Diabetes_McGill_IL6	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
5.12820512821%	2	39	86	Diabetes_McGill_IL6	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
5.12820512821%	2	39	857	Diabetes_McGill_IL6	MARTENS_TRETINOIN_RESPONSE_UP
5.12820512821%	2	39	85	Diabetes_McGill_IL6	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
5.12820512821%	2	39	830	Diabetes_McGill_IL6	CUI_TCF21_TARGETS_2_DN
5.12820512821%	2	39	83	Diabetes_McGill_IL6	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
5.12820512821%	2	39	83	Diabetes_McGill_IL6	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
5.12820512821%	2	39	82	Diabetes_McGill_IL6	FRASOR_RESPONSE_TO_ESTRADIOL_DN
5.12820512821%	2	39	82	Diabetes_McGill_IL6	BHAT_ESR1_TARGETS_VIA_AKT1_DN
5.12820512821%	2	39	81	Diabetes_McGill_IL6	REACTOME_MITOTIC_G2_G2_M_PHASES
5.12820512821%	2	39	81	Diabetes_McGill_IL6	MAHAJAN_RESPONSE_TO_IL1A_UP
5.12820512821%	2	39	80	Diabetes_McGill_IL6	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
5.12820512821%	2	39	795	Diabetes_McGill_IL6	WEI_MYCN_TARGETS_WITH_E_BOX
5.12820512821%	2	39	781	Diabetes_McGill_IL6	GOZGIT_ESR1_TARGETS_DN
5.12820512821%	2	39	77	Diabetes_McGill_IL6	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
5.12820512821%	2	39	77	Diabetes_McGill_IL6	RIZ_ERYTHROID_DIFFERENTIATION
5.12820512821%	2	39	77	Diabetes_McGill_IL6	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
5.12820512821%	2	39	77	Diabetes_McGill_IL6	JACKSON_DNMT1_TARGETS_UP
5.12820512821%	2	39	756	Diabetes_McGill_IL6	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
5.12820512821%	2	39	75	Diabetes_McGill_IL6	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
5.12820512821%	2	39	74	Diabetes_McGill_IL6	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
5.12820512821%	2	39	734	Diabetes_McGill_IL6	BENPORATH_SOX2_TARGETS
5.12820512821%	2	39	73	Diabetes_McGill_IL6	GAURNIER_PSMD4_TARGETS
5.12820512821%	2	39	73	Diabetes_McGill_IL6	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
5.12820512821%	2	39	728	Diabetes_McGill_IL6	MARSON_BOUND_BY_E2F4_UNSTIMULATED
5.12820512821%	2	39	72	Diabetes_McGill_IL6	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
5.12820512821%	2	39	72	Diabetes_McGill_IL6	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
5.12820512821%	2	39	72	Diabetes_McGill_IL6	MATZUK_SPERMATOCYTE
5.12820512821%	2	39	71	Diabetes_McGill_IL6	REACTOME_PI3K_CASCADE
5.12820512821%	2	39	71	Diabetes_McGill_IL6	GEORGANTAS_HSC_MARKERS
5.12820512821%	2	39	70	Diabetes_McGill_IL6	PID_AP1_PATHWAY
5.12820512821%	2	39	7	Diabetes_McGill_IL6	PALOMERO_GSI_SENSITIVITY_UP
5.12820512821%	2	39	69	Diabetes_McGill_IL6	PID_VEGFR1_2_PATHWAY
5.12820512821%	2	39	682	Diabetes_McGill_IL6	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
5.12820512821%	2	39	67	Diabetes_McGill_IL6	ELVIDGE_HIF1A_TARGETS_UP
5.12820512821%	2	39	663	Diabetes_McGill_IL6	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
5.12820512821%	2	39	66	Diabetes_McGill_IL6	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
5.12820512821%	2	39	66	Diabetes_McGill_IL6	PID_LYSOPHOSPHOLIPID_PATHWAY
5.12820512821%	2	39	65	Diabetes_McGill_IL6	PID_RB_1PATHWAY
5.12820512821%	2	39	64	Diabetes_McGill_IL6	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
5.12820512821%	2	39	64	Diabetes_McGill_IL6	BYSTROEM_CORRELATED_WITH_IL5_DN
5.12820512821%	2	39	63	Diabetes_McGill_IL6	PID_ENDOTHELINPATHWAY
5.12820512821%	2	39	62	Diabetes_McGill_IL6	KYNG_DNA_DAMAGE_BY_UV
5.12820512821%	2	39	61	Diabetes_McGill_IL6	BROWNE_HCMV_INFECTION_1HR_UP
5.12820512821%	2	39	60	Diabetes_McGill_IL6	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
5.12820512821%	2	39	591	Diabetes_McGill_IL6	MARTINEZ_RB1_AND_TP53_TARGETS_DN
5.12820512821%	2	39	59	Diabetes_McGill_IL6	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
5.12820512821%	2	39	59	Diabetes_McGill_IL6	PID_FAK_PATHWAY
5.12820512821%	2	39	59	Diabetes_McGill_IL6	KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION
5.12820512821%	2	39	59	Diabetes_McGill_IL6	ELVIDGE_HYPOXIA_BY_DMOG_DN
5.12820512821%	2	39	579	Diabetes_McGill_IL6	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
5.12820512821%	2	39	572	Diabetes_McGill_IL6	CHICAS_RB1_TARGETS_SENESCENT
5.12820512821%	2	39	567	Diabetes_McGill_IL6	PARENT_MTOR_SIGNALING_UP
5.12820512821%	2	39	564	Diabetes_McGill_IL6	SMID_BREAST_CANCER_LUMINAL_B_DN
5.12820512821%	2	39	56	Diabetes_McGill_IL6	HOQUE_METHYLATED_IN_CANCER
5.12820512821%	2	39	55	Diabetes_McGill_IL6	SMIRNOV_RESPONSE_TO_IR_2HR_DN
5.12820512821%	2	39	546	Diabetes_McGill_IL6	WEST_ADRENOCORTICAL_TUMOR_DN
5.12820512821%	2	39	544	Diabetes_McGill_IL6	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
5.12820512821%	2	39	537	Diabetes_McGill_IL6	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
5.12820512821%	2	39	528	Diabetes_McGill_IL6	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
5.12820512821%	2	39	52	Diabetes_McGill_IL6	PID_CASPASE_PATHWAY
5.12820512821%	2	39	52	Diabetes_McGill_IL6	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
5.12820512821%	2	39	52	Diabetes_McGill_IL6	CHIBA_RESPONSE_TO_TSA_UP
5.12820512821%	2	39	518	Diabetes_McGill_IL6	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
5.12820512821%	2	39	51	Diabetes_McGill_IL6	FRASOR_TAMOXIFEN_RESPONSE_UP
5.12820512821%	2	39	51	Diabetes_McGill_IL6	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
5.12820512821%	2	39	508	Diabetes_McGill_IL6	ENK_UV_RESPONSE_EPIDERMIS_DN
5.12820512821%	2	39	504	Diabetes_McGill_IL6	BROWNE_HCMV_INFECTION_48HR_DN
5.12820512821%	2	39	50	Diabetes_McGill_IL6	PARK_APL_PATHOGENESIS_DN
5.12820512821%	2	39	50	Diabetes_McGill_IL6	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
5.12820512821%	2	39	49	Diabetes_McGill_IL6	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP
5.12820512821%	2	39	49	Diabetes_McGill_IL6	GERHOLD_ADIPOGENESIS_UP
5.12820512821%	2	39	49	Diabetes_McGill_IL6	DAUER_STAT3_TARGETS_UP
5.12820512821%	2	39	48	Diabetes_McGill_IL6	PID_HES_HEYPATHWAY
5.12820512821%	2	39	48	Diabetes_McGill_IL6	PID_HEDGEHOG_GLIPATHWAY
5.12820512821%	2	39	48	Diabetes_McGill_IL6	KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
5.12820512821%	2	39	48	Diabetes_McGill_IL6	DELACROIX_RAR_TARGETS_UP
5.12820512821%	2	39	476	Diabetes_McGill_IL6	SMID_BREAST_CANCER_NORMAL_LIKE_UP
5.12820512821%	2	39	475	Diabetes_McGill_IL6	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
5.12820512821%	2	39	47	Diabetes_McGill_IL6	KHETCHOUMIAN_TRIM24_TARGETS_UP
5.12820512821%	2	39	462	Diabetes_McGill_IL6	DELACROIX_RAR_BOUND_ES
5.12820512821%	2	39	46	Diabetes_McGill_IL6	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN
5.12820512821%	2	39	455	Diabetes_McGill_IL6	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
5.12820512821%	2	39	45	Diabetes_McGill_IL6	ST_T_CELL_SIGNAL_TRANSDUCTION
5.12820512821%	2	39	45	Diabetes_McGill_IL6	PID_HNF3BPATHWAY
5.12820512821%	2	39	448	Diabetes_McGill_IL6	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
5.12820512821%	2	39	44	Diabetes_McGill_IL6	WANG_TARGETS_OF_MLL_CBP_FUSION_UP
5.12820512821%	2	39	44	Diabetes_McGill_IL6	MARTIN_INTERACT_WITH_HDAC
5.12820512821%	2	39	44	Diabetes_McGill_IL6	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS
5.12820512821%	2	39	439	Diabetes_McGill_IL6	MITSIADES_RESPONSE_TO_APLIDIN_UP
5.12820512821%	2	39	434	Diabetes_McGill_IL6	BAELDE_DIABETIC_NEPHROPATHY_DN
5.12820512821%	2	39	430	Diabetes_McGill_IL6	RIGGI_EWING_SARCOMA_PROGENITOR_UP
5.12820512821%	2	39	43	Diabetes_McGill_IL6	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK
5.12820512821%	2	39	43	Diabetes_McGill_IL6	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
5.12820512821%	2	39	428	Diabetes_McGill_IL6	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
5.12820512821%	2	39	428	Diabetes_McGill_IL6	CUI_TCF21_TARGETS_2_UP
5.12820512821%	2	39	425	Diabetes_McGill_IL6	ZHANG_BREAST_CANCER_PROGENITORS_UP
5.12820512821%	2	39	425	Diabetes_McGill_IL6	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
5.12820512821%	2	39	422	Diabetes_McGill_IL6	YAGI_AML_WITH_INV_16_TRANSLOCATION
5.12820512821%	2	39	421	Diabetes_McGill_IL6	REACTOME_CELL_CYCLE
5.12820512821%	2	39	414	Diabetes_McGill_IL6	MOHANKUMAR_TLX1_TARGETS_UP
5.12820512821%	2	39	412	Diabetes_McGill_IL6	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
5.12820512821%	2	39	41	Diabetes_McGill_IL6	PID_AMB2_NEUTROPHILS_PATHWAY
5.12820512821%	2	39	41	Diabetes_McGill_IL6	ONO_AML1_TARGETS_DN
5.12820512821%	2	39	40	Diabetes_McGill_IL6	VANASSE_BCL2_TARGETS_UP
5.12820512821%	2	39	40	Diabetes_McGill_IL6	VALK_AML_WITH_FLT3_ITD
5.12820512821%	2	39	40	Diabetes_McGill_IL6	ST_JNK_MAPK_PATHWAY
5.12820512821%	2	39	40	Diabetes_McGill_IL6	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
5.12820512821%	2	39	40	Diabetes_McGill_IL6	PID_EPHBFWDPATHWAY
5.12820512821%	2	39	39	Diabetes_McGill_IL6	PID_ATR_PATHWAY
5.12820512821%	2	39	372	Diabetes_McGill_IL6	WANG_LMO4_TARGETS_UP
5.12820512821%	2	39	366	Diabetes_McGill_IL6	SANSOM_APC_TARGETS_DN
5.12820512821%	2	39	36	Diabetes_McGill_IL6	MARZEC_IL2_SIGNALING_DN
5.12820512821%	2	39	357	Diabetes_McGill_IL6	SHEN_SMARCA2_TARGETS_DN
5.12820512821%	2	39	35	Diabetes_McGill_IL6	KEGG_PRION_DISEASES
5.12820512821%	2	39	342	Diabetes_McGill_IL6	BLUM_RESPONSE_TO_SALIRASIB_DN
5.12820512821%	2	39	341	Diabetes_McGill_IL6	MULLIGHAN_NPM1_SIGNATURE_3_UP
5.12820512821%	2	39	34	Diabetes_McGill_IL6	PID_MAPKTRKPATHWAY
5.12820512821%	2	39	337	Diabetes_McGill_IL6	PHONG_TNF_RESPONSE_NOT_VIA_P38
5.12820512821%	2	39	335	Diabetes_McGill_IL6	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
5.12820512821%	2	39	332	Diabetes_McGill_IL6	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
5.12820512821%	2	39	33	Diabetes_McGill_IL6	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP
5.12820512821%	2	39	33	Diabetes_McGill_IL6	DUTTA_APOPTOSIS_VIA_NFKB
5.12820512821%	2	39	33	Diabetes_McGill_IL6	BURTON_ADIPOGENESIS_1
5.12820512821%	2	39	329	Diabetes_McGill_IL6	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
5.12820512821%	2	39	326	Diabetes_McGill_IL6	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
5.12820512821%	2	39	325	Diabetes_McGill_IL6	REACTOME_CELL_CYCLE_MITOTIC
5.12820512821%	2	39	324	Diabetes_McGill_IL6	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
5.12820512821%	2	39	320	Diabetes_McGill_IL6	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
5.12820512821%	2	39	32	Diabetes_McGill_IL6	TSAI_RESPONSE_TO_RADIATION_THERAPY
5.12820512821%	2	39	32	Diabetes_McGill_IL6	POS_HISTAMINE_RESPONSE_NETWORK
5.12820512821%	2	39	32	Diabetes_McGill_IL6	GROSS_ELK3_TARGETS_DN
5.12820512821%	2	39	32	Diabetes_McGill_IL6	BIOCARTA_HDAC_PATHWAY
5.12820512821%	2	39	318	Diabetes_McGill_IL6	LEI_MYB_TARGETS
5.12820512821%	2	39	317	Diabetes_McGill_IL6	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
5.12820512821%	2	39	315	Diabetes_McGill_IL6	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
5.12820512821%	2	39	314	Diabetes_McGill_IL6	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
5.12820512821%	2	39	31	Diabetes_McGill_IL6	HUNSBERGER_EXERCISE_REGULATED_GENES
5.12820512821%	2	39	31	Diabetes_McGill_IL6	DANG_MYC_TARGETS_DN
5.12820512821%	2	39	307	Diabetes_McGill_IL6	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
5.12820512821%	2	39	30	Diabetes_McGill_IL6	YANAGIHARA_ESX1_TARGETS
5.12820512821%	2	39	30	Diabetes_McGill_IL6	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
5.12820512821%	2	39	30	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
5.12820512821%	2	39	30	Diabetes_McGill_IL6	PID_RAS_PATHWAY
5.12820512821%	2	39	299	Diabetes_McGill_IL6	WALLACE_PROSTATE_CANCER_RACE_UP
5.12820512821%	2	39	295	Diabetes_McGill_IL6	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
5.12820512821%	2	39	29	Diabetes_McGill_IL6	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
5.12820512821%	2	39	29	Diabetes_McGill_IL6	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
5.12820512821%	2	39	289	Diabetes_McGill_IL6	GABRIELY_MIR21_TARGETS
5.12820512821%	2	39	289	Diabetes_McGill_IL6	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
5.12820512821%	2	39	283	Diabetes_McGill_IL6	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
5.12820512821%	2	39	28	Diabetes_McGill_IL6	MOREIRA_RESPONSE_TO_TSA_UP
5.12820512821%	2	39	277	Diabetes_McGill_IL6	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
5.12820512821%	2	39	275	Diabetes_McGill_IL6	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
5.12820512821%	2	39	271	Diabetes_McGill_IL6	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
5.12820512821%	2	39	271	Diabetes_McGill_IL6	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
5.12820512821%	2	39	271	Diabetes_McGill_IL6	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
5.12820512821%	2	39	27	Diabetes_McGill_IL6	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
5.12820512821%	2	39	269	Diabetes_McGill_IL6	WANG_CLIM2_TARGETS_UP
5.12820512821%	2	39	264	Diabetes_McGill_IL6	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
5.12820512821%	2	39	260	Diabetes_McGill_IL6	BOQUEST_STEM_CELL_UP
5.12820512821%	2	39	26	Diabetes_McGill_IL6	PID_RXR_VDR_PATHWAY
5.12820512821%	2	39	26	Diabetes_McGill_IL6	PID_ALK1PATHWAY
5.12820512821%	2	39	254	Diabetes_McGill_IL6	IVANOVA_HEMATOPOIESIS_STEM_CELL
5.12820512821%	2	39	253	Diabetes_McGill_IL6	MCLACHLAN_DENTAL_CARIES_UP
5.12820512821%	2	39	251	Diabetes_McGill_IL6	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
5.12820512821%	2	39	25	Diabetes_McGill_IL6	KEGG_DORSO_VENTRAL_AXIS_FORMATION
5.12820512821%	2	39	25	Diabetes_McGill_IL6	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP
5.12820512821%	2	39	245	Diabetes_McGill_IL6	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
5.12820512821%	2	39	245	Diabetes_McGill_IL6	MCLACHLAN_DENTAL_CARIES_DN
5.12820512821%	2	39	245	Diabetes_McGill_IL6	KONDO_EZH2_TARGETS
5.12820512821%	2	39	245	Diabetes_McGill_IL6	BLUM_RESPONSE_TO_SALIRASIB_UP
5.12820512821%	2	39	24	Diabetes_McGill_IL6	REACTOME_REGULATION_OF_IFNA_SIGNALING
5.12820512821%	2	39	24	Diabetes_McGill_IL6	BIOCARTA_G2_PATHWAY
5.12820512821%	2	39	239	Diabetes_McGill_IL6	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
5.12820512821%	2	39	234	Diabetes_McGill_IL6	AFFAR_YY1_TARGETS_DN
5.12820512821%	2	39	23	Diabetes_McGill_IL6	BIOCARTA_PTDINS_PATHWAY
5.12820512821%	2	39	229	Diabetes_McGill_IL6	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
5.12820512821%	2	39	227	Diabetes_McGill_IL6	RAO_BOUND_BY_SALL4
5.12820512821%	2	39	227	Diabetes_McGill_IL6	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
5.12820512821%	2	39	226	Diabetes_McGill_IL6	KYNG_DNA_DAMAGE_UP
5.12820512821%	2	39	225	Diabetes_McGill_IL6	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
5.12820512821%	2	39	225	Diabetes_McGill_IL6	BROWNE_HCMV_INFECTION_16HR_UP
5.12820512821%	2	39	223	Diabetes_McGill_IL6	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
5.12820512821%	2	39	222	Diabetes_McGill_IL6	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
5.12820512821%	2	39	222	Diabetes_McGill_IL6	BROWNE_HCMV_INFECTION_1HR_DN
5.12820512821%	2	39	22	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_HIPPO
5.12820512821%	2	39	22	Diabetes_McGill_IL6	PID_HEDGEHOG_2PATHWAY
5.12820512821%	2	39	22	Diabetes_McGill_IL6	BIOCARTA_CERAMIDE_PATHWAY
5.12820512821%	2	39	217	Diabetes_McGill_IL6	WIERENGA_STAT5A_TARGETS_UP
5.12820512821%	2	39	217	Diabetes_McGill_IL6	AMUNDSON_RESPONSE_TO_ARSENITE
5.12820512821%	2	39	216	Diabetes_McGill_IL6	WHITFIELD_CELL_CYCLE_G2_M
5.12820512821%	2	39	215	Diabetes_McGill_IL6	MARKEY_RB1_ACUTE_LOF_UP
5.12820512821%	2	39	214	Diabetes_McGill_IL6	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
5.12820512821%	2	39	214	Diabetes_McGill_IL6	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
5.12820512821%	2	39	214	Diabetes_McGill_IL6	KIM_WT1_TARGETS_UP
5.12820512821%	2	39	212	Diabetes_McGill_IL6	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
5.12820512821%	2	39	211	Diabetes_McGill_IL6	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
5.12820512821%	2	39	211	Diabetes_McGill_IL6	FOSTER_KDM1A_TARGETS_DN
5.12820512821%	2	39	21	Diabetes_McGill_IL6	PID_ECADHERIN_KERATINOCYTE_PATHWAY
5.12820512821%	2	39	21	Diabetes_McGill_IL6	BIOCARTA_MITOCHONDRIA_PATHWAY
5.12820512821%	2	39	209	Diabetes_McGill_IL6	CHANG_CORE_SERUM_RESPONSE_DN
5.12820512821%	2	39	207	Diabetes_McGill_IL6	VERHAAK_GLIOBLASTOMA_CLASSICAL
5.12820512821%	2	39	204	Diabetes_McGill_IL6	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
5.12820512821%	2	39	20	Diabetes_McGill_IL6	OUYANG_PROSTATE_CANCER_PROGRESSION_UP
5.12820512821%	2	39	20	Diabetes_McGill_IL6	MURAKAMI_UV_RESPONSE_24HR
5.12820512821%	2	39	20	Diabetes_McGill_IL6	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
5.12820512821%	2	39	199	Diabetes_McGill_IL6	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
5.12820512821%	2	39	198	Diabetes_McGill_IL6	ALONSO_METASTASIS_UP
5.12820512821%	2	39	196	Diabetes_McGill_IL6	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
5.12820512821%	2	39	195	Diabetes_McGill_IL6	KYNG_DNA_DAMAGE_DN
5.12820512821%	2	39	19	Diabetes_McGill_IL6	STREICHER_LSM1_TARGETS_DN
5.12820512821%	2	39	19	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS
5.12820512821%	2	39	19	Diabetes_McGill_IL6	PID_EPHA2_FWDPATHWAY
5.12820512821%	2	39	19	Diabetes_McGill_IL6	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
5.12820512821%	2	39	187	Diabetes_McGill_IL6	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
5.12820512821%	2	39	185	Diabetes_McGill_IL6	DARWICHE_SKIN_TUMOR_PROMOTER_DN
5.12820512821%	2	39	184	Diabetes_McGill_IL6	DOANE_RESPONSE_TO_ANDROGEN_UP
5.12820512821%	2	39	183	Diabetes_McGill_IL6	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
5.12820512821%	2	39	183	Diabetes_McGill_IL6	OKUMURA_INFLAMMATORY_RESPONSE_LPS
5.12820512821%	2	39	181	Diabetes_McGill_IL6	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
5.12820512821%	2	39	181	Diabetes_McGill_IL6	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
5.12820512821%	2	39	181	Diabetes_McGill_IL6	JISON_SICKLE_CELL_DISEASE_UP
5.12820512821%	2	39	181	Diabetes_McGill_IL6	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
5.12820512821%	2	39	180	Diabetes_McGill_IL6	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
5.12820512821%	2	39	18	Diabetes_McGill_IL6	YIH_RESPONSE_TO_ARSENITE_C4
5.12820512821%	2	39	18	Diabetes_McGill_IL6	BIOCARTA_TEL_PATHWAY
5.12820512821%	2	39	175	Diabetes_McGill_IL6	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
5.12820512821%	2	39	1725	Diabetes_McGill_IL6	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
5.12820512821%	2	39	170	Diabetes_McGill_IL6	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
5.12820512821%	2	39	17	Diabetes_McGill_IL6	REACTOME_RAP1_SIGNALLING
5.12820512821%	2	39	17	Diabetes_McGill_IL6	REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP
5.12820512821%	2	39	17	Diabetes_McGill_IL6	REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1
5.12820512821%	2	39	17	Diabetes_McGill_IL6	KANG_AR_TARGETS_UP
5.12820512821%	2	39	17	Diabetes_McGill_IL6	BIOCARTA_IL7_PATHWAY
5.12820512821%	2	39	17	Diabetes_McGill_IL6	BIOCARTA_IL10_PATHWAY
5.12820512821%	2	39	169	Diabetes_McGill_IL6	KEGG_ALZHEIMERS_DISEASE
5.12820512821%	2	39	167	Diabetes_McGill_IL6	VANTVEER_BREAST_CANCER_ESR1_UP
5.12820512821%	2	39	166	Diabetes_McGill_IL6	SMIRNOV_RESPONSE_TO_IR_6HR_UP
5.12820512821%	2	39	164	Diabetes_McGill_IL6	KIM_WT1_TARGETS_8HR_UP
5.12820512821%	2	39	163	Diabetes_McGill_IL6	SERVITJA_ISLET_HNF1A_TARGETS_UP
5.12820512821%	2	39	162	Diabetes_McGill_IL6	DARWICHE_PAPILLOMA_RISK_LOW_UP
5.12820512821%	2	39	16	Diabetes_McGill_IL6	WU_HBX_TARGETS_2_DN
5.12820512821%	2	39	16	Diabetes_McGill_IL6	HE_PTEN_TARGETS_UP
5.12820512821%	2	39	16	Diabetes_McGill_IL6	BAKER_HEMATOPOIESIS_STAT3_TARGETS
5.12820512821%	2	39	159	Diabetes_McGill_IL6	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
5.12820512821%	2	39	157	Diabetes_McGill_IL6	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
5.12820512821%	2	39	156	Diabetes_McGill_IL6	GROSS_HYPOXIA_VIA_ELK3_DN
5.12820512821%	2	39	153	Diabetes_McGill_IL6	LU_AGING_BRAIN_DN
5.12820512821%	2	39	15	Diabetes_McGill_IL6	REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_
5.12820512821%	2	39	15	Diabetes_McGill_IL6	BIOCARTA_LONGEVITY_PATHWAY
5.12820512821%	2	39	149	Diabetes_McGill_IL6	NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON
5.12820512821%	2	39	146	Diabetes_McGill_IL6	ELVIDGE_HYPOXIA_DN
5.12820512821%	2	39	141	Diabetes_McGill_IL6	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
5.12820512821%	2	39	14	Diabetes_McGill_IL6	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN
5.12820512821%	2	39	14	Diabetes_McGill_IL6	PID_IL5_PATHWAY
5.12820512821%	2	39	14	Diabetes_McGill_IL6	MATZUK_OVULATION
5.12820512821%	2	39	139	Diabetes_McGill_IL6	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
5.12820512821%	2	39	138	Diabetes_McGill_IL6	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
5.12820512821%	2	39	137	Diabetes_McGill_IL6	PID_P53DOWNSTREAMPATHWAY
5.12820512821%	2	39	134	Diabetes_McGill_IL6	SCHLOSSER_SERUM_RESPONSE_UP
5.12820512821%	2	39	13	Diabetes_McGill_IL6	WU_HBX_TARGETS_3_DN
5.12820512821%	2	39	129	Diabetes_McGill_IL6	KIM_WT1_TARGETS_8HR_DN
5.12820512821%	2	39	128	Diabetes_McGill_IL6	ZHU_CMV_ALL_DN
5.12820512821%	2	39	128	Diabetes_McGill_IL6	POTTI_TOPOTECAN_SENSITIVITY
5.12820512821%	2	39	128	Diabetes_McGill_IL6	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
5.12820512821%	2	39	125	Diabetes_McGill_IL6	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
5.12820512821%	2	39	123	Diabetes_McGill_IL6	DAZARD_RESPONSE_TO_UV_SCC_UP
5.12820512821%	2	39	1210	Diabetes_McGill_IL6	CHEN_METABOLIC_SYNDROM_NETWORK
5.12820512821%	2	39	120	Diabetes_McGill_IL6	ZHU_CMV_ALL_UP
5.12820512821%	2	39	120	Diabetes_McGill_IL6	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
5.12820512821%	2	39	118	Diabetes_McGill_IL6	REACTOME_TOLL_RECEPTOR_CASCADES
5.12820512821%	2	39	118	Diabetes_McGill_IL6	MARKEY_RB1_CHRONIC_LOF_DN
5.12820512821%	2	39	116	Diabetes_McGill_IL6	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
5.12820512821%	2	39	114	Diabetes_McGill_IL6	SENESE_HDAC2_TARGETS_UP
5.12820512821%	2	39	114	Diabetes_McGill_IL6	BOSCO_TH1_CYTOTOXIC_MODULE
5.12820512821%	2	39	11	Diabetes_McGill_IL6	PID_RANBP2PATHWAY
5.12820512821%	2	39	108	Diabetes_McGill_IL6	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
5.12820512821%	2	39	107	Diabetes_McGill_IL6	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
5.12820512821%	2	39	1069	Diabetes_McGill_IL6	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
5.12820512821%	2	39	1062	Diabetes_McGill_IL6	BENPORATH_EED_TARGETS
5.12820512821%	2	39	101	Diabetes_McGill_IL6	BROWNE_HCMV_INFECTION_10HR_UP
5.12820512821%	2	39	100	Diabetes_McGill_IL6	BENPORATH_ES_CORE_NINE_CORRELATED
5.12820512821%	2	39	10	Diabetes_McGill_IL6	SHANK_TAL1_TARGETS_DN
5.12214342002%	65	1269	1652	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PUJANA_BRCA1_PCC_NETWORK
5.11651469098%	101	1974	648	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_BASAL_UP
5.11651469098%	101	1974	564	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_LUMINAL_B_DN
5.11651469098%	101	1974	396	Mendelian_Nancy_Cox	REACTOME_DEVELOPMENTAL_BIOLOGY
5.11363636364%	180	3520	1781	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
5.11363636364%	180	3520	1652	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PUJANA_BRCA1_PCC_NETWORK
5.08522727273%	179	3520	1839	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
5.07749866382%	95	1871	953	T2D_GENES_TANYA_HEIGHT	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
5.07749866382%	95	1871	918	T2D_GENES_TANYA_HEIGHT	JOHNSTONE_PARVB_TARGETS_3_DN
5.07749866382%	95	1871	898	T2D_GENES_TANYA_HEIGHT	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
5.07749866382%	95	1871	775	T2D_GENES_TANYA_HEIGHT	BENPORATH_MYC_MAX_TARGETS
5.07749866382%	95	1871	1011	T2D_GENES_TANYA_HEIGHT	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
5.06585612969%	100	1974	871	Mendelian_Nancy_Cox	GRADE_COLON_CANCER_UP
5.06585612969%	100	1974	781	Mendelian_Nancy_Cox	GOZGIT_ESR1_TARGETS_DN
5.06585612969%	100	1974	663	Mendelian_Nancy_Cox	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
5.06585612969%	100	1974	466	Mendelian_Nancy_Cox	REACTOME_HEMOSTASIS
5.06523407521%	66	1303	1972	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PILON_KLF1_TARGETS_DN
5.06523407521%	66	1303	1781	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
5.0597976081%	110	2174	882	T2D_GENES_TANYA_LIPIDS	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
5.05709624796%	31	613	918	T2D_GENES_TANYA_BIOMARKER	JOHNSTONE_PARVB_TARGETS_3_DN
5.05709624796%	31	613	848	T2D_GENES_TANYA_BIOMARKER	NUYTTEN_NIPP1_TARGETS_DN
5.05709624796%	31	613	658	T2D_GENES_TANYA_BIOMARKER	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
5.05681818182%	178	3520	1305	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YOSHIMURA_MAPK8_TARGETS_UP
5.05494505495%	23	455	940	T2D_GENES_TANYA_BLOODPRESSURE	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
5.05494505495%	23	455	756	T2D_GENES_TANYA_BLOODPRESSURE	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
5.05494505495%	23	455	466	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_HEMOSTASIS
5.05494505495%	23	455	1278	T2D_GENES_TANYA_BLOODPRESSURE	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
5.05494505495%	23	455	1142	T2D_GENES_TANYA_BLOODPRESSURE	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
5.05494505495%	23	455	1080	T2D_GENES_TANYA_BLOODPRESSURE	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
5.04334121355%	64	1269	1022	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARSON_BOUND_BY_FOXP3_STIMULATED
5.01519756839%	99	1974	612	Mendelian_Nancy_Cox	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
5.01519756839%	99	1974	1022	Mendelian_Nancy_Cox	MARSON_BOUND_BY_FOXP3_STIMULATED
5.01379944802%	109	2174	1174	T2D_GENES_TANYA_LIPIDS	PEREZ_TP53_TARGETS
4.99243570348%	33	661	720	T2D_GENES_TANYA_GLYCEMIC	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
4.99243570348%	33	661	210	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRANSCRIPTION
4.99243570348%	33	661	1142	T2D_GENES_TANYA_GLYCEMIC	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
4.99243570348%	33	661	1137	T2D_GENES_TANYA_GLYCEMIC	BRUINS_UVC_RESPONSE_LATE
4.98614958449%	18	361	1382	T2D_GENES_TANYA_T2D_RSQ05_02CM	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
4.9815498155%	27	542	988	T2D_GENES_TANYA_ANTHROPOMETRIC	BENPORATH_NANOG_TARGETS
4.9815498155%	27	542	957	T2D_GENES_TANYA_ANTHROPOMETRIC	LOPEZ_MBD_TARGETS
4.9815498155%	27	542	783	T2D_GENES_TANYA_ANTHROPOMETRIC	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
4.9815498155%	27	542	747	T2D_GENES_TANYA_ANTHROPOMETRIC	PATIL_LIVER_CANCER
4.9815498155%	27	542	745	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_BMP2_TARGETS_UP
4.9815498155%	27	542	728	T2D_GENES_TANYA_ANTHROPOMETRIC	MARSON_BOUND_BY_E2F4_UNSTIMULATED
4.9815498155%	27	542	682	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
4.96780128795%	108	2174	1062	T2D_GENES_TANYA_LIPIDS	BENPORATH_EED_TARGETS
4.96453900709%	98	1974	756	Mendelian_Nancy_Cox	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
4.96453900709%	98	1974	593	Mendelian_Nancy_Cox	MARTINEZ_TP53_TARGETS_DN
4.96453900709%	98	1974	591	Mendelian_Nancy_Cox	MARTINEZ_RB1_AND_TP53_TARGETS_DN
4.96453900709%	63	1269	1781	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
4.96150556031%	58	1169	1022	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARSON_BOUND_BY_FOXP3_STIMULATED
4.93827160494%	4	81	95	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
4.93827160494%	4	81	911	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
4.93827160494%	4	81	91	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
4.93827160494%	4	81	86	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
4.93827160494%	4	81	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_SMALL_CELL_LUNG_CANCER
4.93827160494%	4	81	824	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
4.93827160494%	4	81	82	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ST_INTEGRIN_SIGNALING_PATHWAY
4.93827160494%	4	81	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WOO_LIVER_CANCER_RECURRENCE_DN
4.93827160494%	4	81	78	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SIGNALING_BY_SCF_KIT
4.93827160494%	4	81	770	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KRIEG_HYPOXIA_NOT_VIA_KDM3A
4.93827160494%	4	81	745	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_BMP2_TARGETS_UP
4.93827160494%	4	81	720	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
4.93827160494%	4	81	71	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_MELANOMA
4.93827160494%	4	81	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
4.93827160494%	4	81	663	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
4.93827160494%	4	81	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_GLIOMA
4.93827160494%	4	81	648	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SMID_BREAST_CANCER_BASAL_UP
4.93827160494%	4	81	648	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BENPORATH_CYCLING_GENES
4.93827160494%	4	81	637	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
4.93827160494%	4	81	612	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
4.93827160494%	4	81	60	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_LIVER_CANCER_CIPROFIBRATE_UP
4.93827160494%	4	81	593	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARTINEZ_TP53_TARGETS_DN
4.93827160494%	4	81	584	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
4.93827160494%	4	81	567	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PARENT_MTOR_SIGNALING_UP
4.93827160494%	4	81	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PI_3K_CASCADE
4.93827160494%	4	81	539	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LIAO_METASTASIS
4.93827160494%	4	81	536	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SENESE_HDAC3_TARGETS_DN
4.93827160494%	4	81	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_MTOR_SIGNALING_PATHWAY
4.93827160494%	4	81	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_ENDOMETRIAL_CANCER
4.93827160494%	4	81	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
4.93827160494%	4	81	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_PI3KCIPATHWAY
4.93827160494%	4	81	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_HES_HEYPATHWAY
4.93827160494%	4	81	459	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KIM_WT1_TARGETS_DN
4.93827160494%	4	81	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SIG_CHEMOTAXIS
4.93827160494%	4	81	447	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MOOTHA_MITOCHONDRIA
4.93827160494%	4	81	442	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
4.93827160494%	4	81	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
4.93827160494%	4	81	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_TCPTP_PATHWAY
4.93827160494%	4	81	429	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MOOTHA_HUMAN_MITODB_6_2002
4.93827160494%	4	81	428	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
4.93827160494%	4	81	425	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
4.93827160494%	4	81	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
4.93827160494%	4	81	409	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FOSTER_TOLERANT_MACROPHAGE_DN
4.93827160494%	4	81	408	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
4.93827160494%	4	81	395	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HAN_SATB1_TARGETS_UP
4.93827160494%	4	81	394	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BERENJENO_TRANSFORMED_BY_RHOA_DN
4.93827160494%	4	81	391	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
4.93827160494%	4	81	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
4.93827160494%	4	81	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PI3K_AKT_ACTIVATION
4.93827160494%	4	81	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_GAB1_SIGNALOSOME
4.93827160494%	4	81	368	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YAGI_AML_WITH_T_8_21_TRANSLOCATION
4.93827160494%	4	81	349	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
4.93827160494%	4	81	341	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
4.93827160494%	4	81	336	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	JOHNSTONE_PARVB_TARGETS_2_DN
4.93827160494%	4	81	330	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
4.93827160494%	4	81	325	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_CELL_CYCLE_MITOTIC
4.93827160494%	4	81	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_HDAC_PATHWAY
4.93827160494%	4	81	293	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HADDAD_B_LYMPHOCYTE_PROGENITOR
4.93827160494%	4	81	289	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WANG_MLL_TARGETS
4.93827160494%	4	81	272	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
4.93827160494%	4	81	266	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
4.93827160494%	4	81	262	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LU_AGING_BRAIN_UP
4.93827160494%	4	81	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_INSULIN_GLUCOSE_PATHWAY
4.93827160494%	4	81	253	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DANG_REGULATED_BY_MYC_DN
4.93827160494%	4	81	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_INSULIN_PATHWAY
4.93827160494%	4	81	217	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SIGNALLING_BY_NGF
4.93827160494%	4	81	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MANALO_HYPOXIA_UP
4.93827160494%	4	81	203	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GRUETZMANN_PANCREATIC_CANCER_DN
4.93827160494%	4	81	198	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PHOSPHOLIPID_METABOLISM
4.93827160494%	4	81	197	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
4.93827160494%	4	81	161	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
4.93827160494%	4	81	153	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DURAND_STROMA_MAX_DN
4.93827160494%	4	81	140	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	JOHNSTONE_PARVB_TARGETS_2_UP
4.93827160494%	4	81	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP
4.93827160494%	4	81	137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
4.93827160494%	4	81	129	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_PDGFRBPATHWAY
4.93827160494%	4	81	1278	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
4.93827160494%	4	81	127	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
4.93827160494%	4	81	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
4.93827160494%	4	81	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
4.93827160494%	4	81	122	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SIGNALING_BY_PDGF
4.93827160494%	4	81	1137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BRUINS_UVC_RESPONSE_LATE
4.93827160494%	4	81	112	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SIGNALING_BY_FGFR
4.93827160494%	4	81	109	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
4.93827160494%	4	81	1080	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
4.93827160494%	4	81	102	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_CXCR4_PATHWAY
4.93827160494%	4	81	1011	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
4.93827160494%	4	81	101	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SIGNALING_BY_ERBB2
4.93827160494%	4	81	100	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
4.93273542601%	22	446	756	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
4.93273542601%	22	446	1821	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DODD_NASOPHARYNGEAL_CARCINOMA_UP
4.92180312787%	107	2174	988	T2D_GENES_TANYA_LIPIDS	BENPORATH_NANOG_TARGETS
4.92180312787%	107	2174	1278	T2D_GENES_TANYA_LIPIDS	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
4.91715660075%	92	1871	811	T2D_GENES_TANYA_HEIGHT	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
4.9138804458%	97	1974	783	Mendelian_Nancy_Cox	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
4.9138804458%	97	1974	540	Mendelian_Nancy_Cox	ACEVEDO_LIVER_CANCER_DN
4.9138804458%	97	1974	244	Mendelian_Nancy_Cox	HSIAO_LIVER_SPECIFIC_GENES
4.9138804458%	97	1974	1024	Mendelian_Nancy_Cox	NUYTTEN_EZH2_TARGETS_DN
4.89396411093%	30	613	911	T2D_GENES_TANYA_BIOMARKER	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
4.89396411093%	30	613	898	T2D_GENES_TANYA_BIOMARKER	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
4.89396411093%	30	613	863	T2D_GENES_TANYA_BIOMARKER	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
4.89396411093%	30	613	612	T2D_GENES_TANYA_BIOMARKER	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
4.89396411093%	30	613	1011	T2D_GENES_TANYA_BIOMARKER	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
4.87804878049%	2	41	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_POTASSIUM_CHANNELS
4.87804878049%	2	41	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GUO_TARGETS_OF_IRS1_AND_IRS2
4.87804878049%	2	41	97	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
4.87804878049%	2	41	953	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
4.87804878049%	2	41	93	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
4.87804878049%	2	41	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KIM_MYCN_AMPLIFICATION_TARGETS_UP
4.87804878049%	2	41	91	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ELVIDGE_HIF1A_TARGETS_DN
4.87804878049%	2	41	9	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK
4.87804878049%	2	41	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
4.87804878049%	2	41	863	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
4.87804878049%	2	41	855	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
4.87804878049%	2	41	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SMID_BREAST_CANCER_LUMINAL_A_UP
4.87804878049%	2	41	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHANG_IMMORTALIZED_BY_HPV31_UP
4.87804878049%	2	41	830	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CUI_TCF21_TARGETS_2_DN
4.87804878049%	2	41	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
4.87804878049%	2	41	824	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
4.87804878049%	2	41	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HUANG_DASATINIB_RESISTANCE_UP
4.87804878049%	2	41	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
4.87804878049%	2	41	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CROMER_METASTASIS_DN
4.87804878049%	2	41	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
4.87804878049%	2	41	783	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
4.87804878049%	2	41	779	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PUJANA_CHEK2_PCC_NETWORK
4.87804878049%	2	41	77	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
4.87804878049%	2	41	769	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NUYTTEN_NIPP1_TARGETS_UP
4.87804878049%	2	41	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MAHAJAN_RESPONSE_TO_IL1A_DN
4.87804878049%	2	41	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_AVB3_INTEGRIN_PATHWAY
4.87804878049%	2	41	747	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PATIL_LIVER_CANCER
4.87804878049%	2	41	745	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LEE_BMP2_TARGETS_UP
4.87804878049%	2	41	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS
4.87804878049%	2	41	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
4.87804878049%	2	41	722	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
4.87804878049%	2	41	721	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WONG_ADULT_TISSUE_STEM_MODULE
4.87804878049%	2	41	72	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
4.87804878049%	2	41	70	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_CDC42_PATHWAY
4.87804878049%	2	41	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_P75NTRPATHWAY
4.87804878049%	2	41	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_PPAR_SIGNALING_PATHWAY
4.87804878049%	2	41	68	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DELPUECH_FOXO3_TARGETS_UP
4.87804878049%	2	41	668	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
4.87804878049%	2	41	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_HIF1_TFPATHWAY
4.87804878049%	2	41	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_IL4_2PATHWAY
4.87804878049%	2	41	648	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SMID_BREAST_CANCER_BASAL_UP
4.87804878049%	2	41	64	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BYSTROEM_CORRELATED_WITH_IL5_DN
4.87804878049%	2	41	634	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
4.87804878049%	2	41	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_TRKRPATHWAY
4.87804878049%	2	41	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_FCER1PATHWAY
4.87804878049%	2	41	60	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LEE_LIVER_CANCER_CIPROFIBRATE_UP
4.87804878049%	2	41	593	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARTINEZ_TP53_TARGETS_DN
4.87804878049%	2	41	591	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARTINEZ_RB1_AND_TP53_TARGETS_DN
4.87804878049%	2	41	59	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_FAK_PATHWAY
4.87804878049%	2	41	584	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
4.87804878049%	2	41	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_SHP2_PATHWAY
4.87804878049%	2	41	555	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
4.87804878049%	2	41	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_IL2_1PATHWAY
4.87804878049%	2	41	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_FGF_PATHWAY
4.87804878049%	2	41	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER
4.87804878049%	2	41	546	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
4.87804878049%	2	41	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_INOSITOL_PHOSPHATE_METABOLISM
4.87804878049%	2	41	536	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
4.87804878049%	2	41	528	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
4.87804878049%	2	41	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PRAMOONJAGO_SOX4_TARGETS_DN
4.87804878049%	2	41	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
4.87804878049%	2	41	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
4.87804878049%	2	41	508	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ENK_UV_RESPONSE_EPIDERMIS_DN
4.87804878049%	2	41	505	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
4.87804878049%	2	41	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_ANGIOPOIETINRECEPTOR_PATHWAY
4.87804878049%	2	41	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NADERI_BREAST_CANCER_PROGNOSIS_UP
4.87804878049%	2	41	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
4.87804878049%	2	41	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_TCR_PATHWAY
4.87804878049%	2	41	479	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
4.87804878049%	2	41	476	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SMID_BREAST_CANCER_NORMAL_LIKE_UP
4.87804878049%	2	41	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_IL6_7PATHWAY
4.87804878049%	2	41	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	IRITANI_MAD1_TARGETS_DN
4.87804878049%	2	41	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT
4.87804878049%	2	41	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
4.87804878049%	2	41	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_A6B1_A6B4_INTEGRIN_PATHWAY
4.87804878049%	2	41	459	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KIM_WT1_TARGETS_DN
4.87804878049%	2	41	457	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
4.87804878049%	2	41	456	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ODONNELL_TFRC_TARGETS_UP
4.87804878049%	2	41	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
4.87804878049%	2	41	448	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
4.87804878049%	2	41	442	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
4.87804878049%	2	41	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SIGNALING_BY_FGFR_MUTANTS
4.87804878049%	2	41	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_ERBB2ERBB3PATHWAY
4.87804878049%	2	41	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MA_MYELOID_DIFFERENTIATION_DN
4.87804878049%	2	41	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KERLEY_RESPONSE_TO_CISPLATIN_UP
4.87804878049%	2	41	439	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MITSIADES_RESPONSE_TO_APLIDIN_UP
4.87804878049%	2	41	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RIZ_ERYTHROID_DIFFERENTIATION_12HR
4.87804878049%	2	41	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_IL_3_5_AND_GM_CSF_SIGNALING
4.87804878049%	2	41	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_THROMBIN_PAR1_PATHWAY
4.87804878049%	2	41	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_CXCR3PATHWAY
4.87804878049%	2	41	428	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
4.87804878049%	2	41	428	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CUI_TCF21_TARGETS_2_UP
4.87804878049%	2	41	425	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
4.87804878049%	2	41	423	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PUJANA_BRCA2_PCC_NETWORK
4.87804878049%	2	41	422	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YAGI_AML_WITH_INV_16_TRANSLOCATION
4.87804878049%	2	41	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LUI_THYROID_CANCER_CLUSTER_2
4.87804878049%	2	41	414	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MOHANKUMAR_TLX1_TARGETS_UP
4.87804878049%	2	41	412	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
4.87804878049%	2	41	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_IL_2_SIGNALING
4.87804878049%	2	41	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_ER_NONGENOMIC_PATHWAY
4.87804878049%	2	41	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_ERBB1_INTERNALIZATION_PATHWAY
4.87804878049%	2	41	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_FCER1_PATHWAY
4.87804878049%	2	41	404	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	OSMAN_BLADDER_CANCER_UP
4.87804878049%	2	41	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RIZ_ERYTHROID_DIFFERENTIATION_6HR
4.87804878049%	2	41	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_IFNGPATHWAY
4.87804878049%	2	41	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_EPHBFWDPATHWAY
4.87804878049%	2	41	393	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
4.87804878049%	2	41	392	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LINDGREN_BLADDER_CANCER_CLUSTER_2B
4.87804878049%	2	41	390	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HATADA_METHYLATED_IN_LUNG_CANCER_UP
4.87804878049%	2	41	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_RET_PATHWAY
4.87804878049%	2	41	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_ECADHERIN_NASCENTAJ_PATHWAY
4.87804878049%	2	41	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BURTON_ADIPOGENESIS_PEAK_AT_8HR
4.87804878049%	2	41	384	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BASAKI_YBX1_TARGETS_DN
4.87804878049%	2	41	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_GLUCOSE_TRANSPORT
4.87804878049%	2	41	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_FASPATHWAY
4.87804878049%	2	41	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_ERBB4_PATHWAY
4.87804878049%	2	41	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KAAB_FAILED_HEART_ATRIUM_UP
4.87804878049%	2	41	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_IL2RB_PATHWAY
4.87804878049%	2	41	371	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WANG_SMARCE1_TARGETS_DN
4.87804878049%	2	41	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_IL23PATHWAY
4.87804878049%	2	41	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_GMCSF_PATHWAY
4.87804878049%	2	41	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_PAR1_PATHWAY
4.87804878049%	2	41	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_ALK_PATHWAY
4.87804878049%	2	41	368	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YAGI_AML_WITH_T_8_21_TRANSLOCATION
4.87804878049%	2	41	367	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	VECCHI_GASTRIC_CANCER_EARLY_DN
4.87804878049%	2	41	366	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YOSHIMURA_MAPK8_TARGETS_DN
4.87804878049%	2	41	366	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SANSOM_APC_TARGETS_DN
4.87804878049%	2	41	36	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ST_ADRENERGIC
4.87804878049%	2	41	36	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_PI3KPLCTRKPATHWAY
4.87804878049%	2	41	358	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GRUETZMANN_PANCREATIC_CANCER_UP
4.87804878049%	2	41	355	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PEREZ_TP63_TARGETS
4.87804878049%	2	41	354	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
4.87804878049%	2	41	352	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
4.87804878049%	2	41	351	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YAGI_AML_WITH_11Q23_REARRANGED
4.87804878049%	2	41	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WANG_METHYLATED_IN_BREAST_CANCER
4.87804878049%	2	41	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
4.87804878049%	2	41	349	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
4.87804878049%	2	41	344	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
4.87804878049%	2	41	342	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BLUM_RESPONSE_TO_SALIRASIB_DN
4.87804878049%	2	41	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SIG_CD40PATHWAYMAP
4.87804878049%	2	41	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_IL2_PI3KPATHWAY
4.87804878049%	2	41	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_IL1PATHWAY
4.87804878049%	2	41	337	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PHONG_TNF_RESPONSE_NOT_VIA_P38
4.87804878049%	2	41	330	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
4.87804878049%	2	41	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SCHRAETS_MLL_TARGETS_DN
4.87804878049%	2	41	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_NCADHERINPATHWAY
4.87804878049%	2	41	325	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_CELL_CYCLE_MITOTIC
4.87804878049%	2	41	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_NETRIN_PATHWAY
4.87804878049%	2	41	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_PDGF_PATHWAY
4.87804878049%	2	41	315	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PASINI_SUZ12_TARGETS_DN
4.87804878049%	2	41	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_INWARDLY_RECTIFYING_K_CHANNELS
4.87804878049%	2	41	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_NEPHRIN_NEPH1_PATHWAY
4.87804878049%	2	41	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_AVB3_OPN_PATHWAY
4.87804878049%	2	41	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_AR_NONGENOMIC_PATHWAY
4.87804878049%	2	41	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_EGF_PATHWAY
4.87804878049%	2	41	307	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LI_INDUCED_T_TO_NATURAL_KILLER_UP
4.87804878049%	2	41	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
4.87804878049%	2	41	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_BASIGIN_INTERACTIONS
4.87804878049%	2	41	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_NECTIN_PATHWAY
4.87804878049%	2	41	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_IL2_STAT5PATHWAY
4.87804878049%	2	41	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_IGF1_PATHWAY
4.87804878049%	2	41	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_EPHRINBREVPATHWAY
4.87804878049%	2	41	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KYNG_NORMAL_AGING_DN
4.87804878049%	2	41	299	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MUELLER_PLURINET
4.87804878049%	2	41	294	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WEST_ADRENOCORTICAL_TUMOR_UP
4.87804878049%	2	41	293	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ENK_UV_RESPONSE_EPIDERMIS_UP
4.87804878049%	2	41	292	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KOYAMA_SEMA3B_TARGETS_UP
4.87804878049%	2	41	291	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SABATES_COLORECTAL_ADENOMA_DN
4.87804878049%	2	41	290	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BENPORATH_OCT4_TARGETS
4.87804878049%	2	41	290	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BASAKI_YBX1_TARGETS_UP
4.87804878049%	2	41	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
4.87804878049%	2	41	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_REELINPATHWAY
4.87804878049%	2	41	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_VEGF_PATHWAY
4.87804878049%	2	41	289	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GABRIELY_MIR21_TARGETS
4.87804878049%	2	41	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_TRAIL_PATHWAY
4.87804878049%	2	41	279	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_NEURONAL_SYSTEM
4.87804878049%	2	41	279	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FORTSCHEGGER_PHF8_TARGETS_UP
4.87804878049%	2	41	270	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
4.87804878049%	2	41	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_IL_RECEPTOR_SHC_SIGNALING
4.87804878049%	2	41	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_IL3_PATHWAY
4.87804878049%	2	41	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_GSK3_PATHWAY
4.87804878049%	2	41	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_EDG1_PATHWAY
4.87804878049%	2	41	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_CREB_PATHWAY
4.87804878049%	2	41	261	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
4.87804878049%	2	41	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ST_INTERLEUKIN_4_PATHWAY
4.87804878049%	2	41	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN
4.87804878049%	2	41	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_RACCYCD_PATHWAY
4.87804878049%	2	41	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_BAD_PATHWAY
4.87804878049%	2	41	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_LYMPHANGIOGENESIS_PATHWAY
4.87804878049%	2	41	247	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_METABOLISM_OF_CARBOHYDRATES
4.87804878049%	2	41	246	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	VERHAAK_AML_WITH_NPM1_MUTATED_DN
4.87804878049%	2	41	244	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PLASARI_TGFB1_TARGETS_10HR_DN
4.87804878049%	2	41	244	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HSIAO_LIVER_SPECIFIC_GENES
4.87804878049%	2	41	242	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MULLIGHAN_MLL_SIGNATURE_1_DN
4.87804878049%	2	41	242	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHYLA_CBFA2T3_TARGETS_DN
4.87804878049%	2	41	240	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	UDAYAKUMAR_MED1_TARGETS_DN
4.87804878049%	2	41	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_TPO_PATHWAY
4.87804878049%	2	41	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_ECM_PATHWAY
4.87804878049%	2	41	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_CXCR4_PATHWAY
4.87804878049%	2	41	239	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
4.87804878049%	2	41	230	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KAUFFMANN_DNA_REPAIR_GENES
4.87804878049%	2	41	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_INSULIN_RECEPTOR_RECYCLING
4.87804878049%	2	41	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_RAS_PATHWAY
4.87804878049%	2	41	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_RAC1_PATHWAY
4.87804878049%	2	41	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_IGF1R_PATHWAY
4.87804878049%	2	41	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_GLEEVEC_PATHWAY
4.87804878049%	2	41	222	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
4.87804878049%	2	41	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_HEDGEHOG_2PATHWAY
4.87804878049%	2	41	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_HER2_PATHWAY
4.87804878049%	2	41	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_GCR_PATHWAY
4.87804878049%	2	41	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_AKT_PATHWAY
4.87804878049%	2	41	211	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
4.87804878049%	2	41	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
4.87804878049%	2	41	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_TFF_PATHWAY
4.87804878049%	2	41	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_IGF1_PATHWAY
4.87804878049%	2	41	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_CTLA4_PATHWAY
4.87804878049%	2	41	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	VERHAAK_GLIOBLASTOMA_CLASSICAL
4.87804878049%	2	41	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MANALO_HYPOXIA_UP
4.87804878049%	2	41	206	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
4.87804878049%	2	41	205	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SHEPARD_BMYB_MORPHOLINO_UP
4.87804878049%	2	41	205	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
4.87804878049%	2	41	204	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
4.87804878049%	2	41	203	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GRUETZMANN_PANCREATIC_CANCER_DN
4.87804878049%	2	41	200	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LEE_DIFFERENTIATING_T_LYMPHOCYTE
4.87804878049%	2	41	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_NEPHRIN_INTERACTIONS
4.87804878049%	2	41	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_NKCELLS_PATHWAY
4.87804878049%	2	41	196	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
4.87804878049%	2	41	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS
4.87804878049%	2	41	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_EPHA2_FWDPATHWAY
4.87804878049%	2	41	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHEN_PDGF_TARGETS
4.87804878049%	2	41	185	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
4.87804878049%	2	41	185	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LEE_LIVER_CANCER_SURVIVAL_UP
4.87804878049%	2	41	184	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
4.87804878049%	2	41	184	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
4.87804878049%	2	41	1839	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
4.87804878049%	2	41	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR
4.87804878049%	2	41	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_REGULATION_OF_SIGNALING_BY_CBL
4.87804878049%	2	41	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_NGF_PATHWAY
4.87804878049%	2	41	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_ERK5_PATHWAY
4.87804878049%	2	41	178	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BROWNE_HCMV_INFECTION_18HR_DN
4.87804878049%	2	41	176	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
4.87804878049%	2	41	175	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YAMAZAKI_TCEB3_TARGETS_UP
4.87804878049%	2	41	175	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FIRESTEIN_PROLIFERATION
4.87804878049%	2	41	171	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ELVIDGE_HYPOXIA_UP
4.87804878049%	2	41	171	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
4.87804878049%	2	41	170	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
4.87804878049%	2	41	170	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
4.87804878049%	2	41	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SA_TRKA_RECEPTOR
4.87804878049%	2	41	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_TIE2_SIGNALING
4.87804878049%	2	41	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SHC_RELATED_EVENTS
4.87804878049%	2	41	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_NFKAPPABATYPICALPATHWAY
4.87804878049%	2	41	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_IL7_PATHWAY
4.87804878049%	2	41	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_HCMV_PATHWAY
4.87804878049%	2	41	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_ARF_PATHWAY
4.87804878049%	2	41	169	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ONDER_CDH1_TARGETS_1_DN
4.87804878049%	2	41	169	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
4.87804878049%	2	41	168	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
4.87804878049%	2	41	160	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BROWNE_HCMV_INFECTION_6HR_DN
4.87804878049%	2	41	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_CDC42RAC_PATHWAY
4.87804878049%	2	41	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_BCELLSURVIVAL_PATHWAY
4.87804878049%	2	41	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_ACH_PATHWAY
4.87804878049%	2	41	154	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
4.87804878049%	2	41	152	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
4.87804878049%	2	41	150	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BROWNE_HCMV_INFECTION_30MIN_DN
4.87804878049%	2	41	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_LONGEVITY_PATHWAY
4.87804878049%	2	41	148	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BROWNE_HCMV_INFECTION_24HR_DN
4.87804878049%	2	41	147	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WHITFIELD_CELL_CYCLE_G1_S
4.87804878049%	2	41	145	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
4.87804878049%	2	41	141	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
4.87804878049%	2	41	140	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	JOHNSTONE_PARVB_TARGETS_2_UP
4.87804878049%	2	41	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR
4.87804878049%	2	41	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHANG_ADIPOGENESIS_BY_BMP7
4.87804878049%	2	41	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SIGNAL_ATTENUATION
4.87804878049%	2	41	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_IL5_PATHWAY
4.87804878049%	2	41	137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_P53DOWNSTREAMPATHWAY
4.87804878049%	2	41	137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
4.87804878049%	2	41	135	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SERVITJA_LIVER_HNF1A_TARGETS_UP
4.87804878049%	2	41	134	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_TIGHT_JUNCTION
4.87804878049%	2	41	132	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
4.87804878049%	2	41	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS
4.87804878049%	2	41	129	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YAGI_AML_SURVIVAL
4.87804878049%	2	41	128	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	POTTI_TOPOTECAN_SENSITIVITY
4.87804878049%	2	41	128	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
4.87804878049%	2	41	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BURTON_ADIPOGENESIS_5
4.87804878049%	2	41	1229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
4.87804878049%	2	41	122	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_CHROMOSOME_MAINTENANCE
4.87804878049%	2	41	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_CELL_CELL_COMMUNICATION
4.87804878049%	2	41	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
4.87804878049%	2	41	12	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_TRKA_PATHWAY
4.87804878049%	2	41	118	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
4.87804878049%	2	41	1174	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PEREZ_TP53_TARGETS
4.87804878049%	2	41	117	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
4.87804878049%	2	41	115	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
4.87804878049%	2	41	114	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ROPERO_HDAC2_TARGETS
4.87804878049%	2	41	1137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BRUINS_UVC_RESPONSE_LATE
4.87804878049%	2	41	109	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SERVITJA_ISLET_HNF1A_TARGETS_DN
4.87804878049%	2	41	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LABBE_TGFB1_TARGETS_DN
4.87804878049%	2	41	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
4.87804878049%	2	41	107	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SIGNALING_BY_ILS
4.87804878049%	2	41	105	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_ERBB1_DOWNSTREAM_PATHWAY
4.87804878049%	2	41	104	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
4.87804878049%	2	41	103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
4.87804878049%	2	41	103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
4.87596236099%	57	1169	1821	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DODD_NASOPHARYNGEAL_CARCINOMA_UP
4.87596236099%	57	1169	1142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
4.8632218845%	96	1974	830	Mendelian_Nancy_Cox	CUI_TCF21_TARGETS_2_DN
4.8632218845%	96	1974	811	Mendelian_Nancy_Cox	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
4.8632218845%	96	1974	266	Mendelian_Nancy_Cox	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
4.84114977307%	32	661	953	T2D_GENES_TANYA_GLYCEMIC	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
4.83870967742%	6	124	91	Diabetes_McGill_Cell_cycle_All_Gene	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
4.83870967742%	6	124	89	Diabetes_McGill_Cell_cycle_All_Gene	WNT_SIGNALING
4.83870967742%	6	124	88	Diabetes_McGill_Cell_cycle_All_Gene	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
4.83870967742%	6	124	830	Diabetes_McGill_Cell_cycle_All_Gene	CUI_TCF21_TARGETS_2_DN
4.83870967742%	6	124	800	Diabetes_McGill_Cell_cycle_All_Gene	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
4.83870967742%	6	124	78	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_SCF_KIT
4.83870967742%	6	124	75	Diabetes_McGill_Cell_cycle_All_Gene	MORI_MATURE_B_LYMPHOCYTE_DN
4.83870967742%	6	124	74	Diabetes_McGill_Cell_cycle_All_Gene	SHEPARD_BMYB_TARGETS
4.83870967742%	6	124	70	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_RENAL_CELL_CARCINOMA
4.83870967742%	6	124	682	Diabetes_McGill_Cell_cycle_All_Gene	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
4.83870967742%	6	124	682	Diabetes_McGill_Cell_cycle_All_Gene	FEVR_CTNNB1_TARGETS_UP
4.83870967742%	6	124	668	Diabetes_McGill_Cell_cycle_All_Gene	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
4.83870967742%	6	124	65	Diabetes_McGill_Cell_cycle_All_Gene	PID_ERA_GENOMIC_PATHWAY
4.83870967742%	6	124	58	Diabetes_McGill_Cell_cycle_All_Gene	SANSOM_WNT_PATHWAY_REQUIRE_MYC
4.83870967742%	6	124	543	Diabetes_McGill_Cell_cycle_All_Gene	MARTINEZ_RB1_TARGETS_DN
4.83870967742%	6	124	514	Diabetes_McGill_Cell_cycle_All_Gene	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
4.83870967742%	6	124	493	Diabetes_McGill_Cell_cycle_All_Gene	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
4.83870967742%	6	124	491	Diabetes_McGill_Cell_cycle_All_Gene	ZHENG_BOUND_BY_FOXP3
4.83870967742%	6	124	48	Diabetes_McGill_Cell_cycle_All_Gene	PID_HES_HEYPATHWAY
4.83870967742%	6	124	47	Diabetes_McGill_Cell_cycle_All_Gene	PID_DELTANP63PATHWAY
4.83870967742%	6	124	462	Diabetes_McGill_Cell_cycle_All_Gene	DELACROIX_RAR_BOUND_ES
4.83870967742%	6	124	42	Diabetes_McGill_Cell_cycle_All_Gene	ONO_FOXP3_TARGETS_DN
4.83870967742%	6	124	42	Diabetes_McGill_Cell_cycle_All_Gene	MODY_HIPPOCAMPUS_PRENATAL
4.83870967742%	6	124	42	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_CHREBP2_PATHWAY
4.83870967742%	6	124	419	Diabetes_McGill_Cell_cycle_All_Gene	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
4.83870967742%	6	124	41	Diabetes_McGill_Cell_cycle_All_Gene	LI_LUNG_CANCER
4.83870967742%	6	124	404	Diabetes_McGill_Cell_cycle_All_Gene	OSMAN_BLADDER_CANCER_UP
4.83870967742%	6	124	40	Diabetes_McGill_Cell_cycle_All_Gene	BURTON_ADIPOGENESIS_PEAK_AT_16HR
4.83870967742%	6	124	395	Diabetes_McGill_Cell_cycle_All_Gene	HAN_SATB1_TARGETS_UP
4.83870967742%	6	124	389	Diabetes_McGill_Cell_cycle_All_Gene	HSIAO_HOUSEKEEPING_GENES
4.83870967742%	6	124	374	Diabetes_McGill_Cell_cycle_All_Gene	WANG_TUMOR_INVASIVENESS_UP
4.83870967742%	6	124	351	Diabetes_McGill_Cell_cycle_All_Gene	YAGI_AML_WITH_11Q23_REARRANGED
4.83870967742%	6	124	35	Diabetes_McGill_Cell_cycle_All_Gene	HU_GENOTOXIC_DAMAGE_4HR
4.83870967742%	6	124	341	Diabetes_McGill_Cell_cycle_All_Gene	MULLIGHAN_NPM1_SIGNATURE_3_UP
4.83870967742%	6	124	338	Diabetes_McGill_Cell_cycle_All_Gene	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
4.83870967742%	6	124	315	Diabetes_McGill_Cell_cycle_All_Gene	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
4.83870967742%	6	124	315	Diabetes_McGill_Cell_cycle_All_Gene	PASINI_SUZ12_TARGETS_DN
4.83870967742%	6	124	31	Diabetes_McGill_Cell_cycle_All_Gene	PID_AURORA_A_PATHWAY
4.83870967742%	6	124	30	Diabetes_McGill_Cell_cycle_All_Gene	PID_RETINOIC_ACID_PATHWAY
4.83870967742%	6	124	298	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_14HR_DN
4.83870967742%	6	124	281	Diabetes_McGill_Cell_cycle_All_Gene	BHAT_ESR1_TARGETS_VIA_AKT1_UP
4.83870967742%	6	124	270	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
4.83870967742%	6	124	26	Diabetes_McGill_Cell_cycle_All_Gene	DEN_INTERACT_WITH_LCA5
4.83870967742%	6	124	26	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_WNT_PATHWAY
4.83870967742%	6	124	244	Diabetes_McGill_Cell_cycle_All_Gene	DAZARD_RESPONSE_TO_UV_NHEK_UP
4.83870967742%	6	124	240	Diabetes_McGill_Cell_cycle_All_Gene	VANTVEER_BREAST_CANCER_ESR1_DN
4.83870967742%	6	124	23	Diabetes_McGill_Cell_cycle_All_Gene	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
4.83870967742%	6	124	23	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_P53HYPOXIA_PATHWAY
4.83870967742%	6	124	225	Diabetes_McGill_Cell_cycle_All_Gene	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
4.83870967742%	6	124	222	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_1HR_DN
4.83870967742%	6	124	221	Diabetes_McGill_Cell_cycle_All_Gene	CHANDRAN_METASTASIS_UP
4.83870967742%	6	124	217	Diabetes_McGill_Cell_cycle_All_Gene	SANSOM_APC_MYC_TARGETS
4.83870967742%	6	124	214	Diabetes_McGill_Cell_cycle_All_Gene	AFFAR_YY1_TARGETS_UP
4.83870967742%	6	124	210	Diabetes_McGill_Cell_cycle_All_Gene	SANSOM_APC_TARGETS_REQUIRE_MYC
4.83870967742%	6	124	206	Diabetes_McGill_Cell_cycle_All_Gene	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
4.83870967742%	6	124	202	Diabetes_McGill_Cell_cycle_All_Gene	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
4.83870967742%	6	124	19	Diabetes_McGill_Cell_cycle_All_Gene	LE_NEURONAL_DIFFERENTIATION_DN
4.83870967742%	6	124	183	Diabetes_McGill_Cell_cycle_All_Gene	OKUMURA_INFLAMMATORY_RESPONSE_LPS
4.83870967742%	6	124	176	Diabetes_McGill_Cell_cycle_All_Gene	NAGASHIMA_NRG1_SIGNALING_UP
4.83870967742%	6	124	176	Diabetes_McGill_Cell_cycle_All_Gene	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
4.83870967742%	6	124	160	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_6HR_DN
4.83870967742%	6	124	16	Diabetes_McGill_Cell_cycle_All_Gene	HE_PTEN_TARGETS_UP
4.83870967742%	6	124	156	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_14HR_UP
4.83870967742%	6	124	155	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_JAK_STAT_SIGNALING_PATHWAY
4.83870967742%	6	124	145	Diabetes_McGill_Cell_cycle_All_Gene	SMITH_TERT_TARGETS_UP
4.83870967742%	6	124	141	Diabetes_McGill_Cell_cycle_All_Gene	WELCSH_BRCA1_TARGETS_DN
4.83870967742%	6	124	14	Diabetes_McGill_Cell_cycle_All_Gene	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
4.83870967742%	6	124	123	Diabetes_McGill_Cell_cycle_All_Gene	DAZARD_RESPONSE_TO_UV_SCC_UP
4.83870967742%	6	124	107	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_ILS
4.83870967742%	6	124	103	Diabetes_McGill_Cell_cycle_All_Gene	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN
4.83516483516%	22	455	957	T2D_GENES_TANYA_BLOODPRESSURE	LOPEZ_MBD_TARGETS
4.83516483516%	22	455	841	T2D_GENES_TANYA_BLOODPRESSURE	MARTENS_TRETINOIN_RESPONSE_DN
4.83516483516%	22	455	718	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_ES_ICP_WITH_H3K4ME3
4.83516483516%	22	455	1011	T2D_GENES_TANYA_BLOODPRESSURE	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
4.82980680773%	105	2174	863	T2D_GENES_TANYA_LIPIDS	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
4.82980680773%	105	2174	800	T2D_GENES_TANYA_LIPIDS	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
4.82980680773%	105	2174	1375	T2D_GENES_TANYA_LIPIDS	DODD_NASOPHARYNGEAL_CARCINOMA_DN
4.79704797048%	26	542	973	T2D_GENES_TANYA_ANTHROPOMETRIC	ACEVEDO_LIVER_CANCER_UP
4.79704797048%	26	542	652	T2D_GENES_TANYA_ANTHROPOMETRIC	BENPORATH_PRC2_TARGETS
4.79704797048%	26	542	510	T2D_GENES_TANYA_ANTHROPOMETRIC	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
4.79704797048%	26	542	1229	T2D_GENES_TANYA_ANTHROPOMETRIC	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
4.79704797048%	26	542	1037	T2D_GENES_TANYA_ANTHROPOMETRIC	NUYTTEN_EZH2_TARGETS_UP
4.78380864765%	104	2174	1118	T2D_GENES_TANYA_LIPIDS	BENPORATH_ES_WITH_H3K27ME3
4.78380864765%	104	2174	1069	T2D_GENES_TANYA_LIPIDS	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
4.77272727273%	168	3520	1229	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
4.7619047619%	94	1974	535	Mendelian_Nancy_Cox	STEIN_ESRRA_TARGETS
4.7619047619%	94	1974	504	Mendelian_Nancy_Cox	PILON_KLF1_TARGETS_UP
4.7619047619%	2	42	99	Diabetes_McGill_RAS	LIM_MAMMARY_LUMINAL_MATURE_DN
4.7619047619%	2	42	988	Diabetes_McGill_RAS	BENPORATH_NANOG_TARGETS
4.7619047619%	2	42	973	Diabetes_McGill_RAS	ACEVEDO_LIVER_CANCER_UP
4.7619047619%	2	42	953	Diabetes_McGill_RAS	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
4.7619047619%	2	42	93	Diabetes_McGill_RAS	REACTOME_REGULATION_OF_INSULIN_SECRETION
4.7619047619%	2	42	92	Diabetes_McGill_RAS	BURTON_ADIPOGENESIS_9
4.7619047619%	2	42	90	Diabetes_McGill_RAS	HILLION_HMGA1_TARGETS
4.7619047619%	2	42	898	Diabetes_McGill_RAS	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
4.7619047619%	2	42	882	Diabetes_McGill_RAS	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
4.7619047619%	2	42	88	Diabetes_McGill_RAS	UEDA_CENTRAL_CLOCK
4.7619047619%	2	42	863	Diabetes_McGill_RAS	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
4.7619047619%	2	42	848	Diabetes_McGill_RAS	NUYTTEN_NIPP1_TARGETS_DN
4.7619047619%	2	42	824	Diabetes_McGill_RAS	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
4.7619047619%	2	42	82	Diabetes_McGill_RAS	ST_INTEGRIN_SIGNALING_PATHWAY
4.7619047619%	2	42	805	Diabetes_McGill_RAS	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
4.7619047619%	2	42	795	Diabetes_McGill_RAS	WEI_MYCN_TARGETS_WITH_E_BOX
4.7619047619%	2	42	79	Diabetes_McGill_RAS	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
4.7619047619%	2	42	79	Diabetes_McGill_RAS	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
4.7619047619%	2	42	783	Diabetes_McGill_RAS	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
4.7619047619%	2	42	770	Diabetes_McGill_RAS	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
4.7619047619%	2	42	76	Diabetes_McGill_RAS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
4.7619047619%	2	42	747	Diabetes_McGill_RAS	PATIL_LIVER_CANCER
4.7619047619%	2	42	734	Diabetes_McGill_RAS	BENPORATH_SOX2_TARGETS
4.7619047619%	2	42	722	Diabetes_McGill_RAS	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
4.7619047619%	2	42	718	Diabetes_McGill_RAS	MIKKELSEN_ES_ICP_WITH_H3K4ME3
4.7619047619%	2	42	712	Diabetes_McGill_RAS	SCHLOSSER_SERUM_RESPONSE_DN
4.7619047619%	2	42	682	Diabetes_McGill_RAS	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
4.7619047619%	2	42	681	Diabetes_McGill_RAS	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
4.7619047619%	2	42	652	Diabetes_McGill_RAS	BENPORATH_PRC2_TARGETS
4.7619047619%	2	42	648	Diabetes_McGill_RAS	SMID_BREAST_CANCER_BASAL_UP
4.7619047619%	2	42	648	Diabetes_McGill_RAS	BENPORATH_CYCLING_GENES
4.7619047619%	2	42	634	Diabetes_McGill_RAS	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
4.7619047619%	2	42	6	Diabetes_McGill_RAS	DING_LUNG_CANCER_MUTATED_RECURRENTLY
4.7619047619%	2	42	584	Diabetes_McGill_RAS	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
4.7619047619%	2	42	555	Diabetes_McGill_RAS	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
4.7619047619%	2	42	544	Diabetes_McGill_RAS	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
4.7619047619%	2	42	539	Diabetes_McGill_RAS	LIAO_METASTASIS
4.7619047619%	2	42	532	Diabetes_McGill_RAS	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
4.7619047619%	2	42	530	Diabetes_McGill_RAS	ENK_UV_RESPONSE_KERATINOCYTE_UP
4.7619047619%	2	42	517	Diabetes_McGill_RAS	RAO_BOUND_BY_SALL4_ISOFORM_B
4.7619047619%	2	42	51	Diabetes_McGill_RAS	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
4.7619047619%	2	42	491	Diabetes_McGill_RAS	ZHENG_BOUND_BY_FOXP3
4.7619047619%	2	42	491	Diabetes_McGill_RAS	MEISSNER_NPC_HCP_WITH_H3K4ME2
4.7619047619%	2	42	49	Diabetes_McGill_RAS	PID_FOXOPATHWAY
4.7619047619%	2	42	487	Diabetes_McGill_RAS	RODWELL_AGING_KIDNEY_UP
4.7619047619%	2	42	485	Diabetes_McGill_RAS	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
4.7619047619%	2	42	48	Diabetes_McGill_RAS	ENGELMANN_CANCER_PROGENITORS_UP
4.7619047619%	2	42	462	Diabetes_McGill_RAS	DELACROIX_RAR_BOUND_ES
4.7619047619%	2	42	461	Diabetes_McGill_RAS	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
4.7619047619%	2	42	46	Diabetes_McGill_RAS	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1
4.7619047619%	2	42	46	Diabetes_McGill_RAS	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON
4.7619047619%	2	42	457	Diabetes_McGill_RAS	SENESE_HDAC1_TARGETS_UP
4.7619047619%	2	42	456	Diabetes_McGill_RAS	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
4.7619047619%	2	42	456	Diabetes_McGill_RAS	ODONNELL_TFRC_TARGETS_UP
4.7619047619%	2	42	455	Diabetes_McGill_RAS	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
4.7619047619%	2	42	445	Diabetes_McGill_RAS	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
4.7619047619%	2	42	43	Diabetes_McGill_RAS	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1
4.7619047619%	2	42	419	Diabetes_McGill_RAS	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
4.7619047619%	2	42	41	Diabetes_McGill_RAS	PID_AMB2_NEUTROPHILS_PATHWAY
4.7619047619%	2	42	408	Diabetes_McGill_RAS	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
4.7619047619%	2	42	405	Diabetes_McGill_RAS	KUMAR_TARGETS_OF_MLL_AF9_FUSION
4.7619047619%	2	42	40	Diabetes_McGill_RAS	PID_IFNGPATHWAY
4.7619047619%	2	42	392	Diabetes_McGill_RAS	LINDGREN_BLADDER_CANCER_CLUSTER_2B
4.7619047619%	2	42	39	Diabetes_McGill_RAS	PID_RET_PATHWAY
4.7619047619%	2	42	39	Diabetes_McGill_RAS	PID_ECADHERIN_NASCENTAJ_PATHWAY
4.7619047619%	2	42	387	Diabetes_McGill_RAS	CHYLA_CBFA2T3_TARGETS_UP
4.7619047619%	2	42	38	Diabetes_McGill_RAS	BIOCARTA_INTEGRIN_PATHWAY
4.7619047619%	2	42	37	Diabetes_McGill_RAS	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS
4.7619047619%	2	42	366	Diabetes_McGill_RAS	SANSOM_APC_TARGETS_DN
4.7619047619%	2	42	364	Diabetes_McGill_RAS	YANG_BCL3_TARGETS_UP
4.7619047619%	2	42	36	Diabetes_McGill_RAS	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
4.7619047619%	2	42	358	Diabetes_McGill_RAS	GRUETZMANN_PANCREATIC_CANCER_UP
4.7619047619%	2	42	353	Diabetes_McGill_RAS	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
4.7619047619%	2	42	352	Diabetes_McGill_RAS	WANG_LMO4_TARGETS_DN
4.7619047619%	2	42	351	Diabetes_McGill_RAS	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
4.7619047619%	2	42	34	Diabetes_McGill_RAS	PID_EPOPATHWAY
4.7619047619%	2	42	33	Diabetes_McGill_RAS	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS
4.7619047619%	2	42	33	Diabetes_McGill_RAS	HEIDENBLAD_AMPLICON_12P11_12_UP
4.7619047619%	2	42	329	Diabetes_McGill_RAS	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
4.7619047619%	2	42	321	Diabetes_McGill_RAS	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
4.7619047619%	2	42	317	Diabetes_McGill_RAS	BRUINS_UVC_RESPONSE_EARLY_LATE
4.7619047619%	2	42	315	Diabetes_McGill_RAS	PASINI_SUZ12_TARGETS_DN
4.7619047619%	2	42	314	Diabetes_McGill_RAS	DOUGLAS_BMI1_TARGETS_DN
4.7619047619%	2	42	31	Diabetes_McGill_RAS	PID_P38ALPHABETAPATHWAY
4.7619047619%	2	42	307	Diabetes_McGill_RAS	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
4.7619047619%	2	42	30	Diabetes_McGill_RAS	PID_NECTIN_PATHWAY
4.7619047619%	2	42	298	Diabetes_McGill_RAS	BROWNE_HCMV_INFECTION_14HR_DN
4.7619047619%	2	42	293	Diabetes_McGill_RAS	ENK_UV_RESPONSE_EPIDERMIS_UP
4.7619047619%	2	42	290	Diabetes_McGill_RAS	BASAKI_YBX1_TARGETS_UP
4.7619047619%	2	42	279	Diabetes_McGill_RAS	REACTOME_NEURONAL_SYSTEM
4.7619047619%	2	42	276	Diabetes_McGill_RAS	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
4.7619047619%	2	42	275	Diabetes_McGill_RAS	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
4.7619047619%	2	42	275	Diabetes_McGill_RAS	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
4.7619047619%	2	42	27	Diabetes_McGill_RAS	REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING
4.7619047619%	2	42	27	Diabetes_McGill_RAS	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS
4.7619047619%	2	42	262	Diabetes_McGill_RAS	LU_AGING_BRAIN_UP
4.7619047619%	2	42	261	Diabetes_McGill_RAS	RICKMAN_METASTASIS_DN
4.7619047619%	2	42	261	Diabetes_McGill_RAS	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
4.7619047619%	2	42	26	Diabetes_McGill_RAS	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
4.7619047619%	2	42	255	Diabetes_McGill_RAS	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
4.7619047619%	2	42	254	Diabetes_McGill_RAS	IVANOVA_HEMATOPOIESIS_STEM_CELL
4.7619047619%	2	42	249	Diabetes_McGill_RAS	MITSIADES_RESPONSE_TO_APLIDIN_DN
4.7619047619%	2	42	240	Diabetes_McGill_RAS	UDAYAKUMAR_MED1_TARGETS_DN
4.7619047619%	2	42	240	Diabetes_McGill_RAS	BROWNE_HCMV_INFECTION_20HR_UP
4.7619047619%	2	42	239	Diabetes_McGill_RAS	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
4.7619047619%	2	42	237	Diabetes_McGill_RAS	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
4.7619047619%	2	42	232	Diabetes_McGill_RAS	DELYS_THYROID_CANCER_DN
4.7619047619%	2	42	23	Diabetes_McGill_RAS	BIOCARTA_RAS_PATHWAY
4.7619047619%	2	42	227	Diabetes_McGill_RAS	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
4.7619047619%	2	42	222	Diabetes_McGill_RAS	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
4.7619047619%	2	42	214	Diabetes_McGill_RAS	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
4.7619047619%	2	42	214	Diabetes_McGill_RAS	KIM_WT1_TARGETS_UP
4.7619047619%	2	42	211	Diabetes_McGill_RAS	FOSTER_KDM1A_TARGETS_DN
4.7619047619%	2	42	209	Diabetes_McGill_RAS	KIM_WT1_TARGETS_12HR_DN
4.7619047619%	2	42	209	Diabetes_McGill_RAS	GROSS_HYPOXIA_VIA_ELK3_UP
4.7619047619%	2	42	208	Diabetes_McGill_RAS	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
4.7619047619%	2	42	207	Diabetes_McGill_RAS	MANALO_HYPOXIA_UP
4.7619047619%	2	42	207	Diabetes_McGill_RAS	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
4.7619047619%	2	42	205	Diabetes_McGill_RAS	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
4.7619047619%	2	42	205	Diabetes_McGill_RAS	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
4.7619047619%	2	42	197	Diabetes_McGill_RAS	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
4.7619047619%	2	42	19	Diabetes_McGill_RAS	MA_PITUITARY_FETAL_VS_ADULT_DN
4.7619047619%	2	42	187	Diabetes_McGill_RAS	BAKKER_FOXO3_TARGETS_DN
4.7619047619%	2	42	186	Diabetes_McGill_RAS	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
4.7619047619%	2	42	180	Diabetes_McGill_RAS	BROWNE_HCMV_INFECTION_48HR_UP
4.7619047619%	2	42	170	Diabetes_McGill_RAS	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
4.7619047619%	2	42	17	Diabetes_McGill_RAS	REACTOME_RAP1_SIGNALLING
4.7619047619%	2	42	169	Diabetes_McGill_RAS	PENG_GLUCOSE_DEPRIVATION_DN
4.7619047619%	2	42	165	Diabetes_McGill_RAS	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
4.7619047619%	2	42	161	Diabetes_McGill_RAS	BIDUS_METASTASIS_DN
4.7619047619%	2	42	15	Diabetes_McGill_RAS	REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS
4.7619047619%	2	42	15	Diabetes_McGill_RAS	REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_
4.7619047619%	2	42	145	Diabetes_McGill_RAS	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
4.7619047619%	2	42	142	Diabetes_McGill_RAS	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
4.7619047619%	2	42	141	Diabetes_McGill_RAS	WELCSH_BRCA1_TARGETS_DN
4.7619047619%	2	42	139	Diabetes_McGill_RAS	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
4.7619047619%	2	42	1375	Diabetes_McGill_RAS	DODD_NASOPHARYNGEAL_CARCINOMA_DN
4.7619047619%	2	42	137	Diabetes_McGill_RAS	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
4.7619047619%	2	42	137	Diabetes_McGill_RAS	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
4.7619047619%	2	42	1278	Diabetes_McGill_RAS	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
4.7619047619%	2	42	127	Diabetes_McGill_RAS	INGRAM_SHH_TARGETS_UP
4.7619047619%	2	42	126	Diabetes_McGill_RAS	GERY_CEBP_TARGETS
4.7619047619%	2	42	123	Diabetes_McGill_RAS	DAZARD_RESPONSE_TO_UV_SCC_UP
4.7619047619%	2	42	120	Diabetes_McGill_RAS	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
4.7619047619%	2	42	1174	Diabetes_McGill_RAS	PEREZ_TP53_TARGETS
4.7619047619%	2	42	1118	Diabetes_McGill_RAS	BENPORATH_ES_WITH_H3K27ME3
4.7619047619%	2	42	1080	Diabetes_McGill_RAS	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
4.7619047619%	2	42	108	Diabetes_McGill_RAS	WESTON_VEGFA_TARGETS
4.7619047619%	2	42	1062	Diabetes_McGill_RAS	BENPORATH_EED_TARGETS
4.7619047619%	2	42	105	Diabetes_McGill_RAS	AMUNDSON_GENOTOXIC_SIGNATURE
4.7619047619%	2	42	1038	Diabetes_McGill_RAS	BENPORATH_SUZ12_TARGETS
4.7619047619%	2	42	102	Diabetes_McGill_RAS	PID_CXCR4_PATHWAY
4.75681453768%	89	1871	747	T2D_GENES_TANYA_HEIGHT	PATIL_LIVER_CANCER
4.74308300395%	12	253	84	Diabetes_McGill_CREBBP_coTF	KEGG_SMALL_CELL_LUNG_CANCER
4.74308300395%	12	253	70	Diabetes_McGill_CREBBP_coTF	KEGG_PANCREATIC_CANCER
4.74308300395%	12	253	68	Diabetes_McGill_CREBBP_coTF	PID_TELOMERASEPATHWAY
4.74308300395%	12	253	66	Diabetes_McGill_CREBBP_coTF	TENEDINI_MEGAKARYOCYTE_MARKERS
4.74308300395%	12	253	658	Diabetes_McGill_CREBBP_coTF	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
4.74308300395%	12	253	63	Diabetes_McGill_CREBBP_coTF	PID_MYC_REPRESSPATHWAY
4.74308300395%	12	253	59	Diabetes_McGill_CREBBP_coTF	PID_NOTCH_PATHWAY
4.74308300395%	12	253	540	Diabetes_McGill_CREBBP_coTF	ACEVEDO_LIVER_CANCER_DN
4.74308300395%	12	253	516	Diabetes_McGill_CREBBP_coTF	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
4.74308300395%	12	253	504	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_48HR_DN
4.74308300395%	12	253	49	Diabetes_McGill_CREBBP_coTF	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
4.74308300395%	12	253	463	Diabetes_McGill_CREBBP_coTF	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
4.74308300395%	12	253	44	Diabetes_McGill_CREBBP_coTF	PID_HNF3APATHWAY
4.74308300395%	12	253	431	Diabetes_McGill_CREBBP_coTF	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
4.74308300395%	12	253	431	Diabetes_McGill_CREBBP_coTF	GARY_CD5_TARGETS_DN
4.74308300395%	12	253	428	Diabetes_McGill_CREBBP_coTF	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
4.74308300395%	12	253	425	Diabetes_McGill_CREBBP_coTF	BOCHKIS_FOXA2_TARGETS
4.74308300395%	12	253	419	Diabetes_McGill_CREBBP_coTF	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
4.74308300395%	12	253	398	Diabetes_McGill_CREBBP_coTF	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
4.74308300395%	12	253	330	Diabetes_McGill_CREBBP_coTF	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
4.74308300395%	12	253	325	Diabetes_McGill_CREBBP_coTF	REACTOME_CELL_CYCLE_MITOTIC
4.74308300395%	12	253	318	Diabetes_McGill_CREBBP_coTF	LEI_MYB_TARGETS
4.74308300395%	12	253	309	Diabetes_McGill_CREBBP_coTF	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
4.74308300395%	12	253	305	Diabetes_McGill_CREBBP_coTF	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
4.74308300395%	12	253	30	Diabetes_McGill_CREBBP_coTF	PID_RETINOIC_ACID_PATHWAY
4.74308300395%	12	253	287	Diabetes_McGill_CREBBP_coTF	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
4.74308300395%	12	253	25	Diabetes_McGill_CREBBP_coTF	PID_HDAC_CLASSIII_PATHWAY
4.74308300395%	12	253	244	Diabetes_McGill_CREBBP_coTF	KAYO_AGING_MUSCLE_UP
4.74308300395%	12	253	228	Diabetes_McGill_CREBBP_coTF	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
4.74308300395%	12	253	217	Diabetes_McGill_CREBBP_coTF	SANSOM_APC_MYC_TARGETS
4.74308300395%	12	253	176	Diabetes_McGill_CREBBP_coTF	NAGASHIMA_NRG1_SIGNALING_UP
4.74308300395%	12	253	169	Diabetes_McGill_CREBBP_coTF	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
4.74308300395%	12	253	156	Diabetes_McGill_CREBBP_coTF	GROSS_HYPOXIA_VIA_ELK3_DN
4.73781048758%	103	2174	953	T2D_GENES_TANYA_LIPIDS	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
4.7308319739%	29	613	953	T2D_GENES_TANYA_BIOMARKER	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
4.71124620061%	93	1974	784	Mendelian_Nancy_Cox	FORTSCHEGGER_PHF8_TARGETS_DN
4.70914127424%	17	361	918	T2D_GENES_TANYA_T2D_RSQ05_02CM	JOHNSTONE_PARVB_TARGETS_3_DN
4.70914127424%	17	361	1442	T2D_GENES_TANYA_T2D_RSQ05_02CM	PUJANA_ATM_PCC_NETWORK
4.70914127424%	17	361	1118	T2D_GENES_TANYA_T2D_RSQ05_02CM	BENPORATH_ES_WITH_H3K27ME3
4.70852017937%	21	446	1382	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
4.70487596236%	55	1169	1382	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
4.69181232751%	102	2174	728	T2D_GENES_TANYA_LIPIDS	MARSON_BOUND_BY_E2F4_UNSTIMULATED
4.68986384266%	31	661	800	T2D_GENES_TANYA_GLYCEMIC	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
4.68986384266%	31	661	769	T2D_GENES_TANYA_GLYCEMIC	NUYTTEN_NIPP1_TARGETS_UP
4.68986384266%	31	661	590	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
4.68986384266%	31	661	122	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
4.66058763931%	92	1974	882	Mendelian_Nancy_Cox	LEE_BMP2_TARGETS_DN
4.66058763931%	92	1974	712	Mendelian_Nancy_Cox	SCHLOSSER_SERUM_RESPONSE_DN
4.66058763931%	92	1974	682	Mendelian_Nancy_Cox	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
4.66058763931%	92	1974	555	Mendelian_Nancy_Cox	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
4.66058763931%	92	1974	549	Mendelian_Nancy_Cox	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
4.66058763931%	92	1974	413	Mendelian_Nancy_Cox	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
4.64991982897%	87	1871	988	T2D_GENES_TANYA_HEIGHT	BENPORATH_NANOG_TARGETS
4.64991982897%	87	1871	882	T2D_GENES_TANYA_HEIGHT	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
4.64991982897%	87	1871	830	T2D_GENES_TANYA_HEIGHT	CUI_TCF21_TARGETS_2_DN
4.64933018125%	59	1269	1821	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DODD_NASOPHARYNGEAL_CARCINOMA_UP
4.61538461538%	21	455	953	T2D_GENES_TANYA_BLOODPRESSURE	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
4.61538461538%	21	455	933	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_IMMUNE_SYSTEM
4.61538461538%	21	455	898	T2D_GENES_TANYA_BLOODPRESSURE	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
4.61538461538%	21	455	848	T2D_GENES_TANYA_BLOODPRESSURE	NUYTTEN_NIPP1_TARGETS_DN
4.61538461538%	21	455	775	T2D_GENES_TANYA_BLOODPRESSURE	BENPORATH_MYC_MAX_TARGETS
4.61538461538%	21	455	769	T2D_GENES_TANYA_BLOODPRESSURE	NUYTTEN_NIPP1_TARGETS_UP
4.61538461538%	21	455	747	T2D_GENES_TANYA_BLOODPRESSURE	PATIL_LIVER_CANCER
4.61538461538%	21	455	514	T2D_GENES_TANYA_BLOODPRESSURE	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
4.61538461538%	21	455	1210	T2D_GENES_TANYA_BLOODPRESSURE	CHEN_METABOLIC_SYNDROM_NETWORK
4.61254612546%	25	542	911	T2D_GENES_TANYA_ANTHROPOMETRIC	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
4.61254612546%	25	542	855	T2D_GENES_TANYA_ANTHROPOMETRIC	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
4.61254612546%	25	542	721	T2D_GENES_TANYA_ANTHROPOMETRIC	WONG_ADULT_TISSUE_STEM_MODULE
4.61254612546%	25	542	718	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_ES_ICP_WITH_H3K4ME3
4.61254612546%	25	542	612	T2D_GENES_TANYA_ANTHROPOMETRIC	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
4.60992907801%	91	1974	918	Mendelian_Nancy_Cox	JOHNSTONE_PARVB_TARGETS_3_DN
4.60992907801%	91	1974	734	Mendelian_Nancy_Cox	BENPORATH_SOX2_TARGETS
4.60475825019%	60	1303	1839	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
4.60475825019%	60	1303	1652	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PUJANA_BRCA1_PCC_NETWORK
4.60475825019%	60	1303	1305	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YOSHIMURA_MAPK8_TARGETS_UP
4.59981600736%	100	2174	911	T2D_GENES_TANYA_LIPIDS	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
4.59647247461%	86	1871	824	T2D_GENES_TANYA_HEIGHT	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
4.57052797478%	58	1269	1442	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PUJANA_ATM_PCC_NETWORK
4.56769983687%	28	613	882	T2D_GENES_TANYA_BIOMARKER	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
4.56769983687%	28	613	783	T2D_GENES_TANYA_BIOMARKER	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
4.56769983687%	28	613	605	T2D_GENES_TANYA_BIOMARKER	CAIRO_HEPATOBLASTOMA_CLASSES_UP
4.55927051672%	90	1974	920	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_GPCR
4.55927051672%	90	1974	722	Mendelian_Nancy_Cox	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
4.55927051672%	90	1974	567	Mendelian_Nancy_Cox	CHICAS_RB1_TARGETS_CONFLUENT
4.55927051672%	90	1974	546	Mendelian_Nancy_Cox	WEST_ADRENOCORTICAL_TUMOR_DN
4.55927051672%	90	1974	491	Mendelian_Nancy_Cox	SWEET_LUNG_CANCER_KRAS_UP
4.55927051672%	90	1974	489	Mendelian_Nancy_Cox	LIM_MAMMARY_STEM_CELL_UP
4.55381784729%	99	2174	824	T2D_GENES_TANYA_LIPIDS	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
4.53857791225%	30	661	863	T2D_GENES_TANYA_GLYCEMIC	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
4.53857791225%	30	661	857	T2D_GENES_TANYA_GLYCEMIC	MARTENS_TRETINOIN_RESPONSE_UP
4.53857791225%	30	661	775	T2D_GENES_TANYA_GLYCEMIC	BENPORATH_MYC_MAX_TARGETS
4.53857791225%	30	661	747	T2D_GENES_TANYA_GLYCEMIC	PATIL_LIVER_CANCER
4.50861195542%	89	1974	602	Mendelian_Nancy_Cox	MARTINEZ_TP53_TARGETS_UP
4.50861195542%	89	1974	601	Mendelian_Nancy_Cox	MARTINEZ_RB1_AND_TP53_TARGETS_UP
4.50861195542%	89	1974	553	Mendelian_Nancy_Cox	FEVR_CTNNB1_TARGETS_DN
4.50861195542%	89	1974	479	Mendelian_Nancy_Cox	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
4.50861195542%	89	1974	398	Mendelian_Nancy_Cox	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
4.48430493274%	20	446	882	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
4.48430493274%	20	446	841	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARTENS_TRETINOIN_RESPONSE_DN
4.48430493274%	20	446	1080	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
4.46182152714%	97	2174	811	T2D_GENES_TANYA_LIPIDS	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
4.45795339412%	88	1974	770	Mendelian_Nancy_Cox	KRIEG_HYPOXIA_NOT_VIA_KDM3A
4.45795339412%	88	1974	584	Mendelian_Nancy_Cox	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
4.45795339412%	88	1974	481	Mendelian_Nancy_Cox	LIU_PROSTATE_CANCER_DN
4.43613041154%	83	1871	911	T2D_GENES_TANYA_HEIGHT	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
4.43213296399%	16	361	1137	T2D_GENES_TANYA_T2D_RSQ05_02CM	BRUINS_UVC_RESPONSE_LATE
4.42804428044%	24	542	882	T2D_GENES_TANYA_ANTHROPOMETRIC	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
4.42804428044%	24	542	811	T2D_GENES_TANYA_ANTHROPOMETRIC	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
4.42804428044%	24	542	701	T2D_GENES_TANYA_ANTHROPOMETRIC	SMID_BREAST_CANCER_BASAL_DN
4.42804428044%	24	542	463	T2D_GENES_TANYA_ANTHROPOMETRIC	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
4.40729483283%	87	1974	435	Mendelian_Nancy_Cox	SWEET_LUNG_CANCER_KRAS_DN
4.40729483283%	87	1974	430	Mendelian_Nancy_Cox	JOHNSTONE_PARVB_TARGETS_3_UP
4.40729483283%	87	1974	394	Mendelian_Nancy_Cox	BERENJENO_TRANSFORMED_BY_RHOA_DN
4.40456769984%	27	613	795	T2D_GENES_TANYA_BIOMARKER	WEI_MYCN_TARGETS_WITH_E_BOX
4.40456769984%	27	613	770	T2D_GENES_TANYA_BIOMARKER	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
4.40340909091%	155	3520	1022	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARSON_BOUND_BY_FOXP3_STIMULATED
4.3956043956%	20	455	824	T2D_GENES_TANYA_BLOODPRESSURE	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
4.3956043956%	20	455	781	T2D_GENES_TANYA_BLOODPRESSURE	GOZGIT_ESR1_TARGETS_DN
4.3956043956%	20	455	75	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TELOMERE_MAINTENANCE
4.3956043956%	20	455	73	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MEIOTIC_SYNAPSIS
4.3956043956%	20	455	682	T2D_GENES_TANYA_BLOODPRESSURE	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
4.3956043956%	20	455	682	T2D_GENES_TANYA_BLOODPRESSURE	FEVR_CTNNB1_TARGETS_UP
4.3956043956%	20	455	663	T2D_GENES_TANYA_BLOODPRESSURE	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
4.3956043956%	20	455	64	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE
4.3956043956%	20	455	48	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PACKAGING_OF_TELOMERE_ENDS
4.3956043956%	20	455	430	T2D_GENES_TANYA_BLOODPRESSURE	RIGGI_EWING_SARCOMA_PROGENITOR_UP
4.3956043956%	20	455	122	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CHROMOSOME_MAINTENANCE
4.3956043956%	20	455	1174	T2D_GENES_TANYA_BLOODPRESSURE	PEREZ_TP53_TARGETS
4.38729198185%	29	661	918	T2D_GENES_TANYA_GLYCEMIC	JOHNSTONE_PARVB_TARGETS_3_DN
4.38729198185%	29	661	89	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RNA_POL_I_TRANSCRIPTION
4.38729198185%	29	661	779	T2D_GENES_TANYA_GLYCEMIC	PUJANA_CHEK2_PCC_NETWORK
4.38729198185%	29	661	718	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_ES_ICP_WITH_H3K4ME3
4.38729198185%	29	661	140	T2D_GENES_TANYA_GLYCEMIC	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
4.38729198185%	29	661	1375	T2D_GENES_TANYA_GLYCEMIC	DODD_NASOPHARYNGEAL_CARCINOMA_DN
4.38729198185%	29	661	1038	T2D_GENES_TANYA_GLYCEMIC	BENPORATH_SUZ12_TARGETS
4.38268305719%	82	1871	712	T2D_GENES_TANYA_HEIGHT	SCHLOSSER_SERUM_RESPONSE_DN
4.37452033768%	57	1303	1442	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PUJANA_ATM_PCC_NETWORK
4.36982520699%	95	2174	933	T2D_GENES_TANYA_LIPIDS	REACTOME_IMMUNE_SYSTEM
4.36982520699%	95	2174	682	T2D_GENES_TANYA_LIPIDS	FEVR_CTNNB1_TARGETS_UP
4.35663627153%	86	1974	747	Mendelian_Nancy_Cox	PATIL_LIVER_CANCER
4.35663627153%	86	1974	718	Mendelian_Nancy_Cox	MIKKELSEN_ES_ICP_WITH_H3K4ME3
4.34782608696%	11	253	911	Diabetes_McGill_CREBBP_coTF	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
4.34782608696%	11	253	898	Diabetes_McGill_CREBBP_coTF	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
4.34782608696%	11	253	79	Diabetes_McGill_CREBBP_coTF	PID_P73PATHWAY
4.34782608696%	11	253	784	Diabetes_McGill_CREBBP_coTF	FORTSCHEGGER_PHF8_TARGETS_DN
4.34782608696%	11	253	722	Diabetes_McGill_CREBBP_coTF	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
4.34782608696%	11	253	720	Diabetes_McGill_CREBBP_coTF	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
4.34782608696%	11	253	637	Diabetes_McGill_CREBBP_coTF	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
4.34782608696%	11	253	62	Diabetes_McGill_CREBBP_coTF	KEGG_COLORECTAL_CANCER
4.34782608696%	11	253	590	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
4.34782608696%	11	253	572	Diabetes_McGill_CREBBP_coTF	CHICAS_RB1_TARGETS_SENESCENT
4.34782608696%	11	253	544	Diabetes_McGill_CREBBP_coTF	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
4.34782608696%	11	253	537	Diabetes_McGill_CREBBP_coTF	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
4.34782608696%	11	253	510	Diabetes_McGill_CREBBP_coTF	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
4.34782608696%	11	253	50	Diabetes_McGill_CREBBP_coTF	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
4.34782608696%	11	253	461	Diabetes_McGill_CREBBP_coTF	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
4.34782608696%	11	253	46	Diabetes_McGill_CREBBP_coTF	PID_PS1PATHWAY
4.34782608696%	11	253	44	Diabetes_McGill_CREBBP_coTF	MA_MYELOID_DIFFERENTIATION_DN
4.34782608696%	11	253	435	Diabetes_McGill_CREBBP_coTF	SWEET_LUNG_CANCER_KRAS_DN
4.34782608696%	11	253	40	Diabetes_McGill_CREBBP_coTF	RIZ_ERYTHROID_DIFFERENTIATION_6HR
4.34782608696%	11	253	395	Diabetes_McGill_CREBBP_coTF	HAN_SATB1_TARGETS_UP
4.34782608696%	11	253	372	Diabetes_McGill_CREBBP_coTF	WANG_LMO4_TARGETS_UP
4.34782608696%	11	253	364	Diabetes_McGill_CREBBP_coTF	YANG_BCL3_TARGETS_UP
4.34782608696%	11	253	358	Diabetes_McGill_CREBBP_coTF	GRUETZMANN_PANCREATIC_CANCER_UP
4.34782608696%	11	253	336	Diabetes_McGill_CREBBP_coTF	JOHNSTONE_PARVB_TARGETS_2_DN
4.34782608696%	11	253	335	Diabetes_McGill_CREBBP_coTF	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
4.34782608696%	11	253	329	Diabetes_McGill_CREBBP_coTF	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
4.34782608696%	11	253	32	Diabetes_McGill_CREBBP_coTF	BIOCARTA_PDGF_PATHWAY
4.34782608696%	11	253	310	Diabetes_McGill_CREBBP_coTF	HORIUCHI_WTAP_TARGETS_DN
4.34782608696%	11	253	31	Diabetes_McGill_CREBBP_coTF	BIOCARTA_EGF_PATHWAY
4.34782608696%	11	253	309	Diabetes_McGill_CREBBP_coTF	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
4.34782608696%	11	253	281	Diabetes_McGill_CREBBP_coTF	MULLIGHAN_MLL_SIGNATURE_2_DN
4.34782608696%	11	253	26	Diabetes_McGill_CREBBP_coTF	PID_RXR_VDR_PATHWAY
4.34782608696%	11	253	229	Diabetes_McGill_CREBBP_coTF	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
4.34782608696%	11	253	223	Diabetes_McGill_CREBBP_coTF	CHEN_HOXA5_TARGETS_9HR_UP
4.34782608696%	11	253	209	Diabetes_McGill_CREBBP_coTF	GROSS_HYPOXIA_VIA_ELK3_UP
4.34782608696%	11	253	198	Diabetes_McGill_CREBBP_coTF	WELCSH_BRCA1_TARGETS_UP
4.34782608696%	11	253	197	Diabetes_McGill_CREBBP_coTF	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
4.34782608696%	11	253	185	Diabetes_McGill_CREBBP_coTF	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
4.34782608696%	11	253	160	Diabetes_McGill_CREBBP_coTF	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
4.34782608696%	11	253	159	Diabetes_McGill_CREBBP_coTF	REACTOME_INTERFERON_SIGNALING
4.34782608696%	11	253	147	Diabetes_McGill_CREBBP_coTF	KAUFFMANN_DNA_REPLICATION_GENES
4.34782608696%	11	253	13	Diabetes_McGill_CREBBP_coTF	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY
4.34782608696%	11	253	127	Diabetes_McGill_CREBBP_coTF	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
4.34782608696%	11	253	104	Diabetes_McGill_CREBBP_coTF	NAKAMURA_ADIPOGENESIS_LATE_UP
4.34782608696%	11	253	1011	Diabetes_McGill_CREBBP_coTF	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
4.34782608696%	1	23	98	Diabetes_McGill_Mtor_pathway	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
4.34782608696%	1	23	96	Diabetes_McGill_Mtor_pathway	ZAMORA_NOS2_TARGETS_DN
4.34782608696%	1	23	96	Diabetes_McGill_Mtor_pathway	LIU_PROSTATE_CANCER_UP
4.34782608696%	1	23	953	Diabetes_McGill_Mtor_pathway	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
4.34782608696%	1	23	95	Diabetes_McGill_Mtor_pathway	HOEBEKE_LYMPHOID_STEM_CELL_UP
4.34782608696%	1	23	940	Diabetes_McGill_Mtor_pathway	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
4.34782608696%	1	23	93	Diabetes_McGill_Mtor_pathway	REACTOME_ACTIVATED_TLR4_SIGNALLING
4.34782608696%	1	23	92	Diabetes_McGill_Mtor_pathway	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
4.34782608696%	1	23	92	Diabetes_McGill_Mtor_pathway	DE_YY1_TARGETS_DN
4.34782608696%	1	23	92	Diabetes_McGill_Mtor_pathway	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
4.34782608696%	1	23	90	Diabetes_McGill_Mtor_pathway	HILLION_HMGA1_TARGETS
4.34782608696%	1	23	9	Diabetes_McGill_Mtor_pathway	ITO_PTTG1_TARGETS_DN
4.34782608696%	1	23	9	Diabetes_McGill_Mtor_pathway	DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN
4.34782608696%	1	23	893	Diabetes_McGill_Mtor_pathway	GEORGES_TARGETS_OF_MIR192_AND_MIR215
4.34782608696%	1	23	89	Diabetes_McGill_Mtor_pathway	WNT_SIGNALING
4.34782608696%	1	23	89	Diabetes_McGill_Mtor_pathway	BHATTACHARYA_EMBRYONIC_STEM_CELL
4.34782608696%	1	23	88	Diabetes_McGill_Mtor_pathway	SEIDEN_ONCOGENESIS_BY_MET
4.34782608696%	1	23	88	Diabetes_McGill_Mtor_pathway	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
4.34782608696%	1	23	88	Diabetes_McGill_Mtor_pathway	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
4.34782608696%	1	23	88	Diabetes_McGill_Mtor_pathway	KEGG_RIBOSOME
4.34782608696%	1	23	87	Diabetes_McGill_Mtor_pathway	SMITH_TERT_TARGETS_DN
4.34782608696%	1	23	87	Diabetes_McGill_Mtor_pathway	REACTOME_MITOTIC_PROMETAPHASE
4.34782608696%	1	23	87	Diabetes_McGill_Mtor_pathway	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
4.34782608696%	1	23	86	Diabetes_McGill_Mtor_pathway	LEE_AGING_CEREBELLUM_DN
4.34782608696%	1	23	86	Diabetes_McGill_Mtor_pathway	HOEBEKE_LYMPHOID_STEM_CELL_DN
4.34782608696%	1	23	85	Diabetes_McGill_Mtor_pathway	XU_GH1_EXOGENOUS_TARGETS_UP
4.34782608696%	1	23	85	Diabetes_McGill_Mtor_pathway	SANA_RESPONSE_TO_IFNG_DN
4.34782608696%	1	23	85	Diabetes_McGill_Mtor_pathway	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
4.34782608696%	1	23	84	Diabetes_McGill_Mtor_pathway	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
4.34782608696%	1	23	84	Diabetes_McGill_Mtor_pathway	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
4.34782608696%	1	23	830	Diabetes_McGill_Mtor_pathway	CUI_TCF21_TARGETS_2_DN
4.34782608696%	1	23	83	Diabetes_McGill_Mtor_pathway	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
4.34782608696%	1	23	83	Diabetes_McGill_Mtor_pathway	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
4.34782608696%	1	23	83	Diabetes_McGill_Mtor_pathway	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
4.34782608696%	1	23	82	Diabetes_McGill_Mtor_pathway	PID_SMAD2_3NUCLEARPATHWAY
4.34782608696%	1	23	82	Diabetes_McGill_Mtor_pathway	PID_REG_GR_PATHWAY
4.34782608696%	1	23	81	Diabetes_McGill_Mtor_pathway	MUNSHI_MULTIPLE_MYELOMA_UP
4.34782608696%	1	23	81	Diabetes_McGill_Mtor_pathway	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
4.34782608696%	1	23	81	Diabetes_McGill_Mtor_pathway	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
4.34782608696%	1	23	81	Diabetes_McGill_Mtor_pathway	GUO_HEX_TARGETS_UP
4.34782608696%	1	23	81	Diabetes_McGill_Mtor_pathway	GRABARCZYK_BCL11B_TARGETS_UP
4.34782608696%	1	23	80	Diabetes_McGill_Mtor_pathway	LEE_AGING_NEOCORTEX_DN
4.34782608696%	1	23	8	Diabetes_McGill_Mtor_pathway	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP
4.34782608696%	1	23	795	Diabetes_McGill_Mtor_pathway	WEI_MYCN_TARGETS_WITH_E_BOX
4.34782608696%	1	23	79	Diabetes_McGill_Mtor_pathway	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
4.34782608696%	1	23	79	Diabetes_McGill_Mtor_pathway	MALONEY_RESPONSE_TO_17AAG_DN
4.34782608696%	1	23	783	Diabetes_McGill_Mtor_pathway	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
4.34782608696%	1	23	781	Diabetes_McGill_Mtor_pathway	GOZGIT_ESR1_TARGETS_DN
4.34782608696%	1	23	78	Diabetes_McGill_Mtor_pathway	REACTOME_PLATELET_HOMEOSTASIS
4.34782608696%	1	23	78	Diabetes_McGill_Mtor_pathway	REACTOME_OPIOID_SIGNALLING
4.34782608696%	1	23	78	Diabetes_McGill_Mtor_pathway	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
4.34782608696%	1	23	77	Diabetes_McGill_Mtor_pathway	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
4.34782608696%	1	23	77	Diabetes_McGill_Mtor_pathway	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
4.34782608696%	1	23	77	Diabetes_McGill_Mtor_pathway	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN
4.34782608696%	1	23	77	Diabetes_McGill_Mtor_pathway	JACKSON_DNMT1_TARGETS_UP
4.34782608696%	1	23	77	Diabetes_McGill_Mtor_pathway	CARD_MIR302A_TARGETS
4.34782608696%	1	23	769	Diabetes_McGill_Mtor_pathway	NUYTTEN_NIPP1_TARGETS_UP
4.34782608696%	1	23	76	Diabetes_McGill_Mtor_pathway	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
4.34782608696%	1	23	76	Diabetes_McGill_Mtor_pathway	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
4.34782608696%	1	23	76	Diabetes_McGill_Mtor_pathway	SU_TESTIS
4.34782608696%	1	23	76	Diabetes_McGill_Mtor_pathway	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
4.34782608696%	1	23	76	Diabetes_McGill_Mtor_pathway	MAHAJAN_RESPONSE_TO_IL1A_DN
4.34782608696%	1	23	75	Diabetes_McGill_Mtor_pathway	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
4.34782608696%	1	23	75	Diabetes_McGill_Mtor_pathway	MCCLUNG_COCAIN_REWARD_4WK
4.34782608696%	1	23	75	Diabetes_McGill_Mtor_pathway	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
4.34782608696%	1	23	74	Diabetes_McGill_Mtor_pathway	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
4.34782608696%	1	23	74	Diabetes_McGill_Mtor_pathway	POTTI_ADRIAMYCIN_SENSITIVITY
4.34782608696%	1	23	74	Diabetes_McGill_Mtor_pathway	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
4.34782608696%	1	23	74	Diabetes_McGill_Mtor_pathway	CORRE_MULTIPLE_MYELOMA_UP
4.34782608696%	1	23	734	Diabetes_McGill_Mtor_pathway	BENPORATH_SOX2_TARGETS
4.34782608696%	1	23	720	Diabetes_McGill_Mtor_pathway	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
4.34782608696%	1	23	72	Diabetes_McGill_Mtor_pathway	SESTO_RESPONSE_TO_UV_C1
4.34782608696%	1	23	72	Diabetes_McGill_Mtor_pathway	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
4.34782608696%	1	23	712	Diabetes_McGill_Mtor_pathway	SCHLOSSER_SERUM_RESPONSE_DN
4.34782608696%	1	23	71	Diabetes_McGill_Mtor_pathway	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
4.34782608696%	1	23	71	Diabetes_McGill_Mtor_pathway	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
4.34782608696%	1	23	70	Diabetes_McGill_Mtor_pathway	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5
4.34782608696%	1	23	70	Diabetes_McGill_Mtor_pathway	PID_AP1_PATHWAY
4.34782608696%	1	23	70	Diabetes_McGill_Mtor_pathway	KEGG_LONG_TERM_DEPRESSION
4.34782608696%	1	23	7	Diabetes_McGill_Mtor_pathway	PALOMERO_GSI_SENSITIVITY_UP
4.34782608696%	1	23	7	Diabetes_McGill_Mtor_pathway	IKEDA_MIR1_TARGETS_DN
4.34782608696%	1	23	69	Diabetes_McGill_Mtor_pathway	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
4.34782608696%	1	23	69	Diabetes_McGill_Mtor_pathway	RIZKI_TUMOR_INVASIVENESS_2D_UP
4.34782608696%	1	23	69	Diabetes_McGill_Mtor_pathway	REACTOME_GLUCOSE_METABOLISM
4.34782608696%	1	23	69	Diabetes_McGill_Mtor_pathway	KEGG_PPAR_SIGNALING_PATHWAY
4.34782608696%	1	23	69	Diabetes_McGill_Mtor_pathway	HOWLIN_PUBERTAL_MAMMARY_GLAND
4.34782608696%	1	23	682	Diabetes_McGill_Mtor_pathway	FEVR_CTNNB1_TARGETS_UP
4.34782608696%	1	23	68	Diabetes_McGill_Mtor_pathway	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
4.34782608696%	1	23	68	Diabetes_McGill_Mtor_pathway	DELPUECH_FOXO3_TARGETS_UP
4.34782608696%	1	23	67	Diabetes_McGill_Mtor_pathway	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
4.34782608696%	1	23	67	Diabetes_McGill_Mtor_pathway	GENTILE_UV_LOW_DOSE_DN
4.34782608696%	1	23	66	Diabetes_McGill_Mtor_pathway	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
4.34782608696%	1	23	66	Diabetes_McGill_Mtor_pathway	PID_HIF1_TFPATHWAY
4.34782608696%	1	23	66	Diabetes_McGill_Mtor_pathway	NAKAMURA_ADIPOGENESIS_EARLY_UP
4.34782608696%	1	23	66	Diabetes_McGill_Mtor_pathway	BRUNO_HEMATOPOIESIS
4.34782608696%	1	23	658	Diabetes_McGill_Mtor_pathway	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
4.34782608696%	1	23	65	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALING_BY_WNT
4.34782608696%	1	23	65	Diabetes_McGill_Mtor_pathway	PID_RB_1PATHWAY
4.34782608696%	1	23	64	Diabetes_McGill_Mtor_pathway	ZHAN_MULTIPLE_MYELOMA_UP
4.34782608696%	1	23	64	Diabetes_McGill_Mtor_pathway	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
4.34782608696%	1	23	63	Diabetes_McGill_Mtor_pathway	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
4.34782608696%	1	23	63	Diabetes_McGill_Mtor_pathway	PID_MYC_REPRESSPATHWAY
4.34782608696%	1	23	63	Diabetes_McGill_Mtor_pathway	PID_IL12_2PATHWAY
4.34782608696%	1	23	63	Diabetes_McGill_Mtor_pathway	PID_ENDOTHELINPATHWAY
4.34782608696%	1	23	63	Diabetes_McGill_Mtor_pathway	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
4.34782608696%	1	23	62	Diabetes_McGill_Mtor_pathway	KYNG_DNA_DAMAGE_BY_UV
4.34782608696%	1	23	61	Diabetes_McGill_Mtor_pathway	PID_AR_PATHWAY
4.34782608696%	1	23	60	Diabetes_McGill_Mtor_pathway	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
4.34782608696%	1	23	6	Diabetes_McGill_Mtor_pathway	KIM_PTEN_TARGETS_DN
4.34782608696%	1	23	6	Diabetes_McGill_Mtor_pathway	KAPOSI_LIVER_CANCER_MET_DN
4.34782608696%	1	23	593	Diabetes_McGill_Mtor_pathway	MARTINEZ_TP53_TARGETS_DN
4.34782608696%	1	23	591	Diabetes_McGill_Mtor_pathway	MARTINEZ_RB1_AND_TP53_TARGETS_DN
4.34782608696%	1	23	59	Diabetes_McGill_Mtor_pathway	ASTIER_INTEGRIN_SIGNALING
4.34782608696%	1	23	584	Diabetes_McGill_Mtor_pathway	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
4.34782608696%	1	23	578	Diabetes_McGill_Mtor_pathway	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
4.34782608696%	1	23	572	Diabetes_McGill_Mtor_pathway	CHICAS_RB1_TARGETS_SENESCENT
4.34782608696%	1	23	57	Diabetes_McGill_Mtor_pathway	PID_TXA2PATHWAY
4.34782608696%	1	23	57	Diabetes_McGill_Mtor_pathway	NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON
4.34782608696%	1	23	57	Diabetes_McGill_Mtor_pathway	DELASERNA_MYOD_TARGETS_DN
4.34782608696%	1	23	567	Diabetes_McGill_Mtor_pathway	CHICAS_RB1_TARGETS_CONFLUENT
4.34782608696%	1	23	56	Diabetes_McGill_Mtor_pathway	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP
4.34782608696%	1	23	557	Diabetes_McGill_Mtor_pathway	TIEN_INTESTINE_PROBIOTICS_24HR_UP
4.34782608696%	1	23	55	Diabetes_McGill_Mtor_pathway	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN
4.34782608696%	1	23	546	Diabetes_McGill_Mtor_pathway	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
4.34782608696%	1	23	544	Diabetes_McGill_Mtor_pathway	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
4.34782608696%	1	23	54	Diabetes_McGill_Mtor_pathway	ROVERSI_GLIOMA_COPY_NUMBER_DN
4.34782608696%	1	23	54	Diabetes_McGill_Mtor_pathway	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM
4.34782608696%	1	23	54	Diabetes_McGill_Mtor_pathway	PID_NFAT_3PATHWAY
4.34782608696%	1	23	539	Diabetes_McGill_Mtor_pathway	LIAO_METASTASIS
4.34782608696%	1	23	536	Diabetes_McGill_Mtor_pathway	SENESE_HDAC3_TARGETS_DN
4.34782608696%	1	23	530	Diabetes_McGill_Mtor_pathway	ENK_UV_RESPONSE_KERATINOCYTE_UP
4.34782608696%	1	23	53	Diabetes_McGill_Mtor_pathway	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0
4.34782608696%	1	23	53	Diabetes_McGill_Mtor_pathway	MORI_IMMATURE_B_LYMPHOCYTE_UP
4.34782608696%	1	23	53	Diabetes_McGill_Mtor_pathway	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
4.34782608696%	1	23	528	Diabetes_McGill_Mtor_pathway	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
4.34782608696%	1	23	52	Diabetes_McGill_Mtor_pathway	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
4.34782608696%	1	23	52	Diabetes_McGill_Mtor_pathway	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6
4.34782608696%	1	23	52	Diabetes_McGill_Mtor_pathway	KENNY_CTNNB1_TARGETS_DN
4.34782608696%	1	23	518	Diabetes_McGill_Mtor_pathway	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
4.34782608696%	1	23	517	Diabetes_McGill_Mtor_pathway	RAO_BOUND_BY_SALL4_ISOFORM_B
4.34782608696%	1	23	510	Diabetes_McGill_Mtor_pathway	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
4.34782608696%	1	23	51	Diabetes_McGill_Mtor_pathway	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
4.34782608696%	1	23	51	Diabetes_McGill_Mtor_pathway	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
4.34782608696%	1	23	501	Diabetes_McGill_Mtor_pathway	SENESE_HDAC3_TARGETS_UP
4.34782608696%	1	23	50	Diabetes_McGill_Mtor_pathway	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
4.34782608696%	1	23	50	Diabetes_McGill_Mtor_pathway	MARTINEZ_RESPONSE_TO_TRABECTEDIN
4.34782608696%	1	23	5	Diabetes_McGill_Mtor_pathway	LAU_APOPTOSIS_CDKN2A_DN
4.34782608696%	1	23	491	Diabetes_McGill_Mtor_pathway	ZHENG_BOUND_BY_FOXP3
4.34782608696%	1	23	49	Diabetes_McGill_Mtor_pathway	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
4.34782608696%	1	23	49	Diabetes_McGill_Mtor_pathway	PID_FOXOPATHWAY
4.34782608696%	1	23	49	Diabetes_McGill_Mtor_pathway	MARCHINI_TRABECTEDIN_RESISTANCE_DN
4.34782608696%	1	23	49	Diabetes_McGill_Mtor_pathway	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP
4.34782608696%	1	23	49	Diabetes_McGill_Mtor_pathway	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP
4.34782608696%	1	23	485	Diabetes_McGill_Mtor_pathway	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
4.34782608696%	1	23	481	Diabetes_McGill_Mtor_pathway	LIU_PROSTATE_CANCER_DN
4.34782608696%	1	23	48	Diabetes_McGill_Mtor_pathway	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE
4.34782608696%	1	23	48	Diabetes_McGill_Mtor_pathway	PID_HEDGEHOG_GLIPATHWAY
4.34782608696%	1	23	48	Diabetes_McGill_Mtor_pathway	PID_CERAMIDE_PATHWAY
4.34782608696%	1	23	48	Diabetes_McGill_Mtor_pathway	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN
4.34782608696%	1	23	48	Diabetes_McGill_Mtor_pathway	ENGELMANN_CANCER_PROGENITORS_UP
4.34782608696%	1	23	476	Diabetes_McGill_Mtor_pathway	SMID_BREAST_CANCER_NORMAL_LIKE_UP
4.34782608696%	1	23	475	Diabetes_McGill_Mtor_pathway	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
4.34782608696%	1	23	47	Diabetes_McGill_Mtor_pathway	POTTI_DOCETAXEL_SENSITIVITY
4.34782608696%	1	23	47	Diabetes_McGill_Mtor_pathway	BOYLAN_MULTIPLE_MYELOMA_C_UP
4.34782608696%	1	23	460	Diabetes_McGill_Mtor_pathway	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
4.34782608696%	1	23	46	Diabetes_McGill_Mtor_pathway	PID_PLK1_PATHWAY
4.34782608696%	1	23	46	Diabetes_McGill_Mtor_pathway	BIOCARTA_KERATINOCYTE_PATHWAY
4.34782608696%	1	23	459	Diabetes_McGill_Mtor_pathway	KIM_WT1_TARGETS_DN
4.34782608696%	1	23	457	Diabetes_McGill_Mtor_pathway	SENESE_HDAC1_TARGETS_UP
4.34782608696%	1	23	456	Diabetes_McGill_Mtor_pathway	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
4.34782608696%	1	23	456	Diabetes_McGill_Mtor_pathway	ODONNELL_TFRC_TARGETS_UP
4.34782608696%	1	23	455	Diabetes_McGill_Mtor_pathway	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
4.34782608696%	1	23	45	Diabetes_McGill_Mtor_pathway	ZHAN_MULTIPLE_MYELOMA_CD1_UP
4.34782608696%	1	23	45	Diabetes_McGill_Mtor_pathway	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN
4.34782608696%	1	23	45	Diabetes_McGill_Mtor_pathway	PID_RHOA_PATHWAY
4.34782608696%	1	23	45	Diabetes_McGill_Mtor_pathway	PID_ILK_PATHWAY
4.34782608696%	1	23	45	Diabetes_McGill_Mtor_pathway	PID_HNF3BPATHWAY
4.34782608696%	1	23	45	Diabetes_McGill_Mtor_pathway	NUTT_GBM_VS_AO_GLIOMA_DN
4.34782608696%	1	23	45	Diabetes_McGill_Mtor_pathway	LUI_THYROID_CANCER_PAX8_PPARG_DN
4.34782608696%	1	23	45	Diabetes_McGill_Mtor_pathway	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN
4.34782608696%	1	23	45	Diabetes_McGill_Mtor_pathway	LEE_AGING_MUSCLE_UP
4.34782608696%	1	23	44	Diabetes_McGill_Mtor_pathway	ZUCCHI_METASTASIS_DN
4.34782608696%	1	23	44	Diabetes_McGill_Mtor_pathway	THILLAINADESAN_ZNF217_TARGETS_UP
4.34782608696%	1	23	44	Diabetes_McGill_Mtor_pathway	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP
4.34782608696%	1	23	44	Diabetes_McGill_Mtor_pathway	FAELT_B_CLL_WITH_VH3_21_UP
4.34782608696%	1	23	44	Diabetes_McGill_Mtor_pathway	CHUNG_BLISTER_CYTOTOXICITY_DN
4.34782608696%	1	23	434	Diabetes_McGill_Mtor_pathway	BAELDE_DIABETIC_NEPHROPATHY_DN
4.34782608696%	1	23	431	Diabetes_McGill_Mtor_pathway	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
4.34782608696%	1	23	430	Diabetes_McGill_Mtor_pathway	RIGGI_EWING_SARCOMA_PROGENITOR_UP
4.34782608696%	1	23	430	Diabetes_McGill_Mtor_pathway	JOHNSTONE_PARVB_TARGETS_3_UP
4.34782608696%	1	23	43	Diabetes_McGill_Mtor_pathway	NAKAYAMA_FRA2_TARGETS
4.34782608696%	1	23	43	Diabetes_McGill_Mtor_pathway	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
4.34782608696%	1	23	429	Diabetes_McGill_Mtor_pathway	MOOTHA_HUMAN_MITODB_6_2002
4.34782608696%	1	23	428	Diabetes_McGill_Mtor_pathway	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
4.34782608696%	1	23	425	Diabetes_McGill_Mtor_pathway	ZHANG_BREAST_CANCER_PROGENITORS_UP
4.34782608696%	1	23	425	Diabetes_McGill_Mtor_pathway	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
4.34782608696%	1	23	422	Diabetes_McGill_Mtor_pathway	YAGI_AML_WITH_INV_16_TRANSLOCATION
4.34782608696%	1	23	421	Diabetes_McGill_Mtor_pathway	REACTOME_CELL_CYCLE
4.34782608696%	1	23	42	Diabetes_McGill_Mtor_pathway	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
4.34782608696%	1	23	42	Diabetes_McGill_Mtor_pathway	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN
4.34782608696%	1	23	42	Diabetes_McGill_Mtor_pathway	BIOCARTA_CHREBP2_PATHWAY
4.34782608696%	1	23	42	Diabetes_McGill_Mtor_pathway	BILBAN_B_CLL_LPL_DN
4.34782608696%	1	23	414	Diabetes_McGill_Mtor_pathway	MOHANKUMAR_TLX1_TARGETS_UP
4.34782608696%	1	23	414	Diabetes_McGill_Mtor_pathway	LU_EZH2_TARGETS_DN
4.34782608696%	1	23	411	Diabetes_McGill_Mtor_pathway	KOYAMA_SEMA3B_TARGETS_DN
4.34782608696%	1	23	41	Diabetes_McGill_Mtor_pathway	PID_AMB2_NEUTROPHILS_PATHWAY
4.34782608696%	1	23	41	Diabetes_McGill_Mtor_pathway	LIN_MELANOMA_COPY_NUMBER_DN
4.34782608696%	1	23	41	Diabetes_McGill_Mtor_pathway	GENTILE_UV_RESPONSE_CLUSTER_D2
4.34782608696%	1	23	41	Diabetes_McGill_Mtor_pathway	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
4.34782608696%	1	23	41	Diabetes_McGill_Mtor_pathway	EHLERS_ANEUPLOIDY_UP
4.34782608696%	1	23	408	Diabetes_McGill_Mtor_pathway	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
4.34782608696%	1	23	408	Diabetes_McGill_Mtor_pathway	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
4.34782608696%	1	23	405	Diabetes_McGill_Mtor_pathway	KUMAR_TARGETS_OF_MLL_AF9_FUSION
4.34782608696%	1	23	403	Diabetes_McGill_Mtor_pathway	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
4.34782608696%	1	23	40	Diabetes_McGill_Mtor_pathway	TOMLINS_PROSTATE_CANCER_UP
4.34782608696%	1	23	40	Diabetes_McGill_Mtor_pathway	ST_JNK_MAPK_PATHWAY
4.34782608696%	1	23	40	Diabetes_McGill_Mtor_pathway	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
4.34782608696%	1	23	40	Diabetes_McGill_Mtor_pathway	BIOCARTA_P38MAPK_PATHWAY
4.34782608696%	1	23	397	Diabetes_McGill_Mtor_pathway	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
4.34782608696%	1	23	396	Diabetes_McGill_Mtor_pathway	REACTOME_DEVELOPMENTAL_BIOLOGY
4.34782608696%	1	23	39	Diabetes_McGill_Mtor_pathway	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2
4.34782608696%	1	23	39	Diabetes_McGill_Mtor_pathway	PID_ATR_PATHWAY
4.34782608696%	1	23	39	Diabetes_McGill_Mtor_pathway	BILANGES_SERUM_SENSITIVE_VIA_TSC2
4.34782608696%	1	23	384	Diabetes_McGill_Mtor_pathway	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
4.34782608696%	1	23	384	Diabetes_McGill_Mtor_pathway	BASAKI_YBX1_TARGETS_DN
4.34782608696%	1	23	382	Diabetes_McGill_Mtor_pathway	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
4.34782608696%	1	23	38	Diabetes_McGill_Mtor_pathway	REACTOME_G1_PHASE
4.34782608696%	1	23	38	Diabetes_McGill_Mtor_pathway	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP
4.34782608696%	1	23	38	Diabetes_McGill_Mtor_pathway	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP
4.34782608696%	1	23	38	Diabetes_McGill_Mtor_pathway	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
4.34782608696%	1	23	38	Diabetes_McGill_Mtor_pathway	APPIERTO_RESPONSE_TO_FENRETINIDE_UP
4.34782608696%	1	23	374	Diabetes_McGill_Mtor_pathway	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
4.34782608696%	1	23	372	Diabetes_McGill_Mtor_pathway	WANG_LMO4_TARGETS_UP
4.34782608696%	1	23	37	Diabetes_McGill_Mtor_pathway	ST_GA13_PATHWAY
4.34782608696%	1	23	37	Diabetes_McGill_Mtor_pathway	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS
4.34782608696%	1	23	37	Diabetes_McGill_Mtor_pathway	BILANGES_SERUM_RESPONSE_TRANSLATION
4.34782608696%	1	23	36	Diabetes_McGill_Mtor_pathway	MMS_MOUSE_LYMPH_HIGH_4HRS_UP
4.34782608696%	1	23	358	Diabetes_McGill_Mtor_pathway	GRUETZMANN_PANCREATIC_CANCER_UP
4.34782608696%	1	23	354	Diabetes_McGill_Mtor_pathway	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
4.34782608696%	1	23	35	Diabetes_McGill_Mtor_pathway	ST_G_ALPHA_I_PATHWAY
4.34782608696%	1	23	35	Diabetes_McGill_Mtor_pathway	SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES
4.34782608696%	1	23	35	Diabetes_McGill_Mtor_pathway	ROZANOV_MMP14_TARGETS_DN
4.34782608696%	1	23	35	Diabetes_McGill_Mtor_pathway	REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION
4.34782608696%	1	23	35	Diabetes_McGill_Mtor_pathway	HU_GENOTOXIC_DAMAGE_24HR
4.34782608696%	1	23	344	Diabetes_McGill_Mtor_pathway	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
4.34782608696%	1	23	341	Diabetes_McGill_Mtor_pathway	MULLIGHAN_NPM1_SIGNATURE_3_UP
4.34782608696%	1	23	34	Diabetes_McGill_Mtor_pathway	WONG_IFNA2_RESISTANCE_DN
4.34782608696%	1	23	34	Diabetes_McGill_Mtor_pathway	ST_WNT_BETA_CATENIN_PATHWAY
4.34782608696%	1	23	34	Diabetes_McGill_Mtor_pathway	PID_EPOPATHWAY
4.34782608696%	1	23	34	Diabetes_McGill_Mtor_pathway	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP
4.34782608696%	1	23	330	Diabetes_McGill_Mtor_pathway	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
4.34782608696%	1	23	33	Diabetes_McGill_Mtor_pathway	REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT
4.34782608696%	1	23	33	Diabetes_McGill_Mtor_pathway	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS
4.34782608696%	1	23	33	Diabetes_McGill_Mtor_pathway	PID_ALPHASYNUCLEIN_PATHWAY
4.34782608696%	1	23	33	Diabetes_McGill_Mtor_pathway	GREENBAUM_E2A_TARGETS_UP
4.34782608696%	1	23	33	Diabetes_McGill_Mtor_pathway	BIOCARTA_NO1_PATHWAY
4.34782608696%	1	23	326	Diabetes_McGill_Mtor_pathway	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
4.34782608696%	1	23	325	Diabetes_McGill_Mtor_pathway	REACTOME_CELL_CYCLE_MITOTIC
4.34782608696%	1	23	321	Diabetes_McGill_Mtor_pathway	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
4.34782608696%	1	23	320	Diabetes_McGill_Mtor_pathway	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
4.34782608696%	1	23	32	Diabetes_McGill_Mtor_pathway	SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY
4.34782608696%	1	23	32	Diabetes_McGill_Mtor_pathway	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN
4.34782608696%	1	23	318	Diabetes_McGill_Mtor_pathway	LEI_MYB_TARGETS
4.34782608696%	1	23	317	Diabetes_McGill_Mtor_pathway	BRUINS_UVC_RESPONSE_EARLY_LATE
4.34782608696%	1	23	315	Diabetes_McGill_Mtor_pathway	PASINI_SUZ12_TARGETS_DN
4.34782608696%	1	23	314	Diabetes_McGill_Mtor_pathway	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
4.34782608696%	1	23	312	Diabetes_McGill_Mtor_pathway	GENTILE_UV_HIGH_DOSE_DN
4.34782608696%	1	23	311	Diabetes_McGill_Mtor_pathway	JIANG_HYPOXIA_NORMAL
4.34782608696%	1	23	31	Diabetes_McGill_Mtor_pathway	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN
4.34782608696%	1	23	31	Diabetes_McGill_Mtor_pathway	PID_CD40_PATHWAY
4.34782608696%	1	23	31	Diabetes_McGill_Mtor_pathway	PID_AURORA_A_PATHWAY
4.34782608696%	1	23	31	Diabetes_McGill_Mtor_pathway	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
4.34782608696%	1	23	309	Diabetes_McGill_Mtor_pathway	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
4.34782608696%	1	23	309	Diabetes_McGill_Mtor_pathway	LIU_SOX4_TARGETS_DN
4.34782608696%	1	23	308	Diabetes_McGill_Mtor_pathway	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
4.34782608696%	1	23	307	Diabetes_McGill_Mtor_pathway	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
4.34782608696%	1	23	306	Diabetes_McGill_Mtor_pathway	CHANDRAN_METASTASIS_DN
4.34782608696%	1	23	305	Diabetes_McGill_Mtor_pathway	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
4.34782608696%	1	23	30	Diabetes_McGill_Mtor_pathway	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
4.34782608696%	1	23	30	Diabetes_McGill_Mtor_pathway	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
4.34782608696%	1	23	30	Diabetes_McGill_Mtor_pathway	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
4.34782608696%	1	23	30	Diabetes_McGill_Mtor_pathway	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES
4.34782608696%	1	23	30	Diabetes_McGill_Mtor_pathway	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
4.34782608696%	1	23	30	Diabetes_McGill_Mtor_pathway	PID_RETINOIC_ACID_PATHWAY
4.34782608696%	1	23	30	Diabetes_McGill_Mtor_pathway	KYNG_NORMAL_AGING_DN
4.34782608696%	1	23	298	Diabetes_McGill_Mtor_pathway	BROWNE_HCMV_INFECTION_14HR_DN
4.34782608696%	1	23	298	Diabetes_McGill_Mtor_pathway	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
4.34782608696%	1	23	295	Diabetes_McGill_Mtor_pathway	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
4.34782608696%	1	23	294	Diabetes_McGill_Mtor_pathway	WEST_ADRENOCORTICAL_TUMOR_UP
4.34782608696%	1	23	293	Diabetes_McGill_Mtor_pathway	ZHANG_TLX_TARGETS_60HR_UP
4.34782608696%	1	23	293	Diabetes_McGill_Mtor_pathway	ENK_UV_RESPONSE_EPIDERMIS_UP
4.34782608696%	1	23	292	Diabetes_McGill_Mtor_pathway	KOYAMA_SEMA3B_TARGETS_UP
4.34782608696%	1	23	292	Diabetes_McGill_Mtor_pathway	HELLER_HDAC_TARGETS_DN
4.34782608696%	1	23	29	Diabetes_McGill_Mtor_pathway	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR
4.34782608696%	1	23	29	Diabetes_McGill_Mtor_pathway	REACTOME_GLYCOLYSIS
4.34782608696%	1	23	29	Diabetes_McGill_Mtor_pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
4.34782608696%	1	23	29	Diabetes_McGill_Mtor_pathway	PID_TCRCALCIUMPATHWAY
4.34782608696%	1	23	29	Diabetes_McGill_Mtor_pathway	PID_S1P_S1P3_PATHWAY
4.34782608696%	1	23	29	Diabetes_McGill_Mtor_pathway	MA_PITUITARY_FETAL_VS_ADULT_UP
4.34782608696%	1	23	29	Diabetes_McGill_Mtor_pathway	KYNG_WERNER_SYNDROM_DN
4.34782608696%	1	23	289	Diabetes_McGill_Mtor_pathway	GABRIELY_MIR21_TARGETS
4.34782608696%	1	23	28	Diabetes_McGill_Mtor_pathway	WIKMAN_ASBESTOS_LUNG_CANCER_DN
4.34782608696%	1	23	28	Diabetes_McGill_Mtor_pathway	ST_GAQ_PATHWAY
4.34782608696%	1	23	28	Diabetes_McGill_Mtor_pathway	MOREIRA_RESPONSE_TO_TSA_UP
4.34782608696%	1	23	28	Diabetes_McGill_Mtor_pathway	HWANG_PROSTATE_CANCER_MARKERS
4.34782608696%	1	23	279	Diabetes_McGill_Mtor_pathway	REACTOME_NEURONAL_SYSTEM
4.34782608696%	1	23	279	Diabetes_McGill_Mtor_pathway	REACTOME_INNATE_IMMUNE_SYSTEM
4.34782608696%	1	23	279	Diabetes_McGill_Mtor_pathway	FORTSCHEGGER_PHF8_TARGETS_UP
4.34782608696%	1	23	277	Diabetes_McGill_Mtor_pathway	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
4.34782608696%	1	23	276	Diabetes_McGill_Mtor_pathway	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
4.34782608696%	1	23	276	Diabetes_McGill_Mtor_pathway	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
4.34782608696%	1	23	275	Diabetes_McGill_Mtor_pathway	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
4.34782608696%	1	23	275	Diabetes_McGill_Mtor_pathway	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
4.34782608696%	1	23	270	Diabetes_McGill_Mtor_pathway	RIZKI_TUMOR_INVASIVENESS_3D_DN
4.34782608696%	1	23	27	Diabetes_McGill_Mtor_pathway	TIEN_INTESTINE_PROBIOTICS_2HR_UP
4.34782608696%	1	23	27	Diabetes_McGill_Mtor_pathway	ST_MYOCYTE_AD_PATHWAY
4.34782608696%	1	23	27	Diabetes_McGill_Mtor_pathway	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
4.34782608696%	1	23	27	Diabetes_McGill_Mtor_pathway	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS
4.34782608696%	1	23	27	Diabetes_McGill_Mtor_pathway	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP
4.34782608696%	1	23	27	Diabetes_McGill_Mtor_pathway	CHOW_RASSF1_TARGETS_UP
4.34782608696%	1	23	268	Diabetes_McGill_Mtor_pathway	XU_GH1_AUTOCRINE_TARGETS_UP
4.34782608696%	1	23	266	Diabetes_McGill_Mtor_pathway	ROZANOV_MMP14_TARGETS_UP
4.34782608696%	1	23	266	Diabetes_McGill_Mtor_pathway	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
4.34782608696%	1	23	265	Diabetes_McGill_Mtor_pathway	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
4.34782608696%	1	23	26	Diabetes_McGill_Mtor_pathway	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS
4.34782608696%	1	23	26	Diabetes_McGill_Mtor_pathway	PID_RXR_VDR_PATHWAY
4.34782608696%	1	23	26	Diabetes_McGill_Mtor_pathway	PID_INSULIN_GLUCOSE_PATHWAY
4.34782608696%	1	23	26	Diabetes_McGill_Mtor_pathway	PID_ALK1PATHWAY
4.34782608696%	1	23	26	Diabetes_McGill_Mtor_pathway	GAZIN_EPIGENETIC_SILENCING_BY_KRAS
4.34782608696%	1	23	26	Diabetes_McGill_Mtor_pathway	BIOCARTA_WNT_PATHWAY
4.34782608696%	1	23	259	Diabetes_McGill_Mtor_pathway	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
4.34782608696%	1	23	258	Diabetes_McGill_Mtor_pathway	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
4.34782608696%	1	23	254	Diabetes_McGill_Mtor_pathway	BROWNE_HCMV_INFECTION_4HR_DN
4.34782608696%	1	23	253	Diabetes_McGill_Mtor_pathway	DANG_REGULATED_BY_MYC_DN
4.34782608696%	1	23	25	Diabetes_McGill_Mtor_pathway	REACTOME_DARPP_32_EVENTS
4.34782608696%	1	23	25	Diabetes_McGill_Mtor_pathway	PID_MYC_PATHWAY
4.34782608696%	1	23	25	Diabetes_McGill_Mtor_pathway	OZEN_MIR125B1_TARGETS
4.34782608696%	1	23	25	Diabetes_McGill_Mtor_pathway	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN
4.34782608696%	1	23	247	Diabetes_McGill_Mtor_pathway	REACTOME_METABOLISM_OF_CARBOHYDRATES
4.34782608696%	1	23	245	Diabetes_McGill_Mtor_pathway	KONDO_EZH2_TARGETS
4.34782608696%	1	23	245	Diabetes_McGill_Mtor_pathway	BLUM_RESPONSE_TO_SALIRASIB_UP
4.34782608696%	1	23	244	Diabetes_McGill_Mtor_pathway	THUM_SYSTOLIC_HEART_FAILURE_DN
4.34782608696%	1	23	243	Diabetes_McGill_Mtor_pathway	CHICAS_RB1_TARGETS_GROWING
4.34782608696%	1	23	240	Diabetes_McGill_Mtor_pathway	UDAYAKUMAR_MED1_TARGETS_DN
4.34782608696%	1	23	24	Diabetes_McGill_Mtor_pathway	YIH_RESPONSE_TO_ARSENITE_C1
4.34782608696%	1	23	24	Diabetes_McGill_Mtor_pathway	SHI_SPARC_TARGETS_UP
4.34782608696%	1	23	24	Diabetes_McGill_Mtor_pathway	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION
4.34782608696%	1	23	238	Diabetes_McGill_Mtor_pathway	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
4.34782608696%	1	23	238	Diabetes_McGill_Mtor_pathway	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
4.34782608696%	1	23	233	Diabetes_McGill_Mtor_pathway	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
4.34782608696%	1	23	230	Diabetes_McGill_Mtor_pathway	KAUFFMANN_DNA_REPAIR_GENES
4.34782608696%	1	23	23	Diabetes_McGill_Mtor_pathway	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
4.34782608696%	1	23	23	Diabetes_McGill_Mtor_pathway	BIOCARTA_P53HYPOXIA_PATHWAY
4.34782608696%	1	23	227	Diabetes_McGill_Mtor_pathway	RAO_BOUND_BY_SALL4
4.34782608696%	1	23	227	Diabetes_McGill_Mtor_pathway	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
4.34782608696%	1	23	225	Diabetes_McGill_Mtor_pathway	BROWNE_HCMV_INFECTION_16HR_UP
4.34782608696%	1	23	220	Diabetes_McGill_Mtor_pathway	RIGGINS_TAMOXIFEN_RESISTANCE_DN
4.34782608696%	1	23	22	Diabetes_McGill_Mtor_pathway	NUMATA_CSF3_SIGNALING_VIA_STAT3
4.34782608696%	1	23	22	Diabetes_McGill_Mtor_pathway	BIOCARTA_CHEMICAL_PATHWAY
4.34782608696%	1	23	214	Diabetes_McGill_Mtor_pathway	ZWANG_EGF_INTERVAL_DN
4.34782608696%	1	23	210	Diabetes_McGill_Mtor_pathway	RIZKI_TUMOR_INVASIVENESS_3D_UP
4.34782608696%	1	23	21	Diabetes_McGill_Mtor_pathway	REACTOME_ERK_MAPK_TARGETS
4.34782608696%	1	23	21	Diabetes_McGill_Mtor_pathway	PID_P38_MK2PATHWAY
4.34782608696%	1	23	21	Diabetes_McGill_Mtor_pathway	LANDEMAINE_LUNG_METASTASIS
4.34782608696%	1	23	21	Diabetes_McGill_Mtor_pathway	KANNAN_TP53_TARGETS_DN
4.34782608696%	1	23	21	Diabetes_McGill_Mtor_pathway	HU_ANGIOGENESIS_UP
4.34782608696%	1	23	21	Diabetes_McGill_Mtor_pathway	HASLINGER_B_CLL_WITH_17P13_DELETION
4.34782608696%	1	23	21	Diabetes_McGill_Mtor_pathway	FOURNIER_ACINAR_DEVELOPMENT_LATE_DN
4.34782608696%	1	23	21	Diabetes_McGill_Mtor_pathway	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP
4.34782608696%	1	23	209	Diabetes_McGill_Mtor_pathway	CHANG_CORE_SERUM_RESPONSE_DN
4.34782608696%	1	23	207	Diabetes_McGill_Mtor_pathway	KARLSSON_TGFB1_TARGETS_DN
4.34782608696%	1	23	206	Diabetes_McGill_Mtor_pathway	BILD_MYC_ONCOGENIC_SIGNATURE
4.34782608696%	1	23	205	Diabetes_McGill_Mtor_pathway	SHEPARD_BMYB_MORPHOLINO_UP
4.34782608696%	1	23	204	Diabetes_McGill_Mtor_pathway	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
4.34782608696%	1	23	203	Diabetes_McGill_Mtor_pathway	REACTOME_INFLUENZA_LIFE_CYCLE
4.34782608696%	1	23	203	Diabetes_McGill_Mtor_pathway	PENG_RAPAMYCIN_RESPONSE_UP
4.34782608696%	1	23	203	Diabetes_McGill_Mtor_pathway	PAL_PRMT5_TARGETS_UP
4.34782608696%	1	23	200	Diabetes_McGill_Mtor_pathway	LEE_DIFFERENTIATING_T_LYMPHOCYTE
4.34782608696%	1	23	20	Diabetes_McGill_Mtor_pathway	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
4.34782608696%	1	23	20	Diabetes_McGill_Mtor_pathway	REACTOME_ENOS_ACTIVATION_AND_REGULATION
4.34782608696%	1	23	197	Diabetes_McGill_Mtor_pathway	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
4.34782608696%	1	23	196	Diabetes_McGill_Mtor_pathway	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
4.34782608696%	1	23	195	Diabetes_McGill_Mtor_pathway	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
4.34782608696%	1	23	194	Diabetes_McGill_Mtor_pathway	PROVENZANI_METASTASIS_UP
4.34782608696%	1	23	193	Diabetes_McGill_Mtor_pathway	MOHANKUMAR_TLX1_TARGETS_DN
4.34782608696%	1	23	192	Diabetes_McGill_Mtor_pathway	REACTOME_DNA_REPLICATION
4.34782608696%	1	23	19	Diabetes_McGill_Mtor_pathway	REACTOME_PYRUVATE_METABOLISM
4.34782608696%	1	23	19	Diabetes_McGill_Mtor_pathway	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
4.34782608696%	1	23	186	Diabetes_McGill_Mtor_pathway	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
4.34782608696%	1	23	185	Diabetes_McGill_Mtor_pathway	ZHANG_TLX_TARGETS_36HR_DN
4.34782608696%	1	23	185	Diabetes_McGill_Mtor_pathway	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
4.34782608696%	1	23	185	Diabetes_McGill_Mtor_pathway	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
4.34782608696%	1	23	184	Diabetes_McGill_Mtor_pathway	DOANE_RESPONSE_TO_ANDROGEN_UP
4.34782608696%	1	23	183	Diabetes_McGill_Mtor_pathway	OKUMURA_INFLAMMATORY_RESPONSE_LPS
4.34782608696%	1	23	182	Diabetes_McGill_Mtor_pathway	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
4.34782608696%	1	23	181	Diabetes_McGill_Mtor_pathway	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
4.34782608696%	1	23	181	Diabetes_McGill_Mtor_pathway	JISON_SICKLE_CELL_DISEASE_UP
4.34782608696%	1	23	180	Diabetes_McGill_Mtor_pathway	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
4.34782608696%	1	23	18	Diabetes_McGill_Mtor_pathway	YIH_RESPONSE_TO_ARSENITE_C4
4.34782608696%	1	23	18	Diabetes_McGill_Mtor_pathway	PIONTEK_PKD1_TARGETS_DN
4.34782608696%	1	23	18	Diabetes_McGill_Mtor_pathway	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8
4.34782608696%	1	23	179	Diabetes_McGill_Mtor_pathway	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE
4.34782608696%	1	23	178	Diabetes_McGill_Mtor_pathway	BROWNE_HCMV_INFECTION_18HR_DN
4.34782608696%	1	23	177	Diabetes_McGill_Mtor_pathway	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
4.34782608696%	1	23	176	Diabetes_McGill_Mtor_pathway	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
4.34782608696%	1	23	175	Diabetes_McGill_Mtor_pathway	LEE_LIVER_CANCER_SURVIVAL_DN
4.34782608696%	1	23	175	Diabetes_McGill_Mtor_pathway	FIRESTEIN_PROLIFERATION
4.34782608696%	1	23	174	Diabetes_McGill_Mtor_pathway	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
4.34782608696%	1	23	172	Diabetes_McGill_Mtor_pathway	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
4.34782608696%	1	23	172	Diabetes_McGill_Mtor_pathway	REACTOME_MITOTIC_M_M_G1_PHASES
4.34782608696%	1	23	170	Diabetes_McGill_Mtor_pathway	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
4.34782608696%	1	23	170	Diabetes_McGill_Mtor_pathway	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
4.34782608696%	1	23	170	Diabetes_McGill_Mtor_pathway	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
4.34782608696%	1	23	17	Diabetes_McGill_Mtor_pathway	ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL
4.34782608696%	1	23	17	Diabetes_McGill_Mtor_pathway	REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP
4.34782608696%	1	23	17	Diabetes_McGill_Mtor_pathway	REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1
4.34782608696%	1	23	17	Diabetes_McGill_Mtor_pathway	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS
4.34782608696%	1	23	17	Diabetes_McGill_Mtor_pathway	LIU_IL13_MEMORY_MODEL_UP
4.34782608696%	1	23	17	Diabetes_McGill_Mtor_pathway	BIOCARTA_CK1_PATHWAY
4.34782608696%	1	23	1691	Diabetes_McGill_Mtor_pathway	BLALOCK_ALZHEIMERS_DISEASE_UP
4.34782608696%	1	23	169	Diabetes_McGill_Mtor_pathway	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION
4.34782608696%	1	23	169	Diabetes_McGill_Mtor_pathway	ONDER_CDH1_TARGETS_1_DN
4.34782608696%	1	23	169	Diabetes_McGill_Mtor_pathway	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
4.34782608696%	1	23	165	Diabetes_McGill_Mtor_pathway	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
4.34782608696%	1	23	165	Diabetes_McGill_Mtor_pathway	LIU_CMYB_TARGETS_UP
4.34782608696%	1	23	163	Diabetes_McGill_Mtor_pathway	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
4.34782608696%	1	23	161	Diabetes_McGill_Mtor_pathway	REACTOME_MRNA_PROCESSING
4.34782608696%	1	23	161	Diabetes_McGill_Mtor_pathway	BIDUS_METASTASIS_DN
4.34782608696%	1	23	161	Diabetes_McGill_Mtor_pathway	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
4.34782608696%	1	23	160	Diabetes_McGill_Mtor_pathway	BROWNE_HCMV_INFECTION_6HR_DN
4.34782608696%	1	23	16	Diabetes_McGill_Mtor_pathway	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION
4.34782608696%	1	23	16	Diabetes_McGill_Mtor_pathway	REACTOME_PLATELET_SENSITIZATION_BY_LDL
4.34782608696%	1	23	16	Diabetes_McGill_Mtor_pathway	REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE
4.34782608696%	1	23	16	Diabetes_McGill_Mtor_pathway	FARMER_BREAST_CANCER_CLUSTER_6
4.34782608696%	1	23	159	Diabetes_McGill_Mtor_pathway	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
4.34782608696%	1	23	158	Diabetes_McGill_Mtor_pathway	RODRIGUES_NTN1_TARGETS_DN
4.34782608696%	1	23	157	Diabetes_McGill_Mtor_pathway	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
4.34782608696%	1	23	153	Diabetes_McGill_Mtor_pathway	REACTOME_PEPTIDE_CHAIN_ELONGATION
4.34782608696%	1	23	153	Diabetes_McGill_Mtor_pathway	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN
4.34782608696%	1	23	151	Diabetes_McGill_Mtor_pathway	KEGG_WNT_SIGNALING_PATHWAY
4.34782608696%	1	23	151	Diabetes_McGill_Mtor_pathway	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
4.34782608696%	1	23	15	Diabetes_McGill_Mtor_pathway	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3
4.34782608696%	1	23	15	Diabetes_McGill_Mtor_pathway	COLLIS_PRKDC_REGULATORS
4.34782608696%	1	23	15	Diabetes_McGill_Mtor_pathway	BIOCARTA_AKAPCENTROSOME_PATHWAY
4.34782608696%	1	23	149	Diabetes_McGill_Mtor_pathway	LANDIS_ERBB2_BREAST_TUMORS_324_DN
4.34782608696%	1	23	149	Diabetes_McGill_Mtor_pathway	HUANG_GATA2_TARGETS_UP
4.34782608696%	1	23	148	Diabetes_McGill_Mtor_pathway	REACTOME_APOPTOSIS
4.34782608696%	1	23	148	Diabetes_McGill_Mtor_pathway	BROWNE_HCMV_INFECTION_24HR_UP
4.34782608696%	1	23	148	Diabetes_McGill_Mtor_pathway	BROWNE_HCMV_INFECTION_24HR_DN
4.34782608696%	1	23	147	Diabetes_McGill_Mtor_pathway	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
4.34782608696%	1	23	147	Diabetes_McGill_Mtor_pathway	KAUFFMANN_DNA_REPLICATION_GENES
4.34782608696%	1	23	146	Diabetes_McGill_Mtor_pathway	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
4.34782608696%	1	23	145	Diabetes_McGill_Mtor_pathway	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
4.34782608696%	1	23	145	Diabetes_McGill_Mtor_pathway	SMITH_TERT_TARGETS_UP
4.34782608696%	1	23	144	Diabetes_McGill_Mtor_pathway	BROCKE_APOPTOSIS_REVERSED_BY_IL6
4.34782608696%	1	23	143	Diabetes_McGill_Mtor_pathway	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
4.34782608696%	1	23	143	Diabetes_McGill_Mtor_pathway	BASSO_B_LYMPHOCYTE_NETWORK
4.34782608696%	1	23	142	Diabetes_McGill_Mtor_pathway	PENG_LEUCINE_DEPRIVATION_UP
4.34782608696%	1	23	141	Diabetes_McGill_Mtor_pathway	WELCSH_BRCA1_TARGETS_DN
4.34782608696%	1	23	141	Diabetes_McGill_Mtor_pathway	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
4.34782608696%	1	23	141	Diabetes_McGill_Mtor_pathway	KAAB_FAILED_HEART_ATRIUM_DN
4.34782608696%	1	23	140	Diabetes_McGill_Mtor_pathway	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
4.34782608696%	1	23	140	Diabetes_McGill_Mtor_pathway	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
4.34782608696%	1	23	140	Diabetes_McGill_Mtor_pathway	JOHNSTONE_PARVB_TARGETS_2_UP
4.34782608696%	1	23	140	Diabetes_McGill_Mtor_pathway	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
4.34782608696%	1	23	14	Diabetes_McGill_Mtor_pathway	WU_ALZHEIMER_DISEASE_UP
4.34782608696%	1	23	139	Diabetes_McGill_Mtor_pathway	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
4.34782608696%	1	23	138	Diabetes_McGill_Mtor_pathway	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
4.34782608696%	1	23	138	Diabetes_McGill_Mtor_pathway	JIANG_VHL_TARGETS
4.34782608696%	1	23	137	Diabetes_McGill_Mtor_pathway	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
4.34782608696%	1	23	137	Diabetes_McGill_Mtor_pathway	REACTOME_MITOTIC_G1_G1_S_PHASES
4.34782608696%	1	23	134	Diabetes_McGill_Mtor_pathway	SCHLOSSER_SERUM_RESPONSE_UP
4.34782608696%	1	23	134	Diabetes_McGill_Mtor_pathway	POOLA_INVASIVE_BREAST_CANCER_DN
4.34782608696%	1	23	1305	Diabetes_McGill_Mtor_pathway	YOSHIMURA_MAPK8_TARGETS_UP
4.34782608696%	1	23	13	Diabetes_McGill_Mtor_pathway	REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION
4.34782608696%	1	23	13	Diabetes_McGill_Mtor_pathway	REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX
4.34782608696%	1	23	13	Diabetes_McGill_Mtor_pathway	REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1
4.34782608696%	1	23	13	Diabetes_McGill_Mtor_pathway	IRITANI_MAD1_TARGETS_UP
4.34782608696%	1	23	13	Diabetes_McGill_Mtor_pathway	GHO_ATF5_TARGETS_UP
4.34782608696%	1	23	13	Diabetes_McGill_Mtor_pathway	CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP
4.34782608696%	1	23	129	Diabetes_McGill_Mtor_pathway	BROWN_MYELOID_CELL_DEVELOPMENT_DN
4.34782608696%	1	23	128	Diabetes_McGill_Mtor_pathway	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
4.34782608696%	1	23	1278	Diabetes_McGill_Mtor_pathway	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
4.34782608696%	1	23	123	Diabetes_McGill_Mtor_pathway	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
4.34782608696%	1	23	123	Diabetes_McGill_Mtor_pathway	DAZARD_RESPONSE_TO_UV_SCC_UP
4.34782608696%	1	23	122	Diabetes_McGill_Mtor_pathway	TOOKER_GEMCITABINE_RESISTANCE_DN
4.34782608696%	1	23	1210	Diabetes_McGill_Mtor_pathway	CHEN_METABOLIC_SYNDROM_NETWORK
4.34782608696%	1	23	121	Diabetes_McGill_Mtor_pathway	RODRIGUES_DCC_TARGETS_DN
4.34782608696%	1	23	121	Diabetes_McGill_Mtor_pathway	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
4.34782608696%	1	23	120	Diabetes_McGill_Mtor_pathway	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
4.34782608696%	1	23	120	Diabetes_McGill_Mtor_pathway	NIKOLSKY_BREAST_CANCER_16P13_AMPLICON
4.34782608696%	1	23	120	Diabetes_McGill_Mtor_pathway	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
4.34782608696%	1	23	120	Diabetes_McGill_Mtor_pathway	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
4.34782608696%	1	23	12	Diabetes_McGill_Mtor_pathway	REACTOME_ERKS_ARE_INACTIVATED
4.34782608696%	1	23	12	Diabetes_McGill_Mtor_pathway	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING
4.34782608696%	1	23	12	Diabetes_McGill_Mtor_pathway	BIOCARTA_VDR_PATHWAY
4.34782608696%	1	23	12	Diabetes_McGill_Mtor_pathway	BIOCARTA_AKAP95_PATHWAY
4.34782608696%	1	23	118	Diabetes_McGill_Mtor_pathway	REACTOME_TOLL_RECEPTOR_CASCADES
4.34782608696%	1	23	118	Diabetes_McGill_Mtor_pathway	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
4.34782608696%	1	23	1174	Diabetes_McGill_Mtor_pathway	PEREZ_TP53_TARGETS
4.34782608696%	1	23	117	Diabetes_McGill_Mtor_pathway	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
4.34782608696%	1	23	116	Diabetes_McGill_Mtor_pathway	MATTIOLI_MGUS_VS_PCL
4.34782608696%	1	23	116	Diabetes_McGill_Mtor_pathway	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
4.34782608696%	1	23	114	Diabetes_McGill_Mtor_pathway	ROPERO_HDAC2_TARGETS
4.34782608696%	1	23	114	Diabetes_McGill_Mtor_pathway	KEGG_OOCYTE_MEIOSIS
4.34782608696%	1	23	112	Diabetes_McGill_Mtor_pathway	REACTOME_G1_S_TRANSITION
4.34782608696%	1	23	110	Diabetes_McGill_Mtor_pathway	WOOD_EBV_EBNA1_TARGETS_UP
4.34782608696%	1	23	11	Diabetes_McGill_Mtor_pathway	REACTOME_IL_7_SIGNALING
4.34782608696%	1	23	11	Diabetes_McGill_Mtor_pathway	PID_ALK2PATHWAY
4.34782608696%	1	23	11	Diabetes_McGill_Mtor_pathway	MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN
4.34782608696%	1	23	11	Diabetes_McGill_Mtor_pathway	BIOCARTA_P35ALZHEIMERS_PATHWAY
4.34782608696%	1	23	108	Diabetes_McGill_Mtor_pathway	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
4.34782608696%	1	23	108	Diabetes_McGill_Mtor_pathway	LE_EGR2_TARGETS_DN
4.34782608696%	1	23	107	Diabetes_McGill_Mtor_pathway	SESTO_RESPONSE_TO_UV_C0
4.34782608696%	1	23	1069	Diabetes_McGill_Mtor_pathway	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
4.34782608696%	1	23	106	Diabetes_McGill_Mtor_pathway	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
4.34782608696%	1	23	106	Diabetes_McGill_Mtor_pathway	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
4.34782608696%	1	23	105	Diabetes_McGill_Mtor_pathway	HELLER_SILENCED_BY_METHYLATION_DN
4.34782608696%	1	23	103	Diabetes_McGill_Mtor_pathway	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
4.34782608696%	1	23	102	Diabetes_McGill_Mtor_pathway	DER_IFN_BETA_RESPONSE_UP
4.34782608696%	1	23	102	Diabetes_McGill_Mtor_pathway	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
4.34782608696%	1	23	101	Diabetes_McGill_Mtor_pathway	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
4.34782608696%	1	23	100	Diabetes_McGill_Mtor_pathway	QI_PLASMACYTOMA_DN
4.34782608696%	1	23	100	Diabetes_McGill_Mtor_pathway	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
4.34782608696%	1	23	100	Diabetes_McGill_Mtor_pathway	CHICAS_RB1_TARGETS_LOW_SERUM
4.34782608696%	1	23	10	Diabetes_McGill_Mtor_pathway	BIOCARTA_SARS_PATHWAY
4.32923570283%	81	1871	920	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_GPCR
4.32923570283%	81	1871	882	T2D_GENES_TANYA_HEIGHT	LEE_BMP2_TARGETS_DN
4.32923570283%	81	1871	800	T2D_GENES_TANYA_HEIGHT	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
4.32923570283%	81	1871	770	T2D_GENES_TANYA_HEIGHT	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
4.30597771023%	85	1974	800	Mendelian_Nancy_Cox	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
4.30597771023%	85	1974	795	Mendelian_Nancy_Cox	WEI_MYCN_TARGETS_WITH_E_BOX
4.30597771023%	85	1974	637	Mendelian_Nancy_Cox	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
4.30597771023%	85	1974	590	Mendelian_Nancy_Cox	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
4.30597771023%	85	1974	584	Mendelian_Nancy_Cox	HAMAI_APOPTOSIS_VIA_TRAIL_UP
4.30597771023%	85	1974	552	Mendelian_Nancy_Cox	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
4.30597771023%	85	1974	514	Mendelian_Nancy_Cox	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
4.30597771023%	85	1974	508	Mendelian_Nancy_Cox	ENK_UV_RESPONSE_EPIDERMIS_DN
4.30597771023%	85	1974	425	Mendelian_Nancy_Cox	BOCHKIS_FOXA2_TARGETS
4.29777436685%	56	1303	1375	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DODD_NASOPHARYNGEAL_CARCINOMA_DN
4.28977272727%	151	3520	1442	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PUJANA_ATM_PCC_NETWORK
4.28571428571%	3	70	97	Diabetes_McGill_Adipocytokine_signallin	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
4.28571428571%	3	70	92	Diabetes_McGill_Adipocytokine_signallin	HILLION_HMGA1B_TARGETS
4.28571428571%	3	70	9	Diabetes_McGill_Adipocytokine_signallin	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK
4.28571428571%	3	70	898	Diabetes_McGill_Adipocytokine_signallin	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
4.28571428571%	3	70	893	Diabetes_McGill_Adipocytokine_signallin	GEORGES_TARGETS_OF_MIR192_AND_MIR215
4.28571428571%	3	70	89	Diabetes_McGill_Adipocytokine_signallin	KANG_IMMORTALIZED_BY_TERT_UP
4.28571428571%	3	70	87	Diabetes_McGill_Adipocytokine_signallin	SMITH_TERT_TARGETS_DN
4.28571428571%	3	70	86	Diabetes_McGill_Adipocytokine_signallin	LEE_AGING_CEREBELLUM_DN
4.28571428571%	3	70	84	Diabetes_McGill_Adipocytokine_signallin	SMID_BREAST_CANCER_LUMINAL_A_UP
4.28571428571%	3	70	811	Diabetes_McGill_Adipocytokine_signallin	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
4.28571428571%	3	70	800	Diabetes_McGill_Adipocytokine_signallin	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
4.28571428571%	3	70	79	Diabetes_McGill_Adipocytokine_signallin	DUAN_PRDM5_TARGETS
4.28571428571%	3	70	783	Diabetes_McGill_Adipocytokine_signallin	ONKEN_UVEAL_MELANOMA_UP
4.28571428571%	3	70	783	Diabetes_McGill_Adipocytokine_signallin	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
4.28571428571%	3	70	78	Diabetes_McGill_Adipocytokine_signallin	RADMACHER_AML_PROGNOSIS
4.28571428571%	3	70	770	Diabetes_McGill_Adipocytokine_signallin	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
4.28571428571%	3	70	77	Diabetes_McGill_Adipocytokine_signallin	JACKSON_DNMT1_TARGETS_UP
4.28571428571%	3	70	76	Diabetes_McGill_Adipocytokine_signallin	KEGG_VEGF_SIGNALING_PATHWAY
4.28571428571%	3	70	75	Diabetes_McGill_Adipocytokine_signallin	PID_AVB3_INTEGRIN_PATHWAY
4.28571428571%	3	70	74	Diabetes_McGill_Adipocytokine_signallin	LEE_LIVER_CANCER_DENA_DN
4.28571428571%	3	70	722	Diabetes_McGill_Adipocytokine_signallin	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
4.28571428571%	3	70	712	Diabetes_McGill_Adipocytokine_signallin	SCHLOSSER_SERUM_RESPONSE_DN
4.28571428571%	3	70	71	Diabetes_McGill_Adipocytokine_signallin	KEGG_MELANOMA
4.28571428571%	3	70	70	Diabetes_McGill_Adipocytokine_signallin	PID_CDC42_PATHWAY
4.28571428571%	3	70	682	Diabetes_McGill_Adipocytokine_signallin	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
4.28571428571%	3	70	68	Diabetes_McGill_Adipocytokine_signallin	PID_TELOMERASEPATHWAY
4.28571428571%	3	70	66	Diabetes_McGill_Adipocytokine_signallin	PID_HIF1_TFPATHWAY
4.28571428571%	3	70	66	Diabetes_McGill_Adipocytokine_signallin	DIRMEIER_LMP1_RESPONSE_EARLY
4.28571428571%	3	70	64	Diabetes_McGill_Adipocytokine_signallin	LEE_LIVER_CANCER_E2F1_DN
4.28571428571%	3	70	612	Diabetes_McGill_Adipocytokine_signallin	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
4.28571428571%	3	70	59	Diabetes_McGill_Adipocytokine_signallin	PID_P53REGULATIONPATHWAY
4.28571428571%	3	70	59	Diabetes_McGill_Adipocytokine_signallin	ASTIER_INTEGRIN_SIGNALING
4.28571428571%	3	70	58	Diabetes_McGill_Adipocytokine_signallin	SCHEIDEREIT_IKK_INTERACTING_PROTEINS
4.28571428571%	3	70	58	Diabetes_McGill_Adipocytokine_signallin	PID_SHP2_PATHWAY
4.28571428571%	3	70	579	Diabetes_McGill_Adipocytokine_signallin	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
4.28571428571%	3	70	548	Diabetes_McGill_Adipocytokine_signallin	KIM_ALL_DISORDERS_CALB1_CORR_UP
4.28571428571%	3	70	546	Diabetes_McGill_Adipocytokine_signallin	WEST_ADRENOCORTICAL_TUMOR_DN
4.28571428571%	3	70	546	Diabetes_McGill_Adipocytokine_signallin	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
4.28571428571%	3	70	54	Diabetes_McGill_Adipocytokine_signallin	PID_RAC1_PATHWAY
4.28571428571%	3	70	54	Diabetes_McGill_Adipocytokine_signallin	PID_NFAT_3PATHWAY
4.28571428571%	3	70	536	Diabetes_McGill_Adipocytokine_signallin	BERENJENO_TRANSFORMED_BY_RHOA_UP
4.28571428571%	3	70	53	Diabetes_McGill_Adipocytokine_signallin	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
4.28571428571%	3	70	52	Diabetes_McGill_Adipocytokine_signallin	KEGG_ENDOMETRIAL_CANCER
4.28571428571%	3	70	508	Diabetes_McGill_Adipocytokine_signallin	ENK_UV_RESPONSE_EPIDERMIS_DN
4.28571428571%	3	70	493	Diabetes_McGill_Adipocytokine_signallin	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
4.28571428571%	3	70	489	Diabetes_McGill_Adipocytokine_signallin	LIM_MAMMARY_STEM_CELL_UP
4.28571428571%	3	70	487	Diabetes_McGill_Adipocytokine_signallin	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
4.28571428571%	3	70	479	Diabetes_McGill_Adipocytokine_signallin	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
4.28571428571%	3	70	461	Diabetes_McGill_Adipocytokine_signallin	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
4.28571428571%	3	70	46	Diabetes_McGill_Adipocytokine_signallin	SIG_BCR_SIGNALING_PATHWAY
4.28571428571%	3	70	46	Diabetes_McGill_Adipocytokine_signallin	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
4.28571428571%	3	70	457	Diabetes_McGill_Adipocytokine_signallin	SENESE_HDAC1_TARGETS_UP
4.28571428571%	3	70	457	Diabetes_McGill_Adipocytokine_signallin	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
4.28571428571%	3	70	456	Diabetes_McGill_Adipocytokine_signallin	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
4.28571428571%	3	70	455	Diabetes_McGill_Adipocytokine_signallin	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
4.28571428571%	3	70	45	Diabetes_McGill_Adipocytokine_signallin	SIG_CHEMOTAXIS
4.28571428571%	3	70	45	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_BIOPEPTIDES_PATHWAY
4.28571428571%	3	70	447	Diabetes_McGill_Adipocytokine_signallin	MOOTHA_MITOCHONDRIA
4.28571428571%	3	70	442	Diabetes_McGill_Adipocytokine_signallin	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
4.28571428571%	3	70	44	Diabetes_McGill_Adipocytokine_signallin	OHGUCHI_LIVER_HNF4A_TARGETS_UP
4.28571428571%	3	70	439	Diabetes_McGill_Adipocytokine_signallin	MITSIADES_RESPONSE_TO_APLIDIN_UP
4.28571428571%	3	70	425	Diabetes_McGill_Adipocytokine_signallin	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
4.28571428571%	3	70	423	Diabetes_McGill_Adipocytokine_signallin	THUM_SYSTOLIC_HEART_FAILURE_UP
4.28571428571%	3	70	422	Diabetes_McGill_Adipocytokine_signallin	YAGI_AML_WITH_INV_16_TRANSLOCATION
4.28571428571%	3	70	42	Diabetes_McGill_Adipocytokine_signallin	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
4.28571428571%	3	70	414	Diabetes_McGill_Adipocytokine_signallin	LU_EZH2_TARGETS_DN
4.28571428571%	3	70	411	Diabetes_McGill_Adipocytokine_signallin	KOYAMA_SEMA3B_TARGETS_DN
4.28571428571%	3	70	41	Diabetes_McGill_Adipocytokine_signallin	PID_AMB2_NEUTROPHILS_PATHWAY
4.28571428571%	3	70	408	Diabetes_McGill_Adipocytokine_signallin	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
4.28571428571%	3	70	406	Diabetes_McGill_Adipocytokine_signallin	OSMAN_BLADDER_CANCER_DN
4.28571428571%	3	70	40	Diabetes_McGill_Adipocytokine_signallin	KEGG_PYRUVATE_METABOLISM
4.28571428571%	3	70	394	Diabetes_McGill_Adipocytokine_signallin	BERENJENO_TRANSFORMED_BY_RHOA_DN
4.28571428571%	3	70	392	Diabetes_McGill_Adipocytokine_signallin	LINDGREN_BLADDER_CANCER_CLUSTER_2B
4.28571428571%	3	70	39	Diabetes_McGill_Adipocytokine_signallin	REACTOME_IL1_SIGNALING
4.28571428571%	3	70	39	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_FMLP_PATHWAY
4.28571428571%	3	70	38	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_IL2RB_PATHWAY
4.28571428571%	3	70	372	Diabetes_McGill_Adipocytokine_signallin	WANG_LMO4_TARGETS_UP
4.28571428571%	3	70	37	Diabetes_McGill_Adipocytokine_signallin	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
4.28571428571%	3	70	37	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_MET_PATHWAY
4.28571428571%	3	70	368	Diabetes_McGill_Adipocytokine_signallin	YAGI_AML_WITH_T_8_21_TRANSLOCATION
4.28571428571%	3	70	367	Diabetes_McGill_Adipocytokine_signallin	VECCHI_GASTRIC_CANCER_EARLY_DN
4.28571428571%	3	70	36	Diabetes_McGill_Adipocytokine_signallin	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
4.28571428571%	3	70	36	Diabetes_McGill_Adipocytokine_signallin	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION
4.28571428571%	3	70	358	Diabetes_McGill_Adipocytokine_signallin	GRUETZMANN_PANCREATIC_CANCER_UP
4.28571428571%	3	70	357	Diabetes_McGill_Adipocytokine_signallin	SHEN_SMARCA2_TARGETS_DN
4.28571428571%	3	70	356	Diabetes_McGill_Adipocytokine_signallin	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
4.28571428571%	3	70	351	Diabetes_McGill_Adipocytokine_signallin	YAGI_AML_WITH_11Q23_REARRANGED
4.28571428571%	3	70	341	Diabetes_McGill_Adipocytokine_signallin	MULLIGHAN_NPM1_SIGNATURE_3_UP
4.28571428571%	3	70	34	Diabetes_McGill_Adipocytokine_signallin	ST_WNT_BETA_CATENIN_PATHWAY
4.28571428571%	3	70	338	Diabetes_McGill_Adipocytokine_signallin	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
4.28571428571%	3	70	335	Diabetes_McGill_Adipocytokine_signallin	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
4.28571428571%	3	70	330	Diabetes_McGill_Adipocytokine_signallin	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
4.28571428571%	3	70	33	Diabetes_McGill_Adipocytokine_signallin	PID_IL12_STAT4PATHWAY
4.28571428571%	3	70	320	Diabetes_McGill_Adipocytokine_signallin	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
4.28571428571%	3	70	32	Diabetes_McGill_Adipocytokine_signallin	PID_WNT_NONCANONICAL_PATHWAY
4.28571428571%	3	70	317	Diabetes_McGill_Adipocytokine_signallin	BRUINS_UVC_RESPONSE_EARLY_LATE
4.28571428571%	3	70	314	Diabetes_McGill_Adipocytokine_signallin	DOUGLAS_BMI1_TARGETS_DN
4.28571428571%	3	70	314	Diabetes_McGill_Adipocytokine_signallin	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
4.28571428571%	3	70	31	Diabetes_McGill_Adipocytokine_signallin	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
4.28571428571%	3	70	309	Diabetes_McGill_Adipocytokine_signallin	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
4.28571428571%	3	70	308	Diabetes_McGill_Adipocytokine_signallin	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
4.28571428571%	3	70	307	Diabetes_McGill_Adipocytokine_signallin	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
4.28571428571%	3	70	30	Diabetes_McGill_Adipocytokine_signallin	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
4.28571428571%	3	70	30	Diabetes_McGill_Adipocytokine_signallin	REACTOME_NOD1_2_SIGNALING_PATHWAY
4.28571428571%	3	70	30	Diabetes_McGill_Adipocytokine_signallin	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES
4.28571428571%	3	70	29	Diabetes_McGill_Adipocytokine_signallin	PID_S1P_S1P3_PATHWAY
4.28571428571%	3	70	29	Diabetes_McGill_Adipocytokine_signallin	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
4.28571428571%	3	70	29	Diabetes_McGill_Adipocytokine_signallin	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
4.28571428571%	3	70	29	Diabetes_McGill_Adipocytokine_signallin	KEGG_THYROID_CANCER
4.28571428571%	3	70	289	Diabetes_McGill_Adipocytokine_signallin	GABRIELY_MIR21_TARGETS
4.28571428571%	3	70	282	Diabetes_McGill_Adipocytokine_signallin	HELLER_SILENCED_BY_METHYLATION_UP
4.28571428571%	3	70	28	Diabetes_McGill_Adipocytokine_signallin	TIAN_TNF_SIGNALING_VIA_NFKB
4.28571428571%	3	70	28	Diabetes_McGill_Adipocytokine_signallin	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
4.28571428571%	3	70	28	Diabetes_McGill_Adipocytokine_signallin	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING
4.28571428571%	3	70	28	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_GH_PATHWAY
4.28571428571%	3	70	276	Diabetes_McGill_Adipocytokine_signallin	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
4.28571428571%	3	70	271	Diabetes_McGill_Adipocytokine_signallin	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
4.28571428571%	3	70	27	Diabetes_McGill_Adipocytokine_signallin	ST_GRANULE_CELL_SURVIVAL_PATHWAY
4.28571428571%	3	70	27	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_GSK3_PATHWAY
4.28571428571%	3	70	261	Diabetes_McGill_Adipocytokine_signallin	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
4.28571428571%	3	70	261	Diabetes_McGill_Adipocytokine_signallin	RICKMAN_METASTASIS_DN
4.28571428571%	3	70	26	Diabetes_McGill_Adipocytokine_signallin	PID_INSULIN_GLUCOSE_PATHWAY
4.28571428571%	3	70	26	Diabetes_McGill_Adipocytokine_signallin	PID_IL27PATHWAY
4.28571428571%	3	70	26	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_PGC1A_PATHWAY
4.28571428571%	3	70	26	Diabetes_McGill_Adipocytokine_signallin	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
4.28571428571%	3	70	259	Diabetes_McGill_Adipocytokine_signallin	QI_PLASMACYTOMA_UP
4.28571428571%	3	70	254	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_4HR_DN
4.28571428571%	3	70	253	Diabetes_McGill_Adipocytokine_signallin	MCLACHLAN_DENTAL_CARIES_UP
4.28571428571%	3	70	253	Diabetes_McGill_Adipocytokine_signallin	DANG_REGULATED_BY_MYC_DN
4.28571428571%	3	70	25	Diabetes_McGill_Adipocytokine_signallin	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
4.28571428571%	3	70	25	Diabetes_McGill_Adipocytokine_signallin	PID_TOLL_ENDOGENOUS_PATHWAY
4.28571428571%	3	70	244	Diabetes_McGill_Adipocytokine_signallin	KAYO_AGING_MUSCLE_UP
4.28571428571%	3	70	242	Diabetes_McGill_Adipocytokine_signallin	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
4.28571428571%	3	70	240	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_20HR_UP
4.28571428571%	3	70	24	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_EIF4_PATHWAY
4.28571428571%	3	70	237	Diabetes_McGill_Adipocytokine_signallin	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
4.28571428571%	3	70	234	Diabetes_McGill_Adipocytokine_signallin	AFFAR_YY1_TARGETS_DN
4.28571428571%	3	70	232	Diabetes_McGill_Adipocytokine_signallin	DELYS_THYROID_CANCER_DN
4.28571428571%	3	70	23	Diabetes_McGill_Adipocytokine_signallin	REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA
4.28571428571%	3	70	23	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_P53HYPOXIA_PATHWAY
4.28571428571%	3	70	23	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_GLEEVEC_PATHWAY
4.28571428571%	3	70	222	Diabetes_McGill_Adipocytokine_signallin	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
4.28571428571%	3	70	221	Diabetes_McGill_Adipocytokine_signallin	PEDRIOLI_MIR31_TARGETS_UP
4.28571428571%	3	70	22	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_IL6_PATHWAY
4.28571428571%	3	70	22	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_GCR_PATHWAY
4.28571428571%	3	70	215	Diabetes_McGill_Adipocytokine_signallin	MARKEY_RB1_ACUTE_LOF_UP
4.28571428571%	3	70	214	Diabetes_McGill_Adipocytokine_signallin	KIM_WT1_TARGETS_UP
4.28571428571%	3	70	21	Diabetes_McGill_Adipocytokine_signallin	REACTOME_CTLA4_INHIBITORY_SIGNALING
4.28571428571%	3	70	21	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_IGF1_PATHWAY
4.28571428571%	3	70	20	Diabetes_McGill_Adipocytokine_signallin	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
4.28571428571%	3	70	1839	Diabetes_McGill_Adipocytokine_signallin	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
4.28571428571%	3	70	181	Diabetes_McGill_Adipocytokine_signallin	JISON_SICKLE_CELL_DISEASE_UP
4.28571428571%	3	70	178	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_18HR_UP
4.28571428571%	3	70	17	Diabetes_McGill_Adipocytokine_signallin	SA_TRKA_RECEPTOR
4.28571428571%	3	70	17	Diabetes_McGill_Adipocytokine_signallin	SA_PTEN_PATHWAY
4.28571428571%	3	70	17	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_PML_PATHWAY
4.28571428571%	3	70	17	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_HCMV_PATHWAY
4.28571428571%	3	70	169	Diabetes_McGill_Adipocytokine_signallin	UEDA_PERIFERAL_CLOCK
4.28571428571%	3	70	169	Diabetes_McGill_Adipocytokine_signallin	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
4.28571428571%	3	70	163	Diabetes_McGill_Adipocytokine_signallin	LIN_NPAS4_TARGETS_UP
4.28571428571%	3	70	161	Diabetes_McGill_Adipocytokine_signallin	BIDUS_METASTASIS_DN
4.28571428571%	3	70	160	Diabetes_McGill_Adipocytokine_signallin	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
4.28571428571%	3	70	16	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_IL22BP_PATHWAY
4.28571428571%	3	70	158	Diabetes_McGill_Adipocytokine_signallin	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
4.28571428571%	3	70	154	Diabetes_McGill_Adipocytokine_signallin	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
4.28571428571%	3	70	151	Diabetes_McGill_Adipocytokine_signallin	KEGG_WNT_SIGNALING_PATHWAY
4.28571428571%	3	70	15	Diabetes_McGill_Adipocytokine_signallin	SA_MMP_CYTOKINE_CONNECTION
4.28571428571%	3	70	149	Diabetes_McGill_Adipocytokine_signallin	LANDIS_ERBB2_BREAST_TUMORS_324_DN
4.28571428571%	3	70	149	Diabetes_McGill_Adipocytokine_signallin	GOZGIT_ESR1_TARGETS_UP
4.28571428571%	3	70	145	Diabetes_McGill_Adipocytokine_signallin	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
4.28571428571%	3	70	141	Diabetes_McGill_Adipocytokine_signallin	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
4.28571428571%	3	70	140	Diabetes_McGill_Adipocytokine_signallin	ONDER_CDH1_TARGETS_1_UP
4.28571428571%	3	70	14	Diabetes_McGill_Adipocytokine_signallin	ZHANG_ADIPOGENESIS_BY_BMP7
4.28571428571%	3	70	14	Diabetes_McGill_Adipocytokine_signallin	REACTOME_P75NTR_SIGNALS_VIA_NFKB
4.28571428571%	3	70	14	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_RANKL_PATHWAY
4.28571428571%	3	70	137	Diabetes_McGill_Adipocytokine_signallin	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
4.28571428571%	3	70	134	Diabetes_McGill_Adipocytokine_signallin	SCHLOSSER_SERUM_RESPONSE_UP
4.28571428571%	3	70	129	Diabetes_McGill_Adipocytokine_signallin	YAGI_AML_SURVIVAL
4.28571428571%	3	70	128	Diabetes_McGill_Adipocytokine_signallin	LENAOUR_DENDRITIC_CELL_MATURATION_DN
4.28571428571%	3	70	12	Diabetes_McGill_Adipocytokine_signallin	REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10
4.28571428571%	3	70	12	Diabetes_McGill_Adipocytokine_signallin	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING
4.28571428571%	3	70	11	Diabetes_McGill_Adipocytokine_signallin	REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL
4.28571428571%	3	70	11	Diabetes_McGill_Adipocytokine_signallin	REACTOME_IL_6_SIGNALING
4.28571428571%	3	70	108	Diabetes_McGill_Adipocytokine_signallin	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
4.28571428571%	3	70	108	Diabetes_McGill_Adipocytokine_signallin	LE_EGR2_TARGETS_DN
4.28571428571%	3	70	105	Diabetes_McGill_Adipocytokine_signallin	AMUNDSON_GENOTOXIC_SIGNATURE
4.28571428571%	3	70	101	Diabetes_McGill_Adipocytokine_signallin	KEGG_GNRH_SIGNALING_PATHWAY
4.28571428571%	3	70	10	Diabetes_McGill_Adipocytokine_signallin	REACTOME_IRAK1_RECRUITS_IKK_COMPLEX
4.28571428571%	3	70	10	Diabetes_McGill_Adipocytokine_signallin	REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1
4.28571428571%	3	70	10	Diabetes_McGill_Adipocytokine_signallin	REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS
4.28571428571%	3	70	10	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_FREE_PATHWAY
4.27782888684%	93	2174	718	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_ES_ICP_WITH_H3K4ME3
4.27578834848%	80	1871	605	T2D_GENES_TANYA_HEIGHT	CAIRO_HEPATOBLASTOMA_CLASSES_UP
4.27578834848%	80	1871	1038	T2D_GENES_TANYA_HEIGHT	BENPORATH_SUZ12_TARGETS
4.2600896861%	19	446	1305	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YOSHIMURA_MAPK8_TARGETS_UP
4.25531914894%	84	1974	476	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_NORMAL_LIKE_UP
4.25531914894%	54	1269	1972	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PILON_KLF1_TARGETS_DN
4.24354243542%	23	542	940	T2D_GENES_TANYA_ANTHROPOMETRIC	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
4.24354243542%	23	542	769	T2D_GENES_TANYA_ANTHROPOMETRIC	NUYTTEN_NIPP1_TARGETS_UP
4.24354243542%	23	542	605	T2D_GENES_TANYA_ANTHROPOMETRIC	CAIRO_HEPATOBLASTOMA_CLASSES_UP
4.24354243542%	23	542	459	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_WT1_TARGETS_DN
4.24354243542%	23	542	1174	T2D_GENES_TANYA_ANTHROPOMETRIC	PEREZ_TP53_TARGETS
4.24354243542%	23	542	1069	T2D_GENES_TANYA_ANTHROPOMETRIC	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
4.24354243542%	23	542	1024	T2D_GENES_TANYA_ANTHROPOMETRIC	NUYTTEN_EZH2_TARGETS_DN
4.24143556281%	26	613	652	T2D_GENES_TANYA_BIOMARKER	BENPORATH_PRC2_TARGETS
4.23600605144%	28	661	988	T2D_GENES_TANYA_GLYCEMIC	BENPORATH_NANOG_TARGETS
4.23600605144%	28	661	911	T2D_GENES_TANYA_GLYCEMIC	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
4.23600605144%	28	661	493	T2D_GENES_TANYA_GLYCEMIC	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
4.23600605144%	28	661	116	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MEIOSIS
4.23600605144%	28	661	100	T2D_GENES_TANYA_GLYCEMIC	ROVERSI_GLIOMA_COPY_NUMBER_UP
4.23183072677%	92	2174	612	T2D_GENES_TANYA_LIPIDS	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
4.22234099412%	79	1871	756	T2D_GENES_TANYA_HEIGHT	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
4.22234099412%	79	1871	701	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_BASAL_DN
4.20466058764%	83	1974	633	Mendelian_Nancy_Cox	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
4.20466058764%	83	1974	543	Mendelian_Nancy_Cox	MARTINEZ_RB1_TARGETS_DN
4.20454545455%	148	3520	1725	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
4.19161676647%	49	1169	973	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ACEVEDO_LIVER_CANCER_UP
4.19161676647%	49	1169	1103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DANG_BOUND_BY_MYC
4.17651694247%	53	1269	1839	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
4.17651694247%	53	1269	1305	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YOSHIMURA_MAPK8_TARGETS_UP
4.17582417582%	19	455	911	T2D_GENES_TANYA_BLOODPRESSURE	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
4.17582417582%	19	455	871	T2D_GENES_TANYA_BLOODPRESSURE	GRADE_COLON_CANCER_UP
4.17582417582%	19	455	855	T2D_GENES_TANYA_BLOODPRESSURE	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
4.17582417582%	19	455	811	T2D_GENES_TANYA_BLOODPRESSURE	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
4.17582417582%	19	455	593	T2D_GENES_TANYA_BLOODPRESSURE	MARTINEZ_TP53_TARGETS_DN
4.17582417582%	19	455	535	T2D_GENES_TANYA_BLOODPRESSURE	STEIN_ESRRA_TARGETS
4.17582417582%	19	455	439	T2D_GENES_TANYA_BLOODPRESSURE	MITSIADES_RESPONSE_TO_APLIDIN_UP
4.17582417582%	19	455	366	T2D_GENES_TANYA_BLOODPRESSURE	YOSHIMURA_MAPK8_TARGETS_DN
4.16666666667%	1	24	99	Diabetes_McGill_TNF_alpha_signalin	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
4.16666666667%	1	24	98	Diabetes_McGill_TNF_alpha_signalin	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
4.16666666667%	1	24	98	Diabetes_McGill_TNF_alpha_signalin	BRUINS_UVC_RESPONSE_MIDDLE
4.16666666667%	1	24	97	Diabetes_McGill_TNF_alpha_signalin	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
4.16666666667%	1	24	940	Diabetes_McGill_TNF_alpha_signalin	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
4.16666666667%	1	24	93	Diabetes_McGill_TNF_alpha_signalin	ZHU_CMV_24_HR_UP
4.16666666667%	1	24	92	Diabetes_McGill_TNF_alpha_signalin	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
4.16666666667%	1	24	92	Diabetes_McGill_TNF_alpha_signalin	KEGG_DILATED_CARDIOMYOPATHY
4.16666666667%	1	24	92	Diabetes_McGill_TNF_alpha_signalin	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
4.16666666667%	1	24	92	Diabetes_McGill_TNF_alpha_signalin	HILLION_HMGA1B_TARGETS
4.16666666667%	1	24	91	Diabetes_McGill_TNF_alpha_signalin	ZHU_CMV_24_HR_DN
4.16666666667%	1	24	91	Diabetes_McGill_TNF_alpha_signalin	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
4.16666666667%	1	24	90	Diabetes_McGill_TNF_alpha_signalin	SASSON_RESPONSE_TO_FORSKOLIN_UP
4.16666666667%	1	24	90	Diabetes_McGill_TNF_alpha_signalin	IVANOVSKA_MIR106B_TARGETS
4.16666666667%	1	24	90	Diabetes_McGill_TNF_alpha_signalin	GAVIN_FOXP3_TARGETS_CLUSTER_P7
4.16666666667%	1	24	90	Diabetes_McGill_TNF_alpha_signalin	BILANGES_SERUM_SENSITIVE_GENES
4.16666666667%	1	24	9	Diabetes_McGill_TNF_alpha_signalin	CHESLER_BRAIN_D6MIT150_QTL_TRANS
4.16666666667%	1	24	893	Diabetes_McGill_TNF_alpha_signalin	GEORGES_TARGETS_OF_MIR192_AND_MIR215
4.16666666667%	1	24	89	Diabetes_McGill_TNF_alpha_signalin	WNT_SIGNALING
4.16666666667%	1	24	89	Diabetes_McGill_TNF_alpha_signalin	SWEET_KRAS_ONCOGENIC_SIGNATURE
4.16666666667%	1	24	89	Diabetes_McGill_TNF_alpha_signalin	REACTOME_RNA_POL_I_TRANSCRIPTION
4.16666666667%	1	24	89	Diabetes_McGill_TNF_alpha_signalin	LI_DCP2_BOUND_MRNA
4.16666666667%	1	24	88	Diabetes_McGill_TNF_alpha_signalin	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
4.16666666667%	1	24	88	Diabetes_McGill_TNF_alpha_signalin	KEGG_HEMATOPOIETIC_CELL_LINEAGE
4.16666666667%	1	24	88	Diabetes_McGill_TNF_alpha_signalin	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
4.16666666667%	1	24	88	Diabetes_McGill_TNF_alpha_signalin	ALCALA_APOPTOSIS
4.16666666667%	1	24	87	Diabetes_McGill_TNF_alpha_signalin	SMITH_TERT_TARGETS_DN
4.16666666667%	1	24	87	Diabetes_McGill_TNF_alpha_signalin	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
4.16666666667%	1	24	863	Diabetes_McGill_TNF_alpha_signalin	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
4.16666666667%	1	24	85	Diabetes_McGill_TNF_alpha_signalin	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
4.16666666667%	1	24	84	Diabetes_McGill_TNF_alpha_signalin	SWEET_KRAS_TARGETS_UP
4.16666666667%	1	24	84	Diabetes_McGill_TNF_alpha_signalin	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP
4.16666666667%	1	24	84	Diabetes_McGill_TNF_alpha_signalin	PID_CMYB_PATHWAY
4.16666666667%	1	24	84	Diabetes_McGill_TNF_alpha_signalin	HINATA_NFKB_TARGETS_FIBROBLAST_UP
4.16666666667%	1	24	84	Diabetes_McGill_TNF_alpha_signalin	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
4.16666666667%	1	24	83	Diabetes_McGill_TNF_alpha_signalin	SANA_TNF_SIGNALING_UP
4.16666666667%	1	24	83	Diabetes_McGill_TNF_alpha_signalin	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
4.16666666667%	1	24	83	Diabetes_McGill_TNF_alpha_signalin	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
4.16666666667%	1	24	82	Diabetes_McGill_TNF_alpha_signalin	ST_INTEGRIN_SIGNALING_PATHWAY
4.16666666667%	1	24	82	Diabetes_McGill_TNF_alpha_signalin	PID_SMAD2_3NUCLEARPATHWAY
4.16666666667%	1	24	811	Diabetes_McGill_TNF_alpha_signalin	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
4.16666666667%	1	24	81	Diabetes_McGill_TNF_alpha_signalin	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
4.16666666667%	1	24	81	Diabetes_McGill_TNF_alpha_signalin	MUNSHI_MULTIPLE_MYELOMA_UP
4.16666666667%	1	24	81	Diabetes_McGill_TNF_alpha_signalin	MAHAJAN_RESPONSE_TO_IL1A_UP
4.16666666667%	1	24	81	Diabetes_McGill_TNF_alpha_signalin	HUANG_DASATINIB_RESISTANCE_UP
4.16666666667%	1	24	81	Diabetes_McGill_TNF_alpha_signalin	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
4.16666666667%	1	24	80	Diabetes_McGill_TNF_alpha_signalin	PID_BETACATENIN_NUC_PATHWAY
4.16666666667%	1	24	80	Diabetes_McGill_TNF_alpha_signalin	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN
4.16666666667%	1	24	80	Diabetes_McGill_TNF_alpha_signalin	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
4.16666666667%	1	24	80	Diabetes_McGill_TNF_alpha_signalin	BASSO_HAIRY_CELL_LEUKEMIA_DN
4.16666666667%	1	24	8	Diabetes_McGill_TNF_alpha_signalin	TURJANSKI_MAPK8_AND_MAPK9_TARGETS
4.16666666667%	1	24	8	Diabetes_McGill_TNF_alpha_signalin	STANHILL_HRAS_TRANSFROMATION_UP
4.16666666667%	1	24	8	Diabetes_McGill_TNF_alpha_signalin	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN
4.16666666667%	1	24	8	Diabetes_McGill_TNF_alpha_signalin	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN
4.16666666667%	1	24	8	Diabetes_McGill_TNF_alpha_signalin	MIKKELSEN_PLURIPOTENT_STATE_DN
4.16666666667%	1	24	8	Diabetes_McGill_TNF_alpha_signalin	GALI_TP53_TARGETS_APOPTOTIC_UP
4.16666666667%	1	24	8	Diabetes_McGill_TNF_alpha_signalin	CLIMENT_BREAST_CANCER_COPY_NUMBER_DN
4.16666666667%	1	24	8	Diabetes_McGill_TNF_alpha_signalin	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP
4.16666666667%	1	24	79	Diabetes_McGill_TNF_alpha_signalin	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
4.16666666667%	1	24	79	Diabetes_McGill_TNF_alpha_signalin	MEISSNER_NPC_HCP_WITH_H3K27ME3
4.16666666667%	1	24	79	Diabetes_McGill_TNF_alpha_signalin	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
4.16666666667%	1	24	781	Diabetes_McGill_TNF_alpha_signalin	GOZGIT_ESR1_TARGETS_DN
4.16666666667%	1	24	78	Diabetes_McGill_TNF_alpha_signalin	REACTOME_OPIOID_SIGNALLING
4.16666666667%	1	24	78	Diabetes_McGill_TNF_alpha_signalin	RADMACHER_AML_PROGNOSIS
4.16666666667%	1	24	78	Diabetes_McGill_TNF_alpha_signalin	BOYLAN_MULTIPLE_MYELOMA_D_DN
4.16666666667%	1	24	77	Diabetes_McGill_TNF_alpha_signalin	SEKI_INFLAMMATORY_RESPONSE_LPS_UP
4.16666666667%	1	24	75	Diabetes_McGill_TNF_alpha_signalin	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
4.16666666667%	1	24	745	Diabetes_McGill_TNF_alpha_signalin	LEE_BMP2_TARGETS_UP
4.16666666667%	1	24	74	Diabetes_McGill_TNF_alpha_signalin	VANASSE_BCL2_TARGETS_DN
4.16666666667%	1	24	74	Diabetes_McGill_TNF_alpha_signalin	OUILLETTE_CLL_13Q14_DELETION_UP
4.16666666667%	1	24	74	Diabetes_McGill_TNF_alpha_signalin	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
4.16666666667%	1	24	74	Diabetes_McGill_TNF_alpha_signalin	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
4.16666666667%	1	24	74	Diabetes_McGill_TNF_alpha_signalin	JI_RESPONSE_TO_FSH_UP
4.16666666667%	1	24	74	Diabetes_McGill_TNF_alpha_signalin	DER_IFN_ALPHA_RESPONSE_UP
4.16666666667%	1	24	74	Diabetes_McGill_TNF_alpha_signalin	DARWICHE_PAPILLOMA_PROGRESSION_RISK
4.16666666667%	1	24	73	Diabetes_McGill_TNF_alpha_signalin	LIN_MELANOMA_COPY_NUMBER_UP
4.16666666667%	1	24	73	Diabetes_McGill_TNF_alpha_signalin	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
4.16666666667%	1	24	721	Diabetes_McGill_TNF_alpha_signalin	WONG_ADULT_TISSUE_STEM_MODULE
4.16666666667%	1	24	72	Diabetes_McGill_TNF_alpha_signalin	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
4.16666666667%	1	24	72	Diabetes_McGill_TNF_alpha_signalin	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
4.16666666667%	1	24	72	Diabetes_McGill_TNF_alpha_signalin	DANG_REGULATED_BY_MYC_UP
4.16666666667%	1	24	712	Diabetes_McGill_TNF_alpha_signalin	SCHLOSSER_SERUM_RESPONSE_DN
4.16666666667%	1	24	71	Diabetes_McGill_TNF_alpha_signalin	KYNG_RESPONSE_TO_H2O2
4.16666666667%	1	24	71	Diabetes_McGill_TNF_alpha_signalin	DER_IFN_GAMMA_RESPONSE_UP
4.16666666667%	1	24	71	Diabetes_McGill_TNF_alpha_signalin	BROWNE_HCMV_INFECTION_6HR_UP
4.16666666667%	1	24	70	Diabetes_McGill_TNF_alpha_signalin	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
4.16666666667%	1	24	70	Diabetes_McGill_TNF_alpha_signalin	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5
4.16666666667%	1	24	70	Diabetes_McGill_TNF_alpha_signalin	PID_AP1_PATHWAY
4.16666666667%	1	24	7	Diabetes_McGill_TNF_alpha_signalin	BUDHU_LIVER_CANCER_METASTASIS_DN
4.16666666667%	1	24	69	Diabetes_McGill_TNF_alpha_signalin	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
4.16666666667%	1	24	69	Diabetes_McGill_TNF_alpha_signalin	LEIN_NEURON_MARKERS
4.16666666667%	1	24	69	Diabetes_McGill_TNF_alpha_signalin	HOWLIN_PUBERTAL_MAMMARY_GLAND
4.16666666667%	1	24	69	Diabetes_McGill_TNF_alpha_signalin	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
4.16666666667%	1	24	69	Diabetes_McGill_TNF_alpha_signalin	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
4.16666666667%	1	24	69	Diabetes_McGill_TNF_alpha_signalin	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
4.16666666667%	1	24	682	Diabetes_McGill_TNF_alpha_signalin	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
4.16666666667%	1	24	68	Diabetes_McGill_TNF_alpha_signalin	AKL_HTLV1_INFECTION_DN
4.16666666667%	1	24	67	Diabetes_McGill_TNF_alpha_signalin	VANHARANTA_UTERINE_FIBROID_DN
4.16666666667%	1	24	67	Diabetes_McGill_TNF_alpha_signalin	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
4.16666666667%	1	24	67	Diabetes_McGill_TNF_alpha_signalin	LINDSTEDT_DENDRITIC_CELL_MATURATION_A
4.16666666667%	1	24	67	Diabetes_McGill_TNF_alpha_signalin	GENTILE_UV_LOW_DOSE_DN
4.16666666667%	1	24	67	Diabetes_McGill_TNF_alpha_signalin	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
4.16666666667%	1	24	668	Diabetes_McGill_TNF_alpha_signalin	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
4.16666666667%	1	24	66	Diabetes_McGill_TNF_alpha_signalin	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES
4.16666666667%	1	24	66	Diabetes_McGill_TNF_alpha_signalin	PID_HIF1_TFPATHWAY
4.16666666667%	1	24	66	Diabetes_McGill_TNF_alpha_signalin	NAKAMURA_ADIPOGENESIS_EARLY_UP
4.16666666667%	1	24	66	Diabetes_McGill_TNF_alpha_signalin	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
4.16666666667%	1	24	65	Diabetes_McGill_TNF_alpha_signalin	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
4.16666666667%	1	24	65	Diabetes_McGill_TNF_alpha_signalin	PID_RB_1PATHWAY
4.16666666667%	1	24	65	Diabetes_McGill_TNF_alpha_signalin	PID_ERA_GENOMIC_PATHWAY
4.16666666667%	1	24	65	Diabetes_McGill_TNF_alpha_signalin	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP
4.16666666667%	1	24	648	Diabetes_McGill_TNF_alpha_signalin	SMID_BREAST_CANCER_BASAL_UP
4.16666666667%	1	24	64	Diabetes_McGill_TNF_alpha_signalin	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
4.16666666667%	1	24	64	Diabetes_McGill_TNF_alpha_signalin	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
4.16666666667%	1	24	64	Diabetes_McGill_TNF_alpha_signalin	BYSTROEM_CORRELATED_WITH_IL5_DN
4.16666666667%	1	24	633	Diabetes_McGill_TNF_alpha_signalin	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
4.16666666667%	1	24	63	Diabetes_McGill_TNF_alpha_signalin	PHONG_TNF_TARGETS_UP
4.16666666667%	1	24	63	Diabetes_McGill_TNF_alpha_signalin	MODY_HIPPOCAMPUS_POSTNATAL
4.16666666667%	1	24	63	Diabetes_McGill_TNF_alpha_signalin	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
4.16666666667%	1	24	62	Diabetes_McGill_TNF_alpha_signalin	REACTOME_RNA_POL_I_PROMOTER_OPENING
4.16666666667%	1	24	61	Diabetes_McGill_TNF_alpha_signalin	PID_AR_PATHWAY
4.16666666667%	1	24	61	Diabetes_McGill_TNF_alpha_signalin	GENTILE_RESPONSE_CLUSTER_D3
4.16666666667%	1	24	60	Diabetes_McGill_TNF_alpha_signalin	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
4.16666666667%	1	24	60	Diabetes_McGill_TNF_alpha_signalin	SONG_TARGETS_OF_IE86_CMV_PROTEIN
4.16666666667%	1	24	60	Diabetes_McGill_TNF_alpha_signalin	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE
4.16666666667%	1	24	60	Diabetes_McGill_TNF_alpha_signalin	OUILLETTE_CLL_13Q14_DELETION_DN
4.16666666667%	1	24	60	Diabetes_McGill_TNF_alpha_signalin	AMIT_EGF_RESPONSE_240_HELA
4.16666666667%	1	24	6	Diabetes_McGill_TNF_alpha_signalin	GERHOLD_RESPONSE_TO_TZD_UP
4.16666666667%	1	24	6	Diabetes_McGill_TNF_alpha_signalin	GALI_TP53_TARGETS_APOPTOTIC_DN
4.16666666667%	1	24	6	Diabetes_McGill_TNF_alpha_signalin	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP
4.16666666667%	1	24	593	Diabetes_McGill_TNF_alpha_signalin	MARTINEZ_TP53_TARGETS_DN
4.16666666667%	1	24	591	Diabetes_McGill_TNF_alpha_signalin	MARTINEZ_RB1_AND_TP53_TARGETS_DN
4.16666666667%	1	24	59	Diabetes_McGill_TNF_alpha_signalin	BOYLAN_MULTIPLE_MYELOMA_C_DN
4.16666666667%	1	24	59	Diabetes_McGill_TNF_alpha_signalin	ASTIER_INTEGRIN_SIGNALING
4.16666666667%	1	24	58	Diabetes_McGill_TNF_alpha_signalin	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
4.16666666667%	1	24	58	Diabetes_McGill_TNF_alpha_signalin	NAGASHIMA_EGF_SIGNALING_UP
4.16666666667%	1	24	58	Diabetes_McGill_TNF_alpha_signalin	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
4.16666666667%	1	24	578	Diabetes_McGill_TNF_alpha_signalin	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
4.16666666667%	1	24	57	Diabetes_McGill_TNF_alpha_signalin	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
4.16666666667%	1	24	57	Diabetes_McGill_TNF_alpha_signalin	NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON
4.16666666667%	1	24	57	Diabetes_McGill_TNF_alpha_signalin	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
4.16666666667%	1	24	564	Diabetes_McGill_TNF_alpha_signalin	SMID_BREAST_CANCER_LUMINAL_B_DN
4.16666666667%	1	24	56	Diabetes_McGill_TNF_alpha_signalin	ZHENG_IL22_SIGNALING_UP
4.16666666667%	1	24	56	Diabetes_McGill_TNF_alpha_signalin	WORSCHECH_TUMOR_REJECTION_UP
4.16666666667%	1	24	56	Diabetes_McGill_TNF_alpha_signalin	REACTOME_PI_3K_CASCADE
4.16666666667%	1	24	56	Diabetes_McGill_TNF_alpha_signalin	HENDRICKS_SMARCA4_TARGETS_UP
4.16666666667%	1	24	56	Diabetes_McGill_TNF_alpha_signalin	BROWNE_HCMV_INFECTION_30MIN_UP
4.16666666667%	1	24	552	Diabetes_McGill_TNF_alpha_signalin	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
4.16666666667%	1	24	55	Diabetes_McGill_TNF_alpha_signalin	SMIRNOV_RESPONSE_TO_IR_2HR_DN
4.16666666667%	1	24	55	Diabetes_McGill_TNF_alpha_signalin	BROWNE_HCMV_INFECTION_4HR_UP
4.16666666667%	1	24	549	Diabetes_McGill_TNF_alpha_signalin	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
4.16666666667%	1	24	546	Diabetes_McGill_TNF_alpha_signalin	WEST_ADRENOCORTICAL_TUMOR_DN
4.16666666667%	1	24	544	Diabetes_McGill_TNF_alpha_signalin	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
4.16666666667%	1	24	54	Diabetes_McGill_TNF_alpha_signalin	ZHOU_TNF_SIGNALING_4HR
4.16666666667%	1	24	54	Diabetes_McGill_TNF_alpha_signalin	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
4.16666666667%	1	24	54	Diabetes_McGill_TNF_alpha_signalin	REACTOME_TCR_SIGNALING
4.16666666667%	1	24	54	Diabetes_McGill_TNF_alpha_signalin	PID_RAC1_PATHWAY
4.16666666667%	1	24	54	Diabetes_McGill_TNF_alpha_signalin	MIKKELSEN_IPS_ICP_WITH_H3K27ME3
4.16666666667%	1	24	54	Diabetes_McGill_TNF_alpha_signalin	AUNG_GASTRIC_CANCER
4.16666666667%	1	24	539	Diabetes_McGill_TNF_alpha_signalin	LIAO_METASTASIS
4.16666666667%	1	24	536	Diabetes_McGill_TNF_alpha_signalin	SENESE_HDAC3_TARGETS_DN
4.16666666667%	1	24	536	Diabetes_McGill_TNF_alpha_signalin	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
4.16666666667%	1	24	535	Diabetes_McGill_TNF_alpha_signalin	STEIN_ESRRA_TARGETS
4.16666666667%	1	24	53	Diabetes_McGill_TNF_alpha_signalin	ZHU_CMV_8_HR_DN
4.16666666667%	1	24	53	Diabetes_McGill_TNF_alpha_signalin	SMIRNOV_RESPONSE_TO_IR_2HR_UP
4.16666666667%	1	24	53	Diabetes_McGill_TNF_alpha_signalin	PID_AR_TF_PATHWAY
4.16666666667%	1	24	53	Diabetes_McGill_TNF_alpha_signalin	HENDRICKS_SMARCA4_TARGETS_DN
4.16666666667%	1	24	528	Diabetes_McGill_TNF_alpha_signalin	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
4.16666666667%	1	24	52	Diabetes_McGill_TNF_alpha_signalin	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN
4.16666666667%	1	24	52	Diabetes_McGill_TNF_alpha_signalin	PRAMOONJAGO_SOX4_TARGETS_UP
4.16666666667%	1	24	52	Diabetes_McGill_TNF_alpha_signalin	PID_KITPATHWAY
4.16666666667%	1	24	52	Diabetes_McGill_TNF_alpha_signalin	CHIBA_RESPONSE_TO_TSA_UP
4.16666666667%	1	24	52	Diabetes_McGill_TNF_alpha_signalin	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
4.16666666667%	1	24	517	Diabetes_McGill_TNF_alpha_signalin	RAO_BOUND_BY_SALL4_ISOFORM_B
4.16666666667%	1	24	516	Diabetes_McGill_TNF_alpha_signalin	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
4.16666666667%	1	24	514	Diabetes_McGill_TNF_alpha_signalin	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
4.16666666667%	1	24	514	Diabetes_McGill_TNF_alpha_signalin	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
4.16666666667%	1	24	51	Diabetes_McGill_TNF_alpha_signalin	TSUNODA_CISPLATIN_RESISTANCE_DN
4.16666666667%	1	24	51	Diabetes_McGill_TNF_alpha_signalin	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
4.16666666667%	1	24	51	Diabetes_McGill_TNF_alpha_signalin	BYSTROEM_CORRELATED_WITH_IL5_UP
4.16666666667%	1	24	51	Diabetes_McGill_TNF_alpha_signalin	BURTON_ADIPOGENESIS_PEAK_AT_2HR
4.16666666667%	1	24	508	Diabetes_McGill_TNF_alpha_signalin	ENK_UV_RESPONSE_EPIDERMIS_DN
4.16666666667%	1	24	504	Diabetes_McGill_TNF_alpha_signalin	BROWNE_HCMV_INFECTION_48HR_DN
4.16666666667%	1	24	50	Diabetes_McGill_TNF_alpha_signalin	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
4.16666666667%	1	24	50	Diabetes_McGill_TNF_alpha_signalin	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
4.16666666667%	1	24	50	Diabetes_McGill_TNF_alpha_signalin	NADERI_BREAST_CANCER_PROGNOSIS_UP
4.16666666667%	1	24	50	Diabetes_McGill_TNF_alpha_signalin	MARTINEZ_RESPONSE_TO_TRABECTEDIN
4.16666666667%	1	24	493	Diabetes_McGill_TNF_alpha_signalin	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
4.16666666667%	1	24	491	Diabetes_McGill_TNF_alpha_signalin	ZHENG_BOUND_BY_FOXP3
4.16666666667%	1	24	491	Diabetes_McGill_TNF_alpha_signalin	SWEET_LUNG_CANCER_KRAS_UP
4.16666666667%	1	24	49	Diabetes_McGill_TNF_alpha_signalin	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN
4.16666666667%	1	24	49	Diabetes_McGill_TNF_alpha_signalin	DAUER_STAT3_TARGETS_UP
4.16666666667%	1	24	49	Diabetes_McGill_TNF_alpha_signalin	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
4.16666666667%	1	24	49	Diabetes_McGill_TNF_alpha_signalin	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP
4.16666666667%	1	24	482	Diabetes_McGill_TNF_alpha_signalin	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
4.16666666667%	1	24	48	Diabetes_McGill_TNF_alpha_signalin	PID_AJDISS_2PATHWAY
4.16666666667%	1	24	479	Diabetes_McGill_TNF_alpha_signalin	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
4.16666666667%	1	24	476	Diabetes_McGill_TNF_alpha_signalin	SMID_BREAST_CANCER_NORMAL_LIKE_UP
4.16666666667%	1	24	47	Diabetes_McGill_TNF_alpha_signalin	ZHU_CMV_8_HR_UP
4.16666666667%	1	24	47	Diabetes_McGill_TNF_alpha_signalin	PID_IL6_7PATHWAY
4.16666666667%	1	24	47	Diabetes_McGill_TNF_alpha_signalin	JIANG_AGING_HYPOTHALAMUS_UP
4.16666666667%	1	24	467	Diabetes_McGill_TNF_alpha_signalin	RATTENBACHER_BOUND_BY_CELF1
4.16666666667%	1	24	464	Diabetes_McGill_TNF_alpha_signalin	ONDER_CDH1_TARGETS_2_DN
4.16666666667%	1	24	46	Diabetes_McGill_TNF_alpha_signalin	PID_A6B1_A6B4_INTEGRIN_PATHWAY
4.16666666667%	1	24	46	Diabetes_McGill_TNF_alpha_signalin	NAKAMURA_CANCER_MICROENVIRONMENT_DN
4.16666666667%	1	24	46	Diabetes_McGill_TNF_alpha_signalin	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN
4.16666666667%	1	24	46	Diabetes_McGill_TNF_alpha_signalin	ABBUD_LIF_SIGNALING_1_UP
4.16666666667%	1	24	459	Diabetes_McGill_TNF_alpha_signalin	KIM_WT1_TARGETS_DN
4.16666666667%	1	24	456	Diabetes_McGill_TNF_alpha_signalin	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
4.16666666667%	1	24	455	Diabetes_McGill_TNF_alpha_signalin	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
4.16666666667%	1	24	45	Diabetes_McGill_TNF_alpha_signalin	TRAYNOR_RETT_SYNDROM_UP
4.16666666667%	1	24	45	Diabetes_McGill_TNF_alpha_signalin	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
4.16666666667%	1	24	45	Diabetes_McGill_TNF_alpha_signalin	PID_RHOA_PATHWAY
4.16666666667%	1	24	45	Diabetes_McGill_TNF_alpha_signalin	PID_ILK_PATHWAY
4.16666666667%	1	24	45	Diabetes_McGill_TNF_alpha_signalin	CHENG_RESPONSE_TO_NICKEL_ACETATE
4.16666666667%	1	24	442	Diabetes_McGill_TNF_alpha_signalin	HAN_SATB1_TARGETS_DN
4.16666666667%	1	24	44	Diabetes_McGill_TNF_alpha_signalin	XU_CREBBP_TARGETS_DN
4.16666666667%	1	24	44	Diabetes_McGill_TNF_alpha_signalin	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
4.16666666667%	1	24	44	Diabetes_McGill_TNF_alpha_signalin	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
4.16666666667%	1	24	44	Diabetes_McGill_TNF_alpha_signalin	PID_HNF3APATHWAY
4.16666666667%	1	24	44	Diabetes_McGill_TNF_alpha_signalin	KEGG_TYPE_I_DIABETES_MELLITUS
4.16666666667%	1	24	435	Diabetes_McGill_TNF_alpha_signalin	SWEET_LUNG_CANCER_KRAS_DN
4.16666666667%	1	24	430	Diabetes_McGill_TNF_alpha_signalin	VECCHI_GASTRIC_CANCER_EARLY_UP
4.16666666667%	1	24	43	Diabetes_McGill_TNF_alpha_signalin	RIZ_ERYTHROID_DIFFERENTIATION_12HR
4.16666666667%	1	24	43	Diabetes_McGill_TNF_alpha_signalin	REACTOME_PLC_BETA_MEDIATED_EVENTS
4.16666666667%	1	24	43	Diabetes_McGill_TNF_alpha_signalin	AMIT_EGF_RESPONSE_480_MCF10A
4.16666666667%	1	24	425	Diabetes_McGill_TNF_alpha_signalin	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
4.16666666667%	1	24	425	Diabetes_McGill_TNF_alpha_signalin	BOCHKIS_FOXA2_TARGETS
4.16666666667%	1	24	423	Diabetes_McGill_TNF_alpha_signalin	PUJANA_BRCA2_PCC_NETWORK
4.16666666667%	1	24	420	Diabetes_McGill_TNF_alpha_signalin	MOOTHA_PGC
4.16666666667%	1	24	42	Diabetes_McGill_TNF_alpha_signalin	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
4.16666666667%	1	24	42	Diabetes_McGill_TNF_alpha_signalin	PID_BMPPATHWAY
4.16666666667%	1	24	42	Diabetes_McGill_TNF_alpha_signalin	MIKKELSEN_ES_ICP_WITH_H3K27ME3
4.16666666667%	1	24	42	Diabetes_McGill_TNF_alpha_signalin	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP
4.16666666667%	1	24	42	Diabetes_McGill_TNF_alpha_signalin	KEGG_GRAFT_VERSUS_HOST_DISEASE
4.16666666667%	1	24	42	Diabetes_McGill_TNF_alpha_signalin	AMIT_EGF_RESPONSE_40_HELA
4.16666666667%	1	24	419	Diabetes_McGill_TNF_alpha_signalin	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
4.16666666667%	1	24	418	Diabetes_McGill_TNF_alpha_signalin	RUTELLA_RESPONSE_TO_HGF_UP
4.16666666667%	1	24	414	Diabetes_McGill_TNF_alpha_signalin	LU_EZH2_TARGETS_DN
4.16666666667%	1	24	41	Diabetes_McGill_TNF_alpha_signalin	LI_LUNG_CANCER
4.16666666667%	1	24	41	Diabetes_McGill_TNF_alpha_signalin	KORKOLA_EMBRYONAL_CARCINOMA_UP
4.16666666667%	1	24	408	Diabetes_McGill_TNF_alpha_signalin	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
4.16666666667%	1	24	406	Diabetes_McGill_TNF_alpha_signalin	OSMAN_BLADDER_CANCER_DN
4.16666666667%	1	24	405	Diabetes_McGill_TNF_alpha_signalin	KUMAR_TARGETS_OF_MLL_AF9_FUSION
4.16666666667%	1	24	404	Diabetes_McGill_TNF_alpha_signalin	OSMAN_BLADDER_CANCER_UP
4.16666666667%	1	24	40	Diabetes_McGill_TNF_alpha_signalin	VARELA_ZMPSTE24_TARGETS_UP
4.16666666667%	1	24	40	Diabetes_McGill_TNF_alpha_signalin	ST_JNK_MAPK_PATHWAY
4.16666666667%	1	24	40	Diabetes_McGill_TNF_alpha_signalin	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER
4.16666666667%	1	24	40	Diabetes_McGill_TNF_alpha_signalin	GENTILE_UV_RESPONSE_CLUSTER_D8
4.16666666667%	1	24	40	Diabetes_McGill_TNF_alpha_signalin	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN
4.16666666667%	1	24	398	Diabetes_McGill_TNF_alpha_signalin	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
4.16666666667%	1	24	395	Diabetes_McGill_TNF_alpha_signalin	HAN_SATB1_TARGETS_UP
4.16666666667%	1	24	394	Diabetes_McGill_TNF_alpha_signalin	BERENJENO_TRANSFORMED_BY_RHOA_DN
4.16666666667%	1	24	393	Diabetes_McGill_TNF_alpha_signalin	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
4.16666666667%	1	24	392	Diabetes_McGill_TNF_alpha_signalin	LINDGREN_BLADDER_CANCER_CLUSTER_2B
4.16666666667%	1	24	391	Diabetes_McGill_TNF_alpha_signalin	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
4.16666666667%	1	24	390	Diabetes_McGill_TNF_alpha_signalin	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
4.16666666667%	1	24	39	Diabetes_McGill_TNF_alpha_signalin	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2
4.16666666667%	1	24	39	Diabetes_McGill_TNF_alpha_signalin	VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1
4.16666666667%	1	24	39	Diabetes_McGill_TNF_alpha_signalin	REACTOME_IL1_SIGNALING
4.16666666667%	1	24	39	Diabetes_McGill_TNF_alpha_signalin	KORKOLA_TERATOMA
4.16666666667%	1	24	39	Diabetes_McGill_TNF_alpha_signalin	GENTILE_UV_RESPONSE_CLUSTER_D5
4.16666666667%	1	24	39	Diabetes_McGill_TNF_alpha_signalin	AMIT_EGF_RESPONSE_60_MCF10A
4.16666666667%	1	24	388	Diabetes_McGill_TNF_alpha_signalin	STEIN_ESRRA_TARGETS_UP
4.16666666667%	1	24	387	Diabetes_McGill_TNF_alpha_signalin	CHYLA_CBFA2T3_TARGETS_UP
4.16666666667%	1	24	384	Diabetes_McGill_TNF_alpha_signalin	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
4.16666666667%	1	24	382	Diabetes_McGill_TNF_alpha_signalin	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
4.16666666667%	1	24	38	Diabetes_McGill_TNF_alpha_signalin	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
4.16666666667%	1	24	38	Diabetes_McGill_TNF_alpha_signalin	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
4.16666666667%	1	24	38	Diabetes_McGill_TNF_alpha_signalin	REACTOME_PI3K_AKT_ACTIVATION
4.16666666667%	1	24	38	Diabetes_McGill_TNF_alpha_signalin	REACTOME_GAB1_SIGNALOSOME
4.16666666667%	1	24	38	Diabetes_McGill_TNF_alpha_signalin	PID_P38ALPHABETADOWNSTREAMPATHWAY
4.16666666667%	1	24	38	Diabetes_McGill_TNF_alpha_signalin	KEGG_ALLOGRAFT_REJECTION
4.16666666667%	1	24	38	Diabetes_McGill_TNF_alpha_signalin	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN
4.16666666667%	1	24	38	Diabetes_McGill_TNF_alpha_signalin	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN
4.16666666667%	1	24	38	Diabetes_McGill_TNF_alpha_signalin	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN
4.16666666667%	1	24	379	Diabetes_McGill_TNF_alpha_signalin	BENPORATH_ES_1
4.16666666667%	1	24	374	Diabetes_McGill_TNF_alpha_signalin	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
4.16666666667%	1	24	371	Diabetes_McGill_TNF_alpha_signalin	WANG_SMARCE1_TARGETS_DN
4.16666666667%	1	24	37	Diabetes_McGill_TNF_alpha_signalin	ST_GA13_PATHWAY
4.16666666667%	1	24	37	Diabetes_McGill_TNF_alpha_signalin	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
4.16666666667%	1	24	37	Diabetes_McGill_TNF_alpha_signalin	REACTOME_DOWNSTREAM_TCR_SIGNALING
4.16666666667%	1	24	37	Diabetes_McGill_TNF_alpha_signalin	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS
4.16666666667%	1	24	37	Diabetes_McGill_TNF_alpha_signalin	PID_FRA_PATHWAY
4.16666666667%	1	24	37	Diabetes_McGill_TNF_alpha_signalin	MURAKAMI_UV_RESPONSE_6HR_UP
4.16666666667%	1	24	368	Diabetes_McGill_TNF_alpha_signalin	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
4.16666666667%	1	24	364	Diabetes_McGill_TNF_alpha_signalin	YANG_BCL3_TARGETS_UP
4.16666666667%	1	24	362	Diabetes_McGill_TNF_alpha_signalin	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
4.16666666667%	1	24	36	Diabetes_McGill_TNF_alpha_signalin	SUBTIL_PROGESTIN_TARGETS
4.16666666667%	1	24	36	Diabetes_McGill_TNF_alpha_signalin	ST_ADRENERGIC
4.16666666667%	1	24	36	Diabetes_McGill_TNF_alpha_signalin	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
4.16666666667%	1	24	36	Diabetes_McGill_TNF_alpha_signalin	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
4.16666666667%	1	24	36	Diabetes_McGill_TNF_alpha_signalin	JIANG_AGING_CEREBRAL_CORTEX_UP
4.16666666667%	1	24	358	Diabetes_McGill_TNF_alpha_signalin	GRUETZMANN_PANCREATIC_CANCER_UP
4.16666666667%	1	24	357	Diabetes_McGill_TNF_alpha_signalin	SHEN_SMARCA2_TARGETS_DN
4.16666666667%	1	24	355	Diabetes_McGill_TNF_alpha_signalin	PEREZ_TP63_TARGETS
4.16666666667%	1	24	353	Diabetes_McGill_TNF_alpha_signalin	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
4.16666666667%	1	24	352	Diabetes_McGill_TNF_alpha_signalin	WANG_LMO4_TARGETS_DN
4.16666666667%	1	24	351	Diabetes_McGill_TNF_alpha_signalin	YAGI_AML_WITH_11Q23_REARRANGED
4.16666666667%	1	24	35	Diabetes_McGill_TNF_alpha_signalin	WEIGEL_OXIDATIVE_STRESS_RESPONSE
4.16666666667%	1	24	35	Diabetes_McGill_TNF_alpha_signalin	ST_G_ALPHA_I_PATHWAY
4.16666666667%	1	24	35	Diabetes_McGill_TNF_alpha_signalin	PID_PI3KCIAKTPATHWAY
4.16666666667%	1	24	35	Diabetes_McGill_TNF_alpha_signalin	HAN_JNK_SINGALING_UP
4.16666666667%	1	24	346	Diabetes_McGill_TNF_alpha_signalin	GOLDRATH_ANTIGEN_RESPONSE
4.16666666667%	1	24	342	Diabetes_McGill_TNF_alpha_signalin	BLUM_RESPONSE_TO_SALIRASIB_DN
4.16666666667%	1	24	34	Diabetes_McGill_TNF_alpha_signalin	PID_IL2_PI3KPATHWAY
4.16666666667%	1	24	34	Diabetes_McGill_TNF_alpha_signalin	PID_EPOPATHWAY
4.16666666667%	1	24	34	Diabetes_McGill_TNF_alpha_signalin	PID_ATM_PATHWAY
4.16666666667%	1	24	336	Diabetes_McGill_TNF_alpha_signalin	JOHNSTONE_PARVB_TARGETS_2_DN
4.16666666667%	1	24	335	Diabetes_McGill_TNF_alpha_signalin	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
4.16666666667%	1	24	33	Diabetes_McGill_TNF_alpha_signalin	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS
4.16666666667%	1	24	33	Diabetes_McGill_TNF_alpha_signalin	PID_IL12_STAT4PATHWAY
4.16666666667%	1	24	320	Diabetes_McGill_TNF_alpha_signalin	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
4.16666666667%	1	24	32	Diabetes_McGill_TNF_alpha_signalin	POS_HISTAMINE_RESPONSE_NETWORK
4.16666666667%	1	24	32	Diabetes_McGill_TNF_alpha_signalin	MOOTHA_GLUCONEOGENESIS
4.16666666667%	1	24	32	Diabetes_McGill_TNF_alpha_signalin	DORSAM_HOXA9_TARGETS_DN
4.16666666667%	1	24	32	Diabetes_McGill_TNF_alpha_signalin	AMIT_SERUM_RESPONSE_40_MCF10A
4.16666666667%	1	24	317	Diabetes_McGill_TNF_alpha_signalin	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
4.16666666667%	1	24	315	Diabetes_McGill_TNF_alpha_signalin	PASINI_SUZ12_TARGETS_DN
4.16666666667%	1	24	31	Diabetes_McGill_TNF_alpha_signalin	PID_P38ALPHABETAPATHWAY
4.16666666667%	1	24	31	Diabetes_McGill_TNF_alpha_signalin	PID_NEPHRIN_NEPH1_PATHWAY
4.16666666667%	1	24	31	Diabetes_McGill_TNF_alpha_signalin	NOJIMA_SFRP2_TARGETS_UP
4.16666666667%	1	24	31	Diabetes_McGill_TNF_alpha_signalin	HUNSBERGER_EXERCISE_REGULATED_GENES
4.16666666667%	1	24	31	Diabetes_McGill_TNF_alpha_signalin	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN
4.16666666667%	1	24	309	Diabetes_McGill_TNF_alpha_signalin	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
4.16666666667%	1	24	306	Diabetes_McGill_TNF_alpha_signalin	HORIUCHI_WTAP_TARGETS_UP
4.16666666667%	1	24	30	Diabetes_McGill_TNF_alpha_signalin	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP
4.16666666667%	1	24	30	Diabetes_McGill_TNF_alpha_signalin	TAVOR_CEBPA_TARGETS_DN
4.16666666667%	1	24	30	Diabetes_McGill_TNF_alpha_signalin	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION
4.16666666667%	1	24	30	Diabetes_McGill_TNF_alpha_signalin	REACTOME_CA_DEPENDENT_EVENTS
4.16666666667%	1	24	30	Diabetes_McGill_TNF_alpha_signalin	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
4.16666666667%	1	24	30	Diabetes_McGill_TNF_alpha_signalin	KEGG_ASTHMA
4.16666666667%	1	24	298	Diabetes_McGill_TNF_alpha_signalin	BROWNE_HCMV_INFECTION_14HR_DN
4.16666666667%	1	24	298	Diabetes_McGill_TNF_alpha_signalin	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
4.16666666667%	1	24	295	Diabetes_McGill_TNF_alpha_signalin	LU_EZH2_TARGETS_UP
4.16666666667%	1	24	293	Diabetes_McGill_TNF_alpha_signalin	ZHANG_TLX_TARGETS_60HR_UP
4.16666666667%	1	24	293	Diabetes_McGill_TNF_alpha_signalin	HADDAD_B_LYMPHOCYTE_PROGENITOR
4.16666666667%	1	24	292	Diabetes_McGill_TNF_alpha_signalin	KOYAMA_SEMA3B_TARGETS_UP
4.16666666667%	1	24	29	Diabetes_McGill_TNF_alpha_signalin	STANELLE_E2F1_TARGETS
4.16666666667%	1	24	29	Diabetes_McGill_TNF_alpha_signalin	REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION
4.16666666667%	1	24	29	Diabetes_McGill_TNF_alpha_signalin	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
4.16666666667%	1	24	29	Diabetes_McGill_TNF_alpha_signalin	PID_TCRCALCIUMPATHWAY
4.16666666667%	1	24	29	Diabetes_McGill_TNF_alpha_signalin	LANG_MYB_FAMILY_TARGETS
4.16666666667%	1	24	29	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_VIP_PATHWAY
4.16666666667%	1	24	29	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_INFLAM_PATHWAY
4.16666666667%	1	24	289	Diabetes_McGill_TNF_alpha_signalin	GABRIELY_MIR21_TARGETS
4.16666666667%	1	24	289	Diabetes_McGill_TNF_alpha_signalin	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
4.16666666667%	1	24	282	Diabetes_McGill_TNF_alpha_signalin	HELLER_SILENCED_BY_METHYLATION_UP
4.16666666667%	1	24	280	Diabetes_McGill_TNF_alpha_signalin	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
4.16666666667%	1	24	28	Diabetes_McGill_TNF_alpha_signalin	VALK_AML_CLUSTER_1
4.16666666667%	1	24	28	Diabetes_McGill_TNF_alpha_signalin	TIAN_TNF_SIGNALING_VIA_NFKB
4.16666666667%	1	24	28	Diabetes_McGill_TNF_alpha_signalin	ST_GAQ_PATHWAY
4.16666666667%	1	24	28	Diabetes_McGill_TNF_alpha_signalin	OLSSON_E2F3_TARGETS_UP
4.16666666667%	1	24	28	Diabetes_McGill_TNF_alpha_signalin	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP
4.16666666667%	1	24	28	Diabetes_McGill_TNF_alpha_signalin	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
4.16666666667%	1	24	279	Diabetes_McGill_TNF_alpha_signalin	REACTOME_NEURONAL_SYSTEM
4.16666666667%	1	24	279	Diabetes_McGill_TNF_alpha_signalin	FORTSCHEGGER_PHF8_TARGETS_UP
4.16666666667%	1	24	276	Diabetes_McGill_TNF_alpha_signalin	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
4.16666666667%	1	24	270	Diabetes_McGill_TNF_alpha_signalin	RIZKI_TUMOR_INVASIVENESS_3D_DN
4.16666666667%	1	24	27	Diabetes_McGill_TNF_alpha_signalin	ST_MYOCYTE_AD_PATHWAY
4.16666666667%	1	24	27	Diabetes_McGill_TNF_alpha_signalin	REACTOME_RECYCLING_PATHWAY_OF_L1
4.16666666667%	1	24	27	Diabetes_McGill_TNF_alpha_signalin	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS
4.16666666667%	1	24	27	Diabetes_McGill_TNF_alpha_signalin	NICK_RESPONSE_TO_PROC_TREATMENT_DN
4.16666666667%	1	24	27	Diabetes_McGill_TNF_alpha_signalin	LEE_DOUBLE_POLAR_THYMOCYTE
4.16666666667%	1	24	27	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_GSK3_PATHWAY
4.16666666667%	1	24	264	Diabetes_McGill_TNF_alpha_signalin	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
4.16666666667%	1	24	261	Diabetes_McGill_TNF_alpha_signalin	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
4.16666666667%	1	24	261	Diabetes_McGill_TNF_alpha_signalin	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
4.16666666667%	1	24	26	Diabetes_McGill_TNF_alpha_signalin	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
4.16666666667%	1	24	26	Diabetes_McGill_TNF_alpha_signalin	PID_RXR_VDR_PATHWAY
4.16666666667%	1	24	26	Diabetes_McGill_TNF_alpha_signalin	PID_P38_MKK3_6PATHWAY
4.16666666667%	1	24	26	Diabetes_McGill_TNF_alpha_signalin	PID_IL27PATHWAY
4.16666666667%	1	24	26	Diabetes_McGill_TNF_alpha_signalin	GAZIN_EPIGENETIC_SILENCING_BY_KRAS
4.16666666667%	1	24	259	Diabetes_McGill_TNF_alpha_signalin	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
4.16666666667%	1	24	255	Diabetes_McGill_TNF_alpha_signalin	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
4.16666666667%	1	24	254	Diabetes_McGill_TNF_alpha_signalin	IVANOVA_HEMATOPOIESIS_STEM_CELL
4.16666666667%	1	24	254	Diabetes_McGill_TNF_alpha_signalin	BROWNE_HCMV_INFECTION_4HR_DN
4.16666666667%	1	24	253	Diabetes_McGill_TNF_alpha_signalin	MCLACHLAN_DENTAL_CARIES_UP
4.16666666667%	1	24	25	Diabetes_McGill_TNF_alpha_signalin	WANG_NFKB_TARGETS
4.16666666667%	1	24	25	Diabetes_McGill_TNF_alpha_signalin	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP
4.16666666667%	1	24	25	Diabetes_McGill_TNF_alpha_signalin	KIM_HYPOXIA
4.16666666667%	1	24	249	Diabetes_McGill_TNF_alpha_signalin	MITSIADES_RESPONSE_TO_APLIDIN_DN
4.16666666667%	1	24	245	Diabetes_McGill_TNF_alpha_signalin	MCLACHLAN_DENTAL_CARIES_DN
4.16666666667%	1	24	244	Diabetes_McGill_TNF_alpha_signalin	KAYO_AGING_MUSCLE_UP
4.16666666667%	1	24	244	Diabetes_McGill_TNF_alpha_signalin	HSIAO_LIVER_SPECIFIC_GENES
4.16666666667%	1	24	243	Diabetes_McGill_TNF_alpha_signalin	CHICAS_RB1_TARGETS_GROWING
4.16666666667%	1	24	242	Diabetes_McGill_TNF_alpha_signalin	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
4.16666666667%	1	24	240	Diabetes_McGill_TNF_alpha_signalin	VANTVEER_BREAST_CANCER_ESR1_DN
4.16666666667%	1	24	240	Diabetes_McGill_TNF_alpha_signalin	BROWNE_HCMV_INFECTION_20HR_UP
4.16666666667%	1	24	24	Diabetes_McGill_TNF_alpha_signalin	YAN_ESCAPE_FROM_ANOIKIS
4.16666666667%	1	24	24	Diabetes_McGill_TNF_alpha_signalin	WANG_TNF_TARGETS
4.16666666667%	1	24	24	Diabetes_McGill_TNF_alpha_signalin	ONO_AML1_TARGETS_UP
4.16666666667%	1	24	24	Diabetes_McGill_TNF_alpha_signalin	MATZUK_SPERMATOGONIA
4.16666666667%	1	24	24	Diabetes_McGill_TNF_alpha_signalin	LA_MEN1_TARGETS
4.16666666667%	1	24	24	Diabetes_McGill_TNF_alpha_signalin	JEON_SMAD6_TARGETS_UP
4.16666666667%	1	24	24	Diabetes_McGill_TNF_alpha_signalin	DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
4.16666666667%	1	24	237	Diabetes_McGill_TNF_alpha_signalin	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
4.16666666667%	1	24	235	Diabetes_McGill_TNF_alpha_signalin	RUTELLA_RESPONSE_TO_HGF_DN
4.16666666667%	1	24	232	Diabetes_McGill_TNF_alpha_signalin	DELYS_THYROID_CANCER_DN
4.16666666667%	1	24	230	Diabetes_McGill_TNF_alpha_signalin	COLDREN_GEFITINIB_RESISTANCE_DN
4.16666666667%	1	24	23	Diabetes_McGill_TNF_alpha_signalin	REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX
4.16666666667%	1	24	23	Diabetes_McGill_TNF_alpha_signalin	ONO_FOXP3_TARGETS_UP
4.16666666667%	1	24	23	Diabetes_McGill_TNF_alpha_signalin	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
4.16666666667%	1	24	23	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_IL12_PATHWAY
4.16666666667%	1	24	229	Diabetes_McGill_TNF_alpha_signalin	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
4.16666666667%	1	24	227	Diabetes_McGill_TNF_alpha_signalin	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
4.16666666667%	1	24	227	Diabetes_McGill_TNF_alpha_signalin	LEE_RECENT_THYMIC_EMIGRANT
4.16666666667%	1	24	225	Diabetes_McGill_TNF_alpha_signalin	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
4.16666666667%	1	24	221	Diabetes_McGill_TNF_alpha_signalin	ZHANG_TLX_TARGETS_36HR_UP
4.16666666667%	1	24	221	Diabetes_McGill_TNF_alpha_signalin	CHANDRAN_METASTASIS_UP
4.16666666667%	1	24	22	Diabetes_McGill_TNF_alpha_signalin	TIAN_TNF_SIGNALING_NOT_VIA_NFKB
4.16666666667%	1	24	22	Diabetes_McGill_TNF_alpha_signalin	SUZUKI_RESPONSE_TO_TSA
4.16666666667%	1	24	22	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNALING_BY_HIPPO
4.16666666667%	1	24	22	Diabetes_McGill_TNF_alpha_signalin	PID_PDGFRAPATHWAY
4.16666666667%	1	24	22	Diabetes_McGill_TNF_alpha_signalin	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
4.16666666667%	1	24	22	Diabetes_McGill_TNF_alpha_signalin	LANDIS_ERBB2_BREAST_TUMORS_65_UP
4.16666666667%	1	24	22	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_GCR_PATHWAY
4.16666666667%	1	24	22	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_CYTOKINE_PATHWAY
4.16666666667%	1	24	216	Diabetes_McGill_TNF_alpha_signalin	BOQUEST_STEM_CELL_DN
4.16666666667%	1	24	215	Diabetes_McGill_TNF_alpha_signalin	MARKEY_RB1_ACUTE_LOF_UP
4.16666666667%	1	24	214	Diabetes_McGill_TNF_alpha_signalin	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
4.16666666667%	1	24	214	Diabetes_McGill_TNF_alpha_signalin	KIM_WT1_TARGETS_UP
4.16666666667%	1	24	214	Diabetes_McGill_TNF_alpha_signalin	BIDUS_METASTASIS_UP
4.16666666667%	1	24	214	Diabetes_McGill_TNF_alpha_signalin	AFFAR_YY1_TARGETS_UP
4.16666666667%	1	24	211	Diabetes_McGill_TNF_alpha_signalin	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
4.16666666667%	1	24	210	Diabetes_McGill_TNF_alpha_signalin	SANSOM_APC_TARGETS_REQUIRE_MYC
4.16666666667%	1	24	210	Diabetes_McGill_TNF_alpha_signalin	RIZKI_TUMOR_INVASIVENESS_3D_UP
4.16666666667%	1	24	210	Diabetes_McGill_TNF_alpha_signalin	REACTOME_TRANSCRIPTION
4.16666666667%	1	24	210	Diabetes_McGill_TNF_alpha_signalin	CAIRO_HEPATOBLASTOMA_CLASSES_DN
4.16666666667%	1	24	21	Diabetes_McGill_TNF_alpha_signalin	VERRECCHIA_RESPONSE_TO_TGFB1_C5
4.16666666667%	1	24	21	Diabetes_McGill_TNF_alpha_signalin	REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION
4.16666666667%	1	24	21	Diabetes_McGill_TNF_alpha_signalin	OUYANG_PROSTATE_CANCER_PROGRESSION_DN
4.16666666667%	1	24	21	Diabetes_McGill_TNF_alpha_signalin	MOOTHA_GLYCOLYSIS
4.16666666667%	1	24	21	Diabetes_McGill_TNF_alpha_signalin	HUI_MAPK14_TARGETS_UP
4.16666666667%	1	24	21	Diabetes_McGill_TNF_alpha_signalin	FERRANDO_TAL1_NEIGHBORS
4.16666666667%	1	24	21	Diabetes_McGill_TNF_alpha_signalin	AMIT_SERUM_RESPONSE_20_MCF10A
4.16666666667%	1	24	209	Diabetes_McGill_TNF_alpha_signalin	KIM_WT1_TARGETS_12HR_DN
4.16666666667%	1	24	209	Diabetes_McGill_TNF_alpha_signalin	GROSS_HYPOXIA_VIA_ELK3_UP
4.16666666667%	1	24	206	Diabetes_McGill_TNF_alpha_signalin	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
4.16666666667%	1	24	206	Diabetes_McGill_TNF_alpha_signalin	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
4.16666666667%	1	24	206	Diabetes_McGill_TNF_alpha_signalin	BILD_MYC_ONCOGENIC_SIGNATURE
4.16666666667%	1	24	206	Diabetes_McGill_TNF_alpha_signalin	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
4.16666666667%	1	24	205	Diabetes_McGill_TNF_alpha_signalin	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
4.16666666667%	1	24	205	Diabetes_McGill_TNF_alpha_signalin	SHEPARD_BMYB_MORPHOLINO_UP
4.16666666667%	1	24	205	Diabetes_McGill_TNF_alpha_signalin	PEREZ_TP53_AND_TP63_TARGETS
4.16666666667%	1	24	203	Diabetes_McGill_TNF_alpha_signalin	PENG_RAPAMYCIN_RESPONSE_UP
4.16666666667%	1	24	203	Diabetes_McGill_TNF_alpha_signalin	PAL_PRMT5_TARGETS_UP
4.16666666667%	1	24	203	Diabetes_McGill_TNF_alpha_signalin	GRUETZMANN_PANCREATIC_CANCER_DN
4.16666666667%	1	24	20	Diabetes_McGill_TNF_alpha_signalin	SESTO_RESPONSE_TO_UV_C4
4.16666666667%	1	24	20	Diabetes_McGill_TNF_alpha_signalin	OUYANG_PROSTATE_CANCER_PROGRESSION_UP
4.16666666667%	1	24	20	Diabetes_McGill_TNF_alpha_signalin	COLLIS_PRKDC_SUBSTRATES
4.16666666667%	1	24	20	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_NKCELLS_PATHWAY
4.16666666667%	1	24	20	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_CCR5_PATHWAY
4.16666666667%	1	24	194	Diabetes_McGill_TNF_alpha_signalin	PROVENZANI_METASTASIS_UP
4.16666666667%	1	24	191	Diabetes_McGill_TNF_alpha_signalin	YAGI_AML_FAB_MARKERS
4.16666666667%	1	24	19	Diabetes_McGill_TNF_alpha_signalin	ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN
4.16666666667%	1	24	19	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_TGFB_PATHWAY
4.16666666667%	1	24	19	Diabetes_McGill_TNF_alpha_signalin	AMIT_EGF_RESPONSE_40_MCF10A
4.16666666667%	1	24	19	Diabetes_McGill_TNF_alpha_signalin	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
4.16666666667%	1	24	187	Diabetes_McGill_TNF_alpha_signalin	PENG_LEUCINE_DEPRIVATION_DN
4.16666666667%	1	24	186	Diabetes_McGill_TNF_alpha_signalin	WANG_CLIM2_TARGETS_DN
4.16666666667%	1	24	186	Diabetes_McGill_TNF_alpha_signalin	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
4.16666666667%	1	24	186	Diabetes_McGill_TNF_alpha_signalin	HAMAI_APOPTOSIS_VIA_TRAIL_DN
4.16666666667%	1	24	185	Diabetes_McGill_TNF_alpha_signalin	DARWICHE_SKIN_TUMOR_PROMOTER_DN
4.16666666667%	1	24	185	Diabetes_McGill_TNF_alpha_signalin	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
4.16666666667%	1	24	1839	Diabetes_McGill_TNF_alpha_signalin	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
4.16666666667%	1	24	183	Diabetes_McGill_TNF_alpha_signalin	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
4.16666666667%	1	24	183	Diabetes_McGill_TNF_alpha_signalin	VERHAAK_AML_WITH_NPM1_MUTATED_UP
4.16666666667%	1	24	182	Diabetes_McGill_TNF_alpha_signalin	RAO_BOUND_BY_SALL4_ISOFORM_A
4.16666666667%	1	24	182	Diabetes_McGill_TNF_alpha_signalin	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
4.16666666667%	1	24	182	Diabetes_McGill_TNF_alpha_signalin	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
4.16666666667%	1	24	181	Diabetes_McGill_TNF_alpha_signalin	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
4.16666666667%	1	24	180	Diabetes_McGill_TNF_alpha_signalin	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
4.16666666667%	1	24	18	Diabetes_McGill_TNF_alpha_signalin	YIH_RESPONSE_TO_ARSENITE_C2
4.16666666667%	1	24	18	Diabetes_McGill_TNF_alpha_signalin	SHIN_B_CELL_LYMPHOMA_CLUSTER_5
4.16666666667%	1	24	18	Diabetes_McGill_TNF_alpha_signalin	SCHEIDEREIT_IKK_TARGETS
4.16666666667%	1	24	18	Diabetes_McGill_TNF_alpha_signalin	REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION
4.16666666667%	1	24	18	Diabetes_McGill_TNF_alpha_signalin	KOBAYASHI_EGFR_SIGNALING_6HR_DN
4.16666666667%	1	24	18	Diabetes_McGill_TNF_alpha_signalin	KAPOSI_LIVER_CANCER_MET_UP
4.16666666667%	1	24	18	Diabetes_McGill_TNF_alpha_signalin	GENTILE_UV_RESPONSE_CLUSTER_D1
4.16666666667%	1	24	18	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_ETS_PATHWAY
4.16666666667%	1	24	178	Diabetes_McGill_TNF_alpha_signalin	BROWNE_HCMV_INFECTION_18HR_UP
4.16666666667%	1	24	177	Diabetes_McGill_TNF_alpha_signalin	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
4.16666666667%	1	24	177	Diabetes_McGill_TNF_alpha_signalin	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
4.16666666667%	1	24	175	Diabetes_McGill_TNF_alpha_signalin	FIRESTEIN_PROLIFERATION
4.16666666667%	1	24	1725	Diabetes_McGill_TNF_alpha_signalin	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
4.16666666667%	1	24	171	Diabetes_McGill_TNF_alpha_signalin	ELVIDGE_HYPOXIA_UP
4.16666666667%	1	24	17	Diabetes_McGill_TNF_alpha_signalin	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS
4.16666666667%	1	24	17	Diabetes_McGill_TNF_alpha_signalin	PID_NFKAPPABATYPICALPATHWAY
4.16666666667%	1	24	17	Diabetes_McGill_TNF_alpha_signalin	MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN
4.16666666667%	1	24	17	Diabetes_McGill_TNF_alpha_signalin	HOWLIN_CITED1_TARGETS_2_DN
4.16666666667%	1	24	17	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_LAIR_PATHWAY
4.16666666667%	1	24	17	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_IL10_PATHWAY
4.16666666667%	1	24	169	Diabetes_McGill_TNF_alpha_signalin	UEDA_PERIFERAL_CLOCK
4.16666666667%	1	24	169	Diabetes_McGill_TNF_alpha_signalin	ONDER_CDH1_TARGETS_1_DN
4.16666666667%	1	24	167	Diabetes_McGill_TNF_alpha_signalin	TIEN_INTESTINE_PROBIOTICS_6HR_DN
4.16666666667%	1	24	166	Diabetes_McGill_TNF_alpha_signalin	SMIRNOV_RESPONSE_TO_IR_6HR_UP
4.16666666667%	1	24	166	Diabetes_McGill_TNF_alpha_signalin	CAIRO_LIVER_DEVELOPMENT_UP
4.16666666667%	1	24	165	Diabetes_McGill_TNF_alpha_signalin	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
4.16666666667%	1	24	165	Diabetes_McGill_TNF_alpha_signalin	DARWICHE_PAPILLOMA_RISK_LOW_DN
4.16666666667%	1	24	164	Diabetes_McGill_TNF_alpha_signalin	KIM_WT1_TARGETS_8HR_UP
4.16666666667%	1	24	163	Diabetes_McGill_TNF_alpha_signalin	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
4.16666666667%	1	24	163	Diabetes_McGill_TNF_alpha_signalin	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
4.16666666667%	1	24	162	Diabetes_McGill_TNF_alpha_signalin	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
4.16666666667%	1	24	162	Diabetes_McGill_TNF_alpha_signalin	DARWICHE_PAPILLOMA_RISK_LOW_UP
4.16666666667%	1	24	161	Diabetes_McGill_TNF_alpha_signalin	BIDUS_METASTASIS_DN
4.16666666667%	1	24	160	Diabetes_McGill_TNF_alpha_signalin	GAVIN_FOXP3_TARGETS_CLUSTER_P3
4.16666666667%	1	24	16	Diabetes_McGill_TNF_alpha_signalin	SU_SALIVARY_GLAND
4.16666666667%	1	24	16	Diabetes_McGill_TNF_alpha_signalin	ST_G_ALPHA_S_PATHWAY
4.16666666667%	1	24	16	Diabetes_McGill_TNF_alpha_signalin	REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1
4.16666666667%	1	24	16	Diabetes_McGill_TNF_alpha_signalin	KORKOLA_TERATOMA_UP
4.16666666667%	1	24	16	Diabetes_McGill_TNF_alpha_signalin	IGLESIAS_E2F_TARGETS_DN
4.16666666667%	1	24	16	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_P53_PATHWAY
4.16666666667%	1	24	16	Diabetes_McGill_TNF_alpha_signalin	ABDELMOHSEN_ELAVL4_TARGETS
4.16666666667%	1	24	159	Diabetes_McGill_TNF_alpha_signalin	REACTOME_INTERFERON_SIGNALING
4.16666666667%	1	24	158	Diabetes_McGill_TNF_alpha_signalin	RODRIGUES_NTN1_TARGETS_DN
4.16666666667%	1	24	158	Diabetes_McGill_TNF_alpha_signalin	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON
4.16666666667%	1	24	156	Diabetes_McGill_TNF_alpha_signalin	FOSTER_TOLERANT_MACROPHAGE_UP
4.16666666667%	1	24	156	Diabetes_McGill_TNF_alpha_signalin	BROWNE_HCMV_INFECTION_14HR_UP
4.16666666667%	1	24	153	Diabetes_McGill_TNF_alpha_signalin	LU_AGING_BRAIN_DN
4.16666666667%	1	24	152	Diabetes_McGill_TNF_alpha_signalin	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
4.16666666667%	1	24	151	Diabetes_McGill_TNF_alpha_signalin	KEGG_WNT_SIGNALING_PATHWAY
4.16666666667%	1	24	151	Diabetes_McGill_TNF_alpha_signalin	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
4.16666666667%	1	24	150	Diabetes_McGill_TNF_alpha_signalin	LANDIS_ERBB2_BREAST_TUMORS_324_UP
4.16666666667%	1	24	15	Diabetes_McGill_TNF_alpha_signalin	MARKS_HDAC_TARGETS_DN
4.16666666667%	1	24	15	Diabetes_McGill_TNF_alpha_signalin	MARKS_ACETYLATED_NON_HISTONE_PROTEINS
4.16666666667%	1	24	15	Diabetes_McGill_TNF_alpha_signalin	FERRANDO_LYL1_NEIGHBORS
4.16666666667%	1	24	15	Diabetes_McGill_TNF_alpha_signalin	COLLIS_PRKDC_REGULATORS
4.16666666667%	1	24	15	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_IL3_PATHWAY
4.16666666667%	1	24	15	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_HIF_PATHWAY
4.16666666667%	1	24	15	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_CD40_PATHWAY
4.16666666667%	1	24	149	Diabetes_McGill_TNF_alpha_signalin	TSAI_RESPONSE_TO_IONIZING_RADIATION
4.16666666667%	1	24	148	Diabetes_McGill_TNF_alpha_signalin	CHANG_CYCLING_GENES
4.16666666667%	1	24	148	Diabetes_McGill_TNF_alpha_signalin	BROWNE_HCMV_INFECTION_24HR_UP
4.16666666667%	1	24	147	Diabetes_McGill_TNF_alpha_signalin	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
4.16666666667%	1	24	147	Diabetes_McGill_TNF_alpha_signalin	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
4.16666666667%	1	24	146	Diabetes_McGill_TNF_alpha_signalin	ELVIDGE_HYPOXIA_DN
4.16666666667%	1	24	146	Diabetes_McGill_TNF_alpha_signalin	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
4.16666666667%	1	24	145	Diabetes_McGill_TNF_alpha_signalin	SMITH_TERT_TARGETS_UP
4.16666666667%	1	24	144	Diabetes_McGill_TNF_alpha_signalin	BROCKE_APOPTOSIS_REVERSED_BY_IL6
4.16666666667%	1	24	143	Diabetes_McGill_TNF_alpha_signalin	BASSO_B_LYMPHOCYTE_NETWORK
4.16666666667%	1	24	142	Diabetes_McGill_TNF_alpha_signalin	DARWICHE_SKIN_TUMOR_PROMOTER_UP
4.16666666667%	1	24	140	Diabetes_McGill_TNF_alpha_signalin	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
4.16666666667%	1	24	140	Diabetes_McGill_TNF_alpha_signalin	QI_HYPOXIA
4.16666666667%	1	24	140	Diabetes_McGill_TNF_alpha_signalin	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
4.16666666667%	1	24	14	Diabetes_McGill_TNF_alpha_signalin	ZHANG_ADIPOGENESIS_BY_BMP7
4.16666666667%	1	24	14	Diabetes_McGill_TNF_alpha_signalin	ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS
4.16666666667%	1	24	14	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNAL_ATTENUATION
4.16666666667%	1	24	14	Diabetes_McGill_TNF_alpha_signalin	REACTOME_P75NTR_SIGNALS_VIA_NFKB
4.16666666667%	1	24	14	Diabetes_McGill_TNF_alpha_signalin	PID_TCRJNKPATHWAY
4.16666666667%	1	24	14	Diabetes_McGill_TNF_alpha_signalin	GILMORE_CORE_NFKB_PATHWAY
4.16666666667%	1	24	14	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_RANKL_PATHWAY
4.16666666667%	1	24	14	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_GRANULOCYTES_PATHWAY
4.16666666667%	1	24	137	Diabetes_McGill_TNF_alpha_signalin	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
4.16666666667%	1	24	136	Diabetes_McGill_TNF_alpha_signalin	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
4.16666666667%	1	24	136	Diabetes_McGill_TNF_alpha_signalin	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
4.16666666667%	1	24	134	Diabetes_McGill_TNF_alpha_signalin	SCHLOSSER_SERUM_RESPONSE_UP
4.16666666667%	1	24	132	Diabetes_McGill_TNF_alpha_signalin	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
4.16666666667%	1	24	130	Diabetes_McGill_TNF_alpha_signalin	ELVIDGE_HYPOXIA_BY_DMOG_UP
4.16666666667%	1	24	13	Diabetes_McGill_TNF_alpha_signalin	REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION
4.16666666667%	1	24	13	Diabetes_McGill_TNF_alpha_signalin	RAY_ALZHEIMERS_DISEASE
4.16666666667%	1	24	13	Diabetes_McGill_TNF_alpha_signalin	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
4.16666666667%	1	24	13	Diabetes_McGill_TNF_alpha_signalin	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN
4.16666666667%	1	24	13	Diabetes_McGill_TNF_alpha_signalin	HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER
4.16666666667%	1	24	129	Diabetes_McGill_TNF_alpha_signalin	YAGI_AML_SURVIVAL
4.16666666667%	1	24	128	Diabetes_McGill_TNF_alpha_signalin	ZHU_CMV_ALL_DN
4.16666666667%	1	24	128	Diabetes_McGill_TNF_alpha_signalin	POTTI_TOPOTECAN_SENSITIVITY
4.16666666667%	1	24	127	Diabetes_McGill_TNF_alpha_signalin	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
4.16666666667%	1	24	126	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
4.16666666667%	1	24	125	Diabetes_McGill_TNF_alpha_signalin	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
4.16666666667%	1	24	125	Diabetes_McGill_TNF_alpha_signalin	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
4.16666666667%	1	24	1237	Diabetes_McGill_TNF_alpha_signalin	BLALOCK_ALZHEIMERS_DISEASE_DN
4.16666666667%	1	24	123	Diabetes_McGill_TNF_alpha_signalin	KAYO_AGING_MUSCLE_DN
4.16666666667%	1	24	123	Diabetes_McGill_TNF_alpha_signalin	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
4.16666666667%	1	24	123	Diabetes_McGill_TNF_alpha_signalin	DAZARD_RESPONSE_TO_UV_SCC_UP
4.16666666667%	1	24	122	Diabetes_McGill_TNF_alpha_signalin	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
4.16666666667%	1	24	120	Diabetes_McGill_TNF_alpha_signalin	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
4.16666666667%	1	24	12	Diabetes_McGill_TNF_alpha_signalin	REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES
4.16666666667%	1	24	12	Diabetes_McGill_TNF_alpha_signalin	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS
4.16666666667%	1	24	12	Diabetes_McGill_TNF_alpha_signalin	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
4.16666666667%	1	24	12	Diabetes_McGill_TNF_alpha_signalin	KRISHNAN_FURIN_TARGETS_UP
4.16666666667%	1	24	116	Diabetes_McGill_TNF_alpha_signalin	MATTIOLI_MGUS_VS_PCL
4.16666666667%	1	24	116	Diabetes_McGill_TNF_alpha_signalin	LI_INDUCED_T_TO_NATURAL_KILLER_DN
4.16666666667%	1	24	116	Diabetes_McGill_TNF_alpha_signalin	IKEDA_MIR30_TARGETS_UP
4.16666666667%	1	24	115	Diabetes_McGill_TNF_alpha_signalin	MARZEC_IL2_SIGNALING_UP
4.16666666667%	1	24	114	Diabetes_McGill_TNF_alpha_signalin	SMIRNOV_RESPONSE_TO_IR_6HR_DN
4.16666666667%	1	24	1137	Diabetes_McGill_TNF_alpha_signalin	BRUINS_UVC_RESPONSE_LATE
4.16666666667%	1	24	110	Diabetes_McGill_TNF_alpha_signalin	SUNG_METASTASIS_STROMA_UP
4.16666666667%	1	24	11	Diabetes_McGill_TNF_alpha_signalin	SEIKE_LUNG_CANCER_POOR_SURVIVAL
4.16666666667%	1	24	11	Diabetes_McGill_TNF_alpha_signalin	HOFFMAN_CLOCK_TARGETS_UP
4.16666666667%	1	24	11	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_EPONFKB_PATHWAY
4.16666666667%	1	24	11	Diabetes_McGill_TNF_alpha_signalin	AMIT_EGF_RESPONSE_20_HELA
4.16666666667%	1	24	109	Diabetes_McGill_TNF_alpha_signalin	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
4.16666666667%	1	24	108	Diabetes_McGill_TNF_alpha_signalin	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
4.16666666667%	1	24	108	Diabetes_McGill_TNF_alpha_signalin	LABBE_TGFB1_TARGETS_DN
4.16666666667%	1	24	108	Diabetes_McGill_TNF_alpha_signalin	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
4.16666666667%	1	24	108	Diabetes_McGill_TNF_alpha_signalin	JAZAG_TGFB1_SIGNALING_UP
4.16666666667%	1	24	107	Diabetes_McGill_TNF_alpha_signalin	ROESSLER_LIVER_CANCER_METASTASIS_UP
4.16666666667%	1	24	1069	Diabetes_McGill_TNF_alpha_signalin	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
4.16666666667%	1	24	105	Diabetes_McGill_TNF_alpha_signalin	AMUNDSON_GENOTOXIC_SIGNATURE
4.16666666667%	1	24	103	Diabetes_McGill_TNF_alpha_signalin	REACTOME_SIGNALING_BY_NOTCH
4.16666666667%	1	24	103	Diabetes_McGill_TNF_alpha_signalin	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
4.16666666667%	1	24	103	Diabetes_McGill_TNF_alpha_signalin	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
4.16666666667%	1	24	102	Diabetes_McGill_TNF_alpha_signalin	DER_IFN_BETA_RESPONSE_UP
4.16666666667%	1	24	1011	Diabetes_McGill_TNF_alpha_signalin	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
4.16666666667%	1	24	101	Diabetes_McGill_TNF_alpha_signalin	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
4.16666666667%	1	24	101	Diabetes_McGill_TNF_alpha_signalin	BROWNE_HCMV_INFECTION_20HR_DN
4.16666666667%	1	24	101	Diabetes_McGill_TNF_alpha_signalin	BROWNE_HCMV_INFECTION_12HR_DN
4.16666666667%	1	24	101	Diabetes_McGill_TNF_alpha_signalin	BASSO_CD40_SIGNALING_UP
4.16666666667%	1	24	100	Diabetes_McGill_TNF_alpha_signalin	WINZEN_DEGRADED_VIA_KHSRP
4.16666666667%	1	24	100	Diabetes_McGill_TNF_alpha_signalin	ROVERSI_GLIOMA_COPY_NUMBER_UP
4.16666666667%	1	24	100	Diabetes_McGill_TNF_alpha_signalin	GAVIN_FOXP3_TARGETS_CLUSTER_P4
4.16666666667%	1	24	100	Diabetes_McGill_TNF_alpha_signalin	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
4.16666666667%	1	24	10	Diabetes_McGill_TNF_alpha_signalin	YEMELYANOV_GR_TARGETS_DN
4.16666666667%	1	24	10	Diabetes_McGill_TNF_alpha_signalin	TSUDA_ALVEOLAR_SOFT_PART_SARCOMA
4.16666666667%	1	24	10	Diabetes_McGill_TNF_alpha_signalin	REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1
4.16666666667%	1	24	10	Diabetes_McGill_TNF_alpha_signalin	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN
4.16666666667%	1	24	10	Diabetes_McGill_TNF_alpha_signalin	MATZUK_PREOVULATORY_FOLLICLE
4.16666666667%	1	24	10	Diabetes_McGill_TNF_alpha_signalin	IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
4.16666666667%	1	24	10	Diabetes_McGill_TNF_alpha_signalin	GOUYER_TATI_TARGETS_UP
4.16666666667%	1	24	10	Diabetes_McGill_TNF_alpha_signalin	CHASSOT_SKIN_WOUND
4.16666666667%	1	24	10	Diabetes_McGill_TNF_alpha_signalin	BIOCARTA_RNA_PATHWAY
4.15512465374%	15	361	1069	T2D_GENES_TANYA_T2D_RSQ05_02CM	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
4.15512465374%	15	361	1062	T2D_GENES_TANYA_T2D_RSQ05_02CM	BENPORATH_EED_TARGETS
4.15512465374%	15	361	1024	T2D_GENES_TANYA_T2D_RSQ05_02CM	NUYTTEN_EZH2_TARGETS_DN
4.15512465374%	15	361	1022	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARSON_BOUND_BY_FOXP3_STIMULATED
4.15400202634%	82	1974	841	Mendelian_Nancy_Cox	MARTENS_TRETINOIN_RESPONSE_DN
4.15400202634%	82	1974	770	Mendelian_Nancy_Cox	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
4.15400202634%	82	1974	634	Mendelian_Nancy_Cox	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
4.15400202634%	82	1974	460	Mendelian_Nancy_Cox	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
4.15400202634%	82	1974	408	Mendelian_Nancy_Cox	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
4.14772727273%	146	3520	1142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
4.13983440662%	90	2174	857	T2D_GENES_TANYA_LIPIDS	MARTENS_TRETINOIN_RESPONSE_UP
4.13983440662%	90	2174	775	T2D_GENES_TANYA_LIPIDS	BENPORATH_MYC_MAX_TARGETS
4.11544628541%	77	1871	855	T2D_GENES_TANYA_HEIGHT	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
4.10607356715%	48	1169	1725	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
4.10334346505%	81	1974	539	Mendelian_Nancy_Cox	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
4.10334346505%	81	1974	443	Mendelian_Nancy_Cox	DELYS_THYROID_CANCER_UP
4.09383624655%	89	2174	668	T2D_GENES_TANYA_LIPIDS	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
4.08472012103%	27	661	86	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MEIOTIC_RECOMBINATION
4.08472012103%	27	661	83	T2D_GENES_TANYA_GLYCEMIC	REACTOME_AMYLOIDS
4.08472012103%	27	661	805	T2D_GENES_TANYA_GLYCEMIC	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
4.08472012103%	27	661	658	T2D_GENES_TANYA_GLYCEMIC	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
4.08472012103%	27	661	62	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RNA_POL_I_PROMOTER_OPENING
4.08472012103%	27	661	510	T2D_GENES_TANYA_GLYCEMIC	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
4.07830342577%	25	613	940	T2D_GENES_TANYA_BIOMARKER	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
4.07830342577%	25	613	871	T2D_GENES_TANYA_BIOMARKER	GRADE_COLON_CANCER_UP
4.07830342577%	25	613	830	T2D_GENES_TANYA_BIOMARKER	CUI_TCF21_TARGETS_2_DN
4.07830342577%	25	613	824	T2D_GENES_TANYA_BIOMARKER	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
4.07830342577%	25	613	805	T2D_GENES_TANYA_BIOMARKER	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
4.07830342577%	25	613	734	T2D_GENES_TANYA_BIOMARKER	BENPORATH_SOX2_TARGETS
4.07830342577%	25	613	728	T2D_GENES_TANYA_BIOMARKER	MARSON_BOUND_BY_E2F4_UNSTIMULATED
4.07830342577%	25	613	133	T2D_GENES_TANYA_BIOMARKER	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON
4.06753645434%	53	1303	1142	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
4.06199893105%	76	1871	770	T2D_GENES_TANYA_HEIGHT	KRIEG_HYPOXIA_NOT_VIA_KDM3A
4.06199893105%	76	1871	682	T2D_GENES_TANYA_HEIGHT	FEVR_CTNNB1_TARGETS_UP
4.06199893105%	76	1871	570	T2D_GENES_TANYA_HEIGHT	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
4.05904059041%	22	542	775	T2D_GENES_TANYA_ANTHROPOMETRIC	BENPORATH_MYC_MAX_TARGETS
4.05904059041%	22	542	712	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHLOSSER_SERUM_RESPONSE_DN
4.05904059041%	22	542	658	T2D_GENES_TANYA_ANTHROPOMETRIC	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
4.04783808648%	88	2174	898	T2D_GENES_TANYA_LIPIDS	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
4.04783808648%	88	2174	745	T2D_GENES_TANYA_LIPIDS	LEE_BMP2_TARGETS_UP
4.03587443946%	18	446	920	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALING_BY_GPCR
4.03587443946%	18	446	1024	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NUYTTEN_EZH2_TARGETS_DN
4.03225806452%	5	124	97	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
4.03225806452%	5	124	953	Diabetes_McGill_Cell_cycle_All_Gene	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
4.03225806452%	5	124	95	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
4.03225806452%	5	124	89	Diabetes_McGill_Cell_cycle_All_Gene	BHATTACHARYA_EMBRYONIC_STEM_CELL
4.03225806452%	5	124	87	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_ERBB_SIGNALING_PATHWAY
4.03225806452%	5	124	87	Diabetes_McGill_Cell_cycle_All_Gene	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
4.03225806452%	5	124	81	Diabetes_McGill_Cell_cycle_All_Gene	SCIBETTA_KDM5B_TARGETS_DN
4.03225806452%	5	124	784	Diabetes_McGill_Cell_cycle_All_Gene	FORTSCHEGGER_PHF8_TARGETS_DN
4.03225806452%	5	124	769	Diabetes_McGill_Cell_cycle_All_Gene	NUYTTEN_NIPP1_TARGETS_UP
4.03225806452%	5	124	75	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_ADHERENS_JUNCTION
4.03225806452%	5	124	73	Diabetes_McGill_Cell_cycle_All_Gene	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
4.03225806452%	5	124	721	Diabetes_McGill_Cell_cycle_All_Gene	WONG_ADULT_TISSUE_STEM_MODULE
4.03225806452%	5	124	72	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
4.03225806452%	5	124	72	Diabetes_McGill_Cell_cycle_All_Gene	MATZUK_SPERMATOCYTE
4.03225806452%	5	124	71	Diabetes_McGill_Cell_cycle_All_Gene	GU_PDEF_TARGETS_UP
4.03225806452%	5	124	7	Diabetes_McGill_Cell_cycle_All_Gene	BAKER_HEMATOPOESIS_STAT5_TARGETS
4.03225806452%	5	124	69	Diabetes_McGill_Cell_cycle_All_Gene	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
4.03225806452%	5	124	66	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
4.03225806452%	5	124	65	Diabetes_McGill_Cell_cycle_All_Gene	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP
4.03225806452%	5	124	64	Diabetes_McGill_Cell_cycle_All_Gene	RHODES_CANCER_META_SIGNATURE
4.03225806452%	5	124	61	Diabetes_McGill_Cell_cycle_All_Gene	PID_AR_PATHWAY
4.03225806452%	5	124	6	Diabetes_McGill_Cell_cycle_All_Gene	ZERBINI_RESPONSE_TO_SULINDAC_DN
4.03225806452%	5	124	578	Diabetes_McGill_Cell_cycle_All_Gene	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
4.03225806452%	5	124	57	Diabetes_McGill_Cell_cycle_All_Gene	PEART_HDAC_PROLIFERATION_CLUSTER_UP
4.03225806452%	5	124	552	Diabetes_McGill_Cell_cycle_All_Gene	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
4.03225806452%	5	124	548	Diabetes_McGill_Cell_cycle_All_Gene	KIM_ALL_DISORDERS_CALB1_CORR_UP
4.03225806452%	5	124	532	Diabetes_McGill_Cell_cycle_All_Gene	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
4.03225806452%	5	124	53	Diabetes_McGill_Cell_cycle_All_Gene	PID_AR_TF_PATHWAY
4.03225806452%	5	124	53	Diabetes_McGill_Cell_cycle_All_Gene	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
4.03225806452%	5	124	526	Diabetes_McGill_Cell_cycle_All_Gene	ONKEN_UVEAL_MELANOMA_DN
4.03225806452%	5	124	517	Diabetes_McGill_Cell_cycle_All_Gene	RAO_BOUND_BY_SALL4_ISOFORM_B
4.03225806452%	5	124	51	Diabetes_McGill_Cell_cycle_All_Gene	ZHANG_PROLIFERATING_VS_QUIESCENT
4.03225806452%	5	124	508	Diabetes_McGill_Cell_cycle_All_Gene	ENK_UV_RESPONSE_EPIDERMIS_DN
4.03225806452%	5	124	473	Diabetes_McGill_Cell_cycle_All_Gene	GARY_CD5_TARGETS_UP
4.03225806452%	5	124	47	Diabetes_McGill_Cell_cycle_All_Gene	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
4.03225806452%	5	124	461	Diabetes_McGill_Cell_cycle_All_Gene	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
4.03225806452%	5	124	46	Diabetes_McGill_Cell_cycle_All_Gene	PID_PS1PATHWAY
4.03225806452%	5	124	45	Diabetes_McGill_Cell_cycle_All_Gene	ZHAN_MULTIPLE_MYELOMA_PR_UP
4.03225806452%	5	124	439	Diabetes_McGill_Cell_cycle_All_Gene	MITSIADES_RESPONSE_TO_APLIDIN_UP
4.03225806452%	5	124	423	Diabetes_McGill_Cell_cycle_All_Gene	THUM_SYSTOLIC_HEART_FAILURE_UP
4.03225806452%	5	124	418	Diabetes_McGill_Cell_cycle_All_Gene	RUTELLA_RESPONSE_TO_HGF_UP
4.03225806452%	5	124	403	Diabetes_McGill_Cell_cycle_All_Gene	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
4.03225806452%	5	124	40	Diabetes_McGill_Cell_cycle_All_Gene	VARELA_ZMPSTE24_TARGETS_UP
4.03225806452%	5	124	380	Diabetes_McGill_Cell_cycle_All_Gene	DAIRKEE_TERT_TARGETS_UP
4.03225806452%	5	124	37	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_ALK_PATHWAY
4.03225806452%	5	124	36	Diabetes_McGill_Cell_cycle_All_Gene	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2
4.03225806452%	5	124	36	Diabetes_McGill_Cell_cycle_All_Gene	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
4.03225806452%	5	124	36	Diabetes_McGill_Cell_cycle_All_Gene	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
4.03225806452%	5	124	36	Diabetes_McGill_Cell_cycle_All_Gene	MARZEC_IL2_SIGNALING_DN
4.03225806452%	5	124	35	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_CARM_ER_PATHWAY
4.03225806452%	5	124	337	Diabetes_McGill_Cell_cycle_All_Gene	PENG_GLUTAMINE_DEPRIVATION_DN
4.03225806452%	5	124	314	Diabetes_McGill_Cell_cycle_All_Gene	DOUGLAS_BMI1_TARGETS_DN
4.03225806452%	5	124	307	Diabetes_McGill_Cell_cycle_All_Gene	LI_INDUCED_T_TO_NATURAL_KILLER_UP
4.03225806452%	5	124	307	Diabetes_McGill_Cell_cycle_All_Gene	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
4.03225806452%	5	124	30	Diabetes_McGill_Cell_cycle_All_Gene	PID_IL2_STAT5PATHWAY
4.03225806452%	5	124	293	Diabetes_McGill_Cell_cycle_All_Gene	ZHANG_TLX_TARGETS_60HR_UP
4.03225806452%	5	124	293	Diabetes_McGill_Cell_cycle_All_Gene	IVANOVA_HEMATOPOIESIS_MATURE_CELL
4.03225806452%	5	124	285	Diabetes_McGill_Cell_cycle_All_Gene	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
4.03225806452%	5	124	282	Diabetes_McGill_Cell_cycle_All_Gene	HELLER_SILENCED_BY_METHYLATION_UP
4.03225806452%	5	124	28	Diabetes_McGill_Cell_cycle_All_Gene	PETROVA_PROX1_TARGETS_UP
4.03225806452%	5	124	25	Diabetes_McGill_Cell_cycle_All_Gene	PID_MYC_PATHWAY
4.03225806452%	5	124	245	Diabetes_McGill_Cell_cycle_All_Gene	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
4.03225806452%	5	124	240	Diabetes_McGill_Cell_cycle_All_Gene	UDAYAKUMAR_MED1_TARGETS_DN
4.03225806452%	5	124	239	Diabetes_McGill_Cell_cycle_All_Gene	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
4.03225806452%	5	124	239	Diabetes_McGill_Cell_cycle_All_Gene	ALFANO_MYC_TARGETS
4.03225806452%	5	124	237	Diabetes_McGill_Cell_cycle_All_Gene	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
4.03225806452%	5	124	233	Diabetes_McGill_Cell_cycle_All_Gene	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
4.03225806452%	5	124	23	Diabetes_McGill_Cell_cycle_All_Gene	CHEN_ETV5_TARGETS_TESTIS
4.03225806452%	5	124	229	Diabetes_McGill_Cell_cycle_All_Gene	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
4.03225806452%	5	124	212	Diabetes_McGill_Cell_cycle_All_Gene	SANSOM_APC_TARGETS
4.03225806452%	5	124	210	Diabetes_McGill_Cell_cycle_All_Gene	WANG_TUMOR_INVASIVENESS_DN
4.03225806452%	5	124	210	Diabetes_McGill_Cell_cycle_All_Gene	VERHAAK_GLIOBLASTOMA_PRONEURAL
4.03225806452%	5	124	21	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_TOB1_PATHWAY
4.03225806452%	5	124	21	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_ATRBRCA_PATHWAY
4.03225806452%	5	124	209	Diabetes_McGill_Cell_cycle_All_Gene	KIM_WT1_TARGETS_12HR_DN
4.03225806452%	5	124	207	Diabetes_McGill_Cell_cycle_All_Gene	CAIRO_HEPATOBLASTOMA_UP
4.03225806452%	5	124	206	Diabetes_McGill_Cell_cycle_All_Gene	RAMALHO_STEMNESS_UP
4.03225806452%	5	124	198	Diabetes_McGill_Cell_cycle_All_Gene	ALONSO_METASTASIS_UP
4.03225806452%	5	124	194	Diabetes_McGill_Cell_cycle_All_Gene	PROVENZANI_METASTASIS_UP
4.03225806452%	5	124	187	Diabetes_McGill_Cell_cycle_All_Gene	PENG_LEUCINE_DEPRIVATION_DN
4.03225806452%	5	124	185	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_HUNTINGTONS_DISEASE
4.03225806452%	5	124	181	Diabetes_McGill_Cell_cycle_All_Gene	JISON_SICKLE_CELL_DISEASE_UP
4.03225806452%	5	124	180	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_48HR_UP
4.03225806452%	5	124	18	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_ETS_PATHWAY
4.03225806452%	5	124	179	Diabetes_McGill_Cell_cycle_All_Gene	BENPORATH_NOS_TARGETS
4.03225806452%	5	124	178	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_18HR_UP
4.03225806452%	5	124	17	Diabetes_McGill_Cell_cycle_All_Gene	SIMBULAN_PARP1_TARGETS_DN
4.03225806452%	5	124	17	Diabetes_McGill_Cell_cycle_All_Gene	INGA_TP53_TARGETS
4.03225806452%	5	124	169	Diabetes_McGill_Cell_cycle_All_Gene	ONDER_CDH1_TARGETS_1_DN
4.03225806452%	5	124	16	Diabetes_McGill_Cell_cycle_All_Gene	BAKER_HEMATOPOIESIS_STAT3_TARGETS
4.03225806452%	5	124	150	Diabetes_McGill_Cell_cycle_All_Gene	LANDIS_ERBB2_BREAST_TUMORS_324_UP
4.03225806452%	5	124	148	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_24HR_UP
4.03225806452%	5	124	145	Diabetes_McGill_Cell_cycle_All_Gene	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
4.03225806452%	5	124	137	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
4.03225806452%	5	124	132	Diabetes_McGill_Cell_cycle_All_Gene	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
4.03225806452%	5	124	128	Diabetes_McGill_Cell_cycle_All_Gene	ZHU_CMV_ALL_DN
4.03225806452%	5	124	127	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
4.03225806452%	5	124	126	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
4.03225806452%	5	124	126	Diabetes_McGill_Cell_cycle_All_Gene	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
4.03225806452%	5	124	122	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_PDGF
4.03225806452%	5	124	12	Diabetes_McGill_Cell_cycle_All_Gene	TURJANSKI_MAPK1_AND_MAPK2_TARGETS
4.03225806452%	5	124	114	Diabetes_McGill_Cell_cycle_All_Gene	SMIRNOV_RESPONSE_TO_IR_6HR_DN
4.03225806452%	5	124	114	Diabetes_McGill_Cell_cycle_All_Gene	SENESE_HDAC2_TARGETS_UP
4.03225806452%	5	124	112	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_FGFR
4.03225806452%	5	124	11	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_SRCRPTP_PATHWAY
4.03225806452%	5	124	109	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
4.03225806452%	5	124	105	Diabetes_McGill_Cell_cycle_All_Gene	WOO_LIVER_CANCER_RECURRENCE_UP
4.03225806452%	5	124	104	Diabetes_McGill_Cell_cycle_All_Gene	NAKAMURA_ADIPOGENESIS_LATE_UP
4.03225806452%	5	124	101	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_ERBB2
4.03225806452%	5	124	100	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
4.03225806452%	5	124	100	Diabetes_McGill_Cell_cycle_All_Gene	CHICAS_RB1_TARGETS_LOW_SERUM
4.0085515767%	75	1871	784	T2D_GENES_TANYA_HEIGHT	FORTSCHEGGER_PHF8_TARGETS_DN
4.0085515767%	75	1871	682	T2D_GENES_TANYA_HEIGHT	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
4.00202634245%	79	1974	720	Mendelian_Nancy_Cox	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
4.00202634245%	79	1974	464	Mendelian_Nancy_Cox	ONDER_CDH1_TARGETS_2_DN
4.00202634245%	79	1974	366	Mendelian_Nancy_Cox	YOSHIMURA_MAPK8_TARGETS_DN
4.00202634245%	79	1974	366	Mendelian_Nancy_Cox	SANSOM_APC_TARGETS_DN
4.0018399264%	87	2174	784	T2D_GENES_TANYA_LIPIDS	FORTSCHEGGER_PHF8_TARGETS_DN
3.95604395604%	18	455	893	T2D_GENES_TANYA_BLOODPRESSURE	GEORGES_TARGETS_OF_MIR192_AND_MIR215
3.95604395604%	18	455	805	T2D_GENES_TANYA_BLOODPRESSURE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
3.95604395604%	18	455	795	T2D_GENES_TANYA_BLOODPRESSURE	WEI_MYCN_TARGETS_WITH_E_BOX
3.95604395604%	18	455	652	T2D_GENES_TANYA_BLOODPRESSURE	BENPORATH_PRC2_TARGETS
3.95604395604%	18	455	648	T2D_GENES_TANYA_BLOODPRESSURE	BENPORATH_CYCLING_GENES
3.95604395604%	18	455	605	T2D_GENES_TANYA_BLOODPRESSURE	CAIRO_HEPATOBLASTOMA_CLASSES_UP
3.95604395604%	18	455	591	T2D_GENES_TANYA_BLOODPRESSURE	MARTINEZ_RB1_AND_TP53_TARGETS_DN
3.95604395604%	18	455	578	T2D_GENES_TANYA_BLOODPRESSURE	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
3.95604395604%	18	455	549	T2D_GENES_TANYA_BLOODPRESSURE	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
3.95604395604%	18	455	543	T2D_GENES_TANYA_BLOODPRESSURE	MARTINEZ_RB1_TARGETS_DN
3.95584176633%	86	2174	855	T2D_GENES_TANYA_LIPIDS	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
3.95584176633%	86	2174	805	T2D_GENES_TANYA_LIPIDS	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
3.95584176633%	86	2174	747	T2D_GENES_TANYA_LIPIDS	PATIL_LIVER_CANCER
3.95584176633%	86	2174	1037	T2D_GENES_TANYA_LIPIDS	NUYTTEN_EZH2_TARGETS_UP
3.95256916996%	10	253	940	Diabetes_McGill_CREBBP_coTF	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
3.95256916996%	10	253	79	Diabetes_McGill_CREBBP_coTF	MEISSNER_NPC_HCP_WITH_H3K27ME3
3.95256916996%	10	253	78	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_SCF_KIT
3.95256916996%	10	253	75	Diabetes_McGill_CREBBP_coTF	KEGG_ADHERENS_JUNCTION
3.95256916996%	10	253	73	Diabetes_McGill_CREBBP_coTF	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
3.95256916996%	10	253	60	Diabetes_McGill_CREBBP_coTF	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
3.95256916996%	10	253	59	Diabetes_McGill_CREBBP_coTF	PID_ATF2_PATHWAY
3.95256916996%	10	253	567	Diabetes_McGill_CREBBP_coTF	PARENT_MTOR_SIGNALING_UP
3.95256916996%	10	253	501	Diabetes_McGill_CREBBP_coTF	SENESE_HDAC3_TARGETS_UP
3.95256916996%	10	253	493	Diabetes_McGill_CREBBP_coTF	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
3.95256916996%	10	253	485	Diabetes_McGill_CREBBP_coTF	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
3.95256916996%	10	253	47	Diabetes_McGill_CREBBP_coTF	PID_IL6_7PATHWAY
3.95256916996%	10	253	43	Diabetes_McGill_CREBBP_coTF	RIZ_ERYTHROID_DIFFERENTIATION_12HR
3.95256916996%	10	253	424	Diabetes_McGill_CREBBP_coTF	SHEN_SMARCA2_TARGETS_UP
3.95256916996%	10	253	40	Diabetes_McGill_CREBBP_coTF	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
3.95256916996%	10	253	394	Diabetes_McGill_CREBBP_coTF	BERENJENO_TRANSFORMED_BY_RHOA_DN
3.95256916996%	10	253	393	Diabetes_McGill_CREBBP_coTF	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
3.95256916996%	10	253	38	Diabetes_McGill_CREBBP_coTF	PID_P38ALPHABETADOWNSTREAMPATHWAY
3.95256916996%	10	253	378	Diabetes_McGill_CREBBP_coTF	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
3.95256916996%	10	253	374	Diabetes_McGill_CREBBP_coTF	WANG_TUMOR_INVASIVENESS_UP
3.95256916996%	10	253	373	Diabetes_McGill_CREBBP_coTF	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
3.95256916996%	10	253	352	Diabetes_McGill_CREBBP_coTF	WANG_LMO4_TARGETS_DN
3.95256916996%	10	253	35	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CARM_ER_PATHWAY
3.95256916996%	10	253	332	Diabetes_McGill_CREBBP_coTF	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
3.95256916996%	10	253	324	Diabetes_McGill_CREBBP_coTF	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
3.95256916996%	10	253	315	Diabetes_McGill_CREBBP_coTF	PASINI_SUZ12_TARGETS_DN
3.95256916996%	10	253	30	Diabetes_McGill_CREBBP_coTF	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES
3.95256916996%	10	253	256	Diabetes_McGill_CREBBP_coTF	ONDER_CDH1_TARGETS_2_UP
3.95256916996%	10	253	253	Diabetes_McGill_CREBBP_coTF	DANG_REGULATED_BY_MYC_DN
3.95256916996%	10	253	242	Diabetes_McGill_CREBBP_coTF	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
3.95256916996%	10	253	240	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_20HR_UP
3.95256916996%	10	253	24	Diabetes_McGill_CREBBP_coTF	REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION
3.95256916996%	10	253	229	Diabetes_McGill_CREBBP_coTF	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
3.95256916996%	10	253	223	Diabetes_McGill_CREBBP_coTF	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
3.95256916996%	10	253	222	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_1HR_DN
3.95256916996%	10	253	193	Diabetes_McGill_CREBBP_coTF	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP
3.95256916996%	10	253	190	Diabetes_McGill_CREBBP_coTF	KEGG_CHEMOKINE_SIGNALING_PATHWAY
3.95256916996%	10	253	185	Diabetes_McGill_CREBBP_coTF	KEGG_HUNTINGTONS_DISEASE
3.95256916996%	10	253	183	Diabetes_McGill_CREBBP_coTF	OKUMURA_INFLAMMATORY_RESPONSE_LPS
3.95256916996%	10	253	171	Diabetes_McGill_CREBBP_coTF	ELVIDGE_HYPOXIA_UP
3.95256916996%	10	253	15	Diabetes_McGill_CREBBP_coTF	MARKS_ACETYLATED_NON_HISTONE_PROTEINS
3.95256916996%	10	253	143	Diabetes_McGill_CREBBP_coTF	DANG_MYC_TARGETS_UP
3.95256916996%	10	253	140	Diabetes_McGill_CREBBP_coTF	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
3.95256916996%	10	253	137	Diabetes_McGill_CREBBP_coTF	REACTOME_MITOTIC_G1_G1_S_PHASES
3.95256916996%	10	253	12	Diabetes_McGill_CREBBP_coTF	BIOCARTA_VDR_PATHWAY
3.95256916996%	10	253	117	Diabetes_McGill_CREBBP_coTF	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
3.95256916996%	10	253	109	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
3.95256916996%	10	253	102	Diabetes_McGill_CREBBP_coTF	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
3.95256916996%	10	253	102	Diabetes_McGill_CREBBP_coTF	DER_IFN_BETA_RESPONSE_UP
3.95136778116%	78	1974	728	Mendelian_Nancy_Cox	MARSON_BOUND_BY_E2F4_UNSTIMULATED
3.95136778116%	78	1974	681	Mendelian_Nancy_Cox	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
3.95136778116%	78	1974	557	Mendelian_Nancy_Cox	TIEN_INTESTINE_PROBIOTICS_24HR_UP
3.95136778116%	78	1974	475	Mendelian_Nancy_Cox	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
3.95136778116%	78	1974	455	Mendelian_Nancy_Cox	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
3.93498716852%	46	1169	1137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BRUINS_UVC_RESPONSE_LATE
3.93343419062%	26	661	811	T2D_GENES_TANYA_GLYCEMIC	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
3.93343419062%	26	661	781	T2D_GENES_TANYA_GLYCEMIC	GOZGIT_ESR1_TARGETS_DN
3.93343419062%	26	661	682	T2D_GENES_TANYA_GLYCEMIC	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
3.93343419062%	26	661	681	T2D_GENES_TANYA_GLYCEMIC	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
3.93343419062%	26	661	648	T2D_GENES_TANYA_GLYCEMIC	BENPORATH_CYCLING_GENES
3.93343419062%	26	661	634	T2D_GENES_TANYA_GLYCEMIC	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
3.93343419062%	26	661	578	T2D_GENES_TANYA_GLYCEMIC	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
3.93343419062%	26	661	528	T2D_GENES_TANYA_GLYCEMIC	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
3.93343419062%	26	661	517	T2D_GENES_TANYA_GLYCEMIC	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
3.93343419062%	26	661	368	T2D_GENES_TANYA_GLYCEMIC	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
3.93343419062%	26	661	122	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CHROMOSOME_MAINTENANCE
3.91517128874%	24	613	893	T2D_GENES_TANYA_BIOMARKER	GEORGES_TARGETS_OF_MIR192_AND_MIR215
3.91517128874%	24	613	682	T2D_GENES_TANYA_BIOMARKER	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
3.91517128874%	24	613	682	T2D_GENES_TANYA_BIOMARKER	FEVR_CTNNB1_TARGETS_UP
3.91517128874%	24	613	591	T2D_GENES_TANYA_BIOMARKER	MARTINEZ_RB1_AND_TP53_TARGETS_DN
3.91404451266%	51	1303	1725	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
3.90984360626%	85	2174	770	T2D_GENES_TANYA_LIPIDS	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
3.90165686799%	73	1871	783	T2D_GENES_TANYA_HEIGHT	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
3.90165686799%	73	1871	681	T2D_GENES_TANYA_HEIGHT	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
3.90070921986%	77	1974	940	Mendelian_Nancy_Cox	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
3.90070921986%	77	1974	526	Mendelian_Nancy_Cox	ONKEN_UVEAL_MELANOMA_DN
3.89204545455%	137	3520	1382	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
3.89204545455%	137	3520	1103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DANG_BOUND_BY_MYC
3.87811634349%	14	361	940	T2D_GENES_TANYA_T2D_RSQ05_02CM	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
3.87811634349%	14	361	882	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_BMP2_TARGETS_DN
3.87811634349%	14	361	681	T2D_GENES_TANYA_T2D_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
3.87811634349%	14	361	605	T2D_GENES_TANYA_T2D_RSQ05_02CM	CAIRO_HEPATOBLASTOMA_CLASSES_UP
3.87453874539%	21	542	920	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_GPCR
3.87453874539%	21	542	857	T2D_GENES_TANYA_ANTHROPOMETRIC	MARTENS_TRETINOIN_RESPONSE_UP
3.87453874539%	21	542	795	T2D_GENES_TANYA_ANTHROPOMETRIC	WEI_MYCN_TARGETS_WITH_E_BOX
3.87453874539%	21	542	784	T2D_GENES_TANYA_ANTHROPOMETRIC	FORTSCHEGGER_PHF8_TARGETS_DN
3.87453874539%	21	542	722	T2D_GENES_TANYA_ANTHROPOMETRIC	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
3.87453874539%	21	542	720	T2D_GENES_TANYA_ANTHROPOMETRIC	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
3.87453874539%	21	542	681	T2D_GENES_TANYA_ANTHROPOMETRIC	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
3.87453874539%	21	542	514	T2D_GENES_TANYA_ANTHROPOMETRIC	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
3.87453874539%	21	542	351	T2D_GENES_TANYA_ANTHROPOMETRIC	YAGI_AML_WITH_11Q23_REARRANGED
3.86384544618%	84	2174	783	T2D_GENES_TANYA_LIPIDS	ONKEN_UVEAL_MELANOMA_UP
3.86384544618%	84	2174	783	T2D_GENES_TANYA_LIPIDS	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
3.86384544618%	84	2174	530	T2D_GENES_TANYA_LIPIDS	ENK_UV_RESPONSE_KERATINOCYTE_UP
3.86130811663%	49	1269	728	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARSON_BOUND_BY_E2F4_UNSTIMULATED
3.85005065856%	76	1974	548	Mendelian_Nancy_Cox	KIM_ALL_DISORDERS_CALB1_CORR_UP
3.85005065856%	76	1974	530	Mendelian_Nancy_Cox	ENK_UV_RESPONSE_KERATINOCYTE_UP
3.85005065856%	76	1974	428	Mendelian_Nancy_Cox	CUI_TCF21_TARGETS_2_UP
3.8494439692%	45	1169	1278	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
3.8494439692%	45	1169	1210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHEN_METABOLIC_SYNDROM_NETWORK
3.84820951363%	72	1871	668	T2D_GENES_TANYA_HEIGHT	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
3.84820951363%	72	1871	648	T2D_GENES_TANYA_HEIGHT	BENPORATH_CYCLING_GENES
3.84820951363%	72	1871	612	T2D_GENES_TANYA_HEIGHT	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
3.84615384615%	1	26	99	Diabetes_McGill_Set_Wnt_pathway	LIM_MAMMARY_LUMINAL_MATURE_DN
3.84615384615%	1	26	98	Diabetes_McGill_Set_Wnt_pathway	BRUINS_UVC_RESPONSE_MIDDLE
3.84615384615%	1	26	98	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
3.84615384615%	1	26	973	Diabetes_McGill_Set_Wnt_pathway	ACEVEDO_LIVER_CANCER_UP
3.84615384615%	1	26	97	Diabetes_McGill_Set_Wnt_pathway	LABBE_WNT3A_TARGETS_DN
3.84615384615%	1	26	97	Diabetes_McGill_GPCRs_expressed_in_beta_cell	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
3.84615384615%	1	26	953	Diabetes_McGill_Set_Wnt_pathway	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
3.84615384615%	1	26	953	Diabetes_McGill_GPCRs_expressed_in_beta_cell	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
3.84615384615%	1	26	95	Diabetes_McGill_Set_Wnt_pathway	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
3.84615384615%	1	26	95	Diabetes_McGill_GPCRs_expressed_in_beta_cell	HECKER_IFNB1_TARGETS
3.84615384615%	1	26	94	Diabetes_McGill_Set_Wnt_pathway	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP
3.84615384615%	1	26	94	Diabetes_McGill_Set_Wnt_pathway	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER
3.84615384615%	1	26	94	Diabetes_McGill_Set_Wnt_pathway	LU_IL4_SIGNALING
3.84615384615%	1	26	94	Diabetes_McGill_Set_Wnt_pathway	GAVIN_FOXP3_TARGETS_CLUSTER_T4
3.84615384615%	1	26	93	Diabetes_McGill_Set_Wnt_pathway	REACTOME_REGULATION_OF_INSULIN_SECRETION
3.84615384615%	1	26	92	Diabetes_McGill_Set_Wnt_pathway	WINTER_HYPOXIA_UP
3.84615384615%	1	26	92	Diabetes_McGill_Set_Wnt_pathway	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
3.84615384615%	1	26	92	Diabetes_McGill_Set_Wnt_pathway	DE_YY1_TARGETS_DN
3.84615384615%	1	26	92	Diabetes_McGill_GPCRs_expressed_in_beta_cell	KEGG_DILATED_CARDIOMYOPATHY
3.84615384615%	1	26	911	Diabetes_McGill_GPCRs_expressed_in_beta_cell	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
3.84615384615%	1	26	91	Diabetes_McGill_Set_Wnt_pathway	ZHU_CMV_24_HR_DN
3.84615384615%	1	26	91	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ZHU_CMV_24_HR_DN
3.84615384615%	1	26	90	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SIGNALING_BY_ERBB4
3.84615384615%	1	26	90	Diabetes_McGill_Set_Wnt_pathway	KEGG_GAP_JUNCTION
3.84615384615%	1	26	90	Diabetes_McGill_Set_Wnt_pathway	IVANOVSKA_MIR106B_TARGETS
3.84615384615%	1	26	90	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MORI_MATURE_B_LYMPHOCYTE_UP
3.84615384615%	1	26	9	Diabetes_McGill_Set_Wnt_pathway	FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1
3.84615384615%	1	26	9	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SASSON_FSH_RESPONSE
3.84615384615%	1	26	9	Diabetes_McGill_GPCRs_expressed_in_beta_cell	CHESLER_BRAIN_D6MIT150_QTL_TRANS
3.84615384615%	1	26	898	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
3.84615384615%	1	26	882	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
3.84615384615%	1	26	88	Diabetes_McGill_Set_Wnt_pathway	WALLACE_PROSTATE_CANCER_RACE_DN
3.84615384615%	1	26	88	Diabetes_McGill_Set_Wnt_pathway	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
3.84615384615%	1	26	88	Diabetes_McGill_Set_Wnt_pathway	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
3.84615384615%	1	26	88	Diabetes_McGill_GPCRs_expressed_in_beta_cell	WALLACE_PROSTATE_CANCER_RACE_DN
3.84615384615%	1	26	88	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
3.84615384615%	1	26	88	Diabetes_McGill_GPCRs_expressed_in_beta_cell	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
3.84615384615%	1	26	88	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
3.84615384615%	1	26	87	Diabetes_McGill_Set_Wnt_pathway	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
3.84615384615%	1	26	87	Diabetes_McGill_Set_Wnt_pathway	REACTOME_MITOTIC_PROMETAPHASE
3.84615384615%	1	26	87	Diabetes_McGill_Set_Wnt_pathway	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
3.84615384615%	1	26	87	Diabetes_McGill_Set_Wnt_pathway	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
3.84615384615%	1	26	87	Diabetes_McGill_GPCRs_expressed_in_beta_cell	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
3.84615384615%	1	26	86	Diabetes_McGill_Set_Wnt_pathway	REACTOME_L1CAM_INTERACTIONS
3.84615384615%	1	26	86	Diabetes_McGill_Set_Wnt_pathway	NGUYEN_NOTCH1_TARGETS_DN
3.84615384615%	1	26	86	Diabetes_McGill_Set_Wnt_pathway	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
3.84615384615%	1	26	86	Diabetes_McGill_Set_Wnt_pathway	LEE_AGING_CEREBELLUM_DN
3.84615384615%	1	26	86	Diabetes_McGill_GPCRs_expressed_in_beta_cell	TAKAO_RESPONSE_TO_UVB_RADIATION_UP
3.84615384615%	1	26	86	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
3.84615384615%	1	26	85	Diabetes_McGill_Set_Wnt_pathway	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE
3.84615384615%	1	26	85	Diabetes_McGill_GPCRs_expressed_in_beta_cell	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
3.84615384615%	1	26	848	Diabetes_McGill_Set_Wnt_pathway	NUYTTEN_NIPP1_TARGETS_DN
3.84615384615%	1	26	84	Diabetes_McGill_Set_Wnt_pathway	LEE_AGING_CEREBELLUM_UP
3.84615384615%	1	26	84	Diabetes_McGill_Set_Wnt_pathway	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
3.84615384615%	1	26	84	Diabetes_McGill_Set_Wnt_pathway	CHANG_IMMORTALIZED_BY_HPV31_UP
3.84615384615%	1	26	84	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SMID_BREAST_CANCER_LUMINAL_A_UP
3.84615384615%	1	26	84	Diabetes_McGill_GPCRs_expressed_in_beta_cell	RASHI_RESPONSE_TO_IONIZING_RADIATION_6
3.84615384615%	1	26	83	Diabetes_McGill_Set_Wnt_pathway	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
3.84615384615%	1	26	83	Diabetes_McGill_Set_Wnt_pathway	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
3.84615384615%	1	26	83	Diabetes_McGill_Set_Wnt_pathway	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
3.84615384615%	1	26	83	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ONDER_CDH1_SIGNALING_VIA_CTNNB1
3.84615384615%	1	26	82	Diabetes_McGill_Set_Wnt_pathway	BHAT_ESR1_TARGETS_VIA_AKT1_DN
3.84615384615%	1	26	82	Diabetes_McGill_GPCRs_expressed_in_beta_cell	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
3.84615384615%	1	26	81	Diabetes_McGill_Set_Wnt_pathway	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
3.84615384615%	1	26	81	Diabetes_McGill_Set_Wnt_pathway	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
3.84615384615%	1	26	81	Diabetes_McGill_Set_Wnt_pathway	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
3.84615384615%	1	26	81	Diabetes_McGill_Set_Wnt_pathway	REACTOME_MITOTIC_G2_G2_M_PHASES
3.84615384615%	1	26	81	Diabetes_McGill_Set_Wnt_pathway	MAHAJAN_RESPONSE_TO_IL1A_UP
3.84615384615%	1	26	81	Diabetes_McGill_Set_Wnt_pathway	LEIN_MEDULLA_MARKERS
3.84615384615%	1	26	81	Diabetes_McGill_Set_Wnt_pathway	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
3.84615384615%	1	26	81	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MAHAJAN_RESPONSE_TO_IL1A_UP
3.84615384615%	1	26	80	Diabetes_McGill_Set_Wnt_pathway	SCHUHMACHER_MYC_TARGETS_UP
3.84615384615%	1	26	80	Diabetes_McGill_Set_Wnt_pathway	MORI_PRE_BI_LYMPHOCYTE_UP
3.84615384615%	1	26	80	Diabetes_McGill_Set_Wnt_pathway	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
3.84615384615%	1	26	80	Diabetes_McGill_Set_Wnt_pathway	BASSO_HAIRY_CELL_LEUKEMIA_DN
3.84615384615%	1	26	80	Diabetes_McGill_GPCRs_expressed_in_beta_cell	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
3.84615384615%	1	26	80	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
3.84615384615%	1	26	8	Diabetes_McGill_Set_Wnt_pathway	TURJANSKI_MAPK7_TARGETS
3.84615384615%	1	26	8	Diabetes_McGill_Set_Wnt_pathway	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN
3.84615384615%	1	26	8	Diabetes_McGill_Set_Wnt_pathway	NADELLA_PRKAR1A_TARGETS_DN
3.84615384615%	1	26	8	Diabetes_McGill_Set_Wnt_pathway	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18
3.84615384615%	1	26	8	Diabetes_McGill_GPCRs_expressed_in_beta_cell	LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP
3.84615384615%	1	26	795	Diabetes_McGill_GPCRs_expressed_in_beta_cell	WEI_MYCN_TARGETS_WITH_E_BOX
3.84615384615%	1	26	79	Diabetes_McGill_Set_Wnt_pathway	PID_P73PATHWAY
3.84615384615%	1	26	79	Diabetes_McGill_Set_Wnt_pathway	MCCLUNG_COCAINE_REWARD_5D
3.84615384615%	1	26	79	Diabetes_McGill_Set_Wnt_pathway	LIU_COMMON_CANCER_GENES
3.84615384615%	1	26	79	Diabetes_McGill_Set_Wnt_pathway	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
3.84615384615%	1	26	79	Diabetes_McGill_Set_Wnt_pathway	DUAN_PRDM5_TARGETS
3.84615384615%	1	26	79	Diabetes_McGill_Set_Wnt_pathway	CROMER_METASTASIS_UP
3.84615384615%	1	26	79	Diabetes_McGill_GPCRs_expressed_in_beta_cell	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
3.84615384615%	1	26	784	Diabetes_McGill_Set_Wnt_pathway	FORTSCHEGGER_PHF8_TARGETS_DN
3.84615384615%	1	26	783	Diabetes_McGill_Set_Wnt_pathway	ONKEN_UVEAL_MELANOMA_UP
3.84615384615%	1	26	783	Diabetes_McGill_Set_Wnt_pathway	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
3.84615384615%	1	26	783	Diabetes_McGill_GPCRs_expressed_in_beta_cell	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
3.84615384615%	1	26	781	Diabetes_McGill_Set_Wnt_pathway	GOZGIT_ESR1_TARGETS_DN
3.84615384615%	1	26	78	Diabetes_McGill_Set_Wnt_pathway	REACTOME_PLATELET_HOMEOSTASIS
3.84615384615%	1	26	78	Diabetes_McGill_Set_Wnt_pathway	REACTOME_OPIOID_SIGNALLING
3.84615384615%	1	26	78	Diabetes_McGill_Set_Wnt_pathway	REACTOME_CELL_JUNCTION_ORGANIZATION
3.84615384615%	1	26	78	Diabetes_McGill_Set_Wnt_pathway	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP
3.84615384615%	1	26	775	Diabetes_McGill_Set_Wnt_pathway	BENPORATH_MYC_MAX_TARGETS
3.84615384615%	1	26	77	Diabetes_McGill_Set_Wnt_pathway	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
3.84615384615%	1	26	77	Diabetes_McGill_Set_Wnt_pathway	ROSS_AML_WITH_PML_RARA_FUSION
3.84615384615%	1	26	77	Diabetes_McGill_Set_Wnt_pathway	LIN_APC_TARGETS
3.84615384615%	1	26	77	Diabetes_McGill_Set_Wnt_pathway	JACKSON_DNMT1_TARGETS_UP
3.84615384615%	1	26	77	Diabetes_McGill_Set_Wnt_pathway	FRIDMAN_SENESCENCE_UP
3.84615384615%	1	26	77	Diabetes_McGill_Set_Wnt_pathway	CHEBOTAEV_GR_TARGETS_UP
3.84615384615%	1	26	77	Diabetes_McGill_Set_Wnt_pathway	CARD_MIR302A_TARGETS
3.84615384615%	1	26	77	Diabetes_McGill_GPCRs_expressed_in_beta_cell	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
3.84615384615%	1	26	769	Diabetes_McGill_Set_Wnt_pathway	NUYTTEN_NIPP1_TARGETS_UP
3.84615384615%	1	26	76	Diabetes_McGill_Set_Wnt_pathway	ROSS_AML_WITH_AML1_ETO_FUSION
3.84615384615%	1	26	76	Diabetes_McGill_Set_Wnt_pathway	NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON
3.84615384615%	1	26	76	Diabetes_McGill_GPCRs_expressed_in_beta_cell	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
3.84615384615%	1	26	76	Diabetes_McGill_GPCRs_expressed_in_beta_cell	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
3.84615384615%	1	26	75	Diabetes_McGill_Set_Wnt_pathway	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
3.84615384615%	1	26	75	Diabetes_McGill_Set_Wnt_pathway	JAIN_NFKB_SIGNALING
3.84615384615%	1	26	75	Diabetes_McGill_Set_Wnt_pathway	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
3.84615384615%	1	26	75	Diabetes_McGill_Set_Wnt_pathway	CHESLER_BRAIN_QTL_CIS
3.84615384615%	1	26	745	Diabetes_McGill_GPCRs_expressed_in_beta_cell	LEE_BMP2_TARGETS_UP
3.84615384615%	1	26	74	Diabetes_McGill_Set_Wnt_pathway	VANASSE_BCL2_TARGETS_DN
3.84615384615%	1	26	74	Diabetes_McGill_Set_Wnt_pathway	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
3.84615384615%	1	26	74	Diabetes_McGill_Set_Wnt_pathway	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
3.84615384615%	1	26	74	Diabetes_McGill_Set_Wnt_pathway	JI_RESPONSE_TO_FSH_UP
3.84615384615%	1	26	74	Diabetes_McGill_Set_Wnt_pathway	DER_IFN_ALPHA_RESPONSE_UP
3.84615384615%	1	26	74	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
3.84615384615%	1	26	74	Diabetes_McGill_GPCRs_expressed_in_beta_cell	FURUKAWA_DUSP6_TARGETS_PCI35_DN
3.84615384615%	1	26	73	Diabetes_McGill_Set_Wnt_pathway	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
3.84615384615%	1	26	73	Diabetes_McGill_Set_Wnt_pathway	KEGG_VIRAL_MYOCARDITIS
3.84615384615%	1	26	73	Diabetes_McGill_Set_Wnt_pathway	DITTMER_PTHLH_TARGETS_DN
3.84615384615%	1	26	721	Diabetes_McGill_GPCRs_expressed_in_beta_cell	WONG_ADULT_TISSUE_STEM_MODULE
3.84615384615%	1	26	720	Diabetes_McGill_GPCRs_expressed_in_beta_cell	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
3.84615384615%	1	26	72	Diabetes_McGill_Set_Wnt_pathway	SESTO_RESPONSE_TO_UV_C8
3.84615384615%	1	26	72	Diabetes_McGill_Set_Wnt_pathway	MATZUK_SPERMATOCYTE
3.84615384615%	1	26	72	Diabetes_McGill_Set_Wnt_pathway	BURTON_ADIPOGENESIS_2
3.84615384615%	1	26	718	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MIKKELSEN_ES_ICP_WITH_H3K4ME3
3.84615384615%	1	26	71	Diabetes_McGill_Set_Wnt_pathway	KYNG_RESPONSE_TO_H2O2
3.84615384615%	1	26	71	Diabetes_McGill_Set_Wnt_pathway	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
3.84615384615%	1	26	71	Diabetes_McGill_Set_Wnt_pathway	KEGG_MELANOMA
3.84615384615%	1	26	71	Diabetes_McGill_Set_Wnt_pathway	BROWNE_HCMV_INFECTION_6HR_UP
3.84615384615%	1	26	701	Diabetes_McGill_Set_Wnt_pathway	SMID_BREAST_CANCER_BASAL_DN
3.84615384615%	1	26	70	Diabetes_McGill_Set_Wnt_pathway	KEGG_RENAL_CELL_CARCINOMA
3.84615384615%	1	26	70	Diabetes_McGill_Set_Wnt_pathway	KEGG_LONG_TERM_POTENTIATION
3.84615384615%	1	26	70	Diabetes_McGill_Set_Wnt_pathway	KEGG_LONG_TERM_DEPRESSION
3.84615384615%	1	26	7	Diabetes_McGill_Set_Wnt_pathway	TESAR_ALK_TARGETS_HUMAN_ES_5D_DN
3.84615384615%	1	26	7	Diabetes_McGill_Set_Wnt_pathway	TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP
3.84615384615%	1	26	7	Diabetes_McGill_Set_Wnt_pathway	SCHRAMM_INHBA_TARGETS_UP
3.84615384615%	1	26	7	Diabetes_McGill_Set_Wnt_pathway	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN
3.84615384615%	1	26	7	Diabetes_McGill_Set_Wnt_pathway	BUSA_SAM68_TARGETS_UP
3.84615384615%	1	26	69	Diabetes_McGill_Set_Wnt_pathway	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
3.84615384615%	1	26	69	Diabetes_McGill_Set_Wnt_pathway	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN
3.84615384615%	1	26	69	Diabetes_McGill_Set_Wnt_pathway	REACTOME_GLUCOSE_METABOLISM
3.84615384615%	1	26	69	Diabetes_McGill_Set_Wnt_pathway	PID_VEGFR1_2_PATHWAY
3.84615384615%	1	26	69	Diabetes_McGill_Set_Wnt_pathway	KEGG_PPAR_SIGNALING_PATHWAY
3.84615384615%	1	26	69	Diabetes_McGill_Set_Wnt_pathway	KEGG_P53_SIGNALING_PATHWAY
3.84615384615%	1	26	69	Diabetes_McGill_Set_Wnt_pathway	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
3.84615384615%	1	26	69	Diabetes_McGill_GPCRs_expressed_in_beta_cell	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
3.84615384615%	1	26	682	Diabetes_McGill_Set_Wnt_pathway	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
3.84615384615%	1	26	682	Diabetes_McGill_GPCRs_expressed_in_beta_cell	FEVR_CTNNB1_TARGETS_UP
3.84615384615%	1	26	68	Diabetes_McGill_Set_Wnt_pathway	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
3.84615384615%	1	26	68	Diabetes_McGill_GPCRs_expressed_in_beta_cell	NOUZOVA_METHYLATED_IN_APL
3.84615384615%	1	26	68	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BASSO_CD40_SIGNALING_DN
3.84615384615%	1	26	668	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
3.84615384615%	1	26	66	Diabetes_McGill_Set_Wnt_pathway	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
3.84615384615%	1	26	66	Diabetes_McGill_Set_Wnt_pathway	TENEDINI_MEGAKARYOCYTE_MARKERS
3.84615384615%	1	26	66	Diabetes_McGill_Set_Wnt_pathway	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
3.84615384615%	1	26	66	Diabetes_McGill_Set_Wnt_pathway	PID_LYSOPHOSPHOLIPID_PATHWAY
3.84615384615%	1	26	66	Diabetes_McGill_Set_Wnt_pathway	MARSON_FOXP3_TARGETS_UP
3.84615384615%	1	26	66	Diabetes_McGill_Set_Wnt_pathway	DIRMEIER_LMP1_RESPONSE_EARLY
3.84615384615%	1	26	66	Diabetes_McGill_Set_Wnt_pathway	BEIER_GLIOMA_STEM_CELL_DN
3.84615384615%	1	26	66	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
3.84615384615%	1	26	652	Diabetes_McGill_Set_Wnt_pathway	BENPORATH_PRC2_TARGETS
3.84615384615%	1	26	65	Diabetes_McGill_Set_Wnt_pathway	ST_FAS_SIGNALING_PATHWAY
3.84615384615%	1	26	65	Diabetes_McGill_Set_Wnt_pathway	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
3.84615384615%	1	26	65	Diabetes_McGill_Set_Wnt_pathway	KEGG_GLIOMA
3.84615384615%	1	26	65	Diabetes_McGill_Set_Wnt_pathway	GUO_HEX_TARGETS_DN
3.84615384615%	1	26	65	Diabetes_McGill_Set_Wnt_pathway	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP
3.84615384615%	1	26	648	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SMID_BREAST_CANCER_BASAL_UP
3.84615384615%	1	26	64	Diabetes_McGill_Set_Wnt_pathway	ZHAN_MULTIPLE_MYELOMA_UP
3.84615384615%	1	26	64	Diabetes_McGill_Set_Wnt_pathway	RHODES_CANCER_META_SIGNATURE
3.84615384615%	1	26	64	Diabetes_McGill_Set_Wnt_pathway	LEE_LIVER_CANCER_ACOX1_UP
3.84615384615%	1	26	64	Diabetes_McGill_Set_Wnt_pathway	GERHOLD_ADIPOGENESIS_DN
3.84615384615%	1	26	637	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
3.84615384615%	1	26	634	Diabetes_McGill_Set_Wnt_pathway	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
3.84615384615%	1	26	633	Diabetes_McGill_GPCRs_expressed_in_beta_cell	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
3.84615384615%	1	26	63	Diabetes_McGill_Set_Wnt_pathway	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
3.84615384615%	1	26	63	Diabetes_McGill_Set_Wnt_pathway	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
3.84615384615%	1	26	63	Diabetes_McGill_Set_Wnt_pathway	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
3.84615384615%	1	26	63	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED
3.84615384615%	1	26	62	Diabetes_McGill_Set_Wnt_pathway	PID_TRKRPATHWAY
3.84615384615%	1	26	62	Diabetes_McGill_Set_Wnt_pathway	CORRE_MULTIPLE_MYELOMA_DN
3.84615384615%	1	26	62	Diabetes_McGill_Set_Wnt_pathway	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP
3.84615384615%	1	26	62	Diabetes_McGill_Set_Wnt_pathway	BILD_SRC_ONCOGENIC_SIGNATURE
3.84615384615%	1	26	612	Diabetes_McGill_GPCRs_expressed_in_beta_cell	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
3.84615384615%	1	26	61	Diabetes_McGill_Set_Wnt_pathway	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
3.84615384615%	1	26	61	Diabetes_McGill_Set_Wnt_pathway	LEE_LIVER_CANCER_MYC_TGFA_UP
3.84615384615%	1	26	61	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MASSARWEH_RESPONSE_TO_ESTRADIOL
3.84615384615%	1	26	605	Diabetes_McGill_Set_Wnt_pathway	CAIRO_HEPATOBLASTOMA_CLASSES_UP
3.84615384615%	1	26	60	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP
3.84615384615%	1	26	6	Diabetes_McGill_Set_Wnt_pathway	TESAR_ALK_TARGETS_HUMAN_ES_4D_DN
3.84615384615%	1	26	6	Diabetes_McGill_Set_Wnt_pathway	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP
3.84615384615%	1	26	6	Diabetes_McGill_Set_Wnt_pathway	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_14
3.84615384615%	1	26	6	Diabetes_McGill_Set_Wnt_pathway	GERHOLD_RESPONSE_TO_TZD_UP
3.84615384615%	1	26	59	Diabetes_McGill_Set_Wnt_pathway	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
3.84615384615%	1	26	59	Diabetes_McGill_Set_Wnt_pathway	PID_FAK_PATHWAY
3.84615384615%	1	26	59	Diabetes_McGill_Set_Wnt_pathway	PID_ATF2_PATHWAY
3.84615384615%	1	26	59	Diabetes_McGill_Set_Wnt_pathway	KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION
3.84615384615%	1	26	59	Diabetes_McGill_Set_Wnt_pathway	BARIS_THYROID_CANCER_DN
3.84615384615%	1	26	59	Diabetes_McGill_GPCRs_expressed_in_beta_cell	WESTON_VEGFA_TARGETS_6HR
3.84615384615%	1	26	59	Diabetes_McGill_GPCRs_expressed_in_beta_cell	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
3.84615384615%	1	26	584	Diabetes_McGill_Set_Wnt_pathway	HAMAI_APOPTOSIS_VIA_TRAIL_UP
3.84615384615%	1	26	58	Diabetes_McGill_Set_Wnt_pathway	NAGASHIMA_NRG1_SIGNALING_DN
3.84615384615%	1	26	58	Diabetes_McGill_Set_Wnt_pathway	NAGASHIMA_EGF_SIGNALING_UP
3.84615384615%	1	26	58	Diabetes_McGill_Set_Wnt_pathway	NADLER_HYPERGLYCEMIA_AT_OBESITY
3.84615384615%	1	26	58	Diabetes_McGill_Set_Wnt_pathway	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
3.84615384615%	1	26	58	Diabetes_McGill_Set_Wnt_pathway	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
3.84615384615%	1	26	579	Diabetes_McGill_Set_Wnt_pathway	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
3.84615384615%	1	26	578	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
3.84615384615%	1	26	572	Diabetes_McGill_Set_Wnt_pathway	CHICAS_RB1_TARGETS_SENESCENT
3.84615384615%	1	26	57	Diabetes_McGill_Set_Wnt_pathway	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
3.84615384615%	1	26	57	Diabetes_McGill_Set_Wnt_pathway	DIRMEIER_LMP1_RESPONSE_LATE_UP
3.84615384615%	1	26	57	Diabetes_McGill_Set_Wnt_pathway	DELASERNA_MYOD_TARGETS_DN
3.84615384615%	1	26	57	Diabetes_McGill_Set_Wnt_pathway	BORLAK_LIVER_CANCER_EGF_UP
3.84615384615%	1	26	57	Diabetes_McGill_GPCRs_expressed_in_beta_cell	AMIT_SERUM_RESPONSE_240_MCF10A
3.84615384615%	1	26	566	Diabetes_McGill_Set_Wnt_pathway	DOUGLAS_BMI1_TARGETS_UP
3.84615384615%	1	26	566	Diabetes_McGill_GPCRs_expressed_in_beta_cell	DOUGLAS_BMI1_TARGETS_UP
3.84615384615%	1	26	564	Diabetes_McGill_Set_Wnt_pathway	SMID_BREAST_CANCER_LUMINAL_B_DN
3.84615384615%	1	26	564	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SMID_BREAST_CANCER_LUMINAL_B_DN
3.84615384615%	1	26	56	Diabetes_McGill_Set_Wnt_pathway	ZHENG_IL22_SIGNALING_UP
3.84615384615%	1	26	56	Diabetes_McGill_Set_Wnt_pathway	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION
3.84615384615%	1	26	56	Diabetes_McGill_Set_Wnt_pathway	HOQUE_METHYLATED_IN_CANCER
3.84615384615%	1	26	56	Diabetes_McGill_Set_Wnt_pathway	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
3.84615384615%	1	26	56	Diabetes_McGill_Set_Wnt_pathway	GALE_APL_WITH_FLT3_MUTATED_UP
3.84615384615%	1	26	557	Diabetes_McGill_Set_Wnt_pathway	TIEN_INTESTINE_PROBIOTICS_24HR_UP
3.84615384615%	1	26	555	Diabetes_McGill_Set_Wnt_pathway	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
3.84615384615%	1	26	553	Diabetes_McGill_GPCRs_expressed_in_beta_cell	FEVR_CTNNB1_TARGETS_DN
3.84615384615%	1	26	552	Diabetes_McGill_Set_Wnt_pathway	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
3.84615384615%	1	26	55	Diabetes_McGill_Set_Wnt_pathway	TIEN_INTESTINE_PROBIOTICS_6HR_UP
3.84615384615%	1	26	55	Diabetes_McGill_Set_Wnt_pathway	PID_IL2_1PATHWAY
3.84615384615%	1	26	55	Diabetes_McGill_Set_Wnt_pathway	LAU_APOPTOSIS_CDKN2A_UP
3.84615384615%	1	26	55	Diabetes_McGill_Set_Wnt_pathway	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR
3.84615384615%	1	26	55	Diabetes_McGill_GPCRs_expressed_in_beta_cell	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
3.84615384615%	1	26	55	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SU_LIVER
3.84615384615%	1	26	549	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
3.84615384615%	1	26	548	Diabetes_McGill_Set_Wnt_pathway	KIM_ALL_DISORDERS_CALB1_CORR_UP
3.84615384615%	1	26	546	Diabetes_McGill_Set_Wnt_pathway	WEST_ADRENOCORTICAL_TUMOR_DN
3.84615384615%	1	26	540	Diabetes_McGill_Set_Wnt_pathway	ACEVEDO_LIVER_CANCER_DN
3.84615384615%	1	26	540	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ACEVEDO_LIVER_CANCER_DN
3.84615384615%	1	26	54	Diabetes_McGill_Set_Wnt_pathway	ZHOU_TNF_SIGNALING_30MIN
3.84615384615%	1	26	54	Diabetes_McGill_Set_Wnt_pathway	REACTOME_TCR_SIGNALING
3.84615384615%	1	26	54	Diabetes_McGill_Set_Wnt_pathway	PID_RAC1_PATHWAY
3.84615384615%	1	26	54	Diabetes_McGill_Set_Wnt_pathway	MARSON_FOXP3_TARGETS_DN
3.84615384615%	1	26	54	Diabetes_McGill_Set_Wnt_pathway	KEGG_NON_SMALL_CELL_LUNG_CANCER
3.84615384615%	1	26	539	Diabetes_McGill_Set_Wnt_pathway	LIAO_METASTASIS
3.84615384615%	1	26	536	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
3.84615384615%	1	26	532	Diabetes_McGill_GPCRs_expressed_in_beta_cell	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
3.84615384615%	1	26	53	Diabetes_McGill_Set_Wnt_pathway	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
3.84615384615%	1	26	53	Diabetes_McGill_Set_Wnt_pathway	HENDRICKS_SMARCA4_TARGETS_DN
3.84615384615%	1	26	53	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ZHU_CMV_8_HR_DN
3.84615384615%	1	26	53	Diabetes_McGill_GPCRs_expressed_in_beta_cell	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
3.84615384615%	1	26	528	Diabetes_McGill_Set_Wnt_pathway	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
3.84615384615%	1	26	528	Diabetes_McGill_GPCRs_expressed_in_beta_cell	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
3.84615384615%	1	26	526	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ONKEN_UVEAL_MELANOMA_DN
3.84615384615%	1	26	52	Diabetes_McGill_Set_Wnt_pathway	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
3.84615384615%	1	26	52	Diabetes_McGill_Set_Wnt_pathway	BECKER_TAMOXIFEN_RESISTANCE_DN
3.84615384615%	1	26	518	Diabetes_McGill_Set_Wnt_pathway	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
3.84615384615%	1	26	517	Diabetes_McGill_GPCRs_expressed_in_beta_cell	RAO_BOUND_BY_SALL4_ISOFORM_B
3.84615384615%	1	26	51	Diabetes_McGill_Set_Wnt_pathway	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
3.84615384615%	1	26	51	Diabetes_McGill_Set_Wnt_pathway	ZHANG_PROLIFERATING_VS_QUIESCENT
3.84615384615%	1	26	51	Diabetes_McGill_Set_Wnt_pathway	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
3.84615384615%	1	26	51	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
3.84615384615%	1	26	51	Diabetes_McGill_Set_Wnt_pathway	LUI_THYROID_CANCER_CLUSTER_1
3.84615384615%	1	26	51	Diabetes_McGill_Set_Wnt_pathway	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
3.84615384615%	1	26	51	Diabetes_McGill_Set_Wnt_pathway	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP
3.84615384615%	1	26	51	Diabetes_McGill_Set_Wnt_pathway	BURTON_ADIPOGENESIS_PEAK_AT_2HR
3.84615384615%	1	26	51	Diabetes_McGill_Set_Wnt_pathway	BURTON_ADIPOGENESIS_7
3.84615384615%	1	26	505	Diabetes_McGill_Set_Wnt_pathway	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
3.84615384615%	1	26	504	Diabetes_McGill_Set_Wnt_pathway	BROWNE_HCMV_INFECTION_48HR_DN
3.84615384615%	1	26	504	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BROWNE_HCMV_INFECTION_48HR_DN
3.84615384615%	1	26	501	Diabetes_McGill_Set_Wnt_pathway	SENESE_HDAC3_TARGETS_UP
3.84615384615%	1	26	50	Diabetes_McGill_Set_Wnt_pathway	KENNY_CTNNB1_TARGETS_UP
3.84615384615%	1	26	50	Diabetes_McGill_Set_Wnt_pathway	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN
3.84615384615%	1	26	5	Diabetes_McGill_Set_Wnt_pathway	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_11
3.84615384615%	1	26	5	Diabetes_McGill_Set_Wnt_pathway	KERLEY_RESPONSE_TO_CISPLATIN_DN
3.84615384615%	1	26	5	Diabetes_McGill_Set_Wnt_pathway	BIERIE_INFLAMMATORY_RESPONSE_TGFB1
3.84615384615%	1	26	5	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SMID_BREAST_CANCER_ERBB2_DN
3.84615384615%	1	26	493	Diabetes_McGill_GPCRs_expressed_in_beta_cell	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
3.84615384615%	1	26	491	Diabetes_McGill_Set_Wnt_pathway	ZHENG_BOUND_BY_FOXP3
3.84615384615%	1	26	49	Diabetes_McGill_Set_Wnt_pathway	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
3.84615384615%	1	26	49	Diabetes_McGill_Set_Wnt_pathway	PID_ARF6_TRAFFICKINGPATHWAY
3.84615384615%	1	26	49	Diabetes_McGill_Set_Wnt_pathway	MARCHINI_TRABECTEDIN_RESISTANCE_DN
3.84615384615%	1	26	49	Diabetes_McGill_Set_Wnt_pathway	BROWNE_HCMV_INFECTION_2HR_DN
3.84615384615%	1	26	49	Diabetes_McGill_Set_Wnt_pathway	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP
3.84615384615%	1	26	49	Diabetes_McGill_GPCRs_expressed_in_beta_cell	PID_ARF6_TRAFFICKINGPATHWAY
3.84615384615%	1	26	487	Diabetes_McGill_GPCRs_expressed_in_beta_cell	RODWELL_AGING_KIDNEY_UP
3.84615384615%	1	26	485	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ENK_UV_RESPONSE_KERATINOCYTE_DN
3.84615384615%	1	26	482	Diabetes_McGill_Set_Wnt_pathway	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
3.84615384615%	1	26	481	Diabetes_McGill_Set_Wnt_pathway	LIU_PROSTATE_CANCER_DN
3.84615384615%	1	26	48	Diabetes_McGill_Set_Wnt_pathway	RASHI_RESPONSE_TO_IONIZING_RADIATION_3
3.84615384615%	1	26	48	Diabetes_McGill_Set_Wnt_pathway	PID_CERAMIDE_PATHWAY
3.84615384615%	1	26	48	Diabetes_McGill_Set_Wnt_pathway	OXFORD_RALA_OR_RALB_TARGETS_UP
3.84615384615%	1	26	48	Diabetes_McGill_Set_Wnt_pathway	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN
3.84615384615%	1	26	478	Diabetes_McGill_Set_Wnt_pathway	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
3.84615384615%	1	26	47	Diabetes_McGill_Set_Wnt_pathway	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
3.84615384615%	1	26	47	Diabetes_McGill_Set_Wnt_pathway	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN
3.84615384615%	1	26	47	Diabetes_McGill_Set_Wnt_pathway	POTTI_DOCETAXEL_SENSITIVITY
3.84615384615%	1	26	47	Diabetes_McGill_Set_Wnt_pathway	PID_IL6_7PATHWAY
3.84615384615%	1	26	47	Diabetes_McGill_Set_Wnt_pathway	PID_DELTANP63PATHWAY
3.84615384615%	1	26	47	Diabetes_McGill_Set_Wnt_pathway	BROWNE_HCMV_INFECTION_8HR_DN
3.84615384615%	1	26	47	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MCCLUNG_DELTA_FOSB_TARGETS_8WK
3.84615384615%	1	26	469	Diabetes_McGill_Set_Wnt_pathway	MCCABE_BOUND_BY_HOXC6
3.84615384615%	1	26	467	Diabetes_McGill_Set_Wnt_pathway	RATTENBACHER_BOUND_BY_CELF1
3.84615384615%	1	26	467	Diabetes_McGill_GPCRs_expressed_in_beta_cell	RATTENBACHER_BOUND_BY_CELF1
3.84615384615%	1	26	464	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ONDER_CDH1_TARGETS_2_DN
3.84615384615%	1	26	461	Diabetes_McGill_Set_Wnt_pathway	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
3.84615384615%	1	26	46	Diabetes_McGill_Set_Wnt_pathway	SIG_BCR_SIGNALING_PATHWAY
3.84615384615%	1	26	46	Diabetes_McGill_Set_Wnt_pathway	PID_PLK1_PATHWAY
3.84615384615%	1	26	46	Diabetes_McGill_Set_Wnt_pathway	KRASNOSELSKAYA_ILF3_TARGETS_DN
3.84615384615%	1	26	46	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_KERATINOCYTE_PATHWAY
3.84615384615%	1	26	46	Diabetes_McGill_Set_Wnt_pathway	AMIT_EGF_RESPONSE_60_HELA
3.84615384615%	1	26	46	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SAGIV_CD24_TARGETS_DN
3.84615384615%	1	26	46	Diabetes_McGill_GPCRs_expressed_in_beta_cell	OSADA_ASCL1_TARGETS_UP
3.84615384615%	1	26	46	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN
3.84615384615%	1	26	459	Diabetes_McGill_Set_Wnt_pathway	KIM_WT1_TARGETS_DN
3.84615384615%	1	26	457	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
3.84615384615%	1	26	456	Diabetes_McGill_Set_Wnt_pathway	MARTENS_BOUND_BY_PML_RARA_FUSION
3.84615384615%	1	26	456	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ODONNELL_TFRC_TARGETS_UP
3.84615384615%	1	26	455	Diabetes_McGill_GPCRs_expressed_in_beta_cell	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
3.84615384615%	1	26	45	Diabetes_McGill_Set_Wnt_pathway	VANHARANTA_UTERINE_FIBROID_UP
3.84615384615%	1	26	45	Diabetes_McGill_Set_Wnt_pathway	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
3.84615384615%	1	26	45	Diabetes_McGill_Set_Wnt_pathway	SHIPP_DLBCL_CURED_VS_FATAL_DN
3.84615384615%	1	26	45	Diabetes_McGill_Set_Wnt_pathway	MCDOWELL_ACUTE_LUNG_INJURY_UP
3.84615384615%	1	26	45	Diabetes_McGill_Set_Wnt_pathway	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN
3.84615384615%	1	26	45	Diabetes_McGill_Set_Wnt_pathway	GRADE_METASTASIS_DN
3.84615384615%	1	26	45	Diabetes_McGill_Set_Wnt_pathway	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
3.84615384615%	1	26	45	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ZHAN_MULTIPLE_MYELOMA_CD2_UP
3.84615384615%	1	26	45	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ZHAN_MULTIPLE_MYELOMA_CD1_UP
3.84615384615%	1	26	45	Diabetes_McGill_GPCRs_expressed_in_beta_cell	VANHARANTA_UTERINE_FIBROID_UP
3.84615384615%	1	26	45	Diabetes_McGill_GPCRs_expressed_in_beta_cell	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
3.84615384615%	1	26	448	Diabetes_McGill_Set_Wnt_pathway	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
3.84615384615%	1	26	448	Diabetes_McGill_GPCRs_expressed_in_beta_cell	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
3.84615384615%	1	26	443	Diabetes_McGill_Set_Wnt_pathway	DELYS_THYROID_CANCER_UP
3.84615384615%	1	26	442	Diabetes_McGill_Set_Wnt_pathway	HAN_SATB1_TARGETS_DN
3.84615384615%	1	26	44	Diabetes_McGill_Set_Wnt_pathway	VANTVEER_BREAST_CANCER_BRCA1_DN
3.84615384615%	1	26	44	Diabetes_McGill_Set_Wnt_pathway	PID_HNF3APATHWAY
3.84615384615%	1	26	44	Diabetes_McGill_Set_Wnt_pathway	PARK_HSC_MARKERS
3.84615384615%	1	26	44	Diabetes_McGill_Set_Wnt_pathway	MA_MYELOID_DIFFERENTIATION_DN
3.84615384615%	1	26	44	Diabetes_McGill_Set_Wnt_pathway	MARTIN_INTERACT_WITH_HDAC
3.84615384615%	1	26	44	Diabetes_McGill_Set_Wnt_pathway	LUI_THYROID_CANCER_PAX8_PPARG_UP
3.84615384615%	1	26	44	Diabetes_McGill_Set_Wnt_pathway	FAELT_B_CLL_WITH_VH3_21_UP
3.84615384615%	1	26	439	Diabetes_McGill_Set_Wnt_pathway	MITSIADES_RESPONSE_TO_APLIDIN_UP
3.84615384615%	1	26	439	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MITSIADES_RESPONSE_TO_APLIDIN_UP
3.84615384615%	1	26	435	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
3.84615384615%	1	26	434	Diabetes_McGill_Set_Wnt_pathway	BAELDE_DIABETIC_NEPHROPATHY_DN
3.84615384615%	1	26	431	Diabetes_McGill_Set_Wnt_pathway	GARY_CD5_TARGETS_DN
3.84615384615%	1	26	430	Diabetes_McGill_Set_Wnt_pathway	RIGGI_EWING_SARCOMA_PROGENITOR_UP
3.84615384615%	1	26	430	Diabetes_McGill_Set_Wnt_pathway	JOHNSTONE_PARVB_TARGETS_3_UP
3.84615384615%	1	26	430	Diabetes_McGill_GPCRs_expressed_in_beta_cell	RIGGI_EWING_SARCOMA_PROGENITOR_UP
3.84615384615%	1	26	43	Diabetes_McGill_Set_Wnt_pathway	PID_TCPTP_PATHWAY
3.84615384615%	1	26	43	Diabetes_McGill_Set_Wnt_pathway	MILI_PSEUDOPODIA
3.84615384615%	1	26	43	Diabetes_McGill_Set_Wnt_pathway	MANTOVANI_NFKB_TARGETS_UP
3.84615384615%	1	26	43	Diabetes_McGill_Set_Wnt_pathway	LEE_CALORIE_RESTRICTION_MUSCLE_UP
3.84615384615%	1	26	43	Diabetes_McGill_Set_Wnt_pathway	IKEDA_MIR133_TARGETS_UP
3.84615384615%	1	26	43	Diabetes_McGill_Set_Wnt_pathway	HUMMEL_BURKITTS_LYMPHOMA_UP
3.84615384615%	1	26	43	Diabetes_McGill_Set_Wnt_pathway	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
3.84615384615%	1	26	43	Diabetes_McGill_Set_Wnt_pathway	DORN_ADENOVIRUS_INFECTION_24HR_DN
3.84615384615%	1	26	43	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1
3.84615384615%	1	26	43	Diabetes_McGill_GPCRs_expressed_in_beta_cell	POTTI_5FU_SENSITIVITY
3.84615384615%	1	26	43	Diabetes_McGill_GPCRs_expressed_in_beta_cell	LIU_TARGETS_OF_VMYB_VS_CMYB_DN
3.84615384615%	1	26	428	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
3.84615384615%	1	26	425	Diabetes_McGill_Set_Wnt_pathway	ZHANG_BREAST_CANCER_PROGENITORS_UP
3.84615384615%	1	26	425	Diabetes_McGill_Set_Wnt_pathway	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
3.84615384615%	1	26	425	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
3.84615384615%	1	26	423	Diabetes_McGill_GPCRs_expressed_in_beta_cell	THUM_SYSTOLIC_HEART_FAILURE_UP
3.84615384615%	1	26	422	Diabetes_McGill_Set_Wnt_pathway	YAGI_AML_WITH_INV_16_TRANSLOCATION
3.84615384615%	1	26	422	Diabetes_McGill_GPCRs_expressed_in_beta_cell	YAGI_AML_WITH_INV_16_TRANSLOCATION
3.84615384615%	1	26	42	Diabetes_McGill_Set_Wnt_pathway	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
3.84615384615%	1	26	42	Diabetes_McGill_Set_Wnt_pathway	PID_ECADHERIN_STABILIZATION_PATHWAY
3.84615384615%	1	26	42	Diabetes_McGill_Set_Wnt_pathway	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER
3.84615384615%	1	26	42	Diabetes_McGill_Set_Wnt_pathway	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN
3.84615384615%	1	26	42	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_CHREBP2_PATHWAY
3.84615384615%	1	26	42	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ONO_FOXP3_TARGETS_DN
3.84615384615%	1	26	42	Diabetes_McGill_GPCRs_expressed_in_beta_cell	LUI_THYROID_CANCER_CLUSTER_2
3.84615384615%	1	26	419	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
3.84615384615%	1	26	418	Diabetes_McGill_Set_Wnt_pathway	MULLIGHAN_MLL_SIGNATURE_2_UP
3.84615384615%	1	26	418	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MULLIGHAN_MLL_SIGNATURE_2_UP
3.84615384615%	1	26	414	Diabetes_McGill_Set_Wnt_pathway	LU_EZH2_TARGETS_DN
3.84615384615%	1	26	41	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ONO_AML1_TARGETS_DN
3.84615384615%	1	26	41	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MALONEY_RESPONSE_TO_17AAG_UP
3.84615384615%	1	26	409	Diabetes_McGill_Set_Wnt_pathway	FOSTER_TOLERANT_MACROPHAGE_DN
3.84615384615%	1	26	406	Diabetes_McGill_Set_Wnt_pathway	OSMAN_BLADDER_CANCER_DN
3.84615384615%	1	26	404	Diabetes_McGill_Set_Wnt_pathway	OSMAN_BLADDER_CANCER_UP
3.84615384615%	1	26	40	Diabetes_McGill_Set_Wnt_pathway	PID_IFNGPATHWAY
3.84615384615%	1	26	40	Diabetes_McGill_Set_Wnt_pathway	GENTILE_UV_RESPONSE_CLUSTER_D7
3.84615384615%	1	26	40	Diabetes_McGill_Set_Wnt_pathway	DORN_ADENOVIRUS_INFECTION_48HR_DN
3.84615384615%	1	26	397	Diabetes_McGill_GPCRs_expressed_in_beta_cell	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
3.84615384615%	1	26	395	Diabetes_McGill_GPCRs_expressed_in_beta_cell	HAN_SATB1_TARGETS_UP
3.84615384615%	1	26	394	Diabetes_McGill_Set_Wnt_pathway	BERENJENO_TRANSFORMED_BY_RHOA_DN
3.84615384615%	1	26	392	Diabetes_McGill_Set_Wnt_pathway	LINDGREN_BLADDER_CANCER_CLUSTER_2B
3.84615384615%	1	26	391	Diabetes_McGill_Set_Wnt_pathway	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
3.84615384615%	1	26	39	Diabetes_McGill_Set_Wnt_pathway	VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1
3.84615384615%	1	26	39	Diabetes_McGill_Set_Wnt_pathway	PID_ATR_PATHWAY
3.84615384615%	1	26	39	Diabetes_McGill_Set_Wnt_pathway	DORN_ADENOVIRUS_INFECTION_32HR_DN
3.84615384615%	1	26	39	Diabetes_McGill_Set_Wnt_pathway	CONRAD_STEM_CELL
3.84615384615%	1	26	39	Diabetes_McGill_Set_Wnt_pathway	BEIER_GLIOMA_STEM_CELL_UP
3.84615384615%	1	26	39	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP
3.84615384615%	1	26	39	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SHIPP_DLBCL_CURED_VS_FATAL_UP
3.84615384615%	1	26	384	Diabetes_McGill_Set_Wnt_pathway	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
3.84615384615%	1	26	380	Diabetes_McGill_Set_Wnt_pathway	MULLIGHAN_MLL_SIGNATURE_1_UP
3.84615384615%	1	26	380	Diabetes_McGill_Set_Wnt_pathway	DAIRKEE_TERT_TARGETS_UP
3.84615384615%	1	26	380	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MULLIGHAN_MLL_SIGNATURE_1_UP
3.84615384615%	1	26	38	Diabetes_McGill_Set_Wnt_pathway	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
3.84615384615%	1	26	38	Diabetes_McGill_Set_Wnt_pathway	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4
3.84615384615%	1	26	38	Diabetes_McGill_Set_Wnt_pathway	PID_P38ALPHABETADOWNSTREAMPATHWAY
3.84615384615%	1	26	38	Diabetes_McGill_Set_Wnt_pathway	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
3.84615384615%	1	26	38	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_IL2RB_PATHWAY
3.84615384615%	1	26	38	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3
3.84615384615%	1	26	38	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
3.84615384615%	1	26	374	Diabetes_McGill_Set_Wnt_pathway	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
3.84615384615%	1	26	371	Diabetes_McGill_Set_Wnt_pathway	WANG_SMARCE1_TARGETS_DN
3.84615384615%	1	26	37	Diabetes_McGill_Set_Wnt_pathway	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN
3.84615384615%	1	26	37	Diabetes_McGill_Set_Wnt_pathway	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
3.84615384615%	1	26	37	Diabetes_McGill_Set_Wnt_pathway	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING
3.84615384615%	1	26	37	Diabetes_McGill_Set_Wnt_pathway	REACTOME_DOWNSTREAM_TCR_SIGNALING
3.84615384615%	1	26	37	Diabetes_McGill_Set_Wnt_pathway	PID_FRA_PATHWAY
3.84615384615%	1	26	37	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_PAR1_PATHWAY
3.84615384615%	1	26	367	Diabetes_McGill_Set_Wnt_pathway	VECCHI_GASTRIC_CANCER_EARLY_DN
3.84615384615%	1	26	366	Diabetes_McGill_Set_Wnt_pathway	YOSHIMURA_MAPK8_TARGETS_DN
3.84615384615%	1	26	366	Diabetes_McGill_GPCRs_expressed_in_beta_cell	YOSHIMURA_MAPK8_TARGETS_DN
3.84615384615%	1	26	362	Diabetes_McGill_Set_Wnt_pathway	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
3.84615384615%	1	26	36	Diabetes_McGill_Set_Wnt_pathway	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2
3.84615384615%	1	26	36	Diabetes_McGill_Set_Wnt_pathway	VANTVEER_BREAST_CANCER_BRCA1_UP
3.84615384615%	1	26	36	Diabetes_McGill_Set_Wnt_pathway	SUBTIL_PROGESTIN_TARGETS
3.84615384615%	1	26	36	Diabetes_McGill_Set_Wnt_pathway	ST_ADRENERGIC
3.84615384615%	1	26	36	Diabetes_McGill_Set_Wnt_pathway	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
3.84615384615%	1	26	36	Diabetes_McGill_Set_Wnt_pathway	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
3.84615384615%	1	26	36	Diabetes_McGill_Set_Wnt_pathway	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION
3.84615384615%	1	26	36	Diabetes_McGill_Set_Wnt_pathway	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
3.84615384615%	1	26	36	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_AGR_PATHWAY
3.84615384615%	1	26	36	Diabetes_McGill_Set_Wnt_pathway	ALONSO_METASTASIS_EMT_UP
3.84615384615%	1	26	358	Diabetes_McGill_Set_Wnt_pathway	GRUETZMANN_PANCREATIC_CANCER_UP
3.84615384615%	1	26	356	Diabetes_McGill_Set_Wnt_pathway	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
3.84615384615%	1	26	355	Diabetes_McGill_GPCRs_expressed_in_beta_cell	PEREZ_TP63_TARGETS
3.84615384615%	1	26	353	Diabetes_McGill_GPCRs_expressed_in_beta_cell	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
3.84615384615%	1	26	351	Diabetes_McGill_GPCRs_expressed_in_beta_cell	YAGI_AML_WITH_11Q23_REARRANGED
3.84615384615%	1	26	351	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
3.84615384615%	1	26	35	Diabetes_McGill_Set_Wnt_pathway	REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION
3.84615384615%	1	26	35	Diabetes_McGill_Set_Wnt_pathway	PID_PI3KCIAKTPATHWAY
3.84615384615%	1	26	35	Diabetes_McGill_Set_Wnt_pathway	DORSAM_HOXA9_TARGETS_UP
3.84615384615%	1	26	35	Diabetes_McGill_GPCRs_expressed_in_beta_cell	PID_ARF6_PATHWAY
3.84615384615%	1	26	35	Diabetes_McGill_GPCRs_expressed_in_beta_cell	LOPEZ_TRANSLATION_VIA_FN1_SIGNALING
3.84615384615%	1	26	349	Diabetes_McGill_Set_Wnt_pathway	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
3.84615384615%	1	26	341	Diabetes_McGill_Set_Wnt_pathway	MULLIGHAN_NPM1_SIGNATURE_3_UP
3.84615384615%	1	26	341	Diabetes_McGill_Set_Wnt_pathway	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
3.84615384615%	1	26	341	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MULLIGHAN_NPM1_SIGNATURE_3_UP
3.84615384615%	1	26	34	Diabetes_McGill_Set_Wnt_pathway	YANG_BREAST_CANCER_ESR1_LASER_UP
3.84615384615%	1	26	34	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SIGNAL_TRANSDUCTION_BY_L1
3.84615384615%	1	26	34	Diabetes_McGill_Set_Wnt_pathway	PID_IL8CXCR2_PATHWAY
3.84615384615%	1	26	34	Diabetes_McGill_Set_Wnt_pathway	PID_IL2_PI3KPATHWAY
3.84615384615%	1	26	34	Diabetes_McGill_Set_Wnt_pathway	PID_HIF2PATHWAY
3.84615384615%	1	26	34	Diabetes_McGill_Set_Wnt_pathway	PID_ATM_PATHWAY
3.84615384615%	1	26	34	Diabetes_McGill_Set_Wnt_pathway	HONMA_DOCETAXEL_RESISTANCE
3.84615384615%	1	26	34	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION
3.84615384615%	1	26	337	Diabetes_McGill_Set_Wnt_pathway	PENG_GLUTAMINE_DEPRIVATION_DN
3.84615384615%	1	26	337	Diabetes_McGill_GPCRs_expressed_in_beta_cell	PHONG_TNF_RESPONSE_NOT_VIA_P38
3.84615384615%	1	26	335	Diabetes_McGill_Set_Wnt_pathway	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
3.84615384615%	1	26	335	Diabetes_McGill_Set_Wnt_pathway	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
3.84615384615%	1	26	335	Diabetes_McGill_GPCRs_expressed_in_beta_cell	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
3.84615384615%	1	26	335	Diabetes_McGill_GPCRs_expressed_in_beta_cell	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
3.84615384615%	1	26	330	Diabetes_McGill_Set_Wnt_pathway	REACTOME_METABOLISM_OF_RNA
3.84615384615%	1	26	330	Diabetes_McGill_Set_Wnt_pathway	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
3.84615384615%	1	26	330	Diabetes_McGill_Set_Wnt_pathway	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
3.84615384615%	1	26	33	Diabetes_McGill_Set_Wnt_pathway	STAEGE_EWING_FAMILY_TUMOR
3.84615384615%	1	26	33	Diabetes_McGill_Set_Wnt_pathway	SIMBULAN_UV_RESPONSE_NORMAL_DN
3.84615384615%	1	26	33	Diabetes_McGill_Set_Wnt_pathway	PID_IL12_STAT4PATHWAY
3.84615384615%	1	26	33	Diabetes_McGill_Set_Wnt_pathway	PID_ALPHASYNUCLEIN_PATHWAY
3.84615384615%	1	26	33	Diabetes_McGill_Set_Wnt_pathway	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN
3.84615384615%	1	26	33	Diabetes_McGill_Set_Wnt_pathway	CAFFAREL_RESPONSE_TO_THC_UP
3.84615384615%	1	26	33	Diabetes_McGill_Set_Wnt_pathway	BURTON_ADIPOGENESIS_1
3.84615384615%	1	26	33	Diabetes_McGill_Set_Wnt_pathway	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN
3.84615384615%	1	26	33	Diabetes_McGill_GPCRs_expressed_in_beta_cell	STAEGE_EWING_FAMILY_TUMOR
3.84615384615%	1	26	33	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SIMBULAN_UV_RESPONSE_NORMAL_DN
3.84615384615%	1	26	33	Diabetes_McGill_GPCRs_expressed_in_beta_cell	PID_NCADHERINPATHWAY
3.84615384615%	1	26	326	Diabetes_McGill_Set_Wnt_pathway	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
3.84615384615%	1	26	326	Diabetes_McGill_GPCRs_expressed_in_beta_cell	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
3.84615384615%	1	26	324	Diabetes_McGill_GPCRs_expressed_in_beta_cell	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
3.84615384615%	1	26	321	Diabetes_McGill_Set_Wnt_pathway	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
3.84615384615%	1	26	320	Diabetes_McGill_GPCRs_expressed_in_beta_cell	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
3.84615384615%	1	26	32	Diabetes_McGill_Set_Wnt_pathway	TRACEY_RESISTANCE_TO_IFNA2_DN
3.84615384615%	1	26	32	Diabetes_McGill_Set_Wnt_pathway	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN
3.84615384615%	1	26	32	Diabetes_McGill_Set_Wnt_pathway	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM
3.84615384615%	1	26	32	Diabetes_McGill_Set_Wnt_pathway	DORSAM_HOXA9_TARGETS_DN
3.84615384615%	1	26	32	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_PDGF_PATHWAY
3.84615384615%	1	26	318	Diabetes_McGill_GPCRs_expressed_in_beta_cell	DAZARD_RESPONSE_TO_UV_NHEK_DN
3.84615384615%	1	26	317	Diabetes_McGill_Set_Wnt_pathway	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
3.84615384615%	1	26	317	Diabetes_McGill_Set_Wnt_pathway	HELLER_HDAC_TARGETS_UP
3.84615384615%	1	26	317	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BRUINS_UVC_RESPONSE_EARLY_LATE
3.84615384615%	1	26	315	Diabetes_McGill_Set_Wnt_pathway	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
3.84615384615%	1	26	315	Diabetes_McGill_Set_Wnt_pathway	PASINI_SUZ12_TARGETS_DN
3.84615384615%	1	26	315	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
3.84615384615%	1	26	314	Diabetes_McGill_Set_Wnt_pathway	DOUGLAS_BMI1_TARGETS_DN
3.84615384615%	1	26	312	Diabetes_McGill_Set_Wnt_pathway	GENTILE_UV_HIGH_DOSE_DN
3.84615384615%	1	26	31	Diabetes_McGill_Set_Wnt_pathway	THEODOROU_MAMMARY_TUMORIGENESIS
3.84615384615%	1	26	31	Diabetes_McGill_Set_Wnt_pathway	SIMBULAN_PARP1_TARGETS_UP
3.84615384615%	1	26	31	Diabetes_McGill_Set_Wnt_pathway	PID_P38ALPHABETAPATHWAY
3.84615384615%	1	26	31	Diabetes_McGill_Set_Wnt_pathway	PID_CD40_PATHWAY
3.84615384615%	1	26	31	Diabetes_McGill_Set_Wnt_pathway	PID_AURORA_A_PATHWAY
3.84615384615%	1	26	31	Diabetes_McGill_Set_Wnt_pathway	DANG_MYC_TARGETS_DN
3.84615384615%	1	26	31	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_EGF_PATHWAY
3.84615384615%	1	26	31	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_SIGNAL_AMPLIFICATION
3.84615384615%	1	26	308	Diabetes_McGill_Set_Wnt_pathway	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
3.84615384615%	1	26	307	Diabetes_McGill_Set_Wnt_pathway	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
3.84615384615%	1	26	307	Diabetes_McGill_GPCRs_expressed_in_beta_cell	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
3.84615384615%	1	26	306	Diabetes_McGill_GPCRs_expressed_in_beta_cell	HORIUCHI_WTAP_TARGETS_UP
3.84615384615%	1	26	306	Diabetes_McGill_GPCRs_expressed_in_beta_cell	CHANDRAN_METASTASIS_DN
3.84615384615%	1	26	302	Diabetes_McGill_GPCRs_expressed_in_beta_cell	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
3.84615384615%	1	26	30	Diabetes_McGill_Set_Wnt_pathway	URS_ADIPOCYTE_DIFFERENTIATION_DN
3.84615384615%	1	26	30	Diabetes_McGill_Set_Wnt_pathway	TAVOR_CEBPA_TARGETS_DN
3.84615384615%	1	26	30	Diabetes_McGill_Set_Wnt_pathway	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
3.84615384615%	1	26	30	Diabetes_McGill_Set_Wnt_pathway	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
3.84615384615%	1	26	30	Diabetes_McGill_Set_Wnt_pathway	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION
3.84615384615%	1	26	30	Diabetes_McGill_Set_Wnt_pathway	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES
3.84615384615%	1	26	30	Diabetes_McGill_Set_Wnt_pathway	PID_NECTIN_PATHWAY
3.84615384615%	1	26	30	Diabetes_McGill_Set_Wnt_pathway	PID_IL2_STAT5PATHWAY
3.84615384615%	1	26	30	Diabetes_McGill_Set_Wnt_pathway	PID_EPHRINBREVPATHWAY
3.84615384615%	1	26	30	Diabetes_McGill_Set_Wnt_pathway	PID_CDC42_REG_PATHWAY
3.84615384615%	1	26	30	Diabetes_McGill_Set_Wnt_pathway	LI_PROSTATE_CANCER_EPIGENETIC
3.84615384615%	1	26	30	Diabetes_McGill_Set_Wnt_pathway	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
3.84615384615%	1	26	30	Diabetes_McGill_Set_Wnt_pathway	GUILLAUMOND_KLF10_TARGETS_DN
3.84615384615%	1	26	30	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_FAS_PATHWAY
3.84615384615%	1	26	298	Diabetes_McGill_Set_Wnt_pathway	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
3.84615384615%	1	26	298	Diabetes_McGill_GPCRs_expressed_in_beta_cell	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
3.84615384615%	1	26	296	Diabetes_McGill_Set_Wnt_pathway	DURAND_STROMA_MAX_UP
3.84615384615%	1	26	295	Diabetes_McGill_Set_Wnt_pathway	LU_EZH2_TARGETS_UP
3.84615384615%	1	26	295	Diabetes_McGill_Set_Wnt_pathway	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
3.84615384615%	1	26	294	Diabetes_McGill_Set_Wnt_pathway	WEST_ADRENOCORTICAL_TUMOR_UP
3.84615384615%	1	26	292	Diabetes_McGill_Set_Wnt_pathway	KOYAMA_SEMA3B_TARGETS_UP
3.84615384615%	1	26	292	Diabetes_McGill_GPCRs_expressed_in_beta_cell	KOYAMA_SEMA3B_TARGETS_UP
3.84615384615%	1	26	290	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BASAKI_YBX1_TARGETS_UP
3.84615384615%	1	26	29	Diabetes_McGill_Set_Wnt_pathway	ST_TUMOR_NECROSIS_FACTOR_PATHWAY
3.84615384615%	1	26	29	Diabetes_McGill_Set_Wnt_pathway	STANELLE_E2F1_TARGETS
3.84615384615%	1	26	29	Diabetes_McGill_Set_Wnt_pathway	REACTOME_GLYCOLYSIS
3.84615384615%	1	26	29	Diabetes_McGill_Set_Wnt_pathway	PID_REELINPATHWAY
3.84615384615%	1	26	29	Diabetes_McGill_Set_Wnt_pathway	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
3.84615384615%	1	26	29	Diabetes_McGill_Set_Wnt_pathway	NGUYEN_NOTCH1_TARGETS_UP
3.84615384615%	1	26	29	Diabetes_McGill_Set_Wnt_pathway	MA_PITUITARY_FETAL_VS_ADULT_UP
3.84615384615%	1	26	29	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_VIP_PATHWAY
3.84615384615%	1	26	29	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_TNFR1_PATHWAY
3.84615384615%	1	26	29	Diabetes_McGill_Set_Wnt_pathway	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
3.84615384615%	1	26	29	Diabetes_McGill_GPCRs_expressed_in_beta_cell	PAL_PRMT5_TARGETS_DN
3.84615384615%	1	26	29	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
3.84615384615%	1	26	29	Diabetes_McGill_GPCRs_expressed_in_beta_cell	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN
3.84615384615%	1	26	29	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BIOCARTA_VIP_PATHWAY
3.84615384615%	1	26	289	Diabetes_McGill_Set_Wnt_pathway	MANALO_HYPOXIA_DN
3.84615384615%	1	26	289	Diabetes_McGill_Set_Wnt_pathway	GABRIELY_MIR21_TARGETS
3.84615384615%	1	26	284	Diabetes_McGill_Set_Wnt_pathway	REACTOME_METABOLISM_OF_MRNA
3.84615384615%	1	26	284	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
3.84615384615%	1	26	282	Diabetes_McGill_GPCRs_expressed_in_beta_cell	HELLER_SILENCED_BY_METHYLATION_UP
3.84615384615%	1	26	280	Diabetes_McGill_Set_Wnt_pathway	WANG_SMARCE1_TARGETS_UP
3.84615384615%	1	26	280	Diabetes_McGill_Set_Wnt_pathway	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
3.84615384615%	1	26	28	Diabetes_McGill_Set_Wnt_pathway	REACTOME_MYOGENESIS
3.84615384615%	1	26	28	Diabetes_McGill_Set_Wnt_pathway	PID_LIS1PATHWAY
3.84615384615%	1	26	28	Diabetes_McGill_Set_Wnt_pathway	PETRETTO_HEART_MASS_QTL_CIS_UP
3.84615384615%	1	26	28	Diabetes_McGill_Set_Wnt_pathway	MOREIRA_RESPONSE_TO_TSA_UP
3.84615384615%	1	26	28	Diabetes_McGill_Set_Wnt_pathway	LOPES_METHYLATED_IN_COLON_CANCER_DN
3.84615384615%	1	26	28	Diabetes_McGill_Set_Wnt_pathway	HWANG_PROSTATE_CANCER_MARKERS
3.84615384615%	1	26	28	Diabetes_McGill_GPCRs_expressed_in_beta_cell	DAIRKEE_CANCER_PRONE_RESPONSE_E2
3.84615384615%	1	26	279	Diabetes_McGill_Set_Wnt_pathway	FORTSCHEGGER_PHF8_TARGETS_UP
3.84615384615%	1	26	276	Diabetes_McGill_Set_Wnt_pathway	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
3.84615384615%	1	26	276	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
3.84615384615%	1	26	276	Diabetes_McGill_GPCRs_expressed_in_beta_cell	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
3.84615384615%	1	26	274	Diabetes_McGill_Set_Wnt_pathway	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
3.84615384615%	1	26	274	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
3.84615384615%	1	26	270	Diabetes_McGill_GPCRs_expressed_in_beta_cell	RIZKI_TUMOR_INVASIVENESS_3D_DN
3.84615384615%	1	26	27	Diabetes_McGill_Set_Wnt_pathway	ST_MYOCYTE_AD_PATHWAY
3.84615384615%	1	26	27	Diabetes_McGill_Set_Wnt_pathway	ST_GRANULE_CELL_SURVIVAL_PATHWAY
3.84615384615%	1	26	27	Diabetes_McGill_Set_Wnt_pathway	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
3.84615384615%	1	26	27	Diabetes_McGill_Set_Wnt_pathway	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP
3.84615384615%	1	26	27	Diabetes_McGill_Set_Wnt_pathway	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS
3.84615384615%	1	26	27	Diabetes_McGill_Set_Wnt_pathway	PID_IL3_PATHWAY
3.84615384615%	1	26	27	Diabetes_McGill_Set_Wnt_pathway	OHM_METHYLATED_IN_ADULT_CANCERS
3.84615384615%	1	26	27	Diabetes_McGill_Set_Wnt_pathway	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN
3.84615384615%	1	26	27	Diabetes_McGill_Set_Wnt_pathway	GROSS_ELK3_TARGETS_UP
3.84615384615%	1	26	27	Diabetes_McGill_Set_Wnt_pathway	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP
3.84615384615%	1	26	27	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ST_MYOCYTE_AD_PATHWAY
3.84615384615%	1	26	27	Diabetes_McGill_GPCRs_expressed_in_beta_cell	HOEGERKORP_CD44_TARGETS_DIRECT_UP
3.84615384615%	1	26	268	Diabetes_McGill_GPCRs_expressed_in_beta_cell	XU_GH1_AUTOCRINE_TARGETS_UP
3.84615384615%	1	26	267	Diabetes_McGill_Set_Wnt_pathway	HOLLMANN_APOPTOSIS_VIA_CD40_DN
3.84615384615%	1	26	267	Diabetes_McGill_GPCRs_expressed_in_beta_cell	CAIRO_HEPATOBLASTOMA_DN
3.84615384615%	1	26	266	Diabetes_McGill_Set_Wnt_pathway	ROZANOV_MMP14_TARGETS_UP
3.84615384615%	1	26	261	Diabetes_McGill_Set_Wnt_pathway	BILD_HRAS_ONCOGENIC_SIGNATURE
3.84615384615%	1	26	261	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BILD_HRAS_ONCOGENIC_SIGNATURE
3.84615384615%	1	26	260	Diabetes_McGill_Set_Wnt_pathway	SENESE_HDAC1_TARGETS_DN
3.84615384615%	1	26	260	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BOQUEST_STEM_CELL_UP
3.84615384615%	1	26	26	Diabetes_McGill_Set_Wnt_pathway	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS
3.84615384615%	1	26	26	Diabetes_McGill_Set_Wnt_pathway	PID_RXR_VDR_PATHWAY
3.84615384615%	1	26	26	Diabetes_McGill_Set_Wnt_pathway	PID_INSULIN_GLUCOSE_PATHWAY
3.84615384615%	1	26	26	Diabetes_McGill_Set_Wnt_pathway	PID_ALK1PATHWAY
3.84615384615%	1	26	26	Diabetes_McGill_Set_Wnt_pathway	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
3.84615384615%	1	26	26	Diabetes_McGill_Set_Wnt_pathway	DEN_INTERACT_WITH_LCA5
3.84615384615%	1	26	26	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_RACCYCD_PATHWAY
3.84615384615%	1	26	26	Diabetes_McGill_GPCRs_expressed_in_beta_cell	FINAK_BREAST_CANCER_SDPP_SIGNATURE
3.84615384615%	1	26	258	Diabetes_McGill_Set_Wnt_pathway	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
3.84615384615%	1	26	255	Diabetes_McGill_Set_Wnt_pathway	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
3.84615384615%	1	26	254	Diabetes_McGill_Set_Wnt_pathway	IVANOVA_HEMATOPOIESIS_STEM_CELL
3.84615384615%	1	26	254	Diabetes_McGill_Set_Wnt_pathway	BROWNE_HCMV_INFECTION_4HR_DN
3.84615384615%	1	26	251	Diabetes_McGill_Set_Wnt_pathway	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
3.84615384615%	1	26	251	Diabetes_McGill_Set_Wnt_pathway	REACTOME_AXON_GUIDANCE
3.84615384615%	1	26	251	Diabetes_McGill_Set_Wnt_pathway	KOBAYASHI_EGFR_SIGNALING_24HR_DN
3.84615384615%	1	26	25	Diabetes_McGill_Set_Wnt_pathway	VERRECCHIA_RESPONSE_TO_TGFB1_C2
3.84615384615%	1	26	25	Diabetes_McGill_Set_Wnt_pathway	REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN
3.84615384615%	1	26	25	Diabetes_McGill_Set_Wnt_pathway	REACTOME_G0_AND_EARLY_G1
3.84615384615%	1	26	25	Diabetes_McGill_Set_Wnt_pathway	REACTOME_DARPP_32_EVENTS
3.84615384615%	1	26	25	Diabetes_McGill_Set_Wnt_pathway	PID_HDAC_CLASSIII_PATHWAY
3.84615384615%	1	26	25	Diabetes_McGill_Set_Wnt_pathway	NOJIMA_SFRP2_TARGETS_DN
3.84615384615%	1	26	25	Diabetes_McGill_Set_Wnt_pathway	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
3.84615384615%	1	26	25	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE
3.84615384615%	1	26	247	Diabetes_McGill_Set_Wnt_pathway	REACTOME_METABOLISM_OF_CARBOHYDRATES
3.84615384615%	1	26	246	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BILD_E2F3_ONCOGENIC_SIGNATURE
3.84615384615%	1	26	245	Diabetes_McGill_Set_Wnt_pathway	BLUM_RESPONSE_TO_SALIRASIB_UP
3.84615384615%	1	26	245	Diabetes_McGill_GPCRs_expressed_in_beta_cell	KONDO_EZH2_TARGETS
3.84615384615%	1	26	242	Diabetes_McGill_Set_Wnt_pathway	WINTER_HYPOXIA_METAGENE
3.84615384615%	1	26	242	Diabetes_McGill_Set_Wnt_pathway	CHYLA_CBFA2T3_TARGETS_DN
3.84615384615%	1	26	241	Diabetes_McGill_Set_Wnt_pathway	DOANE_RESPONSE_TO_ANDROGEN_DN
3.84615384615%	1	26	240	Diabetes_McGill_Set_Wnt_pathway	BROWNE_HCMV_INFECTION_20HR_UP
3.84615384615%	1	26	24	Diabetes_McGill_Set_Wnt_pathway	REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION
3.84615384615%	1	26	24	Diabetes_McGill_Set_Wnt_pathway	REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION
3.84615384615%	1	26	24	Diabetes_McGill_Set_Wnt_pathway	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION
3.84615384615%	1	26	24	Diabetes_McGill_Set_Wnt_pathway	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23
3.84615384615%	1	26	24	Diabetes_McGill_Set_Wnt_pathway	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN
3.84615384615%	1	26	24	Diabetes_McGill_Set_Wnt_pathway	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP
3.84615384615%	1	26	24	Diabetes_McGill_Set_Wnt_pathway	DELACROIX_RAR_TARGETS_DN
3.84615384615%	1	26	24	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_TPO_PATHWAY
3.84615384615%	1	26	24	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_CSK_PATHWAY
3.84615384615%	1	26	24	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ODONNELL_METASTASIS_DN
3.84615384615%	1	26	239	Diabetes_McGill_Set_Wnt_pathway	ALFANO_MYC_TARGETS
3.84615384615%	1	26	238	Diabetes_McGill_Set_Wnt_pathway	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
3.84615384615%	1	26	234	Diabetes_McGill_GPCRs_expressed_in_beta_cell	AFFAR_YY1_TARGETS_DN
3.84615384615%	1	26	233	Diabetes_McGill_Set_Wnt_pathway	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
3.84615384615%	1	26	232	Diabetes_McGill_Set_Wnt_pathway	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
3.84615384615%	1	26	232	Diabetes_McGill_Set_Wnt_pathway	DELYS_THYROID_CANCER_DN
3.84615384615%	1	26	230	Diabetes_McGill_Set_Wnt_pathway	KAUFFMANN_DNA_REPAIR_GENES
3.84615384615%	1	26	23	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SIGNALING_BY_BMP
3.84615384615%	1	26	23	Diabetes_McGill_Set_Wnt_pathway	REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA
3.84615384615%	1	26	23	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_PTDINS_PATHWAY
3.84615384615%	1	26	23	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_MTOR_PATHWAY
3.84615384615%	1	26	23	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_MEF2D_PATHWAY
3.84615384615%	1	26	23	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_GLEEVEC_PATHWAY
3.84615384615%	1	26	23	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_CELLCYCLE_PATHWAY
3.84615384615%	1	26	23	Diabetes_McGill_GPCRs_expressed_in_beta_cell	HASLINGER_B_CLL_WITH_11Q23_DELETION
3.84615384615%	1	26	229	Diabetes_McGill_Set_Wnt_pathway	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
3.84615384615%	1	26	229	Diabetes_McGill_Set_Wnt_pathway	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
3.84615384615%	1	26	229	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
3.84615384615%	1	26	229	Diabetes_McGill_GPCRs_expressed_in_beta_cell	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
3.84615384615%	1	26	227	Diabetes_McGill_GPCRs_expressed_in_beta_cell	LEE_RECENT_THYMIC_EMIGRANT
3.84615384615%	1	26	226	Diabetes_McGill_Set_Wnt_pathway	KYNG_DNA_DAMAGE_UP
3.84615384615%	1	26	226	Diabetes_McGill_Set_Wnt_pathway	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
3.84615384615%	1	26	225	Diabetes_McGill_Set_Wnt_pathway	BROWNE_HCMV_INFECTION_16HR_UP
3.84615384615%	1	26	223	Diabetes_McGill_Set_Wnt_pathway	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
3.84615384615%	1	26	222	Diabetes_McGill_Set_Wnt_pathway	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
3.84615384615%	1	26	222	Diabetes_McGill_Set_Wnt_pathway	BROWNE_HCMV_INFECTION_1HR_DN
3.84615384615%	1	26	222	Diabetes_McGill_GPCRs_expressed_in_beta_cell	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
3.84615384615%	1	26	222	Diabetes_McGill_GPCRs_expressed_in_beta_cell	CAIRO_LIVER_DEVELOPMENT_DN
3.84615384615%	1	26	221	Diabetes_McGill_Set_Wnt_pathway	CHANDRAN_METASTASIS_UP
3.84615384615%	1	26	221	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ZHANG_TLX_TARGETS_36HR_UP
3.84615384615%	1	26	220	Diabetes_McGill_Set_Wnt_pathway	RIGGINS_TAMOXIFEN_RESISTANCE_DN
3.84615384615%	1	26	22	Diabetes_McGill_Set_Wnt_pathway	ZHAN_MULTIPLE_MYELOMA_SPIKED
3.84615384615%	1	26	22	Diabetes_McGill_Set_Wnt_pathway	VERNELL_RETINOBLASTOMA_PATHWAY_DN
3.84615384615%	1	26	22	Diabetes_McGill_Set_Wnt_pathway	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN
3.84615384615%	1	26	22	Diabetes_McGill_Set_Wnt_pathway	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
3.84615384615%	1	26	22	Diabetes_McGill_Set_Wnt_pathway	PID_PDGFRAPATHWAY
3.84615384615%	1	26	22	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_INSULIN_PATHWAY
3.84615384615%	1	26	22	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_IL6_PATHWAY
3.84615384615%	1	26	22	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_IL2_PATHWAY
3.84615384615%	1	26	22	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_AKT_PATHWAY
3.84615384615%	1	26	22	Diabetes_McGill_GPCRs_expressed_in_beta_cell	HANSON_HRAS_SIGNALING_VIA_NFKB
3.84615384615%	1	26	22	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BIOCARTA_GCR_PATHWAY
3.84615384615%	1	26	217	Diabetes_McGill_GPCRs_expressed_in_beta_cell	WIERENGA_STAT5A_TARGETS_UP
3.84615384615%	1	26	217	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_SIGNALLING_BY_NGF
3.84615384615%	1	26	216	Diabetes_McGill_Set_Wnt_pathway	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
3.84615384615%	1	26	216	Diabetes_McGill_Set_Wnt_pathway	BOQUEST_STEM_CELL_DN
3.84615384615%	1	26	216	Diabetes_McGill_GPCRs_expressed_in_beta_cell	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
3.84615384615%	1	26	216	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BOQUEST_STEM_CELL_DN
3.84615384615%	1	26	215	Diabetes_McGill_Set_Wnt_pathway	MARKEY_RB1_ACUTE_LOF_UP
3.84615384615%	1	26	214	Diabetes_McGill_Set_Wnt_pathway	TIEN_INTESTINE_PROBIOTICS_24HR_DN
3.84615384615%	1	26	214	Diabetes_McGill_Set_Wnt_pathway	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
3.84615384615%	1	26	214	Diabetes_McGill_Set_Wnt_pathway	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
3.84615384615%	1	26	214	Diabetes_McGill_Set_Wnt_pathway	BIDUS_METASTASIS_UP
3.84615384615%	1	26	213	Diabetes_McGill_Set_Wnt_pathway	WIERENGA_STAT5A_TARGETS_DN
3.84615384615%	1	26	213	Diabetes_McGill_GPCRs_expressed_in_beta_cell	WIERENGA_STAT5A_TARGETS_DN
3.84615384615%	1	26	212	Diabetes_McGill_Set_Wnt_pathway	SANSOM_APC_TARGETS
3.84615384615%	1	26	212	Diabetes_McGill_Set_Wnt_pathway	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
3.84615384615%	1	26	211	Diabetes_McGill_Set_Wnt_pathway	FOSTER_KDM1A_TARGETS_DN
3.84615384615%	1	26	210	Diabetes_McGill_Set_Wnt_pathway	VERHAAK_GLIOBLASTOMA_PRONEURAL
3.84615384615%	1	26	210	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
3.84615384615%	1	26	21	Diabetes_McGill_Set_Wnt_pathway	VERRECCHIA_RESPONSE_TO_TGFB1_C5
3.84615384615%	1	26	21	Diabetes_McGill_Set_Wnt_pathway	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN
3.84615384615%	1	26	21	Diabetes_McGill_Set_Wnt_pathway	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP
3.84615384615%	1	26	21	Diabetes_McGill_Set_Wnt_pathway	REACTOME_ERK_MAPK_TARGETS
3.84615384615%	1	26	21	Diabetes_McGill_Set_Wnt_pathway	REACTOME_CTLA4_INHIBITORY_SIGNALING
3.84615384615%	1	26	21	Diabetes_McGill_Set_Wnt_pathway	PID_ECADHERIN_KERATINOCYTE_PATHWAY
3.84615384615%	1	26	21	Diabetes_McGill_Set_Wnt_pathway	MOOTHA_GLYCOGEN_METABOLISM
3.84615384615%	1	26	21	Diabetes_McGill_Set_Wnt_pathway	CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP
3.84615384615%	1	26	21	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_TOB1_PATHWAY
3.84615384615%	1	26	21	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_TFF_PATHWAY
3.84615384615%	1	26	21	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_IGF1_PATHWAY
3.84615384615%	1	26	21	Diabetes_McGill_GPCRs_expressed_in_beta_cell	STEGER_ADIPOGENESIS_UP
3.84615384615%	1	26	21	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_ADP_SIGNALLING_THROUGH_P2RY12
3.84615384615%	1	26	21	Diabetes_McGill_GPCRs_expressed_in_beta_cell	LANDEMAINE_LUNG_METASTASIS
3.84615384615%	1	26	209	Diabetes_McGill_Set_Wnt_pathway	GROSS_HYPOXIA_VIA_ELK3_UP
3.84615384615%	1	26	207	Diabetes_McGill_Set_Wnt_pathway	REACTOME_HIV_INFECTION
3.84615384615%	1	26	207	Diabetes_McGill_Set_Wnt_pathway	MANALO_HYPOXIA_UP
3.84615384615%	1	26	207	Diabetes_McGill_Set_Wnt_pathway	CAIRO_HEPATOBLASTOMA_UP
3.84615384615%	1	26	206	Diabetes_McGill_Set_Wnt_pathway	RAMALHO_STEMNESS_UP
3.84615384615%	1	26	206	Diabetes_McGill_Set_Wnt_pathway	LINSLEY_MIR16_TARGETS
3.84615384615%	1	26	206	Diabetes_McGill_Set_Wnt_pathway	BILD_MYC_ONCOGENIC_SIGNATURE
3.84615384615%	1	26	205	Diabetes_McGill_Set_Wnt_pathway	PEREZ_TP53_AND_TP63_TARGETS
3.84615384615%	1	26	205	Diabetes_McGill_GPCRs_expressed_in_beta_cell	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
3.84615384615%	1	26	205	Diabetes_McGill_GPCRs_expressed_in_beta_cell	PEREZ_TP53_AND_TP63_TARGETS
3.84615384615%	1	26	204	Diabetes_McGill_Set_Wnt_pathway	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
3.84615384615%	1	26	203	Diabetes_McGill_Set_Wnt_pathway	PENG_RAPAMYCIN_RESPONSE_UP
3.84615384615%	1	26	203	Diabetes_McGill_Set_Wnt_pathway	PAL_PRMT5_TARGETS_UP
3.84615384615%	1	26	203	Diabetes_McGill_GPCRs_expressed_in_beta_cell	PENG_RAPAMYCIN_RESPONSE_UP
3.84615384615%	1	26	203	Diabetes_McGill_GPCRs_expressed_in_beta_cell	GRUETZMANN_PANCREATIC_CANCER_DN
3.84615384615%	1	26	202	Diabetes_McGill_Set_Wnt_pathway	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
3.84615384615%	1	26	201	Diabetes_McGill_Set_Wnt_pathway	KIM_MYC_AMPLIFICATION_TARGETS_UP
3.84615384615%	1	26	200	Diabetes_McGill_Set_Wnt_pathway	LEE_DIFFERENTIATING_T_LYMPHOCYTE
3.84615384615%	1	26	20	Diabetes_McGill_Set_Wnt_pathway	WALLACE_PROSTATE_CANCER_UP
3.84615384615%	1	26	20	Diabetes_McGill_Set_Wnt_pathway	MURAKAMI_UV_RESPONSE_24HR
3.84615384615%	1	26	20	Diabetes_McGill_Set_Wnt_pathway	MANN_RESPONSE_TO_AMIFOSTINE_UP
3.84615384615%	1	26	20	Diabetes_McGill_Set_Wnt_pathway	HASLINGER_B_CLL_WITH_6Q21_DELETION
3.84615384615%	1	26	20	Diabetes_McGill_Set_Wnt_pathway	DE_YY1_TARGETS_UP
3.84615384615%	1	26	20	Diabetes_McGill_Set_Wnt_pathway	COLLIS_PRKDC_SUBSTRATES
3.84615384615%	1	26	20	Diabetes_McGill_GPCRs_expressed_in_beta_cell	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3
3.84615384615%	1	26	20	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP
3.84615384615%	1	26	199	Diabetes_McGill_GPCRs_expressed_in_beta_cell	PLASARI_TGFB1_TARGETS_10HR_UP
3.84615384615%	1	26	198	Diabetes_McGill_Set_Wnt_pathway	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
3.84615384615%	1	26	198	Diabetes_McGill_Set_Wnt_pathway	ALONSO_METASTASIS_UP
3.84615384615%	1	26	1972	Diabetes_McGill_GPCRs_expressed_in_beta_cell	PILON_KLF1_TARGETS_DN
3.84615384615%	1	26	197	Diabetes_McGill_Set_Wnt_pathway	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
3.84615384615%	1	26	196	Diabetes_McGill_Set_Wnt_pathway	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
3.84615384615%	1	26	195	Diabetes_McGill_GPCRs_expressed_in_beta_cell	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
3.84615384615%	1	26	194	Diabetes_McGill_Set_Wnt_pathway	KASLER_HDAC7_TARGETS_1_UP
3.84615384615%	1	26	194	Diabetes_McGill_GPCRs_expressed_in_beta_cell	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
3.84615384615%	1	26	192	Diabetes_McGill_Set_Wnt_pathway	REACTOME_DNA_REPLICATION
3.84615384615%	1	26	191	Diabetes_McGill_Set_Wnt_pathway	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
3.84615384615%	1	26	190	Diabetes_McGill_Set_Wnt_pathway	KEGG_CHEMOKINE_SIGNALING_PATHWAY
3.84615384615%	1	26	19	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1
3.84615384615%	1	26	19	Diabetes_McGill_Set_Wnt_pathway	NIELSEN_LIPOSARCOMA_DN
3.84615384615%	1	26	19	Diabetes_McGill_Set_Wnt_pathway	MARSON_FOXP3_CORE_DIRECT_TARGETS
3.84615384615%	1	26	19	Diabetes_McGill_Set_Wnt_pathway	MAHADEVAN_RESPONSE_TO_MP470_DN
3.84615384615%	1	26	19	Diabetes_McGill_Set_Wnt_pathway	LAMB_CCND1_TARGETS
3.84615384615%	1	26	19	Diabetes_McGill_Set_Wnt_pathway	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS
3.84615384615%	1	26	19	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_MTA3_PATHWAY
3.84615384615%	1	26	19	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_EPO_PATHWAY
3.84615384615%	1	26	19	Diabetes_McGill_Set_Wnt_pathway	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
3.84615384615%	1	26	19	Diabetes_McGill_GPCRs_expressed_in_beta_cell	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN
3.84615384615%	1	26	188	Diabetes_McGill_Set_Wnt_pathway	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
3.84615384615%	1	26	187	Diabetes_McGill_Set_Wnt_pathway	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
3.84615384615%	1	26	187	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BAKKER_FOXO3_TARGETS_DN
3.84615384615%	1	26	185	Diabetes_McGill_Set_Wnt_pathway	ZHANG_TLX_TARGETS_36HR_DN
3.84615384615%	1	26	183	Diabetes_McGill_Set_Wnt_pathway	OKUMURA_INFLAMMATORY_RESPONSE_LPS
3.84615384615%	1	26	182	Diabetes_McGill_Set_Wnt_pathway	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
3.84615384615%	1	26	182	Diabetes_McGill_GPCRs_expressed_in_beta_cell	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
3.84615384615%	1	26	182	Diabetes_McGill_GPCRs_expressed_in_beta_cell	RAO_BOUND_BY_SALL4_ISOFORM_A
3.84615384615%	1	26	181	Diabetes_McGill_Set_Wnt_pathway	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
3.84615384615%	1	26	180	Diabetes_McGill_Set_Wnt_pathway	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
3.84615384615%	1	26	180	Diabetes_McGill_Set_Wnt_pathway	BROWNE_HCMV_INFECTION_48HR_UP
3.84615384615%	1	26	18	Diabetes_McGill_Set_Wnt_pathway	ZHENG_RESPONSE_TO_ARSENITE_DN
3.84615384615%	1	26	18	Diabetes_McGill_Set_Wnt_pathway	WU_HBX_TARGETS_3_UP
3.84615384615%	1	26	18	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SIGNALING_BY_NODAL
3.84615384615%	1	26	18	Diabetes_McGill_Set_Wnt_pathway	MAINA_VHL_TARGETS_DN
3.84615384615%	1	26	18	Diabetes_McGill_Set_Wnt_pathway	KOBAYASHI_EGFR_SIGNALING_6HR_DN
3.84615384615%	1	26	18	Diabetes_McGill_Set_Wnt_pathway	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
3.84615384615%	1	26	18	Diabetes_McGill_Set_Wnt_pathway	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES
3.84615384615%	1	26	18	Diabetes_McGill_Set_Wnt_pathway	CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB
3.84615384615%	1	26	18	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_NGF_PATHWAY
3.84615384615%	1	26	18	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_CARDIACEGF_PATHWAY
3.84615384615%	1	26	18	Diabetes_McGill_GPCRs_expressed_in_beta_cell	STAMBOLSKY_BOUND_BY_MUTATED_TP53
3.84615384615%	1	26	18	Diabetes_McGill_GPCRs_expressed_in_beta_cell	LE_NEURONAL_DIFFERENTIATION_UP
3.84615384615%	1	26	179	Diabetes_McGill_GPCRs_expressed_in_beta_cell	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
3.84615384615%	1	26	178	Diabetes_McGill_Set_Wnt_pathway	BROWNE_HCMV_INFECTION_18HR_DN
3.84615384615%	1	26	178	Diabetes_McGill_GPCRs_expressed_in_beta_cell	LI_AMPLIFIED_IN_LUNG_CANCER
3.84615384615%	1	26	178	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BROWNE_HCMV_INFECTION_18HR_UP
3.84615384615%	1	26	177	Diabetes_McGill_Set_Wnt_pathway	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
3.84615384615%	1	26	176	Diabetes_McGill_Set_Wnt_pathway	SASAKI_ADULT_T_CELL_LEUKEMIA
3.84615384615%	1	26	176	Diabetes_McGill_Set_Wnt_pathway	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX
3.84615384615%	1	26	176	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SASAKI_ADULT_T_CELL_LEUKEMIA
3.84615384615%	1	26	175	Diabetes_McGill_GPCRs_expressed_in_beta_cell	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
3.84615384615%	1	26	175	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
3.84615384615%	1	26	173	Diabetes_McGill_Set_Wnt_pathway	SENGUPTA_EBNA1_ANTICORRELATED
3.84615384615%	1	26	172	Diabetes_McGill_Set_Wnt_pathway	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
3.84615384615%	1	26	172	Diabetes_McGill_Set_Wnt_pathway	SMID_BREAST_CANCER_LUMINAL_B_UP
3.84615384615%	1	26	172	Diabetes_McGill_Set_Wnt_pathway	REACTOME_MITOTIC_M_M_G1_PHASES
3.84615384615%	1	26	172	Diabetes_McGill_Set_Wnt_pathway	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
3.84615384615%	1	26	170	Diabetes_McGill_Set_Wnt_pathway	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
3.84615384615%	1	26	170	Diabetes_McGill_Set_Wnt_pathway	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
3.84615384615%	1	26	17	Diabetes_McGill_Set_Wnt_pathway	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
3.84615384615%	1	26	17	Diabetes_McGill_Set_Wnt_pathway	RODRIGUES_NTN1_TARGETS_UP
3.84615384615%	1	26	17	Diabetes_McGill_Set_Wnt_pathway	PID_SMAD2_3PATHWAY
3.84615384615%	1	26	17	Diabetes_McGill_Set_Wnt_pathway	PID_NFKAPPABATYPICALPATHWAY
3.84615384615%	1	26	17	Diabetes_McGill_Set_Wnt_pathway	HOWLIN_CITED1_TARGETS_2_UP
3.84615384615%	1	26	17	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_PML_PATHWAY
3.84615384615%	1	26	17	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_IL7_PATHWAY
3.84615384615%	1	26	17	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_ARF_PATHWAY
3.84615384615%	1	26	169	Diabetes_McGill_Set_Wnt_pathway	UEDA_PERIFERAL_CLOCK
3.84615384615%	1	26	169	Diabetes_McGill_Set_Wnt_pathway	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
3.84615384615%	1	26	169	Diabetes_McGill_Set_Wnt_pathway	KEGG_ALZHEIMERS_DISEASE
3.84615384615%	1	26	168	Diabetes_McGill_Set_Wnt_pathway	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
3.84615384615%	1	26	168	Diabetes_McGill_Set_Wnt_pathway	PUJANA_XPRSS_INT_NETWORK
3.84615384615%	1	26	1652	Diabetes_McGill_GPCRs_expressed_in_beta_cell	PUJANA_BRCA1_PCC_NETWORK
3.84615384615%	1	26	165	Diabetes_McGill_Set_Wnt_pathway	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
3.84615384615%	1	26	165	Diabetes_McGill_Set_Wnt_pathway	DARWICHE_PAPILLOMA_RISK_LOW_DN
3.84615384615%	1	26	164	Diabetes_McGill_Set_Wnt_pathway	KIM_WT1_TARGETS_8HR_UP
3.84615384615%	1	26	164	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
3.84615384615%	1	26	163	Diabetes_McGill_Set_Wnt_pathway	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
3.84615384615%	1	26	161	Diabetes_McGill_Set_Wnt_pathway	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
3.84615384615%	1	26	161	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
3.84615384615%	1	26	16	Diabetes_McGill_Set_Wnt_pathway	SUZUKI_AMPLIFIED_IN_ORAL_CANCER
3.84615384615%	1	26	16	Diabetes_McGill_Set_Wnt_pathway	REACTOME_PLATELET_SENSITIZATION_BY_LDL
3.84615384615%	1	26	16	Diabetes_McGill_Set_Wnt_pathway	PID_DNAPK_PATHWAY
3.84615384615%	1	26	16	Diabetes_McGill_Set_Wnt_pathway	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN
3.84615384615%	1	26	16	Diabetes_McGill_Set_Wnt_pathway	KOINUMA_COLON_CANCER_MSI_DN
3.84615384615%	1	26	16	Diabetes_McGill_Set_Wnt_pathway	HUMMERICH_MALIGNANT_SKIN_TUMOR_UP
3.84615384615%	1	26	16	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_SHH_PATHWAY
3.84615384615%	1	26	16	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_RELA_PATHWAY
3.84615384615%	1	26	16	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_P53_PATHWAY
3.84615384615%	1	26	16	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_CDMAC_PATHWAY
3.84615384615%	1	26	16	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS
3.84615384615%	1	26	158	Diabetes_McGill_Set_Wnt_pathway	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
3.84615384615%	1	26	158	Diabetes_McGill_Set_Wnt_pathway	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON
3.84615384615%	1	26	157	Diabetes_McGill_Set_Wnt_pathway	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
3.84615384615%	1	26	157	Diabetes_McGill_Set_Wnt_pathway	SERVITJA_LIVER_HNF1A_TARGETS_DN
3.84615384615%	1	26	157	Diabetes_McGill_Set_Wnt_pathway	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
3.84615384615%	1	26	157	Diabetes_McGill_Set_Wnt_pathway	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
3.84615384615%	1	26	157	Diabetes_McGill_GPCRs_expressed_in_beta_cell	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
3.84615384615%	1	26	156	Diabetes_McGill_Set_Wnt_pathway	GROSS_HYPOXIA_VIA_ELK3_DN
3.84615384615%	1	26	156	Diabetes_McGill_Set_Wnt_pathway	BROWNE_HCMV_INFECTION_14HR_UP
3.84615384615%	1	26	153	Diabetes_McGill_Set_Wnt_pathway	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
3.84615384615%	1	26	153	Diabetes_McGill_Set_Wnt_pathway	RUIZ_TNC_TARGETS_UP
3.84615384615%	1	26	153	Diabetes_McGill_Set_Wnt_pathway	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN
3.84615384615%	1	26	153	Diabetes_McGill_GPCRs_expressed_in_beta_cell	DURAND_STROMA_MAX_DN
3.84615384615%	1	26	152	Diabetes_McGill_GPCRs_expressed_in_beta_cell	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
3.84615384615%	1	26	150	Diabetes_McGill_Set_Wnt_pathway	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
3.84615384615%	1	26	150	Diabetes_McGill_Set_Wnt_pathway	LANDIS_ERBB2_BREAST_TUMORS_324_UP
3.84615384615%	1	26	15	Diabetes_McGill_Set_Wnt_pathway	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN
3.84615384615%	1	26	15	Diabetes_McGill_Set_Wnt_pathway	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP
3.84615384615%	1	26	15	Diabetes_McGill_Set_Wnt_pathway	SA_G1_AND_S_PHASES
3.84615384615%	1	26	15	Diabetes_McGill_Set_Wnt_pathway	SANCHEZ_MDM2_TARGETS
3.84615384615%	1	26	15	Diabetes_McGill_Set_Wnt_pathway	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27
3.84615384615%	1	26	15	Diabetes_McGill_Set_Wnt_pathway	MARKS_HDAC_TARGETS_DN
3.84615384615%	1	26	15	Diabetes_McGill_Set_Wnt_pathway	FINETTI_BREAST_CANCERS_KINOME_GRAY
3.84615384615%	1	26	15	Diabetes_McGill_Set_Wnt_pathway	COLLIS_PRKDC_REGULATORS
3.84615384615%	1	26	15	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_NUCLEARRS_PATHWAY
3.84615384615%	1	26	15	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_AKAPCENTROSOME_PATHWAY
3.84615384615%	1	26	149	Diabetes_McGill_Set_Wnt_pathway	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
3.84615384615%	1	26	149	Diabetes_McGill_Set_Wnt_pathway	TSAI_RESPONSE_TO_IONIZING_RADIATION
3.84615384615%	1	26	149	Diabetes_McGill_GPCRs_expressed_in_beta_cell	OHGUCHI_LIVER_HNF4A_TARGETS_DN
3.84615384615%	1	26	149	Diabetes_McGill_GPCRs_expressed_in_beta_cell	HUANG_GATA2_TARGETS_UP
3.84615384615%	1	26	148	Diabetes_McGill_Set_Wnt_pathway	WHITFIELD_CELL_CYCLE_M_G1
3.84615384615%	1	26	148	Diabetes_McGill_Set_Wnt_pathway	WEI_MIR34A_TARGETS
3.84615384615%	1	26	147	Diabetes_McGill_Set_Wnt_pathway	DARWICHE_PAPILLOMA_RISK_HIGH_UP
3.84615384615%	1	26	147	Diabetes_McGill_GPCRs_expressed_in_beta_cell	SMID_BREAST_CANCER_ERBB2_UP
3.84615384615%	1	26	146	Diabetes_McGill_Set_Wnt_pathway	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
3.84615384615%	1	26	146	Diabetes_McGill_GPCRs_expressed_in_beta_cell	LEE_NEURAL_CREST_STEM_CELL_UP
3.84615384615%	1	26	145	Diabetes_McGill_Set_Wnt_pathway	ZHANG_BREAST_CANCER_PROGENITORS_DN
3.84615384615%	1	26	145	Diabetes_McGill_Set_Wnt_pathway	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
3.84615384615%	1	26	145	Diabetes_McGill_GPCRs_expressed_in_beta_cell	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
3.84615384615%	1	26	1442	Diabetes_McGill_GPCRs_expressed_in_beta_cell	PUJANA_ATM_PCC_NETWORK
3.84615384615%	1	26	142	Diabetes_McGill_Set_Wnt_pathway	DARWICHE_SKIN_TUMOR_PROMOTER_UP
3.84615384615%	1	26	140	Diabetes_McGill_Set_Wnt_pathway	QI_HYPOXIA
3.84615384615%	1	26	140	Diabetes_McGill_Set_Wnt_pathway	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
3.84615384615%	1	26	140	Diabetes_McGill_GPCRs_expressed_in_beta_cell	QI_HYPOXIA
3.84615384615%	1	26	14	Diabetes_McGill_Set_Wnt_pathway	ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS
3.84615384615%	1	26	14	Diabetes_McGill_Set_Wnt_pathway	WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP
3.84615384615%	1	26	14	Diabetes_McGill_Set_Wnt_pathway	VERRECCHIA_RESPONSE_TO_TGFB1_C3
3.84615384615%	1	26	14	Diabetes_McGill_Set_Wnt_pathway	REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY
3.84615384615%	1	26	14	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING
3.84615384615%	1	26	14	Diabetes_McGill_Set_Wnt_pathway	REACTOME_PROLACTIN_RECEPTOR_SIGNALING
3.84615384615%	1	26	14	Diabetes_McGill_Set_Wnt_pathway	PID_TCRJNKPATHWAY
3.84615384615%	1	26	14	Diabetes_McGill_Set_Wnt_pathway	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16
3.84615384615%	1	26	14	Diabetes_McGill_Set_Wnt_pathway	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP
3.84615384615%	1	26	14	Diabetes_McGill_Set_Wnt_pathway	HOEGERKORP_CD44_TARGETS_DIRECT_DN
3.84615384615%	1	26	14	Diabetes_McGill_Set_Wnt_pathway	DORN_ADENOVIRUS_INFECTION_48HR_UP
3.84615384615%	1	26	14	Diabetes_McGill_Set_Wnt_pathway	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
3.84615384615%	1	26	14	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_CELL2CELL_PATHWAY
3.84615384615%	1	26	14	Diabetes_McGill_GPCRs_expressed_in_beta_cell	LEE_SP4_THYMOCYTE
3.84615384615%	1	26	14	Diabetes_McGill_GPCRs_expressed_in_beta_cell	KINNEY_DNMT1_METHYLATION_TARGETS
3.84615384615%	1	26	138	Diabetes_McGill_Set_Wnt_pathway	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
3.84615384615%	1	26	138	Diabetes_McGill_GPCRs_expressed_in_beta_cell	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
3.84615384615%	1	26	1375	Diabetes_McGill_GPCRs_expressed_in_beta_cell	DODD_NASOPHARYNGEAL_CARCINOMA_DN
3.84615384615%	1	26	137	Diabetes_McGill_Set_Wnt_pathway	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
3.84615384615%	1	26	137	Diabetes_McGill_Set_Wnt_pathway	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
3.84615384615%	1	26	137	Diabetes_McGill_Set_Wnt_pathway	KEGG_INSULIN_SIGNALING_PATHWAY
3.84615384615%	1	26	137	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
3.84615384615%	1	26	137	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
3.84615384615%	1	26	137	Diabetes_McGill_GPCRs_expressed_in_beta_cell	LIU_SOX4_TARGETS_UP
3.84615384615%	1	26	136	Diabetes_McGill_Set_Wnt_pathway	PROVENZANI_METASTASIS_DN
3.84615384615%	1	26	136	Diabetes_McGill_Set_Wnt_pathway	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
3.84615384615%	1	26	136	Diabetes_McGill_GPCRs_expressed_in_beta_cell	WIERENGA_STAT5A_TARGETS_GROUP1
3.84615384615%	1	26	134	Diabetes_McGill_Set_Wnt_pathway	SCHLOSSER_SERUM_RESPONSE_UP
3.84615384615%	1	26	134	Diabetes_McGill_Set_Wnt_pathway	POOLA_INVASIVE_BREAST_CANCER_DN
3.84615384615%	1	26	134	Diabetes_McGill_GPCRs_expressed_in_beta_cell	POOLA_INVASIVE_BREAST_CANCER_DN
3.84615384615%	1	26	133	Diabetes_McGill_Set_Wnt_pathway	GAL_LEUKEMIC_STEM_CELL_UP
3.84615384615%	1	26	132	Diabetes_McGill_Set_Wnt_pathway	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS
3.84615384615%	1	26	13	Diabetes_McGill_Set_Wnt_pathway	WACKER_HYPOXIA_TARGETS_OF_VHL
3.84615384615%	1	26	13	Diabetes_McGill_Set_Wnt_pathway	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
3.84615384615%	1	26	13	Diabetes_McGill_Set_Wnt_pathway	SA_REG_CASCADE_OF_CYCLIN_EXPR
3.84615384615%	1	26	13	Diabetes_McGill_Set_Wnt_pathway	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY
3.84615384615%	1	26	13	Diabetes_McGill_Set_Wnt_pathway	REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1
3.84615384615%	1	26	13	Diabetes_McGill_Set_Wnt_pathway	KEGG_CIRCADIAN_RHYTHM_MAMMAL
3.84615384615%	1	26	13	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_CARM1_PATHWAY
3.84615384615%	1	26	129	Diabetes_McGill_Set_Wnt_pathway	KIM_WT1_TARGETS_8HR_DN
3.84615384615%	1	26	129	Diabetes_McGill_Set_Wnt_pathway	KEGG_AXON_GUIDANCE
3.84615384615%	1	26	128	Diabetes_McGill_Set_Wnt_pathway	ZHU_CMV_ALL_DN
3.84615384615%	1	26	128	Diabetes_McGill_Set_Wnt_pathway	LENAOUR_DENDRITIC_CELL_MATURATION_DN
3.84615384615%	1	26	128	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ZHU_CMV_ALL_DN
3.84615384615%	1	26	1278	Diabetes_McGill_GPCRs_expressed_in_beta_cell	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
3.84615384615%	1	26	127	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
3.84615384615%	1	26	127	Diabetes_McGill_Set_Wnt_pathway	KARLSSON_TGFB1_TARGETS_UP
3.84615384615%	1	26	126	Diabetes_McGill_Set_Wnt_pathway	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
3.84615384615%	1	26	126	Diabetes_McGill_Set_Wnt_pathway	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
3.84615384615%	1	26	125	Diabetes_McGill_Set_Wnt_pathway	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
3.84615384615%	1	26	1237	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BLALOCK_ALZHEIMERS_DISEASE_DN
3.84615384615%	1	26	123	Diabetes_McGill_Set_Wnt_pathway	DAZARD_RESPONSE_TO_UV_SCC_DN
3.84615384615%	1	26	1229	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
3.84615384615%	1	26	121	Diabetes_McGill_Set_Wnt_pathway	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
3.84615384615%	1	26	120	Diabetes_McGill_Set_Wnt_pathway	REACTOME_CELL_CELL_COMMUNICATION
3.84615384615%	1	26	120	Diabetes_McGill_Set_Wnt_pathway	NIKOLSKY_BREAST_CANCER_16P13_AMPLICON
3.84615384615%	1	26	120	Diabetes_McGill_GPCRs_expressed_in_beta_cell	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
3.84615384615%	1	26	12	Diabetes_McGill_Set_Wnt_pathway	REACTOME_ERKS_ARE_INACTIVATED
3.84615384615%	1	26	12	Diabetes_McGill_Set_Wnt_pathway	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS
3.84615384615%	1	26	12	Diabetes_McGill_Set_Wnt_pathway	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN
3.84615384615%	1	26	12	Diabetes_McGill_Set_Wnt_pathway	FUNG_IL2_SIGNALING_2
3.84615384615%	1	26	12	Diabetes_McGill_Set_Wnt_pathway	DORN_ADENOVIRUS_INFECTION_24HR_UP
3.84615384615%	1	26	12	Diabetes_McGill_Set_Wnt_pathway	DING_LUNG_CANCER_MUTATED_FREQUENTLY
3.84615384615%	1	26	12	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_AKAP95_PATHWAY
3.84615384615%	1	26	12	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_P2Y_RECEPTORS
3.84615384615%	1	26	12	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BIOCARTA_PLCE_PATHWAY
3.84615384615%	1	26	12	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BIOCARTA_CFTR_PATHWAY
3.84615384615%	1	26	118	Diabetes_McGill_Set_Wnt_pathway	LEE_NEURAL_CREST_STEM_CELL_DN
3.84615384615%	1	26	118	Diabetes_McGill_Set_Wnt_pathway	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
3.84615384615%	1	26	118	Diabetes_McGill_Set_Wnt_pathway	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
3.84615384615%	1	26	1174	Diabetes_McGill_Set_Wnt_pathway	PEREZ_TP53_TARGETS
3.84615384615%	1	26	117	Diabetes_McGill_Set_Wnt_pathway	PUJANA_BRCA_CENTERED_NETWORK
3.84615384615%	1	26	116	Diabetes_McGill_Set_Wnt_pathway	MATTIOLI_MGUS_VS_PCL
3.84615384615%	1	26	116	Diabetes_McGill_Set_Wnt_pathway	LIM_MAMMARY_LUMINAL_MATURE_UP
3.84615384615%	1	26	116	Diabetes_McGill_Set_Wnt_pathway	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
3.84615384615%	1	26	115	Diabetes_McGill_GPCRs_expressed_in_beta_cell	HOELZEL_NF1_TARGETS_DN
3.84615384615%	1	26	1142	Diabetes_McGill_GPCRs_expressed_in_beta_cell	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
3.84615384615%	1	26	114	Diabetes_McGill_Set_Wnt_pathway	SMIRNOV_RESPONSE_TO_IR_6HR_DN
3.84615384615%	1	26	114	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MATZUK_SPERMATOZOA
3.84615384615%	1	26	1137	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BRUINS_UVC_RESPONSE_LATE
3.84615384615%	1	26	112	Diabetes_McGill_Set_Wnt_pathway	REACTOME_SIGNALING_BY_FGFR
3.84615384615%	1	26	112	Diabetes_McGill_Set_Wnt_pathway	LAIHO_COLORECTAL_CANCER_SERRATED_UP
3.84615384615%	1	26	112	Diabetes_McGill_Set_Wnt_pathway	LABBE_WNT3A_TARGETS_UP
3.84615384615%	1	26	112	Diabetes_McGill_Set_Wnt_pathway	DITTMER_PTHLH_TARGETS_UP
3.84615384615%	1	26	111	Diabetes_McGill_Set_Wnt_pathway	BROWNE_HCMV_INFECTION_12HR_UP
3.84615384615%	1	26	111	Diabetes_McGill_Set_Wnt_pathway	BOUDOUKHA_BOUND_BY_IGF2BP2
3.84615384615%	1	26	111	Diabetes_McGill_GPCRs_expressed_in_beta_cell	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
3.84615384615%	1	26	110	Diabetes_McGill_Set_Wnt_pathway	WOOD_EBV_EBNA1_TARGETS_UP
3.84615384615%	1	26	110	Diabetes_McGill_Set_Wnt_pathway	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
3.84615384615%	1	26	110	Diabetes_McGill_Set_Wnt_pathway	CHENG_IMPRINTED_BY_ESTRADIOL
3.84615384615%	1	26	11	Diabetes_McGill_Set_Wnt_pathway	SHIN_B_CELL_LYMPHOMA_CLUSTER_6
3.84615384615%	1	26	11	Diabetes_McGill_Set_Wnt_pathway	ROZANOV_MMP14_CORRELATED
3.84615384615%	1	26	11	Diabetes_McGill_Set_Wnt_pathway	PID_RANBP2PATHWAY
3.84615384615%	1	26	11	Diabetes_McGill_Set_Wnt_pathway	PID_P38GAMMADELTAPATHWAY
3.84615384615%	1	26	11	Diabetes_McGill_Set_Wnt_pathway	PID_ALK2PATHWAY
3.84615384615%	1	26	11	Diabetes_McGill_Set_Wnt_pathway	DORN_ADENOVIRUS_INFECTION_32HR_UP
3.84615384615%	1	26	11	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_SET_PATHWAY
3.84615384615%	1	26	11	Diabetes_McGill_Set_Wnt_pathway	BIOCARTA_EIF2_PATHWAY
3.84615384615%	1	26	11	Diabetes_McGill_GPCRs_expressed_in_beta_cell	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE
3.84615384615%	1	26	109	Diabetes_McGill_Set_Wnt_pathway	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
3.84615384615%	1	26	108	Diabetes_McGill_Set_Wnt_pathway	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
3.84615384615%	1	26	108	Diabetes_McGill_Set_Wnt_pathway	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
3.84615384615%	1	26	108	Diabetes_McGill_Set_Wnt_pathway	LE_EGR2_TARGETS_UP
3.84615384615%	1	26	108	Diabetes_McGill_Set_Wnt_pathway	JAZAG_TGFB1_SIGNALING_UP
3.84615384615%	1	26	108	Diabetes_McGill_Set_Wnt_pathway	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN
3.84615384615%	1	26	108	Diabetes_McGill_GPCRs_expressed_in_beta_cell	WESTON_VEGFA_TARGETS
3.84615384615%	1	26	106	Diabetes_McGill_Set_Wnt_pathway	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
3.84615384615%	1	26	105	Diabetes_McGill_Set_Wnt_pathway	WOO_LIVER_CANCER_RECURRENCE_UP
3.84615384615%	1	26	105	Diabetes_McGill_Set_Wnt_pathway	PID_ERBB1_DOWNSTREAM_PATHWAY
3.84615384615%	1	26	105	Diabetes_McGill_Set_Wnt_pathway	HELLER_SILENCED_BY_METHYLATION_DN
3.84615384615%	1	26	105	Diabetes_McGill_Set_Wnt_pathway	AMUNDSON_GENOTOXIC_SIGNATURE
3.84615384615%	1	26	105	Diabetes_McGill_GPCRs_expressed_in_beta_cell	HELLER_SILENCED_BY_METHYLATION_DN
3.84615384615%	1	26	104	Diabetes_McGill_Set_Wnt_pathway	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
3.84615384615%	1	26	104	Diabetes_McGill_GPCRs_expressed_in_beta_cell	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
3.84615384615%	1	26	1037	Diabetes_McGill_Set_Wnt_pathway	NUYTTEN_EZH2_TARGETS_UP
3.84615384615%	1	26	1037	Diabetes_McGill_GPCRs_expressed_in_beta_cell	NUYTTEN_EZH2_TARGETS_UP
3.84615384615%	1	26	103	Diabetes_McGill_Set_Wnt_pathway	KIM_MYCN_AMPLIFICATION_TARGETS_DN
3.84615384615%	1	26	103	Diabetes_McGill_Set_Wnt_pathway	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
3.84615384615%	1	26	1024	Diabetes_McGill_Set_Wnt_pathway	NUYTTEN_EZH2_TARGETS_DN
3.84615384615%	1	26	1022	Diabetes_McGill_Set_Wnt_pathway	MARSON_BOUND_BY_FOXP3_STIMULATED
3.84615384615%	1	26	102	Diabetes_McGill_Set_Wnt_pathway	MIKKELSEN_IPS_WITH_HCP_H3K27ME3
3.84615384615%	1	26	102	Diabetes_McGill_Set_Wnt_pathway	DER_IFN_BETA_RESPONSE_UP
3.84615384615%	1	26	102	Diabetes_McGill_Set_Wnt_pathway	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
3.84615384615%	1	26	102	Diabetes_McGill_GPCRs_expressed_in_beta_cell	LABBE_TGFB1_TARGETS_UP
3.84615384615%	1	26	1011	Diabetes_McGill_GPCRs_expressed_in_beta_cell	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
3.84615384615%	1	26	101	Diabetes_McGill_Set_Wnt_pathway	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
3.84615384615%	1	26	100	Diabetes_McGill_Set_Wnt_pathway	QI_PLASMACYTOMA_DN
3.84615384615%	1	26	100	Diabetes_McGill_Set_Wnt_pathway	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
3.84615384615%	1	26	100	Diabetes_McGill_GPCRs_expressed_in_beta_cell	WINZEN_DEGRADED_VIA_KHSRP
3.84615384615%	1	26	100	Diabetes_McGill_GPCRs_expressed_in_beta_cell	ROVERSI_GLIOMA_COPY_NUMBER_UP
3.84615384615%	1	26	100	Diabetes_McGill_GPCRs_expressed_in_beta_cell	MCCLUNG_CREB1_TARGETS_UP
3.84615384615%	1	26	10	Diabetes_McGill_Set_Wnt_pathway	SCHLESINGER_METHYLATED_IN_COLON_CANCER
3.84615384615%	1	26	10	Diabetes_McGill_Set_Wnt_pathway	PYEON_HPV_POSITIVE_TUMORS_DN
3.84615384615%	1	26	10	Diabetes_McGill_Set_Wnt_pathway	MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY
3.84615384615%	1	26	10	Diabetes_McGill_Set_Wnt_pathway	BAKER_HEMATOPOESIS_STAT1_TARGETS
3.84615384615%	1	26	10	Diabetes_McGill_GPCRs_expressed_in_beta_cell	RADAEVA_RESPONSE_TO_IFNA1_DN
3.81784728611%	83	2174	682	T2D_GENES_TANYA_LIPIDS	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
3.81784728611%	83	2174	1038	T2D_GENES_TANYA_LIPIDS	BENPORATH_SUZ12_TARGETS
3.81165919283%	17	446	805	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_GPCR_DOWNSTREAM_SIGNALING
3.81165919283%	17	446	784	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FORTSCHEGGER_PHF8_TARGETS_DN
3.81165919283%	17	446	779	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PUJANA_CHEK2_PCC_NETWORK
3.81165919283%	17	446	769	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NUYTTEN_NIPP1_TARGETS_UP
3.81165919283%	17	446	526	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ONKEN_UVEAL_MELANOMA_DN
3.81165919283%	17	446	341	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MULLIGHAN_NPM1_SIGNATURE_3_UP
3.81165919283%	17	446	1375	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DODD_NASOPHARYNGEAL_CARCINOMA_DN
3.81165919283%	17	446	1278	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
3.81165919283%	17	446	1142	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
3.79939209726%	75	1974	510	Mendelian_Nancy_Cox	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
3.79939209726%	75	1974	461	Mendelian_Nancy_Cox	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
3.79939209726%	75	1974	267	Mendelian_Nancy_Cox	CAIRO_HEPATOBLASTOMA_DN
3.79476215927%	71	1871	857	T2D_GENES_TANYA_HEIGHT	MARTENS_TRETINOIN_RESPONSE_UP
3.78250591017%	48	1269	1382	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
3.78214826021%	25	661	893	T2D_GENES_TANYA_GLYCEMIC	GEORGES_TARGETS_OF_MIR192_AND_MIR215
3.78214826021%	25	661	871	T2D_GENES_TANYA_GLYCEMIC	GRADE_COLON_CANCER_UP
3.78214826021%	25	661	824	T2D_GENES_TANYA_GLYCEMIC	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
3.78214826021%	25	661	770	T2D_GENES_TANYA_GLYCEMIC	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
3.78214826021%	25	661	701	T2D_GENES_TANYA_GLYCEMIC	SMID_BREAST_CANCER_BASAL_DN
3.78214826021%	25	661	663	T2D_GENES_TANYA_GLYCEMIC	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
3.78214826021%	25	661	526	T2D_GENES_TANYA_GLYCEMIC	ONKEN_UVEAL_MELANOMA_DN
3.78214826021%	25	661	423	T2D_GENES_TANYA_GLYCEMIC	PUJANA_BRCA2_PCC_NETWORK
3.78214826021%	25	661	1037	T2D_GENES_TANYA_GLYCEMIC	NUYTTEN_EZH2_TARGETS_UP
3.77184912603%	82	2174	637	T2D_GENES_TANYA_LIPIDS	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
3.77184912603%	82	2174	540	T2D_GENES_TANYA_LIPIDS	ACEVEDO_LIVER_CANCER_DN
3.76390076989%	44	1169	855	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
3.76390076989%	44	1169	841	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARTENS_TRETINOIN_RESPONSE_DN
3.76390076989%	44	1169	1375	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DODD_NASOPHARYNGEAL_CARCINOMA_DN
3.76055257099%	49	1303	1022	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARSON_BOUND_BY_FOXP3_STIMULATED
3.75203915171%	23	613	779	T2D_GENES_TANYA_BIOMARKER	PUJANA_CHEK2_PCC_NETWORK
3.75203915171%	23	613	775	T2D_GENES_TANYA_BIOMARKER	BENPORATH_MYC_MAX_TARGETS
3.75203915171%	23	613	747	T2D_GENES_TANYA_BIOMARKER	PATIL_LIVER_CANCER
3.75203915171%	23	613	718	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_ES_ICP_WITH_H3K4ME3
3.75203915171%	23	613	593	T2D_GENES_TANYA_BIOMARKER	MARTINEZ_TP53_TARGETS_DN
3.75203915171%	23	613	543	T2D_GENES_TANYA_BIOMARKER	MARTINEZ_RB1_TARGETS_DN
3.75203915171%	23	613	537	T2D_GENES_TANYA_BIOMARKER	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
3.75203915171%	23	613	380	T2D_GENES_TANYA_BIOMARKER	MULLIGHAN_MLL_SIGNATURE_1_UP
3.74873353597%	74	1974	537	Mendelian_Nancy_Cox	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
3.74873353597%	74	1974	420	Mendelian_Nancy_Cox	MOOTHA_PGC
3.73626373626%	17	455	882	T2D_GENES_TANYA_BLOODPRESSURE	LEE_BMP2_TARGETS_DN
3.73626373626%	17	455	701	T2D_GENES_TANYA_BLOODPRESSURE	SMID_BREAST_CANCER_BASAL_DN
3.73626373626%	17	455	514	T2D_GENES_TANYA_BLOODPRESSURE	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
3.73626373626%	17	455	487	T2D_GENES_TANYA_BLOODPRESSURE	RODWELL_AGING_KIDNEY_UP
3.73626373626%	17	455	293	T2D_GENES_TANYA_BLOODPRESSURE	HADDAD_B_LYMPHOCYTE_PROGENITOR
3.73626373626%	17	455	228	T2D_GENES_TANYA_BLOODPRESSURE	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
3.72585096596%	81	2174	848	T2D_GENES_TANYA_LIPIDS	NUYTTEN_NIPP1_TARGETS_DN
3.72585096596%	81	2174	478	T2D_GENES_TANYA_LIPIDS	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
3.72159090909%	131	3520	882	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
3.72159090909%	131	3520	841	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTENS_TRETINOIN_RESPONSE_DN
3.7037037037%	47	1269	882	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
3.7037037037%	47	1269	1725	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
3.7037037037%	3	81	97	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
3.7037037037%	3	81	953	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
3.7037037037%	3	81	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DELASERNA_MYOD_TARGETS_UP
3.7037037037%	3	81	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_APOPTOSIS
3.7037037037%	3	81	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_ERBB_SIGNALING_PATHWAY
3.7037037037%	3	81	855	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
3.7037037037%	3	81	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
3.7037037037%	3	81	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_MITOTIC_G2_G2_M_PHASES
3.7037037037%	3	81	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_UNFOLDED_PROTEIN_RESPONSE
3.7037037037%	3	81	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_MET_PATHWAY
3.7037037037%	3	81	8	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TCGA_GLIOBLASTOMA_MUTATED
3.7037037037%	3	81	795	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WEI_MYCN_TARGETS_WITH_E_BOX
3.7037037037%	3	81	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MEISSNER_NPC_HCP_WITH_H3K27ME3
3.7037037037%	3	81	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
3.7037037037%	3	81	783	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
3.7037037037%	3	81	770	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
3.7037037037%	3	81	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_VEGF_SIGNALING_PATHWAY
3.7037037037%	3	81	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
3.7037037037%	3	81	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
3.7037037037%	3	81	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	URS_ADIPOCYTE_DIFFERENTIATION_UP
3.7037037037%	3	81	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_CHRONIC_MYELOID_LEUKEMIA
3.7037037037%	3	81	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DITTMER_PTHLH_TARGETS_DN
3.7037037037%	3	81	722	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
3.7037037037%	3	81	721	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WONG_ADULT_TISSUE_STEM_MODULE
3.7037037037%	3	81	72	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
3.7037037037%	3	81	718	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKKELSEN_ES_ICP_WITH_H3K4ME3
3.7037037037%	3	81	70	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_CDC42_PATHWAY
3.7037037037%	3	81	70	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_RENAL_CELL_CARCINOMA
3.7037037037%	3	81	70	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_PANCREATIC_CANCER
3.7037037037%	3	81	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_VEGFR1_2_PATHWAY
3.7037037037%	3	81	681	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
3.7037037037%	3	81	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
3.7037037037%	3	81	668	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
3.7037037037%	3	81	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
3.7037037037%	3	81	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_HIF1_TFPATHWAY
3.7037037037%	3	81	658	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
3.7037037037%	3	81	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_BCR_5PATHWAY
3.7037037037%	3	81	633	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
3.7037037037%	3	81	63	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
3.7037037037%	3	81	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_TRKRPATHWAY
3.7037037037%	3	81	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_COLORECTAL_CANCER
3.7037037037%	3	81	601	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARTINEZ_RB1_AND_TP53_TARGETS_UP
3.7037037037%	3	81	60	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_ACUTE_MYELOID_LEUKEMIA
3.7037037037%	3	81	591	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARTINEZ_RB1_AND_TP53_TARGETS_DN
3.7037037037%	3	81	59	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
3.7037037037%	3	81	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_PPARA_PATHWAY
3.7037037037%	3	81	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_NFAT_PATHWAY
3.7037037037%	3	81	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER
3.7037037037%	3	81	544	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
3.7037037037%	3	81	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_TCR_SIGNALING
3.7037037037%	3	81	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_NON_SMALL_CELL_LUNG_CANCER
3.7037037037%	3	81	530	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ENK_UV_RESPONSE_KERATINOCYTE_UP
3.7037037037%	3	81	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_KITPATHWAY
3.7037037037%	3	81	491	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SWEET_LUNG_CANCER_KRAS_UP
3.7037037037%	3	81	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PI_METABOLISM
3.7037037037%	3	81	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
3.7037037037%	3	81	479	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
3.7037037037%	3	81	476	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SMID_BREAST_CANCER_NORMAL_LIKE_UP
3.7037037037%	3	81	473	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GARY_CD5_TARGETS_UP
3.7037037037%	3	81	473	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
3.7037037037%	3	81	463	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
3.7037037037%	3	81	460	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
3.7037037037%	3	81	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SIG_BCR_SIGNALING_PATHWAY
3.7037037037%	3	81	457	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
3.7037037037%	3	81	455	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
3.7037037037%	3	81	442	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HAN_SATB1_TARGETS_DN
3.7037037037%	3	81	439	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MITSIADES_RESPONSE_TO_APLIDIN_UP
3.7037037037%	3	81	428	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CUI_TCF21_TARGETS_2_UP
3.7037037037%	3	81	423	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PUJANA_BRCA2_PCC_NETWORK
3.7037037037%	3	81	412	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
3.7037037037%	3	81	408	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
3.7037037037%	3	81	404	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	OSMAN_BLADDER_CANCER_UP
3.7037037037%	3	81	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ST_B_CELL_ANTIGEN_RECEPTOR
3.7037037037%	3	81	398	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
3.7037037037%	3	81	390	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HATADA_METHYLATED_IN_LUNG_CANCER_UP
3.7037037037%	3	81	371	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WANG_SMARCE1_TARGETS_DN
3.7037037037%	3	81	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
3.7037037037%	3	81	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_DOWNSTREAM_TCR_SIGNALING
3.7037037037%	3	81	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_MET_PATHWAY
3.7037037037%	3	81	367	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VECCHI_GASTRIC_CANCER_EARLY_DN
3.7037037037%	3	81	366	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YOSHIMURA_MAPK8_TARGETS_DN
3.7037037037%	3	81	366	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SANSOM_APC_TARGETS_DN
3.7037037037%	3	81	36	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
3.7037037037%	3	81	354	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
3.7037037037%	3	81	351	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YAGI_AML_WITH_11Q23_REARRANGED
3.7037037037%	3	81	344	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
3.7037037037%	3	81	335	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WONG_EMBRYONIC_STEM_CELL_CORE
3.7037037037%	3	81	321	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
3.7037037037%	3	81	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_CD28_CO_STIMULATION
3.7037037037%	3	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE
3.7037037037%	3	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
3.7037037037%	3	81	309	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
3.7037037037%	3	81	308	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
3.7037037037%	3	81	307	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LI_INDUCED_T_TO_NATURAL_KILLER_UP
3.7037037037%	3	81	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_IL2_STAT5PATHWAY
3.7037037037%	3	81	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_EPHRINBREVPATHWAY
3.7037037037%	3	81	299	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MUELLER_PLURINET
3.7037037037%	3	81	293	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ENK_UV_RESPONSE_EPIDERMIS_UP
3.7037037037%	3	81	292	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KOYAMA_SEMA3B_TARGETS_UP
3.7037037037%	3	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
3.7037037037%	3	81	283	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
3.7037037037%	3	81	282	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HELLER_SILENCED_BY_METHYLATION_UP
3.7037037037%	3	81	275	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
3.7037037037%	3	81	270	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
3.7037037037%	3	81	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
3.7037037037%	3	81	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_VEGFR1_PATHWAY
3.7037037037%	3	81	246	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
3.7037037037%	3	81	243	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHICAS_RB1_TARGETS_GROWING
3.7037037037%	3	81	241	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
3.7037037037%	3	81	240	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	UDAYAKUMAR_MED1_TARGETS_DN
3.7037037037%	3	81	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_EIF4_PATHWAY
3.7037037037%	3	81	239	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
3.7037037037%	3	81	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_MTOR_PATHWAY
3.7037037037%	3	81	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_CTCF_PATHWAY
3.7037037037%	3	81	222	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BROWNE_HCMV_INFECTION_1HR_DN
3.7037037037%	3	81	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING
3.7037037037%	3	81	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_PDGFRAPATHWAY
3.7037037037%	3	81	217	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SANSOM_APC_MYC_TARGETS
3.7037037037%	3	81	216	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
3.7037037037%	3	81	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_ECADHERIN_KERATINOCYTE_PATHWAY
3.7037037037%	3	81	208	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
3.7037037037%	3	81	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KARLSSON_TGFB1_TARGETS_DN
3.7037037037%	3	81	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
3.7037037037%	3	81	206	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
3.7037037037%	3	81	205	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHEPARD_BMYB_MORPHOLINO_UP
3.7037037037%	3	81	200	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
3.7037037037%	3	81	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_IGF1MTOR_PATHWAY
3.7037037037%	3	81	196	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
3.7037037037%	3	81	190	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_CHEMOKINE_SIGNALING_PATHWAY
3.7037037037%	3	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1
3.7037037037%	3	81	184	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
3.7037037037%	3	81	182	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FERNANDEZ_BOUND_BY_MYC
3.7037037037%	3	81	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_PTEN_PATHWAY
3.7037037037%	3	81	179	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
3.7037037037%	3	81	176	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
3.7037037037%	3	81	175	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YAMAZAKI_TCEB3_TARGETS_UP
3.7037037037%	3	81	175	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FIRESTEIN_PROLIFERATION
3.7037037037%	3	81	170	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
3.7037037037%	3	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SA_PTEN_PATHWAY
3.7037037037%	3	81	169	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
3.7037037037%	3	81	168	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
3.7037037037%	3	81	166	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SMIRNOV_RESPONSE_TO_IR_6HR_UP
3.7037037037%	3	81	165	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
3.7037037037%	3	81	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
3.7037037037%	3	81	159	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
3.7037037037%	3	81	157	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
3.7037037037%	3	81	152	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
3.7037037037%	3	81	152	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
3.7037037037%	3	81	148	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BROWNE_HCMV_INFECTION_24HR_DN
3.7037037037%	3	81	145	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
3.7037037037%	3	81	137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
3.7037037037%	3	81	135	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SERVITJA_LIVER_HNF1A_TARGETS_UP
3.7037037037%	3	81	132	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
3.7037037037%	3	81	129	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YAGI_AML_SURVIVAL
3.7037037037%	3	81	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	XU_GH1_EXOGENOUS_TARGETS_DN
3.7037037037%	3	81	1174	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PEREZ_TP53_TARGETS
3.7037037037%	3	81	109	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SERVITJA_ISLET_HNF1A_TARGETS_DN
3.7037037037%	3	81	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
3.7037037037%	3	81	1024	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NUYTTEN_EZH2_TARGETS_DN
3.7037037037%	3	81	102	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
3.7037037037%	3	81	100	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BENPORATH_ES_CORE_NINE_CORRELATED
3.7037037037%	1	27	98	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
3.7037037037%	1	27	98	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MENSE_HYPOXIA_UP
3.7037037037%	1	27	98	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GUO_TARGETS_OF_IRS1_AND_IRS2
3.7037037037%	1	27	98	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GAVIN_FOXP3_TARGETS_CLUSTER_T7
3.7037037037%	1	27	973	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ACEVEDO_LIVER_CANCER_UP
3.7037037037%	1	27	96	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZAMORA_NOS2_TARGETS_DN
3.7037037037%	1	27	953	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
3.7037037037%	1	27	940	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
3.7037037037%	1	27	93	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZHU_CMV_24_HR_UP
3.7037037037%	1	27	93	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_REGULATION_OF_INSULIN_SECRETION
3.7037037037%	1	27	93	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHEN_LIVER_METABOLISM_QTL_CIS
3.7037037037%	1	27	92	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WINTER_HYPOXIA_UP
3.7037037037%	1	27	92	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DE_YY1_TARGETS_DN
3.7037037037%	1	27	91	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZHU_CMV_24_HR_DN
3.7037037037%	1	27	91	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ELVIDGE_HIF1A_TARGETS_DN
3.7037037037%	1	27	90	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	IGARASHI_ATF4_TARGETS_DN
3.7037037037%	1	27	90	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN
3.7037037037%	1	27	90	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BILANGES_SERUM_SENSITIVE_GENES
3.7037037037%	1	27	88	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	TIEN_INTESTINE_PROBIOTICS_2HR_DN
3.7037037037%	1	27	88	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
3.7037037037%	1	27	88	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DURCHDEWALD_SKIN_CARCINOGENESIS_UP
3.7037037037%	1	27	88	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ALCALA_APOPTOSIS
3.7037037037%	1	27	87	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
3.7037037037%	1	27	87	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
3.7037037037%	1	27	863	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
3.7037037037%	1	27	86	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
3.7037037037%	1	27	86	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HOEBEKE_LYMPHOID_STEM_CELL_DN
3.7037037037%	1	27	85	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
3.7037037037%	1	27	85	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	COLDREN_GEFITINIB_RESISTANCE_UP
3.7037037037%	1	27	841	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MARTENS_TRETINOIN_RESPONSE_DN
3.7037037037%	1	27	84	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LEE_AGING_CEREBELLUM_UP
3.7037037037%	1	27	84	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHANG_IMMORTALIZED_BY_HPV31_UP
3.7037037037%	1	27	83	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
3.7037037037%	1	27	83	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	JIANG_HYPOXIA_CANCER
3.7037037037%	1	27	824	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
3.7037037037%	1	27	82	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ST_INTEGRIN_SIGNALING_PATHWAY
3.7037037037%	1	27	811	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
3.7037037037%	1	27	81	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
3.7037037037%	1	27	795	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WEI_MYCN_TARGETS_WITH_E_BOX
3.7037037037%	1	27	79	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
3.7037037037%	1	27	79	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
3.7037037037%	1	27	79	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PID_MYC_ACTIVPATHWAY
3.7037037037%	1	27	79	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MCCLUNG_COCAINE_REWARD_5D
3.7037037037%	1	27	79	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MALONEY_RESPONSE_TO_17AAG_DN
3.7037037037%	1	27	79	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DUAN_PRDM5_TARGETS
3.7037037037%	1	27	79	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CROMER_METASTASIS_UP
3.7037037037%	1	27	79	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
3.7037037037%	1	27	783	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
3.7037037037%	1	27	78	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RADMACHER_AML_PROGNOSIS
3.7037037037%	1	27	78	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_PEROXISOME
3.7037037037%	1	27	78	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	COATES_MACROPHAGE_M1_VS_M2_DN
3.7037037037%	1	27	770	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
3.7037037037%	1	27	769	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	NUYTTEN_NIPP1_TARGETS_UP
3.7037037037%	1	27	75	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MORI_MATURE_B_LYMPHOCYTE_DN
3.7037037037%	1	27	747	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PATIL_LIVER_CANCER
3.7037037037%	1	27	73	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LIN_MELANOMA_COPY_NUMBER_UP
3.7037037037%	1	27	73	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DITTMER_PTHLH_TARGETS_DN
3.7037037037%	1	27	73	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
3.7037037037%	1	27	728	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MARSON_BOUND_BY_E2F4_UNSTIMULATED
3.7037037037%	1	27	722	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
3.7037037037%	1	27	720	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
3.7037037037%	1	27	72	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DANG_REGULATED_BY_MYC_UP
3.7037037037%	1	27	70	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
3.7037037037%	1	27	70	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MIKKELSEN_MEF_LCP_WITH_H3K27ME3
3.7037037037%	1	27	7	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN
3.7037037037%	1	27	69	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
3.7037037037%	1	27	68	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SESTO_RESPONSE_TO_UV_C7
3.7037037037%	1	27	68	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
3.7037037037%	1	27	68	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN
3.7037037037%	1	27	673	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MARTINEZ_RB1_TARGETS_UP
3.7037037037%	1	27	67	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
3.7037037037%	1	27	67	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DAZARD_UV_RESPONSE_CLUSTER_G1
3.7037037037%	1	27	67	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70
3.7037037037%	1	27	668	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
3.7037037037%	1	27	66	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM
3.7037037037%	1	27	66	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MARSON_FOXP3_TARGETS_UP
3.7037037037%	1	27	66	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN
3.7037037037%	1	27	65	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GOLDRATH_IMMUNE_MEMORY
3.7037037037%	1	27	648	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BENPORATH_CYCLING_GENES
3.7037037037%	1	27	64	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RHODES_CANCER_META_SIGNATURE
3.7037037037%	1	27	64	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LEE_LIVER_CANCER_E2F1_DN
3.7037037037%	1	27	64	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GERHOLD_ADIPOGENESIS_DN
3.7037037037%	1	27	637	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
3.7037037037%	1	27	634	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
3.7037037037%	1	27	63	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CROMER_TUMORIGENESIS_UP
3.7037037037%	1	27	605	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CAIRO_HEPATOBLASTOMA_CLASSES_UP
3.7037037037%	1	27	602	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MARTINEZ_TP53_TARGETS_UP
3.7037037037%	1	27	601	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MARTINEZ_RB1_AND_TP53_TARGETS_UP
3.7037037037%	1	27	60	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WIERENGA_STAT5A_TARGETS_GROUP2
3.7037037037%	1	27	60	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN
3.7037037037%	1	27	6	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KORKOLA_CHORIOCARCINOMA_UP
3.7037037037%	1	27	6	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	IGARASHI_ATF4_TARGETS_UP
3.7037037037%	1	27	59	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HUPER_BREAST_BASAL_VS_LUMINAL_DN
3.7037037037%	1	27	579	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
3.7037037037%	1	27	578	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
3.7037037037%	1	27	57	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	TANG_SENESCENCE_TP53_TARGETS_DN
3.7037037037%	1	27	57	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LEE_EARLY_T_LYMPHOCYTE_DN
3.7037037037%	1	27	564	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SMID_BREAST_CANCER_LUMINAL_B_DN
3.7037037037%	1	27	56	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HENDRICKS_SMARCA4_TARGETS_UP
3.7037037037%	1	27	553	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FEVR_CTNNB1_TARGETS_DN
3.7037037037%	1	27	55	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
3.7037037037%	1	27	55	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SMIRNOV_RESPONSE_TO_IR_2HR_DN
3.7037037037%	1	27	55	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN
3.7037037037%	1	27	54	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN
3.7037037037%	1	27	536	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SENESE_HDAC3_TARGETS_DN
3.7037037037%	1	27	536	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BERENJENO_TRANSFORMED_BY_RHOA_UP
3.7037037037%	1	27	530	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ENK_UV_RESPONSE_KERATINOCYTE_UP
3.7037037037%	1	27	53	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZHU_CMV_8_HR_DN
3.7037037037%	1	27	526	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ONKEN_UVEAL_MELANOMA_DN
3.7037037037%	1	27	52	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PRAMOONJAGO_SOX4_TARGETS_UP
3.7037037037%	1	27	52	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_STARCH_AND_SUCROSE_METABOLISM
3.7037037037%	1	27	52	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
3.7037037037%	1	27	518	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
3.7037037037%	1	27	517	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RAO_BOUND_BY_SALL4_ISOFORM_B
3.7037037037%	1	27	514	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
3.7037037037%	1	27	51	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
3.7037037037%	1	27	51	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
3.7037037037%	1	27	505	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
3.7037037037%	1	27	504	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PILON_KLF1_TARGETS_UP
3.7037037037%	1	27	504	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BROWNE_HCMV_INFECTION_48HR_DN
3.7037037037%	1	27	50	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_GLUTATHIONE_METABOLISM
3.7037037037%	1	27	50	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHIBA_RESPONSE_TO_TSA
3.7037037037%	1	27	5	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RODRIGUES_DCC_TARGETS_UP
3.7037037037%	1	27	491	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SWEET_LUNG_CANCER_KRAS_UP
3.7037037037%	1	27	49	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8
3.7037037037%	1	27	49	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GERHOLD_ADIPOGENESIS_UP
3.7037037037%	1	27	49	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DAUER_STAT3_TARGETS_UP
3.7037037037%	1	27	489	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LIM_MAMMARY_STEM_CELL_UP
3.7037037037%	1	27	485	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
3.7037037037%	1	27	48	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	NADLER_OBESITY_DN
3.7037037037%	1	27	48	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GNATENKO_PLATELET_SIGNATURE
3.7037037037%	1	27	475	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
3.7037037037%	1	27	473	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
3.7037037037%	1	27	47	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MELLMAN_TUT1_TARGETS_DN
3.7037037037%	1	27	464	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ONDER_CDH1_TARGETS_2_DN
3.7037037037%	1	27	463	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
3.7037037037%	1	27	460	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
3.7037037037%	1	27	46	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	AMIT_EGF_RESPONSE_60_HELA
3.7037037037%	1	27	457	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SENESE_HDAC1_TARGETS_UP
3.7037037037%	1	27	457	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
3.7037037037%	1	27	456	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
3.7037037037%	1	27	456	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ODONNELL_TFRC_TARGETS_UP
3.7037037037%	1	27	456	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MARTENS_BOUND_BY_PML_RARA_FUSION
3.7037037037%	1	27	450	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
3.7037037037%	1	27	45	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZHAN_V2_LATE_DIFFERENTIATION_GENES
3.7037037037%	1	27	45	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WANG_TARGETS_OF_MLL_CBP_FUSION_DN
3.7037037037%	1	27	45	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SMITH_LIVER_CANCER
3.7037037037%	1	27	45	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
3.7037037037%	1	27	45	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	NUTT_GBM_VS_AO_GLIOMA_DN
3.7037037037%	1	27	45	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHENG_RESPONSE_TO_NICKEL_ACETATE
3.7037037037%	1	27	443	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DELYS_THYROID_CANCER_UP
3.7037037037%	1	27	44	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KORKOLA_SEMINOMA_UP
3.7037037037%	1	27	44	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
3.7037037037%	1	27	44	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM
3.7037037037%	1	27	434	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BAELDE_DIABETIC_NEPHROPATHY_DN
3.7037037037%	1	27	430	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	VECCHI_GASTRIC_CANCER_EARLY_UP
3.7037037037%	1	27	430	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	JOHNSTONE_PARVB_TARGETS_3_UP
3.7037037037%	1	27	43	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	POTTI_ETOPOSIDE_SENSITIVITY
3.7037037037%	1	27	43	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
3.7037037037%	1	27	425	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
3.7037037037%	1	27	423	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	THUM_SYSTOLIC_HEART_FAILURE_UP
3.7037037037%	1	27	422	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	YAGI_AML_WITH_INV_16_TRANSLOCATION
3.7037037037%	1	27	42	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BARRIER_COLON_CANCER_RECURRENCE_UP
3.7037037037%	1	27	42	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	AMIT_EGF_RESPONSE_40_HELA
3.7037037037%	1	27	411	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KOYAMA_SEMA3B_TARGETS_DN
3.7037037037%	1	27	41	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LIN_MELANOMA_COPY_NUMBER_DN
3.7037037037%	1	27	41	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KORKOLA_EMBRYONAL_CARCINOMA_UP
3.7037037037%	1	27	41	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
3.7037037037%	1	27	408	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
3.7037037037%	1	27	405	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KUMAR_TARGETS_OF_MLL_AF9_FUSION
3.7037037037%	1	27	40	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LIAO_HAVE_SOX4_BINDING_SITES
3.7037037037%	1	27	40	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_TRYPTOPHAN_METABOLISM
3.7037037037%	1	27	40	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN
3.7037037037%	1	27	40	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
3.7037037037%	1	27	394	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BERENJENO_TRANSFORMED_BY_RHOA_DN
3.7037037037%	1	27	39	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SESTO_RESPONSE_TO_UV_C6
3.7037037037%	1	27	389	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HSIAO_HOUSEKEEPING_GENES
3.7037037037%	1	27	384	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
3.7037037037%	1	27	382	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
3.7037037037%	1	27	38	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON
3.7037037037%	1	27	378	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
3.7037037037%	1	27	37	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	VALK_AML_WITH_CEBPA
3.7037037037%	1	27	37	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES
3.7037037037%	1	27	37	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HU_ANGIOGENESIS_DN
3.7037037037%	1	27	367	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DELACROIX_RARG_BOUND_MEF
3.7037037037%	1	27	366	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	YOSHIMURA_MAPK8_TARGETS_DN
3.7037037037%	1	27	366	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SANSOM_APC_TARGETS_DN
3.7037037037%	1	27	364	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	YANG_BCL3_TARGETS_UP
3.7037037037%	1	27	354	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
3.7037037037%	1	27	352	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WANG_LMO4_TARGETS_DN
3.7037037037%	1	27	351	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
3.7037037037%	1	27	35	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GUTIERREZ_MULTIPLE_MYELOMA_DN
3.7037037037%	1	27	344	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
3.7037037037%	1	27	342	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BLUM_RESPONSE_TO_SALIRASIB_DN
3.7037037037%	1	27	34	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP
3.7037037037%	1	27	34	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PID_HIF2PATHWAY
3.7037037037%	1	27	332	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
3.7037037037%	1	27	330	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
3.7037037037%	1	27	33	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP
3.7037037037%	1	27	329	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
3.7037037037%	1	27	326	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
3.7037037037%	1	27	324	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
3.7037037037%	1	27	320	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
3.7037037037%	1	27	32	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZWANG_EGF_PERSISTENTLY_UP
3.7037037037%	1	27	32	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FARDIN_HYPOXIA_11
3.7037037037%	1	27	318	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LEI_MYB_TARGETS
3.7037037037%	1	27	315	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
3.7037037037%	1	27	314	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
3.7037037037%	1	27	310	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HORIUCHI_WTAP_TARGETS_DN
3.7037037037%	1	27	31	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	VALK_AML_CLUSTER_15
3.7037037037%	1	27	31	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM
3.7037037037%	1	27	309	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LIU_SOX4_TARGETS_DN
3.7037037037%	1	27	309	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
3.7037037037%	1	27	307	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
3.7037037037%	1	27	306	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HORIUCHI_WTAP_TARGETS_UP
3.7037037037%	1	27	30	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
3.7037037037%	1	27	299	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WALLACE_PROSTATE_CANCER_RACE_UP
3.7037037037%	1	27	29	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN
3.7037037037%	1	27	289	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MANALO_HYPOXIA_DN
3.7037037037%	1	27	289	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
3.7037037037%	1	27	287	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
3.7037037037%	1	27	285	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
3.7037037037%	1	27	285	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GRADE_COLON_AND_RECTAL_CANCER_UP
3.7037037037%	1	27	282	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HELLER_SILENCED_BY_METHYLATION_UP
3.7037037037%	1	27	281	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
3.7037037037%	1	27	281	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BHAT_ESR1_TARGETS_VIA_AKT1_UP
3.7037037037%	1	27	28	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1
3.7037037037%	1	27	28	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	VALK_AML_CLUSTER_7
3.7037037037%	1	27	28	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	VALK_AML_CLUSTER_1
3.7037037037%	1	27	28	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
3.7037037037%	1	27	28	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHEN_LUNG_CANCER_SURVIVAL
3.7037037037%	1	27	277	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZHANG_TLX_TARGETS_60HR_DN
3.7037037037%	1	27	276	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
3.7037037037%	1	27	275	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
3.7037037037%	1	27	274	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
3.7037037037%	1	27	271	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
3.7037037037%	1	27	271	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
3.7037037037%	1	27	27	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN
3.7037037037%	1	27	267	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HOLLMANN_APOPTOSIS_VIA_CD40_DN
3.7037037037%	1	27	260	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SENESE_HDAC1_TARGETS_DN
3.7037037037%	1	27	26	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	XU_CREBBP_TARGETS_UP
3.7037037037%	1	27	26	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	NIKOLSKY_BREAST_CANCER_5P15_AMPLICON
3.7037037037%	1	27	26	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_GALACTOSE_METABOLISM
3.7037037037%	1	27	26	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ABBUD_LIF_SIGNALING_1_DN
3.7037037037%	1	27	258	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	JAEGER_METASTASIS_DN
3.7037037037%	1	27	254	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BROWNE_HCMV_INFECTION_4HR_DN
3.7037037037%	1	27	253	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MCLACHLAN_DENTAL_CARIES_UP
3.7037037037%	1	27	253	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DANG_REGULATED_BY_MYC_DN
3.7037037037%	1	27	25	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KIM_HYPOXIA
3.7037037037%	1	27	25	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	JACKSON_DNMT1_TARGETS_DN
3.7037037037%	1	27	245	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PENG_RAPAMYCIN_RESPONSE_DN
3.7037037037%	1	27	245	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MCLACHLAN_DENTAL_CARIES_DN
3.7037037037%	1	27	244	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PLASARI_TGFB1_TARGETS_10HR_DN
3.7037037037%	1	27	243	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHICAS_RB1_TARGETS_GROWING
3.7037037037%	1	27	241	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DOANE_RESPONSE_TO_ANDROGEN_DN
3.7037037037%	1	27	240	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	UDAYAKUMAR_MED1_TARGETS_DN
3.7037037037%	1	27	24	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WILLERT_WNT_SIGNALING
3.7037037037%	1	27	24	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23
3.7037037037%	1	27	239	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ALFANO_MYC_TARGETS
3.7037037037%	1	27	237	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
3.7037037037%	1	27	236	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
3.7037037037%	1	27	235	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RUTELLA_RESPONSE_TO_HGF_DN
3.7037037037%	1	27	234	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
3.7037037037%	1	27	233	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
3.7037037037%	1	27	23	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION
3.7037037037%	1	27	229	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
3.7037037037%	1	27	229	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
3.7037037037%	1	27	228	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
3.7037037037%	1	27	228	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MARKEY_RB1_ACUTE_LOF_DN
3.7037037037%	1	27	227	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RAO_BOUND_BY_SALL4
3.7037037037%	1	27	227	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
3.7037037037%	1	27	227	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
3.7037037037%	1	27	226	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KYNG_DNA_DAMAGE_UP
3.7037037037%	1	27	226	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
3.7037037037%	1	27	221	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHANDRAN_METASTASIS_UP
3.7037037037%	1	27	220	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
3.7037037037%	1	27	22	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP
3.7037037037%	1	27	217	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WIERENGA_STAT5A_TARGETS_UP
3.7037037037%	1	27	215	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	YAMAZAKI_TCEB3_TARGETS_DN
3.7037037037%	1	27	214	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
3.7037037037%	1	27	214	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
3.7037037037%	1	27	214	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	AFFAR_YY1_TARGETS_UP
3.7037037037%	1	27	211	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
3.7037037037%	1	27	210	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
3.7037037037%	1	27	21	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RAHMAN_TP53_TARGETS_PHOSPHORYLATED
3.7037037037%	1	27	21	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MOOTHA_GLYCOLYSIS
3.7037037037%	1	27	21	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP
3.7037037037%	1	27	21	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	AMIT_SERUM_RESPONSE_20_MCF10A
3.7037037037%	1	27	209	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KIM_WT1_TARGETS_12HR_DN
3.7037037037%	1	27	208	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
3.7037037037%	1	27	207	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CAIRO_HEPATOBLASTOMA_UP
3.7037037037%	1	27	206	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RAMALHO_STEMNESS_UP
3.7037037037%	1	27	206	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BILD_MYC_ONCOGENIC_SIGNATURE
3.7037037037%	1	27	203	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GRUETZMANN_PANCREATIC_CANCER_DN
3.7037037037%	1	27	201	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HOLLMANN_APOPTOSIS_VIA_CD40_UP
3.7037037037%	1	27	20	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WENG_POR_TARGETS_GLOBAL_UP
3.7037037037%	1	27	20	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KORKOLA_YOLK_SAC_TUMOR_UP
3.7037037037%	1	27	199	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PLASARI_TGFB1_TARGETS_10HR_UP
3.7037037037%	1	27	196	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
3.7037037037%	1	27	191	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	YAGI_AML_FAB_MARKERS
3.7037037037%	1	27	191	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
3.7037037037%	1	27	19	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN
3.7037037037%	1	27	185	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
3.7037037037%	1	27	185	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LEE_LIVER_CANCER_SURVIVAL_UP
3.7037037037%	1	27	185	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DARWICHE_SKIN_TUMOR_PROMOTER_DN
3.7037037037%	1	27	185	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
3.7037037037%	1	27	184	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
3.7037037037%	1	27	1839	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
3.7037037037%	1	27	1821	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DODD_NASOPHARYNGEAL_CARCINOMA_UP
3.7037037037%	1	27	182	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WHITFIELD_CELL_CYCLE_G2
3.7037037037%	1	27	182	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
3.7037037037%	1	27	181	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	JISON_SICKLE_CELL_DISEASE_UP
3.7037037037%	1	27	180	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
3.7037037037%	1	27	18	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	NAM_FXYD5_TARGETS_DN
3.7037037037%	1	27	18	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MOREIRA_RESPONSE_TO_TSA_DN
3.7037037037%	1	27	18	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHOI_ATL_CHRONIC_VS_ACUTE_DN
3.7037037037%	1	27	178	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
3.7037037037%	1	27	175	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
3.7037037037%	1	27	171	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GOLDRATH_HOMEOSTATIC_PROLIFERATION
3.7037037037%	1	27	171	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ELVIDGE_HYPOXIA_UP
3.7037037037%	1	27	170	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
3.7037037037%	1	27	17	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM
3.7037037037%	1	27	17	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KASLER_HDAC7_TARGETS_1_DN
3.7037037037%	1	27	167	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	TIEN_INTESTINE_PROBIOTICS_6HR_DN
3.7037037037%	1	27	166	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CAIRO_LIVER_DEVELOPMENT_UP
3.7037037037%	1	27	165	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
3.7037037037%	1	27	163	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
3.7037037037%	1	27	162	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MULLIGHAN_NPM1_SIGNATURE_3_DN
3.7037037037%	1	27	162	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KIM_WT1_TARGETS_12HR_UP
3.7037037037%	1	27	162	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DARWICHE_PAPILLOMA_RISK_LOW_UP
3.7037037037%	1	27	160	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GAVIN_FOXP3_TARGETS_CLUSTER_P3
3.7037037037%	1	27	16	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZHAN_LATE_DIFFERENTIATION_GENES_DN
3.7037037037%	1	27	16	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KORKOLA_TERATOMA_UP
3.7037037037%	1	27	16	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KANG_FLUOROURACIL_RESISTANCE_DN
3.7037037037%	1	27	16	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GHO_ATF5_TARGETS_DN
3.7037037037%	1	27	159	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
3.7037037037%	1	27	158	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
3.7037037037%	1	27	156	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GROSS_HYPOXIA_VIA_ELK3_DN
3.7037037037%	1	27	153	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RUIZ_TNC_TARGETS_UP
3.7037037037%	1	27	151	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
3.7037037037%	1	27	150	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
3.7037037037%	1	27	15	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP
3.7037037037%	1	27	15	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN
3.7037037037%	1	27	149	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
3.7037037037%	1	27	148	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KATSANOU_ELAVL1_TARGETS_DN
3.7037037037%	1	27	147	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DARWICHE_PAPILLOMA_RISK_HIGH_UP
3.7037037037%	1	27	147	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BENPORATH_PROLIFERATION
3.7037037037%	1	27	146	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KIM_ALL_DISORDERS_DURATION_CORR_DN
3.7037037037%	1	27	146	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ELVIDGE_HYPOXIA_DN
3.7037037037%	1	27	146	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
3.7037037037%	1	27	145	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
3.7037037037%	1	27	145	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RODWELL_AGING_KIDNEY_DN
3.7037037037%	1	27	145	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
3.7037037037%	1	27	144	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BROCKE_APOPTOSIS_REVERSED_BY_IL6
3.7037037037%	1	27	142	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	XU_GH1_AUTOCRINE_TARGETS_DN
3.7037037037%	1	27	142	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MIKKELSEN_ES_LCP_WITH_H3K4ME3
3.7037037037%	1	27	142	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
3.7037037037%	1	27	140	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	QI_HYPOXIA
3.7037037037%	1	27	14	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PARK_APL_PATHOGENESIS_UP
3.7037037037%	1	27	14	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24
3.7037037037%	1	27	14	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	INAMURA_LUNG_CANCER_SCC_UP
3.7037037037%	1	27	14	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP
3.7037037037%	1	27	136	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
3.7037037037%	1	27	132	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
3.7037037037%	1	27	131	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
3.7037037037%	1	27	130	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ELVIDGE_HYPOXIA_BY_DMOG_UP
3.7037037037%	1	27	13	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN
3.7037037037%	1	27	129	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KIM_WT1_TARGETS_8HR_DN
3.7037037037%	1	27	128	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZHU_CMV_ALL_DN
3.7037037037%	1	27	127	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	KARLSSON_TGFB1_TARGETS_UP
3.7037037037%	1	27	126	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
3.7037037037%	1	27	125	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	FIGUEROA_AML_METHYLATION_CLUSTER_1_UP
3.7037037037%	1	27	123	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DAZARD_RESPONSE_TO_UV_SCC_UP
3.7037037037%	1	27	1210	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CHEN_METABOLIC_SYNDROM_NETWORK
3.7037037037%	1	27	121	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	VANTVEER_BREAST_CANCER_METASTASIS_DN
3.7037037037%	1	27	120	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ZHU_CMV_ALL_UP
3.7037037037%	1	27	12	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ITO_PTTG1_TARGETS_UP
3.7037037037%	1	27	12	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DAZARD_UV_RESPONSE_CLUSTER_G5
3.7037037037%	1	27	119	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
3.7037037037%	1	27	116	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
3.7037037037%	1	27	116	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
3.7037037037%	1	27	116	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
3.7037037037%	1	27	115	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MARZEC_IL2_SIGNALING_UP
3.7037037037%	1	27	115	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	MARKEY_RB1_CHRONIC_LOF_UP
3.7037037037%	1	27	1142	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
3.7037037037%	1	27	114	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SMIRNOV_RESPONSE_TO_IR_6HR_DN
3.7037037037%	1	27	114	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	CERVERA_SDHB_TARGETS_2
3.7037037037%	1	27	113	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	RICKMAN_HEAD_AND_NECK_CANCER_C
3.7037037037%	1	27	111	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
3.7037037037%	1	27	110	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GROSS_HYPOXIA_VIA_HIF1A_DN
3.7037037037%	1	27	1080	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
3.7037037037%	1	27	108	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
3.7037037037%	1	27	108	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
3.7037037037%	1	27	108	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LE_EGR2_TARGETS_DN
3.7037037037%	1	27	108	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
3.7037037037%	1	27	107	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
3.7037037037%	1	27	105	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WOO_LIVER_CANCER_RECURRENCE_UP
3.7037037037%	1	27	104	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
3.7037037037%	1	27	101	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
3.7037037037%	1	27	101	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BROWNE_HCMV_INFECTION_20HR_DN
3.7037037037%	1	27	100	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
3.7037037037%	1	27	10	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN
3.7037037037%	1	27	10	Diabetes_McGill_Triggering_pathway_mediating_stimulation_of_insulin_secretion	BIOCARTA_GLYCOLYSIS_PATHWAY
3.69807497467%	73	1974	485	Mendelian_Nancy_Cox	ENK_UV_RESPONSE_KERATINOCYTE_DN
3.69807497467%	73	1974	247	Mendelian_Nancy_Cox	REACTOME_METABOLISM_OF_CARBOHYDRATES
3.69003690037%	20	542	824	T2D_GENES_TANYA_ANTHROPOMETRIC	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
3.69003690037%	20	542	779	T2D_GENES_TANYA_ANTHROPOMETRIC	PUJANA_CHEK2_PCC_NETWORK
3.69003690037%	20	542	590	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
3.69003690037%	20	542	584	T2D_GENES_TANYA_ANTHROPOMETRIC	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
3.69003690037%	20	542	341	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
3.68786745056%	69	1871	805	T2D_GENES_TANYA_HEIGHT	REACTOME_GPCR_DOWNSTREAM_SIGNALING
3.68786745056%	69	1871	734	T2D_GENES_TANYA_HEIGHT	BENPORATH_SOX2_TARGETS
3.68380660015%	48	1303	1382	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
3.67985280589%	80	2174	681	T2D_GENES_TANYA_LIPIDS	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
3.67835757057%	43	1169	478	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
3.67835757057%	43	1169	1062	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BENPORATH_EED_TARGETS
3.67835757057%	43	1169	1011	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
3.64741641337%	72	1974	442	Mendelian_Nancy_Cox	HAN_SATB1_TARGETS_DN
3.64741641337%	72	1974	408	Mendelian_Nancy_Cox	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
3.64741641337%	72	1974	388	Mendelian_Nancy_Cox	STEIN_ESRRA_TARGETS_UP
3.64741641337%	72	1974	351	Mendelian_Nancy_Cox	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
3.64741641337%	72	1974	222	Mendelian_Nancy_Cox	CAIRO_LIVER_DEVELOPMENT_DN
3.63442009621%	68	1871	795	T2D_GENES_TANYA_HEIGHT	WEI_MYCN_TARGETS_WITH_E_BOX
3.63442009621%	68	1871	779	T2D_GENES_TANYA_HEIGHT	PUJANA_CHEK2_PCC_NETWORK
3.63385464581%	79	2174	918	T2D_GENES_TANYA_LIPIDS	JOHNSTONE_PARVB_TARGETS_3_DN
3.63385464581%	79	2174	779	T2D_GENES_TANYA_LIPIDS	PUJANA_CHEK2_PCC_NETWORK
3.63385464581%	79	2174	770	T2D_GENES_TANYA_LIPIDS	KRIEG_HYPOXIA_NOT_VIA_KDM3A
3.6308623298%	24	661	783	T2D_GENES_TANYA_GLYCEMIC	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
3.6308623298%	24	661	75	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TELOMERE_MAINTENANCE
3.6308623298%	24	661	673	T2D_GENES_TANYA_GLYCEMIC	MARTINEZ_RB1_TARGETS_UP
3.6308623298%	24	661	567	T2D_GENES_TANYA_GLYCEMIC	PARENT_MTOR_SIGNALING_UP
3.6308623298%	24	661	553	T2D_GENES_TANYA_GLYCEMIC	FEVR_CTNNB1_TARGETS_DN
3.6308623298%	24	661	341	T2D_GENES_TANYA_GLYCEMIC	MULLIGHAN_NPM1_SIGNATURE_3_UP
3.60110803324%	13	361	898	T2D_GENES_TANYA_T2D_RSQ05_02CM	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
3.60110803324%	13	361	893	T2D_GENES_TANYA_T2D_RSQ05_02CM	GEORGES_TARGETS_OF_MIR192_AND_MIR215
3.60110803324%	13	361	855	T2D_GENES_TANYA_T2D_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
3.60110803324%	13	361	784	T2D_GENES_TANYA_T2D_RSQ05_02CM	FORTSCHEGGER_PHF8_TARGETS_DN
3.60110803324%	13	361	456	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
3.60110803324%	13	361	1278	T2D_GENES_TANYA_T2D_RSQ05_02CM	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
3.59675785208%	71	1974	769	Mendelian_Nancy_Cox	NUYTTEN_NIPP1_TARGETS_UP
3.59675785208%	71	1974	566	Mendelian_Nancy_Cox	DOUGLAS_BMI1_TARGETS_UP
3.59675785208%	71	1974	457	Mendelian_Nancy_Cox	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
3.59675785208%	71	1974	425	Mendelian_Nancy_Cox	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
3.59675785208%	71	1974	200	Mendelian_Nancy_Cox	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
3.59281437126%	42	1169	800	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
3.58890701468%	22	613	933	T2D_GENES_TANYA_BIOMARKER	REACTOME_IMMUNE_SYSTEM
3.58890701468%	22	613	770	T2D_GENES_TANYA_BIOMARKER	KRIEG_HYPOXIA_NOT_VIA_KDM3A
3.58890701468%	22	613	720	T2D_GENES_TANYA_BIOMARKER	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
3.58890701468%	22	613	1037	T2D_GENES_TANYA_BIOMARKER	NUYTTEN_EZH2_TARGETS_UP
3.58744394619%	16	446	663	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
3.58744394619%	16	446	1972	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PILON_KLF1_TARGETS_DN
3.58744394619%	16	446	1839	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
3.58744394619%	16	446	1237	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BLALOCK_ALZHEIMERS_DISEASE_DN
3.58744394619%	16	446	1103	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DANG_BOUND_BY_MYC
3.58744394619%	16	446	1011	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
3.58097274185%	67	1871	893	T2D_GENES_TANYA_HEIGHT	GEORGES_TARGETS_OF_MIR192_AND_MIR215
3.58097274185%	67	1871	805	T2D_GENES_TANYA_HEIGHT	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
3.58097274185%	67	1871	769	T2D_GENES_TANYA_HEIGHT	NUYTTEN_NIPP1_TARGETS_UP
3.58097274185%	67	1871	718	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_ES_ICP_WITH_H3K4ME3
3.58097274185%	67	1871	658	T2D_GENES_TANYA_HEIGHT	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
3.58097274185%	67	1871	637	T2D_GENES_TANYA_HEIGHT	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
3.58097274185%	67	1871	539	T2D_GENES_TANYA_HEIGHT	LIAO_METASTASIS
3.58097274185%	67	1871	530	T2D_GENES_TANYA_HEIGHT	ENK_UV_RESPONSE_KERATINOCYTE_UP
3.58097274185%	67	1871	479	T2D_GENES_TANYA_HEIGHT	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
3.57142857143%	1	28	99	Diabetes_McGill_Cell_cycle_G1	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
3.57142857143%	1	28	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
3.57142857143%	1	28	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
3.57142857143%	1	28	98	Diabetes_McGill_Cell_cycle_G1	HAHTOLA_SEZARY_SYNDROM_UP
3.57142857143%	1	28	97	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
3.57142857143%	1	28	96	Diabetes_McGill_Cell_cycle_G1	LIU_PROSTATE_CANCER_UP
3.57142857143%	1	28	953	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
3.57142857143%	1	28	95	Diabetes_McGill_Cell_cycle_G1	HOEBEKE_LYMPHOID_STEM_CELL_UP
3.57142857143%	1	28	940	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
3.57142857143%	1	28	94	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GAVIN_FOXP3_TARGETS_CLUSTER_T4
3.57142857143%	1	28	93	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
3.57142857143%	1	28	93	Diabetes_McGill_Cell_cycle_G1	ZHU_CMV_24_HR_UP
3.57142857143%	1	28	93	Diabetes_McGill_Cell_cycle_G1	REACTOME_ACTIVATED_TLR4_SIGNALLING
3.57142857143%	1	28	93	Diabetes_McGill_Cell_cycle_G1	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
3.57142857143%	1	28	920	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALING_BY_GPCR
3.57142857143%	1	28	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
3.57142857143%	1	28	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
3.57142857143%	1	28	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_DILATED_CARDIOMYOPATHY
3.57142857143%	1	28	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CAMPS_COLON_CANCER_COPY_NUMBER_UP
3.57142857143%	1	28	92	Diabetes_McGill_Cell_cycle_G1	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
3.57142857143%	1	28	911	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
3.57142857143%	1	28	91	Diabetes_McGill_Cell_cycle_G1	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
3.57142857143%	1	28	91	Diabetes_McGill_Cell_cycle_G1	GAVIN_FOXP3_TARGETS_CLUSTER_P6
3.57142857143%	1	28	90	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HILLION_HMGA1_TARGETS
3.57142857143%	1	28	90	Diabetes_McGill_Cell_cycle_G1	SANA_TNF_SIGNALING_DN
3.57142857143%	1	28	90	Diabetes_McGill_Cell_cycle_G1	KEGG_GAP_JUNCTION
3.57142857143%	1	28	90	Diabetes_McGill_Cell_cycle_G1	IGARASHI_ATF4_TARGETS_DN
3.57142857143%	1	28	90	Diabetes_McGill_Cell_cycle_G1	HILLION_HMGA1_TARGETS
3.57142857143%	1	28	90	Diabetes_McGill_Cell_cycle_G1	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN
3.57142857143%	1	28	9	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30
3.57142857143%	1	28	9	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN
3.57142857143%	1	28	9	Diabetes_McGill_Cell_cycle_G1	THILLAINADESAN_ZNF217_TARGETS_DN
3.57142857143%	1	28	9	Diabetes_McGill_Cell_cycle_G1	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21
3.57142857143%	1	28	9	Diabetes_McGill_Cell_cycle_G1	KOMMAGANI_TP63_GAMMA_TARGETS
3.57142857143%	1	28	9	Diabetes_McGill_Cell_cycle_G1	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN
3.57142857143%	1	28	9	Diabetes_McGill_Cell_cycle_G1	COLLER_MYC_TARGETS_DN
3.57142857143%	1	28	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SWEET_KRAS_ONCOGENIC_SIGNATURE
3.57142857143%	1	28	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	RICKMAN_HEAD_AND_NECK_CANCER_E
3.57142857143%	1	28	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
3.57142857143%	1	28	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
3.57142857143%	1	28	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_PROSTATE_CANCER
3.57142857143%	1	28	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KANG_IMMORTALIZED_BY_TERT_UP
3.57142857143%	1	28	89	Diabetes_McGill_Cell_cycle_G1	ZHANG_TLX_TARGETS_UP
3.57142857143%	1	28	89	Diabetes_McGill_Cell_cycle_G1	BOYLAN_MULTIPLE_MYELOMA_D_UP
3.57142857143%	1	28	89	Diabetes_McGill_Cell_cycle_G1	BHATTACHARYA_EMBRYONIC_STEM_CELL
3.57142857143%	1	28	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
3.57142857143%	1	28	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
3.57142857143%	1	28	88	Diabetes_McGill_Cell_cycle_G1	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
3.57142857143%	1	28	88	Diabetes_McGill_Cell_cycle_G1	WALLACE_PROSTATE_CANCER_RACE_DN
3.57142857143%	1	28	88	Diabetes_McGill_Cell_cycle_G1	SEIDEN_ONCOGENESIS_BY_MET
3.57142857143%	1	28	88	Diabetes_McGill_Cell_cycle_G1	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
3.57142857143%	1	28	88	Diabetes_McGill_Cell_cycle_G1	SASSON_RESPONSE_TO_FORSKOLIN_DN
3.57142857143%	1	28	88	Diabetes_McGill_Cell_cycle_G1	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
3.57142857143%	1	28	88	Diabetes_McGill_Cell_cycle_G1	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
3.57142857143%	1	28	88	Diabetes_McGill_Cell_cycle_G1	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
3.57142857143%	1	28	88	Diabetes_McGill_Cell_cycle_G1	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
3.57142857143%	1	28	88	Diabetes_McGill_Cell_cycle_G1	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
3.57142857143%	1	28	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
3.57142857143%	1	28	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SAFFORD_T_LYMPHOCYTE_ANERGY
3.57142857143%	1	28	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
3.57142857143%	1	28	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
3.57142857143%	1	28	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
3.57142857143%	1	28	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
3.57142857143%	1	28	87	Diabetes_McGill_Cell_cycle_G1	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
3.57142857143%	1	28	87	Diabetes_McGill_Cell_cycle_G1	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
3.57142857143%	1	28	87	Diabetes_McGill_Cell_cycle_G1	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
3.57142857143%	1	28	87	Diabetes_McGill_Cell_cycle_G1	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
3.57142857143%	1	28	863	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
3.57142857143%	1	28	863	Diabetes_McGill_Cell_cycle_G1	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
3.57142857143%	1	28	86	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
3.57142857143%	1	28	86	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
3.57142857143%	1	28	86	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BROWNE_HCMV_INFECTION_16HR_DN
3.57142857143%	1	28	86	Diabetes_McGill_Cell_cycle_G1	NGUYEN_NOTCH1_TARGETS_DN
3.57142857143%	1	28	86	Diabetes_McGill_Cell_cycle_G1	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
3.57142857143%	1	28	86	Diabetes_McGill_Cell_cycle_G1	LEE_AGING_CEREBELLUM_DN
3.57142857143%	1	28	86	Diabetes_McGill_Cell_cycle_G1	BAELDE_DIABETIC_NEPHROPATHY_UP
3.57142857143%	1	28	85	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
3.57142857143%	1	28	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SMID_BREAST_CANCER_LUMINAL_A_UP
3.57142857143%	1	28	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
3.57142857143%	1	28	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	RUAN_RESPONSE_TO_TNF_DN
3.57142857143%	1	28	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LEE_AGING_CEREBELLUM_UP
3.57142857143%	1	28	84	Diabetes_McGill_Cell_cycle_G1	SWEET_KRAS_TARGETS_UP
3.57142857143%	1	28	84	Diabetes_McGill_Cell_cycle_G1	LEE_AGING_CEREBELLUM_UP
3.57142857143%	1	28	84	Diabetes_McGill_Cell_cycle_G1	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
3.57142857143%	1	28	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_AMYLOIDS
3.57142857143%	1	28	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
3.57142857143%	1	28	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
3.57142857143%	1	28	83	Diabetes_McGill_Cell_cycle_G1	WARTERS_RESPONSE_TO_IR_SKIN
3.57142857143%	1	28	83	Diabetes_McGill_Cell_cycle_G1	SANA_TNF_SIGNALING_UP
3.57142857143%	1	28	83	Diabetes_McGill_Cell_cycle_G1	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
3.57142857143%	1	28	83	Diabetes_McGill_Cell_cycle_G1	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
3.57142857143%	1	28	83	Diabetes_McGill_Cell_cycle_G1	JIANG_HYPOXIA_CANCER
3.57142857143%	1	28	824	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
3.57142857143%	1	28	82	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_SMAD2_3NUCLEARPATHWAY
3.57142857143%	1	28	82	Diabetes_McGill_Cell_cycle_G1	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
3.57142857143%	1	28	82	Diabetes_McGill_Cell_cycle_G1	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
3.57142857143%	1	28	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
3.57142857143%	1	28	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_MITOTIC_G2_G2_M_PHASES
3.57142857143%	1	28	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CROMER_METASTASIS_DN
3.57142857143%	1	28	81	Diabetes_McGill_Cell_cycle_G1	SCIBETTA_KDM5B_TARGETS_DN
3.57142857143%	1	28	81	Diabetes_McGill_Cell_cycle_G1	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
3.57142857143%	1	28	81	Diabetes_McGill_Cell_cycle_G1	MUNSHI_MULTIPLE_MYELOMA_UP
3.57142857143%	1	28	81	Diabetes_McGill_Cell_cycle_G1	MAHAJAN_RESPONSE_TO_IL1A_UP
3.57142857143%	1	28	81	Diabetes_McGill_Cell_cycle_G1	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
3.57142857143%	1	28	805	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
3.57142857143%	1	28	805	Diabetes_McGill_Cell_cycle_G1	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
3.57142857143%	1	28	800	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
3.57142857143%	1	28	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
3.57142857143%	1	28	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
3.57142857143%	1	28	80	Diabetes_McGill_Cell_cycle_G1	SCHUHMACHER_MYC_TARGETS_UP
3.57142857143%	1	28	80	Diabetes_McGill_Cell_cycle_G1	LEE_AGING_NEOCORTEX_DN
3.57142857143%	1	28	80	Diabetes_McGill_Cell_cycle_G1	BASSO_HAIRY_CELL_LEUKEMIA_DN
3.57142857143%	1	28	8	Diabetes_McGill_Cell_cycle_G1	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR
3.57142857143%	1	28	8	Diabetes_McGill_Cell_cycle_G1	TURJANSKI_MAPK8_AND_MAPK9_TARGETS
3.57142857143%	1	28	8	Diabetes_McGill_Cell_cycle_G1	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN
3.57142857143%	1	28	8	Diabetes_McGill_Cell_cycle_G1	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN
3.57142857143%	1	28	8	Diabetes_McGill_Cell_cycle_G1	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18
3.57142857143%	1	28	8	Diabetes_McGill_Cell_cycle_G1	MIKKELSEN_PLURIPOTENT_STATE_DN
3.57142857143%	1	28	8	Diabetes_McGill_Cell_cycle_G1	LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP
3.57142857143%	1	28	8	Diabetes_McGill_Cell_cycle_G1	GAUTSCHI_SRC_SIGNALING
3.57142857143%	1	28	8	Diabetes_McGill_Cell_cycle_G1	GALI_TP53_TARGETS_APOPTOTIC_UP
3.57142857143%	1	28	8	Diabetes_McGill_Cell_cycle_G1	GALIE_TUMOR_ANGIOGENESIS
3.57142857143%	1	28	8	Diabetes_McGill_Cell_cycle_G1	FUJIWARA_PARK2_IN_LIVER_CANCER_UP
3.57142857143%	1	28	795	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WEI_MYCN_TARGETS_WITH_E_BOX
3.57142857143%	1	28	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LIU_COMMON_CANCER_GENES
3.57142857143%	1	28	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	DUAN_PRDM5_TARGETS
3.57142857143%	1	28	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
3.57142857143%	1	28	79	Diabetes_McGill_Cell_cycle_G1	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16
3.57142857143%	1	28	79	Diabetes_McGill_Cell_cycle_G1	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
3.57142857143%	1	28	79	Diabetes_McGill_Cell_cycle_G1	DUAN_PRDM5_TARGETS
3.57142857143%	1	28	783	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
3.57142857143%	1	28	783	Diabetes_McGill_Cell_cycle_G1	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
3.57142857143%	1	28	78	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
3.57142857143%	1	28	78	Diabetes_McGill_Cell_cycle_G1	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
3.57142857143%	1	28	78	Diabetes_McGill_Cell_cycle_G1	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE
3.57142857143%	1	28	770	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KRIEG_HYPOXIA_NOT_VIA_KDM3A
3.57142857143%	1	28	77	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LIN_APC_TARGETS
3.57142857143%	1	28	77	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CARD_MIR302A_TARGETS
3.57142857143%	1	28	77	Diabetes_McGill_Cell_cycle_G1	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
3.57142857143%	1	28	77	Diabetes_McGill_Cell_cycle_G1	ROSS_AML_WITH_PML_RARA_FUSION
3.57142857143%	1	28	77	Diabetes_McGill_Cell_cycle_G1	RODRIGUES_THYROID_CARCINOMA_DN
3.57142857143%	1	28	77	Diabetes_McGill_Cell_cycle_G1	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
3.57142857143%	1	28	77	Diabetes_McGill_Cell_cycle_G1	LIN_APC_TARGETS
3.57142857143%	1	28	77	Diabetes_McGill_Cell_cycle_G1	CHEBOTAEV_GR_TARGETS_UP
3.57142857143%	1	28	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
3.57142857143%	1	28	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MAHAJAN_RESPONSE_TO_IL1A_DN
3.57142857143%	1	28	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
3.57142857143%	1	28	76	Diabetes_McGill_Cell_cycle_G1	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
3.57142857143%	1	28	76	Diabetes_McGill_Cell_cycle_G1	SU_TESTIS
3.57142857143%	1	28	76	Diabetes_McGill_Cell_cycle_G1	ROSS_AML_WITH_AML1_ETO_FUSION
3.57142857143%	1	28	76	Diabetes_McGill_Cell_cycle_G1	NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON
3.57142857143%	1	28	76	Diabetes_McGill_Cell_cycle_G1	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
3.57142857143%	1	28	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_ADHERENS_JUNCTION
3.57142857143%	1	28	75	Diabetes_McGill_Cell_cycle_G1	PID_AVB3_INTEGRIN_PATHWAY
3.57142857143%	1	28	75	Diabetes_McGill_Cell_cycle_G1	MORI_MATURE_B_LYMPHOCYTE_DN
3.57142857143%	1	28	75	Diabetes_McGill_Cell_cycle_G1	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
3.57142857143%	1	28	75	Diabetes_McGill_Cell_cycle_G1	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
3.57142857143%	1	28	75	Diabetes_McGill_Cell_cycle_G1	CHESLER_BRAIN_QTL_CIS
3.57142857143%	1	28	75	Diabetes_McGill_Cell_cycle_G1	BAE_BRCA1_TARGETS_UP
3.57142857143%	1	28	747	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PATIL_LIVER_CANCER
3.57142857143%	1	28	745	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LEE_BMP2_TARGETS_UP
3.57142857143%	1	28	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SHEPARD_BMYB_TARGETS
3.57142857143%	1	28	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LEE_LIVER_CANCER_DENA_DN
3.57142857143%	1	28	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CORRE_MULTIPLE_MYELOMA_UP
3.57142857143%	1	28	74	Diabetes_McGill_Cell_cycle_G1	URS_ADIPOCYTE_DIFFERENTIATION_UP
3.57142857143%	1	28	74	Diabetes_McGill_Cell_cycle_G1	SHEPARD_BMYB_TARGETS
3.57142857143%	1	28	74	Diabetes_McGill_Cell_cycle_G1	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
3.57142857143%	1	28	74	Diabetes_McGill_Cell_cycle_G1	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
3.57142857143%	1	28	74	Diabetes_McGill_Cell_cycle_G1	FURUKAWA_DUSP6_TARGETS_PCI35_UP
3.57142857143%	1	28	74	Diabetes_McGill_Cell_cycle_G1	DER_IFN_ALPHA_RESPONSE_UP
3.57142857143%	1	28	74	Diabetes_McGill_Cell_cycle_G1	CORRE_MULTIPLE_MYELOMA_UP
3.57142857143%	1	28	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_MEIOTIC_SYNAPSIS
3.57142857143%	1	28	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	DITTMER_PTHLH_TARGETS_DN
3.57142857143%	1	28	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
3.57142857143%	1	28	73	Diabetes_McGill_Cell_cycle_G1	REACTOME_MEIOTIC_SYNAPSIS
3.57142857143%	1	28	73	Diabetes_McGill_Cell_cycle_G1	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
3.57142857143%	1	28	73	Diabetes_McGill_Cell_cycle_G1	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
3.57142857143%	1	28	73	Diabetes_McGill_Cell_cycle_G1	LIN_MELANOMA_COPY_NUMBER_UP
3.57142857143%	1	28	73	Diabetes_McGill_Cell_cycle_G1	GAURNIER_PSMD4_TARGETS
3.57142857143%	1	28	728	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARSON_BOUND_BY_E2F4_UNSTIMULATED
3.57142857143%	1	28	721	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WONG_ADULT_TISSUE_STEM_MODULE
3.57142857143%	1	28	72	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
3.57142857143%	1	28	72	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MATZUK_SPERMATOCYTE
3.57142857143%	1	28	72	Diabetes_McGill_Cell_cycle_G1	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
3.57142857143%	1	28	72	Diabetes_McGill_Cell_cycle_G1	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1
3.57142857143%	1	28	72	Diabetes_McGill_Cell_cycle_G1	HUANG_GATA2_TARGETS_DN
3.57142857143%	1	28	72	Diabetes_McGill_Cell_cycle_G1	CROONQUIST_NRAS_SIGNALING_DN
3.57142857143%	1	28	718	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MIKKELSEN_ES_ICP_WITH_H3K4ME3
3.57142857143%	1	28	712	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SCHLOSSER_SERUM_RESPONSE_DN
3.57142857143%	1	28	71	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	DER_IFN_GAMMA_RESPONSE_UP
3.57142857143%	1	28	71	Diabetes_McGill_Cell_cycle_G1	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
3.57142857143%	1	28	701	Diabetes_McGill_Cell_cycle_G1	SMID_BREAST_CANCER_BASAL_DN
3.57142857143%	1	28	70	Diabetes_McGill_Cell_cycle_G1	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
3.57142857143%	1	28	70	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALING_BY_NOTCH1
3.57142857143%	1	28	70	Diabetes_McGill_Cell_cycle_G1	PID_CDC42_PATHWAY
3.57142857143%	1	28	70	Diabetes_McGill_Cell_cycle_G1	CADWELL_ATG16L1_TARGETS_DN
3.57142857143%	1	28	7	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MIKI_COEXPRESSED_WITH_CYP19A1
3.57142857143%	1	28	7	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BERGER_MBD2_TARGETS
3.57142857143%	1	28	7	Diabetes_McGill_Cell_cycle_G1	SCHRAMM_INHBA_TARGETS_UP
3.57142857143%	1	28	7	Diabetes_McGill_Cell_cycle_G1	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP
3.57142857143%	1	28	7	Diabetes_McGill_Cell_cycle_G1	MIKKELSEN_DEDIFFERENTIATED_STATE_DN
3.57142857143%	1	28	7	Diabetes_McGill_Cell_cycle_G1	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN
3.57142857143%	1	28	7	Diabetes_McGill_Cell_cycle_G1	HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER
3.57142857143%	1	28	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_PPAR_SIGNALING_PATHWAY
3.57142857143%	1	28	69	Diabetes_McGill_Cell_cycle_G1	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
3.57142857143%	1	28	69	Diabetes_McGill_Cell_cycle_G1	RHODES_UNDIFFERENTIATED_CANCER
3.57142857143%	1	28	69	Diabetes_McGill_Cell_cycle_G1	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
3.57142857143%	1	28	69	Diabetes_McGill_Cell_cycle_G1	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
3.57142857143%	1	28	69	Diabetes_McGill_Cell_cycle_G1	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
3.57142857143%	1	28	69	Diabetes_McGill_Cell_cycle_G1	AMIT_EGF_RESPONSE_120_HELA
3.57142857143%	1	28	682	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
3.57142857143%	1	28	681	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
3.57142857143%	1	28	681	Diabetes_McGill_Cell_cycle_G1	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
3.57142857143%	1	28	68	Diabetes_McGill_Cell_cycle_G1	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
3.57142857143%	1	28	68	Diabetes_McGill_Cell_cycle_G1	LIN_NPAS4_TARGETS_DN
3.57142857143%	1	28	68	Diabetes_McGill_Cell_cycle_G1	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
3.57142857143%	1	28	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	VANHARANTA_UTERINE_FIBROID_DN
3.57142857143%	1	28	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
3.57142857143%	1	28	67	Diabetes_McGill_Cell_cycle_G1	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
3.57142857143%	1	28	67	Diabetes_McGill_Cell_cycle_G1	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
3.57142857143%	1	28	668	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
3.57142857143%	1	28	668	Diabetes_McGill_Cell_cycle_G1	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
3.57142857143%	1	28	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
3.57142857143%	1	28	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	RIGGINS_TAMOXIFEN_RESISTANCE_UP
3.57142857143%	1	28	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
3.57142857143%	1	28	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_HDAC_CLASSI_PATHWAY
3.57142857143%	1	28	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARSON_FOXP3_TARGETS_UP
3.57142857143%	1	28	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LEE_LIVER_CANCER_CIPROFIBRATE_DN
3.57142857143%	1	28	66	Diabetes_McGill_Cell_cycle_G1	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
3.57142857143%	1	28	66	Diabetes_McGill_Cell_cycle_G1	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
3.57142857143%	1	28	66	Diabetes_McGill_Cell_cycle_G1	PID_LYSOPHOSPHOLIPID_PATHWAY
3.57142857143%	1	28	66	Diabetes_McGill_Cell_cycle_G1	PID_HDAC_CLASSI_PATHWAY
3.57142857143%	1	28	66	Diabetes_McGill_Cell_cycle_G1	NAKAMURA_ADIPOGENESIS_EARLY_UP
3.57142857143%	1	28	66	Diabetes_McGill_Cell_cycle_G1	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
3.57142857143%	1	28	66	Diabetes_McGill_Cell_cycle_G1	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN
3.57142857143%	1	28	66	Diabetes_McGill_Cell_cycle_G1	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
3.57142857143%	1	28	66	Diabetes_McGill_Cell_cycle_G1	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP
3.57142857143%	1	28	66	Diabetes_McGill_Cell_cycle_G1	BEIER_GLIOMA_STEM_CELL_DN
3.57142857143%	1	28	658	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
3.57142857143%	1	28	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_RB_1PATHWAY
3.57142857143%	1	28	65	Diabetes_McGill_Cell_cycle_G1	ST_FAS_SIGNALING_PATHWAY
3.57142857143%	1	28	65	Diabetes_McGill_Cell_cycle_G1	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX
3.57142857143%	1	28	648	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SMID_BREAST_CANCER_BASAL_UP
3.57142857143%	1	28	64	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
3.57142857143%	1	28	64	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GERHOLD_ADIPOGENESIS_DN
3.57142857143%	1	28	64	Diabetes_McGill_Cell_cycle_G1	RIZKI_TUMOR_INVASIVENESS_2D_DN
3.57142857143%	1	28	64	Diabetes_McGill_Cell_cycle_G1	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
3.57142857143%	1	28	64	Diabetes_McGill_Cell_cycle_G1	LEE_LIVER_CANCER_ACOX1_UP
3.57142857143%	1	28	64	Diabetes_McGill_Cell_cycle_G1	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
3.57142857143%	1	28	64	Diabetes_McGill_Cell_cycle_G1	INGRAM_SHH_TARGETS_DN
3.57142857143%	1	28	64	Diabetes_McGill_Cell_cycle_G1	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
3.57142857143%	1	28	64	Diabetes_McGill_Cell_cycle_G1	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
3.57142857143%	1	28	64	Diabetes_McGill_Cell_cycle_G1	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
3.57142857143%	1	28	64	Diabetes_McGill_Cell_cycle_G1	BYSTROEM_CORRELATED_WITH_IL5_DN
3.57142857143%	1	28	634	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
3.57142857143%	1	28	63	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BRIDEAU_IMPRINTED_GENES
3.57142857143%	1	28	63	Diabetes_McGill_Cell_cycle_G1	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
3.57142857143%	1	28	63	Diabetes_McGill_Cell_cycle_G1	BURTON_ADIPOGENESIS_PEAK_AT_0HR
3.57142857143%	1	28	63	Diabetes_McGill_Cell_cycle_G1	BRIDEAU_IMPRINTED_GENES
3.57142857143%	1	28	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
3.57142857143%	1	28	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
3.57142857143%	1	28	62	Diabetes_McGill_Cell_cycle_G1	GEORGES_CELL_CYCLE_MIR192_TARGETS
3.57142857143%	1	28	62	Diabetes_McGill_Cell_cycle_G1	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP
3.57142857143%	1	28	612	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
3.57142857143%	1	28	61	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	NADLER_OBESITY_UP
3.57142857143%	1	28	61	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
3.57142857143%	1	28	61	Diabetes_McGill_Cell_cycle_G1	LEE_LIVER_CANCER_MYC_TGFA_UP
3.57142857143%	1	28	61	Diabetes_McGill_Cell_cycle_G1	BAKKER_FOXO3_TARGETS_UP
3.57142857143%	1	28	602	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARTINEZ_TP53_TARGETS_UP
3.57142857143%	1	28	601	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARTINEZ_RB1_AND_TP53_TARGETS_UP
3.57142857143%	1	28	60	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LEE_LIVER_CANCER_CIPROFIBRATE_UP
3.57142857143%	1	28	60	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CUI_GLUCOSE_DEPRIVATION
3.57142857143%	1	28	60	Diabetes_McGill_Cell_cycle_G1	LEE_LIVER_CANCER_CIPROFIBRATE_UP
3.57142857143%	1	28	60	Diabetes_McGill_Cell_cycle_G1	CUI_GLUCOSE_DEPRIVATION
3.57142857143%	1	28	6	Diabetes_McGill_Cell_cycle_G1	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6
3.57142857143%	1	28	6	Diabetes_McGill_Cell_cycle_G1	IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM
3.57142857143%	1	28	6	Diabetes_McGill_Cell_cycle_G1	GERHOLD_RESPONSE_TO_TZD_UP
3.57142857143%	1	28	6	Diabetes_McGill_Cell_cycle_G1	DONATO_CELL_CYCLE_TRETINOIN
3.57142857143%	1	28	6	Diabetes_McGill_Cell_cycle_G1	DING_LUNG_CANCER_MUTATED_RECURRENTLY
3.57142857143%	1	28	6	Diabetes_McGill_Cell_cycle_G1	COURTOIS_SENESCENCE_TRIGGERS
3.57142857143%	1	28	6	Diabetes_McGill_Cell_cycle_G1	BUSA_SAM68_TARGETS_DN
3.57142857143%	1	28	593	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARTINEZ_TP53_TARGETS_DN
3.57142857143%	1	28	591	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARTINEZ_RB1_AND_TP53_TARGETS_DN
3.57142857143%	1	28	59	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
3.57142857143%	1	28	59	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_ATF2_PATHWAY
3.57142857143%	1	28	59	Diabetes_McGill_Cell_cycle_G1	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
3.57142857143%	1	28	59	Diabetes_McGill_Cell_cycle_G1	PID_FAK_PATHWAY
3.57142857143%	1	28	59	Diabetes_McGill_Cell_cycle_G1	KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION
3.57142857143%	1	28	59	Diabetes_McGill_Cell_cycle_G1	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1
3.57142857143%	1	28	59	Diabetes_McGill_Cell_cycle_G1	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
3.57142857143%	1	28	59	Diabetes_McGill_Cell_cycle_G1	DASU_IL6_SIGNALING_UP
3.57142857143%	1	28	584	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
3.57142857143%	1	28	584	Diabetes_McGill_Cell_cycle_G1	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
3.57142857143%	1	28	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LUCAS_HNF4A_TARGETS_UP
3.57142857143%	1	28	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BIOCARTA_PPARA_PATHWAY
3.57142857143%	1	28	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BIOCARTA_HIVNEF_PATHWAY
3.57142857143%	1	28	58	Diabetes_McGill_Cell_cycle_G1	WAKASUGI_HAVE_ZNF143_BINDING_SITES
3.57142857143%	1	28	58	Diabetes_McGill_Cell_cycle_G1	KANNAN_TP53_TARGETS_UP
3.57142857143%	1	28	58	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_PPARA_PATHWAY
3.57142857143%	1	28	58	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_HIVNEF_PATHWAY
3.57142857143%	1	28	579	Diabetes_McGill_Cell_cycle_G1	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
3.57142857143%	1	28	57	Diabetes_McGill_Cell_cycle_G1	LEE_EARLY_T_LYMPHOCYTE_DN
3.57142857143%	1	28	567	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PARENT_MTOR_SIGNALING_UP
3.57142857143%	1	28	567	Diabetes_McGill_Cell_cycle_G1	PARENT_MTOR_SIGNALING_UP
3.57142857143%	1	28	564	Diabetes_McGill_Cell_cycle_G1	SMID_BREAST_CANCER_LUMINAL_B_DN
3.57142857143%	1	28	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HOQUE_METHYLATED_IN_CANCER
3.57142857143%	1	28	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HENDRICKS_SMARCA4_TARGETS_UP
3.57142857143%	1	28	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BIOCARTA_NFAT_PATHWAY
3.57142857143%	1	28	56	Diabetes_McGill_Cell_cycle_G1	VANTVEER_BREAST_CANCER_METASTASIS_UP
3.57142857143%	1	28	56	Diabetes_McGill_Cell_cycle_G1	MAYBURD_RESPONSE_TO_L663536_DN
3.57142857143%	1	28	56	Diabetes_McGill_Cell_cycle_G1	LEE_LIVER_CANCER_MYC_E2F1_UP
3.57142857143%	1	28	56	Diabetes_McGill_Cell_cycle_G1	KEGG_HEDGEHOG_SIGNALING_PATHWAY
3.57142857143%	1	28	56	Diabetes_McGill_Cell_cycle_G1	HENDRICKS_SMARCA4_TARGETS_UP
3.57142857143%	1	28	56	Diabetes_McGill_Cell_cycle_G1	GALE_APL_WITH_FLT3_MUTATED_UP
3.57142857143%	1	28	56	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_NFAT_PATHWAY
3.57142857143%	1	28	555	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
3.57142857143%	1	28	555	Diabetes_McGill_Cell_cycle_G1	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
3.57142857143%	1	28	552	Diabetes_McGill_Cell_cycle_G1	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
3.57142857143%	1	28	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER
3.57142857143%	1	28	55	Diabetes_McGill_Cell_cycle_G1	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
3.57142857143%	1	28	55	Diabetes_McGill_Cell_cycle_G1	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
3.57142857143%	1	28	55	Diabetes_McGill_Cell_cycle_G1	PID_IL2_1PATHWAY
3.57142857143%	1	28	55	Diabetes_McGill_Cell_cycle_G1	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR
3.57142857143%	1	28	549	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
3.57142857143%	1	28	549	Diabetes_McGill_Cell_cycle_G1	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
3.57142857143%	1	28	546	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
3.57142857143%	1	28	546	Diabetes_McGill_Cell_cycle_G1	WEST_ADRENOCORTICAL_TUMOR_DN
3.57142857143%	1	28	546	Diabetes_McGill_Cell_cycle_G1	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
3.57142857143%	1	28	544	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
3.57142857143%	1	28	543	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARTINEZ_RB1_TARGETS_DN
3.57142857143%	1	28	540	Diabetes_McGill_Cell_cycle_G1	ACEVEDO_LIVER_CANCER_DN
3.57142857143%	1	28	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SU_PANCREAS
3.57142857143%	1	28	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_APOPTOTIC_EXECUTION_PHASE
3.57142857143%	1	28	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARSON_FOXP3_TARGETS_DN
3.57142857143%	1	28	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_ARGININE_AND_PROLINE_METABOLISM
3.57142857143%	1	28	54	Diabetes_McGill_Cell_cycle_G1	SUNG_METASTASIS_STROMA_DN
3.57142857143%	1	28	54	Diabetes_McGill_Cell_cycle_G1	ROVERSI_GLIOMA_COPY_NUMBER_DN
3.57142857143%	1	28	54	Diabetes_McGill_Cell_cycle_G1	PID_NFAT_3PATHWAY
3.57142857143%	1	28	54	Diabetes_McGill_Cell_cycle_G1	LEE_LIVER_CANCER_MYC_UP
3.57142857143%	1	28	54	Diabetes_McGill_Cell_cycle_G1	KANG_DOXORUBICIN_RESISTANCE_UP
3.57142857143%	1	28	539	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LIAO_METASTASIS
3.57142857143%	1	28	537	Diabetes_McGill_Cell_cycle_G1	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
3.57142857143%	1	28	536	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
3.57142857143%	1	28	532	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
3.57142857143%	1	28	530	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ENK_UV_RESPONSE_KERATINOCYTE_UP
3.57142857143%	1	28	53	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ZHU_CMV_8_HR_DN
3.57142857143%	1	28	53	Diabetes_McGill_Cell_cycle_G1	MENSSEN_MYC_TARGETS
3.57142857143%	1	28	53	Diabetes_McGill_Cell_cycle_G1	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
3.57142857143%	1	28	53	Diabetes_McGill_Cell_cycle_G1	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN
3.57142857143%	1	28	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_CASPASE_PATHWAY
3.57142857143%	1	28	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_STARCH_AND_SUCROSE_METABOLISM
3.57142857143%	1	28	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_MTOR_SIGNALING_PATHWAY
3.57142857143%	1	28	52	Diabetes_McGill_Cell_cycle_G1	WINTER_HYPOXIA_DN
3.57142857143%	1	28	52	Diabetes_McGill_Cell_cycle_G1	RADAEVA_RESPONSE_TO_IFNA1_UP
3.57142857143%	1	28	52	Diabetes_McGill_Cell_cycle_G1	PID_KITPATHWAY
3.57142857143%	1	28	52	Diabetes_McGill_Cell_cycle_G1	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
3.57142857143%	1	28	52	Diabetes_McGill_Cell_cycle_G1	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6
3.57142857143%	1	28	52	Diabetes_McGill_Cell_cycle_G1	CHIBA_RESPONSE_TO_TSA_UP
3.57142857143%	1	28	52	Diabetes_McGill_Cell_cycle_G1	BECKER_TAMOXIFEN_RESISTANCE_DN
3.57142857143%	1	28	518	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
3.57142857143%	1	28	518	Diabetes_McGill_Cell_cycle_G1	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
3.57142857143%	1	28	514	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
3.57142857143%	1	28	514	Diabetes_McGill_Cell_cycle_G1	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
3.57142857143%	1	28	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PRAMOONJAGO_SOX4_TARGETS_DN
3.57142857143%	1	28	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CROMER_TUMORIGENESIS_DN
3.57142857143%	1	28	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
3.57142857143%	1	28	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
3.57142857143%	1	28	51	Diabetes_McGill_Cell_cycle_G1	ZHANG_PROLIFERATING_VS_QUIESCENT
3.57142857143%	1	28	51	Diabetes_McGill_Cell_cycle_G1	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
3.57142857143%	1	28	51	Diabetes_McGill_Cell_cycle_G1	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
3.57142857143%	1	28	51	Diabetes_McGill_Cell_cycle_G1	PRAMOONJAGO_SOX4_TARGETS_DN
3.57142857143%	1	28	51	Diabetes_McGill_Cell_cycle_G1	LUI_THYROID_CANCER_CLUSTER_1
3.57142857143%	1	28	51	Diabetes_McGill_Cell_cycle_G1	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
3.57142857143%	1	28	51	Diabetes_McGill_Cell_cycle_G1	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
3.57142857143%	1	28	51	Diabetes_McGill_Cell_cycle_G1	BYSTROEM_CORRELATED_WITH_IL5_UP
3.57142857143%	1	28	51	Diabetes_McGill_Cell_cycle_G1	BURTON_ADIPOGENESIS_7
3.57142857143%	1	28	51	Diabetes_McGill_Cell_cycle_G1	APPIERTO_RESPONSE_TO_FENRETINIDE_DN
3.57142857143%	1	28	508	Diabetes_McGill_Cell_cycle_G1	ENK_UV_RESPONSE_EPIDERMIS_DN
3.57142857143%	1	28	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	STOSSI_RESPONSE_TO_ESTRADIOL
3.57142857143%	1	28	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
3.57142857143%	1	28	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	NADERI_BREAST_CANCER_PROGNOSIS_UP
3.57142857143%	1	28	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARTINEZ_RESPONSE_TO_TRABECTEDIN
3.57142857143%	1	28	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS
3.57142857143%	1	28	50	Diabetes_McGill_Cell_cycle_G1	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
3.57142857143%	1	28	50	Diabetes_McGill_Cell_cycle_G1	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
3.57142857143%	1	28	50	Diabetes_McGill_Cell_cycle_G1	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
3.57142857143%	1	28	50	Diabetes_McGill_Cell_cycle_G1	PID_ANGIOPOIETINRECEPTOR_PATHWAY
3.57142857143%	1	28	50	Diabetes_McGill_Cell_cycle_G1	PARK_HSC_AND_MULTIPOTENT_PROGENITORS
3.57142857143%	1	28	50	Diabetes_McGill_Cell_cycle_G1	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
3.57142857143%	1	28	50	Diabetes_McGill_Cell_cycle_G1	MARTINEZ_RESPONSE_TO_TRABECTEDIN
3.57142857143%	1	28	50	Diabetes_McGill_Cell_cycle_G1	KENNY_CTNNB1_TARGETS_UP
3.57142857143%	1	28	50	Diabetes_McGill_Cell_cycle_G1	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
3.57142857143%	1	28	50	Diabetes_McGill_Cell_cycle_G1	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
3.57142857143%	1	28	50	Diabetes_McGill_Cell_cycle_G1	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC
3.57142857143%	1	28	50	Diabetes_McGill_Cell_cycle_G1	CHIBA_RESPONSE_TO_TSA
3.57142857143%	1	28	50	Diabetes_McGill_Cell_cycle_G1	BECKER_TAMOXIFEN_RESISTANCE_UP
3.57142857143%	1	28	5	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BRUNEAU_SEPTATION_ATRIAL
3.57142857143%	1	28	5	Diabetes_McGill_Cell_cycle_G1	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_11
3.57142857143%	1	28	5	Diabetes_McGill_Cell_cycle_G1	CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP
3.57142857143%	1	28	493	Diabetes_McGill_Cell_cycle_G1	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
3.57142857143%	1	28	491	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MEISSNER_NPC_HCP_WITH_H3K4ME2
3.57142857143%	1	28	491	Diabetes_McGill_Cell_cycle_G1	MEISSNER_NPC_HCP_WITH_H3K4ME2
3.57142857143%	1	28	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_ARF6_TRAFFICKINGPATHWAY
3.57142857143%	1	28	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_GLYCEROLIPID_METABOLISM
3.57142857143%	1	28	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GERHOLD_ADIPOGENESIS_UP
3.57142857143%	1	28	49	Diabetes_McGill_Cell_cycle_G1	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
3.57142857143%	1	28	49	Diabetes_McGill_Cell_cycle_G1	OLSSON_E2F3_TARGETS_DN
3.57142857143%	1	28	49	Diabetes_McGill_Cell_cycle_G1	FAELT_B_CLL_WITH_VH3_21_DN
3.57142857143%	1	28	49	Diabetes_McGill_Cell_cycle_G1	BROWNE_HCMV_INFECTION_2HR_DN
3.57142857143%	1	28	489	Diabetes_McGill_Cell_cycle_G1	LIM_MAMMARY_STEM_CELL_UP
3.57142857143%	1	28	482	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
3.57142857143%	1	28	482	Diabetes_McGill_Cell_cycle_G1	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
3.57142857143%	1	28	481	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LIU_PROSTATE_CANCER_DN
3.57142857143%	1	28	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ZHAN_MULTIPLE_MYELOMA_LB_UP
3.57142857143%	1	28	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
3.57142857143%	1	28	48	Diabetes_McGill_Cell_cycle_G1	REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6
3.57142857143%	1	28	48	Diabetes_McGill_Cell_cycle_G1	PID_CERAMIDE_PATHWAY
3.57142857143%	1	28	48	Diabetes_McGill_Cell_cycle_G1	PID_AJDISS_2PATHWAY
3.57142857143%	1	28	48	Diabetes_McGill_Cell_cycle_G1	KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
3.57142857143%	1	28	48	Diabetes_McGill_Cell_cycle_G1	DELACROIX_RAR_TARGETS_UP
3.57142857143%	1	28	475	Diabetes_McGill_Cell_cycle_G1	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
3.57142857143%	1	28	473	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GARY_CD5_TARGETS_UP
3.57142857143%	1	28	473	Diabetes_McGill_Cell_cycle_G1	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
3.57142857143%	1	28	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
3.57142857143%	1	28	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_NFAT_TFPATHWAY
3.57142857143%	1	28	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KHETCHOUMIAN_TRIM24_TARGETS_UP
3.57142857143%	1	28	47	Diabetes_McGill_Cell_cycle_G1	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
3.57142857143%	1	28	47	Diabetes_McGill_Cell_cycle_G1	WARTERS_IR_RESPONSE_5GY
3.57142857143%	1	28	47	Diabetes_McGill_Cell_cycle_G1	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN
3.57142857143%	1	28	47	Diabetes_McGill_Cell_cycle_G1	MELLMAN_TUT1_TARGETS_DN
3.57142857143%	1	28	47	Diabetes_McGill_Cell_cycle_G1	LEONARD_HYPOXIA
3.57142857143%	1	28	47	Diabetes_McGill_Cell_cycle_G1	KEGG_NOTCH_SIGNALING_PATHWAY
3.57142857143%	1	28	47	Diabetes_McGill_Cell_cycle_G1	IRITANI_MAD1_TARGETS_DN
3.57142857143%	1	28	47	Diabetes_McGill_Cell_cycle_G1	BROWNE_HCMV_INFECTION_8HR_DN
3.57142857143%	1	28	47	Diabetes_McGill_Cell_cycle_G1	BOYLAN_MULTIPLE_MYELOMA_C_UP
3.57142857143%	1	28	47	Diabetes_McGill_Cell_cycle_G1	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP
3.57142857143%	1	28	469	Diabetes_McGill_Cell_cycle_G1	MCCABE_BOUND_BY_HOXC6
3.57142857143%	1	28	467	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	RATTENBACHER_BOUND_BY_CELF1
3.57142857143%	1	28	464	Diabetes_McGill_Cell_cycle_G1	ONDER_CDH1_TARGETS_2_DN
3.57142857143%	1	28	463	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
3.57142857143%	1	28	463	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
3.57142857143%	1	28	463	Diabetes_McGill_Cell_cycle_G1	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
3.57142857143%	1	28	462	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	DELACROIX_RAR_BOUND_ES
3.57142857143%	1	28	461	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
3.57142857143%	1	28	460	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
3.57142857143%	1	28	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_PS1PATHWAY
3.57142857143%	1	28	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PARENT_MTOR_SIGNALING_DN
3.57142857143%	1	28	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MADAN_DPPA4_TARGETS
3.57142857143%	1	28	46	Diabetes_McGill_Cell_cycle_G1	SIG_BCR_SIGNALING_PATHWAY
3.57142857143%	1	28	46	Diabetes_McGill_Cell_cycle_G1	SESTO_RESPONSE_TO_UV_C5
3.57142857143%	1	28	46	Diabetes_McGill_Cell_cycle_G1	SAGIV_CD24_TARGETS_DN
3.57142857143%	1	28	46	Diabetes_McGill_Cell_cycle_G1	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION
3.57142857143%	1	28	46	Diabetes_McGill_Cell_cycle_G1	PID_SYNDECAN_1_PATHWAY
3.57142857143%	1	28	46	Diabetes_McGill_Cell_cycle_G1	PID_RHOA_REG_PATHWAY
3.57142857143%	1	28	46	Diabetes_McGill_Cell_cycle_G1	PID_PLK1_PATHWAY
3.57142857143%	1	28	46	Diabetes_McGill_Cell_cycle_G1	PARENT_MTOR_SIGNALING_DN
3.57142857143%	1	28	46	Diabetes_McGill_Cell_cycle_G1	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON
3.57142857143%	1	28	46	Diabetes_McGill_Cell_cycle_G1	NAKAMURA_CANCER_MICROENVIRONMENT_DN
3.57142857143%	1	28	46	Diabetes_McGill_Cell_cycle_G1	JIANG_TIP30_TARGETS_UP
3.57142857143%	1	28	46	Diabetes_McGill_Cell_cycle_G1	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN
3.57142857143%	1	28	46	Diabetes_McGill_Cell_cycle_G1	AMIT_EGF_RESPONSE_60_HELA
3.57142857143%	1	28	457	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
3.57142857143%	1	28	457	Diabetes_McGill_Cell_cycle_G1	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
3.57142857143%	1	28	456	Diabetes_McGill_Cell_cycle_G1	ODONNELL_TFRC_TARGETS_UP
3.57142857143%	1	28	450	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
3.57142857143%	1	28	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ZHAN_MULTIPLE_MYELOMA_CD1_UP
3.57142857143%	1	28	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ZHAN_MULTIPLE_MYELOMA_CD1_DN
3.57142857143%	1	28	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	NUTT_GBM_VS_AO_GLIOMA_DN
3.57142857143%	1	28	45	Diabetes_McGill_Cell_cycle_G1	ZHAN_MULTIPLE_MYELOMA_PR_UP
3.57142857143%	1	28	45	Diabetes_McGill_Cell_cycle_G1	VANHARANTA_UTERINE_FIBROID_UP
3.57142857143%	1	28	45	Diabetes_McGill_Cell_cycle_G1	SHIPP_DLBCL_CURED_VS_FATAL_DN
3.57142857143%	1	28	45	Diabetes_McGill_Cell_cycle_G1	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN
3.57142857143%	1	28	45	Diabetes_McGill_Cell_cycle_G1	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
3.57142857143%	1	28	45	Diabetes_McGill_Cell_cycle_G1	PID_RHOA_PATHWAY
3.57142857143%	1	28	45	Diabetes_McGill_Cell_cycle_G1	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN
3.57142857143%	1	28	45	Diabetes_McGill_Cell_cycle_G1	MCDOWELL_ACUTE_LUNG_INJURY_UP
3.57142857143%	1	28	45	Diabetes_McGill_Cell_cycle_G1	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN
3.57142857143%	1	28	448	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
3.57142857143%	1	28	447	Diabetes_McGill_Cell_cycle_G1	MOOTHA_MITOCHONDRIA
3.57142857143%	1	28	445	Diabetes_McGill_Cell_cycle_G1	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
3.57142857143%	1	28	443	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	DELYS_THYROID_CANCER_UP
3.57142857143%	1	28	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_HNF3APATHWAY
3.57142857143%	1	28	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KERLEY_RESPONSE_TO_CISPLATIN_UP
3.57142857143%	1	28	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
3.57142857143%	1	28	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_TYPE_I_DIABETES_MELLITUS
3.57142857143%	1	28	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_LYSINE_DEGRADATION
3.57142857143%	1	28	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM
3.57142857143%	1	28	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_ABC_TRANSPORTERS
3.57142857143%	1	28	44	Diabetes_McGill_Cell_cycle_G1	XU_CREBBP_TARGETS_DN
3.57142857143%	1	28	44	Diabetes_McGill_Cell_cycle_G1	STREICHER_LSM1_TARGETS_UP
3.57142857143%	1	28	44	Diabetes_McGill_Cell_cycle_G1	PID_HNF3APATHWAY
3.57142857143%	1	28	44	Diabetes_McGill_Cell_cycle_G1	MA_MYELOID_DIFFERENTIATION_DN
3.57142857143%	1	28	44	Diabetes_McGill_Cell_cycle_G1	LUI_THYROID_CANCER_PAX8_PPARG_UP
3.57142857143%	1	28	44	Diabetes_McGill_Cell_cycle_G1	KERLEY_RESPONSE_TO_CISPLATIN_UP
3.57142857143%	1	28	439	Diabetes_McGill_Cell_cycle_G1	MITSIADES_RESPONSE_TO_APLIDIN_UP
3.57142857143%	1	28	435	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SWEET_LUNG_CANCER_KRAS_DN
3.57142857143%	1	28	431	Diabetes_McGill_Cell_cycle_G1	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
3.57142857143%	1	28	430	Diabetes_McGill_Cell_cycle_G1	RIGGI_EWING_SARCOMA_PROGENITOR_UP
3.57142857143%	1	28	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	RIZ_ERYTHROID_DIFFERENTIATION_12HR
3.57142857143%	1	28	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LEE_CALORIE_RESTRICTION_MUSCLE_UP
3.57142857143%	1	28	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HUMMEL_BURKITTS_LYMPHOMA_UP
3.57142857143%	1	28	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
3.57142857143%	1	28	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
3.57142857143%	1	28	43	Diabetes_McGill_Cell_cycle_G1	POTTI_5FU_SENSITIVITY
3.57142857143%	1	28	43	Diabetes_McGill_Cell_cycle_G1	PID_TCPTP_PATHWAY
3.57142857143%	1	28	43	Diabetes_McGill_Cell_cycle_G1	LIU_TARGETS_OF_VMYB_VS_CMYB_DN
3.57142857143%	1	28	43	Diabetes_McGill_Cell_cycle_G1	FUJII_YBX1_TARGETS_UP
3.57142857143%	1	28	43	Diabetes_McGill_Cell_cycle_G1	DORN_ADENOVIRUS_INFECTION_24HR_DN
3.57142857143%	1	28	43	Diabetes_McGill_Cell_cycle_G1	BURTON_ADIPOGENESIS_PEAK_AT_24HR
3.57142857143%	1	28	428	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
3.57142857143%	1	28	428	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CUI_TCF21_TARGETS_2_UP
3.57142857143%	1	28	428	Diabetes_McGill_Cell_cycle_G1	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
3.57142857143%	1	28	425	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
3.57142857143%	1	28	425	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BOCHKIS_FOXA2_TARGETS
3.57142857143%	1	28	422	Diabetes_McGill_Cell_cycle_G1	YAGI_AML_WITH_INV_16_TRANSLOCATION
3.57142857143%	1	28	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
3.57142857143%	1	28	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER
3.57142857143%	1	28	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_FATTY_ACID_METABOLISM
3.57142857143%	1	28	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BIOCARTA_CHREBP2_PATHWAY
3.57142857143%	1	28	42	Diabetes_McGill_Cell_cycle_G1	PID_UPA_UPAR_PATHWAY
3.57142857143%	1	28	42	Diabetes_McGill_Cell_cycle_G1	AMIT_EGF_RESPONSE_40_HELA
3.57142857143%	1	28	419	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
3.57142857143%	1	28	418	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PEDRIOLI_MIR31_TARGETS_DN
3.57142857143%	1	28	418	Diabetes_McGill_Cell_cycle_G1	RUTELLA_RESPONSE_TO_HGF_UP
3.57142857143%	1	28	418	Diabetes_McGill_Cell_cycle_G1	MULLIGHAN_MLL_SIGNATURE_2_UP
3.57142857143%	1	28	414	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MOHANKUMAR_TLX1_TARGETS_UP
3.57142857143%	1	28	414	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LU_EZH2_TARGETS_DN
3.57142857143%	1	28	412	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
3.57142857143%	1	28	411	Diabetes_McGill_Cell_cycle_G1	KOYAMA_SEMA3B_TARGETS_DN
3.57142857143%	1	28	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MALONEY_RESPONSE_TO_17AAG_UP
3.57142857143%	1	28	41	Diabetes_McGill_Cell_cycle_G1	RIZ_ERYTHROID_DIFFERENTIATION_HBZ
3.57142857143%	1	28	41	Diabetes_McGill_Cell_cycle_G1	REACTOME_IL_2_SIGNALING
3.57142857143%	1	28	41	Diabetes_McGill_Cell_cycle_G1	ONO_AML1_TARGETS_DN
3.57142857143%	1	28	41	Diabetes_McGill_Cell_cycle_G1	LI_LUNG_CANCER
3.57142857143%	1	28	41	Diabetes_McGill_Cell_cycle_G1	LIN_MELANOMA_COPY_NUMBER_DN
3.57142857143%	1	28	41	Diabetes_McGill_Cell_cycle_G1	KAMMINGA_EZH2_TARGETS
3.57142857143%	1	28	41	Diabetes_McGill_Cell_cycle_G1	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
3.57142857143%	1	28	41	Diabetes_McGill_Cell_cycle_G1	EHLERS_ANEUPLOIDY_UP
3.57142857143%	1	28	41	Diabetes_McGill_Cell_cycle_G1	CHEN_HOXA5_TARGETS_9HR_DN
3.57142857143%	1	28	409	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FOSTER_TOLERANT_MACROPHAGE_DN
3.57142857143%	1	28	409	Diabetes_McGill_Cell_cycle_G1	FOSTER_TOLERANT_MACROPHAGE_DN
3.57142857143%	1	28	408	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
3.57142857143%	1	28	404	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	OSMAN_BLADDER_CANCER_UP
3.57142857143%	1	28	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	VANASSE_BCL2_TARGETS_UP
3.57142857143%	1	28	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ST_JNK_MAPK_PATHWAY
3.57142857143%	1	28	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
3.57142857143%	1	28	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_TRYPTOPHAN_METABOLISM
3.57142857143%	1	28	40	Diabetes_McGill_Cell_cycle_G1	VARELA_ZMPSTE24_TARGETS_UP
3.57142857143%	1	28	40	Diabetes_McGill_Cell_cycle_G1	ST_JNK_MAPK_PATHWAY
3.57142857143%	1	28	40	Diabetes_McGill_Cell_cycle_G1	RIZ_ERYTHROID_DIFFERENTIATION_6HR
3.57142857143%	1	28	40	Diabetes_McGill_Cell_cycle_G1	HEIDENBLAD_AMPLICON_8Q24_UP
3.57142857143%	1	28	40	Diabetes_McGill_Cell_cycle_G1	DORN_ADENOVIRUS_INFECTION_48HR_DN
3.57142857143%	1	28	40	Diabetes_McGill_Cell_cycle_G1	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
3.57142857143%	1	28	40	Diabetes_McGill_Cell_cycle_G1	BENPORATH_ES_2
3.57142857143%	1	28	40	Diabetes_McGill_Cell_cycle_G1	AMUNDSON_GAMMA_RADIATION_RESPONSE
3.57142857143%	1	28	398	Diabetes_McGill_Cell_cycle_G1	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
3.57142857143%	1	28	394	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BERENJENO_TRANSFORMED_BY_RHOA_DN
3.57142857143%	1	28	393	Diabetes_McGill_Cell_cycle_G1	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
3.57142857143%	1	28	391	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
3.57142857143%	1	28	390	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HATADA_METHYLATED_IN_LUNG_CANCER_UP
3.57142857143%	1	28	390	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
3.57142857143%	1	28	390	Diabetes_McGill_Cell_cycle_G1	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
3.57142857143%	1	28	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	POTTI_PACLITAXEL_SENSITIVITY
3.57142857143%	1	28	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GU_PDEF_TARGETS_DN
3.57142857143%	1	28	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BURTON_ADIPOGENESIS_PEAK_AT_8HR
3.57142857143%	1	28	39	Diabetes_McGill_Cell_cycle_G1	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2
3.57142857143%	1	28	39	Diabetes_McGill_Cell_cycle_G1	POTTI_PACLITAXEL_SENSITIVITY
3.57142857143%	1	28	39	Diabetes_McGill_Cell_cycle_G1	PID_ECADHERIN_NASCENTAJ_PATHWAY
3.57142857143%	1	28	39	Diabetes_McGill_Cell_cycle_G1	NEWMAN_ERCC6_TARGETS_DN
3.57142857143%	1	28	39	Diabetes_McGill_Cell_cycle_G1	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
3.57142857143%	1	28	39	Diabetes_McGill_Cell_cycle_G1	HOFMANN_CELL_LYMPHOMA_DN
3.57142857143%	1	28	39	Diabetes_McGill_Cell_cycle_G1	GU_PDEF_TARGETS_DN
3.57142857143%	1	28	39	Diabetes_McGill_Cell_cycle_G1	DORN_ADENOVIRUS_INFECTION_32HR_DN
3.57142857143%	1	28	389	Diabetes_McGill_Cell_cycle_G1	HSIAO_HOUSEKEEPING_GENES
3.57142857143%	1	28	384	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BASAKI_YBX1_TARGETS_DN
3.57142857143%	1	28	384	Diabetes_McGill_Cell_cycle_G1	BASAKI_YBX1_TARGETS_DN
3.57142857143%	1	28	382	Diabetes_McGill_Cell_cycle_G1	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
3.57142857143%	1	28	380	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MULLIGHAN_MLL_SIGNATURE_1_UP
3.57142857143%	1	28	380	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
3.57142857143%	1	28	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	YOKOE_CANCER_TESTIS_ANTIGENS
3.57142857143%	1	28	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KAAB_FAILED_HEART_ATRIUM_UP
3.57142857143%	1	28	38	Diabetes_McGill_Cell_cycle_G1	YOKOE_CANCER_TESTIS_ANTIGENS
3.57142857143%	1	28	38	Diabetes_McGill_Cell_cycle_G1	PID_P38ALPHABETADOWNSTREAMPATHWAY
3.57142857143%	1	28	38	Diabetes_McGill_Cell_cycle_G1	NAKAMURA_ADIPOGENESIS_LATE_DN
3.57142857143%	1	28	38	Diabetes_McGill_Cell_cycle_G1	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
3.57142857143%	1	28	38	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_IL2RB_PATHWAY
3.57142857143%	1	28	378	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
3.57142857143%	1	28	374	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WANG_TUMOR_INVASIVENESS_UP
3.57142857143%	1	28	374	Diabetes_McGill_Cell_cycle_G1	WANG_TUMOR_INVASIVENESS_UP
3.57142857143%	1	28	372	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WANG_LMO4_TARGETS_UP
3.57142857143%	1	28	372	Diabetes_McGill_Cell_cycle_G1	WANG_LMO4_TARGETS_UP
3.57142857143%	1	28	371	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WANG_SMARCE1_TARGETS_DN
3.57142857143%	1	28	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LANDIS_ERBB2_BREAST_TUMORS_65_DN
3.57142857143%	1	28	37	Diabetes_McGill_Cell_cycle_G1	MURAKAMI_UV_RESPONSE_6HR_UP
3.57142857143%	1	28	37	Diabetes_McGill_Cell_cycle_G1	GENTILE_UV_RESPONSE_CLUSTER_D6
3.57142857143%	1	28	37	Diabetes_McGill_Cell_cycle_G1	CUI_TCF21_TARGETS_UP
3.57142857143%	1	28	368	Diabetes_McGill_Cell_cycle_G1	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
3.57142857143%	1	28	367	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	VECCHI_GASTRIC_CANCER_EARLY_DN
3.57142857143%	1	28	366	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	YOSHIMURA_MAPK8_TARGETS_DN
3.57142857143%	1	28	366	Diabetes_McGill_Cell_cycle_G1	YOSHIMURA_MAPK8_TARGETS_DN
3.57142857143%	1	28	364	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	YANG_BCL3_TARGETS_UP
3.57142857143%	1	28	362	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
3.57142857143%	1	28	36	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	YANG_BREAST_CANCER_ESR1_UP
3.57142857143%	1	28	36	Diabetes_McGill_Cell_cycle_G1	SUBTIL_PROGESTIN_TARGETS
3.57142857143%	1	28	36	Diabetes_McGill_Cell_cycle_G1	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
3.57142857143%	1	28	36	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALLING_TO_ERKS
3.57142857143%	1	28	36	Diabetes_McGill_Cell_cycle_G1	REACTOME_FRS2_MEDIATED_CASCADE
3.57142857143%	1	28	36	Diabetes_McGill_Cell_cycle_G1	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
3.57142857143%	1	28	36	Diabetes_McGill_Cell_cycle_G1	HUANG_FOXA2_TARGETS_DN
3.57142857143%	1	28	358	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GRUETZMANN_PANCREATIC_CANCER_UP
3.57142857143%	1	28	358	Diabetes_McGill_Cell_cycle_G1	GRUETZMANN_PANCREATIC_CANCER_UP
3.57142857143%	1	28	357	Diabetes_McGill_Cell_cycle_G1	SHEN_SMARCA2_TARGETS_DN
3.57142857143%	1	28	353	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
3.57142857143%	1	28	352	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WANG_LMO4_TARGETS_DN
3.57142857143%	1	28	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_REGULATION_OF_AUTOPHAGY
3.57142857143%	1	28	35	Diabetes_McGill_Cell_cycle_G1	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15
3.57142857143%	1	28	35	Diabetes_McGill_Cell_cycle_G1	YAGI_AML_RELAPSE_PROGNOSIS
3.57142857143%	1	28	35	Diabetes_McGill_Cell_cycle_G1	WANG_METHYLATED_IN_BREAST_CANCER
3.57142857143%	1	28	35	Diabetes_McGill_Cell_cycle_G1	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
3.57142857143%	1	28	35	Diabetes_McGill_Cell_cycle_G1	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
3.57142857143%	1	28	349	Diabetes_McGill_Cell_cycle_G1	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
3.57142857143%	1	28	346	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GOLDRATH_ANTIGEN_RESPONSE
3.57142857143%	1	28	344	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
3.57142857143%	1	28	342	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BLUM_RESPONSE_TO_SALIRASIB_DN
3.57142857143%	1	28	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT
3.57142857143%	1	28	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_BUTANOATE_METABOLISM
3.57142857143%	1	28	34	Diabetes_McGill_Cell_cycle_G1	ST_WNT_BETA_CATENIN_PATHWAY
3.57142857143%	1	28	34	Diabetes_McGill_Cell_cycle_G1	SCHOEN_NFKB_SIGNALING
3.57142857143%	1	28	34	Diabetes_McGill_Cell_cycle_G1	PID_IL2_PI3KPATHWAY
3.57142857143%	1	28	34	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_MPR_PATHWAY
3.57142857143%	1	28	34	Diabetes_McGill_Cell_cycle_G1	ABE_VEGFA_TARGETS_2HR
3.57142857143%	1	28	335	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WONG_EMBRYONIC_STEM_CELL_CORE
3.57142857143%	1	28	335	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
3.57142857143%	1	28	332	Diabetes_McGill_Cell_cycle_G1	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
3.57142857143%	1	28	330	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
3.57142857143%	1	28	330	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
3.57142857143%	1	28	330	Diabetes_McGill_Cell_cycle_G1	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
3.57142857143%	1	28	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HEIDENBLAD_AMPLICON_12P11_12_UP
3.57142857143%	1	28	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BIOCARTA_DEATH_PATHWAY
3.57142857143%	1	28	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN
3.57142857143%	1	28	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	APPEL_IMATINIB_RESPONSE
3.57142857143%	1	28	33	Diabetes_McGill_Cell_cycle_G1	TANG_SENESCENCE_TP53_TARGETS_UP
3.57142857143%	1	28	33	Diabetes_McGill_Cell_cycle_G1	STAEGE_EWING_FAMILY_TUMOR
3.57142857143%	1	28	33	Diabetes_McGill_Cell_cycle_G1	SCHRAETS_MLL_TARGETS_DN
3.57142857143%	1	28	33	Diabetes_McGill_Cell_cycle_G1	PID_SYNDECAN_2_PATHWAY
3.57142857143%	1	28	33	Diabetes_McGill_Cell_cycle_G1	PID_IL12_STAT4PATHWAY
3.57142857143%	1	28	33	Diabetes_McGill_Cell_cycle_G1	DUTTA_APOPTOSIS_VIA_NFKB
3.57142857143%	1	28	33	Diabetes_McGill_Cell_cycle_G1	DORN_ADENOVIRUS_INFECTION_12HR_DN
3.57142857143%	1	28	33	Diabetes_McGill_Cell_cycle_G1	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN
3.57142857143%	1	28	329	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
3.57142857143%	1	28	329	Diabetes_McGill_Cell_cycle_G1	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
3.57142857143%	1	28	328	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_PATHWAYS_IN_CANCER
3.57142857143%	1	28	326	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
3.57142857143%	1	28	325	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_CELL_CYCLE_MITOTIC
3.57142857143%	1	28	321	Diabetes_McGill_Cell_cycle_G1	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
3.57142857143%	1	28	320	Diabetes_McGill_Cell_cycle_G1	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
3.57142857143%	1	28	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_WNT_NONCANONICAL_PATHWAY
3.57142857143%	1	28	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM
3.57142857143%	1	28	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BAUS_TFF2_TARGETS_UP
3.57142857143%	1	28	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BAE_BRCA1_TARGETS_DN
3.57142857143%	1	28	32	Diabetes_McGill_Cell_cycle_G1	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
3.57142857143%	1	28	32	Diabetes_McGill_Cell_cycle_G1	POS_HISTAMINE_RESPONSE_NETWORK
3.57142857143%	1	28	32	Diabetes_McGill_Cell_cycle_G1	KASLER_HDAC7_TARGETS_2_DN
3.57142857143%	1	28	317	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HELLER_HDAC_TARGETS_UP
3.57142857143%	1	28	317	Diabetes_McGill_Cell_cycle_G1	HELLER_HDAC_TARGETS_UP
3.57142857143%	1	28	316	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
3.57142857143%	1	28	315	Diabetes_McGill_Cell_cycle_G1	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
3.57142857143%	1	28	314	Diabetes_McGill_Cell_cycle_G1	DOUGLAS_BMI1_TARGETS_DN
3.57142857143%	1	28	312	Diabetes_McGill_Cell_cycle_G1	GENTILE_UV_HIGH_DOSE_DN
3.57142857143%	1	28	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
3.57142857143%	1	28	31	Diabetes_McGill_Cell_cycle_G1	SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN
3.57142857143%	1	28	31	Diabetes_McGill_Cell_cycle_G1	RIZ_ERYTHROID_DIFFERENTIATION_HEMGN
3.57142857143%	1	28	31	Diabetes_McGill_Cell_cycle_G1	REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX
3.57142857143%	1	28	309	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
3.57142857143%	1	28	308	Diabetes_McGill_Cell_cycle_G1	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
3.57142857143%	1	28	307	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LI_INDUCED_T_TO_NATURAL_KILLER_UP
3.57142857143%	1	28	306	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HORIUCHI_WTAP_TARGETS_UP
3.57142857143%	1	28	306	Diabetes_McGill_Cell_cycle_G1	CHANDRAN_METASTASIS_DN
3.57142857143%	1	28	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KYNG_NORMAL_AGING_DN
3.57142857143%	1	28	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GUILLAUMOND_KLF10_TARGETS_DN
3.57142857143%	1	28	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BIOCARTA_FAS_PATHWAY
3.57142857143%	1	28	30	Diabetes_McGill_Cell_cycle_G1	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN
3.57142857143%	1	28	30	Diabetes_McGill_Cell_cycle_G1	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
3.57142857143%	1	28	30	Diabetes_McGill_Cell_cycle_G1	YANAGIHARA_ESX1_TARGETS
3.57142857143%	1	28	30	Diabetes_McGill_Cell_cycle_G1	TSENG_ADIPOGENIC_POTENTIAL_UP
3.57142857143%	1	28	30	Diabetes_McGill_Cell_cycle_G1	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN
3.57142857143%	1	28	30	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALING_BY_ROBO_RECEPTOR
3.57142857143%	1	28	30	Diabetes_McGill_Cell_cycle_G1	PID_IL2_STAT5PATHWAY
3.57142857143%	1	28	30	Diabetes_McGill_Cell_cycle_G1	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP
3.57142857143%	1	28	30	Diabetes_McGill_Cell_cycle_G1	LI_PROSTATE_CANCER_EPIGENETIC
3.57142857143%	1	28	30	Diabetes_McGill_Cell_cycle_G1	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
3.57142857143%	1	28	30	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_FAS_PATHWAY
3.57142857143%	1	28	299	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WALLACE_PROSTATE_CANCER_RACE_UP
3.57142857143%	1	28	299	Diabetes_McGill_Cell_cycle_G1	WALLACE_PROSTATE_CANCER_RACE_UP
3.57142857143%	1	28	298	Diabetes_McGill_Cell_cycle_G1	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
3.57142857143%	1	28	296	Diabetes_McGill_Cell_cycle_G1	DURAND_STROMA_MAX_UP
3.57142857143%	1	28	295	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LU_EZH2_TARGETS_UP
3.57142857143%	1	28	295	Diabetes_McGill_Cell_cycle_G1	LU_EZH2_TARGETS_UP
3.57142857143%	1	28	294	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
3.57142857143%	1	28	294	Diabetes_McGill_Cell_cycle_G1	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
3.57142857143%	1	28	293	Diabetes_McGill_Cell_cycle_G1	ZWANG_DOWN_BY_2ND_EGF_PULSE
3.57142857143%	1	28	293	Diabetes_McGill_Cell_cycle_G1	ENK_UV_RESPONSE_EPIDERMIS_UP
3.57142857143%	1	28	292	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KOYAMA_SEMA3B_TARGETS_UP
3.57142857143%	1	28	291	Diabetes_McGill_Cell_cycle_G1	SABATES_COLORECTAL_ADENOMA_DN
3.57142857143%	1	28	290	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BENPORATH_OCT4_TARGETS
3.57142857143%	1	28	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WILENSKY_RESPONSE_TO_DARAPLADIB
3.57142857143%	1	28	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_PERK_REGULATED_GENE_EXPRESSION
3.57142857143%	1	28	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PAL_PRMT5_TARGETS_DN
3.57142857143%	1	28	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	NGUYEN_NOTCH1_TARGETS_UP
3.57142857143%	1	28	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MAYBURD_RESPONSE_TO_L663536_UP
3.57142857143%	1	28	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_THYROID_CANCER
3.57142857143%	1	28	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BIOCARTA_TNFR1_PATHWAY
3.57142857143%	1	28	29	Diabetes_McGill_Cell_cycle_G1	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR
3.57142857143%	1	28	29	Diabetes_McGill_Cell_cycle_G1	PID_REELINPATHWAY
3.57142857143%	1	28	29	Diabetes_McGill_Cell_cycle_G1	NGUYEN_NOTCH1_TARGETS_UP
3.57142857143%	1	28	29	Diabetes_McGill_Cell_cycle_G1	MA_PITUITARY_FETAL_VS_ADULT_UP
3.57142857143%	1	28	29	Diabetes_McGill_Cell_cycle_G1	KRIGE_AMINO_ACID_DEPRIVATION
3.57142857143%	1	28	29	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_TNFR1_PATHWAY
3.57142857143%	1	28	289	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GABRIELY_MIR21_TARGETS
3.57142857143%	1	28	288	Diabetes_McGill_Cell_cycle_G1	POOLA_INVASIVE_BREAST_CANCER_UP
3.57142857143%	1	28	287	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
3.57142857143%	1	28	285	Diabetes_McGill_Cell_cycle_G1	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
3.57142857143%	1	28	283	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
3.57142857143%	1	28	282	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HELLER_SILENCED_BY_METHYLATION_UP
3.57142857143%	1	28	282	Diabetes_McGill_Cell_cycle_G1	HELLER_SILENCED_BY_METHYLATION_UP
3.57142857143%	1	28	281	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BHAT_ESR1_TARGETS_VIA_AKT1_UP
3.57142857143%	1	28	281	Diabetes_McGill_Cell_cycle_G1	BHAT_ESR1_TARGETS_VIA_AKT1_UP
3.57142857143%	1	28	280	Diabetes_McGill_Cell_cycle_G1	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
3.57142857143%	1	28	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER
3.57142857143%	1	28	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
3.57142857143%	1	28	28	Diabetes_McGill_Cell_cycle_G1	WIKMAN_ASBESTOS_LUNG_CANCER_DN
3.57142857143%	1	28	28	Diabetes_McGill_Cell_cycle_G1	REACTOME_MYOGENESIS
3.57142857143%	1	28	28	Diabetes_McGill_Cell_cycle_G1	PID_LIS1PATHWAY
3.57142857143%	1	28	28	Diabetes_McGill_Cell_cycle_G1	PETROVA_PROX1_TARGETS_UP
3.57142857143%	1	28	28	Diabetes_McGill_Cell_cycle_G1	LOPES_METHYLATED_IN_COLON_CANCER_DN
3.57142857143%	1	28	28	Diabetes_McGill_Cell_cycle_G1	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP
3.57142857143%	1	28	28	Diabetes_McGill_Cell_cycle_G1	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP
3.57142857143%	1	28	279	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FORTSCHEGGER_PHF8_TARGETS_UP
3.57142857143%	1	28	279	Diabetes_McGill_Cell_cycle_G1	REACTOME_INNATE_IMMUNE_SYSTEM
3.57142857143%	1	28	279	Diabetes_McGill_Cell_cycle_G1	FORTSCHEGGER_PHF8_TARGETS_UP
3.57142857143%	1	28	276	Diabetes_McGill_Cell_cycle_G1	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
3.57142857143%	1	28	274	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
3.57142857143%	1	28	274	Diabetes_McGill_Cell_cycle_G1	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
3.57142857143%	1	28	271	Diabetes_McGill_Cell_cycle_G1	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
3.57142857143%	1	28	271	Diabetes_McGill_Cell_cycle_G1	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
3.57142857143%	1	28	271	Diabetes_McGill_Cell_cycle_G1	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
3.57142857143%	1	28	270	Diabetes_McGill_Cell_cycle_G1	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
3.57142857143%	1	28	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
3.57142857143%	1	28	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN
3.57142857143%	1	28	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	OHM_METHYLATED_IN_ADULT_CANCERS
3.57142857143%	1	28	27	Diabetes_McGill_Cell_cycle_G1	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
3.57142857143%	1	28	27	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALLING_TO_RAS
3.57142857143%	1	28	27	Diabetes_McGill_Cell_cycle_G1	PID_IL3_PATHWAY
3.57142857143%	1	28	27	Diabetes_McGill_Cell_cycle_G1	LOPES_METHYLATED_IN_COLON_CANCER_UP
3.57142857143%	1	28	27	Diabetes_McGill_Cell_cycle_G1	GROSS_ELK3_TARGETS_UP
3.57142857143%	1	28	27	Diabetes_McGill_Cell_cycle_G1	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP
3.57142857143%	1	28	269	Diabetes_McGill_Cell_cycle_G1	WANG_CLIM2_TARGETS_UP
3.57142857143%	1	28	266	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ROZANOV_MMP14_TARGETS_UP
3.57142857143%	1	28	266	Diabetes_McGill_Cell_cycle_G1	FOSTER_KDM1A_TARGETS_UP
3.57142857143%	1	28	264	Diabetes_McGill_Cell_cycle_G1	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
3.57142857143%	1	28	261	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	RICKMAN_METASTASIS_DN
3.57142857143%	1	28	261	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
3.57142857143%	1	28	261	Diabetes_McGill_Cell_cycle_G1	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
3.57142857143%	1	28	261	Diabetes_McGill_Cell_cycle_G1	RICKMAN_METASTASIS_DN
3.57142857143%	1	28	260	Diabetes_McGill_Cell_cycle_G1	BOQUEST_STEM_CELL_UP
3.57142857143%	1	28	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
3.57142857143%	1	28	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PID_RXR_VDR_PATHWAY
3.57142857143%	1	28	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	NAKAMURA_CANCER_MICROENVIRONMENT_UP
3.57142857143%	1	28	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_GALACTOSE_METABOLISM
3.57142857143%	1	28	26	Diabetes_McGill_Cell_cycle_G1	WALLACE_JAK2_TARGETS_UP
3.57142857143%	1	28	26	Diabetes_McGill_Cell_cycle_G1	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B
3.57142857143%	1	28	26	Diabetes_McGill_Cell_cycle_G1	PID_RXR_VDR_PATHWAY
3.57142857143%	1	28	26	Diabetes_McGill_Cell_cycle_G1	PID_P38_MKK3_6PATHWAY
3.57142857143%	1	28	26	Diabetes_McGill_Cell_cycle_G1	PID_INSULIN_GLUCOSE_PATHWAY
3.57142857143%	1	28	26	Diabetes_McGill_Cell_cycle_G1	PID_IL27PATHWAY
3.57142857143%	1	28	26	Diabetes_McGill_Cell_cycle_G1	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1
3.57142857143%	1	28	26	Diabetes_McGill_Cell_cycle_G1	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
3.57142857143%	1	28	26	Diabetes_McGill_Cell_cycle_G1	GAZIN_EPIGENETIC_SILENCING_BY_KRAS
3.57142857143%	1	28	26	Diabetes_McGill_Cell_cycle_G1	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN
3.57142857143%	1	28	26	Diabetes_McGill_Cell_cycle_G1	BRACHAT_RESPONSE_TO_METHOTREXATE_UP
3.57142857143%	1	28	259	Diabetes_McGill_Cell_cycle_G1	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
3.57142857143%	1	28	258	Diabetes_McGill_Cell_cycle_G1	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
3.57142857143%	1	28	256	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ONDER_CDH1_TARGETS_2_UP
3.57142857143%	1	28	255	Diabetes_McGill_Cell_cycle_G1	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
3.57142857143%	1	28	254	Diabetes_McGill_Cell_cycle_G1	BROWNE_HCMV_INFECTION_4HR_DN
3.57142857143%	1	28	253	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MCLACHLAN_DENTAL_CARIES_UP
3.57142857143%	1	28	251	Diabetes_McGill_Cell_cycle_G1	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
3.57142857143%	1	28	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP
3.57142857143%	1	28	25	Diabetes_McGill_Cell_cycle_G1	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP
3.57142857143%	1	28	25	Diabetes_McGill_Cell_cycle_G1	NOJIMA_SFRP2_TARGETS_DN
3.57142857143%	1	28	25	Diabetes_McGill_Cell_cycle_G1	LU_TUMOR_ANGIOGENESIS_UP
3.57142857143%	1	28	249	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MITSIADES_RESPONSE_TO_APLIDIN_DN
3.57142857143%	1	28	249	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
3.57142857143%	1	28	246	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BILD_E2F3_ONCOGENIC_SIGNATURE
3.57142857143%	1	28	245	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MCLACHLAN_DENTAL_CARIES_DN
3.57142857143%	1	28	245	Diabetes_McGill_Cell_cycle_G1	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
3.57142857143%	1	28	244	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KAYO_AGING_MUSCLE_UP
3.57142857143%	1	28	244	Diabetes_McGill_Cell_cycle_G1	THUM_SYSTOLIC_HEART_FAILURE_DN
3.57142857143%	1	28	243	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHICAS_RB1_TARGETS_GROWING
3.57142857143%	1	28	243	Diabetes_McGill_Cell_cycle_G1	CHICAS_RB1_TARGETS_GROWING
3.57142857143%	1	28	242	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHYLA_CBFA2T3_TARGETS_DN
3.57142857143%	1	28	240	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	UDAYAKUMAR_MED1_TARGETS_DN
3.57142857143%	1	28	240	Diabetes_McGill_Cell_cycle_G1	UDAYAKUMAR_MED1_TARGETS_DN
3.57142857143%	1	28	240	Diabetes_McGill_Cell_cycle_G1	BROWNE_HCMV_INFECTION_20HR_UP
3.57142857143%	1	28	24	Diabetes_McGill_Cell_cycle_G1	WILLERT_WNT_SIGNALING
3.57142857143%	1	28	24	Diabetes_McGill_Cell_cycle_G1	SCHRAMM_INHBA_TARGETS_DN
3.57142857143%	1	28	24	Diabetes_McGill_Cell_cycle_G1	REACTOME_DOUBLE_STRAND_BREAK_REPAIR
3.57142857143%	1	28	24	Diabetes_McGill_Cell_cycle_G1	ONO_AML1_TARGETS_UP
3.57142857143%	1	28	24	Diabetes_McGill_Cell_cycle_G1	MURATA_VIRULENCE_OF_H_PILORI
3.57142857143%	1	28	24	Diabetes_McGill_Cell_cycle_G1	JIANG_TIP30_TARGETS_DN
3.57142857143%	1	28	24	Diabetes_McGill_Cell_cycle_G1	JEON_SMAD6_TARGETS_UP
3.57142857143%	1	28	24	Diabetes_McGill_Cell_cycle_G1	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP
3.57142857143%	1	28	24	Diabetes_McGill_Cell_cycle_G1	HASLINGER_B_CLL_WITH_13Q14_DELETION
3.57142857143%	1	28	24	Diabetes_McGill_Cell_cycle_G1	DELACROIX_RAR_TARGETS_DN
3.57142857143%	1	28	239	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
3.57142857143%	1	28	239	Diabetes_McGill_Cell_cycle_G1	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
3.57142857143%	1	28	238	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
3.57142857143%	1	28	238	Diabetes_McGill_Cell_cycle_G1	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
3.57142857143%	1	28	238	Diabetes_McGill_Cell_cycle_G1	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
3.57142857143%	1	28	234	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
3.57142857143%	1	28	232	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	DELYS_THYROID_CANCER_DN
3.57142857143%	1	28	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION
3.57142857143%	1	28	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_NITROGEN_METABOLISM
3.57142857143%	1	28	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP
3.57142857143%	1	28	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BIOCARTA_CASPASE_PATHWAY
3.57142857143%	1	28	23	Diabetes_McGill_Cell_cycle_G1	ZIRN_TRETINOIN_RESPONSE_WT1_UP
3.57142857143%	1	28	23	Diabetes_McGill_Cell_cycle_G1	WU_HBX_TARGETS_2_UP
3.57142857143%	1	28	23	Diabetes_McGill_Cell_cycle_G1	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A
3.57142857143%	1	28	23	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALING_BY_BMP
3.57142857143%	1	28	23	Diabetes_McGill_Cell_cycle_G1	REACTOME_PHOSPHORYLATION_OF_THE_APC_C
3.57142857143%	1	28	23	Diabetes_McGill_Cell_cycle_G1	PID_NFKAPPABCANONICALPATHWAY
3.57142857143%	1	28	23	Diabetes_McGill_Cell_cycle_G1	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP
3.57142857143%	1	28	23	Diabetes_McGill_Cell_cycle_G1	HASLINGER_B_CLL_WITH_11Q23_DELETION
3.57142857143%	1	28	23	Diabetes_McGill_Cell_cycle_G1	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP
3.57142857143%	1	28	23	Diabetes_McGill_Cell_cycle_G1	CHIBA_RESPONSE_TO_TSA_DN
3.57142857143%	1	28	23	Diabetes_McGill_Cell_cycle_G1	CHEOK_RESPONSE_TO_HD_MTX_UP
3.57142857143%	1	28	23	Diabetes_McGill_Cell_cycle_G1	CHEN_ETV5_TARGETS_TESTIS
3.57142857143%	1	28	23	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_PTDINS_PATHWAY
3.57142857143%	1	28	23	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_MEF2D_PATHWAY
3.57142857143%	1	28	229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
3.57142857143%	1	28	229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
3.57142857143%	1	28	229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
3.57142857143%	1	28	229	Diabetes_McGill_Cell_cycle_G1	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
3.57142857143%	1	28	229	Diabetes_McGill_Cell_cycle_G1	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
3.57142857143%	1	28	228	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
3.57142857143%	1	28	228	Diabetes_McGill_Cell_cycle_G1	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
3.57142857143%	1	28	228	Diabetes_McGill_Cell_cycle_G1	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
3.57142857143%	1	28	227	Diabetes_McGill_Cell_cycle_G1	RAO_BOUND_BY_SALL4
3.57142857143%	1	28	226	Diabetes_McGill_Cell_cycle_G1	KYNG_DNA_DAMAGE_UP
3.57142857143%	1	28	226	Diabetes_McGill_Cell_cycle_G1	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
3.57142857143%	1	28	225	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
3.57142857143%	1	28	222	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BROWNE_HCMV_INFECTION_1HR_DN
3.57142857143%	1	28	221	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PEDRIOLI_MIR31_TARGETS_UP
3.57142857143%	1	28	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SPIRA_SMOKERS_LUNG_CANCER_DN
3.57142857143%	1	28	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
3.57142857143%	1	28	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
3.57142857143%	1	28	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
3.57142857143%	1	28	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MOOTHA_FFA_OXYDATION
3.57142857143%	1	28	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MATZUK_IMPLANTATION_AND_UTERINE
3.57142857143%	1	28	22	Diabetes_McGill_Cell_cycle_G1	ZHAN_MULTIPLE_MYELOMA_SPIKED
3.57142857143%	1	28	22	Diabetes_McGill_Cell_cycle_G1	VERNELL_RETINOBLASTOMA_PATHWAY_DN
3.57142857143%	1	28	22	Diabetes_McGill_Cell_cycle_G1	SUZUKI_RESPONSE_TO_TSA
3.57142857143%	1	28	22	Diabetes_McGill_Cell_cycle_G1	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN
3.57142857143%	1	28	22	Diabetes_McGill_Cell_cycle_G1	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING
3.57142857143%	1	28	22	Diabetes_McGill_Cell_cycle_G1	PID_HEDGEHOG_2PATHWAY
3.57142857143%	1	28	22	Diabetes_McGill_Cell_cycle_G1	NUMATA_CSF3_SIGNALING_VIA_STAT3
3.57142857143%	1	28	22	Diabetes_McGill_Cell_cycle_G1	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
3.57142857143%	1	28	22	Diabetes_McGill_Cell_cycle_G1	KANG_FLUOROURACIL_RESISTANCE_UP
3.57142857143%	1	28	22	Diabetes_McGill_Cell_cycle_G1	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP
3.57142857143%	1	28	22	Diabetes_McGill_Cell_cycle_G1	GAVIN_PDE3B_TARGETS
3.57142857143%	1	28	22	Diabetes_McGill_Cell_cycle_G1	BRACHAT_RESPONSE_TO_CISPLATIN
3.57142857143%	1	28	217	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WONG_MITOCHONDRIA_GENE_MODULE
3.57142857143%	1	28	217	Diabetes_McGill_Cell_cycle_G1	AMUNDSON_RESPONSE_TO_ARSENITE
3.57142857143%	1	28	216	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WHITFIELD_CELL_CYCLE_G2_M
3.57142857143%	1	28	216	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
3.57142857143%	1	28	216	Diabetes_McGill_Cell_cycle_G1	BOQUEST_STEM_CELL_DN
3.57142857143%	1	28	214	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KIM_WT1_TARGETS_UP
3.57142857143%	1	28	214	Diabetes_McGill_Cell_cycle_G1	KIM_WT1_TARGETS_UP
3.57142857143%	1	28	213	Diabetes_McGill_Cell_cycle_G1	WIERENGA_STAT5A_TARGETS_DN
3.57142857143%	1	28	212	Diabetes_McGill_Cell_cycle_G1	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
3.57142857143%	1	28	211	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
3.57142857143%	1	28	211	Diabetes_McGill_Cell_cycle_G1	FOSTER_KDM1A_TARGETS_DN
3.57142857143%	1	28	211	Diabetes_McGill_Cell_cycle_G1	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
3.57142857143%	1	28	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SANSOM_APC_TARGETS_REQUIRE_MYC
3.57142857143%	1	28	210	Diabetes_McGill_Cell_cycle_G1	WANG_TUMOR_INVASIVENESS_DN
3.57142857143%	1	28	210	Diabetes_McGill_Cell_cycle_G1	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
3.57142857143%	1	28	210	Diabetes_McGill_Cell_cycle_G1	RIZKI_TUMOR_INVASIVENESS_3D_UP
3.57142857143%	1	28	210	Diabetes_McGill_Cell_cycle_G1	CAIRO_HEPATOBLASTOMA_CLASSES_DN
3.57142857143%	1	28	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	STEGER_ADIPOGENESIS_UP
3.57142857143%	1	28	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING
3.57142857143%	1	28	21	Diabetes_McGill_Cell_cycle_G1	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP
3.57142857143%	1	28	21	Diabetes_McGill_Cell_cycle_G1	MOOTHA_GLYCOGEN_METABOLISM
3.57142857143%	1	28	21	Diabetes_McGill_Cell_cycle_G1	LEE_INTRATHYMIC_T_PROGENITOR
3.57142857143%	1	28	21	Diabetes_McGill_Cell_cycle_G1	KANNAN_TP53_TARGETS_DN
3.57142857143%	1	28	21	Diabetes_McGill_Cell_cycle_G1	HASLINGER_B_CLL_WITH_17P13_DELETION
3.57142857143%	1	28	21	Diabetes_McGill_Cell_cycle_G1	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE
3.57142857143%	1	28	21	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_CALCINEURIN_PATHWAY
3.57142857143%	1	28	209	Diabetes_McGill_Cell_cycle_G1	KIM_WT1_TARGETS_12HR_DN
3.57142857143%	1	28	209	Diabetes_McGill_Cell_cycle_G1	CHANG_CORE_SERUM_RESPONSE_DN
3.57142857143%	1	28	208	Diabetes_McGill_Cell_cycle_G1	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
3.57142857143%	1	28	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	VERHAAK_GLIOBLASTOMA_CLASSICAL
3.57142857143%	1	28	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KARLSSON_TGFB1_TARGETS_DN
3.57142857143%	1	28	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CAIRO_HEPATOBLASTOMA_UP
3.57142857143%	1	28	207	Diabetes_McGill_Cell_cycle_G1	VERHAAK_GLIOBLASTOMA_CLASSICAL
3.57142857143%	1	28	205	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PEREZ_TP53_AND_TP63_TARGETS
3.57142857143%	1	28	205	Diabetes_McGill_Cell_cycle_G1	SHEPARD_BMYB_MORPHOLINO_UP
3.57142857143%	1	28	205	Diabetes_McGill_Cell_cycle_G1	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
3.57142857143%	1	28	204	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
3.57142857143%	1	28	204	Diabetes_McGill_Cell_cycle_G1	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
3.57142857143%	1	28	203	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PENG_RAPAMYCIN_RESPONSE_UP
3.57142857143%	1	28	203	Diabetes_McGill_Cell_cycle_G1	PENG_RAPAMYCIN_RESPONSE_UP
3.57142857143%	1	28	203	Diabetes_McGill_Cell_cycle_G1	PAL_PRMT5_TARGETS_UP
3.57142857143%	1	28	203	Diabetes_McGill_Cell_cycle_G1	GRUETZMANN_PANCREATIC_CANCER_DN
3.57142857143%	1	28	202	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FUJII_YBX1_TARGETS_DN
3.57142857143%	1	28	202	Diabetes_McGill_Cell_cycle_G1	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
3.57142857143%	1	28	200	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SHEPARD_BMYB_MORPHOLINO_DN
3.57142857143%	1	28	200	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
3.57142857143%	1	28	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WENG_POR_TARGETS_GLOBAL_UP
3.57142857143%	1	28	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WANG_THOC1_TARGETS_DN
3.57142857143%	1	28	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN
3.57142857143%	1	28	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	NIELSEN_SYNOVIAL_SARCOMA_DN
3.57142857143%	1	28	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KYNG_WERNER_SYNDROM_UP
3.57142857143%	1	28	20	Diabetes_McGill_Cell_cycle_G1	ZHU_SKIL_TARGETS_UP
3.57142857143%	1	28	20	Diabetes_McGill_Cell_cycle_G1	REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING
3.57142857143%	1	28	20	Diabetes_McGill_Cell_cycle_G1	REACTOME_ENOS_ACTIVATION_AND_REGULATION
3.57142857143%	1	28	20	Diabetes_McGill_Cell_cycle_G1	PID_WNT_CANONICAL_PATHWAY
3.57142857143%	1	28	20	Diabetes_McGill_Cell_cycle_G1	MURAKAMI_UV_RESPONSE_24HR
3.57142857143%	1	28	20	Diabetes_McGill_Cell_cycle_G1	MANN_RESPONSE_TO_AMIFOSTINE_UP
3.57142857143%	1	28	20	Diabetes_McGill_Cell_cycle_G1	DING_LUNG_CANCER_BY_MUTATION_RATE
3.57142857143%	1	28	20	Diabetes_McGill_Cell_cycle_G1	COLLIS_PRKDC_SUBSTRATES
3.57142857143%	1	28	20	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_IGF1MTOR_PATHWAY
3.57142857143%	1	28	199	Diabetes_McGill_Cell_cycle_G1	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
3.57142857143%	1	28	199	Diabetes_McGill_Cell_cycle_G1	PLASARI_TGFB1_TARGETS_10HR_UP
3.57142857143%	1	28	198	Diabetes_McGill_Cell_cycle_G1	ALONSO_METASTASIS_UP
3.57142857143%	1	28	197	Diabetes_McGill_Cell_cycle_G1	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
3.57142857143%	1	28	196	Diabetes_McGill_Cell_cycle_G1	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
3.57142857143%	1	28	195	Diabetes_McGill_Cell_cycle_G1	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
3.57142857143%	1	28	191	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	RIGGI_EWING_SARCOMA_PROGENITOR_DN
3.57142857143%	1	28	191	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
3.57142857143%	1	28	191	Diabetes_McGill_Cell_cycle_G1	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
3.57142857143%	1	28	190	Diabetes_McGill_Cell_cycle_G1	KEGG_CHEMOKINE_SIGNALING_PATHWAY
3.57142857143%	1	28	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE
3.57142857143%	1	28	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	VERNOCHET_ADIPOGENESIS
3.57142857143%	1	28	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SYED_ESTRADIOL_RESPONSE
3.57142857143%	1	28	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	RUAN_RESPONSE_TO_TROGLITAZONE_DN
3.57142857143%	1	28	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	OUYANG_PROSTATE_CANCER_MARKERS
3.57142857143%	1	28	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARSON_FOXP3_CORE_DIRECT_TARGETS
3.57142857143%	1	28	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN
3.57142857143%	1	28	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BIOCARTA_MAL_PATHWAY
3.57142857143%	1	28	19	Diabetes_McGill_Cell_cycle_G1	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN
3.57142857143%	1	28	19	Diabetes_McGill_Cell_cycle_G1	STREICHER_LSM1_TARGETS_DN
3.57142857143%	1	28	19	Diabetes_McGill_Cell_cycle_G1	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS
3.57142857143%	1	28	19	Diabetes_McGill_Cell_cycle_G1	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP
3.57142857143%	1	28	19	Diabetes_McGill_Cell_cycle_G1	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7
3.57142857143%	1	28	19	Diabetes_McGill_Cell_cycle_G1	LE_NEURONAL_DIFFERENTIATION_DN
3.57142857143%	1	28	19	Diabetes_McGill_Cell_cycle_G1	KANG_CISPLATIN_RESISTANCE_UP
3.57142857143%	1	28	19	Diabetes_McGill_Cell_cycle_G1	KANG_AR_TARGETS_DN
3.57142857143%	1	28	19	Diabetes_McGill_Cell_cycle_G1	JEON_SMAD6_TARGETS_DN
3.57142857143%	1	28	19	Diabetes_McGill_Cell_cycle_G1	GENTLES_LEUKEMIC_STEM_CELL_DN
3.57142857143%	1	28	19	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_STATHMIN_PATHWAY
3.57142857143%	1	28	19	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_MTA3_PATHWAY
3.57142857143%	1	28	189	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BURTON_ADIPOGENESIS_6
3.57142857143%	1	28	187	Diabetes_McGill_Cell_cycle_G1	PENG_LEUCINE_DEPRIVATION_DN
3.57142857143%	1	28	187	Diabetes_McGill_Cell_cycle_G1	BAKKER_FOXO3_TARGETS_DN
3.57142857143%	1	28	185	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
3.57142857143%	1	28	185	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_HUNTINGTONS_DISEASE
3.57142857143%	1	28	185	Diabetes_McGill_Cell_cycle_G1	ZHANG_TLX_TARGETS_36HR_DN
3.57142857143%	1	28	185	Diabetes_McGill_Cell_cycle_G1	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
3.57142857143%	1	28	185	Diabetes_McGill_Cell_cycle_G1	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
3.57142857143%	1	28	184	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
3.57142857143%	1	28	1839	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
3.57142857143%	1	28	183	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	VERHAAK_AML_WITH_NPM1_MUTATED_UP
3.57142857143%	1	28	183	Diabetes_McGill_Cell_cycle_G1	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
3.57142857143%	1	28	183	Diabetes_McGill_Cell_cycle_G1	OKUMURA_INFLAMMATORY_RESPONSE_LPS
3.57142857143%	1	28	1821	Diabetes_McGill_Cell_cycle_G1	DODD_NASOPHARYNGEAL_CARCINOMA_UP
3.57142857143%	1	28	182	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	RAO_BOUND_BY_SALL4_ISOFORM_A
3.57142857143%	1	28	182	Diabetes_McGill_Cell_cycle_G1	RAO_BOUND_BY_SALL4_ISOFORM_A
3.57142857143%	1	28	182	Diabetes_McGill_Cell_cycle_G1	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
3.57142857143%	1	28	181	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
3.57142857143%	1	28	181	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
3.57142857143%	1	28	181	Diabetes_McGill_Cell_cycle_G1	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
3.57142857143%	1	28	181	Diabetes_McGill_Cell_cycle_G1	JISON_SICKLE_CELL_DISEASE_UP
3.57142857143%	1	28	180	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BROWNE_HCMV_INFECTION_48HR_UP
3.57142857143%	1	28	180	Diabetes_McGill_Cell_cycle_G1	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
3.57142857143%	1	28	180	Diabetes_McGill_Cell_cycle_G1	BROWNE_HCMV_INFECTION_48HR_UP
3.57142857143%	1	28	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE
3.57142857143%	1	28	18	Diabetes_McGill_Cell_cycle_G1	WU_HBX_TARGETS_3_UP
3.57142857143%	1	28	18	Diabetes_McGill_Cell_cycle_G1	WEBER_METHYLATED_IN_COLON_CANCER
3.57142857143%	1	28	18	Diabetes_McGill_Cell_cycle_G1	STAMBOLSKY_BOUND_BY_MUTATED_TP53
3.57142857143%	1	28	18	Diabetes_McGill_Cell_cycle_G1	SMID_BREAST_CANCER_LUMINAL_A_DN
3.57142857143%	1	28	18	Diabetes_McGill_Cell_cycle_G1	SHIN_B_CELL_LYMPHOMA_CLUSTER_5
3.57142857143%	1	28	18	Diabetes_McGill_Cell_cycle_G1	SCHEIDEREIT_IKK_TARGETS
3.57142857143%	1	28	18	Diabetes_McGill_Cell_cycle_G1	PODAR_RESPONSE_TO_ADAPHOSTIN_DN
3.57142857143%	1	28	18	Diabetes_McGill_Cell_cycle_G1	PID_BETACATENIN_DEG_PATHWAY
3.57142857143%	1	28	18	Diabetes_McGill_Cell_cycle_G1	NIELSEN_SYNOVIAL_SARCOMA_UP
3.57142857143%	1	28	18	Diabetes_McGill_Cell_cycle_G1	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN
3.57142857143%	1	28	18	Diabetes_McGill_Cell_cycle_G1	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8
3.57142857143%	1	28	18	Diabetes_McGill_Cell_cycle_G1	MAINA_VHL_TARGETS_DN
3.57142857143%	1	28	18	Diabetes_McGill_Cell_cycle_G1	KOBAYASHI_EGFR_SIGNALING_6HR_DN
3.57142857143%	1	28	18	Diabetes_McGill_Cell_cycle_G1	KIM_PTEN_TARGETS_UP
3.57142857143%	1	28	18	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_PTEN_PATHWAY
3.57142857143%	1	28	18	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_ETS_PATHWAY
3.57142857143%	1	28	178	Diabetes_McGill_Cell_cycle_G1	BROWNE_HCMV_INFECTION_18HR_UP
3.57142857143%	1	28	178	Diabetes_McGill_Cell_cycle_G1	BROWNE_HCMV_INFECTION_18HR_DN
3.57142857143%	1	28	177	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
3.57142857143%	1	28	177	Diabetes_McGill_Cell_cycle_G1	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
3.57142857143%	1	28	176	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	NAGASHIMA_NRG1_SIGNALING_UP
3.57142857143%	1	28	176	Diabetes_McGill_Cell_cycle_G1	NAGASHIMA_NRG1_SIGNALING_UP
3.57142857143%	1	28	176	Diabetes_McGill_Cell_cycle_G1	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
3.57142857143%	1	28	175	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	YAMAZAKI_TCEB3_TARGETS_UP
3.57142857143%	1	28	175	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FIRESTEIN_PROLIFERATION
3.57142857143%	1	28	175	Diabetes_McGill_Cell_cycle_G1	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
3.57142857143%	1	28	175	Diabetes_McGill_Cell_cycle_G1	LEE_LIVER_CANCER_SURVIVAL_DN
3.57142857143%	1	28	174	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
3.57142857143%	1	28	1725	Diabetes_McGill_Cell_cycle_G1	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
3.57142857143%	1	28	172	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SMID_BREAST_CANCER_LUMINAL_B_UP
3.57142857143%	1	28	172	Diabetes_McGill_Cell_cycle_G1	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
3.57142857143%	1	28	172	Diabetes_McGill_Cell_cycle_G1	SMID_BREAST_CANCER_LUMINAL_B_UP
3.57142857143%	1	28	172	Diabetes_McGill_Cell_cycle_G1	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
3.57142857143%	1	28	171	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
3.57142857143%	1	28	171	Diabetes_McGill_Cell_cycle_G1	GOLDRATH_HOMEOSTATIC_PROLIFERATION
3.57142857143%	1	28	171	Diabetes_McGill_Cell_cycle_G1	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
3.57142857143%	1	28	170	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
3.57142857143%	1	28	170	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
3.57142857143%	1	28	170	Diabetes_McGill_Cell_cycle_G1	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
3.57142857143%	1	28	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION
3.57142857143%	1	28	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
3.57142857143%	1	28	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_STEROID_BIOSYNTHESIS
3.57142857143%	1	28	17	Diabetes_McGill_Cell_cycle_G1	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
3.57142857143%	1	28	17	Diabetes_McGill_Cell_cycle_G1	THUM_MIR21_TARGETS_HEART_DISEASE_UP
3.57142857143%	1	28	17	Diabetes_McGill_Cell_cycle_G1	SA_TRKA_RECEPTOR
3.57142857143%	1	28	17	Diabetes_McGill_Cell_cycle_G1	REACTOME_SHC_RELATED_EVENTS
3.57142857143%	1	28	17	Diabetes_McGill_Cell_cycle_G1	REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS
3.57142857143%	1	28	17	Diabetes_McGill_Cell_cycle_G1	REACTOME_ARMS_MEDIATED_ACTIVATION
3.57142857143%	1	28	17	Diabetes_McGill_Cell_cycle_G1	KEGG_ONE_CARBON_POOL_BY_FOLATE
3.57142857143%	1	28	17	Diabetes_McGill_Cell_cycle_G1	INGA_TP53_TARGETS
3.57142857143%	1	28	17	Diabetes_McGill_Cell_cycle_G1	DORMOY_ELAVL1_TARGETS
3.57142857143%	1	28	17	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_HCMV_PATHWAY
3.57142857143%	1	28	169	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	UEDA_PERIFERAL_CLOCK
3.57142857143%	1	28	169	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_ALZHEIMERS_DISEASE
3.57142857143%	1	28	169	Diabetes_McGill_Cell_cycle_G1	ONDER_CDH1_TARGETS_1_DN
3.57142857143%	1	28	169	Diabetes_McGill_Cell_cycle_G1	KEGG_ALZHEIMERS_DISEASE
3.57142857143%	1	28	167	Diabetes_McGill_Cell_cycle_G1	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
3.57142857143%	1	28	166	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SMIRNOV_RESPONSE_TO_IR_6HR_UP
3.57142857143%	1	28	166	Diabetes_McGill_Cell_cycle_G1	SMIRNOV_RESPONSE_TO_IR_6HR_UP
3.57142857143%	1	28	166	Diabetes_McGill_Cell_cycle_G1	CAIRO_LIVER_DEVELOPMENT_UP
3.57142857143%	1	28	165	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
3.57142857143%	1	28	165	Diabetes_McGill_Cell_cycle_G1	DARWICHE_PAPILLOMA_RISK_LOW_DN
3.57142857143%	1	28	165	Diabetes_McGill_Cell_cycle_G1	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
3.57142857143%	1	28	164	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
3.57142857143%	1	28	164	Diabetes_McGill_Cell_cycle_G1	AMIT_EGF_RESPONSE_480_HELA
3.57142857143%	1	28	163	Diabetes_McGill_Cell_cycle_G1	LIN_NPAS4_TARGETS_UP
3.57142857143%	1	28	162	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MULLIGHAN_NPM1_SIGNATURE_3_DN
3.57142857143%	1	28	162	Diabetes_McGill_Cell_cycle_G1	WHITFIELD_CELL_CYCLE_S
3.57142857143%	1	28	162	Diabetes_McGill_Cell_cycle_G1	KIM_WT1_TARGETS_12HR_UP
3.57142857143%	1	28	160	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BROWNE_HCMV_INFECTION_6HR_DN
3.57142857143%	1	28	160	Diabetes_McGill_Cell_cycle_G1	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
3.57142857143%	1	28	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN
3.57142857143%	1	28	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
3.57142857143%	1	28	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	IGLESIAS_E2F_TARGETS_DN
3.57142857143%	1	28	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHIN_BREAST_CANCER_COPY_NUMBER_DN
3.57142857143%	1	28	16	Diabetes_McGill_Cell_cycle_G1	WU_HBX_TARGETS_2_DN
3.57142857143%	1	28	16	Diabetes_McGill_Cell_cycle_G1	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP
3.57142857143%	1	28	16	Diabetes_McGill_Cell_cycle_G1	SUZUKI_AMPLIFIED_IN_ORAL_CANCER
3.57142857143%	1	28	16	Diabetes_McGill_Cell_cycle_G1	SCHAVOLT_TARGETS_OF_TP53_AND_TP63
3.57142857143%	1	28	16	Diabetes_McGill_Cell_cycle_G1	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION
3.57142857143%	1	28	16	Diabetes_McGill_Cell_cycle_G1	PID_CIRCADIANPATHWAY
3.57142857143%	1	28	16	Diabetes_McGill_Cell_cycle_G1	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN
3.57142857143%	1	28	16	Diabetes_McGill_Cell_cycle_G1	HUMMERICH_MALIGNANT_SKIN_TUMOR_UP
3.57142857143%	1	28	16	Diabetes_McGill_Cell_cycle_G1	GEISS_RESPONSE_TO_DSRNA_DN
3.57142857143%	1	28	16	Diabetes_McGill_Cell_cycle_G1	FINETTI_BREAST_CANCER_KINOME_RED
3.57142857143%	1	28	16	Diabetes_McGill_Cell_cycle_G1	CAFFAREL_RESPONSE_TO_THC_8HR_5_UP
3.57142857143%	1	28	16	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_SHH_PATHWAY
3.57142857143%	1	28	16	Diabetes_McGill_Cell_cycle_G1	BAKER_HEMATOPOIESIS_STAT3_TARGETS
3.57142857143%	1	28	16	Diabetes_McGill_Cell_cycle_G1	AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
3.57142857143%	1	28	158	Diabetes_McGill_Cell_cycle_G1	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON
3.57142857143%	1	28	157	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
3.57142857143%	1	28	155	Diabetes_McGill_Cell_cycle_G1	KEGG_JAK_STAT_SIGNALING_PATHWAY
3.57142857143%	1	28	154	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
3.57142857143%	1	28	153	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
3.57142857143%	1	28	153	Diabetes_McGill_Cell_cycle_G1	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
3.57142857143%	1	28	152	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
3.57142857143%	1	28	152	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
3.57142857143%	1	28	152	Diabetes_McGill_Cell_cycle_G1	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
3.57142857143%	1	28	151	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	IGLESIAS_E2F_TARGETS_UP
3.57142857143%	1	28	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SU_KIDNEY
3.57142857143%	1	28	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP
3.57142857143%	1	28	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BIOCARTA_NUCLEARRS_PATHWAY
3.57142857143%	1	28	15	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN
3.57142857143%	1	28	15	Diabetes_McGill_Cell_cycle_G1	REACTOME_SHC_MEDIATED_SIGNALLING
3.57142857143%	1	28	15	Diabetes_McGill_Cell_cycle_G1	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING
3.57142857143%	1	28	15	Diabetes_McGill_Cell_cycle_G1	MARKS_HDAC_TARGETS_DN
3.57142857143%	1	28	15	Diabetes_McGill_Cell_cycle_G1	DAZARD_UV_RESPONSE_CLUSTER_G3
3.57142857143%	1	28	15	Diabetes_McGill_Cell_cycle_G1	COLLIS_PRKDC_REGULATORS
3.57142857143%	1	28	15	Diabetes_McGill_Cell_cycle_G1	CHANG_POU5F1_TARGETS_UP
3.57142857143%	1	28	15	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_AKAPCENTROSOME_PATHWAY
3.57142857143%	1	28	149	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LANDIS_ERBB2_BREAST_TUMORS_324_DN
3.57142857143%	1	28	149	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GOZGIT_ESR1_TARGETS_UP
3.57142857143%	1	28	149	Diabetes_McGill_Cell_cycle_G1	GOZGIT_ESR1_TARGETS_UP
3.57142857143%	1	28	148	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_APOPTOSIS
3.57142857143%	1	28	148	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BROWNE_HCMV_INFECTION_24HR_UP
3.57142857143%	1	28	148	Diabetes_McGill_Cell_cycle_G1	KATSANOU_ELAVL1_TARGETS_DN
3.57142857143%	1	28	148	Diabetes_McGill_Cell_cycle_G1	BROWNE_HCMV_INFECTION_24HR_UP
3.57142857143%	1	28	148	Diabetes_McGill_Cell_cycle_G1	BROWNE_HCMV_INFECTION_24HR_DN
3.57142857143%	1	28	147	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SMID_BREAST_CANCER_ERBB2_UP
3.57142857143%	1	28	147	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
3.57142857143%	1	28	147	Diabetes_McGill_Cell_cycle_G1	KAUFFMANN_DNA_REPLICATION_GENES
3.57142857143%	1	28	147	Diabetes_McGill_Cell_cycle_G1	DARWICHE_PAPILLOMA_RISK_HIGH_UP
3.57142857143%	1	28	147	Diabetes_McGill_Cell_cycle_G1	BENPORATH_PROLIFERATION
3.57142857143%	1	28	146	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PECE_MAMMARY_STEM_CELL_UP
3.57142857143%	1	28	146	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PECE_MAMMARY_STEM_CELL_DN
3.57142857143%	1	28	146	Diabetes_McGill_Cell_cycle_G1	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
3.57142857143%	1	28	145	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SMITH_TERT_TARGETS_UP
3.57142857143%	1	28	145	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
3.57142857143%	1	28	145	Diabetes_McGill_Cell_cycle_G1	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
3.57142857143%	1	28	144	Diabetes_McGill_Cell_cycle_G1	BROCKE_APOPTOSIS_REVERSED_BY_IL6
3.57142857143%	1	28	143	Diabetes_McGill_Cell_cycle_G1	BASSO_B_LYMPHOCYTE_NETWORK
3.57142857143%	1	28	142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PENG_LEUCINE_DEPRIVATION_UP
3.57142857143%	1	28	142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
3.57142857143%	1	28	142	Diabetes_McGill_Cell_cycle_G1	PENG_LEUCINE_DEPRIVATION_UP
3.57142857143%	1	28	142	Diabetes_McGill_Cell_cycle_G1	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
3.57142857143%	1	28	142	Diabetes_McGill_Cell_cycle_G1	DARWICHE_SKIN_TUMOR_PROMOTER_UP
3.57142857143%	1	28	141	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
3.57142857143%	1	28	141	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KAAB_FAILED_HEART_ATRIUM_DN
3.57142857143%	1	28	141	Diabetes_McGill_Cell_cycle_G1	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
3.57142857143%	1	28	140	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	JOHNSTONE_PARVB_TARGETS_2_UP
3.57142857143%	1	28	140	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
3.57142857143%	1	28	140	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
3.57142857143%	1	28	140	Diabetes_McGill_Cell_cycle_G1	QI_HYPOXIA
3.57142857143%	1	28	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP
3.57142857143%	1	28	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION
3.57142857143%	1	28	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BIOCARTA_PS1_PATHWAY
3.57142857143%	1	28	14	Diabetes_McGill_Cell_cycle_G1	REACTOME_SOS_MEDIATED_SIGNALLING
3.57142857143%	1	28	14	Diabetes_McGill_Cell_cycle_G1	REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX
3.57142857143%	1	28	14	Diabetes_McGill_Cell_cycle_G1	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP
3.57142857143%	1	28	14	Diabetes_McGill_Cell_cycle_G1	INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP
3.57142857143%	1	28	14	Diabetes_McGill_Cell_cycle_G1	CASTELLANO_NRAS_TARGETS_DN
3.57142857143%	1	28	14	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_PS1_PATHWAY
3.57142857143%	1	28	139	Diabetes_McGill_Cell_cycle_G1	ODONNELL_TFRC_TARGETS_DN
3.57142857143%	1	28	139	Diabetes_McGill_Cell_cycle_G1	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
3.57142857143%	1	28	139	Diabetes_McGill_Cell_cycle_G1	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
3.57142857143%	1	28	138	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
3.57142857143%	1	28	138	Diabetes_McGill_Cell_cycle_G1	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
3.57142857143%	1	28	138	Diabetes_McGill_Cell_cycle_G1	JIANG_VHL_TARGETS
3.57142857143%	1	28	137	Diabetes_McGill_Cell_cycle_G1	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
3.57142857143%	1	28	137	Diabetes_McGill_Cell_cycle_G1	LIU_SOX4_TARGETS_UP
3.57142857143%	1	28	137	Diabetes_McGill_Cell_cycle_G1	KEGG_INSULIN_SIGNALING_PATHWAY
3.57142857143%	1	28	136	Diabetes_McGill_Cell_cycle_G1	PROVENZANI_METASTASIS_DN
3.57142857143%	1	28	135	Diabetes_McGill_Cell_cycle_G1	UDAYAKUMAR_MED1_TARGETS_UP
3.57142857143%	1	28	134	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHUNG_BLISTER_CYTOTOXICITY_UP
3.57142857143%	1	28	134	Diabetes_McGill_Cell_cycle_G1	KEGG_TIGHT_JUNCTION
3.57142857143%	1	28	134	Diabetes_McGill_Cell_cycle_G1	CHUNG_BLISTER_CYTOTOXICITY_UP
3.57142857143%	1	28	133	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON
3.57142857143%	1	28	133	Diabetes_McGill_Cell_cycle_G1	GAL_LEUKEMIC_STEM_CELL_UP
3.57142857143%	1	28	132	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
3.57142857143%	1	28	131	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
3.57142857143%	1	28	131	Diabetes_McGill_Cell_cycle_G1	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
3.57142857143%	1	28	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	SHIN_B_CELL_LYMPHOMA_CLUSTER_1
3.57142857143%	1	28	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GERHOLD_RESPONSE_TO_TZD_DN
3.57142857143%	1	28	13	Diabetes_McGill_Cell_cycle_G1	WAGSCHAL_EHMT2_TARGETS_UP
3.57142857143%	1	28	13	Diabetes_McGill_Cell_cycle_G1	WACKER_HYPOXIA_TARGETS_OF_VHL
3.57142857143%	1	28	13	Diabetes_McGill_Cell_cycle_G1	TSAI_DNAJB4_TARGETS_UP
3.57142857143%	1	28	13	Diabetes_McGill_Cell_cycle_G1	REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION
3.57142857143%	1	28	13	Diabetes_McGill_Cell_cycle_G1	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
3.57142857143%	1	28	13	Diabetes_McGill_Cell_cycle_G1	HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER
3.57142857143%	1	28	13	Diabetes_McGill_Cell_cycle_G1	CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP
3.57142857143%	1	28	129	Diabetes_McGill_Cell_cycle_G1	YAGI_AML_SURVIVAL
3.57142857143%	1	28	129	Diabetes_McGill_Cell_cycle_G1	PID_PDGFRBPATHWAY
3.57142857143%	1	28	129	Diabetes_McGill_Cell_cycle_G1	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP
3.57142857143%	1	28	129	Diabetes_McGill_Cell_cycle_G1	BROWN_MYELOID_CELL_DEVELOPMENT_DN
3.57142857143%	1	28	128	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	ZHU_CMV_ALL_DN
3.57142857143%	1	28	128	Diabetes_McGill_Cell_cycle_G1	YEGNASUBRAMANIAN_PROSTATE_CANCER
3.57142857143%	1	28	1278	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
3.57142857143%	1	28	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
3.57142857143%	1	28	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
3.57142857143%	1	28	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	GERY_CEBP_TARGETS
3.57142857143%	1	28	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BURTON_ADIPOGENESIS_5
3.57142857143%	1	28	126	Diabetes_McGill_Cell_cycle_G1	SANSOM_APC_TARGETS_UP
3.57142857143%	1	28	126	Diabetes_McGill_Cell_cycle_G1	MISSIAGLIA_REGULATED_BY_METHYLATION_UP
3.57142857143%	1	28	126	Diabetes_McGill_Cell_cycle_G1	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
3.57142857143%	1	28	125	Diabetes_McGill_Cell_cycle_G1	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
3.57142857143%	1	28	123	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KAYO_AGING_MUSCLE_DN
3.57142857143%	1	28	123	Diabetes_McGill_Cell_cycle_G1	DAZARD_RESPONSE_TO_UV_SCC_UP
3.57142857143%	1	28	1229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
3.57142857143%	1	28	122	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_CHROMOSOME_MAINTENANCE
3.57142857143%	1	28	122	Diabetes_McGill_Cell_cycle_G1	REACTOME_CHROMOSOME_MAINTENANCE
3.57142857143%	1	28	121	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
3.57142857143%	1	28	121	Diabetes_McGill_Cell_cycle_G1	RODRIGUES_DCC_TARGETS_DN
3.57142857143%	1	28	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHEBOTAEV_GR_TARGETS_DN
3.57142857143%	1	28	120	Diabetes_McGill_Cell_cycle_G1	ZHU_CMV_ALL_UP
3.57142857143%	1	28	120	Diabetes_McGill_Cell_cycle_G1	CHEBOTAEV_GR_TARGETS_DN
3.57142857143%	1	28	12	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS
3.57142857143%	1	28	12	Diabetes_McGill_Cell_cycle_G1	MIZUKAMI_HYPOXIA_UP
3.57142857143%	1	28	12	Diabetes_McGill_Cell_cycle_G1	MCBRYAN_TERMINAL_END_BUD_UP
3.57142857143%	1	28	12	Diabetes_McGill_Cell_cycle_G1	LOPEZ_MESOTHELIOMA_SURVIVAL_DN
3.57142857143%	1	28	12	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_VDR_PATHWAY
3.57142857143%	1	28	12	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_AKAP95_PATHWAY
3.57142857143%	1	28	118	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
3.57142857143%	1	28	118	Diabetes_McGill_Cell_cycle_G1	REACTOME_TOLL_RECEPTOR_CASCADES
3.57142857143%	1	28	118	Diabetes_McGill_Cell_cycle_G1	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
3.57142857143%	1	28	117	Diabetes_McGill_Cell_cycle_G1	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
3.57142857143%	1	28	116	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_MEIOSIS
3.57142857143%	1	28	116	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LIM_MAMMARY_LUMINAL_MATURE_UP
3.57142857143%	1	28	116	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
3.57142857143%	1	28	116	Diabetes_McGill_Cell_cycle_G1	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
3.57142857143%	1	28	115	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
3.57142857143%	1	28	114	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LENAOUR_DENDRITIC_CELL_MATURATION_UP
3.57142857143%	1	28	114	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KEGG_OOCYTE_MEIOSIS
3.57142857143%	1	28	114	Diabetes_McGill_Cell_cycle_G1	MATZUK_SPERMATOZOA
3.57142857143%	1	28	114	Diabetes_McGill_Cell_cycle_G1	LENAOUR_DENDRITIC_CELL_MATURATION_UP
3.57142857143%	1	28	114	Diabetes_McGill_Cell_cycle_G1	CERVERA_SDHB_TARGETS_2
3.57142857143%	1	28	114	Diabetes_McGill_Cell_cycle_G1	BOSCO_TH1_CYTOTOXIC_MODULE
3.57142857143%	1	28	113	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
3.57142857143%	1	28	113	Diabetes_McGill_Cell_cycle_G1	TSENG_IRS1_TARGETS_UP
3.57142857143%	1	28	113	Diabetes_McGill_Cell_cycle_G1	RICKMAN_HEAD_AND_NECK_CANCER_C
3.57142857143%	1	28	112	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
3.57142857143%	1	28	112	Diabetes_McGill_Cell_cycle_G1	DITTMER_PTHLH_TARGETS_UP
3.57142857143%	1	28	1118	Diabetes_McGill_Cell_cycle_G1	BENPORATH_ES_WITH_H3K27ME3
3.57142857143%	1	28	111	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
3.57142857143%	1	28	111	Diabetes_McGill_Cell_cycle_G1	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
3.57142857143%	1	28	111	Diabetes_McGill_Cell_cycle_G1	BOUDOUKHA_BOUND_BY_IGF2BP2
3.57142857143%	1	28	110	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
3.57142857143%	1	28	110	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
3.57142857143%	1	28	110	Diabetes_McGill_Cell_cycle_G1	WOOD_EBV_EBNA1_TARGETS_UP
3.57142857143%	1	28	110	Diabetes_McGill_Cell_cycle_G1	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
3.57142857143%	1	28	110	Diabetes_McGill_Cell_cycle_G1	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
3.57142857143%	1	28	110	Diabetes_McGill_Cell_cycle_G1	GHANDHI_DIRECT_IRRADIATION_UP
3.57142857143%	1	28	110	Diabetes_McGill_Cell_cycle_G1	CHENG_IMPRINTED_BY_ESTRADIOL
3.57142857143%	1	28	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BIOCARTA_EIF2_PATHWAY
3.57142857143%	1	28	11	Diabetes_McGill_Cell_cycle_G1	WHITESIDE_CISPLATIN_RESISTANCE_UP
3.57142857143%	1	28	11	Diabetes_McGill_Cell_cycle_G1	STEGMEIER_PRE-MITOTIC_CELL_CYCLE_REGULATORS
3.57142857143%	1	28	11	Diabetes_McGill_Cell_cycle_G1	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP
3.57142857143%	1	28	11	Diabetes_McGill_Cell_cycle_G1	REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX
3.57142857143%	1	28	11	Diabetes_McGill_Cell_cycle_G1	PID_RANBP2PATHWAY
3.57142857143%	1	28	11	Diabetes_McGill_Cell_cycle_G1	PID_P38GAMMADELTAPATHWAY
3.57142857143%	1	28	11	Diabetes_McGill_Cell_cycle_G1	PID_ALK2PATHWAY
3.57142857143%	1	28	11	Diabetes_McGill_Cell_cycle_G1	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
3.57142857143%	1	28	11	Diabetes_McGill_Cell_cycle_G1	KEGG_FOLATE_BIOSYNTHESIS
3.57142857143%	1	28	11	Diabetes_McGill_Cell_cycle_G1	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN
3.57142857143%	1	28	11	Diabetes_McGill_Cell_cycle_G1	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN
3.57142857143%	1	28	11	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_P35ALZHEIMERS_PATHWAY
3.57142857143%	1	28	11	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_EPONFKB_PATHWAY
3.57142857143%	1	28	11	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_EIF2_PATHWAY
3.57142857143%	1	28	109	Diabetes_McGill_Cell_cycle_G1	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
3.57142857143%	1	28	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
3.57142857143%	1	28	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	LABBE_TGFB1_TARGETS_DN
3.57142857143%	1	28	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
3.57142857143%	1	28	108	Diabetes_McGill_Cell_cycle_G1	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
3.57142857143%	1	28	108	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
3.57142857143%	1	28	108	Diabetes_McGill_Cell_cycle_G1	LE_EGR2_TARGETS_DN
3.57142857143%	1	28	108	Diabetes_McGill_Cell_cycle_G1	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
3.57142857143%	1	28	108	Diabetes_McGill_Cell_cycle_G1	JAZAG_TGFB1_SIGNALING_UP
3.57142857143%	1	28	107	Diabetes_McGill_Cell_cycle_G1	REACTOME_SIGNALING_BY_ILS
3.57142857143%	1	28	1062	Diabetes_McGill_Cell_cycle_G1	BENPORATH_EED_TARGETS
3.57142857143%	1	28	104	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
3.57142857143%	1	28	104	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	NAKAMURA_ADIPOGENESIS_LATE_UP
3.57142857143%	1	28	104	Diabetes_McGill_Cell_cycle_G1	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
3.57142857143%	1	28	1038	Diabetes_McGill_Cell_cycle_G1	BENPORATH_SUZ12_TARGETS
3.57142857143%	1	28	103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
3.57142857143%	1	28	103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KIM_MYCN_AMPLIFICATION_TARGETS_DN
3.57142857143%	1	28	103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
3.57142857143%	1	28	103	Diabetes_McGill_Cell_cycle_G1	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
3.57142857143%	1	28	103	Diabetes_McGill_Cell_cycle_G1	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
3.57142857143%	1	28	103	Diabetes_McGill_Cell_cycle_G1	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
3.57142857143%	1	28	102	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	DER_IFN_BETA_RESPONSE_UP
3.57142857143%	1	28	102	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
3.57142857143%	1	28	102	Diabetes_McGill_Cell_cycle_G1	KEGG_MELANOGENESIS
3.57142857143%	1	28	102	Diabetes_McGill_Cell_cycle_G1	KANG_IMMORTALIZED_BY_TERT_DN
3.57142857143%	1	28	102	Diabetes_McGill_Cell_cycle_G1	DER_IFN_BETA_RESPONSE_UP
3.57142857143%	1	28	1011	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
3.57142857143%	1	28	101	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	WIELAND_UP_BY_HBV_INFECTION
3.57142857143%	1	28	101	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BROWNE_HCMV_INFECTION_10HR_UP
3.57142857143%	1	28	100	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	MCCLUNG_CREB1_TARGETS_UP
3.57142857143%	1	28	100	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BENPORATH_ES_CORE_NINE_CORRELATED
3.57142857143%	1	28	100	Diabetes_McGill_Cell_cycle_G1	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
3.57142857143%	1	28	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	YEMELYANOV_GR_TARGETS_DN
3.57142857143%	1	28	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_STRICT	BRUNEAU_SEPTATION_VENTRICULAR
3.57142857143%	1	28	10	Diabetes_McGill_Cell_cycle_G1	YEMELYANOV_GR_TARGETS_DN
3.57142857143%	1	28	10	Diabetes_McGill_Cell_cycle_G1	TURJANSKI_MAPK14_TARGETS
3.57142857143%	1	28	10	Diabetes_McGill_Cell_cycle_G1	REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES
3.57142857143%	1	28	10	Diabetes_McGill_Cell_cycle_G1	REACTOME_RAF_MAP_KINASE_CASCADE
3.57142857143%	1	28	10	Diabetes_McGill_Cell_cycle_G1	PYEON_HPV_POSITIVE_TUMORS_DN
3.57142857143%	1	28	10	Diabetes_McGill_Cell_cycle_G1	KONG_E2F1_TARGETS
3.57142857143%	1	28	10	Diabetes_McGill_Cell_cycle_G1	BIOCARTA_RNA_PATHWAY
3.55731225296%	9	253	97	Diabetes_McGill_CREBBP_coTF	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
3.55731225296%	9	253	90	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_ERBB4
3.55731225296%	9	253	88	Diabetes_McGill_CREBBP_coTF	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
3.55731225296%	9	253	86	Diabetes_McGill_CREBBP_coTF	KEGG_TGF_BETA_SIGNALING_PATHWAY
3.55731225296%	9	253	77	Diabetes_McGill_CREBBP_coTF	CARD_MIR302A_TARGETS
3.55731225296%	9	253	76	Diabetes_McGill_CREBBP_coTF	PEART_HDAC_PROLIFERATION_CLUSTER_DN
3.55731225296%	9	253	74	Diabetes_McGill_CREBBP_coTF	DER_IFN_ALPHA_RESPONSE_UP
3.55731225296%	9	253	681	Diabetes_McGill_CREBBP_coTF	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
3.55731225296%	9	253	67	Diabetes_McGill_CREBBP_coTF	VANHARANTA_UTERINE_FIBROID_DN
3.55731225296%	9	253	67	Diabetes_McGill_CREBBP_coTF	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
3.55731225296%	9	253	65	Diabetes_McGill_CREBBP_coTF	PID_IL4_2PATHWAY
3.55731225296%	9	253	65	Diabetes_McGill_CREBBP_coTF	PID_BCR_5PATHWAY
3.55731225296%	9	253	633	Diabetes_McGill_CREBBP_coTF	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
3.55731225296%	9	253	59	Diabetes_McGill_CREBBP_coTF	PID_P53REGULATIONPATHWAY
3.55731225296%	9	253	58	Diabetes_McGill_CREBBP_coTF	SCHEIDEREIT_IKK_INTERACTING_PROTEINS
3.55731225296%	9	253	567	Diabetes_McGill_CREBBP_coTF	CHICAS_RB1_TARGETS_CONFLUENT
3.55731225296%	9	253	535	Diabetes_McGill_CREBBP_coTF	STEIN_ESRRA_TARGETS
3.55731225296%	9	253	532	Diabetes_McGill_CREBBP_coTF	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
3.55731225296%	9	253	517	Diabetes_McGill_CREBBP_coTF	RAO_BOUND_BY_SALL4_ISOFORM_B
3.55731225296%	9	253	49	Diabetes_McGill_CREBBP_coTF	PID_FOXOPATHWAY
3.55731225296%	9	253	487	Diabetes_McGill_CREBBP_coTF	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
3.55731225296%	9	253	46	Diabetes_McGill_CREBBP_coTF	BIOCARTA_KERATINOCYTE_PATHWAY
3.55731225296%	9	253	457	Diabetes_McGill_CREBBP_coTF	SENESE_HDAC1_TARGETS_UP
3.55731225296%	9	253	456	Diabetes_McGill_CREBBP_coTF	ODONNELL_TFRC_TARGETS_UP
3.55731225296%	9	253	428	Diabetes_McGill_CREBBP_coTF	CUI_TCF21_TARGETS_2_UP
3.55731225296%	9	253	422	Diabetes_McGill_CREBBP_coTF	YAGI_AML_WITH_INV_16_TRANSLOCATION
3.55731225296%	9	253	418	Diabetes_McGill_CREBBP_coTF	PEDRIOLI_MIR31_TARGETS_DN
3.55731225296%	9	253	418	Diabetes_McGill_CREBBP_coTF	MULLIGHAN_MLL_SIGNATURE_2_UP
3.55731225296%	9	253	414	Diabetes_McGill_CREBBP_coTF	LU_EZH2_TARGETS_DN
3.55731225296%	9	253	404	Diabetes_McGill_CREBBP_coTF	OSMAN_BLADDER_CANCER_UP
3.55731225296%	9	253	403	Diabetes_McGill_CREBBP_coTF	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
3.55731225296%	9	253	392	Diabetes_McGill_CREBBP_coTF	LINDGREN_BLADDER_CANCER_CLUSTER_2B
3.55731225296%	9	253	389	Diabetes_McGill_CREBBP_coTF	HSIAO_HOUSEKEEPING_GENES
3.55731225296%	9	253	380	Diabetes_McGill_CREBBP_coTF	MULLIGHAN_MLL_SIGNATURE_1_UP
3.55731225296%	9	253	368	Diabetes_McGill_CREBBP_coTF	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
3.55731225296%	9	253	344	Diabetes_McGill_CREBBP_coTF	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
3.55731225296%	9	253	317	Diabetes_McGill_CREBBP_coTF	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
3.55731225296%	9	253	311	Diabetes_McGill_CREBBP_coTF	JIANG_HYPOXIA_NORMAL
3.55731225296%	9	253	309	Diabetes_McGill_CREBBP_coTF	LIU_SOX4_TARGETS_DN
3.55731225296%	9	253	299	Diabetes_McGill_CREBBP_coTF	WALLACE_PROSTATE_CANCER_RACE_UP
3.55731225296%	9	253	298	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_14HR_DN
3.55731225296%	9	253	285	Diabetes_McGill_CREBBP_coTF	GRADE_COLON_AND_RECTAL_CANCER_UP
3.55731225296%	9	253	281	Diabetes_McGill_CREBBP_coTF	BHAT_ESR1_TARGETS_VIA_AKT1_UP
3.55731225296%	9	253	271	Diabetes_McGill_CREBBP_coTF	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
3.55731225296%	9	253	260	Diabetes_McGill_CREBBP_coTF	SENESE_HDAC1_TARGETS_DN
3.55731225296%	9	253	251	Diabetes_McGill_CREBBP_coTF	KOBAYASHI_EGFR_SIGNALING_24HR_DN
3.55731225296%	9	253	249	Diabetes_McGill_CREBBP_coTF	MITSIADES_RESPONSE_TO_APLIDIN_DN
3.55731225296%	9	253	246	Diabetes_McGill_CREBBP_coTF	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
3.55731225296%	9	253	242	Diabetes_McGill_CREBBP_coTF	MULLIGHAN_MLL_SIGNATURE_1_DN
3.55731225296%	9	253	240	Diabetes_McGill_CREBBP_coTF	UDAYAKUMAR_MED1_TARGETS_DN
3.55731225296%	9	253	239	Diabetes_McGill_CREBBP_coTF	ALFANO_MYC_TARGETS
3.55731225296%	9	253	228	Diabetes_McGill_CREBBP_coTF	MARKEY_RB1_ACUTE_LOF_DN
3.55731225296%	9	253	222	Diabetes_McGill_CREBBP_coTF	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
3.55731225296%	9	253	220	Diabetes_McGill_CREBBP_coTF	RIGGINS_TAMOXIFEN_RESISTANCE_DN
3.55731225296%	9	253	216	Diabetes_McGill_CREBBP_coTF	WHITFIELD_CELL_CYCLE_G2_M
3.55731225296%	9	253	203	Diabetes_McGill_CREBBP_coTF	GRUETZMANN_PANCREATIC_CANCER_DN
3.55731225296%	9	253	201	Diabetes_McGill_CREBBP_coTF	HOLLMANN_APOPTOSIS_VIA_CD40_UP
3.55731225296%	9	253	199	Diabetes_McGill_CREBBP_coTF	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
3.55731225296%	9	253	196	Diabetes_McGill_CREBBP_coTF	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
3.55731225296%	9	253	187	Diabetes_McGill_CREBBP_coTF	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
3.55731225296%	9	253	185	Diabetes_McGill_CREBBP_coTF	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
3.55731225296%	9	253	182	Diabetes_McGill_CREBBP_coTF	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
3.55731225296%	9	253	175	Diabetes_McGill_CREBBP_coTF	FIRESTEIN_PROLIFERATION
3.55731225296%	9	253	164	Diabetes_McGill_CREBBP_coTF	KIM_WT1_TARGETS_8HR_UP
3.55731225296%	9	253	162	Diabetes_McGill_CREBBP_coTF	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
3.55731225296%	9	253	160	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_6HR_DN
3.55731225296%	9	253	15	Diabetes_McGill_CREBBP_coTF	BIOCARTA_RARRXR_PATHWAY
3.55731225296%	9	253	148	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_24HR_UP
3.55731225296%	9	253	142	Diabetes_McGill_CREBBP_coTF	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
3.55731225296%	9	253	126	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
3.55731225296%	9	253	125	Diabetes_McGill_CREBBP_coTF	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
3.55731225296%	9	253	12	Diabetes_McGill_CREBBP_coTF	TURJANSKI_MAPK1_AND_MAPK2_TARGETS
3.55731225296%	9	253	112	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_FGFR
3.55731225296%	9	253	100	Diabetes_McGill_CREBBP_coTF	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
3.54609929078%	70	1974	648	Mendelian_Nancy_Cox	BENPORATH_CYCLING_GENES
3.54609929078%	70	1974	351	Mendelian_Nancy_Cox	YAGI_AML_WITH_11Q23_REARRANGED
3.54609929078%	70	1974	261	Mendelian_Nancy_Cox	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
3.54185832567%	77	2174	882	T2D_GENES_TANYA_LIPIDS	LEE_BMP2_TARGETS_DN
3.52752538749%	66	1871	546	T2D_GENES_TANYA_HEIGHT	WEST_ADRENOCORTICAL_TUMOR_DN
3.51648351648%	16	455	783	T2D_GENES_TANYA_BLOODPRESSURE	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
3.51648351648%	16	455	779	T2D_GENES_TANYA_BLOODPRESSURE	PUJANA_CHEK2_PCC_NETWORK
3.51648351648%	16	455	770	T2D_GENES_TANYA_BLOODPRESSURE	KRIEG_HYPOXIA_NOT_VIA_KDM3A
3.51648351648%	16	455	734	T2D_GENES_TANYA_BLOODPRESSURE	BENPORATH_SOX2_TARGETS
3.51648351648%	16	455	668	T2D_GENES_TANYA_BLOODPRESSURE	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
3.51648351648%	16	455	633	T2D_GENES_TANYA_BLOODPRESSURE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
3.51648351648%	16	455	570	T2D_GENES_TANYA_BLOODPRESSURE	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
3.51648351648%	16	455	564	T2D_GENES_TANYA_BLOODPRESSURE	SMID_BREAST_CANCER_LUMINAL_B_DN
3.51648351648%	16	455	536	T2D_GENES_TANYA_BLOODPRESSURE	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
3.51648351648%	16	455	526	T2D_GENES_TANYA_BLOODPRESSURE	ONKEN_UVEAL_MELANOMA_DN
3.51648351648%	16	455	435	T2D_GENES_TANYA_BLOODPRESSURE	SWEET_LUNG_CANCER_KRAS_DN
3.51648351648%	16	455	368	T2D_GENES_TANYA_BLOODPRESSURE	YAGI_AML_WITH_T_8_21_TRANSLOCATION
3.51648351648%	16	455	368	T2D_GENES_TANYA_BLOODPRESSURE	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
3.50727117194%	41	1169	988	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BENPORATH_NANOG_TARGETS
3.50727117194%	41	1169	882	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
3.50727117194%	41	1169	882	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
3.50727117194%	41	1169	811	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
3.50727117194%	41	1169	1080	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
3.50553505535%	19	542	830	T2D_GENES_TANYA_ANTHROPOMETRIC	CUI_TCF21_TARGETS_2_DN
3.50553505535%	19	542	783	T2D_GENES_TANYA_ANTHROPOMETRIC	ONKEN_UVEAL_MELANOMA_UP
3.50553505535%	19	542	668	T2D_GENES_TANYA_ANTHROPOMETRIC	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
3.50553505535%	19	542	637	T2D_GENES_TANYA_ANTHROPOMETRIC	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
3.50553505535%	19	542	567	T2D_GENES_TANYA_ANTHROPOMETRIC	PARENT_MTOR_SIGNALING_UP
3.50553505535%	19	542	390	T2D_GENES_TANYA_ANTHROPOMETRIC	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
3.50553505535%	19	542	367	T2D_GENES_TANYA_ANTHROPOMETRIC	DELACROIX_RARG_BOUND_MEF
3.50553505535%	19	542	341	T2D_GENES_TANYA_ANTHROPOMETRIC	MULLIGHAN_NPM1_SIGNATURE_3_UP
3.50553505535%	19	542	335	T2D_GENES_TANYA_ANTHROPOMETRIC	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
3.50553505535%	19	542	335	T2D_GENES_TANYA_ANTHROPOMETRIC	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
3.49586016559%	76	2174	663	T2D_GENES_TANYA_LIPIDS	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
3.49586016559%	76	2174	605	T2D_GENES_TANYA_LIPIDS	CAIRO_HEPATOBLASTOMA_CLASSES_UP
3.49544072948%	69	1974	579	Mendelian_Nancy_Cox	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
3.49544072948%	69	1974	536	Mendelian_Nancy_Cox	BERENJENO_TRANSFORMED_BY_RHOA_UP
3.49544072948%	69	1974	473	Mendelian_Nancy_Cox	GARY_CD5_TARGETS_UP
3.47957639939%	23	661	882	T2D_GENES_TANYA_GLYCEMIC	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
3.47957639939%	23	661	848	T2D_GENES_TANYA_GLYCEMIC	NUYTTEN_NIPP1_TARGETS_DN
3.47957639939%	23	661	637	T2D_GENES_TANYA_GLYCEMIC	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
3.47957639939%	23	661	602	T2D_GENES_TANYA_GLYCEMIC	MARTINEZ_TP53_TARGETS_UP
3.47957639939%	23	661	601	T2D_GENES_TANYA_GLYCEMIC	MARTINEZ_RB1_AND_TP53_TARGETS_UP
3.47957639939%	23	661	557	T2D_GENES_TANYA_GLYCEMIC	TIEN_INTESTINE_PROBIOTICS_24HR_UP
3.47957639939%	23	661	546	T2D_GENES_TANYA_GLYCEMIC	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
3.47957639939%	23	661	504	T2D_GENES_TANYA_GLYCEMIC	PILON_KLF1_TARGETS_UP
3.47957639939%	23	661	504	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_48HR_DN
3.47957639939%	23	661	461	T2D_GENES_TANYA_GLYCEMIC	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
3.47407803314%	65	1871	940	T2D_GENES_TANYA_HEIGHT	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
3.47407803314%	65	1871	783	T2D_GENES_TANYA_HEIGHT	ONKEN_UVEAL_MELANOMA_UP
3.47407803314%	65	1871	564	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_LUMINAL_B_DN
3.46729708432%	44	1269	1103	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DANG_BOUND_BY_MYC
3.46729708432%	44	1269	1062	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BENPORATH_EED_TARGETS
3.44986200552%	75	2174	648	T2D_GENES_TANYA_LIPIDS	BENPORATH_CYCLING_GENES
3.44986200552%	75	2174	493	T2D_GENES_TANYA_LIPIDS	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
3.44986200552%	75	2174	473	T2D_GENES_TANYA_LIPIDS	GARY_CD5_TARGETS_UP
3.44478216819%	68	1974	805	Mendelian_Nancy_Cox	REACTOME_GPCR_DOWNSTREAM_SIGNALING
3.44478216819%	68	1974	605	Mendelian_Nancy_Cox	CAIRO_HEPATOBLASTOMA_CLASSES_UP
3.44478216819%	68	1974	528	Mendelian_Nancy_Cox	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
3.44478216819%	68	1974	462	Mendelian_Nancy_Cox	DELACROIX_RAR_BOUND_ES
3.44478216819%	68	1974	418	Mendelian_Nancy_Cox	RUTELLA_RESPONSE_TO_HGF_UP
3.44478216819%	68	1974	405	Mendelian_Nancy_Cox	KUMAR_TARGETS_OF_MLL_AF9_FUSION
3.44478216819%	68	1974	287	Mendelian_Nancy_Cox	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
3.42577487765%	21	613	784	T2D_GENES_TANYA_BIOMARKER	FORTSCHEGGER_PHF8_TARGETS_DN
3.42577487765%	21	613	701	T2D_GENES_TANYA_BIOMARKER	SMID_BREAST_CANCER_BASAL_DN
3.42577487765%	21	613	681	T2D_GENES_TANYA_BIOMARKER	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
3.42577487765%	21	613	633	T2D_GENES_TANYA_BIOMARKER	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
3.42577487765%	21	613	425	T2D_GENES_TANYA_BIOMARKER	BOCHKIS_FOXA2_TARGETS
3.42172797263%	40	1169	863	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
3.42172797263%	40	1169	1237	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BLALOCK_ALZHEIMERS_DISEASE_DN
3.42063067878%	64	1871	722	T2D_GENES_TANYA_HEIGHT	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
3.42063067878%	64	1871	720	T2D_GENES_TANYA_HEIGHT	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
3.40909090909%	120	3520	1237	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BLALOCK_ALZHEIMERS_DISEASE_DN
3.40386384545%	74	2174	830	T2D_GENES_TANYA_LIPIDS	CUI_TCF21_TARGETS_2_DN
3.39412360689%	67	1974	572	Mendelian_Nancy_Cox	CHICAS_RB1_TARGETS_SENESCENT
3.39412360689%	67	1974	518	Mendelian_Nancy_Cox	REACTOME_METABOLISM_OF_PROTEINS
3.39412360689%	67	1974	487	Mendelian_Nancy_Cox	RODWELL_AGING_KIDNEY_UP
3.39412360689%	67	1974	395	Mendelian_Nancy_Cox	HAN_SATB1_TARGETS_UP
3.39412360689%	67	1974	358	Mendelian_Nancy_Cox	GRUETZMANN_PANCREATIC_CANCER_UP
3.37682271681%	44	1303	1237	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BLALOCK_ALZHEIMERS_DISEASE_DN
3.36718332443%	63	1871	335	T2D_GENES_TANYA_HEIGHT	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
3.36322869955%	15	446	973	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ACEVEDO_LIVER_CANCER_UP
3.36322869955%	15	446	811	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
3.36322869955%	15	446	728	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARSON_BOUND_BY_E2F4_UNSTIMULATED
3.36322869955%	15	446	718	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_ES_ICP_WITH_H3K4ME3
3.36322869955%	15	446	681	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
3.36322869955%	15	446	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TRANSCRIPTION
3.36322869955%	15	446	1174	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PEREZ_TP53_TARGETS
3.36322869955%	15	446	1062	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BENPORATH_EED_TARGETS
3.35227272727%	118	3520	1210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEN_METABOLIC_SYNDROM_NETWORK
3.35227272727%	118	3520	1137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_LATE
3.34346504559%	66	1974	539	Mendelian_Nancy_Cox	LIAO_METASTASIS
3.34346504559%	66	1974	501	Mendelian_Nancy_Cox	SENESE_HDAC3_TARGETS_UP
3.34346504559%	66	1974	435	Mendelian_Nancy_Cox	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
3.34346504559%	66	1974	434	Mendelian_Nancy_Cox	BAELDE_DIABETIC_NEPHROPATHY_DN
3.34346504559%	66	1974	419	Mendelian_Nancy_Cox	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
3.34346504559%	66	1974	251	Mendelian_Nancy_Cox	REACTOME_AXON_GUIDANCE
3.33618477331%	39	1169	612	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
3.33333333333%	1	30	98	Mendelian_Hereditary_Sensory_Neuropathy	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
3.33333333333%	1	30	98	Mendelian_Hereditary_Sensory_Neuropathy	MENSE_HYPOXIA_UP
3.33333333333%	1	30	98	Mendelian_Hereditary_Sensory_Neuropathy	GAVIN_FOXP3_TARGETS_CLUSTER_T7
3.33333333333%	1	30	98	Mendelian_Hereditary_Sensory_Neuropathy	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
3.33333333333%	1	30	973	Mendelian_Hereditary_Sensory_Neuropathy	ACEVEDO_LIVER_CANCER_UP
3.33333333333%	1	30	97	Mendelian_Hereditary_Sensory_Neuropathy	LABBE_WNT3A_TARGETS_DN
3.33333333333%	1	30	97	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
3.33333333333%	1	30	96	Mendelian_Hereditary_Sensory_Neuropathy	LIU_PROSTATE_CANCER_UP
3.33333333333%	1	30	95	Mendelian_Hereditary_Sensory_Neuropathy	KAYO_CALORIE_RESTRICTION_MUSCLE_UP
3.33333333333%	1	30	95	Mendelian_Hereditary_Sensory_Neuropathy	HECKER_IFNB1_TARGETS
3.33333333333%	1	30	95	Mendelian_Hereditary_Sensory_Neuropathy	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
3.33333333333%	1	30	940	Mendelian_Hereditary_Sensory_Neuropathy	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
3.33333333333%	1	30	94	Mendelian_Hereditary_Sensory_Neuropathy	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5
3.33333333333%	1	30	94	Mendelian_Hereditary_Sensory_Neuropathy	GAVIN_FOXP3_TARGETS_CLUSTER_T4
3.33333333333%	1	30	920	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_SIGNALING_BY_GPCR
3.33333333333%	1	30	92	Mendelian_Hereditary_Sensory_Neuropathy	WINTER_HYPOXIA_UP
3.33333333333%	1	30	92	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_DILATED_CARDIOMYOPATHY
3.33333333333%	1	30	918	Mendelian_Hereditary_Sensory_Neuropathy	JOHNSTONE_PARVB_TARGETS_3_DN
3.33333333333%	1	30	91	Mendelian_Hereditary_Sensory_Neuropathy	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
3.33333333333%	1	30	91	Mendelian_Hereditary_Sensory_Neuropathy	ELVIDGE_HIF1A_TARGETS_DN
3.33333333333%	1	30	90	Mendelian_Hereditary_Sensory_Neuropathy	IVANOVSKA_MIR106B_TARGETS
3.33333333333%	1	30	89	Mendelian_Hereditary_Sensory_Neuropathy	LEE_AGING_NEOCORTEX_UP
3.33333333333%	1	30	89	Mendelian_Hereditary_Sensory_Neuropathy	DELASERNA_MYOD_TARGETS_UP
3.33333333333%	1	30	89	Mendelian_Hereditary_Sensory_Neuropathy	BOYLAN_MULTIPLE_MYELOMA_D_UP
3.33333333333%	1	30	882	Mendelian_Hereditary_Sensory_Neuropathy	LEE_BMP2_TARGETS_DN
3.33333333333%	1	30	88	Mendelian_Hereditary_Sensory_Neuropathy	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
3.33333333333%	1	30	88	Mendelian_Hereditary_Sensory_Neuropathy	WALLACE_PROSTATE_CANCER_RACE_DN
3.33333333333%	1	30	88	Mendelian_Hereditary_Sensory_Neuropathy	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
3.33333333333%	1	30	88	Mendelian_Hereditary_Sensory_Neuropathy	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
3.33333333333%	1	30	88	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_APOPTOSIS
3.33333333333%	1	30	88	Mendelian_Hereditary_Sensory_Neuropathy	DURCHDEWALD_SKIN_CARCINOGENESIS_UP
3.33333333333%	1	30	871	Mendelian_Hereditary_Sensory_Neuropathy	GRADE_COLON_CANCER_UP
3.33333333333%	1	30	87	Mendelian_Hereditary_Sensory_Neuropathy	SMITH_TERT_TARGETS_DN
3.33333333333%	1	30	87	Mendelian_Hereditary_Sensory_Neuropathy	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
3.33333333333%	1	30	863	Mendelian_Hereditary_Sensory_Neuropathy	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
3.33333333333%	1	30	86	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_L1CAM_INTERACTIONS
3.33333333333%	1	30	86	Mendelian_Hereditary_Sensory_Neuropathy	NGUYEN_NOTCH1_TARGETS_DN
3.33333333333%	1	30	86	Mendelian_Hereditary_Sensory_Neuropathy	NELSON_RESPONSE_TO_ANDROGEN_UP
3.33333333333%	1	30	86	Mendelian_Hereditary_Sensory_Neuropathy	HOEBEKE_LYMPHOID_STEM_CELL_DN
3.33333333333%	1	30	86	Mendelian_Hereditary_Sensory_Neuropathy	BURTON_ADIPOGENESIS_8
3.33333333333%	1	30	86	Mendelian_Hereditary_Sensory_Neuropathy	BROWNE_HCMV_INFECTION_16HR_DN
3.33333333333%	1	30	857	Mendelian_Hereditary_Sensory_Neuropathy	MARTENS_TRETINOIN_RESPONSE_UP
3.33333333333%	1	30	85	Mendelian_Hereditary_Sensory_Neuropathy	STEIN_ESR1_TARGETS
3.33333333333%	1	30	85	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
3.33333333333%	1	30	85	Mendelian_Hereditary_Sensory_Neuropathy	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
3.33333333333%	1	30	841	Mendelian_Hereditary_Sensory_Neuropathy	MARTENS_TRETINOIN_RESPONSE_DN
3.33333333333%	1	30	84	Mendelian_Hereditary_Sensory_Neuropathy	SWEET_KRAS_TARGETS_UP
3.33333333333%	1	30	84	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
3.33333333333%	1	30	84	Mendelian_Hereditary_Sensory_Neuropathy	HINATA_NFKB_TARGETS_FIBROBLAST_UP
3.33333333333%	1	30	83	Mendelian_Hereditary_Sensory_Neuropathy	ONDER_CDH1_SIGNALING_VIA_CTNNB1
3.33333333333%	1	30	82	Mendelian_Hereditary_Sensory_Neuropathy	LEIN_MIDBRAIN_MARKERS
3.33333333333%	1	30	81	Mendelian_Hereditary_Sensory_Neuropathy	SCIBETTA_KDM5B_TARGETS_DN
3.33333333333%	1	30	81	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
3.33333333333%	1	30	81	Mendelian_Hereditary_Sensory_Neuropathy	LEIN_MEDULLA_MARKERS
3.33333333333%	1	30	81	Mendelian_Hereditary_Sensory_Neuropathy	HARRIS_HYPOXIA
3.33333333333%	1	30	81	Mendelian_Hereditary_Sensory_Neuropathy	GRABARCZYK_BCL11B_TARGETS_UP
3.33333333333%	1	30	81	Mendelian_Hereditary_Sensory_Neuropathy	CROMER_METASTASIS_DN
3.33333333333%	1	30	805	Mendelian_Hereditary_Sensory_Neuropathy	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
3.33333333333%	1	30	805	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_GPCR_DOWNSTREAM_SIGNALING
3.33333333333%	1	30	80	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_UNFOLDED_PROTEIN_RESPONSE
3.33333333333%	1	30	8	Mendelian_Hereditary_Sensory_Neuropathy	STANHILL_HRAS_TRANSFROMATION_UP
3.33333333333%	1	30	8	Mendelian_Hereditary_Sensory_Neuropathy	LUCAS_HNF4A_TARGETS_DN
3.33333333333%	1	30	795	Mendelian_Hereditary_Sensory_Neuropathy	WEI_MYCN_TARGETS_WITH_E_BOX
3.33333333333%	1	30	79	Mendelian_Hereditary_Sensory_Neuropathy	PID_P73PATHWAY
3.33333333333%	1	30	79	Mendelian_Hereditary_Sensory_Neuropathy	CROMER_METASTASIS_UP
3.33333333333%	1	30	781	Mendelian_Hereditary_Sensory_Neuropathy	GOZGIT_ESR1_TARGETS_DN
3.33333333333%	1	30	78	Mendelian_Hereditary_Sensory_Neuropathy	RADMACHER_AML_PROGNOSIS
3.33333333333%	1	30	78	Mendelian_Hereditary_Sensory_Neuropathy	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
3.33333333333%	1	30	775	Mendelian_Hereditary_Sensory_Neuropathy	BENPORATH_MYC_MAX_TARGETS
3.33333333333%	1	30	770	Mendelian_Hereditary_Sensory_Neuropathy	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
3.33333333333%	1	30	77	Mendelian_Hereditary_Sensory_Neuropathy	SEKI_INFLAMMATORY_RESPONSE_LPS_UP
3.33333333333%	1	30	77	Mendelian_Hereditary_Sensory_Neuropathy	RIZ_ERYTHROID_DIFFERENTIATION
3.33333333333%	1	30	77	Mendelian_Hereditary_Sensory_Neuropathy	JACKSON_DNMT1_TARGETS_UP
3.33333333333%	1	30	769	Mendelian_Hereditary_Sensory_Neuropathy	NUYTTEN_NIPP1_TARGETS_UP
3.33333333333%	1	30	76	Mendelian_Hereditary_Sensory_Neuropathy	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
3.33333333333%	1	30	76	Mendelian_Hereditary_Sensory_Neuropathy	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
3.33333333333%	1	30	76	Mendelian_Hereditary_Sensory_Neuropathy	MAHAJAN_RESPONSE_TO_IL1A_DN
3.33333333333%	1	30	76	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_VEGF_SIGNALING_PATHWAY
3.33333333333%	1	30	76	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
3.33333333333%	1	30	75	Mendelian_Hereditary_Sensory_Neuropathy	MCCLUNG_COCAIN_REWARD_4WK
3.33333333333%	1	30	75	Mendelian_Hereditary_Sensory_Neuropathy	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
3.33333333333%	1	30	75	Mendelian_Hereditary_Sensory_Neuropathy	BAE_BRCA1_TARGETS_UP
3.33333333333%	1	30	745	Mendelian_Hereditary_Sensory_Neuropathy	LEE_BMP2_TARGETS_UP
3.33333333333%	1	30	74	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS
3.33333333333%	1	30	74	Mendelian_Hereditary_Sensory_Neuropathy	POTTI_ADRIAMYCIN_SENSITIVITY
3.33333333333%	1	30	73	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_MEIOTIC_SYNAPSIS
3.33333333333%	1	30	73	Mendelian_Hereditary_Sensory_Neuropathy	DITTMER_PTHLH_TARGETS_DN
3.33333333333%	1	30	722	Mendelian_Hereditary_Sensory_Neuropathy	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
3.33333333333%	1	30	720	Mendelian_Hereditary_Sensory_Neuropathy	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
3.33333333333%	1	30	72	Mendelian_Hereditary_Sensory_Neuropathy	MATZUK_SPERMATOCYTE
3.33333333333%	1	30	71	Mendelian_Hereditary_Sensory_Neuropathy	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
3.33333333333%	1	30	71	Mendelian_Hereditary_Sensory_Neuropathy	GEORGANTAS_HSC_MARKERS
3.33333333333%	1	30	70	Mendelian_Hereditary_Sensory_Neuropathy	LANDIS_BREAST_CANCER_PROGRESSION_DN
3.33333333333%	1	30	70	Mendelian_Hereditary_Sensory_Neuropathy	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
3.33333333333%	1	30	70	Mendelian_Hereditary_Sensory_Neuropathy	ENGELMANN_CANCER_PROGENITORS_DN
3.33333333333%	1	30	7	Mendelian_Hereditary_Sensory_Neuropathy	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN
3.33333333333%	1	30	7	Mendelian_Hereditary_Sensory_Neuropathy	MIKKELSEN_DEDIFFERENTIATED_STATE_DN
3.33333333333%	1	30	7	Mendelian_Hereditary_Sensory_Neuropathy	INGRAM_SHH_TARGETS
3.33333333333%	1	30	69	Mendelian_Hereditary_Sensory_Neuropathy	RHODES_UNDIFFERENTIATED_CANCER
3.33333333333%	1	30	69	Mendelian_Hereditary_Sensory_Neuropathy	PID_VEGFR1_2_PATHWAY
3.33333333333%	1	30	69	Mendelian_Hereditary_Sensory_Neuropathy	PID_P75NTRPATHWAY
3.33333333333%	1	30	69	Mendelian_Hereditary_Sensory_Neuropathy	LEIN_NEURON_MARKERS
3.33333333333%	1	30	69	Mendelian_Hereditary_Sensory_Neuropathy	BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE
3.33333333333%	1	30	68	Mendelian_Hereditary_Sensory_Neuropathy	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
3.33333333333%	1	30	68	Mendelian_Hereditary_Sensory_Neuropathy	SESTO_RESPONSE_TO_UV_C7
3.33333333333%	1	30	68	Mendelian_Hereditary_Sensory_Neuropathy	LIN_NPAS4_TARGETS_DN
3.33333333333%	1	30	68	Mendelian_Hereditary_Sensory_Neuropathy	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
3.33333333333%	1	30	673	Mendelian_Hereditary_Sensory_Neuropathy	MARTINEZ_RB1_TARGETS_UP
3.33333333333%	1	30	67	Mendelian_Hereditary_Sensory_Neuropathy	VANHARANTA_UTERINE_FIBROID_DN
3.33333333333%	1	30	67	Mendelian_Hereditary_Sensory_Neuropathy	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
3.33333333333%	1	30	66	Mendelian_Hereditary_Sensory_Neuropathy	RIGGINS_TAMOXIFEN_RESISTANCE_UP
3.33333333333%	1	30	66	Mendelian_Hereditary_Sensory_Neuropathy	PID_HIF1_TFPATHWAY
3.33333333333%	1	30	66	Mendelian_Hereditary_Sensory_Neuropathy	KIM_GERMINAL_CENTER_T_HELPER_UP
3.33333333333%	1	30	66	Mendelian_Hereditary_Sensory_Neuropathy	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
3.33333333333%	1	30	66	Mendelian_Hereditary_Sensory_Neuropathy	DIRMEIER_LMP1_RESPONSE_EARLY
3.33333333333%	1	30	66	Mendelian_Hereditary_Sensory_Neuropathy	BRUNO_HEMATOPOIESIS
3.33333333333%	1	30	658	Mendelian_Hereditary_Sensory_Neuropathy	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
3.33333333333%	1	30	65	Mendelian_Hereditary_Sensory_Neuropathy	ST_FAS_SIGNALING_PATHWAY
3.33333333333%	1	30	65	Mendelian_Hereditary_Sensory_Neuropathy	PID_IL4_2PATHWAY
3.33333333333%	1	30	64	Mendelian_Hereditary_Sensory_Neuropathy	LEE_LIVER_CANCER_ACOX1_UP
3.33333333333%	1	30	64	Mendelian_Hereditary_Sensory_Neuropathy	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
3.33333333333%	1	30	637	Mendelian_Hereditary_Sensory_Neuropathy	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
3.33333333333%	1	30	63	Mendelian_Hereditary_Sensory_Neuropathy	PID_MYC_REPRESSPATHWAY
3.33333333333%	1	30	63	Mendelian_Hereditary_Sensory_Neuropathy	PID_IL12_2PATHWAY
3.33333333333%	1	30	63	Mendelian_Hereditary_Sensory_Neuropathy	PHONG_TNF_TARGETS_UP
3.33333333333%	1	30	63	Mendelian_Hereditary_Sensory_Neuropathy	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
3.33333333333%	1	30	63	Mendelian_Hereditary_Sensory_Neuropathy	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
3.33333333333%	1	30	62	Mendelian_Hereditary_Sensory_Neuropathy	PID_TRKRPATHWAY
3.33333333333%	1	30	62	Mendelian_Hereditary_Sensory_Neuropathy	KYNG_DNA_DAMAGE_BY_UV
3.33333333333%	1	30	61	Mendelian_Hereditary_Sensory_Neuropathy	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
3.33333333333%	1	30	61	Mendelian_Hereditary_Sensory_Neuropathy	LEE_LIVER_CANCER_MYC_TGFA_UP
3.33333333333%	1	30	605	Mendelian_Hereditary_Sensory_Neuropathy	CAIRO_HEPATOBLASTOMA_CLASSES_UP
3.33333333333%	1	30	60	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING
3.33333333333%	1	30	60	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE
3.33333333333%	1	30	60	Mendelian_Hereditary_Sensory_Neuropathy	LEE_LIVER_CANCER_DENA_UP
3.33333333333%	1	30	60	Mendelian_Hereditary_Sensory_Neuropathy	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN
3.33333333333%	1	30	60	Mendelian_Hereditary_Sensory_Neuropathy	AMIT_EGF_RESPONSE_240_HELA
3.33333333333%	1	30	6	Mendelian_Hereditary_Sensory_Neuropathy	MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN
3.33333333333%	1	30	6	Mendelian_Hereditary_Sensory_Neuropathy	CASTELLANO_HRAS_TARGETS_DN
3.33333333333%	1	30	593	Mendelian_Hereditary_Sensory_Neuropathy	MARTINEZ_TP53_TARGETS_DN
3.33333333333%	1	30	591	Mendelian_Hereditary_Sensory_Neuropathy	MARTINEZ_RB1_AND_TP53_TARGETS_DN
3.33333333333%	1	30	59	Mendelian_Hereditary_Sensory_Neuropathy	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
3.33333333333%	1	30	59	Mendelian_Hereditary_Sensory_Neuropathy	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1
3.33333333333%	1	30	59	Mendelian_Hereditary_Sensory_Neuropathy	DASU_IL6_SIGNALING_UP
3.33333333333%	1	30	59	Mendelian_Hereditary_Sensory_Neuropathy	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
3.33333333333%	1	30	58	Mendelian_Hereditary_Sensory_Neuropathy	PID_SHP2_PATHWAY
3.33333333333%	1	30	58	Mendelian_Hereditary_Sensory_Neuropathy	NAGASHIMA_EGF_SIGNALING_UP
3.33333333333%	1	30	58	Mendelian_Hereditary_Sensory_Neuropathy	MIKKELSEN_NPC_LCP_WITH_H3K4ME3
3.33333333333%	1	30	58	Mendelian_Hereditary_Sensory_Neuropathy	KANNAN_TP53_TARGETS_UP
3.33333333333%	1	30	58	Mendelian_Hereditary_Sensory_Neuropathy	JI_RESPONSE_TO_FSH_DN
3.33333333333%	1	30	58	Mendelian_Hereditary_Sensory_Neuropathy	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
3.33333333333%	1	30	58	Mendelian_Hereditary_Sensory_Neuropathy	BIOCARTA_HIVNEF_PATHWAY
3.33333333333%	1	30	566	Mendelian_Hereditary_Sensory_Neuropathy	DOUGLAS_BMI1_TARGETS_UP
3.33333333333%	1	30	564	Mendelian_Hereditary_Sensory_Neuropathy	SMID_BREAST_CANCER_LUMINAL_B_DN
3.33333333333%	1	30	56	Mendelian_Hereditary_Sensory_Neuropathy	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP
3.33333333333%	1	30	56	Mendelian_Hereditary_Sensory_Neuropathy	HENDRICKS_SMARCA4_TARGETS_UP
3.33333333333%	1	30	56	Mendelian_Hereditary_Sensory_Neuropathy	BROWNE_HCMV_INFECTION_30MIN_UP
3.33333333333%	1	30	555	Mendelian_Hereditary_Sensory_Neuropathy	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
3.33333333333%	1	30	552	Mendelian_Hereditary_Sensory_Neuropathy	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
3.33333333333%	1	30	55	Mendelian_Hereditary_Sensory_Neuropathy	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
3.33333333333%	1	30	54	Mendelian_Hereditary_Sensory_Neuropathy	ZHOU_TNF_SIGNALING_30MIN
3.33333333333%	1	30	54	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_APOPTOTIC_EXECUTION_PHASE
3.33333333333%	1	30	54	Mendelian_Hereditary_Sensory_Neuropathy	PID_TAP63PATHWAY
3.33333333333%	1	30	54	Mendelian_Hereditary_Sensory_Neuropathy	HUPER_BREAST_BASAL_VS_LUMINAL_UP
3.33333333333%	1	30	537	Mendelian_Hereditary_Sensory_Neuropathy	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
3.33333333333%	1	30	532	Mendelian_Hereditary_Sensory_Neuropathy	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
3.33333333333%	1	30	530	Mendelian_Hereditary_Sensory_Neuropathy	ENK_UV_RESPONSE_KERATINOCYTE_UP
3.33333333333%	1	30	53	Mendelian_Hereditary_Sensory_Neuropathy	ZHU_CMV_8_HR_DN
3.33333333333%	1	30	53	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS
3.33333333333%	1	30	53	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0
3.33333333333%	1	30	53	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
3.33333333333%	1	30	53	Mendelian_Hereditary_Sensory_Neuropathy	IKEDA_MIR1_TARGETS_UP
3.33333333333%	1	30	53	Mendelian_Hereditary_Sensory_Neuropathy	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP
3.33333333333%	1	30	52	Mendelian_Hereditary_Sensory_Neuropathy	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN
3.33333333333%	1	30	52	Mendelian_Hereditary_Sensory_Neuropathy	VILIMAS_NOTCH1_TARGETS_UP
3.33333333333%	1	30	52	Mendelian_Hereditary_Sensory_Neuropathy	RADAEVA_RESPONSE_TO_IFNA1_UP
3.33333333333%	1	30	52	Mendelian_Hereditary_Sensory_Neuropathy	PRAMOONJAGO_SOX4_TARGETS_UP
3.33333333333%	1	30	52	Mendelian_Hereditary_Sensory_Neuropathy	PID_CASPASE_PATHWAY
3.33333333333%	1	30	518	Mendelian_Hereditary_Sensory_Neuropathy	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
3.33333333333%	1	30	517	Mendelian_Hereditary_Sensory_Neuropathy	RAO_BOUND_BY_SALL4_ISOFORM_B
3.33333333333%	1	30	516	Mendelian_Hereditary_Sensory_Neuropathy	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
3.33333333333%	1	30	510	Mendelian_Hereditary_Sensory_Neuropathy	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
3.33333333333%	1	30	51	Mendelian_Hereditary_Sensory_Neuropathy	ZHANG_PROLIFERATING_VS_QUIESCENT
3.33333333333%	1	30	51	Mendelian_Hereditary_Sensory_Neuropathy	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN
3.33333333333%	1	30	51	Mendelian_Hereditary_Sensory_Neuropathy	GUILLAUMOND_KLF10_TARGETS_UP
3.33333333333%	1	30	51	Mendelian_Hereditary_Sensory_Neuropathy	FRASOR_TAMOXIFEN_RESPONSE_UP
3.33333333333%	1	30	504	Mendelian_Hereditary_Sensory_Neuropathy	PILON_KLF1_TARGETS_UP
3.33333333333%	1	30	504	Mendelian_Hereditary_Sensory_Neuropathy	BROWNE_HCMV_INFECTION_48HR_DN
3.33333333333%	1	30	50	Mendelian_Hereditary_Sensory_Neuropathy	CHIBA_RESPONSE_TO_TSA
3.33333333333%	1	30	5	Mendelian_Hereditary_Sensory_Neuropathy	GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN
3.33333333333%	1	30	491	Mendelian_Hereditary_Sensory_Neuropathy	MEISSNER_NPC_HCP_WITH_H3K4ME2
3.33333333333%	1	30	49	Mendelian_Hereditary_Sensory_Neuropathy	PID_ARF6_TRAFFICKINGPATHWAY
3.33333333333%	1	30	49	Mendelian_Hereditary_Sensory_Neuropathy	GERHOLD_ADIPOGENESIS_UP
3.33333333333%	1	30	49	Mendelian_Hereditary_Sensory_Neuropathy	APRELIKOVA_BRCA1_TARGETS
3.33333333333%	1	30	487	Mendelian_Hereditary_Sensory_Neuropathy	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
3.33333333333%	1	30	48	Mendelian_Hereditary_Sensory_Neuropathy	MCCLUNG_DELTA_FOSB_TARGETS_2WK
3.33333333333%	1	30	48	Mendelian_Hereditary_Sensory_Neuropathy	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN
3.33333333333%	1	30	48	Mendelian_Hereditary_Sensory_Neuropathy	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN
3.33333333333%	1	30	48	Mendelian_Hereditary_Sensory_Neuropathy	ENGELMANN_CANCER_PROGENITORS_UP
3.33333333333%	1	30	479	Mendelian_Hereditary_Sensory_Neuropathy	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
3.33333333333%	1	30	475	Mendelian_Hereditary_Sensory_Neuropathy	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
3.33333333333%	1	30	473	Mendelian_Hereditary_Sensory_Neuropathy	GARY_CD5_TARGETS_UP
3.33333333333%	1	30	47	Mendelian_Hereditary_Sensory_Neuropathy	PID_NFAT_TFPATHWAY
3.33333333333%	1	30	47	Mendelian_Hereditary_Sensory_Neuropathy	MCCLUNG_DELTA_FOSB_TARGETS_8WK
3.33333333333%	1	30	467	Mendelian_Hereditary_Sensory_Neuropathy	RATTENBACHER_BOUND_BY_CELF1
3.33333333333%	1	30	466	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_HEMOSTASIS
3.33333333333%	1	30	464	Mendelian_Hereditary_Sensory_Neuropathy	ONDER_CDH1_TARGETS_2_DN
3.33333333333%	1	30	462	Mendelian_Hereditary_Sensory_Neuropathy	DELACROIX_RAR_BOUND_ES
3.33333333333%	1	30	46	Mendelian_Hereditary_Sensory_Neuropathy	SAGIV_CD24_TARGETS_DN
3.33333333333%	1	30	46	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
3.33333333333%	1	30	46	Mendelian_Hereditary_Sensory_Neuropathy	PID_A6B1_A6B4_INTEGRIN_PATHWAY
3.33333333333%	1	30	46	Mendelian_Hereditary_Sensory_Neuropathy	LEE_AGING_MUSCLE_DN
3.33333333333%	1	30	46	Mendelian_Hereditary_Sensory_Neuropathy	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN
3.33333333333%	1	30	457	Mendelian_Hereditary_Sensory_Neuropathy	SENESE_HDAC1_TARGETS_UP
3.33333333333%	1	30	456	Mendelian_Hereditary_Sensory_Neuropathy	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
3.33333333333%	1	30	45	Mendelian_Hereditary_Sensory_Neuropathy	MCDOWELL_ACUTE_LUNG_INJURY_UP
3.33333333333%	1	30	45	Mendelian_Hereditary_Sensory_Neuropathy	LUI_THYROID_CANCER_PAX8_PPARG_DN
3.33333333333%	1	30	45	Mendelian_Hereditary_Sensory_Neuropathy	LEE_AGING_MUSCLE_UP
3.33333333333%	1	30	45	Mendelian_Hereditary_Sensory_Neuropathy	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN
3.33333333333%	1	30	447	Mendelian_Hereditary_Sensory_Neuropathy	MOOTHA_MITOCHONDRIA
3.33333333333%	1	30	44	Mendelian_Hereditary_Sensory_Neuropathy	ZHAN_MULTIPLE_MYELOMA_PR_DN
3.33333333333%	1	30	44	Mendelian_Hereditary_Sensory_Neuropathy	WANG_TARGETS_OF_MLL_CBP_FUSION_UP
3.33333333333%	1	30	44	Mendelian_Hereditary_Sensory_Neuropathy	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
3.33333333333%	1	30	44	Mendelian_Hereditary_Sensory_Neuropathy	STREICHER_LSM1_TARGETS_UP
3.33333333333%	1	30	44	Mendelian_Hereditary_Sensory_Neuropathy	MA_MYELOID_DIFFERENTIATION_DN
3.33333333333%	1	30	44	Mendelian_Hereditary_Sensory_Neuropathy	LANDIS_BREAST_CANCER_PROGRESSION_UP
3.33333333333%	1	30	44	Mendelian_Hereditary_Sensory_Neuropathy	KORKOLA_SEMINOMA_UP
3.33333333333%	1	30	439	Mendelian_Hereditary_Sensory_Neuropathy	MITSIADES_RESPONSE_TO_APLIDIN_UP
3.33333333333%	1	30	431	Mendelian_Hereditary_Sensory_Neuropathy	GARY_CD5_TARGETS_DN
3.33333333333%	1	30	430	Mendelian_Hereditary_Sensory_Neuropathy	VECCHI_GASTRIC_CANCER_EARLY_UP
3.33333333333%	1	30	43	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK
3.33333333333%	1	30	43	Mendelian_Hereditary_Sensory_Neuropathy	PID_THROMBIN_PAR1_PATHWAY
3.33333333333%	1	30	43	Mendelian_Hereditary_Sensory_Neuropathy	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN
3.33333333333%	1	30	43	Mendelian_Hereditary_Sensory_Neuropathy	NAKAMURA_METASTASIS_MODEL_DN
3.33333333333%	1	30	43	Mendelian_Hereditary_Sensory_Neuropathy	IKEDA_MIR133_TARGETS_UP
3.33333333333%	1	30	429	Mendelian_Hereditary_Sensory_Neuropathy	MOOTHA_HUMAN_MITODB_6_2002
3.33333333333%	1	30	428	Mendelian_Hereditary_Sensory_Neuropathy	LIM_MAMMARY_STEM_CELL_DN
3.33333333333%	1	30	424	Mendelian_Hereditary_Sensory_Neuropathy	SHEN_SMARCA2_TARGETS_UP
3.33333333333%	1	30	423	Mendelian_Hereditary_Sensory_Neuropathy	PUJANA_BRCA2_PCC_NETWORK
3.33333333333%	1	30	421	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_CELL_CYCLE
3.33333333333%	1	30	420	Mendelian_Hereditary_Sensory_Neuropathy	MOOTHA_PGC
3.33333333333%	1	30	42	Mendelian_Hereditary_Sensory_Neuropathy	WIERENGA_PML_INTERACTOME
3.33333333333%	1	30	42	Mendelian_Hereditary_Sensory_Neuropathy	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN
3.33333333333%	1	30	418	Mendelian_Hereditary_Sensory_Neuropathy	MULLIGHAN_MLL_SIGNATURE_2_UP
3.33333333333%	1	30	414	Mendelian_Hereditary_Sensory_Neuropathy	LU_EZH2_TARGETS_DN
3.33333333333%	1	30	41	Mendelian_Hereditary_Sensory_Neuropathy	LI_LUNG_CANCER
3.33333333333%	1	30	409	Mendelian_Hereditary_Sensory_Neuropathy	FOSTER_TOLERANT_MACROPHAGE_DN
3.33333333333%	1	30	408	Mendelian_Hereditary_Sensory_Neuropathy	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
3.33333333333%	1	30	403	Mendelian_Hereditary_Sensory_Neuropathy	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
3.33333333333%	1	30	40	Mendelian_Hereditary_Sensory_Neuropathy	TOMLINS_PROSTATE_CANCER_DN
3.33333333333%	1	30	40	Mendelian_Hereditary_Sensory_Neuropathy	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
3.33333333333%	1	30	40	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
3.33333333333%	1	30	40	Mendelian_Hereditary_Sensory_Neuropathy	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS
3.33333333333%	1	30	40	Mendelian_Hereditary_Sensory_Neuropathy	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
3.33333333333%	1	30	40	Mendelian_Hereditary_Sensory_Neuropathy	GENTILE_UV_RESPONSE_CLUSTER_D7
3.33333333333%	1	30	40	Mendelian_Hereditary_Sensory_Neuropathy	BURTON_ADIPOGENESIS_PEAK_AT_16HR
3.33333333333%	1	30	40	Mendelian_Hereditary_Sensory_Neuropathy	BIOCARTA_P38MAPK_PATHWAY
3.33333333333%	1	30	397	Mendelian_Hereditary_Sensory_Neuropathy	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
3.33333333333%	1	30	394	Mendelian_Hereditary_Sensory_Neuropathy	BERENJENO_TRANSFORMED_BY_RHOA_DN
3.33333333333%	1	30	392	Mendelian_Hereditary_Sensory_Neuropathy	LINDGREN_BLADDER_CANCER_CLUSTER_2B
3.33333333333%	1	30	391	Mendelian_Hereditary_Sensory_Neuropathy	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
3.33333333333%	1	30	39	Mendelian_Hereditary_Sensory_Neuropathy	WHITEHURST_PACLITAXEL_SENSITIVITY
3.33333333333%	1	30	39	Mendelian_Hereditary_Sensory_Neuropathy	WANG_LSD1_TARGETS_DN
3.33333333333%	1	30	39	Mendelian_Hereditary_Sensory_Neuropathy	POTTI_PACLITAXEL_SENSITIVITY
3.33333333333%	1	30	39	Mendelian_Hereditary_Sensory_Neuropathy	BILANGES_SERUM_SENSITIVE_VIA_TSC2
3.33333333333%	1	30	388	Mendelian_Hereditary_Sensory_Neuropathy	STEIN_ESRRA_TARGETS_UP
3.33333333333%	1	30	384	Mendelian_Hereditary_Sensory_Neuropathy	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
3.33333333333%	1	30	380	Mendelian_Hereditary_Sensory_Neuropathy	MULLIGHAN_MLL_SIGNATURE_1_UP
3.33333333333%	1	30	380	Mendelian_Hereditary_Sensory_Neuropathy	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
3.33333333333%	1	30	38	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_PI3K_AKT_ACTIVATION
3.33333333333%	1	30	38	Mendelian_Hereditary_Sensory_Neuropathy	PIONTEK_PKD1_TARGETS_UP
3.33333333333%	1	30	38	Mendelian_Hereditary_Sensory_Neuropathy	PID_P38ALPHABETADOWNSTREAMPATHWAY
3.33333333333%	1	30	38	Mendelian_Hereditary_Sensory_Neuropathy	KYNG_DNA_DAMAGE_BY_4NQO
3.33333333333%	1	30	379	Mendelian_Hereditary_Sensory_Neuropathy	BENPORATH_ES_1
3.33333333333%	1	30	378	Mendelian_Hereditary_Sensory_Neuropathy	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
3.33333333333%	1	30	374	Mendelian_Hereditary_Sensory_Neuropathy	WANG_TUMOR_INVASIVENESS_UP
3.33333333333%	1	30	37	Mendelian_Hereditary_Sensory_Neuropathy	VALK_AML_WITH_CEBPA
3.33333333333%	1	30	37	Mendelian_Hereditary_Sensory_Neuropathy	ST_P38_MAPK_PATHWAY
3.33333333333%	1	30	37	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS
3.33333333333%	1	30	368	Mendelian_Hereditary_Sensory_Neuropathy	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
3.33333333333%	1	30	367	Mendelian_Hereditary_Sensory_Neuropathy	VECCHI_GASTRIC_CANCER_EARLY_DN
3.33333333333%	1	30	364	Mendelian_Hereditary_Sensory_Neuropathy	YANG_BCL3_TARGETS_UP
3.33333333333%	1	30	362	Mendelian_Hereditary_Sensory_Neuropathy	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
3.33333333333%	1	30	36	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_SIGNALLING_TO_ERKS
3.33333333333%	1	30	36	Mendelian_Hereditary_Sensory_Neuropathy	PID_PI3KPLCTRKPATHWAY
3.33333333333%	1	30	36	Mendelian_Hereditary_Sensory_Neuropathy	JIANG_AGING_CEREBRAL_CORTEX_UP
3.33333333333%	1	30	353	Mendelian_Hereditary_Sensory_Neuropathy	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
3.33333333333%	1	30	352	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
3.33333333333%	1	30	351	Mendelian_Hereditary_Sensory_Neuropathy	YAGI_AML_WITH_11Q23_REARRANGED
3.33333333333%	1	30	35	Mendelian_Hereditary_Sensory_Neuropathy	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP
3.33333333333%	1	30	341	Mendelian_Hereditary_Sensory_Neuropathy	MULLIGHAN_NPM1_SIGNATURE_3_UP
3.33333333333%	1	30	34	Mendelian_Hereditary_Sensory_Neuropathy	SCHOEN_NFKB_SIGNALING
3.33333333333%	1	30	34	Mendelian_Hereditary_Sensory_Neuropathy	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP
3.33333333333%	1	30	34	Mendelian_Hereditary_Sensory_Neuropathy	PLASARI_TGFB1_TARGETS_1HR_UP
3.33333333333%	1	30	34	Mendelian_Hereditary_Sensory_Neuropathy	PID_IL8CXCR2_PATHWAY
3.33333333333%	1	30	34	Mendelian_Hereditary_Sensory_Neuropathy	LUI_TARGETS_OF_PAX8_PPARG_FUSION
3.33333333333%	1	30	34	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM
3.33333333333%	1	30	335	Mendelian_Hereditary_Sensory_Neuropathy	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
3.33333333333%	1	30	332	Mendelian_Hereditary_Sensory_Neuropathy	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
3.33333333333%	1	30	330	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_METABOLISM_OF_RNA
3.33333333333%	1	30	33	Mendelian_Hereditary_Sensory_Neuropathy	STAEGE_EWING_FAMILY_TUMOR
3.33333333333%	1	30	33	Mendelian_Hereditary_Sensory_Neuropathy	SCHRAETS_MLL_TARGETS_DN
3.33333333333%	1	30	33	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS
3.33333333333%	1	30	33	Mendelian_Hereditary_Sensory_Neuropathy	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS
3.33333333333%	1	30	33	Mendelian_Hereditary_Sensory_Neuropathy	BURTON_ADIPOGENESIS_1
3.33333333333%	1	30	33	Mendelian_Hereditary_Sensory_Neuropathy	BIOCARTA_DEATH_PATHWAY
3.33333333333%	1	30	329	Mendelian_Hereditary_Sensory_Neuropathy	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
3.33333333333%	1	30	329	Mendelian_Hereditary_Sensory_Neuropathy	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
3.33333333333%	1	30	328	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_PATHWAYS_IN_CANCER
3.33333333333%	1	30	326	Mendelian_Hereditary_Sensory_Neuropathy	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
3.33333333333%	1	30	323	Mendelian_Hereditary_Sensory_Neuropathy	GRESHOCK_CANCER_COPY_NUMBER_UP
3.33333333333%	1	30	321	Mendelian_Hereditary_Sensory_Neuropathy	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
3.33333333333%	1	30	32	Mendelian_Hereditary_Sensory_Neuropathy	POS_HISTAMINE_RESPONSE_NETWORK
3.33333333333%	1	30	32	Mendelian_Hereditary_Sensory_Neuropathy	PID_SYNDECAN_4_PATHWAY
3.33333333333%	1	30	32	Mendelian_Hereditary_Sensory_Neuropathy	FARDIN_HYPOXIA_11
3.33333333333%	1	30	317	Mendelian_Hereditary_Sensory_Neuropathy	BRUINS_UVC_RESPONSE_EARLY_LATE
3.33333333333%	1	30	316	Mendelian_Hereditary_Sensory_Neuropathy	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
3.33333333333%	1	30	312	Mendelian_Hereditary_Sensory_Neuropathy	GENTILE_UV_HIGH_DOSE_DN
3.33333333333%	1	30	31	Mendelian_Hereditary_Sensory_Neuropathy	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP
3.33333333333%	1	30	31	Mendelian_Hereditary_Sensory_Neuropathy	VALK_AML_CLUSTER_15
3.33333333333%	1	30	31	Mendelian_Hereditary_Sensory_Neuropathy	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP
3.33333333333%	1	30	31	Mendelian_Hereditary_Sensory_Neuropathy	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD
3.33333333333%	1	30	31	Mendelian_Hereditary_Sensory_Neuropathy	IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM
3.33333333333%	1	30	31	Mendelian_Hereditary_Sensory_Neuropathy	HUNSBERGER_EXERCISE_REGULATED_GENES
3.33333333333%	1	30	31	Mendelian_Hereditary_Sensory_Neuropathy	DANG_MYC_TARGETS_DN
3.33333333333%	1	30	309	Mendelian_Hereditary_Sensory_Neuropathy	LIU_SOX4_TARGETS_DN
3.33333333333%	1	30	308	Mendelian_Hereditary_Sensory_Neuropathy	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
3.33333333333%	1	30	307	Mendelian_Hereditary_Sensory_Neuropathy	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
3.33333333333%	1	30	305	Mendelian_Hereditary_Sensory_Neuropathy	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
3.33333333333%	1	30	302	Mendelian_Hereditary_Sensory_Neuropathy	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
3.33333333333%	1	30	30	Mendelian_Hereditary_Sensory_Neuropathy	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN
3.33333333333%	1	30	30	Mendelian_Hereditary_Sensory_Neuropathy	BIOCARTA_FAS_PATHWAY
3.33333333333%	1	30	299	Mendelian_Hereditary_Sensory_Neuropathy	WALLACE_PROSTATE_CANCER_RACE_UP
3.33333333333%	1	30	298	Mendelian_Hereditary_Sensory_Neuropathy	BROWNE_HCMV_INFECTION_14HR_DN
3.33333333333%	1	30	295	Mendelian_Hereditary_Sensory_Neuropathy	LU_EZH2_TARGETS_UP
3.33333333333%	1	30	294	Mendelian_Hereditary_Sensory_Neuropathy	WEST_ADRENOCORTICAL_TUMOR_UP
3.33333333333%	1	30	293	Mendelian_Hereditary_Sensory_Neuropathy	IVANOVA_HEMATOPOIESIS_MATURE_CELL
3.33333333333%	1	30	292	Mendelian_Hereditary_Sensory_Neuropathy	KOYAMA_SEMA3B_TARGETS_UP
3.33333333333%	1	30	29	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_THYROID_CANCER
3.33333333333%	1	30	29	Mendelian_Hereditary_Sensory_Neuropathy	DALESSIO_TSA_RESPONSE
3.33333333333%	1	30	29	Mendelian_Hereditary_Sensory_Neuropathy	BIOCARTA_VIP_PATHWAY
3.33333333333%	1	30	29	Mendelian_Hereditary_Sensory_Neuropathy	BIOCARTA_TNFR1_PATHWAY
3.33333333333%	1	30	29	Mendelian_Hereditary_Sensory_Neuropathy	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP
3.33333333333%	1	30	29	Mendelian_Hereditary_Sensory_Neuropathy	ABE_VEGFA_TARGETS_30MIN
3.33333333333%	1	30	289	Mendelian_Hereditary_Sensory_Neuropathy	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
3.33333333333%	1	30	287	Mendelian_Hereditary_Sensory_Neuropathy	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
3.33333333333%	1	30	285	Mendelian_Hereditary_Sensory_Neuropathy	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
3.33333333333%	1	30	284	Mendelian_Hereditary_Sensory_Neuropathy	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
3.33333333333%	1	30	284	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_METABOLISM_OF_MRNA
3.33333333333%	1	30	281	Mendelian_Hereditary_Sensory_Neuropathy	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
3.33333333333%	1	30	281	Mendelian_Hereditary_Sensory_Neuropathy	BHAT_ESR1_TARGETS_VIA_AKT1_UP
3.33333333333%	1	30	280	Mendelian_Hereditary_Sensory_Neuropathy	WANG_SMARCE1_TARGETS_UP
3.33333333333%	1	30	28	Mendelian_Hereditary_Sensory_Neuropathy	WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1
3.33333333333%	1	30	28	Mendelian_Hereditary_Sensory_Neuropathy	TERAO_AOX4_TARGETS_HG_UP
3.33333333333%	1	30	28	Mendelian_Hereditary_Sensory_Neuropathy	LUI_THYROID_CANCER_CLUSTER_3
3.33333333333%	1	30	28	Mendelian_Hereditary_Sensory_Neuropathy	HWANG_PROSTATE_CANCER_MARKERS
3.33333333333%	1	30	28	Mendelian_Hereditary_Sensory_Neuropathy	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN
3.33333333333%	1	30	279	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_NEURONAL_SYSTEM
3.33333333333%	1	30	279	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_INNATE_IMMUNE_SYSTEM
3.33333333333%	1	30	277	Mendelian_Hereditary_Sensory_Neuropathy	ZHANG_TLX_TARGETS_60HR_DN
3.33333333333%	1	30	277	Mendelian_Hereditary_Sensory_Neuropathy	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
3.33333333333%	1	30	276	Mendelian_Hereditary_Sensory_Neuropathy	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
3.33333333333%	1	30	274	Mendelian_Hereditary_Sensory_Neuropathy	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
3.33333333333%	1	30	271	Mendelian_Hereditary_Sensory_Neuropathy	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
3.33333333333%	1	30	27	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_SIGNALLING_TO_RAS
3.33333333333%	1	30	27	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_RECYCLING_PATHWAY_OF_L1
3.33333333333%	1	30	27	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS
3.33333333333%	1	30	27	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_PENTOSE_PHOSPHATE_PATHWAY
3.33333333333%	1	30	269	Mendelian_Hereditary_Sensory_Neuropathy	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
3.33333333333%	1	30	266	Mendelian_Hereditary_Sensory_Neuropathy	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
3.33333333333%	1	30	265	Mendelian_Hereditary_Sensory_Neuropathy	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
3.33333333333%	1	30	264	Mendelian_Hereditary_Sensory_Neuropathy	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
3.33333333333%	1	30	261	Mendelian_Hereditary_Sensory_Neuropathy	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
3.33333333333%	1	30	260	Mendelian_Hereditary_Sensory_Neuropathy	BOQUEST_STEM_CELL_UP
3.33333333333%	1	30	26	Mendelian_Hereditary_Sensory_Neuropathy	WILLIAMS_ESR1_TARGETS_UP
3.33333333333%	1	30	26	Mendelian_Hereditary_Sensory_Neuropathy	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
3.33333333333%	1	30	26	Mendelian_Hereditary_Sensory_Neuropathy	NEWMAN_ERCC6_TARGETS_UP
3.33333333333%	1	30	26	Mendelian_Hereditary_Sensory_Neuropathy	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
3.33333333333%	1	30	259	Mendelian_Hereditary_Sensory_Neuropathy	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
3.33333333333%	1	30	256	Mendelian_Hereditary_Sensory_Neuropathy	ONDER_CDH1_TARGETS_2_UP
3.33333333333%	1	30	255	Mendelian_Hereditary_Sensory_Neuropathy	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
3.33333333333%	1	30	252	Mendelian_Hereditary_Sensory_Neuropathy	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
3.33333333333%	1	30	251	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_AXON_GUIDANCE
3.33333333333%	1	30	251	Mendelian_Hereditary_Sensory_Neuropathy	KOBAYASHI_EGFR_SIGNALING_24HR_DN
3.33333333333%	1	30	250	Mendelian_Hereditary_Sensory_Neuropathy	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
3.33333333333%	1	30	25	Mendelian_Hereditary_Sensory_Neuropathy	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP
3.33333333333%	1	30	25	Mendelian_Hereditary_Sensory_Neuropathy	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17
3.33333333333%	1	30	249	Mendelian_Hereditary_Sensory_Neuropathy	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
3.33333333333%	1	30	247	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_METABOLISM_OF_CARBOHYDRATES
3.33333333333%	1	30	246	Mendelian_Hereditary_Sensory_Neuropathy	VERHAAK_AML_WITH_NPM1_MUTATED_DN
3.33333333333%	1	30	246	Mendelian_Hereditary_Sensory_Neuropathy	BILD_E2F3_ONCOGENIC_SIGNATURE
3.33333333333%	1	30	245	Mendelian_Hereditary_Sensory_Neuropathy	PENG_RAPAMYCIN_RESPONSE_DN
3.33333333333%	1	30	245	Mendelian_Hereditary_Sensory_Neuropathy	BLUM_RESPONSE_TO_SALIRASIB_UP
3.33333333333%	1	30	244	Mendelian_Hereditary_Sensory_Neuropathy	THUM_SYSTOLIC_HEART_FAILURE_DN
3.33333333333%	1	30	244	Mendelian_Hereditary_Sensory_Neuropathy	PLASARI_TGFB1_TARGETS_10HR_DN
3.33333333333%	1	30	244	Mendelian_Hereditary_Sensory_Neuropathy	HSIAO_LIVER_SPECIFIC_GENES
3.33333333333%	1	30	244	Mendelian_Hereditary_Sensory_Neuropathy	GAL_LEUKEMIC_STEM_CELL_DN
3.33333333333%	1	30	243	Mendelian_Hereditary_Sensory_Neuropathy	CHICAS_RB1_TARGETS_GROWING
3.33333333333%	1	30	242	Mendelian_Hereditary_Sensory_Neuropathy	WINTER_HYPOXIA_METAGENE
3.33333333333%	1	30	240	Mendelian_Hereditary_Sensory_Neuropathy	BROWNE_HCMV_INFECTION_20HR_UP
3.33333333333%	1	30	239	Mendelian_Hereditary_Sensory_Neuropathy	ALFANO_MYC_TARGETS
3.33333333333%	1	30	238	Mendelian_Hereditary_Sensory_Neuropathy	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
3.33333333333%	1	30	234	Mendelian_Hereditary_Sensory_Neuropathy	AFFAR_YY1_TARGETS_DN
3.33333333333%	1	30	233	Mendelian_Hereditary_Sensory_Neuropathy	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
3.33333333333%	1	30	232	Mendelian_Hereditary_Sensory_Neuropathy	DELYS_THYROID_CANCER_DN
3.33333333333%	1	30	230	Mendelian_Hereditary_Sensory_Neuropathy	COLDREN_GEFITINIB_RESISTANCE_DN
3.33333333333%	1	30	230	Mendelian_Hereditary_Sensory_Neuropathy	BENPORATH_MYC_TARGETS_WITH_EBOX
3.33333333333%	1	30	23	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_LYSOSOME_VESICLE_BIOGENESIS
3.33333333333%	1	30	23	Mendelian_Hereditary_Sensory_Neuropathy	BIOCARTA_CASPASE_PATHWAY
3.33333333333%	1	30	229	Mendelian_Hereditary_Sensory_Neuropathy	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
3.33333333333%	1	30	228	Mendelian_Hereditary_Sensory_Neuropathy	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
3.33333333333%	1	30	227	Mendelian_Hereditary_Sensory_Neuropathy	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
3.33333333333%	1	30	227	Mendelian_Hereditary_Sensory_Neuropathy	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
3.33333333333%	1	30	226	Mendelian_Hereditary_Sensory_Neuropathy	KYNG_DNA_DAMAGE_UP
3.33333333333%	1	30	225	Mendelian_Hereditary_Sensory_Neuropathy	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
3.33333333333%	1	30	223	Mendelian_Hereditary_Sensory_Neuropathy	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
3.33333333333%	1	30	222	Mendelian_Hereditary_Sensory_Neuropathy	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
3.33333333333%	1	30	220	Mendelian_Hereditary_Sensory_Neuropathy	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
3.33333333333%	1	30	22	Mendelian_Hereditary_Sensory_Neuropathy	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
3.33333333333%	1	30	22	Mendelian_Hereditary_Sensory_Neuropathy	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP
3.33333333333%	1	30	217	Mendelian_Hereditary_Sensory_Neuropathy	WONG_MITOCHONDRIA_GENE_MODULE
3.33333333333%	1	30	217	Mendelian_Hereditary_Sensory_Neuropathy	AMUNDSON_RESPONSE_TO_ARSENITE
3.33333333333%	1	30	216	Mendelian_Hereditary_Sensory_Neuropathy	WHITFIELD_CELL_CYCLE_G2_M
3.33333333333%	1	30	215	Mendelian_Hereditary_Sensory_Neuropathy	MARKEY_RB1_ACUTE_LOF_UP
3.33333333333%	1	30	214	Mendelian_Hereditary_Sensory_Neuropathy	ZWANG_EGF_INTERVAL_DN
3.33333333333%	1	30	214	Mendelian_Hereditary_Sensory_Neuropathy	KIM_WT1_TARGETS_UP
3.33333333333%	1	30	210	Mendelian_Hereditary_Sensory_Neuropathy	VERHAAK_GLIOBLASTOMA_PRONEURAL
3.33333333333%	1	30	210	Mendelian_Hereditary_Sensory_Neuropathy	CAIRO_HEPATOBLASTOMA_CLASSES_DN
3.33333333333%	1	30	21	Mendelian_Hereditary_Sensory_Neuropathy	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP
3.33333333333%	1	30	21	Mendelian_Hereditary_Sensory_Neuropathy	PID_P38_MK2PATHWAY
3.33333333333%	1	30	21	Mendelian_Hereditary_Sensory_Neuropathy	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
3.33333333333%	1	30	21	Mendelian_Hereditary_Sensory_Neuropathy	KANNAN_TP53_TARGETS_DN
3.33333333333%	1	30	21	Mendelian_Hereditary_Sensory_Neuropathy	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN
3.33333333333%	1	30	21	Mendelian_Hereditary_Sensory_Neuropathy	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN
3.33333333333%	1	30	21	Mendelian_Hereditary_Sensory_Neuropathy	GESERICK_TERT_TARGETS_DN
3.33333333333%	1	30	21	Mendelian_Hereditary_Sensory_Neuropathy	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE
3.33333333333%	1	30	209	Mendelian_Hereditary_Sensory_Neuropathy	GROSS_HYPOXIA_VIA_ELK3_UP
3.33333333333%	1	30	207	Mendelian_Hereditary_Sensory_Neuropathy	MANALO_HYPOXIA_UP
3.33333333333%	1	30	207	Mendelian_Hereditary_Sensory_Neuropathy	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
3.33333333333%	1	30	207	Mendelian_Hereditary_Sensory_Neuropathy	CAIRO_HEPATOBLASTOMA_UP
3.33333333333%	1	30	206	Mendelian_Hereditary_Sensory_Neuropathy	RAMALHO_STEMNESS_UP
3.33333333333%	1	30	206	Mendelian_Hereditary_Sensory_Neuropathy	LINSLEY_MIR16_TARGETS
3.33333333333%	1	30	205	Mendelian_Hereditary_Sensory_Neuropathy	SHEPARD_BMYB_MORPHOLINO_UP
3.33333333333%	1	30	204	Mendelian_Hereditary_Sensory_Neuropathy	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
3.33333333333%	1	30	203	Mendelian_Hereditary_Sensory_Neuropathy	PENG_RAPAMYCIN_RESPONSE_UP
3.33333333333%	1	30	203	Mendelian_Hereditary_Sensory_Neuropathy	GRUETZMANN_PANCREATIC_CANCER_DN
3.33333333333%	1	30	200	Mendelian_Hereditary_Sensory_Neuropathy	SHEPARD_BMYB_MORPHOLINO_DN
3.33333333333%	1	30	20	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_ENOS_ACTIVATION_AND_REGULATION
3.33333333333%	1	30	20	Mendelian_Hereditary_Sensory_Neuropathy	BIOCARTA_ACTINY_PATHWAY
3.33333333333%	1	30	20	Mendelian_Hereditary_Sensory_Neuropathy	ABE_VEGFA_TARGETS
3.33333333333%	1	30	199	Mendelian_Hereditary_Sensory_Neuropathy	PLASARI_TGFB1_TARGETS_10HR_UP
3.33333333333%	1	30	198	Mendelian_Hereditary_Sensory_Neuropathy	WELCSH_BRCA1_TARGETS_UP
3.33333333333%	1	30	197	Mendelian_Hereditary_Sensory_Neuropathy	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
3.33333333333%	1	30	196	Mendelian_Hereditary_Sensory_Neuropathy	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
3.33333333333%	1	30	195	Mendelian_Hereditary_Sensory_Neuropathy	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
3.33333333333%	1	30	194	Mendelian_Hereditary_Sensory_Neuropathy	PROVENZANI_METASTASIS_UP
3.33333333333%	1	30	193	Mendelian_Hereditary_Sensory_Neuropathy	MOHANKUMAR_TLX1_TARGETS_DN
3.33333333333%	1	30	193	Mendelian_Hereditary_Sensory_Neuropathy	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
3.33333333333%	1	30	191	Mendelian_Hereditary_Sensory_Neuropathy	YAGI_AML_FAB_MARKERS
3.33333333333%	1	30	19	Mendelian_Hereditary_Sensory_Neuropathy	ZHANG_RESPONSE_TO_CANTHARIDIN_UP
3.33333333333%	1	30	19	Mendelian_Hereditary_Sensory_Neuropathy	SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP
3.33333333333%	1	30	19	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS
3.33333333333%	1	30	19	Mendelian_Hereditary_Sensory_Neuropathy	CHEN_PDGF_TARGETS
3.33333333333%	1	30	19	Mendelian_Hereditary_Sensory_Neuropathy	BIOCARTA_MTA3_PATHWAY
3.33333333333%	1	30	19	Mendelian_Hereditary_Sensory_Neuropathy	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP
3.33333333333%	1	30	187	Mendelian_Hereditary_Sensory_Neuropathy	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
3.33333333333%	1	30	187	Mendelian_Hereditary_Sensory_Neuropathy	BAKKER_FOXO3_TARGETS_DN
3.33333333333%	1	30	186	Mendelian_Hereditary_Sensory_Neuropathy	WANG_CLIM2_TARGETS_DN
3.33333333333%	1	30	186	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
3.33333333333%	1	30	186	Mendelian_Hereditary_Sensory_Neuropathy	HAMAI_APOPTOSIS_VIA_TRAIL_DN
3.33333333333%	1	30	185	Mendelian_Hereditary_Sensory_Neuropathy	LEE_LIVER_CANCER_SURVIVAL_UP
3.33333333333%	1	30	184	Mendelian_Hereditary_Sensory_Neuropathy	DOANE_RESPONSE_TO_ANDROGEN_UP
3.33333333333%	1	30	183	Mendelian_Hereditary_Sensory_Neuropathy	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
3.33333333333%	1	30	183	Mendelian_Hereditary_Sensory_Neuropathy	VERHAAK_AML_WITH_NPM1_MUTATED_UP
3.33333333333%	1	30	182	Mendelian_Hereditary_Sensory_Neuropathy	RAO_BOUND_BY_SALL4_ISOFORM_A
3.33333333333%	1	30	182	Mendelian_Hereditary_Sensory_Neuropathy	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
3.33333333333%	1	30	182	Mendelian_Hereditary_Sensory_Neuropathy	FERNANDEZ_BOUND_BY_MYC
3.33333333333%	1	30	182	Mendelian_Hereditary_Sensory_Neuropathy	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
3.33333333333%	1	30	181	Mendelian_Hereditary_Sensory_Neuropathy	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
3.33333333333%	1	30	181	Mendelian_Hereditary_Sensory_Neuropathy	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
3.33333333333%	1	30	180	Mendelian_Hereditary_Sensory_Neuropathy	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
3.33333333333%	1	30	180	Mendelian_Hereditary_Sensory_Neuropathy	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
3.33333333333%	1	30	18	Mendelian_Hereditary_Sensory_Neuropathy	ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE
3.33333333333%	1	30	18	Mendelian_Hereditary_Sensory_Neuropathy	TOMIDA_METASTASIS_DN
3.33333333333%	1	30	18	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_GAP_JUNCTION_ASSEMBLY
3.33333333333%	1	30	18	Mendelian_Hereditary_Sensory_Neuropathy	BIOCARTA_ERK5_PATHWAY
3.33333333333%	1	30	18	Mendelian_Hereditary_Sensory_Neuropathy	ALONSO_METASTASIS_NEURAL_UP
3.33333333333%	1	30	178	Mendelian_Hereditary_Sensory_Neuropathy	LI_AMPLIFIED_IN_LUNG_CANCER
3.33333333333%	1	30	178	Mendelian_Hereditary_Sensory_Neuropathy	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
3.33333333333%	1	30	176	Mendelian_Hereditary_Sensory_Neuropathy	NAGASHIMA_NRG1_SIGNALING_UP
3.33333333333%	1	30	176	Mendelian_Hereditary_Sensory_Neuropathy	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
3.33333333333%	1	30	175	Mendelian_Hereditary_Sensory_Neuropathy	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
3.33333333333%	1	30	175	Mendelian_Hereditary_Sensory_Neuropathy	FIRESTEIN_PROLIFERATION
3.33333333333%	1	30	173	Mendelian_Hereditary_Sensory_Neuropathy	SENGUPTA_EBNA1_ANTICORRELATED
3.33333333333%	1	30	171	Mendelian_Hereditary_Sensory_Neuropathy	ELVIDGE_HYPOXIA_UP
3.33333333333%	1	30	171	Mendelian_Hereditary_Sensory_Neuropathy	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
3.33333333333%	1	30	170	Mendelian_Hereditary_Sensory_Neuropathy	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
3.33333333333%	1	30	17	Mendelian_Hereditary_Sensory_Neuropathy	ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL
3.33333333333%	1	30	17	Mendelian_Hereditary_Sensory_Neuropathy	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN
3.33333333333%	1	30	17	Mendelian_Hereditary_Sensory_Neuropathy	SA_TRKA_RECEPTOR
3.33333333333%	1	30	17	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE
3.33333333333%	1	30	17	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR
3.33333333333%	1	30	17	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_ARMS_MEDIATED_ACTIVATION
3.33333333333%	1	30	17	Mendelian_Hereditary_Sensory_Neuropathy	LE_SKI_TARGETS_UP
3.33333333333%	1	30	168	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
3.33333333333%	1	30	168	Mendelian_Hereditary_Sensory_Neuropathy	PUJANA_XPRSS_INT_NETWORK
3.33333333333%	1	30	166	Mendelian_Hereditary_Sensory_Neuropathy	SMIRNOV_RESPONSE_TO_IR_6HR_UP
3.33333333333%	1	30	165	Mendelian_Hereditary_Sensory_Neuropathy	LIU_CMYB_TARGETS_UP
3.33333333333%	1	30	165	Mendelian_Hereditary_Sensory_Neuropathy	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
3.33333333333%	1	30	162	Mendelian_Hereditary_Sensory_Neuropathy	WHITFIELD_CELL_CYCLE_S
3.33333333333%	1	30	162	Mendelian_Hereditary_Sensory_Neuropathy	MULLIGHAN_NPM1_SIGNATURE_3_DN
3.33333333333%	1	30	160	Mendelian_Hereditary_Sensory_Neuropathy	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
3.33333333333%	1	30	16	Mendelian_Hereditary_Sensory_Neuropathy	TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN
3.33333333333%	1	30	16	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_RIBOFLAVIN_METABOLISM
3.33333333333%	1	30	16	Mendelian_Hereditary_Sensory_Neuropathy	FARMER_BREAST_CANCER_CLUSTER_4
3.33333333333%	1	30	16	Mendelian_Hereditary_Sensory_Neuropathy	DASU_IL6_SIGNALING_SCAR_DN
3.33333333333%	1	30	16	Mendelian_Hereditary_Sensory_Neuropathy	CAFFAREL_RESPONSE_TO_THC_8HR_5_UP
3.33333333333%	1	30	159	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_PURINE_METABOLISM
3.33333333333%	1	30	157	Mendelian_Hereditary_Sensory_Neuropathy	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
3.33333333333%	1	30	156	Mendelian_Hereditary_Sensory_Neuropathy	GROSS_HYPOXIA_VIA_ELK3_DN
3.33333333333%	1	30	153	Mendelian_Hereditary_Sensory_Neuropathy	LU_AGING_BRAIN_DN
3.33333333333%	1	30	151	Mendelian_Hereditary_Sensory_Neuropathy	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
3.33333333333%	1	30	150	Mendelian_Hereditary_Sensory_Neuropathy	LANDIS_ERBB2_BREAST_TUMORS_324_UP
3.33333333333%	1	30	15	Mendelian_Hereditary_Sensory_Neuropathy	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP
3.33333333333%	1	30	15	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION
3.33333333333%	1	30	15	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN
3.33333333333%	1	30	15	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII
3.33333333333%	1	30	15	Mendelian_Hereditary_Sensory_Neuropathy	FIGUEROA_AML_METHYLATION_CLUSTER_4_DN
3.33333333333%	1	30	15	Mendelian_Hereditary_Sensory_Neuropathy	BIOCARTA_HSP27_PATHWAY
3.33333333333%	1	30	149	Mendelian_Hereditary_Sensory_Neuropathy	LANDIS_ERBB2_BREAST_TUMORS_324_DN
3.33333333333%	1	30	149	Mendelian_Hereditary_Sensory_Neuropathy	HUANG_GATA2_TARGETS_UP
3.33333333333%	1	30	148	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_APOPTOSIS
3.33333333333%	1	30	148	Mendelian_Hereditary_Sensory_Neuropathy	BROWNE_HCMV_INFECTION_24HR_DN
3.33333333333%	1	30	147	Mendelian_Hereditary_Sensory_Neuropathy	WHITFIELD_CELL_CYCLE_G1_S
3.33333333333%	1	30	147	Mendelian_Hereditary_Sensory_Neuropathy	BENPORATH_PROLIFERATION
3.33333333333%	1	30	146	Mendelian_Hereditary_Sensory_Neuropathy	PECE_MAMMARY_STEM_CELL_DN
3.33333333333%	1	30	146	Mendelian_Hereditary_Sensory_Neuropathy	KIM_ALL_DISORDERS_DURATION_CORR_DN
3.33333333333%	1	30	1442	Mendelian_Hereditary_Sensory_Neuropathy	PUJANA_ATM_PCC_NETWORK
3.33333333333%	1	30	144	Mendelian_Hereditary_Sensory_Neuropathy	BROCKE_APOPTOSIS_REVERSED_BY_IL6
3.33333333333%	1	30	142	Mendelian_Hereditary_Sensory_Neuropathy	XU_GH1_AUTOCRINE_TARGETS_DN
3.33333333333%	1	30	142	Mendelian_Hereditary_Sensory_Neuropathy	RUIZ_TNC_TARGETS_DN
3.33333333333%	1	30	142	Mendelian_Hereditary_Sensory_Neuropathy	PENG_LEUCINE_DEPRIVATION_UP
3.33333333333%	1	30	142	Mendelian_Hereditary_Sensory_Neuropathy	MIKKELSEN_ES_LCP_WITH_H3K4ME3
3.33333333333%	1	30	142	Mendelian_Hereditary_Sensory_Neuropathy	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
3.33333333333%	1	30	142	Mendelian_Hereditary_Sensory_Neuropathy	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
3.33333333333%	1	30	141	Mendelian_Hereditary_Sensory_Neuropathy	WELCSH_BRCA1_TARGETS_DN
3.33333333333%	1	30	141	Mendelian_Hereditary_Sensory_Neuropathy	SABATES_COLORECTAL_ADENOMA_UP
3.33333333333%	1	30	141	Mendelian_Hereditary_Sensory_Neuropathy	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
3.33333333333%	1	30	141	Mendelian_Hereditary_Sensory_Neuropathy	KAAB_FAILED_HEART_ATRIUM_DN
3.33333333333%	1	30	140	Mendelian_Hereditary_Sensory_Neuropathy	QI_HYPOXIA
3.33333333333%	1	30	140	Mendelian_Hereditary_Sensory_Neuropathy	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
3.33333333333%	1	30	14	Mendelian_Hereditary_Sensory_Neuropathy	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP
3.33333333333%	1	30	14	Mendelian_Hereditary_Sensory_Neuropathy	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24
3.33333333333%	1	30	14	Mendelian_Hereditary_Sensory_Neuropathy	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP
3.33333333333%	1	30	14	Mendelian_Hereditary_Sensory_Neuropathy	LIM_MAMMARY_LUMINAL_PROGENITOR_DN
3.33333333333%	1	30	139	Mendelian_Hereditary_Sensory_Neuropathy	HOELZEL_NF1_TARGETS_UP
3.33333333333%	1	30	138	Mendelian_Hereditary_Sensory_Neuropathy	JIANG_VHL_TARGETS
3.33333333333%	1	30	137	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
3.33333333333%	1	30	137	Mendelian_Hereditary_Sensory_Neuropathy	PID_P53DOWNSTREAMPATHWAY
3.33333333333%	1	30	136	Mendelian_Hereditary_Sensory_Neuropathy	PROVENZANI_METASTASIS_DN
3.33333333333%	1	30	135	Mendelian_Hereditary_Sensory_Neuropathy	UDAYAKUMAR_MED1_TARGETS_UP
3.33333333333%	1	30	135	Mendelian_Hereditary_Sensory_Neuropathy	TSENG_IRS1_TARGETS_DN
3.33333333333%	1	30	134	Mendelian_Hereditary_Sensory_Neuropathy	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
3.33333333333%	1	30	134	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_CELL_ADHESION_MOLECULES_CAMS
3.33333333333%	1	30	133	Mendelian_Hereditary_Sensory_Neuropathy	SENESE_HDAC2_TARGETS_DN
3.33333333333%	1	30	133	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_DIABETES_PATHWAYS
3.33333333333%	1	30	132	Mendelian_Hereditary_Sensory_Neuropathy	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
3.33333333333%	1	30	132	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
3.33333333333%	1	30	132	Mendelian_Hereditary_Sensory_Neuropathy	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
3.33333333333%	1	30	131	Mendelian_Hereditary_Sensory_Neuropathy	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
3.33333333333%	1	30	131	Mendelian_Hereditary_Sensory_Neuropathy	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
3.33333333333%	1	30	130	Mendelian_Hereditary_Sensory_Neuropathy	ELVIDGE_HYPOXIA_BY_DMOG_UP
3.33333333333%	1	30	13	Mendelian_Hereditary_Sensory_Neuropathy	XU_RESPONSE_TO_TRETINOIN_DN
3.33333333333%	1	30	13	Mendelian_Hereditary_Sensory_Neuropathy	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD
3.33333333333%	1	30	13	Mendelian_Hereditary_Sensory_Neuropathy	KIM_MYCL1_AMPLIFICATION_TARGETS_UP
3.33333333333%	1	30	13	Mendelian_Hereditary_Sensory_Neuropathy	GERHOLD_RESPONSE_TO_TZD_DN
3.33333333333%	1	30	13	Mendelian_Hereditary_Sensory_Neuropathy	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN
3.33333333333%	1	30	129	Mendelian_Hereditary_Sensory_Neuropathy	PID_PDGFRBPATHWAY
3.33333333333%	1	30	129	Mendelian_Hereditary_Sensory_Neuropathy	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP
3.33333333333%	1	30	128	Mendelian_Hereditary_Sensory_Neuropathy	ZHU_CMV_ALL_DN
3.33333333333%	1	30	128	Mendelian_Hereditary_Sensory_Neuropathy	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS
3.33333333333%	1	30	128	Mendelian_Hereditary_Sensory_Neuropathy	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
3.33333333333%	1	30	127	Mendelian_Hereditary_Sensory_Neuropathy	KARLSSON_TGFB1_TARGETS_UP
3.33333333333%	1	30	127	Mendelian_Hereditary_Sensory_Neuropathy	INGRAM_SHH_TARGETS_UP
3.33333333333%	1	30	127	Mendelian_Hereditary_Sensory_Neuropathy	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
3.33333333333%	1	30	126	Mendelian_Hereditary_Sensory_Neuropathy	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
3.33333333333%	1	30	126	Mendelian_Hereditary_Sensory_Neuropathy	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
3.33333333333%	1	30	126	Mendelian_Hereditary_Sensory_Neuropathy	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
3.33333333333%	1	30	126	Mendelian_Hereditary_Sensory_Neuropathy	BURTON_ADIPOGENESIS_5
3.33333333333%	1	30	124	Mendelian_Hereditary_Sensory_Neuropathy	DAIRKEE_TERT_TARGETS_DN
3.33333333333%	1	30	123	Mendelian_Hereditary_Sensory_Neuropathy	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
3.33333333333%	1	30	123	Mendelian_Hereditary_Sensory_Neuropathy	HOOI_ST7_TARGETS_DN
3.33333333333%	1	30	122	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_CHROMOSOME_MAINTENANCE
3.33333333333%	1	30	121	Mendelian_Hereditary_Sensory_Neuropathy	RODRIGUES_DCC_TARGETS_DN
3.33333333333%	1	30	121	Mendelian_Hereditary_Sensory_Neuropathy	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
3.33333333333%	1	30	121	Mendelian_Hereditary_Sensory_Neuropathy	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
3.33333333333%	1	30	12	Mendelian_Hereditary_Sensory_Neuropathy	PETRETTO_BLOOD_PRESSURE_UP
3.33333333333%	1	30	12	Mendelian_Hereditary_Sensory_Neuropathy	PARK_TRETINOIN_RESPONSE
3.33333333333%	1	30	12	Mendelian_Hereditary_Sensory_Neuropathy	MCBRYAN_TERMINAL_END_BUD_UP
3.33333333333%	1	30	12	Mendelian_Hereditary_Sensory_Neuropathy	MALIK_REPRESSED_BY_ESTROGEN
3.33333333333%	1	30	12	Mendelian_Hereditary_Sensory_Neuropathy	LEI_HOXC8_TARGETS_UP
3.33333333333%	1	30	12	Mendelian_Hereditary_Sensory_Neuropathy	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS
3.33333333333%	1	30	12	Mendelian_Hereditary_Sensory_Neuropathy	BIOCARTA_TRKA_PATHWAY
3.33333333333%	1	30	12	Mendelian_Hereditary_Sensory_Neuropathy	BIOCARTA_RAB_PATHWAY
3.33333333333%	1	30	119	Mendelian_Hereditary_Sensory_Neuropathy	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
3.33333333333%	1	30	118	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_TOLL_RECEPTOR_CASCADES
3.33333333333%	1	30	117	Mendelian_Hereditary_Sensory_Neuropathy	PUJANA_BRCA_CENTERED_NETWORK
3.33333333333%	1	30	116	Mendelian_Hereditary_Sensory_Neuropathy	WHITEFORD_PEDIATRIC_CANCER_MARKERS
3.33333333333%	1	30	116	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_MEIOSIS
3.33333333333%	1	30	116	Mendelian_Hereditary_Sensory_Neuropathy	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
3.33333333333%	1	30	1137	Mendelian_Hereditary_Sensory_Neuropathy	BRUINS_UVC_RESPONSE_LATE
3.33333333333%	1	30	113	Mendelian_Hereditary_Sensory_Neuropathy	TSENG_IRS1_TARGETS_UP
3.33333333333%	1	30	113	Mendelian_Hereditary_Sensory_Neuropathy	RICKMAN_HEAD_AND_NECK_CANCER_C
3.33333333333%	1	30	113	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_SIGNALING_BY_RHO_GTPASES
3.33333333333%	1	30	113	Mendelian_Hereditary_Sensory_Neuropathy	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
3.33333333333%	1	30	113	Mendelian_Hereditary_Sensory_Neuropathy	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
3.33333333333%	1	30	112	Mendelian_Hereditary_Sensory_Neuropathy	LAIHO_COLORECTAL_CANCER_SERRATED_UP
3.33333333333%	1	30	112	Mendelian_Hereditary_Sensory_Neuropathy	DITTMER_PTHLH_TARGETS_UP
3.33333333333%	1	30	111	Mendelian_Hereditary_Sensory_Neuropathy	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
3.33333333333%	1	30	111	Mendelian_Hereditary_Sensory_Neuropathy	BOUDOUKHA_BOUND_BY_IGF2BP2
3.33333333333%	1	30	109	Mendelian_Hereditary_Sensory_Neuropathy	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
3.33333333333%	1	30	108	Mendelian_Hereditary_Sensory_Neuropathy	LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT
3.33333333333%	1	30	108	Mendelian_Hereditary_Sensory_Neuropathy	JAZAG_TGFB1_SIGNALING_UP
3.33333333333%	1	30	107	Mendelian_Hereditary_Sensory_Neuropathy	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
3.33333333333%	1	30	105	Mendelian_Hereditary_Sensory_Neuropathy	WOO_LIVER_CANCER_RECURRENCE_UP
3.33333333333%	1	30	104	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
3.33333333333%	1	30	104	Mendelian_Hereditary_Sensory_Neuropathy	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
3.33333333333%	1	30	104	Mendelian_Hereditary_Sensory_Neuropathy	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
3.33333333333%	1	30	103	Mendelian_Hereditary_Sensory_Neuropathy	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
3.33333333333%	1	30	103	Mendelian_Hereditary_Sensory_Neuropathy	LEIN_CHOROID_PLEXUS_MARKERS
3.33333333333%	1	30	103	Mendelian_Hereditary_Sensory_Neuropathy	KIM_MYCN_AMPLIFICATION_TARGETS_DN
3.33333333333%	1	30	103	Mendelian_Hereditary_Sensory_Neuropathy	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
3.33333333333%	1	30	1024	Mendelian_Hereditary_Sensory_Neuropathy	NUYTTEN_EZH2_TARGETS_DN
3.33333333333%	1	30	1022	Mendelian_Hereditary_Sensory_Neuropathy	MARSON_BOUND_BY_FOXP3_STIMULATED
3.33333333333%	1	30	102	Mendelian_Hereditary_Sensory_Neuropathy	LABBE_TGFB1_TARGETS_UP
3.33333333333%	1	30	102	Mendelian_Hereditary_Sensory_Neuropathy	KANG_IMMORTALIZED_BY_TERT_DN
3.33333333333%	1	30	102	Mendelian_Hereditary_Sensory_Neuropathy	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
3.33333333333%	1	30	101	Mendelian_Hereditary_Sensory_Neuropathy	BROWNE_HCMV_INFECTION_20HR_DN
3.33333333333%	1	30	101	Mendelian_Hereditary_Sensory_Neuropathy	BROWNE_HCMV_INFECTION_12HR_DN
3.33333333333%	1	30	101	Mendelian_Hereditary_Sensory_Neuropathy	BASSO_CD40_SIGNALING_UP
3.33333333333%	1	30	100	Mendelian_Hereditary_Sensory_Neuropathy	MCCLUNG_CREB1_TARGETS_UP
3.33333333333%	1	30	100	Mendelian_Hereditary_Sensory_Neuropathy	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
3.33333333333%	1	30	10	Mendelian_Hereditary_Sensory_Neuropathy	TSUDA_ALVEOLAR_SOFT_PART_SARCOMA
3.33333333333%	1	30	10	Mendelian_Hereditary_Sensory_Neuropathy	REACTOME_GAP_JUNCTION_DEGRADATION
3.33333333333%	1	30	10	Mendelian_Hereditary_Sensory_Neuropathy	CHASSOT_SKIN_WOUND
3.33333333333%	1	30	10	Mendelian_Hereditary_Sensory_Neuropathy	CAFFAREL_RESPONSE_TO_THC_8HR_3_DN
3.32829046899%	22	661	933	T2D_GENES_TANYA_GLYCEMIC	REACTOME_IMMUNE_SYSTEM
3.32829046899%	22	661	745	T2D_GENES_TANYA_GLYCEMIC	LEE_BMP2_TARGETS_UP
3.32829046899%	22	661	549	T2D_GENES_TANYA_GLYCEMIC	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
3.32829046899%	22	661	413	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
3.32409972299%	12	361	973	T2D_GENES_TANYA_T2D_RSQ05_02CM	ACEVEDO_LIVER_CANCER_UP
3.32409972299%	12	361	882	T2D_GENES_TANYA_T2D_RSQ05_02CM	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
3.32409972299%	12	361	800	T2D_GENES_TANYA_T2D_RSQ05_02CM	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
3.32409972299%	12	361	795	T2D_GENES_TANYA_T2D_RSQ05_02CM	WEI_MYCN_TARGETS_WITH_E_BOX
3.32409972299%	12	361	770	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
3.32409972299%	12	361	612	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
3.32409972299%	12	361	1038	T2D_GENES_TANYA_T2D_RSQ05_02CM	BENPORATH_SUZ12_TARGETS
3.32103321033%	18	542	893	T2D_GENES_TANYA_ANTHROPOMETRIC	GEORGES_TARGETS_OF_MIR192_AND_MIR215
3.32103321033%	18	542	848	T2D_GENES_TANYA_ANTHROPOMETRIC	NUYTTEN_NIPP1_TARGETS_DN
3.32103321033%	18	542	805	T2D_GENES_TANYA_ANTHROPOMETRIC	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
3.32103321033%	18	542	805	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GPCR_DOWNSTREAM_SIGNALING
3.32103321033%	18	542	539	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
3.32103321033%	18	542	530	T2D_GENES_TANYA_ANTHROPOMETRIC	ENK_UV_RESPONSE_KERATINOCYTE_UP
3.32103321033%	18	542	517	T2D_GENES_TANYA_ANTHROPOMETRIC	RAO_BOUND_BY_SALL4_ISOFORM_B
3.32103321033%	18	542	493	T2D_GENES_TANYA_ANTHROPOMETRIC	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
3.32103321033%	18	542	487	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
3.32103321033%	18	542	487	T2D_GENES_TANYA_ANTHROPOMETRIC	RODWELL_AGING_KIDNEY_UP
3.32103321033%	18	542	473	T2D_GENES_TANYA_ANTHROPOMETRIC	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
3.32103321033%	18	542	466	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_HEMOSTASIS
3.32103321033%	18	542	429	T2D_GENES_TANYA_ANTHROPOMETRIC	MOOTHA_HUMAN_MITODB_6_2002
3.32103321033%	18	542	389	T2D_GENES_TANYA_ANTHROPOMETRIC	HSIAO_HOUSEKEEPING_GENES
3.32103321033%	18	542	180	T2D_GENES_TANYA_ANTHROPOMETRIC	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
3.31373597007%	62	1871	745	T2D_GENES_TANYA_HEIGHT	LEE_BMP2_TARGETS_UP
3.31373597007%	62	1871	591	T2D_GENES_TANYA_HEIGHT	MARTINEZ_RB1_AND_TP53_TARGETS_DN
3.31373597007%	62	1871	566	T2D_GENES_TANYA_HEIGHT	DOUGLAS_BMI1_TARGETS_UP
3.31373597007%	62	1871	514	T2D_GENES_TANYA_HEIGHT	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
3.31373597007%	62	1871	421	T2D_GENES_TANYA_HEIGHT	REACTOME_CELL_CYCLE
3.3118675253%	72	2174	734	T2D_GENES_TANYA_LIPIDS	BENPORATH_SOX2_TARGETS
3.30007674597%	43	1303	1821	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DODD_NASOPHARYNGEAL_CARCINOMA_UP
3.30007674597%	43	1303	1278	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
3.30007674597%	43	1303	1069	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
3.2967032967%	15	455	920	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_GPCR
3.2967032967%	15	455	784	T2D_GENES_TANYA_BLOODPRESSURE	FORTSCHEGGER_PHF8_TARGETS_DN
3.2967032967%	15	455	681	T2D_GENES_TANYA_BLOODPRESSURE	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
3.2967032967%	15	455	637	T2D_GENES_TANYA_BLOODPRESSURE	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
3.2967032967%	15	455	546	T2D_GENES_TANYA_BLOODPRESSURE	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
3.2967032967%	15	455	510	T2D_GENES_TANYA_BLOODPRESSURE	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
3.2967032967%	15	455	476	T2D_GENES_TANYA_BLOODPRESSURE	SMID_BREAST_CANCER_NORMAL_LIKE_UP
3.2967032967%	15	455	456	T2D_GENES_TANYA_BLOODPRESSURE	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
3.2967032967%	15	455	397	T2D_GENES_TANYA_BLOODPRESSURE	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
3.2967032967%	15	455	393	T2D_GENES_TANYA_BLOODPRESSURE	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
3.2967032967%	15	455	371	T2D_GENES_TANYA_BLOODPRESSURE	WANG_SMARCE1_TARGETS_DN
3.2967032967%	15	455	293	T2D_GENES_TANYA_BLOODPRESSURE	ENK_UV_RESPONSE_EPIDERMIS_UP
3.2928064843%	65	1974	544	Mendelian_Nancy_Cox	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
3.2928064843%	65	1974	463	Mendelian_Nancy_Cox	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
3.2928064843%	65	1974	423	Mendelian_Nancy_Cox	THUM_SYSTOLIC_HEART_FAILURE_UP
3.2928064843%	65	1974	423	Mendelian_Nancy_Cox	PUJANA_BRCA2_PCC_NETWORK
3.2928064843%	65	1974	390	Mendelian_Nancy_Cox	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
3.2928064843%	65	1974	318	Mendelian_Nancy_Cox	LEI_MYB_TARGETS
3.26704545455%	115	3520	1024	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NUYTTEN_EZH2_TARGETS_DN
3.26586936523%	71	2174	701	T2D_GENES_TANYA_LIPIDS	SMID_BREAST_CANCER_BASAL_DN
3.26586936523%	71	2174	567	T2D_GENES_TANYA_LIPIDS	PARENT_MTOR_SIGNALING_UP
3.26264274062%	20	613	857	T2D_GENES_TANYA_BIOMARKER	MARTENS_TRETINOIN_RESPONSE_UP
3.26264274062%	20	613	800	T2D_GENES_TANYA_BIOMARKER	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
3.26264274062%	20	613	567	T2D_GENES_TANYA_BIOMARKER	PARENT_MTOR_SIGNALING_UP
3.26264274062%	20	613	540	T2D_GENES_TANYA_BIOMARKER	ACEVEDO_LIVER_CANCER_DN
3.26264274062%	20	613	536	T2D_GENES_TANYA_BIOMARKER	BERENJENO_TRANSFORMED_BY_RHOA_UP
3.26264274062%	20	613	530	T2D_GENES_TANYA_BIOMARKER	ENK_UV_RESPONSE_KERATINOCYTE_UP
3.26264274062%	20	613	505	T2D_GENES_TANYA_BIOMARKER	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
3.26264274062%	20	613	479	T2D_GENES_TANYA_BIOMARKER	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
3.26028861571%	61	1871	721	T2D_GENES_TANYA_HEIGHT	WONG_ADULT_TISSUE_STEM_MODULE
3.25064157399%	38	1169	783	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ONKEN_UVEAL_MELANOMA_UP
3.25064157399%	38	1169	1069	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
3.242147923%	64	1974	578	Mendelian_Nancy_Cox	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
3.242147923%	64	1974	505	Mendelian_Nancy_Cox	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
3.242147923%	64	1974	456	Mendelian_Nancy_Cox	MARTENS_BOUND_BY_PML_RARA_FUSION
3.242147923%	64	1974	418	Mendelian_Nancy_Cox	MULLIGHAN_MLL_SIGNATURE_2_UP
3.242147923%	64	1974	392	Mendelian_Nancy_Cox	LINDGREN_BLADDER_CANCER_CLUSTER_2B
3.242147923%	64	1974	315	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
3.23089046493%	41	1269	920	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_GPCR
3.23089046493%	41	1269	1080	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
3.22580645161%	4	124	98	Diabetes_McGill_Cell_cycle_All_Gene	PYEON_HPV_POSITIVE_TUMORS_UP
3.22580645161%	4	124	98	Diabetes_McGill_Cell_cycle_All_Gene	HAHTOLA_SEZARY_SYNDROM_UP
3.22580645161%	4	124	92	Diabetes_McGill_Cell_cycle_All_Gene	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
3.22580645161%	4	124	9	Diabetes_McGill_Cell_cycle_All_Gene	ZHU_SKIL_TARGETS_DN
3.22580645161%	4	124	89	Diabetes_McGill_Cell_cycle_All_Gene	DELASERNA_MYOD_TARGETS_UP
3.22580645161%	4	124	87	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_MAPK_PATHWAY
3.22580645161%	4	124	86	Diabetes_McGill_Cell_cycle_All_Gene	NGUYEN_NOTCH1_TARGETS_DN
3.22580645161%	4	124	83	Diabetes_McGill_Cell_cycle_All_Gene	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
3.22580645161%	4	124	82	Diabetes_McGill_Cell_cycle_All_Gene	FRASOR_RESPONSE_TO_ESTRADIOL_DN
3.22580645161%	4	124	81	Diabetes_McGill_Cell_cycle_All_Gene	HARRIS_HYPOXIA
3.22580645161%	4	124	805	Diabetes_McGill_Cell_cycle_All_Gene	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
3.22580645161%	4	124	80	Diabetes_McGill_Cell_cycle_All_Gene	LEE_AGING_NEOCORTEX_DN
3.22580645161%	4	124	80	Diabetes_McGill_Cell_cycle_All_Gene	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
3.22580645161%	4	124	79	Diabetes_McGill_Cell_cycle_All_Gene	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
3.22580645161%	4	124	79	Diabetes_McGill_Cell_cycle_All_Gene	DUAN_PRDM5_TARGETS
3.22580645161%	4	124	77	Diabetes_McGill_Cell_cycle_All_Gene	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
3.22580645161%	4	124	756	Diabetes_McGill_Cell_cycle_All_Gene	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
3.22580645161%	4	124	75	Diabetes_McGill_Cell_cycle_All_Gene	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
3.22580645161%	4	124	66	Diabetes_McGill_Cell_cycle_All_Gene	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM
3.22580645161%	4	124	66	Diabetes_McGill_Cell_cycle_All_Gene	PID_HIF1_TFPATHWAY
3.22580645161%	4	124	66	Diabetes_McGill_Cell_cycle_All_Gene	PID_HDAC_CLASSI_PATHWAY
3.22580645161%	4	124	66	Diabetes_McGill_Cell_cycle_All_Gene	NAKAMURA_ADIPOGENESIS_EARLY_UP
3.22580645161%	4	124	64	Diabetes_McGill_Cell_cycle_All_Gene	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
3.22580645161%	4	124	63	Diabetes_McGill_Cell_cycle_All_Gene	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
3.22580645161%	4	124	60	Diabetes_McGill_Cell_cycle_All_Gene	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
3.22580645161%	4	124	6	Diabetes_McGill_Cell_cycle_All_Gene	CROSBY_E2F4_TARGETS
3.22580645161%	4	124	59	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
3.22580645161%	4	124	59	Diabetes_McGill_Cell_cycle_All_Gene	BARIS_THYROID_CANCER_DN
3.22580645161%	4	124	58	Diabetes_McGill_Cell_cycle_All_Gene	WAKASUGI_HAVE_ZNF143_BINDING_SITES
3.22580645161%	4	124	58	Diabetes_McGill_Cell_cycle_All_Gene	SCHEIDEREIT_IKK_INTERACTING_PROTEINS
3.22580645161%	4	124	58	Diabetes_McGill_Cell_cycle_All_Gene	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN
3.22580645161%	4	124	58	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_PPARA_PATHWAY
3.22580645161%	4	124	564	Diabetes_McGill_Cell_cycle_All_Gene	SMID_BREAST_CANCER_LUMINAL_B_DN
3.22580645161%	4	124	56	Diabetes_McGill_Cell_cycle_All_Gene	HOQUE_METHYLATED_IN_CANCER
3.22580645161%	4	124	55	Diabetes_McGill_Cell_cycle_All_Gene	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
3.22580645161%	4	124	546	Diabetes_McGill_Cell_cycle_All_Gene	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
3.22580645161%	4	124	544	Diabetes_McGill_Cell_cycle_All_Gene	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
3.22580645161%	4	124	53	Diabetes_McGill_Cell_cycle_All_Gene	SMIRNOV_RESPONSE_TO_IR_2HR_UP
3.22580645161%	4	124	53	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_CIRCADIAN_CLOCK
3.22580645161%	4	124	52	Diabetes_McGill_Cell_cycle_All_Gene	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
3.22580645161%	4	124	52	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_ENDOMETRIAL_CANCER
3.22580645161%	4	124	52	Diabetes_McGill_Cell_cycle_All_Gene	BECKER_TAMOXIFEN_RESISTANCE_DN
3.22580645161%	4	124	51	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT
3.22580645161%	4	124	504	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_48HR_DN
3.22580645161%	4	124	50	Diabetes_McGill_Cell_cycle_All_Gene	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
3.22580645161%	4	124	50	Diabetes_McGill_Cell_cycle_All_Gene	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC
3.22580645161%	4	124	48	Diabetes_McGill_Cell_cycle_All_Gene	PID_HEDGEHOG_GLIPATHWAY
3.22580645161%	4	124	47	Diabetes_McGill_Cell_cycle_All_Gene	WARTERS_IR_RESPONSE_5GY
3.22580645161%	4	124	47	Diabetes_McGill_Cell_cycle_All_Gene	KHETCHOUMIAN_TRIM24_TARGETS_UP
3.22580645161%	4	124	47	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_NOTCH_SIGNALING_PATHWAY
3.22580645161%	4	124	46	Diabetes_McGill_Cell_cycle_All_Gene	NAKAMURA_CANCER_MICROENVIRONMENT_DN
3.22580645161%	4	124	456	Diabetes_McGill_Cell_cycle_All_Gene	ODONNELL_TFRC_TARGETS_UP
3.22580645161%	4	124	456	Diabetes_McGill_Cell_cycle_All_Gene	MARTENS_BOUND_BY_PML_RARA_FUSION
3.22580645161%	4	124	455	Diabetes_McGill_Cell_cycle_All_Gene	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
3.22580645161%	4	124	443	Diabetes_McGill_Cell_cycle_All_Gene	DELYS_THYROID_CANCER_UP
3.22580645161%	4	124	442	Diabetes_McGill_Cell_cycle_All_Gene	HAN_SATB1_TARGETS_DN
3.22580645161%	4	124	44	Diabetes_McGill_Cell_cycle_All_Gene	STREICHER_LSM1_TARGETS_UP
3.22580645161%	4	124	44	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_NUCLEOTIDE_EXCISION_REPAIR
3.22580645161%	4	124	430	Diabetes_McGill_Cell_cycle_All_Gene	JOHNSTONE_PARVB_TARGETS_3_UP
3.22580645161%	4	124	414	Diabetes_McGill_Cell_cycle_All_Gene	LU_EZH2_TARGETS_DN
3.22580645161%	4	124	411	Diabetes_McGill_Cell_cycle_All_Gene	KOYAMA_SEMA3B_TARGETS_DN
3.22580645161%	4	124	41	Diabetes_McGill_Cell_cycle_All_Gene	RIZ_ERYTHROID_DIFFERENTIATION_HBZ
3.22580645161%	4	124	409	Diabetes_McGill_Cell_cycle_All_Gene	FOSTER_TOLERANT_MACROPHAGE_DN
3.22580645161%	4	124	408	Diabetes_McGill_Cell_cycle_All_Gene	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
3.22580645161%	4	124	408	Diabetes_McGill_Cell_cycle_All_Gene	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
3.22580645161%	4	124	40	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_P38MAPK_PATHWAY
3.22580645161%	4	124	40	Diabetes_McGill_Cell_cycle_All_Gene	BENPORATH_ES_2
3.22580645161%	4	124	393	Diabetes_McGill_Cell_cycle_All_Gene	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
3.22580645161%	4	124	391	Diabetes_McGill_Cell_cycle_All_Gene	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
3.22580645161%	4	124	39	Diabetes_McGill_Cell_cycle_All_Gene	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2
3.22580645161%	4	124	39	Diabetes_McGill_Cell_cycle_All_Gene	MATZUK_MEIOTIC_AND_DNA_REPAIR
3.22580645161%	4	124	38	Diabetes_McGill_Cell_cycle_All_Gene	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN
3.22580645161%	4	124	373	Diabetes_McGill_Cell_cycle_All_Gene	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
3.22580645161%	4	124	372	Diabetes_McGill_Cell_cycle_All_Gene	WANG_LMO4_TARGETS_UP
3.22580645161%	4	124	37	Diabetes_McGill_Cell_cycle_All_Gene	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
3.22580645161%	4	124	37	Diabetes_McGill_Cell_cycle_All_Gene	PID_FRA_PATHWAY
3.22580645161%	4	124	366	Diabetes_McGill_Cell_cycle_All_Gene	SANSOM_APC_TARGETS_DN
3.22580645161%	4	124	36	Diabetes_McGill_Cell_cycle_All_Gene	YIH_RESPONSE_TO_ARSENITE_C3
3.22580645161%	4	124	34	Diabetes_McGill_Cell_cycle_All_Gene	FRIDMAN_IMMORTALIZATION_DN
3.22580645161%	4	124	332	Diabetes_McGill_Cell_cycle_All_Gene	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
3.22580645161%	4	124	330	Diabetes_McGill_Cell_cycle_All_Gene	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
3.22580645161%	4	124	317	Diabetes_McGill_Cell_cycle_All_Gene	HELLER_HDAC_TARGETS_UP
3.22580645161%	4	124	317	Diabetes_McGill_Cell_cycle_All_Gene	BRUINS_UVC_RESPONSE_EARLY_LATE
3.22580645161%	4	124	311	Diabetes_McGill_Cell_cycle_All_Gene	JIANG_HYPOXIA_NORMAL
3.22580645161%	4	124	31	Diabetes_McGill_Cell_cycle_All_Gene	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN
3.22580645161%	4	124	31	Diabetes_McGill_Cell_cycle_All_Gene	SIMBULAN_PARP1_TARGETS_UP
3.22580645161%	4	124	31	Diabetes_McGill_Cell_cycle_All_Gene	DANG_MYC_TARGETS_DN
3.22580645161%	4	124	31	Diabetes_McGill_Cell_cycle_All_Gene	CAFFAREL_RESPONSE_TO_THC_DN
3.22580645161%	4	124	30	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
3.22580645161%	4	124	298	Diabetes_McGill_Cell_cycle_All_Gene	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
3.22580645161%	4	124	293	Diabetes_McGill_Cell_cycle_All_Gene	ENK_UV_RESPONSE_EPIDERMIS_UP
3.22580645161%	4	124	289	Diabetes_McGill_Cell_cycle_All_Gene	GABRIELY_MIR21_TARGETS
3.22580645161%	4	124	287	Diabetes_McGill_Cell_cycle_All_Gene	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
3.22580645161%	4	124	28	Diabetes_McGill_Cell_cycle_All_Gene	MOREIRA_RESPONSE_TO_TSA_UP
3.22580645161%	4	124	276	Diabetes_McGill_Cell_cycle_All_Gene	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
3.22580645161%	4	124	275	Diabetes_McGill_Cell_cycle_All_Gene	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
3.22580645161%	4	124	27	Diabetes_McGill_Cell_cycle_All_Gene	PID_GLYPICAN_1PATHWAY
3.22580645161%	4	124	27	Diabetes_McGill_Cell_cycle_All_Gene	CHIN_BREAST_CANCER_COPY_NUMBER_UP
3.22580645161%	4	124	261	Diabetes_McGill_Cell_cycle_All_Gene	BILD_HRAS_ONCOGENIC_SIGNATURE
3.22580645161%	4	124	26	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS
3.22580645161%	4	124	26	Diabetes_McGill_Cell_cycle_All_Gene	PID_P38_MKK3_6PATHWAY
3.22580645161%	4	124	26	Diabetes_McGill_Cell_cycle_All_Gene	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
3.22580645161%	4	124	26	Diabetes_McGill_Cell_cycle_All_Gene	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
3.22580645161%	4	124	255	Diabetes_McGill_Cell_cycle_All_Gene	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
3.22580645161%	4	124	254	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_4HR_DN
3.22580645161%	4	124	25	Diabetes_McGill_Cell_cycle_All_Gene	PID_HDAC_CLASSIII_PATHWAY
3.22580645161%	4	124	245	Diabetes_McGill_Cell_cycle_All_Gene	BLUM_RESPONSE_TO_SALIRASIB_UP
3.22580645161%	4	124	240	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_20HR_UP
3.22580645161%	4	124	24	Diabetes_McGill_Cell_cycle_All_Gene	WANG_LSD1_TARGETS_UP
3.22580645161%	4	124	24	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_NTHI_PATHWAY
3.22580645161%	4	124	238	Diabetes_McGill_Cell_cycle_All_Gene	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
3.22580645161%	4	124	235	Diabetes_McGill_Cell_cycle_All_Gene	RUTELLA_RESPONSE_TO_HGF_DN
3.22580645161%	4	124	232	Diabetes_McGill_Cell_cycle_All_Gene	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
3.22580645161%	4	124	23	Diabetes_McGill_Cell_cycle_All_Gene	PID_PRLSIGNALINGEVENTSPATHWAY
3.22580645161%	4	124	23	Diabetes_McGill_Cell_cycle_All_Gene	MARKS_HDAC_TARGETS_UP
3.22580645161%	4	124	23	Diabetes_McGill_Cell_cycle_All_Gene	FERRANDO_HOX11_NEIGHBORS
3.22580645161%	4	124	228	Diabetes_McGill_Cell_cycle_All_Gene	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
3.22580645161%	4	124	227	Diabetes_McGill_Cell_cycle_All_Gene	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
3.22580645161%	4	124	225	Diabetes_McGill_Cell_cycle_All_Gene	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
3.22580645161%	4	124	215	Diabetes_McGill_Cell_cycle_All_Gene	YAMAZAKI_TCEB3_TARGETS_DN
3.22580645161%	4	124	214	Diabetes_McGill_Cell_cycle_All_Gene	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
3.22580645161%	4	124	214	Diabetes_McGill_Cell_cycle_All_Gene	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
3.22580645161%	4	124	214	Diabetes_McGill_Cell_cycle_All_Gene	KIM_WT1_TARGETS_UP
3.22580645161%	4	124	212	Diabetes_McGill_Cell_cycle_All_Gene	CHANG_CORE_SERUM_RESPONSE_UP
3.22580645161%	4	124	21	Diabetes_McGill_Cell_cycle_All_Gene	MACLACHLAN_BRCA1_TARGETS_UP
3.22580645161%	4	124	209	Diabetes_McGill_Cell_cycle_All_Gene	CHANG_CORE_SERUM_RESPONSE_DN
3.22580645161%	4	124	208	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
3.22580645161%	4	124	207	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_HIV_INFECTION
3.22580645161%	4	124	206	Diabetes_McGill_Cell_cycle_All_Gene	BILD_MYC_ONCOGENIC_SIGNATURE
3.22580645161%	4	124	201	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_FOCAL_ADHESION
3.22580645161%	4	124	20	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY
3.22580645161%	4	124	198	Diabetes_McGill_Cell_cycle_All_Gene	WELCSH_BRCA1_TARGETS_UP
3.22580645161%	4	124	19	Diabetes_McGill_Cell_cycle_All_Gene	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS
3.22580645161%	4	124	19	Diabetes_McGill_Cell_cycle_All_Gene	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
3.22580645161%	4	124	1821	Diabetes_McGill_Cell_cycle_All_Gene	DODD_NASOPHARYNGEAL_CARCINOMA_UP
3.22580645161%	4	124	17	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS
3.22580645161%	4	124	17	Diabetes_McGill_Cell_cycle_All_Gene	DORMOY_ELAVL1_TARGETS
3.22580645161%	4	124	166	Diabetes_McGill_Cell_cycle_All_Gene	SMIRNOV_RESPONSE_TO_IR_6HR_UP
3.22580645161%	4	124	165	Diabetes_McGill_Cell_cycle_All_Gene	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
3.22580645161%	4	124	164	Diabetes_McGill_Cell_cycle_All_Gene	AMIT_EGF_RESPONSE_480_HELA
3.22580645161%	4	124	162	Diabetes_McGill_Cell_cycle_All_Gene	WHITFIELD_CELL_CYCLE_S
3.22580645161%	4	124	160	Diabetes_McGill_Cell_cycle_All_Gene	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
3.22580645161%	4	124	16	Diabetes_McGill_Cell_cycle_All_Gene	SCHAVOLT_TARGETS_OF_TP53_AND_TP63
3.22580645161%	4	124	16	Diabetes_McGill_Cell_cycle_All_Gene	LY_AGING_MIDDLE_DN
3.22580645161%	4	124	15	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_PITX2_PATHWAY
3.22580645161%	4	124	148	Diabetes_McGill_Cell_cycle_All_Gene	WHITFIELD_CELL_CYCLE_M_G1
3.22580645161%	4	124	148	Diabetes_McGill_Cell_cycle_All_Gene	WEI_MIR34A_TARGETS
3.22580645161%	4	124	148	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_APOPTOSIS
3.22580645161%	4	124	144	Diabetes_McGill_Cell_cycle_All_Gene	BROCKE_APOPTOSIS_REVERSED_BY_IL6
3.22580645161%	4	124	141	Diabetes_McGill_Cell_cycle_All_Gene	KAAB_FAILED_HEART_ATRIUM_DN
3.22580645161%	4	124	140	Diabetes_McGill_Cell_cycle_All_Gene	ONDER_CDH1_TARGETS_1_UP
3.22580645161%	4	124	140	Diabetes_McGill_Cell_cycle_All_Gene	JOHNSTONE_PARVB_TARGETS_2_UP
3.22580645161%	4	124	13	Diabetes_McGill_Cell_cycle_All_Gene	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
3.22580645161%	4	124	121	Diabetes_McGill_Cell_cycle_All_Gene	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP
3.22580645161%	4	124	117	Diabetes_McGill_Cell_cycle_All_Gene	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
3.22580645161%	4	124	116	Diabetes_McGill_Cell_cycle_All_Gene	IKEDA_MIR30_TARGETS_UP
3.22580645161%	4	124	111	Diabetes_McGill_Cell_cycle_All_Gene	WANG_HCP_PROSTATE_CANCER
3.22580645161%	4	124	110	Diabetes_McGill_Cell_cycle_All_Gene	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
3.22580645161%	4	124	1080	Diabetes_McGill_Cell_cycle_All_Gene	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
3.22580645161%	4	124	108	Diabetes_McGill_Cell_cycle_All_Gene	ZHANG_TLX_TARGETS_DN
3.22580645161%	4	124	1062	Diabetes_McGill_Cell_cycle_All_Gene	BENPORATH_EED_TARGETS
3.22580645161%	4	124	1038	Diabetes_McGill_Cell_cycle_All_Gene	BENPORATH_SUZ12_TARGETS
3.22580645161%	4	124	1037	Diabetes_McGill_Cell_cycle_All_Gene	NUYTTEN_EZH2_TARGETS_UP
3.22580645161%	4	124	103	Diabetes_McGill_Cell_cycle_All_Gene	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
3.22580645161%	1	31	99	Diabetes_McGill_IL10	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
3.22580645161%	1	31	98	Diabetes_McGill_IL10	GAVIN_FOXP3_TARGETS_CLUSTER_T7
3.22580645161%	1	31	98	Diabetes_McGill_IL10	CROONQUIST_IL6_DEPRIVATION_DN
3.22580645161%	1	31	973	Diabetes_McGill_IL10	ACEVEDO_LIVER_CANCER_UP
3.22580645161%	1	31	97	Diabetes_McGill_IL10	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
3.22580645161%	1	31	97	Diabetes_McGill_IL10	KONG_E2F3_TARGETS
3.22580645161%	1	31	96	Diabetes_McGill_IL10	ZAMORA_NOS2_TARGETS_DN
3.22580645161%	1	31	953	Diabetes_McGill_IL10	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
3.22580645161%	1	31	95	Diabetes_McGill_IL10	HECKER_IFNB1_TARGETS
3.22580645161%	1	31	95	Diabetes_McGill_IL10	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
3.22580645161%	1	31	940	Diabetes_McGill_IL10	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
3.22580645161%	1	31	94	Diabetes_McGill_IL10	GAVIN_FOXP3_TARGETS_CLUSTER_T4
3.22580645161%	1	31	93	Diabetes_McGill_IL10	ZHU_CMV_24_HR_UP
3.22580645161%	1	31	93	Diabetes_McGill_IL10	CADWELL_ATG16L1_TARGETS_UP
3.22580645161%	1	31	92	Diabetes_McGill_IL10	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
3.22580645161%	1	31	92	Diabetes_McGill_IL10	REACTOME_SYNTHESIS_OF_DNA
3.22580645161%	1	31	92	Diabetes_McGill_IL10	KEGG_DILATED_CARDIOMYOPATHY
3.22580645161%	1	31	92	Diabetes_McGill_IL10	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
3.22580645161%	1	31	92	Diabetes_McGill_IL10	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
3.22580645161%	1	31	91	Diabetes_McGill_IL10	ZHU_CMV_24_HR_DN
3.22580645161%	1	31	91	Diabetes_McGill_IL10	GAVIN_FOXP3_TARGETS_CLUSTER_P6
3.22580645161%	1	31	90	Diabetes_McGill_IL10	SASSON_RESPONSE_TO_FORSKOLIN_UP
3.22580645161%	1	31	90	Diabetes_McGill_IL10	IGARASHI_ATF4_TARGETS_DN
3.22580645161%	1	31	90	Diabetes_McGill_IL10	HILLION_HMGA1_TARGETS
3.22580645161%	1	31	90	Diabetes_McGill_IL10	GAVIN_FOXP3_TARGETS_CLUSTER_P7
3.22580645161%	1	31	9	Diabetes_McGill_IL10	ST_JAK_STAT_PATHWAY
3.22580645161%	1	31	9	Diabetes_McGill_IL10	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK
3.22580645161%	1	31	9	Diabetes_McGill_IL10	FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1
3.22580645161%	1	31	9	Diabetes_McGill_IL10	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA
3.22580645161%	1	31	89	Diabetes_McGill_IL10	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
3.22580645161%	1	31	89	Diabetes_McGill_IL10	ZHANG_TLX_TARGETS_UP
3.22580645161%	1	31	89	Diabetes_McGill_IL10	SWEET_KRAS_ONCOGENIC_SIGNATURE
3.22580645161%	1	31	89	Diabetes_McGill_IL10	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
3.22580645161%	1	31	89	Diabetes_McGill_IL10	KANG_IMMORTALIZED_BY_TERT_UP
3.22580645161%	1	31	89	Diabetes_McGill_IL10	DELASERNA_MYOD_TARGETS_UP
3.22580645161%	1	31	88	Diabetes_McGill_IL10	UEDA_CENTRAL_CLOCK
3.22580645161%	1	31	88	Diabetes_McGill_IL10	TIEN_INTESTINE_PROBIOTICS_2HR_DN
3.22580645161%	1	31	88	Diabetes_McGill_IL10	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
3.22580645161%	1	31	88	Diabetes_McGill_IL10	KEGG_HEMATOPOIETIC_CELL_LINEAGE
3.22580645161%	1	31	88	Diabetes_McGill_IL10	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
3.22580645161%	1	31	87	Diabetes_McGill_IL10	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
3.22580645161%	1	31	87	Diabetes_McGill_IL10	SMITH_TERT_TARGETS_DN
3.22580645161%	1	31	87	Diabetes_McGill_IL10	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
3.22580645161%	1	31	87	Diabetes_McGill_IL10	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION
3.22580645161%	1	31	87	Diabetes_McGill_IL10	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
3.22580645161%	1	31	87	Diabetes_McGill_IL10	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
3.22580645161%	1	31	87	Diabetes_McGill_IL10	MOOTHA_VOXPHOS
3.22580645161%	1	31	87	Diabetes_McGill_IL10	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
3.22580645161%	1	31	87	Diabetes_McGill_IL10	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
3.22580645161%	1	31	87	Diabetes_McGill_IL10	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
3.22580645161%	1	31	86	Diabetes_McGill_IL10	NGUYEN_NOTCH1_TARGETS_DN
3.22580645161%	1	31	86	Diabetes_McGill_IL10	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
3.22580645161%	1	31	86	Diabetes_McGill_IL10	LEE_AGING_CEREBELLUM_DN
3.22580645161%	1	31	85	Diabetes_McGill_IL10	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
3.22580645161%	1	31	85	Diabetes_McGill_IL10	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE
3.22580645161%	1	31	85	Diabetes_McGill_IL10	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
3.22580645161%	1	31	85	Diabetes_McGill_IL10	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
3.22580645161%	1	31	84	Diabetes_McGill_IL10	SWEET_KRAS_TARGETS_UP
3.22580645161%	1	31	84	Diabetes_McGill_IL10	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP
3.22580645161%	1	31	84	Diabetes_McGill_IL10	LEE_AGING_CEREBELLUM_UP
3.22580645161%	1	31	84	Diabetes_McGill_IL10	KIM_GLIS2_TARGETS_UP
3.22580645161%	1	31	84	Diabetes_McGill_IL10	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
3.22580645161%	1	31	83	Diabetes_McGill_IL10	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
3.22580645161%	1	31	82	Diabetes_McGill_IL10	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
3.22580645161%	1	31	82	Diabetes_McGill_IL10	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
3.22580645161%	1	31	82	Diabetes_McGill_IL10	PID_REG_GR_PATHWAY
3.22580645161%	1	31	82	Diabetes_McGill_IL10	ODONNELL_METASTASIS_UP
3.22580645161%	1	31	82	Diabetes_McGill_IL10	BHAT_ESR1_TARGETS_VIA_AKT1_DN
3.22580645161%	1	31	81	Diabetes_McGill_IL10	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
3.22580645161%	1	31	81	Diabetes_McGill_IL10	REACTOME_MITOTIC_G2_G2_M_PHASES
3.22580645161%	1	31	81	Diabetes_McGill_IL10	MAHAJAN_RESPONSE_TO_IL1A_UP
3.22580645161%	1	31	81	Diabetes_McGill_IL10	LEIN_MEDULLA_MARKERS
3.22580645161%	1	31	81	Diabetes_McGill_IL10	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
3.22580645161%	1	31	81	Diabetes_McGill_IL10	HARRIS_HYPOXIA
3.22580645161%	1	31	805	Diabetes_McGill_IL10	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
3.22580645161%	1	31	80	Diabetes_McGill_IL10	SCHUHMACHER_MYC_TARGETS_UP
3.22580645161%	1	31	80	Diabetes_McGill_IL10	BASSO_HAIRY_CELL_LEUKEMIA_DN
3.22580645161%	1	31	8	Diabetes_McGill_IL10	TURJANSKI_MAPK7_TARGETS
3.22580645161%	1	31	8	Diabetes_McGill_IL10	TCGA_GLIOBLASTOMA_MUTATED
3.22580645161%	1	31	8	Diabetes_McGill_IL10	STANHILL_HRAS_TRANSFROMATION_UP
3.22580645161%	1	31	8	Diabetes_McGill_IL10	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN
3.22580645161%	1	31	8	Diabetes_McGill_IL10	MIKKELSEN_PLURIPOTENT_STATE_DN
3.22580645161%	1	31	8	Diabetes_McGill_IL10	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2
3.22580645161%	1	31	8	Diabetes_McGill_IL10	CHANG_POU5F1_TARGETS_DN
3.22580645161%	1	31	8	Diabetes_McGill_IL10	BOYLAN_MULTIPLE_MYELOMA_PCA1_DN
3.22580645161%	1	31	8	Diabetes_McGill_IL10	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP
3.22580645161%	1	31	795	Diabetes_McGill_IL10	WEI_MYCN_TARGETS_WITH_E_BOX
3.22580645161%	1	31	79	Diabetes_McGill_IL10	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
3.22580645161%	1	31	79	Diabetes_McGill_IL10	CROMER_METASTASIS_UP
3.22580645161%	1	31	783	Diabetes_McGill_IL10	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
3.22580645161%	1	31	781	Diabetes_McGill_IL10	GOZGIT_ESR1_TARGETS_DN
3.22580645161%	1	31	78	Diabetes_McGill_IL10	ROSS_LEUKEMIA_WITH_MLL_FUSIONS
3.22580645161%	1	31	78	Diabetes_McGill_IL10	REACTOME_PLATELET_HOMEOSTASIS
3.22580645161%	1	31	77	Diabetes_McGill_IL10	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
3.22580645161%	1	31	77	Diabetes_McGill_IL10	LIN_APC_TARGETS
3.22580645161%	1	31	769	Diabetes_McGill_IL10	NUYTTEN_NIPP1_TARGETS_UP
3.22580645161%	1	31	76	Diabetes_McGill_IL10	ROSS_AML_WITH_AML1_ETO_FUSION
3.22580645161%	1	31	76	Diabetes_McGill_IL10	PEART_HDAC_PROLIFERATION_CLUSTER_DN
3.22580645161%	1	31	76	Diabetes_McGill_IL10	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
3.22580645161%	1	31	75	Diabetes_McGill_IL10	MORI_MATURE_B_LYMPHOCYTE_DN
3.22580645161%	1	31	75	Diabetes_McGill_IL10	JAIN_NFKB_SIGNALING
3.22580645161%	1	31	75	Diabetes_McGill_IL10	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
3.22580645161%	1	31	74	Diabetes_McGill_IL10	WESTON_VEGFA_TARGETS_3HR
3.22580645161%	1	31	74	Diabetes_McGill_IL10	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
3.22580645161%	1	31	74	Diabetes_McGill_IL10	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
3.22580645161%	1	31	74	Diabetes_McGill_IL10	LIAN_LIPA_TARGETS_6M
3.22580645161%	1	31	74	Diabetes_McGill_IL10	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
3.22580645161%	1	31	74	Diabetes_McGill_IL10	JI_RESPONSE_TO_FSH_UP
3.22580645161%	1	31	74	Diabetes_McGill_IL10	FURUKAWA_DUSP6_TARGETS_PCI35_UP
3.22580645161%	1	31	74	Diabetes_McGill_IL10	FURUKAWA_DUSP6_TARGETS_PCI35_DN
3.22580645161%	1	31	74	Diabetes_McGill_IL10	DARWICHE_PAPILLOMA_PROGRESSION_RISK
3.22580645161%	1	31	73	Diabetes_McGill_IL10	KEGG_VIRAL_MYOCARDITIS
3.22580645161%	1	31	73	Diabetes_McGill_IL10	DITTMER_PTHLH_TARGETS_DN
3.22580645161%	1	31	73	Diabetes_McGill_IL10	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
3.22580645161%	1	31	720	Diabetes_McGill_IL10	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
3.22580645161%	1	31	72	Diabetes_McGill_IL10	SESTO_RESPONSE_TO_UV_C1
3.22580645161%	1	31	72	Diabetes_McGill_IL10	MATZUK_SPERMATOCYTE
3.22580645161%	1	31	72	Diabetes_McGill_IL10	CROONQUIST_NRAS_SIGNALING_DN
3.22580645161%	1	31	72	Diabetes_McGill_IL10	BURTON_ADIPOGENESIS_2
3.22580645161%	1	31	701	Diabetes_McGill_IL10	SMID_BREAST_CANCER_BASAL_DN
3.22580645161%	1	31	70	Diabetes_McGill_IL10	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
3.22580645161%	1	31	70	Diabetes_McGill_IL10	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5
3.22580645161%	1	31	70	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_NOTCH1
3.22580645161%	1	31	70	Diabetes_McGill_IL10	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
3.22580645161%	1	31	7	Diabetes_McGill_IL10	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN
3.22580645161%	1	31	7	Diabetes_McGill_IL10	TESAR_ALK_TARGETS_HUMAN_ES_5D_DN
3.22580645161%	1	31	7	Diabetes_McGill_IL10	TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP
3.22580645161%	1	31	7	Diabetes_McGill_IL10	SCHRAMM_INHBA_TARGETS_UP
3.22580645161%	1	31	7	Diabetes_McGill_IL10	KUWANO_RNA_STABILIZED_BY_NO
3.22580645161%	1	31	7	Diabetes_McGill_IL10	HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER
3.22580645161%	1	31	7	Diabetes_McGill_IL10	FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES
3.22580645161%	1	31	7	Diabetes_McGill_IL10	BUSA_SAM68_TARGETS_UP
3.22580645161%	1	31	7	Diabetes_McGill_IL10	BUDHU_LIVER_CANCER_METASTASIS_DN
3.22580645161%	1	31	69	Diabetes_McGill_IL10	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
3.22580645161%	1	31	69	Diabetes_McGill_IL10	ZAMORA_NOS2_TARGETS_UP
3.22580645161%	1	31	69	Diabetes_McGill_IL10	RHODES_UNDIFFERENTIATED_CANCER
3.22580645161%	1	31	69	Diabetes_McGill_IL10	PID_P75NTRPATHWAY
3.22580645161%	1	31	69	Diabetes_McGill_IL10	PID_MTOR_4PATHWAY
3.22580645161%	1	31	69	Diabetes_McGill_IL10	LEIN_NEURON_MARKERS
3.22580645161%	1	31	69	Diabetes_McGill_IL10	HOWLIN_PUBERTAL_MAMMARY_GLAND
3.22580645161%	1	31	69	Diabetes_McGill_IL10	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
3.22580645161%	1	31	682	Diabetes_McGill_IL10	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
3.22580645161%	1	31	68	Diabetes_McGill_IL10	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
3.22580645161%	1	31	67	Diabetes_McGill_IL10	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
3.22580645161%	1	31	67	Diabetes_McGill_IL10	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN
3.22580645161%	1	31	67	Diabetes_McGill_IL10	LINDSTEDT_DENDRITIC_CELL_MATURATION_A
3.22580645161%	1	31	67	Diabetes_McGill_IL10	ELVIDGE_HIF1A_TARGETS_UP
3.22580645161%	1	31	668	Diabetes_McGill_IL10	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
3.22580645161%	1	31	66	Diabetes_McGill_IL10	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
3.22580645161%	1	31	66	Diabetes_McGill_IL10	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES
3.22580645161%	1	31	66	Diabetes_McGill_IL10	PID_HIF1_TFPATHWAY
3.22580645161%	1	31	66	Diabetes_McGill_IL10	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
3.22580645161%	1	31	66	Diabetes_McGill_IL10	BEIER_GLIOMA_STEM_CELL_DN
3.22580645161%	1	31	658	Diabetes_McGill_IL10	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
3.22580645161%	1	31	65	Diabetes_McGill_IL10	ST_FAS_SIGNALING_PATHWAY
3.22580645161%	1	31	65	Diabetes_McGill_IL10	PID_CD8TCRDOWNSTREAMPATHWAY
3.22580645161%	1	31	65	Diabetes_McGill_IL10	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS
3.22580645161%	1	31	65	Diabetes_McGill_IL10	AMIT_SERUM_RESPONSE_120_MCF10A
3.22580645161%	1	31	64	Diabetes_McGill_IL10	RHODES_CANCER_META_SIGNATURE
3.22580645161%	1	31	64	Diabetes_McGill_IL10	INGRAM_SHH_TARGETS_DN
3.22580645161%	1	31	64	Diabetes_McGill_IL10	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
3.22580645161%	1	31	633	Diabetes_McGill_IL10	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
3.22580645161%	1	31	63	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
3.22580645161%	1	31	63	Diabetes_McGill_IL10	PID_ENDOTHELINPATHWAY
3.22580645161%	1	31	63	Diabetes_McGill_IL10	PHONG_TNF_TARGETS_UP
3.22580645161%	1	31	63	Diabetes_McGill_IL10	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
3.22580645161%	1	31	63	Diabetes_McGill_IL10	CROMER_TUMORIGENESIS_UP
3.22580645161%	1	31	63	Diabetes_McGill_IL10	BILBAN_B_CLL_LPL_UP
3.22580645161%	1	31	62	Diabetes_McGill_IL10	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
3.22580645161%	1	31	62	Diabetes_McGill_IL10	KYNG_DNA_DAMAGE_BY_UV
3.22580645161%	1	31	62	Diabetes_McGill_IL10	GEORGES_CELL_CYCLE_MIR192_TARGETS
3.22580645161%	1	31	62	Diabetes_McGill_IL10	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP
3.22580645161%	1	31	62	Diabetes_McGill_IL10	BILD_SRC_ONCOGENIC_SIGNATURE
3.22580645161%	1	31	612	Diabetes_McGill_IL10	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
3.22580645161%	1	31	61	Diabetes_McGill_IL10	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
3.22580645161%	1	31	61	Diabetes_McGill_IL10	REN_BOUND_BY_E2F
3.22580645161%	1	31	61	Diabetes_McGill_IL10	LEE_LIVER_CANCER_MYC_TGFA_UP
3.22580645161%	1	31	61	Diabetes_McGill_IL10	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
3.22580645161%	1	31	60	Diabetes_McGill_IL10	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
3.22580645161%	1	31	60	Diabetes_McGill_IL10	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
3.22580645161%	1	31	6	Diabetes_McGill_IL10	TESAR_ALK_TARGETS_HUMAN_ES_4D_DN
3.22580645161%	1	31	6	Diabetes_McGill_IL10	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6
3.22580645161%	1	31	6	Diabetes_McGill_IL10	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_14
3.22580645161%	1	31	6	Diabetes_McGill_IL10	KAPOSI_LIVER_CANCER_MET_DN
3.22580645161%	1	31	6	Diabetes_McGill_IL10	IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM
3.22580645161%	1	31	59	Diabetes_McGill_IL10	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
3.22580645161%	1	31	59	Diabetes_McGill_IL10	LIAN_LIPA_TARGETS_3M
3.22580645161%	1	31	59	Diabetes_McGill_IL10	DASU_IL6_SIGNALING_UP
3.22580645161%	1	31	584	Diabetes_McGill_IL10	HAMAI_APOPTOSIS_VIA_TRAIL_UP
3.22580645161%	1	31	58	Diabetes_McGill_IL10	ZHENG_GLIOBLASTOMA_PLASTICITY_DN
3.22580645161%	1	31	58	Diabetes_McGill_IL10	SCHEIDEREIT_IKK_INTERACTING_PROTEINS
3.22580645161%	1	31	58	Diabetes_McGill_IL10	NAGASHIMA_NRG1_SIGNALING_DN
3.22580645161%	1	31	58	Diabetes_McGill_IL10	NADLER_HYPERGLYCEMIA_AT_OBESITY
3.22580645161%	1	31	58	Diabetes_McGill_IL10	MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
3.22580645161%	1	31	58	Diabetes_McGill_IL10	MIKKELSEN_NPC_LCP_WITH_H3K4ME3
3.22580645161%	1	31	58	Diabetes_McGill_IL10	JI_RESPONSE_TO_FSH_DN
3.22580645161%	1	31	58	Diabetes_McGill_IL10	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
3.22580645161%	1	31	58	Diabetes_McGill_IL10	BIOCARTA_HIVNEF_PATHWAY
3.22580645161%	1	31	572	Diabetes_McGill_IL10	CHICAS_RB1_TARGETS_SENESCENT
3.22580645161%	1	31	57	Diabetes_McGill_IL10	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
3.22580645161%	1	31	57	Diabetes_McGill_IL10	TANG_SENESCENCE_TP53_TARGETS_DN
3.22580645161%	1	31	57	Diabetes_McGill_IL10	GRABARCZYK_BCL11B_TARGETS_DN
3.22580645161%	1	31	57	Diabetes_McGill_IL10	DIRMEIER_LMP1_RESPONSE_LATE_UP
3.22580645161%	1	31	57	Diabetes_McGill_IL10	BORLAK_LIVER_CANCER_EGF_UP
3.22580645161%	1	31	57	Diabetes_McGill_IL10	AMIT_SERUM_RESPONSE_240_MCF10A
3.22580645161%	1	31	566	Diabetes_McGill_IL10	DOUGLAS_BMI1_TARGETS_UP
3.22580645161%	1	31	56	Diabetes_McGill_IL10	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21
3.22580645161%	1	31	56	Diabetes_McGill_IL10	LY_AGING_OLD_DN
3.22580645161%	1	31	552	Diabetes_McGill_IL10	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
3.22580645161%	1	31	55	Diabetes_McGill_IL10	YU_MYC_TARGETS_DN
3.22580645161%	1	31	55	Diabetes_McGill_IL10	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
3.22580645161%	1	31	55	Diabetes_McGill_IL10	TIEN_INTESTINE_PROBIOTICS_6HR_UP
3.22580645161%	1	31	55	Diabetes_McGill_IL10	PID_TGFBRPATHWAY
3.22580645161%	1	31	55	Diabetes_McGill_IL10	GENTILE_UV_RESPONSE_CLUSTER_D4
3.22580645161%	1	31	548	Diabetes_McGill_IL10	KIM_ALL_DISORDERS_CALB1_CORR_UP
3.22580645161%	1	31	546	Diabetes_McGill_IL10	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
3.22580645161%	1	31	544	Diabetes_McGill_IL10	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
3.22580645161%	1	31	543	Diabetes_McGill_IL10	MARTINEZ_RB1_TARGETS_DN
3.22580645161%	1	31	54	Diabetes_McGill_IL10	SU_PANCREAS
3.22580645161%	1	31	54	Diabetes_McGill_IL10	SESTO_RESPONSE_TO_UV_C2
3.22580645161%	1	31	54	Diabetes_McGill_IL10	MIKKELSEN_IPS_ICP_WITH_H3K27ME3
3.22580645161%	1	31	54	Diabetes_McGill_IL10	MARSON_FOXP3_TARGETS_DN
3.22580645161%	1	31	54	Diabetes_McGill_IL10	JIANG_AGING_CEREBRAL_CORTEX_DN
3.22580645161%	1	31	536	Diabetes_McGill_IL10	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
3.22580645161%	1	31	535	Diabetes_McGill_IL10	STEIN_ESRRA_TARGETS
3.22580645161%	1	31	530	Diabetes_McGill_IL10	ENK_UV_RESPONSE_KERATINOCYTE_UP
3.22580645161%	1	31	53	Diabetes_McGill_IL10	ZHU_CMV_8_HR_DN
3.22580645161%	1	31	53	Diabetes_McGill_IL10	SMIRNOV_RESPONSE_TO_IR_2HR_UP
3.22580645161%	1	31	53	Diabetes_McGill_IL10	MORI_IMMATURE_B_LYMPHOCYTE_UP
3.22580645161%	1	31	53	Diabetes_McGill_IL10	KRIEG_HYPOXIA_VIA_KDM3A
3.22580645161%	1	31	53	Diabetes_McGill_IL10	KEGG_AUTOIMMUNE_THYROID_DISEASE
3.22580645161%	1	31	53	Diabetes_McGill_IL10	ISHIDA_E2F_TARGETS
3.22580645161%	1	31	53	Diabetes_McGill_IL10	HENDRICKS_SMARCA4_TARGETS_DN
3.22580645161%	1	31	53	Diabetes_McGill_IL10	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN
3.22580645161%	1	31	52	Diabetes_McGill_IL10	VILIMAS_NOTCH1_TARGETS_UP
3.22580645161%	1	31	52	Diabetes_McGill_IL10	ROSS_AML_WITH_CBFB_MYH11_FUSION
3.22580645161%	1	31	52	Diabetes_McGill_IL10	PID_CASPASE_PATHWAY
3.22580645161%	1	31	52	Diabetes_McGill_IL10	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6
3.22580645161%	1	31	52	Diabetes_McGill_IL10	HALMOS_CEBPA_TARGETS_UP
3.22580645161%	1	31	52	Diabetes_McGill_IL10	BECKER_TAMOXIFEN_RESISTANCE_DN
3.22580645161%	1	31	514	Diabetes_McGill_IL10	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
3.22580645161%	1	31	51	Diabetes_McGill_IL10	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
3.22580645161%	1	31	51	Diabetes_McGill_IL10	LUI_THYROID_CANCER_CLUSTER_1
3.22580645161%	1	31	51	Diabetes_McGill_IL10	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN
3.22580645161%	1	31	51	Diabetes_McGill_IL10	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
3.22580645161%	1	31	51	Diabetes_McGill_IL10	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
3.22580645161%	1	31	51	Diabetes_McGill_IL10	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP
3.22580645161%	1	31	51	Diabetes_McGill_IL10	BURTON_ADIPOGENESIS_7
3.22580645161%	1	31	51	Diabetes_McGill_IL10	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
3.22580645161%	1	31	505	Diabetes_McGill_IL10	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
3.22580645161%	1	31	50	Diabetes_McGill_IL10	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
3.22580645161%	1	31	50	Diabetes_McGill_IL10	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
3.22580645161%	1	31	50	Diabetes_McGill_IL10	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
3.22580645161%	1	31	50	Diabetes_McGill_IL10	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
3.22580645161%	1	31	5	Diabetes_McGill_IL10	WANG_THOC1_TARGETS_UP
3.22580645161%	1	31	5	Diabetes_McGill_IL10	RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP
3.22580645161%	1	31	5	Diabetes_McGill_IL10	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2
3.22580645161%	1	31	5	Diabetes_McGill_IL10	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_11
3.22580645161%	1	31	5	Diabetes_McGill_IL10	KERLEY_RESPONSE_TO_CISPLATIN_DN
3.22580645161%	1	31	5	Diabetes_McGill_IL10	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP
3.22580645161%	1	31	5	Diabetes_McGill_IL10	BIERIE_INFLAMMATORY_RESPONSE_TGFB1
3.22580645161%	1	31	491	Diabetes_McGill_IL10	MEISSNER_NPC_HCP_WITH_H3K4ME2
3.22580645161%	1	31	49	Diabetes_McGill_IL10	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8
3.22580645161%	1	31	49	Diabetes_McGill_IL10	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
3.22580645161%	1	31	49	Diabetes_McGill_IL10	OLSSON_E2F3_TARGETS_DN
3.22580645161%	1	31	49	Diabetes_McGill_IL10	GERHOLD_ADIPOGENESIS_UP
3.22580645161%	1	31	49	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_2HR_DN
3.22580645161%	1	31	487	Diabetes_McGill_IL10	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
3.22580645161%	1	31	48	Diabetes_McGill_IL10	PID_HES_HEYPATHWAY
3.22580645161%	1	31	48	Diabetes_McGill_IL10	OXFORD_RALA_OR_RALB_TARGETS_UP
3.22580645161%	1	31	48	Diabetes_McGill_IL10	KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
3.22580645161%	1	31	48	Diabetes_McGill_IL10	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
3.22580645161%	1	31	48	Diabetes_McGill_IL10	DELACROIX_RAR_TARGETS_UP
3.22580645161%	1	31	476	Diabetes_McGill_IL10	SMID_BREAST_CANCER_NORMAL_LIKE_UP
3.22580645161%	1	31	475	Diabetes_McGill_IL10	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
3.22580645161%	1	31	47	Diabetes_McGill_IL10	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
3.22580645161%	1	31	47	Diabetes_McGill_IL10	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN
3.22580645161%	1	31	47	Diabetes_McGill_IL10	POTTI_DOCETAXEL_SENSITIVITY
3.22580645161%	1	31	47	Diabetes_McGill_IL10	PID_NFAT_TFPATHWAY
3.22580645161%	1	31	47	Diabetes_McGill_IL10	PID_LKB1_PATHWAY
3.22580645161%	1	31	47	Diabetes_McGill_IL10	MELLMAN_TUT1_TARGETS_DN
3.22580645161%	1	31	463	Diabetes_McGill_IL10	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
3.22580645161%	1	31	461	Diabetes_McGill_IL10	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
3.22580645161%	1	31	46	Diabetes_McGill_IL10	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6
3.22580645161%	1	31	46	Diabetes_McGill_IL10	SESTO_RESPONSE_TO_UV_C5
3.22580645161%	1	31	46	Diabetes_McGill_IL10	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION
3.22580645161%	1	31	46	Diabetes_McGill_IL10	PID_TNFPATHWAY
3.22580645161%	1	31	46	Diabetes_McGill_IL10	PID_SYNDECAN_1_PATHWAY
3.22580645161%	1	31	46	Diabetes_McGill_IL10	NUTT_GBM_VS_AO_GLIOMA_UP
3.22580645161%	1	31	46	Diabetes_McGill_IL10	AMIT_EGF_RESPONSE_60_HELA
3.22580645161%	1	31	456	Diabetes_McGill_IL10	ODONNELL_TFRC_TARGETS_UP
3.22580645161%	1	31	45	Diabetes_McGill_IL10	ZHAN_MULTIPLE_MYELOMA_CD1_DN
3.22580645161%	1	31	45	Diabetes_McGill_IL10	WANG_TARGETS_OF_MLL_CBP_FUSION_DN
3.22580645161%	1	31	45	Diabetes_McGill_IL10	VANHARANTA_UTERINE_FIBROID_UP
3.22580645161%	1	31	45	Diabetes_McGill_IL10	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
3.22580645161%	1	31	45	Diabetes_McGill_IL10	PID_RHOA_PATHWAY
3.22580645161%	1	31	45	Diabetes_McGill_IL10	PID_ILK_PATHWAY
3.22580645161%	1	31	45	Diabetes_McGill_IL10	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN
3.22580645161%	1	31	45	Diabetes_McGill_IL10	CHENG_RESPONSE_TO_NICKEL_ACETATE
3.22580645161%	1	31	448	Diabetes_McGill_IL10	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
3.22580645161%	1	31	447	Diabetes_McGill_IL10	MOOTHA_MITOCHONDRIA
3.22580645161%	1	31	442	Diabetes_McGill_IL10	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
3.22580645161%	1	31	44	Diabetes_McGill_IL10	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
3.22580645161%	1	31	44	Diabetes_McGill_IL10	MEDINA_SMARCA4_TARGETS
3.22580645161%	1	31	44	Diabetes_McGill_IL10	LUI_THYROID_CANCER_PAX8_PPARG_UP
3.22580645161%	1	31	44	Diabetes_McGill_IL10	KORKOLA_SEMINOMA_UP
3.22580645161%	1	31	44	Diabetes_McGill_IL10	KEGG_TYPE_I_DIABETES_MELLITUS
3.22580645161%	1	31	44	Diabetes_McGill_IL10	GROSS_HYPOXIA_VIA_ELK3_ONLY_DN
3.22580645161%	1	31	44	Diabetes_McGill_IL10	FARMER_BREAST_CANCER_CLUSTER_1
3.22580645161%	1	31	439	Diabetes_McGill_IL10	MITSIADES_RESPONSE_TO_APLIDIN_UP
3.22580645161%	1	31	435	Diabetes_McGill_IL10	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
3.22580645161%	1	31	434	Diabetes_McGill_IL10	BAELDE_DIABETIC_NEPHROPATHY_DN
3.22580645161%	1	31	431	Diabetes_McGill_IL10	GARY_CD5_TARGETS_DN
3.22580645161%	1	31	430	Diabetes_McGill_IL10	VECCHI_GASTRIC_CANCER_EARLY_UP
3.22580645161%	1	31	43	Diabetes_McGill_IL10	ZUCCHI_METASTASIS_UP
3.22580645161%	1	31	43	Diabetes_McGill_IL10	PID_THROMBIN_PAR1_PATHWAY
3.22580645161%	1	31	43	Diabetes_McGill_IL10	MILI_PSEUDOPODIA
3.22580645161%	1	31	43	Diabetes_McGill_IL10	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
3.22580645161%	1	31	43	Diabetes_McGill_IL10	DORN_ADENOVIRUS_INFECTION_24HR_DN
3.22580645161%	1	31	43	Diabetes_McGill_IL10	BURTON_ADIPOGENESIS_PEAK_AT_24HR
3.22580645161%	1	31	429	Diabetes_McGill_IL10	MOOTHA_HUMAN_MITODB_6_2002
3.22580645161%	1	31	428	Diabetes_McGill_IL10	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
3.22580645161%	1	31	425	Diabetes_McGill_IL10	ZHANG_BREAST_CANCER_PROGENITORS_UP
3.22580645161%	1	31	425	Diabetes_McGill_IL10	BOCHKIS_FOXA2_TARGETS
3.22580645161%	1	31	420	Diabetes_McGill_IL10	MOOTHA_PGC
3.22580645161%	1	31	42	Diabetes_McGill_IL10	PID_UPA_UPAR_PATHWAY
3.22580645161%	1	31	42	Diabetes_McGill_IL10	ONO_FOXP3_TARGETS_DN
3.22580645161%	1	31	42	Diabetes_McGill_IL10	MODY_HIPPOCAMPUS_PRENATAL
3.22580645161%	1	31	42	Diabetes_McGill_IL10	MIKKELSEN_ES_ICP_WITH_H3K27ME3
3.22580645161%	1	31	42	Diabetes_McGill_IL10	KEGG_GRAFT_VERSUS_HOST_DISEASE
3.22580645161%	1	31	42	Diabetes_McGill_IL10	AMIT_EGF_RESPONSE_40_HELA
3.22580645161%	1	31	414	Diabetes_McGill_IL10	LU_EZH2_TARGETS_DN
3.22580645161%	1	31	413	Diabetes_McGill_IL10	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
3.22580645161%	1	31	41	Diabetes_McGill_IL10	WENG_POR_TARGETS_LIVER_UP
3.22580645161%	1	31	41	Diabetes_McGill_IL10	KORKOLA_EMBRYONAL_CARCINOMA_UP
3.22580645161%	1	31	41	Diabetes_McGill_IL10	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM
3.22580645161%	1	31	41	Diabetes_McGill_IL10	KAAB_FAILED_HEART_VENTRICLE_DN
3.22580645161%	1	31	41	Diabetes_McGill_IL10	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
3.22580645161%	1	31	41	Diabetes_McGill_IL10	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
3.22580645161%	1	31	41	Diabetes_McGill_IL10	DELPUECH_FOXO3_TARGETS_DN
3.22580645161%	1	31	406	Diabetes_McGill_IL10	OSMAN_BLADDER_CANCER_DN
3.22580645161%	1	31	405	Diabetes_McGill_IL10	KUMAR_TARGETS_OF_MLL_AF9_FUSION
3.22580645161%	1	31	403	Diabetes_McGill_IL10	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
3.22580645161%	1	31	40	Diabetes_McGill_IL10	VANASSE_BCL2_TARGETS_UP
3.22580645161%	1	31	40	Diabetes_McGill_IL10	VALK_AML_WITH_FLT3_ITD
3.22580645161%	1	31	40	Diabetes_McGill_IL10	ST_JNK_MAPK_PATHWAY
3.22580645161%	1	31	40	Diabetes_McGill_IL10	PID_EPHBFWDPATHWAY
3.22580645161%	1	31	40	Diabetes_McGill_IL10	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP
3.22580645161%	1	31	40	Diabetes_McGill_IL10	GENTILE_UV_RESPONSE_CLUSTER_D8
3.22580645161%	1	31	40	Diabetes_McGill_IL10	DORN_ADENOVIRUS_INFECTION_48HR_DN
3.22580645161%	1	31	40	Diabetes_McGill_IL10	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
3.22580645161%	1	31	40	Diabetes_McGill_IL10	AMUNDSON_GAMMA_RADIATION_RESPONSE
3.22580645161%	1	31	391	Diabetes_McGill_IL10	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
3.22580645161%	1	31	390	Diabetes_McGill_IL10	HATADA_METHYLATED_IN_LUNG_CANCER_UP
3.22580645161%	1	31	39	Diabetes_McGill_IL10	SHIPP_DLBCL_CURED_VS_FATAL_UP
3.22580645161%	1	31	39	Diabetes_McGill_IL10	SESTO_RESPONSE_TO_UV_C6
3.22580645161%	1	31	39	Diabetes_McGill_IL10	REACTOME_IL1_SIGNALING
3.22580645161%	1	31	39	Diabetes_McGill_IL10	POTTI_PACLITAXEL_SENSITIVITY
3.22580645161%	1	31	39	Diabetes_McGill_IL10	PID_RET_PATHWAY
3.22580645161%	1	31	39	Diabetes_McGill_IL10	PID_ATR_PATHWAY
3.22580645161%	1	31	39	Diabetes_McGill_IL10	MA_MYELOID_DIFFERENTIATION_UP
3.22580645161%	1	31	39	Diabetes_McGill_IL10	KORKOLA_TERATOMA
3.22580645161%	1	31	39	Diabetes_McGill_IL10	HAN_JNK_SINGALING_DN
3.22580645161%	1	31	39	Diabetes_McGill_IL10	GU_PDEF_TARGETS_DN
3.22580645161%	1	31	39	Diabetes_McGill_IL10	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
3.22580645161%	1	31	39	Diabetes_McGill_IL10	DORN_ADENOVIRUS_INFECTION_32HR_DN
3.22580645161%	1	31	39	Diabetes_McGill_IL10	BIOCARTA_FMLP_PATHWAY
3.22580645161%	1	31	388	Diabetes_McGill_IL10	STEIN_ESRRA_TARGETS_UP
3.22580645161%	1	31	387	Diabetes_McGill_IL10	CHYLA_CBFA2T3_TARGETS_UP
3.22580645161%	1	31	384	Diabetes_McGill_IL10	BASAKI_YBX1_TARGETS_DN
3.22580645161%	1	31	380	Diabetes_McGill_IL10	DAIRKEE_TERT_TARGETS_UP
3.22580645161%	1	31	380	Diabetes_McGill_IL10	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
3.22580645161%	1	31	38	Diabetes_McGill_IL10	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
3.22580645161%	1	31	38	Diabetes_McGill_IL10	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER
3.22580645161%	1	31	38	Diabetes_McGill_IL10	PID_P38ALPHABETADOWNSTREAMPATHWAY
3.22580645161%	1	31	38	Diabetes_McGill_IL10	PENG_GLUTAMINE_DEPRIVATION_UP
3.22580645161%	1	31	38	Diabetes_McGill_IL10	CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN
3.22580645161%	1	31	378	Diabetes_McGill_IL10	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
3.22580645161%	1	31	374	Diabetes_McGill_IL10	WANG_TUMOR_INVASIVENESS_UP
3.22580645161%	1	31	371	Diabetes_McGill_IL10	WANG_SMARCE1_TARGETS_DN
3.22580645161%	1	31	37	Diabetes_McGill_IL10	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN
3.22580645161%	1	31	37	Diabetes_McGill_IL10	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
3.22580645161%	1	31	37	Diabetes_McGill_IL10	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
3.22580645161%	1	31	37	Diabetes_McGill_IL10	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2
3.22580645161%	1	31	37	Diabetes_McGill_IL10	MURAKAMI_UV_RESPONSE_6HR_UP
3.22580645161%	1	31	37	Diabetes_McGill_IL10	HOWLIN_CITED1_TARGETS_1_DN
3.22580645161%	1	31	37	Diabetes_McGill_IL10	CUI_TCF21_TARGETS_UP
3.22580645161%	1	31	37	Diabetes_McGill_IL10	BIOCARTA_PAR1_PATHWAY
3.22580645161%	1	31	37	Diabetes_McGill_IL10	BIOCARTA_BCR_PATHWAY
3.22580645161%	1	31	368	Diabetes_McGill_IL10	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
3.22580645161%	1	31	366	Diabetes_McGill_IL10	SANSOM_APC_TARGETS_DN
3.22580645161%	1	31	362	Diabetes_McGill_IL10	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
3.22580645161%	1	31	36	Diabetes_McGill_IL10	YIH_RESPONSE_TO_ARSENITE_C3
3.22580645161%	1	31	36	Diabetes_McGill_IL10	VANTVEER_BREAST_CANCER_BRCA1_UP
3.22580645161%	1	31	36	Diabetes_McGill_IL10	SUBTIL_PROGESTIN_TARGETS
3.22580645161%	1	31	36	Diabetes_McGill_IL10	STEARMAN_TUMOR_FIELD_EFFECT_UP
3.22580645161%	1	31	36	Diabetes_McGill_IL10	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
3.22580645161%	1	31	36	Diabetes_McGill_IL10	SEMENZA_HIF1_TARGETS
3.22580645161%	1	31	36	Diabetes_McGill_IL10	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
3.22580645161%	1	31	36	Diabetes_McGill_IL10	REACTOME_IRON_UPTAKE_AND_TRANSPORT
3.22580645161%	1	31	36	Diabetes_McGill_IL10	MARZEC_IL2_SIGNALING_DN
3.22580645161%	1	31	36	Diabetes_McGill_IL10	HOUSTIS_ROS
3.22580645161%	1	31	36	Diabetes_McGill_IL10	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN
3.22580645161%	1	31	36	Diabetes_McGill_IL10	BIOCARTA_AT1R_PATHWAY
3.22580645161%	1	31	357	Diabetes_McGill_IL10	SHEN_SMARCA2_TARGETS_DN
3.22580645161%	1	31	355	Diabetes_McGill_IL10	PEREZ_TP63_TARGETS
3.22580645161%	1	31	353	Diabetes_McGill_IL10	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
3.22580645161%	1	31	352	Diabetes_McGill_IL10	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
3.22580645161%	1	31	35	Diabetes_McGill_IL10	YAGI_AML_RELAPSE_PROGNOSIS
3.22580645161%	1	31	35	Diabetes_McGill_IL10	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
3.22580645161%	1	31	35	Diabetes_McGill_IL10	ROZANOV_MMP14_TARGETS_DN
3.22580645161%	1	31	35	Diabetes_McGill_IL10	PID_HIVNEFPATHWAY
3.22580645161%	1	31	35	Diabetes_McGill_IL10	KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION
3.22580645161%	1	31	35	Diabetes_McGill_IL10	HOWLIN_CITED1_TARGETS_1_UP
3.22580645161%	1	31	35	Diabetes_McGill_IL10	HAN_JNK_SINGALING_UP
3.22580645161%	1	31	35	Diabetes_McGill_IL10	DORSAM_HOXA9_TARGETS_UP
3.22580645161%	1	31	35	Diabetes_McGill_IL10	BIOCARTA_CARM_ER_PATHWAY
3.22580645161%	1	31	344	Diabetes_McGill_IL10	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
3.22580645161%	1	31	34	Diabetes_McGill_IL10	ST_WNT_BETA_CATENIN_PATHWAY
3.22580645161%	1	31	34	Diabetes_McGill_IL10	SCHOEN_NFKB_SIGNALING
3.22580645161%	1	31	34	Diabetes_McGill_IL10	PID_MAPKTRKPATHWAY
3.22580645161%	1	31	34	Diabetes_McGill_IL10	PID_IL8CXCR2_PATHWAY
3.22580645161%	1	31	34	Diabetes_McGill_IL10	PID_IL1PATHWAY
3.22580645161%	1	31	34	Diabetes_McGill_IL10	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP
3.22580645161%	1	31	336	Diabetes_McGill_IL10	JOHNSTONE_PARVB_TARGETS_2_DN
3.22580645161%	1	31	332	Diabetes_McGill_IL10	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
3.22580645161%	1	31	330	Diabetes_McGill_IL10	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
3.22580645161%	1	31	33	Diabetes_McGill_IL10	WENDT_COHESIN_TARGETS_UP
3.22580645161%	1	31	33	Diabetes_McGill_IL10	TANG_SENESCENCE_TP53_TARGETS_UP
3.22580645161%	1	31	33	Diabetes_McGill_IL10	SIMBULAN_UV_RESPONSE_NORMAL_DN
3.22580645161%	1	31	33	Diabetes_McGill_IL10	PID_NCADHERINPATHWAY
3.22580645161%	1	31	33	Diabetes_McGill_IL10	PID_IL12_STAT4PATHWAY
3.22580645161%	1	31	33	Diabetes_McGill_IL10	JEPSEN_SMRT_TARGETS
3.22580645161%	1	31	33	Diabetes_McGill_IL10	GREENBAUM_E2A_TARGETS_UP
3.22580645161%	1	31	33	Diabetes_McGill_IL10	FARMER_BREAST_CANCER_CLUSTER_2
3.22580645161%	1	31	33	Diabetes_McGill_IL10	CHO_NR4A1_TARGETS
3.22580645161%	1	31	33	Diabetes_McGill_IL10	CAFFAREL_RESPONSE_TO_THC_UP
3.22580645161%	1	31	33	Diabetes_McGill_IL10	BURTON_ADIPOGENESIS_1
3.22580645161%	1	31	33	Diabetes_McGill_IL10	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN
3.22580645161%	1	31	329	Diabetes_McGill_IL10	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
3.22580645161%	1	31	324	Diabetes_McGill_IL10	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
3.22580645161%	1	31	321	Diabetes_McGill_IL10	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
3.22580645161%	1	31	32	Diabetes_McGill_IL10	PID_SYNDECAN_4_PATHWAY
3.22580645161%	1	31	32	Diabetes_McGill_IL10	PID_NETRIN_PATHWAY
3.22580645161%	1	31	32	Diabetes_McGill_IL10	LIANG_SILENCED_BY_METHYLATION_UP
3.22580645161%	1	31	32	Diabetes_McGill_IL10	GROSS_ELK3_TARGETS_DN
3.22580645161%	1	31	32	Diabetes_McGill_IL10	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP
3.22580645161%	1	31	32	Diabetes_McGill_IL10	DORSAM_HOXA9_TARGETS_DN
3.22580645161%	1	31	32	Diabetes_McGill_IL10	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
3.22580645161%	1	31	32	Diabetes_McGill_IL10	BAE_BRCA1_TARGETS_DN
3.22580645161%	1	31	32	Diabetes_McGill_IL10	AMIT_SERUM_RESPONSE_40_MCF10A
3.22580645161%	1	31	318	Diabetes_McGill_IL10	DAZARD_RESPONSE_TO_UV_NHEK_DN
3.22580645161%	1	31	317	Diabetes_McGill_IL10	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
3.22580645161%	1	31	317	Diabetes_McGill_IL10	BRUINS_UVC_RESPONSE_EARLY_LATE
3.22580645161%	1	31	316	Diabetes_McGill_IL10	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
3.22580645161%	1	31	315	Diabetes_McGill_IL10	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
3.22580645161%	1	31	312	Diabetes_McGill_IL10	GENTILE_UV_HIGH_DOSE_DN
3.22580645161%	1	31	310	Diabetes_McGill_IL10	HORIUCHI_WTAP_TARGETS_DN
3.22580645161%	1	31	31	Diabetes_McGill_IL10	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP
3.22580645161%	1	31	31	Diabetes_McGill_IL10	REACTOME_SIGNAL_AMPLIFICATION
3.22580645161%	1	31	31	Diabetes_McGill_IL10	PID_AR_NONGENOMIC_PATHWAY
3.22580645161%	1	31	31	Diabetes_McGill_IL10	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
3.22580645161%	1	31	31	Diabetes_McGill_IL10	CAFFAREL_RESPONSE_TO_THC_DN
3.22580645161%	1	31	31	Diabetes_McGill_IL10	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
3.22580645161%	1	31	31	Diabetes_McGill_IL10	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN
3.22580645161%	1	31	306	Diabetes_McGill_IL10	HORIUCHI_WTAP_TARGETS_UP
3.22580645161%	1	31	306	Diabetes_McGill_IL10	CHANDRAN_METASTASIS_DN
3.22580645161%	1	31	305	Diabetes_McGill_IL10	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
3.22580645161%	1	31	30	Diabetes_McGill_IL10	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
3.22580645161%	1	31	30	Diabetes_McGill_IL10	URS_ADIPOCYTE_DIFFERENTIATION_DN
3.22580645161%	1	31	30	Diabetes_McGill_IL10	TAVOR_CEBPA_TARGETS_DN
3.22580645161%	1	31	30	Diabetes_McGill_IL10	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
3.22580645161%	1	31	30	Diabetes_McGill_IL10	REACTOME_NOD1_2_SIGNALING_PATHWAY
3.22580645161%	1	31	30	Diabetes_McGill_IL10	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES
3.22580645161%	1	31	30	Diabetes_McGill_IL10	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
3.22580645161%	1	31	30	Diabetes_McGill_IL10	PID_RETINOIC_ACID_PATHWAY
3.22580645161%	1	31	30	Diabetes_McGill_IL10	PID_NECTIN_PATHWAY
3.22580645161%	1	31	30	Diabetes_McGill_IL10	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
3.22580645161%	1	31	30	Diabetes_McGill_IL10	LI_PROSTATE_CANCER_EPIGENETIC
3.22580645161%	1	31	30	Diabetes_McGill_IL10	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
3.22580645161%	1	31	30	Diabetes_McGill_IL10	DASU_IL6_SIGNALING_SCAR_UP
3.22580645161%	1	31	30	Diabetes_McGill_IL10	BIOCARTA_FAS_PATHWAY
3.22580645161%	1	31	298	Diabetes_McGill_IL10	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
3.22580645161%	1	31	295	Diabetes_McGill_IL10	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
3.22580645161%	1	31	293	Diabetes_McGill_IL10	HADDAD_B_LYMPHOCYTE_PROGENITOR
3.22580645161%	1	31	290	Diabetes_McGill_IL10	BENPORATH_OCT4_TARGETS
3.22580645161%	1	31	29	Diabetes_McGill_IL10	YU_BAP1_TARGETS
3.22580645161%	1	31	29	Diabetes_McGill_IL10	WEINMANN_ADAPTATION_TO_HYPOXIA_UP
3.22580645161%	1	31	29	Diabetes_McGill_IL10	WANG_RESPONSE_TO_BEXAROTENE_DN
3.22580645161%	1	31	29	Diabetes_McGill_IL10	VALK_AML_CLUSTER_2
3.22580645161%	1	31	29	Diabetes_McGill_IL10	STANELLE_E2F1_TARGETS
3.22580645161%	1	31	29	Diabetes_McGill_IL10	REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION
3.22580645161%	1	31	29	Diabetes_McGill_IL10	REACTOME_PKB_MEDIATED_EVENTS
3.22580645161%	1	31	29	Diabetes_McGill_IL10	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
3.22580645161%	1	31	29	Diabetes_McGill_IL10	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX
3.22580645161%	1	31	29	Diabetes_McGill_IL10	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
3.22580645161%	1	31	29	Diabetes_McGill_IL10	PID_S1P_S1P3_PATHWAY
3.22580645161%	1	31	29	Diabetes_McGill_IL10	PID_REELINPATHWAY
3.22580645161%	1	31	29	Diabetes_McGill_IL10	MA_PITUITARY_FETAL_VS_ADULT_UP
3.22580645161%	1	31	29	Diabetes_McGill_IL10	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
3.22580645161%	1	31	29	Diabetes_McGill_IL10	MARSHALL_VIRAL_INFECTION_RESPONSE_DN
3.22580645161%	1	31	29	Diabetes_McGill_IL10	LU_TUMOR_VASCULATURE_UP
3.22580645161%	1	31	29	Diabetes_McGill_IL10	BIOCARTA_VIP_PATHWAY
3.22580645161%	1	31	29	Diabetes_McGill_IL10	BIOCARTA_VEGF_PATHWAY
3.22580645161%	1	31	29	Diabetes_McGill_IL10	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
3.22580645161%	1	31	289	Diabetes_McGill_IL10	MANALO_HYPOXIA_DN
3.22580645161%	1	31	285	Diabetes_McGill_IL10	GRADE_COLON_AND_RECTAL_CANCER_UP
3.22580645161%	1	31	283	Diabetes_McGill_IL10	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
3.22580645161%	1	31	281	Diabetes_McGill_IL10	MULLIGHAN_MLL_SIGNATURE_2_DN
3.22580645161%	1	31	281	Diabetes_McGill_IL10	BHAT_ESR1_TARGETS_VIA_AKT1_UP
3.22580645161%	1	31	280	Diabetes_McGill_IL10	WANG_SMARCE1_TARGETS_UP
3.22580645161%	1	31	28	Diabetes_McGill_IL10	TIAN_TNF_SIGNALING_VIA_NFKB
3.22580645161%	1	31	28	Diabetes_McGill_IL10	ST_GAQ_PATHWAY
3.22580645161%	1	31	28	Diabetes_McGill_IL10	REACTOME_MYOGENESIS
3.22580645161%	1	31	28	Diabetes_McGill_IL10	PID_IL8CXCR1_PATHWAY
3.22580645161%	1	31	28	Diabetes_McGill_IL10	MOREIRA_RESPONSE_TO_TSA_UP
3.22580645161%	1	31	28	Diabetes_McGill_IL10	HWANG_PROSTATE_CANCER_MARKERS
3.22580645161%	1	31	28	Diabetes_McGill_IL10	GENTILE_UV_RESPONSE_CLUSTER_D9
3.22580645161%	1	31	28	Diabetes_McGill_IL10	DAZARD_UV_RESPONSE_CLUSTER_G24
3.22580645161%	1	31	28	Diabetes_McGill_IL10	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
3.22580645161%	1	31	28	Diabetes_McGill_IL10	BIOCARTA_GH_PATHWAY
3.22580645161%	1	31	28	Diabetes_McGill_IL10	BIOCARTA_G1_PATHWAY
3.22580645161%	1	31	279	Diabetes_McGill_IL10	FORTSCHEGGER_PHF8_TARGETS_UP
3.22580645161%	1	31	277	Diabetes_McGill_IL10	ZHANG_TLX_TARGETS_60HR_DN
3.22580645161%	1	31	275	Diabetes_McGill_IL10	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
3.22580645161%	1	31	275	Diabetes_McGill_IL10	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
3.22580645161%	1	31	274	Diabetes_McGill_IL10	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
3.22580645161%	1	31	271	Diabetes_McGill_IL10	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
3.22580645161%	1	31	270	Diabetes_McGill_IL10	RIZKI_TUMOR_INVASIVENESS_3D_DN
3.22580645161%	1	31	27	Diabetes_McGill_IL10	YE_METASTATIC_LIVER_CANCER
3.22580645161%	1	31	27	Diabetes_McGill_IL10	ST_GRANULE_CELL_SURVIVAL_PATHWAY
3.22580645161%	1	31	27	Diabetes_McGill_IL10	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
3.22580645161%	1	31	27	Diabetes_McGill_IL10	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION
3.22580645161%	1	31	27	Diabetes_McGill_IL10	OHM_METHYLATED_IN_ADULT_CANCERS
3.22580645161%	1	31	27	Diabetes_McGill_IL10	LOPES_METHYLATED_IN_COLON_CANCER_UP
3.22580645161%	1	31	27	Diabetes_McGill_IL10	HOEGERKORP_CD44_TARGETS_DIRECT_UP
3.22580645161%	1	31	27	Diabetes_McGill_IL10	GROSS_ELK3_TARGETS_UP
3.22580645161%	1	31	27	Diabetes_McGill_IL10	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP
3.22580645161%	1	31	27	Diabetes_McGill_IL10	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN
3.22580645161%	1	31	27	Diabetes_McGill_IL10	BIOCARTA_EDG1_PATHWAY
3.22580645161%	1	31	269	Diabetes_McGill_IL10	WANG_CLIM2_TARGETS_UP
3.22580645161%	1	31	266	Diabetes_McGill_IL10	ROZANOV_MMP14_TARGETS_UP
3.22580645161%	1	31	266	Diabetes_McGill_IL10	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
3.22580645161%	1	31	265	Diabetes_McGill_IL10	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
3.22580645161%	1	31	264	Diabetes_McGill_IL10	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
3.22580645161%	1	31	261	Diabetes_McGill_IL10	RICKMAN_METASTASIS_DN
3.22580645161%	1	31	261	Diabetes_McGill_IL10	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
3.22580645161%	1	31	260	Diabetes_McGill_IL10	SENESE_HDAC1_TARGETS_DN
3.22580645161%	1	31	26	Diabetes_McGill_IL10	XU_CREBBP_TARGETS_UP
3.22580645161%	1	31	26	Diabetes_McGill_IL10	WILLIAMS_ESR1_TARGETS_UP
3.22580645161%	1	31	26	Diabetes_McGill_IL10	PID_P38_MKK3_6PATHWAY
3.22580645161%	1	31	26	Diabetes_McGill_IL10	HAHTOLA_CTCL_CUTANEOUS
3.22580645161%	1	31	26	Diabetes_McGill_IL10	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
3.22580645161%	1	31	259	Diabetes_McGill_IL10	QI_PLASMACYTOMA_UP
3.22580645161%	1	31	258	Diabetes_McGill_IL10	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
3.22580645161%	1	31	256	Diabetes_McGill_IL10	ONDER_CDH1_TARGETS_2_UP
3.22580645161%	1	31	251	Diabetes_McGill_IL10	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
3.22580645161%	1	31	25	Diabetes_McGill_IL10	REACTOME_G0_AND_EARLY_G1
3.22580645161%	1	31	25	Diabetes_McGill_IL10	REACTOME_ADP_SIGNALLING_THROUGH_P2RY1
3.22580645161%	1	31	25	Diabetes_McGill_IL10	PID_MYC_PATHWAY
3.22580645161%	1	31	25	Diabetes_McGill_IL10	OZEN_MIR125B1_TARGETS
3.22580645161%	1	31	25	Diabetes_McGill_IL10	LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS
3.22580645161%	1	31	25	Diabetes_McGill_IL10	HOEGERKORP_CD44_TARGETS_TEMPORAL_DN
3.22580645161%	1	31	25	Diabetes_McGill_IL10	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
3.22580645161%	1	31	25	Diabetes_McGill_IL10	COLLER_MYC_TARGETS_UP
3.22580645161%	1	31	246	Diabetes_McGill_IL10	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
3.22580645161%	1	31	246	Diabetes_McGill_IL10	BILD_E2F3_ONCOGENIC_SIGNATURE
3.22580645161%	1	31	245	Diabetes_McGill_IL10	BLUM_RESPONSE_TO_SALIRASIB_UP
3.22580645161%	1	31	244	Diabetes_McGill_IL10	KAYO_AGING_MUSCLE_UP
3.22580645161%	1	31	243	Diabetes_McGill_IL10	CHICAS_RB1_TARGETS_GROWING
3.22580645161%	1	31	242	Diabetes_McGill_IL10	MULLIGHAN_MLL_SIGNATURE_1_DN
3.22580645161%	1	31	24	Diabetes_McGill_IL10	YIH_RESPONSE_TO_ARSENITE_C1
3.22580645161%	1	31	24	Diabetes_McGill_IL10	WILLERT_WNT_SIGNALING
3.22580645161%	1	31	24	Diabetes_McGill_IL10	SHI_SPARC_TARGETS_UP
3.22580645161%	1	31	24	Diabetes_McGill_IL10	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION
3.22580645161%	1	31	24	Diabetes_McGill_IL10	PID_S1P_S1P2_PATHWAY
3.22580645161%	1	31	24	Diabetes_McGill_IL10	OSADA_ASCL1_TARGETS_DN
3.22580645161%	1	31	24	Diabetes_McGill_IL10	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23
3.22580645161%	1	31	24	Diabetes_McGill_IL10	MURATA_VIRULENCE_OF_H_PILORI
3.22580645161%	1	31	24	Diabetes_McGill_IL10	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
3.22580645161%	1	31	24	Diabetes_McGill_IL10	MATZUK_SPERMATOGONIA
3.22580645161%	1	31	24	Diabetes_McGill_IL10	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP
3.22580645161%	1	31	24	Diabetes_McGill_IL10	GOLUB_ALL_VS_AML_UP
3.22580645161%	1	31	24	Diabetes_McGill_IL10	DELACROIX_RAR_TARGETS_DN
3.22580645161%	1	31	24	Diabetes_McGill_IL10	DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
3.22580645161%	1	31	24	Diabetes_McGill_IL10	BIOCARTA_G2_PATHWAY
3.22580645161%	1	31	24	Diabetes_McGill_IL10	BIOCARTA_ECM_PATHWAY
3.22580645161%	1	31	24	Diabetes_McGill_IL10	BIOCARTA_CXCR4_PATHWAY
3.22580645161%	1	31	24	Diabetes_McGill_IL10	AZARE_STAT3_TARGETS
3.22580645161%	1	31	239	Diabetes_McGill_IL10	ALFANO_MYC_TARGETS
3.22580645161%	1	31	234	Diabetes_McGill_IL10	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
3.22580645161%	1	31	23	Diabetes_McGill_IL10	WU_HBX_TARGETS_2_UP
3.22580645161%	1	31	23	Diabetes_McGill_IL10	WU_HBX_TARGETS_1_DN
3.22580645161%	1	31	23	Diabetes_McGill_IL10	PID_PRLSIGNALINGEVENTSPATHWAY
3.22580645161%	1	31	23	Diabetes_McGill_IL10	PID_NFKAPPABCANONICALPATHWAY
3.22580645161%	1	31	23	Diabetes_McGill_IL10	ONO_FOXP3_TARGETS_UP
3.22580645161%	1	31	23	Diabetes_McGill_IL10	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN
3.22580645161%	1	31	23	Diabetes_McGill_IL10	FERRANDO_HOX11_NEIGHBORS
3.22580645161%	1	31	23	Diabetes_McGill_IL10	EGUCHI_CELL_CYCLE_RB1_TARGETS
3.22580645161%	1	31	23	Diabetes_McGill_IL10	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
3.22580645161%	1	31	23	Diabetes_McGill_IL10	BIOCARTA_PTDINS_PATHWAY
3.22580645161%	1	31	23	Diabetes_McGill_IL10	BIOCARTA_NFKB_PATHWAY
3.22580645161%	1	31	23	Diabetes_McGill_IL10	BIOCARTA_IGF1R_PATHWAY
3.22580645161%	1	31	229	Diabetes_McGill_IL10	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
3.22580645161%	1	31	228	Diabetes_McGill_IL10	MARKEY_RB1_ACUTE_LOF_DN
3.22580645161%	1	31	227	Diabetes_McGill_IL10	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
3.22580645161%	1	31	227	Diabetes_McGill_IL10	LEE_RECENT_THYMIC_EMIGRANT
3.22580645161%	1	31	225	Diabetes_McGill_IL10	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
3.22580645161%	1	31	225	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_16HR_UP
3.22580645161%	1	31	223	Diabetes_McGill_IL10	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
3.22580645161%	1	31	222	Diabetes_McGill_IL10	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
3.22580645161%	1	31	222	Diabetes_McGill_IL10	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
3.22580645161%	1	31	222	Diabetes_McGill_IL10	CAIRO_LIVER_DEVELOPMENT_DN
3.22580645161%	1	31	222	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_1HR_DN
3.22580645161%	1	31	221	Diabetes_McGill_IL10	ZHANG_TLX_TARGETS_36HR_UP
3.22580645161%	1	31	221	Diabetes_McGill_IL10	CHANDRAN_METASTASIS_UP
3.22580645161%	1	31	220	Diabetes_McGill_IL10	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
3.22580645161%	1	31	220	Diabetes_McGill_IL10	RIGGINS_TAMOXIFEN_RESISTANCE_DN
3.22580645161%	1	31	22	Diabetes_McGill_IL10	ZHAN_MULTIPLE_MYELOMA_SPIKED
3.22580645161%	1	31	22	Diabetes_McGill_IL10	VERNELL_RETINOBLASTOMA_PATHWAY_DN
3.22580645161%	1	31	22	Diabetes_McGill_IL10	PID_HEDGEHOG_2PATHWAY
3.22580645161%	1	31	22	Diabetes_McGill_IL10	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
3.22580645161%	1	31	22	Diabetes_McGill_IL10	LU_TUMOR_ENDOTHELIAL_MARKERS_UP
3.22580645161%	1	31	22	Diabetes_McGill_IL10	GAVIN_PDE3B_TARGETS
3.22580645161%	1	31	22	Diabetes_McGill_IL10	BIOCARTA_INSULIN_PATHWAY
3.22580645161%	1	31	22	Diabetes_McGill_IL10	BIOCARTA_IL2_PATHWAY
3.22580645161%	1	31	22	Diabetes_McGill_IL10	BIOCARTA_GCR_PATHWAY
3.22580645161%	1	31	22	Diabetes_McGill_IL10	BIOCARTA_DC_PATHWAY
3.22580645161%	1	31	22	Diabetes_McGill_IL10	BIOCARTA_CHEMICAL_PATHWAY
3.22580645161%	1	31	22	Diabetes_McGill_IL10	BIOCARTA_CERAMIDE_PATHWAY
3.22580645161%	1	31	22	Diabetes_McGill_IL10	BIOCARTA_AKT_PATHWAY
3.22580645161%	1	31	217	Diabetes_McGill_IL10	AMUNDSON_RESPONSE_TO_ARSENITE
3.22580645161%	1	31	216	Diabetes_McGill_IL10	BOQUEST_STEM_CELL_DN
3.22580645161%	1	31	215	Diabetes_McGill_IL10	YAMAZAKI_TCEB3_TARGETS_DN
3.22580645161%	1	31	215	Diabetes_McGill_IL10	MARKEY_RB1_ACUTE_LOF_UP
3.22580645161%	1	31	214	Diabetes_McGill_IL10	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
3.22580645161%	1	31	214	Diabetes_McGill_IL10	KIM_WT1_TARGETS_UP
3.22580645161%	1	31	214	Diabetes_McGill_IL10	BIDUS_METASTASIS_UP
3.22580645161%	1	31	214	Diabetes_McGill_IL10	AFFAR_YY1_TARGETS_UP
3.22580645161%	1	31	213	Diabetes_McGill_IL10	WIERENGA_STAT5A_TARGETS_DN
3.22580645161%	1	31	212	Diabetes_McGill_IL10	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
3.22580645161%	1	31	211	Diabetes_McGill_IL10	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
3.22580645161%	1	31	210	Diabetes_McGill_IL10	WANG_TUMOR_INVASIVENESS_DN
3.22580645161%	1	31	210	Diabetes_McGill_IL10	SANSOM_APC_TARGETS_REQUIRE_MYC
3.22580645161%	1	31	21	Diabetes_McGill_IL10	WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP
3.22580645161%	1	31	21	Diabetes_McGill_IL10	WENG_POR_DOSAGE
3.22580645161%	1	31	21	Diabetes_McGill_IL10	SCHURINGA_STAT5A_TARGETS_UP
3.22580645161%	1	31	21	Diabetes_McGill_IL10	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP
3.22580645161%	1	31	21	Diabetes_McGill_IL10	REACTOME_ERK_MAPK_TARGETS
3.22580645161%	1	31	21	Diabetes_McGill_IL10	REACTOME_CTLA4_INHIBITORY_SIGNALING
3.22580645161%	1	31	21	Diabetes_McGill_IL10	PID_P38_MK2PATHWAY
3.22580645161%	1	31	21	Diabetes_McGill_IL10	PID_ECADHERIN_KERATINOCYTE_PATHWAY
3.22580645161%	1	31	21	Diabetes_McGill_IL10	HU_ANGIOGENESIS_UP
3.22580645161%	1	31	21	Diabetes_McGill_IL10	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP
3.22580645161%	1	31	21	Diabetes_McGill_IL10	GESERICK_TERT_TARGETS_DN
3.22580645161%	1	31	21	Diabetes_McGill_IL10	DAZARD_UV_RESPONSE_CLUSTER_G4
3.22580645161%	1	31	21	Diabetes_McGill_IL10	CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP
3.22580645161%	1	31	21	Diabetes_McGill_IL10	BIOCARTA_TFF_PATHWAY
3.22580645161%	1	31	21	Diabetes_McGill_IL10	BIOCARTA_MITOCHONDRIA_PATHWAY
3.22580645161%	1	31	21	Diabetes_McGill_IL10	BIOCARTA_IGF1_PATHWAY
3.22580645161%	1	31	21	Diabetes_McGill_IL10	BIOCARTA_CTLA4_PATHWAY
3.22580645161%	1	31	207	Diabetes_McGill_IL10	VERHAAK_GLIOBLASTOMA_CLASSICAL
3.22580645161%	1	31	207	Diabetes_McGill_IL10	CAIRO_HEPATOBLASTOMA_UP
3.22580645161%	1	31	206	Diabetes_McGill_IL10	RAMALHO_STEMNESS_UP
3.22580645161%	1	31	206	Diabetes_McGill_IL10	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
3.22580645161%	1	31	206	Diabetes_McGill_IL10	BILD_MYC_ONCOGENIC_SIGNATURE
3.22580645161%	1	31	205	Diabetes_McGill_IL10	SHEPARD_BMYB_MORPHOLINO_UP
3.22580645161%	1	31	205	Diabetes_McGill_IL10	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
3.22580645161%	1	31	204	Diabetes_McGill_IL10	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
3.22580645161%	1	31	203	Diabetes_McGill_IL10	PAL_PRMT5_TARGETS_UP
3.22580645161%	1	31	202	Diabetes_McGill_IL10	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
3.22580645161%	1	31	201	Diabetes_McGill_IL10	KIM_MYC_AMPLIFICATION_TARGETS_UP
3.22580645161%	1	31	200	Diabetes_McGill_IL10	LEE_DIFFERENTIATING_T_LYMPHOCYTE
3.22580645161%	1	31	20	Diabetes_McGill_IL10	WALLACE_PROSTATE_CANCER_UP
3.22580645161%	1	31	20	Diabetes_McGill_IL10	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
3.22580645161%	1	31	20	Diabetes_McGill_IL10	NIELSEN_LEIOMYOSARCOMA_CNN1_DN
3.22580645161%	1	31	20	Diabetes_McGill_IL10	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN
3.22580645161%	1	31	20	Diabetes_McGill_IL10	MANN_RESPONSE_TO_AMIFOSTINE_UP
3.22580645161%	1	31	20	Diabetes_McGill_IL10	KORKOLA_YOLK_SAC_TUMOR_UP
3.22580645161%	1	31	20	Diabetes_McGill_IL10	DING_LUNG_CANCER_BY_MUTATION_RATE
3.22580645161%	1	31	20	Diabetes_McGill_IL10	COLLIS_PRKDC_SUBSTRATES
3.22580645161%	1	31	20	Diabetes_McGill_IL10	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
3.22580645161%	1	31	20	Diabetes_McGill_IL10	BIOCARTA_NKCELLS_PATHWAY
3.22580645161%	1	31	20	Diabetes_McGill_IL10	BIOCARTA_CCR5_PATHWAY
3.22580645161%	1	31	199	Diabetes_McGill_IL10	PLASARI_TGFB1_TARGETS_10HR_UP
3.22580645161%	1	31	196	Diabetes_McGill_IL10	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
3.22580645161%	1	31	194	Diabetes_McGill_IL10	KASLER_HDAC7_TARGETS_1_UP
3.22580645161%	1	31	193	Diabetes_McGill_IL10	MOHANKUMAR_TLX1_TARGETS_DN
3.22580645161%	1	31	192	Diabetes_McGill_IL10	REACTOME_DNA_REPLICATION
3.22580645161%	1	31	191	Diabetes_McGill_IL10	YAGI_AML_FAB_MARKERS
3.22580645161%	1	31	19	Diabetes_McGill_IL10	ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN
3.22580645161%	1	31	19	Diabetes_McGill_IL10	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP
3.22580645161%	1	31	19	Diabetes_McGill_IL10	PID_EPHA2_FWDPATHWAY
3.22580645161%	1	31	19	Diabetes_McGill_IL10	MATZUK_EMBRYONIC_GERM_CELL
3.22580645161%	1	31	19	Diabetes_McGill_IL10	MARSON_FOXP3_CORE_DIRECT_TARGETS
3.22580645161%	1	31	19	Diabetes_McGill_IL10	MAHADEVAN_RESPONSE_TO_MP470_DN
3.22580645161%	1	31	19	Diabetes_McGill_IL10	HAHTOLA_MYCOSIS_FUNGOIDES_UP
3.22580645161%	1	31	19	Diabetes_McGill_IL10	GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP
3.22580645161%	1	31	19	Diabetes_McGill_IL10	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS
3.22580645161%	1	31	19	Diabetes_McGill_IL10	BIOCARTA_TID_PATHWAY
3.22580645161%	1	31	19	Diabetes_McGill_IL10	AMIT_EGF_RESPONSE_40_MCF10A
3.22580645161%	1	31	19	Diabetes_McGill_IL10	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
3.22580645161%	1	31	188	Diabetes_McGill_IL10	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
3.22580645161%	1	31	185	Diabetes_McGill_IL10	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
3.22580645161%	1	31	184	Diabetes_McGill_IL10	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
3.22580645161%	1	31	183	Diabetes_McGill_IL10	OKUMURA_INFLAMMATORY_RESPONSE_LPS
3.22580645161%	1	31	1821	Diabetes_McGill_IL10	DODD_NASOPHARYNGEAL_CARCINOMA_UP
3.22580645161%	1	31	182	Diabetes_McGill_IL10	WHITFIELD_CELL_CYCLE_G2
3.22580645161%	1	31	182	Diabetes_McGill_IL10	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
3.22580645161%	1	31	182	Diabetes_McGill_IL10	FERNANDEZ_BOUND_BY_MYC
3.22580645161%	1	31	182	Diabetes_McGill_IL10	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
3.22580645161%	1	31	181	Diabetes_McGill_IL10	JISON_SICKLE_CELL_DISEASE_UP
3.22580645161%	1	31	181	Diabetes_McGill_IL10	JISON_SICKLE_CELL_DISEASE_DN
3.22580645161%	1	31	181	Diabetes_McGill_IL10	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
3.22580645161%	1	31	180	Diabetes_McGill_IL10	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
3.22580645161%	1	31	180	Diabetes_McGill_IL10	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
3.22580645161%	1	31	18	Diabetes_McGill_IL10	ZHENG_RESPONSE_TO_ARSENITE_UP
3.22580645161%	1	31	18	Diabetes_McGill_IL10	WU_HBX_TARGETS_3_UP
3.22580645161%	1	31	18	Diabetes_McGill_IL10	SCHEIDEREIT_IKK_TARGETS
3.22580645161%	1	31	18	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR
3.22580645161%	1	31	18	Diabetes_McGill_IL10	REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION
3.22580645161%	1	31	18	Diabetes_McGill_IL10	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP
3.22580645161%	1	31	18	Diabetes_McGill_IL10	PIONTEK_PKD1_TARGETS_DN
3.22580645161%	1	31	18	Diabetes_McGill_IL10	OZANNE_AP1_TARGETS_UP
3.22580645161%	1	31	18	Diabetes_McGill_IL10	MAINA_VHL_TARGETS_DN
3.22580645161%	1	31	18	Diabetes_McGill_IL10	KOBAYASHI_EGFR_SIGNALING_6HR_DN
3.22580645161%	1	31	18	Diabetes_McGill_IL10	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES
3.22580645161%	1	31	18	Diabetes_McGill_IL10	BIOCARTA_TEL_PATHWAY
3.22580645161%	1	31	18	Diabetes_McGill_IL10	BIOCARTA_PTEN_PATHWAY
3.22580645161%	1	31	18	Diabetes_McGill_IL10	BIOCARTA_NGF_PATHWAY
3.22580645161%	1	31	18	Diabetes_McGill_IL10	BIOCARTA_ERK5_PATHWAY
3.22580645161%	1	31	18	Diabetes_McGill_IL10	BIOCARTA_CARDIACEGF_PATHWAY
3.22580645161%	1	31	18	Diabetes_McGill_IL10	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP
3.22580645161%	1	31	18	Diabetes_McGill_IL10	AMIT_DELAYED_EARLY_GENES
3.22580645161%	1	31	179	Diabetes_McGill_IL10	BENPORATH_NOS_TARGETS
3.22580645161%	1	31	178	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_18HR_UP
3.22580645161%	1	31	178	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_18HR_DN
3.22580645161%	1	31	177	Diabetes_McGill_IL10	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
3.22580645161%	1	31	177	Diabetes_McGill_IL10	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
3.22580645161%	1	31	176	Diabetes_McGill_IL10	SASAKI_ADULT_T_CELL_LEUKEMIA
3.22580645161%	1	31	175	Diabetes_McGill_IL10	YAMAZAKI_TCEB3_TARGETS_UP
3.22580645161%	1	31	175	Diabetes_McGill_IL10	LEE_LIVER_CANCER_SURVIVAL_DN
3.22580645161%	1	31	172	Diabetes_McGill_IL10	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
3.22580645161%	1	31	172	Diabetes_McGill_IL10	SMID_BREAST_CANCER_LUMINAL_B_UP
3.22580645161%	1	31	171	Diabetes_McGill_IL10	ELVIDGE_HYPOXIA_UP
3.22580645161%	1	31	17	Diabetes_McGill_IL10	ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL
3.22580645161%	1	31	17	Diabetes_McGill_IL10	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN
3.22580645161%	1	31	17	Diabetes_McGill_IL10	SIMBULAN_PARP1_TARGETS_DN
3.22580645161%	1	31	17	Diabetes_McGill_IL10	SA_TRKA_RECEPTOR
3.22580645161%	1	31	17	Diabetes_McGill_IL10	SA_PTEN_PATHWAY
3.22580645161%	1	31	17	Diabetes_McGill_IL10	REACTOME_SHC_RELATED_EVENTS
3.22580645161%	1	31	17	Diabetes_McGill_IL10	REACTOME_INFLAMMASOMES
3.22580645161%	1	31	17	Diabetes_McGill_IL10	REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP
3.22580645161%	1	31	17	Diabetes_McGill_IL10	REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP
3.22580645161%	1	31	17	Diabetes_McGill_IL10	KANG_AR_TARGETS_UP
3.22580645161%	1	31	17	Diabetes_McGill_IL10	BIOCARTA_PML_PATHWAY
3.22580645161%	1	31	17	Diabetes_McGill_IL10	BIOCARTA_NO2IL12_PATHWAY
3.22580645161%	1	31	17	Diabetes_McGill_IL10	BIOCARTA_LAIR_PATHWAY
3.22580645161%	1	31	17	Diabetes_McGill_IL10	BIOCARTA_41BB_PATHWAY
3.22580645161%	1	31	169	Diabetes_McGill_IL10	UEDA_PERIFERAL_CLOCK
3.22580645161%	1	31	169	Diabetes_McGill_IL10	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
3.22580645161%	1	31	169	Diabetes_McGill_IL10	KEGG_ALZHEIMERS_DISEASE
3.22580645161%	1	31	168	Diabetes_McGill_IL10	PUJANA_XPRSS_INT_NETWORK
3.22580645161%	1	31	167	Diabetes_McGill_IL10	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
3.22580645161%	1	31	166	Diabetes_McGill_IL10	CAIRO_LIVER_DEVELOPMENT_UP
3.22580645161%	1	31	165	Diabetes_McGill_IL10	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
3.22580645161%	1	31	164	Diabetes_McGill_IL10	KIM_WT1_TARGETS_8HR_UP
3.22580645161%	1	31	163	Diabetes_McGill_IL10	LIN_NPAS4_TARGETS_UP
3.22580645161%	1	31	163	Diabetes_McGill_IL10	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
3.22580645161%	1	31	162	Diabetes_McGill_IL10	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
3.22580645161%	1	31	162	Diabetes_McGill_IL10	MULLIGHAN_NPM1_SIGNATURE_3_DN
3.22580645161%	1	31	160	Diabetes_McGill_IL10	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
3.22580645161%	1	31	160	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_6HR_DN
3.22580645161%	1	31	160	Diabetes_McGill_IL10	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
3.22580645161%	1	31	16	Diabetes_McGill_IL10	XU_RESPONSE_TO_TRETINOIN_UP
3.22580645161%	1	31	16	Diabetes_McGill_IL10	VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN
3.22580645161%	1	31	16	Diabetes_McGill_IL10	TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN
3.22580645161%	1	31	16	Diabetes_McGill_IL10	REACTOME_PLATELET_SENSITIZATION_BY_LDL
3.22580645161%	1	31	16	Diabetes_McGill_IL10	REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1
3.22580645161%	1	31	16	Diabetes_McGill_IL10	LY_AGING_MIDDLE_DN
3.22580645161%	1	31	16	Diabetes_McGill_IL10	LUND_SILENCED_BY_METHYLATION
3.22580645161%	1	31	16	Diabetes_McGill_IL10	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN
3.22580645161%	1	31	16	Diabetes_McGill_IL10	LEE_LIVER_CANCER_HEPATOBLAST
3.22580645161%	1	31	16	Diabetes_McGill_IL10	KORKOLA_TERATOMA_UP
3.22580645161%	1	31	16	Diabetes_McGill_IL10	HUMMERICH_MALIGNANT_SKIN_TUMOR_UP
3.22580645161%	1	31	16	Diabetes_McGill_IL10	HE_PTEN_TARGETS_UP
3.22580645161%	1	31	16	Diabetes_McGill_IL10	HAHTOLA_CTCL_PATHOGENESIS
3.22580645161%	1	31	16	Diabetes_McGill_IL10	GHO_ATF5_TARGETS_DN
3.22580645161%	1	31	16	Diabetes_McGill_IL10	FARMER_BREAST_CANCER_CLUSTER_6
3.22580645161%	1	31	16	Diabetes_McGill_IL10	DASU_IL6_SIGNALING_SCAR_DN
3.22580645161%	1	31	16	Diabetes_McGill_IL10	BIOCARTA_RELA_PATHWAY
3.22580645161%	1	31	16	Diabetes_McGill_IL10	BIOCARTA_P53_PATHWAY
3.22580645161%	1	31	16	Diabetes_McGill_IL10	BIOCARTA_GATA3_PATHWAY
3.22580645161%	1	31	16	Diabetes_McGill_IL10	BIOCARTA_CDC42RAC_PATHWAY
3.22580645161%	1	31	16	Diabetes_McGill_IL10	BIOCARTA_BCELLSURVIVAL_PATHWAY
3.22580645161%	1	31	16	Diabetes_McGill_IL10	BIOCARTA_ACH_PATHWAY
3.22580645161%	1	31	159	Diabetes_McGill_IL10	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
3.22580645161%	1	31	158	Diabetes_McGill_IL10	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
3.22580645161%	1	31	158	Diabetes_McGill_IL10	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON
3.22580645161%	1	31	157	Diabetes_McGill_IL10	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
3.22580645161%	1	31	157	Diabetes_McGill_IL10	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
3.22580645161%	1	31	156	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_14HR_UP
3.22580645161%	1	31	154	Diabetes_McGill_IL10	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
3.22580645161%	1	31	153	Diabetes_McGill_IL10	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
3.22580645161%	1	31	153	Diabetes_McGill_IL10	LU_AGING_BRAIN_DN
3.22580645161%	1	31	153	Diabetes_McGill_IL10	DURAND_STROMA_MAX_DN
3.22580645161%	1	31	152	Diabetes_McGill_IL10	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
3.22580645161%	1	31	151	Diabetes_McGill_IL10	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
3.22580645161%	1	31	151	Diabetes_McGill_IL10	IGLESIAS_E2F_TARGETS_UP
3.22580645161%	1	31	151	Diabetes_McGill_IL10	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
3.22580645161%	1	31	151	Diabetes_McGill_IL10	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
3.22580645161%	1	31	150	Diabetes_McGill_IL10	LANDIS_ERBB2_BREAST_TUMORS_324_UP
3.22580645161%	1	31	150	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_30MIN_DN
3.22580645161%	1	31	15	Diabetes_McGill_IL10	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP
3.22580645161%	1	31	15	Diabetes_McGill_IL10	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN
3.22580645161%	1	31	15	Diabetes_McGill_IL10	VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP
3.22580645161%	1	31	15	Diabetes_McGill_IL10	SINGH_NFE2L2_TARGETS
3.22580645161%	1	31	15	Diabetes_McGill_IL10	SA_MMP_CYTOKINE_CONNECTION
3.22580645161%	1	31	15	Diabetes_McGill_IL10	SA_G1_AND_S_PHASES
3.22580645161%	1	31	15	Diabetes_McGill_IL10	SANCHEZ_MDM2_TARGETS
3.22580645161%	1	31	15	Diabetes_McGill_IL10	REACTOME_SHC_MEDIATED_SIGNALLING
3.22580645161%	1	31	15	Diabetes_McGill_IL10	REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION
3.22580645161%	1	31	15	Diabetes_McGill_IL10	HUMMEL_BURKITTS_LYMPHOMA_DN
3.22580645161%	1	31	15	Diabetes_McGill_IL10	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN
3.22580645161%	1	31	15	Diabetes_McGill_IL10	FERRANDO_LYL1_NEIGHBORS
3.22580645161%	1	31	15	Diabetes_McGill_IL10	EHRLICH_ICF_SYNDROM_DN
3.22580645161%	1	31	15	Diabetes_McGill_IL10	BIOCARTA_TALL1_PATHWAY
3.22580645161%	1	31	15	Diabetes_McGill_IL10	BIOCARTA_LONGEVITY_PATHWAY
3.22580645161%	1	31	15	Diabetes_McGill_IL10	BIOCARTA_HSP27_PATHWAY
3.22580645161%	1	31	149	Diabetes_McGill_IL10	TSAI_RESPONSE_TO_IONIZING_RADIATION
3.22580645161%	1	31	149	Diabetes_McGill_IL10	GOZGIT_ESR1_TARGETS_UP
3.22580645161%	1	31	148	Diabetes_McGill_IL10	CHANG_CYCLING_GENES
3.22580645161%	1	31	147	Diabetes_McGill_IL10	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
3.22580645161%	1	31	147	Diabetes_McGill_IL10	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
3.22580645161%	1	31	146	Diabetes_McGill_IL10	PECE_MAMMARY_STEM_CELL_DN
3.22580645161%	1	31	145	Diabetes_McGill_IL10	ZHANG_BREAST_CANCER_PROGENITORS_DN
3.22580645161%	1	31	143	Diabetes_McGill_IL10	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
3.22580645161%	1	31	143	Diabetes_McGill_IL10	DANG_MYC_TARGETS_UP
3.22580645161%	1	31	142	Diabetes_McGill_IL10	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
3.22580645161%	1	31	142	Diabetes_McGill_IL10	RUIZ_TNC_TARGETS_DN
3.22580645161%	1	31	142	Diabetes_McGill_IL10	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
3.22580645161%	1	31	142	Diabetes_McGill_IL10	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
3.22580645161%	1	31	141	Diabetes_McGill_IL10	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
3.22580645161%	1	31	141	Diabetes_McGill_IL10	KAAB_FAILED_HEART_ATRIUM_DN
3.22580645161%	1	31	140	Diabetes_McGill_IL10	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
3.22580645161%	1	31	140	Diabetes_McGill_IL10	QI_HYPOXIA
3.22580645161%	1	31	140	Diabetes_McGill_IL10	JOHNSTONE_PARVB_TARGETS_2_UP
3.22580645161%	1	31	14	Diabetes_McGill_IL10	ZHANG_ADIPOGENESIS_BY_BMP7
3.22580645161%	1	31	14	Diabetes_McGill_IL10	REACTOME_SIGNAL_ATTENUATION
3.22580645161%	1	31	14	Diabetes_McGill_IL10	REACTOME_METABOLISM_OF_PORPHYRINS
3.22580645161%	1	31	14	Diabetes_McGill_IL10	PID_TCRJNKPATHWAY
3.22580645161%	1	31	14	Diabetes_McGill_IL10	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16
3.22580645161%	1	31	14	Diabetes_McGill_IL10	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP
3.22580645161%	1	31	14	Diabetes_McGill_IL10	DORN_ADENOVIRUS_INFECTION_48HR_UP
3.22580645161%	1	31	14	Diabetes_McGill_IL10	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
3.22580645161%	1	31	14	Diabetes_McGill_IL10	BIOCARTA_GRANULOCYTES_PATHWAY
3.22580645161%	1	31	139	Diabetes_McGill_IL10	ODONNELL_TFRC_TARGETS_DN
3.22580645161%	1	31	139	Diabetes_McGill_IL10	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
3.22580645161%	1	31	139	Diabetes_McGill_IL10	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
3.22580645161%	1	31	138	Diabetes_McGill_IL10	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
3.22580645161%	1	31	137	Diabetes_McGill_IL10	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
3.22580645161%	1	31	137	Diabetes_McGill_IL10	PID_P53DOWNSTREAMPATHWAY
3.22580645161%	1	31	137	Diabetes_McGill_IL10	LIU_SOX4_TARGETS_UP
3.22580645161%	1	31	136	Diabetes_McGill_IL10	WIERENGA_STAT5A_TARGETS_GROUP1
3.22580645161%	1	31	136	Diabetes_McGill_IL10	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
3.22580645161%	1	31	135	Diabetes_McGill_IL10	SERVITJA_LIVER_HNF1A_TARGETS_UP
3.22580645161%	1	31	134	Diabetes_McGill_IL10	POOLA_INVASIVE_BREAST_CANCER_DN
3.22580645161%	1	31	134	Diabetes_McGill_IL10	KEGG_TIGHT_JUNCTION
3.22580645161%	1	31	133	Diabetes_McGill_IL10	GAL_LEUKEMIC_STEM_CELL_UP
3.22580645161%	1	31	131	Diabetes_McGill_IL10	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
3.22580645161%	1	31	130	Diabetes_McGill_IL10	ELVIDGE_HYPOXIA_BY_DMOG_UP
3.22580645161%	1	31	13	Diabetes_McGill_IL10	WACKER_HYPOXIA_TARGETS_OF_VHL
3.22580645161%	1	31	13	Diabetes_McGill_IL10	SHIN_B_CELL_LYMPHOMA_CLUSTER_1
3.22580645161%	1	31	13	Diabetes_McGill_IL10	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
3.22580645161%	1	31	13	Diabetes_McGill_IL10	REACTOME_P38MAPK_EVENTS
3.22580645161%	1	31	13	Diabetes_McGill_IL10	REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS
3.22580645161%	1	31	13	Diabetes_McGill_IL10	RAY_ALZHEIMERS_DISEASE
3.22580645161%	1	31	13	Diabetes_McGill_IL10	ONGUSAHA_BRCA1_TARGETS_UP
3.22580645161%	1	31	13	Diabetes_McGill_IL10	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
3.22580645161%	1	31	13	Diabetes_McGill_IL10	NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON
3.22580645161%	1	31	13	Diabetes_McGill_IL10	MATZUK_EARLY_ANTRAL_FOLLICLE
3.22580645161%	1	31	13	Diabetes_McGill_IL10	IRITANI_MAD1_TARGETS_UP
3.22580645161%	1	31	13	Diabetes_McGill_IL10	BIOCARTA_RB_PATHWAY
3.22580645161%	1	31	13	Diabetes_McGill_IL10	BIOCARTA_ARENRF2_PATHWAY
3.22580645161%	1	31	128	Diabetes_McGill_IL10	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
3.22580645161%	1	31	128	Diabetes_McGill_IL10	POTTI_TOPOTECAN_SENSITIVITY
3.22580645161%	1	31	128	Diabetes_McGill_IL10	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS
3.22580645161%	1	31	128	Diabetes_McGill_IL10	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
3.22580645161%	1	31	1278	Diabetes_McGill_IL10	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
3.22580645161%	1	31	127	Diabetes_McGill_IL10	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
3.22580645161%	1	31	127	Diabetes_McGill_IL10	KARLSSON_TGFB1_TARGETS_UP
3.22580645161%	1	31	126	Diabetes_McGill_IL10	SANSOM_APC_TARGETS_UP
3.22580645161%	1	31	126	Diabetes_McGill_IL10	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
3.22580645161%	1	31	126	Diabetes_McGill_IL10	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
3.22580645161%	1	31	125	Diabetes_McGill_IL10	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
3.22580645161%	1	31	123	Diabetes_McGill_IL10	KAYO_AGING_MUSCLE_DN
3.22580645161%	1	31	123	Diabetes_McGill_IL10	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
3.22580645161%	1	31	123	Diabetes_McGill_IL10	DAZARD_RESPONSE_TO_UV_SCC_UP
3.22580645161%	1	31	123	Diabetes_McGill_IL10	DAZARD_RESPONSE_TO_UV_SCC_DN
3.22580645161%	1	31	122	Diabetes_McGill_IL10	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
3.22580645161%	1	31	121	Diabetes_McGill_IL10	VANTVEER_BREAST_CANCER_METASTASIS_DN
3.22580645161%	1	31	121	Diabetes_McGill_IL10	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
3.22580645161%	1	31	121	Diabetes_McGill_IL10	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
3.22580645161%	1	31	121	Diabetes_McGill_IL10	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
3.22580645161%	1	31	121	Diabetes_McGill_IL10	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
3.22580645161%	1	31	120	Diabetes_McGill_IL10	ZHU_CMV_ALL_UP
3.22580645161%	1	31	12	Diabetes_McGill_IL10	TURJANSKI_MAPK1_AND_MAPK2_TARGETS
3.22580645161%	1	31	12	Diabetes_McGill_IL10	SA_PROGRAMMED_CELL_DEATH
3.22580645161%	1	31	12	Diabetes_McGill_IL10	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING
3.22580645161%	1	31	12	Diabetes_McGill_IL10	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
3.22580645161%	1	31	12	Diabetes_McGill_IL10	PARK_TRETINOIN_RESPONSE
3.22580645161%	1	31	12	Diabetes_McGill_IL10	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP
3.22580645161%	1	31	12	Diabetes_McGill_IL10	FUNG_IL2_SIGNALING_2
3.22580645161%	1	31	12	Diabetes_McGill_IL10	DORN_ADENOVIRUS_INFECTION_24HR_UP
3.22580645161%	1	31	12	Diabetes_McGill_IL10	DING_LUNG_CANCER_MUTATED_FREQUENTLY
3.22580645161%	1	31	12	Diabetes_McGill_IL10	BIOCARTA_TRKA_PATHWAY
3.22580645161%	1	31	12	Diabetes_McGill_IL10	BIOCARTA_ASBCELL_PATHWAY
3.22580645161%	1	31	118	Diabetes_McGill_IL10	MARKEY_RB1_CHRONIC_LOF_DN
3.22580645161%	1	31	118	Diabetes_McGill_IL10	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
3.22580645161%	1	31	1174	Diabetes_McGill_IL10	PEREZ_TP53_TARGETS
3.22580645161%	1	31	117	Diabetes_McGill_IL10	PUJANA_BRCA_CENTERED_NETWORK
3.22580645161%	1	31	116	Diabetes_McGill_IL10	WHITEFORD_PEDIATRIC_CANCER_MARKERS
3.22580645161%	1	31	116	Diabetes_McGill_IL10	IKEDA_MIR30_TARGETS_UP
3.22580645161%	1	31	116	Diabetes_McGill_IL10	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
3.22580645161%	1	31	114	Diabetes_McGill_IL10	LENAOUR_DENDRITIC_CELL_MATURATION_UP
3.22580645161%	1	31	114	Diabetes_McGill_IL10	BOSCO_TH1_CYTOTOXIC_MODULE
3.22580645161%	1	31	1137	Diabetes_McGill_IL10	BRUINS_UVC_RESPONSE_LATE
3.22580645161%	1	31	113	Diabetes_McGill_IL10	REACTOME_SIGNALING_BY_RHO_GTPASES
3.22580645161%	1	31	113	Diabetes_McGill_IL10	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
3.22580645161%	1	31	1118	Diabetes_McGill_IL10	BENPORATH_ES_WITH_H3K27ME3
3.22580645161%	1	31	111	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_12HR_UP
3.22580645161%	1	31	110	Diabetes_McGill_IL10	WOOD_EBV_EBNA1_TARGETS_UP
3.22580645161%	1	31	110	Diabetes_McGill_IL10	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
3.22580645161%	1	31	110	Diabetes_McGill_IL10	GROSS_HYPOXIA_VIA_HIF1A_DN
3.22580645161%	1	31	11	Diabetes_McGill_IL10	REACTOME_MTORC1_MEDIATED_SIGNALLING
3.22580645161%	1	31	11	Diabetes_McGill_IL10	REACTOME_DSCAM_INTERACTIONS
3.22580645161%	1	31	11	Diabetes_McGill_IL10	PID_P38GAMMADELTAPATHWAY
3.22580645161%	1	31	11	Diabetes_McGill_IL10	LIANG_SILENCED_BY_METHYLATION_DN
3.22580645161%	1	31	11	Diabetes_McGill_IL10	IIZUKA_LIVER_CANCER_EARLY_RECURRENCE
3.22580645161%	1	31	11	Diabetes_McGill_IL10	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP
3.22580645161%	1	31	11	Diabetes_McGill_IL10	FUNG_IL2_SIGNALING_1
3.22580645161%	1	31	11	Diabetes_McGill_IL10	DORN_ADENOVIRUS_INFECTION_32HR_UP
3.22580645161%	1	31	11	Diabetes_McGill_IL10	CHUANG_OXIDATIVE_STRESS_RESPONSE_DN
3.22580645161%	1	31	11	Diabetes_McGill_IL10	BIOCARTA_EGFR_SMRTE_PATHWAY
3.22580645161%	1	31	109	Diabetes_McGill_IL10	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
3.22580645161%	1	31	108	Diabetes_McGill_IL10	WESTON_VEGFA_TARGETS
3.22580645161%	1	31	108	Diabetes_McGill_IL10	LE_EGR2_TARGETS_DN
3.22580645161%	1	31	107	Diabetes_McGill_IL10	ROESSLER_LIVER_CANCER_METASTASIS_UP
3.22580645161%	1	31	106	Diabetes_McGill_IL10	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
3.22580645161%	1	31	104	Diabetes_McGill_IL10	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
3.22580645161%	1	31	104	Diabetes_McGill_IL10	NAKAMURA_ADIPOGENESIS_LATE_UP
3.22580645161%	1	31	1037	Diabetes_McGill_IL10	NUYTTEN_EZH2_TARGETS_UP
3.22580645161%	1	31	103	Diabetes_McGill_IL10	LEIN_CHOROID_PLEXUS_MARKERS
3.22580645161%	1	31	103	Diabetes_McGill_IL10	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
3.22580645161%	1	31	103	Diabetes_McGill_IL10	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
3.22580645161%	1	31	102	Diabetes_McGill_IL10	MIKKELSEN_IPS_WITH_HCP_H3K27ME3
3.22580645161%	1	31	102	Diabetes_McGill_IL10	KANG_IMMORTALIZED_BY_TERT_DN
3.22580645161%	1	31	101	Diabetes_McGill_IL10	WIELAND_UP_BY_HBV_INFECTION
3.22580645161%	1	31	101	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_20HR_DN
3.22580645161%	1	31	101	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_12HR_DN
3.22580645161%	1	31	101	Diabetes_McGill_IL10	BROWNE_HCMV_INFECTION_10HR_UP
3.22580645161%	1	31	101	Diabetes_McGill_IL10	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
3.22580645161%	1	31	101	Diabetes_McGill_IL10	BASSO_CD40_SIGNALING_UP
3.22580645161%	1	31	100	Diabetes_McGill_IL10	QI_PLASMACYTOMA_DN
3.22580645161%	1	31	100	Diabetes_McGill_IL10	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
3.22580645161%	1	31	100	Diabetes_McGill_IL10	GAVIN_FOXP3_TARGETS_CLUSTER_P4
3.22580645161%	1	31	100	Diabetes_McGill_IL10	BENPORATH_ES_CORE_NINE_CORRELATED
3.22580645161%	1	31	10	Diabetes_McGill_IL10	TSUDA_ALVEOLAR_SOFT_PART_SARCOMA
3.22580645161%	1	31	10	Diabetes_McGill_IL10	ST_INTERFERON_GAMMA_PATHWAY
3.22580645161%	1	31	10	Diabetes_McGill_IL10	SHANK_TAL1_TARGETS_DN
3.22580645161%	1	31	10	Diabetes_McGill_IL10	REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS
3.22580645161%	1	31	10	Diabetes_McGill_IL10	PYEON_HPV_POSITIVE_TUMORS_DN
3.22580645161%	1	31	10	Diabetes_McGill_IL10	MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY
3.22580645161%	1	31	10	Diabetes_McGill_IL10	KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN
3.22580645161%	1	31	10	Diabetes_McGill_IL10	GOUYER_TATI_TARGETS_UP
3.22580645161%	1	31	10	Diabetes_McGill_IL10	BUDHU_LIVER_CANCER_METASTASIS_UP
3.22580645161%	1	31	10	Diabetes_McGill_IL10	BIOCARTA_SODD_PATHWAY
3.22580645161%	1	31	10	Diabetes_McGill_IL10	BIOCARTA_SARS_PATHWAY
3.22580645161%	1	31	10	Diabetes_McGill_IL10	BIOCARTA_FREE_PATHWAY
3.22580645161%	1	31	10	Diabetes_McGill_IL10	AGARWAL_AKT_PATHWAY_TARGETS
3.22333077513%	42	1303	800	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
3.22333077513%	42	1303	1024	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NUYTTEN_EZH2_TARGETS_DN
3.21987120515%	70	2174	721	T2D_GENES_TANYA_LIPIDS	WONG_ADULT_TISSUE_STEM_MODULE
3.21987120515%	70	2174	570	T2D_GENES_TANYA_LIPIDS	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
3.21987120515%	70	2174	425	T2D_GENES_TANYA_LIPIDS	BOCHKIS_FOXA2_TARGETS
3.21022727273%	113	3520	973	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ACEVEDO_LIVER_CANCER_UP
3.21022727273%	113	3520	1080	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
3.20684126136%	60	1871	781	T2D_GENES_TANYA_HEIGHT	GOZGIT_ESR1_TARGETS_DN
3.20684126136%	60	1871	593	T2D_GENES_TANYA_HEIGHT	MARTINEZ_TP53_TARGETS_DN
3.20684126136%	60	1871	473	T2D_GENES_TANYA_HEIGHT	GARY_CD5_TARGETS_UP
3.20684126136%	60	1871	456	T2D_GENES_TANYA_HEIGHT	MARTENS_BOUND_BY_PML_RARA_FUSION
3.20684126136%	60	1871	366	T2D_GENES_TANYA_HEIGHT	SANSOM_APC_TARGETS_DN
3.1914893617%	63	1974	487	Mendelian_Nancy_Cox	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
3.1914893617%	63	1974	457	Mendelian_Nancy_Cox	SENESE_HDAC1_TARGETS_UP
3.1914893617%	63	1974	422	Mendelian_Nancy_Cox	YAGI_AML_WITH_INV_16_TRANSLOCATION
3.1914893617%	63	1974	253	Mendelian_Nancy_Cox	DANG_REGULATED_BY_MYC_DN
3.18181818182%	112	3520	871	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRADE_COLON_CANCER_UP
3.17700453858%	21	661	898	T2D_GENES_TANYA_GLYCEMIC	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
3.17700453858%	21	661	73	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MEIOTIC_SYNAPSIS
3.17700453858%	21	661	722	T2D_GENES_TANYA_GLYCEMIC	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
3.17700453858%	21	661	712	T2D_GENES_TANYA_GLYCEMIC	SCHLOSSER_SERUM_RESPONSE_DN
3.17700453858%	21	661	682	T2D_GENES_TANYA_GLYCEMIC	FEVR_CTNNB1_TARGETS_UP
3.17700453858%	21	661	64	T2D_GENES_TANYA_GLYCEMIC	REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE
3.17700453858%	21	661	612	T2D_GENES_TANYA_GLYCEMIC	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
3.17700453858%	21	661	535	T2D_GENES_TANYA_GLYCEMIC	STEIN_ESRRA_TARGETS
3.17700453858%	21	661	517	T2D_GENES_TANYA_GLYCEMIC	RAO_BOUND_BY_SALL4_ISOFORM_B
3.17700453858%	21	661	514	T2D_GENES_TANYA_GLYCEMIC	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
3.17700453858%	21	661	479	T2D_GENES_TANYA_GLYCEMIC	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
3.17700453858%	21	661	456	T2D_GENES_TANYA_GLYCEMIC	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
3.17700453858%	21	661	447	T2D_GENES_TANYA_GLYCEMIC	MOOTHA_MITOCHONDRIA
3.17700453858%	21	661	418	T2D_GENES_TANYA_GLYCEMIC	MULLIGHAN_MLL_SIGNATURE_2_UP
3.17387304508%	69	2174	795	T2D_GENES_TANYA_LIPIDS	WEI_MYCN_TARGETS_WITH_E_BOX
3.17387304508%	69	2174	658	T2D_GENES_TANYA_LIPIDS	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
3.17387304508%	69	2174	335	T2D_GENES_TANYA_LIPIDS	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
3.16509837468%	37	1169	953	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
3.16509837468%	37	1169	911	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
3.16509837468%	37	1169	756	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
3.16509837468%	37	1169	747	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PATIL_LIVER_CANCER
3.16509837468%	37	1169	728	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARSON_BOUND_BY_E2F4_UNSTIMULATED
3.16205533597%	8	253	75	Diabetes_McGill_CREBBP_coTF	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
3.16205533597%	8	253	73	Diabetes_McGill_CREBBP_coTF	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
3.16205533597%	8	253	71	Diabetes_McGill_CREBBP_coTF	GU_PDEF_TARGETS_UP
3.16205533597%	8	253	71	Diabetes_McGill_CREBBP_coTF	DER_IFN_GAMMA_RESPONSE_UP
3.16205533597%	8	253	69	Diabetes_McGill_CREBBP_coTF	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
3.16205533597%	8	253	68	Diabetes_McGill_CREBBP_coTF	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
3.16205533597%	8	253	63	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
3.16205533597%	8	253	63	Diabetes_McGill_CREBBP_coTF	PID_IL12_2PATHWAY
3.16205533597%	8	253	584	Diabetes_McGill_CREBBP_coTF	HAMAI_APOPTOSIS_VIA_TRAIL_UP
3.16205533597%	8	253	579	Diabetes_McGill_CREBBP_coTF	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
3.16205533597%	8	253	557	Diabetes_McGill_CREBBP_coTF	TIEN_INTESTINE_PROBIOTICS_24HR_UP
3.16205533597%	8	253	549	Diabetes_McGill_CREBBP_coTF	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
3.16205533597%	8	253	54	Diabetes_McGill_CREBBP_coTF	PID_TAP63PATHWAY
3.16205533597%	8	253	528	Diabetes_McGill_CREBBP_coTF	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
3.16205533597%	8	253	526	Diabetes_McGill_CREBBP_coTF	ONKEN_UVEAL_MELANOMA_DN
3.16205533597%	8	253	50	Diabetes_McGill_CREBBP_coTF	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN
3.16205533597%	8	253	481	Diabetes_McGill_CREBBP_coTF	LIU_PROSTATE_CANCER_DN
3.16205533597%	8	253	47	Diabetes_McGill_CREBBP_coTF	PID_NFAT_TFPATHWAY
3.16205533597%	8	253	456	Diabetes_McGill_CREBBP_coTF	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
3.16205533597%	8	253	45	Diabetes_McGill_CREBBP_coTF	KLEIN_TARGETS_OF_BCR_ABL1_FUSION
3.16205533597%	8	253	443	Diabetes_McGill_CREBBP_coTF	DELYS_THYROID_CANCER_UP
3.16205533597%	8	253	442	Diabetes_McGill_CREBBP_coTF	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
3.16205533597%	8	253	442	Diabetes_McGill_CREBBP_coTF	HAN_SATB1_TARGETS_DN
3.16205533597%	8	253	44	Diabetes_McGill_CREBBP_coTF	MARTIN_INTERACT_WITH_HDAC
3.16205533597%	8	253	430	Diabetes_McGill_CREBBP_coTF	RIGGI_EWING_SARCOMA_PROGENITOR_UP
3.16205533597%	8	253	43	Diabetes_McGill_CREBBP_coTF	PID_TCPTP_PATHWAY
3.16205533597%	8	253	408	Diabetes_McGill_CREBBP_coTF	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
3.16205533597%	8	253	40	Diabetes_McGill_CREBBP_coTF	PID_IFNGPATHWAY
3.16205533597%	8	253	40	Diabetes_McGill_CREBBP_coTF	PID_FOXM1PATHWAY
3.16205533597%	8	253	39	Diabetes_McGill_CREBBP_coTF	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2
3.16205533597%	8	253	38	Diabetes_McGill_CREBBP_coTF	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER
3.16205533597%	8	253	379	Diabetes_McGill_CREBBP_coTF	BENPORATH_ES_1
3.16205533597%	8	253	37	Diabetes_McGill_CREBBP_coTF	BIOCARTA_TOLL_PATHWAY
3.16205533597%	8	253	354	Diabetes_McGill_CREBBP_coTF	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
3.16205533597%	8	253	349	Diabetes_McGill_CREBBP_coTF	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
3.16205533597%	8	253	34	Diabetes_McGill_CREBBP_coTF	PID_MAPKTRKPATHWAY
3.16205533597%	8	253	330	Diabetes_McGill_CREBBP_coTF	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
3.16205533597%	8	253	317	Diabetes_McGill_CREBBP_coTF	HELLER_HDAC_TARGETS_UP
3.16205533597%	8	253	316	Diabetes_McGill_CREBBP_coTF	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
3.16205533597%	8	253	306	Diabetes_McGill_CREBBP_coTF	CHANDRAN_METASTASIS_DN
3.16205533597%	8	253	293	Diabetes_McGill_CREBBP_coTF	ENK_UV_RESPONSE_EPIDERMIS_UP
3.16205533597%	8	253	292	Diabetes_McGill_CREBBP_coTF	HELLER_HDAC_TARGETS_DN
3.16205533597%	8	253	282	Diabetes_McGill_CREBBP_coTF	HELLER_SILENCED_BY_METHYLATION_UP
3.16205533597%	8	253	280	Diabetes_McGill_CREBBP_coTF	WANG_SMARCE1_TARGETS_UP
3.16205533597%	8	253	279	Diabetes_McGill_CREBBP_coTF	REACTOME_NEURONAL_SYSTEM
3.16205533597%	8	253	271	Diabetes_McGill_CREBBP_coTF	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
3.16205533597%	8	253	27	Diabetes_McGill_CREBBP_coTF	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION
3.16205533597%	8	253	259	Diabetes_McGill_CREBBP_coTF	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
3.16205533597%	8	253	251	Diabetes_McGill_CREBBP_coTF	REACTOME_AXON_GUIDANCE
3.16205533597%	8	253	245	Diabetes_McGill_CREBBP_coTF	BLUM_RESPONSE_TO_SALIRASIB_UP
3.16205533597%	8	253	244	Diabetes_McGill_CREBBP_coTF	PLASARI_TGFB1_TARGETS_10HR_DN
3.16205533597%	8	253	243	Diabetes_McGill_CREBBP_coTF	CHICAS_RB1_TARGETS_GROWING
3.16205533597%	8	253	24	Diabetes_McGill_CREBBP_coTF	BIOCARTA_NTHI_PATHWAY
3.16205533597%	8	253	24	Diabetes_McGill_CREBBP_coTF	BIOCARTA_G2_PATHWAY
3.16205533597%	8	253	239	Diabetes_McGill_CREBBP_coTF	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
3.16205533597%	8	253	226	Diabetes_McGill_CREBBP_coTF	KYNG_DNA_DAMAGE_UP
3.16205533597%	8	253	22	Diabetes_McGill_CREBBP_coTF	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
3.16205533597%	8	253	217	Diabetes_McGill_CREBBP_coTF	AMUNDSON_RESPONSE_TO_ARSENITE
3.16205533597%	8	253	216	Diabetes_McGill_CREBBP_coTF	BOQUEST_STEM_CELL_DN
3.16205533597%	8	253	212	Diabetes_McGill_CREBBP_coTF	SANSOM_APC_TARGETS
3.16205533597%	8	253	210	Diabetes_McGill_CREBBP_coTF	SANSOM_APC_TARGETS_REQUIRE_MYC
3.16205533597%	8	253	205	Diabetes_McGill_CREBBP_coTF	SHEPARD_BMYB_MORPHOLINO_UP
3.16205533597%	8	253	183	Diabetes_McGill_CREBBP_coTF	VERHAAK_AML_WITH_NPM1_MUTATED_UP
3.16205533597%	8	253	180	Diabetes_McGill_CREBBP_coTF	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
3.16205533597%	8	253	180	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_48HR_UP
3.16205533597%	8	253	169	Diabetes_McGill_CREBBP_coTF	PENG_GLUCOSE_DEPRIVATION_DN
3.16205533597%	8	253	168	Diabetes_McGill_CREBBP_coTF	PUJANA_XPRSS_INT_NETWORK
3.16205533597%	8	253	166	Diabetes_McGill_CREBBP_coTF	SMIRNOV_RESPONSE_TO_IR_6HR_UP
3.16205533597%	8	253	157	Diabetes_McGill_CREBBP_coTF	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
3.16205533597%	8	253	153	Diabetes_McGill_CREBBP_coTF	DAZARD_UV_RESPONSE_CLUSTER_G6
3.16205533597%	8	253	147	Diabetes_McGill_CREBBP_coTF	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
3.16205533597%	8	253	144	Diabetes_McGill_CREBBP_coTF	BROCKE_APOPTOSIS_REVERSED_BY_IL6
3.16205533597%	8	253	139	Diabetes_McGill_CREBBP_coTF	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
3.16205533597%	8	253	137	Diabetes_McGill_CREBBP_coTF	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
3.16205533597%	8	253	134	Diabetes_McGill_CREBBP_coTF	SCHLOSSER_SERUM_RESPONSE_UP
3.16205533597%	8	253	130	Diabetes_McGill_CREBBP_coTF	ELVIDGE_HYPOXIA_BY_DMOG_UP
3.16205533597%	8	253	128	Diabetes_McGill_CREBBP_coTF	ZHU_CMV_ALL_DN
3.16205533597%	8	253	128	Diabetes_McGill_CREBBP_coTF	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
3.16205533597%	8	253	116	Diabetes_McGill_CREBBP_coTF	LI_INDUCED_T_TO_NATURAL_KILLER_DN
3.16205533597%	8	253	108	Diabetes_McGill_CREBBP_coTF	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
3.16205533597%	8	253	107	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_ILS
3.16205533597%	8	253	102	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_IPS_WITH_HCP_H3K27ME3
3.16205533597%	8	253	101	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_ERBB2
3.15340909091%	111	3520	957	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LOPEZ_MBD_TARGETS
3.153393907%	59	1871	510	T2D_GENES_TANYA_HEIGHT	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
3.15208825847%	40	1269	1011	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
3.1465848043%	41	1303	988	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BENPORATH_NANOG_TARGETS
3.1465848043%	41	1303	1137	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_LATE
3.14083080041%	62	1974	536	Mendelian_Nancy_Cox	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
3.14083080041%	62	1974	517	Mendelian_Nancy_Cox	RAO_BOUND_BY_SALL4_ISOFORM_B
3.14083080041%	62	1974	491	Mendelian_Nancy_Cox	ZHENG_BOUND_BY_FOXP3
3.14083080041%	62	1974	491	Mendelian_Nancy_Cox	MEISSNER_NPC_HCP_WITH_H3K4ME2
3.14083080041%	62	1974	483	Mendelian_Nancy_Cox	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
3.14083080041%	62	1974	428	Mendelian_Nancy_Cox	LIM_MAMMARY_STEM_CELL_DN
3.14083080041%	62	1974	330	Mendelian_Nancy_Cox	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
3.13901345291%	14	446	953	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
3.13901345291%	14	446	800	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
3.13901345291%	14	446	682	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
3.13901345291%	14	446	658	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
3.13901345291%	14	446	413	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
3.13901345291%	14	446	389	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_OLFACTORY_TRANSDUCTION
3.13901345291%	14	446	1725	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
3.13901345291%	14	446	1137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BRUINS_UVC_RESPONSE_LATE
3.13901345291%	14	446	1037	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NUYTTEN_EZH2_TARGETS_UP
3.13653136531%	17	542	781	T2D_GENES_TANYA_ANTHROPOMETRIC	GOZGIT_ESR1_TARGETS_DN
3.13653136531%	17	542	770	T2D_GENES_TANYA_ANTHROPOMETRIC	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
3.13653136531%	17	542	593	T2D_GENES_TANYA_ANTHROPOMETRIC	MARTINEZ_TP53_TARGETS_DN
3.13653136531%	17	542	578	T2D_GENES_TANYA_ANTHROPOMETRIC	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
3.13653136531%	17	542	567	T2D_GENES_TANYA_ANTHROPOMETRIC	CHICAS_RB1_TARGETS_CONFLUENT
3.13653136531%	17	542	566	T2D_GENES_TANYA_ANTHROPOMETRIC	DOUGLAS_BMI1_TARGETS_UP
3.13653136531%	17	542	552	T2D_GENES_TANYA_ANTHROPOMETRIC	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
3.13653136531%	17	542	517	T2D_GENES_TANYA_ANTHROPOMETRIC	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
3.13653136531%	17	542	478	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
3.13653136531%	17	542	456	T2D_GENES_TANYA_ANTHROPOMETRIC	MARTENS_BOUND_BY_PML_RARA_FUSION
3.13653136531%	17	542	374	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_TUMOR_INVASIVENESS_UP
3.13653136531%	17	542	368	T2D_GENES_TANYA_ANTHROPOMETRIC	YAGI_AML_WITH_T_8_21_TRANSLOCATION
3.13653136531%	17	542	309	T2D_GENES_TANYA_ANTHROPOMETRIC	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
3.13653136531%	17	542	289	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_MLL_TARGETS
3.13653136531%	17	542	206	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
3.127874885%	68	2174	673	T2D_GENES_TANYA_LIPIDS	MARTINEZ_RB1_TARGETS_UP
3.127874885%	68	2174	504	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_48HR_DN
3.125%	1	32	988	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BENPORATH_NANOG_TARGETS
3.125%	1	32	98	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GAVIN_FOXP3_TARGETS_CLUSTER_T7
3.125%	1	32	973	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ACEVEDO_LIVER_CANCER_UP
3.125%	1	32	96	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZAMORA_NOS2_TARGETS_DN
3.125%	1	32	95	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HECKER_IFNB1_TARGETS
3.125%	1	32	940	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
3.125%	1	32	94	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5
3.125%	1	32	94	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER
3.125%	1	32	92	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
3.125%	1	32	92	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
3.125%	1	32	92	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
3.125%	1	32	91	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
3.125%	1	32	90	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SASSON_RESPONSE_TO_FORSKOLIN_UP
3.125%	1	32	9	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON
3.125%	1	32	9	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP
3.125%	1	32	89	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
3.125%	1	32	88	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
3.125%	1	32	87	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SAFFORD_T_LYMPHOCYTE_ANERGY
3.125%	1	32	87	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
3.125%	1	32	863	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
3.125%	1	32	86	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
3.125%	1	32	86	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BROWNE_HCMV_INFECTION_16HR_DN
3.125%	1	32	855	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
3.125%	1	32	848	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	NUYTTEN_NIPP1_TARGETS_DN
3.125%	1	32	83	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	WARTERS_RESPONSE_TO_IR_SKIN
3.125%	1	32	83	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
3.125%	1	32	83	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
3.125%	1	32	824	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
3.125%	1	32	81	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MAHAJAN_RESPONSE_TO_IL1A_UP
3.125%	1	32	805	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
3.125%	1	32	80	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
3.125%	1	32	80	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BASSO_HAIRY_CELL_LEUKEMIA_DN
3.125%	1	32	795	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	WEI_MYCN_TARGETS_WITH_E_BOX
3.125%	1	32	79	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MEISSNER_NPC_HCP_WITH_H3K27ME3
3.125%	1	32	79	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DUAN_PRDM5_TARGETS
3.125%	1	32	783	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ONKEN_UVEAL_MELANOMA_UP
3.125%	1	32	781	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GOZGIT_ESR1_TARGETS_DN
3.125%	1	32	78	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
3.125%	1	32	775	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BENPORATH_MYC_MAX_TARGETS
3.125%	1	32	770	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KRIEG_HYPOXIA_NOT_VIA_KDM3A
3.125%	1	32	77	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ROSS_AML_WITH_PML_RARA_FUSION
3.125%	1	32	77	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RODRIGUES_THYROID_CARCINOMA_DN
3.125%	1	32	77	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN
3.125%	1	32	77	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
3.125%	1	32	77	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CHEBOTAEV_GR_TARGETS_UP
3.125%	1	32	769	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	NUYTTEN_NIPP1_TARGETS_UP
3.125%	1	32	76	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ROSS_AML_WITH_AML1_ETO_FUSION
3.125%	1	32	75	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MCCLUNG_COCAIN_REWARD_4WK
3.125%	1	32	747	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PATIL_LIVER_CANCER
3.125%	1	32	745	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LEE_BMP2_TARGETS_UP
3.125%	1	32	74	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	URS_ADIPOCYTE_DIFFERENTIATION_UP
3.125%	1	32	734	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BENPORATH_SOX2_TARGETS
3.125%	1	32	73	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
3.125%	1	32	722	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
3.125%	1	32	72	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
3.125%	1	32	72	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DOANE_BREAST_CANCER_CLASSES_UP
3.125%	1	32	72	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BURTON_ADIPOGENESIS_2
3.125%	1	32	718	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MIKKELSEN_ES_ICP_WITH_H3K4ME3
3.125%	1	32	712	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SCHLOSSER_SERUM_RESPONSE_DN
3.125%	1	32	70	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LIU_NASOPHARYNGEAL_CARCINOMA
3.125%	1	32	7	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	IKEDA_MIR1_TARGETS_DN
3.125%	1	32	7	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HOLLEMAN_DAUNORUBICIN_ALL_UP
3.125%	1	32	7	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CHESLER_BRAIN_D6MIT150_QTL_CIS
3.125%	1	32	7	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ABBUD_LIF_SIGNALING_2_DN
3.125%	1	32	69	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LEIN_NEURON_MARKERS
3.125%	1	32	682	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
3.125%	1	32	682	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	FEVR_CTNNB1_TARGETS_UP
3.125%	1	32	68	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
3.125%	1	32	68	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
3.125%	1	32	68	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ROSS_AML_OF_FAB_M7_TYPE
3.125%	1	32	68	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	NOUZOVA_METHYLATED_IN_APL
3.125%	1	32	68	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BASSO_CD40_SIGNALING_DN
3.125%	1	32	673	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MARTINEZ_RB1_TARGETS_UP
3.125%	1	32	67	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
3.125%	1	32	66	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RIGGINS_TAMOXIFEN_RESISTANCE_UP
3.125%	1	32	66	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
3.125%	1	32	66	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
3.125%	1	32	66	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BEIER_GLIOMA_STEM_CELL_DN
3.125%	1	32	65	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP
3.125%	1	32	64	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZHANG_GATA6_TARGETS_DN
3.125%	1	32	64	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
3.125%	1	32	64	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LIU_SMARCA4_TARGETS
3.125%	1	32	64	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LEE_LIVER_CANCER_E2F1_DN
3.125%	1	32	64	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
3.125%	1	32	634	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
3.125%	1	32	63	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED
3.125%	1	32	63	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BRIDEAU_IMPRINTED_GENES
3.125%	1	32	612	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
3.125%	1	32	61	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZWANG_EGF_PERSISTENTLY_DN
3.125%	1	32	61	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RAMASWAMY_METASTASIS_DN
3.125%	1	32	59	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3
3.125%	1	32	59	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
3.125%	1	32	59	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BOYLAN_MULTIPLE_MYELOMA_C_DN
3.125%	1	32	58	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LIM_MAMMARY_LUMINAL_PROGENITOR_UP
3.125%	1	32	58	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
3.125%	1	32	57	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
3.125%	1	32	57	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DELASERNA_MYOD_TARGETS_DN
3.125%	1	32	564	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SMID_BREAST_CANCER_LUMINAL_B_DN
3.125%	1	32	56	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_VIBRIO_CHOLERAE_INFECTION
3.125%	1	32	56	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
3.125%	1	32	56	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BROWNE_HCMV_INFECTION_10HR_DN
3.125%	1	32	555	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
3.125%	1	32	55	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SMIRNOV_RESPONSE_TO_IR_2HR_DN
3.125%	1	32	549	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
3.125%	1	32	546	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	WEST_ADRENOCORTICAL_TUMOR_DN
3.125%	1	32	546	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
3.125%	1	32	544	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
3.125%	1	32	540	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ACEVEDO_LIVER_CANCER_DN
3.125%	1	32	54	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ROVERSI_GLIOMA_COPY_NUMBER_DN
3.125%	1	32	54	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	JIANG_AGING_CEREBRAL_CORTEX_DN
3.125%	1	32	537	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
3.125%	1	32	536	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BERENJENO_TRANSFORMED_BY_RHOA_UP
3.125%	1	32	53	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
3.125%	1	32	517	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RAO_BOUND_BY_SALL4_ISOFORM_B
3.125%	1	32	516	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
3.125%	1	32	510	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
3.125%	1	32	51	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
3.125%	1	32	51	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	TSUNODA_CISPLATIN_RESISTANCE_DN
3.125%	1	32	501	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SENESE_HDAC3_TARGETS_UP
3.125%	1	32	50	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MARTINEZ_RESPONSE_TO_TRABECTEDIN
3.125%	1	32	493	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
3.125%	1	32	489	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LIM_MAMMARY_STEM_CELL_UP
3.125%	1	32	487	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
3.125%	1	32	487	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RODWELL_AGING_KIDNEY_UP
3.125%	1	32	485	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
3.125%	1	32	482	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
3.125%	1	32	48	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZHAN_MULTIPLE_MYELOMA_LB_UP
3.125%	1	32	48	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
3.125%	1	32	48	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ENGELMANN_CANCER_PROGENITORS_UP
3.125%	1	32	475	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
3.125%	1	32	473	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GARY_CD5_TARGETS_UP
3.125%	1	32	47	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZHAN_MULTIPLE_MYELOMA_HP_DN
3.125%	1	32	47	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MCCLUNG_DELTA_FOSB_TARGETS_8WK
3.125%	1	32	47	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	JIANG_AGING_HYPOTHALAMUS_UP
3.125%	1	32	467	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RATTENBACHER_BOUND_BY_CELF1
3.125%	1	32	463	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
3.125%	1	32	462	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DELACROIX_RAR_BOUND_ES
3.125%	1	32	46	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	OSADA_ASCL1_TARGETS_UP
3.125%	1	32	46	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HEIDENBLAD_AMPLICON_8Q24_DN
3.125%	1	32	46	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN
3.125%	1	32	457	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SENESE_HDAC1_TARGETS_UP
3.125%	1	32	457	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
3.125%	1	32	456	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ODONNELL_TFRC_TARGETS_UP
3.125%	1	32	450	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
3.125%	1	32	45	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZHAN_MULTIPLE_MYELOMA_CD1_DN
3.125%	1	32	45	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	NUTT_GBM_VS_AO_GLIOMA_DN
3.125%	1	32	448	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
3.125%	1	32	442	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
3.125%	1	32	442	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HAN_SATB1_TARGETS_DN
3.125%	1	32	44	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LANDIS_BREAST_CANCER_PROGRESSION_UP
3.125%	1	32	44	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_ABC_TRANSPORTERS
3.125%	1	32	439	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MITSIADES_RESPONSE_TO_APLIDIN_UP
3.125%	1	32	431	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
3.125%	1	32	430	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	VECCHI_GASTRIC_CANCER_EARLY_UP
3.125%	1	32	43	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ULE_SPLICING_VIA_NOVA2
3.125%	1	32	428	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LIM_MAMMARY_STEM_CELL_DN
3.125%	1	32	425	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BOCHKIS_FOXA2_TARGETS
3.125%	1	32	422	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	YAGI_AML_WITH_INV_16_TRANSLOCATION
3.125%	1	32	42	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LUI_THYROID_CANCER_CLUSTER_2
3.125%	1	32	42	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
3.125%	1	32	42	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	AMIT_EGF_RESPONSE_40_HELA
3.125%	1	32	419	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
3.125%	1	32	418	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PEDRIOLI_MIR31_TARGETS_DN
3.125%	1	32	414	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MOHANKUMAR_TLX1_TARGETS_UP
3.125%	1	32	413	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
3.125%	1	32	41	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MIKKELSEN_ES_HCP_WITH_H3K27ME3
3.125%	1	32	41	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MALONEY_RESPONSE_TO_17AAG_UP
3.125%	1	32	41	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
3.125%	1	32	406	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	OSMAN_BLADDER_CANCER_DN
3.125%	1	32	405	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KUMAR_TARGETS_OF_MLL_AF9_FUSION
3.125%	1	32	403	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
3.125%	1	32	40	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP
3.125%	1	32	40	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	VANASSE_BCL2_TARGETS_UP
3.125%	1	32	40	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	TOMLINS_PROSTATE_CANCER_UP
3.125%	1	32	397	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
3.125%	1	32	395	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HAN_SATB1_TARGETS_UP
3.125%	1	32	391	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
3.125%	1	32	39	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_NCAM1_INTERACTIONS
3.125%	1	32	389	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HSIAO_HOUSEKEEPING_GENES
3.125%	1	32	380	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
3.125%	1	32	38	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
3.125%	1	32	38	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PENG_GLUTAMINE_DEPRIVATION_UP
3.125%	1	32	38	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP
3.125%	1	32	38	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP
3.125%	1	32	38	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CERVERA_SDHB_TARGETS_1_DN
3.125%	1	32	379	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BENPORATH_ES_1
3.125%	1	32	374	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
3.125%	1	32	37	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ROLEF_GLIS3_TARGETS
3.125%	1	32	37	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KIM_ALL_DISORDERS_CALB1_CORR_DN
3.125%	1	32	368	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	YAGI_AML_WITH_T_8_21_TRANSLOCATION
3.125%	1	32	368	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
3.125%	1	32	367	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	VECCHI_GASTRIC_CANCER_EARLY_DN
3.125%	1	32	366	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SANSOM_APC_TARGETS_DN
3.125%	1	32	364	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	YANG_BCL3_TARGETS_UP
3.125%	1	32	36	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	VANTVEER_BREAST_CANCER_BRCA1_UP
3.125%	1	32	36	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	VALK_AML_CLUSTER_11
3.125%	1	32	36	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MARZEC_IL2_SIGNALING_DN
3.125%	1	32	358	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GRUETZMANN_PANCREATIC_CANCER_UP
3.125%	1	32	357	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SHEN_SMARCA2_TARGETS_DN
3.125%	1	32	354	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
3.125%	1	32	351	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	YAGI_AML_WITH_11Q23_REARRANGED
3.125%	1	32	35	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
3.125%	1	32	35	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LOPEZ_TRANSLATION_VIA_FN1_SIGNALING
3.125%	1	32	349	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
3.125%	1	32	344	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
3.125%	1	32	34	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT
3.125%	1	32	338	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
3.125%	1	32	337	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PHONG_TNF_RESPONSE_NOT_VIA_P38
3.125%	1	32	335	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
3.125%	1	32	330	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
3.125%	1	32	33	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	VALK_AML_CLUSTER_5
3.125%	1	32	33	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	VALK_AML_CLUSTER_3
3.125%	1	32	33	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP
3.125%	1	32	33	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HEIDENBLAD_AMPLICON_12P11_12_UP
3.125%	1	32	33	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BIOCARTA_NO1_PATHWAY
3.125%	1	32	329	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
3.125%	1	32	326	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
3.125%	1	32	321	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
3.125%	1	32	32	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN
3.125%	1	32	318	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LEI_MYB_TARGETS
3.125%	1	32	316	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
3.125%	1	32	315	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
3.125%	1	32	315	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
3.125%	1	32	314	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DOUGLAS_BMI1_TARGETS_DN
3.125%	1	32	311	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	JIANG_HYPOXIA_NORMAL
3.125%	1	32	31	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER
3.125%	1	32	309	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
3.125%	1	32	309	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LIU_SOX4_TARGETS_DN
3.125%	1	32	309	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
3.125%	1	32	307	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
3.125%	1	32	306	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CHANDRAN_METASTASIS_DN
3.125%	1	32	30	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
3.125%	1	32	298	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BROWNE_HCMV_INFECTION_14HR_DN
3.125%	1	32	294	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
3.125%	1	32	293	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HADDAD_B_LYMPHOCYTE_PROGENITOR
3.125%	1	32	292	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HELLER_HDAC_TARGETS_DN
3.125%	1	32	291	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SABATES_COLORECTAL_ADENOMA_DN
3.125%	1	32	29	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	NGUYEN_NOTCH1_TARGETS_UP
3.125%	1	32	282	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HELLER_SILENCED_BY_METHYLATION_UP
3.125%	1	32	281	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
3.125%	1	32	279	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	FORTSCHEGGER_PHF8_TARGETS_UP
3.125%	1	32	275	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
3.125%	1	32	271	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
3.125%	1	32	27	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
3.125%	1	32	27	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	NICK_RESPONSE_TO_PROC_TREATMENT_DN
3.125%	1	32	27	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP
3.125%	1	32	266	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
3.125%	1	32	264	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
3.125%	1	32	261	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
3.125%	1	32	261	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
3.125%	1	32	259	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
3.125%	1	32	258	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
3.125%	1	32	258	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	JAEGER_METASTASIS_DN
3.125%	1	32	254	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	IVANOVA_HEMATOPOIESIS_STEM_CELL
3.125%	1	32	252	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
3.125%	1	32	250	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
3.125%	1	32	25	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	VANDESLUIS_NORMAL_EMBRYOS_DN
3.125%	1	32	25	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PID_INTEGRIN_A9B1_PATHWAY
3.125%	1	32	25	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP
3.125%	1	32	246	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BILD_E2F3_ONCOGENIC_SIGNATURE
3.125%	1	32	245	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KONDO_EZH2_TARGETS
3.125%	1	32	244	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	THUM_SYSTOLIC_HEART_FAILURE_DN
3.125%	1	32	244	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KAYO_AGING_MUSCLE_UP
3.125%	1	32	244	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DAZARD_RESPONSE_TO_UV_NHEK_UP
3.125%	1	32	243	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CHICAS_RB1_TARGETS_GROWING
3.125%	1	32	240	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	VANTVEER_BREAST_CANCER_ESR1_DN
3.125%	1	32	240	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	UDAYAKUMAR_MED1_TARGETS_DN
3.125%	1	32	240	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BROWNE_HCMV_INFECTION_20HR_UP
3.125%	1	32	24	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN
3.125%	1	32	237	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
3.125%	1	32	234	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
3.125%	1	32	228	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
3.125%	1	32	227	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
3.125%	1	32	227	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
3.125%	1	32	225	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
3.125%	1	32	225	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BROWNE_HCMV_INFECTION_16HR_UP
3.125%	1	32	222	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
3.125%	1	32	222	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CAIRO_LIVER_DEVELOPMENT_DN
3.125%	1	32	221	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZHANG_TLX_TARGETS_36HR_UP
3.125%	1	32	221	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PEDRIOLI_MIR31_TARGETS_UP
3.125%	1	32	221	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CHANDRAN_METASTASIS_UP
3.125%	1	32	220	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
3.125%	1	32	22	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LANDIS_ERBB2_BREAST_TUMORS_65_UP
3.125%	1	32	216	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	WHITFIELD_CELL_CYCLE_G2_M
3.125%	1	32	215	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	YAMAZAKI_TCEB3_TARGETS_DN
3.125%	1	32	214	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	TIEN_INTESTINE_PROBIOTICS_24HR_DN
3.125%	1	32	214	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
3.125%	1	32	214	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
3.125%	1	32	211	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
3.125%	1	32	210	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
3.125%	1	32	21	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4
3.125%	1	32	207	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MANALO_HYPOXIA_UP
3.125%	1	32	207	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
3.125%	1	32	206	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
3.125%	1	32	205	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
3.125%	1	32	205	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
3.125%	1	32	205	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PEREZ_TP53_AND_TP63_TARGETS
3.125%	1	32	204	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
3.125%	1	32	201	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HOLLMANN_APOPTOSIS_VIA_CD40_UP
3.125%	1	32	20	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN
3.125%	1	32	20	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PHESSE_TARGETS_OF_APC_AND_MBD2_UP
3.125%	1	32	20	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP
3.125%	1	32	197	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
3.125%	1	32	196	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
3.125%	1	32	19	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SEIDEN_MET_SIGNALING
3.125%	1	32	19	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MA_PITUITARY_FETAL_VS_ADULT_DN
3.125%	1	32	19	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN
3.125%	1	32	187	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
3.125%	1	32	185	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LEE_LIVER_CANCER_SURVIVAL_UP
3.125%	1	32	185	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEGG_HUNTINGTONS_DISEASE
3.125%	1	32	185	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
3.125%	1	32	184	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DOANE_RESPONSE_TO_ANDROGEN_UP
3.125%	1	32	183	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
3.125%	1	32	183	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	OKUMURA_INFLAMMATORY_RESPONSE_LPS
3.125%	1	32	182	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
3.125%	1	32	182	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RAO_BOUND_BY_SALL4_ISOFORM_A
3.125%	1	32	181	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	JISON_SICKLE_CELL_DISEASE_DN
3.125%	1	32	180	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
3.125%	1	32	180	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
3.125%	1	32	18	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE
3.125%	1	32	18	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	NIELSEN_LEIOMYOSARCOMA_UP
3.125%	1	32	18	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LE_NEURONAL_DIFFERENTIATION_UP
3.125%	1	32	178	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BROWNE_HCMV_INFECTION_18HR_DN
3.125%	1	32	177	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
3.125%	1	32	176	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
3.125%	1	32	175	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LEE_LIVER_CANCER_SURVIVAL_DN
3.125%	1	32	174	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
3.125%	1	32	172	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
3.125%	1	32	171	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ELVIDGE_HYPOXIA_UP
3.125%	1	32	170	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
3.125%	1	32	17	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ONDER_CDH1_TARGETS_3_UP
3.125%	1	32	17	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES
3.125%	1	32	166	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SMIRNOV_RESPONSE_TO_IR_6HR_UP
3.125%	1	32	165	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
3.125%	1	32	165	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DARWICHE_PAPILLOMA_RISK_LOW_DN
3.125%	1	32	164	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	AMIT_EGF_RESPONSE_480_HELA
3.125%	1	32	162	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MULLIGHAN_NPM1_SIGNATURE_3_DN
3.125%	1	32	162	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
3.125%	1	32	161	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BIDUS_METASTASIS_DN
3.125%	1	32	161	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
3.125%	1	32	160	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
3.125%	1	32	158	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
3.125%	1	32	158	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RODRIGUES_NTN1_TARGETS_DN
3.125%	1	32	156	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GROSS_HYPOXIA_VIA_ELK3_DN
3.125%	1	32	153	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
3.125%	1	32	153	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DURAND_STROMA_MAX_DN
3.125%	1	32	150	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
3.125%	1	32	150	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BROWNE_HCMV_INFECTION_30MIN_DN
3.125%	1	32	15	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PIEPOLI_LGI1_TARGETS_UP
3.125%	1	32	149	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HUANG_GATA2_TARGETS_UP
3.125%	1	32	149	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GOZGIT_ESR1_TARGETS_UP
3.125%	1	32	148	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BROWNE_HCMV_INFECTION_24HR_DN
3.125%	1	32	147	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DARWICHE_PAPILLOMA_RISK_HIGH_UP
3.125%	1	32	146	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
3.125%	1	32	1442	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PUJANA_ATM_PCC_NETWORK
3.125%	1	32	142	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
3.125%	1	32	142	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DARWICHE_SKIN_TUMOR_PROMOTER_UP
3.125%	1	32	140	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	QI_HYPOXIA
3.125%	1	32	140	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ONDER_CDH1_TARGETS_1_UP
3.125%	1	32	14	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MIKKELSEN_ES_LCP_WITH_H3K27ME3
3.125%	1	32	14	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION
3.125%	1	32	139	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HOELZEL_NF1_TARGETS_UP
3.125%	1	32	137	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PID_P53DOWNSTREAMPATHWAY
3.125%	1	32	137	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
3.125%	1	32	137	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
3.125%	1	32	137	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LIU_SOX4_TARGETS_UP
3.125%	1	32	135	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	TSENG_IRS1_TARGETS_DN
3.125%	1	32	134	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
3.125%	1	32	132	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
3.125%	1	32	130	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ELVIDGE_HYPOXIA_BY_DMOG_UP
3.125%	1	32	128	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LENAOUR_DENDRITIC_CELL_MATURATION_DN
3.125%	1	32	1278	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
3.125%	1	32	127	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	INGRAM_SHH_TARGETS_UP
3.125%	1	32	126	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SANSOM_APC_TARGETS_UP
3.125%	1	32	126	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
3.125%	1	32	126	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
3.125%	1	32	123	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HOOI_ST7_TARGETS_DN
3.125%	1	32	1229	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
3.125%	1	32	121	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
3.125%	1	32	120	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	XU_GH1_EXOGENOUS_TARGETS_DN
3.125%	1	32	120	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	NIKOLSKY_BREAST_CANCER_16P13_AMPLICON
3.125%	1	32	12	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP
3.125%	1	32	116	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LI_INDUCED_T_TO_NATURAL_KILLER_DN
3.125%	1	32	116	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
3.125%	1	32	116	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LIM_MAMMARY_LUMINAL_MATURE_UP
3.125%	1	32	116	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
3.125%	1	32	115	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MARKEY_RB1_CHRONIC_LOF_UP
3.125%	1	32	115	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HOELZEL_NF1_TARGETS_DN
3.125%	1	32	1142	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
3.125%	1	32	114	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SMIRNOV_RESPONSE_TO_IR_6HR_DN
3.125%	1	32	114	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ROPERO_HDAC2_TARGETS
3.125%	1	32	114	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	CERVERA_SDHB_TARGETS_2
3.125%	1	32	114	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BOSCO_TH1_CYTOTOXIC_MODULE
3.125%	1	32	113	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
3.125%	1	32	113	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
3.125%	1	32	112	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PASINI_SUZ12_TARGETS_UP
3.125%	1	32	112	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DOANE_BREAST_CANCER_ESR1_UP
3.125%	1	32	111	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
3.125%	1	32	1103	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	DANG_BOUND_BY_MYC
3.125%	1	32	110	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GROSS_HYPOXIA_VIA_HIF1A_DN
3.125%	1	32	109	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
3.125%	1	32	108	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	TAVAZOIE_METASTASIS
3.125%	1	32	108	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
3.125%	1	32	107	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ROESSLER_LIVER_CANCER_METASTASIS_UP
3.125%	1	32	106	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
3.125%	1	32	106	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
3.125%	1	32	104	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
3.125%	1	32	103	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
3.125%	1	32	103	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
3.125%	1	32	1022	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MARSON_BOUND_BY_FOXP3_STIMULATED
3.125%	1	32	102	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	MIKKELSEN_IPS_WITH_HCP_H3K27ME3
3.125%	1	32	102	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	LABBE_TGFB1_TARGETS_UP
3.125%	1	32	101	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BROWNE_HCMV_INFECTION_12HR_DN
3.125%	1	32	101	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BROWNE_HCMV_INFECTION_10HR_UP
3.125%	1	32	101	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
3.125%	1	32	101	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	BASSO_CD40_SIGNALING_UP
3.125%	1	32	10	Diabetes_McGill_Calcium-influx_pathway_Katp-independent_and_dependent	HOLLEMAN_DAUNORUBICIN_B_ALL_UP
3.09994655265%	58	1871	633	T2D_GENES_TANYA_HEIGHT	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
3.09994655265%	58	1871	567	T2D_GENES_TANYA_HEIGHT	PARENT_MTOR_SIGNALING_UP
3.09951060359%	19	613	882	T2D_GENES_TANYA_BIOMARKER	LEE_BMP2_TARGETS_DN
3.09951060359%	19	613	783	T2D_GENES_TANYA_BIOMARKER	ONKEN_UVEAL_MELANOMA_UP
3.09951060359%	19	613	648	T2D_GENES_TANYA_BIOMARKER	SMID_BREAST_CANCER_BASAL_UP
3.09951060359%	19	613	584	T2D_GENES_TANYA_BIOMARKER	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
3.09951060359%	19	613	548	T2D_GENES_TANYA_BIOMARKER	KIM_ALL_DISORDERS_CALB1_CORR_UP
3.09951060359%	19	613	546	T2D_GENES_TANYA_BIOMARKER	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
3.09951060359%	19	613	544	T2D_GENES_TANYA_BIOMARKER	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
3.09951060359%	19	613	544	T2D_GENES_TANYA_BIOMARKER	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
3.09951060359%	19	613	517	T2D_GENES_TANYA_BIOMARKER	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
3.09951060359%	19	613	504	T2D_GENES_TANYA_BIOMARKER	PILON_KLF1_TARGETS_UP
3.09951060359%	19	613	493	T2D_GENES_TANYA_BIOMARKER	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
3.09951060359%	19	613	491	T2D_GENES_TANYA_BIOMARKER	ZHENG_BOUND_BY_FOXP3
3.09951060359%	19	613	456	T2D_GENES_TANYA_BIOMARKER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
3.09951060359%	19	613	428	T2D_GENES_TANYA_BIOMARKER	LIM_MAMMARY_STEM_CELL_DN
3.09951060359%	19	613	428	T2D_GENES_TANYA_BIOMARKER	CUI_TCF21_TARGETS_2_UP
3.09951060359%	19	613	419	T2D_GENES_TANYA_BIOMARKER	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
3.09951060359%	19	613	418	T2D_GENES_TANYA_BIOMARKER	MULLIGHAN_MLL_SIGNATURE_2_UP
3.09951060359%	19	613	413	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
3.09951060359%	19	613	335	T2D_GENES_TANYA_BIOMARKER	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
3.09659090909%	109	3520	756	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
3.09017223911%	61	1974	532	Mendelian_Nancy_Cox	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
3.09017223911%	61	1974	493	Mendelian_Nancy_Cox	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
3.09017223911%	61	1974	456	Mendelian_Nancy_Cox	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
3.09017223911%	61	1974	201	Mendelian_Nancy_Cox	KEGG_FOCAL_ADHESION
3.08187672493%	67	2174	893	T2D_GENES_TANYA_LIPIDS	GEORGES_TARGETS_OF_MIR192_AND_MIR215
3.08187672493%	67	2174	461	T2D_GENES_TANYA_LIPIDS	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
3.08187672493%	67	2174	456	T2D_GENES_TANYA_LIPIDS	MARTENS_BOUND_BY_PML_RARA_FUSION
3.08187672493%	67	2174	430	T2D_GENES_TANYA_LIPIDS	JOHNSTONE_PARVB_TARGETS_3_UP
3.07955517536%	36	1169	718	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_ES_ICP_WITH_H3K4ME3
3.07955517536%	36	1169	682	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FEVR_CTNNB1_TARGETS_UP
3.07955517536%	36	1169	1024	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NUYTTEN_EZH2_TARGETS_DN
3.07692307692%	14	455	918	T2D_GENES_TANYA_BLOODPRESSURE	JOHNSTONE_PARVB_TARGETS_3_DN
3.07692307692%	14	455	712	T2D_GENES_TANYA_BLOODPRESSURE	SCHLOSSER_SERUM_RESPONSE_DN
3.07692307692%	14	455	584	T2D_GENES_TANYA_BLOODPRESSURE	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
3.07692307692%	14	455	567	T2D_GENES_TANYA_BLOODPRESSURE	PARENT_MTOR_SIGNALING_UP
3.07692307692%	14	455	548	T2D_GENES_TANYA_BLOODPRESSURE	KIM_ALL_DISORDERS_CALB1_CORR_UP
3.07692307692%	14	455	546	T2D_GENES_TANYA_BLOODPRESSURE	WEST_ADRENOCORTICAL_TUMOR_DN
3.07692307692%	14	455	540	T2D_GENES_TANYA_BLOODPRESSURE	ACEVEDO_LIVER_CANCER_DN
3.07692307692%	14	455	423	T2D_GENES_TANYA_BLOODPRESSURE	THUM_SYSTOLIC_HEART_FAILURE_UP
3.07692307692%	14	455	418	T2D_GENES_TANYA_BLOODPRESSURE	PEDRIOLI_MIR31_TARGETS_DN
3.07692307692%	14	455	414	T2D_GENES_TANYA_BLOODPRESSURE	LU_EZH2_TARGETS_DN
3.07692307692%	14	455	412	T2D_GENES_TANYA_BLOODPRESSURE	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
3.07692307692%	14	455	411	T2D_GENES_TANYA_BLOODPRESSURE	KOYAMA_SEMA3B_TARGETS_DN
3.07692307692%	14	455	366	T2D_GENES_TANYA_BLOODPRESSURE	SANSOM_APC_TARGETS_DN
3.07692307692%	14	455	335	T2D_GENES_TANYA_BLOODPRESSURE	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
3.07692307692%	14	455	317	T2D_GENES_TANYA_BLOODPRESSURE	HELLER_HDAC_TARGETS_UP
3.07328605201%	39	1269	805	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GPCR_DOWNSTREAM_SIGNALING
3.07328605201%	39	1269	756	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
3.07328605201%	39	1269	421	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CELL_CYCLE
3.07328605201%	39	1269	1278	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
3.07328605201%	39	1269	1237	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BLALOCK_ALZHEIMERS_DISEASE_DN
3.07328605201%	39	1269	1142	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP
3.06983883346%	40	1303	882	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
3.04709141274%	11	361	988	T2D_GENES_TANYA_T2D_RSQ05_02CM	BENPORATH_NANOG_TARGETS
3.04709141274%	11	361	882	T2D_GENES_TANYA_T2D_RSQ05_02CM	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
3.04709141274%	11	361	863	T2D_GENES_TANYA_T2D_RSQ05_02CM	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
3.04709141274%	11	361	848	T2D_GENES_TANYA_T2D_RSQ05_02CM	NUYTTEN_NIPP1_TARGETS_DN
3.04709141274%	11	361	779	T2D_GENES_TANYA_T2D_RSQ05_02CM	PUJANA_CHEK2_PCC_NETWORK
3.04709141274%	11	361	673	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARTINEZ_RB1_TARGETS_UP
3.04709141274%	11	361	663	T2D_GENES_TANYA_T2D_RSQ05_02CM	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
3.04709141274%	11	361	602	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARTINEZ_TP53_TARGETS_UP
3.04709141274%	11	361	601	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARTINEZ_RB1_AND_TP53_TARGETS_UP
3.04709141274%	11	361	514	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
3.04709141274%	11	361	1229	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
3.04709141274%	11	361	1174	T2D_GENES_TANYA_T2D_RSQ05_02CM	PEREZ_TP53_TARGETS
3.04709141274%	11	361	1037	T2D_GENES_TANYA_T2D_RSQ05_02CM	NUYTTEN_EZH2_TARGETS_UP
3.04649919829%	57	1871	648	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_BASAL_UP
3.03977272727%	107	3520	1174	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PEREZ_TP53_TARGETS
3.03977272727%	107	3520	1062	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BENPORATH_EED_TARGETS
3.03951367781%	60	1974	517	Mendelian_Nancy_Cox	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
3.03951367781%	60	1974	357	Mendelian_Nancy_Cox	SHEN_SMARCA2_TARGETS_DN
3.03951367781%	60	1974	326	Mendelian_Nancy_Cox	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
3.03951367781%	60	1974	298	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_14HR_DN
3.03951367781%	60	1974	237	Mendelian_Nancy_Cox	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
3.03587856486%	66	2174	536	T2D_GENES_TANYA_LIPIDS	SENESE_HDAC3_TARGETS_DN
3.03587856486%	66	2174	479	T2D_GENES_TANYA_LIPIDS	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
3.0303030303%	1	33	99	Mendelian_Metabolism	LIM_MAMMARY_LUMINAL_MATURE_DN
3.0303030303%	1	33	99	Diabetes_McGill_ER_Stress	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
3.0303030303%	1	33	988	Mendelian_Metabolism	BENPORATH_NANOG_TARGETS
3.0303030303%	1	33	98	Mendelian_Metabolism	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
3.0303030303%	1	33	98	Mendelian_Metabolism	KEGG_PYRIMIDINE_METABOLISM
3.0303030303%	1	33	98	Diabetes_McGill_ER_Stress	MENSE_HYPOXIA_UP
3.0303030303%	1	33	98	Diabetes_McGill_ER_Stress	GUO_TARGETS_OF_IRS1_AND_IRS2
3.0303030303%	1	33	98	Diabetes_McGill_ER_Stress	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
3.0303030303%	1	33	98	Diabetes_McGill_ER_Stress	BRUINS_UVC_RESPONSE_MIDDLE
3.0303030303%	1	33	973	Mendelian_Metabolism	ACEVEDO_LIVER_CANCER_UP
3.0303030303%	1	33	97	Mendelian_Metabolism	LABBE_WNT3A_TARGETS_DN
3.0303030303%	1	33	97	Diabetes_McGill_ER_Stress	KONG_E2F3_TARGETS
3.0303030303%	1	33	97	Diabetes_McGill_ER_Stress	KIM_MYC_AMPLIFICATION_TARGETS_DN
3.0303030303%	1	33	96	Mendelian_Metabolism	ZAMORA_NOS2_TARGETS_DN
3.0303030303%	1	33	96	Mendelian_Metabolism	LIU_PROSTATE_CANCER_UP
3.0303030303%	1	33	95	Mendelian_Metabolism	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
3.0303030303%	1	33	95	Mendelian_Metabolism	HOEBEKE_LYMPHOID_STEM_CELL_UP
3.0303030303%	1	33	95	Mendelian_Metabolism	HECKER_IFNB1_TARGETS
3.0303030303%	1	33	95	Diabetes_McGill_ER_Stress	HECKER_IFNB1_TARGETS
3.0303030303%	1	33	94	Mendelian_Metabolism	REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES
3.0303030303%	1	33	94	Mendelian_Metabolism	GAVIN_FOXP3_TARGETS_CLUSTER_T4
3.0303030303%	1	33	94	Diabetes_McGill_ER_Stress	GAVIN_FOXP3_TARGETS_CLUSTER_T4
3.0303030303%	1	33	933	Mendelian_Metabolism	REACTOME_IMMUNE_SYSTEM
3.0303030303%	1	33	93	Mendelian_Metabolism	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
3.0303030303%	1	33	93	Diabetes_McGill_ER_Stress	REACTOME_ACTIVATED_TLR4_SIGNALLING
3.0303030303%	1	33	92	Mendelian_Metabolism	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
3.0303030303%	1	33	92	Mendelian_Metabolism	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
3.0303030303%	1	33	92	Diabetes_McGill_ER_Stress	WINTER_HYPOXIA_UP
3.0303030303%	1	33	92	Diabetes_McGill_ER_Stress	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
3.0303030303%	1	33	92	Diabetes_McGill_ER_Stress	KEGG_DILATED_CARDIOMYOPATHY
3.0303030303%	1	33	91	Mendelian_Metabolism	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION
3.0303030303%	1	33	91	Mendelian_Metabolism	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
3.0303030303%	1	33	91	Mendelian_Metabolism	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
3.0303030303%	1	33	91	Diabetes_McGill_ER_Stress	ZHU_CMV_24_HR_DN
3.0303030303%	1	33	91	Diabetes_McGill_ER_Stress	GAVIN_FOXP3_TARGETS_CLUSTER_P6
3.0303030303%	1	33	91	Diabetes_McGill_ER_Stress	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
3.0303030303%	1	33	90	Mendelian_Metabolism	MORI_MATURE_B_LYMPHOCYTE_UP
3.0303030303%	1	33	90	Mendelian_Metabolism	GAVIN_FOXP3_TARGETS_CLUSTER_P7
3.0303030303%	1	33	90	Diabetes_McGill_ER_Stress	SASSON_RESPONSE_TO_FORSKOLIN_UP
3.0303030303%	1	33	90	Diabetes_McGill_ER_Stress	IGARASHI_ATF4_TARGETS_DN
3.0303030303%	1	33	9	Diabetes_McGill_ER_Stress	SA_FAS_SIGNALING
3.0303030303%	1	33	9	Diabetes_McGill_ER_Stress	NOUSHMEHR_GBM_SOMATIC_MUTATED
3.0303030303%	1	33	9	Diabetes_McGill_ER_Stress	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21
3.0303030303%	1	33	898	Diabetes_McGill_ER_Stress	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
3.0303030303%	1	33	893	Mendelian_Metabolism	GEORGES_TARGETS_OF_MIR192_AND_MIR215
3.0303030303%	1	33	89	Mendelian_Metabolism	WNT_SIGNALING
3.0303030303%	1	33	89	Mendelian_Metabolism	VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP
3.0303030303%	1	33	89	Mendelian_Metabolism	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
3.0303030303%	1	33	89	Mendelian_Metabolism	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
3.0303030303%	1	33	89	Mendelian_Metabolism	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
3.0303030303%	1	33	89	Mendelian_Metabolism	LEE_AGING_NEOCORTEX_UP
3.0303030303%	1	33	89	Diabetes_McGill_ER_Stress	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
3.0303030303%	1	33	89	Diabetes_McGill_ER_Stress	LEE_AGING_NEOCORTEX_UP
3.0303030303%	1	33	89	Diabetes_McGill_ER_Stress	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION
3.0303030303%	1	33	89	Diabetes_McGill_ER_Stress	BOYLAN_MULTIPLE_MYELOMA_D_UP
3.0303030303%	1	33	882	Mendelian_Metabolism	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
3.0303030303%	1	33	882	Diabetes_McGill_ER_Stress	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
3.0303030303%	1	33	88	Mendelian_Metabolism	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
3.0303030303%	1	33	88	Mendelian_Metabolism	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
3.0303030303%	1	33	88	Mendelian_Metabolism	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
3.0303030303%	1	33	88	Mendelian_Metabolism	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
3.0303030303%	1	33	88	Diabetes_McGill_ER_Stress	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
3.0303030303%	1	33	88	Diabetes_McGill_ER_Stress	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
3.0303030303%	1	33	88	Diabetes_McGill_ER_Stress	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
3.0303030303%	1	33	88	Diabetes_McGill_ER_Stress	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
3.0303030303%	1	33	88	Diabetes_McGill_ER_Stress	KEGG_APOPTOSIS
3.0303030303%	1	33	88	Diabetes_McGill_ER_Stress	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
3.0303030303%	1	33	871	Mendelian_Metabolism	GRADE_COLON_CANCER_UP
3.0303030303%	1	33	87	Mendelian_Metabolism	SMITH_TERT_TARGETS_DN
3.0303030303%	1	33	87	Mendelian_Metabolism	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
3.0303030303%	1	33	87	Mendelian_Metabolism	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
3.0303030303%	1	33	87	Mendelian_Metabolism	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
3.0303030303%	1	33	87	Diabetes_McGill_ER_Stress	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
3.0303030303%	1	33	87	Diabetes_McGill_ER_Stress	KEGG_ERBB_SIGNALING_PATHWAY
3.0303030303%	1	33	87	Diabetes_McGill_ER_Stress	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
3.0303030303%	1	33	87	Diabetes_McGill_ER_Stress	BIOCARTA_MAPK_PATHWAY
3.0303030303%	1	33	86	Mendelian_Metabolism	NGUYEN_NOTCH1_TARGETS_DN
3.0303030303%	1	33	86	Mendelian_Metabolism	GHANDHI_BYSTANDER_IRRADIATION_UP
3.0303030303%	1	33	86	Mendelian_Metabolism	BAELDE_DIABETIC_NEPHROPATHY_UP
3.0303030303%	1	33	86	Diabetes_McGill_ER_Stress	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
3.0303030303%	1	33	86	Diabetes_McGill_ER_Stress	NGUYEN_NOTCH1_TARGETS_DN
3.0303030303%	1	33	86	Diabetes_McGill_ER_Stress	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
3.0303030303%	1	33	86	Diabetes_McGill_ER_Stress	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
3.0303030303%	1	33	855	Diabetes_McGill_ER_Stress	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
3.0303030303%	1	33	85	Diabetes_McGill_ER_Stress	STEIN_ESR1_TARGETS
3.0303030303%	1	33	85	Diabetes_McGill_ER_Stress	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
3.0303030303%	1	33	85	Diabetes_McGill_ER_Stress	COLDREN_GEFITINIB_RESISTANCE_UP
3.0303030303%	1	33	84	Mendelian_Metabolism	SWEET_KRAS_TARGETS_UP
3.0303030303%	1	33	84	Mendelian_Metabolism	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP
3.0303030303%	1	33	84	Mendelian_Metabolism	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
3.0303030303%	1	33	84	Mendelian_Metabolism	RUAN_RESPONSE_TO_TNF_DN
3.0303030303%	1	33	84	Mendelian_Metabolism	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
3.0303030303%	1	33	84	Diabetes_McGill_ER_Stress	REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S
3.0303030303%	1	33	84	Diabetes_McGill_ER_Stress	RASHI_RESPONSE_TO_IONIZING_RADIATION_6
3.0303030303%	1	33	84	Diabetes_McGill_ER_Stress	PID_CMYB_PATHWAY
3.0303030303%	1	33	84	Diabetes_McGill_ER_Stress	KEGG_SMALL_CELL_LUNG_CANCER
3.0303030303%	1	33	84	Diabetes_McGill_ER_Stress	CHANG_IMMORTALIZED_BY_HPV31_UP
3.0303030303%	1	33	83	Mendelian_Metabolism	REACTOME_AMYLOIDS
3.0303030303%	1	33	83	Mendelian_Metabolism	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
3.0303030303%	1	33	83	Diabetes_McGill_ER_Stress	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
3.0303030303%	1	33	83	Diabetes_McGill_ER_Stress	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
3.0303030303%	1	33	83	Diabetes_McGill_ER_Stress	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
3.0303030303%	1	33	82	Mendelian_Metabolism	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
3.0303030303%	1	33	82	Mendelian_Metabolism	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
3.0303030303%	1	33	82	Diabetes_McGill_ER_Stress	ST_INTEGRIN_SIGNALING_PATHWAY
3.0303030303%	1	33	82	Diabetes_McGill_ER_Stress	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
3.0303030303%	1	33	82	Diabetes_McGill_ER_Stress	PID_REG_GR_PATHWAY
3.0303030303%	1	33	81	Mendelian_Metabolism	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
3.0303030303%	1	33	81	Mendelian_Metabolism	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION
3.0303030303%	1	33	81	Mendelian_Metabolism	COATES_MACROPHAGE_M1_VS_M2_UP
3.0303030303%	1	33	81	Diabetes_McGill_ER_Stress	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
3.0303030303%	1	33	81	Diabetes_McGill_ER_Stress	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
3.0303030303%	1	33	81	Diabetes_McGill_ER_Stress	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
3.0303030303%	1	33	81	Diabetes_McGill_ER_Stress	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
3.0303030303%	1	33	81	Diabetes_McGill_ER_Stress	HARRIS_HYPOXIA
3.0303030303%	1	33	805	Mendelian_Metabolism	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
3.0303030303%	1	33	805	Diabetes_McGill_ER_Stress	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
3.0303030303%	1	33	80	Mendelian_Metabolism	SCHUHMACHER_MYC_TARGETS_UP
3.0303030303%	1	33	80	Mendelian_Metabolism	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
3.0303030303%	1	33	80	Mendelian_Metabolism	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
3.0303030303%	1	33	80	Diabetes_McGill_ER_Stress	PID_MET_PATHWAY
3.0303030303%	1	33	80	Diabetes_McGill_ER_Stress	LEE_AGING_NEOCORTEX_DN
3.0303030303%	1	33	80	Diabetes_McGill_ER_Stress	KEGG_CARDIAC_MUSCLE_CONTRACTION
3.0303030303%	1	33	80	Diabetes_McGill_ER_Stress	FALVELLA_SMOKERS_WITH_LUNG_CANCER
3.0303030303%	1	33	80	Diabetes_McGill_ER_Stress	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
3.0303030303%	1	33	8	Mendelian_Metabolism	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN
3.0303030303%	1	33	8	Diabetes_McGill_ER_Stress	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18
3.0303030303%	1	33	8	Diabetes_McGill_ER_Stress	CAFFAREL_RESPONSE_TO_THC_24HR_3_UP
3.0303030303%	1	33	79	Mendelian_Metabolism	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
3.0303030303%	1	33	79	Mendelian_Metabolism	TOOKER_GEMCITABINE_RESISTANCE_UP
3.0303030303%	1	33	79	Diabetes_McGill_ER_Stress	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
3.0303030303%	1	33	79	Diabetes_McGill_ER_Stress	PID_MYC_ACTIVPATHWAY
3.0303030303%	1	33	79	Diabetes_McGill_ER_Stress	MEISSNER_NPC_HCP_WITH_H3K27ME3
3.0303030303%	1	33	79	Diabetes_McGill_ER_Stress	MCCLUNG_COCAINE_REWARD_5D
3.0303030303%	1	33	79	Diabetes_McGill_ER_Stress	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
3.0303030303%	1	33	784	Mendelian_Metabolism	FORTSCHEGGER_PHF8_TARGETS_DN
3.0303030303%	1	33	781	Mendelian_Metabolism	GOZGIT_ESR1_TARGETS_DN
3.0303030303%	1	33	781	Diabetes_McGill_ER_Stress	GOZGIT_ESR1_TARGETS_DN
3.0303030303%	1	33	78	Mendelian_Metabolism	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
3.0303030303%	1	33	78	Mendelian_Metabolism	REACTOME_PLATELET_HOMEOSTASIS
3.0303030303%	1	33	78	Mendelian_Metabolism	LINDVALL_IMMORTALIZED_BY_TERT_UP
3.0303030303%	1	33	78	Mendelian_Metabolism	COATES_MACROPHAGE_M1_VS_M2_DN
3.0303030303%	1	33	78	Diabetes_McGill_ER_Stress	REACTOME_PLATELET_HOMEOSTASIS
3.0303030303%	1	33	78	Diabetes_McGill_ER_Stress	LINDVALL_IMMORTALIZED_BY_TERT_UP
3.0303030303%	1	33	78	Diabetes_McGill_ER_Stress	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
3.0303030303%	1	33	78	Diabetes_McGill_ER_Stress	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP
3.0303030303%	1	33	78	Diabetes_McGill_ER_Stress	COATES_MACROPHAGE_M1_VS_M2_DN
3.0303030303%	1	33	78	Diabetes_McGill_ER_Stress	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE
3.0303030303%	1	33	779	Mendelian_Metabolism	PUJANA_CHEK2_PCC_NETWORK
3.0303030303%	1	33	770	Mendelian_Metabolism	KRIEG_HYPOXIA_NOT_VIA_KDM3A
3.0303030303%	1	33	77	Mendelian_Metabolism	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM
3.0303030303%	1	33	77	Mendelian_Metabolism	JACKSON_DNMT1_TARGETS_UP
3.0303030303%	1	33	77	Mendelian_Metabolism	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
3.0303030303%	1	33	77	Diabetes_McGill_ER_Stress	ROSS_AML_WITH_PML_RARA_FUSION
3.0303030303%	1	33	77	Diabetes_McGill_ER_Stress	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
3.0303030303%	1	33	77	Diabetes_McGill_ER_Stress	LIN_APC_TARGETS
3.0303030303%	1	33	77	Diabetes_McGill_ER_Stress	JACKSON_DNMT1_TARGETS_UP
3.0303030303%	1	33	76	Mendelian_Metabolism	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
3.0303030303%	1	33	76	Mendelian_Metabolism	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
3.0303030303%	1	33	76	Diabetes_McGill_ER_Stress	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
3.0303030303%	1	33	76	Diabetes_McGill_ER_Stress	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
3.0303030303%	1	33	75	Mendelian_Metabolism	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
3.0303030303%	1	33	75	Mendelian_Metabolism	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
3.0303030303%	1	33	75	Diabetes_McGill_ER_Stress	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
3.0303030303%	1	33	75	Diabetes_McGill_ER_Stress	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
3.0303030303%	1	33	75	Diabetes_McGill_ER_Stress	BAE_BRCA1_TARGETS_UP
3.0303030303%	1	33	747	Mendelian_Metabolism	PATIL_LIVER_CANCER
3.0303030303%	1	33	74	Mendelian_Metabolism	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN
3.0303030303%	1	33	74	Mendelian_Metabolism	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
3.0303030303%	1	33	74	Mendelian_Metabolism	LEIN_OLIGODENDROCYTE_MARKERS
3.0303030303%	1	33	74	Mendelian_Metabolism	CORRE_MULTIPLE_MYELOMA_UP
3.0303030303%	1	33	74	Diabetes_McGill_ER_Stress	VANASSE_BCL2_TARGETS_DN
3.0303030303%	1	33	74	Diabetes_McGill_ER_Stress	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
3.0303030303%	1	33	74	Diabetes_McGill_ER_Stress	REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX
3.0303030303%	1	33	74	Diabetes_McGill_ER_Stress	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
3.0303030303%	1	33	73	Mendelian_Metabolism	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
3.0303030303%	1	33	73	Diabetes_McGill_ER_Stress	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP
3.0303030303%	1	33	73	Diabetes_McGill_ER_Stress	LIN_MELANOMA_COPY_NUMBER_UP
3.0303030303%	1	33	73	Diabetes_McGill_ER_Stress	HOSHIDA_LIVER_CANCER_SURVIVAL_UP
3.0303030303%	1	33	722	Mendelian_Metabolism	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
3.0303030303%	1	33	722	Diabetes_McGill_ER_Stress	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
3.0303030303%	1	33	720	Mendelian_Metabolism	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
3.0303030303%	1	33	720	Diabetes_McGill_ER_Stress	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
3.0303030303%	1	33	72	Mendelian_Metabolism	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
3.0303030303%	1	33	72	Mendelian_Metabolism	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
3.0303030303%	1	33	72	Mendelian_Metabolism	DANG_REGULATED_BY_MYC_UP
3.0303030303%	1	33	72	Diabetes_McGill_ER_Stress	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
3.0303030303%	1	33	72	Diabetes_McGill_ER_Stress	DOANE_BREAST_CANCER_CLASSES_UP
3.0303030303%	1	33	72	Diabetes_McGill_ER_Stress	DANG_REGULATED_BY_MYC_UP
3.0303030303%	1	33	712	Mendelian_Metabolism	SCHLOSSER_SERUM_RESPONSE_DN
3.0303030303%	1	33	71	Mendelian_Metabolism	REACTOME_PI3K_CASCADE
3.0303030303%	1	33	71	Mendelian_Metabolism	KEGG_MELANOMA
3.0303030303%	1	33	71	Diabetes_McGill_ER_Stress	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
3.0303030303%	1	33	70	Mendelian_Metabolism	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS
3.0303030303%	1	33	70	Mendelian_Metabolism	PID_AP1_PATHWAY
3.0303030303%	1	33	70	Mendelian_Metabolism	MIKKELSEN_MEF_LCP_WITH_H3K27ME3
3.0303030303%	1	33	70	Diabetes_McGill_ER_Stress	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
3.0303030303%	1	33	70	Diabetes_McGill_ER_Stress	RAGHAVACHARI_PLATELET_SPECIFIC_GENES
3.0303030303%	1	33	70	Diabetes_McGill_ER_Stress	PID_CDC42_PATHWAY
3.0303030303%	1	33	70	Diabetes_McGill_ER_Stress	MIKKELSEN_MEF_LCP_WITH_H3K27ME3
3.0303030303%	1	33	70	Diabetes_McGill_ER_Stress	LANDIS_BREAST_CANCER_PROGRESSION_DN
3.0303030303%	1	33	70	Diabetes_McGill_ER_Stress	KEGG_PANCREATIC_CANCER
3.0303030303%	1	33	70	Diabetes_McGill_ER_Stress	KEGG_LONG_TERM_POTENTIATION
3.0303030303%	1	33	7	Diabetes_McGill_ER_Stress	ZHAN_EARLY_DIFFERENTIATION_GENES_UP
3.0303030303%	1	33	7	Diabetes_McGill_ER_Stress	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN
3.0303030303%	1	33	7	Diabetes_McGill_ER_Stress	TESAR_JAK_TARGETS_MOUSE_ES_D3_UP
3.0303030303%	1	33	7	Diabetes_McGill_ER_Stress	BAKER_HEMATOPOESIS_STAT5_TARGETS
3.0303030303%	1	33	69	Mendelian_Metabolism	ZAMORA_NOS2_TARGETS_UP
3.0303030303%	1	33	69	Mendelian_Metabolism	RIZKI_TUMOR_INVASIVENESS_2D_UP
3.0303030303%	1	33	69	Mendelian_Metabolism	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
3.0303030303%	1	33	69	Mendelian_Metabolism	HUANG_DASATINIB_RESISTANCE_DN
3.0303030303%	1	33	69	Diabetes_McGill_ER_Stress	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10
3.0303030303%	1	33	69	Diabetes_McGill_ER_Stress	RHODES_UNDIFFERENTIATED_CANCER
3.0303030303%	1	33	69	Diabetes_McGill_ER_Stress	PID_P75NTRPATHWAY
3.0303030303%	1	33	69	Diabetes_McGill_ER_Stress	LEIN_NEURON_MARKERS
3.0303030303%	1	33	69	Diabetes_McGill_ER_Stress	KEGG_P53_SIGNALING_PATHWAY
3.0303030303%	1	33	68	Mendelian_Metabolism	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
3.0303030303%	1	33	68	Mendelian_Metabolism	SESTO_RESPONSE_TO_UV_C7
3.0303030303%	1	33	68	Diabetes_McGill_ER_Stress	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
3.0303030303%	1	33	68	Diabetes_McGill_ER_Stress	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
3.0303030303%	1	33	68	Diabetes_McGill_ER_Stress	BROWNE_INTERFERON_RESPONSIVE_GENES
3.0303030303%	1	33	67	Mendelian_Metabolism	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
3.0303030303%	1	33	67	Mendelian_Metabolism	GENTILE_UV_LOW_DOSE_DN
3.0303030303%	1	33	67	Diabetes_McGill_ER_Stress	VANHARANTA_UTERINE_FIBROID_DN
3.0303030303%	1	33	67	Diabetes_McGill_ER_Stress	LINDSTEDT_DENDRITIC_CELL_MATURATION_A
3.0303030303%	1	33	67	Diabetes_McGill_ER_Stress	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
3.0303030303%	1	33	663	Diabetes_McGill_ER_Stress	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
3.0303030303%	1	33	66	Mendelian_Metabolism	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
3.0303030303%	1	33	66	Mendelian_Metabolism	NAKAMURA_ADIPOGENESIS_EARLY_UP
3.0303030303%	1	33	66	Mendelian_Metabolism	KIM_GERMINAL_CENTER_T_HELPER_UP
3.0303030303%	1	33	66	Diabetes_McGill_ER_Stress	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
3.0303030303%	1	33	66	Diabetes_McGill_ER_Stress	TENEDINI_MEGAKARYOCYTE_MARKERS
3.0303030303%	1	33	66	Diabetes_McGill_ER_Stress	RIGGINS_TAMOXIFEN_RESISTANCE_UP
3.0303030303%	1	33	66	Diabetes_McGill_ER_Stress	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES
3.0303030303%	1	33	66	Diabetes_McGill_ER_Stress	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
3.0303030303%	1	33	66	Diabetes_McGill_ER_Stress	BRUNO_HEMATOPOIESIS
3.0303030303%	1	33	658	Mendelian_Metabolism	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
3.0303030303%	1	33	65	Mendelian_Metabolism	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN
3.0303030303%	1	33	65	Mendelian_Metabolism	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
3.0303030303%	1	33	65	Mendelian_Metabolism	PID_IL4_2PATHWAY
3.0303030303%	1	33	65	Mendelian_Metabolism	GUO_HEX_TARGETS_DN
3.0303030303%	1	33	65	Diabetes_McGill_ER_Stress	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
3.0303030303%	1	33	65	Diabetes_McGill_ER_Stress	PID_CD8TCRDOWNSTREAMPATHWAY
3.0303030303%	1	33	65	Diabetes_McGill_ER_Stress	PID_BCR_5PATHWAY
3.0303030303%	1	33	65	Diabetes_McGill_ER_Stress	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP
3.0303030303%	1	33	648	Mendelian_Metabolism	SMID_BREAST_CANCER_BASAL_UP
3.0303030303%	1	33	64	Mendelian_Metabolism	RHODES_CANCER_META_SIGNATURE
3.0303030303%	1	33	64	Mendelian_Metabolism	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
3.0303030303%	1	33	64	Mendelian_Metabolism	LEE_LIVER_CANCER_MYC_E2F1_DN
3.0303030303%	1	33	64	Mendelian_Metabolism	LEE_LIVER_CANCER_ACOX1_UP
3.0303030303%	1	33	64	Mendelian_Metabolism	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
3.0303030303%	1	33	64	Diabetes_McGill_ER_Stress	ZHAN_MULTIPLE_MYELOMA_UP
3.0303030303%	1	33	64	Diabetes_McGill_ER_Stress	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
3.0303030303%	1	33	64	Diabetes_McGill_ER_Stress	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
3.0303030303%	1	33	634	Diabetes_McGill_ER_Stress	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
3.0303030303%	1	33	63	Mendelian_Metabolism	BURTON_ADIPOGENESIS_PEAK_AT_0HR
3.0303030303%	1	33	63	Mendelian_Metabolism	BRIDEAU_IMPRINTED_GENES
3.0303030303%	1	33	63	Mendelian_Metabolism	BILBAN_B_CLL_LPL_UP
3.0303030303%	1	33	63	Diabetes_McGill_ER_Stress	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
3.0303030303%	1	33	63	Diabetes_McGill_ER_Stress	PID_ENDOTHELINPATHWAY
3.0303030303%	1	33	63	Diabetes_McGill_ER_Stress	MODY_HIPPOCAMPUS_POSTNATAL
3.0303030303%	1	33	63	Diabetes_McGill_ER_Stress	LEE_LIVER_CANCER_MYC_DN
3.0303030303%	1	33	63	Diabetes_McGill_ER_Stress	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
3.0303030303%	1	33	63	Diabetes_McGill_ER_Stress	CROMER_TUMORIGENESIS_UP
3.0303030303%	1	33	63	Diabetes_McGill_ER_Stress	BURTON_ADIPOGENESIS_PEAK_AT_0HR
3.0303030303%	1	33	63	Diabetes_McGill_ER_Stress	BILBAN_B_CLL_LPL_UP
3.0303030303%	1	33	62	Mendelian_Metabolism	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
3.0303030303%	1	33	62	Mendelian_Metabolism	LEE_LIVER_CANCER_E2F1_UP
3.0303030303%	1	33	62	Mendelian_Metabolism	KORKOLA_YOLK_SAC_TUMOR
3.0303030303%	1	33	62	Diabetes_McGill_ER_Stress	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
3.0303030303%	1	33	62	Diabetes_McGill_ER_Stress	PID_FCER1PATHWAY
3.0303030303%	1	33	62	Diabetes_McGill_ER_Stress	MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN
3.0303030303%	1	33	62	Diabetes_McGill_ER_Stress	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
3.0303030303%	1	33	62	Diabetes_McGill_ER_Stress	GEORGES_CELL_CYCLE_MIR192_TARGETS
3.0303030303%	1	33	62	Diabetes_McGill_ER_Stress	BILD_SRC_ONCOGENIC_SIGNATURE
3.0303030303%	1	33	612	Mendelian_Metabolism	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
3.0303030303%	1	33	612	Diabetes_McGill_ER_Stress	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
3.0303030303%	1	33	61	Mendelian_Metabolism	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
3.0303030303%	1	33	61	Mendelian_Metabolism	REN_BOUND_BY_E2F
3.0303030303%	1	33	61	Mendelian_Metabolism	BAKKER_FOXO3_TARGETS_UP
3.0303030303%	1	33	61	Diabetes_McGill_ER_Stress	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
3.0303030303%	1	33	61	Diabetes_McGill_ER_Stress	MASSARWEH_RESPONSE_TO_ESTRADIOL
3.0303030303%	1	33	61	Diabetes_McGill_ER_Stress	GENTILE_RESPONSE_CLUSTER_D3
3.0303030303%	1	33	61	Diabetes_McGill_ER_Stress	BROWNE_HCMV_INFECTION_1HR_UP
3.0303030303%	1	33	605	Diabetes_McGill_ER_Stress	CAIRO_HEPATOBLASTOMA_CLASSES_UP
3.0303030303%	1	33	602	Mendelian_Metabolism	MARTINEZ_TP53_TARGETS_UP
3.0303030303%	1	33	602	Diabetes_McGill_ER_Stress	MARTINEZ_TP53_TARGETS_UP
3.0303030303%	1	33	601	Mendelian_Metabolism	MARTINEZ_RB1_AND_TP53_TARGETS_UP
3.0303030303%	1	33	60	Mendelian_Metabolism	WIERENGA_STAT5A_TARGETS_GROUP2
3.0303030303%	1	33	60	Mendelian_Metabolism	SONG_TARGETS_OF_IE86_CMV_PROTEIN
3.0303030303%	1	33	60	Mendelian_Metabolism	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
3.0303030303%	1	33	60	Diabetes_McGill_ER_Stress	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE
3.0303030303%	1	33	60	Diabetes_McGill_ER_Stress	CUI_GLUCOSE_DEPRIVATION
3.0303030303%	1	33	60	Diabetes_McGill_ER_Stress	CROONQUIST_STROMAL_STIMULATION_UP
3.0303030303%	1	33	6	Diabetes_McGill_ER_Stress	PLASARI_TGFB1_TARGETS_1HR_DN
3.0303030303%	1	33	6	Diabetes_McGill_ER_Stress	ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS
3.0303030303%	1	33	6	Diabetes_McGill_ER_Stress	CHESLER_BRAIN_QTL_TRANS
3.0303030303%	1	33	591	Diabetes_McGill_ER_Stress	MARTINEZ_RB1_AND_TP53_TARGETS_DN
3.0303030303%	1	33	590	Diabetes_McGill_ER_Stress	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
3.0303030303%	1	33	59	Mendelian_Metabolism	PID_ATF2_PATHWAY
3.0303030303%	1	33	59	Mendelian_Metabolism	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
3.0303030303%	1	33	59	Diabetes_McGill_ER_Stress	PID_P53REGULATIONPATHWAY
3.0303030303%	1	33	59	Diabetes_McGill_ER_Stress	PID_FAK_PATHWAY
3.0303030303%	1	33	59	Diabetes_McGill_ER_Stress	ASTIER_INTEGRIN_SIGNALING
3.0303030303%	1	33	58	Mendelian_Metabolism	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
3.0303030303%	1	33	58	Mendelian_Metabolism	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
3.0303030303%	1	33	58	Mendelian_Metabolism	KANNAN_TP53_TARGETS_UP
3.0303030303%	1	33	58	Mendelian_Metabolism	BERNARD_PPAPDC1B_TARGETS_DN
3.0303030303%	1	33	58	Diabetes_McGill_ER_Stress	SCHEIDEREIT_IKK_INTERACTING_PROTEINS
3.0303030303%	1	33	58	Diabetes_McGill_ER_Stress	LIM_MAMMARY_LUMINAL_PROGENITOR_UP
3.0303030303%	1	33	58	Diabetes_McGill_ER_Stress	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
3.0303030303%	1	33	58	Diabetes_McGill_ER_Stress	BIOCARTA_PPARA_PATHWAY
3.0303030303%	1	33	578	Diabetes_McGill_ER_Stress	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
3.0303030303%	1	33	572	Mendelian_Metabolism	CHICAS_RB1_TARGETS_SENESCENT
3.0303030303%	1	33	570	Mendelian_Metabolism	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
3.0303030303%	1	33	57	Mendelian_Metabolism	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
3.0303030303%	1	33	57	Mendelian_Metabolism	BORLAK_LIVER_CANCER_EGF_UP
3.0303030303%	1	33	57	Diabetes_McGill_ER_Stress	DELASERNA_MYOD_TARGETS_DN
3.0303030303%	1	33	57	Diabetes_McGill_ER_Stress	BURTON_ADIPOGENESIS_11
3.0303030303%	1	33	57	Diabetes_McGill_ER_Stress	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
3.0303030303%	1	33	57	Diabetes_McGill_ER_Stress	AMIT_SERUM_RESPONSE_240_MCF10A
3.0303030303%	1	33	56	Mendelian_Metabolism	ZHENG_IL22_SIGNALING_UP
3.0303030303%	1	33	56	Mendelian_Metabolism	REACTOME_PI_3K_CASCADE
3.0303030303%	1	33	56	Mendelian_Metabolism	LEE_LIVER_CANCER_MYC_E2F1_UP
3.0303030303%	1	33	56	Diabetes_McGill_ER_Stress	GALE_APL_WITH_FLT3_MUTATED_UP
3.0303030303%	1	33	56	Diabetes_McGill_ER_Stress	BIOCARTA_NFAT_PATHWAY
3.0303030303%	1	33	553	Mendelian_Metabolism	FEVR_CTNNB1_TARGETS_DN
3.0303030303%	1	33	552	Mendelian_Metabolism	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
3.0303030303%	1	33	55	Mendelian_Metabolism	YU_MYC_TARGETS_DN
3.0303030303%	1	33	55	Mendelian_Metabolism	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
3.0303030303%	1	33	55	Mendelian_Metabolism	PID_FGF_PATHWAY
3.0303030303%	1	33	55	Diabetes_McGill_ER_Stress	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
3.0303030303%	1	33	55	Diabetes_McGill_ER_Stress	SMIRNOV_RESPONSE_TO_IR_2HR_DN
3.0303030303%	1	33	55	Diabetes_McGill_ER_Stress	REACTOME_ION_CHANNEL_TRANSPORT
3.0303030303%	1	33	55	Diabetes_McGill_ER_Stress	PID_TGFBRPATHWAY
3.0303030303%	1	33	55	Diabetes_McGill_ER_Stress	LAU_APOPTOSIS_CDKN2A_UP
3.0303030303%	1	33	55	Diabetes_McGill_ER_Stress	DEMAGALHAES_AGING_UP
3.0303030303%	1	33	549	Mendelian_Metabolism	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
3.0303030303%	1	33	549	Diabetes_McGill_ER_Stress	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
3.0303030303%	1	33	546	Mendelian_Metabolism	WEST_ADRENOCORTICAL_TUMOR_DN
3.0303030303%	1	33	546	Diabetes_McGill_ER_Stress	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
3.0303030303%	1	33	544	Mendelian_Metabolism	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
3.0303030303%	1	33	544	Diabetes_McGill_ER_Stress	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
3.0303030303%	1	33	543	Mendelian_Metabolism	MARTINEZ_RB1_TARGETS_DN
3.0303030303%	1	33	543	Diabetes_McGill_ER_Stress	MARTINEZ_RB1_TARGETS_DN
3.0303030303%	1	33	54	Mendelian_Metabolism	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE
3.0303030303%	1	33	54	Diabetes_McGill_ER_Stress	ZHOU_TNF_SIGNALING_30MIN
3.0303030303%	1	33	54	Diabetes_McGill_ER_Stress	PID_RAC1_PATHWAY
3.0303030303%	1	33	54	Diabetes_McGill_ER_Stress	JIANG_AGING_CEREBRAL_CORTEX_DN
3.0303030303%	1	33	539	Mendelian_Metabolism	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
3.0303030303%	1	33	539	Mendelian_Metabolism	LIAO_METASTASIS
3.0303030303%	1	33	539	Diabetes_McGill_ER_Stress	LIAO_METASTASIS
3.0303030303%	1	33	536	Diabetes_McGill_ER_Stress	SENESE_HDAC3_TARGETS_DN
3.0303030303%	1	33	536	Diabetes_McGill_ER_Stress	BERENJENO_TRANSFORMED_BY_RHOA_UP
3.0303030303%	1	33	535	Mendelian_Metabolism	STEIN_ESRRA_TARGETS
3.0303030303%	1	33	535	Diabetes_McGill_ER_Stress	STEIN_ESRRA_TARGETS
3.0303030303%	1	33	53	Mendelian_Metabolism	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP
3.0303030303%	1	33	53	Mendelian_Metabolism	NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON
3.0303030303%	1	33	53	Diabetes_McGill_ER_Stress	SMIRNOV_RESPONSE_TO_IR_2HR_UP
3.0303030303%	1	33	53	Diabetes_McGill_ER_Stress	PID_AR_TF_PATHWAY
3.0303030303%	1	33	53	Diabetes_McGill_ER_Stress	LINDSTEDT_DENDRITIC_CELL_MATURATION_B
3.0303030303%	1	33	53	Diabetes_McGill_ER_Stress	LIANG_SILENCED_BY_METHYLATION_2
3.0303030303%	1	33	53	Diabetes_McGill_ER_Stress	KRIEG_HYPOXIA_VIA_KDM3A
3.0303030303%	1	33	526	Diabetes_McGill_ER_Stress	ONKEN_UVEAL_MELANOMA_DN
3.0303030303%	1	33	52	Mendelian_Metabolism	KEGG_STARCH_AND_SUCROSE_METABOLISM
3.0303030303%	1	33	52	Mendelian_Metabolism	CHIBA_RESPONSE_TO_TSA_UP
3.0303030303%	1	33	52	Diabetes_McGill_ER_Stress	WINTER_HYPOXIA_DN
3.0303030303%	1	33	52	Diabetes_McGill_ER_Stress	PID_CASPASE_PATHWAY
3.0303030303%	1	33	52	Diabetes_McGill_ER_Stress	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
3.0303030303%	1	33	518	Mendelian_Metabolism	REACTOME_METABOLISM_OF_PROTEINS
3.0303030303%	1	33	518	Diabetes_McGill_ER_Stress	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
3.0303030303%	1	33	517	Mendelian_Metabolism	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
3.0303030303%	1	33	514	Diabetes_McGill_ER_Stress	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
3.0303030303%	1	33	51	Mendelian_Metabolism	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
3.0303030303%	1	33	51	Mendelian_Metabolism	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE
3.0303030303%	1	33	51	Mendelian_Metabolism	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
3.0303030303%	1	33	51	Mendelian_Metabolism	GUILLAUMOND_KLF10_TARGETS_UP
3.0303030303%	1	33	51	Mendelian_Metabolism	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
3.0303030303%	1	33	51	Diabetes_McGill_ER_Stress	ZHANG_PROLIFERATING_VS_QUIESCENT
3.0303030303%	1	33	51	Diabetes_McGill_ER_Stress	MORI_PLASMA_CELL_UP
3.0303030303%	1	33	51	Diabetes_McGill_ER_Stress	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
3.0303030303%	1	33	51	Diabetes_McGill_ER_Stress	GUILLAUMOND_KLF10_TARGETS_UP
3.0303030303%	1	33	51	Diabetes_McGill_ER_Stress	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
3.0303030303%	1	33	51	Diabetes_McGill_ER_Stress	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
3.0303030303%	1	33	51	Diabetes_McGill_ER_Stress	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP
3.0303030303%	1	33	51	Diabetes_McGill_ER_Stress	BURTON_ADIPOGENESIS_PEAK_AT_2HR
3.0303030303%	1	33	505	Mendelian_Metabolism	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
3.0303030303%	1	33	505	Diabetes_McGill_ER_Stress	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
3.0303030303%	1	33	504	Diabetes_McGill_ER_Stress	PILON_KLF1_TARGETS_UP
3.0303030303%	1	33	501	Diabetes_McGill_ER_Stress	SENESE_HDAC3_TARGETS_UP
3.0303030303%	1	33	50	Mendelian_Metabolism	KEGG_GLUTATHIONE_METABOLISM
3.0303030303%	1	33	50	Diabetes_McGill_ER_Stress	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
3.0303030303%	1	33	50	Diabetes_McGill_ER_Stress	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
3.0303030303%	1	33	50	Diabetes_McGill_ER_Stress	PID_ANGIOPOIETINRECEPTOR_PATHWAY
3.0303030303%	1	33	50	Diabetes_McGill_ER_Stress	NADERI_BREAST_CANCER_PROGNOSIS_UP
3.0303030303%	1	33	50	Diabetes_McGill_ER_Stress	MARTINEZ_RESPONSE_TO_TRABECTEDIN
3.0303030303%	1	33	50	Diabetes_McGill_ER_Stress	HOFMANN_CELL_LYMPHOMA_UP
3.0303030303%	1	33	50	Diabetes_McGill_ER_Stress	DAUER_STAT3_TARGETS_DN
3.0303030303%	1	33	50	Diabetes_McGill_ER_Stress	BECKER_TAMOXIFEN_RESISTANCE_UP
3.0303030303%	1	33	493	Mendelian_Metabolism	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
3.0303030303%	1	33	491	Mendelian_Metabolism	ZHENG_BOUND_BY_FOXP3
3.0303030303%	1	33	491	Diabetes_McGill_ER_Stress	ZHENG_BOUND_BY_FOXP3
3.0303030303%	1	33	49	Mendelian_Metabolism	OLSSON_E2F3_TARGETS_DN
3.0303030303%	1	33	49	Mendelian_Metabolism	MANTOVANI_VIRAL_GPCR_SIGNALING_DN
3.0303030303%	1	33	49	Mendelian_Metabolism	LEE_LIVER_CANCER
3.0303030303%	1	33	49	Mendelian_Metabolism	KEGG_GLYCEROLIPID_METABOLISM
3.0303030303%	1	33	49	Mendelian_Metabolism	DAUER_STAT3_TARGETS_UP
3.0303030303%	1	33	49	Mendelian_Metabolism	BROWNE_HCMV_INFECTION_2HR_DN
3.0303030303%	1	33	49	Diabetes_McGill_ER_Stress	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
3.0303030303%	1	33	49	Diabetes_McGill_ER_Stress	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
3.0303030303%	1	33	49	Diabetes_McGill_ER_Stress	PID_FOXOPATHWAY
3.0303030303%	1	33	49	Diabetes_McGill_ER_Stress	MARCHINI_TRABECTEDIN_RESISTANCE_DN
3.0303030303%	1	33	49	Diabetes_McGill_ER_Stress	GERHOLD_ADIPOGENESIS_UP
3.0303030303%	1	33	49	Diabetes_McGill_ER_Stress	BIOCARTA_TCR_PATHWAY
3.0303030303%	1	33	49	Diabetes_McGill_ER_Stress	APRELIKOVA_BRCA1_TARGETS
3.0303030303%	1	33	489	Mendelian_Metabolism	LIM_MAMMARY_STEM_CELL_UP
3.0303030303%	1	33	487	Mendelian_Metabolism	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
3.0303030303%	1	33	487	Mendelian_Metabolism	RODWELL_AGING_KIDNEY_UP
3.0303030303%	1	33	487	Diabetes_McGill_ER_Stress	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
3.0303030303%	1	33	485	Mendelian_Metabolism	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
3.0303030303%	1	33	485	Diabetes_McGill_ER_Stress	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
3.0303030303%	1	33	483	Mendelian_Metabolism	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
3.0303030303%	1	33	48	Mendelian_Metabolism	TAVOR_CEBPA_TARGETS_UP
3.0303030303%	1	33	48	Mendelian_Metabolism	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
3.0303030303%	1	33	48	Mendelian_Metabolism	DOANE_BREAST_CANCER_ESR1_DN
3.0303030303%	1	33	48	Mendelian_Metabolism	DELACROIX_RAR_TARGETS_UP
3.0303030303%	1	33	48	Mendelian_Metabolism	CHANGOLKAR_H2AFY_TARGETS_UP
3.0303030303%	1	33	48	Diabetes_McGill_ER_Stress	PENG_GLUCOSE_DEPRIVATION_UP
3.0303030303%	1	33	48	Diabetes_McGill_ER_Stress	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
3.0303030303%	1	33	48	Diabetes_McGill_ER_Stress	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN
3.0303030303%	1	33	48	Diabetes_McGill_ER_Stress	ENGELMANN_CANCER_PROGENITORS_UP
3.0303030303%	1	33	476	Mendelian_Metabolism	SMID_BREAST_CANCER_NORMAL_LIKE_UP
3.0303030303%	1	33	475	Diabetes_McGill_ER_Stress	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
3.0303030303%	1	33	473	Diabetes_McGill_ER_Stress	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
3.0303030303%	1	33	47	Mendelian_Metabolism	POTTI_DOCETAXEL_SENSITIVITY
3.0303030303%	1	33	47	Mendelian_Metabolism	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP
3.0303030303%	1	33	47	Diabetes_McGill_ER_Stress	ZHU_CMV_8_HR_UP
3.0303030303%	1	33	47	Diabetes_McGill_ER_Stress	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
3.0303030303%	1	33	47	Diabetes_McGill_ER_Stress	LEONARD_HYPOXIA
3.0303030303%	1	33	469	Diabetes_McGill_ER_Stress	MCCABE_BOUND_BY_HOXC6
3.0303030303%	1	33	464	Mendelian_Metabolism	ONDER_CDH1_TARGETS_2_DN
3.0303030303%	1	33	463	Mendelian_Metabolism	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
3.0303030303%	1	33	463	Diabetes_McGill_ER_Stress	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
3.0303030303%	1	33	463	Diabetes_McGill_ER_Stress	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
3.0303030303%	1	33	462	Mendelian_Metabolism	DELACROIX_RAR_BOUND_ES
3.0303030303%	1	33	46	Mendelian_Metabolism	TSENG_ADIPOGENIC_POTENTIAL_DN
3.0303030303%	1	33	46	Mendelian_Metabolism	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON
3.0303030303%	1	33	46	Mendelian_Metabolism	NAKAMURA_CANCER_MICROENVIRONMENT_DN
3.0303030303%	1	33	46	Mendelian_Metabolism	KUNINGER_IGF1_VS_PDGFB_TARGETS_DN
3.0303030303%	1	33	46	Mendelian_Metabolism	JIANG_TIP30_TARGETS_UP
3.0303030303%	1	33	46	Diabetes_McGill_ER_Stress	SESTO_RESPONSE_TO_UV_C5
3.0303030303%	1	33	46	Diabetes_McGill_ER_Stress	SAGIV_CD24_TARGETS_DN
3.0303030303%	1	33	46	Diabetes_McGill_ER_Stress	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
3.0303030303%	1	33	46	Diabetes_McGill_ER_Stress	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN
3.0303030303%	1	33	46	Diabetes_McGill_ER_Stress	HEIDENBLAD_AMPLICON_8Q24_DN
3.0303030303%	1	33	46	Diabetes_McGill_ER_Stress	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN
3.0303030303%	1	33	46	Diabetes_McGill_ER_Stress	ABBUD_LIF_SIGNALING_1_UP
3.0303030303%	1	33	459	Mendelian_Metabolism	KIM_WT1_TARGETS_DN
3.0303030303%	1	33	457	Diabetes_McGill_ER_Stress	SENESE_HDAC1_TARGETS_UP
3.0303030303%	1	33	456	Mendelian_Metabolism	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
3.0303030303%	1	33	456	Mendelian_Metabolism	ODONNELL_TFRC_TARGETS_UP
3.0303030303%	1	33	456	Diabetes_McGill_ER_Stress	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
3.0303030303%	1	33	456	Diabetes_McGill_ER_Stress	ODONNELL_TFRC_TARGETS_UP
3.0303030303%	1	33	456	Diabetes_McGill_ER_Stress	MARTENS_BOUND_BY_PML_RARA_FUSION
3.0303030303%	1	33	45	Mendelian_Metabolism	ZHAN_MULTIPLE_MYELOMA_CD2_UP
3.0303030303%	1	33	45	Mendelian_Metabolism	ZHAN_MULTIPLE_MYELOMA_CD1_DN
3.0303030303%	1	33	45	Mendelian_Metabolism	SHIPP_DLBCL_CURED_VS_FATAL_DN
3.0303030303%	1	33	45	Mendelian_Metabolism	PID_HNF3BPATHWAY
3.0303030303%	1	33	45	Mendelian_Metabolism	HUANG_FOXA2_TARGETS_UP
3.0303030303%	1	33	45	Diabetes_McGill_ER_Stress	ZHAN_MULTIPLE_MYELOMA_CD1_UP
3.0303030303%	1	33	45	Diabetes_McGill_ER_Stress	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
3.0303030303%	1	33	45	Diabetes_McGill_ER_Stress	PID_RHOA_PATHWAY
3.0303030303%	1	33	45	Diabetes_McGill_ER_Stress	PID_HNF3BPATHWAY
3.0303030303%	1	33	45	Diabetes_McGill_ER_Stress	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN
3.0303030303%	1	33	45	Diabetes_McGill_ER_Stress	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN
3.0303030303%	1	33	45	Diabetes_McGill_ER_Stress	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN
3.0303030303%	1	33	45	Diabetes_McGill_ER_Stress	GRADE_METASTASIS_DN
3.0303030303%	1	33	45	Diabetes_McGill_ER_Stress	BIOCARTA_BIOPEPTIDES_PATHWAY
3.0303030303%	1	33	447	Diabetes_McGill_ER_Stress	MOOTHA_MITOCHONDRIA
3.0303030303%	1	33	443	Mendelian_Metabolism	DELYS_THYROID_CANCER_UP
3.0303030303%	1	33	442	Mendelian_Metabolism	HAN_SATB1_TARGETS_DN
3.0303030303%	1	33	44	Mendelian_Metabolism	REACTOME_SIGNALING_BY_FGFR_MUTANTS
3.0303030303%	1	33	44	Mendelian_Metabolism	PID_HNF3APATHWAY
3.0303030303%	1	33	44	Mendelian_Metabolism	KEGG_LYSINE_DEGRADATION
3.0303030303%	1	33	44	Mendelian_Metabolism	KEGG_ABC_TRANSPORTERS
3.0303030303%	1	33	44	Mendelian_Metabolism	JAEGER_METASTASIS_UP
3.0303030303%	1	33	44	Diabetes_McGill_ER_Stress	ZUCCHI_METASTASIS_DN
3.0303030303%	1	33	44	Diabetes_McGill_ER_Stress	WANG_TARGETS_OF_MLL_CBP_FUSION_UP
3.0303030303%	1	33	44	Diabetes_McGill_ER_Stress	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
3.0303030303%	1	33	44	Diabetes_McGill_ER_Stress	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
3.0303030303%	1	33	44	Diabetes_McGill_ER_Stress	PID_HNF3APATHWAY
3.0303030303%	1	33	44	Diabetes_McGill_ER_Stress	PID_ERBB2ERBB3PATHWAY
3.0303030303%	1	33	44	Diabetes_McGill_ER_Stress	MARTIN_INTERACT_WITH_HDAC
3.0303030303%	1	33	44	Diabetes_McGill_ER_Stress	LANDIS_BREAST_CANCER_PROGRESSION_UP
3.0303030303%	1	33	44	Diabetes_McGill_ER_Stress	JAEGER_METASTASIS_UP
3.0303030303%	1	33	44	Diabetes_McGill_ER_Stress	GROSS_HYPOXIA_VIA_ELK3_ONLY_DN
3.0303030303%	1	33	435	Mendelian_Metabolism	SWEET_LUNG_CANCER_KRAS_DN
3.0303030303%	1	33	435	Mendelian_Metabolism	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
3.0303030303%	1	33	435	Diabetes_McGill_ER_Stress	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
3.0303030303%	1	33	434	Mendelian_Metabolism	BAELDE_DIABETIC_NEPHROPATHY_DN
3.0303030303%	1	33	431	Mendelian_Metabolism	GARY_CD5_TARGETS_DN
3.0303030303%	1	33	430	Mendelian_Metabolism	VECCHI_GASTRIC_CANCER_EARLY_UP
3.0303030303%	1	33	430	Mendelian_Metabolism	JOHNSTONE_PARVB_TARGETS_3_UP
3.0303030303%	1	33	430	Diabetes_McGill_ER_Stress	JOHNSTONE_PARVB_TARGETS_3_UP
3.0303030303%	1	33	43	Mendelian_Metabolism	ZUCCHI_METASTASIS_UP
3.0303030303%	1	33	43	Mendelian_Metabolism	AMIT_EGF_RESPONSE_480_MCF10A
3.0303030303%	1	33	43	Diabetes_McGill_ER_Stress	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK
3.0303030303%	1	33	43	Diabetes_McGill_ER_Stress	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
3.0303030303%	1	33	43	Diabetes_McGill_ER_Stress	PID_TCPTP_PATHWAY
3.0303030303%	1	33	43	Diabetes_McGill_ER_Stress	MANTOVANI_NFKB_TARGETS_UP
3.0303030303%	1	33	43	Diabetes_McGill_ER_Stress	LEE_CALORIE_RESTRICTION_MUSCLE_UP
3.0303030303%	1	33	43	Diabetes_McGill_ER_Stress	IKEDA_MIR133_TARGETS_UP
3.0303030303%	1	33	43	Diabetes_McGill_ER_Stress	HUMMEL_BURKITTS_LYMPHOMA_UP
3.0303030303%	1	33	429	Diabetes_McGill_ER_Stress	MOOTHA_HUMAN_MITODB_6_2002
3.0303030303%	1	33	428	Mendelian_Metabolism	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
3.0303030303%	1	33	428	Mendelian_Metabolism	CUI_TCF21_TARGETS_2_UP
3.0303030303%	1	33	428	Diabetes_McGill_ER_Stress	LIM_MAMMARY_STEM_CELL_DN
3.0303030303%	1	33	425	Mendelian_Metabolism	ZHANG_BREAST_CANCER_PROGENITORS_UP
3.0303030303%	1	33	425	Diabetes_McGill_ER_Stress	ZHANG_BREAST_CANCER_PROGENITORS_UP
3.0303030303%	1	33	424	Diabetes_McGill_ER_Stress	SHEN_SMARCA2_TARGETS_UP
3.0303030303%	1	33	423	Mendelian_Metabolism	PUJANA_BRCA2_PCC_NETWORK
3.0303030303%	1	33	422	Diabetes_McGill_ER_Stress	YAGI_AML_WITH_INV_16_TRANSLOCATION
3.0303030303%	1	33	42	Mendelian_Metabolism	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
3.0303030303%	1	33	42	Mendelian_Metabolism	LEIN_ASTROCYTE_MARKERS
3.0303030303%	1	33	42	Mendelian_Metabolism	KEGG_FATTY_ACID_METABOLISM
3.0303030303%	1	33	42	Diabetes_McGill_ER_Stress	ZHENG_IL22_SIGNALING_DN
3.0303030303%	1	33	42	Diabetes_McGill_ER_Stress	WIERENGA_PML_INTERACTOME
3.0303030303%	1	33	42	Diabetes_McGill_ER_Stress	PID_BMPPATHWAY
3.0303030303%	1	33	42	Diabetes_McGill_ER_Stress	ONO_FOXP3_TARGETS_DN
3.0303030303%	1	33	42	Diabetes_McGill_ER_Stress	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER
3.0303030303%	1	33	42	Diabetes_McGill_ER_Stress	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP
3.0303030303%	1	33	42	Diabetes_McGill_ER_Stress	LUI_THYROID_CANCER_CLUSTER_2
3.0303030303%	1	33	42	Diabetes_McGill_ER_Stress	HAHTOLA_SEZARY_SYNDROM_DN
3.0303030303%	1	33	42	Diabetes_McGill_ER_Stress	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN
3.0303030303%	1	33	42	Diabetes_McGill_ER_Stress	AMIT_EGF_RESPONSE_40_HELA
3.0303030303%	1	33	419	Mendelian_Metabolism	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
3.0303030303%	1	33	419	Diabetes_McGill_ER_Stress	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
3.0303030303%	1	33	418	Mendelian_Metabolism	RUTELLA_RESPONSE_TO_HGF_UP
3.0303030303%	1	33	418	Mendelian_Metabolism	PEDRIOLI_MIR31_TARGETS_DN
3.0303030303%	1	33	418	Diabetes_McGill_ER_Stress	RUTELLA_RESPONSE_TO_HGF_UP
3.0303030303%	1	33	414	Mendelian_Metabolism	LU_EZH2_TARGETS_DN
3.0303030303%	1	33	414	Diabetes_McGill_ER_Stress	LU_EZH2_TARGETS_DN
3.0303030303%	1	33	413	Diabetes_McGill_ER_Stress	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
3.0303030303%	1	33	412	Mendelian_Metabolism	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
3.0303030303%	1	33	41	Mendelian_Metabolism	ZHAN_MULTIPLE_MYELOMA_DN
3.0303030303%	1	33	41	Mendelian_Metabolism	WENG_POR_TARGETS_LIVER_UP
3.0303030303%	1	33	41	Mendelian_Metabolism	WEINMANN_ADAPTATION_TO_HYPOXIA_DN
3.0303030303%	1	33	41	Mendelian_Metabolism	PID_AMB2_NEUTROPHILS_PATHWAY
3.0303030303%	1	33	41	Mendelian_Metabolism	KAMMINGA_EZH2_TARGETS
3.0303030303%	1	33	41	Mendelian_Metabolism	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
3.0303030303%	1	33	41	Mendelian_Metabolism	CROONQUIST_NRAS_SIGNALING_UP
3.0303030303%	1	33	41	Diabetes_McGill_ER_Stress	KAAB_FAILED_HEART_VENTRICLE_DN
3.0303030303%	1	33	41	Diabetes_McGill_ER_Stress	BIOCARTA_FCER1_PATHWAY
3.0303030303%	1	33	408	Mendelian_Metabolism	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
3.0303030303%	1	33	408	Diabetes_McGill_ER_Stress	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
3.0303030303%	1	33	406	Diabetes_McGill_ER_Stress	OSMAN_BLADDER_CANCER_DN
3.0303030303%	1	33	404	Diabetes_McGill_ER_Stress	OSMAN_BLADDER_CANCER_UP
3.0303030303%	1	33	403	Diabetes_McGill_ER_Stress	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
3.0303030303%	1	33	40	Mendelian_Metabolism	TOMLINS_PROSTATE_CANCER_DN
3.0303030303%	1	33	40	Mendelian_Metabolism	KEGG_TRYPTOPHAN_METABOLISM
3.0303030303%	1	33	40	Mendelian_Metabolism	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
3.0303030303%	1	33	40	Mendelian_Metabolism	BURTON_ADIPOGENESIS_PEAK_AT_16HR
3.0303030303%	1	33	40	Diabetes_McGill_ER_Stress	VARELA_ZMPSTE24_TARGETS_UP
3.0303030303%	1	33	40	Diabetes_McGill_ER_Stress	VANASSE_BCL2_TARGETS_UP
3.0303030303%	1	33	40	Diabetes_McGill_ER_Stress	ST_JNK_MAPK_PATHWAY
3.0303030303%	1	33	40	Diabetes_McGill_ER_Stress	JIANG_AGING_HYPOTHALAMUS_DN
3.0303030303%	1	33	40	Diabetes_McGill_ER_Stress	BIOCARTA_P38MAPK_PATHWAY
3.0303030303%	1	33	398	Diabetes_McGill_ER_Stress	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
3.0303030303%	1	33	396	Mendelian_Metabolism	REACTOME_DEVELOPMENTAL_BIOLOGY
3.0303030303%	1	33	395	Mendelian_Metabolism	HAN_SATB1_TARGETS_UP
3.0303030303%	1	33	393	Diabetes_McGill_ER_Stress	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
3.0303030303%	1	33	391	Mendelian_Metabolism	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
3.0303030303%	1	33	390	Mendelian_Metabolism	HATADA_METHYLATED_IN_LUNG_CANCER_UP
3.0303030303%	1	33	390	Mendelian_Metabolism	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
3.0303030303%	1	33	390	Diabetes_McGill_ER_Stress	HATADA_METHYLATED_IN_LUNG_CANCER_UP
3.0303030303%	1	33	390	Diabetes_McGill_ER_Stress	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
3.0303030303%	1	33	39	Mendelian_Metabolism	POTTI_PACLITAXEL_SENSITIVITY
3.0303030303%	1	33	39	Mendelian_Metabolism	HAN_JNK_SINGALING_DN
3.0303030303%	1	33	39	Mendelian_Metabolism	BEIER_GLIOMA_STEM_CELL_UP
3.0303030303%	1	33	39	Mendelian_Metabolism	AIYAR_COBRA1_TARGETS_UP
3.0303030303%	1	33	39	Diabetes_McGill_ER_Stress	WANG_LSD1_TARGETS_DN
3.0303030303%	1	33	39	Diabetes_McGill_ER_Stress	VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN
3.0303030303%	1	33	39	Diabetes_McGill_ER_Stress	STONER_ESOPHAGEAL_CARCINOGENESIS_UP
3.0303030303%	1	33	39	Diabetes_McGill_ER_Stress	SESTO_RESPONSE_TO_UV_C6
3.0303030303%	1	33	39	Diabetes_McGill_ER_Stress	PID_RET_PATHWAY
3.0303030303%	1	33	39	Diabetes_McGill_ER_Stress	GENTILE_UV_RESPONSE_CLUSTER_D5
3.0303030303%	1	33	39	Diabetes_McGill_ER_Stress	AIYAR_COBRA1_TARGETS_UP
3.0303030303%	1	33	388	Mendelian_Metabolism	STEIN_ESRRA_TARGETS_UP
3.0303030303%	1	33	388	Diabetes_McGill_ER_Stress	STEIN_ESRRA_TARGETS_UP
3.0303030303%	1	33	387	Mendelian_Metabolism	CHYLA_CBFA2T3_TARGETS_UP
3.0303030303%	1	33	387	Diabetes_McGill_ER_Stress	CHYLA_CBFA2T3_TARGETS_UP
3.0303030303%	1	33	384	Mendelian_Metabolism	BASAKI_YBX1_TARGETS_DN
3.0303030303%	1	33	384	Diabetes_McGill_ER_Stress	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
3.0303030303%	1	33	382	Mendelian_Metabolism	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
3.0303030303%	1	33	380	Mendelian_Metabolism	DAIRKEE_TERT_TARGETS_UP
3.0303030303%	1	33	380	Mendelian_Metabolism	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
3.0303030303%	1	33	38	Mendelian_Metabolism	PIONTEK_PKD1_TARGETS_UP
3.0303030303%	1	33	38	Mendelian_Metabolism	GRADE_COLON_VS_RECTAL_CANCER_UP
3.0303030303%	1	33	38	Mendelian_Metabolism	CERVERA_SDHB_TARGETS_1_DN
3.0303030303%	1	33	38	Diabetes_McGill_ER_Stress	YOKOE_CANCER_TESTIS_ANTIGENS
3.0303030303%	1	33	38	Diabetes_McGill_ER_Stress	PID_FASPATHWAY
3.0303030303%	1	33	38	Diabetes_McGill_ER_Stress	BIOCARTA_INTEGRIN_PATHWAY
3.0303030303%	1	33	38	Diabetes_McGill_ER_Stress	BIOCARTA_IL2RB_PATHWAY
3.0303030303%	1	33	38	Diabetes_McGill_ER_Stress	APPIERTO_RESPONSE_TO_FENRETINIDE_UP
3.0303030303%	1	33	379	Mendelian_Metabolism	BENPORATH_ES_1
3.0303030303%	1	33	378	Diabetes_McGill_ER_Stress	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
3.0303030303%	1	33	374	Mendelian_Metabolism	WANG_TUMOR_INVASIVENESS_UP
3.0303030303%	1	33	374	Mendelian_Metabolism	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
3.0303030303%	1	33	374	Diabetes_McGill_ER_Stress	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
3.0303030303%	1	33	373	Mendelian_Metabolism	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
3.0303030303%	1	33	372	Mendelian_Metabolism	WANG_LMO4_TARGETS_UP
3.0303030303%	1	33	372	Diabetes_McGill_ER_Stress	WANG_LMO4_TARGETS_UP
3.0303030303%	1	33	371	Diabetes_McGill_ER_Stress	WANG_SMARCE1_TARGETS_DN
3.0303030303%	1	33	37	Mendelian_Metabolism	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING
3.0303030303%	1	33	37	Mendelian_Metabolism	HU_ANGIOGENESIS_DN
3.0303030303%	1	33	37	Mendelian_Metabolism	FRASOR_RESPONSE_TO_ESTRADIOL_UP
3.0303030303%	1	33	37	Diabetes_McGill_ER_Stress	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN
3.0303030303%	1	33	37	Diabetes_McGill_ER_Stress	PID_FRA_PATHWAY
3.0303030303%	1	33	37	Diabetes_McGill_ER_Stress	LANDIS_ERBB2_BREAST_TUMORS_65_DN
3.0303030303%	1	33	37	Diabetes_McGill_ER_Stress	FRASOR_RESPONSE_TO_ESTRADIOL_UP
3.0303030303%	1	33	37	Diabetes_McGill_ER_Stress	BIOCARTA_MET_PATHWAY
3.0303030303%	1	33	37	Diabetes_McGill_ER_Stress	BIOCARTA_BCR_PATHWAY
3.0303030303%	1	33	368	Mendelian_Metabolism	YAGI_AML_WITH_T_8_21_TRANSLOCATION
3.0303030303%	1	33	368	Diabetes_McGill_ER_Stress	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
3.0303030303%	1	33	367	Diabetes_McGill_ER_Stress	DELACROIX_RARG_BOUND_MEF
3.0303030303%	1	33	366	Mendelian_Metabolism	YOSHIMURA_MAPK8_TARGETS_DN
3.0303030303%	1	33	366	Diabetes_McGill_ER_Stress	YOSHIMURA_MAPK8_TARGETS_DN
3.0303030303%	1	33	364	Diabetes_McGill_ER_Stress	YANG_BCL3_TARGETS_UP
3.0303030303%	1	33	362	Diabetes_McGill_ER_Stress	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
3.0303030303%	1	33	36	Mendelian_Metabolism	VALK_AML_CLUSTER_11
3.0303030303%	1	33	36	Mendelian_Metabolism	STEARMAN_TUMOR_FIELD_EFFECT_UP
3.0303030303%	1	33	36	Mendelian_Metabolism	REACTOME_FRS2_MEDIATED_CASCADE
3.0303030303%	1	33	36	Mendelian_Metabolism	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP
3.0303030303%	1	33	36	Diabetes_McGill_ER_Stress	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
3.0303030303%	1	33	36	Diabetes_McGill_ER_Stress	MMS_MOUSE_LYMPH_HIGH_4HRS_UP
3.0303030303%	1	33	36	Diabetes_McGill_ER_Stress	BIOCARTA_AT1R_PATHWAY
3.0303030303%	1	33	36	Diabetes_McGill_ER_Stress	BIOCARTA_AGR_PATHWAY
3.0303030303%	1	33	358	Diabetes_McGill_ER_Stress	GRUETZMANN_PANCREATIC_CANCER_UP
3.0303030303%	1	33	357	Diabetes_McGill_ER_Stress	SHEN_SMARCA2_TARGETS_DN
3.0303030303%	1	33	355	Mendelian_Metabolism	PEREZ_TP63_TARGETS
3.0303030303%	1	33	353	Mendelian_Metabolism	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
3.0303030303%	1	33	352	Diabetes_McGill_ER_Stress	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
3.0303030303%	1	33	35	Mendelian_Metabolism	WEIGEL_OXIDATIVE_STRESS_RESPONSE
3.0303030303%	1	33	35	Mendelian_Metabolism	REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D
3.0303030303%	1	33	35	Mendelian_Metabolism	MODY_HIPPOCAMPUS_NEONATAL
3.0303030303%	1	33	35	Mendelian_Metabolism	HOWLIN_CITED1_TARGETS_1_UP
3.0303030303%	1	33	35	Diabetes_McGill_ER_Stress	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
3.0303030303%	1	33	35	Diabetes_McGill_ER_Stress	KEGG_PRION_DISEASES
3.0303030303%	1	33	35	Diabetes_McGill_ER_Stress	HU_GENOTOXIC_DAMAGE_24HR
3.0303030303%	1	33	35	Diabetes_McGill_ER_Stress	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP
3.0303030303%	1	33	349	Mendelian_Metabolism	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
3.0303030303%	1	33	349	Diabetes_McGill_ER_Stress	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
3.0303030303%	1	33	344	Diabetes_McGill_ER_Stress	RICKMAN_METASTASIS_UP
3.0303030303%	1	33	342	Mendelian_Metabolism	BLUM_RESPONSE_TO_SALIRASIB_DN
3.0303030303%	1	33	341	Diabetes_McGill_ER_Stress	MULLIGHAN_NPM1_SIGNATURE_3_UP
3.0303030303%	1	33	341	Diabetes_McGill_ER_Stress	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
3.0303030303%	1	33	34	Mendelian_Metabolism	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT
3.0303030303%	1	33	34	Mendelian_Metabolism	PETRETTO_CARDIAC_HYPERTROPHY
3.0303030303%	1	33	34	Mendelian_Metabolism	HONMA_DOCETAXEL_RESISTANCE
3.0303030303%	1	33	34	Diabetes_McGill_ER_Stress	SIG_CD40PATHWAYMAP
3.0303030303%	1	33	34	Diabetes_McGill_ER_Stress	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES
3.0303030303%	1	33	34	Diabetes_McGill_ER_Stress	PID_IL2_PI3KPATHWAY
3.0303030303%	1	33	34	Diabetes_McGill_ER_Stress	PID_IL1PATHWAY
3.0303030303%	1	33	34	Diabetes_McGill_ER_Stress	HONMA_DOCETAXEL_RESISTANCE
3.0303030303%	1	33	338	Mendelian_Metabolism	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
3.0303030303%	1	33	338	Diabetes_McGill_ER_Stress	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
3.0303030303%	1	33	337	Mendelian_Metabolism	PHONG_TNF_RESPONSE_NOT_VIA_P38
3.0303030303%	1	33	336	Mendelian_Metabolism	JOHNSTONE_PARVB_TARGETS_2_DN
3.0303030303%	1	33	335	Mendelian_Metabolism	WONG_EMBRYONIC_STEM_CELL_CORE
3.0303030303%	1	33	335	Diabetes_McGill_ER_Stress	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
3.0303030303%	1	33	330	Diabetes_McGill_ER_Stress	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
3.0303030303%	1	33	33	Mendelian_Metabolism	TANG_SENESCENCE_TP53_TARGETS_UP
3.0303030303%	1	33	33	Mendelian_Metabolism	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION
3.0303030303%	1	33	33	Mendelian_Metabolism	JEPSEN_SMRT_TARGETS
3.0303030303%	1	33	33	Mendelian_Metabolism	GHANDHI_DIRECT_IRRADIATION_DN
3.0303030303%	1	33	33	Mendelian_Metabolism	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN
3.0303030303%	1	33	33	Diabetes_McGill_ER_Stress	ZHAN_LATE_DIFFERENTIATION_GENES_UP
3.0303030303%	1	33	33	Diabetes_McGill_ER_Stress	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP
3.0303030303%	1	33	33	Diabetes_McGill_ER_Stress	PID_SYNDECAN_2_PATHWAY
3.0303030303%	1	33	33	Diabetes_McGill_ER_Stress	PID_NCADHERINPATHWAY
3.0303030303%	1	33	33	Diabetes_McGill_ER_Stress	PID_IL12_STAT4PATHWAY
3.0303030303%	1	33	33	Diabetes_McGill_ER_Stress	PID_ALPHASYNUCLEIN_PATHWAY
3.0303030303%	1	33	33	Diabetes_McGill_ER_Stress	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN
3.0303030303%	1	33	33	Diabetes_McGill_ER_Stress	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN
3.0303030303%	1	33	33	Diabetes_McGill_ER_Stress	DUTTA_APOPTOSIS_VIA_NFKB
3.0303030303%	1	33	33	Diabetes_McGill_ER_Stress	BIOCARTA_IL1R_PATHWAY
3.0303030303%	1	33	33	Diabetes_McGill_ER_Stress	BIOCARTA_DEATH_PATHWAY
3.0303030303%	1	33	329	Mendelian_Metabolism	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
3.0303030303%	1	33	329	Mendelian_Metabolism	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
3.0303030303%	1	33	328	Mendelian_Metabolism	KEGG_PATHWAYS_IN_CANCER
3.0303030303%	1	33	321	Mendelian_Metabolism	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
3.0303030303%	1	33	320	Diabetes_McGill_ER_Stress	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
3.0303030303%	1	33	32	Diabetes_McGill_ER_Stress	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN
3.0303030303%	1	33	32	Diabetes_McGill_ER_Stress	PID_WNT_NONCANONICAL_PATHWAY
3.0303030303%	1	33	32	Diabetes_McGill_ER_Stress	BIOCARTA_PDGF_PATHWAY
3.0303030303%	1	33	318	Mendelian_Metabolism	LEI_MYB_TARGETS
3.0303030303%	1	33	318	Diabetes_McGill_ER_Stress	LEI_MYB_TARGETS
3.0303030303%	1	33	317	Mendelian_Metabolism	HELLER_HDAC_TARGETS_UP
3.0303030303%	1	33	316	Mendelian_Metabolism	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
3.0303030303%	1	33	315	Diabetes_McGill_ER_Stress	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
3.0303030303%	1	33	314	Mendelian_Metabolism	DOUGLAS_BMI1_TARGETS_DN
3.0303030303%	1	33	310	Diabetes_McGill_ER_Stress	HORIUCHI_WTAP_TARGETS_DN
3.0303030303%	1	33	31	Diabetes_McGill_ER_Stress	RIZ_ERYTHROID_DIFFERENTIATION_HEMGN
3.0303030303%	1	33	31	Diabetes_McGill_ER_Stress	PID_NEPHRIN_NEPH1_PATHWAY
3.0303030303%	1	33	31	Diabetes_McGill_ER_Stress	PID_CD40_PATHWAY
3.0303030303%	1	33	31	Diabetes_McGill_ER_Stress	PID_AVB3_OPN_PATHWAY
3.0303030303%	1	33	31	Diabetes_McGill_ER_Stress	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP
3.0303030303%	1	33	31	Diabetes_McGill_ER_Stress	BIOCARTA_PYK2_PATHWAY
3.0303030303%	1	33	31	Diabetes_McGill_ER_Stress	BIOCARTA_EGF_PATHWAY
3.0303030303%	1	33	31	Diabetes_McGill_ER_Stress	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
3.0303030303%	1	33	31	Diabetes_McGill_ER_Stress	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN
3.0303030303%	1	33	309	Mendelian_Metabolism	LIU_SOX4_TARGETS_DN
3.0303030303%	1	33	309	Mendelian_Metabolism	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
3.0303030303%	1	33	309	Diabetes_McGill_ER_Stress	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
3.0303030303%	1	33	309	Diabetes_McGill_ER_Stress	LIU_SOX4_TARGETS_DN
3.0303030303%	1	33	308	Mendelian_Metabolism	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
3.0303030303%	1	33	306	Mendelian_Metabolism	HORIUCHI_WTAP_TARGETS_UP
3.0303030303%	1	33	30	Mendelian_Metabolism	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
3.0303030303%	1	33	30	Mendelian_Metabolism	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN
3.0303030303%	1	33	30	Mendelian_Metabolism	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
3.0303030303%	1	33	30	Mendelian_Metabolism	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY
3.0303030303%	1	33	30	Mendelian_Metabolism	BURTON_ADIPOGENESIS_10
3.0303030303%	1	33	30	Diabetes_McGill_ER_Stress	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
3.0303030303%	1	33	30	Diabetes_McGill_ER_Stress	SU_PLACENTA
3.0303030303%	1	33	30	Diabetes_McGill_ER_Stress	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
3.0303030303%	1	33	30	Diabetes_McGill_ER_Stress	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES
3.0303030303%	1	33	30	Diabetes_McGill_ER_Stress	PID_RETINOIC_ACID_PATHWAY
3.0303030303%	1	33	30	Diabetes_McGill_ER_Stress	PID_IL2_STAT5PATHWAY
3.0303030303%	1	33	30	Diabetes_McGill_ER_Stress	PID_EPHRINBREVPATHWAY
3.0303030303%	1	33	30	Diabetes_McGill_ER_Stress	GUILLAUMOND_KLF10_TARGETS_DN
3.0303030303%	1	33	30	Diabetes_McGill_ER_Stress	DAZARD_UV_RESPONSE_CLUSTER_G2
3.0303030303%	1	33	30	Diabetes_McGill_ER_Stress	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP
3.0303030303%	1	33	30	Diabetes_McGill_ER_Stress	BIOCARTA_FAS_PATHWAY
3.0303030303%	1	33	299	Mendelian_Metabolism	WALLACE_PROSTATE_CANCER_RACE_UP
3.0303030303%	1	33	299	Mendelian_Metabolism	MUELLER_PLURINET
3.0303030303%	1	33	299	Diabetes_McGill_ER_Stress	MUELLER_PLURINET
3.0303030303%	1	33	298	Mendelian_Metabolism	BROWNE_HCMV_INFECTION_14HR_DN
3.0303030303%	1	33	298	Mendelian_Metabolism	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
3.0303030303%	1	33	298	Diabetes_McGill_ER_Stress	BROWNE_HCMV_INFECTION_14HR_DN
3.0303030303%	1	33	298	Diabetes_McGill_ER_Stress	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
3.0303030303%	1	33	293	Diabetes_McGill_ER_Stress	ZHANG_TLX_TARGETS_60HR_UP
3.0303030303%	1	33	292	Mendelian_Metabolism	HELLER_HDAC_TARGETS_DN
3.0303030303%	1	33	292	Diabetes_McGill_ER_Stress	KOYAMA_SEMA3B_TARGETS_UP
3.0303030303%	1	33	290	Mendelian_Metabolism	BENPORATH_OCT4_TARGETS
3.0303030303%	1	33	290	Mendelian_Metabolism	BASAKI_YBX1_TARGETS_UP
3.0303030303%	1	33	290	Diabetes_McGill_ER_Stress	BENPORATH_OCT4_TARGETS
3.0303030303%	1	33	29	Mendelian_Metabolism	WEINMANN_ADAPTATION_TO_HYPOXIA_UP
3.0303030303%	1	33	29	Mendelian_Metabolism	REACTOME_STEROID_HORMONES
3.0303030303%	1	33	29	Mendelian_Metabolism	KRIGE_AMINO_ACID_DEPRIVATION
3.0303030303%	1	33	29	Mendelian_Metabolism	AIYAR_COBRA1_TARGETS_DN
3.0303030303%	1	33	29	Diabetes_McGill_ER_Stress	PID_REELINPATHWAY
3.0303030303%	1	33	29	Diabetes_McGill_ER_Stress	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
3.0303030303%	1	33	29	Diabetes_McGill_ER_Stress	MAYBURD_RESPONSE_TO_L663536_UP
3.0303030303%	1	33	29	Diabetes_McGill_ER_Stress	DORN_ADENOVIRUS_INFECTION_12HR_UP
3.0303030303%	1	33	29	Diabetes_McGill_ER_Stress	DALESSIO_TSA_RESPONSE
3.0303030303%	1	33	29	Diabetes_McGill_ER_Stress	BIOCARTA_VEGF_PATHWAY
3.0303030303%	1	33	29	Diabetes_McGill_ER_Stress	BIOCARTA_TNFR1_PATHWAY
3.0303030303%	1	33	29	Diabetes_McGill_ER_Stress	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP
3.0303030303%	1	33	289	Mendelian_Metabolism	WANG_MLL_TARGETS
3.0303030303%	1	33	289	Mendelian_Metabolism	GABRIELY_MIR21_TARGETS
3.0303030303%	1	33	289	Diabetes_McGill_ER_Stress	MANALO_HYPOXIA_DN
3.0303030303%	1	33	289	Diabetes_McGill_ER_Stress	GABRIELY_MIR21_TARGETS
3.0303030303%	1	33	287	Mendelian_Metabolism	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
3.0303030303%	1	33	285	Mendelian_Metabolism	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
3.0303030303%	1	33	285	Mendelian_Metabolism	GRADE_COLON_AND_RECTAL_CANCER_UP
3.0303030303%	1	33	285	Diabetes_McGill_ER_Stress	GRADE_COLON_AND_RECTAL_CANCER_UP
3.0303030303%	1	33	284	Mendelian_Metabolism	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
3.0303030303%	1	33	281	Mendelian_Metabolism	MULLIGHAN_MLL_SIGNATURE_2_DN
3.0303030303%	1	33	281	Mendelian_Metabolism	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
3.0303030303%	1	33	281	Mendelian_Metabolism	BHAT_ESR1_TARGETS_VIA_AKT1_UP
3.0303030303%	1	33	280	Mendelian_Metabolism	WANG_SMARCE1_TARGETS_UP
3.0303030303%	1	33	28	Mendelian_Metabolism	REACTOME_SHC_MEDIATED_CASCADE
3.0303030303%	1	33	28	Mendelian_Metabolism	CHEN_LUNG_CANCER_SURVIVAL
3.0303030303%	1	33	28	Diabetes_McGill_ER_Stress	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
3.0303030303%	1	33	28	Diabetes_McGill_ER_Stress	PID_TRAIL_PATHWAY
3.0303030303%	1	33	28	Diabetes_McGill_ER_Stress	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
3.0303030303%	1	33	28	Diabetes_McGill_ER_Stress	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
3.0303030303%	1	33	28	Diabetes_McGill_ER_Stress	CHEN_LUNG_CANCER_SURVIVAL
3.0303030303%	1	33	277	Mendelian_Metabolism	ZHANG_TLX_TARGETS_60HR_DN
3.0303030303%	1	33	277	Diabetes_McGill_ER_Stress	ZHANG_TLX_TARGETS_60HR_DN
3.0303030303%	1	33	276	Diabetes_McGill_ER_Stress	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
3.0303030303%	1	33	275	Mendelian_Metabolism	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
3.0303030303%	1	33	275	Diabetes_McGill_ER_Stress	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
3.0303030303%	1	33	271	Mendelian_Metabolism	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
3.0303030303%	1	33	271	Diabetes_McGill_ER_Stress	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
3.0303030303%	1	33	271	Diabetes_McGill_ER_Stress	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
3.0303030303%	1	33	270	Diabetes_McGill_ER_Stress	RIZKI_TUMOR_INVASIVENESS_3D_DN
3.0303030303%	1	33	270	Diabetes_McGill_ER_Stress	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
3.0303030303%	1	33	27	Mendelian_Metabolism	KEGG_PENTOSE_PHOSPHATE_PATHWAY
3.0303030303%	1	33	27	Mendelian_Metabolism	GROSS_ELK3_TARGETS_UP
3.0303030303%	1	33	27	Diabetes_McGill_ER_Stress	TERAO_AOX4_TARGETS_SKIN_DN
3.0303030303%	1	33	27	Diabetes_McGill_ER_Stress	ST_GRANULE_CELL_SURVIVAL_PATHWAY
3.0303030303%	1	33	27	Diabetes_McGill_ER_Stress	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
3.0303030303%	1	33	27	Diabetes_McGill_ER_Stress	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP
3.0303030303%	1	33	27	Diabetes_McGill_ER_Stress	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
3.0303030303%	1	33	27	Diabetes_McGill_ER_Stress	IKEDA_MIR30_TARGETS_DN
3.0303030303%	1	33	27	Diabetes_McGill_ER_Stress	EINAV_INTERFERON_SIGNATURE_IN_CANCER
3.0303030303%	1	33	27	Diabetes_McGill_ER_Stress	BRACHAT_RESPONSE_TO_METHOTREXATE_DN
3.0303030303%	1	33	27	Diabetes_McGill_ER_Stress	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP
3.0303030303%	1	33	27	Diabetes_McGill_ER_Stress	BIOCARTA_GSK3_PATHWAY
3.0303030303%	1	33	268	Mendelian_Metabolism	XU_GH1_AUTOCRINE_TARGETS_UP
3.0303030303%	1	33	268	Diabetes_McGill_ER_Stress	XU_GH1_AUTOCRINE_TARGETS_UP
3.0303030303%	1	33	267	Mendelian_Metabolism	KEGG_MAPK_SIGNALING_PATHWAY
3.0303030303%	1	33	267	Diabetes_McGill_ER_Stress	HOLLMANN_APOPTOSIS_VIA_CD40_DN
3.0303030303%	1	33	266	Mendelian_Metabolism	ROZANOV_MMP14_TARGETS_UP
3.0303030303%	1	33	266	Mendelian_Metabolism	FOSTER_KDM1A_TARGETS_UP
3.0303030303%	1	33	265	Mendelian_Metabolism	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
3.0303030303%	1	33	262	Mendelian_Metabolism	LU_AGING_BRAIN_UP
3.0303030303%	1	33	261	Diabetes_McGill_ER_Stress	BILD_HRAS_ONCOGENIC_SIGNATURE
3.0303030303%	1	33	260	Mendelian_Metabolism	SENESE_HDAC1_TARGETS_DN
3.0303030303%	1	33	26	Mendelian_Metabolism	PID_RXR_VDR_PATHWAY
3.0303030303%	1	33	26	Mendelian_Metabolism	NAKAMURA_CANCER_MICROENVIRONMENT_UP
3.0303030303%	1	33	26	Mendelian_Metabolism	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP
3.0303030303%	1	33	26	Diabetes_McGill_ER_Stress	WILLIAMS_ESR1_TARGETS_UP
3.0303030303%	1	33	26	Diabetes_McGill_ER_Stress	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
3.0303030303%	1	33	26	Diabetes_McGill_ER_Stress	ST_INTERLEUKIN_4_PATHWAY
3.0303030303%	1	33	26	Diabetes_McGill_ER_Stress	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS
3.0303030303%	1	33	26	Diabetes_McGill_ER_Stress	PID_RXR_VDR_PATHWAY
3.0303030303%	1	33	26	Diabetes_McGill_ER_Stress	DEN_INTERACT_WITH_LCA5
3.0303030303%	1	33	26	Diabetes_McGill_ER_Stress	BIOCARTA_BAD_PATHWAY
3.0303030303%	1	33	259	Diabetes_McGill_ER_Stress	QI_PLASMACYTOMA_UP
3.0303030303%	1	33	258	Mendelian_Metabolism	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
3.0303030303%	1	33	258	Mendelian_Metabolism	JAEGER_METASTASIS_DN
3.0303030303%	1	33	256	Mendelian_Metabolism	ONDER_CDH1_TARGETS_2_UP
3.0303030303%	1	33	254	Mendelian_Metabolism	BROWNE_HCMV_INFECTION_4HR_DN
3.0303030303%	1	33	254	Diabetes_McGill_ER_Stress	IVANOVA_HEMATOPOIESIS_STEM_CELL
3.0303030303%	1	33	254	Diabetes_McGill_ER_Stress	BROWNE_HCMV_INFECTION_4HR_DN
3.0303030303%	1	33	253	Mendelian_Metabolism	MCLACHLAN_DENTAL_CARIES_UP
3.0303030303%	1	33	251	Mendelian_Metabolism	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
3.0303030303%	1	33	250	Mendelian_Metabolism	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
3.0303030303%	1	33	25	Mendelian_Metabolism	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN
3.0303030303%	1	33	25	Diabetes_McGill_ER_Stress	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP
3.0303030303%	1	33	25	Diabetes_McGill_ER_Stress	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
3.0303030303%	1	33	25	Diabetes_McGill_ER_Stress	BIOCARTA_STRESS_PATHWAY
3.0303030303%	1	33	249	Mendelian_Metabolism	MITSIADES_RESPONSE_TO_APLIDIN_DN
3.0303030303%	1	33	249	Diabetes_McGill_ER_Stress	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
3.0303030303%	1	33	247	Mendelian_Metabolism	REACTOME_METABOLISM_OF_CARBOHYDRATES
3.0303030303%	1	33	245	Mendelian_Metabolism	PENG_RAPAMYCIN_RESPONSE_DN
3.0303030303%	1	33	245	Mendelian_Metabolism	MCLACHLAN_DENTAL_CARIES_DN
3.0303030303%	1	33	244	Mendelian_Metabolism	PLASARI_TGFB1_TARGETS_10HR_DN
3.0303030303%	1	33	244	Mendelian_Metabolism	DAZARD_RESPONSE_TO_UV_NHEK_UP
3.0303030303%	1	33	244	Diabetes_McGill_ER_Stress	PLASARI_TGFB1_TARGETS_10HR_DN
3.0303030303%	1	33	244	Diabetes_McGill_ER_Stress	HSIAO_LIVER_SPECIFIC_GENES
3.0303030303%	1	33	242	Mendelian_Metabolism	WINTER_HYPOXIA_METAGENE
3.0303030303%	1	33	242	Mendelian_Metabolism	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
3.0303030303%	1	33	242	Diabetes_McGill_ER_Stress	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
3.0303030303%	1	33	240	Mendelian_Metabolism	VANTVEER_BREAST_CANCER_ESR1_DN
3.0303030303%	1	33	240	Mendelian_Metabolism	UDAYAKUMAR_MED1_TARGETS_DN
3.0303030303%	1	33	240	Mendelian_Metabolism	BROWNE_HCMV_INFECTION_20HR_UP
3.0303030303%	1	33	240	Diabetes_McGill_ER_Stress	BROWNE_HCMV_INFECTION_20HR_UP
3.0303030303%	1	33	24	Mendelian_Metabolism	REACTOME_PYRIMIDINE_METABOLISM
3.0303030303%	1	33	24	Mendelian_Metabolism	MAEKAWA_ATF2_TARGETS
3.0303030303%	1	33	24	Mendelian_Metabolism	KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM
3.0303030303%	1	33	24	Mendelian_Metabolism	JIANG_TIP30_TARGETS_DN
3.0303030303%	1	33	24	Diabetes_McGill_ER_Stress	YIH_RESPONSE_TO_ARSENITE_C1
3.0303030303%	1	33	24	Diabetes_McGill_ER_Stress	PID_S1P_S1P2_PATHWAY
3.0303030303%	1	33	24	Diabetes_McGill_ER_Stress	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN
3.0303030303%	1	33	239	Mendelian_Metabolism	ALFANO_MYC_TARGETS
3.0303030303%	1	33	239	Diabetes_McGill_ER_Stress	ALFANO_MYC_TARGETS
3.0303030303%	1	33	238	Mendelian_Metabolism	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
3.0303030303%	1	33	238	Diabetes_McGill_ER_Stress	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
3.0303030303%	1	33	238	Diabetes_McGill_ER_Stress	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
3.0303030303%	1	33	235	Diabetes_McGill_ER_Stress	RUTELLA_RESPONSE_TO_HGF_DN
3.0303030303%	1	33	234	Mendelian_Metabolism	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
3.0303030303%	1	33	234	Diabetes_McGill_ER_Stress	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
3.0303030303%	1	33	233	Diabetes_McGill_ER_Stress	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
3.0303030303%	1	33	23	Mendelian_Metabolism	WENG_POR_TARGETS_GLOBAL_DN
3.0303030303%	1	33	23	Mendelian_Metabolism	KEGG_NITROGEN_METABOLISM
3.0303030303%	1	33	23	Mendelian_Metabolism	FERRANDO_HOX11_NEIGHBORS
3.0303030303%	1	33	23	Diabetes_McGill_ER_Stress	WU_HBX_TARGETS_1_DN
3.0303030303%	1	33	23	Diabetes_McGill_ER_Stress	WENG_POR_TARGETS_GLOBAL_DN
3.0303030303%	1	33	23	Diabetes_McGill_ER_Stress	ST_GA12_PATHWAY
3.0303030303%	1	33	23	Diabetes_McGill_ER_Stress	REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING
3.0303030303%	1	33	23	Diabetes_McGill_ER_Stress	PID_PRLSIGNALINGEVENTSPATHWAY
3.0303030303%	1	33	23	Diabetes_McGill_ER_Stress	BIOCARTA_P53HYPOXIA_PATHWAY
3.0303030303%	1	33	23	Diabetes_McGill_ER_Stress	BIOCARTA_IL12_PATHWAY
3.0303030303%	1	33	23	Diabetes_McGill_ER_Stress	BIOCARTA_GLEEVEC_PATHWAY
3.0303030303%	1	33	23	Diabetes_McGill_ER_Stress	BARIS_THYROID_CANCER_UP
3.0303030303%	1	33	229	Mendelian_Metabolism	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
3.0303030303%	1	33	229	Mendelian_Metabolism	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
3.0303030303%	1	33	229	Mendelian_Metabolism	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
3.0303030303%	1	33	229	Diabetes_McGill_ER_Stress	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
3.0303030303%	1	33	229	Diabetes_McGill_ER_Stress	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
3.0303030303%	1	33	229	Diabetes_McGill_ER_Stress	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
3.0303030303%	1	33	228	Mendelian_Metabolism	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
3.0303030303%	1	33	228	Mendelian_Metabolism	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
3.0303030303%	1	33	228	Mendelian_Metabolism	MARKEY_RB1_ACUTE_LOF_DN
3.0303030303%	1	33	228	Diabetes_McGill_ER_Stress	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
3.0303030303%	1	33	228	Diabetes_McGill_ER_Stress	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
3.0303030303%	1	33	227	Mendelian_Metabolism	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
3.0303030303%	1	33	227	Diabetes_McGill_ER_Stress	RAO_BOUND_BY_SALL4
3.0303030303%	1	33	226	Mendelian_Metabolism	KYNG_DNA_DAMAGE_UP
3.0303030303%	1	33	226	Mendelian_Metabolism	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
3.0303030303%	1	33	226	Diabetes_McGill_ER_Stress	KYNG_DNA_DAMAGE_UP
3.0303030303%	1	33	225	Diabetes_McGill_ER_Stress	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
3.0303030303%	1	33	221	Mendelian_Metabolism	PEDRIOLI_MIR31_TARGETS_UP
3.0303030303%	1	33	220	Diabetes_McGill_ER_Stress	RIGGINS_TAMOXIFEN_RESISTANCE_DN
3.0303030303%	1	33	22	Mendelian_Metabolism	REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION
3.0303030303%	1	33	22	Mendelian_Metabolism	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP
3.0303030303%	1	33	22	Diabetes_McGill_ER_Stress	TIAN_TNF_SIGNALING_NOT_VIA_NFKB
3.0303030303%	1	33	22	Diabetes_McGill_ER_Stress	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP
3.0303030303%	1	33	22	Diabetes_McGill_ER_Stress	NUMATA_CSF3_SIGNALING_VIA_STAT3
3.0303030303%	1	33	22	Diabetes_McGill_ER_Stress	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
3.0303030303%	1	33	22	Diabetes_McGill_ER_Stress	GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION
3.0303030303%	1	33	22	Diabetes_McGill_ER_Stress	FERRARI_RESPONSE_TO_FENRETINIDE_UP
3.0303030303%	1	33	22	Diabetes_McGill_ER_Stress	BIOCARTA_INSULIN_PATHWAY
3.0303030303%	1	33	22	Diabetes_McGill_ER_Stress	BIOCARTA_IL2_PATHWAY
3.0303030303%	1	33	217	Mendelian_Metabolism	WONG_MITOCHONDRIA_GENE_MODULE
3.0303030303%	1	33	217	Mendelian_Metabolism	WIERENGA_STAT5A_TARGETS_UP
3.0303030303%	1	33	217	Diabetes_McGill_ER_Stress	REACTOME_SIGNALLING_BY_NGF
3.0303030303%	1	33	216	Mendelian_Metabolism	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
3.0303030303%	1	33	215	Diabetes_McGill_ER_Stress	YAMAZAKI_TCEB3_TARGETS_DN
3.0303030303%	1	33	215	Diabetes_McGill_ER_Stress	MARKEY_RB1_ACUTE_LOF_UP
3.0303030303%	1	33	214	Mendelian_Metabolism	AFFAR_YY1_TARGETS_UP
3.0303030303%	1	33	214	Diabetes_McGill_ER_Stress	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
3.0303030303%	1	33	212	Mendelian_Metabolism	SANSOM_APC_TARGETS
3.0303030303%	1	33	212	Diabetes_McGill_ER_Stress	CHANG_CORE_SERUM_RESPONSE_UP
3.0303030303%	1	33	211	Mendelian_Metabolism	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
3.0303030303%	1	33	211	Mendelian_Metabolism	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
3.0303030303%	1	33	211	Diabetes_McGill_ER_Stress	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
3.0303030303%	1	33	211	Diabetes_McGill_ER_Stress	FOSTER_KDM1A_TARGETS_DN
3.0303030303%	1	33	210	Mendelian_Metabolism	VERHAAK_GLIOBLASTOMA_PRONEURAL
3.0303030303%	1	33	210	Mendelian_Metabolism	CAIRO_HEPATOBLASTOMA_CLASSES_DN
3.0303030303%	1	33	210	Diabetes_McGill_ER_Stress	VERHAAK_GLIOBLASTOMA_PRONEURAL
3.0303030303%	1	33	210	Diabetes_McGill_ER_Stress	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
3.0303030303%	1	33	210	Diabetes_McGill_ER_Stress	RIZKI_TUMOR_INVASIVENESS_3D_UP
3.0303030303%	1	33	21	Mendelian_Metabolism	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP
3.0303030303%	1	33	21	Mendelian_Metabolism	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN
3.0303030303%	1	33	21	Mendelian_Metabolism	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC
3.0303030303%	1	33	21	Mendelian_Metabolism	HU_ANGIOGENESIS_UP
3.0303030303%	1	33	21	Mendelian_Metabolism	DAZARD_UV_RESPONSE_CLUSTER_G4
3.0303030303%	1	33	21	Diabetes_McGill_ER_Stress	WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC
3.0303030303%	1	33	21	Diabetes_McGill_ER_Stress	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP
3.0303030303%	1	33	21	Diabetes_McGill_ER_Stress	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP
3.0303030303%	1	33	21	Diabetes_McGill_ER_Stress	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC
3.0303030303%	1	33	21	Diabetes_McGill_ER_Stress	MACLACHLAN_BRCA1_TARGETS_UP
3.0303030303%	1	33	21	Diabetes_McGill_ER_Stress	GESERICK_TERT_TARGETS_DN
3.0303030303%	1	33	21	Diabetes_McGill_ER_Stress	DAZARD_UV_RESPONSE_CLUSTER_G4
3.0303030303%	1	33	21	Diabetes_McGill_ER_Stress	BIOCARTA_MITOCHONDRIA_PATHWAY
3.0303030303%	1	33	21	Diabetes_McGill_ER_Stress	BIOCARTA_IGF1_PATHWAY
3.0303030303%	1	33	209	Mendelian_Metabolism	CHANG_CORE_SERUM_RESPONSE_DN
3.0303030303%	1	33	208	Mendelian_Metabolism	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
3.0303030303%	1	33	208	Diabetes_McGill_ER_Stress	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
3.0303030303%	1	33	207	Mendelian_Metabolism	VERHAAK_GLIOBLASTOMA_CLASSICAL
3.0303030303%	1	33	207	Diabetes_McGill_ER_Stress	CAIRO_HEPATOBLASTOMA_UP
3.0303030303%	1	33	206	Mendelian_Metabolism	RAMALHO_STEMNESS_UP
3.0303030303%	1	33	206	Diabetes_McGill_ER_Stress	LINSLEY_MIR16_TARGETS
3.0303030303%	1	33	206	Diabetes_McGill_ER_Stress	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
3.0303030303%	1	33	205	Mendelian_Metabolism	SHEPARD_BMYB_MORPHOLINO_UP
3.0303030303%	1	33	204	Mendelian_Metabolism	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
3.0303030303%	1	33	204	Diabetes_McGill_ER_Stress	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
3.0303030303%	1	33	203	Mendelian_Metabolism	PAL_PRMT5_TARGETS_UP
3.0303030303%	1	33	202	Mendelian_Metabolism	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
3.0303030303%	1	33	200	Diabetes_McGill_ER_Stress	SHEPARD_BMYB_MORPHOLINO_DN
3.0303030303%	1	33	20	Mendelian_Metabolism	WALLACE_PROSTATE_CANCER_UP
3.0303030303%	1	33	20	Diabetes_McGill_ER_Stress	ZHU_SKIL_TARGETS_UP
3.0303030303%	1	33	20	Diabetes_McGill_ER_Stress	WENG_POR_TARGETS_LIVER_DN
3.0303030303%	1	33	20	Diabetes_McGill_ER_Stress	SESTO_RESPONSE_TO_UV_C3
3.0303030303%	1	33	20	Diabetes_McGill_ER_Stress	BIOCARTA_IGF1MTOR_PATHWAY
3.0303030303%	1	33	20	Diabetes_McGill_ER_Stress	BIOCARTA_CCR5_PATHWAY
3.0303030303%	1	33	20	Diabetes_McGill_ER_Stress	BIOCARTA_ATM_PATHWAY
3.0303030303%	1	33	198	Mendelian_Metabolism	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
3.0303030303%	1	33	198	Diabetes_McGill_ER_Stress	WELCSH_BRCA1_TARGETS_UP
3.0303030303%	1	33	197	Mendelian_Metabolism	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
3.0303030303%	1	33	196	Mendelian_Metabolism	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
3.0303030303%	1	33	196	Mendelian_Metabolism	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
3.0303030303%	1	33	196	Diabetes_McGill_ER_Stress	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
3.0303030303%	1	33	194	Mendelian_Metabolism	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
3.0303030303%	1	33	194	Diabetes_McGill_ER_Stress	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
3.0303030303%	1	33	193	Diabetes_McGill_ER_Stress	MOHANKUMAR_TLX1_TARGETS_DN
3.0303030303%	1	33	193	Diabetes_McGill_ER_Stress	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
3.0303030303%	1	33	191	Diabetes_McGill_ER_Stress	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
3.0303030303%	1	33	19	Mendelian_Metabolism	VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP
3.0303030303%	1	33	19	Mendelian_Metabolism	TRAYNOR_RETT_SYNDROM_DN
3.0303030303%	1	33	19	Mendelian_Metabolism	TERAMOTO_OPN_TARGETS_CLUSTER_7
3.0303030303%	1	33	19	Mendelian_Metabolism	MELLMAN_TUT1_TARGETS_UP
3.0303030303%	1	33	19	Mendelian_Metabolism	KANG_AR_TARGETS_DN
3.0303030303%	1	33	19	Diabetes_McGill_ER_Stress	TERAMOTO_OPN_TARGETS_CLUSTER_7
3.0303030303%	1	33	19	Diabetes_McGill_ER_Stress	SCIBETTA_KDM5B_TARGETS_UP
3.0303030303%	1	33	19	Diabetes_McGill_ER_Stress	OUYANG_PROSTATE_CANCER_MARKERS
3.0303030303%	1	33	19	Diabetes_McGill_ER_Stress	MELLMAN_TUT1_TARGETS_UP
3.0303030303%	1	33	19	Diabetes_McGill_ER_Stress	MATZUK_EMBRYONIC_GERM_CELL
3.0303030303%	1	33	19	Diabetes_McGill_ER_Stress	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN
3.0303030303%	1	33	19	Diabetes_McGill_ER_Stress	BIOCARTA_MAL_PATHWAY
3.0303030303%	1	33	19	Diabetes_McGill_ER_Stress	BIOCARTA_EPO_PATHWAY
3.0303030303%	1	33	19	Diabetes_McGill_ER_Stress	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP
3.0303030303%	1	33	19	Diabetes_McGill_ER_Stress	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
3.0303030303%	1	33	188	Mendelian_Metabolism	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
3.0303030303%	1	33	188	Mendelian_Metabolism	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
3.0303030303%	1	33	187	Diabetes_McGill_ER_Stress	BAKKER_FOXO3_TARGETS_DN
3.0303030303%	1	33	186	Diabetes_McGill_ER_Stress	HAMAI_APOPTOSIS_VIA_TRAIL_DN
3.0303030303%	1	33	185	Mendelian_Metabolism	DARWICHE_SKIN_TUMOR_PROMOTER_DN
3.0303030303%	1	33	185	Diabetes_McGill_ER_Stress	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
3.0303030303%	1	33	184	Mendelian_Metabolism	DOANE_RESPONSE_TO_ANDROGEN_UP
3.0303030303%	1	33	1839	Diabetes_McGill_ER_Stress	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
3.0303030303%	1	33	183	Diabetes_McGill_ER_Stress	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
3.0303030303%	1	33	183	Diabetes_McGill_ER_Stress	OKUMURA_INFLAMMATORY_RESPONSE_LPS
3.0303030303%	1	33	1821	Diabetes_McGill_ER_Stress	DODD_NASOPHARYNGEAL_CARCINOMA_UP
3.0303030303%	1	33	182	Mendelian_Metabolism	RAO_BOUND_BY_SALL4_ISOFORM_A
3.0303030303%	1	33	182	Mendelian_Metabolism	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
3.0303030303%	1	33	182	Diabetes_McGill_ER_Stress	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
3.0303030303%	1	33	182	Diabetes_McGill_ER_Stress	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
3.0303030303%	1	33	181	Mendelian_Metabolism	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
3.0303030303%	1	33	181	Diabetes_McGill_ER_Stress	JISON_SICKLE_CELL_DISEASE_UP
3.0303030303%	1	33	181	Diabetes_McGill_ER_Stress	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
3.0303030303%	1	33	180	Mendelian_Metabolism	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
3.0303030303%	1	33	180	Mendelian_Metabolism	BROWNE_HCMV_INFECTION_48HR_UP
3.0303030303%	1	33	18	Mendelian_Metabolism	REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS
3.0303030303%	1	33	18	Mendelian_Metabolism	NIELSEN_SCHWANNOMA_DN
3.0303030303%	1	33	18	Mendelian_Metabolism	NIELSEN_LIPOSARCOMA_UP
3.0303030303%	1	33	18	Mendelian_Metabolism	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES
3.0303030303%	1	33	18	Diabetes_McGill_ER_Stress	ZHENG_RESPONSE_TO_ARSENITE_UP
3.0303030303%	1	33	18	Diabetes_McGill_ER_Stress	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA
3.0303030303%	1	33	18	Diabetes_McGill_ER_Stress	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS
3.0303030303%	1	33	18	Diabetes_McGill_ER_Stress	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN
3.0303030303%	1	33	18	Diabetes_McGill_ER_Stress	NAM_FXYD5_TARGETS_DN
3.0303030303%	1	33	18	Diabetes_McGill_ER_Stress	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
3.0303030303%	1	33	18	Diabetes_McGill_ER_Stress	BIOCARTA_TEL_PATHWAY
3.0303030303%	1	33	18	Diabetes_McGill_ER_Stress	BIOCARTA_NGF_PATHWAY
3.0303030303%	1	33	1781	Mendelian_Metabolism	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
3.0303030303%	1	33	178	Mendelian_Metabolism	LI_AMPLIFIED_IN_LUNG_CANCER
3.0303030303%	1	33	178	Mendelian_Metabolism	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
3.0303030303%	1	33	178	Diabetes_McGill_ER_Stress	KEGG_CALCIUM_SIGNALING_PATHWAY
3.0303030303%	1	33	177	Mendelian_Metabolism	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
3.0303030303%	1	33	177	Diabetes_McGill_ER_Stress	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
3.0303030303%	1	33	176	Mendelian_Metabolism	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
3.0303030303%	1	33	176	Mendelian_Metabolism	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
3.0303030303%	1	33	176	Mendelian_Metabolism	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
3.0303030303%	1	33	176	Diabetes_McGill_ER_Stress	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
3.0303030303%	1	33	176	Diabetes_McGill_ER_Stress	REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION
3.0303030303%	1	33	175	Mendelian_Metabolism	YAMAZAKI_TCEB3_TARGETS_UP
3.0303030303%	1	33	175	Mendelian_Metabolism	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
3.0303030303%	1	33	175	Mendelian_Metabolism	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
3.0303030303%	1	33	175	Diabetes_McGill_ER_Stress	YAMAZAKI_TCEB3_TARGETS_UP
3.0303030303%	1	33	175	Diabetes_McGill_ER_Stress	FIRESTEIN_PROLIFERATION
3.0303030303%	1	33	174	Diabetes_McGill_ER_Stress	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
3.0303030303%	1	33	1725	Mendelian_Metabolism	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
3.0303030303%	1	33	172	Mendelian_Metabolism	SMID_BREAST_CANCER_LUMINAL_B_UP
3.0303030303%	1	33	172	Mendelian_Metabolism	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
3.0303030303%	1	33	172	Diabetes_McGill_ER_Stress	SMID_BREAST_CANCER_LUMINAL_B_UP
3.0303030303%	1	33	171	Diabetes_McGill_ER_Stress	GOLDRATH_HOMEOSTATIC_PROLIFERATION
3.0303030303%	1	33	170	Mendelian_Metabolism	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
3.0303030303%	1	33	170	Mendelian_Metabolism	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
3.0303030303%	1	33	17	Mendelian_Metabolism	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP
3.0303030303%	1	33	17	Mendelian_Metabolism	REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION
3.0303030303%	1	33	17	Mendelian_Metabolism	LEI_HOXC8_TARGETS_DN
3.0303030303%	1	33	17	Mendelian_Metabolism	KEGG_STEROID_BIOSYNTHESIS
3.0303030303%	1	33	17	Mendelian_Metabolism	KANG_AR_TARGETS_UP
3.0303030303%	1	33	17	Mendelian_Metabolism	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP
3.0303030303%	1	33	17	Mendelian_Metabolism	GRATIAS_RETINOBLASTOMA_16Q24
3.0303030303%	1	33	17	Diabetes_McGill_ER_Stress	REACTOME_INFLAMMASOMES
3.0303030303%	1	33	17	Diabetes_McGill_ER_Stress	NGO_MALIGNANT_GLIOMA_1P_LOH
3.0303030303%	1	33	17	Diabetes_McGill_ER_Stress	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
3.0303030303%	1	33	17	Diabetes_McGill_ER_Stress	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL
3.0303030303%	1	33	17	Diabetes_McGill_ER_Stress	GRATIAS_RETINOBLASTOMA_16Q24
3.0303030303%	1	33	17	Diabetes_McGill_ER_Stress	BIOCARTA_IL7_PATHWAY
3.0303030303%	1	33	17	Diabetes_McGill_ER_Stress	BIOCARTA_41BB_PATHWAY
3.0303030303%	1	33	169	Mendelian_Metabolism	PENG_GLUCOSE_DEPRIVATION_DN
3.0303030303%	1	33	169	Mendelian_Metabolism	ONDER_CDH1_TARGETS_1_DN
3.0303030303%	1	33	169	Mendelian_Metabolism	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
3.0303030303%	1	33	169	Mendelian_Metabolism	KEGG_ALZHEIMERS_DISEASE
3.0303030303%	1	33	169	Mendelian_Metabolism	KATSANOU_ELAVL1_TARGETS_UP
3.0303030303%	1	33	169	Mendelian_Metabolism	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
3.0303030303%	1	33	169	Diabetes_McGill_ER_Stress	UEDA_PERIFERAL_CLOCK
3.0303030303%	1	33	167	Mendelian_Metabolism	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
3.0303030303%	1	33	165	Mendelian_Metabolism	LIU_CMYB_TARGETS_UP
3.0303030303%	1	33	165	Mendelian_Metabolism	BROWN_MYELOID_CELL_DEVELOPMENT_UP
3.0303030303%	1	33	163	Mendelian_Metabolism	SERVITJA_ISLET_HNF1A_TARGETS_UP
3.0303030303%	1	33	163	Mendelian_Metabolism	LIN_NPAS4_TARGETS_UP
3.0303030303%	1	33	163	Mendelian_Metabolism	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
3.0303030303%	1	33	163	Diabetes_McGill_ER_Stress	SERVITJA_ISLET_HNF1A_TARGETS_UP
3.0303030303%	1	33	163	Diabetes_McGill_ER_Stress	LIN_NPAS4_TARGETS_UP
3.0303030303%	1	33	163	Diabetes_McGill_ER_Stress	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
3.0303030303%	1	33	162	Mendelian_Metabolism	DARWICHE_PAPILLOMA_RISK_LOW_UP
3.0303030303%	1	33	162	Diabetes_McGill_ER_Stress	WINNEPENNINCKX_MELANOMA_METASTASIS_UP
3.0303030303%	1	33	162	Diabetes_McGill_ER_Stress	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
3.0303030303%	1	33	162	Diabetes_McGill_ER_Stress	MULLIGHAN_NPM1_SIGNATURE_3_DN
3.0303030303%	1	33	161	Mendelian_Metabolism	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
3.0303030303%	1	33	160	Mendelian_Metabolism	GAVIN_FOXP3_TARGETS_CLUSTER_P3
3.0303030303%	1	33	160	Diabetes_McGill_ER_Stress	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
3.0303030303%	1	33	16	Mendelian_Metabolism	WANG_RECURRENT_LIVER_CANCER_DN
3.0303030303%	1	33	16	Mendelian_Metabolism	REACTOME_PLATELET_SENSITIZATION_BY_LDL
3.0303030303%	1	33	16	Mendelian_Metabolism	REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2
3.0303030303%	1	33	16	Mendelian_Metabolism	KEGG_RIBOFLAVIN_METABOLISM
3.0303030303%	1	33	16	Mendelian_Metabolism	KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS
3.0303030303%	1	33	16	Mendelian_Metabolism	IGLESIAS_E2F_TARGETS_DN
3.0303030303%	1	33	16	Diabetes_McGill_ER_Stress	WU_HBX_TARGETS_2_DN
3.0303030303%	1	33	16	Diabetes_McGill_ER_Stress	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI
3.0303030303%	1	33	16	Diabetes_McGill_ER_Stress	REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1
3.0303030303%	1	33	16	Diabetes_McGill_ER_Stress	BIOCARTA_P53_PATHWAY
3.0303030303%	1	33	16	Diabetes_McGill_ER_Stress	BIOCARTA_EIF_PATHWAY
3.0303030303%	1	33	16	Diabetes_McGill_ER_Stress	BAKER_HEMATOPOIESIS_STAT3_TARGETS
3.0303030303%	1	33	159	Mendelian_Metabolism	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
3.0303030303%	1	33	159	Diabetes_McGill_ER_Stress	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
3.0303030303%	1	33	159	Diabetes_McGill_ER_Stress	REACTOME_INTERFERON_SIGNALING
3.0303030303%	1	33	157	Mendelian_Metabolism	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
3.0303030303%	1	33	157	Diabetes_McGill_ER_Stress	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
3.0303030303%	1	33	157	Diabetes_McGill_ER_Stress	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
3.0303030303%	1	33	157	Diabetes_McGill_ER_Stress	SERVITJA_LIVER_HNF1A_TARGETS_DN
3.0303030303%	1	33	157	Diabetes_McGill_ER_Stress	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
3.0303030303%	1	33	157	Diabetes_McGill_ER_Stress	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
3.0303030303%	1	33	156	Mendelian_Metabolism	GROSS_HYPOXIA_VIA_ELK3_DN
3.0303030303%	1	33	156	Mendelian_Metabolism	FOSTER_TOLERANT_MACROPHAGE_UP
3.0303030303%	1	33	156	Diabetes_McGill_ER_Stress	BROWNE_HCMV_INFECTION_14HR_UP
3.0303030303%	1	33	153	Mendelian_Metabolism	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
3.0303030303%	1	33	153	Diabetes_McGill_ER_Stress	LU_AGING_BRAIN_DN
3.0303030303%	1	33	152	Mendelian_Metabolism	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
3.0303030303%	1	33	151	Mendelian_Metabolism	IGLESIAS_E2F_TARGETS_UP
3.0303030303%	1	33	151	Diabetes_McGill_ER_Stress	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
3.0303030303%	1	33	150	Diabetes_McGill_ER_Stress	LANDIS_ERBB2_BREAST_TUMORS_324_UP
3.0303030303%	1	33	15	Mendelian_Metabolism	SU_KIDNEY
3.0303030303%	1	33	15	Mendelian_Metabolism	SINGH_NFE2L2_TARGETS
3.0303030303%	1	33	15	Diabetes_McGill_ER_Stress	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP
3.0303030303%	1	33	15	Diabetes_McGill_ER_Stress	REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS
3.0303030303%	1	33	15	Diabetes_McGill_ER_Stress	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP
3.0303030303%	1	33	15	Diabetes_McGill_ER_Stress	PID_ERB_GENOMIC_PATHWAY
3.0303030303%	1	33	15	Diabetes_McGill_ER_Stress	MARKS_HDAC_TARGETS_DN
3.0303030303%	1	33	15	Diabetes_McGill_ER_Stress	FERRANDO_LYL1_NEIGHBORS
3.0303030303%	1	33	15	Diabetes_McGill_ER_Stress	DAZARD_UV_RESPONSE_CLUSTER_G3
3.0303030303%	1	33	15	Diabetes_McGill_ER_Stress	BIOCARTA_TALL1_PATHWAY
3.0303030303%	1	33	15	Diabetes_McGill_ER_Stress	BIOCARTA_NUCLEARRS_PATHWAY
3.0303030303%	1	33	15	Diabetes_McGill_ER_Stress	BIOCARTA_HSP27_PATHWAY
3.0303030303%	1	33	149	Mendelian_Metabolism	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
3.0303030303%	1	33	149	Mendelian_Metabolism	OHGUCHI_LIVER_HNF4A_TARGETS_DN
3.0303030303%	1	33	149	Mendelian_Metabolism	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
3.0303030303%	1	33	149	Mendelian_Metabolism	GOZGIT_ESR1_TARGETS_UP
3.0303030303%	1	33	149	Diabetes_McGill_ER_Stress	LANDIS_ERBB2_BREAST_TUMORS_324_DN
3.0303030303%	1	33	148	Mendelian_Metabolism	BROWNE_HCMV_INFECTION_24HR_DN
3.0303030303%	1	33	147	Mendelian_Metabolism	DARWICHE_PAPILLOMA_RISK_HIGH_UP
3.0303030303%	1	33	147	Diabetes_McGill_ER_Stress	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
3.0303030303%	1	33	146	Mendelian_Metabolism	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
3.0303030303%	1	33	146	Diabetes_McGill_ER_Stress	PECE_MAMMARY_STEM_CELL_UP
3.0303030303%	1	33	145	Mendelian_Metabolism	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
3.0303030303%	1	33	145	Mendelian_Metabolism	SMITH_TERT_TARGETS_UP
3.0303030303%	1	33	145	Mendelian_Metabolism	RODWELL_AGING_KIDNEY_DN
3.0303030303%	1	33	145	Mendelian_Metabolism	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
3.0303030303%	1	33	145	Diabetes_McGill_ER_Stress	ZHANG_BREAST_CANCER_PROGENITORS_DN
3.0303030303%	1	33	145	Diabetes_McGill_ER_Stress	RODWELL_AGING_KIDNEY_DN
3.0303030303%	1	33	145	Diabetes_McGill_ER_Stress	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
3.0303030303%	1	33	144	Mendelian_Metabolism	BROCKE_APOPTOSIS_REVERSED_BY_IL6
3.0303030303%	1	33	143	Mendelian_Metabolism	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
3.0303030303%	1	33	143	Mendelian_Metabolism	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
3.0303030303%	1	33	143	Mendelian_Metabolism	BASSO_B_LYMPHOCYTE_NETWORK
3.0303030303%	1	33	142	Mendelian_Metabolism	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
3.0303030303%	1	33	142	Mendelian_Metabolism	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
3.0303030303%	1	33	142	Diabetes_McGill_ER_Stress	RUIZ_TNC_TARGETS_DN
3.0303030303%	1	33	142	Diabetes_McGill_ER_Stress	MIKKELSEN_ES_LCP_WITH_H3K4ME3
3.0303030303%	1	33	142	Diabetes_McGill_ER_Stress	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
3.0303030303%	1	33	142	Diabetes_McGill_ER_Stress	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
3.0303030303%	1	33	140	Mendelian_Metabolism	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
3.0303030303%	1	33	140	Mendelian_Metabolism	JOHNSTONE_PARVB_TARGETS_2_UP
3.0303030303%	1	33	140	Diabetes_McGill_ER_Stress	QI_HYPOXIA
3.0303030303%	1	33	14	Mendelian_Metabolism	REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION
3.0303030303%	1	33	14	Mendelian_Metabolism	MATZUK_POST-IMPLANTATION_AND_POST-PARTUM
3.0303030303%	1	33	14	Diabetes_McGill_ER_Stress	ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR
3.0303030303%	1	33	14	Diabetes_McGill_ER_Stress	ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS
3.0303030303%	1	33	14	Diabetes_McGill_ER_Stress	PID_TCRJNKPATHWAY
3.0303030303%	1	33	14	Diabetes_McGill_ER_Stress	GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
3.0303030303%	1	33	14	Diabetes_McGill_ER_Stress	DORN_ADENOVIRUS_INFECTION_48HR_UP
3.0303030303%	1	33	139	Mendelian_Metabolism	HOELZEL_NF1_TARGETS_UP
3.0303030303%	1	33	138	Mendelian_Metabolism	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
3.0303030303%	1	33	138	Mendelian_Metabolism	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
3.0303030303%	1	33	138	Diabetes_McGill_ER_Stress	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
3.0303030303%	1	33	137	Mendelian_Metabolism	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
3.0303030303%	1	33	137	Diabetes_McGill_ER_Stress	PID_P53DOWNSTREAMPATHWAY
3.0303030303%	1	33	137	Diabetes_McGill_ER_Stress	LIU_SOX4_TARGETS_UP
3.0303030303%	1	33	137	Diabetes_McGill_ER_Stress	KEGG_INSULIN_SIGNALING_PATHWAY
3.0303030303%	1	33	136	Diabetes_McGill_ER_Stress	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
3.0303030303%	1	33	136	Diabetes_McGill_ER_Stress	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
3.0303030303%	1	33	135	Mendelian_Metabolism	UDAYAKUMAR_MED1_TARGETS_UP
3.0303030303%	1	33	135	Mendelian_Metabolism	TSENG_IRS1_TARGETS_DN
3.0303030303%	1	33	135	Diabetes_McGill_ER_Stress	UDAYAKUMAR_MED1_TARGETS_UP
3.0303030303%	1	33	134	Mendelian_Metabolism	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
3.0303030303%	1	33	134	Diabetes_McGill_ER_Stress	SCHLOSSER_SERUM_RESPONSE_UP
3.0303030303%	1	33	134	Diabetes_McGill_ER_Stress	CHUNG_BLISTER_CYTOTOXICITY_UP
3.0303030303%	1	33	133	Mendelian_Metabolism	SENESE_HDAC2_TARGETS_DN
3.0303030303%	1	33	133	Diabetes_McGill_ER_Stress	KEGG_PARKINSONS_DISEASE
3.0303030303%	1	33	132	Mendelian_Metabolism	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
3.0303030303%	1	33	131	Mendelian_Metabolism	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
3.0303030303%	1	33	13	Mendelian_Metabolism	REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT
3.0303030303%	1	33	13	Mendelian_Metabolism	HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER
3.0303030303%	1	33	13	Mendelian_Metabolism	CROONQUIST_STROMAL_STIMULATION_DN
3.0303030303%	1	33	13	Diabetes_McGill_ER_Stress	BIOCARTA_ARENRF2_PATHWAY
3.0303030303%	1	33	129	Mendelian_Metabolism	YAGI_AML_SURVIVAL
3.0303030303%	1	33	129	Mendelian_Metabolism	REACTOME_MEMBRANE_TRAFFICKING
3.0303030303%	1	33	129	Mendelian_Metabolism	KIM_WT1_TARGETS_8HR_DN
3.0303030303%	1	33	129	Diabetes_McGill_ER_Stress	YAGI_AML_SURVIVAL
3.0303030303%	1	33	128	Mendelian_Metabolism	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
3.0303030303%	1	33	128	Mendelian_Metabolism	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS
3.0303030303%	1	33	128	Diabetes_McGill_ER_Stress	ZHU_CMV_ALL_DN
3.0303030303%	1	33	128	Diabetes_McGill_ER_Stress	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
3.0303030303%	1	33	128	Diabetes_McGill_ER_Stress	YEGNASUBRAMANIAN_PROSTATE_CANCER
3.0303030303%	1	33	1278	Mendelian_Metabolism	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
3.0303030303%	1	33	127	Mendelian_Metabolism	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
3.0303030303%	1	33	127	Mendelian_Metabolism	INGRAM_SHH_TARGETS_UP
3.0303030303%	1	33	127	Diabetes_McGill_ER_Stress	KARLSSON_TGFB1_TARGETS_UP
3.0303030303%	1	33	126	Mendelian_Metabolism	SANSOM_APC_TARGETS_UP
3.0303030303%	1	33	126	Mendelian_Metabolism	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
3.0303030303%	1	33	126	Mendelian_Metabolism	BURTON_ADIPOGENESIS_5
3.0303030303%	1	33	126	Diabetes_McGill_ER_Stress	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
3.0303030303%	1	33	126	Diabetes_McGill_ER_Stress	BURTON_ADIPOGENESIS_5
3.0303030303%	1	33	1237	Mendelian_Metabolism	BLALOCK_ALZHEIMERS_DISEASE_DN
3.0303030303%	1	33	123	Mendelian_Metabolism	HOOI_ST7_TARGETS_DN
3.0303030303%	1	33	123	Mendelian_Metabolism	DAZARD_RESPONSE_TO_UV_SCC_UP
3.0303030303%	1	33	123	Diabetes_McGill_ER_Stress	KAYO_AGING_MUSCLE_DN
3.0303030303%	1	33	123	Diabetes_McGill_ER_Stress	DAZARD_RESPONSE_TO_UV_SCC_UP
3.0303030303%	1	33	1210	Diabetes_McGill_ER_Stress	CHEN_METABOLIC_SYNDROM_NETWORK
3.0303030303%	1	33	121	Mendelian_Metabolism	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
3.0303030303%	1	33	121	Mendelian_Metabolism	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
3.0303030303%	1	33	120	Mendelian_Metabolism	XU_GH1_EXOGENOUS_TARGETS_DN
3.0303030303%	1	33	120	Diabetes_McGill_ER_Stress	ZHU_CMV_ALL_UP
3.0303030303%	1	33	120	Diabetes_McGill_ER_Stress	REACTOME_CELL_CELL_COMMUNICATION
3.0303030303%	1	33	120	Diabetes_McGill_ER_Stress	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
3.0303030303%	1	33	12	Mendelian_Metabolism	RUAN_RESPONSE_TO_TNF_UP
3.0303030303%	1	33	12	Mendelian_Metabolism	REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION
3.0303030303%	1	33	12	Mendelian_Metabolism	REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION
3.0303030303%	1	33	12	Mendelian_Metabolism	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN
3.0303030303%	1	33	12	Diabetes_McGill_ER_Stress	TURJANSKI_MAPK1_AND_MAPK2_TARGETS
3.0303030303%	1	33	12	Diabetes_McGill_ER_Stress	SA_PROGRAMMED_CELL_DEATH
3.0303030303%	1	33	12	Diabetes_McGill_ER_Stress	NEBEN_AML_WITH_FLT3_OR_NRAS_DN
3.0303030303%	1	33	12	Diabetes_McGill_ER_Stress	DORN_ADENOVIRUS_INFECTION_24HR_UP
3.0303030303%	1	33	12	Diabetes_McGill_ER_Stress	CLAUS_PGR_POSITIVE_MENINGIOMA_DN
3.0303030303%	1	33	119	Mendelian_Metabolism	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
3.0303030303%	1	33	118	Mendelian_Metabolism	LEE_NEURAL_CREST_STEM_CELL_DN
3.0303030303%	1	33	118	Mendelian_Metabolism	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
3.0303030303%	1	33	118	Diabetes_McGill_ER_Stress	REACTOME_TOLL_RECEPTOR_CASCADES
3.0303030303%	1	33	118	Diabetes_McGill_ER_Stress	MARKEY_RB1_CHRONIC_LOF_DN
3.0303030303%	1	33	118	Diabetes_McGill_ER_Stress	LEE_NEURAL_CREST_STEM_CELL_DN
3.0303030303%	1	33	117	Mendelian_Metabolism	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
3.0303030303%	1	33	117	Diabetes_McGill_ER_Stress	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
3.0303030303%	1	33	116	Mendelian_Metabolism	LI_INDUCED_T_TO_NATURAL_KILLER_DN
3.0303030303%	1	33	116	Mendelian_Metabolism	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
3.0303030303%	1	33	116	Mendelian_Metabolism	LIM_MAMMARY_LUMINAL_MATURE_UP
3.0303030303%	1	33	116	Mendelian_Metabolism	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
3.0303030303%	1	33	116	Diabetes_McGill_ER_Stress	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
3.0303030303%	1	33	116	Diabetes_McGill_ER_Stress	MATTIOLI_MGUS_VS_PCL
3.0303030303%	1	33	116	Diabetes_McGill_ER_Stress	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
3.0303030303%	1	33	116	Diabetes_McGill_ER_Stress	LIM_MAMMARY_LUMINAL_MATURE_UP
3.0303030303%	1	33	116	Diabetes_McGill_ER_Stress	IKEDA_MIR30_TARGETS_UP
3.0303030303%	1	33	115	Mendelian_Metabolism	MARZEC_IL2_SIGNALING_UP
3.0303030303%	1	33	115	Diabetes_McGill_ER_Stress	MARZEC_IL2_SIGNALING_UP
3.0303030303%	1	33	114	Mendelian_Metabolism	MATZUK_SPERMATOZOA
3.0303030303%	1	33	114	Mendelian_Metabolism	CERVERA_SDHB_TARGETS_2
3.0303030303%	1	33	114	Diabetes_McGill_ER_Stress	ROPERO_HDAC2_TARGETS
3.0303030303%	1	33	114	Diabetes_McGill_ER_Stress	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN
3.0303030303%	1	33	113	Diabetes_McGill_ER_Stress	TSENG_IRS1_TARGETS_UP
3.0303030303%	1	33	112	Mendelian_Metabolism	REACTOME_SIGNALING_BY_FGFR
3.0303030303%	1	33	111	Mendelian_Metabolism	WANG_HCP_PROSTATE_CANCER
3.0303030303%	1	33	111	Mendelian_Metabolism	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
3.0303030303%	1	33	111	Diabetes_McGill_ER_Stress	WANG_HCP_PROSTATE_CANCER
3.0303030303%	1	33	111	Diabetes_McGill_ER_Stress	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
3.0303030303%	1	33	111	Diabetes_McGill_ER_Stress	BOUDOUKHA_BOUND_BY_IGF2BP2
3.0303030303%	1	33	110	Mendelian_Metabolism	WOOD_EBV_EBNA1_TARGETS_UP
3.0303030303%	1	33	110	Mendelian_Metabolism	SUNG_METASTASIS_STROMA_UP
3.0303030303%	1	33	110	Mendelian_Metabolism	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
3.0303030303%	1	33	110	Mendelian_Metabolism	GROSS_HYPOXIA_VIA_HIF1A_DN
3.0303030303%	1	33	11	Mendelian_Metabolism	REACTOME_SIGNALING_BY_FGFR3_MUTANTS
3.0303030303%	1	33	11	Mendelian_Metabolism	REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1
3.0303030303%	1	33	11	Diabetes_McGill_ER_Stress	ZHOU_PANCREATIC_EXOCRINE_PROGENITOR
3.0303030303%	1	33	11	Diabetes_McGill_ER_Stress	REACTOME_DSCAM_INTERACTIONS
3.0303030303%	1	33	11	Diabetes_McGill_ER_Stress	MUNSHI_MULTIPLE_MYELOMA_DN
3.0303030303%	1	33	11	Diabetes_McGill_ER_Stress	MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN
3.0303030303%	1	33	11	Diabetes_McGill_ER_Stress	DORN_ADENOVIRUS_INFECTION_32HR_UP
3.0303030303%	1	33	11	Diabetes_McGill_ER_Stress	AMIT_EGF_RESPONSE_20_HELA
3.0303030303%	1	33	109	Mendelian_Metabolism	SERVITJA_ISLET_HNF1A_TARGETS_DN
3.0303030303%	1	33	109	Mendelian_Metabolism	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
3.0303030303%	1	33	109	Mendelian_Metabolism	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
3.0303030303%	1	33	1080	Mendelian_Metabolism	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
3.0303030303%	1	33	108	Mendelian_Metabolism	TAVAZOIE_METASTASIS
3.0303030303%	1	33	108	Mendelian_Metabolism	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
3.0303030303%	1	33	108	Mendelian_Metabolism	LE_EGR2_TARGETS_DN
3.0303030303%	1	33	108	Diabetes_McGill_ER_Stress	ZHANG_TLX_TARGETS_DN
3.0303030303%	1	33	108	Diabetes_McGill_ER_Stress	JAZAG_TGFB1_SIGNALING_UP
3.0303030303%	1	33	107	Mendelian_Metabolism	ROESSLER_LIVER_CANCER_METASTASIS_UP
3.0303030303%	1	33	107	Diabetes_McGill_ER_Stress	SESTO_RESPONSE_TO_UV_C0
3.0303030303%	1	33	106	Mendelian_Metabolism	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
3.0303030303%	1	33	105	Diabetes_McGill_ER_Stress	PID_ERBB1_DOWNSTREAM_PATHWAY
3.0303030303%	1	33	104	Mendelian_Metabolism	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
3.0303030303%	1	33	104	Mendelian_Metabolism	NAKAMURA_ADIPOGENESIS_LATE_UP
3.0303030303%	1	33	104	Mendelian_Metabolism	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
3.0303030303%	1	33	1037	Mendelian_Metabolism	NUYTTEN_EZH2_TARGETS_UP
3.0303030303%	1	33	103	Mendelian_Metabolism	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
3.0303030303%	1	33	103	Diabetes_McGill_ER_Stress	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
3.0303030303%	1	33	103	Diabetes_McGill_ER_Stress	REACTOME_SIGNALING_BY_NOTCH
3.0303030303%	1	33	103	Diabetes_McGill_ER_Stress	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY
3.0303030303%	1	33	1022	Mendelian_Metabolism	MARSON_BOUND_BY_FOXP3_STIMULATED
3.0303030303%	1	33	102	Mendelian_Metabolism	LABBE_TGFB1_TARGETS_UP
3.0303030303%	1	33	102	Diabetes_McGill_ER_Stress	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
3.0303030303%	1	33	102	Diabetes_McGill_ER_Stress	DER_IFN_BETA_RESPONSE_UP
3.0303030303%	1	33	101	Mendelian_Metabolism	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
3.0303030303%	1	33	101	Mendelian_Metabolism	KOBAYASHI_EGFR_SIGNALING_24HR_UP
3.0303030303%	1	33	101	Mendelian_Metabolism	BURTON_ADIPOGENESIS_3
3.0303030303%	1	33	101	Diabetes_McGill_ER_Stress	BASSO_CD40_SIGNALING_UP
3.0303030303%	1	33	100	Mendelian_Metabolism	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
3.0303030303%	1	33	100	Diabetes_McGill_ER_Stress	BENPORATH_ES_CORE_NINE_CORRELATED
3.0303030303%	1	33	10	Diabetes_McGill_ER_Stress	TURJANSKI_MAPK14_TARGETS
3.0303030303%	1	33	10	Diabetes_McGill_ER_Stress	SHANK_TAL1_TARGETS_DN
3.0303030303%	1	33	10	Diabetes_McGill_ER_Stress	REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS
3.0303030303%	1	33	10	Diabetes_McGill_ER_Stress	BAKER_HEMATOPOESIS_STAT1_TARGETS
3.02571860817%	20	661	795	T2D_GENES_TANYA_GLYCEMIC	WEI_MYCN_TARGETS_WITH_E_BOX
3.02571860817%	20	661	652	T2D_GENES_TANYA_GLYCEMIC	BENPORATH_PRC2_TARGETS
3.02571860817%	20	661	567	T2D_GENES_TANYA_GLYCEMIC	CHICAS_RB1_TARGETS_CONFLUENT
3.02571860817%	20	661	48	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PACKAGING_OF_TELOMERE_ENDS
3.02571860817%	20	661	467	T2D_GENES_TANYA_GLYCEMIC	RATTENBACHER_BOUND_BY_CELF1
3.02571860817%	20	661	466	T2D_GENES_TANYA_GLYCEMIC	REACTOME_HEMOSTASIS
3.02571860817%	20	661	462	T2D_GENES_TANYA_GLYCEMIC	DELACROIX_RAR_BOUND_ES
3.02571860817%	20	661	443	T2D_GENES_TANYA_GLYCEMIC	DELYS_THYROID_CANCER_UP
3.02571860817%	20	661	435	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
3.02571860817%	20	661	389	T2D_GENES_TANYA_GLYCEMIC	KEGG_OLFACTORY_TRANSDUCTION
3.02571860817%	20	661	380	T2D_GENES_TANYA_GLYCEMIC	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
3.02571860817%	20	661	364	T2D_GENES_TANYA_GLYCEMIC	YANG_BCL3_TARGETS_UP
3.02571860817%	20	661	276	T2D_GENES_TANYA_GLYCEMIC	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
3.01136363636%	106	3520	1011	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
2.99448384555%	38	1269	841	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARTENS_TRETINOIN_RESPONSE_DN
2.99448384555%	38	1269	1174	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PEREZ_TP53_TARGETS
2.99448384555%	38	1269	1069	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
2.99401197605%	35	1169	779	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PUJANA_CHEK2_PCC_NETWORK
2.99401197605%	35	1169	648	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BENPORATH_CYCLING_GENES
2.99401197605%	35	1169	540	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ACEVEDO_LIVER_CANCER_DN
2.99401197605%	35	1169	1174	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PEREZ_TP53_TARGETS
2.99305184393%	56	1871	673	T2D_GENES_TANYA_HEIGHT	MARTINEZ_RB1_TARGETS_UP
2.99305184393%	56	1871	487	T2D_GENES_TANYA_HEIGHT	RODWELL_AGING_KIDNEY_UP
2.99305184393%	56	1871	457	T2D_GENES_TANYA_HEIGHT	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
2.99305184393%	56	1871	140	T2D_GENES_TANYA_HEIGHT	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
2.98988040478%	65	2174	781	T2D_GENES_TANYA_LIPIDS	GOZGIT_ESR1_TARGETS_DN
2.98988040478%	65	2174	769	T2D_GENES_TANYA_LIPIDS	NUYTTEN_NIPP1_TARGETS_UP
2.98988040478%	65	2174	539	T2D_GENES_TANYA_LIPIDS	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
2.98885511651%	59	1974	544	Mendelian_Nancy_Cox	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
2.98885511651%	59	1974	448	Mendelian_Nancy_Cox	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
2.98885511651%	59	1974	379	Mendelian_Nancy_Cox	BENPORATH_ES_1
2.98885511651%	59	1974	367	Mendelian_Nancy_Cox	VECCHI_GASTRIC_CANCER_EARLY_DN
2.98885511651%	59	1974	362	Mendelian_Nancy_Cox	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
2.98885511651%	59	1974	260	Mendelian_Nancy_Cox	BOQUEST_STEM_CELL_UP
2.98885511651%	59	1974	217	Mendelian_Nancy_Cox	WONG_MITOCHONDRIA_GENE_MODULE
2.98295454545%	105	3520	800	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
2.95454545455%	104	3520	882	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
2.9520295203%	16	542	663	T2D_GENES_TANYA_ANTHROPOMETRIC	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
2.9520295203%	16	542	546	T2D_GENES_TANYA_ANTHROPOMETRIC	WEST_ADRENOCORTICAL_TUMOR_DN
2.9520295203%	16	542	537	T2D_GENES_TANYA_ANTHROPOMETRIC	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
2.9520295203%	16	542	504	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_48HR_DN
2.9520295203%	16	542	425	T2D_GENES_TANYA_ANTHROPOMETRIC	BOCHKIS_FOXA2_TARGETS
2.9520295203%	16	542	408	T2D_GENES_TANYA_ANTHROPOMETRIC	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
2.9520295203%	16	542	398	T2D_GENES_TANYA_ANTHROPOMETRIC	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
2.9520295203%	16	542	378	T2D_GENES_TANYA_ANTHROPOMETRIC	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
2.9520295203%	16	542	318	T2D_GENES_TANYA_ANTHROPOMETRIC	DAZARD_RESPONSE_TO_UV_NHEK_DN
2.9520295203%	16	542	298	T2D_GENES_TANYA_ANTHROPOMETRIC	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
2.94388224471%	64	2174	712	T2D_GENES_TANYA_LIPIDS	SCHLOSSER_SERUM_RESPONSE_DN
2.94388224471%	64	2174	552	T2D_GENES_TANYA_LIPIDS	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
2.94388224471%	64	2174	462	T2D_GENES_TANYA_LIPIDS	DELACROIX_RAR_BOUND_ES
2.94388224471%	64	2174	421	T2D_GENES_TANYA_LIPIDS	REACTOME_CELL_CYCLE
2.94388224471%	64	2174	418	T2D_GENES_TANYA_LIPIDS	MULLIGHAN_MLL_SIGNATURE_2_UP
2.93960448958%	55	1871	663	T2D_GENES_TANYA_HEIGHT	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
2.93960448958%	55	1871	634	T2D_GENES_TANYA_HEIGHT	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
2.93960448958%	55	1871	553	T2D_GENES_TANYA_HEIGHT	FEVR_CTNNB1_TARGETS_DN
2.93960448958%	55	1871	552	T2D_GENES_TANYA_HEIGHT	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
2.93960448958%	55	1871	536	T2D_GENES_TANYA_HEIGHT	SENESE_HDAC3_TARGETS_DN
2.93960448958%	55	1871	456	T2D_GENES_TANYA_HEIGHT	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
2.93819655522%	58	1974	570	Mendelian_Nancy_Cox	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
2.93819655522%	58	1974	536	Mendelian_Nancy_Cox	SENESE_HDAC3_TARGETS_DN
2.93819655522%	58	1974	442	Mendelian_Nancy_Cox	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
2.93819655522%	58	1974	424	Mendelian_Nancy_Cox	SHEN_SMARCA2_TARGETS_UP
2.93819655522%	58	1974	414	Mendelian_Nancy_Cox	MOHANKUMAR_TLX1_TARGETS_UP
2.93819655522%	58	1974	408	Mendelian_Nancy_Cox	REACTOME_GPCR_LIGAND_BINDING
2.93819655522%	58	1974	230	Mendelian_Nancy_Cox	BENPORATH_MYC_TARGETS_WITH_EBOX
2.93637846656%	18	613	855	T2D_GENES_TANYA_BIOMARKER	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
2.93637846656%	18	613	745	T2D_GENES_TANYA_BIOMARKER	LEE_BMP2_TARGETS_UP
2.93637846656%	18	613	673	T2D_GENES_TANYA_BIOMARKER	MARTINEZ_RB1_TARGETS_UP
2.93637846656%	18	613	668	T2D_GENES_TANYA_BIOMARKER	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
2.93637846656%	18	613	637	T2D_GENES_TANYA_BIOMARKER	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
2.93637846656%	18	613	602	T2D_GENES_TANYA_BIOMARKER	MARTINEZ_TP53_TARGETS_UP
2.93637846656%	18	613	526	T2D_GENES_TANYA_BIOMARKER	ONKEN_UVEAL_MELANOMA_DN
2.93637846656%	18	613	514	T2D_GENES_TANYA_BIOMARKER	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
2.93637846656%	18	613	491	T2D_GENES_TANYA_BIOMARKER	SWEET_LUNG_CANCER_KRAS_UP
2.93637846656%	18	613	456	T2D_GENES_TANYA_BIOMARKER	MARTENS_BOUND_BY_PML_RARA_FUSION
2.93637846656%	18	613	450	T2D_GENES_TANYA_BIOMARKER	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
2.93637846656%	18	613	447	T2D_GENES_TANYA_BIOMARKER	MOOTHA_MITOCHONDRIA
2.93637846656%	18	613	439	T2D_GENES_TANYA_BIOMARKER	MITSIADES_RESPONSE_TO_APLIDIN_UP
2.93637846656%	18	613	390	T2D_GENES_TANYA_BIOMARKER	HATADA_METHYLATED_IN_LUNG_CANCER_UP
2.93637846656%	18	613	351	T2D_GENES_TANYA_BIOMARKER	YAGI_AML_WITH_11Q23_REARRANGED
2.93637846656%	18	613	287	T2D_GENES_TANYA_BIOMARKER	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
2.92613636364%	103	3520	1375	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DODD_NASOPHARYNGEAL_CARCINOMA_DN
2.92613636364%	103	3520	1118	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BENPORATH_ES_WITH_H3K27ME3
2.91634689179%	38	1303	1229	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
2.91568163909%	37	1269	973	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ACEVEDO_LIVER_CANCER_UP
2.91568163909%	37	1269	1118	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BENPORATH_ES_WITH_H3K27ME3
2.91568163909%	37	1269	1024	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NUYTTEN_EZH2_TARGETS_DN
2.91479820628%	13	446	863	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
2.91479820628%	13	446	720	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
2.91479820628%	13	446	514	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
2.91479820628%	13	446	493	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
2.91479820628%	13	446	461	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
2.91479820628%	13	446	328	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_OLFACTORY_SIGNALING_PATHWAY
2.91479820628%	13	446	276	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
2.91479820628%	13	446	122	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
2.91479820628%	13	446	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ROVERSI_GLIOMA_COPY_NUMBER_UP
2.90846877673%	34	1169	957	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LOPEZ_MBD_TARGETS
2.90846877673%	34	1169	848	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NUYTTEN_NIPP1_TARGETS_DN
2.90846877673%	34	1169	514	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
2.90846877673%	34	1169	425	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOCHKIS_FOXA2_TARGETS
2.89788408464%	63	2174	634	T2D_GENES_TANYA_LIPIDS	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
2.89788408464%	63	2174	546	T2D_GENES_TANYA_LIPIDS	WEST_ADRENOCORTICAL_TUMOR_DN
2.88753799392%	57	1974	485	Mendelian_Nancy_Cox	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
2.88753799392%	57	1974	430	Mendelian_Nancy_Cox	RIGGI_EWING_SARCOMA_PROGENITOR_UP
2.88753799392%	57	1974	428	Mendelian_Nancy_Cox	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
2.88753799392%	57	1974	384	Mendelian_Nancy_Cox	BASAKI_YBX1_TARGETS_DN
2.88753799392%	57	1974	315	Mendelian_Nancy_Cox	PASINI_SUZ12_TARGETS_DN
2.88753799392%	57	1974	242	Mendelian_Nancy_Cox	WINTER_HYPOXIA_METAGENE
2.88615713522%	54	1871	590	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
2.88615713522%	54	1871	543	T2D_GENES_TANYA_HEIGHT	MARTINEZ_RB1_TARGETS_DN
2.88615713522%	54	1871	508	T2D_GENES_TANYA_HEIGHT	ENK_UV_RESPONSE_EPIDERMIS_DN
2.87443267776%	19	661	882	T2D_GENES_TANYA_GLYCEMIC	LEE_BMP2_TARGETS_DN
2.87443267776%	19	661	721	T2D_GENES_TANYA_GLYCEMIC	WONG_ADULT_TISSUE_STEM_MODULE
2.87443267776%	19	661	668	T2D_GENES_TANYA_GLYCEMIC	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
2.87443267776%	19	661	648	T2D_GENES_TANYA_GLYCEMIC	SMID_BREAST_CANCER_BASAL_UP
2.87443267776%	19	661	633	T2D_GENES_TANYA_GLYCEMIC	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
2.87443267776%	19	661	570	T2D_GENES_TANYA_GLYCEMIC	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
2.87443267776%	19	661	555	T2D_GENES_TANYA_GLYCEMIC	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
2.87443267776%	19	661	536	T2D_GENES_TANYA_GLYCEMIC	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
2.87443267776%	19	661	483	T2D_GENES_TANYA_GLYCEMIC	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
2.87443267776%	19	661	293	T2D_GENES_TANYA_GLYCEMIC	HADDAD_B_LYMPHOCYTE_PROGENITOR
2.87443267776%	19	661	293	T2D_GENES_TANYA_GLYCEMIC	ENK_UV_RESPONSE_EPIDERMIS_UP
2.87443267776%	19	661	228	T2D_GENES_TANYA_GLYCEMIC	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
2.86931818182%	101	3520	988	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BENPORATH_NANOG_TARGETS
2.86931818182%	101	3520	1278	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
2.86931818182%	101	3520	1069	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
2.85714285714%	2	70	96	Diabetes_McGill_Adipocytokine_signallin	ZAMORA_NOS2_TARGETS_DN
2.85714285714%	2	70	953	Diabetes_McGill_Adipocytokine_signallin	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
2.85714285714%	2	70	93	Diabetes_McGill_Adipocytokine_signallin	ZHU_CMV_24_HR_UP
2.85714285714%	2	70	93	Diabetes_McGill_Adipocytokine_signallin	REACTOME_REGULATION_OF_INSULIN_SECRETION
2.85714285714%	2	70	93	Diabetes_McGill_Adipocytokine_signallin	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
2.85714285714%	2	70	92	Diabetes_McGill_Adipocytokine_signallin	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
2.85714285714%	2	70	89	Diabetes_McGill_Adipocytokine_signallin	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
2.85714285714%	2	70	882	Diabetes_McGill_Adipocytokine_signallin	LEE_BMP2_TARGETS_DN
2.85714285714%	2	70	88	Diabetes_McGill_Adipocytokine_signallin	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
2.85714285714%	2	70	88	Diabetes_McGill_Adipocytokine_signallin	KEGG_HEMATOPOIETIC_CELL_LINEAGE
2.85714285714%	2	70	88	Diabetes_McGill_Adipocytokine_signallin	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
2.85714285714%	2	70	87	Diabetes_McGill_Adipocytokine_signallin	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
2.85714285714%	2	70	87	Diabetes_McGill_Adipocytokine_signallin	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
2.85714285714%	2	70	87	Diabetes_McGill_Adipocytokine_signallin	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
2.85714285714%	2	70	86	Diabetes_McGill_Adipocytokine_signallin	NELSON_RESPONSE_TO_ANDROGEN_UP
2.85714285714%	2	70	848	Diabetes_McGill_Adipocytokine_signallin	NUYTTEN_NIPP1_TARGETS_DN
2.85714285714%	2	70	82	Diabetes_McGill_Adipocytokine_signallin	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
2.85714285714%	2	70	81	Diabetes_McGill_Adipocytokine_signallin	HARRIS_HYPOXIA
2.85714285714%	2	70	80	Diabetes_McGill_Adipocytokine_signallin	BASSO_HAIRY_CELL_LEUKEMIA_DN
2.85714285714%	2	70	79	Diabetes_McGill_Adipocytokine_signallin	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
2.85714285714%	2	70	779	Diabetes_McGill_Adipocytokine_signallin	PUJANA_CHEK2_PCC_NETWORK
2.85714285714%	2	70	77	Diabetes_McGill_Adipocytokine_signallin	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
2.85714285714%	2	70	77	Diabetes_McGill_Adipocytokine_signallin	SEKI_INFLAMMATORY_RESPONSE_LPS_UP
2.85714285714%	2	70	77	Diabetes_McGill_Adipocytokine_signallin	GROSS_HYPOXIA_VIA_HIF1A_UP
2.85714285714%	2	70	76	Diabetes_McGill_Adipocytokine_signallin	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
2.85714285714%	2	70	756	Diabetes_McGill_Adipocytokine_signallin	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
2.85714285714%	2	70	75	Diabetes_McGill_Adipocytokine_signallin	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
2.85714285714%	2	70	747	Diabetes_McGill_Adipocytokine_signallin	PATIL_LIVER_CANCER
2.85714285714%	2	70	74	Diabetes_McGill_Adipocytokine_signallin	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
2.85714285714%	2	70	734	Diabetes_McGill_Adipocytokine_signallin	BENPORATH_SOX2_TARGETS
2.85714285714%	2	70	73	Diabetes_McGill_Adipocytokine_signallin	GAURNIER_PSMD4_TARGETS
2.85714285714%	2	70	72	Diabetes_McGill_Adipocytokine_signallin	DANG_REGULATED_BY_MYC_UP
2.85714285714%	2	70	69	Diabetes_McGill_Adipocytokine_signallin	REACTOME_GLUCOSE_METABOLISM
2.85714285714%	2	70	69	Diabetes_McGill_Adipocytokine_signallin	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
2.85714285714%	2	70	69	Diabetes_McGill_Adipocytokine_signallin	HOWLIN_PUBERTAL_MAMMARY_GLAND
2.85714285714%	2	70	68	Diabetes_McGill_Adipocytokine_signallin	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
2.85714285714%	2	70	68	Diabetes_McGill_Adipocytokine_signallin	SESTO_RESPONSE_TO_UV_C7
2.85714285714%	2	70	67	Diabetes_McGill_Adipocytokine_signallin	LINDSTEDT_DENDRITIC_CELL_MATURATION_A
2.85714285714%	2	70	67	Diabetes_McGill_Adipocytokine_signallin	ELVIDGE_HIF1A_TARGETS_UP
2.85714285714%	2	70	67	Diabetes_McGill_Adipocytokine_signallin	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70
2.85714285714%	2	70	663	Diabetes_McGill_Adipocytokine_signallin	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
2.85714285714%	2	70	66	Diabetes_McGill_Adipocytokine_signallin	TENEDINI_MEGAKARYOCYTE_MARKERS
2.85714285714%	2	70	66	Diabetes_McGill_Adipocytokine_signallin	LEE_LIVER_CANCER_CIPROFIBRATE_DN
2.85714285714%	2	70	65	Diabetes_McGill_Adipocytokine_signallin	LEE_LIVER_CANCER_MYC_TGFA_DN
2.85714285714%	2	70	648	Diabetes_McGill_Adipocytokine_signallin	SMID_BREAST_CANCER_BASAL_UP
2.85714285714%	2	70	637	Diabetes_McGill_Adipocytokine_signallin	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
2.85714285714%	2	70	633	Diabetes_McGill_Adipocytokine_signallin	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
2.85714285714%	2	70	63	Diabetes_McGill_Adipocytokine_signallin	REACTOME_INTERFERON_GAMMA_SIGNALING
2.85714285714%	2	70	63	Diabetes_McGill_Adipocytokine_signallin	LEE_LIVER_CANCER_MYC_DN
2.85714285714%	2	70	62	Diabetes_McGill_Adipocytokine_signallin	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
2.85714285714%	2	70	62	Diabetes_McGill_Adipocytokine_signallin	PID_TRKRPATHWAY
2.85714285714%	2	70	62	Diabetes_McGill_Adipocytokine_signallin	KYNG_DNA_DAMAGE_BY_UV
2.85714285714%	2	70	61	Diabetes_McGill_Adipocytokine_signallin	MASSARWEH_RESPONSE_TO_ESTRADIOL
2.85714285714%	2	70	60	Diabetes_McGill_Adipocytokine_signallin	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
2.85714285714%	2	70	60	Diabetes_McGill_Adipocytokine_signallin	LEE_LIVER_CANCER_CIPROFIBRATE_UP
2.85714285714%	2	70	6	Diabetes_McGill_Adipocytokine_signallin	CORRADETTI_MTOR_PATHWAY_REGULATORS_DN
2.85714285714%	2	70	59	Diabetes_McGill_Adipocytokine_signallin	PID_FAK_PATHWAY
2.85714285714%	2	70	59	Diabetes_McGill_Adipocytokine_signallin	BOYLAN_MULTIPLE_MYELOMA_C_DN
2.85714285714%	2	70	584	Diabetes_McGill_Adipocytokine_signallin	HAMAI_APOPTOSIS_VIA_TRAIL_UP
2.85714285714%	2	70	578	Diabetes_McGill_Adipocytokine_signallin	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
2.85714285714%	2	70	57	Diabetes_McGill_Adipocytokine_signallin	PID_TXA2PATHWAY
2.85714285714%	2	70	57	Diabetes_McGill_Adipocytokine_signallin	DIRMEIER_LMP1_RESPONSE_LATE_UP
2.85714285714%	2	70	567	Diabetes_McGill_Adipocytokine_signallin	CHICAS_RB1_TARGETS_CONFLUENT
2.85714285714%	2	70	566	Diabetes_McGill_Adipocytokine_signallin	DOUGLAS_BMI1_TARGETS_UP
2.85714285714%	2	70	56	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_30MIN_UP
2.85714285714%	2	70	56	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_NFAT_PATHWAY
2.85714285714%	2	70	552	Diabetes_McGill_Adipocytokine_signallin	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
2.85714285714%	2	70	55	Diabetes_McGill_Adipocytokine_signallin	PID_FGF_PATHWAY
2.85714285714%	2	70	55	Diabetes_McGill_Adipocytokine_signallin	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN
2.85714285714%	2	70	54	Diabetes_McGill_Adipocytokine_signallin	ZHOU_TNF_SIGNALING_4HR
2.85714285714%	2	70	54	Diabetes_McGill_Adipocytokine_signallin	PID_TAP63PATHWAY
2.85714285714%	2	70	54	Diabetes_McGill_Adipocytokine_signallin	MARSON_FOXP3_TARGETS_DN
2.85714285714%	2	70	539	Diabetes_McGill_Adipocytokine_signallin	LIAO_METASTASIS
2.85714285714%	2	70	537	Diabetes_McGill_Adipocytokine_signallin	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
2.85714285714%	2	70	536	Diabetes_McGill_Adipocytokine_signallin	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
2.85714285714%	2	70	535	Diabetes_McGill_Adipocytokine_signallin	STEIN_ESRRA_TARGETS
2.85714285714%	2	70	530	Diabetes_McGill_Adipocytokine_signallin	ENK_UV_RESPONSE_KERATINOCYTE_UP
2.85714285714%	2	70	53	Diabetes_McGill_Adipocytokine_signallin	LINDSTEDT_DENDRITIC_CELL_MATURATION_B
2.85714285714%	2	70	528	Diabetes_McGill_Adipocytokine_signallin	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
2.85714285714%	2	70	52	Diabetes_McGill_Adipocytokine_signallin	KEGG_STARCH_AND_SUCROSE_METABOLISM
2.85714285714%	2	70	518	Diabetes_McGill_Adipocytokine_signallin	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
2.85714285714%	2	70	517	Diabetes_McGill_Adipocytokine_signallin	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
2.85714285714%	2	70	516	Diabetes_McGill_Adipocytokine_signallin	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
2.85714285714%	2	70	514	Diabetes_McGill_Adipocytokine_signallin	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
2.85714285714%	2	70	51	Diabetes_McGill_Adipocytokine_signallin	GUILLAUMOND_KLF10_TARGETS_UP
2.85714285714%	2	70	51	Diabetes_McGill_Adipocytokine_signallin	BYSTROEM_CORRELATED_WITH_IL5_UP
2.85714285714%	2	70	504	Diabetes_McGill_Adipocytokine_signallin	PILON_KLF1_TARGETS_UP
2.85714285714%	2	70	50	Diabetes_McGill_Adipocytokine_signallin	HOFMANN_CELL_LYMPHOMA_UP
2.85714285714%	2	70	491	Diabetes_McGill_Adipocytokine_signallin	MEISSNER_NPC_HCP_WITH_H3K4ME2
2.85714285714%	2	70	49	Diabetes_McGill_Adipocytokine_signallin	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN
2.85714285714%	2	70	49	Diabetes_McGill_Adipocytokine_signallin	DAUER_STAT3_TARGETS_UP
2.85714285714%	2	70	487	Diabetes_McGill_Adipocytokine_signallin	RODWELL_AGING_KIDNEY_UP
2.85714285714%	2	70	483	Diabetes_McGill_Adipocytokine_signallin	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
2.85714285714%	2	70	482	Diabetes_McGill_Adipocytokine_signallin	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
2.85714285714%	2	70	48	Diabetes_McGill_Adipocytokine_signallin	PID_HES_HEYPATHWAY
2.85714285714%	2	70	48	Diabetes_McGill_Adipocytokine_signallin	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
2.85714285714%	2	70	48	Diabetes_McGill_Adipocytokine_signallin	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
2.85714285714%	2	70	47	Diabetes_McGill_Adipocytokine_signallin	PID_NFAT_TFPATHWAY
2.85714285714%	2	70	467	Diabetes_McGill_Adipocytokine_signallin	RATTENBACHER_BOUND_BY_CELF1
2.85714285714%	2	70	463	Diabetes_McGill_Adipocytokine_signallin	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
2.85714285714%	2	70	463	Diabetes_McGill_Adipocytokine_signallin	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
2.85714285714%	2	70	460	Diabetes_McGill_Adipocytokine_signallin	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
2.85714285714%	2	70	46	Diabetes_McGill_Adipocytokine_signallin	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6
2.85714285714%	2	70	46	Diabetes_McGill_Adipocytokine_signallin	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN
2.85714285714%	2	70	448	Diabetes_McGill_Adipocytokine_signallin	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
2.85714285714%	2	70	443	Diabetes_McGill_Adipocytokine_signallin	DELYS_THYROID_CANCER_UP
2.85714285714%	2	70	44	Diabetes_McGill_Adipocytokine_signallin	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS
2.85714285714%	2	70	430	Diabetes_McGill_Adipocytokine_signallin	RIGGI_EWING_SARCOMA_PROGENITOR_UP
2.85714285714%	2	70	43	Diabetes_McGill_Adipocytokine_signallin	PID_CXCR3PATHWAY
2.85714285714%	2	70	43	Diabetes_McGill_Adipocytokine_signallin	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
2.85714285714%	2	70	43	Diabetes_McGill_Adipocytokine_signallin	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
2.85714285714%	2	70	428	Diabetes_McGill_Adipocytokine_signallin	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
2.85714285714%	2	70	428	Diabetes_McGill_Adipocytokine_signallin	LIM_MAMMARY_STEM_CELL_DN
2.85714285714%	2	70	424	Diabetes_McGill_Adipocytokine_signallin	SHEN_SMARCA2_TARGETS_UP
2.85714285714%	2	70	42	Diabetes_McGill_Adipocytokine_signallin	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
2.85714285714%	2	70	42	Diabetes_McGill_Adipocytokine_signallin	MIKKELSEN_ES_ICP_WITH_H3K27ME3
2.85714285714%	2	70	419	Diabetes_McGill_Adipocytokine_signallin	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
2.85714285714%	2	70	418	Diabetes_McGill_Adipocytokine_signallin	PEDRIOLI_MIR31_TARGETS_DN
2.85714285714%	2	70	414	Diabetes_McGill_Adipocytokine_signallin	MOHANKUMAR_TLX1_TARGETS_UP
2.85714285714%	2	70	408	Diabetes_McGill_Adipocytokine_signallin	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
2.85714285714%	2	70	408	Diabetes_McGill_Adipocytokine_signallin	REACTOME_GPCR_LIGAND_BINDING
2.85714285714%	2	70	405	Diabetes_McGill_Adipocytokine_signallin	KUMAR_TARGETS_OF_MLL_AF9_FUSION
2.85714285714%	2	70	40	Diabetes_McGill_Adipocytokine_signallin	VARELA_ZMPSTE24_TARGETS_UP
2.85714285714%	2	70	40	Diabetes_McGill_Adipocytokine_signallin	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP
2.85714285714%	2	70	40	Diabetes_McGill_Adipocytokine_signallin	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN
2.85714285714%	2	70	40	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_P38MAPK_PATHWAY
2.85714285714%	2	70	398	Diabetes_McGill_Adipocytokine_signallin	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
2.85714285714%	2	70	397	Diabetes_McGill_Adipocytokine_signallin	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
2.85714285714%	2	70	390	Diabetes_McGill_Adipocytokine_signallin	HATADA_METHYLATED_IN_LUNG_CANCER_UP
2.85714285714%	2	70	39	Diabetes_McGill_Adipocytokine_signallin	HOFMANN_CELL_LYMPHOMA_DN
2.85714285714%	2	70	389	Diabetes_McGill_Adipocytokine_signallin	HSIAO_HOUSEKEEPING_GENES
2.85714285714%	2	70	388	Diabetes_McGill_Adipocytokine_signallin	STEIN_ESRRA_TARGETS_UP
2.85714285714%	2	70	387	Diabetes_McGill_Adipocytokine_signallin	CHYLA_CBFA2T3_TARGETS_UP
2.85714285714%	2	70	382	Diabetes_McGill_Adipocytokine_signallin	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
2.85714285714%	2	70	380	Diabetes_McGill_Adipocytokine_signallin	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
2.85714285714%	2	70	38	Diabetes_McGill_Adipocytokine_signallin	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
2.85714285714%	2	70	38	Diabetes_McGill_Adipocytokine_signallin	KYNG_DNA_DAMAGE_BY_4NQO
2.85714285714%	2	70	38	Diabetes_McGill_Adipocytokine_signallin	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP
2.85714285714%	2	70	38	Diabetes_McGill_Adipocytokine_signallin	GEISS_RESPONSE_TO_DSRNA_UP
2.85714285714%	2	70	374	Diabetes_McGill_Adipocytokine_signallin	WANG_TUMOR_INVASIVENESS_UP
2.85714285714%	2	70	37	Diabetes_McGill_Adipocytokine_signallin	ST_P38_MAPK_PATHWAY
2.85714285714%	2	70	368	Diabetes_McGill_Adipocytokine_signallin	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
2.85714285714%	2	70	36	Diabetes_McGill_Adipocytokine_signallin	ST_ADRENERGIC
2.85714285714%	2	70	36	Diabetes_McGill_Adipocytokine_signallin	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
2.85714285714%	2	70	355	Diabetes_McGill_Adipocytokine_signallin	PEREZ_TP63_TARGETS
2.85714285714%	2	70	353	Diabetes_McGill_Adipocytokine_signallin	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
2.85714285714%	2	70	351	Diabetes_McGill_Adipocytokine_signallin	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
2.85714285714%	2	70	35	Diabetes_McGill_Adipocytokine_signallin	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
2.85714285714%	2	70	35	Diabetes_McGill_Adipocytokine_signallin	KEGG_REGULATION_OF_AUTOPHAGY
2.85714285714%	2	70	35	Diabetes_McGill_Adipocytokine_signallin	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP
2.85714285714%	2	70	341	Diabetes_McGill_Adipocytokine_signallin	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
2.85714285714%	2	70	34	Diabetes_McGill_Adipocytokine_signallin	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP
2.85714285714%	2	70	34	Diabetes_McGill_Adipocytokine_signallin	REACTOME_GLUCONEOGENESIS
2.85714285714%	2	70	34	Diabetes_McGill_Adipocytokine_signallin	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP
2.85714285714%	2	70	336	Diabetes_McGill_Adipocytokine_signallin	JOHNSTONE_PARVB_TARGETS_2_DN
2.85714285714%	2	70	33	Diabetes_McGill_Adipocytokine_signallin	PID_NCADHERINPATHWAY
2.85714285714%	2	70	33	Diabetes_McGill_Adipocytokine_signallin	DUTTA_APOPTOSIS_VIA_NFKB
2.85714285714%	2	70	329	Diabetes_McGill_Adipocytokine_signallin	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
2.85714285714%	2	70	324	Diabetes_McGill_Adipocytokine_signallin	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
2.85714285714%	2	70	32	Diabetes_McGill_Adipocytokine_signallin	MOOTHA_GLUCONEOGENESIS
2.85714285714%	2	70	32	Diabetes_McGill_Adipocytokine_signallin	KEGG_CITRATE_CYCLE_TCA_CYCLE
2.85714285714%	2	70	32	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_PDGF_PATHWAY
2.85714285714%	2	70	318	Diabetes_McGill_Adipocytokine_signallin	DAZARD_RESPONSE_TO_UV_NHEK_DN
2.85714285714%	2	70	317	Diabetes_McGill_Adipocytokine_signallin	HELLER_HDAC_TARGETS_UP
2.85714285714%	2	70	316	Diabetes_McGill_Adipocytokine_signallin	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
2.85714285714%	2	70	315	Diabetes_McGill_Adipocytokine_signallin	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
2.85714285714%	2	70	311	Diabetes_McGill_Adipocytokine_signallin	JIANG_HYPOXIA_NORMAL
2.85714285714%	2	70	31	Diabetes_McGill_Adipocytokine_signallin	PID_AURORA_A_PATHWAY
2.85714285714%	2	70	31	Diabetes_McGill_Adipocytokine_signallin	HUNSBERGER_EXERCISE_REGULATED_GENES
2.85714285714%	2	70	31	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_EGF_PATHWAY
2.85714285714%	2	70	309	Diabetes_McGill_Adipocytokine_signallin	LIU_SOX4_TARGETS_DN
2.85714285714%	2	70	307	Diabetes_McGill_Adipocytokine_signallin	LI_INDUCED_T_TO_NATURAL_KILLER_UP
2.85714285714%	2	70	306	Diabetes_McGill_Adipocytokine_signallin	HORIUCHI_WTAP_TARGETS_UP
2.85714285714%	2	70	305	Diabetes_McGill_Adipocytokine_signallin	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
2.85714285714%	2	70	305	Diabetes_McGill_Adipocytokine_signallin	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
2.85714285714%	2	70	30	Diabetes_McGill_Adipocytokine_signallin	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
2.85714285714%	2	70	299	Diabetes_McGill_Adipocytokine_signallin	WALLACE_PROSTATE_CANCER_RACE_UP
2.85714285714%	2	70	298	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_14HR_DN
2.85714285714%	2	70	298	Diabetes_McGill_Adipocytokine_signallin	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
2.85714285714%	2	70	295	Diabetes_McGill_Adipocytokine_signallin	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
2.85714285714%	2	70	294	Diabetes_McGill_Adipocytokine_signallin	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
2.85714285714%	2	70	293	Diabetes_McGill_Adipocytokine_signallin	IVANOVA_HEMATOPOIESIS_MATURE_CELL
2.85714285714%	2	70	293	Diabetes_McGill_Adipocytokine_signallin	HADDAD_B_LYMPHOCYTE_PROGENITOR
2.85714285714%	2	70	290	Diabetes_McGill_Adipocytokine_signallin	BENPORATH_OCT4_TARGETS
2.85714285714%	2	70	29	Diabetes_McGill_Adipocytokine_signallin	WANG_RESPONSE_TO_ANDROGEN_UP
2.85714285714%	2	70	29	Diabetes_McGill_Adipocytokine_signallin	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR
2.85714285714%	2	70	29	Diabetes_McGill_Adipocytokine_signallin	PID_REELINPATHWAY
2.85714285714%	2	70	29	Diabetes_McGill_Adipocytokine_signallin	MARSHALL_VIRAL_INFECTION_RESPONSE_DN
2.85714285714%	2	70	289	Diabetes_McGill_Adipocytokine_signallin	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
2.85714285714%	2	70	281	Diabetes_McGill_Adipocytokine_signallin	BHAT_ESR1_TARGETS_VIA_AKT1_UP
2.85714285714%	2	70	280	Diabetes_McGill_Adipocytokine_signallin	WANG_SMARCE1_TARGETS_UP
2.85714285714%	2	70	276	Diabetes_McGill_Adipocytokine_signallin	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
2.85714285714%	2	70	275	Diabetes_McGill_Adipocytokine_signallin	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
2.85714285714%	2	70	272	Diabetes_McGill_Adipocytokine_signallin	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
2.85714285714%	2	70	271	Diabetes_McGill_Adipocytokine_signallin	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
2.85714285714%	2	70	271	Diabetes_McGill_Adipocytokine_signallin	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
2.85714285714%	2	70	27	Diabetes_McGill_Adipocytokine_signallin	PID_IL3_PATHWAY
2.85714285714%	2	70	269	Diabetes_McGill_Adipocytokine_signallin	WANG_CLIM2_TARGETS_UP
2.85714285714%	2	70	262	Diabetes_McGill_Adipocytokine_signallin	LU_AGING_BRAIN_UP
2.85714285714%	2	70	261	Diabetes_McGill_Adipocytokine_signallin	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
2.85714285714%	2	70	260	Diabetes_McGill_Adipocytokine_signallin	BOQUEST_STEM_CELL_UP
2.85714285714%	2	70	26	Diabetes_McGill_Adipocytokine_signallin	WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG
2.85714285714%	2	70	26	Diabetes_McGill_Adipocytokine_signallin	PID_VEGFR1_PATHWAY
2.85714285714%	2	70	26	Diabetes_McGill_Adipocytokine_signallin	KEGG_GALACTOSE_METABOLISM
2.85714285714%	2	70	258	Diabetes_McGill_Adipocytokine_signallin	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
2.85714285714%	2	70	251	Diabetes_McGill_Adipocytokine_signallin	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
2.85714285714%	2	70	250	Diabetes_McGill_Adipocytokine_signallin	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
2.85714285714%	2	70	25	Diabetes_McGill_Adipocytokine_signallin	RUAN_RESPONSE_TO_TROGLITAZONE_UP
2.85714285714%	2	70	249	Diabetes_McGill_Adipocytokine_signallin	MITSIADES_RESPONSE_TO_APLIDIN_DN
2.85714285714%	2	70	246	Diabetes_McGill_Adipocytokine_signallin	BILD_E2F3_ONCOGENIC_SIGNATURE
2.85714285714%	2	70	245	Diabetes_McGill_Adipocytokine_signallin	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
2.85714285714%	2	70	245	Diabetes_McGill_Adipocytokine_signallin	MCLACHLAN_DENTAL_CARIES_DN
2.85714285714%	2	70	245	Diabetes_McGill_Adipocytokine_signallin	BLUM_RESPONSE_TO_SALIRASIB_UP
2.85714285714%	2	70	244	Diabetes_McGill_Adipocytokine_signallin	PLASARI_TGFB1_TARGETS_10HR_DN
2.85714285714%	2	70	241	Diabetes_McGill_Adipocytokine_signallin	DOANE_RESPONSE_TO_ANDROGEN_DN
2.85714285714%	2	70	240	Diabetes_McGill_Adipocytokine_signallin	VANTVEER_BREAST_CANCER_ESR1_DN
2.85714285714%	2	70	24	Diabetes_McGill_Adipocytokine_signallin	REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION
2.85714285714%	2	70	24	Diabetes_McGill_Adipocytokine_signallin	PID_S1P_S1P2_PATHWAY
2.85714285714%	2	70	24	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_TPO_PATHWAY
2.85714285714%	2	70	24	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_CXCR4_PATHWAY
2.85714285714%	2	70	234	Diabetes_McGill_Adipocytokine_signallin	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
2.85714285714%	2	70	230	Diabetes_McGill_Adipocytokine_signallin	BENPORATH_MYC_TARGETS_WITH_EBOX
2.85714285714%	2	70	23	Diabetes_McGill_Adipocytokine_signallin	WANG_RESPONSE_TO_FORSKOLIN_UP
2.85714285714%	2	70	23	Diabetes_McGill_Adipocytokine_signallin	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION
2.85714285714%	2	70	23	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_MTOR_PATHWAY
2.85714285714%	2	70	23	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_IL12_PATHWAY
2.85714285714%	2	70	23	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_IGF1R_PATHWAY
2.85714285714%	2	70	229	Diabetes_McGill_Adipocytokine_signallin	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
2.85714285714%	2	70	228	Diabetes_McGill_Adipocytokine_signallin	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
2.85714285714%	2	70	227	Diabetes_McGill_Adipocytokine_signallin	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
2.85714285714%	2	70	226	Diabetes_McGill_Adipocytokine_signallin	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
2.85714285714%	2	70	223	Diabetes_McGill_Adipocytokine_signallin	CHEN_HOXA5_TARGETS_9HR_UP
2.85714285714%	2	70	22	Diabetes_McGill_Adipocytokine_signallin	MOOTHA_FFA_OXYDATION
2.85714285714%	2	70	22	Diabetes_McGill_Adipocytokine_signallin	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER
2.85714285714%	2	70	217	Diabetes_McGill_Adipocytokine_signallin	WONG_MITOCHONDRIA_GENE_MODULE
2.85714285714%	2	70	217	Diabetes_McGill_Adipocytokine_signallin	AMUNDSON_RESPONSE_TO_ARSENITE
2.85714285714%	2	70	214	Diabetes_McGill_Adipocytokine_signallin	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
2.85714285714%	2	70	214	Diabetes_McGill_Adipocytokine_signallin	AFFAR_YY1_TARGETS_UP
2.85714285714%	2	70	211	Diabetes_McGill_Adipocytokine_signallin	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
2.85714285714%	2	70	210	Diabetes_McGill_Adipocytokine_signallin	VERHAAK_GLIOBLASTOMA_NEURAL
2.85714285714%	2	70	21	Diabetes_McGill_Adipocytokine_signallin	SCHURINGA_STAT5A_TARGETS_UP
2.85714285714%	2	70	21	Diabetes_McGill_Adipocytokine_signallin	PID_ECADHERIN_KERATINOCYTE_PATHWAY
2.85714285714%	2	70	21	Diabetes_McGill_Adipocytokine_signallin	CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP
2.85714285714%	2	70	209	Diabetes_McGill_Adipocytokine_signallin	KIM_WT1_TARGETS_12HR_DN
2.85714285714%	2	70	209	Diabetes_McGill_Adipocytokine_signallin	GROSS_HYPOXIA_VIA_ELK3_UP
2.85714285714%	2	70	208	Diabetes_McGill_Adipocytokine_signallin	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
2.85714285714%	2	70	207	Diabetes_McGill_Adipocytokine_signallin	KARLSSON_TGFB1_TARGETS_DN
2.85714285714%	2	70	205	Diabetes_McGill_Adipocytokine_signallin	SHEPARD_BMYB_MORPHOLINO_UP
2.85714285714%	2	70	203	Diabetes_McGill_Adipocytokine_signallin	PAL_PRMT5_TARGETS_UP
2.85714285714%	2	70	203	Diabetes_McGill_Adipocytokine_signallin	GRUETZMANN_PANCREATIC_CANCER_DN
2.85714285714%	2	70	20	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_IGF1MTOR_PATHWAY
2.85714285714%	2	70	196	Diabetes_McGill_Adipocytokine_signallin	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
2.85714285714%	2	70	195	Diabetes_McGill_Adipocytokine_signallin	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
2.85714285714%	2	70	19	Diabetes_McGill_Adipocytokine_signallin	RASHI_NFKB1_TARGETS
2.85714285714%	2	70	19	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_EPO_PATHWAY
2.85714285714%	2	70	189	Diabetes_McGill_Adipocytokine_signallin	BURTON_ADIPOGENESIS_6
2.85714285714%	2	70	188	Diabetes_McGill_Adipocytokine_signallin	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
2.85714285714%	2	70	187	Diabetes_McGill_Adipocytokine_signallin	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
2.85714285714%	2	70	184	Diabetes_McGill_Adipocytokine_signallin	DOANE_RESPONSE_TO_ANDROGEN_UP
2.85714285714%	2	70	183	Diabetes_McGill_Adipocytokine_signallin	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
2.85714285714%	2	70	182	Diabetes_McGill_Adipocytokine_signallin	RAO_BOUND_BY_SALL4_ISOFORM_A
2.85714285714%	2	70	181	Diabetes_McGill_Adipocytokine_signallin	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
2.85714285714%	2	70	181	Diabetes_McGill_Adipocytokine_signallin	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
2.85714285714%	2	70	18	Diabetes_McGill_Adipocytokine_signallin	SHIN_B_CELL_LYMPHOMA_CLUSTER_5
2.85714285714%	2	70	18	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_CARDIACEGF_PATHWAY
2.85714285714%	2	70	179	Diabetes_McGill_Adipocytokine_signallin	BENPORATH_NOS_TARGETS
2.85714285714%	2	70	177	Diabetes_McGill_Adipocytokine_signallin	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
2.85714285714%	2	70	176	Diabetes_McGill_Adipocytokine_signallin	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
2.85714285714%	2	70	174	Diabetes_McGill_Adipocytokine_signallin	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
2.85714285714%	2	70	1725	Diabetes_McGill_Adipocytokine_signallin	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
2.85714285714%	2	70	170	Diabetes_McGill_Adipocytokine_signallin	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
2.85714285714%	2	70	17	Diabetes_McGill_Adipocytokine_signallin	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS
2.85714285714%	2	70	17	Diabetes_McGill_Adipocytokine_signallin	PID_SYNDECAN_3_PATHWAY
2.85714285714%	2	70	17	Diabetes_McGill_Adipocytokine_signallin	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
2.85714285714%	2	70	17	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_IL10_PATHWAY
2.85714285714%	2	70	169	Diabetes_McGill_Adipocytokine_signallin	KEGG_ALZHEIMERS_DISEASE
2.85714285714%	2	70	166	Diabetes_McGill_Adipocytokine_signallin	SMIRNOV_RESPONSE_TO_IR_6HR_UP
2.85714285714%	2	70	165	Diabetes_McGill_Adipocytokine_signallin	BROWN_MYELOID_CELL_DEVELOPMENT_UP
2.85714285714%	2	70	162	Diabetes_McGill_Adipocytokine_signallin	MULLIGHAN_NPM1_SIGNATURE_3_DN
2.85714285714%	2	70	16	Diabetes_McGill_Adipocytokine_signallin	KANG_FLUOROURACIL_RESISTANCE_DN
2.85714285714%	2	70	16	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_CACAM_PATHWAY
2.85714285714%	2	70	16	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_BCELLSURVIVAL_PATHWAY
2.85714285714%	2	70	159	Diabetes_McGill_Adipocytokine_signallin	REACTOME_INTERFERON_SIGNALING
2.85714285714%	2	70	159	Diabetes_McGill_Adipocytokine_signallin	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
2.85714285714%	2	70	157	Diabetes_McGill_Adipocytokine_signallin	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
2.85714285714%	2	70	157	Diabetes_McGill_Adipocytokine_signallin	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
2.85714285714%	2	70	156	Diabetes_McGill_Adipocytokine_signallin	FOSTER_TOLERANT_MACROPHAGE_UP
2.85714285714%	2	70	153	Diabetes_McGill_Adipocytokine_signallin	LU_AGING_BRAIN_DN
2.85714285714%	2	70	153	Diabetes_McGill_Adipocytokine_signallin	DAZARD_UV_RESPONSE_CLUSTER_G6
2.85714285714%	2	70	151	Diabetes_McGill_Adipocytokine_signallin	IGLESIAS_E2F_TARGETS_UP
2.85714285714%	2	70	151	Diabetes_McGill_Adipocytokine_signallin	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
2.85714285714%	2	70	150	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_30MIN_DN
2.85714285714%	2	70	15	Diabetes_McGill_Adipocytokine_signallin	SANDERSON_PPARA_TARGETS
2.85714285714%	2	70	15	Diabetes_McGill_Adipocytokine_signallin	HUMMEL_BURKITTS_LYMPHOMA_DN
2.85714285714%	2	70	146	Diabetes_McGill_Adipocytokine_signallin	ELVIDGE_HYPOXIA_DN
2.85714285714%	2	70	145	Diabetes_McGill_Adipocytokine_signallin	SMITH_TERT_TARGETS_UP
2.85714285714%	2	70	145	Diabetes_McGill_Adipocytokine_signallin	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
2.85714285714%	2	70	142	Diabetes_McGill_Adipocytokine_signallin	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
2.85714285714%	2	70	141	Diabetes_McGill_Adipocytokine_signallin	WELCSH_BRCA1_TARGETS_DN
2.85714285714%	2	70	140	Diabetes_McGill_Adipocytokine_signallin	QI_HYPOXIA
2.85714285714%	2	70	14	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SOS_MEDIATED_SIGNALLING
2.85714285714%	2	70	14	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SIGNAL_ATTENUATION
2.85714285714%	2	70	14	Diabetes_McGill_Adipocytokine_signallin	REACTOME_REGULATION_OF_IFNG_SIGNALING
2.85714285714%	2	70	14	Diabetes_McGill_Adipocytokine_signallin	PID_IL5_PATHWAY
2.85714285714%	2	70	139	Diabetes_McGill_Adipocytokine_signallin	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
2.85714285714%	2	70	138	Diabetes_McGill_Adipocytokine_signallin	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
2.85714285714%	2	70	138	Diabetes_McGill_Adipocytokine_signallin	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
2.85714285714%	2	70	137	Diabetes_McGill_Adipocytokine_signallin	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
2.85714285714%	2	70	13	Diabetes_McGill_Adipocytokine_signallin	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
2.85714285714%	2	70	128	Diabetes_McGill_Adipocytokine_signallin	POTTI_TOPOTECAN_SENSITIVITY
2.85714285714%	2	70	128	Diabetes_McGill_Adipocytokine_signallin	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
2.85714285714%	2	70	128	Diabetes_McGill_Adipocytokine_signallin	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
2.85714285714%	2	70	121	Diabetes_McGill_Adipocytokine_signallin	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
2.85714285714%	2	70	121	Diabetes_McGill_Adipocytokine_signallin	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
2.85714285714%	2	70	120	Diabetes_McGill_Adipocytokine_signallin	ZHU_CMV_ALL_UP
2.85714285714%	2	70	12	Diabetes_McGill_Adipocytokine_signallin	REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS
2.85714285714%	2	70	116	Diabetes_McGill_Adipocytokine_signallin	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
2.85714285714%	2	70	116	Diabetes_McGill_Adipocytokine_signallin	IKEDA_MIR30_TARGETS_UP
2.85714285714%	2	70	115	Diabetes_McGill_Adipocytokine_signallin	MARZEC_IL2_SIGNALING_UP
2.85714285714%	2	70	113	Diabetes_McGill_Adipocytokine_signallin	RICKMAN_HEAD_AND_NECK_CANCER_C
2.85714285714%	2	70	110	Diabetes_McGill_Adipocytokine_signallin	GROSS_HYPOXIA_VIA_HIF1A_DN
2.85714285714%	2	70	11	Diabetes_McGill_Adipocytokine_signallin	ST_STAT3_PATHWAY
2.85714285714%	2	70	11	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_IL4_PATHWAY
2.85714285714%	2	70	107	Diabetes_McGill_Adipocytokine_signallin	SESTO_RESPONSE_TO_UV_C0
2.85714285714%	2	70	104	Diabetes_McGill_Adipocytokine_signallin	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
2.85714285714%	2	70	103	Diabetes_McGill_Adipocytokine_signallin	LEIN_CHOROID_PLEXUS_MARKERS
2.85714285714%	2	70	103	Diabetes_McGill_Adipocytokine_signallin	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
2.85714285714%	2	70	103	Diabetes_McGill_Adipocytokine_signallin	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
2.85714285714%	2	70	1024	Diabetes_McGill_Adipocytokine_signallin	NUYTTEN_EZH2_TARGETS_DN
2.85714285714%	2	70	101	Diabetes_McGill_Adipocytokine_signallin	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
2.85714285714%	2	70	101	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_12HR_DN
2.85714285714%	2	70	100	Diabetes_McGill_Adipocytokine_signallin	WINZEN_DEGRADED_VIA_KHSRP
2.85714285714%	2	70	100	Diabetes_McGill_Adipocytokine_signallin	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
2.85714285714%	2	70	100	Diabetes_McGill_Adipocytokine_signallin	GAVIN_FOXP3_TARGETS_CLUSTER_P4
2.85714285714%	2	70	10	Diabetes_McGill_Adipocytokine_signallin	TSUDA_ALVEOLAR_SOFT_PART_SARCOMA
2.85714285714%	2	70	10	Diabetes_McGill_Adipocytokine_signallin	MATZUK_PREOVULATORY_FOLLICLE
2.85714285714%	13	455	612	T2D_GENES_TANYA_BLOODPRESSURE	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
2.85714285714%	13	455	590	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
2.85714285714%	13	455	566	T2D_GENES_TANYA_BLOODPRESSURE	DOUGLAS_BMI1_TARGETS_UP
2.85714285714%	13	455	539	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
2.85714285714%	13	455	530	T2D_GENES_TANYA_BLOODPRESSURE	ENK_UV_RESPONSE_KERATINOCYTE_UP
2.85714285714%	13	455	482	T2D_GENES_TANYA_BLOODPRESSURE	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
2.85714285714%	13	455	481	T2D_GENES_TANYA_BLOODPRESSURE	LIU_PROSTATE_CANCER_DN
2.85714285714%	13	455	478	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
2.85714285714%	13	455	463	T2D_GENES_TANYA_BLOODPRESSURE	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
2.85714285714%	13	455	462	T2D_GENES_TANYA_BLOODPRESSURE	DELACROIX_RAR_BOUND_ES
2.85714285714%	13	455	457	T2D_GENES_TANYA_BLOODPRESSURE	SENESE_HDAC1_TARGETS_UP
2.85714285714%	13	455	420	T2D_GENES_TANYA_BLOODPRESSURE	MOOTHA_PGC
2.85714285714%	13	455	419	T2D_GENES_TANYA_BLOODPRESSURE	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
2.85714285714%	13	455	403	T2D_GENES_TANYA_BLOODPRESSURE	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
2.85714285714%	13	455	374	T2D_GENES_TANYA_BLOODPRESSURE	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
2.85714285714%	13	455	355	T2D_GENES_TANYA_BLOODPRESSURE	PEREZ_TP63_TARGETS
2.85714285714%	13	455	341	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
2.85714285714%	13	455	267	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_MAPK_SIGNALING_PATHWAY
2.85714285714%	13	455	132	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
2.85188592456%	62	2174	602	T2D_GENES_TANYA_LIPIDS	MARTINEZ_TP53_TARGETS_UP
2.85188592456%	62	2174	601	T2D_GENES_TANYA_LIPIDS	MARTINEZ_RB1_AND_TP53_TARGETS_UP
2.85188592456%	62	2174	590	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
2.85188592456%	62	2174	549	T2D_GENES_TANYA_LIPIDS	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
2.85188592456%	62	2174	514	T2D_GENES_TANYA_LIPIDS	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
2.85188592456%	62	2174	487	T2D_GENES_TANYA_LIPIDS	RODWELL_AGING_KIDNEY_UP
2.85188592456%	62	2174	450	T2D_GENES_TANYA_LIPIDS	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
2.83960092095%	37	1303	1118	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BENPORATH_ES_WITH_H3K27ME3
2.83687943262%	56	1974	390	Mendelian_Nancy_Cox	HATADA_METHYLATED_IN_LUNG_CANCER_UP
2.83687943262%	56	1974	380	Mendelian_Nancy_Cox	MULLIGHAN_MLL_SIGNATURE_1_UP
2.83687943262%	56	1974	374	Mendelian_Nancy_Cox	WANG_TUMOR_INVASIVENESS_UP
2.83687943262%	56	1974	289	Mendelian_Nancy_Cox	WANG_MLL_TARGETS
2.83687943262%	56	1974	267	Mendelian_Nancy_Cox	KEGG_MAPK_SIGNALING_PATHWAY
2.83687943262%	56	1974	262	Mendelian_Nancy_Cox	LU_AGING_BRAIN_UP
2.83687943262%	36	1269	953	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
2.83687943262%	36	1269	1210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHEN_METABOLIC_SYNDROM_NETWORK
2.83270978087%	53	1871	549	T2D_GENES_TANYA_HEIGHT	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
2.83270978087%	53	1871	539	T2D_GENES_TANYA_HEIGHT	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
2.83270978087%	53	1871	476	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_NORMAL_LIKE_UP
2.83270978087%	53	1871	466	T2D_GENES_TANYA_HEIGHT	REACTOME_HEMOSTASIS
2.83270978087%	53	1871	463	T2D_GENES_TANYA_HEIGHT	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
2.83270978087%	53	1871	395	T2D_GENES_TANYA_HEIGHT	HAN_SATB1_TARGETS_UP
2.82292557742%	33	1169	893	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GEORGES_TARGETS_OF_MIR192_AND_MIR215
2.8125%	99	3520	953	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
2.8125%	99	3520	863	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
2.8125%	99	3520	682	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FEVR_CTNNB1_TARGETS_UP
2.80588776449%	61	2174	940	T2D_GENES_TANYA_LIPIDS	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
2.78622087133%	55	1974	403	Mendelian_Nancy_Cox	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
2.78622087133%	55	1974	391	Mendelian_Nancy_Cox	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
2.78622087133%	55	1974	364	Mendelian_Nancy_Cox	YANG_BCL3_TARGETS_UP
2.78622087133%	55	1974	337	Mendelian_Nancy_Cox	PENG_GLUTAMINE_DEPRIVATION_DN
2.78622087133%	55	1974	330	Mendelian_Nancy_Cox	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
2.78622087133%	55	1974	269	Mendelian_Nancy_Cox	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
2.78622087133%	55	1974	261	Mendelian_Nancy_Cox	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
2.78622087133%	55	1974	121	Mendelian_Nancy_Cox	KEGG_LYSOSOME
2.77926242651%	52	1871	536	T2D_GENES_TANYA_HEIGHT	BERENJENO_TRANSFORMED_BY_RHOA_UP
2.77926242651%	52	1871	532	T2D_GENES_TANYA_HEIGHT	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
2.77926242651%	52	1871	460	T2D_GENES_TANYA_HEIGHT	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
2.77926242651%	52	1871	428	T2D_GENES_TANYA_HEIGHT	CUI_TCF21_TARGETS_2_UP
2.77324632953%	17	613	811	T2D_GENES_TANYA_BIOMARKER	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
2.77324632953%	17	613	769	T2D_GENES_TANYA_BIOMARKER	NUYTTEN_NIPP1_TARGETS_UP
2.77324632953%	17	613	722	T2D_GENES_TANYA_BIOMARKER	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
2.77324632953%	17	613	601	T2D_GENES_TANYA_BIOMARKER	MARTINEZ_RB1_AND_TP53_TARGETS_UP
2.77324632953%	17	613	584	T2D_GENES_TANYA_BIOMARKER	HAMAI_APOPTOSIS_VIA_TRAIL_UP
2.77324632953%	17	613	572	T2D_GENES_TANYA_BIOMARKER	CHICAS_RB1_TARGETS_SENESCENT
2.77324632953%	17	613	546	T2D_GENES_TANYA_BIOMARKER	WEST_ADRENOCORTICAL_TUMOR_DN
2.77324632953%	17	613	535	T2D_GENES_TANYA_BIOMARKER	STEIN_ESRRA_TARGETS
2.77324632953%	17	613	501	T2D_GENES_TANYA_BIOMARKER	SENESE_HDAC3_TARGETS_UP
2.77324632953%	17	613	487	T2D_GENES_TANYA_BIOMARKER	RODWELL_AGING_KIDNEY_UP
2.77324632953%	17	613	463	T2D_GENES_TANYA_BIOMARKER	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
2.77324632953%	17	613	456	T2D_GENES_TANYA_BIOMARKER	ODONNELL_TFRC_TARGETS_UP
2.77324632953%	17	613	423	T2D_GENES_TANYA_BIOMARKER	THUM_SYSTOLIC_HEART_FAILURE_UP
2.77324632953%	17	613	378	T2D_GENES_TANYA_BIOMARKER	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
2.77324632953%	17	613	374	T2D_GENES_TANYA_BIOMARKER	WANG_TUMOR_INVASIVENESS_UP
2.77008310249%	10	361	811	T2D_GENES_TANYA_T2D_RSQ05_02CM	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
2.77008310249%	10	361	783	T2D_GENES_TANYA_T2D_RSQ05_02CM	ONKEN_UVEAL_MELANOMA_UP
2.77008310249%	10	361	781	T2D_GENES_TANYA_T2D_RSQ05_02CM	GOZGIT_ESR1_TARGETS_DN
2.77008310249%	10	361	633	T2D_GENES_TANYA_T2D_RSQ05_02CM	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
2.77008310249%	10	361	566	T2D_GENES_TANYA_T2D_RSQ05_02CM	DOUGLAS_BMI1_TARGETS_UP
2.77008310249%	10	361	539	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIAO_METASTASIS
2.77008310249%	10	361	537	T2D_GENES_TANYA_T2D_RSQ05_02CM	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
2.77008310249%	10	361	518	T2D_GENES_TANYA_T2D_RSQ05_02CM	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
2.77008310249%	10	361	505	T2D_GENES_TANYA_T2D_RSQ05_02CM	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
2.77008310249%	10	361	491	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHENG_BOUND_BY_FOXP3
2.77008310249%	10	361	414	T2D_GENES_TANYA_T2D_RSQ05_02CM	MOHANKUMAR_TLX1_TARGETS_UP
2.77008310249%	10	361	1237	T2D_GENES_TANYA_T2D_RSQ05_02CM	BLALOCK_ALZHEIMERS_DISEASE_DN
2.77008310249%	10	361	1103	T2D_GENES_TANYA_T2D_RSQ05_02CM	DANG_BOUND_BY_MYC
2.77008310249%	10	361	1080	T2D_GENES_TANYA_T2D_RSQ05_02CM	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
2.76752767528%	15	542	882	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_BMP2_TARGETS_DN
2.76752767528%	15	542	863	T2D_GENES_TANYA_ANTHROPOMETRIC	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
2.76752767528%	15	542	770	T2D_GENES_TANYA_ANTHROPOMETRIC	KRIEG_HYPOXIA_NOT_VIA_KDM3A
2.76752767528%	15	542	734	T2D_GENES_TANYA_ANTHROPOMETRIC	BENPORATH_SOX2_TARGETS
2.76752767528%	15	542	648	T2D_GENES_TANYA_ANTHROPOMETRIC	SMID_BREAST_CANCER_BASAL_UP
2.76752767528%	15	542	633	T2D_GENES_TANYA_ANTHROPOMETRIC	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
2.76752767528%	15	542	549	T2D_GENES_TANYA_ANTHROPOMETRIC	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
2.76752767528%	15	542	543	T2D_GENES_TANYA_ANTHROPOMETRIC	MARTINEZ_RB1_TARGETS_DN
2.76752767528%	15	542	535	T2D_GENES_TANYA_ANTHROPOMETRIC	STEIN_ESRRA_TARGETS
2.76752767528%	15	542	481	T2D_GENES_TANYA_ANTHROPOMETRIC	LIU_PROSTATE_CANCER_DN
2.76752767528%	15	542	473	T2D_GENES_TANYA_ANTHROPOMETRIC	GARY_CD5_TARGETS_UP
2.76752767528%	15	542	445	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
2.76752767528%	15	542	439	T2D_GENES_TANYA_ANTHROPOMETRIC	MITSIADES_RESPONSE_TO_APLIDIN_UP
2.76752767528%	15	542	435	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
2.76752767528%	15	542	279	T2D_GENES_TANYA_ANTHROPOMETRIC	FORTSCHEGGER_PHF8_TARGETS_UP
2.76752767528%	15	542	276	T2D_GENES_TANYA_ANTHROPOMETRIC	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
2.76752767528%	15	542	100	T2D_GENES_TANYA_ANTHROPOMETRIC	ROVERSI_GLIOMA_COPY_NUMBER_UP
2.76679841897%	7	253	99	Diabetes_McGill_CREBBP_coTF	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
2.76679841897%	7	253	88	Diabetes_McGill_CREBBP_coTF	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
2.76679841897%	7	253	86	Diabetes_McGill_CREBBP_coTF	REACTOME_L1CAM_INTERACTIONS
2.76679841897%	7	253	86	Diabetes_McGill_CREBBP_coTF	NGUYEN_NOTCH1_TARGETS_DN
2.76679841897%	7	253	86	Diabetes_McGill_CREBBP_coTF	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
2.76679841897%	7	253	857	Diabetes_McGill_CREBBP_coTF	MARTENS_TRETINOIN_RESPONSE_UP
2.76679841897%	7	253	85	Diabetes_McGill_CREBBP_coTF	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
2.76679841897%	7	253	84	Diabetes_McGill_CREBBP_coTF	SMID_BREAST_CANCER_LUMINAL_A_UP
2.76679841897%	7	253	81	Diabetes_McGill_CREBBP_coTF	MAHAJAN_RESPONSE_TO_IL1A_UP
2.76679841897%	7	253	77	Diabetes_McGill_CREBBP_coTF	FRIDMAN_SENESCENCE_UP
2.76679841897%	7	253	70	Diabetes_McGill_CREBBP_coTF	KEGG_LONG_TERM_POTENTIATION
2.76679841897%	7	253	65	Diabetes_McGill_CREBBP_coTF	PID_CD8TCRDOWNSTREAMPATHWAY
2.76679841897%	7	253	64	Diabetes_McGill_CREBBP_coTF	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
2.76679841897%	7	253	64	Diabetes_McGill_CREBBP_coTF	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
2.76679841897%	7	253	63	Diabetes_McGill_CREBBP_coTF	REACTOME_INTERFERON_GAMMA_SIGNALING
2.76679841897%	7	253	62	Diabetes_McGill_CREBBP_coTF	PID_FCER1PATHWAY
2.76679841897%	7	253	58	Diabetes_McGill_CREBBP_coTF	SANSOM_WNT_PATHWAY_REQUIRE_MYC
2.76679841897%	7	253	564	Diabetes_McGill_CREBBP_coTF	SMID_BREAST_CANCER_LUMINAL_B_DN
2.76679841897%	7	253	56	Diabetes_McGill_CREBBP_coTF	REACTOME_PI_3K_CASCADE
2.76679841897%	7	253	55	Diabetes_McGill_CREBBP_coTF	PID_IL2_1PATHWAY
2.76679841897%	7	253	55	Diabetes_McGill_CREBBP_coTF	PID_FGF_PATHWAY
2.76679841897%	7	253	54	Diabetes_McGill_CREBBP_coTF	PID_NFAT_3PATHWAY
2.76679841897%	7	253	53	Diabetes_McGill_CREBBP_coTF	SMIRNOV_RESPONSE_TO_IR_2HR_UP
2.76679841897%	7	253	50	Diabetes_McGill_CREBBP_coTF	PID_ANGIOPOIETINRECEPTOR_PATHWAY
2.76679841897%	7	253	491	Diabetes_McGill_CREBBP_coTF	SWEET_LUNG_CANCER_KRAS_UP
2.76679841897%	7	253	491	Diabetes_McGill_CREBBP_coTF	MEISSNER_NPC_HCP_WITH_H3K4ME2
2.76679841897%	7	253	487	Diabetes_McGill_CREBBP_coTF	RODWELL_AGING_KIDNEY_UP
2.76679841897%	7	253	48	Diabetes_McGill_CREBBP_coTF	PID_HEDGEHOG_GLIPATHWAY
2.76679841897%	7	253	47	Diabetes_McGill_CREBBP_coTF	PID_LKB1_PATHWAY
2.76679841897%	7	253	464	Diabetes_McGill_CREBBP_coTF	ONDER_CDH1_TARGETS_2_DN
2.76679841897%	7	253	45	Diabetes_McGill_CREBBP_coTF	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
2.76679841897%	7	253	45	Diabetes_McGill_CREBBP_coTF	PID_HNF3BPATHWAY
2.76679841897%	7	253	45	Diabetes_McGill_CREBBP_coTF	BIOCARTA_BIOPEPTIDES_PATHWAY
2.76679841897%	7	253	425	Diabetes_McGill_CREBBP_coTF	ZHANG_BREAST_CANCER_PROGENITORS_UP
2.76679841897%	7	253	42	Diabetes_McGill_CREBBP_coTF	KEGG_BLADDER_CANCER
2.76679841897%	7	253	414	Diabetes_McGill_CREBBP_coTF	MOHANKUMAR_TLX1_TARGETS_UP
2.76679841897%	7	253	408	Diabetes_McGill_CREBBP_coTF	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
2.76679841897%	7	253	40	Diabetes_McGill_CREBBP_coTF	BIOCARTA_P38MAPK_PATHWAY
2.76679841897%	7	253	387	Diabetes_McGill_CREBBP_coTF	CHYLA_CBFA2T3_TARGETS_UP
2.76679841897%	7	253	384	Diabetes_McGill_CREBBP_coTF	BASAKI_YBX1_TARGETS_DN
2.76679841897%	7	253	380	Diabetes_McGill_CREBBP_coTF	DAIRKEE_TERT_TARGETS_UP
2.76679841897%	7	253	38	Diabetes_McGill_CREBBP_coTF	REACTOME_GAB1_SIGNALOSOME
2.76679841897%	7	253	371	Diabetes_McGill_CREBBP_coTF	WANG_SMARCE1_TARGETS_DN
2.76679841897%	7	253	37	Diabetes_McGill_CREBBP_coTF	BIOCARTA_GPCR_PATHWAY
2.76679841897%	7	253	351	Diabetes_McGill_CREBBP_coTF	YAGI_AML_WITH_11Q23_REARRANGED
2.76679841897%	7	253	34	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNAL_TRANSDUCTION_BY_L1
2.76679841897%	7	253	34	Diabetes_McGill_CREBBP_coTF	PID_HDAC_CLASSII_PATHWAY
2.76679841897%	7	253	337	Diabetes_McGill_CREBBP_coTF	PENG_GLUTAMINE_DEPRIVATION_DN
2.76679841897%	7	253	320	Diabetes_McGill_CREBBP_coTF	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
2.76679841897%	7	253	315	Diabetes_McGill_CREBBP_coTF	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
2.76679841897%	7	253	315	Diabetes_McGill_CREBBP_coTF	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
2.76679841897%	7	253	314	Diabetes_McGill_CREBBP_coTF	DOUGLAS_BMI1_TARGETS_DN
2.76679841897%	7	253	307	Diabetes_McGill_CREBBP_coTF	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
2.76679841897%	7	253	302	Diabetes_McGill_CREBBP_coTF	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
2.76679841897%	7	253	298	Diabetes_McGill_CREBBP_coTF	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
2.76679841897%	7	253	294	Diabetes_McGill_CREBBP_coTF	WEST_ADRENOCORTICAL_TUMOR_UP
2.76679841897%	7	253	293	Diabetes_McGill_CREBBP_coTF	ZHANG_TLX_TARGETS_60HR_UP
2.76679841897%	7	253	290	Diabetes_McGill_CREBBP_coTF	BASAKI_YBX1_TARGETS_UP
2.76679841897%	7	253	29	Diabetes_McGill_CREBBP_coTF	KEGG_THYROID_CANCER
2.76679841897%	7	253	289	Diabetes_McGill_CREBBP_coTF	GABRIELY_MIR21_TARGETS
2.76679841897%	7	253	285	Diabetes_McGill_CREBBP_coTF	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
2.76679841897%	7	253	277	Diabetes_McGill_CREBBP_coTF	ZHANG_TLX_TARGETS_60HR_DN
2.76679841897%	7	253	276	Diabetes_McGill_CREBBP_coTF	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
2.76679841897%	7	253	274	Diabetes_McGill_CREBBP_coTF	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
2.76679841897%	7	253	261	Diabetes_McGill_CREBBP_coTF	RICKMAN_METASTASIS_DN
2.76679841897%	7	253	261	Diabetes_McGill_CREBBP_coTF	BILD_HRAS_ONCOGENIC_SIGNATURE
2.76679841897%	7	253	26	Diabetes_McGill_CREBBP_coTF	BIOCARTA_WNT_PATHWAY
2.76679841897%	7	253	254	Diabetes_McGill_CREBBP_coTF	IVANOVA_HEMATOPOIESIS_STEM_CELL
2.76679841897%	7	253	246	Diabetes_McGill_CREBBP_coTF	VERHAAK_AML_WITH_NPM1_MUTATED_DN
2.76679841897%	7	253	245	Diabetes_McGill_CREBBP_coTF	PENG_RAPAMYCIN_RESPONSE_DN
2.76679841897%	7	253	244	Diabetes_McGill_CREBBP_coTF	DAZARD_RESPONSE_TO_UV_NHEK_UP
2.76679841897%	7	253	24	Diabetes_McGill_CREBBP_coTF	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION
2.76679841897%	7	253	237	Diabetes_McGill_CREBBP_coTF	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
2.76679841897%	7	253	235	Diabetes_McGill_CREBBP_coTF	RUTELLA_RESPONSE_TO_HGF_DN
2.76679841897%	7	253	220	Diabetes_McGill_CREBBP_coTF	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
2.76679841897%	7	253	22	Diabetes_McGill_CREBBP_coTF	BIOCARTA_AKT_PATHWAY
2.76679841897%	7	253	214	Diabetes_McGill_CREBBP_coTF	ZWANG_EGF_INTERVAL_DN
2.76679841897%	7	253	214	Diabetes_McGill_CREBBP_coTF	TIEN_INTESTINE_PROBIOTICS_24HR_DN
2.76679841897%	7	253	211	Diabetes_McGill_CREBBP_coTF	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
2.76679841897%	7	253	210	Diabetes_McGill_CREBBP_coTF	WANG_TUMOR_INVASIVENESS_DN
2.76679841897%	7	253	210	Diabetes_McGill_CREBBP_coTF	REACTOME_TRANSCRIPTION
2.76679841897%	7	253	207	Diabetes_McGill_CREBBP_coTF	MANALO_HYPOXIA_UP
2.76679841897%	7	253	206	Diabetes_McGill_CREBBP_coTF	RAMALHO_STEMNESS_UP
2.76679841897%	7	253	202	Diabetes_McGill_CREBBP_coTF	FUJII_YBX1_TARGETS_DN
2.76679841897%	7	253	20	Diabetes_McGill_CREBBP_coTF	BIOCARTA_ATM_PATHWAY
2.76679841897%	7	253	197	Diabetes_McGill_CREBBP_coTF	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
2.76679841897%	7	253	196	Diabetes_McGill_CREBBP_coTF	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
2.76679841897%	7	253	196	Diabetes_McGill_CREBBP_coTF	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
2.76679841897%	7	253	194	Diabetes_McGill_CREBBP_coTF	KASLER_HDAC7_TARGETS_1_UP
2.76679841897%	7	253	186	Diabetes_McGill_CREBBP_coTF	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
2.76679841897%	7	253	181	Diabetes_McGill_CREBBP_coTF	JISON_SICKLE_CELL_DISEASE_UP
2.76679841897%	7	253	178	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_18HR_UP
2.76679841897%	7	253	177	Diabetes_McGill_CREBBP_coTF	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
2.76679841897%	7	253	175	Diabetes_McGill_CREBBP_coTF	LEE_LIVER_CANCER_SURVIVAL_DN
2.76679841897%	7	253	17	Diabetes_McGill_CREBBP_coTF	BIOCARTA_IL10_PATHWAY
2.76679841897%	7	253	163	Diabetes_McGill_CREBBP_coTF	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
2.76679841897%	7	253	162	Diabetes_McGill_CREBBP_coTF	KIM_WT1_TARGETS_12HR_UP
2.76679841897%	7	253	161	Diabetes_McGill_CREBBP_coTF	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
2.76679841897%	7	253	16	Diabetes_McGill_CREBBP_coTF	BIOCARTA_RELA_PATHWAY
2.76679841897%	7	253	16	Diabetes_McGill_CREBBP_coTF	BIOCARTA_IL22BP_PATHWAY
2.76679841897%	7	253	159	Diabetes_McGill_CREBBP_coTF	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
2.76679841897%	7	253	158	Diabetes_McGill_CREBBP_coTF	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
2.76679841897%	7	253	158	Diabetes_McGill_CREBBP_coTF	RODRIGUES_NTN1_TARGETS_DN
2.76679841897%	7	253	154	Diabetes_McGill_CREBBP_coTF	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
2.76679841897%	7	253	148	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_24HR_DN
2.76679841897%	7	253	141	Diabetes_McGill_CREBBP_coTF	WELCSH_BRCA1_TARGETS_DN
2.76679841897%	7	253	137	Diabetes_McGill_CREBBP_coTF	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
2.76679841897%	7	253	136	Diabetes_McGill_CREBBP_coTF	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
2.76679841897%	7	253	131	Diabetes_McGill_CREBBP_coTF	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
2.76679841897%	7	253	13	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CARM1_PATHWAY
2.76679841897%	7	253	126	Diabetes_McGill_CREBBP_coTF	SANSOM_APC_TARGETS_UP
2.76679841897%	7	253	126	Diabetes_McGill_CREBBP_coTF	GERY_CEBP_TARGETS
2.76679841897%	7	253	123	Diabetes_McGill_CREBBP_coTF	DAZARD_RESPONSE_TO_UV_SCC_UP
2.76679841897%	7	253	121	Diabetes_McGill_CREBBP_coTF	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
2.76679841897%	7	253	120	Diabetes_McGill_CREBBP_coTF	ZHU_CMV_ALL_UP
2.76679841897%	7	253	117	Diabetes_McGill_CREBBP_coTF	PUJANA_BRCA_CENTERED_NETWORK
2.76679841897%	7	253	116	Diabetes_McGill_CREBBP_coTF	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
2.76679841897%	7	253	115	Diabetes_McGill_CREBBP_coTF	MARKEY_RB1_CHRONIC_LOF_UP
2.76679841897%	7	253	113	Diabetes_McGill_CREBBP_coTF	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
2.76679841897%	7	253	112	Diabetes_McGill_CREBBP_coTF	REACTOME_DNA_REPAIR
2.76679841897%	7	253	111	Diabetes_McGill_CREBBP_coTF	WANG_HCP_PROSTATE_CANCER
2.76679841897%	7	253	110	Diabetes_McGill_CREBBP_coTF	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
2.76679841897%	7	253	108	Diabetes_McGill_CREBBP_coTF	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
2.76679841897%	7	253	107	Diabetes_McGill_CREBBP_coTF	SESTO_RESPONSE_TO_UV_C0
2.76679841897%	7	253	105	Diabetes_McGill_CREBBP_coTF	HELLER_SILENCED_BY_METHYLATION_DN
2.76679841897%	7	253	105	Diabetes_McGill_CREBBP_coTF	AMUNDSON_GENOTOXIC_SIGNATURE
2.76679841897%	7	253	103	Diabetes_McGill_CREBBP_coTF	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
2.76679841897%	7	253	102	Diabetes_McGill_CREBBP_coTF	PID_CXCR4_PATHWAY
2.76285495012%	36	1303	673	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTINEZ_RB1_TARGETS_UP
2.76285495012%	36	1303	1080	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN
2.76285495012%	36	1303	1062	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BENPORATH_EED_TARGETS
2.75988960442%	60	2174	920	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_GPCR
2.75988960442%	60	2174	593	T2D_GENES_TANYA_LIPIDS	MARTINEZ_TP53_TARGETS_DN
2.75988960442%	60	2174	591	T2D_GENES_TANYA_LIPIDS	MARTINEZ_RB1_AND_TP53_TARGETS_DN
2.75988960442%	60	2174	536	T2D_GENES_TANYA_LIPIDS	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
2.75988960442%	60	2174	528	T2D_GENES_TANYA_LIPIDS	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
2.75988960442%	60	2174	443	T2D_GENES_TANYA_LIPIDS	DELYS_THYROID_CANCER_UP
2.75807722616%	35	1269	784	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FORTSCHEGGER_PHF8_TARGETS_DN
2.75807722616%	35	1269	770	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KRIEG_HYPOXIA_NOT_VIA_KDM3A
2.75568181818%	97	3520	933	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_IMMUNE_SYSTEM
2.7373823781%	32	1169	933	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_IMMUNE_SYSTEM
2.7373823781%	32	1169	871	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRADE_COLON_CANCER_UP
2.7373823781%	32	1169	784	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FORTSCHEGGER_PHF8_TARGETS_DN
2.7373823781%	32	1169	775	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BENPORATH_MYC_MAX_TARGETS
2.7373823781%	32	1169	605	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CAIRO_HEPATOBLASTOMA_CLASSES_UP
2.7373823781%	32	1169	567	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PARENT_MTOR_SIGNALING_UP
2.73556231003%	54	1974	514	Mendelian_Nancy_Cox	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
2.73556231003%	54	1974	368	Mendelian_Nancy_Cox	YAGI_AML_WITH_T_8_21_TRANSLOCATION
2.73556231003%	54	1974	296	Mendelian_Nancy_Cox	DURAND_STROMA_MAX_UP
2.73556231003%	54	1974	258	Mendelian_Nancy_Cox	JAEGER_METASTASIS_DN
2.73556231003%	54	1974	241	Mendelian_Nancy_Cox	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
2.73556231003%	54	1974	232	Mendelian_Nancy_Cox	DELYS_THYROID_CANCER_DN
2.72581507215%	51	1871	652	T2D_GENES_TANYA_HEIGHT	BENPORATH_PRC2_TARGETS
2.72581507215%	51	1871	584	T2D_GENES_TANYA_HEIGHT	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
2.72581507215%	51	1871	555	T2D_GENES_TANYA_HEIGHT	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
2.72581507215%	51	1871	493	T2D_GENES_TANYA_HEIGHT	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
2.72581507215%	51	1871	475	T2D_GENES_TANYA_HEIGHT	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
2.72581507215%	51	1871	461	T2D_GENES_TANYA_HEIGHT	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
2.72581507215%	51	1871	431	T2D_GENES_TANYA_HEIGHT	GARY_CD5_TARGETS_DN
2.72314674735%	18	661	830	T2D_GENES_TANYA_GLYCEMIC	CUI_TCF21_TARGETS_2_DN
2.72314674735%	18	661	593	T2D_GENES_TANYA_GLYCEMIC	MARTINEZ_TP53_TARGETS_DN
2.72314674735%	18	661	591	T2D_GENES_TANYA_GLYCEMIC	MARTINEZ_RB1_AND_TP53_TARGETS_DN
2.72314674735%	18	661	566	T2D_GENES_TANYA_GLYCEMIC	DOUGLAS_BMI1_TARGETS_UP
2.72314674735%	18	661	546	T2D_GENES_TANYA_GLYCEMIC	WEST_ADRENOCORTICAL_TUMOR_DN
2.72314674735%	18	661	543	T2D_GENES_TANYA_GLYCEMIC	MARTINEZ_RB1_TARGETS_DN
2.72314674735%	18	661	540	T2D_GENES_TANYA_GLYCEMIC	ACEVEDO_LIVER_CANCER_DN
2.72314674735%	18	661	514	T2D_GENES_TANYA_GLYCEMIC	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
2.72314674735%	18	661	487	T2D_GENES_TANYA_GLYCEMIC	RODWELL_AGING_KIDNEY_UP
2.72314674735%	18	661	482	T2D_GENES_TANYA_GLYCEMIC	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
2.72314674735%	18	661	473	T2D_GENES_TANYA_GLYCEMIC	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
2.72314674735%	18	661	457	T2D_GENES_TANYA_GLYCEMIC	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
2.72314674735%	18	661	456	T2D_GENES_TANYA_GLYCEMIC	MARTENS_BOUND_BY_PML_RARA_FUSION
2.72314674735%	18	661	439	T2D_GENES_TANYA_GLYCEMIC	MITSIADES_RESPONSE_TO_APLIDIN_UP
2.72314674735%	18	661	429	T2D_GENES_TANYA_GLYCEMIC	MOOTHA_HUMAN_MITODB_6_2002
2.72314674735%	18	661	428	T2D_GENES_TANYA_GLYCEMIC	CUI_TCF21_TARGETS_2_UP
2.72314674735%	18	661	406	T2D_GENES_TANYA_GLYCEMIC	OSMAN_BLADDER_CANCER_DN
2.72314674735%	18	661	396	T2D_GENES_TANYA_GLYCEMIC	REACTOME_DEVELOPMENTAL_BIOLOGY
2.72314674735%	18	661	328	T2D_GENES_TANYA_GLYCEMIC	REACTOME_OLFACTORY_SIGNALING_PATHWAY
2.72314674735%	18	661	325	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CELL_CYCLE_MITOTIC
2.71389144434%	59	2174	566	T2D_GENES_TANYA_LIPIDS	DOUGLAS_BMI1_TARGETS_UP
2.71389144434%	59	2174	557	T2D_GENES_TANYA_LIPIDS	TIEN_INTESTINE_PROBIOTICS_24HR_UP
2.71389144434%	59	2174	466	T2D_GENES_TANYA_LIPIDS	REACTOME_HEMOSTASIS
2.7027027027%	1	37	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
2.7027027027%	1	37	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_PYRIMIDINE_METABOLISM
2.7027027027%	1	37	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
2.7027027027%	1	37	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CROONQUIST_IL6_DEPRIVATION_DN
2.7027027027%	1	37	97	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
2.7027027027%	1	37	940	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
2.7027027027%	1	37	94	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GAVIN_FOXP3_TARGETS_CLUSTER_T4
2.7027027027%	1	37	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WINTER_HYPOXIA_UP
2.7027027027%	1	37	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
2.7027027027%	1	37	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SYNTHESIS_OF_DNA
2.7027027027%	1	37	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
2.7027027027%	1	37	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_DILATED_CARDIOMYOPATHY
2.7027027027%	1	37	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DE_YY1_TARGETS_DN
2.7027027027%	1	37	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CAMPS_COLON_CANCER_COPY_NUMBER_UP
2.7027027027%	1	37	90	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MORI_IMMATURE_B_LYMPHOCYTE_DN
2.7027027027%	1	37	90	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HILLION_HMGA1_TARGETS
2.7027027027%	1	37	9	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN
2.7027027027%	1	37	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SWEET_KRAS_ONCOGENIC_SIGNATURE
2.7027027027%	1	37	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_RNA_POL_I_TRANSCRIPTION
2.7027027027%	1	37	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
2.7027027027%	1	37	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LEE_AGING_NEOCORTEX_UP
2.7027027027%	1	37	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KANG_IMMORTALIZED_BY_TERT_UP
2.7027027027%	1	37	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DELASERNA_MYOD_TARGETS_UP
2.7027027027%	1	37	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BHATTACHARYA_EMBRYONIC_STEM_CELL
2.7027027027%	1	37	882	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LEE_BMP2_TARGETS_DN
2.7027027027%	1	37	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
2.7027027027%	1	37	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WALLACE_PROSTATE_CANCER_RACE_DN
2.7027027027%	1	37	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SEIDEN_ONCOGENESIS_BY_MET
2.7027027027%	1	37	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
2.7027027027%	1	37	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
2.7027027027%	1	37	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
2.7027027027%	1	37	871	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GRADE_COLON_CANCER_UP
2.7027027027%	1	37	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
2.7027027027%	1	37	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SAFFORD_T_LYMPHOCYTE_ANERGY
2.7027027027%	1	37	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
2.7027027027%	1	37	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
2.7027027027%	1	37	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
2.7027027027%	1	37	86	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BROWNE_HCMV_INFECTION_16HR_DN
2.7027027027%	1	37	855	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
2.7027027027%	1	37	85	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	STEIN_ESR1_TARGETS
2.7027027027%	1	37	85	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
2.7027027027%	1	37	85	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
2.7027027027%	1	37	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
2.7027027027%	1	37	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RUAN_RESPONSE_TO_TNF_DN
2.7027027027%	1	37	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LEE_AGING_CEREBELLUM_UP
2.7027027027%	1	37	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
2.7027027027%	1	37	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_AMYLOIDS
2.7027027027%	1	37	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
2.7027027027%	1	37	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
2.7027027027%	1	37	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
2.7027027027%	1	37	82	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
2.7027027027%	1	37	82	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_SMAD2_3NUCLEARPATHWAY
2.7027027027%	1	37	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
2.7027027027%	1	37	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SCIBETTA_KDM5B_TARGETS_DN
2.7027027027%	1	37	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_MITOTIC_G2_G2_M_PHASES
2.7027027027%	1	37	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MAHAJAN_RESPONSE_TO_IL1A_UP
2.7027027027%	1	37	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
2.7027027027%	1	37	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GUO_HEX_TARGETS_UP
2.7027027027%	1	37	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GRABARCZYK_BCL11B_TARGETS_UP
2.7027027027%	1	37	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SCHUHMACHER_MYC_TARGETS_UP
2.7027027027%	1	37	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
2.7027027027%	1	37	8	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7
2.7027027027%	1	37	8	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	IKEDA_MIR133_TARGETS_DN
2.7027027027%	1	37	8	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP
2.7027027027%	1	37	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
2.7027027027%	1	37	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LIU_COMMON_CANCER_GENES
2.7027027027%	1	37	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DUAN_PRDM5_TARGETS
2.7027027027%	1	37	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
2.7027027027%	1	37	784	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FORTSCHEGGER_PHF8_TARGETS_DN
2.7027027027%	1	37	78	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
2.7027027027%	1	37	78	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LINDVALL_IMMORTALIZED_BY_TERT_UP
2.7027027027%	1	37	78	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
2.7027027027%	1	37	78	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
2.7027027027%	1	37	779	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PUJANA_CHEK2_PCC_NETWORK
2.7027027027%	1	37	775	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BENPORATH_MYC_MAX_TARGETS
2.7027027027%	1	37	770	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
2.7027027027%	1	37	77	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RIZ_ERYTHROID_DIFFERENTIATION
2.7027027027%	1	37	77	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LIN_APC_TARGETS
2.7027027027%	1	37	77	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CARD_MIR302A_TARGETS
2.7027027027%	1	37	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
2.7027027027%	1	37	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ROSS_AML_WITH_AML1_ETO_FUSION
2.7027027027%	1	37	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
2.7027027027%	1	37	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
2.7027027027%	1	37	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
2.7027027027%	1	37	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_TELOMERE_MAINTENANCE
2.7027027027%	1	37	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MORI_MATURE_B_LYMPHOCYTE_DN
2.7027027027%	1	37	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_ADHERENS_JUNCTION
2.7027027027%	1	37	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SHEPARD_BMYB_TARGETS
2.7027027027%	1	37	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LEE_LIVER_CANCER_DENA_DN
2.7027027027%	1	37	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CORRE_MULTIPLE_MYELOMA_UP
2.7027027027%	1	37	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_MEIOTIC_SYNAPSIS
2.7027027027%	1	37	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
2.7027027027%	1	37	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_VIRAL_MYOCARDITIS
2.7027027027%	1	37	728	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARSON_BOUND_BY_E2F4_UNSTIMULATED
2.7027027027%	1	37	72	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MATZUK_SPERMATOCYTE
2.7027027027%	1	37	72	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DANG_REGULATED_BY_MYC_UP
2.7027027027%	1	37	72	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CROONQUIST_NRAS_SIGNALING_DN
2.7027027027%	1	37	712	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SCHLOSSER_SERUM_RESPONSE_DN
2.7027027027%	1	37	71	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DER_IFN_GAMMA_RESPONSE_UP
2.7027027027%	1	37	70	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_AP1_PATHWAY
2.7027027027%	1	37	7	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PALOMERO_GSI_SENSITIVITY_UP
2.7027027027%	1	37	7	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MIKI_COEXPRESSED_WITH_CYP19A1
2.7027027027%	1	37	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
2.7027027027%	1	37	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN
2.7027027027%	1	37	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RHODES_UNDIFFERENTIATED_CANCER
2.7027027027%	1	37	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_P53_SIGNALING_PATHWAY
2.7027027027%	1	37	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HOWLIN_PUBERTAL_MAMMARY_GLAND
2.7027027027%	1	37	682	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
2.7027027027%	1	37	681	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
2.7027027027%	1	37	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
2.7027027027%	1	37	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	VANHARANTA_UTERINE_FIBROID_DN
2.7027027027%	1	37	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
2.7027027027%	1	37	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
2.7027027027%	1	37	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
2.7027027027%	1	37	668	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
2.7027027027%	1	37	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
2.7027027027%	1	37	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SWEET_KRAS_TARGETS_DN
2.7027027027%	1	37	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RIGGINS_TAMOXIFEN_RESISTANCE_UP
2.7027027027%	1	37	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
2.7027027027%	1	37	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_TCR_PATHWAY
2.7027027027%	1	37	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_LYSOPHOSPHOLIPID_PATHWAY
2.7027027027%	1	37	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_HDAC_CLASSI_PATHWAY
2.7027027027%	1	37	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NAKAMURA_ADIPOGENESIS_EARLY_UP
2.7027027027%	1	37	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARSON_FOXP3_TARGETS_UP
2.7027027027%	1	37	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LEE_LIVER_CANCER_CIPROFIBRATE_DN
2.7027027027%	1	37	658	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
2.7027027027%	1	37	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
2.7027027027%	1	37	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_RB_1PATHWAY
2.7027027027%	1	37	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GUO_HEX_TARGETS_DN
2.7027027027%	1	37	64	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
2.7027027027%	1	37	64	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LEE_LIVER_CANCER_ACOX1_UP
2.7027027027%	1	37	64	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GERHOLD_ADIPOGENESIS_DN
2.7027027027%	1	37	64	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
2.7027027027%	1	37	64	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BYSTROEM_CORRELATED_WITH_IL5_DN
2.7027027027%	1	37	633	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
2.7027027027%	1	37	63	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
2.7027027027%	1	37	63	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BRIDEAU_IMPRINTED_GENES
2.7027027027%	1	37	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
2.7027027027%	1	37	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
2.7027027027%	1	37	612	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
2.7027027027%	1	37	61	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
2.7027027027%	1	37	61	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REN_BOUND_BY_E2F
2.7027027027%	1	37	61	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NADLER_OBESITY_UP
2.7027027027%	1	37	61	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
2.7027027027%	1	37	605	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CAIRO_HEPATOBLASTOMA_CLASSES_UP
2.7027027027%	1	37	602	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARTINEZ_TP53_TARGETS_UP
2.7027027027%	1	37	601	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARTINEZ_RB1_AND_TP53_TARGETS_UP
2.7027027027%	1	37	6	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KIM_PTEN_TARGETS_DN
2.7027027027%	1	37	6	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KAPOSI_LIVER_CANCER_MET_DN
2.7027027027%	1	37	6	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	COURTOIS_SENESCENCE_TRIGGERS
2.7027027027%	1	37	593	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARTINEZ_TP53_TARGETS_DN
2.7027027027%	1	37	591	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARTINEZ_RB1_AND_TP53_TARGETS_DN
2.7027027027%	1	37	59	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
2.7027027027%	1	37	59	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_ATF2_PATHWAY
2.7027027027%	1	37	59	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ELVIDGE_HYPOXIA_BY_DMOG_DN
2.7027027027%	1	37	584	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
2.7027027027%	1	37	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHENG_GLIOBLASTOMA_PLASTICITY_DN
2.7027027027%	1	37	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
2.7027027027%	1	37	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WAKASUGI_HAVE_ZNF143_BINDING_SITES
2.7027027027%	1	37	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LUCAS_HNF4A_TARGETS_UP
2.7027027027%	1	37	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_HIVNEF_PATHWAY
2.7027027027%	1	37	579	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
2.7027027027%	1	37	570	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
2.7027027027%	1	37	57	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
2.7027027027%	1	37	57	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DELASERNA_MYOD_TARGETS_DN
2.7027027027%	1	37	567	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PARENT_MTOR_SIGNALING_UP
2.7027027027%	1	37	566	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DOUGLAS_BMI1_TARGETS_UP
2.7027027027%	1	37	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HOQUE_METHYLATED_IN_CANCER
2.7027027027%	1	37	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HENDRICKS_SMARCA4_TARGETS_UP
2.7027027027%	1	37	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
2.7027027027%	1	37	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_TGFBRPATHWAY
2.7027027027%	1	37	549	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
2.7027027027%	1	37	543	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARTINEZ_RB1_TARGETS_DN
2.7027027027%	1	37	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SU_PANCREAS
2.7027027027%	1	37	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ROVERSI_GLIOMA_COPY_NUMBER_DN
2.7027027027%	1	37	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_APOPTOTIC_EXECUTION_PHASE
2.7027027027%	1	37	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARSON_FOXP3_TARGETS_DN
2.7027027027%	1	37	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_ARGININE_AND_PROLINE_METABOLISM
2.7027027027%	1	37	539	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LIAO_METASTASIS
2.7027027027%	1	37	536	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BERENJENO_TRANSFORMED_BY_RHOA_UP
2.7027027027%	1	37	535	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	STEIN_ESRRA_TARGETS
2.7027027027%	1	37	532	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
2.7027027027%	1	37	530	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ENK_UV_RESPONSE_KERATINOCYTE_UP
2.7027027027%	1	37	53	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHU_CMV_8_HR_DN
2.7027027027%	1	37	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_CASPASE_PATHWAY
2.7027027027%	1	37	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_STARCH_AND_SUCROSE_METABOLISM
2.7027027027%	1	37	518	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
2.7027027027%	1	37	517	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
2.7027027027%	1	37	514	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
2.7027027027%	1	37	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_NUCLEOTIDE_EXCISION_REPAIR
2.7027027027%	1	37	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
2.7027027027%	1	37	508	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ENK_UV_RESPONSE_EPIDERMIS_DN
2.7027027027%	1	37	501	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SENESE_HDAC3_TARGETS_UP
2.7027027027%	1	37	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	STOSSI_RESPONSE_TO_ESTRADIOL
2.7027027027%	1	37	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
2.7027027027%	1	37	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
2.7027027027%	1	37	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARTINEZ_RESPONSE_TO_TRABECTEDIN
2.7027027027%	1	37	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
2.7027027027%	1	37	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHIBA_RESPONSE_TO_TSA
2.7027027027%	1	37	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS
2.7027027027%	1	37	5	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BRUNEAU_SEPTATION_ATRIAL
2.7027027027%	1	37	491	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHENG_BOUND_BY_FOXP3
2.7027027027%	1	37	491	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MEISSNER_NPC_HCP_WITH_H3K4ME2
2.7027027027%	1	37	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_ARF6_TRAFFICKINGPATHWAY
2.7027027027%	1	37	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARCHINI_TRABECTEDIN_RESISTANCE_DN
2.7027027027%	1	37	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GERHOLD_ADIPOGENESIS_UP
2.7027027027%	1	37	489	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LIM_MAMMARY_STEM_CELL_UP
2.7027027027%	1	37	485	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ENK_UV_RESPONSE_KERATINOCYTE_DN
2.7027027027%	1	37	482	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
2.7027027027%	1	37	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHAN_MULTIPLE_MYELOMA_LB_UP
2.7027027027%	1	37	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE
2.7027027027%	1	37	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MCDOWELL_ACUTE_LUNG_INJURY_DN
2.7027027027%	1	37	473	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GARY_CD5_TARGETS_UP
2.7027027027%	1	37	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
2.7027027027%	1	37	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_NFAT_TFPATHWAY
2.7027027027%	1	37	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KHETCHOUMIAN_TRIM24_TARGETS_UP
2.7027027027%	1	37	467	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RATTENBACHER_BOUND_BY_CELF1
2.7027027027%	1	37	463	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
2.7027027027%	1	37	463	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
2.7027027027%	1	37	462	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DELACROIX_RAR_BOUND_ES
2.7027027027%	1	37	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SAGIV_CD24_TARGETS_DN
2.7027027027%	1	37	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_TNFPATHWAY
2.7027027027%	1	37	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PARENT_MTOR_SIGNALING_DN
2.7027027027%	1	37	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NAKAJIMA_MAST_CELL
2.7027027027%	1	37	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MADAN_DPPA4_TARGETS
2.7027027027%	1	37	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN
2.7027027027%	1	37	459	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KIM_WT1_TARGETS_DN
2.7027027027%	1	37	457	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SENESE_HDAC1_TARGETS_UP
2.7027027027%	1	37	457	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
2.7027027027%	1	37	456	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
2.7027027027%	1	37	456	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARTENS_BOUND_BY_PML_RARA_FUSION
2.7027027027%	1	37	450	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
2.7027027027%	1	37	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHAN_MULTIPLE_MYELOMA_CD1_UP
2.7027027027%	1	37	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHAN_MULTIPLE_MYELOMA_CD1_DN
2.7027027027%	1	37	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER
2.7027027027%	1	37	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_RHOA_PATHWAY
2.7027027027%	1	37	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NUTT_GBM_VS_AO_GLIOMA_DN
2.7027027027%	1	37	443	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DELYS_THYROID_CANCER_UP
2.7027027027%	1	37	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_HNF3APATHWAY
2.7027027027%	1	37	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MA_MYELOID_DIFFERENTIATION_DN
2.7027027027%	1	37	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
2.7027027027%	1	37	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_TYPE_I_DIABETES_MELLITUS
2.7027027027%	1	37	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_NUCLEOTIDE_EXCISION_REPAIR
2.7027027027%	1	37	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_LYSINE_DEGRADATION
2.7027027027%	1	37	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM
2.7027027027%	1	37	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_ABC_TRANSPORTERS
2.7027027027%	1	37	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HARRIS_BRAIN_CANCER_PROGENITORS
2.7027027027%	1	37	439	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MITSIADES_RESPONSE_TO_APLIDIN_UP
2.7027027027%	1	37	430	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RIGGI_EWING_SARCOMA_PROGENITOR_UP
2.7027027027%	1	37	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	POTTI_ETOPOSIDE_SENSITIVITY
2.7027027027%	1	37	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LEE_CALORIE_RESTRICTION_MUSCLE_UP
2.7027027027%	1	37	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
2.7027027027%	1	37	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HUMMEL_BURKITTS_LYMPHOMA_UP
2.7027027027%	1	37	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
2.7027027027%	1	37	425	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BOCHKIS_FOXA2_TARGETS
2.7027027027%	1	37	423	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	THUM_SYSTOLIC_HEART_FAILURE_UP
2.7027027027%	1	37	423	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PUJANA_BRCA2_PCC_NETWORK
2.7027027027%	1	37	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
2.7027027027%	1	37	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER
2.7027027027%	1	37	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_FATTY_ACID_METABOLISM
2.7027027027%	1	37	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_CHREBP2_PATHWAY
2.7027027027%	1	37	419	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
2.7027027027%	1	37	418	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MULLIGHAN_MLL_SIGNATURE_2_UP
2.7027027027%	1	37	414	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LU_EZH2_TARGETS_DN
2.7027027027%	1	37	411	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KOYAMA_SEMA3B_TARGETS_DN
2.7027027027%	1	37	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MALONEY_RESPONSE_TO_17AAG_UP
2.7027027027%	1	37	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LIN_MELANOMA_COPY_NUMBER_DN
2.7027027027%	1	37	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	EHLERS_ANEUPLOIDY_UP
2.7027027027%	1	37	406	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	OSMAN_BLADDER_CANCER_DN
2.7027027027%	1	37	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	VANASSE_BCL2_TARGETS_UP
2.7027027027%	1	37	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	TOMLINS_PROSTATE_CANCER_DN
2.7027027027%	1	37	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ST_JNK_MAPK_PATHWAY
2.7027027027%	1	37	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
2.7027027027%	1	37	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP
2.7027027027%	1	37	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_TRYPTOPHAN_METABOLISM
2.7027027027%	1	37	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HEIDENBLAD_AMPLICON_8Q24_UP
2.7027027027%	1	37	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BURTON_ADIPOGENESIS_PEAK_AT_16HR
2.7027027027%	1	37	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
2.7027027027%	1	37	391	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
2.7027027027%	1	37	390	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
2.7027027027%	1	37	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	POTTI_PACLITAXEL_SENSITIVITY
2.7027027027%	1	37	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
2.7027027027%	1	37	388	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	STEIN_ESRRA_TARGETS_UP
2.7027027027%	1	37	384	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
2.7027027027%	1	37	382	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
2.7027027027%	1	37	380	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MULLIGHAN_MLL_SIGNATURE_1_UP
2.7027027027%	1	37	380	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DAIRKEE_TERT_TARGETS_UP
2.7027027027%	1	37	380	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
2.7027027027%	1	37	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YOKOE_CANCER_TESTIS_ANTIGENS
2.7027027027%	1	37	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP
2.7027027027%	1	37	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_INTEGRIN_PATHWAY
2.7027027027%	1	37	379	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BENPORATH_ES_1
2.7027027027%	1	37	378	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
2.7027027027%	1	37	374	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WANG_TUMOR_INVASIVENESS_UP
2.7027027027%	1	37	374	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
2.7027027027%	1	37	372	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WANG_LMO4_TARGETS_UP
2.7027027027%	1	37	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	VALK_AML_WITH_CEBPA
2.7027027027%	1	37	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ST_GA13_PATHWAY
2.7027027027%	1	37	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LANDIS_ERBB2_BREAST_TUMORS_65_DN
2.7027027027%	1	37	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_ALK_PATHWAY
2.7027027027%	1	37	364	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YANG_BCL3_TARGETS_UP
2.7027027027%	1	37	362	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
2.7027027027%	1	37	36	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YANG_BREAST_CANCER_ESR1_UP
2.7027027027%	1	37	36	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_DNA_REPLICATION
2.7027027027%	1	37	353	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
2.7027027027%	1	37	352	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WANG_LMO4_TARGETS_DN
2.7027027027%	1	37	351	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
2.7027027027%	1	37	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WEIGEL_OXIDATIVE_STRESS_RESPONSE
2.7027027027%	1	37	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ST_G_ALPHA_I_PATHWAY
2.7027027027%	1	37	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ROZANOV_MMP14_TARGETS_DN
2.7027027027%	1	37	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_GLOBAL_GENOMIC_NER_GG_NER
2.7027027027%	1	37	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_PI3KCIAKTPATHWAY
2.7027027027%	1	37	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION
2.7027027027%	1	37	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_REGULATION_OF_AUTOPHAGY
2.7027027027%	1	37	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_BASE_EXCISION_REPAIR
2.7027027027%	1	37	346	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GOLDRATH_ANTIGEN_RESPONSE
2.7027027027%	1	37	341	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MULLIGHAN_NPM1_SIGNATURE_3_UP
2.7027027027%	1	37	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ST_WNT_BETA_CATENIN_PATHWAY
2.7027027027%	1	37	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT
2.7027027027%	1	37	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	POTTI_CYTOXAN_SENSITIVITY
2.7027027027%	1	37	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_EPOPATHWAY
2.7027027027%	1	37	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_BUTANOATE_METABOLISM
2.7027027027%	1	37	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	JIANG_HYPOXIA_VIA_VHL
2.7027027027%	1	37	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DOANE_BREAST_CANCER_CLASSES_DN
2.7027027027%	1	37	337	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PENG_GLUTAMINE_DEPRIVATION_DN
2.7027027027%	1	37	335	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
2.7027027027%	1	37	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHAN_LATE_DIFFERENTIATION_GENES_UP
2.7027027027%	1	37	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HEIDENBLAD_AMPLICON_12P11_12_UP
2.7027027027%	1	37	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_NO1_PATHWAY
2.7027027027%	1	37	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_DEATH_PATHWAY
2.7027027027%	1	37	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN
2.7027027027%	1	37	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	APPEL_IMATINIB_RESPONSE
2.7027027027%	1	37	329	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
2.7027027027%	1	37	326	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
2.7027027027%	1	37	324	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
2.7027027027%	1	37	320	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
2.7027027027%	1	37	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	TRACEY_RESISTANCE_TO_IFNA2_DN
2.7027027027%	1	37	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_WNT_NONCANONICAL_PATHWAY
2.7027027027%	1	37	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM
2.7027027027%	1	37	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BAUS_TFF2_TARGETS_UP
2.7027027027%	1	37	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BAE_BRCA1_TARGETS_DN
2.7027027027%	1	37	318	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LEI_MYB_TARGETS
2.7027027027%	1	37	317	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HELLER_HDAC_TARGETS_UP
2.7027027027%	1	37	316	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
2.7027027027%	1	37	315	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
2.7027027027%	1	37	311	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	JIANG_HYPOXIA_NORMAL
2.7027027027%	1	37	310	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HORIUCHI_WTAP_TARGETS_DN
2.7027027027%	1	37	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP
2.7027027027%	1	37	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	VALK_AML_CLUSTER_15
2.7027027027%	1	37	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN
2.7027027027%	1	37	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP
2.7027027027%	1	37	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SIMBULAN_PARP1_TARGETS_UP
2.7027027027%	1	37	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
2.7027027027%	1	37	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER
2.7027027027%	1	37	309	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
2.7027027027%	1	37	309	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
2.7027027027%	1	37	308	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
2.7027027027%	1	37	307	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
2.7027027027%	1	37	306	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HORIUCHI_WTAP_TARGETS_UP
2.7027027027%	1	37	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	VALK_AML_CLUSTER_13
2.7027027027%	1	37	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_DNA_STRAND_ELONGATION
2.7027027027%	1	37	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LI_PROSTATE_CANCER_EPIGENETIC
2.7027027027%	1	37	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GUILLAUMOND_KLF10_TARGETS_DN
2.7027027027%	1	37	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_FAS_PATHWAY
2.7027027027%	1	37	299	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WALLACE_PROSTATE_CANCER_RACE_UP
2.7027027027%	1	37	299	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MUELLER_PLURINET
2.7027027027%	1	37	295	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LU_EZH2_TARGETS_UP
2.7027027027%	1	37	295	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
2.7027027027%	1	37	294	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
2.7027027027%	1	37	293	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	IVANOVA_HEMATOPOIESIS_MATURE_CELL
2.7027027027%	1	37	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WILENSKY_RESPONSE_TO_DARAPLADIB
2.7027027027%	1	37	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_PKB_MEDIATED_EVENTS
2.7027027027%	1	37	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
2.7027027027%	1	37	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PAL_PRMT5_TARGETS_DN
2.7027027027%	1	37	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NGUYEN_NOTCH1_TARGETS_UP
2.7027027027%	1	37	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MA_PITUITARY_FETAL_VS_ADULT_UP
2.7027027027%	1	37	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KYNG_WERNER_SYNDROM_DN
2.7027027027%	1	37	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_THYROID_CANCER
2.7027027027%	1	37	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN
2.7027027027%	1	37	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_TNFR1_PATHWAY
2.7027027027%	1	37	289	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GABRIELY_MIR21_TARGETS
2.7027027027%	1	37	287	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
2.7027027027%	1	37	285	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
2.7027027027%	1	37	283	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
2.7027027027%	1	37	281	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MULLIGHAN_MLL_SIGNATURE_2_DN
2.7027027027%	1	37	281	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BHAT_ESR1_TARGETS_VIA_AKT1_UP
2.7027027027%	1	37	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ST_GAQ_PATHWAY
2.7027027027%	1	37	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER
2.7027027027%	1	37	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING
2.7027027027%	1	37	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_HOMOLOGOUS_RECOMBINATION
2.7027027027%	1	37	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
2.7027027027%	1	37	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HWANG_PROSTATE_CANCER_MARKERS
2.7027027027%	1	37	277	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHANG_TLX_TARGETS_60HR_DN
2.7027027027%	1	37	275	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
2.7027027027%	1	37	274	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
2.7027027027%	1	37	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
2.7027027027%	1	37	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
2.7027027027%	1	37	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN
2.7027027027%	1	37	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_EXTENSION_OF_TELOMERES
2.7027027027%	1	37	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	OHM_METHYLATED_IN_ADULT_CANCERS
2.7027027027%	1	37	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GROSS_ELK3_TARGETS_UP
2.7027027027%	1	37	267	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_MAPK_SIGNALING_PATHWAY
2.7027027027%	1	37	266	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ROZANOV_MMP14_TARGETS_UP
2.7027027027%	1	37	261	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RICKMAN_METASTASIS_DN
2.7027027027%	1	37	260	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SENESE_HDAC1_TARGETS_DN
2.7027027027%	1	37	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
2.7027027027%	1	37	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_RXR_VDR_PATHWAY
2.7027027027%	1	37	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_ALK1PATHWAY
2.7027027027%	1	37	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NAKAMURA_CANCER_MICROENVIRONMENT_UP
2.7027027027%	1	37	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_GALACTOSE_METABOLISM
2.7027027027%	1	37	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
2.7027027027%	1	37	258	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
2.7027027027%	1	37	256	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ONDER_CDH1_TARGETS_2_UP
2.7027027027%	1	37	255	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
2.7027027027%	1	37	253	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MCLACHLAN_DENTAL_CARIES_UP
2.7027027027%	1	37	252	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
2.7027027027%	1	37	250	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
2.7027027027%	1	37	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
2.7027027027%	1	37	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP
2.7027027027%	1	37	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	JACKSON_DNMT1_TARGETS_DN
2.7027027027%	1	37	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	COLLER_MYC_TARGETS_UP
2.7027027027%	1	37	249	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MITSIADES_RESPONSE_TO_APLIDIN_DN
2.7027027027%	1	37	249	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
2.7027027027%	1	37	246	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BILD_E2F3_ONCOGENIC_SIGNATURE
2.7027027027%	1	37	245	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PENG_RAPAMYCIN_RESPONSE_DN
2.7027027027%	1	37	245	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MCLACHLAN_DENTAL_CARIES_DN
2.7027027027%	1	37	244	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	THUM_SYSTOLIC_HEART_FAILURE_DN
2.7027027027%	1	37	244	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KAYO_AGING_MUSCLE_UP
2.7027027027%	1	37	242	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WINTER_HYPOXIA_METAGENE
2.7027027027%	1	37	242	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHYLA_CBFA2T3_TARGETS_DN
2.7027027027%	1	37	240	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	UDAYAKUMAR_MED1_TARGETS_DN
2.7027027027%	1	37	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YIH_RESPONSE_TO_ARSENITE_C1
2.7027027027%	1	37	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SHI_SPARC_TARGETS_UP
2.7027027027%	1	37	239	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ALFANO_MYC_TARGETS
2.7027027027%	1	37	238	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
2.7027027027%	1	37	232	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
2.7027027027%	1	37	232	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DELYS_THYROID_CANCER_DN
2.7027027027%	1	37	230	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KAUFFMANN_DNA_REPAIR_GENES
2.7027027027%	1	37	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SAGIV_CD24_TARGETS_UP
2.7027027027%	1	37	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION
2.7027027027%	1	37	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_NITROGEN_METABOLISM
2.7027027027%	1	37	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_MISMATCH_REPAIR
2.7027027027%	1	37	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP
2.7027027027%	1	37	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_CASPASE_PATHWAY
2.7027027027%	1	37	229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
2.7027027027%	1	37	229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
2.7027027027%	1	37	229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
2.7027027027%	1	37	229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
2.7027027027%	1	37	228	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
2.7027027027%	1	37	228	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARKEY_RB1_ACUTE_LOF_DN
2.7027027027%	1	37	227	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
2.7027027027%	1	37	227	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
2.7027027027%	1	37	225	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
2.7027027027%	1	37	225	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
2.7027027027%	1	37	225	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BROWNE_HCMV_INFECTION_16HR_UP
2.7027027027%	1	37	222	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
2.7027027027%	1	37	222	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
2.7027027027%	1	37	222	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BROWNE_HCMV_INFECTION_1HR_DN
2.7027027027%	1	37	221	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHANG_TLX_TARGETS_36HR_UP
2.7027027027%	1	37	221	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PEDRIOLI_MIR31_TARGETS_UP
2.7027027027%	1	37	221	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHANDRAN_METASTASIS_UP
2.7027027027%	1	37	220	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RIGGINS_TAMOXIFEN_RESISTANCE_DN
2.7027027027%	1	37	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SPIRA_SMOKERS_LUNG_CANCER_DN
2.7027027027%	1	37	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION
2.7027027027%	1	37	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
2.7027027027%	1	37	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
2.7027027027%	1	37	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MOOTHA_FFA_OXYDATION
2.7027027027%	1	37	217	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WONG_MITOCHONDRIA_GENE_MODULE
2.7027027027%	1	37	216	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WHITFIELD_CELL_CYCLE_G2_M
2.7027027027%	1	37	214	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZWANG_EGF_INTERVAL_DN
2.7027027027%	1	37	214	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
2.7027027027%	1	37	214	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KIM_WT1_TARGETS_UP
2.7027027027%	1	37	212	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHANG_CORE_SERUM_RESPONSE_UP
2.7027027027%	1	37	211	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
2.7027027027%	1	37	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	VERHAAK_GLIOBLASTOMA_PRONEURAL
2.7027027027%	1	37	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
2.7027027027%	1	37	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SANSOM_APC_TARGETS_REQUIRE_MYC
2.7027027027%	1	37	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_TRANSCRIPTION
2.7027027027%	1	37	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CAIRO_HEPATOBLASTOMA_CLASSES_DN
2.7027027027%	1	37	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	STEGER_ADIPOGENESIS_UP
2.7027027027%	1	37	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING
2.7027027027%	1	37	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_CTLA4_INHIBITORY_SIGNALING
2.7027027027%	1	37	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MOOTHA_GLYCOGEN_METABOLISM
2.7027027027%	1	37	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LANDEMAINE_LUNG_METASTASIS
2.7027027027%	1	37	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HU_ANGIOGENESIS_UP
2.7027027027%	1	37	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
2.7027027027%	1	37	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CAIRO_HEPATOBLASTOMA_UP
2.7027027027%	1	37	205	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
2.7027027027%	1	37	205	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PEREZ_TP53_AND_TP63_TARGETS
2.7027027027%	1	37	204	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
2.7027027027%	1	37	203	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PENG_RAPAMYCIN_RESPONSE_UP
2.7027027027%	1	37	202	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
2.7027027027%	1	37	202	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FUJII_YBX1_TARGETS_DN
2.7027027027%	1	37	201	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KIM_MYC_AMPLIFICATION_TARGETS_UP
2.7027027027%	1	37	200	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SHEPARD_BMYB_MORPHOLINO_DN
2.7027027027%	1	37	200	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
2.7027027027%	1	37	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WENG_POR_TARGETS_GLOBAL_UP
2.7027027027%	1	37	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WANG_THOC1_TARGETS_DN
2.7027027027%	1	37	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN
2.7027027027%	1	37	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_ENOS_ACTIVATION_AND_REGULATION
2.7027027027%	1	37	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PID_WNT_CANONICAL_PATHWAY
2.7027027027%	1	37	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NIELSEN_SYNOVIAL_SARCOMA_DN
2.7027027027%	1	37	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KYNG_WERNER_SYNDROM_UP
2.7027027027%	1	37	199	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
2.7027027027%	1	37	198	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ALONSO_METASTASIS_UP
2.7027027027%	1	37	196	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
2.7027027027%	1	37	195	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
2.7027027027%	1	37	194	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
2.7027027027%	1	37	192	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_DNA_REPLICATION
2.7027027027%	1	37	191	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YAGI_AML_FAB_MARKERS
2.7027027027%	1	37	191	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RIGGI_EWING_SARCOMA_PROGENITOR_DN
2.7027027027%	1	37	191	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
2.7027027027%	1	37	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE
2.7027027027%	1	37	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	VERNOCHET_ADIPOGENESIS
2.7027027027%	1	37	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SYED_ESTRADIOL_RESPONSE
2.7027027027%	1	37	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RUAN_RESPONSE_TO_TROGLITAZONE_DN
2.7027027027%	1	37	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_PYRUVATE_METABOLISM
2.7027027027%	1	37	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_LAGGING_STRAND_SYNTHESIS
2.7027027027%	1	37	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_BASE_EXCISION_REPAIR
2.7027027027%	1	37	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	OUYANG_PROSTATE_CANCER_MARKERS
2.7027027027%	1	37	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARSON_FOXP3_CORE_DIRECT_TARGETS
2.7027027027%	1	37	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN
2.7027027027%	1	37	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
2.7027027027%	1	37	189	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BURTON_ADIPOGENESIS_6
2.7027027027%	1	37	185	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHANG_TLX_TARGETS_36HR_DN
2.7027027027%	1	37	185	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_HUNTINGTONS_DISEASE
2.7027027027%	1	37	184	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DOANE_RESPONSE_TO_ANDROGEN_UP
2.7027027027%	1	37	183	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
2.7027027027%	1	37	183	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	VERHAAK_AML_WITH_NPM1_MUTATED_UP
2.7027027027%	1	37	182	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
2.7027027027%	1	37	182	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RAO_BOUND_BY_SALL4_ISOFORM_A
2.7027027027%	1	37	181	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
2.7027027027%	1	37	181	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	JISON_SICKLE_CELL_DISEASE_UP
2.7027027027%	1	37	181	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
2.7027027027%	1	37	180	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
2.7027027027%	1	37	180	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BROWNE_HCMV_INFECTION_48HR_UP
2.7027027027%	1	37	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE
2.7027027027%	1	37	177	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
2.7027027027%	1	37	176	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SASAKI_ADULT_T_CELL_LEUKEMIA
2.7027027027%	1	37	176	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NAGASHIMA_NRG1_SIGNALING_UP
2.7027027027%	1	37	176	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
2.7027027027%	1	37	174	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
2.7027027027%	1	37	172	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SMID_BREAST_CANCER_LUMINAL_B_UP
2.7027027027%	1	37	172	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
2.7027027027%	1	37	172	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
2.7027027027%	1	37	170	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
2.7027027027%	1	37	170	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
2.7027027027%	1	37	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY
2.7027027027%	1	37	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION
2.7027027027%	1	37	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MATTHEWS_AP1_TARGETS
2.7027027027%	1	37	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
2.7027027027%	1	37	169	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	UEDA_PERIFERAL_CLOCK
2.7027027027%	1	37	166	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SMIRNOV_RESPONSE_TO_IR_6HR_UP
2.7027027027%	1	37	165	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
2.7027027027%	1	37	165	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
2.7027027027%	1	37	164	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
2.7027027027%	1	37	163	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SERVITJA_ISLET_HNF1A_TARGETS_UP
2.7027027027%	1	37	163	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
2.7027027027%	1	37	162	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MULLIGHAN_NPM1_SIGNATURE_3_DN
2.7027027027%	1	37	160	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
2.7027027027%	1	37	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WONG_IFNA2_RESISTANCE_UP
2.7027027027%	1	37	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN
2.7027027027%	1	37	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
2.7027027027%	1	37	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	HE_PTEN_TARGETS_UP
2.7027027027%	1	37	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHIN_BREAST_CANCER_COPY_NUMBER_DN
2.7027027027%	1	37	159	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
2.7027027027%	1	37	159	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_PURINE_METABOLISM
2.7027027027%	1	37	158	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RODRIGUES_NTN1_TARGETS_DN
2.7027027027%	1	37	157	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
2.7027027027%	1	37	152	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
2.7027027027%	1	37	151	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	IGLESIAS_E2F_TARGETS_UP
2.7027027027%	1	37	151	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
2.7027027027%	1	37	150	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BROWNE_HCMV_INFECTION_30MIN_DN
2.7027027027%	1	37	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3
2.7027027027%	1	37	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SU_KIDNEY
2.7027027027%	1	37	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP
2.7027027027%	1	37	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND
2.7027027027%	1	37	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BIOCARTA_NUCLEARRS_PATHWAY
2.7027027027%	1	37	149	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LANDIS_ERBB2_BREAST_TUMORS_324_DN
2.7027027027%	1	37	149	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GOZGIT_ESR1_TARGETS_UP
2.7027027027%	1	37	148	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_APOPTOSIS
2.7027027027%	1	37	148	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BROWNE_HCMV_INFECTION_24HR_UP
2.7027027027%	1	37	147	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SMID_BREAST_CANCER_ERBB2_UP
2.7027027027%	1	37	147	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
2.7027027027%	1	37	147	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KAUFFMANN_DNA_REPLICATION_GENES
2.7027027027%	1	37	146	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PECE_MAMMARY_STEM_CELL_UP
2.7027027027%	1	37	146	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PECE_MAMMARY_STEM_CELL_DN
2.7027027027%	1	37	146	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ELVIDGE_HYPOXIA_DN
2.7027027027%	1	37	146	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
2.7027027027%	1	37	145	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHANG_BREAST_CANCER_PROGENITORS_DN
2.7027027027%	1	37	145	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SMITH_TERT_TARGETS_UP
2.7027027027%	1	37	145	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
2.7027027027%	1	37	143	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION
2.7027027027%	1	37	142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	XU_GH1_AUTOCRINE_TARGETS_DN
2.7027027027%	1	37	142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RUIZ_TNC_TARGETS_DN
2.7027027027%	1	37	142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PENG_LEUCINE_DEPRIVATION_UP
2.7027027027%	1	37	142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
2.7027027027%	1	37	141	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WELCSH_BRCA1_TARGETS_DN
2.7027027027%	1	37	141	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KAAB_FAILED_HEART_ATRIUM_DN
2.7027027027%	1	37	140	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
2.7027027027%	1	37	140	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
2.7027027027%	1	37	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP
2.7027027027%	1	37	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER
2.7027027027%	1	37	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION
2.7027027027%	1	37	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	INAMURA_LUNG_CANCER_SCC_DN
2.7027027027%	1	37	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
2.7027027027%	1	37	139	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
2.7027027027%	1	37	138	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
2.7027027027%	1	37	138	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
2.7027027027%	1	37	138	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	JIANG_VHL_TARGETS
2.7027027027%	1	37	135	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	UDAYAKUMAR_MED1_TARGETS_UP
2.7027027027%	1	37	134	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	POOLA_INVASIVE_BREAST_CANCER_DN
2.7027027027%	1	37	134	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHUNG_BLISTER_CYTOTOXICITY_UP
2.7027027027%	1	37	133	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON
2.7027027027%	1	37	132	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
2.7027027027%	1	37	131	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
2.7027027027%	1	37	130	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ELVIDGE_HYPOXIA_BY_DMOG_UP
2.7027027027%	1	37	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SHIN_B_CELL_LYMPHOMA_CLUSTER_1
2.7027027027%	1	37	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_POL_SWITCHING
2.7027027027%	1	37	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	IRITANI_MAD1_TARGETS_UP
2.7027027027%	1	37	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GERHOLD_RESPONSE_TO_TZD_DN
2.7027027027%	1	37	129	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BROWN_MYELOID_CELL_DEVELOPMENT_DN
2.7027027027%	1	37	128	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHU_CMV_ALL_DN
2.7027027027%	1	37	128	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
2.7027027027%	1	37	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
2.7027027027%	1	37	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
2.7027027027%	1	37	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GERY_CEBP_TARGETS
2.7027027027%	1	37	123	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KAYO_AGING_MUSCLE_DN
2.7027027027%	1	37	1229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARSON_BOUND_BY_FOXP3_UNSTIMULATED
2.7027027027%	1	37	122	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	TOOKER_GEMCITABINE_RESISTANCE_DN
2.7027027027%	1	37	122	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
2.7027027027%	1	37	122	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
2.7027027027%	1	37	121	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
2.7027027027%	1	37	121	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RODRIGUES_DCC_TARGETS_DN
2.7027027027%	1	37	121	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
2.7027027027%	1	37	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
2.7027027027%	1	37	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHEBOTAEV_GR_TARGETS_DN
2.7027027027%	1	37	12	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS
2.7027027027%	1	37	12	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING
2.7027027027%	1	37	12	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
2.7027027027%	1	37	118	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
2.7027027027%	1	37	1174	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PEREZ_TP53_TARGETS
2.7027027027%	1	37	116	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_MEIOSIS
2.7027027027%	1	37	116	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LIM_MAMMARY_LUMINAL_MATURE_UP
2.7027027027%	1	37	116	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
2.7027027027%	1	37	115	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MARKEY_RB1_CHRONIC_LOF_UP
2.7027027027%	1	37	115	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
2.7027027027%	1	37	114	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SENESE_HDAC2_TARGETS_UP
2.7027027027%	1	37	114	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LENAOUR_DENDRITIC_CELL_MATURATION_UP
2.7027027027%	1	37	114	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEGG_OOCYTE_MEIOSIS
2.7027027027%	1	37	113	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
2.7027027027%	1	37	112	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_DNA_REPAIR
2.7027027027%	1	37	112	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LAIHO_COLORECTAL_CANCER_SERRATED_UP
2.7027027027%	1	37	112	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LABBE_WNT3A_TARGETS_UP
2.7027027027%	1	37	112	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
2.7027027027%	1	37	111	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
2.7027027027%	1	37	110	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SUNG_METASTASIS_STROMA_UP
2.7027027027%	1	37	110	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
2.7027027027%	1	37	110	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
2.7027027027%	1	37	110	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
2.7027027027%	1	37	110	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	GROSS_HYPOXIA_VIA_HIF1A_DN
2.7027027027%	1	37	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_IL_7_SIGNALING
2.7027027027%	1	37	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS
2.7027027027%	1	37	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KALMA_E2F1_TARGETS
2.7027027027%	1	37	109	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_S_PHASE
2.7027027027%	1	37	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
2.7027027027%	1	37	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	LE_EGR2_TARGETS_DN
2.7027027027%	1	37	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
2.7027027027%	1	37	106	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
2.7027027027%	1	37	106	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
2.7027027027%	1	37	104	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
2.7027027027%	1	37	104	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	NAKAMURA_ADIPOGENESIS_LATE_UP
2.7027027027%	1	37	103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
2.7027027027%	1	37	103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	KIM_MYCN_AMPLIFICATION_TARGETS_DN
2.7027027027%	1	37	102	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DER_IFN_BETA_RESPONSE_UP
2.7027027027%	1	37	102	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
2.7027027027%	1	37	101	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	WIELAND_UP_BY_HBV_INFECTION
2.7027027027%	1	37	101	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
2.7027027027%	1	37	100	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	MCCLUNG_CREB1_TARGETS_UP
2.7027027027%	1	37	100	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
2.7027027027%	1	37	100	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BENPORATH_ES_CORE_NINE_CORRELATED
2.7027027027%	1	37	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	YEMELYANOV_GR_TARGETS_DN
2.7027027027%	1	37	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND
2.7027027027%	1	37	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	PYEON_HPV_POSITIVE_TUMORS_DN
2.7027027027%	1	37	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_INSULIN	BRUNEAU_SEPTATION_VENTRICULAR
2.69058295964%	12	446	940	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
2.69058295964%	12	446	933	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_IMMUNE_SYSTEM
2.69058295964%	12	446	911	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
2.69058295964%	12	446	871	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRADE_COLON_CANCER_UP
2.69058295964%	12	446	648	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BENPORATH_CYCLING_GENES
2.69058295964%	12	446	605	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CAIRO_HEPATOBLASTOMA_CLASSES_UP
2.69058295964%	12	446	602	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARTINEZ_TP53_TARGETS_UP
2.69058295964%	12	446	578	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
2.69058295964%	12	446	517	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
2.69058295964%	12	446	510	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
2.69058295964%	12	446	140	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
2.69058295964%	12	446	1210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHEN_METABOLIC_SYNDROM_NETWORK
2.69058295964%	12	446	1069	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3
2.68610897928%	35	1303	973	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ACEVEDO_LIVER_CANCER_UP
2.68610897928%	35	1303	848	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NUYTTEN_NIPP1_TARGETS_DN
2.68610897928%	35	1303	1011	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
2.68490374873%	53	1974	425	Mendelian_Nancy_Cox	ZHANG_BREAST_CANCER_PROGENITORS_UP
2.68490374873%	53	1974	397	Mendelian_Nancy_Cox	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
2.68490374873%	53	1974	338	Mendelian_Nancy_Cox	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
2.68490374873%	53	1974	335	Mendelian_Nancy_Cox	WONG_EMBRYONIC_STEM_CELL_CORE
2.68490374873%	53	1974	309	Mendelian_Nancy_Cox	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
2.68490374873%	53	1974	293	Mendelian_Nancy_Cox	ZHANG_TLX_TARGETS_60HR_UP
2.68490374873%	53	1974	244	Mendelian_Nancy_Cox	KAYO_AGING_MUSCLE_UP
2.68490374873%	53	1974	205	Mendelian_Nancy_Cox	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
2.68490374873%	53	1974	189	Mendelian_Nancy_Cox	BURTON_ADIPOGENESIS_6
2.6792750197%	34	1269	957	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LOPEZ_MBD_TARGETS
2.6792750197%	34	1269	911	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
2.6792750197%	34	1269	769	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NUYTTEN_NIPP1_TARGETS_UP
2.6792750197%	34	1269	1375	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DODD_NASOPHARYNGEAL_CARCINOMA_DN
2.6792750197%	34	1269	1137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_LATE
2.6723677178%	50	1871	602	T2D_GENES_TANYA_HEIGHT	MARTINEZ_TP53_TARGETS_UP
2.6723677178%	50	1871	455	T2D_GENES_TANYA_HEIGHT	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
2.67045454545%	94	3520	911	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
2.67045454545%	94	3520	811	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
2.66789328427%	58	2174	567	T2D_GENES_TANYA_LIPIDS	CHICAS_RB1_TARGETS_CONFLUENT
2.66789328427%	58	2174	526	T2D_GENES_TANYA_LIPIDS	ONKEN_UVEAL_MELANOMA_DN
2.66789328427%	58	2174	514	T2D_GENES_TANYA_LIPIDS	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
2.66789328427%	58	2174	457	T2D_GENES_TANYA_LIPIDS	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
2.65183917879%	31	1169	918	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JOHNSTONE_PARVB_TARGETS_3_DN
2.65183917879%	31	1169	745	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_BMP2_TARGETS_UP
2.65183917879%	31	1169	720	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
2.65183917879%	31	1169	658	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
2.65183917879%	31	1169	570	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
2.65183917879%	31	1169	473	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GARY_CD5_TARGETS_UP
2.65183917879%	31	1169	244	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HSIAO_LIVER_SPECIFIC_GENES
2.64204545455%	93	3520	824	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
2.63736263736%	12	455	783	T2D_GENES_TANYA_BLOODPRESSURE	ONKEN_UVEAL_MELANOMA_UP
2.63736263736%	12	455	722	T2D_GENES_TANYA_BLOODPRESSURE	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
2.63736263736%	12	455	721	T2D_GENES_TANYA_BLOODPRESSURE	WONG_ADULT_TISSUE_STEM_MODULE
2.63736263736%	12	455	71	T2D_GENES_TANYA_BLOODPRESSURE	GEORGANTAS_HSC_MARKERS
2.63736263736%	12	455	673	T2D_GENES_TANYA_BLOODPRESSURE	MARTINEZ_RB1_TARGETS_UP
2.63736263736%	12	455	572	T2D_GENES_TANYA_BLOODPRESSURE	CHICAS_RB1_TARGETS_SENESCENT
2.63736263736%	12	455	544	T2D_GENES_TANYA_BLOODPRESSURE	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
2.63736263736%	12	455	539	T2D_GENES_TANYA_BLOODPRESSURE	LIAO_METASTASIS
2.63736263736%	12	455	517	T2D_GENES_TANYA_BLOODPRESSURE	RAO_BOUND_BY_SALL4_ISOFORM_B
2.63736263736%	12	455	491	T2D_GENES_TANYA_BLOODPRESSURE	SWEET_LUNG_CANCER_KRAS_UP
2.63736263736%	12	455	487	T2D_GENES_TANYA_BLOODPRESSURE	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
2.63736263736%	12	455	485	T2D_GENES_TANYA_BLOODPRESSURE	ENK_UV_RESPONSE_KERATINOCYTE_DN
2.63736263736%	12	455	479	T2D_GENES_TANYA_BLOODPRESSURE	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
2.63736263736%	12	455	457	T2D_GENES_TANYA_BLOODPRESSURE	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
2.63736263736%	12	455	448	T2D_GENES_TANYA_BLOODPRESSURE	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
2.63736263736%	12	455	445	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
2.63736263736%	12	455	443	T2D_GENES_TANYA_BLOODPRESSURE	DELYS_THYROID_CANCER_UP
2.63736263736%	12	455	435	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
2.63736263736%	12	455	434	T2D_GENES_TANYA_BLOODPRESSURE	BAELDE_DIABETIC_NEPHROPATHY_DN
2.63736263736%	12	455	430	T2D_GENES_TANYA_BLOODPRESSURE	VECCHI_GASTRIC_CANCER_EARLY_UP
2.63736263736%	12	455	430	T2D_GENES_TANYA_BLOODPRESSURE	JOHNSTONE_PARVB_TARGETS_3_UP
2.63736263736%	12	455	428	T2D_GENES_TANYA_BLOODPRESSURE	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
2.63736263736%	12	455	414	T2D_GENES_TANYA_BLOODPRESSURE	MOHANKUMAR_TLX1_TARGETS_UP
2.63736263736%	12	455	405	T2D_GENES_TANYA_BLOODPRESSURE	KUMAR_TARGETS_OF_MLL_AF9_FUSION
2.63736263736%	12	455	398	T2D_GENES_TANYA_BLOODPRESSURE	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
2.63736263736%	12	455	374	T2D_GENES_TANYA_BLOODPRESSURE	WANG_TUMOR_INVASIVENESS_UP
2.63736263736%	12	455	353	T2D_GENES_TANYA_BLOODPRESSURE	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
2.63736263736%	12	455	335	T2D_GENES_TANYA_BLOODPRESSURE	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
2.63736263736%	12	455	329	T2D_GENES_TANYA_BLOODPRESSURE	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
2.63736263736%	12	455	293	T2D_GENES_TANYA_BLOODPRESSURE	ZWANG_DOWN_BY_2ND_EGF_PULSE
2.63736263736%	12	455	289	T2D_GENES_TANYA_BLOODPRESSURE	WANG_MLL_TARGETS
2.63736263736%	12	455	269	T2D_GENES_TANYA_BLOODPRESSURE	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
2.63736263736%	12	455	228	T2D_GENES_TANYA_BLOODPRESSURE	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
2.63424518744%	52	1974	516	Mendelian_Nancy_Cox	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
2.63424518744%	52	1974	412	Mendelian_Nancy_Cox	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
2.63424518744%	52	1974	411	Mendelian_Nancy_Cox	KOYAMA_SEMA3B_TARGETS_DN
2.63424518744%	52	1974	349	Mendelian_Nancy_Cox	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
2.63424518744%	52	1974	239	Mendelian_Nancy_Cox	ALFANO_MYC_TARGETS
2.6218951242%	57	2174	722	T2D_GENES_TANYA_LIPIDS	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
2.6218951242%	57	2174	543	T2D_GENES_TANYA_LIPIDS	MARTINEZ_RB1_TARGETS_DN
2.6218951242%	57	2174	539	T2D_GENES_TANYA_LIPIDS	LIAO_METASTASIS
2.6218951242%	57	2174	517	T2D_GENES_TANYA_LIPIDS	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
2.6218951242%	57	2174	412	T2D_GENES_TANYA_LIPIDS	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
2.61892036344%	49	1871	473	T2D_GENES_TANYA_HEIGHT	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
2.61892036344%	49	1871	430	T2D_GENES_TANYA_HEIGHT	VECCHI_GASTRIC_CANCER_EARLY_UP
2.61892036344%	49	1871	428	T2D_GENES_TANYA_HEIGHT	LIM_MAMMARY_STEM_CELL_DN
2.61892036344%	49	1871	210	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANSCRIPTION
2.61892036344%	49	1871	120	T2D_GENES_TANYA_HEIGHT	NIKOLSKY_BREAST_CANCER_16P13_AMPLICON
2.61363636364%	92	3520	728	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARSON_BOUND_BY_E2F4_UNSTIMULATED
2.6101141925%	16	613	781	T2D_GENES_TANYA_BIOMARKER	GOZGIT_ESR1_TARGETS_DN
2.6101141925%	16	613	721	T2D_GENES_TANYA_BIOMARKER	WONG_ADULT_TISSUE_STEM_MODULE
2.6101141925%	16	613	663	T2D_GENES_TANYA_BIOMARKER	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
2.6101141925%	16	613	570	T2D_GENES_TANYA_BIOMARKER	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
2.6101141925%	16	613	566	T2D_GENES_TANYA_BIOMARKER	DOUGLAS_BMI1_TARGETS_UP
2.6101141925%	16	613	539	T2D_GENES_TANYA_BIOMARKER	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
2.6101141925%	16	613	487	T2D_GENES_TANYA_BIOMARKER	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
2.6101141925%	16	613	473	T2D_GENES_TANYA_BIOMARKER	GARY_CD5_TARGETS_UP
2.6101141925%	16	613	466	T2D_GENES_TANYA_BIOMARKER	REACTOME_HEMOSTASIS
2.6101141925%	16	613	431	T2D_GENES_TANYA_BIOMARKER	GARY_CD5_TARGETS_DN
2.6101141925%	16	613	430	T2D_GENES_TANYA_BIOMARKER	VECCHI_GASTRIC_CANCER_EARLY_UP
2.6101141925%	16	613	393	T2D_GENES_TANYA_BIOMARKER	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
2.6101141925%	16	613	380	T2D_GENES_TANYA_BIOMARKER	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
2.6101141925%	16	613	266	T2D_GENES_TANYA_BIOMARKER	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
2.60936300844%	34	1303	855	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
2.60936300844%	34	1303	602	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTINEZ_TP53_TARGETS_UP
2.60936300844%	34	1303	601	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTINEZ_RB1_AND_TP53_TARGETS_UP
2.60936300844%	34	1303	1037	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NUYTTEN_EZH2_TARGETS_UP
2.60047281324%	33	1269	940	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
2.60047281324%	33	1269	855	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
2.60047281324%	33	1269	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRANSCRIPTION
2.58522727273%	91	3520	857	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTENS_TRETINOIN_RESPONSE_UP
2.58358662614%	51	1974	430	Mendelian_Nancy_Cox	VECCHI_GASTRIC_CANCER_EARLY_UP
2.58358662614%	51	1974	408	Mendelian_Nancy_Cox	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
2.58358662614%	51	1974	367	Mendelian_Nancy_Cox	DELACROIX_RARG_BOUND_MEF
2.58358662614%	51	1974	308	Mendelian_Nancy_Cox	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
2.58358662614%	51	1974	256	Mendelian_Nancy_Cox	ONDER_CDH1_TARGETS_2_UP
2.58358662614%	51	1974	182	Mendelian_Nancy_Cox	FERNANDEZ_BOUND_BY_MYC
2.58302583026%	14	542	648	T2D_GENES_TANYA_ANTHROPOMETRIC	BENPORATH_CYCLING_GENES
2.58302583026%	14	542	591	T2D_GENES_TANYA_ANTHROPOMETRIC	MARTINEZ_RB1_AND_TP53_TARGETS_DN
2.58302583026%	14	542	584	T2D_GENES_TANYA_ANTHROPOMETRIC	HAMAI_APOPTOSIS_VIA_TRAIL_UP
2.58302583026%	14	542	570	T2D_GENES_TANYA_ANTHROPOMETRIC	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
2.58302583026%	14	542	548	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_ALL_DISORDERS_CALB1_CORR_UP
2.58302583026%	14	542	546	T2D_GENES_TANYA_ANTHROPOMETRIC	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
2.58302583026%	14	542	544	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
2.58302583026%	14	542	536	T2D_GENES_TANYA_ANTHROPOMETRIC	SENESE_HDAC3_TARGETS_DN
2.58302583026%	14	542	528	T2D_GENES_TANYA_ANTHROPOMETRIC	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
2.58302583026%	14	542	526	T2D_GENES_TANYA_ANTHROPOMETRIC	ONKEN_UVEAL_MELANOMA_DN
2.58302583026%	14	542	504	T2D_GENES_TANYA_ANTHROPOMETRIC	PILON_KLF1_TARGETS_UP
2.58302583026%	14	542	491	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHENG_BOUND_BY_FOXP3
2.58302583026%	14	542	485	T2D_GENES_TANYA_ANTHROPOMETRIC	ENK_UV_RESPONSE_KERATINOCYTE_DN
2.58302583026%	14	542	483	T2D_GENES_TANYA_ANTHROPOMETRIC	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
2.58302583026%	14	542	482	T2D_GENES_TANYA_ANTHROPOMETRIC	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
2.58302583026%	14	542	479	T2D_GENES_TANYA_ANTHROPOMETRIC	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
2.58302583026%	14	542	448	T2D_GENES_TANYA_ANTHROPOMETRIC	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
2.58302583026%	14	542	447	T2D_GENES_TANYA_ANTHROPOMETRIC	MOOTHA_MITOCHONDRIA
2.58302583026%	14	542	443	T2D_GENES_TANYA_ANTHROPOMETRIC	DELYS_THYROID_CANCER_UP
2.58302583026%	14	542	435	T2D_GENES_TANYA_ANTHROPOMETRIC	SWEET_LUNG_CANCER_KRAS_DN
2.58302583026%	14	542	431	T2D_GENES_TANYA_ANTHROPOMETRIC	GARY_CD5_TARGETS_DN
2.58302583026%	14	542	420	T2D_GENES_TANYA_ANTHROPOMETRIC	MOOTHA_PGC
2.58302583026%	14	542	419	T2D_GENES_TANYA_ANTHROPOMETRIC	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
2.58302583026%	14	542	414	T2D_GENES_TANYA_ANTHROPOMETRIC	MOHANKUMAR_TLX1_TARGETS_UP
2.58302583026%	14	542	403	T2D_GENES_TANYA_ANTHROPOMETRIC	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
2.58302583026%	14	542	397	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
2.58302583026%	14	542	366	T2D_GENES_TANYA_ANTHROPOMETRIC	YOSHIMURA_MAPK8_TARGETS_DN
2.58302583026%	14	542	315	T2D_GENES_TANYA_ANTHROPOMETRIC	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
2.58302583026%	14	542	269	T2D_GENES_TANYA_ANTHROPOMETRIC	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
2.58302583026%	14	542	221	T2D_GENES_TANYA_ANTHROPOMETRIC	CHANDRAN_METASTASIS_UP
2.58302583026%	14	542	102	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_IPS_WITH_HCP_H3K27ME3
2.57589696412%	56	2174	564	T2D_GENES_TANYA_LIPIDS	SMID_BREAST_CANCER_LUMINAL_B_DN
2.57589696412%	56	2174	535	T2D_GENES_TANYA_LIPIDS	STEIN_ESRRA_TARGETS
2.57589696412%	56	2174	510	T2D_GENES_TANYA_LIPIDS	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
2.57589696412%	56	2174	491	T2D_GENES_TANYA_LIPIDS	SWEET_LUNG_CANCER_KRAS_UP
2.57589696412%	56	2174	476	T2D_GENES_TANYA_LIPIDS	SMID_BREAST_CANCER_NORMAL_LIKE_UP
2.57589696412%	56	2174	463	T2D_GENES_TANYA_LIPIDS	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
2.57589696412%	56	2174	463	T2D_GENES_TANYA_LIPIDS	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
2.57589696412%	56	2174	445	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
2.57186081694%	17	661	734	T2D_GENES_TANYA_GLYCEMIC	BENPORATH_SOX2_TARGETS
2.57186081694%	17	661	579	T2D_GENES_TANYA_GLYCEMIC	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
2.57186081694%	17	661	530	T2D_GENES_TANYA_GLYCEMIC	ENK_UV_RESPONSE_KERATINOCYTE_UP
2.57186081694%	17	661	475	T2D_GENES_TANYA_GLYCEMIC	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
2.57186081694%	17	661	445	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
2.57186081694%	17	661	384	T2D_GENES_TANYA_GLYCEMIC	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
2.57186081694%	17	661	351	T2D_GENES_TANYA_GLYCEMIC	YAGI_AML_WITH_11Q23_REARRANGED
2.56629597947%	30	1169	882	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_BMP2_TARGETS_DN
2.56629597947%	30	1169	770	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
2.56629597947%	30	1169	682	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
2.56629597947%	30	1169	663	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
2.56629597947%	30	1169	487	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RODWELL_AGING_KIDNEY_UP
2.56547300909%	48	1871	578	T2D_GENES_TANYA_HEIGHT	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
2.56547300909%	48	1871	557	T2D_GENES_TANYA_HEIGHT	TIEN_INTESTINE_PROBIOTICS_24HR_UP
2.56547300909%	48	1871	517	T2D_GENES_TANYA_HEIGHT	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
2.56547300909%	48	1871	514	T2D_GENES_TANYA_HEIGHT	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
2.56547300909%	48	1871	467	T2D_GENES_TANYA_HEIGHT	RATTENBACHER_BOUND_BY_CELF1
2.56547300909%	48	1871	456	T2D_GENES_TANYA_HEIGHT	ODONNELL_TFRC_TARGETS_UP
2.56547300909%	48	1871	430	T2D_GENES_TANYA_HEIGHT	JOHNSTONE_PARVB_TARGETS_3_UP
2.56547300909%	48	1871	422	T2D_GENES_TANYA_HEIGHT	YAGI_AML_WITH_INV_16_TRANSLOCATION
2.56547300909%	48	1871	368	T2D_GENES_TANYA_HEIGHT	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
2.56547300909%	48	1871	317	T2D_GENES_TANYA_HEIGHT	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
2.5641025641%	1	39	99	Diabetes_McGill_IL6	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
2.5641025641%	1	39	988	Diabetes_McGill_IL6	BENPORATH_NANOG_TARGETS
2.5641025641%	1	39	98	Diabetes_McGill_IL6	MENSE_HYPOXIA_UP
2.5641025641%	1	39	98	Diabetes_McGill_IL6	HAHTOLA_SEZARY_SYNDROM_UP
2.5641025641%	1	39	98	Diabetes_McGill_IL6	GAVIN_FOXP3_TARGETS_CLUSTER_T7
2.5641025641%	1	39	98	Diabetes_McGill_IL6	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
2.5641025641%	1	39	97	Diabetes_McGill_IL6	KIM_MYC_AMPLIFICATION_TARGETS_DN
2.5641025641%	1	39	96	Diabetes_McGill_IL6	LIU_PROSTATE_CANCER_UP
2.5641025641%	1	39	953	Diabetes_McGill_IL6	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
2.5641025641%	1	39	95	Diabetes_McGill_IL6	KAYO_CALORIE_RESTRICTION_MUSCLE_UP
2.5641025641%	1	39	95	Diabetes_McGill_IL6	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
2.5641025641%	1	39	940	Diabetes_McGill_IL6	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
2.5641025641%	1	39	94	Diabetes_McGill_IL6	HOOI_ST7_TARGETS_UP
2.5641025641%	1	39	93	Diabetes_McGill_IL6	ZHU_CMV_24_HR_UP
2.5641025641%	1	39	93	Diabetes_McGill_IL6	CADWELL_ATG16L1_TARGETS_UP
2.5641025641%	1	39	92	Diabetes_McGill_IL6	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
2.5641025641%	1	39	92	Diabetes_McGill_IL6	HILLION_HMGA1B_TARGETS
2.5641025641%	1	39	92	Diabetes_McGill_IL6	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
2.5641025641%	1	39	91	Diabetes_McGill_IL6	ZHU_CMV_24_HR_DN
2.5641025641%	1	39	91	Diabetes_McGill_IL6	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN
2.5641025641%	1	39	91	Diabetes_McGill_IL6	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
2.5641025641%	1	39	91	Diabetes_McGill_IL6	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
2.5641025641%	1	39	90	Diabetes_McGill_IL6	SASSON_RESPONSE_TO_FORSKOLIN_UP
2.5641025641%	1	39	90	Diabetes_McGill_IL6	MORI_MATURE_B_LYMPHOCYTE_UP
2.5641025641%	1	39	90	Diabetes_McGill_IL6	IGARASHI_ATF4_TARGETS_DN
2.5641025641%	1	39	90	Diabetes_McGill_IL6	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN
2.5641025641%	1	39	9	Diabetes_McGill_IL6	WANG_RESPONSE_TO_FORSKOLIN_DN
2.5641025641%	1	39	9	Diabetes_McGill_IL6	SIMBULAN_UV_RESPONSE_NORMAL_UP
2.5641025641%	1	39	9	Diabetes_McGill_IL6	SA_FAS_SIGNALING
2.5641025641%	1	39	9	Diabetes_McGill_IL6	KOMMAGANI_TP63_GAMMA_TARGETS
2.5641025641%	1	39	9	Diabetes_McGill_IL6	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN
2.5641025641%	1	39	9	Diabetes_McGill_IL6	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
2.5641025641%	1	39	89	Diabetes_McGill_IL6	SWEET_KRAS_ONCOGENIC_SIGNATURE
2.5641025641%	1	39	89	Diabetes_McGill_IL6	RICKMAN_HEAD_AND_NECK_CANCER_E
2.5641025641%	1	39	89	Diabetes_McGill_IL6	LEE_AGING_NEOCORTEX_UP
2.5641025641%	1	39	89	Diabetes_McGill_IL6	DELASERNA_MYOD_TARGETS_UP
2.5641025641%	1	39	89	Diabetes_McGill_IL6	BOYLAN_MULTIPLE_MYELOMA_D_UP
2.5641025641%	1	39	882	Diabetes_McGill_IL6	LEE_BMP2_TARGETS_DN
2.5641025641%	1	39	88	Diabetes_McGill_IL6	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
2.5641025641%	1	39	88	Diabetes_McGill_IL6	UEDA_CENTRAL_CLOCK
2.5641025641%	1	39	88	Diabetes_McGill_IL6	TIEN_INTESTINE_PROBIOTICS_2HR_DN
2.5641025641%	1	39	88	Diabetes_McGill_IL6	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
2.5641025641%	1	39	88	Diabetes_McGill_IL6	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
2.5641025641%	1	39	87	Diabetes_McGill_IL6	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
2.5641025641%	1	39	87	Diabetes_McGill_IL6	SMITH_TERT_TARGETS_DN
2.5641025641%	1	39	87	Diabetes_McGill_IL6	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
2.5641025641%	1	39	87	Diabetes_McGill_IL6	MOOTHA_VOXPHOS
2.5641025641%	1	39	87	Diabetes_McGill_IL6	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
2.5641025641%	1	39	87	Diabetes_McGill_IL6	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
2.5641025641%	1	39	86	Diabetes_McGill_IL6	NELSON_RESPONSE_TO_ANDROGEN_UP
2.5641025641%	1	39	86	Diabetes_McGill_IL6	HOEBEKE_LYMPHOID_STEM_CELL_DN
2.5641025641%	1	39	86	Diabetes_McGill_IL6	BURTON_ADIPOGENESIS_8
2.5641025641%	1	39	85	Diabetes_McGill_IL6	XU_GH1_EXOGENOUS_TARGETS_UP
2.5641025641%	1	39	85	Diabetes_McGill_IL6	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
2.5641025641%	1	39	85	Diabetes_McGill_IL6	SANA_RESPONSE_TO_IFNG_DN
2.5641025641%	1	39	841	Diabetes_McGill_IL6	MARTENS_TRETINOIN_RESPONSE_DN
2.5641025641%	1	39	84	Diabetes_McGill_IL6	SWEET_KRAS_TARGETS_UP
2.5641025641%	1	39	84	Diabetes_McGill_IL6	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP
2.5641025641%	1	39	84	Diabetes_McGill_IL6	KIM_GLIS2_TARGETS_UP
2.5641025641%	1	39	84	Diabetes_McGill_IL6	HINATA_NFKB_TARGETS_FIBROBLAST_UP
2.5641025641%	1	39	83	Diabetes_McGill_IL6	REACTOME_AMYLOIDS
2.5641025641%	1	39	83	Diabetes_McGill_IL6	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
2.5641025641%	1	39	824	Diabetes_McGill_IL6	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
2.5641025641%	1	39	82	Diabetes_McGill_IL6	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
2.5641025641%	1	39	81	Diabetes_McGill_IL6	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
2.5641025641%	1	39	81	Diabetes_McGill_IL6	MUNSHI_MULTIPLE_MYELOMA_UP
2.5641025641%	1	39	81	Diabetes_McGill_IL6	HUANG_DASATINIB_RESISTANCE_UP
2.5641025641%	1	39	81	Diabetes_McGill_IL6	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
2.5641025641%	1	39	800	Diabetes_McGill_IL6	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
2.5641025641%	1	39	80	Diabetes_McGill_IL6	REACTOME_UNFOLDED_PROTEIN_RESPONSE
2.5641025641%	1	39	80	Diabetes_McGill_IL6	MORI_PRE_BI_LYMPHOCYTE_UP
2.5641025641%	1	39	80	Diabetes_McGill_IL6	LINDVALL_IMMORTALIZED_BY_TERT_DN
2.5641025641%	1	39	80	Diabetes_McGill_IL6	LEE_AGING_NEOCORTEX_DN
2.5641025641%	1	39	80	Diabetes_McGill_IL6	FALVELLA_SMOKERS_WITH_LUNG_CANCER
2.5641025641%	1	39	8	Diabetes_McGill_IL6	TURJANSKI_MAPK8_AND_MAPK9_TARGETS
2.5641025641%	1	39	8	Diabetes_McGill_IL6	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN
2.5641025641%	1	39	8	Diabetes_McGill_IL6	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18
2.5641025641%	1	39	8	Diabetes_McGill_IL6	MIKKELSEN_PLURIPOTENT_STATE_DN
2.5641025641%	1	39	8	Diabetes_McGill_IL6	MATZUK_LUTEAL_GENES
2.5641025641%	1	39	8	Diabetes_McGill_IL6	LE_SKI_TARGETS_DN
2.5641025641%	1	39	8	Diabetes_McGill_IL6	KONDO_HYPOXIA
2.5641025641%	1	39	8	Diabetes_McGill_IL6	GAUTSCHI_SRC_SIGNALING
2.5641025641%	1	39	8	Diabetes_McGill_IL6	GALIE_TUMOR_ANGIOGENESIS
2.5641025641%	1	39	8	Diabetes_McGill_IL6	CHANG_POU5F1_TARGETS_DN
2.5641025641%	1	39	8	Diabetes_McGill_IL6	BOYLAN_MULTIPLE_MYELOMA_PCA1_DN
2.5641025641%	1	39	79	Diabetes_McGill_IL6	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
2.5641025641%	1	39	79	Diabetes_McGill_IL6	MALONEY_RESPONSE_TO_17AAG_DN
2.5641025641%	1	39	79	Diabetes_McGill_IL6	GAVIN_FOXP3_TARGETS_CLUSTER_P2
2.5641025641%	1	39	783	Diabetes_McGill_IL6	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
2.5641025641%	1	39	78	Diabetes_McGill_IL6	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
2.5641025641%	1	39	78	Diabetes_McGill_IL6	ROSS_AML_WITH_MLL_FUSIONS
2.5641025641%	1	39	78	Diabetes_McGill_IL6	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
2.5641025641%	1	39	78	Diabetes_McGill_IL6	RADMACHER_AML_PROGNOSIS
2.5641025641%	1	39	78	Diabetes_McGill_IL6	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
2.5641025641%	1	39	77	Diabetes_McGill_IL6	CHEBOTAEV_GR_TARGETS_UP
2.5641025641%	1	39	77	Diabetes_McGill_IL6	CARD_MIR302A_TARGETS
2.5641025641%	1	39	769	Diabetes_McGill_IL6	NUYTTEN_NIPP1_TARGETS_UP
2.5641025641%	1	39	76	Diabetes_McGill_IL6	SU_TESTIS
2.5641025641%	1	39	76	Diabetes_McGill_IL6	ROSS_AML_WITH_AML1_ETO_FUSION
2.5641025641%	1	39	76	Diabetes_McGill_IL6	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
2.5641025641%	1	39	75	Diabetes_McGill_IL6	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
2.5641025641%	1	39	75	Diabetes_McGill_IL6	PID_AVB3_INTEGRIN_PATHWAY
2.5641025641%	1	39	75	Diabetes_McGill_IL6	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
2.5641025641%	1	39	75	Diabetes_McGill_IL6	JAIN_NFKB_SIGNALING
2.5641025641%	1	39	75	Diabetes_McGill_IL6	BAE_BRCA1_TARGETS_UP
2.5641025641%	1	39	745	Diabetes_McGill_IL6	LEE_BMP2_TARGETS_UP
2.5641025641%	1	39	74	Diabetes_McGill_IL6	VANASSE_BCL2_TARGETS_DN
2.5641025641%	1	39	74	Diabetes_McGill_IL6	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS
2.5641025641%	1	39	74	Diabetes_McGill_IL6	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
2.5641025641%	1	39	74	Diabetes_McGill_IL6	FURUKAWA_DUSP6_TARGETS_PCI35_UP
2.5641025641%	1	39	74	Diabetes_McGill_IL6	DER_IFN_ALPHA_RESPONSE_UP
2.5641025641%	1	39	74	Diabetes_McGill_IL6	CAMPS_COLON_CANCER_COPY_NUMBER_DN
2.5641025641%	1	39	73	Diabetes_McGill_IL6	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
2.5641025641%	1	39	73	Diabetes_McGill_IL6	HOSHIDA_LIVER_CANCER_SURVIVAL_UP
2.5641025641%	1	39	72	Diabetes_McGill_IL6	SESTO_RESPONSE_TO_UV_C8
2.5641025641%	1	39	72	Diabetes_McGill_IL6	SESTO_RESPONSE_TO_UV_C1
2.5641025641%	1	39	72	Diabetes_McGill_IL6	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
2.5641025641%	1	39	72	Diabetes_McGill_IL6	DANG_REGULATED_BY_MYC_UP
2.5641025641%	1	39	71	Diabetes_McGill_IL6	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
2.5641025641%	1	39	71	Diabetes_McGill_IL6	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
2.5641025641%	1	39	71	Diabetes_McGill_IL6	GU_PDEF_TARGETS_UP
2.5641025641%	1	39	71	Diabetes_McGill_IL6	DER_IFN_GAMMA_RESPONSE_UP
2.5641025641%	1	39	70	Diabetes_McGill_IL6	RAGHAVACHARI_PLATELET_SPECIFIC_GENES
2.5641025641%	1	39	7	Diabetes_McGill_IL6	TESAR_JAK_TARGETS_MOUSE_ES_D3_UP
2.5641025641%	1	39	7	Diabetes_McGill_IL6	ST_INTERLEUKIN_13_PATHWAY
2.5641025641%	1	39	7	Diabetes_McGill_IL6	ST_IL_13_PATHWAY
2.5641025641%	1	39	7	Diabetes_McGill_IL6	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN
2.5641025641%	1	39	7	Diabetes_McGill_IL6	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP
2.5641025641%	1	39	7	Diabetes_McGill_IL6	MIKKELSEN_DEDIFFERENTIATED_STATE_DN
2.5641025641%	1	39	7	Diabetes_McGill_IL6	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP
2.5641025641%	1	39	7	Diabetes_McGill_IL6	FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES
2.5641025641%	1	39	7	Diabetes_McGill_IL6	BAKER_HEMATOPOESIS_STAT5_TARGETS
2.5641025641%	1	39	69	Diabetes_McGill_IL6	ZAMORA_NOS2_TARGETS_UP
2.5641025641%	1	39	69	Diabetes_McGill_IL6	LEIN_NEURON_MARKERS
2.5641025641%	1	39	69	Diabetes_McGill_IL6	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
2.5641025641%	1	39	681	Diabetes_McGill_IL6	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
2.5641025641%	1	39	68	Diabetes_McGill_IL6	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
2.5641025641%	1	39	67	Diabetes_McGill_IL6	LINDSTEDT_DENDRITIC_CELL_MATURATION_A
2.5641025641%	1	39	67	Diabetes_McGill_IL6	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
2.5641025641%	1	39	67	Diabetes_McGill_IL6	DAZARD_UV_RESPONSE_CLUSTER_G1
2.5641025641%	1	39	67	Diabetes_McGill_IL6	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70
2.5641025641%	1	39	66	Diabetes_McGill_IL6	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
2.5641025641%	1	39	66	Diabetes_McGill_IL6	SWEET_KRAS_TARGETS_DN
2.5641025641%	1	39	66	Diabetes_McGill_IL6	PID_HIF1_TFPATHWAY
2.5641025641%	1	39	66	Diabetes_McGill_IL6	PID_HDAC_CLASSI_PATHWAY
2.5641025641%	1	39	66	Diabetes_McGill_IL6	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
2.5641025641%	1	39	66	Diabetes_McGill_IL6	BRUNO_HEMATOPOIESIS
2.5641025641%	1	39	66	Diabetes_McGill_IL6	BEIER_GLIOMA_STEM_CELL_DN
2.5641025641%	1	39	652	Diabetes_McGill_IL6	BENPORATH_PRC2_TARGETS
2.5641025641%	1	39	65	Diabetes_McGill_IL6	PID_ERA_GENOMIC_PATHWAY
2.5641025641%	1	39	65	Diabetes_McGill_IL6	PID_CD8TCRDOWNSTREAMPATHWAY
2.5641025641%	1	39	64	Diabetes_McGill_IL6	PETROVA_PROX1_TARGETS_DN
2.5641025641%	1	39	64	Diabetes_McGill_IL6	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
2.5641025641%	1	39	64	Diabetes_McGill_IL6	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
2.5641025641%	1	39	64	Diabetes_McGill_IL6	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
2.5641025641%	1	39	63	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
2.5641025641%	1	39	63	Diabetes_McGill_IL6	PID_MYC_REPRESSPATHWAY
2.5641025641%	1	39	63	Diabetes_McGill_IL6	PHONG_TNF_TARGETS_UP
2.5641025641%	1	39	63	Diabetes_McGill_IL6	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
2.5641025641%	1	39	63	Diabetes_McGill_IL6	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
2.5641025641%	1	39	63	Diabetes_McGill_IL6	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
2.5641025641%	1	39	63	Diabetes_McGill_IL6	CROMER_TUMORIGENESIS_UP
2.5641025641%	1	39	63	Diabetes_McGill_IL6	BURTON_ADIPOGENESIS_PEAK_AT_0HR
2.5641025641%	1	39	62	Diabetes_McGill_IL6	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
2.5641025641%	1	39	62	Diabetes_McGill_IL6	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP
2.5641025641%	1	39	62	Diabetes_McGill_IL6	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
2.5641025641%	1	39	62	Diabetes_McGill_IL6	GEORGES_CELL_CYCLE_MIR192_TARGETS
2.5641025641%	1	39	61	Diabetes_McGill_IL6	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
2.5641025641%	1	39	61	Diabetes_McGill_IL6	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
2.5641025641%	1	39	61	Diabetes_McGill_IL6	LEE_LIVER_CANCER_MYC_TGFA_UP
2.5641025641%	1	39	605	Diabetes_McGill_IL6	CAIRO_HEPATOBLASTOMA_CLASSES_UP
2.5641025641%	1	39	60	Diabetes_McGill_IL6	WIERENGA_STAT5A_TARGETS_GROUP2
2.5641025641%	1	39	60	Diabetes_McGill_IL6	CROONQUIST_STROMAL_STIMULATION_UP
2.5641025641%	1	39	6	Diabetes_McGill_IL6	WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP
2.5641025641%	1	39	6	Diabetes_McGill_IL6	ELVIDGE_HIF2A_TARGETS_UP
2.5641025641%	1	39	6	Diabetes_McGill_IL6	COURTOIS_SENESCENCE_TRIGGERS
2.5641025641%	1	39	593	Diabetes_McGill_IL6	MARTINEZ_TP53_TARGETS_DN
2.5641025641%	1	39	59	Diabetes_McGill_IL6	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
2.5641025641%	1	39	59	Diabetes_McGill_IL6	PID_P53REGULATIONPATHWAY
2.5641025641%	1	39	59	Diabetes_McGill_IL6	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
2.5641025641%	1	39	59	Diabetes_McGill_IL6	BARIS_THYROID_CANCER_DN
2.5641025641%	1	39	584	Diabetes_McGill_IL6	HAMAI_APOPTOSIS_VIA_TRAIL_UP
2.5641025641%	1	39	58	Diabetes_McGill_IL6	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
2.5641025641%	1	39	58	Diabetes_McGill_IL6	NAGASHIMA_NRG1_SIGNALING_DN
2.5641025641%	1	39	58	Diabetes_McGill_IL6	MIKKELSEN_NPC_LCP_WITH_H3K4ME3
2.5641025641%	1	39	58	Diabetes_McGill_IL6	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
2.5641025641%	1	39	58	Diabetes_McGill_IL6	JI_RESPONSE_TO_FSH_DN
2.5641025641%	1	39	58	Diabetes_McGill_IL6	BIOCARTA_HIVNEF_PATHWAY
2.5641025641%	1	39	58	Diabetes_McGill_IL6	BERNARD_PPAPDC1B_TARGETS_DN
2.5641025641%	1	39	578	Diabetes_McGill_IL6	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
2.5641025641%	1	39	57	Diabetes_McGill_IL6	PID_TXA2PATHWAY
2.5641025641%	1	39	57	Diabetes_McGill_IL6	MCCLUNG_CREB1_TARGETS_DN
2.5641025641%	1	39	57	Diabetes_McGill_IL6	LEE_EARLY_T_LYMPHOCYTE_DN
2.5641025641%	1	39	57	Diabetes_McGill_IL6	GRABARCZYK_BCL11B_TARGETS_DN
2.5641025641%	1	39	57	Diabetes_McGill_IL6	AMIT_SERUM_RESPONSE_240_MCF10A
2.5641025641%	1	39	56	Diabetes_McGill_IL6	VANTVEER_BREAST_CANCER_METASTASIS_UP
2.5641025641%	1	39	56	Diabetes_McGill_IL6	MAYBURD_RESPONSE_TO_L663536_DN
2.5641025641%	1	39	56	Diabetes_McGill_IL6	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
2.5641025641%	1	39	56	Diabetes_McGill_IL6	GRADE_COLON_VS_RECTAL_CANCER_DN
2.5641025641%	1	39	56	Diabetes_McGill_IL6	GALE_APL_WITH_FLT3_MUTATED_UP
2.5641025641%	1	39	56	Diabetes_McGill_IL6	BROWNE_HCMV_INFECTION_30MIN_UP
2.5641025641%	1	39	56	Diabetes_McGill_IL6	BIOCARTA_NFAT_PATHWAY
2.5641025641%	1	39	557	Diabetes_McGill_IL6	TIEN_INTESTINE_PROBIOTICS_24HR_UP
2.5641025641%	1	39	553	Diabetes_McGill_IL6	FEVR_CTNNB1_TARGETS_DN
2.5641025641%	1	39	55	Diabetes_McGill_IL6	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
2.5641025641%	1	39	55	Diabetes_McGill_IL6	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
2.5641025641%	1	39	55	Diabetes_McGill_IL6	TIEN_INTESTINE_PROBIOTICS_6HR_UP
2.5641025641%	1	39	55	Diabetes_McGill_IL6	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER
2.5641025641%	1	39	55	Diabetes_McGill_IL6	LAU_APOPTOSIS_CDKN2A_UP
2.5641025641%	1	39	55	Diabetes_McGill_IL6	BROWNE_HCMV_INFECTION_4HR_UP
2.5641025641%	1	39	546	Diabetes_McGill_IL6	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
2.5641025641%	1	39	540	Diabetes_McGill_IL6	ACEVEDO_LIVER_CANCER_DN
2.5641025641%	1	39	54	Diabetes_McGill_IL6	ZHOU_TNF_SIGNALING_30MIN
2.5641025641%	1	39	54	Diabetes_McGill_IL6	PID_TAP63PATHWAY
2.5641025641%	1	39	54	Diabetes_McGill_IL6	PID_RAC1_PATHWAY
2.5641025641%	1	39	54	Diabetes_McGill_IL6	MARSON_FOXP3_TARGETS_DN
2.5641025641%	1	39	54	Diabetes_McGill_IL6	FIGUEROA_AML_METHYLATION_CLUSTER_2_UP
2.5641025641%	1	39	536	Diabetes_McGill_IL6	SENESE_HDAC3_TARGETS_DN
2.5641025641%	1	39	535	Diabetes_McGill_IL6	STEIN_ESRRA_TARGETS
2.5641025641%	1	39	53	Diabetes_McGill_IL6	ZHU_CMV_8_HR_DN
2.5641025641%	1	39	53	Diabetes_McGill_IL6	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
2.5641025641%	1	39	53	Diabetes_McGill_IL6	MENSSEN_MYC_TARGETS
2.5641025641%	1	39	53	Diabetes_McGill_IL6	LIANG_SILENCED_BY_METHYLATION_2
2.5641025641%	1	39	53	Diabetes_McGill_IL6	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
2.5641025641%	1	39	53	Diabetes_McGill_IL6	KRIEG_HYPOXIA_VIA_KDM3A
2.5641025641%	1	39	53	Diabetes_McGill_IL6	IKEDA_MIR1_TARGETS_UP
2.5641025641%	1	39	526	Diabetes_McGill_IL6	ONKEN_UVEAL_MELANOMA_DN
2.5641025641%	1	39	52	Diabetes_McGill_IL6	WINTER_HYPOXIA_DN
2.5641025641%	1	39	52	Diabetes_McGill_IL6	KENNY_CTNNB1_TARGETS_DN
2.5641025641%	1	39	52	Diabetes_McGill_IL6	HALMOS_CEBPA_TARGETS_UP
2.5641025641%	1	39	52	Diabetes_McGill_IL6	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP
2.5641025641%	1	39	517	Diabetes_McGill_IL6	RAO_BOUND_BY_SALL4_ISOFORM_B
2.5641025641%	1	39	51	Diabetes_McGill_IL6	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
2.5641025641%	1	39	51	Diabetes_McGill_IL6	ZHANG_PROLIFERATING_VS_QUIESCENT
2.5641025641%	1	39	51	Diabetes_McGill_IL6	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
2.5641025641%	1	39	51	Diabetes_McGill_IL6	LEE_CALORIE_RESTRICTION_MUSCLE_DN
2.5641025641%	1	39	51	Diabetes_McGill_IL6	GUILLAUMOND_KLF10_TARGETS_UP
2.5641025641%	1	39	51	Diabetes_McGill_IL6	BURTON_ADIPOGENESIS_PEAK_AT_2HR
2.5641025641%	1	39	51	Diabetes_McGill_IL6	BURTON_ADIPOGENESIS_7
2.5641025641%	1	39	50	Diabetes_McGill_IL6	YANG_BREAST_CANCER_ESR1_LASER_DN
2.5641025641%	1	39	50	Diabetes_McGill_IL6	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN
2.5641025641%	1	39	50	Diabetes_McGill_IL6	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
2.5641025641%	1	39	50	Diabetes_McGill_IL6	KENNY_CTNNB1_TARGETS_UP
2.5641025641%	1	39	50	Diabetes_McGill_IL6	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
2.5641025641%	1	39	5	Diabetes_McGill_IL6	TURJANSKI_MAPK11_TARGETS
2.5641025641%	1	39	5	Diabetes_McGill_IL6	LAU_APOPTOSIS_CDKN2A_DN
2.5641025641%	1	39	5	Diabetes_McGill_IL6	INAMURA_LUNG_CANCER_SCC_SUBTYPES_DN
2.5641025641%	1	39	491	Diabetes_McGill_IL6	MEISSNER_NPC_HCP_WITH_H3K4ME2
2.5641025641%	1	39	49	Diabetes_McGill_IL6	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
2.5641025641%	1	39	49	Diabetes_McGill_IL6	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
2.5641025641%	1	39	49	Diabetes_McGill_IL6	MARCHINI_TRABECTEDIN_RESISTANCE_DN
2.5641025641%	1	39	49	Diabetes_McGill_IL6	FAELT_B_CLL_WITH_VH3_21_DN
2.5641025641%	1	39	49	Diabetes_McGill_IL6	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
2.5641025641%	1	39	49	Diabetes_McGill_IL6	APRELIKOVA_BRCA1_TARGETS
2.5641025641%	1	39	487	Diabetes_McGill_IL6	RODWELL_AGING_KIDNEY_UP
2.5641025641%	1	39	485	Diabetes_McGill_IL6	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
2.5641025641%	1	39	485	Diabetes_McGill_IL6	ENK_UV_RESPONSE_KERATINOCYTE_DN
2.5641025641%	1	39	482	Diabetes_McGill_IL6	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
2.5641025641%	1	39	48	Diabetes_McGill_IL6	RASHI_RESPONSE_TO_IONIZING_RADIATION_3
2.5641025641%	1	39	48	Diabetes_McGill_IL6	PENG_GLUCOSE_DEPRIVATION_UP
2.5641025641%	1	39	48	Diabetes_McGill_IL6	GNATENKO_PLATELET_SIGNATURE
2.5641025641%	1	39	48	Diabetes_McGill_IL6	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
2.5641025641%	1	39	48	Diabetes_McGill_IL6	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN
2.5641025641%	1	39	48	Diabetes_McGill_IL6	ENGELMANN_CANCER_PROGENITORS_UP
2.5641025641%	1	39	47	Diabetes_McGill_IL6	ZHU_CMV_8_HR_UP
2.5641025641%	1	39	47	Diabetes_McGill_IL6	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
2.5641025641%	1	39	47	Diabetes_McGill_IL6	WARTERS_IR_RESPONSE_5GY
2.5641025641%	1	39	47	Diabetes_McGill_IL6	POTTI_DOCETAXEL_SENSITIVITY
2.5641025641%	1	39	47	Diabetes_McGill_IL6	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
2.5641025641%	1	39	469	Diabetes_McGill_IL6	MCCABE_BOUND_BY_HOXC6
2.5641025641%	1	39	463	Diabetes_McGill_IL6	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
2.5641025641%	1	39	463	Diabetes_McGill_IL6	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
2.5641025641%	1	39	461	Diabetes_McGill_IL6	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
2.5641025641%	1	39	46	Diabetes_McGill_IL6	ZHAN_MULTIPLE_MYELOMA_CD2_DN
2.5641025641%	1	39	46	Diabetes_McGill_IL6	TSENG_ADIPOGENIC_POTENTIAL_DN
2.5641025641%	1	39	46	Diabetes_McGill_IL6	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6
2.5641025641%	1	39	46	Diabetes_McGill_IL6	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
2.5641025641%	1	39	46	Diabetes_McGill_IL6	PID_SYNDECAN_1_PATHWAY
2.5641025641%	1	39	46	Diabetes_McGill_IL6	PARENT_MTOR_SIGNALING_DN
2.5641025641%	1	39	46	Diabetes_McGill_IL6	LEE_AGING_MUSCLE_DN
2.5641025641%	1	39	46	Diabetes_McGill_IL6	KRASNOSELSKAYA_ILF3_TARGETS_DN
2.5641025641%	1	39	46	Diabetes_McGill_IL6	BIOCARTA_KERATINOCYTE_PATHWAY
2.5641025641%	1	39	45	Diabetes_McGill_IL6	ZHAN_MULTIPLE_MYELOMA_CD1_UP
2.5641025641%	1	39	45	Diabetes_McGill_IL6	ZHAN_MULTIPLE_MYELOMA_CD1_DN
2.5641025641%	1	39	45	Diabetes_McGill_IL6	TRAYNOR_RETT_SYNDROM_UP
2.5641025641%	1	39	45	Diabetes_McGill_IL6	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN
2.5641025641%	1	39	45	Diabetes_McGill_IL6	PID_RHOA_PATHWAY
2.5641025641%	1	39	45	Diabetes_McGill_IL6	PID_ILK_PATHWAY
2.5641025641%	1	39	45	Diabetes_McGill_IL6	LUI_THYROID_CANCER_PAX8_PPARG_DN
2.5641025641%	1	39	45	Diabetes_McGill_IL6	HUANG_FOXA2_TARGETS_UP
2.5641025641%	1	39	45	Diabetes_McGill_IL6	GRADE_METASTASIS_DN
2.5641025641%	1	39	45	Diabetes_McGill_IL6	CHENG_RESPONSE_TO_NICKEL_ACETATE
2.5641025641%	1	39	45	Diabetes_McGill_IL6	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP
2.5641025641%	1	39	45	Diabetes_McGill_IL6	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
2.5641025641%	1	39	445	Diabetes_McGill_IL6	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
2.5641025641%	1	39	44	Diabetes_McGill_IL6	ZUCCHI_METASTASIS_DN
2.5641025641%	1	39	44	Diabetes_McGill_IL6	ZHAN_MULTIPLE_MYELOMA_PR_DN
2.5641025641%	1	39	44	Diabetes_McGill_IL6	XU_CREBBP_TARGETS_DN
2.5641025641%	1	39	44	Diabetes_McGill_IL6	STREICHER_LSM1_TARGETS_UP
2.5641025641%	1	39	44	Diabetes_McGill_IL6	PID_HNF3APATHWAY
2.5641025641%	1	39	44	Diabetes_McGill_IL6	MEDINA_SMARCA4_TARGETS
2.5641025641%	1	39	435	Diabetes_McGill_IL6	SWEET_LUNG_CANCER_KRAS_DN
2.5641025641%	1	39	430	Diabetes_McGill_IL6	JOHNSTONE_PARVB_TARGETS_3_UP
2.5641025641%	1	39	43	Diabetes_McGill_IL6	RIZ_ERYTHROID_DIFFERENTIATION_12HR
2.5641025641%	1	39	43	Diabetes_McGill_IL6	PID_CXCR3PATHWAY
2.5641025641%	1	39	43	Diabetes_McGill_IL6	MANTOVANI_NFKB_TARGETS_UP
2.5641025641%	1	39	43	Diabetes_McGill_IL6	LIU_TARGETS_OF_VMYB_VS_CMYB_DN
2.5641025641%	1	39	43	Diabetes_McGill_IL6	DORN_ADENOVIRUS_INFECTION_24HR_DN
2.5641025641%	1	39	424	Diabetes_McGill_IL6	SHEN_SMARCA2_TARGETS_UP
2.5641025641%	1	39	42	Diabetes_McGill_IL6	PID_UPA_UPAR_PATHWAY
2.5641025641%	1	39	42	Diabetes_McGill_IL6	ONO_FOXP3_TARGETS_DN
2.5641025641%	1	39	42	Diabetes_McGill_IL6	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP
2.5641025641%	1	39	42	Diabetes_McGill_IL6	KEGG_GRAFT_VERSUS_HOST_DISEASE
2.5641025641%	1	39	42	Diabetes_McGill_IL6	HAHTOLA_SEZARY_SYNDROM_DN
2.5641025641%	1	39	418	Diabetes_McGill_IL6	PEDRIOLI_MIR31_TARGETS_DN
2.5641025641%	1	39	411	Diabetes_McGill_IL6	KOYAMA_SEMA3B_TARGETS_DN
2.5641025641%	1	39	41	Diabetes_McGill_IL6	WEINMANN_ADAPTATION_TO_HYPOXIA_DN
2.5641025641%	1	39	41	Diabetes_McGill_IL6	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
2.5641025641%	1	39	41	Diabetes_McGill_IL6	LI_LUNG_CANCER
2.5641025641%	1	39	41	Diabetes_McGill_IL6	KAAB_FAILED_HEART_VENTRICLE_DN
2.5641025641%	1	39	41	Diabetes_McGill_IL6	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
2.5641025641%	1	39	408	Diabetes_McGill_IL6	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
2.5641025641%	1	39	408	Diabetes_McGill_IL6	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
2.5641025641%	1	39	408	Diabetes_McGill_IL6	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
2.5641025641%	1	39	408	Diabetes_McGill_IL6	REACTOME_GPCR_LIGAND_BINDING
2.5641025641%	1	39	405	Diabetes_McGill_IL6	KUMAR_TARGETS_OF_MLL_AF9_FUSION
2.5641025641%	1	39	40	Diabetes_McGill_IL6	VARELA_ZMPSTE24_TARGETS_UP
2.5641025641%	1	39	40	Diabetes_McGill_IL6	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP
2.5641025641%	1	39	40	Diabetes_McGill_IL6	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS
2.5641025641%	1	39	40	Diabetes_McGill_IL6	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
2.5641025641%	1	39	40	Diabetes_McGill_IL6	DORN_ADENOVIRUS_INFECTION_48HR_DN
2.5641025641%	1	39	40	Diabetes_McGill_IL6	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN
2.5641025641%	1	39	398	Diabetes_McGill_IL6	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
2.5641025641%	1	39	393	Diabetes_McGill_IL6	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
2.5641025641%	1	39	39	Diabetes_McGill_IL6	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2
2.5641025641%	1	39	39	Diabetes_McGill_IL6	SHIPP_DLBCL_CURED_VS_FATAL_UP
2.5641025641%	1	39	39	Diabetes_McGill_IL6	PID_ECADHERIN_NASCENTAJ_PATHWAY
2.5641025641%	1	39	39	Diabetes_McGill_IL6	HOFMANN_CELL_LYMPHOMA_DN
2.5641025641%	1	39	39	Diabetes_McGill_IL6	HAN_JNK_SINGALING_DN
2.5641025641%	1	39	39	Diabetes_McGill_IL6	GU_PDEF_TARGETS_DN
2.5641025641%	1	39	39	Diabetes_McGill_IL6	GENTILE_UV_RESPONSE_CLUSTER_D5
2.5641025641%	1	39	39	Diabetes_McGill_IL6	CONRAD_STEM_CELL
2.5641025641%	1	39	39	Diabetes_McGill_IL6	BURTON_ADIPOGENESIS_PEAK_AT_8HR
2.5641025641%	1	39	39	Diabetes_McGill_IL6	BIOCARTA_FMLP_PATHWAY
2.5641025641%	1	39	39	Diabetes_McGill_IL6	BEIER_GLIOMA_STEM_CELL_UP
2.5641025641%	1	39	39	Diabetes_McGill_IL6	AMIT_EGF_RESPONSE_60_MCF10A
2.5641025641%	1	39	388	Diabetes_McGill_IL6	STEIN_ESRRA_TARGETS_UP
2.5641025641%	1	39	380	Diabetes_McGill_IL6	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
2.5641025641%	1	39	38	Diabetes_McGill_IL6	SPIRA_SMOKERS_LUNG_CANCER_UP
2.5641025641%	1	39	38	Diabetes_McGill_IL6	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4
2.5641025641%	1	39	38	Diabetes_McGill_IL6	PID_RAC1_REG_PATHWAY
2.5641025641%	1	39	38	Diabetes_McGill_IL6	PID_P38ALPHABETADOWNSTREAMPATHWAY
2.5641025641%	1	39	38	Diabetes_McGill_IL6	PID_FASPATHWAY
2.5641025641%	1	39	38	Diabetes_McGill_IL6	NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON
2.5641025641%	1	39	38	Diabetes_McGill_IL6	NAKAMURA_ADIPOGENESIS_LATE_DN
2.5641025641%	1	39	38	Diabetes_McGill_IL6	NAKAMURA_ADIPOGENESIS_EARLY_DN
2.5641025641%	1	39	38	Diabetes_McGill_IL6	KRASNOSELSKAYA_ILF3_TARGETS_UP
2.5641025641%	1	39	38	Diabetes_McGill_IL6	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP
2.5641025641%	1	39	38	Diabetes_McGill_IL6	HATADA_METHYLATED_IN_LUNG_CANCER_DN
2.5641025641%	1	39	38	Diabetes_McGill_IL6	CHANDRAN_METASTASIS_TOP50_UP
2.5641025641%	1	39	374	Diabetes_McGill_IL6	WANG_TUMOR_INVASIVENESS_UP
2.5641025641%	1	39	37	Diabetes_McGill_IL6	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN
2.5641025641%	1	39	37	Diabetes_McGill_IL6	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING
2.5641025641%	1	39	37	Diabetes_McGill_IL6	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2
2.5641025641%	1	39	37	Diabetes_McGill_IL6	PID_FRA_PATHWAY
2.5641025641%	1	39	37	Diabetes_McGill_IL6	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR
2.5641025641%	1	39	37	Diabetes_McGill_IL6	BIOCARTA_TOLL_PATHWAY
2.5641025641%	1	39	37	Diabetes_McGill_IL6	BIOCARTA_GPCR_PATHWAY
2.5641025641%	1	39	368	Diabetes_McGill_IL6	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
2.5641025641%	1	39	367	Diabetes_McGill_IL6	VECCHI_GASTRIC_CANCER_EARLY_DN
2.5641025641%	1	39	362	Diabetes_McGill_IL6	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
2.5641025641%	1	39	36	Diabetes_McGill_IL6	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2
2.5641025641%	1	39	36	Diabetes_McGill_IL6	VALK_AML_CLUSTER_11
2.5641025641%	1	39	36	Diabetes_McGill_IL6	ST_ADRENERGIC
2.5641025641%	1	39	36	Diabetes_McGill_IL6	STEARMAN_TUMOR_FIELD_EFFECT_UP
2.5641025641%	1	39	36	Diabetes_McGill_IL6	SEMENZA_HIF1_TARGETS
2.5641025641%	1	39	36	Diabetes_McGill_IL6	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
2.5641025641%	1	39	36	Diabetes_McGill_IL6	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP
2.5641025641%	1	39	355	Diabetes_McGill_IL6	PEREZ_TP63_TARGETS
2.5641025641%	1	39	354	Diabetes_McGill_IL6	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
2.5641025641%	1	39	351	Diabetes_McGill_IL6	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
2.5641025641%	1	39	35	Diabetes_McGill_IL6	WEIGEL_OXIDATIVE_STRESS_RESPONSE
2.5641025641%	1	39	35	Diabetes_McGill_IL6	SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES
2.5641025641%	1	39	35	Diabetes_McGill_IL6	PID_HIVNEFPATHWAY
2.5641025641%	1	39	35	Diabetes_McGill_IL6	LOPEZ_TRANSLATION_VIA_FN1_SIGNALING
2.5641025641%	1	39	35	Diabetes_McGill_IL6	KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION
2.5641025641%	1	39	35	Diabetes_McGill_IL6	KEGG_PRIMARY_IMMUNODEFICIENCY
2.5641025641%	1	39	35	Diabetes_McGill_IL6	HOWLIN_CITED1_TARGETS_1_UP
2.5641025641%	1	39	35	Diabetes_McGill_IL6	GUTIERREZ_MULTIPLE_MYELOMA_DN
2.5641025641%	1	39	349	Diabetes_McGill_IL6	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
2.5641025641%	1	39	349	Diabetes_McGill_IL6	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
2.5641025641%	1	39	346	Diabetes_McGill_IL6	GOLDRATH_ANTIGEN_RESPONSE
2.5641025641%	1	39	34	Diabetes_McGill_IL6	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP
2.5641025641%	1	39	34	Diabetes_McGill_IL6	PLASARI_TGFB1_TARGETS_1HR_UP
2.5641025641%	1	39	34	Diabetes_McGill_IL6	PID_IL8CXCR2_PATHWAY
2.5641025641%	1	39	34	Diabetes_McGill_IL6	PID_HIF2PATHWAY
2.5641025641%	1	39	34	Diabetes_McGill_IL6	PID_ATM_PATHWAY
2.5641025641%	1	39	34	Diabetes_McGill_IL6	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP
2.5641025641%	1	39	337	Diabetes_McGill_IL6	PENG_GLUTAMINE_DEPRIVATION_DN
2.5641025641%	1	39	336	Diabetes_McGill_IL6	JOHNSTONE_PARVB_TARGETS_2_DN
2.5641025641%	1	39	330	Diabetes_McGill_IL6	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
2.5641025641%	1	39	33	Diabetes_McGill_IL6	ZHAN_LATE_DIFFERENTIATION_GENES_UP
2.5641025641%	1	39	33	Diabetes_McGill_IL6	VALK_AML_CLUSTER_3
2.5641025641%	1	39	33	Diabetes_McGill_IL6	PID_SYNDECAN_2_PATHWAY
2.5641025641%	1	39	33	Diabetes_McGill_IL6	PID_INTEGRIN_A4B1_PATHWAY
2.5641025641%	1	39	33	Diabetes_McGill_IL6	PID_ALPHASYNUCLEIN_PATHWAY
2.5641025641%	1	39	33	Diabetes_McGill_IL6	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN
2.5641025641%	1	39	33	Diabetes_McGill_IL6	GRADE_COLON_CANCER_DN
2.5641025641%	1	39	33	Diabetes_McGill_IL6	DORN_ADENOVIRUS_INFECTION_12HR_DN
2.5641025641%	1	39	33	Diabetes_McGill_IL6	CAFFAREL_RESPONSE_TO_THC_UP
2.5641025641%	1	39	33	Diabetes_McGill_IL6	BIOCARTA_NO1_PATHWAY
2.5641025641%	1	39	33	Diabetes_McGill_IL6	BIOCARTA_DEATH_PATHWAY
2.5641025641%	1	39	329	Diabetes_McGill_IL6	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
2.5641025641%	1	39	321	Diabetes_McGill_IL6	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
2.5641025641%	1	39	32	Diabetes_McGill_IL6	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN
2.5641025641%	1	39	317	Diabetes_McGill_IL6	BRUINS_UVC_RESPONSE_EARLY_LATE
2.5641025641%	1	39	312	Diabetes_McGill_IL6	GENTILE_UV_HIGH_DOSE_DN
2.5641025641%	1	39	311	Diabetes_McGill_IL6	JIANG_HYPOXIA_NORMAL
2.5641025641%	1	39	31	Diabetes_McGill_IL6	SIMBULAN_PARP1_TARGETS_UP
2.5641025641%	1	39	31	Diabetes_McGill_IL6	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
2.5641025641%	1	39	31	Diabetes_McGill_IL6	PID_AURORA_A_PATHWAY
2.5641025641%	1	39	31	Diabetes_McGill_IL6	PID_AR_NONGENOMIC_PATHWAY
2.5641025641%	1	39	31	Diabetes_McGill_IL6	IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM
2.5641025641%	1	39	31	Diabetes_McGill_IL6	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER
2.5641025641%	1	39	31	Diabetes_McGill_IL6	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
2.5641025641%	1	39	309	Diabetes_McGill_IL6	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
2.5641025641%	1	39	309	Diabetes_McGill_IL6	LIU_SOX4_TARGETS_DN
2.5641025641%	1	39	309	Diabetes_McGill_IL6	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
2.5641025641%	1	39	308	Diabetes_McGill_IL6	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
2.5641025641%	1	39	306	Diabetes_McGill_IL6	HORIUCHI_WTAP_TARGETS_UP
2.5641025641%	1	39	305	Diabetes_McGill_IL6	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
2.5641025641%	1	39	30	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_ROBO_RECEPTOR
2.5641025641%	1	39	30	Diabetes_McGill_IL6	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES
2.5641025641%	1	39	30	Diabetes_McGill_IL6	PID_RETINOIC_ACID_PATHWAY
2.5641025641%	1	39	298	Diabetes_McGill_IL6	BROWNE_HCMV_INFECTION_14HR_DN
2.5641025641%	1	39	293	Diabetes_McGill_IL6	ZHANG_TLX_TARGETS_60HR_UP
2.5641025641%	1	39	293	Diabetes_McGill_IL6	HADDAD_B_LYMPHOCYTE_PROGENITOR
2.5641025641%	1	39	291	Diabetes_McGill_IL6	SABATES_COLORECTAL_ADENOMA_DN
2.5641025641%	1	39	290	Diabetes_McGill_IL6	BENPORATH_OCT4_TARGETS
2.5641025641%	1	39	290	Diabetes_McGill_IL6	BASAKI_YBX1_TARGETS_UP
2.5641025641%	1	39	29	Diabetes_McGill_IL6	WANG_RESPONSE_TO_ANDROGEN_UP
2.5641025641%	1	39	29	Diabetes_McGill_IL6	STANELLE_E2F1_TARGETS
2.5641025641%	1	39	29	Diabetes_McGill_IL6	REACTOME_PKB_MEDIATED_EVENTS
2.5641025641%	1	39	29	Diabetes_McGill_IL6	PID_REELINPATHWAY
2.5641025641%	1	39	29	Diabetes_McGill_IL6	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6
2.5641025641%	1	39	29	Diabetes_McGill_IL6	MARSON_FOXP3_TARGETS_STIMULATED_UP
2.5641025641%	1	39	29	Diabetes_McGill_IL6	KRIGE_AMINO_ACID_DEPRIVATION
2.5641025641%	1	39	29	Diabetes_McGill_IL6	BIOCARTA_VEGF_PATHWAY
2.5641025641%	1	39	289	Diabetes_McGill_IL6	WANG_MLL_TARGETS
2.5641025641%	1	39	289	Diabetes_McGill_IL6	MANALO_HYPOXIA_DN
2.5641025641%	1	39	288	Diabetes_McGill_IL6	POOLA_INVASIVE_BREAST_CANCER_UP
2.5641025641%	1	39	281	Diabetes_McGill_IL6	MULLIGHAN_MLL_SIGNATURE_2_DN
2.5641025641%	1	39	280	Diabetes_McGill_IL6	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
2.5641025641%	1	39	28	Diabetes_McGill_IL6	WEBER_METHYLATED_HCP_IN_SPERM_DN
2.5641025641%	1	39	28	Diabetes_McGill_IL6	VALK_AML_CLUSTER_1
2.5641025641%	1	39	28	Diabetes_McGill_IL6	TIAN_TNF_SIGNALING_VIA_NFKB
2.5641025641%	1	39	28	Diabetes_McGill_IL6	SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER
2.5641025641%	1	39	28	Diabetes_McGill_IL6	PID_LIS1PATHWAY
2.5641025641%	1	39	28	Diabetes_McGill_IL6	PID_IL8CXCR1_PATHWAY
2.5641025641%	1	39	279	Diabetes_McGill_IL6	FORTSCHEGGER_PHF8_TARGETS_UP
2.5641025641%	1	39	276	Diabetes_McGill_IL6	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
2.5641025641%	1	39	270	Diabetes_McGill_IL6	RIZKI_TUMOR_INVASIVENESS_3D_DN
2.5641025641%	1	39	27	Diabetes_McGill_IL6	ST_MYOCYTE_AD_PATHWAY
2.5641025641%	1	39	27	Diabetes_McGill_IL6	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
2.5641025641%	1	39	27	Diabetes_McGill_IL6	OHM_METHYLATED_IN_ADULT_CANCERS
2.5641025641%	1	39	27	Diabetes_McGill_IL6	LOPES_METHYLATED_IN_COLON_CANCER_UP
2.5641025641%	1	39	27	Diabetes_McGill_IL6	HOEGERKORP_CD44_TARGETS_DIRECT_UP
2.5641025641%	1	39	27	Diabetes_McGill_IL6	CHIN_BREAST_CANCER_COPY_NUMBER_UP
2.5641025641%	1	39	27	Diabetes_McGill_IL6	BRACHAT_RESPONSE_TO_METHOTREXATE_DN
2.5641025641%	1	39	27	Diabetes_McGill_IL6	BIOCARTA_GSK3_PATHWAY
2.5641025641%	1	39	27	Diabetes_McGill_IL6	BIOCARTA_EDG1_PATHWAY
2.5641025641%	1	39	27	Diabetes_McGill_IL6	AKL_HTLV1_INFECTION_UP
2.5641025641%	1	39	267	Diabetes_McGill_IL6	CAIRO_HEPATOBLASTOMA_DN
2.5641025641%	1	39	266	Diabetes_McGill_IL6	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
2.5641025641%	1	39	266	Diabetes_McGill_IL6	FOSTER_KDM1A_TARGETS_UP
2.5641025641%	1	39	264	Diabetes_McGill_IL6	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
2.5641025641%	1	39	262	Diabetes_McGill_IL6	LU_AGING_BRAIN_UP
2.5641025641%	1	39	261	Diabetes_McGill_IL6	RICKMAN_METASTASIS_DN
2.5641025641%	1	39	260	Diabetes_McGill_IL6	SENESE_HDAC1_TARGETS_DN
2.5641025641%	1	39	26	Diabetes_McGill_IL6	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
2.5641025641%	1	39	26	Diabetes_McGill_IL6	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS
2.5641025641%	1	39	26	Diabetes_McGill_IL6	PID_VEGFR1_PATHWAY
2.5641025641%	1	39	26	Diabetes_McGill_IL6	HAHTOLA_CTCL_CUTANEOUS
2.5641025641%	1	39	26	Diabetes_McGill_IL6	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
2.5641025641%	1	39	26	Diabetes_McGill_IL6	BIOCARTA_RACCYCD_PATHWAY
2.5641025641%	1	39	26	Diabetes_McGill_IL6	BIOCARTA_PGC1A_PATHWAY
2.5641025641%	1	39	26	Diabetes_McGill_IL6	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
2.5641025641%	1	39	259	Diabetes_McGill_IL6	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
2.5641025641%	1	39	258	Diabetes_McGill_IL6	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
2.5641025641%	1	39	255	Diabetes_McGill_IL6	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
2.5641025641%	1	39	252	Diabetes_McGill_IL6	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
2.5641025641%	1	39	250	Diabetes_McGill_IL6	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
2.5641025641%	1	39	25	Diabetes_McGill_IL6	REACTOME_EGFR_DOWNREGULATION
2.5641025641%	1	39	25	Diabetes_McGill_IL6	OZEN_MIR125B1_TARGETS
2.5641025641%	1	39	25	Diabetes_McGill_IL6	NOJIMA_SFRP2_TARGETS_DN
2.5641025641%	1	39	25	Diabetes_McGill_IL6	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD
2.5641025641%	1	39	25	Diabetes_McGill_IL6	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN
2.5641025641%	1	39	25	Diabetes_McGill_IL6	KIM_HYPOXIA
2.5641025641%	1	39	25	Diabetes_McGill_IL6	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP
2.5641025641%	1	39	249	Diabetes_McGill_IL6	MITSIADES_RESPONSE_TO_APLIDIN_DN
2.5641025641%	1	39	246	Diabetes_McGill_IL6	VERHAAK_AML_WITH_NPM1_MUTATED_DN
2.5641025641%	1	39	246	Diabetes_McGill_IL6	BILD_E2F3_ONCOGENIC_SIGNATURE
2.5641025641%	1	39	244	Diabetes_McGill_IL6	PLASARI_TGFB1_TARGETS_10HR_DN
2.5641025641%	1	39	244	Diabetes_McGill_IL6	KAYO_AGING_MUSCLE_UP
2.5641025641%	1	39	242	Diabetes_McGill_IL6	MULLIGHAN_MLL_SIGNATURE_1_DN
2.5641025641%	1	39	241	Diabetes_McGill_IL6	DOANE_RESPONSE_TO_ANDROGEN_DN
2.5641025641%	1	39	24	Diabetes_McGill_IL6	WANG_TNF_TARGETS
2.5641025641%	1	39	24	Diabetes_McGill_IL6	WANG_LSD1_TARGETS_UP
2.5641025641%	1	39	24	Diabetes_McGill_IL6	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION
2.5641025641%	1	39	24	Diabetes_McGill_IL6	PID_S1P_S1P2_PATHWAY
2.5641025641%	1	39	24	Diabetes_McGill_IL6	OSADA_ASCL1_TARGETS_DN
2.5641025641%	1	39	24	Diabetes_McGill_IL6	JEON_SMAD6_TARGETS_UP
2.5641025641%	1	39	24	Diabetes_McGill_IL6	DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
2.5641025641%	1	39	24	Diabetes_McGill_IL6	CHEOK_RESPONSE_TO_HD_MTX_DN
2.5641025641%	1	39	24	Diabetes_McGill_IL6	BIOCARTA_EIF4_PATHWAY
2.5641025641%	1	39	24	Diabetes_McGill_IL6	BIOCARTA_ECM_PATHWAY
2.5641025641%	1	39	239	Diabetes_McGill_IL6	ALFANO_MYC_TARGETS
2.5641025641%	1	39	238	Diabetes_McGill_IL6	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
2.5641025641%	1	39	237	Diabetes_McGill_IL6	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
2.5641025641%	1	39	236	Diabetes_McGill_IL6	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
2.5641025641%	1	39	233	Diabetes_McGill_IL6	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
2.5641025641%	1	39	232	Diabetes_McGill_IL6	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
2.5641025641%	1	39	232	Diabetes_McGill_IL6	DELYS_THYROID_CANCER_DN
2.5641025641%	1	39	23	Diabetes_McGill_IL6	YANG_BREAST_CANCER_ESR1_BULK_DN
2.5641025641%	1	39	23	Diabetes_McGill_IL6	UROSEVIC_RESPONSE_TO_IMIQUIMOD
2.5641025641%	1	39	23	Diabetes_McGill_IL6	REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX
2.5641025641%	1	39	23	Diabetes_McGill_IL6	REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING
2.5641025641%	1	39	23	Diabetes_McGill_IL6	ONO_FOXP3_TARGETS_UP
2.5641025641%	1	39	23	Diabetes_McGill_IL6	MARKS_HDAC_TARGETS_UP
2.5641025641%	1	39	23	Diabetes_McGill_IL6	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN
2.5641025641%	1	39	23	Diabetes_McGill_IL6	CHIBA_RESPONSE_TO_TSA_DN
2.5641025641%	1	39	23	Diabetes_McGill_IL6	BIOCARTA_P53HYPOXIA_PATHWAY
2.5641025641%	1	39	23	Diabetes_McGill_IL6	BIOCARTA_MTOR_PATHWAY
2.5641025641%	1	39	23	Diabetes_McGill_IL6	BIOCARTA_IL12_PATHWAY
2.5641025641%	1	39	229	Diabetes_McGill_IL6	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
2.5641025641%	1	39	229	Diabetes_McGill_IL6	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
2.5641025641%	1	39	228	Diabetes_McGill_IL6	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
2.5641025641%	1	39	228	Diabetes_McGill_IL6	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
2.5641025641%	1	39	227	Diabetes_McGill_IL6	LEE_RECENT_THYMIC_EMIGRANT
2.5641025641%	1	39	225	Diabetes_McGill_IL6	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
2.5641025641%	1	39	223	Diabetes_McGill_IL6	CHEN_HOXA5_TARGETS_9HR_UP
2.5641025641%	1	39	222	Diabetes_McGill_IL6	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
2.5641025641%	1	39	222	Diabetes_McGill_IL6	CAIRO_LIVER_DEVELOPMENT_DN
2.5641025641%	1	39	221	Diabetes_McGill_IL6	PEDRIOLI_MIR31_TARGETS_UP
2.5641025641%	1	39	221	Diabetes_McGill_IL6	CHANDRAN_METASTASIS_UP
2.5641025641%	1	39	220	Diabetes_McGill_IL6	RIGGINS_TAMOXIFEN_RESISTANCE_DN
2.5641025641%	1	39	22	Diabetes_McGill_IL6	NUMATA_CSF3_SIGNALING_VIA_STAT3
2.5641025641%	1	39	22	Diabetes_McGill_IL6	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP
2.5641025641%	1	39	22	Diabetes_McGill_IL6	GAVIN_PDE3B_TARGETS
2.5641025641%	1	39	22	Diabetes_McGill_IL6	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN
2.5641025641%	1	39	22	Diabetes_McGill_IL6	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER
2.5641025641%	1	39	22	Diabetes_McGill_IL6	BIOCARTA_GCR_PATHWAY
2.5641025641%	1	39	22	Diabetes_McGill_IL6	BIOCARTA_CYTOKINE_PATHWAY
2.5641025641%	1	39	217	Diabetes_McGill_IL6	WONG_MITOCHONDRIA_GENE_MODULE
2.5641025641%	1	39	216	Diabetes_McGill_IL6	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
2.5641025641%	1	39	216	Diabetes_McGill_IL6	BOQUEST_STEM_CELL_DN
2.5641025641%	1	39	214	Diabetes_McGill_IL6	ZWANG_EGF_INTERVAL_DN
2.5641025641%	1	39	214	Diabetes_McGill_IL6	TIEN_INTESTINE_PROBIOTICS_24HR_DN
2.5641025641%	1	39	214	Diabetes_McGill_IL6	BIDUS_METASTASIS_UP
2.5641025641%	1	39	210	Diabetes_McGill_IL6	WANG_TUMOR_INVASIVENESS_DN
2.5641025641%	1	39	210	Diabetes_McGill_IL6	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
2.5641025641%	1	39	210	Diabetes_McGill_IL6	RIZKI_TUMOR_INVASIVENESS_3D_UP
2.5641025641%	1	39	210	Diabetes_McGill_IL6	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
2.5641025641%	1	39	210	Diabetes_McGill_IL6	CAIRO_HEPATOBLASTOMA_CLASSES_DN
2.5641025641%	1	39	21	Diabetes_McGill_IL6	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP
2.5641025641%	1	39	21	Diabetes_McGill_IL6	REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION
2.5641025641%	1	39	21	Diabetes_McGill_IL6	REACTOME_ERK_MAPK_TARGETS
2.5641025641%	1	39	21	Diabetes_McGill_IL6	OUYANG_PROSTATE_CANCER_PROGRESSION_DN
2.5641025641%	1	39	21	Diabetes_McGill_IL6	MARCHINI_TRABECTEDIN_RESISTANCE_UP
2.5641025641%	1	39	21	Diabetes_McGill_IL6	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN
2.5641025641%	1	39	21	Diabetes_McGill_IL6	BIOCARTA_CTLA4_PATHWAY
2.5641025641%	1	39	209	Diabetes_McGill_IL6	GROSS_HYPOXIA_VIA_ELK3_UP
2.5641025641%	1	39	207	Diabetes_McGill_IL6	KARLSSON_TGFB1_TARGETS_DN
2.5641025641%	1	39	207	Diabetes_McGill_IL6	CAIRO_HEPATOBLASTOMA_UP
2.5641025641%	1	39	206	Diabetes_McGill_IL6	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
2.5641025641%	1	39	205	Diabetes_McGill_IL6	SHEPARD_BMYB_MORPHOLINO_UP
2.5641025641%	1	39	203	Diabetes_McGill_IL6	PAL_PRMT5_TARGETS_UP
2.5641025641%	1	39	203	Diabetes_McGill_IL6	GRUETZMANN_PANCREATIC_CANCER_DN
2.5641025641%	1	39	202	Diabetes_McGill_IL6	FUJII_YBX1_TARGETS_DN
2.5641025641%	1	39	20	Diabetes_McGill_IL6	REACTOME_ENOS_ACTIVATION_AND_REGULATION
2.5641025641%	1	39	20	Diabetes_McGill_IL6	NIELSEN_LEIOMYOSARCOMA_CNN1_DN
2.5641025641%	1	39	20	Diabetes_McGill_IL6	COLLIS_PRKDC_SUBSTRATES
2.5641025641%	1	39	20	Diabetes_McGill_IL6	CHEN_ETV5_TARGETS_SERTOLI
2.5641025641%	1	39	20	Diabetes_McGill_IL6	BIOCARTA_IGF1MTOR_PATHWAY
2.5641025641%	1	39	20	Diabetes_McGill_IL6	AMIT_EGF_RESPONSE_240_MCF10A
2.5641025641%	1	39	198	Diabetes_McGill_IL6	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
2.5641025641%	1	39	197	Diabetes_McGill_IL6	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
2.5641025641%	1	39	196	Diabetes_McGill_IL6	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
2.5641025641%	1	39	195	Diabetes_McGill_IL6	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
2.5641025641%	1	39	19	Diabetes_McGill_IL6	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN
2.5641025641%	1	39	19	Diabetes_McGill_IL6	SYED_ESTRADIOL_RESPONSE
2.5641025641%	1	39	19	Diabetes_McGill_IL6	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP
2.5641025641%	1	39	19	Diabetes_McGill_IL6	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS
2.5641025641%	1	39	19	Diabetes_McGill_IL6	OUYANG_PROSTATE_CANCER_MARKERS
2.5641025641%	1	39	19	Diabetes_McGill_IL6	MATZUK_EMBRYONIC_GERM_CELL
2.5641025641%	1	39	19	Diabetes_McGill_IL6	MARSON_FOXP3_CORE_DIRECT_TARGETS
2.5641025641%	1	39	19	Diabetes_McGill_IL6	LEE_NAIVE_T_LYMPHOCYTE
2.5641025641%	1	39	19	Diabetes_McGill_IL6	LAMB_CCND1_TARGETS
2.5641025641%	1	39	19	Diabetes_McGill_IL6	KANG_AR_TARGETS_DN
2.5641025641%	1	39	19	Diabetes_McGill_IL6	HAHTOLA_MYCOSIS_FUNGOIDES_UP
2.5641025641%	1	39	19	Diabetes_McGill_IL6	BIOCARTA_TID_PATHWAY
2.5641025641%	1	39	19	Diabetes_McGill_IL6	BIOCARTA_MAL_PATHWAY
2.5641025641%	1	39	188	Diabetes_McGill_IL6	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
2.5641025641%	1	39	186	Diabetes_McGill_IL6	HAMAI_APOPTOSIS_VIA_TRAIL_DN
2.5641025641%	1	39	185	Diabetes_McGill_IL6	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
2.5641025641%	1	39	185	Diabetes_McGill_IL6	LEE_LIVER_CANCER_SURVIVAL_UP
2.5641025641%	1	39	185	Diabetes_McGill_IL6	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
2.5641025641%	1	39	184	Diabetes_McGill_IL6	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
2.5641025641%	1	39	1839	Diabetes_McGill_IL6	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY
2.5641025641%	1	39	183	Diabetes_McGill_IL6	VERHAAK_AML_WITH_NPM1_MUTATED_UP
2.5641025641%	1	39	1821	Diabetes_McGill_IL6	DODD_NASOPHARYNGEAL_CARCINOMA_UP
2.5641025641%	1	39	181	Diabetes_McGill_IL6	JISON_SICKLE_CELL_DISEASE_DN
2.5641025641%	1	39	18	Diabetes_McGill_IL6	ZHENG_RESPONSE_TO_ARSENITE_UP
2.5641025641%	1	39	18	Diabetes_McGill_IL6	ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE
2.5641025641%	1	39	18	Diabetes_McGill_IL6	YIH_RESPONSE_TO_ARSENITE_C2
2.5641025641%	1	39	18	Diabetes_McGill_IL6	WEBER_METHYLATED_IN_COLON_CANCER
2.5641025641%	1	39	18	Diabetes_McGill_IL6	SCHEIDEREIT_IKK_TARGETS
2.5641025641%	1	39	18	Diabetes_McGill_IL6	REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI
2.5641025641%	1	39	18	Diabetes_McGill_IL6	REACTOME_REGULATION_OF_SIGNALING_BY_CBL
2.5641025641%	1	39	18	Diabetes_McGill_IL6	NIELSEN_SYNOVIAL_SARCOMA_UP
2.5641025641%	1	39	18	Diabetes_McGill_IL6	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN
2.5641025641%	1	39	18	Diabetes_McGill_IL6	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
2.5641025641%	1	39	18	Diabetes_McGill_IL6	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP
2.5641025641%	1	39	18	Diabetes_McGill_IL6	AMIT_DELAYED_EARLY_GENES
2.5641025641%	1	39	179	Diabetes_McGill_IL6	BENPORATH_NOS_TARGETS
2.5641025641%	1	39	178	Diabetes_McGill_IL6	LI_AMPLIFIED_IN_LUNG_CANCER
2.5641025641%	1	39	178	Diabetes_McGill_IL6	BROWNE_HCMV_INFECTION_18HR_DN
2.5641025641%	1	39	177	Diabetes_McGill_IL6	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
2.5641025641%	1	39	176	Diabetes_McGill_IL6	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
2.5641025641%	1	39	176	Diabetes_McGill_IL6	SASAKI_ADULT_T_CELL_LEUKEMIA
2.5641025641%	1	39	175	Diabetes_McGill_IL6	YAMAZAKI_TCEB3_TARGETS_UP
2.5641025641%	1	39	175	Diabetes_McGill_IL6	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
2.5641025641%	1	39	175	Diabetes_McGill_IL6	FIRESTEIN_PROLIFERATION
2.5641025641%	1	39	172	Diabetes_McGill_IL6	SMID_BREAST_CANCER_LUMINAL_B_UP
2.5641025641%	1	39	170	Diabetes_McGill_IL6	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
2.5641025641%	1	39	170	Diabetes_McGill_IL6	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
2.5641025641%	1	39	17	Diabetes_McGill_IL6	ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN
2.5641025641%	1	39	17	Diabetes_McGill_IL6	WIKMAN_ASBESTOS_LUNG_CANCER_UP
2.5641025641%	1	39	17	Diabetes_McGill_IL6	THUM_MIR21_TARGETS_HEART_DISEASE_UP
2.5641025641%	1	39	17	Diabetes_McGill_IL6	RODRIGUES_NTN1_TARGETS_UP
2.5641025641%	1	39	17	Diabetes_McGill_IL6	REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP
2.5641025641%	1	39	17	Diabetes_McGill_IL6	REACTOME_ARMS_MEDIATED_ACTIVATION
2.5641025641%	1	39	17	Diabetes_McGill_IL6	PID_SMAD2_3PATHWAY
2.5641025641%	1	39	17	Diabetes_McGill_IL6	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
2.5641025641%	1	39	17	Diabetes_McGill_IL6	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
2.5641025641%	1	39	17	Diabetes_McGill_IL6	GALE_APL_WITH_FLT3_MUTATED_DN
2.5641025641%	1	39	17	Diabetes_McGill_IL6	DORMOY_ELAVL1_TARGETS
2.5641025641%	1	39	17	Diabetes_McGill_IL6	BIOCARTA_NO2IL12_PATHWAY
2.5641025641%	1	39	17	Diabetes_McGill_IL6	BIOCARTA_LAIR_PATHWAY
2.5641025641%	1	39	17	Diabetes_McGill_IL6	BIOCARTA_IL17_PATHWAY
2.5641025641%	1	39	17	Diabetes_McGill_IL6	BIOCARTA_HCMV_PATHWAY
2.5641025641%	1	39	169	Diabetes_McGill_IL6	UEDA_PERIFERAL_CLOCK
2.5641025641%	1	39	169	Diabetes_McGill_IL6	PENG_GLUCOSE_DEPRIVATION_DN
2.5641025641%	1	39	169	Diabetes_McGill_IL6	ONDER_CDH1_TARGETS_1_DN
2.5641025641%	1	39	167	Diabetes_McGill_IL6	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
2.5641025641%	1	39	165	Diabetes_McGill_IL6	DARWICHE_PAPILLOMA_RISK_LOW_DN
2.5641025641%	1	39	164	Diabetes_McGill_IL6	AMIT_EGF_RESPONSE_480_HELA
2.5641025641%	1	39	163	Diabetes_McGill_IL6	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
2.5641025641%	1	39	163	Diabetes_McGill_IL6	LIN_NPAS4_TARGETS_UP
2.5641025641%	1	39	163	Diabetes_McGill_IL6	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
2.5641025641%	1	39	162	Diabetes_McGill_IL6	WHITFIELD_CELL_CYCLE_S
2.5641025641%	1	39	162	Diabetes_McGill_IL6	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
2.5641025641%	1	39	162	Diabetes_McGill_IL6	MULLIGHAN_NPM1_SIGNATURE_3_DN
2.5641025641%	1	39	16	Diabetes_McGill_IL6	WU_HBX_TARGETS_1_UP
2.5641025641%	1	39	16	Diabetes_McGill_IL6	WONG_IFNA2_RESISTANCE_UP
2.5641025641%	1	39	16	Diabetes_McGill_IL6	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP
2.5641025641%	1	39	16	Diabetes_McGill_IL6	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION
2.5641025641%	1	39	16	Diabetes_McGill_IL6	MACLACHLAN_BRCA1_TARGETS_DN
2.5641025641%	1	39	16	Diabetes_McGill_IL6	LEE_LIVER_CANCER_HEPATOBLAST
2.5641025641%	1	39	16	Diabetes_McGill_IL6	GHO_ATF5_TARGETS_DN
2.5641025641%	1	39	16	Diabetes_McGill_IL6	FINETTI_BREAST_CANCER_KINOME_GREEN
2.5641025641%	1	39	16	Diabetes_McGill_IL6	BIOCARTA_P53_PATHWAY
2.5641025641%	1	39	16	Diabetes_McGill_IL6	BIOCARTA_BCELLSURVIVAL_PATHWAY
2.5641025641%	1	39	16	Diabetes_McGill_IL6	ABDELMOHSEN_ELAVL4_TARGETS
2.5641025641%	1	39	157	Diabetes_McGill_IL6	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
2.5641025641%	1	39	154	Diabetes_McGill_IL6	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
2.5641025641%	1	39	153	Diabetes_McGill_IL6	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
2.5641025641%	1	39	152	Diabetes_McGill_IL6	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
2.5641025641%	1	39	151	Diabetes_McGill_IL6	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
2.5641025641%	1	39	150	Diabetes_McGill_IL6	LANDIS_ERBB2_BREAST_TUMORS_324_UP
2.5641025641%	1	39	150	Diabetes_McGill_IL6	BROWNE_HCMV_INFECTION_30MIN_DN
2.5641025641%	1	39	15	Diabetes_McGill_IL6	REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN
2.5641025641%	1	39	15	Diabetes_McGill_IL6	HUMMEL_BURKITTS_LYMPHOMA_DN
2.5641025641%	1	39	15	Diabetes_McGill_IL6	FERRANDO_LYL1_NEIGHBORS
2.5641025641%	1	39	15	Diabetes_McGill_IL6	CHANG_POU5F1_TARGETS_UP
2.5641025641%	1	39	15	Diabetes_McGill_IL6	BIOCARTA_STEM_PATHWAY
2.5641025641%	1	39	15	Diabetes_McGill_IL6	BIOCARTA_HSP27_PATHWAY
2.5641025641%	1	39	149	Diabetes_McGill_IL6	TSAI_RESPONSE_TO_IONIZING_RADIATION
2.5641025641%	1	39	149	Diabetes_McGill_IL6	LANDIS_ERBB2_BREAST_TUMORS_324_DN
2.5641025641%	1	39	147	Diabetes_McGill_IL6	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
2.5641025641%	1	39	146	Diabetes_McGill_IL6	PECE_MAMMARY_STEM_CELL_UP
2.5641025641%	1	39	146	Diabetes_McGill_IL6	PECE_MAMMARY_STEM_CELL_DN
2.5641025641%	1	39	146	Diabetes_McGill_IL6	LEE_NEURAL_CREST_STEM_CELL_UP
2.5641025641%	1	39	146	Diabetes_McGill_IL6	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
2.5641025641%	1	39	145	Diabetes_McGill_IL6	ZHANG_BREAST_CANCER_PROGENITORS_DN
2.5641025641%	1	39	145	Diabetes_McGill_IL6	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
2.5641025641%	1	39	142	Diabetes_McGill_IL6	RUIZ_TNC_TARGETS_DN
2.5641025641%	1	39	142	Diabetes_McGill_IL6	PENG_LEUCINE_DEPRIVATION_UP
2.5641025641%	1	39	142	Diabetes_McGill_IL6	DARWICHE_SKIN_TUMOR_PROMOTER_UP
2.5641025641%	1	39	140	Diabetes_McGill_IL6	ONDER_CDH1_TARGETS_1_UP
2.5641025641%	1	39	140	Diabetes_McGill_IL6	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
2.5641025641%	1	39	14	Diabetes_McGill_IL6	REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING
2.5641025641%	1	39	14	Diabetes_McGill_IL6	REACTOME_PROLACTIN_RECEPTOR_SIGNALING
2.5641025641%	1	39	14	Diabetes_McGill_IL6	REACTOME_ACTIVATION_OF_RAC
2.5641025641%	1	39	14	Diabetes_McGill_IL6	PID_TCRRASPATHWAY
2.5641025641%	1	39	14	Diabetes_McGill_IL6	BIOCARTA_PLATELETAPP_PATHWAY
2.5641025641%	1	39	139	Diabetes_McGill_IL6	HOELZEL_NF1_TARGETS_UP
2.5641025641%	1	39	137	Diabetes_McGill_IL6	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
2.5641025641%	1	39	137	Diabetes_McGill_IL6	LIU_SOX4_TARGETS_UP
2.5641025641%	1	39	136	Diabetes_McGill_IL6	WIERENGA_STAT5A_TARGETS_GROUP1
2.5641025641%	1	39	136	Diabetes_McGill_IL6	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
2.5641025641%	1	39	135	Diabetes_McGill_IL6	TSENG_IRS1_TARGETS_DN
2.5641025641%	1	39	133	Diabetes_McGill_IL6	REACTOME_DIABETES_PATHWAYS
2.5641025641%	1	39	133	Diabetes_McGill_IL6	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON
2.5641025641%	1	39	132	Diabetes_McGill_IL6	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
2.5641025641%	1	39	132	Diabetes_McGill_IL6	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
2.5641025641%	1	39	131	Diabetes_McGill_IL6	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
2.5641025641%	1	39	130	Diabetes_McGill_IL6	YAGI_AML_WITH_T_9_11_TRANSLOCATION
2.5641025641%	1	39	13	Diabetes_McGill_IL6	REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION
2.5641025641%	1	39	13	Diabetes_McGill_IL6	REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING
2.5641025641%	1	39	13	Diabetes_McGill_IL6	PHESSE_TARGETS_OF_APC_AND_MBD2_DN
2.5641025641%	1	39	13	Diabetes_McGill_IL6	BIOCARTA_RB_PATHWAY
2.5641025641%	1	39	13	Diabetes_McGill_IL6	BIOCARTA_CBL_PATHWAY
2.5641025641%	1	39	128	Diabetes_McGill_IL6	LENAOUR_DENDRITIC_CELL_MATURATION_DN
2.5641025641%	1	39	126	Diabetes_McGill_IL6	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
2.5641025641%	1	39	126	Diabetes_McGill_IL6	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
2.5641025641%	1	39	126	Diabetes_McGill_IL6	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
2.5641025641%	1	39	123	Diabetes_McGill_IL6	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
2.5641025641%	1	39	122	Diabetes_McGill_IL6	TOOKER_GEMCITABINE_RESISTANCE_DN
2.5641025641%	1	39	121	Diabetes_McGill_IL6	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
2.5641025641%	1	39	121	Diabetes_McGill_IL6	RODRIGUES_DCC_TARGETS_DN
2.5641025641%	1	39	121	Diabetes_McGill_IL6	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
2.5641025641%	1	39	120	Diabetes_McGill_IL6	REACTOME_CELL_CELL_COMMUNICATION
2.5641025641%	1	39	120	Diabetes_McGill_IL6	CHEBOTAEV_GR_TARGETS_DN
2.5641025641%	1	39	12	Diabetes_McGill_IL6	TURJANSKI_MAPK1_AND_MAPK2_TARGETS
2.5641025641%	1	39	12	Diabetes_McGill_IL6	REACTOME_THE_NLRP3_INFLAMMASOME
2.5641025641%	1	39	12	Diabetes_McGill_IL6	REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS
2.5641025641%	1	39	12	Diabetes_McGill_IL6	MIZUKAMI_HYPOXIA_UP
2.5641025641%	1	39	12	Diabetes_McGill_IL6	FIGUEROA_AML_METHYLATION_CLUSTER_5_UP
2.5641025641%	1	39	12	Diabetes_McGill_IL6	CLAUS_PGR_POSITIVE_MENINGIOMA_DN
2.5641025641%	1	39	119	Diabetes_McGill_IL6	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
2.5641025641%	1	39	118	Diabetes_McGill_IL6	LEE_NEURAL_CREST_STEM_CELL_DN
2.5641025641%	1	39	118	Diabetes_McGill_IL6	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
2.5641025641%	1	39	118	Diabetes_McGill_IL6	CERVERA_SDHB_TARGETS_1_UP
2.5641025641%	1	39	117	Diabetes_McGill_IL6	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
2.5641025641%	1	39	116	Diabetes_McGill_IL6	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
2.5641025641%	1	39	114	Diabetes_McGill_IL6	MATZUK_SPERMATOZOA
2.5641025641%	1	39	114	Diabetes_McGill_IL6	CERVERA_SDHB_TARGETS_2
2.5641025641%	1	39	113	Diabetes_McGill_IL6	TSENG_IRS1_TARGETS_UP
2.5641025641%	1	39	113	Diabetes_McGill_IL6	REACTOME_SIGNALING_BY_RHO_GTPASES
2.5641025641%	1	39	113	Diabetes_McGill_IL6	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
2.5641025641%	1	39	112	Diabetes_McGill_IL6	LAIHO_COLORECTAL_CANCER_SERRATED_UP
2.5641025641%	1	39	112	Diabetes_McGill_IL6	LABBE_WNT3A_TARGETS_UP
2.5641025641%	1	39	112	Diabetes_McGill_IL6	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
2.5641025641%	1	39	112	Diabetes_McGill_IL6	DOANE_BREAST_CANCER_ESR1_UP
2.5641025641%	1	39	1118	Diabetes_McGill_IL6	BENPORATH_ES_WITH_H3K27ME3
2.5641025641%	1	39	111	Diabetes_McGill_IL6	WANG_HCP_PROSTATE_CANCER
2.5641025641%	1	39	110	Diabetes_McGill_IL6	SUNG_METASTASIS_STROMA_UP
2.5641025641%	1	39	110	Diabetes_McGill_IL6	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
2.5641025641%	1	39	110	Diabetes_McGill_IL6	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
2.5641025641%	1	39	110	Diabetes_McGill_IL6	GHANDHI_DIRECT_IRRADIATION_UP
2.5641025641%	1	39	11	Diabetes_McGill_IL6	STEGMEIER_PRE-MITOTIC_CELL_CYCLE_REGULATORS
2.5641025641%	1	39	11	Diabetes_McGill_IL6	SHIN_B_CELL_LYMPHOMA_CLUSTER_6
2.5641025641%	1	39	11	Diabetes_McGill_IL6	REACTOME_IL_7_SIGNALING
2.5641025641%	1	39	11	Diabetes_McGill_IL6	REACTOME_CD28_DEPENDENT_VAV1_PATHWAY
2.5641025641%	1	39	11	Diabetes_McGill_IL6	LOPEZ_MESOTHELIOMA_SURVIVAL_UP
2.5641025641%	1	39	11	Diabetes_McGill_IL6	FUNG_IL2_SIGNALING_1
2.5641025641%	1	39	11	Diabetes_McGill_IL6	BIOCARTA_SRCRPTP_PATHWAY
2.5641025641%	1	39	11	Diabetes_McGill_IL6	BIOCARTA_P35ALZHEIMERS_PATHWAY
2.5641025641%	1	39	11	Diabetes_McGill_IL6	BIOCARTA_EPONFKB_PATHWAY
2.5641025641%	1	39	109	Diabetes_McGill_IL6	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
2.5641025641%	1	39	108	Diabetes_McGill_IL6	ZHANG_TLX_TARGETS_DN
2.5641025641%	1	39	108	Diabetes_McGill_IL6	LABBE_TGFB1_TARGETS_DN
2.5641025641%	1	39	108	Diabetes_McGill_IL6	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
2.5641025641%	1	39	107	Diabetes_McGill_IL6	SESTO_RESPONSE_TO_UV_C0
2.5641025641%	1	39	105	Diabetes_McGill_IL6	HELLER_SILENCED_BY_METHYLATION_DN
2.5641025641%	1	39	104	Diabetes_McGill_IL6	NAKAMURA_ADIPOGENESIS_LATE_UP
2.5641025641%	1	39	1038	Diabetes_McGill_IL6	BENPORATH_SUZ12_TARGETS
2.5641025641%	1	39	103	Diabetes_McGill_IL6	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY
2.5641025641%	1	39	103	Diabetes_McGill_IL6	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
2.5641025641%	1	39	103	Diabetes_McGill_IL6	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
2.5641025641%	1	39	102	Diabetes_McGill_IL6	DER_IFN_BETA_RESPONSE_UP
2.5641025641%	1	39	102	Diabetes_McGill_IL6	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
2.5641025641%	1	39	101	Diabetes_McGill_IL6	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
2.5641025641%	1	39	101	Diabetes_McGill_IL6	GRADE_COLON_AND_RECTAL_CANCER_DN
2.5641025641%	1	39	101	Diabetes_McGill_IL6	BROWNE_HCMV_INFECTION_20HR_DN
2.5641025641%	1	39	101	Diabetes_McGill_IL6	BROWNE_HCMV_INFECTION_12HR_DN
2.5641025641%	1	39	101	Diabetes_McGill_IL6	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
2.5641025641%	1	39	101	Diabetes_McGill_IL6	BASSO_CD40_SIGNALING_UP
2.5641025641%	1	39	100	Diabetes_McGill_IL6	WINZEN_DEGRADED_VIA_KHSRP
2.5641025641%	1	39	100	Diabetes_McGill_IL6	RICKMAN_HEAD_AND_NECK_CANCER_A
2.5641025641%	1	39	10	Diabetes_McGill_IL6	YEMELYANOV_GR_TARGETS_DN
2.5641025641%	1	39	10	Diabetes_McGill_IL6	TURJANSKI_MAPK14_TARGETS
2.5641025641%	1	39	10	Diabetes_McGill_IL6	ST_INTERFERON_GAMMA_PATHWAY
2.5641025641%	1	39	10	Diabetes_McGill_IL6	REACTOME_RAF_MAP_KINASE_CASCADE
2.5641025641%	1	39	10	Diabetes_McGill_IL6	MURAKAMI_UV_RESPONSE_1HR_DN
2.5641025641%	1	39	10	Diabetes_McGill_IL6	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP
2.5641025641%	1	39	10	Diabetes_McGill_IL6	BRUNEAU_SEPTATION_VENTRICULAR
2.5641025641%	1	39	10	Diabetes_McGill_IL6	BIOCARTA_IL5_PATHWAY
2.5641025641%	1	39	10	Diabetes_McGill_IL6	BAKER_HEMATOPOESIS_STAT1_TARGETS
2.53292806484%	50	1974	414	Mendelian_Nancy_Cox	LU_EZH2_TARGETS_DN
2.53292806484%	50	1974	329	Mendelian_Nancy_Cox	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
2.53292806484%	50	1974	307	Mendelian_Nancy_Cox	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
2.53292806484%	50	1974	294	Mendelian_Nancy_Cox	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
2.53292806484%	50	1974	279	Mendelian_Nancy_Cox	REACTOME_NEURONAL_SYSTEM
2.53292806484%	50	1974	230	Mendelian_Nancy_Cox	KAUFFMANN_DNA_REPAIR_GENES
2.53292806484%	50	1974	208	Mendelian_Nancy_Cox	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
2.53292806484%	50	1974	185	Mendelian_Nancy_Cox	LEE_LIVER_CANCER_SURVIVAL_UP
2.53292806484%	50	1974	179	Mendelian_Nancy_Cox	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
2.53261703761%	33	1303	957	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LOPEZ_MBD_TARGETS
2.53261703761%	33	1303	940	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
2.53261703761%	33	1303	918	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JOHNSTONE_PARVB_TARGETS_3_DN
2.53261703761%	33	1303	882	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
2.53261703761%	33	1303	779	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PUJANA_CHEK2_PCC_NETWORK
2.53261703761%	33	1303	682	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FEVR_CTNNB1_TARGETS_UP
2.53261703761%	33	1303	1174	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PEREZ_TP53_TARGETS
2.52989880405%	55	2174	544	T2D_GENES_TANYA_LIPIDS	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
2.52989880405%	55	2174	536	T2D_GENES_TANYA_LIPIDS	BERENJENO_TRANSFORMED_BY_RHOA_UP
2.52989880405%	55	2174	473	T2D_GENES_TANYA_LIPIDS	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
2.52989880405%	55	2174	414	T2D_GENES_TANYA_LIPIDS	MOHANKUMAR_TLX1_TARGETS_UP
2.52989880405%	55	2174	389	T2D_GENES_TANYA_LIPIDS	HSIAO_HOUSEKEEPING_GENES
2.52840909091%	89	3520	1037	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NUYTTEN_EZH2_TARGETS_UP
2.51202565473%	47	1871	601	T2D_GENES_TANYA_HEIGHT	MARTINEZ_RB1_AND_TP53_TARGETS_UP
2.51202565473%	47	1871	584	T2D_GENES_TANYA_HEIGHT	HAMAI_APOPTOSIS_VIA_TRAIL_UP
2.51202565473%	47	1871	579	T2D_GENES_TANYA_HEIGHT	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
2.51202565473%	47	1871	504	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_48HR_DN
2.51202565473%	47	1871	419	T2D_GENES_TANYA_HEIGHT	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
2.51202565473%	47	1871	412	T2D_GENES_TANYA_HEIGHT	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
2.51202565473%	47	1871	355	T2D_GENES_TANYA_HEIGHT	PEREZ_TP63_TARGETS
2.51202565473%	47	1871	337	T2D_GENES_TANYA_HEIGHT	PHONG_TNF_RESPONSE_NOT_VIA_P38
2.5%	88	3520	612	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
2.49307479224%	9	361	957	T2D_GENES_TANYA_T2D_RSQ05_02CM	LOPEZ_MBD_TARGETS
2.49307479224%	9	361	933	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_IMMUNE_SYSTEM
2.49307479224%	9	361	857	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARTENS_TRETINOIN_RESPONSE_UP
2.49307479224%	9	361	841	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARTENS_TRETINOIN_RESPONSE_DN
2.49307479224%	9	361	805	T2D_GENES_TANYA_T2D_RSQ05_02CM	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
2.49307479224%	9	361	718	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_ES_ICP_WITH_H3K4ME3
2.49307479224%	9	361	557	T2D_GENES_TANYA_T2D_RSQ05_02CM	TIEN_INTESTINE_PROBIOTICS_24HR_UP
2.49307479224%	9	361	552	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
2.49307479224%	9	361	546	T2D_GENES_TANYA_T2D_RSQ05_02CM	WEST_ADRENOCORTICAL_TUMOR_DN
2.49307479224%	9	361	516	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
2.49307479224%	9	361	510	T2D_GENES_TANYA_T2D_RSQ05_02CM	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
2.49307479224%	9	361	504	T2D_GENES_TANYA_T2D_RSQ05_02CM	PILON_KLF1_TARGETS_UP
2.49307479224%	9	361	463	T2D_GENES_TANYA_T2D_RSQ05_02CM	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
2.49307479224%	9	361	412	T2D_GENES_TANYA_T2D_RSQ05_02CM	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
2.49307479224%	9	361	396	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_DEVELOPMENTAL_BIOLOGY
2.49307479224%	9	361	378	T2D_GENES_TANYA_T2D_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
2.49307479224%	9	361	362	T2D_GENES_TANYA_T2D_RSQ05_02CM	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
2.49307479224%	9	361	1821	T2D_GENES_TANYA_T2D_RSQ05_02CM	DODD_NASOPHARYNGEAL_CARCINOMA_UP
2.48390064397%	54	2174	544	T2D_GENES_TANYA_LIPIDS	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
2.48390064397%	54	2174	428	T2D_GENES_TANYA_LIPIDS	LIM_MAMMARY_STEM_CELL_DN
2.48390064397%	54	2174	423	T2D_GENES_TANYA_LIPIDS	PUJANA_BRCA2_PCC_NETWORK
2.48390064397%	54	2174	380	T2D_GENES_TANYA_LIPIDS	MULLIGHAN_MLL_SIGNATURE_1_UP
2.48226950355%	49	1974	482	Mendelian_Nancy_Cox	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
2.48226950355%	49	1974	467	Mendelian_Nancy_Cox	RATTENBACHER_BOUND_BY_CELF1
2.48226950355%	49	1974	456	Mendelian_Nancy_Cox	ODONNELL_TFRC_TARGETS_UP
2.48226950355%	49	1974	445	Mendelian_Nancy_Cox	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
2.48226950355%	49	1974	439	Mendelian_Nancy_Cox	MITSIADES_RESPONSE_TO_APLIDIN_UP
2.48226950355%	49	1974	421	Mendelian_Nancy_Cox	REACTOME_CELL_CYCLE
2.48226950355%	49	1974	389	Mendelian_Nancy_Cox	HSIAO_HOUSEKEEPING_GENES
2.48226950355%	49	1974	356	Mendelian_Nancy_Cox	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
2.48226950355%	49	1974	354	Mendelian_Nancy_Cox	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
2.48226950355%	49	1974	342	Mendelian_Nancy_Cox	BLUM_RESPONSE_TO_SALIRASIB_DN
2.48226950355%	49	1974	299	Mendelian_Nancy_Cox	MUELLER_PLURINET
2.48226950355%	49	1974	267	Mendelian_Nancy_Cox	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
2.48075278015%	29	1169	681	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
2.48075278015%	29	1169	552	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
2.48075278015%	29	1169	1118	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BENPORATH_ES_WITH_H3K27ME3
2.47159090909%	87	3520	775	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BENPORATH_MYC_MAX_TARGETS
2.47159090909%	87	3520	718	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_ES_ICP_WITH_H3K4ME3
2.46913580247%	2	81	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_POTASSIUM_CHANNELS
2.46913580247%	2	81	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GUO_TARGETS_OF_IRS1_AND_IRS2
2.46913580247%	2	81	97	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
2.46913580247%	2	81	957	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LOPEZ_MBD_TARGETS
2.46913580247%	2	81	940	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
2.46913580247%	2	81	94	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GAVIN_FOXP3_TARGETS_CLUSTER_T4
2.46913580247%	2	81	93	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
2.46913580247%	2	81	93	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CADWELL_ATG16L1_TARGETS_UP
2.46913580247%	2	81	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KIM_MYCN_AMPLIFICATION_TARGETS_UP
2.46913580247%	2	81	91	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ELVIDGE_HIF1A_TARGETS_DN
2.46913580247%	2	81	9	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK
2.46913580247%	2	81	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
2.46913580247%	2	81	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
2.46913580247%	2	81	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KANG_IMMORTALIZED_BY_TERT_UP
2.46913580247%	2	81	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
2.46913580247%	2	81	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
2.46913580247%	2	81	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
2.46913580247%	2	81	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
2.46913580247%	2	81	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
2.46913580247%	2	81	863	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
2.46913580247%	2	81	85	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
2.46913580247%	2	81	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
2.46913580247%	2	81	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RUAN_RESPONSE_TO_TNF_DN
2.46913580247%	2	81	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHANG_IMMORTALIZED_BY_HPV31_UP
2.46913580247%	2	81	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
2.46913580247%	2	81	830	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CUI_TCF21_TARGETS_2_DN
2.46913580247%	2	81	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
2.46913580247%	2	81	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HUANG_DASATINIB_RESISTANCE_UP
2.46913580247%	2	81	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
2.46913580247%	2	81	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CROMER_METASTASIS_DN
2.46913580247%	2	81	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
2.46913580247%	2	81	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
2.46913580247%	2	81	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DUAN_PRDM5_TARGETS
2.46913580247%	2	81	784	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FORTSCHEGGER_PHF8_TARGETS_DN
2.46913580247%	2	81	78	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LINDVALL_IMMORTALIZED_BY_TERT_UP
2.46913580247%	2	81	779	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PUJANA_CHEK2_PCC_NETWORK
2.46913580247%	2	81	775	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BENPORATH_MYC_MAX_TARGETS
2.46913580247%	2	81	77	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
2.46913580247%	2	81	77	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RIZ_ERYTHROID_DIFFERENTIATION
2.46913580247%	2	81	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ROSS_AML_WITH_AML1_ETO_FUSION
2.46913580247%	2	81	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MAHAJAN_RESPONSE_TO_IL1A_DN
2.46913580247%	2	81	756	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
2.46913580247%	2	81	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_AVB3_INTEGRIN_PATHWAY
2.46913580247%	2	81	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MCCLUNG_COCAIN_REWARD_4WK
2.46913580247%	2	81	747	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PATIL_LIVER_CANCER
2.46913580247%	2	81	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS
2.46913580247%	2	81	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
2.46913580247%	2	81	728	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARSON_BOUND_BY_E2F4_UNSTIMULATED
2.46913580247%	2	81	72	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
2.46913580247%	2	81	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_P75NTRPATHWAY
2.46913580247%	2	81	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_PPAR_SIGNALING_PATHWAY
2.46913580247%	2	81	68	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DELPUECH_FOXO3_TARGETS_UP
2.46913580247%	2	81	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VANHARANTA_UTERINE_FIBROID_DN
2.46913580247%	2	81	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
2.46913580247%	2	81	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_HDAC_CLASSI_PATHWAY
2.46913580247%	2	81	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_RB_1PATHWAY
2.46913580247%	2	81	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_IL4_2PATHWAY
2.46913580247%	2	81	64	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_LIVER_CANCER_ACOX1_UP
2.46913580247%	2	81	64	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BYSTROEM_CORRELATED_WITH_IL5_DN
2.46913580247%	2	81	63	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BRIDEAU_IMPRINTED_GENES
2.46913580247%	2	81	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_FCER1PATHWAY
2.46913580247%	2	81	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_LIVER_CANCER_E2F1_UP
2.46913580247%	2	81	61	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NADLER_OBESITY_UP
2.46913580247%	2	81	602	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARTINEZ_TP53_TARGETS_UP
2.46913580247%	2	81	59	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_FAK_PATHWAY
2.46913580247%	2	81	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHENG_GLIOBLASTOMA_PLASTICITY_DN
2.46913580247%	2	81	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_SHP2_PATHWAY
2.46913580247%	2	81	579	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
2.46913580247%	2	81	570	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
2.46913580247%	2	81	566	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DOUGLAS_BMI1_TARGETS_UP
2.46913580247%	2	81	555	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
2.46913580247%	2	81	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_IL2_1PATHWAY
2.46913580247%	2	81	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_FGF_PATHWAY
2.46913580247%	2	81	546	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
2.46913580247%	2	81	543	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARTINEZ_RB1_TARGETS_DN
2.46913580247%	2	81	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ROVERSI_GLIOMA_COPY_NUMBER_DN
2.46913580247%	2	81	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_INOSITOL_PHOSPHATE_METABOLISM
2.46913580247%	2	81	536	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
2.46913580247%	2	81	535	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	STEIN_ESRRA_TARGETS
2.46913580247%	2	81	532	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
2.46913580247%	2	81	528	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
2.46913580247%	2	81	518	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
2.46913580247%	2	81	517	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
2.46913580247%	2	81	514	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
2.46913580247%	2	81	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PRAMOONJAGO_SOX4_TARGETS_DN
2.46913580247%	2	81	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
2.46913580247%	2	81	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
2.46913580247%	2	81	505	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
2.46913580247%	2	81	501	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SENESE_HDAC3_TARGETS_UP
2.46913580247%	2	81	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_ANGIOPOIETINRECEPTOR_PATHWAY
2.46913580247%	2	81	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NADERI_BREAST_CANCER_PROGNOSIS_UP
2.46913580247%	2	81	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KOHOUTEK_CCNT1_TARGETS
2.46913580247%	2	81	491	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHENG_BOUND_BY_FOXP3
2.46913580247%	2	81	491	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MEISSNER_NPC_HCP_WITH_H3K4ME2
2.46913580247%	2	81	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
2.46913580247%	2	81	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_GLYCEROLIPID_METABOLISM
2.46913580247%	2	81	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GERHOLD_ADIPOGENESIS_UP
2.46913580247%	2	81	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_TCR_PATHWAY
2.46913580247%	2	81	489	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LIM_MAMMARY_STEM_CELL_UP
2.46913580247%	2	81	475	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
2.46913580247%	2	81	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_NFAT_TFPATHWAY
2.46913580247%	2	81	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_IL6_7PATHWAY
2.46913580247%	2	81	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	IRITANI_MAD1_TARGETS_DN
2.46913580247%	2	81	462	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DELACROIX_RAR_BOUND_ES
2.46913580247%	2	81	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT
2.46913580247%	2	81	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
2.46913580247%	2	81	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_A6B1_A6B4_INTEGRIN_PATHWAY
2.46913580247%	2	81	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MADAN_DPPA4_TARGETS
2.46913580247%	2	81	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN
2.46913580247%	2	81	456	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ODONNELL_TFRC_TARGETS_UP
2.46913580247%	2	81	456	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARTENS_BOUND_BY_PML_RARA_FUSION
2.46913580247%	2	81	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
2.46913580247%	2	81	448	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
2.46913580247%	2	81	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SIGNALING_BY_FGFR_MUTANTS
2.46913580247%	2	81	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_ERBB2ERBB3PATHWAY
2.46913580247%	2	81	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MA_MYELOID_DIFFERENTIATION_DN
2.46913580247%	2	81	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KERLEY_RESPONSE_TO_CISPLATIN_UP
2.46913580247%	2	81	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_ABC_TRANSPORTERS
2.46913580247%	2	81	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RIZ_ERYTHROID_DIFFERENTIATION_12HR
2.46913580247%	2	81	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_IL_3_5_AND_GM_CSF_SIGNALING
2.46913580247%	2	81	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_THROMBIN_PAR1_PATHWAY
2.46913580247%	2	81	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_CXCR3PATHWAY
2.46913580247%	2	81	425	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BOCHKIS_FOXA2_TARGETS
2.46913580247%	2	81	423	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	THUM_SYSTOLIC_HEART_FAILURE_UP
2.46913580247%	2	81	422	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YAGI_AML_WITH_INV_16_TRANSLOCATION
2.46913580247%	2	81	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER
2.46913580247%	2	81	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LUI_THYROID_CANCER_CLUSTER_2
2.46913580247%	2	81	419	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
2.46913580247%	2	81	414	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MOHANKUMAR_TLX1_TARGETS_UP
2.46913580247%	2	81	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_IL_2_SIGNALING
2.46913580247%	2	81	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_ER_NONGENOMIC_PATHWAY
2.46913580247%	2	81	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_ERBB1_INTERNALIZATION_PATHWAY
2.46913580247%	2	81	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_FCER1_PATHWAY
2.46913580247%	2	81	408	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_GPCR_LIGAND_BINDING
2.46913580247%	2	81	405	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KUMAR_TARGETS_OF_MLL_AF9_FUSION
2.46913580247%	2	81	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RIZ_ERYTHROID_DIFFERENTIATION_6HR
2.46913580247%	2	81	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_IFNGPATHWAY
2.46913580247%	2	81	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_EPHBFWDPATHWAY
2.46913580247%	2	81	397	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
2.46913580247%	2	81	393	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
2.46913580247%	2	81	392	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LINDGREN_BLADDER_CANCER_CLUSTER_2B
2.46913580247%	2	81	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_RET_PATHWAY
2.46913580247%	2	81	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_ECADHERIN_NASCENTAJ_PATHWAY
2.46913580247%	2	81	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BURTON_ADIPOGENESIS_PEAK_AT_8HR
2.46913580247%	2	81	388	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	STEIN_ESRRA_TARGETS_UP
2.46913580247%	2	81	384	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
2.46913580247%	2	81	384	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BASAKI_YBX1_TARGETS_DN
2.46913580247%	2	81	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_GLUCOSE_TRANSPORT
2.46913580247%	2	81	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_FASPATHWAY
2.46913580247%	2	81	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_ERBB4_PATHWAY
2.46913580247%	2	81	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KAAB_FAILED_HEART_ATRIUM_UP
2.46913580247%	2	81	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_IL2RB_PATHWAY
2.46913580247%	2	81	379	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BENPORATH_ES_1
2.46913580247%	2	81	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_IL23PATHWAY
2.46913580247%	2	81	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_GMCSF_PATHWAY
2.46913580247%	2	81	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_PAR1_PATHWAY
2.46913580247%	2	81	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_ALK_PATHWAY
2.46913580247%	2	81	36	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YANG_BREAST_CANCER_ESR1_UP
2.46913580247%	2	81	36	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ST_ADRENERGIC
2.46913580247%	2	81	36	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_PI3KPLCTRKPATHWAY
2.46913580247%	2	81	358	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GRUETZMANN_PANCREATIC_CANCER_UP
2.46913580247%	2	81	355	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PEREZ_TP63_TARGETS
2.46913580247%	2	81	352	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
2.46913580247%	2	81	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WANG_METHYLATED_IN_BREAST_CANCER
2.46913580247%	2	81	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ROZANOV_MMP14_TARGETS_DN
2.46913580247%	2	81	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
2.46913580247%	2	81	342	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BLUM_RESPONSE_TO_SALIRASIB_DN
2.46913580247%	2	81	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SIG_CD40PATHWAYMAP
2.46913580247%	2	81	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT
2.46913580247%	2	81	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_IL2_PI3KPATHWAY
2.46913580247%	2	81	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_IL1PATHWAY
2.46913580247%	2	81	337	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PHONG_TNF_RESPONSE_NOT_VIA_P38
2.46913580247%	2	81	335	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
2.46913580247%	2	81	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SCHRAETS_MLL_TARGETS_DN
2.46913580247%	2	81	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_NCADHERINPATHWAY
2.46913580247%	2	81	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_NETRIN_PATHWAY
2.46913580247%	2	81	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_PDGF_PATHWAY
2.46913580247%	2	81	318	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEI_MYB_TARGETS
2.46913580247%	2	81	316	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
2.46913580247%	2	81	315	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
2.46913580247%	2	81	315	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PASINI_SUZ12_TARGETS_DN
2.46913580247%	2	81	314	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DOUGLAS_BMI1_TARGETS_DN
2.46913580247%	2	81	311	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	JIANG_HYPOXIA_NORMAL
2.46913580247%	2	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_INWARDLY_RECTIFYING_K_CHANNELS
2.46913580247%	2	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_NEPHRIN_NEPH1_PATHWAY
2.46913580247%	2	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_AVB3_OPN_PATHWAY
2.46913580247%	2	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_AR_NONGENOMIC_PATHWAY
2.46913580247%	2	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP
2.46913580247%	2	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_EGF_PATHWAY
2.46913580247%	2	81	307	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
2.46913580247%	2	81	306	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HORIUCHI_WTAP_TARGETS_UP
2.46913580247%	2	81	305	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
2.46913580247%	2	81	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
2.46913580247%	2	81	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_BASIGIN_INTERACTIONS
2.46913580247%	2	81	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_NECTIN_PATHWAY
2.46913580247%	2	81	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_IGF1_PATHWAY
2.46913580247%	2	81	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KYNG_NORMAL_AGING_DN
2.46913580247%	2	81	294	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WEST_ADRENOCORTICAL_TUMOR_UP
2.46913580247%	2	81	293	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	IVANOVA_HEMATOPOIESIS_MATURE_CELL
2.46913580247%	2	81	291	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SABATES_COLORECTAL_ADENOMA_DN
2.46913580247%	2	81	290	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BENPORATH_OCT4_TARGETS
2.46913580247%	2	81	290	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BASAKI_YBX1_TARGETS_UP
2.46913580247%	2	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
2.46913580247%	2	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
2.46913580247%	2	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_REELINPATHWAY
2.46913580247%	2	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_VEGF_PATHWAY
2.46913580247%	2	81	289	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GABRIELY_MIR21_TARGETS
2.46913580247%	2	81	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_TRAIL_PATHWAY
2.46913580247%	2	81	279	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_NEURONAL_SYSTEM
2.46913580247%	2	81	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
2.46913580247%	2	81	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_IL_RECEPTOR_SHC_SIGNALING
2.46913580247%	2	81	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_IL3_PATHWAY
2.46913580247%	2	81	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_GSK3_PATHWAY
2.46913580247%	2	81	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_EDG1_PATHWAY
2.46913580247%	2	81	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_CREB_PATHWAY
2.46913580247%	2	81	267	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
2.46913580247%	2	81	267	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CAIRO_HEPATOBLASTOMA_DN
2.46913580247%	2	81	266	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ROZANOV_MMP14_TARGETS_UP
2.46913580247%	2	81	264	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
2.46913580247%	2	81	261	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
2.46913580247%	2	81	260	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BOQUEST_STEM_CELL_UP
2.46913580247%	2	81	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ST_INTERLEUKIN_4_PATHWAY
2.46913580247%	2	81	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN
2.46913580247%	2	81	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_RACCYCD_PATHWAY
2.46913580247%	2	81	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_BAD_PATHWAY
2.46913580247%	2	81	256	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ONDER_CDH1_TARGETS_2_UP
2.46913580247%	2	81	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_LYMPHANGIOGENESIS_PATHWAY
2.46913580247%	2	81	247	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_METABOLISM_OF_CARBOHYDRATES
2.46913580247%	2	81	246	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VERHAAK_AML_WITH_NPM1_MUTATED_DN
2.46913580247%	2	81	244	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PLASARI_TGFB1_TARGETS_10HR_DN
2.46913580247%	2	81	244	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KAYO_AGING_MUSCLE_UP
2.46913580247%	2	81	244	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HSIAO_LIVER_SPECIFIC_GENES
2.46913580247%	2	81	242	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WINTER_HYPOXIA_METAGENE
2.46913580247%	2	81	242	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MULLIGHAN_MLL_SIGNATURE_1_DN
2.46913580247%	2	81	242	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHYLA_CBFA2T3_TARGETS_DN
2.46913580247%	2	81	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_TPO_PATHWAY
2.46913580247%	2	81	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_ECM_PATHWAY
2.46913580247%	2	81	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_CXCR4_PATHWAY
2.46913580247%	2	81	238	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
2.46913580247%	2	81	238	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
2.46913580247%	2	81	230	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KAUFFMANN_DNA_REPAIR_GENES
2.46913580247%	2	81	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_INSULIN_RECEPTOR_RECYCLING
2.46913580247%	2	81	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_RAS_PATHWAY
2.46913580247%	2	81	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_RAC1_PATHWAY
2.46913580247%	2	81	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_IGF1R_PATHWAY
2.46913580247%	2	81	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_GLEEVEC_PATHWAY
2.46913580247%	2	81	229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
2.46913580247%	2	81	229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
2.46913580247%	2	81	227	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
2.46913580247%	2	81	225	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BROWNE_HCMV_INFECTION_16HR_UP
2.46913580247%	2	81	222	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
2.46913580247%	2	81	221	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHANG_TLX_TARGETS_36HR_UP
2.46913580247%	2	81	221	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PEDRIOLI_MIR31_TARGETS_UP
2.46913580247%	2	81	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_HEDGEHOG_2PATHWAY
2.46913580247%	2	81	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_HER2_PATHWAY
2.46913580247%	2	81	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_GCR_PATHWAY
2.46913580247%	2	81	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_AKT_PATHWAY
2.46913580247%	2	81	214	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
2.46913580247%	2	81	214	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KIM_WT1_TARGETS_UP
2.46913580247%	2	81	214	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	AFFAR_YY1_TARGETS_UP
2.46913580247%	2	81	212	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHANG_CORE_SERUM_RESPONSE_UP
2.46913580247%	2	81	211	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
2.46913580247%	2	81	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VERHAAK_GLIOBLASTOMA_PRONEURAL
2.46913580247%	2	81	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
2.46913580247%	2	81	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	STEGER_ADIPOGENESIS_UP
2.46913580247%	2	81	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING
2.46913580247%	2	81	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_TFF_PATHWAY
2.46913580247%	2	81	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_IGF1_PATHWAY
2.46913580247%	2	81	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_CTLA4_PATHWAY
2.46913580247%	2	81	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VERHAAK_GLIOBLASTOMA_CLASSICAL
2.46913580247%	2	81	205	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
2.46913580247%	2	81	204	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
2.46913580247%	2	81	204	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
2.46913580247%	2	81	201	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KIM_MYC_AMPLIFICATION_TARGETS_UP
2.46913580247%	2	81	200	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHEPARD_BMYB_MORPHOLINO_DN
2.46913580247%	2	81	200	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_DIFFERENTIATING_T_LYMPHOCYTE
2.46913580247%	2	81	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_NEPHRIN_INTERACTIONS
2.46913580247%	2	81	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_NKCELLS_PATHWAY
2.46913580247%	2	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS
2.46913580247%	2	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_EPHA2_FWDPATHWAY
2.46913580247%	2	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHEN_PDGF_TARGETS
2.46913580247%	2	81	189	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BURTON_ADIPOGENESIS_6
2.46913580247%	2	81	188	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
2.46913580247%	2	81	185	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
2.46913580247%	2	81	185	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_LIVER_CANCER_SURVIVAL_UP
2.46913580247%	2	81	184	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
2.46913580247%	2	81	184	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DOANE_RESPONSE_TO_ANDROGEN_UP
2.46913580247%	2	81	182	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RAO_BOUND_BY_SALL4_ISOFORM_A
2.46913580247%	2	81	181	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
2.46913580247%	2	81	180	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
2.46913580247%	2	81	180	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BROWNE_HCMV_INFECTION_48HR_UP
2.46913580247%	2	81	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR
2.46913580247%	2	81	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_REGULATION_OF_SIGNALING_BY_CBL
2.46913580247%	2	81	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_NGF_PATHWAY
2.46913580247%	2	81	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_ERK5_PATHWAY
2.46913580247%	2	81	178	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BROWNE_HCMV_INFECTION_18HR_DN
2.46913580247%	2	81	174	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
2.46913580247%	2	81	172	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SMID_BREAST_CANCER_LUMINAL_B_UP
2.46913580247%	2	81	171	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ELVIDGE_HYPOXIA_UP
2.46913580247%	2	81	171	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
2.46913580247%	2	81	170	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
2.46913580247%	2	81	170	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
2.46913580247%	2	81	170	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
2.46913580247%	2	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SA_TRKA_RECEPTOR
2.46913580247%	2	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_TIE2_SIGNALING
2.46913580247%	2	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SHC_RELATED_EVENTS
2.46913580247%	2	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_SYNDECAN_3_PATHWAY
2.46913580247%	2	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_NFKAPPABATYPICALPATHWAY
2.46913580247%	2	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_IL7_PATHWAY
2.46913580247%	2	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_HCMV_PATHWAY
2.46913580247%	2	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_ARF_PATHWAY
2.46913580247%	2	81	169	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ONDER_CDH1_TARGETS_1_DN
2.46913580247%	2	81	169	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KATSANOU_ELAVL1_TARGETS_UP
2.46913580247%	2	81	163	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SERVITJA_ISLET_HNF1A_TARGETS_UP
2.46913580247%	2	81	160	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BROWNE_HCMV_INFECTION_6HR_DN
2.46913580247%	2	81	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HE_PTEN_TARGETS_UP
2.46913580247%	2	81	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_CDC42RAC_PATHWAY
2.46913580247%	2	81	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_BCELLSURVIVAL_PATHWAY
2.46913580247%	2	81	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_ACH_PATHWAY
2.46913580247%	2	81	159	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
2.46913580247%	2	81	158	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RODRIGUES_NTN1_TARGETS_DN
2.46913580247%	2	81	154	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
2.46913580247%	2	81	150	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BROWNE_HCMV_INFECTION_30MIN_DN
2.46913580247%	2	81	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_LONGEVITY_PATHWAY
2.46913580247%	2	81	149	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LANDIS_ERBB2_BREAST_TUMORS_324_DN
2.46913580247%	2	81	147	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WHITFIELD_CELL_CYCLE_G1_S
2.46913580247%	2	81	143	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION
2.46913580247%	2	81	141	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WELCSH_BRCA1_TARGETS_DN
2.46913580247%	2	81	141	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
2.46913580247%	2	81	140	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
2.46913580247%	2	81	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHANG_ADIPOGENESIS_BY_BMP7
2.46913580247%	2	81	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SIGNAL_ATTENUATION
2.46913580247%	2	81	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS
2.46913580247%	2	81	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_IL5_PATHWAY
2.46913580247%	2	81	138	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
2.46913580247%	2	81	138	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
2.46913580247%	2	81	138	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
2.46913580247%	2	81	137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_P53DOWNSTREAMPATHWAY
2.46913580247%	2	81	137	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
2.46913580247%	2	81	134	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_TIGHT_JUNCTION
2.46913580247%	2	81	132	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
2.46913580247%	2	81	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS
2.46913580247%	2	81	128	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YEGNASUBRAMANIAN_PROSTATE_CANCER
2.46913580247%	2	81	128	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	POTTI_TOPOTECAN_SENSITIVITY
2.46913580247%	2	81	128	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKKELSEN_MEF_LCP_WITH_H3K4ME3
2.46913580247%	2	81	128	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
2.46913580247%	2	81	127	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LIU_VMYB_TARGETS_UP
2.46913580247%	2	81	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
2.46913580247%	2	81	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BURTON_ADIPOGENESIS_5
2.46913580247%	2	81	122	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_CHROMOSOME_MAINTENANCE
2.46913580247%	2	81	121	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
2.46913580247%	2	81	121	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS
2.46913580247%	2	81	121	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
2.46913580247%	2	81	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_CELL_CELL_COMMUNICATION
2.46913580247%	2	81	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
2.46913580247%	2	81	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
2.46913580247%	2	81	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHEBOTAEV_GR_TARGETS_DN
2.46913580247%	2	81	12	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_TRKA_PATHWAY
2.46913580247%	2	81	118	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_NEURAL_CREST_STEM_CELL_DN
2.46913580247%	2	81	118	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
2.46913580247%	2	81	118	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
2.46913580247%	2	81	117	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
2.46913580247%	2	81	116	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LIM_MAMMARY_LUMINAL_MATURE_UP
2.46913580247%	2	81	115	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
2.46913580247%	2	81	114	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ROPERO_HDAC2_TARGETS
2.46913580247%	2	81	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_LEPTIN_PATHWAY
2.46913580247%	2	81	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
2.46913580247%	2	81	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LABBE_TGFB1_TARGETS_DN
2.46913580247%	2	81	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
2.46913580247%	2	81	107	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SIGNALING_BY_ILS
2.46913580247%	2	81	105	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_ERBB1_DOWNSTREAM_PATHWAY
2.46913580247%	2	81	104	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
2.46913580247%	2	81	103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
2.46913580247%	2	81	103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
2.46913580247%	2	81	100	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GAVIN_FOXP3_TARGETS_CLUSTER_P4
2.46913580247%	2	81	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YEMELYANOV_GR_TARGETS_DN
2.466367713%	11	446	957	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LOPEZ_MBD_TARGETS
2.466367713%	11	446	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_RNA_POL_I_TRANSCRIPTION
2.466367713%	11	446	882	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
2.466367713%	11	446	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_MEIOTIC_RECOMBINATION
2.466367713%	11	446	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_AMYLOIDS
2.466367713%	11	446	781	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GOZGIT_ESR1_TARGETS_DN
2.466367713%	11	446	747	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PATIL_LIVER_CANCER
2.466367713%	11	446	673	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARTINEZ_RB1_TARGETS_UP
2.466367713%	11	446	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_RNA_POL_I_PROMOTER_OPENING
2.466367713%	11	446	612	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
2.466367713%	11	446	601	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARTINEZ_RB1_AND_TP53_TARGETS_UP
2.466367713%	11	446	567	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PARENT_MTOR_SIGNALING_UP
2.466367713%	11	446	504	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_48HR_DN
2.466367713%	11	446	473	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
2.466367713%	11	446	447	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MOOTHA_MITOCHONDRIA
2.466367713%	11	446	423	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PUJANA_BRCA2_PCC_NETWORK
2.466367713%	11	446	421	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CELL_CYCLE
2.466367713%	11	446	351	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAGI_AML_WITH_11Q23_REARRANGED
2.466367713%	11	446	287	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
2.466367713%	11	446	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_MEIOSIS
2.45857830037%	46	1871	548	T2D_GENES_TANYA_HEIGHT	KIM_ALL_DISORDERS_CALB1_CORR_UP
2.45857830037%	46	1871	546	T2D_GENES_TANYA_HEIGHT	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
2.45857830037%	46	1871	526	T2D_GENES_TANYA_HEIGHT	ONKEN_UVEAL_MELANOMA_DN
2.45857830037%	46	1871	516	T2D_GENES_TANYA_HEIGHT	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
2.45857830037%	46	1871	501	T2D_GENES_TANYA_HEIGHT	SENESE_HDAC3_TARGETS_UP
2.45857830037%	46	1871	491	T2D_GENES_TANYA_HEIGHT	SWEET_LUNG_CANCER_KRAS_UP
2.45857830037%	46	1871	435	T2D_GENES_TANYA_HEIGHT	SWEET_LUNG_CANCER_KRAS_DN
2.45857830037%	46	1871	384	T2D_GENES_TANYA_HEIGHT	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
2.45857830037%	46	1871	324	T2D_GENES_TANYA_HEIGHT	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
2.45857830037%	46	1871	116	T2D_GENES_TANYA_HEIGHT	REACTOME_MEIOSIS
2.45587106677%	32	1303	911	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
2.45587106677%	32	1303	882	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_BMP2_TARGETS_DN
2.45587106677%	32	1303	863	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
2.45587106677%	32	1303	1210	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHEN_METABOLIC_SYNDROM_NETWORK
2.44698205546%	15	613	712	T2D_GENES_TANYA_BIOMARKER	SCHLOSSER_SERUM_RESPONSE_DN
2.44698205546%	15	613	648	T2D_GENES_TANYA_BIOMARKER	BENPORATH_CYCLING_GENES
2.44698205546%	15	613	634	T2D_GENES_TANYA_BIOMARKER	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
2.44698205546%	15	613	549	T2D_GENES_TANYA_BIOMARKER	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
2.44698205546%	15	613	539	T2D_GENES_TANYA_BIOMARKER	LIAO_METASTASIS
2.44698205546%	15	613	517	T2D_GENES_TANYA_BIOMARKER	RAO_BOUND_BY_SALL4_ISOFORM_B
2.44698205546%	15	613	462	T2D_GENES_TANYA_BIOMARKER	DELACROIX_RAR_BOUND_ES
2.44698205546%	15	613	457	T2D_GENES_TANYA_BIOMARKER	SENESE_HDAC1_TARGETS_UP
2.44698205546%	15	613	457	T2D_GENES_TANYA_BIOMARKER	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
2.44698205546%	15	613	430	T2D_GENES_TANYA_BIOMARKER	JOHNSTONE_PARVB_TARGETS_3_UP
2.44698205546%	15	613	43	T2D_GENES_TANYA_BIOMARKER	LASTOWSKA_COAMPLIFIED_WITH_MYCN
2.44698205546%	15	613	418	T2D_GENES_TANYA_BIOMARKER	PEDRIOLI_MIR31_TARGETS_DN
2.44698205546%	15	613	406	T2D_GENES_TANYA_BIOMARKER	OSMAN_BLADDER_CANCER_DN
2.44698205546%	15	613	397	T2D_GENES_TANYA_BIOMARKER	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
2.44698205546%	15	613	388	T2D_GENES_TANYA_BIOMARKER	STEIN_ESRRA_TARGETS_UP
2.44698205546%	15	613	380	T2D_GENES_TANYA_BIOMARKER	DAIRKEE_TERT_TARGETS_UP
2.44698205546%	15	613	38	T2D_GENES_TANYA_BIOMARKER	NIKOLSKY_BREAST_CANCER_7P22_AMPLICON
2.44698205546%	15	613	367	T2D_GENES_TANYA_BIOMARKER	DELACROIX_RARG_BOUND_MEF
2.44698205546%	15	613	352	T2D_GENES_TANYA_BIOMARKER	WANG_LMO4_TARGETS_DN
2.44698205546%	15	613	293	T2D_GENES_TANYA_BIOMARKER	ENK_UV_RESPONSE_EPIDERMIS_UP
2.44698205546%	15	613	244	T2D_GENES_TANYA_BIOMARKER	HSIAO_LIVER_SPECIFIC_GENES
2.44698205546%	15	613	241	T2D_GENES_TANYA_BIOMARKER	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
2.44698205546%	15	613	222	T2D_GENES_TANYA_BIOMARKER	CAIRO_LIVER_DEVELOPMENT_DN
2.44286840032%	31	1269	857	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARTENS_TRETINOIN_RESPONSE_UP
2.44286840032%	31	1269	800	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
2.44286840032%	31	1269	779	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PUJANA_CHEK2_PCC_NETWORK
2.44286840032%	31	1269	590	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
2.44286840032%	31	1269	122	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
2.43902439024%	1	41	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
2.43902439024%	1	41	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_PYRIMIDINE_METABOLISM
2.43902439024%	1	41	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
2.43902439024%	1	41	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CROONQUIST_IL6_DEPRIVATION_DN
2.43902439024%	1	41	97	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
2.43902439024%	1	41	940	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
2.43902439024%	1	41	94	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GAVIN_FOXP3_TARGETS_CLUSTER_T4
2.43902439024%	1	41	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WINTER_HYPOXIA_UP
2.43902439024%	1	41	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
2.43902439024%	1	41	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SYNTHESIS_OF_DNA
2.43902439024%	1	41	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
2.43902439024%	1	41	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_DILATED_CARDIOMYOPATHY
2.43902439024%	1	41	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DE_YY1_TARGETS_DN
2.43902439024%	1	41	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CAMPS_COLON_CANCER_COPY_NUMBER_UP
2.43902439024%	1	41	90	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MORI_IMMATURE_B_LYMPHOCYTE_DN
2.43902439024%	1	41	90	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HILLION_HMGA1_TARGETS
2.43902439024%	1	41	9	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30
2.43902439024%	1	41	9	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN
2.43902439024%	1	41	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SWEET_KRAS_ONCOGENIC_SIGNATURE
2.43902439024%	1	41	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RICKMAN_HEAD_AND_NECK_CANCER_E
2.43902439024%	1	41	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_RNA_POL_I_TRANSCRIPTION
2.43902439024%	1	41	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
2.43902439024%	1	41	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LEE_AGING_NEOCORTEX_UP
2.43902439024%	1	41	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KANG_IMMORTALIZED_BY_TERT_UP
2.43902439024%	1	41	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DELASERNA_MYOD_TARGETS_UP
2.43902439024%	1	41	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BHATTACHARYA_EMBRYONIC_STEM_CELL
2.43902439024%	1	41	882	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LEE_BMP2_TARGETS_DN
2.43902439024%	1	41	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
2.43902439024%	1	41	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WALLACE_PROSTATE_CANCER_RACE_DN
2.43902439024%	1	41	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SEIDEN_ONCOGENESIS_BY_MET
2.43902439024%	1	41	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
2.43902439024%	1	41	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
2.43902439024%	1	41	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
2.43902439024%	1	41	871	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GRADE_COLON_CANCER_UP
2.43902439024%	1	41	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
2.43902439024%	1	41	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SAFFORD_T_LYMPHOCYTE_ANERGY
2.43902439024%	1	41	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
2.43902439024%	1	41	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
2.43902439024%	1	41	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
2.43902439024%	1	41	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
2.43902439024%	1	41	86	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
2.43902439024%	1	41	86	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BROWNE_HCMV_INFECTION_16HR_DN
2.43902439024%	1	41	85	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	STEIN_ESR1_TARGETS
2.43902439024%	1	41	85	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
2.43902439024%	1	41	85	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
2.43902439024%	1	41	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
2.43902439024%	1	41	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RUAN_RESPONSE_TO_TNF_DN
2.43902439024%	1	41	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LEE_AGING_CEREBELLUM_UP
2.43902439024%	1	41	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
2.43902439024%	1	41	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_AMYLOIDS
2.43902439024%	1	41	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
2.43902439024%	1	41	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
2.43902439024%	1	41	82	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
2.43902439024%	1	41	82	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_SMAD2_3NUCLEARPATHWAY
2.43902439024%	1	41	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
2.43902439024%	1	41	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
2.43902439024%	1	41	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SCIBETTA_KDM5B_TARGETS_DN
2.43902439024%	1	41	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
2.43902439024%	1	41	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_MITOTIC_G2_G2_M_PHASES
2.43902439024%	1	41	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MAHAJAN_RESPONSE_TO_IL1A_UP
2.43902439024%	1	41	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GUO_HEX_TARGETS_UP
2.43902439024%	1	41	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GRABARCZYK_BCL11B_TARGETS_UP
2.43902439024%	1	41	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SCHUHMACHER_MYC_TARGETS_UP
2.43902439024%	1	41	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
2.43902439024%	1	41	8	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9
2.43902439024%	1	41	8	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7
2.43902439024%	1	41	8	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	IKEDA_MIR133_TARGETS_DN
2.43902439024%	1	41	8	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP
2.43902439024%	1	41	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
2.43902439024%	1	41	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MALONEY_RESPONSE_TO_17AAG_DN
2.43902439024%	1	41	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LIU_COMMON_CANCER_GENES
2.43902439024%	1	41	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DUAN_PRDM5_TARGETS
2.43902439024%	1	41	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
2.43902439024%	1	41	784	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FORTSCHEGGER_PHF8_TARGETS_DN
2.43902439024%	1	41	78	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
2.43902439024%	1	41	78	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LINDVALL_IMMORTALIZED_BY_TERT_UP
2.43902439024%	1	41	78	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
2.43902439024%	1	41	78	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
2.43902439024%	1	41	775	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BENPORATH_MYC_MAX_TARGETS
2.43902439024%	1	41	770	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
2.43902439024%	1	41	77	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RIZ_ERYTHROID_DIFFERENTIATION
2.43902439024%	1	41	77	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LIN_APC_TARGETS
2.43902439024%	1	41	77	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CARD_MIR302A_TARGETS
2.43902439024%	1	41	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
2.43902439024%	1	41	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ROSS_AML_WITH_AML1_ETO_FUSION
2.43902439024%	1	41	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
2.43902439024%	1	41	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
2.43902439024%	1	41	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
2.43902439024%	1	41	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_TELOMERE_MAINTENANCE
2.43902439024%	1	41	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MORI_MATURE_B_LYMPHOCYTE_DN
2.43902439024%	1	41	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_ADHERENS_JUNCTION
2.43902439024%	1	41	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SHEPARD_BMYB_TARGETS
2.43902439024%	1	41	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LEE_LIVER_CANCER_DENA_DN
2.43902439024%	1	41	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CORRE_MULTIPLE_MYELOMA_UP
2.43902439024%	1	41	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_MEIOTIC_SYNAPSIS
2.43902439024%	1	41	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
2.43902439024%	1	41	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_VIRAL_MYOCARDITIS
2.43902439024%	1	41	728	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARSON_BOUND_BY_E2F4_UNSTIMULATED
2.43902439024%	1	41	72	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MATZUK_SPERMATOCYTE
2.43902439024%	1	41	72	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DANG_REGULATED_BY_MYC_UP
2.43902439024%	1	41	72	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CROONQUIST_NRAS_SIGNALING_DN
2.43902439024%	1	41	718	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MIKKELSEN_ES_ICP_WITH_H3K4ME3
2.43902439024%	1	41	712	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SCHLOSSER_SERUM_RESPONSE_DN
2.43902439024%	1	41	71	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DER_IFN_GAMMA_RESPONSE_UP
2.43902439024%	1	41	70	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_AP1_PATHWAY
2.43902439024%	1	41	7	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PALOMERO_GSI_SENSITIVITY_UP
2.43902439024%	1	41	7	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MIKI_COEXPRESSED_WITH_CYP19A1
2.43902439024%	1	41	7	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BERGER_MBD2_TARGETS
2.43902439024%	1	41	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
2.43902439024%	1	41	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN
2.43902439024%	1	41	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RHODES_UNDIFFERENTIATED_CANCER
2.43902439024%	1	41	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_P53_SIGNALING_PATHWAY
2.43902439024%	1	41	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HOWLIN_PUBERTAL_MAMMARY_GLAND
2.43902439024%	1	41	682	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
2.43902439024%	1	41	681	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
2.43902439024%	1	41	68	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_TELOMERASEPATHWAY
2.43902439024%	1	41	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
2.43902439024%	1	41	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	VANHARANTA_UTERINE_FIBROID_DN
2.43902439024%	1	41	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
2.43902439024%	1	41	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
2.43902439024%	1	41	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
2.43902439024%	1	41	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
2.43902439024%	1	41	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SWEET_KRAS_TARGETS_DN
2.43902439024%	1	41	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RIGGINS_TAMOXIFEN_RESISTANCE_UP
2.43902439024%	1	41	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
2.43902439024%	1	41	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_TCR_PATHWAY
2.43902439024%	1	41	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_LYSOPHOSPHOLIPID_PATHWAY
2.43902439024%	1	41	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_HDAC_CLASSI_PATHWAY
2.43902439024%	1	41	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NAKAMURA_ADIPOGENESIS_EARLY_UP
2.43902439024%	1	41	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARSON_FOXP3_TARGETS_UP
2.43902439024%	1	41	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LEE_LIVER_CANCER_CIPROFIBRATE_DN
2.43902439024%	1	41	658	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
2.43902439024%	1	41	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
2.43902439024%	1	41	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_RB_1PATHWAY
2.43902439024%	1	41	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GUO_HEX_TARGETS_DN
2.43902439024%	1	41	64	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
2.43902439024%	1	41	64	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LEE_LIVER_CANCER_ACOX1_UP
2.43902439024%	1	41	64	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GERHOLD_ADIPOGENESIS_DN
2.43902439024%	1	41	64	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
2.43902439024%	1	41	633	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
2.43902439024%	1	41	63	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
2.43902439024%	1	41	63	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BRIDEAU_IMPRINTED_GENES
2.43902439024%	1	41	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
2.43902439024%	1	41	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
2.43902439024%	1	41	612	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
2.43902439024%	1	41	61	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
2.43902439024%	1	41	61	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REN_BOUND_BY_E2F
2.43902439024%	1	41	61	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NADLER_OBESITY_UP
2.43902439024%	1	41	61	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
2.43902439024%	1	41	605	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CAIRO_HEPATOBLASTOMA_CLASSES_UP
2.43902439024%	1	41	602	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARTINEZ_TP53_TARGETS_UP
2.43902439024%	1	41	601	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARTINEZ_RB1_AND_TP53_TARGETS_UP
2.43902439024%	1	41	60	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CUI_GLUCOSE_DEPRIVATION
2.43902439024%	1	41	6	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KIM_PTEN_TARGETS_DN
2.43902439024%	1	41	6	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KAPOSI_LIVER_CANCER_MET_DN
2.43902439024%	1	41	6	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	COURTOIS_SENESCENCE_TRIGGERS
2.43902439024%	1	41	59	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
2.43902439024%	1	41	59	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_ATF2_PATHWAY
2.43902439024%	1	41	59	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ELVIDGE_HYPOXIA_BY_DMOG_DN
2.43902439024%	1	41	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHENG_GLIOBLASTOMA_PLASTICITY_DN
2.43902439024%	1	41	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
2.43902439024%	1	41	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WAKASUGI_HAVE_ZNF143_BINDING_SITES
2.43902439024%	1	41	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LUCAS_HNF4A_TARGETS_UP
2.43902439024%	1	41	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_HIVNEF_PATHWAY
2.43902439024%	1	41	579	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
2.43902439024%	1	41	570	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
2.43902439024%	1	41	57	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
2.43902439024%	1	41	57	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DELASERNA_MYOD_TARGETS_DN
2.43902439024%	1	41	567	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PARENT_MTOR_SIGNALING_UP
2.43902439024%	1	41	566	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DOUGLAS_BMI1_TARGETS_UP
2.43902439024%	1	41	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HOQUE_METHYLATED_IN_CANCER
2.43902439024%	1	41	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HENDRICKS_SMARCA4_TARGETS_UP
2.43902439024%	1	41	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
2.43902439024%	1	41	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_TGFBRPATHWAY
2.43902439024%	1	41	549	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
2.43902439024%	1	41	543	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARTINEZ_RB1_TARGETS_DN
2.43902439024%	1	41	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SU_PANCREAS
2.43902439024%	1	41	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ROVERSI_GLIOMA_COPY_NUMBER_DN
2.43902439024%	1	41	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_APOPTOTIC_EXECUTION_PHASE
2.43902439024%	1	41	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARSON_FOXP3_TARGETS_DN
2.43902439024%	1	41	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_ARGININE_AND_PROLINE_METABOLISM
2.43902439024%	1	41	539	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LIAO_METASTASIS
2.43902439024%	1	41	536	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BERENJENO_TRANSFORMED_BY_RHOA_UP
2.43902439024%	1	41	535	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	STEIN_ESRRA_TARGETS
2.43902439024%	1	41	532	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
2.43902439024%	1	41	530	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ENK_UV_RESPONSE_KERATINOCYTE_UP
2.43902439024%	1	41	53	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHU_CMV_8_HR_DN
2.43902439024%	1	41	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_CASPASE_PATHWAY
2.43902439024%	1	41	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_STARCH_AND_SUCROSE_METABOLISM
2.43902439024%	1	41	518	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
2.43902439024%	1	41	517	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
2.43902439024%	1	41	516	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
2.43902439024%	1	41	514	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
2.43902439024%	1	41	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_NUCLEOTIDE_EXCISION_REPAIR
2.43902439024%	1	41	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CROMER_TUMORIGENESIS_DN
2.43902439024%	1	41	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
2.43902439024%	1	41	501	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SENESE_HDAC3_TARGETS_UP
2.43902439024%	1	41	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	STOSSI_RESPONSE_TO_ESTRADIOL
2.43902439024%	1	41	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
2.43902439024%	1	41	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
2.43902439024%	1	41	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARTINEZ_RESPONSE_TO_TRABECTEDIN
2.43902439024%	1	41	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
2.43902439024%	1	41	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHIBA_RESPONSE_TO_TSA
2.43902439024%	1	41	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS
2.43902439024%	1	41	5	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BRUNEAU_SEPTATION_ATRIAL
2.43902439024%	1	41	491	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHENG_BOUND_BY_FOXP3
2.43902439024%	1	41	491	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MEISSNER_NPC_HCP_WITH_H3K4ME2
2.43902439024%	1	41	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_ARF6_TRAFFICKINGPATHWAY
2.43902439024%	1	41	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARCHINI_TRABECTEDIN_RESISTANCE_DN
2.43902439024%	1	41	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_GLYCEROLIPID_METABOLISM
2.43902439024%	1	41	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GERHOLD_ADIPOGENESIS_UP
2.43902439024%	1	41	489	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LIM_MAMMARY_STEM_CELL_UP
2.43902439024%	1	41	485	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ENK_UV_RESPONSE_KERATINOCYTE_DN
2.43902439024%	1	41	483	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
2.43902439024%	1	41	482	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
2.43902439024%	1	41	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHAN_MULTIPLE_MYELOMA_LB_UP
2.43902439024%	1	41	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE
2.43902439024%	1	41	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MCDOWELL_ACUTE_LUNG_INJURY_DN
2.43902439024%	1	41	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
2.43902439024%	1	41	473	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GARY_CD5_TARGETS_UP
2.43902439024%	1	41	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
2.43902439024%	1	41	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_NFAT_TFPATHWAY
2.43902439024%	1	41	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KHETCHOUMIAN_TRIM24_TARGETS_UP
2.43902439024%	1	41	467	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RATTENBACHER_BOUND_BY_CELF1
2.43902439024%	1	41	463	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
2.43902439024%	1	41	463	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
2.43902439024%	1	41	462	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DELACROIX_RAR_BOUND_ES
2.43902439024%	1	41	461	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
2.43902439024%	1	41	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SAGIV_CD24_TARGETS_DN
2.43902439024%	1	41	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_TNFPATHWAY
2.43902439024%	1	41	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_PS1PATHWAY
2.43902439024%	1	41	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PARENT_MTOR_SIGNALING_DN
2.43902439024%	1	41	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NAKAJIMA_MAST_CELL
2.43902439024%	1	41	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MADAN_DPPA4_TARGETS
2.43902439024%	1	41	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN
2.43902439024%	1	41	457	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SENESE_HDAC1_TARGETS_UP
2.43902439024%	1	41	456	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
2.43902439024%	1	41	456	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARTENS_BOUND_BY_PML_RARA_FUSION
2.43902439024%	1	41	450	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
2.43902439024%	1	41	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHAN_MULTIPLE_MYELOMA_CD1_UP
2.43902439024%	1	41	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHAN_MULTIPLE_MYELOMA_CD1_DN
2.43902439024%	1	41	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER
2.43902439024%	1	41	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_RHOA_PATHWAY
2.43902439024%	1	41	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NUTT_GBM_VS_AO_GLIOMA_DN
2.43902439024%	1	41	443	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DELYS_THYROID_CANCER_UP
2.43902439024%	1	41	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_HNF3APATHWAY
2.43902439024%	1	41	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
2.43902439024%	1	41	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_TYPE_I_DIABETES_MELLITUS
2.43902439024%	1	41	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_NUCLEOTIDE_EXCISION_REPAIR
2.43902439024%	1	41	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_LYSINE_DEGRADATION
2.43902439024%	1	41	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM
2.43902439024%	1	41	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_ABC_TRANSPORTERS
2.43902439024%	1	41	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HARRIS_BRAIN_CANCER_PROGENITORS
2.43902439024%	1	41	430	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RIGGI_EWING_SARCOMA_PROGENITOR_UP
2.43902439024%	1	41	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	POTTI_ETOPOSIDE_SENSITIVITY
2.43902439024%	1	41	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LEE_CALORIE_RESTRICTION_MUSCLE_UP
2.43902439024%	1	41	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
2.43902439024%	1	41	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HUMMEL_BURKITTS_LYMPHOMA_UP
2.43902439024%	1	41	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
2.43902439024%	1	41	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
2.43902439024%	1	41	425	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BOCHKIS_FOXA2_TARGETS
2.43902439024%	1	41	423	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	THUM_SYSTOLIC_HEART_FAILURE_UP
2.43902439024%	1	41	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
2.43902439024%	1	41	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER
2.43902439024%	1	41	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_FATTY_ACID_METABOLISM
2.43902439024%	1	41	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_CHREBP2_PATHWAY
2.43902439024%	1	41	419	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
2.43902439024%	1	41	418	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PEDRIOLI_MIR31_TARGETS_DN
2.43902439024%	1	41	418	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MULLIGHAN_MLL_SIGNATURE_2_UP
2.43902439024%	1	41	414	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LU_EZH2_TARGETS_DN
2.43902439024%	1	41	411	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KOYAMA_SEMA3B_TARGETS_DN
2.43902439024%	1	41	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MALONEY_RESPONSE_TO_17AAG_UP
2.43902439024%	1	41	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LIN_MELANOMA_COPY_NUMBER_DN
2.43902439024%	1	41	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	EHLERS_ANEUPLOIDY_UP
2.43902439024%	1	41	408	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
2.43902439024%	1	41	406	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	OSMAN_BLADDER_CANCER_DN
2.43902439024%	1	41	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	VANASSE_BCL2_TARGETS_UP
2.43902439024%	1	41	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	TOMLINS_PROSTATE_CANCER_DN
2.43902439024%	1	41	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ST_JNK_MAPK_PATHWAY
2.43902439024%	1	41	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
2.43902439024%	1	41	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP
2.43902439024%	1	41	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_TRYPTOPHAN_METABOLISM
2.43902439024%	1	41	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HEIDENBLAD_AMPLICON_8Q24_UP
2.43902439024%	1	41	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BURTON_ADIPOGENESIS_PEAK_AT_16HR
2.43902439024%	1	41	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
2.43902439024%	1	41	391	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
2.43902439024%	1	41	390	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
2.43902439024%	1	41	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	POTTI_PACLITAXEL_SENSITIVITY
2.43902439024%	1	41	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GU_PDEF_TARGETS_DN
2.43902439024%	1	41	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
2.43902439024%	1	41	388	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	STEIN_ESRRA_TARGETS_UP
2.43902439024%	1	41	384	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
2.43902439024%	1	41	382	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
2.43902439024%	1	41	380	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MULLIGHAN_MLL_SIGNATURE_1_UP
2.43902439024%	1	41	380	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DAIRKEE_TERT_TARGETS_UP
2.43902439024%	1	41	380	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
2.43902439024%	1	41	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YOKOE_CANCER_TESTIS_ANTIGENS
2.43902439024%	1	41	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP
2.43902439024%	1	41	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_INTEGRIN_PATHWAY
2.43902439024%	1	41	379	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BENPORATH_ES_1
2.43902439024%	1	41	378	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
2.43902439024%	1	41	374	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WANG_TUMOR_INVASIVENESS_UP
2.43902439024%	1	41	374	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
2.43902439024%	1	41	372	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WANG_LMO4_TARGETS_UP
2.43902439024%	1	41	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	VALK_AML_WITH_CEBPA
2.43902439024%	1	41	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ST_GA13_PATHWAY
2.43902439024%	1	41	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LANDIS_ERBB2_BREAST_TUMORS_65_DN
2.43902439024%	1	41	364	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YANG_BCL3_TARGETS_UP
2.43902439024%	1	41	362	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
2.43902439024%	1	41	36	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YANG_BREAST_CANCER_ESR1_UP
2.43902439024%	1	41	36	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_DNA_REPLICATION
2.43902439024%	1	41	353	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
2.43902439024%	1	41	352	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WANG_LMO4_TARGETS_DN
2.43902439024%	1	41	351	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
2.43902439024%	1	41	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WEIGEL_OXIDATIVE_STRESS_RESPONSE
2.43902439024%	1	41	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ST_G_ALPHA_I_PATHWAY
2.43902439024%	1	41	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ROZANOV_MMP14_TARGETS_DN
2.43902439024%	1	41	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_GLOBAL_GENOMIC_NER_GG_NER
2.43902439024%	1	41	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_PI3KCIAKTPATHWAY
2.43902439024%	1	41	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION
2.43902439024%	1	41	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_REGULATION_OF_AUTOPHAGY
2.43902439024%	1	41	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_BASE_EXCISION_REPAIR
2.43902439024%	1	41	346	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GOLDRATH_ANTIGEN_RESPONSE
2.43902439024%	1	41	341	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MULLIGHAN_NPM1_SIGNATURE_3_UP
2.43902439024%	1	41	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ST_WNT_BETA_CATENIN_PATHWAY
2.43902439024%	1	41	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT
2.43902439024%	1	41	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	POTTI_CYTOXAN_SENSITIVITY
2.43902439024%	1	41	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_EPOPATHWAY
2.43902439024%	1	41	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_BUTANOATE_METABOLISM
2.43902439024%	1	41	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	JIANG_HYPOXIA_VIA_VHL
2.43902439024%	1	41	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DOANE_BREAST_CANCER_CLASSES_DN
2.43902439024%	1	41	337	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PENG_GLUTAMINE_DEPRIVATION_DN
2.43902439024%	1	41	335	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
2.43902439024%	1	41	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHAN_LATE_DIFFERENTIATION_GENES_UP
2.43902439024%	1	41	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HEIDENBLAD_AMPLICON_12P11_12_UP
2.43902439024%	1	41	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_NO1_PATHWAY
2.43902439024%	1	41	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_DEATH_PATHWAY
2.43902439024%	1	41	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN
2.43902439024%	1	41	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	APPEL_IMATINIB_RESPONSE
2.43902439024%	1	41	329	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
2.43902439024%	1	41	326	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
2.43902439024%	1	41	324	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
2.43902439024%	1	41	320	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
2.43902439024%	1	41	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	TRACEY_RESISTANCE_TO_IFNA2_DN
2.43902439024%	1	41	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_WNT_NONCANONICAL_PATHWAY
2.43902439024%	1	41	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM
2.43902439024%	1	41	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BAUS_TFF2_TARGETS_UP
2.43902439024%	1	41	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BAE_BRCA1_TARGETS_DN
2.43902439024%	1	41	318	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LEI_MYB_TARGETS
2.43902439024%	1	41	317	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HELLER_HDAC_TARGETS_UP
2.43902439024%	1	41	316	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
2.43902439024%	1	41	315	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
2.43902439024%	1	41	311	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	JIANG_HYPOXIA_NORMAL
2.43902439024%	1	41	310	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HORIUCHI_WTAP_TARGETS_DN
2.43902439024%	1	41	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP
2.43902439024%	1	41	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	VALK_AML_CLUSTER_15
2.43902439024%	1	41	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN
2.43902439024%	1	41	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP
2.43902439024%	1	41	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SIMBULAN_PARP1_TARGETS_UP
2.43902439024%	1	41	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
2.43902439024%	1	41	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER
2.43902439024%	1	41	309	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
2.43902439024%	1	41	309	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
2.43902439024%	1	41	308	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
2.43902439024%	1	41	307	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
2.43902439024%	1	41	306	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HORIUCHI_WTAP_TARGETS_UP
2.43902439024%	1	41	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	VALK_AML_CLUSTER_13
2.43902439024%	1	41	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_DNA_STRAND_ELONGATION
2.43902439024%	1	41	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LI_PROSTATE_CANCER_EPIGENETIC
2.43902439024%	1	41	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GUILLAUMOND_KLF10_TARGETS_DN
2.43902439024%	1	41	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_FAS_PATHWAY
2.43902439024%	1	41	299	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WALLACE_PROSTATE_CANCER_RACE_UP
2.43902439024%	1	41	295	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LU_EZH2_TARGETS_UP
2.43902439024%	1	41	295	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
2.43902439024%	1	41	294	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
2.43902439024%	1	41	293	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	IVANOVA_HEMATOPOIESIS_MATURE_CELL
2.43902439024%	1	41	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WILENSKY_RESPONSE_TO_DARAPLADIB
2.43902439024%	1	41	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_PKB_MEDIATED_EVENTS
2.43902439024%	1	41	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_PERK_REGULATED_GENE_EXPRESSION
2.43902439024%	1	41	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
2.43902439024%	1	41	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PAL_PRMT5_TARGETS_DN
2.43902439024%	1	41	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NGUYEN_NOTCH1_TARGETS_UP
2.43902439024%	1	41	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MA_PITUITARY_FETAL_VS_ADULT_UP
2.43902439024%	1	41	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MAYBURD_RESPONSE_TO_L663536_UP
2.43902439024%	1	41	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KYNG_WERNER_SYNDROM_DN
2.43902439024%	1	41	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_THYROID_CANCER
2.43902439024%	1	41	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN
2.43902439024%	1	41	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_TNFR1_PATHWAY
2.43902439024%	1	41	287	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
2.43902439024%	1	41	285	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
2.43902439024%	1	41	283	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
2.43902439024%	1	41	282	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HELLER_SILENCED_BY_METHYLATION_UP
2.43902439024%	1	41	281	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MULLIGHAN_MLL_SIGNATURE_2_DN
2.43902439024%	1	41	281	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BHAT_ESR1_TARGETS_VIA_AKT1_UP
2.43902439024%	1	41	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ST_GAQ_PATHWAY
2.43902439024%	1	41	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER
2.43902439024%	1	41	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING
2.43902439024%	1	41	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_HOMOLOGOUS_RECOMBINATION
2.43902439024%	1	41	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
2.43902439024%	1	41	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HWANG_PROSTATE_CANCER_MARKERS
2.43902439024%	1	41	277	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHANG_TLX_TARGETS_60HR_DN
2.43902439024%	1	41	275	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
2.43902439024%	1	41	274	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
2.43902439024%	1	41	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
2.43902439024%	1	41	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
2.43902439024%	1	41	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN
2.43902439024%	1	41	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_EXTENSION_OF_TELOMERES
2.43902439024%	1	41	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	OHM_METHYLATED_IN_ADULT_CANCERS
2.43902439024%	1	41	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GROSS_ELK3_TARGETS_UP
2.43902439024%	1	41	267	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_MAPK_SIGNALING_PATHWAY
2.43902439024%	1	41	266	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ROZANOV_MMP14_TARGETS_UP
2.43902439024%	1	41	261	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RICKMAN_METASTASIS_DN
2.43902439024%	1	41	260	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SENESE_HDAC1_TARGETS_DN
2.43902439024%	1	41	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
2.43902439024%	1	41	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_RXR_VDR_PATHWAY
2.43902439024%	1	41	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_ALK1PATHWAY
2.43902439024%	1	41	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NAKAMURA_CANCER_MICROENVIRONMENT_UP
2.43902439024%	1	41	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_GALACTOSE_METABOLISM
2.43902439024%	1	41	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
2.43902439024%	1	41	258	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
2.43902439024%	1	41	256	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ONDER_CDH1_TARGETS_2_UP
2.43902439024%	1	41	255	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
2.43902439024%	1	41	253	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MCLACHLAN_DENTAL_CARIES_UP
2.43902439024%	1	41	252	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
2.43902439024%	1	41	250	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
2.43902439024%	1	41	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
2.43902439024%	1	41	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP
2.43902439024%	1	41	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	JACKSON_DNMT1_TARGETS_DN
2.43902439024%	1	41	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	COLLER_MYC_TARGETS_UP
2.43902439024%	1	41	249	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MITSIADES_RESPONSE_TO_APLIDIN_DN
2.43902439024%	1	41	249	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
2.43902439024%	1	41	246	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BILD_E2F3_ONCOGENIC_SIGNATURE
2.43902439024%	1	41	245	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PENG_RAPAMYCIN_RESPONSE_DN
2.43902439024%	1	41	245	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MCLACHLAN_DENTAL_CARIES_DN
2.43902439024%	1	41	244	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	THUM_SYSTOLIC_HEART_FAILURE_DN
2.43902439024%	1	41	244	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KAYO_AGING_MUSCLE_UP
2.43902439024%	1	41	242	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WINTER_HYPOXIA_METAGENE
2.43902439024%	1	41	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YIH_RESPONSE_TO_ARSENITE_C1
2.43902439024%	1	41	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SHI_SPARC_TARGETS_UP
2.43902439024%	1	41	239	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ALFANO_MYC_TARGETS
2.43902439024%	1	41	238	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
2.43902439024%	1	41	238	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
2.43902439024%	1	41	234	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
2.43902439024%	1	41	232	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
2.43902439024%	1	41	232	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DELYS_THYROID_CANCER_DN
2.43902439024%	1	41	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SAGIV_CD24_TARGETS_UP
2.43902439024%	1	41	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION
2.43902439024%	1	41	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_NITROGEN_METABOLISM
2.43902439024%	1	41	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_MISMATCH_REPAIR
2.43902439024%	1	41	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP
2.43902439024%	1	41	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_CASPASE_PATHWAY
2.43902439024%	1	41	229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
2.43902439024%	1	41	229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
2.43902439024%	1	41	229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
2.43902439024%	1	41	229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
2.43902439024%	1	41	228	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
2.43902439024%	1	41	228	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARKEY_RB1_ACUTE_LOF_DN
2.43902439024%	1	41	227	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
2.43902439024%	1	41	227	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
2.43902439024%	1	41	225	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
2.43902439024%	1	41	225	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
2.43902439024%	1	41	225	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BROWNE_HCMV_INFECTION_16HR_UP
2.43902439024%	1	41	222	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
2.43902439024%	1	41	222	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BROWNE_HCMV_INFECTION_1HR_DN
2.43902439024%	1	41	221	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHANG_TLX_TARGETS_36HR_UP
2.43902439024%	1	41	221	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PEDRIOLI_MIR31_TARGETS_UP
2.43902439024%	1	41	221	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHANDRAN_METASTASIS_UP
2.43902439024%	1	41	220	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RIGGINS_TAMOXIFEN_RESISTANCE_DN
2.43902439024%	1	41	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SPIRA_SMOKERS_LUNG_CANCER_DN
2.43902439024%	1	41	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION
2.43902439024%	1	41	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
2.43902439024%	1	41	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
2.43902439024%	1	41	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
2.43902439024%	1	41	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MOOTHA_FFA_OXYDATION
2.43902439024%	1	41	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MATZUK_IMPLANTATION_AND_UTERINE
2.43902439024%	1	41	217	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WONG_MITOCHONDRIA_GENE_MODULE
2.43902439024%	1	41	216	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WHITFIELD_CELL_CYCLE_G2_M
2.43902439024%	1	41	214	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZWANG_EGF_INTERVAL_DN
2.43902439024%	1	41	214	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
2.43902439024%	1	41	214	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KIM_WT1_TARGETS_UP
2.43902439024%	1	41	212	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHANG_CORE_SERUM_RESPONSE_UP
2.43902439024%	1	41	211	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
2.43902439024%	1	41	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	VERHAAK_GLIOBLASTOMA_PRONEURAL
2.43902439024%	1	41	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
2.43902439024%	1	41	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SANSOM_APC_TARGETS_REQUIRE_MYC
2.43902439024%	1	41	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_TRANSCRIPTION
2.43902439024%	1	41	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CAIRO_HEPATOBLASTOMA_CLASSES_DN
2.43902439024%	1	41	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	STEGER_ADIPOGENESIS_UP
2.43902439024%	1	41	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING
2.43902439024%	1	41	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_CTLA4_INHIBITORY_SIGNALING
2.43902439024%	1	41	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MOOTHA_GLYCOGEN_METABOLISM
2.43902439024%	1	41	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LANDEMAINE_LUNG_METASTASIS
2.43902439024%	1	41	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HU_ANGIOGENESIS_UP
2.43902439024%	1	41	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
2.43902439024%	1	41	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CAIRO_HEPATOBLASTOMA_UP
2.43902439024%	1	41	205	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
2.43902439024%	1	41	205	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PEREZ_TP53_AND_TP63_TARGETS
2.43902439024%	1	41	204	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
2.43902439024%	1	41	203	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PENG_RAPAMYCIN_RESPONSE_UP
2.43902439024%	1	41	202	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
2.43902439024%	1	41	202	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FUJII_YBX1_TARGETS_DN
2.43902439024%	1	41	201	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KIM_MYC_AMPLIFICATION_TARGETS_UP
2.43902439024%	1	41	200	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SHEPARD_BMYB_MORPHOLINO_DN
2.43902439024%	1	41	200	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
2.43902439024%	1	41	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WENG_POR_TARGETS_GLOBAL_UP
2.43902439024%	1	41	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WANG_THOC1_TARGETS_DN
2.43902439024%	1	41	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN
2.43902439024%	1	41	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_ENOS_ACTIVATION_AND_REGULATION
2.43902439024%	1	41	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PID_WNT_CANONICAL_PATHWAY
2.43902439024%	1	41	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NIELSEN_SYNOVIAL_SARCOMA_DN
2.43902439024%	1	41	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KYNG_WERNER_SYNDROM_UP
2.43902439024%	1	41	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	COLLIS_PRKDC_SUBSTRATES
2.43902439024%	1	41	199	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
2.43902439024%	1	41	198	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ALONSO_METASTASIS_UP
2.43902439024%	1	41	196	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
2.43902439024%	1	41	195	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
2.43902439024%	1	41	194	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
2.43902439024%	1	41	192	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_DNA_REPLICATION
2.43902439024%	1	41	191	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YAGI_AML_FAB_MARKERS
2.43902439024%	1	41	191	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RIGGI_EWING_SARCOMA_PROGENITOR_DN
2.43902439024%	1	41	191	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
2.43902439024%	1	41	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE
2.43902439024%	1	41	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	VERNOCHET_ADIPOGENESIS
2.43902439024%	1	41	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SYED_ESTRADIOL_RESPONSE
2.43902439024%	1	41	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RUAN_RESPONSE_TO_TROGLITAZONE_DN
2.43902439024%	1	41	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_PYRUVATE_METABOLISM
2.43902439024%	1	41	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_LAGGING_STRAND_SYNTHESIS
2.43902439024%	1	41	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_BASE_EXCISION_REPAIR
2.43902439024%	1	41	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	OUYANG_PROSTATE_CANCER_MARKERS
2.43902439024%	1	41	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARSON_FOXP3_CORE_DIRECT_TARGETS
2.43902439024%	1	41	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN
2.43902439024%	1	41	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_MAL_PATHWAY
2.43902439024%	1	41	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
2.43902439024%	1	41	189	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BURTON_ADIPOGENESIS_6
2.43902439024%	1	41	185	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHANG_TLX_TARGETS_36HR_DN
2.43902439024%	1	41	185	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_HUNTINGTONS_DISEASE
2.43902439024%	1	41	184	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DOANE_RESPONSE_TO_ANDROGEN_UP
2.43902439024%	1	41	183	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
2.43902439024%	1	41	183	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	VERHAAK_AML_WITH_NPM1_MUTATED_UP
2.43902439024%	1	41	182	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
2.43902439024%	1	41	182	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RAO_BOUND_BY_SALL4_ISOFORM_A
2.43902439024%	1	41	181	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
2.43902439024%	1	41	181	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	JISON_SICKLE_CELL_DISEASE_UP
2.43902439024%	1	41	181	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
2.43902439024%	1	41	180	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
2.43902439024%	1	41	180	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BROWNE_HCMV_INFECTION_48HR_UP
2.43902439024%	1	41	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE
2.43902439024%	1	41	177	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
2.43902439024%	1	41	176	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SASAKI_ADULT_T_CELL_LEUKEMIA
2.43902439024%	1	41	176	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NAGASHIMA_NRG1_SIGNALING_UP
2.43902439024%	1	41	176	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
2.43902439024%	1	41	174	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
2.43902439024%	1	41	172	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SMID_BREAST_CANCER_LUMINAL_B_UP
2.43902439024%	1	41	172	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
2.43902439024%	1	41	172	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
2.43902439024%	1	41	170	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
2.43902439024%	1	41	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY
2.43902439024%	1	41	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION
2.43902439024%	1	41	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MATTHEWS_AP1_TARGETS
2.43902439024%	1	41	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
2.43902439024%	1	41	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_STEROID_BIOSYNTHESIS
2.43902439024%	1	41	169	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	UEDA_PERIFERAL_CLOCK
2.43902439024%	1	41	169	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_ALZHEIMERS_DISEASE
2.43902439024%	1	41	166	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SMIRNOV_RESPONSE_TO_IR_6HR_UP
2.43902439024%	1	41	165	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
2.43902439024%	1	41	165	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
2.43902439024%	1	41	164	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
2.43902439024%	1	41	163	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SERVITJA_ISLET_HNF1A_TARGETS_UP
2.43902439024%	1	41	163	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
2.43902439024%	1	41	162	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MULLIGHAN_NPM1_SIGNATURE_3_DN
2.43902439024%	1	41	160	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
2.43902439024%	1	41	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WONG_IFNA2_RESISTANCE_UP
2.43902439024%	1	41	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN
2.43902439024%	1	41	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
2.43902439024%	1	41	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	IGLESIAS_E2F_TARGETS_DN
2.43902439024%	1	41	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	HE_PTEN_TARGETS_UP
2.43902439024%	1	41	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHIN_BREAST_CANCER_COPY_NUMBER_DN
2.43902439024%	1	41	159	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
2.43902439024%	1	41	159	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_PURINE_METABOLISM
2.43902439024%	1	41	158	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RODRIGUES_NTN1_TARGETS_DN
2.43902439024%	1	41	157	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
2.43902439024%	1	41	153	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
2.43902439024%	1	41	152	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
2.43902439024%	1	41	151	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	IGLESIAS_E2F_TARGETS_UP
2.43902439024%	1	41	151	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
2.43902439024%	1	41	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3
2.43902439024%	1	41	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SU_KIDNEY
2.43902439024%	1	41	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP
2.43902439024%	1	41	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND
2.43902439024%	1	41	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARKS_ACETYLATED_NON_HISTONE_PROTEINS
2.43902439024%	1	41	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_NUCLEARRS_PATHWAY
2.43902439024%	1	41	149	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LANDIS_ERBB2_BREAST_TUMORS_324_DN
2.43902439024%	1	41	149	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GOZGIT_ESR1_TARGETS_UP
2.43902439024%	1	41	148	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_APOPTOSIS
2.43902439024%	1	41	148	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BROWNE_HCMV_INFECTION_24HR_UP
2.43902439024%	1	41	147	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SMID_BREAST_CANCER_ERBB2_UP
2.43902439024%	1	41	147	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
2.43902439024%	1	41	147	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
2.43902439024%	1	41	147	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KAUFFMANN_DNA_REPLICATION_GENES
2.43902439024%	1	41	146	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PECE_MAMMARY_STEM_CELL_UP
2.43902439024%	1	41	146	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PECE_MAMMARY_STEM_CELL_DN
2.43902439024%	1	41	146	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ELVIDGE_HYPOXIA_DN
2.43902439024%	1	41	146	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
2.43902439024%	1	41	145	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHANG_BREAST_CANCER_PROGENITORS_DN
2.43902439024%	1	41	145	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SMITH_TERT_TARGETS_UP
2.43902439024%	1	41	145	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
2.43902439024%	1	41	143	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION
2.43902439024%	1	41	142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	XU_GH1_AUTOCRINE_TARGETS_DN
2.43902439024%	1	41	142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RUIZ_TNC_TARGETS_DN
2.43902439024%	1	41	142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PENG_LEUCINE_DEPRIVATION_UP
2.43902439024%	1	41	142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
2.43902439024%	1	41	141	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WELCSH_BRCA1_TARGETS_DN
2.43902439024%	1	41	141	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KAAB_FAILED_HEART_ATRIUM_DN
2.43902439024%	1	41	140	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
2.43902439024%	1	41	140	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
2.43902439024%	1	41	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP
2.43902439024%	1	41	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER
2.43902439024%	1	41	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION
2.43902439024%	1	41	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	INAMURA_LUNG_CANCER_SCC_DN
2.43902439024%	1	41	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
2.43902439024%	1	41	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_PS1_PATHWAY
2.43902439024%	1	41	139	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
2.43902439024%	1	41	138	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
2.43902439024%	1	41	138	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
2.43902439024%	1	41	138	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	JIANG_VHL_TARGETS
2.43902439024%	1	41	135	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	UDAYAKUMAR_MED1_TARGETS_UP
2.43902439024%	1	41	134	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	POOLA_INVASIVE_BREAST_CANCER_DN
2.43902439024%	1	41	134	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHUNG_BLISTER_CYTOTOXICITY_UP
2.43902439024%	1	41	133	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON
2.43902439024%	1	41	132	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
2.43902439024%	1	41	131	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
2.43902439024%	1	41	130	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ELVIDGE_HYPOXIA_BY_DMOG_UP
2.43902439024%	1	41	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SHIN_B_CELL_LYMPHOMA_CLUSTER_1
2.43902439024%	1	41	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_POL_SWITCHING
2.43902439024%	1	41	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	IRITANI_MAD1_TARGETS_UP
2.43902439024%	1	41	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GERHOLD_RESPONSE_TO_TZD_DN
2.43902439024%	1	41	129	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BROWN_MYELOID_CELL_DEVELOPMENT_DN
2.43902439024%	1	41	128	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHU_CMV_ALL_DN
2.43902439024%	1	41	128	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
2.43902439024%	1	41	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
2.43902439024%	1	41	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
2.43902439024%	1	41	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GERY_CEBP_TARGETS
2.43902439024%	1	41	123	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KAYO_AGING_MUSCLE_DN
2.43902439024%	1	41	122	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	TOOKER_GEMCITABINE_RESISTANCE_DN
2.43902439024%	1	41	122	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
2.43902439024%	1	41	122	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
2.43902439024%	1	41	121	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
2.43902439024%	1	41	121	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RODRIGUES_DCC_TARGETS_DN
2.43902439024%	1	41	121	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
2.43902439024%	1	41	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
2.43902439024%	1	41	120	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHEBOTAEV_GR_TARGETS_DN
2.43902439024%	1	41	12	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS
2.43902439024%	1	41	12	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING
2.43902439024%	1	41	12	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
2.43902439024%	1	41	118	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
2.43902439024%	1	41	116	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_MEIOSIS
2.43902439024%	1	41	116	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LIM_MAMMARY_LUMINAL_MATURE_UP
2.43902439024%	1	41	116	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
2.43902439024%	1	41	115	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MARKEY_RB1_CHRONIC_LOF_UP
2.43902439024%	1	41	115	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
2.43902439024%	1	41	114	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SENESE_HDAC2_TARGETS_UP
2.43902439024%	1	41	114	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LENAOUR_DENDRITIC_CELL_MATURATION_UP
2.43902439024%	1	41	114	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEGG_OOCYTE_MEIOSIS
2.43902439024%	1	41	113	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
2.43902439024%	1	41	112	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_DNA_REPAIR
2.43902439024%	1	41	112	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LAIHO_COLORECTAL_CANCER_SERRATED_UP
2.43902439024%	1	41	112	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LABBE_WNT3A_TARGETS_UP
2.43902439024%	1	41	112	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
2.43902439024%	1	41	111	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
2.43902439024%	1	41	110	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SUNG_METASTASIS_STROMA_UP
2.43902439024%	1	41	110	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
2.43902439024%	1	41	110	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
2.43902439024%	1	41	110	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
2.43902439024%	1	41	110	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	GROSS_HYPOXIA_VIA_HIF1A_DN
2.43902439024%	1	41	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_IL_7_SIGNALING
2.43902439024%	1	41	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS
2.43902439024%	1	41	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KALMA_E2F1_TARGETS
2.43902439024%	1	41	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BIOCARTA_EIF2_PATHWAY
2.43902439024%	1	41	109	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_S_PHASE
2.43902439024%	1	41	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
2.43902439024%	1	41	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	LE_EGR2_TARGETS_DN
2.43902439024%	1	41	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
2.43902439024%	1	41	106	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
2.43902439024%	1	41	106	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
2.43902439024%	1	41	104	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
2.43902439024%	1	41	104	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	NAKAMURA_ADIPOGENESIS_LATE_UP
2.43902439024%	1	41	103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
2.43902439024%	1	41	103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	KIM_MYCN_AMPLIFICATION_TARGETS_DN
2.43902439024%	1	41	102	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DER_IFN_BETA_RESPONSE_UP
2.43902439024%	1	41	102	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
2.43902439024%	1	41	101	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	WIELAND_UP_BY_HBV_INFECTION
2.43902439024%	1	41	101	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
2.43902439024%	1	41	101	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BROWNE_HCMV_INFECTION_10HR_UP
2.43902439024%	1	41	100	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	MCCLUNG_CREB1_TARGETS_UP
2.43902439024%	1	41	100	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
2.43902439024%	1	41	100	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BENPORATH_ES_CORE_NINE_CORRELATED
2.43902439024%	1	41	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	YEMELYANOV_GR_TARGETS_DN
2.43902439024%	1	41	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND
2.43902439024%	1	41	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	PYEON_HPV_POSITIVE_TUMORS_DN
2.43902439024%	1	41	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_GLUCOSE	BRUNEAU_SEPTATION_VENTRICULAR
2.4379024839%	53	2174	555	T2D_GENES_TANYA_LIPIDS	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
2.4379024839%	53	2174	546	T2D_GENES_TANYA_LIPIDS	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
2.4379024839%	53	2174	442	T2D_GENES_TANYA_LIPIDS	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
2.4379024839%	53	2174	419	T2D_GENES_TANYA_LIPIDS	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
2.4379024839%	53	2174	413	T2D_GENES_TANYA_LIPIDS	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
2.4379024839%	53	2174	380	T2D_GENES_TANYA_LIPIDS	DAIRKEE_TERT_TARGETS_UP
2.4379024839%	53	2174	354	T2D_GENES_TANYA_LIPIDS	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
2.43161094225%	48	1974	518	Mendelian_Nancy_Cox	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
2.43161094225%	48	1974	450	Mendelian_Nancy_Cox	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
2.43161094225%	48	1974	431	Mendelian_Nancy_Cox	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
2.43161094225%	48	1974	353	Mendelian_Nancy_Cox	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
2.43161094225%	48	1974	341	Mendelian_Nancy_Cox	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
2.43161094225%	48	1974	309	Mendelian_Nancy_Cox	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
2.43161094225%	48	1974	280	Mendelian_Nancy_Cox	WANG_SMARCE1_TARGETS_UP
2.43161094225%	48	1974	216	Mendelian_Nancy_Cox	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
2.42057488654%	16	661	605	T2D_GENES_TANYA_GLYCEMIC	CAIRO_HEPATOBLASTOMA_CLASSES_UP
2.42057488654%	16	661	572	T2D_GENES_TANYA_GLYCEMIC	CHICAS_RB1_TARGETS_SENESCENT
2.42057488654%	16	661	564	T2D_GENES_TANYA_GLYCEMIC	SMID_BREAST_CANCER_LUMINAL_B_DN
2.42057488654%	16	661	532	T2D_GENES_TANYA_GLYCEMIC	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
2.42057488654%	16	661	505	T2D_GENES_TANYA_GLYCEMIC	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
2.42057488654%	16	661	491	T2D_GENES_TANYA_GLYCEMIC	MEISSNER_NPC_HCP_WITH_H3K4ME2
2.42057488654%	16	661	485	T2D_GENES_TANYA_GLYCEMIC	ENK_UV_RESPONSE_KERATINOCYTE_DN
2.42057488654%	16	661	476	T2D_GENES_TANYA_GLYCEMIC	SMID_BREAST_CANCER_NORMAL_LIKE_UP
2.42057488654%	16	661	469	T2D_GENES_TANYA_GLYCEMIC	MCCABE_BOUND_BY_HOXC6
2.42057488654%	16	661	463	T2D_GENES_TANYA_GLYCEMIC	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
2.42057488654%	16	661	460	T2D_GENES_TANYA_GLYCEMIC	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
2.42057488654%	16	661	459	T2D_GENES_TANYA_GLYCEMIC	KIM_WT1_TARGETS_DN
2.42057488654%	16	661	424	T2D_GENES_TANYA_GLYCEMIC	SHEN_SMARCA2_TARGETS_UP
2.42057488654%	16	661	403	T2D_GENES_TANYA_GLYCEMIC	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
2.42057488654%	16	661	388	T2D_GENES_TANYA_GLYCEMIC	STEIN_ESRRA_TARGETS_UP
2.42057488654%	16	661	380	T2D_GENES_TANYA_GLYCEMIC	MULLIGHAN_MLL_SIGNATURE_1_UP
2.42057488654%	16	661	380	T2D_GENES_TANYA_GLYCEMIC	DAIRKEE_TERT_TARGETS_UP
2.42057488654%	16	661	378	T2D_GENES_TANYA_GLYCEMIC	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
2.42057488654%	16	661	341	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
2.42057488654%	16	661	328	T2D_GENES_TANYA_GLYCEMIC	KEGG_PATHWAYS_IN_CANCER
2.42057488654%	16	661	287	T2D_GENES_TANYA_GLYCEMIC	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
2.41935483871%	3	124	93	Diabetes_McGill_Cell_cycle_All_Gene	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
2.41935483871%	3	124	92	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_DILATED_CARDIOMYOPATHY
2.41935483871%	3	124	92	Diabetes_McGill_Cell_cycle_All_Gene	BURTON_ADIPOGENESIS_9
2.41935483871%	3	124	91	Diabetes_McGill_Cell_cycle_All_Gene	ZHU_CMV_24_HR_DN
2.41935483871%	3	124	91	Diabetes_McGill_Cell_cycle_All_Gene	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
2.41935483871%	3	124	91	Diabetes_McGill_Cell_cycle_All_Gene	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
2.41935483871%	3	124	9	Diabetes_McGill_Cell_cycle_All_Gene	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP
2.41935483871%	3	124	9	Diabetes_McGill_Cell_cycle_All_Gene	KOMMAGANI_TP63_GAMMA_TARGETS
2.41935483871%	3	124	89	Diabetes_McGill_Cell_cycle_All_Gene	SWEET_KRAS_ONCOGENIC_SIGNATURE
2.41935483871%	3	124	89	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
2.41935483871%	3	124	89	Diabetes_McGill_Cell_cycle_All_Gene	KANG_IMMORTALIZED_BY_TERT_UP
2.41935483871%	3	124	88	Diabetes_McGill_Cell_cycle_All_Gene	UEDA_CENTRAL_CLOCK
2.41935483871%	3	124	88	Diabetes_McGill_Cell_cycle_All_Gene	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
2.41935483871%	3	124	88	Diabetes_McGill_Cell_cycle_All_Gene	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
2.41935483871%	3	124	88	Diabetes_McGill_Cell_cycle_All_Gene	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
2.41935483871%	3	124	88	Diabetes_McGill_Cell_cycle_All_Gene	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
2.41935483871%	3	124	87	Diabetes_McGill_Cell_cycle_All_Gene	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
2.41935483871%	3	124	86	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_MEIOTIC_RECOMBINATION
2.41935483871%	3	124	85	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
2.41935483871%	3	124	84	Diabetes_McGill_Cell_cycle_All_Gene	HINATA_NFKB_TARGETS_FIBROBLAST_UP
2.41935483871%	3	124	82	Diabetes_McGill_Cell_cycle_All_Gene	BHAT_ESR1_TARGETS_VIA_AKT1_DN
2.41935483871%	3	124	81	Diabetes_McGill_Cell_cycle_All_Gene	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
2.41935483871%	3	124	81	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
2.41935483871%	3	124	80	Diabetes_McGill_Cell_cycle_All_Gene	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
2.41935483871%	3	124	79	Diabetes_McGill_Cell_cycle_All_Gene	MALONEY_RESPONSE_TO_17AAG_DN
2.41935483871%	3	124	79	Diabetes_McGill_Cell_cycle_All_Gene	CROMER_METASTASIS_UP
2.41935483871%	3	124	781	Diabetes_McGill_Cell_cycle_All_Gene	GOZGIT_ESR1_TARGETS_DN
2.41935483871%	3	124	77	Diabetes_McGill_Cell_cycle_All_Gene	JACKSON_DNMT1_TARGETS_UP
2.41935483871%	3	124	76	Diabetes_McGill_Cell_cycle_All_Gene	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
2.41935483871%	3	124	76	Diabetes_McGill_Cell_cycle_All_Gene	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
2.41935483871%	3	124	75	Diabetes_McGill_Cell_cycle_All_Gene	CHESLER_BRAIN_QTL_CIS
2.41935483871%	3	124	73	Diabetes_McGill_Cell_cycle_All_Gene	LIN_MELANOMA_COPY_NUMBER_UP
2.41935483871%	3	124	72	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_LEISHMANIA_INFECTION
2.41935483871%	3	124	72	Diabetes_McGill_Cell_cycle_All_Gene	DANG_REGULATED_BY_MYC_UP
2.41935483871%	3	124	71	Diabetes_McGill_Cell_cycle_All_Gene	KYNG_RESPONSE_TO_H2O2
2.41935483871%	3	124	70	Diabetes_McGill_Cell_cycle_All_Gene	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
2.41935483871%	3	124	7	Diabetes_McGill_Cell_cycle_All_Gene	HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER
2.41935483871%	3	124	69	Diabetes_McGill_Cell_cycle_All_Gene	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
2.41935483871%	3	124	69	Diabetes_McGill_Cell_cycle_All_Gene	PID_P75NTRPATHWAY
2.41935483871%	3	124	69	Diabetes_McGill_Cell_cycle_All_Gene	AMIT_EGF_RESPONSE_120_HELA
2.41935483871%	3	124	681	Diabetes_McGill_Cell_cycle_All_Gene	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
2.41935483871%	3	124	68	Diabetes_McGill_Cell_cycle_All_Gene	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
2.41935483871%	3	124	65	Diabetes_McGill_Cell_cycle_All_Gene	AMIT_SERUM_RESPONSE_120_MCF10A
2.41935483871%	3	124	64	Diabetes_McGill_Cell_cycle_All_Gene	GERHOLD_ADIPOGENESIS_DN
2.41935483871%	3	124	63	Diabetes_McGill_Cell_cycle_All_Gene	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
2.41935483871%	3	124	62	Diabetes_McGill_Cell_cycle_All_Gene	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP
2.41935483871%	3	124	60	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_ACUTE_MYELOID_LEUKEMIA
2.41935483871%	3	124	59	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION
2.41935483871%	3	124	58	Diabetes_McGill_Cell_cycle_All_Gene	KANNAN_TP53_TARGETS_UP
2.41935483871%	3	124	58	Diabetes_McGill_Cell_cycle_All_Gene	JI_RESPONSE_TO_FSH_DN
2.41935483871%	3	124	58	Diabetes_McGill_Cell_cycle_All_Gene	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
2.41935483871%	3	124	58	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_HIVNEF_PATHWAY
2.41935483871%	3	124	579	Diabetes_McGill_Cell_cycle_All_Gene	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
2.41935483871%	3	124	57	Diabetes_McGill_Cell_cycle_All_Gene	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
2.41935483871%	3	124	57	Diabetes_McGill_Cell_cycle_All_Gene	BORLAK_LIVER_CANCER_EGF_UP
2.41935483871%	3	124	566	Diabetes_McGill_Cell_cycle_All_Gene	DOUGLAS_BMI1_TARGETS_UP
2.41935483871%	3	124	56	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_PI_3K_CASCADE
2.41935483871%	3	124	56	Diabetes_McGill_Cell_cycle_All_Gene	MAYBURD_RESPONSE_TO_L663536_DN
2.41935483871%	3	124	56	Diabetes_McGill_Cell_cycle_All_Gene	GALE_APL_WITH_FLT3_MUTATED_UP
2.41935483871%	3	124	549	Diabetes_McGill_Cell_cycle_All_Gene	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
2.41935483871%	3	124	535	Diabetes_McGill_Cell_cycle_All_Gene	STEIN_ESRRA_TARGETS
2.41935483871%	3	124	53	Diabetes_McGill_Cell_cycle_All_Gene	ZHU_CMV_8_HR_DN
2.41935483871%	3	124	53	Diabetes_McGill_Cell_cycle_All_Gene	MENSSEN_MYC_TARGETS
2.41935483871%	3	124	51	Diabetes_McGill_Cell_cycle_All_Gene	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
2.41935483871%	3	124	51	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
2.41935483871%	3	124	51	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_NUCLEOTIDE_EXCISION_REPAIR
2.41935483871%	3	124	51	Diabetes_McGill_Cell_cycle_All_Gene	PRAMOONJAGO_SOX4_TARGETS_DN
2.41935483871%	3	124	51	Diabetes_McGill_Cell_cycle_All_Gene	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
2.41935483871%	3	124	51	Diabetes_McGill_Cell_cycle_All_Gene	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP
2.41935483871%	3	124	51	Diabetes_McGill_Cell_cycle_All_Gene	BURTON_ADIPOGENESIS_PEAK_AT_2HR
2.41935483871%	3	124	50	Diabetes_McGill_Cell_cycle_All_Gene	PARK_HSC_AND_MULTIPOTENT_PROGENITORS
2.41935483871%	3	124	50	Diabetes_McGill_Cell_cycle_All_Gene	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
2.41935483871%	3	124	50	Diabetes_McGill_Cell_cycle_All_Gene	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
2.41935483871%	3	124	491	Diabetes_McGill_Cell_cycle_All_Gene	SWEET_LUNG_CANCER_KRAS_UP
2.41935483871%	3	124	491	Diabetes_McGill_Cell_cycle_All_Gene	MEISSNER_NPC_HCP_WITH_H3K4ME2
2.41935483871%	3	124	49	Diabetes_McGill_Cell_cycle_All_Gene	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
2.41935483871%	3	124	49	Diabetes_McGill_Cell_cycle_All_Gene	FAELT_B_CLL_WITH_VH3_21_DN
2.41935483871%	3	124	489	Diabetes_McGill_Cell_cycle_All_Gene	LIM_MAMMARY_STEM_CELL_UP
2.41935483871%	3	124	481	Diabetes_McGill_Cell_cycle_All_Gene	LIU_PROSTATE_CANCER_DN
2.41935483871%	3	124	47	Diabetes_McGill_Cell_cycle_All_Gene	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN
2.41935483871%	3	124	47	Diabetes_McGill_Cell_cycle_All_Gene	PID_FANCONI_PATHWAY
2.41935483871%	3	124	469	Diabetes_McGill_Cell_cycle_All_Gene	MCCABE_BOUND_BY_HOXC6
2.41935483871%	3	124	464	Diabetes_McGill_Cell_cycle_All_Gene	ONDER_CDH1_TARGETS_2_DN
2.41935483871%	3	124	46	Diabetes_McGill_Cell_cycle_All_Gene	KRASNOSELSKAYA_ILF3_TARGETS_DN
2.41935483871%	3	124	46	Diabetes_McGill_Cell_cycle_All_Gene	JIANG_TIP30_TARGETS_UP
2.41935483871%	3	124	45	Diabetes_McGill_Cell_cycle_All_Gene	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN
2.41935483871%	3	124	45	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER
2.41935483871%	3	124	45	Diabetes_McGill_Cell_cycle_All_Gene	MCDOWELL_ACUTE_LUNG_INJURY_UP
2.41935483871%	3	124	442	Diabetes_McGill_Cell_cycle_All_Gene	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
2.41935483871%	3	124	44	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
2.41935483871%	3	124	44	Diabetes_McGill_Cell_cycle_All_Gene	PID_HNF3APATHWAY
2.41935483871%	3	124	44	Diabetes_McGill_Cell_cycle_All_Gene	GROSS_HYPOXIA_VIA_ELK3_ONLY_DN
2.41935483871%	3	124	435	Diabetes_McGill_Cell_cycle_All_Gene	SWEET_LUNG_CANCER_KRAS_DN
2.41935483871%	3	124	43	Diabetes_McGill_Cell_cycle_All_Gene	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
2.41935483871%	3	124	425	Diabetes_McGill_Cell_cycle_All_Gene	BOCHKIS_FOXA2_TARGETS
2.41935483871%	3	124	422	Diabetes_McGill_Cell_cycle_All_Gene	YAGI_AML_WITH_INV_16_TRANSLOCATION
2.41935483871%	3	124	42	Diabetes_McGill_Cell_cycle_All_Gene	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP
2.41935483871%	3	124	418	Diabetes_McGill_Cell_cycle_All_Gene	PEDRIOLI_MIR31_TARGETS_DN
2.41935483871%	3	124	418	Diabetes_McGill_Cell_cycle_All_Gene	MULLIGHAN_MLL_SIGNATURE_2_UP
2.41935483871%	3	124	408	Diabetes_McGill_Cell_cycle_All_Gene	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
2.41935483871%	3	124	40	Diabetes_McGill_Cell_cycle_All_Gene	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
2.41935483871%	3	124	392	Diabetes_McGill_Cell_cycle_All_Gene	LINDGREN_BLADDER_CANCER_CLUSTER_2B
2.41935483871%	3	124	39	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_IL1_SIGNALING
2.41935483871%	3	124	39	Diabetes_McGill_Cell_cycle_All_Gene	MA_MYELOID_DIFFERENTIATION_UP
2.41935483871%	3	124	39	Diabetes_McGill_Cell_cycle_All_Gene	KORKOLA_TERATOMA
2.41935483871%	3	124	39	Diabetes_McGill_Cell_cycle_All_Gene	HOFMANN_CELL_LYMPHOMA_DN
2.41935483871%	3	124	38	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
2.41935483871%	3	124	38	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_PI3K_AKT_ACTIVATION
2.41935483871%	3	124	38	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4
2.41935483871%	3	124	38	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_GAB1_SIGNALOSOME
2.41935483871%	3	124	38	Diabetes_McGill_Cell_cycle_All_Gene	ONGUSAHA_TP53_TARGETS
2.41935483871%	3	124	367	Diabetes_McGill_Cell_cycle_All_Gene	DELACROIX_RARG_BOUND_MEF
2.41935483871%	3	124	36	Diabetes_McGill_Cell_cycle_All_Gene	SUBTIL_PROGESTIN_TARGETS
2.41935483871%	3	124	357	Diabetes_McGill_Cell_cycle_All_Gene	SHEN_SMARCA2_TARGETS_DN
2.41935483871%	3	124	35	Diabetes_McGill_Cell_cycle_All_Gene	WEIGEL_OXIDATIVE_STRESS_RESPONSE
2.41935483871%	3	124	35	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_GLOBAL_GENOMIC_NER_GG_NER
2.41935483871%	3	124	34	Diabetes_McGill_Cell_cycle_All_Gene	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP
2.41935483871%	3	124	34	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_MPR_PATHWAY
2.41935483871%	3	124	337	Diabetes_McGill_Cell_cycle_All_Gene	PHONG_TNF_RESPONSE_NOT_VIA_P38
2.41935483871%	3	124	33	Diabetes_McGill_Cell_cycle_All_Gene	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN
2.41935483871%	3	124	33	Diabetes_McGill_Cell_cycle_All_Gene	DUTTA_APOPTOSIS_VIA_NFKB
2.41935483871%	3	124	33	Diabetes_McGill_Cell_cycle_All_Gene	CAFFAREL_RESPONSE_TO_THC_UP
2.41935483871%	3	124	33	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_IL1R_PATHWAY
2.41935483871%	3	124	326	Diabetes_McGill_Cell_cycle_All_Gene	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
2.41935483871%	3	124	316	Diabetes_McGill_Cell_cycle_All_Gene	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
2.41935483871%	3	124	315	Diabetes_McGill_Cell_cycle_All_Gene	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
2.41935483871%	3	124	30	Diabetes_McGill_Cell_cycle_All_Gene	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
2.41935483871%	3	124	30	Diabetes_McGill_Cell_cycle_All_Gene	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
2.41935483871%	3	124	30	Diabetes_McGill_Cell_cycle_All_Gene	LY_AGING_PREMATURE_DN
2.41935483871%	3	124	299	Diabetes_McGill_Cell_cycle_All_Gene	WALLACE_PROSTATE_CANCER_RACE_UP
2.41935483871%	3	124	293	Diabetes_McGill_Cell_cycle_All_Gene	ZWANG_DOWN_BY_2ND_EGF_PULSE
2.41935483871%	3	124	29	Diabetes_McGill_Cell_cycle_All_Gene	STANELLE_E2F1_TARGETS
2.41935483871%	3	124	29	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
2.41935483871%	3	124	29	Diabetes_McGill_Cell_cycle_All_Gene	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
2.41935483871%	3	124	29	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_THYROID_CANCER
2.41935483871%	3	124	29	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_NKT_PATHWAY
2.41935483871%	3	124	29	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_INFLAM_PATHWAY
2.41935483871%	3	124	28	Diabetes_McGill_Cell_cycle_All_Gene	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
2.41935483871%	3	124	28	Diabetes_McGill_Cell_cycle_All_Gene	REICHERT_MITOSIS_LIN9_TARGETS
2.41935483871%	3	124	279	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_INNATE_IMMUNE_SYSTEM
2.41935483871%	3	124	279	Diabetes_McGill_Cell_cycle_All_Gene	FORTSCHEGGER_PHF8_TARGETS_UP
2.41935483871%	3	124	276	Diabetes_McGill_Cell_cycle_All_Gene	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
2.41935483871%	3	124	271	Diabetes_McGill_Cell_cycle_All_Gene	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
2.41935483871%	3	124	27	Diabetes_McGill_Cell_cycle_All_Gene	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
2.41935483871%	3	124	27	Diabetes_McGill_Cell_cycle_All_Gene	PID_IL3_PATHWAY
2.41935483871%	3	124	27	Diabetes_McGill_Cell_cycle_All_Gene	OHM_METHYLATED_IN_ADULT_CANCERS
2.41935483871%	3	124	267	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
2.41935483871%	3	124	267	Diabetes_McGill_Cell_cycle_All_Gene	HOLLMANN_APOPTOSIS_VIA_CD40_DN
2.41935483871%	3	124	265	Diabetes_McGill_Cell_cycle_All_Gene	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
2.41935483871%	3	124	264	Diabetes_McGill_Cell_cycle_All_Gene	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
2.41935483871%	3	124	261	Diabetes_McGill_Cell_cycle_All_Gene	RICKMAN_METASTASIS_DN
2.41935483871%	3	124	261	Diabetes_McGill_Cell_cycle_All_Gene	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
2.41935483871%	3	124	260	Diabetes_McGill_Cell_cycle_All_Gene	SENESE_HDAC1_TARGETS_DN
2.41935483871%	3	124	26	Diabetes_McGill_Cell_cycle_All_Gene	WILLIAMS_ESR1_TARGETS_UP
2.41935483871%	3	124	26	Diabetes_McGill_Cell_cycle_All_Gene	PID_ALK1PATHWAY
2.41935483871%	3	124	258	Diabetes_McGill_Cell_cycle_All_Gene	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
2.41935483871%	3	124	256	Diabetes_McGill_Cell_cycle_All_Gene	ONDER_CDH1_TARGETS_2_UP
2.41935483871%	3	124	251	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_AXON_GUIDANCE
2.41935483871%	3	124	25	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN
2.41935483871%	3	124	25	Diabetes_McGill_Cell_cycle_All_Gene	NOJIMA_SFRP2_TARGETS_DN
2.41935483871%	3	124	25	Diabetes_McGill_Cell_cycle_All_Gene	LU_TUMOR_ANGIOGENESIS_UP
2.41935483871%	3	124	249	Diabetes_McGill_Cell_cycle_All_Gene	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
2.41935483871%	3	124	246	Diabetes_McGill_Cell_cycle_All_Gene	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
2.41935483871%	3	124	244	Diabetes_McGill_Cell_cycle_All_Gene	KAYO_AGING_MUSCLE_UP
2.41935483871%	3	124	238	Diabetes_McGill_Cell_cycle_All_Gene	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
2.41935483871%	3	124	236	Diabetes_McGill_Cell_cycle_All_Gene	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
2.41935483871%	3	124	23	Diabetes_McGill_Cell_cycle_All_Gene	WU_HBX_TARGETS_1_DN
2.41935483871%	3	124	23	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING
2.41935483871%	3	124	23	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_MEF2D_PATHWAY
2.41935483871%	3	124	229	Diabetes_McGill_Cell_cycle_All_Gene	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
2.41935483871%	3	124	227	Diabetes_McGill_Cell_cycle_All_Gene	RAO_BOUND_BY_SALL4
2.41935483871%	3	124	227	Diabetes_McGill_Cell_cycle_All_Gene	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
2.41935483871%	3	124	22	Diabetes_McGill_Cell_cycle_All_Gene	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER
2.41935483871%	3	124	217	Diabetes_McGill_Cell_cycle_All_Gene	WIERENGA_STAT5A_TARGETS_UP
2.41935483871%	3	124	211	Diabetes_McGill_Cell_cycle_All_Gene	FOSTER_KDM1A_TARGETS_DN
2.41935483871%	3	124	211	Diabetes_McGill_Cell_cycle_All_Gene	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
2.41935483871%	3	124	21	Diabetes_McGill_Cell_cycle_All_Gene	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE
2.41935483871%	3	124	207	Diabetes_McGill_Cell_cycle_All_Gene	KARLSSON_TGFB1_TARGETS_DN
2.41935483871%	3	124	204	Diabetes_McGill_Cell_cycle_All_Gene	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
2.41935483871%	3	124	203	Diabetes_McGill_Cell_cycle_All_Gene	GRUETZMANN_PANCREATIC_CANCER_DN
2.41935483871%	3	124	20	Diabetes_McGill_Cell_cycle_All_Gene	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN
2.41935483871%	3	124	20	Diabetes_McGill_Cell_cycle_All_Gene	MANN_RESPONSE_TO_AMIFOSTINE_UP
2.41935483871%	3	124	199	Diabetes_McGill_Cell_cycle_All_Gene	PLASARI_TGFB1_TARGETS_10HR_UP
2.41935483871%	3	124	197	Diabetes_McGill_Cell_cycle_All_Gene	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
2.41935483871%	3	124	194	Diabetes_McGill_Cell_cycle_All_Gene	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
2.41935483871%	3	124	191	Diabetes_McGill_Cell_cycle_All_Gene	YAGI_AML_FAB_MARKERS
2.41935483871%	3	124	19	Diabetes_McGill_Cell_cycle_All_Gene	PID_HIF1APATHWAY
2.41935483871%	3	124	19	Diabetes_McGill_Cell_cycle_All_Gene	OUYANG_PROSTATE_CANCER_MARKERS
2.41935483871%	3	124	19	Diabetes_McGill_Cell_cycle_All_Gene	LI_WILMS_TUMOR_ANAPLASTIC_UP
2.41935483871%	3	124	187	Diabetes_McGill_Cell_cycle_All_Gene	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
2.41935483871%	3	124	181	Diabetes_McGill_Cell_cycle_All_Gene	JISON_SICKLE_CELL_DISEASE_DN
2.41935483871%	3	124	180	Diabetes_McGill_Cell_cycle_All_Gene	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
2.41935483871%	3	124	18	Diabetes_McGill_Cell_cycle_All_Gene	YIH_RESPONSE_TO_ARSENITE_C2
2.41935483871%	3	124	18	Diabetes_McGill_Cell_cycle_All_Gene	SMID_BREAST_CANCER_LUMINAL_A_DN
2.41935483871%	3	124	18	Diabetes_McGill_Cell_cycle_All_Gene	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN
2.41935483871%	3	124	18	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_NODAL
2.41935483871%	3	124	18	Diabetes_McGill_Cell_cycle_All_Gene	PID_BETACATENIN_DEG_PATHWAY
2.41935483871%	3	124	18	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_TEL_PATHWAY
2.41935483871%	3	124	177	Diabetes_McGill_Cell_cycle_All_Gene	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
2.41935483871%	3	124	1725	Diabetes_McGill_Cell_cycle_All_Gene	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
2.41935483871%	3	124	171	Diabetes_McGill_Cell_cycle_All_Gene	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
2.41935483871%	3	124	170	Diabetes_McGill_Cell_cycle_All_Gene	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
2.41935483871%	3	124	17	Diabetes_McGill_Cell_cycle_All_Gene	PID_SMAD2_3PATHWAY
2.41935483871%	3	124	17	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_PML_PATHWAY
2.41935483871%	3	124	169	Diabetes_McGill_Cell_cycle_All_Gene	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
2.41935483871%	3	124	165	Diabetes_McGill_Cell_cycle_All_Gene	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
2.41935483871%	3	124	163	Diabetes_McGill_Cell_cycle_All_Gene	SERVITJA_ISLET_HNF1A_TARGETS_UP
2.41935483871%	3	124	162	Diabetes_McGill_Cell_cycle_All_Gene	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
2.41935483871%	3	124	161	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_MRNA_PROCESSING
2.41935483871%	3	124	161	Diabetes_McGill_Cell_cycle_All_Gene	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
2.41935483871%	3	124	160	Diabetes_McGill_Cell_cycle_All_Gene	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
2.41935483871%	3	124	159	Diabetes_McGill_Cell_cycle_All_Gene	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
2.41935483871%	3	124	157	Diabetes_McGill_Cell_cycle_All_Gene	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
2.41935483871%	3	124	154	Diabetes_McGill_Cell_cycle_All_Gene	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
2.41935483871%	3	124	153	Diabetes_McGill_Cell_cycle_All_Gene	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
2.41935483871%	3	124	153	Diabetes_McGill_Cell_cycle_All_Gene	LU_AGING_BRAIN_DN
2.41935483871%	3	124	15	Diabetes_McGill_Cell_cycle_All_Gene	MARKS_ACETYLATED_NON_HISTONE_PROTEINS
2.41935483871%	3	124	15	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_ERYTH_PATHWAY
2.41935483871%	3	124	147	Diabetes_McGill_Cell_cycle_All_Gene	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
2.41935483871%	3	124	14	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_PROLACTIN_RECEPTOR_SIGNALING
2.41935483871%	3	124	139	Diabetes_McGill_Cell_cycle_All_Gene	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
2.41935483871%	3	124	138	Diabetes_McGill_Cell_cycle_All_Gene	JIANG_VHL_TARGETS
2.41935483871%	3	124	138	Diabetes_McGill_Cell_cycle_All_Gene	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
2.41935483871%	3	124	135	Diabetes_McGill_Cell_cycle_All_Gene	UDAYAKUMAR_MED1_TARGETS_UP
2.41935483871%	3	124	134	Diabetes_McGill_Cell_cycle_All_Gene	CHUNG_BLISTER_CYTOTOXICITY_UP
2.41935483871%	3	124	13	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1
2.41935483871%	3	124	13	Diabetes_McGill_Cell_cycle_All_Gene	FRIDMAN_SENESCENCE_DN
2.41935483871%	3	124	129	Diabetes_McGill_Cell_cycle_All_Gene	KIM_WT1_TARGETS_8HR_DN
2.41935483871%	3	124	127	Diabetes_McGill_Cell_cycle_All_Gene	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
2.41935483871%	3	124	123	Diabetes_McGill_Cell_cycle_All_Gene	DAZARD_RESPONSE_TO_UV_SCC_DN
2.41935483871%	3	124	121	Diabetes_McGill_Cell_cycle_All_Gene	RODRIGUES_DCC_TARGETS_DN
2.41935483871%	3	124	121	Diabetes_McGill_Cell_cycle_All_Gene	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
2.41935483871%	3	124	12	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
2.41935483871%	3	124	12	Diabetes_McGill_Cell_cycle_All_Gene	NEBEN_AML_WITH_FLT3_OR_NRAS_DN
2.41935483871%	3	124	12	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_VDR_PATHWAY
2.41935483871%	3	124	118	Diabetes_McGill_Cell_cycle_All_Gene	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
2.41935483871%	3	124	115	Diabetes_McGill_Cell_cycle_All_Gene	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
2.41935483871%	3	124	114	Diabetes_McGill_Cell_cycle_All_Gene	LENAOUR_DENDRITIC_CELL_MATURATION_UP
2.41935483871%	3	124	112	Diabetes_McGill_Cell_cycle_All_Gene	DITTMER_PTHLH_TARGETS_UP
2.41935483871%	3	124	110	Diabetes_McGill_Cell_cycle_All_Gene	GHANDHI_DIRECT_IRRADIATION_UP
2.41935483871%	3	124	11	Diabetes_McGill_Cell_cycle_All_Gene	KALMA_E2F1_TARGETS
2.41935483871%	3	124	11	Diabetes_McGill_Cell_cycle_All_Gene	CHUANG_OXIDATIVE_STRESS_RESPONSE_DN
2.41935483871%	3	124	109	Diabetes_McGill_Cell_cycle_All_Gene	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
2.41935483871%	3	124	108	Diabetes_McGill_Cell_cycle_All_Gene	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
2.41935483871%	3	124	107	Diabetes_McGill_Cell_cycle_All_Gene	SESTO_RESPONSE_TO_UV_C0
2.41935483871%	3	124	105	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_8HR_UP
2.41935483871%	3	124	104	Diabetes_McGill_Cell_cycle_All_Gene	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
2.41935483871%	3	124	103	Diabetes_McGill_Cell_cycle_All_Gene	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
2.41935483871%	3	124	102	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_MELANOGENESIS
2.41935483871%	3	124	101	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_10HR_UP
2.41935483871%	3	124	10	Diabetes_McGill_Cell_cycle_All_Gene	MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY
2.41935483871%	3	124	10	Diabetes_McGill_Cell_cycle_All_Gene	KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN
2.41758241758%	11	455	805	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GPCR_DOWNSTREAM_SIGNALING
2.41758241758%	11	455	557	T2D_GENES_TANYA_BLOODPRESSURE	TIEN_INTESTINE_PROBIOTICS_24HR_UP
2.41758241758%	11	455	555	T2D_GENES_TANYA_BLOODPRESSURE	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
2.41758241758%	11	455	552	T2D_GENES_TANYA_BLOODPRESSURE	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
2.41758241758%	11	455	537	T2D_GENES_TANYA_BLOODPRESSURE	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
2.41758241758%	11	455	536	T2D_GENES_TANYA_BLOODPRESSURE	SENESE_HDAC3_TARGETS_DN
2.41758241758%	11	455	518	T2D_GENES_TANYA_BLOODPRESSURE	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
2.41758241758%	11	455	516	T2D_GENES_TANYA_BLOODPRESSURE	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
2.41758241758%	11	455	508	T2D_GENES_TANYA_BLOODPRESSURE	ENK_UV_RESPONSE_EPIDERMIS_DN
2.41758241758%	11	455	505	T2D_GENES_TANYA_BLOODPRESSURE	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
2.41758241758%	11	455	504	T2D_GENES_TANYA_BLOODPRESSURE	PILON_KLF1_TARGETS_UP
2.41758241758%	11	455	501	T2D_GENES_TANYA_BLOODPRESSURE	SENESE_HDAC3_TARGETS_UP
2.41758241758%	11	455	485	T2D_GENES_TANYA_BLOODPRESSURE	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
2.41758241758%	11	455	456	T2D_GENES_TANYA_BLOODPRESSURE	MARTENS_BOUND_BY_PML_RARA_FUSION
2.41758241758%	11	455	425	T2D_GENES_TANYA_BLOODPRESSURE	BOCHKIS_FOXA2_TARGETS
2.41758241758%	11	455	418	T2D_GENES_TANYA_BLOODPRESSURE	MULLIGHAN_MLL_SIGNATURE_2_UP
2.41758241758%	11	455	408	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GPCR_LIGAND_BINDING
2.41758241758%	11	455	395	T2D_GENES_TANYA_BLOODPRESSURE	HAN_SATB1_TARGETS_UP
2.41758241758%	11	455	389	T2D_GENES_TANYA_BLOODPRESSURE	HSIAO_HOUSEKEEPING_GENES
2.41758241758%	11	455	388	T2D_GENES_TANYA_BLOODPRESSURE	STEIN_ESRRA_TARGETS_UP
2.41758241758%	11	455	349	T2D_GENES_TANYA_BLOODPRESSURE	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
2.41758241758%	11	455	337	T2D_GENES_TANYA_BLOODPRESSURE	PENG_GLUTAMINE_DEPRIVATION_DN
2.41758241758%	11	455	330	T2D_GENES_TANYA_BLOODPRESSURE	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
2.41758241758%	11	455	298	T2D_GENES_TANYA_BLOODPRESSURE	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
2.41758241758%	11	455	294	T2D_GENES_TANYA_BLOODPRESSURE	WEST_ADRENOCORTICAL_TUMOR_UP
2.41758241758%	11	455	282	T2D_GENES_TANYA_BLOODPRESSURE	HELLER_SILENCED_BY_METHYLATION_UP
2.41758241758%	11	455	267	T2D_GENES_TANYA_BLOODPRESSURE	HOLLMANN_APOPTOSIS_VIA_CD40_DN
2.41758241758%	11	455	206	T2D_GENES_TANYA_BLOODPRESSURE	LINSLEY_MIR16_TARGETS
2.41477272727%	85	3520	747	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PATIL_LIVER_CANCER
2.40513094602%	45	1871	487	T2D_GENES_TANYA_HEIGHT	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
2.40513094602%	45	1871	478	T2D_GENES_TANYA_HEIGHT	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
2.40513094602%	45	1871	459	T2D_GENES_TANYA_HEIGHT	KIM_WT1_TARGETS_DN
2.40513094602%	45	1871	380	T2D_GENES_TANYA_HEIGHT	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
2.40513094602%	45	1871	368	T2D_GENES_TANYA_HEIGHT	YAGI_AML_WITH_T_8_21_TRANSLOCATION
2.40513094602%	45	1871	317	T2D_GENES_TANYA_HEIGHT	HELLER_HDAC_TARGETS_UP
2.39852398524%	13	542	601	T2D_GENES_TANYA_ANTHROPOMETRIC	MARTINEZ_RB1_AND_TP53_TARGETS_UP
2.39852398524%	13	542	553	T2D_GENES_TANYA_ANTHROPOMETRIC	FEVR_CTNNB1_TARGETS_DN
2.39852398524%	13	542	540	T2D_GENES_TANYA_ANTHROPOMETRIC	ACEVEDO_LIVER_CANCER_DN
2.39852398524%	13	542	518	T2D_GENES_TANYA_ANTHROPOMETRIC	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
2.39852398524%	13	542	508	T2D_GENES_TANYA_ANTHROPOMETRIC	ENK_UV_RESPONSE_EPIDERMIS_DN
2.39852398524%	13	542	505	T2D_GENES_TANYA_ANTHROPOMETRIC	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
2.39852398524%	13	542	491	T2D_GENES_TANYA_ANTHROPOMETRIC	SWEET_LUNG_CANCER_KRAS_UP
2.39852398524%	13	542	485	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
2.39852398524%	13	542	457	T2D_GENES_TANYA_ANTHROPOMETRIC	SENESE_HDAC1_TARGETS_UP
2.39852398524%	13	542	456	T2D_GENES_TANYA_ANTHROPOMETRIC	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
2.39852398524%	13	542	431	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
2.39852398524%	13	542	428	T2D_GENES_TANYA_ANTHROPOMETRIC	CUI_TCF21_TARGETS_2_UP
2.39852398524%	13	542	396	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_DEVELOPMENTAL_BIOLOGY
2.39852398524%	13	542	394	T2D_GENES_TANYA_ANTHROPOMETRIC	BERENJENO_TRANSFORMED_BY_RHOA_DN
2.39852398524%	13	542	388	T2D_GENES_TANYA_ANTHROPOMETRIC	STEIN_ESRRA_TARGETS_UP
2.39852398524%	13	542	387	T2D_GENES_TANYA_ANTHROPOMETRIC	CHYLA_CBFA2T3_TARGETS_UP
2.39852398524%	13	542	371	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_SMARCE1_TARGETS_DN
2.39852398524%	13	542	368	T2D_GENES_TANYA_ANTHROPOMETRIC	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
2.39852398524%	13	542	349	T2D_GENES_TANYA_ANTHROPOMETRIC	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
2.39852398524%	13	542	337	T2D_GENES_TANYA_ANTHROPOMETRIC	PHONG_TNF_RESPONSE_NOT_VIA_P38
2.39852398524%	13	542	336	T2D_GENES_TANYA_ANTHROPOMETRIC	JOHNSTONE_PARVB_TARGETS_2_DN
2.39852398524%	13	542	330	T2D_GENES_TANYA_ANTHROPOMETRIC	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
2.39852398524%	13	542	323	T2D_GENES_TANYA_ANTHROPOMETRIC	GRESHOCK_CANCER_COPY_NUMBER_UP
2.39852398524%	13	542	317	T2D_GENES_TANYA_ANTHROPOMETRIC	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
2.39852398524%	13	542	312	T2D_GENES_TANYA_ANTHROPOMETRIC	GENTILE_UV_HIGH_DOSE_DN
2.39852398524%	13	542	309	T2D_GENES_TANYA_ANTHROPOMETRIC	LIU_SOX4_TARGETS_DN
2.39852398524%	13	542	287	T2D_GENES_TANYA_ANTHROPOMETRIC	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
2.39852398524%	13	542	267	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_MAPK_SIGNALING_PATHWAY
2.39852398524%	13	542	203	T2D_GENES_TANYA_ANTHROPOMETRIC	GRUETZMANN_PANCREATIC_CANCER_DN
2.39520958084%	28	1169	898	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
2.39520958084%	28	1169	805	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
2.39520958084%	28	1169	795	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEI_MYCN_TARGETS_WITH_E_BOX
2.39520958084%	28	1169	783	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
2.39520958084%	28	1169	668	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
2.39520958084%	28	1169	602	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARTINEZ_TP53_TARGETS_UP
2.39520958084%	28	1169	483	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
2.39190432383%	52	2174	720	T2D_GENES_TANYA_LIPIDS	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
2.39190432383%	52	2174	652	T2D_GENES_TANYA_LIPIDS	BENPORATH_PRC2_TARGETS
2.39190432383%	52	2174	648	T2D_GENES_TANYA_LIPIDS	SMID_BREAST_CANCER_BASAL_UP
2.39190432383%	52	2174	584	T2D_GENES_TANYA_LIPIDS	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
2.39190432383%	52	2174	578	T2D_GENES_TANYA_LIPIDS	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
2.39190432383%	52	2174	537	T2D_GENES_TANYA_LIPIDS	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
2.39190432383%	52	2174	517	T2D_GENES_TANYA_LIPIDS	RAO_BOUND_BY_SALL4_ISOFORM_B
2.39190432383%	52	2174	428	T2D_GENES_TANYA_LIPIDS	CUI_TCF21_TARGETS_2_UP
2.39190432383%	52	2174	398	T2D_GENES_TANYA_LIPIDS	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
2.39190432383%	52	2174	351	T2D_GENES_TANYA_LIPIDS	YAGI_AML_WITH_11Q23_REARRANGED
2.38095238095%	47	1974	418	Mendelian_Nancy_Cox	PEDRIOLI_MIR31_TARGETS_DN
2.38095238095%	47	1974	368	Mendelian_Nancy_Cox	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
2.38095238095%	47	1974	344	Mendelian_Nancy_Cox	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
2.38095238095%	47	1974	332	Mendelian_Nancy_Cox	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
2.38095238095%	47	1974	279	Mendelian_Nancy_Cox	REACTOME_INNATE_IMMUNE_SYSTEM
2.38095238095%	47	1974	210	Mendelian_Nancy_Cox	VERHAAK_GLIOBLASTOMA_NEURAL
2.38095238095%	47	1974	203	Mendelian_Nancy_Cox	GRUETZMANN_PANCREATIC_CANCER_DN
2.38095238095%	1	42	98	Diabetes_McGill_RAS	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
2.38095238095%	1	42	98	Diabetes_McGill_RAS	BRUINS_UVC_RESPONSE_MIDDLE
2.38095238095%	1	42	97	Diabetes_McGill_RAS	KIM_MYC_AMPLIFICATION_TARGETS_DN
2.38095238095%	1	42	97	Diabetes_McGill_RAS	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP
2.38095238095%	1	42	96	Diabetes_McGill_RAS	ZAMORA_NOS2_TARGETS_DN
2.38095238095%	1	42	95	Diabetes_McGill_RAS	KAYO_CALORIE_RESTRICTION_MUSCLE_UP
2.38095238095%	1	42	92	Diabetes_McGill_RAS	HILLION_HMGA1B_TARGETS
2.38095238095%	1	42	92	Diabetes_McGill_RAS	DE_YY1_TARGETS_DN
2.38095238095%	1	42	92	Diabetes_McGill_RAS	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
2.38095238095%	1	42	918	Diabetes_McGill_RAS	JOHNSTONE_PARVB_TARGETS_3_DN
2.38095238095%	1	42	91	Diabetes_McGill_RAS	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
2.38095238095%	1	42	90	Diabetes_McGill_RAS	IVANOVSKA_MIR106B_TARGETS
2.38095238095%	1	42	9	Diabetes_McGill_RAS	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP
2.38095238095%	1	42	9	Diabetes_McGill_RAS	ITO_PTTG1_TARGETS_DN
2.38095238095%	1	42	893	Diabetes_McGill_RAS	GEORGES_TARGETS_OF_MIR192_AND_MIR215
2.38095238095%	1	42	89	Diabetes_McGill_RAS	RICKMAN_HEAD_AND_NECK_CANCER_E
2.38095238095%	1	42	89	Diabetes_McGill_RAS	LEIN_PONS_MARKERS
2.38095238095%	1	42	882	Diabetes_McGill_RAS	LEE_BMP2_TARGETS_DN
2.38095238095%	1	42	88	Diabetes_McGill_RAS	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
2.38095238095%	1	42	88	Diabetes_McGill_RAS	SASSON_RESPONSE_TO_FORSKOLIN_DN
2.38095238095%	1	42	88	Diabetes_McGill_RAS	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
2.38095238095%	1	42	88	Diabetes_McGill_RAS	ALCALA_APOPTOSIS
2.38095238095%	1	42	87	Diabetes_McGill_RAS	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
2.38095238095%	1	42	87	Diabetes_McGill_RAS	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
2.38095238095%	1	42	87	Diabetes_McGill_RAS	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
2.38095238095%	1	42	87	Diabetes_McGill_RAS	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
2.38095238095%	1	42	87	Diabetes_McGill_RAS	BIOCARTA_MAPK_PATHWAY
2.38095238095%	1	42	86	Diabetes_McGill_RAS	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
2.38095238095%	1	42	84	Diabetes_McGill_RAS	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
2.38095238095%	1	42	84	Diabetes_McGill_RAS	RUAN_RESPONSE_TO_TNF_DN
2.38095238095%	1	42	84	Diabetes_McGill_RAS	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
2.38095238095%	1	42	81	Diabetes_McGill_RAS	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
2.38095238095%	1	42	81	Diabetes_McGill_RAS	LEIN_MEDULLA_MARKERS
2.38095238095%	1	42	80	Diabetes_McGill_RAS	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
2.38095238095%	1	42	80	Diabetes_McGill_RAS	BASSO_HAIRY_CELL_LEUKEMIA_DN
2.38095238095%	1	42	8	Diabetes_McGill_RAS	CASTELLANO_HRAS_AND_NRAS_TARGETS_DN
2.38095238095%	1	42	79	Diabetes_McGill_RAS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
2.38095238095%	1	42	783	Diabetes_McGill_RAS	ONKEN_UVEAL_MELANOMA_UP
2.38095238095%	1	42	78	Diabetes_McGill_RAS	COATES_MACROPHAGE_M1_VS_M2_DN
2.38095238095%	1	42	78	Diabetes_McGill_RAS	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
2.38095238095%	1	42	779	Diabetes_McGill_RAS	PUJANA_CHEK2_PCC_NETWORK
2.38095238095%	1	42	77	Diabetes_McGill_RAS	ROSS_AML_WITH_PML_RARA_FUSION
2.38095238095%	1	42	77	Diabetes_McGill_RAS	GROSS_HYPOXIA_VIA_HIF1A_UP
2.38095238095%	1	42	77	Diabetes_McGill_RAS	FRIDMAN_SENESCENCE_UP
2.38095238095%	1	42	77	Diabetes_McGill_RAS	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
2.38095238095%	1	42	77	Diabetes_McGill_RAS	CHEBOTAEV_GR_TARGETS_UP
2.38095238095%	1	42	769	Diabetes_McGill_RAS	NUYTTEN_NIPP1_TARGETS_UP
2.38095238095%	1	42	76	Diabetes_McGill_RAS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
2.38095238095%	1	42	76	Diabetes_McGill_RAS	MAHAJAN_RESPONSE_TO_IL1A_DN
2.38095238095%	1	42	74	Diabetes_McGill_RAS	WESTON_VEGFA_TARGETS_3HR
2.38095238095%	1	42	74	Diabetes_McGill_RAS	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
2.38095238095%	1	42	74	Diabetes_McGill_RAS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN
2.38095238095%	1	42	73	Diabetes_McGill_RAS	LIN_MELANOMA_COPY_NUMBER_UP
2.38095238095%	1	42	73	Diabetes_McGill_RAS	DITTMER_PTHLH_TARGETS_DN
2.38095238095%	1	42	728	Diabetes_McGill_RAS	MARSON_BOUND_BY_E2F4_UNSTIMULATED
2.38095238095%	1	42	72	Diabetes_McGill_RAS	DOANE_BREAST_CANCER_CLASSES_UP
2.38095238095%	1	42	71	Diabetes_McGill_RAS	KUMAR_AUTOPHAGY_NETWORK
2.38095238095%	1	42	71	Diabetes_McGill_RAS	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
2.38095238095%	1	42	70	Diabetes_McGill_RAS	PID_CDC42_PATHWAY
2.38095238095%	1	42	70	Diabetes_McGill_RAS	LIU_NASOPHARYNGEAL_CARCINOMA
2.38095238095%	1	42	7	Diabetes_McGill_RAS	TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP
2.38095238095%	1	42	7	Diabetes_McGill_RAS	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN
2.38095238095%	1	42	7	Diabetes_McGill_RAS	HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3
2.38095238095%	1	42	69	Diabetes_McGill_RAS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10
2.38095238095%	1	42	69	Diabetes_McGill_RAS	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP
2.38095238095%	1	42	69	Diabetes_McGill_RAS	AMIT_EGF_RESPONSE_120_HELA
2.38095238095%	1	42	682	Diabetes_McGill_RAS	FEVR_CTNNB1_TARGETS_UP
2.38095238095%	1	42	68	Diabetes_McGill_RAS	REACTOME_SEMAPHORIN_INTERACTIONS
2.38095238095%	1	42	67	Diabetes_McGill_RAS	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
2.38095238095%	1	42	67	Diabetes_McGill_RAS	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
2.38095238095%	1	42	67	Diabetes_McGill_RAS	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70
2.38095238095%	1	42	663	Diabetes_McGill_RAS	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
2.38095238095%	1	42	66	Diabetes_McGill_RAS	SWEET_KRAS_TARGETS_DN
2.38095238095%	1	42	66	Diabetes_McGill_RAS	PID_LYSOPHOSPHOLIPID_PATHWAY
2.38095238095%	1	42	66	Diabetes_McGill_RAS	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN
2.38095238095%	1	42	658	Diabetes_McGill_RAS	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
2.38095238095%	1	42	65	Diabetes_McGill_RAS	PID_BCR_5PATHWAY
2.38095238095%	1	42	65	Diabetes_McGill_RAS	GOLDRATH_IMMUNE_MEMORY
2.38095238095%	1	42	65	Diabetes_McGill_RAS	AMIT_SERUM_RESPONSE_120_MCF10A
2.38095238095%	1	42	64	Diabetes_McGill_RAS	ZHANG_GATA6_TARGETS_DN
2.38095238095%	1	42	64	Diabetes_McGill_RAS	PETROVA_PROX1_TARGETS_DN
2.38095238095%	1	42	64	Diabetes_McGill_RAS	INGRAM_SHH_TARGETS_DN
2.38095238095%	1	42	633	Diabetes_McGill_RAS	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
2.38095238095%	1	42	63	Diabetes_McGill_RAS	PID_ENDOTHELINPATHWAY
2.38095238095%	1	42	63	Diabetes_McGill_RAS	PHONG_TNF_TARGETS_UP
2.38095238095%	1	42	63	Diabetes_McGill_RAS	MODY_HIPPOCAMPUS_POSTNATAL
2.38095238095%	1	42	63	Diabetes_McGill_RAS	BURTON_ADIPOGENESIS_PEAK_AT_0HR
2.38095238095%	1	42	62	Diabetes_McGill_RAS	PID_FCER1PATHWAY
2.38095238095%	1	42	62	Diabetes_McGill_RAS	KORKOLA_YOLK_SAC_TUMOR
2.38095238095%	1	42	62	Diabetes_McGill_RAS	KEGG_COLORECTAL_CANCER
2.38095238095%	1	42	61	Diabetes_McGill_RAS	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
2.38095238095%	1	42	61	Diabetes_McGill_RAS	LEE_LIVER_CANCER_MYC_TGFA_UP
2.38095238095%	1	42	61	Diabetes_McGill_RAS	BAKKER_FOXO3_TARGETS_UP
2.38095238095%	1	42	602	Diabetes_McGill_RAS	MARTINEZ_TP53_TARGETS_UP
2.38095238095%	1	42	601	Diabetes_McGill_RAS	MARTINEZ_RB1_AND_TP53_TARGETS_UP
2.38095238095%	1	42	60	Diabetes_McGill_RAS	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
2.38095238095%	1	42	6	Diabetes_McGill_RAS	WALLACE_PROSTATE_CANCER_DN
2.38095238095%	1	42	6	Diabetes_McGill_RAS	CASTELLANO_HRAS_TARGETS_DN
2.38095238095%	1	42	590	Diabetes_McGill_RAS	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
2.38095238095%	1	42	59	Diabetes_McGill_RAS	WESTON_VEGFA_TARGETS_6HR
2.38095238095%	1	42	59	Diabetes_McGill_RAS	PID_P53REGULATIONPATHWAY
2.38095238095%	1	42	59	Diabetes_McGill_RAS	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
2.38095238095%	1	42	59	Diabetes_McGill_RAS	DASU_IL6_SIGNALING_UP
2.38095238095%	1	42	59	Diabetes_McGill_RAS	ASTIER_INTEGRIN_SIGNALING
2.38095238095%	1	42	584	Diabetes_McGill_RAS	HAMAI_APOPTOSIS_VIA_TRAIL_UP
2.38095238095%	1	42	58	Diabetes_McGill_RAS	NAGASHIMA_EGF_SIGNALING_UP
2.38095238095%	1	42	58	Diabetes_McGill_RAS	NADLER_HYPERGLYCEMIA_AT_OBESITY
2.38095238095%	1	42	58	Diabetes_McGill_RAS	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
2.38095238095%	1	42	58	Diabetes_McGill_RAS	KANNAN_TP53_TARGETS_UP
2.38095238095%	1	42	579	Diabetes_McGill_RAS	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
2.38095238095%	1	42	57	Diabetes_McGill_RAS	PEART_HDAC_PROLIFERATION_CLUSTER_UP
2.38095238095%	1	42	57	Diabetes_McGill_RAS	GYORFFY_MITOXANTRONE_RESISTANCE
2.38095238095%	1	42	57	Diabetes_McGill_RAS	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
2.38095238095%	1	42	56	Diabetes_McGill_RAS	WORSCHECH_TUMOR_REJECTION_UP
2.38095238095%	1	42	56	Diabetes_McGill_RAS	HOQUE_METHYLATED_IN_CANCER
2.38095238095%	1	42	56	Diabetes_McGill_RAS	GALE_APL_WITH_FLT3_MUTATED_UP
2.38095238095%	1	42	56	Diabetes_McGill_RAS	BIOCARTA_NFAT_PATHWAY
2.38095238095%	1	42	546	Diabetes_McGill_RAS	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
2.38095238095%	1	42	543	Diabetes_McGill_RAS	MARTINEZ_RB1_TARGETS_DN
2.38095238095%	1	42	54	Diabetes_McGill_RAS	LEE_LIVER_CANCER_MYC_UP
2.38095238095%	1	42	537	Diabetes_McGill_RAS	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
2.38095238095%	1	42	536	Diabetes_McGill_RAS	SENESE_HDAC3_TARGETS_DN
2.38095238095%	1	42	535	Diabetes_McGill_RAS	STEIN_ESRRA_TARGETS
2.38095238095%	1	42	53	Diabetes_McGill_RAS	SMIRNOV_RESPONSE_TO_IR_2HR_UP
2.38095238095%	1	42	528	Diabetes_McGill_RAS	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
2.38095238095%	1	42	52	Diabetes_McGill_RAS	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN
2.38095238095%	1	42	52	Diabetes_McGill_RAS	VILIMAS_NOTCH1_TARGETS_UP
2.38095238095%	1	42	52	Diabetes_McGill_RAS	PID_KITPATHWAY
2.38095238095%	1	42	514	Diabetes_McGill_RAS	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
2.38095238095%	1	42	514	Diabetes_McGill_RAS	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
2.38095238095%	1	42	51	Diabetes_McGill_RAS	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
2.38095238095%	1	42	51	Diabetes_McGill_RAS	WANG_BARRETTS_ESOPHAGUS_UP
2.38095238095%	1	42	505	Diabetes_McGill_RAS	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
2.38095238095%	1	42	501	Diabetes_McGill_RAS	SENESE_HDAC3_TARGETS_UP
2.38095238095%	1	42	50	Diabetes_McGill_RAS	STOSSI_RESPONSE_TO_ESTRADIOL
2.38095238095%	1	42	50	Diabetes_McGill_RAS	HOFMANN_CELL_LYMPHOMA_UP
2.38095238095%	1	42	50	Diabetes_McGill_RAS	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION
2.38095238095%	1	42	5	Diabetes_McGill_RAS	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2
2.38095238095%	1	42	491	Diabetes_McGill_RAS	SWEET_LUNG_CANCER_KRAS_UP
2.38095238095%	1	42	49	Diabetes_McGill_RAS	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
2.38095238095%	1	42	49	Diabetes_McGill_RAS	PID_ARF6_TRAFFICKINGPATHWAY
2.38095238095%	1	42	49	Diabetes_McGill_RAS	BIOCARTA_TCR_PATHWAY
2.38095238095%	1	42	49	Diabetes_McGill_RAS	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP
2.38095238095%	1	42	485	Diabetes_McGill_RAS	ENK_UV_RESPONSE_KERATINOCYTE_DN
2.38095238095%	1	42	483	Diabetes_McGill_RAS	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
2.38095238095%	1	42	48	Diabetes_McGill_RAS	PID_AJDISS_2PATHWAY
2.38095238095%	1	42	48	Diabetes_McGill_RAS	NADLER_OBESITY_DN
2.38095238095%	1	42	48	Diabetes_McGill_RAS	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN
2.38095238095%	1	42	479	Diabetes_McGill_RAS	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
2.38095238095%	1	42	476	Diabetes_McGill_RAS	SMID_BREAST_CANCER_NORMAL_LIKE_UP
2.38095238095%	1	42	475	Diabetes_McGill_RAS	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
2.38095238095%	1	42	473	Diabetes_McGill_RAS	GARY_CD5_TARGETS_UP
2.38095238095%	1	42	47	Diabetes_McGill_RAS	ZHAN_MULTIPLE_MYELOMA_MF_UP
2.38095238095%	1	42	47	Diabetes_McGill_RAS	WARTERS_IR_RESPONSE_5GY
2.38095238095%	1	42	47	Diabetes_McGill_RAS	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP
2.38095238095%	1	42	47	Diabetes_McGill_RAS	PID_DELTANP63PATHWAY
2.38095238095%	1	42	47	Diabetes_McGill_RAS	MCCLUNG_DELTA_FOSB_TARGETS_8WK
2.38095238095%	1	42	467	Diabetes_McGill_RAS	RATTENBACHER_BOUND_BY_CELF1
2.38095238095%	1	42	464	Diabetes_McGill_RAS	ONDER_CDH1_TARGETS_2_DN
2.38095238095%	1	42	463	Diabetes_McGill_RAS	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
2.38095238095%	1	42	46	Diabetes_McGill_RAS	SAGIV_CD24_TARGETS_DN
2.38095238095%	1	42	46	Diabetes_McGill_RAS	PID_A6B1_A6B4_INTEGRIN_PATHWAY
2.38095238095%	1	42	46	Diabetes_McGill_RAS	OSADA_ASCL1_TARGETS_UP
2.38095238095%	1	42	46	Diabetes_McGill_RAS	BIOCARTA_KERATINOCYTE_PATHWAY
2.38095238095%	1	42	459	Diabetes_McGill_RAS	KIM_WT1_TARGETS_DN
2.38095238095%	1	42	450	Diabetes_McGill_RAS	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
2.38095238095%	1	42	45	Diabetes_McGill_RAS	WANG_TARGETS_OF_MLL_CBP_FUSION_DN
2.38095238095%	1	42	45	Diabetes_McGill_RAS	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN
2.38095238095%	1	42	45	Diabetes_McGill_RAS	PID_INSULIN_PATHWAY
2.38095238095%	1	42	45	Diabetes_McGill_RAS	BIOCARTA_BIOPEPTIDES_PATHWAY
2.38095238095%	1	42	448	Diabetes_McGill_RAS	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
2.38095238095%	1	42	443	Diabetes_McGill_RAS	DELYS_THYROID_CANCER_UP
2.38095238095%	1	42	44	Diabetes_McGill_RAS	ZUCCHI_METASTASIS_DN
2.38095238095%	1	42	44	Diabetes_McGill_RAS	ZHAN_MULTIPLE_MYELOMA_LB_DN
2.38095238095%	1	42	44	Diabetes_McGill_RAS	MEDINA_SMARCA4_TARGETS
2.38095238095%	1	42	44	Diabetes_McGill_RAS	CHOI_ATL_STAGE_PREDICTOR
2.38095238095%	1	42	439	Diabetes_McGill_RAS	MITSIADES_RESPONSE_TO_APLIDIN_UP
2.38095238095%	1	42	430	Diabetes_McGill_RAS	JOHNSTONE_PARVB_TARGETS_3_UP
2.38095238095%	1	42	43	Diabetes_McGill_RAS	REACTOME_IL_3_5_AND_GM_CSF_SIGNALING
2.38095238095%	1	42	43	Diabetes_McGill_RAS	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN
2.38095238095%	1	42	43	Diabetes_McGill_RAS	IKEDA_MIR133_TARGETS_UP
2.38095238095%	1	42	428	Diabetes_McGill_RAS	LIM_MAMMARY_STEM_CELL_DN
2.38095238095%	1	42	425	Diabetes_McGill_RAS	ZHANG_BREAST_CANCER_PROGENITORS_UP
2.38095238095%	1	42	425	Diabetes_McGill_RAS	BOCHKIS_FOXA2_TARGETS
2.38095238095%	1	42	424	Diabetes_McGill_RAS	SHEN_SMARCA2_TARGETS_UP
2.38095238095%	1	42	422	Diabetes_McGill_RAS	YAGI_AML_WITH_INV_16_TRANSLOCATION
2.38095238095%	1	42	42	Diabetes_McGill_RAS	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
2.38095238095%	1	42	42	Diabetes_McGill_RAS	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP
2.38095238095%	1	42	42	Diabetes_McGill_RAS	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
2.38095238095%	1	42	42	Diabetes_McGill_RAS	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
2.38095238095%	1	42	42	Diabetes_McGill_RAS	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
2.38095238095%	1	42	414	Diabetes_McGill_RAS	LU_EZH2_TARGETS_DN
2.38095238095%	1	42	412	Diabetes_McGill_RAS	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
2.38095238095%	1	42	41	Diabetes_McGill_RAS	KORKOLA_EMBRYONAL_CARCINOMA_UP
2.38095238095%	1	42	41	Diabetes_McGill_RAS	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
2.38095238095%	1	42	41	Diabetes_McGill_RAS	CROONQUIST_NRAS_SIGNALING_UP
2.38095238095%	1	42	41	Diabetes_McGill_RAS	BIOCARTA_FCER1_PATHWAY
2.38095238095%	1	42	409	Diabetes_McGill_RAS	FOSTER_TOLERANT_MACROPHAGE_DN
2.38095238095%	1	42	404	Diabetes_McGill_RAS	OSMAN_BLADDER_CANCER_UP
2.38095238095%	1	42	40	Diabetes_McGill_RAS	GENTILE_UV_RESPONSE_CLUSTER_D7
2.38095238095%	1	42	40	Diabetes_McGill_RAS	BIOCARTA_P38MAPK_PATHWAY
2.38095238095%	1	42	394	Diabetes_McGill_RAS	BERENJENO_TRANSFORMED_BY_RHOA_DN
2.38095238095%	1	42	391	Diabetes_McGill_RAS	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
2.38095238095%	1	42	39	Diabetes_McGill_RAS	SESTO_RESPONSE_TO_UV_C6
2.38095238095%	1	42	39	Diabetes_McGill_RAS	POTTI_PACLITAXEL_SENSITIVITY
2.38095238095%	1	42	39	Diabetes_McGill_RAS	HOFMANN_CELL_LYMPHOMA_DN
2.38095238095%	1	42	39	Diabetes_McGill_RAS	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
2.38095238095%	1	42	39	Diabetes_McGill_RAS	BURTON_ADIPOGENESIS_PEAK_AT_8HR
2.38095238095%	1	42	39	Diabetes_McGill_RAS	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP
2.38095238095%	1	42	39	Diabetes_McGill_RAS	BIOCARTA_FMLP_PATHWAY
2.38095238095%	1	42	388	Diabetes_McGill_RAS	STEIN_ESRRA_TARGETS_UP
2.38095238095%	1	42	384	Diabetes_McGill_RAS	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
2.38095238095%	1	42	380	Diabetes_McGill_RAS	DAIRKEE_TERT_TARGETS_UP
2.38095238095%	1	42	38	Diabetes_McGill_RAS	YOKOE_CANCER_TESTIS_ANTIGENS
2.38095238095%	1	42	38	Diabetes_McGill_RAS	CHANDRAN_METASTASIS_TOP50_UP
2.38095238095%	1	42	38	Diabetes_McGill_RAS	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
2.38095238095%	1	42	38	Diabetes_McGill_RAS	BIOCARTA_IL2RB_PATHWAY
2.38095238095%	1	42	379	Diabetes_McGill_RAS	BENPORATH_ES_1
2.38095238095%	1	42	374	Diabetes_McGill_RAS	WANG_TUMOR_INVASIVENESS_UP
2.38095238095%	1	42	373	Diabetes_McGill_RAS	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
2.38095238095%	1	42	371	Diabetes_McGill_RAS	WANG_SMARCE1_TARGETS_DN
2.38095238095%	1	42	37	Diabetes_McGill_RAS	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
2.38095238095%	1	42	37	Diabetes_McGill_RAS	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR
2.38095238095%	1	42	37	Diabetes_McGill_RAS	BIOCARTA_GPCR_PATHWAY
2.38095238095%	1	42	37	Diabetes_McGill_RAS	BIOCARTA_BCR_PATHWAY
2.38095238095%	1	42	368	Diabetes_McGill_RAS	YAGI_AML_WITH_T_8_21_TRANSLOCATION
2.38095238095%	1	42	367	Diabetes_McGill_RAS	VECCHI_GASTRIC_CANCER_EARLY_DN
2.38095238095%	1	42	367	Diabetes_McGill_RAS	DELACROIX_RARG_BOUND_MEF
2.38095238095%	1	42	366	Diabetes_McGill_RAS	YOSHIMURA_MAPK8_TARGETS_DN
2.38095238095%	1	42	36	Diabetes_McGill_RAS	YIH_RESPONSE_TO_ARSENITE_C3
2.38095238095%	1	42	36	Diabetes_McGill_RAS	SUBTIL_PROGESTIN_TARGETS
2.38095238095%	1	42	36	Diabetes_McGill_RAS	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP
2.38095238095%	1	42	36	Diabetes_McGill_RAS	BIOCARTA_AT1R_PATHWAY
2.38095238095%	1	42	356	Diabetes_McGill_RAS	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
2.38095238095%	1	42	355	Diabetes_McGill_RAS	PEREZ_TP63_TARGETS
2.38095238095%	1	42	35	Diabetes_McGill_RAS	WESTON_VEGFA_TARGETS_12HR
2.38095238095%	1	42	35	Diabetes_McGill_RAS	DORSAM_HOXA9_TARGETS_UP
2.38095238095%	1	42	35	Diabetes_McGill_RAS	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP
2.38095238095%	1	42	349	Diabetes_McGill_RAS	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
2.38095238095%	1	42	349	Diabetes_McGill_RAS	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
2.38095238095%	1	42	346	Diabetes_McGill_RAS	GOLDRATH_ANTIGEN_RESPONSE
2.38095238095%	1	42	341	Diabetes_McGill_RAS	MULLIGHAN_NPM1_SIGNATURE_3_UP
2.38095238095%	1	42	34	Diabetes_McGill_RAS	PLASARI_TGFB1_TARGETS_1HR_UP
2.38095238095%	1	42	34	Diabetes_McGill_RAS	BIOCARTA_MPR_PATHWAY
2.38095238095%	1	42	337	Diabetes_McGill_RAS	PHONG_TNF_RESPONSE_NOT_VIA_P38
2.38095238095%	1	42	337	Diabetes_McGill_RAS	PENG_GLUTAMINE_DEPRIVATION_DN
2.38095238095%	1	42	335	Diabetes_McGill_RAS	WONG_EMBRYONIC_STEM_CELL_CORE
2.38095238095%	1	42	335	Diabetes_McGill_RAS	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
2.38095238095%	1	42	332	Diabetes_McGill_RAS	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
2.38095238095%	1	42	330	Diabetes_McGill_RAS	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
2.38095238095%	1	42	33	Diabetes_McGill_RAS	VALK_AML_CLUSTER_5
2.38095238095%	1	42	33	Diabetes_McGill_RAS	VALK_AML_CLUSTER_3
2.38095238095%	1	42	33	Diabetes_McGill_RAS	PID_SYNDECAN_2_PATHWAY
2.38095238095%	1	42	33	Diabetes_McGill_RAS	FIRESTEIN_CTNNB1_PATHWAY
2.38095238095%	1	42	329	Diabetes_McGill_RAS	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
2.38095238095%	1	42	326	Diabetes_McGill_RAS	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
2.38095238095%	1	42	324	Diabetes_McGill_RAS	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
2.38095238095%	1	42	320	Diabetes_McGill_RAS	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
2.38095238095%	1	42	32	Diabetes_McGill_RAS	ST_ERK1_ERK2_MAPK_PATHWAY
2.38095238095%	1	42	32	Diabetes_McGill_RAS	REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING
2.38095238095%	1	42	32	Diabetes_McGill_RAS	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN
2.38095238095%	1	42	32	Diabetes_McGill_RAS	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
2.38095238095%	1	42	32	Diabetes_McGill_RAS	BIOCARTA_PDGF_PATHWAY
2.38095238095%	1	42	318	Diabetes_McGill_RAS	LEI_MYB_TARGETS
2.38095238095%	1	42	317	Diabetes_McGill_RAS	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
2.38095238095%	1	42	317	Diabetes_McGill_RAS	HELLER_HDAC_TARGETS_UP
2.38095238095%	1	42	315	Diabetes_McGill_RAS	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
2.38095238095%	1	42	310	Diabetes_McGill_RAS	HORIUCHI_WTAP_TARGETS_DN
2.38095238095%	1	42	31	Diabetes_McGill_RAS	THEODOROU_MAMMARY_TUMORIGENESIS
2.38095238095%	1	42	31	Diabetes_McGill_RAS	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
2.38095238095%	1	42	31	Diabetes_McGill_RAS	PID_AR_NONGENOMIC_PATHWAY
2.38095238095%	1	42	31	Diabetes_McGill_RAS	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER
2.38095238095%	1	42	31	Diabetes_McGill_RAS	CUI_TCF21_TARGETS_DN
2.38095238095%	1	42	31	Diabetes_McGill_RAS	BIOCARTA_PYK2_PATHWAY
2.38095238095%	1	42	31	Diabetes_McGill_RAS	BIOCARTA_EGF_PATHWAY
2.38095238095%	1	42	309	Diabetes_McGill_RAS	LIU_SOX4_TARGETS_DN
2.38095238095%	1	42	306	Diabetes_McGill_RAS	HORIUCHI_WTAP_TARGETS_UP
2.38095238095%	1	42	302	Diabetes_McGill_RAS	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
2.38095238095%	1	42	30	Diabetes_McGill_RAS	YANAGIHARA_ESX1_TARGETS
2.38095238095%	1	42	30	Diabetes_McGill_RAS	PID_IGF1_PATHWAY
2.38095238095%	1	42	30	Diabetes_McGill_RAS	LI_PROSTATE_CANCER_EPIGENETIC
2.38095238095%	1	42	30	Diabetes_McGill_RAS	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
2.38095238095%	1	42	299	Diabetes_McGill_RAS	MUELLER_PLURINET
2.38095238095%	1	42	298	Diabetes_McGill_RAS	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
2.38095238095%	1	42	296	Diabetes_McGill_RAS	DURAND_STROMA_MAX_UP
2.38095238095%	1	42	294	Diabetes_McGill_RAS	WEST_ADRENOCORTICAL_TUMOR_UP
2.38095238095%	1	42	294	Diabetes_McGill_RAS	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
2.38095238095%	1	42	293	Diabetes_McGill_RAS	ZWANG_DOWN_BY_2ND_EGF_PULSE
2.38095238095%	1	42	293	Diabetes_McGill_RAS	HADDAD_B_LYMPHOCYTE_PROGENITOR
2.38095238095%	1	42	291	Diabetes_McGill_RAS	SABATES_COLORECTAL_ADENOMA_DN
2.38095238095%	1	42	29	Diabetes_McGill_RAS	PID_REELINPATHWAY
2.38095238095%	1	42	29	Diabetes_McGill_RAS	DORN_ADENOVIRUS_INFECTION_12HR_UP
2.38095238095%	1	42	29	Diabetes_McGill_RAS	BIOCARTA_VEGF_PATHWAY
2.38095238095%	1	42	29	Diabetes_McGill_RAS	ABE_VEGFA_TARGETS_30MIN
2.38095238095%	1	42	289	Diabetes_McGill_RAS	WANG_MLL_TARGETS
2.38095238095%	1	42	289	Diabetes_McGill_RAS	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
2.38095238095%	1	42	288	Diabetes_McGill_RAS	POOLA_INVASIVE_BREAST_CANCER_UP
2.38095238095%	1	42	285	Diabetes_McGill_RAS	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
2.38095238095%	1	42	282	Diabetes_McGill_RAS	HELLER_SILENCED_BY_METHYLATION_UP
2.38095238095%	1	42	281	Diabetes_McGill_RAS	MULLIGHAN_MLL_SIGNATURE_2_DN
2.38095238095%	1	42	280	Diabetes_McGill_RAS	WANG_SMARCE1_TARGETS_UP
2.38095238095%	1	42	28	Diabetes_McGill_RAS	HWANG_PROSTATE_CANCER_MARKERS
2.38095238095%	1	42	28	Diabetes_McGill_RAS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
2.38095238095%	1	42	28	Diabetes_McGill_RAS	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
2.38095238095%	1	42	28	Diabetes_McGill_RAS	BIOCARTA_GH_PATHWAY
2.38095238095%	1	42	28	Diabetes_McGill_RAS	BIOCARTA_ERK_PATHWAY
2.38095238095%	1	42	271	Diabetes_McGill_RAS	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
2.38095238095%	1	42	27	Diabetes_McGill_RAS	REACTOME_IL_RECEPTOR_SHC_SIGNALING
2.38095238095%	1	42	27	Diabetes_McGill_RAS	OHM_METHYLATED_IN_ADULT_CANCERS
2.38095238095%	1	42	27	Diabetes_McGill_RAS	LEE_DOUBLE_POLAR_THYMOCYTE
2.38095238095%	1	42	27	Diabetes_McGill_RAS	GROSS_ELK3_TARGETS_UP
2.38095238095%	1	42	27	Diabetes_McGill_RAS	BOYAULT_LIVER_CANCER_SUBCLASS_G2
2.38095238095%	1	42	27	Diabetes_McGill_RAS	BIOCARTA_CREB_PATHWAY
2.38095238095%	1	42	269	Diabetes_McGill_RAS	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
2.38095238095%	1	42	266	Diabetes_McGill_RAS	FOSTER_KDM1A_TARGETS_UP
2.38095238095%	1	42	265	Diabetes_McGill_RAS	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
2.38095238095%	1	42	264	Diabetes_McGill_RAS	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
2.38095238095%	1	42	264	Diabetes_McGill_RAS	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
2.38095238095%	1	42	261	Diabetes_McGill_RAS	BILD_HRAS_ONCOGENIC_SIGNATURE
2.38095238095%	1	42	260	Diabetes_McGill_RAS	SENESE_HDAC1_TARGETS_DN
2.38095238095%	1	42	260	Diabetes_McGill_RAS	BOQUEST_STEM_CELL_UP
2.38095238095%	1	42	26	Diabetes_McGill_RAS	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN
2.38095238095%	1	42	26	Diabetes_McGill_RAS	BIOCARTA_RACCYCD_PATHWAY
2.38095238095%	1	42	258	Diabetes_McGill_RAS	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
2.38095238095%	1	42	252	Diabetes_McGill_RAS	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
2.38095238095%	1	42	250	Diabetes_McGill_RAS	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
2.38095238095%	1	42	25	Diabetes_McGill_RAS	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP
2.38095238095%	1	42	25	Diabetes_McGill_RAS	YANG_BREAST_CANCER_ESR1_DN
2.38095238095%	1	42	25	Diabetes_McGill_RAS	RUAN_RESPONSE_TO_TROGLITAZONE_UP
2.38095238095%	1	42	25	Diabetes_McGill_RAS	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP
2.38095238095%	1	42	25	Diabetes_McGill_RAS	KEGG_DORSO_VENTRAL_AXIS_FORMATION
2.38095238095%	1	42	25	Diabetes_McGill_RAS	GENTILE_UV_HIGH_DOSE_UP
2.38095238095%	1	42	25	Diabetes_McGill_RAS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN
2.38095238095%	1	42	25	Diabetes_McGill_RAS	BIOCARTA_MCALPAIN_PATHWAY
2.38095238095%	1	42	246	Diabetes_McGill_RAS	VERHAAK_AML_WITH_NPM1_MUTATED_DN
2.38095238095%	1	42	246	Diabetes_McGill_RAS	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
2.38095238095%	1	42	246	Diabetes_McGill_RAS	BILD_E2F3_ONCOGENIC_SIGNATURE
2.38095238095%	1	42	245	Diabetes_McGill_RAS	BLUM_RESPONSE_TO_SALIRASIB_UP
2.38095238095%	1	42	244	Diabetes_McGill_RAS	PLASARI_TGFB1_TARGETS_10HR_DN
2.38095238095%	1	42	244	Diabetes_McGill_RAS	KAYO_AGING_MUSCLE_UP
2.38095238095%	1	42	244	Diabetes_McGill_RAS	GAL_LEUKEMIC_STEM_CELL_DN
2.38095238095%	1	42	242	Diabetes_McGill_RAS	MULLIGHAN_MLL_SIGNATURE_1_DN
2.38095238095%	1	42	241	Diabetes_McGill_RAS	DOANE_RESPONSE_TO_ANDROGEN_DN
2.38095238095%	1	42	240	Diabetes_McGill_RAS	VANTVEER_BREAST_CANCER_ESR1_DN
2.38095238095%	1	42	24	Diabetes_McGill_RAS	YIH_RESPONSE_TO_ARSENITE_C1
2.38095238095%	1	42	24	Diabetes_McGill_RAS	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN
2.38095238095%	1	42	24	Diabetes_McGill_RAS	SCHRAMM_INHBA_TARGETS_DN
2.38095238095%	1	42	24	Diabetes_McGill_RAS	SA_B_CELL_RECEPTOR_COMPLEXES
2.38095238095%	1	42	24	Diabetes_McGill_RAS	OSADA_ASCL1_TARGETS_DN
2.38095238095%	1	42	24	Diabetes_McGill_RAS	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
2.38095238095%	1	42	24	Diabetes_McGill_RAS	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP
2.38095238095%	1	42	24	Diabetes_McGill_RAS	BIOCARTA_TPO_PATHWAY
2.38095238095%	1	42	24	Diabetes_McGill_RAS	BIOCARTA_ECM_PATHWAY
2.38095238095%	1	42	24	Diabetes_McGill_RAS	BIOCARTA_CXCR4_PATHWAY
2.38095238095%	1	42	239	Diabetes_McGill_RAS	ALFANO_MYC_TARGETS
2.38095238095%	1	42	238	Diabetes_McGill_RAS	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
2.38095238095%	1	42	238	Diabetes_McGill_RAS	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
2.38095238095%	1	42	234	Diabetes_McGill_RAS	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
2.38095238095%	1	42	233	Diabetes_McGill_RAS	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
2.38095238095%	1	42	23	Diabetes_McGill_RAS	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP
2.38095238095%	1	42	23	Diabetes_McGill_RAS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP
2.38095238095%	1	42	23	Diabetes_McGill_RAS	BIOCARTA_IGF1R_PATHWAY
2.38095238095%	1	42	23	Diabetes_McGill_RAS	BIOCARTA_GLEEVEC_PATHWAY
2.38095238095%	1	42	23	Diabetes_McGill_RAS	BIOCARTA_CCR3_PATHWAY
2.38095238095%	1	42	229	Diabetes_McGill_RAS	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
2.38095238095%	1	42	229	Diabetes_McGill_RAS	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
2.38095238095%	1	42	229	Diabetes_McGill_RAS	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
2.38095238095%	1	42	228	Diabetes_McGill_RAS	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
2.38095238095%	1	42	227	Diabetes_McGill_RAS	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
2.38095238095%	1	42	225	Diabetes_McGill_RAS	BROWNE_HCMV_INFECTION_16HR_UP
2.38095238095%	1	42	223	Diabetes_McGill_RAS	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
2.38095238095%	1	42	223	Diabetes_McGill_RAS	CHEN_HOXA5_TARGETS_9HR_UP
2.38095238095%	1	42	222	Diabetes_McGill_RAS	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
2.38095238095%	1	42	222	Diabetes_McGill_RAS	BROWNE_HCMV_INFECTION_1HR_DN
2.38095238095%	1	42	221	Diabetes_McGill_RAS	PEDRIOLI_MIR31_TARGETS_UP
2.38095238095%	1	42	221	Diabetes_McGill_RAS	CHANDRAN_METASTASIS_UP
2.38095238095%	1	42	220	Diabetes_McGill_RAS	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
2.38095238095%	1	42	22	Diabetes_McGill_RAS	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP
2.38095238095%	1	42	22	Diabetes_McGill_RAS	BIOCARTA_SPPA_PATHWAY
2.38095238095%	1	42	22	Diabetes_McGill_RAS	BIOCARTA_INSULIN_PATHWAY
2.38095238095%	1	42	22	Diabetes_McGill_RAS	BIOCARTA_IL6_PATHWAY
2.38095238095%	1	42	22	Diabetes_McGill_RAS	BIOCARTA_IL2_PATHWAY
2.38095238095%	1	42	22	Diabetes_McGill_RAS	BIOCARTA_HER2_PATHWAY
2.38095238095%	1	42	217	Diabetes_McGill_RAS	SANSOM_APC_MYC_TARGETS
2.38095238095%	1	42	214	Diabetes_McGill_RAS	BIDUS_METASTASIS_UP
2.38095238095%	1	42	212	Diabetes_McGill_RAS	SANSOM_APC_TARGETS
2.38095238095%	1	42	210	Diabetes_McGill_RAS	WANG_TUMOR_INVASIVENESS_DN
2.38095238095%	1	42	210	Diabetes_McGill_RAS	VERHAAK_GLIOBLASTOMA_PRONEURAL
2.38095238095%	1	42	210	Diabetes_McGill_RAS	VERHAAK_GLIOBLASTOMA_NEURAL
2.38095238095%	1	42	210	Diabetes_McGill_RAS	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
2.38095238095%	1	42	210	Diabetes_McGill_RAS	SANSOM_APC_TARGETS_REQUIRE_MYC
2.38095238095%	1	42	210	Diabetes_McGill_RAS	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
2.38095238095%	1	42	210	Diabetes_McGill_RAS	CAIRO_HEPATOBLASTOMA_CLASSES_DN
2.38095238095%	1	42	21	Diabetes_McGill_RAS	OUYANG_PROSTATE_CANCER_PROGRESSION_DN
2.38095238095%	1	42	21	Diabetes_McGill_RAS	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4
2.38095238095%	1	42	21	Diabetes_McGill_RAS	LEE_INTRATHYMIC_T_PROGENITOR
2.38095238095%	1	42	21	Diabetes_McGill_RAS	HASLINGER_B_CLL_WITH_17P13_DELETION
2.38095238095%	1	42	21	Diabetes_McGill_RAS	BIOCARTA_TFF_PATHWAY
2.38095238095%	1	42	21	Diabetes_McGill_RAS	BIOCARTA_IGF1_PATHWAY
2.38095238095%	1	42	208	Diabetes_McGill_RAS	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
2.38095238095%	1	42	207	Diabetes_McGill_RAS	KARLSSON_TGFB1_TARGETS_DN
2.38095238095%	1	42	207	Diabetes_McGill_RAS	CAIRO_HEPATOBLASTOMA_UP
2.38095238095%	1	42	206	Diabetes_McGill_RAS	RAMALHO_STEMNESS_UP
2.38095238095%	1	42	206	Diabetes_McGill_RAS	LINSLEY_MIR16_TARGETS
2.38095238095%	1	42	206	Diabetes_McGill_RAS	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
2.38095238095%	1	42	205	Diabetes_McGill_RAS	SHEPARD_BMYB_MORPHOLINO_UP
2.38095238095%	1	42	205	Diabetes_McGill_RAS	PEREZ_TP53_AND_TP63_TARGETS
2.38095238095%	1	42	203	Diabetes_McGill_RAS	GRUETZMANN_PANCREATIC_CANCER_DN
2.38095238095%	1	42	202	Diabetes_McGill_RAS	FUJII_YBX1_TARGETS_DN
2.38095238095%	1	42	201	Diabetes_McGill_RAS	HOLLMANN_APOPTOSIS_VIA_CD40_UP
2.38095238095%	1	42	200	Diabetes_McGill_RAS	LEE_DIFFERENTIATING_T_LYMPHOCYTE
2.38095238095%	1	42	20	Diabetes_McGill_RAS	OUYANG_PROSTATE_CANCER_PROGRESSION_UP
2.38095238095%	1	42	20	Diabetes_McGill_RAS	KIM_MYCL1_AMPLIFICATION_TARGETS_DN
2.38095238095%	1	42	20	Diabetes_McGill_RAS	CROONQUIST_IL6_DEPRIVATION_UP
2.38095238095%	1	42	199	Diabetes_McGill_RAS	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
2.38095238095%	1	42	199	Diabetes_McGill_RAS	PLASARI_TGFB1_TARGETS_10HR_UP
2.38095238095%	1	42	198	Diabetes_McGill_RAS	WELCSH_BRCA1_TARGETS_UP
2.38095238095%	1	42	198	Diabetes_McGill_RAS	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
2.38095238095%	1	42	197	Diabetes_McGill_RAS	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
2.38095238095%	1	42	196	Diabetes_McGill_RAS	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
2.38095238095%	1	42	196	Diabetes_McGill_RAS	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
2.38095238095%	1	42	194	Diabetes_McGill_RAS	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
2.38095238095%	1	42	194	Diabetes_McGill_RAS	PROVENZANI_METASTASIS_UP
2.38095238095%	1	42	194	Diabetes_McGill_RAS	KASLER_HDAC7_TARGETS_1_UP
2.38095238095%	1	42	193	Diabetes_McGill_RAS	MOHANKUMAR_TLX1_TARGETS_DN
2.38095238095%	1	42	191	Diabetes_McGill_RAS	YAGI_AML_FAB_MARKERS
2.38095238095%	1	42	19	Diabetes_McGill_RAS	WU_ALZHEIMER_DISEASE_DN
2.38095238095%	1	42	19	Diabetes_McGill_RAS	SYED_ESTRADIOL_RESPONSE
2.38095238095%	1	42	19	Diabetes_McGill_RAS	MAHADEVAN_RESPONSE_TO_MP470_DN
2.38095238095%	1	42	19	Diabetes_McGill_RAS	GRANDVAUX_IRF3_TARGETS_DN
2.38095238095%	1	42	19	Diabetes_McGill_RAS	BIOCARTA_MAL_PATHWAY
2.38095238095%	1	42	19	Diabetes_McGill_RAS	BIOCARTA_EPO_PATHWAY
2.38095238095%	1	42	188	Diabetes_McGill_RAS	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
2.38095238095%	1	42	187	Diabetes_McGill_RAS	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
2.38095238095%	1	42	187	Diabetes_McGill_RAS	PENG_LEUCINE_DEPRIVATION_DN
2.38095238095%	1	42	186	Diabetes_McGill_RAS	WANG_CLIM2_TARGETS_DN
2.38095238095%	1	42	185	Diabetes_McGill_RAS	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
2.38095238095%	1	42	185	Diabetes_McGill_RAS	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
2.38095238095%	1	42	185	Diabetes_McGill_RAS	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
2.38095238095%	1	42	183	Diabetes_McGill_RAS	KEGG_ENDOCYTOSIS
2.38095238095%	1	42	1821	Diabetes_McGill_RAS	DODD_NASOPHARYNGEAL_CARCINOMA_UP
2.38095238095%	1	42	182	Diabetes_McGill_RAS	FERNANDEZ_BOUND_BY_MYC
2.38095238095%	1	42	181	Diabetes_McGill_RAS	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
2.38095238095%	1	42	180	Diabetes_McGill_RAS	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
2.38095238095%	1	42	18	Diabetes_McGill_RAS	ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE
2.38095238095%	1	42	18	Diabetes_McGill_RAS	WEBER_METHYLATED_IN_COLON_CANCER
2.38095238095%	1	42	18	Diabetes_McGill_RAS	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP
2.38095238095%	1	42	18	Diabetes_McGill_RAS	NIELSEN_SCHWANNOMA_UP
2.38095238095%	1	42	18	Diabetes_McGill_RAS	GENTILE_UV_RESPONSE_CLUSTER_D1
2.38095238095%	1	42	18	Diabetes_McGill_RAS	BIOCARTA_TEL_PATHWAY
2.38095238095%	1	42	18	Diabetes_McGill_RAS	BIOCARTA_SPRY_PATHWAY
2.38095238095%	1	42	18	Diabetes_McGill_RAS	BIOCARTA_NGF_PATHWAY
2.38095238095%	1	42	18	Diabetes_McGill_RAS	BIOCARTA_ETS_PATHWAY
2.38095238095%	1	42	18	Diabetes_McGill_RAS	BIOCARTA_ERK5_PATHWAY
2.38095238095%	1	42	18	Diabetes_McGill_RAS	BIOCARTA_CARDIACEGF_PATHWAY
2.38095238095%	1	42	178	Diabetes_McGill_RAS	BROWNE_HCMV_INFECTION_18HR_UP
2.38095238095%	1	42	178	Diabetes_McGill_RAS	BROWNE_HCMV_INFECTION_18HR_DN
2.38095238095%	1	42	176	Diabetes_McGill_RAS	NAGASHIMA_NRG1_SIGNALING_UP
2.38095238095%	1	42	176	Diabetes_McGill_RAS	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
2.38095238095%	1	42	175	Diabetes_McGill_RAS	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
2.38095238095%	1	42	175	Diabetes_McGill_RAS	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
2.38095238095%	1	42	175	Diabetes_McGill_RAS	LEE_LIVER_CANCER_SURVIVAL_DN
2.38095238095%	1	42	170	Diabetes_McGill_RAS	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
2.38095238095%	1	42	17	Diabetes_McGill_RAS	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN
2.38095238095%	1	42	17	Diabetes_McGill_RAS	SA_TRKA_RECEPTOR
2.38095238095%	1	42	17	Diabetes_McGill_RAS	REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR
2.38095238095%	1	42	17	Diabetes_McGill_RAS	BIOCARTA_PML_PATHWAY
2.38095238095%	1	42	164	Diabetes_McGill_RAS	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
2.38095238095%	1	42	164	Diabetes_McGill_RAS	KIM_WT1_TARGETS_8HR_UP
2.38095238095%	1	42	163	Diabetes_McGill_RAS	LIN_NPAS4_TARGETS_UP
2.38095238095%	1	42	162	Diabetes_McGill_RAS	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
2.38095238095%	1	42	162	Diabetes_McGill_RAS	KIM_WT1_TARGETS_12HR_UP
2.38095238095%	1	42	160	Diabetes_McGill_RAS	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
2.38095238095%	1	42	16	Diabetes_McGill_RAS	TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN
2.38095238095%	1	42	16	Diabetes_McGill_RAS	GHO_ATF5_TARGETS_DN
2.38095238095%	1	42	16	Diabetes_McGill_RAS	CHIN_BREAST_CANCER_COPY_NUMBER_DN
2.38095238095%	1	42	16	Diabetes_McGill_RAS	BIOCARTA_CDMAC_PATHWAY
2.38095238095%	1	42	157	Diabetes_McGill_RAS	SERVITJA_LIVER_HNF1A_TARGETS_DN
2.38095238095%	1	42	156	Diabetes_McGill_RAS	FOSTER_TOLERANT_MACROPHAGE_UP
2.38095238095%	1	42	154	Diabetes_McGill_RAS	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
2.38095238095%	1	42	153	Diabetes_McGill_RAS	LU_AGING_BRAIN_DN
2.38095238095%	1	42	15	Diabetes_McGill_RAS	PIEPOLI_LGI1_TARGETS_UP
2.38095238095%	1	42	15	Diabetes_McGill_RAS	HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN
2.38095238095%	1	42	15	Diabetes_McGill_RAS	BIOCARTA_LONGEVITY_PATHWAY
2.38095238095%	1	42	15	Diabetes_McGill_RAS	BIOCARTA_IL3_PATHWAY
2.38095238095%	1	42	15	Diabetes_McGill_RAS	BIOCARTA_BARRESTIN_SRC_PATHWAY
2.38095238095%	1	42	149	Diabetes_McGill_RAS	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
2.38095238095%	1	42	149	Diabetes_McGill_RAS	LANDIS_ERBB2_BREAST_TUMORS_324_DN
2.38095238095%	1	42	149	Diabetes_McGill_RAS	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
2.38095238095%	1	42	148	Diabetes_McGill_RAS	WHITFIELD_CELL_CYCLE_M_G1
2.38095238095%	1	42	148	Diabetes_McGill_RAS	BROWNE_HCMV_INFECTION_24HR_DN
2.38095238095%	1	42	147	Diabetes_McGill_RAS	WHITFIELD_CELL_CYCLE_G1_S
2.38095238095%	1	42	147	Diabetes_McGill_RAS	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
2.38095238095%	1	42	147	Diabetes_McGill_RAS	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
2.38095238095%	1	42	146	Diabetes_McGill_RAS	PECE_MAMMARY_STEM_CELL_DN
2.38095238095%	1	42	146	Diabetes_McGill_RAS	LEE_NEURAL_CREST_STEM_CELL_UP
2.38095238095%	1	42	146	Diabetes_McGill_RAS	KIM_ALL_DISORDERS_DURATION_CORR_DN
2.38095238095%	1	42	145	Diabetes_McGill_RAS	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
2.38095238095%	1	42	144	Diabetes_McGill_RAS	BROCKE_APOPTOSIS_REVERSED_BY_IL6
2.38095238095%	1	42	143	Diabetes_McGill_RAS	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
2.38095238095%	1	42	143	Diabetes_McGill_RAS	DANG_MYC_TARGETS_UP
2.38095238095%	1	42	142	Diabetes_McGill_RAS	RUIZ_TNC_TARGETS_DN
2.38095238095%	1	42	142	Diabetes_McGill_RAS	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
2.38095238095%	1	42	141	Diabetes_McGill_RAS	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
2.38095238095%	1	42	140	Diabetes_McGill_RAS	QI_HYPOXIA
2.38095238095%	1	42	140	Diabetes_McGill_RAS	ONDER_CDH1_TARGETS_1_UP
2.38095238095%	1	42	14	Diabetes_McGill_RAS	ZHANG_ADIPOGENESIS_BY_BMP7
2.38095238095%	1	42	14	Diabetes_McGill_RAS	INAMURA_LUNG_CANCER_SCC_DN
2.38095238095%	1	42	14	Diabetes_McGill_RAS	DORN_ADENOVIRUS_INFECTION_48HR_UP
2.38095238095%	1	42	14	Diabetes_McGill_RAS	CASTELLANO_NRAS_TARGETS_DN
2.38095238095%	1	42	138	Diabetes_McGill_RAS	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
2.38095238095%	1	42	137	Diabetes_McGill_RAS	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
2.38095238095%	1	42	136	Diabetes_McGill_RAS	PROVENZANI_METASTASIS_DN
2.38095238095%	1	42	134	Diabetes_McGill_RAS	CHUNG_BLISTER_CYTOTOXICITY_UP
2.38095238095%	1	42	132	Diabetes_McGill_RAS	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
2.38095238095%	1	42	131	Diabetes_McGill_RAS	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
2.38095238095%	1	42	13	Diabetes_McGill_RAS	XU_RESPONSE_TO_TRETINOIN_DN
2.38095238095%	1	42	13	Diabetes_McGill_RAS	REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION
2.38095238095%	1	42	13	Diabetes_McGill_RAS	NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON
2.38095238095%	1	42	13	Diabetes_McGill_RAS	KORKOLA_SEMINOMA_DN
2.38095238095%	1	42	13	Diabetes_McGill_RAS	KORKOLA_EMBRYONAL_CARCINOMA_DN
2.38095238095%	1	42	129	Diabetes_McGill_RAS	YAGI_AML_SURVIVAL
2.38095238095%	1	42	128	Diabetes_McGill_RAS	POTTI_TOPOTECAN_SENSITIVITY
2.38095238095%	1	42	128	Diabetes_McGill_RAS	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
2.38095238095%	1	42	126	Diabetes_McGill_RAS	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
2.38095238095%	1	42	126	Diabetes_McGill_RAS	BURTON_ADIPOGENESIS_5
2.38095238095%	1	42	125	Diabetes_McGill_RAS	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
2.38095238095%	1	42	125	Diabetes_McGill_RAS	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
2.38095238095%	1	42	123	Diabetes_McGill_RAS	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
2.38095238095%	1	42	123	Diabetes_McGill_RAS	HOOI_ST7_TARGETS_DN
2.38095238095%	1	42	12	Diabetes_McGill_RAS	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP
2.38095238095%	1	42	12	Diabetes_McGill_RAS	DORN_ADENOVIRUS_INFECTION_24HR_UP
2.38095238095%	1	42	12	Diabetes_McGill_RAS	BIOCARTA_TRKA_PATHWAY
2.38095238095%	1	42	12	Diabetes_McGill_RAS	BIOCARTA_PLCE_PATHWAY
2.38095238095%	1	42	118	Diabetes_McGill_RAS	MARKEY_RB1_CHRONIC_LOF_DN
2.38095238095%	1	42	116	Diabetes_McGill_RAS	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
2.38095238095%	1	42	115	Diabetes_McGill_RAS	MARZEC_IL2_SIGNALING_UP
2.38095238095%	1	42	113	Diabetes_McGill_RAS	RICKMAN_HEAD_AND_NECK_CANCER_C
2.38095238095%	1	42	112	Diabetes_McGill_RAS	LAIHO_COLORECTAL_CANCER_SERRATED_UP
2.38095238095%	1	42	111	Diabetes_McGill_RAS	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
2.38095238095%	1	42	110	Diabetes_McGill_RAS	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
2.38095238095%	1	42	11	Diabetes_McGill_RAS	KORKOLA_CHORIOCARCINOMA_DN
2.38095238095%	1	42	11	Diabetes_McGill_RAS	DORN_ADENOVIRUS_INFECTION_32HR_UP
2.38095238095%	1	42	11	Diabetes_McGill_RAS	BIOCARTA_CDK5_PATHWAY
2.38095238095%	1	42	108	Diabetes_McGill_RAS	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
2.38095238095%	1	42	108	Diabetes_McGill_RAS	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
2.38095238095%	1	42	105	Diabetes_McGill_RAS	WOO_LIVER_CANCER_RECURRENCE_UP
2.38095238095%	1	42	105	Diabetes_McGill_RAS	BROWNE_HCMV_INFECTION_8HR_UP
2.38095238095%	1	42	103	Diabetes_McGill_RAS	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN
2.38095238095%	1	42	103	Diabetes_McGill_RAS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
2.38095238095%	1	42	103	Diabetes_McGill_RAS	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
2.38095238095%	1	42	103	Diabetes_McGill_RAS	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
2.38095238095%	1	42	1022	Diabetes_McGill_RAS	MARSON_BOUND_BY_FOXP3_STIMULATED
2.38095238095%	1	42	102	Diabetes_McGill_RAS	LABBE_TGFB1_TARGETS_UP
2.38095238095%	1	42	101	Diabetes_McGill_RAS	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
2.38095238095%	1	42	101	Diabetes_McGill_RAS	BROWNE_HCMV_INFECTION_20HR_DN
2.38095238095%	1	42	101	Diabetes_McGill_RAS	BROWNE_HCMV_INFECTION_10HR_UP
2.38095238095%	1	42	100	Diabetes_McGill_RAS	WINZEN_DEGRADED_VIA_KHSRP
2.38095238095%	1	42	100	Diabetes_McGill_RAS	MCCLUNG_CREB1_TARGETS_UP
2.38095238095%	1	42	10	Diabetes_McGill_RAS	OXFORD_RALA_TARGETS_DN
2.38095238095%	1	42	10	Diabetes_McGill_RAS	MANN_RESPONSE_TO_AMIFOSTINE_DN
2.38095238095%	1	42	10	Diabetes_McGill_RAS	BRUNEAU_SEPTATION_VENTRICULAR
2.38095238095%	1	42	10	Diabetes_McGill_RAS	BIOCARTA_EPHA4_PATHWAY
2.37912509593%	31	1303	824	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
2.37912509593%	31	1303	811	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
2.37912509593%	31	1303	781	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GOZGIT_ESR1_TARGETS_DN
2.37912509593%	31	1303	681	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
2.37912509593%	31	1303	612	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
2.37912509593%	31	1303	1038	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BENPORATH_SUZ12_TARGETS
2.37154150198%	6	253	98	Diabetes_McGill_CREBBP_coTF	CROONQUIST_IL6_DEPRIVATION_DN
2.37154150198%	6	253	94	Diabetes_McGill_CREBBP_coTF	LU_IL4_SIGNALING
2.37154150198%	6	253	920	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_GPCR
2.37154150198%	6	253	90	Diabetes_McGill_CREBBP_coTF	MORI_IMMATURE_B_LYMPHOCYTE_DN
2.37154150198%	6	253	89	Diabetes_McGill_CREBBP_coTF	WNT_SIGNALING
2.37154150198%	6	253	88	Diabetes_McGill_CREBBP_coTF	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
2.37154150198%	6	253	88	Diabetes_McGill_CREBBP_coTF	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
2.37154150198%	6	253	88	Diabetes_McGill_CREBBP_coTF	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
2.37154150198%	6	253	87	Diabetes_McGill_CREBBP_coTF	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
2.37154150198%	6	253	87	Diabetes_McGill_CREBBP_coTF	KEGG_ERBB_SIGNALING_PATHWAY
2.37154150198%	6	253	87	Diabetes_McGill_CREBBP_coTF	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
2.37154150198%	6	253	84	Diabetes_McGill_CREBBP_coTF	HINATA_NFKB_TARGETS_FIBROBLAST_UP
2.37154150198%	6	253	83	Diabetes_McGill_CREBBP_coTF	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
2.37154150198%	6	253	81	Diabetes_McGill_CREBBP_coTF	LEIN_MEDULLA_MARKERS
2.37154150198%	6	253	75	Diabetes_McGill_CREBBP_coTF	MORI_MATURE_B_LYMPHOCYTE_DN
2.37154150198%	6	253	75	Diabetes_McGill_CREBBP_coTF	MCCLUNG_COCAIN_REWARD_4WK
2.37154150198%	6	253	72	Diabetes_McGill_CREBBP_coTF	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
2.37154150198%	6	253	72	Diabetes_McGill_CREBBP_coTF	DANG_REGULATED_BY_MYC_UP
2.37154150198%	6	253	71	Diabetes_McGill_CREBBP_coTF	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
2.37154150198%	6	253	71	Diabetes_McGill_CREBBP_coTF	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
2.37154150198%	6	253	71	Diabetes_McGill_CREBBP_coTF	KEGG_MELANOMA
2.37154150198%	6	253	69	Diabetes_McGill_CREBBP_coTF	PID_MTOR_4PATHWAY
2.37154150198%	6	253	69	Diabetes_McGill_CREBBP_coTF	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
2.37154150198%	6	253	68	Diabetes_McGill_CREBBP_coTF	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
2.37154150198%	6	253	68	Diabetes_McGill_CREBBP_coTF	BROWNE_INTERFERON_RESPONSIVE_GENES
2.37154150198%	6	253	67	Diabetes_McGill_CREBBP_coTF	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
2.37154150198%	6	253	66	Diabetes_McGill_CREBBP_coTF	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
2.37154150198%	6	253	66	Diabetes_McGill_CREBBP_coTF	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP
2.37154150198%	6	253	65	Diabetes_McGill_CREBBP_coTF	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP
2.37154150198%	6	253	65	Diabetes_McGill_CREBBP_coTF	AMIT_SERUM_RESPONSE_120_MCF10A
2.37154150198%	6	253	58	Diabetes_McGill_CREBBP_coTF	NAGASHIMA_EGF_SIGNALING_UP
2.37154150198%	6	253	56	Diabetes_McGill_CREBBP_coTF	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
2.37154150198%	6	253	56	Diabetes_McGill_CREBBP_coTF	HOQUE_METHYLATED_IN_CANCER
2.37154150198%	6	253	55	Diabetes_McGill_CREBBP_coTF	PID_TGFBRPATHWAY
2.37154150198%	6	253	55	Diabetes_McGill_CREBBP_coTF	LAU_APOPTOSIS_CDKN2A_UP
2.37154150198%	6	253	54	Diabetes_McGill_CREBBP_coTF	AUNG_GASTRIC_CANCER
2.37154150198%	6	253	536	Diabetes_McGill_CREBBP_coTF	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
2.37154150198%	6	253	52	Diabetes_McGill_CREBBP_coTF	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6
2.37154150198%	6	253	50	Diabetes_McGill_CREBBP_coTF	MARTINEZ_RESPONSE_TO_TRABECTEDIN
2.37154150198%	6	253	50	Diabetes_McGill_CREBBP_coTF	HOFMANN_CELL_LYMPHOMA_UP
2.37154150198%	6	253	49	Diabetes_McGill_CREBBP_coTF	DAUER_STAT3_TARGETS_UP
2.37154150198%	6	253	49	Diabetes_McGill_CREBBP_coTF	BIOCARTA_TCR_PATHWAY
2.37154150198%	6	253	482	Diabetes_McGill_CREBBP_coTF	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
2.37154150198%	6	253	460	Diabetes_McGill_CREBBP_coTF	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
2.37154150198%	6	253	44	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_FGFR_MUTANTS
2.37154150198%	6	253	44	Diabetes_McGill_CREBBP_coTF	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
2.37154150198%	6	253	435	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
2.37154150198%	6	253	428	Diabetes_McGill_CREBBP_coTF	LIM_MAMMARY_STEM_CELL_DN
2.37154150198%	6	253	423	Diabetes_McGill_CREBBP_coTF	THUM_SYSTOLIC_HEART_FAILURE_UP
2.37154150198%	6	253	42	Diabetes_McGill_CREBBP_coTF	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
2.37154150198%	6	253	42	Diabetes_McGill_CREBBP_coTF	AMIT_EGF_RESPONSE_40_HELA
2.37154150198%	6	253	418	Diabetes_McGill_CREBBP_coTF	RUTELLA_RESPONSE_TO_HGF_UP
2.37154150198%	6	253	408	Diabetes_McGill_CREBBP_coTF	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
2.37154150198%	6	253	406	Diabetes_McGill_CREBBP_coTF	OSMAN_BLADDER_CANCER_DN
2.37154150198%	6	253	391	Diabetes_McGill_CREBBP_coTF	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
2.37154150198%	6	253	38	Diabetes_McGill_CREBBP_coTF	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
2.37154150198%	6	253	38	Diabetes_McGill_CREBBP_coTF	REACTOME_PI3K_AKT_ACTIVATION
2.37154150198%	6	253	38	Diabetes_McGill_CREBBP_coTF	BIOCARTA_IL2RB_PATHWAY
2.37154150198%	6	253	37	Diabetes_McGill_CREBBP_coTF	PID_GMCSF_PATHWAY
2.37154150198%	6	253	37	Diabetes_McGill_CREBBP_coTF	BIOCARTA_ALK_PATHWAY
2.37154150198%	6	253	36	Diabetes_McGill_CREBBP_coTF	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
2.37154150198%	6	253	36	Diabetes_McGill_CREBBP_coTF	PID_PI3KPLCTRKPATHWAY
2.37154150198%	6	253	36	Diabetes_McGill_CREBBP_coTF	LIU_CDX2_TARGETS_UP
2.37154150198%	6	253	357	Diabetes_McGill_CREBBP_coTF	SHEN_SMARCA2_TARGETS_DN
2.37154150198%	6	253	356	Diabetes_McGill_CREBBP_coTF	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
2.37154150198%	6	253	353	Diabetes_McGill_CREBBP_coTF	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
2.37154150198%	6	253	35	Diabetes_McGill_CREBBP_coTF	RODRIGUES_NTN1_AND_DCC_TARGETS
2.37154150198%	6	253	35	Diabetes_McGill_CREBBP_coTF	DORSAM_HOXA9_TARGETS_UP
2.37154150198%	6	253	338	Diabetes_McGill_CREBBP_coTF	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
2.37154150198%	6	253	335	Diabetes_McGill_CREBBP_coTF	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
2.37154150198%	6	253	329	Diabetes_McGill_CREBBP_coTF	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
2.37154150198%	6	253	326	Diabetes_McGill_CREBBP_coTF	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
2.37154150198%	6	253	32	Diabetes_McGill_CREBBP_coTF	ST_ERK1_ERK2_MAPK_PATHWAY
2.37154150198%	6	253	306	Diabetes_McGill_CREBBP_coTF	HORIUCHI_WTAP_TARGETS_UP
2.37154150198%	6	253	30	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
2.37154150198%	6	253	30	Diabetes_McGill_CREBBP_coTF	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
2.37154150198%	6	253	294	Diabetes_McGill_CREBBP_coTF	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
2.37154150198%	6	253	293	Diabetes_McGill_CREBBP_coTF	IVANOVA_HEMATOPOIESIS_MATURE_CELL
2.37154150198%	6	253	290	Diabetes_McGill_CREBBP_coTF	BENPORATH_OCT4_TARGETS
2.37154150198%	6	253	29	Diabetes_McGill_CREBBP_coTF	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
2.37154150198%	6	253	29	Diabetes_McGill_CREBBP_coTF	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
2.37154150198%	6	253	289	Diabetes_McGill_CREBBP_coTF	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
2.37154150198%	6	253	280	Diabetes_McGill_CREBBP_coTF	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
2.37154150198%	6	253	28	Diabetes_McGill_CREBBP_coTF	BIOCARTA_G1_PATHWAY
2.37154150198%	6	253	27	Diabetes_McGill_CREBBP_coTF	CHIN_BREAST_CANCER_COPY_NUMBER_UP
2.37154150198%	6	253	267	Diabetes_McGill_CREBBP_coTF	HOLLMANN_APOPTOSIS_VIA_CD40_DN
2.37154150198%	6	253	264	Diabetes_McGill_CREBBP_coTF	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
2.37154150198%	6	253	26	Diabetes_McGill_CREBBP_coTF	BIOCARTA_RACCYCD_PATHWAY
2.37154150198%	6	253	259	Diabetes_McGill_CREBBP_coTF	QI_PLASMACYTOMA_UP
2.37154150198%	6	253	258	Diabetes_McGill_CREBBP_coTF	JAEGER_METASTASIS_DN
2.37154150198%	6	253	254	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_4HR_DN
2.37154150198%	6	253	25	Diabetes_McGill_CREBBP_coTF	PID_MYC_PATHWAY
2.37154150198%	6	253	25	Diabetes_McGill_CREBBP_coTF	KEGG_DORSO_VENTRAL_AXIS_FORMATION
2.37154150198%	6	253	25	Diabetes_McGill_CREBBP_coTF	BIOCARTA_STRESS_PATHWAY
2.37154150198%	6	253	249	Diabetes_McGill_CREBBP_coTF	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
2.37154150198%	6	253	245	Diabetes_McGill_CREBBP_coTF	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
2.37154150198%	6	253	24	Diabetes_McGill_CREBBP_coTF	SA_B_CELL_RECEPTOR_COMPLEXES
2.37154150198%	6	253	24	Diabetes_McGill_CREBBP_coTF	BIOCARTA_TPO_PATHWAY
2.37154150198%	6	253	238	Diabetes_McGill_CREBBP_coTF	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
2.37154150198%	6	253	236	Diabetes_McGill_CREBBP_coTF	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
2.37154150198%	6	253	234	Diabetes_McGill_CREBBP_coTF	AFFAR_YY1_TARGETS_DN
2.37154150198%	6	253	232	Diabetes_McGill_CREBBP_coTF	DELYS_THYROID_CANCER_DN
2.37154150198%	6	253	23	Diabetes_McGill_CREBBP_coTF	BIOCARTA_P53HYPOXIA_PATHWAY
2.37154150198%	6	253	23	Diabetes_McGill_CREBBP_coTF	BIOCARTA_GLEEVEC_PATHWAY
2.37154150198%	6	253	226	Diabetes_McGill_CREBBP_coTF	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
2.37154150198%	6	253	225	Diabetes_McGill_CREBBP_coTF	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
2.37154150198%	6	253	225	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_16HR_UP
2.37154150198%	6	253	22	Diabetes_McGill_CREBBP_coTF	BIOCARTA_IL6_PATHWAY
2.37154150198%	6	253	215	Diabetes_McGill_CREBBP_coTF	MARKEY_RB1_ACUTE_LOF_UP
2.37154150198%	6	253	214	Diabetes_McGill_CREBBP_coTF	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
2.37154150198%	6	253	214	Diabetes_McGill_CREBBP_coTF	BIDUS_METASTASIS_UP
2.37154150198%	6	253	214	Diabetes_McGill_CREBBP_coTF	AFFAR_YY1_TARGETS_UP
2.37154150198%	6	253	210	Diabetes_McGill_CREBBP_coTF	RIZKI_TUMOR_INVASIVENESS_3D_UP
2.37154150198%	6	253	207	Diabetes_McGill_CREBBP_coTF	REACTOME_HIV_INFECTION
2.37154150198%	6	253	205	Diabetes_McGill_CREBBP_coTF	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
2.37154150198%	6	253	203	Diabetes_McGill_CREBBP_coTF	PENG_RAPAMYCIN_RESPONSE_UP
2.37154150198%	6	253	198	Diabetes_McGill_CREBBP_coTF	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
2.37154150198%	6	253	195	Diabetes_McGill_CREBBP_coTF	KYNG_DNA_DAMAGE_DN
2.37154150198%	6	253	194	Diabetes_McGill_CREBBP_coTF	PROVENZANI_METASTASIS_UP
2.37154150198%	6	253	186	Diabetes_McGill_CREBBP_coTF	HAMAI_APOPTOSIS_VIA_TRAIL_DN
2.37154150198%	6	253	183	Diabetes_McGill_CREBBP_coTF	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
2.37154150198%	6	253	182	Diabetes_McGill_CREBBP_coTF	WHITFIELD_CELL_CYCLE_G2
2.37154150198%	6	253	182	Diabetes_McGill_CREBBP_coTF	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
2.37154150198%	6	253	181	Diabetes_McGill_CREBBP_coTF	JISON_SICKLE_CELL_DISEASE_DN
2.37154150198%	6	253	178	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_18HR_DN
2.37154150198%	6	253	175	Diabetes_McGill_CREBBP_coTF	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
2.37154150198%	6	253	167	Diabetes_McGill_CREBBP_coTF	VANTVEER_BREAST_CANCER_ESR1_UP
2.37154150198%	6	253	165	Diabetes_McGill_CREBBP_coTF	LIU_CMYB_TARGETS_UP
2.37154150198%	6	253	164	Diabetes_McGill_CREBBP_coTF	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
2.37154150198%	6	253	157	Diabetes_McGill_CREBBP_coTF	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
2.37154150198%	6	253	157	Diabetes_McGill_CREBBP_coTF	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
2.37154150198%	6	253	148	Diabetes_McGill_CREBBP_coTF	WEI_MIR34A_TARGETS
2.37154150198%	6	253	145	Diabetes_McGill_CREBBP_coTF	SMITH_TERT_TARGETS_UP
2.37154150198%	6	253	142	Diabetes_McGill_CREBBP_coTF	RUIZ_TNC_TARGETS_DN
2.37154150198%	6	253	140	Diabetes_McGill_CREBBP_coTF	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
2.37154150198%	6	253	138	Diabetes_McGill_CREBBP_coTF	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
2.37154150198%	6	253	137	Diabetes_McGill_CREBBP_coTF	KEGG_INSULIN_SIGNALING_PATHWAY
2.37154150198%	6	253	128	Diabetes_McGill_CREBBP_coTF	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
2.37154150198%	6	253	126	Diabetes_McGill_CREBBP_coTF	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
2.37154150198%	6	253	115	Diabetes_McGill_CREBBP_coTF	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
2.37154150198%	6	253	108	Diabetes_McGill_CREBBP_coTF	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
2.37154150198%	6	253	105	Diabetes_McGill_CREBBP_coTF	WOO_LIVER_CANCER_RECURRENCE_UP
2.37154150198%	6	253	105	Diabetes_McGill_CREBBP_coTF	STEIN_ESRRA_TARGETS_DN
2.37154150198%	6	253	103	Diabetes_McGill_CREBBP_coTF	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN
2.37154150198%	6	253	101	Diabetes_McGill_CREBBP_coTF	BASSO_CD40_SIGNALING_UP
2.37154150198%	6	253	10	Diabetes_McGill_CREBBP_coTF	YEMELYANOV_GR_TARGETS_DN
2.37154150198%	6	253	10	Diabetes_McGill_CREBBP_coTF	TURJANSKI_MAPK14_TARGETS
2.36406619385%	30	1269	863	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
2.36406619385%	30	1269	775	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BENPORATH_MYC_MAX_TARGETS
2.36406619385%	30	1269	747	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PATIL_LIVER_CANCER
2.36406619385%	30	1269	720	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
2.36406619385%	30	1269	681	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
2.35795454545%	83	3520	805	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
2.35795454545%	83	3520	784	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FORTSCHEGGER_PHF8_TARGETS_DN
2.35795454545%	83	3520	783	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ONKEN_UVEAL_MELANOMA_UP
2.35795454545%	83	3520	682	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
2.35795454545%	83	3520	668	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
2.35795454545%	83	3520	1038	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BENPORATH_SUZ12_TARGETS
2.35168359166%	44	1871	572	T2D_GENES_TANYA_HEIGHT	CHICAS_RB1_TARGETS_SENESCENT
2.35168359166%	44	1871	567	T2D_GENES_TANYA_HEIGHT	CHICAS_RB1_TARGETS_CONFLUENT
2.35168359166%	44	1871	535	T2D_GENES_TANYA_HEIGHT	STEIN_ESRRA_TARGETS
2.35168359166%	44	1871	483	T2D_GENES_TANYA_HEIGHT	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
2.35168359166%	44	1871	435	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
2.35168359166%	44	1871	425	T2D_GENES_TANYA_HEIGHT	BOCHKIS_FOXA2_TARGETS
2.35168359166%	44	1871	423	T2D_GENES_TANYA_HEIGHT	THUM_SYSTOLIC_HEART_FAILURE_UP
2.35168359166%	44	1871	423	T2D_GENES_TANYA_HEIGHT	PUJANA_BRCA2_PCC_NETWORK
2.35168359166%	44	1871	414	T2D_GENES_TANYA_HEIGHT	MOHANKUMAR_TLX1_TARGETS_UP
2.35168359166%	44	1871	389	T2D_GENES_TANYA_HEIGHT	HSIAO_HOUSEKEEPING_GENES
2.35168359166%	44	1871	372	T2D_GENES_TANYA_HEIGHT	WANG_LMO4_TARGETS_UP
2.35168359166%	44	1871	346	T2D_GENES_TANYA_HEIGHT	GOLDRATH_ANTIGEN_RESPONSE
2.34590616375%	51	2174	439	T2D_GENES_TANYA_LIPIDS	MITSIADES_RESPONSE_TO_APLIDIN_UP
2.34590616375%	51	2174	390	T2D_GENES_TANYA_LIPIDS	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
2.33029381966%	46	1974	69	Mendelian_Nancy_Cox	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES
2.33029381966%	46	1974	409	Mendelian_Nancy_Cox	FOSTER_TOLERANT_MACROPHAGE_DN
2.33029381966%	46	1974	404	Mendelian_Nancy_Cox	OSMAN_BLADDER_CANCER_UP
2.33029381966%	46	1974	387	Mendelian_Nancy_Cox	CHYLA_CBFA2T3_TARGETS_UP
2.33029381966%	46	1974	382	Mendelian_Nancy_Cox	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
2.33029381966%	46	1974	378	Mendelian_Nancy_Cox	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
2.33029381966%	46	1974	355	Mendelian_Nancy_Cox	PEREZ_TP63_TARGETS
2.33029381966%	46	1974	321	Mendelian_Nancy_Cox	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
2.33029381966%	46	1974	316	Mendelian_Nancy_Cox	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
2.33029381966%	46	1974	293	Mendelian_Nancy_Cox	ENK_UV_RESPONSE_EPIDERMIS_UP
2.33029381966%	46	1974	288	Mendelian_Nancy_Cox	POOLA_INVASIVE_BREAST_CANCER_UP
2.33029381966%	46	1974	274	Mendelian_Nancy_Cox	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
2.32954545455%	82	3520	898	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
2.32954545455%	82	3520	855	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
2.32954545455%	82	3520	478	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
2.30966638152%	27	1169	857	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARTENS_TRETINOIN_RESPONSE_UP
2.30966638152%	27	1169	721	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WONG_ADULT_TISSUE_STEM_MODULE
2.30966638152%	27	1169	673	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARTINEZ_RB1_TARGETS_UP
2.30966638152%	27	1169	601	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARTINEZ_RB1_AND_TP53_TARGETS_UP
2.30966638152%	27	1169	546	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
2.30966638152%	27	1169	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROVERSI_GLIOMA_COPY_NUMBER_UP
2.3023791251%	30	1303	841	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTENS_TRETINOIN_RESPONSE_DN
2.3023791251%	30	1303	734	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BENPORATH_SOX2_TARGETS
2.3023791251%	30	1303	721	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WONG_ADULT_TISSUE_STEM_MODULE
2.30113636364%	81	3520	745	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_BMP2_TARGETS_UP
2.30113636364%	81	3520	540	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ACEVEDO_LIVER_CANCER_DN
2.29990800368%	50	2174	579	T2D_GENES_TANYA_LIPIDS	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
2.29990800368%	50	2174	532	T2D_GENES_TANYA_LIPIDS	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
2.29990800368%	50	2174	487	T2D_GENES_TANYA_LIPIDS	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
2.29990800368%	50	2174	406	T2D_GENES_TANYA_LIPIDS	OSMAN_BLADDER_CANCER_DN
2.29990800368%	50	2174	309	T2D_GENES_TANYA_LIPIDS	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
2.29823623731%	43	1871	518	T2D_GENES_TANYA_HEIGHT	REACTOME_METABOLISM_OF_PROTEINS
2.29823623731%	43	1871	504	T2D_GENES_TANYA_HEIGHT	PILON_KLF1_TARGETS_UP
2.29823623731%	43	1871	439	T2D_GENES_TANYA_HEIGHT	MITSIADES_RESPONSE_TO_APLIDIN_UP
2.29823623731%	43	1871	428	T2D_GENES_TANYA_HEIGHT	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
2.29823623731%	43	1871	406	T2D_GENES_TANYA_HEIGHT	OSMAN_BLADDER_CANCER_DN
2.29823623731%	43	1871	405	T2D_GENES_TANYA_HEIGHT	KUMAR_TARGETS_OF_MLL_AF9_FUSION
2.29823623731%	43	1871	403	T2D_GENES_TANYA_HEIGHT	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
2.29823623731%	43	1871	393	T2D_GENES_TANYA_HEIGHT	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
2.29823623731%	43	1871	380	T2D_GENES_TANYA_HEIGHT	MULLIGHAN_MLL_SIGNATURE_1_UP
2.29823623731%	43	1871	351	T2D_GENES_TANYA_HEIGHT	YAGI_AML_WITH_11Q23_REARRANGED
2.29823623731%	43	1871	349	T2D_GENES_TANYA_HEIGHT	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
2.28526398739%	29	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RNA_POL_I_TRANSCRIPTION
2.28526398739%	29	1269	811	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
2.28526398739%	29	1269	805	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
2.28526398739%	29	1269	658	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
2.28526398739%	29	1269	140	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
2.28526398739%	29	1269	1038	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BENPORATH_SUZ12_TARGETS
2.28526398739%	29	1269	1037	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NUYTTEN_EZH2_TARGETS_UP
2.28384991843%	14	613	564	T2D_GENES_TANYA_BIOMARKER	SMID_BREAST_CANCER_LUMINAL_B_DN
2.28384991843%	14	613	532	T2D_GENES_TANYA_BIOMARKER	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
2.28384991843%	14	613	516	T2D_GENES_TANYA_BIOMARKER	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
2.28384991843%	14	613	514	T2D_GENES_TANYA_BIOMARKER	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
2.28384991843%	14	613	508	T2D_GENES_TANYA_BIOMARKER	ENK_UV_RESPONSE_EPIDERMIS_DN
2.28384991843%	14	613	467	T2D_GENES_TANYA_BIOMARKER	RATTENBACHER_BOUND_BY_CELF1
2.28384991843%	14	613	463	T2D_GENES_TANYA_BIOMARKER	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
2.28384991843%	14	613	459	T2D_GENES_TANYA_BIOMARKER	KIM_WT1_TARGETS_DN
2.28384991843%	14	613	445	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
2.28384991843%	14	613	411	T2D_GENES_TANYA_BIOMARKER	KOYAMA_SEMA3B_TARGETS_DN
2.28384991843%	14	613	403	T2D_GENES_TANYA_BIOMARKER	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
2.28384991843%	14	613	391	T2D_GENES_TANYA_BIOMARKER	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
2.28384991843%	14	613	390	T2D_GENES_TANYA_BIOMARKER	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
2.28384991843%	14	613	366	T2D_GENES_TANYA_BIOMARKER	SANSOM_APC_TARGETS_DN
2.28384991843%	14	613	337	T2D_GENES_TANYA_BIOMARKER	PENG_GLUTAMINE_DEPRIVATION_DN
2.28384991843%	14	613	317	T2D_GENES_TANYA_BIOMARKER	HELLER_HDAC_TARGETS_UP
2.28384991843%	14	613	242	T2D_GENES_TANYA_BIOMARKER	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
2.28384991843%	14	613	225	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_16HR_UP
2.28384991843%	14	613	206	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
2.28384991843%	14	613	180	T2D_GENES_TANYA_BIOMARKER	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
2.27963525836%	45	1974	469	Mendelian_Nancy_Cox	MCCABE_BOUND_BY_HOXC6
2.27963525836%	45	1974	431	Mendelian_Nancy_Cox	GARY_CD5_TARGETS_DN
2.27963525836%	45	1974	373	Mendelian_Nancy_Cox	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
2.27963525836%	45	1974	371	Mendelian_Nancy_Cox	WANG_SMARCE1_TARGETS_DN
2.27963525836%	45	1974	346	Mendelian_Nancy_Cox	GOLDRATH_ANTIGEN_RESPONSE
2.27963525836%	45	1974	315	Mendelian_Nancy_Cox	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
2.27963525836%	45	1974	302	Mendelian_Nancy_Cox	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
2.27963525836%	45	1974	291	Mendelian_Nancy_Cox	SABATES_COLORECTAL_ADENOMA_DN
2.27963525836%	45	1974	290	Mendelian_Nancy_Cox	BENPORATH_OCT4_TARGETS
2.27963525836%	45	1974	289	Mendelian_Nancy_Cox	MANALO_HYPOXIA_DN
2.27963525836%	45	1974	253	Mendelian_Nancy_Cox	MCLACHLAN_DENTAL_CARIES_UP
2.27963525836%	45	1974	215	Mendelian_Nancy_Cox	YAMAZAKI_TCEB3_TARGETS_DN
2.27272727273%	80	3520	783	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
2.26928895613%	15	661	552	T2D_GENES_TANYA_GLYCEMIC	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
2.26928895613%	15	661	548	T2D_GENES_TANYA_GLYCEMIC	KIM_ALL_DISORDERS_CALB1_CORR_UP
2.26928895613%	15	661	501	T2D_GENES_TANYA_GLYCEMIC	SENESE_HDAC3_TARGETS_UP
2.26928895613%	15	661	491	T2D_GENES_TANYA_GLYCEMIC	ZHENG_BOUND_BY_FOXP3
2.26928895613%	15	661	473	T2D_GENES_TANYA_GLYCEMIC	GARY_CD5_TARGETS_UP
2.26928895613%	15	661	463	T2D_GENES_TANYA_GLYCEMIC	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
2.26928895613%	15	661	457	T2D_GENES_TANYA_GLYCEMIC	SENESE_HDAC1_TARGETS_UP
2.26928895613%	15	661	450	T2D_GENES_TANYA_GLYCEMIC	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
2.26928895613%	15	661	430	T2D_GENES_TANYA_GLYCEMIC	RIGGI_EWING_SARCOMA_PROGENITOR_UP
2.26928895613%	15	661	428	T2D_GENES_TANYA_GLYCEMIC	LIM_MAMMARY_STEM_CELL_DN
2.26928895613%	15	661	425	T2D_GENES_TANYA_GLYCEMIC	BOCHKIS_FOXA2_TARGETS
2.26928895613%	15	661	390	T2D_GENES_TANYA_GLYCEMIC	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
2.26928895613%	15	661	344	T2D_GENES_TANYA_GLYCEMIC	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
2.26928895613%	15	661	335	T2D_GENES_TANYA_GLYCEMIC	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
2.26928895613%	15	661	324	T2D_GENES_TANYA_GLYCEMIC	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
2.26928895613%	15	661	323	T2D_GENES_TANYA_GLYCEMIC	GRESHOCK_CANCER_COPY_NUMBER_UP
2.26928895613%	15	661	241	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
2.25390984361%	49	2174	805	T2D_GENES_TANYA_LIPIDS	REACTOME_GPCR_DOWNSTREAM_SIGNALING
2.25390984361%	49	2174	548	T2D_GENES_TANYA_LIPIDS	KIM_ALL_DISORDERS_CALB1_CORR_UP
2.25390984361%	49	2174	504	T2D_GENES_TANYA_LIPIDS	PILON_KLF1_TARGETS_UP
2.25390984361%	49	2174	483	T2D_GENES_TANYA_LIPIDS	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
2.25390984361%	49	2174	447	T2D_GENES_TANYA_LIPIDS	MOOTHA_MITOCHONDRIA
2.25390984361%	49	2174	408	T2D_GENES_TANYA_LIPIDS	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
2.25390984361%	49	2174	387	T2D_GENES_TANYA_LIPIDS	CHYLA_CBFA2T3_TARGETS_UP
2.25390984361%	49	2174	368	T2D_GENES_TANYA_LIPIDS	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
2.25390984361%	49	2174	366	T2D_GENES_TANYA_LIPIDS	SANSOM_APC_TARGETS_DN
2.25390984361%	49	2174	329	T2D_GENES_TANYA_LIPIDS	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
2.24478888295%	42	1871	544	T2D_GENES_TANYA_HEIGHT	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
2.24478888295%	42	1871	491	T2D_GENES_TANYA_HEIGHT	MEISSNER_NPC_HCP_WITH_H3K4ME2
2.24478888295%	42	1871	408	T2D_GENES_TANYA_HEIGHT	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
2.24478888295%	42	1871	335	T2D_GENES_TANYA_HEIGHT	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
2.24478888295%	42	1871	330	T2D_GENES_TANYA_HEIGHT	REACTOME_METABOLISM_OF_RNA
2.24478888295%	42	1871	287	T2D_GENES_TANYA_HEIGHT	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
2.24478888295%	42	1871	270	T2D_GENES_TANYA_HEIGHT	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
2.24478888295%	42	1871	133	T2D_GENES_TANYA_HEIGHT	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON
2.24431818182%	79	3520	770	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
2.24431818182%	79	3520	637	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
2.24215246637%	10	446	988	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BENPORATH_NANOG_TARGETS
2.24215246637%	10	446	918	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JOHNSTONE_PARVB_TARGETS_3_DN
2.24215246637%	10	446	893	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GEORGES_TARGETS_OF_MIR192_AND_MIR215
2.24215246637%	10	446	857	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARTENS_TRETINOIN_RESPONSE_UP
2.24215246637%	10	446	805	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
2.24215246637%	10	446	775	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BENPORATH_MYC_MAX_TARGETS
2.24215246637%	10	446	770	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KRIEG_HYPOXIA_NOT_VIA_KDM3A
2.24215246637%	10	446	745	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_BMP2_TARGETS_UP
2.24215246637%	10	446	637	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
2.24215246637%	10	446	546	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WEST_ADRENOCORTICAL_TUMOR_DN
2.24215246637%	10	446	482	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
2.24215246637%	10	446	462	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DELACROIX_RAR_BOUND_ES
2.24215246637%	10	446	439	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MITSIADES_RESPONSE_TO_APLIDIN_UP
2.24215246637%	10	446	406	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	OSMAN_BLADDER_CANCER_DN
2.24215246637%	10	446	396	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_DEVELOPMENTAL_BIOLOGY
2.24215246637%	10	446	368	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
2.24215246637%	10	446	241	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
2.24215246637%	10	446	211	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FOSTER_KDM1A_TARGETS_DN
2.24215246637%	10	446	185	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_LIVER_CANCER_SURVIVAL_UP
2.24215246637%	10	446	1118	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BENPORATH_ES_WITH_H3K27ME3
2.22897669706%	44	1974	374	Mendelian_Nancy_Cox	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
2.22897669706%	44	1974	337	Mendelian_Nancy_Cox	PHONG_TNF_RESPONSE_NOT_VIA_P38
2.22897669706%	44	1974	295	Mendelian_Nancy_Cox	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
2.22897669706%	44	1974	293	Mendelian_Nancy_Cox	HADDAD_B_LYMPHOCYTE_PROGENITOR
2.22897669706%	44	1974	292	Mendelian_Nancy_Cox	HELLER_HDAC_TARGETS_DN
2.22897669706%	44	1974	254	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_4HR_DN
2.22897669706%	44	1974	234	Mendelian_Nancy_Cox	AFFAR_YY1_TARGETS_DN
2.22897669706%	44	1974	210	Mendelian_Nancy_Cox	CAIRO_HEPATOBLASTOMA_CLASSES_DN
2.22897669706%	44	1974	202	Mendelian_Nancy_Cox	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
2.22897669706%	44	1974	200	Mendelian_Nancy_Cox	SHEPARD_BMYB_MORPHOLINO_DN
2.22897669706%	44	1974	188	Mendelian_Nancy_Cox	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
2.22563315426%	29	1303	953	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
2.22563315426%	29	1303	540	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ACEVEDO_LIVER_CANCER_DN
2.22412318221%	26	1169	504	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PILON_KLF1_TARGETS_UP
2.22412318221%	26	1169	463	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
2.22412318221%	26	1169	461	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
2.21606648199%	8	361	871	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRADE_COLON_CANCER_UP
2.21606648199%	8	361	830	T2D_GENES_TANYA_T2D_RSQ05_02CM	CUI_TCF21_TARGETS_2_DN
2.21606648199%	8	361	770	T2D_GENES_TANYA_T2D_RSQ05_02CM	KRIEG_HYPOXIA_NOT_VIA_KDM3A
2.21606648199%	8	361	769	T2D_GENES_TANYA_T2D_RSQ05_02CM	NUYTTEN_NIPP1_TARGETS_UP
2.21606648199%	8	361	747	T2D_GENES_TANYA_T2D_RSQ05_02CM	PATIL_LIVER_CANCER
2.21606648199%	8	361	701	T2D_GENES_TANYA_T2D_RSQ05_02CM	SMID_BREAST_CANCER_BASAL_DN
2.21606648199%	8	361	682	T2D_GENES_TANYA_T2D_RSQ05_02CM	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
2.21606648199%	8	361	652	T2D_GENES_TANYA_T2D_RSQ05_02CM	BENPORATH_PRC2_TARGETS
2.21606648199%	8	361	648	T2D_GENES_TANYA_T2D_RSQ05_02CM	SMID_BREAST_CANCER_BASAL_UP
2.21606648199%	8	361	637	T2D_GENES_TANYA_T2D_RSQ05_02CM	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
2.21606648199%	8	361	634	T2D_GENES_TANYA_T2D_RSQ05_02CM	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
2.21606648199%	8	361	567	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHICAS_RB1_TARGETS_CONFLUENT
2.21606648199%	8	361	553	T2D_GENES_TANYA_T2D_RSQ05_02CM	FEVR_CTNNB1_TARGETS_DN
2.21606648199%	8	361	504	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_48HR_DN
2.21606648199%	8	361	493	T2D_GENES_TANYA_T2D_RSQ05_02CM	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
2.21606648199%	8	361	491	T2D_GENES_TANYA_T2D_RSQ05_02CM	SWEET_LUNG_CANCER_KRAS_UP
2.21606648199%	8	361	481	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIU_PROSTATE_CANCER_DN
2.21606648199%	8	361	475	T2D_GENES_TANYA_T2D_RSQ05_02CM	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
2.21606648199%	8	361	448	T2D_GENES_TANYA_T2D_RSQ05_02CM	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
2.21606648199%	8	361	423	T2D_GENES_TANYA_T2D_RSQ05_02CM	PUJANA_BRCA2_PCC_NETWORK
2.21606648199%	8	361	413	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
2.21606648199%	8	361	393	T2D_GENES_TANYA_T2D_RSQ05_02CM	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
2.21606648199%	8	361	390	T2D_GENES_TANYA_T2D_RSQ05_02CM	HATADA_METHYLATED_IN_LUNG_CANCER_UP
2.21606648199%	8	361	373	T2D_GENES_TANYA_T2D_RSQ05_02CM	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
2.21606648199%	8	361	368	T2D_GENES_TANYA_T2D_RSQ05_02CM	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
2.21606648199%	8	361	328	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_PATHWAYS_IN_CANCER
2.21606648199%	8	361	271	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
2.21606648199%	8	361	1210	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHEN_METABOLIC_SYNDROM_NETWORK
2.21606648199%	8	361	1011	T2D_GENES_TANYA_T2D_RSQ05_02CM	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
2.21590909091%	78	3520	918	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JOHNSTONE_PARVB_TARGETS_3_DN
2.21590909091%	78	3520	681	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
2.21402214022%	12	542	673	T2D_GENES_TANYA_ANTHROPOMETRIC	MARTINEZ_RB1_TARGETS_UP
2.21402214022%	12	542	579	T2D_GENES_TANYA_ANTHROPOMETRIC	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
2.21402214022%	12	542	555	T2D_GENES_TANYA_ANTHROPOMETRIC	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
2.21402214022%	12	542	516	T2D_GENES_TANYA_ANTHROPOMETRIC	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
2.21402214022%	12	542	514	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
2.21402214022%	12	542	469	T2D_GENES_TANYA_ANTHROPOMETRIC	MCCABE_BOUND_BY_HOXC6
2.21402214022%	12	542	463	T2D_GENES_TANYA_ANTHROPOMETRIC	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
2.21402214022%	12	542	462	T2D_GENES_TANYA_ANTHROPOMETRIC	DELACROIX_RAR_BOUND_ES
2.21402214022%	12	542	456	T2D_GENES_TANYA_ANTHROPOMETRIC	ODONNELL_TFRC_TARGETS_UP
2.21402214022%	12	542	442	T2D_GENES_TANYA_ANTHROPOMETRIC	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
2.21402214022%	12	542	430	T2D_GENES_TANYA_ANTHROPOMETRIC	VECCHI_GASTRIC_CANCER_EARLY_UP
2.21402214022%	12	542	428	T2D_GENES_TANYA_ANTHROPOMETRIC	LIM_MAMMARY_STEM_CELL_DN
2.21402214022%	12	542	425	T2D_GENES_TANYA_ANTHROPOMETRIC	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
2.21402214022%	12	542	418	T2D_GENES_TANYA_ANTHROPOMETRIC	MULLIGHAN_MLL_SIGNATURE_2_UP
2.21402214022%	12	542	393	T2D_GENES_TANYA_ANTHROPOMETRIC	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
2.21402214022%	12	542	390	T2D_GENES_TANYA_ANTHROPOMETRIC	HATADA_METHYLATED_IN_LUNG_CANCER_UP
2.21402214022%	12	542	380	T2D_GENES_TANYA_ANTHROPOMETRIC	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
2.21402214022%	12	542	379	T2D_GENES_TANYA_ANTHROPOMETRIC	BENPORATH_ES_1
2.21402214022%	12	542	373	T2D_GENES_TANYA_ANTHROPOMETRIC	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
2.21402214022%	12	542	356	T2D_GENES_TANYA_ANTHROPOMETRIC	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
2.21402214022%	12	542	330	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_METABOLISM_OF_RNA
2.21402214022%	12	542	329	T2D_GENES_TANYA_ANTHROPOMETRIC	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
2.21402214022%	12	542	245	T2D_GENES_TANYA_ANTHROPOMETRIC	BLUM_RESPONSE_TO_SALIRASIB_UP
2.21402214022%	12	542	236	T2D_GENES_TANYA_ANTHROPOMETRIC	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
2.21402214022%	12	542	222	T2D_GENES_TANYA_ANTHROPOMETRIC	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
2.21402214022%	12	542	209	T2D_GENES_TANYA_ANTHROPOMETRIC	CHANG_CORE_SERUM_RESPONSE_DN
2.20791168353%	48	2174	553	T2D_GENES_TANYA_LIPIDS	FEVR_CTNNB1_TARGETS_DN
2.20791168353%	48	2174	508	T2D_GENES_TANYA_LIPIDS	ENK_UV_RESPONSE_EPIDERMIS_DN
2.20791168353%	48	2174	448	T2D_GENES_TANYA_LIPIDS	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
2.20791168353%	48	2174	442	T2D_GENES_TANYA_LIPIDS	HAN_SATB1_TARGETS_DN
2.20791168353%	48	2174	422	T2D_GENES_TANYA_LIPIDS	YAGI_AML_WITH_INV_16_TRANSLOCATION
2.20791168353%	48	2174	382	T2D_GENES_TANYA_LIPIDS	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
2.20791168353%	48	2174	378	T2D_GENES_TANYA_LIPIDS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
2.20791168353%	48	2174	368	T2D_GENES_TANYA_LIPIDS	YAGI_AML_WITH_T_8_21_TRANSLOCATION
2.20791168353%	48	2174	318	T2D_GENES_TANYA_LIPIDS	LEI_MYB_TARGETS
2.20646178093%	28	1269	988	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BENPORATH_NANOG_TARGETS
2.20646178093%	28	1269	783	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
2.20646178093%	28	1269	770	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
2.20646178093%	28	1269	718	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_ES_ICP_WITH_H3K4ME3
2.20646178093%	28	1269	682	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
2.20646178093%	28	1269	493	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
2.20646178093%	28	1269	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_MEIOSIS
2.20646178093%	28	1269	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROVERSI_GLIOMA_COPY_NUMBER_UP
2.1978021978%	10	455	770	T2D_GENES_TANYA_BLOODPRESSURE	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
2.1978021978%	10	455	601	T2D_GENES_TANYA_BLOODPRESSURE	MARTINEZ_RB1_AND_TP53_TARGETS_UP
2.1978021978%	10	455	579	T2D_GENES_TANYA_BLOODPRESSURE	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
2.1978021978%	10	455	483	T2D_GENES_TANYA_BLOODPRESSURE	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
2.1978021978%	10	455	467	T2D_GENES_TANYA_BLOODPRESSURE	RATTENBACHER_BOUND_BY_CELF1
2.1978021978%	10	455	431	T2D_GENES_TANYA_BLOODPRESSURE	GARY_CD5_TARGETS_DN
2.1978021978%	10	455	413	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
2.1978021978%	10	455	408	T2D_GENES_TANYA_BLOODPRESSURE	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
2.1978021978%	10	455	406	T2D_GENES_TANYA_BLOODPRESSURE	OSMAN_BLADDER_CANCER_DN
2.1978021978%	10	455	396	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_DEVELOPMENTAL_BIOLOGY
2.1978021978%	10	455	392	T2D_GENES_TANYA_BLOODPRESSURE	LINDGREN_BLADDER_CANCER_CLUSTER_2B
2.1978021978%	10	455	380	T2D_GENES_TANYA_BLOODPRESSURE	MULLIGHAN_MLL_SIGNATURE_1_UP
2.1978021978%	10	455	379	T2D_GENES_TANYA_BLOODPRESSURE	BENPORATH_ES_1
2.1978021978%	10	455	373	T2D_GENES_TANYA_BLOODPRESSURE	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
2.1978021978%	10	455	367	T2D_GENES_TANYA_BLOODPRESSURE	DELACROIX_RARG_BOUND_MEF
2.1978021978%	10	455	328	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_PATHWAYS_IN_CANCER
2.1978021978%	10	455	326	T2D_GENES_TANYA_BLOODPRESSURE	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
2.1978021978%	10	455	324	T2D_GENES_TANYA_BLOODPRESSURE	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
2.1978021978%	10	455	314	T2D_GENES_TANYA_BLOODPRESSURE	DOUGLAS_BMI1_TARGETS_DN
2.1978021978%	10	455	314	T2D_GENES_TANYA_BLOODPRESSURE	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
2.1978021978%	10	455	310	T2D_GENES_TANYA_BLOODPRESSURE	HORIUCHI_WTAP_TARGETS_DN
2.1978021978%	10	455	298	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_14HR_DN
2.1978021978%	10	455	279	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INNATE_IMMUNE_SYSTEM
2.1978021978%	10	455	271	T2D_GENES_TANYA_BLOODPRESSURE	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
2.1978021978%	10	455	269	T2D_GENES_TANYA_BLOODPRESSURE	WANG_CLIM2_TARGETS_UP
2.1978021978%	10	455	253	T2D_GENES_TANYA_BLOODPRESSURE	DANG_REGULATED_BY_MYC_DN
2.1978021978%	10	455	239	T2D_GENES_TANYA_BLOODPRESSURE	ALFANO_MYC_TARGETS
2.1978021978%	10	455	236	T2D_GENES_TANYA_BLOODPRESSURE	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
2.1978021978%	10	455	230	T2D_GENES_TANYA_BLOODPRESSURE	BENPORATH_MYC_TARGETS_WITH_EBOX
2.1978021978%	10	455	217	T2D_GENES_TANYA_BLOODPRESSURE	WIERENGA_STAT5A_TARGETS_UP
2.1978021978%	10	455	213	T2D_GENES_TANYA_BLOODPRESSURE	WIERENGA_STAT5A_TARGETS_DN
2.1978021978%	10	455	210	T2D_GENES_TANYA_BLOODPRESSURE	VERHAAK_GLIOBLASTOMA_NEURAL
2.1978021978%	10	455	206	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
2.1978021978%	10	455	205	T2D_GENES_TANYA_BLOODPRESSURE	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
2.1978021978%	10	455	180	T2D_GENES_TANYA_BLOODPRESSURE	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
2.1978021978%	10	455	120	T2D_GENES_TANYA_BLOODPRESSURE	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN
2.19134152859%	41	1871	86	T2D_GENES_TANYA_HEIGHT	REACTOME_MEIOTIC_RECOMBINATION
2.19134152859%	41	1871	544	T2D_GENES_TANYA_HEIGHT	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
2.19134152859%	41	1871	536	T2D_GENES_TANYA_HEIGHT	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
2.19134152859%	41	1871	491	T2D_GENES_TANYA_HEIGHT	ZHENG_BOUND_BY_FOXP3
2.19134152859%	41	1871	450	T2D_GENES_TANYA_HEIGHT	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
2.19134152859%	41	1871	418	T2D_GENES_TANYA_HEIGHT	PEDRIOLI_MIR31_TARGETS_DN
2.19134152859%	41	1871	418	T2D_GENES_TANYA_HEIGHT	MULLIGHAN_MLL_SIGNATURE_2_UP
2.19134152859%	41	1871	408	T2D_GENES_TANYA_HEIGHT	REACTOME_GPCR_LIGAND_BINDING
2.19134152859%	41	1871	356	T2D_GENES_TANYA_HEIGHT	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
2.1875%	77	3520	848	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NUYTTEN_NIPP1_TARGETS_DN
2.1875%	77	3520	779	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PUJANA_CHEK2_PCC_NETWORK
2.17831813576%	43	1974	270	Mendelian_Nancy_Cox	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
2.17831813576%	43	1974	201	Mendelian_Nancy_Cox	KIM_MYC_AMPLIFICATION_TARGETS_UP
2.17831813576%	43	1974	169	Mendelian_Nancy_Cox	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
2.17831813576%	43	1974	141	Mendelian_Nancy_Cox	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
2.17831813576%	43	1974	128	Mendelian_Nancy_Cox	ZHU_CMV_ALL_DN
2.16191352346%	47	2174	516	T2D_GENES_TANYA_LIPIDS	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
2.16191352346%	47	2174	501	T2D_GENES_TANYA_LIPIDS	SENESE_HDAC3_TARGETS_UP
2.16191352346%	47	2174	485	T2D_GENES_TANYA_LIPIDS	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
2.16191352346%	47	2174	469	T2D_GENES_TANYA_LIPIDS	MCCABE_BOUND_BY_HOXC6
2.16191352346%	47	2174	467	T2D_GENES_TANYA_LIPIDS	RATTENBACHER_BOUND_BY_CELF1
2.16191352346%	47	2174	464	T2D_GENES_TANYA_LIPIDS	ONDER_CDH1_TARGETS_2_DN
2.16191352346%	47	2174	456	T2D_GENES_TANYA_LIPIDS	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
2.16191352346%	47	2174	429	T2D_GENES_TANYA_LIPIDS	MOOTHA_HUMAN_MITODB_6_2002
2.16191352346%	47	2174	393	T2D_GENES_TANYA_LIPIDS	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
2.16191352346%	47	2174	390	T2D_GENES_TANYA_LIPIDS	HATADA_METHYLATED_IN_LUNG_CANCER_UP
2.15909090909%	76	3520	605	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAIRO_HEPATOBLASTOMA_CLASSES_UP
2.14888718342%	28	1303	871	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRADE_COLON_CANCER_UP
2.14888718342%	28	1303	795	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WEI_MYCN_TARGETS_WITH_E_BOX
2.14888718342%	28	1303	783	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ONKEN_UVEAL_MELANOMA_UP
2.14888718342%	28	1303	770	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
2.13857998289%	25	1169	557	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TIEN_INTESTINE_PROBIOTICS_24HR_UP
2.13857998289%	25	1169	423	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PUJANA_BRCA2_PCC_NETWORK
2.13857998289%	25	1169	390	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
2.13857998289%	25	1169	368	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAGI_AML_WITH_T_8_21_TRANSLOCATION
2.13789417424%	40	1871	528	T2D_GENES_TANYA_HEIGHT	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
2.13789417424%	40	1871	517	T2D_GENES_TANYA_HEIGHT	RAO_BOUND_BY_SALL4_ISOFORM_B
2.13789417424%	40	1871	413	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
2.13789417424%	40	1871	409	T2D_GENES_TANYA_HEIGHT	FOSTER_TOLERANT_MACROPHAGE_DN
2.13789417424%	40	1871	367	T2D_GENES_TANYA_HEIGHT	DELACROIX_RARG_BOUND_MEF
2.13789417424%	40	1871	341	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
2.13789417424%	40	1871	293	T2D_GENES_TANYA_HEIGHT	HADDAD_B_LYMPHOCYTE_PROGENITOR
2.13789417424%	40	1871	122	T2D_GENES_TANYA_HEIGHT	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
2.13068181818%	75	3520	882	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_BMP2_TARGETS_DN
2.12765957447%	42	1974	463	Mendelian_Nancy_Cox	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
2.12765957447%	42	1974	341	Mendelian_Nancy_Cox	MULLIGHAN_NPM1_SIGNATURE_3_UP
2.12765957447%	42	1974	324	Mendelian_Nancy_Cox	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
2.12765957447%	42	1974	317	Mendelian_Nancy_Cox	HELLER_HDAC_TARGETS_UP
2.12765957447%	42	1974	309	Mendelian_Nancy_Cox	LIU_SOX4_TARGETS_DN
2.12765957447%	42	1974	281	Mendelian_Nancy_Cox	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
2.12765957447%	42	1974	271	Mendelian_Nancy_Cox	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
2.12765957447%	42	1974	214	Mendelian_Nancy_Cox	AFFAR_YY1_TARGETS_UP
2.12765957447%	42	1974	211	Mendelian_Nancy_Cox	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
2.12765957447%	42	1974	169	Mendelian_Nancy_Cox	KEGG_ALZHEIMERS_DISEASE
2.12765957447%	42	1974	149	Mendelian_Nancy_Cox	LANDIS_ERBB2_BREAST_TUMORS_324_DN
2.12765957447%	42	1974	122	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_PDGF
2.12765957447%	27	1269	918	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JOHNSTONE_PARVB_TARGETS_3_DN
2.12765957447%	27	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_MEIOTIC_RECOMBINATION
2.12765957447%	27	1269	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_AMYLOIDS
2.12765957447%	27	1269	634	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
2.12765957447%	27	1269	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RNA_POL_I_PROMOTER_OPENING
2.12765957447%	27	1269	567	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PARENT_MTOR_SIGNALING_UP
2.12765957447%	27	1269	510	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
2.1207177814%	13	613	73	T2D_GENES_TANYA_BIOMARKER	LIN_MELANOMA_COPY_NUMBER_UP
2.1207177814%	13	613	579	T2D_GENES_TANYA_BIOMARKER	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
2.1207177814%	13	613	567	T2D_GENES_TANYA_BIOMARKER	CHICAS_RB1_TARGETS_CONFLUENT
2.1207177814%	13	613	536	T2D_GENES_TANYA_BIOMARKER	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
2.1207177814%	13	613	528	T2D_GENES_TANYA_BIOMARKER	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
2.1207177814%	13	613	518	T2D_GENES_TANYA_BIOMARKER	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
2.1207177814%	13	613	510	T2D_GENES_TANYA_BIOMARKER	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
2.1207177814%	13	613	485	T2D_GENES_TANYA_BIOMARKER	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
2.1207177814%	13	613	485	T2D_GENES_TANYA_BIOMARKER	ENK_UV_RESPONSE_KERATINOCYTE_DN
2.1207177814%	13	613	481	T2D_GENES_TANYA_BIOMARKER	LIU_PROSTATE_CANCER_DN
2.1207177814%	13	613	429	T2D_GENES_TANYA_BIOMARKER	MOOTHA_HUMAN_MITODB_6_2002
2.1207177814%	13	613	382	T2D_GENES_TANYA_BIOMARKER	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
2.1207177814%	13	613	371	T2D_GENES_TANYA_BIOMARKER	WANG_SMARCE1_TARGETS_DN
2.1207177814%	13	613	317	T2D_GENES_TANYA_BIOMARKER	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
2.1207177814%	13	613	317	T2D_GENES_TANYA_BIOMARKER	BRUINS_UVC_RESPONSE_EARLY_LATE
2.1207177814%	13	613	309	T2D_GENES_TANYA_BIOMARKER	LIU_SOX4_TARGETS_DN
2.1207177814%	13	613	285	T2D_GENES_TANYA_BIOMARKER	GRADE_COLON_AND_RECTAL_CANCER_UP
2.1207177814%	13	613	275	T2D_GENES_TANYA_BIOMARKER	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
2.1207177814%	13	613	274	T2D_GENES_TANYA_BIOMARKER	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
2.1207177814%	13	613	225	T2D_GENES_TANYA_BIOMARKER	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
2.1207177814%	13	613	211	T2D_GENES_TANYA_BIOMARKER	FOSTER_KDM1A_TARGETS_DN
2.1207177814%	13	613	180	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_48HR_UP
2.11800302572%	14	661	584	T2D_GENES_TANYA_GLYCEMIC	HAMAI_APOPTOSIS_VIA_TRAIL_UP
2.11800302572%	14	661	539	T2D_GENES_TANYA_GLYCEMIC	LIAO_METASTASIS
2.11800302572%	14	661	518	T2D_GENES_TANYA_GLYCEMIC	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
2.11800302572%	14	661	478	T2D_GENES_TANYA_GLYCEMIC	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
2.11800302572%	14	661	448	T2D_GENES_TANYA_GLYCEMIC	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
2.11800302572%	14	661	442	T2D_GENES_TANYA_GLYCEMIC	HAN_SATB1_TARGETS_DN
2.11800302572%	14	661	430	T2D_GENES_TANYA_GLYCEMIC	VECCHI_GASTRIC_CANCER_EARLY_UP
2.11800302572%	14	661	425	T2D_GENES_TANYA_GLYCEMIC	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
2.11800302572%	14	661	414	T2D_GENES_TANYA_GLYCEMIC	MOHANKUMAR_TLX1_TARGETS_UP
2.11800302572%	14	661	409	T2D_GENES_TANYA_GLYCEMIC	FOSTER_TOLERANT_MACROPHAGE_DN
2.11800302572%	14	661	387	T2D_GENES_TANYA_GLYCEMIC	CHYLA_CBFA2T3_TARGETS_UP
2.11800302572%	14	661	342	T2D_GENES_TANYA_GLYCEMIC	BLUM_RESPONSE_TO_SALIRASIB_DN
2.11800302572%	14	661	336	T2D_GENES_TANYA_GLYCEMIC	JOHNSTONE_PARVB_TARGETS_2_DN
2.11800302572%	14	661	332	T2D_GENES_TANYA_GLYCEMIC	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
2.11800302572%	14	661	330	T2D_GENES_TANYA_GLYCEMIC	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
2.11800302572%	14	661	283	T2D_GENES_TANYA_GLYCEMIC	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
2.11800302572%	14	661	261	T2D_GENES_TANYA_GLYCEMIC	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
2.11800302572%	14	661	162	T2D_GENES_TANYA_GLYCEMIC	WHITFIELD_CELL_CYCLE_S
2.11591536339%	46	2174	572	T2D_GENES_TANYA_LIPIDS	CHICAS_RB1_TARGETS_SENESCENT
2.11591536339%	46	2174	431	T2D_GENES_TANYA_LIPIDS	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
2.11591536339%	46	2174	380	T2D_GENES_TANYA_LIPIDS	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
2.11591536339%	46	2174	295	T2D_GENES_TANYA_LIPIDS	LU_EZH2_TARGETS_UP
2.11591536339%	46	2174	293	T2D_GENES_TANYA_LIPIDS	ENK_UV_RESPONSE_EPIDERMIS_UP
2.10227272727%	74	3520	830	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CUI_TCF21_TARGETS_2_DN
2.10227272727%	74	3520	770	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KRIEG_HYPOXIA_NOT_VIA_KDM3A
2.10227272727%	74	3520	530	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ENK_UV_RESPONSE_KERATINOCYTE_UP
2.08444681988%	39	1871	89	T2D_GENES_TANYA_HEIGHT	REACTOME_RNA_POL_I_TRANSCRIPTION
2.08444681988%	39	1871	469	T2D_GENES_TANYA_HEIGHT	MCCABE_BOUND_BY_HOXC6
2.08444681988%	39	1871	384	T2D_GENES_TANYA_HEIGHT	BASAKI_YBX1_TARGETS_DN
2.08444681988%	39	1871	380	T2D_GENES_TANYA_HEIGHT	DAIRKEE_TERT_TARGETS_UP
2.08444681988%	39	1871	351	T2D_GENES_TANYA_HEIGHT	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
2.08444681988%	39	1871	284	T2D_GENES_TANYA_HEIGHT	REACTOME_METABOLISM_OF_MRNA
2.07700101317%	41	1974	380	Mendelian_Nancy_Cox	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
2.07700101317%	41	1974	372	Mendelian_Nancy_Cox	WANG_LMO4_TARGETS_UP
2.07700101317%	41	1974	306	Mendelian_Nancy_Cox	HORIUCHI_WTAP_TARGETS_UP
2.07700101317%	41	1974	298	Mendelian_Nancy_Cox	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
2.07700101317%	41	1974	289	Mendelian_Nancy_Cox	GABRIELY_MIR21_TARGETS
2.07700101317%	41	1974	281	Mendelian_Nancy_Cox	BHAT_ESR1_TARGETS_VIA_AKT1_UP
2.07700101317%	41	1974	255	Mendelian_Nancy_Cox	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
2.07700101317%	41	1974	249	Mendelian_Nancy_Cox	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
2.07700101317%	41	1974	246	Mendelian_Nancy_Cox	VERHAAK_AML_WITH_NPM1_MUTATED_DN
2.07700101317%	41	1974	245	Mendelian_Nancy_Cox	MCLACHLAN_DENTAL_CARIES_DN
2.07700101317%	41	1974	222	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_1HR_DN
2.07700101317%	41	1974	163	Mendelian_Nancy_Cox	SERVITJA_ISLET_HNF1A_TARGETS_UP
2.07386363636%	73	3520	493	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
2.07214121259%	27	1303	933	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_IMMUNE_SYSTEM
2.07214121259%	27	1303	893	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GEORGES_TARGETS_OF_MIR192_AND_MIR215
2.07214121259%	27	1303	830	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CUI_TCF21_TARGETS_2_DN
2.07214121259%	27	1303	756	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
2.07214121259%	27	1303	722	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
2.07214121259%	27	1303	712	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHLOSSER_SERUM_RESPONSE_DN
2.07214121259%	27	1303	567	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHICAS_RB1_TARGETS_CONFLUENT
2.07214121259%	27	1303	504	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PILON_KLF1_TARGETS_UP
2.06991720331%	45	2174	482	T2D_GENES_TANYA_LIPIDS	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
2.06991720331%	45	2174	475	T2D_GENES_TANYA_LIPIDS	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
2.06991720331%	45	2174	460	T2D_GENES_TANYA_LIPIDS	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
2.06991720331%	45	2174	431	T2D_GENES_TANYA_LIPIDS	GARY_CD5_TARGETS_DN
2.06991720331%	45	2174	420	T2D_GENES_TANYA_LIPIDS	MOOTHA_PGC
2.06991720331%	45	2174	418	T2D_GENES_TANYA_LIPIDS	RUTELLA_RESPONSE_TO_HGF_UP
2.06991720331%	45	2174	210	T2D_GENES_TANYA_LIPIDS	REACTOME_TRANSCRIPTION
2.05303678358%	24	1169	770	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KRIEG_HYPOXIA_NOT_VIA_KDM3A
2.05303678358%	24	1169	637	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
2.05303678358%	24	1169	539	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
2.05303678358%	24	1169	536	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SENESE_HDAC3_TARGETS_DN
2.05303678358%	24	1169	526	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ONKEN_UVEAL_MELANOMA_DN
2.05303678358%	24	1169	510	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
2.05303678358%	24	1169	466	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_HEMOSTASIS
2.05303678358%	24	1169	443	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DELYS_THYROID_CANCER_UP
2.05303678358%	24	1169	393	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
2.05303678358%	24	1169	351	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAGI_AML_WITH_11Q23_REARRANGED
2.04885736801%	26	1269	781	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GOZGIT_ESR1_TARGETS_DN
2.04885736801%	26	1269	663	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
2.04885736801%	26	1269	526	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ONKEN_UVEAL_MELANOMA_DN
2.04885736801%	26	1269	368	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
2.04885736801%	26	1269	341	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MULLIGHAN_NPM1_SIGNATURE_3_UP
2.04885736801%	26	1269	122	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CHROMOSOME_MAINTENANCE
2.04545454545%	72	3520	567	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PARENT_MTOR_SIGNALING_UP
2.03099946553%	38	1871	83	T2D_GENES_TANYA_HEIGHT	REACTOME_AMYLOIDS
2.03099946553%	38	1871	485	T2D_GENES_TANYA_HEIGHT	ENK_UV_RESPONSE_KERATINOCYTE_DN
2.03099946553%	38	1871	448	T2D_GENES_TANYA_HEIGHT	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
2.03099946553%	38	1871	442	T2D_GENES_TANYA_HEIGHT	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
2.03099946553%	38	1871	424	T2D_GENES_TANYA_HEIGHT	SHEN_SMARCA2_TARGETS_UP
2.03099946553%	38	1871	394	T2D_GENES_TANYA_HEIGHT	BERENJENO_TRANSFORMED_BY_RHOA_DN
2.03099946553%	38	1871	382	T2D_GENES_TANYA_HEIGHT	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
2.03099946553%	38	1871	332	T2D_GENES_TANYA_HEIGHT	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
2.03099946553%	38	1871	267	T2D_GENES_TANYA_HEIGHT	KEGG_MAPK_SIGNALING_PATHWAY
2.0295202952%	11	542	79	T2D_GENES_TANYA_ANTHROPOMETRIC	MEISSNER_NPC_HCP_WITH_H3K27ME3
2.0295202952%	11	542	564	T2D_GENES_TANYA_ANTHROPOMETRIC	SMID_BREAST_CANCER_LUMINAL_B_DN
2.0295202952%	11	542	539	T2D_GENES_TANYA_ANTHROPOMETRIC	LIAO_METASTASIS
2.0295202952%	11	542	532	T2D_GENES_TANYA_ANTHROPOMETRIC	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
2.0295202952%	11	542	518	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_METABOLISM_OF_PROTEINS
2.0295202952%	11	542	476	T2D_GENES_TANYA_ANTHROPOMETRIC	SMID_BREAST_CANCER_NORMAL_LIKE_UP
2.0295202952%	11	542	475	T2D_GENES_TANYA_ANTHROPOMETRIC	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
2.0295202952%	11	542	467	T2D_GENES_TANYA_ANTHROPOMETRIC	RATTENBACHER_BOUND_BY_CELF1
2.0295202952%	11	542	464	T2D_GENES_TANYA_ANTHROPOMETRIC	ONDER_CDH1_TARGETS_2_DN
2.0295202952%	11	542	460	T2D_GENES_TANYA_ANTHROPOMETRIC	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
2.0295202952%	11	542	457	T2D_GENES_TANYA_ANTHROPOMETRIC	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
2.0295202952%	11	542	413	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
2.0295202952%	11	542	404	T2D_GENES_TANYA_ANTHROPOMETRIC	OSMAN_BLADDER_CANCER_UP
2.0295202952%	11	542	391	T2D_GENES_TANYA_ANTHROPOMETRIC	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
2.0295202952%	11	542	357	T2D_GENES_TANYA_ANTHROPOMETRIC	SHEN_SMARCA2_TARGETS_DN
2.0295202952%	11	542	335	T2D_GENES_TANYA_ANTHROPOMETRIC	WONG_EMBRYONIC_STEM_CELL_CORE
2.0295202952%	11	542	332	T2D_GENES_TANYA_ANTHROPOMETRIC	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
2.0295202952%	11	542	318	T2D_GENES_TANYA_ANTHROPOMETRIC	LEI_MYB_TARGETS
2.0295202952%	11	542	299	T2D_GENES_TANYA_ANTHROPOMETRIC	MUELLER_PLURINET
2.0295202952%	11	542	298	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_14HR_DN
2.0295202952%	11	542	293	T2D_GENES_TANYA_ANTHROPOMETRIC	ENK_UV_RESPONSE_EPIDERMIS_UP
2.0295202952%	11	542	275	T2D_GENES_TANYA_ANTHROPOMETRIC	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
2.0295202952%	11	542	266	T2D_GENES_TANYA_ANTHROPOMETRIC	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
2.0295202952%	11	542	259	T2D_GENES_TANYA_ANTHROPOMETRIC	QI_PLASMACYTOMA_UP
2.0295202952%	11	542	172	T2D_GENES_TANYA_ANTHROPOMETRIC	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
2.0295202952%	11	542	126	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
2.02634245187%	40	1974	459	Mendelian_Nancy_Cox	KIM_WT1_TARGETS_DN
2.02634245187%	40	1974	270	Mendelian_Nancy_Cox	RIZKI_TUMOR_INVASIVENESS_3D_DN
2.02634245187%	40	1974	268	Mendelian_Nancy_Cox	XU_GH1_AUTOCRINE_TARGETS_UP
2.02634245187%	40	1974	264	Mendelian_Nancy_Cox	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
2.02634245187%	40	1974	261	Mendelian_Nancy_Cox	RICKMAN_METASTASIS_DN
2.02634245187%	40	1974	244	Mendelian_Nancy_Cox	GAL_LEUKEMIC_STEM_CELL_DN
2.02634245187%	40	1974	207	Mendelian_Nancy_Cox	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
2.02634245187%	40	1974	206	Mendelian_Nancy_Cox	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
2.02634245187%	40	1974	184	Mendelian_Nancy_Cox	WU_CELL_MIGRATION
2.02634245187%	40	1974	165	Mendelian_Nancy_Cox	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
2.02391904324%	44	2174	435	T2D_GENES_TANYA_LIPIDS	SWEET_LUNG_CANCER_KRAS_DN
2.02391904324%	44	2174	397	T2D_GENES_TANYA_LIPIDS	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
2.02391904324%	44	2174	396	T2D_GENES_TANYA_LIPIDS	REACTOME_DEVELOPMENTAL_BIOLOGY
2.02391904324%	44	2174	367	T2D_GENES_TANYA_LIPIDS	DELACROIX_RARG_BOUND_MEF
2.02391904324%	44	2174	244	T2D_GENES_TANYA_LIPIDS	HSIAO_LIVER_SPECIFIC_GENES
2.02391904324%	44	2174	222	T2D_GENES_TANYA_LIPIDS	CAIRO_LIVER_DEVELOPMENT_DN
2.01793721973%	9	446	855	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
2.01793721973%	9	446	824	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
2.01793721973%	9	446	795	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WEI_MYCN_TARGETS_WITH_E_BOX
2.01793721973%	9	446	783	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
2.01793721973%	9	446	770	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN
2.01793721973%	9	446	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TELOMERE_MAINTENANCE
2.01793721973%	9	446	712	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCHLOSSER_SERUM_RESPONSE_DN
2.01793721973%	9	446	682	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FEVR_CTNNB1_TARGETS_UP
2.01793721973%	9	446	634	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
2.01793721973%	9	446	557	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TIEN_INTESTINE_PROBIOTICS_24HR_UP
2.01793721973%	9	446	540	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ACEVEDO_LIVER_CANCER_DN
2.01793721973%	9	446	535	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	STEIN_ESRRA_TARGETS
2.01793721973%	9	446	501	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SENESE_HDAC3_TARGETS_UP
2.01793721973%	9	446	457	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SENESE_HDAC1_TARGETS_UP
2.01793721973%	9	446	456	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
2.01793721973%	9	446	443	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DELYS_THYROID_CANCER_UP
2.01793721973%	9	446	442	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
2.01793721973%	9	446	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LASTOWSKA_COAMPLIFIED_WITH_MYCN
2.01793721973%	9	446	429	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MOOTHA_HUMAN_MITODB_6_2002
2.01793721973%	9	446	414	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MOHANKUMAR_TLX1_TARGETS_UP
2.01793721973%	9	446	393	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
2.01793721973%	9	446	390	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
2.01793721973%	9	446	293	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHANG_TLX_TARGETS_60HR_UP
2.01793721973%	9	446	122	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CHROMOSOME_MAINTENANCE
2.01704545455%	71	3520	425	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOCHKIS_FOXA2_TARGETS
1.99539524175%	26	1303	745	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_BMP2_TARGETS_UP
1.99539524175%	26	1303	682	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
1.99539524175%	26	1303	633	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
1.99539524175%	26	1303	553	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FEVR_CTNNB1_TARGETS_DN
1.99539524175%	26	1303	549	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
1.98863636364%	70	3520	701	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMID_BREAST_CANCER_BASAL_DN
1.98863636364%	70	3520	663	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
1.98863636364%	70	3520	648	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BENPORATH_CYCLING_GENES
1.97802197802%	9	455	857	T2D_GENES_TANYA_BLOODPRESSURE	MARTENS_TRETINOIN_RESPONSE_UP
1.97802197802%	9	455	602	T2D_GENES_TANYA_BLOODPRESSURE	MARTINEZ_TP53_TARGETS_UP
1.97802197802%	9	455	536	T2D_GENES_TANYA_BLOODPRESSURE	BERENJENO_TRANSFORMED_BY_RHOA_UP
1.97802197802%	9	455	532	T2D_GENES_TANYA_BLOODPRESSURE	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
1.97802197802%	9	455	504	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_48HR_DN
1.97802197802%	9	455	491	T2D_GENES_TANYA_BLOODPRESSURE	ZHENG_BOUND_BY_FOXP3
1.97802197802%	9	455	489	T2D_GENES_TANYA_BLOODPRESSURE	LIM_MAMMARY_STEM_CELL_UP
1.97802197802%	9	455	464	T2D_GENES_TANYA_BLOODPRESSURE	ONDER_CDH1_TARGETS_2_DN
1.97802197802%	9	455	463	T2D_GENES_TANYA_BLOODPRESSURE	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
1.97802197802%	9	455	442	T2D_GENES_TANYA_BLOODPRESSURE	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
1.97802197802%	9	455	429	T2D_GENES_TANYA_BLOODPRESSURE	MOOTHA_HUMAN_MITODB_6_2002
1.97802197802%	9	455	428	T2D_GENES_TANYA_BLOODPRESSURE	LIM_MAMMARY_STEM_CELL_DN
1.97802197802%	9	455	391	T2D_GENES_TANYA_BLOODPRESSURE	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
1.97802197802%	9	455	390	T2D_GENES_TANYA_BLOODPRESSURE	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
1.97802197802%	9	455	358	T2D_GENES_TANYA_BLOODPRESSURE	GRUETZMANN_PANCREATIC_CANCER_UP
1.97802197802%	9	455	309	T2D_GENES_TANYA_BLOODPRESSURE	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
1.97802197802%	9	455	299	T2D_GENES_TANYA_BLOODPRESSURE	MUELLER_PLURINET
1.97802197802%	9	455	288	T2D_GENES_TANYA_BLOODPRESSURE	POOLA_INVASIVE_BREAST_CANCER_UP
1.97802197802%	9	455	268	T2D_GENES_TANYA_BLOODPRESSURE	XU_GH1_AUTOCRINE_TARGETS_UP
1.97802197802%	9	455	262	T2D_GENES_TANYA_BLOODPRESSURE	LU_AGING_BRAIN_UP
1.97802197802%	9	455	259	T2D_GENES_TANYA_BLOODPRESSURE	QI_PLASMACYTOMA_UP
1.97802197802%	9	455	259	T2D_GENES_TANYA_BLOODPRESSURE	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
1.97802197802%	9	455	250	T2D_GENES_TANYA_BLOODPRESSURE	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
1.97802197802%	9	455	244	T2D_GENES_TANYA_BLOODPRESSURE	PLASARI_TGFB1_TARGETS_10HR_DN
1.97802197802%	9	455	240	T2D_GENES_TANYA_BLOODPRESSURE	UDAYAKUMAR_MED1_TARGETS_DN
1.97802197802%	9	455	232	T2D_GENES_TANYA_BLOODPRESSURE	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
1.97802197802%	9	455	229	T2D_GENES_TANYA_BLOODPRESSURE	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
1.97802197802%	9	455	215	T2D_GENES_TANYA_BLOODPRESSURE	MARKEY_RB1_ACUTE_LOF_UP
1.97802197802%	9	455	210	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
1.97802197802%	9	455	183	T2D_GENES_TANYA_BLOODPRESSURE	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
1.97802197802%	9	455	174	T2D_GENES_TANYA_BLOODPRESSURE	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
1.97802197802%	9	455	162	T2D_GENES_TANYA_BLOODPRESSURE	WHITFIELD_CELL_CYCLE_S
1.97802197802%	9	455	148	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_APOPTOSIS
1.97792088316%	43	2174	633	T2D_GENES_TANYA_LIPIDS	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
1.97792088316%	43	2174	456	T2D_GENES_TANYA_LIPIDS	ODONNELL_TFRC_TARGETS_UP
1.97792088316%	43	2174	430	T2D_GENES_TANYA_LIPIDS	RIGGI_EWING_SARCOMA_PROGENITOR_UP
1.97792088316%	43	2174	411	T2D_GENES_TANYA_LIPIDS	KOYAMA_SEMA3B_TARGETS_DN
1.97792088316%	43	2174	405	T2D_GENES_TANYA_LIPIDS	KUMAR_TARGETS_OF_MLL_AF9_FUSION
1.97792088316%	43	2174	395	T2D_GENES_TANYA_LIPIDS	HAN_SATB1_TARGETS_UP
1.97792088316%	43	2174	346	T2D_GENES_TANYA_LIPIDS	GOLDRATH_ANTIGEN_RESPONSE
1.97792088316%	43	2174	337	T2D_GENES_TANYA_LIPIDS	PENG_GLUTAMINE_DEPRIVATION_DN
1.97792088316%	43	2174	274	T2D_GENES_TANYA_LIPIDS	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
1.97755211117%	37	1871	462	T2D_GENES_TANYA_HEIGHT	DELACROIX_RAR_BOUND_ES
1.97755211117%	37	1871	442	T2D_GENES_TANYA_HEIGHT	HAN_SATB1_TARGETS_DN
1.97755211117%	37	1871	420	T2D_GENES_TANYA_HEIGHT	MOOTHA_PGC
1.97755211117%	37	1871	411	T2D_GENES_TANYA_HEIGHT	KOYAMA_SEMA3B_TARGETS_DN
1.97755211117%	37	1871	408	T2D_GENES_TANYA_HEIGHT	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
1.97755211117%	37	1871	404	T2D_GENES_TANYA_HEIGHT	OSMAN_BLADDER_CANCER_UP
1.97755211117%	37	1871	374	T2D_GENES_TANYA_HEIGHT	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
1.97755211117%	37	1871	366	T2D_GENES_TANYA_HEIGHT	YOSHIMURA_MAPK8_TARGETS_DN
1.97755211117%	37	1871	337	T2D_GENES_TANYA_HEIGHT	PENG_GLUTAMINE_DEPRIVATION_DN
1.97755211117%	37	1871	309	T2D_GENES_TANYA_HEIGHT	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
1.97755211117%	37	1871	282	T2D_GENES_TANYA_HEIGHT	HELLER_SILENCED_BY_METHYLATION_UP
1.97628458498%	5	253	98	Diabetes_McGill_CREBBP_coTF	PYEON_HPV_POSITIVE_TUMORS_UP
1.97628458498%	5	253	98	Diabetes_McGill_CREBBP_coTF	MENSE_HYPOXIA_UP
1.97628458498%	5	253	98	Diabetes_McGill_CREBBP_coTF	GUO_TARGETS_OF_IRS1_AND_IRS2
1.97628458498%	5	253	92	Diabetes_McGill_CREBBP_coTF	BURTON_ADIPOGENESIS_9
1.97628458498%	5	253	91	Diabetes_McGill_CREBBP_coTF	ZHU_CMV_24_HR_DN
1.97628458498%	5	253	90	Diabetes_McGill_CREBBP_coTF	BILANGES_SERUM_SENSITIVE_GENES
1.97628458498%	5	253	89	Diabetes_McGill_CREBBP_coTF	SWEET_KRAS_ONCOGENIC_SIGNATURE
1.97628458498%	5	253	89	Diabetes_McGill_CREBBP_coTF	REACTOME_RNA_POL_I_TRANSCRIPTION
1.97628458498%	5	253	88	Diabetes_McGill_CREBBP_coTF	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
1.97628458498%	5	253	88	Diabetes_McGill_CREBBP_coTF	KEGG_APOPTOSIS
1.97628458498%	5	253	88	Diabetes_McGill_CREBBP_coTF	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
1.97628458498%	5	253	85	Diabetes_McGill_CREBBP_coTF	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
1.97628458498%	5	253	81	Diabetes_McGill_CREBBP_coTF	HARRIS_HYPOXIA
1.97628458498%	5	253	8	Diabetes_McGill_CREBBP_coTF	TURJANSKI_MAPK8_AND_MAPK9_TARGETS
1.97628458498%	5	253	79	Diabetes_McGill_CREBBP_coTF	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
1.97628458498%	5	253	78	Diabetes_McGill_CREBBP_coTF	RADMACHER_AML_PROGNOSIS
1.97628458498%	5	253	78	Diabetes_McGill_CREBBP_coTF	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
1.97628458498%	5	253	77	Diabetes_McGill_CREBBP_coTF	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
1.97628458498%	5	253	77	Diabetes_McGill_CREBBP_coTF	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
1.97628458498%	5	253	77	Diabetes_McGill_CREBBP_coTF	GROSS_HYPOXIA_VIA_HIF1A_UP
1.97628458498%	5	253	75	Diabetes_McGill_CREBBP_coTF	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
1.97628458498%	5	253	74	Diabetes_McGill_CREBBP_coTF	URS_ADIPOCYTE_DIFFERENTIATION_UP
1.97628458498%	5	253	72	Diabetes_McGill_CREBBP_coTF	KEGG_LEISHMANIA_INFECTION
1.97628458498%	5	253	718	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_ES_ICP_WITH_H3K4ME3
1.97628458498%	5	253	71	Diabetes_McGill_CREBBP_coTF	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
1.97628458498%	5	253	71	Diabetes_McGill_CREBBP_coTF	GEORGANTAS_HSC_MARKERS
1.97628458498%	5	253	70	Diabetes_McGill_CREBBP_coTF	KEGG_RENAL_CELL_CARCINOMA
1.97628458498%	5	253	69	Diabetes_McGill_CREBBP_coTF	PID_P75NTRPATHWAY
1.97628458498%	5	253	66	Diabetes_McGill_CREBBP_coTF	NAKAMURA_ADIPOGENESIS_EARLY_UP
1.97628458498%	5	253	65	Diabetes_McGill_CREBBP_coTF	KEGG_GLIOMA
1.97628458498%	5	253	64	Diabetes_McGill_CREBBP_coTF	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
1.97628458498%	5	253	63	Diabetes_McGill_CREBBP_coTF	PHONG_TNF_TARGETS_UP
1.97628458498%	5	253	63	Diabetes_McGill_CREBBP_coTF	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
1.97628458498%	5	253	62	Diabetes_McGill_CREBBP_coTF	GEORGES_CELL_CYCLE_MIR192_TARGETS
1.97628458498%	5	253	60	Diabetes_McGill_CREBBP_coTF	SONG_TARGETS_OF_IE86_CMV_PROTEIN
1.97628458498%	5	253	58	Diabetes_McGill_CREBBP_coTF	WAKASUGI_HAVE_ZNF143_BINDING_SITES
1.97628458498%	5	253	58	Diabetes_McGill_CREBBP_coTF	BIOCARTA_HIVNEF_PATHWAY
1.97628458498%	5	253	546	Diabetes_McGill_CREBBP_coTF	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
1.97628458498%	5	253	54	Diabetes_McGill_CREBBP_coTF	ZHOU_TNF_SIGNALING_30MIN
1.97628458498%	5	253	54	Diabetes_McGill_CREBBP_coTF	REACTOME_TCR_SIGNALING
1.97628458498%	5	253	54	Diabetes_McGill_CREBBP_coTF	PID_RAC1_PATHWAY
1.97628458498%	5	253	54	Diabetes_McGill_CREBBP_coTF	KEGG_NON_SMALL_CELL_LUNG_CANCER
1.97628458498%	5	253	53	Diabetes_McGill_CREBBP_coTF	ZHU_CMV_8_HR_DN
1.97628458498%	5	253	52	Diabetes_McGill_CREBBP_coTF	PID_PTP1BPATHWAY
1.97628458498%	5	253	52	Diabetes_McGill_CREBBP_coTF	KEGG_ENDOMETRIAL_CANCER
1.97628458498%	5	253	51	Diabetes_McGill_CREBBP_coTF	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
1.97628458498%	5	253	51	Diabetes_McGill_CREBBP_coTF	BYSTROEM_CORRELATED_WITH_IL5_UP
1.97628458498%	5	253	49	Diabetes_McGill_CREBBP_coTF	GERHOLD_ADIPOGENESIS_UP
1.97628458498%	5	253	489	Diabetes_McGill_CREBBP_coTF	LIM_MAMMARY_STEM_CELL_UP
1.97628458498%	5	253	48	Diabetes_McGill_CREBBP_coTF	RASHI_RESPONSE_TO_IONIZING_RADIATION_3
1.97628458498%	5	253	47	Diabetes_McGill_CREBBP_coTF	ZHU_CMV_8_HR_UP
1.97628458498%	5	253	47	Diabetes_McGill_CREBBP_coTF	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
1.97628458498%	5	253	47	Diabetes_McGill_CREBBP_coTF	KHETCHOUMIAN_TRIM24_TARGETS_UP
1.97628458498%	5	253	469	Diabetes_McGill_CREBBP_coTF	MCCABE_BOUND_BY_HOXC6
1.97628458498%	5	253	46	Diabetes_McGill_CREBBP_coTF	PID_TNFPATHWAY
1.97628458498%	5	253	448	Diabetes_McGill_CREBBP_coTF	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
1.97628458498%	5	253	44	Diabetes_McGill_CREBBP_coTF	WHITFIELD_CELL_CYCLE_LITERATURE
1.97628458498%	5	253	41	Diabetes_McGill_CREBBP_coTF	BIOCARTA_FCER1_PATHWAY
1.97628458498%	5	253	390	Diabetes_McGill_CREBBP_coTF	HATADA_METHYLATED_IN_LUNG_CANCER_UP
1.97628458498%	5	253	39	Diabetes_McGill_CREBBP_coTF	GENTILE_UV_RESPONSE_CLUSTER_D5
1.97628458498%	5	253	380	Diabetes_McGill_CREBBP_coTF	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
1.97628458498%	5	253	37	Diabetes_McGill_CREBBP_coTF	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
1.97628458498%	5	253	37	Diabetes_McGill_CREBBP_coTF	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
1.97628458498%	5	253	37	Diabetes_McGill_CREBBP_coTF	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS
1.97628458498%	5	253	37	Diabetes_McGill_CREBBP_coTF	PID_IL23PATHWAY
1.97628458498%	5	253	37	Diabetes_McGill_CREBBP_coTF	BIOCARTA_BCR_PATHWAY
1.97628458498%	5	253	367	Diabetes_McGill_CREBBP_coTF	VECCHI_GASTRIC_CANCER_EARLY_DN
1.97628458498%	5	253	367	Diabetes_McGill_CREBBP_coTF	DELACROIX_RARG_BOUND_MEF
1.97628458498%	5	253	36	Diabetes_McGill_CREBBP_coTF	SUBTIL_PROGESTIN_TARGETS
1.97628458498%	5	253	355	Diabetes_McGill_CREBBP_coTF	PEREZ_TP63_TARGETS
1.97628458498%	5	253	35	Diabetes_McGill_CREBBP_coTF	PID_PI3KCIAKTPATHWAY
1.97628458498%	5	253	34	Diabetes_McGill_CREBBP_coTF	PID_IL1PATHWAY
1.97628458498%	5	253	34	Diabetes_McGill_CREBBP_coTF	PID_HIF2PATHWAY
1.97628458498%	5	253	34	Diabetes_McGill_CREBBP_coTF	PID_ATM_PATHWAY
1.97628458498%	5	253	33	Diabetes_McGill_CREBBP_coTF	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS
1.97628458498%	5	253	33	Diabetes_McGill_CREBBP_coTF	PID_IL12_STAT4PATHWAY
1.97628458498%	5	253	32	Diabetes_McGill_CREBBP_coTF	AMIT_SERUM_RESPONSE_40_MCF10A
1.97628458498%	5	253	308	Diabetes_McGill_CREBBP_coTF	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
1.97628458498%	5	253	296	Diabetes_McGill_CREBBP_coTF	DURAND_STROMA_MAX_UP
1.97628458498%	5	253	295	Diabetes_McGill_CREBBP_coTF	LU_EZH2_TARGETS_UP
1.97628458498%	5	253	289	Diabetes_McGill_CREBBP_coTF	MANALO_HYPOXIA_DN
1.97628458498%	5	253	283	Diabetes_McGill_CREBBP_coTF	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
1.97628458498%	5	253	28	Diabetes_McGill_CREBBP_coTF	VALK_AML_CLUSTER_1
1.97628458498%	5	253	28	Diabetes_McGill_CREBBP_coTF	REACTOME_MYOGENESIS
1.97628458498%	5	253	28	Diabetes_McGill_CREBBP_coTF	BIOCARTA_GH_PATHWAY
1.97628458498%	5	253	28	Diabetes_McGill_CREBBP_coTF	BIOCARTA_ERK_PATHWAY
1.97628458498%	5	253	277	Diabetes_McGill_CREBBP_coTF	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
1.97628458498%	5	253	271	Diabetes_McGill_CREBBP_coTF	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
1.97628458498%	5	253	270	Diabetes_McGill_CREBBP_coTF	RIZKI_TUMOR_INVASIVENESS_3D_DN
1.97628458498%	5	253	27	Diabetes_McGill_CREBBP_coTF	REACTOME_RECYCLING_PATHWAY_OF_L1
1.97628458498%	5	253	269	Diabetes_McGill_CREBBP_coTF	WANG_CLIM2_TARGETS_UP
1.97628458498%	5	253	268	Diabetes_McGill_CREBBP_coTF	XU_GH1_AUTOCRINE_TARGETS_UP
1.97628458498%	5	253	265	Diabetes_McGill_CREBBP_coTF	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
1.97628458498%	5	253	26	Diabetes_McGill_CREBBP_coTF	PID_IL27PATHWAY
1.97628458498%	5	253	258	Diabetes_McGill_CREBBP_coTF	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
1.97628458498%	5	253	252	Diabetes_McGill_CREBBP_coTF	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
1.97628458498%	5	253	25	Diabetes_McGill_CREBBP_coTF	REACTOME_G0_AND_EARLY_G1
1.97628458498%	5	253	240	Diabetes_McGill_CREBBP_coTF	VANTVEER_BREAST_CANCER_ESR1_DN
1.97628458498%	5	253	238	Diabetes_McGill_CREBBP_coTF	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
1.97628458498%	5	253	232	Diabetes_McGill_CREBBP_coTF	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
1.97628458498%	5	253	23	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CTCF_PATHWAY
1.97628458498%	5	253	229	Diabetes_McGill_CREBBP_coTF	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
1.97628458498%	5	253	227	Diabetes_McGill_CREBBP_coTF	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
1.97628458498%	5	253	221	Diabetes_McGill_CREBBP_coTF	ZHANG_TLX_TARGETS_36HR_UP
1.97628458498%	5	253	22	Diabetes_McGill_CREBBP_coTF	MATZUK_IMPLANTATION_AND_UTERINE
1.97628458498%	5	253	22	Diabetes_McGill_CREBBP_coTF	BIOCARTA_IL2_PATHWAY
1.97628458498%	5	253	212	Diabetes_McGill_CREBBP_coTF	CHANG_CORE_SERUM_RESPONSE_UP
1.97628458498%	5	253	211	Diabetes_McGill_CREBBP_coTF	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
1.97628458498%	5	253	210	Diabetes_McGill_CREBBP_coTF	VERHAAK_GLIOBLASTOMA_NEURAL
1.97628458498%	5	253	210	Diabetes_McGill_CREBBP_coTF	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
1.97628458498%	5	253	21	Diabetes_McGill_CREBBP_coTF	REACTOME_ERK_MAPK_TARGETS
1.97628458498%	5	253	21	Diabetes_McGill_CREBBP_coTF	PID_P38_MK2PATHWAY
1.97628458498%	5	253	207	Diabetes_McGill_CREBBP_coTF	KARLSSON_TGFB1_TARGETS_DN
1.97628458498%	5	253	207	Diabetes_McGill_CREBBP_coTF	CAIRO_HEPATOBLASTOMA_UP
1.97628458498%	5	253	206	Diabetes_McGill_CREBBP_coTF	LINSLEY_MIR16_TARGETS
1.97628458498%	5	253	205	Diabetes_McGill_CREBBP_coTF	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
1.97628458498%	5	253	205	Diabetes_McGill_CREBBP_coTF	PEREZ_TP53_AND_TP63_TARGETS
1.97628458498%	5	253	203	Diabetes_McGill_CREBBP_coTF	PAL_PRMT5_TARGETS_UP
1.97628458498%	5	253	20	Diabetes_McGill_CREBBP_coTF	WANG_THOC1_TARGETS_DN
1.97628458498%	5	253	20	Diabetes_McGill_CREBBP_coTF	MANN_RESPONSE_TO_AMIFOSTINE_UP
1.97628458498%	5	253	20	Diabetes_McGill_CREBBP_coTF	COLLIS_PRKDC_SUBSTRATES
1.97628458498%	5	253	198	Diabetes_McGill_CREBBP_coTF	ALONSO_METASTASIS_UP
1.97628458498%	5	253	193	Diabetes_McGill_CREBBP_coTF	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
1.97628458498%	5	253	192	Diabetes_McGill_CREBBP_coTF	REACTOME_DNA_REPLICATION
1.97628458498%	5	253	191	Diabetes_McGill_CREBBP_coTF	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
1.97628458498%	5	253	19	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS
1.97628458498%	5	253	19	Diabetes_McGill_CREBBP_coTF	BIOCARTA_TGFB_PATHWAY
1.97628458498%	5	253	19	Diabetes_McGill_CREBBP_coTF	BIOCARTA_EPO_PATHWAY
1.97628458498%	5	253	188	Diabetes_McGill_CREBBP_coTF	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
1.97628458498%	5	253	187	Diabetes_McGill_CREBBP_coTF	PENG_LEUCINE_DEPRIVATION_DN
1.97628458498%	5	253	185	Diabetes_McGill_CREBBP_coTF	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
1.97628458498%	5	253	181	Diabetes_McGill_CREBBP_coTF	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
1.97628458498%	5	253	18	Diabetes_McGill_CREBBP_coTF	BIOCARTA_ETS_PATHWAY
1.97628458498%	5	253	173	Diabetes_McGill_CREBBP_coTF	SENGUPTA_EBNA1_ANTICORRELATED
1.97628458498%	5	253	171	Diabetes_McGill_CREBBP_coTF	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
1.97628458498%	5	253	17	Diabetes_McGill_CREBBP_coTF	BIOCARTA_PML_PATHWAY
1.97628458498%	5	253	17	Diabetes_McGill_CREBBP_coTF	BIOCARTA_IL7_PATHWAY
1.97628458498%	5	253	17	Diabetes_McGill_CREBBP_coTF	BIOCARTA_41BB_PATHWAY
1.97628458498%	5	253	169	Diabetes_McGill_CREBBP_coTF	UEDA_PERIFERAL_CLOCK
1.97628458498%	5	253	169	Diabetes_McGill_CREBBP_coTF	KATSANOU_ELAVL1_TARGETS_UP
1.97628458498%	5	253	166	Diabetes_McGill_CREBBP_coTF	CAIRO_LIVER_DEVELOPMENT_UP
1.97628458498%	5	253	164	Diabetes_McGill_CREBBP_coTF	AMIT_EGF_RESPONSE_480_HELA
1.97628458498%	5	253	163	Diabetes_McGill_CREBBP_coTF	SERVITJA_ISLET_HNF1A_TARGETS_UP
1.97628458498%	5	253	162	Diabetes_McGill_CREBBP_coTF	WHITFIELD_CELL_CYCLE_S
1.97628458498%	5	253	16	Diabetes_McGill_CREBBP_coTF	FUKUSHIMA_TNFSF11_TARGETS
1.97628458498%	5	253	159	Diabetes_McGill_CREBBP_coTF	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
1.97628458498%	5	253	156	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_14HR_UP
1.97628458498%	5	253	153	Diabetes_McGill_CREBBP_coTF	LU_AGING_BRAIN_DN
1.97628458498%	5	253	15	Diabetes_McGill_CREBBP_coTF	PID_ERB_GENOMIC_PATHWAY
1.97628458498%	5	253	15	Diabetes_McGill_CREBBP_coTF	BIOCARTA_PITX2_PATHWAY
1.97628458498%	5	253	149	Diabetes_McGill_CREBBP_coTF	NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON
1.97628458498%	5	253	149	Diabetes_McGill_CREBBP_coTF	GOZGIT_ESR1_TARGETS_UP
1.97628458498%	5	253	148	Diabetes_McGill_CREBBP_coTF	WHITFIELD_CELL_CYCLE_M_G1
1.97628458498%	5	253	147	Diabetes_McGill_CREBBP_coTF	BENPORATH_PROLIFERATION
1.97628458498%	5	253	146	Diabetes_McGill_CREBBP_coTF	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
1.97628458498%	5	253	145	Diabetes_McGill_CREBBP_coTF	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
1.97628458498%	5	253	142	Diabetes_McGill_CREBBP_coTF	PENG_LEUCINE_DEPRIVATION_UP
1.97628458498%	5	253	142	Diabetes_McGill_CREBBP_coTF	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
1.97628458498%	5	253	14	Diabetes_McGill_CREBBP_coTF	ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS
1.97628458498%	5	253	14	Diabetes_McGill_CREBBP_coTF	GILMORE_CORE_NFKB_PATHWAY
1.97628458498%	5	253	14	Diabetes_McGill_CREBBP_coTF	BIOCARTA_DREAM_PATHWAY
1.97628458498%	5	253	134	Diabetes_McGill_CREBBP_coTF	CHUNG_BLISTER_CYTOTOXICITY_UP
1.97628458498%	5	253	133	Diabetes_McGill_CREBBP_coTF	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON
1.97628458498%	5	253	130	Diabetes_McGill_CREBBP_coTF	YAGI_AML_WITH_T_9_11_TRANSLOCATION
1.97628458498%	5	253	13	Diabetes_McGill_CREBBP_coTF	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
1.97628458498%	5	253	128	Diabetes_McGill_CREBBP_coTF	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
1.97628458498%	5	253	125	Diabetes_McGill_CREBBP_coTF	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
1.97628458498%	5	253	124	Diabetes_McGill_CREBBP_coTF	REACTOME_CELL_CYCLE_CHECKPOINTS
1.97628458498%	5	253	122	Diabetes_McGill_CREBBP_coTF	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
1.97628458498%	5	253	122	Diabetes_McGill_CREBBP_coTF	REACTOME_CHROMOSOME_MAINTENANCE
1.97628458498%	5	253	116	Diabetes_McGill_CREBBP_coTF	LIM_MAMMARY_LUMINAL_MATURE_UP
1.97628458498%	5	253	114	Diabetes_McGill_CREBBP_coTF	KEGG_OOCYTE_MEIOSIS
1.97628458498%	5	253	112	Diabetes_McGill_CREBBP_coTF	REACTOME_G1_S_TRANSITION
1.97628458498%	5	253	11	Diabetes_McGill_CREBBP_coTF	ZHOU_PANCREATIC_EXOCRINE_PROGENITOR
1.97628458498%	5	253	109	Diabetes_McGill_CREBBP_coTF	REACTOME_S_PHASE
1.97628458498%	5	253	104	Diabetes_McGill_CREBBP_coTF	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
1.97628458498%	5	253	102	Diabetes_McGill_CREBBP_coTF	KEGG_MELANOGENESIS
1.97628458498%	5	253	101	Diabetes_McGill_CREBBP_coTF	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
1.97628458498%	5	253	101	Diabetes_McGill_CREBBP_coTF	BURTON_ADIPOGENESIS_3
1.97568389058%	39	1974	85	Mendelian_Nancy_Cox	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
1.97568389058%	39	1974	406	Mendelian_Nancy_Cox	OSMAN_BLADDER_CANCER_DN
1.97568389058%	39	1974	380	Mendelian_Nancy_Cox	DAIRKEE_TERT_TARGETS_UP
1.97568389058%	39	1974	318	Mendelian_Nancy_Cox	DAZARD_RESPONSE_TO_UV_NHEK_DN
1.97568389058%	39	1974	305	Mendelian_Nancy_Cox	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
1.97568389058%	39	1974	305	Mendelian_Nancy_Cox	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
1.97568389058%	39	1974	289	Mendelian_Nancy_Cox	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
1.97568389058%	39	1974	285	Mendelian_Nancy_Cox	GRADE_COLON_AND_RECTAL_CANCER_UP
1.97568389058%	39	1974	282	Mendelian_Nancy_Cox	HELLER_SILENCED_BY_METHYLATION_UP
1.97568389058%	39	1974	207	Mendelian_Nancy_Cox	MANALO_HYPOXIA_UP
1.97568389058%	39	1974	198	Mendelian_Nancy_Cox	REACTOME_PHOSPHOLIPID_METABOLISM
1.97005516154%	25	1269	893	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GEORGES_TARGETS_OF_MIR192_AND_MIR215
1.97005516154%	25	1269	871	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRADE_COLON_CANCER_UP
1.97005516154%	25	1269	824	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
1.97005516154%	25	1269	701	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMID_BREAST_CANCER_BASAL_DN
1.97005516154%	25	1269	578	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
1.97005516154%	25	1269	528	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
1.97005516154%	25	1269	462	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DELACROIX_RAR_BOUND_ES
1.97005516154%	25	1269	423	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PUJANA_BRCA2_PCC_NETWORK
1.96749358426%	23	1169	920	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_GPCR
1.96749358426%	23	1169	830	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CUI_TCF21_TARGETS_2_DN
1.96749358426%	23	1169	722	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
1.96749358426%	23	1169	712	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHLOSSER_SERUM_RESPONSE_DN
1.96749358426%	23	1169	701	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMID_BREAST_CANCER_BASAL_DN
1.96749358426%	23	1169	555	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
1.96749358426%	23	1169	501	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SENESE_HDAC3_TARGETS_UP
1.96749358426%	23	1169	456	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
1.96749358426%	23	1169	412	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
1.96749358426%	23	1169	185	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_LIVER_CANCER_SURVIVAL_UP
1.96749358426%	23	1169	1037	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NUYTTEN_EZH2_TARGETS_UP
1.96671709531%	13	661	544	T2D_GENES_TANYA_GLYCEMIC	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
1.96671709531%	13	661	539	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
1.96671709531%	13	661	536	T2D_GENES_TANYA_GLYCEMIC	SENESE_HDAC3_TARGETS_DN
1.96671709531%	13	661	518	T2D_GENES_TANYA_GLYCEMIC	REACTOME_METABOLISM_OF_PROTEINS
1.96671709531%	13	661	442	T2D_GENES_TANYA_GLYCEMIC	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
1.96671709531%	13	661	428	T2D_GENES_TANYA_GLYCEMIC	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
1.96671709531%	13	661	395	T2D_GENES_TANYA_GLYCEMIC	HAN_SATB1_TARGETS_UP
1.96671709531%	13	661	394	T2D_GENES_TANYA_GLYCEMIC	BERENJENO_TRANSFORMED_BY_RHOA_DN
1.96671709531%	13	661	390	T2D_GENES_TANYA_GLYCEMIC	HATADA_METHYLATED_IN_LUNG_CANCER_UP
1.96671709531%	13	661	374	T2D_GENES_TANYA_GLYCEMIC	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
1.96671709531%	13	661	335	T2D_GENES_TANYA_GLYCEMIC	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
1.96671709531%	13	661	330	T2D_GENES_TANYA_GLYCEMIC	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
1.96671709531%	13	661	329	T2D_GENES_TANYA_GLYCEMIC	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
1.96671709531%	13	661	317	T2D_GENES_TANYA_GLYCEMIC	HELLER_HDAC_TARGETS_UP
1.96671709531%	13	661	312	T2D_GENES_TANYA_GLYCEMIC	GENTILE_UV_HIGH_DOSE_DN
1.96671709531%	13	661	311	T2D_GENES_TANYA_GLYCEMIC	JIANG_HYPOXIA_NORMAL
1.96671709531%	13	661	309	T2D_GENES_TANYA_GLYCEMIC	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
1.96671709531%	13	661	293	T2D_GENES_TANYA_GLYCEMIC	ZHANG_TLX_TARGETS_60HR_UP
1.96671709531%	13	661	250	T2D_GENES_TANYA_GLYCEMIC	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
1.96671709531%	13	661	246	T2D_GENES_TANYA_GLYCEMIC	BILD_E2F3_ONCOGENIC_SIGNATURE
1.96671709531%	13	661	244	T2D_GENES_TANYA_GLYCEMIC	GAL_LEUKEMIC_STEM_CELL_DN
1.96671709531%	13	661	238	T2D_GENES_TANYA_GLYCEMIC	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
1.96671709531%	13	661	230	T2D_GENES_TANYA_GLYCEMIC	KAUFFMANN_DNA_REPAIR_GENES
1.96671709531%	13	661	222	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_1HR_DN
1.96671709531%	13	661	192	T2D_GENES_TANYA_GLYCEMIC	REACTOME_DNA_REPLICATION
1.96671709531%	13	661	163	T2D_GENES_TANYA_GLYCEMIC	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
1.95758564437%	12	613	920	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_GPCR
1.95758564437%	12	613	590	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
1.95758564437%	12	613	555	T2D_GENES_TANYA_BIOMARKER	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
1.95758564437%	12	613	553	T2D_GENES_TANYA_BIOMARKER	FEVR_CTNNB1_TARGETS_DN
1.95758564437%	12	613	504	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_48HR_DN
1.95758564437%	12	613	461	T2D_GENES_TANYA_BIOMARKER	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
1.95758564437%	12	613	431	T2D_GENES_TANYA_BIOMARKER	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
1.95758564437%	12	613	430	T2D_GENES_TANYA_BIOMARKER	RIGGI_EWING_SARCOMA_PROGENITOR_UP
1.95758564437%	12	613	425	T2D_GENES_TANYA_BIOMARKER	ZHANG_BREAST_CANCER_PROGENITORS_UP
1.95758564437%	12	613	422	T2D_GENES_TANYA_BIOMARKER	YAGI_AML_WITH_INV_16_TRANSLOCATION
1.95758564437%	12	613	420	T2D_GENES_TANYA_BIOMARKER	MOOTHA_PGC
1.95758564437%	12	613	408	T2D_GENES_TANYA_BIOMARKER	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
1.95758564437%	12	613	405	T2D_GENES_TANYA_BIOMARKER	KUMAR_TARGETS_OF_MLL_AF9_FUSION
1.95758564437%	12	613	395	T2D_GENES_TANYA_BIOMARKER	HAN_SATB1_TARGETS_UP
1.95758564437%	12	613	392	T2D_GENES_TANYA_BIOMARKER	LINDGREN_BLADDER_CANCER_CLUSTER_2B
1.95758564437%	12	613	387	T2D_GENES_TANYA_BIOMARKER	CHYLA_CBFA2T3_TARGETS_UP
1.95758564437%	12	613	384	T2D_GENES_TANYA_BIOMARKER	BASAKI_YBX1_TARGETS_DN
1.95758564437%	12	613	362	T2D_GENES_TANYA_BIOMARKER	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
1.95758564437%	12	613	354	T2D_GENES_TANYA_BIOMARKER	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
1.95758564437%	12	613	349	T2D_GENES_TANYA_BIOMARKER	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
1.95758564437%	12	613	341	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
1.95758564437%	12	613	306	T2D_GENES_TANYA_BIOMARKER	CHANDRAN_METASTASIS_DN
1.95758564437%	12	613	281	T2D_GENES_TANYA_BIOMARKER	BHAT_ESR1_TARGETS_VIA_AKT1_UP
1.95758564437%	12	613	266	T2D_GENES_TANYA_BIOMARKER	FOSTER_KDM1A_TARGETS_UP
1.95758564437%	12	613	183	T2D_GENES_TANYA_BIOMARKER	KEGG_ENDOCYTOSIS
1.95758564437%	12	613	165	T2D_GENES_TANYA_BIOMARKER	DARWICHE_PAPILLOMA_RISK_LOW_DN
1.95758564437%	12	613	147	T2D_GENES_TANYA_BIOMARKER	SMID_BREAST_CANCER_ERBB2_UP
1.93905817175%	7	361	920	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SIGNALING_BY_GPCR
1.93905817175%	7	361	911	T2D_GENES_TANYA_T2D_RSQ05_02CM	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
1.93905817175%	7	361	805	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_GPCR_DOWNSTREAM_SIGNALING
1.93905817175%	7	361	756	T2D_GENES_TANYA_T2D_RSQ05_02CM	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
1.93905817175%	7	361	745	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_BMP2_TARGETS_UP
1.93905817175%	7	361	722	T2D_GENES_TANYA_T2D_RSQ05_02CM	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
1.93905817175%	7	361	682	T2D_GENES_TANYA_T2D_RSQ05_02CM	FEVR_CTNNB1_TARGETS_UP
1.93905817175%	7	361	570	T2D_GENES_TANYA_T2D_RSQ05_02CM	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
1.93905817175%	7	361	567	T2D_GENES_TANYA_T2D_RSQ05_02CM	PARENT_MTOR_SIGNALING_UP
1.93905817175%	7	361	528	T2D_GENES_TANYA_T2D_RSQ05_02CM	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
1.93905817175%	7	361	489	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIM_MAMMARY_STEM_CELL_UP
1.93905817175%	7	361	483	T2D_GENES_TANYA_T2D_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
1.93905817175%	7	361	456	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARTENS_BOUND_BY_PML_RARA_FUSION
1.93905817175%	7	361	43	T2D_GENES_TANYA_T2D_RSQ05_02CM	LASTOWSKA_COAMPLIFIED_WITH_MYCN
1.93905817175%	7	361	418	T2D_GENES_TANYA_T2D_RSQ05_02CM	PEDRIOLI_MIR31_TARGETS_DN
1.93905817175%	7	361	384	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
1.93905817175%	7	361	380	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
1.93905817175%	7	361	366	T2D_GENES_TANYA_T2D_RSQ05_02CM	YOSHIMURA_MAPK8_TARGETS_DN
1.93905817175%	7	361	364	T2D_GENES_TANYA_T2D_RSQ05_02CM	YANG_BCL3_TARGETS_UP
1.93905817175%	7	361	352	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
1.93905817175%	7	361	349	T2D_GENES_TANYA_T2D_RSQ05_02CM	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
1.93905817175%	7	361	335	T2D_GENES_TANYA_T2D_RSQ05_02CM	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
1.93905817175%	7	361	329	T2D_GENES_TANYA_T2D_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
1.93905817175%	7	361	326	T2D_GENES_TANYA_T2D_RSQ05_02CM	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
1.93905817175%	7	361	324	T2D_GENES_TANYA_T2D_RSQ05_02CM	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
1.93905817175%	7	361	323	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRESHOCK_CANCER_COPY_NUMBER_UP
1.93905817175%	7	361	290	T2D_GENES_TANYA_T2D_RSQ05_02CM	BENPORATH_OCT4_TARGETS
1.93905817175%	7	361	289	T2D_GENES_TANYA_T2D_RSQ05_02CM	MANALO_HYPOXIA_DN
1.93905817175%	7	361	279	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_NEURONAL_SYSTEM
1.93905817175%	7	361	165	T2D_GENES_TANYA_T2D_RSQ05_02CM	DARWICHE_PAPILLOMA_RISK_LOW_DN
1.93905817175%	7	361	143	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
1.93192272309%	42	2174	518	T2D_GENES_TANYA_LIPIDS	REACTOME_METABOLISM_OF_PROTEINS
1.93192272309%	42	2174	485	T2D_GENES_TANYA_LIPIDS	ENK_UV_RESPONSE_KERATINOCYTE_DN
1.93192272309%	42	2174	457	T2D_GENES_TANYA_LIPIDS	SENESE_HDAC1_TARGETS_UP
1.93192272309%	42	2174	435	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
1.93192272309%	42	2174	434	T2D_GENES_TANYA_LIPIDS	BAELDE_DIABETIC_NEPHROPATHY_DN
1.93192272309%	42	2174	394	T2D_GENES_TANYA_LIPIDS	BERENJENO_TRANSFORMED_BY_RHOA_DN
1.93192272309%	42	2174	358	T2D_GENES_TANYA_LIPIDS	GRUETZMANN_PANCREATIC_CANCER_UP
1.93192272309%	42	2174	287	T2D_GENES_TANYA_LIPIDS	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
1.93192272309%	42	2174	253	T2D_GENES_TANYA_LIPIDS	DANG_REGULATED_BY_MYC_DN
1.93192272309%	42	2174	217	T2D_GENES_TANYA_LIPIDS	AMUNDSON_RESPONSE_TO_ARSENITE
1.93192272309%	42	2174	140	T2D_GENES_TANYA_LIPIDS	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
1.93181818182%	68	3520	795	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEI_MYCN_TARGETS_WITH_E_BOX
1.93181818182%	68	3520	673	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTINEZ_RB1_TARGETS_UP
1.93181818182%	68	3520	658	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
1.93181818182%	68	3520	570	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
1.92502532928%	38	1974	92	Mendelian_Nancy_Cox	KEGG_DILATED_CARDIOMYOPATHY
1.92502532928%	38	1974	317	Mendelian_Nancy_Cox	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
1.92502532928%	38	1974	299	Mendelian_Nancy_Cox	WALLACE_PROSTATE_CANCER_RACE_UP
1.92502532928%	38	1974	284	Mendelian_Nancy_Cox	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
1.92502532928%	38	1974	281	Mendelian_Nancy_Cox	MULLIGHAN_MLL_SIGNATURE_2_DN
1.92502532928%	38	1974	272	Mendelian_Nancy_Cox	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
1.92502532928%	38	1974	266	Mendelian_Nancy_Cox	FOSTER_KDM1A_TARGETS_UP
1.92502532928%	38	1974	249	Mendelian_Nancy_Cox	MITSIADES_RESPONSE_TO_APLIDIN_DN
1.92502532928%	38	1974	245	Mendelian_Nancy_Cox	PENG_RAPAMYCIN_RESPONSE_DN
1.92502532928%	38	1974	232	Mendelian_Nancy_Cox	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
1.92502532928%	38	1974	220	Mendelian_Nancy_Cox	RIGGINS_TAMOXIFEN_RESISTANCE_DN
1.92502532928%	38	1974	196	Mendelian_Nancy_Cox	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
1.92502532928%	38	1974	185	Mendelian_Nancy_Cox	KEGG_HUNTINGTONS_DISEASE
1.92502532928%	38	1974	185	Mendelian_Nancy_Cox	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
1.92502532928%	38	1974	175	Mendelian_Nancy_Cox	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
1.92502532928%	38	1974	137	Mendelian_Nancy_Cox	KEGG_INSULIN_SIGNALING_PATHWAY
1.92410475681%	36	1871	62	T2D_GENES_TANYA_HEIGHT	REACTOME_RNA_POL_I_PROMOTER_OPENING
1.92410475681%	36	1871	518	T2D_GENES_TANYA_HEIGHT	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
1.92410475681%	36	1871	485	T2D_GENES_TANYA_HEIGHT	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
1.92410475681%	36	1871	443	T2D_GENES_TANYA_HEIGHT	DELYS_THYROID_CANCER_UP
1.92410475681%	36	1871	418	T2D_GENES_TANYA_HEIGHT	RUTELLA_RESPONSE_TO_HGF_UP
1.92410475681%	36	1871	390	T2D_GENES_TANYA_HEIGHT	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
1.92410475681%	36	1871	387	T2D_GENES_TANYA_HEIGHT	CHYLA_CBFA2T3_TARGETS_UP
1.92410475681%	36	1871	362	T2D_GENES_TANYA_HEIGHT	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
1.92410475681%	36	1871	323	T2D_GENES_TANYA_HEIGHT	GRESHOCK_CANCER_COPY_NUMBER_UP
1.92410475681%	36	1871	320	T2D_GENES_TANYA_HEIGHT	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
1.92410475681%	36	1871	309	T2D_GENES_TANYA_HEIGHT	LIU_SOX4_TARGETS_DN
1.92410475681%	36	1871	295	T2D_GENES_TANYA_HEIGHT	LU_EZH2_TARGETS_UP
1.91864927091%	25	1303	920	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_GPCR
1.91864927091%	25	1303	898	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
1.91864927091%	25	1303	805	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
1.91864927091%	25	1303	769	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NUYTTEN_NIPP1_TARGETS_UP
1.91864927091%	25	1303	663	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
1.91864927091%	25	1303	552	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
1.91864927091%	25	1303	530	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ENK_UV_RESPONSE_KERATINOCYTE_UP
1.91864927091%	25	1303	501	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SENESE_HDAC3_TARGETS_UP
1.91864927091%	25	1303	493	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
1.91864927091%	25	1303	491	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHENG_BOUND_BY_FOXP3
1.91864927091%	25	1303	1103	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DANG_BOUND_BY_MYC
1.90340909091%	67	3520	721	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WONG_ADULT_TISSUE_STEM_MODULE
1.90340909091%	67	3520	539	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
1.90340909091%	67	3520	461	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
1.89125295508%	24	1269	933	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_IMMUNE_SYSTEM
1.89125295508%	24	1269	882	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS
1.89125295508%	24	1269	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TELOMERE_MAINTENANCE
1.89125295508%	24	1269	722	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
1.89125295508%	24	1269	712	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHLOSSER_SERUM_RESPONSE_DN
1.89125295508%	24	1269	673	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARTINEZ_RB1_TARGETS_UP
1.89125295508%	24	1269	648	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BENPORATH_CYCLING_GENES
1.89125295508%	24	1269	612	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP
1.89125295508%	24	1269	553	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FEVR_CTNNB1_TARGETS_DN
1.89125295508%	24	1269	546	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
1.89125295508%	24	1269	517	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
1.89125295508%	24	1269	504	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_48HR_DN
1.89125295508%	24	1269	461	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
1.88592456302%	41	2174	459	T2D_GENES_TANYA_LIPIDS	KIM_WT1_TARGETS_DN
1.88592456302%	41	2174	391	T2D_GENES_TANYA_LIPIDS	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
1.88592456302%	41	2174	355	T2D_GENES_TANYA_LIPIDS	PEREZ_TP63_TARGETS
1.88592456302%	41	2174	330	T2D_GENES_TANYA_LIPIDS	REACTOME_METABOLISM_OF_RNA
1.88195038494%	22	1169	824	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
1.88195038494%	22	1169	734	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BENPORATH_SOX2_TARGETS
1.88195038494%	22	1169	517	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
1.88195038494%	22	1169	493	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
1.88195038494%	22	1169	485	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ENK_UV_RESPONSE_KERATINOCYTE_DN
1.88195038494%	22	1169	463	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
1.88195038494%	22	1169	457	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SENESE_HDAC1_TARGETS_UP
1.88195038494%	22	1169	430	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JOHNSTONE_PARVB_TARGETS_3_UP
1.88195038494%	22	1169	354	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
1.88195038494%	22	1169	335	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
1.88195038494%	22	1169	309	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
1.88195038494%	22	1169	1038	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BENPORATH_SUZ12_TARGETS
1.875%	66	3520	473	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARY_CD5_TARGETS_UP
1.87436676798%	37	1974	320	Mendelian_Nancy_Cox	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
1.87436676798%	37	1974	314	Mendelian_Nancy_Cox	DOUGLAS_BMI1_TARGETS_DN
1.87436676798%	37	1974	276	Mendelian_Nancy_Cox	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
1.87436676798%	37	1974	266	Mendelian_Nancy_Cox	ROZANOV_MMP14_TARGETS_UP
1.87436676798%	37	1974	259	Mendelian_Nancy_Cox	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
1.87436676798%	37	1974	245	Mendelian_Nancy_Cox	BLUM_RESPONSE_TO_SALIRASIB_UP
1.87436676798%	37	1974	244	Mendelian_Nancy_Cox	DAZARD_RESPONSE_TO_UV_NHEK_UP
1.87436676798%	37	1974	238	Mendelian_Nancy_Cox	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
1.87436676798%	37	1974	214	Mendelian_Nancy_Cox	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
1.87436676798%	37	1974	199	Mendelian_Nancy_Cox	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
1.87436676798%	37	1974	175	Mendelian_Nancy_Cox	YAMAZAKI_TCEB3_TARGETS_UP
1.87436676798%	37	1974	151	Mendelian_Nancy_Cox	IGLESIAS_E2F_TARGETS_UP
1.87436676798%	37	1974	135	Mendelian_Nancy_Cox	TSENG_IRS1_TARGETS_DN
1.87436676798%	37	1974	128	Mendelian_Nancy_Cox	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
1.87065740246%	35	1871	540	T2D_GENES_TANYA_HEIGHT	ACEVEDO_LIVER_CANCER_DN
1.87065740246%	35	1871	445	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
1.87065740246%	35	1871	431	T2D_GENES_TANYA_HEIGHT	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
1.87065740246%	35	1871	429	T2D_GENES_TANYA_HEIGHT	MOOTHA_HUMAN_MITODB_6_2002
1.87065740246%	35	1871	425	T2D_GENES_TANYA_HEIGHT	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
1.87065740246%	35	1871	398	T2D_GENES_TANYA_HEIGHT	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
1.87065740246%	35	1871	379	T2D_GENES_TANYA_HEIGHT	BENPORATH_ES_1
1.87065740246%	35	1871	357	T2D_GENES_TANYA_HEIGHT	SHEN_SMARCA2_TARGETS_DN
1.87065740246%	35	1871	353	T2D_GENES_TANYA_HEIGHT	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
1.87065740246%	35	1871	329	T2D_GENES_TANYA_HEIGHT	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
1.87065740246%	35	1871	294	T2D_GENES_TANYA_HEIGHT	WEST_ADRENOCORTICAL_TUMOR_UP
1.87065740246%	35	1871	122	T2D_GENES_TANYA_HEIGHT	REACTOME_CHROMOSOME_MAINTENANCE
1.84659090909%	65	3520	893	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GEORGES_TARGETS_OF_MIR192_AND_MIR215
1.84659090909%	65	3520	781	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOZGIT_ESR1_TARGETS_DN
1.84659090909%	65	3520	769	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NUYTTEN_NIPP1_TARGETS_UP
1.84659090909%	65	3520	504	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_48HR_DN
1.84501845018%	10	542	800	T2D_GENES_TANYA_ANTHROPOMETRIC	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
1.84501845018%	10	542	682	T2D_GENES_TANYA_ANTHROPOMETRIC	FEVR_CTNNB1_TARGETS_UP
1.84501845018%	10	542	602	T2D_GENES_TANYA_ANTHROPOMETRIC	MARTINEZ_TP53_TARGETS_UP
1.84501845018%	10	542	461	T2D_GENES_TANYA_ANTHROPOMETRIC	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
1.84501845018%	10	542	450	T2D_GENES_TANYA_ANTHROPOMETRIC	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
1.84501845018%	10	542	430	T2D_GENES_TANYA_ANTHROPOMETRIC	JOHNSTONE_PARVB_TARGETS_3_UP
1.84501845018%	10	542	424	T2D_GENES_TANYA_ANTHROPOMETRIC	SHEN_SMARCA2_TARGETS_UP
1.84501845018%	10	542	423	T2D_GENES_TANYA_ANTHROPOMETRIC	THUM_SYSTOLIC_HEART_FAILURE_UP
1.84501845018%	10	542	422	T2D_GENES_TANYA_ANTHROPOMETRIC	YAGI_AML_WITH_INV_16_TRANSLOCATION
1.84501845018%	10	542	418	T2D_GENES_TANYA_ANTHROPOMETRIC	RUTELLA_RESPONSE_TO_HGF_UP
1.84501845018%	10	542	412	T2D_GENES_TANYA_ANTHROPOMETRIC	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
1.84501845018%	10	542	409	T2D_GENES_TANYA_ANTHROPOMETRIC	FOSTER_TOLERANT_MACROPHAGE_DN
1.84501845018%	10	542	408	T2D_GENES_TANYA_ANTHROPOMETRIC	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
1.84501845018%	10	542	395	T2D_GENES_TANYA_ANTHROPOMETRIC	HAN_SATB1_TARGETS_UP
1.84501845018%	10	542	384	T2D_GENES_TANYA_ANTHROPOMETRIC	BASAKI_YBX1_TARGETS_DN
1.84501845018%	10	542	337	T2D_GENES_TANYA_ANTHROPOMETRIC	PENG_GLUTAMINE_DEPRIVATION_DN
1.84501845018%	10	542	330	T2D_GENES_TANYA_ANTHROPOMETRIC	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
1.84501845018%	10	542	328	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PATHWAYS_IN_CANCER
1.84501845018%	10	542	326	T2D_GENES_TANYA_ANTHROPOMETRIC	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
1.84501845018%	10	542	307	T2D_GENES_TANYA_ANTHROPOMETRIC	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
1.84501845018%	10	542	302	T2D_GENES_TANYA_ANTHROPOMETRIC	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
1.84501845018%	10	542	294	T2D_GENES_TANYA_ANTHROPOMETRIC	WEST_ADRENOCORTICAL_TUMOR_UP
1.84501845018%	10	542	292	T2D_GENES_TANYA_ANTHROPOMETRIC	HELLER_HDAC_TARGETS_DN
1.84501845018%	10	542	284	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
1.84501845018%	10	542	281	T2D_GENES_TANYA_ANTHROPOMETRIC	BHAT_ESR1_TARGETS_VIA_AKT1_UP
1.84501845018%	10	542	264	T2D_GENES_TANYA_ANTHROPOMETRIC	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
1.84501845018%	10	542	235	T2D_GENES_TANYA_ANTHROPOMETRIC	RUTELLA_RESPONSE_TO_HGF_DN
1.84501845018%	10	542	228	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
1.84501845018%	10	542	211	T2D_GENES_TANYA_ANTHROPOMETRIC	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
1.84501845018%	10	542	207	T2D_GENES_TANYA_ANTHROPOMETRIC	KARLSSON_TGFB1_TARGETS_DN
1.84501845018%	10	542	207	T2D_GENES_TANYA_ANTHROPOMETRIC	CAIRO_HEPATOBLASTOMA_UP
1.84501845018%	10	542	185	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_HUNTINGTONS_DISEASE
1.84501845018%	10	542	183	T2D_GENES_TANYA_ANTHROPOMETRIC	VERHAAK_AML_WITH_NPM1_MUTATED_UP
1.84501845018%	10	542	182	T2D_GENES_TANYA_ANTHROPOMETRIC	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
1.84501845018%	10	542	182	T2D_GENES_TANYA_ANTHROPOMETRIC	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
1.84501845018%	10	542	140	T2D_GENES_TANYA_ANTHROPOMETRIC	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
1.84190330008%	24	1303	857	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTENS_TRETINOIN_RESPONSE_UP
1.84190330008%	24	1303	784	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FORTSCHEGGER_PHF8_TARGETS_DN
1.84190330008%	24	1303	770	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KRIEG_HYPOXIA_NOT_VIA_KDM3A
1.84190330008%	24	1303	747	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PATIL_LIVER_CANCER
1.84190330008%	24	1303	648	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMID_BREAST_CANCER_BASAL_UP
1.84190330008%	24	1303	566	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DOUGLAS_BMI1_TARGETS_UP
1.84190330008%	24	1303	510	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
1.84190330008%	24	1303	463	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
1.84190330008%	24	1303	414	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOHANKUMAR_TLX1_TARGETS_UP
1.83992640294%	40	2174	491	T2D_GENES_TANYA_LIPIDS	MEISSNER_NPC_HCP_WITH_H3K4ME2
1.83992640294%	40	2174	430	T2D_GENES_TANYA_LIPIDS	VECCHI_GASTRIC_CANCER_EARLY_UP
1.83992640294%	40	2174	425	T2D_GENES_TANYA_LIPIDS	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
1.83992640294%	40	2174	364	T2D_GENES_TANYA_LIPIDS	YANG_BCL3_TARGETS_UP
1.83992640294%	40	2174	317	T2D_GENES_TANYA_LIPIDS	HELLER_HDAC_TARGETS_UP
1.83992640294%	40	2174	315	T2D_GENES_TANYA_LIPIDS	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
1.83992640294%	40	2174	267	T2D_GENES_TANYA_LIPIDS	CAIRO_HEPATOBLASTOMA_DN
1.83992640294%	40	2174	266	T2D_GENES_TANYA_LIPIDS	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
1.83992640294%	40	2174	261	T2D_GENES_TANYA_LIPIDS	RICKMAN_METASTASIS_DN
1.83992640294%	40	2174	244	T2D_GENES_TANYA_LIPIDS	DAZARD_RESPONSE_TO_UV_NHEK_UP
1.82370820669%	36	1974	87	Mendelian_Nancy_Cox	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION
1.82370820669%	36	1974	384	Mendelian_Nancy_Cox	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
1.82370820669%	36	1974	352	Mendelian_Nancy_Cox	WANG_LMO4_TARGETS_DN
1.82370820669%	36	1974	317	Mendelian_Nancy_Cox	BRUINS_UVC_RESPONSE_EARLY_LATE
1.82370820669%	36	1974	292	Mendelian_Nancy_Cox	KOYAMA_SEMA3B_TARGETS_UP
1.82370820669%	36	1974	285	Mendelian_Nancy_Cox	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
1.82370820669%	36	1974	277	Mendelian_Nancy_Cox	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
1.82370820669%	36	1974	267	Mendelian_Nancy_Cox	HOLLMANN_APOPTOSIS_VIA_CD40_DN
1.82370820669%	36	1974	246	Mendelian_Nancy_Cox	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
1.82370820669%	36	1974	245	Mendelian_Nancy_Cox	KONDO_EZH2_TARGETS
1.82370820669%	36	1974	244	Mendelian_Nancy_Cox	PLASARI_TGFB1_TARGETS_10HR_DN
1.82370820669%	36	1974	238	Mendelian_Nancy_Cox	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
1.82370820669%	36	1974	238	Mendelian_Nancy_Cox	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
1.82370820669%	36	1974	234	Mendelian_Nancy_Cox	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
1.82370820669%	36	1974	229	Mendelian_Nancy_Cox	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
1.82370820669%	36	1974	229	Mendelian_Nancy_Cox	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
1.82370820669%	36	1974	225	Mendelian_Nancy_Cox	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
1.82370820669%	36	1974	215	Mendelian_Nancy_Cox	MARKEY_RB1_ACUTE_LOF_UP
1.82370820669%	36	1974	210	Mendelian_Nancy_Cox	RIZKI_TUMOR_INVASIVENESS_3D_UP
1.82370820669%	36	1974	186	Mendelian_Nancy_Cox	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
1.82370820669%	36	1974	170	Mendelian_Nancy_Cox	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
1.82370820669%	36	1974	161	Mendelian_Nancy_Cox	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
1.82370820669%	36	1974	149	Mendelian_Nancy_Cox	OHGUCHI_LIVER_HNF4A_TARGETS_DN
1.81818181818%	64	3520	712	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHLOSSER_SERUM_RESPONSE_DN
1.81818181818%	64	3520	552	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
1.81818181818%	64	3520	456	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTENS_BOUND_BY_PML_RARA_FUSION
1.8172100481%	34	1871	373	T2D_GENES_TANYA_HEIGHT	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
1.8172100481%	34	1871	354	T2D_GENES_TANYA_HEIGHT	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
1.8172100481%	34	1871	321	T2D_GENES_TANYA_HEIGHT	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
1.8172100481%	34	1871	289	T2D_GENES_TANYA_HEIGHT	MANALO_HYPOXIA_DN
1.8172100481%	34	1871	281	T2D_GENES_TANYA_HEIGHT	BHAT_ESR1_TARGETS_VIA_AKT1_UP
1.8172100481%	34	1871	267	T2D_GENES_TANYA_HEIGHT	HOLLMANN_APOPTOSIS_VIA_CD40_DN
1.8172100481%	34	1871	249	T2D_GENES_TANYA_HEIGHT	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
1.8154311649%	12	661	783	T2D_GENES_TANYA_GLYCEMIC	ONKEN_UVEAL_MELANOMA_UP
1.8154311649%	12	661	491	T2D_GENES_TANYA_GLYCEMIC	SWEET_LUNG_CANCER_KRAS_UP
1.8154311649%	12	661	489	T2D_GENES_TANYA_GLYCEMIC	LIM_MAMMARY_STEM_CELL_UP
1.8154311649%	12	661	481	T2D_GENES_TANYA_GLYCEMIC	LIU_PROSTATE_CANCER_DN
1.8154311649%	12	661	455	T2D_GENES_TANYA_GLYCEMIC	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
1.8154311649%	12	661	431	T2D_GENES_TANYA_GLYCEMIC	GARY_CD5_TARGETS_DN
1.8154311649%	12	661	423	T2D_GENES_TANYA_GLYCEMIC	THUM_SYSTOLIC_HEART_FAILURE_UP
1.8154311649%	12	661	422	T2D_GENES_TANYA_GLYCEMIC	YAGI_AML_WITH_INV_16_TRANSLOCATION
1.8154311649%	12	661	397	T2D_GENES_TANYA_GLYCEMIC	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
1.8154311649%	12	661	393	T2D_GENES_TANYA_GLYCEMIC	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
1.8154311649%	12	661	392	T2D_GENES_TANYA_GLYCEMIC	LINDGREN_BLADDER_CANCER_CLUSTER_2B
1.8154311649%	12	661	389	T2D_GENES_TANYA_GLYCEMIC	HSIAO_HOUSEKEEPING_GENES
1.8154311649%	12	661	366	T2D_GENES_TANYA_GLYCEMIC	YOSHIMURA_MAPK8_TARGETS_DN
1.8154311649%	12	661	366	T2D_GENES_TANYA_GLYCEMIC	SANSOM_APC_TARGETS_DN
1.8154311649%	12	661	357	T2D_GENES_TANYA_GLYCEMIC	SHEN_SMARCA2_TARGETS_DN
1.8154311649%	12	661	354	T2D_GENES_TANYA_GLYCEMIC	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
1.8154311649%	12	661	352	T2D_GENES_TANYA_GLYCEMIC	WANG_LMO4_TARGETS_DN
1.8154311649%	12	661	337	T2D_GENES_TANYA_GLYCEMIC	PHONG_TNF_RESPONSE_NOT_VIA_P38
1.8154311649%	12	661	329	T2D_GENES_TANYA_GLYCEMIC	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
1.8154311649%	12	661	309	T2D_GENES_TANYA_GLYCEMIC	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
1.8154311649%	12	661	308	T2D_GENES_TANYA_GLYCEMIC	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
1.8154311649%	12	661	292	T2D_GENES_TANYA_GLYCEMIC	KOYAMA_SEMA3B_TARGETS_UP
1.8154311649%	12	661	289	T2D_GENES_TANYA_GLYCEMIC	MANALO_HYPOXIA_DN
1.8154311649%	12	661	276	T2D_GENES_TANYA_GLYCEMIC	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
1.8154311649%	12	661	272	T2D_GENES_TANYA_GLYCEMIC	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
1.8154311649%	12	661	269	T2D_GENES_TANYA_GLYCEMIC	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
1.8154311649%	12	661	228	T2D_GENES_TANYA_GLYCEMIC	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
1.8154311649%	12	661	225	T2D_GENES_TANYA_GLYCEMIC	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
1.8154311649%	12	661	203	T2D_GENES_TANYA_GLYCEMIC	GRUETZMANN_PANCREATIC_CANCER_DN
1.8154311649%	12	661	174	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
1.81245074862%	23	1269	848	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NUYTTEN_NIPP1_TARGETS_DN
1.81245074862%	23	1269	682	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FEVR_CTNNB1_TARGETS_UP
1.81245074862%	23	1269	637	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
1.81245074862%	23	1269	602	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARTINEZ_TP53_TARGETS_UP
1.81245074862%	23	1269	557	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TIEN_INTESTINE_PROBIOTICS_24HR_UP
1.81245074862%	23	1269	514	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
1.81245074862%	23	1269	467	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RATTENBACHER_BOUND_BY_CELF1
1.81245074862%	23	1269	418	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MULLIGHAN_MLL_SIGNATURE_2_UP
1.79640718563%	21	1169	567	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHICAS_RB1_TARGETS_CONFLUENT
1.79640718563%	21	1169	447	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOOTHA_MITOCHONDRIA
1.79640718563%	21	1169	445	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
1.79640718563%	21	1169	287	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
1.79640718563%	21	1169	266	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
1.79445350734%	11	613	557	T2D_GENES_TANYA_BIOMARKER	TIEN_INTESTINE_PROBIOTICS_24HR_UP
1.79445350734%	11	613	552	T2D_GENES_TANYA_BIOMARKER	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
1.79445350734%	11	613	536	T2D_GENES_TANYA_BIOMARKER	SENESE_HDAC3_TARGETS_DN
1.79445350734%	11	613	518	T2D_GENES_TANYA_BIOMARKER	REACTOME_METABOLISM_OF_PROTEINS
1.79445350734%	11	613	482	T2D_GENES_TANYA_BIOMARKER	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
1.79445350734%	11	613	478	T2D_GENES_TANYA_BIOMARKER	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
1.79445350734%	11	613	476	T2D_GENES_TANYA_BIOMARKER	SMID_BREAST_CANCER_NORMAL_LIKE_UP
1.79445350734%	11	613	435	T2D_GENES_TANYA_BIOMARKER	SWEET_LUNG_CANCER_KRAS_DN
1.79445350734%	11	613	421	T2D_GENES_TANYA_BIOMARKER	REACTOME_CELL_CYCLE
1.79445350734%	11	613	404	T2D_GENES_TANYA_BIOMARKER	OSMAN_BLADDER_CANCER_UP
1.79445350734%	11	613	396	T2D_GENES_TANYA_BIOMARKER	REACTOME_DEVELOPMENTAL_BIOLOGY
1.79445350734%	11	613	374	T2D_GENES_TANYA_BIOMARKER	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
1.79445350734%	11	613	358	T2D_GENES_TANYA_BIOMARKER	GRUETZMANN_PANCREATIC_CANCER_UP
1.79445350734%	11	613	330	T2D_GENES_TANYA_BIOMARKER	REACTOME_METABOLISM_OF_RNA
1.79445350734%	11	613	298	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_14HR_DN
1.79445350734%	11	613	294	T2D_GENES_TANYA_BIOMARKER	WEST_ADRENOCORTICAL_TUMOR_UP
1.79445350734%	11	613	293	T2D_GENES_TANYA_BIOMARKER	HADDAD_B_LYMPHOCYTE_PROGENITOR
1.79445350734%	11	613	277	T2D_GENES_TANYA_BIOMARKER	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
1.79445350734%	11	613	267	T2D_GENES_TANYA_BIOMARKER	CAIRO_HEPATOBLASTOMA_DN
1.79445350734%	11	613	261	T2D_GENES_TANYA_BIOMARKER	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
1.79445350734%	11	613	240	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_20HR_UP
1.79445350734%	11	613	217	T2D_GENES_TANYA_BIOMARKER	SANSOM_APC_MYC_TARGETS
1.79445350734%	11	613	207	T2D_GENES_TANYA_BIOMARKER	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
1.79445350734%	11	613	185	T2D_GENES_TANYA_BIOMARKER	DARWICHE_SKIN_TUMOR_PROMOTER_DN
1.79392824287%	39	2174	423	T2D_GENES_TANYA_LIPIDS	THUM_SYSTOLIC_HEART_FAILURE_UP
1.79392824287%	39	2174	414	T2D_GENES_TANYA_LIPIDS	LU_EZH2_TARGETS_DN
1.79392824287%	39	2174	384	T2D_GENES_TANYA_LIPIDS	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
1.79392824287%	39	2174	384	T2D_GENES_TANYA_LIPIDS	BASAKI_YBX1_TARGETS_DN
1.79392824287%	39	2174	341	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
1.79392824287%	39	2174	328	T2D_GENES_TANYA_LIPIDS	KEGG_PATHWAYS_IN_CANCER
1.79392824287%	39	2174	309	T2D_GENES_TANYA_LIPIDS	LIU_SOX4_TARGETS_DN
1.79392824287%	39	2174	298	T2D_GENES_TANYA_LIPIDS	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
1.79392824287%	39	2174	282	T2D_GENES_TANYA_LIPIDS	HELLER_SILENCED_BY_METHYLATION_UP
1.79392824287%	39	2174	277	T2D_GENES_TANYA_LIPIDS	ZHANG_TLX_TARGETS_60HR_DN
1.79392824287%	39	2174	265	T2D_GENES_TANYA_LIPIDS	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
1.79392824287%	39	2174	122	T2D_GENES_TANYA_LIPIDS	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
1.79372197309%	8	446	898	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
1.79372197309%	8	446	882	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_BMP2_TARGETS_DN
1.79372197309%	8	446	848	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NUYTTEN_NIPP1_TARGETS_DN
1.79372197309%	8	446	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_MEIOTIC_SYNAPSIS
1.79372197309%	8	446	668	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
1.79372197309%	8	446	648	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SMID_BREAST_CANCER_BASAL_UP
1.79372197309%	8	446	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE
1.79372197309%	8	446	590	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
1.79372197309%	8	446	567	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHICAS_RB1_TARGETS_CONFLUENT
1.79372197309%	8	446	566	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DOUGLAS_BMI1_TARGETS_UP
1.79372197309%	8	446	553	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FEVR_CTNNB1_TARGETS_DN
1.79372197309%	8	446	546	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
1.79372197309%	8	446	543	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARTINEZ_RB1_TARGETS_DN
1.79372197309%	8	446	528	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
1.79372197309%	8	446	514	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
1.79372197309%	8	446	504	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PILON_KLF1_TARGETS_UP
1.79372197309%	8	446	485	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ENK_UV_RESPONSE_KERATINOCYTE_DN
1.79372197309%	8	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PACKAGING_OF_TELOMERE_ENDS
1.79372197309%	8	446	478	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
1.79372197309%	8	446	456	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARTENS_BOUND_BY_PML_RARA_FUSION
1.79372197309%	8	446	445	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
1.79372197309%	8	446	431	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GARY_CD5_TARGETS_DN
1.79372197309%	8	446	374	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
1.79372197309%	8	446	364	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YANG_BCL3_TARGETS_UP
1.79372197309%	8	446	352	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_LMO4_TARGETS_DN
1.79372197309%	8	446	329	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
1.79372197309%	8	446	266	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
1.79372197309%	8	446	174	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
1.78977272727%	63	3520	536	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SENESE_HDAC3_TARGETS_DN
1.78977272727%	63	3520	514	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
1.78977272727%	63	3520	430	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JOHNSTONE_PARVB_TARGETS_3_UP
1.77304964539%	35	1974	84	Mendelian_Nancy_Cox	KEGG_ECM_RECEPTOR_INTERACTION
1.77304964539%	35	1974	393	Mendelian_Nancy_Cox	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
1.77304964539%	35	1974	306	Mendelian_Nancy_Cox	CHANDRAN_METASTASIS_DN
1.77304964539%	35	1974	283	Mendelian_Nancy_Cox	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
1.77304964539%	35	1974	276	Mendelian_Nancy_Cox	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
1.77304964539%	35	1974	259	Mendelian_Nancy_Cox	QI_PLASMACYTOMA_UP
1.77304964539%	35	1974	226	Mendelian_Nancy_Cox	KYNG_DNA_DAMAGE_UP
1.77304964539%	35	1974	225	Mendelian_Nancy_Cox	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
1.77304964539%	35	1974	222	Mendelian_Nancy_Cox	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
1.77304964539%	35	1974	214	Mendelian_Nancy_Cox	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
1.77304964539%	35	1974	214	Mendelian_Nancy_Cox	KIM_WT1_TARGETS_UP
1.77304964539%	35	1974	203	Mendelian_Nancy_Cox	PAL_PRMT5_TARGETS_UP
1.77304964539%	35	1974	199	Mendelian_Nancy_Cox	PLASARI_TGFB1_TARGETS_10HR_UP
1.77304964539%	35	1974	197	Mendelian_Nancy_Cox	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
1.77304964539%	35	1974	168	Mendelian_Nancy_Cox	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
1.77304964539%	35	1974	148	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_24HR_DN
1.77304964539%	35	1974	132	Mendelian_Nancy_Cox	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
1.76515732924%	23	1303	805	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GPCR_DOWNSTREAM_SIGNALING
1.76515732924%	23	1303	546	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WEST_ADRENOCORTICAL_TUMOR_DN
1.76376269375%	33	1871	537	T2D_GENES_TANYA_HEIGHT	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
1.76376269375%	33	1871	505	T2D_GENES_TANYA_HEIGHT	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
1.76376269375%	33	1871	489	T2D_GENES_TANYA_HEIGHT	LIM_MAMMARY_STEM_CELL_UP
1.76376269375%	33	1871	482	T2D_GENES_TANYA_HEIGHT	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
1.76376269375%	33	1871	463	T2D_GENES_TANYA_HEIGHT	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
1.76376269375%	33	1871	447	T2D_GENES_TANYA_HEIGHT	MOOTHA_MITOCHONDRIA
1.76376269375%	33	1871	430	T2D_GENES_TANYA_HEIGHT	RIGGI_EWING_SARCOMA_PROGENITOR_UP
1.76376269375%	33	1871	414	T2D_GENES_TANYA_HEIGHT	LU_EZH2_TARGETS_DN
1.76376269375%	33	1871	408	T2D_GENES_TANYA_HEIGHT	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
1.76376269375%	33	1871	392	T2D_GENES_TANYA_HEIGHT	LINDGREN_BLADDER_CANCER_CLUSTER_2B
1.76376269375%	33	1871	390	T2D_GENES_TANYA_HEIGHT	HATADA_METHYLATED_IN_LUNG_CANCER_UP
1.76376269375%	33	1871	374	T2D_GENES_TANYA_HEIGHT	WANG_TUMOR_INVASIVENESS_UP
1.76376269375%	33	1871	364	T2D_GENES_TANYA_HEIGHT	YANG_BCL3_TARGETS_UP
1.76376269375%	33	1871	329	T2D_GENES_TANYA_HEIGHT	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
1.76376269375%	33	1871	299	T2D_GENES_TANYA_HEIGHT	WALLACE_PROSTATE_CANCER_RACE_UP
1.76376269375%	33	1871	277	T2D_GENES_TANYA_HEIGHT	ZHANG_TLX_TARGETS_60HR_DN
1.76376269375%	33	1871	230	T2D_GENES_TANYA_HEIGHT	BENPORATH_MYC_TARGETS_WITH_EBOX
1.76376269375%	33	1871	183	T2D_GENES_TANYA_HEIGHT	KEGG_ENDOCYTOSIS
1.76136363636%	62	3520	734	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BENPORATH_SOX2_TARGETS
1.76136363636%	62	3520	487	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RODWELL_AGING_KIDNEY_UP
1.75824175824%	8	455	648	T2D_GENES_TANYA_BLOODPRESSURE	SMID_BREAST_CANCER_BASAL_UP
1.75824175824%	8	455	634	T2D_GENES_TANYA_BLOODPRESSURE	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
1.75824175824%	8	455	584	T2D_GENES_TANYA_BLOODPRESSURE	HAMAI_APOPTOSIS_VIA_TRAIL_UP
1.75824175824%	8	455	544	T2D_GENES_TANYA_BLOODPRESSURE	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
1.75824175824%	8	455	528	T2D_GENES_TANYA_BLOODPRESSURE	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
1.75824175824%	8	455	491	T2D_GENES_TANYA_BLOODPRESSURE	MEISSNER_NPC_HCP_WITH_H3K4ME2
1.75824175824%	8	455	475	T2D_GENES_TANYA_BLOODPRESSURE	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
1.75824175824%	8	455	456	T2D_GENES_TANYA_BLOODPRESSURE	ODONNELL_TFRC_TARGETS_UP
1.75824175824%	8	455	455	T2D_GENES_TANYA_BLOODPRESSURE	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
1.75824175824%	8	455	447	T2D_GENES_TANYA_BLOODPRESSURE	MOOTHA_MITOCHONDRIA
1.75824175824%	8	455	431	T2D_GENES_TANYA_BLOODPRESSURE	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
1.75824175824%	8	455	428	T2D_GENES_TANYA_BLOODPRESSURE	CUI_TCF21_TARGETS_2_UP
1.75824175824%	8	455	384	T2D_GENES_TANYA_BLOODPRESSURE	BASAKI_YBX1_TARGETS_DN
1.75824175824%	8	455	380	T2D_GENES_TANYA_BLOODPRESSURE	DAIRKEE_TERT_TARGETS_UP
1.75824175824%	8	455	378	T2D_GENES_TANYA_BLOODPRESSURE	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
1.75824175824%	8	455	356	T2D_GENES_TANYA_BLOODPRESSURE	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
1.75824175824%	8	455	354	T2D_GENES_TANYA_BLOODPRESSURE	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
1.75824175824%	8	455	349	T2D_GENES_TANYA_BLOODPRESSURE	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
1.75824175824%	8	455	344	T2D_GENES_TANYA_BLOODPRESSURE	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
1.75824175824%	8	455	337	T2D_GENES_TANYA_BLOODPRESSURE	PHONG_TNF_RESPONSE_NOT_VIA_P38
1.75824175824%	8	455	336	T2D_GENES_TANYA_BLOODPRESSURE	JOHNSTONE_PARVB_TARGETS_2_DN
1.75824175824%	8	455	330	T2D_GENES_TANYA_BLOODPRESSURE	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
1.75824175824%	8	455	329	T2D_GENES_TANYA_BLOODPRESSURE	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
1.75824175824%	8	455	323	T2D_GENES_TANYA_BLOODPRESSURE	GRESHOCK_CANCER_COPY_NUMBER_UP
1.75824175824%	8	455	317	T2D_GENES_TANYA_BLOODPRESSURE	BRUINS_UVC_RESPONSE_EARLY_LATE
1.75824175824%	8	455	312	T2D_GENES_TANYA_BLOODPRESSURE	GENTILE_UV_HIGH_DOSE_DN
1.75824175824%	8	455	309	T2D_GENES_TANYA_BLOODPRESSURE	LIU_SOX4_TARGETS_DN
1.75824175824%	8	455	307	T2D_GENES_TANYA_BLOODPRESSURE	LI_INDUCED_T_TO_NATURAL_KILLER_UP
1.75824175824%	8	455	307	T2D_GENES_TANYA_BLOODPRESSURE	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
1.75824175824%	8	455	306	T2D_GENES_TANYA_BLOODPRESSURE	CHANDRAN_METASTASIS_DN
1.75824175824%	8	455	285	T2D_GENES_TANYA_BLOODPRESSURE	GRADE_COLON_AND_RECTAL_CANCER_UP
1.75824175824%	8	455	281	T2D_GENES_TANYA_BLOODPRESSURE	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
1.75824175824%	8	455	276	T2D_GENES_TANYA_BLOODPRESSURE	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
1.75824175824%	8	455	275	T2D_GENES_TANYA_BLOODPRESSURE	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
1.75824175824%	8	455	271	T2D_GENES_TANYA_BLOODPRESSURE	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
1.75824175824%	8	455	265	T2D_GENES_TANYA_BLOODPRESSURE	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
1.75824175824%	8	455	261	T2D_GENES_TANYA_BLOODPRESSURE	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
1.75824175824%	8	455	251	T2D_GENES_TANYA_BLOODPRESSURE	KOBAYASHI_EGFR_SIGNALING_24HR_DN
1.75824175824%	8	455	249	T2D_GENES_TANYA_BLOODPRESSURE	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
1.75824175824%	8	455	245	T2D_GENES_TANYA_BLOODPRESSURE	BLUM_RESPONSE_TO_SALIRASIB_UP
1.75824175824%	8	455	244	T2D_GENES_TANYA_BLOODPRESSURE	KAYO_AGING_MUSCLE_UP
1.75824175824%	8	455	244	T2D_GENES_TANYA_BLOODPRESSURE	DAZARD_RESPONSE_TO_UV_NHEK_UP
1.75824175824%	8	455	242	T2D_GENES_TANYA_BLOODPRESSURE	WINTER_HYPOXIA_METAGENE
1.75824175824%	8	455	240	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_20HR_UP
1.75824175824%	8	455	230	T2D_GENES_TANYA_BLOODPRESSURE	COLDREN_GEFITINIB_RESISTANCE_DN
1.75824175824%	8	455	229	T2D_GENES_TANYA_BLOODPRESSURE	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
1.75824175824%	8	455	223	T2D_GENES_TANYA_BLOODPRESSURE	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
1.75824175824%	8	455	214	T2D_GENES_TANYA_BLOODPRESSURE	KIM_WT1_TARGETS_UP
1.75824175824%	8	455	211	T2D_GENES_TANYA_BLOODPRESSURE	FOSTER_KDM1A_TARGETS_DN
1.75824175824%	8	455	210	T2D_GENES_TANYA_BLOODPRESSURE	VERHAAK_GLIOBLASTOMA_PRONEURAL
1.75824175824%	8	455	209	T2D_GENES_TANYA_BLOODPRESSURE	CHANG_CORE_SERUM_RESPONSE_DN
1.75824175824%	8	455	207	T2D_GENES_TANYA_BLOODPRESSURE	KARLSSON_TGFB1_TARGETS_DN
1.75824175824%	8	455	206	T2D_GENES_TANYA_BLOODPRESSURE	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
1.75824175824%	8	455	183	T2D_GENES_TANYA_BLOODPRESSURE	VERHAAK_AML_WITH_NPM1_MUTATED_UP
1.75824175824%	8	455	183	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_ENDOCYTOSIS
1.75824175824%	8	455	175	T2D_GENES_TANYA_BLOODPRESSURE	YAMAZAKI_TCEB3_TARGETS_UP
1.75824175824%	8	455	169	T2D_GENES_TANYA_BLOODPRESSURE	ONDER_CDH1_TARGETS_1_DN
1.75824175824%	8	455	162	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
1.75824175824%	8	455	149	T2D_GENES_TANYA_BLOODPRESSURE	NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON
1.75824175824%	8	455	143	T2D_GENES_TANYA_BLOODPRESSURE	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION
1.75824175824%	8	455	139	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_BIOLOGICAL_OXIDATIONS
1.7479300828%	38	2174	505	T2D_GENES_TANYA_LIPIDS	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
1.7479300828%	38	2174	481	T2D_GENES_TANYA_LIPIDS	LIU_PROSTATE_CANCER_DN
1.7479300828%	38	2174	455	T2D_GENES_TANYA_LIPIDS	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
1.7479300828%	38	2174	418	T2D_GENES_TANYA_LIPIDS	PEDRIOLI_MIR31_TARGETS_DN
1.7479300828%	38	2174	403	T2D_GENES_TANYA_LIPIDS	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
1.7479300828%	38	2174	392	T2D_GENES_TANYA_LIPIDS	LINDGREN_BLADDER_CANCER_CLUSTER_2B
1.7479300828%	38	2174	374	T2D_GENES_TANYA_LIPIDS	WANG_TUMOR_INVASIVENESS_UP
1.7479300828%	38	2174	374	T2D_GENES_TANYA_LIPIDS	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
1.7479300828%	38	2174	352	T2D_GENES_TANYA_LIPIDS	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
1.7479300828%	38	2174	341	T2D_GENES_TANYA_LIPIDS	MULLIGHAN_NPM1_SIGNATURE_3_UP
1.7479300828%	38	2174	324	T2D_GENES_TANYA_LIPIDS	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
1.7479300828%	38	2174	317	T2D_GENES_TANYA_LIPIDS	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
1.7479300828%	38	2174	293	T2D_GENES_TANYA_LIPIDS	HADDAD_B_LYMPHOCYTE_PROGENITOR
1.7479300828%	38	2174	284	T2D_GENES_TANYA_LIPIDS	REACTOME_METABOLISM_OF_MRNA
1.7479300828%	38	2174	281	T2D_GENES_TANYA_LIPIDS	BHAT_ESR1_TARGETS_VIA_AKT1_UP
1.7479300828%	38	2174	100	T2D_GENES_TANYA_LIPIDS	ROVERSI_GLIOMA_COPY_NUMBER_UP
1.73364854216%	22	1269	795	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WEI_MYCN_TARGETS_WITH_E_BOX
1.73364854216%	22	1269	601	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARTINEZ_RB1_AND_TP53_TARGETS_UP
1.73364854216%	22	1269	549	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
1.73364854216%	22	1269	540	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ACEVEDO_LIVER_CANCER_DN
1.73364854216%	22	1269	504	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PILON_KLF1_TARGETS_UP
1.73364854216%	22	1269	466	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_HEMOSTASIS
1.73364854216%	22	1269	447	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOOTHA_MITOCHONDRIA
1.73364854216%	22	1269	364	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YANG_BCL3_TARGETS_UP
1.73295454545%	61	3520	546	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEST_ADRENOCORTICAL_TUMOR_DN
1.73295454545%	61	3520	544	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
1.73295454545%	61	3520	479	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
1.73295454545%	61	3520	421	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CELL_CYCLE
1.72239108409%	34	1974	89	Mendelian_Nancy_Cox	KEGG_PROSTATE_CANCER
1.72239108409%	34	1974	325	Mendelian_Nancy_Cox	REACTOME_CELL_CYCLE_MITOTIC
1.72239108409%	34	1974	311	Mendelian_Nancy_Cox	JIANG_HYPOXIA_NORMAL
1.72239108409%	34	1974	271	Mendelian_Nancy_Cox	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
1.72239108409%	34	1974	260	Mendelian_Nancy_Cox	SENESE_HDAC1_TARGETS_DN
1.72239108409%	34	1974	252	Mendelian_Nancy_Cox	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
1.72239108409%	34	1974	246	Mendelian_Nancy_Cox	BILD_E2F3_ONCOGENIC_SIGNATURE
1.72239108409%	34	1974	243	Mendelian_Nancy_Cox	CHICAS_RB1_TARGETS_GROWING
1.72239108409%	34	1974	242	Mendelian_Nancy_Cox	MULLIGHAN_MLL_SIGNATURE_1_DN
1.72239108409%	34	1974	240	Mendelian_Nancy_Cox	VANTVEER_BREAST_CANCER_ESR1_DN
1.72239108409%	34	1974	240	Mendelian_Nancy_Cox	UDAYAKUMAR_MED1_TARGETS_DN
1.72239108409%	34	1974	226	Mendelian_Nancy_Cox	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
1.72239108409%	34	1974	203	Mendelian_Nancy_Cox	PENG_RAPAMYCIN_RESPONSE_UP
1.72239108409%	34	1974	196	Mendelian_Nancy_Cox	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
1.72239108409%	34	1974	187	Mendelian_Nancy_Cox	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
1.72239108409%	34	1974	182	Mendelian_Nancy_Cox	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
1.72239108409%	34	1974	178	Mendelian_Nancy_Cox	LI_AMPLIFIED_IN_LUNG_CANCER
1.72239108409%	34	1974	178	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_18HR_DN
1.72239108409%	34	1974	176	Mendelian_Nancy_Cox	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
1.72239108409%	34	1974	162	Mendelian_Nancy_Cox	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
1.72239108409%	34	1974	159	Mendelian_Nancy_Cox	KEGG_PURINE_METABOLISM
1.72239108409%	34	1974	155	Mendelian_Nancy_Cox	KEGG_JAK_STAT_SIGNALING_PATHWAY
1.72239108409%	34	1974	150	Mendelian_Nancy_Cox	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
1.72239108409%	34	1974	142	Mendelian_Nancy_Cox	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
1.72239108409%	34	1974	117	Mendelian_Nancy_Cox	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
1.71086398631%	20	1169	781	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GOZGIT_ESR1_TARGETS_DN
1.71086398631%	20	1169	769	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NUYTTEN_NIPP1_TARGETS_UP
1.71086398631%	20	1169	634	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
1.71086398631%	20	1169	491	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SWEET_LUNG_CANCER_KRAS_UP
1.71086398631%	20	1169	457	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
1.71086398631%	20	1169	442	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
1.71086398631%	20	1169	442	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HAN_SATB1_TARGETS_DN
1.71086398631%	20	1169	439	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MITSIADES_RESPONSE_TO_APLIDIN_UP
1.71086398631%	20	1169	431	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GARY_CD5_TARGETS_DN
1.71086398631%	20	1169	425	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
1.71086398631%	20	1169	418	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MULLIGHAN_MLL_SIGNATURE_2_UP
1.71086398631%	20	1169	406	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OSMAN_BLADDER_CANCER_DN
1.71086398631%	20	1169	378	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
1.71086398631%	20	1169	293	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ENK_UV_RESPONSE_EPIDERMIS_UP
1.71086398631%	20	1169	222	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CAIRO_LIVER_DEVELOPMENT_DN
1.71031533939%	32	1871	391	T2D_GENES_TANYA_HEIGHT	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
1.71031533939%	32	1871	352	T2D_GENES_TANYA_HEIGHT	WANG_LMO4_TARGETS_DN
1.71031533939%	32	1871	336	T2D_GENES_TANYA_HEIGHT	JOHNSTONE_PARVB_TARGETS_2_DN
1.71031533939%	32	1871	325	T2D_GENES_TANYA_HEIGHT	REACTOME_CELL_CYCLE_MITOTIC
1.71031533939%	32	1871	311	T2D_GENES_TANYA_HEIGHT	JIANG_HYPOXIA_NORMAL
1.71031533939%	32	1871	244	T2D_GENES_TANYA_HEIGHT	DAZARD_RESPONSE_TO_UV_NHEK_UP
1.71031533939%	32	1871	240	T2D_GENES_TANYA_HEIGHT	UDAYAKUMAR_MED1_TARGETS_DN
1.70454545455%	60	3520	634	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
1.70454545455%	60	3520	602	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTINEZ_TP53_TARGETS_UP
1.70454545455%	60	3520	591	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTINEZ_RB1_AND_TP53_TARGETS_DN
1.70454545455%	60	3520	443	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DELYS_THYROID_CANCER_UP
1.70454545455%	60	3520	335	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
1.70193192272%	37	2174	489	T2D_GENES_TANYA_LIPIDS	LIM_MAMMARY_STEM_CELL_UP
1.70193192272%	37	2174	388	T2D_GENES_TANYA_LIPIDS	STEIN_ESRRA_TARGETS_UP
1.70193192272%	37	2174	275	T2D_GENES_TANYA_LIPIDS	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
1.70193192272%	37	2174	267	T2D_GENES_TANYA_LIPIDS	KEGG_MAPK_SIGNALING_PATHWAY
1.70193192272%	37	2174	261	T2D_GENES_TANYA_LIPIDS	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
1.6884113584%	22	1303	783	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
1.6884113584%	22	1303	718	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_ES_ICP_WITH_H3K4ME3
1.6884113584%	22	1303	668	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
1.6884113584%	22	1303	634	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
1.6884113584%	22	1303	578	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
1.6884113584%	22	1303	564	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMID_BREAST_CANCER_LUMINAL_B_DN
1.6884113584%	22	1303	557	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TIEN_INTESTINE_PROBIOTICS_24HR_UP
1.6884113584%	22	1303	548	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_ALL_DISORDERS_CALB1_CORR_UP
1.6884113584%	22	1303	536	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
1.6884113584%	22	1303	518	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
1.6884113584%	22	1303	514	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
1.67613636364%	59	3520	940	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
1.67613636364%	59	3520	920	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_GPCR
1.67613636364%	59	3520	601	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTINEZ_RB1_AND_TP53_TARGETS_UP
1.67613636364%	59	3520	593	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTINEZ_TP53_TARGETS_DN
1.67613636364%	59	3520	590	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
1.67613636364%	59	3520	491	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SWEET_LUNG_CANCER_KRAS_UP
1.67613636364%	59	3520	462	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DELACROIX_RAR_BOUND_ES
1.6717325228%	33	1974	64	Mendelian_Nancy_Cox	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
1.6717325228%	33	1974	473	Mendelian_Nancy_Cox	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
1.6717325228%	33	1974	329	Mendelian_Nancy_Cox	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
1.6717325228%	33	1974	293	Mendelian_Nancy_Cox	IVANOVA_HEMATOPOIESIS_MATURE_CELL
1.6717325228%	33	1974	290	Mendelian_Nancy_Cox	BASAKI_YBX1_TARGETS_UP
1.6717325228%	33	1974	217	Mendelian_Nancy_Cox	REACTOME_SIGNALLING_BY_NGF
1.6717325228%	33	1974	204	Mendelian_Nancy_Cox	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
1.6717325228%	33	1974	198	Mendelian_Nancy_Cox	WELCSH_BRCA1_TARGETS_UP
1.6717325228%	33	1974	191	Mendelian_Nancy_Cox	YAGI_AML_FAB_MARKERS
1.6717325228%	33	1974	171	Mendelian_Nancy_Cox	ELVIDGE_HYPOXIA_UP
1.6717325228%	33	1974	163	Mendelian_Nancy_Cox	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
1.6717325228%	33	1974	157	Mendelian_Nancy_Cox	SERVITJA_LIVER_HNF1A_TARGETS_DN
1.6717325228%	33	1974	154	Mendelian_Nancy_Cox	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
1.6717325228%	33	1974	146	Mendelian_Nancy_Cox	LEE_NEURAL_CREST_STEM_CELL_UP
1.6717325228%	33	1974	128	Mendelian_Nancy_Cox	POTTI_TOPOTECAN_SENSITIVITY
1.6717325228%	33	1974	127	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
1.6717325228%	33	1974	100	Mendelian_Nancy_Cox	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
1.66414523449%	11	661	584	T2D_GENES_TANYA_GLYCEMIC	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
1.66414523449%	11	661	537	T2D_GENES_TANYA_GLYCEMIC	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
1.66414523449%	11	661	536	T2D_GENES_TANYA_GLYCEMIC	BERENJENO_TRANSFORMED_BY_RHOA_UP
1.66414523449%	11	661	464	T2D_GENES_TANYA_GLYCEMIC	ONDER_CDH1_TARGETS_2_DN
1.66414523449%	11	661	431	T2D_GENES_TANYA_GLYCEMIC	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
1.66414523449%	11	661	418	T2D_GENES_TANYA_GLYCEMIC	RUTELLA_RESPONSE_TO_HGF_UP
1.66414523449%	11	661	408	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GPCR_LIGAND_BINDING
1.66414523449%	11	661	391	T2D_GENES_TANYA_GLYCEMIC	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
1.66414523449%	11	661	384	T2D_GENES_TANYA_GLYCEMIC	BASAKI_YBX1_TARGETS_DN
1.66414523449%	11	661	382	T2D_GENES_TANYA_GLYCEMIC	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
1.66414523449%	11	661	379	T2D_GENES_TANYA_GLYCEMIC	BENPORATH_ES_1
1.66414523449%	11	661	368	T2D_GENES_TANYA_GLYCEMIC	YAGI_AML_WITH_T_8_21_TRANSLOCATION
1.66414523449%	11	661	349	T2D_GENES_TANYA_GLYCEMIC	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
1.66414523449%	11	661	346	T2D_GENES_TANYA_GLYCEMIC	GOLDRATH_ANTIGEN_RESPONSE
1.66414523449%	11	661	338	T2D_GENES_TANYA_GLYCEMIC	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
1.66414523449%	11	661	326	T2D_GENES_TANYA_GLYCEMIC	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
1.66414523449%	11	661	318	T2D_GENES_TANYA_GLYCEMIC	DAZARD_RESPONSE_TO_UV_NHEK_DN
1.66414523449%	11	661	317	T2D_GENES_TANYA_GLYCEMIC	BRUINS_UVC_RESPONSE_EARLY_LATE
1.66414523449%	11	661	316	T2D_GENES_TANYA_GLYCEMIC	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
1.66414523449%	11	661	314	T2D_GENES_TANYA_GLYCEMIC	DOUGLAS_BMI1_TARGETS_DN
1.66414523449%	11	661	307	T2D_GENES_TANYA_GLYCEMIC	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
1.66414523449%	11	661	306	T2D_GENES_TANYA_GLYCEMIC	CHANDRAN_METASTASIS_DN
1.66414523449%	11	661	302	T2D_GENES_TANYA_GLYCEMIC	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
1.66414523449%	11	661	298	T2D_GENES_TANYA_GLYCEMIC	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
1.66414523449%	11	661	289	T2D_GENES_TANYA_GLYCEMIC	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
1.66414523449%	11	661	275	T2D_GENES_TANYA_GLYCEMIC	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
1.66414523449%	11	661	268	T2D_GENES_TANYA_GLYCEMIC	XU_GH1_AUTOCRINE_TARGETS_UP
1.66414523449%	11	661	267	T2D_GENES_TANYA_GLYCEMIC	HOLLMANN_APOPTOSIS_VIA_CD40_DN
1.66414523449%	11	661	262	T2D_GENES_TANYA_GLYCEMIC	LU_AGING_BRAIN_UP
1.66414523449%	11	661	258	T2D_GENES_TANYA_GLYCEMIC	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
1.66414523449%	11	661	251	T2D_GENES_TANYA_GLYCEMIC	REACTOME_AXON_GUIDANCE
1.66414523449%	11	661	249	T2D_GENES_TANYA_GLYCEMIC	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
1.66414523449%	11	661	246	T2D_GENES_TANYA_GLYCEMIC	VERHAAK_AML_WITH_NPM1_MUTATED_DN
1.66414523449%	11	661	243	T2D_GENES_TANYA_GLYCEMIC	CHICAS_RB1_TARGETS_GROWING
1.66414523449%	11	661	232	T2D_GENES_TANYA_GLYCEMIC	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
1.66414523449%	11	661	227	T2D_GENES_TANYA_GLYCEMIC	RAO_BOUND_BY_SALL4
1.66414523449%	11	661	227	T2D_GENES_TANYA_GLYCEMIC	LEE_RECENT_THYMIC_EMIGRANT
1.66414523449%	11	661	221	T2D_GENES_TANYA_GLYCEMIC	ZHANG_TLX_TARGETS_36HR_UP
1.66414523449%	11	661	217	T2D_GENES_TANYA_GLYCEMIC	SANSOM_APC_MYC_TARGETS
1.66414523449%	11	661	211	T2D_GENES_TANYA_GLYCEMIC	FOSTER_KDM1A_TARGETS_DN
1.66414523449%	11	661	210	T2D_GENES_TANYA_GLYCEMIC	SANSOM_APC_TARGETS_REQUIRE_MYC
1.66414523449%	11	661	207	T2D_GENES_TANYA_GLYCEMIC	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
1.66414523449%	11	661	183	T2D_GENES_TANYA_GLYCEMIC	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
1.6620498615%	6	361	88	T2D_GENES_TANYA_T2D_RSQ05_02CM	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
1.6620498615%	6	361	775	T2D_GENES_TANYA_T2D_RSQ05_02CM	BENPORATH_MYC_MAX_TARGETS
1.6620498615%	6	361	734	T2D_GENES_TANYA_T2D_RSQ05_02CM	BENPORATH_SOX2_TARGETS
1.6620498615%	6	361	721	T2D_GENES_TANYA_T2D_RSQ05_02CM	WONG_ADULT_TISSUE_STEM_MODULE
1.6620498615%	6	361	712	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHLOSSER_SERUM_RESPONSE_DN
1.6620498615%	6	361	648	T2D_GENES_TANYA_T2D_RSQ05_02CM	BENPORATH_CYCLING_GENES
1.6620498615%	6	361	593	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARTINEZ_TP53_TARGETS_DN
1.6620498615%	6	361	591	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARTINEZ_RB1_AND_TP53_TARGETS_DN
1.6620498615%	6	361	590	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
1.6620498615%	6	361	578	T2D_GENES_TANYA_T2D_RSQ05_02CM	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
1.6620498615%	6	361	564	T2D_GENES_TANYA_T2D_RSQ05_02CM	SMID_BREAST_CANCER_LUMINAL_B_DN
1.6620498615%	6	361	549	T2D_GENES_TANYA_T2D_RSQ05_02CM	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
1.6620498615%	6	361	543	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARTINEZ_RB1_TARGETS_DN
1.6620498615%	6	361	540	T2D_GENES_TANYA_T2D_RSQ05_02CM	ACEVEDO_LIVER_CANCER_DN
1.6620498615%	6	361	536	T2D_GENES_TANYA_T2D_RSQ05_02CM	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
1.6620498615%	6	361	536	T2D_GENES_TANYA_T2D_RSQ05_02CM	BERENJENO_TRANSFORMED_BY_RHOA_UP
1.6620498615%	6	361	517	T2D_GENES_TANYA_T2D_RSQ05_02CM	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
1.6620498615%	6	361	514	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
1.6620498615%	6	361	501	T2D_GENES_TANYA_T2D_RSQ05_02CM	SENESE_HDAC3_TARGETS_UP
1.6620498615%	6	361	476	T2D_GENES_TANYA_T2D_RSQ05_02CM	SMID_BREAST_CANCER_NORMAL_LIKE_UP
1.6620498615%	6	361	463	T2D_GENES_TANYA_T2D_RSQ05_02CM	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
1.6620498615%	6	361	462	T2D_GENES_TANYA_T2D_RSQ05_02CM	DELACROIX_RAR_BOUND_ES
1.6620498615%	6	361	460	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
1.6620498615%	6	361	459	T2D_GENES_TANYA_T2D_RSQ05_02CM	KIM_WT1_TARGETS_DN
1.6620498615%	6	361	45	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_HNF3BPATHWAY
1.6620498615%	6	361	445	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
1.6620498615%	6	361	435	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
1.6620498615%	6	361	431	T2D_GENES_TANYA_T2D_RSQ05_02CM	GARY_CD5_TARGETS_DN
1.6620498615%	6	361	428	T2D_GENES_TANYA_T2D_RSQ05_02CM	CUI_TCF21_TARGETS_2_UP
1.6620498615%	6	361	424	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHEN_SMARCA2_TARGETS_UP
1.6620498615%	6	361	421	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_CELL_CYCLE
1.6620498615%	6	361	403	T2D_GENES_TANYA_T2D_RSQ05_02CM	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
1.6620498615%	6	361	392	T2D_GENES_TANYA_T2D_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_2B
1.6620498615%	6	361	380	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAIRKEE_TERT_TARGETS_UP
1.6620498615%	6	361	366	T2D_GENES_TANYA_T2D_RSQ05_02CM	SANSOM_APC_TARGETS_DN
1.6620498615%	6	361	351	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAGI_AML_WITH_11Q23_REARRANGED
1.6620498615%	6	361	346	T2D_GENES_TANYA_T2D_RSQ05_02CM	GOLDRATH_ANTIGEN_RESPONSE
1.6620498615%	6	361	342	T2D_GENES_TANYA_T2D_RSQ05_02CM	BLUM_RESPONSE_TO_SALIRASIB_DN
1.6620498615%	6	361	341	T2D_GENES_TANYA_T2D_RSQ05_02CM	MULLIGHAN_NPM1_SIGNATURE_3_UP
1.6620498615%	6	361	337	T2D_GENES_TANYA_T2D_RSQ05_02CM	PENG_GLUTAMINE_DEPRIVATION_DN
1.6620498615%	6	361	325	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_CELL_CYCLE_MITOTIC
1.6620498615%	6	361	315	T2D_GENES_TANYA_T2D_RSQ05_02CM	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
1.6620498615%	6	361	309	T2D_GENES_TANYA_T2D_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
1.6620498615%	6	361	294	T2D_GENES_TANYA_T2D_RSQ05_02CM	WEST_ADRENOCORTICAL_TUMOR_UP
1.6620498615%	6	361	287	T2D_GENES_TANYA_T2D_RSQ05_02CM	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
1.6620498615%	6	361	264	T2D_GENES_TANYA_T2D_RSQ05_02CM	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
1.6620498615%	6	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG
1.6620498615%	6	361	241	T2D_GENES_TANYA_T2D_RSQ05_02CM	DOANE_RESPONSE_TO_ANDROGEN_DN
1.6620498615%	6	361	232	T2D_GENES_TANYA_T2D_RSQ05_02CM	DELYS_THYROID_CANCER_DN
1.6620498615%	6	361	212	T2D_GENES_TANYA_T2D_RSQ05_02CM	SANSOM_APC_TARGETS
1.6620498615%	6	361	210	T2D_GENES_TANYA_T2D_RSQ05_02CM	RIZKI_TUMOR_INVASIVENESS_3D_UP
1.6620498615%	6	361	203	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRUETZMANN_PANCREATIC_CANCER_DN
1.6620498615%	6	361	180	T2D_GENES_TANYA_T2D_RSQ05_02CM	DARWICHE_PAPILLOMA_RISK_HIGH_DN
1.66051660517%	9	542	634	T2D_GENES_TANYA_ANTHROPOMETRIC	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
1.66051660517%	9	542	536	T2D_GENES_TANYA_ANTHROPOMETRIC	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
1.66051660517%	9	542	536	T2D_GENES_TANYA_ANTHROPOMETRIC	BERENJENO_TRANSFORMED_BY_RHOA_UP
1.66051660517%	9	542	501	T2D_GENES_TANYA_ANTHROPOMETRIC	SENESE_HDAC3_TARGETS_UP
1.66051660517%	9	542	491	T2D_GENES_TANYA_ANTHROPOMETRIC	MEISSNER_NPC_HCP_WITH_H3K4ME2
1.66051660517%	9	542	489	T2D_GENES_TANYA_ANTHROPOMETRIC	LIM_MAMMARY_STEM_CELL_UP
1.66051660517%	9	542	434	T2D_GENES_TANYA_ANTHROPOMETRIC	BAELDE_DIABETIC_NEPHROPATHY_DN
1.66051660517%	9	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
1.66051660517%	9	542	414	T2D_GENES_TANYA_ANTHROPOMETRIC	LU_EZH2_TARGETS_DN
1.66051660517%	9	542	411	T2D_GENES_TANYA_ANTHROPOMETRIC	KOYAMA_SEMA3B_TARGETS_DN
1.66051660517%	9	542	408	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GPCR_LIGAND_BINDING
1.66051660517%	9	542	405	T2D_GENES_TANYA_ANTHROPOMETRIC	KUMAR_TARGETS_OF_MLL_AF9_FUSION
1.66051660517%	9	542	380	T2D_GENES_TANYA_ANTHROPOMETRIC	DAIRKEE_TERT_TARGETS_UP
1.66051660517%	9	542	355	T2D_GENES_TANYA_ANTHROPOMETRIC	PEREZ_TP63_TARGETS
1.66051660517%	9	542	353	T2D_GENES_TANYA_ANTHROPOMETRIC	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
1.66051660517%	9	542	344	T2D_GENES_TANYA_ANTHROPOMETRIC	RICKMAN_METASTASIS_UP
1.66051660517%	9	542	324	T2D_GENES_TANYA_ANTHROPOMETRIC	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
1.66051660517%	9	542	320	T2D_GENES_TANYA_ANTHROPOMETRIC	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
1.66051660517%	9	542	317	T2D_GENES_TANYA_ANTHROPOMETRIC	HELLER_HDAC_TARGETS_UP
1.66051660517%	9	542	316	T2D_GENES_TANYA_ANTHROPOMETRIC	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
1.66051660517%	9	542	310	T2D_GENES_TANYA_ANTHROPOMETRIC	HORIUCHI_WTAP_TARGETS_DN
1.66051660517%	9	542	305	T2D_GENES_TANYA_ANTHROPOMETRIC	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
1.66051660517%	9	542	296	T2D_GENES_TANYA_ANTHROPOMETRIC	DURAND_STROMA_MAX_UP
1.66051660517%	9	542	294	T2D_GENES_TANYA_ANTHROPOMETRIC	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
1.66051660517%	9	542	293	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHANG_TLX_TARGETS_60HR_UP
1.66051660517%	9	542	292	T2D_GENES_TANYA_ANTHROPOMETRIC	KOYAMA_SEMA3B_TARGETS_UP
1.66051660517%	9	542	289	T2D_GENES_TANYA_ANTHROPOMETRIC	MANALO_HYPOXIA_DN
1.66051660517%	9	542	284	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_METABOLISM_OF_MRNA
1.66051660517%	9	542	279	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_NEURONAL_SYSTEM
1.66051660517%	9	542	277	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHANG_TLX_TARGETS_60HR_DN
1.66051660517%	9	542	261	T2D_GENES_TANYA_ANTHROPOMETRIC	RICKMAN_METASTASIS_DN
1.66051660517%	9	542	260	T2D_GENES_TANYA_ANTHROPOMETRIC	SENESE_HDAC1_TARGETS_DN
1.66051660517%	9	542	253	T2D_GENES_TANYA_ANTHROPOMETRIC	DANG_REGULATED_BY_MYC_DN
1.66051660517%	9	542	240	T2D_GENES_TANYA_ANTHROPOMETRIC	UDAYAKUMAR_MED1_TARGETS_DN
1.66051660517%	9	542	239	T2D_GENES_TANYA_ANTHROPOMETRIC	ALFANO_MYC_TARGETS
1.66051660517%	9	542	238	T2D_GENES_TANYA_ANTHROPOMETRIC	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
1.66051660517%	9	542	230	T2D_GENES_TANYA_ANTHROPOMETRIC	KAUFFMANN_DNA_REPAIR_GENES
1.66051660517%	9	542	225	T2D_GENES_TANYA_ANTHROPOMETRIC	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
1.66051660517%	9	542	225	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_16HR_UP
1.66051660517%	9	542	217	T2D_GENES_TANYA_ANTHROPOMETRIC	WONG_MITOCHONDRIA_GENE_MODULE
1.66051660517%	9	542	217	T2D_GENES_TANYA_ANTHROPOMETRIC	SANSOM_APC_MYC_TARGETS
1.66051660517%	9	542	210	T2D_GENES_TANYA_ANTHROPOMETRIC	SANSOM_APC_TARGETS_REQUIRE_MYC
1.66051660517%	9	542	210	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
1.66051660517%	9	542	209	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_WT1_TARGETS_12HR_DN
1.66051660517%	9	542	206	T2D_GENES_TANYA_ANTHROPOMETRIC	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
1.66051660517%	9	542	203	T2D_GENES_TANYA_ANTHROPOMETRIC	PENG_RAPAMYCIN_RESPONSE_UP
1.66051660517%	9	542	185	T2D_GENES_TANYA_ANTHROPOMETRIC	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
1.66051660517%	9	542	185	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_LIVER_CANCER_SURVIVAL_UP
1.66051660517%	9	542	183	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_ENDOCYTOSIS
1.66051660517%	9	542	181	T2D_GENES_TANYA_ANTHROPOMETRIC	JISON_SICKLE_CELL_DISEASE_DN
1.66051660517%	9	542	178	T2D_GENES_TANYA_ANTHROPOMETRIC	LI_AMPLIFIED_IN_LUNG_CANCER
1.66051660517%	9	542	169	T2D_GENES_TANYA_ANTHROPOMETRIC	PENG_GLUCOSE_DEPRIVATION_DN
1.66051660517%	9	542	162	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_WT1_TARGETS_12HR_UP
1.66051660517%	9	542	158	T2D_GENES_TANYA_ANTHROPOMETRIC	RODRIGUES_NTN1_TARGETS_DN
1.66051660517%	9	542	145	T2D_GENES_TANYA_ANTHROPOMETRIC	SMITH_TERT_TARGETS_UP
1.66051660517%	9	542	140	T2D_GENES_TANYA_ANTHROPOMETRIC	ONDER_CDH1_TARGETS_1_UP
1.66051660517%	9	542	139	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_BIOLOGICAL_OXIDATIONS
1.66051660517%	9	542	139	T2D_GENES_TANYA_ANTHROPOMETRIC	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
1.66051660517%	9	542	137	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
1.65686798503%	31	1871	73	T2D_GENES_TANYA_HEIGHT	REACTOME_MEIOTIC_SYNAPSIS
1.65686798503%	31	1871	481	T2D_GENES_TANYA_HEIGHT	LIU_PROSTATE_CANCER_DN
1.65686798503%	31	1871	457	T2D_GENES_TANYA_HEIGHT	SENESE_HDAC1_TARGETS_UP
1.65686798503%	31	1871	378	T2D_GENES_TANYA_HEIGHT	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
1.65686798503%	31	1871	371	T2D_GENES_TANYA_HEIGHT	WANG_SMARCE1_TARGETS_DN
1.65686798503%	31	1871	358	T2D_GENES_TANYA_HEIGHT	GRUETZMANN_PANCREATIC_CANCER_UP
1.65686798503%	31	1871	338	T2D_GENES_TANYA_HEIGHT	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
1.65686798503%	31	1871	335	T2D_GENES_TANYA_HEIGHT	WONG_EMBRYONIC_STEM_CELL_CORE
1.65686798503%	31	1871	326	T2D_GENES_TANYA_HEIGHT	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
1.65686798503%	31	1871	309	T2D_GENES_TANYA_HEIGHT	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
1.65686798503%	31	1871	285	T2D_GENES_TANYA_HEIGHT	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
1.65686798503%	31	1871	279	T2D_GENES_TANYA_HEIGHT	REACTOME_NEURONAL_SYSTEM
1.65686798503%	31	1871	276	T2D_GENES_TANYA_HEIGHT	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
1.65686798503%	31	1871	265	T2D_GENES_TANYA_HEIGHT	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
1.65686798503%	31	1871	251	T2D_GENES_TANYA_HEIGHT	KOBAYASHI_EGFR_SIGNALING_24HR_DN
1.65686798503%	31	1871	245	T2D_GENES_TANYA_HEIGHT	PENG_RAPAMYCIN_RESPONSE_DN
1.65686798503%	31	1871	220	T2D_GENES_TANYA_HEIGHT	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
1.65593376265%	36	2174	491	T2D_GENES_TANYA_LIPIDS	ZHENG_BOUND_BY_FOXP3
1.65593376265%	36	2174	408	T2D_GENES_TANYA_LIPIDS	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
1.65593376265%	36	2174	372	T2D_GENES_TANYA_LIPIDS	WANG_LMO4_TARGETS_UP
1.65593376265%	36	2174	366	T2D_GENES_TANYA_LIPIDS	YOSHIMURA_MAPK8_TARGETS_DN
1.65593376265%	36	2174	357	T2D_GENES_TANYA_LIPIDS	SHEN_SMARCA2_TARGETS_DN
1.65593376265%	36	2174	323	T2D_GENES_TANYA_LIPIDS	GRESHOCK_CANCER_COPY_NUMBER_UP
1.65593376265%	36	2174	320	T2D_GENES_TANYA_LIPIDS	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
1.65593376265%	36	2174	307	T2D_GENES_TANYA_LIPIDS	LI_INDUCED_T_TO_NATURAL_KILLER_UP
1.65593376265%	36	2174	302	T2D_GENES_TANYA_LIPIDS	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
1.65593376265%	36	2174	276	T2D_GENES_TANYA_LIPIDS	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
1.65593376265%	36	2174	217	T2D_GENES_TANYA_LIPIDS	SANSOM_APC_MYC_TARGETS
1.65593376265%	36	2174	211	T2D_GENES_TANYA_LIPIDS	FOSTER_KDM1A_TARGETS_DN
1.65593376265%	36	2174	180	T2D_GENES_TANYA_LIPIDS	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
1.65593376265%	36	2174	116	T2D_GENES_TANYA_LIPIDS	REACTOME_MEIOSIS
1.6548463357%	21	1269	745	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_BMP2_TARGETS_UP
1.6548463357%	21	1269	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_MEIOTIC_SYNAPSIS
1.6548463357%	21	1269	652	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BENPORATH_PRC2_TARGETS
1.6548463357%	21	1269	648	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMID_BREAST_CANCER_BASAL_UP
1.6548463357%	21	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE
1.6548463357%	21	1269	535	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STEIN_ESRRA_TARGETS
1.6548463357%	21	1269	517	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RAO_BOUND_BY_SALL4_ISOFORM_B
1.6548463357%	21	1269	479	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
1.6548463357%	21	1269	456	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARTENS_BOUND_BY_PML_RARA_FUSION
1.6548463357%	21	1269	413	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
1.6548463357%	21	1269	380	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
1.6548463357%	21	1269	276	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
1.64772727273%	58	3520	564	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMID_BREAST_CANCER_LUMINAL_B_DN
1.64772727273%	58	3520	549	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
1.64772727273%	58	3520	536	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
1.64772727273%	58	3520	510	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING
1.63132137031%	10	613	93	T2D_GENES_TANYA_BIOMARKER	CADWELL_ATG16L1_TARGETS_UP
1.63132137031%	10	613	578	T2D_GENES_TANYA_BIOMARKER	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
1.63132137031%	10	613	491	T2D_GENES_TANYA_BIOMARKER	MEISSNER_NPC_HCP_WITH_H3K4ME2
1.63132137031%	10	613	464	T2D_GENES_TANYA_BIOMARKER	ONDER_CDH1_TARGETS_2_DN
1.63132137031%	10	613	448	T2D_GENES_TANYA_BIOMARKER	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
1.63132137031%	10	613	443	T2D_GENES_TANYA_BIOMARKER	DELYS_THYROID_CANCER_UP
1.63132137031%	10	613	442	T2D_GENES_TANYA_BIOMARKER	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
1.63132137031%	10	613	434	T2D_GENES_TANYA_BIOMARKER	BAELDE_DIABETIC_NEPHROPATHY_DN
1.63132137031%	10	613	418	T2D_GENES_TANYA_BIOMARKER	RUTELLA_RESPONSE_TO_HGF_UP
1.63132137031%	10	613	414	T2D_GENES_TANYA_BIOMARKER	MOHANKUMAR_TLX1_TARGETS_UP
1.63132137031%	10	613	414	T2D_GENES_TANYA_BIOMARKER	LU_EZH2_TARGETS_DN
1.63132137031%	10	613	408	T2D_GENES_TANYA_BIOMARKER	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
1.63132137031%	10	613	389	T2D_GENES_TANYA_BIOMARKER	HSIAO_HOUSEKEEPING_GENES
1.63132137031%	10	613	384	T2D_GENES_TANYA_BIOMARKER	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
1.63132137031%	10	613	368	T2D_GENES_TANYA_BIOMARKER	YAGI_AML_WITH_T_8_21_TRANSLOCATION
1.63132137031%	10	613	368	T2D_GENES_TANYA_BIOMARKER	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
1.63132137031%	10	613	349	T2D_GENES_TANYA_BIOMARKER	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
1.63132137031%	10	613	337	T2D_GENES_TANYA_BIOMARKER	PHONG_TNF_RESPONSE_NOT_VIA_P38
1.63132137031%	10	613	335	T2D_GENES_TANYA_BIOMARKER	WONG_EMBRYONIC_STEM_CELL_CORE
1.63132137031%	10	613	329	T2D_GENES_TANYA_BIOMARKER	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
1.63132137031%	10	613	324	T2D_GENES_TANYA_BIOMARKER	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
1.63132137031%	10	613	321	T2D_GENES_TANYA_BIOMARKER	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
1.63132137031%	10	613	320	T2D_GENES_TANYA_BIOMARKER	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
1.63132137031%	10	613	315	T2D_GENES_TANYA_BIOMARKER	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
1.63132137031%	10	613	311	T2D_GENES_TANYA_BIOMARKER	JIANG_HYPOXIA_NORMAL
1.63132137031%	10	613	307	T2D_GENES_TANYA_BIOMARKER	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
1.63132137031%	10	613	302	T2D_GENES_TANYA_BIOMARKER	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
1.63132137031%	10	613	295	T2D_GENES_TANYA_BIOMARKER	LU_EZH2_TARGETS_UP
1.63132137031%	10	613	293	T2D_GENES_TANYA_BIOMARKER	ZHANG_TLX_TARGETS_60HR_UP
1.63132137031%	10	613	281	T2D_GENES_TANYA_BIOMARKER	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
1.63132137031%	10	613	280	T2D_GENES_TANYA_BIOMARKER	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
1.63132137031%	10	613	270	T2D_GENES_TANYA_BIOMARKER	RIZKI_TUMOR_INVASIVENESS_3D_DN
1.63132137031%	10	613	264	T2D_GENES_TANYA_BIOMARKER	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
1.63132137031%	10	613	241	T2D_GENES_TANYA_BIOMARKER	DOANE_RESPONSE_TO_ANDROGEN_DN
1.63132137031%	10	613	232	T2D_GENES_TANYA_BIOMARKER	DELYS_THYROID_CANCER_DN
1.63132137031%	10	613	227	T2D_GENES_TANYA_BIOMARKER	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
1.63132137031%	10	613	199	T2D_GENES_TANYA_BIOMARKER	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
1.63132137031%	10	613	196	T2D_GENES_TANYA_BIOMARKER	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
1.63132137031%	10	613	185	T2D_GENES_TANYA_BIOMARKER	LEE_LIVER_CANCER_SURVIVAL_UP
1.63132137031%	10	613	182	T2D_GENES_TANYA_BIOMARKER	FERNANDEZ_BOUND_BY_MYC
1.63132137031%	10	613	176	T2D_GENES_TANYA_BIOMARKER	SASAKI_ADULT_T_CELL_LEUKEMIA
1.63132137031%	10	613	174	T2D_GENES_TANYA_BIOMARKER	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
1.63132137031%	10	613	172	T2D_GENES_TANYA_BIOMARKER	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
1.63132137031%	10	613	169	T2D_GENES_TANYA_BIOMARKER	PENG_GLUCOSE_DEPRIVATION_DN
1.63132137031%	10	613	157	T2D_GENES_TANYA_BIOMARKER	SERVITJA_LIVER_HNF1A_TARGETS_DN
1.63132137031%	10	613	10	T2D_GENES_TANYA_BIOMARKER	NIKOLSKY_BREAST_CANCER_17P11_AMPLICON
1.625320787%	19	1169	805	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GPCR_DOWNSTREAM_SIGNALING
1.625320787%	19	1169	546	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEST_ADRENOCORTICAL_TUMOR_DN
1.625320787%	19	1169	530	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ENK_UV_RESPONSE_KERATINOCYTE_UP
1.625320787%	19	1169	514	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
1.625320787%	19	1169	504	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_48HR_DN
1.625320787%	19	1169	469	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCCABE_BOUND_BY_HOXC6
1.625320787%	19	1169	429	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOOTHA_HUMAN_MITODB_6_2002
1.625320787%	19	1169	419	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
1.625320787%	19	1169	397	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
1.625320787%	19	1169	380	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MULLIGHAN_MLL_SIGNATURE_1_UP
1.625320787%	19	1169	380	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAIRKEE_TERT_TARGETS_UP
1.625320787%	19	1169	366	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SANSOM_APC_TARGETS_DN
1.625320787%	19	1169	352	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_LMO4_TARGETS_DN
1.625320787%	19	1169	318	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEI_MYB_TARGETS
1.625320787%	19	1169	226	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_DNA_DAMAGE_UP
1.625320787%	19	1169	179	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
1.625320787%	19	1169	140	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
1.6210739615%	32	1974	91	Mendelian_Nancy_Cox	ZHU_CMV_24_HR_DN
1.6210739615%	32	1974	76	Mendelian_Nancy_Cox	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
1.6210739615%	32	1974	73	Mendelian_Nancy_Cox	KEGG_CHRONIC_MYELOID_LEUKEMIA
1.6210739615%	32	1974	66	Mendelian_Nancy_Cox	PID_INTEGRIN1_PATHWAY
1.6210739615%	32	1974	344	Mendelian_Nancy_Cox	RICKMAN_METASTASIS_UP
1.6210739615%	32	1974	335	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
1.6210739615%	32	1974	335	Mendelian_Nancy_Cox	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
1.6210739615%	32	1974	277	Mendelian_Nancy_Cox	ZHANG_TLX_TARGETS_60HR_DN
1.6210739615%	32	1974	261	Mendelian_Nancy_Cox	BILD_HRAS_ONCOGENIC_SIGNATURE
1.6210739615%	32	1974	221	Mendelian_Nancy_Cox	ZHANG_TLX_TARGETS_36HR_UP
1.6210739615%	32	1974	217	Mendelian_Nancy_Cox	AMUNDSON_RESPONSE_TO_ARSENITE
1.6210739615%	32	1974	206	Mendelian_Nancy_Cox	BILD_MYC_ONCOGENIC_SIGNATURE
1.6210739615%	32	1974	185	Mendelian_Nancy_Cox	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
1.6210739615%	32	1974	169	Mendelian_Nancy_Cox	KATSANOU_ELAVL1_TARGETS_UP
1.6210739615%	32	1974	160	Mendelian_Nancy_Cox	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
1.6210739615%	32	1974	137	Mendelian_Nancy_Cox	PID_P53DOWNSTREAMPATHWAY
1.6210739615%	32	1974	133	Mendelian_Nancy_Cox	KEGG_PARKINSONS_DISEASE
1.6210739615%	32	1974	108	Mendelian_Nancy_Cox	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
1.61931818182%	57	3520	566	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DOUGLAS_BMI1_TARGETS_UP
1.61931818182%	57	3520	526	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ONKEN_UVEAL_MELANOMA_DN
1.61931818182%	57	3520	463	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
1.61931818182%	57	3520	450	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
1.61290322581%	2	124	98	Diabetes_McGill_Cell_cycle_All_Gene	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
1.61290322581%	2	124	98	Diabetes_McGill_Cell_cycle_All_Gene	NIELSEN_GIST
1.61290322581%	2	124	97	Diabetes_McGill_Cell_cycle_All_Gene	LABBE_WNT3A_TARGETS_DN
1.61290322581%	2	124	96	Diabetes_McGill_Cell_cycle_All_Gene	LIU_PROSTATE_CANCER_UP
1.61290322581%	2	124	95	Diabetes_McGill_Cell_cycle_All_Gene	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
1.61290322581%	2	124	94	Diabetes_McGill_Cell_cycle_All_Gene	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5
1.61290322581%	2	124	94	Diabetes_McGill_Cell_cycle_All_Gene	GAVIN_FOXP3_TARGETS_CLUSTER_T4
1.61290322581%	2	124	920	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_GPCR
1.61290322581%	2	124	92	Diabetes_McGill_Cell_cycle_All_Gene	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
1.61290322581%	2	124	92	Diabetes_McGill_Cell_cycle_All_Gene	HILLION_HMGA1B_TARGETS
1.61290322581%	2	124	90	Diabetes_McGill_Cell_cycle_All_Gene	SANA_TNF_SIGNALING_DN
1.61290322581%	2	124	90	Diabetes_McGill_Cell_cycle_All_Gene	IVANOVSKA_MIR106B_TARGETS
1.61290322581%	2	124	90	Diabetes_McGill_Cell_cycle_All_Gene	HILLION_HMGA1_TARGETS
1.61290322581%	2	124	898	Diabetes_McGill_Cell_cycle_All_Gene	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
1.61290322581%	2	124	89	Diabetes_McGill_Cell_cycle_All_Gene	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
1.61290322581%	2	124	89	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_RNA_POL_I_TRANSCRIPTION
1.61290322581%	2	124	89	Diabetes_McGill_Cell_cycle_All_Gene	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
1.61290322581%	2	124	89	Diabetes_McGill_Cell_cycle_All_Gene	BOYLAN_MULTIPLE_MYELOMA_D_UP
1.61290322581%	2	124	88	Diabetes_McGill_Cell_cycle_All_Gene	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
1.61290322581%	2	124	88	Diabetes_McGill_Cell_cycle_All_Gene	SASSON_RESPONSE_TO_FORSKOLIN_DN
1.61290322581%	2	124	88	Diabetes_McGill_Cell_cycle_All_Gene	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
1.61290322581%	2	124	88	Diabetes_McGill_Cell_cycle_All_Gene	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
1.61290322581%	2	124	88	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_APOPTOSIS
1.61290322581%	2	124	88	Diabetes_McGill_Cell_cycle_All_Gene	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
1.61290322581%	2	124	87	Diabetes_McGill_Cell_cycle_All_Gene	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
1.61290322581%	2	124	87	Diabetes_McGill_Cell_cycle_All_Gene	SAFFORD_T_LYMPHOCYTE_ANERGY
1.61290322581%	2	124	87	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
1.61290322581%	2	124	87	Diabetes_McGill_Cell_cycle_All_Gene	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
1.61290322581%	2	124	86	Diabetes_McGill_Cell_cycle_All_Gene	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
1.61290322581%	2	124	86	Diabetes_McGill_Cell_cycle_All_Gene	BAELDE_DIABETIC_NEPHROPATHY_UP
1.61290322581%	2	124	85	Diabetes_McGill_Cell_cycle_All_Gene	SANA_RESPONSE_TO_IFNG_DN
1.61290322581%	2	124	85	Diabetes_McGill_Cell_cycle_All_Gene	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
1.61290322581%	2	124	84	Diabetes_McGill_Cell_cycle_All_Gene	SWEET_KRAS_TARGETS_UP
1.61290322581%	2	124	84	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
1.61290322581%	2	124	84	Diabetes_McGill_Cell_cycle_All_Gene	LEE_AGING_CEREBELLUM_UP
1.61290322581%	2	124	84	Diabetes_McGill_Cell_cycle_All_Gene	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
1.61290322581%	2	124	84	Diabetes_McGill_Cell_cycle_All_Gene	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
1.61290322581%	2	124	83	Diabetes_McGill_Cell_cycle_All_Gene	WARTERS_RESPONSE_TO_IR_SKIN
1.61290322581%	2	124	83	Diabetes_McGill_Cell_cycle_All_Gene	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
1.61290322581%	2	124	82	Diabetes_McGill_Cell_cycle_All_Gene	ST_INTEGRIN_SIGNALING_PATHWAY
1.61290322581%	2	124	82	Diabetes_McGill_Cell_cycle_All_Gene	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
1.61290322581%	2	124	81	Diabetes_McGill_Cell_cycle_All_Gene	MUNSHI_MULTIPLE_MYELOMA_UP
1.61290322581%	2	124	81	Diabetes_McGill_Cell_cycle_All_Gene	MAHAJAN_RESPONSE_TO_IL1A_UP
1.61290322581%	2	124	81	Diabetes_McGill_Cell_cycle_All_Gene	CROMER_METASTASIS_DN
1.61290322581%	2	124	80	Diabetes_McGill_Cell_cycle_All_Gene	SCHUHMACHER_MYC_TARGETS_UP
1.61290322581%	2	124	8	Diabetes_McGill_Cell_cycle_All_Gene	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR
1.61290322581%	2	124	8	Diabetes_McGill_Cell_cycle_All_Gene	TCGA_GLIOBLASTOMA_MUTATED
1.61290322581%	2	124	8	Diabetes_McGill_Cell_cycle_All_Gene	OHM_EMBRYONIC_CARCINOMA_DN
1.61290322581%	2	124	8	Diabetes_McGill_Cell_cycle_All_Gene	MIKKELSEN_PLURIPOTENT_STATE_DN
1.61290322581%	2	124	8	Diabetes_McGill_Cell_cycle_All_Gene	MATZUK_LUTEAL_GENES
1.61290322581%	2	124	8	Diabetes_McGill_Cell_cycle_All_Gene	GALI_TP53_TARGETS_APOPTOTIC_UP
1.61290322581%	2	124	783	Diabetes_McGill_Cell_cycle_All_Gene	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
1.61290322581%	2	124	78	Diabetes_McGill_Cell_cycle_All_Gene	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP
1.61290322581%	2	124	77	Diabetes_McGill_Cell_cycle_All_Gene	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
1.61290322581%	2	124	77	Diabetes_McGill_Cell_cycle_All_Gene	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
1.61290322581%	2	124	77	Diabetes_McGill_Cell_cycle_All_Gene	ROSS_AML_WITH_PML_RARA_FUSION
1.61290322581%	2	124	77	Diabetes_McGill_Cell_cycle_All_Gene	LIN_APC_TARGETS
1.61290322581%	2	124	77	Diabetes_McGill_Cell_cycle_All_Gene	GROSS_HYPOXIA_VIA_HIF1A_UP
1.61290322581%	2	124	76	Diabetes_McGill_Cell_cycle_All_Gene	MAHAJAN_RESPONSE_TO_IL1A_DN
1.61290322581%	2	124	75	Diabetes_McGill_Cell_cycle_All_Gene	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
1.61290322581%	2	124	75	Diabetes_McGill_Cell_cycle_All_Gene	JAIN_NFKB_SIGNALING
1.61290322581%	2	124	75	Diabetes_McGill_Cell_cycle_All_Gene	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
1.61290322581%	2	124	74	Diabetes_McGill_Cell_cycle_All_Gene	VANASSE_BCL2_TARGETS_DN
1.61290322581%	2	124	74	Diabetes_McGill_Cell_cycle_All_Gene	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
1.61290322581%	2	124	74	Diabetes_McGill_Cell_cycle_All_Gene	DER_IFN_ALPHA_RESPONSE_UP
1.61290322581%	2	124	73	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
1.61290322581%	2	124	73	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_VIRAL_MYOCARDITIS
1.61290322581%	2	124	720	Diabetes_McGill_Cell_cycle_All_Gene	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
1.61290322581%	2	124	72	Diabetes_McGill_Cell_cycle_All_Gene	SESTO_RESPONSE_TO_UV_C8
1.61290322581%	2	124	72	Diabetes_McGill_Cell_cycle_All_Gene	SESTO_RESPONSE_TO_UV_C1
1.61290322581%	2	124	72	Diabetes_McGill_Cell_cycle_All_Gene	HUANG_GATA2_TARGETS_DN
1.61290322581%	2	124	71	Diabetes_McGill_Cell_cycle_All_Gene	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
1.61290322581%	2	124	70	Diabetes_McGill_Cell_cycle_All_Gene	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
1.61290322581%	2	124	70	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_LONG_TERM_POTENTIATION
1.61290322581%	2	124	70	Diabetes_McGill_Cell_cycle_All_Gene	CADWELL_ATG16L1_TARGETS_DN
1.61290322581%	2	124	7	Diabetes_McGill_Cell_cycle_All_Gene	GLINSKY_CANCER_DEATH_UP
1.61290322581%	2	124	7	Diabetes_McGill_Cell_cycle_All_Gene	BUSA_SAM68_TARGETS_UP
1.61290322581%	2	124	69	Diabetes_McGill_Cell_cycle_All_Gene	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
1.61290322581%	2	124	68	Diabetes_McGill_Cell_cycle_All_Gene	SESTO_RESPONSE_TO_UV_C7
1.61290322581%	2	124	68	Diabetes_McGill_Cell_cycle_All_Gene	LIN_NPAS4_TARGETS_DN
1.61290322581%	2	124	68	Diabetes_McGill_Cell_cycle_All_Gene	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
1.61290322581%	2	124	67	Diabetes_McGill_Cell_cycle_All_Gene	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
1.61290322581%	2	124	67	Diabetes_McGill_Cell_cycle_All_Gene	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
1.61290322581%	2	124	66	Diabetes_McGill_Cell_cycle_All_Gene	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT
1.61290322581%	2	124	66	Diabetes_McGill_Cell_cycle_All_Gene	RAMASWAMY_METASTASIS_UP
1.61290322581%	2	124	66	Diabetes_McGill_Cell_cycle_All_Gene	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
1.61290322581%	2	124	66	Diabetes_McGill_Cell_cycle_All_Gene	DIRMEIER_LMP1_RESPONSE_EARLY
1.61290322581%	2	124	66	Diabetes_McGill_Cell_cycle_All_Gene	BEIER_GLIOMA_STEM_CELL_DN
1.61290322581%	2	124	65	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_WNT
1.61290322581%	2	124	65	Diabetes_McGill_Cell_cycle_All_Gene	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS
1.61290322581%	2	124	64	Diabetes_McGill_Cell_cycle_All_Gene	ZHAN_MULTIPLE_MYELOMA_UP
1.61290322581%	2	124	64	Diabetes_McGill_Cell_cycle_All_Gene	RIZKI_TUMOR_INVASIVENESS_2D_DN
1.61290322581%	2	124	64	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
1.61290322581%	2	124	64	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS
1.61290322581%	2	124	64	Diabetes_McGill_Cell_cycle_All_Gene	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
1.61290322581%	2	124	64	Diabetes_McGill_Cell_cycle_All_Gene	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
1.61290322581%	2	124	64	Diabetes_McGill_Cell_cycle_All_Gene	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
1.61290322581%	2	124	634	Diabetes_McGill_Cell_cycle_All_Gene	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
1.61290322581%	2	124	63	Diabetes_McGill_Cell_cycle_All_Gene	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP
1.61290322581%	2	124	63	Diabetes_McGill_Cell_cycle_All_Gene	PID_IL12_2PATHWAY
1.61290322581%	2	124	63	Diabetes_McGill_Cell_cycle_All_Gene	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
1.61290322581%	2	124	63	Diabetes_McGill_Cell_cycle_All_Gene	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
1.61290322581%	2	124	63	Diabetes_McGill_Cell_cycle_All_Gene	BURTON_ADIPOGENESIS_PEAK_AT_0HR
1.61290322581%	2	124	63	Diabetes_McGill_Cell_cycle_All_Gene	BRIDEAU_IMPRINTED_GENES
1.61290322581%	2	124	62	Diabetes_McGill_Cell_cycle_All_Gene	PID_TRKRPATHWAY
1.61290322581%	2	124	62	Diabetes_McGill_Cell_cycle_All_Gene	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
1.61290322581%	2	124	62	Diabetes_McGill_Cell_cycle_All_Gene	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP
1.61290322581%	2	124	61	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS
1.61290322581%	2	124	61	Diabetes_McGill_Cell_cycle_All_Gene	GENTILE_RESPONSE_CLUSTER_D3
1.61290322581%	2	124	61	Diabetes_McGill_Cell_cycle_All_Gene	BAKKER_FOXO3_TARGETS_UP
1.61290322581%	2	124	60	Diabetes_McGill_Cell_cycle_All_Gene	CUI_GLUCOSE_DEPRIVATION
1.61290322581%	2	124	6	Diabetes_McGill_Cell_cycle_All_Gene	IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM
1.61290322581%	2	124	6	Diabetes_McGill_Cell_cycle_All_Gene	GERHOLD_RESPONSE_TO_TZD_UP
1.61290322581%	2	124	6	Diabetes_McGill_Cell_cycle_All_Gene	COURTOIS_SENESCENCE_TRIGGERS
1.61290322581%	2	124	59	Diabetes_McGill_Cell_cycle_All_Gene	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
1.61290322581%	2	124	59	Diabetes_McGill_Cell_cycle_All_Gene	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
1.61290322581%	2	124	59	Diabetes_McGill_Cell_cycle_All_Gene	DASU_IL6_SIGNALING_UP
1.61290322581%	2	124	59	Diabetes_McGill_Cell_cycle_All_Gene	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
1.61290322581%	2	124	57	Diabetes_McGill_Cell_cycle_All_Gene	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
1.61290322581%	2	124	567	Diabetes_McGill_Cell_cycle_All_Gene	PARENT_MTOR_SIGNALING_UP
1.61290322581%	2	124	56	Diabetes_McGill_Cell_cycle_All_Gene	LEE_LIVER_CANCER_MYC_E2F1_UP
1.61290322581%	2	124	56	Diabetes_McGill_Cell_cycle_All_Gene	HENDRICKS_SMARCA4_TARGETS_UP
1.61290322581%	2	124	56	Diabetes_McGill_Cell_cycle_All_Gene	GRADE_COLON_VS_RECTAL_CANCER_DN
1.61290322581%	2	124	56	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_NFAT_PATHWAY
1.61290322581%	2	124	55	Diabetes_McGill_Cell_cycle_All_Gene	TIEN_INTESTINE_PROBIOTICS_6HR_UP
1.61290322581%	2	124	55	Diabetes_McGill_Cell_cycle_All_Gene	PID_IL2_1PATHWAY
1.61290322581%	2	124	55	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_BASAL_CELL_CARCINOMA
1.61290322581%	2	124	55	Diabetes_McGill_Cell_cycle_All_Gene	GENTILE_UV_RESPONSE_CLUSTER_D4
1.61290322581%	2	124	54	Diabetes_McGill_Cell_cycle_All_Gene	MARSON_FOXP3_TARGETS_DN
1.61290322581%	2	124	54	Diabetes_McGill_Cell_cycle_All_Gene	LEE_LIVER_CANCER_MYC_UP
1.61290322581%	2	124	537	Diabetes_McGill_Cell_cycle_All_Gene	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
1.61290322581%	2	124	53	Diabetes_McGill_Cell_cycle_All_Gene	IKEDA_MIR1_TARGETS_UP
1.61290322581%	2	124	52	Diabetes_McGill_Cell_cycle_All_Gene	RADAEVA_RESPONSE_TO_IFNA1_UP
1.61290322581%	2	124	52	Diabetes_McGill_Cell_cycle_All_Gene	PID_KITPATHWAY
1.61290322581%	2	124	52	Diabetes_McGill_Cell_cycle_All_Gene	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6
1.61290322581%	2	124	52	Diabetes_McGill_Cell_cycle_All_Gene	CHIBA_RESPONSE_TO_TSA_UP
1.61290322581%	2	124	51	Diabetes_McGill_Cell_cycle_All_Gene	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
1.61290322581%	2	124	51	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1
1.61290322581%	2	124	51	Diabetes_McGill_Cell_cycle_All_Gene	LUI_THYROID_CANCER_CLUSTER_1
1.61290322581%	2	124	51	Diabetes_McGill_Cell_cycle_All_Gene	FRASOR_TAMOXIFEN_RESPONSE_UP
1.61290322581%	2	124	51	Diabetes_McGill_Cell_cycle_All_Gene	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
1.61290322581%	2	124	51	Diabetes_McGill_Cell_cycle_All_Gene	BYSTROEM_CORRELATED_WITH_IL5_UP
1.61290322581%	2	124	50	Diabetes_McGill_Cell_cycle_All_Gene	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
1.61290322581%	2	124	50	Diabetes_McGill_Cell_cycle_All_Gene	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
1.61290322581%	2	124	50	Diabetes_McGill_Cell_cycle_All_Gene	NADERI_BREAST_CANCER_PROGNOSIS_UP
1.61290322581%	2	124	50	Diabetes_McGill_Cell_cycle_All_Gene	KENNY_CTNNB1_TARGETS_UP
1.61290322581%	2	124	50	Diabetes_McGill_Cell_cycle_All_Gene	CHIBA_RESPONSE_TO_TSA
1.61290322581%	2	124	49	Diabetes_McGill_Cell_cycle_All_Gene	GERHOLD_ADIPOGENESIS_UP
1.61290322581%	2	124	49	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_2HR_DN
1.61290322581%	2	124	487	Diabetes_McGill_Cell_cycle_All_Gene	RODWELL_AGING_KIDNEY_UP
1.61290322581%	2	124	485	Diabetes_McGill_Cell_cycle_All_Gene	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
1.61290322581%	2	124	48	Diabetes_McGill_Cell_cycle_All_Gene	RICKMAN_HEAD_AND_NECK_CANCER_B
1.61290322581%	2	124	48	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6
1.61290322581%	2	124	48	Diabetes_McGill_Cell_cycle_All_Gene	PID_CERAMIDE_PATHWAY
1.61290322581%	2	124	48	Diabetes_McGill_Cell_cycle_All_Gene	PID_AJDISS_2PATHWAY
1.61290322581%	2	124	478	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
1.61290322581%	2	124	473	Diabetes_McGill_Cell_cycle_All_Gene	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
1.61290322581%	2	124	47	Diabetes_McGill_Cell_cycle_All_Gene	PID_NFAT_TFPATHWAY
1.61290322581%	2	124	47	Diabetes_McGill_Cell_cycle_All_Gene	MELLMAN_TUT1_TARGETS_DN
1.61290322581%	2	124	47	Diabetes_McGill_Cell_cycle_All_Gene	LEONARD_HYPOXIA
1.61290322581%	2	124	47	Diabetes_McGill_Cell_cycle_All_Gene	IRITANI_MAD1_TARGETS_DN
1.61290322581%	2	124	47	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_8HR_DN
1.61290322581%	2	124	47	Diabetes_McGill_Cell_cycle_All_Gene	BOYLAN_MULTIPLE_MYELOMA_C_UP
1.61290322581%	2	124	463	Diabetes_McGill_Cell_cycle_All_Gene	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
1.61290322581%	2	124	46	Diabetes_McGill_Cell_cycle_All_Gene	SESTO_RESPONSE_TO_UV_C5
1.61290322581%	2	124	46	Diabetes_McGill_Cell_cycle_All_Gene	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON
1.61290322581%	2	124	457	Diabetes_McGill_Cell_cycle_All_Gene	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
1.61290322581%	2	124	45	Diabetes_McGill_Cell_cycle_All_Gene	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP
1.61290322581%	2	124	45	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_
1.61290322581%	2	124	45	Diabetes_McGill_Cell_cycle_All_Gene	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
1.61290322581%	2	124	45	Diabetes_McGill_Cell_cycle_All_Gene	PID_ILK_PATHWAY
1.61290322581%	2	124	45	Diabetes_McGill_Cell_cycle_All_Gene	LUI_THYROID_CANCER_PAX8_PPARG_DN
1.61290322581%	2	124	45	Diabetes_McGill_Cell_cycle_All_Gene	LEE_AGING_MUSCLE_UP
1.61290322581%	2	124	45	Diabetes_McGill_Cell_cycle_All_Gene	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP
1.61290322581%	2	124	45	Diabetes_McGill_Cell_cycle_All_Gene	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
1.61290322581%	2	124	447	Diabetes_McGill_Cell_cycle_All_Gene	MOOTHA_MITOCHONDRIA
1.61290322581%	2	124	445	Diabetes_McGill_Cell_cycle_All_Gene	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
1.61290322581%	2	124	44	Diabetes_McGill_Cell_cycle_All_Gene	ZUCCHI_METASTASIS_DN
1.61290322581%	2	124	44	Diabetes_McGill_Cell_cycle_All_Gene	MA_MYELOID_DIFFERENTIATION_DN
1.61290322581%	2	124	44	Diabetes_McGill_Cell_cycle_All_Gene	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP
1.61290322581%	2	124	44	Diabetes_McGill_Cell_cycle_All_Gene	KERLEY_RESPONSE_TO_CISPLATIN_UP
1.61290322581%	2	124	44	Diabetes_McGill_Cell_cycle_All_Gene	FAELT_B_CLL_WITH_VH3_21_UP
1.61290322581%	2	124	430	Diabetes_McGill_Cell_cycle_All_Gene	RIGGI_EWING_SARCOMA_PROGENITOR_UP
1.61290322581%	2	124	43	Diabetes_McGill_Cell_cycle_All_Gene	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
1.61290322581%	2	124	43	Diabetes_McGill_Cell_cycle_All_Gene	PID_TCPTP_PATHWAY
1.61290322581%	2	124	43	Diabetes_McGill_Cell_cycle_All_Gene	MANTOVANI_NFKB_TARGETS_UP
1.61290322581%	2	124	428	Diabetes_McGill_Cell_cycle_All_Gene	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
1.61290322581%	2	124	42	Diabetes_McGill_Cell_cycle_All_Gene	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
1.61290322581%	2	124	42	Diabetes_McGill_Cell_cycle_All_Gene	WIERENGA_PML_INTERACTOME
1.61290322581%	2	124	42	Diabetes_McGill_Cell_cycle_All_Gene	PID_BMPPATHWAY
1.61290322581%	2	124	412	Diabetes_McGill_Cell_cycle_All_Gene	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
1.61290322581%	2	124	41	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING
1.61290322581%	2	124	41	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_IL_2_SIGNALING
1.61290322581%	2	124	41	Diabetes_McGill_Cell_cycle_All_Gene	ONO_AML1_TARGETS_DN
1.61290322581%	2	124	41	Diabetes_McGill_Cell_cycle_All_Gene	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
1.61290322581%	2	124	405	Diabetes_McGill_Cell_cycle_All_Gene	KUMAR_TARGETS_OF_MLL_AF9_FUSION
1.61290322581%	2	124	40	Diabetes_McGill_Cell_cycle_All_Gene	ST_JNK_MAPK_PATHWAY
1.61290322581%	2	124	40	Diabetes_McGill_Cell_cycle_All_Gene	PID_IFNGPATHWAY
1.61290322581%	2	124	40	Diabetes_McGill_Cell_cycle_All_Gene	HEIDENBLAD_AMPLICON_8Q24_UP
1.61290322581%	2	124	40	Diabetes_McGill_Cell_cycle_All_Gene	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
1.61290322581%	2	124	40	Diabetes_McGill_Cell_cycle_All_Gene	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
1.61290322581%	2	124	39	Diabetes_McGill_Cell_cycle_All_Gene	WANG_LSD1_TARGETS_DN
1.61290322581%	2	124	39	Diabetes_McGill_Cell_cycle_All_Gene	POTTI_PACLITAXEL_SENSITIVITY
1.61290322581%	2	124	387	Diabetes_McGill_Cell_cycle_All_Gene	CHYLA_CBFA2T3_TARGETS_UP
1.61290322581%	2	124	384	Diabetes_McGill_Cell_cycle_All_Gene	BASAKI_YBX1_TARGETS_DN
1.61290322581%	2	124	382	Diabetes_McGill_Cell_cycle_All_Gene	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
1.61290322581%	2	124	380	Diabetes_McGill_Cell_cycle_All_Gene	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
1.61290322581%	2	124	38	Diabetes_McGill_Cell_cycle_All_Gene	PENG_GLUTAMINE_DEPRIVATION_UP
1.61290322581%	2	124	38	Diabetes_McGill_Cell_cycle_All_Gene	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
1.61290322581%	2	124	38	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_IL2RB_PATHWAY
1.61290322581%	2	124	37	Diabetes_McGill_Cell_cycle_All_Gene	MURAKAMI_UV_RESPONSE_6HR_UP
1.61290322581%	2	124	37	Diabetes_McGill_Cell_cycle_All_Gene	GENTILE_UV_RESPONSE_CLUSTER_D6
1.61290322581%	2	124	37	Diabetes_McGill_Cell_cycle_All_Gene	CUI_TCF21_TARGETS_UP
1.61290322581%	2	124	36	Diabetes_McGill_Cell_cycle_All_Gene	SEMENZA_HIF1_TARGETS
1.61290322581%	2	124	36	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALLING_TO_ERKS
1.61290322581%	2	124	36	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_FRS2_MEDIATED_CASCADE
1.61290322581%	2	124	36	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION
1.61290322581%	2	124	36	Diabetes_McGill_Cell_cycle_All_Gene	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
1.61290322581%	2	124	35	Diabetes_McGill_Cell_cycle_All_Gene	WANG_METHYLATED_IN_BREAST_CANCER
1.61290322581%	2	124	344	Diabetes_McGill_Cell_cycle_All_Gene	RICKMAN_METASTASIS_UP
1.61290322581%	2	124	34	Diabetes_McGill_Cell_cycle_All_Gene	SCHOEN_NFKB_SIGNALING
1.61290322581%	2	124	34	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX
1.61290322581%	2	124	34	Diabetes_McGill_Cell_cycle_All_Gene	PLASARI_TGFB1_TARGETS_1HR_UP
1.61290322581%	2	124	34	Diabetes_McGill_Cell_cycle_All_Gene	PID_IL2_PI3KPATHWAY
1.61290322581%	2	124	34	Diabetes_McGill_Cell_cycle_All_Gene	PID_HIF2PATHWAY
1.61290322581%	2	124	34	Diabetes_McGill_Cell_cycle_All_Gene	PID_HDAC_CLASSII_PATHWAY
1.61290322581%	2	124	34	Diabetes_McGill_Cell_cycle_All_Gene	HONMA_DOCETAXEL_RESISTANCE
1.61290322581%	2	124	34	Diabetes_McGill_Cell_cycle_All_Gene	ABE_VEGFA_TARGETS_2HR
1.61290322581%	2	124	330	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_METABOLISM_OF_RNA
1.61290322581%	2	124	33	Diabetes_McGill_Cell_cycle_All_Gene	TANG_SENESCENCE_TP53_TARGETS_UP
1.61290322581%	2	124	33	Diabetes_McGill_Cell_cycle_All_Gene	SIMBULAN_UV_RESPONSE_NORMAL_DN
1.61290322581%	2	124	33	Diabetes_McGill_Cell_cycle_All_Gene	PID_IL12_STAT4PATHWAY
1.61290322581%	2	124	33	Diabetes_McGill_Cell_cycle_All_Gene	FIRESTEIN_CTNNB1_PATHWAY
1.61290322581%	2	124	33	Diabetes_McGill_Cell_cycle_All_Gene	DORN_ADENOVIRUS_INFECTION_12HR_DN
1.61290322581%	2	124	33	Diabetes_McGill_Cell_cycle_All_Gene	BURTON_ADIPOGENESIS_1
1.61290322581%	2	124	321	Diabetes_McGill_Cell_cycle_All_Gene	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
1.61290322581%	2	124	320	Diabetes_McGill_Cell_cycle_All_Gene	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
1.61290322581%	2	124	32	Diabetes_McGill_Cell_cycle_All_Gene	TSAI_RESPONSE_TO_RADIATION_THERAPY
1.61290322581%	2	124	32	Diabetes_McGill_Cell_cycle_All_Gene	TRACEY_RESISTANCE_TO_IFNA2_DN
1.61290322581%	2	124	32	Diabetes_McGill_Cell_cycle_All_Gene	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN
1.61290322581%	2	124	32	Diabetes_McGill_Cell_cycle_All_Gene	KIM_TIAL1_TARGETS
1.61290322581%	2	124	32	Diabetes_McGill_Cell_cycle_All_Gene	KASLER_HDAC7_TARGETS_2_DN
1.61290322581%	2	124	31	Diabetes_McGill_Cell_cycle_All_Gene	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP
1.61290322581%	2	124	31	Diabetes_McGill_Cell_cycle_All_Gene	SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN
1.61290322581%	2	124	31	Diabetes_McGill_Cell_cycle_All_Gene	NOJIMA_SFRP2_TARGETS_UP
1.61290322581%	2	124	308	Diabetes_McGill_Cell_cycle_All_Gene	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
1.61290322581%	2	124	30	Diabetes_McGill_Cell_cycle_All_Gene	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN
1.61290322581%	2	124	30	Diabetes_McGill_Cell_cycle_All_Gene	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
1.61290322581%	2	124	30	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION
1.61290322581%	2	124	30	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_MRNA_CAPPING
1.61290322581%	2	124	30	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX
1.61290322581%	2	124	30	Diabetes_McGill_Cell_cycle_All_Gene	PID_IGF1_PATHWAY
1.61290322581%	2	124	30	Diabetes_McGill_Cell_cycle_All_Gene	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP
1.61290322581%	2	124	30	Diabetes_McGill_Cell_cycle_All_Gene	LI_PROSTATE_CANCER_EPIGENETIC
1.61290322581%	2	124	30	Diabetes_McGill_Cell_cycle_All_Gene	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
1.61290322581%	2	124	30	Diabetes_McGill_Cell_cycle_All_Gene	DASU_IL6_SIGNALING_SCAR_UP
1.61290322581%	2	124	30	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_FAS_PATHWAY
1.61290322581%	2	124	296	Diabetes_McGill_Cell_cycle_All_Gene	DURAND_STROMA_MAX_UP
1.61290322581%	2	124	29	Diabetes_McGill_Cell_cycle_All_Gene	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR
1.61290322581%	2	124	29	Diabetes_McGill_Cell_cycle_All_Gene	TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN
1.61290322581%	2	124	29	Diabetes_McGill_Cell_cycle_All_Gene	KRIGE_AMINO_ACID_DEPRIVATION
1.61290322581%	2	124	29	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_TNFR1_PATHWAY
1.61290322581%	2	124	284	Diabetes_McGill_Cell_cycle_All_Gene	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
1.61290322581%	2	124	284	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_METABOLISM_OF_MRNA
1.61290322581%	2	124	280	Diabetes_McGill_Cell_cycle_All_Gene	WANG_SMARCE1_TARGETS_UP
1.61290322581%	2	124	280	Diabetes_McGill_Cell_cycle_All_Gene	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
1.61290322581%	2	124	28	Diabetes_McGill_Cell_cycle_All_Gene	PID_LIS1PATHWAY
1.61290322581%	2	124	28	Diabetes_McGill_Cell_cycle_All_Gene	LOPES_METHYLATED_IN_COLON_CANCER_DN
1.61290322581%	2	124	28	Diabetes_McGill_Cell_cycle_All_Gene	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP
1.61290322581%	2	124	275	Diabetes_McGill_Cell_cycle_All_Gene	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
1.61290322581%	2	124	274	Diabetes_McGill_Cell_cycle_All_Gene	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
1.61290322581%	2	124	27	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALLING_TO_RAS
1.61290322581%	2	124	27	Diabetes_McGill_Cell_cycle_All_Gene	LOPES_METHYLATED_IN_COLON_CANCER_UP
1.61290322581%	2	124	27	Diabetes_McGill_Cell_cycle_All_Gene	GROSS_ELK3_TARGETS_UP
1.61290322581%	2	124	27	Diabetes_McGill_Cell_cycle_All_Gene	GENTILE_UV_LOW_DOSE_UP
1.61290322581%	2	124	27	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_GSK3_PATHWAY
1.61290322581%	2	124	269	Diabetes_McGill_Cell_cycle_All_Gene	WANG_CLIM2_TARGETS_UP
1.61290322581%	2	124	262	Diabetes_McGill_Cell_cycle_All_Gene	LU_AGING_BRAIN_UP
1.61290322581%	2	124	260	Diabetes_McGill_Cell_cycle_All_Gene	BOQUEST_STEM_CELL_UP
1.61290322581%	2	124	26	Diabetes_McGill_Cell_cycle_All_Gene	WALLACE_JAK2_TARGETS_UP
1.61290322581%	2	124	26	Diabetes_McGill_Cell_cycle_All_Gene	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
1.61290322581%	2	124	26	Diabetes_McGill_Cell_cycle_All_Gene	BRACHAT_RESPONSE_TO_METHOTREXATE_UP
1.61290322581%	2	124	259	Diabetes_McGill_Cell_cycle_All_Gene	QI_PLASMACYTOMA_UP
1.61290322581%	2	124	254	Diabetes_McGill_Cell_cycle_All_Gene	IVANOVA_HEMATOPOIESIS_STEM_CELL
1.61290322581%	2	124	25	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION
1.61290322581%	2	124	25	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_FANCONI_ANEMIA_PATHWAY
1.61290322581%	2	124	245	Diabetes_McGill_Cell_cycle_All_Gene	PENG_RAPAMYCIN_RESPONSE_DN
1.61290322581%	2	124	244	Diabetes_McGill_Cell_cycle_All_Gene	THUM_SYSTOLIC_HEART_FAILURE_DN
1.61290322581%	2	124	244	Diabetes_McGill_Cell_cycle_All_Gene	PLASARI_TGFB1_TARGETS_10HR_DN
1.61290322581%	2	124	24	Diabetes_McGill_Cell_cycle_All_Gene	SHI_SPARC_TARGETS_UP
1.61290322581%	2	124	24	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION
1.61290322581%	2	124	24	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_DOUBLE_STRAND_BREAK_REPAIR
1.61290322581%	2	124	24	Diabetes_McGill_Cell_cycle_All_Gene	ONO_AML1_TARGETS_UP
1.61290322581%	2	124	24	Diabetes_McGill_Cell_cycle_All_Gene	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23
1.61290322581%	2	124	24	Diabetes_McGill_Cell_cycle_All_Gene	MURATA_VIRULENCE_OF_H_PILORI
1.61290322581%	2	124	24	Diabetes_McGill_Cell_cycle_All_Gene	GOLUB_ALL_VS_AML_UP
1.61290322581%	2	124	23	Diabetes_McGill_Cell_cycle_All_Gene	WU_HBX_TARGETS_2_UP
1.61290322581%	2	124	23	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER
1.61290322581%	2	124	23	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA
1.61290322581%	2	124	23	Diabetes_McGill_Cell_cycle_All_Gene	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP
1.61290322581%	2	124	23	Diabetes_McGill_Cell_cycle_All_Gene	CHIBA_RESPONSE_TO_TSA_DN
1.61290322581%	2	124	226	Diabetes_McGill_Cell_cycle_All_Gene	KYNG_DNA_DAMAGE_UP
1.61290322581%	2	124	226	Diabetes_McGill_Cell_cycle_All_Gene	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
1.61290322581%	2	124	225	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_16HR_UP
1.61290322581%	2	124	223	Diabetes_McGill_Cell_cycle_All_Gene	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
1.61290322581%	2	124	223	Diabetes_McGill_Cell_cycle_All_Gene	CHEN_HOXA5_TARGETS_9HR_UP
1.61290322581%	2	124	22	Diabetes_McGill_Cell_cycle_All_Gene	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP
1.61290322581%	2	124	22	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_HIPPO
1.61290322581%	2	124	22	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION
1.61290322581%	2	124	22	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING
1.61290322581%	2	124	22	Diabetes_McGill_Cell_cycle_All_Gene	BRACHAT_RESPONSE_TO_CISPLATIN
1.61290322581%	2	124	22	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_CHEMICAL_PATHWAY
1.61290322581%	2	124	217	Diabetes_McGill_Cell_cycle_All_Gene	AMUNDSON_RESPONSE_TO_ARSENITE
1.61290322581%	2	124	213	Diabetes_McGill_Cell_cycle_All_Gene	WIERENGA_STAT5A_TARGETS_DN
1.61290322581%	2	124	210	Diabetes_McGill_Cell_cycle_All_Gene	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
1.61290322581%	2	124	210	Diabetes_McGill_Cell_cycle_All_Gene	RIZKI_TUMOR_INVASIVENESS_3D_UP
1.61290322581%	2	124	210	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_TRANSCRIPTION
1.61290322581%	2	124	210	Diabetes_McGill_Cell_cycle_All_Gene	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
1.61290322581%	2	124	21	Diabetes_McGill_Cell_cycle_All_Gene	MURAKAMI_UV_RESPONSE_6HR_DN
1.61290322581%	2	124	21	Diabetes_McGill_Cell_cycle_All_Gene	KANNAN_TP53_TARGETS_DN
1.61290322581%	2	124	21	Diabetes_McGill_Cell_cycle_All_Gene	HUI_MAPK14_TARGETS_UP
1.61290322581%	2	124	21	Diabetes_McGill_Cell_cycle_All_Gene	GESERICK_TERT_TARGETS_DN
1.61290322581%	2	124	21	Diabetes_McGill_Cell_cycle_All_Gene	DAZARD_UV_RESPONSE_CLUSTER_G4
1.61290322581%	2	124	208	Diabetes_McGill_Cell_cycle_All_Gene	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
1.61290322581%	2	124	207	Diabetes_McGill_Cell_cycle_All_Gene	VERHAAK_GLIOBLASTOMA_CLASSICAL
1.61290322581%	2	124	207	Diabetes_McGill_Cell_cycle_All_Gene	MANALO_HYPOXIA_UP
1.61290322581%	2	124	206	Diabetes_McGill_Cell_cycle_All_Gene	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
1.61290322581%	2	124	205	Diabetes_McGill_Cell_cycle_All_Gene	SHEPARD_BMYB_MORPHOLINO_UP
1.61290322581%	2	124	205	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
1.61290322581%	2	124	203	Diabetes_McGill_Cell_cycle_All_Gene	PENG_RAPAMYCIN_RESPONSE_UP
1.61290322581%	2	124	201	Diabetes_McGill_Cell_cycle_All_Gene	HOLLMANN_APOPTOSIS_VIA_CD40_UP
1.61290322581%	2	124	20	Diabetes_McGill_Cell_cycle_All_Gene	ZHU_SKIL_TARGETS_UP
1.61290322581%	2	124	20	Diabetes_McGill_Cell_cycle_All_Gene	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN
1.61290322581%	2	124	20	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING
1.61290322581%	2	124	20	Diabetes_McGill_Cell_cycle_All_Gene	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP
1.61290322581%	2	124	20	Diabetes_McGill_Cell_cycle_All_Gene	DING_LUNG_CANCER_BY_MUTATION_RATE
1.61290322581%	2	124	20	Diabetes_McGill_Cell_cycle_All_Gene	DAZARD_UV_RESPONSE_CLUSTER_G28
1.61290322581%	2	124	20	Diabetes_McGill_Cell_cycle_All_Gene	COLLIS_PRKDC_SUBSTRATES
1.61290322581%	2	124	20	Diabetes_McGill_Cell_cycle_All_Gene	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
1.61290322581%	2	124	197	Diabetes_McGill_Cell_cycle_All_Gene	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
1.61290322581%	2	124	196	Diabetes_McGill_Cell_cycle_All_Gene	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
1.61290322581%	2	124	196	Diabetes_McGill_Cell_cycle_All_Gene	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
1.61290322581%	2	124	194	Diabetes_McGill_Cell_cycle_All_Gene	KASLER_HDAC7_TARGETS_1_UP
1.61290322581%	2	124	191	Diabetes_McGill_Cell_cycle_All_Gene	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
1.61290322581%	2	124	19	Diabetes_McGill_Cell_cycle_All_Gene	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN
1.61290322581%	2	124	19	Diabetes_McGill_Cell_cycle_All_Gene	STREICHER_LSM1_TARGETS_DN
1.61290322581%	2	124	19	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS
1.61290322581%	2	124	19	Diabetes_McGill_Cell_cycle_All_Gene	MARSON_FOXP3_CORE_DIRECT_TARGETS
1.61290322581%	2	124	19	Diabetes_McGill_Cell_cycle_All_Gene	MAHADEVAN_RESPONSE_TO_MP470_DN
1.61290322581%	2	124	19	Diabetes_McGill_Cell_cycle_All_Gene	LAMB_CCND1_TARGETS
1.61290322581%	2	124	19	Diabetes_McGill_Cell_cycle_All_Gene	GAJATE_RESPONSE_TO_TRABECTEDIN_DN
1.61290322581%	2	124	19	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_TID_PATHWAY
1.61290322581%	2	124	19	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_STATHMIN_PATHWAY
1.61290322581%	2	124	187	Diabetes_McGill_Cell_cycle_All_Gene	BAKKER_FOXO3_TARGETS_DN
1.61290322581%	2	124	185	Diabetes_McGill_Cell_cycle_All_Gene	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
1.61290322581%	2	124	183	Diabetes_McGill_Cell_cycle_All_Gene	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
1.61290322581%	2	124	182	Diabetes_McGill_Cell_cycle_All_Gene	RAO_BOUND_BY_SALL4_ISOFORM_A
1.61290322581%	2	124	182	Diabetes_McGill_Cell_cycle_All_Gene	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
1.61290322581%	2	124	181	Diabetes_McGill_Cell_cycle_All_Gene	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
1.61290322581%	2	124	180	Diabetes_McGill_Cell_cycle_All_Gene	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
1.61290322581%	2	124	18	Diabetes_McGill_Cell_cycle_All_Gene	WU_HBX_TARGETS_3_UP
1.61290322581%	2	124	18	Diabetes_McGill_Cell_cycle_All_Gene	SCHEIDEREIT_IKK_TARGETS
1.61290322581%	2	124	18	Diabetes_McGill_Cell_cycle_All_Gene	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN
1.61290322581%	2	124	18	Diabetes_McGill_Cell_cycle_All_Gene	KARAKAS_TGFB1_SIGNALING
1.61290322581%	2	124	18	Diabetes_McGill_Cell_cycle_All_Gene	GENTILE_UV_RESPONSE_CLUSTER_D1
1.61290322581%	2	124	178	Diabetes_McGill_Cell_cycle_All_Gene	LI_AMPLIFIED_IN_LUNG_CANCER
1.61290322581%	2	124	176	Diabetes_McGill_Cell_cycle_All_Gene	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
1.61290322581%	2	124	175	Diabetes_McGill_Cell_cycle_All_Gene	YAMAZAKI_TCEB3_TARGETS_UP
1.61290322581%	2	124	174	Diabetes_McGill_Cell_cycle_All_Gene	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
1.61290322581%	2	124	173	Diabetes_McGill_Cell_cycle_All_Gene	SENGUPTA_EBNA1_ANTICORRELATED
1.61290322581%	2	124	172	Diabetes_McGill_Cell_cycle_All_Gene	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
1.61290322581%	2	124	171	Diabetes_McGill_Cell_cycle_All_Gene	GOLDRATH_HOMEOSTATIC_PROLIFERATION
1.61290322581%	2	124	170	Diabetes_McGill_Cell_cycle_All_Gene	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
1.61290322581%	2	124	17	Diabetes_McGill_Cell_cycle_All_Gene	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN
1.61290322581%	2	124	17	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SHC_RELATED_EVENTS
1.61290322581%	2	124	17	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_RAP1_SIGNALLING
1.61290322581%	2	124	17	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_ARMS_MEDIATED_ACTIVATION
1.61290322581%	2	124	17	Diabetes_McGill_Cell_cycle_All_Gene	KANG_AR_TARGETS_UP
1.61290322581%	2	124	17	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_IL7_PATHWAY
1.61290322581%	2	124	169	Diabetes_McGill_Cell_cycle_All_Gene	KATSANOU_ELAVL1_TARGETS_UP
1.61290322581%	2	124	168	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
1.61290322581%	2	124	167	Diabetes_McGill_Cell_cycle_All_Gene	VANTVEER_BREAST_CANCER_ESR1_UP
1.61290322581%	2	124	166	Diabetes_McGill_Cell_cycle_All_Gene	CAIRO_LIVER_DEVELOPMENT_UP
1.61290322581%	2	124	165	Diabetes_McGill_Cell_cycle_All_Gene	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
1.61290322581%	2	124	162	Diabetes_McGill_Cell_cycle_All_Gene	DARWICHE_PAPILLOMA_RISK_LOW_UP
1.61290322581%	2	124	161	Diabetes_McGill_Cell_cycle_All_Gene	BIDUS_METASTASIS_DN
1.61290322581%	2	124	16	Diabetes_McGill_Cell_cycle_All_Gene	SUZUKI_AMPLIFIED_IN_ORAL_CANCER
1.61290322581%	2	124	16	Diabetes_McGill_Cell_cycle_All_Gene	PID_CIRCADIANPATHWAY
1.61290322581%	2	124	16	Diabetes_McGill_Cell_cycle_All_Gene	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA
1.61290322581%	2	124	16	Diabetes_McGill_Cell_cycle_All_Gene	LIU_TOPBP1_TARGETS
1.61290322581%	2	124	16	Diabetes_McGill_Cell_cycle_All_Gene	GHO_ATF5_TARGETS_DN
1.61290322581%	2	124	16	Diabetes_McGill_Cell_cycle_All_Gene	GEISS_RESPONSE_TO_DSRNA_DN
1.61290322581%	2	124	16	Diabetes_McGill_Cell_cycle_All_Gene	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL
1.61290322581%	2	124	16	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_RELA_PATHWAY
1.61290322581%	2	124	16	Diabetes_McGill_Cell_cycle_All_Gene	AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
1.61290322581%	2	124	158	Diabetes_McGill_Cell_cycle_All_Gene	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
1.61290322581%	2	124	157	Diabetes_McGill_Cell_cycle_All_Gene	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
1.61290322581%	2	124	157	Diabetes_McGill_Cell_cycle_All_Gene	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
1.61290322581%	2	124	156	Diabetes_McGill_Cell_cycle_All_Gene	GROSS_HYPOXIA_VIA_ELK3_DN
1.61290322581%	2	124	152	Diabetes_McGill_Cell_cycle_All_Gene	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
1.61290322581%	2	124	151	Diabetes_McGill_Cell_cycle_All_Gene	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
1.61290322581%	2	124	150	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_30MIN_DN
1.61290322581%	2	124	15	Diabetes_McGill_Cell_cycle_All_Gene	SA_MMP_CYTOKINE_CONNECTION
1.61290322581%	2	124	15	Diabetes_McGill_Cell_cycle_All_Gene	SANCHEZ_MDM2_TARGETS
1.61290322581%	2	124	15	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN
1.61290322581%	2	124	15	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SHC_MEDIATED_SIGNALLING
1.61290322581%	2	124	15	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING
1.61290322581%	2	124	15	Diabetes_McGill_Cell_cycle_All_Gene	MARKS_HDAC_TARGETS_DN
1.61290322581%	2	124	149	Diabetes_McGill_Cell_cycle_All_Gene	HUANG_GATA2_TARGETS_UP
1.61290322581%	2	124	149	Diabetes_McGill_Cell_cycle_All_Gene	GOZGIT_ESR1_TARGETS_UP
1.61290322581%	2	124	147	Diabetes_McGill_Cell_cycle_All_Gene	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
1.61290322581%	2	124	147	Diabetes_McGill_Cell_cycle_All_Gene	DARWICHE_PAPILLOMA_RISK_HIGH_UP
1.61290322581%	2	124	146	Diabetes_McGill_Cell_cycle_All_Gene	ELVIDGE_HYPOXIA_DN
1.61290322581%	2	124	146	Diabetes_McGill_Cell_cycle_All_Gene	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
1.61290322581%	2	124	145	Diabetes_McGill_Cell_cycle_All_Gene	ZHANG_BREAST_CANCER_PROGENITORS_DN
1.61290322581%	2	124	145	Diabetes_McGill_Cell_cycle_All_Gene	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
1.61290322581%	2	124	143	Diabetes_McGill_Cell_cycle_All_Gene	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
1.61290322581%	2	124	142	Diabetes_McGill_Cell_cycle_All_Gene	DARWICHE_SKIN_TUMOR_PROMOTER_UP
1.61290322581%	2	124	14	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY
1.61290322581%	2	124	14	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SOS_MEDIATED_SIGNALLING
1.61290322581%	2	124	14	Diabetes_McGill_Cell_cycle_All_Gene	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP
1.61290322581%	2	124	139	Diabetes_McGill_Cell_cycle_All_Gene	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
1.61290322581%	2	124	138	Diabetes_McGill_Cell_cycle_All_Gene	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
1.61290322581%	2	124	137	Diabetes_McGill_Cell_cycle_All_Gene	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
1.61290322581%	2	124	137	Diabetes_McGill_Cell_cycle_All_Gene	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
1.61290322581%	2	124	137	Diabetes_McGill_Cell_cycle_All_Gene	LIU_SOX4_TARGETS_UP
1.61290322581%	2	124	136	Diabetes_McGill_Cell_cycle_All_Gene	PROVENZANI_METASTASIS_DN
1.61290322581%	2	124	136	Diabetes_McGill_Cell_cycle_All_Gene	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
1.61290322581%	2	124	133	Diabetes_McGill_Cell_cycle_All_Gene	GAL_LEUKEMIC_STEM_CELL_UP
1.61290322581%	2	124	132	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS
1.61290322581%	2	124	132	Diabetes_McGill_Cell_cycle_All_Gene	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
1.61290322581%	2	124	131	Diabetes_McGill_Cell_cycle_All_Gene	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
1.61290322581%	2	124	13	Diabetes_McGill_Cell_cycle_All_Gene	WU_HBX_TARGETS_3_DN
1.61290322581%	2	124	13	Diabetes_McGill_Cell_cycle_All_Gene	HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER
1.61290322581%	2	124	13	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_CARM1_PATHWAY
1.61290322581%	2	124	129	Diabetes_McGill_Cell_cycle_All_Gene	YAGI_AML_SURVIVAL
1.61290322581%	2	124	129	Diabetes_McGill_Cell_cycle_All_Gene	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP
1.61290322581%	2	124	129	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_AXON_GUIDANCE
1.61290322581%	2	124	127	Diabetes_McGill_Cell_cycle_All_Gene	KARLSSON_TGFB1_TARGETS_UP
1.61290322581%	2	124	126	Diabetes_McGill_Cell_cycle_All_Gene	MISSIAGLIA_REGULATED_BY_METHYLATION_UP
1.61290322581%	2	124	126	Diabetes_McGill_Cell_cycle_All_Gene	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
1.61290322581%	2	124	126	Diabetes_McGill_Cell_cycle_All_Gene	GERY_CEBP_TARGETS
1.61290322581%	2	124	125	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_HIV_LIFE_CYCLE
1.61290322581%	2	124	122	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
1.61290322581%	2	124	120	Diabetes_McGill_Cell_cycle_All_Gene	XU_GH1_EXOGENOUS_TARGETS_DN
1.61290322581%	2	124	12	Diabetes_McGill_Cell_cycle_All_Gene	DING_LUNG_CANCER_MUTATED_FREQUENTLY
1.61290322581%	2	124	12	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_AKAP95_PATHWAY
1.61290322581%	2	124	119	Diabetes_McGill_Cell_cycle_All_Gene	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
1.61290322581%	2	124	118	Diabetes_McGill_Cell_cycle_All_Gene	MARKEY_RB1_CHRONIC_LOF_DN
1.61290322581%	2	124	116	Diabetes_McGill_Cell_cycle_All_Gene	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
1.61290322581%	2	124	114	Diabetes_McGill_Cell_cycle_All_Gene	MATZUK_SPERMATOZOA
1.61290322581%	2	124	114	Diabetes_McGill_Cell_cycle_All_Gene	CERVERA_SDHB_TARGETS_2
1.61290322581%	2	124	114	Diabetes_McGill_Cell_cycle_All_Gene	BOSCO_TH1_CYTOTOXIC_MODULE
1.61290322581%	2	124	113	Diabetes_McGill_Cell_cycle_All_Gene	TSENG_IRS1_TARGETS_UP
1.61290322581%	2	124	1118	Diabetes_McGill_Cell_cycle_All_Gene	BENPORATH_ES_WITH_H3K27ME3
1.61290322581%	2	124	111	Diabetes_McGill_Cell_cycle_All_Gene	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
1.61290322581%	2	124	111	Diabetes_McGill_Cell_cycle_All_Gene	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
1.61290322581%	2	124	111	Diabetes_McGill_Cell_cycle_All_Gene	BOUDOUKHA_BOUND_BY_IGF2BP2
1.61290322581%	2	124	110	Diabetes_McGill_Cell_cycle_All_Gene	WOOD_EBV_EBNA1_TARGETS_UP
1.61290322581%	2	124	110	Diabetes_McGill_Cell_cycle_All_Gene	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
1.61290322581%	2	124	110	Diabetes_McGill_Cell_cycle_All_Gene	CHENG_IMPRINTED_BY_ESTRADIOL
1.61290322581%	2	124	11	Diabetes_McGill_Cell_cycle_All_Gene	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP
1.61290322581%	2	124	11	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY
1.61290322581%	2	124	11	Diabetes_McGill_Cell_cycle_All_Gene	PID_RANBP2PATHWAY
1.61290322581%	2	124	11	Diabetes_McGill_Cell_cycle_All_Gene	LIANG_SILENCED_BY_METHYLATION_DN
1.61290322581%	2	124	108	Diabetes_McGill_Cell_cycle_All_Gene	TAVAZOIE_METASTASIS
1.61290322581%	2	124	108	Diabetes_McGill_Cell_cycle_All_Gene	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
1.61290322581%	2	124	108	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
1.61290322581%	2	124	108	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
1.61290322581%	2	124	108	Diabetes_McGill_Cell_cycle_All_Gene	JAZAG_TGFB1_SIGNALING_UP
1.61290322581%	2	124	106	Diabetes_McGill_Cell_cycle_All_Gene	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
1.61290322581%	2	124	105	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_RNA_POL_II_TRANSCRIPTION
1.61290322581%	2	124	105	Diabetes_McGill_Cell_cycle_All_Gene	HELLER_SILENCED_BY_METHYLATION_DN
1.61290322581%	2	124	104	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
1.61290322581%	2	124	104	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE
1.61290322581%	2	124	103	Diabetes_McGill_Cell_cycle_All_Gene	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
1.61290322581%	2	124	103	Diabetes_McGill_Cell_cycle_All_Gene	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
1.61290322581%	2	124	102	Diabetes_McGill_Cell_cycle_All_Gene	LABBE_TGFB1_TARGETS_UP
1.61290322581%	2	124	102	Diabetes_McGill_Cell_cycle_All_Gene	DER_IFN_BETA_RESPONSE_UP
1.61290322581%	2	124	101	Diabetes_McGill_Cell_cycle_All_Gene	WIELAND_UP_BY_HBV_INFECTION
1.61290322581%	2	124	101	Diabetes_McGill_Cell_cycle_All_Gene	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
1.61290322581%	2	124	100	Diabetes_McGill_Cell_cycle_All_Gene	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
1.61290322581%	2	124	100	Diabetes_McGill_Cell_cycle_All_Gene	GAVIN_FOXP3_TARGETS_CLUSTER_P4
1.61290322581%	2	124	10	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES
1.61290322581%	2	124	10	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_RAF_MAP_KINASE_CASCADE
1.61290322581%	2	124	10	Diabetes_McGill_Cell_cycle_All_Gene	MANN_RESPONSE_TO_AMIFOSTINE_DN
1.61166538757%	21	1303	701	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMID_BREAST_CANCER_BASAL_DN
1.61166538757%	21	1303	532	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
1.61166538757%	21	1303	505	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
1.61166538757%	21	1303	482	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
1.61166538757%	21	1303	456	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
1.61166538757%	21	1303	406	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OSMAN_BLADDER_CANCER_DN
1.61166538757%	21	1303	335	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
1.60993560258%	35	2174	338	T2D_GENES_TANYA_LIPIDS	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
1.60993560258%	35	2174	325	T2D_GENES_TANYA_LIPIDS	REACTOME_CELL_CYCLE_MITOTIC
1.60993560258%	35	2174	299	T2D_GENES_TANYA_LIPIDS	MUELLER_PLURINET
1.60993560258%	35	2174	269	T2D_GENES_TANYA_LIPIDS	WANG_CLIM2_TARGETS_UP
1.60993560258%	35	2174	230	T2D_GENES_TANYA_LIPIDS	BENPORATH_MYC_TARGETS_WITH_EBOX
1.60993560258%	35	2174	185	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER_SURVIVAL_UP
1.60342063068%	30	1871	388	T2D_GENES_TANYA_HEIGHT	STEIN_ESRRA_TARGETS_UP
1.60342063068%	30	1871	317	T2D_GENES_TANYA_HEIGHT	BRUINS_UVC_RESPONSE_EARLY_LATE
1.60342063068%	30	1871	315	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
1.60342063068%	30	1871	312	T2D_GENES_TANYA_HEIGHT	GENTILE_UV_HIGH_DOSE_DN
1.60342063068%	30	1871	293	T2D_GENES_TANYA_HEIGHT	ENK_UV_RESPONSE_EPIDERMIS_UP
1.60342063068%	30	1871	259	T2D_GENES_TANYA_HEIGHT	QI_PLASMACYTOMA_UP
1.60342063068%	30	1871	249	T2D_GENES_TANYA_HEIGHT	MITSIADES_RESPONSE_TO_APLIDIN_DN
1.60342063068%	30	1871	240	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_20HR_UP
1.60342063068%	30	1871	228	T2D_GENES_TANYA_HEIGHT	MARKEY_RB1_ACUTE_LOF_DN
1.60342063068%	30	1871	215	T2D_GENES_TANYA_HEIGHT	MARKEY_RB1_ACUTE_LOF_UP
1.60342063068%	30	1871	211	T2D_GENES_TANYA_HEIGHT	FOSTER_KDM1A_TARGETS_DN
1.60342063068%	30	1871	181	T2D_GENES_TANYA_HEIGHT	JISON_SICKLE_CELL_DISEASE_UP
1.60342063068%	30	1871	180	T2D_GENES_TANYA_HEIGHT	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
1.59090909091%	56	3520	722	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
1.59090909091%	56	3520	557	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TIEN_INTESTINE_PROBIOTICS_24HR_UP
1.59090909091%	56	3520	539	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIAO_METASTASIS
1.59090909091%	56	3520	528	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
1.59090909091%	56	3520	476	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMID_BREAST_CANCER_NORMAL_LIKE_UP
1.59090909091%	56	3520	418	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MULLIGHAN_MLL_SIGNATURE_2_UP
1.58102766798%	4	253	97	Diabetes_McGill_CREBBP_coTF	KONG_E2F3_TARGETS
1.58102766798%	4	253	96	Diabetes_McGill_CREBBP_coTF	ZAMORA_NOS2_TARGETS_DN
1.58102766798%	4	253	93	Diabetes_McGill_CREBBP_coTF	ZHU_CMV_24_HR_UP
1.58102766798%	4	253	92	Diabetes_McGill_CREBBP_coTF	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
1.58102766798%	4	253	92	Diabetes_McGill_CREBBP_coTF	CAMPS_COLON_CANCER_COPY_NUMBER_UP
1.58102766798%	4	253	91	Diabetes_McGill_CREBBP_coTF	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
1.58102766798%	4	253	91	Diabetes_McGill_CREBBP_coTF	ELVIDGE_HIF1A_TARGETS_DN
1.58102766798%	4	253	90	Diabetes_McGill_CREBBP_coTF	SASSON_RESPONSE_TO_FORSKOLIN_UP
1.58102766798%	4	253	90	Diabetes_McGill_CREBBP_coTF	GAVIN_FOXP3_TARGETS_CLUSTER_P7
1.58102766798%	4	253	9	Diabetes_McGill_CREBBP_coTF	RAFFEL_VEGFA_TARGETS_UP
1.58102766798%	4	253	9	Diabetes_McGill_CREBBP_coTF	KOMMAGANI_TP63_GAMMA_TARGETS
1.58102766798%	4	253	89	Diabetes_McGill_CREBBP_coTF	DELASERNA_MYOD_TARGETS_UP
1.58102766798%	4	253	88	Diabetes_McGill_CREBBP_coTF	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
1.58102766798%	4	253	87	Diabetes_McGill_CREBBP_coTF	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
1.58102766798%	4	253	86	Diabetes_McGill_CREBBP_coTF	REACTOME_MEIOTIC_RECOMBINATION
1.58102766798%	4	253	86	Diabetes_McGill_CREBBP_coTF	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
1.58102766798%	4	253	85	Diabetes_McGill_CREBBP_coTF	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
1.58102766798%	4	253	83	Diabetes_McGill_CREBBP_coTF	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
1.58102766798%	4	253	82	Diabetes_McGill_CREBBP_coTF	BILD_CTNNB1_ONCOGENIC_SIGNATURE
1.58102766798%	4	253	81	Diabetes_McGill_CREBBP_coTF	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
1.58102766798%	4	253	81	Diabetes_McGill_CREBBP_coTF	REACTOME_M_G1_TRANSITION
1.58102766798%	4	253	81	Diabetes_McGill_CREBBP_coTF	REACTOME_MITOTIC_G2_G2_M_PHASES
1.58102766798%	4	253	81	Diabetes_McGill_CREBBP_coTF	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
1.58102766798%	4	253	80	Diabetes_McGill_CREBBP_coTF	PID_MET_PATHWAY
1.58102766798%	4	253	80	Diabetes_McGill_CREBBP_coTF	MORI_PRE_BI_LYMPHOCYTE_UP
1.58102766798%	4	253	80	Diabetes_McGill_CREBBP_coTF	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
1.58102766798%	4	253	80	Diabetes_McGill_CREBBP_coTF	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
1.58102766798%	4	253	8	Diabetes_McGill_CREBBP_coTF	TURJANSKI_MAPK7_TARGETS
1.58102766798%	4	253	79	Diabetes_McGill_CREBBP_coTF	TOOKER_GEMCITABINE_RESISTANCE_UP
1.58102766798%	4	253	78	Diabetes_McGill_CREBBP_coTF	ROSS_LEUKEMIA_WITH_MLL_FUSIONS
1.58102766798%	4	253	78	Diabetes_McGill_CREBBP_coTF	ROSS_AML_WITH_MLL_FUSIONS
1.58102766798%	4	253	78	Diabetes_McGill_CREBBP_coTF	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
1.58102766798%	4	253	76	Diabetes_McGill_CREBBP_coTF	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
1.58102766798%	4	253	756	Diabetes_McGill_CREBBP_coTF	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP
1.58102766798%	4	253	74	Diabetes_McGill_CREBBP_coTF	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
1.58102766798%	4	253	72	Diabetes_McGill_CREBBP_coTF	MATZUK_SPERMATOCYTE
1.58102766798%	4	253	72	Diabetes_McGill_CREBBP_coTF	CROONQUIST_NRAS_SIGNALING_DN
1.58102766798%	4	253	71	Diabetes_McGill_CREBBP_coTF	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
1.58102766798%	4	253	71	Diabetes_McGill_CREBBP_coTF	KYNG_RESPONSE_TO_H2O2
1.58102766798%	4	253	71	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_6HR_UP
1.58102766798%	4	253	70	Diabetes_McGill_CREBBP_coTF	CADWELL_ATG16L1_TARGETS_DN
1.58102766798%	4	253	69	Diabetes_McGill_CREBBP_coTF	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
1.58102766798%	4	253	69	Diabetes_McGill_CREBBP_coTF	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
1.58102766798%	4	253	69	Diabetes_McGill_CREBBP_coTF	KEGG_PPAR_SIGNALING_PATHWAY
1.58102766798%	4	253	69	Diabetes_McGill_CREBBP_coTF	KEGG_P53_SIGNALING_PATHWAY
1.58102766798%	4	253	69	Diabetes_McGill_CREBBP_coTF	HOWLIN_PUBERTAL_MAMMARY_GLAND
1.58102766798%	4	253	68	Diabetes_McGill_CREBBP_coTF	ROSS_AML_OF_FAB_M7_TYPE
1.58102766798%	4	253	66	Diabetes_McGill_CREBBP_coTF	PID_TCR_PATHWAY
1.58102766798%	4	253	66	Diabetes_McGill_CREBBP_coTF	PID_LYSOPHOSPHOLIPID_PATHWAY
1.58102766798%	4	253	66	Diabetes_McGill_CREBBP_coTF	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
1.58102766798%	4	253	66	Diabetes_McGill_CREBBP_coTF	DIRMEIER_LMP1_RESPONSE_EARLY
1.58102766798%	4	253	64	Diabetes_McGill_CREBBP_coTF	ZHAN_MULTIPLE_MYELOMA_UP
1.58102766798%	4	253	64	Diabetes_McGill_CREBBP_coTF	RHODES_CANCER_META_SIGNATURE
1.58102766798%	4	253	64	Diabetes_McGill_CREBBP_coTF	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS
1.58102766798%	4	253	64	Diabetes_McGill_CREBBP_coTF	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
1.58102766798%	4	253	64	Diabetes_McGill_CREBBP_coTF	BYSTROEM_CORRELATED_WITH_IL5_DN
1.58102766798%	4	253	63	Diabetes_McGill_CREBBP_coTF	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
1.58102766798%	4	253	62	Diabetes_McGill_CREBBP_coTF	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
1.58102766798%	4	253	62	Diabetes_McGill_CREBBP_coTF	REACTOME_RNA_POL_I_PROMOTER_OPENING
1.58102766798%	4	253	62	Diabetes_McGill_CREBBP_coTF	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP
1.58102766798%	4	253	62	Diabetes_McGill_CREBBP_coTF	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
1.58102766798%	4	253	62	Diabetes_McGill_CREBBP_coTF	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
1.58102766798%	4	253	62	Diabetes_McGill_CREBBP_coTF	CORRE_MULTIPLE_MYELOMA_DN
1.58102766798%	4	253	61	Diabetes_McGill_CREBBP_coTF	KAUFFMANN_MELANOMA_RELAPSE_UP
1.58102766798%	4	253	61	Diabetes_McGill_CREBBP_coTF	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
1.58102766798%	4	253	59	Diabetes_McGill_CREBBP_coTF	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
1.58102766798%	4	253	59	Diabetes_McGill_CREBBP_coTF	DASU_IL6_SIGNALING_UP
1.58102766798%	4	253	58	Diabetes_McGill_CREBBP_coTF	KANNAN_TP53_TARGETS_UP
1.58102766798%	4	253	58	Diabetes_McGill_CREBBP_coTF	JI_RESPONSE_TO_FSH_DN
1.58102766798%	4	253	57	Diabetes_McGill_CREBBP_coTF	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
1.58102766798%	4	253	57	Diabetes_McGill_CREBBP_coTF	BORLAK_LIVER_CANCER_EGF_UP
1.58102766798%	4	253	56	Diabetes_McGill_CREBBP_coTF	MAYBURD_RESPONSE_TO_L663536_DN
1.58102766798%	4	253	56	Diabetes_McGill_CREBBP_coTF	HENDRICKS_SMARCA4_TARGETS_UP
1.58102766798%	4	253	56	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_10HR_DN
1.58102766798%	4	253	56	Diabetes_McGill_CREBBP_coTF	BIOCARTA_NFAT_PATHWAY
1.58102766798%	4	253	55	Diabetes_McGill_CREBBP_coTF	KEGG_BASAL_CELL_CARCINOMA
1.58102766798%	4	253	544	Diabetes_McGill_CREBBP_coTF	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
1.58102766798%	4	253	54	Diabetes_McGill_CREBBP_coTF	SESTO_RESPONSE_TO_UV_C2
1.58102766798%	4	253	54	Diabetes_McGill_CREBBP_coTF	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE
1.58102766798%	4	253	53	Diabetes_McGill_CREBBP_coTF	PID_CD8TCRPATHWAY
1.58102766798%	4	253	53	Diabetes_McGill_CREBBP_coTF	IKEDA_MIR1_TARGETS_UP
1.58102766798%	4	253	52	Diabetes_McGill_CREBBP_coTF	PID_KITPATHWAY
1.58102766798%	4	253	52	Diabetes_McGill_CREBBP_coTF	KEGG_MTOR_SIGNALING_PATHWAY
1.58102766798%	4	253	51	Diabetes_McGill_CREBBP_coTF	ZHANG_PROLIFERATING_VS_QUIESCENT
1.58102766798%	4	253	51	Diabetes_McGill_CREBBP_coTF	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
1.58102766798%	4	253	51	Diabetes_McGill_CREBBP_coTF	BURTON_ADIPOGENESIS_PEAK_AT_2HR
1.58102766798%	4	253	50	Diabetes_McGill_CREBBP_coTF	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN
1.58102766798%	4	253	50	Diabetes_McGill_CREBBP_coTF	PARK_HSC_AND_MULTIPOTENT_PROGENITORS
1.58102766798%	4	253	48	Diabetes_McGill_CREBBP_coTF	PENG_GLUCOSE_DEPRIVATION_UP
1.58102766798%	4	253	48	Diabetes_McGill_CREBBP_coTF	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
1.58102766798%	4	253	48	Diabetes_McGill_CREBBP_coTF	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
1.58102766798%	4	253	476	Diabetes_McGill_CREBBP_coTF	SMID_BREAST_CANCER_NORMAL_LIKE_UP
1.58102766798%	4	253	47	Diabetes_McGill_CREBBP_coTF	WARTERS_IR_RESPONSE_5GY
1.58102766798%	4	253	47	Diabetes_McGill_CREBBP_coTF	PID_DELTANP63PATHWAY
1.58102766798%	4	253	47	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_8HR_DN
1.58102766798%	4	253	467	Diabetes_McGill_CREBBP_coTF	RATTENBACHER_BOUND_BY_CELF1
1.58102766798%	4	253	46	Diabetes_McGill_CREBBP_coTF	SESTO_RESPONSE_TO_UV_C5
1.58102766798%	4	253	46	Diabetes_McGill_CREBBP_coTF	ABBUD_LIF_SIGNALING_1_UP
1.58102766798%	4	253	450	Diabetes_McGill_CREBBP_coTF	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
1.58102766798%	4	253	45	Diabetes_McGill_CREBBP_coTF	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
1.58102766798%	4	253	45	Diabetes_McGill_CREBBP_coTF	PID_RHOA_PATHWAY
1.58102766798%	4	253	45	Diabetes_McGill_CREBBP_coTF	PID_ILK_PATHWAY
1.58102766798%	4	253	45	Diabetes_McGill_CREBBP_coTF	LEE_AGING_MUSCLE_UP
1.58102766798%	4	253	45	Diabetes_McGill_CREBBP_coTF	ABRAMSON_INTERACT_WITH_AIRE
1.58102766798%	4	253	447	Diabetes_McGill_CREBBP_coTF	MOOTHA_MITOCHONDRIA
1.58102766798%	4	253	44	Diabetes_McGill_CREBBP_coTF	ZHAN_MULTIPLE_MYELOMA_LB_DN
1.58102766798%	4	253	44	Diabetes_McGill_CREBBP_coTF	STREICHER_LSM1_TARGETS_UP
1.58102766798%	4	253	44	Diabetes_McGill_CREBBP_coTF	PID_ERBB2ERBB3PATHWAY
1.58102766798%	4	253	43	Diabetes_McGill_CREBBP_coTF	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
1.58102766798%	4	253	43	Diabetes_McGill_CREBBP_coTF	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
1.58102766798%	4	253	43	Diabetes_McGill_CREBBP_coTF	IKEDA_MIR133_TARGETS_UP
1.58102766798%	4	253	420	Diabetes_McGill_CREBBP_coTF	MOOTHA_PGC
1.58102766798%	4	253	412	Diabetes_McGill_CREBBP_coTF	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
1.58102766798%	4	253	411	Diabetes_McGill_CREBBP_coTF	KOYAMA_SEMA3B_TARGETS_DN
1.58102766798%	4	253	41	Diabetes_McGill_CREBBP_coTF	RIZ_ERYTHROID_DIFFERENTIATION_HBZ
1.58102766798%	4	253	40	Diabetes_McGill_CREBBP_coTF	VARELA_ZMPSTE24_TARGETS_UP
1.58102766798%	4	253	40	Diabetes_McGill_CREBBP_coTF	VALK_AML_WITH_FLT3_ITD
1.58102766798%	4	253	40	Diabetes_McGill_CREBBP_coTF	GENTILE_UV_RESPONSE_CLUSTER_D7
1.58102766798%	4	253	39	Diabetes_McGill_CREBBP_coTF	CONRAD_STEM_CELL
1.58102766798%	4	253	39	Diabetes_McGill_CREBBP_coTF	BURTON_ADIPOGENESIS_PEAK_AT_8HR
1.58102766798%	4	253	39	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_2HR_UP
1.58102766798%	4	253	39	Diabetes_McGill_CREBBP_coTF	BIOCARTA_FMLP_PATHWAY
1.58102766798%	4	253	384	Diabetes_McGill_CREBBP_coTF	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
1.58102766798%	4	253	38	Diabetes_McGill_CREBBP_coTF	REACTOME_G1_PHASE
1.58102766798%	4	253	38	Diabetes_McGill_CREBBP_coTF	KAAB_FAILED_HEART_ATRIUM_UP
1.58102766798%	4	253	37	Diabetes_McGill_CREBBP_coTF	ST_P38_MAPK_PATHWAY
1.58102766798%	4	253	37	Diabetes_McGill_CREBBP_coTF	REACTOME_DOWNSTREAM_TCR_SIGNALING
1.58102766798%	4	253	37	Diabetes_McGill_CREBBP_coTF	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2
1.58102766798%	4	253	37	Diabetes_McGill_CREBBP_coTF	PID_FRA_PATHWAY
1.58102766798%	4	253	37	Diabetes_McGill_CREBBP_coTF	BIOCARTA_MET_PATHWAY
1.58102766798%	4	253	366	Diabetes_McGill_CREBBP_coTF	SANSOM_APC_TARGETS_DN
1.58102766798%	4	253	35	Diabetes_McGill_CREBBP_coTF	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP
1.58102766798%	4	253	346	Diabetes_McGill_CREBBP_coTF	GOLDRATH_ANTIGEN_RESPONSE
1.58102766798%	4	253	34	Diabetes_McGill_CREBBP_coTF	PID_IL2_PI3KPATHWAY
1.58102766798%	4	253	33	Diabetes_McGill_CREBBP_coTF	DORN_ADENOVIRUS_INFECTION_12HR_DN
1.58102766798%	4	253	33	Diabetes_McGill_CREBBP_coTF	BIOCARTA_IL1R_PATHWAY
1.58102766798%	4	253	31	Diabetes_McGill_CREBBP_coTF	VALK_AML_CLUSTER_15
1.58102766798%	4	253	31	Diabetes_McGill_CREBBP_coTF	RIZ_ERYTHROID_DIFFERENTIATION_HEMGN
1.58102766798%	4	253	31	Diabetes_McGill_CREBBP_coTF	PID_CD40_PATHWAY
1.58102766798%	4	253	31	Diabetes_McGill_CREBBP_coTF	PID_AVB3_OPN_PATHWAY
1.58102766798%	4	253	31	Diabetes_McGill_CREBBP_coTF	PID_AURORA_A_PATHWAY
1.58102766798%	4	253	307	Diabetes_McGill_CREBBP_coTF	LI_INDUCED_T_TO_NATURAL_KILLER_UP
1.58102766798%	4	253	30	Diabetes_McGill_CREBBP_coTF	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
1.58102766798%	4	253	30	Diabetes_McGill_CREBBP_coTF	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION
1.58102766798%	4	253	30	Diabetes_McGill_CREBBP_coTF	LI_PROSTATE_CANCER_EPIGENETIC
1.58102766798%	4	253	291	Diabetes_McGill_CREBBP_coTF	SABATES_COLORECTAL_ADENOMA_DN
1.58102766798%	4	253	29	Diabetes_McGill_CREBBP_coTF	PID_TCRCALCIUMPATHWAY
1.58102766798%	4	253	29	Diabetes_McGill_CREBBP_coTF	PID_BARD1PATHWAY
1.58102766798%	4	253	29	Diabetes_McGill_CREBBP_coTF	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
1.58102766798%	4	253	29	Diabetes_McGill_CREBBP_coTF	BIOCARTA_VIP_PATHWAY
1.58102766798%	4	253	284	Diabetes_McGill_CREBBP_coTF	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
1.58102766798%	4	253	28	Diabetes_McGill_CREBBP_coTF	MOREIRA_RESPONSE_TO_TSA_UP
1.58102766798%	4	253	28	Diabetes_McGill_CREBBP_coTF	LOPES_METHYLATED_IN_COLON_CANCER_DN
1.58102766798%	4	253	28	Diabetes_McGill_CREBBP_coTF	GENTILE_UV_RESPONSE_CLUSTER_D9
1.58102766798%	4	253	275	Diabetes_McGill_CREBBP_coTF	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
1.58102766798%	4	253	27	Diabetes_McGill_CREBBP_coTF	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
1.58102766798%	4	253	27	Diabetes_McGill_CREBBP_coTF	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
1.58102766798%	4	253	27	Diabetes_McGill_CREBBP_coTF	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS
1.58102766798%	4	253	27	Diabetes_McGill_CREBBP_coTF	PID_IL3_PATHWAY
1.58102766798%	4	253	27	Diabetes_McGill_CREBBP_coTF	OHM_METHYLATED_IN_ADULT_CANCERS
1.58102766798%	4	253	27	Diabetes_McGill_CREBBP_coTF	LOPES_METHYLATED_IN_COLON_CANCER_UP
1.58102766798%	4	253	267	Diabetes_McGill_CREBBP_coTF	CAIRO_HEPATOBLASTOMA_DN
1.58102766798%	4	253	266	Diabetes_McGill_CREBBP_coTF	ROZANOV_MMP14_TARGETS_UP
1.58102766798%	4	253	266	Diabetes_McGill_CREBBP_coTF	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
1.58102766798%	4	253	260	Diabetes_McGill_CREBBP_coTF	BOQUEST_STEM_CELL_UP
1.58102766798%	4	253	26	Diabetes_McGill_CREBBP_coTF	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN
1.58102766798%	4	253	26	Diabetes_McGill_CREBBP_coTF	BIOCARTA_PGC1A_PATHWAY
1.58102766798%	4	253	26	Diabetes_McGill_CREBBP_coTF	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
1.58102766798%	4	253	253	Diabetes_McGill_CREBBP_coTF	MCLACHLAN_DENTAL_CARIES_UP
1.58102766798%	4	253	25	Diabetes_McGill_CREBBP_coTF	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG
1.58102766798%	4	253	25	Diabetes_McGill_CREBBP_coTF	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
1.58102766798%	4	253	245	Diabetes_McGill_CREBBP_coTF	MCLACHLAN_DENTAL_CARIES_DN
1.58102766798%	4	253	242	Diabetes_McGill_CREBBP_coTF	CHYLA_CBFA2T3_TARGETS_DN
1.58102766798%	4	253	241	Diabetes_McGill_CREBBP_coTF	DOANE_RESPONSE_TO_ANDROGEN_DN
1.58102766798%	4	253	24	Diabetes_McGill_CREBBP_coTF	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING
1.58102766798%	4	253	24	Diabetes_McGill_CREBBP_coTF	REACTOME_DOUBLE_STRAND_BREAK_REPAIR
1.58102766798%	4	253	24	Diabetes_McGill_CREBBP_coTF	ONO_AML1_TARGETS_UP
1.58102766798%	4	253	24	Diabetes_McGill_CREBBP_coTF	GOLUB_ALL_VS_AML_UP
1.58102766798%	4	253	234	Diabetes_McGill_CREBBP_coTF	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
1.58102766798%	4	253	23	Diabetes_McGill_CREBBP_coTF	REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX
1.58102766798%	4	253	23	Diabetes_McGill_CREBBP_coTF	PID_NFKAPPABCANONICALPATHWAY
1.58102766798%	4	253	23	Diabetes_McGill_CREBBP_coTF	ONO_FOXP3_TARGETS_UP
1.58102766798%	4	253	23	Diabetes_McGill_CREBBP_coTF	BIOCARTA_RAS_PATHWAY
1.58102766798%	4	253	23	Diabetes_McGill_CREBBP_coTF	BIOCARTA_NFKB_PATHWAY
1.58102766798%	4	253	229	Diabetes_McGill_CREBBP_coTF	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
1.58102766798%	4	253	227	Diabetes_McGill_CREBBP_coTF	LEE_RECENT_THYMIC_EMIGRANT
1.58102766798%	4	253	22	Diabetes_McGill_CREBBP_coTF	PID_PDGFRAPATHWAY
1.58102766798%	4	253	22	Diabetes_McGill_CREBBP_coTF	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP
1.58102766798%	4	253	22	Diabetes_McGill_CREBBP_coTF	BIOCARTA_INSULIN_PATHWAY
1.58102766798%	4	253	22	Diabetes_McGill_CREBBP_coTF	BIOCARTA_HER2_PATHWAY
1.58102766798%	4	253	215	Diabetes_McGill_CREBBP_coTF	YAMAZAKI_TCEB3_TARGETS_DN
1.58102766798%	4	253	214	Diabetes_McGill_CREBBP_coTF	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
1.58102766798%	4	253	211	Diabetes_McGill_CREBBP_coTF	FOSTER_KDM1A_TARGETS_DN
1.58102766798%	4	253	210	Diabetes_McGill_CREBBP_coTF	VERHAAK_GLIOBLASTOMA_PRONEURAL
1.58102766798%	4	253	21	Diabetes_McGill_CREBBP_coTF	REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION
1.58102766798%	4	253	21	Diabetes_McGill_CREBBP_coTF	BIOCARTA_IGF1_PATHWAY
1.58102766798%	4	253	209	Diabetes_McGill_CREBBP_coTF	KIM_WT1_TARGETS_12HR_DN
1.58102766798%	4	253	209	Diabetes_McGill_CREBBP_coTF	CHANG_CORE_SERUM_RESPONSE_DN
1.58102766798%	4	253	207	Diabetes_McGill_CREBBP_coTF	VERHAAK_GLIOBLASTOMA_CLASSICAL
1.58102766798%	4	253	207	Diabetes_McGill_CREBBP_coTF	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
1.58102766798%	4	253	200	Diabetes_McGill_CREBBP_coTF	SHEPARD_BMYB_MORPHOLINO_DN
1.58102766798%	4	253	20	Diabetes_McGill_CREBBP_coTF	REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY
1.58102766798%	4	253	20	Diabetes_McGill_CREBBP_coTF	OUYANG_PROSTATE_CANCER_PROGRESSION_UP
1.58102766798%	4	253	194	Diabetes_McGill_CREBBP_coTF	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
1.58102766798%	4	253	191	Diabetes_McGill_CREBBP_coTF	YAGI_AML_FAB_MARKERS
1.58102766798%	4	253	19	Diabetes_McGill_CREBBP_coTF	BIOCARTA_TID_PATHWAY
1.58102766798%	4	253	186	Diabetes_McGill_CREBBP_coTF	WANG_CLIM2_TARGETS_DN
1.58102766798%	4	253	182	Diabetes_McGill_CREBBP_coTF	RAO_BOUND_BY_SALL4_ISOFORM_A
1.58102766798%	4	253	182	Diabetes_McGill_CREBBP_coTF	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
1.58102766798%	4	253	18	Diabetes_McGill_CREBBP_coTF	SCHEIDEREIT_IKK_TARGETS
1.58102766798%	4	253	18	Diabetes_McGill_CREBBP_coTF	REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI
1.58102766798%	4	253	18	Diabetes_McGill_CREBBP_coTF	BIOCARTA_TNFR2_PATHWAY
1.58102766798%	4	253	18	Diabetes_McGill_CREBBP_coTF	BIOCARTA_TEL_PATHWAY
1.58102766798%	4	253	18	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CARDIACEGF_PATHWAY
1.58102766798%	4	253	179	Diabetes_McGill_CREBBP_coTF	BENPORATH_NOS_TARGETS
1.58102766798%	4	253	178	Diabetes_McGill_CREBBP_coTF	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
1.58102766798%	4	253	175	Diabetes_McGill_CREBBP_coTF	YAMAZAKI_TCEB3_TARGETS_UP
1.58102766798%	4	253	172	Diabetes_McGill_CREBBP_coTF	REACTOME_MITOTIC_M_M_G1_PHASES
1.58102766798%	4	253	172	Diabetes_McGill_CREBBP_coTF	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
1.58102766798%	4	253	170	Diabetes_McGill_CREBBP_coTF	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
1.58102766798%	4	253	17	Diabetes_McGill_CREBBP_coTF	PID_SMAD2_3PATHWAY
1.58102766798%	4	253	17	Diabetes_McGill_CREBBP_coTF	PID_NFKAPPABATYPICALPATHWAY
1.58102766798%	4	253	17	Diabetes_McGill_CREBBP_coTF	BIOCARTA_ARF_PATHWAY
1.58102766798%	4	253	169	Diabetes_McGill_CREBBP_coTF	ONDER_CDH1_TARGETS_1_DN
1.58102766798%	4	253	169	Diabetes_McGill_CREBBP_coTF	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
1.58102766798%	4	253	165	Diabetes_McGill_CREBBP_coTF	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
1.58102766798%	4	253	165	Diabetes_McGill_CREBBP_coTF	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
1.58102766798%	4	253	165	Diabetes_McGill_CREBBP_coTF	DARWICHE_PAPILLOMA_RISK_LOW_DN
1.58102766798%	4	253	162	Diabetes_McGill_CREBBP_coTF	MULLIGHAN_NPM1_SIGNATURE_3_DN
1.58102766798%	4	253	160	Diabetes_McGill_CREBBP_coTF	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
1.58102766798%	4	253	16	Diabetes_McGill_CREBBP_coTF	LIU_TOPBP1_TARGETS
1.58102766798%	4	253	16	Diabetes_McGill_CREBBP_coTF	HE_PTEN_TARGETS_UP
1.58102766798%	4	253	16	Diabetes_McGill_CREBBP_coTF	BIOCARTA_P53_PATHWAY
1.58102766798%	4	253	16	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CDMAC_PATHWAY
1.58102766798%	4	253	157	Diabetes_McGill_CREBBP_coTF	SERVITJA_LIVER_HNF1A_TARGETS_DN
1.58102766798%	4	253	153	Diabetes_McGill_CREBBP_coTF	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN
1.58102766798%	4	253	151	Diabetes_McGill_CREBBP_coTF	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
1.58102766798%	4	253	151	Diabetes_McGill_CREBBP_coTF	IGLESIAS_E2F_TARGETS_UP
1.58102766798%	4	253	15	Diabetes_McGill_CREBBP_coTF	SA_G1_AND_S_PHASES
1.58102766798%	4	253	15	Diabetes_McGill_CREBBP_coTF	BIOCARTA_HIF_PATHWAY
1.58102766798%	4	253	15	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CD40_PATHWAY
1.58102766798%	4	253	148	Diabetes_McGill_CREBBP_coTF	REACTOME_APOPTOSIS
1.58102766798%	4	253	147	Diabetes_McGill_CREBBP_coTF	WHITFIELD_CELL_CYCLE_G1_S
1.58102766798%	4	253	147	Diabetes_McGill_CREBBP_coTF	SMID_BREAST_CANCER_ERBB2_UP
1.58102766798%	4	253	147	Diabetes_McGill_CREBBP_coTF	DARWICHE_PAPILLOMA_RISK_HIGH_UP
1.58102766798%	4	253	146	Diabetes_McGill_CREBBP_coTF	ELVIDGE_HYPOXIA_DN
1.58102766798%	4	253	142	Diabetes_McGill_CREBBP_coTF	DARWICHE_SKIN_TUMOR_PROMOTER_UP
1.58102766798%	4	253	140	Diabetes_McGill_CREBBP_coTF	QI_HYPOXIA
1.58102766798%	4	253	14	Diabetes_McGill_CREBBP_coTF	REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY
1.58102766798%	4	253	14	Diabetes_McGill_CREBBP_coTF	BIOCARTA_RANKL_PATHWAY
1.58102766798%	4	253	14	Diabetes_McGill_CREBBP_coTF	BIOCARTA_PS1_PATHWAY
1.58102766798%	4	253	138	Diabetes_McGill_CREBBP_coTF	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
1.58102766798%	4	253	136	Diabetes_McGill_CREBBP_coTF	PROVENZANI_METASTASIS_DN
1.58102766798%	4	253	136	Diabetes_McGill_CREBBP_coTF	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
1.58102766798%	4	253	134	Diabetes_McGill_CREBBP_coTF	POOLA_INVASIVE_BREAST_CANCER_DN
1.58102766798%	4	253	134	Diabetes_McGill_CREBBP_coTF	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
1.58102766798%	4	253	133	Diabetes_McGill_CREBBP_coTF	REACTOME_DIABETES_PATHWAYS
1.58102766798%	4	253	133	Diabetes_McGill_CREBBP_coTF	GAL_LEUKEMIC_STEM_CELL_UP
1.58102766798%	4	253	13	Diabetes_McGill_CREBBP_coTF	BIOCARTA_ARENRF2_PATHWAY
1.58102766798%	4	253	129	Diabetes_McGill_CREBBP_coTF	YAGI_AML_SURVIVAL
1.58102766798%	4	253	128	Diabetes_McGill_CREBBP_coTF	POTTI_TOPOTECAN_SENSITIVITY
1.58102766798%	4	253	127	Diabetes_McGill_CREBBP_coTF	LIU_VMYB_TARGETS_UP
1.58102766798%	4	253	127	Diabetes_McGill_CREBBP_coTF	INGRAM_SHH_TARGETS_UP
1.58102766798%	4	253	126	Diabetes_McGill_CREBBP_coTF	MISSIAGLIA_REGULATED_BY_METHYLATION_UP
1.58102766798%	4	253	126	Diabetes_McGill_CREBBP_coTF	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
1.58102766798%	4	253	125	Diabetes_McGill_CREBBP_coTF	REACTOME_HIV_LIFE_CYCLE
1.58102766798%	4	253	123	Diabetes_McGill_CREBBP_coTF	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
1.58102766798%	4	253	123	Diabetes_McGill_CREBBP_coTF	DAZARD_RESPONSE_TO_UV_SCC_DN
1.58102766798%	4	253	122	Diabetes_McGill_CREBBP_coTF	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
1.58102766798%	4	253	121	Diabetes_McGill_CREBBP_coTF	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
1.58102766798%	4	253	118	Diabetes_McGill_CREBBP_coTF	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
1.58102766798%	4	253	118	Diabetes_McGill_CREBBP_coTF	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
1.58102766798%	4	253	116	Diabetes_McGill_CREBBP_coTF	WHITEFORD_PEDIATRIC_CANCER_MARKERS
1.58102766798%	4	253	116	Diabetes_McGill_CREBBP_coTF	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
1.58102766798%	4	253	116	Diabetes_McGill_CREBBP_coTF	REACTOME_MEIOSIS
1.58102766798%	4	253	116	Diabetes_McGill_CREBBP_coTF	IKEDA_MIR30_TARGETS_UP
1.58102766798%	4	253	116	Diabetes_McGill_CREBBP_coTF	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
1.58102766798%	4	253	115	Diabetes_McGill_CREBBP_coTF	MARZEC_IL2_SIGNALING_UP
1.58102766798%	4	253	114	Diabetes_McGill_CREBBP_coTF	MATZUK_SPERMATOZOA
1.58102766798%	4	253	114	Diabetes_McGill_CREBBP_coTF	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN
1.58102766798%	4	253	113	Diabetes_McGill_CREBBP_coTF	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
1.58102766798%	4	253	112	Diabetes_McGill_CREBBP_coTF	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
1.58102766798%	4	253	112	Diabetes_McGill_CREBBP_coTF	DOANE_BREAST_CANCER_ESR1_UP
1.58102766798%	4	253	111	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_12HR_UP
1.58102766798%	4	253	110	Diabetes_McGill_CREBBP_coTF	WOOD_EBV_EBNA1_TARGETS_UP
1.58102766798%	4	253	110	Diabetes_McGill_CREBBP_coTF	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
1.58102766798%	4	253	110	Diabetes_McGill_CREBBP_coTF	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
1.58102766798%	4	253	110	Diabetes_McGill_CREBBP_coTF	GROSS_HYPOXIA_VIA_HIF1A_DN
1.58102766798%	4	253	109	Diabetes_McGill_CREBBP_coTF	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
1.58102766798%	4	253	109	Diabetes_McGill_CREBBP_coTF	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
1.58102766798%	4	253	108	Diabetes_McGill_CREBBP_coTF	LE_EGR2_TARGETS_UP
1.58102766798%	4	253	108	Diabetes_McGill_CREBBP_coTF	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
1.58102766798%	4	253	108	Diabetes_McGill_CREBBP_coTF	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN
1.58102766798%	4	253	105	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_8HR_UP
1.58102766798%	4	253	103	Diabetes_McGill_CREBBP_coTF	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
1.58102766798%	4	253	102	Diabetes_McGill_CREBBP_coTF	LABBE_TGFB1_TARGETS_UP
1.58102766798%	4	253	102	Diabetes_McGill_CREBBP_coTF	KANG_IMMORTALIZED_BY_TERT_DN
1.58102766798%	4	253	101	Diabetes_McGill_CREBBP_coTF	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
1.58102766798%	4	253	101	Diabetes_McGill_CREBBP_coTF	KEGG_GNRH_SIGNALING_PATHWAY
1.58102766798%	4	253	101	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_12HR_DN
1.58102766798%	4	253	101	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_10HR_UP
1.58102766798%	4	253	100	Diabetes_McGill_CREBBP_coTF	QI_PLASMACYTOMA_DN
1.58102766798%	4	253	100	Diabetes_McGill_CREBBP_coTF	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
1.58102766798%	4	253	100	Diabetes_McGill_CREBBP_coTF	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
1.57604412924%	20	1269	898	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
1.57604412924%	20	1269	882	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_BMP2_TARGETS_DN
1.57604412924%	20	1269	721	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WONG_ADULT_TISSUE_STEM_MODULE
1.57604412924%	20	1269	633	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
1.57604412924%	20	1269	567	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHICAS_RB1_TARGETS_CONFLUENT
1.57604412924%	20	1269	536	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
1.57604412924%	20	1269	514	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
1.57604412924%	20	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PACKAGING_OF_TELOMERE_ENDS
1.57604412924%	20	1269	456	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
1.57604412924%	20	1269	439	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MITSIADES_RESPONSE_TO_APLIDIN_UP
1.57604412924%	20	1269	435	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
1.5704154002%	31	1974	80	Mendelian_Nancy_Cox	WOO_LIVER_CANCER_RECURRENCE_DN
1.5704154002%	31	1974	75	Mendelian_Nancy_Cox	PID_AVB3_INTEGRIN_PATHWAY
1.5704154002%	31	1974	71	Mendelian_Nancy_Cox	KEGG_MELANOMA
1.5704154002%	31	1974	35	Mendelian_Nancy_Cox	KEGG_PRIMARY_IMMUNODEFICIENCY
1.5704154002%	31	1974	312	Mendelian_Nancy_Cox	GENTILE_UV_HIGH_DOSE_DN
1.5704154002%	31	1974	294	Mendelian_Nancy_Cox	WEST_ADRENOCORTICAL_TUMOR_UP
1.5704154002%	31	1974	275	Mendelian_Nancy_Cox	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
1.5704154002%	31	1974	265	Mendelian_Nancy_Cox	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
1.5704154002%	31	1974	264	Mendelian_Nancy_Cox	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
1.5704154002%	31	1974	258	Mendelian_Nancy_Cox	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
1.5704154002%	31	1974	250	Mendelian_Nancy_Cox	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
1.5704154002%	31	1974	242	Mendelian_Nancy_Cox	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
1.5704154002%	31	1974	241	Mendelian_Nancy_Cox	DOANE_RESPONSE_TO_ANDROGEN_DN
1.5704154002%	31	1974	239	Mendelian_Nancy_Cox	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
1.5704154002%	31	1974	228	Mendelian_Nancy_Cox	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
1.5704154002%	31	1974	227	Mendelian_Nancy_Cox	RAO_BOUND_BY_SALL4
1.5704154002%	31	1974	217	Mendelian_Nancy_Cox	SANSOM_APC_MYC_TARGETS
1.5704154002%	31	1974	206	Mendelian_Nancy_Cox	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
1.5704154002%	31	1974	205	Mendelian_Nancy_Cox	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
1.5704154002%	31	1974	195	Mendelian_Nancy_Cox	KYNG_DNA_DAMAGE_DN
1.5704154002%	31	1974	183	Mendelian_Nancy_Cox	VERHAAK_AML_WITH_NPM1_MUTATED_UP
1.5704154002%	31	1974	181	Mendelian_Nancy_Cox	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
1.5704154002%	31	1974	179	Mendelian_Nancy_Cox	BENPORATH_NOS_TARGETS
1.5704154002%	31	1974	169	Mendelian_Nancy_Cox	UEDA_PERIFERAL_CLOCK
1.5704154002%	31	1974	134	Mendelian_Nancy_Cox	POOLA_INVASIVE_BREAST_CANCER_DN
1.5704154002%	31	1974	108	Mendelian_Nancy_Cox	WESTON_VEGFA_TARGETS
1.5704154002%	31	1974	102	Mendelian_Nancy_Cox	KEGG_MELANOGENESIS
1.5704154002%	31	1974	101	Mendelian_Nancy_Cox	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
1.56950672646%	7	446	830	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CUI_TCF21_TARGETS_2_DN
1.56950672646%	7	446	722	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
1.56950672646%	7	446	701	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SMID_BREAST_CANCER_BASAL_DN
1.56950672646%	7	446	591	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARTINEZ_RB1_AND_TP53_TARGETS_DN
1.56950672646%	7	446	572	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHICAS_RB1_TARGETS_SENESCENT
1.56950672646%	7	446	548	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_ALL_DISORDERS_CALB1_CORR_UP
1.56950672646%	7	446	537	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
1.56950672646%	7	446	536	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
1.56950672646%	7	446	481	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIU_PROSTATE_CANCER_DN
1.56950672646%	7	446	469	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MCCABE_BOUND_BY_HOXC6
1.56950672646%	7	446	467	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RATTENBACHER_BOUND_BY_CELF1
1.56950672646%	7	446	463	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
1.56950672646%	7	446	460	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
1.56950672646%	7	446	442	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HAN_SATB1_TARGETS_DN
1.56950672646%	7	446	435	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
1.56950672646%	7	446	428	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIM_MAMMARY_STEM_CELL_DN
1.56950672646%	7	446	425	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOCHKIS_FOXA2_TARGETS
1.56950672646%	7	446	418	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MULLIGHAN_MLL_SIGNATURE_2_UP
1.56950672646%	7	446	409	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FOSTER_TOLERANT_MACROPHAGE_DN
1.56950672646%	7	446	397	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
1.56950672646%	7	446	390	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HATADA_METHYLATED_IN_LUNG_CANCER_UP
1.56950672646%	7	446	388	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	STEIN_ESRRA_TARGETS_UP
1.56950672646%	7	446	367	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VECCHI_GASTRIC_CANCER_EARLY_DN
1.56950672646%	7	446	344	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
1.56950672646%	7	446	337	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PENG_GLUTAMINE_DEPRIVATION_DN
1.56950672646%	7	446	335	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
1.56950672646%	7	446	328	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_PATHWAYS_IN_CANCER
1.56950672646%	7	446	314	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DOUGLAS_BMI1_TARGETS_DN
1.56950672646%	7	446	311	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JIANG_HYPOXIA_NORMAL
1.56950672646%	7	446	279	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FORTSCHEGGER_PHF8_TARGETS_UP
1.56950672646%	7	446	270	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
1.56950672646%	7	446	254	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_STEM_CELL
1.56950672646%	7	446	228	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
1.56950672646%	7	446	197	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
1.56950672646%	7	446	159	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_INTERFERON_SIGNALING
1.56950672646%	7	446	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
1.56950672646%	7	446	1038	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BENPORATH_SUZ12_TARGETS
1.5639374425%	34	2174	89	T2D_GENES_TANYA_LIPIDS	REACTOME_RNA_POL_I_TRANSCRIPTION
1.5639374425%	34	2174	404	T2D_GENES_TANYA_LIPIDS	OSMAN_BLADDER_CANCER_UP
1.5639374425%	34	2174	349	T2D_GENES_TANYA_LIPIDS	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
1.5639374425%	34	2174	344	T2D_GENES_TANYA_LIPIDS	RICKMAN_METASTASIS_UP
1.5639374425%	34	2174	332	T2D_GENES_TANYA_LIPIDS	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
1.5639374425%	34	2174	312	T2D_GENES_TANYA_LIPIDS	GENTILE_UV_HIGH_DOSE_DN
1.5639374425%	34	2174	296	T2D_GENES_TANYA_LIPIDS	DURAND_STROMA_MAX_UP
1.5639374425%	34	2174	264	T2D_GENES_TANYA_LIPIDS	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
1.5639374425%	34	2174	228	T2D_GENES_TANYA_LIPIDS	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
1.5639374425%	34	2174	194	T2D_GENES_TANYA_LIPIDS	KASLER_HDAC7_TARGETS_1_UP
1.5639374425%	34	2174	182	T2D_GENES_TANYA_LIPIDS	FERNANDEZ_BOUND_BY_MYC
1.5625%	55	3520	412	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
1.54997327632%	29	1871	75	T2D_GENES_TANYA_HEIGHT	REACTOME_TELOMERE_MAINTENANCE
1.54997327632%	29	1871	344	T2D_GENES_TANYA_HEIGHT	RICKMAN_METASTASIS_UP
1.54997327632%	29	1871	342	T2D_GENES_TANYA_HEIGHT	BLUM_RESPONSE_TO_SALIRASIB_DN
1.54997327632%	29	1871	328	T2D_GENES_TANYA_HEIGHT	KEGG_PATHWAYS_IN_CANCER
1.54997327632%	29	1871	289	T2D_GENES_TANYA_HEIGHT	WANG_MLL_TARGETS
1.54997327632%	29	1871	285	T2D_GENES_TANYA_HEIGHT	GRADE_COLON_AND_RECTAL_CANCER_UP
1.54997327632%	29	1871	284	T2D_GENES_TANYA_HEIGHT	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
1.54997327632%	29	1871	244	T2D_GENES_TANYA_HEIGHT	GAL_LEUKEMIC_STEM_CELL_DN
1.54997327632%	29	1871	225	T2D_GENES_TANYA_HEIGHT	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
1.54997327632%	29	1871	217	T2D_GENES_TANYA_HEIGHT	AMUNDSON_RESPONSE_TO_ARSENITE
1.54997327632%	29	1871	212	T2D_GENES_TANYA_HEIGHT	CHANG_CORE_SERUM_RESPONSE_UP
1.54997327632%	29	1871	210	T2D_GENES_TANYA_HEIGHT	SANSOM_APC_TARGETS_REQUIRE_MYC
1.54997327632%	29	1871	203	T2D_GENES_TANYA_HEIGHT	PENG_RAPAMYCIN_RESPONSE_UP
1.54997327632%	29	1871	182	T2D_GENES_TANYA_HEIGHT	FERNANDEZ_BOUND_BY_MYC
1.54997327632%	29	1871	181	T2D_GENES_TANYA_HEIGHT	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
1.54997327632%	29	1871	176	T2D_GENES_TANYA_HEIGHT	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
1.54997327632%	29	1871	134	T2D_GENES_TANYA_HEIGHT	SCHLOSSER_SERUM_RESPONSE_UP
1.53977758768%	18	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_RETINOL_METABOLISM
1.53977758768%	18	1169	578	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
1.53977758768%	18	1169	566	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DOUGLAS_BMI1_TARGETS_UP
1.53977758768%	18	1169	549	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
1.53977758768%	18	1169	528	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
1.53977758768%	18	1169	487	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
1.53977758768%	18	1169	476	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMID_BREAST_CANCER_NORMAL_LIKE_UP
1.53977758768%	18	1169	460	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
1.53977758768%	18	1169	456	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARTENS_BOUND_BY_PML_RARA_FUSION
1.53977758768%	18	1169	450	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
1.53977758768%	18	1169	422	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAGI_AML_WITH_INV_16_TRANSLOCATION
1.53977758768%	18	1169	421	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CELL_CYCLE
1.53977758768%	18	1169	414	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOHANKUMAR_TLX1_TARGETS_UP
1.53977758768%	18	1169	413	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
1.53977758768%	18	1169	408	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
1.53977758768%	18	1169	396	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DEVELOPMENTAL_BIOLOGY
1.53977758768%	18	1169	368	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
1.53977758768%	18	1169	328	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PATHWAYS_IN_CANCER
1.53977758768%	18	1169	282	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HELLER_SILENCED_BY_METHYLATION_UP
1.53977758768%	18	1169	267	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_MAPK_SIGNALING_PATHWAY
1.53977758768%	18	1169	264	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
1.53977758768%	18	1169	253	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DANG_REGULATED_BY_MYC_DN
1.53977758768%	18	1169	156	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_14HR_UP
1.53977758768%	18	1169	139	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_BIOLOGICAL_OXIDATIONS
1.53846153846%	7	455	98	T2D_GENES_TANYA_BLOODPRESSURE	NIELSEN_GIST
1.53846153846%	7	455	88	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS
1.53846153846%	7	455	88	T2D_GENES_TANYA_BLOODPRESSURE	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
1.53846153846%	7	455	88	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_APOPTOSIS
1.53846153846%	7	455	79	T2D_GENES_TANYA_BLOODPRESSURE	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
1.53846153846%	7	455	518	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_METABOLISM_OF_PROTEINS
1.53846153846%	7	455	473	T2D_GENES_TANYA_BLOODPRESSURE	GARY_CD5_TARGETS_UP
1.53846153846%	7	455	459	T2D_GENES_TANYA_BLOODPRESSURE	KIM_WT1_TARGETS_DN
1.53846153846%	7	455	450	T2D_GENES_TANYA_BLOODPRESSURE	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
1.53846153846%	7	455	408	T2D_GENES_TANYA_BLOODPRESSURE	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
1.53846153846%	7	455	404	T2D_GENES_TANYA_BLOODPRESSURE	OSMAN_BLADDER_CANCER_UP
1.53846153846%	7	455	367	T2D_GENES_TANYA_BLOODPRESSURE	VECCHI_GASTRIC_CANCER_EARLY_DN
1.53846153846%	7	455	357	T2D_GENES_TANYA_BLOODPRESSURE	SHEN_SMARCA2_TARGETS_DN
1.53846153846%	7	455	352	T2D_GENES_TANYA_BLOODPRESSURE	WANG_LMO4_TARGETS_DN
1.53846153846%	7	455	351	T2D_GENES_TANYA_BLOODPRESSURE	YAGI_AML_WITH_11Q23_REARRANGED
1.53846153846%	7	455	344	T2D_GENES_TANYA_BLOODPRESSURE	RICKMAN_METASTASIS_UP
1.53846153846%	7	455	341	T2D_GENES_TANYA_BLOODPRESSURE	MULLIGHAN_NPM1_SIGNATURE_3_UP
1.53846153846%	7	455	318	T2D_GENES_TANYA_BLOODPRESSURE	LEI_MYB_TARGETS
1.53846153846%	7	455	318	T2D_GENES_TANYA_BLOODPRESSURE	DAZARD_RESPONSE_TO_UV_NHEK_DN
1.53846153846%	7	455	315	T2D_GENES_TANYA_BLOODPRESSURE	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
1.53846153846%	7	455	315	T2D_GENES_TANYA_BLOODPRESSURE	PASINI_SUZ12_TARGETS_DN
1.53846153846%	7	455	306	T2D_GENES_TANYA_BLOODPRESSURE	HORIUCHI_WTAP_TARGETS_UP
1.53846153846%	7	455	302	T2D_GENES_TANYA_BLOODPRESSURE	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
1.53846153846%	7	455	295	T2D_GENES_TANYA_BLOODPRESSURE	LU_EZH2_TARGETS_UP
1.53846153846%	7	455	293	T2D_GENES_TANYA_BLOODPRESSURE	IVANOVA_HEMATOPOIESIS_MATURE_CELL
1.53846153846%	7	455	292	T2D_GENES_TANYA_BLOODPRESSURE	KOYAMA_SEMA3B_TARGETS_UP
1.53846153846%	7	455	292	T2D_GENES_TANYA_BLOODPRESSURE	HELLER_HDAC_TARGETS_DN
1.53846153846%	7	455	291	T2D_GENES_TANYA_BLOODPRESSURE	SABATES_COLORECTAL_ADENOMA_DN
1.53846153846%	7	455	277	T2D_GENES_TANYA_BLOODPRESSURE	ZHANG_TLX_TARGETS_60HR_DN
1.53846153846%	7	455	275	T2D_GENES_TANYA_BLOODPRESSURE	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
1.53846153846%	7	455	267	T2D_GENES_TANYA_BLOODPRESSURE	CAIRO_HEPATOBLASTOMA_DN
1.53846153846%	7	455	261	T2D_GENES_TANYA_BLOODPRESSURE	BILD_HRAS_ONCOGENIC_SIGNATURE
1.53846153846%	7	455	254	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_4HR_DN
1.53846153846%	7	455	253	T2D_GENES_TANYA_BLOODPRESSURE	MCLACHLAN_DENTAL_CARIES_UP
1.53846153846%	7	455	251	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
1.53846153846%	7	455	251	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_AXON_GUIDANCE
1.53846153846%	7	455	246	T2D_GENES_TANYA_BLOODPRESSURE	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
1.53846153846%	7	455	245	T2D_GENES_TANYA_BLOODPRESSURE	MCLACHLAN_DENTAL_CARIES_DN
1.53846153846%	7	455	241	T2D_GENES_TANYA_BLOODPRESSURE	DOANE_RESPONSE_TO_ANDROGEN_DN
1.53846153846%	7	455	239	T2D_GENES_TANYA_BLOODPRESSURE	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
1.53846153846%	7	455	235	T2D_GENES_TANYA_BLOODPRESSURE	RUTELLA_RESPONSE_TO_HGF_DN
1.53846153846%	7	455	234	T2D_GENES_TANYA_BLOODPRESSURE	AFFAR_YY1_TARGETS_DN
1.53846153846%	7	455	230	T2D_GENES_TANYA_BLOODPRESSURE	KAUFFMANN_DNA_REPAIR_GENES
1.53846153846%	7	455	225	T2D_GENES_TANYA_BLOODPRESSURE	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
1.53846153846%	7	455	222	T2D_GENES_TANYA_BLOODPRESSURE	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
1.53846153846%	7	455	222	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_1HR_DN
1.53846153846%	7	455	216	T2D_GENES_TANYA_BLOODPRESSURE	BOQUEST_STEM_CELL_DN
1.53846153846%	7	455	210	T2D_GENES_TANYA_BLOODPRESSURE	CAIRO_HEPATOBLASTOMA_CLASSES_DN
1.53846153846%	7	455	206	T2D_GENES_TANYA_BLOODPRESSURE	BILD_MYC_ONCOGENIC_SIGNATURE
1.53846153846%	7	455	200	T2D_GENES_TANYA_BLOODPRESSURE	SHEPARD_BMYB_MORPHOLINO_DN
1.53846153846%	7	455	193	T2D_GENES_TANYA_BLOODPRESSURE	MOHANKUMAR_TLX1_TARGETS_DN
1.53846153846%	7	455	185	T2D_GENES_TANYA_BLOODPRESSURE	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
1.53846153846%	7	455	185	T2D_GENES_TANYA_BLOODPRESSURE	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
1.53846153846%	7	455	182	T2D_GENES_TANYA_BLOODPRESSURE	FERNANDEZ_BOUND_BY_MYC
1.53846153846%	7	455	181	T2D_GENES_TANYA_BLOODPRESSURE	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
1.53846153846%	7	455	181	T2D_GENES_TANYA_BLOODPRESSURE	JISON_SICKLE_CELL_DISEASE_UP
1.53846153846%	7	455	181	T2D_GENES_TANYA_BLOODPRESSURE	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
1.53846153846%	7	455	180	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_48HR_UP
1.53846153846%	7	455	165	T2D_GENES_TANYA_BLOODPRESSURE	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
1.53846153846%	7	455	160	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_6HR_DN
1.53846153846%	7	455	153	T2D_GENES_TANYA_BLOODPRESSURE	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN
1.53846153846%	7	455	151	T2D_GENES_TANYA_BLOODPRESSURE	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
1.53846153846%	7	455	148	T2D_GENES_TANYA_BLOODPRESSURE	WEI_MIR34A_TARGETS
1.53846153846%	7	455	142	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_ES_LCP_WITH_H3K4ME3
1.53846153846%	7	455	141	T2D_GENES_TANYA_BLOODPRESSURE	WELCSH_BRCA1_TARGETS_DN
1.53846153846%	7	455	137	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
1.53846153846%	7	455	136	T2D_GENES_TANYA_BLOODPRESSURE	WIERENGA_STAT5A_TARGETS_GROUP1
1.53846153846%	7	455	128	T2D_GENES_TANYA_BLOODPRESSURE	LENAOUR_DENDRITIC_CELL_MATURATION_DN
1.53846153846%	7	455	120	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
1.53846153846%	7	455	112	T2D_GENES_TANYA_BLOODPRESSURE	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
1.53846153846%	7	455	110	T2D_GENES_TANYA_BLOODPRESSURE	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
1.53491941673%	20	1303	652	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BENPORATH_PRC2_TARGETS
1.53491941673%	20	1303	637	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
1.53491941673%	20	1303	567	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PARENT_MTOR_SIGNALING_UP
1.53491941673%	20	1303	539	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIAO_METASTASIS
1.53491941673%	20	1303	528	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
1.53491941673%	20	1303	514	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
1.53491941673%	20	1303	491	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SWEET_LUNG_CANCER_KRAS_UP
1.53491941673%	20	1303	430	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JOHNSTONE_PARVB_TARGETS_3_UP
1.53491941673%	20	1303	396	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_DEVELOPMENTAL_BIOLOGY
1.53491941673%	20	1303	351	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAGI_AML_WITH_11Q23_REARRANGED
1.53409090909%	54	3520	652	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BENPORATH_PRC2_TARGETS
1.53409090909%	54	3520	584	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
1.53409090909%	54	3520	567	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHICAS_RB1_TARGETS_CONFLUENT
1.53409090909%	54	3520	543	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTINEZ_RB1_TARGETS_DN
1.53409090909%	54	3520	517	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
1.53409090909%	54	3520	457	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
1.53409090909%	54	3520	423	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PUJANA_BRCA2_PCC_NETWORK
1.51975683891%	30	1974	98	Mendelian_Nancy_Cox	GUO_TARGETS_OF_IRS1_AND_IRS2
1.51975683891%	30	1974	95	Mendelian_Nancy_Cox	KAYO_CALORIE_RESTRICTION_MUSCLE_UP
1.51975683891%	30	1974	89	Mendelian_Nancy_Cox	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
1.51975683891%	30	1974	58	Mendelian_Nancy_Cox	REACTOME_COLLAGEN_FORMATION
1.51975683891%	30	1974	314	Mendelian_Nancy_Cox	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
1.51975683891%	30	1974	310	Mendelian_Nancy_Cox	HORIUCHI_WTAP_TARGETS_DN
1.51975683891%	30	1974	254	Mendelian_Nancy_Cox	IVANOVA_HEMATOPOIESIS_STEM_CELL
1.51975683891%	30	1974	251	Mendelian_Nancy_Cox	KOBAYASHI_EGFR_SIGNALING_24HR_DN
1.51975683891%	30	1974	235	Mendelian_Nancy_Cox	RUTELLA_RESPONSE_TO_HGF_DN
1.51975683891%	30	1974	228	Mendelian_Nancy_Cox	MARKEY_RB1_ACUTE_LOF_DN
1.51975683891%	30	1974	220	Mendelian_Nancy_Cox	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
1.51975683891%	30	1974	210	Mendelian_Nancy_Cox	VERHAAK_GLIOBLASTOMA_PRONEURAL
1.51975683891%	30	1974	210	Mendelian_Nancy_Cox	SANSOM_APC_TARGETS_REQUIRE_MYC
1.51975683891%	30	1974	210	Mendelian_Nancy_Cox	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
1.51975683891%	30	1974	205	Mendelian_Nancy_Cox	PEREZ_TP53_AND_TP63_TARGETS
1.51975683891%	30	1974	198	Mendelian_Nancy_Cox	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
1.51975683891%	30	1974	198	Mendelian_Nancy_Cox	ALONSO_METASTASIS_UP
1.51975683891%	30	1974	185	Mendelian_Nancy_Cox	DARWICHE_SKIN_TUMOR_PROMOTER_DN
1.51975683891%	30	1974	183	Mendelian_Nancy_Cox	OKUMURA_INFLAMMATORY_RESPONSE_LPS
1.51975683891%	30	1974	181	Mendelian_Nancy_Cox	JISON_SICKLE_CELL_DISEASE_UP
1.51975683891%	30	1974	172	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_LUMINAL_B_UP
1.51975683891%	30	1974	165	Mendelian_Nancy_Cox	BROWN_MYELOID_CELL_DEVELOPMENT_UP
1.51975683891%	30	1974	162	Mendelian_Nancy_Cox	MULLIGHAN_NPM1_SIGNATURE_3_DN
1.51975683891%	30	1974	158	Mendelian_Nancy_Cox	RODRIGUES_NTN1_TARGETS_DN
1.51975683891%	30	1974	149	Mendelian_Nancy_Cox	TSAI_RESPONSE_TO_IONIZING_RADIATION
1.51975683891%	30	1974	145	Mendelian_Nancy_Cox	RODWELL_AGING_KIDNEY_DN
1.51975683891%	30	1974	141	Mendelian_Nancy_Cox	WELCSH_BRCA1_TARGETS_DN
1.51975683891%	30	1974	118	Mendelian_Nancy_Cox	LEE_NEURAL_CREST_STEM_CELL_DN
1.51793928243%	33	2174	352	T2D_GENES_TANYA_LIPIDS	WANG_LMO4_TARGETS_DN
1.51793928243%	33	2174	344	T2D_GENES_TANYA_LIPIDS	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
1.51793928243%	33	2174	299	T2D_GENES_TANYA_LIPIDS	WALLACE_PROSTATE_CANCER_RACE_UP
1.51793928243%	33	2174	290	T2D_GENES_TANYA_LIPIDS	BASAKI_YBX1_TARGETS_UP
1.51793928243%	33	2174	284	T2D_GENES_TANYA_LIPIDS	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
1.51793928243%	33	2174	249	T2D_GENES_TANYA_LIPIDS	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
1.51793928243%	33	2174	242	T2D_GENES_TANYA_LIPIDS	CHYLA_CBFA2T3_TARGETS_DN
1.51793928243%	33	2174	210	T2D_GENES_TANYA_LIPIDS	SANSOM_APC_TARGETS_REQUIRE_MYC
1.51793928243%	33	2174	207	T2D_GENES_TANYA_LIPIDS	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
1.51285930408%	10	661	544	T2D_GENES_TANYA_GLYCEMIC	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
1.51285930408%	10	661	516	T2D_GENES_TANYA_GLYCEMIC	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
1.51285930408%	10	661	508	T2D_GENES_TANYA_GLYCEMIC	ENK_UV_RESPONSE_EPIDERMIS_DN
1.51285930408%	10	661	487	T2D_GENES_TANYA_GLYCEMIC	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
1.51285930408%	10	661	456	T2D_GENES_TANYA_GLYCEMIC	ODONNELL_TFRC_TARGETS_UP
1.51285930408%	10	661	420	T2D_GENES_TANYA_GLYCEMIC	MOOTHA_PGC
1.51285930408%	10	661	412	T2D_GENES_TANYA_GLYCEMIC	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
1.51285930408%	10	661	408	T2D_GENES_TANYA_GLYCEMIC	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
1.51285930408%	10	661	408	T2D_GENES_TANYA_GLYCEMIC	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
1.51285930408%	10	661	404	T2D_GENES_TANYA_GLYCEMIC	OSMAN_BLADDER_CANCER_UP
1.51285930408%	10	661	371	T2D_GENES_TANYA_GLYCEMIC	WANG_SMARCE1_TARGETS_DN
1.51285930408%	10	661	367	T2D_GENES_TANYA_GLYCEMIC	DELACROIX_RARG_BOUND_MEF
1.51285930408%	10	661	358	T2D_GENES_TANYA_GLYCEMIC	GRUETZMANN_PANCREATIC_CANCER_UP
1.51285930408%	10	661	344	T2D_GENES_TANYA_GLYCEMIC	RICKMAN_METASTASIS_UP
1.51285930408%	10	661	309	T2D_GENES_TANYA_GLYCEMIC	LIU_SOX4_TARGETS_DN
1.51285930408%	10	661	306	T2D_GENES_TANYA_GLYCEMIC	HORIUCHI_WTAP_TARGETS_UP
1.51285930408%	10	661	305	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
1.51285930408%	10	661	305	T2D_GENES_TANYA_GLYCEMIC	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
1.51285930408%	10	661	299	T2D_GENES_TANYA_GLYCEMIC	WALLACE_PROSTATE_CANCER_RACE_UP
1.51285930408%	10	661	298	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_14HR_DN
1.51285930408%	10	661	293	T2D_GENES_TANYA_GLYCEMIC	IVANOVA_HEMATOPOIESIS_MATURE_CELL
1.51285930408%	10	661	281	T2D_GENES_TANYA_GLYCEMIC	MULLIGHAN_MLL_SIGNATURE_2_DN
1.51285930408%	10	661	280	T2D_GENES_TANYA_GLYCEMIC	WANG_SMARCE1_TARGETS_UP
1.51285930408%	10	661	277	T2D_GENES_TANYA_GLYCEMIC	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
1.51285930408%	10	661	271	T2D_GENES_TANYA_GLYCEMIC	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
1.51285930408%	10	661	266	T2D_GENES_TANYA_GLYCEMIC	ROZANOV_MMP14_TARGETS_UP
1.51285930408%	10	661	266	T2D_GENES_TANYA_GLYCEMIC	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
1.51285930408%	10	661	260	T2D_GENES_TANYA_GLYCEMIC	SENESE_HDAC1_TARGETS_DN
1.51285930408%	10	661	247	T2D_GENES_TANYA_GLYCEMIC	REACTOME_METABOLISM_OF_CARBOHYDRATES
1.51285930408%	10	661	245	T2D_GENES_TANYA_GLYCEMIC	KONDO_EZH2_TARGETS
1.51285930408%	10	661	242	T2D_GENES_TANYA_GLYCEMIC	CHYLA_CBFA2T3_TARGETS_DN
1.51285930408%	10	661	241	T2D_GENES_TANYA_GLYCEMIC	DOANE_RESPONSE_TO_ANDROGEN_DN
1.51285930408%	10	661	240	T2D_GENES_TANYA_GLYCEMIC	UDAYAKUMAR_MED1_TARGETS_DN
1.51285930408%	10	661	239	T2D_GENES_TANYA_GLYCEMIC	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
1.51285930408%	10	661	222	T2D_GENES_TANYA_GLYCEMIC	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
1.51285930408%	10	661	213	T2D_GENES_TANYA_GLYCEMIC	WIERENGA_STAT5A_TARGETS_DN
1.51285930408%	10	661	210	T2D_GENES_TANYA_GLYCEMIC	WANG_TUMOR_INVASIVENESS_DN
1.51285930408%	10	661	210	T2D_GENES_TANYA_GLYCEMIC	RIZKI_TUMOR_INVASIVENESS_3D_UP
1.51285930408%	10	661	210	T2D_GENES_TANYA_GLYCEMIC	CAIRO_HEPATOBLASTOMA_CLASSES_DN
1.51285930408%	10	661	206	T2D_GENES_TANYA_GLYCEMIC	LINSLEY_MIR16_TARGETS
1.51285930408%	10	661	206	T2D_GENES_TANYA_GLYCEMIC	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
1.51285930408%	10	661	205	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
1.51285930408%	10	661	201	T2D_GENES_TANYA_GLYCEMIC	KEGG_FOCAL_ADHESION
1.51285930408%	10	661	186	T2D_GENES_TANYA_GLYCEMIC	HAMAI_APOPTOSIS_VIA_TRAIL_DN
1.51285930408%	10	661	185	T2D_GENES_TANYA_GLYCEMIC	LEE_LIVER_CANCER_SURVIVAL_UP
1.51285930408%	10	661	181	T2D_GENES_TANYA_GLYCEMIC	JISON_SICKLE_CELL_DISEASE_DN
1.51285930408%	10	661	180	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_48HR_UP
1.51285930408%	10	661	172	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MITOTIC_M_M_G1_PHASES
1.51285930408%	10	661	169	T2D_GENES_TANYA_GLYCEMIC	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
1.51285930408%	10	661	168	T2D_GENES_TANYA_GLYCEMIC	PUJANA_XPRSS_INT_NETWORK
1.51285930408%	10	661	167	T2D_GENES_TANYA_GLYCEMIC	VANTVEER_BREAST_CANCER_ESR1_UP
1.51285930408%	10	661	156	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_14HR_UP
1.51285930408%	10	661	139	T2D_GENES_TANYA_GLYCEMIC	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
1.51285930408%	10	661	125	T2D_GENES_TANYA_GLYCEMIC	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
1.50568181818%	53	3520	546	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
1.50568181818%	53	3520	544	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
1.50568181818%	53	3520	535	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STEIN_ESRRA_TARGETS
1.50568181818%	53	3520	428	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIM_MAMMARY_STEM_CELL_DN
1.49724192277%	19	1269	830	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CUI_TCF21_TARGETS_2_DN
1.49724192277%	19	1269	668	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
1.49724192277%	19	1269	605	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CAIRO_HEPATOBLASTOMA_CLASSES_UP
1.49724192277%	19	1269	555	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
1.49724192277%	19	1269	487	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RODWELL_AGING_KIDNEY_UP
1.49724192277%	19	1269	483	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
1.49724192277%	19	1269	457	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
1.49724192277%	19	1269	443	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DELYS_THYROID_CANCER_UP
1.49724192277%	19	1269	429	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOOTHA_HUMAN_MITODB_6_2002
1.49724192277%	19	1269	389	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_OLFACTORY_TRANSDUCTION
1.49724192277%	19	1269	293	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HADDAD_B_LYMPHOCYTE_PROGENITOR
1.49652592197%	28	1871	64	T2D_GENES_TANYA_HEIGHT	REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE
1.49652592197%	28	1871	434	T2D_GENES_TANYA_HEIGHT	BAELDE_DIABETIC_NEPHROPATHY_DN
1.49652592197%	28	1871	389	T2D_GENES_TANYA_HEIGHT	KEGG_OLFACTORY_TRANSDUCTION
1.49652592197%	28	1871	330	T2D_GENES_TANYA_HEIGHT	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
1.49652592197%	28	1871	315	T2D_GENES_TANYA_HEIGHT	PASINI_SUZ12_TARGETS_DN
1.49652592197%	28	1871	314	T2D_GENES_TANYA_HEIGHT	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
1.49652592197%	28	1871	296	T2D_GENES_TANYA_HEIGHT	DURAND_STROMA_MAX_UP
1.49652592197%	28	1871	294	T2D_GENES_TANYA_HEIGHT	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
1.49652592197%	28	1871	281	T2D_GENES_TANYA_HEIGHT	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
1.49652592197%	28	1871	259	T2D_GENES_TANYA_HEIGHT	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
1.49652592197%	28	1871	246	T2D_GENES_TANYA_HEIGHT	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
1.49652592197%	28	1871	239	T2D_GENES_TANYA_HEIGHT	ALFANO_MYC_TARGETS
1.49652592197%	28	1871	237	T2D_GENES_TANYA_HEIGHT	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
1.49652592197%	28	1871	228	T2D_GENES_TANYA_HEIGHT	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
1.49652592197%	28	1871	217	T2D_GENES_TANYA_HEIGHT	SANSOM_APC_MYC_TARGETS
1.49652592197%	28	1871	211	T2D_GENES_TANYA_HEIGHT	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
1.49652592197%	28	1871	210	T2D_GENES_TANYA_HEIGHT	WANG_TUMOR_INVASIVENESS_DN
1.47727272727%	52	3520	720	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
1.47727272727%	52	3520	555	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
1.47727272727%	52	3520	537	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
1.47727272727%	52	3520	517	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAO_BOUND_BY_SALL4_ISOFORM_B
1.47727272727%	52	3520	487	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
1.47727272727%	52	3520	466	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_HEMOSTASIS
1.47727272727%	52	3520	419	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
1.47727272727%	52	3520	390	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
1.47601476015%	8	542	98	T2D_GENES_TANYA_ANTHROPOMETRIC	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
1.47601476015%	8	542	91	T2D_GENES_TANYA_ANTHROPOMETRIC	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
1.47601476015%	8	542	572	T2D_GENES_TANYA_ANTHROPOMETRIC	CHICAS_RB1_TARGETS_SENESCENT
1.47601476015%	8	542	557	T2D_GENES_TANYA_ANTHROPOMETRIC	TIEN_INTESTINE_PROBIOTICS_24HR_UP
1.47601476015%	8	542	423	T2D_GENES_TANYA_ANTHROPOMETRIC	PUJANA_BRCA2_PCC_NETWORK
1.47601476015%	8	542	418	T2D_GENES_TANYA_ANTHROPOMETRIC	PEDRIOLI_MIR31_TARGETS_DN
1.47601476015%	8	542	408	T2D_GENES_TANYA_ANTHROPOMETRIC	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
1.47601476015%	8	542	406	T2D_GENES_TANYA_ANTHROPOMETRIC	OSMAN_BLADDER_CANCER_DN
1.47601476015%	8	542	382	T2D_GENES_TANYA_ANTHROPOMETRIC	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
1.47601476015%	8	542	380	T2D_GENES_TANYA_ANTHROPOMETRIC	MULLIGHAN_MLL_SIGNATURE_1_UP
1.47601476015%	8	542	372	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_LMO4_TARGETS_UP
1.47601476015%	8	542	366	T2D_GENES_TANYA_ANTHROPOMETRIC	SANSOM_APC_TARGETS_DN
1.47601476015%	8	542	362	T2D_GENES_TANYA_ANTHROPOMETRIC	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
1.47601476015%	8	542	354	T2D_GENES_TANYA_ANTHROPOMETRIC	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
1.47601476015%	8	542	352	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_LMO4_TARGETS_DN
1.47601476015%	8	542	314	T2D_GENES_TANYA_ANTHROPOMETRIC	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
1.47601476015%	8	542	311	T2D_GENES_TANYA_ANTHROPOMETRIC	JIANG_HYPOXIA_NORMAL
1.47601476015%	8	542	308	T2D_GENES_TANYA_ANTHROPOMETRIC	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
1.47601476015%	8	542	306	T2D_GENES_TANYA_ANTHROPOMETRIC	CHANDRAN_METASTASIS_DN
1.47601476015%	8	542	293	T2D_GENES_TANYA_ANTHROPOMETRIC	IVANOVA_HEMATOPOIESIS_MATURE_CELL
1.47601476015%	8	542	285	T2D_GENES_TANYA_ANTHROPOMETRIC	GRADE_COLON_AND_RECTAL_CANCER_UP
1.47601476015%	8	542	279	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_INNATE_IMMUNE_SYSTEM
1.47601476015%	8	542	274	T2D_GENES_TANYA_ANTHROPOMETRIC	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
1.47601476015%	8	542	271	T2D_GENES_TANYA_ANTHROPOMETRIC	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
1.47601476015%	8	542	270	T2D_GENES_TANYA_ANTHROPOMETRIC	RIZKI_TUMOR_INVASIVENESS_3D_DN
1.47601476015%	8	542	267	T2D_GENES_TANYA_ANTHROPOMETRIC	HOLLMANN_APOPTOSIS_VIA_CD40_DN
1.47601476015%	8	542	266	T2D_GENES_TANYA_ANTHROPOMETRIC	ROZANOV_MMP14_TARGETS_UP
1.47601476015%	8	542	264	T2D_GENES_TANYA_ANTHROPOMETRIC	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
1.47601476015%	8	542	262	T2D_GENES_TANYA_ANTHROPOMETRIC	LU_AGING_BRAIN_UP
1.47601476015%	8	542	260	T2D_GENES_TANYA_ANTHROPOMETRIC	BOQUEST_STEM_CELL_UP
1.47601476015%	8	542	258	T2D_GENES_TANYA_ANTHROPOMETRIC	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
1.47601476015%	8	542	254	T2D_GENES_TANYA_ANTHROPOMETRIC	IVANOVA_HEMATOPOIESIS_STEM_CELL
1.47601476015%	8	542	250	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
1.47601476015%	8	542	245	T2D_GENES_TANYA_ANTHROPOMETRIC	PENG_RAPAMYCIN_RESPONSE_DN
1.47601476015%	8	542	242	T2D_GENES_TANYA_ANTHROPOMETRIC	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
1.47601476015%	8	542	240	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_20HR_UP
1.47601476015%	8	542	239	T2D_GENES_TANYA_ANTHROPOMETRIC	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
1.47601476015%	8	542	234	T2D_GENES_TANYA_ANTHROPOMETRIC	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
1.47601476015%	8	542	232	T2D_GENES_TANYA_ANTHROPOMETRIC	DELYS_THYROID_CANCER_DN
1.47601476015%	8	542	227	T2D_GENES_TANYA_ANTHROPOMETRIC	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
1.47601476015%	8	542	225	T2D_GENES_TANYA_ANTHROPOMETRIC	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
1.47601476015%	8	542	220	T2D_GENES_TANYA_ANTHROPOMETRIC	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
1.47601476015%	8	542	217	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALLING_BY_NGF
1.47601476015%	8	542	214	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_WT1_TARGETS_UP
1.47601476015%	8	542	211	T2D_GENES_TANYA_ANTHROPOMETRIC	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
1.47601476015%	8	542	207	T2D_GENES_TANYA_ANTHROPOMETRIC	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
1.47601476015%	8	542	205	T2D_GENES_TANYA_ANTHROPOMETRIC	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
1.47601476015%	8	542	174	T2D_GENES_TANYA_ANTHROPOMETRIC	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
1.47601476015%	8	542	169	T2D_GENES_TANYA_ANTHROPOMETRIC	KATSANOU_ELAVL1_TARGETS_UP
1.47601476015%	8	542	167	T2D_GENES_TANYA_ANTHROPOMETRIC	VANTVEER_BREAST_CANCER_ESR1_UP
1.47601476015%	8	542	165	T2D_GENES_TANYA_ANTHROPOMETRIC	DARWICHE_PAPILLOMA_RISK_LOW_DN
1.47601476015%	8	542	151	T2D_GENES_TANYA_ANTHROPOMETRIC	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
1.47601476015%	8	542	149	T2D_GENES_TANYA_ANTHROPOMETRIC	TSAI_RESPONSE_TO_IONIZING_RADIATION
1.47601476015%	8	542	137	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
1.47601476015%	8	542	132	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
1.47601476015%	8	542	128	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_SPLICEOSOME
1.47601476015%	8	542	127	T2D_GENES_TANYA_ANTHROPOMETRIC	INGRAM_SHH_TARGETS_UP
1.47601476015%	8	542	120	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
1.47601476015%	8	542	120	T2D_GENES_TANYA_ANTHROPOMETRIC	CHEBOTAEV_GR_TARGETS_DN
1.47601476015%	8	542	115	T2D_GENES_TANYA_ANTHROPOMETRIC	MARZEC_IL2_SIGNALING_UP
1.47601476015%	8	542	112	T2D_GENES_TANYA_ANTHROPOMETRIC	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
1.47601476015%	8	542	111	T2D_GENES_TANYA_ANTHROPOMETRIC	BOUDOUKHA_BOUND_BY_IGF2BP2
1.47194112236%	32	2174	379	T2D_GENES_TANYA_LIPIDS	BENPORATH_ES_1
1.47194112236%	32	2174	362	T2D_GENES_TANYA_LIPIDS	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
1.47194112236%	32	2174	337	T2D_GENES_TANYA_LIPIDS	PHONG_TNF_RESPONSE_NOT_VIA_P38
1.47194112236%	32	2174	335	T2D_GENES_TANYA_LIPIDS	WONG_EMBRYONIC_STEM_CELL_CORE
1.47194112236%	32	2174	288	T2D_GENES_TANYA_LIPIDS	POOLA_INVASIVE_BREAST_CANCER_UP
1.47194112236%	32	2174	254	T2D_GENES_TANYA_LIPIDS	IVANOVA_HEMATOPOIESIS_STEM_CELL
1.47194112236%	32	2174	244	T2D_GENES_TANYA_LIPIDS	KAYO_AGING_MUSCLE_UP
1.47194112236%	32	2174	244	T2D_GENES_TANYA_LIPIDS	GAL_LEUKEMIC_STEM_CELL_DN
1.47194112236%	32	2174	214	T2D_GENES_TANYA_LIPIDS	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
1.47194112236%	32	2174	207	T2D_GENES_TANYA_LIPIDS	REACTOME_HIV_INFECTION
1.46909827761%	29	1974	98	Mendelian_Nancy_Cox	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
1.46909827761%	29	1974	89	Mendelian_Nancy_Cox	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
1.46909827761%	29	1974	88	Mendelian_Nancy_Cox	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
1.46909827761%	29	1974	44	Mendelian_Nancy_Cox	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
1.46909827761%	29	1974	275	Mendelian_Nancy_Cox	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
1.46909827761%	29	1974	269	Mendelian_Nancy_Cox	WANG_CLIM2_TARGETS_UP
1.46909827761%	29	1974	244	Mendelian_Nancy_Cox	THUM_SYSTOLIC_HEART_FAILURE_DN
1.46909827761%	29	1974	229	Mendelian_Nancy_Cox	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
1.46909827761%	29	1974	217	Mendelian_Nancy_Cox	WIERENGA_STAT5A_TARGETS_UP
1.46909827761%	29	1974	211	Mendelian_Nancy_Cox	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
1.46909827761%	29	1974	210	Mendelian_Nancy_Cox	WANG_TUMOR_INVASIVENESS_DN
1.46909827761%	29	1974	208	Mendelian_Nancy_Cox	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
1.46909827761%	29	1974	183	Mendelian_Nancy_Cox	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
1.46909827761%	29	1974	178	Mendelian_Nancy_Cox	KEGG_CALCIUM_SIGNALING_PATHWAY
1.46909827761%	29	1974	175	Mendelian_Nancy_Cox	FIRESTEIN_PROLIFERATION
1.46909827761%	29	1974	158	Mendelian_Nancy_Cox	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
1.46909827761%	29	1974	138	Mendelian_Nancy_Cox	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
1.46909827761%	29	1974	127	Mendelian_Nancy_Cox	INGRAM_SHH_TARGETS_UP
1.46909827761%	29	1974	113	Mendelian_Nancy_Cox	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
1.46909827761%	29	1974	112	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_FGFR
1.46909827761%	29	1974	105	Mendelian_Nancy_Cox	WOO_LIVER_CANCER_RECURRENCE_UP
1.46818923328%	9	613	805	T2D_GENES_TANYA_BIOMARKER	REACTOME_GPCR_DOWNSTREAM_SIGNALING
1.46818923328%	9	613	489	T2D_GENES_TANYA_BIOMARKER	LIM_MAMMARY_STEM_CELL_UP
1.46818923328%	9	613	425	T2D_GENES_TANYA_BIOMARKER	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
1.46818923328%	9	613	423	T2D_GENES_TANYA_BIOMARKER	PUJANA_BRCA2_PCC_NETWORK
1.46818923328%	9	613	412	T2D_GENES_TANYA_BIOMARKER	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
1.46818923328%	9	613	394	T2D_GENES_TANYA_BIOMARKER	BERENJENO_TRANSFORMED_BY_RHOA_DN
1.46818923328%	9	613	356	T2D_GENES_TANYA_BIOMARKER	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
1.46818923328%	9	613	344	T2D_GENES_TANYA_BIOMARKER	RICKMAN_METASTASIS_UP
1.46818923328%	9	613	341	T2D_GENES_TANYA_BIOMARKER	MULLIGHAN_NPM1_SIGNATURE_3_UP
1.46818923328%	9	613	328	T2D_GENES_TANYA_BIOMARKER	KEGG_PATHWAYS_IN_CANCER
1.46818923328%	9	613	325	T2D_GENES_TANYA_BIOMARKER	REACTOME_CELL_CYCLE_MITOTIC
1.46818923328%	9	613	323	T2D_GENES_TANYA_BIOMARKER	GRESHOCK_CANCER_COPY_NUMBER_UP
1.46818923328%	9	613	318	T2D_GENES_TANYA_BIOMARKER	LEI_MYB_TARGETS
1.46818923328%	9	613	318	T2D_GENES_TANYA_BIOMARKER	DAZARD_RESPONSE_TO_UV_NHEK_DN
1.46818923328%	9	613	315	T2D_GENES_TANYA_BIOMARKER	PASINI_SUZ12_TARGETS_DN
1.46818923328%	9	613	314	T2D_GENES_TANYA_BIOMARKER	DOUGLAS_BMI1_TARGETS_DN
1.46818923328%	9	613	310	T2D_GENES_TANYA_BIOMARKER	HORIUCHI_WTAP_TARGETS_DN
1.46818923328%	9	613	309	T2D_GENES_TANYA_BIOMARKER	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
1.46818923328%	9	613	307	T2D_GENES_TANYA_BIOMARKER	LI_INDUCED_T_TO_NATURAL_KILLER_UP
1.46818923328%	9	613	293	T2D_GENES_TANYA_BIOMARKER	IVANOVA_HEMATOPOIESIS_MATURE_CELL
1.46818923328%	9	613	289	T2D_GENES_TANYA_BIOMARKER	MANALO_HYPOXIA_DN
1.46818923328%	9	613	284	T2D_GENES_TANYA_BIOMARKER	REACTOME_METABOLISM_OF_MRNA
1.46818923328%	9	613	276	T2D_GENES_TANYA_BIOMARKER	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
1.46818923328%	9	613	271	T2D_GENES_TANYA_BIOMARKER	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
1.46818923328%	9	613	267	T2D_GENES_TANYA_BIOMARKER	KEGG_MAPK_SIGNALING_PATHWAY
1.46818923328%	9	613	267	T2D_GENES_TANYA_BIOMARKER	HOLLMANN_APOPTOSIS_VIA_CD40_DN
1.46818923328%	9	613	265	T2D_GENES_TANYA_BIOMARKER	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
1.46818923328%	9	613	260	T2D_GENES_TANYA_BIOMARKER	SENESE_HDAC1_TARGETS_DN
1.46818923328%	9	613	259	T2D_GENES_TANYA_BIOMARKER	QI_PLASMACYTOMA_UP
1.46818923328%	9	613	253	T2D_GENES_TANYA_BIOMARKER	DANG_REGULATED_BY_MYC_DN
1.46818923328%	9	613	252	T2D_GENES_TANYA_BIOMARKER	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
1.46818923328%	9	613	245	T2D_GENES_TANYA_BIOMARKER	PENG_RAPAMYCIN_RESPONSE_DN
1.46818923328%	9	613	242	T2D_GENES_TANYA_BIOMARKER	CHYLA_CBFA2T3_TARGETS_DN
1.46818923328%	9	613	236	T2D_GENES_TANYA_BIOMARKER	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
1.46818923328%	9	613	234	T2D_GENES_TANYA_BIOMARKER	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
1.46818923328%	9	613	225	T2D_GENES_TANYA_BIOMARKER	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
1.46818923328%	9	613	223	T2D_GENES_TANYA_BIOMARKER	CHEN_HOXA5_TARGETS_9HR_UP
1.46818923328%	9	613	221	T2D_GENES_TANYA_BIOMARKER	CHANDRAN_METASTASIS_UP
1.46818923328%	9	613	220	T2D_GENES_TANYA_BIOMARKER	RIGGINS_TAMOXIFEN_RESISTANCE_DN
1.46818923328%	9	613	217	T2D_GENES_TANYA_BIOMARKER	WIERENGA_STAT5A_TARGETS_UP
1.46818923328%	9	613	216	T2D_GENES_TANYA_BIOMARKER	BOQUEST_STEM_CELL_DN
1.46818923328%	9	613	213	T2D_GENES_TANYA_BIOMARKER	WIERENGA_STAT5A_TARGETS_DN
1.46818923328%	9	613	211	T2D_GENES_TANYA_BIOMARKER	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
1.46818923328%	9	613	210	T2D_GENES_TANYA_BIOMARKER	CAIRO_HEPATOBLASTOMA_CLASSES_DN
1.46818923328%	9	613	207	T2D_GENES_TANYA_BIOMARKER	REACTOME_HIV_INFECTION
1.46818923328%	9	613	202	T2D_GENES_TANYA_BIOMARKER	FUJII_YBX1_TARGETS_DN
1.46818923328%	9	613	200	T2D_GENES_TANYA_BIOMARKER	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
1.46818923328%	9	613	194	T2D_GENES_TANYA_BIOMARKER	KASLER_HDAC7_TARGETS_1_UP
1.46818923328%	9	613	191	T2D_GENES_TANYA_BIOMARKER	YAGI_AML_FAB_MARKERS
1.46818923328%	9	613	185	T2D_GENES_TANYA_BIOMARKER	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
1.46818923328%	9	613	183	T2D_GENES_TANYA_BIOMARKER	OKUMURA_INFLAMMATORY_RESPONSE_LPS
1.46818923328%	9	613	182	T2D_GENES_TANYA_BIOMARKER	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
1.46818923328%	9	613	181	T2D_GENES_TANYA_BIOMARKER	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
1.46818923328%	9	613	180	T2D_GENES_TANYA_BIOMARKER	DARWICHE_PAPILLOMA_RISK_HIGH_DN
1.46818923328%	9	613	179	T2D_GENES_TANYA_BIOMARKER	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
1.46818923328%	9	613	172	T2D_GENES_TANYA_BIOMARKER	SMID_BREAST_CANCER_LUMINAL_B_UP
1.46818923328%	9	613	165	T2D_GENES_TANYA_BIOMARKER	BROWN_MYELOID_CELL_DEVELOPMENT_UP
1.46818923328%	9	613	161	T2D_GENES_TANYA_BIOMARKER	BIDUS_METASTASIS_DN
1.46818923328%	9	613	151	T2D_GENES_TANYA_BIOMARKER	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
1.46818923328%	9	613	149	T2D_GENES_TANYA_BIOMARKER	OHGUCHI_LIVER_HNF4A_TARGETS_DN
1.46818923328%	9	613	145	T2D_GENES_TANYA_BIOMARKER	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
1.46818923328%	9	613	143	T2D_GENES_TANYA_BIOMARKER	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION
1.46818923328%	9	613	138	T2D_GENES_TANYA_BIOMARKER	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
1.46818923328%	9	613	128	T2D_GENES_TANYA_BIOMARKER	LENAOUR_DENDRITIC_CELL_MATURATION_DN
1.45817344589%	19	1303	605	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAIRO_HEPATOBLASTOMA_CLASSES_UP
1.45817344589%	19	1303	593	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTINEZ_TP53_TARGETS_DN
1.45817344589%	19	1303	591	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTINEZ_RB1_AND_TP53_TARGETS_DN
1.45817344589%	19	1303	546	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
1.45817344589%	19	1303	543	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTINEZ_RB1_TARGETS_DN
1.45817344589%	19	1303	518	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_PROTEINS
1.45817344589%	19	1303	516	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
1.45817344589%	19	1303	489	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIM_MAMMARY_STEM_CELL_UP
1.45817344589%	19	1303	483	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
1.45817344589%	19	1303	479	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
1.45817344589%	19	1303	473	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
1.45817344589%	19	1303	457	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SENESE_HDAC1_TARGETS_UP
1.45817344589%	19	1303	447	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOOTHA_MITOCHONDRIA
1.45817344589%	19	1303	434	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BAELDE_DIABETIC_NEPHROPATHY_DN
1.45817344589%	19	1303	423	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PUJANA_BRCA2_PCC_NETWORK
1.45817344589%	19	1303	413	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
1.45817344589%	19	1303	412	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
1.45817344589%	19	1303	368	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
1.45817344589%	19	1303	317	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_EARLY_LATE
1.45423438837%	17	1169	591	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARTINEZ_RB1_AND_TP53_TARGETS_DN
1.45423438837%	17	1169	590	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
1.45423438837%	17	1169	544	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
1.45423438837%	17	1169	544	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
1.45423438837%	17	1169	543	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARTINEZ_RB1_TARGETS_DN
1.45423438837%	17	1169	537	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
1.45423438837%	17	1169	536	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
1.45423438837%	17	1169	532	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
1.45423438837%	17	1169	508	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ENK_UV_RESPONSE_EPIDERMIS_DN
1.45423438837%	17	1169	475	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
1.45423438837%	17	1169	473	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
1.45423438837%	17	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT
1.45423438837%	17	1169	398	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
1.45423438837%	17	1169	366	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YOSHIMURA_MAPK8_TARGETS_DN
1.45423438837%	17	1169	364	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YANG_BCL3_TARGETS_UP
1.45423438837%	17	1169	358	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRUETZMANN_PANCREATIC_CANCER_UP
1.45423438837%	17	1169	329	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
1.45423438837%	17	1169	317	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HELLER_HDAC_TARGETS_UP
1.45423438837%	17	1169	267	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CAIRO_HEPATOBLASTOMA_DN
1.45423438837%	17	1169	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRANSCRIPTION
1.44886363636%	51	3520	532	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
1.44886363636%	51	3520	445	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
1.44886363636%	51	3520	389	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HSIAO_HOUSEKEEPING_GENES
1.44886363636%	51	3520	380	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAIRKEE_TERT_TARGETS_UP
1.44886363636%	51	3520	351	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAGI_AML_WITH_11Q23_REARRANGED
1.44307856761%	27	1871	48	T2D_GENES_TANYA_HEIGHT	REACTOME_PACKAGING_OF_TELOMERE_ENDS
1.44307856761%	27	1871	397	T2D_GENES_TANYA_HEIGHT	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
1.44307856761%	27	1871	352	T2D_GENES_TANYA_HEIGHT	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
1.44307856761%	27	1871	344	T2D_GENES_TANYA_HEIGHT	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
1.44307856761%	27	1871	330	T2D_GENES_TANYA_HEIGHT	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
1.44307856761%	27	1871	310	T2D_GENES_TANYA_HEIGHT	HORIUCHI_WTAP_TARGETS_DN
1.44307856761%	27	1871	307	T2D_GENES_TANYA_HEIGHT	LI_INDUCED_T_TO_NATURAL_KILLER_UP
1.44307856761%	27	1871	292	T2D_GENES_TANYA_HEIGHT	HELLER_HDAC_TARGETS_DN
1.44307856761%	27	1871	280	T2D_GENES_TANYA_HEIGHT	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
1.44307856761%	27	1871	277	T2D_GENES_TANYA_HEIGHT	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
1.44307856761%	27	1871	234	T2D_GENES_TANYA_HEIGHT	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
1.44307856761%	27	1871	225	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_16HR_UP
1.44307856761%	27	1871	223	T2D_GENES_TANYA_HEIGHT	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
1.44307856761%	27	1871	216	T2D_GENES_TANYA_HEIGHT	BOQUEST_STEM_CELL_DN
1.44307856761%	27	1871	210	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
1.44307856761%	27	1871	209	T2D_GENES_TANYA_HEIGHT	GROSS_HYPOXIA_VIA_ELK3_UP
1.44307856761%	27	1871	206	T2D_GENES_TANYA_HEIGHT	LINSLEY_MIR16_TARGETS
1.44307856761%	27	1871	164	T2D_GENES_TANYA_HEIGHT	KIM_WT1_TARGETS_8HR_UP
1.44307856761%	27	1871	159	T2D_GENES_TANYA_HEIGHT	REACTOME_INTERFERON_SIGNALING
1.42857142857%	1	70	99	Diabetes_McGill_Adipocytokine_signallin	LIM_MAMMARY_LUMINAL_MATURE_DN
1.42857142857%	1	70	99	Diabetes_McGill_Adipocytokine_signallin	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
1.42857142857%	1	70	98	Diabetes_McGill_Adipocytokine_signallin	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
1.42857142857%	1	70	98	Diabetes_McGill_Adipocytokine_signallin	NIELSEN_GIST
1.42857142857%	1	70	98	Diabetes_McGill_Adipocytokine_signallin	GAVIN_FOXP3_TARGETS_CLUSTER_T7
1.42857142857%	1	70	97	Diabetes_McGill_Adipocytokine_signallin	LABBE_WNT3A_TARGETS_DN
1.42857142857%	1	70	97	Diabetes_McGill_Adipocytokine_signallin	KONG_E2F3_TARGETS
1.42857142857%	1	70	96	Diabetes_McGill_Adipocytokine_signallin	LIU_PROSTATE_CANCER_UP
1.42857142857%	1	70	95	Diabetes_McGill_Adipocytokine_signallin	KAYO_CALORIE_RESTRICTION_MUSCLE_UP
1.42857142857%	1	70	94	Diabetes_McGill_Adipocytokine_signallin	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP
1.42857142857%	1	70	94	Diabetes_McGill_Adipocytokine_signallin	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER
1.42857142857%	1	70	94	Diabetes_McGill_Adipocytokine_signallin	HOOI_ST7_TARGETS_UP
1.42857142857%	1	70	92	Diabetes_McGill_Adipocytokine_signallin	WINTER_HYPOXIA_UP
1.42857142857%	1	70	92	Diabetes_McGill_Adipocytokine_signallin	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
1.42857142857%	1	70	92	Diabetes_McGill_Adipocytokine_signallin	KEGG_DILATED_CARDIOMYOPATHY
1.42857142857%	1	70	92	Diabetes_McGill_Adipocytokine_signallin	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
1.42857142857%	1	70	92	Diabetes_McGill_Adipocytokine_signallin	DE_YY1_TARGETS_DN
1.42857142857%	1	70	92	Diabetes_McGill_Adipocytokine_signallin	CAMPS_COLON_CANCER_COPY_NUMBER_UP
1.42857142857%	1	70	918	Diabetes_McGill_Adipocytokine_signallin	JOHNSTONE_PARVB_TARGETS_3_DN
1.42857142857%	1	70	91	Diabetes_McGill_Adipocytokine_signallin	ZHU_CMV_24_HR_DN
1.42857142857%	1	70	91	Diabetes_McGill_Adipocytokine_signallin	ELVIDGE_HIF1A_TARGETS_DN
1.42857142857%	1	70	91	Diabetes_McGill_Adipocytokine_signallin	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
1.42857142857%	1	70	90	Diabetes_McGill_Adipocytokine_signallin	SASSON_RESPONSE_TO_FORSKOLIN_UP
1.42857142857%	1	70	90	Diabetes_McGill_Adipocytokine_signallin	MORI_MATURE_B_LYMPHOCYTE_UP
1.42857142857%	1	70	90	Diabetes_McGill_Adipocytokine_signallin	MORI_IMMATURE_B_LYMPHOCYTE_DN
1.42857142857%	1	70	90	Diabetes_McGill_Adipocytokine_signallin	BILANGES_SERUM_SENSITIVE_GENES
1.42857142857%	1	70	9	Diabetes_McGill_Adipocytokine_signallin	ST_JAK_STAT_PATHWAY
1.42857142857%	1	70	9	Diabetes_McGill_Adipocytokine_signallin	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30
1.42857142857%	1	70	89	Diabetes_McGill_Adipocytokine_signallin	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
1.42857142857%	1	70	89	Diabetes_McGill_Adipocytokine_signallin	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
1.42857142857%	1	70	89	Diabetes_McGill_Adipocytokine_signallin	LEE_AGING_NEOCORTEX_UP
1.42857142857%	1	70	89	Diabetes_McGill_Adipocytokine_signallin	DELASERNA_MYOD_TARGETS_UP
1.42857142857%	1	70	89	Diabetes_McGill_Adipocytokine_signallin	BOYLAN_MULTIPLE_MYELOMA_D_UP
1.42857142857%	1	70	88	Diabetes_McGill_Adipocytokine_signallin	WALLACE_PROSTATE_CANCER_RACE_DN
1.42857142857%	1	70	88	Diabetes_McGill_Adipocytokine_signallin	UEDA_CENTRAL_CLOCK
1.42857142857%	1	70	88	Diabetes_McGill_Adipocytokine_signallin	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
1.42857142857%	1	70	88	Diabetes_McGill_Adipocytokine_signallin	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
1.42857142857%	1	70	88	Diabetes_McGill_Adipocytokine_signallin	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
1.42857142857%	1	70	871	Diabetes_McGill_Adipocytokine_signallin	GRADE_COLON_CANCER_UP
1.42857142857%	1	70	87	Diabetes_McGill_Adipocytokine_signallin	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
1.42857142857%	1	70	87	Diabetes_McGill_Adipocytokine_signallin	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
1.42857142857%	1	70	87	Diabetes_McGill_Adipocytokine_signallin	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
1.42857142857%	1	70	863	Diabetes_McGill_Adipocytokine_signallin	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
1.42857142857%	1	70	86	Diabetes_McGill_Adipocytokine_signallin	KEGG_TGF_BETA_SIGNALING_PATHWAY
1.42857142857%	1	70	86	Diabetes_McGill_Adipocytokine_signallin	HOEBEKE_LYMPHOID_STEM_CELL_DN
1.42857142857%	1	70	85	Diabetes_McGill_Adipocytokine_signallin	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
1.42857142857%	1	70	85	Diabetes_McGill_Adipocytokine_signallin	SANA_RESPONSE_TO_IFNG_DN
1.42857142857%	1	70	85	Diabetes_McGill_Adipocytokine_signallin	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
1.42857142857%	1	70	84	Diabetes_McGill_Adipocytokine_signallin	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP
1.42857142857%	1	70	84	Diabetes_McGill_Adipocytokine_signallin	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
1.42857142857%	1	70	84	Diabetes_McGill_Adipocytokine_signallin	KIM_GLIS2_TARGETS_UP
1.42857142857%	1	70	84	Diabetes_McGill_Adipocytokine_signallin	KEGG_ECM_RECEPTOR_INTERACTION
1.42857142857%	1	70	84	Diabetes_McGill_Adipocytokine_signallin	CHANG_IMMORTALIZED_BY_HPV31_UP
1.42857142857%	1	70	84	Diabetes_McGill_Adipocytokine_signallin	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
1.42857142857%	1	70	83	Diabetes_McGill_Adipocytokine_signallin	SANA_TNF_SIGNALING_UP
1.42857142857%	1	70	83	Diabetes_McGill_Adipocytokine_signallin	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
1.42857142857%	1	70	83	Diabetes_McGill_Adipocytokine_signallin	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
1.42857142857%	1	70	82	Diabetes_McGill_Adipocytokine_signallin	PID_SMAD2_3NUCLEARPATHWAY
1.42857142857%	1	70	81	Diabetes_McGill_Adipocytokine_signallin	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
1.42857142857%	1	70	81	Diabetes_McGill_Adipocytokine_signallin	MUNSHI_MULTIPLE_MYELOMA_UP
1.42857142857%	1	70	81	Diabetes_McGill_Adipocytokine_signallin	MAHAJAN_RESPONSE_TO_IL1A_UP
1.42857142857%	1	70	81	Diabetes_McGill_Adipocytokine_signallin	LEIN_MEDULLA_MARKERS
1.42857142857%	1	70	80	Diabetes_McGill_Adipocytokine_signallin	SCHUHMACHER_MYC_TARGETS_UP
1.42857142857%	1	70	80	Diabetes_McGill_Adipocytokine_signallin	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
1.42857142857%	1	70	80	Diabetes_McGill_Adipocytokine_signallin	LEE_AGING_NEOCORTEX_DN
1.42857142857%	1	70	80	Diabetes_McGill_Adipocytokine_signallin	FALVELLA_SMOKERS_WITH_LUNG_CANCER
1.42857142857%	1	70	80	Diabetes_McGill_Adipocytokine_signallin	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
1.42857142857%	1	70	8	Diabetes_McGill_Adipocytokine_signallin	MIKKELSEN_PLURIPOTENT_STATE_DN
1.42857142857%	1	70	8	Diabetes_McGill_Adipocytokine_signallin	CHANG_POU5F1_TARGETS_DN
1.42857142857%	1	70	8	Diabetes_McGill_Adipocytokine_signallin	BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS
1.42857142857%	1	70	8	Diabetes_McGill_Adipocytokine_signallin	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP
1.42857142857%	1	70	795	Diabetes_McGill_Adipocytokine_signallin	WEI_MYCN_TARGETS_WITH_E_BOX
1.42857142857%	1	70	79	Diabetes_McGill_Adipocytokine_signallin	TOOKER_GEMCITABINE_RESISTANCE_UP
1.42857142857%	1	70	79	Diabetes_McGill_Adipocytokine_signallin	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
1.42857142857%	1	70	79	Diabetes_McGill_Adipocytokine_signallin	PID_P73PATHWAY
1.42857142857%	1	70	79	Diabetes_McGill_Adipocytokine_signallin	PID_MYC_ACTIVPATHWAY
1.42857142857%	1	70	79	Diabetes_McGill_Adipocytokine_signallin	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
1.42857142857%	1	70	784	Diabetes_McGill_Adipocytokine_signallin	FORTSCHEGGER_PHF8_TARGETS_DN
1.42857142857%	1	70	78	Diabetes_McGill_Adipocytokine_signallin	REACTOME_OPIOID_SIGNALLING
1.42857142857%	1	70	78	Diabetes_McGill_Adipocytokine_signallin	COATES_MACROPHAGE_M1_VS_M2_DN
1.42857142857%	1	70	78	Diabetes_McGill_Adipocytokine_signallin	BOYLAN_MULTIPLE_MYELOMA_D_DN
1.42857142857%	1	70	77	Diabetes_McGill_Adipocytokine_signallin	RIZ_ERYTHROID_DIFFERENTIATION
1.42857142857%	1	70	77	Diabetes_McGill_Adipocytokine_signallin	MORI_PRE_BI_LYMPHOCYTE_DN
1.42857142857%	1	70	77	Diabetes_McGill_Adipocytokine_signallin	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
1.42857142857%	1	70	77	Diabetes_McGill_Adipocytokine_signallin	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
1.42857142857%	1	70	77	Diabetes_McGill_Adipocytokine_signallin	CARD_MIR302A_TARGETS
1.42857142857%	1	70	76	Diabetes_McGill_Adipocytokine_signallin	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
1.42857142857%	1	70	76	Diabetes_McGill_Adipocytokine_signallin	SU_TESTIS
1.42857142857%	1	70	76	Diabetes_McGill_Adipocytokine_signallin	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION
1.42857142857%	1	70	75	Diabetes_McGill_Adipocytokine_signallin	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
1.42857142857%	1	70	75	Diabetes_McGill_Adipocytokine_signallin	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
1.42857142857%	1	70	75	Diabetes_McGill_Adipocytokine_signallin	JAIN_NFKB_SIGNALING
1.42857142857%	1	70	74	Diabetes_McGill_Adipocytokine_signallin	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
1.42857142857%	1	70	74	Diabetes_McGill_Adipocytokine_signallin	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
1.42857142857%	1	70	74	Diabetes_McGill_Adipocytokine_signallin	JI_RESPONSE_TO_FSH_UP
1.42857142857%	1	70	74	Diabetes_McGill_Adipocytokine_signallin	DARWICHE_PAPILLOMA_PROGRESSION_RISK
1.42857142857%	1	70	72	Diabetes_McGill_Adipocytokine_signallin	SESTO_RESPONSE_TO_UV_C8
1.42857142857%	1	70	72	Diabetes_McGill_Adipocytokine_signallin	HUANG_GATA2_TARGETS_DN
1.42857142857%	1	70	72	Diabetes_McGill_Adipocytokine_signallin	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
1.42857142857%	1	70	71	Diabetes_McGill_Adipocytokine_signallin	KYNG_RESPONSE_TO_H2O2
1.42857142857%	1	70	71	Diabetes_McGill_Adipocytokine_signallin	KUMAR_AUTOPHAGY_NETWORK
1.42857142857%	1	70	71	Diabetes_McGill_Adipocytokine_signallin	GU_PDEF_TARGETS_UP
1.42857142857%	1	70	71	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_6HR_UP
1.42857142857%	1	70	70	Diabetes_McGill_Adipocytokine_signallin	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
1.42857142857%	1	70	70	Diabetes_McGill_Adipocytokine_signallin	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS
1.42857142857%	1	70	70	Diabetes_McGill_Adipocytokine_signallin	MIKKELSEN_MEF_LCP_WITH_H3K27ME3
1.42857142857%	1	70	70	Diabetes_McGill_Adipocytokine_signallin	LANDIS_BREAST_CANCER_PROGRESSION_DN
1.42857142857%	1	70	70	Diabetes_McGill_Adipocytokine_signallin	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
1.42857142857%	1	70	70	Diabetes_McGill_Adipocytokine_signallin	CADWELL_ATG16L1_TARGETS_DN
1.42857142857%	1	70	7	Diabetes_McGill_Adipocytokine_signallin	ST_INTERLEUKIN_13_PATHWAY
1.42857142857%	1	70	7	Diabetes_McGill_Adipocytokine_signallin	ST_IL_13_PATHWAY
1.42857142857%	1	70	7	Diabetes_McGill_Adipocytokine_signallin	BUDHU_LIVER_CANCER_METASTASIS_DN
1.42857142857%	1	70	69	Diabetes_McGill_Adipocytokine_signallin	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
1.42857142857%	1	70	69	Diabetes_McGill_Adipocytokine_signallin	HUANG_DASATINIB_RESISTANCE_DN
1.42857142857%	1	70	69	Diabetes_McGill_Adipocytokine_signallin	AMIT_EGF_RESPONSE_120_HELA
1.42857142857%	1	70	68	Diabetes_McGill_Adipocytokine_signallin	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
1.42857142857%	1	70	68	Diabetes_McGill_Adipocytokine_signallin	BASSO_CD40_SIGNALING_DN
1.42857142857%	1	70	67	Diabetes_McGill_Adipocytokine_signallin	VANHARANTA_UTERINE_FIBROID_DN
1.42857142857%	1	70	67	Diabetes_McGill_Adipocytokine_signallin	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
1.42857142857%	1	70	66	Diabetes_McGill_Adipocytokine_signallin	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
1.42857142857%	1	70	66	Diabetes_McGill_Adipocytokine_signallin	SWEET_KRAS_TARGETS_DN
1.42857142857%	1	70	66	Diabetes_McGill_Adipocytokine_signallin	NAKAMURA_ADIPOGENESIS_EARLY_UP
1.42857142857%	1	70	652	Diabetes_McGill_Adipocytokine_signallin	BENPORATH_PRC2_TARGETS
1.42857142857%	1	70	65	Diabetes_McGill_Adipocytokine_signallin	PID_RB_1PATHWAY
1.42857142857%	1	70	65	Diabetes_McGill_Adipocytokine_signallin	PID_ERA_GENOMIC_PATHWAY
1.42857142857%	1	70	65	Diabetes_McGill_Adipocytokine_signallin	LEE_LIVER_CANCER_ACOX1_DN
1.42857142857%	1	70	65	Diabetes_McGill_Adipocytokine_signallin	GOLDRATH_IMMUNE_MEMORY
1.42857142857%	1	70	65	Diabetes_McGill_Adipocytokine_signallin	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP
1.42857142857%	1	70	65	Diabetes_McGill_Adipocytokine_signallin	AMIT_SERUM_RESPONSE_120_MCF10A
1.42857142857%	1	70	64	Diabetes_McGill_Adipocytokine_signallin	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
1.42857142857%	1	70	64	Diabetes_McGill_Adipocytokine_signallin	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
1.42857142857%	1	70	64	Diabetes_McGill_Adipocytokine_signallin	BYSTROEM_CORRELATED_WITH_IL5_DN
1.42857142857%	1	70	63	Diabetes_McGill_Adipocytokine_signallin	PHONG_TNF_TARGETS_UP
1.42857142857%	1	70	63	Diabetes_McGill_Adipocytokine_signallin	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
1.42857142857%	1	70	63	Diabetes_McGill_Adipocytokine_signallin	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
1.42857142857%	1	70	63	Diabetes_McGill_Adipocytokine_signallin	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
1.42857142857%	1	70	63	Diabetes_McGill_Adipocytokine_signallin	BURTON_ADIPOGENESIS_PEAK_AT_0HR
1.42857142857%	1	70	63	Diabetes_McGill_Adipocytokine_signallin	BILBAN_B_CLL_LPL_UP
1.42857142857%	1	70	62	Diabetes_McGill_Adipocytokine_signallin	LEE_LIVER_CANCER_E2F1_UP
1.42857142857%	1	70	61	Diabetes_McGill_Adipocytokine_signallin	ZWANG_EGF_PERSISTENTLY_DN
1.42857142857%	1	70	61	Diabetes_McGill_Adipocytokine_signallin	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
1.42857142857%	1	70	61	Diabetes_McGill_Adipocytokine_signallin	PID_AR_PATHWAY
1.42857142857%	1	70	61	Diabetes_McGill_Adipocytokine_signallin	NADLER_OBESITY_UP
1.42857142857%	1	70	61	Diabetes_McGill_Adipocytokine_signallin	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
1.42857142857%	1	70	61	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_1HR_UP
1.42857142857%	1	70	61	Diabetes_McGill_Adipocytokine_signallin	BAKKER_FOXO3_TARGETS_UP
1.42857142857%	1	70	605	Diabetes_McGill_Adipocytokine_signallin	CAIRO_HEPATOBLASTOMA_CLASSES_UP
1.42857142857%	1	70	60	Diabetes_McGill_Adipocytokine_signallin	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE
1.42857142857%	1	70	60	Diabetes_McGill_Adipocytokine_signallin	LEE_LIVER_CANCER_DENA_UP
1.42857142857%	1	70	60	Diabetes_McGill_Adipocytokine_signallin	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
1.42857142857%	1	70	60	Diabetes_McGill_Adipocytokine_signallin	CUI_GLUCOSE_DEPRIVATION
1.42857142857%	1	70	60	Diabetes_McGill_Adipocytokine_signallin	CROONQUIST_STROMAL_STIMULATION_UP
1.42857142857%	1	70	60	Diabetes_McGill_Adipocytokine_signallin	AMIT_EGF_RESPONSE_240_HELA
1.42857142857%	1	70	6	Diabetes_McGill_Adipocytokine_signallin	KORKOLA_CHORIOCARCINOMA
1.42857142857%	1	70	6	Diabetes_McGill_Adipocytokine_signallin	ELVIDGE_HIF2A_TARGETS_UP
1.42857142857%	1	70	6	Diabetes_McGill_Adipocytokine_signallin	DING_LUNG_CANCER_MUTATED_RECURRENTLY
1.42857142857%	1	70	6	Diabetes_McGill_Adipocytokine_signallin	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP
1.42857142857%	1	70	6	Diabetes_McGill_Adipocytokine_signallin	COURTOIS_SENESCENCE_TRIGGERS
1.42857142857%	1	70	590	Diabetes_McGill_Adipocytokine_signallin	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
1.42857142857%	1	70	59	Diabetes_McGill_Adipocytokine_signallin	WESTON_VEGFA_TARGETS_6HR
1.42857142857%	1	70	59	Diabetes_McGill_Adipocytokine_signallin	ELVIDGE_HYPOXIA_BY_DMOG_DN
1.42857142857%	1	70	59	Diabetes_McGill_Adipocytokine_signallin	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
1.42857142857%	1	70	58	Diabetes_McGill_Adipocytokine_signallin	MIKKELSEN_NPC_LCP_WITH_H3K4ME3
1.42857142857%	1	70	58	Diabetes_McGill_Adipocytokine_signallin	LUCAS_HNF4A_TARGETS_UP
1.42857142857%	1	70	58	Diabetes_McGill_Adipocytokine_signallin	LIM_MAMMARY_LUMINAL_PROGENITOR_UP
1.42857142857%	1	70	58	Diabetes_McGill_Adipocytokine_signallin	KANNAN_TP53_TARGETS_UP
1.42857142857%	1	70	58	Diabetes_McGill_Adipocytokine_signallin	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
1.42857142857%	1	70	57	Diabetes_McGill_Adipocytokine_signallin	NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON
1.42857142857%	1	70	57	Diabetes_McGill_Adipocytokine_signallin	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP
1.42857142857%	1	70	57	Diabetes_McGill_Adipocytokine_signallin	AMIT_SERUM_RESPONSE_60_MCF10A
1.42857142857%	1	70	57	Diabetes_McGill_Adipocytokine_signallin	AMIT_SERUM_RESPONSE_240_MCF10A
1.42857142857%	1	70	564	Diabetes_McGill_Adipocytokine_signallin	SMID_BREAST_CANCER_LUMINAL_B_DN
1.42857142857%	1	70	56	Diabetes_McGill_Adipocytokine_signallin	WORSCHECH_TUMOR_REJECTION_UP
1.42857142857%	1	70	56	Diabetes_McGill_Adipocytokine_signallin	HOQUE_METHYLATED_IN_CANCER
1.42857142857%	1	70	56	Diabetes_McGill_Adipocytokine_signallin	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
1.42857142857%	1	70	56	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_10HR_DN
1.42857142857%	1	70	553	Diabetes_McGill_Adipocytokine_signallin	FEVR_CTNNB1_TARGETS_DN
1.42857142857%	1	70	55	Diabetes_McGill_Adipocytokine_signallin	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
1.42857142857%	1	70	55	Diabetes_McGill_Adipocytokine_signallin	SU_LIVER
1.42857142857%	1	70	55	Diabetes_McGill_Adipocytokine_signallin	SMIRNOV_RESPONSE_TO_IR_2HR_DN
1.42857142857%	1	70	55	Diabetes_McGill_Adipocytokine_signallin	LAU_APOPTOSIS_CDKN2A_UP
1.42857142857%	1	70	55	Diabetes_McGill_Adipocytokine_signallin	DEMAGALHAES_AGING_UP
1.42857142857%	1	70	55	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_4HR_UP
1.42857142857%	1	70	549	Diabetes_McGill_Adipocytokine_signallin	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
1.42857142857%	1	70	54	Diabetes_McGill_Adipocytokine_signallin	ZHOU_TNF_SIGNALING_30MIN
1.42857142857%	1	70	54	Diabetes_McGill_Adipocytokine_signallin	REACTOME_APOPTOTIC_EXECUTION_PHASE
1.42857142857%	1	70	54	Diabetes_McGill_Adipocytokine_signallin	MIKKELSEN_IPS_ICP_WITH_H3K27ME3
1.42857142857%	1	70	54	Diabetes_McGill_Adipocytokine_signallin	AUNG_GASTRIC_CANCER
1.42857142857%	1	70	536	Diabetes_McGill_Adipocytokine_signallin	SENESE_HDAC3_TARGETS_DN
1.42857142857%	1	70	532	Diabetes_McGill_Adipocytokine_signallin	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
1.42857142857%	1	70	53	Diabetes_McGill_Adipocytokine_signallin	ZHU_CMV_8_HR_DN
1.42857142857%	1	70	53	Diabetes_McGill_Adipocytokine_signallin	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
1.42857142857%	1	70	53	Diabetes_McGill_Adipocytokine_signallin	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
1.42857142857%	1	70	53	Diabetes_McGill_Adipocytokine_signallin	KRIEG_HYPOXIA_VIA_KDM3A
1.42857142857%	1	70	52	Diabetes_McGill_Adipocytokine_signallin	VILIMAS_NOTCH1_TARGETS_UP
1.42857142857%	1	70	52	Diabetes_McGill_Adipocytokine_signallin	RADAEVA_RESPONSE_TO_IFNA1_UP
1.42857142857%	1	70	52	Diabetes_McGill_Adipocytokine_signallin	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
1.42857142857%	1	70	52	Diabetes_McGill_Adipocytokine_signallin	HALMOS_CEBPA_TARGETS_UP
1.42857142857%	1	70	52	Diabetes_McGill_Adipocytokine_signallin	CHIBA_RESPONSE_TO_TSA_UP
1.42857142857%	1	70	517	Diabetes_McGill_Adipocytokine_signallin	RAO_BOUND_BY_SALL4_ISOFORM_B
1.42857142857%	1	70	51	Diabetes_McGill_Adipocytokine_signallin	ZHANG_PROLIFERATING_VS_QUIESCENT
1.42857142857%	1	70	51	Diabetes_McGill_Adipocytokine_signallin	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
1.42857142857%	1	70	51	Diabetes_McGill_Adipocytokine_signallin	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
1.42857142857%	1	70	51	Diabetes_McGill_Adipocytokine_signallin	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE
1.42857142857%	1	70	51	Diabetes_McGill_Adipocytokine_signallin	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
1.42857142857%	1	70	51	Diabetes_McGill_Adipocytokine_signallin	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
1.42857142857%	1	70	51	Diabetes_McGill_Adipocytokine_signallin	BURTON_ADIPOGENESIS_PEAK_AT_2HR
1.42857142857%	1	70	51	Diabetes_McGill_Adipocytokine_signallin	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
1.42857142857%	1	70	505	Diabetes_McGill_Adipocytokine_signallin	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
1.42857142857%	1	70	50	Diabetes_McGill_Adipocytokine_signallin	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
1.42857142857%	1	70	50	Diabetes_McGill_Adipocytokine_signallin	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
1.42857142857%	1	70	50	Diabetes_McGill_Adipocytokine_signallin	PARK_APL_PATHOGENESIS_DN
1.42857142857%	1	70	50	Diabetes_McGill_Adipocytokine_signallin	MARTINEZ_RESPONSE_TO_TRABECTEDIN
1.42857142857%	1	70	50	Diabetes_McGill_Adipocytokine_signallin	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
1.42857142857%	1	70	50	Diabetes_McGill_Adipocytokine_signallin	FIGUEROA_AML_METHYLATION_CLUSTER_5_DN
1.42857142857%	1	70	5	Diabetes_McGill_Adipocytokine_signallin	RODRIGUES_DCC_TARGETS_UP
1.42857142857%	1	70	5	Diabetes_McGill_Adipocytokine_signallin	LAU_APOPTOSIS_CDKN2A_DN
1.42857142857%	1	70	5	Diabetes_McGill_Adipocytokine_signallin	IM_SREBF1A_TARGETS
1.42857142857%	1	70	491	Diabetes_McGill_Adipocytokine_signallin	ZHENG_BOUND_BY_FOXP3
1.42857142857%	1	70	49	Diabetes_McGill_Adipocytokine_signallin	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
1.42857142857%	1	70	49	Diabetes_McGill_Adipocytokine_signallin	PID_ARF6_TRAFFICKINGPATHWAY
1.42857142857%	1	70	49	Diabetes_McGill_Adipocytokine_signallin	OLSSON_E2F3_TARGETS_DN
1.42857142857%	1	70	49	Diabetes_McGill_Adipocytokine_signallin	MARCHINI_TRABECTEDIN_RESISTANCE_DN
1.42857142857%	1	70	49	Diabetes_McGill_Adipocytokine_signallin	LEE_LIVER_CANCER
1.42857142857%	1	70	49	Diabetes_McGill_Adipocytokine_signallin	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP
1.42857142857%	1	70	481	Diabetes_McGill_Adipocytokine_signallin	LIU_PROSTATE_CANCER_DN
1.42857142857%	1	70	48	Diabetes_McGill_Adipocytokine_signallin	TAVOR_CEBPA_TARGETS_UP
1.42857142857%	1	70	48	Diabetes_McGill_Adipocytokine_signallin	PID_HEDGEHOG_GLIPATHWAY
1.42857142857%	1	70	48	Diabetes_McGill_Adipocytokine_signallin	PENG_GLUCOSE_DEPRIVATION_UP
1.42857142857%	1	70	48	Diabetes_McGill_Adipocytokine_signallin	NADLER_OBESITY_DN
1.42857142857%	1	70	48	Diabetes_McGill_Adipocytokine_signallin	DELACROIX_RAR_TARGETS_UP
1.42857142857%	1	70	48	Diabetes_McGill_Adipocytokine_signallin	BURTON_ADIPOGENESIS_4
1.42857142857%	1	70	47	Diabetes_McGill_Adipocytokine_signallin	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
1.42857142857%	1	70	47	Diabetes_McGill_Adipocytokine_signallin	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP
1.42857142857%	1	70	47	Diabetes_McGill_Adipocytokine_signallin	LEONARD_HYPOXIA
1.42857142857%	1	70	47	Diabetes_McGill_Adipocytokine_signallin	BOYLAN_MULTIPLE_MYELOMA_C_UP
1.42857142857%	1	70	469	Diabetes_McGill_Adipocytokine_signallin	MCCABE_BOUND_BY_HOXC6
1.42857142857%	1	70	46	Diabetes_McGill_Adipocytokine_signallin	KRASNOSELSKAYA_ILF3_TARGETS_DN
1.42857142857%	1	70	46	Diabetes_McGill_Adipocytokine_signallin	JIANG_TIP30_TARGETS_UP
1.42857142857%	1	70	46	Diabetes_McGill_Adipocytokine_signallin	AMIT_EGF_RESPONSE_60_HELA
1.42857142857%	1	70	459	Diabetes_McGill_Adipocytokine_signallin	KIM_WT1_TARGETS_DN
1.42857142857%	1	70	456	Diabetes_McGill_Adipocytokine_signallin	MARTENS_BOUND_BY_PML_RARA_FUSION
1.42857142857%	1	70	450	Diabetes_McGill_Adipocytokine_signallin	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
1.42857142857%	1	70	45	Diabetes_McGill_Adipocytokine_signallin	ZHAN_MULTIPLE_MYELOMA_CD1_UP
1.42857142857%	1	70	45	Diabetes_McGill_Adipocytokine_signallin	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
1.42857142857%	1	70	45	Diabetes_McGill_Adipocytokine_signallin	PID_RHOA_PATHWAY
1.42857142857%	1	70	45	Diabetes_McGill_Adipocytokine_signallin	PID_ILK_PATHWAY
1.42857142857%	1	70	45	Diabetes_McGill_Adipocytokine_signallin	MCDOWELL_ACUTE_LUNG_INJURY_UP
1.42857142857%	1	70	45	Diabetes_McGill_Adipocytokine_signallin	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN
1.42857142857%	1	70	45	Diabetes_McGill_Adipocytokine_signallin	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN
1.42857142857%	1	70	45	Diabetes_McGill_Adipocytokine_signallin	HUANG_FOXA2_TARGETS_UP
1.42857142857%	1	70	442	Diabetes_McGill_Adipocytokine_signallin	HAN_SATB1_TARGETS_DN
1.42857142857%	1	70	44	Diabetes_McGill_Adipocytokine_signallin	ZUCCHI_METASTASIS_DN
1.42857142857%	1	70	44	Diabetes_McGill_Adipocytokine_signallin	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
1.42857142857%	1	70	44	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SIGNALING_BY_FGFR_MUTANTS
1.42857142857%	1	70	44	Diabetes_McGill_Adipocytokine_signallin	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS
1.42857142857%	1	70	44	Diabetes_McGill_Adipocytokine_signallin	MEDINA_SMARCA4_TARGETS
1.42857142857%	1	70	44	Diabetes_McGill_Adipocytokine_signallin	MARTIN_INTERACT_WITH_HDAC
1.42857142857%	1	70	44	Diabetes_McGill_Adipocytokine_signallin	LANDIS_BREAST_CANCER_PROGRESSION_UP
1.42857142857%	1	70	44	Diabetes_McGill_Adipocytokine_signallin	KEGG_TYPE_I_DIABETES_MELLITUS
1.42857142857%	1	70	431	Diabetes_McGill_Adipocytokine_signallin	GARY_CD5_TARGETS_DN
1.42857142857%	1	70	43	Diabetes_McGill_Adipocytokine_signallin	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK
1.42857142857%	1	70	43	Diabetes_McGill_Adipocytokine_signallin	REACTOME_IL_3_5_AND_GM_CSF_SIGNALING
1.42857142857%	1	70	43	Diabetes_McGill_Adipocytokine_signallin	PID_TCPTP_PATHWAY
1.42857142857%	1	70	43	Diabetes_McGill_Adipocytokine_signallin	LEE_CALORIE_RESTRICTION_MUSCLE_UP
1.42857142857%	1	70	43	Diabetes_McGill_Adipocytokine_signallin	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
1.42857142857%	1	70	43	Diabetes_McGill_Adipocytokine_signallin	DORN_ADENOVIRUS_INFECTION_24HR_DN
1.42857142857%	1	70	428	Diabetes_McGill_Adipocytokine_signallin	CUI_TCF21_TARGETS_2_UP
1.42857142857%	1	70	425	Diabetes_McGill_Adipocytokine_signallin	ZHANG_BREAST_CANCER_PROGENITORS_UP
1.42857142857%	1	70	423	Diabetes_McGill_Adipocytokine_signallin	PUJANA_BRCA2_PCC_NETWORK
1.42857142857%	1	70	42	Diabetes_McGill_Adipocytokine_signallin	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
1.42857142857%	1	70	42	Diabetes_McGill_Adipocytokine_signallin	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER
1.42857142857%	1	70	42	Diabetes_McGill_Adipocytokine_signallin	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP
1.42857142857%	1	70	42	Diabetes_McGill_Adipocytokine_signallin	KEGG_GRAFT_VERSUS_HOST_DISEASE
1.42857142857%	1	70	41	Diabetes_McGill_Adipocytokine_signallin	WENG_POR_TARGETS_LIVER_UP
1.42857142857%	1	70	41	Diabetes_McGill_Adipocytokine_signallin	REACTOME_NETRIN1_SIGNALING
1.42857142857%	1	70	41	Diabetes_McGill_Adipocytokine_signallin	REACTOME_IL_2_SIGNALING
1.42857142857%	1	70	41	Diabetes_McGill_Adipocytokine_signallin	PID_ER_NONGENOMIC_PATHWAY
1.42857142857%	1	70	41	Diabetes_McGill_Adipocytokine_signallin	ONO_AML1_TARGETS_DN
1.42857142857%	1	70	41	Diabetes_McGill_Adipocytokine_signallin	LI_LUNG_CANCER
1.42857142857%	1	70	41	Diabetes_McGill_Adipocytokine_signallin	KORKOLA_EMBRYONAL_CARCINOMA_UP
1.42857142857%	1	70	41	Diabetes_McGill_Adipocytokine_signallin	KAAB_FAILED_HEART_VENTRICLE_DN
1.42857142857%	1	70	41	Diabetes_McGill_Adipocytokine_signallin	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
1.42857142857%	1	70	41	Diabetes_McGill_Adipocytokine_signallin	DELPUECH_FOXO3_TARGETS_DN
1.42857142857%	1	70	41	Diabetes_McGill_Adipocytokine_signallin	CHEN_HOXA5_TARGETS_9HR_DN
1.42857142857%	1	70	41	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_FCER1_PATHWAY
1.42857142857%	1	70	404	Diabetes_McGill_Adipocytokine_signallin	OSMAN_BLADDER_CANCER_UP
1.42857142857%	1	70	403	Diabetes_McGill_Adipocytokine_signallin	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
1.42857142857%	1	70	40	Diabetes_McGill_Adipocytokine_signallin	VANASSE_BCL2_TARGETS_UP
1.42857142857%	1	70	40	Diabetes_McGill_Adipocytokine_signallin	TOMLINS_PROSTATE_CANCER_UP
1.42857142857%	1	70	40	Diabetes_McGill_Adipocytokine_signallin	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
1.42857142857%	1	70	40	Diabetes_McGill_Adipocytokine_signallin	RIZ_ERYTHROID_DIFFERENTIATION_6HR
1.42857142857%	1	70	40	Diabetes_McGill_Adipocytokine_signallin	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
1.42857142857%	1	70	40	Diabetes_McGill_Adipocytokine_signallin	LIAO_HAVE_SOX4_BINDING_SITES
1.42857142857%	1	70	40	Diabetes_McGill_Adipocytokine_signallin	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN
1.42857142857%	1	70	40	Diabetes_McGill_Adipocytokine_signallin	GENTILE_UV_RESPONSE_CLUSTER_D8
1.42857142857%	1	70	40	Diabetes_McGill_Adipocytokine_signallin	GENTILE_UV_RESPONSE_CLUSTER_D7
1.42857142857%	1	70	40	Diabetes_McGill_Adipocytokine_signallin	DORN_ADENOVIRUS_INFECTION_48HR_DN
1.42857142857%	1	70	40	Diabetes_McGill_Adipocytokine_signallin	CHESLER_BRAIN_HIGHEST_EXPRESSION
1.42857142857%	1	70	395	Diabetes_McGill_Adipocytokine_signallin	HAN_SATB1_TARGETS_UP
1.42857142857%	1	70	391	Diabetes_McGill_Adipocytokine_signallin	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
1.42857142857%	1	70	390	Diabetes_McGill_Adipocytokine_signallin	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
1.42857142857%	1	70	39	Diabetes_McGill_Adipocytokine_signallin	WANG_LSD1_TARGETS_DN
1.42857142857%	1	70	39	Diabetes_McGill_Adipocytokine_signallin	VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1
1.42857142857%	1	70	39	Diabetes_McGill_Adipocytokine_signallin	SHIPP_DLBCL_CURED_VS_FATAL_UP
1.42857142857%	1	70	39	Diabetes_McGill_Adipocytokine_signallin	POTTI_PACLITAXEL_SENSITIVITY
1.42857142857%	1	70	39	Diabetes_McGill_Adipocytokine_signallin	PID_ECADHERIN_NASCENTAJ_PATHWAY
1.42857142857%	1	70	39	Diabetes_McGill_Adipocytokine_signallin	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
1.42857142857%	1	70	39	Diabetes_McGill_Adipocytokine_signallin	MA_MYELOID_DIFFERENTIATION_UP
1.42857142857%	1	70	39	Diabetes_McGill_Adipocytokine_signallin	MATZUK_MEIOTIC_AND_DNA_REPAIR
1.42857142857%	1	70	39	Diabetes_McGill_Adipocytokine_signallin	HAN_JNK_SINGALING_DN
1.42857142857%	1	70	39	Diabetes_McGill_Adipocytokine_signallin	DORN_ADENOVIRUS_INFECTION_32HR_DN
1.42857142857%	1	70	39	Diabetes_McGill_Adipocytokine_signallin	CONRAD_STEM_CELL
1.42857142857%	1	70	39	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_2HR_UP
1.42857142857%	1	70	39	Diabetes_McGill_Adipocytokine_signallin	BILANGES_RAPAMYCIN_SENSITIVE_GENES
1.42857142857%	1	70	384	Diabetes_McGill_Adipocytokine_signallin	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
1.42857142857%	1	70	384	Diabetes_McGill_Adipocytokine_signallin	BASAKI_YBX1_TARGETS_DN
1.42857142857%	1	70	380	Diabetes_McGill_Adipocytokine_signallin	MULLIGHAN_MLL_SIGNATURE_1_UP
1.42857142857%	1	70	380	Diabetes_McGill_Adipocytokine_signallin	DAIRKEE_TERT_TARGETS_UP
1.42857142857%	1	70	38	Diabetes_McGill_Adipocytokine_signallin	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4
1.42857142857%	1	70	38	Diabetes_McGill_Adipocytokine_signallin	PID_P38ALPHABETADOWNSTREAMPATHWAY
1.42857142857%	1	70	38	Diabetes_McGill_Adipocytokine_signallin	PID_ERBB4_PATHWAY
1.42857142857%	1	70	38	Diabetes_McGill_Adipocytokine_signallin	LIU_LIVER_CANCER
1.42857142857%	1	70	38	Diabetes_McGill_Adipocytokine_signallin	KEGG_ALLOGRAFT_REJECTION
1.42857142857%	1	70	38	Diabetes_McGill_Adipocytokine_signallin	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN
1.42857142857%	1	70	38	Diabetes_McGill_Adipocytokine_signallin	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
1.42857142857%	1	70	38	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_INTEGRIN_PATHWAY
1.42857142857%	1	70	378	Diabetes_McGill_Adipocytokine_signallin	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
1.42857142857%	1	70	371	Diabetes_McGill_Adipocytokine_signallin	WANG_SMARCE1_TARGETS_DN
1.42857142857%	1	70	37	Diabetes_McGill_Adipocytokine_signallin	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN
1.42857142857%	1	70	37	Diabetes_McGill_Adipocytokine_signallin	ROLEF_GLIS3_TARGETS
1.42857142857%	1	70	37	Diabetes_McGill_Adipocytokine_signallin	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS
1.42857142857%	1	70	37	Diabetes_McGill_Adipocytokine_signallin	MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED
1.42857142857%	1	70	37	Diabetes_McGill_Adipocytokine_signallin	LANDIS_ERBB2_BREAST_TUMORS_65_DN
1.42857142857%	1	70	37	Diabetes_McGill_Adipocytokine_signallin	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR
1.42857142857%	1	70	37	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_BCR_PATHWAY
1.42857142857%	1	70	37	Diabetes_McGill_Adipocytokine_signallin	BILANGES_SERUM_RESPONSE_TRANSLATION
1.42857142857%	1	70	367	Diabetes_McGill_Adipocytokine_signallin	DELACROIX_RARG_BOUND_MEF
1.42857142857%	1	70	36	Diabetes_McGill_Adipocytokine_signallin	STEARMAN_TUMOR_FIELD_EFFECT_UP
1.42857142857%	1	70	36	Diabetes_McGill_Adipocytokine_signallin	SEMENZA_HIF1_TARGETS
1.42857142857%	1	70	36	Diabetes_McGill_Adipocytokine_signallin	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
1.42857142857%	1	70	36	Diabetes_McGill_Adipocytokine_signallin	PID_PI3KPLCTRKPATHWAY
1.42857142857%	1	70	36	Diabetes_McGill_Adipocytokine_signallin	MARZEC_IL2_SIGNALING_DN
1.42857142857%	1	70	36	Diabetes_McGill_Adipocytokine_signallin	HUANG_FOXA2_TARGETS_DN
1.42857142857%	1	70	36	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_AT1R_PATHWAY
1.42857142857%	1	70	36	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_AGR_PATHWAY
1.42857142857%	1	70	352	Diabetes_McGill_Adipocytokine_signallin	WANG_LMO4_TARGETS_DN
1.42857142857%	1	70	35	Diabetes_McGill_Adipocytokine_signallin	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15
1.42857142857%	1	70	35	Diabetes_McGill_Adipocytokine_signallin	YAGI_AML_RELAPSE_PROGNOSIS
1.42857142857%	1	70	35	Diabetes_McGill_Adipocytokine_signallin	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
1.42857142857%	1	70	35	Diabetes_McGill_Adipocytokine_signallin	WEIGEL_OXIDATIVE_STRESS_RESPONSE
1.42857142857%	1	70	35	Diabetes_McGill_Adipocytokine_signallin	WANG_METHYLATED_IN_BREAST_CANCER
1.42857142857%	1	70	35	Diabetes_McGill_Adipocytokine_signallin	SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES
1.42857142857%	1	70	35	Diabetes_McGill_Adipocytokine_signallin	RODRIGUES_NTN1_AND_DCC_TARGETS
1.42857142857%	1	70	35	Diabetes_McGill_Adipocytokine_signallin	REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D
1.42857142857%	1	70	35	Diabetes_McGill_Adipocytokine_signallin	KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION
1.42857142857%	1	70	35	Diabetes_McGill_Adipocytokine_signallin	KEGG_PRIMARY_IMMUNODEFICIENCY
1.42857142857%	1	70	35	Diabetes_McGill_Adipocytokine_signallin	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN
1.42857142857%	1	70	35	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_CARM_ER_PATHWAY
1.42857142857%	1	70	344	Diabetes_McGill_Adipocytokine_signallin	RICKMAN_METASTASIS_UP
1.42857142857%	1	70	344	Diabetes_McGill_Adipocytokine_signallin	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
1.42857142857%	1	70	342	Diabetes_McGill_Adipocytokine_signallin	BLUM_RESPONSE_TO_SALIRASIB_DN
1.42857142857%	1	70	34	Diabetes_McGill_Adipocytokine_signallin	YANG_BREAST_CANCER_ESR1_LASER_UP
1.42857142857%	1	70	34	Diabetes_McGill_Adipocytokine_signallin	SCHOEN_NFKB_SIGNALING
1.42857142857%	1	70	34	Diabetes_McGill_Adipocytokine_signallin	PID_IL8CXCR2_PATHWAY
1.42857142857%	1	70	34	Diabetes_McGill_Adipocytokine_signallin	PID_HIF2PATHWAY
1.42857142857%	1	70	335	Diabetes_McGill_Adipocytokine_signallin	WONG_EMBRYONIC_STEM_CELL_CORE
1.42857142857%	1	70	335	Diabetes_McGill_Adipocytokine_signallin	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
1.42857142857%	1	70	332	Diabetes_McGill_Adipocytokine_signallin	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
1.42857142857%	1	70	330	Diabetes_McGill_Adipocytokine_signallin	REACTOME_METABOLISM_OF_RNA
1.42857142857%	1	70	330	Diabetes_McGill_Adipocytokine_signallin	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
1.42857142857%	1	70	33	Diabetes_McGill_Adipocytokine_signallin	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS
1.42857142857%	1	70	33	Diabetes_McGill_Adipocytokine_signallin	PID_SYNDECAN_2_PATHWAY
1.42857142857%	1	70	33	Diabetes_McGill_Adipocytokine_signallin	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN
1.42857142857%	1	70	33	Diabetes_McGill_Adipocytokine_signallin	KEGG_PROPANOATE_METABOLISM
1.42857142857%	1	70	33	Diabetes_McGill_Adipocytokine_signallin	GRADE_COLON_CANCER_DN
1.42857142857%	1	70	33	Diabetes_McGill_Adipocytokine_signallin	FIRESTEIN_CTNNB1_PATHWAY
1.42857142857%	1	70	33	Diabetes_McGill_Adipocytokine_signallin	DORN_ADENOVIRUS_INFECTION_12HR_DN
1.42857142857%	1	70	33	Diabetes_McGill_Adipocytokine_signallin	BURTON_ADIPOGENESIS_1
1.42857142857%	1	70	33	Diabetes_McGill_Adipocytokine_signallin	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN
1.42857142857%	1	70	33	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_NO1_PATHWAY
1.42857142857%	1	70	33	Diabetes_McGill_Adipocytokine_signallin	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN
1.42857142857%	1	70	329	Diabetes_McGill_Adipocytokine_signallin	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
1.42857142857%	1	70	32	Diabetes_McGill_Adipocytokine_signallin	ST_ERK1_ERK2_MAPK_PATHWAY
1.42857142857%	1	70	32	Diabetes_McGill_Adipocytokine_signallin	KASLER_HDAC7_TARGETS_2_DN
1.42857142857%	1	70	32	Diabetes_McGill_Adipocytokine_signallin	GROSS_ELK3_TARGETS_DN
1.42857142857%	1	70	32	Diabetes_McGill_Adipocytokine_signallin	DORSAM_HOXA9_TARGETS_DN
1.42857142857%	1	70	32	Diabetes_McGill_Adipocytokine_signallin	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
1.42857142857%	1	70	32	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_HDAC_PATHWAY
1.42857142857%	1	70	32	Diabetes_McGill_Adipocytokine_signallin	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP
1.42857142857%	1	70	32	Diabetes_McGill_Adipocytokine_signallin	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN
1.42857142857%	1	70	315	Diabetes_McGill_Adipocytokine_signallin	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
1.42857142857%	1	70	312	Diabetes_McGill_Adipocytokine_signallin	GENTILE_UV_HIGH_DOSE_DN
1.42857142857%	1	70	31	Diabetes_McGill_Adipocytokine_signallin	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
1.42857142857%	1	70	31	Diabetes_McGill_Adipocytokine_signallin	PID_AR_NONGENOMIC_PATHWAY
1.42857142857%	1	70	31	Diabetes_McGill_Adipocytokine_signallin	NOJIMA_SFRP2_TARGETS_UP
1.42857142857%	1	70	31	Diabetes_McGill_Adipocytokine_signallin	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER
1.42857142857%	1	70	31	Diabetes_McGill_Adipocytokine_signallin	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
1.42857142857%	1	70	31	Diabetes_McGill_Adipocytokine_signallin	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP
1.42857142857%	1	70	31	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_PYK2_PATHWAY
1.42857142857%	1	70	302	Diabetes_McGill_Adipocytokine_signallin	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
1.42857142857%	1	70	30	Diabetes_McGill_Adipocytokine_signallin	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
1.42857142857%	1	70	30	Diabetes_McGill_Adipocytokine_signallin	YANAGIHARA_ESX1_TARGETS
1.42857142857%	1	70	30	Diabetes_McGill_Adipocytokine_signallin	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP
1.42857142857%	1	70	30	Diabetes_McGill_Adipocytokine_signallin	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN
1.42857142857%	1	70	30	Diabetes_McGill_Adipocytokine_signallin	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
1.42857142857%	1	70	30	Diabetes_McGill_Adipocytokine_signallin	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION
1.42857142857%	1	70	30	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
1.42857142857%	1	70	30	Diabetes_McGill_Adipocytokine_signallin	PID_IL2_STAT5PATHWAY
1.42857142857%	1	70	30	Diabetes_McGill_Adipocytokine_signallin	PID_EPHRINBREVPATHWAY
1.42857142857%	1	70	30	Diabetes_McGill_Adipocytokine_signallin	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
1.42857142857%	1	70	30	Diabetes_McGill_Adipocytokine_signallin	KYNG_NORMAL_AGING_DN
1.42857142857%	1	70	30	Diabetes_McGill_Adipocytokine_signallin	KEGG_ASTHMA
1.42857142857%	1	70	30	Diabetes_McGill_Adipocytokine_signallin	GUILLAUMOND_KLF10_TARGETS_DN
1.42857142857%	1	70	30	Diabetes_McGill_Adipocytokine_signallin	DASU_IL6_SIGNALING_SCAR_UP
1.42857142857%	1	70	30	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_FAS_PATHWAY
1.42857142857%	1	70	299	Diabetes_McGill_Adipocytokine_signallin	MUELLER_PLURINET
1.42857142857%	1	70	295	Diabetes_McGill_Adipocytokine_signallin	LU_EZH2_TARGETS_UP
1.42857142857%	1	70	290	Diabetes_McGill_Adipocytokine_signallin	BASAKI_YBX1_TARGETS_UP
1.42857142857%	1	70	29	Diabetes_McGill_Adipocytokine_signallin	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN
1.42857142857%	1	70	29	Diabetes_McGill_Adipocytokine_signallin	REACTOME_STEROID_HORMONES
1.42857142857%	1	70	29	Diabetes_McGill_Adipocytokine_signallin	MARSON_FOXP3_TARGETS_STIMULATED_UP
1.42857142857%	1	70	29	Diabetes_McGill_Adipocytokine_signallin	KYNG_WERNER_SYNDROM_DN
1.42857142857%	1	70	29	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_INFLAM_PATHWAY
1.42857142857%	1	70	287	Diabetes_McGill_Adipocytokine_signallin	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
1.42857142857%	1	70	285	Diabetes_McGill_Adipocytokine_signallin	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
1.42857142857%	1	70	284	Diabetes_McGill_Adipocytokine_signallin	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
1.42857142857%	1	70	284	Diabetes_McGill_Adipocytokine_signallin	REACTOME_METABOLISM_OF_MRNA
1.42857142857%	1	70	283	Diabetes_McGill_Adipocytokine_signallin	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
1.42857142857%	1	70	281	Diabetes_McGill_Adipocytokine_signallin	MULLIGHAN_MLL_SIGNATURE_2_DN
1.42857142857%	1	70	280	Diabetes_McGill_Adipocytokine_signallin	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
1.42857142857%	1	70	28	Diabetes_McGill_Adipocytokine_signallin	WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1
1.42857142857%	1	70	28	Diabetes_McGill_Adipocytokine_signallin	VALK_AML_CLUSTER_7
1.42857142857%	1	70	28	Diabetes_McGill_Adipocytokine_signallin	TERAO_AOX4_TARGETS_HG_UP
1.42857142857%	1	70	28	Diabetes_McGill_Adipocytokine_signallin	PID_IL8CXCR1_PATHWAY
1.42857142857%	1	70	28	Diabetes_McGill_Adipocytokine_signallin	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
1.42857142857%	1	70	28	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_ERK_PATHWAY
1.42857142857%	1	70	279	Diabetes_McGill_Adipocytokine_signallin	REACTOME_NEURONAL_SYSTEM
1.42857142857%	1	70	279	Diabetes_McGill_Adipocytokine_signallin	FORTSCHEGGER_PHF8_TARGETS_UP
1.42857142857%	1	70	277	Diabetes_McGill_Adipocytokine_signallin	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
1.42857142857%	1	70	275	Diabetes_McGill_Adipocytokine_signallin	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
1.42857142857%	1	70	274	Diabetes_McGill_Adipocytokine_signallin	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
1.42857142857%	1	70	270	Diabetes_McGill_Adipocytokine_signallin	RIZKI_TUMOR_INVASIVENESS_3D_DN
1.42857142857%	1	70	27	Diabetes_McGill_Adipocytokine_signallin	TERAO_AOX4_TARGETS_SKIN_DN
1.42857142857%	1	70	27	Diabetes_McGill_Adipocytokine_signallin	TERAMOTO_OPN_TARGETS_CLUSTER_6
1.42857142857%	1	70	27	Diabetes_McGill_Adipocytokine_signallin	ST_MYOCYTE_AD_PATHWAY
1.42857142857%	1	70	27	Diabetes_McGill_Adipocytokine_signallin	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP
1.42857142857%	1	70	27	Diabetes_McGill_Adipocytokine_signallin	REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING
1.42857142857%	1	70	27	Diabetes_McGill_Adipocytokine_signallin	REACTOME_IL_RECEPTOR_SHC_SIGNALING
1.42857142857%	1	70	27	Diabetes_McGill_Adipocytokine_signallin	REACTOME_G_PROTEIN_ACTIVATION
1.42857142857%	1	70	27	Diabetes_McGill_Adipocytokine_signallin	NICK_RESPONSE_TO_PROC_TREATMENT_DN
1.42857142857%	1	70	27	Diabetes_McGill_Adipocytokine_signallin	LEE_DOUBLE_POLAR_THYMOCYTE
1.42857142857%	1	70	27	Diabetes_McGill_Adipocytokine_signallin	EINAV_INTERFERON_SIGNATURE_IN_CANCER
1.42857142857%	1	70	27	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_EDG1_PATHWAY
1.42857142857%	1	70	27	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_CREB_PATHWAY
1.42857142857%	1	70	269	Diabetes_McGill_Adipocytokine_signallin	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
1.42857142857%	1	70	266	Diabetes_McGill_Adipocytokine_signallin	FOSTER_KDM1A_TARGETS_UP
1.42857142857%	1	70	264	Diabetes_McGill_Adipocytokine_signallin	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
1.42857142857%	1	70	260	Diabetes_McGill_Adipocytokine_signallin	SENESE_HDAC1_TARGETS_DN
1.42857142857%	1	70	26	Diabetes_McGill_Adipocytokine_signallin	PID_P38_MKK3_6PATHWAY
1.42857142857%	1	70	26	Diabetes_McGill_Adipocytokine_signallin	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1
1.42857142857%	1	70	26	Diabetes_McGill_Adipocytokine_signallin	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
1.42857142857%	1	70	26	Diabetes_McGill_Adipocytokine_signallin	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP
1.42857142857%	1	70	26	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_BAD_PATHWAY
1.42857142857%	1	70	259	Diabetes_McGill_Adipocytokine_signallin	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
1.42857142857%	1	70	258	Diabetes_McGill_Adipocytokine_signallin	JAEGER_METASTASIS_DN
1.42857142857%	1	70	256	Diabetes_McGill_Adipocytokine_signallin	ONDER_CDH1_TARGETS_2_UP
1.42857142857%	1	70	255	Diabetes_McGill_Adipocytokine_signallin	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
1.42857142857%	1	70	252	Diabetes_McGill_Adipocytokine_signallin	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
1.42857142857%	1	70	251	Diabetes_McGill_Adipocytokine_signallin	REACTOME_AXON_GUIDANCE
1.42857142857%	1	70	25	Diabetes_McGill_Adipocytokine_signallin	REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS
1.42857142857%	1	70	25	Diabetes_McGill_Adipocytokine_signallin	PID_LYMPHANGIOGENESIS_PATHWAY
1.42857142857%	1	70	25	Diabetes_McGill_Adipocytokine_signallin	PID_HDAC_CLASSIII_PATHWAY
1.42857142857%	1	70	25	Diabetes_McGill_Adipocytokine_signallin	OZEN_MIR125B1_TARGETS
1.42857142857%	1	70	25	Diabetes_McGill_Adipocytokine_signallin	KIM_HYPOXIA
1.42857142857%	1	70	25	Diabetes_McGill_Adipocytokine_signallin	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP
1.42857142857%	1	70	25	Diabetes_McGill_Adipocytokine_signallin	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP
1.42857142857%	1	70	246	Diabetes_McGill_Adipocytokine_signallin	VERHAAK_AML_WITH_NPM1_MUTATED_DN
1.42857142857%	1	70	246	Diabetes_McGill_Adipocytokine_signallin	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
1.42857142857%	1	70	245	Diabetes_McGill_Adipocytokine_signallin	PENG_RAPAMYCIN_RESPONSE_DN
1.42857142857%	1	70	245	Diabetes_McGill_Adipocytokine_signallin	KONDO_EZH2_TARGETS
1.42857142857%	1	70	244	Diabetes_McGill_Adipocytokine_signallin	THUM_SYSTOLIC_HEART_FAILURE_DN
1.42857142857%	1	70	244	Diabetes_McGill_Adipocytokine_signallin	DAZARD_RESPONSE_TO_UV_NHEK_UP
1.42857142857%	1	70	243	Diabetes_McGill_Adipocytokine_signallin	CHICAS_RB1_TARGETS_GROWING
1.42857142857%	1	70	242	Diabetes_McGill_Adipocytokine_signallin	MULLIGHAN_MLL_SIGNATURE_1_DN
1.42857142857%	1	70	24	Diabetes_McGill_Adipocytokine_signallin	YAN_ESCAPE_FROM_ANOIKIS
1.42857142857%	1	70	24	Diabetes_McGill_Adipocytokine_signallin	WILLERT_WNT_SIGNALING
1.42857142857%	1	70	24	Diabetes_McGill_Adipocytokine_signallin	WANG_TNF_TARGETS
1.42857142857%	1	70	24	Diabetes_McGill_Adipocytokine_signallin	REACTOME_REGULATION_OF_IFNA_SIGNALING
1.42857142857%	1	70	24	Diabetes_McGill_Adipocytokine_signallin	OSADA_ASCL1_TARGETS_DN
1.42857142857%	1	70	24	Diabetes_McGill_Adipocytokine_signallin	MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED
1.42857142857%	1	70	24	Diabetes_McGill_Adipocytokine_signallin	KIM_GERMINAL_CENTER_T_HELPER_DN
1.42857142857%	1	70	24	Diabetes_McGill_Adipocytokine_signallin	GOLUB_ALL_VS_AML_DN
1.42857142857%	1	70	24	Diabetes_McGill_Adipocytokine_signallin	DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
1.42857142857%	1	70	239	Diabetes_McGill_Adipocytokine_signallin	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
1.42857142857%	1	70	239	Diabetes_McGill_Adipocytokine_signallin	ALFANO_MYC_TARGETS
1.42857142857%	1	70	238	Diabetes_McGill_Adipocytokine_signallin	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
1.42857142857%	1	70	238	Diabetes_McGill_Adipocytokine_signallin	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
1.42857142857%	1	70	236	Diabetes_McGill_Adipocytokine_signallin	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
1.42857142857%	1	70	235	Diabetes_McGill_Adipocytokine_signallin	RUTELLA_RESPONSE_TO_HGF_DN
1.42857142857%	1	70	230	Diabetes_McGill_Adipocytokine_signallin	KAUFFMANN_DNA_REPAIR_GENES
1.42857142857%	1	70	23	Diabetes_McGill_Adipocytokine_signallin	ST_GA12_PATHWAY
1.42857142857%	1	70	23	Diabetes_McGill_Adipocytokine_signallin	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN
1.42857142857%	1	70	23	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_PTDINS_PATHWAY
1.42857142857%	1	70	23	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_CTCF_PATHWAY
1.42857142857%	1	70	229	Diabetes_McGill_Adipocytokine_signallin	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
1.42857142857%	1	70	229	Diabetes_McGill_Adipocytokine_signallin	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
1.42857142857%	1	70	228	Diabetes_McGill_Adipocytokine_signallin	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
1.42857142857%	1	70	227	Diabetes_McGill_Adipocytokine_signallin	RAO_BOUND_BY_SALL4
1.42857142857%	1	70	227	Diabetes_McGill_Adipocytokine_signallin	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
1.42857142857%	1	70	227	Diabetes_McGill_Adipocytokine_signallin	LEE_RECENT_THYMIC_EMIGRANT
1.42857142857%	1	70	226	Diabetes_McGill_Adipocytokine_signallin	KYNG_DNA_DAMAGE_UP
1.42857142857%	1	70	225	Diabetes_McGill_Adipocytokine_signallin	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
1.42857142857%	1	70	225	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_16HR_UP
1.42857142857%	1	70	222	Diabetes_McGill_Adipocytokine_signallin	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
1.42857142857%	1	70	222	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_1HR_DN
1.42857142857%	1	70	221	Diabetes_McGill_Adipocytokine_signallin	CHANDRAN_METASTASIS_UP
1.42857142857%	1	70	220	Diabetes_McGill_Adipocytokine_signallin	RIGGINS_TAMOXIFEN_RESISTANCE_DN
1.42857142857%	1	70	22	Diabetes_McGill_Adipocytokine_signallin	SUZUKI_RESPONSE_TO_TSA
1.42857142857%	1	70	22	Diabetes_McGill_Adipocytokine_signallin	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
1.42857142857%	1	70	22	Diabetes_McGill_Adipocytokine_signallin	PID_HEDGEHOG_2PATHWAY
1.42857142857%	1	70	22	Diabetes_McGill_Adipocytokine_signallin	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
1.42857142857%	1	70	22	Diabetes_McGill_Adipocytokine_signallin	MATZUK_IMPLANTATION_AND_UTERINE
1.42857142857%	1	70	22	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_IL2_PATHWAY
1.42857142857%	1	70	22	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_HER2_PATHWAY
1.42857142857%	1	70	22	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_CYTOKINE_PATHWAY
1.42857142857%	1	70	22	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_CHEMICAL_PATHWAY
1.42857142857%	1	70	217	Diabetes_McGill_Adipocytokine_signallin	SANSOM_APC_MYC_TARGETS
1.42857142857%	1	70	216	Diabetes_McGill_Adipocytokine_signallin	BOQUEST_STEM_CELL_DN
1.42857142857%	1	70	215	Diabetes_McGill_Adipocytokine_signallin	YAMAZAKI_TCEB3_TARGETS_DN
1.42857142857%	1	70	214	Diabetes_McGill_Adipocytokine_signallin	TIEN_INTESTINE_PROBIOTICS_24HR_DN
1.42857142857%	1	70	213	Diabetes_McGill_Adipocytokine_signallin	WIERENGA_STAT5A_TARGETS_DN
1.42857142857%	1	70	212	Diabetes_McGill_Adipocytokine_signallin	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
1.42857142857%	1	70	211	Diabetes_McGill_Adipocytokine_signallin	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
1.42857142857%	1	70	210	Diabetes_McGill_Adipocytokine_signallin	VERHAAK_GLIOBLASTOMA_PRONEURAL
1.42857142857%	1	70	210	Diabetes_McGill_Adipocytokine_signallin	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
1.42857142857%	1	70	210	Diabetes_McGill_Adipocytokine_signallin	RIZKI_TUMOR_INVASIVENESS_3D_UP
1.42857142857%	1	70	210	Diabetes_McGill_Adipocytokine_signallin	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
1.42857142857%	1	70	21	Diabetes_McGill_Adipocytokine_signallin	VERRECCHIA_RESPONSE_TO_TGFB1_C5
1.42857142857%	1	70	21	Diabetes_McGill_Adipocytokine_signallin	OUYANG_PROSTATE_CANCER_PROGRESSION_DN
1.42857142857%	1	70	21	Diabetes_McGill_Adipocytokine_signallin	MOOTHA_GLYCOGEN_METABOLISM
1.42857142857%	1	70	21	Diabetes_McGill_Adipocytokine_signallin	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP
1.42857142857%	1	70	21	Diabetes_McGill_Adipocytokine_signallin	FINETTI_BREAST_CANCERS_KINOME_BLUE
1.42857142857%	1	70	21	Diabetes_McGill_Adipocytokine_signallin	FERRANDO_TAL1_NEIGHBORS
1.42857142857%	1	70	21	Diabetes_McGill_Adipocytokine_signallin	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN
1.42857142857%	1	70	21	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_TFF_PATHWAY
1.42857142857%	1	70	21	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_CTLA4_PATHWAY
1.42857142857%	1	70	209	Diabetes_McGill_Adipocytokine_signallin	CHANG_CORE_SERUM_RESPONSE_DN
1.42857142857%	1	70	207	Diabetes_McGill_Adipocytokine_signallin	MANALO_HYPOXIA_UP
1.42857142857%	1	70	206	Diabetes_McGill_Adipocytokine_signallin	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
1.42857142857%	1	70	206	Diabetes_McGill_Adipocytokine_signallin	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
1.42857142857%	1	70	205	Diabetes_McGill_Adipocytokine_signallin	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
1.42857142857%	1	70	203	Diabetes_McGill_Adipocytokine_signallin	PENG_RAPAMYCIN_RESPONSE_UP
1.42857142857%	1	70	202	Diabetes_McGill_Adipocytokine_signallin	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
1.42857142857%	1	70	200	Diabetes_McGill_Adipocytokine_signallin	SHEPARD_BMYB_MORPHOLINO_DN
1.42857142857%	1	70	200	Diabetes_McGill_Adipocytokine_signallin	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
1.42857142857%	1	70	200	Diabetes_McGill_Adipocytokine_signallin	LEE_DIFFERENTIATING_T_LYMPHOCYTE
1.42857142857%	1	70	20	Diabetes_McGill_Adipocytokine_signallin	WANG_RECURRENT_LIVER_CANCER_UP
1.42857142857%	1	70	20	Diabetes_McGill_Adipocytokine_signallin	SESTO_RESPONSE_TO_UV_C4
1.42857142857%	1	70	20	Diabetes_McGill_Adipocytokine_signallin	REACTOME_ENOS_ACTIVATION_AND_REGULATION
1.42857142857%	1	70	20	Diabetes_McGill_Adipocytokine_signallin	OUYANG_PROSTATE_CANCER_PROGRESSION_UP
1.42857142857%	1	70	20	Diabetes_McGill_Adipocytokine_signallin	NIELSEN_LEIOMYOSARCOMA_CNN1_DN
1.42857142857%	1	70	20	Diabetes_McGill_Adipocytokine_signallin	NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN
1.42857142857%	1	70	20	Diabetes_McGill_Adipocytokine_signallin	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP
1.42857142857%	1	70	20	Diabetes_McGill_Adipocytokine_signallin	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN
1.42857142857%	1	70	20	Diabetes_McGill_Adipocytokine_signallin	DING_LUNG_CANCER_BY_MUTATION_RATE
1.42857142857%	1	70	20	Diabetes_McGill_Adipocytokine_signallin	DE_YY1_TARGETS_UP
1.42857142857%	1	70	20	Diabetes_McGill_Adipocytokine_signallin	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
1.42857142857%	1	70	20	Diabetes_McGill_Adipocytokine_signallin	CHEN_ETV5_TARGETS_SERTOLI
1.42857142857%	1	70	20	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_CCR5_PATHWAY
1.42857142857%	1	70	199	Diabetes_McGill_Adipocytokine_signallin	PLASARI_TGFB1_TARGETS_10HR_UP
1.42857142857%	1	70	198	Diabetes_McGill_Adipocytokine_signallin	WELCSH_BRCA1_TARGETS_UP
1.42857142857%	1	70	198	Diabetes_McGill_Adipocytokine_signallin	ALONSO_METASTASIS_UP
1.42857142857%	1	70	196	Diabetes_McGill_Adipocytokine_signallin	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
1.42857142857%	1	70	195	Diabetes_McGill_Adipocytokine_signallin	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
1.42857142857%	1	70	194	Diabetes_McGill_Adipocytokine_signallin	KASLER_HDAC7_TARGETS_1_UP
1.42857142857%	1	70	193	Diabetes_McGill_Adipocytokine_signallin	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
1.42857142857%	1	70	191	Diabetes_McGill_Adipocytokine_signallin	YAGI_AML_FAB_MARKERS
1.42857142857%	1	70	19	Diabetes_McGill_Adipocytokine_signallin	ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE
1.42857142857%	1	70	19	Diabetes_McGill_Adipocytokine_signallin	ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN
1.42857142857%	1	70	19	Diabetes_McGill_Adipocytokine_signallin	VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP
1.42857142857%	1	70	19	Diabetes_McGill_Adipocytokine_signallin	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP
1.42857142857%	1	70	19	Diabetes_McGill_Adipocytokine_signallin	RUAN_RESPONSE_TO_TROGLITAZONE_DN
1.42857142857%	1	70	19	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1
1.42857142857%	1	70	19	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS
1.42857142857%	1	70	19	Diabetes_McGill_Adipocytokine_signallin	MARSON_FOXP3_CORE_DIRECT_TARGETS
1.42857142857%	1	70	19	Diabetes_McGill_Adipocytokine_signallin	JEON_SMAD6_TARGETS_DN
1.42857142857%	1	70	19	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_MAL_PATHWAY
1.42857142857%	1	70	19	Diabetes_McGill_Adipocytokine_signallin	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
1.42857142857%	1	70	187	Diabetes_McGill_Adipocytokine_signallin	PENG_LEUCINE_DEPRIVATION_DN
1.42857142857%	1	70	187	Diabetes_McGill_Adipocytokine_signallin	BAKKER_FOXO3_TARGETS_DN
1.42857142857%	1	70	186	Diabetes_McGill_Adipocytokine_signallin	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
1.42857142857%	1	70	186	Diabetes_McGill_Adipocytokine_signallin	HAMAI_APOPTOSIS_VIA_TRAIL_DN
1.42857142857%	1	70	185	Diabetes_McGill_Adipocytokine_signallin	KEGG_HUNTINGTONS_DISEASE
1.42857142857%	1	70	185	Diabetes_McGill_Adipocytokine_signallin	DARWICHE_SKIN_TUMOR_PROMOTER_DN
1.42857142857%	1	70	184	Diabetes_McGill_Adipocytokine_signallin	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
1.42857142857%	1	70	182	Diabetes_McGill_Adipocytokine_signallin	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
1.42857142857%	1	70	182	Diabetes_McGill_Adipocytokine_signallin	FERNANDEZ_BOUND_BY_MYC
1.42857142857%	1	70	182	Diabetes_McGill_Adipocytokine_signallin	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
1.42857142857%	1	70	181	Diabetes_McGill_Adipocytokine_signallin	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
1.42857142857%	1	70	181	Diabetes_McGill_Adipocytokine_signallin	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
1.42857142857%	1	70	181	Diabetes_McGill_Adipocytokine_signallin	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
1.42857142857%	1	70	180	Diabetes_McGill_Adipocytokine_signallin	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
1.42857142857%	1	70	180	Diabetes_McGill_Adipocytokine_signallin	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
1.42857142857%	1	70	180	Diabetes_McGill_Adipocytokine_signallin	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
1.42857142857%	1	70	180	Diabetes_McGill_Adipocytokine_signallin	DARWICHE_PAPILLOMA_RISK_HIGH_DN
1.42857142857%	1	70	18	Diabetes_McGill_Adipocytokine_signallin	ZHENG_RESPONSE_TO_ARSENITE_DN
1.42857142857%	1	70	18	Diabetes_McGill_Adipocytokine_signallin	STAMBOLSKY_BOUND_BY_MUTATED_TP53
1.42857142857%	1	70	18	Diabetes_McGill_Adipocytokine_signallin	REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION
1.42857142857%	1	70	18	Diabetes_McGill_Adipocytokine_signallin	OZANNE_AP1_TARGETS_UP
1.42857142857%	1	70	18	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_TEL_PATHWAY
1.42857142857%	1	70	18	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_PTEN_PATHWAY
1.42857142857%	1	70	18	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_NGF_PATHWAY
1.42857142857%	1	70	18	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_ERK5_PATHWAY
1.42857142857%	1	70	179	Diabetes_McGill_Adipocytokine_signallin	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
1.42857142857%	1	70	178	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_18HR_DN
1.42857142857%	1	70	177	Diabetes_McGill_Adipocytokine_signallin	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
1.42857142857%	1	70	176	Diabetes_McGill_Adipocytokine_signallin	NAGASHIMA_NRG1_SIGNALING_UP
1.42857142857%	1	70	175	Diabetes_McGill_Adipocytokine_signallin	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
1.42857142857%	1	70	175	Diabetes_McGill_Adipocytokine_signallin	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
1.42857142857%	1	70	174	Diabetes_McGill_Adipocytokine_signallin	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
1.42857142857%	1	70	172	Diabetes_McGill_Adipocytokine_signallin	SMID_BREAST_CANCER_LUMINAL_B_UP
1.42857142857%	1	70	171	Diabetes_McGill_Adipocytokine_signallin	GOLDRATH_HOMEOSTATIC_PROLIFERATION
1.42857142857%	1	70	171	Diabetes_McGill_Adipocytokine_signallin	ELVIDGE_HYPOXIA_UP
1.42857142857%	1	70	17	Diabetes_McGill_Adipocytokine_signallin	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP
1.42857142857%	1	70	17	Diabetes_McGill_Adipocytokine_signallin	REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP
1.42857142857%	1	70	17	Diabetes_McGill_Adipocytokine_signallin	REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1
1.42857142857%	1	70	17	Diabetes_McGill_Adipocytokine_signallin	PID_ANTHRAXPATHWAY
1.42857142857%	1	70	17	Diabetes_McGill_Adipocytokine_signallin	ONDER_CDH1_TARGETS_3_UP
1.42857142857%	1	70	17	Diabetes_McGill_Adipocytokine_signallin	MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN
1.42857142857%	1	70	17	Diabetes_McGill_Adipocytokine_signallin	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL
1.42857142857%	1	70	17	Diabetes_McGill_Adipocytokine_signallin	KASLER_HDAC7_TARGETS_1_DN
1.42857142857%	1	70	17	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_NO2IL12_PATHWAY
1.42857142857%	1	70	17	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_LAIR_PATHWAY
1.42857142857%	1	70	169	Diabetes_McGill_Adipocytokine_signallin	KATSANOU_ELAVL1_TARGETS_UP
1.42857142857%	1	70	169	Diabetes_McGill_Adipocytokine_signallin	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
1.42857142857%	1	70	167	Diabetes_McGill_Adipocytokine_signallin	VANTVEER_BREAST_CANCER_ESR1_UP
1.42857142857%	1	70	167	Diabetes_McGill_Adipocytokine_signallin	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
1.42857142857%	1	70	166	Diabetes_McGill_Adipocytokine_signallin	CAIRO_LIVER_DEVELOPMENT_UP
1.42857142857%	1	70	165	Diabetes_McGill_Adipocytokine_signallin	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
1.42857142857%	1	70	165	Diabetes_McGill_Adipocytokine_signallin	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
1.42857142857%	1	70	165	Diabetes_McGill_Adipocytokine_signallin	DARWICHE_PAPILLOMA_RISK_LOW_DN
1.42857142857%	1	70	165	Diabetes_McGill_Adipocytokine_signallin	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
1.42857142857%	1	70	164	Diabetes_McGill_Adipocytokine_signallin	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
1.42857142857%	1	70	164	Diabetes_McGill_Adipocytokine_signallin	AMIT_EGF_RESPONSE_480_HELA
1.42857142857%	1	70	163	Diabetes_McGill_Adipocytokine_signallin	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
1.42857142857%	1	70	163	Diabetes_McGill_Adipocytokine_signallin	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
1.42857142857%	1	70	162	Diabetes_McGill_Adipocytokine_signallin	KIM_WT1_TARGETS_12HR_UP
1.42857142857%	1	70	162	Diabetes_McGill_Adipocytokine_signallin	DARWICHE_PAPILLOMA_RISK_LOW_UP
1.42857142857%	1	70	16	Diabetes_McGill_Adipocytokine_signallin	WONG_IFNA2_RESISTANCE_UP
1.42857142857%	1	70	16	Diabetes_McGill_Adipocytokine_signallin	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
1.42857142857%	1	70	16	Diabetes_McGill_Adipocytokine_signallin	MACLACHLAN_BRCA1_TARGETS_DN
1.42857142857%	1	70	16	Diabetes_McGill_Adipocytokine_signallin	KORKOLA_TERATOMA_UP
1.42857142857%	1	70	16	Diabetes_McGill_Adipocytokine_signallin	HE_PTEN_TARGETS_UP
1.42857142857%	1	70	16	Diabetes_McGill_Adipocytokine_signallin	GHO_ATF5_TARGETS_DN
1.42857142857%	1	70	16	Diabetes_McGill_Adipocytokine_signallin	GEISS_RESPONSE_TO_DSRNA_DN
1.42857142857%	1	70	16	Diabetes_McGill_Adipocytokine_signallin	FINETTI_BREAST_CANCER_KINOME_GREEN
1.42857142857%	1	70	16	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_ACH_PATHWAY
1.42857142857%	1	70	158	Diabetes_McGill_Adipocytokine_signallin	RODRIGUES_NTN1_TARGETS_DN
1.42857142857%	1	70	158	Diabetes_McGill_Adipocytokine_signallin	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON
1.42857142857%	1	70	156	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_14HR_UP
1.42857142857%	1	70	153	Diabetes_McGill_Adipocytokine_signallin	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
1.42857142857%	1	70	153	Diabetes_McGill_Adipocytokine_signallin	RUIZ_TNC_TARGETS_UP
1.42857142857%	1	70	153	Diabetes_McGill_Adipocytokine_signallin	DURAND_STROMA_MAX_DN
1.42857142857%	1	70	152	Diabetes_McGill_Adipocytokine_signallin	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
1.42857142857%	1	70	152	Diabetes_McGill_Adipocytokine_signallin	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
1.42857142857%	1	70	150	Diabetes_McGill_Adipocytokine_signallin	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
1.42857142857%	1	70	150	Diabetes_McGill_Adipocytokine_signallin	LANDIS_ERBB2_BREAST_TUMORS_324_UP
1.42857142857%	1	70	15	Diabetes_McGill_Adipocytokine_signallin	ZHANG_GATA6_TARGETS_UP
1.42857142857%	1	70	15	Diabetes_McGill_Adipocytokine_signallin	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3
1.42857142857%	1	70	15	Diabetes_McGill_Adipocytokine_signallin	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP
1.42857142857%	1	70	15	Diabetes_McGill_Adipocytokine_signallin	REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS
1.42857142857%	1	70	15	Diabetes_McGill_Adipocytokine_signallin	REACTOME_ENDOGENOUS_STEROLS
1.42857142857%	1	70	15	Diabetes_McGill_Adipocytokine_signallin	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27
1.42857142857%	1	70	15	Diabetes_McGill_Adipocytokine_signallin	MARKS_HDAC_TARGETS_DN
1.42857142857%	1	70	15	Diabetes_McGill_Adipocytokine_signallin	MARKS_ACETYLATED_NON_HISTONE_PROTEINS
1.42857142857%	1	70	15	Diabetes_McGill_Adipocytokine_signallin	FINETTI_BREAST_CANCERS_KINOME_GRAY
1.42857142857%	1	70	15	Diabetes_McGill_Adipocytokine_signallin	FERRANDO_LYL1_NEIGHBORS
1.42857142857%	1	70	15	Diabetes_McGill_Adipocytokine_signallin	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN
1.42857142857%	1	70	15	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_RARRXR_PATHWAY
1.42857142857%	1	70	15	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_NUCLEARRS_PATHWAY
1.42857142857%	1	70	15	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_LONGEVITY_PATHWAY
1.42857142857%	1	70	15	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_IL3_PATHWAY
1.42857142857%	1	70	15	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_HSP27_PATHWAY
1.42857142857%	1	70	15	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_AKAPCENTROSOME_PATHWAY
1.42857142857%	1	70	149	Diabetes_McGill_Adipocytokine_signallin	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
1.42857142857%	1	70	149	Diabetes_McGill_Adipocytokine_signallin	NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON
1.42857142857%	1	70	148	Diabetes_McGill_Adipocytokine_signallin	WEI_MIR34A_TARGETS
1.42857142857%	1	70	148	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_24HR_UP
1.42857142857%	1	70	148	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_24HR_DN
1.42857142857%	1	70	147	Diabetes_McGill_Adipocytokine_signallin	SMID_BREAST_CANCER_ERBB2_UP
1.42857142857%	1	70	147	Diabetes_McGill_Adipocytokine_signallin	DARWICHE_PAPILLOMA_RISK_HIGH_UP
1.42857142857%	1	70	146	Diabetes_McGill_Adipocytokine_signallin	PECE_MAMMARY_STEM_CELL_DN
1.42857142857%	1	70	145	Diabetes_McGill_Adipocytokine_signallin	ZHANG_BREAST_CANCER_PROGENITORS_DN
1.42857142857%	1	70	145	Diabetes_McGill_Adipocytokine_signallin	RODWELL_AGING_KIDNEY_DN
1.42857142857%	1	70	143	Diabetes_McGill_Adipocytokine_signallin	BASSO_B_LYMPHOCYTE_NETWORK
1.42857142857%	1	70	142	Diabetes_McGill_Adipocytokine_signallin	XU_GH1_AUTOCRINE_TARGETS_DN
1.42857142857%	1	70	142	Diabetes_McGill_Adipocytokine_signallin	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
1.42857142857%	1	70	142	Diabetes_McGill_Adipocytokine_signallin	PENG_LEUCINE_DEPRIVATION_UP
1.42857142857%	1	70	142	Diabetes_McGill_Adipocytokine_signallin	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
1.42857142857%	1	70	142	Diabetes_McGill_Adipocytokine_signallin	DARWICHE_SKIN_TUMOR_PROMOTER_UP
1.42857142857%	1	70	142	Diabetes_McGill_Adipocytokine_signallin	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
1.42857142857%	1	70	141	Diabetes_McGill_Adipocytokine_signallin	SABATES_COLORECTAL_ADENOMA_UP
1.42857142857%	1	70	141	Diabetes_McGill_Adipocytokine_signallin	KAAB_FAILED_HEART_ATRIUM_DN
1.42857142857%	1	70	140	Diabetes_McGill_Adipocytokine_signallin	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
1.42857142857%	1	70	14	Diabetes_McGill_Adipocytokine_signallin	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN
1.42857142857%	1	70	14	Diabetes_McGill_Adipocytokine_signallin	REACTOME_PROLACTIN_RECEPTOR_SIGNALING
1.42857142857%	1	70	14	Diabetes_McGill_Adipocytokine_signallin	REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS
1.42857142857%	1	70	14	Diabetes_McGill_Adipocytokine_signallin	PID_TCRJNKPATHWAY
1.42857142857%	1	70	14	Diabetes_McGill_Adipocytokine_signallin	INAMURA_LUNG_CANCER_SCC_UP
1.42857142857%	1	70	14	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_GRANULOCYTES_PATHWAY
1.42857142857%	1	70	139	Diabetes_McGill_Adipocytokine_signallin	REACTOME_BIOLOGICAL_OXIDATIONS
1.42857142857%	1	70	138	Diabetes_McGill_Adipocytokine_signallin	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
1.42857142857%	1	70	137	Diabetes_McGill_Adipocytokine_signallin	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
1.42857142857%	1	70	137	Diabetes_McGill_Adipocytokine_signallin	PID_P53DOWNSTREAMPATHWAY
1.42857142857%	1	70	136	Diabetes_McGill_Adipocytokine_signallin	PROVENZANI_METASTASIS_DN
1.42857142857%	1	70	136	Diabetes_McGill_Adipocytokine_signallin	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
1.42857142857%	1	70	135	Diabetes_McGill_Adipocytokine_signallin	UDAYAKUMAR_MED1_TARGETS_UP
1.42857142857%	1	70	135	Diabetes_McGill_Adipocytokine_signallin	SERVITJA_LIVER_HNF1A_TARGETS_UP
1.42857142857%	1	70	134	Diabetes_McGill_Adipocytokine_signallin	CHUNG_BLISTER_CYTOTOXICITY_UP
1.42857142857%	1	70	133	Diabetes_McGill_Adipocytokine_signallin	REACTOME_DIABETES_PATHWAYS
1.42857142857%	1	70	132	Diabetes_McGill_Adipocytokine_signallin	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
1.42857142857%	1	70	131	Diabetes_McGill_Adipocytokine_signallin	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
1.42857142857%	1	70	130	Diabetes_McGill_Adipocytokine_signallin	YAGI_AML_WITH_T_9_11_TRANSLOCATION
1.42857142857%	1	70	130	Diabetes_McGill_Adipocytokine_signallin	ELVIDGE_HYPOXIA_BY_DMOG_UP
1.42857142857%	1	70	13	Diabetes_McGill_Adipocytokine_signallin	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
1.42857142857%	1	70	13	Diabetes_McGill_Adipocytokine_signallin	REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION
1.42857142857%	1	70	13	Diabetes_McGill_Adipocytokine_signallin	RAY_ALZHEIMERS_DISEASE
1.42857142857%	1	70	13	Diabetes_McGill_Adipocytokine_signallin	KRISHNAN_FURIN_TARGETS_DN
1.42857142857%	1	70	13	Diabetes_McGill_Adipocytokine_signallin	CAFFAREL_RESPONSE_TO_THC_24HR_3_DN
1.42857142857%	1	70	13	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_CARM1_PATHWAY
1.42857142857%	1	70	13	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_ARENRF2_PATHWAY
1.42857142857%	1	70	128	Diabetes_McGill_Adipocytokine_signallin	ZHU_CMV_ALL_DN
1.42857142857%	1	70	127	Diabetes_McGill_Adipocytokine_signallin	INGRAM_SHH_TARGETS_UP
1.42857142857%	1	70	127	Diabetes_McGill_Adipocytokine_signallin	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
1.42857142857%	1	70	126	Diabetes_McGill_Adipocytokine_signallin	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
1.42857142857%	1	70	126	Diabetes_McGill_Adipocytokine_signallin	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
1.42857142857%	1	70	126	Diabetes_McGill_Adipocytokine_signallin	GERY_CEBP_TARGETS
1.42857142857%	1	70	126	Diabetes_McGill_Adipocytokine_signallin	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
1.42857142857%	1	70	126	Diabetes_McGill_Adipocytokine_signallin	BURTON_ADIPOGENESIS_5
1.42857142857%	1	70	123	Diabetes_McGill_Adipocytokine_signallin	KAYO_AGING_MUSCLE_DN
1.42857142857%	1	70	123	Diabetes_McGill_Adipocytokine_signallin	DAZARD_RESPONSE_TO_UV_SCC_UP
1.42857142857%	1	70	123	Diabetes_McGill_Adipocytokine_signallin	DAZARD_RESPONSE_TO_UV_SCC_DN
1.42857142857%	1	70	122	Diabetes_McGill_Adipocytokine_signallin	TOOKER_GEMCITABINE_RESISTANCE_DN
1.42857142857%	1	70	121	Diabetes_McGill_Adipocytokine_signallin	RODRIGUES_DCC_TARGETS_DN
1.42857142857%	1	70	121	Diabetes_McGill_Adipocytokine_signallin	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS
1.42857142857%	1	70	121	Diabetes_McGill_Adipocytokine_signallin	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
1.42857142857%	1	70	121	Diabetes_McGill_Adipocytokine_signallin	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
1.42857142857%	1	70	121	Diabetes_McGill_Adipocytokine_signallin	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
1.42857142857%	1	70	120	Diabetes_McGill_Adipocytokine_signallin	REACTOME_CELL_CELL_COMMUNICATION
1.42857142857%	1	70	120	Diabetes_McGill_Adipocytokine_signallin	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
1.42857142857%	1	70	12	Diabetes_McGill_Adipocytokine_signallin	ZHENG_FOXP3_TARGETS_IN_THYMUS_DN
1.42857142857%	1	70	12	Diabetes_McGill_Adipocytokine_signallin	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN
1.42857142857%	1	70	12	Diabetes_McGill_Adipocytokine_signallin	REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES
1.42857142857%	1	70	12	Diabetes_McGill_Adipocytokine_signallin	REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM
1.42857142857%	1	70	12	Diabetes_McGill_Adipocytokine_signallin	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN
1.42857142857%	1	70	12	Diabetes_McGill_Adipocytokine_signallin	DING_LUNG_CANCER_MUTATED_FREQUENTLY
1.42857142857%	1	70	12	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_VDR_PATHWAY
1.42857142857%	1	70	12	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_TRKA_PATHWAY
1.42857142857%	1	70	12	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_AKAP95_PATHWAY
1.42857142857%	1	70	12	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_AKAP13_PATHWAY
1.42857142857%	1	70	118	Diabetes_McGill_Adipocytokine_signallin	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
1.42857142857%	1	70	118	Diabetes_McGill_Adipocytokine_signallin	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
1.42857142857%	1	70	1174	Diabetes_McGill_Adipocytokine_signallin	PEREZ_TP53_TARGETS
1.42857142857%	1	70	116	Diabetes_McGill_Adipocytokine_signallin	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
1.42857142857%	1	70	116	Diabetes_McGill_Adipocytokine_signallin	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
1.42857142857%	1	70	116	Diabetes_McGill_Adipocytokine_signallin	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
1.42857142857%	1	70	115	Diabetes_McGill_Adipocytokine_signallin	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
1.42857142857%	1	70	115	Diabetes_McGill_Adipocytokine_signallin	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
1.42857142857%	1	70	115	Diabetes_McGill_Adipocytokine_signallin	HOELZEL_NF1_TARGETS_DN
1.42857142857%	1	70	114	Diabetes_McGill_Adipocytokine_signallin	SMIRNOV_RESPONSE_TO_IR_6HR_DN
1.42857142857%	1	70	114	Diabetes_McGill_Adipocytokine_signallin	MATZUK_SPERMATOZOA
1.42857142857%	1	70	114	Diabetes_McGill_Adipocytokine_signallin	CERVERA_SDHB_TARGETS_2
1.42857142857%	1	70	114	Diabetes_McGill_Adipocytokine_signallin	BOSCO_TH1_CYTOTOXIC_MODULE
1.42857142857%	1	70	113	Diabetes_McGill_Adipocytokine_signallin	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
1.42857142857%	1	70	112	Diabetes_McGill_Adipocytokine_signallin	PASINI_SUZ12_TARGETS_UP
1.42857142857%	1	70	111	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_12HR_UP
1.42857142857%	1	70	110	Diabetes_McGill_Adipocytokine_signallin	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
1.42857142857%	1	70	11	Diabetes_McGill_Adipocytokine_signallin	SEIKE_LUNG_CANCER_POOR_SURVIVAL
1.42857142857%	1	70	11	Diabetes_McGill_Adipocytokine_signallin	REACTOME_MTORC1_MEDIATED_SIGNALLING
1.42857142857%	1	70	11	Diabetes_McGill_Adipocytokine_signallin	REACTOME_DSCAM_INTERACTIONS
1.42857142857%	1	70	11	Diabetes_McGill_Adipocytokine_signallin	HOFFMAN_CLOCK_TARGETS_UP
1.42857142857%	1	70	11	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_VITCB_PATHWAY
1.42857142857%	1	70	11	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_EGFR_SMRTE_PATHWAY
1.42857142857%	1	70	109	Diabetes_McGill_Adipocytokine_signallin	SERVITJA_ISLET_HNF1A_TARGETS_DN
1.42857142857%	1	70	109	Diabetes_McGill_Adipocytokine_signallin	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
1.42857142857%	1	70	108	Diabetes_McGill_Adipocytokine_signallin	WESTON_VEGFA_TARGETS
1.42857142857%	1	70	108	Diabetes_McGill_Adipocytokine_signallin	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
1.42857142857%	1	70	108	Diabetes_McGill_Adipocytokine_signallin	LABBE_TGFB1_TARGETS_DN
1.42857142857%	1	70	108	Diabetes_McGill_Adipocytokine_signallin	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN
1.42857142857%	1	70	107	Diabetes_McGill_Adipocytokine_signallin	ROESSLER_LIVER_CANCER_METASTASIS_UP
1.42857142857%	1	70	107	Diabetes_McGill_Adipocytokine_signallin	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
1.42857142857%	1	70	1062	Diabetes_McGill_Adipocytokine_signallin	BENPORATH_EED_TARGETS
1.42857142857%	1	70	105	Diabetes_McGill_Adipocytokine_signallin	ZWANG_EGF_INTERVAL_UP
1.42857142857%	1	70	105	Diabetes_McGill_Adipocytokine_signallin	HELLER_SILENCED_BY_METHYLATION_DN
1.42857142857%	1	70	105	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_8HR_UP
1.42857142857%	1	70	104	Diabetes_McGill_Adipocytokine_signallin	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
1.42857142857%	1	70	102	Diabetes_McGill_Adipocytokine_signallin	KEGG_MELANOGENESIS
1.42857142857%	1	70	102	Diabetes_McGill_Adipocytokine_signallin	DER_IFN_BETA_RESPONSE_UP
1.42857142857%	1	70	101	Diabetes_McGill_Adipocytokine_signallin	KOBAYASHI_EGFR_SIGNALING_24HR_UP
1.42857142857%	1	70	101	Diabetes_McGill_Adipocytokine_signallin	BROWNE_HCMV_INFECTION_20HR_DN
1.42857142857%	1	70	100	Diabetes_McGill_Adipocytokine_signallin	ROVERSI_GLIOMA_COPY_NUMBER_UP
1.42857142857%	1	70	100	Diabetes_McGill_Adipocytokine_signallin	MCCLUNG_CREB1_TARGETS_UP
1.42857142857%	1	70	100	Diabetes_McGill_Adipocytokine_signallin	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
1.42857142857%	1	70	100	Diabetes_McGill_Adipocytokine_signallin	BENPORATH_ES_CORE_NINE_CORRELATED
1.42857142857%	1	70	10	Diabetes_McGill_Adipocytokine_signallin	ST_INTERFERON_GAMMA_PATHWAY
1.42857142857%	1	70	10	Diabetes_McGill_Adipocytokine_signallin	REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR
1.42857142857%	1	70	10	Diabetes_McGill_Adipocytokine_signallin	REACTOME_ANDROGEN_BIOSYNTHESIS
1.42857142857%	1	70	10	Diabetes_McGill_Adipocytokine_signallin	REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM
1.42857142857%	1	70	10	Diabetes_McGill_Adipocytokine_signallin	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN
1.42857142857%	1	70	10	Diabetes_McGill_Adipocytokine_signallin	IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
1.42857142857%	1	70	10	Diabetes_McGill_Adipocytokine_signallin	GOUYER_TATI_TARGETS_UP
1.42857142857%	1	70	10	Diabetes_McGill_Adipocytokine_signallin	BRUNEAU_SEPTATION_VENTRICULAR
1.42857142857%	1	70	10	Diabetes_McGill_Adipocytokine_signallin	BIOCARTA_BARRESTIN_PATHWAY
1.42594296228%	31	2174	86	T2D_GENES_TANYA_LIPIDS	REACTOME_MEIOTIC_RECOMBINATION
1.42594296228%	31	2174	351	T2D_GENES_TANYA_LIPIDS	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
1.42594296228%	31	2174	317	T2D_GENES_TANYA_LIPIDS	BRUINS_UVC_RESPONSE_EARLY_LATE
1.42594296228%	31	2174	311	T2D_GENES_TANYA_LIPIDS	JIANG_HYPOXIA_NORMAL
1.42594296228%	31	2174	292	T2D_GENES_TANYA_LIPIDS	HELLER_HDAC_TARGETS_DN
1.42594296228%	31	2174	289	T2D_GENES_TANYA_LIPIDS	MANALO_HYPOXIA_DN
1.42594296228%	31	2174	279	T2D_GENES_TANYA_LIPIDS	FORTSCHEGGER_PHF8_TARGETS_UP
1.42594296228%	31	2174	266	T2D_GENES_TANYA_LIPIDS	FOSTER_KDM1A_TARGETS_UP
1.42594296228%	31	2174	261	T2D_GENES_TANYA_LIPIDS	BILD_HRAS_ONCOGENIC_SIGNATURE
1.42594296228%	31	2174	252	T2D_GENES_TANYA_LIPIDS	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
1.42594296228%	31	2174	241	T2D_GENES_TANYA_LIPIDS	DOANE_RESPONSE_TO_ANDROGEN_DN
1.42594296228%	31	2174	240	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_20HR_UP
1.42594296228%	31	2174	230	T2D_GENES_TANYA_LIPIDS	COLDREN_GEFITINIB_RESISTANCE_DN
1.42594296228%	31	2174	203	T2D_GENES_TANYA_LIPIDS	PAL_PRMT5_TARGETS_UP
1.42594296228%	31	2174	122	T2D_GENES_TANYA_LIPIDS	REACTOME_CHROMOSOME_MAINTENANCE
1.42045454545%	50	3520	648	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMID_BREAST_CANCER_BASAL_UP
1.42045454545%	50	3520	578	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
1.42045454545%	50	3520	536	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BERENJENO_TRANSFORMED_BY_RHOA_UP
1.42045454545%	50	3520	463	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
1.42045454545%	50	3520	442	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
1.42045454545%	50	3520	428	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CUI_TCF21_TARGETS_2_UP
1.42045454545%	50	3520	406	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OSMAN_BLADDER_CANCER_DN
1.41843971631%	28	1974	98	Mendelian_Nancy_Cox	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
1.41843971631%	28	1974	73	Mendelian_Nancy_Cox	KEGG_VIRAL_MYOCARDITIS
1.41843971631%	28	1974	336	Mendelian_Nancy_Cox	JOHNSTONE_PARVB_TARGETS_2_DN
1.41843971631%	28	1974	280	Mendelian_Nancy_Cox	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
1.41843971631%	28	1974	279	Mendelian_Nancy_Cox	FORTSCHEGGER_PHF8_TARGETS_UP
1.41843971631%	28	1974	242	Mendelian_Nancy_Cox	CHYLA_CBFA2T3_TARGETS_DN
1.41843971631%	28	1974	228	Mendelian_Nancy_Cox	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
1.41843971631%	28	1974	227	Mendelian_Nancy_Cox	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
1.41843971631%	28	1974	214	Mendelian_Nancy_Cox	TIEN_INTESTINE_PROBIOTICS_24HR_DN
1.41843971631%	28	1974	207	Mendelian_Nancy_Cox	KARLSSON_TGFB1_TARGETS_DN
1.41843971631%	28	1974	207	Mendelian_Nancy_Cox	CAIRO_HEPATOBLASTOMA_UP
1.41843971631%	28	1974	206	Mendelian_Nancy_Cox	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
1.41843971631%	28	1974	205	Mendelian_Nancy_Cox	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
1.41843971631%	28	1974	202	Mendelian_Nancy_Cox	FUJII_YBX1_TARGETS_DN
1.41843971631%	28	1974	194	Mendelian_Nancy_Cox	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
1.41843971631%	28	1974	187	Mendelian_Nancy_Cox	PENG_LEUCINE_DEPRIVATION_DN
1.41843971631%	28	1974	177	Mendelian_Nancy_Cox	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
1.41843971631%	28	1974	176	Mendelian_Nancy_Cox	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
1.41843971631%	28	1974	170	Mendelian_Nancy_Cox	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
1.41843971631%	28	1974	165	Mendelian_Nancy_Cox	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
1.41843971631%	28	1974	151	Mendelian_Nancy_Cox	KEGG_WNT_SIGNALING_PATHWAY
1.41843971631%	28	1974	145	Mendelian_Nancy_Cox	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
1.41843971631%	28	1974	140	Mendelian_Nancy_Cox	QI_HYPOXIA
1.41843971631%	28	1974	103	Mendelian_Nancy_Cox	LEIN_CHOROID_PLEXUS_MARKERS
1.41843971631%	18	1269	579	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
1.41843971631%	18	1269	566	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DOUGLAS_BMI1_TARGETS_UP
1.41843971631%	18	1269	552	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
1.41843971631%	18	1269	482	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
1.41843971631%	18	1269	473	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
1.41843971631%	18	1269	463	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
1.41843971631%	18	1269	428	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIM_MAMMARY_STEM_CELL_DN
1.41843971631%	18	1269	406	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OSMAN_BLADDER_CANCER_DN
1.41843971631%	18	1269	396	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_DEVELOPMENTAL_BIOLOGY
1.41843971631%	18	1269	380	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MULLIGHAN_MLL_SIGNATURE_1_UP
1.41843971631%	18	1269	351	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAGI_AML_WITH_11Q23_REARRANGED
1.41843971631%	18	1269	328	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_OLFACTORY_SIGNALING_PATHWAY
1.41843971631%	18	1269	325	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CELL_CYCLE_MITOTIC
1.41843971631%	18	1269	293	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ENK_UV_RESPONSE_EPIDERMIS_UP
1.41843971631%	18	1269	228	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
1.39204545455%	49	3520	514	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN
1.39204545455%	49	3520	504	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PILON_KLF1_TARGETS_UP
1.39204545455%	49	3520	473	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
1.39204545455%	49	3520	439	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MITSIADES_RESPONSE_TO_APLIDIN_UP
1.39204545455%	49	3520	413	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
1.39204545455%	49	3520	408	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
1.39204545455%	49	3520	398	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
1.39204545455%	49	3520	368	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAGI_AML_WITH_T_8_21_TRANSLOCATION
1.39204545455%	49	3520	366	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SANSOM_APC_TARGETS_DN
1.39204545455%	49	3520	354	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
1.38963121325%	26	1871	425	T2D_GENES_TANYA_HEIGHT	ZHANG_BREAST_CANCER_PROGENITORS_UP
1.38963121325%	26	1871	341	T2D_GENES_TANYA_HEIGHT	MULLIGHAN_NPM1_SIGNATURE_3_UP
1.38963121325%	26	1871	318	T2D_GENES_TANYA_HEIGHT	LEI_MYB_TARGETS
1.38963121325%	26	1871	318	T2D_GENES_TANYA_HEIGHT	DAZARD_RESPONSE_TO_UV_NHEK_DN
1.38963121325%	26	1871	306	T2D_GENES_TANYA_HEIGHT	HORIUCHI_WTAP_TARGETS_UP
1.38963121325%	26	1871	305	T2D_GENES_TANYA_HEIGHT	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
1.38963121325%	26	1871	298	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_14HR_DN
1.38963121325%	26	1871	293	T2D_GENES_TANYA_HEIGHT	ZWANG_DOWN_BY_2ND_EGF_PULSE
1.38963121325%	26	1871	288	T2D_GENES_TANYA_HEIGHT	POOLA_INVASIVE_BREAST_CANCER_UP
1.38963121325%	26	1871	271	T2D_GENES_TANYA_HEIGHT	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
1.38963121325%	26	1871	266	T2D_GENES_TANYA_HEIGHT	FOSTER_KDM1A_TARGETS_UP
1.38963121325%	26	1871	261	T2D_GENES_TANYA_HEIGHT	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
1.38963121325%	26	1871	260	T2D_GENES_TANYA_HEIGHT	BOQUEST_STEM_CELL_UP
1.38963121325%	26	1871	251	T2D_GENES_TANYA_HEIGHT	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
1.38963121325%	26	1871	241	T2D_GENES_TANYA_HEIGHT	DOANE_RESPONSE_TO_ANDROGEN_DN
1.38963121325%	26	1871	217	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALLING_BY_NGF
1.38963121325%	26	1871	207	T2D_GENES_TANYA_HEIGHT	CAIRO_HEPATOBLASTOMA_UP
1.38963121325%	26	1871	206	T2D_GENES_TANYA_HEIGHT	BILD_MYC_ONCOGENIC_SIGNATURE
1.38963121325%	26	1871	173	T2D_GENES_TANYA_HEIGHT	SENGUPTA_EBNA1_ANTICORRELATED
1.38504155125%	5	361	98	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_POTASSIUM_CHANNELS
1.38504155125%	5	361	86	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
1.38504155125%	5	361	824	T2D_GENES_TANYA_T2D_RSQ05_02CM	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3
1.38504155125%	5	361	728	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARSON_BOUND_BY_E2F4_UNSTIMULATED
1.38504155125%	5	361	668	T2D_GENES_TANYA_T2D_RSQ05_02CM	MILI_PSEUDOPODIA_HAPTOTAXIS_DN
1.38504155125%	5	361	658	T2D_GENES_TANYA_T2D_RSQ05_02CM	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
1.38504155125%	5	361	548	T2D_GENES_TANYA_T2D_RSQ05_02CM	KIM_ALL_DISORDERS_CALB1_CORR_UP
1.38504155125%	5	361	539	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
1.38504155125%	5	361	535	T2D_GENES_TANYA_T2D_RSQ05_02CM	STEIN_ESRRA_TARGETS
1.38504155125%	5	361	532	T2D_GENES_TANYA_T2D_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
1.38504155125%	5	361	518	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_METABOLISM_OF_PROTEINS
1.38504155125%	5	361	491	T2D_GENES_TANYA_T2D_RSQ05_02CM	MEISSNER_NPC_HCP_WITH_H3K4ME2
1.38504155125%	5	361	487	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
1.38504155125%	5	361	482	T2D_GENES_TANYA_T2D_RSQ05_02CM	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
1.38504155125%	5	361	479	T2D_GENES_TANYA_T2D_RSQ05_02CM	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
1.38504155125%	5	361	473	T2D_GENES_TANYA_T2D_RSQ05_02CM	GARY_CD5_TARGETS_UP
1.38504155125%	5	361	473	T2D_GENES_TANYA_T2D_RSQ05_02CM	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
1.38504155125%	5	361	466	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_HEMOSTASIS
1.38504155125%	5	361	464	T2D_GENES_TANYA_T2D_RSQ05_02CM	ONDER_CDH1_TARGETS_2_DN
1.38504155125%	5	361	457	T2D_GENES_TANYA_T2D_RSQ05_02CM	SENESE_HDAC1_TARGETS_UP
1.38504155125%	5	361	456	T2D_GENES_TANYA_T2D_RSQ05_02CM	ODONNELL_TFRC_TARGETS_UP
1.38504155125%	5	361	447	T2D_GENES_TANYA_T2D_RSQ05_02CM	MOOTHA_MITOCHONDRIA
1.38504155125%	5	361	442	T2D_GENES_TANYA_T2D_RSQ05_02CM	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
1.38504155125%	5	361	434	T2D_GENES_TANYA_T2D_RSQ05_02CM	BAELDE_DIABETIC_NEPHROPATHY_DN
1.38504155125%	5	361	428	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIM_MAMMARY_STEM_CELL_DN
1.38504155125%	5	361	408	T2D_GENES_TANYA_T2D_RSQ05_02CM	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
1.38504155125%	5	361	405	T2D_GENES_TANYA_T2D_RSQ05_02CM	KUMAR_TARGETS_OF_MLL_AF9_FUSION
1.38504155125%	5	361	404	T2D_GENES_TANYA_T2D_RSQ05_02CM	OSMAN_BLADDER_CANCER_UP
1.38504155125%	5	361	398	T2D_GENES_TANYA_T2D_RSQ05_02CM	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
1.38504155125%	5	361	374	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
1.38504155125%	5	361	371	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_SMARCE1_TARGETS_DN
1.38504155125%	5	361	357	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHEN_SMARCA2_TARGETS_DN
1.38504155125%	5	361	356	T2D_GENES_TANYA_T2D_RSQ05_02CM	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
1.38504155125%	5	361	355	T2D_GENES_TANYA_T2D_RSQ05_02CM	PEREZ_TP63_TARGETS
1.38504155125%	5	361	354	T2D_GENES_TANYA_T2D_RSQ05_02CM	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
1.38504155125%	5	361	341	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
1.38504155125%	5	361	337	T2D_GENES_TANYA_T2D_RSQ05_02CM	PHONG_TNF_RESPONSE_NOT_VIA_P38
1.38504155125%	5	361	332	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
1.38504155125%	5	361	330	T2D_GENES_TANYA_T2D_RSQ05_02CM	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
1.38504155125%	5	361	329	T2D_GENES_TANYA_T2D_RSQ05_02CM	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
1.38504155125%	5	361	321	T2D_GENES_TANYA_T2D_RSQ05_02CM	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
1.38504155125%	5	361	317	T2D_GENES_TANYA_T2D_RSQ05_02CM	BRUINS_UVC_RESPONSE_EARLY_LATE
1.38504155125%	5	361	312	T2D_GENES_TANYA_T2D_RSQ05_02CM	GENTILE_UV_HIGH_DOSE_DN
1.38504155125%	5	361	305	T2D_GENES_TANYA_T2D_RSQ05_02CM	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
1.38504155125%	5	361	298	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_14HR_DN
1.38504155125%	5	361	281	T2D_GENES_TANYA_T2D_RSQ05_02CM	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
1.38504155125%	5	361	271	T2D_GENES_TANYA_T2D_RSQ05_02CM	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
1.38504155125%	5	361	264	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
1.38504155125%	5	361	260	T2D_GENES_TANYA_T2D_RSQ05_02CM	BOQUEST_STEM_CELL_UP
1.38504155125%	5	361	251	T2D_GENES_TANYA_T2D_RSQ05_02CM	KOBAYASHI_EGFR_SIGNALING_24HR_DN
1.38504155125%	5	361	242	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHYLA_CBFA2T3_TARGETS_DN
1.38504155125%	5	361	241	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
1.38504155125%	5	361	240	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_20HR_UP
1.38504155125%	5	361	235	T2D_GENES_TANYA_T2D_RSQ05_02CM	RUTELLA_RESPONSE_TO_HGF_DN
1.38504155125%	5	361	210	T2D_GENES_TANYA_T2D_RSQ05_02CM	SANSOM_APC_TARGETS_REQUIRE_MYC
1.38504155125%	5	361	204	T2D_GENES_TANYA_T2D_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
1.38504155125%	5	361	203	T2D_GENES_TANYA_T2D_RSQ05_02CM	PAL_PRMT5_TARGETS_UP
1.38504155125%	5	361	202	T2D_GENES_TANYA_T2D_RSQ05_02CM	FUJII_YBX1_TARGETS_DN
1.38504155125%	5	361	197	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
1.38504155125%	5	361	194	T2D_GENES_TANYA_T2D_RSQ05_02CM	PROVENZANI_METASTASIS_UP
1.38504155125%	5	361	183	T2D_GENES_TANYA_T2D_RSQ05_02CM	OKUMURA_INFLAMMATORY_RESPONSE_LPS
1.38504155125%	5	361	163	T2D_GENES_TANYA_T2D_RSQ05_02CM	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
1.38504155125%	5	361	143	T2D_GENES_TANYA_T2D_RSQ05_02CM	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION
1.38504155125%	5	361	141	T2D_GENES_TANYA_T2D_RSQ05_02CM	WELCSH_BRCA1_TARGETS_DN
1.38504155125%	5	361	140	T2D_GENES_TANYA_T2D_RSQ05_02CM	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
1.38504155125%	5	361	137	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_MITOTIC_G1_G1_S_PHASES
1.38142747506%	18	1303	658	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D
1.38142747506%	18	1303	584	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
1.38142747506%	18	1303	570	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
1.38142747506%	18	1303	555	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
1.38142747506%	18	1303	517	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
1.38142747506%	18	1303	504	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_48HR_DN
1.38142747506%	18	1303	491	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MEISSNER_NPC_HCP_WITH_H3K4ME2
1.38142747506%	18	1303	476	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMID_BREAST_CANCER_NORMAL_LIKE_UP
1.38142747506%	18	1303	460	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
1.38142747506%	18	1303	448	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
1.38142747506%	18	1303	429	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOOTHA_HUMAN_MITODB_6_2002
1.38142747506%	18	1303	424	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHEN_SMARCA2_TARGETS_UP
1.38142747506%	18	1303	419	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
1.38142747506%	18	1303	378	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
1.38142747506%	18	1303	362	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
1.38142747506%	18	1303	323	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRESHOCK_CANCER_COPY_NUMBER_UP
1.38142747506%	18	1303	302	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
1.37994480221%	30	2174	83	T2D_GENES_TANYA_LIPIDS	REACTOME_AMYLOIDS
1.37994480221%	30	2174	428	T2D_GENES_TANYA_LIPIDS	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
1.37994480221%	30	2174	349	T2D_GENES_TANYA_LIPIDS	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
1.37994480221%	30	2174	326	T2D_GENES_TANYA_LIPIDS	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
1.37994480221%	30	2174	314	T2D_GENES_TANYA_LIPIDS	DOUGLAS_BMI1_TARGETS_DN
1.37994480221%	30	2174	310	T2D_GENES_TANYA_LIPIDS	HORIUCHI_WTAP_TARGETS_DN
1.37994480221%	30	2174	308	T2D_GENES_TANYA_LIPIDS	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
1.37994480221%	30	2174	293	T2D_GENES_TANYA_LIPIDS	ZHANG_TLX_TARGETS_60HR_UP
1.37994480221%	30	2174	281	T2D_GENES_TANYA_LIPIDS	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
1.37994480221%	30	2174	279	T2D_GENES_TANYA_LIPIDS	REACTOME_NEURONAL_SYSTEM
1.37994480221%	30	2174	267	T2D_GENES_TANYA_LIPIDS	HOLLMANN_APOPTOSIS_VIA_CD40_DN
1.37994480221%	30	2174	245	T2D_GENES_TANYA_LIPIDS	BLUM_RESPONSE_TO_SALIRASIB_UP
1.37994480221%	30	2174	241	T2D_GENES_TANYA_LIPIDS	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
1.37994480221%	30	2174	235	T2D_GENES_TANYA_LIPIDS	RUTELLA_RESPONSE_TO_HGF_DN
1.37994480221%	30	2174	226	T2D_GENES_TANYA_LIPIDS	KYNG_DNA_DAMAGE_UP
1.37994480221%	30	2174	225	T2D_GENES_TANYA_LIPIDS	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
1.37994480221%	30	2174	210	T2D_GENES_TANYA_LIPIDS	CAIRO_HEPATOBLASTOMA_CLASSES_DN
1.37994480221%	30	2174	206	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
1.37994480221%	30	2174	203	T2D_GENES_TANYA_LIPIDS	PENG_RAPAMYCIN_RESPONSE_UP
1.37994480221%	30	2174	173	T2D_GENES_TANYA_LIPIDS	SENGUPTA_EBNA1_ANTICORRELATED
1.37994480221%	30	2174	168	T2D_GENES_TANYA_LIPIDS	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
1.37994480221%	30	2174	133	T2D_GENES_TANYA_LIPIDS	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON
1.36869118905%	16	1169	940	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
1.36869118905%	16	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450
1.36869118905%	16	1169	652	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BENPORATH_PRC2_TARGETS
1.36869118905%	16	1169	648	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMID_BREAST_CANCER_BASAL_UP
1.36869118905%	16	1169	593	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARTINEZ_TP53_TARGETS_DN
1.36869118905%	16	1169	584	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
1.36869118905%	16	1169	548	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_ALL_DISORDERS_CALB1_CORR_UP
1.36869118905%	16	1169	535	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STEIN_ESRRA_TARGETS
1.36869118905%	16	1169	516	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
1.36869118905%	16	1169	491	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHENG_BOUND_BY_FOXP3
1.36869118905%	16	1169	462	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DELACROIX_RAR_BOUND_ES
1.36869118905%	16	1169	459	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_WT1_TARGETS_DN
1.36869118905%	16	1169	418	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RUTELLA_RESPONSE_TO_HGF_UP
1.36869118905%	16	1169	395	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HAN_SATB1_TARGETS_UP
1.36869118905%	16	1169	387	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHYLA_CBFA2T3_TARGETS_UP
1.36869118905%	16	1169	341	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MULLIGHAN_NPM1_SIGNATURE_3_UP
1.36869118905%	16	1169	337	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PENG_GLUTAMINE_DEPRIVATION_DN
1.36869118905%	16	1169	318	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAZARD_RESPONSE_TO_UV_NHEK_DN
1.36869118905%	16	1169	295	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LU_EZH2_TARGETS_UP
1.36869118905%	16	1169	276	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
1.36869118905%	16	1169	261	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
1.36869118905%	16	1169	253	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCLACHLAN_DENTAL_CARIES_UP
1.36869118905%	16	1169	240	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_20HR_UP
1.36869118905%	16	1169	194	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KASLER_HDAC7_TARGETS_1_UP
1.36869118905%	16	1169	189	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BURTON_ADIPOGENESIS_6
1.36778115502%	27	1974	79	Mendelian_Nancy_Cox	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT
1.36778115502%	27	1974	78	Mendelian_Nancy_Cox	KEGG_PEROXISOME
1.36778115502%	27	1974	71	Mendelian_Nancy_Cox	GU_PDEF_TARGETS_UP
1.36778115502%	27	1974	62	Mendelian_Nancy_Cox	KEGG_COLORECTAL_CANCER
1.36778115502%	27	1974	46	Mendelian_Nancy_Cox	PID_SYNDECAN_1_PATHWAY
1.36778115502%	27	1974	352	Mendelian_Nancy_Cox	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
1.36778115502%	27	1974	307	Mendelian_Nancy_Cox	LI_INDUCED_T_TO_NATURAL_KILLER_UP
1.36778115502%	27	1974	240	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_20HR_UP
1.36778115502%	27	1974	227	Mendelian_Nancy_Cox	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
1.36778115502%	27	1974	225	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_16HR_UP
1.36778115502%	27	1974	214	Mendelian_Nancy_Cox	ZWANG_EGF_INTERVAL_DN
1.36778115502%	27	1974	209	Mendelian_Nancy_Cox	CHANG_CORE_SERUM_RESPONSE_DN
1.36778115502%	27	1974	206	Mendelian_Nancy_Cox	RAMALHO_STEMNESS_UP
1.36778115502%	27	1974	205	Mendelian_Nancy_Cox	SHEPARD_BMYB_MORPHOLINO_UP
1.36778115502%	27	1974	190	Mendelian_Nancy_Cox	KEGG_CHEMOKINE_SIGNALING_PATHWAY
1.36778115502%	27	1974	186	Mendelian_Nancy_Cox	HAMAI_APOPTOSIS_VIA_TRAIL_DN
1.36778115502%	27	1974	176	Mendelian_Nancy_Cox	SASAKI_ADULT_T_CELL_LEUKEMIA
1.36778115502%	27	1974	169	Mendelian_Nancy_Cox	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
1.36778115502%	27	1974	163	Mendelian_Nancy_Cox	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
1.36778115502%	27	1974	156	Mendelian_Nancy_Cox	GROSS_HYPOXIA_VIA_ELK3_DN
1.36778115502%	27	1974	152	Mendelian_Nancy_Cox	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
1.36778115502%	27	1974	146	Mendelian_Nancy_Cox	PECE_MAMMARY_STEM_CELL_DN
1.36778115502%	27	1974	138	Mendelian_Nancy_Cox	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
1.36778115502%	27	1974	134	Mendelian_Nancy_Cox	KEGG_TIGHT_JUNCTION
1.36778115502%	27	1974	116	Mendelian_Nancy_Cox	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
1.36778115502%	27	1974	115	Mendelian_Nancy_Cox	MARKEY_RB1_CHRONIC_LOF_UP
1.36778115502%	27	1974	100	Mendelian_Nancy_Cox	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
1.36363636364%	48	3520	805	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GPCR_DOWNSTREAM_SIGNALING
1.36363636364%	48	3520	579	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
1.36363636364%	48	3520	548	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_ALL_DISORDERS_CALB1_CORR_UP
1.36363636364%	48	3520	483	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
1.36363636364%	48	3520	475	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
1.36363636364%	48	3520	467	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RATTENBACHER_BOUND_BY_CELF1
1.36363636364%	48	3520	448	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
1.36363636364%	48	3520	431	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARY_CD5_TARGETS_DN
1.36363636364%	48	3520	293	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ENK_UV_RESPONSE_EPIDERMIS_UP
1.36363636364%	48	3520	244	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HSIAO_LIVER_SPECIFIC_GENES
1.36157337368%	9	661	97	T2D_GENES_TANYA_GLYCEMIC	KONG_E2F3_TARGETS
1.36157337368%	9	661	71	T2D_GENES_TANYA_GLYCEMIC	GEORGANTAS_HSC_MARKERS
1.36157337368%	9	661	485	T2D_GENES_TANYA_GLYCEMIC	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
1.36157337368%	9	661	434	T2D_GENES_TANYA_GLYCEMIC	BAELDE_DIABETIC_NEPHROPATHY_DN
1.36157337368%	9	661	430	T2D_GENES_TANYA_GLYCEMIC	JOHNSTONE_PARVB_TARGETS_3_UP
1.36157337368%	9	661	43	T2D_GENES_TANYA_GLYCEMIC	LASTOWSKA_COAMPLIFIED_WITH_MYCN
1.36157337368%	9	661	425	T2D_GENES_TANYA_GLYCEMIC	ZHANG_BREAST_CANCER_PROGENITORS_UP
1.36157337368%	9	661	418	T2D_GENES_TANYA_GLYCEMIC	PEDRIOLI_MIR31_TARGETS_DN
1.36157337368%	9	661	408	T2D_GENES_TANYA_GLYCEMIC	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
1.36157337368%	9	661	374	T2D_GENES_TANYA_GLYCEMIC	WANG_TUMOR_INVASIVENESS_UP
1.36157337368%	9	661	372	T2D_GENES_TANYA_GLYCEMIC	WANG_LMO4_TARGETS_UP
1.36157337368%	9	661	367	T2D_GENES_TANYA_GLYCEMIC	VECCHI_GASTRIC_CANCER_EARLY_DN
1.36157337368%	9	661	355	T2D_GENES_TANYA_GLYCEMIC	PEREZ_TP63_TARGETS
1.36157337368%	9	661	351	T2D_GENES_TANYA_GLYCEMIC	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
1.36157337368%	9	661	349	T2D_GENES_TANYA_GLYCEMIC	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
1.36157337368%	9	661	321	T2D_GENES_TANYA_GLYCEMIC	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
1.36157337368%	9	661	320	T2D_GENES_TANYA_GLYCEMIC	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
1.36157337368%	9	661	315	T2D_GENES_TANYA_GLYCEMIC	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
1.36157337368%	9	661	314	T2D_GENES_TANYA_GLYCEMIC	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
1.36157337368%	9	661	310	T2D_GENES_TANYA_GLYCEMIC	HORIUCHI_WTAP_TARGETS_DN
1.36157337368%	9	661	296	T2D_GENES_TANYA_GLYCEMIC	DURAND_STROMA_MAX_UP
1.36157337368%	9	661	291	T2D_GENES_TANYA_GLYCEMIC	SABATES_COLORECTAL_ADENOMA_DN
1.36157337368%	9	661	289	T2D_GENES_TANYA_GLYCEMIC	WANG_MLL_TARGETS
1.36157337368%	9	661	289	T2D_GENES_TANYA_GLYCEMIC	GABRIELY_MIR21_TARGETS
1.36157337368%	9	661	288	T2D_GENES_TANYA_GLYCEMIC	POOLA_INVASIVE_BREAST_CANCER_UP
1.36157337368%	9	661	282	T2D_GENES_TANYA_GLYCEMIC	HELLER_SILENCED_BY_METHYLATION_UP
1.36157337368%	9	661	279	T2D_GENES_TANYA_GLYCEMIC	FORTSCHEGGER_PHF8_TARGETS_UP
1.36157337368%	9	661	277	T2D_GENES_TANYA_GLYCEMIC	ZHANG_TLX_TARGETS_60HR_DN
1.36157337368%	9	661	274	T2D_GENES_TANYA_GLYCEMIC	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
1.36157337368%	9	661	271	T2D_GENES_TANYA_GLYCEMIC	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
1.36157337368%	9	661	270	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
1.36157337368%	9	661	269	T2D_GENES_TANYA_GLYCEMIC	WANG_CLIM2_TARGETS_UP
1.36157337368%	9	661	267	T2D_GENES_TANYA_GLYCEMIC	CAIRO_HEPATOBLASTOMA_DN
1.36157337368%	9	661	264	T2D_GENES_TANYA_GLYCEMIC	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
1.36157337368%	9	661	256	T2D_GENES_TANYA_GLYCEMIC	ONDER_CDH1_TARGETS_2_UP
1.36157337368%	9	661	253	T2D_GENES_TANYA_GLYCEMIC	DANG_REGULATED_BY_MYC_DN
1.36157337368%	9	661	251	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
1.36157337368%	9	661	244	T2D_GENES_TANYA_GLYCEMIC	KAYO_AGING_MUSCLE_UP
1.36157337368%	9	661	244	T2D_GENES_TANYA_GLYCEMIC	DAZARD_RESPONSE_TO_UV_NHEK_UP
1.36157337368%	9	661	239	T2D_GENES_TANYA_GLYCEMIC	ALFANO_MYC_TARGETS
1.36157337368%	9	661	234	T2D_GENES_TANYA_GLYCEMIC	AFFAR_YY1_TARGETS_DN
1.36157337368%	9	661	229	T2D_GENES_TANYA_GLYCEMIC	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
1.36157337368%	9	661	217	T2D_GENES_TANYA_GLYCEMIC	AMUNDSON_RESPONSE_TO_ARSENITE
1.36157337368%	9	661	214	T2D_GENES_TANYA_GLYCEMIC	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
1.36157337368%	9	661	212	T2D_GENES_TANYA_GLYCEMIC	SANSOM_APC_TARGETS
1.36157337368%	9	661	210	T2D_GENES_TANYA_GLYCEMIC	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
1.36157337368%	9	661	207	T2D_GENES_TANYA_GLYCEMIC	VERHAAK_GLIOBLASTOMA_CLASSICAL
1.36157337368%	9	661	207	T2D_GENES_TANYA_GLYCEMIC	CAIRO_HEPATOBLASTOMA_UP
1.36157337368%	9	661	202	T2D_GENES_TANYA_GLYCEMIC	FUJII_YBX1_TARGETS_DN
1.36157337368%	9	661	201	T2D_GENES_TANYA_GLYCEMIC	KIM_MYC_AMPLIFICATION_TARGETS_UP
1.36157337368%	9	661	197	T2D_GENES_TANYA_GLYCEMIC	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
1.36157337368%	9	661	188	T2D_GENES_TANYA_GLYCEMIC	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
1.36157337368%	9	661	184	T2D_GENES_TANYA_GLYCEMIC	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
1.36157337368%	9	661	180	T2D_GENES_TANYA_GLYCEMIC	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
1.36157337368%	9	661	178	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_18HR_DN
1.36157337368%	9	661	177	T2D_GENES_TANYA_GLYCEMIC	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
1.36157337368%	9	661	175	T2D_GENES_TANYA_GLYCEMIC	FIRESTEIN_PROLIFERATION
1.36157337368%	9	661	173	T2D_GENES_TANYA_GLYCEMIC	SENGUPTA_EBNA1_ANTICORRELATED
1.36157337368%	9	661	159	T2D_GENES_TANYA_GLYCEMIC	KEGG_PURINE_METABOLISM
1.36157337368%	9	661	145	T2D_GENES_TANYA_GLYCEMIC	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
1.36157337368%	9	661	128	T2D_GENES_TANYA_GLYCEMIC	ZHU_CMV_ALL_DN
1.36157337368%	9	661	128	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_MEF_LCP_WITH_H3K4ME3
1.36157337368%	9	661	127	T2D_GENES_TANYA_GLYCEMIC	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
1.36157337368%	9	661	120	T2D_GENES_TANYA_GLYCEMIC	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN
1.36157337368%	9	661	115	T2D_GENES_TANYA_GLYCEMIC	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
1.34529147982%	6	446	652	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BENPORATH_PRC2_TARGETS
1.34529147982%	6	446	593	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARTINEZ_TP53_TARGETS_DN
1.34529147982%	6	446	584	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
1.34529147982%	6	446	552	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP
1.34529147982%	6	446	539	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
1.34529147982%	6	446	518	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_METABOLISM_OF_PROTEINS
1.34529147982%	6	446	475	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
1.34529147982%	6	446	466	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_HEMOSTASIS
1.34529147982%	6	446	457	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
1.34529147982%	6	446	455	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
1.34529147982%	6	446	434	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BAELDE_DIABETIC_NEPHROPATHY_DN
1.34529147982%	6	446	431	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
1.34529147982%	6	446	430	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VECCHI_GASTRIC_CANCER_EARLY_UP
1.34529147982%	6	446	430	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JOHNSTONE_PARVB_TARGETS_3_UP
1.34529147982%	6	446	428	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
1.34529147982%	6	446	425	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
1.34529147982%	6	446	412	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
1.34529147982%	6	446	408	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
1.34529147982%	6	446	403	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
1.34529147982%	6	446	395	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HAN_SATB1_TARGETS_UP
1.34529147982%	6	446	394	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BERENJENO_TRANSFORMED_BY_RHOA_DN
1.34529147982%	6	446	389	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HSIAO_HOUSEKEEPING_GENES
1.34529147982%	6	446	387	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHYLA_CBFA2T3_TARGETS_UP
1.34529147982%	6	446	384	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
1.34529147982%	6	446	380	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MULLIGHAN_MLL_SIGNATURE_1_UP
1.34529147982%	6	446	368	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAGI_AML_WITH_T_8_21_TRANSLOCATION
1.34529147982%	6	446	358	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRUETZMANN_PANCREATIC_CANCER_UP
1.34529147982%	6	446	354	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
1.34529147982%	6	446	337	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PHONG_TNF_RESPONSE_NOT_VIA_P38
1.34529147982%	6	446	320	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
1.34529147982%	6	446	317	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HELLER_HDAC_TARGETS_UP
1.34529147982%	6	446	309	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIU_SOX4_TARGETS_DN
1.34529147982%	6	446	309	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
1.34529147982%	6	446	302	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
1.34529147982%	6	446	271	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
1.34529147982%	6	446	267	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOLLMANN_APOPTOSIS_VIA_CD40_DN
1.34529147982%	6	446	266	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ROZANOV_MMP14_TARGETS_UP
1.34529147982%	6	446	261	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RICKMAN_METASTASIS_DN
1.34529147982%	6	446	261	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
1.34529147982%	6	446	250	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
1.34529147982%	6	446	247	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_METABOLISM_OF_CARBOHYDRATES
1.34529147982%	6	446	240	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_20HR_UP
1.34529147982%	6	446	228	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
1.34529147982%	6	446	206	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LINSLEY_MIR16_TARGETS
1.34529147982%	6	446	193	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
1.34529147982%	6	446	183	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VERHAAK_AML_WITH_NPM1_MUTATED_UP
1.34529147982%	6	446	175	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FIRESTEIN_PROLIFERATION
1.34529147982%	6	446	168	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PUJANA_XPRSS_INT_NETWORK
1.34529147982%	6	446	163	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
1.34529147982%	6	446	162	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WHITFIELD_CELL_CYCLE_S
1.34529147982%	6	446	146	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_ALL_DISORDERS_DURATION_CORR_DN
1.34529147982%	6	446	145	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
1.34529147982%	6	446	140	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
1.34529147982%	6	446	130	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAGI_AML_WITH_T_9_11_TRANSLOCATION
1.34529147982%	6	446	129	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_PDGFRBPATHWAY
1.33963750985%	17	1269	734	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BENPORATH_SOX2_TARGETS
1.33963750985%	17	1269	591	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARTINEZ_RB1_AND_TP53_TARGETS_DN
1.33963750985%	17	1269	564	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMID_BREAST_CANCER_LUMINAL_B_DN
1.33963750985%	17	1269	548	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_ALL_DISORDERS_CALB1_CORR_UP
1.33963750985%	17	1269	546	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WEST_ADRENOCORTICAL_TUMOR_DN
1.33963750985%	17	1269	532	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
1.33963750985%	17	1269	530	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ENK_UV_RESPONSE_KERATINOCYTE_UP
1.33963750985%	17	1269	501	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SENESE_HDAC3_TARGETS_UP
1.33963750985%	17	1269	491	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MEISSNER_NPC_HCP_WITH_H3K4ME2
1.33963750985%	17	1269	476	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMID_BREAST_CANCER_NORMAL_LIKE_UP
1.33963750985%	17	1269	475	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
1.33963750985%	17	1269	463	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
1.33963750985%	17	1269	457	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SENESE_HDAC1_TARGETS_UP
1.33963750985%	17	1269	442	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HAN_SATB1_TARGETS_DN
1.33963750985%	17	1269	384	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
1.33963750985%	17	1269	380	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAIRKEE_TERT_TARGETS_UP
1.3361838589%	25	1871	464	T2D_GENES_TANYA_HEIGHT	ONDER_CDH1_TARGETS_2_DN
1.3361838589%	25	1871	314	T2D_GENES_TANYA_HEIGHT	DOUGLAS_BMI1_TARGETS_DN
1.3361838589%	25	1871	299	T2D_GENES_TANYA_HEIGHT	MUELLER_PLURINET
1.3361838589%	25	1871	293	T2D_GENES_TANYA_HEIGHT	IVANOVA_HEMATOPOIESIS_MATURE_CELL
1.3361838589%	25	1871	283	T2D_GENES_TANYA_HEIGHT	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
1.3361838589%	25	1871	281	T2D_GENES_TANYA_HEIGHT	MULLIGHAN_MLL_SIGNATURE_2_DN
1.3361838589%	25	1871	279	T2D_GENES_TANYA_HEIGHT	FORTSCHEGGER_PHF8_TARGETS_UP
1.3361838589%	25	1871	269	T2D_GENES_TANYA_HEIGHT	WANG_CLIM2_TARGETS_UP
1.3361838589%	25	1871	267	T2D_GENES_TANYA_HEIGHT	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
1.3361838589%	25	1871	266	T2D_GENES_TANYA_HEIGHT	ROZANOV_MMP14_TARGETS_UP
1.3361838589%	25	1871	266	T2D_GENES_TANYA_HEIGHT	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
1.3361838589%	25	1871	262	T2D_GENES_TANYA_HEIGHT	LU_AGING_BRAIN_UP
1.3361838589%	25	1871	261	T2D_GENES_TANYA_HEIGHT	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
1.3361838589%	25	1871	261	T2D_GENES_TANYA_HEIGHT	RICKMAN_METASTASIS_DN
1.3361838589%	25	1871	256	T2D_GENES_TANYA_HEIGHT	ONDER_CDH1_TARGETS_2_UP
1.3361838589%	25	1871	254	T2D_GENES_TANYA_HEIGHT	IVANOVA_HEMATOPOIESIS_STEM_CELL
1.3361838589%	25	1871	244	T2D_GENES_TANYA_HEIGHT	KAYO_AGING_MUSCLE_UP
1.3361838589%	25	1871	232	T2D_GENES_TANYA_HEIGHT	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
1.3361838589%	25	1871	228	T2D_GENES_TANYA_HEIGHT	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
1.3361838589%	25	1871	227	T2D_GENES_TANYA_HEIGHT	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
1.3361838589%	25	1871	214	T2D_GENES_TANYA_HEIGHT	AFFAR_YY1_TARGETS_UP
1.3361838589%	25	1871	209	T2D_GENES_TANYA_HEIGHT	CHANG_CORE_SERUM_RESPONSE_DN
1.3361838589%	25	1871	207	T2D_GENES_TANYA_HEIGHT	MANALO_HYPOXIA_UP
1.3361838589%	25	1871	207	T2D_GENES_TANYA_HEIGHT	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
1.3361838589%	25	1871	205	T2D_GENES_TANYA_HEIGHT	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
1.3361838589%	25	1871	205	T2D_GENES_TANYA_HEIGHT	PEREZ_TP53_AND_TP63_TARGETS
1.3361838589%	25	1871	194	T2D_GENES_TANYA_HEIGHT	KASLER_HDAC7_TARGETS_1_UP
1.3361838589%	25	1871	188	T2D_GENES_TANYA_HEIGHT	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
1.3361838589%	25	1871	162	T2D_GENES_TANYA_HEIGHT	WHITFIELD_CELL_CYCLE_S
1.33522727273%	47	3520	572	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHICAS_RB1_TARGETS_SENESCENT
1.33522727273%	47	3520	516	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
1.33522727273%	47	3520	456	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
1.33522727273%	47	3520	414	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOHANKUMAR_TLX1_TARGETS_UP
1.33522727273%	47	3520	387	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHYLA_CBFA2T3_TARGETS_UP
1.33522727273%	47	3520	382	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
1.33522727273%	47	3520	380	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MULLIGHAN_MLL_SIGNATURE_1_UP
1.33522727273%	47	3520	378	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
1.33522727273%	47	3520	140	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
1.33394664213%	29	2174	518	T2D_GENES_TANYA_LIPIDS	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
1.33394664213%	29	2174	367	T2D_GENES_TANYA_LIPIDS	VECCHI_GASTRIC_CANCER_EARLY_DN
1.33394664213%	29	2174	342	T2D_GENES_TANYA_LIPIDS	BLUM_RESPONSE_TO_SALIRASIB_DN
1.33394664213%	29	2174	321	T2D_GENES_TANYA_LIPIDS	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
1.33394664213%	29	2174	318	T2D_GENES_TANYA_LIPIDS	DAZARD_RESPONSE_TO_UV_NHEK_DN
1.33394664213%	29	2174	306	T2D_GENES_TANYA_LIPIDS	CHANDRAN_METASTASIS_DN
1.33394664213%	29	2174	285	T2D_GENES_TANYA_LIPIDS	GRADE_COLON_AND_RECTAL_CANCER_UP
1.33394664213%	29	2174	276	T2D_GENES_TANYA_LIPIDS	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
1.33394664213%	29	2174	269	T2D_GENES_TANYA_LIPIDS	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
1.33394664213%	29	2174	260	T2D_GENES_TANYA_LIPIDS	BOQUEST_STEM_CELL_UP
1.33394664213%	29	2174	251	T2D_GENES_TANYA_LIPIDS	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
1.33394664213%	29	2174	242	T2D_GENES_TANYA_LIPIDS	WINTER_HYPOXIA_METAGENE
1.33394664213%	29	2174	242	T2D_GENES_TANYA_LIPIDS	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
1.33394664213%	29	2174	238	T2D_GENES_TANYA_LIPIDS	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
1.33394664213%	29	2174	236	T2D_GENES_TANYA_LIPIDS	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
1.33394664213%	29	2174	227	T2D_GENES_TANYA_LIPIDS	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
1.33394664213%	29	2174	221	T2D_GENES_TANYA_LIPIDS	ZHANG_TLX_TARGETS_36HR_UP
1.33394664213%	29	2174	216	T2D_GENES_TANYA_LIPIDS	BOQUEST_STEM_CELL_DN
1.33394664213%	29	2174	215	T2D_GENES_TANYA_LIPIDS	MARKEY_RB1_ACUTE_LOF_UP
1.33394664213%	29	2174	214	T2D_GENES_TANYA_LIPIDS	AFFAR_YY1_TARGETS_UP
1.31868131868%	6	455	93	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_REGULATION_OF_INSULIN_SECRETION
1.31868131868%	6	455	90	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_GAP_JUNCTION
1.31868131868%	6	455	89	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION
1.31868131868%	6	455	89	T2D_GENES_TANYA_BLOODPRESSURE	BHATTACHARYA_EMBRYONIC_STEM_CELL
1.31868131868%	6	455	88	T2D_GENES_TANYA_BLOODPRESSURE	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
1.31868131868%	6	455	88	T2D_GENES_TANYA_BLOODPRESSURE	DURCHDEWALD_SKIN_CARCINOGENESIS_UP
1.31868131868%	6	455	83	T2D_GENES_TANYA_BLOODPRESSURE	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
1.31868131868%	6	455	75	T2D_GENES_TANYA_BLOODPRESSURE	MCCLUNG_COCAIN_REWARD_4WK
1.31868131868%	6	455	74	T2D_GENES_TANYA_BLOODPRESSURE	JI_RESPONSE_TO_FSH_UP
1.31868131868%	6	455	71	T2D_GENES_TANYA_BLOODPRESSURE	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
1.31868131868%	6	455	70	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS
1.31868131868%	6	455	64	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_UP
1.31868131868%	6	455	567	T2D_GENES_TANYA_BLOODPRESSURE	CHICAS_RB1_TARGETS_CONFLUENT
1.31868131868%	6	455	553	T2D_GENES_TANYA_BLOODPRESSURE	FEVR_CTNNB1_TARGETS_DN
1.31868131868%	6	455	55	T2D_GENES_TANYA_BLOODPRESSURE	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
1.31868131868%	6	455	54	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_APOPTOTIC_EXECUTION_PHASE
1.31868131868%	6	455	473	T2D_GENES_TANYA_BLOODPRESSURE	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
1.31868131868%	6	455	469	T2D_GENES_TANYA_BLOODPRESSURE	MCCABE_BOUND_BY_HOXC6
1.31868131868%	6	455	460	T2D_GENES_TANYA_BLOODPRESSURE	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
1.31868131868%	6	455	442	T2D_GENES_TANYA_BLOODPRESSURE	HAN_SATB1_TARGETS_DN
1.31868131868%	6	455	425	T2D_GENES_TANYA_BLOODPRESSURE	ZHANG_BREAST_CANCER_PROGENITORS_UP
1.31868131868%	6	455	422	T2D_GENES_TANYA_BLOODPRESSURE	YAGI_AML_WITH_INV_16_TRANSLOCATION
1.31868131868%	6	455	409	T2D_GENES_TANYA_BLOODPRESSURE	FOSTER_TOLERANT_MACROPHAGE_DN
1.31868131868%	6	455	382	T2D_GENES_TANYA_BLOODPRESSURE	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
1.31868131868%	6	455	380	T2D_GENES_TANYA_BLOODPRESSURE	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
1.31868131868%	6	455	364	T2D_GENES_TANYA_BLOODPRESSURE	YANG_BCL3_TARGETS_UP
1.31868131868%	6	455	362	T2D_GENES_TANYA_BLOODPRESSURE	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
1.31868131868%	6	455	335	T2D_GENES_TANYA_BLOODPRESSURE	WONG_EMBRYONIC_STEM_CELL_CORE
1.31868131868%	6	455	330	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_METABOLISM_OF_RNA
1.31868131868%	6	455	325	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CELL_CYCLE_MITOTIC
1.31868131868%	6	455	321	T2D_GENES_TANYA_BLOODPRESSURE	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
1.31868131868%	6	455	317	T2D_GENES_TANYA_BLOODPRESSURE	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
1.31868131868%	6	455	309	T2D_GENES_TANYA_BLOODPRESSURE	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
1.31868131868%	6	455	308	T2D_GENES_TANYA_BLOODPRESSURE	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
1.31868131868%	6	455	299	T2D_GENES_TANYA_BLOODPRESSURE	WALLACE_PROSTATE_CANCER_RACE_UP
1.31868131868%	6	455	289	T2D_GENES_TANYA_BLOODPRESSURE	MANALO_HYPOXIA_DN
1.31868131868%	6	455	287	T2D_GENES_TANYA_BLOODPRESSURE	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
1.31868131868%	6	455	285	T2D_GENES_TANYA_BLOODPRESSURE	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
1.31868131868%	6	455	284	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_METABOLISM_OF_MRNA
1.31868131868%	6	455	280	T2D_GENES_TANYA_BLOODPRESSURE	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
1.31868131868%	6	455	277	T2D_GENES_TANYA_BLOODPRESSURE	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
1.31868131868%	6	455	276	T2D_GENES_TANYA_BLOODPRESSURE	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
1.31868131868%	6	455	267	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
1.31868131868%	6	455	266	T2D_GENES_TANYA_BLOODPRESSURE	ROZANOV_MMP14_TARGETS_UP
1.31868131868%	6	455	266	T2D_GENES_TANYA_BLOODPRESSURE	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
1.31868131868%	6	455	261	T2D_GENES_TANYA_BLOODPRESSURE	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
1.31868131868%	6	455	258	T2D_GENES_TANYA_BLOODPRESSURE	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
1.31868131868%	6	455	245	T2D_GENES_TANYA_BLOODPRESSURE	PENG_RAPAMYCIN_RESPONSE_DN
1.31868131868%	6	455	244	T2D_GENES_TANYA_BLOODPRESSURE	HSIAO_LIVER_SPECIFIC_GENES
1.31868131868%	6	455	241	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
1.31868131868%	6	455	240	T2D_GENES_TANYA_BLOODPRESSURE	VANTVEER_BREAST_CANCER_ESR1_DN
1.31868131868%	6	455	238	T2D_GENES_TANYA_BLOODPRESSURE	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
1.31868131868%	6	455	229	T2D_GENES_TANYA_BLOODPRESSURE	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
1.31868131868%	6	455	227	T2D_GENES_TANYA_BLOODPRESSURE	RAO_BOUND_BY_SALL4
1.31868131868%	6	455	227	T2D_GENES_TANYA_BLOODPRESSURE	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
1.31868131868%	6	455	222	T2D_GENES_TANYA_BLOODPRESSURE	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
1.31868131868%	6	455	215	T2D_GENES_TANYA_BLOODPRESSURE	YAMAZAKI_TCEB3_TARGETS_DN
1.31868131868%	6	455	214	T2D_GENES_TANYA_BLOODPRESSURE	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
1.31868131868%	6	455	214	T2D_GENES_TANYA_BLOODPRESSURE	AFFAR_YY1_TARGETS_UP
1.31868131868%	6	455	211	T2D_GENES_TANYA_BLOODPRESSURE	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
1.31868131868%	6	455	210	T2D_GENES_TANYA_BLOODPRESSURE	RIZKI_TUMOR_INVASIVENESS_3D_UP
1.31868131868%	6	455	207	T2D_GENES_TANYA_BLOODPRESSURE	MANALO_HYPOXIA_UP
1.31868131868%	6	455	207	T2D_GENES_TANYA_BLOODPRESSURE	CAIRO_HEPATOBLASTOMA_UP
1.31868131868%	6	455	203	T2D_GENES_TANYA_BLOODPRESSURE	PENG_RAPAMYCIN_RESPONSE_UP
1.31868131868%	6	455	203	T2D_GENES_TANYA_BLOODPRESSURE	PAL_PRMT5_TARGETS_UP
1.31868131868%	6	455	199	T2D_GENES_TANYA_BLOODPRESSURE	PLASARI_TGFB1_TARGETS_10HR_UP
1.31868131868%	6	455	198	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PHOSPHOLIPID_METABOLISM
1.31868131868%	6	455	198	T2D_GENES_TANYA_BLOODPRESSURE	ALONSO_METASTASIS_UP
1.31868131868%	6	455	194	T2D_GENES_TANYA_BLOODPRESSURE	KASLER_HDAC7_TARGETS_1_UP
1.31868131868%	6	455	191	T2D_GENES_TANYA_BLOODPRESSURE	YAGI_AML_FAB_MARKERS
1.31868131868%	6	455	185	T2D_GENES_TANYA_BLOODPRESSURE	ZHANG_TLX_TARGETS_36HR_DN
1.31868131868%	6	455	182	T2D_GENES_TANYA_BLOODPRESSURE	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
1.31868131868%	6	455	180	T2D_GENES_TANYA_BLOODPRESSURE	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
1.31868131868%	6	455	178	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_CALCIUM_SIGNALING_PATHWAY
1.31868131868%	6	455	174	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
1.31868131868%	6	455	173	T2D_GENES_TANYA_BLOODPRESSURE	SENGUPTA_EBNA1_ANTICORRELATED
1.31868131868%	6	455	172	T2D_GENES_TANYA_BLOODPRESSURE	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
1.31868131868%	6	455	169	T2D_GENES_TANYA_BLOODPRESSURE	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
1.31868131868%	6	455	169	T2D_GENES_TANYA_BLOODPRESSURE	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
1.31868131868%	6	455	164	T2D_GENES_TANYA_BLOODPRESSURE	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
1.31868131868%	6	455	163	T2D_GENES_TANYA_BLOODPRESSURE	SERVITJA_ISLET_HNF1A_TARGETS_UP
1.31868131868%	6	455	162	T2D_GENES_TANYA_BLOODPRESSURE	MULLIGHAN_NPM1_SIGNATURE_3_DN
1.31868131868%	6	455	160	T2D_GENES_TANYA_BLOODPRESSURE	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
1.31868131868%	6	455	159	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_PURINE_METABOLISM
1.31868131868%	6	455	157	T2D_GENES_TANYA_BLOODPRESSURE	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
1.31868131868%	6	455	157	T2D_GENES_TANYA_BLOODPRESSURE	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
1.31868131868%	6	455	151	T2D_GENES_TANYA_BLOODPRESSURE	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
1.31868131868%	6	455	142	T2D_GENES_TANYA_BLOODPRESSURE	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
1.31868131868%	6	455	140	T2D_GENES_TANYA_BLOODPRESSURE	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
1.31868131868%	6	455	137	T2D_GENES_TANYA_BLOODPRESSURE	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
1.31868131868%	6	455	137	T2D_GENES_TANYA_BLOODPRESSURE	LIU_SOX4_TARGETS_UP
1.31868131868%	6	455	132	T2D_GENES_TANYA_BLOODPRESSURE	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
1.31868131868%	6	455	129	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MEMBRANE_TRAFFICKING
1.31868131868%	6	455	128	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_SPLICEOSOME
1.31868131868%	6	455	126	T2D_GENES_TANYA_BLOODPRESSURE	MISSIAGLIA_REGULATED_BY_METHYLATION_UP
1.31868131868%	6	455	126	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
1.31868131868%	6	455	120	T2D_GENES_TANYA_BLOODPRESSURE	XU_GH1_EXOGENOUS_TARGETS_DN
1.31868131868%	6	455	118	T2D_GENES_TANYA_BLOODPRESSURE	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
1.31868131868%	6	455	114	T2D_GENES_TANYA_BLOODPRESSURE	CERVERA_SDHB_TARGETS_2
1.31868131868%	6	455	110	T2D_GENES_TANYA_BLOODPRESSURE	SUNG_METASTASIS_STROMA_UP
1.31868131868%	6	455	105	T2D_GENES_TANYA_BLOODPRESSURE	STEIN_ESRRA_TARGETS_DN
1.31868131868%	6	455	103	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_NOTCH
1.31712259372%	26	1974	88	Mendelian_Nancy_Cox	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
1.31712259372%	26	1974	86	Mendelian_Nancy_Cox	KEGG_TGF_BETA_SIGNALING_PATHWAY
1.31712259372%	26	1974	84	Mendelian_Nancy_Cox	KEGG_SMALL_CELL_LUNG_CANCER
1.31712259372%	26	1974	74	Mendelian_Nancy_Cox	LEE_LIVER_CANCER_DENA_DN
1.31712259372%	26	1974	70	Mendelian_Nancy_Cox	PID_AP1_PATHWAY
1.31712259372%	26	1974	70	Mendelian_Nancy_Cox	KEGG_PANCREATIC_CANCER
1.31712259372%	26	1974	69	Mendelian_Nancy_Cox	REACTOME_GLUCOSE_METABOLISM
1.31712259372%	26	1974	245	Mendelian_Nancy_Cox	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
1.31712259372%	26	1974	222	Mendelian_Nancy_Cox	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
1.31712259372%	26	1974	211	Mendelian_Nancy_Cox	FOSTER_KDM1A_TARGETS_DN
1.31712259372%	26	1974	207	Mendelian_Nancy_Cox	VERHAAK_GLIOBLASTOMA_CLASSICAL
1.31712259372%	26	1974	200	Mendelian_Nancy_Cox	LEE_DIFFERENTIATING_T_LYMPHOCYTE
1.31712259372%	26	1974	194	Mendelian_Nancy_Cox	PROVENZANI_METASTASIS_UP
1.31712259372%	26	1974	194	Mendelian_Nancy_Cox	KASLER_HDAC7_TARGETS_1_UP
1.31712259372%	26	1974	182	Mendelian_Nancy_Cox	RAO_BOUND_BY_SALL4_ISOFORM_A
1.31712259372%	26	1974	182	Mendelian_Nancy_Cox	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
1.31712259372%	26	1974	181	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
1.31712259372%	26	1974	180	Mendelian_Nancy_Cox	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
1.31712259372%	26	1974	180	Mendelian_Nancy_Cox	DARWICHE_PAPILLOMA_RISK_HIGH_DN
1.31712259372%	26	1974	153	Mendelian_Nancy_Cox	RUIZ_TNC_TARGETS_UP
1.31712259372%	26	1974	148	Mendelian_Nancy_Cox	REACTOME_APOPTOSIS
1.31712259372%	26	1974	145	Mendelian_Nancy_Cox	SMITH_TERT_TARGETS_UP
1.31712259372%	26	1974	142	Mendelian_Nancy_Cox	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
1.31712259372%	26	1974	139	Mendelian_Nancy_Cox	REACTOME_BIOLOGICAL_OXIDATIONS
1.31712259372%	26	1974	137	Mendelian_Nancy_Cox	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
1.31712259372%	26	1974	135	Mendelian_Nancy_Cox	KEGG_OXIDATIVE_PHOSPHORYLATION
1.31712259372%	26	1974	133	Mendelian_Nancy_Cox	GAL_LEUKEMIC_STEM_CELL_UP
1.31712259372%	26	1974	130	Mendelian_Nancy_Cox	ELVIDGE_HYPOXIA_BY_DMOG_UP
1.31712259372%	26	1974	129	Mendelian_Nancy_Cox	YAGI_AML_SURVIVAL
1.31712259372%	26	1974	129	Mendelian_Nancy_Cox	PID_PDGFRBPATHWAY
1.31712259372%	26	1974	128	Mendelian_Nancy_Cox	LENAOUR_DENDRITIC_CELL_MATURATION_DN
1.31712259372%	26	1974	126	Mendelian_Nancy_Cox	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
1.31712259372%	26	1974	126	Mendelian_Nancy_Cox	BURTON_ADIPOGENESIS_5
1.31712259372%	26	1974	111	Mendelian_Nancy_Cox	REACTOME_GLYCOSAMINOGLYCAN_METABOLISM
1.31712259372%	26	1974	108	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
1.30681818182%	46	3520	508	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ENK_UV_RESPONSE_EPIDERMIS_DN
1.30681818182%	46	3520	501	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SENESE_HDAC3_TARGETS_UP
1.30681818182%	46	3520	447	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOOTHA_MITOCHONDRIA
1.30681818182%	46	3520	442	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HAN_SATB1_TARGETS_DN
1.30681818182%	46	3520	422	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAGI_AML_WITH_INV_16_TRANSLOCATION
1.30681818182%	46	3520	418	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_HGF_UP
1.30681818182%	46	3520	393	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
1.30681818182%	46	3520	390	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HATADA_METHYLATED_IN_LUNG_CANCER_UP
1.30681818182%	46	3520	368	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP
1.30681818182%	46	3520	274	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
1.30681818182%	46	3520	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRANSCRIPTION
1.30505709625%	8	613	58	T2D_GENES_TANYA_BIOMARKER	MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
1.30505709625%	8	613	483	T2D_GENES_TANYA_BIOMARKER	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
1.30505709625%	8	613	475	T2D_GENES_TANYA_BIOMARKER	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
1.30505709625%	8	613	473	T2D_GENES_TANYA_BIOMARKER	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
1.30505709625%	8	613	460	T2D_GENES_TANYA_BIOMARKER	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
1.30505709625%	8	613	455	T2D_GENES_TANYA_BIOMARKER	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
1.30505709625%	8	613	442	T2D_GENES_TANYA_BIOMARKER	HAN_SATB1_TARGETS_DN
1.30505709625%	8	613	435	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
1.30505709625%	8	613	424	T2D_GENES_TANYA_BIOMARKER	SHEN_SMARCA2_TARGETS_UP
1.30505709625%	8	613	398	T2D_GENES_TANYA_BIOMARKER	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
1.30505709625%	8	613	373	T2D_GENES_TANYA_BIOMARKER	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
1.30505709625%	8	613	372	T2D_GENES_TANYA_BIOMARKER	WANG_LMO4_TARGETS_UP
1.30505709625%	8	613	357	T2D_GENES_TANYA_BIOMARKER	SHEN_SMARCA2_TARGETS_DN
1.30505709625%	8	613	353	T2D_GENES_TANYA_BIOMARKER	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
1.30505709625%	8	613	351	T2D_GENES_TANYA_BIOMARKER	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
1.30505709625%	8	613	346	T2D_GENES_TANYA_BIOMARKER	GOLDRATH_ANTIGEN_RESPONSE
1.30505709625%	8	613	344	T2D_GENES_TANYA_BIOMARKER	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
1.30505709625%	8	613	336	T2D_GENES_TANYA_BIOMARKER	JOHNSTONE_PARVB_TARGETS_2_DN
1.30505709625%	8	613	332	T2D_GENES_TANYA_BIOMARKER	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
1.30505709625%	8	613	330	T2D_GENES_TANYA_BIOMARKER	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
1.30505709625%	8	613	312	T2D_GENES_TANYA_BIOMARKER	GENTILE_UV_HIGH_DOSE_DN
1.30505709625%	8	613	299	T2D_GENES_TANYA_BIOMARKER	MUELLER_PLURINET
1.30505709625%	8	613	290	T2D_GENES_TANYA_BIOMARKER	BASAKI_YBX1_TARGETS_UP
1.30505709625%	8	613	289	T2D_GENES_TANYA_BIOMARKER	WANG_MLL_TARGETS
1.30505709625%	8	613	289	T2D_GENES_TANYA_BIOMARKER	GABRIELY_MIR21_TARGETS
1.30505709625%	8	613	288	T2D_GENES_TANYA_BIOMARKER	POOLA_INVASIVE_BREAST_CANCER_UP
1.30505709625%	8	613	279	T2D_GENES_TANYA_BIOMARKER	REACTOME_INNATE_IMMUNE_SYSTEM
1.30505709625%	8	613	279	T2D_GENES_TANYA_BIOMARKER	FORTSCHEGGER_PHF8_TARGETS_UP
1.30505709625%	8	613	269	T2D_GENES_TANYA_BIOMARKER	WANG_CLIM2_TARGETS_UP
1.30505709625%	8	613	261	T2D_GENES_TANYA_BIOMARKER	RICKMAN_METASTASIS_DN
1.30505709625%	8	613	261	T2D_GENES_TANYA_BIOMARKER	BILD_HRAS_ONCOGENIC_SIGNATURE
1.30505709625%	8	613	258	T2D_GENES_TANYA_BIOMARKER	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
1.30505709625%	8	613	253	T2D_GENES_TANYA_BIOMARKER	MCLACHLAN_DENTAL_CARIES_UP
1.30505709625%	8	613	251	T2D_GENES_TANYA_BIOMARKER	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
1.30505709625%	8	613	246	T2D_GENES_TANYA_BIOMARKER	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
1.30505709625%	8	613	245	T2D_GENES_TANYA_BIOMARKER	BLUM_RESPONSE_TO_SALIRASIB_UP
1.30505709625%	8	613	244	T2D_GENES_TANYA_BIOMARKER	KAYO_AGING_MUSCLE_UP
1.30505709625%	8	613	238	T2D_GENES_TANYA_BIOMARKER	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
1.30505709625%	8	613	228	T2D_GENES_TANYA_BIOMARKER	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
1.30505709625%	8	613	221	T2D_GENES_TANYA_BIOMARKER	PEDRIOLI_MIR31_TARGETS_UP
1.30505709625%	8	613	217	T2D_GENES_TANYA_BIOMARKER	AMUNDSON_RESPONSE_TO_ARSENITE
1.30505709625%	8	613	214	T2D_GENES_TANYA_BIOMARKER	ZWANG_EGF_INTERVAL_DN
1.30505709625%	8	613	214	T2D_GENES_TANYA_BIOMARKER	KIM_WT1_TARGETS_UP
1.30505709625%	8	613	214	T2D_GENES_TANYA_BIOMARKER	AFFAR_YY1_TARGETS_UP
1.30505709625%	8	613	210	T2D_GENES_TANYA_BIOMARKER	VERHAAK_GLIOBLASTOMA_NEURAL
1.30505709625%	8	613	209	T2D_GENES_TANYA_BIOMARKER	CHANG_CORE_SERUM_RESPONSE_DN
1.30505709625%	8	613	207	T2D_GENES_TANYA_BIOMARKER	KARLSSON_TGFB1_TARGETS_DN
1.30505709625%	8	613	206	T2D_GENES_TANYA_BIOMARKER	BILD_MYC_ONCOGENIC_SIGNATURE
1.30505709625%	8	613	206	T2D_GENES_TANYA_BIOMARKER	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
1.30505709625%	8	613	187	T2D_GENES_TANYA_BIOMARKER	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
1.30505709625%	8	613	187	T2D_GENES_TANYA_BIOMARKER	PENG_LEUCINE_DEPRIVATION_DN
1.30505709625%	8	613	184	T2D_GENES_TANYA_BIOMARKER	DOANE_RESPONSE_TO_ANDROGEN_UP
1.30505709625%	8	613	176	T2D_GENES_TANYA_BIOMARKER	NAGASHIMA_NRG1_SIGNALING_UP
1.30505709625%	8	613	176	T2D_GENES_TANYA_BIOMARKER	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
1.30505709625%	8	613	175	T2D_GENES_TANYA_BIOMARKER	YAMAZAKI_TCEB3_TARGETS_UP
1.30505709625%	8	613	165	T2D_GENES_TANYA_BIOMARKER	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
1.30505709625%	8	613	165	T2D_GENES_TANYA_BIOMARKER	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
1.30505709625%	8	613	162	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
1.30505709625%	8	613	157	T2D_GENES_TANYA_BIOMARKER	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
1.30505709625%	8	613	152	T2D_GENES_TANYA_BIOMARKER	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
1.30505709625%	8	613	141	T2D_GENES_TANYA_BIOMARKER	WELCSH_BRCA1_TARGETS_DN
1.30505709625%	8	613	141	T2D_GENES_TANYA_BIOMARKER	SABATES_COLORECTAL_ADENOMA_UP
1.30505709625%	8	613	137	T2D_GENES_TANYA_BIOMARKER	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
1.30505709625%	8	613	134	T2D_GENES_TANYA_BIOMARKER	SCHLOSSER_SERUM_RESPONSE_UP
1.30505709625%	8	613	134	T2D_GENES_TANYA_BIOMARKER	POOLA_INVASIVE_BREAST_CANCER_DN
1.30505709625%	8	613	125	T2D_GENES_TANYA_BIOMARKER	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
1.30505709625%	8	613	121	T2D_GENES_TANYA_BIOMARKER	KEGG_LYSOSOME
1.30505709625%	8	613	113	T2D_GENES_TANYA_BIOMARKER	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
1.30468150422%	17	1303	584	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HAMAI_APOPTOSIS_VIA_TRAIL_UP
1.30468150422%	17	1303	572	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHICAS_RB1_TARGETS_SENESCENT
1.30468150422%	17	1303	544	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
1.30468150422%	17	1303	475	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MATSUDA_NATURAL_KILLER_DIFFERENTIATION
1.30468150422%	17	1303	428	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CUI_TCF21_TARGETS_2_UP
1.30468150422%	17	1303	411	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KOYAMA_SEMA3B_TARGETS_DN
1.30468150422%	17	1303	408	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
1.30468150422%	17	1303	408	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
1.30468150422%	17	1303	403	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
1.30468150422%	17	1303	393	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
1.30468150422%	17	1303	390	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HATADA_METHYLATED_IN_LUNG_CANCER_UP
1.30468150422%	17	1303	384	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
1.30468150422%	17	1303	330	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
1.30468150422%	17	1303	324	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
1.30468150422%	17	1303	316	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
1.30468150422%	17	1303	289	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MANALO_HYPOXIA_DN
1.29151291513%	7	542	90	T2D_GENES_TANYA_ANTHROPOMETRIC	SASSON_RESPONSE_TO_FORSKOLIN_UP
1.29151291513%	7	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
1.29151291513%	7	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
1.29151291513%	7	542	442	T2D_GENES_TANYA_ANTHROPOMETRIC	HAN_SATB1_TARGETS_DN
1.29151291513%	7	542	425	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHANG_BREAST_CANCER_PROGENITORS_UP
1.29151291513%	7	542	421	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CELL_CYCLE
1.29151291513%	7	542	384	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
1.29151291513%	7	542	374	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
1.29151291513%	7	542	344	T2D_GENES_TANYA_ANTHROPOMETRIC	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
1.29151291513%	7	542	342	T2D_GENES_TANYA_ANTHROPOMETRIC	BLUM_RESPONSE_TO_SALIRASIB_DN
1.29151291513%	7	542	329	T2D_GENES_TANYA_ANTHROPOMETRIC	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
1.29151291513%	7	542	321	T2D_GENES_TANYA_ANTHROPOMETRIC	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
1.29151291513%	7	542	315	T2D_GENES_TANYA_ANTHROPOMETRIC	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
1.29151291513%	7	542	314	T2D_GENES_TANYA_ANTHROPOMETRIC	DOUGLAS_BMI1_TARGETS_DN
1.29151291513%	7	542	309	T2D_GENES_TANYA_ANTHROPOMETRIC	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
1.29151291513%	7	542	307	T2D_GENES_TANYA_ANTHROPOMETRIC	LI_INDUCED_T_TO_NATURAL_KILLER_UP
1.29151291513%	7	542	305	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
1.29151291513%	7	542	281	T2D_GENES_TANYA_ANTHROPOMETRIC	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
1.29151291513%	7	542	280	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_SMARCE1_TARGETS_UP
1.29151291513%	7	542	261	T2D_GENES_TANYA_ANTHROPOMETRIC	BILD_HRAS_ONCOGENIC_SIGNATURE
1.29151291513%	7	542	259	T2D_GENES_TANYA_ANTHROPOMETRIC	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
1.29151291513%	7	542	254	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_4HR_DN
1.29151291513%	7	542	246	T2D_GENES_TANYA_ANTHROPOMETRIC	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
1.29151291513%	7	542	244	T2D_GENES_TANYA_ANTHROPOMETRIC	KAYO_AGING_MUSCLE_UP
1.29151291513%	7	542	244	T2D_GENES_TANYA_ANTHROPOMETRIC	HSIAO_LIVER_SPECIFIC_GENES
1.29151291513%	7	542	242	T2D_GENES_TANYA_ANTHROPOMETRIC	MULLIGHAN_MLL_SIGNATURE_1_DN
1.29151291513%	7	542	232	T2D_GENES_TANYA_ANTHROPOMETRIC	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
1.29151291513%	7	542	229	T2D_GENES_TANYA_ANTHROPOMETRIC	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
1.29151291513%	7	542	223	T2D_GENES_TANYA_ANTHROPOMETRIC	CHEN_HOXA5_TARGETS_9HR_UP
1.29151291513%	7	542	222	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRANSLATION
1.29151291513%	7	542	220	T2D_GENES_TANYA_ANTHROPOMETRIC	RIGGINS_TAMOXIFEN_RESISTANCE_DN
1.29151291513%	7	542	216	T2D_GENES_TANYA_ANTHROPOMETRIC	BOQUEST_STEM_CELL_DN
1.29151291513%	7	542	214	T2D_GENES_TANYA_ANTHROPOMETRIC	TIEN_INTESTINE_PROBIOTICS_24HR_DN
1.29151291513%	7	542	214	T2D_GENES_TANYA_ANTHROPOMETRIC	AFFAR_YY1_TARGETS_UP
1.29151291513%	7	542	211	T2D_GENES_TANYA_ANTHROPOMETRIC	FOSTER_KDM1A_TARGETS_DN
1.29151291513%	7	542	208	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
1.29151291513%	7	542	207	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_HIV_INFECTION
1.29151291513%	7	542	207	T2D_GENES_TANYA_ANTHROPOMETRIC	MANALO_HYPOXIA_UP
1.29151291513%	7	542	206	T2D_GENES_TANYA_ANTHROPOMETRIC	LINSLEY_MIR16_TARGETS
1.29151291513%	7	542	205	T2D_GENES_TANYA_ANTHROPOMETRIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
1.29151291513%	7	542	203	T2D_GENES_TANYA_ANTHROPOMETRIC	PAL_PRMT5_TARGETS_UP
1.29151291513%	7	542	198	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PHOSPHOLIPID_METABOLISM
1.29151291513%	7	542	195	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
1.29151291513%	7	542	186	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
1.29151291513%	7	542	186	T2D_GENES_TANYA_ANTHROPOMETRIC	HAMAI_APOPTOSIS_VIA_TRAIL_DN
1.29151291513%	7	542	185	T2D_GENES_TANYA_ANTHROPOMETRIC	DARWICHE_SKIN_TUMOR_PROMOTER_DN
1.29151291513%	7	542	182	T2D_GENES_TANYA_ANTHROPOMETRIC	RAO_BOUND_BY_SALL4_ISOFORM_A
1.29151291513%	7	542	181	T2D_GENES_TANYA_ANTHROPOMETRIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
1.29151291513%	7	542	180	T2D_GENES_TANYA_ANTHROPOMETRIC	DARWICHE_PAPILLOMA_RISK_HIGH_DN
1.29151291513%	7	542	180	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_48HR_UP
1.29151291513%	7	542	178	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_CALCIUM_SIGNALING_PATHWAY
1.29151291513%	7	542	171	T2D_GENES_TANYA_ANTHROPOMETRIC	GOLDRATH_HOMEOSTATIC_PROLIFERATION
1.29151291513%	7	542	169	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_ALZHEIMERS_DISEASE
1.29151291513%	7	542	168	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
1.29151291513%	7	542	166	T2D_GENES_TANYA_ANTHROPOMETRIC	SMIRNOV_RESPONSE_TO_IR_6HR_UP
1.29151291513%	7	542	164	T2D_GENES_TANYA_ANTHROPOMETRIC	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
1.29151291513%	7	542	157	T2D_GENES_TANYA_ANTHROPOMETRIC	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
1.29151291513%	7	542	153	T2D_GENES_TANYA_ANTHROPOMETRIC	DAZARD_UV_RESPONSE_CLUSTER_G6
1.29151291513%	7	542	153	T2D_GENES_TANYA_ANTHROPOMETRIC	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN
1.29151291513%	7	542	151	T2D_GENES_TANYA_ANTHROPOMETRIC	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
1.29151291513%	7	542	149	T2D_GENES_TANYA_ANTHROPOMETRIC	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
1.29151291513%	7	542	147	T2D_GENES_TANYA_ANTHROPOMETRIC	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
1.29151291513%	7	542	146	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_ALL_DISORDERS_DURATION_CORR_DN
1.29151291513%	7	542	142	T2D_GENES_TANYA_ANTHROPOMETRIC	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
1.29151291513%	7	542	139	T2D_GENES_TANYA_ANTHROPOMETRIC	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
1.29151291513%	7	542	137	T2D_GENES_TANYA_ANTHROPOMETRIC	LIU_SOX4_TARGETS_UP
1.29151291513%	7	542	128	T2D_GENES_TANYA_ANTHROPOMETRIC	YEGNASUBRAMANIAN_PROSTATE_CANCER
1.29151291513%	7	542	117	T2D_GENES_TANYA_ANTHROPOMETRIC	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
1.29151291513%	7	542	116	T2D_GENES_TANYA_ANTHROPOMETRIC	LIM_MAMMARY_LUMINAL_MATURE_UP
1.29151291513%	7	542	107	T2D_GENES_TANYA_ANTHROPOMETRIC	ROESSLER_LIVER_CANCER_METASTASIS_UP
1.29151291513%	7	542	104	T2D_GENES_TANYA_ANTHROPOMETRIC	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
1.28794848206%	28	2174	62	T2D_GENES_TANYA_LIPIDS	REACTOME_RNA_POL_I_PROMOTER_OPENING
1.28794848206%	28	2174	408	T2D_GENES_TANYA_LIPIDS	REACTOME_GPCR_LIGAND_BINDING
1.28794848206%	28	2174	371	T2D_GENES_TANYA_LIPIDS	WANG_SMARCE1_TARGETS_DN
1.28794848206%	28	2174	329	T2D_GENES_TANYA_LIPIDS	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
1.28794848206%	28	2174	314	T2D_GENES_TANYA_LIPIDS	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
1.28794848206%	28	2174	307	T2D_GENES_TANYA_LIPIDS	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
1.28794848206%	28	2174	285	T2D_GENES_TANYA_LIPIDS	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
1.28794848206%	28	2174	264	T2D_GENES_TANYA_LIPIDS	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
1.28794848206%	28	2174	229	T2D_GENES_TANYA_LIPIDS	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
1.28794848206%	28	2174	225	T2D_GENES_TANYA_LIPIDS	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
1.28794848206%	28	2174	225	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_16HR_UP
1.28794848206%	28	2174	222	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_1HR_DN
1.28794848206%	28	2174	210	T2D_GENES_TANYA_LIPIDS	WANG_TUMOR_INVASIVENESS_DN
1.28794848206%	28	2174	204	T2D_GENES_TANYA_LIPIDS	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
1.28794848206%	28	2174	203	T2D_GENES_TANYA_LIPIDS	GRUETZMANN_PANCREATIC_CANCER_DN
1.28794848206%	28	2174	202	T2D_GENES_TANYA_LIPIDS	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
1.28794848206%	28	2174	197	T2D_GENES_TANYA_LIPIDS	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
1.28794848206%	28	2174	186	T2D_GENES_TANYA_LIPIDS	HAMAI_APOPTOSIS_VIA_TRAIL_DN
1.28794848206%	28	2174	185	T2D_GENES_TANYA_LIPIDS	DARWICHE_SKIN_TUMOR_PROMOTER_DN
1.28794848206%	28	2174	183	T2D_GENES_TANYA_LIPIDS	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
1.28794848206%	28	2174	183	T2D_GENES_TANYA_LIPIDS	VERHAAK_AML_WITH_NPM1_MUTATED_UP
1.28794848206%	28	2174	183	T2D_GENES_TANYA_LIPIDS	KEGG_ENDOCYTOSIS
1.28794848206%	28	2174	180	T2D_GENES_TANYA_LIPIDS	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
1.28794848206%	28	2174	179	T2D_GENES_TANYA_LIPIDS	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
1.28794848206%	28	2174	162	T2D_GENES_TANYA_LIPIDS	DARWICHE_PAPILLOMA_RISK_LOW_UP
1.28794848206%	28	2174	157	T2D_GENES_TANYA_LIPIDS	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
1.28314798973%	15	1169	572	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHICAS_RB1_TARGETS_SENESCENT
1.28314798973%	15	1169	539	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIAO_METASTASIS
1.28314798973%	15	1169	536	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BERENJENO_TRANSFORMED_BY_RHOA_UP
1.28314798973%	15	1169	485	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
1.28314798973%	15	1169	479	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
1.28314798973%	15	1169	448	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
1.28314798973%	15	1169	435	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SWEET_LUNG_CANCER_KRAS_DN
1.28314798973%	15	1169	434	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BAELDE_DIABETIC_NEPHROPATHY_DN
1.28314798973%	15	1169	431	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
1.28314798973%	15	1169	428	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIM_MAMMARY_STEM_CELL_DN
1.28314798973%	15	1169	423	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	THUM_SYSTOLIC_HEART_FAILURE_UP
1.28314798973%	15	1169	418	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PEDRIOLI_MIR31_TARGETS_DN
1.28314798973%	15	1169	403	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
1.28314798973%	15	1169	392	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_2B
1.28314798973%	15	1169	382	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
1.28314798973%	15	1169	374	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_TUMOR_INVASIVENESS_UP
1.28314798973%	15	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_LIPOPROTEIN_METABOLISM
1.28314798973%	15	1169	279	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FORTSCHEGGER_PHF8_TARGETS_UP
1.28314798973%	15	1169	277	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHANG_TLX_TARGETS_60HR_DN
1.28314798973%	15	1169	275	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
1.28314798973%	15	1169	274	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
1.28314798973%	15	1169	261	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RICKMAN_METASTASIS_DN
1.28314798973%	15	1169	249	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
1.28314798973%	15	1169	245	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCLACHLAN_DENTAL_CARIES_DN
1.28314798973%	15	1169	228	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
1.28314798973%	15	1169	225	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
1.28314798973%	15	1169	215	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARKEY_RB1_ACUTE_LOF_UP
1.28314798973%	15	1169	168	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
1.28314798973%	15	1169	152	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
1.28314798973%	15	1169	133	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON
1.28314798973%	15	1169	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MEIOSIS
1.28273650454%	24	1871	396	T2D_GENES_TANYA_HEIGHT	REACTOME_DEVELOPMENTAL_BIOLOGY
1.28273650454%	24	1871	349	T2D_GENES_TANYA_HEIGHT	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
1.28273650454%	24	1871	316	T2D_GENES_TANYA_HEIGHT	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
1.28273650454%	24	1871	315	T2D_GENES_TANYA_HEIGHT	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
1.28273650454%	24	1871	307	T2D_GENES_TANYA_HEIGHT	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
1.28273650454%	24	1871	292	T2D_GENES_TANYA_HEIGHT	KOYAMA_SEMA3B_TARGETS_UP
1.28273650454%	24	1871	290	T2D_GENES_TANYA_HEIGHT	BASAKI_YBX1_TARGETS_UP
1.28273650454%	24	1871	271	T2D_GENES_TANYA_HEIGHT	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
1.28273650454%	24	1871	250	T2D_GENES_TANYA_HEIGHT	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
1.28273650454%	24	1871	246	T2D_GENES_TANYA_HEIGHT	BILD_E2F3_ONCOGENIC_SIGNATURE
1.28273650454%	24	1871	244	T2D_GENES_TANYA_HEIGHT	THUM_SYSTOLIC_HEART_FAILURE_DN
1.28273650454%	24	1871	236	T2D_GENES_TANYA_HEIGHT	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
1.28273650454%	24	1871	227	T2D_GENES_TANYA_HEIGHT	LEE_RECENT_THYMIC_EMIGRANT
1.28273650454%	24	1871	221	T2D_GENES_TANYA_HEIGHT	CHANDRAN_METASTASIS_UP
1.28273650454%	24	1871	208	T2D_GENES_TANYA_HEIGHT	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
1.28273650454%	24	1871	198	T2D_GENES_TANYA_HEIGHT	REACTOME_PHOSPHOLIPID_METABOLISM
1.28273650454%	24	1871	192	T2D_GENES_TANYA_HEIGHT	REACTOME_DNA_REPLICATION
1.28273650454%	24	1871	186	T2D_GENES_TANYA_HEIGHT	HAMAI_APOPTOSIS_VIA_TRAIL_DN
1.28273650454%	24	1871	178	T2D_GENES_TANYA_HEIGHT	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
1.28273650454%	24	1871	178	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_18HR_DN
1.28273650454%	24	1871	148	T2D_GENES_TANYA_HEIGHT	WHITFIELD_CELL_CYCLE_M_G1
1.28273650454%	24	1871	107	T2D_GENES_TANYA_HEIGHT	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
1.27840909091%	45	3520	485	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
1.27840909091%	45	3520	482	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
1.27840909091%	45	3520	431	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
1.27840909091%	45	3520	429	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOOTHA_HUMAN_MITODB_6_2002
1.27840909091%	45	3520	329	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
1.27840909091%	45	3520	318	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEI_MYB_TARGETS
1.27840909091%	45	3520	266	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
1.26646403242%	25	1974	88	Mendelian_Nancy_Cox	KEGG_HEMATOPOIETIC_CELL_LINEAGE
1.26646403242%	25	1974	87	Mendelian_Nancy_Cox	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
1.26646403242%	25	1974	72	Mendelian_Nancy_Cox	REACTOME_METABOLISM_OF_NUCLEOTIDES
1.26646403242%	25	1974	45	Mendelian_Nancy_Cox	PID_HNF3BPATHWAY
1.26646403242%	25	1974	233	Mendelian_Nancy_Cox	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
1.26646403242%	25	1974	223	Mendelian_Nancy_Cox	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
1.26646403242%	25	1974	209	Mendelian_Nancy_Cox	GROSS_HYPOXIA_VIA_ELK3_UP
1.26646403242%	25	1974	191	Mendelian_Nancy_Cox	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
1.26646403242%	25	1974	188	Mendelian_Nancy_Cox	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
1.26646403242%	25	1974	181	Mendelian_Nancy_Cox	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
1.26646403242%	25	1974	176	Mendelian_Nancy_Cox	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
1.26646403242%	25	1974	168	Mendelian_Nancy_Cox	PUJANA_XPRSS_INT_NETWORK
1.26646403242%	25	1974	153	Mendelian_Nancy_Cox	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN
1.26646403242%	25	1974	149	Mendelian_Nancy_Cox	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
1.26646403242%	25	1974	149	Mendelian_Nancy_Cox	GOZGIT_ESR1_TARGETS_UP
1.26646403242%	25	1974	147	Mendelian_Nancy_Cox	KAUFFMANN_DNA_REPLICATION_GENES
1.26646403242%	25	1974	142	Mendelian_Nancy_Cox	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
1.26646403242%	25	1974	137	Mendelian_Nancy_Cox	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
1.26646403242%	25	1974	136	Mendelian_Nancy_Cox	PROVENZANI_METASTASIS_DN
1.26646403242%	25	1974	134	Mendelian_Nancy_Cox	SCHLOSSER_SERUM_RESPONSE_UP
1.26646403242%	25	1974	128	Mendelian_Nancy_Cox	KEGG_CELL_CYCLE
1.26646403242%	25	1974	126	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
1.26646403242%	25	1974	126	Mendelian_Nancy_Cox	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
1.26646403242%	25	1974	123	Mendelian_Nancy_Cox	DAZARD_RESPONSE_TO_UV_SCC_UP
1.26646403242%	25	1974	110	Mendelian_Nancy_Cox	WOOD_EBV_EBNA1_TARGETS_UP
1.26646403242%	25	1974	108	Mendelian_Nancy_Cox	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
1.26646403242%	25	1974	107	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_ILS
1.26083530339%	16	1269	593	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARTINEZ_TP53_TARGETS_DN
1.26083530339%	16	1269	570	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
1.26083530339%	16	1269	543	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARTINEZ_RB1_TARGETS_DN
1.26083530339%	16	1269	505	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
1.26083530339%	16	1269	485	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ENK_UV_RESPONSE_KERATINOCYTE_DN
1.26083530339%	16	1269	460	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
1.26083530339%	16	1269	450	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
1.26083530339%	16	1269	448	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
1.26083530339%	16	1269	430	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RIGGI_EWING_SARCOMA_PROGENITOR_UP
1.26083530339%	16	1269	428	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CUI_TCF21_TARGETS_2_UP
1.26083530339%	16	1269	425	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOCHKIS_FOXA2_TARGETS
1.26083530339%	16	1269	424	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHEN_SMARCA2_TARGETS_UP
1.26083530339%	16	1269	414	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOHANKUMAR_TLX1_TARGETS_UP
1.26083530339%	16	1269	403	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
1.26083530339%	16	1269	390	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
1.26083530339%	16	1269	388	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STEIN_ESRRA_TARGETS_UP
1.26083530339%	16	1269	341	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
1.26083530339%	16	1269	335	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
1.26083530339%	16	1269	287	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
1.25%	44	3520	553	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FEVR_CTNNB1_TARGETS_DN
1.25%	44	3520	457	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SENESE_HDAC1_TARGETS_UP
1.25%	44	3520	420	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOOTHA_PGC
1.25%	44	3520	396	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DEVELOPMENTAL_BIOLOGY
1.25%	44	3520	309	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
1.25%	44	3520	295	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LU_EZH2_TARGETS_UP
1.24195032199%	27	2174	75	T2D_GENES_TANYA_LIPIDS	REACTOME_TELOMERE_MAINTENANCE
1.24195032199%	27	2174	425	T2D_GENES_TANYA_LIPIDS	ZHANG_BREAST_CANCER_PROGENITORS_UP
1.24195032199%	27	2174	424	T2D_GENES_TANYA_LIPIDS	SHEN_SMARCA2_TARGETS_UP
1.24195032199%	27	2174	409	T2D_GENES_TANYA_LIPIDS	FOSTER_TOLERANT_MACROPHAGE_DN
1.24195032199%	27	2174	373	T2D_GENES_TANYA_LIPIDS	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
1.24195032199%	27	2174	356	T2D_GENES_TANYA_LIPIDS	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
1.24195032199%	27	2174	353	T2D_GENES_TANYA_LIPIDS	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
1.24195032199%	27	2174	298	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_14HR_DN
1.24195032199%	27	2174	294	T2D_GENES_TANYA_LIPIDS	WEST_ADRENOCORTICAL_TUMOR_UP
1.24195032199%	27	2174	292	T2D_GENES_TANYA_LIPIDS	KOYAMA_SEMA3B_TARGETS_UP
1.24195032199%	27	2174	277	T2D_GENES_TANYA_LIPIDS	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
1.24195032199%	27	2174	271	T2D_GENES_TANYA_LIPIDS	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
1.24195032199%	27	2174	259	T2D_GENES_TANYA_LIPIDS	QI_PLASMACYTOMA_UP
1.24195032199%	27	2174	253	T2D_GENES_TANYA_LIPIDS	MCLACHLAN_DENTAL_CARIES_UP
1.24195032199%	27	2174	246	T2D_GENES_TANYA_LIPIDS	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
1.24195032199%	27	2174	239	T2D_GENES_TANYA_LIPIDS	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
1.24195032199%	27	2174	237	T2D_GENES_TANYA_LIPIDS	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
1.24195032199%	27	2174	228	T2D_GENES_TANYA_LIPIDS	MARKEY_RB1_ACUTE_LOF_DN
1.24195032199%	27	2174	227	T2D_GENES_TANYA_LIPIDS	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
1.24195032199%	27	2174	211	T2D_GENES_TANYA_LIPIDS	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
1.24195032199%	27	2174	207	T2D_GENES_TANYA_LIPIDS	KARLSSON_TGFB1_TARGETS_DN
1.24195032199%	27	2174	206	T2D_GENES_TANYA_LIPIDS	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
1.24195032199%	27	2174	200	T2D_GENES_TANYA_LIPIDS	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
1.24195032199%	27	2174	199	T2D_GENES_TANYA_LIPIDS	PLASARI_TGFB1_TARGETS_10HR_UP
1.24195032199%	27	2174	196	T2D_GENES_TANYA_LIPIDS	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
1.24195032199%	27	2174	195	T2D_GENES_TANYA_LIPIDS	KYNG_DNA_DAMAGE_DN
1.24195032199%	27	2174	181	T2D_GENES_TANYA_LIPIDS	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
1.24195032199%	27	2174	151	T2D_GENES_TANYA_LIPIDS	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
1.23456790123%	1	81	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
1.23456790123%	1	81	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
1.23456790123%	1	81	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_PYRIMIDINE_METABOLISM
1.23456790123%	1	81	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
1.23456790123%	1	81	98	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CROONQUIST_IL6_DEPRIVATION_DN
1.23456790123%	1	81	97	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP
1.23456790123%	1	81	97	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
1.23456790123%	1	81	95	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
1.23456790123%	1	81	94	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER
1.23456790123%	1	81	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WINTER_HYPOXIA_UP
1.23456790123%	1	81	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
1.23456790123%	1	81	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SYNTHESIS_OF_DNA
1.23456790123%	1	81	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
1.23456790123%	1	81	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_DILATED_CARDIOMYOPATHY
1.23456790123%	1	81	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DE_YY1_TARGETS_DN
1.23456790123%	1	81	92	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CAMPS_COLON_CANCER_COPY_NUMBER_UP
1.23456790123%	1	81	91	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
1.23456790123%	1	81	90	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MORI_IMMATURE_B_LYMPHOCYTE_DN
1.23456790123%	1	81	90	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	IGARASHI_ATF4_TARGETS_DN
1.23456790123%	1	81	90	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HILLION_HMGA1_TARGETS
1.23456790123%	1	81	9	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30
1.23456790123%	1	81	9	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GOUYER_TUMOR_INVASIVENESS
1.23456790123%	1	81	9	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN
1.23456790123%	1	81	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SWEET_KRAS_ONCOGENIC_SIGNATURE
1.23456790123%	1	81	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RICKMAN_HEAD_AND_NECK_CANCER_E
1.23456790123%	1	81	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_RNA_POL_I_TRANSCRIPTION
1.23456790123%	1	81	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_AGING_NEOCORTEX_UP
1.23456790123%	1	81	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BOYLAN_MULTIPLE_MYELOMA_D_UP
1.23456790123%	1	81	89	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BHATTACHARYA_EMBRYONIC_STEM_CELL
1.23456790123%	1	81	882	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_BMP2_TARGETS_DN
1.23456790123%	1	81	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
1.23456790123%	1	81	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WALLACE_PROSTATE_CANCER_RACE_DN
1.23456790123%	1	81	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SEIDEN_ONCOGENESIS_BY_MET
1.23456790123%	1	81	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
1.23456790123%	1	81	88	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
1.23456790123%	1	81	871	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GRADE_COLON_CANCER_UP
1.23456790123%	1	81	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SAFFORD_T_LYMPHOCYTE_ANERGY
1.23456790123%	1	81	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION
1.23456790123%	1	81	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
1.23456790123%	1	81	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
1.23456790123%	1	81	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
1.23456790123%	1	81	87	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
1.23456790123%	1	81	86	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
1.23456790123%	1	81	86	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LAIHO_COLORECTAL_CANCER_SERRATED_DN
1.23456790123%	1	81	86	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BROWNE_HCMV_INFECTION_16HR_DN
1.23456790123%	1	81	85	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	STEIN_ESR1_TARGETS
1.23456790123%	1	81	85	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
1.23456790123%	1	81	85	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
1.23456790123%	1	81	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_AGING_CEREBELLUM_UP
1.23456790123%	1	81	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KIM_GLIS2_TARGETS_UP
1.23456790123%	1	81	84	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
1.23456790123%	1	81	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
1.23456790123%	1	81	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_AMYLOIDS
1.23456790123%	1	81	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
1.23456790123%	1	81	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
1.23456790123%	1	81	83	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
1.23456790123%	1	81	82	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
1.23456790123%	1	81	82	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS
1.23456790123%	1	81	82	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_SMAD2_3NUCLEARPATHWAY
1.23456790123%	1	81	82	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_REG_GR_PATHWAY
1.23456790123%	1	81	82	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ODONNELL_METASTASIS_UP
1.23456790123%	1	81	82	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BILD_CTNNB1_ONCOGENIC_SIGNATURE
1.23456790123%	1	81	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
1.23456790123%	1	81	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SCIBETTA_KDM5B_TARGETS_DN
1.23456790123%	1	81	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
1.23456790123%	1	81	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MUNSHI_MULTIPLE_MYELOMA_UP
1.23456790123%	1	81	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MAHAJAN_RESPONSE_TO_IL1A_UP
1.23456790123%	1	81	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GUO_HEX_TARGETS_UP
1.23456790123%	1	81	81	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GRABARCZYK_BCL11B_TARGETS_UP
1.23456790123%	1	81	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SCHUHMACHER_MYC_TARGETS_UP
1.23456790123%	1	81	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
1.23456790123%	1	81	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
1.23456790123%	1	81	80	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
1.23456790123%	1	81	8	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9
1.23456790123%	1	81	8	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7
1.23456790123%	1	81	8	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	IKEDA_MIR133_TARGETS_DN
1.23456790123%	1	81	8	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP
1.23456790123%	1	81	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16
1.23456790123%	1	81	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_P73PATHWAY
1.23456790123%	1	81	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MALONEY_RESPONSE_TO_17AAG_DN
1.23456790123%	1	81	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LIU_COMMON_CANCER_GENES
1.23456790123%	1	81	79	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
1.23456790123%	1	81	78	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
1.23456790123%	1	81	78	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_OPIOID_SIGNALLING
1.23456790123%	1	81	78	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
1.23456790123%	1	81	78	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
1.23456790123%	1	81	77	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
1.23456790123%	1	81	77	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MORI_PRE_BI_LYMPHOCYTE_DN
1.23456790123%	1	81	77	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LIN_APC_TARGETS
1.23456790123%	1	81	77	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM
1.23456790123%	1	81	77	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CARD_MIR302A_TARGETS
1.23456790123%	1	81	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
1.23456790123%	1	81	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
1.23456790123%	1	81	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
1.23456790123%	1	81	76	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
1.23456790123%	1	81	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
1.23456790123%	1	81	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_TELOMERE_MAINTENANCE
1.23456790123%	1	81	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MORI_MATURE_B_LYMPHOCYTE_DN
1.23456790123%	1	81	75	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_ADHERENS_JUNCTION
1.23456790123%	1	81	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WESTON_VEGFA_TARGETS_3HR
1.23456790123%	1	81	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHEPARD_BMYB_TARGETS
1.23456790123%	1	81	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_E2F_PATHWAY
1.23456790123%	1	81	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
1.23456790123%	1	81	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_LIVER_CANCER_DENA_DN
1.23456790123%	1	81	74	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CORRE_MULTIPLE_MYELOMA_UP
1.23456790123%	1	81	734	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BENPORATH_SOX2_TARGETS
1.23456790123%	1	81	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_MEIOTIC_SYNAPSIS
1.23456790123%	1	81	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
1.23456790123%	1	81	73	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_VIRAL_MYOCARDITIS
1.23456790123%	1	81	72	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MATZUK_SPERMATOCYTE
1.23456790123%	1	81	72	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DANG_REGULATED_BY_MYC_UP
1.23456790123%	1	81	72	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CROONQUIST_NRAS_SIGNALING_DN
1.23456790123%	1	81	712	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SCHLOSSER_SERUM_RESPONSE_DN
1.23456790123%	1	81	71	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
1.23456790123%	1	81	71	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DER_IFN_GAMMA_RESPONSE_UP
1.23456790123%	1	81	70	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
1.23456790123%	1	81	70	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS
1.23456790123%	1	81	70	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_AP1_PATHWAY
1.23456790123%	1	81	70	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKKELSEN_MEF_LCP_WITH_H3K27ME3
1.23456790123%	1	81	70	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LANDIS_BREAST_CANCER_PROGRESSION_DN
1.23456790123%	1	81	7	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TESAR_ALK_TARGETS_EPISC_4D_UP
1.23456790123%	1	81	7	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PALOMERO_GSI_SENSITIVITY_UP
1.23456790123%	1	81	7	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKKELSEN_NPC_WITH_LCP_H3K27ME3
1.23456790123%	1	81	7	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKI_COEXPRESSED_WITH_CYP19A1
1.23456790123%	1	81	7	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BERGER_MBD2_TARGETS
1.23456790123%	1	81	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
1.23456790123%	1	81	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN
1.23456790123%	1	81	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RHODES_UNDIFFERENTIATED_CANCER
1.23456790123%	1	81	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
1.23456790123%	1	81	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_P53_SIGNALING_PATHWAY
1.23456790123%	1	81	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HOWLIN_PUBERTAL_MAMMARY_GLAND
1.23456790123%	1	81	69	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	AMIT_EGF_RESPONSE_120_HELA
1.23456790123%	1	81	682	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
1.23456790123%	1	81	68	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
1.23456790123%	1	81	68	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
1.23456790123%	1	81	68	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_TELOMERASEPATHWAY
1.23456790123%	1	81	68	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NOUZOVA_METHYLATED_IN_APL
1.23456790123%	1	81	68	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
1.23456790123%	1	81	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
1.23456790123%	1	81	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
1.23456790123%	1	81	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP
1.23456790123%	1	81	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
1.23456790123%	1	81	67	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70
1.23456790123%	1	81	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
1.23456790123%	1	81	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SWEET_KRAS_TARGETS_DN
1.23456790123%	1	81	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RIGGINS_TAMOXIFEN_RESISTANCE_UP
1.23456790123%	1	81	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RAMASWAMY_METASTASIS_UP
1.23456790123%	1	81	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_TCR_PATHWAY
1.23456790123%	1	81	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_LYSOPHOSPHOLIPID_PATHWAY
1.23456790123%	1	81	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NAKAMURA_ADIPOGENESIS_EARLY_UP
1.23456790123%	1	81	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARSON_FOXP3_TARGETS_UP
1.23456790123%	1	81	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_LIVER_CANCER_CIPROFIBRATE_DN
1.23456790123%	1	81	66	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
1.23456790123%	1	81	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
1.23456790123%	1	81	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GUO_HEX_TARGETS_DN
1.23456790123%	1	81	65	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHANG_IMMORTALIZED_BY_HPV31_DN
1.23456790123%	1	81	64	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
1.23456790123%	1	81	64	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GERHOLD_ADIPOGENESIS_DN
1.23456790123%	1	81	64	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
1.23456790123%	1	81	63	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
1.23456790123%	1	81	63	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
1.23456790123%	1	81	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
1.23456790123%	1	81	62	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
1.23456790123%	1	81	61	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
1.23456790123%	1	81	61	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REN_BOUND_BY_E2F
1.23456790123%	1	81	61	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
1.23456790123%	1	81	61	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
1.23456790123%	1	81	605	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CAIRO_HEPATOBLASTOMA_CLASSES_UP
1.23456790123%	1	81	60	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_LIVER_CANCER_DENA_UP
1.23456790123%	1	81	60	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CUI_GLUCOSE_DEPRIVATION
1.23456790123%	1	81	6	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KORKOLA_CHORIOCARCINOMA
1.23456790123%	1	81	6	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KIM_PTEN_TARGETS_DN
1.23456790123%	1	81	6	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KAPOSI_LIVER_CANCER_MET_DN
1.23456790123%	1	81	6	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	COURTOIS_SENESCENCE_TRIGGERS
1.23456790123%	1	81	59	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WESTON_VEGFA_TARGETS_6HR
1.23456790123%	1	81	59	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_ATF2_PATHWAY
1.23456790123%	1	81	59	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ELVIDGE_HYPOXIA_BY_DMOG_DN
1.23456790123%	1	81	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
1.23456790123%	1	81	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WAKASUGI_HAVE_ZNF143_BINDING_SITES
1.23456790123%	1	81	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LUCAS_HNF4A_TARGETS_UP
1.23456790123%	1	81	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KANNAN_TP53_TARGETS_UP
1.23456790123%	1	81	58	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_HIVNEF_PATHWAY
1.23456790123%	1	81	578	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MASSARWEH_TAMOXIFEN_RESISTANCE_UP
1.23456790123%	1	81	57	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
1.23456790123%	1	81	57	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_TXA2PATHWAY
1.23456790123%	1	81	57	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MCCLUNG_CREB1_TARGETS_DN
1.23456790123%	1	81	57	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DELASERNA_MYOD_TARGETS_DN
1.23456790123%	1	81	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_LIVER_CANCER_MYC_E2F1_UP
1.23456790123%	1	81	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_VIBRIO_CHOLERAE_INFECTION
1.23456790123%	1	81	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HOQUE_METHYLATED_IN_CANCER
1.23456790123%	1	81	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HENDRICKS_SMARCA4_TARGETS_UP
1.23456790123%	1	81	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GYORFFY_DOXORUBICIN_RESISTANCE
1.23456790123%	1	81	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GALE_APL_WITH_FLT3_MUTATED_UP
1.23456790123%	1	81	56	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BROWNE_HCMV_INFECTION_10HR_DN
1.23456790123%	1	81	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YU_MYC_TARGETS_DN
1.23456790123%	1	81	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
1.23456790123%	1	81	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
1.23456790123%	1	81	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SMIRNOV_RESPONSE_TO_IR_2HR_DN
1.23456790123%	1	81	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_TGFBRPATHWAY
1.23456790123%	1	81	55	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN
1.23456790123%	1	81	549	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
1.23456790123%	1	81	548	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KIM_ALL_DISORDERS_CALB1_CORR_UP
1.23456790123%	1	81	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SU_PANCREAS
1.23456790123%	1	81	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_APOPTOTIC_EXECUTION_PHASE
1.23456790123%	1	81	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARSON_FOXP3_TARGETS_DN
1.23456790123%	1	81	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_LIVER_CANCER_MYC_UP
1.23456790123%	1	81	54	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_ARGININE_AND_PROLINE_METABOLISM
1.23456790123%	1	81	536	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BERENJENO_TRANSFORMED_BY_RHOA_UP
1.23456790123%	1	81	53	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHU_CMV_8_HR_DN
1.23456790123%	1	81	53	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_AR_TF_PATHWAY
1.23456790123%	1	81	53	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KRIEG_HYPOXIA_VIA_KDM3A
1.23456790123%	1	81	53	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HENDRICKS_SMARCA4_TARGETS_DN
1.23456790123%	1	81	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN
1.23456790123%	1	81	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_CASPASE_PATHWAY
1.23456790123%	1	81	52	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_STARCH_AND_SUCROSE_METABOLISM
1.23456790123%	1	81	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_NUCLEOTIDE_EXCISION_REPAIR
1.23456790123%	1	81	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
1.23456790123%	1	81	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE
1.23456790123%	1	81	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
1.23456790123%	1	81	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CROMER_TUMORIGENESIS_DN
1.23456790123%	1	81	51	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
1.23456790123%	1	81	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	STOSSI_RESPONSE_TO_ESTRADIOL
1.23456790123%	1	81	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
1.23456790123%	1	81	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
1.23456790123%	1	81	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
1.23456790123%	1	81	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARTINEZ_RESPONSE_TO_TRABECTEDIN
1.23456790123%	1	81	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HOFMANN_CELL_LYMPHOMA_UP
1.23456790123%	1	81	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
1.23456790123%	1	81	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHIBA_RESPONSE_TO_TSA
1.23456790123%	1	81	50	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS
1.23456790123%	1	81	5	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TESAR_ALK_TARGETS_HUMAN_ES_5D_UP
1.23456790123%	1	81	5	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP
1.23456790123%	1	81	5	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BRUNEAU_SEPTATION_ATRIAL
1.23456790123%	1	81	493	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN
1.23456790123%	1	81	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
1.23456790123%	1	81	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_FOXOPATHWAY
1.23456790123%	1	81	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_ARF6_TRAFFICKINGPATHWAY
1.23456790123%	1	81	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARCHINI_TRABECTEDIN_RESISTANCE_DN
1.23456790123%	1	81	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DAUER_STAT3_TARGETS_UP
1.23456790123%	1	81	49	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP
1.23456790123%	1	81	487	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
1.23456790123%	1	81	485	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
1.23456790123%	1	81	485	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ENK_UV_RESPONSE_KERATINOCYTE_DN
1.23456790123%	1	81	483	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
1.23456790123%	1	81	482	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
1.23456790123%	1	81	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHAN_MULTIPLE_MYELOMA_LB_UP
1.23456790123%	1	81	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE
1.23456790123%	1	81	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RASHI_RESPONSE_TO_IONIZING_RADIATION_3
1.23456790123%	1	81	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MCDOWELL_ACUTE_LUNG_INJURY_DN
1.23456790123%	1	81	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
1.23456790123%	1	81	48	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DOANE_BREAST_CANCER_ESR1_DN
1.23456790123%	1	81	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
1.23456790123%	1	81	47	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KHETCHOUMIAN_TRIM24_TARGETS_UP
1.23456790123%	1	81	469	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MCCABE_BOUND_BY_HOXC6
1.23456790123%	1	81	467	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RATTENBACHER_BOUND_BY_CELF1
1.23456790123%	1	81	463	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
1.23456790123%	1	81	461	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
1.23456790123%	1	81	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6
1.23456790123%	1	81	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SAGIV_CD24_TARGETS_DN
1.23456790123%	1	81	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_TNFPATHWAY
1.23456790123%	1	81	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_PS1PATHWAY
1.23456790123%	1	81	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PARENT_MTOR_SIGNALING_DN
1.23456790123%	1	81	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NAKAJIMA_MAST_CELL
1.23456790123%	1	81	46	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ABBUD_LIF_SIGNALING_1_UP
1.23456790123%	1	81	457	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SENESE_HDAC1_TARGETS_UP
1.23456790123%	1	81	456	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
1.23456790123%	1	81	450	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
1.23456790123%	1	81	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHAN_MULTIPLE_MYELOMA_CD1_UP
1.23456790123%	1	81	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHAN_MULTIPLE_MYELOMA_CD1_DN
1.23456790123%	1	81	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER
1.23456790123%	1	81	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_RHOA_PATHWAY
1.23456790123%	1	81	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NUTT_GBM_VS_AO_GLIOMA_DN
1.23456790123%	1	81	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_AGING_MUSCLE_UP
1.23456790123%	1	81	45	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HUANG_FOXA2_TARGETS_UP
1.23456790123%	1	81	445	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
1.23456790123%	1	81	443	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DELYS_THYROID_CANCER_UP
1.23456790123%	1	81	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_HNF3APATHWAY
1.23456790123%	1	81	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	OHGUCHI_LIVER_HNF4A_TARGETS_UP
1.23456790123%	1	81	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARTIN_INTERACT_WITH_HDAC
1.23456790123%	1	81	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
1.23456790123%	1	81	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_TYPE_I_DIABETES_MELLITUS
1.23456790123%	1	81	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_NUCLEOTIDE_EXCISION_REPAIR
1.23456790123%	1	81	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_LYSINE_DEGRADATION
1.23456790123%	1	81	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM
1.23456790123%	1	81	44	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HARRIS_BRAIN_CANCER_PROGENITORS
1.23456790123%	1	81	431	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
1.23456790123%	1	81	430	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VECCHI_GASTRIC_CANCER_EARLY_UP
1.23456790123%	1	81	430	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RIGGI_EWING_SARCOMA_PROGENITOR_UP
1.23456790123%	1	81	430	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	JOHNSTONE_PARVB_TARGETS_3_UP
1.23456790123%	1	81	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	POTTI_ETOPOSIDE_SENSITIVITY
1.23456790123%	1	81	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NAKAMURA_METASTASIS_MODEL_DN
1.23456790123%	1	81	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEE_CALORIE_RESTRICTION_MUSCLE_UP
1.23456790123%	1	81	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LASTOWSKA_COAMPLIFIED_WITH_MYCN
1.23456790123%	1	81	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
1.23456790123%	1	81	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HUMMEL_BURKITTS_LYMPHOMA_UP
1.23456790123%	1	81	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
1.23456790123%	1	81	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
1.23456790123%	1	81	43	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FUJII_YBX1_TARGETS_UP
1.23456790123%	1	81	424	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHEN_SMARCA2_TARGETS_UP
1.23456790123%	1	81	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
1.23456790123%	1	81	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
1.23456790123%	1	81	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKKELSEN_ES_ICP_WITH_H3K27ME3
1.23456790123%	1	81	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_FATTY_ACID_METABOLISM
1.23456790123%	1	81	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_CHREBP2_PATHWAY
1.23456790123%	1	81	42	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BARRIER_COLON_CANCER_RECURRENCE_UP
1.23456790123%	1	81	418	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PEDRIOLI_MIR31_TARGETS_DN
1.23456790123%	1	81	418	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MULLIGHAN_MLL_SIGNATURE_2_UP
1.23456790123%	1	81	414	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LU_EZH2_TARGETS_DN
1.23456790123%	1	81	411	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KOYAMA_SEMA3B_TARGETS_DN
1.23456790123%	1	81	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_AMB2_NEUTROPHILS_PATHWAY
1.23456790123%	1	81	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MALONEY_RESPONSE_TO_17AAG_UP
1.23456790123%	1	81	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LIN_MELANOMA_COPY_NUMBER_DN
1.23456790123%	1	81	41	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	EHLERS_ANEUPLOIDY_UP
1.23456790123%	1	81	406	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	OSMAN_BLADDER_CANCER_DN
1.23456790123%	1	81	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VARELA_ZMPSTE24_TARGETS_UP
1.23456790123%	1	81	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VANASSE_BCL2_TARGETS_UP
1.23456790123%	1	81	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TOMLINS_PROSTATE_CANCER_DN
1.23456790123%	1	81	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ST_JNK_MAPK_PATHWAY
1.23456790123%	1	81	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
1.23456790123%	1	81	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP
1.23456790123%	1	81	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_TRYPTOPHAN_METABOLISM
1.23456790123%	1	81	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HEIDENBLAD_AMPLICON_8Q24_UP
1.23456790123%	1	81	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BURTON_ADIPOGENESIS_PEAK_AT_16HR
1.23456790123%	1	81	40	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
1.23456790123%	1	81	390	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
1.23456790123%	1	81	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WANG_LSD1_TARGETS_DN
1.23456790123%	1	81	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	POTTI_PACLITAXEL_SENSITIVITY
1.23456790123%	1	81	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GU_PDEF_TARGETS_DN
1.23456790123%	1	81	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
1.23456790123%	1	81	39	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP
1.23456790123%	1	81	389	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HSIAO_HOUSEKEEPING_GENES
1.23456790123%	1	81	382	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
1.23456790123%	1	81	380	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MULLIGHAN_MLL_SIGNATURE_1_UP
1.23456790123%	1	81	380	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DAIRKEE_TERT_TARGETS_UP
1.23456790123%	1	81	380	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
1.23456790123%	1	81	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YOKOE_CANCER_TESTIS_ANTIGENS
1.23456790123%	1	81	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
1.23456790123%	1	81	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS
1.23456790123%	1	81	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4
1.23456790123%	1	81	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PENG_GLUTAMINE_DEPRIVATION_UP
1.23456790123%	1	81	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3
1.23456790123%	1	81	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP
1.23456790123%	1	81	38	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_INTEGRIN_PATHWAY
1.23456790123%	1	81	378	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
1.23456790123%	1	81	374	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WANG_TUMOR_INVASIVENESS_UP
1.23456790123%	1	81	374	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
1.23456790123%	1	81	372	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WANG_LMO4_TARGETS_UP
1.23456790123%	1	81	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VALK_AML_WITH_CEBPA
1.23456790123%	1	81	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ST_GA13_PATHWAY
1.23456790123%	1	81	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2
1.23456790123%	1	81	37	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LANDIS_ERBB2_BREAST_TUMORS_65_DN
1.23456790123%	1	81	367	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DELACROIX_RARG_BOUND_MEF
1.23456790123%	1	81	364	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YANG_BCL3_TARGETS_UP
1.23456790123%	1	81	362	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
1.23456790123%	1	81	36	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_DNA_REPLICATION
1.23456790123%	1	81	36	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HUANG_FOXA2_TARGETS_DN
1.23456790123%	1	81	357	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHEN_SMARCA2_TARGETS_DN
1.23456790123%	1	81	356	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
1.23456790123%	1	81	353	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
1.23456790123%	1	81	352	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WANG_LMO4_TARGETS_DN
1.23456790123%	1	81	351	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
1.23456790123%	1	81	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WEIGEL_OXIDATIVE_STRESS_RESPONSE
1.23456790123%	1	81	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ST_G_ALPHA_I_PATHWAY
1.23456790123%	1	81	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D
1.23456790123%	1	81	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_GLOBAL_GENOMIC_NER_GG_NER
1.23456790123%	1	81	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_PI3KCIAKTPATHWAY
1.23456790123%	1	81	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
1.23456790123%	1	81	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION
1.23456790123%	1	81	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_REGULATION_OF_AUTOPHAGY
1.23456790123%	1	81	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_PRIMARY_IMMUNODEFICIENCY
1.23456790123%	1	81	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_BASE_EXCISION_REPAIR
1.23456790123%	1	81	35	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
1.23456790123%	1	81	346	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GOLDRATH_ANTIGEN_RESPONSE
1.23456790123%	1	81	344	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RICKMAN_METASTASIS_UP
1.23456790123%	1	81	341	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MULLIGHAN_NPM1_SIGNATURE_3_UP
1.23456790123%	1	81	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ST_WNT_BETA_CATENIN_PATHWAY
1.23456790123%	1	81	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	POTTI_CYTOXAN_SENSITIVITY
1.23456790123%	1	81	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_HIF2PATHWAY
1.23456790123%	1	81	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_EPOPATHWAY
1.23456790123%	1	81	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_EPHA_FWDPATHWAY
1.23456790123%	1	81	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_BUTANOATE_METABOLISM
1.23456790123%	1	81	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	JIANG_HYPOXIA_VIA_VHL
1.23456790123%	1	81	34	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DOANE_BREAST_CANCER_CLASSES_DN
1.23456790123%	1	81	337	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PENG_GLUTAMINE_DEPRIVATION_DN
1.23456790123%	1	81	335	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
1.23456790123%	1	81	332	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
1.23456790123%	1	81	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHAN_LATE_DIFFERENTIATION_GENES_UP
1.23456790123%	1	81	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_ALPHASYNUCLEIN_PATHWAY
1.23456790123%	1	81	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HEIDENBLAD_AMPLICON_12P11_12_UP
1.23456790123%	1	81	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_NO1_PATHWAY
1.23456790123%	1	81	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_DEATH_PATHWAY
1.23456790123%	1	81	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN
1.23456790123%	1	81	33	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	APPEL_IMATINIB_RESPONSE
1.23456790123%	1	81	329	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
1.23456790123%	1	81	329	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
1.23456790123%	1	81	326	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
1.23456790123%	1	81	324	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
1.23456790123%	1	81	320	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
1.23456790123%	1	81	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TRACEY_RESISTANCE_TO_IFNA2_DN
1.23456790123%	1	81	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_WNT_NONCANONICAL_PATHWAY
1.23456790123%	1	81	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM
1.23456790123%	1	81	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN
1.23456790123%	1	81	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BAUS_TFF2_TARGETS_UP
1.23456790123%	1	81	32	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BAE_BRCA1_TARGETS_DN
1.23456790123%	1	81	317	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HELLER_HDAC_TARGETS_UP
1.23456790123%	1	81	310	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HORIUCHI_WTAP_TARGETS_DN
1.23456790123%	1	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP
1.23456790123%	1	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VALK_AML_CLUSTER_15
1.23456790123%	1	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN
1.23456790123%	1	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP
1.23456790123%	1	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SIMBULAN_PARP1_TARGETS_UP
1.23456790123%	1	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_P38ALPHABETAPATHWAY
1.23456790123%	1	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NOJIMA_SFRP2_TARGETS_UP
1.23456790123%	1	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
1.23456790123%	1	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER
1.23456790123%	1	81	31	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DORSEY_GAB2_TARGETS
1.23456790123%	1	81	309	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
1.23456790123%	1	81	306	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHANDRAN_METASTASIS_DN
1.23456790123%	1	81	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VALK_AML_CLUSTER_13
1.23456790123%	1	81	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN
1.23456790123%	1	81	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN
1.23456790123%	1	81	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_DNA_STRAND_ELONGATION
1.23456790123%	1	81	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LI_PROSTATE_CANCER_EPIGENETIC
1.23456790123%	1	81	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GUILLAUMOND_KLF10_TARGETS_DN
1.23456790123%	1	81	30	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_FAS_PATHWAY
1.23456790123%	1	81	299	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WALLACE_PROSTATE_CANCER_RACE_UP
1.23456790123%	1	81	298	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
1.23456790123%	1	81	296	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DURAND_STROMA_MAX_UP
1.23456790123%	1	81	295	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LU_EZH2_TARGETS_UP
1.23456790123%	1	81	295	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
1.23456790123%	1	81	294	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
1.23456790123%	1	81	293	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZWANG_DOWN_BY_2ND_EGF_PULSE
1.23456790123%	1	81	293	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHANG_TLX_TARGETS_60HR_UP
1.23456790123%	1	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WILENSKY_RESPONSE_TO_DARAPLADIB
1.23456790123%	1	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_STEROID_HORMONES
1.23456790123%	1	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PKB_MEDIATED_EVENTS
1.23456790123%	1	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PERK_REGULATED_GENE_EXPRESSION
1.23456790123%	1	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX
1.23456790123%	1	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PAL_PRMT5_TARGETS_DN
1.23456790123%	1	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NGUYEN_NOTCH1_TARGETS_UP
1.23456790123%	1	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MA_PITUITARY_FETAL_VS_ADULT_UP
1.23456790123%	1	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MAYBURD_RESPONSE_TO_L663536_UP
1.23456790123%	1	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KYNG_WERNER_SYNDROM_DN
1.23456790123%	1	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_THYROID_CANCER
1.23456790123%	1	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN
1.23456790123%	1	81	29	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_TNFR1_PATHWAY
1.23456790123%	1	81	287	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
1.23456790123%	1	81	285	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
1.23456790123%	1	81	284	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
1.23456790123%	1	81	281	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MULLIGHAN_MLL_SIGNATURE_2_DN
1.23456790123%	1	81	281	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BHAT_ESR1_TARGETS_VIA_AKT1_UP
1.23456790123%	1	81	280	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
1.23456790123%	1	81	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ST_GAQ_PATHWAY
1.23456790123%	1	81	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER
1.23456790123%	1	81	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING
1.23456790123%	1	81	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_HOMOLOGOUS_RECOMBINATION
1.23456790123%	1	81	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
1.23456790123%	1	81	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HWANG_PROSTATE_CANCER_MARKERS
1.23456790123%	1	81	28	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GENTILE_UV_RESPONSE_CLUSTER_D9
1.23456790123%	1	81	277	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHANG_TLX_TARGETS_60HR_DN
1.23456790123%	1	81	276	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
1.23456790123%	1	81	274	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
1.23456790123%	1	81	271	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
1.23456790123%	1	81	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
1.23456790123%	1	81	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_SYNTHESIS_OF_PA
1.23456790123%	1	81	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN
1.23456790123%	1	81	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_G_PROTEIN_ACTIVATION
1.23456790123%	1	81	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_EXTENSION_OF_TELOMERES
1.23456790123%	1	81	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_GLYPICAN_1PATHWAY
1.23456790123%	1	81	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	OHM_METHYLATED_IN_ADULT_CANCERS
1.23456790123%	1	81	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GROSS_ELK3_TARGETS_UP
1.23456790123%	1	81	27	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP
1.23456790123%	1	81	269	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WANG_CLIM2_TARGETS_UP
1.23456790123%	1	81	268	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	XU_GH1_AUTOCRINE_TARGETS_UP
1.23456790123%	1	81	267	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_MAPK_SIGNALING_PATHWAY
1.23456790123%	1	81	266	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FOSTER_KDM1A_TARGETS_UP
1.23456790123%	1	81	261	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RICKMAN_METASTASIS_DN
1.23456790123%	1	81	261	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BILD_HRAS_ONCOGENIC_SIGNATURE
1.23456790123%	1	81	260	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SENESE_HDAC1_TARGETS_DN
1.23456790123%	1	81	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHENG_FOXP3_TARGETS_UP
1.23456790123%	1	81	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG
1.23456790123%	1	81	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
1.23456790123%	1	81	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_RXR_VDR_PATHWAY
1.23456790123%	1	81	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_ALK1PATHWAY
1.23456790123%	1	81	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NAKAMURA_CANCER_MICROENVIRONMENT_UP
1.23456790123%	1	81	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_GALACTOSE_METABOLISM
1.23456790123%	1	81	26	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
1.23456790123%	1	81	259	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	QI_PLASMACYTOMA_UP
1.23456790123%	1	81	258	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
1.23456790123%	1	81	255	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
1.23456790123%	1	81	253	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MCLACHLAN_DENTAL_CARIES_UP
1.23456790123%	1	81	252	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
1.23456790123%	1	81	251	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
1.23456790123%	1	81	250	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
1.23456790123%	1	81	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RUAN_RESPONSE_TO_TROGLITAZONE_UP
1.23456790123%	1	81	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
1.23456790123%	1	81	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_HDAC_CLASSIII_PATHWAY
1.23456790123%	1	81	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP
1.23456790123%	1	81	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	JACKSON_DNMT1_TARGETS_DN
1.23456790123%	1	81	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP
1.23456790123%	1	81	25	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	COLLER_MYC_TARGETS_UP
1.23456790123%	1	81	249	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MITSIADES_RESPONSE_TO_APLIDIN_DN
1.23456790123%	1	81	249	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
1.23456790123%	1	81	246	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BILD_E2F3_ONCOGENIC_SIGNATURE
1.23456790123%	1	81	245	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PENG_RAPAMYCIN_RESPONSE_DN
1.23456790123%	1	81	245	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MCLACHLAN_DENTAL_CARIES_DN
1.23456790123%	1	81	245	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BLUM_RESPONSE_TO_SALIRASIB_UP
1.23456790123%	1	81	244	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	THUM_SYSTOLIC_HEART_FAILURE_DN
1.23456790123%	1	81	244	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DAZARD_RESPONSE_TO_UV_NHEK_UP
1.23456790123%	1	81	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YIH_RESPONSE_TO_ARSENITE_C1
1.23456790123%	1	81	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN
1.23456790123%	1	81	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHI_SPARC_TARGETS_UP
1.23456790123%	1	81	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING
1.23456790123%	1	81	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED
1.23456790123%	1	81	24	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MATZUK_SPERMATOGONIA
1.23456790123%	1	81	239	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ALFANO_MYC_TARGETS
1.23456790123%	1	81	238	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
1.23456790123%	1	81	234	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
1.23456790123%	1	81	234	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	AFFAR_YY1_TARGETS_DN
1.23456790123%	1	81	232	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
1.23456790123%	1	81	232	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DELYS_THYROID_CANCER_DN
1.23456790123%	1	81	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SAGIV_CD24_TARGETS_UP
1.23456790123%	1	81	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION
1.23456790123%	1	81	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_NITROGEN_METABOLISM
1.23456790123%	1	81	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_MISMATCH_REPAIR
1.23456790123%	1	81	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP
1.23456790123%	1	81	23	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_CASPASE_PATHWAY
1.23456790123%	1	81	229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
1.23456790123%	1	81	229	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
1.23456790123%	1	81	228	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
1.23456790123%	1	81	228	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
1.23456790123%	1	81	228	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARKEY_RB1_ACUTE_LOF_DN
1.23456790123%	1	81	227	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RAO_BOUND_BY_SALL4
1.23456790123%	1	81	227	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
1.23456790123%	1	81	225	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
1.23456790123%	1	81	225	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
1.23456790123%	1	81	222	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
1.23456790123%	1	81	221	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHANDRAN_METASTASIS_UP
1.23456790123%	1	81	220	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
1.23456790123%	1	81	220	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RIGGINS_TAMOXIFEN_RESISTANCE_DN
1.23456790123%	1	81	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SUZUKI_RESPONSE_TO_TSA
1.23456790123%	1	81	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SPIRA_SMOKERS_LUNG_CANCER_DN
1.23456790123%	1	81	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION
1.23456790123%	1	81	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
1.23456790123%	1	81	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
1.23456790123%	1	81	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MOOTHA_FFA_OXYDATION
1.23456790123%	1	81	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MATZUK_IMPLANTATION_AND_UTERINE
1.23456790123%	1	81	22	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN
1.23456790123%	1	81	217	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WONG_MITOCHONDRIA_GENE_MODULE
1.23456790123%	1	81	217	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	AMUNDSON_RESPONSE_TO_ARSENITE
1.23456790123%	1	81	216	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WHITFIELD_CELL_CYCLE_G2_M
1.23456790123%	1	81	214	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZWANG_EGF_INTERVAL_DN
1.23456790123%	1	81	212	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
1.23456790123%	1	81	211	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
1.23456790123%	1	81	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
1.23456790123%	1	81	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SANSOM_APC_TARGETS_REQUIRE_MYC
1.23456790123%	1	81	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_TRANSCRIPTION
1.23456790123%	1	81	210	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CAIRO_HEPATOBLASTOMA_CLASSES_DN
1.23456790123%	1	81	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SCHURINGA_STAT5A_TARGETS_UP
1.23456790123%	1	81	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_CTLA4_INHIBITORY_SIGNALING
1.23456790123%	1	81	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MOOTHA_GLYCOGEN_METABOLISM
1.23456790123%	1	81	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LANDEMAINE_LUNG_METASTASIS
1.23456790123%	1	81	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HU_ANGIOGENESIS_UP
1.23456790123%	1	81	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GREENBAUM_E2A_TARGETS_DN
1.23456790123%	1	81	21	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP
1.23456790123%	1	81	209	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KIM_WT1_TARGETS_12HR_DN
1.23456790123%	1	81	209	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GROSS_HYPOXIA_VIA_ELK3_UP
1.23456790123%	1	81	208	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
1.23456790123%	1	81	207	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CAIRO_HEPATOBLASTOMA_UP
1.23456790123%	1	81	205	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
1.23456790123%	1	81	205	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PEREZ_TP53_AND_TP63_TARGETS
1.23456790123%	1	81	203	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PENG_RAPAMYCIN_RESPONSE_UP
1.23456790123%	1	81	203	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PAL_PRMT5_TARGETS_UP
1.23456790123%	1	81	202	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
1.23456790123%	1	81	202	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FUJII_YBX1_TARGETS_DN
1.23456790123%	1	81	201	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HOLLMANN_APOPTOSIS_VIA_CD40_UP
1.23456790123%	1	81	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WENG_POR_TARGETS_GLOBAL_UP
1.23456790123%	1	81	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WANG_THOC1_TARGETS_DN
1.23456790123%	1	81	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN
1.23456790123%	1	81	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_ENOS_ACTIVATION_AND_REGULATION
1.23456790123%	1	81	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PID_WNT_CANONICAL_PATHWAY
1.23456790123%	1	81	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NIELSEN_SYNOVIAL_SARCOMA_DN
1.23456790123%	1	81	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NIELSEN_LEIOMYOSARCOMA_CNN1_DN
1.23456790123%	1	81	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MCCABE_HOXC6_TARGETS_CANCER_DN
1.23456790123%	1	81	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KYNG_WERNER_SYNDROM_UP
1.23456790123%	1	81	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	COLLIS_PRKDC_SUBSTRATES
1.23456790123%	1	81	20	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
1.23456790123%	1	81	199	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
1.23456790123%	1	81	198	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ALONSO_METASTASIS_UP
1.23456790123%	1	81	197	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
1.23456790123%	1	81	196	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
1.23456790123%	1	81	195	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
1.23456790123%	1	81	195	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
1.23456790123%	1	81	194	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
1.23456790123%	1	81	192	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_DNA_REPLICATION
1.23456790123%	1	81	191	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YAGI_AML_FAB_MARKERS
1.23456790123%	1	81	191	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RIGGI_EWING_SARCOMA_PROGENITOR_DN
1.23456790123%	1	81	191	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
1.23456790123%	1	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE
1.23456790123%	1	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VERNOCHET_ADIPOGENESIS
1.23456790123%	1	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP
1.23456790123%	1	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SYED_ESTRADIOL_RESPONSE
1.23456790123%	1	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SCIBETTA_KDM5B_TARGETS_UP
1.23456790123%	1	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RUAN_RESPONSE_TO_TROGLITAZONE_DN
1.23456790123%	1	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PYRUVATE_METABOLISM
1.23456790123%	1	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_LAGGING_STRAND_SYNTHESIS
1.23456790123%	1	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_BASE_EXCISION_REPAIR
1.23456790123%	1	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	OUYANG_PROSTATE_CANCER_MARKERS
1.23456790123%	1	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARSON_FOXP3_CORE_DIRECT_TARGETS
1.23456790123%	1	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP
1.23456790123%	1	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN
1.23456790123%	1	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_MAL_PATHWAY
1.23456790123%	1	81	19	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
1.23456790123%	1	81	187	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BAKKER_FOXO3_TARGETS_DN
1.23456790123%	1	81	185	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHANG_TLX_TARGETS_36HR_DN
1.23456790123%	1	81	185	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_HUNTINGTONS_DISEASE
1.23456790123%	1	81	184	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WU_CELL_MIGRATION
1.23456790123%	1	81	183	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
1.23456790123%	1	81	183	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VERHAAK_AML_WITH_NPM1_MUTATED_UP
1.23456790123%	1	81	182	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
1.23456790123%	1	81	181	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
1.23456790123%	1	81	181	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
1.23456790123%	1	81	181	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	JISON_SICKLE_CELL_DISEASE_UP
1.23456790123%	1	81	181	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	JISON_SICKLE_CELL_DISEASE_DN
1.23456790123%	1	81	181	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
1.23456790123%	1	81	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE
1.23456790123%	1	81	18	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WEBER_METHYLATED_IN_COLON_CANCER
1.23456790123%	1	81	178	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LI_AMPLIFIED_IN_LUNG_CANCER
1.23456790123%	1	81	177	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
1.23456790123%	1	81	177	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
1.23456790123%	1	81	176	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SASAKI_ADULT_T_CELL_LEUKEMIA
1.23456790123%	1	81	176	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NAGASHIMA_NRG1_SIGNALING_UP
1.23456790123%	1	81	176	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
1.23456790123%	1	81	176	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
1.23456790123%	1	81	172	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
1.23456790123%	1	81	172	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
1.23456790123%	1	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP
1.23456790123%	1	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY
1.23456790123%	1	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION
1.23456790123%	1	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ONDER_CDH1_TARGETS_3_UP
1.23456790123%	1	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MATTHEWS_AP1_TARGETS
1.23456790123%	1	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
1.23456790123%	1	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEI_HOXC8_TARGETS_DN
1.23456790123%	1	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_STEROID_BIOSYNTHESIS
1.23456790123%	1	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
1.23456790123%	1	81	17	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_PML_PATHWAY
1.23456790123%	1	81	169	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	UEDA_PERIFERAL_CLOCK
1.23456790123%	1	81	169	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PENG_GLUCOSE_DEPRIVATION_DN
1.23456790123%	1	81	169	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_ALZHEIMERS_DISEASE
1.23456790123%	1	81	167	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TIEN_INTESTINE_PROBIOTICS_6HR_DN
1.23456790123%	1	81	165	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
1.23456790123%	1	81	164	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
1.23456790123%	1	81	163	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
1.23456790123%	1	81	162	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WHITFIELD_CELL_CYCLE_S
1.23456790123%	1	81	162	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MULLIGHAN_NPM1_SIGNATURE_3_DN
1.23456790123%	1	81	162	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
1.23456790123%	1	81	161	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIDUS_METASTASIS_DN
1.23456790123%	1	81	160	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
1.23456790123%	1	81	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WONG_IFNA2_RESISTANCE_UP
1.23456790123%	1	81	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN
1.23456790123%	1	81	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON
1.23456790123%	1	81	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	IGLESIAS_E2F_TARGETS_DN
1.23456790123%	1	81	16	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHIN_BREAST_CANCER_COPY_NUMBER_DN
1.23456790123%	1	81	159	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_PURINE_METABOLISM
1.23456790123%	1	81	158	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON
1.23456790123%	1	81	157	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
1.23456790123%	1	81	153	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
1.23456790123%	1	81	151	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	IGLESIAS_E2F_TARGETS_UP
1.23456790123%	1	81	151	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
1.23456790123%	1	81	151	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
1.23456790123%	1	81	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3
1.23456790123%	1	81	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SU_KIDNEY
1.23456790123%	1	81	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP
1.23456790123%	1	81	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND
1.23456790123%	1	81	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_ENDOGENOUS_STEROLS
1.23456790123%	1	81	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARKS_ACETYLATED_NON_HISTONE_PROTEINS
1.23456790123%	1	81	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	EHRLICH_ICF_SYNDROM_DN
1.23456790123%	1	81	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DAZARD_UV_RESPONSE_CLUSTER_G3
1.23456790123%	1	81	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_NUCLEARRS_PATHWAY
1.23456790123%	1	81	15	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_AKAPCENTROSOME_PATHWAY
1.23456790123%	1	81	149	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
1.23456790123%	1	81	149	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HUANG_GATA2_TARGETS_UP
1.23456790123%	1	81	149	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GOZGIT_ESR1_TARGETS_UP
1.23456790123%	1	81	148	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WEI_MIR34A_TARGETS
1.23456790123%	1	81	148	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_APOPTOSIS
1.23456790123%	1	81	148	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BROWNE_HCMV_INFECTION_24HR_UP
1.23456790123%	1	81	147	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SMID_BREAST_CANCER_ERBB2_UP
1.23456790123%	1	81	147	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
1.23456790123%	1	81	147	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
1.23456790123%	1	81	147	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KAUFFMANN_DNA_REPLICATION_GENES
1.23456790123%	1	81	146	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PECE_MAMMARY_STEM_CELL_UP
1.23456790123%	1	81	146	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PECE_MAMMARY_STEM_CELL_DN
1.23456790123%	1	81	146	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ELVIDGE_HYPOXIA_DN
1.23456790123%	1	81	146	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
1.23456790123%	1	81	145	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHANG_BREAST_CANCER_PROGENITORS_DN
1.23456790123%	1	81	145	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SMITH_TERT_TARGETS_UP
1.23456790123%	1	81	145	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
1.23456790123%	1	81	142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	XU_GH1_AUTOCRINE_TARGETS_DN
1.23456790123%	1	81	142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RUIZ_TNC_TARGETS_DN
1.23456790123%	1	81	142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PENG_LEUCINE_DEPRIVATION_UP
1.23456790123%	1	81	142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKKELSEN_ES_LCP_WITH_H3K4ME3
1.23456790123%	1	81	142	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
1.23456790123%	1	81	141	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SABATES_COLORECTAL_ADENOMA_UP
1.23456790123%	1	81	141	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
1.23456790123%	1	81	141	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KAAB_FAILED_HEART_ATRIUM_DN
1.23456790123%	1	81	141	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP
1.23456790123%	1	81	140	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	QI_HYPOXIA
1.23456790123%	1	81	140	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ONDER_CDH1_TARGETS_1_UP
1.23456790123%	1	81	140	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
1.23456790123%	1	81	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER
1.23456790123%	1	81	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PROLACTIN_RECEPTOR_SIGNALING
1.23456790123%	1	81	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION
1.23456790123%	1	81	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MATZUK_OVULATION
1.23456790123%	1	81	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KINNEY_DNMT1_METHYLATION_TARGETS
1.23456790123%	1	81	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	INAMURA_LUNG_CANCER_SCC_DN
1.23456790123%	1	81	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
1.23456790123%	1	81	14	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_PS1_PATHWAY
1.23456790123%	1	81	139	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_BIOLOGICAL_OXIDATIONS
1.23456790123%	1	81	139	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
1.23456790123%	1	81	138	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	JIANG_VHL_TARGETS
1.23456790123%	1	81	136	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
1.23456790123%	1	81	135	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	UDAYAKUMAR_MED1_TARGETS_UP
1.23456790123%	1	81	134	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	POOLA_INVASIVE_BREAST_CANCER_DN
1.23456790123%	1	81	134	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHUNG_BLISTER_CYTOTOXICITY_UP
1.23456790123%	1	81	133	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON
1.23456790123%	1	81	131	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
1.23456790123%	1	81	130	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ELVIDGE_HYPOXIA_BY_DMOG_UP
1.23456790123%	1	81	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WAGSCHAL_EHMT2_TARGETS_UP
1.23456790123%	1	81	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHIN_B_CELL_LYMPHOMA_CLUSTER_1
1.23456790123%	1	81	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_POL_SWITCHING
1.23456790123%	1	81	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MATZUK_EARLY_ANTRAL_FOLLICLE
1.23456790123%	1	81	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LUI_THYROID_CANCER_CLUSTER_5
1.23456790123%	1	81	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KRISHNAN_FURIN_TARGETS_DN
1.23456790123%	1	81	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	IRITANI_MAD1_TARGETS_UP
1.23456790123%	1	81	13	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GERHOLD_RESPONSE_TO_TZD_DN
1.23456790123%	1	81	129	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KIM_WT1_TARGETS_8HR_DN
1.23456790123%	1	81	129	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BROWN_MYELOID_CELL_DEVELOPMENT_DN
1.23456790123%	1	81	128	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHU_CMV_ALL_DN
1.23456790123%	1	81	128	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
1.23456790123%	1	81	128	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LENAOUR_DENDRITIC_CELL_MATURATION_DN
1.23456790123%	1	81	127	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
1.23456790123%	1	81	127	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	INGRAM_SHH_TARGETS_UP
1.23456790123%	1	81	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
1.23456790123%	1	81	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
1.23456790123%	1	81	126	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GERY_CEBP_TARGETS
1.23456790123%	1	81	123	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KAYO_AGING_MUSCLE_DN
1.23456790123%	1	81	122	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TOOKER_GEMCITABINE_RESISTANCE_DN
1.23456790123%	1	81	122	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
1.23456790123%	1	81	122	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
1.23456790123%	1	81	121	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RODRIGUES_DCC_TARGETS_DN
1.23456790123%	1	81	12	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS
1.23456790123%	1	81	12	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING
1.23456790123%	1	81	12	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
1.23456790123%	1	81	12	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_CFTR_PATHWAY
1.23456790123%	1	81	116	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_MEIOSIS
1.23456790123%	1	81	116	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
1.23456790123%	1	81	116	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
1.23456790123%	1	81	115	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MARKEY_RB1_CHRONIC_LOF_UP
1.23456790123%	1	81	115	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
1.23456790123%	1	81	115	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HOELZEL_NF1_TARGETS_DN
1.23456790123%	1	81	114	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SENESE_HDAC2_TARGETS_UP
1.23456790123%	1	81	114	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LENAOUR_DENDRITIC_CELL_MATURATION_UP
1.23456790123%	1	81	114	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_OOCYTE_MEIOSIS
1.23456790123%	1	81	114	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CERVERA_SDHB_TARGETS_2
1.23456790123%	1	81	113	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
1.23456790123%	1	81	112	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_DNA_REPAIR
1.23456790123%	1	81	112	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PASINI_SUZ12_TARGETS_UP
1.23456790123%	1	81	112	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LAIHO_COLORECTAL_CANCER_SERRATED_UP
1.23456790123%	1	81	112	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LABBE_WNT3A_TARGETS_UP
1.23456790123%	1	81	112	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
1.23456790123%	1	81	111	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
1.23456790123%	1	81	110	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SUNG_METASTASIS_STROMA_UP
1.23456790123%	1	81	110	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
1.23456790123%	1	81	110	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
1.23456790123%	1	81	110	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
1.23456790123%	1	81	110	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GROSS_HYPOXIA_VIA_HIF1A_DN
1.23456790123%	1	81	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	STEGMEIER_PRE-MITOTIC_CELL_CYCLE_REGULATORS
1.23456790123%	1	81	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_IL_7_SIGNALING
1.23456790123%	1	81	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS
1.23456790123%	1	81	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KALMA_E2F1_TARGETS
1.23456790123%	1	81	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP
1.23456790123%	1	81	11	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BIOCARTA_EIF2_PATHWAY
1.23456790123%	1	81	109	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_S_PHASE
1.23456790123%	1	81	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	ZHANG_TLX_TARGETS_DN
1.23456790123%	1	81	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WESTON_VEGFA_TARGETS
1.23456790123%	1	81	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LE_EGR2_TARGETS_DN
1.23456790123%	1	81	108	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
1.23456790123%	1	81	106	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
1.23456790123%	1	81	106	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
1.23456790123%	1	81	105	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WOO_LIVER_CANCER_RECURRENCE_UP
1.23456790123%	1	81	104	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
1.23456790123%	1	81	104	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	NAKAMURA_ADIPOGENESIS_LATE_UP
1.23456790123%	1	81	103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
1.23456790123%	1	81	103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LEIN_CHOROID_PLEXUS_MARKERS
1.23456790123%	1	81	103	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KIM_MYCN_AMPLIFICATION_TARGETS_DN
1.23456790123%	1	81	102	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	LABBE_TGFB1_TARGETS_UP
1.23456790123%	1	81	102	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	KEGG_MELANOGENESIS
1.23456790123%	1	81	102	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DER_IFN_BETA_RESPONSE_UP
1.23456790123%	1	81	102	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
1.23456790123%	1	81	101	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WIELAND_UP_BY_HBV_INFECTION
1.23456790123%	1	81	101	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
1.23456790123%	1	81	101	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BROWNE_HCMV_INFECTION_20HR_DN
1.23456790123%	1	81	101	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BROWNE_HCMV_INFECTION_10HR_UP
1.23456790123%	1	81	100	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	WINZEN_DEGRADED_VIA_KHSRP
1.23456790123%	1	81	100	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MCCLUNG_CREB1_TARGETS_UP
1.23456790123%	1	81	100	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
1.23456790123%	1	81	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND
1.23456790123%	1	81	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	REACTOME_ANDROGEN_BIOSYNTHESIS
1.23456790123%	1	81	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	PYEON_HPV_POSITIVE_TUMORS_DN
1.23456790123%	1	81	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP
1.23456790123%	1	81	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	MATZUK_PREOVULATORY_FOLLICLE
1.23456790123%	1	81	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP
1.23456790123%	1	81	10	MODY_MONOGENIC_ONSET_DIABETES_OF_THE_YOUNG_ALL	BRUNEAU_SEPTATION_VENTRICULAR
1.22928915019%	23	1871	367	T2D_GENES_TANYA_HEIGHT	VECCHI_GASTRIC_CANCER_EARLY_DN
1.22928915019%	23	1871	306	T2D_GENES_TANYA_HEIGHT	CHANDRAN_METASTASIS_DN
1.22928915019%	23	1871	305	T2D_GENES_TANYA_HEIGHT	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
1.22928915019%	23	1871	293	T2D_GENES_TANYA_HEIGHT	ZHANG_TLX_TARGETS_60HR_UP
1.22928915019%	23	1871	289	T2D_GENES_TANYA_HEIGHT	GABRIELY_MIR21_TARGETS
1.22928915019%	23	1871	279	T2D_GENES_TANYA_HEIGHT	REACTOME_INNATE_IMMUNE_SYSTEM
1.22928915019%	23	1871	272	T2D_GENES_TANYA_HEIGHT	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
1.22928915019%	23	1871	271	T2D_GENES_TANYA_HEIGHT	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
1.22928915019%	23	1871	270	T2D_GENES_TANYA_HEIGHT	RIZKI_TUMOR_INVASIVENESS_3D_DN
1.22928915019%	23	1871	269	T2D_GENES_TANYA_HEIGHT	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
1.22928915019%	23	1871	254	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_4HR_DN
1.22928915019%	23	1871	253	T2D_GENES_TANYA_HEIGHT	DANG_REGULATED_BY_MYC_DN
1.22928915019%	23	1871	252	T2D_GENES_TANYA_HEIGHT	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
1.22928915019%	23	1871	247	T2D_GENES_TANYA_HEIGHT	REACTOME_METABOLISM_OF_CARBOHYDRATES
1.22928915019%	23	1871	246	T2D_GENES_TANYA_HEIGHT	VERHAAK_AML_WITH_NPM1_MUTATED_DN
1.22928915019%	23	1871	245	T2D_GENES_TANYA_HEIGHT	MCLACHLAN_DENTAL_CARIES_DN
1.22928915019%	23	1871	245	T2D_GENES_TANYA_HEIGHT	BLUM_RESPONSE_TO_SALIRASIB_UP
1.22928915019%	23	1871	242	T2D_GENES_TANYA_HEIGHT	CHYLA_CBFA2T3_TARGETS_DN
1.22928915019%	23	1871	240	T2D_GENES_TANYA_HEIGHT	VANTVEER_BREAST_CANCER_ESR1_DN
1.22928915019%	23	1871	229	T2D_GENES_TANYA_HEIGHT	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
1.22928915019%	23	1871	229	T2D_GENES_TANYA_HEIGHT	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
1.22928915019%	23	1871	227	T2D_GENES_TANYA_HEIGHT	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
1.22928915019%	23	1871	206	T2D_GENES_TANYA_HEIGHT	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
1.22928915019%	23	1871	203	T2D_GENES_TANYA_HEIGHT	REACTOME_INFLUENZA_LIFE_CYCLE
1.22928915019%	23	1871	202	T2D_GENES_TANYA_HEIGHT	FUJII_YBX1_TARGETS_DN
1.22928915019%	23	1871	193	T2D_GENES_TANYA_HEIGHT	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP
1.22928915019%	23	1871	184	T2D_GENES_TANYA_HEIGHT	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
1.22928915019%	23	1871	180	T2D_GENES_TANYA_HEIGHT	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
1.22928915019%	23	1871	172	T2D_GENES_TANYA_HEIGHT	REACTOME_MITOTIC_M_M_G1_PHASES
1.22928915019%	23	1871	167	T2D_GENES_TANYA_HEIGHT	VANTVEER_BREAST_CANCER_ESR1_UP
1.22928915019%	23	1871	164	T2D_GENES_TANYA_HEIGHT	AMIT_EGF_RESPONSE_480_HELA
1.22928915019%	23	1871	131	T2D_GENES_TANYA_HEIGHT	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
1.22793553338%	16	1303	720	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
1.22793553338%	16	1303	648	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BENPORATH_CYCLING_GENES
1.22793553338%	16	1303	517	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RAO_BOUND_BY_SALL4_ISOFORM_B
1.22793553338%	16	1303	485	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ENK_UV_RESPONSE_KERATINOCYTE_DN
1.22793553338%	16	1303	473	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GARY_CD5_TARGETS_UP
1.22793553338%	16	1303	464	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ONDER_CDH1_TARGETS_2_DN
1.22793553338%	16	1303	462	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DELACROIX_RAR_BOUND_ES
1.22793553338%	16	1303	422	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAGI_AML_WITH_INV_16_TRANSLOCATION
1.22793553338%	16	1303	421	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CELL_CYCLE
1.22793553338%	16	1303	392	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_2B
1.22793553338%	16	1303	371	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_SMARCE1_TARGETS_DN
1.22793553338%	16	1303	368	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAGI_AML_WITH_T_8_21_TRANSLOCATION
1.22793553338%	16	1303	366	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SANSOM_APC_TARGETS_DN
1.22793553338%	16	1303	364	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YANG_BCL3_TARGETS_UP
1.22793553338%	16	1303	326	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
1.22793553338%	16	1303	325	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CELL_CYCLE_MITOTIC
1.22793553338%	16	1303	309	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
1.22793553338%	16	1303	287	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
1.22793553338%	16	1303	212	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SANSOM_APC_TARGETS
1.22159090909%	43	3520	633	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
1.22159090909%	43	3520	485	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ENK_UV_RESPONSE_KERATINOCYTE_DN
1.22159090909%	43	3520	435	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SWEET_LUNG_CANCER_KRAS_DN
1.22159090909%	43	3520	430	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RIGGI_EWING_SARCOMA_PROGENITOR_UP
1.22159090909%	43	3520	397	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
1.22159090909%	43	3520	380	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
1.22159090909%	43	3520	287	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
1.22159090909%	43	3520	217	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMUNDSON_RESPONSE_TO_ARSENITE
1.21580547112%	24	1974	95	Mendelian_Nancy_Cox	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
1.21580547112%	24	1974	87	Mendelian_Nancy_Cox	SMITH_TERT_TARGETS_DN
1.21580547112%	24	1974	87	Mendelian_Nancy_Cox	MOOTHA_VOXPHOS
1.21580547112%	24	1974	86	Mendelian_Nancy_Cox	REACTOME_L1CAM_INTERACTIONS
1.21580547112%	24	1974	84	Mendelian_Nancy_Cox	PID_CMYB_PATHWAY
1.21580547112%	24	1974	79	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16
1.21580547112%	24	1974	79	Mendelian_Nancy_Cox	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
1.21580547112%	24	1974	78	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_SCF_KIT
1.21580547112%	24	1974	70	Mendelian_Nancy_Cox	KEGG_RENAL_CELL_CARCINOMA
1.21580547112%	24	1974	66	Mendelian_Nancy_Cox	PID_HIF1_TFPATHWAY
1.21580547112%	24	1974	65	Mendelian_Nancy_Cox	KEGG_GLIOMA
1.21580547112%	24	1974	62	Mendelian_Nancy_Cox	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
1.21580547112%	24	1974	60	Mendelian_Nancy_Cox	KEGG_ACUTE_MYELOID_LEUKEMIA
1.21580547112%	24	1974	52	Mendelian_Nancy_Cox	KEGG_ENDOMETRIAL_CANCER
1.21580547112%	24	1974	229	Mendelian_Nancy_Cox	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
1.21580547112%	24	1974	214	Mendelian_Nancy_Cox	BIDUS_METASTASIS_UP
1.21580547112%	24	1974	197	Mendelian_Nancy_Cox	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
1.21580547112%	24	1974	191	Mendelian_Nancy_Cox	RIGGI_EWING_SARCOMA_PROGENITOR_DN
1.21580547112%	24	1974	185	Mendelian_Nancy_Cox	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
1.21580547112%	24	1974	181	Mendelian_Nancy_Cox	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
1.21580547112%	24	1974	172	Mendelian_Nancy_Cox	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
1.21580547112%	24	1974	165	Mendelian_Nancy_Cox	DARWICHE_PAPILLOMA_RISK_LOW_DN
1.21580547112%	24	1974	164	Mendelian_Nancy_Cox	AMIT_EGF_RESPONSE_480_HELA
1.21580547112%	24	1974	147	Mendelian_Nancy_Cox	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
1.21580547112%	24	1974	141	Mendelian_Nancy_Cox	SABATES_COLORECTAL_ADENOMA_UP
1.21580547112%	24	1974	131	Mendelian_Nancy_Cox	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
1.21580547112%	24	1974	130	Mendelian_Nancy_Cox	YAGI_AML_WITH_T_9_11_TRANSLOCATION
1.21580547112%	24	1974	129	Mendelian_Nancy_Cox	REACTOME_MEMBRANE_TRAFFICKING
1.21580547112%	24	1974	116	Mendelian_Nancy_Cox	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
1.21580547112%	24	1974	114	Mendelian_Nancy_Cox	CERVERA_SDHB_TARGETS_2
1.21580547112%	24	1974	111	Mendelian_Nancy_Cox	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
1.21580547112%	24	1974	109	Mendelian_Nancy_Cox	SERVITJA_ISLET_HNF1A_TARGETS_DN
1.21580547112%	24	1974	107	Mendelian_Nancy_Cox	ROESSLER_LIVER_CANCER_METASTASIS_UP
1.21580547112%	24	1974	102	Mendelian_Nancy_Cox	PID_CXCR4_PATHWAY
1.21580547112%	24	1974	102	Mendelian_Nancy_Cox	LABBE_TGFB1_TARGETS_UP
1.21028744327%	8	661	45	T2D_GENES_TANYA_GLYCEMIC	PID_HNF3BPATHWAY
1.21028744327%	8	661	362	T2D_GENES_TANYA_GLYCEMIC	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
1.21028744327%	8	661	353	T2D_GENES_TANYA_GLYCEMIC	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
1.21028744327%	8	661	318	T2D_GENES_TANYA_GLYCEMIC	LEI_MYB_TARGETS
1.21028744327%	8	661	294	T2D_GENES_TANYA_GLYCEMIC	WEST_ADRENOCORTICAL_TUMOR_UP
1.21028744327%	8	661	284	T2D_GENES_TANYA_GLYCEMIC	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
1.21028744327%	8	661	279	T2D_GENES_TANYA_GLYCEMIC	REACTOME_NEURONAL_SYSTEM
1.21028744327%	8	661	271	T2D_GENES_TANYA_GLYCEMIC	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
1.21028744327%	8	661	267	T2D_GENES_TANYA_GLYCEMIC	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
1.21028744327%	8	661	259	T2D_GENES_TANYA_GLYCEMIC	QI_PLASMACYTOMA_UP
1.21028744327%	8	661	254	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_4HR_DN
1.21028744327%	8	661	253	T2D_GENES_TANYA_GLYCEMIC	MCLACHLAN_DENTAL_CARIES_UP
1.21028744327%	8	661	251	T2D_GENES_TANYA_GLYCEMIC	KOBAYASHI_EGFR_SIGNALING_24HR_DN
1.21028744327%	8	661	246	T2D_GENES_TANYA_GLYCEMIC	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
1.21028744327%	8	661	244	T2D_GENES_TANYA_GLYCEMIC	PLASARI_TGFB1_TARGETS_10HR_DN
1.21028744327%	8	661	242	T2D_GENES_TANYA_GLYCEMIC	WINTER_HYPOXIA_METAGENE
1.21028744327%	8	661	242	T2D_GENES_TANYA_GLYCEMIC	MULLIGHAN_MLL_SIGNATURE_1_DN
1.21028744327%	8	661	242	T2D_GENES_TANYA_GLYCEMIC	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
1.21028744327%	8	661	240	T2D_GENES_TANYA_GLYCEMIC	VANTVEER_BREAST_CANCER_ESR1_DN
1.21028744327%	8	661	233	T2D_GENES_TANYA_GLYCEMIC	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
1.21028744327%	8	661	230	T2D_GENES_TANYA_GLYCEMIC	BENPORATH_MYC_TARGETS_WITH_EBOX
1.21028744327%	8	661	226	T2D_GENES_TANYA_GLYCEMIC	KYNG_DNA_DAMAGE_UP
1.21028744327%	8	661	216	T2D_GENES_TANYA_GLYCEMIC	BOQUEST_STEM_CELL_DN
1.21028744327%	8	661	215	T2D_GENES_TANYA_GLYCEMIC	MARKEY_RB1_ACUTE_LOF_UP
1.21028744327%	8	661	214	T2D_GENES_TANYA_GLYCEMIC	TIEN_INTESTINE_PROBIOTICS_24HR_DN
1.21028744327%	8	661	214	T2D_GENES_TANYA_GLYCEMIC	BIDUS_METASTASIS_UP
1.21028744327%	8	661	214	T2D_GENES_TANYA_GLYCEMIC	AFFAR_YY1_TARGETS_UP
1.21028744327%	8	661	210	T2D_GENES_TANYA_GLYCEMIC	VERHAAK_GLIOBLASTOMA_PRONEURAL
1.21028744327%	8	661	208	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
1.21028744327%	8	661	206	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
1.21028744327%	8	661	205	T2D_GENES_TANYA_GLYCEMIC	PEREZ_TP53_AND_TP63_TARGETS
1.21028744327%	8	661	200	T2D_GENES_TANYA_GLYCEMIC	SHEPARD_BMYB_MORPHOLINO_DN
1.21028744327%	8	661	196	T2D_GENES_TANYA_GLYCEMIC	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
1.21028744327%	8	661	196	T2D_GENES_TANYA_GLYCEMIC	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
1.21028744327%	8	661	196	T2D_GENES_TANYA_GLYCEMIC	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
1.21028744327%	8	661	194	T2D_GENES_TANYA_GLYCEMIC	PROVENZANI_METASTASIS_UP
1.21028744327%	8	661	193	T2D_GENES_TANYA_GLYCEMIC	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
1.21028744327%	8	661	187	T2D_GENES_TANYA_GLYCEMIC	BAKKER_FOXO3_TARGETS_DN
1.21028744327%	8	661	184	T2D_GENES_TANYA_GLYCEMIC	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
1.21028744327%	8	661	183	T2D_GENES_TANYA_GLYCEMIC	VERHAAK_AML_WITH_NPM1_MUTATED_UP
1.21028744327%	8	661	180	T2D_GENES_TANYA_GLYCEMIC	DARWICHE_PAPILLOMA_RISK_HIGH_DN
1.21028744327%	8	661	176	T2D_GENES_TANYA_GLYCEMIC	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
1.21028744327%	8	661	172	T2D_GENES_TANYA_GLYCEMIC	SMID_BREAST_CANCER_LUMINAL_B_UP
1.21028744327%	8	661	162	T2D_GENES_TANYA_GLYCEMIC	MULLIGHAN_NPM1_SIGNATURE_3_DN
1.21028744327%	8	661	158	T2D_GENES_TANYA_GLYCEMIC	RODRIGUES_NTN1_TARGETS_DN
1.21028744327%	8	661	148	T2D_GENES_TANYA_GLYCEMIC	WHITFIELD_CELL_CYCLE_M_G1
1.21028744327%	8	661	148	T2D_GENES_TANYA_GLYCEMIC	WEI_MIR34A_TARGETS
1.21028744327%	8	661	146	T2D_GENES_TANYA_GLYCEMIC	KIM_ALL_DISORDERS_DURATION_CORR_DN
1.21028744327%	8	661	145	T2D_GENES_TANYA_GLYCEMIC	ZHANG_BREAST_CANCER_PROGENITORS_DN
1.21028744327%	8	661	138	T2D_GENES_TANYA_GLYCEMIC	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
1.21028744327%	8	661	132	T2D_GENES_TANYA_GLYCEMIC	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
1.21028744327%	8	661	118	T2D_GENES_TANYA_GLYCEMIC	LEE_NEURAL_CREST_STEM_CELL_DN
1.19760479042%	14	1169	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_DRUG_METABOLISM_CYTOCHROME_P450
1.19760479042%	14	1169	579	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
1.19760479042%	14	1169	564	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMID_BREAST_CANCER_LUMINAL_B_DN
1.19760479042%	14	1169	553	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FEVR_CTNNB1_TARGETS_DN
1.19760479042%	14	1169	518	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
1.19760479042%	14	1169	505	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
1.19760479042%	14	1169	481	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIU_PROSTATE_CANCER_DN
1.19760479042%	14	1169	464	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ONDER_CDH1_TARGETS_2_DN
1.19760479042%	14	1169	456	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ODONNELL_TFRC_TARGETS_UP
1.19760479042%	14	1169	430	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RIGGI_EWING_SARCOMA_PROGENITOR_UP
1.19760479042%	14	1169	428	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CUI_TCF21_TARGETS_2_UP
1.19760479042%	14	1169	420	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOOTHA_PGC
1.19760479042%	14	1169	414	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LU_EZH2_TARGETS_DN
1.19760479042%	14	1169	394	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BERENJENO_TRANSFORMED_BY_RHOA_DN
1.19760479042%	14	1169	390	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HATADA_METHYLATED_IN_LUNG_CANCER_UP
1.19760479042%	14	1169	384	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BASAKI_YBX1_TARGETS_DN
1.19760479042%	14	1169	371	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_SMARCE1_TARGETS_DN
1.19760479042%	14	1169	355	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PEREZ_TP63_TARGETS
1.19760479042%	14	1169	349	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
1.19760479042%	14	1169	315	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
1.19760479042%	14	1169	307	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
1.19760479042%	14	1169	281	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BHAT_ESR1_TARGETS_VIA_AKT1_UP
1.19760479042%	14	1169	269	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_CLIM2_TARGETS_UP
1.19760479042%	14	1169	244	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KAYO_AGING_MUSCLE_UP
1.19760479042%	14	1169	216	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOQUEST_STEM_CELL_DN
1.19760479042%	14	1169	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SANSOM_APC_TARGETS_REQUIRE_MYC
1.19760479042%	14	1169	207	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
1.19760479042%	14	1169	185	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DARWICHE_SKIN_TUMOR_PROMOTER_DN
1.19760479042%	14	1169	180	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
1.19760479042%	14	1169	122	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
1.19595216191%	26	2174	73	T2D_GENES_TANYA_LIPIDS	REACTOME_MEIOTIC_SYNAPSIS
1.19595216191%	26	2174	330	T2D_GENES_TANYA_LIPIDS	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
1.19595216191%	26	2174	283	T2D_GENES_TANYA_LIPIDS	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
1.19595216191%	26	2174	280	T2D_GENES_TANYA_LIPIDS	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
1.19595216191%	26	2174	270	T2D_GENES_TANYA_LIPIDS	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
1.19595216191%	26	2174	246	T2D_GENES_TANYA_LIPIDS	BILD_E2F3_ONCOGENIC_SIGNATURE
1.19595216191%	26	2174	245	T2D_GENES_TANYA_LIPIDS	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
1.19595216191%	26	2174	245	T2D_GENES_TANYA_LIPIDS	MCLACHLAN_DENTAL_CARIES_DN
1.19595216191%	26	2174	234	T2D_GENES_TANYA_LIPIDS	AFFAR_YY1_TARGETS_DN
1.19595216191%	26	2174	216	T2D_GENES_TANYA_LIPIDS	WHITFIELD_CELL_CYCLE_G2_M
1.19595216191%	26	2174	210	T2D_GENES_TANYA_LIPIDS	RIZKI_TUMOR_INVASIVENESS_3D_UP
1.19595216191%	26	2174	207	T2D_GENES_TANYA_LIPIDS	MANALO_HYPOXIA_UP
1.19595216191%	26	2174	198	T2D_GENES_TANYA_LIPIDS	REACTOME_PHOSPHOLIPID_METABOLISM
1.19595216191%	26	2174	184	T2D_GENES_TANYA_LIPIDS	DOANE_RESPONSE_TO_ANDROGEN_UP
1.19595216191%	26	2174	182	T2D_GENES_TANYA_LIPIDS	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
1.19595216191%	26	2174	181	T2D_GENES_TANYA_LIPIDS	JISON_SICKLE_CELL_DISEASE_UP
1.19595216191%	26	2174	181	T2D_GENES_TANYA_LIPIDS	JISON_SICKLE_CELL_DISEASE_DN
1.19595216191%	26	2174	180	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_48HR_UP
1.19595216191%	26	2174	171	T2D_GENES_TANYA_LIPIDS	ELVIDGE_HYPOXIA_UP
1.19595216191%	26	2174	156	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_14HR_UP
1.19595216191%	26	2174	152	T2D_GENES_TANYA_LIPIDS	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
1.19318181818%	42	3520	464	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ONDER_CDH1_TARGETS_2_DN
1.19318181818%	42	3520	411	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KOYAMA_SEMA3B_TARGETS_DN
1.19318181818%	42	3520	395	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HAN_SATB1_TARGETS_UP
1.19318181818%	42	3520	394	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BERENJENO_TRANSFORMED_BY_RHOA_DN
1.19318181818%	42	3520	367	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DELACROIX_RARG_BOUND_MEF
1.19318181818%	42	3520	358	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRUETZMANN_PANCREATIC_CANCER_UP
1.19318181818%	42	3520	222	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAIRO_LIVER_DEVELOPMENT_DN
1.18577075099%	3	253	97	Diabetes_McGill_CREBBP_coTF	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
1.18577075099%	3	253	97	Diabetes_McGill_CREBBP_coTF	KIM_MYC_AMPLIFICATION_TARGETS_DN
1.18577075099%	3	253	96	Diabetes_McGill_CREBBP_coTF	LIU_PROSTATE_CANCER_UP
1.18577075099%	3	253	95	Diabetes_McGill_CREBBP_coTF	HOEBEKE_LYMPHOID_STEM_CELL_UP
1.18577075099%	3	253	95	Diabetes_McGill_CREBBP_coTF	HECKER_IFNB1_TARGETS
1.18577075099%	3	253	95	Diabetes_McGill_CREBBP_coTF	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
1.18577075099%	3	253	94	Diabetes_McGill_CREBBP_coTF	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5
1.18577075099%	3	253	94	Diabetes_McGill_CREBBP_coTF	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER
1.18577075099%	3	253	93	Diabetes_McGill_CREBBP_coTF	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
1.18577075099%	3	253	92	Diabetes_McGill_CREBBP_coTF	REACTOME_SYNTHESIS_OF_DNA
1.18577075099%	3	253	91	Diabetes_McGill_CREBBP_coTF	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN
1.18577075099%	3	253	90	Diabetes_McGill_CREBBP_coTF	IGARASHI_ATF4_TARGETS_DN
1.18577075099%	3	253	90	Diabetes_McGill_CREBBP_coTF	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN
1.18577075099%	3	253	9	Diabetes_McGill_CREBBP_coTF	ST_TYPE_I_INTERFERON_PATHWAY
1.18577075099%	3	253	9	Diabetes_McGill_CREBBP_coTF	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA
1.18577075099%	3	253	9	Diabetes_McGill_CREBBP_coTF	BENPORATH_ES_CORE_NINE
1.18577075099%	3	253	89	Diabetes_McGill_CREBBP_coTF	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
1.18577075099%	3	253	89	Diabetes_McGill_CREBBP_coTF	BHATTACHARYA_EMBRYONIC_STEM_CELL
1.18577075099%	3	253	88	Diabetes_McGill_CREBBP_coTF	UEDA_CENTRAL_CLOCK
1.18577075099%	3	253	88	Diabetes_McGill_CREBBP_coTF	SASSON_RESPONSE_TO_FORSKOLIN_DN
1.18577075099%	3	253	88	Diabetes_McGill_CREBBP_coTF	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
1.18577075099%	3	253	87	Diabetes_McGill_CREBBP_coTF	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
1.18577075099%	3	253	87	Diabetes_McGill_CREBBP_coTF	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
1.18577075099%	3	253	87	Diabetes_McGill_CREBBP_coTF	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
1.18577075099%	3	253	86	Diabetes_McGill_CREBBP_coTF	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
1.18577075099%	3	253	86	Diabetes_McGill_CREBBP_coTF	NELSON_RESPONSE_TO_ANDROGEN_UP
1.18577075099%	3	253	86	Diabetes_McGill_CREBBP_coTF	LEE_AGING_CEREBELLUM_DN
1.18577075099%	3	253	86	Diabetes_McGill_CREBBP_coTF	HOEBEKE_LYMPHOID_STEM_CELL_DN
1.18577075099%	3	253	85	Diabetes_McGill_CREBBP_coTF	XU_GH1_EXOGENOUS_TARGETS_UP
1.18577075099%	3	253	85	Diabetes_McGill_CREBBP_coTF	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
1.18577075099%	3	253	85	Diabetes_McGill_CREBBP_coTF	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
1.18577075099%	3	253	84	Diabetes_McGill_CREBBP_coTF	LEE_AGING_CEREBELLUM_UP
1.18577075099%	3	253	83	Diabetes_McGill_CREBBP_coTF	WARTERS_RESPONSE_TO_IR_SKIN
1.18577075099%	3	253	83	Diabetes_McGill_CREBBP_coTF	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
1.18577075099%	3	253	83	Diabetes_McGill_CREBBP_coTF	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
1.18577075099%	3	253	81	Diabetes_McGill_CREBBP_coTF	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
1.18577075099%	3	253	81	Diabetes_McGill_CREBBP_coTF	CROMER_METASTASIS_DN
1.18577075099%	3	253	80	Diabetes_McGill_CREBBP_coTF	REACTOME_UNFOLDED_PROTEIN_RESPONSE
1.18577075099%	3	253	80	Diabetes_McGill_CREBBP_coTF	LEE_AGING_NEOCORTEX_DN
1.18577075099%	3	253	80	Diabetes_McGill_CREBBP_coTF	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN
1.18577075099%	3	253	80	Diabetes_McGill_CREBBP_coTF	BASSO_HAIRY_CELL_LEUKEMIA_DN
1.18577075099%	3	253	8	Diabetes_McGill_CREBBP_coTF	NADELLA_PRKAR1A_TARGETS_DN
1.18577075099%	3	253	79	Diabetes_McGill_CREBBP_coTF	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
1.18577075099%	3	253	79	Diabetes_McGill_CREBBP_coTF	CROMER_METASTASIS_UP
1.18577075099%	3	253	78	Diabetes_McGill_CREBBP_coTF	REACTOME_OPIOID_SIGNALLING
1.18577075099%	3	253	78	Diabetes_McGill_CREBBP_coTF	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP
1.18577075099%	3	253	78	Diabetes_McGill_CREBBP_coTF	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE
1.18577075099%	3	253	77	Diabetes_McGill_CREBBP_coTF	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN
1.18577075099%	3	253	77	Diabetes_McGill_CREBBP_coTF	LIN_APC_TARGETS
1.18577075099%	3	253	77	Diabetes_McGill_CREBBP_coTF	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
1.18577075099%	3	253	76	Diabetes_McGill_CREBBP_coTF	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
1.18577075099%	3	253	76	Diabetes_McGill_CREBBP_coTF	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
1.18577075099%	3	253	75	Diabetes_McGill_CREBBP_coTF	JAIN_NFKB_SIGNALING
1.18577075099%	3	253	75	Diabetes_McGill_CREBBP_coTF	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
1.18577075099%	3	253	75	Diabetes_McGill_CREBBP_coTF	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
1.18577075099%	3	253	74	Diabetes_McGill_CREBBP_coTF	SHEPARD_BMYB_TARGETS
1.18577075099%	3	253	73	Diabetes_McGill_CREBBP_coTF	LIN_MELANOMA_COPY_NUMBER_UP
1.18577075099%	3	253	72	Diabetes_McGill_CREBBP_coTF	SESTO_RESPONSE_TO_UV_C1
1.18577075099%	3	253	72	Diabetes_McGill_CREBBP_coTF	HUANG_GATA2_TARGETS_DN
1.18577075099%	3	253	70	Diabetes_McGill_CREBBP_coTF	VERNELL_RETINOBLASTOMA_PATHWAY_UP
1.18577075099%	3	253	70	Diabetes_McGill_CREBBP_coTF	PID_CDC42_PATHWAY
1.18577075099%	3	253	7	Diabetes_McGill_CREBBP_coTF	MIKI_COEXPRESSED_WITH_CYP19A1
1.18577075099%	3	253	69	Diabetes_McGill_CREBBP_coTF	ZAMORA_NOS2_TARGETS_UP
1.18577075099%	3	253	69	Diabetes_McGill_CREBBP_coTF	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN
1.18577075099%	3	253	69	Diabetes_McGill_CREBBP_coTF	RIZKI_TUMOR_INVASIVENESS_2D_UP
1.18577075099%	3	253	69	Diabetes_McGill_CREBBP_coTF	RHODES_UNDIFFERENTIATED_CANCER
1.18577075099%	3	253	68	Diabetes_McGill_CREBBP_coTF	LIN_NPAS4_TARGETS_DN
1.18577075099%	3	253	67	Diabetes_McGill_CREBBP_coTF	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP
1.18577075099%	3	253	67	Diabetes_McGill_CREBBP_coTF	LINDSTEDT_DENDRITIC_CELL_MATURATION_A
1.18577075099%	3	253	67	Diabetes_McGill_CREBBP_coTF	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
1.18577075099%	3	253	66	Diabetes_McGill_CREBBP_coTF	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES
1.18577075099%	3	253	66	Diabetes_McGill_CREBBP_coTF	KIM_GERMINAL_CENTER_T_HELPER_UP
1.18577075099%	3	253	66	Diabetes_McGill_CREBBP_coTF	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
1.18577075099%	3	253	65	Diabetes_McGill_CREBBP_coTF	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX
1.18577075099%	3	253	65	Diabetes_McGill_CREBBP_coTF	GUO_HEX_TARGETS_DN
1.18577075099%	3	253	65	Diabetes_McGill_CREBBP_coTF	CHANG_IMMORTALIZED_BY_HPV31_DN
1.18577075099%	3	253	64	Diabetes_McGill_CREBBP_coTF	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
1.18577075099%	3	253	64	Diabetes_McGill_CREBBP_coTF	REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE
1.18577075099%	3	253	64	Diabetes_McGill_CREBBP_coTF	PETROVA_PROX1_TARGETS_DN
1.18577075099%	3	253	64	Diabetes_McGill_CREBBP_coTF	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
1.18577075099%	3	253	64	Diabetes_McGill_CREBBP_coTF	INGRAM_SHH_TARGETS_DN
1.18577075099%	3	253	64	Diabetes_McGill_CREBBP_coTF	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
1.18577075099%	3	253	64	Diabetes_McGill_CREBBP_coTF	GERHOLD_ADIPOGENESIS_DN
1.18577075099%	3	253	64	Diabetes_McGill_CREBBP_coTF	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
1.18577075099%	3	253	63	Diabetes_McGill_CREBBP_coTF	PID_ENDOTHELINPATHWAY
1.18577075099%	3	253	62	Diabetes_McGill_CREBBP_coTF	MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN
1.18577075099%	3	253	62	Diabetes_McGill_CREBBP_coTF	KYNG_DNA_DAMAGE_BY_UV
1.18577075099%	3	253	62	Diabetes_McGill_CREBBP_coTF	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP
1.18577075099%	3	253	61	Diabetes_McGill_CREBBP_coTF	REN_BOUND_BY_E2F
1.18577075099%	3	253	61	Diabetes_McGill_CREBBP_coTF	MASSARWEH_RESPONSE_TO_ESTRADIOL
1.18577075099%	3	253	61	Diabetes_McGill_CREBBP_coTF	GENTILE_RESPONSE_CLUSTER_D3
1.18577075099%	3	253	61	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_1HR_UP
1.18577075099%	3	253	60	Diabetes_McGill_CREBBP_coTF	LEE_LIVER_CANCER_CIPROFIBRATE_UP
1.18577075099%	3	253	60	Diabetes_McGill_CREBBP_coTF	CROONQUIST_STROMAL_STIMULATION_UP
1.18577075099%	3	253	59	Diabetes_McGill_CREBBP_coTF	PID_FAK_PATHWAY
1.18577075099%	3	253	58	Diabetes_McGill_CREBBP_coTF	LUCAS_HNF4A_TARGETS_UP
1.18577075099%	3	253	57	Diabetes_McGill_CREBBP_coTF	REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE
1.18577075099%	3	253	57	Diabetes_McGill_CREBBP_coTF	PEART_HDAC_PROLIFERATION_CLUSTER_UP
1.18577075099%	3	253	57	Diabetes_McGill_CREBBP_coTF	MCCLUNG_CREB1_TARGETS_DN
1.18577075099%	3	253	57	Diabetes_McGill_CREBBP_coTF	DIRMEIER_LMP1_RESPONSE_LATE_UP
1.18577075099%	3	253	57	Diabetes_McGill_CREBBP_coTF	BURTON_ADIPOGENESIS_11
1.18577075099%	3	253	57	Diabetes_McGill_CREBBP_coTF	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
1.18577075099%	3	253	56	Diabetes_McGill_CREBBP_coTF	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP
1.18577075099%	3	253	56	Diabetes_McGill_CREBBP_coTF	LY_AGING_OLD_DN
1.18577075099%	3	253	55	Diabetes_McGill_CREBBP_coTF	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53
1.18577075099%	3	253	548	Diabetes_McGill_CREBBP_coTF	KIM_ALL_DISORDERS_CALB1_CORR_UP
1.18577075099%	3	253	53	Diabetes_McGill_CREBBP_coTF	MENSSEN_MYC_TARGETS
1.18577075099%	3	253	52	Diabetes_McGill_CREBBP_coTF	VILIMAS_NOTCH1_TARGETS_UP
1.18577075099%	3	253	52	Diabetes_McGill_CREBBP_coTF	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN
1.18577075099%	3	253	52	Diabetes_McGill_CREBBP_coTF	RADAEVA_RESPONSE_TO_IFNA1_UP
1.18577075099%	3	253	52	Diabetes_McGill_CREBBP_coTF	BECKER_TAMOXIFEN_RESISTANCE_DN
1.18577075099%	3	253	517	Diabetes_McGill_CREBBP_coTF	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
1.18577075099%	3	253	51	Diabetes_McGill_CREBBP_coTF	ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF
1.18577075099%	3	253	50	Diabetes_McGill_CREBBP_coTF	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
1.18577075099%	3	253	50	Diabetes_McGill_CREBBP_coTF	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
1.18577075099%	3	253	50	Diabetes_McGill_CREBBP_coTF	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC
1.18577075099%	3	253	50	Diabetes_McGill_CREBBP_coTF	CHIBA_RESPONSE_TO_TSA
1.18577075099%	3	253	50	Diabetes_McGill_CREBBP_coTF	BECKER_TAMOXIFEN_RESISTANCE_UP
1.18577075099%	3	253	5	Diabetes_McGill_CREBBP_coTF	TURJANSKI_MAPK11_TARGETS
1.18577075099%	3	253	49	Diabetes_McGill_CREBBP_coTF	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8
1.18577075099%	3	253	49	Diabetes_McGill_CREBBP_coTF	MARCHINI_TRABECTEDIN_RESISTANCE_DN
1.18577075099%	3	253	49	Diabetes_McGill_CREBBP_coTF	FAELT_B_CLL_WITH_VH3_21_DN
1.18577075099%	3	253	49	Diabetes_McGill_CREBBP_coTF	APRELIKOVA_BRCA1_TARGETS
1.18577075099%	3	253	48	Diabetes_McGill_CREBBP_coTF	PID_CERAMIDE_PATHWAY
1.18577075099%	3	253	48	Diabetes_McGill_CREBBP_coTF	PID_AJDISS_2PATHWAY
1.18577075099%	3	253	48	Diabetes_McGill_CREBBP_coTF	OXFORD_RALA_OR_RALB_TARGETS_UP
1.18577075099%	3	253	47	Diabetes_McGill_CREBBP_coTF	BOYLAN_MULTIPLE_MYELOMA_C_UP
1.18577075099%	3	253	46	Diabetes_McGill_CREBBP_coTF	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
1.18577075099%	3	253	46	Diabetes_McGill_CREBBP_coTF	PID_A6B1_A6B4_INTEGRIN_PATHWAY
1.18577075099%	3	253	46	Diabetes_McGill_CREBBP_coTF	OSADA_ASCL1_TARGETS_UP
1.18577075099%	3	253	46	Diabetes_McGill_CREBBP_coTF	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN
1.18577075099%	3	253	45	Diabetes_McGill_CREBBP_coTF	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP
1.18577075099%	3	253	45	Diabetes_McGill_CREBBP_coTF	SHIPP_DLBCL_CURED_VS_FATAL_DN
1.18577075099%	3	253	45	Diabetes_McGill_CREBBP_coTF	MCDOWELL_ACUTE_LUNG_INJURY_UP
1.18577075099%	3	253	45	Diabetes_McGill_CREBBP_coTF	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
1.18577075099%	3	253	445	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
1.18577075099%	3	253	44	Diabetes_McGill_CREBBP_coTF	PARK_HSC_MARKERS
1.18577075099%	3	253	44	Diabetes_McGill_CREBBP_coTF	FAELT_B_CLL_WITH_VH3_21_UP
1.18577075099%	3	253	43	Diabetes_McGill_CREBBP_coTF	REACTOME_PLC_BETA_MEDIATED_EVENTS
1.18577075099%	3	253	43	Diabetes_McGill_CREBBP_coTF	FUJII_YBX1_TARGETS_UP
1.18577075099%	3	253	43	Diabetes_McGill_CREBBP_coTF	DORN_ADENOVIRUS_INFECTION_24HR_DN
1.18577075099%	3	253	42	Diabetes_McGill_CREBBP_coTF	ONO_FOXP3_TARGETS_DN
1.18577075099%	3	253	41	Diabetes_McGill_CREBBP_coTF	LI_LUNG_CANCER
1.18577075099%	3	253	41	Diabetes_McGill_CREBBP_coTF	GENTILE_UV_RESPONSE_CLUSTER_D2
1.18577075099%	3	253	40	Diabetes_McGill_CREBBP_coTF	ST_JNK_MAPK_PATHWAY
1.18577075099%	3	253	40	Diabetes_McGill_CREBBP_coTF	DORN_ADENOVIRUS_INFECTION_48HR_DN
1.18577075099%	3	253	40	Diabetes_McGill_CREBBP_coTF	BURTON_ADIPOGENESIS_PEAK_AT_16HR
1.18577075099%	3	253	397	Diabetes_McGill_CREBBP_coTF	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
1.18577075099%	3	253	39	Diabetes_McGill_CREBBP_coTF	SESTO_RESPONSE_TO_UV_C6
1.18577075099%	3	253	39	Diabetes_McGill_CREBBP_coTF	REACTOME_IL1_SIGNALING
1.18577075099%	3	253	39	Diabetes_McGill_CREBBP_coTF	POTTI_PACLITAXEL_SENSITIVITY
1.18577075099%	3	253	39	Diabetes_McGill_CREBBP_coTF	PID_ATR_PATHWAY
1.18577075099%	3	253	39	Diabetes_McGill_CREBBP_coTF	MA_MYELOID_DIFFERENTIATION_UP
1.18577075099%	3	253	39	Diabetes_McGill_CREBBP_coTF	KORKOLA_TERATOMA
1.18577075099%	3	253	39	Diabetes_McGill_CREBBP_coTF	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
1.18577075099%	3	253	39	Diabetes_McGill_CREBBP_coTF	DORN_ADENOVIRUS_INFECTION_32HR_DN
1.18577075099%	3	253	39	Diabetes_McGill_CREBBP_coTF	AMIT_EGF_RESPONSE_60_MCF10A
1.18577075099%	3	253	388	Diabetes_McGill_CREBBP_coTF	STEIN_ESRRA_TARGETS_UP
1.18577075099%	3	253	382	Diabetes_McGill_CREBBP_coTF	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
1.18577075099%	3	253	38	Diabetes_McGill_CREBBP_coTF	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4
1.18577075099%	3	253	38	Diabetes_McGill_CREBBP_coTF	PID_FASPATHWAY
1.18577075099%	3	253	38	Diabetes_McGill_CREBBP_coTF	PID_ERBB4_PATHWAY
1.18577075099%	3	253	38	Diabetes_McGill_CREBBP_coTF	ONGUSAHA_TP53_TARGETS
1.18577075099%	3	253	38	Diabetes_McGill_CREBBP_coTF	GEISS_RESPONSE_TO_DSRNA_UP
1.18577075099%	3	253	37	Diabetes_McGill_CREBBP_coTF	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
1.18577075099%	3	253	37	Diabetes_McGill_CREBBP_coTF	HOWLIN_CITED1_TARGETS_1_DN
1.18577075099%	3	253	36	Diabetes_McGill_CREBBP_coTF	YIH_RESPONSE_TO_ARSENITE_C3
1.18577075099%	3	253	36	Diabetes_McGill_CREBBP_coTF	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2
1.18577075099%	3	253	36	Diabetes_McGill_CREBBP_coTF	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
1.18577075099%	3	253	36	Diabetes_McGill_CREBBP_coTF	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
1.18577075099%	3	253	36	Diabetes_McGill_CREBBP_coTF	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
1.18577075099%	3	253	36	Diabetes_McGill_CREBBP_coTF	BIOCARTA_AT1R_PATHWAY
1.18577075099%	3	253	35	Diabetes_McGill_CREBBP_coTF	WEIGEL_OXIDATIVE_STRESS_RESPONSE
1.18577075099%	3	253	35	Diabetes_McGill_CREBBP_coTF	PID_HIVNEFPATHWAY
1.18577075099%	3	253	35	Diabetes_McGill_CREBBP_coTF	KEGG_PRION_DISEASES
1.18577075099%	3	253	35	Diabetes_McGill_CREBBP_coTF	HAN_JNK_SINGALING_UP
1.18577075099%	3	253	35	Diabetes_McGill_CREBBP_coTF	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
1.18577075099%	3	253	349	Diabetes_McGill_CREBBP_coTF	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
1.18577075099%	3	253	34	Diabetes_McGill_CREBBP_coTF	PID_EPOPATHWAY
1.18577075099%	3	253	34	Diabetes_McGill_CREBBP_coTF	FRIDMAN_IMMORTALIZATION_DN
1.18577075099%	3	253	34	Diabetes_McGill_CREBBP_coTF	ABE_VEGFA_TARGETS_2HR
1.18577075099%	3	253	330	Diabetes_McGill_CREBBP_coTF	REACTOME_METABOLISM_OF_RNA
1.18577075099%	3	253	33	Diabetes_McGill_CREBBP_coTF	PID_NCADHERINPATHWAY
1.18577075099%	3	253	33	Diabetes_McGill_CREBBP_coTF	JEPSEN_SMRT_TARGETS
1.18577075099%	3	253	33	Diabetes_McGill_CREBBP_coTF	FIRESTEIN_CTNNB1_PATHWAY
1.18577075099%	3	253	33	Diabetes_McGill_CREBBP_coTF	CHO_NR4A1_TARGETS
1.18577075099%	3	253	33	Diabetes_McGill_CREBBP_coTF	BURTON_ADIPOGENESIS_1
1.18577075099%	3	253	33	Diabetes_McGill_CREBBP_coTF	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN
1.18577075099%	3	253	321	Diabetes_McGill_CREBBP_coTF	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
1.18577075099%	3	253	32	Diabetes_McGill_CREBBP_coTF	REACTOME_DAG_AND_IP3_SIGNALING
1.18577075099%	3	253	32	Diabetes_McGill_CREBBP_coTF	PID_WNT_NONCANONICAL_PATHWAY
1.18577075099%	3	253	32	Diabetes_McGill_CREBBP_coTF	DORSAM_HOXA9_TARGETS_DN
1.18577075099%	3	253	32	Diabetes_McGill_CREBBP_coTF	BIOCARTA_HDAC_PATHWAY
1.18577075099%	3	253	317	Diabetes_McGill_CREBBP_coTF	BRUINS_UVC_RESPONSE_EARLY_LATE
1.18577075099%	3	253	31	Diabetes_McGill_CREBBP_coTF	SIMBULAN_PARP1_TARGETS_UP
1.18577075099%	3	253	31	Diabetes_McGill_CREBBP_coTF	PID_AR_NONGENOMIC_PATHWAY
1.18577075099%	3	253	30	Diabetes_McGill_CREBBP_coTF	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
1.18577075099%	3	253	30	Diabetes_McGill_CREBBP_coTF	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP
1.18577075099%	3	253	30	Diabetes_McGill_CREBBP_coTF	TAVOR_CEBPA_TARGETS_DN
1.18577075099%	3	253	30	Diabetes_McGill_CREBBP_coTF	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
1.18577075099%	3	253	30	Diabetes_McGill_CREBBP_coTF	REACTOME_NOD1_2_SIGNALING_PATHWAY
1.18577075099%	3	253	30	Diabetes_McGill_CREBBP_coTF	REACTOME_CA_DEPENDENT_EVENTS
1.18577075099%	3	253	30	Diabetes_McGill_CREBBP_coTF	PID_IL2_STAT5PATHWAY
1.18577075099%	3	253	30	Diabetes_McGill_CREBBP_coTF	LY_AGING_PREMATURE_DN
1.18577075099%	3	253	30	Diabetes_McGill_CREBBP_coTF	DAZARD_UV_RESPONSE_CLUSTER_G2
1.18577075099%	3	253	30	Diabetes_McGill_CREBBP_coTF	DASU_IL6_SIGNALING_SCAR_UP
1.18577075099%	3	253	30	Diabetes_McGill_CREBBP_coTF	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY
1.18577075099%	3	253	292	Diabetes_McGill_CREBBP_coTF	KOYAMA_SEMA3B_TARGETS_UP
1.18577075099%	3	253	29	Diabetes_McGill_CREBBP_coTF	NGUYEN_NOTCH1_TARGETS_UP
1.18577075099%	3	253	29	Diabetes_McGill_CREBBP_coTF	MA_PITUITARY_FETAL_VS_ADULT_UP
1.18577075099%	3	253	29	Diabetes_McGill_CREBBP_coTF	KRIGE_AMINO_ACID_DEPRIVATION
1.18577075099%	3	253	28	Diabetes_McGill_CREBBP_coTF	PID_TRAIL_PATHWAY
1.18577075099%	3	253	28	Diabetes_McGill_CREBBP_coTF	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP
1.18577075099%	3	253	279	Diabetes_McGill_CREBBP_coTF	FORTSCHEGGER_PHF8_TARGETS_UP
1.18577075099%	3	253	275	Diabetes_McGill_CREBBP_coTF	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
1.18577075099%	3	253	27	Diabetes_McGill_CREBBP_coTF	ST_GRANULE_CELL_SURVIVAL_PATHWAY
1.18577075099%	3	253	27	Diabetes_McGill_CREBBP_coTF	LI_WILMS_TUMOR
1.18577075099%	3	253	27	Diabetes_McGill_CREBBP_coTF	EINAV_INTERFERON_SIGNATURE_IN_CANCER
1.18577075099%	3	253	27	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CREB_PATHWAY
1.18577075099%	3	253	264	Diabetes_McGill_CREBBP_coTF	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
1.18577075099%	3	253	262	Diabetes_McGill_CREBBP_coTF	LU_AGING_BRAIN_UP
1.18577075099%	3	253	261	Diabetes_McGill_CREBBP_coTF	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
1.18577075099%	3	253	26	Diabetes_McGill_CREBBP_coTF	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS
1.18577075099%	3	253	26	Diabetes_McGill_CREBBP_coTF	PID_ALK1PATHWAY
1.18577075099%	3	253	26	Diabetes_McGill_CREBBP_coTF	DEN_INTERACT_WITH_LCA5
1.18577075099%	3	253	25	Diabetes_McGill_CREBBP_coTF	REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN
1.18577075099%	3	253	25	Diabetes_McGill_CREBBP_coTF	PID_TOLL_ENDOGENOUS_PATHWAY
1.18577075099%	3	253	25	Diabetes_McGill_CREBBP_coTF	LU_TUMOR_ANGIOGENESIS_UP
1.18577075099%	3	253	24	Diabetes_McGill_CREBBP_coTF	YAN_ESCAPE_FROM_ANOIKIS
1.18577075099%	3	253	24	Diabetes_McGill_CREBBP_coTF	WILLERT_WNT_SIGNALING
1.18577075099%	3	253	24	Diabetes_McGill_CREBBP_coTF	REACTOME_REGULATION_OF_IFNA_SIGNALING
1.18577075099%	3	253	24	Diabetes_McGill_CREBBP_coTF	PID_S1P_S1P2_PATHWAY
1.18577075099%	3	253	23	Diabetes_McGill_CREBBP_coTF	ZHANG_INTERFERON_RESPONSE
1.18577075099%	3	253	23	Diabetes_McGill_CREBBP_coTF	UROSEVIC_RESPONSE_TO_IMIQUIMOD
1.18577075099%	3	253	23	Diabetes_McGill_CREBBP_coTF	KEGG_MISMATCH_REPAIR
1.18577075099%	3	253	23	Diabetes_McGill_CREBBP_coTF	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP
1.18577075099%	3	253	23	Diabetes_McGill_CREBBP_coTF	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP
1.18577075099%	3	253	23	Diabetes_McGill_CREBBP_coTF	BIOCARTA_MEF2D_PATHWAY
1.18577075099%	3	253	228	Diabetes_McGill_CREBBP_coTF	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
1.18577075099%	3	253	227	Diabetes_McGill_CREBBP_coTF	RAO_BOUND_BY_SALL4
1.18577075099%	3	253	221	Diabetes_McGill_CREBBP_coTF	CHANDRAN_METASTASIS_UP
1.18577075099%	3	253	22	Diabetes_McGill_CREBBP_coTF	YUAN_ZNF143_PARTNERS
1.18577075099%	3	253	22	Diabetes_McGill_CREBBP_coTF	WELCH_GATA1_TARGETS
1.18577075099%	3	253	22	Diabetes_McGill_CREBBP_coTF	TIAN_TNF_SIGNALING_NOT_VIA_NFKB
1.18577075099%	3	253	22	Diabetes_McGill_CREBBP_coTF	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN
1.18577075099%	3	253	22	Diabetes_McGill_CREBBP_coTF	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP
1.18577075099%	3	253	22	Diabetes_McGill_CREBBP_coTF	KANG_FLUOROURACIL_RESISTANCE_UP
1.18577075099%	3	253	22	Diabetes_McGill_CREBBP_coTF	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER
1.18577075099%	3	253	217	Diabetes_McGill_CREBBP_coTF	WIERENGA_STAT5A_TARGETS_UP
1.18577075099%	3	253	210	Diabetes_McGill_CREBBP_coTF	CAIRO_HEPATOBLASTOMA_CLASSES_DN
1.18577075099%	3	253	21	Diabetes_McGill_CREBBP_coTF	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE
1.18577075099%	3	253	21	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CALCINEURIN_PATHWAY
1.18577075099%	3	253	208	Diabetes_McGill_CREBBP_coTF	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
1.18577075099%	3	253	206	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
1.18577075099%	3	253	206	Diabetes_McGill_CREBBP_coTF	BILD_MYC_ONCOGENIC_SIGNATURE
1.18577075099%	3	253	206	Diabetes_McGill_CREBBP_coTF	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
1.18577075099%	3	253	204	Diabetes_McGill_CREBBP_coTF	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
1.18577075099%	3	253	202	Diabetes_McGill_CREBBP_coTF	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
1.18577075099%	3	253	201	Diabetes_McGill_CREBBP_coTF	KIM_MYC_AMPLIFICATION_TARGETS_UP
1.18577075099%	3	253	201	Diabetes_McGill_CREBBP_coTF	KEGG_FOCAL_ADHESION
1.18577075099%	3	253	200	Diabetes_McGill_CREBBP_coTF	LEE_DIFFERENTIATING_T_LYMPHOCYTE
1.18577075099%	3	253	20	Diabetes_McGill_CREBBP_coTF	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
1.18577075099%	3	253	195	Diabetes_McGill_CREBBP_coTF	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
1.18577075099%	3	253	193	Diabetes_McGill_CREBBP_coTF	MOHANKUMAR_TLX1_TARGETS_DN
1.18577075099%	3	253	191	Diabetes_McGill_CREBBP_coTF	RIGGI_EWING_SARCOMA_PROGENITOR_DN
1.18577075099%	3	253	19	Diabetes_McGill_CREBBP_coTF	SHIN_B_CELL_LYMPHOMA_CLUSTER_9
1.18577075099%	3	253	19	Diabetes_McGill_CREBBP_coTF	OUYANG_PROSTATE_CANCER_MARKERS
1.18577075099%	3	253	19	Diabetes_McGill_CREBBP_coTF	NELSON_RESPONSE_TO_ANDROGEN_DN
1.18577075099%	3	253	19	Diabetes_McGill_CREBBP_coTF	AMIT_EGF_RESPONSE_40_MCF10A
1.18577075099%	3	253	19	Diabetes_McGill_CREBBP_coTF	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
1.18577075099%	3	253	189	Diabetes_McGill_CREBBP_coTF	BURTON_ADIPOGENESIS_6
1.18577075099%	3	253	185	Diabetes_McGill_CREBBP_coTF	DARWICHE_SKIN_TUMOR_PROMOTER_DN
1.18577075099%	3	253	184	Diabetes_McGill_CREBBP_coTF	WU_CELL_MIGRATION
1.18577075099%	3	253	184	Diabetes_McGill_CREBBP_coTF	DOANE_RESPONSE_TO_ANDROGEN_UP
1.18577075099%	3	253	184	Diabetes_McGill_CREBBP_coTF	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
1.18577075099%	3	253	183	Diabetes_McGill_CREBBP_coTF	KEGG_ENDOCYTOSIS
1.18577075099%	3	253	181	Diabetes_McGill_CREBBP_coTF	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
1.18577075099%	3	253	181	Diabetes_McGill_CREBBP_coTF	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
1.18577075099%	3	253	181	Diabetes_McGill_CREBBP_coTF	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
1.18577075099%	3	253	180	Diabetes_McGill_CREBBP_coTF	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
1.18577075099%	3	253	180	Diabetes_McGill_CREBBP_coTF	DARWICHE_PAPILLOMA_RISK_HIGH_DN
1.18577075099%	3	253	18	Diabetes_McGill_CREBBP_coTF	ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE
1.18577075099%	3	253	18	Diabetes_McGill_CREBBP_coTF	WU_HBX_TARGETS_3_UP
1.18577075099%	3	253	18	Diabetes_McGill_CREBBP_coTF	SHIN_B_CELL_LYMPHOMA_CLUSTER_5
1.18577075099%	3	253	18	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_NODAL
1.18577075099%	3	253	18	Diabetes_McGill_CREBBP_coTF	BOWIE_RESPONSE_TO_TAMOXIFEN
1.18577075099%	3	253	18	Diabetes_McGill_CREBBP_coTF	BIOCARTA_NGF_PATHWAY
1.18577075099%	3	253	18	Diabetes_McGill_CREBBP_coTF	AMIT_DELAYED_EARLY_GENES
1.18577075099%	3	253	176	Diabetes_McGill_CREBBP_coTF	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
1.18577075099%	3	253	174	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
1.18577075099%	3	253	172	Diabetes_McGill_CREBBP_coTF	SMID_BREAST_CANCER_LUMINAL_B_UP
1.18577075099%	3	253	171	Diabetes_McGill_CREBBP_coTF	GOLDRATH_HOMEOSTATIC_PROLIFERATION
1.18577075099%	3	253	170	Diabetes_McGill_CREBBP_coTF	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
1.18577075099%	3	253	170	Diabetes_McGill_CREBBP_coTF	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
1.18577075099%	3	253	170	Diabetes_McGill_CREBBP_coTF	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
1.18577075099%	3	253	17	Diabetes_McGill_CREBBP_coTF	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
1.18577075099%	3	253	17	Diabetes_McGill_CREBBP_coTF	REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS
1.18577075099%	3	253	17	Diabetes_McGill_CREBBP_coTF	INGA_TP53_TARGETS
1.18577075099%	3	253	17	Diabetes_McGill_CREBBP_coTF	HOWLIN_CITED1_TARGETS_2_UP
1.18577075099%	3	253	167	Diabetes_McGill_CREBBP_coTF	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
1.18577075099%	3	253	165	Diabetes_McGill_CREBBP_coTF	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
1.18577075099%	3	253	163	Diabetes_McGill_CREBBP_coTF	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
1.18577075099%	3	253	162	Diabetes_McGill_CREBBP_coTF	WINNEPENNINCKX_MELANOMA_METASTASIS_UP
1.18577075099%	3	253	162	Diabetes_McGill_CREBBP_coTF	DARWICHE_PAPILLOMA_RISK_LOW_UP
1.18577075099%	3	253	161	Diabetes_McGill_CREBBP_coTF	BIDUS_METASTASIS_DN
1.18577075099%	3	253	16	Diabetes_McGill_CREBBP_coTF	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI
1.18577075099%	3	253	16	Diabetes_McGill_CREBBP_coTF	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8
1.18577075099%	3	253	157	Diabetes_McGill_CREBBP_coTF	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
1.18577075099%	3	253	156	Diabetes_McGill_CREBBP_coTF	FOSTER_TOLERANT_MACROPHAGE_UP
1.18577075099%	3	253	151	Diabetes_McGill_CREBBP_coTF	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
1.18577075099%	3	253	151	Diabetes_McGill_CREBBP_coTF	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
1.18577075099%	3	253	15	Diabetes_McGill_CREBBP_coTF	LIU_IL13_PRIMING_MODEL
1.18577075099%	3	253	15	Diabetes_McGill_CREBBP_coTF	COLLIS_PRKDC_REGULATORS
1.18577075099%	3	253	15	Diabetes_McGill_CREBBP_coTF	BIOCARTA_NUCLEARRS_PATHWAY
1.18577075099%	3	253	15	Diabetes_McGill_CREBBP_coTF	BIOCARTA_IL3_PATHWAY
1.18577075099%	3	253	149	Diabetes_McGill_CREBBP_coTF	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
1.18577075099%	3	253	147	Diabetes_McGill_CREBBP_coTF	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
1.18577075099%	3	253	146	Diabetes_McGill_CREBBP_coTF	LEE_NEURAL_CREST_STEM_CELL_UP
1.18577075099%	3	253	145	Diabetes_McGill_CREBBP_coTF	ZHANG_BREAST_CANCER_PROGENITORS_DN
1.18577075099%	3	253	143	Diabetes_McGill_CREBBP_coTF	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
1.18577075099%	3	253	143	Diabetes_McGill_CREBBP_coTF	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
1.18577075099%	3	253	142	Diabetes_McGill_CREBBP_coTF	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
1.18577075099%	3	253	142	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_ES_LCP_WITH_H3K4ME3
1.18577075099%	3	253	142	Diabetes_McGill_CREBBP_coTF	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
1.18577075099%	3	253	140	Diabetes_McGill_CREBBP_coTF	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
1.18577075099%	3	253	140	Diabetes_McGill_CREBBP_coTF	JOHNSTONE_PARVB_TARGETS_2_UP
1.18577075099%	3	253	14	Diabetes_McGill_CREBBP_coTF	GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
1.18577075099%	3	253	139	Diabetes_McGill_CREBBP_coTF	HOELZEL_NF1_TARGETS_UP
1.18577075099%	3	253	139	Diabetes_McGill_CREBBP_coTF	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
1.18577075099%	3	253	138	Diabetes_McGill_CREBBP_coTF	JIANG_VHL_TARGETS
1.18577075099%	3	253	138	Diabetes_McGill_CREBBP_coTF	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
1.18577075099%	3	253	137	Diabetes_McGill_CREBBP_coTF	LIU_SOX4_TARGETS_UP
1.18577075099%	3	253	137	Diabetes_McGill_CREBBP_coTF	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
1.18577075099%	3	253	135	Diabetes_McGill_CREBBP_coTF	UDAYAKUMAR_MED1_TARGETS_UP
1.18577075099%	3	253	134	Diabetes_McGill_CREBBP_coTF	KEGG_TIGHT_JUNCTION
1.18577075099%	3	253	132	Diabetes_McGill_CREBBP_coTF	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS
1.18577075099%	3	253	131	Diabetes_McGill_CREBBP_coTF	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
1.18577075099%	3	253	13	Diabetes_McGill_CREBBP_coTF	TSAI_DNAJB4_TARGETS_UP
1.18577075099%	3	253	13	Diabetes_McGill_CREBBP_coTF	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
1.18577075099%	3	253	13	Diabetes_McGill_CREBBP_coTF	HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER
1.18577075099%	3	253	13	Diabetes_McGill_CREBBP_coTF	BIOCARTA_RB_PATHWAY
1.18577075099%	3	253	129	Diabetes_McGill_CREBBP_coTF	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP
1.18577075099%	3	253	129	Diabetes_McGill_CREBBP_coTF	BROWN_MYELOID_CELL_DEVELOPMENT_DN
1.18577075099%	3	253	128	Diabetes_McGill_CREBBP_coTF	YEGNASUBRAMANIAN_PROSTATE_CANCER
1.18577075099%	3	253	128	Diabetes_McGill_CREBBP_coTF	LENAOUR_DENDRITIC_CELL_MATURATION_DN
1.18577075099%	3	253	128	Diabetes_McGill_CREBBP_coTF	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS
1.18577075099%	3	253	127	Diabetes_McGill_CREBBP_coTF	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
1.18577075099%	3	253	126	Diabetes_McGill_CREBBP_coTF	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
1.18577075099%	3	253	123	Diabetes_McGill_CREBBP_coTF	KAYO_AGING_MUSCLE_DN
1.18577075099%	3	253	122	Diabetes_McGill_CREBBP_coTF	TOOKER_GEMCITABINE_RESISTANCE_DN
1.18577075099%	3	253	12	Diabetes_McGill_CREBBP_coTF	REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR
1.18577075099%	3	253	12	Diabetes_McGill_CREBBP_coTF	REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10
1.18577075099%	3	253	12	Diabetes_McGill_CREBBP_coTF	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
1.18577075099%	3	253	12	Diabetes_McGill_CREBBP_coTF	KRISHNAN_FURIN_TARGETS_UP
1.18577075099%	3	253	119	Diabetes_McGill_CREBBP_coTF	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
1.18577075099%	3	253	118	Diabetes_McGill_CREBBP_coTF	LEE_NEURAL_CREST_STEM_CELL_DN
1.18577075099%	3	253	117	Diabetes_McGill_CREBBP_coTF	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
1.18577075099%	3	253	116	Diabetes_McGill_CREBBP_coTF	MATTIOLI_MGUS_VS_PCL
1.18577075099%	3	253	116	Diabetes_McGill_CREBBP_coTF	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
1.18577075099%	3	253	114	Diabetes_McGill_CREBBP_coTF	SENESE_HDAC2_TARGETS_UP
1.18577075099%	3	253	112	Diabetes_McGill_CREBBP_coTF	PASINI_SUZ12_TARGETS_UP
1.18577075099%	3	253	111	Diabetes_McGill_CREBBP_coTF	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
1.18577075099%	3	253	111	Diabetes_McGill_CREBBP_coTF	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
1.18577075099%	3	253	110	Diabetes_McGill_CREBBP_coTF	GHANDHI_DIRECT_IRRADIATION_UP
1.18577075099%	3	253	11	Diabetes_McGill_CREBBP_coTF	ZHOU_PANCREATIC_BETA_CELL
1.18577075099%	3	253	11	Diabetes_McGill_CREBBP_coTF	PID_RANBP2PATHWAY
1.18577075099%	3	253	11	Diabetes_McGill_CREBBP_coTF	PID_ALK2PATHWAY
1.18577075099%	3	253	11	Diabetes_McGill_CREBBP_coTF	NIKOLSKY_BREAST_CANCER_7P15_AMPLICON
1.18577075099%	3	253	11	Diabetes_McGill_CREBBP_coTF	BIOCARTA_EPONFKB_PATHWAY
1.18577075099%	3	253	11	Diabetes_McGill_CREBBP_coTF	BIOCARTA_EGFR_SMRTE_PATHWAY
1.18577075099%	3	253	108	Diabetes_McGill_CREBBP_coTF	ZHANG_TLX_TARGETS_DN
1.18577075099%	3	253	106	Diabetes_McGill_CREBBP_coTF	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
1.18577075099%	3	253	106	Diabetes_McGill_CREBBP_coTF	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
1.18577075099%	3	253	104	Diabetes_McGill_CREBBP_coTF	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
1.18577075099%	3	253	10	Diabetes_McGill_CREBBP_coTF	REACTOME_IRAK1_RECRUITS_IKK_COMPLEX
1.18577075099%	3	253	10	Diabetes_McGill_CREBBP_coTF	REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1
1.18577075099%	3	253	10	Diabetes_McGill_CREBBP_coTF	REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS
1.18577075099%	3	253	10	Diabetes_McGill_CREBBP_coTF	CHASSOT_SKIN_WOUND
1.18577075099%	3	253	10	Diabetes_McGill_CREBBP_coTF	BIOCARTA_RNA_PATHWAY
1.18203309693%	15	1269	584	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
1.18203309693%	15	1269	572	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHICAS_RB1_TARGETS_SENESCENT
1.18203309693%	15	1269	544	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
1.18203309693%	15	1269	491	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHENG_BOUND_BY_FOXP3
1.18203309693%	15	1269	473	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GARY_CD5_TARGETS_UP
1.18203309693%	15	1269	469	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCCABE_BOUND_BY_HOXC6
1.18203309693%	15	1269	459	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_WT1_TARGETS_DN
1.18203309693%	15	1269	445	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
1.18203309693%	15	1269	431	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
1.18203309693%	15	1269	393	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP
1.18203309693%	15	1269	387	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHYLA_CBFA2T3_TARGETS_UP
1.18203309693%	15	1269	378	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
1.18203309693%	15	1269	344	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
1.18203309693%	15	1269	328	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PATHWAYS_IN_CANCER
1.18203309693%	15	1269	323	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRESHOCK_CANCER_COPY_NUMBER_UP
1.18203309693%	15	1269	261	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
1.18203309693%	15	1269	241	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
1.17584179583%	22	1871	290	T2D_GENES_TANYA_HEIGHT	BENPORATH_OCT4_TARGETS
1.17584179583%	22	1871	276	T2D_GENES_TANYA_HEIGHT	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
1.17584179583%	22	1871	275	T2D_GENES_TANYA_HEIGHT	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
1.17584179583%	22	1871	253	T2D_GENES_TANYA_HEIGHT	MCLACHLAN_DENTAL_CARIES_UP
1.17584179583%	22	1871	243	T2D_GENES_TANYA_HEIGHT	CHICAS_RB1_TARGETS_GROWING
1.17584179583%	22	1871	242	T2D_GENES_TANYA_HEIGHT	MULLIGHAN_MLL_SIGNATURE_1_DN
1.17584179583%	22	1871	242	T2D_GENES_TANYA_HEIGHT	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
1.17584179583%	22	1871	241	T2D_GENES_TANYA_HEIGHT	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
1.17584179583%	22	1871	238	T2D_GENES_TANYA_HEIGHT	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
1.17584179583%	22	1871	222	T2D_GENES_TANYA_HEIGHT	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
1.17584179583%	22	1871	222	T2D_GENES_TANYA_HEIGHT	CAIRO_LIVER_DEVELOPMENT_DN
1.17584179583%	22	1871	221	T2D_GENES_TANYA_HEIGHT	PEDRIOLI_MIR31_TARGETS_UP
1.17584179583%	22	1871	214	T2D_GENES_TANYA_HEIGHT	TIEN_INTESTINE_PROBIOTICS_24HR_DN
1.17584179583%	22	1871	212	T2D_GENES_TANYA_HEIGHT	SANSOM_APC_TARGETS
1.17584179583%	22	1871	211	T2D_GENES_TANYA_HEIGHT	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
1.17584179583%	22	1871	210	T2D_GENES_TANYA_HEIGHT	RIZKI_TUMOR_INVASIVENESS_3D_UP
1.17584179583%	22	1871	207	T2D_GENES_TANYA_HEIGHT	REACTOME_HIV_INFECTION
1.17584179583%	22	1871	197	T2D_GENES_TANYA_HEIGHT	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
1.17584179583%	22	1871	187	T2D_GENES_TANYA_HEIGHT	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
1.17584179583%	22	1871	183	T2D_GENES_TANYA_HEIGHT	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
1.17584179583%	22	1871	175	T2D_GENES_TANYA_HEIGHT	FIRESTEIN_PROLIFERATION
1.17584179583%	22	1871	172	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_LUMINAL_B_UP
1.17584179583%	22	1871	171	T2D_GENES_TANYA_HEIGHT	GOLDRATH_HOMEOSTATIC_PROLIFERATION
1.17584179583%	22	1871	167	T2D_GENES_TANYA_HEIGHT	TIEN_INTESTINE_PROBIOTICS_6HR_DN
1.17584179583%	22	1871	154	T2D_GENES_TANYA_HEIGHT	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
1.17584179583%	22	1871	132	T2D_GENES_TANYA_HEIGHT	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
1.17584179583%	22	1871	101	T2D_GENES_TANYA_HEIGHT	WIELAND_UP_BY_HBV_INFECTION
1.16514690983%	23	1974	97	Mendelian_Nancy_Cox	LABBE_WNT3A_TARGETS_DN
1.16514690983%	23	1974	90	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_ERBB4
1.16514690983%	23	1974	89	Mendelian_Nancy_Cox	DELASERNA_MYOD_TARGETS_UP
1.16514690983%	23	1974	81	Mendelian_Nancy_Cox	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION
1.16514690983%	23	1974	81	Mendelian_Nancy_Cox	HARRIS_HYPOXIA
1.16514690983%	23	1974	75	Mendelian_Nancy_Cox	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
1.16514690983%	23	1974	66	Mendelian_Nancy_Cox	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM
1.16514690983%	23	1974	32	Mendelian_Nancy_Cox	REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE
1.16514690983%	23	1974	251	Mendelian_Nancy_Cox	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
1.16514690983%	23	1974	230	Mendelian_Nancy_Cox	COLDREN_GEFITINIB_RESISTANCE_DN
1.16514690983%	23	1974	221	Mendelian_Nancy_Cox	PEDRIOLI_MIR31_TARGETS_UP
1.16514690983%	23	1974	213	Mendelian_Nancy_Cox	WIERENGA_STAT5A_TARGETS_DN
1.16514690983%	23	1974	209	Mendelian_Nancy_Cox	KIM_WT1_TARGETS_12HR_DN
1.16514690983%	23	1974	193	Mendelian_Nancy_Cox	MOHANKUMAR_TLX1_TARGETS_DN
1.16514690983%	23	1974	185	Mendelian_Nancy_Cox	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
1.16514690983%	23	1974	184	Mendelian_Nancy_Cox	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
1.16514690983%	23	1974	184	Mendelian_Nancy_Cox	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
1.16514690983%	23	1974	180	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_48HR_UP
1.16514690983%	23	1974	171	Mendelian_Nancy_Cox	GOLDRATH_HOMEOSTATIC_PROLIFERATION
1.16514690983%	23	1974	162	Mendelian_Nancy_Cox	KIM_WT1_TARGETS_12HR_UP
1.16514690983%	23	1974	162	Mendelian_Nancy_Cox	DARWICHE_PAPILLOMA_RISK_LOW_UP
1.16514690983%	23	1974	160	Mendelian_Nancy_Cox	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
1.16514690983%	23	1974	150	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_30MIN_DN
1.16514690983%	23	1974	134	Mendelian_Nancy_Cox	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
1.16514690983%	23	1974	134	Mendelian_Nancy_Cox	KEGG_CELL_ADHESION_MOLECULES_CAMS
1.16514690983%	23	1974	133	Mendelian_Nancy_Cox	REACTOME_DIABETES_PATHWAYS
1.16514690983%	23	1974	131	Mendelian_Nancy_Cox	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
1.16514690983%	23	1974	129	Mendelian_Nancy_Cox	BROWN_MYELOID_CELL_DEVELOPMENT_DN
1.16514690983%	23	1974	123	Mendelian_Nancy_Cox	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
1.16514690983%	23	1974	121	Mendelian_Nancy_Cox	RODRIGUES_DCC_TARGETS_DN
1.16514690983%	23	1974	118	Mendelian_Nancy_Cox	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
1.16514690983%	23	1974	116	Mendelian_Nancy_Cox	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
1.16514690983%	23	1974	114	Mendelian_Nancy_Cox	LENAOUR_DENDRITIC_CELL_MATURATION_UP
1.16514690983%	23	1974	113	Mendelian_Nancy_Cox	TSENG_IRS1_TARGETS_UP
1.16514690983%	23	1974	112	Mendelian_Nancy_Cox	LABBE_WNT3A_TARGETS_UP
1.16514690983%	23	1974	110	Mendelian_Nancy_Cox	SUNG_METASTASIS_STROMA_UP
1.16514690983%	23	1974	104	Mendelian_Nancy_Cox	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
1.16477272727%	41	3520	469	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCCABE_BOUND_BY_HOXC6
1.16477272727%	41	3520	460	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
1.16477272727%	41	3520	456	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ODONNELL_TFRC_TARGETS_UP
1.16477272727%	41	3520	434	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BAELDE_DIABETIC_NEPHROPATHY_DN
1.16477272727%	41	3520	425	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
1.16477272727%	41	3520	423	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	THUM_SYSTOLIC_HEART_FAILURE_UP
1.16477272727%	41	3520	392	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_2B
1.16477272727%	41	3520	346	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOLDRATH_ANTIGEN_RESPONSE
1.16477272727%	41	3520	317	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HELLER_HDAC_TARGETS_UP
1.16477272727%	41	3520	282	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HELLER_SILENCED_BY_METHYLATION_UP
1.16477272727%	41	3520	267	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAIRO_HEPATOBLASTOMA_DN
1.16477272727%	41	3520	253	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DANG_REGULATED_BY_MYC_DN
1.15118956255%	15	1303	539	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
1.15118956255%	15	1303	537	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
1.15118956255%	15	1303	508	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ENK_UV_RESPONSE_EPIDERMIS_DN
1.15118956255%	15	1303	466	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_HEMOSTASIS
1.15118956255%	15	1303	461	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
1.15118956255%	15	1303	456	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTENS_BOUND_BY_PML_RARA_FUSION
1.15118956255%	15	1303	428	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIM_MAMMARY_STEM_CELL_DN
1.15118956255%	15	1303	418	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PEDRIOLI_MIR31_TARGETS_DN
1.15118956255%	15	1303	404	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OSMAN_BLADDER_CANCER_UP
1.15118956255%	15	1303	380	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAIRKEE_TERT_TARGETS_UP
1.15118956255%	15	1303	341	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MULLIGHAN_NPM1_SIGNATURE_3_UP
1.15118956255%	15	1303	315	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
1.15118956255%	15	1303	315	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
1.15118956255%	15	1303	314	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
1.15118956255%	15	1303	312	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GENTILE_UV_HIGH_DOSE_DN
1.15118956255%	15	1303	309	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIU_SOX4_TARGETS_DN
1.15118956255%	15	1303	290	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BENPORATH_OCT4_TARGETS
1.15118956255%	15	1303	266	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
1.15118956255%	15	1303	249	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
1.15118956255%	15	1303	203	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRUETZMANN_PANCREATIC_CANCER_DN
1.14995400184%	25	2174	584	T2D_GENES_TANYA_LIPIDS	HAMAI_APOPTOSIS_VIA_TRAIL_UP
1.14995400184%	25	2174	315	T2D_GENES_TANYA_LIPIDS	PASINI_SUZ12_TARGETS_DN
1.14995400184%	25	2174	272	T2D_GENES_TANYA_LIPIDS	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
1.14995400184%	25	2174	271	T2D_GENES_TANYA_LIPIDS	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
1.14995400184%	25	2174	268	T2D_GENES_TANYA_LIPIDS	XU_GH1_AUTOCRINE_TARGETS_UP
1.14995400184%	25	2174	254	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_4HR_DN
1.14995400184%	25	2174	251	T2D_GENES_TANYA_LIPIDS	KOBAYASHI_EGFR_SIGNALING_24HR_DN
1.14995400184%	25	2174	239	T2D_GENES_TANYA_LIPIDS	ALFANO_MYC_TARGETS
1.14995400184%	25	2174	234	T2D_GENES_TANYA_LIPIDS	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
1.14995400184%	25	2174	233	T2D_GENES_TANYA_LIPIDS	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
1.14995400184%	25	2174	217	T2D_GENES_TANYA_LIPIDS	WONG_MITOCHONDRIA_GENE_MODULE
1.14995400184%	25	2174	214	T2D_GENES_TANYA_LIPIDS	TIEN_INTESTINE_PROBIOTICS_24HR_DN
1.14995400184%	25	2174	207	T2D_GENES_TANYA_LIPIDS	CAIRO_HEPATOBLASTOMA_UP
1.14995400184%	25	2174	206	T2D_GENES_TANYA_LIPIDS	BILD_MYC_ONCOGENIC_SIGNATURE
1.14995400184%	25	2174	180	T2D_GENES_TANYA_LIPIDS	DARWICHE_PAPILLOMA_RISK_HIGH_DN
1.14995400184%	25	2174	176	T2D_GENES_TANYA_LIPIDS	NAGASHIMA_NRG1_SIGNALING_UP
1.14995400184%	25	2174	174	T2D_GENES_TANYA_LIPIDS	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
1.14995400184%	25	2174	170	T2D_GENES_TANYA_LIPIDS	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
1.14995400184%	25	2174	161	T2D_GENES_TANYA_LIPIDS	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
1.14995400184%	25	2174	147	T2D_GENES_TANYA_LIPIDS	DARWICHE_PAPILLOMA_RISK_HIGH_UP
1.14192495922%	7	613	89	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
1.14192495922%	7	613	78	T2D_GENES_TANYA_BIOMARKER	ROSS_LEUKEMIA_WITH_MLL_FUSIONS
1.14192495922%	7	613	77	T2D_GENES_TANYA_BIOMARKER	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
1.14192495922%	7	613	74	T2D_GENES_TANYA_BIOMARKER	CAMPS_COLON_CANCER_COPY_NUMBER_DN
1.14192495922%	7	613	7	T2D_GENES_TANYA_BIOMARKER	FARMER_BREAST_CANCER_CLUSTER_8
1.14192495922%	7	613	55	T2D_GENES_TANYA_BIOMARKER	SU_LIVER
1.14192495922%	7	613	469	T2D_GENES_TANYA_BIOMARKER	MCCABE_BOUND_BY_HOXC6
1.14192495922%	7	613	428	T2D_GENES_TANYA_BIOMARKER	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
1.14192495922%	7	613	379	T2D_GENES_TANYA_BIOMARKER	BENPORATH_ES_1
1.14192495922%	7	613	366	T2D_GENES_TANYA_BIOMARKER	YOSHIMURA_MAPK8_TARGETS_DN
1.14192495922%	7	613	364	T2D_GENES_TANYA_BIOMARKER	YANG_BCL3_TARGETS_UP
1.14192495922%	7	613	329	T2D_GENES_TANYA_BIOMARKER	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
1.14192495922%	7	613	326	T2D_GENES_TANYA_BIOMARKER	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
1.14192495922%	7	613	315	T2D_GENES_TANYA_BIOMARKER	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
1.14192495922%	7	613	309	T2D_GENES_TANYA_BIOMARKER	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
1.14192495922%	7	613	299	T2D_GENES_TANYA_BIOMARKER	WALLACE_PROSTATE_CANCER_RACE_UP
1.14192495922%	7	613	292	T2D_GENES_TANYA_BIOMARKER	KOYAMA_SEMA3B_TARGETS_UP
1.14192495922%	7	613	283	T2D_GENES_TANYA_BIOMARKER	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
1.14192495922%	7	613	264	T2D_GENES_TANYA_BIOMARKER	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
1.14192495922%	7	613	259	T2D_GENES_TANYA_BIOMARKER	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
1.14192495922%	7	613	254	T2D_GENES_TANYA_BIOMARKER	IVANOVA_HEMATOPOIESIS_STEM_CELL
1.14192495922%	7	613	249	T2D_GENES_TANYA_BIOMARKER	MITSIADES_RESPONSE_TO_APLIDIN_DN
1.14192495922%	7	613	247	T2D_GENES_TANYA_BIOMARKER	REACTOME_METABOLISM_OF_CARBOHYDRATES
1.14192495922%	7	613	244	T2D_GENES_TANYA_BIOMARKER	THUM_SYSTOLIC_HEART_FAILURE_DN
1.14192495922%	7	613	244	T2D_GENES_TANYA_BIOMARKER	PLASARI_TGFB1_TARGETS_10HR_DN
1.14192495922%	7	613	239	T2D_GENES_TANYA_BIOMARKER	ALFANO_MYC_TARGETS
1.14192495922%	7	613	237	T2D_GENES_TANYA_BIOMARKER	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
1.14192495922%	7	613	230	T2D_GENES_TANYA_BIOMARKER	KAUFFMANN_DNA_REPAIR_GENES
1.14192495922%	7	613	230	T2D_GENES_TANYA_BIOMARKER	COLDREN_GEFITINIB_RESISTANCE_DN
1.14192495922%	7	613	230	T2D_GENES_TANYA_BIOMARKER	BENPORATH_MYC_TARGETS_WITH_EBOX
1.14192495922%	7	613	227	T2D_GENES_TANYA_BIOMARKER	LEE_RECENT_THYMIC_EMIGRANT
1.14192495922%	7	613	226	T2D_GENES_TANYA_BIOMARKER	KYNG_DNA_DAMAGE_UP
1.14192495922%	7	613	221	T2D_GENES_TANYA_BIOMARKER	ZHANG_TLX_TARGETS_36HR_UP
1.14192495922%	7	613	217	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALLING_BY_NGF
1.14192495922%	7	613	214	T2D_GENES_TANYA_BIOMARKER	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
1.14192495922%	7	613	210	T2D_GENES_TANYA_BIOMARKER	SANSOM_APC_TARGETS_REQUIRE_MYC
1.14192495922%	7	613	208	T2D_GENES_TANYA_BIOMARKER	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
1.14192495922%	7	613	207	T2D_GENES_TANYA_BIOMARKER	MANALO_HYPOXIA_UP
1.14192495922%	7	613	206	T2D_GENES_TANYA_BIOMARKER	LINSLEY_MIR16_TARGETS
1.14192495922%	7	613	205	T2D_GENES_TANYA_BIOMARKER	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
1.14192495922%	7	613	205	T2D_GENES_TANYA_BIOMARKER	SHEPARD_BMYB_MORPHOLINO_UP
1.14192495922%	7	613	192	T2D_GENES_TANYA_BIOMARKER	REACTOME_DNA_REPLICATION
1.14192495922%	7	613	188	T2D_GENES_TANYA_BIOMARKER	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
1.14192495922%	7	613	185	T2D_GENES_TANYA_BIOMARKER	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
1.14192495922%	7	613	183	T2D_GENES_TANYA_BIOMARKER	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
1.14192495922%	7	613	183	T2D_GENES_TANYA_BIOMARKER	VERHAAK_AML_WITH_NPM1_MUTATED_UP
1.14192495922%	7	613	181	T2D_GENES_TANYA_BIOMARKER	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
1.14192495922%	7	613	181	T2D_GENES_TANYA_BIOMARKER	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
1.14192495922%	7	613	180	T2D_GENES_TANYA_BIOMARKER	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
1.14192495922%	7	613	178	T2D_GENES_TANYA_BIOMARKER	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
1.14192495922%	7	613	177	T2D_GENES_TANYA_BIOMARKER	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
1.14192495922%	7	613	176	T2D_GENES_TANYA_BIOMARKER	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
1.14192495922%	7	613	176	T2D_GENES_TANYA_BIOMARKER	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
1.14192495922%	7	613	173	T2D_GENES_TANYA_BIOMARKER	SENGUPTA_EBNA1_ANTICORRELATED
1.14192495922%	7	613	172	T2D_GENES_TANYA_BIOMARKER	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
1.14192495922%	7	613	162	T2D_GENES_TANYA_BIOMARKER	WHITFIELD_CELL_CYCLE_S
1.14192495922%	7	613	149	T2D_GENES_TANYA_BIOMARKER	TSAI_RESPONSE_TO_IONIZING_RADIATION
1.14192495922%	7	613	148	T2D_GENES_TANYA_BIOMARKER	REACTOME_APOPTOSIS
1.14192495922%	7	613	147	T2D_GENES_TANYA_BIOMARKER	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
1.14192495922%	7	613	139	T2D_GENES_TANYA_BIOMARKER	REACTOME_BIOLOGICAL_OXIDATIONS
1.14192495922%	7	613	136	T2D_GENES_TANYA_BIOMARKER	WIERENGA_STAT5A_TARGETS_GROUP1
1.14192495922%	7	613	129	T2D_GENES_TANYA_BIOMARKER	REACTOME_MEMBRANE_TRAFFICKING
1.14192495922%	7	613	126	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
1.14192495922%	7	613	126	T2D_GENES_TANYA_BIOMARKER	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
1.14192495922%	7	613	126	T2D_GENES_TANYA_BIOMARKER	BURTON_ADIPOGENESIS_5
1.14192495922%	7	613	121	T2D_GENES_TANYA_BIOMARKER	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
1.14192495922%	7	613	115	T2D_GENES_TANYA_BIOMARKER	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
1.14192495922%	7	613	112	T2D_GENES_TANYA_BIOMARKER	REACTOME_DNA_REPAIR
1.14192495922%	7	613	112	T2D_GENES_TANYA_BIOMARKER	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
1.14192495922%	7	613	109	T2D_GENES_TANYA_BIOMARKER	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
1.14192495922%	7	613	101	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_ERBB2
1.14192495922%	7	613	101	T2D_GENES_TANYA_BIOMARKER	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
1.13636363636%	40	3520	518	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_PROTEINS
1.13636363636%	40	3520	491	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MEISSNER_NPC_HCP_WITH_H3K4ME2
1.13636363636%	40	3520	459	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_WT1_TARGETS_DN
1.13636363636%	40	3520	455	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
1.13636363636%	40	3520	435	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
1.13636363636%	40	3520	430	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VECCHI_GASTRIC_CANCER_EARLY_UP
1.13636363636%	40	3520	384	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BASAKI_YBX1_TARGETS_DN
1.13636363636%	40	3520	317	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
1.13636363636%	40	3520	315	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
1.12239444148%	21	1871	89	T2D_GENES_TANYA_HEIGHT	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION
1.12239444148%	21	1871	308	T2D_GENES_TANYA_HEIGHT	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
1.12239444148%	21	1871	291	T2D_GENES_TANYA_HEIGHT	SABATES_COLORECTAL_ADENOMA_DN
1.12239444148%	21	1871	267	T2D_GENES_TANYA_HEIGHT	CAIRO_HEPATOBLASTOMA_DN
1.12239444148%	21	1871	261	T2D_GENES_TANYA_HEIGHT	BILD_HRAS_ONCOGENIC_SIGNATURE
1.12239444148%	21	1871	239	T2D_GENES_TANYA_HEIGHT	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
1.12239444148%	21	1871	229	T2D_GENES_TANYA_HEIGHT	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
1.12239444148%	21	1871	217	T2D_GENES_TANYA_HEIGHT	WONG_MITOCHONDRIA_GENE_MODULE
1.12239444148%	21	1871	210	T2D_GENES_TANYA_HEIGHT	VERHAAK_GLIOBLASTOMA_PRONEURAL
1.12239444148%	21	1871	210	T2D_GENES_TANYA_HEIGHT	CAIRO_HEPATOBLASTOMA_CLASSES_DN
1.12239444148%	21	1871	205	T2D_GENES_TANYA_HEIGHT	SHEPARD_BMYB_MORPHOLINO_UP
1.12239444148%	21	1871	205	T2D_GENES_TANYA_HEIGHT	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
1.12239444148%	21	1871	204	T2D_GENES_TANYA_HEIGHT	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
1.12239444148%	21	1871	203	T2D_GENES_TANYA_HEIGHT	GRUETZMANN_PANCREATIC_CANCER_DN
1.12239444148%	21	1871	200	T2D_GENES_TANYA_HEIGHT	LEE_DIFFERENTIATING_T_LYMPHOCYTE
1.12239444148%	21	1871	199	T2D_GENES_TANYA_HEIGHT	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
1.12239444148%	21	1871	187	T2D_GENES_TANYA_HEIGHT	BAKKER_FOXO3_TARGETS_DN
1.12239444148%	21	1871	186	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
1.12239444148%	21	1871	183	T2D_GENES_TANYA_HEIGHT	VERHAAK_AML_WITH_NPM1_MUTATED_UP
1.12239444148%	21	1871	182	T2D_GENES_TANYA_HEIGHT	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
1.12239444148%	21	1871	181	T2D_GENES_TANYA_HEIGHT	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
1.12239444148%	21	1871	176	T2D_GENES_TANYA_HEIGHT	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX
1.12239444148%	21	1871	162	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
1.12239444148%	21	1871	161	T2D_GENES_TANYA_HEIGHT	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
1.12239444148%	21	1871	148	T2D_GENES_TANYA_HEIGHT	REACTOME_APOPTOSIS
1.12239444148%	21	1871	141	T2D_GENES_TANYA_HEIGHT	WELCSH_BRCA1_TARGETS_DN
1.12107623318%	5	446	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
1.12107623318%	5	446	783	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ONKEN_UVEAL_MELANOMA_UP
1.12107623318%	5	446	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_VEGFR1_2_PATHWAY
1.12107623318%	5	446	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
1.12107623318%	5	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
1.12107623318%	5	446	584	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HAMAI_APOPTOSIS_VIA_TRAIL_UP
1.12107623318%	5	446	579	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
1.12107623318%	5	446	570	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
1.12107623318%	5	446	564	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SMID_BREAST_CANCER_LUMINAL_B_DN
1.12107623318%	5	446	555	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
1.12107623318%	5	446	549	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B
1.12107623318%	5	446	544	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
1.12107623318%	5	446	544	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
1.12107623318%	5	446	536	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SENESE_HDAC3_TARGETS_DN
1.12107623318%	5	446	532	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
1.12107623318%	5	446	518	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
1.12107623318%	5	446	517	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RAO_BOUND_BY_SALL4_ISOFORM_B
1.12107623318%	5	446	505	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
1.12107623318%	5	446	491	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SWEET_LUNG_CANCER_KRAS_UP
1.12107623318%	5	446	491	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MEISSNER_NPC_HCP_WITH_H3K4ME2
1.12107623318%	5	446	487	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
1.12107623318%	5	446	483	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN
1.12107623318%	5	446	476	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SMID_BREAST_CANCER_NORMAL_LIKE_UP
1.12107623318%	5	446	473	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GARY_CD5_TARGETS_UP
1.12107623318%	5	446	463	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C
1.12107623318%	5	446	459	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_WT1_TARGETS_DN
1.12107623318%	5	446	430	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RIGGI_EWING_SARCOMA_PROGENITOR_UP
1.12107623318%	5	446	428	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CUI_TCF21_TARGETS_2_UP
1.12107623318%	5	446	422	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAGI_AML_WITH_INV_16_TRANSLOCATION
1.12107623318%	5	446	408	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
1.12107623318%	5	446	404	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	OSMAN_BLADDER_CANCER_UP
1.12107623318%	5	446	391	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
1.12107623318%	5	446	380	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
1.12107623318%	5	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_GLUCOSE_TRANSPORT
1.12107623318%	5	446	379	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BENPORATH_ES_1
1.12107623318%	5	446	374	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_TUMOR_INVASIVENESS_UP
1.12107623318%	5	446	371	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_SMARCE1_TARGETS_DN
1.12107623318%	5	446	366	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SANSOM_APC_TARGETS_DN
1.12107623318%	5	446	357	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHEN_SMARCA2_TARGETS_DN
1.12107623318%	5	446	349	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
1.12107623318%	5	446	336	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JOHNSTONE_PARVB_TARGETS_2_DN
1.12107623318%	5	446	332	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
1.12107623318%	5	446	324	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
1.12107623318%	5	446	323	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRESHOCK_CANCER_COPY_NUMBER_UP
1.12107623318%	5	446	314	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
1.12107623318%	5	446	310	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HORIUCHI_WTAP_TARGETS_DN
1.12107623318%	5	446	294	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WEST_ADRENOCORTICAL_TUMOR_UP
1.12107623318%	5	446	293	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HADDAD_B_LYMPHOCYTE_PROGENITOR
1.12107623318%	5	446	293	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ENK_UV_RESPONSE_EPIDERMIS_UP
1.12107623318%	5	446	292	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KOYAMA_SEMA3B_TARGETS_UP
1.12107623318%	5	446	291	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SABATES_COLORECTAL_ADENOMA_DN
1.12107623318%	5	446	289	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_MLL_TARGETS
1.12107623318%	5	446	289	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MANALO_HYPOXIA_DN
1.12107623318%	5	446	276	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
1.12107623318%	5	446	275	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
1.12107623318%	5	446	266	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FOSTER_KDM1A_TARGETS_UP
1.12107623318%	5	446	260	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SENESE_HDAC1_TARGETS_DN
1.12107623318%	5	446	253	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DANG_REGULATED_BY_MYC_DN
1.12107623318%	5	446	251	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
1.12107623318%	5	446	251	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_AXON_GUIDANCE
1.12107623318%	5	446	244	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KAYO_AGING_MUSCLE_UP
1.12107623318%	5	446	242	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHYLA_CBFA2T3_TARGETS_DN
1.12107623318%	5	446	236	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
1.12107623318%	5	446	234	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AFFAR_YY1_TARGETS_DN
1.12107623318%	5	446	230	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KAUFFMANN_DNA_REPAIR_GENES
1.12107623318%	5	446	225	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
1.12107623318%	5	446	221	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHANG_TLX_TARGETS_36HR_UP
1.12107623318%	5	446	217	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SANSOM_APC_MYC_TARGETS
1.12107623318%	5	446	214	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
1.12107623318%	5	446	212	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
1.12107623318%	5	446	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
1.12107623318%	5	446	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RIZKI_TUMOR_INVASIVENESS_3D_UP
1.12107623318%	5	446	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CAIRO_HEPATOBLASTOMA_CLASSES_DN
1.12107623318%	5	446	207	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VERHAAK_GLIOBLASTOMA_CLASSICAL
1.12107623318%	5	446	202	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
1.12107623318%	5	446	196	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
1.12107623318%	5	446	186	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HAMAI_APOPTOSIS_VIA_TRAIL_DN
1.12107623318%	5	446	181	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JISON_SICKLE_CELL_DISEASE_DN
1.12107623318%	5	446	180	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_48HR_UP
1.12107623318%	5	446	176	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
1.12107623318%	5	446	165	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
1.12107623318%	5	446	153	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN
1.12107623318%	5	446	142	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
1.12107623318%	5	446	141	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WELCSH_BRCA1_TARGETS_DN
1.12107623318%	5	446	139	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
1.12107623318%	5	446	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_MEF_LCP_WITH_H3K4ME3
1.12107623318%	5	446	127	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIU_VMYB_TARGETS_UP
1.12107623318%	5	446	125	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
1.12107623318%	5	446	109	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
1.12107623318%	5	446	105	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_8HR_UP
1.11448834853%	22	1974	96	Mendelian_Nancy_Cox	ZAMORA_NOS2_TARGETS_DN
1.11448834853%	22	1974	91	Mendelian_Nancy_Cox	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
1.11448834853%	22	1974	90	Mendelian_Nancy_Cox	HILLION_HMGA1_TARGETS
1.11448834853%	22	1974	88	Mendelian_Nancy_Cox	KEGG_APOPTOSIS
1.11448834853%	22	1974	87	Mendelian_Nancy_Cox	KEGG_ERBB_SIGNALING_PATHWAY
1.11448834853%	22	1974	86	Mendelian_Nancy_Cox	BURTON_ADIPOGENESIS_8
1.11448834853%	22	1974	82	Mendelian_Nancy_Cox	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
1.11448834853%	22	1974	80	Mendelian_Nancy_Cox	KEGG_CARDIAC_MUSCLE_CONTRACTION
1.11448834853%	22	1974	77	Mendelian_Nancy_Cox	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
1.11448834853%	22	1974	76	Mendelian_Nancy_Cox	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
1.11448834853%	22	1974	74	Mendelian_Nancy_Cox	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN
1.11448834853%	22	1974	70	Mendelian_Nancy_Cox	LANDIS_BREAST_CANCER_PROGRESSION_DN
1.11448834853%	22	1974	66	Mendelian_Nancy_Cox	LEE_LIVER_CANCER_CIPROFIBRATE_DN
1.11448834853%	22	1974	58	Mendelian_Nancy_Cox	PID_SHP2_PATHWAY
1.11448834853%	22	1974	45	Mendelian_Nancy_Cox	KLEIN_TARGETS_OF_BCR_ABL1_FUSION
1.11448834853%	22	1974	39	Mendelian_Nancy_Cox	REACTOME_NCAM1_INTERACTIONS
1.11448834853%	22	1974	295	Mendelian_Nancy_Cox	LU_EZH2_TARGETS_UP
1.11448834853%	22	1974	236	Mendelian_Nancy_Cox	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
1.11448834853%	22	1974	227	Mendelian_Nancy_Cox	LEE_RECENT_THYMIC_EMIGRANT
1.11448834853%	22	1974	212	Mendelian_Nancy_Cox	CHANG_CORE_SERUM_RESPONSE_UP
1.11448834853%	22	1974	210	Mendelian_Nancy_Cox	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
1.11448834853%	22	1974	196	Mendelian_Nancy_Cox	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
1.11448834853%	22	1974	195	Mendelian_Nancy_Cox	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
1.11448834853%	22	1974	195	Mendelian_Nancy_Cox	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
1.11448834853%	22	1974	184	Mendelian_Nancy_Cox	DOANE_RESPONSE_TO_ANDROGEN_UP
1.11448834853%	22	1974	183	Mendelian_Nancy_Cox	KEGG_ENDOCYTOSIS
1.11448834853%	22	1974	178	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_18HR_UP
1.11448834853%	22	1974	177	Mendelian_Nancy_Cox	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
1.11448834853%	22	1974	167	Mendelian_Nancy_Cox	VANTVEER_BREAST_CANCER_ESR1_UP
1.11448834853%	22	1974	166	Mendelian_Nancy_Cox	SMIRNOV_RESPONSE_TO_IR_6HR_UP
1.11448834853%	22	1974	166	Mendelian_Nancy_Cox	CAIRO_LIVER_DEVELOPMENT_UP
1.11448834853%	22	1974	157	Mendelian_Nancy_Cox	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
1.11448834853%	22	1974	153	Mendelian_Nancy_Cox	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
1.11448834853%	22	1974	148	Mendelian_Nancy_Cox	KATSANOU_ELAVL1_TARGETS_DN
1.11448834853%	22	1974	146	Mendelian_Nancy_Cox	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
1.11448834853%	22	1974	145	Mendelian_Nancy_Cox	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
1.11448834853%	22	1974	143	Mendelian_Nancy_Cox	DANG_MYC_TARGETS_UP
1.11448834853%	22	1974	141	Mendelian_Nancy_Cox	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
1.11448834853%	22	1974	141	Mendelian_Nancy_Cox	KAAB_FAILED_HEART_ATRIUM_DN
1.11448834853%	22	1974	140	Mendelian_Nancy_Cox	ONDER_CDH1_TARGETS_1_UP
1.11448834853%	22	1974	140	Mendelian_Nancy_Cox	JOHNSTONE_PARVB_TARGETS_2_UP
1.11448834853%	22	1974	140	Mendelian_Nancy_Cox	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
1.11448834853%	22	1974	137	Mendelian_Nancy_Cox	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
1.11448834853%	22	1974	133	Mendelian_Nancy_Cox	SENESE_HDAC2_TARGETS_DN
1.11448834853%	22	1974	127	Mendelian_Nancy_Cox	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
1.11448834853%	22	1974	126	Mendelian_Nancy_Cox	GERY_CEBP_TARGETS
1.11448834853%	22	1974	120	Mendelian_Nancy_Cox	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
1.11448834853%	22	1974	118	Mendelian_Nancy_Cox	MARKEY_RB1_CHRONIC_LOF_DN
1.11448834853%	22	1974	117	Mendelian_Nancy_Cox	PUJANA_BRCA_CENTERED_NETWORK
1.11448834853%	22	1974	112	Mendelian_Nancy_Cox	REACTOME_DNA_REPAIR
1.11448834853%	22	1974	104	Mendelian_Nancy_Cox	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
1.11448834853%	22	1974	101	Mendelian_Nancy_Cox	KEGG_GNRH_SIGNALING_PATHWAY
1.1120615911%	13	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RNA_POL_I_TRANSCRIPTION
1.1120615911%	13	1169	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MEIOTIC_RECOMBINATION
1.1120615911%	13	1169	428	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
1.1120615911%	13	1169	411	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KOYAMA_SEMA3B_TARGETS_DN
1.1120615911%	13	1169	408	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
1.1120615911%	13	1169	391	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
1.1120615911%	13	1169	384	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
1.1120615911%	13	1169	380	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
1.1120615911%	13	1169	344	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
1.1120615911%	13	1169	342	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BLUM_RESPONSE_TO_SALIRASIB_DN
1.1120615911%	13	1169	341	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
1.1120615911%	13	1169	329	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
1.1120615911%	13	1169	324	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
1.1120615911%	13	1169	323	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRESHOCK_CANCER_COPY_NUMBER_UP
1.1120615911%	13	1169	320	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
1.1120615911%	13	1169	317	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
1.1120615911%	13	1169	312	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GENTILE_UV_HIGH_DOSE_DN
1.1120615911%	13	1169	309	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIU_SOX4_TARGETS_DN
1.1120615911%	13	1169	292	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KOYAMA_SEMA3B_TARGETS_UP
1.1120615911%	13	1169	281	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
1.1120615911%	13	1169	265	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
1.1120615911%	13	1169	242	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHYLA_CBFA2T3_TARGETS_DN
1.1120615911%	13	1169	240	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	UDAYAKUMAR_MED1_TARGETS_DN
1.1120615911%	13	1169	221	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHANDRAN_METASTASIS_UP
1.1120615911%	13	1169	211	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FOSTER_KDM1A_TARGETS_DN
1.1120615911%	13	1169	206	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
1.1120615911%	13	1169	202	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
1.1120615911%	13	1169	196	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
1.1120615911%	13	1169	186	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HAMAI_APOPTOSIS_VIA_TRAIL_DN
1.1120615911%	13	1169	174	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
1.108033241%	4	361	98	T2D_GENES_TANYA_T2D_RSQ05_02CM	PYEON_HPV_POSITIVE_TUMORS_UP
1.108033241%	4	361	953	T2D_GENES_TANYA_T2D_RSQ05_02CM	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
1.108033241%	4	361	93	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_REGULATION_OF_INSULIN_SECRETION
1.108033241%	4	361	91	T2D_GENES_TANYA_T2D_RSQ05_02CM	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
1.108033241%	4	361	89	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
1.108033241%	4	361	84	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_SMALL_CELL_LUNG_CANCER
1.108033241%	4	361	80	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_BETACATENIN_NUC_PATHWAY
1.108033241%	4	361	79	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
1.108033241%	4	361	79	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
1.108033241%	4	361	74	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHEPARD_BMYB_TARGETS
1.108033241%	4	361	720	T2D_GENES_TANYA_T2D_RSQ05_02CM	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3
1.108033241%	4	361	66	T2D_GENES_TANYA_T2D_RSQ05_02CM	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
1.108033241%	4	361	584	T2D_GENES_TANYA_T2D_RSQ05_02CM	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
1.108033241%	4	361	584	T2D_GENES_TANYA_T2D_RSQ05_02CM	HAMAI_APOPTOSIS_VIA_TRAIL_UP
1.108033241%	4	361	572	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHICAS_RB1_TARGETS_SENESCENT
1.108033241%	4	361	57	T2D_GENES_TANYA_T2D_RSQ05_02CM	NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON
1.108033241%	4	361	55	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER
1.108033241%	4	361	546	T2D_GENES_TANYA_T2D_RSQ05_02CM	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
1.108033241%	4	361	544	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
1.108033241%	4	361	530	T2D_GENES_TANYA_T2D_RSQ05_02CM	ENK_UV_RESPONSE_KERATINOCYTE_UP
1.108033241%	4	361	517	T2D_GENES_TANYA_T2D_RSQ05_02CM	RAO_BOUND_BY_SALL4_ISOFORM_B
1.108033241%	4	361	508	T2D_GENES_TANYA_T2D_RSQ05_02CM	ENK_UV_RESPONSE_EPIDERMIS_DN
1.108033241%	4	361	50	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARTINEZ_RESPONSE_TO_TRABECTEDIN
1.108033241%	4	361	49	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
1.108033241%	4	361	485	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
1.108033241%	4	361	485	T2D_GENES_TANYA_T2D_RSQ05_02CM	ENK_UV_RESPONSE_KERATINOCYTE_DN
1.108033241%	4	361	430	T2D_GENES_TANYA_T2D_RSQ05_02CM	JOHNSTONE_PARVB_TARGETS_3_UP
1.108033241%	4	361	429	T2D_GENES_TANYA_T2D_RSQ05_02CM	MOOTHA_HUMAN_MITODB_6_2002
1.108033241%	4	361	425	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHANG_BREAST_CANCER_PROGENITORS_UP
1.108033241%	4	361	425	T2D_GENES_TANYA_T2D_RSQ05_02CM	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
1.108033241%	4	361	423	T2D_GENES_TANYA_T2D_RSQ05_02CM	THUM_SYSTOLIC_HEART_FAILURE_UP
1.108033241%	4	361	422	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAGI_AML_WITH_INV_16_TRANSLOCATION
1.108033241%	4	361	419	T2D_GENES_TANYA_T2D_RSQ05_02CM	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
1.108033241%	4	361	411	T2D_GENES_TANYA_T2D_RSQ05_02CM	KOYAMA_SEMA3B_TARGETS_DN
1.108033241%	4	361	409	T2D_GENES_TANYA_T2D_RSQ05_02CM	FOSTER_TOLERANT_MACROPHAGE_DN
1.108033241%	4	361	408	T2D_GENES_TANYA_T2D_RSQ05_02CM	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
1.108033241%	4	361	406	T2D_GENES_TANYA_T2D_RSQ05_02CM	OSMAN_BLADDER_CANCER_DN
1.108033241%	4	361	395	T2D_GENES_TANYA_T2D_RSQ05_02CM	HAN_SATB1_TARGETS_UP
1.108033241%	4	361	394	T2D_GENES_TANYA_T2D_RSQ05_02CM	BERENJENO_TRANSFORMED_BY_RHOA_DN
1.108033241%	4	361	388	T2D_GENES_TANYA_T2D_RSQ05_02CM	STEIN_ESRRA_TARGETS_UP
1.108033241%	4	361	379	T2D_GENES_TANYA_T2D_RSQ05_02CM	BENPORATH_ES_1
1.108033241%	4	361	368	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAGI_AML_WITH_T_8_21_TRANSLOCATION
1.108033241%	4	361	352	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_LMO4_TARGETS_DN
1.108033241%	4	361	344	T2D_GENES_TANYA_T2D_RSQ05_02CM	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
1.108033241%	4	361	330	T2D_GENES_TANYA_T2D_RSQ05_02CM	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
1.108033241%	4	361	320	T2D_GENES_TANYA_T2D_RSQ05_02CM	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
1.108033241%	4	361	316	T2D_GENES_TANYA_T2D_RSQ05_02CM	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
1.108033241%	4	361	315	T2D_GENES_TANYA_T2D_RSQ05_02CM	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
1.108033241%	4	361	314	T2D_GENES_TANYA_T2D_RSQ05_02CM	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
1.108033241%	4	361	31	T2D_GENES_TANYA_T2D_RSQ05_02CM	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN
1.108033241%	4	361	307	T2D_GENES_TANYA_T2D_RSQ05_02CM	LI_INDUCED_T_TO_NATURAL_KILLER_UP
1.108033241%	4	361	307	T2D_GENES_TANYA_T2D_RSQ05_02CM	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
1.108033241%	4	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
1.108033241%	4	361	296	T2D_GENES_TANYA_T2D_RSQ05_02CM	DURAND_STROMA_MAX_UP
1.108033241%	4	361	294	T2D_GENES_TANYA_T2D_RSQ05_02CM	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
1.108033241%	4	361	293	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZWANG_DOWN_BY_2ND_EGF_PULSE
1.108033241%	4	361	293	T2D_GENES_TANYA_T2D_RSQ05_02CM	HADDAD_B_LYMPHOCYTE_PROGENITOR
1.108033241%	4	361	292	T2D_GENES_TANYA_T2D_RSQ05_02CM	KOYAMA_SEMA3B_TARGETS_UP
1.108033241%	4	361	291	T2D_GENES_TANYA_T2D_RSQ05_02CM	SABATES_COLORECTAL_ADENOMA_DN
1.108033241%	4	361	289	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_MLL_TARGETS
1.108033241%	4	361	289	T2D_GENES_TANYA_T2D_RSQ05_02CM	GABRIELY_MIR21_TARGETS
1.108033241%	4	361	285	T2D_GENES_TANYA_T2D_RSQ05_02CM	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
1.108033241%	4	361	283	T2D_GENES_TANYA_T2D_RSQ05_02CM	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
1.108033241%	4	361	276	T2D_GENES_TANYA_T2D_RSQ05_02CM	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
1.108033241%	4	361	276	T2D_GENES_TANYA_T2D_RSQ05_02CM	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
1.108033241%	4	361	275	T2D_GENES_TANYA_T2D_RSQ05_02CM	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
1.108033241%	4	361	272	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
1.108033241%	4	361	266	T2D_GENES_TANYA_T2D_RSQ05_02CM	FOSTER_KDM1A_TARGETS_UP
1.108033241%	4	361	256	T2D_GENES_TANYA_T2D_RSQ05_02CM	ONDER_CDH1_TARGETS_2_UP
1.108033241%	4	361	255	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
1.108033241%	4	361	250	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
1.108033241%	4	361	249	T2D_GENES_TANYA_T2D_RSQ05_02CM	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
1.108033241%	4	361	244	T2D_GENES_TANYA_T2D_RSQ05_02CM	KAYO_AGING_MUSCLE_UP
1.108033241%	4	361	240	T2D_GENES_TANYA_T2D_RSQ05_02CM	VANTVEER_BREAST_CANCER_ESR1_DN
1.108033241%	4	361	234	T2D_GENES_TANYA_T2D_RSQ05_02CM	AFFAR_YY1_TARGETS_DN
1.108033241%	4	361	229	T2D_GENES_TANYA_T2D_RSQ05_02CM	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
1.108033241%	4	361	228	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
1.108033241%	4	361	228	T2D_GENES_TANYA_T2D_RSQ05_02CM	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
1.108033241%	4	361	222	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_1HR_DN
1.108033241%	4	361	221	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHANG_TLX_TARGETS_36HR_UP
1.108033241%	4	361	215	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAMAZAKI_TCEB3_TARGETS_DN
1.108033241%	4	361	214	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIDUS_METASTASIS_UP
1.108033241%	4	361	214	T2D_GENES_TANYA_T2D_RSQ05_02CM	AFFAR_YY1_TARGETS_UP
1.108033241%	4	361	211	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
1.108033241%	4	361	211	T2D_GENES_TANYA_T2D_RSQ05_02CM	FOSTER_KDM1A_TARGETS_DN
1.108033241%	4	361	210	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_TUMOR_INVASIVENESS_DN
1.108033241%	4	361	209	T2D_GENES_TANYA_T2D_RSQ05_02CM	GROSS_HYPOXIA_VIA_ELK3_UP
1.108033241%	4	361	207	T2D_GENES_TANYA_T2D_RSQ05_02CM	VERHAAK_GLIOBLASTOMA_CLASSICAL
1.108033241%	4	361	207	T2D_GENES_TANYA_T2D_RSQ05_02CM	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
1.108033241%	4	361	206	T2D_GENES_TANYA_T2D_RSQ05_02CM	LINSLEY_MIR16_TARGETS
1.108033241%	4	361	206	T2D_GENES_TANYA_T2D_RSQ05_02CM	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
1.108033241%	4	361	205	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHEPARD_BMYB_MORPHOLINO_UP
1.108033241%	4	361	205	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
1.108033241%	4	361	201	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_FOCAL_ADHESION
1.108033241%	4	361	200	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHEPARD_BMYB_MORPHOLINO_DN
1.108033241%	4	361	194	T2D_GENES_TANYA_T2D_RSQ05_02CM	KASLER_HDAC7_TARGETS_1_UP
1.108033241%	4	361	193	T2D_GENES_TANYA_T2D_RSQ05_02CM	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP
1.108033241%	4	361	185	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHANG_TLX_TARGETS_36HR_DN
1.108033241%	4	361	185	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
1.108033241%	4	361	185	T2D_GENES_TANYA_T2D_RSQ05_02CM	DARWICHE_SKIN_TUMOR_PROMOTER_DN
1.108033241%	4	361	184	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
1.108033241%	4	361	181	T2D_GENES_TANYA_T2D_RSQ05_02CM	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
1.108033241%	4	361	180	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_48HR_UP
1.108033241%	4	361	178	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_18HR_UP
1.108033241%	4	361	177	T2D_GENES_TANYA_T2D_RSQ05_02CM	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
1.108033241%	4	361	175	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAMAZAKI_TCEB3_TARGETS_UP
1.108033241%	4	361	175	T2D_GENES_TANYA_T2D_RSQ05_02CM	FIRESTEIN_PROLIFERATION
1.108033241%	4	361	174	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
1.108033241%	4	361	170	T2D_GENES_TANYA_T2D_RSQ05_02CM	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
1.108033241%	4	361	170	T2D_GENES_TANYA_T2D_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
1.108033241%	4	361	169	T2D_GENES_TANYA_T2D_RSQ05_02CM	PENG_GLUCOSE_DEPRIVATION_DN
1.108033241%	4	361	167	T2D_GENES_TANYA_T2D_RSQ05_02CM	VANTVEER_BREAST_CANCER_ESR1_UP
1.108033241%	4	361	165	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIU_CMYB_TARGETS_UP
1.108033241%	4	361	157	T2D_GENES_TANYA_T2D_RSQ05_02CM	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
1.108033241%	4	361	151	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_WNT_SIGNALING_PATHWAY
1.108033241%	4	361	149	T2D_GENES_TANYA_T2D_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
1.108033241%	4	361	149	T2D_GENES_TANYA_T2D_RSQ05_02CM	GOZGIT_ESR1_TARGETS_UP
1.108033241%	4	361	146	T2D_GENES_TANYA_T2D_RSQ05_02CM	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
1.108033241%	4	361	142	T2D_GENES_TANYA_T2D_RSQ05_02CM	DARWICHE_SKIN_TUMOR_PROMOTER_UP
1.108033241%	4	361	133	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_DIABETES_PATHWAYS
1.108033241%	4	361	132	T2D_GENES_TANYA_T2D_RSQ05_02CM	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
1.108033241%	4	361	131	T2D_GENES_TANYA_T2D_RSQ05_02CM	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
1.108033241%	4	361	128	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHU_CMV_ALL_DN
1.108033241%	4	361	128	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_CELL_CYCLE
1.108033241%	4	361	120	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
1.108033241%	4	361	11	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHOU_PANCREATIC_EXOCRINE_PROGENITOR
1.108033241%	4	361	108	T2D_GENES_TANYA_T2D_RSQ05_02CM	LE_EGR2_TARGETS_UP
1.108033241%	4	361	103	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SIGNALING_BY_NOTCH
1.108033241%	4	361	101	T2D_GENES_TANYA_T2D_RSQ05_02CM	BURTON_ADIPOGENESIS_3
1.10795454545%	39	3520	418	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PEDRIOLI_MIR31_TARGETS_DN
1.10795454545%	39	3520	405	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KUMAR_TARGETS_OF_MLL_AF9_FUSION
1.10795454545%	39	3520	364	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YANG_BCL3_TARGETS_UP
1.10795454545%	39	3520	355	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PEREZ_TP63_TARGETS
1.10795454545%	39	3520	309	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_SOX4_TARGETS_DN
1.10795454545%	39	3520	277	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_60HR_DN
1.10795454545%	39	3520	122	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
1.10701107011%	6	542	98	T2D_GENES_TANYA_ANTHROPOMETRIC	GUO_TARGETS_OF_IRS1_AND_IRS2
1.10701107011%	6	542	97	T2D_GENES_TANYA_ANTHROPOMETRIC	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP
1.10701107011%	6	542	91	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION
1.10701107011%	6	542	91	T2D_GENES_TANYA_ANTHROPOMETRIC	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
1.10701107011%	6	542	90	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_GAP_JUNCTION
1.10701107011%	6	542	90	T2D_GENES_TANYA_ANTHROPOMETRIC	HILLION_HMGA1_TARGETS
1.10701107011%	6	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	SASSON_RESPONSE_TO_FORSKOLIN_DN
1.10701107011%	6	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	LAIHO_COLORECTAL_CANCER_SERRATED_DN
1.10701107011%	6	542	84	T2D_GENES_TANYA_ANTHROPOMETRIC	SMID_BREAST_CANCER_LUMINAL_A_UP
1.10701107011%	6	542	83	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
1.10701107011%	6	542	82	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_REG_GR_PATHWAY
1.10701107011%	6	542	81	T2D_GENES_TANYA_ANTHROPOMETRIC	COATES_MACROPHAGE_M1_VS_M2_UP
1.10701107011%	6	542	80	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_MET_PATHWAY
1.10701107011%	6	542	78	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_OPIOID_SIGNALLING
1.10701107011%	6	542	78	T2D_GENES_TANYA_ANTHROPOMETRIC	RADMACHER_AML_PROGNOSIS
1.10701107011%	6	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	RODRIGUES_THYROID_CARCINOMA_DN
1.10701107011%	6	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	DARWICHE_PAPILLOMA_PROGRESSION_RISK
1.10701107011%	6	542	72	T2D_GENES_TANYA_ANTHROPOMETRIC	DOANE_BREAST_CANCER_CLASSES_UP
1.10701107011%	6	542	71	T2D_GENES_TANYA_ANTHROPOMETRIC	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
1.10701107011%	6	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PHASE_II_CONJUGATION
1.10701107011%	6	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
1.10701107011%	6	542	68	T2D_GENES_TANYA_ANTHROPOMETRIC	LIN_NPAS4_TARGETS_DN
1.10701107011%	6	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
1.10701107011%	6	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_SHP2_PATHWAY
1.10701107011%	6	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_PPARA_PATHWAY
1.10701107011%	6	542	544	T2D_GENES_TANYA_ANTHROPOMETRIC	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
1.10701107011%	6	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	MELLMAN_TUT1_TARGETS_DN
1.10701107011%	6	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN
1.10701107011%	6	542	430	T2D_GENES_TANYA_ANTHROPOMETRIC	RIGGI_EWING_SARCOMA_PROGENITOR_UP
1.10701107011%	6	542	392	T2D_GENES_TANYA_ANTHROPOMETRIC	LINDGREN_BLADDER_CANCER_CLUSTER_2B
1.10701107011%	6	542	389	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_OLFACTORY_TRANSDUCTION
1.10701107011%	6	542	364	T2D_GENES_TANYA_ANTHROPOMETRIC	YANG_BCL3_TARGETS_UP
1.10701107011%	6	542	358	T2D_GENES_TANYA_ANTHROPOMETRIC	GRUETZMANN_PANCREATIC_CANCER_UP
1.10701107011%	6	542	352	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
1.10701107011%	6	542	351	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
1.10701107011%	6	542	338	T2D_GENES_TANYA_ANTHROPOMETRIC	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
1.10701107011%	6	542	325	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CELL_CYCLE_MITOTIC
1.10701107011%	6	542	317	T2D_GENES_TANYA_ANTHROPOMETRIC	BRUINS_UVC_RESPONSE_EARLY_LATE
1.10701107011%	6	542	290	T2D_GENES_TANYA_ANTHROPOMETRIC	BASAKI_YBX1_TARGETS_UP
1.10701107011%	6	542	282	T2D_GENES_TANYA_ANTHROPOMETRIC	HELLER_SILENCED_BY_METHYLATION_UP
1.10701107011%	6	542	277	T2D_GENES_TANYA_ANTHROPOMETRIC	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
1.10701107011%	6	542	275	T2D_GENES_TANYA_ANTHROPOMETRIC	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
1.10701107011%	6	542	272	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
1.10701107011%	6	542	271	T2D_GENES_TANYA_ANTHROPOMETRIC	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
1.10701107011%	6	542	267	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
1.10701107011%	6	542	267	T2D_GENES_TANYA_ANTHROPOMETRIC	CAIRO_HEPATOBLASTOMA_DN
1.10701107011%	6	542	266	T2D_GENES_TANYA_ANTHROPOMETRIC	FOSTER_KDM1A_TARGETS_UP
1.10701107011%	6	542	261	T2D_GENES_TANYA_ANTHROPOMETRIC	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
1.10701107011%	6	542	256	T2D_GENES_TANYA_ANTHROPOMETRIC	ONDER_CDH1_TARGETS_2_UP
1.10701107011%	6	542	251	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
1.10701107011%	6	542	246	T2D_GENES_TANYA_ANTHROPOMETRIC	VERHAAK_AML_WITH_NPM1_MUTATED_DN
1.10701107011%	6	542	245	T2D_GENES_TANYA_ANTHROPOMETRIC	KONDO_EZH2_TARGETS
1.10701107011%	6	542	244	T2D_GENES_TANYA_ANTHROPOMETRIC	PLASARI_TGFB1_TARGETS_10HR_DN
1.10701107011%	6	542	244	T2D_GENES_TANYA_ANTHROPOMETRIC	DAZARD_RESPONSE_TO_UV_NHEK_UP
1.10701107011%	6	542	243	T2D_GENES_TANYA_ANTHROPOMETRIC	CHICAS_RB1_TARGETS_GROWING
1.10701107011%	6	542	230	T2D_GENES_TANYA_ANTHROPOMETRIC	COLDREN_GEFITINIB_RESISTANCE_DN
1.10701107011%	6	542	229	T2D_GENES_TANYA_ANTHROPOMETRIC	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
1.10701107011%	6	542	221	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHANG_TLX_TARGETS_36HR_UP
1.10701107011%	6	542	217	T2D_GENES_TANYA_ANTHROPOMETRIC	AMUNDSON_RESPONSE_TO_ARSENITE
1.10701107011%	6	542	215	T2D_GENES_TANYA_ANTHROPOMETRIC	MARKEY_RB1_ACUTE_LOF_UP
1.10701107011%	6	542	214	T2D_GENES_TANYA_ANTHROPOMETRIC	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
1.10701107011%	6	542	210	T2D_GENES_TANYA_ANTHROPOMETRIC	VERHAAK_GLIOBLASTOMA_NEURAL
1.10701107011%	6	542	210	T2D_GENES_TANYA_ANTHROPOMETRIC	RIZKI_TUMOR_INVASIVENESS_3D_UP
1.10701107011%	6	542	208	T2D_GENES_TANYA_ANTHROPOMETRIC	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
1.10701107011%	6	542	206	T2D_GENES_TANYA_ANTHROPOMETRIC	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
1.10701107011%	6	542	206	T2D_GENES_TANYA_ANTHROPOMETRIC	BILD_MYC_ONCOGENIC_SIGNATURE
1.10701107011%	6	542	205	T2D_GENES_TANYA_ANTHROPOMETRIC	SHEPARD_BMYB_MORPHOLINO_UP
1.10701107011%	6	542	203	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_INFLUENZA_LIFE_CYCLE
1.10701107011%	6	542	201	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_FOCAL_ADHESION
1.10701107011%	6	542	200	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_DIFFERENTIATING_T_LYMPHOCYTE
1.10701107011%	6	542	195	T2D_GENES_TANYA_ANTHROPOMETRIC	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
1.10701107011%	6	542	194	T2D_GENES_TANYA_ANTHROPOMETRIC	KASLER_HDAC7_TARGETS_1_UP
1.10701107011%	6	542	190	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_CHEMOKINE_SIGNALING_PATHWAY
1.10701107011%	6	542	189	T2D_GENES_TANYA_ANTHROPOMETRIC	BURTON_ADIPOGENESIS_6
1.10701107011%	6	542	187	T2D_GENES_TANYA_ANTHROPOMETRIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
1.10701107011%	6	542	182	T2D_GENES_TANYA_ANTHROPOMETRIC	FERNANDEZ_BOUND_BY_MYC
1.10701107011%	6	542	181	T2D_GENES_TANYA_ANTHROPOMETRIC	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
1.10701107011%	6	542	180	T2D_GENES_TANYA_ANTHROPOMETRIC	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
1.10701107011%	6	542	179	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE
1.10701107011%	6	542	179	T2D_GENES_TANYA_ANTHROPOMETRIC	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
1.10701107011%	6	542	176	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
1.10701107011%	6	542	176	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION
1.10701107011%	6	542	175	T2D_GENES_TANYA_ANTHROPOMETRIC	FIRESTEIN_PROLIFERATION
1.10701107011%	6	542	170	T2D_GENES_TANYA_ANTHROPOMETRIC	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
1.10701107011%	6	542	166	T2D_GENES_TANYA_ANTHROPOMETRIC	CAIRO_LIVER_DEVELOPMENT_UP
1.10701107011%	6	542	165	T2D_GENES_TANYA_ANTHROPOMETRIC	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
1.10701107011%	6	542	164	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_WT1_TARGETS_8HR_UP
1.10701107011%	6	542	163	T2D_GENES_TANYA_ANTHROPOMETRIC	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
1.10701107011%	6	542	159	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PURINE_METABOLISM
1.10701107011%	6	542	153	T2D_GENES_TANYA_ANTHROPOMETRIC	LU_AGING_BRAIN_DN
1.10701107011%	6	542	150	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_30MIN_DN
1.10701107011%	6	542	148	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_APOPTOSIS
1.10701107011%	6	542	147	T2D_GENES_TANYA_ANTHROPOMETRIC	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
1.10701107011%	6	542	146	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_NEURAL_CREST_STEM_CELL_UP
1.10701107011%	6	542	145	T2D_GENES_TANYA_ANTHROPOMETRIC	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
1.10701107011%	6	542	143	T2D_GENES_TANYA_ANTHROPOMETRIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
1.10701107011%	6	542	143	T2D_GENES_TANYA_ANTHROPOMETRIC	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION
1.10701107011%	6	542	141	T2D_GENES_TANYA_ANTHROPOMETRIC	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP
1.10701107011%	6	542	140	T2D_GENES_TANYA_ANTHROPOMETRIC	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
1.10701107011%	6	542	138	T2D_GENES_TANYA_ANTHROPOMETRIC	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
1.10701107011%	6	542	138	T2D_GENES_TANYA_ANTHROPOMETRIC	JIANG_VHL_TARGETS
1.10701107011%	6	542	137	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_P53DOWNSTREAMPATHWAY
1.10701107011%	6	542	137	T2D_GENES_TANYA_ANTHROPOMETRIC	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
1.10701107011%	6	542	136	T2D_GENES_TANYA_ANTHROPOMETRIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
1.10701107011%	6	542	135	T2D_GENES_TANYA_ANTHROPOMETRIC	SERVITJA_LIVER_HNF1A_TARGETS_UP
1.10701107011%	6	542	134	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHLOSSER_SERUM_RESPONSE_UP
1.10701107011%	6	542	129	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_PDGFRBPATHWAY
1.10701107011%	6	542	126	T2D_GENES_TANYA_ANTHROPOMETRIC	GERY_CEBP_TARGETS
1.10701107011%	6	542	121	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS
1.10701107011%	6	542	121	T2D_GENES_TANYA_ANTHROPOMETRIC	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
1.10701107011%	6	542	121	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_LYSOSOME
1.10701107011%	6	542	120	T2D_GENES_TANYA_ANTHROPOMETRIC	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
1.10701107011%	6	542	116	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
1.10701107011%	6	542	114	T2D_GENES_TANYA_ANTHROPOMETRIC	CERVERA_SDHB_TARGETS_2
1.10701107011%	6	542	112	T2D_GENES_TANYA_ANTHROPOMETRIC	DOANE_BREAST_CANCER_ESR1_UP
1.10701107011%	6	542	108	T2D_GENES_TANYA_ANTHROPOMETRIC	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN
1.10701107011%	6	542	103	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY
1.10701107011%	6	542	102	T2D_GENES_TANYA_ANTHROPOMETRIC	LABBE_TGFB1_TARGETS_UP
1.10701107011%	6	542	102	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_MELANOGENESIS
1.10395584177%	24	2174	408	T2D_GENES_TANYA_LIPIDS	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
1.10395584177%	24	2174	305	T2D_GENES_TANYA_LIPIDS	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
1.10395584177%	24	2174	281	T2D_GENES_TANYA_LIPIDS	MULLIGHAN_MLL_SIGNATURE_2_DN
1.10395584177%	24	2174	279	T2D_GENES_TANYA_LIPIDS	REACTOME_INNATE_IMMUNE_SYSTEM
1.10395584177%	24	2174	270	T2D_GENES_TANYA_LIPIDS	RIZKI_TUMOR_INVASIVENESS_3D_DN
1.10395584177%	24	2174	266	T2D_GENES_TANYA_LIPIDS	ROZANOV_MMP14_TARGETS_UP
1.10395584177%	24	2174	250	T2D_GENES_TANYA_LIPIDS	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
1.10395584177%	24	2174	247	T2D_GENES_TANYA_LIPIDS	REACTOME_METABOLISM_OF_CARBOHYDRATES
1.10395584177%	24	2174	245	T2D_GENES_TANYA_LIPIDS	PENG_RAPAMYCIN_RESPONSE_DN
1.10395584177%	24	2174	242	T2D_GENES_TANYA_LIPIDS	MULLIGHAN_MLL_SIGNATURE_1_DN
1.10395584177%	24	2174	232	T2D_GENES_TANYA_LIPIDS	DELYS_THYROID_CANCER_DN
1.10395584177%	24	2174	216	T2D_GENES_TANYA_LIPIDS	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
1.10395584177%	24	2174	214	T2D_GENES_TANYA_LIPIDS	ZWANG_EGF_INTERVAL_DN
1.10395584177%	24	2174	212	T2D_GENES_TANYA_LIPIDS	CHANG_CORE_SERUM_RESPONSE_UP
1.10395584177%	24	2174	210	T2D_GENES_TANYA_LIPIDS	VERHAAK_GLIOBLASTOMA_NEURAL
1.10395584177%	24	2174	209	T2D_GENES_TANYA_LIPIDS	GROSS_HYPOXIA_VIA_ELK3_UP
1.10395584177%	24	2174	206	T2D_GENES_TANYA_LIPIDS	LINSLEY_MIR16_TARGETS
1.10395584177%	24	2174	205	T2D_GENES_TANYA_LIPIDS	SHEPARD_BMYB_MORPHOLINO_UP
1.10395584177%	24	2174	200	T2D_GENES_TANYA_LIPIDS	SHEPARD_BMYB_MORPHOLINO_DN
1.10395584177%	24	2174	194	T2D_GENES_TANYA_LIPIDS	PROVENZANI_METASTASIS_UP
1.10395584177%	24	2174	189	T2D_GENES_TANYA_LIPIDS	BURTON_ADIPOGENESIS_6
1.10395584177%	24	2174	187	T2D_GENES_TANYA_LIPIDS	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
1.10395584177%	24	2174	175	T2D_GENES_TANYA_LIPIDS	YAMAZAKI_TCEB3_TARGETS_UP
1.10395584177%	24	2174	172	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
1.10395584177%	24	2174	162	T2D_GENES_TANYA_LIPIDS	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
1.10395584177%	24	2174	153	T2D_GENES_TANYA_LIPIDS	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
1.10395584177%	24	2174	146	T2D_GENES_TANYA_LIPIDS	PECE_MAMMARY_STEM_CELL_DN
1.10323089046%	14	1269	584	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HAMAI_APOPTOSIS_VIA_TRAIL_UP
1.10323089046%	14	1269	539	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIAO_METASTASIS
1.10323089046%	14	1269	536	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SENESE_HDAC3_TARGETS_DN
1.10323089046%	14	1269	518	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_PROTEINS
1.10323089046%	14	1269	518	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
1.10323089046%	14	1269	478	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
1.10323089046%	14	1269	442	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
1.10323089046%	14	1269	425	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
1.10323089046%	14	1269	409	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FOSTER_TOLERANT_MACROPHAGE_DN
1.10323089046%	14	1269	395	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HAN_SATB1_TARGETS_UP
1.10323089046%	14	1269	366	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SANSOM_APC_TARGETS_DN
1.10323089046%	14	1269	354	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
1.10323089046%	14	1269	336	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JOHNSTONE_PARVB_TARGETS_2_DN
1.10323089046%	14	1269	332	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
1.10323089046%	14	1269	330	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
1.10323089046%	14	1269	324	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
1.10323089046%	14	1269	312	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GENTILE_UV_HIGH_DOSE_DN
1.10323089046%	14	1269	309	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP
1.10323089046%	14	1269	283	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
1.10323089046%	14	1269	250	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
1.10323089046%	14	1269	228	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
1.10323089046%	14	1269	192	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_DNA_REPLICATION
1.10323089046%	14	1269	174	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
1.10323089046%	14	1269	162	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_S
1.0989010989%	5	455	98	T2D_GENES_TANYA_BLOODPRESSURE	MENSE_HYPOXIA_UP
1.0989010989%	5	455	97	T2D_GENES_TANYA_BLOODPRESSURE	KONG_E2F3_TARGETS
1.0989010989%	5	455	95	T2D_GENES_TANYA_BLOODPRESSURE	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
1.0989010989%	5	455	92	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_DILATED_CARDIOMYOPATHY
1.0989010989%	5	455	89	T2D_GENES_TANYA_BLOODPRESSURE	SWEET_KRAS_ONCOGENIC_SIGNATURE
1.0989010989%	5	455	88	T2D_GENES_TANYA_BLOODPRESSURE	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
1.0989010989%	5	455	88	T2D_GENES_TANYA_BLOODPRESSURE	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
1.0989010989%	5	455	86	T2D_GENES_TANYA_BLOODPRESSURE	LEE_AGING_CEREBELLUM_DN
1.0989010989%	5	455	86	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
1.0989010989%	5	455	86	T2D_GENES_TANYA_BLOODPRESSURE	HOEBEKE_LYMPHOID_STEM_CELL_DN
1.0989010989%	5	455	85	T2D_GENES_TANYA_BLOODPRESSURE	COLDREN_GEFITINIB_RESISTANCE_UP
1.0989010989%	5	455	79	T2D_GENES_TANYA_BLOODPRESSURE	DUAN_PRDM5_TARGETS
1.0989010989%	5	455	78	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PLATELET_HOMEOSTASIS
1.0989010989%	5	455	78	T2D_GENES_TANYA_BLOODPRESSURE	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
1.0989010989%	5	455	77	T2D_GENES_TANYA_BLOODPRESSURE	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
1.0989010989%	5	455	77	T2D_GENES_TANYA_BLOODPRESSURE	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN
1.0989010989%	5	455	77	T2D_GENES_TANYA_BLOODPRESSURE	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
1.0989010989%	5	455	76	T2D_GENES_TANYA_BLOODPRESSURE	ROSS_AML_WITH_AML1_ETO_FUSION
1.0989010989%	5	455	73	T2D_GENES_TANYA_BLOODPRESSURE	GAURNIER_PSMD4_TARGETS
1.0989010989%	5	455	71	T2D_GENES_TANYA_BLOODPRESSURE	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
1.0989010989%	5	455	69	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES
1.0989010989%	5	455	69	T2D_GENES_TANYA_BLOODPRESSURE	HOWLIN_PUBERTAL_MAMMARY_GLAND
1.0989010989%	5	455	68	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
1.0989010989%	5	455	66	T2D_GENES_TANYA_BLOODPRESSURE	DIRMEIER_LMP1_RESPONSE_EARLY
1.0989010989%	5	455	58	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_HIVNEF_PATHWAY
1.0989010989%	5	455	56	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_NFAT_PATHWAY
1.0989010989%	5	455	53	T2D_GENES_TANYA_BLOODPRESSURE	LINDSTEDT_DENDRITIC_CELL_MATURATION_B
1.0989010989%	5	455	517	T2D_GENES_TANYA_BLOODPRESSURE	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
1.0989010989%	5	455	51	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE
1.0989010989%	5	455	51	T2D_GENES_TANYA_BLOODPRESSURE	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
1.0989010989%	5	455	50	T2D_GENES_TANYA_BLOODPRESSURE	PID_ANGIOPOIETINRECEPTOR_PATHWAY
1.0989010989%	5	455	49	T2D_GENES_TANYA_BLOODPRESSURE	OLSSON_E2F3_TARGETS_DN
1.0989010989%	5	455	425	T2D_GENES_TANYA_BLOODPRESSURE	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
1.0989010989%	5	455	394	T2D_GENES_TANYA_BLOODPRESSURE	BERENJENO_TRANSFORMED_BY_RHOA_DN
1.0989010989%	5	455	387	T2D_GENES_TANYA_BLOODPRESSURE	CHYLA_CBFA2T3_TARGETS_UP
1.0989010989%	5	455	384	T2D_GENES_TANYA_BLOODPRESSURE	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
1.0989010989%	5	455	372	T2D_GENES_TANYA_BLOODPRESSURE	WANG_LMO4_TARGETS_UP
1.0989010989%	5	455	352	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
1.0989010989%	5	455	35	T2D_GENES_TANYA_BLOODPRESSURE	PID_HIVNEFPATHWAY
1.0989010989%	5	455	332	T2D_GENES_TANYA_BLOODPRESSURE	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
1.0989010989%	5	455	293	T2D_GENES_TANYA_BLOODPRESSURE	ZHANG_TLX_TARGETS_60HR_UP
1.0989010989%	5	455	289	T2D_GENES_TANYA_BLOODPRESSURE	GABRIELY_MIR21_TARGETS
1.0989010989%	5	455	289	T2D_GENES_TANYA_BLOODPRESSURE	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
1.0989010989%	5	455	284	T2D_GENES_TANYA_BLOODPRESSURE	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
1.0989010989%	5	455	280	T2D_GENES_TANYA_BLOODPRESSURE	WANG_SMARCE1_TARGETS_UP
1.0989010989%	5	455	28	T2D_GENES_TANYA_BLOODPRESSURE	ST_GAQ_PATHWAY
1.0989010989%	5	455	279	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NEURONAL_SYSTEM
1.0989010989%	5	455	274	T2D_GENES_TANYA_BLOODPRESSURE	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
1.0989010989%	5	455	270	T2D_GENES_TANYA_BLOODPRESSURE	RIZKI_TUMOR_INVASIVENESS_3D_DN
1.0989010989%	5	455	264	T2D_GENES_TANYA_BLOODPRESSURE	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
1.0989010989%	5	455	261	T2D_GENES_TANYA_BLOODPRESSURE	RICKMAN_METASTASIS_DN
1.0989010989%	5	455	258	T2D_GENES_TANYA_BLOODPRESSURE	JAEGER_METASTASIS_DN
1.0989010989%	5	455	246	T2D_GENES_TANYA_BLOODPRESSURE	VERHAAK_AML_WITH_NPM1_MUTATED_DN
1.0989010989%	5	455	244	T2D_GENES_TANYA_BLOODPRESSURE	THUM_SYSTOLIC_HEART_FAILURE_DN
1.0989010989%	5	455	242	T2D_GENES_TANYA_BLOODPRESSURE	MULLIGHAN_MLL_SIGNATURE_1_DN
1.0989010989%	5	455	238	T2D_GENES_TANYA_BLOODPRESSURE	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
1.0989010989%	5	455	229	T2D_GENES_TANYA_BLOODPRESSURE	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
1.0989010989%	5	455	228	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
1.0989010989%	5	455	223	T2D_GENES_TANYA_BLOODPRESSURE	CHEN_HOXA5_TARGETS_9HR_UP
1.0989010989%	5	455	221	T2D_GENES_TANYA_BLOODPRESSURE	ZHANG_TLX_TARGETS_36HR_UP
1.0989010989%	5	455	221	T2D_GENES_TANYA_BLOODPRESSURE	PEDRIOLI_MIR31_TARGETS_UP
1.0989010989%	5	455	217	T2D_GENES_TANYA_BLOODPRESSURE	SANSOM_APC_MYC_TARGETS
1.0989010989%	5	455	217	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALLING_BY_NGF
1.0989010989%	5	455	217	T2D_GENES_TANYA_BLOODPRESSURE	AMUNDSON_RESPONSE_TO_ARSENITE
1.0989010989%	5	455	216	T2D_GENES_TANYA_BLOODPRESSURE	WHITFIELD_CELL_CYCLE_G2_M
1.0989010989%	5	455	216	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
1.0989010989%	5	455	214	T2D_GENES_TANYA_BLOODPRESSURE	ZWANG_EGF_INTERVAL_DN
1.0989010989%	5	455	212	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
1.0989010989%	5	455	210	T2D_GENES_TANYA_BLOODPRESSURE	WANG_TUMOR_INVASIVENESS_DN
1.0989010989%	5	455	210	T2D_GENES_TANYA_BLOODPRESSURE	SANSOM_APC_TARGETS_REQUIRE_MYC
1.0989010989%	5	455	209	T2D_GENES_TANYA_BLOODPRESSURE	GROSS_HYPOXIA_VIA_ELK3_UP
1.0989010989%	5	455	207	T2D_GENES_TANYA_BLOODPRESSURE	VERHAAK_GLIOBLASTOMA_CLASSICAL
1.0989010989%	5	455	207	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_HIV_INFECTION
1.0989010989%	5	455	205	T2D_GENES_TANYA_BLOODPRESSURE	PEREZ_TP53_AND_TP63_TARGETS
1.0989010989%	5	455	204	T2D_GENES_TANYA_BLOODPRESSURE	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
1.0989010989%	5	455	202	T2D_GENES_TANYA_BLOODPRESSURE	FUJII_YBX1_TARGETS_DN
1.0989010989%	5	455	199	T2D_GENES_TANYA_BLOODPRESSURE	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
1.0989010989%	5	455	198	T2D_GENES_TANYA_BLOODPRESSURE	WELCSH_BRCA1_TARGETS_UP
1.0989010989%	5	455	196	T2D_GENES_TANYA_BLOODPRESSURE	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
1.0989010989%	5	455	193	T2D_GENES_TANYA_BLOODPRESSURE	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
1.0989010989%	5	455	19	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_COMP_PATHWAY
1.0989010989%	5	455	188	T2D_GENES_TANYA_BLOODPRESSURE	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
1.0989010989%	5	455	187	T2D_GENES_TANYA_BLOODPRESSURE	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
1.0989010989%	5	455	185	T2D_GENES_TANYA_BLOODPRESSURE	DARWICHE_SKIN_TUMOR_PROMOTER_DN
1.0989010989%	5	455	185	T2D_GENES_TANYA_BLOODPRESSURE	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
1.0989010989%	5	455	184	T2D_GENES_TANYA_BLOODPRESSURE	DOANE_RESPONSE_TO_ANDROGEN_UP
1.0989010989%	5	455	183	T2D_GENES_TANYA_BLOODPRESSURE	OKUMURA_INFLAMMATORY_RESPONSE_LPS
1.0989010989%	5	455	182	T2D_GENES_TANYA_BLOODPRESSURE	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
1.0989010989%	5	455	181	T2D_GENES_TANYA_BLOODPRESSURE	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
1.0989010989%	5	455	181	T2D_GENES_TANYA_BLOODPRESSURE	JISON_SICKLE_CELL_DISEASE_DN
1.0989010989%	5	455	181	T2D_GENES_TANYA_BLOODPRESSURE	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
1.0989010989%	5	455	179	T2D_GENES_TANYA_BLOODPRESSURE	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
1.0989010989%	5	455	178	T2D_GENES_TANYA_BLOODPRESSURE	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
1.0989010989%	5	455	178	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_18HR_UP
1.0989010989%	5	455	176	T2D_GENES_TANYA_BLOODPRESSURE	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
1.0989010989%	5	455	176	T2D_GENES_TANYA_BLOODPRESSURE	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
1.0989010989%	5	455	175	T2D_GENES_TANYA_BLOODPRESSURE	LEE_LIVER_CANCER_SURVIVAL_DN
1.0989010989%	5	455	175	T2D_GENES_TANYA_BLOODPRESSURE	FIRESTEIN_PROLIFERATION
1.0989010989%	5	455	172	T2D_GENES_TANYA_BLOODPRESSURE	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
1.0989010989%	5	455	169	T2D_GENES_TANYA_BLOODPRESSURE	PENG_GLUCOSE_DEPRIVATION_DN
1.0989010989%	5	455	169	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_ALZHEIMERS_DISEASE
1.0989010989%	5	455	168	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
1.0989010989%	5	455	165	T2D_GENES_TANYA_BLOODPRESSURE	BROWN_MYELOID_CELL_DEVELOPMENT_UP
1.0989010989%	5	455	165	T2D_GENES_TANYA_BLOODPRESSURE	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
1.0989010989%	5	455	162	T2D_GENES_TANYA_BLOODPRESSURE	KIM_WT1_TARGETS_12HR_UP
1.0989010989%	5	455	158	T2D_GENES_TANYA_BLOODPRESSURE	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
1.0989010989%	5	455	156	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_14HR_UP
1.0989010989%	5	455	153	T2D_GENES_TANYA_BLOODPRESSURE	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
1.0989010989%	5	455	153	T2D_GENES_TANYA_BLOODPRESSURE	RUIZ_TNC_TARGETS_UP
1.0989010989%	5	455	153	T2D_GENES_TANYA_BLOODPRESSURE	DURAND_STROMA_MAX_DN
1.0989010989%	5	455	151	T2D_GENES_TANYA_BLOODPRESSURE	IGLESIAS_E2F_TARGETS_UP
1.0989010989%	5	455	151	T2D_GENES_TANYA_BLOODPRESSURE	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
1.0989010989%	5	455	150	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_30MIN_DN
1.0989010989%	5	455	149	T2D_GENES_TANYA_BLOODPRESSURE	TSAI_RESPONSE_TO_IONIZING_RADIATION
1.0989010989%	5	455	146	T2D_GENES_TANYA_BLOODPRESSURE	PECE_MAMMARY_STEM_CELL_UP
1.0989010989%	5	455	146	T2D_GENES_TANYA_BLOODPRESSURE	LEE_NEURAL_CREST_STEM_CELL_UP
1.0989010989%	5	455	142	T2D_GENES_TANYA_BLOODPRESSURE	PENG_LEUCINE_DEPRIVATION_UP
1.0989010989%	5	455	140	T2D_GENES_TANYA_BLOODPRESSURE	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
1.0989010989%	5	455	138	T2D_GENES_TANYA_BLOODPRESSURE	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
1.0989010989%	5	455	134	T2D_GENES_TANYA_BLOODPRESSURE	POOLA_INVASIVE_BREAST_CANCER_DN
1.0989010989%	5	455	133	T2D_GENES_TANYA_BLOODPRESSURE	GAL_LEUKEMIC_STEM_CELL_UP
1.0989010989%	5	455	13	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION
1.0989010989%	5	455	129	T2D_GENES_TANYA_BLOODPRESSURE	PID_PDGFRBPATHWAY
1.0989010989%	5	455	129	T2D_GENES_TANYA_BLOODPRESSURE	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP
1.0989010989%	5	455	128	T2D_GENES_TANYA_BLOODPRESSURE	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS
1.0989010989%	5	455	126	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
1.0989010989%	5	455	126	T2D_GENES_TANYA_BLOODPRESSURE	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
1.0989010989%	5	455	126	T2D_GENES_TANYA_BLOODPRESSURE	GERY_CEBP_TARGETS
1.0989010989%	5	455	125	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_HIV_LIFE_CYCLE
1.0989010989%	5	455	123	T2D_GENES_TANYA_BLOODPRESSURE	KAYO_AGING_MUSCLE_DN
1.0989010989%	5	455	121	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS
1.0989010989%	5	455	121	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_LYSOSOME
1.0989010989%	5	455	118	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TOLL_RECEPTOR_CASCADES
1.0989010989%	5	455	116	T2D_GENES_TANYA_BLOODPRESSURE	LIM_MAMMARY_LUMINAL_MATURE_UP
1.0989010989%	5	455	115	T2D_GENES_TANYA_BLOODPRESSURE	MARZEC_IL2_SIGNALING_UP
1.0989010989%	5	455	114	T2D_GENES_TANYA_BLOODPRESSURE	ROPERO_HDAC2_TARGETS
1.0989010989%	5	455	112	T2D_GENES_TANYA_BLOODPRESSURE	PASINI_SUZ12_TARGETS_UP
1.0989010989%	5	455	111	T2D_GENES_TANYA_BLOODPRESSURE	BOUDOUKHA_BOUND_BY_IGF2BP2
1.0989010989%	5	455	104	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE
1.0989010989%	5	455	103	T2D_GENES_TANYA_BLOODPRESSURE	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY
1.0989010989%	5	455	102	T2D_GENES_TANYA_BLOODPRESSURE	PID_CXCR4_PATHWAY
1.0989010989%	5	455	101	T2D_GENES_TANYA_BLOODPRESSURE	BASSO_CD40_SIGNALING_UP
1.0989010989%	5	455	100	T2D_GENES_TANYA_BLOODPRESSURE	MCCLUNG_CREB1_TARGETS_UP
1.07954545455%	38	3520	491	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHENG_BOUND_BY_FOXP3
1.07954545455%	38	3520	374	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_TUMOR_INVASIVENESS_UP
1.07954545455%	38	3520	357	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHEN_SMARCA2_TARGETS_DN
1.07954545455%	38	3520	341	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
1.07954545455%	38	3520	330	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_RNA
1.07954545455%	38	3520	328	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PATHWAYS_IN_CANCER
1.07954545455%	38	3520	324	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
1.07954545455%	38	3520	298	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
1.07954545455%	38	3520	269	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_CLIM2_TARGETS_UP
1.07954545455%	38	3520	265	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
1.07954545455%	38	3520	244	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAZARD_RESPONSE_TO_UV_NHEK_UP
1.07954545455%	38	3520	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROVERSI_GLIOMA_COPY_NUMBER_UP
1.07444359171%	14	1303	579	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
1.07444359171%	14	1303	487	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RODWELL_AGING_KIDNEY_UP
1.07444359171%	14	1303	481	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIU_PROSTATE_CANCER_DN
1.07444359171%	14	1303	478	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
1.07444359171%	14	1303	456	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ODONNELL_TFRC_TARGETS_UP
1.07444359171%	14	1303	435	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
1.07444359171%	14	1303	414	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LU_EZH2_TARGETS_DN
1.07444359171%	14	1303	409	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FOSTER_TOLERANT_MACROPHAGE_DN
1.07444359171%	14	1303	408	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GPCR_LIGAND_BINDING
1.07444359171%	14	1303	405	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KUMAR_TARGETS_OF_MLL_AF9_FUSION
1.07444359171%	14	1303	337	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PHONG_TNF_RESPONSE_NOT_VIA_P38
1.07444359171%	14	1303	332	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
1.07444359171%	14	1303	321	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
1.07444359171%	14	1303	318	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAZARD_RESPONSE_TO_UV_NHEK_DN
1.07444359171%	14	1303	298	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_14HR_DN
1.07444359171%	14	1303	293	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HADDAD_B_LYMPHOCYTE_PROGENITOR
1.07444359171%	14	1303	281	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MULLIGHAN_MLL_SIGNATURE_2_DN
1.07444359171%	14	1303	271	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
1.07444359171%	14	1303	239	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ALFANO_MYC_TARGETS
1.07444359171%	14	1303	222	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_1HR_DN
1.07444359171%	14	1303	210	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SANSOM_APC_TARGETS_REQUIRE_MYC
1.07444359171%	14	1303	194	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PROVENZANI_METASTASIS_UP
1.06894708712%	20	1871	71	T2D_GENES_TANYA_HEIGHT	GEORGANTAS_HSC_MARKERS
1.06894708712%	20	1871	328	T2D_GENES_TANYA_HEIGHT	REACTOME_OLFACTORY_SIGNALING_PATHWAY
1.06894708712%	20	1871	275	T2D_GENES_TANYA_HEIGHT	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
1.06894708712%	20	1871	264	T2D_GENES_TANYA_HEIGHT	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
1.06894708712%	20	1871	258	T2D_GENES_TANYA_HEIGHT	JAEGER_METASTASIS_DN
1.06894708712%	20	1871	230	T2D_GENES_TANYA_HEIGHT	KAUFFMANN_DNA_REPAIR_GENES
1.06894708712%	20	1871	226	T2D_GENES_TANYA_HEIGHT	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
1.06894708712%	20	1871	225	T2D_GENES_TANYA_HEIGHT	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
1.06894708712%	20	1871	222	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANSLATION
1.06894708712%	20	1871	222	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_1HR_DN
1.06894708712%	20	1871	214	T2D_GENES_TANYA_HEIGHT	BIDUS_METASTASIS_UP
1.06894708712%	20	1871	213	T2D_GENES_TANYA_HEIGHT	WIERENGA_STAT5A_TARGETS_DN
1.06894708712%	20	1871	212	T2D_GENES_TANYA_HEIGHT	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
1.06894708712%	20	1871	209	T2D_GENES_TANYA_HEIGHT	KIM_WT1_TARGETS_12HR_DN
1.06894708712%	20	1871	208	T2D_GENES_TANYA_HEIGHT	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
1.06894708712%	20	1871	207	T2D_GENES_TANYA_HEIGHT	VERHAAK_GLIOBLASTOMA_CLASSICAL
1.06894708712%	20	1871	207	T2D_GENES_TANYA_HEIGHT	KARLSSON_TGFB1_TARGETS_DN
1.06894708712%	20	1871	206	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
1.06894708712%	20	1871	206	T2D_GENES_TANYA_HEIGHT	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
1.06894708712%	20	1871	203	T2D_GENES_TANYA_HEIGHT	PAL_PRMT5_TARGETS_UP
1.06894708712%	20	1871	200	T2D_GENES_TANYA_HEIGHT	SHEPARD_BMYB_MORPHOLINO_DN
1.06894708712%	20	1871	198	T2D_GENES_TANYA_HEIGHT	WELCSH_BRCA1_TARGETS_UP
1.06894708712%	20	1871	195	T2D_GENES_TANYA_HEIGHT	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
1.06894708712%	20	1871	195	T2D_GENES_TANYA_HEIGHT	KYNG_DNA_DAMAGE_DN
1.06894708712%	20	1871	190	T2D_GENES_TANYA_HEIGHT	KEGG_CHEMOKINE_SIGNALING_PATHWAY
1.06894708712%	20	1871	182	T2D_GENES_TANYA_HEIGHT	WHITFIELD_CELL_CYCLE_G2
1.06894708712%	20	1871	178	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_18HR_UP
1.06894708712%	20	1871	175	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER_SURVIVAL_DN
1.06894708712%	20	1871	172	T2D_GENES_TANYA_HEIGHT	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
1.06894708712%	20	1871	163	T2D_GENES_TANYA_HEIGHT	SERVITJA_ISLET_HNF1A_TARGETS_UP
1.06894708712%	20	1871	157	T2D_GENES_TANYA_HEIGHT	SERVITJA_LIVER_HNF1A_TARGETS_DN
1.06894708712%	20	1871	151	T2D_GENES_TANYA_HEIGHT	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
1.06894708712%	20	1871	143	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
1.06894708712%	20	1871	137	T2D_GENES_TANYA_HEIGHT	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
1.06894708712%	20	1871	126	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
1.06382978723%	21	1974	94	Mendelian_Nancy_Cox	REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES
1.06382978723%	21	1974	91	Mendelian_Nancy_Cox	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
1.06382978723%	21	1974	90	Mendelian_Nancy_Cox	KEGG_GAP_JUNCTION
1.06382978723%	21	1974	87	Mendelian_Nancy_Cox	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
1.06382978723%	21	1974	86	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
1.06382978723%	21	1974	84	Mendelian_Nancy_Cox	SWEET_KRAS_TARGETS_UP
1.06382978723%	21	1974	84	Mendelian_Nancy_Cox	RUAN_RESPONSE_TO_TNF_DN
1.06382978723%	21	1974	84	Mendelian_Nancy_Cox	KIM_GLIS2_TARGETS_UP
1.06382978723%	21	1974	80	Mendelian_Nancy_Cox	PID_BETACATENIN_NUC_PATHWAY
1.06382978723%	21	1974	76	Mendelian_Nancy_Cox	MAHAJAN_RESPONSE_TO_IL1A_DN
1.06382978723%	21	1974	75	Mendelian_Nancy_Cox	KEGG_ADHERENS_JUNCTION
1.06382978723%	21	1974	69	Mendelian_Nancy_Cox	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP
1.06382978723%	21	1974	68	Mendelian_Nancy_Cox	PID_TELOMERASEPATHWAY
1.06382978723%	21	1974	66	Mendelian_Nancy_Cox	TENEDINI_MEGAKARYOCYTE_MARKERS
1.06382978723%	21	1974	64	Mendelian_Nancy_Cox	ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE
1.06382978723%	21	1974	63	Mendelian_Nancy_Cox	BRIDEAU_IMPRINTED_GENES
1.06382978723%	21	1974	59	Mendelian_Nancy_Cox	WESTON_VEGFA_TARGETS_6HR
1.06382978723%	21	1974	54	Mendelian_Nancy_Cox	KEGG_ARGININE_AND_PROLINE_METABOLISM
1.06382978723%	21	1974	228	Mendelian_Nancy_Cox	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
1.06382978723%	21	1974	221	Mendelian_Nancy_Cox	CHANDRAN_METASTASIS_UP
1.06382978723%	21	1974	216	Mendelian_Nancy_Cox	WHITFIELD_CELL_CYCLE_G2_M
1.06382978723%	21	1974	207	Mendelian_Nancy_Cox	REACTOME_HIV_INFECTION
1.06382978723%	21	1974	188	Mendelian_Nancy_Cox	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
1.06382978723%	21	1974	187	Mendelian_Nancy_Cox	BAKKER_FOXO3_TARGETS_DN
1.06382978723%	21	1974	175	Mendelian_Nancy_Cox	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
1.06382978723%	21	1974	175	Mendelian_Nancy_Cox	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
1.06382978723%	21	1974	172	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
1.06382978723%	21	1974	170	Mendelian_Nancy_Cox	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
1.06382978723%	21	1974	170	Mendelian_Nancy_Cox	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
1.06382978723%	21	1974	169	Mendelian_Nancy_Cox	ONDER_CDH1_TARGETS_1_DN
1.06382978723%	21	1974	167	Mendelian_Nancy_Cox	TIEN_INTESTINE_PROBIOTICS_6HR_DN
1.06382978723%	21	1974	160	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_6HR_DN
1.06382978723%	21	1974	153	Mendelian_Nancy_Cox	DAZARD_UV_RESPONSE_CLUSTER_G6
1.06382978723%	21	1974	151	Mendelian_Nancy_Cox	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
1.06382978723%	21	1974	150	Mendelian_Nancy_Cox	LANDIS_ERBB2_BREAST_TUMORS_324_UP
1.06382978723%	21	1974	147	Mendelian_Nancy_Cox	DARWICHE_PAPILLOMA_RISK_HIGH_UP
1.06382978723%	21	1974	140	Mendelian_Nancy_Cox	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
1.06382978723%	21	1974	139	Mendelian_Nancy_Cox	HOELZEL_NF1_TARGETS_UP
1.06382978723%	21	1974	138	Mendelian_Nancy_Cox	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
1.06382978723%	21	1974	132	Mendelian_Nancy_Cox	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
1.06382978723%	21	1974	128	Mendelian_Nancy_Cox	YEGNASUBRAMANIAN_PROSTATE_CANCER
1.06382978723%	21	1974	121	Mendelian_Nancy_Cox	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
1.06382978723%	21	1974	121	Mendelian_Nancy_Cox	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP
1.06382978723%	21	1974	117	Mendelian_Nancy_Cox	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
1.06382978723%	21	1974	116	Mendelian_Nancy_Cox	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
1.06382978723%	21	1974	115	Mendelian_Nancy_Cox	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
1.06382978723%	21	1974	109	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
1.06382978723%	21	1974	108	Mendelian_Nancy_Cox	LABBE_TGFB1_TARGETS_DN
1.06382978723%	21	1974	107	Mendelian_Nancy_Cox	SESTO_RESPONSE_TO_UV_C0
1.06382978723%	21	1974	103	Mendelian_Nancy_Cox	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
1.06382978723%	21	1974	101	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_ERBB2
1.05900151286%	7	661	91	T2D_GENES_TANYA_GLYCEMIC	ZHU_CMV_24_HR_DN
1.05900151286%	7	661	89	T2D_GENES_TANYA_GLYCEMIC	LEIN_PONS_MARKERS
1.05900151286%	7	661	84	T2D_GENES_TANYA_GLYCEMIC	RUAN_RESPONSE_TO_TNF_DN
1.05900151286%	7	661	82	T2D_GENES_TANYA_GLYCEMIC	ST_INTEGRIN_SIGNALING_PATHWAY
1.05900151286%	7	661	82	T2D_GENES_TANYA_GLYCEMIC	LEIN_MIDBRAIN_MARKERS
1.05900151286%	7	661	81	T2D_GENES_TANYA_GLYCEMIC	HUANG_DASATINIB_RESISTANCE_UP
1.05900151286%	7	661	76	T2D_GENES_TANYA_GLYCEMIC	ROSS_AML_WITH_AML1_ETO_FUSION
1.05900151286%	7	661	74	T2D_GENES_TANYA_GLYCEMIC	OUILLETTE_CLL_13Q14_DELETION_UP
1.05900151286%	7	661	57	T2D_GENES_TANYA_GLYCEMIC	NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON
1.05900151286%	7	661	414	T2D_GENES_TANYA_GLYCEMIC	LU_EZH2_TARGETS_DN
1.05900151286%	7	661	405	T2D_GENES_TANYA_GLYCEMIC	KUMAR_TARGETS_OF_MLL_AF9_FUSION
1.05900151286%	7	661	356	T2D_GENES_TANYA_GLYCEMIC	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
1.05900151286%	7	661	337	T2D_GENES_TANYA_GLYCEMIC	PENG_GLUTAMINE_DEPRIVATION_DN
1.05900151286%	7	661	299	T2D_GENES_TANYA_GLYCEMIC	MUELLER_PLURINET
1.05900151286%	7	661	295	T2D_GENES_TANYA_GLYCEMIC	LU_EZH2_TARGETS_UP
1.05900151286%	7	661	294	T2D_GENES_TANYA_GLYCEMIC	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
1.05900151286%	7	661	290	T2D_GENES_TANYA_GLYCEMIC	BASAKI_YBX1_TARGETS_UP
1.05900151286%	7	661	281	T2D_GENES_TANYA_GLYCEMIC	BHAT_ESR1_TARGETS_VIA_AKT1_UP
1.05900151286%	7	661	275	T2D_GENES_TANYA_GLYCEMIC	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
1.05900151286%	7	661	266	T2D_GENES_TANYA_GLYCEMIC	FOSTER_KDM1A_TARGETS_UP
1.05900151286%	7	661	264	T2D_GENES_TANYA_GLYCEMIC	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
1.05900151286%	7	661	261	T2D_GENES_TANYA_GLYCEMIC	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
1.05900151286%	7	661	261	T2D_GENES_TANYA_GLYCEMIC	RICKMAN_METASTASIS_DN
1.05900151286%	7	661	254	T2D_GENES_TANYA_GLYCEMIC	IVANOVA_HEMATOPOIESIS_STEM_CELL
1.05900151286%	7	661	252	T2D_GENES_TANYA_GLYCEMIC	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
1.05900151286%	7	661	249	T2D_GENES_TANYA_GLYCEMIC	MITSIADES_RESPONSE_TO_APLIDIN_DN
1.05900151286%	7	661	245	T2D_GENES_TANYA_GLYCEMIC	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
1.05900151286%	7	661	245	T2D_GENES_TANYA_GLYCEMIC	MCLACHLAN_DENTAL_CARIES_DN
1.05900151286%	7	661	234	T2D_GENES_TANYA_GLYCEMIC	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
1.05900151286%	7	661	230	T2D_GENES_TANYA_GLYCEMIC	COLDREN_GEFITINIB_RESISTANCE_DN
1.05900151286%	7	661	229	T2D_GENES_TANYA_GLYCEMIC	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
1.05900151286%	7	661	225	T2D_GENES_TANYA_GLYCEMIC	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
1.05900151286%	7	661	222	T2D_GENES_TANYA_GLYCEMIC	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
1.05900151286%	7	661	216	T2D_GENES_TANYA_GLYCEMIC	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
1.05900151286%	7	661	212	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
1.05900151286%	7	661	212	T2D_GENES_TANYA_GLYCEMIC	CHANG_CORE_SERUM_RESPONSE_UP
1.05900151286%	7	661	211	T2D_GENES_TANYA_GLYCEMIC	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
1.05900151286%	7	661	206	T2D_GENES_TANYA_GLYCEMIC	BILD_MYC_ONCOGENIC_SIGNATURE
1.05900151286%	7	661	205	T2D_GENES_TANYA_GLYCEMIC	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
1.05900151286%	7	661	202	T2D_GENES_TANYA_GLYCEMIC	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
1.05900151286%	7	661	200	T2D_GENES_TANYA_GLYCEMIC	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
1.05900151286%	7	661	195	T2D_GENES_TANYA_GLYCEMIC	KYNG_DNA_DAMAGE_DN
1.05900151286%	7	661	191	T2D_GENES_TANYA_GLYCEMIC	YAGI_AML_FAB_MARKERS
1.05900151286%	7	661	190	T2D_GENES_TANYA_GLYCEMIC	KEGG_CHEMOKINE_SIGNALING_PATHWAY
1.05900151286%	7	661	189	T2D_GENES_TANYA_GLYCEMIC	BURTON_ADIPOGENESIS_6
1.05900151286%	7	661	187	T2D_GENES_TANYA_GLYCEMIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
1.05900151286%	7	661	186	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
1.05900151286%	7	661	185	T2D_GENES_TANYA_GLYCEMIC	ZHANG_TLX_TARGETS_36HR_DN
1.05900151286%	7	661	185	T2D_GENES_TANYA_GLYCEMIC	KEGG_HUNTINGTONS_DISEASE
1.05900151286%	7	661	185	T2D_GENES_TANYA_GLYCEMIC	DARWICHE_SKIN_TUMOR_PROMOTER_DN
1.05900151286%	7	661	184	T2D_GENES_TANYA_GLYCEMIC	WU_CELL_MIGRATION
1.05900151286%	7	661	184	T2D_GENES_TANYA_GLYCEMIC	DOANE_RESPONSE_TO_ANDROGEN_UP
1.05900151286%	7	661	182	T2D_GENES_TANYA_GLYCEMIC	RAO_BOUND_BY_SALL4_ISOFORM_A
1.05900151286%	7	661	178	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_18HR_UP
1.05900151286%	7	661	172	T2D_GENES_TANYA_GLYCEMIC	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
1.05900151286%	7	661	171	T2D_GENES_TANYA_GLYCEMIC	GOLDRATH_HOMEOSTATIC_PROLIFERATION
1.05900151286%	7	661	171	T2D_GENES_TANYA_GLYCEMIC	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
1.05900151286%	7	661	165	T2D_GENES_TANYA_GLYCEMIC	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
1.05900151286%	7	661	165	T2D_GENES_TANYA_GLYCEMIC	DARWICHE_PAPILLOMA_RISK_LOW_DN
1.05900151286%	7	661	162	T2D_GENES_TANYA_GLYCEMIC	WINNEPENNINCKX_MELANOMA_METASTASIS_UP
1.05900151286%	7	661	160	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_6HR_DN
1.05900151286%	7	661	157	T2D_GENES_TANYA_GLYCEMIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
1.05900151286%	7	661	151	T2D_GENES_TANYA_GLYCEMIC	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
1.05900151286%	7	661	151	T2D_GENES_TANYA_GLYCEMIC	KEGG_WNT_SIGNALING_PATHWAY
1.05900151286%	7	661	15	T2D_GENES_TANYA_GLYCEMIC	NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON
1.05900151286%	7	661	148	T2D_GENES_TANYA_GLYCEMIC	REACTOME_APOPTOSIS
1.05900151286%	7	661	143	T2D_GENES_TANYA_GLYCEMIC	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION
1.05900151286%	7	661	142	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_ES_LCP_WITH_H3K4ME3
1.05900151286%	7	661	140	T2D_GENES_TANYA_GLYCEMIC	ONDER_CDH1_TARGETS_1_UP
1.05900151286%	7	661	140	T2D_GENES_TANYA_GLYCEMIC	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
1.05900151286%	7	661	137	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MITOTIC_G1_G1_S_PHASES
1.05900151286%	7	661	137	T2D_GENES_TANYA_GLYCEMIC	KEGG_INSULIN_SIGNALING_PATHWAY
1.05900151286%	7	661	133	T2D_GENES_TANYA_GLYCEMIC	REACTOME_DIABETES_PATHWAYS
1.05900151286%	7	661	131	T2D_GENES_TANYA_GLYCEMIC	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
1.05900151286%	7	661	130	T2D_GENES_TANYA_GLYCEMIC	YAGI_AML_WITH_T_9_11_TRANSLOCATION
1.05900151286%	7	661	129	T2D_GENES_TANYA_GLYCEMIC	PID_PDGFRBPATHWAY
1.05900151286%	7	661	127	T2D_GENES_TANYA_GLYCEMIC	LIU_VMYB_TARGETS_UP
1.05900151286%	7	661	126	T2D_GENES_TANYA_GLYCEMIC	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
1.05900151286%	7	661	120	T2D_GENES_TANYA_GLYCEMIC	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
1.05900151286%	7	661	120	T2D_GENES_TANYA_GLYCEMIC	CHEBOTAEV_GR_TARGETS_DN
1.05900151286%	7	661	116	T2D_GENES_TANYA_GLYCEMIC	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
1.05900151286%	7	661	113	T2D_GENES_TANYA_GLYCEMIC	TSENG_IRS1_TARGETS_UP
1.05900151286%	7	661	113	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_RHO_GTPASES
1.05900151286%	7	661	101	T2D_GENES_TANYA_GLYCEMIC	KOBAYASHI_EGFR_SIGNALING_24HR_UP
1.05900151286%	7	661	101	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_10HR_UP
1.05900151286%	7	661	100	T2D_GENES_TANYA_GLYCEMIC	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
1.05795768169%	23	2174	48	T2D_GENES_TANYA_LIPIDS	REACTOME_PACKAGING_OF_TELOMERE_ENDS
1.05795768169%	23	2174	335	T2D_GENES_TANYA_LIPIDS	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
1.05795768169%	23	2174	330	T2D_GENES_TANYA_LIPIDS	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
1.05795768169%	23	2174	309	T2D_GENES_TANYA_LIPIDS	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
1.05795768169%	23	2174	293	T2D_GENES_TANYA_LIPIDS	IVANOVA_HEMATOPOIESIS_MATURE_CELL
1.05795768169%	23	2174	289	T2D_GENES_TANYA_LIPIDS	WANG_MLL_TARGETS
1.05795768169%	23	2174	280	T2D_GENES_TANYA_LIPIDS	WANG_SMARCE1_TARGETS_UP
1.05795768169%	23	2174	275	T2D_GENES_TANYA_LIPIDS	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
1.05795768169%	23	2174	262	T2D_GENES_TANYA_LIPIDS	LU_AGING_BRAIN_UP
1.05795768169%	23	2174	240	T2D_GENES_TANYA_LIPIDS	VANTVEER_BREAST_CANCER_ESR1_DN
1.05795768169%	23	2174	223	T2D_GENES_TANYA_LIPIDS	CHEN_HOXA5_TARGETS_9HR_UP
1.05795768169%	23	2174	217	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALLING_BY_NGF
1.05795768169%	23	2174	215	T2D_GENES_TANYA_LIPIDS	YAMAZAKI_TCEB3_TARGETS_DN
1.05795768169%	23	2174	214	T2D_GENES_TANYA_LIPIDS	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
1.05795768169%	23	2174	213	T2D_GENES_TANYA_LIPIDS	WIERENGA_STAT5A_TARGETS_DN
1.05795768169%	23	2174	212	T2D_GENES_TANYA_LIPIDS	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
1.05795768169%	23	2174	208	T2D_GENES_TANYA_LIPIDS	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
1.05795768169%	23	2174	192	T2D_GENES_TANYA_LIPIDS	REACTOME_DNA_REPLICATION
1.05795768169%	23	2174	191	T2D_GENES_TANYA_LIPIDS	YAGI_AML_FAB_MARKERS
1.05795768169%	23	2174	187	T2D_GENES_TANYA_LIPIDS	BAKKER_FOXO3_TARGETS_DN
1.05795768169%	23	2174	185	T2D_GENES_TANYA_LIPIDS	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
1.05795768169%	23	2174	185	T2D_GENES_TANYA_LIPIDS	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
1.05795768169%	23	2174	176	T2D_GENES_TANYA_LIPIDS	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
1.05795768169%	23	2174	168	T2D_GENES_TANYA_LIPIDS	PUJANA_XPRSS_INT_NETWORK
1.05795768169%	23	2174	164	T2D_GENES_TANYA_LIPIDS	KIM_WT1_TARGETS_8HR_UP
1.05795768169%	23	2174	158	T2D_GENES_TANYA_LIPIDS	RODRIGUES_NTN1_TARGETS_DN
1.05795768169%	23	2174	148	T2D_GENES_TANYA_LIPIDS	REACTOME_APOPTOSIS
1.05795768169%	23	2174	146	T2D_GENES_TANYA_LIPIDS	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
1.05795768169%	23	2174	145	T2D_GENES_TANYA_LIPIDS	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
1.05795768169%	23	2174	141	T2D_GENES_TANYA_LIPIDS	WELCSH_BRCA1_TARGETS_DN
1.05795768169%	23	2174	139	T2D_GENES_TANYA_LIPIDS	REACTOME_BIOLOGICAL_OXIDATIONS
1.05795768169%	23	2174	137	T2D_GENES_TANYA_LIPIDS	KEGG_INSULIN_SIGNALING_PATHWAY
1.05113636364%	37	3520	481	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_PROSTATE_CANCER_DN
1.05113636364%	37	3520	414	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LU_EZH2_TARGETS_DN
1.05113636364%	37	3520	388	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STEIN_ESRRA_TARGETS_UP
1.05113636364%	37	3520	374	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
1.05113636364%	37	3520	352	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
1.05113636364%	37	3520	337	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PENG_GLUTAMINE_DEPRIVATION_DN
1.05113636364%	37	3520	320	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
1.05113636364%	37	3520	293	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HADDAD_B_LYMPHOCYTE_PROGENITOR
1.05113636364%	37	3520	281	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BHAT_ESR1_TARGETS_VIA_AKT1_UP
1.05113636364%	37	3520	275	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
1.05113636364%	37	3520	267	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_MAPK_SIGNALING_PATHWAY
1.05113636364%	37	3520	185	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER_SURVIVAL_UP
1.02651839179%	12	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION
1.02651839179%	12	1169	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_AMYLOIDS
1.02651839179%	12	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
1.02651839179%	12	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PPAR_SIGNALING_PATHWAY
1.02651839179%	12	1169	633	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
1.02651839179%	12	1169	584	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HAMAI_APOPTOSIS_VIA_TRAIL_UP
1.02651839179%	12	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_STEROID_HORMONE_BIOSYNTHESIS
1.02651839179%	12	1169	517	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RAO_BOUND_BY_SALL4_ISOFORM_B
1.02651839179%	12	1169	491	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MEISSNER_NPC_HCP_WITH_H3K4ME2
1.02651839179%	12	1169	482	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
1.02651839179%	12	1169	424	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHEN_SMARCA2_TARGETS_UP
1.02651839179%	12	1169	409	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FOSTER_TOLERANT_MACROPHAGE_DN
1.02651839179%	12	1169	379	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BENPORATH_ES_1
1.02651839179%	12	1169	352	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
1.02651839179%	12	1169	338	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
1.02651839179%	12	1169	326	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
1.02651839179%	12	1169	315	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PASINI_SUZ12_TARGETS_DN
1.02651839179%	12	1169	314	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DOUGLAS_BMI1_TARGETS_DN
1.02651839179%	12	1169	305	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
1.02651839179%	12	1169	302	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
1.02651839179%	12	1169	293	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HADDAD_B_LYMPHOCYTE_PROGENITOR
1.02651839179%	12	1169	289	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MANALO_HYPOXIA_DN
1.02651839179%	12	1169	276	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
1.02651839179%	12	1169	270	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RIZKI_TUMOR_INVASIVENESS_3D_DN
1.02651839179%	12	1169	264	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
1.02651839179%	12	1169	261	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BILD_HRAS_ONCOGENIC_SIGNATURE
1.02651839179%	12	1169	251	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
1.02651839179%	12	1169	246	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
1.02651839179%	12	1169	245	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BLUM_RESPONSE_TO_SALIRASIB_UP
1.02651839179%	12	1169	241	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
1.02651839179%	12	1169	229	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
1.02651839179%	12	1169	227	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RAO_BOUND_BY_SALL4
1.02651839179%	12	1169	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CAIRO_HEPATOBLASTOMA_CLASSES_DN
1.02651839179%	12	1169	207	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CAIRO_HEPATOBLASTOMA_UP
1.02651839179%	12	1169	204	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
1.02651839179%	12	1169	198	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PHOSPHOLIPID_METABOLISM
1.02651839179%	12	1169	183	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VERHAAK_AML_WITH_NPM1_MUTATED_UP
1.02651839179%	12	1169	183	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ENDOCYTOSIS
1.02651839179%	12	1169	181	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
1.02651839179%	12	1169	168	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PUJANA_XPRSS_INT_NETWORK
1.02651839179%	12	1169	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
1.024428684%	13	1269	783	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ONKEN_UVEAL_MELANOMA_UP
1.024428684%	13	1269	544	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
1.024428684%	13	1269	539	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ADAPTIVE_IMMUNE_SYSTEM
1.024428684%	13	1269	537	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN
1.024428684%	13	1269	491	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SWEET_LUNG_CANCER_KRAS_UP
1.024428684%	13	1269	431	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GARY_CD5_TARGETS_DN
1.024428684%	13	1269	430	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VECCHI_GASTRIC_CANCER_EARLY_UP
1.024428684%	13	1269	422	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAGI_AML_WITH_INV_16_TRANSLOCATION
1.024428684%	13	1269	397	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
1.024428684%	13	1269	390	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HATADA_METHYLATED_IN_LUNG_CANCER_UP
1.024428684%	13	1269	389	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HSIAO_HOUSEKEEPING_GENES
1.024428684%	13	1269	384	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BASAKI_YBX1_TARGETS_DN
1.024428684%	13	1269	342	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BLUM_RESPONSE_TO_SALIRASIB_DN
1.024428684%	13	1269	337	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PHONG_TNF_RESPONSE_NOT_VIA_P38
1.024428684%	13	1269	335	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
1.024428684%	13	1269	317	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HELLER_HDAC_TARGETS_UP
1.024428684%	13	1269	314	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DOUGLAS_BMI1_TARGETS_DN
1.024428684%	13	1269	314	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
1.024428684%	13	1269	311	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JIANG_HYPOXIA_NORMAL
1.024428684%	13	1269	308	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
1.024428684%	13	1269	302	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
1.024428684%	13	1269	293	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_60HR_UP
1.024428684%	13	1269	289	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MANALO_HYPOXIA_DN
1.024428684%	13	1269	289	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
1.024428684%	13	1269	246	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VERHAAK_AML_WITH_NPM1_MUTATED_DN
1.024428684%	13	1269	246	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BILD_E2F3_ONCOGENIC_SIGNATURE
1.024428684%	13	1269	244	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAL_LEUKEMIC_STEM_CELL_DN
1.024428684%	13	1269	222	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_1HR_DN
1.02272727273%	36	3520	505	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
1.02272727273%	36	3520	489	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIM_MAMMARY_STEM_CELL_UP
1.02272727273%	36	3520	391	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
1.02272727273%	36	3520	384	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
1.02272727273%	36	3520	366	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YOSHIMURA_MAPK8_TARGETS_DN
1.02272727273%	36	3520	341	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MULLIGHAN_NPM1_SIGNATURE_3_UP
1.02272727273%	36	3520	284	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_MRNA
1.02272727273%	36	3520	261	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RICKMAN_METASTASIS_DN
1.02272727273%	36	3520	261	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
1.02272727273%	36	3520	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MEIOSIS
1.01549973276%	19	1871	260	T2D_GENES_TANYA_HEIGHT	SENESE_HDAC1_TARGETS_DN
1.01549973276%	19	1871	258	T2D_GENES_TANYA_HEIGHT	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
1.01549973276%	19	1871	242	T2D_GENES_TANYA_HEIGHT	WINTER_HYPOXIA_METAGENE
1.01549973276%	19	1871	238	T2D_GENES_TANYA_HEIGHT	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
1.01549973276%	19	1871	235	T2D_GENES_TANYA_HEIGHT	RUTELLA_RESPONSE_TO_HGF_DN
1.01549973276%	19	1871	222	T2D_GENES_TANYA_HEIGHT	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
1.01549973276%	19	1871	220	T2D_GENES_TANYA_HEIGHT	RIGGINS_TAMOXIFEN_RESISTANCE_DN
1.01549973276%	19	1871	217	T2D_GENES_TANYA_HEIGHT	WIERENGA_STAT5A_TARGETS_UP
1.01549973276%	19	1871	214	T2D_GENES_TANYA_HEIGHT	ZWANG_EGF_INTERVAL_DN
1.01549973276%	19	1871	210	T2D_GENES_TANYA_HEIGHT	VERHAAK_GLIOBLASTOMA_NEURAL
1.01549973276%	19	1871	210	T2D_GENES_TANYA_HEIGHT	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
1.01549973276%	19	1871	201	T2D_GENES_TANYA_HEIGHT	HOLLMANN_APOPTOSIS_VIA_CD40_UP
1.01549973276%	19	1871	197	T2D_GENES_TANYA_HEIGHT	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
1.01549973276%	19	1871	187	T2D_GENES_TANYA_HEIGHT	PENG_LEUCINE_DEPRIVATION_DN
1.01549973276%	19	1871	184	T2D_GENES_TANYA_HEIGHT	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
1.01549973276%	19	1871	182	T2D_GENES_TANYA_HEIGHT	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
1.01549973276%	19	1871	181	T2D_GENES_TANYA_HEIGHT	JISON_SICKLE_CELL_DISEASE_DN
1.01549973276%	19	1871	180	T2D_GENES_TANYA_HEIGHT	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
1.01549973276%	19	1871	179	T2D_GENES_TANYA_HEIGHT	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE
1.01549973276%	19	1871	169	T2D_GENES_TANYA_HEIGHT	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION
1.01549973276%	19	1871	168	T2D_GENES_TANYA_HEIGHT	PUJANA_XPRSS_INT_NETWORK
1.01549973276%	19	1871	165	T2D_GENES_TANYA_HEIGHT	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
1.01549973276%	19	1871	165	T2D_GENES_TANYA_HEIGHT	LIU_CMYB_TARGETS_UP
1.01549973276%	19	1871	157	T2D_GENES_TANYA_HEIGHT	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
1.01549973276%	19	1871	146	T2D_GENES_TANYA_HEIGHT	PECE_MAMMARY_STEM_CELL_DN
1.01549973276%	19	1871	138	T2D_GENES_TANYA_HEIGHT	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
1.01549973276%	19	1871	137	T2D_GENES_TANYA_HEIGHT	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
1.01549973276%	19	1871	137	T2D_GENES_TANYA_HEIGHT	REACTOME_MITOTIC_G1_G1_S_PHASES
1.01549973276%	19	1871	135	T2D_GENES_TANYA_HEIGHT	UDAYAKUMAR_MED1_TARGETS_UP
1.01549973276%	19	1871	128	T2D_GENES_TANYA_HEIGHT	KEGG_SPLICEOSOME
1.01549973276%	19	1871	126	T2D_GENES_TANYA_HEIGHT	MISSIAGLIA_REGULATED_BY_METHYLATION_UP
1.01317122594%	20	1974	97	Mendelian_Nancy_Cox	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
1.01317122594%	20	1974	89	Mendelian_Nancy_Cox	WNT_SIGNALING
1.01317122594%	20	1974	89	Mendelian_Nancy_Cox	VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP
1.01317122594%	20	1974	88	Mendelian_Nancy_Cox	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
1.01317122594%	20	1974	88	Mendelian_Nancy_Cox	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
1.01317122594%	20	1974	82	Mendelian_Nancy_Cox	PID_SMAD2_3NUCLEARPATHWAY
1.01317122594%	20	1974	82	Mendelian_Nancy_Cox	FRASOR_RESPONSE_TO_ESTRADIOL_DN
1.01317122594%	20	1974	81	Mendelian_Nancy_Cox	HUANG_DASATINIB_RESISTANCE_UP
1.01317122594%	20	1974	71	Mendelian_Nancy_Cox	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
1.01317122594%	20	1974	69	Mendelian_Nancy_Cox	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
1.01317122594%	20	1974	66	Mendelian_Nancy_Cox	PID_TCR_PATHWAY
1.01317122594%	20	1974	54	Mendelian_Nancy_Cox	KEGG_NON_SMALL_CELL_LUNG_CANCER
1.01317122594%	20	1974	52	Mendelian_Nancy_Cox	PID_KITPATHWAY
1.01317122594%	20	1974	51	Mendelian_Nancy_Cox	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
1.01317122594%	20	1974	42	Mendelian_Nancy_Cox	KEGG_BLADDER_CANCER
1.01317122594%	20	1974	23	Mendelian_Nancy_Cox	BIOCARTA_INTRINSIC_PATHWAY
1.01317122594%	20	1974	204	Mendelian_Nancy_Cox	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
1.01317122594%	20	1974	185	Mendelian_Nancy_Cox	ZHANG_TLX_TARGETS_36HR_DN
1.01317122594%	20	1974	164	Mendelian_Nancy_Cox	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
1.01317122594%	20	1974	161	Mendelian_Nancy_Cox	BIDUS_METASTASIS_DN
1.01317122594%	20	1974	159	Mendelian_Nancy_Cox	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
1.01317122594%	20	1974	157	Mendelian_Nancy_Cox	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
1.01317122594%	20	1974	149	Mendelian_Nancy_Cox	HUANG_GATA2_TARGETS_UP
1.01317122594%	20	1974	148	Mendelian_Nancy_Cox	WEI_MIR34A_TARGETS
1.01317122594%	20	1974	148	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_24HR_UP
1.01317122594%	20	1974	147	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_ERBB2_UP
1.01317122594%	20	1974	143	Mendelian_Nancy_Cox	BASSO_B_LYMPHOCYTE_NETWORK
1.01317122594%	20	1974	138	Mendelian_Nancy_Cox	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
1.01317122594%	20	1974	128	Mendelian_Nancy_Cox	MIKKELSEN_MEF_LCP_WITH_H3K4ME3
1.01317122594%	20	1974	127	Mendelian_Nancy_Cox	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
1.01317122594%	20	1974	125	Mendelian_Nancy_Cox	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
1.01317122594%	20	1974	122	Mendelian_Nancy_Cox	TOOKER_GEMCITABINE_RESISTANCE_DN
1.01317122594%	20	1974	121	Mendelian_Nancy_Cox	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS
1.01317122594%	20	1974	120	Mendelian_Nancy_Cox	XU_GH1_EXOGENOUS_TARGETS_DN
1.01317122594%	20	1974	120	Mendelian_Nancy_Cox	CHEBOTAEV_GR_TARGETS_DN
1.01317122594%	20	1974	116	Mendelian_Nancy_Cox	LIM_MAMMARY_LUMINAL_MATURE_UP
1.01317122594%	20	1974	115	Mendelian_Nancy_Cox	MARZEC_IL2_SIGNALING_UP
1.01317122594%	20	1974	101	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_12HR_DN
1.01317122594%	20	1974	100	Mendelian_Nancy_Cox	QI_PLASMACYTOMA_DN
1.01195952162%	22	2174	64	T2D_GENES_TANYA_LIPIDS	REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE
1.01195952162%	22	2174	64	T2D_GENES_TANYA_LIPIDS	KEGG_RETINOL_METABOLISM
1.01195952162%	22	2174	46	T2D_GENES_TANYA_LIPIDS	REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT
1.01195952162%	22	2174	336	T2D_GENES_TANYA_LIPIDS	JOHNSTONE_PARVB_TARGETS_2_DN
1.01195952162%	22	2174	315	T2D_GENES_TANYA_LIPIDS	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
1.01195952162%	22	2174	306	T2D_GENES_TANYA_LIPIDS	HORIUCHI_WTAP_TARGETS_UP
1.01195952162%	22	2174	305	T2D_GENES_TANYA_LIPIDS	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
1.01195952162%	22	2174	293	T2D_GENES_TANYA_LIPIDS	ZWANG_DOWN_BY_2ND_EGF_PULSE
1.01195952162%	22	2174	271	T2D_GENES_TANYA_LIPIDS	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
1.01195952162%	22	2174	267	T2D_GENES_TANYA_LIPIDS	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
1.01195952162%	22	2174	258	T2D_GENES_TANYA_LIPIDS	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
1.01195952162%	22	2174	258	T2D_GENES_TANYA_LIPIDS	JAEGER_METASTASIS_DN
1.01195952162%	22	2174	255	T2D_GENES_TANYA_LIPIDS	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
1.01195952162%	22	2174	249	T2D_GENES_TANYA_LIPIDS	MITSIADES_RESPONSE_TO_APLIDIN_DN
1.01195952162%	22	2174	246	T2D_GENES_TANYA_LIPIDS	VERHAAK_AML_WITH_NPM1_MUTATED_DN
1.01195952162%	22	2174	243	T2D_GENES_TANYA_LIPIDS	CHICAS_RB1_TARGETS_GROWING
1.01195952162%	22	2174	240	T2D_GENES_TANYA_LIPIDS	UDAYAKUMAR_MED1_TARGETS_DN
1.01195952162%	22	2174	228	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
1.01195952162%	22	2174	222	T2D_GENES_TANYA_LIPIDS	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
1.01195952162%	22	2174	221	T2D_GENES_TANYA_LIPIDS	CHANDRAN_METASTASIS_UP
1.01195952162%	22	2174	205	T2D_GENES_TANYA_LIPIDS	PEREZ_TP53_AND_TP63_TARGETS
1.01195952162%	22	2174	198	T2D_GENES_TANYA_LIPIDS	WELCSH_BRCA1_TARGETS_UP
1.01195952162%	22	2174	188	T2D_GENES_TANYA_LIPIDS	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
1.01195952162%	22	2174	187	T2D_GENES_TANYA_LIPIDS	PENG_LEUCINE_DEPRIVATION_DN
1.01195952162%	22	2174	181	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
1.01195952162%	22	2174	172	T2D_GENES_TANYA_LIPIDS	REACTOME_MITOTIC_M_M_G1_PHASES
1.01195952162%	22	2174	172	T2D_GENES_TANYA_LIPIDS	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
1.01195952162%	22	2174	169	T2D_GENES_TANYA_LIPIDS	PENG_GLUCOSE_DEPRIVATION_DN
1.01195952162%	22	2174	169	T2D_GENES_TANYA_LIPIDS	KATSANOU_ELAVL1_TARGETS_UP
1.01195952162%	22	2174	165	T2D_GENES_TANYA_LIPIDS	DARWICHE_PAPILLOMA_RISK_LOW_DN
1.01195952162%	22	2174	163	T2D_GENES_TANYA_LIPIDS	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
1.01195952162%	22	2174	159	T2D_GENES_TANYA_LIPIDS	REACTOME_INTERFERON_SIGNALING
1.01195952162%	22	2174	149	T2D_GENES_TANYA_LIPIDS	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
1.01195952162%	22	2174	149	T2D_GENES_TANYA_LIPIDS	HUANG_GATA2_TARGETS_UP
1.01195952162%	22	2174	143	T2D_GENES_TANYA_LIPIDS	DANG_MYC_TARGETS_UP
1.01195952162%	22	2174	142	T2D_GENES_TANYA_LIPIDS	DARWICHE_SKIN_TUMOR_PROMOTER_UP
1.01195952162%	22	2174	140	T2D_GENES_TANYA_LIPIDS	ONDER_CDH1_TARGETS_1_UP
0.997697620875%	13	1303	590	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_MEF_HCP_WITH_H3K27ME3
0.997697620875%	13	1303	544	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.997697620875%	13	1303	487	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
0.997697620875%	13	1303	469	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCCABE_BOUND_BY_HOXC6
0.997697620875%	13	1303	467	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RATTENBACHER_BOUND_BY_CELF1
0.997697620875%	13	1303	463	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.997697620875%	13	1303	457	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
0.997697620875%	13	1303	450	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
0.997697620875%	13	1303	443	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DELYS_THYROID_CANCER_UP
0.997697620875%	13	1303	439	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MITSIADES_RESPONSE_TO_APLIDIN_UP
0.997697620875%	13	1303	425	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_BREAST_CANCER_PROGENITORS_UP
0.997697620875%	13	1303	425	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP
0.997697620875%	13	1303	420	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOOTHA_PGC
0.997697620875%	13	1303	395	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HAN_SATB1_TARGETS_UP
0.997697620875%	13	1303	380	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
0.997697620875%	13	1303	374	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
0.997697620875%	13	1303	373	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
0.997697620875%	13	1303	342	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BLUM_RESPONSE_TO_SALIRASIB_DN
0.997697620875%	13	1303	337	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PENG_GLUTAMINE_DEPRIVATION_DN
0.997697620875%	13	1303	330	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
0.997697620875%	13	1303	329	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
0.997697620875%	13	1303	328	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_PATHWAYS_IN_CANCER
0.997697620875%	13	1303	292	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HELLER_HDAC_TARGETS_DN
0.997697620875%	13	1303	275	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.997697620875%	13	1303	274	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
0.997697620875%	13	1303	272	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
0.997697620875%	13	1303	240	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_ESR1_DN
0.997697620875%	13	1303	235	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_HGF_DN
0.997697620875%	13	1303	204	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
0.997697620875%	13	1303	160	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_6HR_DN
0.994318181818%	35	3520	338	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
0.994318181818%	35	3520	307	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LI_INDUCED_T_TO_NATURAL_KILLER_UP
0.994318181818%	35	3520	302	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
0.994318181818%	35	3520	211	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FOSTER_KDM1A_TARGETS_DN
0.994318181818%	35	3520	180	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
0.978792822186%	6	613	97	T2D_GENES_TANYA_BIOMARKER	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
0.978792822186%	6	613	92	T2D_GENES_TANYA_BIOMARKER	HILLION_HMGA1B_TARGETS
0.978792822186%	6	613	90	T2D_GENES_TANYA_BIOMARKER	MORI_MATURE_B_LYMPHOCYTE_UP
0.978792822186%	6	613	90	T2D_GENES_TANYA_BIOMARKER	HILLION_HMGA1_TARGETS
0.978792822186%	6	613	88	T2D_GENES_TANYA_BIOMARKER	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
0.978792822186%	6	613	87	T2D_GENES_TANYA_BIOMARKER	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
0.978792822186%	6	613	85	T2D_GENES_TANYA_BIOMARKER	LEIN_CEREBELLUM_MARKERS
0.978792822186%	6	613	84	T2D_GENES_TANYA_BIOMARKER	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
0.978792822186%	6	613	84	T2D_GENES_TANYA_BIOMARKER	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
0.978792822186%	6	613	81	T2D_GENES_TANYA_BIOMARKER	COATES_MACROPHAGE_M1_VS_M2_UP
0.978792822186%	6	613	80	T2D_GENES_TANYA_BIOMARKER	FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.978792822186%	6	613	78	T2D_GENES_TANYA_BIOMARKER	COATES_MACROPHAGE_M1_VS_M2_DN
0.978792822186%	6	613	76	T2D_GENES_TANYA_BIOMARKER	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION
0.978792822186%	6	613	72	T2D_GENES_TANYA_BIOMARKER	KEGG_DRUG_METABOLISM_CYTOCHROME_P450
0.978792822186%	6	613	70	T2D_GENES_TANYA_BIOMARKER	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450
0.978792822186%	6	613	55	T2D_GENES_TANYA_BIOMARKER	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
0.978792822186%	6	613	45	T2D_GENES_TANYA_BIOMARKER	ZHAN_V2_LATE_DIFFERENTIATION_GENES
0.978792822186%	6	613	409	T2D_GENES_TANYA_BIOMARKER	FOSTER_TOLERANT_MACROPHAGE_DN
0.978792822186%	6	613	408	T2D_GENES_TANYA_BIOMARKER	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
0.978792822186%	6	613	355	T2D_GENES_TANYA_BIOMARKER	PEREZ_TP63_TARGETS
0.978792822186%	6	613	342	T2D_GENES_TANYA_BIOMARKER	BLUM_RESPONSE_TO_SALIRASIB_DN
0.978792822186%	6	613	338	T2D_GENES_TANYA_BIOMARKER	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
0.978792822186%	6	613	335	T2D_GENES_TANYA_BIOMARKER	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
0.978792822186%	6	613	316	T2D_GENES_TANYA_BIOMARKER	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
0.978792822186%	6	613	314	T2D_GENES_TANYA_BIOMARKER	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.978792822186%	6	613	308	T2D_GENES_TANYA_BIOMARKER	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
0.978792822186%	6	613	296	T2D_GENES_TANYA_BIOMARKER	DURAND_STROMA_MAX_UP
0.978792822186%	6	613	292	T2D_GENES_TANYA_BIOMARKER	HELLER_HDAC_TARGETS_DN
0.978792822186%	6	613	284	T2D_GENES_TANYA_BIOMARKER	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
0.978792822186%	6	613	279	T2D_GENES_TANYA_BIOMARKER	REACTOME_NEURONAL_SYSTEM
0.978792822186%	6	613	276	T2D_GENES_TANYA_BIOMARKER	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
0.978792822186%	6	613	271	T2D_GENES_TANYA_BIOMARKER	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
0.978792822186%	6	613	270	T2D_GENES_TANYA_BIOMARKER	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
0.978792822186%	6	613	269	T2D_GENES_TANYA_BIOMARKER	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
0.978792822186%	6	613	267	T2D_GENES_TANYA_BIOMARKER	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.978792822186%	6	613	266	T2D_GENES_TANYA_BIOMARKER	ROZANOV_MMP14_TARGETS_UP
0.978792822186%	6	613	261	T2D_GENES_TANYA_BIOMARKER	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
0.978792822186%	6	613	254	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_4HR_DN
0.978792822186%	6	613	251	T2D_GENES_TANYA_BIOMARKER	KOBAYASHI_EGFR_SIGNALING_24HR_DN
0.978792822186%	6	613	250	T2D_GENES_TANYA_BIOMARKER	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
0.978792822186%	6	613	246	T2D_GENES_TANYA_BIOMARKER	VERHAAK_AML_WITH_NPM1_MUTATED_DN
0.978792822186%	6	613	246	T2D_GENES_TANYA_BIOMARKER	BILD_E2F3_ONCOGENIC_SIGNATURE
0.978792822186%	6	613	245	T2D_GENES_TANYA_BIOMARKER	MCLACHLAN_DENTAL_CARIES_DN
0.978792822186%	6	613	244	T2D_GENES_TANYA_BIOMARKER	GAL_LEUKEMIC_STEM_CELL_DN
0.978792822186%	6	613	235	T2D_GENES_TANYA_BIOMARKER	RUTELLA_RESPONSE_TO_HGF_DN
0.978792822186%	6	613	233	T2D_GENES_TANYA_BIOMARKER	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.978792822186%	6	613	229	T2D_GENES_TANYA_BIOMARKER	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
0.978792822186%	6	613	229	T2D_GENES_TANYA_BIOMARKER	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
0.978792822186%	6	613	229	T2D_GENES_TANYA_BIOMARKER	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
0.978792822186%	6	613	227	T2D_GENES_TANYA_BIOMARKER	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.978792822186%	6	613	222	T2D_GENES_TANYA_BIOMARKER	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
0.978792822186%	6	613	222	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRANSLATION
0.978792822186%	6	613	220	T2D_GENES_TANYA_BIOMARKER	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
0.978792822186%	6	613	217	T2D_GENES_TANYA_BIOMARKER	WONG_MITOCHONDRIA_GENE_MODULE
0.978792822186%	6	613	216	T2D_GENES_TANYA_BIOMARKER	WHITFIELD_CELL_CYCLE_G2_M
0.978792822186%	6	613	214	T2D_GENES_TANYA_BIOMARKER	BIDUS_METASTASIS_UP
0.978792822186%	6	613	212	T2D_GENES_TANYA_BIOMARKER	CHANG_CORE_SERUM_RESPONSE_UP
0.978792822186%	6	613	210	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.978792822186%	6	613	209	T2D_GENES_TANYA_BIOMARKER	KIM_WT1_TARGETS_12HR_DN
0.978792822186%	6	613	209	T2D_GENES_TANYA_BIOMARKER	GROSS_HYPOXIA_VIA_ELK3_UP
0.978792822186%	6	613	206	T2D_GENES_TANYA_BIOMARKER	RAMALHO_STEMNESS_UP
0.978792822186%	6	613	204	T2D_GENES_TANYA_BIOMARKER	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
0.978792822186%	6	613	204	T2D_GENES_TANYA_BIOMARKER	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
0.978792822186%	6	613	203	T2D_GENES_TANYA_BIOMARKER	GRUETZMANN_PANCREATIC_CANCER_DN
0.978792822186%	6	613	200	T2D_GENES_TANYA_BIOMARKER	SHEPARD_BMYB_MORPHOLINO_DN
0.978792822186%	6	613	199	T2D_GENES_TANYA_BIOMARKER	PLASARI_TGFB1_TARGETS_10HR_UP
0.978792822186%	6	613	198	T2D_GENES_TANYA_BIOMARKER	WELCSH_BRCA1_TARGETS_UP
0.978792822186%	6	613	196	T2D_GENES_TANYA_BIOMARKER	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
0.978792822186%	6	613	195	T2D_GENES_TANYA_BIOMARKER	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.978792822186%	6	613	194	T2D_GENES_TANYA_BIOMARKER	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.978792822186%	6	613	190	T2D_GENES_TANYA_BIOMARKER	KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.978792822186%	6	613	189	T2D_GENES_TANYA_BIOMARKER	BURTON_ADIPOGENESIS_6
0.978792822186%	6	613	187	T2D_GENES_TANYA_BIOMARKER	BAKKER_FOXO3_TARGETS_DN
0.978792822186%	6	613	181	T2D_GENES_TANYA_BIOMARKER	JISON_SICKLE_CELL_DISEASE_DN
0.978792822186%	6	613	181	T2D_GENES_TANYA_BIOMARKER	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
0.978792822186%	6	613	180	T2D_GENES_TANYA_BIOMARKER	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
0.978792822186%	6	613	178	T2D_GENES_TANYA_BIOMARKER	KEGG_CALCIUM_SIGNALING_PATHWAY
0.978792822186%	6	613	178	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_18HR_DN
0.978792822186%	6	613	177	T2D_GENES_TANYA_BIOMARKER	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
0.978792822186%	6	613	172	T2D_GENES_TANYA_BIOMARKER	REACTOME_MITOTIC_M_M_G1_PHASES
0.978792822186%	6	613	170	T2D_GENES_TANYA_BIOMARKER	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
0.978792822186%	6	613	169	T2D_GENES_TANYA_BIOMARKER	UEDA_PERIFERAL_CLOCK
0.978792822186%	6	613	169	T2D_GENES_TANYA_BIOMARKER	KATSANOU_ELAVL1_TARGETS_UP
0.978792822186%	6	613	168	T2D_GENES_TANYA_BIOMARKER	PUJANA_XPRSS_INT_NETWORK
0.978792822186%	6	613	164	T2D_GENES_TANYA_BIOMARKER	KIM_WT1_TARGETS_8HR_UP
0.978792822186%	6	613	163	T2D_GENES_TANYA_BIOMARKER	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
0.978792822186%	6	613	162	T2D_GENES_TANYA_BIOMARKER	WINNEPENNINCKX_MELANOMA_METASTASIS_UP
0.978792822186%	6	613	161	T2D_GENES_TANYA_BIOMARKER	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
0.978792822186%	6	613	160	T2D_GENES_TANYA_BIOMARKER	GAVIN_FOXP3_TARGETS_CLUSTER_P3
0.978792822186%	6	613	158	T2D_GENES_TANYA_BIOMARKER	RODRIGUES_NTN1_TARGETS_DN
0.978792822186%	6	613	157	T2D_GENES_TANYA_BIOMARKER	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
0.978792822186%	6	613	156	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_14HR_UP
0.978792822186%	6	613	150	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_30MIN_DN
0.978792822186%	6	613	148	T2D_GENES_TANYA_BIOMARKER	CHANG_CYCLING_GENES
0.978792822186%	6	613	147	T2D_GENES_TANYA_BIOMARKER	DARWICHE_PAPILLOMA_RISK_HIGH_UP
0.978792822186%	6	613	147	T2D_GENES_TANYA_BIOMARKER	BENPORATH_PROLIFERATION
0.978792822186%	6	613	146	T2D_GENES_TANYA_BIOMARKER	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
0.978792822186%	6	613	145	T2D_GENES_TANYA_BIOMARKER	ZHANG_BREAST_CANCER_PROGENITORS_DN
0.978792822186%	6	613	140	T2D_GENES_TANYA_BIOMARKER	ONDER_CDH1_TARGETS_1_UP
0.978792822186%	6	613	138	T2D_GENES_TANYA_BIOMARKER	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
0.978792822186%	6	613	134	T2D_GENES_TANYA_BIOMARKER	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
0.978792822186%	6	613	134	T2D_GENES_TANYA_BIOMARKER	KEGG_TIGHT_JUNCTION
0.978792822186%	6	613	133	T2D_GENES_TANYA_BIOMARKER	GAL_LEUKEMIC_STEM_CELL_UP
0.978792822186%	6	613	132	T2D_GENES_TANYA_BIOMARKER	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS
0.978792822186%	6	613	128	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_MEF_LCP_WITH_H3K4ME3
0.978792822186%	6	613	122	T2D_GENES_TANYA_BIOMARKER	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
0.978792822186%	6	613	118	T2D_GENES_TANYA_BIOMARKER	REACTOME_TOLL_RECEPTOR_CASCADES
0.978792822186%	6	613	118	T2D_GENES_TANYA_BIOMARKER	MARKEY_RB1_CHRONIC_LOF_DN
0.978792822186%	6	613	117	T2D_GENES_TANYA_BIOMARKER	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.978792822186%	6	613	116	T2D_GENES_TANYA_BIOMARKER	LI_INDUCED_T_TO_NATURAL_KILLER_DN
0.978792822186%	6	613	115	T2D_GENES_TANYA_BIOMARKER	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
0.978792822186%	6	613	114	T2D_GENES_TANYA_BIOMARKER	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN
0.978792822186%	6	613	112	T2D_GENES_TANYA_BIOMARKER	PASINI_SUZ12_TARGETS_UP
0.978792822186%	6	613	109	T2D_GENES_TANYA_BIOMARKER	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
0.978792822186%	6	613	108	T2D_GENES_TANYA_BIOMARKER	LE_EGR2_TARGETS_DN
0.978792822186%	6	613	106	T2D_GENES_TANYA_BIOMARKER	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
0.978792822186%	6	613	103	T2D_GENES_TANYA_BIOMARKER	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
0.965961361546%	21	2174	89	T2D_GENES_TANYA_LIPIDS	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION
0.965961361546%	21	2174	70	T2D_GENES_TANYA_LIPIDS	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450
0.965961361546%	21	2174	389	T2D_GENES_TANYA_LIPIDS	KEGG_OLFACTORY_TRANSDUCTION
0.965961361546%	21	2174	261	T2D_GENES_TANYA_LIPIDS	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
0.965961361546%	21	2174	259	T2D_GENES_TANYA_LIPIDS	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
0.965961361546%	21	2174	251	T2D_GENES_TANYA_LIPIDS	REACTOME_AXON_GUIDANCE
0.965961361546%	21	2174	232	T2D_GENES_TANYA_LIPIDS	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
0.965961361546%	21	2174	230	T2D_GENES_TANYA_LIPIDS	KAUFFMANN_DNA_REPAIR_GENES
0.965961361546%	21	2174	222	T2D_GENES_TANYA_LIPIDS	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
0.965961361546%	21	2174	222	T2D_GENES_TANYA_LIPIDS	REACTOME_TRANSLATION
0.965961361546%	21	2174	212	T2D_GENES_TANYA_LIPIDS	SANSOM_APC_TARGETS
0.965961361546%	21	2174	211	T2D_GENES_TANYA_LIPIDS	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
0.965961361546%	21	2174	204	T2D_GENES_TANYA_LIPIDS	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
0.965961361546%	21	2174	200	T2D_GENES_TANYA_LIPIDS	LEE_DIFFERENTIATING_T_LYMPHOCYTE
0.965961361546%	21	2174	197	T2D_GENES_TANYA_LIPIDS	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
0.965961361546%	21	2174	178	T2D_GENES_TANYA_LIPIDS	LI_AMPLIFIED_IN_LUNG_CANCER
0.965961361546%	21	2174	174	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
0.965961361546%	21	2174	169	T2D_GENES_TANYA_LIPIDS	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
0.965961361546%	21	2174	169	T2D_GENES_TANYA_LIPIDS	KEGG_ALZHEIMERS_DISEASE
0.965961361546%	21	2174	166	T2D_GENES_TANYA_LIPIDS	SMIRNOV_RESPONSE_TO_IR_6HR_UP
0.965961361546%	21	2174	163	T2D_GENES_TANYA_LIPIDS	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
0.965961361546%	21	2174	162	T2D_GENES_TANYA_LIPIDS	MULLIGHAN_NPM1_SIGNATURE_3_DN
0.965961361546%	21	2174	160	T2D_GENES_TANYA_LIPIDS	GAVIN_FOXP3_TARGETS_CLUSTER_P3
0.965961361546%	21	2174	157	T2D_GENES_TANYA_LIPIDS	SERVITJA_LIVER_HNF1A_TARGETS_DN
0.965961361546%	21	2174	147	T2D_GENES_TANYA_LIPIDS	SMID_BREAST_CANCER_ERBB2_UP
0.965961361546%	21	2174	146	T2D_GENES_TANYA_LIPIDS	KIM_ALL_DISORDERS_DURATION_CORR_DN
0.965961361546%	21	2174	145	T2D_GENES_TANYA_LIPIDS	SMITH_TERT_TARGETS_UP
0.965961361546%	21	2174	132	T2D_GENES_TANYA_LIPIDS	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
0.965961361546%	21	2174	126	T2D_GENES_TANYA_LIPIDS	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
0.965961361546%	21	2174	126	T2D_GENES_TANYA_LIPIDS	GERY_CEBP_TARGETS
0.965909090909%	34	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RNA_POL_I_TRANSCRIPTION
0.965909090909%	34	3520	408	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
0.965909090909%	34	3520	403	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7
0.965909090909%	34	3520	372	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_LMO4_TARGETS_UP
0.965909090909%	34	3520	349	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
0.965909090909%	34	3520	325	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CELL_CYCLE_MITOTIC
0.965909090909%	34	3520	296	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DURAND_STROMA_MAX_UP
0.965909090909%	34	3520	217	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SANSOM_APC_MYC_TARGETS
0.965909090909%	34	3520	194	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KASLER_HDAC7_TARGETS_1_UP
0.96251266464%	19	1974	99	Mendelian_Nancy_Cox	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.96251266464%	19	1974	93	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_INSULIN_SECRETION
0.96251266464%	19	1974	91	Mendelian_Nancy_Cox	ELVIDGE_HIF1A_TARGETS_DN
0.96251266464%	19	1974	90	Mendelian_Nancy_Cox	SASSON_RESPONSE_TO_FORSKOLIN_UP
0.96251266464%	19	1974	86	Mendelian_Nancy_Cox	LEE_AGING_CEREBELLUM_DN
0.96251266464%	19	1974	86	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_16HR_DN
0.96251266464%	19	1974	84	Mendelian_Nancy_Cox	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
0.96251266464%	19	1974	84	Mendelian_Nancy_Cox	LEE_AGING_CEREBELLUM_UP
0.96251266464%	19	1974	82	Mendelian_Nancy_Cox	PID_REG_GR_PATHWAY
0.96251266464%	19	1974	81	Mendelian_Nancy_Cox	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
0.96251266464%	19	1974	81	Mendelian_Nancy_Cox	CROMER_METASTASIS_DN
0.96251266464%	19	1974	78	Mendelian_Nancy_Cox	LINDVALL_IMMORTALIZED_BY_TERT_UP
0.96251266464%	19	1974	77	Mendelian_Nancy_Cox	FRIDMAN_SENESCENCE_UP
0.96251266464%	19	1974	73	Mendelian_Nancy_Cox	DITTMER_PTHLH_TARGETS_DN
0.96251266464%	19	1974	72	Mendelian_Nancy_Cox	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
0.96251266464%	19	1974	67	Mendelian_Nancy_Cox	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
0.96251266464%	19	1974	66	Mendelian_Nancy_Cox	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
0.96251266464%	19	1974	66	Mendelian_Nancy_Cox	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.96251266464%	19	1974	65	Mendelian_Nancy_Cox	LEE_LIVER_CANCER_ACOX1_DN
0.96251266464%	19	1974	63	Mendelian_Nancy_Cox	PID_MYC_REPRESSPATHWAY
0.96251266464%	19	1974	56	Mendelian_Nancy_Cox	KEGG_HEDGEHOG_SIGNALING_PATHWAY
0.96251266464%	19	1974	55	Mendelian_Nancy_Cox	KEGG_STEROID_HORMONE_BIOSYNTHESIS
0.96251266464%	19	1974	55	Mendelian_Nancy_Cox	KEGG_BASAL_CELL_CARCINOMA
0.96251266464%	19	1974	54	Mendelian_Nancy_Cox	RICKMAN_HEAD_AND_NECK_CANCER_F
0.96251266464%	19	1974	51	Mendelian_Nancy_Cox	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
0.96251266464%	19	1974	48	Mendelian_Nancy_Cox	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE
0.96251266464%	19	1974	349	Mendelian_Nancy_Cox	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
0.96251266464%	19	1974	32	Mendelian_Nancy_Cox	REACTOME_COMPLEMENT_CASCADE
0.96251266464%	19	1974	29	Mendelian_Nancy_Cox	KEGG_THYROID_CANCER
0.96251266464%	19	1974	271	Mendelian_Nancy_Cox	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
0.96251266464%	19	1974	216	Mendelian_Nancy_Cox	BOQUEST_STEM_CELL_DN
0.96251266464%	19	1974	212	Mendelian_Nancy_Cox	SANSOM_APC_TARGETS
0.96251266464%	19	1974	201	Mendelian_Nancy_Cox	HOLLMANN_APOPTOSIS_VIA_CD40_UP
0.96251266464%	19	1974	193	Mendelian_Nancy_Cox	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP
0.96251266464%	19	1974	182	Mendelian_Nancy_Cox	WHITFIELD_CELL_CYCLE_G2
0.96251266464%	19	1974	181	Mendelian_Nancy_Cox	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
0.96251266464%	19	1974	174	Mendelian_Nancy_Cox	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
0.96251266464%	19	1974	172	Mendelian_Nancy_Cox	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
0.96251266464%	19	1974	169	Mendelian_Nancy_Cox	PENG_GLUCOSE_DEPRIVATION_DN
0.96251266464%	19	1974	165	Mendelian_Nancy_Cox	LIU_CMYB_TARGETS_UP
0.96251266464%	19	1974	159	Mendelian_Nancy_Cox	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
0.96251266464%	19	1974	157	Mendelian_Nancy_Cox	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.96251266464%	19	1974	152	Mendelian_Nancy_Cox	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
0.96251266464%	19	1974	142	Mendelian_Nancy_Cox	XU_GH1_AUTOCRINE_TARGETS_DN
0.96251266464%	19	1974	128	Mendelian_Nancy_Cox	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS
0.96251266464%	19	1974	126	Mendelian_Nancy_Cox	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
0.96251266464%	19	1974	121	Mendelian_Nancy_Cox	VANTVEER_BREAST_CANCER_METASTASIS_DN
0.96251266464%	19	1974	121	Mendelian_Nancy_Cox	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
0.96251266464%	19	1974	116	Mendelian_Nancy_Cox	REACTOME_MEIOSIS
0.96251266464%	19	1974	114	Mendelian_Nancy_Cox	ROPERO_HDAC2_TARGETS
0.96251266464%	19	1974	114	Mendelian_Nancy_Cox	MATZUK_SPERMATOZOA
0.96251266464%	19	1974	112	Mendelian_Nancy_Cox	DITTMER_PTHLH_TARGETS_UP
0.96251266464%	19	1974	108	Mendelian_Nancy_Cox	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
0.96251266464%	19	1974	106	Mendelian_Nancy_Cox	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
0.96251266464%	19	1974	102	Mendelian_Nancy_Cox	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.96251266464%	19	1974	102	Mendelian_Nancy_Cox	KANG_IMMORTALIZED_BY_TERT_DN
0.96251266464%	19	1974	102	Mendelian_Nancy_Cox	DER_IFN_BETA_RESPONSE_UP
0.96251266464%	19	1974	101	Mendelian_Nancy_Cox	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
0.962052378407%	18	1871	88	T2D_GENES_TANYA_HEIGHT	KEGG_RIBOSOME
0.962052378407%	18	1871	72	T2D_GENES_TANYA_HEIGHT	KEGG_LEISHMANIA_INFECTION
0.962052378407%	18	1871	31	T2D_GENES_TANYA_HEIGHT	NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON
0.962052378407%	18	1871	302	T2D_GENES_TANYA_HEIGHT	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
0.962052378407%	18	1871	245	T2D_GENES_TANYA_HEIGHT	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.962052378407%	18	1871	244	T2D_GENES_TANYA_HEIGHT	PLASARI_TGFB1_TARGETS_10HR_DN
0.962052378407%	18	1871	244	T2D_GENES_TANYA_HEIGHT	HSIAO_LIVER_SPECIFIC_GENES
0.962052378407%	18	1871	238	T2D_GENES_TANYA_HEIGHT	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
0.962052378407%	18	1871	229	T2D_GENES_TANYA_HEIGHT	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
0.962052378407%	18	1871	223	T2D_GENES_TANYA_HEIGHT	CHEN_HOXA5_TARGETS_9HR_UP
0.962052378407%	18	1871	221	T2D_GENES_TANYA_HEIGHT	ZHANG_TLX_TARGETS_36HR_UP
0.962052378407%	18	1871	214	T2D_GENES_TANYA_HEIGHT	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
0.962052378407%	18	1871	214	T2D_GENES_TANYA_HEIGHT	KIM_WT1_TARGETS_UP
0.962052378407%	18	1871	199	T2D_GENES_TANYA_HEIGHT	PLASARI_TGFB1_TARGETS_10HR_UP
0.962052378407%	18	1871	196	T2D_GENES_TANYA_HEIGHT	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
0.962052378407%	18	1871	195	T2D_GENES_TANYA_HEIGHT	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
0.962052378407%	18	1871	185	T2D_GENES_TANYA_HEIGHT	ZHANG_TLX_TARGETS_36HR_DN
0.962052378407%	18	1871	185	T2D_GENES_TANYA_HEIGHT	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
0.962052378407%	18	1871	185	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER_SURVIVAL_UP
0.962052378407%	18	1871	185	T2D_GENES_TANYA_HEIGHT	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
0.962052378407%	18	1871	178	T2D_GENES_TANYA_HEIGHT	LI_AMPLIFIED_IN_LUNG_CANCER
0.962052378407%	18	1871	176	T2D_GENES_TANYA_HEIGHT	REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION
0.962052378407%	18	1871	170	T2D_GENES_TANYA_HEIGHT	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
0.962052378407%	18	1871	169	T2D_GENES_TANYA_HEIGHT	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
0.962052378407%	18	1871	169	T2D_GENES_TANYA_HEIGHT	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
0.962052378407%	18	1871	163	T2D_GENES_TANYA_HEIGHT	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
0.962052378407%	18	1871	162	T2D_GENES_TANYA_HEIGHT	KIM_WT1_TARGETS_12HR_UP
0.962052378407%	18	1871	161	T2D_GENES_TANYA_HEIGHT	REACTOME_MRNA_PROCESSING
0.962052378407%	18	1871	155	T2D_GENES_TANYA_HEIGHT	KEGG_JAK_STAT_SIGNALING_PATHWAY
0.962052378407%	18	1871	153	T2D_GENES_TANYA_HEIGHT	REACTOME_PEPTIDE_CHAIN_ELONGATION
0.962052378407%	18	1871	151	T2D_GENES_TANYA_HEIGHT	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
0.962052378407%	18	1871	148	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_24HR_DN
0.962052378407%	18	1871	147	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_ERBB2_UP
0.962052378407%	18	1871	145	T2D_GENES_TANYA_HEIGHT	ZHANG_BREAST_CANCER_PROGENITORS_DN
0.962052378407%	18	1871	145	T2D_GENES_TANYA_HEIGHT	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
0.962052378407%	18	1871	140	T2D_GENES_TANYA_HEIGHT	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
0.962052378407%	18	1871	127	T2D_GENES_TANYA_HEIGHT	LIU_VMYB_TARGETS_UP
0.962052378407%	18	1871	120	T2D_GENES_TANYA_HEIGHT	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN
0.945626477541%	12	1269	508	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ENK_UV_RESPONSE_EPIDERMIS_DN
0.945626477541%	12	1269	489	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIM_MAMMARY_STEM_CELL_UP
0.945626477541%	12	1269	464	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ONDER_CDH1_TARGETS_2_DN
0.945626477541%	12	1269	456	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ODONNELL_TFRC_TARGETS_UP
0.945626477541%	12	1269	434	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BAELDE_DIABETIC_NEPHROPATHY_DN
0.945626477541%	12	1269	428	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
0.945626477541%	12	1269	423	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	THUM_SYSTOLIC_HEART_FAILURE_UP
0.945626477541%	12	1269	420	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOOTHA_PGC
0.945626477541%	12	1269	394	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BERENJENO_TRANSFORMED_BY_RHOA_DN
0.945626477541%	12	1269	392	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.945626477541%	12	1269	374	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
0.945626477541%	12	1269	367	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DELACROIX_RARG_BOUND_MEF
0.945626477541%	12	1269	366	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YOSHIMURA_MAPK8_TARGETS_DN
0.945626477541%	12	1269	352	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_LMO4_TARGETS_DN
0.945626477541%	12	1269	330	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
0.945626477541%	12	1269	329	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
0.945626477541%	12	1269	299	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WALLACE_PROSTATE_CANCER_RACE_UP
0.945626477541%	12	1269	292	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KOYAMA_SEMA3B_TARGETS_UP
0.945626477541%	12	1269	276	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
0.945626477541%	12	1269	272	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
0.945626477541%	12	1269	271	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
0.945626477541%	12	1269	270	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
0.945626477541%	12	1269	269	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
0.945626477541%	12	1269	240	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	UDAYAKUMAR_MED1_TARGETS_DN
0.945626477541%	12	1269	238	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
0.945626477541%	12	1269	230	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KAUFFMANN_DNA_REPAIR_GENES
0.945626477541%	12	1269	225	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
0.945626477541%	12	1269	211	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FOSTER_KDM1A_TARGETS_DN
0.945626477541%	12	1269	203	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRUETZMANN_PANCREATIC_CANCER_DN
0.945626477541%	12	1269	201	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_FOCAL_ADHESION
0.945626477541%	12	1269	183	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.945626477541%	12	1269	163	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
0.940975192472%	11	1169	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GUO_TARGETS_OF_IRS1_AND_IRS2
0.940975192472%	11	1169	93	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CADWELL_ATG16L1_TARGETS_UP
0.940975192472%	11	1169	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WOO_LIVER_CANCER_RECURRENCE_DN
0.940975192472%	11	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RNA_POL_I_PROMOTER_OPENING
0.940975192472%	11	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_STARCH_AND_SUCROSE_METABOLISM
0.940975192472%	11	1169	467	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RATTENBACHER_BOUND_BY_CELF1
0.940975192472%	11	1169	430	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VECCHI_GASTRIC_CANCER_EARLY_UP
0.940975192472%	11	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM
0.940975192472%	11	1169	405	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KUMAR_TARGETS_OF_MLL_AF9_FUSION
0.940975192472%	11	1169	404	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OSMAN_BLADDER_CANCER_UP
0.940975192472%	11	1169	374	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
0.940975192472%	11	1169	373	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
0.940975192472%	11	1169	367	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VECCHI_GASTRIC_CANCER_EARLY_DN
0.940975192472%	11	1169	357	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHEN_SMARCA2_TARGETS_DN
0.940975192472%	11	1169	346	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GOLDRATH_ANTIGEN_RESPONSE
0.940975192472%	11	1169	321	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
0.940975192472%	11	1169	317	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BRUINS_UVC_RESPONSE_EARLY_LATE
0.940975192472%	11	1169	311	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JIANG_HYPOXIA_NORMAL
0.940975192472%	11	1169	299	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MUELLER_PLURINET
0.940975192472%	11	1169	296	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DURAND_STROMA_MAX_UP
0.940975192472%	11	1169	294	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEST_ADRENOCORTICAL_TUMOR_UP
0.940975192472%	11	1169	292	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HELLER_HDAC_TARGETS_DN
0.940975192472%	11	1169	288	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	POOLA_INVASIVE_BREAST_CANCER_UP
0.940975192472%	11	1169	284	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
0.940975192472%	11	1169	277	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
0.940975192472%	11	1169	271	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.940975192472%	11	1169	270	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
0.940975192472%	11	1169	254	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_STEM_CELL
0.940975192472%	11	1169	225	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_16HR_UP
0.940975192472%	11	1169	223	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHEN_HOXA5_TARGETS_9HR_UP
0.940975192472%	11	1169	212	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHANG_CORE_SERUM_RESPONSE_UP
0.940975192472%	11	1169	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_TUMOR_INVASIVENESS_DN
0.940975192472%	11	1169	208	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
0.940975192472%	11	1169	207	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MANALO_HYPOXIA_UP
0.940975192472%	11	1169	198	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WELCSH_BRCA1_TARGETS_UP
0.940975192472%	11	1169	194	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PROVENZANI_METASTASIS_UP
0.940975192472%	11	1169	188	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
0.940975192472%	11	1169	183	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.940975192472%	11	1169	182	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FERNANDEZ_BOUND_BY_MYC
0.940975192472%	11	1169	180	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
0.940975192472%	11	1169	180	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_48HR_UP
0.940975192472%	11	1169	175	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FIRESTEIN_PROLIFERATION
0.940975192472%	11	1169	147	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMID_BREAST_CANCER_ERBB2_UP
0.940975192472%	11	1169	145	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMITH_TERT_TARGETS_UP
0.940975192472%	11	1169	122	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CHROMOSOME_MAINTENANCE
0.940975192472%	11	1169	104	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
0.9375%	33	3520	404	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OSMAN_BLADDER_CANCER_UP
0.9375%	33	3520	367	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VECCHI_GASTRIC_CANCER_EARLY_DN
0.9375%	33	3520	352	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_LMO4_TARGETS_DN
0.9375%	33	3520	323	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRESHOCK_CANCER_COPY_NUMBER_UP
0.9375%	33	3520	308	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
0.9375%	33	3520	276	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
0.9375%	33	3520	230	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BENPORATH_MYC_TARGETS_WITH_EBOX
0.9375%	33	3520	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SANSOM_APC_TARGETS_REQUIRE_MYC
0.9375%	33	3520	207	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.9375%	33	3520	182	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FERNANDEZ_BOUND_BY_MYC
0.922509225092%	5	542	97	T2D_GENES_TANYA_ANTHROPOMETRIC	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP
0.922509225092%	5	542	93	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_REGULATION_OF_INSULIN_SECRETION
0.922509225092%	5	542	92	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_DILATED_CARDIOMYOPATHY
0.922509225092%	5	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION
0.922509225092%	5	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	DELASERNA_MYOD_TARGETS_UP
0.922509225092%	5	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	BHATTACHARYA_EMBRYONIC_STEM_CELL
0.922509225092%	5	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	UEDA_CENTRAL_CLOCK
0.922509225092%	5	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
0.922509225092%	5	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_RIBOSOME
0.922509225092%	5	542	87	T2D_GENES_TANYA_ANTHROPOMETRIC	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.922509225092%	5	542	87	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_MAPK_PATHWAY
0.922509225092%	5	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	TAKAO_RESPONSE_TO_UVB_RADIATION_UP
0.922509225092%	5	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	HOEBEKE_LYMPHOID_STEM_CELL_DN
0.922509225092%	5	542	84	T2D_GENES_TANYA_ANTHROPOMETRIC	RUAN_RESPONSE_TO_TNF_DN
0.922509225092%	5	542	83	T2D_GENES_TANYA_ANTHROPOMETRIC	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
0.922509225092%	5	542	81	T2D_GENES_TANYA_ANTHROPOMETRIC	GUO_HEX_TARGETS_UP
0.922509225092%	5	542	80	T2D_GENES_TANYA_ANTHROPOMETRIC	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
0.922509225092%	5	542	80	T2D_GENES_TANYA_ANTHROPOMETRIC	BASSO_HAIRY_CELL_LEUKEMIA_DN
0.922509225092%	5	542	79	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_MYC_ACTIVPATHWAY
0.922509225092%	5	542	78	T2D_GENES_TANYA_ANTHROPOMETRIC	COATES_MACROPHAGE_M1_VS_M2_DN
0.922509225092%	5	542	78	T2D_GENES_TANYA_ANTHROPOMETRIC	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE
0.922509225092%	5	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
0.922509225092%	5	542	75	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_ADHERENS_JUNCTION
0.922509225092%	5	542	75	T2D_GENES_TANYA_ANTHROPOMETRIC	JAIN_NFKB_SIGNALING
0.922509225092%	5	542	73	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_CHRONIC_MYELOID_LEUKEMIA
0.922509225092%	5	542	73	T2D_GENES_TANYA_ANTHROPOMETRIC	GAURNIER_PSMD4_TARGETS
0.922509225092%	5	542	72	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_DRUG_METABOLISM_CYTOCHROME_P450
0.922509225092%	5	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_RENAL_CELL_CARCINOMA
0.922509225092%	5	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PANCREATIC_CANCER
0.922509225092%	5	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450
0.922509225092%	5	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES
0.922509225092%	5	542	68	T2D_GENES_TANYA_ANTHROPOMETRIC	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES
0.922509225092%	5	542	67	T2D_GENES_TANYA_ANTHROPOMETRIC	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
0.922509225092%	5	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_LYSOPHOSPHOLIPID_PATHWAY
0.922509225092%	5	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_HIF1_TFPATHWAY
0.922509225092%	5	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_HDAC_CLASSI_PATHWAY
0.922509225092%	5	542	65	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_FAS_SIGNALING_PATHWAY
0.922509225092%	5	542	65	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_RB_1PATHWAY
0.922509225092%	5	542	65	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_ERA_GENOMIC_PATHWAY
0.922509225092%	5	542	63	T2D_GENES_TANYA_ANTHROPOMETRIC	MODY_HIPPOCAMPUS_POSTNATAL
0.922509225092%	5	542	62	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_FCER1PATHWAY
0.922509225092%	5	542	60	T2D_GENES_TANYA_ANTHROPOMETRIC	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
0.922509225092%	5	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
0.922509225092%	5	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHOU_TNF_SIGNALING_30MIN
0.922509225092%	5	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_AR_TF_PATHWAY
0.922509225092%	5	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT
0.922509225092%	5	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_GLUTATHIONE_METABOLISM
0.922509225092%	5	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
0.922509225092%	5	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_CERAMIDE_PATHWAY
0.922509225092%	5	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_KERATINOCYTE_PATHWAY
0.922509225092%	5	542	455	T2D_GENES_TANYA_ANTHROPOMETRIC	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.922509225092%	5	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PLC_BETA_MEDIATED_EVENTS
0.922509225092%	5	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_CALORIE_RESTRICTION_MUSCLE_UP
0.922509225092%	5	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_IFNGPATHWAY
0.922509225092%	5	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_GA13_PATHWAY
0.922509225092%	5	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	VALK_AML_CLUSTER_11
0.922509225092%	5	542	328	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_OLFACTORY_SIGNALING_PATHWAY
0.922509225092%	5	542	306	T2D_GENES_TANYA_ANTHROPOMETRIC	HORIUCHI_WTAP_TARGETS_UP
0.922509225092%	5	542	299	T2D_GENES_TANYA_ANTHROPOMETRIC	WALLACE_PROSTATE_CANCER_RACE_UP
0.922509225092%	5	542	295	T2D_GENES_TANYA_ANTHROPOMETRIC	LU_EZH2_TARGETS_UP
0.922509225092%	5	542	293	T2D_GENES_TANYA_ANTHROPOMETRIC	HADDAD_B_LYMPHOCYTE_PROGENITOR
0.922509225092%	5	542	289	T2D_GENES_TANYA_ANTHROPOMETRIC	GABRIELY_MIR21_TARGETS
0.922509225092%	5	542	288	T2D_GENES_TANYA_ANTHROPOMETRIC	POOLA_INVASIVE_BREAST_CANCER_UP
0.922509225092%	5	542	283	T2D_GENES_TANYA_ANTHROPOMETRIC	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
0.922509225092%	5	542	276	T2D_GENES_TANYA_ANTHROPOMETRIC	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
0.922509225092%	5	542	271	T2D_GENES_TANYA_ANTHROPOMETRIC	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.922509225092%	5	542	268	T2D_GENES_TANYA_ANTHROPOMETRIC	XU_GH1_AUTOCRINE_TARGETS_UP
0.922509225092%	5	542	265	T2D_GENES_TANYA_ANTHROPOMETRIC	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
0.922509225092%	5	542	258	T2D_GENES_TANYA_ANTHROPOMETRIC	JAEGER_METASTASIS_DN
0.922509225092%	5	542	253	T2D_GENES_TANYA_ANTHROPOMETRIC	MCLACHLAN_DENTAL_CARIES_UP
0.922509225092%	5	542	251	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_AXON_GUIDANCE
0.922509225092%	5	542	249	T2D_GENES_TANYA_ANTHROPOMETRIC	MITSIADES_RESPONSE_TO_APLIDIN_DN
0.922509225092%	5	542	249	T2D_GENES_TANYA_ANTHROPOMETRIC	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
0.922509225092%	5	542	246	T2D_GENES_TANYA_ANTHROPOMETRIC	BILD_E2F3_ONCOGENIC_SIGNATURE
0.922509225092%	5	542	245	T2D_GENES_TANYA_ANTHROPOMETRIC	MCLACHLAN_DENTAL_CARIES_DN
0.922509225092%	5	542	244	T2D_GENES_TANYA_ANTHROPOMETRIC	THUM_SYSTOLIC_HEART_FAILURE_DN
0.922509225092%	5	542	241	T2D_GENES_TANYA_ANTHROPOMETRIC	DOANE_RESPONSE_TO_ANDROGEN_DN
0.922509225092%	5	542	238	T2D_GENES_TANYA_ANTHROPOMETRIC	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.922509225092%	5	542	233	T2D_GENES_TANYA_ANTHROPOMETRIC	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.922509225092%	5	542	230	T2D_GENES_TANYA_ANTHROPOMETRIC	BENPORATH_MYC_TARGETS_WITH_EBOX
0.922509225092%	5	542	229	T2D_GENES_TANYA_ANTHROPOMETRIC	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
0.922509225092%	5	542	227	T2D_GENES_TANYA_ANTHROPOMETRIC	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.922509225092%	5	542	221	T2D_GENES_TANYA_ANTHROPOMETRIC	PEDRIOLI_MIR31_TARGETS_UP
0.922509225092%	5	542	216	T2D_GENES_TANYA_ANTHROPOMETRIC	WHITFIELD_CELL_CYCLE_G2_M
0.922509225092%	5	542	215	T2D_GENES_TANYA_ANTHROPOMETRIC	YAMAZAKI_TCEB3_TARGETS_DN
0.922509225092%	5	542	214	T2D_GENES_TANYA_ANTHROPOMETRIC	ZWANG_EGF_INTERVAL_DN
0.922509225092%	5	542	212	T2D_GENES_TANYA_ANTHROPOMETRIC	CHANG_CORE_SERUM_RESPONSE_UP
0.922509225092%	5	542	210	T2D_GENES_TANYA_ANTHROPOMETRIC	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
0.922509225092%	5	542	210	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRANSCRIPTION
0.922509225092%	5	542	210	T2D_GENES_TANYA_ANTHROPOMETRIC	CAIRO_HEPATOBLASTOMA_CLASSES_DN
0.922509225092%	5	542	209	T2D_GENES_TANYA_ANTHROPOMETRIC	GROSS_HYPOXIA_VIA_ELK3_UP
0.922509225092%	5	542	205	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
0.922509225092%	5	542	202	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
0.922509225092%	5	542	198	T2D_GENES_TANYA_ANTHROPOMETRIC	WELCSH_BRCA1_TARGETS_UP
0.922509225092%	5	542	198	T2D_GENES_TANYA_ANTHROPOMETRIC	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.922509225092%	5	542	197	T2D_GENES_TANYA_ANTHROPOMETRIC	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
0.922509225092%	5	542	196	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
0.922509225092%	5	542	196	T2D_GENES_TANYA_ANTHROPOMETRIC	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
0.922509225092%	5	542	193	T2D_GENES_TANYA_ANTHROPOMETRIC	MOHANKUMAR_TLX1_TARGETS_DN
0.922509225092%	5	542	193	T2D_GENES_TANYA_ANTHROPOMETRIC	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
0.922509225092%	5	542	192	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_DNA_REPLICATION
0.922509225092%	5	542	188	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.922509225092%	5	542	187	T2D_GENES_TANYA_ANTHROPOMETRIC	BAKKER_FOXO3_TARGETS_DN
0.922509225092%	5	542	185	T2D_GENES_TANYA_ANTHROPOMETRIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.922509225092%	5	542	183	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.922509225092%	5	542	181	T2D_GENES_TANYA_ANTHROPOMETRIC	JISON_SICKLE_CELL_DISEASE_UP
0.922509225092%	5	542	178	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_18HR_UP
0.922509225092%	5	542	176	T2D_GENES_TANYA_ANTHROPOMETRIC	SASAKI_ADULT_T_CELL_LEUKEMIA
0.922509225092%	5	542	176	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX
0.922509225092%	5	542	175	T2D_GENES_TANYA_ANTHROPOMETRIC	YAMAZAKI_TCEB3_TARGETS_UP
0.922509225092%	5	542	172	T2D_GENES_TANYA_ANTHROPOMETRIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
0.922509225092%	5	542	172	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MITOTIC_M_M_G1_PHASES
0.922509225092%	5	542	170	T2D_GENES_TANYA_ANTHROPOMETRIC	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
0.922509225092%	5	542	169	T2D_GENES_TANYA_ANTHROPOMETRIC	UEDA_PERIFERAL_CLOCK
0.922509225092%	5	542	169	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION
0.922509225092%	5	542	165	T2D_GENES_TANYA_ANTHROPOMETRIC	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.922509225092%	5	542	165	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWN_MYELOID_CELL_DEVELOPMENT_UP
0.922509225092%	5	542	164	T2D_GENES_TANYA_ANTHROPOMETRIC	AMIT_EGF_RESPONSE_480_HELA
0.922509225092%	5	542	163	T2D_GENES_TANYA_ANTHROPOMETRIC	SERVITJA_ISLET_HNF1A_TARGETS_UP
0.922509225092%	5	542	162	T2D_GENES_TANYA_ANTHROPOMETRIC	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
0.922509225092%	5	542	161	T2D_GENES_TANYA_ANTHROPOMETRIC	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
0.922509225092%	5	542	157	T2D_GENES_TANYA_ANTHROPOMETRIC	SERVITJA_LIVER_HNF1A_TARGETS_DN
0.922509225092%	5	542	156	T2D_GENES_TANYA_ANTHROPOMETRIC	GROSS_HYPOXIA_VIA_ELK3_DN
0.922509225092%	5	542	153	T2D_GENES_TANYA_ANTHROPOMETRIC	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
0.922509225092%	5	542	153	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PEPTIDE_CHAIN_ELONGATION
0.922509225092%	5	542	149	T2D_GENES_TANYA_ANTHROPOMETRIC	HUANG_GATA2_TARGETS_UP
0.922509225092%	5	542	148	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_24HR_DN
0.922509225092%	5	542	146	T2D_GENES_TANYA_ANTHROPOMETRIC	ELVIDGE_HYPOXIA_DN
0.922509225092%	5	542	146	T2D_GENES_TANYA_ANTHROPOMETRIC	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
0.922509225092%	5	542	146	T2D_GENES_TANYA_ANTHROPOMETRIC	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
0.922509225092%	5	542	143	T2D_GENES_TANYA_ANTHROPOMETRIC	DANG_MYC_TARGETS_UP
0.922509225092%	5	542	142	T2D_GENES_TANYA_ANTHROPOMETRIC	XU_GH1_AUTOCRINE_TARGETS_DN
0.922509225092%	5	542	142	T2D_GENES_TANYA_ANTHROPOMETRIC	PENG_LEUCINE_DEPRIVATION_UP
0.922509225092%	5	542	142	T2D_GENES_TANYA_ANTHROPOMETRIC	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
0.922509225092%	5	542	141	T2D_GENES_TANYA_ANTHROPOMETRIC	WELCSH_BRCA1_TARGETS_DN
0.922509225092%	5	542	141	T2D_GENES_TANYA_ANTHROPOMETRIC	KAAB_FAILED_HEART_ATRIUM_DN
0.922509225092%	5	542	140	T2D_GENES_TANYA_ANTHROPOMETRIC	JOHNSTONE_PARVB_TARGETS_2_UP
0.922509225092%	5	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION
0.922509225092%	5	542	138	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
0.922509225092%	5	542	137	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
0.922509225092%	5	542	137	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.922509225092%	5	542	136	T2D_GENES_TANYA_ANTHROPOMETRIC	PROVENZANI_METASTASIS_DN
0.922509225092%	5	542	135	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_OXIDATIVE_PHOSPHORYLATION
0.922509225092%	5	542	133	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_DIABETES_PATHWAYS
0.922509225092%	5	542	132	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
0.922509225092%	5	542	132	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS
0.922509225092%	5	542	129	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MEMBRANE_TRAFFICKING
0.922509225092%	5	542	128	T2D_GENES_TANYA_ANTHROPOMETRIC	LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.922509225092%	5	542	128	T2D_GENES_TANYA_ANTHROPOMETRIC	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.922509225092%	5	542	128	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_CELL_CYCLE
0.922509225092%	5	542	127	T2D_GENES_TANYA_ANTHROPOMETRIC	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
0.922509225092%	5	542	126	T2D_GENES_TANYA_ANTHROPOMETRIC	BURTON_ADIPOGENESIS_5
0.922509225092%	5	542	125	T2D_GENES_TANYA_ANTHROPOMETRIC	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
0.922509225092%	5	542	121	T2D_GENES_TANYA_ANTHROPOMETRIC	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP
0.922509225092%	5	542	121	T2D_GENES_TANYA_ANTHROPOMETRIC	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
0.922509225092%	5	542	118	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
0.922509225092%	5	542	115	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
0.922509225092%	5	542	115	T2D_GENES_TANYA_ANTHROPOMETRIC	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
0.922509225092%	5	542	115	T2D_GENES_TANYA_ANTHROPOMETRIC	HOELZEL_NF1_TARGETS_DN
0.922509225092%	5	542	113	T2D_GENES_TANYA_ANTHROPOMETRIC	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
0.922509225092%	5	542	112	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_DNA_REPAIR
0.922509225092%	5	542	112	T2D_GENES_TANYA_ANTHROPOMETRIC	LABBE_WNT3A_TARGETS_UP
0.922509225092%	5	542	110	T2D_GENES_TANYA_ANTHROPOMETRIC	WOOD_EBV_EBNA1_TARGETS_UP
0.922509225092%	5	542	109	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
0.922509225092%	5	542	108	T2D_GENES_TANYA_ANTHROPOMETRIC	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
0.922509225092%	5	542	108	T2D_GENES_TANYA_ANTHROPOMETRIC	LE_EGR2_TARGETS_DN
0.922509225092%	5	542	108	T2D_GENES_TANYA_ANTHROPOMETRIC	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
0.922509225092%	5	542	105	T2D_GENES_TANYA_ANTHROPOMETRIC	AMUNDSON_GENOTOXIC_SIGNATURE
0.922509225092%	5	542	104	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
0.922509225092%	5	542	101	T2D_GENES_TANYA_ANTHROPOMETRIC	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
0.922509225092%	5	542	101	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_GNRH_SIGNALING_PATHWAY
0.920951650038%	12	1303	775	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BENPORATH_MYC_MAX_TARGETS
0.920951650038%	12	1303	728	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARSON_BOUND_BY_E2F4_UNSTIMULATED
0.920951650038%	12	1303	536	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BERENJENO_TRANSFORMED_BY_RHOA_UP
0.920951650038%	12	1303	526	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ONKEN_UVEAL_MELANOMA_DN
0.920951650038%	12	1303	459	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_WT1_TARGETS_DN
0.920951650038%	12	1303	455	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.920951650038%	12	1303	445	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_NPC_ICP_WITH_H3K4ME3
0.920951650038%	12	1303	442	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROME_INSULIN_TARGETS_IN_MUSCLE_UP
0.920951650038%	12	1303	442	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HAN_SATB1_TARGETS_DN
0.920951650038%	12	1303	435	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SWEET_LUNG_CANCER_KRAS_DN
0.920951650038%	12	1303	431	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GARY_CD5_TARGETS_DN
0.920951650038%	12	1303	428	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
0.920951650038%	12	1303	425	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOCHKIS_FOXA2_TARGETS
0.920951650038%	12	1303	418	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MULLIGHAN_MLL_SIGNATURE_2_UP
0.920951650038%	12	1303	384	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BASAKI_YBX1_TARGETS_DN
0.920951650038%	12	1303	379	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BENPORATH_ES_1
0.920951650038%	12	1303	366	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YOSHIMURA_MAPK8_TARGETS_DN
0.920951650038%	12	1303	344	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
0.920951650038%	12	1303	336	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JOHNSTONE_PARVB_TARGETS_2_DN
0.920951650038%	12	1303	305	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
0.920951650038%	12	1303	295	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LU_EZH2_TARGETS_UP
0.920951650038%	12	1303	289	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
0.920951650038%	12	1303	283	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
0.920951650038%	12	1303	277	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
0.920951650038%	12	1303	275	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
0.920951650038%	12	1303	271	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.920951650038%	12	1303	271	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.920951650038%	12	1303	268	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	XU_GH1_AUTOCRINE_TARGETS_UP
0.920951650038%	12	1303	251	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KOBAYASHI_EGFR_SIGNALING_24HR_DN
0.920951650038%	12	1303	241	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DOANE_RESPONSE_TO_ANDROGEN_DN
0.920951650038%	12	1303	239	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.920951650038%	12	1303	232	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DELYS_THYROID_CANCER_DN
0.920951650038%	12	1303	230	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	COLDREN_GEFITINIB_RESISTANCE_DN
0.920951650038%	12	1303	227	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_RECENT_THYMIC_EMIGRANT
0.920951650038%	12	1303	221	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_36HR_UP
0.920951650038%	12	1303	211	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
0.920951650038%	12	1303	207	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MANALO_HYPOXIA_UP
0.920951650038%	12	1303	205	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
0.920951650038%	12	1303	180	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DARWICHE_PAPILLOMA_RISK_HIGH_DN
0.920951650038%	12	1303	178	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_18HR_UP
0.919963201472%	20	2174	98	T2D_GENES_TANYA_LIPIDS	GUO_TARGETS_OF_IRS1_AND_IRS2
0.919963201472%	20	2174	31	T2D_GENES_TANYA_LIPIDS	NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON
0.919963201472%	20	2174	289	T2D_GENES_TANYA_LIPIDS	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
0.919963201472%	20	2174	244	T2D_GENES_TANYA_LIPIDS	THUM_SYSTOLIC_HEART_FAILURE_DN
0.919963201472%	20	2174	238	T2D_GENES_TANYA_LIPIDS	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
0.919963201472%	20	2174	227	T2D_GENES_TANYA_LIPIDS	RAO_BOUND_BY_SALL4
0.919963201472%	20	2174	226	T2D_GENES_TANYA_LIPIDS	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.919963201472%	20	2174	223	T2D_GENES_TANYA_LIPIDS	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.919963201472%	20	2174	214	T2D_GENES_TANYA_LIPIDS	BIDUS_METASTASIS_UP
0.919963201472%	20	2174	210	T2D_GENES_TANYA_LIPIDS	VERHAAK_GLIOBLASTOMA_PRONEURAL
0.919963201472%	20	2174	206	T2D_GENES_TANYA_LIPIDS	RAMALHO_STEMNESS_UP
0.919963201472%	20	2174	205	T2D_GENES_TANYA_LIPIDS	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.919963201472%	20	2174	203	T2D_GENES_TANYA_LIPIDS	REACTOME_INFLUENZA_LIFE_CYCLE
0.919963201472%	20	2174	202	T2D_GENES_TANYA_LIPIDS	FUJII_YBX1_TARGETS_DN
0.919963201472%	20	2174	201	T2D_GENES_TANYA_LIPIDS	KEGG_FOCAL_ADHESION
0.919963201472%	20	2174	186	T2D_GENES_TANYA_LIPIDS	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
0.919963201472%	20	2174	185	T2D_GENES_TANYA_LIPIDS	KEGG_HUNTINGTONS_DISEASE
0.919963201472%	20	2174	182	T2D_GENES_TANYA_LIPIDS	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
0.919963201472%	20	2174	176	T2D_GENES_TANYA_LIPIDS	SASAKI_ADULT_T_CELL_LEUKEMIA
0.919963201472%	20	2174	176	T2D_GENES_TANYA_LIPIDS	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
0.919963201472%	20	2174	175	T2D_GENES_TANYA_LIPIDS	FIRESTEIN_PROLIFERATION
0.919963201472%	20	2174	167	T2D_GENES_TANYA_LIPIDS	VANTVEER_BREAST_CANCER_ESR1_UP
0.919963201472%	20	2174	161	T2D_GENES_TANYA_LIPIDS	REACTOME_MRNA_PROCESSING
0.919963201472%	20	2174	157	T2D_GENES_TANYA_LIPIDS	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.919963201472%	20	2174	157	T2D_GENES_TANYA_LIPIDS	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
0.919963201472%	20	2174	148	T2D_GENES_TANYA_LIPIDS	CHANG_CYCLING_GENES
0.919963201472%	20	2174	147	T2D_GENES_TANYA_LIPIDS	WHITFIELD_CELL_CYCLE_G1_S
0.919963201472%	20	2174	144	T2D_GENES_TANYA_LIPIDS	BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.919963201472%	20	2174	143	T2D_GENES_TANYA_LIPIDS	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION
0.919963201472%	20	2174	142	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_ES_LCP_WITH_H3K4ME3
0.919963201472%	20	2174	140	T2D_GENES_TANYA_LIPIDS	JOHNSTONE_PARVB_TARGETS_2_UP
0.919963201472%	20	2174	140	T2D_GENES_TANYA_LIPIDS	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
0.919963201472%	20	2174	138	T2D_GENES_TANYA_LIPIDS	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
0.919963201472%	20	2174	134	T2D_GENES_TANYA_LIPIDS	SCHLOSSER_SERUM_RESPONSE_UP
0.919963201472%	20	2174	134	T2D_GENES_TANYA_LIPIDS	KEGG_CELL_ADHESION_MOLECULES_CAMS
0.919963201472%	20	2174	130	T2D_GENES_TANYA_LIPIDS	ELVIDGE_HYPOXIA_BY_DMOG_UP
0.919963201472%	20	2174	129	T2D_GENES_TANYA_LIPIDS	BROWN_MYELOID_CELL_DEVELOPMENT_DN
0.919963201472%	20	2174	128	T2D_GENES_TANYA_LIPIDS	KEGG_SPLICEOSOME
0.911854103343%	18	1974	95	Mendelian_Nancy_Cox	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
0.911854103343%	18	1974	91	Mendelian_Nancy_Cox	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
0.911854103343%	18	1974	91	Mendelian_Nancy_Cox	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION
0.911854103343%	18	1974	89	Mendelian_Nancy_Cox	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
0.911854103343%	18	1974	89	Mendelian_Nancy_Cox	LI_DCP2_BOUND_MRNA
0.911854103343%	18	1974	88	Mendelian_Nancy_Cox	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.911854103343%	18	1974	86	Mendelian_Nancy_Cox	LAIHO_COLORECTAL_CANCER_SERRATED_DN
0.911854103343%	18	1974	84	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_LUMINAL_A_UP
0.911854103343%	18	1974	83	Mendelian_Nancy_Cox	ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.911854103343%	18	1974	81	Mendelian_Nancy_Cox	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.911854103343%	18	1974	79	Mendelian_Nancy_Cox	PID_MYC_ACTIVPATHWAY
0.911854103343%	18	1974	76	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
0.911854103343%	18	1974	74	Mendelian_Nancy_Cox	WESTON_VEGFA_TARGETS_3HR
0.911854103343%	18	1974	71	Mendelian_Nancy_Cox	REACTOME_PI3K_CASCADE
0.911854103343%	18	1974	70	Mendelian_Nancy_Cox	KEGG_LONG_TERM_DEPRESSION
0.911854103343%	18	1974	69	Mendelian_Nancy_Cox	REACTOME_SPHINGOLIPID_METABOLISM
0.911854103343%	18	1974	68	Mendelian_Nancy_Cox	ROSS_AML_OF_FAB_M7_TYPE
0.911854103343%	18	1974	65	Mendelian_Nancy_Cox	PID_RB_1PATHWAY
0.911854103343%	18	1974	65	Mendelian_Nancy_Cox	PID_BCR_5PATHWAY
0.911854103343%	18	1974	65	Mendelian_Nancy_Cox	GUO_HEX_TARGETS_DN
0.911854103343%	18	1974	63	Mendelian_Nancy_Cox	MODY_HIPPOCAMPUS_POSTNATAL
0.911854103343%	18	1974	63	Mendelian_Nancy_Cox	CROMER_TUMORIGENESIS_UP
0.911854103343%	18	1974	59	Mendelian_Nancy_Cox	PID_ATF2_PATHWAY
0.911854103343%	18	1974	51	Mendelian_Nancy_Cox	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN
0.911854103343%	18	1974	49	Mendelian_Nancy_Cox	GERHOLD_ADIPOGENESIS_UP
0.911854103343%	18	1974	46	Mendelian_Nancy_Cox	REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT
0.911854103343%	18	1974	44	Mendelian_Nancy_Cox	PID_ERBB2ERBB3PATHWAY
0.911854103343%	18	1974	43	Mendelian_Nancy_Cox	PID_INTEGRIN3_PATHWAY
0.911854103343%	18	1974	178	Mendelian_Nancy_Cox	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
0.911854103343%	18	1974	176	Mendelian_Nancy_Cox	NAGASHIMA_NRG1_SIGNALING_UP
0.911854103343%	18	1974	176	Mendelian_Nancy_Cox	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
0.911854103343%	18	1974	163	Mendelian_Nancy_Cox	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
0.911854103343%	18	1974	162	Mendelian_Nancy_Cox	WINNEPENNINCKX_MELANOMA_METASTASIS_UP
0.911854103343%	18	1974	158	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON
0.911854103343%	18	1974	157	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
0.911854103343%	18	1974	147	Mendelian_Nancy_Cox	WHITFIELD_CELL_CYCLE_G1_S
0.911854103343%	18	1974	147	Mendelian_Nancy_Cox	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.911854103343%	18	1974	146	Mendelian_Nancy_Cox	PECE_MAMMARY_STEM_CELL_UP
0.911854103343%	18	1974	146	Mendelian_Nancy_Cox	KIM_ALL_DISORDERS_DURATION_CORR_DN
0.911854103343%	18	1974	145	Mendelian_Nancy_Cox	ZHANG_BREAST_CANCER_PROGENITORS_DN
0.911854103343%	18	1974	143	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
0.911854103343%	18	1974	137	Mendelian_Nancy_Cox	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.911854103343%	18	1974	137	Mendelian_Nancy_Cox	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
0.911854103343%	18	1974	135	Mendelian_Nancy_Cox	SERVITJA_LIVER_HNF1A_TARGETS_UP
0.911854103343%	18	1974	134	Mendelian_Nancy_Cox	CHUNG_BLISTER_CYTOTOXICITY_UP
0.911854103343%	18	1974	129	Mendelian_Nancy_Cox	KIM_WT1_TARGETS_8HR_DN
0.911854103343%	18	1974	121	Mendelian_Nancy_Cox	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
0.911854103343%	18	1974	120	Mendelian_Nancy_Cox	ZHU_CMV_ALL_UP
0.911854103343%	18	1974	120	Mendelian_Nancy_Cox	REACTOME_CELL_CELL_COMMUNICATION
0.911854103343%	18	1974	120	Mendelian_Nancy_Cox	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
0.911854103343%	18	1974	120	Mendelian_Nancy_Cox	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.911854103343%	18	1974	118	Mendelian_Nancy_Cox	REACTOME_TOLL_RECEPTOR_CASCADES
0.911854103343%	18	1974	115	Mendelian_Nancy_Cox	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
0.911854103343%	18	1974	114	Mendelian_Nancy_Cox	SENESE_HDAC2_TARGETS_UP
0.911854103343%	18	1974	110	Mendelian_Nancy_Cox	CHENG_IMPRINTED_BY_ESTRADIOL
0.911854103343%	18	1974	108	Mendelian_Nancy_Cox	ZHANG_TLX_TARGETS_DN
0.911854103343%	18	1974	108	Mendelian_Nancy_Cox	LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT
0.911854103343%	18	1974	108	Mendelian_Nancy_Cox	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN
0.911854103343%	18	1974	107	Mendelian_Nancy_Cox	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.911854103343%	18	1974	105	Mendelian_Nancy_Cox	HELLER_SILENCED_BY_METHYLATION_DN
0.911854103343%	18	1974	103	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_NOTCH
0.911854103343%	18	1974	102	Mendelian_Nancy_Cox	MIKKELSEN_IPS_WITH_HCP_H3K27ME3
0.909090909091%	32	3520	362	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
0.909090909091%	32	3520	351	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.909090909091%	32	3520	344	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP
0.909090909091%	32	3520	317	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_EARLY_LATE
0.909090909091%	32	3520	299	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MUELLER_PLURINET
0.909090909091%	32	3520	290	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BASAKI_YBX1_TARGETS_UP
0.909090909091%	32	3520	288	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	POOLA_INVASIVE_BREAST_CANCER_UP
0.909090909091%	32	3520	266	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FOSTER_KDM1A_TARGETS_UP
0.909090909091%	32	3520	264	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
0.909090909091%	32	3520	214	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
0.908605024051%	17	1871	98	T2D_GENES_TANYA_HEIGHT	REACTOME_POTASSIUM_CHANNELS
0.908605024051%	17	1871	97	T2D_GENES_TANYA_HEIGHT	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
0.908605024051%	17	1871	90	T2D_GENES_TANYA_HEIGHT	MORI_MATURE_B_LYMPHOCYTE_UP
0.908605024051%	17	1871	84	T2D_GENES_TANYA_HEIGHT	KIM_GLIS2_TARGETS_UP
0.908605024051%	17	1871	83	T2D_GENES_TANYA_HEIGHT	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
0.908605024051%	17	1871	78	T2D_GENES_TANYA_HEIGHT	SANA_RESPONSE_TO_IFNG_UP
0.908605024051%	17	1871	280	T2D_GENES_TANYA_HEIGHT	WANG_SMARCE1_TARGETS_UP
0.908605024051%	17	1871	233	T2D_GENES_TANYA_HEIGHT	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.908605024051%	17	1871	230	T2D_GENES_TANYA_HEIGHT	COLDREN_GEFITINIB_RESISTANCE_DN
0.908605024051%	17	1871	227	T2D_GENES_TANYA_HEIGHT	RAO_BOUND_BY_SALL4
0.908605024051%	17	1871	216	T2D_GENES_TANYA_HEIGHT	WHITFIELD_CELL_CYCLE_G2_M
0.908605024051%	17	1871	206	T2D_GENES_TANYA_HEIGHT	RAMALHO_STEMNESS_UP
0.908605024051%	17	1871	205	T2D_GENES_TANYA_HEIGHT	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
0.908605024051%	17	1871	198	T2D_GENES_TANYA_HEIGHT	ALONSO_METASTASIS_UP
0.908605024051%	17	1871	191	T2D_GENES_TANYA_HEIGHT	RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.908605024051%	17	1871	191	T2D_GENES_TANYA_HEIGHT	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
0.908605024051%	17	1871	186	T2D_GENES_TANYA_HEIGHT	WANG_CLIM2_TARGETS_DN
0.908605024051%	17	1871	177	T2D_GENES_TANYA_HEIGHT	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.908605024051%	17	1871	175	T2D_GENES_TANYA_HEIGHT	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.908605024051%	17	1871	174	T2D_GENES_TANYA_HEIGHT	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
0.908605024051%	17	1871	169	T2D_GENES_TANYA_HEIGHT	ONDER_CDH1_TARGETS_1_DN
0.908605024051%	17	1871	167	T2D_GENES_TANYA_HEIGHT	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
0.908605024051%	17	1871	165	T2D_GENES_TANYA_HEIGHT	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.908605024051%	17	1871	163	T2D_GENES_TANYA_HEIGHT	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
0.908605024051%	17	1871	162	T2D_GENES_TANYA_HEIGHT	DARWICHE_PAPILLOMA_RISK_LOW_UP
0.908605024051%	17	1871	159	T2D_GENES_TANYA_HEIGHT	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
0.908605024051%	17	1871	151	T2D_GENES_TANYA_HEIGHT	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
0.908605024051%	17	1871	149	T2D_GENES_TANYA_HEIGHT	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
0.908605024051%	17	1871	145	T2D_GENES_TANYA_HEIGHT	SMITH_TERT_TARGETS_UP
0.908605024051%	17	1871	145	T2D_GENES_TANYA_HEIGHT	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
0.908605024051%	17	1871	142	T2D_GENES_TANYA_HEIGHT	PENG_LEUCINE_DEPRIVATION_UP
0.908605024051%	17	1871	137	T2D_GENES_TANYA_HEIGHT	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
0.908605024051%	17	1871	133	T2D_GENES_TANYA_HEIGHT	SENESE_HDAC2_TARGETS_DN
0.908605024051%	17	1871	129	T2D_GENES_TANYA_HEIGHT	REACTOME_MEMBRANE_TRAFFICKING
0.908605024051%	17	1871	127	T2D_GENES_TANYA_HEIGHT	INGRAM_SHH_TARGETS_UP
0.908605024051%	17	1871	126	T2D_GENES_TANYA_HEIGHT	SANSOM_APC_TARGETS_UP
0.908605024051%	17	1871	120	T2D_GENES_TANYA_HEIGHT	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
0.908605024051%	17	1871	115	T2D_GENES_TANYA_HEIGHT	MARZEC_IL2_SIGNALING_UP
0.908605024051%	17	1871	108	T2D_GENES_TANYA_HEIGHT	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
0.907715582451%	6	661	98	T2D_GENES_TANYA_GLYCEMIC	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
0.907715582451%	6	661	95	T2D_GENES_TANYA_GLYCEMIC	HOEBEKE_LYMPHOID_STEM_CELL_UP
0.907715582451%	6	661	93	T2D_GENES_TANYA_GLYCEMIC	REACTOME_REGULATION_OF_INSULIN_SECRETION
0.907715582451%	6	661	92	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SYNTHESIS_OF_DNA
0.907715582451%	6	661	88	T2D_GENES_TANYA_GLYCEMIC	KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.907715582451%	6	661	87	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MITOTIC_PROMETAPHASE
0.907715582451%	6	661	85	T2D_GENES_TANYA_GLYCEMIC	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
0.907715582451%	6	661	81	T2D_GENES_TANYA_GLYCEMIC	LEIN_MEDULLA_MARKERS
0.907715582451%	6	661	80	T2D_GENES_TANYA_GLYCEMIC	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
0.907715582451%	6	661	80	T2D_GENES_TANYA_GLYCEMIC	BASSO_HAIRY_CELL_LEUKEMIA_DN
0.907715582451%	6	661	79	T2D_GENES_TANYA_GLYCEMIC	MEISSNER_NPC_HCP_WITH_H3K27ME3
0.907715582451%	6	661	79	T2D_GENES_TANYA_GLYCEMIC	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
0.907715582451%	6	661	74	T2D_GENES_TANYA_GLYCEMIC	PID_E2F_PATHWAY
0.907715582451%	6	661	69	T2D_GENES_TANYA_GLYCEMIC	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
0.907715582451%	6	661	66	T2D_GENES_TANYA_GLYCEMIC	RIGGINS_TAMOXIFEN_RESISTANCE_UP
0.907715582451%	6	661	66	T2D_GENES_TANYA_GLYCEMIC	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
0.907715582451%	6	661	66	T2D_GENES_TANYA_GLYCEMIC	BRUNO_HEMATOPOIESIS
0.907715582451%	6	661	65	T2D_GENES_TANYA_GLYCEMIC	PID_RB_1PATHWAY
0.907715582451%	6	661	65	T2D_GENES_TANYA_GLYCEMIC	KEGG_GLIOMA
0.907715582451%	6	661	61	T2D_GENES_TANYA_GLYCEMIC	REN_BOUND_BY_E2F
0.907715582451%	6	661	60	T2D_GENES_TANYA_GLYCEMIC	KEGG_ACUTE_MYELOID_LEUKEMIA
0.907715582451%	6	661	57	T2D_GENES_TANYA_GLYCEMIC	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP
0.907715582451%	6	661	54	T2D_GENES_TANYA_GLYCEMIC	SESTO_RESPONSE_TO_UV_C2
0.907715582451%	6	661	54	T2D_GENES_TANYA_GLYCEMIC	REACTOME_APOPTOTIC_EXECUTION_PHASE
0.907715582451%	6	661	49	T2D_GENES_TANYA_GLYCEMIC	OLSSON_E2F3_TARGETS_DN
0.907715582451%	6	661	45	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_BIOPEPTIDES_PATHWAY
0.907715582451%	6	661	419	T2D_GENES_TANYA_GLYCEMIC	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.907715582451%	6	661	352	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
0.907715582451%	6	661	315	T2D_GENES_TANYA_GLYCEMIC	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.907715582451%	6	661	315	T2D_GENES_TANYA_GLYCEMIC	PASINI_SUZ12_TARGETS_DN
0.907715582451%	6	661	307	T2D_GENES_TANYA_GLYCEMIC	LI_INDUCED_T_TO_NATURAL_KILLER_UP
0.907715582451%	6	661	30	T2D_GENES_TANYA_GLYCEMIC	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
0.907715582451%	6	661	293	T2D_GENES_TANYA_GLYCEMIC	ZWANG_DOWN_BY_2ND_EGF_PULSE
0.907715582451%	6	661	270	T2D_GENES_TANYA_GLYCEMIC	RIZKI_TUMOR_INVASIVENESS_3D_DN
0.907715582451%	6	661	267	T2D_GENES_TANYA_GLYCEMIC	KEGG_MAPK_SIGNALING_PATHWAY
0.907715582451%	6	661	260	T2D_GENES_TANYA_GLYCEMIC	BOQUEST_STEM_CELL_UP
0.907715582451%	6	661	259	T2D_GENES_TANYA_GLYCEMIC	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
0.907715582451%	6	661	258	T2D_GENES_TANYA_GLYCEMIC	JAEGER_METASTASIS_DN
0.907715582451%	6	661	25	T2D_GENES_TANYA_GLYCEMIC	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG
0.907715582451%	6	661	245	T2D_GENES_TANYA_GLYCEMIC	BLUM_RESPONSE_TO_SALIRASIB_UP
0.907715582451%	6	661	244	T2D_GENES_TANYA_GLYCEMIC	HSIAO_LIVER_SPECIFIC_GENES
0.907715582451%	6	661	240	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_20HR_UP
0.907715582451%	6	661	238	T2D_GENES_TANYA_GLYCEMIC	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.907715582451%	6	661	236	T2D_GENES_TANYA_GLYCEMIC	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
0.907715582451%	6	661	235	T2D_GENES_TANYA_GLYCEMIC	RUTELLA_RESPONSE_TO_HGF_DN
0.907715582451%	6	661	232	T2D_GENES_TANYA_GLYCEMIC	DELYS_THYROID_CANCER_DN
0.907715582451%	6	661	23	T2D_GENES_TANYA_GLYCEMIC	FERRANDO_HOX11_NEIGHBORS
0.907715582451%	6	661	229	T2D_GENES_TANYA_GLYCEMIC	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
0.907715582451%	6	661	223	T2D_GENES_TANYA_GLYCEMIC	CHEN_HOXA5_TARGETS_9HR_UP
0.907715582451%	6	661	222	T2D_GENES_TANYA_GLYCEMIC	CAIRO_LIVER_DEVELOPMENT_DN
0.907715582451%	6	661	221	T2D_GENES_TANYA_GLYCEMIC	CHANDRAN_METASTASIS_UP
0.907715582451%	6	661	217	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALLING_BY_NGF
0.907715582451%	6	661	214	T2D_GENES_TANYA_GLYCEMIC	KIM_WT1_TARGETS_UP
0.907715582451%	6	661	210	T2D_GENES_TANYA_GLYCEMIC	VERHAAK_GLIOBLASTOMA_NEURAL
0.907715582451%	6	661	210	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.907715582451%	6	661	209	T2D_GENES_TANYA_GLYCEMIC	KIM_WT1_TARGETS_12HR_DN
0.907715582451%	6	661	209	T2D_GENES_TANYA_GLYCEMIC	CHANG_CORE_SERUM_RESPONSE_DN
0.907715582451%	6	661	208	T2D_GENES_TANYA_GLYCEMIC	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
0.907715582451%	6	661	206	T2D_GENES_TANYA_GLYCEMIC	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.907715582451%	6	661	204	T2D_GENES_TANYA_GLYCEMIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
0.907715582451%	6	661	203	T2D_GENES_TANYA_GLYCEMIC	PENG_RAPAMYCIN_RESPONSE_UP
0.907715582451%	6	661	203	T2D_GENES_TANYA_GLYCEMIC	PAL_PRMT5_TARGETS_UP
0.907715582451%	6	661	199	T2D_GENES_TANYA_GLYCEMIC	PLASARI_TGFB1_TARGETS_10HR_UP
0.907715582451%	6	661	198	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PHOSPHOLIPID_METABOLISM
0.907715582451%	6	661	198	T2D_GENES_TANYA_GLYCEMIC	ALONSO_METASTASIS_UP
0.907715582451%	6	661	197	T2D_GENES_TANYA_GLYCEMIC	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
0.907715582451%	6	661	195	T2D_GENES_TANYA_GLYCEMIC	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
0.907715582451%	6	661	193	T2D_GENES_TANYA_GLYCEMIC	MOHANKUMAR_TLX1_TARGETS_DN
0.907715582451%	6	661	188	T2D_GENES_TANYA_GLYCEMIC	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
0.907715582451%	6	661	183	T2D_GENES_TANYA_GLYCEMIC	OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.907715582451%	6	661	182	T2D_GENES_TANYA_GLYCEMIC	FERNANDEZ_BOUND_BY_MYC
0.907715582451%	6	661	181	T2D_GENES_TANYA_GLYCEMIC	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
0.907715582451%	6	661	181	T2D_GENES_TANYA_GLYCEMIC	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
0.907715582451%	6	661	181	T2D_GENES_TANYA_GLYCEMIC	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
0.907715582451%	6	661	180	T2D_GENES_TANYA_GLYCEMIC	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
0.907715582451%	6	661	180	T2D_GENES_TANYA_GLYCEMIC	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
0.907715582451%	6	661	178	T2D_GENES_TANYA_GLYCEMIC	LI_AMPLIFIED_IN_LUNG_CANCER
0.907715582451%	6	661	176	T2D_GENES_TANYA_GLYCEMIC	SASAKI_ADULT_T_CELL_LEUKEMIA
0.907715582451%	6	661	176	T2D_GENES_TANYA_GLYCEMIC	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
0.907715582451%	6	661	175	T2D_GENES_TANYA_GLYCEMIC	YAMAZAKI_TCEB3_TARGETS_UP
0.907715582451%	6	661	175	T2D_GENES_TANYA_GLYCEMIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.907715582451%	6	661	174	T2D_GENES_TANYA_GLYCEMIC	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
0.907715582451%	6	661	170	T2D_GENES_TANYA_GLYCEMIC	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
0.907715582451%	6	661	169	T2D_GENES_TANYA_GLYCEMIC	UEDA_PERIFERAL_CLOCK
0.907715582451%	6	661	169	T2D_GENES_TANYA_GLYCEMIC	ONDER_CDH1_TARGETS_1_DN
0.907715582451%	6	661	169	T2D_GENES_TANYA_GLYCEMIC	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
0.907715582451%	6	661	168	T2D_GENES_TANYA_GLYCEMIC	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
0.907715582451%	6	661	165	T2D_GENES_TANYA_GLYCEMIC	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
0.907715582451%	6	661	164	T2D_GENES_TANYA_GLYCEMIC	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
0.907715582451%	6	661	164	T2D_GENES_TANYA_GLYCEMIC	KIM_WT1_TARGETS_8HR_UP
0.907715582451%	6	661	160	T2D_GENES_TANYA_GLYCEMIC	GAVIN_FOXP3_TARGETS_CLUSTER_P3
0.907715582451%	6	661	159	T2D_GENES_TANYA_GLYCEMIC	REACTOME_INTERFERON_SIGNALING
0.907715582451%	6	661	158	T2D_GENES_TANYA_GLYCEMIC	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.907715582451%	6	661	157	T2D_GENES_TANYA_GLYCEMIC	SERVITJA_LIVER_HNF1A_TARGETS_DN
0.907715582451%	6	661	157	T2D_GENES_TANYA_GLYCEMIC	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
0.907715582451%	6	661	153	T2D_GENES_TANYA_GLYCEMIC	RUIZ_TNC_TARGETS_UP
0.907715582451%	6	661	153	T2D_GENES_TANYA_GLYCEMIC	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN
0.907715582451%	6	661	149	T2D_GENES_TANYA_GLYCEMIC	HUANG_GATA2_TARGETS_UP
0.907715582451%	6	661	149	T2D_GENES_TANYA_GLYCEMIC	GOZGIT_ESR1_TARGETS_UP
0.907715582451%	6	661	148	T2D_GENES_TANYA_GLYCEMIC	CHANG_CYCLING_GENES
0.907715582451%	6	661	148	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_24HR_UP
0.907715582451%	6	661	147	T2D_GENES_TANYA_GLYCEMIC	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.907715582451%	6	661	147	T2D_GENES_TANYA_GLYCEMIC	KAUFFMANN_DNA_REPLICATION_GENES
0.907715582451%	6	661	143	T2D_GENES_TANYA_GLYCEMIC	BASSO_B_LYMPHOCYTE_NETWORK
0.907715582451%	6	661	142	T2D_GENES_TANYA_GLYCEMIC	PENG_LEUCINE_DEPRIVATION_UP
0.907715582451%	6	661	142	T2D_GENES_TANYA_GLYCEMIC	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
0.907715582451%	6	661	141	T2D_GENES_TANYA_GLYCEMIC	WELCSH_BRCA1_TARGETS_DN
0.907715582451%	6	661	140	T2D_GENES_TANYA_GLYCEMIC	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
0.907715582451%	6	661	137	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.907715582451%	6	661	137	T2D_GENES_TANYA_GLYCEMIC	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
0.907715582451%	6	661	133	T2D_GENES_TANYA_GLYCEMIC	GAL_LEUKEMIC_STEM_CELL_UP
0.907715582451%	6	661	129	T2D_GENES_TANYA_GLYCEMIC	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP
0.907715582451%	6	661	129	T2D_GENES_TANYA_GLYCEMIC	KEGG_AXON_GUIDANCE
0.907715582451%	6	661	128	T2D_GENES_TANYA_GLYCEMIC	KEGG_CELL_CYCLE
0.907715582451%	6	661	126	T2D_GENES_TANYA_GLYCEMIC	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
0.907715582451%	6	661	126	T2D_GENES_TANYA_GLYCEMIC	GERY_CEBP_TARGETS
0.907715582451%	6	661	123	T2D_GENES_TANYA_GLYCEMIC	KAYO_AGING_MUSCLE_DN
0.907715582451%	6	661	120	T2D_GENES_TANYA_GLYCEMIC	XU_GH1_EXOGENOUS_TARGETS_DN
0.907715582451%	6	661	120	T2D_GENES_TANYA_GLYCEMIC	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
0.907715582451%	6	661	118	T2D_GENES_TANYA_GLYCEMIC	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
0.907715582451%	6	661	117	T2D_GENES_TANYA_GLYCEMIC	PUJANA_BRCA_CENTERED_NETWORK
0.907715582451%	6	661	116	T2D_GENES_TANYA_GLYCEMIC	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
0.907715582451%	6	661	115	T2D_GENES_TANYA_GLYCEMIC	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
0.907715582451%	6	661	114	T2D_GENES_TANYA_GLYCEMIC	LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.907715582451%	6	661	114	T2D_GENES_TANYA_GLYCEMIC	CERVERA_SDHB_TARGETS_2
0.907715582451%	6	661	112	T2D_GENES_TANYA_GLYCEMIC	REACTOME_DNA_REPAIR
0.907715582451%	6	661	112	T2D_GENES_TANYA_GLYCEMIC	DITTMER_PTHLH_TARGETS_UP
0.907715582451%	6	661	111	T2D_GENES_TANYA_GLYCEMIC	BOUDOUKHA_BOUND_BY_IGF2BP2
0.907715582451%	6	661	110	T2D_GENES_TANYA_GLYCEMIC	SUNG_METASTASIS_STROMA_UP
0.907715582451%	6	661	110	T2D_GENES_TANYA_GLYCEMIC	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
0.907715582451%	6	661	109	T2D_GENES_TANYA_GLYCEMIC	SERVITJA_ISLET_HNF1A_TARGETS_DN
0.907715582451%	6	661	109	T2D_GENES_TANYA_GLYCEMIC	REACTOME_S_PHASE
0.907715582451%	6	661	107	T2D_GENES_TANYA_GLYCEMIC	LEE_EARLY_T_LYMPHOCYTE_UP
0.907715582451%	6	661	104	T2D_GENES_TANYA_GLYCEMIC	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
0.907715582451%	6	661	103	T2D_GENES_TANYA_GLYCEMIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
0.907715582451%	6	661	101	T2D_GENES_TANYA_GLYCEMIC	BURTON_ADIPOGENESIS_3
0.907715582451%	6	661	101	T2D_GENES_TANYA_GLYCEMIC	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.896860986547%	4	446	93	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_REGULATION_OF_INSULIN_SECRETION
0.896860986547%	4	446	93	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
0.896860986547%	4	446	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_DILATED_CARDIOMYOPATHY
0.896860986547%	4	446	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CAMPS_COLON_CANCER_COPY_NUMBER_UP
0.896860986547%	4	446	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DELASERNA_MYOD_TARGETS_UP
0.896860986547%	4	446	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
0.896860986547%	4	446	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_MET_PATHWAY
0.896860986547%	4	446	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
0.896860986547%	4	446	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
0.896860986547%	4	446	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JI_RESPONSE_TO_FSH_UP
0.896860986547%	4	446	734	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BENPORATH_SOX2_TARGETS
0.896860986547%	4	446	721	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WONG_ADULT_TISSUE_STEM_MODULE
0.896860986547%	4	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BRUNO_HEMATOPOIESIS
0.896860986547%	4	446	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
0.896860986547%	4	446	633	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
0.896860986547%	4	446	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_INTERFERON_GAMMA_SIGNALING
0.896860986547%	4	446	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
0.896860986547%	4	446	539	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIAO_METASTASIS
0.896860986547%	4	446	536	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BERENJENO_TRANSFORMED_BY_RHOA_UP
0.896860986547%	4	446	530	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ENK_UV_RESPONSE_KERATINOCYTE_UP
0.896860986547%	4	446	508	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ENK_UV_RESPONSE_EPIDERMIS_DN
0.896860986547%	4	446	489	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIM_MAMMARY_STEM_CELL_UP
0.896860986547%	4	446	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_TYPE_II_DIABETES_MELLITUS
0.896860986547%	4	446	464	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ONDER_CDH1_TARGETS_2_DN
0.896860986547%	4	446	456	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ODONNELL_TFRC_TARGETS_UP
0.896860986547%	4	446	450	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
0.896860986547%	4	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_HNF3BPATHWAY
0.896860986547%	4	446	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
0.896860986547%	4	446	424	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHEN_SMARCA2_TARGETS_UP
0.896860986547%	4	446	420	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MOOTHA_PGC
0.896860986547%	4	446	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHENG_IL22_SIGNALING_DN
0.896860986547%	4	446	418	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RUTELLA_RESPONSE_TO_HGF_UP
0.896860986547%	4	446	408	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
0.896860986547%	4	446	380	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DAIRKEE_TERT_TARGETS_UP
0.896860986547%	4	446	378	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
0.896860986547%	4	446	366	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YOSHIMURA_MAPK8_TARGETS_DN
0.896860986547%	4	446	356	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
0.896860986547%	4	446	355	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PEREZ_TP63_TARGETS
0.896860986547%	4	446	352	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
0.896860986547%	4	446	341	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
0.896860986547%	4	446	338	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
0.896860986547%	4	446	335	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
0.896860986547%	4	446	330	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
0.896860986547%	4	446	330	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
0.896860986547%	4	446	329	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
0.896860986547%	4	446	318	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEI_MYB_TARGETS
0.896860986547%	4	446	315	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
0.896860986547%	4	446	309	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
0.896860986547%	4	446	305	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
0.896860986547%	4	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
0.896860986547%	4	446	299	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MUELLER_PLURINET
0.896860986547%	4	446	293	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_MATURE_CELL
0.896860986547%	4	446	290	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BASAKI_YBX1_TARGETS_UP
0.896860986547%	4	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NAKAYAMA_FGF2_TARGETS
0.896860986547%	4	446	280	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
0.896860986547%	4	446	279	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_NEURONAL_SYSTEM
0.896860986547%	4	446	277	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
0.896860986547%	4	446	275	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
0.896860986547%	4	446	274	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
0.896860986547%	4	446	271	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.896860986547%	4	446	271	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.896860986547%	4	446	269	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_CLIM2_TARGETS_UP
0.896860986547%	4	446	269	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
0.896860986547%	4	446	265	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
0.896860986547%	4	446	258	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
0.896860986547%	4	446	255	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.896860986547%	4	446	251	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KOBAYASHI_EGFR_SIGNALING_24HR_DN
0.896860986547%	4	446	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG
0.896860986547%	4	446	249	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MITSIADES_RESPONSE_TO_APLIDIN_DN
0.896860986547%	4	446	246	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BILD_E2F3_ONCOGENIC_SIGNATURE
0.896860986547%	4	446	245	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PENG_RAPAMYCIN_RESPONSE_DN
0.896860986547%	4	446	244	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PLASARI_TGFB1_TARGETS_10HR_DN
0.896860986547%	4	446	244	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GAL_LEUKEMIC_STEM_CELL_DN
0.896860986547%	4	446	241	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DOANE_RESPONSE_TO_ANDROGEN_DN
0.896860986547%	4	446	240	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	UDAYAKUMAR_MED1_TARGETS_DN
0.896860986547%	4	446	239	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.896860986547%	4	446	238	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
0.896860986547%	4	446	232	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
0.896860986547%	4	446	230	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BENPORATH_MYC_TARGETS_WITH_EBOX
0.896860986547%	4	446	222	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_1HR_DN
0.896860986547%	4	446	217	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALLING_BY_NGF
0.896860986547%	4	446	215	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAMAZAKI_TCEB3_TARGETS_DN
0.896860986547%	4	446	215	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARKEY_RB1_ACUTE_LOF_UP
0.896860986547%	4	446	214	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZWANG_EGF_INTERVAL_DN
0.896860986547%	4	446	214	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AFFAR_YY1_TARGETS_UP
0.896860986547%	4	446	213	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WIERENGA_STAT5A_TARGETS_DN
0.896860986547%	4	446	212	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SANSOM_APC_TARGETS
0.896860986547%	4	446	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SANSOM_APC_TARGETS_REQUIRE_MYC
0.896860986547%	4	446	207	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_HIV_INFECTION
0.896860986547%	4	446	207	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CAIRO_HEPATOBLASTOMA_UP
0.896860986547%	4	446	206	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
0.896860986547%	4	446	206	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.896860986547%	4	446	204	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
0.896860986547%	4	446	203	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRUETZMANN_PANCREATIC_CANCER_DN
0.896860986547%	4	446	202	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FUJII_YBX1_TARGETS_DN
0.896860986547%	4	446	201	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_MYC_AMPLIFICATION_TARGETS_UP
0.896860986547%	4	446	201	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_FOCAL_ADHESION
0.896860986547%	4	446	200	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
0.896860986547%	4	446	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
0.896860986547%	4	446	199	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PLASARI_TGFB1_TARGETS_10HR_UP
0.896860986547%	4	446	198	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ALONSO_METASTASIS_UP
0.896860986547%	4	446	197	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
0.896860986547%	4	446	196	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
0.896860986547%	4	446	194	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PROVENZANI_METASTASIS_UP
0.896860986547%	4	446	187	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
0.896860986547%	4	446	187	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PENG_LEUCINE_DEPRIVATION_DN
0.896860986547%	4	446	186	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
0.896860986547%	4	446	185	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_HUNTINGTONS_DISEASE
0.896860986547%	4	446	183	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.896860986547%	4	446	182	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.896860986547%	4	446	182	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FERNANDEZ_BOUND_BY_MYC
0.896860986547%	4	446	180	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
0.896860986547%	4	446	178	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_18HR_DN
0.896860986547%	4	446	176	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SASAKI_ADULT_T_CELL_LEUKEMIA
0.896860986547%	4	446	176	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
0.896860986547%	4	446	175	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAMAZAKI_TCEB3_TARGETS_UP
0.896860986547%	4	446	174	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
0.896860986547%	4	446	170	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
0.896860986547%	4	446	169	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	UEDA_PERIFERAL_CLOCK
0.896860986547%	4	446	168	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
0.896860986547%	4	446	167	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VANTVEER_BREAST_CANCER_ESR1_UP
0.896860986547%	4	446	165	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIU_CMYB_TARGETS_UP
0.896860986547%	4	446	162	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WINNEPENNINCKX_MELANOMA_METASTASIS_UP
0.896860986547%	4	446	162	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MULLIGHAN_NPM1_SIGNATURE_3_DN
0.896860986547%	4	446	162	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
0.896860986547%	4	446	157	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.896860986547%	4	446	152	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
0.896860986547%	4	446	151	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
0.896860986547%	4	446	149	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GOZGIT_ESR1_TARGETS_UP
0.896860986547%	4	446	140	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ONDER_CDH1_TARGETS_1_UP
0.896860986547%	4	446	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
0.896860986547%	4	446	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
0.896860986547%	4	446	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_INSULIN_SIGNALING_PATHWAY
0.896860986547%	4	446	132	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
0.896860986547%	4	446	131	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
0.896860986547%	4	446	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHU_CMV_ALL_DN
0.896860986547%	4	446	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
0.896860986547%	4	446	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BURTON_ADIPOGENESIS_5
0.896860986547%	4	446	123	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KAYO_AGING_MUSCLE_DN
0.896860986547%	4	446	122	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALING_BY_PDGF
0.896860986547%	4	446	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
0.896860986547%	4	446	120	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
0.896860986547%	4	446	120	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN
0.896860986547%	4	446	118	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
0.896860986547%	4	446	117	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PUJANA_BRCA_CENTERED_NETWORK
0.896860986547%	4	446	115	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
0.896860986547%	4	446	110	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SUNG_METASTASIS_STROMA_UP
0.896860986547%	4	446	103	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
0.896860986547%	4	446	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KOBAYASHI_EGFR_SIGNALING_24HR_UP
0.880681818182%	31	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MEIOTIC_RECOMBINATION
0.880681818182%	31	3520	379	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BENPORATH_ES_1
0.880681818182%	31	3520	337	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PHONG_TNF_RESPONSE_NOT_VIA_P38
0.880681818182%	31	3520	312	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GENTILE_UV_HIGH_DOSE_DN
0.880681818182%	31	3520	311	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JIANG_HYPOXIA_NORMAL
0.880681818182%	31	3520	298	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_14HR_DN
0.880681818182%	31	3520	292	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HELLER_HDAC_TARGETS_DN
0.880681818182%	31	3520	279	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FORTSCHEGGER_PHF8_TARGETS_UP
0.880681818182%	31	3520	253	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCLACHLAN_DENTAL_CARIES_UP
0.880681818182%	31	3520	244	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAYO_AGING_MUSCLE_UP
0.880681818182%	31	3520	244	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAL_LEUKEMIC_STEM_CELL_DN
0.880681818182%	31	3520	242	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHYLA_CBFA2T3_TARGETS_DN
0.880681818182%	31	3520	215	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARKEY_RB1_ACUTE_LOF_UP
0.880681818182%	31	3520	207	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_HIV_INFECTION
0.880681818182%	31	3520	203	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PAL_PRMT5_TARGETS_UP
0.879120879121%	4	455	98	T2D_GENES_TANYA_BLOODPRESSURE	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
0.879120879121%	4	455	98	T2D_GENES_TANYA_BLOODPRESSURE	HAHTOLA_SEZARY_SYNDROM_UP
0.879120879121%	4	455	98	T2D_GENES_TANYA_BLOODPRESSURE	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
0.879120879121%	4	455	97	T2D_GENES_TANYA_BLOODPRESSURE	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP
0.879120879121%	4	455	97	T2D_GENES_TANYA_BLOODPRESSURE	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP
0.879120879121%	4	455	94	T2D_GENES_TANYA_BLOODPRESSURE	LU_IL4_SIGNALING
0.879120879121%	4	455	93	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ACTIVATED_TLR4_SIGNALLING
0.879120879121%	4	455	92	T2D_GENES_TANYA_BLOODPRESSURE	CAMPS_COLON_CANCER_COPY_NUMBER_UP
0.879120879121%	4	455	90	T2D_GENES_TANYA_BLOODPRESSURE	BILANGES_SERUM_SENSITIVE_GENES
0.879120879121%	4	455	89	T2D_GENES_TANYA_BLOODPRESSURE	VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP
0.879120879121%	4	455	87	T2D_GENES_TANYA_BLOODPRESSURE	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
0.879120879121%	4	455	87	T2D_GENES_TANYA_BLOODPRESSURE	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.879120879121%	4	455	87	T2D_GENES_TANYA_BLOODPRESSURE	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.879120879121%	4	455	86	T2D_GENES_TANYA_BLOODPRESSURE	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
0.879120879121%	4	455	86	T2D_GENES_TANYA_BLOODPRESSURE	LAIHO_COLORECTAL_CANCER_SERRATED_DN
0.879120879121%	4	455	85	T2D_GENES_TANYA_BLOODPRESSURE	STEIN_ESR1_TARGETS
0.879120879121%	4	455	84	T2D_GENES_TANYA_BLOODPRESSURE	HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.879120879121%	4	455	83	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
0.879120879121%	4	455	83	T2D_GENES_TANYA_BLOODPRESSURE	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.879120879121%	4	455	81	T2D_GENES_TANYA_BLOODPRESSURE	GUO_HEX_TARGETS_UP
0.879120879121%	4	455	79	T2D_GENES_TANYA_BLOODPRESSURE	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
0.879120879121%	4	455	79	T2D_GENES_TANYA_BLOODPRESSURE	MEISSNER_NPC_HCP_WITH_H3K27ME3
0.879120879121%	4	455	78	T2D_GENES_TANYA_BLOODPRESSURE	LINDVALL_IMMORTALIZED_BY_TERT_UP
0.879120879121%	4	455	78	T2D_GENES_TANYA_BLOODPRESSURE	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE
0.879120879121%	4	455	77	T2D_GENES_TANYA_BLOODPRESSURE	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
0.879120879121%	4	455	77	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
0.879120879121%	4	455	76	T2D_GENES_TANYA_BLOODPRESSURE	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.879120879121%	4	455	76	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
0.879120879121%	4	455	75	T2D_GENES_TANYA_BLOODPRESSURE	PID_AVB3_INTEGRIN_PATHWAY
0.879120879121%	4	455	74	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
0.879120879121%	4	455	74	T2D_GENES_TANYA_BLOODPRESSURE	OUILLETTE_CLL_13Q14_DELETION_UP
0.879120879121%	4	455	74	T2D_GENES_TANYA_BLOODPRESSURE	LIAN_LIPA_TARGETS_6M
0.879120879121%	4	455	73	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_CHRONIC_MYELOID_LEUKEMIA
0.879120879121%	4	455	72	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
0.879120879121%	4	455	72	T2D_GENES_TANYA_BLOODPRESSURE	DANG_REGULATED_BY_MYC_UP
0.879120879121%	4	455	70	T2D_GENES_TANYA_BLOODPRESSURE	RAGHAVACHARI_PLATELET_SPECIFIC_GENES
0.879120879121%	4	455	70	T2D_GENES_TANYA_BLOODPRESSURE	CADWELL_ATG16L1_TARGETS_DN
0.879120879121%	4	455	69	T2D_GENES_TANYA_BLOODPRESSURE	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.879120879121%	4	455	69	T2D_GENES_TANYA_BLOODPRESSURE	AMIT_EGF_RESPONSE_120_HELA
0.879120879121%	4	455	68	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SEMAPHORIN_INTERACTIONS
0.879120879121%	4	455	68	T2D_GENES_TANYA_BLOODPRESSURE	DELPUECH_FOXO3_TARGETS_UP
0.879120879121%	4	455	68	T2D_GENES_TANYA_BLOODPRESSURE	BASSO_CD40_SIGNALING_DN
0.879120879121%	4	455	66	T2D_GENES_TANYA_BLOODPRESSURE	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM
0.879120879121%	4	455	66	T2D_GENES_TANYA_BLOODPRESSURE	RIGGINS_TAMOXIFEN_RESISTANCE_UP
0.879120879121%	4	455	66	T2D_GENES_TANYA_BLOODPRESSURE	BEIER_GLIOMA_STEM_CELL_DN
0.879120879121%	4	455	65	T2D_GENES_TANYA_BLOODPRESSURE	ST_FAS_SIGNALING_PATHWAY
0.879120879121%	4	455	60	T2D_GENES_TANYA_BLOODPRESSURE	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
0.879120879121%	4	455	60	T2D_GENES_TANYA_BLOODPRESSURE	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.879120879121%	4	455	59	T2D_GENES_TANYA_BLOODPRESSURE	PID_NOTCH_PATHWAY
0.879120879121%	4	455	59	T2D_GENES_TANYA_BLOODPRESSURE	MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3
0.879120879121%	4	455	59	T2D_GENES_TANYA_BLOODPRESSURE	LIAN_LIPA_TARGETS_3M
0.879120879121%	4	455	59	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_RNA_DEGRADATION
0.879120879121%	4	455	58	T2D_GENES_TANYA_BLOODPRESSURE	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
0.879120879121%	4	455	58	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_NPC_LCP_WITH_H3K4ME3
0.879120879121%	4	455	58	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_PPARA_PATHWAY
0.879120879121%	4	455	56	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_HEDGEHOG_SIGNALING_PATHWAY
0.879120879121%	4	455	55	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_STEROID_HORMONE_BIOSYNTHESIS
0.879120879121%	4	455	55	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_BASAL_CELL_CARCINOMA
0.879120879121%	4	455	55	T2D_GENES_TANYA_BLOODPRESSURE	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR
0.879120879121%	4	455	55	T2D_GENES_TANYA_BLOODPRESSURE	DEMAGALHAES_AGING_UP
0.879120879121%	4	455	54	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_INOSITOL_PHOSPHATE_METABOLISM
0.879120879121%	4	455	53	T2D_GENES_TANYA_BLOODPRESSURE	MENSSEN_MYC_TARGETS
0.879120879121%	4	455	52	T2D_GENES_TANYA_BLOODPRESSURE	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP
0.879120879121%	4	455	50	T2D_GENES_TANYA_BLOODPRESSURE	HOFMANN_CELL_LYMPHOMA_UP
0.879120879121%	4	455	50	T2D_GENES_TANYA_BLOODPRESSURE	DAUER_STAT3_TARGETS_DN
0.879120879121%	4	455	49	T2D_GENES_TANYA_BLOODPRESSURE	DAUER_STAT3_TARGETS_UP
0.879120879121%	4	455	48	T2D_GENES_TANYA_BLOODPRESSURE	NADLER_OBESITY_DN
0.879120879121%	4	455	48	T2D_GENES_TANYA_BLOODPRESSURE	MCCLUNG_DELTA_FOSB_TARGETS_2WK
0.879120879121%	4	455	45	T2D_GENES_TANYA_BLOODPRESSURE	ST_T_CELL_SIGNAL_TRANSDUCTION
0.879120879121%	4	455	45	T2D_GENES_TANYA_BLOODPRESSURE	GRADE_METASTASIS_DN
0.879120879121%	4	455	423	T2D_GENES_TANYA_BLOODPRESSURE	PUJANA_BRCA2_PCC_NETWORK
0.879120879121%	4	455	42	T2D_GENES_TANYA_BLOODPRESSURE	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER
0.879120879121%	4	455	418	T2D_GENES_TANYA_BLOODPRESSURE	RUTELLA_RESPONSE_TO_HGF_UP
0.879120879121%	4	455	41	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_DN
0.879120879121%	4	455	41	T2D_GENES_TANYA_BLOODPRESSURE	PID_AMB2_NEUTROPHILS_PATHWAY
0.879120879121%	4	455	408	T2D_GENES_TANYA_BLOODPRESSURE	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
0.879120879121%	4	455	40	T2D_GENES_TANYA_BLOODPRESSURE	VANASSE_BCL2_TARGETS_UP
0.879120879121%	4	455	40	T2D_GENES_TANYA_BLOODPRESSURE	ST_B_CELL_ANTIGEN_RECEPTOR
0.879120879121%	4	455	40	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_TRYPTOPHAN_METABOLISM
0.879120879121%	4	455	40	T2D_GENES_TANYA_BLOODPRESSURE	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
0.879120879121%	4	455	37	T2D_GENES_TANYA_BLOODPRESSURE	ST_GA13_PATHWAY
0.879120879121%	4	455	35	T2D_GENES_TANYA_BLOODPRESSURE	BALDWIN_PRKCI_TARGETS_UP
0.879120879121%	4	455	346	T2D_GENES_TANYA_BLOODPRESSURE	GOLDRATH_ANTIGEN_RESPONSE
0.879120879121%	4	455	342	T2D_GENES_TANYA_BLOODPRESSURE	BLUM_RESPONSE_TO_SALIRASIB_DN
0.879120879121%	4	455	34	T2D_GENES_TANYA_BLOODPRESSURE	SIG_CD40PATHWAYMAP
0.879120879121%	4	455	34	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_BUTANOATE_METABOLISM
0.879120879121%	4	455	338	T2D_GENES_TANYA_BLOODPRESSURE	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
0.879120879121%	4	455	33	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_DEATH_PATHWAY
0.879120879121%	4	455	320	T2D_GENES_TANYA_BLOODPRESSURE	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
0.879120879121%	4	455	32	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_COMPLEMENT_CASCADE
0.879120879121%	4	455	31	T2D_GENES_TANYA_BLOODPRESSURE	CUI_TCF21_TARGETS_DN
0.879120879121%	4	455	305	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
0.879120879121%	4	455	30	T2D_GENES_TANYA_BLOODPRESSURE	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP
0.879120879121%	4	455	296	T2D_GENES_TANYA_BLOODPRESSURE	DURAND_STROMA_MAX_UP
0.879120879121%	4	455	295	T2D_GENES_TANYA_BLOODPRESSURE	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
0.879120879121%	4	455	290	T2D_GENES_TANYA_BLOODPRESSURE	BENPORATH_OCT4_TARGETS
0.879120879121%	4	455	29	T2D_GENES_TANYA_BLOODPRESSURE	ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.879120879121%	4	455	283	T2D_GENES_TANYA_BLOODPRESSURE	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
0.879120879121%	4	455	279	T2D_GENES_TANYA_BLOODPRESSURE	FORTSCHEGGER_PHF8_TARGETS_UP
0.879120879121%	4	455	27	T2D_GENES_TANYA_BLOODPRESSURE	ST_MYOCYTE_AD_PATHWAY
0.879120879121%	4	455	260	T2D_GENES_TANYA_BLOODPRESSURE	BOQUEST_STEM_CELL_UP
0.879120879121%	4	455	26	T2D_GENES_TANYA_BLOODPRESSURE	DEN_INTERACT_WITH_LCA5
0.879120879121%	4	455	25	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_STRESS_PATHWAY
0.879120879121%	4	455	249	T2D_GENES_TANYA_BLOODPRESSURE	MITSIADES_RESPONSE_TO_APLIDIN_DN
0.879120879121%	4	455	245	T2D_GENES_TANYA_BLOODPRESSURE	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.879120879121%	4	455	244	T2D_GENES_TANYA_BLOODPRESSURE	GAL_LEUKEMIC_STEM_CELL_DN
0.879120879121%	4	455	242	T2D_GENES_TANYA_BLOODPRESSURE	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
0.879120879121%	4	455	242	T2D_GENES_TANYA_BLOODPRESSURE	CHYLA_CBFA2T3_TARGETS_DN
0.879120879121%	4	455	237	T2D_GENES_TANYA_BLOODPRESSURE	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.879120879121%	4	455	232	T2D_GENES_TANYA_BLOODPRESSURE	DELYS_THYROID_CANCER_DN
0.879120879121%	4	455	227	T2D_GENES_TANYA_BLOODPRESSURE	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
0.879120879121%	4	455	225	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_16HR_UP
0.879120879121%	4	455	221	T2D_GENES_TANYA_BLOODPRESSURE	CHANDRAN_METASTASIS_UP
0.879120879121%	4	455	220	T2D_GENES_TANYA_BLOODPRESSURE	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
0.879120879121%	4	455	22	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_GCR_PATHWAY
0.879120879121%	4	455	212	T2D_GENES_TANYA_BLOODPRESSURE	SANSOM_APC_TARGETS
0.879120879121%	4	455	212	T2D_GENES_TANYA_BLOODPRESSURE	CHANG_CORE_SERUM_RESPONSE_UP
0.879120879121%	4	455	208	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
0.879120879121%	4	455	208	T2D_GENES_TANYA_BLOODPRESSURE	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
0.879120879121%	4	455	205	T2D_GENES_TANYA_BLOODPRESSURE	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
0.879120879121%	4	455	205	T2D_GENES_TANYA_BLOODPRESSURE	SHEPARD_BMYB_MORPHOLINO_UP
0.879120879121%	4	455	205	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
0.879120879121%	4	455	204	T2D_GENES_TANYA_BLOODPRESSURE	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
0.879120879121%	4	455	203	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INFLUENZA_LIFE_CYCLE
0.879120879121%	4	455	202	T2D_GENES_TANYA_BLOODPRESSURE	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
0.879120879121%	4	455	201	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_FOCAL_ADHESION
0.879120879121%	4	455	20	T2D_GENES_TANYA_BLOODPRESSURE	HASLINGER_B_CLL_WITH_6Q21_DELETION
0.879120879121%	4	455	198	T2D_GENES_TANYA_BLOODPRESSURE	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.879120879121%	4	455	197	T2D_GENES_TANYA_BLOODPRESSURE	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
0.879120879121%	4	455	196	T2D_GENES_TANYA_BLOODPRESSURE	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
0.879120879121%	4	455	196	T2D_GENES_TANYA_BLOODPRESSURE	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
0.879120879121%	4	455	195	T2D_GENES_TANYA_BLOODPRESSURE	KYNG_DNA_DAMAGE_DN
0.879120879121%	4	455	190	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.879120879121%	4	455	186	T2D_GENES_TANYA_BLOODPRESSURE	WANG_CLIM2_TARGETS_DN
0.879120879121%	4	455	186	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
0.879120879121%	4	455	186	T2D_GENES_TANYA_BLOODPRESSURE	HAMAI_APOPTOSIS_VIA_TRAIL_DN
0.879120879121%	4	455	185	T2D_GENES_TANYA_BLOODPRESSURE	LEE_LIVER_CANCER_SURVIVAL_UP
0.879120879121%	4	455	185	T2D_GENES_TANYA_BLOODPRESSURE	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
0.879120879121%	4	455	184	T2D_GENES_TANYA_BLOODPRESSURE	WU_CELL_MIGRATION
0.879120879121%	4	455	184	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
0.879120879121%	4	455	180	T2D_GENES_TANYA_BLOODPRESSURE	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
0.879120879121%	4	455	180	T2D_GENES_TANYA_BLOODPRESSURE	DARWICHE_PAPILLOMA_RISK_HIGH_DN
0.879120879121%	4	455	179	T2D_GENES_TANYA_BLOODPRESSURE	BENPORATH_NOS_TARGETS
0.879120879121%	4	455	175	T2D_GENES_TANYA_BLOODPRESSURE	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.879120879121%	4	455	172	T2D_GENES_TANYA_BLOODPRESSURE	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
0.879120879121%	4	455	170	T2D_GENES_TANYA_BLOODPRESSURE	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
0.879120879121%	4	455	169	T2D_GENES_TANYA_BLOODPRESSURE	UEDA_PERIFERAL_CLOCK
0.879120879121%	4	455	167	T2D_GENES_TANYA_BLOODPRESSURE	TIEN_INTESTINE_PROBIOTICS_6HR_DN
0.879120879121%	4	455	167	T2D_GENES_TANYA_BLOODPRESSURE	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
0.879120879121%	4	455	166	T2D_GENES_TANYA_BLOODPRESSURE	CAIRO_LIVER_DEVELOPMENT_UP
0.879120879121%	4	455	165	T2D_GENES_TANYA_BLOODPRESSURE	DARWICHE_PAPILLOMA_RISK_LOW_DN
0.879120879121%	4	455	164	T2D_GENES_TANYA_BLOODPRESSURE	KIM_WT1_TARGETS_8HR_UP
0.879120879121%	4	455	162	T2D_GENES_TANYA_BLOODPRESSURE	WINNEPENNINCKX_MELANOMA_METASTASIS_UP
0.879120879121%	4	455	162	T2D_GENES_TANYA_BLOODPRESSURE	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
0.879120879121%	4	455	16	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT
0.879120879121%	4	455	157	T2D_GENES_TANYA_BLOODPRESSURE	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.879120879121%	4	455	153	T2D_GENES_TANYA_BLOODPRESSURE	DAZARD_UV_RESPONSE_CLUSTER_G6
0.879120879121%	4	455	152	T2D_GENES_TANYA_BLOODPRESSURE	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
0.879120879121%	4	455	151	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_WNT_SIGNALING_PATHWAY
0.879120879121%	4	455	149	T2D_GENES_TANYA_BLOODPRESSURE	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
0.879120879121%	4	455	149	T2D_GENES_TANYA_BLOODPRESSURE	GOZGIT_ESR1_TARGETS_UP
0.879120879121%	4	455	147	T2D_GENES_TANYA_BLOODPRESSURE	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.879120879121%	4	455	146	T2D_GENES_TANYA_BLOODPRESSURE	PECE_MAMMARY_STEM_CELL_DN
0.879120879121%	4	455	146	T2D_GENES_TANYA_BLOODPRESSURE	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
0.879120879121%	4	455	146	T2D_GENES_TANYA_BLOODPRESSURE	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
0.879120879121%	4	455	145	T2D_GENES_TANYA_BLOODPRESSURE	RODWELL_AGING_KIDNEY_DN
0.879120879121%	4	455	145	T2D_GENES_TANYA_BLOODPRESSURE	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
0.879120879121%	4	455	143	T2D_GENES_TANYA_BLOODPRESSURE	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
0.879120879121%	4	455	142	T2D_GENES_TANYA_BLOODPRESSURE	RUIZ_TNC_TARGETS_DN
0.879120879121%	4	455	142	T2D_GENES_TANYA_BLOODPRESSURE	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
0.879120879121%	4	455	142	T2D_GENES_TANYA_BLOODPRESSURE	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
0.879120879121%	4	455	141	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
0.879120879121%	4	455	140	T2D_GENES_TANYA_BLOODPRESSURE	ONDER_CDH1_TARGETS_1_UP
0.879120879121%	4	455	139	T2D_GENES_TANYA_BLOODPRESSURE	ODONNELL_TFRC_TARGETS_DN
0.879120879121%	4	455	139	T2D_GENES_TANYA_BLOODPRESSURE	HOELZEL_NF1_TARGETS_UP
0.879120879121%	4	455	139	T2D_GENES_TANYA_BLOODPRESSURE	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
0.879120879121%	4	455	138	T2D_GENES_TANYA_BLOODPRESSURE	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
0.879120879121%	4	455	137	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.879120879121%	4	455	135	T2D_GENES_TANYA_BLOODPRESSURE	TSENG_IRS1_TARGETS_DN
0.879120879121%	4	455	135	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_OXIDATIVE_PHOSPHORYLATION
0.879120879121%	4	455	134	T2D_GENES_TANYA_BLOODPRESSURE	SCHLOSSER_SERUM_RESPONSE_UP
0.879120879121%	4	455	131	T2D_GENES_TANYA_BLOODPRESSURE	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
0.879120879121%	4	455	131	T2D_GENES_TANYA_BLOODPRESSURE	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.879120879121%	4	455	128	T2D_GENES_TANYA_BLOODPRESSURE	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.879120879121%	4	455	128	T2D_GENES_TANYA_BLOODPRESSURE	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
0.879120879121%	4	455	127	T2D_GENES_TANYA_BLOODPRESSURE	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.879120879121%	4	455	126	T2D_GENES_TANYA_BLOODPRESSURE	BURTON_ADIPOGENESIS_5
0.879120879121%	4	455	125	T2D_GENES_TANYA_BLOODPRESSURE	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
0.879120879121%	4	455	125	T2D_GENES_TANYA_BLOODPRESSURE	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
0.879120879121%	4	455	124	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CELL_CYCLE_CHECKPOINTS
0.879120879121%	4	455	123	T2D_GENES_TANYA_BLOODPRESSURE	DAZARD_RESPONSE_TO_UV_SCC_UP
0.879120879121%	4	455	121	T2D_GENES_TANYA_BLOODPRESSURE	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.879120879121%	4	455	121	T2D_GENES_TANYA_BLOODPRESSURE	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
0.879120879121%	4	455	121	T2D_GENES_TANYA_BLOODPRESSURE	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
0.879120879121%	4	455	12	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_LECTIN_PATHWAY
0.879120879121%	4	455	118	T2D_GENES_TANYA_BLOODPRESSURE	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
0.879120879121%	4	455	116	T2D_GENES_TANYA_BLOODPRESSURE	WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.879120879121%	4	455	116	T2D_GENES_TANYA_BLOODPRESSURE	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
0.879120879121%	4	455	116	T2D_GENES_TANYA_BLOODPRESSURE	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
0.879120879121%	4	455	115	T2D_GENES_TANYA_BLOODPRESSURE	MARKEY_RB1_CHRONIC_LOF_UP
0.879120879121%	4	455	115	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
0.879120879121%	4	455	115	T2D_GENES_TANYA_BLOODPRESSURE	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
0.879120879121%	4	455	115	T2D_GENES_TANYA_BLOODPRESSURE	HOELZEL_NF1_TARGETS_DN
0.879120879121%	4	455	112	T2D_GENES_TANYA_BLOODPRESSURE	DITTMER_PTHLH_TARGETS_UP
0.879120879121%	4	455	108	T2D_GENES_TANYA_BLOODPRESSURE	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
0.879120879121%	4	455	108	T2D_GENES_TANYA_BLOODPRESSURE	LE_EGR2_TARGETS_UP
0.879120879121%	4	455	108	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.879120879121%	4	455	107	T2D_GENES_TANYA_BLOODPRESSURE	LEE_EARLY_T_LYMPHOCYTE_UP
0.879120879121%	4	455	105	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_8HR_UP
0.879120879121%	4	455	105	T2D_GENES_TANYA_BLOODPRESSURE	AMUNDSON_GENOTOXIC_SIGNATURE
0.879120879121%	4	455	104	T2D_GENES_TANYA_BLOODPRESSURE	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
0.879120879121%	4	455	104	T2D_GENES_TANYA_BLOODPRESSURE	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
0.879120879121%	4	455	103	T2D_GENES_TANYA_BLOODPRESSURE	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
0.879120879121%	4	455	102	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_IPS_WITH_HCP_H3K27ME3
0.879120879121%	4	455	102	T2D_GENES_TANYA_BLOODPRESSURE	LABBE_TGFB1_TARGETS_UP
0.879120879121%	4	455	102	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_MELANOGENESIS
0.879120879121%	4	455	102	T2D_GENES_TANYA_BLOODPRESSURE	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.879120879121%	4	455	101	T2D_GENES_TANYA_BLOODPRESSURE	KOBAYASHI_EGFR_SIGNALING_24HR_UP
0.879120879121%	4	455	101	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_12HR_DN
0.879120879121%	4	455	100	T2D_GENES_TANYA_BLOODPRESSURE	QI_PLASMACYTOMA_DN
0.873965041398%	19	2174	92	T2D_GENES_TANYA_LIPIDS	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
0.873965041398%	19	2174	316	T2D_GENES_TANYA_LIPIDS	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
0.873965041398%	19	2174	291	T2D_GENES_TANYA_LIPIDS	SABATES_COLORECTAL_ADENOMA_DN
0.873965041398%	19	2174	290	T2D_GENES_TANYA_LIPIDS	BENPORATH_OCT4_TARGETS
0.873965041398%	19	2174	260	T2D_GENES_TANYA_LIPIDS	SENESE_HDAC1_TARGETS_DN
0.873965041398%	19	2174	256	T2D_GENES_TANYA_LIPIDS	ONDER_CDH1_TARGETS_2_UP
0.873965041398%	19	2174	229	T2D_GENES_TANYA_LIPIDS	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
0.873965041398%	19	2174	229	T2D_GENES_TANYA_LIPIDS	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
0.873965041398%	19	2174	227	T2D_GENES_TANYA_LIPIDS	LEE_RECENT_THYMIC_EMIGRANT
0.873965041398%	19	2174	220	T2D_GENES_TANYA_LIPIDS	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
0.873965041398%	19	2174	220	T2D_GENES_TANYA_LIPIDS	RIGGINS_TAMOXIFEN_RESISTANCE_DN
0.873965041398%	19	2174	198	T2D_GENES_TANYA_LIPIDS	ALONSO_METASTASIS_UP
0.873965041398%	19	2174	193	T2D_GENES_TANYA_LIPIDS	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
0.873965041398%	19	2174	184	T2D_GENES_TANYA_LIPIDS	WU_CELL_MIGRATION
0.873965041398%	19	2174	178	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_18HR_DN
0.873965041398%	19	2174	176	T2D_GENES_TANYA_LIPIDS	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
0.873965041398%	19	2174	165	T2D_GENES_TANYA_LIPIDS	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.873965041398%	19	2174	165	T2D_GENES_TANYA_LIPIDS	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
0.873965041398%	19	2174	164	T2D_GENES_TANYA_LIPIDS	AMIT_EGF_RESPONSE_480_HELA
0.873965041398%	19	2174	162	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
0.873965041398%	19	2174	147	T2D_GENES_TANYA_LIPIDS	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.873965041398%	19	2174	145	T2D_GENES_TANYA_LIPIDS	ZHANG_BREAST_CANCER_PROGENITORS_DN
0.873965041398%	19	2174	142	T2D_GENES_TANYA_LIPIDS	RUIZ_TNC_TARGETS_DN
0.873965041398%	19	2174	142	T2D_GENES_TANYA_LIPIDS	PENG_LEUCINE_DEPRIVATION_UP
0.873965041398%	19	2174	140	T2D_GENES_TANYA_LIPIDS	QI_HYPOXIA
0.873965041398%	19	2174	129	T2D_GENES_TANYA_LIPIDS	REACTOME_MEMBRANE_TRAFFICKING
0.873965041398%	19	2174	129	T2D_GENES_TANYA_LIPIDS	KEGG_AXON_GUIDANCE
0.873965041398%	19	2174	128	T2D_GENES_TANYA_LIPIDS	LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.873965041398%	19	2174	125	T2D_GENES_TANYA_LIPIDS	REACTOME_HIV_LIFE_CYCLE
0.873965041398%	19	2174	121	T2D_GENES_TANYA_LIPIDS	KEGG_LYSOSOME
0.873965041398%	19	2174	118	T2D_GENES_TANYA_LIPIDS	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
0.873965041398%	19	2174	116	T2D_GENES_TANYA_LIPIDS	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
0.873965041398%	19	2174	114	T2D_GENES_TANYA_LIPIDS	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN
0.873965041398%	19	2174	107	T2D_GENES_TANYA_LIPIDS	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.86682427108%	11	1269	481	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIU_PROSTATE_CANCER_DN
0.86682427108%	11	1269	455	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.86682427108%	11	1269	418	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_HGF_UP
0.86682427108%	11	1269	412	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
0.86682427108%	11	1269	408	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GPCR_LIGAND_BINDING
0.86682427108%	11	1269	404	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OSMAN_BLADDER_CANCER_UP
0.86682427108%	11	1269	382	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.86682427108%	11	1269	371	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_SMARCE1_TARGETS_DN
0.86682427108%	11	1269	368	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAGI_AML_WITH_T_8_21_TRANSLOCATION
0.86682427108%	11	1269	358	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRUETZMANN_PANCREATIC_CANCER_UP
0.86682427108%	11	1269	357	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHEN_SMARCA2_TARGETS_DN
0.86682427108%	11	1269	349	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
0.86682427108%	11	1269	346	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GOLDRATH_ANTIGEN_RESPONSE
0.86682427108%	11	1269	338	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
0.86682427108%	11	1269	329	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
0.86682427108%	11	1269	326	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
0.86682427108%	11	1269	320	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
0.86682427108%	11	1269	318	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAZARD_RESPONSE_TO_UV_NHEK_DN
0.86682427108%	11	1269	317	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_EARLY_LATE
0.86682427108%	11	1269	316	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
0.86682427108%	11	1269	309	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
0.86682427108%	11	1269	309	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIU_SOX4_TARGETS_DN
0.86682427108%	11	1269	306	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHANDRAN_METASTASIS_DN
0.86682427108%	11	1269	298	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
0.86682427108%	11	1269	282	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HELLER_SILENCED_BY_METHYLATION_UP
0.86682427108%	11	1269	281	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MULLIGHAN_MLL_SIGNATURE_2_DN
0.86682427108%	11	1269	279	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FORTSCHEGGER_PHF8_TARGETS_UP
0.86682427108%	11	1269	275	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES
0.86682427108%	11	1269	268	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	XU_GH1_AUTOCRINE_TARGETS_UP
0.86682427108%	11	1269	267	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOLLMANN_APOPTOSIS_VIA_CD40_DN
0.86682427108%	11	1269	266	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROZANOV_MMP14_TARGETS_UP
0.86682427108%	11	1269	266	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
0.86682427108%	11	1269	258	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
0.86682427108%	11	1269	253	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DANG_REGULATED_BY_MYC_DN
0.86682427108%	11	1269	251	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_AXON_GUIDANCE
0.86682427108%	11	1269	249	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
0.86682427108%	11	1269	243	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHICAS_RB1_TARGETS_GROWING
0.86682427108%	11	1269	232	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
0.86682427108%	11	1269	227	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_RECENT_THYMIC_EMIGRANT
0.86682427108%	11	1269	217	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SANSOM_APC_MYC_TARGETS
0.86682427108%	11	1269	213	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WIERENGA_STAT5A_TARGETS_DN
0.86682427108%	11	1269	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SANSOM_APC_TARGETS_REQUIRE_MYC
0.86682427108%	11	1269	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CAIRO_HEPATOBLASTOMA_CLASSES_DN
0.86682427108%	11	1269	207	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.86682427108%	11	1269	206	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.86682427108%	11	1269	205	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
0.86682427108%	11	1269	186	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HAMAI_APOPTOSIS_VIA_TRAIL_DN
0.86682427108%	11	1269	185	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_LIVER_CANCER_SURVIVAL_UP
0.86682427108%	11	1269	181	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JISON_SICKLE_CELL_DISEASE_DN
0.86682427108%	11	1269	172	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_MITOTIC_M_M_G1_PHASES
0.86682427108%	11	1269	169	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
0.86682427108%	11	1269	168	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PUJANA_XPRSS_INT_NETWORK
0.86682427108%	11	1269	115	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
0.861195542047%	17	1974	94	Mendelian_Nancy_Cox	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5
0.861195542047%	17	1974	92	Mendelian_Nancy_Cox	KIM_MYCN_AMPLIFICATION_TARGETS_UP
0.861195542047%	17	1974	90	Mendelian_Nancy_Cox	IGARASHI_ATF4_TARGETS_DN
0.861195542047%	17	1974	89	Mendelian_Nancy_Cox	KANG_IMMORTALIZED_BY_TERT_UP
0.861195542047%	17	1974	88	Mendelian_Nancy_Cox	REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS
0.861195542047%	17	1974	87	Mendelian_Nancy_Cox	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
0.861195542047%	17	1974	86	Mendelian_Nancy_Cox	NGUYEN_NOTCH1_TARGETS_DN
0.861195542047%	17	1974	85	Mendelian_Nancy_Cox	XU_GH1_EXOGENOUS_TARGETS_UP
0.861195542047%	17	1974	83	Mendelian_Nancy_Cox	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.861195542047%	17	1974	82	Mendelian_Nancy_Cox	WONG_ENDMETRIUM_CANCER_DN
0.861195542047%	17	1974	82	Mendelian_Nancy_Cox	ST_INTEGRIN_SIGNALING_PATHWAY
0.861195542047%	17	1974	81	Mendelian_Nancy_Cox	COATES_MACROPHAGE_M1_VS_M2_UP
0.861195542047%	17	1974	80	Mendelian_Nancy_Cox	PID_MET_PATHWAY
0.861195542047%	17	1974	80	Mendelian_Nancy_Cox	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.861195542047%	17	1974	77	Mendelian_Nancy_Cox	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.861195542047%	17	1974	75	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
0.861195542047%	17	1974	75	Mendelian_Nancy_Cox	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
0.861195542047%	17	1974	75	Mendelian_Nancy_Cox	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
0.861195542047%	17	1974	75	Mendelian_Nancy_Cox	JAIN_NFKB_SIGNALING
0.861195542047%	17	1974	74	Mendelian_Nancy_Cox	POTTI_ADRIAMYCIN_SENSITIVITY
0.861195542047%	17	1974	73	Mendelian_Nancy_Cox	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.861195542047%	17	1974	73	Mendelian_Nancy_Cox	LIN_MELANOMA_COPY_NUMBER_UP
0.861195542047%	17	1974	72	Mendelian_Nancy_Cox	SESTO_RESPONSE_TO_UV_C8
0.861195542047%	17	1974	72	Mendelian_Nancy_Cox	KEGG_LEISHMANIA_INFECTION
0.861195542047%	17	1974	71	Mendelian_Nancy_Cox	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.861195542047%	17	1974	70	Mendelian_Nancy_Cox	MIKKELSEN_MEF_LCP_WITH_H3K27ME3
0.861195542047%	17	1974	68	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.861195542047%	17	1974	68	Mendelian_Nancy_Cox	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN
0.861195542047%	17	1974	65	Mendelian_Nancy_Cox	PID_IL4_2PATHWAY
0.861195542047%	17	1974	65	Mendelian_Nancy_Cox	PID_CD8TCRDOWNSTREAMPATHWAY
0.861195542047%	17	1974	58	Mendelian_Nancy_Cox	WAKASUGI_HAVE_ZNF143_BINDING_SITES
0.861195542047%	17	1974	58	Mendelian_Nancy_Cox	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
0.861195542047%	17	1974	56	Mendelian_Nancy_Cox	REACTOME_PI_3K_CASCADE
0.861195542047%	17	1974	56	Mendelian_Nancy_Cox	HOQUE_METHYLATED_IN_CANCER
0.861195542047%	17	1974	55	Mendelian_Nancy_Cox	SU_LIVER
0.861195542047%	17	1974	55	Mendelian_Nancy_Cox	PID_IL2_1PATHWAY
0.861195542047%	17	1974	55	Mendelian_Nancy_Cox	PID_FGF_PATHWAY
0.861195542047%	17	1974	55	Mendelian_Nancy_Cox	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN
0.861195542047%	17	1974	53	Mendelian_Nancy_Cox	PID_CD8TCRPATHWAY
0.861195542047%	17	1974	52	Mendelian_Nancy_Cox	KEGG_STARCH_AND_SUCROSE_METABOLISM
0.861195542047%	17	1974	50	Mendelian_Nancy_Cox	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
0.861195542047%	17	1974	48	Mendelian_Nancy_Cox	PID_HES_HEYPATHWAY
0.861195542047%	17	1974	48	Mendelian_Nancy_Cox	PID_CERAMIDE_PATHWAY
0.861195542047%	17	1974	44	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_FGFR_MUTANTS
0.861195542047%	17	1974	42	Mendelian_Nancy_Cox	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
0.861195542047%	17	1974	37	Mendelian_Nancy_Cox	BIOCARTA_ALK_PATHWAY
0.861195542047%	17	1974	35	Mendelian_Nancy_Cox	REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D
0.861195542047%	17	1974	293	Mendelian_Nancy_Cox	ZWANG_DOWN_BY_2ND_EGF_PULSE
0.861195542047%	17	1974	29	Mendelian_Nancy_Cox	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
0.861195542047%	17	1974	196	Mendelian_Nancy_Cox	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
0.861195542047%	17	1974	192	Mendelian_Nancy_Cox	REACTOME_DNA_REPLICATION
0.861195542047%	17	1974	186	Mendelian_Nancy_Cox	WANG_CLIM2_TARGETS_DN
0.861195542047%	17	1974	181	Mendelian_Nancy_Cox	JISON_SICKLE_CELL_DISEASE_DN
0.861195542047%	17	1974	171	Mendelian_Nancy_Cox	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
0.861195542047%	17	1974	160	Mendelian_Nancy_Cox	GAVIN_FOXP3_TARGETS_CLUSTER_P3
0.861195542047%	17	1974	159	Mendelian_Nancy_Cox	REACTOME_INTERFERON_SIGNALING
0.861195542047%	17	1974	153	Mendelian_Nancy_Cox	LU_AGING_BRAIN_DN
0.861195542047%	17	1974	153	Mendelian_Nancy_Cox	DURAND_STROMA_MAX_DN
0.861195542047%	17	1974	149	Mendelian_Nancy_Cox	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
0.861195542047%	17	1974	146	Mendelian_Nancy_Cox	ELVIDGE_HYPOXIA_DN
0.861195542047%	17	1974	142	Mendelian_Nancy_Cox	PENG_LEUCINE_DEPRIVATION_UP
0.861195542047%	17	1974	142	Mendelian_Nancy_Cox	DARWICHE_SKIN_TUMOR_PROMOTER_UP
0.861195542047%	17	1974	136	Mendelian_Nancy_Cox	WIERENGA_STAT5A_TARGETS_GROUP1
0.861195542047%	17	1974	132	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
0.861195542047%	17	1974	129	Mendelian_Nancy_Cox	KEGG_AXON_GUIDANCE
0.861195542047%	17	1974	128	Mendelian_Nancy_Cox	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
0.861195542047%	17	1974	122	Mendelian_Nancy_Cox	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
0.861195542047%	17	1974	120	Mendelian_Nancy_Cox	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN
0.861195542047%	17	1974	116	Mendelian_Nancy_Cox	LI_INDUCED_T_TO_NATURAL_KILLER_DN
0.861195542047%	17	1974	112	Mendelian_Nancy_Cox	PASINI_SUZ12_TARGETS_UP
0.861195542047%	17	1974	112	Mendelian_Nancy_Cox	LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.861195542047%	17	1974	111	Mendelian_Nancy_Cox	WANG_HCP_PROSTATE_CANCER
0.861195542047%	17	1974	111	Mendelian_Nancy_Cox	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.861195542047%	17	1974	108	Mendelian_Nancy_Cox	TAVAZOIE_METASTASIS
0.861195542047%	17	1974	108	Mendelian_Nancy_Cox	JAZAG_TGFB1_SIGNALING_UP
0.861195542047%	17	1974	105	Mendelian_Nancy_Cox	PID_ERBB1_DOWNSTREAM_PATHWAY
0.861195542047%	17	1974	104	Mendelian_Nancy_Cox	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
0.861195542047%	17	1974	101	Mendelian_Nancy_Cox	BURTON_ADIPOGENESIS_3
0.861195542047%	17	1974	101	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_10HR_UP
0.855431993157%	10	1169	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_MET_PATHWAY
0.855431993157%	10	1169	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_VEGF_SIGNALING_PATHWAY
0.855431993157%	10	1169	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TELOMERE_MAINTENANCE
0.855431993157%	10	1169	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MEIOTIC_SYNAPSIS
0.855431993157%	10	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_PPARA_PATHWAY
0.855431993157%	10	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_DRUG_METABOLISM_OTHER_ENZYMES
0.855431993157%	10	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
0.855431993157%	10	1169	455	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.855431993157%	10	1169	389	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HSIAO_HOUSEKEEPING_GENES
0.855431993157%	10	1169	367	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DELACROIX_RARG_BOUND_MEF
0.855431993157%	10	1169	362	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
0.855431993157%	10	1169	353	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
0.855431993157%	10	1169	351	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.855431993157%	10	1169	349	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
0.855431993157%	10	1169	337	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PHONG_TNF_RESPONSE_NOT_VIA_P38
0.855431993157%	10	1169	335	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WONG_EMBRYONIC_STEM_CELL_CORE
0.855431993157%	10	1169	314	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.855431993157%	10	1169	310	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HORIUCHI_WTAP_TARGETS_DN
0.855431993157%	10	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON
0.855431993157%	10	1169	298	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_14HR_DN
0.855431993157%	10	1169	293	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZWANG_DOWN_BY_2ND_EGF_PULSE
0.855431993157%	10	1169	293	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHANG_TLX_TARGETS_60HR_UP
0.855431993157%	10	1169	293	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_MATURE_CELL
0.855431993157%	10	1169	279	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_INNATE_IMMUNE_SYSTEM
0.855431993157%	10	1169	266	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FOSTER_KDM1A_TARGETS_UP
0.855431993157%	10	1169	260	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOQUEST_STEM_CELL_UP
0.855431993157%	10	1169	259	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	QI_PLASMACYTOMA_UP
0.855431993157%	10	1169	251	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KOBAYASHI_EGFR_SIGNALING_24HR_DN
0.855431993157%	10	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM
0.855431993157%	10	1169	244	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAL_LEUKEMIC_STEM_CELL_DN
0.855431993157%	10	1169	242	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MULLIGHAN_MLL_SIGNATURE_1_DN
0.855431993157%	10	1169	240	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANTVEER_BREAST_CANCER_ESR1_DN
0.855431993157%	10	1169	239	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.855431993157%	10	1169	238	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.855431993157%	10	1169	235	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RUTELLA_RESPONSE_TO_HGF_DN
0.855431993157%	10	1169	234	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AFFAR_YY1_TARGETS_DN
0.855431993157%	10	1169	233	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.855431993157%	10	1169	227	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_RECENT_THYMIC_EMIGRANT
0.855431993157%	10	1169	225	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
0.855431993157%	10	1169	222	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
0.855431993157%	10	1169	217	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SANSOM_APC_MYC_TARGETS
0.855431993157%	10	1169	217	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMUNDSON_RESPONSE_TO_ARSENITE
0.855431993157%	10	1169	214	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
0.855431993157%	10	1169	214	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIDUS_METASTASIS_UP
0.855431993157%	10	1169	214	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AFFAR_YY1_TARGETS_UP
0.855431993157%	10	1169	212	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
0.855431993157%	10	1169	206	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
0.855431993157%	10	1169	206	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BILD_MYC_ONCOGENIC_SIGNATURE
0.855431993157%	10	1169	205	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.855431993157%	10	1169	203	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PAL_PRMT5_TARGETS_UP
0.855431993157%	10	1169	199	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PLASARI_TGFB1_TARGETS_10HR_UP
0.855431993157%	10	1169	197	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
0.855431993157%	10	1169	197	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
0.855431993157%	10	1169	196	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
0.855431993157%	10	1169	180	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DARWICHE_PAPILLOMA_RISK_HIGH_DN
0.855431993157%	10	1169	177	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.855431993157%	10	1169	173	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SENGUPTA_EBNA1_ANTICORRELATED
0.855431993157%	10	1169	172	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
0.855431993157%	10	1169	171	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ELVIDGE_HYPOXIA_UP
0.855431993157%	10	1169	165	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DARWICHE_PAPILLOMA_RISK_LOW_DN
0.855431993157%	10	1169	163	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
0.855431993157%	10	1169	162	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MULLIGHAN_NPM1_SIGNATURE_3_DN
0.855431993157%	10	1169	162	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DARWICHE_PAPILLOMA_RISK_LOW_UP
0.855431993157%	10	1169	157	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SERVITJA_LIVER_HNF1A_TARGETS_DN
0.855431993157%	10	1169	148	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHANG_CYCLING_GENES
0.855431993157%	10	1169	147	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WHITFIELD_CELL_CYCLE_G1_S
0.855431993157%	10	1169	147	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DARWICHE_PAPILLOMA_RISK_HIGH_UP
0.855431993157%	10	1169	141	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WELCSH_BRCA1_TARGETS_DN
0.855431993157%	10	1169	140	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ONDER_CDH1_TARGETS_1_UP
0.855431993157%	10	1169	140	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JOHNSTONE_PARVB_TARGETS_2_UP
0.855431993157%	10	1169	138	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
0.855431993157%	10	1169	132	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
0.855431993157%	10	1169	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_SPLICEOSOME
0.855431993157%	10	1169	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GERY_CEBP_TARGETS
0.855431993157%	10	1169	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
0.855157669695%	16	1871	84	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
0.855157669695%	16	1871	76	T2D_GENES_TANYA_HEIGHT	PEART_HDAC_PROLIFERATION_CLUSTER_DN
0.855157669695%	16	1871	59	T2D_GENES_TANYA_HEIGHT	PID_P53REGULATIONPATHWAY
0.855157669695%	16	1871	44	T2D_GENES_TANYA_HEIGHT	KEGG_TYPE_I_DIABETES_MELLITUS
0.855157669695%	16	1871	38	T2D_GENES_TANYA_HEIGHT	KEGG_ALLOGRAFT_REJECTION
0.855157669695%	16	1871	298	T2D_GENES_TANYA_HEIGHT	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
0.855157669695%	16	1871	289	T2D_GENES_TANYA_HEIGHT	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
0.855157669695%	16	1871	234	T2D_GENES_TANYA_HEIGHT	AFFAR_YY1_TARGETS_DN
0.855157669695%	16	1871	232	T2D_GENES_TANYA_HEIGHT	DELYS_THYROID_CANCER_DN
0.855157669695%	16	1871	228	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
0.855157669695%	16	1871	202	T2D_GENES_TANYA_HEIGHT	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
0.855157669695%	16	1871	200	T2D_GENES_TANYA_HEIGHT	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
0.855157669695%	16	1871	194	T2D_GENES_TANYA_HEIGHT	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.855157669695%	16	1871	191	T2D_GENES_TANYA_HEIGHT	YAGI_AML_FAB_MARKERS
0.855157669695%	16	1871	185	T2D_GENES_TANYA_HEIGHT	DARWICHE_SKIN_TUMOR_PROMOTER_DN
0.855157669695%	16	1871	185	T2D_GENES_TANYA_HEIGHT	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
0.855157669695%	16	1871	184	T2D_GENES_TANYA_HEIGHT	DOANE_RESPONSE_TO_ANDROGEN_UP
0.855157669695%	16	1871	182	T2D_GENES_TANYA_HEIGHT	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
0.855157669695%	16	1871	181	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
0.855157669695%	16	1871	181	T2D_GENES_TANYA_HEIGHT	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
0.855157669695%	16	1871	180	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_48HR_UP
0.855157669695%	16	1871	179	T2D_GENES_TANYA_HEIGHT	BENPORATH_NOS_TARGETS
0.855157669695%	16	1871	176	T2D_GENES_TANYA_HEIGHT	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
0.855157669695%	16	1871	176	T2D_GENES_TANYA_HEIGHT	NAGASHIMA_NRG1_SIGNALING_UP
0.855157669695%	16	1871	175	T2D_GENES_TANYA_HEIGHT	YAMAZAKI_TCEB3_TARGETS_UP
0.855157669695%	16	1871	166	T2D_GENES_TANYA_HEIGHT	SMIRNOV_RESPONSE_TO_IR_6HR_UP
0.855157669695%	16	1871	166	T2D_GENES_TANYA_HEIGHT	CAIRO_LIVER_DEVELOPMENT_UP
0.855157669695%	16	1871	158	T2D_GENES_TANYA_HEIGHT	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON
0.855157669695%	16	1871	156	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_14HR_UP
0.855157669695%	16	1871	153	T2D_GENES_TANYA_HEIGHT	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN
0.855157669695%	16	1871	151	T2D_GENES_TANYA_HEIGHT	KEGG_WNT_SIGNALING_PATHWAY
0.855157669695%	16	1871	149	T2D_GENES_TANYA_HEIGHT	GOZGIT_ESR1_TARGETS_UP
0.855157669695%	16	1871	148	T2D_GENES_TANYA_HEIGHT	CHANG_CYCLING_GENES
0.855157669695%	16	1871	148	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_24HR_UP
0.855157669695%	16	1871	147	T2D_GENES_TANYA_HEIGHT	WHITFIELD_CELL_CYCLE_G1_S
0.855157669695%	16	1871	147	T2D_GENES_TANYA_HEIGHT	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
0.855157669695%	16	1871	146	T2D_GENES_TANYA_HEIGHT	ELVIDGE_HYPOXIA_DN
0.855157669695%	16	1871	140	T2D_GENES_TANYA_HEIGHT	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
0.855157669695%	16	1871	140	T2D_GENES_TANYA_HEIGHT	ONDER_CDH1_TARGETS_1_UP
0.855157669695%	16	1871	134	T2D_GENES_TANYA_HEIGHT	KEGG_CELL_ADHESION_MOLECULES_CAMS
0.855157669695%	16	1871	133	T2D_GENES_TANYA_HEIGHT	REACTOME_DIABETES_PATHWAYS
0.855157669695%	16	1871	127	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
0.855157669695%	16	1871	126	T2D_GENES_TANYA_HEIGHT	GERY_CEBP_TARGETS
0.855157669695%	16	1871	121	T2D_GENES_TANYA_HEIGHT	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP
0.855157669695%	16	1871	116	T2D_GENES_TANYA_HEIGHT	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
0.855157669695%	16	1871	116	T2D_GENES_TANYA_HEIGHT	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
0.855157669695%	16	1871	114	T2D_GENES_TANYA_HEIGHT	ROPERO_HDAC2_TARGETS
0.855157669695%	16	1871	112	T2D_GENES_TANYA_HEIGHT	REACTOME_G1_S_TRANSITION
0.855157669695%	16	1871	110	T2D_GENES_TANYA_HEIGHT	SUNG_METASTASIS_STROMA_UP
0.855157669695%	16	1871	108	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
0.855157669695%	16	1871	102	T2D_GENES_TANYA_HEIGHT	PID_CXCR4_PATHWAY
0.855157669695%	16	1871	102	T2D_GENES_TANYA_HEIGHT	DER_IFN_BETA_RESPONSE_UP
0.855157669695%	16	1871	100	T2D_GENES_TANYA_HEIGHT	CHICAS_RB1_TARGETS_LOW_SERUM
0.852272727273%	30	3520	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_AMYLOIDS
0.852272727273%	30	3520	409	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FOSTER_TOLERANT_MACROPHAGE_DN
0.852272727273%	30	3520	371	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_SMARCE1_TARGETS_DN
0.852272727273%	30	3520	356	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
0.852272727273%	30	3520	344	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RICKMAN_METASTASIS_UP
0.852272727273%	30	3520	332	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
0.852272727273%	30	3520	307	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
0.852272727273%	30	3520	299	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WALLACE_PROSTATE_CANCER_RACE_UP
0.852272727273%	30	3520	289	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MANALO_HYPOXIA_DN
0.852272727273%	30	3520	281	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
0.852272727273%	30	3520	260	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOQUEST_STEM_CELL_UP
0.852272727273%	30	3520	254	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_STEM_CELL
0.852272727273%	30	3520	249	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
0.852272727273%	30	3520	245	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCLACHLAN_DENTAL_CARIES_DN
0.852272727273%	30	3520	245	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BLUM_RESPONSE_TO_SALIRASIB_UP
0.852272727273%	30	3520	242	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WINTER_HYPOXIA_METAGENE
0.852272727273%	30	3520	238	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
0.852272727273%	30	3520	228	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
0.852272727273%	30	3520	216	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOQUEST_STEM_CELL_DN
0.852272727273%	30	3520	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAIRO_HEPATOBLASTOMA_CLASSES_DN
0.852272727273%	30	3520	204	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
0.852272727273%	30	3520	183	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.852272727273%	30	3520	183	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.852272727273%	30	3520	133	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON
0.852272727273%	30	3520	122	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CHROMOSOME_MAINTENANCE
0.844205679202%	11	1303	55	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER
0.844205679202%	11	1303	536	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SENESE_HDAC3_TARGETS_DN
0.844205679202%	11	1303	535	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STEIN_ESRRA_TARGETS
0.844205679202%	11	1303	423	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	THUM_SYSTOLIC_HEART_FAILURE_UP
0.844205679202%	11	1303	408	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
0.844205679202%	11	1303	398	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
0.844205679202%	11	1303	394	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BERENJENO_TRANSFORMED_BY_RHOA_DN
0.844205679202%	11	1303	390	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
0.844205679202%	11	1303	387	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHYLA_CBFA2T3_TARGETS_UP
0.844205679202%	11	1303	372	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_LMO4_TARGETS_UP
0.844205679202%	11	1303	355	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PEREZ_TP63_TARGETS
0.844205679202%	11	1303	353	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
0.844205679202%	11	1303	352	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_LMO4_TARGETS_DN
0.844205679202%	11	1303	352	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
0.844205679202%	11	1303	346	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GOLDRATH_ANTIGEN_RESPONSE
0.844205679202%	11	1303	341	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_NPC_HCP_WITH_H3K27ME3
0.844205679202%	11	1303	315	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PASINI_SUZ12_TARGETS_DN
0.844205679202%	11	1303	309	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
0.844205679202%	11	1303	308	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
0.844205679202%	11	1303	305	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
0.844205679202%	11	1303	296	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DURAND_STROMA_MAX_UP
0.844205679202%	11	1303	291	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SABATES_COLORECTAL_ADENOMA_DN
0.844205679202%	11	1303	289	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_MLL_TARGETS
0.844205679202%	11	1303	280	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
0.844205679202%	11	1303	267	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOLLMANN_APOPTOSIS_VIA_CD40_DN
0.844205679202%	11	1303	264	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
0.844205679202%	11	1303	262	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LU_AGING_BRAIN_UP
0.844205679202%	11	1303	261	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
0.844205679202%	11	1303	249	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MITSIADES_RESPONSE_TO_APLIDIN_DN
0.844205679202%	11	1303	247	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_CARBOHYDRATES
0.844205679202%	11	1303	246	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BILD_E2F3_ONCOGENIC_SIGNATURE
0.844205679202%	11	1303	244	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KAYO_AGING_MUSCLE_UP
0.844205679202%	11	1303	244	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAZARD_RESPONSE_TO_UV_NHEK_UP
0.844205679202%	11	1303	242	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHYLA_CBFA2T3_TARGETS_DN
0.844205679202%	11	1303	241	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
0.844205679202%	11	1303	230	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BENPORATH_MYC_TARGETS_WITH_EBOX
0.844205679202%	11	1303	214	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZWANG_EGF_INTERVAL_DN
0.844205679202%	11	1303	214	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIDUS_METASTASIS_UP
0.844205679202%	11	1303	185	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_LIVER_CANCER_SURVIVAL_UP
0.844205679202%	11	1303	184	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
0.844205679202%	11	1303	181	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
0.844205679202%	11	1303	181	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
0.844205679202%	11	1303	177	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.844205679202%	11	1303	141	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WELCSH_BRCA1_TARGETS_DN
0.844205679202%	11	1303	138	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
0.844205679202%	11	1303	129	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAGI_AML_SURVIVAL
0.844205679202%	11	1303	118	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_NEURAL_CREST_STEM_CELL_DN
0.831024930748%	3	361	97	T2D_GENES_TANYA_T2D_RSQ05_02CM	KONG_E2F3_TARGETS
0.831024930748%	3	361	97	T2D_GENES_TANYA_T2D_RSQ05_02CM	KIM_MYC_AMPLIFICATION_TARGETS_DN
0.831024930748%	3	361	92	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_DILATED_CARDIOMYOPATHY
0.831024930748%	3	361	92	T2D_GENES_TANYA_T2D_RSQ05_02CM	CAMPS_COLON_CANCER_COPY_NUMBER_UP
0.831024930748%	3	361	92	T2D_GENES_TANYA_T2D_RSQ05_02CM	BURTON_ADIPOGENESIS_9
0.831024930748%	3	361	91	T2D_GENES_TANYA_T2D_RSQ05_02CM	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
0.831024930748%	3	361	89	T2D_GENES_TANYA_T2D_RSQ05_02CM	VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP
0.831024930748%	3	361	89	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_PROSTATE_CANCER
0.831024930748%	3	361	88	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
0.831024930748%	3	361	88	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
0.831024930748%	3	361	88	T2D_GENES_TANYA_T2D_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.831024930748%	3	361	88	T2D_GENES_TANYA_T2D_RSQ05_02CM	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
0.831024930748%	3	361	87	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.831024930748%	3	361	86	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_L1CAM_INTERACTIONS
0.831024930748%	3	361	86	T2D_GENES_TANYA_T2D_RSQ05_02CM	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
0.831024930748%	3	361	84	T2D_GENES_TANYA_T2D_RSQ05_02CM	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
0.831024930748%	3	361	84	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_CMYB_PATHWAY
0.831024930748%	3	361	83	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
0.831024930748%	3	361	82	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_SMAD2_3NUCLEARPATHWAY
0.831024930748%	3	361	79	T2D_GENES_TANYA_T2D_RSQ05_02CM	DUAN_PRDM5_TARGETS
0.831024930748%	3	361	78	T2D_GENES_TANYA_T2D_RSQ05_02CM	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
0.831024930748%	3	361	76	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
0.831024930748%	3	361	75	T2D_GENES_TANYA_T2D_RSQ05_02CM	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
0.831024930748%	3	361	74	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_E2F_PATHWAY
0.831024930748%	3	361	74	T2D_GENES_TANYA_T2D_RSQ05_02CM	FURUKAWA_DUSP6_TARGETS_PCI35_DN
0.831024930748%	3	361	73	T2D_GENES_TANYA_T2D_RSQ05_02CM	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
0.831024930748%	3	361	73	T2D_GENES_TANYA_T2D_RSQ05_02CM	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.831024930748%	3	361	72	T2D_GENES_TANYA_T2D_RSQ05_02CM	BURTON_ADIPOGENESIS_2
0.831024930748%	3	361	70	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
0.831024930748%	3	361	70	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SIGNALING_BY_NOTCH1
0.831024930748%	3	361	67	T2D_GENES_TANYA_T2D_RSQ05_02CM	GENTILE_UV_LOW_DOSE_DN
0.831024930748%	3	361	67	T2D_GENES_TANYA_T2D_RSQ05_02CM	ELVIDGE_HIF1A_TARGETS_UP
0.831024930748%	3	361	66	T2D_GENES_TANYA_T2D_RSQ05_02CM	TENEDINI_MEGAKARYOCYTE_MARKERS
0.831024930748%	3	361	66	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_LYSOPHOSPHOLIPID_PATHWAY
0.831024930748%	3	361	66	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_HIF1_TFPATHWAY
0.831024930748%	3	361	65	T2D_GENES_TANYA_T2D_RSQ05_02CM	ST_FAS_SIGNALING_PATHWAY
0.831024930748%	3	361	65	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_RB_1PATHWAY
0.831024930748%	3	361	59	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_NOTCH_PATHWAY
0.831024930748%	3	361	59	T2D_GENES_TANYA_T2D_RSQ05_02CM	MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3
0.831024930748%	3	361	58	T2D_GENES_TANYA_T2D_RSQ05_02CM	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
0.831024930748%	3	361	579	T2D_GENES_TANYA_T2D_RSQ05_02CM	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
0.831024930748%	3	361	56	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_10HR_DN
0.831024930748%	3	361	555	T2D_GENES_TANYA_T2D_RSQ05_02CM	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
0.831024930748%	3	361	544	T2D_GENES_TANYA_T2D_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
0.831024930748%	3	361	526	T2D_GENES_TANYA_T2D_RSQ05_02CM	ONKEN_UVEAL_MELANOMA_DN
0.831024930748%	3	361	52	T2D_GENES_TANYA_T2D_RSQ05_02CM	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP
0.831024930748%	3	361	48	T2D_GENES_TANYA_T2D_RSQ05_02CM	ENGELMANN_CANCER_PROGENITORS_UP
0.831024930748%	3	361	478	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
0.831024930748%	3	361	47	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
0.831024930748%	3	361	47	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_TYPE_II_DIABETES_MELLITUS
0.831024930748%	3	361	469	T2D_GENES_TANYA_T2D_RSQ05_02CM	MCCABE_BOUND_BY_HOXC6
0.831024930748%	3	361	467	T2D_GENES_TANYA_T2D_RSQ05_02CM	RATTENBACHER_BOUND_BY_CELF1
0.831024930748%	3	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION
0.831024930748%	3	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_PS1PATHWAY
0.831024930748%	3	361	455	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.831024930748%	3	361	45	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_AGING_MUSCLE_UP
0.831024930748%	3	361	443	T2D_GENES_TANYA_T2D_RSQ05_02CM	DELYS_THYROID_CANCER_UP
0.831024930748%	3	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	MA_MYELOID_DIFFERENTIATION_DN
0.831024930748%	3	361	435	T2D_GENES_TANYA_T2D_RSQ05_02CM	SWEET_LUNG_CANCER_KRAS_DN
0.831024930748%	3	361	430	T2D_GENES_TANYA_T2D_RSQ05_02CM	VECCHI_GASTRIC_CANCER_EARLY_UP
0.831024930748%	3	361	430	T2D_GENES_TANYA_T2D_RSQ05_02CM	RIGGI_EWING_SARCOMA_PROGENITOR_UP
0.831024930748%	3	361	420	T2D_GENES_TANYA_T2D_RSQ05_02CM	MOOTHA_PGC
0.831024930748%	3	361	414	T2D_GENES_TANYA_T2D_RSQ05_02CM	LU_EZH2_TARGETS_DN
0.831024930748%	3	361	408	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_GPCR_LIGAND_BINDING
0.831024930748%	3	361	397	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
0.831024930748%	3	361	390	T2D_GENES_TANYA_T2D_RSQ05_02CM	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
0.831024930748%	3	361	387	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHYLA_CBFA2T3_TARGETS_UP
0.831024930748%	3	361	38	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_G1_PHASE
0.831024930748%	3	361	374	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_TUMOR_INVASIVENESS_UP
0.831024930748%	3	361	372	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_LMO4_TARGETS_UP
0.831024930748%	3	361	353	T2D_GENES_TANYA_T2D_RSQ05_02CM	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
0.831024930748%	3	361	336	T2D_GENES_TANYA_T2D_RSQ05_02CM	JOHNSTONE_PARVB_TARGETS_2_DN
0.831024930748%	3	361	335	T2D_GENES_TANYA_T2D_RSQ05_02CM	WONG_EMBRYONIC_STEM_CELL_CORE
0.831024930748%	3	361	318	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAZARD_RESPONSE_TO_UV_NHEK_DN
0.831024930748%	3	361	317	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
0.831024930748%	3	361	315	T2D_GENES_TANYA_T2D_RSQ05_02CM	PASINI_SUZ12_TARGETS_DN
0.831024930748%	3	361	314	T2D_GENES_TANYA_T2D_RSQ05_02CM	DOUGLAS_BMI1_TARGETS_DN
0.831024930748%	3	361	310	T2D_GENES_TANYA_T2D_RSQ05_02CM	HORIUCHI_WTAP_TARGETS_DN
0.831024930748%	3	361	309	T2D_GENES_TANYA_T2D_RSQ05_02CM	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
0.831024930748%	3	361	309	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIU_SOX4_TARGETS_DN
0.831024930748%	3	361	306	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHANDRAN_METASTASIS_DN
0.831024930748%	3	361	305	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
0.831024930748%	3	361	302	T2D_GENES_TANYA_T2D_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM
0.831024930748%	3	361	293	T2D_GENES_TANYA_T2D_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_MATURE_CELL
0.831024930748%	3	361	292	T2D_GENES_TANYA_T2D_RSQ05_02CM	HELLER_HDAC_TARGETS_DN
0.831024930748%	3	361	290	T2D_GENES_TANYA_T2D_RSQ05_02CM	BASAKI_YBX1_TARGETS_UP
0.831024930748%	3	361	289	T2D_GENES_TANYA_T2D_RSQ05_02CM	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
0.831024930748%	3	361	288	T2D_GENES_TANYA_T2D_RSQ05_02CM	POOLA_INVASIVE_BREAST_CANCER_UP
0.831024930748%	3	361	279	T2D_GENES_TANYA_T2D_RSQ05_02CM	FORTSCHEGGER_PHF8_TARGETS_UP
0.831024930748%	3	361	277	T2D_GENES_TANYA_T2D_RSQ05_02CM	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
0.831024930748%	3	361	275	T2D_GENES_TANYA_T2D_RSQ05_02CM	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.831024930748%	3	361	271	T2D_GENES_TANYA_T2D_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.831024930748%	3	361	268	T2D_GENES_TANYA_T2D_RSQ05_02CM	XU_GH1_AUTOCRINE_TARGETS_UP
0.831024930748%	3	361	265	T2D_GENES_TANYA_T2D_RSQ05_02CM	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
0.831024930748%	3	361	259	T2D_GENES_TANYA_T2D_RSQ05_02CM	QI_PLASMACYTOMA_UP
0.831024930748%	3	361	254	T2D_GENES_TANYA_T2D_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_STEM_CELL
0.831024930748%	3	361	251	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
0.831024930748%	3	361	251	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_AXON_GUIDANCE
0.831024930748%	3	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_MYC_PATHWAY
0.831024930748%	3	361	249	T2D_GENES_TANYA_T2D_RSQ05_02CM	MITSIADES_RESPONSE_TO_APLIDIN_DN
0.831024930748%	3	361	247	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_METABOLISM_OF_CARBOHYDRATES
0.831024930748%	3	361	246	T2D_GENES_TANYA_T2D_RSQ05_02CM	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
0.831024930748%	3	361	246	T2D_GENES_TANYA_T2D_RSQ05_02CM	BILD_E2F3_ONCOGENIC_SIGNATURE
0.831024930748%	3	361	245	T2D_GENES_TANYA_T2D_RSQ05_02CM	BLUM_RESPONSE_TO_SALIRASIB_UP
0.831024930748%	3	361	244	T2D_GENES_TANYA_T2D_RSQ05_02CM	PLASARI_TGFB1_TARGETS_10HR_DN
0.831024930748%	3	361	230	T2D_GENES_TANYA_T2D_RSQ05_02CM	COLDREN_GEFITINIB_RESISTANCE_DN
0.831024930748%	3	361	230	T2D_GENES_TANYA_T2D_RSQ05_02CM	BENPORATH_MYC_TARGETS_WITH_EBOX
0.831024930748%	3	361	23	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_CELLCYCLE_PATHWAY
0.831024930748%	3	361	229	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
0.831024930748%	3	361	228	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARKEY_RB1_ACUTE_LOF_DN
0.831024930748%	3	361	227	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.831024930748%	3	361	226	T2D_GENES_TANYA_T2D_RSQ05_02CM	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.831024930748%	3	361	225	T2D_GENES_TANYA_T2D_RSQ05_02CM	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
0.831024930748%	3	361	225	T2D_GENES_TANYA_T2D_RSQ05_02CM	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
0.831024930748%	3	361	214	T2D_GENES_TANYA_T2D_RSQ05_02CM	KIM_WT1_TARGETS_UP
0.831024930748%	3	361	212	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
0.831024930748%	3	361	210	T2D_GENES_TANYA_T2D_RSQ05_02CM	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
0.831024930748%	3	361	210	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.831024930748%	3	361	209	T2D_GENES_TANYA_T2D_RSQ05_02CM	KIM_WT1_TARGETS_12HR_DN
0.831024930748%	3	361	208	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
0.831024930748%	3	361	207	T2D_GENES_TANYA_T2D_RSQ05_02CM	MANALO_HYPOXIA_UP
0.831024930748%	3	361	207	T2D_GENES_TANYA_T2D_RSQ05_02CM	CAIRO_HEPATOBLASTOMA_UP
0.831024930748%	3	361	206	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
0.831024930748%	3	361	206	T2D_GENES_TANYA_T2D_RSQ05_02CM	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.831024930748%	3	361	205	T2D_GENES_TANYA_T2D_RSQ05_02CM	PEREZ_TP53_AND_TP63_TARGETS
0.831024930748%	3	361	200	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_DIFFERENTIATING_T_LYMPHOCYTE
0.831024930748%	3	361	20	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
0.831024930748%	3	361	199	T2D_GENES_TANYA_T2D_RSQ05_02CM	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
0.831024930748%	3	361	198	T2D_GENES_TANYA_T2D_RSQ05_02CM	WELCSH_BRCA1_TARGETS_UP
0.831024930748%	3	361	198	T2D_GENES_TANYA_T2D_RSQ05_02CM	ALONSO_METASTASIS_UP
0.831024930748%	3	361	195	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.831024930748%	3	361	190	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.831024930748%	3	361	186	T2D_GENES_TANYA_T2D_RSQ05_02CM	HAMAI_APOPTOSIS_VIA_TRAIL_DN
0.831024930748%	3	361	185	T2D_GENES_TANYA_T2D_RSQ05_02CM	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
0.831024930748%	3	361	182	T2D_GENES_TANYA_T2D_RSQ05_02CM	WHITFIELD_CELL_CYCLE_G2
0.831024930748%	3	361	182	T2D_GENES_TANYA_T2D_RSQ05_02CM	RAO_BOUND_BY_SALL4_ISOFORM_A
0.831024930748%	3	361	182	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
0.831024930748%	3	361	181	T2D_GENES_TANYA_T2D_RSQ05_02CM	JISON_SICKLE_CELL_DISEASE_DN
0.831024930748%	3	361	181	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
0.831024930748%	3	361	180	T2D_GENES_TANYA_T2D_RSQ05_02CM	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
0.831024930748%	3	361	180	T2D_GENES_TANYA_T2D_RSQ05_02CM	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
0.831024930748%	3	361	179	T2D_GENES_TANYA_T2D_RSQ05_02CM	BENPORATH_NOS_TARGETS
0.831024930748%	3	361	178	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
0.831024930748%	3	361	177	T2D_GENES_TANYA_T2D_RSQ05_02CM	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
0.831024930748%	3	361	176	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
0.831024930748%	3	361	172	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
0.831024930748%	3	361	172	T2D_GENES_TANYA_T2D_RSQ05_02CM	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
0.831024930748%	3	361	171	T2D_GENES_TANYA_T2D_RSQ05_02CM	GOLDRATH_HOMEOSTATIC_PROLIFERATION
0.831024930748%	3	361	168	T2D_GENES_TANYA_T2D_RSQ05_02CM	PUJANA_XPRSS_INT_NETWORK
0.831024930748%	3	361	167	T2D_GENES_TANYA_T2D_RSQ05_02CM	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
0.831024930748%	3	361	165	T2D_GENES_TANYA_T2D_RSQ05_02CM	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
0.831024930748%	3	361	163	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
0.831024930748%	3	361	162	T2D_GENES_TANYA_T2D_RSQ05_02CM	WINNEPENNINCKX_MELANOMA_METASTASIS_UP
0.831024930748%	3	361	161	T2D_GENES_TANYA_T2D_RSQ05_02CM	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
0.831024930748%	3	361	160	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_6HR_DN
0.831024930748%	3	361	156	T2D_GENES_TANYA_T2D_RSQ05_02CM	FOSTER_TOLERANT_MACROPHAGE_UP
0.831024930748%	3	361	153	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAZARD_UV_RESPONSE_CLUSTER_G6
0.831024930748%	3	361	151	T2D_GENES_TANYA_T2D_RSQ05_02CM	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
0.831024930748%	3	361	150	T2D_GENES_TANYA_T2D_RSQ05_02CM	LANDIS_ERBB2_BREAST_TUMORS_324_UP
0.831024930748%	3	361	149	T2D_GENES_TANYA_T2D_RSQ05_02CM	HUANG_GATA2_TARGETS_UP
0.831024930748%	3	361	147	T2D_GENES_TANYA_T2D_RSQ05_02CM	WHITFIELD_CELL_CYCLE_G1_S
0.831024930748%	3	361	147	T2D_GENES_TANYA_T2D_RSQ05_02CM	KAUFFMANN_DNA_REPLICATION_GENES
0.831024930748%	3	361	147	T2D_GENES_TANYA_T2D_RSQ05_02CM	BENPORATH_PROLIFERATION
0.831024930748%	3	361	146	T2D_GENES_TANYA_T2D_RSQ05_02CM	ELVIDGE_HYPOXIA_DN
0.831024930748%	3	361	140	T2D_GENES_TANYA_T2D_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
0.831024930748%	3	361	14	T2D_GENES_TANYA_T2D_RSQ05_02CM	TOMLINS_METASTASIS_UP
0.831024930748%	3	361	139	T2D_GENES_TANYA_T2D_RSQ05_02CM	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
0.831024930748%	3	361	138	T2D_GENES_TANYA_T2D_RSQ05_02CM	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
0.831024930748%	3	361	138	T2D_GENES_TANYA_T2D_RSQ05_02CM	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
0.831024930748%	3	361	137	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIU_SOX4_TARGETS_UP
0.831024930748%	3	361	13	T2D_GENES_TANYA_T2D_RSQ05_02CM	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN
0.831024930748%	3	361	128	T2D_GENES_TANYA_T2D_RSQ05_02CM	LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.831024930748%	3	361	127	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIU_VMYB_TARGETS_UP
0.831024930748%	3	361	126	T2D_GENES_TANYA_T2D_RSQ05_02CM	BURTON_ADIPOGENESIS_5
0.831024930748%	3	361	123	T2D_GENES_TANYA_T2D_RSQ05_02CM	KAYO_AGING_MUSCLE_DN
0.831024930748%	3	361	123	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOOI_ST7_TARGETS_DN
0.831024930748%	3	361	122	T2D_GENES_TANYA_T2D_RSQ05_02CM	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
0.831024930748%	3	361	115	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARZEC_IL2_SIGNALING_UP
0.831024930748%	3	361	114	T2D_GENES_TANYA_T2D_RSQ05_02CM	SENESE_HDAC2_TARGETS_UP
0.831024930748%	3	361	114	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_OOCYTE_MEIOSIS
0.831024930748%	3	361	112	T2D_GENES_TANYA_T2D_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
0.831024930748%	3	361	109	T2D_GENES_TANYA_T2D_RSQ05_02CM	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
0.831024930748%	3	361	109	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_S_PHASE
0.831024930748%	3	361	108	T2D_GENES_TANYA_T2D_RSQ05_02CM	TAVAZOIE_METASTASIS
0.831024930748%	3	361	108	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
0.831024930748%	3	361	105	T2D_GENES_TANYA_T2D_RSQ05_02CM	WOO_LIVER_CANCER_RECURRENCE_UP
0.831024930748%	3	361	103	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN
0.831024930748%	3	361	103	T2D_GENES_TANYA_T2D_RSQ05_02CM	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY
0.831024930748%	3	361	102	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_MELANOGENESIS
0.831024930748%	3	361	101	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
0.831024930748%	3	361	101	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_10HR_UP
0.831024930748%	3	361	100	T2D_GENES_TANYA_T2D_RSQ05_02CM	RICKMAN_HEAD_AND_NECK_CANCER_A
0.831024930748%	3	361	100	T2D_GENES_TANYA_T2D_RSQ05_02CM	GAVIN_FOXP3_TARGETS_CLUSTER_P4
0.831024930748%	3	361	100	T2D_GENES_TANYA_T2D_RSQ05_02CM	BENPORATH_ES_CORE_NINE_CORRELATED
0.827966881325%	18	2174	97	T2D_GENES_TANYA_LIPIDS	KONG_E2F3_TARGETS
0.827966881325%	18	2174	86	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_16HR_DN
0.827966881325%	18	2174	79	T2D_GENES_TANYA_LIPIDS	PID_MYC_ACTIVPATHWAY
0.827966881325%	18	2174	73	T2D_GENES_TANYA_LIPIDS	KEGG_VIRAL_MYOCARDITIS
0.827966881325%	18	2174	294	T2D_GENES_TANYA_LIPIDS	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
0.827966881325%	18	2174	28	T2D_GENES_TANYA_LIPIDS	REACTOME_LIPOPROTEIN_METABOLISM
0.827966881325%	18	2174	228	T2D_GENES_TANYA_LIPIDS	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
0.827966881325%	18	2174	209	T2D_GENES_TANYA_LIPIDS	CHANG_CORE_SERUM_RESPONSE_DN
0.827966881325%	18	2174	208	T2D_GENES_TANYA_LIPIDS	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
0.827966881325%	18	2174	196	T2D_GENES_TANYA_LIPIDS	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
0.827966881325%	18	2174	195	T2D_GENES_TANYA_LIPIDS	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.827966881325%	18	2174	178	T2D_GENES_TANYA_LIPIDS	KEGG_CALCIUM_SIGNALING_PATHWAY
0.827966881325%	18	2174	170	T2D_GENES_TANYA_LIPIDS	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
0.827966881325%	18	2174	169	T2D_GENES_TANYA_LIPIDS	UEDA_PERIFERAL_CLOCK
0.827966881325%	18	2174	165	T2D_GENES_TANYA_LIPIDS	BROWN_MYELOID_CELL_DEVELOPMENT_UP
0.827966881325%	18	2174	157	T2D_GENES_TANYA_LIPIDS	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
0.827966881325%	18	2174	146	T2D_GENES_TANYA_LIPIDS	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
0.827966881325%	18	2174	143	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
0.827966881325%	18	2174	137	T2D_GENES_TANYA_LIPIDS	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
0.827966881325%	18	2174	132	T2D_GENES_TANYA_LIPIDS	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS
0.827966881325%	18	2174	123	T2D_GENES_TANYA_LIPIDS	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.827966881325%	18	2174	112	T2D_GENES_TANYA_LIPIDS	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
0.827966881325%	18	2174	108	T2D_GENES_TANYA_LIPIDS	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
0.827966881325%	18	2174	108	T2D_GENES_TANYA_LIPIDS	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.827966881325%	18	2174	107	T2D_GENES_TANYA_LIPIDS	SESTO_RESPONSE_TO_UV_C0
0.827966881325%	18	2174	107	T2D_GENES_TANYA_LIPIDS	ROESSLER_LIVER_CANCER_METASTASIS_UP
0.827966881325%	18	2174	104	T2D_GENES_TANYA_LIPIDS	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
0.827966881325%	18	2174	100	T2D_GENES_TANYA_LIPIDS	CHICAS_RB1_TARGETS_LOW_SERUM
0.823863636364%	29	3520	518	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MILI_PSEUDOPODIA_HAPTOTAXIS_UP
0.823863636364%	29	3520	428	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
0.823863636364%	29	3520	349	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
0.823863636364%	29	3520	342	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BLUM_RESPONSE_TO_SALIRASIB_DN
0.823863636364%	29	3520	326	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
0.823863636364%	29	3520	314	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DOUGLAS_BMI1_TARGETS_DN
0.823863636364%	29	3520	314	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.823863636364%	29	3520	310	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HORIUCHI_WTAP_TARGETS_DN
0.823863636364%	29	3520	293	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_60HR_UP
0.823863636364%	29	3520	277	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
0.823863636364%	29	3520	269	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
0.823863636364%	29	3520	261	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BILD_HRAS_ONCOGENIC_SIGNATURE
0.823863636364%	29	3520	251	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
0.823863636364%	29	3520	242	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
0.823863636364%	29	3520	239	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.823863636364%	29	3520	235	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_HGF_DN
0.823863636364%	29	3520	225	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
0.823863636364%	29	3520	221	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_36HR_UP
0.823863636364%	29	3520	206	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
0.823863636364%	29	3520	203	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PENG_RAPAMYCIN_RESPONSE_UP
0.823863636364%	29	3520	185	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DARWICHE_SKIN_TUMOR_PROMOTER_DN
0.823863636364%	29	3520	179	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
0.823863636364%	29	3520	168	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
0.815660685155%	5	613	98	T2D_GENES_TANYA_BIOMARKER	HAHTOLA_SEZARY_SYNDROM_UP
0.815660685155%	5	613	97	T2D_GENES_TANYA_BIOMARKER	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
0.815660685155%	5	613	95	T2D_GENES_TANYA_BIOMARKER	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
0.815660685155%	5	613	94	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES
0.815660685155%	5	613	89	T2D_GENES_TANYA_BIOMARKER	LEE_AGING_NEOCORTEX_UP
0.815660685155%	5	613	88	T2D_GENES_TANYA_BIOMARKER	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
0.815660685155%	5	613	87	T2D_GENES_TANYA_BIOMARKER	SMITH_TERT_TARGETS_DN
0.815660685155%	5	613	87	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_MAPK_PATHWAY
0.815660685155%	5	613	85	T2D_GENES_TANYA_BIOMARKER	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
0.815660685155%	5	613	85	T2D_GENES_TANYA_BIOMARKER	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
0.815660685155%	5	613	85	T2D_GENES_TANYA_BIOMARKER	COLDREN_GEFITINIB_RESISTANCE_UP
0.815660685155%	5	613	85	T2D_GENES_TANYA_BIOMARKER	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
0.815660685155%	5	613	84	T2D_GENES_TANYA_BIOMARKER	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
0.815660685155%	5	613	84	T2D_GENES_TANYA_BIOMARKER	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
0.815660685155%	5	613	83	T2D_GENES_TANYA_BIOMARKER	WARTERS_RESPONSE_TO_IR_SKIN
0.815660685155%	5	613	78	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_SCF_KIT
0.815660685155%	5	613	78	T2D_GENES_TANYA_BIOMARKER	REACTOME_OPIOID_SIGNALLING
0.815660685155%	5	613	77	T2D_GENES_TANYA_BIOMARKER	ROSS_AML_WITH_PML_RARA_FUSION
0.815660685155%	5	613	77	T2D_GENES_TANYA_BIOMARKER	MORI_PRE_BI_LYMPHOCYTE_DN
0.815660685155%	5	613	76	T2D_GENES_TANYA_BIOMARKER	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
0.815660685155%	5	613	76	T2D_GENES_TANYA_BIOMARKER	SU_TESTIS
0.815660685155%	5	613	76	T2D_GENES_TANYA_BIOMARKER	PEART_HDAC_PROLIFERATION_CLUSTER_DN
0.815660685155%	5	613	76	T2D_GENES_TANYA_BIOMARKER	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
0.815660685155%	5	613	75	T2D_GENES_TANYA_BIOMARKER	BAE_BRCA1_TARGETS_UP
0.815660685155%	5	613	74	T2D_GENES_TANYA_BIOMARKER	DARWICHE_PAPILLOMA_PROGRESSION_RISK
0.815660685155%	5	613	72	T2D_GENES_TANYA_BIOMARKER	SESTO_RESPONSE_TO_UV_C1
0.815660685155%	5	613	72	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
0.815660685155%	5	613	71	T2D_GENES_TANYA_BIOMARKER	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.815660685155%	5	613	71	T2D_GENES_TANYA_BIOMARKER	KUMAR_AUTOPHAGY_NETWORK
0.815660685155%	5	613	70	T2D_GENES_TANYA_BIOMARKER	REACTOME_PHASE_II_CONJUGATION
0.815660685155%	5	613	70	T2D_GENES_TANYA_BIOMARKER	KEGG_PANCREATIC_CANCER
0.815660685155%	5	613	69	T2D_GENES_TANYA_BIOMARKER	RIZKI_TUMOR_INVASIVENESS_2D_UP
0.815660685155%	5	613	69	T2D_GENES_TANYA_BIOMARKER	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
0.815660685155%	5	613	68	T2D_GENES_TANYA_BIOMARKER	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
0.815660685155%	5	613	64	T2D_GENES_TANYA_BIOMARKER	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
0.815660685155%	5	613	63	T2D_GENES_TANYA_BIOMARKER	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.815660685155%	5	613	62	T2D_GENES_TANYA_BIOMARKER	LEE_LIVER_CANCER_E2F1_UP
0.815660685155%	5	613	61	T2D_GENES_TANYA_BIOMARKER	REACTOME_ER_PHAGOSOME_PATHWAY
0.815660685155%	5	613	59	T2D_GENES_TANYA_BIOMARKER	BARIS_THYROID_CANCER_DN
0.815660685155%	5	613	58	T2D_GENES_TANYA_BIOMARKER	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
0.815660685155%	5	613	56	T2D_GENES_TANYA_BIOMARKER	KEGG_VIBRIO_CHOLERAE_INFECTION
0.815660685155%	5	613	54	T2D_GENES_TANYA_BIOMARKER	KEGG_INOSITOL_PHOSPHATE_METABOLISM
0.815660685155%	5	613	54	T2D_GENES_TANYA_BIOMARKER	KEGG_ARGININE_AND_PROLINE_METABOLISM
0.815660685155%	5	613	54	T2D_GENES_TANYA_BIOMARKER	AUNG_GASTRIC_CANCER
0.815660685155%	5	613	51	T2D_GENES_TANYA_BIOMARKER	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
0.815660685155%	5	613	50	T2D_GENES_TANYA_BIOMARKER	KEGG_GLUTATHIONE_METABOLISM
0.815660685155%	5	613	49	T2D_GENES_TANYA_BIOMARKER	LEE_LIVER_CANCER
0.815660685155%	5	613	48	T2D_GENES_TANYA_BIOMARKER	CHANGOLKAR_H2AFY_TARGETS_UP
0.815660685155%	5	613	45	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_CD1_DN
0.815660685155%	5	613	44	T2D_GENES_TANYA_BIOMARKER	KEGG_LYSINE_DEGRADATION
0.815660685155%	5	613	408	T2D_GENES_TANYA_BIOMARKER	REACTOME_GPCR_LIGAND_BINDING
0.815660685155%	5	613	39	T2D_GENES_TANYA_BIOMARKER	POTTI_PACLITAXEL_SENSITIVITY
0.815660685155%	5	613	367	T2D_GENES_TANYA_BIOMARKER	VECCHI_GASTRIC_CANCER_EARLY_DN
0.815660685155%	5	613	36	T2D_GENES_TANYA_BIOMARKER	STEARMAN_TUMOR_FIELD_EFFECT_UP
0.815660685155%	5	613	34	T2D_GENES_TANYA_BIOMARKER	KEGG_BUTANOATE_METABOLISM
0.815660685155%	5	613	330	T2D_GENES_TANYA_BIOMARKER	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
0.815660685155%	5	613	306	T2D_GENES_TANYA_BIOMARKER	HORIUCHI_WTAP_TARGETS_UP
0.815660685155%	5	613	305	T2D_GENES_TANYA_BIOMARKER	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
0.815660685155%	5	613	295	T2D_GENES_TANYA_BIOMARKER	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
0.815660685155%	5	613	293	T2D_GENES_TANYA_BIOMARKER	ZWANG_DOWN_BY_2ND_EGF_PULSE
0.815660685155%	5	613	289	T2D_GENES_TANYA_BIOMARKER	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
0.815660685155%	5	613	285	T2D_GENES_TANYA_BIOMARKER	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
0.815660685155%	5	613	282	T2D_GENES_TANYA_BIOMARKER	HELLER_SILENCED_BY_METHYLATION_UP
0.815660685155%	5	613	281	T2D_GENES_TANYA_BIOMARKER	MULLIGHAN_MLL_SIGNATURE_2_DN
0.815660685155%	5	613	277	T2D_GENES_TANYA_BIOMARKER	ZHANG_TLX_TARGETS_60HR_DN
0.815660685155%	5	613	275	T2D_GENES_TANYA_BIOMARKER	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.815660685155%	5	613	271	T2D_GENES_TANYA_BIOMARKER	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.815660685155%	5	613	268	T2D_GENES_TANYA_BIOMARKER	XU_GH1_AUTOCRINE_TARGETS_UP
0.815660685155%	5	613	260	T2D_GENES_TANYA_BIOMARKER	BOQUEST_STEM_CELL_UP
0.815660685155%	5	613	255	T2D_GENES_TANYA_BIOMARKER	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.815660685155%	5	613	251	T2D_GENES_TANYA_BIOMARKER	REACTOME_AXON_GUIDANCE
0.815660685155%	5	613	249	T2D_GENES_TANYA_BIOMARKER	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
0.815660685155%	5	613	244	T2D_GENES_TANYA_BIOMARKER	DAZARD_RESPONSE_TO_UV_NHEK_UP
0.815660685155%	5	613	240	T2D_GENES_TANYA_BIOMARKER	UDAYAKUMAR_MED1_TARGETS_DN
0.815660685155%	5	613	239	T2D_GENES_TANYA_BIOMARKER	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.815660685155%	5	613	232	T2D_GENES_TANYA_BIOMARKER	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
0.815660685155%	5	613	229	T2D_GENES_TANYA_BIOMARKER	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
0.815660685155%	5	613	228	T2D_GENES_TANYA_BIOMARKER	MARKEY_RB1_ACUTE_LOF_DN
0.815660685155%	5	613	222	T2D_GENES_TANYA_BIOMARKER	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
0.815660685155%	5	613	216	T2D_GENES_TANYA_BIOMARKER	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
0.815660685155%	5	613	215	T2D_GENES_TANYA_BIOMARKER	YAMAZAKI_TCEB3_TARGETS_DN
0.815660685155%	5	613	212	T2D_GENES_TANYA_BIOMARKER	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
0.815660685155%	5	613	210	T2D_GENES_TANYA_BIOMARKER	WANG_TUMOR_INVASIVENESS_DN
0.815660685155%	5	613	210	T2D_GENES_TANYA_BIOMARKER	VERHAAK_GLIOBLASTOMA_PRONEURAL
0.815660685155%	5	613	210	T2D_GENES_TANYA_BIOMARKER	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
0.815660685155%	5	613	207	T2D_GENES_TANYA_BIOMARKER	CAIRO_HEPATOBLASTOMA_UP
0.815660685155%	5	613	203	T2D_GENES_TANYA_BIOMARKER	PENG_RAPAMYCIN_RESPONSE_UP
0.815660685155%	5	613	201	T2D_GENES_TANYA_BIOMARKER	KIM_MYC_AMPLIFICATION_TARGETS_UP
0.815660685155%	5	613	201	T2D_GENES_TANYA_BIOMARKER	HOLLMANN_APOPTOSIS_VIA_CD40_UP
0.815660685155%	5	613	200	T2D_GENES_TANYA_BIOMARKER	LEE_DIFFERENTIATING_T_LYMPHOCYTE
0.815660685155%	5	613	193	T2D_GENES_TANYA_BIOMARKER	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP
0.815660685155%	5	613	191	T2D_GENES_TANYA_BIOMARKER	RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.815660685155%	5	613	191	T2D_GENES_TANYA_BIOMARKER	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
0.815660685155%	5	613	186	T2D_GENES_TANYA_BIOMARKER	WANG_CLIM2_TARGETS_DN
0.815660685155%	5	613	186	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
0.815660685155%	5	613	186	T2D_GENES_TANYA_BIOMARKER	HAMAI_APOPTOSIS_VIA_TRAIL_DN
0.815660685155%	5	613	185	T2D_GENES_TANYA_BIOMARKER	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
0.815660685155%	5	613	184	T2D_GENES_TANYA_BIOMARKER	WU_CELL_MIGRATION
0.815660685155%	5	613	182	T2D_GENES_TANYA_BIOMARKER	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.815660685155%	5	613	182	T2D_GENES_TANYA_BIOMARKER	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
0.815660685155%	5	613	178	T2D_GENES_TANYA_BIOMARKER	LI_AMPLIFIED_IN_LUNG_CANCER
0.815660685155%	5	613	175	T2D_GENES_TANYA_BIOMARKER	LEE_LIVER_CANCER_SURVIVAL_DN
0.815660685155%	5	613	175	T2D_GENES_TANYA_BIOMARKER	FIRESTEIN_PROLIFERATION
0.815660685155%	5	613	174	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
0.815660685155%	5	613	170	T2D_GENES_TANYA_BIOMARKER	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
0.815660685155%	5	613	169	T2D_GENES_TANYA_BIOMARKER	ONDER_CDH1_TARGETS_1_DN
0.815660685155%	5	613	166	T2D_GENES_TANYA_BIOMARKER	CAIRO_LIVER_DEVELOPMENT_UP
0.815660685155%	5	613	164	T2D_GENES_TANYA_BIOMARKER	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
0.815660685155%	5	613	164	T2D_GENES_TANYA_BIOMARKER	AMIT_EGF_RESPONSE_480_HELA
0.815660685155%	5	613	163	T2D_GENES_TANYA_BIOMARKER	LIN_NPAS4_TARGETS_UP
0.815660685155%	5	613	162	T2D_GENES_TANYA_BIOMARKER	KIM_WT1_TARGETS_12HR_UP
0.815660685155%	5	613	159	T2D_GENES_TANYA_BIOMARKER	REACTOME_INTERFERON_SIGNALING
0.815660685155%	5	613	159	T2D_GENES_TANYA_BIOMARKER	KEGG_PURINE_METABOLISM
0.815660685155%	5	613	157	T2D_GENES_TANYA_BIOMARKER	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.815660685155%	5	613	153	T2D_GENES_TANYA_BIOMARKER	DURAND_STROMA_MAX_DN
0.815660685155%	5	613	152	T2D_GENES_TANYA_BIOMARKER	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
0.815660685155%	5	613	151	T2D_GENES_TANYA_BIOMARKER	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
0.815660685155%	5	613	149	T2D_GENES_TANYA_BIOMARKER	GOZGIT_ESR1_TARGETS_UP
0.815660685155%	5	613	148	T2D_GENES_TANYA_BIOMARKER	KATSANOU_ELAVL1_TARGETS_DN
0.815660685155%	5	613	148	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_24HR_DN
0.815660685155%	5	613	147	T2D_GENES_TANYA_BIOMARKER	WHITFIELD_CELL_CYCLE_G1_S
0.815660685155%	5	613	147	T2D_GENES_TANYA_BIOMARKER	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
0.815660685155%	5	613	146	T2D_GENES_TANYA_BIOMARKER	KIM_ALL_DISORDERS_DURATION_CORR_DN
0.815660685155%	5	613	146	T2D_GENES_TANYA_BIOMARKER	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
0.815660685155%	5	613	145	T2D_GENES_TANYA_BIOMARKER	SMITH_TERT_TARGETS_UP
0.815660685155%	5	613	143	T2D_GENES_TANYA_BIOMARKER	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
0.815660685155%	5	613	143	T2D_GENES_TANYA_BIOMARKER	DANG_MYC_TARGETS_UP
0.815660685155%	5	613	142	T2D_GENES_TANYA_BIOMARKER	PENG_LEUCINE_DEPRIVATION_UP
0.815660685155%	5	613	142	T2D_GENES_TANYA_BIOMARKER	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.815660685155%	5	613	140	T2D_GENES_TANYA_BIOMARKER	QI_HYPOXIA
0.815660685155%	5	613	140	T2D_GENES_TANYA_BIOMARKER	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
0.815660685155%	5	613	139	T2D_GENES_TANYA_BIOMARKER	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
0.815660685155%	5	613	138	T2D_GENES_TANYA_BIOMARKER	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
0.815660685155%	5	613	137	T2D_GENES_TANYA_BIOMARKER	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
0.815660685155%	5	613	135	T2D_GENES_TANYA_BIOMARKER	TSENG_IRS1_TARGETS_DN
0.815660685155%	5	613	135	T2D_GENES_TANYA_BIOMARKER	SERVITJA_LIVER_HNF1A_TARGETS_UP
0.815660685155%	5	613	133	T2D_GENES_TANYA_BIOMARKER	REACTOME_DIABETES_PATHWAYS
0.815660685155%	5	613	129	T2D_GENES_TANYA_BIOMARKER	KEGG_AXON_GUIDANCE
0.815660685155%	5	613	128	T2D_GENES_TANYA_BIOMARKER	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
0.815660685155%	5	613	128	T2D_GENES_TANYA_BIOMARKER	YEGNASUBRAMANIAN_PROSTATE_CANCER
0.815660685155%	5	613	127	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
0.815660685155%	5	613	127	T2D_GENES_TANYA_BIOMARKER	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
0.815660685155%	5	613	126	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
0.815660685155%	5	613	126	T2D_GENES_TANYA_BIOMARKER	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.815660685155%	5	613	125	T2D_GENES_TANYA_BIOMARKER	REACTOME_HIV_LIFE_CYCLE
0.815660685155%	5	613	124	T2D_GENES_TANYA_BIOMARKER	REACTOME_CELL_CYCLE_CHECKPOINTS
0.815660685155%	5	613	122	T2D_GENES_TANYA_BIOMARKER	TOOKER_GEMCITABINE_RESISTANCE_DN
0.815660685155%	5	613	122	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_PDGF
0.815660685155%	5	613	118	T2D_GENES_TANYA_BIOMARKER	LEE_NEURAL_CREST_STEM_CELL_DN
0.815660685155%	5	613	116	T2D_GENES_TANYA_BIOMARKER	MATTIOLI_MGUS_VS_PCL
0.815660685155%	5	613	114	T2D_GENES_TANYA_BIOMARKER	SMIRNOV_RESPONSE_TO_IR_6HR_DN
0.815660685155%	5	613	114	T2D_GENES_TANYA_BIOMARKER	SENESE_HDAC2_TARGETS_UP
0.815660685155%	5	613	114	T2D_GENES_TANYA_BIOMARKER	ROPERO_HDAC2_TARGETS
0.815660685155%	5	613	114	T2D_GENES_TANYA_BIOMARKER	LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.815660685155%	5	613	112	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_FGFR
0.815660685155%	5	613	110	T2D_GENES_TANYA_BIOMARKER	WOOD_EBV_EBNA1_TARGETS_UP
0.815660685155%	5	613	103	T2D_GENES_TANYA_BIOMARKER	KIM_MYCN_AMPLIFICATION_TARGETS_DN
0.815660685155%	5	613	102	T2D_GENES_TANYA_BIOMARKER	PID_CXCR4_PATHWAY
0.815660685155%	5	613	102	T2D_GENES_TANYA_BIOMARKER	DER_IFN_BETA_RESPONSE_UP
0.815660685155%	5	613	101	T2D_GENES_TANYA_BIOMARKER	WIELAND_UP_BY_HBV_INFECTION
0.815660685155%	5	613	101	T2D_GENES_TANYA_BIOMARKER	GRADE_COLON_AND_RECTAL_CANCER_DN
0.815660685155%	5	613	100	T2D_GENES_TANYA_BIOMARKER	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
0.815660685155%	5	613	100	T2D_GENES_TANYA_BIOMARKER	QI_PLASMACYTOMA_DN
0.815660685155%	5	613	100	T2D_GENES_TANYA_BIOMARKER	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
0.81053698075%	16	1974	99	Mendelian_Nancy_Cox	LIM_MAMMARY_LUMINAL_MATURE_DN
0.81053698075%	16	1974	98	Mendelian_Nancy_Cox	KEGG_PYRIMIDINE_METABOLISM
0.81053698075%	16	1974	98	Mendelian_Nancy_Cox	HAHTOLA_SEZARY_SYNDROM_UP
0.81053698075%	16	1974	97	Mendelian_Nancy_Cox	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP
0.81053698075%	16	1974	93	Mendelian_Nancy_Cox	REACTOME_ACTIVATED_TLR4_SIGNALLING
0.81053698075%	16	1974	93	Mendelian_Nancy_Cox	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
0.81053698075%	16	1974	92	Mendelian_Nancy_Cox	WINTER_HYPOXIA_UP
0.81053698075%	16	1974	92	Mendelian_Nancy_Cox	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
0.81053698075%	16	1974	89	Mendelian_Nancy_Cox	LEE_AGING_NEOCORTEX_UP
0.81053698075%	16	1974	89	Mendelian_Nancy_Cox	BOYLAN_MULTIPLE_MYELOMA_D_UP
0.81053698075%	16	1974	87	Mendelian_Nancy_Cox	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
0.81053698075%	16	1974	87	Mendelian_Nancy_Cox	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.81053698075%	16	1974	87	Mendelian_Nancy_Cox	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.81053698075%	16	1974	81	Mendelian_Nancy_Cox	GUO_HEX_TARGETS_UP
0.81053698075%	16	1974	80	Mendelian_Nancy_Cox	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
0.81053698075%	16	1974	80	Mendelian_Nancy_Cox	LINDVALL_IMMORTALIZED_BY_TERT_DN
0.81053698075%	16	1974	80	Mendelian_Nancy_Cox	BASSO_HAIRY_CELL_LEUKEMIA_DN
0.81053698075%	16	1974	79	Mendelian_Nancy_Cox	PID_P73PATHWAY
0.81053698075%	16	1974	79	Mendelian_Nancy_Cox	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
0.81053698075%	16	1974	77	Mendelian_Nancy_Cox	RIZ_ERYTHROID_DIFFERENTIATION
0.81053698075%	16	1974	76	Mendelian_Nancy_Cox	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.81053698075%	16	1974	74	Mendelian_Nancy_Cox	URS_ADIPOCYTE_DIFFERENTIATION_UP
0.81053698075%	16	1974	74	Mendelian_Nancy_Cox	PID_E2F_PATHWAY
0.81053698075%	16	1974	71	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_6HR_UP
0.81053698075%	16	1974	70	Mendelian_Nancy_Cox	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS
0.81053698075%	16	1974	70	Mendelian_Nancy_Cox	KEGG_LONG_TERM_POTENTIATION
0.81053698075%	16	1974	69	Mendelian_Nancy_Cox	KEGG_PPAR_SIGNALING_PATHWAY
0.81053698075%	16	1974	67	Mendelian_Nancy_Cox	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.81053698075%	16	1974	66	Mendelian_Nancy_Cox	RIGGINS_TAMOXIFEN_RESISTANCE_UP
0.81053698075%	16	1974	64	Mendelian_Nancy_Cox	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
0.81053698075%	16	1974	52	Mendelian_Nancy_Cox	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM
0.81053698075%	16	1974	52	Mendelian_Nancy_Cox	PID_CASPASE_PATHWAY
0.81053698075%	16	1974	50	Mendelian_Nancy_Cox	KOHOUTEK_CCNT1_TARGETS
0.81053698075%	16	1974	48	Mendelian_Nancy_Cox	PID_AJDISS_2PATHWAY
0.81053698075%	16	1974	44	Mendelian_Nancy_Cox	KEGG_ABC_TRANSPORTERS
0.81053698075%	16	1974	36	Mendelian_Nancy_Cox	REACTOME_FRS2_MEDIATED_CASCADE
0.81053698075%	16	1974	33	Mendelian_Nancy_Cox	KEGG_PROPANOATE_METABOLISM
0.81053698075%	16	1974	19	Mendelian_Nancy_Cox	BIOCARTA_COMP_PATHWAY
0.81053698075%	16	1974	180	Mendelian_Nancy_Cox	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
0.81053698075%	16	1974	180	Mendelian_Nancy_Cox	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
0.81053698075%	16	1974	164	Mendelian_Nancy_Cox	KIM_WT1_TARGETS_8HR_UP
0.81053698075%	16	1974	143	Mendelian_Nancy_Cox	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.81053698075%	16	1974	137	Mendelian_Nancy_Cox	LIU_SOX4_TARGETS_UP
0.81053698075%	16	1974	127	Mendelian_Nancy_Cox	KARLSSON_TGFB1_TARGETS_UP
0.81053698075%	16	1974	126	Mendelian_Nancy_Cox	SANSOM_APC_TARGETS_UP
0.81053698075%	16	1974	126	Mendelian_Nancy_Cox	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.81053698075%	16	1974	126	Mendelian_Nancy_Cox	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
0.81053698075%	16	1974	123	Mendelian_Nancy_Cox	KAYO_AGING_MUSCLE_DN
0.81053698075%	16	1974	122	Mendelian_Nancy_Cox	REACTOME_CHROMOSOME_MAINTENANCE
0.81053698075%	16	1974	116	Mendelian_Nancy_Cox	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
0.81053698075%	16	1974	112	Mendelian_Nancy_Cox	DOANE_BREAST_CANCER_ESR1_UP
0.81053698075%	16	1974	111	Mendelian_Nancy_Cox	BOUDOUKHA_BOUND_BY_IGF2BP2
0.81053698075%	16	1974	110	Mendelian_Nancy_Cox	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
0.81053698075%	16	1974	110	Mendelian_Nancy_Cox	GROSS_HYPOXIA_VIA_HIF1A_DN
0.81053698075%	16	1974	106	Mendelian_Nancy_Cox	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
0.81053698075%	16	1974	105	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_8HR_UP
0.81053698075%	16	1974	104	Mendelian_Nancy_Cox	NAKAMURA_ADIPOGENESIS_LATE_UP
0.81053698075%	16	1974	101	Mendelian_Nancy_Cox	WIELAND_UP_BY_HBV_INFECTION
0.81053698075%	16	1974	101	Mendelian_Nancy_Cox	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
0.81053698075%	16	1974	100	Mendelian_Nancy_Cox	BENPORATH_ES_CORE_NINE_CORRELATED
0.806451612903%	1	124	98	Diabetes_McGill_Cell_cycle_All_Gene	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
0.806451612903%	1	124	98	Diabetes_McGill_Cell_cycle_All_Gene	MENSE_HYPOXIA_UP
0.806451612903%	1	124	98	Diabetes_McGill_Cell_cycle_All_Gene	GUO_TARGETS_OF_IRS1_AND_IRS2
0.806451612903%	1	124	98	Diabetes_McGill_Cell_cycle_All_Gene	GAVIN_FOXP3_TARGETS_CLUSTER_T7
0.806451612903%	1	124	98	Diabetes_McGill_Cell_cycle_All_Gene	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
0.806451612903%	1	124	96	Diabetes_McGill_Cell_cycle_All_Gene	ZAMORA_NOS2_TARGETS_DN
0.806451612903%	1	124	95	Diabetes_McGill_Cell_cycle_All_Gene	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
0.806451612903%	1	124	95	Diabetes_McGill_Cell_cycle_All_Gene	HOEBEKE_LYMPHOID_STEM_CELL_UP
0.806451612903%	1	124	940	Diabetes_McGill_Cell_cycle_All_Gene	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
0.806451612903%	1	124	94	Diabetes_McGill_Cell_cycle_All_Gene	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.806451612903%	1	124	93	Diabetes_McGill_Cell_cycle_All_Gene	ZHU_CMV_24_HR_UP
0.806451612903%	1	124	93	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_ACTIVATED_TLR4_SIGNALLING
0.806451612903%	1	124	92	Diabetes_McGill_Cell_cycle_All_Gene	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
0.806451612903%	1	124	92	Diabetes_McGill_Cell_cycle_All_Gene	CAMPS_COLON_CANCER_COPY_NUMBER_UP
0.806451612903%	1	124	90	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_GAP_JUNCTION
0.806451612903%	1	124	90	Diabetes_McGill_Cell_cycle_All_Gene	IGARASHI_ATF4_TARGETS_DN
0.806451612903%	1	124	90	Diabetes_McGill_Cell_cycle_All_Gene	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN
0.806451612903%	1	124	90	Diabetes_McGill_Cell_cycle_All_Gene	BILANGES_SERUM_SENSITIVE_GENES
0.806451612903%	1	124	9	Diabetes_McGill_Cell_cycle_All_Gene	ZERBINI_RESPONSE_TO_SULINDAC_UP
0.806451612903%	1	124	9	Diabetes_McGill_Cell_cycle_All_Gene	THILLAINADESAN_ZNF217_TARGETS_DN
0.806451612903%	1	124	9	Diabetes_McGill_Cell_cycle_All_Gene	RAFFEL_VEGFA_TARGETS_UP
0.806451612903%	1	124	9	Diabetes_McGill_Cell_cycle_All_Gene	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN
0.806451612903%	1	124	9	Diabetes_McGill_Cell_cycle_All_Gene	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21
0.806451612903%	1	124	9	Diabetes_McGill_Cell_cycle_All_Gene	KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP
0.806451612903%	1	124	9	Diabetes_McGill_Cell_cycle_All_Gene	ITO_PTTG1_TARGETS_DN
0.806451612903%	1	124	9	Diabetes_McGill_Cell_cycle_All_Gene	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN
0.806451612903%	1	124	9	Diabetes_McGill_Cell_cycle_All_Gene	FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1
0.806451612903%	1	124	9	Diabetes_McGill_Cell_cycle_All_Gene	COLLER_MYC_TARGETS_DN
0.806451612903%	1	124	9	Diabetes_McGill_Cell_cycle_All_Gene	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA
0.806451612903%	1	124	9	Diabetes_McGill_Cell_cycle_All_Gene	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1
0.806451612903%	1	124	89	Diabetes_McGill_Cell_cycle_All_Gene	LI_DCP2_BOUND_MRNA
0.806451612903%	1	124	89	Diabetes_McGill_Cell_cycle_All_Gene	LEE_AGING_NEOCORTEX_UP
0.806451612903%	1	124	88	Diabetes_McGill_Cell_cycle_All_Gene	SEIDEN_ONCOGENESIS_BY_MET
0.806451612903%	1	124	88	Diabetes_McGill_Cell_cycle_All_Gene	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
0.806451612903%	1	124	88	Diabetes_McGill_Cell_cycle_All_Gene	DURCHDEWALD_SKIN_CARCINOGENESIS_UP
0.806451612903%	1	124	87	Diabetes_McGill_Cell_cycle_All_Gene	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
0.806451612903%	1	124	87	Diabetes_McGill_Cell_cycle_All_Gene	SMITH_TERT_TARGETS_DN
0.806451612903%	1	124	87	Diabetes_McGill_Cell_cycle_All_Gene	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
0.806451612903%	1	124	86	Diabetes_McGill_Cell_cycle_All_Gene	NELSON_RESPONSE_TO_ANDROGEN_UP
0.806451612903%	1	124	86	Diabetes_McGill_Cell_cycle_All_Gene	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.806451612903%	1	124	86	Diabetes_McGill_Cell_cycle_All_Gene	LEE_AGING_CEREBELLUM_DN
0.806451612903%	1	124	86	Diabetes_McGill_Cell_cycle_All_Gene	HOEBEKE_LYMPHOID_STEM_CELL_DN
0.806451612903%	1	124	86	Diabetes_McGill_Cell_cycle_All_Gene	GHANDHI_BYSTANDER_IRRADIATION_UP
0.806451612903%	1	124	857	Diabetes_McGill_Cell_cycle_All_Gene	MARTENS_TRETINOIN_RESPONSE_UP
0.806451612903%	1	124	84	Diabetes_McGill_Cell_cycle_All_Gene	RUAN_RESPONSE_TO_TNF_DN
0.806451612903%	1	124	83	Diabetes_McGill_Cell_cycle_All_Gene	SANA_TNF_SIGNALING_UP
0.806451612903%	1	124	83	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
0.806451612903%	1	124	83	Diabetes_McGill_Cell_cycle_All_Gene	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
0.806451612903%	1	124	83	Diabetes_McGill_Cell_cycle_All_Gene	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.806451612903%	1	124	82	Diabetes_McGill_Cell_cycle_All_Gene	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
0.806451612903%	1	124	82	Diabetes_McGill_Cell_cycle_All_Gene	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
0.806451612903%	1	124	82	Diabetes_McGill_Cell_cycle_All_Gene	BILD_CTNNB1_ONCOGENIC_SIGNATURE
0.806451612903%	1	124	81	Diabetes_McGill_Cell_cycle_All_Gene	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.806451612903%	1	124	81	Diabetes_McGill_Cell_cycle_All_Gene	LEIN_MEDULLA_MARKERS
0.806451612903%	1	124	81	Diabetes_McGill_Cell_cycle_All_Gene	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
0.806451612903%	1	124	80	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_UNFOLDED_PROTEIN_RESPONSE
0.806451612903%	1	124	80	Diabetes_McGill_Cell_cycle_All_Gene	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN
0.806451612903%	1	124	80	Diabetes_McGill_Cell_cycle_All_Gene	BASSO_HAIRY_CELL_LEUKEMIA_DN
0.806451612903%	1	124	8	Diabetes_McGill_Cell_cycle_All_Gene	TURJANSKI_MAPK8_AND_MAPK9_TARGETS
0.806451612903%	1	124	8	Diabetes_McGill_Cell_cycle_All_Gene	TURJANSKI_MAPK7_TARGETS
0.806451612903%	1	124	8	Diabetes_McGill_Cell_cycle_All_Gene	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN
0.806451612903%	1	124	8	Diabetes_McGill_Cell_cycle_All_Gene	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN
0.806451612903%	1	124	8	Diabetes_McGill_Cell_cycle_All_Gene	NAKAMURA_LUNG_CANCER
0.806451612903%	1	124	8	Diabetes_McGill_Cell_cycle_All_Gene	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18
0.806451612903%	1	124	8	Diabetes_McGill_Cell_cycle_All_Gene	LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP
0.806451612903%	1	124	8	Diabetes_McGill_Cell_cycle_All_Gene	GAUTSCHI_SRC_SIGNALING
0.806451612903%	1	124	8	Diabetes_McGill_Cell_cycle_All_Gene	GALIE_TUMOR_ANGIOGENESIS
0.806451612903%	1	124	8	Diabetes_McGill_Cell_cycle_All_Gene	FUJIWARA_PARK2_IN_LIVER_CANCER_UP
0.806451612903%	1	124	79	Diabetes_McGill_Cell_cycle_All_Gene	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16
0.806451612903%	1	124	79	Diabetes_McGill_Cell_cycle_All_Gene	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
0.806451612903%	1	124	79	Diabetes_McGill_Cell_cycle_All_Gene	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
0.806451612903%	1	124	79	Diabetes_McGill_Cell_cycle_All_Gene	MCCLUNG_COCAINE_REWARD_5D
0.806451612903%	1	124	79	Diabetes_McGill_Cell_cycle_All_Gene	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.806451612903%	1	124	79	Diabetes_McGill_Cell_cycle_All_Gene	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
0.806451612903%	1	124	78	Diabetes_McGill_Cell_cycle_All_Gene	ROSS_LEUKEMIA_WITH_MLL_FUSIONS
0.806451612903%	1	124	78	Diabetes_McGill_Cell_cycle_All_Gene	ROSS_AML_WITH_MLL_FUSIONS
0.806451612903%	1	124	78	Diabetes_McGill_Cell_cycle_All_Gene	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
0.806451612903%	1	124	78	Diabetes_McGill_Cell_cycle_All_Gene	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.806451612903%	1	124	78	Diabetes_McGill_Cell_cycle_All_Gene	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE
0.806451612903%	1	124	77	Diabetes_McGill_Cell_cycle_All_Gene	SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.806451612903%	1	124	77	Diabetes_McGill_Cell_cycle_All_Gene	RODRIGUES_THYROID_CARCINOMA_DN
0.806451612903%	1	124	77	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
0.806451612903%	1	124	77	Diabetes_McGill_Cell_cycle_All_Gene	CHEBOTAEV_GR_TARGETS_UP
0.806451612903%	1	124	76	Diabetes_McGill_Cell_cycle_All_Gene	ROSS_AML_WITH_AML1_ETO_FUSION
0.806451612903%	1	124	76	Diabetes_McGill_Cell_cycle_All_Gene	NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON
0.806451612903%	1	124	75	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_TELOMERE_MAINTENANCE
0.806451612903%	1	124	75	Diabetes_McGill_Cell_cycle_All_Gene	PID_AVB3_INTEGRIN_PATHWAY
0.806451612903%	1	124	75	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.806451612903%	1	124	75	Diabetes_McGill_Cell_cycle_All_Gene	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
0.806451612903%	1	124	75	Diabetes_McGill_Cell_cycle_All_Gene	BAE_BRCA1_TARGETS_UP
0.806451612903%	1	124	74	Diabetes_McGill_Cell_cycle_All_Gene	WESTON_VEGFA_TARGETS_3HR
0.806451612903%	1	124	74	Diabetes_McGill_Cell_cycle_All_Gene	URS_ADIPOCYTE_DIFFERENTIATION_UP
0.806451612903%	1	124	74	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
0.806451612903%	1	124	74	Diabetes_McGill_Cell_cycle_All_Gene	OUILLETTE_CLL_13Q14_DELETION_UP
0.806451612903%	1	124	74	Diabetes_McGill_Cell_cycle_All_Gene	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
0.806451612903%	1	124	74	Diabetes_McGill_Cell_cycle_All_Gene	FURUKAWA_DUSP6_TARGETS_PCI35_UP
0.806451612903%	1	124	74	Diabetes_McGill_Cell_cycle_All_Gene	DARWICHE_PAPILLOMA_PROGRESSION_RISK
0.806451612903%	1	124	74	Diabetes_McGill_Cell_cycle_All_Gene	CORRE_MULTIPLE_MYELOMA_UP
0.806451612903%	1	124	73	Diabetes_McGill_Cell_cycle_All_Gene	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.806451612903%	1	124	73	Diabetes_McGill_Cell_cycle_All_Gene	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.806451612903%	1	124	73	Diabetes_McGill_Cell_cycle_All_Gene	GAURNIER_PSMD4_TARGETS
0.806451612903%	1	124	73	Diabetes_McGill_Cell_cycle_All_Gene	DITTMER_PTHLH_TARGETS_DN
0.806451612903%	1	124	72	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
0.806451612903%	1	124	72	Diabetes_McGill_Cell_cycle_All_Gene	BURTON_ADIPOGENESIS_2
0.806451612903%	1	124	71	Diabetes_McGill_Cell_cycle_All_Gene	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.806451612903%	1	124	71	Diabetes_McGill_Cell_cycle_All_Gene	DER_IFN_GAMMA_RESPONSE_UP
0.806451612903%	1	124	701	Diabetes_McGill_Cell_cycle_All_Gene	SMID_BREAST_CANCER_BASAL_DN
0.806451612903%	1	124	70	Diabetes_McGill_Cell_cycle_All_Gene	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5
0.806451612903%	1	124	70	Diabetes_McGill_Cell_cycle_All_Gene	PID_CDC42_PATHWAY
0.806451612903%	1	124	70	Diabetes_McGill_Cell_cycle_All_Gene	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
0.806451612903%	1	124	70	Diabetes_McGill_Cell_cycle_All_Gene	ENGELMANN_CANCER_PROGENITORS_DN
0.806451612903%	1	124	7	Diabetes_McGill_Cell_cycle_All_Gene	TESAR_ALK_TARGETS_HUMAN_ES_5D_DN
0.806451612903%	1	124	7	Diabetes_McGill_Cell_cycle_All_Gene	TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP
0.806451612903%	1	124	7	Diabetes_McGill_Cell_cycle_All_Gene	SCHRAMM_INHBA_TARGETS_UP
0.806451612903%	1	124	7	Diabetes_McGill_Cell_cycle_All_Gene	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN
0.806451612903%	1	124	7	Diabetes_McGill_Cell_cycle_All_Gene	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP
0.806451612903%	1	124	7	Diabetes_McGill_Cell_cycle_All_Gene	MIKKELSEN_DEDIFFERENTIATED_STATE_DN
0.806451612903%	1	124	7	Diabetes_McGill_Cell_cycle_All_Gene	KUWANO_RNA_STABILIZED_BY_NO
0.806451612903%	1	124	7	Diabetes_McGill_Cell_cycle_All_Gene	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.806451612903%	1	124	7	Diabetes_McGill_Cell_cycle_All_Gene	FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES
0.806451612903%	1	124	69	Diabetes_McGill_Cell_cycle_All_Gene	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10
0.806451612903%	1	124	69	Diabetes_McGill_Cell_cycle_All_Gene	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.806451612903%	1	124	69	Diabetes_McGill_Cell_cycle_All_Gene	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.806451612903%	1	124	69	Diabetes_McGill_Cell_cycle_All_Gene	LEIN_NEURON_MARKERS
0.806451612903%	1	124	69	Diabetes_McGill_Cell_cycle_All_Gene	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
0.806451612903%	1	124	68	Diabetes_McGill_Cell_cycle_All_Gene	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
0.806451612903%	1	124	68	Diabetes_McGill_Cell_cycle_All_Gene	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.806451612903%	1	124	68	Diabetes_McGill_Cell_cycle_All_Gene	DELPUECH_FOXO3_TARGETS_UP
0.806451612903%	1	124	67	Diabetes_McGill_Cell_cycle_All_Gene	VANHARANTA_UTERINE_FIBROID_DN
0.806451612903%	1	124	67	Diabetes_McGill_Cell_cycle_All_Gene	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
0.806451612903%	1	124	67	Diabetes_McGill_Cell_cycle_All_Gene	ELVIDGE_HIF1A_TARGETS_UP
0.806451612903%	1	124	67	Diabetes_McGill_Cell_cycle_All_Gene	DAZARD_UV_RESPONSE_CLUSTER_G1
0.806451612903%	1	124	67	Diabetes_McGill_Cell_cycle_All_Gene	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70
0.806451612903%	1	124	66	Diabetes_McGill_Cell_cycle_All_Gene	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
0.806451612903%	1	124	66	Diabetes_McGill_Cell_cycle_All_Gene	PID_LYSOPHOSPHOLIPID_PATHWAY
0.806451612903%	1	124	66	Diabetes_McGill_Cell_cycle_All_Gene	LEE_LIVER_CANCER_CIPROFIBRATE_DN
0.806451612903%	1	124	66	Diabetes_McGill_Cell_cycle_All_Gene	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.806451612903%	1	124	66	Diabetes_McGill_Cell_cycle_All_Gene	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN
0.806451612903%	1	124	66	Diabetes_McGill_Cell_cycle_All_Gene	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP
0.806451612903%	1	124	66	Diabetes_McGill_Cell_cycle_All_Gene	BRUNO_HEMATOPOIESIS
0.806451612903%	1	124	652	Diabetes_McGill_Cell_cycle_All_Gene	BENPORATH_PRC2_TARGETS
0.806451612903%	1	124	65	Diabetes_McGill_Cell_cycle_All_Gene	ST_FAS_SIGNALING_PATHWAY
0.806451612903%	1	124	65	Diabetes_McGill_Cell_cycle_All_Gene	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
0.806451612903%	1	124	65	Diabetes_McGill_Cell_cycle_All_Gene	GUO_HEX_TARGETS_DN
0.806451612903%	1	124	65	Diabetes_McGill_Cell_cycle_All_Gene	CHANG_IMMORTALIZED_BY_HPV31_DN
0.806451612903%	1	124	64	Diabetes_McGill_Cell_cycle_All_Gene	ZHANG_GATA6_TARGETS_DN
0.806451612903%	1	124	64	Diabetes_McGill_Cell_cycle_All_Gene	LEE_LIVER_CANCER_ACOX1_UP
0.806451612903%	1	124	64	Diabetes_McGill_Cell_cycle_All_Gene	INGRAM_SHH_TARGETS_DN
0.806451612903%	1	124	64	Diabetes_McGill_Cell_cycle_All_Gene	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.806451612903%	1	124	64	Diabetes_McGill_Cell_cycle_All_Gene	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
0.806451612903%	1	124	64	Diabetes_McGill_Cell_cycle_All_Gene	BYSTROEM_CORRELATED_WITH_IL5_DN
0.806451612903%	1	124	62	Diabetes_McGill_Cell_cycle_All_Gene	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
0.806451612903%	1	124	62	Diabetes_McGill_Cell_cycle_All_Gene	MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN
0.806451612903%	1	124	62	Diabetes_McGill_Cell_cycle_All_Gene	KYNG_DNA_DAMAGE_BY_UV
0.806451612903%	1	124	62	Diabetes_McGill_Cell_cycle_All_Gene	BILD_SRC_ONCOGENIC_SIGNATURE
0.806451612903%	1	124	61	Diabetes_McGill_Cell_cycle_All_Gene	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
0.806451612903%	1	124	61	Diabetes_McGill_Cell_cycle_All_Gene	LEE_LIVER_CANCER_MYC_TGFA_UP
0.806451612903%	1	124	60	Diabetes_McGill_Cell_cycle_All_Gene	WIERENGA_STAT5A_TARGETS_GROUP2
0.806451612903%	1	124	60	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE
0.806451612903%	1	124	60	Diabetes_McGill_Cell_cycle_All_Gene	LEE_LIVER_CANCER_DENA_UP
0.806451612903%	1	124	60	Diabetes_McGill_Cell_cycle_All_Gene	LEE_LIVER_CANCER_CIPROFIBRATE_UP
0.806451612903%	1	124	6	Diabetes_McGill_Cell_cycle_All_Gene	TESAR_ALK_TARGETS_HUMAN_ES_4D_DN
0.806451612903%	1	124	6	Diabetes_McGill_Cell_cycle_All_Gene	OHASHI_AURKA_TARGETS
0.806451612903%	1	124	6	Diabetes_McGill_Cell_cycle_All_Gene	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6
0.806451612903%	1	124	6	Diabetes_McGill_Cell_cycle_All_Gene	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_14
0.806451612903%	1	124	6	Diabetes_McGill_Cell_cycle_All_Gene	MAINA_HYPOXIA_VHL_TARGETS_UP
0.806451612903%	1	124	6	Diabetes_McGill_Cell_cycle_All_Gene	GALI_TP53_TARGETS_APOPTOTIC_DN
0.806451612903%	1	124	6	Diabetes_McGill_Cell_cycle_All_Gene	DONATO_CELL_CYCLE_TRETINOIN
0.806451612903%	1	124	6	Diabetes_McGill_Cell_cycle_All_Gene	DING_LUNG_CANCER_MUTATED_RECURRENTLY
0.806451612903%	1	124	6	Diabetes_McGill_Cell_cycle_All_Gene	BUSA_SAM68_TARGETS_DN
0.806451612903%	1	124	59	Diabetes_McGill_Cell_cycle_All_Gene	PID_FAK_PATHWAY
0.806451612903%	1	124	59	Diabetes_McGill_Cell_cycle_All_Gene	ELVIDGE_HYPOXIA_BY_DMOG_DN
0.806451612903%	1	124	59	Diabetes_McGill_Cell_cycle_All_Gene	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1
0.806451612903%	1	124	58	Diabetes_McGill_Cell_cycle_All_Gene	NAGASHIMA_NRG1_SIGNALING_DN
0.806451612903%	1	124	58	Diabetes_McGill_Cell_cycle_All_Gene	NAGASHIMA_EGF_SIGNALING_UP
0.806451612903%	1	124	57	Diabetes_McGill_Cell_cycle_All_Gene	MCCLUNG_CREB1_TARGETS_DN
0.806451612903%	1	124	57	Diabetes_McGill_Cell_cycle_All_Gene	LEE_EARLY_T_LYMPHOCYTE_DN
0.806451612903%	1	124	57	Diabetes_McGill_Cell_cycle_All_Gene	GRABARCZYK_BCL11B_TARGETS_DN
0.806451612903%	1	124	57	Diabetes_McGill_Cell_cycle_All_Gene	BURTON_ADIPOGENESIS_11
0.806451612903%	1	124	57	Diabetes_McGill_Cell_cycle_All_Gene	AMIT_SERUM_RESPONSE_240_MCF10A
0.806451612903%	1	124	56	Diabetes_McGill_Cell_cycle_All_Gene	VANTVEER_BREAST_CANCER_METASTASIS_UP
0.806451612903%	1	124	56	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_HEDGEHOG_SIGNALING_PATHWAY
0.806451612903%	1	124	55	Diabetes_McGill_Cell_cycle_All_Gene	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
0.806451612903%	1	124	55	Diabetes_McGill_Cell_cycle_All_Gene	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR
0.806451612903%	1	124	546	Diabetes_McGill_Cell_cycle_All_Gene	WEST_ADRENOCORTICAL_TUMOR_DN
0.806451612903%	1	124	540	Diabetes_McGill_Cell_cycle_All_Gene	ACEVEDO_LIVER_CANCER_DN
0.806451612903%	1	124	54	Diabetes_McGill_Cell_cycle_All_Gene	ZHOU_TNF_SIGNALING_4HR
0.806451612903%	1	124	54	Diabetes_McGill_Cell_cycle_All_Gene	ZHOU_TNF_SIGNALING_30MIN
0.806451612903%	1	124	54	Diabetes_McGill_Cell_cycle_All_Gene	SESTO_RESPONSE_TO_UV_C2
0.806451612903%	1	124	54	Diabetes_McGill_Cell_cycle_All_Gene	ROVERSI_GLIOMA_COPY_NUMBER_DN
0.806451612903%	1	124	54	Diabetes_McGill_Cell_cycle_All_Gene	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN
0.806451612903%	1	124	54	Diabetes_McGill_Cell_cycle_All_Gene	JIANG_AGING_CEREBRAL_CORTEX_DN
0.806451612903%	1	124	54	Diabetes_McGill_Cell_cycle_All_Gene	HUPER_BREAST_BASAL_VS_LUMINAL_UP
0.806451612903%	1	124	536	Diabetes_McGill_Cell_cycle_All_Gene	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
0.806451612903%	1	124	53	Diabetes_McGill_Cell_cycle_All_Gene	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP
0.806451612903%	1	124	53	Diabetes_McGill_Cell_cycle_All_Gene	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
0.806451612903%	1	124	53	Diabetes_McGill_Cell_cycle_All_Gene	LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.806451612903%	1	124	53	Diabetes_McGill_Cell_cycle_All_Gene	KRIEG_HYPOXIA_VIA_KDM3A
0.806451612903%	1	124	53	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
0.806451612903%	1	124	53	Diabetes_McGill_Cell_cycle_All_Gene	HENDRICKS_SMARCA4_TARGETS_DN
0.806451612903%	1	124	52	Diabetes_McGill_Cell_cycle_All_Gene	WINTER_HYPOXIA_DN
0.806451612903%	1	124	52	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.806451612903%	1	124	52	Diabetes_McGill_Cell_cycle_All_Gene	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN
0.806451612903%	1	124	51	Diabetes_McGill_Cell_cycle_All_Gene	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN
0.806451612903%	1	124	51	Diabetes_McGill_Cell_cycle_All_Gene	GUILLAUMOND_KLF10_TARGETS_UP
0.806451612903%	1	124	51	Diabetes_McGill_Cell_cycle_All_Gene	BURTON_ADIPOGENESIS_7
0.806451612903%	1	124	504	Diabetes_McGill_Cell_cycle_All_Gene	PILON_KLF1_TARGETS_UP
0.806451612903%	1	124	50	Diabetes_McGill_Cell_cycle_All_Gene	YANG_BREAST_CANCER_ESR1_LASER_DN
0.806451612903%	1	124	50	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
0.806451612903%	1	124	50	Diabetes_McGill_Cell_cycle_All_Gene	PID_ANGIOPOIETINRECEPTOR_PATHWAY
0.806451612903%	1	124	50	Diabetes_McGill_Cell_cycle_All_Gene	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
0.806451612903%	1	124	50	Diabetes_McGill_Cell_cycle_All_Gene	MARTINEZ_RESPONSE_TO_TRABECTEDIN
0.806451612903%	1	124	50	Diabetes_McGill_Cell_cycle_All_Gene	KOHOUTEK_CCNT1_TARGETS
0.806451612903%	1	124	50	Diabetes_McGill_Cell_cycle_All_Gene	BECKER_TAMOXIFEN_RESISTANCE_UP
0.806451612903%	1	124	5	Diabetes_McGill_Cell_cycle_All_Gene	WANG_THOC1_TARGETS_UP
0.806451612903%	1	124	5	Diabetes_McGill_Cell_cycle_All_Gene	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3
0.806451612903%	1	124	5	Diabetes_McGill_Cell_cycle_All_Gene	PASTURAL_RIZ1_TARGETS_DN
0.806451612903%	1	124	5	Diabetes_McGill_Cell_cycle_All_Gene	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2
0.806451612903%	1	124	5	Diabetes_McGill_Cell_cycle_All_Gene	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_11
0.806451612903%	1	124	5	Diabetes_McGill_Cell_cycle_All_Gene	KERLEY_RESPONSE_TO_CISPLATIN_DN
0.806451612903%	1	124	5	Diabetes_McGill_Cell_cycle_All_Gene	CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN
0.806451612903%	1	124	5	Diabetes_McGill_Cell_cycle_All_Gene	CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP
0.806451612903%	1	124	5	Diabetes_McGill_Cell_cycle_All_Gene	BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.806451612903%	1	124	49	Diabetes_McGill_Cell_cycle_All_Gene	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8
0.806451612903%	1	124	49	Diabetes_McGill_Cell_cycle_All_Gene	WONG_PROTEASOME_GENE_MODULE
0.806451612903%	1	124	49	Diabetes_McGill_Cell_cycle_All_Gene	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
0.806451612903%	1	124	49	Diabetes_McGill_Cell_cycle_All_Gene	DAUER_STAT3_TARGETS_UP
0.806451612903%	1	124	49	Diabetes_McGill_Cell_cycle_All_Gene	APRELIKOVA_BRCA1_TARGETS
0.806451612903%	1	124	487	Diabetes_McGill_Cell_cycle_All_Gene	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
0.806451612903%	1	124	482	Diabetes_McGill_Cell_cycle_All_Gene	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
0.806451612903%	1	124	48	Diabetes_McGill_Cell_cycle_All_Gene	TAVOR_CEBPA_TARGETS_UP
0.806451612903%	1	124	48	Diabetes_McGill_Cell_cycle_All_Gene	NADLER_OBESITY_DN
0.806451612903%	1	124	48	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.806451612903%	1	124	48	Diabetes_McGill_Cell_cycle_All_Gene	GNATENKO_PLATELET_SIGNATURE
0.806451612903%	1	124	48	Diabetes_McGill_Cell_cycle_All_Gene	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN
0.806451612903%	1	124	48	Diabetes_McGill_Cell_cycle_All_Gene	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
0.806451612903%	1	124	48	Diabetes_McGill_Cell_cycle_All_Gene	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN
0.806451612903%	1	124	48	Diabetes_McGill_Cell_cycle_All_Gene	ENGELMANN_CANCER_PROGENITORS_UP
0.806451612903%	1	124	48	Diabetes_McGill_Cell_cycle_All_Gene	DELACROIX_RAR_TARGETS_UP
0.806451612903%	1	124	476	Diabetes_McGill_Cell_cycle_All_Gene	SMID_BREAST_CANCER_NORMAL_LIKE_UP
0.806451612903%	1	124	47	Diabetes_McGill_Cell_cycle_All_Gene	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
0.806451612903%	1	124	47	Diabetes_McGill_Cell_cycle_All_Gene	PID_IL6_7PATHWAY
0.806451612903%	1	124	47	Diabetes_McGill_Cell_cycle_All_Gene	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP
0.806451612903%	1	124	467	Diabetes_McGill_Cell_cycle_All_Gene	RATTENBACHER_BOUND_BY_CELF1
0.806451612903%	1	124	46	Diabetes_McGill_Cell_cycle_All_Gene	TSENG_ADIPOGENIC_POTENTIAL_DN
0.806451612903%	1	124	46	Diabetes_McGill_Cell_cycle_All_Gene	SIG_BCR_SIGNALING_PATHWAY
0.806451612903%	1	124	46	Diabetes_McGill_Cell_cycle_All_Gene	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6
0.806451612903%	1	124	46	Diabetes_McGill_Cell_cycle_All_Gene	SAGIV_CD24_TARGETS_DN
0.806451612903%	1	124	46	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
0.806451612903%	1	124	46	Diabetes_McGill_Cell_cycle_All_Gene	PID_SYNDECAN_1_PATHWAY
0.806451612903%	1	124	46	Diabetes_McGill_Cell_cycle_All_Gene	PID_RHOA_REG_PATHWAY
0.806451612903%	1	124	46	Diabetes_McGill_Cell_cycle_All_Gene	PARENT_MTOR_SIGNALING_DN
0.806451612903%	1	124	46	Diabetes_McGill_Cell_cycle_All_Gene	NUTT_GBM_VS_AO_GLIOMA_UP
0.806451612903%	1	124	46	Diabetes_McGill_Cell_cycle_All_Gene	HALMOS_CEBPA_TARGETS_DN
0.806451612903%	1	124	46	Diabetes_McGill_Cell_cycle_All_Gene	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN
0.806451612903%	1	124	46	Diabetes_McGill_Cell_cycle_All_Gene	AMIT_EGF_RESPONSE_60_HELA
0.806451612903%	1	124	45	Diabetes_McGill_Cell_cycle_All_Gene	ZHAN_V2_LATE_DIFFERENTIATION_GENES
0.806451612903%	1	124	45	Diabetes_McGill_Cell_cycle_All_Gene	WANG_TARGETS_OF_MLL_CBP_FUSION_DN
0.806451612903%	1	124	45	Diabetes_McGill_Cell_cycle_All_Gene	VANHARANTA_UTERINE_FIBROID_UP
0.806451612903%	1	124	45	Diabetes_McGill_Cell_cycle_All_Gene	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
0.806451612903%	1	124	45	Diabetes_McGill_Cell_cycle_All_Gene	SHIPP_DLBCL_CURED_VS_FATAL_DN
0.806451612903%	1	124	45	Diabetes_McGill_Cell_cycle_All_Gene	PID_RHOA_PATHWAY
0.806451612903%	1	124	45	Diabetes_McGill_Cell_cycle_All_Gene	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN
0.806451612903%	1	124	45	Diabetes_McGill_Cell_cycle_All_Gene	GRADE_METASTASIS_DN
0.806451612903%	1	124	448	Diabetes_McGill_Cell_cycle_All_Gene	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
0.806451612903%	1	124	44	Diabetes_McGill_Cell_cycle_All_Gene	XU_CREBBP_TARGETS_DN
0.806451612903%	1	124	44	Diabetes_McGill_Cell_cycle_All_Gene	WANG_TARGETS_OF_MLL_CBP_FUSION_UP
0.806451612903%	1	124	44	Diabetes_McGill_Cell_cycle_All_Gene	VANTVEER_BREAST_CANCER_BRCA1_DN
0.806451612903%	1	124	44	Diabetes_McGill_Cell_cycle_All_Gene	THILLAINADESAN_ZNF217_TARGETS_UP
0.806451612903%	1	124	44	Diabetes_McGill_Cell_cycle_All_Gene	ROVERSI_GLIOMA_LOH_REGIONS
0.806451612903%	1	124	44	Diabetes_McGill_Cell_cycle_All_Gene	PARK_HSC_MARKERS
0.806451612903%	1	124	44	Diabetes_McGill_Cell_cycle_All_Gene	OHGUCHI_LIVER_HNF4A_TARGETS_UP
0.806451612903%	1	124	44	Diabetes_McGill_Cell_cycle_All_Gene	MEDINA_SMARCA4_TARGETS
0.806451612903%	1	124	44	Diabetes_McGill_Cell_cycle_All_Gene	MARTIN_INTERACT_WITH_HDAC
0.806451612903%	1	124	44	Diabetes_McGill_Cell_cycle_All_Gene	LUI_THYROID_CANCER_PAX8_PPARG_UP
0.806451612903%	1	124	44	Diabetes_McGill_Cell_cycle_All_Gene	KORKOLA_SEMINOMA_UP
0.806451612903%	1	124	44	Diabetes_McGill_Cell_cycle_All_Gene	JAEGER_METASTASIS_UP
0.806451612903%	1	124	44	Diabetes_McGill_Cell_cycle_All_Gene	CHUNG_BLISTER_CYTOTOXICITY_DN
0.806451612903%	1	124	431	Diabetes_McGill_Cell_cycle_All_Gene	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.806451612903%	1	124	43	Diabetes_McGill_Cell_cycle_All_Gene	ZUCCHI_METASTASIS_UP
0.806451612903%	1	124	43	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_IL_3_5_AND_GM_CSF_SIGNALING
0.806451612903%	1	124	43	Diabetes_McGill_Cell_cycle_All_Gene	POTTI_5FU_SENSITIVITY
0.806451612903%	1	124	43	Diabetes_McGill_Cell_cycle_All_Gene	NAKAYAMA_FRA2_TARGETS
0.806451612903%	1	124	43	Diabetes_McGill_Cell_cycle_All_Gene	MILI_PSEUDOPODIA
0.806451612903%	1	124	43	Diabetes_McGill_Cell_cycle_All_Gene	LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.806451612903%	1	124	43	Diabetes_McGill_Cell_cycle_All_Gene	HUMMEL_BURKITTS_LYMPHOMA_UP
0.806451612903%	1	124	43	Diabetes_McGill_Cell_cycle_All_Gene	FUJII_YBX1_TARGETS_UP
0.806451612903%	1	124	43	Diabetes_McGill_Cell_cycle_All_Gene	DORN_ADENOVIRUS_INFECTION_24HR_DN
0.806451612903%	1	124	420	Diabetes_McGill_Cell_cycle_All_Gene	MOOTHA_PGC
0.806451612903%	1	124	42	Diabetes_McGill_Cell_cycle_All_Gene	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
0.806451612903%	1	124	42	Diabetes_McGill_Cell_cycle_All_Gene	PID_UPA_UPAR_PATHWAY
0.806451612903%	1	124	42	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
0.806451612903%	1	124	42	Diabetes_McGill_Cell_cycle_All_Gene	AMIT_EGF_RESPONSE_40_HELA
0.806451612903%	1	124	41	Diabetes_McGill_Cell_cycle_All_Gene	WENG_POR_TARGETS_LIVER_UP
0.806451612903%	1	124	41	Diabetes_McGill_Cell_cycle_All_Gene	LIN_MELANOMA_COPY_NUMBER_DN
0.806451612903%	1	124	41	Diabetes_McGill_Cell_cycle_All_Gene	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN
0.806451612903%	1	124	41	Diabetes_McGill_Cell_cycle_All_Gene	KORKOLA_EMBRYONAL_CARCINOMA_UP
0.806451612903%	1	124	41	Diabetes_McGill_Cell_cycle_All_Gene	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
0.806451612903%	1	124	41	Diabetes_McGill_Cell_cycle_All_Gene	EHLERS_ANEUPLOIDY_UP
0.806451612903%	1	124	41	Diabetes_McGill_Cell_cycle_All_Gene	DELPUECH_FOXO3_TARGETS_DN
0.806451612903%	1	124	41	Diabetes_McGill_Cell_cycle_All_Gene	CHEN_HOXA5_TARGETS_9HR_DN
0.806451612903%	1	124	40	Diabetes_McGill_Cell_cycle_All_Gene	RIZ_ERYTHROID_DIFFERENTIATION_6HR
0.806451612903%	1	124	40	Diabetes_McGill_Cell_cycle_All_Gene	MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.806451612903%	1	124	40	Diabetes_McGill_Cell_cycle_All_Gene	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP
0.806451612903%	1	124	40	Diabetes_McGill_Cell_cycle_All_Gene	GENTILE_UV_RESPONSE_CLUSTER_D7
0.806451612903%	1	124	40	Diabetes_McGill_Cell_cycle_All_Gene	DORN_ADENOVIRUS_INFECTION_48HR_DN
0.806451612903%	1	124	40	Diabetes_McGill_Cell_cycle_All_Gene	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN
0.806451612903%	1	124	40	Diabetes_McGill_Cell_cycle_All_Gene	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.806451612903%	1	124	398	Diabetes_McGill_Cell_cycle_All_Gene	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
0.806451612903%	1	124	39	Diabetes_McGill_Cell_cycle_All_Gene	STONER_ESOPHAGEAL_CARCINOGENESIS_UP
0.806451612903%	1	124	39	Diabetes_McGill_Cell_cycle_All_Gene	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP
0.806451612903%	1	124	39	Diabetes_McGill_Cell_cycle_All_Gene	SESTO_RESPONSE_TO_UV_C6
0.806451612903%	1	124	39	Diabetes_McGill_Cell_cycle_All_Gene	PID_ECADHERIN_NASCENTAJ_PATHWAY
0.806451612903%	1	124	39	Diabetes_McGill_Cell_cycle_All_Gene	PID_AURORA_B_PATHWAY
0.806451612903%	1	124	39	Diabetes_McGill_Cell_cycle_All_Gene	NEWMAN_ERCC6_TARGETS_DN
0.806451612903%	1	124	39	Diabetes_McGill_Cell_cycle_All_Gene	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
0.806451612903%	1	124	39	Diabetes_McGill_Cell_cycle_All_Gene	GU_PDEF_TARGETS_DN
0.806451612903%	1	124	39	Diabetes_McGill_Cell_cycle_All_Gene	DORN_ADENOVIRUS_INFECTION_32HR_DN
0.806451612903%	1	124	39	Diabetes_McGill_Cell_cycle_All_Gene	CONRAD_STEM_CELL
0.806451612903%	1	124	39	Diabetes_McGill_Cell_cycle_All_Gene	AMIT_EGF_RESPONSE_60_MCF10A
0.806451612903%	1	124	39	Diabetes_McGill_Cell_cycle_All_Gene	AIYAR_COBRA1_TARGETS_UP
0.806451612903%	1	124	388	Diabetes_McGill_Cell_cycle_All_Gene	STEIN_ESRRA_TARGETS_UP
0.806451612903%	1	124	384	Diabetes_McGill_Cell_cycle_All_Gene	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
0.806451612903%	1	124	380	Diabetes_McGill_Cell_cycle_All_Gene	MULLIGHAN_MLL_SIGNATURE_1_UP
0.806451612903%	1	124	38	Diabetes_McGill_Cell_cycle_All_Gene	YOKOE_CANCER_TESTIS_ANTIGENS
0.806451612903%	1	124	38	Diabetes_McGill_Cell_cycle_All_Gene	TERAO_AOX4_TARGETS_SKIN_UP
0.806451612903%	1	124	38	Diabetes_McGill_Cell_cycle_All_Gene	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
0.806451612903%	1	124	38	Diabetes_McGill_Cell_cycle_All_Gene	SPIRA_SMOKERS_LUNG_CANCER_UP
0.806451612903%	1	124	38	Diabetes_McGill_Cell_cycle_All_Gene	PID_P38ALPHABETADOWNSTREAMPATHWAY
0.806451612903%	1	124	38	Diabetes_McGill_Cell_cycle_All_Gene	PID_ERBB4_PATHWAY
0.806451612903%	1	124	38	Diabetes_McGill_Cell_cycle_All_Gene	NIKOLSKY_BREAST_CANCER_7P22_AMPLICON
0.806451612903%	1	124	38	Diabetes_McGill_Cell_cycle_All_Gene	NAKAMURA_ADIPOGENESIS_LATE_DN
0.806451612903%	1	124	38	Diabetes_McGill_Cell_cycle_All_Gene	GRADE_COLON_VS_RECTAL_CANCER_UP
0.806451612903%	1	124	38	Diabetes_McGill_Cell_cycle_All_Gene	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP
0.806451612903%	1	124	38	Diabetes_McGill_Cell_cycle_All_Gene	CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN
0.806451612903%	1	124	37	Diabetes_McGill_Cell_cycle_All_Gene	ST_P38_MAPK_PATHWAY
0.806451612903%	1	124	37	Diabetes_McGill_Cell_cycle_All_Gene	PID_GMCSF_PATHWAY
0.806451612903%	1	124	37	Diabetes_McGill_Cell_cycle_All_Gene	KIM_ALL_DISORDERS_CALB1_CORR_DN
0.806451612903%	1	124	37	Diabetes_McGill_Cell_cycle_All_Gene	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR
0.806451612903%	1	124	37	Diabetes_McGill_Cell_cycle_All_Gene	HU_ANGIOGENESIS_DN
0.806451612903%	1	124	37	Diabetes_McGill_Cell_cycle_All_Gene	FRASOR_RESPONSE_TO_ESTRADIOL_UP
0.806451612903%	1	124	37	Diabetes_McGill_Cell_cycle_All_Gene	CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE
0.806451612903%	1	124	367	Diabetes_McGill_Cell_cycle_All_Gene	VECCHI_GASTRIC_CANCER_EARLY_DN
0.806451612903%	1	124	36	Diabetes_McGill_Cell_cycle_All_Gene	VANTVEER_BREAST_CANCER_BRCA1_UP
0.806451612903%	1	124	36	Diabetes_McGill_Cell_cycle_All_Gene	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
0.806451612903%	1	124	36	Diabetes_McGill_Cell_cycle_All_Gene	MMS_MOUSE_LYMPH_HIGH_4HRS_UP
0.806451612903%	1	124	36	Diabetes_McGill_Cell_cycle_All_Gene	JIANG_AGING_CEREBRAL_CORTEX_UP
0.806451612903%	1	124	36	Diabetes_McGill_Cell_cycle_All_Gene	HUANG_FOXA2_TARGETS_DN
0.806451612903%	1	124	36	Diabetes_McGill_Cell_cycle_All_Gene	BURTON_ADIPOGENESIS_12
0.806451612903%	1	124	355	Diabetes_McGill_Cell_cycle_All_Gene	PEREZ_TP63_TARGETS
0.806451612903%	1	124	353	Diabetes_McGill_Cell_cycle_All_Gene	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
0.806451612903%	1	124	352	Diabetes_McGill_Cell_cycle_All_Gene	WANG_LMO4_TARGETS_DN
0.806451612903%	1	124	351	Diabetes_McGill_Cell_cycle_All_Gene	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.806451612903%	1	124	35	Diabetes_McGill_Cell_cycle_All_Gene	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15
0.806451612903%	1	124	35	Diabetes_McGill_Cell_cycle_All_Gene	YAGI_AML_RELAPSE_PROGNOSIS
0.806451612903%	1	124	35	Diabetes_McGill_Cell_cycle_All_Gene	RODRIGUES_NTN1_AND_DCC_TARGETS
0.806451612903%	1	124	35	Diabetes_McGill_Cell_cycle_All_Gene	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
0.806451612903%	1	124	35	Diabetes_McGill_Cell_cycle_All_Gene	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.806451612903%	1	124	35	Diabetes_McGill_Cell_cycle_All_Gene	LIEN_BREAST_CARCINOMA_METAPLASTIC
0.806451612903%	1	124	35	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_BASE_EXCISION_REPAIR
0.806451612903%	1	124	35	Diabetes_McGill_Cell_cycle_All_Gene	HAN_JNK_SINGALING_UP
0.806451612903%	1	124	35	Diabetes_McGill_Cell_cycle_All_Gene	GUTIERREZ_MULTIPLE_MYELOMA_DN
0.806451612903%	1	124	35	Diabetes_McGill_Cell_cycle_All_Gene	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.806451612903%	1	124	35	Diabetes_McGill_Cell_cycle_All_Gene	DORSAM_HOXA9_TARGETS_UP
0.806451612903%	1	124	35	Diabetes_McGill_Cell_cycle_All_Gene	BALDWIN_PRKCI_TARGETS_UP
0.806451612903%	1	124	35	Diabetes_McGill_Cell_cycle_All_Gene	AIGNER_ZEB1_TARGETS
0.806451612903%	1	124	349	Diabetes_McGill_Cell_cycle_All_Gene	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
0.806451612903%	1	124	34	Diabetes_McGill_Cell_cycle_All_Gene	ST_WNT_BETA_CATENIN_PATHWAY
0.806451612903%	1	124	34	Diabetes_McGill_Cell_cycle_All_Gene	LUI_TARGETS_OF_PAX8_PPARG_FUSION
0.806451612903%	1	124	34	Diabetes_McGill_Cell_cycle_All_Gene	JIANG_HYPOXIA_VIA_VHL
0.806451612903%	1	124	33	Diabetes_McGill_Cell_cycle_All_Gene	STAEGE_EWING_FAMILY_TUMOR
0.806451612903%	1	124	33	Diabetes_McGill_Cell_cycle_All_Gene	SCHRAETS_MLL_TARGETS_DN
0.806451612903%	1	124	33	Diabetes_McGill_Cell_cycle_All_Gene	PID_SYNDECAN_2_PATHWAY
0.806451612903%	1	124	33	Diabetes_McGill_Cell_cycle_All_Gene	PID_INTEGRIN_A4B1_PATHWAY
0.806451612903%	1	124	33	Diabetes_McGill_Cell_cycle_All_Gene	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP
0.806451612903%	1	124	33	Diabetes_McGill_Cell_cycle_All_Gene	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN
0.806451612903%	1	124	33	Diabetes_McGill_Cell_cycle_All_Gene	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN
0.806451612903%	1	124	329	Diabetes_McGill_Cell_cycle_All_Gene	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
0.806451612903%	1	124	32	Diabetes_McGill_Cell_cycle_All_Gene	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.806451612903%	1	124	32	Diabetes_McGill_Cell_cycle_All_Gene	POS_HISTAMINE_RESPONSE_NETWORK
0.806451612903%	1	124	32	Diabetes_McGill_Cell_cycle_All_Gene	LIANG_SILENCED_BY_METHYLATION_UP
0.806451612903%	1	124	32	Diabetes_McGill_Cell_cycle_All_Gene	DORSAM_HOXA9_TARGETS_DN
0.806451612903%	1	124	32	Diabetes_McGill_Cell_cycle_All_Gene	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
0.806451612903%	1	124	32	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_HDAC_PATHWAY
0.806451612903%	1	124	32	Diabetes_McGill_Cell_cycle_All_Gene	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN
0.806451612903%	1	124	32	Diabetes_McGill_Cell_cycle_All_Gene	AMIT_SERUM_RESPONSE_40_MCF10A
0.806451612903%	1	124	317	Diabetes_McGill_Cell_cycle_All_Gene	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
0.806451612903%	1	124	31	Diabetes_McGill_Cell_cycle_All_Gene	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP
0.806451612903%	1	124	31	Diabetes_McGill_Cell_cycle_All_Gene	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.806451612903%	1	124	31	Diabetes_McGill_Cell_cycle_All_Gene	RIZ_ERYTHROID_DIFFERENTIATION_HEMGN
0.806451612903%	1	124	31	Diabetes_McGill_Cell_cycle_All_Gene	PID_CD40_PATHWAY
0.806451612903%	1	124	306	Diabetes_McGill_Cell_cycle_All_Gene	CHANDRAN_METASTASIS_DN
0.806451612903%	1	124	30	Diabetes_McGill_Cell_cycle_All_Gene	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.806451612903%	1	124	30	Diabetes_McGill_Cell_cycle_All_Gene	YANAGIHARA_ESX1_TARGETS
0.806451612903%	1	124	30	Diabetes_McGill_Cell_cycle_All_Gene	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN
0.806451612903%	1	124	30	Diabetes_McGill_Cell_cycle_All_Gene	URS_ADIPOCYTE_DIFFERENTIATION_DN
0.806451612903%	1	124	30	Diabetes_McGill_Cell_cycle_All_Gene	TSENG_ADIPOGENIC_POTENTIAL_UP
0.806451612903%	1	124	30	Diabetes_McGill_Cell_cycle_All_Gene	TAVOR_CEBPA_TARGETS_DN
0.806451612903%	1	124	30	Diabetes_McGill_Cell_cycle_All_Gene	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN
0.806451612903%	1	124	30	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_ROBO_RECEPTOR
0.806451612903%	1	124	30	Diabetes_McGill_Cell_cycle_All_Gene	DAZARD_UV_RESPONSE_CLUSTER_G2
0.806451612903%	1	124	30	Diabetes_McGill_Cell_cycle_All_Gene	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY
0.806451612903%	1	124	295	Diabetes_McGill_Cell_cycle_All_Gene	LU_EZH2_TARGETS_UP
0.806451612903%	1	124	291	Diabetes_McGill_Cell_cycle_All_Gene	SABATES_COLORECTAL_ADENOMA_DN
0.806451612903%	1	124	29	Diabetes_McGill_Cell_cycle_All_Gene	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN
0.806451612903%	1	124	29	Diabetes_McGill_Cell_cycle_All_Gene	PID_REELINPATHWAY
0.806451612903%	1	124	29	Diabetes_McGill_Cell_cycle_All_Gene	PATTERSON_DOCETAXEL_RESISTANCE
0.806451612903%	1	124	29	Diabetes_McGill_Cell_cycle_All_Gene	NGUYEN_NOTCH1_TARGETS_UP
0.806451612903%	1	124	29	Diabetes_McGill_Cell_cycle_All_Gene	MA_PITUITARY_FETAL_VS_ADULT_UP
0.806451612903%	1	124	29	Diabetes_McGill_Cell_cycle_All_Gene	MARSHALL_VIRAL_INFECTION_RESPONSE_DN
0.806451612903%	1	124	29	Diabetes_McGill_Cell_cycle_All_Gene	LANG_MYB_FAMILY_TARGETS
0.806451612903%	1	124	29	Diabetes_McGill_Cell_cycle_All_Gene	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN
0.806451612903%	1	124	29	Diabetes_McGill_Cell_cycle_All_Gene	DALESSIO_TSA_RESPONSE
0.806451612903%	1	124	29	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_VIP_PATHWAY
0.806451612903%	1	124	29	Diabetes_McGill_Cell_cycle_All_Gene	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.806451612903%	1	124	29	Diabetes_McGill_Cell_cycle_All_Gene	AIYAR_COBRA1_TARGETS_DN
0.806451612903%	1	124	29	Diabetes_McGill_Cell_cycle_All_Gene	ABE_VEGFA_TARGETS_30MIN
0.806451612903%	1	124	289	Diabetes_McGill_Cell_cycle_All_Gene	WANG_MLL_TARGETS
0.806451612903%	1	124	283	Diabetes_McGill_Cell_cycle_All_Gene	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
0.806451612903%	1	124	28	Diabetes_McGill_Cell_cycle_All_Gene	WIKMAN_ASBESTOS_LUNG_CANCER_DN
0.806451612903%	1	124	28	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS
0.806451612903%	1	124	28	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_MYOGENESIS
0.806451612903%	1	124	28	Diabetes_McGill_Cell_cycle_All_Gene	MATZUK_MALE_REPRODUCTION_SERTOLI
0.806451612903%	1	124	28	Diabetes_McGill_Cell_cycle_All_Gene	GENTILE_UV_RESPONSE_CLUSTER_D9
0.806451612903%	1	124	28	Diabetes_McGill_Cell_cycle_All_Gene	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.806451612903%	1	124	28	Diabetes_McGill_Cell_cycle_All_Gene	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP
0.806451612903%	1	124	28	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_ERK_PATHWAY
0.806451612903%	1	124	279	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_NEURONAL_SYSTEM
0.806451612903%	1	124	271	Diabetes_McGill_Cell_cycle_All_Gene	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.806451612903%	1	124	27	Diabetes_McGill_Cell_cycle_All_Gene	YANG_BREAST_CANCER_ESR1_BULK_UP
0.806451612903%	1	124	27	Diabetes_McGill_Cell_cycle_All_Gene	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
0.806451612903%	1	124	27	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_EXTENSION_OF_TELOMERES
0.806451612903%	1	124	27	Diabetes_McGill_Cell_cycle_All_Gene	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN
0.806451612903%	1	124	27	Diabetes_McGill_Cell_cycle_All_Gene	CHOW_RASSF1_TARGETS_UP
0.806451612903%	1	124	27	Diabetes_McGill_Cell_cycle_All_Gene	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP
0.806451612903%	1	124	268	Diabetes_McGill_Cell_cycle_All_Gene	XU_GH1_AUTOCRINE_TARGETS_UP
0.806451612903%	1	124	267	Diabetes_McGill_Cell_cycle_All_Gene	CAIRO_HEPATOBLASTOMA_DN
0.806451612903%	1	124	266	Diabetes_McGill_Cell_cycle_All_Gene	ROZANOV_MMP14_TARGETS_UP
0.806451612903%	1	124	266	Diabetes_McGill_Cell_cycle_All_Gene	FOSTER_KDM1A_TARGETS_UP
0.806451612903%	1	124	261	Diabetes_McGill_Cell_cycle_All_Gene	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
0.806451612903%	1	124	26	Diabetes_McGill_Cell_cycle_All_Gene	XU_CREBBP_TARGETS_UP
0.806451612903%	1	124	26	Diabetes_McGill_Cell_cycle_All_Gene	TOMIDA_METASTASIS_UP
0.806451612903%	1	124	26	Diabetes_McGill_Cell_cycle_All_Gene	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN
0.806451612903%	1	124	26	Diabetes_McGill_Cell_cycle_All_Gene	PID_RXR_VDR_PATHWAY
0.806451612903%	1	124	26	Diabetes_McGill_Cell_cycle_All_Gene	PID_IL27PATHWAY
0.806451612903%	1	124	26	Diabetes_McGill_Cell_cycle_All_Gene	NEWMAN_ERCC6_TARGETS_UP
0.806451612903%	1	124	26	Diabetes_McGill_Cell_cycle_All_Gene	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1
0.806451612903%	1	124	26	Diabetes_McGill_Cell_cycle_All_Gene	HAHTOLA_CTCL_CUTANEOUS
0.806451612903%	1	124	26	Diabetes_McGill_Cell_cycle_All_Gene	GAZIN_EPIGENETIC_SILENCING_BY_KRAS
0.806451612903%	1	124	26	Diabetes_McGill_Cell_cycle_All_Gene	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN
0.806451612903%	1	124	26	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_PGC1A_PATHWAY
0.806451612903%	1	124	26	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_BAD_PATHWAY
0.806451612903%	1	124	259	Diabetes_McGill_Cell_cycle_All_Gene	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
0.806451612903%	1	124	258	Diabetes_McGill_Cell_cycle_All_Gene	JAEGER_METASTASIS_DN
0.806451612903%	1	124	252	Diabetes_McGill_Cell_cycle_All_Gene	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.806451612903%	1	124	25	Diabetes_McGill_Cell_cycle_All_Gene	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP
0.806451612903%	1	124	25	Diabetes_McGill_Cell_cycle_All_Gene	HOEGERKORP_CD44_TARGETS_TEMPORAL_DN
0.806451612903%	1	124	25	Diabetes_McGill_Cell_cycle_All_Gene	GENTILE_UV_HIGH_DOSE_UP
0.806451612903%	1	124	25	Diabetes_McGill_Cell_cycle_All_Gene	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.806451612903%	1	124	25	Diabetes_McGill_Cell_cycle_All_Gene	COLLER_MYC_TARGETS_UP
0.806451612903%	1	124	25	Diabetes_McGill_Cell_cycle_All_Gene	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP
0.806451612903%	1	124	246	Diabetes_McGill_Cell_cycle_All_Gene	VERHAAK_AML_WITH_NPM1_MUTATED_DN
0.806451612903%	1	124	24	Diabetes_McGill_Cell_cycle_All_Gene	YIH_RESPONSE_TO_ARSENITE_C1
0.806451612903%	1	124	24	Diabetes_McGill_Cell_cycle_All_Gene	WILLERT_WNT_SIGNALING
0.806451612903%	1	124	24	Diabetes_McGill_Cell_cycle_All_Gene	SCHRAMM_INHBA_TARGETS_DN
0.806451612903%	1	124	24	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION
0.806451612903%	1	124	24	Diabetes_McGill_Cell_cycle_All_Gene	MATZUK_SPERMATOGONIA
0.806451612903%	1	124	24	Diabetes_McGill_Cell_cycle_All_Gene	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN
0.806451612903%	1	124	24	Diabetes_McGill_Cell_cycle_All_Gene	JIANG_TIP30_TARGETS_DN
0.806451612903%	1	124	24	Diabetes_McGill_Cell_cycle_All_Gene	JEON_SMAD6_TARGETS_UP
0.806451612903%	1	124	24	Diabetes_McGill_Cell_cycle_All_Gene	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP
0.806451612903%	1	124	24	Diabetes_McGill_Cell_cycle_All_Gene	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY
0.806451612903%	1	124	24	Diabetes_McGill_Cell_cycle_All_Gene	HASLINGER_B_CLL_WITH_13Q14_DELETION
0.806451612903%	1	124	24	Diabetes_McGill_Cell_cycle_All_Gene	DELACROIX_RAR_TARGETS_DN
0.806451612903%	1	124	24	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_CSK_PATHWAY
0.806451612903%	1	124	24	Diabetes_McGill_Cell_cycle_All_Gene	AZARE_STAT3_TARGETS
0.806451612903%	1	124	238	Diabetes_McGill_Cell_cycle_All_Gene	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
0.806451612903%	1	124	230	Diabetes_McGill_Cell_cycle_All_Gene	COLDREN_GEFITINIB_RESISTANCE_DN
0.806451612903%	1	124	23	Diabetes_McGill_Cell_cycle_All_Gene	ZIRN_TRETINOIN_RESPONSE_WT1_UP
0.806451612903%	1	124	23	Diabetes_McGill_Cell_cycle_All_Gene	YANG_BREAST_CANCER_ESR1_BULK_DN
0.806451612903%	1	124	23	Diabetes_McGill_Cell_cycle_All_Gene	VIETOR_IFRD1_TARGETS
0.806451612903%	1	124	23	Diabetes_McGill_Cell_cycle_All_Gene	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A
0.806451612903%	1	124	23	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_SIGNALING_BY_BMP
0.806451612903%	1	124	23	Diabetes_McGill_Cell_cycle_All_Gene	PID_NFKAPPABCANONICALPATHWAY
0.806451612903%	1	124	23	Diabetes_McGill_Cell_cycle_All_Gene	ONO_FOXP3_TARGETS_UP
0.806451612903%	1	124	23	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_MISMATCH_REPAIR
0.806451612903%	1	124	23	Diabetes_McGill_Cell_cycle_All_Gene	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP
0.806451612903%	1	124	23	Diabetes_McGill_Cell_cycle_All_Gene	HASLINGER_B_CLL_WITH_11Q23_DELETION
0.806451612903%	1	124	23	Diabetes_McGill_Cell_cycle_All_Gene	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN
0.806451612903%	1	124	23	Diabetes_McGill_Cell_cycle_All_Gene	CHEOK_RESPONSE_TO_HD_MTX_UP
0.806451612903%	1	124	23	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_PTDINS_PATHWAY
0.806451612903%	1	124	23	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_IGF1R_PATHWAY
0.806451612903%	1	124	23	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_GLEEVEC_PATHWAY
0.806451612903%	1	124	228	Diabetes_McGill_Cell_cycle_All_Gene	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
0.806451612903%	1	124	227	Diabetes_McGill_Cell_cycle_All_Gene	LEE_RECENT_THYMIC_EMIGRANT
0.806451612903%	1	124	222	Diabetes_McGill_Cell_cycle_All_Gene	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
0.806451612903%	1	124	221	Diabetes_McGill_Cell_cycle_All_Gene	PEDRIOLI_MIR31_TARGETS_UP
0.806451612903%	1	124	22	Diabetes_McGill_Cell_cycle_All_Gene	ZHAN_MULTIPLE_MYELOMA_SPIKED
0.806451612903%	1	124	22	Diabetes_McGill_Cell_cycle_All_Gene	VERNELL_RETINOBLASTOMA_PATHWAY_DN
0.806451612903%	1	124	22	Diabetes_McGill_Cell_cycle_All_Gene	SUZUKI_RESPONSE_TO_TSA
0.806451612903%	1	124	22	Diabetes_McGill_Cell_cycle_All_Gene	PID_HEDGEHOG_2PATHWAY
0.806451612903%	1	124	22	Diabetes_McGill_Cell_cycle_All_Gene	NUMATA_CSF3_SIGNALING_VIA_STAT3
0.806451612903%	1	124	22	Diabetes_McGill_Cell_cycle_All_Gene	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
0.806451612903%	1	124	22	Diabetes_McGill_Cell_cycle_All_Gene	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP
0.806451612903%	1	124	22	Diabetes_McGill_Cell_cycle_All_Gene	KANG_FLUOROURACIL_RESISTANCE_UP
0.806451612903%	1	124	22	Diabetes_McGill_Cell_cycle_All_Gene	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP
0.806451612903%	1	124	22	Diabetes_McGill_Cell_cycle_All_Gene	GAVIN_PDE3B_TARGETS
0.806451612903%	1	124	22	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_HER2_PATHWAY
0.806451612903%	1	124	22	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_AKT_PATHWAY
0.806451612903%	1	124	216	Diabetes_McGill_Cell_cycle_All_Gene	BOQUEST_STEM_CELL_DN
0.806451612903%	1	124	215	Diabetes_McGill_Cell_cycle_All_Gene	MARKEY_RB1_ACUTE_LOF_UP
0.806451612903%	1	124	214	Diabetes_McGill_Cell_cycle_All_Gene	TIEN_INTESTINE_PROBIOTICS_24HR_DN
0.806451612903%	1	124	210	Diabetes_McGill_Cell_cycle_All_Gene	CAIRO_HEPATOBLASTOMA_CLASSES_DN
0.806451612903%	1	124	21	Diabetes_McGill_Cell_cycle_All_Gene	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP
0.806451612903%	1	124	21	Diabetes_McGill_Cell_cycle_All_Gene	WENG_POR_DOSAGE
0.806451612903%	1	124	21	Diabetes_McGill_Cell_cycle_All_Gene	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.806451612903%	1	124	21	Diabetes_McGill_Cell_cycle_All_Gene	MOOTHA_GLYCOGEN_METABOLISM
0.806451612903%	1	124	21	Diabetes_McGill_Cell_cycle_All_Gene	MARCHINI_TRABECTEDIN_RESISTANCE_UP
0.806451612903%	1	124	21	Diabetes_McGill_Cell_cycle_All_Gene	LEE_INTRATHYMIC_T_PROGENITOR
0.806451612903%	1	124	21	Diabetes_McGill_Cell_cycle_All_Gene	HASLINGER_B_CLL_WITH_17P13_DELETION
0.806451612903%	1	124	21	Diabetes_McGill_Cell_cycle_All_Gene	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP
0.806451612903%	1	124	21	Diabetes_McGill_Cell_cycle_All_Gene	CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP
0.806451612903%	1	124	21	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_CALCINEURIN_PATHWAY
0.806451612903%	1	124	207	Diabetes_McGill_Cell_cycle_All_Gene	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.806451612903%	1	124	205	Diabetes_McGill_Cell_cycle_All_Gene	PEREZ_TP53_AND_TP63_TARGETS
0.806451612903%	1	124	204	Diabetes_McGill_Cell_cycle_All_Gene	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
0.806451612903%	1	124	201	Diabetes_McGill_Cell_cycle_All_Gene	KIM_MYC_AMPLIFICATION_TARGETS_UP
0.806451612903%	1	124	200	Diabetes_McGill_Cell_cycle_All_Gene	LEE_DIFFERENTIATING_T_LYMPHOCYTE
0.806451612903%	1	124	20	Diabetes_McGill_Cell_cycle_All_Gene	WALLACE_PROSTATE_CANCER_UP
0.806451612903%	1	124	20	Diabetes_McGill_Cell_cycle_All_Gene	PID_WNT_CANONICAL_PATHWAY
0.806451612903%	1	124	20	Diabetes_McGill_Cell_cycle_All_Gene	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP
0.806451612903%	1	124	20	Diabetes_McGill_Cell_cycle_All_Gene	MURAKAMI_UV_RESPONSE_24HR
0.806451612903%	1	124	20	Diabetes_McGill_Cell_cycle_All_Gene	KORKOLA_YOLK_SAC_TUMOR_UP
0.806451612903%	1	124	20	Diabetes_McGill_Cell_cycle_All_Gene	HEDENFALK_BREAST_CANCER_BRACX_DN
0.806451612903%	1	124	20	Diabetes_McGill_Cell_cycle_All_Gene	DE_YY1_TARGETS_UP
0.806451612903%	1	124	20	Diabetes_McGill_Cell_cycle_All_Gene	CROONQUIST_IL6_DEPRIVATION_UP
0.806451612903%	1	124	20	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_IGF1MTOR_PATHWAY
0.806451612903%	1	124	20	Diabetes_McGill_Cell_cycle_All_Gene	ABE_VEGFA_TARGETS
0.806451612903%	1	124	199	Diabetes_McGill_Cell_cycle_All_Gene	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
0.806451612903%	1	124	198	Diabetes_McGill_Cell_cycle_All_Gene	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.806451612903%	1	124	195	Diabetes_McGill_Cell_cycle_All_Gene	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
0.806451612903%	1	124	191	Diabetes_McGill_Cell_cycle_All_Gene	RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.806451612903%	1	124	190	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	VISALA_AGING_LYMPHOCYTE_DN
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	SEIDEN_MET_SIGNALING
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	SCIBETTA_KDM5B_TARGETS_UP
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	RUAN_RESPONSE_TO_TROGLITAZONE_DN
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_LAGGING_STRAND_SYNTHESIS
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_BASE_EXCISION_REPAIR
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	RASHI_NFKB1_TARGETS
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	NELSON_RESPONSE_TO_ANDROGEN_DN
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	KANG_CISPLATIN_RESISTANCE_UP
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	KANG_AR_TARGETS_DN
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	JEON_SMAD6_TARGETS_DN
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	HAHTOLA_MYCOSIS_FUNGOIDES_UP
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	GENTLES_LEUKEMIC_STEM_CELL_DN
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_MTA3_PATHWAY
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP
0.806451612903%	1	124	19	Diabetes_McGill_Cell_cycle_All_Gene	AMIT_EGF_RESPONSE_40_MCF10A
0.806451612903%	1	124	189	Diabetes_McGill_Cell_cycle_All_Gene	BURTON_ADIPOGENESIS_6
0.806451612903%	1	124	186	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
0.806451612903%	1	124	186	Diabetes_McGill_Cell_cycle_All_Gene	HAMAI_APOPTOSIS_VIA_TRAIL_DN
0.806451612903%	1	124	185	Diabetes_McGill_Cell_cycle_All_Gene	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
0.806451612903%	1	124	185	Diabetes_McGill_Cell_cycle_All_Gene	DARWICHE_SKIN_TUMOR_PROMOTER_DN
0.806451612903%	1	124	184	Diabetes_McGill_Cell_cycle_All_Gene	WU_CELL_MIGRATION
0.806451612903%	1	124	184	Diabetes_McGill_Cell_cycle_All_Gene	DOANE_RESPONSE_TO_ANDROGEN_UP
0.806451612903%	1	124	183	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_ENDOCYTOSIS
0.806451612903%	1	124	182	Diabetes_McGill_Cell_cycle_All_Gene	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.806451612903%	1	124	182	Diabetes_McGill_Cell_cycle_All_Gene	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
0.806451612903%	1	124	181	Diabetes_McGill_Cell_cycle_All_Gene	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
0.806451612903%	1	124	181	Diabetes_McGill_Cell_cycle_All_Gene	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
0.806451612903%	1	124	181	Diabetes_McGill_Cell_cycle_All_Gene	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
0.806451612903%	1	124	180	Diabetes_McGill_Cell_cycle_All_Gene	DARWICHE_PAPILLOMA_RISK_HIGH_DN
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	ZHENG_RESPONSE_TO_ARSENITE_DN
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	WEBER_METHYLATED_IN_COLON_CANCER
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	STAMBOLSKY_BOUND_BY_MUTATED_TP53
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	SHIN_B_CELL_LYMPHOMA_CLUSTER_5
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	PODAR_RESPONSE_TO_ADAPHOSTIN_DN
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	PIONTEK_PKD1_TARGETS_DN
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	NIELSEN_SYNOVIAL_SARCOMA_UP
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	MCGOWAN_RSP6_TARGETS_UP
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	MAINA_VHL_TARGETS_DN
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	KIM_PTEN_TARGETS_UP
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_PTEN_PATHWAY
0.806451612903%	1	124	18	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_CARDIACEGF_PATHWAY
0.806451612903%	1	124	179	Diabetes_McGill_Cell_cycle_All_Gene	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
0.806451612903%	1	124	178	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_18HR_DN
0.806451612903%	1	124	177	Diabetes_McGill_Cell_cycle_All_Gene	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.806451612903%	1	124	176	Diabetes_McGill_Cell_cycle_All_Gene	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
0.806451612903%	1	124	175	Diabetes_McGill_Cell_cycle_All_Gene	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.806451612903%	1	124	172	Diabetes_McGill_Cell_cycle_All_Gene	SMID_BREAST_CANCER_LUMINAL_B_UP
0.806451612903%	1	124	171	Diabetes_McGill_Cell_cycle_All_Gene	ELVIDGE_HYPOXIA_UP
0.806451612903%	1	124	170	Diabetes_McGill_Cell_cycle_All_Gene	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
0.806451612903%	1	124	170	Diabetes_McGill_Cell_cycle_All_Gene	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.806451612903%	1	124	17	Diabetes_McGill_Cell_cycle_All_Gene	ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN
0.806451612903%	1	124	17	Diabetes_McGill_Cell_cycle_All_Gene	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
0.806451612903%	1	124	17	Diabetes_McGill_Cell_cycle_All_Gene	WIKMAN_ASBESTOS_LUNG_CANCER_UP
0.806451612903%	1	124	17	Diabetes_McGill_Cell_cycle_All_Gene	THUM_MIR21_TARGETS_HEART_DISEASE_UP
0.806451612903%	1	124	17	Diabetes_McGill_Cell_cycle_All_Gene	SA_TRKA_RECEPTOR
0.806451612903%	1	124	17	Diabetes_McGill_Cell_cycle_All_Gene	SA_PTEN_PATHWAY
0.806451612903%	1	124	17	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY
0.806451612903%	1	124	17	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS
0.806451612903%	1	124	17	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP
0.806451612903%	1	124	17	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP
0.806451612903%	1	124	17	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1
0.806451612903%	1	124	17	Diabetes_McGill_Cell_cycle_All_Gene	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL
0.806451612903%	1	124	17	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_HCMV_PATHWAY
0.806451612903%	1	124	169	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_ALZHEIMERS_DISEASE
0.806451612903%	1	124	167	Diabetes_McGill_Cell_cycle_All_Gene	TIEN_INTESTINE_PROBIOTICS_6HR_DN
0.806451612903%	1	124	165	Diabetes_McGill_Cell_cycle_All_Gene	DARWICHE_PAPILLOMA_RISK_LOW_DN
0.806451612903%	1	124	165	Diabetes_McGill_Cell_cycle_All_Gene	BROWN_MYELOID_CELL_DEVELOPMENT_UP
0.806451612903%	1	124	164	Diabetes_McGill_Cell_cycle_All_Gene	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
0.806451612903%	1	124	164	Diabetes_McGill_Cell_cycle_All_Gene	KIM_WT1_TARGETS_8HR_UP
0.806451612903%	1	124	163	Diabetes_McGill_Cell_cycle_All_Gene	LIN_NPAS4_TARGETS_UP
0.806451612903%	1	124	162	Diabetes_McGill_Cell_cycle_All_Gene	KIM_WT1_TARGETS_12HR_UP
0.806451612903%	1	124	16	Diabetes_McGill_Cell_cycle_All_Gene	XU_RESPONSE_TO_TRETINOIN_UP
0.806451612903%	1	124	16	Diabetes_McGill_Cell_cycle_All_Gene	WU_HBX_TARGETS_2_DN
0.806451612903%	1	124	16	Diabetes_McGill_Cell_cycle_All_Gene	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP
0.806451612903%	1	124	16	Diabetes_McGill_Cell_cycle_All_Gene	TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN
0.806451612903%	1	124	16	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION
0.806451612903%	1	124	16	Diabetes_McGill_Cell_cycle_All_Gene	PID_DNAPK_PATHWAY
0.806451612903%	1	124	16	Diabetes_McGill_Cell_cycle_All_Gene	MACLACHLAN_BRCA1_TARGETS_DN
0.806451612903%	1	124	16	Diabetes_McGill_Cell_cycle_All_Gene	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN
0.806451612903%	1	124	16	Diabetes_McGill_Cell_cycle_All_Gene	LEE_LIVER_CANCER_HEPATOBLAST
0.806451612903%	1	124	16	Diabetes_McGill_Cell_cycle_All_Gene	KORKOLA_TERATOMA_UP
0.806451612903%	1	124	16	Diabetes_McGill_Cell_cycle_All_Gene	HUMMERICH_MALIGNANT_SKIN_TUMOR_UP
0.806451612903%	1	124	16	Diabetes_McGill_Cell_cycle_All_Gene	CHIN_BREAST_CANCER_COPY_NUMBER_DN
0.806451612903%	1	124	16	Diabetes_McGill_Cell_cycle_All_Gene	CAFFAREL_RESPONSE_TO_THC_8HR_5_UP
0.806451612903%	1	124	16	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_SHH_PATHWAY
0.806451612903%	1	124	16	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_CDMAC_PATHWAY
0.806451612903%	1	124	16	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_ACH_PATHWAY
0.806451612903%	1	124	158	Diabetes_McGill_Cell_cycle_All_Gene	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON
0.806451612903%	1	124	157	Diabetes_McGill_Cell_cycle_All_Gene	SERVITJA_LIVER_HNF1A_TARGETS_DN
0.806451612903%	1	124	15	Diabetes_McGill_Cell_cycle_All_Gene	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3
0.806451612903%	1	124	15	Diabetes_McGill_Cell_cycle_All_Gene	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN
0.806451612903%	1	124	15	Diabetes_McGill_Cell_cycle_All_Gene	VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP
0.806451612903%	1	124	15	Diabetes_McGill_Cell_cycle_All_Gene	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP
0.806451612903%	1	124	15	Diabetes_McGill_Cell_cycle_All_Gene	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN
0.806451612903%	1	124	15	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND
0.806451612903%	1	124	15	Diabetes_McGill_Cell_cycle_All_Gene	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN
0.806451612903%	1	124	15	Diabetes_McGill_Cell_cycle_All_Gene	FERRANDO_LYL1_NEIGHBORS
0.806451612903%	1	124	15	Diabetes_McGill_Cell_cycle_All_Gene	DAZARD_UV_RESPONSE_CLUSTER_G3
0.806451612903%	1	124	15	Diabetes_McGill_Cell_cycle_All_Gene	COLLIS_PRKDC_REGULATORS
0.806451612903%	1	124	15	Diabetes_McGill_Cell_cycle_All_Gene	CHANG_POU5F1_TARGETS_UP
0.806451612903%	1	124	15	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_HIF_PATHWAY
0.806451612903%	1	124	15	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_AKAPCENTROSOME_PATHWAY
0.806451612903%	1	124	149	Diabetes_McGill_Cell_cycle_All_Gene	NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON
0.806451612903%	1	124	149	Diabetes_McGill_Cell_cycle_All_Gene	LANDIS_ERBB2_BREAST_TUMORS_324_DN
0.806451612903%	1	124	148	Diabetes_McGill_Cell_cycle_All_Gene	KATSANOU_ELAVL1_TARGETS_DN
0.806451612903%	1	124	148	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_24HR_DN
0.806451612903%	1	124	146	Diabetes_McGill_Cell_cycle_All_Gene	PECE_MAMMARY_STEM_CELL_UP
0.806451612903%	1	124	143	Diabetes_McGill_Cell_cycle_All_Gene	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.806451612903%	1	124	143	Diabetes_McGill_Cell_cycle_All_Gene	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION
0.806451612903%	1	124	142	Diabetes_McGill_Cell_cycle_All_Gene	PENG_LEUCINE_DEPRIVATION_UP
0.806451612903%	1	124	142	Diabetes_McGill_Cell_cycle_All_Gene	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.806451612903%	1	124	141	Diabetes_McGill_Cell_cycle_All_Gene	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.806451612903%	1	124	140	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
0.806451612903%	1	124	140	Diabetes_McGill_Cell_cycle_All_Gene	QI_HYPOXIA
0.806451612903%	1	124	140	Diabetes_McGill_Cell_cycle_All_Gene	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
0.806451612903%	1	124	14	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER
0.806451612903%	1	124	14	Diabetes_McGill_Cell_cycle_All_Gene	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16
0.806451612903%	1	124	14	Diabetes_McGill_Cell_cycle_All_Gene	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP
0.806451612903%	1	124	14	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_NON_HOMOLOGOUS_END_JOINING
0.806451612903%	1	124	14	Diabetes_McGill_Cell_cycle_All_Gene	INAMURA_LUNG_CANCER_SCC_UP
0.806451612903%	1	124	14	Diabetes_McGill_Cell_cycle_All_Gene	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION
0.806451612903%	1	124	14	Diabetes_McGill_Cell_cycle_All_Gene	DORN_ADENOVIRUS_INFECTION_48HR_UP
0.806451612903%	1	124	14	Diabetes_McGill_Cell_cycle_All_Gene	CASTELLANO_NRAS_TARGETS_DN
0.806451612903%	1	124	14	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_PS1_PATHWAY
0.806451612903%	1	124	139	Diabetes_McGill_Cell_cycle_All_Gene	HOELZEL_NF1_TARGETS_UP
0.806451612903%	1	124	137	Diabetes_McGill_Cell_cycle_All_Gene	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
0.806451612903%	1	124	137	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
0.806451612903%	1	124	137	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_INSULIN_SIGNALING_PATHWAY
0.806451612903%	1	124	136	Diabetes_McGill_Cell_cycle_All_Gene	WIERENGA_STAT5A_TARGETS_GROUP1
0.806451612903%	1	124	136	Diabetes_McGill_Cell_cycle_All_Gene	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.806451612903%	1	124	135	Diabetes_McGill_Cell_cycle_All_Gene	TSENG_IRS1_TARGETS_DN
0.806451612903%	1	124	134	Diabetes_McGill_Cell_cycle_All_Gene	KEGG_TIGHT_JUNCTION
0.806451612903%	1	124	133	Diabetes_McGill_Cell_cycle_All_Gene	SENESE_HDAC2_TARGETS_DN
0.806451612903%	1	124	133	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_DIABETES_PATHWAYS
0.806451612903%	1	124	133	Diabetes_McGill_Cell_cycle_All_Gene	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON
0.806451612903%	1	124	130	Diabetes_McGill_Cell_cycle_All_Gene	YAGI_AML_WITH_T_9_11_TRANSLOCATION
0.806451612903%	1	124	13	Diabetes_McGill_Cell_cycle_All_Gene	XU_RESPONSE_TO_TRETINOIN_DN
0.806451612903%	1	124	13	Diabetes_McGill_Cell_cycle_All_Gene	WAGSCHAL_EHMT2_TARGETS_UP
0.806451612903%	1	124	13	Diabetes_McGill_Cell_cycle_All_Gene	WACKER_HYPOXIA_TARGETS_OF_VHL
0.806451612903%	1	124	13	Diabetes_McGill_Cell_cycle_All_Gene	TSAI_DNAJB4_TARGETS_UP
0.806451612903%	1	124	13	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_POL_SWITCHING
0.806451612903%	1	124	13	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY
0.806451612903%	1	124	13	Diabetes_McGill_Cell_cycle_All_Gene	PHESSE_TARGETS_OF_APC_AND_MBD2_DN
0.806451612903%	1	124	13	Diabetes_McGill_Cell_cycle_All_Gene	ONGUSAHA_BRCA1_TARGETS_UP
0.806451612903%	1	124	13	Diabetes_McGill_Cell_cycle_All_Gene	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
0.806451612903%	1	124	13	Diabetes_McGill_Cell_cycle_All_Gene	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22
0.806451612903%	1	124	13	Diabetes_McGill_Cell_cycle_All_Gene	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15
0.806451612903%	1	124	13	Diabetes_McGill_Cell_cycle_All_Gene	MATZUK_EARLY_ANTRAL_FOLLICLE
0.806451612903%	1	124	13	Diabetes_McGill_Cell_cycle_All_Gene	CROONQUIST_STROMAL_STIMULATION_DN
0.806451612903%	1	124	13	Diabetes_McGill_Cell_cycle_All_Gene	CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP
0.806451612903%	1	124	129	Diabetes_McGill_Cell_cycle_All_Gene	BROWN_MYELOID_CELL_DEVELOPMENT_DN
0.806451612903%	1	124	128	Diabetes_McGill_Cell_cycle_All_Gene	YEGNASUBRAMANIAN_PROSTATE_CANCER
0.806451612903%	1	124	128	Diabetes_McGill_Cell_cycle_All_Gene	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS
0.806451612903%	1	124	128	Diabetes_McGill_Cell_cycle_All_Gene	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
0.806451612903%	1	124	127	Diabetes_McGill_Cell_cycle_All_Gene	INGRAM_SHH_TARGETS_UP
0.806451612903%	1	124	125	Diabetes_McGill_Cell_cycle_All_Gene	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
0.806451612903%	1	124	123	Diabetes_McGill_Cell_cycle_All_Gene	KAYO_AGING_MUSCLE_DN
0.806451612903%	1	124	123	Diabetes_McGill_Cell_cycle_All_Gene	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.806451612903%	1	124	121	Diabetes_McGill_Cell_cycle_All_Gene	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.806451612903%	1	124	121	Diabetes_McGill_Cell_cycle_All_Gene	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
0.806451612903%	1	124	121	Diabetes_McGill_Cell_cycle_All_Gene	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
0.806451612903%	1	124	120	Diabetes_McGill_Cell_cycle_All_Gene	ZHU_CMV_ALL_UP
0.806451612903%	1	124	120	Diabetes_McGill_Cell_cycle_All_Gene	NIKOLSKY_BREAST_CANCER_16P13_AMPLICON
0.806451612903%	1	124	120	Diabetes_McGill_Cell_cycle_All_Gene	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
0.806451612903%	1	124	120	Diabetes_McGill_Cell_cycle_All_Gene	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.806451612903%	1	124	120	Diabetes_McGill_Cell_cycle_All_Gene	CHEBOTAEV_GR_TARGETS_DN
0.806451612903%	1	124	12	Diabetes_McGill_Cell_cycle_All_Gene	WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53
0.806451612903%	1	124	12	Diabetes_McGill_Cell_cycle_All_Gene	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN
0.806451612903%	1	124	12	Diabetes_McGill_Cell_cycle_All_Gene	MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP
0.806451612903%	1	124	12	Diabetes_McGill_Cell_cycle_All_Gene	MIZUKAMI_HYPOXIA_UP
0.806451612903%	1	124	12	Diabetes_McGill_Cell_cycle_All_Gene	MCBRYAN_TERMINAL_END_BUD_UP
0.806451612903%	1	124	12	Diabetes_McGill_Cell_cycle_All_Gene	LOPEZ_MESOTHELIOMA_SURVIVAL_DN
0.806451612903%	1	124	12	Diabetes_McGill_Cell_cycle_All_Gene	FUNG_IL2_SIGNALING_2
0.806451612903%	1	124	12	Diabetes_McGill_Cell_cycle_All_Gene	DORN_ADENOVIRUS_INFECTION_24HR_UP
0.806451612903%	1	124	118	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_TOLL_RECEPTOR_CASCADES
0.806451612903%	1	124	118	Diabetes_McGill_Cell_cycle_All_Gene	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
0.806451612903%	1	124	116	Diabetes_McGill_Cell_cycle_All_Gene	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
0.806451612903%	1	124	116	Diabetes_McGill_Cell_cycle_All_Gene	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
0.806451612903%	1	124	116	Diabetes_McGill_Cell_cycle_All_Gene	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
0.806451612903%	1	124	116	Diabetes_McGill_Cell_cycle_All_Gene	LIM_MAMMARY_LUMINAL_MATURE_UP
0.806451612903%	1	124	116	Diabetes_McGill_Cell_cycle_All_Gene	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.806451612903%	1	124	116	Diabetes_McGill_Cell_cycle_All_Gene	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
0.806451612903%	1	124	114	Diabetes_McGill_Cell_cycle_All_Gene	ROPERO_HDAC2_TARGETS
0.806451612903%	1	124	113	Diabetes_McGill_Cell_cycle_All_Gene	RICKMAN_HEAD_AND_NECK_CANCER_C
0.806451612903%	1	124	113	Diabetes_McGill_Cell_cycle_All_Gene	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
0.806451612903%	1	124	112	Diabetes_McGill_Cell_cycle_All_Gene	LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.806451612903%	1	124	111	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_MRNA_SPLICING
0.806451612903%	1	124	111	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_12HR_UP
0.806451612903%	1	124	110	Diabetes_McGill_Cell_cycle_All_Gene	GROSS_HYPOXIA_VIA_HIF1A_DN
0.806451612903%	1	124	11	Diabetes_McGill_Cell_cycle_All_Gene	WHITESIDE_CISPLATIN_RESISTANCE_UP
0.806451612903%	1	124	11	Diabetes_McGill_Cell_cycle_All_Gene	STEGMEIER_PRE-MITOTIC_CELL_CYCLE_REGULATORS
0.806451612903%	1	124	11	Diabetes_McGill_Cell_cycle_All_Gene	PID_P38GAMMADELTAPATHWAY
0.806451612903%	1	124	11	Diabetes_McGill_Cell_cycle_All_Gene	PID_ALK2PATHWAY
0.806451612903%	1	124	11	Diabetes_McGill_Cell_cycle_All_Gene	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.806451612903%	1	124	11	Diabetes_McGill_Cell_cycle_All_Gene	MIKKELSEN_PLURIPOTENT_STATE_UP
0.806451612903%	1	124	11	Diabetes_McGill_Cell_cycle_All_Gene	IIZUKA_LIVER_CANCER_EARLY_RECURRENCE
0.806451612903%	1	124	11	Diabetes_McGill_Cell_cycle_All_Gene	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN
0.806451612903%	1	124	11	Diabetes_McGill_Cell_cycle_All_Gene	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN
0.806451612903%	1	124	11	Diabetes_McGill_Cell_cycle_All_Gene	FUNG_IL2_SIGNALING_1
0.806451612903%	1	124	11	Diabetes_McGill_Cell_cycle_All_Gene	DORN_ADENOVIRUS_INFECTION_32HR_UP
0.806451612903%	1	124	11	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_SET_PATHWAY
0.806451612903%	1	124	11	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_P35ALZHEIMERS_PATHWAY
0.806451612903%	1	124	11	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_EPONFKB_PATHWAY
0.806451612903%	1	124	11	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_EIF2_PATHWAY
0.806451612903%	1	124	11	Diabetes_McGill_Cell_cycle_All_Gene	AMIT_EGF_RESPONSE_20_HELA
0.806451612903%	1	124	109	Diabetes_McGill_Cell_cycle_All_Gene	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
0.806451612903%	1	124	108	Diabetes_McGill_Cell_cycle_All_Gene	WESTON_VEGFA_TARGETS
0.806451612903%	1	124	108	Diabetes_McGill_Cell_cycle_All_Gene	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
0.806451612903%	1	124	108	Diabetes_McGill_Cell_cycle_All_Gene	LE_EGR2_TARGETS_DN
0.806451612903%	1	124	108	Diabetes_McGill_Cell_cycle_All_Gene	LABBE_TGFB1_TARGETS_DN
0.806451612903%	1	124	107	Diabetes_McGill_Cell_cycle_All_Gene	ROESSLER_LIVER_CANCER_METASTASIS_UP
0.806451612903%	1	124	106	Diabetes_McGill_Cell_cycle_All_Gene	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
0.806451612903%	1	124	105	Diabetes_McGill_Cell_cycle_All_Gene	ZWANG_EGF_INTERVAL_UP
0.806451612903%	1	124	105	Diabetes_McGill_Cell_cycle_All_Gene	STEIN_ESRRA_TARGETS_DN
0.806451612903%	1	124	104	Diabetes_McGill_Cell_cycle_All_Gene	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
0.806451612903%	1	124	103	Diabetes_McGill_Cell_cycle_All_Gene	LEIN_CHOROID_PLEXUS_MARKERS
0.806451612903%	1	124	103	Diabetes_McGill_Cell_cycle_All_Gene	KIM_MYCN_AMPLIFICATION_TARGETS_DN
0.806451612903%	1	124	102	Diabetes_McGill_Cell_cycle_All_Gene	KANG_IMMORTALIZED_BY_TERT_DN
0.806451612903%	1	124	102	Diabetes_McGill_Cell_cycle_All_Gene	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.806451612903%	1	124	101	Diabetes_McGill_Cell_cycle_All_Gene	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
0.806451612903%	1	124	101	Diabetes_McGill_Cell_cycle_All_Gene	BROWNE_HCMV_INFECTION_20HR_DN
0.806451612903%	1	124	101	Diabetes_McGill_Cell_cycle_All_Gene	BASSO_CD40_SIGNALING_UP
0.806451612903%	1	124	100	Diabetes_McGill_Cell_cycle_All_Gene	ROVERSI_GLIOMA_COPY_NUMBER_UP
0.806451612903%	1	124	100	Diabetes_McGill_Cell_cycle_All_Gene	QI_PLASMACYTOMA_DN
0.806451612903%	1	124	100	Diabetes_McGill_Cell_cycle_All_Gene	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
0.806451612903%	1	124	10	Diabetes_McGill_Cell_cycle_All_Gene	YEMELYANOV_GR_TARGETS_DN
0.806451612903%	1	124	10	Diabetes_McGill_Cell_cycle_All_Gene	WONG_ENDOMETRIAL_CANCER_LATE
0.806451612903%	1	124	10	Diabetes_McGill_Cell_cycle_All_Gene	TURJANSKI_MAPK14_TARGETS
0.806451612903%	1	124	10	Diabetes_McGill_Cell_cycle_All_Gene	REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND
0.806451612903%	1	124	10	Diabetes_McGill_Cell_cycle_All_Gene	PYEON_HPV_POSITIVE_TUMORS_DN
0.806451612903%	1	124	10	Diabetes_McGill_Cell_cycle_All_Gene	OXFORD_RALA_AND_RALB_TARGETS_UP
0.806451612903%	1	124	10	Diabetes_McGill_Cell_cycle_All_Gene	MAINA_VHL_TARGETS_UP
0.806451612903%	1	124	10	Diabetes_McGill_Cell_cycle_All_Gene	KONG_E2F1_TARGETS
0.806451612903%	1	124	10	Diabetes_McGill_Cell_cycle_All_Gene	FREDERICK_PRKCI_TARGETS
0.806451612903%	1	124	10	Diabetes_McGill_Cell_cycle_All_Gene	CHEN_HOXA5_TARGETS_6HR_UP
0.806451612903%	1	124	10	Diabetes_McGill_Cell_cycle_All_Gene	BIOCARTA_RNA_PATHWAY
0.806451612903%	1	124	10	Diabetes_McGill_Cell_cycle_All_Gene	BAKER_HEMATOPOESIS_STAT1_TARGETS
0.801710315339%	15	1871	97	T2D_GENES_TANYA_HEIGHT	KONG_E2F3_TARGETS
0.801710315339%	15	1871	91	T2D_GENES_TANYA_HEIGHT	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
0.801710315339%	15	1871	88	T2D_GENES_TANYA_HEIGHT	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
0.801710315339%	15	1871	87	T2D_GENES_TANYA_HEIGHT	BIOCARTA_MAPK_PATHWAY
0.801710315339%	15	1871	81	T2D_GENES_TANYA_HEIGHT	REACTOME_M_G1_TRANSITION
0.801710315339%	15	1871	79	T2D_GENES_TANYA_HEIGHT	DUAN_PRDM5_TARGETS
0.801710315339%	15	1871	73	T2D_GENES_TANYA_HEIGHT	GAURNIER_PSMD4_TARGETS
0.801710315339%	15	1871	70	T2D_GENES_TANYA_HEIGHT	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
0.801710315339%	15	1871	63	T2D_GENES_TANYA_HEIGHT	REACTOME_INTERFERON_GAMMA_SIGNALING
0.801710315339%	15	1871	58	T2D_GENES_TANYA_HEIGHT	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
0.801710315339%	15	1871	53	T2D_GENES_TANYA_HEIGHT	NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON
0.801710315339%	15	1871	53	T2D_GENES_TANYA_HEIGHT	KEGG_AUTOIMMUNE_THYROID_DISEASE
0.801710315339%	15	1871	30	T2D_GENES_TANYA_HEIGHT	KEGG_ASTHMA
0.801710315339%	15	1871	274	T2D_GENES_TANYA_HEIGHT	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
0.801710315339%	15	1871	268	T2D_GENES_TANYA_HEIGHT	XU_GH1_AUTOCRINE_TARGETS_UP
0.801710315339%	15	1871	255	T2D_GENES_TANYA_HEIGHT	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.801710315339%	15	1871	251	T2D_GENES_TANYA_HEIGHT	REACTOME_AXON_GUIDANCE
0.801710315339%	15	1871	215	T2D_GENES_TANYA_HEIGHT	YAMAZAKI_TCEB3_TARGETS_DN
0.801710315339%	15	1871	204	T2D_GENES_TANYA_HEIGHT	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
0.801710315339%	15	1871	193	T2D_GENES_TANYA_HEIGHT	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
0.801710315339%	15	1871	188	T2D_GENES_TANYA_HEIGHT	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
0.801710315339%	15	1871	177	T2D_GENES_TANYA_HEIGHT	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
0.801710315339%	15	1871	176	T2D_GENES_TANYA_HEIGHT	SASAKI_ADULT_T_CELL_LEUKEMIA
0.801710315339%	15	1871	172	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
0.801710315339%	15	1871	169	T2D_GENES_TANYA_HEIGHT	PENG_GLUCOSE_DEPRIVATION_DN
0.801710315339%	15	1871	162	T2D_GENES_TANYA_HEIGHT	WINNEPENNINCKX_MELANOMA_METASTASIS_UP
0.801710315339%	15	1871	162	T2D_GENES_TANYA_HEIGHT	MULLIGHAN_NPM1_SIGNATURE_3_DN
0.801710315339%	15	1871	159	T2D_GENES_TANYA_HEIGHT	KEGG_PURINE_METABOLISM
0.801710315339%	15	1871	148	T2D_GENES_TANYA_HEIGHT	WEI_MIR34A_TARGETS
0.801710315339%	15	1871	146	T2D_GENES_TANYA_HEIGHT	KIM_ALL_DISORDERS_DURATION_CORR_DN
0.801710315339%	15	1871	143	T2D_GENES_TANYA_HEIGHT	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION
0.801710315339%	15	1871	140	T2D_GENES_TANYA_HEIGHT	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
0.801710315339%	15	1871	131	T2D_GENES_TANYA_HEIGHT	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
0.801710315339%	15	1871	129	T2D_GENES_TANYA_HEIGHT	KIM_WT1_TARGETS_8HR_DN
0.801710315339%	15	1871	128	T2D_GENES_TANYA_HEIGHT	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
0.801710315339%	15	1871	127	T2D_GENES_TANYA_HEIGHT	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.801710315339%	15	1871	127	T2D_GENES_TANYA_HEIGHT	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
0.801710315339%	15	1871	126	T2D_GENES_TANYA_HEIGHT	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
0.801710315339%	15	1871	126	T2D_GENES_TANYA_HEIGHT	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.801710315339%	15	1871	122	T2D_GENES_TANYA_HEIGHT	TOOKER_GEMCITABINE_RESISTANCE_DN
0.801710315339%	15	1871	121	T2D_GENES_TANYA_HEIGHT	KEGG_LYSOSOME
0.801710315339%	15	1871	118	T2D_GENES_TANYA_HEIGHT	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
0.801710315339%	15	1871	116	T2D_GENES_TANYA_HEIGHT	LI_INDUCED_T_TO_NATURAL_KILLER_DN
0.801710315339%	15	1871	112	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_FGFR
0.801710315339%	15	1871	112	T2D_GENES_TANYA_HEIGHT	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
0.801710315339%	15	1871	111	T2D_GENES_TANYA_HEIGHT	WANG_HCP_PROSTATE_CANCER
0.801710315339%	15	1871	111	T2D_GENES_TANYA_HEIGHT	BOUDOUKHA_BOUND_BY_IGF2BP2
0.801710315339%	15	1871	109	T2D_GENES_TANYA_HEIGHT	REACTOME_S_PHASE
0.801710315339%	15	1871	108	T2D_GENES_TANYA_HEIGHT	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.801710315339%	15	1871	107	T2D_GENES_TANYA_HEIGHT	LEE_EARLY_T_LYMPHOCYTE_UP
0.795454545455%	28	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RNA_POL_I_PROMOTER_OPENING
0.795454545455%	28	3520	408	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GPCR_LIGAND_BINDING
0.795454545455%	28	3520	335	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WONG_EMBRYONIC_STEM_CELL_CORE
0.795454545455%	28	3520	321	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
0.795454545455%	28	3520	285	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRADE_COLON_AND_RECTAL_CANCER_UP
0.795454545455%	28	3520	284	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
0.795454545455%	28	3520	267	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOLLMANN_APOPTOSIS_VIA_CD40_DN
0.795454545455%	28	3520	252	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.795454545455%	28	3520	241	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
0.795454545455%	28	3520	241	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DOANE_RESPONSE_TO_ANDROGEN_DN
0.795454545455%	28	3520	229	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
0.795454545455%	28	3520	226	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_UP
0.795454545455%	28	3520	225	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
0.795454545455%	28	3520	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_TUMOR_INVASIVENESS_DN
0.795454545455%	28	3520	207	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KARLSSON_TGFB1_TARGETS_DN
0.795454545455%	28	3520	206	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.795454545455%	28	3520	202	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
0.795454545455%	28	3520	196	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
0.795454545455%	28	3520	173	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SENGUPTA_EBNA1_ANTICORRELATED
0.795454545455%	28	3520	162	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DARWICHE_PAPILLOMA_RISK_LOW_UP
0.795454545455%	28	3520	157	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
0.790513833992%	2	253	99	Diabetes_McGill_CREBBP_coTF	LIM_MAMMARY_LUMINAL_MATURE_DN
0.790513833992%	2	253	98	Diabetes_McGill_CREBBP_coTF	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
0.790513833992%	2	253	98	Diabetes_McGill_CREBBP_coTF	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
0.790513833992%	2	253	98	Diabetes_McGill_CREBBP_coTF	NIELSEN_GIST
0.790513833992%	2	253	98	Diabetes_McGill_CREBBP_coTF	HAHTOLA_SEZARY_SYNDROM_UP
0.790513833992%	2	253	98	Diabetes_McGill_CREBBP_coTF	GAVIN_FOXP3_TARGETS_CLUSTER_T7
0.790513833992%	2	253	97	Diabetes_McGill_CREBBP_coTF	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP
0.790513833992%	2	253	97	Diabetes_McGill_CREBBP_coTF	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP
0.790513833992%	2	253	95	Diabetes_McGill_CREBBP_coTF	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
0.790513833992%	2	253	95	Diabetes_McGill_CREBBP_coTF	KAYO_CALORIE_RESTRICTION_MUSCLE_UP
0.790513833992%	2	253	94	Diabetes_McGill_CREBBP_coTF	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.790513833992%	2	253	94	Diabetes_McGill_CREBBP_coTF	GAVIN_FOXP3_TARGETS_CLUSTER_T4
0.790513833992%	2	253	93	Diabetes_McGill_CREBBP_coTF	REACTOME_REGULATION_OF_INSULIN_SECRETION
0.790513833992%	2	253	92	Diabetes_McGill_CREBBP_coTF	HILLION_HMGA1B_TARGETS
0.790513833992%	2	253	92	Diabetes_McGill_CREBBP_coTF	DE_YY1_TARGETS_DN
0.790513833992%	2	253	91	Diabetes_McGill_CREBBP_coTF	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION
0.790513833992%	2	253	91	Diabetes_McGill_CREBBP_coTF	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
0.790513833992%	2	253	91	Diabetes_McGill_CREBBP_coTF	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
0.790513833992%	2	253	90	Diabetes_McGill_CREBBP_coTF	MORI_MATURE_B_LYMPHOCYTE_UP
0.790513833992%	2	253	90	Diabetes_McGill_CREBBP_coTF	IVANOVSKA_MIR106B_TARGETS
0.790513833992%	2	253	90	Diabetes_McGill_CREBBP_coTF	HILLION_HMGA1_TARGETS
0.790513833992%	2	253	9	Diabetes_McGill_CREBBP_coTF	ZERBINI_RESPONSE_TO_SULINDAC_UP
0.790513833992%	2	253	9	Diabetes_McGill_CREBBP_coTF	WANG_RESPONSE_TO_FORSKOLIN_DN
0.790513833992%	2	253	9	Diabetes_McGill_CREBBP_coTF	ST_JAK_STAT_PATHWAY
0.790513833992%	2	253	9	Diabetes_McGill_CREBBP_coTF	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP
0.790513833992%	2	253	9	Diabetes_McGill_CREBBP_coTF	FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION
0.790513833992%	2	253	89	Diabetes_McGill_CREBBP_coTF	LEIN_PONS_MARKERS
0.790513833992%	2	253	89	Diabetes_McGill_CREBBP_coTF	LEE_AGING_NEOCORTEX_UP
0.790513833992%	2	253	89	Diabetes_McGill_CREBBP_coTF	KANG_IMMORTALIZED_BY_TERT_UP
0.790513833992%	2	253	89	Diabetes_McGill_CREBBP_coTF	BOYLAN_MULTIPLE_MYELOMA_D_UP
0.790513833992%	2	253	88	Diabetes_McGill_CREBBP_coTF	SEIDEN_ONCOGENESIS_BY_MET
0.790513833992%	2	253	87	Diabetes_McGill_CREBBP_coTF	SMITH_TERT_TARGETS_DN
0.790513833992%	2	253	87	Diabetes_McGill_CREBBP_coTF	SAFFORD_T_LYMPHOCYTE_ANERGY
0.790513833992%	2	253	87	Diabetes_McGill_CREBBP_coTF	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.790513833992%	2	253	87	Diabetes_McGill_CREBBP_coTF	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.790513833992%	2	253	86	Diabetes_McGill_CREBBP_coTF	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
0.790513833992%	2	253	86	Diabetes_McGill_CREBBP_coTF	LAIHO_COLORECTAL_CANCER_SERRATED_DN
0.790513833992%	2	253	86	Diabetes_McGill_CREBBP_coTF	BURTON_ADIPOGENESIS_8
0.790513833992%	2	253	86	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_16HR_DN
0.790513833992%	2	253	86	Diabetes_McGill_CREBBP_coTF	BAELDE_DIABETIC_NEPHROPATHY_UP
0.790513833992%	2	253	85	Diabetes_McGill_CREBBP_coTF	COLDREN_GEFITINIB_RESISTANCE_UP
0.790513833992%	2	253	84	Diabetes_McGill_CREBBP_coTF	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP
0.790513833992%	2	253	84	Diabetes_McGill_CREBBP_coTF	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
0.790513833992%	2	253	84	Diabetes_McGill_CREBBP_coTF	RUAN_RESPONSE_TO_TNF_DN
0.790513833992%	2	253	84	Diabetes_McGill_CREBBP_coTF	CHANG_IMMORTALIZED_BY_HPV31_UP
0.790513833992%	2	253	83	Diabetes_McGill_CREBBP_coTF	REACTOME_AMYLOIDS
0.790513833992%	2	253	83	Diabetes_McGill_CREBBP_coTF	ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.790513833992%	2	253	83	Diabetes_McGill_CREBBP_coTF	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.790513833992%	2	253	82	Diabetes_McGill_CREBBP_coTF	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
0.790513833992%	2	253	82	Diabetes_McGill_CREBBP_coTF	ODONNELL_METASTASIS_UP
0.790513833992%	2	253	82	Diabetes_McGill_CREBBP_coTF	LEIN_MIDBRAIN_MARKERS
0.790513833992%	2	253	81	Diabetes_McGill_CREBBP_coTF	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
0.790513833992%	2	253	81	Diabetes_McGill_CREBBP_coTF	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.790513833992%	2	253	81	Diabetes_McGill_CREBBP_coTF	SCIBETTA_KDM5B_TARGETS_DN
0.790513833992%	2	253	81	Diabetes_McGill_CREBBP_coTF	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
0.790513833992%	2	253	81	Diabetes_McGill_CREBBP_coTF	MUNSHI_MULTIPLE_MYELOMA_UP
0.790513833992%	2	253	81	Diabetes_McGill_CREBBP_coTF	GRABARCZYK_BCL11B_TARGETS_UP
0.790513833992%	2	253	80	Diabetes_McGill_CREBBP_coTF	WOO_LIVER_CANCER_RECURRENCE_DN
0.790513833992%	2	253	8	Diabetes_McGill_CREBBP_coTF	STANHILL_HRAS_TRANSFROMATION_UP
0.790513833992%	2	253	8	Diabetes_McGill_CREBBP_coTF	SA_G2_AND_M_PHASES
0.790513833992%	2	253	8	Diabetes_McGill_CREBBP_coTF	MATZUK_LUTEAL_GENES
0.790513833992%	2	253	8	Diabetes_McGill_CREBBP_coTF	KREPPEL_CD99_TARGETS_DN
0.790513833992%	2	253	8	Diabetes_McGill_CREBBP_coTF	ISHIKAWA_STING_SIGNALING
0.790513833992%	2	253	8	Diabetes_McGill_CREBBP_coTF	BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS
0.790513833992%	2	253	79	Diabetes_McGill_CREBBP_coTF	MCCLUNG_COCAINE_REWARD_5D
0.790513833992%	2	253	78	Diabetes_McGill_CREBBP_coTF	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
0.790513833992%	2	253	78	Diabetes_McGill_CREBBP_coTF	REACTOME_CELL_JUNCTION_ORGANIZATION
0.790513833992%	2	253	78	Diabetes_McGill_CREBBP_coTF	LINDVALL_IMMORTALIZED_BY_TERT_UP
0.790513833992%	2	253	77	Diabetes_McGill_CREBBP_coTF	RODRIGUES_THYROID_CARCINOMA_DN
0.790513833992%	2	253	77	Diabetes_McGill_CREBBP_coTF	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
0.790513833992%	2	253	77	Diabetes_McGill_CREBBP_coTF	CHEBOTAEV_GR_TARGETS_UP
0.790513833992%	2	253	76	Diabetes_McGill_CREBBP_coTF	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.790513833992%	2	253	76	Diabetes_McGill_CREBBP_coTF	ROSS_AML_WITH_AML1_ETO_FUSION
0.790513833992%	2	253	76	Diabetes_McGill_CREBBP_coTF	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
0.790513833992%	2	253	76	Diabetes_McGill_CREBBP_coTF	KEGG_VEGF_SIGNALING_PATHWAY
0.790513833992%	2	253	75	Diabetes_McGill_CREBBP_coTF	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
0.790513833992%	2	253	75	Diabetes_McGill_CREBBP_coTF	REACTOME_TELOMERE_MAINTENANCE
0.790513833992%	2	253	75	Diabetes_McGill_CREBBP_coTF	BAE_BRCA1_TARGETS_UP
0.790513833992%	2	253	74	Diabetes_McGill_CREBBP_coTF	WESTON_VEGFA_TARGETS_3HR
0.790513833992%	2	253	74	Diabetes_McGill_CREBBP_coTF	VANASSE_BCL2_TARGETS_DN
0.790513833992%	2	253	74	Diabetes_McGill_CREBBP_coTF	POTTI_ADRIAMYCIN_SENSITIVITY
0.790513833992%	2	253	74	Diabetes_McGill_CREBBP_coTF	OUILLETTE_CLL_13Q14_DELETION_UP
0.790513833992%	2	253	74	Diabetes_McGill_CREBBP_coTF	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN
0.790513833992%	2	253	72	Diabetes_McGill_CREBBP_coTF	SESTO_RESPONSE_TO_UV_C8
0.790513833992%	2	253	7	Diabetes_McGill_CREBBP_coTF	TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP
0.790513833992%	2	253	69	Diabetes_McGill_CREBBP_coTF	PID_VEGFR1_2_PATHWAY
0.790513833992%	2	253	69	Diabetes_McGill_CREBBP_coTF	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
0.790513833992%	2	253	69	Diabetes_McGill_CREBBP_coTF	AMIT_EGF_RESPONSE_120_HELA
0.790513833992%	2	253	68	Diabetes_McGill_CREBBP_coTF	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.790513833992%	2	253	68	Diabetes_McGill_CREBBP_coTF	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
0.790513833992%	2	253	68	Diabetes_McGill_CREBBP_coTF	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.790513833992%	2	253	68	Diabetes_McGill_CREBBP_coTF	AKL_HTLV1_INFECTION_DN
0.790513833992%	2	253	67	Diabetes_McGill_CREBBP_coTF	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.790513833992%	2	253	67	Diabetes_McGill_CREBBP_coTF	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
0.790513833992%	2	253	67	Diabetes_McGill_CREBBP_coTF	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN
0.790513833992%	2	253	67	Diabetes_McGill_CREBBP_coTF	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
0.790513833992%	2	253	67	Diabetes_McGill_CREBBP_coTF	GENTILE_UV_LOW_DOSE_DN
0.790513833992%	2	253	66	Diabetes_McGill_CREBBP_coTF	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
0.790513833992%	2	253	66	Diabetes_McGill_CREBBP_coTF	RAMASWAMY_METASTASIS_UP
0.790513833992%	2	253	65	Diabetes_McGill_CREBBP_coTF	ST_FAS_SIGNALING_PATHWAY
0.790513833992%	2	253	65	Diabetes_McGill_CREBBP_coTF	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
0.790513833992%	2	253	65	Diabetes_McGill_CREBBP_coTF	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
0.790513833992%	2	253	65	Diabetes_McGill_CREBBP_coTF	GOLDRATH_IMMUNE_MEMORY
0.790513833992%	2	253	65	Diabetes_McGill_CREBBP_coTF	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS
0.790513833992%	2	253	64	Diabetes_McGill_CREBBP_coTF	LEE_LIVER_CANCER_ACOX1_UP
0.790513833992%	2	253	63	Diabetes_McGill_CREBBP_coTF	BRIDEAU_IMPRINTED_GENES
0.790513833992%	2	253	62	Diabetes_McGill_CREBBP_coTF	KORKOLA_YOLK_SAC_TUMOR
0.790513833992%	2	253	61	Diabetes_McGill_CREBBP_coTF	REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS
0.790513833992%	2	253	61	Diabetes_McGill_CREBBP_coTF	LEE_LIVER_CANCER_MYC_TGFA_UP
0.790513833992%	2	253	60	Diabetes_McGill_CREBBP_coTF	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING
0.790513833992%	2	253	60	Diabetes_McGill_CREBBP_coTF	LEE_LIVER_CANCER_DENA_UP
0.790513833992%	2	253	60	Diabetes_McGill_CREBBP_coTF	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
0.790513833992%	2	253	60	Diabetes_McGill_CREBBP_coTF	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.790513833992%	2	253	60	Diabetes_McGill_CREBBP_coTF	AMIT_EGF_RESPONSE_240_HELA
0.790513833992%	2	253	6	Diabetes_McGill_CREBBP_coTF	KAUFFMANN_MELANOMA_RELAPSE_DN
0.790513833992%	2	253	6	Diabetes_McGill_CREBBP_coTF	COURTOIS_SENESCENCE_TRIGGERS
0.790513833992%	2	253	59	Diabetes_McGill_CREBBP_coTF	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
0.790513833992%	2	253	59	Diabetes_McGill_CREBBP_coTF	ELVIDGE_HYPOXIA_BY_DMOG_DN
0.790513833992%	2	253	59	Diabetes_McGill_CREBBP_coTF	BOYLAN_MULTIPLE_MYELOMA_C_DN
0.790513833992%	2	253	59	Diabetes_McGill_CREBBP_coTF	BARIS_THYROID_CANCER_DN
0.790513833992%	2	253	59	Diabetes_McGill_CREBBP_coTF	ASTIER_INTEGRIN_SIGNALING
0.790513833992%	2	253	58	Diabetes_McGill_CREBBP_coTF	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
0.790513833992%	2	253	58	Diabetes_McGill_CREBBP_coTF	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN
0.790513833992%	2	253	58	Diabetes_McGill_CREBBP_coTF	KOHOUTEK_CCNT2_TARGETS
0.790513833992%	2	253	58	Diabetes_McGill_CREBBP_coTF	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
0.790513833992%	2	253	58	Diabetes_McGill_CREBBP_coTF	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
0.790513833992%	2	253	57	Diabetes_McGill_CREBBP_coTF	YAMASHITA_METHYLATED_IN_PROSTATE_CANCER
0.790513833992%	2	253	57	Diabetes_McGill_CREBBP_coTF	NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON
0.790513833992%	2	253	57	Diabetes_McGill_CREBBP_coTF	LEE_EARLY_T_LYMPHOCYTE_DN
0.790513833992%	2	253	57	Diabetes_McGill_CREBBP_coTF	AMIT_SERUM_RESPONSE_60_MCF10A
0.790513833992%	2	253	56	Diabetes_McGill_CREBBP_coTF	WORSCHECH_TUMOR_REJECTION_UP
0.790513833992%	2	253	56	Diabetes_McGill_CREBBP_coTF	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION
0.790513833992%	2	253	56	Diabetes_McGill_CREBBP_coTF	GRADE_COLON_VS_RECTAL_CANCER_DN
0.790513833992%	2	253	56	Diabetes_McGill_CREBBP_coTF	GALE_APL_WITH_FLT3_MUTATED_UP
0.790513833992%	2	253	55	Diabetes_McGill_CREBBP_coTF	YU_MYC_TARGETS_DN
0.790513833992%	2	253	55	Diabetes_McGill_CREBBP_coTF	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
0.790513833992%	2	253	55	Diabetes_McGill_CREBBP_coTF	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
0.790513833992%	2	253	55	Diabetes_McGill_CREBBP_coTF	TIEN_INTESTINE_PROBIOTICS_6HR_UP
0.790513833992%	2	253	55	Diabetes_McGill_CREBBP_coTF	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER
0.790513833992%	2	253	55	Diabetes_McGill_CREBBP_coTF	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR
0.790513833992%	2	253	55	Diabetes_McGill_CREBBP_coTF	GENTILE_UV_RESPONSE_CLUSTER_D4
0.790513833992%	2	253	54	Diabetes_McGill_CREBBP_coTF	ZHOU_TNF_SIGNALING_4HR
0.790513833992%	2	253	54	Diabetes_McGill_CREBBP_coTF	SU_PANCREAS
0.790513833992%	2	253	54	Diabetes_McGill_CREBBP_coTF	SUNG_METASTASIS_STROMA_DN
0.790513833992%	2	253	54	Diabetes_McGill_CREBBP_coTF	ROVERSI_GLIOMA_COPY_NUMBER_DN
0.790513833992%	2	253	54	Diabetes_McGill_CREBBP_coTF	REACTOME_APOPTOTIC_EXECUTION_PHASE
0.790513833992%	2	253	54	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_IPS_ICP_WITH_H3K27ME3
0.790513833992%	2	253	54	Diabetes_McGill_CREBBP_coTF	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN
0.790513833992%	2	253	53	Diabetes_McGill_CREBBP_coTF	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS
0.790513833992%	2	253	53	Diabetes_McGill_CREBBP_coTF	LIANG_SILENCED_BY_METHYLATION_2
0.790513833992%	2	253	53	Diabetes_McGill_CREBBP_coTF	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
0.790513833992%	2	253	53	Diabetes_McGill_CREBBP_coTF	ISHIDA_E2F_TARGETS
0.790513833992%	2	253	52	Diabetes_McGill_CREBBP_coTF	PRAMOONJAGO_SOX4_TARGETS_UP
0.790513833992%	2	253	52	Diabetes_McGill_CREBBP_coTF	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
0.790513833992%	2	253	52	Diabetes_McGill_CREBBP_coTF	HALMOS_CEBPA_TARGETS_UP
0.790513833992%	2	253	51	Diabetes_McGill_CREBBP_coTF	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
0.790513833992%	2	253	51	Diabetes_McGill_CREBBP_coTF	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.790513833992%	2	253	51	Diabetes_McGill_CREBBP_coTF	REACTOME_NUCLEOTIDE_EXCISION_REPAIR
0.790513833992%	2	253	51	Diabetes_McGill_CREBBP_coTF	LUI_THYROID_CANCER_CLUSTER_1
0.790513833992%	2	253	51	Diabetes_McGill_CREBBP_coTF	FRASOR_TAMOXIFEN_RESPONSE_UP
0.790513833992%	2	253	51	Diabetes_McGill_CREBBP_coTF	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
0.790513833992%	2	253	51	Diabetes_McGill_CREBBP_coTF	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP
0.790513833992%	2	253	50	Diabetes_McGill_CREBBP_coTF	YANG_BREAST_CANCER_ESR1_LASER_DN
0.790513833992%	2	253	50	Diabetes_McGill_CREBBP_coTF	PARK_APL_PATHOGENESIS_DN
0.790513833992%	2	253	50	Diabetes_McGill_CREBBP_coTF	NADERI_BREAST_CANCER_PROGNOSIS_UP
0.790513833992%	2	253	50	Diabetes_McGill_CREBBP_coTF	DAUER_STAT3_TARGETS_DN
0.790513833992%	2	253	5	Diabetes_McGill_CREBBP_coTF	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_3
0.790513833992%	2	253	49	Diabetes_McGill_CREBBP_coTF	OLSSON_E2F3_TARGETS_DN
0.790513833992%	2	253	49	Diabetes_McGill_CREBBP_coTF	MANTOVANI_VIRAL_GPCR_SIGNALING_DN
0.790513833992%	2	253	49	Diabetes_McGill_CREBBP_coTF	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP
0.790513833992%	2	253	49	Diabetes_McGill_CREBBP_coTF	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP
0.790513833992%	2	253	48	Diabetes_McGill_CREBBP_coTF	TAVOR_CEBPA_TARGETS_UP
0.790513833992%	2	253	48	Diabetes_McGill_CREBBP_coTF	MCCLUNG_DELTA_FOSB_TARGETS_2WK
0.790513833992%	2	253	48	Diabetes_McGill_CREBBP_coTF	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
0.790513833992%	2	253	48	Diabetes_McGill_CREBBP_coTF	GNATENKO_PLATELET_SIGNATURE
0.790513833992%	2	253	48	Diabetes_McGill_CREBBP_coTF	ENGELMANN_CANCER_PROGENITORS_UP
0.790513833992%	2	253	48	Diabetes_McGill_CREBBP_coTF	DELACROIX_RAR_TARGETS_UP
0.790513833992%	2	253	48	Diabetes_McGill_CREBBP_coTF	BURTON_ADIPOGENESIS_4
0.790513833992%	2	253	473	Diabetes_McGill_CREBBP_coTF	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
0.790513833992%	2	253	47	Diabetes_McGill_CREBBP_coTF	POTTI_DOCETAXEL_SENSITIVITY
0.790513833992%	2	253	47	Diabetes_McGill_CREBBP_coTF	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP
0.790513833992%	2	253	47	Diabetes_McGill_CREBBP_coTF	PID_FANCONI_PATHWAY
0.790513833992%	2	253	47	Diabetes_McGill_CREBBP_coTF	KEGG_TYPE_II_DIABETES_MELLITUS
0.790513833992%	2	253	46	Diabetes_McGill_CREBBP_coTF	ZHAN_MULTIPLE_MYELOMA_CD2_DN
0.790513833992%	2	253	46	Diabetes_McGill_CREBBP_coTF	SIG_BCR_SIGNALING_PATHWAY
0.790513833992%	2	253	46	Diabetes_McGill_CREBBP_coTF	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6
0.790513833992%	2	253	46	Diabetes_McGill_CREBBP_coTF	SAGIV_CD24_TARGETS_DN
0.790513833992%	2	253	46	Diabetes_McGill_CREBBP_coTF	NUTT_GBM_VS_AO_GLIOMA_UP
0.790513833992%	2	253	46	Diabetes_McGill_CREBBP_coTF	NAKAJIMA_MAST_CELL
0.790513833992%	2	253	46	Diabetes_McGill_CREBBP_coTF	KRASNOSELSKAYA_ILF3_TARGETS_DN
0.790513833992%	2	253	46	Diabetes_McGill_CREBBP_coTF	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN
0.790513833992%	2	253	46	Diabetes_McGill_CREBBP_coTF	AMIT_EGF_RESPONSE_60_HELA
0.790513833992%	2	253	45	Diabetes_McGill_CREBBP_coTF	ZHAN_V2_LATE_DIFFERENTIATION_GENES
0.790513833992%	2	253	45	Diabetes_McGill_CREBBP_coTF	ZHAN_MULTIPLE_MYELOMA_PR_UP
0.790513833992%	2	253	45	Diabetes_McGill_CREBBP_coTF	ZHAN_MULTIPLE_MYELOMA_CD1_DN
0.790513833992%	2	253	45	Diabetes_McGill_CREBBP_coTF	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN
0.790513833992%	2	253	45	Diabetes_McGill_CREBBP_coTF	REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER
0.790513833992%	2	253	45	Diabetes_McGill_CREBBP_coTF	REACTOME_G2_M_CHECKPOINTS
0.790513833992%	2	253	45	Diabetes_McGill_CREBBP_coTF	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN
0.790513833992%	2	253	45	Diabetes_McGill_CREBBP_coTF	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN
0.790513833992%	2	253	45	Diabetes_McGill_CREBBP_coTF	HUANG_FOXA2_TARGETS_UP
0.790513833992%	2	253	45	Diabetes_McGill_CREBBP_coTF	CHENG_RESPONSE_TO_NICKEL_ACETATE
0.790513833992%	2	253	45	Diabetes_McGill_CREBBP_coTF	CHANDRAN_METASTASIS_TOP50_DN
0.790513833992%	2	253	44	Diabetes_McGill_CREBBP_coTF	VANTVEER_BREAST_CANCER_BRCA1_DN
0.790513833992%	2	253	44	Diabetes_McGill_CREBBP_coTF	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.790513833992%	2	253	44	Diabetes_McGill_CREBBP_coTF	THILLAINADESAN_ZNF217_TARGETS_UP
0.790513833992%	2	253	44	Diabetes_McGill_CREBBP_coTF	MEDINA_SMARCA4_TARGETS
0.790513833992%	2	253	44	Diabetes_McGill_CREBBP_coTF	KERLEY_RESPONSE_TO_CISPLATIN_UP
0.790513833992%	2	253	44	Diabetes_McGill_CREBBP_coTF	KEGG_ABC_TRANSPORTERS
0.790513833992%	2	253	44	Diabetes_McGill_CREBBP_coTF	GROSS_HYPOXIA_VIA_ELK3_ONLY_DN
0.790513833992%	2	253	44	Diabetes_McGill_CREBBP_coTF	CHUNG_BLISTER_CYTOTOXICITY_DN
0.790513833992%	2	253	44	Diabetes_McGill_CREBBP_coTF	CHOI_ATL_STAGE_PREDICTOR
0.790513833992%	2	253	43	Diabetes_McGill_CREBBP_coTF	ZUCCHI_METASTASIS_UP
0.790513833992%	2	253	43	Diabetes_McGill_CREBBP_coTF	REACTOME_IL_3_5_AND_GM_CSF_SIGNALING
0.790513833992%	2	253	43	Diabetes_McGill_CREBBP_coTF	POTTI_5FU_SENSITIVITY
0.790513833992%	2	253	43	Diabetes_McGill_CREBBP_coTF	NAKAYAMA_FRA2_TARGETS
0.790513833992%	2	253	43	Diabetes_McGill_CREBBP_coTF	HUMMEL_BURKITTS_LYMPHOMA_UP
0.790513833992%	2	253	43	Diabetes_McGill_CREBBP_coTF	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
0.790513833992%	2	253	429	Diabetes_McGill_CREBBP_coTF	MOOTHA_HUMAN_MITODB_6_2002
0.790513833992%	2	253	42	Diabetes_McGill_CREBBP_coTF	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
0.790513833992%	2	253	42	Diabetes_McGill_CREBBP_coTF	PID_BMPPATHWAY
0.790513833992%	2	253	42	Diabetes_McGill_CREBBP_coTF	MODY_HIPPOCAMPUS_PRENATAL
0.790513833992%	2	253	42	Diabetes_McGill_CREBBP_coTF	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP
0.790513833992%	2	253	42	Diabetes_McGill_CREBBP_coTF	BILBAN_B_CLL_LPL_DN
0.790513833992%	2	253	41	Diabetes_McGill_CREBBP_coTF	REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING
0.790513833992%	2	253	41	Diabetes_McGill_CREBBP_coTF	REACTOME_IL_2_SIGNALING
0.790513833992%	2	253	41	Diabetes_McGill_CREBBP_coTF	ONO_AML1_TARGETS_DN
0.790513833992%	2	253	41	Diabetes_McGill_CREBBP_coTF	KAMMINGA_EZH2_TARGETS
0.790513833992%	2	253	40	Diabetes_McGill_CREBBP_coTF	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
0.790513833992%	2	253	40	Diabetes_McGill_CREBBP_coTF	HEIDENBLAD_AMPLICON_8Q24_UP
0.790513833992%	2	253	40	Diabetes_McGill_CREBBP_coTF	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
0.790513833992%	2	253	40	Diabetes_McGill_CREBBP_coTF	CHANGOLKAR_H2AFY_TARGETS_DN
0.790513833992%	2	253	40	Diabetes_McGill_CREBBP_coTF	AMUNDSON_GAMMA_RADIATION_RESPONSE
0.790513833992%	2	253	39	Diabetes_McGill_CREBBP_coTF	WANG_LSD1_TARGETS_DN
0.790513833992%	2	253	39	Diabetes_McGill_CREBBP_coTF	VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1
0.790513833992%	2	253	39	Diabetes_McGill_CREBBP_coTF	PID_RET_PATHWAY
0.790513833992%	2	253	39	Diabetes_McGill_CREBBP_coTF	PID_ECADHERIN_NASCENTAJ_PATHWAY
0.790513833992%	2	253	39	Diabetes_McGill_CREBBP_coTF	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
0.790513833992%	2	253	39	Diabetes_McGill_CREBBP_coTF	MATZUK_MEIOTIC_AND_DNA_REPAIR
0.790513833992%	2	253	39	Diabetes_McGill_CREBBP_coTF	HOFMANN_CELL_LYMPHOMA_DN
0.790513833992%	2	253	39	Diabetes_McGill_CREBBP_coTF	HAN_JNK_SINGALING_DN
0.790513833992%	2	253	39	Diabetes_McGill_CREBBP_coTF	GU_PDEF_TARGETS_DN
0.790513833992%	2	253	39	Diabetes_McGill_CREBBP_coTF	CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP
0.790513833992%	2	253	38	Diabetes_McGill_CREBBP_coTF	SPIRA_SMOKERS_LUNG_CANCER_UP
0.790513833992%	2	253	38	Diabetes_McGill_CREBBP_coTF	REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS
0.790513833992%	2	253	38	Diabetes_McGill_CREBBP_coTF	PENG_GLUTAMINE_DEPRIVATION_UP
0.790513833992%	2	253	38	Diabetes_McGill_CREBBP_coTF	LIU_LIVER_CANCER
0.790513833992%	2	253	38	Diabetes_McGill_CREBBP_coTF	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN
0.790513833992%	2	253	38	Diabetes_McGill_CREBBP_coTF	CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN
0.790513833992%	2	253	38	Diabetes_McGill_CREBBP_coTF	BIOCARTA_INTEGRIN_PATHWAY
0.790513833992%	2	253	37	Diabetes_McGill_CREBBP_coTF	VALK_AML_WITH_CEBPA
0.790513833992%	2	253	37	Diabetes_McGill_CREBBP_coTF	ST_GA13_PATHWAY
0.790513833992%	2	253	37	Diabetes_McGill_CREBBP_coTF	MATZUK_SPERMATID_DIFFERENTIATION
0.790513833992%	2	253	37	Diabetes_McGill_CREBBP_coTF	LANDIS_ERBB2_BREAST_TUMORS_65_DN
0.790513833992%	2	253	37	Diabetes_McGill_CREBBP_coTF	FRASOR_RESPONSE_TO_ESTRADIOL_UP
0.790513833992%	2	253	36	Diabetes_McGill_CREBBP_coTF	VANTVEER_BREAST_CANCER_BRCA1_UP
0.790513833992%	2	253	36	Diabetes_McGill_CREBBP_coTF	SEMENZA_HIF1_TARGETS
0.790513833992%	2	253	36	Diabetes_McGill_CREBBP_coTF	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
0.790513833992%	2	253	36	Diabetes_McGill_CREBBP_coTF	KEGG_DNA_REPLICATION
0.790513833992%	2	253	36	Diabetes_McGill_CREBBP_coTF	KEGG_BASAL_TRANSCRIPTION_FACTORS
0.790513833992%	2	253	36	Diabetes_McGill_CREBBP_coTF	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP
0.790513833992%	2	253	35	Diabetes_McGill_CREBBP_coTF	SCHRAETS_MLL_TARGETS_UP
0.790513833992%	2	253	35	Diabetes_McGill_CREBBP_coTF	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
0.790513833992%	2	253	35	Diabetes_McGill_CREBBP_coTF	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.790513833992%	2	253	35	Diabetes_McGill_CREBBP_coTF	KEGG_PRIMARY_IMMUNODEFICIENCY
0.790513833992%	2	253	35	Diabetes_McGill_CREBBP_coTF	HU_GENOTOXIC_DAMAGE_4HR
0.790513833992%	2	253	344	Diabetes_McGill_CREBBP_coTF	RICKMAN_METASTASIS_UP
0.790513833992%	2	253	34	Diabetes_McGill_CREBBP_coTF	YANG_BREAST_CANCER_ESR1_LASER_UP
0.790513833992%	2	253	34	Diabetes_McGill_CREBBP_coTF	WONG_IFNA2_RESISTANCE_DN
0.790513833992%	2	253	34	Diabetes_McGill_CREBBP_coTF	WANG_RESPONSE_TO_BEXAROTENE_UP
0.790513833992%	2	253	33	Diabetes_McGill_CREBBP_coTF	SIMBULAN_UV_RESPONSE_NORMAL_DN
0.790513833992%	2	253	33	Diabetes_McGill_CREBBP_coTF	ROZANOV_MMP14_TARGETS_SUBSET
0.790513833992%	2	253	33	Diabetes_McGill_CREBBP_coTF	MORI_PLASMA_CELL_DN
0.790513833992%	2	253	33	Diabetes_McGill_CREBBP_coTF	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP
0.790513833992%	2	253	33	Diabetes_McGill_CREBBP_coTF	GHANDHI_DIRECT_IRRADIATION_DN
0.790513833992%	2	253	33	Diabetes_McGill_CREBBP_coTF	DUTTA_APOPTOSIS_VIA_NFKB
0.790513833992%	2	253	33	Diabetes_McGill_CREBBP_coTF	BIOCARTA_DEATH_PATHWAY
0.790513833992%	2	253	33	Diabetes_McGill_CREBBP_coTF	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN
0.790513833992%	2	253	32	Diabetes_McGill_CREBBP_coTF	TSAI_RESPONSE_TO_RADIATION_THERAPY
0.790513833992%	2	253	32	Diabetes_McGill_CREBBP_coTF	POS_HISTAMINE_RESPONSE_NETWORK
0.790513833992%	2	253	32	Diabetes_McGill_CREBBP_coTF	PID_SYNDECAN_4_PATHWAY
0.790513833992%	2	253	32	Diabetes_McGill_CREBBP_coTF	KASLER_HDAC7_TARGETS_2_DN
0.790513833992%	2	253	31	Diabetes_McGill_CREBBP_coTF	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP
0.790513833992%	2	253	31	Diabetes_McGill_CREBBP_coTF	SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN
0.790513833992%	2	253	31	Diabetes_McGill_CREBBP_coTF	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.790513833992%	2	253	31	Diabetes_McGill_CREBBP_coTF	REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX
0.790513833992%	2	253	31	Diabetes_McGill_CREBBP_coTF	NOJIMA_SFRP2_TARGETS_UP
0.790513833992%	2	253	31	Diabetes_McGill_CREBBP_coTF	MCCABE_HOXC6_TARGETS_CANCER_UP
0.790513833992%	2	253	31	Diabetes_McGill_CREBBP_coTF	HUNSBERGER_EXERCISE_REGULATED_GENES
0.790513833992%	2	253	31	Diabetes_McGill_CREBBP_coTF	DANG_MYC_TARGETS_DN
0.790513833992%	2	253	31	Diabetes_McGill_CREBBP_coTF	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.790513833992%	2	253	30	Diabetes_McGill_CREBBP_coTF	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.790513833992%	2	253	30	Diabetes_McGill_CREBBP_coTF	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN
0.790513833992%	2	253	30	Diabetes_McGill_CREBBP_coTF	SU_PLACENTA
0.790513833992%	2	253	30	Diabetes_McGill_CREBBP_coTF	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
0.790513833992%	2	253	30	Diabetes_McGill_CREBBP_coTF	REACTOME_DNA_STRAND_ELONGATION
0.790513833992%	2	253	30	Diabetes_McGill_CREBBP_coTF	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP
0.790513833992%	2	253	30	Diabetes_McGill_CREBBP_coTF	KYNG_NORMAL_AGING_DN
0.790513833992%	2	253	30	Diabetes_McGill_CREBBP_coTF	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP
0.790513833992%	2	253	30	Diabetes_McGill_CREBBP_coTF	BIOCARTA_FAS_PATHWAY
0.790513833992%	2	253	29	Diabetes_McGill_CREBBP_coTF	YU_BAP1_TARGETS
0.790513833992%	2	253	29	Diabetes_McGill_CREBBP_coTF	WANG_RESPONSE_TO_ANDROGEN_UP
0.790513833992%	2	253	29	Diabetes_McGill_CREBBP_coTF	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR
0.790513833992%	2	253	29	Diabetes_McGill_CREBBP_coTF	ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.790513833992%	2	253	29	Diabetes_McGill_CREBBP_coTF	REACTOME_PERK_REGULATED_GENE_EXPRESSION
0.790513833992%	2	253	29	Diabetes_McGill_CREBBP_coTF	PATTERSON_DOCETAXEL_RESISTANCE
0.790513833992%	2	253	29	Diabetes_McGill_CREBBP_coTF	KYNG_WERNER_SYNDROM_DN
0.790513833992%	2	253	29	Diabetes_McGill_CREBBP_coTF	DALESSIO_TSA_RESPONSE
0.790513833992%	2	253	29	Diabetes_McGill_CREBBP_coTF	BIOCARTA_VEGF_PATHWAY
0.790513833992%	2	253	284	Diabetes_McGill_CREBBP_coTF	REACTOME_METABOLISM_OF_MRNA
0.790513833992%	2	253	28	Diabetes_McGill_CREBBP_coTF	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS
0.790513833992%	2	253	28	Diabetes_McGill_CREBBP_coTF	REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS
0.790513833992%	2	253	28	Diabetes_McGill_CREBBP_coTF	PETROVA_PROX1_TARGETS_UP
0.790513833992%	2	253	28	Diabetes_McGill_CREBBP_coTF	MATZUK_MALE_REPRODUCTION_SERTOLI
0.790513833992%	2	253	28	Diabetes_McGill_CREBBP_coTF	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.790513833992%	2	253	28	Diabetes_McGill_CREBBP_coTF	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.790513833992%	2	253	28	Diabetes_McGill_CREBBP_coTF	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP
0.790513833992%	2	253	272	Diabetes_McGill_CREBBP_coTF	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
0.790513833992%	2	253	27	Diabetes_McGill_CREBBP_coTF	XU_AKT1_TARGETS_6HR
0.790513833992%	2	253	27	Diabetes_McGill_CREBBP_coTF	TIEN_INTESTINE_PROBIOTICS_2HR_UP
0.790513833992%	2	253	27	Diabetes_McGill_CREBBP_coTF	REACTOME_EXTENSION_OF_TELOMERES
0.790513833992%	2	253	27	Diabetes_McGill_CREBBP_coTF	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS
0.790513833992%	2	253	27	Diabetes_McGill_CREBBP_coTF	PID_GLYPICAN_1PATHWAY
0.790513833992%	2	253	27	Diabetes_McGill_CREBBP_coTF	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN
0.790513833992%	2	253	27	Diabetes_McGill_CREBBP_coTF	BIOCARTA_GSK3_PATHWAY
0.790513833992%	2	253	267	Diabetes_McGill_CREBBP_coTF	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.790513833992%	2	253	26	Diabetes_McGill_CREBBP_coTF	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN
0.790513833992%	2	253	26	Diabetes_McGill_CREBBP_coTF	REACTOME_ACTIVATION_OF_GENES_BY_ATF4
0.790513833992%	2	253	26	Diabetes_McGill_CREBBP_coTF	PID_INSULIN_GLUCOSE_PATHWAY
0.790513833992%	2	253	26	Diabetes_McGill_CREBBP_coTF	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
0.790513833992%	2	253	26	Diabetes_McGill_CREBBP_coTF	BRACHAT_RESPONSE_TO_METHOTREXATE_UP
0.790513833992%	2	253	26	Diabetes_McGill_CREBBP_coTF	BIOCARTA_BAD_PATHWAY
0.790513833992%	2	253	251	Diabetes_McGill_CREBBP_coTF	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
0.790513833992%	2	253	25	Diabetes_McGill_CREBBP_coTF	WANG_BARRETTS_ESOPHAGUS_DN
0.790513833992%	2	253	25	Diabetes_McGill_CREBBP_coTF	RUAN_RESPONSE_TO_TROGLITAZONE_UP
0.790513833992%	2	253	25	Diabetes_McGill_CREBBP_coTF	REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION
0.790513833992%	2	253	25	Diabetes_McGill_CREBBP_coTF	PID_LYMPHANGIOGENESIS_PATHWAY
0.790513833992%	2	253	25	Diabetes_McGill_CREBBP_coTF	NOJIMA_SFRP2_TARGETS_DN
0.790513833992%	2	253	25	Diabetes_McGill_CREBBP_coTF	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP
0.790513833992%	2	253	246	Diabetes_McGill_CREBBP_coTF	BILD_E2F3_ONCOGENIC_SIGNATURE
0.790513833992%	2	253	245	Diabetes_McGill_CREBBP_coTF	KONDO_EZH2_TARGETS
0.790513833992%	2	253	244	Diabetes_McGill_CREBBP_coTF	GAL_LEUKEMIC_STEM_CELL_DN
0.790513833992%	2	253	24	Diabetes_McGill_CREBBP_coTF	YIH_RESPONSE_TO_ARSENITE_C1
0.790513833992%	2	253	24	Diabetes_McGill_CREBBP_coTF	WANG_TNF_TARGETS
0.790513833992%	2	253	24	Diabetes_McGill_CREBBP_coTF	OSADA_ASCL1_TARGETS_DN
0.790513833992%	2	253	24	Diabetes_McGill_CREBBP_coTF	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23
0.790513833992%	2	253	24	Diabetes_McGill_CREBBP_coTF	MURATA_VIRULENCE_OF_H_PILORI
0.790513833992%	2	253	24	Diabetes_McGill_CREBBP_coTF	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
0.790513833992%	2	253	24	Diabetes_McGill_CREBBP_coTF	CHEOK_RESPONSE_TO_HD_MTX_DN
0.790513833992%	2	253	24	Diabetes_McGill_CREBBP_coTF	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN
0.790513833992%	2	253	24	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CSK_PATHWAY
0.790513833992%	2	253	238	Diabetes_McGill_CREBBP_coTF	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
0.790513833992%	2	253	230	Diabetes_McGill_CREBBP_coTF	COLDREN_GEFITINIB_RESISTANCE_DN
0.790513833992%	2	253	23	Diabetes_McGill_CREBBP_coTF	WU_HBX_TARGETS_1_DN
0.790513833992%	2	253	23	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_BMP
0.790513833992%	2	253	23	Diabetes_McGill_CREBBP_coTF	REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING
0.790513833992%	2	253	23	Diabetes_McGill_CREBBP_coTF	PID_PRLSIGNALINGEVENTSPATHWAY
0.790513833992%	2	253	23	Diabetes_McGill_CREBBP_coTF	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN
0.790513833992%	2	253	23	Diabetes_McGill_CREBBP_coTF	BIOCARTA_IL12_PATHWAY
0.790513833992%	2	253	23	Diabetes_McGill_CREBBP_coTF	BIOCARTA_IGF1R_PATHWAY
0.790513833992%	2	253	23	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CELLCYCLE_PATHWAY
0.790513833992%	2	253	222	Diabetes_McGill_CREBBP_coTF	CAIRO_LIVER_DEVELOPMENT_DN
0.790513833992%	2	253	221	Diabetes_McGill_CREBBP_coTF	PEDRIOLI_MIR31_TARGETS_UP
0.790513833992%	2	253	22	Diabetes_McGill_CREBBP_coTF	VALK_AML_WITH_11Q23_REARRANGED
0.790513833992%	2	253	22	Diabetes_McGill_CREBBP_coTF	ROY_WOUND_BLOOD_VESSEL_DN
0.790513833992%	2	253	22	Diabetes_McGill_CREBBP_coTF	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
0.790513833992%	2	253	22	Diabetes_McGill_CREBBP_coTF	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
0.790513833992%	2	253	22	Diabetes_McGill_CREBBP_coTF	NUMATA_CSF3_SIGNALING_VIA_STAT3
0.790513833992%	2	253	22	Diabetes_McGill_CREBBP_coTF	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN
0.790513833992%	2	253	22	Diabetes_McGill_CREBBP_coTF	BRACHAT_RESPONSE_TO_CISPLATIN
0.790513833992%	2	253	22	Diabetes_McGill_CREBBP_coTF	BIOCARTA_GCR_PATHWAY
0.790513833992%	2	253	22	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CHEMICAL_PATHWAY
0.790513833992%	2	253	216	Diabetes_McGill_CREBBP_coTF	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
0.790513833992%	2	253	213	Diabetes_McGill_CREBBP_coTF	WIERENGA_STAT5A_TARGETS_DN
0.790513833992%	2	253	212	Diabetes_McGill_CREBBP_coTF	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
0.790513833992%	2	253	210	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.790513833992%	2	253	21	Diabetes_McGill_CREBBP_coTF	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP
0.790513833992%	2	253	21	Diabetes_McGill_CREBBP_coTF	REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS
0.790513833992%	2	253	21	Diabetes_McGill_CREBBP_coTF	REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE
0.790513833992%	2	253	21	Diabetes_McGill_CREBBP_coTF	MURAKAMI_UV_RESPONSE_6HR_DN
0.790513833992%	2	253	21	Diabetes_McGill_CREBBP_coTF	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4
0.790513833992%	2	253	21	Diabetes_McGill_CREBBP_coTF	MACLACHLAN_BRCA1_TARGETS_UP
0.790513833992%	2	253	21	Diabetes_McGill_CREBBP_coTF	LEE_INTRATHYMIC_T_PROGENITOR
0.790513833992%	2	253	21	Diabetes_McGill_CREBBP_coTF	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP
0.790513833992%	2	253	21	Diabetes_McGill_CREBBP_coTF	FINETTI_BREAST_CANCERS_KINOME_BLUE
0.790513833992%	2	253	21	Diabetes_McGill_CREBBP_coTF	FERRANDO_TAL1_NEIGHBORS
0.790513833992%	2	253	21	Diabetes_McGill_CREBBP_coTF	CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP
0.790513833992%	2	253	21	Diabetes_McGill_CREBBP_coTF	BIOCARTA_TOB1_PATHWAY
0.790513833992%	2	253	21	Diabetes_McGill_CREBBP_coTF	BIOCARTA_ATRBRCA_PATHWAY
0.790513833992%	2	253	208	Diabetes_McGill_CREBBP_coTF	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
0.790513833992%	2	253	204	Diabetes_McGill_CREBBP_coTF	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
0.790513833992%	2	253	20	Diabetes_McGill_CREBBP_coTF	SU_THYMUS
0.790513833992%	2	253	20	Diabetes_McGill_CREBBP_coTF	SESTO_RESPONSE_TO_UV_C3
0.790513833992%	2	253	20	Diabetes_McGill_CREBBP_coTF	MURAKAMI_UV_RESPONSE_24HR
0.790513833992%	2	253	20	Diabetes_McGill_CREBBP_coTF	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN
0.790513833992%	2	253	20	Diabetes_McGill_CREBBP_coTF	HEDENFALK_BREAST_CANCER_BRACX_DN
0.790513833992%	2	253	20	Diabetes_McGill_CREBBP_coTF	FARMER_BREAST_CANCER_CLUSTER_7
0.790513833992%	2	253	20	Diabetes_McGill_CREBBP_coTF	DING_LUNG_CANCER_BY_MUTATION_RATE
0.790513833992%	2	253	20	Diabetes_McGill_CREBBP_coTF	DAZARD_UV_RESPONSE_CLUSTER_G28
0.790513833992%	2	253	20	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CCR5_PATHWAY
0.790513833992%	2	253	20	Diabetes_McGill_CREBBP_coTF	BARRIER_COLON_CANCER_RECURRENCE_DN
0.790513833992%	2	253	199	Diabetes_McGill_CREBBP_coTF	PLASARI_TGFB1_TARGETS_10HR_UP
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	ZHANG_RESPONSE_TO_CANTHARIDIN_UP
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	VISALA_AGING_LYMPHOCYTE_DN
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	VERRECCHIA_RESPONSE_TO_TGFB1_C1
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	TRAYNOR_RETT_SYNDROM_DN
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	SYED_ESTRADIOL_RESPONSE
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	SA_CASPASE_CASCADE
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	PID_HIF1APATHWAY
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	MATZUK_EMBRYONIC_GERM_CELL
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	MAHADEVAN_RESPONSE_TO_MP470_DN
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	LI_WILMS_TUMOR_ANAPLASTIC_UP
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	LAMB_CCND1_TARGETS
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	BIOCARTA_MTA3_PATHWAY
0.790513833992%	2	253	19	Diabetes_McGill_CREBBP_coTF	BIOCARTA_MAL_PATHWAY
0.790513833992%	2	253	185	Diabetes_McGill_CREBBP_coTF	ZHANG_TLX_TARGETS_36HR_DN
0.790513833992%	2	253	181	Diabetes_McGill_CREBBP_coTF	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
0.790513833992%	2	253	180	Diabetes_McGill_CREBBP_coTF	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
0.790513833992%	2	253	18	Diabetes_McGill_CREBBP_coTF	YIH_RESPONSE_TO_ARSENITE_C4
0.790513833992%	2	253	18	Diabetes_McGill_CREBBP_coTF	YIH_RESPONSE_TO_ARSENITE_C2
0.790513833992%	2	253	18	Diabetes_McGill_CREBBP_coTF	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP
0.790513833992%	2	253	18	Diabetes_McGill_CREBBP_coTF	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN
0.790513833992%	2	253	18	Diabetes_McGill_CREBBP_coTF	OZANNE_AP1_TARGETS_UP
0.790513833992%	2	253	18	Diabetes_McGill_CREBBP_coTF	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN
0.790513833992%	2	253	18	Diabetes_McGill_CREBBP_coTF	MOREIRA_RESPONSE_TO_TSA_DN
0.790513833992%	2	253	18	Diabetes_McGill_CREBBP_coTF	MCGOWAN_RSP6_TARGETS_UP
0.790513833992%	2	253	18	Diabetes_McGill_CREBBP_coTF	KARAKAS_TGFB1_SIGNALING
0.790513833992%	2	253	18	Diabetes_McGill_CREBBP_coTF	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
0.790513833992%	2	253	18	Diabetes_McGill_CREBBP_coTF	BIOCARTA_ERK5_PATHWAY
0.790513833992%	2	253	179	Diabetes_McGill_CREBBP_coTF	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
0.790513833992%	2	253	177	Diabetes_McGill_CREBBP_coTF	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
0.790513833992%	2	253	176	Diabetes_McGill_CREBBP_coTF	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
0.790513833992%	2	253	176	Diabetes_McGill_CREBBP_coTF	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
0.790513833992%	2	253	176	Diabetes_McGill_CREBBP_coTF	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
0.790513833992%	2	253	175	Diabetes_McGill_CREBBP_coTF	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
0.790513833992%	2	253	172	Diabetes_McGill_CREBBP_coTF	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
0.790513833992%	2	253	17	Diabetes_McGill_CREBBP_coTF	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN
0.790513833992%	2	253	17	Diabetes_McGill_CREBBP_coTF	SA_TRKA_RECEPTOR
0.790513833992%	2	253	17	Diabetes_McGill_CREBBP_coTF	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP
0.790513833992%	2	253	17	Diabetes_McGill_CREBBP_coTF	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS
0.790513833992%	2	253	17	Diabetes_McGill_CREBBP_coTF	LEI_HOXC8_TARGETS_DN
0.790513833992%	2	253	17	Diabetes_McGill_CREBBP_coTF	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6
0.790513833992%	2	253	17	Diabetes_McGill_CREBBP_coTF	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
0.790513833992%	2	253	17	Diabetes_McGill_CREBBP_coTF	BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.790513833992%	2	253	17	Diabetes_McGill_CREBBP_coTF	BIOCARTA_HCMV_PATHWAY
0.790513833992%	2	253	167	Diabetes_McGill_CREBBP_coTF	TIEN_INTESTINE_PROBIOTICS_6HR_DN
0.790513833992%	2	253	163	Diabetes_McGill_CREBBP_coTF	LIN_NPAS4_TARGETS_UP
0.790513833992%	2	253	162	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
0.790513833992%	2	253	161	Diabetes_McGill_CREBBP_coTF	REACTOME_MRNA_PROCESSING
0.790513833992%	2	253	16	Diabetes_McGill_CREBBP_coTF	WU_HBX_TARGETS_2_DN
0.790513833992%	2	253	16	Diabetes_McGill_CREBBP_coTF	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP
0.790513833992%	2	253	16	Diabetes_McGill_CREBBP_coTF	TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN
0.790513833992%	2	253	16	Diabetes_McGill_CREBBP_coTF	SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.790513833992%	2	253	16	Diabetes_McGill_CREBBP_coTF	REACTOME_INTEGRATION_OF_PROVIRUS
0.790513833992%	2	253	16	Diabetes_McGill_CREBBP_coTF	PID_DNAPK_PATHWAY
0.790513833992%	2	253	16	Diabetes_McGill_CREBBP_coTF	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS
0.790513833992%	2	253	16	Diabetes_McGill_CREBBP_coTF	LY_AGING_MIDDLE_DN
0.790513833992%	2	253	16	Diabetes_McGill_CREBBP_coTF	LUND_SILENCED_BY_METHYLATION
0.790513833992%	2	253	16	Diabetes_McGill_CREBBP_coTF	BIOCARTA_GATA3_PATHWAY
0.790513833992%	2	253	16	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CACAM_PATHWAY
0.790513833992%	2	253	16	Diabetes_McGill_CREBBP_coTF	BAKER_HEMATOPOIESIS_STAT3_TARGETS
0.790513833992%	2	253	16	Diabetes_McGill_CREBBP_coTF	AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
0.790513833992%	2	253	157	Diabetes_McGill_CREBBP_coTF	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
0.790513833992%	2	253	153	Diabetes_McGill_CREBBP_coTF	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
0.790513833992%	2	253	152	Diabetes_McGill_CREBBP_coTF	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
0.790513833992%	2	253	152	Diabetes_McGill_CREBBP_coTF	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
0.790513833992%	2	253	15	Diabetes_McGill_CREBBP_coTF	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN
0.790513833992%	2	253	15	Diabetes_McGill_CREBBP_coTF	PIEPOLI_LGI1_TARGETS_UP
0.790513833992%	2	253	15	Diabetes_McGill_CREBBP_coTF	PID_LPA4_PATHWAY
0.790513833992%	2	253	15	Diabetes_McGill_CREBBP_coTF	MARKS_HDAC_TARGETS_DN
0.790513833992%	2	253	15	Diabetes_McGill_CREBBP_coTF	HUMMEL_BURKITTS_LYMPHOMA_DN
0.790513833992%	2	253	15	Diabetes_McGill_CREBBP_coTF	CHANG_POU5F1_TARGETS_UP
0.790513833992%	2	253	15	Diabetes_McGill_CREBBP_coTF	BIOCARTA_TALL1_PATHWAY
0.790513833992%	2	253	149	Diabetes_McGill_CREBBP_coTF	LANDIS_ERBB2_BREAST_TUMORS_324_DN
0.790513833992%	2	253	149	Diabetes_McGill_CREBBP_coTF	HUANG_GATA2_TARGETS_UP
0.790513833992%	2	253	148	Diabetes_McGill_CREBBP_coTF	KATSANOU_ELAVL1_TARGETS_DN
0.790513833992%	2	253	148	Diabetes_McGill_CREBBP_coTF	CHANG_CYCLING_GENES
0.790513833992%	2	253	146	Diabetes_McGill_CREBBP_coTF	PECE_MAMMARY_STEM_CELL_UP
0.790513833992%	2	253	145	Diabetes_McGill_CREBBP_coTF	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
0.790513833992%	2	253	145	Diabetes_McGill_CREBBP_coTF	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.790513833992%	2	253	141	Diabetes_McGill_CREBBP_coTF	KAAB_FAILED_HEART_ATRIUM_DN
0.790513833992%	2	253	141	Diabetes_McGill_CREBBP_coTF	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP
0.790513833992%	2	253	140	Diabetes_McGill_CREBBP_coTF	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
0.790513833992%	2	253	140	Diabetes_McGill_CREBBP_coTF	ONDER_CDH1_TARGETS_1_UP
0.790513833992%	2	253	140	Diabetes_McGill_CREBBP_coTF	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
0.790513833992%	2	253	14	Diabetes_McGill_CREBBP_coTF	REACTOME_REGULATION_OF_IFNG_SIGNALING
0.790513833992%	2	253	14	Diabetes_McGill_CREBBP_coTF	REACTOME_PROLACTIN_RECEPTOR_SIGNALING
0.790513833992%	2	253	14	Diabetes_McGill_CREBBP_coTF	REACTOME_P75NTR_SIGNALS_VIA_NFKB
0.790513833992%	2	253	14	Diabetes_McGill_CREBBP_coTF	REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX
0.790513833992%	2	253	14	Diabetes_McGill_CREBBP_coTF	REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON
0.790513833992%	2	253	14	Diabetes_McGill_CREBBP_coTF	PID_TCRRASPATHWAY
0.790513833992%	2	253	14	Diabetes_McGill_CREBBP_coTF	PID_IL5_PATHWAY
0.790513833992%	2	253	14	Diabetes_McGill_CREBBP_coTF	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16
0.790513833992%	2	253	14	Diabetes_McGill_CREBBP_coTF	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP
0.790513833992%	2	253	14	Diabetes_McGill_CREBBP_coTF	MATZUK_POST-IMPLANTATION_AND_POST-PARTUM
0.790513833992%	2	253	14	Diabetes_McGill_CREBBP_coTF	DORN_ADENOVIRUS_INFECTION_48HR_UP
0.790513833992%	2	253	14	Diabetes_McGill_CREBBP_coTF	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
0.790513833992%	2	253	14	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CELL2CELL_PATHWAY
0.790513833992%	2	253	139	Diabetes_McGill_CREBBP_coTF	ODONNELL_TFRC_TARGETS_DN
0.790513833992%	2	253	137	Diabetes_McGill_CREBBP_coTF	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
0.790513833992%	2	253	135	Diabetes_McGill_CREBBP_coTF	TSENG_IRS1_TARGETS_DN
0.790513833992%	2	253	132	Diabetes_McGill_CREBBP_coTF	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
0.790513833992%	2	253	132	Diabetes_McGill_CREBBP_coTF	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
0.790513833992%	2	253	13	Diabetes_McGill_CREBBP_coTF	WU_HBX_TARGETS_3_DN
0.790513833992%	2	253	13	Diabetes_McGill_CREBBP_coTF	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22
0.790513833992%	2	253	13	Diabetes_McGill_CREBBP_coTF	FRIDMAN_SENESCENCE_DN
0.790513833992%	2	253	13	Diabetes_McGill_CREBBP_coTF	EHRLICH_ICF_SYNDROM_UP
0.790513833992%	2	253	129	Diabetes_McGill_CREBBP_coTF	REACTOME_MEMBRANE_TRAFFICKING
0.790513833992%	2	253	129	Diabetes_McGill_CREBBP_coTF	KIM_WT1_TARGETS_8HR_DN
0.790513833992%	2	253	129	Diabetes_McGill_CREBBP_coTF	KEGG_AXON_GUIDANCE
0.790513833992%	2	253	128	Diabetes_McGill_CREBBP_coTF	KEGG_SPLICEOSOME
0.790513833992%	2	253	125	Diabetes_McGill_CREBBP_coTF	FIGUEROA_AML_METHYLATION_CLUSTER_1_UP
0.790513833992%	2	253	121	Diabetes_McGill_CREBBP_coTF	VANTVEER_BREAST_CANCER_METASTASIS_DN
0.790513833992%	2	253	121	Diabetes_McGill_CREBBP_coTF	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
0.790513833992%	2	253	120	Diabetes_McGill_CREBBP_coTF	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
0.790513833992%	2	253	120	Diabetes_McGill_CREBBP_coTF	REACTOME_CELL_CELL_COMMUNICATION
0.790513833992%	2	253	120	Diabetes_McGill_CREBBP_coTF	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.790513833992%	2	253	12	Diabetes_McGill_CREBBP_coTF	RUAN_RESPONSE_TO_TNF_UP
0.790513833992%	2	253	12	Diabetes_McGill_CREBBP_coTF	DORN_ADENOVIRUS_INFECTION_24HR_UP
0.790513833992%	2	253	12	Diabetes_McGill_CREBBP_coTF	DING_LUNG_CANCER_MUTATED_FREQUENTLY
0.790513833992%	2	253	12	Diabetes_McGill_CREBBP_coTF	BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1
0.790513833992%	2	253	118	Diabetes_McGill_CREBBP_coTF	MARKEY_RB1_CHRONIC_LOF_DN
0.790513833992%	2	253	118	Diabetes_McGill_CREBBP_coTF	CERVERA_SDHB_TARGETS_1_UP
0.790513833992%	2	253	116	Diabetes_McGill_CREBBP_coTF	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
0.790513833992%	2	253	115	Diabetes_McGill_CREBBP_coTF	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
0.790513833992%	2	253	115	Diabetes_McGill_CREBBP_coTF	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
0.790513833992%	2	253	114	Diabetes_McGill_CREBBP_coTF	SMIRNOV_RESPONSE_TO_IR_6HR_DN
0.790513833992%	2	253	114	Diabetes_McGill_CREBBP_coTF	ROPERO_HDAC2_TARGETS
0.790513833992%	2	253	114	Diabetes_McGill_CREBBP_coTF	LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.790513833992%	2	253	114	Diabetes_McGill_CREBBP_coTF	CERVERA_SDHB_TARGETS_2
0.790513833992%	2	253	114	Diabetes_McGill_CREBBP_coTF	BOSCO_TH1_CYTOTOXIC_MODULE
0.790513833992%	2	253	113	Diabetes_McGill_CREBBP_coTF	TSENG_IRS1_TARGETS_UP
0.790513833992%	2	253	112	Diabetes_McGill_CREBBP_coTF	LABBE_WNT3A_TARGETS_UP
0.790513833992%	2	253	112	Diabetes_McGill_CREBBP_coTF	DITTMER_PTHLH_TARGETS_UP
0.790513833992%	2	253	111	Diabetes_McGill_CREBBP_coTF	REACTOME_MRNA_SPLICING
0.790513833992%	2	253	111	Diabetes_McGill_CREBBP_coTF	BOUDOUKHA_BOUND_BY_IGF2BP2
0.790513833992%	2	253	11	Diabetes_McGill_CREBBP_coTF	ST_STAT3_PATHWAY
0.790513833992%	2	253	11	Diabetes_McGill_CREBBP_coTF	REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL
0.790513833992%	2	253	11	Diabetes_McGill_CREBBP_coTF	REACTOME_IL_7_SIGNALING
0.790513833992%	2	253	11	Diabetes_McGill_CREBBP_coTF	REACTOME_IL_6_SIGNALING
0.790513833992%	2	253	11	Diabetes_McGill_CREBBP_coTF	REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX
0.790513833992%	2	253	11	Diabetes_McGill_CREBBP_coTF	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29
0.790513833992%	2	253	11	Diabetes_McGill_CREBBP_coTF	MUNSHI_MULTIPLE_MYELOMA_DN
0.790513833992%	2	253	11	Diabetes_McGill_CREBBP_coTF	KALMA_E2F1_TARGETS
0.790513833992%	2	253	11	Diabetes_McGill_CREBBP_coTF	DORN_ADENOVIRUS_INFECTION_32HR_UP
0.790513833992%	2	253	11	Diabetes_McGill_CREBBP_coTF	BIOCARTA_SRCRPTP_PATHWAY
0.790513833992%	2	253	11	Diabetes_McGill_CREBBP_coTF	AMIT_EGF_RESPONSE_20_HELA
0.790513833992%	2	253	108	Diabetes_McGill_CREBBP_coTF	WESTON_VEGFA_TARGETS
0.790513833992%	2	253	108	Diabetes_McGill_CREBBP_coTF	TAVAZOIE_METASTASIS
0.790513833992%	2	253	108	Diabetes_McGill_CREBBP_coTF	LE_EGR2_TARGETS_DN
0.790513833992%	2	253	108	Diabetes_McGill_CREBBP_coTF	JAZAG_TGFB1_SIGNALING_UP
0.790513833992%	2	253	107	Diabetes_McGill_CREBBP_coTF	ROESSLER_LIVER_CANCER_METASTASIS_UP
0.790513833992%	2	253	107	Diabetes_McGill_CREBBP_coTF	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.790513833992%	2	253	105	Diabetes_McGill_CREBBP_coTF	REACTOME_RNA_POL_II_TRANSCRIPTION
0.790513833992%	2	253	104	Diabetes_McGill_CREBBP_coTF	REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE
0.790513833992%	2	253	103	Diabetes_McGill_CREBBP_coTF	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
0.790513833992%	2	253	103	Diabetes_McGill_CREBBP_coTF	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
0.790513833992%	2	253	103	Diabetes_McGill_CREBBP_coTF	LEIN_CHOROID_PLEXUS_MARKERS
0.790513833992%	2	253	103	Diabetes_McGill_CREBBP_coTF	KIM_MYCN_AMPLIFICATION_TARGETS_DN
0.790513833992%	2	253	103	Diabetes_McGill_CREBBP_coTF	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
0.790513833992%	2	253	102	Diabetes_McGill_CREBBP_coTF	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.790513833992%	2	253	101	Diabetes_McGill_CREBBP_coTF	WIELAND_UP_BY_HBV_INFECTION
0.790513833992%	2	253	101	Diabetes_McGill_CREBBP_coTF	GRADE_COLON_AND_RECTAL_CANCER_DN
0.790513833992%	2	253	100	Diabetes_McGill_CREBBP_coTF	ROVERSI_GLIOMA_COPY_NUMBER_UP
0.790513833992%	2	253	100	Diabetes_McGill_CREBBP_coTF	RICKMAN_HEAD_AND_NECK_CANCER_A
0.790513833992%	2	253	10	Diabetes_McGill_CREBBP_coTF	SCHLESINGER_METHYLATED_IN_COLON_CANCER
0.790513833992%	2	253	10	Diabetes_McGill_CREBBP_coTF	RADAEVA_RESPONSE_TO_IFNA1_DN
0.790513833992%	2	253	10	Diabetes_McGill_CREBBP_coTF	IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.788022064618%	10	1269	536	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BERENJENO_TRANSFORMED_BY_RHOA_UP
0.788022064618%	10	1269	516	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
0.788022064618%	10	1269	485	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.788022064618%	10	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LASTOWSKA_COAMPLIFIED_WITH_MYCN
0.788022064618%	10	1269	414	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LU_EZH2_TARGETS_DN
0.788022064618%	10	1269	408	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
0.788022064618%	10	1269	408	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.788022064618%	10	1269	391	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
0.788022064618%	10	1269	379	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BENPORATH_ES_1
0.788022064618%	10	1269	372	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_LMO4_TARGETS_UP
0.788022064618%	10	1269	315	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
0.788022064618%	10	1269	307	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
0.788022064618%	10	1269	306	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HORIUCHI_WTAP_TARGETS_UP
0.788022064618%	10	1269	305	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
0.788022064618%	10	1269	305	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
0.788022064618%	10	1269	298	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_14HR_DN
0.788022064618%	10	1269	293	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_MATURE_CELL
0.788022064618%	10	1269	262	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LU_AGING_BRAIN_UP
0.788022064618%	10	1269	261	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RICKMAN_METASTASIS_DN
0.788022064618%	10	1269	244	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KAYO_AGING_MUSCLE_UP
0.788022064618%	10	1269	244	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAZARD_RESPONSE_TO_UV_NHEK_UP
0.788022064618%	10	1269	242	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHYLA_CBFA2T3_TARGETS_DN
0.788022064618%	10	1269	241	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DOANE_RESPONSE_TO_ANDROGEN_DN
0.788022064618%	10	1269	227	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RAO_BOUND_BY_SALL4
0.788022064618%	10	1269	222	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
0.788022064618%	10	1269	221	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_36HR_UP
0.788022064618%	10	1269	212	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SANSOM_APC_TARGETS
0.788022064618%	10	1269	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_TUMOR_INVASIVENESS_DN
0.788022064618%	10	1269	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
0.788022064618%	10	1269	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RIZKI_TUMOR_INVASIVENESS_3D_UP
0.788022064618%	10	1269	207	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CAIRO_HEPATOBLASTOMA_UP
0.788022064618%	10	1269	206	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LINSLEY_MIR16_TARGETS
0.788022064618%	10	1269	184	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
0.788022064618%	10	1269	180	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_48HR_UP
0.788022064618%	10	1269	156	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_14HR_UP
0.788022064618%	10	1269	145	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
0.788022064618%	10	1269	139	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
0.788022064618%	10	1269	125	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
0.781968721251%	17	2174	91	T2D_GENES_TANYA_LIPIDS	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
0.781968721251%	17	2174	88	T2D_GENES_TANYA_LIPIDS	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
0.781968721251%	17	2174	88	T2D_GENES_TANYA_LIPIDS	ALCALA_APOPTOSIS
0.781968721251%	17	2174	81	T2D_GENES_TANYA_LIPIDS	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
0.781968721251%	17	2174	76	T2D_GENES_TANYA_LIPIDS	KEGG_VEGF_SIGNALING_PATHWAY
0.781968721251%	17	2174	69	T2D_GENES_TANYA_LIPIDS	PID_VEGFR1_2_PATHWAY
0.781968721251%	17	2174	289	T2D_GENES_TANYA_LIPIDS	GABRIELY_MIR21_TARGETS
0.781968721251%	17	2174	244	T2D_GENES_TANYA_LIPIDS	PLASARI_TGFB1_TARGETS_10HR_DN
0.781968721251%	17	2174	214	T2D_GENES_TANYA_LIPIDS	KIM_WT1_TARGETS_UP
0.781968721251%	17	2174	210	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.781968721251%	17	2174	207	T2D_GENES_TANYA_LIPIDS	VERHAAK_GLIOBLASTOMA_CLASSICAL
0.781968721251%	17	2174	205	T2D_GENES_TANYA_LIPIDS	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
0.781968721251%	17	2174	201	T2D_GENES_TANYA_LIPIDS	HOLLMANN_APOPTOSIS_VIA_CD40_UP
0.781968721251%	17	2174	199	T2D_GENES_TANYA_LIPIDS	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
0.781968721251%	17	2174	196	T2D_GENES_TANYA_LIPIDS	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
0.781968721251%	17	2174	196	T2D_GENES_TANYA_LIPIDS	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
0.781968721251%	17	2174	195	T2D_GENES_TANYA_LIPIDS	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
0.781968721251%	17	2174	188	T2D_GENES_TANYA_LIPIDS	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
0.781968721251%	17	2174	182	T2D_GENES_TANYA_LIPIDS	WHITFIELD_CELL_CYCLE_G2
0.781968721251%	17	2174	181	T2D_GENES_TANYA_LIPIDS	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
0.781968721251%	17	2174	177	T2D_GENES_TANYA_LIPIDS	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.781968721251%	17	2174	172	T2D_GENES_TANYA_LIPIDS	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
0.781968721251%	17	2174	169	T2D_GENES_TANYA_LIPIDS	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
0.781968721251%	17	2174	163	T2D_GENES_TANYA_LIPIDS	LIN_NPAS4_TARGETS_UP
0.781968721251%	17	2174	162	T2D_GENES_TANYA_LIPIDS	KIM_WT1_TARGETS_12HR_UP
0.781968721251%	17	2174	160	T2D_GENES_TANYA_LIPIDS	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
0.781968721251%	17	2174	159	T2D_GENES_TANYA_LIPIDS	KEGG_PURINE_METABOLISM
0.781968721251%	17	2174	153	T2D_GENES_TANYA_LIPIDS	RUIZ_TNC_TARGETS_UP
0.781968721251%	17	2174	151	T2D_GENES_TANYA_LIPIDS	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
0.781968721251%	17	2174	150	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_30MIN_DN
0.781968721251%	17	2174	149	T2D_GENES_TANYA_LIPIDS	OHGUCHI_LIVER_HNF4A_TARGETS_DN
0.781968721251%	17	2174	146	T2D_GENES_TANYA_LIPIDS	LEE_NEURAL_CREST_STEM_CELL_UP
0.781968721251%	17	2174	140	T2D_GENES_TANYA_LIPIDS	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
0.781968721251%	17	2174	138	T2D_GENES_TANYA_LIPIDS	JIANG_VHL_TARGETS
0.781968721251%	17	2174	137	T2D_GENES_TANYA_LIPIDS	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
0.781968721251%	17	2174	137	T2D_GENES_TANYA_LIPIDS	PID_P53DOWNSTREAMPATHWAY
0.781968721251%	17	2174	137	T2D_GENES_TANYA_LIPIDS	LIU_SOX4_TARGETS_UP
0.781968721251%	17	2174	134	T2D_GENES_TANYA_LIPIDS	CHUNG_BLISTER_CYTOTOXICITY_UP
0.781968721251%	17	2174	133	T2D_GENES_TANYA_LIPIDS	REACTOME_DIABETES_PATHWAYS
0.781968721251%	17	2174	131	T2D_GENES_TANYA_LIPIDS	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.781968721251%	17	2174	129	T2D_GENES_TANYA_LIPIDS	PID_PDGFRBPATHWAY
0.781968721251%	17	2174	127	T2D_GENES_TANYA_LIPIDS	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.781968721251%	17	2174	127	T2D_GENES_TANYA_LIPIDS	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
0.781968721251%	17	2174	111	T2D_GENES_TANYA_LIPIDS	WANG_HCP_PROSTATE_CANCER
0.781968721251%	17	2174	109	T2D_GENES_TANYA_LIPIDS	SERVITJA_ISLET_HNF1A_TARGETS_DN
0.781968721251%	17	2174	108	T2D_GENES_TANYA_LIPIDS	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
0.781968721251%	17	2174	104	T2D_GENES_TANYA_LIPIDS	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.781968721251%	17	2174	102	T2D_GENES_TANYA_LIPIDS	PID_CXCR4_PATHWAY
0.781968721251%	17	2174	101	T2D_GENES_TANYA_LIPIDS	WIELAND_UP_BY_HBV_INFECTION
0.769888793841%	9	1169	97	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
0.769888793841%	9	1169	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MORI_MATURE_B_LYMPHOCYTE_UP
0.769888793841%	9	1169	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
0.769888793841%	9	1169	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_16HR_DN
0.769888793841%	9	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_GLIS2_TARGETS_UP
0.769888793841%	9	1169	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
0.769888793841%	9	1169	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
0.769888793841%	9	1169	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAURNIER_PSMD4_TARGETS
0.769888793841%	9	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PHASE_II_CONJUGATION
0.769888793841%	9	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS
0.769888793841%	9	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.769888793841%	9	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SU_LIVER
0.769888793841%	9	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ANGIOPOIETINRECEPTOR_PATHWAY
0.769888793841%	9	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PACKAGING_OF_TELOMERE_ENDS
0.769888793841%	9	1169	408	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
0.769888793841%	9	1169	388	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STEIN_ESRRA_TARGETS_UP
0.769888793841%	9	1169	344	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RICKMAN_METASTASIS_UP
0.769888793841%	9	1169	336	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JOHNSTONE_PARVB_TARGETS_2_DN
0.769888793841%	9	1169	330	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_METABOLISM_OF_RNA
0.769888793841%	9	1169	325	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CELL_CYCLE_MITOTIC
0.769888793841%	9	1169	307	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LI_INDUCED_T_TO_NATURAL_KILLER_UP
0.769888793841%	9	1169	306	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHANDRAN_METASTASIS_DN
0.769888793841%	9	1169	298	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
0.769888793841%	9	1169	289	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GABRIELY_MIR21_TARGETS
0.769888793841%	9	1169	284	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_METABOLISM_OF_MRNA
0.769888793841%	9	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS
0.769888793841%	9	1169	267	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.769888793841%	9	1169	262	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LU_AGING_BRAIN_UP
0.769888793841%	9	1169	260	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SENESE_HDAC1_TARGETS_DN
0.769888793841%	9	1169	251	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_AXON_GUIDANCE
0.769888793841%	9	1169	245	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PENG_RAPAMYCIN_RESPONSE_DN
0.769888793841%	9	1169	241	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DOANE_RESPONSE_TO_ANDROGEN_DN
0.769888793841%	9	1169	239	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ALFANO_MYC_TARGETS
0.769888793841%	9	1169	234	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
0.769888793841%	9	1169	230	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BENPORATH_MYC_TARGETS_WITH_EBOX
0.769888793841%	9	1169	217	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WIERENGA_STAT5A_TARGETS_UP
0.769888793841%	9	1169	216	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WHITFIELD_CELL_CYCLE_G2_M
0.769888793841%	9	1169	215	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAMAZAKI_TCEB3_TARGETS_DN
0.769888793841%	9	1169	214	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
0.769888793841%	9	1169	211	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
0.769888793841%	9	1169	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VERHAAK_GLIOBLASTOMA_NEURAL
0.769888793841%	9	1169	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RIZKI_TUMOR_INVASIVENESS_3D_UP
0.769888793841%	9	1169	201	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_FOCAL_ADHESION
0.769888793841%	9	1169	185	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
0.769888793841%	9	1169	181	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JISON_SICKLE_CELL_DISEASE_UP
0.769888793841%	9	1169	175	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAMAZAKI_TCEB3_TARGETS_UP
0.769888793841%	9	1169	172	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
0.769888793841%	9	1169	169	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	UEDA_PERIFERAL_CLOCK
0.769888793841%	9	1169	164	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_WT1_TARGETS_8HR_UP
0.769888793841%	9	1169	163	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
0.769888793841%	9	1169	162	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WHITFIELD_CELL_CYCLE_S
0.769888793841%	9	1169	161	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIDUS_METASTASIS_DN
0.769888793841%	9	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT
0.769888793841%	9	1169	159	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_INTERFERON_SIGNALING
0.769888793841%	9	1169	151	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
0.769888793841%	9	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_HDL_MEDIATED_LIPID_TRANSPORT
0.769888793841%	9	1169	148	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_APOPTOSIS
0.769888793841%	9	1169	145	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
0.769888793841%	9	1169	143	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION
0.769888793841%	9	1169	130	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ELVIDGE_HYPOXIA_BY_DMOG_UP
0.769888793841%	9	1169	129	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_PDGFRBPATHWAY
0.769888793841%	9	1169	129	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_AXON_GUIDANCE
0.769888793841%	9	1169	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.769888793841%	9	1169	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
0.769888793841%	9	1169	119	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
0.769888793841%	9	1169	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
0.767459708365%	10	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
0.767459708365%	10	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SAFFORD_T_LYMPHOCYTE_ANERGY
0.767459708365%	10	1303	84	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RUAN_RESPONSE_TO_TNF_DN
0.767459708365%	10	1303	63	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRIDEAU_IMPRINTED_GENES
0.767459708365%	10	1303	485	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.767459708365%	10	1303	430	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RIGGI_EWING_SARCOMA_PROGENITOR_UP
0.767459708365%	10	1303	391	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
0.767459708365%	10	1303	382	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.767459708365%	10	1303	380	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MULLIGHAN_MLL_SIGNATURE_1_UP
0.767459708365%	10	1303	354	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
0.767459708365%	10	1303	349	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
0.767459708365%	10	1303	307	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LI_INDUCED_T_TO_NATURAL_KILLER_UP
0.767459708365%	10	1303	307	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
0.767459708365%	10	1303	306	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHANDRAN_METASTASIS_DN
0.767459708365%	10	1303	294	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WEST_ADRENOCORTICAL_TUMOR_UP
0.767459708365%	10	1303	294	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
0.767459708365%	10	1303	293	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZWANG_DOWN_BY_2ND_EGF_PULSE
0.767459708365%	10	1303	281	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
0.767459708365%	10	1303	281	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BHAT_ESR1_TARGETS_VIA_AKT1_UP
0.767459708365%	10	1303	279	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NEURONAL_SYSTEM
0.767459708365%	10	1303	276	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HUTTMANN_B_CLL_POOR_SURVIVAL_UP
0.767459708365%	10	1303	266	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FOSTER_KDM1A_TARGETS_UP
0.767459708365%	10	1303	261	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BILD_HRAS_ONCOGENIC_SIGNATURE
0.767459708365%	10	1303	260	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOQUEST_STEM_CELL_UP
0.767459708365%	10	1303	253	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DANG_REGULATED_BY_MYC_DN
0.767459708365%	10	1303	250	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
0.767459708365%	10	1303	245	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BLUM_RESPONSE_TO_SALIRASIB_UP
0.767459708365%	10	1303	240	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_20HR_UP
0.767459708365%	10	1303	237	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.767459708365%	10	1303	233	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.767459708365%	10	1303	229	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
0.767459708365%	10	1303	210	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RIZKI_TUMOR_INVASIVENESS_3D_UP
0.767459708365%	10	1303	210	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAIRO_HEPATOBLASTOMA_CLASSES_DN
0.767459708365%	10	1303	209	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_UP
0.767459708365%	10	1303	206	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.767459708365%	10	1303	194	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KASLER_HDAC7_TARGETS_1_UP
0.767459708365%	10	1303	183	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.767459708365%	10	1303	171	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GOLDRATH_HOMEOSTATIC_PROLIFERATION
0.767459708365%	10	1303	165	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DARWICHE_PAPILLOMA_RISK_LOW_DN
0.767045454545%	27	3520	425	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_BREAST_CANCER_PROGENITORS_UP
0.767045454545%	27	3520	424	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHEN_SMARCA2_TARGETS_UP
0.767045454545%	27	3520	353	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
0.767045454545%	27	3520	329	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
0.767045454545%	27	3520	318	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAZARD_RESPONSE_TO_UV_NHEK_DN
0.767045454545%	27	3520	285	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
0.767045454545%	27	3520	276	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
0.767045454545%	27	3520	271	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.767045454545%	27	3520	264	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
0.767045454545%	27	3520	259	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	QI_PLASMACYTOMA_UP
0.767045454545%	27	3520	246	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
0.767045454545%	27	3520	230	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	COLDREN_GEFITINIB_RESISTANCE_DN
0.767045454545%	27	3520	227	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.767045454545%	27	3520	211	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
0.767045454545%	27	3520	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RIZKI_TUMOR_INVASIVENESS_3D_UP
0.767045454545%	27	3520	203	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRUETZMANN_PANCREATIC_CANCER_DN
0.767045454545%	27	3520	200	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
0.767045454545%	27	3520	186	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HAMAI_APOPTOSIS_VIA_TRAIL_DN
0.767045454545%	27	3520	183	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ENDOCYTOSIS
0.767045454545%	27	3520	181	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
0.759878419453%	15	1974	98	Mendelian_Nancy_Cox	REACTOME_POTASSIUM_CHANNELS
0.759878419453%	15	1974	97	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP
0.759878419453%	15	1974	92	Mendelian_Nancy_Cox	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
0.759878419453%	15	1974	92	Mendelian_Nancy_Cox	DE_YY1_TARGETS_DN
0.759878419453%	15	1974	90	Mendelian_Nancy_Cox	MORI_MATURE_B_LYMPHOCYTE_UP
0.759878419453%	15	1974	89	Mendelian_Nancy_Cox	VANLOO_SP3_TARGETS_DN
0.759878419453%	15	1974	89	Mendelian_Nancy_Cox	SWEET_KRAS_ONCOGENIC_SIGNATURE
0.759878419453%	15	1974	88	Mendelian_Nancy_Cox	DURCHDEWALD_SKIN_CARCINOGENESIS_UP
0.759878419453%	15	1974	87	Mendelian_Nancy_Cox	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
0.759878419453%	15	1974	86	Mendelian_Nancy_Cox	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
0.759878419453%	15	1974	86	Mendelian_Nancy_Cox	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
0.759878419453%	15	1974	86	Mendelian_Nancy_Cox	BAELDE_DIABETIC_NEPHROPATHY_UP
0.759878419453%	15	1974	85	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
0.759878419453%	15	1974	84	Mendelian_Nancy_Cox	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
0.759878419453%	15	1974	80	Mendelian_Nancy_Cox	SCHUHMACHER_MYC_TARGETS_UP
0.759878419453%	15	1974	79	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
0.759878419453%	15	1974	78	Mendelian_Nancy_Cox	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
0.759878419453%	15	1974	76	Mendelian_Nancy_Cox	KEGG_VEGF_SIGNALING_PATHWAY
0.759878419453%	15	1974	74	Mendelian_Nancy_Cox	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
0.759878419453%	15	1974	74	Mendelian_Nancy_Cox	LEIN_OLIGODENDROCYTE_MARKERS
0.759878419453%	15	1974	71	Mendelian_Nancy_Cox	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
0.759878419453%	15	1974	70	Mendelian_Nancy_Cox	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
0.759878419453%	15	1974	70	Mendelian_Nancy_Cox	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.759878419453%	15	1974	69	Mendelian_Nancy_Cox	KEGG_P53_SIGNALING_PATHWAY
0.759878419453%	15	1974	68	Mendelian_Nancy_Cox	SESTO_RESPONSE_TO_UV_C7
0.759878419453%	15	1974	67	Mendelian_Nancy_Cox	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
0.759878419453%	15	1974	65	Mendelian_Nancy_Cox	ST_FAS_SIGNALING_PATHWAY
0.759878419453%	15	1974	65	Mendelian_Nancy_Cox	LEE_LIVER_CANCER_MYC_TGFA_DN
0.759878419453%	15	1974	64	Mendelian_Nancy_Cox	LEE_LIVER_CANCER_MYC_E2F1_DN
0.759878419453%	15	1974	64	Mendelian_Nancy_Cox	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
0.759878419453%	15	1974	63	Mendelian_Nancy_Cox	PID_ENDOTHELINPATHWAY
0.759878419453%	15	1974	62	Mendelian_Nancy_Cox	KORKOLA_YOLK_SAC_TUMOR
0.759878419453%	15	1974	59	Mendelian_Nancy_Cox	BARIS_THYROID_CANCER_DN
0.759878419453%	15	1974	58	Mendelian_Nancy_Cox	LUCAS_HNF4A_TARGETS_UP
0.759878419453%	15	1974	58	Mendelian_Nancy_Cox	BIOCARTA_PPARA_PATHWAY
0.759878419453%	15	1974	58	Mendelian_Nancy_Cox	BIOCARTA_HIVNEF_PATHWAY
0.759878419453%	15	1974	56	Mendelian_Nancy_Cox	BIOCARTA_NFAT_PATHWAY
0.759878419453%	15	1974	55	Mendelian_Nancy_Cox	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
0.759878419453%	15	1974	55	Mendelian_Nancy_Cox	DEMAGALHAES_AGING_UP
0.759878419453%	15	1974	54	Mendelian_Nancy_Cox	REACTOME_APOPTOTIC_EXECUTION_PHASE
0.759878419453%	15	1974	52	Mendelian_Nancy_Cox	PID_PTP1BPATHWAY
0.759878419453%	15	1974	50	Mendelian_Nancy_Cox	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
0.759878419453%	15	1974	47	Mendelian_Nancy_Cox	KHETCHOUMIAN_TRIM24_TARGETS_UP
0.759878419453%	15	1974	46	Mendelian_Nancy_Cox	SIG_BCR_SIGNALING_PATHWAY
0.759878419453%	15	1974	46	Mendelian_Nancy_Cox	PID_A6B1_A6B4_INTEGRIN_PATHWAY
0.759878419453%	15	1974	46	Mendelian_Nancy_Cox	KRASNOSELSKAYA_ILF3_TARGETS_DN
0.759878419453%	15	1974	46	Mendelian_Nancy_Cox	KEGG_N_GLYCAN_BIOSYNTHESIS
0.759878419453%	15	1974	45	Mendelian_Nancy_Cox	VANHARANTA_UTERINE_FIBROID_UP
0.759878419453%	15	1974	45	Mendelian_Nancy_Cox	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN
0.759878419453%	15	1974	43	Mendelian_Nancy_Cox	LEE_CALORIE_RESTRICTION_MUSCLE_UP
0.759878419453%	15	1974	41	Mendelian_Nancy_Cox	REACTOME_IL_2_SIGNALING
0.759878419453%	15	1974	40	Mendelian_Nancy_Cox	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
0.759878419453%	15	1974	38	Mendelian_Nancy_Cox	REACTOME_GLYCOSPHINGOLIPID_METABOLISM
0.759878419453%	15	1974	35	Mendelian_Nancy_Cox	ST_G_ALPHA_I_PATHWAY
0.759878419453%	15	1974	35	Mendelian_Nancy_Cox	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP
0.759878419453%	15	1974	330	Mendelian_Nancy_Cox	REACTOME_METABOLISM_OF_RNA
0.759878419453%	15	1974	33	Mendelian_Nancy_Cox	SCHRAETS_MLL_TARGETS_DN
0.759878419453%	15	1974	33	Mendelian_Nancy_Cox	APPEL_IMATINIB_RESPONSE
0.759878419453%	15	1974	32	Mendelian_Nancy_Cox	KEGG_CITRATE_CYCLE_TCA_CYCLE
0.759878419453%	15	1974	30	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
0.759878419453%	15	1974	29	Mendelian_Nancy_Cox	REACTOME_STEROID_HORMONES
0.759878419453%	15	1974	29	Mendelian_Nancy_Cox	REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN
0.759878419453%	15	1974	193	Mendelian_Nancy_Cox	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
0.759878419453%	15	1974	175	Mendelian_Nancy_Cox	LEE_LIVER_CANCER_SURVIVAL_DN
0.759878419453%	15	1974	173	Mendelian_Nancy_Cox	SENGUPTA_EBNA1_ANTICORRELATED
0.759878419453%	15	1974	172	Mendelian_Nancy_Cox	REACTOME_MITOTIC_M_M_G1_PHASES
0.759878419453%	15	1974	163	Mendelian_Nancy_Cox	LIN_NPAS4_TARGETS_UP
0.759878419453%	15	1974	157	Mendelian_Nancy_Cox	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
0.759878419453%	15	1974	151	Mendelian_Nancy_Cox	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
0.759878419453%	15	1974	148	Mendelian_Nancy_Cox	CHANG_CYCLING_GENES
0.759878419453%	15	1974	143	Mendelian_Nancy_Cox	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION
0.759878419453%	15	1974	142	Mendelian_Nancy_Cox	RUIZ_TNC_TARGETS_DN
0.759878419453%	15	1974	142	Mendelian_Nancy_Cox	MIKKELSEN_ES_LCP_WITH_H3K4ME3
0.759878419453%	15	1974	142	Mendelian_Nancy_Cox	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.759878419453%	15	1974	139	Mendelian_Nancy_Cox	ODONNELL_TFRC_TARGETS_DN
0.759878419453%	15	1974	137	Mendelian_Nancy_Cox	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
0.759878419453%	15	1974	135	Mendelian_Nancy_Cox	UDAYAKUMAR_MED1_TARGETS_UP
0.759878419453%	15	1974	126	Mendelian_Nancy_Cox	MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.759878419453%	15	1974	123	Mendelian_Nancy_Cox	DAZARD_RESPONSE_TO_UV_SCC_DN
0.759878419453%	15	1974	118	Mendelian_Nancy_Cox	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
0.759878419453%	15	1974	115	Mendelian_Nancy_Cox	HOELZEL_NF1_TARGETS_DN
0.759878419453%	15	1974	113	Mendelian_Nancy_Cox	RICKMAN_HEAD_AND_NECK_CANCER_C
0.759878419453%	15	1974	109	Mendelian_Nancy_Cox	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
0.759878419453%	15	1974	108	Mendelian_Nancy_Cox	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
0.759878419453%	15	1974	108	Mendelian_Nancy_Cox	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
0.759878419453%	15	1974	108	Mendelian_Nancy_Cox	LE_EGR2_TARGETS_UP
0.759878419453%	15	1974	105	Mendelian_Nancy_Cox	STEIN_ESRRA_TARGETS_DN
0.759878419453%	15	1974	101	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_20HR_DN
0.756429652042%	5	661	99	T2D_GENES_TANYA_GLYCEMIC	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.756429652042%	5	661	98	T2D_GENES_TANYA_GLYCEMIC	MENSE_HYPOXIA_UP
0.756429652042%	5	661	98	T2D_GENES_TANYA_GLYCEMIC	KEGG_PYRIMIDINE_METABOLISM
0.756429652042%	5	661	98	T2D_GENES_TANYA_GLYCEMIC	GAVIN_FOXP3_TARGETS_CLUSTER_T7
0.756429652042%	5	661	98	T2D_GENES_TANYA_GLYCEMIC	CROONQUIST_IL6_DEPRIVATION_DN
0.756429652042%	5	661	95	T2D_GENES_TANYA_GLYCEMIC	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
0.756429652042%	5	661	93	T2D_GENES_TANYA_GLYCEMIC	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
0.756429652042%	5	661	92	T2D_GENES_TANYA_GLYCEMIC	CAMPS_COLON_CANCER_COPY_NUMBER_UP
0.756429652042%	5	661	92	T2D_GENES_TANYA_GLYCEMIC	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
0.756429652042%	5	661	91	T2D_GENES_TANYA_GLYCEMIC	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
0.756429652042%	5	661	91	T2D_GENES_TANYA_GLYCEMIC	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
0.756429652042%	5	661	89	T2D_GENES_TANYA_GLYCEMIC	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
0.756429652042%	5	661	89	T2D_GENES_TANYA_GLYCEMIC	ZHANG_TLX_TARGETS_UP
0.756429652042%	5	661	89	T2D_GENES_TANYA_GLYCEMIC	VANLOO_SP3_TARGETS_DN
0.756429652042%	5	661	89	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
0.756429652042%	5	661	89	T2D_GENES_TANYA_GLYCEMIC	LI_DCP2_BOUND_MRNA
0.756429652042%	5	661	89	T2D_GENES_TANYA_GLYCEMIC	KEGG_PROSTATE_CANCER
0.756429652042%	5	661	89	T2D_GENES_TANYA_GLYCEMIC	DELASERNA_MYOD_TARGETS_UP
0.756429652042%	5	661	88	T2D_GENES_TANYA_GLYCEMIC	ALCALA_APOPTOSIS
0.756429652042%	5	661	87	T2D_GENES_TANYA_GLYCEMIC	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
0.756429652042%	5	661	87	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_MAPK_PATHWAY
0.756429652042%	5	661	86	T2D_GENES_TANYA_GLYCEMIC	LEE_AGING_CEREBELLUM_DN
0.756429652042%	5	661	86	T2D_GENES_TANYA_GLYCEMIC	HOEBEKE_LYMPHOID_STEM_CELL_DN
0.756429652042%	5	661	85	T2D_GENES_TANYA_GLYCEMIC	SANA_RESPONSE_TO_IFNG_DN
0.756429652042%	5	661	84	T2D_GENES_TANYA_GLYCEMIC	SMID_BREAST_CANCER_LUMINAL_A_UP
0.756429652042%	5	661	83	T2D_GENES_TANYA_GLYCEMIC	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
0.756429652042%	5	661	81	T2D_GENES_TANYA_GLYCEMIC	MAHAJAN_RESPONSE_TO_IL1A_UP
0.756429652042%	5	661	80	T2D_GENES_TANYA_GLYCEMIC	PID_MET_PATHWAY
0.756429652042%	5	661	78	T2D_GENES_TANYA_GLYCEMIC	RADMACHER_AML_PROGNOSIS
0.756429652042%	5	661	77	T2D_GENES_TANYA_GLYCEMIC	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
0.756429652042%	5	661	75	T2D_GENES_TANYA_GLYCEMIC	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
0.756429652042%	5	661	74	T2D_GENES_TANYA_GLYCEMIC	JI_RESPONSE_TO_FSH_UP
0.756429652042%	5	661	72	T2D_GENES_TANYA_GLYCEMIC	CROONQUIST_NRAS_SIGNALING_DN
0.756429652042%	5	661	71	T2D_GENES_TANYA_GLYCEMIC	KEGG_MELANOMA
0.756429652042%	5	661	70	T2D_GENES_TANYA_GLYCEMIC	KEGG_PANCREATIC_CANCER
0.756429652042%	5	661	69	T2D_GENES_TANYA_GLYCEMIC	PID_VEGFR1_2_PATHWAY
0.756429652042%	5	661	69	T2D_GENES_TANYA_GLYCEMIC	LEIN_NEURON_MARKERS
0.756429652042%	5	661	69	T2D_GENES_TANYA_GLYCEMIC	KEGG_PPAR_SIGNALING_PATHWAY
0.756429652042%	5	661	68	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SEMAPHORIN_INTERACTIONS
0.756429652042%	5	661	66	T2D_GENES_TANYA_GLYCEMIC	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.756429652042%	5	661	65	T2D_GENES_TANYA_GLYCEMIC	ST_FAS_SIGNALING_PATHWAY
0.756429652042%	5	661	64	T2D_GENES_TANYA_GLYCEMIC	ZHAN_MULTIPLE_MYELOMA_UP
0.756429652042%	5	661	63	T2D_GENES_TANYA_GLYCEMIC	BRIDEAU_IMPRINTED_GENES
0.756429652042%	5	661	62	T2D_GENES_TANYA_GLYCEMIC	KEGG_COLORECTAL_CANCER
0.756429652042%	5	661	60	T2D_GENES_TANYA_GLYCEMIC	AMIT_EGF_RESPONSE_240_HELA
0.756429652042%	5	661	58	T2D_GENES_TANYA_GLYCEMIC	ZHENG_GLIOBLASTOMA_PLASTICITY_DN
0.756429652042%	5	661	58	T2D_GENES_TANYA_GLYCEMIC	NAGASHIMA_NRG1_SIGNALING_DN
0.756429652042%	5	661	55	T2D_GENES_TANYA_GLYCEMIC	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER
0.756429652042%	5	661	54	T2D_GENES_TANYA_GLYCEMIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
0.756429652042%	5	661	51	T2D_GENES_TANYA_GLYCEMIC	REACTOME_NUCLEOTIDE_EXCISION_REPAIR
0.756429652042%	5	661	47	T2D_GENES_TANYA_GLYCEMIC	KEGG_TYPE_II_DIABETES_MELLITUS
0.756429652042%	5	661	47	T2D_GENES_TANYA_GLYCEMIC	BOYLAN_MULTIPLE_MYELOMA_C_UP
0.756429652042%	5	661	46	T2D_GENES_TANYA_GLYCEMIC	PID_RHOA_REG_PATHWAY
0.756429652042%	5	661	44	T2D_GENES_TANYA_GLYCEMIC	KEGG_NUCLEOTIDE_EXCISION_REPAIR
0.756429652042%	5	661	42	T2D_GENES_TANYA_GLYCEMIC	ZHENG_IL22_SIGNALING_DN
0.756429652042%	5	661	398	T2D_GENES_TANYA_GLYCEMIC	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
0.756429652042%	5	661	38	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GLUCOSE_TRANSPORT
0.756429652042%	5	661	373	T2D_GENES_TANYA_GLYCEMIC	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
0.756429652042%	5	661	37	T2D_GENES_TANYA_GLYCEMIC	ROLEF_GLIS3_TARGETS
0.756429652042%	5	661	37	T2D_GENES_TANYA_GLYCEMIC	MATZUK_SPERMATID_DIFFERENTIATION
0.756429652042%	5	661	35	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GLOBAL_GENOMIC_NER_GG_NER
0.756429652042%	5	661	30	T2D_GENES_TANYA_GLYCEMIC	TSENG_ADIPOGENIC_POTENTIAL_UP
0.756429652042%	5	661	295	T2D_GENES_TANYA_GLYCEMIC	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
0.756429652042%	5	661	29	T2D_GENES_TANYA_GLYCEMIC	NAKAYAMA_FGF2_TARGETS
0.756429652042%	5	661	285	T2D_GENES_TANYA_GLYCEMIC	GRADE_COLON_AND_RECTAL_CANCER_UP
0.756429652042%	5	661	280	T2D_GENES_TANYA_GLYCEMIC	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
0.756429652042%	5	661	279	T2D_GENES_TANYA_GLYCEMIC	REACTOME_INNATE_IMMUNE_SYSTEM
0.756429652042%	5	661	265	T2D_GENES_TANYA_GLYCEMIC	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
0.756429652042%	5	661	261	T2D_GENES_TANYA_GLYCEMIC	BILD_HRAS_ONCOGENIC_SIGNATURE
0.756429652042%	5	661	255	T2D_GENES_TANYA_GLYCEMIC	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.756429652042%	5	661	245	T2D_GENES_TANYA_GLYCEMIC	PENG_RAPAMYCIN_RESPONSE_DN
0.756429652042%	5	661	244	T2D_GENES_TANYA_GLYCEMIC	THUM_SYSTOLIC_HEART_FAILURE_DN
0.756429652042%	5	661	237	T2D_GENES_TANYA_GLYCEMIC	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.756429652042%	5	661	228	T2D_GENES_TANYA_GLYCEMIC	MARKEY_RB1_ACUTE_LOF_DN
0.756429652042%	5	661	227	T2D_GENES_TANYA_GLYCEMIC	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
0.756429652042%	5	661	226	T2D_GENES_TANYA_GLYCEMIC	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.756429652042%	5	661	215	T2D_GENES_TANYA_GLYCEMIC	YAMAZAKI_TCEB3_TARGETS_DN
0.756429652042%	5	661	214	T2D_GENES_TANYA_GLYCEMIC	ZWANG_EGF_INTERVAL_DN
0.756429652042%	5	661	214	T2D_GENES_TANYA_GLYCEMIC	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
0.756429652042%	5	661	211	T2D_GENES_TANYA_GLYCEMIC	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
0.756429652042%	5	661	207	T2D_GENES_TANYA_GLYCEMIC	REACTOME_HIV_INFECTION
0.756429652042%	5	661	207	T2D_GENES_TANYA_GLYCEMIC	MANALO_HYPOXIA_UP
0.756429652042%	5	661	207	T2D_GENES_TANYA_GLYCEMIC	KARLSSON_TGFB1_TARGETS_DN
0.756429652042%	5	661	205	T2D_GENES_TANYA_GLYCEMIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
0.756429652042%	5	661	204	T2D_GENES_TANYA_GLYCEMIC	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
0.756429652042%	5	661	20	T2D_GENES_TANYA_GLYCEMIC	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
0.756429652042%	5	661	20	T2D_GENES_TANYA_GLYCEMIC	HASLINGER_B_CLL_WITH_6Q21_DELETION
0.756429652042%	5	661	199	T2D_GENES_TANYA_GLYCEMIC	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
0.756429652042%	5	661	195	T2D_GENES_TANYA_GLYCEMIC	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.756429652042%	5	661	194	T2D_GENES_TANYA_GLYCEMIC	KASLER_HDAC7_TARGETS_1_UP
0.756429652042%	5	661	188	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.756429652042%	5	661	187	T2D_GENES_TANYA_GLYCEMIC	PENG_LEUCINE_DEPRIVATION_DN
0.756429652042%	5	661	185	T2D_GENES_TANYA_GLYCEMIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.756429652042%	5	661	185	T2D_GENES_TANYA_GLYCEMIC	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
0.756429652042%	5	661	182	T2D_GENES_TANYA_GLYCEMIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.756429652042%	5	661	181	T2D_GENES_TANYA_GLYCEMIC	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
0.756429652042%	5	661	178	T2D_GENES_TANYA_GLYCEMIC	KEGG_CALCIUM_SIGNALING_PATHWAY
0.756429652042%	5	661	172	T2D_GENES_TANYA_GLYCEMIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
0.756429652042%	5	661	169	T2D_GENES_TANYA_GLYCEMIC	KATSANOU_ELAVL1_TARGETS_UP
0.756429652042%	5	661	167	T2D_GENES_TANYA_GLYCEMIC	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
0.756429652042%	5	661	166	T2D_GENES_TANYA_GLYCEMIC	CAIRO_LIVER_DEVELOPMENT_UP
0.756429652042%	5	661	165	T2D_GENES_TANYA_GLYCEMIC	LIU_CMYB_TARGETS_UP
0.756429652042%	5	661	163	T2D_GENES_TANYA_GLYCEMIC	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
0.756429652042%	5	661	162	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
0.756429652042%	5	661	161	T2D_GENES_TANYA_GLYCEMIC	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
0.756429652042%	5	661	157	T2D_GENES_TANYA_GLYCEMIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.756429652042%	5	661	156	T2D_GENES_TANYA_GLYCEMIC	GROSS_HYPOXIA_VIA_ELK3_DN
0.756429652042%	5	661	154	T2D_GENES_TANYA_GLYCEMIC	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
0.756429652042%	5	661	153	T2D_GENES_TANYA_GLYCEMIC	DAZARD_UV_RESPONSE_CLUSTER_G6
0.756429652042%	5	661	152	T2D_GENES_TANYA_GLYCEMIC	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
0.756429652042%	5	661	151	T2D_GENES_TANYA_GLYCEMIC	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
0.756429652042%	5	661	148	T2D_GENES_TANYA_GLYCEMIC	KATSANOU_ELAVL1_TARGETS_DN
0.756429652042%	5	661	148	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_24HR_DN
0.756429652042%	5	661	146	T2D_GENES_TANYA_GLYCEMIC	ELVIDGE_HYPOXIA_DN
0.756429652042%	5	661	144	T2D_GENES_TANYA_GLYCEMIC	BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.756429652042%	5	661	143	T2D_GENES_TANYA_GLYCEMIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
0.756429652042%	5	661	142	T2D_GENES_TANYA_GLYCEMIC	XU_GH1_AUTOCRINE_TARGETS_DN
0.756429652042%	5	661	142	T2D_GENES_TANYA_GLYCEMIC	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.756429652042%	5	661	141	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
0.756429652042%	5	661	141	T2D_GENES_TANYA_GLYCEMIC	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.756429652042%	5	661	138	T2D_GENES_TANYA_GLYCEMIC	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
0.756429652042%	5	661	137	T2D_GENES_TANYA_GLYCEMIC	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
0.756429652042%	5	661	135	T2D_GENES_TANYA_GLYCEMIC	KEGG_OXIDATIVE_PHOSPHORYLATION
0.756429652042%	5	661	134	T2D_GENES_TANYA_GLYCEMIC	SCHLOSSER_SERUM_RESPONSE_UP
0.756429652042%	5	661	134	T2D_GENES_TANYA_GLYCEMIC	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
0.756429652042%	5	661	133	T2D_GENES_TANYA_GLYCEMIC	KEGG_PARKINSONS_DISEASE
0.756429652042%	5	661	129	T2D_GENES_TANYA_GLYCEMIC	YAGI_AML_SURVIVAL
0.756429652042%	5	661	128	T2D_GENES_TANYA_GLYCEMIC	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
0.756429652042%	5	661	128	T2D_GENES_TANYA_GLYCEMIC	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
0.756429652042%	5	661	127	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
0.756429652042%	5	661	126	T2D_GENES_TANYA_GLYCEMIC	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
0.756429652042%	5	661	126	T2D_GENES_TANYA_GLYCEMIC	BURTON_ADIPOGENESIS_5
0.756429652042%	5	661	124	T2D_GENES_TANYA_GLYCEMIC	DAIRKEE_TERT_TARGETS_DN
0.756429652042%	5	661	123	T2D_GENES_TANYA_GLYCEMIC	HOOI_ST7_TARGETS_DN
0.756429652042%	5	661	123	T2D_GENES_TANYA_GLYCEMIC	DAZARD_RESPONSE_TO_UV_SCC_DN
0.756429652042%	5	661	122	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_PDGF
0.756429652042%	5	661	121	T2D_GENES_TANYA_GLYCEMIC	VANTVEER_BREAST_CANCER_METASTASIS_DN
0.756429652042%	5	661	121	T2D_GENES_TANYA_GLYCEMIC	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
0.756429652042%	5	661	117	T2D_GENES_TANYA_GLYCEMIC	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.756429652042%	5	661	116	T2D_GENES_TANYA_GLYCEMIC	LIM_MAMMARY_LUMINAL_MATURE_UP
0.756429652042%	5	661	112	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_FGFR
0.756429652042%	5	661	112	T2D_GENES_TANYA_GLYCEMIC	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
0.756429652042%	5	661	109	T2D_GENES_TANYA_GLYCEMIC	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
0.756429652042%	5	661	108	T2D_GENES_TANYA_GLYCEMIC	ZHANG_TLX_TARGETS_DN
0.756429652042%	5	661	108	T2D_GENES_TANYA_GLYCEMIC	LE_EGR2_TARGETS_DN
0.756429652042%	5	661	103	T2D_GENES_TANYA_GLYCEMIC	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY
0.756429652042%	5	661	101	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_ERBB2
0.756429652042%	5	661	101	T2D_GENES_TANYA_GLYCEMIC	KEGG_GNRH_SIGNALING_PATHWAY
0.756429652042%	5	661	101	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_20HR_DN
0.756429652042%	5	661	100	T2D_GENES_TANYA_GLYCEMIC	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
0.756429652042%	5	661	100	T2D_GENES_TANYA_GLYCEMIC	BENPORATH_ES_CORE_NINE_CORRELATED
0.748262960983%	14	1871	94	T2D_GENES_TANYA_HEIGHT	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER
0.748262960983%	14	1871	90	T2D_GENES_TANYA_HEIGHT	SANA_TNF_SIGNALING_DN
0.748262960983%	14	1871	89	T2D_GENES_TANYA_HEIGHT	LEIN_PONS_MARKERS
0.748262960983%	14	1871	88	T2D_GENES_TANYA_HEIGHT	REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS
0.748262960983%	14	1871	88	T2D_GENES_TANYA_HEIGHT	KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.748262960983%	14	1871	86	T2D_GENES_TANYA_HEIGHT	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
0.748262960983%	14	1871	84	T2D_GENES_TANYA_HEIGHT	LEE_AGING_CEREBELLUM_UP
0.748262960983%	14	1871	82	T2D_GENES_TANYA_HEIGHT	PID_REG_GR_PATHWAY
0.748262960983%	14	1871	76	T2D_GENES_TANYA_HEIGHT	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION
0.748262960983%	14	1871	74	T2D_GENES_TANYA_HEIGHT	DER_IFN_ALPHA_RESPONSE_UP
0.748262960983%	14	1871	73	T2D_GENES_TANYA_HEIGHT	KEGG_VIRAL_MYOCARDITIS
0.748262960983%	14	1871	55	T2D_GENES_TANYA_HEIGHT	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER
0.748262960983%	14	1871	48	T2D_GENES_TANYA_HEIGHT	KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.748262960983%	14	1871	42	T2D_GENES_TANYA_HEIGHT	KEGG_GRAFT_VERSUS_HOST_DISEASE
0.748262960983%	14	1871	216	T2D_GENES_TANYA_HEIGHT	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
0.748262960983%	14	1871	196	T2D_GENES_TANYA_HEIGHT	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
0.748262960983%	14	1871	196	T2D_GENES_TANYA_HEIGHT	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
0.748262960983%	14	1871	189	T2D_GENES_TANYA_HEIGHT	BURTON_ADIPOGENESIS_6
0.748262960983%	14	1871	185	T2D_GENES_TANYA_HEIGHT	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.748262960983%	14	1871	183	T2D_GENES_TANYA_HEIGHT	OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.748262960983%	14	1871	171	T2D_GENES_TANYA_HEIGHT	ELVIDGE_HYPOXIA_UP
0.748262960983%	14	1871	163	T2D_GENES_TANYA_HEIGHT	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
0.748262960983%	14	1871	160	T2D_GENES_TANYA_HEIGHT	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
0.748262960983%	14	1871	157	T2D_GENES_TANYA_HEIGHT	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.748262960983%	14	1871	157	T2D_GENES_TANYA_HEIGHT	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.748262960983%	14	1871	156	T2D_GENES_TANYA_HEIGHT	FOSTER_TOLERANT_MACROPHAGE_UP
0.748262960983%	14	1871	153	T2D_GENES_TANYA_HEIGHT	RUIZ_TNC_TARGETS_UP
0.748262960983%	14	1871	152	T2D_GENES_TANYA_HEIGHT	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
0.748262960983%	14	1871	151	T2D_GENES_TANYA_HEIGHT	IGLESIAS_E2F_TARGETS_UP
0.748262960983%	14	1871	149	T2D_GENES_TANYA_HEIGHT	TSAI_RESPONSE_TO_IONIZING_RADIATION
0.748262960983%	14	1871	147	T2D_GENES_TANYA_HEIGHT	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.748262960983%	14	1871	147	T2D_GENES_TANYA_HEIGHT	DARWICHE_PAPILLOMA_RISK_HIGH_UP
0.748262960983%	14	1871	147	T2D_GENES_TANYA_HEIGHT	BENPORATH_PROLIFERATION
0.748262960983%	14	1871	146	T2D_GENES_TANYA_HEIGHT	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
0.748262960983%	14	1871	143	T2D_GENES_TANYA_HEIGHT	DANG_MYC_TARGETS_UP
0.748262960983%	14	1871	142	T2D_GENES_TANYA_HEIGHT	XU_GH1_AUTOCRINE_TARGETS_DN
0.748262960983%	14	1871	142	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_ES_LCP_WITH_H3K4ME3
0.748262960983%	14	1871	142	T2D_GENES_TANYA_HEIGHT	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
0.748262960983%	14	1871	139	T2D_GENES_TANYA_HEIGHT	ODONNELL_TFRC_TARGETS_DN
0.748262960983%	14	1871	139	T2D_GENES_TANYA_HEIGHT	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
0.748262960983%	14	1871	137	T2D_GENES_TANYA_HEIGHT	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
0.748262960983%	14	1871	137	T2D_GENES_TANYA_HEIGHT	KEGG_INSULIN_SIGNALING_PATHWAY
0.748262960983%	14	1871	136	T2D_GENES_TANYA_HEIGHT	WIERENGA_STAT5A_TARGETS_GROUP1
0.748262960983%	14	1871	135	T2D_GENES_TANYA_HEIGHT	TSENG_IRS1_TARGETS_DN
0.748262960983%	14	1871	129	T2D_GENES_TANYA_HEIGHT	YAGI_AML_SURVIVAL
0.748262960983%	14	1871	128	T2D_GENES_TANYA_HEIGHT	LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.748262960983%	14	1871	128	T2D_GENES_TANYA_HEIGHT	KEGG_CELL_CYCLE
0.748262960983%	14	1871	126	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
0.748262960983%	14	1871	126	T2D_GENES_TANYA_HEIGHT	BURTON_ADIPOGENESIS_5
0.748262960983%	14	1871	125	T2D_GENES_TANYA_HEIGHT	REACTOME_HIV_LIFE_CYCLE
0.748262960983%	14	1871	124	T2D_GENES_TANYA_HEIGHT	DAIRKEE_TERT_TARGETS_DN
0.748262960983%	14	1871	121	T2D_GENES_TANYA_HEIGHT	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.748262960983%	14	1871	121	T2D_GENES_TANYA_HEIGHT	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
0.748262960983%	14	1871	120	T2D_GENES_TANYA_HEIGHT	ZHU_CMV_ALL_UP
0.748262960983%	14	1871	118	T2D_GENES_TANYA_HEIGHT	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
0.748262960983%	14	1871	116	T2D_GENES_TANYA_HEIGHT	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
0.748262960983%	14	1871	114	T2D_GENES_TANYA_HEIGHT	KEGG_OOCYTE_MEIOSIS
0.748262960983%	14	1871	114	T2D_GENES_TANYA_HEIGHT	BOSCO_TH1_CYTOTOXIC_MODULE
0.748262960983%	14	1871	112	T2D_GENES_TANYA_HEIGHT	REACTOME_DNA_REPAIR
0.748262960983%	14	1871	112	T2D_GENES_TANYA_HEIGHT	DOANE_BREAST_CANCER_ESR1_UP
0.748262960983%	14	1871	108	T2D_GENES_TANYA_HEIGHT	LE_EGR2_TARGETS_UP
0.748262960983%	14	1871	107	T2D_GENES_TANYA_HEIGHT	SESTO_RESPONSE_TO_UV_C0
0.748262960983%	14	1871	103	T2D_GENES_TANYA_HEIGHT	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
0.748262960983%	14	1871	101	T2D_GENES_TANYA_HEIGHT	KOBAYASHI_EGFR_SIGNALING_24HR_UP
0.748262960983%	14	1871	101	T2D_GENES_TANYA_HEIGHT	BURTON_ADIPOGENESIS_3
0.748262960983%	14	1871	100	T2D_GENES_TANYA_HEIGHT	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
0.738636363636%	26	3520	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TELOMERE_MAINTENANCE
0.738636363636%	26	3520	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MEIOTIC_SYNAPSIS
0.738636363636%	26	3520	294	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEST_ADRENOCORTICAL_TUMOR_UP
0.738636363636%	26	3520	292	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KOYAMA_SEMA3B_TARGETS_UP
0.738636363636%	26	3520	283	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
0.738636363636%	26	3520	279	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NEURONAL_SYSTEM
0.738636363636%	26	3520	279	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INNATE_IMMUNE_SYSTEM
0.738636363636%	26	3520	272	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
0.738636363636%	26	3520	266	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROZANOV_MMP14_TARGETS_UP
0.738636363636%	26	3520	245	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.738636363636%	26	3520	240	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_20HR_UP
0.738636363636%	26	3520	236	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
0.738636363636%	26	3520	234	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
0.738636363636%	26	3520	232	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DELYS_THYROID_CANCER_DN
0.738636363636%	26	3520	225	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_16HR_UP
0.738636363636%	26	3520	214	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AFFAR_YY1_TARGETS_UP
0.738636363636%	26	3520	207	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAIRO_HEPATOBLASTOMA_UP
0.738636363636%	26	3520	200	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHEPARD_BMYB_MORPHOLINO_DN
0.738636363636%	26	3520	199	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PLASARI_TGFB1_TARGETS_10HR_UP
0.738636363636%	26	3520	198	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PHOSPHOLIPID_METABOLISM
0.738636363636%	26	3520	197	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
0.738636363636%	26	3520	182	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
0.738636363636%	26	3520	181	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JISON_SICKLE_CELL_DISEASE_UP
0.738636363636%	26	3520	180	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
0.738636363636%	26	3520	174	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
0.738636363636%	26	3520	156	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_14HR_UP
0.738636363636%	26	3520	152	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
0.738636363636%	26	3520	151	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
0.738636363636%	26	3520	147	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DARWICHE_PAPILLOMA_RISK_HIGH_UP
0.738636363636%	26	3520	146	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PECE_MAMMARY_STEM_CELL_DN
0.738007380074%	4	542	97	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
0.738007380074%	4	542	95	T2D_GENES_TANYA_ANTHROPOMETRIC	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
0.738007380074%	4	542	95	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
0.738007380074%	4	542	92	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_MYCN_AMPLIFICATION_TARGETS_UP
0.738007380074%	4	542	92	T2D_GENES_TANYA_ANTHROPOMETRIC	HILLION_HMGA1B_TARGETS
0.738007380074%	4	542	92	T2D_GENES_TANYA_ANTHROPOMETRIC	BURTON_ADIPOGENESIS_9
0.738007380074%	4	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RNA_POL_I_TRANSCRIPTION
0.738007380074%	4	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PROSTATE_CANCER
0.738007380074%	4	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
0.738007380074%	4	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.738007380074%	4	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
0.738007380074%	4	542	87	T2D_GENES_TANYA_ANTHROPOMETRIC	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
0.738007380074%	4	542	87	T2D_GENES_TANYA_ANTHROPOMETRIC	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
0.738007380074%	4	542	87	T2D_GENES_TANYA_ANTHROPOMETRIC	MOOTHA_VOXPHOS
0.738007380074%	4	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
0.738007380074%	4	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	NELSON_RESPONSE_TO_ANDROGEN_UP
0.738007380074%	4	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_TGF_BETA_SIGNALING_PATHWAY
0.738007380074%	4	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
0.738007380074%	4	542	85	T2D_GENES_TANYA_ANTHROPOMETRIC	STEIN_ESR1_TARGETS
0.738007380074%	4	542	85	T2D_GENES_TANYA_ANTHROPOMETRIC	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
0.738007380074%	4	542	85	T2D_GENES_TANYA_ANTHROPOMETRIC	SANA_RESPONSE_TO_IFNG_DN
0.738007380074%	4	542	84	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
0.738007380074%	4	542	84	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_CMYB_PATHWAY
0.738007380074%	4	542	84	T2D_GENES_TANYA_ANTHROPOMETRIC	HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.738007380074%	4	542	84	T2D_GENES_TANYA_ANTHROPOMETRIC	CHANG_IMMORTALIZED_BY_HPV31_UP
0.738007380074%	4	542	83	T2D_GENES_TANYA_ANTHROPOMETRIC	WARTERS_RESPONSE_TO_IR_SKIN
0.738007380074%	4	542	83	T2D_GENES_TANYA_ANTHROPOMETRIC	SANA_TNF_SIGNALING_UP
0.738007380074%	4	542	83	T2D_GENES_TANYA_ANTHROPOMETRIC	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
0.738007380074%	4	542	80	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_AGING_NEOCORTEX_DN
0.738007380074%	4	542	78	T2D_GENES_TANYA_ANTHROPOMETRIC	LINDVALL_IMMORTALIZED_BY_TERT_UP
0.738007380074%	4	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.738007380074%	4	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	ROSS_AML_WITH_PML_RARA_FUSION
0.738007380074%	4	542	76	T2D_GENES_TANYA_ANTHROPOMETRIC	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
0.738007380074%	4	542	76	T2D_GENES_TANYA_ANTHROPOMETRIC	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
0.738007380074%	4	542	76	T2D_GENES_TANYA_ANTHROPOMETRIC	MAHAJAN_RESPONSE_TO_IL1A_DN
0.738007380074%	4	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	URS_ADIPOCYTE_DIFFERENTIATION_UP
0.738007380074%	4	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_E2F_PATHWAY
0.738007380074%	4	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
0.738007380074%	4	542	73	T2D_GENES_TANYA_ANTHROPOMETRIC	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.738007380074%	4	542	72	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
0.738007380074%	4	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
0.738007380074%	4	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_CDC42_PATHWAY
0.738007380074%	4	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_LONG_TERM_POTENTIATION
0.738007380074%	4	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SPHINGOLIPID_METABOLISM
0.738007380074%	4	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_VEGFR1_2_PATHWAY
0.738007380074%	4	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	LEIN_NEURON_MARKERS
0.738007380074%	4	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_P53_SIGNALING_PATHWAY
0.738007380074%	4	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
0.738007380074%	4	542	68	T2D_GENES_TANYA_ANTHROPOMETRIC	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.738007380074%	4	542	68	T2D_GENES_TANYA_ANTHROPOMETRIC	BASSO_CD40_SIGNALING_DN
0.738007380074%	4	542	67	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
0.738007380074%	4	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	RIGGINS_TAMOXIFEN_RESISTANCE_UP
0.738007380074%	4	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
0.738007380074%	4	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	DIRMEIER_LMP1_RESPONSE_EARLY
0.738007380074%	4	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	BRUNO_HEMATOPOIESIS
0.738007380074%	4	542	65	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_IL4_2PATHWAY
0.738007380074%	4	542	65	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_BCR_5PATHWAY
0.738007380074%	4	542	65	T2D_GENES_TANYA_ANTHROPOMETRIC	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP
0.738007380074%	4	542	63	T2D_GENES_TANYA_ANTHROPOMETRIC	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP
0.738007380074%	4	542	63	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_ENDOTHELINPATHWAY
0.738007380074%	4	542	62	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_TRKRPATHWAY
0.738007380074%	4	542	61	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_LIVER_CANCER_MYC_TGFA_UP
0.738007380074%	4	542	61	T2D_GENES_TANYA_ANTHROPOMETRIC	BAKKER_FOXO3_TARGETS_UP
0.738007380074%	4	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	WAKASUGI_HAVE_ZNF143_BINDING_SITES
0.738007380074%	4	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	KANNAN_TP53_TARGETS_UP
0.738007380074%	4	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_HIVNEF_PATHWAY
0.738007380074%	4	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_EARLY_T_LYMPHOCYTE_DN
0.738007380074%	4	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	BURTON_ADIPOGENESIS_11
0.738007380074%	4	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_KITPATHWAY
0.738007380074%	4	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
0.738007380074%	4	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_ANGIOPOIETINRECEPTOR_PATHWAY
0.738007380074%	4	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	DAUER_STAT3_TARGETS_DN
0.738007380074%	4	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN
0.738007380074%	4	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_GLYCEROLIPID_METABOLISM
0.738007380074%	4	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_TCR_PATHWAY
0.738007380074%	4	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_NFAT_TFPATHWAY
0.738007380074%	4	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_TNFPATHWAY
0.738007380074%	4	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	AMIT_EGF_RESPONSE_60_HELA
0.738007380074%	4	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_T_CELL_SIGNAL_TRANSDUCTION
0.738007380074%	4	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	LUI_THYROID_CANCER_PAX8_PPARG_DN
0.738007380074%	4	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	GRADE_METASTASIS_DN
0.738007380074%	4	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	CHENG_RESPONSE_TO_NICKEL_ACETATE
0.738007380074%	4	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_HNF3APATHWAY
0.738007380074%	4	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_TYPE_I_DIABETES_MELLITUS
0.738007380074%	4	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_TCPTP_PATHWAY
0.738007380074%	4	542	428	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
0.738007380074%	4	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	VALK_AML_WITH_FLT3_ITD
0.738007380074%	4	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_B_CELL_ANTIGEN_RECEPTOR
0.738007380074%	4	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	RIZ_ERYTHROID_DIFFERENTIATION_6HR
0.738007380074%	4	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	POTTI_PACLITAXEL_SENSITIVITY
0.738007380074%	4	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	PENG_GLUTAMINE_DEPRIVATION_UP
0.738007380074%	4	542	367	T2D_GENES_TANYA_ANTHROPOMETRIC	VECCHI_GASTRIC_CANCER_EARLY_DN
0.738007380074%	4	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	WEIGEL_OXIDATIVE_STRESS_RESPONSE
0.738007380074%	4	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D
0.738007380074%	4	542	349	T2D_GENES_TANYA_ANTHROPOMETRIC	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
0.738007380074%	4	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_EPOPATHWAY
0.738007380074%	4	542	315	T2D_GENES_TANYA_ANTHROPOMETRIC	PASINI_SUZ12_TARGETS_DN
0.738007380074%	4	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	VALK_AML_CLUSTER_15
0.738007380074%	4	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER
0.738007380074%	4	542	293	T2D_GENES_TANYA_ANTHROPOMETRIC	ZWANG_DOWN_BY_2ND_EGF_PULSE
0.738007380074%	4	542	291	T2D_GENES_TANYA_ANTHROPOMETRIC	SABATES_COLORECTAL_ADENOMA_DN
0.738007380074%	4	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_RESPONSE_TO_ANDROGEN_UP
0.738007380074%	4	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_STEROID_HORMONES
0.738007380074%	4	542	285	T2D_GENES_TANYA_ANTHROPOMETRIC	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
0.738007380074%	4	542	281	T2D_GENES_TANYA_ANTHROPOMETRIC	MULLIGHAN_MLL_SIGNATURE_2_DN
0.738007380074%	4	542	280	T2D_GENES_TANYA_ANTHROPOMETRIC	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
0.738007380074%	4	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_GAQ_PATHWAY
0.738007380074%	4	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
0.738007380074%	4	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	DAIRKEE_CANCER_PRONE_RESPONSE_E2
0.738007380074%	4	542	270	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
0.738007380074%	4	542	269	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_CLIM2_TARGETS_UP
0.738007380074%	4	542	261	T2D_GENES_TANYA_ANTHROPOMETRIC	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
0.738007380074%	4	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_RXR_VDR_PATHWAY
0.738007380074%	4	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	DEN_INTERACT_WITH_LCA5
0.738007380074%	4	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION
0.738007380074%	4	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_STRESS_PATHWAY
0.738007380074%	4	542	245	T2D_GENES_TANYA_ANTHROPOMETRIC	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.738007380074%	4	542	242	T2D_GENES_TANYA_ANTHROPOMETRIC	WINTER_HYPOXIA_METAGENE
0.738007380074%	4	542	241	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT
0.738007380074%	4	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_KINESINS
0.738007380074%	4	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_NTHI_PATHWAY
0.738007380074%	4	542	238	T2D_GENES_TANYA_ANTHROPOMETRIC	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
0.738007380074%	4	542	237	T2D_GENES_TANYA_ANTHROPOMETRIC	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.738007380074%	4	542	234	T2D_GENES_TANYA_ANTHROPOMETRIC	AFFAR_YY1_TARGETS_DN
0.738007380074%	4	542	228	T2D_GENES_TANYA_ANTHROPOMETRIC	MARKEY_RB1_ACUTE_LOF_DN
0.738007380074%	4	542	227	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_RECENT_THYMIC_EMIGRANT
0.738007380074%	4	542	222	T2D_GENES_TANYA_ANTHROPOMETRIC	CAIRO_LIVER_DEVELOPMENT_DN
0.738007380074%	4	542	213	T2D_GENES_TANYA_ANTHROPOMETRIC	WIERENGA_STAT5A_TARGETS_DN
0.738007380074%	4	542	212	T2D_GENES_TANYA_ANTHROPOMETRIC	SANSOM_APC_TARGETS
0.738007380074%	4	542	212	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
0.738007380074%	4	542	206	T2D_GENES_TANYA_ANTHROPOMETRIC	RAMALHO_STEMNESS_UP
0.738007380074%	4	542	204	T2D_GENES_TANYA_ANTHROPOMETRIC	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
0.738007380074%	4	542	200	T2D_GENES_TANYA_ANTHROPOMETRIC	SHEPARD_BMYB_MORPHOLINO_DN
0.738007380074%	4	542	200	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
0.738007380074%	4	542	199	T2D_GENES_TANYA_ANTHROPOMETRIC	PLASARI_TGFB1_TARGETS_10HR_UP
0.738007380074%	4	542	197	T2D_GENES_TANYA_ANTHROPOMETRIC	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
0.738007380074%	4	542	194	T2D_GENES_TANYA_ANTHROPOMETRIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.738007380074%	4	542	194	T2D_GENES_TANYA_ANTHROPOMETRIC	PROVENZANI_METASTASIS_UP
0.738007380074%	4	542	193	T2D_GENES_TANYA_ANTHROPOMETRIC	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP
0.738007380074%	4	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_COMP_PATHWAY
0.738007380074%	4	542	188	T2D_GENES_TANYA_ANTHROPOMETRIC	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
0.738007380074%	4	542	184	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
0.738007380074%	4	542	184	T2D_GENES_TANYA_ANTHROPOMETRIC	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
0.738007380074%	4	542	183	T2D_GENES_TANYA_ANTHROPOMETRIC	OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.738007380074%	4	542	182	T2D_GENES_TANYA_ANTHROPOMETRIC	WHITFIELD_CELL_CYCLE_G2
0.738007380074%	4	542	177	T2D_GENES_TANYA_ANTHROPOMETRIC	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
0.738007380074%	4	542	177	T2D_GENES_TANYA_ANTHROPOMETRIC	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.738007380074%	4	542	176	T2D_GENES_TANYA_ANTHROPOMETRIC	NAGASHIMA_NRG1_SIGNALING_UP
0.738007380074%	4	542	176	T2D_GENES_TANYA_ANTHROPOMETRIC	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
0.738007380074%	4	542	176	T2D_GENES_TANYA_ANTHROPOMETRIC	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
0.738007380074%	4	542	174	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
0.738007380074%	4	542	172	T2D_GENES_TANYA_ANTHROPOMETRIC	SMID_BREAST_CANCER_LUMINAL_B_UP
0.738007380074%	4	542	172	T2D_GENES_TANYA_ANTHROPOMETRIC	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
0.738007380074%	4	542	169	T2D_GENES_TANYA_ANTHROPOMETRIC	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
0.738007380074%	4	542	168	T2D_GENES_TANYA_ANTHROPOMETRIC	PUJANA_XPRSS_INT_NETWORK
0.738007380074%	4	542	167	T2D_GENES_TANYA_ANTHROPOMETRIC	TIEN_INTESTINE_PROBIOTICS_6HR_DN
0.738007380074%	4	542	163	T2D_GENES_TANYA_ANTHROPOMETRIC	LIN_NPAS4_TARGETS_UP
0.738007380074%	4	542	162	T2D_GENES_TANYA_ANTHROPOMETRIC	MULLIGHAN_NPM1_SIGNATURE_3_DN
0.738007380074%	4	542	162	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
0.738007380074%	4	542	161	T2D_GENES_TANYA_ANTHROPOMETRIC	BIDUS_METASTASIS_DN
0.738007380074%	4	542	160	T2D_GENES_TANYA_ANTHROPOMETRIC	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
0.738007380074%	4	542	157	T2D_GENES_TANYA_ANTHROPOMETRIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.738007380074%	4	542	157	T2D_GENES_TANYA_ANTHROPOMETRIC	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
0.738007380074%	4	542	156	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_14HR_UP
0.738007380074%	4	542	153	T2D_GENES_TANYA_ANTHROPOMETRIC	DURAND_STROMA_MAX_DN
0.738007380074%	4	542	149	T2D_GENES_TANYA_ANTHROPOMETRIC	LANDIS_ERBB2_BREAST_TUMORS_324_DN
0.738007380074%	4	542	149	T2D_GENES_TANYA_ANTHROPOMETRIC	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
0.738007380074%	4	542	149	T2D_GENES_TANYA_ANTHROPOMETRIC	GOZGIT_ESR1_TARGETS_UP
0.738007380074%	4	542	148	T2D_GENES_TANYA_ANTHROPOMETRIC	WHITFIELD_CELL_CYCLE_M_G1
0.738007380074%	4	542	148	T2D_GENES_TANYA_ANTHROPOMETRIC	KATSANOU_ELAVL1_TARGETS_DN
0.738007380074%	4	542	148	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_24HR_UP
0.738007380074%	4	542	147	T2D_GENES_TANYA_ANTHROPOMETRIC	SMID_BREAST_CANCER_ERBB2_UP
0.738007380074%	4	542	147	T2D_GENES_TANYA_ANTHROPOMETRIC	DARWICHE_PAPILLOMA_RISK_HIGH_UP
0.738007380074%	4	542	145	T2D_GENES_TANYA_ANTHROPOMETRIC	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
0.738007380074%	4	542	143	T2D_GENES_TANYA_ANTHROPOMETRIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
0.738007380074%	4	542	142	T2D_GENES_TANYA_ANTHROPOMETRIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.738007380074%	4	542	142	T2D_GENES_TANYA_ANTHROPOMETRIC	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
0.738007380074%	4	542	142	T2D_GENES_TANYA_ANTHROPOMETRIC	DARWICHE_SKIN_TUMOR_PROMOTER_UP
0.738007380074%	4	542	141	T2D_GENES_TANYA_ANTHROPOMETRIC	SABATES_COLORECTAL_ADENOMA_UP
0.738007380074%	4	542	140	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.738007380074%	4	542	137	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MITOTIC_G1_G1_S_PHASES
0.738007380074%	4	542	136	T2D_GENES_TANYA_ANTHROPOMETRIC	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.738007380074%	4	542	134	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_TIGHT_JUNCTION
0.738007380074%	4	542	134	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_CELL_ADHESION_MOLECULES_CAMS
0.738007380074%	4	542	133	T2D_GENES_TANYA_ANTHROPOMETRIC	SENESE_HDAC2_TARGETS_DN
0.738007380074%	4	542	133	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PARKINSONS_DISEASE
0.738007380074%	4	542	130	T2D_GENES_TANYA_ANTHROPOMETRIC	YAGI_AML_WITH_T_9_11_TRANSLOCATION
0.738007380074%	4	542	129	T2D_GENES_TANYA_ANTHROPOMETRIC	YAGI_AML_SURVIVAL
0.738007380074%	4	542	128	T2D_GENES_TANYA_ANTHROPOMETRIC	POTTI_TOPOTECAN_SENSITIVITY
0.738007380074%	4	542	128	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_MEF_LCP_WITH_H3K4ME3
0.738007380074%	4	542	127	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
0.738007380074%	4	542	127	T2D_GENES_TANYA_ANTHROPOMETRIC	KARLSSON_TGFB1_TARGETS_UP
0.738007380074%	4	542	126	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
0.738007380074%	4	542	126	T2D_GENES_TANYA_ANTHROPOMETRIC	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
0.738007380074%	4	542	126	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
0.738007380074%	4	542	126	T2D_GENES_TANYA_ANTHROPOMETRIC	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.738007380074%	4	542	123	T2D_GENES_TANYA_ANTHROPOMETRIC	DAZARD_RESPONSE_TO_UV_SCC_DN
0.738007380074%	4	542	122	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_PDGF
0.738007380074%	4	542	122	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
0.738007380074%	4	542	121	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.738007380074%	4	542	118	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TOLL_RECEPTOR_CASCADES
0.738007380074%	4	542	118	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_NEURAL_CREST_STEM_CELL_DN
0.738007380074%	4	542	118	T2D_GENES_TANYA_ANTHROPOMETRIC	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
0.738007380074%	4	542	116	T2D_GENES_TANYA_ANTHROPOMETRIC	LI_INDUCED_T_TO_NATURAL_KILLER_DN
0.738007380074%	4	542	116	T2D_GENES_TANYA_ANTHROPOMETRIC	IKEDA_MIR30_TARGETS_UP
0.738007380074%	4	542	116	T2D_GENES_TANYA_ANTHROPOMETRIC	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
0.738007380074%	4	542	112	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_FGFR
0.738007380074%	4	542	112	T2D_GENES_TANYA_ANTHROPOMETRIC	PASINI_SUZ12_TARGETS_UP
0.738007380074%	4	542	109	T2D_GENES_TANYA_ANTHROPOMETRIC	SERVITJA_ISLET_HNF1A_TARGETS_DN
0.738007380074%	4	542	109	T2D_GENES_TANYA_ANTHROPOMETRIC	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
0.738007380074%	4	542	108	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
0.738007380074%	4	542	108	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
0.738007380074%	4	542	108	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.738007380074%	4	542	105	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_ERBB1_DOWNSTREAM_PATHWAY
0.738007380074%	4	542	105	T2D_GENES_TANYA_ANTHROPOMETRIC	HELLER_SILENCED_BY_METHYLATION_DN
0.738007380074%	4	542	103	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN
0.738007380074%	4	542	103	T2D_GENES_TANYA_ANTHROPOMETRIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
0.738007380074%	4	542	101	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
0.738007380074%	4	542	101	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_ERBB2
0.738007380074%	4	542	101	T2D_GENES_TANYA_ANTHROPOMETRIC	BASSO_CD40_SIGNALING_UP
0.738007380074%	4	542	100	T2D_GENES_TANYA_ANTHROPOMETRIC	WINZEN_DEGRADED_VIA_KHSRP
0.738007380074%	4	542	100	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
0.738007380074%	4	542	100	T2D_GENES_TANYA_ANTHROPOMETRIC	GAVIN_FOXP3_TARGETS_CLUSTER_P4
0.738007380074%	4	542	100	T2D_GENES_TANYA_ANTHROPOMETRIC	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
0.738007380074%	4	542	100	T2D_GENES_TANYA_ANTHROPOMETRIC	BENPORATH_ES_CORE_NINE_CORRELATED
0.735970561178%	16	2174	97	T2D_GENES_TANYA_LIPIDS	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
0.735970561178%	16	2174	93	T2D_GENES_TANYA_LIPIDS	CADWELL_ATG16L1_TARGETS_UP
0.735970561178%	16	2174	91	T2D_GENES_TANYA_LIPIDS	ELVIDGE_HIF1A_TARGETS_DN
0.735970561178%	16	2174	90	T2D_GENES_TANYA_LIPIDS	MORI_MATURE_B_LYMPHOCYTE_UP
0.735970561178%	16	2174	89	T2D_GENES_TANYA_LIPIDS	LEE_AGING_NEOCORTEX_UP
0.735970561178%	16	2174	88	T2D_GENES_TANYA_LIPIDS	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
0.735970561178%	16	2174	87	T2D_GENES_TANYA_LIPIDS	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
0.735970561178%	16	2174	85	T2D_GENES_TANYA_LIPIDS	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
0.735970561178%	16	2174	82	T2D_GENES_TANYA_LIPIDS	PID_REG_GR_PATHWAY
0.735970561178%	16	2174	80	T2D_GENES_TANYA_LIPIDS	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
0.735970561178%	16	2174	80	T2D_GENES_TANYA_LIPIDS	FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.735970561178%	16	2174	73	T2D_GENES_TANYA_LIPIDS	LIN_MELANOMA_COPY_NUMBER_UP
0.735970561178%	16	2174	72	T2D_GENES_TANYA_LIPIDS	KEGG_DRUG_METABOLISM_CYTOCHROME_P450
0.735970561178%	16	2174	69	T2D_GENES_TANYA_LIPIDS	KEGG_PPAR_SIGNALING_PATHWAY
0.735970561178%	16	2174	55	T2D_GENES_TANYA_LIPIDS	KEGG_STEROID_HORMONE_BIOSYNTHESIS
0.735970561178%	16	2174	238	T2D_GENES_TANYA_LIPIDS	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.735970561178%	16	2174	221	T2D_GENES_TANYA_LIPIDS	PEDRIOLI_MIR31_TARGETS_UP
0.735970561178%	16	2174	217	T2D_GENES_TANYA_LIPIDS	WIERENGA_STAT5A_TARGETS_UP
0.735970561178%	16	2174	179	T2D_GENES_TANYA_LIPIDS	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE
0.735970561178%	16	2174	176	T2D_GENES_TANYA_LIPIDS	REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION
0.735970561178%	16	2174	175	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER_SURVIVAL_DN
0.735970561178%	16	2174	172	T2D_GENES_TANYA_LIPIDS	SMID_BREAST_CANCER_LUMINAL_B_UP
0.735970561178%	16	2174	169	T2D_GENES_TANYA_LIPIDS	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION
0.735970561178%	16	2174	163	T2D_GENES_TANYA_LIPIDS	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
0.735970561178%	16	2174	162	T2D_GENES_TANYA_LIPIDS	WHITFIELD_CELL_CYCLE_S
0.735970561178%	16	2174	158	T2D_GENES_TANYA_LIPIDS	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.735970561178%	16	2174	151	T2D_GENES_TANYA_LIPIDS	KEGG_WNT_SIGNALING_PATHWAY
0.735970561178%	16	2174	149	T2D_GENES_TANYA_LIPIDS	GOZGIT_ESR1_TARGETS_UP
0.735970561178%	16	2174	148	T2D_GENES_TANYA_LIPIDS	WEI_MIR34A_TARGETS
0.735970561178%	16	2174	147	T2D_GENES_TANYA_LIPIDS	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
0.735970561178%	16	2174	146	T2D_GENES_TANYA_LIPIDS	ELVIDGE_HYPOXIA_DN
0.735970561178%	16	2174	141	T2D_GENES_TANYA_LIPIDS	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.735970561178%	16	2174	140	T2D_GENES_TANYA_LIPIDS	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
0.735970561178%	16	2174	137	T2D_GENES_TANYA_LIPIDS	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
0.735970561178%	16	2174	134	T2D_GENES_TANYA_LIPIDS	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
0.735970561178%	16	2174	134	T2D_GENES_TANYA_LIPIDS	KEGG_TIGHT_JUNCTION
0.735970561178%	16	2174	129	T2D_GENES_TANYA_LIPIDS	YAGI_AML_SURVIVAL
0.735970561178%	16	2174	126	T2D_GENES_TANYA_LIPIDS	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
0.735970561178%	16	2174	126	T2D_GENES_TANYA_LIPIDS	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.735970561178%	16	2174	120	T2D_GENES_TANYA_LIPIDS	ZHU_CMV_ALL_UP
0.735970561178%	16	2174	118	T2D_GENES_TANYA_LIPIDS	REACTOME_TOLL_RECEPTOR_CASCADES
0.735970561178%	16	2174	118	T2D_GENES_TANYA_LIPIDS	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
0.735970561178%	16	2174	115	T2D_GENES_TANYA_LIPIDS	MARKEY_RB1_CHRONIC_LOF_UP
0.735970561178%	16	2174	108	T2D_GENES_TANYA_LIPIDS	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN
0.735970561178%	16	2174	103	T2D_GENES_TANYA_LIPIDS	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY
0.735970561178%	16	2174	101	T2D_GENES_TANYA_LIPIDS	GRADE_COLON_AND_RECTAL_CANCER_DN
0.710227272727%	25	3520	584	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HAMAI_APOPTOSIS_VIA_TRAIL_UP
0.710227272727%	25	3520	306	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHANDRAN_METASTASIS_DN
0.710227272727%	25	3520	289	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_MLL_TARGETS
0.710227272727%	25	3520	280	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
0.710227272727%	25	3520	250	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
0.710227272727%	25	3520	237	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.710227272727%	25	3520	228	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARKEY_RB1_ACUTE_LOF_DN
0.710227272727%	25	3520	227	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
0.710227272727%	25	3520	222	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_1HR_DN
0.710227272727%	25	3520	217	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WONG_MITOCHONDRIA_GENE_MODULE
0.710227272727%	25	3520	214	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TIEN_INTESTINE_PROBIOTICS_24HR_DN
0.710227272727%	25	3520	212	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHANG_CORE_SERUM_RESPONSE_UP
0.710227272727%	25	3520	206	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BILD_MYC_ONCOGENIC_SIGNATURE
0.710227272727%	25	3520	184	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DOANE_RESPONSE_TO_ANDROGEN_UP
0.710227272727%	25	3520	180	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DARWICHE_PAPILLOMA_RISK_HIGH_DN
0.710227272727%	25	3520	180	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_48HR_UP
0.710227272727%	25	3520	170	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
0.710227272727%	25	3520	162	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
0.709219858156%	9	1269	97	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KONG_E2F3_TARGETS
0.709219858156%	9	1269	71	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GEORGANTAS_HSC_MARKERS
0.709219858156%	9	1269	487	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP
0.709219858156%	9	1269	430	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JOHNSTONE_PARVB_TARGETS_3_UP
0.709219858156%	9	1269	425	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHANG_BREAST_CANCER_PROGENITORS_UP
0.709219858156%	9	1269	419	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.709219858156%	9	1269	418	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PEDRIOLI_MIR31_TARGETS_DN
0.709219858156%	9	1269	374	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_TUMOR_INVASIVENESS_UP
0.709219858156%	9	1269	367	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VECCHI_GASTRIC_CANCER_EARLY_DN
0.709219858156%	9	1269	355	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PEREZ_TP63_TARGETS
0.709219858156%	9	1269	351	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.709219858156%	9	1269	349	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
0.709219858156%	9	1269	344	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RICKMAN_METASTASIS_UP
0.709219858156%	9	1269	321	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
0.709219858156%	9	1269	296	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DURAND_STROMA_MAX_UP
0.709219858156%	9	1269	289	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_MLL_TARGETS
0.709219858156%	9	1269	280	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_SMARCE1_TARGETS_UP
0.709219858156%	9	1269	279	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_NEURONAL_SYSTEM
0.709219858156%	9	1269	277	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_60HR_DN
0.709219858156%	9	1269	277	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FOURNIER_ACINAR_DEVELOPMENT_LATE_2
0.709219858156%	9	1269	274	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
0.709219858156%	9	1269	271	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.709219858156%	9	1269	269	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_CLIM2_TARGETS_UP
0.709219858156%	9	1269	267	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CAIRO_HEPATOBLASTOMA_DN
0.709219858156%	9	1269	266	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FOSTER_KDM1A_TARGETS_UP
0.709219858156%	9	1269	264	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
0.709219858156%	9	1269	260	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SENESE_HDAC1_TARGETS_DN
0.709219858156%	9	1269	256	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ONDER_CDH1_TARGETS_2_UP
0.709219858156%	9	1269	252	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.709219858156%	9	1269	251	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
0.709219858156%	9	1269	247	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_CARBOHYDRATES
0.709219858156%	9	1269	246	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
0.709219858156%	9	1269	245	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KONDO_EZH2_TARGETS
0.709219858156%	9	1269	239	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.709219858156%	9	1269	239	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ALFANO_MYC_TARGETS
0.709219858156%	9	1269	234	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AFFAR_YY1_TARGETS_DN
0.709219858156%	9	1269	230	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BENPORATH_MYC_TARGETS_WITH_EBOX
0.709219858156%	9	1269	229	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
0.709219858156%	9	1269	217	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMUNDSON_RESPONSE_TO_ARSENITE
0.709219858156%	9	1269	216	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
0.709219858156%	9	1269	216	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOQUEST_STEM_CELL_DN
0.709219858156%	9	1269	215	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARKEY_RB1_ACUTE_LOF_UP
0.709219858156%	9	1269	214	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
0.709219858156%	9	1269	214	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIDUS_METASTASIS_UP
0.709219858156%	9	1269	208	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
0.709219858156%	9	1269	206	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
0.709219858156%	9	1269	202	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FUJII_YBX1_TARGETS_DN
0.709219858156%	9	1269	201	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_MYC_AMPLIFICATION_TARGETS_UP
0.709219858156%	9	1269	197	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
0.709219858156%	9	1269	196	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
0.709219858156%	9	1269	188	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
0.709219858156%	9	1269	187	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BAKKER_FOXO3_TARGETS_DN
0.709219858156%	9	1269	180	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
0.709219858156%	9	1269	178	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_18HR_DN
0.709219858156%	9	1269	177	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.709219858156%	9	1269	176	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SASAKI_ADULT_T_CELL_LEUKEMIA
0.709219858156%	9	1269	175	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FIRESTEIN_PROLIFERATION
0.709219858156%	9	1269	173	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SENGUPTA_EBNA1_ANTICORRELATED
0.709219858156%	9	1269	167	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_ESR1_UP
0.709219858156%	9	1269	159	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_INTERFERON_SIGNALING
0.709219858156%	9	1269	159	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PURINE_METABOLISM
0.709219858156%	9	1269	157	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.709219858156%	9	1269	132	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
0.709219858156%	9	1269	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_MEF_LCP_WITH_H3K4ME3
0.709219858156%	9	1269	127	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
0.709219858156%	9	1269	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
0.709219858156%	9	1269	120	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN
0.709219858156%	9	1269	118	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
0.709219858156%	14	1974	98	Mendelian_Nancy_Cox	NIELSEN_GIST
0.709219858156%	14	1974	98	Mendelian_Nancy_Cox	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
0.709219858156%	14	1974	97	Mendelian_Nancy_Cox	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
0.709219858156%	14	1974	95	Mendelian_Nancy_Cox	HOEBEKE_LYMPHOID_STEM_CELL_UP
0.709219858156%	14	1974	95	Mendelian_Nancy_Cox	HECKER_IFNB1_TARGETS
0.709219858156%	14	1974	93	Mendelian_Nancy_Cox	ZHU_CMV_24_HR_UP
0.709219858156%	14	1974	93	Mendelian_Nancy_Cox	CADWELL_ATG16L1_TARGETS_UP
0.709219858156%	14	1974	92	Mendelian_Nancy_Cox	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
0.709219858156%	14	1974	91	Mendelian_Nancy_Cox	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.709219858156%	14	1974	90	Mendelian_Nancy_Cox	GAVIN_FOXP3_TARGETS_CLUSTER_P7
0.709219858156%	14	1974	89	Mendelian_Nancy_Cox	LEIN_PONS_MARKERS
0.709219858156%	14	1974	87	Mendelian_Nancy_Cox	BIOCARTA_MAPK_PATHWAY
0.709219858156%	14	1974	84	Mendelian_Nancy_Cox	RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.709219858156%	14	1974	84	Mendelian_Nancy_Cox	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
0.709219858156%	14	1974	83	Mendelian_Nancy_Cox	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
0.709219858156%	14	1974	83	Mendelian_Nancy_Cox	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
0.709219858156%	14	1974	81	Mendelian_Nancy_Cox	SCIBETTA_KDM5B_TARGETS_DN
0.709219858156%	14	1974	81	Mendelian_Nancy_Cox	REACTOME_MITOTIC_G2_G2_M_PHASES
0.709219858156%	14	1974	81	Mendelian_Nancy_Cox	MAHAJAN_RESPONSE_TO_IL1A_UP
0.709219858156%	14	1974	81	Mendelian_Nancy_Cox	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
0.709219858156%	14	1974	79	Mendelian_Nancy_Cox	GAVIN_FOXP3_TARGETS_CLUSTER_P2
0.709219858156%	14	1974	79	Mendelian_Nancy_Cox	DUAN_PRDM5_TARGETS
0.709219858156%	14	1974	78	Mendelian_Nancy_Cox	ROSS_LEUKEMIA_WITH_MLL_FUSIONS
0.709219858156%	14	1974	78	Mendelian_Nancy_Cox	ROSS_AML_WITH_MLL_FUSIONS
0.709219858156%	14	1974	78	Mendelian_Nancy_Cox	RADMACHER_AML_PROGNOSIS
0.709219858156%	14	1974	78	Mendelian_Nancy_Cox	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
0.709219858156%	14	1974	78	Mendelian_Nancy_Cox	COATES_MACROPHAGE_M1_VS_M2_DN
0.709219858156%	14	1974	77	Mendelian_Nancy_Cox	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN
0.709219858156%	14	1974	76	Mendelian_Nancy_Cox	PEART_HDAC_PROLIFERATION_CLUSTER_DN
0.709219858156%	14	1974	75	Mendelian_Nancy_Cox	MCCLUNG_COCAIN_REWARD_4WK
0.709219858156%	14	1974	74	Mendelian_Nancy_Cox	RAMALHO_STEMNESS_DN
0.709219858156%	14	1974	74	Mendelian_Nancy_Cox	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
0.709219858156%	14	1974	74	Mendelian_Nancy_Cox	DER_IFN_ALPHA_RESPONSE_UP
0.709219858156%	14	1974	72	Mendelian_Nancy_Cox	MATZUK_SPERMATOCYTE
0.709219858156%	14	1974	71	Mendelian_Nancy_Cox	KUMAR_AUTOPHAGY_NETWORK
0.709219858156%	14	1974	71	Mendelian_Nancy_Cox	DER_IFN_GAMMA_RESPONSE_UP
0.709219858156%	14	1974	69	Mendelian_Nancy_Cox	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
0.709219858156%	14	1974	69	Mendelian_Nancy_Cox	PID_P75NTRPATHWAY
0.709219858156%	14	1974	69	Mendelian_Nancy_Cox	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
0.709219858156%	14	1974	68	Mendelian_Nancy_Cox	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.709219858156%	14	1974	66	Mendelian_Nancy_Cox	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
0.709219858156%	14	1974	66	Mendelian_Nancy_Cox	RAMASWAMY_METASTASIS_UP
0.709219858156%	14	1974	66	Mendelian_Nancy_Cox	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
0.709219858156%	14	1974	64	Mendelian_Nancy_Cox	LEE_LIVER_CANCER_E2F1_DN
0.709219858156%	14	1974	64	Mendelian_Nancy_Cox	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
0.709219858156%	14	1974	64	Mendelian_Nancy_Cox	GERHOLD_ADIPOGENESIS_DN
0.709219858156%	14	1974	63	Mendelian_Nancy_Cox	BURTON_ADIPOGENESIS_PEAK_AT_0HR
0.709219858156%	14	1974	62	Mendelian_Nancy_Cox	PID_FCER1PATHWAY
0.709219858156%	14	1974	62	Mendelian_Nancy_Cox	KYNG_DNA_DAMAGE_BY_UV
0.709219858156%	14	1974	61	Mendelian_Nancy_Cox	BAKKER_FOXO3_TARGETS_UP
0.709219858156%	14	1974	59	Mendelian_Nancy_Cox	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
0.709219858156%	14	1974	59	Mendelian_Nancy_Cox	PID_NOTCH_PATHWAY
0.709219858156%	14	1974	55	Mendelian_Nancy_Cox	REACTOME_ION_CHANNEL_TRANSPORT
0.709219858156%	14	1974	51	Mendelian_Nancy_Cox	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
0.709219858156%	14	1974	51	Mendelian_Nancy_Cox	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE
0.709219858156%	14	1974	50	Mendelian_Nancy_Cox	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION
0.709219858156%	14	1974	49	Mendelian_Nancy_Cox	PID_ARF6_TRAFFICKINGPATHWAY
0.709219858156%	14	1974	49	Mendelian_Nancy_Cox	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP
0.709219858156%	14	1974	48	Mendelian_Nancy_Cox	REACTOME_MUSCLE_CONTRACTION
0.709219858156%	14	1974	47	Mendelian_Nancy_Cox	KEGG_TYPE_II_DIABETES_MELLITUS
0.709219858156%	14	1974	45	Mendelian_Nancy_Cox	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
0.709219858156%	14	1974	44	Mendelian_Nancy_Cox	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.709219858156%	14	1974	44	Mendelian_Nancy_Cox	KEGG_LYSINE_DEGRADATION
0.709219858156%	14	1974	43	Mendelian_Nancy_Cox	PID_TCPTP_PATHWAY
0.709219858156%	14	1974	42	Mendelian_Nancy_Cox	KEGG_FATTY_ACID_METABOLISM
0.709219858156%	14	1974	40	Mendelian_Nancy_Cox	ST_B_CELL_ANTIGEN_RECEPTOR
0.709219858156%	14	1974	40	Mendelian_Nancy_Cox	KEGG_PYRUVATE_METABOLISM
0.709219858156%	14	1974	37	Mendelian_Nancy_Cox	PID_FRA_PATHWAY
0.709219858156%	14	1974	36	Mendelian_Nancy_Cox	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
0.709219858156%	14	1974	36	Mendelian_Nancy_Cox	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
0.709219858156%	14	1974	34	Mendelian_Nancy_Cox	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT
0.709219858156%	14	1974	34	Mendelian_Nancy_Cox	KEGG_BUTANOATE_METABOLISM
0.709219858156%	14	1974	33	Mendelian_Nancy_Cox	ROZANOV_MMP14_TARGETS_SUBSET
0.709219858156%	14	1974	32	Mendelian_Nancy_Cox	MOOTHA_GLUCONEOGENESIS
0.709219858156%	14	1974	31	Mendelian_Nancy_Cox	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM
0.709219858156%	14	1974	28	Mendelian_Nancy_Cox	REACTOME_LIPOPROTEIN_METABOLISM
0.709219858156%	14	1974	24	Mendelian_Nancy_Cox	PID_RHODOPSIN_PATHWAY
0.709219858156%	14	1974	23	Mendelian_Nancy_Cox	PID_CONE_PATHWAY
0.709219858156%	14	1974	21	Mendelian_Nancy_Cox	KEGG_GLYCOSAMINOGLYCAN_DEGRADATION
0.709219858156%	14	1974	20	Mendelian_Nancy_Cox	BIOCARTA_AMI_PATHWAY
0.709219858156%	14	1974	17	Mendelian_Nancy_Cox	REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM
0.709219858156%	14	1974	162	Mendelian_Nancy_Cox	WHITFIELD_CELL_CYCLE_S
0.709219858156%	14	1974	162	Mendelian_Nancy_Cox	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
0.709219858156%	14	1974	146	Mendelian_Nancy_Cox	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
0.709219858156%	14	1974	141	Mendelian_Nancy_Cox	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP
0.709219858156%	14	1974	14	Mendelian_Nancy_Cox	BIOCARTA_CLASSIC_PATHWAY
0.709219858156%	14	1974	139	Mendelian_Nancy_Cox	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
0.709219858156%	14	1974	137	Mendelian_Nancy_Cox	REACTOME_MITOTIC_G1_G1_S_PHASES
0.709219858156%	14	1974	121	Mendelian_Nancy_Cox	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
0.709219858156%	14	1974	121	Mendelian_Nancy_Cox	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
0.709219858156%	14	1974	118	Mendelian_Nancy_Cox	CERVERA_SDHB_TARGETS_1_UP
0.709219858156%	14	1974	116	Mendelian_Nancy_Cox	WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.709219858156%	14	1974	109	Mendelian_Nancy_Cox	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
0.709219858156%	14	1974	108	Mendelian_Nancy_Cox	LE_EGR2_TARGETS_DN
0.709219858156%	14	1974	103	Mendelian_Nancy_Cox	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN
0.709219858156%	14	1974	103	Mendelian_Nancy_Cox	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.709219858156%	14	1974	101	Mendelian_Nancy_Cox	KOBAYASHI_EGFR_SIGNALING_24HR_UP
0.709219858156%	14	1974	100	Mendelian_Nancy_Cox	ROVERSI_GLIOMA_COPY_NUMBER_UP
0.709219858156%	14	1974	100	Mendelian_Nancy_Cox	RICKMAN_HEAD_AND_NECK_CANCER_A
0.694815606627%	13	1871	98	T2D_GENES_TANYA_HEIGHT	PYEON_HPV_POSITIVE_TUMORS_UP
0.694815606627%	13	1871	95	T2D_GENES_TANYA_HEIGHT	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.694815606627%	13	1871	93	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_INSULIN_SECRETION
0.694815606627%	13	1871	92	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_OF_DNA
0.694815606627%	13	1871	90	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_ERBB4
0.694815606627%	13	1871	88	T2D_GENES_TANYA_HEIGHT	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
0.694815606627%	13	1871	88	T2D_GENES_TANYA_HEIGHT	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
0.694815606627%	13	1871	87	T2D_GENES_TANYA_HEIGHT	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
0.694815606627%	13	1871	86	T2D_GENES_TANYA_HEIGHT	KEGG_TGF_BETA_SIGNALING_PATHWAY
0.694815606627%	13	1871	85	T2D_GENES_TANYA_HEIGHT	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
0.694815606627%	13	1871	84	T2D_GENES_TANYA_HEIGHT	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
0.694815606627%	13	1871	81	T2D_GENES_TANYA_HEIGHT	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
0.694815606627%	13	1871	77	T2D_GENES_TANYA_HEIGHT	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
0.694815606627%	13	1871	71	T2D_GENES_TANYA_HEIGHT	DER_IFN_GAMMA_RESPONSE_UP
0.694815606627%	13	1871	66	T2D_GENES_TANYA_HEIGHT	BEIER_GLIOMA_STEM_CELL_DN
0.694815606627%	13	1871	64	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_UP
0.694815606627%	13	1871	64	T2D_GENES_TANYA_HEIGHT	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS
0.694815606627%	13	1871	58	T2D_GENES_TANYA_HEIGHT	SCHEIDEREIT_IKK_INTERACTING_PROTEINS
0.694815606627%	13	1871	57	T2D_GENES_TANYA_HEIGHT	PID_TXA2PATHWAY
0.694815606627%	13	1871	56	T2D_GENES_TANYA_HEIGHT	KEGG_HEDGEHOG_SIGNALING_PATHWAY
0.694815606627%	13	1871	54	T2D_GENES_TANYA_HEIGHT	REACTOME_TCR_SIGNALING
0.694815606627%	13	1871	48	T2D_GENES_TANYA_HEIGHT	GNATENKO_PLATELET_SIGNATURE
0.694815606627%	13	1871	264	T2D_GENES_TANYA_HEIGHT	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
0.694815606627%	13	1871	181	T2D_GENES_TANYA_HEIGHT	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
0.694815606627%	13	1871	180	T2D_GENES_TANYA_HEIGHT	DARWICHE_PAPILLOMA_RISK_HIGH_DN
0.694815606627%	13	1871	178	T2D_GENES_TANYA_HEIGHT	KEGG_CALCIUM_SIGNALING_PATHWAY
0.694815606627%	13	1871	176	T2D_GENES_TANYA_HEIGHT	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
0.694815606627%	13	1871	176	T2D_GENES_TANYA_HEIGHT	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
0.694815606627%	13	1871	174	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
0.694815606627%	13	1871	169	T2D_GENES_TANYA_HEIGHT	KEGG_ALZHEIMERS_DISEASE
0.694815606627%	13	1871	168	T2D_GENES_TANYA_HEIGHT	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
0.694815606627%	13	1871	152	T2D_GENES_TANYA_HEIGHT	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
0.694815606627%	13	1871	149	T2D_GENES_TANYA_HEIGHT	LANDIS_ERBB2_BREAST_TUMORS_324_DN
0.694815606627%	13	1871	146	T2D_GENES_TANYA_HEIGHT	LEE_NEURAL_CREST_STEM_CELL_UP
0.694815606627%	13	1871	145	T2D_GENES_TANYA_HEIGHT	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.694815606627%	13	1871	140	T2D_GENES_TANYA_HEIGHT	QI_HYPOXIA
0.694815606627%	13	1871	140	T2D_GENES_TANYA_HEIGHT	JOHNSTONE_PARVB_TARGETS_2_UP
0.694815606627%	13	1871	138	T2D_GENES_TANYA_HEIGHT	JIANG_VHL_TARGETS
0.694815606627%	13	1871	135	T2D_GENES_TANYA_HEIGHT	KEGG_OXIDATIVE_PHOSPHORYLATION
0.694815606627%	13	1871	134	T2D_GENES_TANYA_HEIGHT	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
0.694815606627%	13	1871	132	T2D_GENES_TANYA_HEIGHT	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS
0.694815606627%	13	1871	130	T2D_GENES_TANYA_HEIGHT	YAGI_AML_WITH_T_9_11_TRANSLOCATION
0.694815606627%	13	1871	129	T2D_GENES_TANYA_HEIGHT	KEGG_AXON_GUIDANCE
0.694815606627%	13	1871	129	T2D_GENES_TANYA_HEIGHT	BROWN_MYELOID_CELL_DEVELOPMENT_DN
0.694815606627%	13	1871	128	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_MEF_LCP_WITH_H3K4ME3
0.694815606627%	13	1871	121	T2D_GENES_TANYA_HEIGHT	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS
0.694815606627%	13	1871	119	T2D_GENES_TANYA_HEIGHT	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
0.694815606627%	13	1871	116	T2D_GENES_TANYA_HEIGHT	MATTIOLI_MGUS_VS_PCL
0.694815606627%	13	1871	114	T2D_GENES_TANYA_HEIGHT	CERVERA_SDHB_TARGETS_2
0.694815606627%	13	1871	113	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_RHO_GTPASES
0.694815606627%	13	1871	112	T2D_GENES_TANYA_HEIGHT	LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.694815606627%	13	1871	109	T2D_GENES_TANYA_HEIGHT	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
0.694815606627%	13	1871	108	T2D_GENES_TANYA_HEIGHT	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
0.694815606627%	13	1871	108	T2D_GENES_TANYA_HEIGHT	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
0.694815606627%	13	1871	105	T2D_GENES_TANYA_HEIGHT	STEIN_ESRRA_TARGETS_DN
0.694815606627%	13	1871	104	T2D_GENES_TANYA_HEIGHT	REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE
0.694815606627%	13	1871	103	T2D_GENES_TANYA_HEIGHT	KIM_MYCN_AMPLIFICATION_TARGETS_DN
0.694815606627%	13	1871	101	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_ERBB2
0.694815606627%	13	1871	101	T2D_GENES_TANYA_HEIGHT	BASSO_CD40_SIGNALING_UP
0.690713737529%	9	1303	91	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
0.690713737529%	9	1303	430	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VECCHI_GASTRIC_CANCER_EARLY_UP
0.690713737529%	9	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LASTOWSKA_COAMPLIFIED_WITH_MYCN
0.690713737529%	9	1303	388	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STEIN_ESRRA_TARGETS_UP
0.690713737529%	9	1303	357	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHEN_SMARCA2_TARGETS_DN
0.690713737529%	9	1303	356	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
0.690713737529%	9	1303	349	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
0.690713737529%	9	1303	329	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
0.690713737529%	9	1303	320	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
0.690713737529%	9	1303	318	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEI_MYB_TARGETS
0.690713737529%	9	1303	314	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DOUGLAS_BMI1_TARGETS_DN
0.690713737529%	9	1303	299	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WALLACE_PROSTATE_CANCER_RACE_UP
0.690713737529%	9	1303	299	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MUELLER_PLURINET
0.690713737529%	9	1303	293	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ENK_UV_RESPONSE_EPIDERMIS_UP
0.690713737529%	9	1303	285	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
0.690713737529%	9	1303	282	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HELLER_SILENCED_BY_METHYLATION_UP
0.690713737529%	9	1303	279	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FORTSCHEGGER_PHF8_TARGETS_UP
0.690713737529%	9	1303	276	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP
0.690713737529%	9	1303	270	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
0.690713737529%	9	1303	267	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAIRO_HEPATOBLASTOMA_DN
0.690713737529%	9	1303	256	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ONDER_CDH1_TARGETS_2_UP
0.690713737529%	9	1303	254	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_STEM_CELL
0.690713737529%	9	1303	251	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION
0.690713737529%	9	1303	245	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PENG_RAPAMYCIN_RESPONSE_DN
0.690713737529%	9	1303	244	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PLASARI_TGFB1_TARGETS_10HR_DN
0.690713737529%	9	1303	243	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHICAS_RB1_TARGETS_GROWING
0.690713737529%	9	1303	230	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KAUFFMANN_DNA_REPAIR_GENES
0.690713737529%	9	1303	229	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
0.690713737529%	9	1303	228	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARKEY_RB1_ACUTE_LOF_DN
0.690713737529%	9	1303	228	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
0.690713737529%	9	1303	227	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.690713737529%	9	1303	225	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
0.690713737529%	9	1303	222	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAIRO_LIVER_DEVELOPMENT_DN
0.690713737529%	9	1303	216	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOQUEST_STEM_CELL_DN
0.690713737529%	9	1303	214	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AFFAR_YY1_TARGETS_UP
0.690713737529%	9	1303	213	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WIERENGA_STAT5A_TARGETS_DN
0.690713737529%	9	1303	211	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FOSTER_KDM1A_TARGETS_DN
0.690713737529%	9	1303	210	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_TUMOR_INVASIVENESS_DN
0.690713737529%	9	1303	210	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
0.690713737529%	9	1303	209	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_WT1_TARGETS_12HR_DN
0.690713737529%	9	1303	208	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
0.690713737529%	9	1303	208	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
0.690713737529%	9	1303	207	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VERHAAK_GLIOBLASTOMA_CLASSICAL
0.690713737529%	9	1303	207	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAIRO_HEPATOBLASTOMA_UP
0.690713737529%	9	1303	206	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LINSLEY_MIR16_TARGETS
0.690713737529%	9	1303	206	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.690713737529%	9	1303	203	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PAL_PRMT5_TARGETS_UP
0.690713737529%	9	1303	200	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHEPARD_BMYB_MORPHOLINO_DN
0.690713737529%	9	1303	195	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
0.690713737529%	9	1303	192	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_DNA_REPLICATION
0.690713737529%	9	1303	186	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HAMAI_APOPTOSIS_VIA_TRAIL_DN
0.690713737529%	9	1303	185	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
0.690713737529%	9	1303	184	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WU_CELL_MIGRATION
0.690713737529%	9	1303	181	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JISON_SICKLE_CELL_DISEASE_DN
0.690713737529%	9	1303	174	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
0.690713737529%	9	1303	169	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PENG_GLUCOSE_DEPRIVATION_DN
0.690713737529%	9	1303	168	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PUJANA_XPRSS_INT_NETWORK
0.690713737529%	9	1303	165	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
0.690713737529%	9	1303	157	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.690713737529%	9	1303	153	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G6
0.690713737529%	9	1303	149	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HUANG_GATA2_TARGETS_UP
0.690713737529%	9	1303	147	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KAUFFMANN_DNA_REPLICATION_GENES
0.690713737529%	9	1303	143	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION
0.690713737529%	9	1303	133	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAL_LEUKEMIC_STEM_CELL_UP
0.690713737529%	9	1303	132	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
0.690713737529%	9	1303	128	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_CELL_CYCLE
0.689972401104%	15	2174	98	T2D_GENES_TANYA_LIPIDS	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
0.689972401104%	15	2174	95	T2D_GENES_TANYA_LIPIDS	HOEBEKE_LYMPHOID_STEM_CELL_UP
0.689972401104%	15	2174	88	T2D_GENES_TANYA_LIPIDS	KEGG_RIBOSOME
0.689972401104%	15	2174	86	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
0.689972401104%	15	2174	84	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
0.689972401104%	15	2174	84	T2D_GENES_TANYA_LIPIDS	KIM_GLIS2_TARGETS_UP
0.689972401104%	15	2174	81	T2D_GENES_TANYA_LIPIDS	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
0.689972401104%	15	2174	80	T2D_GENES_TANYA_LIPIDS	WOO_LIVER_CANCER_RECURRENCE_DN
0.689972401104%	15	2174	80	T2D_GENES_TANYA_LIPIDS	PID_MET_PATHWAY
0.689972401104%	15	2174	76	T2D_GENES_TANYA_LIPIDS	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION
0.689972401104%	15	2174	72	T2D_GENES_TANYA_LIPIDS	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
0.689972401104%	15	2174	70	T2D_GENES_TANYA_LIPIDS	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
0.689972401104%	15	2174	69	T2D_GENES_TANYA_LIPIDS	ZAMORA_NOS2_TARGETS_UP
0.689972401104%	15	2174	69	T2D_GENES_TANYA_LIPIDS	AMIT_EGF_RESPONSE_120_HELA
0.689972401104%	15	2174	66	T2D_GENES_TANYA_LIPIDS	BEIER_GLIOMA_STEM_CELL_DN
0.689972401104%	15	2174	64	T2D_GENES_TANYA_LIPIDS	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
0.689972401104%	15	2174	58	T2D_GENES_TANYA_LIPIDS	BIOCARTA_PPARA_PATHWAY
0.689972401104%	15	2174	210	T2D_GENES_TANYA_LIPIDS	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
0.689972401104%	15	2174	206	T2D_GENES_TANYA_LIPIDS	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.689972401104%	15	2174	205	T2D_GENES_TANYA_LIPIDS	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
0.689972401104%	15	2174	194	T2D_GENES_TANYA_LIPIDS	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.689972401104%	15	2174	190	T2D_GENES_TANYA_LIPIDS	KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.689972401104%	15	2174	188	T2D_GENES_TANYA_LIPIDS	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.689972401104%	15	2174	182	T2D_GENES_TANYA_LIPIDS	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.689972401104%	15	2174	176	T2D_GENES_TANYA_LIPIDS	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX
0.689972401104%	15	2174	170	T2D_GENES_TANYA_LIPIDS	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
0.689972401104%	15	2174	167	T2D_GENES_TANYA_LIPIDS	TIEN_INTESTINE_PROBIOTICS_6HR_DN
0.689972401104%	15	2174	167	T2D_GENES_TANYA_LIPIDS	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
0.689972401104%	15	2174	161	T2D_GENES_TANYA_LIPIDS	BIDUS_METASTASIS_DN
0.689972401104%	15	2174	156	T2D_GENES_TANYA_LIPIDS	GROSS_HYPOXIA_VIA_ELK3_DN
0.689972401104%	15	2174	152	T2D_GENES_TANYA_LIPIDS	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
0.689972401104%	15	2174	149	T2D_GENES_TANYA_LIPIDS	TSAI_RESPONSE_TO_IONIZING_RADIATION
0.689972401104%	15	2174	148	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_24HR_DN
0.689972401104%	15	2174	143	T2D_GENES_TANYA_LIPIDS	BASSO_B_LYMPHOCYTE_NETWORK
0.689972401104%	15	2174	142	T2D_GENES_TANYA_LIPIDS	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
0.689972401104%	15	2174	138	T2D_GENES_TANYA_LIPIDS	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
0.689972401104%	15	2174	138	T2D_GENES_TANYA_LIPIDS	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
0.689972401104%	15	2174	137	T2D_GENES_TANYA_LIPIDS	REACTOME_MITOTIC_G1_G1_S_PHASES
0.689972401104%	15	2174	135	T2D_GENES_TANYA_LIPIDS	KEGG_OXIDATIVE_PHOSPHORYLATION
0.689972401104%	15	2174	130	T2D_GENES_TANYA_LIPIDS	YAGI_AML_WITH_T_9_11_TRANSLOCATION
0.689972401104%	15	2174	129	T2D_GENES_TANYA_LIPIDS	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP
0.689972401104%	15	2174	128	T2D_GENES_TANYA_LIPIDS	YEGNASUBRAMANIAN_PROSTATE_CANCER
0.689972401104%	15	2174	126	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
0.689972401104%	15	2174	125	T2D_GENES_TANYA_LIPIDS	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
0.689972401104%	15	2174	124	T2D_GENES_TANYA_LIPIDS	REACTOME_CELL_CYCLE_CHECKPOINTS
0.689972401104%	15	2174	121	T2D_GENES_TANYA_LIPIDS	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
0.689972401104%	15	2174	120	T2D_GENES_TANYA_LIPIDS	XU_GH1_EXOGENOUS_TARGETS_DN
0.689972401104%	15	2174	120	T2D_GENES_TANYA_LIPIDS	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN
0.689972401104%	15	2174	118	T2D_GENES_TANYA_LIPIDS	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
0.689972401104%	15	2174	117	T2D_GENES_TANYA_LIPIDS	PUJANA_BRCA_CENTERED_NETWORK
0.689972401104%	15	2174	115	T2D_GENES_TANYA_LIPIDS	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
0.689972401104%	15	2174	114	T2D_GENES_TANYA_LIPIDS	LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.689972401104%	15	2174	109	T2D_GENES_TANYA_LIPIDS	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.689972401104%	15	2174	104	T2D_GENES_TANYA_LIPIDS	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
0.689972401104%	15	2174	102	T2D_GENES_TANYA_LIPIDS	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.689972401104%	15	2174	100	T2D_GENES_TANYA_LIPIDS	QI_PLASMACYTOMA_DN
0.684345594525%	8	1169	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
0.684345594525%	8	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	UEDA_CENTRAL_CLOCK
0.684345594525%	8	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
0.684345594525%	8	1169	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOEBEKE_LYMPHOID_STEM_CELL_DN
0.684345594525%	8	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RUAN_RESPONSE_TO_TNF_DN
0.684345594525%	8	1169	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
0.684345594525%	8	1169	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
0.684345594525%	8	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_VEGFR1_2_PATHWAY
0.684345594525%	8	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BEIER_GLIOMA_STEM_CELL_DN
0.684345594525%	8	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE
0.684345594525%	8	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
0.684345594525%	8	1169	518	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_METABOLISM_OF_PROTEINS
0.684345594525%	8	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_LIVER_CANCER
0.684345594525%	8	1169	489	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIM_MAMMARY_STEM_CELL_UP
0.684345594525%	8	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_A6B1_A6B4_INTEGRIN_PATHWAY
0.684345594525%	8	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_TYPE_I_DIABETES_MELLITUS
0.684345594525%	8	1169	408	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GPCR_LIGAND_BINDING
0.684345594525%	8	1169	389	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_OLFACTORY_TRANSDUCTION
0.684345594525%	8	1169	332	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP
0.684345594525%	8	1169	306	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HORIUCHI_WTAP_TARGETS_UP
0.684345594525%	8	1169	299	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WALLACE_PROSTATE_CANCER_RACE_UP
0.684345594525%	8	1169	291	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SABATES_COLORECTAL_ADENOMA_DN
0.684345594525%	8	1169	290	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BASAKI_YBX1_TARGETS_UP
0.684345594525%	8	1169	289	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_MLL_TARGETS
0.684345594525%	8	1169	285	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
0.684345594525%	8	1169	281	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MULLIGHAN_MLL_SIGNATURE_2_DN
0.684345594525%	8	1169	280	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
0.684345594525%	8	1169	272	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
0.684345594525%	8	1169	271	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.684345594525%	8	1169	271	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
0.684345594525%	8	1169	254	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_4HR_DN
0.684345594525%	8	1169	246	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BILD_E2F3_ONCOGENIC_SIGNATURE
0.684345594525%	8	1169	245	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.684345594525%	8	1169	242	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WINTER_HYPOXIA_METAGENE
0.684345594525%	8	1169	242	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
0.684345594525%	8	1169	237	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.684345594525%	8	1169	232	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
0.684345594525%	8	1169	227	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
0.684345594525%	8	1169	217	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALLING_BY_NGF
0.684345594525%	8	1169	214	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZWANG_EGF_INTERVAL_DN
0.684345594525%	8	1169	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
0.684345594525%	8	1169	207	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_HIV_INFECTION
0.684345594525%	8	1169	206	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RAMALHO_STEMNESS_UP
0.684345594525%	8	1169	206	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LINSLEY_MIR16_TARGETS
0.684345594525%	8	1169	205	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHEPARD_BMYB_MORPHOLINO_UP
0.684345594525%	8	1169	203	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRUETZMANN_PANCREATIC_CANCER_DN
0.684345594525%	8	1169	200	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHEPARD_BMYB_MORPHOLINO_DN
0.684345594525%	8	1169	198	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ALONSO_METASTASIS_UP
0.684345594525%	8	1169	195	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_DNA_DAMAGE_DN
0.684345594525%	8	1169	193	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP
0.684345594525%	8	1169	193	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
0.684345594525%	8	1169	192	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DNA_REPLICATION
0.684345594525%	8	1169	191	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAGI_AML_FAB_MARKERS
0.684345594525%	8	1169	185	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.684345594525%	8	1169	182	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RAO_BOUND_BY_SALL4_ISOFORM_A
0.684345594525%	8	1169	181	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
0.684345594525%	8	1169	181	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JISON_SICKLE_CELL_DISEASE_DN
0.684345594525%	8	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GLUCURONIDATION
0.684345594525%	8	1169	178	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_18HR_UP
0.684345594525%	8	1169	178	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_18HR_DN
0.684345594525%	8	1169	176	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
0.684345594525%	8	1169	176	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
0.684345594525%	8	1169	169	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PENG_GLUCOSE_DEPRIVATION_DN
0.684345594525%	8	1169	169	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ALZHEIMERS_DISEASE
0.684345594525%	8	1169	169	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KATSANOU_ELAVL1_TARGETS_UP
0.684345594525%	8	1169	165	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWN_MYELOID_CELL_DEVELOPMENT_UP
0.684345594525%	8	1169	161	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
0.684345594525%	8	1169	160	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
0.684345594525%	8	1169	153	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
0.684345594525%	8	1169	152	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
0.684345594525%	8	1169	151	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_WNT_SIGNALING_PATHWAY
0.684345594525%	8	1169	150	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_30MIN_DN
0.684345594525%	8	1169	149	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OHGUCHI_LIVER_HNF4A_TARGETS_DN
0.684345594525%	8	1169	149	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LANDIS_ERBB2_BREAST_TUMORS_324_DN
0.684345594525%	8	1169	146	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
0.684345594525%	8	1169	144	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.684345594525%	8	1169	131	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.684345594525%	8	1169	123	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KAYO_AGING_MUSCLE_DN
0.684345594525%	8	1169	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_LYSOSOME
0.684345594525%	8	1169	120	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN
0.684345594525%	8	1169	118	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARKEY_RB1_CHRONIC_LOF_DN
0.684345594525%	8	1169	117	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.684345594525%	8	1169	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMIRNOV_RESPONSE_TO_IR_6HR_DN
0.684345594525%	8	1169	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MATZUK_SPERMATOZOA
0.684345594525%	8	1169	113	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
0.684345594525%	8	1169	109	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
0.684345594525%	8	1169	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
0.684345594525%	8	1169	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.684345594525%	8	1169	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN
0.684345594525%	8	1169	104	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
0.684345594525%	8	1169	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHICAS_RB1_TARGETS_LOW_SERUM
0.681818181818%	24	3520	330	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
0.681818181818%	24	3520	309	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
0.681818181818%	24	3520	305	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
0.681818181818%	24	3520	281	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MULLIGHAN_MLL_SIGNATURE_2_DN
0.681818181818%	24	3520	275	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.681818181818%	24	3520	270	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
0.681818181818%	24	3520	268	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_GH1_AUTOCRINE_TARGETS_UP
0.681818181818%	24	3520	262	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LU_AGING_BRAIN_UP
0.681818181818%	24	3520	254	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_4HR_DN
0.681818181818%	24	3520	246	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BILD_E2F3_ONCOGENIC_SIGNATURE
0.681818181818%	24	3520	245	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PENG_RAPAMYCIN_RESPONSE_DN
0.681818181818%	24	3520	239	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ALFANO_MYC_TARGETS
0.681818181818%	24	3520	209	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_UP
0.681818181818%	24	3520	207	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MANALO_HYPOXIA_UP
0.681818181818%	24	3520	195	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_DN
0.681818181818%	24	3520	175	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAMAZAKI_TCEB3_TARGETS_UP
0.681818181818%	24	3520	146	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
0.681818181818%	24	3520	139	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_BIOLOGICAL_OXIDATIONS
0.67264573991%	3	446	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
0.67264573991%	3	446	97	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KONG_E2F3_TARGETS
0.67264573991%	3	446	95	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
0.67264573991%	3	446	95	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HECKER_IFNB1_TARGETS
0.67264573991%	3	446	95	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
0.67264573991%	3	446	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
0.67264573991%	3	446	91	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
0.67264573991%	3	446	90	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SASSON_RESPONSE_TO_FORSKOLIN_UP
0.67264573991%	3	446	90	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IVANOVSKA_MIR106B_TARGETS
0.67264573991%	3	446	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
0.67264573991%	3	446	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_PROSTATE_CANCER
0.67264573991%	3	446	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BHATTACHARYA_EMBRYONIC_STEM_CELL
0.67264573991%	3	446	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_AGING_CEREBELLUM_DN
0.67264573991%	3	446	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SANA_RESPONSE_TO_IFNG_DN
0.67264573991%	3	446	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
0.67264573991%	3	446	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SANA_TNF_SIGNALING_UP
0.67264573991%	3	446	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
0.67264573991%	3	446	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEIN_MIDBRAIN_MARKERS
0.67264573991%	3	446	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CROMER_METASTASIS_UP
0.67264573991%	3	446	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
0.67264573991%	3	446	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SANA_RESPONSE_TO_IFNG_UP
0.67264573991%	3	446	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE
0.67264573991%	3	446	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
0.67264573991%	3	446	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_AVB3_INTEGRIN_PATHWAY
0.67264573991%	3	446	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_ADHERENS_JUNCTION
0.67264573991%	3	446	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CORRE_MULTIPLE_MYELOMA_UP
0.67264573991%	3	446	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_METABOLISM_OF_NUCLEOTIDES
0.67264573991%	3	446	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
0.67264573991%	3	446	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_PPAR_SIGNALING_PATHWAY
0.67264573991%	3	446	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_INTERFERON_RESPONSIVE_GENES
0.67264573991%	3	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_LYSOPHOSPHOLIPID_PATHWAY
0.67264573991%	3	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_LIVER_CANCER_CIPROFIBRATE_DN
0.67264573991%	3	446	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_LIVER_CANCER_MYC_TGFA_DN
0.67264573991%	3	446	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_GLIOMA
0.67264573991%	3	446	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHANG_GATA6_TARGETS_DN
0.67264573991%	3	446	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
0.67264573991%	3	446	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
0.67264573991%	3	446	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BILBAN_B_CLL_LPL_UP
0.67264573991%	3	446	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_TRKRPATHWAY
0.67264573991%	3	446	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AMIT_EGF_RESPONSE_240_HELA
0.67264573991%	3	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_SHP2_PATHWAY
0.67264573991%	3	446	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.67264573991%	3	446	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP
0.67264573991%	3	446	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE
0.67264573991%	3	446	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIANG_SILENCED_BY_METHYLATION_2
0.67264573991%	3	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_STARCH_AND_SUCROSE_METABOLISM
0.67264573991%	3	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN
0.67264573991%	3	446	516	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF
0.67264573991%	3	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHANG_PROLIFERATING_VS_QUIESCENT
0.67264573991%	3	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT
0.67264573991%	3	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
0.67264573991%	3	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARTINEZ_RESPONSE_TO_TRABECTEDIN
0.67264573991%	3	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DAUER_STAT3_TARGETS_DN
0.67264573991%	3	446	491	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHENG_BOUND_BY_FOXP3
0.67264573991%	3	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
0.67264573991%	3	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GERHOLD_ADIPOGENESIS_UP
0.67264573991%	3	446	487	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RODWELL_AGING_KIDNEY_UP
0.67264573991%	3	446	485	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.67264573991%	3	446	479	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
0.67264573991%	3	446	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHU_CMV_8_HR_UP
0.67264573991%	3	446	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MELLMAN_TUT1_TARGETS_DN
0.67264573991%	3	446	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOYLAN_MULTIPLE_MYELOMA_C_UP
0.67264573991%	3	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
0.67264573991%	3	446	448	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
0.67264573991%	3	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KERLEY_RESPONSE_TO_CISPLATIN_UP
0.67264573991%	3	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM
0.67264573991%	3	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FARMER_BREAST_CANCER_CLUSTER_1
0.67264573991%	3	446	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
0.67264573991%	3	446	423	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	THUM_SYSTOLIC_HEART_FAILURE_UP
0.67264573991%	3	446	419	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.67264573991%	3	446	418	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PEDRIOLI_MIR31_TARGETS_DN
0.67264573991%	3	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_TRYPTOPHAN_METABOLISM
0.67264573991%	3	446	398	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
0.67264573991%	3	446	392	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.67264573991%	3	446	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_RET_PATHWAY
0.67264573991%	3	446	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MA_MYELOID_DIFFERENTIATION_UP
0.67264573991%	3	446	384	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BASAKI_YBX1_TARGETS_DN
0.67264573991%	3	446	382	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.67264573991%	3	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KRASNOSELSKAYA_ILF3_TARGETS_UP
0.67264573991%	3	446	373	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
0.67264573991%	3	446	372	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_LMO4_TARGETS_UP
0.67264573991%	3	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ROLEF_GLIS3_TARGETS
0.67264573991%	3	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2
0.67264573991%	3	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MATZUK_SPERMATID_DIFFERENTIATION
0.67264573991%	3	446	367	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DELACROIX_RARG_BOUND_MEF
0.67264573991%	3	446	362	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
0.67264573991%	3	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP
0.67264573991%	3	446	353	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
0.67264573991%	3	446	346	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GOLDRATH_ANTIGEN_RESPONSE
0.67264573991%	3	446	344	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RICKMAN_METASTASIS_UP
0.67264573991%	3	446	342	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BLUM_RESPONSE_TO_SALIRASIB_DN
0.67264573991%	3	446	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM
0.67264573991%	3	446	330	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_METABOLISM_OF_RNA
0.67264573991%	3	446	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_NCADHERINPATHWAY
0.67264573991%	3	446	326	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL
0.67264573991%	3	446	325	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CELL_CYCLE_MITOTIC
0.67264573991%	3	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_DAG_AND_IP3_SIGNALING
0.67264573991%	3	446	312	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GENTILE_UV_HIGH_DOSE_DN
0.67264573991%	3	446	308	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
0.67264573991%	3	446	307	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
0.67264573991%	3	446	306	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HORIUCHI_WTAP_TARGETS_UP
0.67264573991%	3	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_IGF1_PATHWAY
0.67264573991%	3	446	298	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_14HR_DN
0.67264573991%	3	446	285	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
0.67264573991%	3	446	283	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
0.67264573991%	3	446	280	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_SMARCE1_TARGETS_UP
0.67264573991%	3	446	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP
0.67264573991%	3	446	277	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHANG_TLX_TARGETS_60HR_DN
0.67264573991%	3	446	270	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RIZKI_TUMOR_INVASIVENESS_3D_DN
0.67264573991%	3	446	267	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CAIRO_HEPATOBLASTOMA_DN
0.67264573991%	3	446	264	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
0.67264573991%	3	446	264	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
0.67264573991%	3	446	262	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LU_AGING_BRAIN_UP
0.67264573991%	3	446	261	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
0.67264573991%	3	446	261	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BILD_HRAS_ONCOGENIC_SIGNATURE
0.67264573991%	3	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_GALACTOSE_METABOLISM
0.67264573991%	3	446	259	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	QI_PLASMACYTOMA_UP
0.67264573991%	3	446	254	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_4HR_DN
0.67264573991%	3	446	246	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
0.67264573991%	3	446	245	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KONDO_EZH2_TARGETS
0.67264573991%	3	446	245	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BLUM_RESPONSE_TO_SALIRASIB_UP
0.67264573991%	3	446	244	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	THUM_SYSTOLIC_HEART_FAILURE_DN
0.67264573991%	3	446	244	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HSIAO_LIVER_SPECIFIC_GENES
0.67264573991%	3	446	244	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DAZARD_RESPONSE_TO_UV_NHEK_UP
0.67264573991%	3	446	243	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHICAS_RB1_TARGETS_GROWING
0.67264573991%	3	446	240	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VANTVEER_BREAST_CANCER_ESR1_DN
0.67264573991%	3	446	238	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.67264573991%	3	446	234	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
0.67264573991%	3	446	233	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.67264573991%	3	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHANG_INTERFERON_RESPONSE
0.67264573991%	3	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.67264573991%	3	446	229	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
0.67264573991%	3	446	227	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RAO_BOUND_BY_SALL4
0.67264573991%	3	446	227	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_RECENT_THYMIC_EMIGRANT
0.67264573991%	3	446	223	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHEN_HOXA5_TARGETS_9HR_UP
0.67264573991%	3	446	222	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
0.67264573991%	3	446	221	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHANDRAN_METASTASIS_UP
0.67264573991%	3	446	214	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TIEN_INTESTINE_PROBIOTICS_24HR_DN
0.67264573991%	3	446	214	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIDUS_METASTASIS_UP
0.67264573991%	3	446	212	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHANG_CORE_SERUM_RESPONSE_UP
0.67264573991%	3	446	211	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
0.67264573991%	3	446	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VERHAAK_GLIOBLASTOMA_PRONEURAL
0.67264573991%	3	446	209	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHANG_CORE_SERUM_RESPONSE_DN
0.67264573991%	3	446	207	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MANALO_HYPOXIA_UP
0.67264573991%	3	446	207	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.67264573991%	3	446	206	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.67264573991%	3	446	205	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.67264573991%	3	446	205	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PEREZ_TP53_AND_TP63_TARGETS
0.67264573991%	3	446	204	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
0.67264573991%	3	446	201	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOLLMANN_APOPTOSIS_VIA_CD40_UP
0.67264573991%	3	446	199	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
0.67264573991%	3	446	195	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KYNG_DNA_DAMAGE_DN
0.67264573991%	3	446	194	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.67264573991%	3	446	192	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_DNA_REPLICATION
0.67264573991%	3	446	188	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
0.67264573991%	3	446	187	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BAKKER_FOXO3_TARGETS_DN
0.67264573991%	3	446	186	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_CLIM2_TARGETS_DN
0.67264573991%	3	446	184	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WU_CELL_MIGRATION
0.67264573991%	3	446	183	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.67264573991%	3	446	182	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RAO_BOUND_BY_SALL4_ISOFORM_A
0.67264573991%	3	446	181	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
0.67264573991%	3	446	181	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JISON_SICKLE_CELL_DISEASE_UP
0.67264573991%	3	446	181	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
0.67264573991%	3	446	181	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
0.67264573991%	3	446	180	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
0.67264573991%	3	446	180	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DARWICHE_PAPILLOMA_RISK_HIGH_DN
0.67264573991%	3	446	179	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
0.67264573991%	3	446	178	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LI_AMPLIFIED_IN_LUNG_CANCER
0.67264573991%	3	446	177	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.67264573991%	3	446	175	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.67264573991%	3	446	175	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_LIVER_CANCER_SURVIVAL_DN
0.67264573991%	3	446	172	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
0.67264573991%	3	446	172	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
0.67264573991%	3	446	171	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GOLDRATH_HOMEOSTATIC_PROLIFERATION
0.67264573991%	3	446	171	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
0.67264573991%	3	446	170	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
0.67264573991%	3	446	169	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
0.67264573991%	3	446	165	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DARWICHE_PAPILLOMA_RISK_LOW_DN
0.67264573991%	3	446	164	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_WT1_TARGETS_8HR_UP
0.67264573991%	3	446	160	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
0.67264573991%	3	446	159	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
0.67264573991%	3	446	157	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SERVITJA_LIVER_HNF1A_TARGETS_DN
0.67264573991%	3	446	156	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_14HR_UP
0.67264573991%	3	446	151	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_WNT_SIGNALING_PATHWAY
0.67264573991%	3	446	151	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
0.67264573991%	3	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_NUCLEARRS_PATHWAY
0.67264573991%	3	446	149	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HUANG_GATA2_TARGETS_UP
0.67264573991%	3	446	148	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_APOPTOSIS
0.67264573991%	3	446	148	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_24HR_DN
0.67264573991%	3	446	146	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ELVIDGE_HYPOXIA_DN
0.67264573991%	3	446	144	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.67264573991%	3	446	143	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION
0.67264573991%	3	446	143	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BASSO_B_LYMPHOCYTE_NETWORK
0.67264573991%	3	446	142	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PENG_LEUCINE_DEPRIVATION_UP
0.67264573991%	3	446	142	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_ES_LCP_WITH_H3K4ME3
0.67264573991%	3	446	141	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SABATES_COLORECTAL_ADENOMA_UP
0.67264573991%	3	446	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TOMLINS_METASTASIS_UP
0.67264573991%	3	446	138	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
0.67264573991%	3	446	138	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JIANG_VHL_TARGETS
0.67264573991%	3	446	138	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
0.67264573991%	3	446	134	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
0.67264573991%	3	446	133	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_DIABETES_PATHWAYS
0.67264573991%	3	446	127	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
0.67264573991%	3	446	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
0.67264573991%	3	446	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.67264573991%	3	446	125	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_HIV_LIFE_CYCLE
0.67264573991%	3	446	123	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOOI_ST7_TARGETS_DN
0.67264573991%	3	446	122	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TOOKER_GEMCITABINE_RESISTANCE_DN
0.67264573991%	3	446	120	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHU_CMV_ALL_UP
0.67264573991%	3	446	120	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	XU_GH1_EXOGENOUS_TARGETS_DN
0.67264573991%	3	446	120	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHEBOTAEV_GR_TARGETS_DN
0.67264573991%	3	446	118	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARKEY_RB1_CHRONIC_LOF_DN
0.67264573991%	3	446	114	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_OOCYTE_MEIOSIS
0.67264573991%	3	446	113	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALING_BY_RHO_GTPASES
0.67264573991%	3	446	113	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
0.67264573991%	3	446	112	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALING_BY_FGFR
0.67264573991%	3	446	112	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DITTMER_PTHLH_TARGETS_UP
0.67264573991%	3	446	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHOU_PANCREATIC_EXOCRINE_PROGENITOR
0.67264573991%	3	446	109	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SERVITJA_ISLET_HNF1A_TARGETS_DN
0.67264573991%	3	446	109	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
0.67264573991%	3	446	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHANG_TLX_TARGETS_DN
0.67264573991%	3	446	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LE_EGR2_TARGETS_DN
0.67264573991%	3	446	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN
0.67264573991%	3	446	107	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.67264573991%	3	446	102	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_MELANOGENESIS
0.67264573991%	3	446	102	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DER_IFN_BETA_RESPONSE_UP
0.67264573991%	3	446	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALING_BY_ERBB2
0.67264573991%	3	446	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BURTON_ADIPOGENESIS_3
0.67264573991%	3	446	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_10HR_UP
0.67264573991%	3	446	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
0.67264573991%	3	446	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHICAS_RB1_TARGETS_LOW_SERUM
0.659340659341%	3	455	98	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
0.659340659341%	3	455	98	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_PYRIMIDINE_METABOLISM
0.659340659341%	3	455	97	T2D_GENES_TANYA_BLOODPRESSURE	LABBE_WNT3A_TARGETS_DN
0.659340659341%	3	455	96	T2D_GENES_TANYA_BLOODPRESSURE	LIU_PROSTATE_CANCER_UP
0.659340659341%	3	455	95	T2D_GENES_TANYA_BLOODPRESSURE	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
0.659340659341%	3	455	94	T2D_GENES_TANYA_BLOODPRESSURE	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.659340659341%	3	455	94	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES
0.659340659341%	3	455	94	T2D_GENES_TANYA_BLOODPRESSURE	HOOI_ST7_TARGETS_UP
0.659340659341%	3	455	93	T2D_GENES_TANYA_BLOODPRESSURE	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
0.659340659341%	3	455	93	T2D_GENES_TANYA_BLOODPRESSURE	CADWELL_ATG16L1_TARGETS_UP
0.659340659341%	3	455	92	T2D_GENES_TANYA_BLOODPRESSURE	WINTER_HYPOXIA_UP
0.659340659341%	3	455	92	T2D_GENES_TANYA_BLOODPRESSURE	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
0.659340659341%	3	455	91	T2D_GENES_TANYA_BLOODPRESSURE	ZHU_CMV_24_HR_DN
0.659340659341%	3	455	91	T2D_GENES_TANYA_BLOODPRESSURE	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
0.659340659341%	3	455	91	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION
0.659340659341%	3	455	91	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
0.659340659341%	3	455	91	T2D_GENES_TANYA_BLOODPRESSURE	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
0.659340659341%	3	455	90	T2D_GENES_TANYA_BLOODPRESSURE	SASSON_RESPONSE_TO_FORSKOLIN_UP
0.659340659341%	3	455	90	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_ERBB4
0.659340659341%	3	455	90	T2D_GENES_TANYA_BLOODPRESSURE	MORI_IMMATURE_B_LYMPHOCYTE_DN
0.659340659341%	3	455	90	T2D_GENES_TANYA_BLOODPRESSURE	IGARASHI_ATF4_TARGETS_DN
0.659340659341%	3	455	90	T2D_GENES_TANYA_BLOODPRESSURE	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN
0.659340659341%	3	455	89	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
0.659340659341%	3	455	89	T2D_GENES_TANYA_BLOODPRESSURE	WNT_SIGNALING
0.659340659341%	3	455	89	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
0.659340659341%	3	455	89	T2D_GENES_TANYA_BLOODPRESSURE	LI_DCP2_BOUND_MRNA
0.659340659341%	3	455	89	T2D_GENES_TANYA_BLOODPRESSURE	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.659340659341%	3	455	89	T2D_GENES_TANYA_BLOODPRESSURE	LEE_AGING_NEOCORTEX_UP
0.659340659341%	3	455	89	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_PROSTATE_CANCER
0.659340659341%	3	455	89	T2D_GENES_TANYA_BLOODPRESSURE	DELASERNA_MYOD_TARGETS_UP
0.659340659341%	3	455	88	T2D_GENES_TANYA_BLOODPRESSURE	WALLACE_PROSTATE_CANCER_RACE_DN
0.659340659341%	3	455	88	T2D_GENES_TANYA_BLOODPRESSURE	UEDA_CENTRAL_CLOCK
0.659340659341%	3	455	88	T2D_GENES_TANYA_BLOODPRESSURE	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
0.659340659341%	3	455	88	T2D_GENES_TANYA_BLOODPRESSURE	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
0.659340659341%	3	455	88	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_RIBOSOME
0.659340659341%	3	455	88	T2D_GENES_TANYA_BLOODPRESSURE	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.659340659341%	3	455	87	T2D_GENES_TANYA_BLOODPRESSURE	SAFFORD_T_LYMPHOCYTE_ANERGY
0.659340659341%	3	455	87	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION
0.659340659341%	3	455	87	T2D_GENES_TANYA_BLOODPRESSURE	MOOTHA_VOXPHOS
0.659340659341%	3	455	87	T2D_GENES_TANYA_BLOODPRESSURE	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
0.659340659341%	3	455	87	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_MAPK_PATHWAY
0.659340659341%	3	455	86	T2D_GENES_TANYA_BLOODPRESSURE	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
0.659340659341%	3	455	86	T2D_GENES_TANYA_BLOODPRESSURE	GHANDHI_BYSTANDER_IRRADIATION_UP
0.659340659341%	3	455	86	T2D_GENES_TANYA_BLOODPRESSURE	BAELDE_DIABETIC_NEPHROPATHY_UP
0.659340659341%	3	455	85	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
0.659340659341%	3	455	85	T2D_GENES_TANYA_BLOODPRESSURE	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
0.659340659341%	3	455	84	T2D_GENES_TANYA_BLOODPRESSURE	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
0.659340659341%	3	455	84	T2D_GENES_TANYA_BLOODPRESSURE	LEE_AGING_CEREBELLUM_UP
0.659340659341%	3	455	84	T2D_GENES_TANYA_BLOODPRESSURE	KIM_GLIS2_TARGETS_UP
0.659340659341%	3	455	84	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_ECM_RECEPTOR_INTERACTION
0.659340659341%	3	455	84	T2D_GENES_TANYA_BLOODPRESSURE	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
0.659340659341%	3	455	83	T2D_GENES_TANYA_BLOODPRESSURE	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
0.659340659341%	3	455	83	T2D_GENES_TANYA_BLOODPRESSURE	JIANG_HYPOXIA_CANCER
0.659340659341%	3	455	82	T2D_GENES_TANYA_BLOODPRESSURE	WONG_ENDMETRIUM_CANCER_DN
0.659340659341%	3	455	82	T2D_GENES_TANYA_BLOODPRESSURE	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
0.659340659341%	3	455	82	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS
0.659340659341%	3	455	82	T2D_GENES_TANYA_BLOODPRESSURE	ODONNELL_METASTASIS_UP
0.659340659341%	3	455	81	T2D_GENES_TANYA_BLOODPRESSURE	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
0.659340659341%	3	455	81	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MITOTIC_G2_G2_M_PHASES
0.659340659341%	3	455	81	T2D_GENES_TANYA_BLOODPRESSURE	MAHAJAN_RESPONSE_TO_IL1A_UP
0.659340659341%	3	455	81	T2D_GENES_TANYA_BLOODPRESSURE	HUANG_DASATINIB_RESISTANCE_UP
0.659340659341%	3	455	81	T2D_GENES_TANYA_BLOODPRESSURE	HARRIS_HYPOXIA
0.659340659341%	3	455	80	T2D_GENES_TANYA_BLOODPRESSURE	MORI_PRE_BI_LYMPHOCYTE_UP
0.659340659341%	3	455	80	T2D_GENES_TANYA_BLOODPRESSURE	LINDVALL_IMMORTALIZED_BY_TERT_DN
0.659340659341%	3	455	80	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_CARDIAC_MUSCLE_CONTRACTION
0.659340659341%	3	455	80	T2D_GENES_TANYA_BLOODPRESSURE	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.659340659341%	3	455	79	T2D_GENES_TANYA_BLOODPRESSURE	MCCLUNG_COCAINE_REWARD_5D
0.659340659341%	3	455	78	T2D_GENES_TANYA_BLOODPRESSURE	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.659340659341%	3	455	78	T2D_GENES_TANYA_BLOODPRESSURE	RADMACHER_AML_PROGNOSIS
0.659340659341%	3	455	78	T2D_GENES_TANYA_BLOODPRESSURE	COATES_MACROPHAGE_M1_VS_M2_DN
0.659340659341%	3	455	78	T2D_GENES_TANYA_BLOODPRESSURE	BOYLAN_MULTIPLE_MYELOMA_D_DN
0.659340659341%	3	455	77	T2D_GENES_TANYA_BLOODPRESSURE	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.659340659341%	3	455	77	T2D_GENES_TANYA_BLOODPRESSURE	SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.659340659341%	3	455	77	T2D_GENES_TANYA_BLOODPRESSURE	MORI_PRE_BI_LYMPHOCYTE_DN
0.659340659341%	3	455	77	T2D_GENES_TANYA_BLOODPRESSURE	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.659340659341%	3	455	77	T2D_GENES_TANYA_BLOODPRESSURE	CHEBOTAEV_GR_TARGETS_UP
0.659340659341%	3	455	76	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION
0.659340659341%	3	455	76	T2D_GENES_TANYA_BLOODPRESSURE	PEART_HDAC_PROLIFERATION_CLUSTER_DN
0.659340659341%	3	455	75	T2D_GENES_TANYA_BLOODPRESSURE	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
0.659340659341%	3	455	75	T2D_GENES_TANYA_BLOODPRESSURE	MORI_MATURE_B_LYMPHOCYTE_DN
0.659340659341%	3	455	75	T2D_GENES_TANYA_BLOODPRESSURE	JAIN_NFKB_SIGNALING
0.659340659341%	3	455	75	T2D_GENES_TANYA_BLOODPRESSURE	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
0.659340659341%	3	455	75	T2D_GENES_TANYA_BLOODPRESSURE	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
0.659340659341%	3	455	74	T2D_GENES_TANYA_BLOODPRESSURE	VANASSE_BCL2_TARGETS_DN
0.659340659341%	3	455	74	T2D_GENES_TANYA_BLOODPRESSURE	SHEPARD_BMYB_TARGETS
0.659340659341%	3	455	74	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS
0.659340659341%	3	455	73	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
0.659340659341%	3	455	73	T2D_GENES_TANYA_BLOODPRESSURE	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
0.659340659341%	3	455	72	T2D_GENES_TANYA_BLOODPRESSURE	HUANG_GATA2_TARGETS_DN
0.659340659341%	3	455	71	T2D_GENES_TANYA_BLOODPRESSURE	KUMAR_AUTOPHAGY_NETWORK
0.659340659341%	3	455	71	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_MELANOMA
0.659340659341%	3	455	70	T2D_GENES_TANYA_BLOODPRESSURE	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
0.659340659341%	3	455	70	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_NOTCH1
0.659340659341%	3	455	70	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PHASE_II_CONJUGATION
0.659340659341%	3	455	70	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_LONG_TERM_DEPRESSION
0.659340659341%	3	455	70	T2D_GENES_TANYA_BLOODPRESSURE	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
0.659340659341%	3	455	69	T2D_GENES_TANYA_BLOODPRESSURE	PID_VEGFR1_2_PATHWAY
0.659340659341%	3	455	69	T2D_GENES_TANYA_BLOODPRESSURE	PID_P75NTRPATHWAY
0.659340659341%	3	455	68	T2D_GENES_TANYA_BLOODPRESSURE	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.659340659341%	3	455	68	T2D_GENES_TANYA_BLOODPRESSURE	LIN_NPAS4_TARGETS_DN
0.659340659341%	3	455	68	T2D_GENES_TANYA_BLOODPRESSURE	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES
0.659340659341%	3	455	67	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
0.659340659341%	3	455	66	T2D_GENES_TANYA_BLOODPRESSURE	PID_TCR_PATHWAY
0.659340659341%	3	455	66	T2D_GENES_TANYA_BLOODPRESSURE	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN
0.659340659341%	3	455	66	T2D_GENES_TANYA_BLOODPRESSURE	BRUNO_HEMATOPOIESIS
0.659340659341%	3	455	65	T2D_GENES_TANYA_BLOODPRESSURE	PID_IL4_2PATHWAY
0.659340659341%	3	455	65	T2D_GENES_TANYA_BLOODPRESSURE	GOLDRATH_IMMUNE_MEMORY
0.659340659341%	3	455	64	T2D_GENES_TANYA_BLOODPRESSURE	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
0.659340659341%	3	455	64	T2D_GENES_TANYA_BLOODPRESSURE	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
0.659340659341%	3	455	63	T2D_GENES_TANYA_BLOODPRESSURE	PID_IL12_2PATHWAY
0.659340659341%	3	455	63	T2D_GENES_TANYA_BLOODPRESSURE	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
0.659340659341%	3	455	63	T2D_GENES_TANYA_BLOODPRESSURE	BURTON_ADIPOGENESIS_PEAK_AT_0HR
0.659340659341%	3	455	62	T2D_GENES_TANYA_BLOODPRESSURE	MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN
0.659340659341%	3	455	61	T2D_GENES_TANYA_BLOODPRESSURE	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.659340659341%	3	455	61	T2D_GENES_TANYA_BLOODPRESSURE	REN_BOUND_BY_E2F
0.659340659341%	3	455	61	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS
0.659340659341%	3	455	61	T2D_GENES_TANYA_BLOODPRESSURE	NADLER_OBESITY_UP
0.659340659341%	3	455	61	T2D_GENES_TANYA_BLOODPRESSURE	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
0.659340659341%	3	455	60	T2D_GENES_TANYA_BLOODPRESSURE	WIERENGA_STAT5A_TARGETS_GROUP2
0.659340659341%	3	455	60	T2D_GENES_TANYA_BLOODPRESSURE	SONG_TARGETS_OF_IE86_CMV_PROTEIN
0.659340659341%	3	455	60	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING
0.659340659341%	3	455	59	T2D_GENES_TANYA_BLOODPRESSURE	DASU_IL6_SIGNALING_UP
0.659340659341%	3	455	59	T2D_GENES_TANYA_BLOODPRESSURE	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
0.659340659341%	3	455	58	T2D_GENES_TANYA_BLOODPRESSURE	KOHOUTEK_CCNT2_TARGETS
0.659340659341%	3	455	57	T2D_GENES_TANYA_BLOODPRESSURE	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
0.659340659341%	3	455	57	T2D_GENES_TANYA_BLOODPRESSURE	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.659340659341%	3	455	57	T2D_GENES_TANYA_BLOODPRESSURE	DIRMEIER_LMP1_RESPONSE_LATE_UP
0.659340659341%	3	455	55	T2D_GENES_TANYA_BLOODPRESSURE	YU_MYC_TARGETS_DN
0.659340659341%	3	455	53	T2D_GENES_TANYA_BLOODPRESSURE	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP
0.659340659341%	3	455	53	T2D_GENES_TANYA_BLOODPRESSURE	KRIEG_HYPOXIA_VIA_KDM3A
0.659340659341%	3	455	53	T2D_GENES_TANYA_BLOODPRESSURE	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN
0.659340659341%	3	455	52	T2D_GENES_TANYA_BLOODPRESSURE	PRAMOONJAGO_SOX4_TARGETS_UP
0.659340659341%	3	455	52	T2D_GENES_TANYA_BLOODPRESSURE	PID_PTP1BPATHWAY
0.659340659341%	3	455	52	T2D_GENES_TANYA_BLOODPRESSURE	PID_CASPASE_PATHWAY
0.659340659341%	3	455	51	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
0.659340659341%	3	455	51	T2D_GENES_TANYA_BLOODPRESSURE	ZHANG_PROLIFERATING_VS_QUIESCENT
0.659340659341%	3	455	51	T2D_GENES_TANYA_BLOODPRESSURE	TSUNODA_CISPLATIN_RESISTANCE_DN
0.659340659341%	3	455	51	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT
0.659340659341%	3	455	51	T2D_GENES_TANYA_BLOODPRESSURE	LUI_THYROID_CANCER_CLUSTER_1
0.659340659341%	3	455	51	T2D_GENES_TANYA_BLOODPRESSURE	BYSTROEM_CORRELATED_WITH_IL5_UP
0.659340659341%	3	455	51	T2D_GENES_TANYA_BLOODPRESSURE	APPIERTO_RESPONSE_TO_FENRETINIDE_DN
0.659340659341%	3	455	50	T2D_GENES_TANYA_BLOODPRESSURE	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.659340659341%	3	455	50	T2D_GENES_TANYA_BLOODPRESSURE	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS
0.659340659341%	3	455	49	T2D_GENES_TANYA_BLOODPRESSURE	MANTOVANI_VIRAL_GPCR_SIGNALING_DN
0.659340659341%	3	455	49	T2D_GENES_TANYA_BLOODPRESSURE	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP
0.659340659341%	3	455	47	T2D_GENES_TANYA_BLOODPRESSURE	PID_FANCONI_PATHWAY
0.659340659341%	3	455	47	T2D_GENES_TANYA_BLOODPRESSURE	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.659340659341%	3	455	46	T2D_GENES_TANYA_BLOODPRESSURE	NUTT_GBM_VS_AO_GLIOMA_UP
0.659340659341%	3	455	46	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_KERATINOCYTE_PATHWAY
0.659340659341%	3	455	46	T2D_GENES_TANYA_BLOODPRESSURE	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN
0.659340659341%	3	455	45	T2D_GENES_TANYA_BLOODPRESSURE	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN
0.659340659341%	3	455	44	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS
0.659340659341%	3	455	44	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
0.659340659341%	3	455	44	T2D_GENES_TANYA_BLOODPRESSURE	LUI_THYROID_CANCER_PAX8_PPARG_UP
0.659340659341%	3	455	44	T2D_GENES_TANYA_BLOODPRESSURE	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS
0.659340659341%	3	455	44	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_TYPE_I_DIABETES_MELLITUS
0.659340659341%	3	455	44	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_LYSINE_DEGRADATION
0.659340659341%	3	455	43	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1
0.659340659341%	3	455	424	T2D_GENES_TANYA_BLOODPRESSURE	SHEN_SMARCA2_TARGETS_UP
0.659340659341%	3	455	42	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
0.659340659341%	3	455	42	T2D_GENES_TANYA_BLOODPRESSURE	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP
0.659340659341%	3	455	41	T2D_GENES_TANYA_BLOODPRESSURE	DELPUECH_FOXO3_TARGETS_DN
0.659340659341%	3	455	40	T2D_GENES_TANYA_BLOODPRESSURE	VARELA_ZMPSTE24_TARGETS_UP
0.659340659341%	3	455	40	T2D_GENES_TANYA_BLOODPRESSURE	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN
0.659340659341%	3	455	40	T2D_GENES_TANYA_BLOODPRESSURE	BENPORATH_ES_2
0.659340659341%	3	455	390	T2D_GENES_TANYA_BLOODPRESSURE	HATADA_METHYLATED_IN_LUNG_CANCER_UP
0.659340659341%	3	455	39	T2D_GENES_TANYA_BLOODPRESSURE	POTTI_PACLITAXEL_SENSITIVITY
0.659340659341%	3	455	39	T2D_GENES_TANYA_BLOODPRESSURE	GENTILE_UV_RESPONSE_CLUSTER_D5
0.659340659341%	3	455	39	T2D_GENES_TANYA_BLOODPRESSURE	BILANGES_SERUM_SENSITIVE_VIA_TSC2
0.659340659341%	3	455	38	T2D_GENES_TANYA_BLOODPRESSURE	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
0.659340659341%	3	455	38	T2D_GENES_TANYA_BLOODPRESSURE	KRASNOSELSKAYA_ILF3_TARGETS_UP
0.659340659341%	3	455	38	T2D_GENES_TANYA_BLOODPRESSURE	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN
0.659340659341%	3	455	37	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_ALK_PATHWAY
0.659340659341%	3	455	37	T2D_GENES_TANYA_BLOODPRESSURE	BILANGES_SERUM_RESPONSE_TRANSLATION
0.659340659341%	3	455	36	T2D_GENES_TANYA_BLOODPRESSURE	YIH_RESPONSE_TO_ARSENITE_C3
0.659340659341%	3	455	36	T2D_GENES_TANYA_BLOODPRESSURE	ST_ADRENERGIC
0.659340659341%	3	455	36	T2D_GENES_TANYA_BLOODPRESSURE	LIU_CDX2_TARGETS_UP
0.659340659341%	3	455	351	T2D_GENES_TANYA_BLOODPRESSURE	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.659340659341%	3	455	35	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D
0.659340659341%	3	455	35	T2D_GENES_TANYA_BLOODPRESSURE	LI_CISPLATIN_RESISTANCE_DN
0.659340659341%	3	455	35	T2D_GENES_TANYA_BLOODPRESSURE	HU_GENOTOXIC_DAMAGE_4HR
0.659340659341%	3	455	34	T2D_GENES_TANYA_BLOODPRESSURE	PID_EPOPATHWAY
0.659340659341%	3	455	34	T2D_GENES_TANYA_BLOODPRESSURE	PETRETTO_CARDIAC_HYPERTROPHY
0.659340659341%	3	455	34	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_MPR_PATHWAY
0.659340659341%	3	455	33	T2D_GENES_TANYA_BLOODPRESSURE	SCHRAETS_MLL_TARGETS_DN
0.659340659341%	3	455	33	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS
0.659340659341%	3	455	33	T2D_GENES_TANYA_BLOODPRESSURE	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP
0.659340659341%	3	455	33	T2D_GENES_TANYA_BLOODPRESSURE	DORN_ADENOVIRUS_INFECTION_12HR_DN
0.659340659341%	3	455	33	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_IL1R_PATHWAY
0.659340659341%	3	455	33	T2D_GENES_TANYA_BLOODPRESSURE	APPEL_IMATINIB_RESPONSE
0.659340659341%	3	455	316	T2D_GENES_TANYA_BLOODPRESSURE	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
0.659340659341%	3	455	311	T2D_GENES_TANYA_BLOODPRESSURE	JIANG_HYPOXIA_NORMAL
0.659340659341%	3	455	31	T2D_GENES_TANYA_BLOODPRESSURE	THEODOROU_MAMMARY_TUMORIGENESIS
0.659340659341%	3	455	31	T2D_GENES_TANYA_BLOODPRESSURE	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP
0.659340659341%	3	455	31	T2D_GENES_TANYA_BLOODPRESSURE	PID_AVB3_OPN_PATHWAY
0.659340659341%	3	455	305	T2D_GENES_TANYA_BLOODPRESSURE	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
0.659340659341%	3	455	30	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
0.659340659341%	3	455	30	T2D_GENES_TANYA_BLOODPRESSURE	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN
0.659340659341%	3	455	294	T2D_GENES_TANYA_BLOODPRESSURE	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
0.659340659341%	3	455	290	T2D_GENES_TANYA_BLOODPRESSURE	BASAKI_YBX1_TARGETS_UP
0.659340659341%	3	455	29	T2D_GENES_TANYA_BLOODPRESSURE	YU_BAP1_TARGETS
0.659340659341%	3	455	29	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_STEROID_HORMONES
0.659340659341%	3	455	29	T2D_GENES_TANYA_BLOODPRESSURE	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
0.659340659341%	3	455	29	T2D_GENES_TANYA_BLOODPRESSURE	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP
0.659340659341%	3	455	281	T2D_GENES_TANYA_BLOODPRESSURE	MULLIGHAN_MLL_SIGNATURE_2_DN
0.659340659341%	3	455	281	T2D_GENES_TANYA_BLOODPRESSURE	BHAT_ESR1_TARGETS_VIA_AKT1_UP
0.659340659341%	3	455	28	T2D_GENES_TANYA_BLOODPRESSURE	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
0.659340659341%	3	455	28	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_ERK_PATHWAY
0.659340659341%	3	455	271	T2D_GENES_TANYA_BLOODPRESSURE	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.659340659341%	3	455	270	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
0.659340659341%	3	455	27	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS
0.659340659341%	3	455	27	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_EDG1_PATHWAY
0.659340659341%	3	455	266	T2D_GENES_TANYA_BLOODPRESSURE	FOSTER_KDM1A_TARGETS_UP
0.659340659341%	3	455	264	T2D_GENES_TANYA_BLOODPRESSURE	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
0.659340659341%	3	455	260	T2D_GENES_TANYA_BLOODPRESSURE	SENESE_HDAC1_TARGETS_DN
0.659340659341%	3	455	256	T2D_GENES_TANYA_BLOODPRESSURE	ONDER_CDH1_TARGETS_2_UP
0.659340659341%	3	455	255	T2D_GENES_TANYA_BLOODPRESSURE	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.659340659341%	3	455	254	T2D_GENES_TANYA_BLOODPRESSURE	IVANOVA_HEMATOPOIESIS_STEM_CELL
0.659340659341%	3	455	252	T2D_GENES_TANYA_BLOODPRESSURE	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.659340659341%	3	455	25	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE
0.659340659341%	3	455	25	T2D_GENES_TANYA_BLOODPRESSURE	LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS
0.659340659341%	3	455	246	T2D_GENES_TANYA_BLOODPRESSURE	BILD_E2F3_ONCOGENIC_SIGNATURE
0.659340659341%	3	455	245	T2D_GENES_TANYA_BLOODPRESSURE	KONDO_EZH2_TARGETS
0.659340659341%	3	455	243	T2D_GENES_TANYA_BLOODPRESSURE	CHICAS_RB1_TARGETS_GROWING
0.659340659341%	3	455	24	T2D_GENES_TANYA_BLOODPRESSURE	YAN_ESCAPE_FROM_ANOIKIS
0.659340659341%	3	455	24	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_NTHI_PATHWAY
0.659340659341%	3	455	24	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CSK_PATHWAY
0.659340659341%	3	455	238	T2D_GENES_TANYA_BLOODPRESSURE	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
0.659340659341%	3	455	234	T2D_GENES_TANYA_BLOODPRESSURE	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
0.659340659341%	3	455	233	T2D_GENES_TANYA_BLOODPRESSURE	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.659340659341%	3	455	23	T2D_GENES_TANYA_BLOODPRESSURE	HASLINGER_B_CLL_WITH_11Q23_DELETION
0.659340659341%	3	455	23	T2D_GENES_TANYA_BLOODPRESSURE	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP
0.659340659341%	3	455	23	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_NFKB_PATHWAY
0.659340659341%	3	455	228	T2D_GENES_TANYA_BLOODPRESSURE	MARKEY_RB1_ACUTE_LOF_DN
0.659340659341%	3	455	227	T2D_GENES_TANYA_BLOODPRESSURE	LEE_RECENT_THYMIC_EMIGRANT
0.659340659341%	3	455	226	T2D_GENES_TANYA_BLOODPRESSURE	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.659340659341%	3	455	225	T2D_GENES_TANYA_BLOODPRESSURE	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
0.659340659341%	3	455	222	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRANSLATION
0.659340659341%	3	455	222	T2D_GENES_TANYA_BLOODPRESSURE	CAIRO_LIVER_DEVELOPMENT_DN
0.659340659341%	3	455	220	T2D_GENES_TANYA_BLOODPRESSURE	RIGGINS_TAMOXIFEN_RESISTANCE_DN
0.659340659341%	3	455	22	T2D_GENES_TANYA_BLOODPRESSURE	WEBER_METHYLATED_ICP_IN_FIBROBLAST
0.659340659341%	3	455	217	T2D_GENES_TANYA_BLOODPRESSURE	WONG_MITOCHONDRIA_GENE_MODULE
0.659340659341%	3	455	214	T2D_GENES_TANYA_BLOODPRESSURE	BIDUS_METASTASIS_UP
0.659340659341%	3	455	207	T2D_GENES_TANYA_BLOODPRESSURE	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.659340659341%	3	455	206	T2D_GENES_TANYA_BLOODPRESSURE	RAMALHO_STEMNESS_UP
0.659340659341%	3	455	203	T2D_GENES_TANYA_BLOODPRESSURE	GRUETZMANN_PANCREATIC_CANCER_DN
0.659340659341%	3	455	201	T2D_GENES_TANYA_BLOODPRESSURE	HOLLMANN_APOPTOSIS_VIA_CD40_UP
0.659340659341%	3	455	200	T2D_GENES_TANYA_BLOODPRESSURE	LEE_DIFFERENTIATING_T_LYMPHOCYTE
0.659340659341%	3	455	197	T2D_GENES_TANYA_BLOODPRESSURE	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
0.659340659341%	3	455	196	T2D_GENES_TANYA_BLOODPRESSURE	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
0.659340659341%	3	455	195	T2D_GENES_TANYA_BLOODPRESSURE	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
0.659340659341%	3	455	195	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.659340659341%	3	455	191	T2D_GENES_TANYA_BLOODPRESSURE	RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.659340659341%	3	455	191	T2D_GENES_TANYA_BLOODPRESSURE	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
0.659340659341%	3	455	19	T2D_GENES_TANYA_BLOODPRESSURE	SA_CASPASE_CASCADE
0.659340659341%	3	455	19	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_TID_PATHWAY
0.659340659341%	3	455	188	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.659340659341%	3	455	185	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_HUNTINGTONS_DISEASE
0.659340659341%	3	455	184	T2D_GENES_TANYA_BLOODPRESSURE	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
0.659340659341%	3	455	182	T2D_GENES_TANYA_BLOODPRESSURE	WHITFIELD_CELL_CYCLE_G2
0.659340659341%	3	455	181	T2D_GENES_TANYA_BLOODPRESSURE	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
0.659340659341%	3	455	18	T2D_GENES_TANYA_BLOODPRESSURE	PLASARI_NFIC_TARGETS_BASAL_DN
0.659340659341%	3	455	18	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_TNFR2_PATHWAY
0.659340659341%	3	455	179	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE
0.659340659341%	3	455	178	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_18HR_DN
0.659340659341%	3	455	177	T2D_GENES_TANYA_BLOODPRESSURE	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
0.659340659341%	3	455	176	T2D_GENES_TANYA_BLOODPRESSURE	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
0.659340659341%	3	455	176	T2D_GENES_TANYA_BLOODPRESSURE	SASAKI_ADULT_T_CELL_LEUKEMIA
0.659340659341%	3	455	176	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX
0.659340659341%	3	455	176	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION
0.659340659341%	3	455	176	T2D_GENES_TANYA_BLOODPRESSURE	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
0.659340659341%	3	455	175	T2D_GENES_TANYA_BLOODPRESSURE	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.659340659341%	3	455	172	T2D_GENES_TANYA_BLOODPRESSURE	SMID_BREAST_CANCER_LUMINAL_B_UP
0.659340659341%	3	455	171	T2D_GENES_TANYA_BLOODPRESSURE	GOLDRATH_HOMEOSTATIC_PROLIFERATION
0.659340659341%	3	455	170	T2D_GENES_TANYA_BLOODPRESSURE	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
0.659340659341%	3	455	170	T2D_GENES_TANYA_BLOODPRESSURE	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.659340659341%	3	455	17	T2D_GENES_TANYA_BLOODPRESSURE	PID_ANTHRAXPATHWAY
0.659340659341%	3	455	169	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION
0.659340659341%	3	455	169	T2D_GENES_TANYA_BLOODPRESSURE	KATSANOU_ELAVL1_TARGETS_UP
0.659340659341%	3	455	167	T2D_GENES_TANYA_BLOODPRESSURE	VANTVEER_BREAST_CANCER_ESR1_UP
0.659340659341%	3	455	165	T2D_GENES_TANYA_BLOODPRESSURE	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
0.659340659341%	3	455	165	T2D_GENES_TANYA_BLOODPRESSURE	LIU_CMYB_TARGETS_UP
0.659340659341%	3	455	163	T2D_GENES_TANYA_BLOODPRESSURE	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
0.659340659341%	3	455	163	T2D_GENES_TANYA_BLOODPRESSURE	LIN_NPAS4_TARGETS_UP
0.659340659341%	3	455	163	T2D_GENES_TANYA_BLOODPRESSURE	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
0.659340659341%	3	455	162	T2D_GENES_TANYA_BLOODPRESSURE	DARWICHE_PAPILLOMA_RISK_LOW_UP
0.659340659341%	3	455	161	T2D_GENES_TANYA_BLOODPRESSURE	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
0.659340659341%	3	455	160	T2D_GENES_TANYA_BLOODPRESSURE	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
0.659340659341%	3	455	16	T2D_GENES_TANYA_BLOODPRESSURE	RODRIGUES_THYROID_CARCINOMA_UP
0.659340659341%	3	455	158	T2D_GENES_TANYA_BLOODPRESSURE	RODRIGUES_NTN1_TARGETS_DN
0.659340659341%	3	455	157	T2D_GENES_TANYA_BLOODPRESSURE	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.659340659341%	3	455	157	T2D_GENES_TANYA_BLOODPRESSURE	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
0.659340659341%	3	455	156	T2D_GENES_TANYA_BLOODPRESSURE	GROSS_HYPOXIA_VIA_ELK3_DN
0.659340659341%	3	455	154	T2D_GENES_TANYA_BLOODPRESSURE	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
0.659340659341%	3	455	153	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PEPTIDE_CHAIN_ELONGATION
0.659340659341%	3	455	153	T2D_GENES_TANYA_BLOODPRESSURE	LU_AGING_BRAIN_DN
0.659340659341%	3	455	15	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN
0.659340659341%	3	455	15	T2D_GENES_TANYA_BLOODPRESSURE	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP
0.659340659341%	3	455	15	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ENDOGENOUS_STEROLS
0.659340659341%	3	455	149	T2D_GENES_TANYA_BLOODPRESSURE	OHGUCHI_LIVER_HNF4A_TARGETS_DN
0.659340659341%	3	455	149	T2D_GENES_TANYA_BLOODPRESSURE	LANDIS_ERBB2_BREAST_TUMORS_324_DN
0.659340659341%	3	455	149	T2D_GENES_TANYA_BLOODPRESSURE	HUANG_GATA2_TARGETS_UP
0.659340659341%	3	455	148	T2D_GENES_TANYA_BLOODPRESSURE	KATSANOU_ELAVL1_TARGETS_DN
0.659340659341%	3	455	148	T2D_GENES_TANYA_BLOODPRESSURE	CHANG_CYCLING_GENES
0.659340659341%	3	455	148	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_24HR_DN
0.659340659341%	3	455	147	T2D_GENES_TANYA_BLOODPRESSURE	WHITFIELD_CELL_CYCLE_G1_S
0.659340659341%	3	455	147	T2D_GENES_TANYA_BLOODPRESSURE	SMID_BREAST_CANCER_ERBB2_UP
0.659340659341%	3	455	147	T2D_GENES_TANYA_BLOODPRESSURE	DARWICHE_PAPILLOMA_RISK_HIGH_UP
0.659340659341%	3	455	146	T2D_GENES_TANYA_BLOODPRESSURE	KIM_ALL_DISORDERS_DURATION_CORR_DN
0.659340659341%	3	455	145	T2D_GENES_TANYA_BLOODPRESSURE	ZHANG_BREAST_CANCER_PROGENITORS_DN
0.659340659341%	3	455	145	T2D_GENES_TANYA_BLOODPRESSURE	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
0.659340659341%	3	455	145	T2D_GENES_TANYA_BLOODPRESSURE	SMITH_TERT_TARGETS_UP
0.659340659341%	3	455	145	T2D_GENES_TANYA_BLOODPRESSURE	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.659340659341%	3	455	144	T2D_GENES_TANYA_BLOODPRESSURE	BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.659340659341%	3	455	143	T2D_GENES_TANYA_BLOODPRESSURE	DANG_MYC_TARGETS_UP
0.659340659341%	3	455	141	T2D_GENES_TANYA_BLOODPRESSURE	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.659340659341%	3	455	141	T2D_GENES_TANYA_BLOODPRESSURE	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP
0.659340659341%	3	455	140	T2D_GENES_TANYA_BLOODPRESSURE	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
0.659340659341%	3	455	140	T2D_GENES_TANYA_BLOODPRESSURE	QI_HYPOXIA
0.659340659341%	3	455	140	T2D_GENES_TANYA_BLOODPRESSURE	JOHNSTONE_PARVB_TARGETS_2_UP
0.659340659341%	3	455	14	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_REGULATION_OF_COMPLEMENT_CASCADE
0.659340659341%	3	455	14	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CLASSIC_PATHWAY
0.659340659341%	3	455	139	T2D_GENES_TANYA_BLOODPRESSURE	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
0.659340659341%	3	455	138	T2D_GENES_TANYA_BLOODPRESSURE	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
0.659340659341%	3	455	135	T2D_GENES_TANYA_BLOODPRESSURE	UDAYAKUMAR_MED1_TARGETS_UP
0.659340659341%	3	455	134	T2D_GENES_TANYA_BLOODPRESSURE	CHUNG_BLISTER_CYTOTOXICITY_UP
0.659340659341%	3	455	133	T2D_GENES_TANYA_BLOODPRESSURE	SENESE_HDAC2_TARGETS_DN
0.659340659341%	3	455	133	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_PARKINSONS_DISEASE
0.659340659341%	3	455	129	T2D_GENES_TANYA_BLOODPRESSURE	YAGI_AML_SURVIVAL
0.659340659341%	3	455	129	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_AXON_GUIDANCE
0.659340659341%	3	455	129	T2D_GENES_TANYA_BLOODPRESSURE	BROWN_MYELOID_CELL_DEVELOPMENT_DN
0.659340659341%	3	455	128	T2D_GENES_TANYA_BLOODPRESSURE	ZHU_CMV_ALL_DN
0.659340659341%	3	455	128	T2D_GENES_TANYA_BLOODPRESSURE	YEGNASUBRAMANIAN_PROSTATE_CANCER
0.659340659341%	3	455	128	T2D_GENES_TANYA_BLOODPRESSURE	POTTI_TOPOTECAN_SENSITIVITY
0.659340659341%	3	455	128	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_MEF_LCP_WITH_H3K4ME3
0.659340659341%	3	455	128	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_CELL_CYCLE
0.659340659341%	3	455	127	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
0.659340659341%	3	455	127	T2D_GENES_TANYA_BLOODPRESSURE	LIU_VMYB_TARGETS_UP
0.659340659341%	3	455	126	T2D_GENES_TANYA_BLOODPRESSURE	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
0.659340659341%	3	455	123	T2D_GENES_TANYA_BLOODPRESSURE	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.659340659341%	3	455	122	T2D_GENES_TANYA_BLOODPRESSURE	TOOKER_GEMCITABINE_RESISTANCE_DN
0.659340659341%	3	455	122	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_PDGF
0.659340659341%	3	455	122	T2D_GENES_TANYA_BLOODPRESSURE	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
0.659340659341%	3	455	120	T2D_GENES_TANYA_BLOODPRESSURE	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
0.659340659341%	3	455	12	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR
0.659340659341%	3	455	12	T2D_GENES_TANYA_BLOODPRESSURE	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.659340659341%	3	455	12	T2D_GENES_TANYA_BLOODPRESSURE	BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1
0.659340659341%	3	455	12	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_PLCE_PATHWAY
0.659340659341%	3	455	118	T2D_GENES_TANYA_BLOODPRESSURE	MARKEY_RB1_CHRONIC_LOF_DN
0.659340659341%	3	455	118	T2D_GENES_TANYA_BLOODPRESSURE	LEE_NEURAL_CREST_STEM_CELL_DN
0.659340659341%	3	455	117	T2D_GENES_TANYA_BLOODPRESSURE	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.659340659341%	3	455	115	T2D_GENES_TANYA_BLOODPRESSURE	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
0.659340659341%	3	455	114	T2D_GENES_TANYA_BLOODPRESSURE	SMIRNOV_RESPONSE_TO_IR_6HR_DN
0.659340659341%	3	455	114	T2D_GENES_TANYA_BLOODPRESSURE	SENESE_HDAC2_TARGETS_UP
0.659340659341%	3	455	114	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_OOCYTE_MEIOSIS
0.659340659341%	3	455	113	T2D_GENES_TANYA_BLOODPRESSURE	TSENG_IRS1_TARGETS_UP
0.659340659341%	3	455	113	T2D_GENES_TANYA_BLOODPRESSURE	RICKMAN_HEAD_AND_NECK_CANCER_C
0.659340659341%	3	455	113	T2D_GENES_TANYA_BLOODPRESSURE	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
0.659340659341%	3	455	112	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_FGFR
0.659340659341%	3	455	112	T2D_GENES_TANYA_BLOODPRESSURE	LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.659340659341%	3	455	112	T2D_GENES_TANYA_BLOODPRESSURE	LABBE_WNT3A_TARGETS_UP
0.659340659341%	3	455	112	T2D_GENES_TANYA_BLOODPRESSURE	DOANE_BREAST_CANCER_ESR1_UP
0.659340659341%	3	455	110	T2D_GENES_TANYA_BLOODPRESSURE	WOOD_EBV_EBNA1_TARGETS_UP
0.659340659341%	3	455	109	T2D_GENES_TANYA_BLOODPRESSURE	SERVITJA_ISLET_HNF1A_TARGETS_DN
0.659340659341%	3	455	109	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
0.659340659341%	3	455	108	T2D_GENES_TANYA_BLOODPRESSURE	ZHANG_TLX_TARGETS_DN
0.659340659341%	3	455	108	T2D_GENES_TANYA_BLOODPRESSURE	TAVAZOIE_METASTASIS
0.659340659341%	3	455	108	T2D_GENES_TANYA_BLOODPRESSURE	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
0.659340659341%	3	455	108	T2D_GENES_TANYA_BLOODPRESSURE	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
0.659340659341%	3	455	108	T2D_GENES_TANYA_BLOODPRESSURE	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
0.659340659341%	3	455	108	T2D_GENES_TANYA_BLOODPRESSURE	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN
0.659340659341%	3	455	107	T2D_GENES_TANYA_BLOODPRESSURE	SESTO_RESPONSE_TO_UV_C0
0.659340659341%	3	455	105	T2D_GENES_TANYA_BLOODPRESSURE	WOO_LIVER_CANCER_RECURRENCE_UP
0.659340659341%	3	455	105	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_RNA_POL_II_TRANSCRIPTION
0.659340659341%	3	455	105	T2D_GENES_TANYA_BLOODPRESSURE	HELLER_SILENCED_BY_METHYLATION_DN
0.659340659341%	3	455	104	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
0.659340659341%	3	455	103	T2D_GENES_TANYA_BLOODPRESSURE	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN
0.659340659341%	3	455	103	T2D_GENES_TANYA_BLOODPRESSURE	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
0.659340659341%	3	455	102	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.659340659341%	3	455	101	T2D_GENES_TANYA_BLOODPRESSURE	WIELAND_UP_BY_HBV_INFECTION
0.659340659341%	3	455	101	T2D_GENES_TANYA_BLOODPRESSURE	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
0.659340659341%	3	455	101	T2D_GENES_TANYA_BLOODPRESSURE	BURTON_ADIPOGENESIS_3
0.659340659341%	3	455	101	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_10HR_UP
0.659340659341%	3	455	100	T2D_GENES_TANYA_BLOODPRESSURE	WINZEN_DEGRADED_VIA_KHSRP
0.659340659341%	3	455	100	T2D_GENES_TANYA_BLOODPRESSURE	GAVIN_FOXP3_TARGETS_CLUSTER_P4
0.659340659341%	3	455	100	T2D_GENES_TANYA_BLOODPRESSURE	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
0.658561296859%	13	1974	98	Mendelian_Nancy_Cox	CROONQUIST_IL6_DEPRIVATION_DN
0.658561296859%	13	1974	97	Mendelian_Nancy_Cox	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
0.658561296859%	13	1974	94	Mendelian_Nancy_Cox	LU_IL4_SIGNALING
0.658561296859%	13	1974	93	Mendelian_Nancy_Cox	CHEN_LIVER_METABOLISM_QTL_CIS
0.658561296859%	13	1974	92	Mendelian_Nancy_Cox	HILLION_HMGA1B_TARGETS
0.658561296859%	13	1974	91	Mendelian_Nancy_Cox	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
0.658561296859%	13	1974	90	Mendelian_Nancy_Cox	BILANGES_SERUM_SENSITIVE_GENES
0.658561296859%	13	1974	88	Mendelian_Nancy_Cox	SEIDEN_ONCOGENESIS_BY_MET
0.658561296859%	13	1974	88	Mendelian_Nancy_Cox	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
0.658561296859%	13	1974	88	Mendelian_Nancy_Cox	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
0.658561296859%	13	1974	88	Mendelian_Nancy_Cox	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
0.658561296859%	13	1974	88	Mendelian_Nancy_Cox	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
0.658561296859%	13	1974	88	Mendelian_Nancy_Cox	ALCALA_APOPTOSIS
0.658561296859%	13	1974	87	Mendelian_Nancy_Cox	SAFFORD_T_LYMPHOCYTE_ANERGY
0.658561296859%	13	1974	87	Mendelian_Nancy_Cox	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
0.658561296859%	13	1974	86	Mendelian_Nancy_Cox	NELSON_RESPONSE_TO_ANDROGEN_UP
0.658561296859%	13	1974	84	Mendelian_Nancy_Cox	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
0.658561296859%	13	1974	82	Mendelian_Nancy_Cox	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
0.658561296859%	13	1974	82	Mendelian_Nancy_Cox	ODONNELL_METASTASIS_UP
0.658561296859%	13	1974	82	Mendelian_Nancy_Cox	BILD_CTNNB1_ONCOGENIC_SIGNATURE
0.658561296859%	13	1974	80	Mendelian_Nancy_Cox	LEE_AGING_NEOCORTEX_DN
0.658561296859%	13	1974	79	Mendelian_Nancy_Cox	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
0.658561296859%	13	1974	78	Mendelian_Nancy_Cox	REACTOME_CELL_JUNCTION_ORGANIZATION
0.658561296859%	13	1974	76	Mendelian_Nancy_Cox	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
0.658561296859%	13	1974	74	Mendelian_Nancy_Cox	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
0.658561296859%	13	1974	74	Mendelian_Nancy_Cox	LIAN_LIPA_TARGETS_6M
0.658561296859%	13	1974	73	Mendelian_Nancy_Cox	HOSHIDA_LIVER_CANCER_SURVIVAL_UP
0.658561296859%	13	1974	72	Mendelian_Nancy_Cox	DOANE_BREAST_CANCER_CLASSES_UP
0.658561296859%	13	1974	70	Mendelian_Nancy_Cox	RAGHAVACHARI_PLATELET_SPECIFIC_GENES
0.658561296859%	13	1974	69	Mendelian_Nancy_Cox	ZAMORA_NOS2_TARGETS_UP
0.658561296859%	13	1974	69	Mendelian_Nancy_Cox	BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE
0.658561296859%	13	1974	68	Mendelian_Nancy_Cox	REACTOME_SEMAPHORIN_INTERACTIONS
0.658561296859%	13	1974	67	Mendelian_Nancy_Cox	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
0.658561296859%	13	1974	67	Mendelian_Nancy_Cox	GENTILE_UV_LOW_DOSE_DN
0.658561296859%	13	1974	65	Mendelian_Nancy_Cox	CHANG_IMMORTALIZED_BY_HPV31_DN
0.658561296859%	13	1974	64	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_UP
0.658561296859%	13	1974	63	Mendelian_Nancy_Cox	PID_IL12_2PATHWAY
0.658561296859%	13	1974	62	Mendelian_Nancy_Cox	PID_TRKRPATHWAY
0.658561296859%	13	1974	62	Mendelian_Nancy_Cox	BILD_SRC_ONCOGENIC_SIGNATURE
0.658561296859%	13	1974	61	Mendelian_Nancy_Cox	NADLER_OBESITY_UP
0.658561296859%	13	1974	60	Mendelian_Nancy_Cox	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING
0.658561296859%	13	1974	60	Mendelian_Nancy_Cox	CUI_GLUCOSE_DEPRIVATION
0.658561296859%	13	1974	60	Mendelian_Nancy_Cox	CROONQUIST_STROMAL_STIMULATION_UP
0.658561296859%	13	1974	59	Mendelian_Nancy_Cox	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
0.658561296859%	13	1974	59	Mendelian_Nancy_Cox	MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3
0.658561296859%	13	1974	58	Mendelian_Nancy_Cox	ZHENG_GLIOBLASTOMA_PLASTICITY_DN
0.658561296859%	13	1974	58	Mendelian_Nancy_Cox	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
0.658561296859%	13	1974	58	Mendelian_Nancy_Cox	NADLER_HYPERGLYCEMIA_AT_OBESITY
0.658561296859%	13	1974	58	Mendelian_Nancy_Cox	KANNAN_TP53_TARGETS_UP
0.658561296859%	13	1974	58	Mendelian_Nancy_Cox	JI_RESPONSE_TO_FSH_DN
0.658561296859%	13	1974	57	Mendelian_Nancy_Cox	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP
0.658561296859%	13	1974	55	Mendelian_Nancy_Cox	PID_TGFBRPATHWAY
0.658561296859%	13	1974	54	Mendelian_Nancy_Cox	PID_TAP63PATHWAY
0.658561296859%	13	1974	54	Mendelian_Nancy_Cox	HUPER_BREAST_BASAL_VS_LUMINAL_UP
0.658561296859%	13	1974	53	Mendelian_Nancy_Cox	ZHU_CMV_8_HR_DN
0.658561296859%	13	1974	53	Mendelian_Nancy_Cox	IKEDA_MIR1_TARGETS_UP
0.658561296859%	13	1974	52	Mendelian_Nancy_Cox	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN
0.658561296859%	13	1974	52	Mendelian_Nancy_Cox	CHIBA_RESPONSE_TO_TSA_UP
0.658561296859%	13	1974	51	Mendelian_Nancy_Cox	KEGG_DRUG_METABOLISM_OTHER_ENZYMES
0.658561296859%	13	1974	51	Mendelian_Nancy_Cox	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
0.658561296859%	13	1974	50	Mendelian_Nancy_Cox	PARK_APL_PATHOGENESIS_DN
0.658561296859%	13	1974	49	Mendelian_Nancy_Cox	REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM
0.658561296859%	13	1974	49	Mendelian_Nancy_Cox	MARCHINI_TRABECTEDIN_RESISTANCE_DN
0.658561296859%	13	1974	46	Mendelian_Nancy_Cox	TSENG_ADIPOGENIC_POTENTIAL_DN
0.658561296859%	13	1974	46	Mendelian_Nancy_Cox	LEE_AGING_MUSCLE_DN
0.658561296859%	13	1974	45	Mendelian_Nancy_Cox	BIOCARTA_BIOPEPTIDES_PATHWAY
0.658561296859%	13	1974	45	Mendelian_Nancy_Cox	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.658561296859%	13	1974	44	Mendelian_Nancy_Cox	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM
0.658561296859%	13	1974	42	Mendelian_Nancy_Cox	LEIN_ASTROCYTE_MARKERS
0.658561296859%	13	1974	41	Mendelian_Nancy_Cox	PID_ER_NONGENOMIC_PATHWAY
0.658561296859%	13	1974	40	Mendelian_Nancy_Cox	TOMLINS_PROSTATE_CANCER_DN
0.658561296859%	13	1974	38	Mendelian_Nancy_Cox	BIOCARTA_IL2RB_PATHWAY
0.658561296859%	13	1974	36	Mendelian_Nancy_Cox	ST_ADRENERGIC
0.658561296859%	13	1974	35	Mendelian_Nancy_Cox	WESTON_VEGFA_TARGETS_12HR
0.658561296859%	13	1974	35	Mendelian_Nancy_Cox	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
0.658561296859%	13	1974	35	Mendelian_Nancy_Cox	KEGG_PRION_DISEASES
0.658561296859%	13	1974	33	Mendelian_Nancy_Cox	REACTOME_PURINE_METABOLISM
0.658561296859%	13	1974	28	Mendelian_Nancy_Cox	REACTOME_SHC_MEDIATED_CASCADE
0.658561296859%	13	1974	27	Mendelian_Nancy_Cox	REACTOME_STRIATED_MUSCLE_CONTRACTION
0.658561296859%	13	1974	26	Mendelian_Nancy_Cox	KEGG_GALACTOSE_METABOLISM
0.658561296859%	13	1974	23	Mendelian_Nancy_Cox	BIOCARTA_CTCF_PATHWAY
0.658561296859%	13	1974	22	Mendelian_Nancy_Cox	MOOTHA_FFA_OXYDATION
0.658561296859%	13	1974	212	Mendelian_Nancy_Cox	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
0.658561296859%	13	1974	210	Mendelian_Nancy_Cox	REACTOME_TRANSCRIPTION
0.658561296859%	13	1974	182	Mendelian_Nancy_Cox	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.658561296859%	13	1974	17	Mendelian_Nancy_Cox	REACTOME_INTRINSIC_PATHWAY
0.658561296859%	13	1974	167	Mendelian_Nancy_Cox	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
0.658561296859%	13	1974	165	Mendelian_Nancy_Cox	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
0.658561296859%	13	1974	149	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON
0.658561296859%	13	1974	140	Mendelian_Nancy_Cox	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
0.658561296859%	13	1974	140	Mendelian_Nancy_Cox	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
0.658561296859%	13	1974	139	Mendelian_Nancy_Cox	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
0.658561296859%	13	1974	138	Mendelian_Nancy_Cox	JIANG_VHL_TARGETS
0.658561296859%	13	1974	132	Mendelian_Nancy_Cox	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS
0.658561296859%	13	1974	127	Mendelian_Nancy_Cox	LIU_VMYB_TARGETS_UP
0.658561296859%	13	1974	125	Mendelian_Nancy_Cox	REACTOME_HIV_LIFE_CYCLE
0.658561296859%	13	1974	123	Mendelian_Nancy_Cox	HOOI_ST7_TARGETS_DN
0.658561296859%	13	1974	116	Mendelian_Nancy_Cox	MATTIOLI_MGUS_VS_PCL
0.658561296859%	13	1974	116	Mendelian_Nancy_Cox	IKEDA_MIR30_TARGETS_UP
0.658561296859%	13	1974	114	Mendelian_Nancy_Cox	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN
0.658561296859%	13	1974	113	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_RHO_GTPASES
0.658561296859%	13	1974	113	Mendelian_Nancy_Cox	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
0.658561296859%	13	1974	112	Mendelian_Nancy_Cox	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
0.658561296859%	13	1974	110	Mendelian_Nancy_Cox	GHANDHI_DIRECT_IRRADIATION_UP
0.658561296859%	13	1974	103	Mendelian_Nancy_Cox	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY
0.658561296859%	13	1974	101	Mendelian_Nancy_Cox	GRADE_COLON_AND_RECTAL_CANCER_DN
0.658561296859%	13	1974	101	Mendelian_Nancy_Cox	BASSO_CD40_SIGNALING_UP
0.658561296859%	13	1974	100	Mendelian_Nancy_Cox	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
0.653409090909%	23	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_RETINOL_METABOLISM
0.653409090909%	23	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PACKAGING_OF_TELOMERE_ENDS
0.653409090909%	23	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT
0.653409090909%	23	3520	373	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
0.653409090909%	23	3520	335	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
0.653409090909%	23	3520	330	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
0.653409090909%	23	3520	306	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HORIUCHI_WTAP_TARGETS_UP
0.653409090909%	23	3520	280	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_SMARCE1_TARGETS_UP
0.653409090909%	23	3520	271	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.653409090909%	23	3520	270	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RIZKI_TUMOR_INVASIVENESS_3D_DN
0.653409090909%	23	3520	261	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
0.653409090909%	23	3520	247	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_CARBOHYDRATES
0.653409090909%	23	3520	243	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHICAS_RB1_TARGETS_GROWING
0.653409090909%	23	3520	242	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MULLIGHAN_MLL_SIGNATURE_1_DN
0.653409090909%	23	3520	240	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_ESR1_DN
0.653409090909%	23	3520	234	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AFFAR_YY1_TARGETS_DN
0.653409090909%	23	3520	233	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.653409090909%	23	3520	223	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEN_HOXA5_TARGETS_9HR_UP
0.653409090909%	23	3520	217	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALLING_BY_NGF
0.653409090909%	23	3520	215	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAMAZAKI_TCEB3_TARGETS_DN
0.653409090909%	23	3520	214	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
0.653409090909%	23	3520	212	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
0.653409090909%	23	3520	206	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LINSLEY_MIR16_TARGETS
0.653409090909%	23	3520	205	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHEPARD_BMYB_MORPHOLINO_UP
0.653409090909%	23	3520	192	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DNA_REPLICATION
0.653409090909%	23	3520	185	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.653409090909%	23	3520	185	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
0.653409090909%	23	3520	181	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JISON_SICKLE_CELL_DISEASE_DN
0.653409090909%	23	3520	172	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
0.653409090909%	23	3520	171	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ELVIDGE_HYPOXIA_UP
0.653409090909%	23	3520	168	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PUJANA_XPRSS_INT_NETWORK
0.653409090909%	23	3520	165	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DARWICHE_PAPILLOMA_RISK_LOW_DN
0.653409090909%	23	3520	164	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_WT1_TARGETS_8HR_UP
0.653409090909%	23	3520	145	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
0.652528548124%	4	613	98	T2D_GENES_TANYA_BIOMARKER	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
0.652528548124%	4	613	98	T2D_GENES_TANYA_BIOMARKER	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
0.652528548124%	4	613	98	T2D_GENES_TANYA_BIOMARKER	CROONQUIST_IL6_DEPRIVATION_DN
0.652528548124%	4	613	98	T2D_GENES_TANYA_BIOMARKER	BRUINS_UVC_RESPONSE_MIDDLE
0.652528548124%	4	613	97	T2D_GENES_TANYA_BIOMARKER	KONG_E2F3_TARGETS
0.652528548124%	4	613	97	T2D_GENES_TANYA_BIOMARKER	KIM_MYC_AMPLIFICATION_TARGETS_DN
0.652528548124%	4	613	96	T2D_GENES_TANYA_BIOMARKER	ZAMORA_NOS2_TARGETS_DN
0.652528548124%	4	613	93	T2D_GENES_TANYA_BIOMARKER	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
0.652528548124%	4	613	92	T2D_GENES_TANYA_BIOMARKER	WINTER_HYPOXIA_UP
0.652528548124%	4	613	92	T2D_GENES_TANYA_BIOMARKER	REACTOME_SYNTHESIS_OF_DNA
0.652528548124%	4	613	92	T2D_GENES_TANYA_BIOMARKER	KIM_MYCN_AMPLIFICATION_TARGETS_UP
0.652528548124%	4	613	92	T2D_GENES_TANYA_BIOMARKER	KEGG_DILATED_CARDIOMYOPATHY
0.652528548124%	4	613	91	T2D_GENES_TANYA_BIOMARKER	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
0.652528548124%	4	613	90	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_ERBB4
0.652528548124%	4	613	89	T2D_GENES_TANYA_BIOMARKER	SWEET_KRAS_ONCOGENIC_SIGNATURE
0.652528548124%	4	613	89	T2D_GENES_TANYA_BIOMARKER	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
0.652528548124%	4	613	89	T2D_GENES_TANYA_BIOMARKER	KEGG_PROSTATE_CANCER
0.652528548124%	4	613	89	T2D_GENES_TANYA_BIOMARKER	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION
0.652528548124%	4	613	88	T2D_GENES_TANYA_BIOMARKER	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
0.652528548124%	4	613	88	T2D_GENES_TANYA_BIOMARKER	SASSON_RESPONSE_TO_FORSKOLIN_DN
0.652528548124%	4	613	88	T2D_GENES_TANYA_BIOMARKER	KEGG_APOPTOSIS
0.652528548124%	4	613	87	T2D_GENES_TANYA_BIOMARKER	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.652528548124%	4	613	87	T2D_GENES_TANYA_BIOMARKER	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
0.652528548124%	4	613	85	T2D_GENES_TANYA_BIOMARKER	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
0.652528548124%	4	613	84	T2D_GENES_TANYA_BIOMARKER	RUAN_RESPONSE_TO_TNF_DN
0.652528548124%	4	613	84	T2D_GENES_TANYA_BIOMARKER	KIM_GLIS2_TARGETS_UP
0.652528548124%	4	613	83	T2D_GENES_TANYA_BIOMARKER	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
0.652528548124%	4	613	82	T2D_GENES_TANYA_BIOMARKER	ODONNELL_METASTASIS_UP
0.652528548124%	4	613	82	T2D_GENES_TANYA_BIOMARKER	FRASOR_RESPONSE_TO_ESTRADIOL_DN
0.652528548124%	4	613	81	T2D_GENES_TANYA_BIOMARKER	GRABARCZYK_BCL11B_TARGETS_UP
0.652528548124%	4	613	80	T2D_GENES_TANYA_BIOMARKER	WOO_LIVER_CANCER_RECURRENCE_DN
0.652528548124%	4	613	80	T2D_GENES_TANYA_BIOMARKER	SCHUHMACHER_MYC_TARGETS_UP
0.652528548124%	4	613	80	T2D_GENES_TANYA_BIOMARKER	REACTOME_UNFOLDED_PROTEIN_RESPONSE
0.652528548124%	4	613	80	T2D_GENES_TANYA_BIOMARKER	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
0.652528548124%	4	613	79	T2D_GENES_TANYA_BIOMARKER	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16
0.652528548124%	4	613	79	T2D_GENES_TANYA_BIOMARKER	PID_MYC_ACTIVPATHWAY
0.652528548124%	4	613	79	T2D_GENES_TANYA_BIOMARKER	LIU_COMMON_CANCER_GENES
0.652528548124%	4	613	78	T2D_GENES_TANYA_BIOMARKER	ROSS_AML_WITH_MLL_FUSIONS
0.652528548124%	4	613	78	T2D_GENES_TANYA_BIOMARKER	LINDVALL_IMMORTALIZED_BY_TERT_UP
0.652528548124%	4	613	77	T2D_GENES_TANYA_BIOMARKER	LIN_APC_TARGETS
0.652528548124%	4	613	77	T2D_GENES_TANYA_BIOMARKER	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
0.652528548124%	4	613	76	T2D_GENES_TANYA_BIOMARKER	MAHAJAN_RESPONSE_TO_IL1A_DN
0.652528548124%	4	613	75	T2D_GENES_TANYA_BIOMARKER	JAIN_NFKB_SIGNALING
0.652528548124%	4	613	74	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
0.652528548124%	4	613	72	T2D_GENES_TANYA_BIOMARKER	BURTON_ADIPOGENESIS_2
0.652528548124%	4	613	70	T2D_GENES_TANYA_BIOMARKER	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
0.652528548124%	4	613	70	T2D_GENES_TANYA_BIOMARKER	CADWELL_ATG16L1_TARGETS_DN
0.652528548124%	4	613	69	T2D_GENES_TANYA_BIOMARKER	AMIT_EGF_RESPONSE_120_HELA
0.652528548124%	4	613	68	T2D_GENES_TANYA_BIOMARKER	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
0.652528548124%	4	613	68	T2D_GENES_TANYA_BIOMARKER	ROSS_AML_OF_FAB_M7_TYPE
0.652528548124%	4	613	68	T2D_GENES_TANYA_BIOMARKER	LIN_NPAS4_TARGETS_DN
0.652528548124%	4	613	68	T2D_GENES_TANYA_BIOMARKER	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
0.652528548124%	4	613	68	T2D_GENES_TANYA_BIOMARKER	BASSO_CD40_SIGNALING_DN
0.652528548124%	4	613	67	T2D_GENES_TANYA_BIOMARKER	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.652528548124%	4	613	67	T2D_GENES_TANYA_BIOMARKER	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
0.652528548124%	4	613	66	T2D_GENES_TANYA_BIOMARKER	RIGGINS_TAMOXIFEN_RESISTANCE_UP
0.652528548124%	4	613	66	T2D_GENES_TANYA_BIOMARKER	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
0.652528548124%	4	613	66	T2D_GENES_TANYA_BIOMARKER	DIRMEIER_LMP1_RESPONSE_EARLY
0.652528548124%	4	613	65	T2D_GENES_TANYA_BIOMARKER	GUO_HEX_TARGETS_DN
0.652528548124%	4	613	64	T2D_GENES_TANYA_BIOMARKER	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS
0.652528548124%	4	613	63	T2D_GENES_TANYA_BIOMARKER	PID_MYC_REPRESSPATHWAY
0.652528548124%	4	613	63	T2D_GENES_TANYA_BIOMARKER	BURTON_ADIPOGENESIS_PEAK_AT_0HR
0.652528548124%	4	613	63	T2D_GENES_TANYA_BIOMARKER	BRIDEAU_IMPRINTED_GENES
0.652528548124%	4	613	61	T2D_GENES_TANYA_BIOMARKER	KAUFFMANN_MELANOMA_RELAPSE_UP
0.652528548124%	4	613	60	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING
0.652528548124%	4	613	60	T2D_GENES_TANYA_BIOMARKER	CUI_GLUCOSE_DEPRIVATION
0.652528548124%	4	613	59	T2D_GENES_TANYA_BIOMARKER	PID_P53REGULATIONPATHWAY
0.652528548124%	4	613	58	T2D_GENES_TANYA_BIOMARKER	ZHENG_GLIOBLASTOMA_PLASTICITY_DN
0.652528548124%	4	613	58	T2D_GENES_TANYA_BIOMARKER	REACTOME_REGULATION_OF_APOPTOSIS
0.652528548124%	4	613	58	T2D_GENES_TANYA_BIOMARKER	NAGASHIMA_EGF_SIGNALING_UP
0.652528548124%	4	613	58	T2D_GENES_TANYA_BIOMARKER	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
0.652528548124%	4	613	58	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_PPARA_PATHWAY
0.652528548124%	4	613	58	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_HIVNEF_PATHWAY
0.652528548124%	4	613	58	T2D_GENES_TANYA_BIOMARKER	BERNARD_PPAPDC1B_TARGETS_DN
0.652528548124%	4	613	57	T2D_GENES_TANYA_BIOMARKER	TONG_INTERACT_WITH_PTTG1
0.652528548124%	4	613	57	T2D_GENES_TANYA_BIOMARKER	GRABARCZYK_BCL11B_TARGETS_DN
0.652528548124%	4	613	55	T2D_GENES_TANYA_BIOMARKER	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER
0.652528548124%	4	613	54	T2D_GENES_TANYA_BIOMARKER	PID_RAC1_PATHWAY
0.652528548124%	4	613	54	T2D_GENES_TANYA_BIOMARKER	LEE_LIVER_CANCER_MYC_UP
0.652528548124%	4	613	53	T2D_GENES_TANYA_BIOMARKER	ROESSLER_LIVER_CANCER_METASTASIS_DN
0.652528548124%	4	613	53	T2D_GENES_TANYA_BIOMARKER	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS
0.652528548124%	4	613	53	T2D_GENES_TANYA_BIOMARKER	MORI_IMMATURE_B_LYMPHOCYTE_UP
0.652528548124%	4	613	51	T2D_GENES_TANYA_BIOMARKER	ZHANG_PROLIFERATING_VS_QUIESCENT
0.652528548124%	4	613	51	T2D_GENES_TANYA_BIOMARKER	TSUNODA_CISPLATIN_RESISTANCE_DN
0.652528548124%	4	613	50	T2D_GENES_TANYA_BIOMARKER	PID_ANGIOPOIETINRECEPTOR_PATHWAY
0.652528548124%	4	613	50	T2D_GENES_TANYA_BIOMARKER	HOFMANN_CELL_LYMPHOMA_UP
0.652528548124%	4	613	50	T2D_GENES_TANYA_BIOMARKER	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS
0.652528548124%	4	613	49	T2D_GENES_TANYA_BIOMARKER	REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS
0.652528548124%	4	613	49	T2D_GENES_TANYA_BIOMARKER	MANTOVANI_VIRAL_GPCR_SIGNALING_DN
0.652528548124%	4	613	49	T2D_GENES_TANYA_BIOMARKER	GERHOLD_ADIPOGENESIS_UP
0.652528548124%	4	613	48	T2D_GENES_TANYA_BIOMARKER	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
0.652528548124%	4	613	47	T2D_GENES_TANYA_BIOMARKER	POTTI_DOCETAXEL_SENSITIVITY
0.652528548124%	4	613	47	T2D_GENES_TANYA_BIOMARKER	PID_FANCONI_PATHWAY
0.652528548124%	4	613	46	T2D_GENES_TANYA_BIOMARKER	SAGIV_CD24_TARGETS_DN
0.652528548124%	4	613	46	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_KERATINOCYTE_PATHWAY
0.652528548124%	4	613	45	T2D_GENES_TANYA_BIOMARKER	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN
0.652528548124%	4	613	45	T2D_GENES_TANYA_BIOMARKER	HUANG_FOXA2_TARGETS_UP
0.652528548124%	4	613	45	T2D_GENES_TANYA_BIOMARKER	GRADE_METASTASIS_DN
0.652528548124%	4	613	44	T2D_GENES_TANYA_BIOMARKER	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
0.652528548124%	4	613	44	T2D_GENES_TANYA_BIOMARKER	KEGG_TYPE_I_DIABETES_MELLITUS
0.652528548124%	4	613	43	T2D_GENES_TANYA_BIOMARKER	REACTOME_PLC_BETA_MEDIATED_EVENTS
0.652528548124%	4	613	42	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_ES_ICP_WITH_H3K27ME3
0.652528548124%	4	613	41	T2D_GENES_TANYA_BIOMARKER	WENG_POR_TARGETS_LIVER_UP
0.652528548124%	4	613	40	T2D_GENES_TANYA_BIOMARKER	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.652528548124%	4	613	40	T2D_GENES_TANYA_BIOMARKER	CHANGOLKAR_H2AFY_TARGETS_DN
0.652528548124%	4	613	35	T2D_GENES_TANYA_BIOMARKER	HU_GENOTOXIC_DAMAGE_4HR
0.652528548124%	4	613	34	T2D_GENES_TANYA_BIOMARKER	PID_HIF2PATHWAY
0.652528548124%	4	613	33	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_NO1_PATHWAY
0.652528548124%	4	613	298	T2D_GENES_TANYA_BIOMARKER	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
0.652528548124%	4	613	290	T2D_GENES_TANYA_BIOMARKER	BENPORATH_OCT4_TARGETS
0.652528548124%	4	613	29	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_VEGF_PATHWAY
0.652528548124%	4	613	280	T2D_GENES_TANYA_BIOMARKER	WANG_SMARCE1_TARGETS_UP
0.652528548124%	4	613	258	T2D_GENES_TANYA_BIOMARKER	JAEGER_METASTASIS_DN
0.652528548124%	4	613	245	T2D_GENES_TANYA_BIOMARKER	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.652528548124%	4	613	240	T2D_GENES_TANYA_BIOMARKER	VANTVEER_BREAST_CANCER_ESR1_DN
0.652528548124%	4	613	234	T2D_GENES_TANYA_BIOMARKER	AFFAR_YY1_TARGETS_DN
0.652528548124%	4	613	228	T2D_GENES_TANYA_BIOMARKER	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
0.652528548124%	4	613	226	T2D_GENES_TANYA_BIOMARKER	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.652528548124%	4	613	223	T2D_GENES_TANYA_BIOMARKER	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.652528548124%	4	613	222	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_1HR_DN
0.652528548124%	4	613	215	T2D_GENES_TANYA_BIOMARKER	MARKEY_RB1_ACUTE_LOF_UP
0.652528548124%	4	613	214	T2D_GENES_TANYA_BIOMARKER	TIEN_INTESTINE_PROBIOTICS_24HR_DN
0.652528548124%	4	613	214	T2D_GENES_TANYA_BIOMARKER	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
0.652528548124%	4	613	212	T2D_GENES_TANYA_BIOMARKER	SANSOM_APC_TARGETS
0.652528548124%	4	613	211	T2D_GENES_TANYA_BIOMARKER	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
0.652528548124%	4	613	210	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRANSCRIPTION
0.652528548124%	4	613	208	T2D_GENES_TANYA_BIOMARKER	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
0.652528548124%	4	613	205	T2D_GENES_TANYA_BIOMARKER	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
0.652528548124%	4	613	203	T2D_GENES_TANYA_BIOMARKER	PAL_PRMT5_TARGETS_UP
0.652528548124%	4	613	202	T2D_GENES_TANYA_BIOMARKER	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
0.652528548124%	4	613	198	T2D_GENES_TANYA_BIOMARKER	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.652528548124%	4	613	196	T2D_GENES_TANYA_BIOMARKER	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
0.652528548124%	4	613	195	T2D_GENES_TANYA_BIOMARKER	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
0.652528548124%	4	613	194	T2D_GENES_TANYA_BIOMARKER	PROVENZANI_METASTASIS_UP
0.652528548124%	4	613	185	T2D_GENES_TANYA_BIOMARKER	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.652528548124%	4	613	182	T2D_GENES_TANYA_BIOMARKER	WHITFIELD_CELL_CYCLE_G2
0.652528548124%	4	613	176	T2D_GENES_TANYA_BIOMARKER	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
0.652528548124%	4	613	172	T2D_GENES_TANYA_BIOMARKER	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
0.652528548124%	4	613	171	T2D_GENES_TANYA_BIOMARKER	GOLDRATH_HOMEOSTATIC_PROLIFERATION
0.652528548124%	4	613	171	T2D_GENES_TANYA_BIOMARKER	ELVIDGE_HYPOXIA_UP
0.652528548124%	4	613	170	T2D_GENES_TANYA_BIOMARKER	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.652528548124%	4	613	169	T2D_GENES_TANYA_BIOMARKER	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
0.652528548124%	4	613	169	T2D_GENES_TANYA_BIOMARKER	KEGG_ALZHEIMERS_DISEASE
0.652528548124%	4	613	169	T2D_GENES_TANYA_BIOMARKER	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
0.652528548124%	4	613	167	T2D_GENES_TANYA_BIOMARKER	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
0.652528548124%	4	613	163	T2D_GENES_TANYA_BIOMARKER	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
0.652528548124%	4	613	163	T2D_GENES_TANYA_BIOMARKER	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
0.652528548124%	4	613	162	T2D_GENES_TANYA_BIOMARKER	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
0.652528548124%	4	613	157	T2D_GENES_TANYA_BIOMARKER	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.652528548124%	4	613	156	T2D_GENES_TANYA_BIOMARKER	FOSTER_TOLERANT_MACROPHAGE_UP
0.652528548124%	4	613	153	T2D_GENES_TANYA_BIOMARKER	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
0.652528548124%	4	613	153	T2D_GENES_TANYA_BIOMARKER	RUIZ_TNC_TARGETS_UP
0.652528548124%	4	613	153	T2D_GENES_TANYA_BIOMARKER	LU_AGING_BRAIN_DN
0.652528548124%	4	613	150	T2D_GENES_TANYA_BIOMARKER	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
0.652528548124%	4	613	150	T2D_GENES_TANYA_BIOMARKER	LANDIS_ERBB2_BREAST_TUMORS_324_UP
0.652528548124%	4	613	149	T2D_GENES_TANYA_BIOMARKER	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
0.652528548124%	4	613	149	T2D_GENES_TANYA_BIOMARKER	HUANG_GATA2_TARGETS_UP
0.652528548124%	4	613	148	T2D_GENES_TANYA_BIOMARKER	WEI_MIR34A_TARGETS
0.652528548124%	4	613	146	T2D_GENES_TANYA_BIOMARKER	ELVIDGE_HYPOXIA_DN
0.652528548124%	4	613	144	T2D_GENES_TANYA_BIOMARKER	BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.652528548124%	4	613	142	T2D_GENES_TANYA_BIOMARKER	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.652528548124%	4	613	142	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_ES_LCP_WITH_H3K4ME3
0.652528548124%	4	613	142	T2D_GENES_TANYA_BIOMARKER	DARWICHE_SKIN_TUMOR_PROMOTER_UP
0.652528548124%	4	613	141	T2D_GENES_TANYA_BIOMARKER	KAAB_FAILED_HEART_ATRIUM_DN
0.652528548124%	4	613	140	T2D_GENES_TANYA_BIOMARKER	JOHNSTONE_PARVB_TARGETS_2_UP
0.652528548124%	4	613	140	T2D_GENES_TANYA_BIOMARKER	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
0.652528548124%	4	613	139	T2D_GENES_TANYA_BIOMARKER	ODONNELL_TFRC_TARGETS_DN
0.652528548124%	4	613	139	T2D_GENES_TANYA_BIOMARKER	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
0.652528548124%	4	613	137	T2D_GENES_TANYA_BIOMARKER	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
0.652528548124%	4	613	137	T2D_GENES_TANYA_BIOMARKER	LIU_SOX4_TARGETS_UP
0.652528548124%	4	613	136	T2D_GENES_TANYA_BIOMARKER	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.652528548124%	4	613	136	T2D_GENES_TANYA_BIOMARKER	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.652528548124%	4	613	133	T2D_GENES_TANYA_BIOMARKER	SENESE_HDAC2_TARGETS_DN
0.652528548124%	4	613	132	T2D_GENES_TANYA_BIOMARKER	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
0.652528548124%	4	613	131	T2D_GENES_TANYA_BIOMARKER	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.652528548124%	4	613	130	T2D_GENES_TANYA_BIOMARKER	YAGI_AML_WITH_T_9_11_TRANSLOCATION
0.652528548124%	4	613	129	T2D_GENES_TANYA_BIOMARKER	YAGI_AML_SURVIVAL
0.652528548124%	4	613	129	T2D_GENES_TANYA_BIOMARKER	KIM_WT1_TARGETS_8HR_DN
0.652528548124%	4	613	129	T2D_GENES_TANYA_BIOMARKER	BROWN_MYELOID_CELL_DEVELOPMENT_DN
0.652528548124%	4	613	128	T2D_GENES_TANYA_BIOMARKER	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.652528548124%	4	613	128	T2D_GENES_TANYA_BIOMARKER	KEGG_SPLICEOSOME
0.652528548124%	4	613	127	T2D_GENES_TANYA_BIOMARKER	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.652528548124%	4	613	127	T2D_GENES_TANYA_BIOMARKER	LIU_VMYB_TARGETS_UP
0.652528548124%	4	613	126	T2D_GENES_TANYA_BIOMARKER	GERY_CEBP_TARGETS
0.652528548124%	4	613	124	T2D_GENES_TANYA_BIOMARKER	DAIRKEE_TERT_TARGETS_DN
0.652528548124%	4	613	123	T2D_GENES_TANYA_BIOMARKER	KAYO_AGING_MUSCLE_DN
0.652528548124%	4	613	123	T2D_GENES_TANYA_BIOMARKER	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.652528548124%	4	613	122	T2D_GENES_TANYA_BIOMARKER	REACTOME_CHROMOSOME_MAINTENANCE
0.652528548124%	4	613	121	T2D_GENES_TANYA_BIOMARKER	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP
0.652528548124%	4	613	121	T2D_GENES_TANYA_BIOMARKER	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
0.652528548124%	4	613	120	T2D_GENES_TANYA_BIOMARKER	REACTOME_CELL_CELL_COMMUNICATION
0.652528548124%	4	613	120	T2D_GENES_TANYA_BIOMARKER	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
0.652528548124%	4	613	120	T2D_GENES_TANYA_BIOMARKER	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN
0.652528548124%	4	613	119	T2D_GENES_TANYA_BIOMARKER	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
0.652528548124%	4	613	118	T2D_GENES_TANYA_BIOMARKER	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
0.652528548124%	4	613	118	T2D_GENES_TANYA_BIOMARKER	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
0.652528548124%	4	613	117	T2D_GENES_TANYA_BIOMARKER	PUJANA_BRCA_CENTERED_NETWORK
0.652528548124%	4	613	117	T2D_GENES_TANYA_BIOMARKER	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.652528548124%	4	613	116	T2D_GENES_TANYA_BIOMARKER	WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.652528548124%	4	613	116	T2D_GENES_TANYA_BIOMARKER	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
0.652528548124%	4	613	116	T2D_GENES_TANYA_BIOMARKER	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.652528548124%	4	613	116	T2D_GENES_TANYA_BIOMARKER	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
0.652528548124%	4	613	112	T2D_GENES_TANYA_BIOMARKER	LABBE_WNT3A_TARGETS_UP
0.652528548124%	4	613	112	T2D_GENES_TANYA_BIOMARKER	DOANE_BREAST_CANCER_ESR1_UP
0.652528548124%	4	613	112	T2D_GENES_TANYA_BIOMARKER	DITTMER_PTHLH_TARGETS_UP
0.652528548124%	4	613	111	T2D_GENES_TANYA_BIOMARKER	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.652528548124%	4	613	111	T2D_GENES_TANYA_BIOMARKER	BOUDOUKHA_BOUND_BY_IGF2BP2
0.652528548124%	4	613	110	T2D_GENES_TANYA_BIOMARKER	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.652528548124%	4	613	109	T2D_GENES_TANYA_BIOMARKER	REACTOME_S_PHASE
0.652528548124%	4	613	109	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
0.652528548124%	4	613	109	T2D_GENES_TANYA_BIOMARKER	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.652528548124%	4	613	108	T2D_GENES_TANYA_BIOMARKER	ZHANG_TLX_TARGETS_DN
0.652528548124%	4	613	108	T2D_GENES_TANYA_BIOMARKER	TAVAZOIE_METASTASIS
0.652528548124%	4	613	108	T2D_GENES_TANYA_BIOMARKER	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
0.652528548124%	4	613	108	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
0.652528548124%	4	613	108	T2D_GENES_TANYA_BIOMARKER	LE_EGR2_TARGETS_UP
0.652528548124%	4	613	108	T2D_GENES_TANYA_BIOMARKER	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
0.652528548124%	4	613	108	T2D_GENES_TANYA_BIOMARKER	JAZAG_TGFB1_SIGNALING_UP
0.652528548124%	4	613	108	T2D_GENES_TANYA_BIOMARKER	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN
0.652528548124%	4	613	107	T2D_GENES_TANYA_BIOMARKER	LEE_EARLY_T_LYMPHOCYTE_UP
0.652528548124%	4	613	104	T2D_GENES_TANYA_BIOMARKER	REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE
0.652528548124%	4	613	104	T2D_GENES_TANYA_BIOMARKER	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
0.652528548124%	4	613	103	T2D_GENES_TANYA_BIOMARKER	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY
0.652528548124%	4	613	102	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_IPS_WITH_HCP_H3K27ME3
0.652528548124%	4	613	102	T2D_GENES_TANYA_BIOMARKER	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.652528548124%	4	613	101	T2D_GENES_TANYA_BIOMARKER	BURTON_ADIPOGENESIS_3
0.652528548124%	4	613	101	T2D_GENES_TANYA_BIOMARKER	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.652528548124%	4	613	100	T2D_GENES_TANYA_BIOMARKER	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
0.64397424103%	14	2174	93	T2D_GENES_TANYA_LIPIDS	ZHU_CMV_24_HR_UP
0.64397424103%	14	2174	92	T2D_GENES_TANYA_LIPIDS	KEGG_DILATED_CARDIOMYOPATHY
0.64397424103%	14	2174	91	T2D_GENES_TANYA_LIPIDS	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION
0.64397424103%	14	2174	89	T2D_GENES_TANYA_LIPIDS	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
0.64397424103%	14	2174	88	T2D_GENES_TANYA_LIPIDS	DURCHDEWALD_SKIN_CARCINOGENESIS_UP
0.64397424103%	14	2174	87	T2D_GENES_TANYA_LIPIDS	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
0.64397424103%	14	2174	86	T2D_GENES_TANYA_LIPIDS	KEGG_TGF_BETA_SIGNALING_PATHWAY
0.64397424103%	14	2174	86	T2D_GENES_TANYA_LIPIDS	BAELDE_DIABETIC_NEPHROPATHY_UP
0.64397424103%	14	2174	80	T2D_GENES_TANYA_LIPIDS	KEGG_CARDIAC_MUSCLE_CONTRACTION
0.64397424103%	14	2174	79	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
0.64397424103%	14	2174	77	T2D_GENES_TANYA_LIPIDS	LIN_APC_TARGETS
0.64397424103%	14	2174	74	T2D_GENES_TANYA_LIPIDS	DER_IFN_ALPHA_RESPONSE_UP
0.64397424103%	14	2174	72	T2D_GENES_TANYA_LIPIDS	DANG_REGULATED_BY_MYC_UP
0.64397424103%	14	2174	71	T2D_GENES_TANYA_LIPIDS	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.64397424103%	14	2174	70	T2D_GENES_TANYA_LIPIDS	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.64397424103%	14	2174	70	T2D_GENES_TANYA_LIPIDS	KEGG_PANCREATIC_CANCER
0.64397424103%	14	2174	70	T2D_GENES_TANYA_LIPIDS	ENGELMANN_CANCER_PROGENITORS_DN
0.64397424103%	14	2174	67	T2D_GENES_TANYA_LIPIDS	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
0.64397424103%	14	2174	64	T2D_GENES_TANYA_LIPIDS	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
0.64397424103%	14	2174	62	T2D_GENES_TANYA_LIPIDS	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
0.64397424103%	14	2174	61	T2D_GENES_TANYA_LIPIDS	REACTOME_ER_PHAGOSOME_PATHWAY
0.64397424103%	14	2174	58	T2D_GENES_TANYA_LIPIDS	MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.64397424103%	14	2174	50	T2D_GENES_TANYA_LIPIDS	PID_ANGIOPOIETINRECEPTOR_PATHWAY
0.64397424103%	14	2174	44	T2D_GENES_TANYA_LIPIDS	KEGG_TYPE_I_DIABETES_MELLITUS
0.64397424103%	14	2174	44	T2D_GENES_TANYA_LIPIDS	KEGG_ABC_TRANSPORTERS
0.64397424103%	14	2174	41	T2D_GENES_TANYA_LIPIDS	PID_AMB2_NEUTROPHILS_PATHWAY
0.64397424103%	14	2174	41	T2D_GENES_TANYA_LIPIDS	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM
0.64397424103%	14	2174	38	T2D_GENES_TANYA_LIPIDS	KEGG_ALLOGRAFT_REJECTION
0.64397424103%	14	2174	229	T2D_GENES_TANYA_LIPIDS	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
0.64397424103%	14	2174	209	T2D_GENES_TANYA_LIPIDS	KIM_WT1_TARGETS_12HR_DN
0.64397424103%	14	2174	184	T2D_GENES_TANYA_LIPIDS	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
0.64397424103%	14	2174	182	T2D_GENES_TANYA_LIPIDS	RAO_BOUND_BY_SALL4_ISOFORM_A
0.64397424103%	14	2174	178	T2D_GENES_TANYA_LIPIDS	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
0.64397424103%	14	2174	178	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_18HR_UP
0.64397424103%	14	2174	175	T2D_GENES_TANYA_LIPIDS	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.64397424103%	14	2174	169	T2D_GENES_TANYA_LIPIDS	ONDER_CDH1_TARGETS_1_DN
0.64397424103%	14	2174	166	T2D_GENES_TANYA_LIPIDS	CAIRO_LIVER_DEVELOPMENT_UP
0.64397424103%	14	2174	165	T2D_GENES_TANYA_LIPIDS	LIU_CMYB_TARGETS_UP
0.64397424103%	14	2174	160	T2D_GENES_TANYA_LIPIDS	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
0.64397424103%	14	2174	160	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_6HR_DN
0.64397424103%	14	2174	154	T2D_GENES_TANYA_LIPIDS	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
0.64397424103%	14	2174	153	T2D_GENES_TANYA_LIPIDS	REACTOME_PEPTIDE_CHAIN_ELONGATION
0.64397424103%	14	2174	153	T2D_GENES_TANYA_LIPIDS	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN
0.64397424103%	14	2174	151	T2D_GENES_TANYA_LIPIDS	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
0.64397424103%	14	2174	151	T2D_GENES_TANYA_LIPIDS	IGLESIAS_E2F_TARGETS_UP
0.64397424103%	14	2174	148	T2D_GENES_TANYA_LIPIDS	KATSANOU_ELAVL1_TARGETS_DN
0.64397424103%	14	2174	136	T2D_GENES_TANYA_LIPIDS	PROVENZANI_METASTASIS_DN
0.64397424103%	14	2174	135	T2D_GENES_TANYA_LIPIDS	TSENG_IRS1_TARGETS_DN
0.64397424103%	14	2174	128	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_MEF_LCP_WITH_H3K4ME3
0.64397424103%	14	2174	126	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
0.64397424103%	14	2174	126	T2D_GENES_TANYA_LIPIDS	BURTON_ADIPOGENESIS_5
0.64397424103%	14	2174	123	T2D_GENES_TANYA_LIPIDS	KAYO_AGING_MUSCLE_DN
0.64397424103%	14	2174	122	T2D_GENES_TANYA_LIPIDS	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
0.64397424103%	14	2174	117	T2D_GENES_TANYA_LIPIDS	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.64397424103%	14	2174	116	T2D_GENES_TANYA_LIPIDS	LIM_MAMMARY_LUMINAL_MATURE_UP
0.64397424103%	14	2174	112	T2D_GENES_TANYA_LIPIDS	REACTOME_DNA_REPAIR
0.64397424103%	14	2174	111	T2D_GENES_TANYA_LIPIDS	REACTOME_MRNA_SPLICING
0.64397424103%	14	2174	110	T2D_GENES_TANYA_LIPIDS	WOOD_EBV_EBNA1_TARGETS_UP
0.64397424103%	14	2174	110	T2D_GENES_TANYA_LIPIDS	CHENG_IMPRINTED_BY_ESTRADIOL
0.64397424103%	14	2174	109	T2D_GENES_TANYA_LIPIDS	REACTOME_S_PHASE
0.64397424103%	14	2174	108	T2D_GENES_TANYA_LIPIDS	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
0.64397424103%	14	2174	105	T2D_GENES_TANYA_LIPIDS	HELLER_SILENCED_BY_METHYLATION_DN
0.64397424103%	14	2174	104	T2D_GENES_TANYA_LIPIDS	REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE
0.64397424103%	14	2174	102	T2D_GENES_TANYA_LIPIDS	KEGG_MELANOGENESIS
0.64397424103%	14	2174	102	T2D_GENES_TANYA_LIPIDS	DER_IFN_BETA_RESPONSE_UP
0.64397424103%	14	2174	101	T2D_GENES_TANYA_LIPIDS	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.64397424103%	14	2174	101	T2D_GENES_TANYA_LIPIDS	BASSO_CD40_SIGNALING_UP
0.641368252272%	12	1871	98	T2D_GENES_TANYA_HEIGHT	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
0.641368252272%	12	1871	97	T2D_GENES_TANYA_HEIGHT	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
0.641368252272%	12	1871	93	T2D_GENES_TANYA_HEIGHT	REACTOME_ACTIVATED_TLR4_SIGNALLING
0.641368252272%	12	1871	92	T2D_GENES_TANYA_HEIGHT	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
0.641368252272%	12	1871	92	T2D_GENES_TANYA_HEIGHT	DE_YY1_TARGETS_DN
0.641368252272%	12	1871	90	T2D_GENES_TANYA_HEIGHT	MORI_IMMATURE_B_LYMPHOCYTE_DN
0.641368252272%	12	1871	87	T2D_GENES_TANYA_HEIGHT	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
0.641368252272%	12	1871	87	T2D_GENES_TANYA_HEIGHT	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
0.641368252272%	12	1871	87	T2D_GENES_TANYA_HEIGHT	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
0.641368252272%	12	1871	86	T2D_GENES_TANYA_HEIGHT	HOEBEKE_LYMPHOID_STEM_CELL_DN
0.641368252272%	12	1871	83	T2D_GENES_TANYA_HEIGHT	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
0.641368252272%	12	1871	82	T2D_GENES_TANYA_HEIGHT	PID_SMAD2_3NUCLEARPATHWAY
0.641368252272%	12	1871	82	T2D_GENES_TANYA_HEIGHT	LEIN_MIDBRAIN_MARKERS
0.641368252272%	12	1871	81	T2D_GENES_TANYA_HEIGHT	HUANG_DASATINIB_RESISTANCE_UP
0.641368252272%	12	1871	81	T2D_GENES_TANYA_HEIGHT	GUO_HEX_TARGETS_UP
0.641368252272%	12	1871	79	T2D_GENES_TANYA_HEIGHT	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
0.641368252272%	12	1871	78	T2D_GENES_TANYA_HEIGHT	REACTOME_OPIOID_SIGNALLING
0.641368252272%	12	1871	75	T2D_GENES_TANYA_HEIGHT	JAIN_NFKB_SIGNALING
0.641368252272%	12	1871	74	T2D_GENES_TANYA_HEIGHT	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS
0.641368252272%	12	1871	71	T2D_GENES_TANYA_HEIGHT	REACTOME_PI3K_CASCADE
0.641368252272%	12	1871	66	T2D_GENES_TANYA_HEIGHT	PID_LYSOPHOSPHOLIPID_PATHWAY
0.641368252272%	12	1871	65	T2D_GENES_TANYA_HEIGHT	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
0.641368252272%	12	1871	65	T2D_GENES_TANYA_HEIGHT	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX
0.641368252272%	12	1871	65	T2D_GENES_TANYA_HEIGHT	PID_RB_1PATHWAY
0.641368252272%	12	1871	63	T2D_GENES_TANYA_HEIGHT	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
0.641368252272%	12	1871	63	T2D_GENES_TANYA_HEIGHT	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.641368252272%	12	1871	61	T2D_GENES_TANYA_HEIGHT	REN_BOUND_BY_E2F
0.641368252272%	12	1871	61	T2D_GENES_TANYA_HEIGHT	REACTOME_ER_PHAGOSOME_PATHWAY
0.641368252272%	12	1871	57	T2D_GENES_TANYA_HEIGHT	LEE_EARLY_T_LYMPHOCYTE_DN
0.641368252272%	12	1871	37	T2D_GENES_TANYA_HEIGHT	REACTOME_DOWNSTREAM_TCR_SIGNALING
0.641368252272%	12	1871	29	T2D_GENES_TANYA_HEIGHT	BIOCARTA_INFLAM_PATHWAY
0.641368252272%	12	1871	245	T2D_GENES_TANYA_HEIGHT	KONDO_EZH2_TARGETS
0.641368252272%	12	1871	226	T2D_GENES_TANYA_HEIGHT	KYNG_DNA_DAMAGE_UP
0.641368252272%	12	1871	196	T2D_GENES_TANYA_HEIGHT	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
0.641368252272%	12	1871	188	T2D_GENES_TANYA_HEIGHT	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.641368252272%	12	1871	171	T2D_GENES_TANYA_HEIGHT	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
0.641368252272%	12	1871	170	T2D_GENES_TANYA_HEIGHT	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
0.641368252272%	12	1871	170	T2D_GENES_TANYA_HEIGHT	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.641368252272%	12	1871	169	T2D_GENES_TANYA_HEIGHT	UEDA_PERIFERAL_CLOCK
0.641368252272%	12	1871	169	T2D_GENES_TANYA_HEIGHT	KATSANOU_ELAVL1_TARGETS_UP
0.641368252272%	12	1871	165	T2D_GENES_TANYA_HEIGHT	BROWN_MYELOID_CELL_DEVELOPMENT_UP
0.641368252272%	12	1871	165	T2D_GENES_TANYA_HEIGHT	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
0.641368252272%	12	1871	163	T2D_GENES_TANYA_HEIGHT	LIN_NPAS4_TARGETS_UP
0.641368252272%	12	1871	162	T2D_GENES_TANYA_HEIGHT	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
0.641368252272%	12	1871	161	T2D_GENES_TANYA_HEIGHT	BIDUS_METASTASIS_DN
0.641368252272%	12	1871	160	T2D_GENES_TANYA_HEIGHT	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
0.641368252272%	12	1871	158	T2D_GENES_TANYA_HEIGHT	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.641368252272%	12	1871	157	T2D_GENES_TANYA_HEIGHT	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
0.641368252272%	12	1871	156	T2D_GENES_TANYA_HEIGHT	GROSS_HYPOXIA_VIA_ELK3_DN
0.641368252272%	12	1871	153	T2D_GENES_TANYA_HEIGHT	DAZARD_UV_RESPONSE_CLUSTER_G6
0.641368252272%	12	1871	149	T2D_GENES_TANYA_HEIGHT	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
0.641368252272%	12	1871	149	T2D_GENES_TANYA_HEIGHT	HUANG_GATA2_TARGETS_UP
0.641368252272%	12	1871	146	T2D_GENES_TANYA_HEIGHT	PECE_MAMMARY_STEM_CELL_UP
0.641368252272%	12	1871	142	T2D_GENES_TANYA_HEIGHT	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.641368252272%	12	1871	142	T2D_GENES_TANYA_HEIGHT	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
0.641368252272%	12	1871	141	T2D_GENES_TANYA_HEIGHT	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.641368252272%	12	1871	139	T2D_GENES_TANYA_HEIGHT	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
0.641368252272%	12	1871	138	T2D_GENES_TANYA_HEIGHT	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
0.641368252272%	12	1871	137	T2D_GENES_TANYA_HEIGHT	PID_P53DOWNSTREAMPATHWAY
0.641368252272%	12	1871	137	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.641368252272%	12	1871	137	T2D_GENES_TANYA_HEIGHT	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
0.641368252272%	12	1871	135	T2D_GENES_TANYA_HEIGHT	SERVITJA_LIVER_HNF1A_TARGETS_UP
0.641368252272%	12	1871	133	T2D_GENES_TANYA_HEIGHT	GAL_LEUKEMIC_STEM_CELL_UP
0.641368252272%	12	1871	132	T2D_GENES_TANYA_HEIGHT	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
0.641368252272%	12	1871	128	T2D_GENES_TANYA_HEIGHT	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS
0.641368252272%	12	1871	125	T2D_GENES_TANYA_HEIGHT	FIGUEROA_AML_METHYLATION_CLUSTER_1_UP
0.641368252272%	12	1871	124	T2D_GENES_TANYA_HEIGHT	REACTOME_CELL_CYCLE_CHECKPOINTS
0.641368252272%	12	1871	123	T2D_GENES_TANYA_HEIGHT	KAYO_AGING_MUSCLE_DN
0.641368252272%	12	1871	118	T2D_GENES_TANYA_HEIGHT	REACTOME_TOLL_RECEPTOR_CASCADES
0.641368252272%	12	1871	117	T2D_GENES_TANYA_HEIGHT	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.641368252272%	12	1871	116	T2D_GENES_TANYA_HEIGHT	WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.641368252272%	12	1871	116	T2D_GENES_TANYA_HEIGHT	LIM_MAMMARY_LUMINAL_MATURE_UP
0.641368252272%	12	1871	115	T2D_GENES_TANYA_HEIGHT	MARKEY_RB1_CHRONIC_LOF_UP
0.641368252272%	12	1871	115	T2D_GENES_TANYA_HEIGHT	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
0.641368252272%	12	1871	114	T2D_GENES_TANYA_HEIGHT	SENESE_HDAC2_TARGETS_UP
0.641368252272%	12	1871	113	T2D_GENES_TANYA_HEIGHT	TSENG_IRS1_TARGETS_UP
0.641368252272%	12	1871	111	T2D_GENES_TANYA_HEIGHT	REACTOME_MRNA_SPLICING
0.641368252272%	12	1871	110	T2D_GENES_TANYA_HEIGHT	WOOD_EBV_EBNA1_TARGETS_UP
0.641368252272%	12	1871	106	T2D_GENES_TANYA_HEIGHT	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
0.641368252272%	12	1871	103	T2D_GENES_TANYA_HEIGHT	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN
0.641368252272%	12	1871	103	T2D_GENES_TANYA_HEIGHT	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY
0.641368252272%	12	1871	100	T2D_GENES_TANYA_HEIGHT	QI_PLASMACYTOMA_DN
0.630417651694%	8	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HUANG_DASATINIB_RESISTANCE_UP
0.630417651694%	8	1269	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROSS_AML_WITH_AML1_ETO_FUSION
0.630417651694%	8	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_HNF3BPATHWAY
0.630417651694%	8	1269	408	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
0.630417651694%	8	1269	405	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KUMAR_TARGETS_OF_MLL_AF9_FUSION
0.630417651694%	8	1269	356	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
0.630417651694%	8	1269	318	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEI_MYB_TARGETS
0.630417651694%	8	1269	307	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LI_INDUCED_T_TO_NATURAL_KILLER_UP
0.630417651694%	8	1269	294	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WEST_ADRENOCORTICAL_TUMOR_UP
0.630417651694%	8	1269	291	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SABATES_COLORECTAL_ADENOMA_DN
0.630417651694%	8	1269	289	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GABRIELY_MIR21_TARGETS
0.630417651694%	8	1269	288	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	POOLA_INVASIVE_BREAST_CANCER_UP
0.630417651694%	8	1269	284	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
0.630417651694%	8	1269	271	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.630417651694%	8	1269	267	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.630417651694%	8	1269	254	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_STEM_CELL
0.630417651694%	8	1269	254	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_4HR_DN
0.630417651694%	8	1269	253	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCLACHLAN_DENTAL_CARIES_UP
0.630417651694%	8	1269	251	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KOBAYASHI_EGFR_SIGNALING_24HR_DN
0.630417651694%	8	1269	244	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PLASARI_TGFB1_TARGETS_10HR_DN
0.630417651694%	8	1269	242	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WINTER_HYPOXIA_METAGENE
0.630417651694%	8	1269	242	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MULLIGHAN_MLL_SIGNATURE_1_DN
0.630417651694%	8	1269	242	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
0.630417651694%	8	1269	240	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_ESR1_DN
0.630417651694%	8	1269	240	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_20HR_UP
0.630417651694%	8	1269	236	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
0.630417651694%	8	1269	226	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_UP
0.630417651694%	8	1269	225	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
0.630417651694%	8	1269	223	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHEN_HOXA5_TARGETS_9HR_UP
0.630417651694%	8	1269	214	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TIEN_INTESTINE_PROBIOTICS_24HR_DN
0.630417651694%	8	1269	214	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_WT1_TARGETS_UP
0.630417651694%	8	1269	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VERHAAK_GLIOBLASTOMA_PRONEURAL
0.630417651694%	8	1269	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VERHAAK_GLIOBLASTOMA_NEURAL
0.630417651694%	8	1269	207	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VERHAAK_GLIOBLASTOMA_CLASSICAL
0.630417651694%	8	1269	205	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PEREZ_TP53_AND_TP63_TARGETS
0.630417651694%	8	1269	200	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHEPARD_BMYB_MORPHOLINO_DN
0.630417651694%	8	1269	196	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
0.630417651694%	8	1269	194	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PROVENZANI_METASTASIS_UP
0.630417651694%	8	1269	194	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KASLER_HDAC7_TARGETS_1_UP
0.630417651694%	8	1269	187	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
0.630417651694%	8	1269	186	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
0.630417651694%	8	1269	183	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.630417651694%	8	1269	182	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.630417651694%	8	1269	182	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RAO_BOUND_BY_SALL4_ISOFORM_A
0.630417651694%	8	1269	182	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FERNANDEZ_BOUND_BY_MYC
0.630417651694%	8	1269	180	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DARWICHE_PAPILLOMA_RISK_HIGH_DN
0.630417651694%	8	1269	176	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
0.630417651694%	8	1269	175	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.630417651694%	8	1269	172	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMID_BREAST_CANCER_LUMINAL_B_UP
0.630417651694%	8	1269	165	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
0.630417651694%	8	1269	162	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MULLIGHAN_NPM1_SIGNATURE_3_DN
0.630417651694%	8	1269	158	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RODRIGUES_NTN1_TARGETS_DN
0.630417651694%	8	1269	157	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.630417651694%	8	1269	149	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HUANG_GATA2_TARGETS_UP
0.630417651694%	8	1269	148	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WEI_MIR34A_TARGETS
0.630417651694%	8	1269	145	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHANG_BREAST_CANCER_PROGENITORS_DN
0.630417651694%	8	1269	142	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_ES_LCP_WITH_H3K4ME3
0.630417651694%	8	1269	138	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
0.630417651694%	8	1269	130	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAGI_AML_WITH_T_9_11_TRANSLOCATION
0.630417651694%	8	1269	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHU_CMV_ALL_DN
0.630417651694%	8	1269	118	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_NEURAL_CREST_STEM_CELL_DN
0.630417651694%	8	1269	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.625%	22	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION
0.625%	22	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE
0.625%	22	3520	408	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
0.625%	22	3520	315	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PASINI_SUZ12_TARGETS_DN
0.625%	22	3520	305	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
0.625%	22	3520	293	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_MATURE_CELL
0.625%	22	3520	271	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
0.625%	22	3520	251	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KOBAYASHI_EGFR_SIGNALING_24HR_DN
0.625%	22	3520	249	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MITSIADES_RESPONSE_TO_APLIDIN_DN
0.625%	22	3520	246	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VERHAAK_AML_WITH_NPM1_MUTATED_DN
0.625%	22	3520	222	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
0.625%	22	3520	221	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHANDRAN_METASTASIS_UP
0.625%	22	3520	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VERHAAK_GLIOBLASTOMA_NEURAL
0.625%	22	3520	205	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.625%	22	3520	197	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
0.625%	22	3520	194	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PROVENZANI_METASTASIS_UP
0.625%	22	3520	191	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAGI_AML_FAB_MARKERS
0.625%	22	3520	189	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_6
0.625%	22	3520	188	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
0.625%	22	3520	187	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
0.625%	22	3520	187	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PENG_LEUCINE_DEPRIVATION_DN
0.625%	22	3520	187	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BAKKER_FOXO3_TARGETS_DN
0.625%	22	3520	181	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
0.625%	22	3520	176	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAGASHIMA_NRG1_SIGNALING_UP
0.625%	22	3520	176	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
0.625%	22	3520	172	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
0.625%	22	3520	172	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MITOTIC_M_M_G1_PHASES
0.625%	22	3520	167	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_ESR1_UP
0.625%	22	3520	148	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_APOPTOSIS
0.625%	22	3520	146	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_ALL_DISORDERS_DURATION_CORR_DN
0.625%	22	3520	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DARWICHE_SKIN_TUMOR_PROMOTER_UP
0.625%	22	3520	141	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WELCSH_BRCA1_TARGETS_DN
0.613967766692%	8	1303	92	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAMPS_COLON_CANCER_COPY_NUMBER_UP
0.613967766692%	8	1303	86	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
0.613967766692%	8	1303	80	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
0.613967766692%	8	1303	75	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
0.613967766692%	8	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_HNF3BPATHWAY
0.613967766692%	8	1303	418	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_HGF_UP
0.613967766692%	8	1303	397	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
0.613967766692%	8	1303	389	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HSIAO_HOUSEKEEPING_GENES
0.613967766692%	8	1303	351	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.613967766692%	8	1303	335	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WONG_EMBRYONIC_STEM_CELL_CORE
0.613967766692%	8	1303	317	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
0.613967766692%	8	1303	317	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HELLER_HDAC_TARGETS_UP
0.613967766692%	8	1303	295	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
0.613967766692%	8	1303	292	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KOYAMA_SEMA3B_TARGETS_UP
0.613967766692%	8	1303	289	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GABRIELY_MIR21_TARGETS
0.613967766692%	8	1303	279	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INNATE_IMMUNE_SYSTEM
0.613967766692%	8	1303	270	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RIZKI_TUMOR_INVASIVENESS_3D_DN
0.613967766692%	8	1303	269	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
0.613967766692%	8	1303	265	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
0.613967766692%	8	1303	264	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
0.613967766692%	8	1303	259	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
0.613967766692%	8	1303	251	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_AXON_GUIDANCE
0.613967766692%	8	1303	246	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING
0.613967766692%	8	1303	245	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KONDO_EZH2_TARGETS
0.613967766692%	8	1303	244	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HSIAO_LIVER_SPECIFIC_GENES
0.613967766692%	8	1303	242	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MULLIGHAN_MLL_SIGNATURE_1_DN
0.613967766692%	8	1303	240	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	UDAYAKUMAR_MED1_TARGETS_DN
0.613967766692%	8	1303	238	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.613967766692%	8	1303	238	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
0.613967766692%	8	1303	236	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
0.613967766692%	8	1303	227	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RAO_BOUND_BY_SALL4
0.613967766692%	8	1303	225	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN
0.613967766692%	8	1303	225	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_16HR_UP
0.613967766692%	8	1303	222	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRANSLATION
0.613967766692%	8	1303	215	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAMAZAKI_TCEB3_TARGETS_DN
0.613967766692%	8	1303	214	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TIEN_INTESTINE_PROBIOTICS_24HR_DN
0.613967766692%	8	1303	214	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_WT1_TARGETS_UP
0.613967766692%	8	1303	207	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.613967766692%	8	1303	202	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FUJII_YBX1_TARGETS_DN
0.613967766692%	8	1303	201	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_MYC_AMPLIFICATION_TARGETS_UP
0.613967766692%	8	1303	201	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_FOCAL_ADHESION
0.613967766692%	8	1303	199	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PLASARI_TGFB1_TARGETS_10HR_UP
0.613967766692%	8	1303	197	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
0.613967766692%	8	1303	189	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_6
0.613967766692%	8	1303	185	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.613967766692%	8	1303	185	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DARWICHE_SKIN_TUMOR_PROMOTER_DN
0.613967766692%	8	1303	184	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
0.613967766692%	8	1303	183	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.613967766692%	8	1303	183	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_ENDOCYTOSIS
0.613967766692%	8	1303	182	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RAO_BOUND_BY_SALL4_ISOFORM_A
0.613967766692%	8	1303	182	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FERNANDEZ_BOUND_BY_MYC
0.613967766692%	8	1303	180	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
0.613967766692%	8	1303	180	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_48HR_UP
0.613967766692%	8	1303	179	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BENPORATH_NOS_TARGETS
0.613967766692%	8	1303	176	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SASAKI_ADULT_T_CELL_LEUKEMIA
0.613967766692%	8	1303	175	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAMAZAKI_TCEB3_TARGETS_UP
0.613967766692%	8	1303	174	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
0.613967766692%	8	1303	170	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
0.613967766692%	8	1303	169	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
0.613967766692%	8	1303	163	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
0.613967766692%	8	1303	162	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
0.613967766692%	8	1303	160	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
0.613967766692%	8	1303	159	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_PURINE_METABOLISM
0.613967766692%	8	1303	157	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
0.613967766692%	8	1303	156	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_DN
0.613967766692%	8	1303	150	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LANDIS_ERBB2_BREAST_TUMORS_324_UP
0.613967766692%	8	1303	149	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
0.613967766692%	8	1303	145	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_BREAST_CANCER_PROGENITORS_DN
0.613967766692%	8	1303	143	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
0.613967766692%	8	1303	142	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DARWICHE_SKIN_TUMOR_PROMOTER_UP
0.613967766692%	8	1303	137	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MITOTIC_G1_G1_S_PHASES
0.613967766692%	8	1303	137	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_P53DOWNSTREAMPATHWAY
0.613967766692%	8	1303	133	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_DIABETES_PATHWAYS
0.613967766692%	8	1303	129	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MEMBRANE_TRAFFICKING
0.613967766692%	8	1303	128	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHU_CMV_ALL_DN
0.613967766692%	8	1303	128	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.613967766692%	8	1303	126	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_5
0.613967766692%	8	1303	123	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAZARD_RESPONSE_TO_UV_SCC_UP
0.613967766692%	8	1303	120	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	XU_GH1_EXOGENOUS_TARGETS_DN
0.613967766692%	8	1303	105	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WOO_LIVER_CANCER_RECURRENCE_UP
0.613967766692%	8	1303	103	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_NOTCH
0.613967766692%	8	1303	102	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DER_IFN_BETA_RESPONSE_UP
0.607902735562%	12	1974	97	Mendelian_Nancy_Cox	KIM_MYC_AMPLIFICATION_TARGETS_DN
0.607902735562%	12	1974	94	Mendelian_Nancy_Cox	GAVIN_FOXP3_TARGETS_CLUSTER_T4
0.607902735562%	12	1974	91	Mendelian_Nancy_Cox	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
0.607902735562%	12	1974	89	Mendelian_Nancy_Cox	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION
0.607902735562%	12	1974	89	Mendelian_Nancy_Cox	BHATTACHARYA_EMBRYONIC_STEM_CELL
0.607902735562%	12	1974	84	Mendelian_Nancy_Cox	CHANG_IMMORTALIZED_BY_HPV31_UP
0.607902735562%	12	1974	83	Mendelian_Nancy_Cox	SANA_TNF_SIGNALING_UP
0.607902735562%	12	1974	83	Mendelian_Nancy_Cox	REACTOME_AMYLOIDS
0.607902735562%	12	1974	83	Mendelian_Nancy_Cox	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
0.607902735562%	12	1974	82	Mendelian_Nancy_Cox	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
0.607902735562%	12	1974	81	Mendelian_Nancy_Cox	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
0.607902735562%	12	1974	81	Mendelian_Nancy_Cox	MUNSHI_MULTIPLE_MYELOMA_UP
0.607902735562%	12	1974	80	Mendelian_Nancy_Cox	REACTOME_UNFOLDED_PROTEIN_RESPONSE
0.607902735562%	12	1974	79	Mendelian_Nancy_Cox	MEISSNER_NPC_HCP_WITH_H3K27ME3
0.607902735562%	12	1974	79	Mendelian_Nancy_Cox	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
0.607902735562%	12	1974	79	Mendelian_Nancy_Cox	CROMER_METASTASIS_UP
0.607902735562%	12	1974	78	Mendelian_Nancy_Cox	REACTOME_OPIOID_SIGNALLING
0.607902735562%	12	1974	78	Mendelian_Nancy_Cox	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP
0.607902735562%	12	1974	78	Mendelian_Nancy_Cox	BOYLAN_MULTIPLE_MYELOMA_D_DN
0.607902735562%	12	1974	77	Mendelian_Nancy_Cox	RODRIGUES_THYROID_CARCINOMA_DN
0.607902735562%	12	1974	77	Mendelian_Nancy_Cox	JACKSON_DNMT1_TARGETS_UP
0.607902735562%	12	1974	77	Mendelian_Nancy_Cox	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
0.607902735562%	12	1974	77	Mendelian_Nancy_Cox	CARD_MIR302A_TARGETS
0.607902735562%	12	1974	76	Mendelian_Nancy_Cox	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
0.607902735562%	12	1974	75	Mendelian_Nancy_Cox	MORI_MATURE_B_LYMPHOCYTE_DN
0.607902735562%	12	1974	75	Mendelian_Nancy_Cox	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
0.607902735562%	12	1974	70	Mendelian_Nancy_Cox	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
0.607902735562%	12	1974	69	Mendelian_Nancy_Cox	RIZKI_TUMOR_INVASIVENESS_2D_UP
0.607902735562%	12	1974	69	Mendelian_Nancy_Cox	PID_VEGFR1_2_PATHWAY
0.607902735562%	12	1974	69	Mendelian_Nancy_Cox	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.607902735562%	12	1974	69	Mendelian_Nancy_Cox	HOWLIN_PUBERTAL_MAMMARY_GLAND
0.607902735562%	12	1974	68	Mendelian_Nancy_Cox	CASTELLANO_NRAS_TARGETS_UP
0.607902735562%	12	1974	67	Mendelian_Nancy_Cox	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
0.607902735562%	12	1974	66	Mendelian_Nancy_Cox	MARSON_FOXP3_TARGETS_UP
0.607902735562%	12	1974	66	Mendelian_Nancy_Cox	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN
0.607902735562%	12	1974	66	Mendelian_Nancy_Cox	BRUNO_HEMATOPOIESIS
0.607902735562%	12	1974	65	Mendelian_Nancy_Cox	GOLDRATH_IMMUNE_MEMORY
0.607902735562%	12	1974	63	Mendelian_Nancy_Cox	LEE_LIVER_CANCER_MYC_DN
0.607902735562%	12	1974	63	Mendelian_Nancy_Cox	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
0.607902735562%	12	1974	62	Mendelian_Nancy_Cox	MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN
0.607902735562%	12	1974	62	Mendelian_Nancy_Cox	ISSAEVA_MLL2_TARGETS
0.607902735562%	12	1974	61	Mendelian_Nancy_Cox	PID_AR_PATHWAY
0.607902735562%	12	1974	60	Mendelian_Nancy_Cox	SONG_TARGETS_OF_IE86_CMV_PROTEIN
0.607902735562%	12	1974	60	Mendelian_Nancy_Cox	LEE_LIVER_CANCER_DENA_UP
0.607902735562%	12	1974	59	Mendelian_Nancy_Cox	ELVIDGE_HYPOXIA_BY_DMOG_DN
0.607902735562%	12	1974	58	Mendelian_Nancy_Cox	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
0.607902735562%	12	1974	56	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_30MIN_UP
0.607902735562%	12	1974	55	Mendelian_Nancy_Cox	YU_MYC_TARGETS_DN
0.607902735562%	12	1974	55	Mendelian_Nancy_Cox	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.607902735562%	12	1974	55	Mendelian_Nancy_Cox	LAU_APOPTOSIS_CDKN2A_UP
0.607902735562%	12	1974	54	Mendelian_Nancy_Cox	SU_PANCREAS
0.607902735562%	12	1974	54	Mendelian_Nancy_Cox	REACTOME_TCR_SIGNALING
0.607902735562%	12	1974	54	Mendelian_Nancy_Cox	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE
0.607902735562%	12	1974	53	Mendelian_Nancy_Cox	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS
0.607902735562%	12	1974	53	Mendelian_Nancy_Cox	KEGG_AUTOIMMUNE_THYROID_DISEASE
0.607902735562%	12	1974	52	Mendelian_Nancy_Cox	KEGG_MTOR_SIGNALING_PATHWAY
0.607902735562%	12	1974	51	Mendelian_Nancy_Cox	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
0.607902735562%	12	1974	51	Mendelian_Nancy_Cox	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
0.607902735562%	12	1974	51	Mendelian_Nancy_Cox	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.607902735562%	12	1974	50	Mendelian_Nancy_Cox	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.607902735562%	12	1974	50	Mendelian_Nancy_Cox	ROY_WOUND_BLOOD_VESSEL_UP
0.607902735562%	12	1974	49	Mendelian_Nancy_Cox	BIOCARTA_TCR_PATHWAY
0.607902735562%	12	1974	48	Mendelian_Nancy_Cox	RASHI_RESPONSE_TO_IONIZING_RADIATION_3
0.607902735562%	12	1974	48	Mendelian_Nancy_Cox	DOANE_BREAST_CANCER_ESR1_DN
0.607902735562%	12	1974	47	Mendelian_Nancy_Cox	PID_NFAT_TFPATHWAY
0.607902735562%	12	1974	47	Mendelian_Nancy_Cox	PID_DELTANP63PATHWAY
0.607902735562%	12	1974	47	Mendelian_Nancy_Cox	JIANG_AGING_HYPOTHALAMUS_UP
0.607902735562%	12	1974	45	Mendelian_Nancy_Cox	ZHAN_V2_LATE_DIFFERENTIATION_GENES
0.607902735562%	12	1974	45	Mendelian_Nancy_Cox	SIG_CHEMOTAXIS
0.607902735562%	12	1974	44	Mendelian_Nancy_Cox	STREICHER_LSM1_TARGETS_UP
0.607902735562%	12	1974	44	Mendelian_Nancy_Cox	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
0.607902735562%	12	1974	44	Mendelian_Nancy_Cox	PID_HNF3APATHWAY
0.607902735562%	12	1974	44	Mendelian_Nancy_Cox	HARRIS_BRAIN_CANCER_PROGENITORS
0.607902735562%	12	1974	43	Mendelian_Nancy_Cox	REACTOME_IL_3_5_AND_GM_CSF_SIGNALING
0.607902735562%	12	1974	43	Mendelian_Nancy_Cox	PID_CXCR3PATHWAY
0.607902735562%	12	1974	42	Mendelian_Nancy_Cox	PID_UPA_UPAR_PATHWAY
0.607902735562%	12	1974	42	Mendelian_Nancy_Cox	PID_BMPPATHWAY
0.607902735562%	12	1974	42	Mendelian_Nancy_Cox	KEGG_TYROSINE_METABOLISM
0.607902735562%	12	1974	40	Mendelian_Nancy_Cox	PID_IFNGPATHWAY
0.607902735562%	12	1974	40	Mendelian_Nancy_Cox	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN
0.607902735562%	12	1974	38	Mendelian_Nancy_Cox	PID_FASPATHWAY
0.607902735562%	12	1974	37	Mendelian_Nancy_Cox	PID_GMCSF_PATHWAY
0.607902735562%	12	1974	37	Mendelian_Nancy_Cox	BIOCARTA_MET_PATHWAY
0.607902735562%	12	1974	36	Mendelian_Nancy_Cox	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN
0.607902735562%	12	1974	34	Mendelian_Nancy_Cox	KEGG_CYSTEINE_AND_METHIONINE_METABOLISM
0.607902735562%	12	1974	31	Mendelian_Nancy_Cox	DANG_MYC_TARGETS_DN
0.607902735562%	12	1974	30	Mendelian_Nancy_Cox	PID_IL2_STAT5PATHWAY
0.607902735562%	12	1974	28	Mendelian_Nancy_Cox	LOPES_METHYLATED_IN_COLON_CANCER_DN
0.607902735562%	12	1974	28	Mendelian_Nancy_Cox	BIOCARTA_GH_PATHWAY
0.607902735562%	12	1974	27	Mendelian_Nancy_Cox	REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION
0.607902735562%	12	1974	26	Mendelian_Nancy_Cox	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
0.607902735562%	12	1974	25	Mendelian_Nancy_Cox	JACKSON_DNMT1_TARGETS_DN
0.607902735562%	12	1974	23	Mendelian_Nancy_Cox	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS
0.607902735562%	12	1974	223	Mendelian_Nancy_Cox	CHEN_HOXA5_TARGETS_9HR_UP
0.607902735562%	12	1974	21	Mendelian_Nancy_Cox	MOOTHA_GLYCOGEN_METABOLISM
0.607902735562%	12	1974	20	Mendelian_Nancy_Cox	WANG_THOC1_TARGETS_DN
0.607902735562%	12	1974	20	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
0.607902735562%	12	1974	17	Mendelian_Nancy_Cox	KANG_AR_TARGETS_UP
0.607902735562%	12	1974	161	Mendelian_Nancy_Cox	REACTOME_MRNA_PROCESSING
0.607902735562%	12	1974	156	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_14HR_UP
0.607902735562%	12	1974	151	Mendelian_Nancy_Cox	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
0.607902735562%	12	1974	145	Mendelian_Nancy_Cox	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.607902735562%	12	1974	144	Mendelian_Nancy_Cox	BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.607902735562%	12	1974	14	Mendelian_Nancy_Cox	BIOCARTA_PLATELETAPP_PATHWAY
0.607902735562%	12	1974	136	Mendelian_Nancy_Cox	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.607902735562%	12	1974	136	Mendelian_Nancy_Cox	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.607902735562%	12	1974	129	Mendelian_Nancy_Cox	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP
0.607902735562%	12	1974	124	Mendelian_Nancy_Cox	REACTOME_CELL_CYCLE_CHECKPOINTS
0.607902735562%	12	1974	119	Mendelian_Nancy_Cox	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
0.607902735562%	12	1974	112	Mendelian_Nancy_Cox	REACTOME_G1_S_TRANSITION
0.607902735562%	12	1974	111	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_12HR_UP
0.607902735562%	12	1974	110	Mendelian_Nancy_Cox	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
0.607902735562%	12	1974	109	Mendelian_Nancy_Cox	REACTOME_S_PHASE
0.607902735562%	12	1974	109	Mendelian_Nancy_Cox	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.607902735562%	12	1974	103	Mendelian_Nancy_Cox	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
0.607902735562%	12	1974	101	Mendelian_Nancy_Cox	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.607902735562%	12	1974	100	Mendelian_Nancy_Cox	GAVIN_FOXP3_TARGETS_CLUSTER_P4
0.605143721634%	4	661	98	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
0.605143721634%	4	661	98	T2D_GENES_TANYA_GLYCEMIC	HAHTOLA_SEZARY_SYNDROM_UP
0.605143721634%	4	661	98	T2D_GENES_TANYA_GLYCEMIC	GUO_TARGETS_OF_IRS1_AND_IRS2
0.605143721634%	4	661	97	T2D_GENES_TANYA_GLYCEMIC	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP
0.605143721634%	4	661	97	T2D_GENES_TANYA_GLYCEMIC	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
0.605143721634%	4	661	95	T2D_GENES_TANYA_GLYCEMIC	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
0.605143721634%	4	661	95	T2D_GENES_TANYA_GLYCEMIC	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
0.605143721634%	4	661	95	T2D_GENES_TANYA_GLYCEMIC	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.605143721634%	4	661	94	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES
0.605143721634%	4	661	93	T2D_GENES_TANYA_GLYCEMIC	CHEN_LIVER_METABOLISM_QTL_CIS
0.605143721634%	4	661	93	T2D_GENES_TANYA_GLYCEMIC	CADWELL_ATG16L1_TARGETS_UP
0.605143721634%	4	661	92	T2D_GENES_TANYA_GLYCEMIC	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
0.605143721634%	4	661	92	T2D_GENES_TANYA_GLYCEMIC	KEGG_DILATED_CARDIOMYOPATHY
0.605143721634%	4	661	92	T2D_GENES_TANYA_GLYCEMIC	DE_YY1_TARGETS_DN
0.605143721634%	4	661	91	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
0.605143721634%	4	661	90	T2D_GENES_TANYA_GLYCEMIC	IVANOVSKA_MIR106B_TARGETS
0.605143721634%	4	661	90	T2D_GENES_TANYA_GLYCEMIC	BILANGES_SERUM_SENSITIVE_GENES
0.605143721634%	4	661	89	T2D_GENES_TANYA_GLYCEMIC	VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP
0.605143721634%	4	661	89	T2D_GENES_TANYA_GLYCEMIC	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.605143721634%	4	661	89	T2D_GENES_TANYA_GLYCEMIC	KANG_IMMORTALIZED_BY_TERT_UP
0.605143721634%	4	661	89	T2D_GENES_TANYA_GLYCEMIC	BHATTACHARYA_EMBRYONIC_STEM_CELL
0.605143721634%	4	661	88	T2D_GENES_TANYA_GLYCEMIC	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
0.605143721634%	4	661	88	T2D_GENES_TANYA_GLYCEMIC	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
0.605143721634%	4	661	88	T2D_GENES_TANYA_GLYCEMIC	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
0.605143721634%	4	661	88	T2D_GENES_TANYA_GLYCEMIC	DURCHDEWALD_SKIN_CARCINOGENESIS_UP
0.605143721634%	4	661	87	T2D_GENES_TANYA_GLYCEMIC	SAFFORD_T_LYMPHOCYTE_ANERGY
0.605143721634%	4	661	87	T2D_GENES_TANYA_GLYCEMIC	MOOTHA_VOXPHOS
0.605143721634%	4	661	87	T2D_GENES_TANYA_GLYCEMIC	KEGG_ERBB_SIGNALING_PATHWAY
0.605143721634%	4	661	87	T2D_GENES_TANYA_GLYCEMIC	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.605143721634%	4	661	86	T2D_GENES_TANYA_GLYCEMIC	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.605143721634%	4	661	86	T2D_GENES_TANYA_GLYCEMIC	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
0.605143721634%	4	661	85	T2D_GENES_TANYA_GLYCEMIC	LEIN_CEREBELLUM_MARKERS
0.605143721634%	4	661	85	T2D_GENES_TANYA_GLYCEMIC	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
0.605143721634%	4	661	84	T2D_GENES_TANYA_GLYCEMIC	LEE_AGING_CEREBELLUM_UP
0.605143721634%	4	661	83	T2D_GENES_TANYA_GLYCEMIC	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
0.605143721634%	4	661	82	T2D_GENES_TANYA_GLYCEMIC	FRASOR_RESPONSE_TO_ESTRADIOL_DN
0.605143721634%	4	661	81	T2D_GENES_TANYA_GLYCEMIC	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
0.605143721634%	4	661	81	T2D_GENES_TANYA_GLYCEMIC	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.605143721634%	4	661	81	T2D_GENES_TANYA_GLYCEMIC	REACTOME_M_G1_TRANSITION
0.605143721634%	4	661	81	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MITOTIC_G2_G2_M_PHASES
0.605143721634%	4	661	81	T2D_GENES_TANYA_GLYCEMIC	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
0.605143721634%	4	661	80	T2D_GENES_TANYA_GLYCEMIC	PID_BETACATENIN_NUC_PATHWAY
0.605143721634%	4	661	79	T2D_GENES_TANYA_GLYCEMIC	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
0.605143721634%	4	661	79	T2D_GENES_TANYA_GLYCEMIC	MALONEY_RESPONSE_TO_17AAG_DN
0.605143721634%	4	661	79	T2D_GENES_TANYA_GLYCEMIC	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
0.605143721634%	4	661	79	T2D_GENES_TANYA_GLYCEMIC	DUAN_PRDM5_TARGETS
0.605143721634%	4	661	78	T2D_GENES_TANYA_GLYCEMIC	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
0.605143721634%	4	661	78	T2D_GENES_TANYA_GLYCEMIC	ROSS_LEUKEMIA_WITH_MLL_FUSIONS
0.605143721634%	4	661	78	T2D_GENES_TANYA_GLYCEMIC	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
0.605143721634%	4	661	75	T2D_GENES_TANYA_GLYCEMIC	KEGG_ADHERENS_JUNCTION
0.605143721634%	4	661	75	T2D_GENES_TANYA_GLYCEMIC	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
0.605143721634%	4	661	74	T2D_GENES_TANYA_GLYCEMIC	URS_ADIPOCYTE_DIFFERENTIATION_UP
0.605143721634%	4	661	74	T2D_GENES_TANYA_GLYCEMIC	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS
0.605143721634%	4	661	74	T2D_GENES_TANYA_GLYCEMIC	FURUKAWA_DUSP6_TARGETS_PCI35_DN
0.605143721634%	4	661	74	T2D_GENES_TANYA_GLYCEMIC	CORRE_MULTIPLE_MYELOMA_UP
0.605143721634%	4	661	73	T2D_GENES_TANYA_GLYCEMIC	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
0.605143721634%	4	661	72	T2D_GENES_TANYA_GLYCEMIC	REACTOME_METABOLISM_OF_NUCLEOTIDES
0.605143721634%	4	661	72	T2D_GENES_TANYA_GLYCEMIC	DANG_REGULATED_BY_MYC_UP
0.605143721634%	4	661	70	T2D_GENES_TANYA_GLYCEMIC	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
0.605143721634%	4	661	70	T2D_GENES_TANYA_GLYCEMIC	ENGELMANN_CANCER_PROGENITORS_DN
0.605143721634%	4	661	69	T2D_GENES_TANYA_GLYCEMIC	PID_MTOR_4PATHWAY
0.605143721634%	4	661	69	T2D_GENES_TANYA_GLYCEMIC	KEGG_P53_SIGNALING_PATHWAY
0.605143721634%	4	661	69	T2D_GENES_TANYA_GLYCEMIC	HUANG_DASATINIB_RESISTANCE_DN
0.605143721634%	4	661	69	T2D_GENES_TANYA_GLYCEMIC	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
0.605143721634%	4	661	68	T2D_GENES_TANYA_GLYCEMIC	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.605143721634%	4	661	68	T2D_GENES_TANYA_GLYCEMIC	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN
0.605143721634%	4	661	67	T2D_GENES_TANYA_GLYCEMIC	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.605143721634%	4	661	66	T2D_GENES_TANYA_GLYCEMIC	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN
0.605143721634%	4	661	65	T2D_GENES_TANYA_GLYCEMIC	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
0.605143721634%	4	661	65	T2D_GENES_TANYA_GLYCEMIC	LEE_LIVER_CANCER_MYC_TGFA_DN
0.605143721634%	4	661	65	T2D_GENES_TANYA_GLYCEMIC	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP
0.605143721634%	4	661	64	T2D_GENES_TANYA_GLYCEMIC	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
0.605143721634%	4	661	64	T2D_GENES_TANYA_GLYCEMIC	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
0.605143721634%	4	661	64	T2D_GENES_TANYA_GLYCEMIC	BYSTROEM_CORRELATED_WITH_IL5_DN
0.605143721634%	4	661	63	T2D_GENES_TANYA_GLYCEMIC	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP
0.605143721634%	4	661	63	T2D_GENES_TANYA_GLYCEMIC	PID_MYC_REPRESSPATHWAY
0.605143721634%	4	661	63	T2D_GENES_TANYA_GLYCEMIC	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
0.605143721634%	4	661	62	T2D_GENES_TANYA_GLYCEMIC	PID_FCER1PATHWAY
0.605143721634%	4	661	62	T2D_GENES_TANYA_GLYCEMIC	KYNG_DNA_DAMAGE_BY_UV
0.605143721634%	4	661	62	T2D_GENES_TANYA_GLYCEMIC	KORKOLA_YOLK_SAC_TUMOR
0.605143721634%	4	661	62	T2D_GENES_TANYA_GLYCEMIC	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
0.605143721634%	4	661	62	T2D_GENES_TANYA_GLYCEMIC	GEORGES_CELL_CYCLE_MIR192_TARGETS
0.605143721634%	4	661	61	T2D_GENES_TANYA_GLYCEMIC	RAMASWAMY_METASTASIS_DN
0.605143721634%	4	661	59	T2D_GENES_TANYA_GLYCEMIC	PID_P53REGULATIONPATHWAY
0.605143721634%	4	661	59	T2D_GENES_TANYA_GLYCEMIC	ELVIDGE_HYPOXIA_BY_DMOG_DN
0.605143721634%	4	661	58	T2D_GENES_TANYA_GLYCEMIC	PID_SHP2_PATHWAY
0.605143721634%	4	661	58	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_NPC_LCP_WITH_H3K4ME3
0.605143721634%	4	661	58	T2D_GENES_TANYA_GLYCEMIC	KANNAN_TP53_TARGETS_UP
0.605143721634%	4	661	57	T2D_GENES_TANYA_GLYCEMIC	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.605143721634%	4	661	56	T2D_GENES_TANYA_GLYCEMIC	HOQUE_METHYLATED_IN_CANCER
0.605143721634%	4	661	56	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_NFAT_PATHWAY
0.605143721634%	4	661	54	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE
0.605143721634%	4	661	54	T2D_GENES_TANYA_GLYCEMIC	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN
0.605143721634%	4	661	54	T2D_GENES_TANYA_GLYCEMIC	KEGG_NON_SMALL_CELL_LUNG_CANCER
0.605143721634%	4	661	52	T2D_GENES_TANYA_GLYCEMIC	HALMOS_CEBPA_TARGETS_UP
0.605143721634%	4	661	51	T2D_GENES_TANYA_GLYCEMIC	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
0.605143721634%	4	661	50	T2D_GENES_TANYA_GLYCEMIC	PARK_APL_PATHOGENESIS_DN
0.605143721634%	4	661	50	T2D_GENES_TANYA_GLYCEMIC	NADERI_BREAST_CANCER_PROGNOSIS_UP
0.605143721634%	4	661	50	T2D_GENES_TANYA_GLYCEMIC	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN
0.605143721634%	4	661	49	T2D_GENES_TANYA_GLYCEMIC	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
0.605143721634%	4	661	49	T2D_GENES_TANYA_GLYCEMIC	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.605143721634%	4	661	48	T2D_GENES_TANYA_GLYCEMIC	PID_CERAMIDE_PATHWAY
0.605143721634%	4	661	48	T2D_GENES_TANYA_GLYCEMIC	GNATENKO_PLATELET_SIGNATURE
0.605143721634%	4	661	47	T2D_GENES_TANYA_GLYCEMIC	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
0.605143721634%	4	661	46	T2D_GENES_TANYA_GLYCEMIC	WINNEPENNINCKX_MELANOMA_METASTASIS_DN
0.605143721634%	4	661	45	T2D_GENES_TANYA_GLYCEMIC	VANHARANTA_UTERINE_FIBROID_UP
0.605143721634%	4	661	45	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER
0.605143721634%	4	661	45	T2D_GENES_TANYA_GLYCEMIC	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN
0.605143721634%	4	661	44	T2D_GENES_TANYA_GLYCEMIC	KERLEY_RESPONSE_TO_CISPLATIN_UP
0.605143721634%	4	661	44	T2D_GENES_TANYA_GLYCEMIC	CHUNG_BLISTER_CYTOTOXICITY_DN
0.605143721634%	4	661	435	T2D_GENES_TANYA_GLYCEMIC	SWEET_LUNG_CANCER_KRAS_DN
0.605143721634%	4	661	43	T2D_GENES_TANYA_GLYCEMIC	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
0.605143721634%	4	661	43	T2D_GENES_TANYA_GLYCEMIC	NAKAMURA_METASTASIS_MODEL_DN
0.605143721634%	4	661	43	T2D_GENES_TANYA_GLYCEMIC	LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.605143721634%	4	661	42	T2D_GENES_TANYA_GLYCEMIC	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
0.605143721634%	4	661	42	T2D_GENES_TANYA_GLYCEMIC	BILBAN_B_CLL_LPL_DN
0.605143721634%	4	661	411	T2D_GENES_TANYA_GLYCEMIC	KOYAMA_SEMA3B_TARGETS_DN
0.605143721634%	4	661	41	T2D_GENES_TANYA_GLYCEMIC	RIZ_ERYTHROID_DIFFERENTIATION_HBZ
0.605143721634%	4	661	40	T2D_GENES_TANYA_GLYCEMIC	ST_JNK_MAPK_PATHWAY
0.605143721634%	4	661	40	T2D_GENES_TANYA_GLYCEMIC	PID_FOXM1PATHWAY
0.605143721634%	4	661	40	T2D_GENES_TANYA_GLYCEMIC	CHANGOLKAR_H2AFY_TARGETS_DN
0.605143721634%	4	661	39	T2D_GENES_TANYA_GLYCEMIC	VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1
0.605143721634%	4	661	39	T2D_GENES_TANYA_GLYCEMIC	PID_AURORA_B_PATHWAY
0.605143721634%	4	661	38	T2D_GENES_TANYA_GLYCEMIC	REACTOME_G1_PHASE
0.605143721634%	4	661	37	T2D_GENES_TANYA_GLYCEMIC	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2
0.605143721634%	4	661	36	T2D_GENES_TANYA_GLYCEMIC	KEGG_DNA_REPLICATION
0.605143721634%	4	661	36	T2D_GENES_TANYA_GLYCEMIC	JIANG_AGING_CEREBRAL_CORTEX_UP
0.605143721634%	4	661	34	T2D_GENES_TANYA_GLYCEMIC	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM
0.605143721634%	4	661	335	T2D_GENES_TANYA_GLYCEMIC	WONG_EMBRYONIC_STEM_CELL_CORE
0.605143721634%	4	661	330	T2D_GENES_TANYA_GLYCEMIC	REACTOME_METABOLISM_OF_RNA
0.605143721634%	4	661	33	T2D_GENES_TANYA_GLYCEMIC	PID_NCADHERINPATHWAY
0.605143721634%	4	661	32	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING
0.605143721634%	4	661	32	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_PDGF_PATHWAY
0.605143721634%	4	661	317	T2D_GENES_TANYA_GLYCEMIC	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
0.605143721634%	4	661	31	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_EGF_PATHWAY
0.605143721634%	4	661	30	T2D_GENES_TANYA_GLYCEMIC	REACTOME_DNA_STRAND_ELONGATION
0.605143721634%	4	661	285	T2D_GENES_TANYA_GLYCEMIC	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
0.605143721634%	4	661	27	T2D_GENES_TANYA_GLYCEMIC	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN
0.605143721634%	4	661	27	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE
0.605143721634%	4	661	27	T2D_GENES_TANYA_GLYCEMIC	REACTOME_EXTENSION_OF_TELOMERES
0.605143721634%	4	661	238	T2D_GENES_TANYA_GLYCEMIC	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
0.605143721634%	4	661	229	T2D_GENES_TANYA_GLYCEMIC	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
0.605143721634%	4	661	225	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_16HR_UP
0.605143721634%	4	661	217	T2D_GENES_TANYA_GLYCEMIC	WIERENGA_STAT5A_TARGETS_UP
0.605143721634%	4	661	216	T2D_GENES_TANYA_GLYCEMIC	WHITFIELD_CELL_CYCLE_G2_M
0.605143721634%	4	661	209	T2D_GENES_TANYA_GLYCEMIC	GROSS_HYPOXIA_VIA_ELK3_UP
0.605143721634%	4	661	200	T2D_GENES_TANYA_GLYCEMIC	LEE_DIFFERENTIATING_T_LYMPHOCYTE
0.605143721634%	4	661	196	T2D_GENES_TANYA_GLYCEMIC	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
0.605143721634%	4	661	194	T2D_GENES_TANYA_GLYCEMIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.605143721634%	4	661	193	T2D_GENES_TANYA_GLYCEMIC	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP
0.605143721634%	4	661	186	T2D_GENES_TANYA_GLYCEMIC	WANG_CLIM2_TARGETS_DN
0.605143721634%	4	661	185	T2D_GENES_TANYA_GLYCEMIC	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
0.605143721634%	4	661	185	T2D_GENES_TANYA_GLYCEMIC	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
0.605143721634%	4	661	183	T2D_GENES_TANYA_GLYCEMIC	KEGG_ENDOCYTOSIS
0.605143721634%	4	661	182	T2D_GENES_TANYA_GLYCEMIC	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
0.605143721634%	4	661	181	T2D_GENES_TANYA_GLYCEMIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
0.605143721634%	4	661	179	T2D_GENES_TANYA_GLYCEMIC	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
0.605143721634%	4	661	176	T2D_GENES_TANYA_GLYCEMIC	NAGASHIMA_NRG1_SIGNALING_UP
0.605143721634%	4	661	175	T2D_GENES_TANYA_GLYCEMIC	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.605143721634%	4	661	172	T2D_GENES_TANYA_GLYCEMIC	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
0.605143721634%	4	661	170	T2D_GENES_TANYA_GLYCEMIC	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
0.605143721634%	4	661	170	T2D_GENES_TANYA_GLYCEMIC	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.605143721634%	4	661	169	T2D_GENES_TANYA_GLYCEMIC	KEGG_ALZHEIMERS_DISEASE
0.605143721634%	4	661	167	T2D_GENES_TANYA_GLYCEMIC	TIEN_INTESTINE_PROBIOTICS_6HR_DN
0.605143721634%	4	661	164	T2D_GENES_TANYA_GLYCEMIC	AMIT_EGF_RESPONSE_480_HELA
0.605143721634%	4	661	162	T2D_GENES_TANYA_GLYCEMIC	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
0.605143721634%	4	661	162	T2D_GENES_TANYA_GLYCEMIC	KIM_WT1_TARGETS_12HR_UP
0.605143721634%	4	661	160	T2D_GENES_TANYA_GLYCEMIC	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
0.605143721634%	4	661	159	T2D_GENES_TANYA_GLYCEMIC	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
0.605143721634%	4	661	155	T2D_GENES_TANYA_GLYCEMIC	KEGG_JAK_STAT_SIGNALING_PATHWAY
0.605143721634%	4	661	153	T2D_GENES_TANYA_GLYCEMIC	LU_AGING_BRAIN_DN
0.605143721634%	4	661	153	T2D_GENES_TANYA_GLYCEMIC	DURAND_STROMA_MAX_DN
0.605143721634%	4	661	150	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_30MIN_DN
0.605143721634%	4	661	15	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_NUCLEARRS_PATHWAY
0.605143721634%	4	661	149	T2D_GENES_TANYA_GLYCEMIC	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
0.605143721634%	4	661	147	T2D_GENES_TANYA_GLYCEMIC	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
0.605143721634%	4	661	145	T2D_GENES_TANYA_GLYCEMIC	SMITH_TERT_TARGETS_UP
0.605143721634%	4	661	145	T2D_GENES_TANYA_GLYCEMIC	RODWELL_AGING_KIDNEY_DN
0.605143721634%	4	661	145	T2D_GENES_TANYA_GLYCEMIC	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.605143721634%	4	661	143	T2D_GENES_TANYA_GLYCEMIC	DANG_MYC_TARGETS_UP
0.605143721634%	4	661	141	T2D_GENES_TANYA_GLYCEMIC	SABATES_COLORECTAL_ADENOMA_UP
0.605143721634%	4	661	141	T2D_GENES_TANYA_GLYCEMIC	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP
0.605143721634%	4	661	140	T2D_GENES_TANYA_GLYCEMIC	QI_HYPOXIA
0.605143721634%	4	661	139	T2D_GENES_TANYA_GLYCEMIC	ODONNELL_TFRC_TARGETS_DN
0.605143721634%	4	661	137	T2D_GENES_TANYA_GLYCEMIC	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
0.605143721634%	4	661	137	T2D_GENES_TANYA_GLYCEMIC	PID_P53DOWNSTREAMPATHWAY
0.605143721634%	4	661	134	T2D_GENES_TANYA_GLYCEMIC	POOLA_INVASIVE_BREAST_CANCER_DN
0.605143721634%	4	661	13	T2D_GENES_TANYA_GLYCEMIC	REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION
0.605143721634%	4	661	128	T2D_GENES_TANYA_GLYCEMIC	YEGNASUBRAMANIAN_PROSTATE_CANCER
0.605143721634%	4	661	128	T2D_GENES_TANYA_GLYCEMIC	LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.605143721634%	4	661	128	T2D_GENES_TANYA_GLYCEMIC	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.605143721634%	4	661	128	T2D_GENES_TANYA_GLYCEMIC	KEGG_SPLICEOSOME
0.605143721634%	4	661	126	T2D_GENES_TANYA_GLYCEMIC	SANSOM_APC_TARGETS_UP
0.605143721634%	4	661	125	T2D_GENES_TANYA_GLYCEMIC	REACTOME_HIV_LIFE_CYCLE
0.605143721634%	4	661	122	T2D_GENES_TANYA_GLYCEMIC	TOOKER_GEMCITABINE_RESISTANCE_DN
0.605143721634%	4	661	122	T2D_GENES_TANYA_GLYCEMIC	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
0.605143721634%	4	661	121	T2D_GENES_TANYA_GLYCEMIC	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.605143721634%	4	661	121	T2D_GENES_TANYA_GLYCEMIC	RODRIGUES_DCC_TARGETS_DN
0.605143721634%	4	661	121	T2D_GENES_TANYA_GLYCEMIC	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS
0.605143721634%	4	661	121	T2D_GENES_TANYA_GLYCEMIC	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
0.605143721634%	4	661	119	T2D_GENES_TANYA_GLYCEMIC	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
0.605143721634%	4	661	118	T2D_GENES_TANYA_GLYCEMIC	MARKEY_RB1_CHRONIC_LOF_DN
0.605143721634%	4	661	118	T2D_GENES_TANYA_GLYCEMIC	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
0.605143721634%	4	661	118	T2D_GENES_TANYA_GLYCEMIC	CERVERA_SDHB_TARGETS_1_UP
0.605143721634%	4	661	116	T2D_GENES_TANYA_GLYCEMIC	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
0.605143721634%	4	661	116	T2D_GENES_TANYA_GLYCEMIC	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
0.605143721634%	4	661	115	T2D_GENES_TANYA_GLYCEMIC	HOELZEL_NF1_TARGETS_DN
0.605143721634%	4	661	114	T2D_GENES_TANYA_GLYCEMIC	KEGG_OOCYTE_MEIOSIS
0.605143721634%	4	661	112	T2D_GENES_TANYA_GLYCEMIC	PASINI_SUZ12_TARGETS_UP
0.605143721634%	4	661	112	T2D_GENES_TANYA_GLYCEMIC	LABBE_WNT3A_TARGETS_UP
0.605143721634%	4	661	109	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
0.605143721634%	4	661	108	T2D_GENES_TANYA_GLYCEMIC	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
0.605143721634%	4	661	108	T2D_GENES_TANYA_GLYCEMIC	TAVAZOIE_METASTASIS
0.605143721634%	4	661	108	T2D_GENES_TANYA_GLYCEMIC	JAZAG_TGFB1_SIGNALING_UP
0.605143721634%	4	661	108	T2D_GENES_TANYA_GLYCEMIC	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN
0.605143721634%	4	661	107	T2D_GENES_TANYA_GLYCEMIC	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.605143721634%	4	661	106	T2D_GENES_TANYA_GLYCEMIC	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
0.605143721634%	4	661	105	T2D_GENES_TANYA_GLYCEMIC	STEIN_ESRRA_TARGETS_DN
0.605143721634%	4	661	105	T2D_GENES_TANYA_GLYCEMIC	AMUNDSON_GENOTOXIC_SIGNATURE
0.605143721634%	4	661	104	T2D_GENES_TANYA_GLYCEMIC	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
0.605143721634%	4	661	102	T2D_GENES_TANYA_GLYCEMIC	KEGG_MELANOGENESIS
0.605143721634%	4	661	101	T2D_GENES_TANYA_GLYCEMIC	WIELAND_UP_BY_HBV_INFECTION
0.605143721634%	4	661	100	T2D_GENES_TANYA_GLYCEMIC	QI_PLASMACYTOMA_DN
0.605143721634%	4	661	100	T2D_GENES_TANYA_GLYCEMIC	CHICAS_RB1_TARGETS_LOW_SERUM
0.59880239521%	7	1169	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIELSEN_GIST
0.59880239521%	7	1169	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_DILATED_CARDIOMYOPATHY
0.59880239521%	7	1169	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DE_YY1_TARGETS_DN
0.59880239521%	7	1169	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
0.59880239521%	7	1169	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ELVIDGE_HIF1A_TARGETS_DN
0.59880239521%	7	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
0.59880239521%	7	1169	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
0.59880239521%	7	1169	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS
0.59880239521%	7	1169	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
0.59880239521%	7	1169	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN
0.59880239521%	7	1169	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
0.59880239521%	7	1169	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PEART_HDAC_PROLIFERATION_CLUSTER_DN
0.59880239521%	7	1169	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.59880239521%	7	1169	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ADHERENS_JUNCTION
0.59880239521%	7	1169	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_VIRAL_MYOCARDITIS
0.59880239521%	7	1169	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_LEISHMANIA_INFECTION
0.59880239521%	7	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
0.59880239521%	7	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
0.59880239521%	7	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3
0.59880239521%	7	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FARMER_BREAST_CANCER_CLUSTER_8
0.59880239521%	7	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_MTOR_4PATHWAY
0.59880239521%	7	1169	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROSS_AML_OF_FAB_M7_TYPE
0.59880239521%	7	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_LYSOPHOSPHOLIPID_PATHWAY
0.59880239521%	7	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
0.59880239521%	7	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GEORGES_CELL_CYCLE_MIR192_TARGETS
0.59880239521%	7	1169	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.59880239521%	7	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YU_MYC_TARGETS_DN
0.59880239521%	7	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN
0.59880239521%	7	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_GLYCEROLIPID_METABOLISM
0.59880239521%	7	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_CERAMIDE_PATHWAY
0.59880239521%	7	1169	435	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
0.59880239521%	7	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LASTOWSKA_COAMPLIFIED_WITH_MYCN
0.59880239521%	7	1169	425	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHANG_BREAST_CANCER_PROGENITORS_UP
0.59880239521%	7	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_TYROSINE_METABOLISM
0.59880239521%	7	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_GRAFT_VERSUS_HOST_DISEASE
0.59880239521%	7	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_FATTY_ACID_METABOLISM
0.59880239521%	7	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_AMB2_NEUTROPHILS_PATHWAY
0.59880239521%	7	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIKOLSKY_BREAST_CANCER_7P22_AMPLICON
0.59880239521%	7	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ALLOGRAFT_REJECTION
0.59880239521%	7	1169	372	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_LMO4_TARGETS_UP
0.59880239521%	7	1169	356	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	COLINA_TARGETS_OF_4EBP1_AND_4EBP2
0.59880239521%	7	1169	328	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_OLFACTORY_SIGNALING_PATHWAY
0.59880239521%	7	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_SYNDECAN_4_PATHWAY
0.59880239521%	7	1169	316	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
0.59880239521%	7	1169	309	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
0.59880239521%	7	1169	283	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP
0.59880239521%	7	1169	279	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NEURONAL_SYSTEM
0.59880239521%	7	1169	275	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.59880239521%	7	1169	269	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
0.59880239521%	7	1169	267	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOLLMANN_APOPTOSIS_VIA_CD40_DN
0.59880239521%	7	1169	259	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
0.59880239521%	7	1169	249	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MITSIADES_RESPONSE_TO_APLIDIN_DN
0.59880239521%	7	1169	244	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAZARD_RESPONSE_TO_UV_NHEK_UP
0.59880239521%	7	1169	238	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
0.59880239521%	7	1169	236	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
0.59880239521%	7	1169	230	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KAUFFMANN_DNA_REPAIR_GENES
0.59880239521%	7	1169	230	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	COLDREN_GEFITINIB_RESISTANCE_DN
0.59880239521%	7	1169	228	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
0.59880239521%	7	1169	223	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.59880239521%	7	1169	222	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_1HR_DN
0.59880239521%	7	1169	221	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHANG_TLX_TARGETS_36HR_UP
0.59880239521%	7	1169	220	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
0.59880239521%	7	1169	216	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
0.59880239521%	7	1169	212	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SANSOM_APC_TARGETS
0.59880239521%	7	1169	211	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
0.59880239521%	7	1169	209	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GROSS_HYPOXIA_VIA_ELK3_UP
0.59880239521%	7	1169	207	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KARLSSON_TGFB1_TARGETS_DN
0.59880239521%	7	1169	205	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PEREZ_TP53_AND_TP63_TARGETS
0.59880239521%	7	1169	200	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
0.59880239521%	7	1169	187	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
0.59880239521%	7	1169	182	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
0.59880239521%	7	1169	178	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_CALCIUM_SIGNALING_PATHWAY
0.59880239521%	7	1169	176	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAGASHIMA_NRG1_SIGNALING_UP
0.59880239521%	7	1169	176	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
0.59880239521%	7	1169	172	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MITOTIC_M_M_G1_PHASES
0.59880239521%	7	1169	171	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GOLDRATH_HOMEOSTATIC_PROLIFERATION
0.59880239521%	7	1169	169	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ONDER_CDH1_TARGETS_1_DN
0.59880239521%	7	1169	165	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.59880239521%	7	1169	165	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
0.59880239521%	7	1169	162	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
0.59880239521%	7	1169	158	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RODRIGUES_NTN1_TARGETS_DN
0.59880239521%	7	1169	157	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
0.59880239521%	7	1169	157	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
0.59880239521%	7	1169	151	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
0.59880239521%	7	1169	151	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IGLESIAS_E2F_TARGETS_UP
0.59880239521%	7	1169	151	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
0.59880239521%	7	1169	149	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HUANG_GATA2_TARGETS_UP
0.59880239521%	7	1169	148	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_24HR_DN
0.59880239521%	7	1169	146	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_ALL_DISORDERS_DURATION_CORR_DN
0.59880239521%	7	1169	145	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHANG_BREAST_CANCER_PROGENITORS_DN
0.59880239521%	7	1169	141	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SABATES_COLORECTAL_ADENOMA_UP
0.59880239521%	7	1169	140	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
0.59880239521%	7	1169	134	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHLOSSER_SERUM_RESPONSE_UP
0.59880239521%	7	1169	134	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_CELL_ADHESION_MOLECULES_CAMS
0.59880239521%	7	1169	129	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWN_MYELOID_CELL_DEVELOPMENT_DN
0.59880239521%	7	1169	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BURTON_ADIPOGENESIS_5
0.59880239521%	7	1169	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP
0.59880239521%	7	1169	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
0.59880239521%	7	1169	115	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARKEY_RB1_CHRONIC_LOF_UP
0.59880239521%	7	1169	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.59880239521%	7	1169	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CERVERA_SDHB_TARGETS_2
0.59880239521%	7	1169	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
0.59880239521%	7	1169	111	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOUDOUKHA_BOUND_BY_IGF2BP2
0.59880239521%	7	1169	109	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SERVITJA_ISLET_HNF1A_TARGETS_DN
0.59880239521%	7	1169	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
0.59880239521%	7	1169	107	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.59880239521%	7	1169	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
0.59880239521%	7	1169	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY
0.597976080957%	13	2174	98	T2D_GENES_TANYA_LIPIDS	GAVIN_FOXP3_TARGETS_CLUSTER_T7
0.597976080957%	13	2174	94	T2D_GENES_TANYA_LIPIDS	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5
0.597976080957%	13	2174	92	T2D_GENES_TANYA_LIPIDS	WINTER_HYPOXIA_UP
0.597976080957%	13	2174	92	T2D_GENES_TANYA_LIPIDS	REACTOME_SYNTHESIS_OF_DNA
0.597976080957%	13	2174	92	T2D_GENES_TANYA_LIPIDS	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
0.597976080957%	13	2174	90	T2D_GENES_TANYA_LIPIDS	HILLION_HMGA1_TARGETS
0.597976080957%	13	2174	89	T2D_GENES_TANYA_LIPIDS	VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP
0.597976080957%	13	2174	89	T2D_GENES_TANYA_LIPIDS	DELASERNA_MYOD_TARGETS_UP
0.597976080957%	13	2174	89	T2D_GENES_TANYA_LIPIDS	BHATTACHARYA_EMBRYONIC_STEM_CELL
0.597976080957%	13	2174	88	T2D_GENES_TANYA_LIPIDS	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
0.597976080957%	13	2174	87	T2D_GENES_TANYA_LIPIDS	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
0.597976080957%	13	2174	87	T2D_GENES_TANYA_LIPIDS	BIOCARTA_MAPK_PATHWAY
0.597976080957%	13	2174	86	T2D_GENES_TANYA_LIPIDS	TAKAO_RESPONSE_TO_UVB_RADIATION_UP
0.597976080957%	13	2174	85	T2D_GENES_TANYA_LIPIDS	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
0.597976080957%	13	2174	84	T2D_GENES_TANYA_LIPIDS	RUAN_RESPONSE_TO_TNF_DN
0.597976080957%	13	2174	84	T2D_GENES_TANYA_LIPIDS	RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.597976080957%	13	2174	82	T2D_GENES_TANYA_LIPIDS	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS
0.597976080957%	13	2174	81	T2D_GENES_TANYA_LIPIDS	REACTOME_M_G1_TRANSITION
0.597976080957%	13	2174	80	T2D_GENES_TANYA_LIPIDS	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.597976080957%	13	2174	80	T2D_GENES_TANYA_LIPIDS	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN
0.597976080957%	13	2174	77	T2D_GENES_TANYA_LIPIDS	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.597976080957%	13	2174	77	T2D_GENES_TANYA_LIPIDS	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM
0.597976080957%	13	2174	77	T2D_GENES_TANYA_LIPIDS	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
0.597976080957%	13	2174	76	T2D_GENES_TANYA_LIPIDS	PEART_HDAC_PROLIFERATION_CLUSTER_DN
0.597976080957%	13	2174	75	T2D_GENES_TANYA_LIPIDS	JAIN_NFKB_SIGNALING
0.597976080957%	13	2174	74	T2D_GENES_TANYA_LIPIDS	URS_ADIPOCYTE_DIFFERENTIATION_UP
0.597976080957%	13	2174	73	T2D_GENES_TANYA_LIPIDS	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.597976080957%	13	2174	71	T2D_GENES_TANYA_LIPIDS	DER_IFN_GAMMA_RESPONSE_UP
0.597976080957%	13	2174	70	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_MEF_LCP_WITH_H3K27ME3
0.597976080957%	13	2174	69	T2D_GENES_TANYA_LIPIDS	PID_MTOR_4PATHWAY
0.597976080957%	13	2174	63	T2D_GENES_TANYA_LIPIDS	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP
0.597976080957%	13	2174	63	T2D_GENES_TANYA_LIPIDS	PID_IL12_2PATHWAY
0.597976080957%	13	2174	58	T2D_GENES_TANYA_LIPIDS	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
0.597976080957%	13	2174	57	T2D_GENES_TANYA_LIPIDS	LEE_EARLY_T_LYMPHOCYTE_DN
0.597976080957%	13	2174	55	T2D_GENES_TANYA_LIPIDS	SU_LIVER
0.597976080957%	13	2174	53	T2D_GENES_TANYA_LIPIDS	KEGG_AUTOIMMUNE_THYROID_DISEASE
0.597976080957%	13	2174	52	T2D_GENES_TANYA_LIPIDS	KEGG_STARCH_AND_SUCROSE_METABOLISM
0.597976080957%	13	2174	50	T2D_GENES_TANYA_LIPIDS	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION
0.597976080957%	13	2174	49	T2D_GENES_TANYA_LIPIDS	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
0.597976080957%	13	2174	49	T2D_GENES_TANYA_LIPIDS	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.597976080957%	13	2174	49	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER
0.597976080957%	13	2174	48	T2D_GENES_TANYA_LIPIDS	PID_CERAMIDE_PATHWAY
0.597976080957%	13	2174	48	T2D_GENES_TANYA_LIPIDS	KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.597976080957%	13	2174	42	T2D_GENES_TANYA_LIPIDS	KEGG_GRAFT_VERSUS_HOST_DISEASE
0.597976080957%	13	2174	42	T2D_GENES_TANYA_LIPIDS	KEGG_FATTY_ACID_METABOLISM
0.597976080957%	13	2174	245	T2D_GENES_TANYA_LIPIDS	KONDO_EZH2_TARGETS
0.597976080957%	13	2174	201	T2D_GENES_TANYA_LIPIDS	KIM_MYC_AMPLIFICATION_TARGETS_UP
0.597976080957%	13	2174	186	T2D_GENES_TANYA_LIPIDS	WANG_CLIM2_TARGETS_DN
0.597976080957%	13	2174	185	T2D_GENES_TANYA_LIPIDS	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
0.597976080957%	13	2174	184	T2D_GENES_TANYA_LIPIDS	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
0.597976080957%	13	2174	183	T2D_GENES_TANYA_LIPIDS	OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.597976080957%	13	2174	180	T2D_GENES_TANYA_LIPIDS	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
0.597976080957%	13	2174	177	T2D_GENES_TANYA_LIPIDS	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
0.597976080957%	13	2174	171	T2D_GENES_TANYA_LIPIDS	GOLDRATH_HOMEOSTATIC_PROLIFERATION
0.597976080957%	13	2174	165	T2D_GENES_TANYA_LIPIDS	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
0.597976080957%	13	2174	156	T2D_GENES_TANYA_LIPIDS	FOSTER_TOLERANT_MACROPHAGE_UP
0.597976080957%	13	2174	155	T2D_GENES_TANYA_LIPIDS	KEGG_JAK_STAT_SIGNALING_PATHWAY
0.597976080957%	13	2174	153	T2D_GENES_TANYA_LIPIDS	DURAND_STROMA_MAX_DN
0.597976080957%	13	2174	149	T2D_GENES_TANYA_LIPIDS	LANDIS_ERBB2_BREAST_TUMORS_324_DN
0.597976080957%	13	2174	148	T2D_GENES_TANYA_LIPIDS	WHITFIELD_CELL_CYCLE_M_G1
0.597976080957%	13	2174	143	T2D_GENES_TANYA_LIPIDS	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.597976080957%	13	2174	142	T2D_GENES_TANYA_LIPIDS	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
0.597976080957%	13	2174	141	T2D_GENES_TANYA_LIPIDS	KAAB_FAILED_HEART_ATRIUM_DN
0.597976080957%	13	2174	139	T2D_GENES_TANYA_LIPIDS	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
0.597976080957%	13	2174	138	T2D_GENES_TANYA_LIPIDS	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
0.597976080957%	13	2174	137	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.597976080957%	13	2174	133	T2D_GENES_TANYA_LIPIDS	SENESE_HDAC2_TARGETS_DN
0.597976080957%	13	2174	133	T2D_GENES_TANYA_LIPIDS	GAL_LEUKEMIC_STEM_CELL_UP
0.597976080957%	13	2174	128	T2D_GENES_TANYA_LIPIDS	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.597976080957%	13	2174	123	T2D_GENES_TANYA_LIPIDS	HOOI_ST7_TARGETS_DN
0.597976080957%	13	2174	122	T2D_GENES_TANYA_LIPIDS	TOOKER_GEMCITABINE_RESISTANCE_DN
0.597976080957%	13	2174	121	T2D_GENES_TANYA_LIPIDS	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
0.597976080957%	13	2174	119	T2D_GENES_TANYA_LIPIDS	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
0.597976080957%	13	2174	117	T2D_GENES_TANYA_LIPIDS	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.597976080957%	13	2174	116	T2D_GENES_TANYA_LIPIDS	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.597976080957%	13	2174	115	T2D_GENES_TANYA_LIPIDS	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
0.597976080957%	13	2174	115	T2D_GENES_TANYA_LIPIDS	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
0.597976080957%	13	2174	114	T2D_GENES_TANYA_LIPIDS	ROPERO_HDAC2_TARGETS
0.597976080957%	13	2174	114	T2D_GENES_TANYA_LIPIDS	MATZUK_SPERMATOZOA
0.597976080957%	13	2174	113	T2D_GENES_TANYA_LIPIDS	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
0.597976080957%	13	2174	112	T2D_GENES_TANYA_LIPIDS	DOANE_BREAST_CANCER_ESR1_UP
0.597976080957%	13	2174	111	T2D_GENES_TANYA_LIPIDS	BOUDOUKHA_BOUND_BY_IGF2BP2
0.597976080957%	13	2174	108	T2D_GENES_TANYA_LIPIDS	LE_EGR2_TARGETS_UP
0.597976080957%	13	2174	108	T2D_GENES_TANYA_LIPIDS	LABBE_TGFB1_TARGETS_DN
0.597976080957%	13	2174	103	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
0.597976080957%	13	2174	103	T2D_GENES_TANYA_LIPIDS	KIM_MYCN_AMPLIFICATION_TARGETS_DN
0.597976080957%	13	2174	101	T2D_GENES_TANYA_LIPIDS	KOBAYASHI_EGFR_SIGNALING_24HR_UP
0.597976080957%	13	2174	101	T2D_GENES_TANYA_LIPIDS	KEGG_GNRH_SIGNALING_PATHWAY
0.597976080957%	13	2174	101	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_10HR_UP
0.597976080957%	13	2174	100	T2D_GENES_TANYA_LIPIDS	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
0.596590909091%	21	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450
0.596590909091%	21	3520	315	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
0.596590909091%	21	3520	255	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.596590909091%	21	3520	244	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	THUM_SYSTOLIC_HEART_FAILURE_DN
0.596590909091%	21	3520	232	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
0.596590909091%	21	3520	228	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
0.596590909091%	21	3520	223	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.596590909091%	21	3520	220	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
0.596590909091%	21	3520	216	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_G2_M
0.596590909091%	21	3520	214	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZWANG_EGF_INTERVAL_DN
0.596590909091%	21	3520	213	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WIERENGA_STAT5A_TARGETS_DN
0.596590909091%	21	3520	211	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
0.596590909091%	21	3520	208	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
0.596590909091%	21	3520	204	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
0.596590909091%	21	3520	184	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WU_CELL_MIGRATION
0.596590909091%	21	3520	178	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LI_AMPLIFIED_IN_LUNG_CANCER
0.596590909091%	21	3520	169	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PENG_GLUCOSE_DEPRIVATION_DN
0.596590909091%	21	3520	169	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ALZHEIMERS_DISEASE
0.596590909091%	21	3520	162	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MULLIGHAN_NPM1_SIGNATURE_3_DN
0.596590909091%	21	3520	160	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_P3
0.596590909091%	21	3520	158	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RODRIGUES_NTN1_TARGETS_DN
0.596590909091%	21	3520	157	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.596590909091%	21	3520	157	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SERVITJA_LIVER_HNF1A_TARGETS_DN
0.596590909091%	21	3520	149	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
0.596590909091%	21	3520	149	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUANG_GATA2_TARGETS_UP
0.596590909091%	21	3520	145	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMITH_TERT_TARGETS_UP
0.596590909091%	21	3520	143	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION
0.596590909091%	21	3520	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PENG_LEUCINE_DEPRIVATION_UP
0.596590909091%	21	3520	107	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.587920897916%	11	1871	92	T2D_GENES_TANYA_HEIGHT	KEGG_DILATED_CARDIOMYOPATHY
0.587920897916%	11	1871	88	T2D_GENES_TANYA_HEIGHT	DURCHDEWALD_SKIN_CARCINOGENESIS_UP
0.587920897916%	11	1871	86	T2D_GENES_TANYA_HEIGHT	BAELDE_DIABETIC_NEPHROPATHY_UP
0.587920897916%	11	1871	85	T2D_GENES_TANYA_HEIGHT	SANA_RESPONSE_TO_IFNG_DN
0.587920897916%	11	1871	85	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE
0.587920897916%	11	1871	85	T2D_GENES_TANYA_HEIGHT	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
0.587920897916%	11	1871	84	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_LUMINAL_A_UP
0.587920897916%	11	1871	83	T2D_GENES_TANYA_HEIGHT	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
0.587920897916%	11	1871	83	T2D_GENES_TANYA_HEIGHT	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
0.587920897916%	11	1871	81	T2D_GENES_TANYA_HEIGHT	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
0.587920897916%	11	1871	79	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
0.587920897916%	11	1871	79	T2D_GENES_TANYA_HEIGHT	PID_P73PATHWAY
0.587920897916%	11	1871	79	T2D_GENES_TANYA_HEIGHT	MEISSNER_NPC_HCP_WITH_H3K27ME3
0.587920897916%	11	1871	78	T2D_GENES_TANYA_HEIGHT	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
0.587920897916%	11	1871	77	T2D_GENES_TANYA_HEIGHT	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
0.587920897916%	11	1871	77	T2D_GENES_TANYA_HEIGHT	CHEBOTAEV_GR_TARGETS_UP
0.587920897916%	11	1871	76	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.587920897916%	11	1871	76	T2D_GENES_TANYA_HEIGHT	ROSS_AML_WITH_AML1_ETO_FUSION
0.587920897916%	11	1871	76	T2D_GENES_TANYA_HEIGHT	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
0.587920897916%	11	1871	75	T2D_GENES_TANYA_HEIGHT	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
0.587920897916%	11	1871	75	T2D_GENES_TANYA_HEIGHT	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
0.587920897916%	11	1871	74	T2D_GENES_TANYA_HEIGHT	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
0.587920897916%	11	1871	69	T2D_GENES_TANYA_HEIGHT	AMIT_EGF_RESPONSE_120_HELA
0.587920897916%	11	1871	68	T2D_GENES_TANYA_HEIGHT	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
0.587920897916%	11	1871	68	T2D_GENES_TANYA_HEIGHT	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES
0.587920897916%	11	1871	67	T2D_GENES_TANYA_HEIGHT	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN
0.587920897916%	11	1871	66	T2D_GENES_TANYA_HEIGHT	PID_TCR_PATHWAY
0.587920897916%	11	1871	65	T2D_GENES_TANYA_HEIGHT	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
0.587920897916%	11	1871	63	T2D_GENES_TANYA_HEIGHT	PID_IL12_2PATHWAY
0.587920897916%	11	1871	59	T2D_GENES_TANYA_HEIGHT	KEGG_RNA_DEGRADATION
0.587920897916%	11	1871	59	T2D_GENES_TANYA_HEIGHT	HUPER_BREAST_BASAL_VS_LUMINAL_DN
0.587920897916%	11	1871	58	T2D_GENES_TANYA_HEIGHT	MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.587920897916%	11	1871	57	T2D_GENES_TANYA_HEIGHT	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
0.587920897916%	11	1871	52	T2D_GENES_TANYA_HEIGHT	REACTOME_GABA_RECEPTOR_ACTIVATION
0.587920897916%	11	1871	48	T2D_GENES_TANYA_HEIGHT	OXFORD_RALA_OR_RALB_TARGETS_UP
0.587920897916%	11	1871	47	T2D_GENES_TANYA_HEIGHT	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.587920897916%	11	1871	38	T2D_GENES_TANYA_HEIGHT	REACTOME_GABA_B_RECEPTOR_ACTIVATION
0.587920897916%	11	1871	31	T2D_GENES_TANYA_HEIGHT	REACTOME_INWARDLY_RECTIFYING_K_CHANNELS
0.587920897916%	11	1871	194	T2D_GENES_TANYA_HEIGHT	PROVENZANI_METASTASIS_UP
0.587920897916%	11	1871	175	T2D_GENES_TANYA_HEIGHT	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.587920897916%	11	1871	172	T2D_GENES_TANYA_HEIGHT	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
0.587920897916%	11	1871	160	T2D_GENES_TANYA_HEIGHT	GAVIN_FOXP3_TARGETS_CLUSTER_P3
0.587920897916%	11	1871	160	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_6HR_DN
0.587920897916%	11	1871	158	T2D_GENES_TANYA_HEIGHT	RODRIGUES_NTN1_TARGETS_DN
0.587920897916%	11	1871	153	T2D_GENES_TANYA_HEIGHT	LU_AGING_BRAIN_DN
0.587920897916%	11	1871	150	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_30MIN_DN
0.587920897916%	11	1871	149	T2D_GENES_TANYA_HEIGHT	OHGUCHI_LIVER_HNF4A_TARGETS_DN
0.587920897916%	11	1871	144	T2D_GENES_TANYA_HEIGHT	BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.587920897916%	11	1871	142	T2D_GENES_TANYA_HEIGHT	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.587920897916%	11	1871	142	T2D_GENES_TANYA_HEIGHT	RUIZ_TNC_TARGETS_DN
0.587920897916%	11	1871	142	T2D_GENES_TANYA_HEIGHT	DARWICHE_SKIN_TUMOR_PROMOTER_UP
0.587920897916%	11	1871	138	T2D_GENES_TANYA_HEIGHT	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
0.587920897916%	11	1871	136	T2D_GENES_TANYA_HEIGHT	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.587920897916%	11	1871	128	T2D_GENES_TANYA_HEIGHT	POTTI_TOPOTECAN_SENSITIVITY
0.587920897916%	11	1871	128	T2D_GENES_TANYA_HEIGHT	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
0.587920897916%	11	1871	126	T2D_GENES_TANYA_HEIGHT	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
0.587920897916%	11	1871	123	T2D_GENES_TANYA_HEIGHT	DAZARD_RESPONSE_TO_UV_SCC_UP
0.587920897916%	11	1871	121	T2D_GENES_TANYA_HEIGHT	RODRIGUES_DCC_TARGETS_DN
0.587920897916%	11	1871	118	T2D_GENES_TANYA_HEIGHT	CERVERA_SDHB_TARGETS_1_UP
0.587920897916%	11	1871	117	T2D_GENES_TANYA_HEIGHT	PUJANA_BRCA_CENTERED_NETWORK
0.587920897916%	11	1871	116	T2D_GENES_TANYA_HEIGHT	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
0.587920897916%	11	1871	110	T2D_GENES_TANYA_HEIGHT	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.587920897916%	11	1871	108	T2D_GENES_TANYA_HEIGHT	WESTON_VEGFA_TARGETS
0.587920897916%	11	1871	108	T2D_GENES_TANYA_HEIGHT	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
0.587920897916%	11	1871	108	T2D_GENES_TANYA_HEIGHT	JAZAG_TGFB1_SIGNALING_UP
0.587920897916%	11	1871	108	T2D_GENES_TANYA_HEIGHT	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN
0.587920897916%	11	1871	107	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_ILS
0.587920897916%	11	1871	105	T2D_GENES_TANYA_HEIGHT	REACTOME_RNA_POL_II_TRANSCRIPTION
0.587920897916%	11	1871	105	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_8HR_UP
0.587920897916%	11	1871	104	T2D_GENES_TANYA_HEIGHT	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
0.587920897916%	11	1871	102	T2D_GENES_TANYA_HEIGHT	KEGG_MELANOGENESIS
0.587920897916%	11	1871	101	T2D_GENES_TANYA_HEIGHT	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
0.587920897916%	11	1871	101	T2D_GENES_TANYA_HEIGHT	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
0.587920897916%	11	1871	101	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_20HR_DN
0.587920897916%	11	1871	101	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_10HR_UP
0.587920897916%	11	1871	101	T2D_GENES_TANYA_HEIGHT	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.587920897916%	11	1871	100	T2D_GENES_TANYA_HEIGHT	WINZEN_DEGRADED_VIA_KHSRP
0.568181818182%	20	3520	336	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JOHNSTONE_PARVB_TARGETS_2_DN
0.568181818182%	20	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON
0.568181818182%	20	3520	293	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZWANG_DOWN_BY_2ND_EGF_PULSE
0.568181818182%	20	3520	289	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
0.568181818182%	20	3520	258	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
0.568181818182%	20	3520	258	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JAEGER_METASTASIS_DN
0.568181818182%	20	3520	251	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_AXON_GUIDANCE
0.568181818182%	20	3520	240	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	UDAYAKUMAR_MED1_TARGETS_DN
0.568181818182%	20	3520	238	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
0.568181818182%	20	3520	222	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
0.568181818182%	20	3520	222	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRANSLATION
0.568181818182%	20	3520	214	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIDUS_METASTASIS_UP
0.568181818182%	20	3520	212	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SANSOM_APC_TARGETS
0.568181818182%	20	3520	205	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PEREZ_TP53_AND_TP63_TARGETS
0.568181818182%	20	3520	198	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WELCSH_BRCA1_TARGETS_UP
0.568181818182%	20	3520	186	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
0.568181818182%	20	3520	176	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
0.568181818182%	20	3520	175	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FIRESTEIN_PROLIFERATION
0.568181818182%	20	3520	169	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
0.568181818182%	20	3520	169	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KATSANOU_ELAVL1_TARGETS_UP
0.568181818182%	20	3520	163	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
0.568181818182%	20	3520	159	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INTERFERON_SIGNALING
0.568181818182%	20	3520	153	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
0.568181818182%	20	3520	147	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMID_BREAST_CANCER_ERBB2_UP
0.568181818182%	20	3520	143	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DANG_MYC_TARGETS_UP
0.568181818182%	20	3520	140	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ONDER_CDH1_TARGETS_1_UP
0.568181818182%	20	3520	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_INSULIN_SIGNALING_PATHWAY
0.568181818182%	20	3520	132	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
0.568181818182%	20	3520	131	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.568181818182%	20	3520	130	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ELVIDGE_HYPOXIA_BY_DMOG_UP
0.568181818182%	20	3520	129	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWN_MYELOID_CELL_DEVELOPMENT_DN
0.568181818182%	20	3520	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
0.568181818182%	20	3520	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GERY_CEBP_TARGETS
0.568181818182%	20	3520	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHICAS_RB1_TARGETS_LOW_SERUM
0.557244174265%	11	1974	98	Mendelian_Nancy_Cox	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
0.557244174265%	11	1974	98	Mendelian_Nancy_Cox	MENSE_HYPOXIA_UP
0.557244174265%	11	1974	97	Mendelian_Nancy_Cox	KONG_E2F3_TARGETS
0.557244174265%	11	1974	96	Mendelian_Nancy_Cox	LIU_PROSTATE_CANCER_UP
0.557244174265%	11	1974	94	Mendelian_Nancy_Cox	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.557244174265%	11	1974	92	Mendelian_Nancy_Cox	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
0.557244174265%	11	1974	90	Mendelian_Nancy_Cox	MORI_IMMATURE_B_LYMPHOCYTE_DN
0.557244174265%	11	1974	89	Mendelian_Nancy_Cox	ZHANG_TLX_TARGETS_UP
0.557244174265%	11	1974	87	Mendelian_Nancy_Cox	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.557244174265%	11	1974	86	Mendelian_Nancy_Cox	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.557244174265%	11	1974	86	Mendelian_Nancy_Cox	HOEBEKE_LYMPHOID_STEM_CELL_DN
0.557244174265%	11	1974	85	Mendelian_Nancy_Cox	SANA_RESPONSE_TO_IFNG_DN
0.557244174265%	11	1974	85	Mendelian_Nancy_Cox	LEIN_CEREBELLUM_MARKERS
0.557244174265%	11	1974	81	Mendelian_Nancy_Cox	LEIN_MEDULLA_MARKERS
0.557244174265%	11	1974	80	Mendelian_Nancy_Cox	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN
0.557244174265%	11	1974	79	Mendelian_Nancy_Cox	TOOKER_GEMCITABINE_RESISTANCE_UP
0.557244174265%	11	1974	77	Mendelian_Nancy_Cox	SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.557244174265%	11	1974	77	Mendelian_Nancy_Cox	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
0.557244174265%	11	1974	77	Mendelian_Nancy_Cox	LIN_APC_TARGETS
0.557244174265%	11	1974	76	Mendelian_Nancy_Cox	ROSS_AML_WITH_AML1_ETO_FUSION
0.557244174265%	11	1974	76	Mendelian_Nancy_Cox	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
0.557244174265%	11	1974	75	Mendelian_Nancy_Cox	BAE_BRCA1_TARGETS_UP
0.557244174265%	11	1974	74	Mendelian_Nancy_Cox	VANASSE_BCL2_TARGETS_DN
0.557244174265%	11	1974	74	Mendelian_Nancy_Cox	DARWICHE_PAPILLOMA_PROGRESSION_RISK
0.557244174265%	11	1974	73	Mendelian_Nancy_Cox	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
0.557244174265%	11	1974	73	Mendelian_Nancy_Cox	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
0.557244174265%	11	1974	73	Mendelian_Nancy_Cox	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
0.557244174265%	11	1974	72	Mendelian_Nancy_Cox	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
0.557244174265%	11	1974	72	Mendelian_Nancy_Cox	DANG_REGULATED_BY_MYC_UP
0.557244174265%	11	1974	72	Mendelian_Nancy_Cox	BURTON_ADIPOGENESIS_2
0.557244174265%	11	1974	71	Mendelian_Nancy_Cox	KYNG_RESPONSE_TO_H2O2
0.557244174265%	11	1974	70	Mendelian_Nancy_Cox	PID_CDC42_PATHWAY
0.557244174265%	11	1974	70	Mendelian_Nancy_Cox	LIU_NASOPHARYNGEAL_CARCINOMA
0.557244174265%	11	1974	70	Mendelian_Nancy_Cox	ENGELMANN_CANCER_PROGENITORS_DN
0.557244174265%	11	1974	68	Mendelian_Nancy_Cox	DELPUECH_FOXO3_TARGETS_UP
0.557244174265%	11	1974	67	Mendelian_Nancy_Cox	VANHARANTA_UTERINE_FIBROID_DN
0.557244174265%	11	1974	66	Mendelian_Nancy_Cox	PID_HDAC_CLASSI_PATHWAY
0.557244174265%	11	1974	66	Mendelian_Nancy_Cox	NAKAMURA_ADIPOGENESIS_EARLY_UP
0.557244174265%	11	1974	66	Mendelian_Nancy_Cox	DIRMEIER_LMP1_RESPONSE_EARLY
0.557244174265%	11	1974	65	Mendelian_Nancy_Cox	PID_ERA_GENOMIC_PATHWAY
0.557244174265%	11	1974	64	Mendelian_Nancy_Cox	PETROVA_PROX1_TARGETS_DN
0.557244174265%	11	1974	64	Mendelian_Nancy_Cox	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.557244174265%	11	1974	64	Mendelian_Nancy_Cox	BYSTROEM_CORRELATED_WITH_IL5_DN
0.557244174265%	11	1974	62	Mendelian_Nancy_Cox	LEE_LIVER_CANCER_E2F1_UP
0.557244174265%	11	1974	62	Mendelian_Nancy_Cox	GEORGES_CELL_CYCLE_MIR192_TARGETS
0.557244174265%	11	1974	62	Mendelian_Nancy_Cox	CORRE_MULTIPLE_MYELOMA_DN
0.557244174265%	11	1974	61	Mendelian_Nancy_Cox	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.557244174265%	11	1974	61	Mendelian_Nancy_Cox	KAUFFMANN_MELANOMA_RELAPSE_UP
0.557244174265%	11	1974	60	Mendelian_Nancy_Cox	WIERENGA_STAT5A_TARGETS_GROUP2
0.557244174265%	11	1974	58	Mendelian_Nancy_Cox	SCHEIDEREIT_IKK_INTERACTING_PROTEINS
0.557244174265%	11	1974	58	Mendelian_Nancy_Cox	MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.557244174265%	11	1974	58	Mendelian_Nancy_Cox	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
0.557244174265%	11	1974	57	Mendelian_Nancy_Cox	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
0.557244174265%	11	1974	57	Mendelian_Nancy_Cox	MCCLUNG_CREB1_TARGETS_DN
0.557244174265%	11	1974	53	Mendelian_Nancy_Cox	MENSSEN_MYC_TARGETS
0.557244174265%	11	1974	53	Mendelian_Nancy_Cox	HENDRICKS_SMARCA4_TARGETS_DN
0.557244174265%	11	1974	51	Mendelian_Nancy_Cox	WANG_BARRETTS_ESOPHAGUS_UP
0.557244174265%	11	1974	51	Mendelian_Nancy_Cox	TSUNODA_CISPLATIN_RESISTANCE_DN
0.557244174265%	11	1974	51	Mendelian_Nancy_Cox	CROMER_TUMORIGENESIS_DN
0.557244174265%	11	1974	50	Mendelian_Nancy_Cox	PID_ANGIOPOIETINRECEPTOR_PATHWAY
0.557244174265%	11	1974	50	Mendelian_Nancy_Cox	MARTINEZ_RESPONSE_TO_TRABECTEDIN
0.557244174265%	11	1974	49	Mendelian_Nancy_Cox	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
0.557244174265%	11	1974	49	Mendelian_Nancy_Cox	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
0.557244174265%	11	1974	49	Mendelian_Nancy_Cox	REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS
0.557244174265%	11	1974	49	Mendelian_Nancy_Cox	LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE
0.557244174265%	11	1974	49	Mendelian_Nancy_Cox	LEE_LIVER_CANCER
0.557244174265%	11	1974	48	Mendelian_Nancy_Cox	TAVOR_CEBPA_TARGETS_UP
0.557244174265%	11	1974	48	Mendelian_Nancy_Cox	REACTOME_PI_METABOLISM
0.557244174265%	11	1974	48	Mendelian_Nancy_Cox	PID_HEDGEHOG_GLIPATHWAY
0.557244174265%	11	1974	48	Mendelian_Nancy_Cox	PENG_GLUCOSE_DEPRIVATION_UP
0.557244174265%	11	1974	48	Mendelian_Nancy_Cox	NADLER_OBESITY_DN
0.557244174265%	11	1974	48	Mendelian_Nancy_Cox	MCDOWELL_ACUTE_LUNG_INJURY_DN
0.557244174265%	11	1974	48	Mendelian_Nancy_Cox	KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.557244174265%	11	1974	48	Mendelian_Nancy_Cox	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
0.557244174265%	11	1974	47	Mendelian_Nancy_Cox	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP
0.557244174265%	11	1974	47	Mendelian_Nancy_Cox	PID_IL6_7PATHWAY
0.557244174265%	11	1974	46	Mendelian_Nancy_Cox	BIOCARTA_KERATINOCYTE_PATHWAY
0.557244174265%	11	1974	45	Mendelian_Nancy_Cox	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP
0.557244174265%	11	1974	45	Mendelian_Nancy_Cox	PID_INSULIN_PATHWAY
0.557244174265%	11	1974	45	Mendelian_Nancy_Cox	HUANG_FOXA2_TARGETS_UP
0.557244174265%	11	1974	44	Mendelian_Nancy_Cox	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
0.557244174265%	11	1974	44	Mendelian_Nancy_Cox	MARTIN_INTERACT_WITH_HDAC
0.557244174265%	11	1974	44	Mendelian_Nancy_Cox	KEGG_NUCLEOTIDE_EXCISION_REPAIR
0.557244174265%	11	1974	44	Mendelian_Nancy_Cox	JAEGER_METASTASIS_UP
0.557244174265%	11	1974	43	Mendelian_Nancy_Cox	RIZ_ERYTHROID_DIFFERENTIATION_12HR
0.557244174265%	11	1974	42	Mendelian_Nancy_Cox	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
0.557244174265%	11	1974	41	Mendelian_Nancy_Cox	KORKOLA_EMBRYONAL_CARCINOMA_UP
0.557244174265%	11	1974	41	Mendelian_Nancy_Cox	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM
0.557244174265%	11	1974	40	Mendelian_Nancy_Cox	VANASSE_BCL2_TARGETS_UP
0.557244174265%	11	1974	40	Mendelian_Nancy_Cox	PID_FOXM1PATHWAY
0.557244174265%	11	1974	40	Mendelian_Nancy_Cox	KEGG_TRYPTOPHAN_METABOLISM
0.557244174265%	11	1974	39	Mendelian_Nancy_Cox	SHIPP_DLBCL_CURED_VS_FATAL_UP
0.557244174265%	11	1974	39	Mendelian_Nancy_Cox	GU_PDEF_TARGETS_DN
0.557244174265%	11	1974	39	Mendelian_Nancy_Cox	BEIER_GLIOMA_STEM_CELL_UP
0.557244174265%	11	1974	38	Mendelian_Nancy_Cox	REACTOME_PI3K_AKT_ACTIVATION
0.557244174265%	11	1974	38	Mendelian_Nancy_Cox	REACTOME_GLUCOSE_TRANSPORT
0.557244174265%	11	1974	37	Mendelian_Nancy_Cox	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING
0.557244174265%	11	1974	36	Mendelian_Nancy_Cox	SEMENZA_HIF1_TARGETS
0.557244174265%	11	1974	35	Mendelian_Nancy_Cox	SCHRAETS_MLL_TARGETS_UP
0.557244174265%	11	1974	34	Mendelian_Nancy_Cox	REACTOME_GLUCONEOGENESIS
0.557244174265%	11	1974	34	Mendelian_Nancy_Cox	PID_ATM_PATHWAY
0.557244174265%	11	1974	33	Mendelian_Nancy_Cox	PID_SYNDECAN_2_PATHWAY
0.557244174265%	11	1974	33	Mendelian_Nancy_Cox	PID_NCADHERINPATHWAY
0.557244174265%	11	1974	33	Mendelian_Nancy_Cox	PID_IL12_STAT4PATHWAY
0.557244174265%	11	1974	32	Mendelian_Nancy_Cox	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.557244174265%	11	1974	32	Mendelian_Nancy_Cox	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM
0.557244174265%	11	1974	31	Mendelian_Nancy_Cox	SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN
0.557244174265%	11	1974	31	Mendelian_Nancy_Cox	PID_AR_NONGENOMIC_PATHWAY
0.557244174265%	11	1974	29	Mendelian_Nancy_Cox	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
0.557244174265%	11	1974	29	Mendelian_Nancy_Cox	PID_INTEGRIN2_PATHWAY
0.557244174265%	11	1974	28	Mendelian_Nancy_Cox	BIOCARTA_G1_PATHWAY
0.557244174265%	11	1974	27	Mendelian_Nancy_Cox	REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM
0.557244174265%	11	1974	27	Mendelian_Nancy_Cox	HOEGERKORP_CD44_TARGETS_DIRECT_UP
0.557244174265%	11	1974	26	Mendelian_Nancy_Cox	PID_ALK1PATHWAY
0.557244174265%	11	1974	26	Mendelian_Nancy_Cox	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
0.557244174265%	11	1974	25	Mendelian_Nancy_Cox	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG
0.557244174265%	11	1974	24	Mendelian_Nancy_Cox	BIOCARTA_TPO_PATHWAY
0.557244174265%	11	1974	23	Mendelian_Nancy_Cox	BIOCARTA_GLEEVEC_PATHWAY
0.557244174265%	11	1974	22	Mendelian_Nancy_Cox	PID_HEDGEHOG_2PATHWAY
0.557244174265%	11	1974	22	Mendelian_Nancy_Cox	KEGG_BETA_ALANINE_METABOLISM
0.557244174265%	11	1974	21	Mendelian_Nancy_Cox	BIOCARTA_TOB1_PATHWAY
0.557244174265%	11	1974	206	Mendelian_Nancy_Cox	LINSLEY_MIR16_TARGETS
0.557244174265%	11	1974	19	Mendelian_Nancy_Cox	BIOCARTA_TGFB_PATHWAY
0.557244174265%	11	1974	148	Mendelian_Nancy_Cox	WHITFIELD_CELL_CYCLE_M_G1
0.557244174265%	11	1974	14	Mendelian_Nancy_Cox	REACTOME_COMMON_PATHWAY
0.557244174265%	11	1974	124	Mendelian_Nancy_Cox	DAIRKEE_TERT_TARGETS_DN
0.557244174265%	11	1974	118	Mendelian_Nancy_Cox	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
0.557244174265%	11	1974	115	Mendelian_Nancy_Cox	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
0.557244174265%	11	1974	114	Mendelian_Nancy_Cox	BOSCO_TH1_CYTOTOXIC_MODULE
0.557244174265%	11	1974	105	Mendelian_Nancy_Cox	AMUNDSON_GENOTOXIC_SIGNATURE
0.557244174265%	11	1974	103	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
0.557244174265%	11	1974	102	Mendelian_Nancy_Cox	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.557244174265%	11	1974	100	Mendelian_Nancy_Cox	CHICAS_RB1_TARGETS_LOW_SERUM
0.554016620499%	2	361	98	T2D_GENES_TANYA_T2D_RSQ05_02CM	GUO_TARGETS_OF_IRS1_AND_IRS2
0.554016620499%	2	361	98	T2D_GENES_TANYA_T2D_RSQ05_02CM	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
0.554016620499%	2	361	98	T2D_GENES_TANYA_T2D_RSQ05_02CM	CROONQUIST_IL6_DEPRIVATION_DN
0.554016620499%	2	361	98	T2D_GENES_TANYA_T2D_RSQ05_02CM	BRUINS_UVC_RESPONSE_MIDDLE
0.554016620499%	2	361	97	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
0.554016620499%	2	361	97	T2D_GENES_TANYA_T2D_RSQ05_02CM	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
0.554016620499%	2	361	95	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
0.554016620499%	2	361	95	T2D_GENES_TANYA_T2D_RSQ05_02CM	HECKER_IFNB1_TARGETS
0.554016620499%	2	361	94	T2D_GENES_TANYA_T2D_RSQ05_02CM	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER
0.554016620499%	2	361	93	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHU_CMV_24_HR_UP
0.554016620499%	2	361	93	T2D_GENES_TANYA_T2D_RSQ05_02CM	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
0.554016620499%	2	361	93	T2D_GENES_TANYA_T2D_RSQ05_02CM	CADWELL_ATG16L1_TARGETS_UP
0.554016620499%	2	361	92	T2D_GENES_TANYA_T2D_RSQ05_02CM	WINTER_HYPOXIA_UP
0.554016620499%	2	361	92	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SYNTHESIS_OF_DNA
0.554016620499%	2	361	92	T2D_GENES_TANYA_T2D_RSQ05_02CM	DE_YY1_TARGETS_DN
0.554016620499%	2	361	92	T2D_GENES_TANYA_T2D_RSQ05_02CM	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
0.554016620499%	2	361	91	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHU_CMV_24_HR_DN
0.554016620499%	2	361	91	T2D_GENES_TANYA_T2D_RSQ05_02CM	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
0.554016620499%	2	361	90	T2D_GENES_TANYA_T2D_RSQ05_02CM	SASSON_RESPONSE_TO_FORSKOLIN_UP
0.554016620499%	2	361	90	T2D_GENES_TANYA_T2D_RSQ05_02CM	MORI_IMMATURE_B_LYMPHOCYTE_DN
0.554016620499%	2	361	90	T2D_GENES_TANYA_T2D_RSQ05_02CM	BILANGES_SERUM_SENSITIVE_GENES
0.554016620499%	2	361	9	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHU_SKIL_TARGETS_DN
0.554016620499%	2	361	89	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHANG_TLX_TARGETS_UP
0.554016620499%	2	361	89	T2D_GENES_TANYA_T2D_RSQ05_02CM	WNT_SIGNALING
0.554016620499%	2	361	89	T2D_GENES_TANYA_T2D_RSQ05_02CM	SWEET_KRAS_ONCOGENIC_SIGNATURE
0.554016620499%	2	361	89	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
0.554016620499%	2	361	89	T2D_GENES_TANYA_T2D_RSQ05_02CM	BHATTACHARYA_EMBRYONIC_STEM_CELL
0.554016620499%	2	361	88	T2D_GENES_TANYA_T2D_RSQ05_02CM	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
0.554016620499%	2	361	87	T2D_GENES_TANYA_T2D_RSQ05_02CM	SMITH_TERT_TARGETS_DN
0.554016620499%	2	361	87	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION
0.554016620499%	2	361	87	T2D_GENES_TANYA_T2D_RSQ05_02CM	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
0.554016620499%	2	361	87	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.554016620499%	2	361	86	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_AGING_CEREBELLUM_DN
0.554016620499%	2	361	86	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_TGF_BETA_SIGNALING_PATHWAY
0.554016620499%	2	361	86	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_16HR_DN
0.554016620499%	2	361	85	T2D_GENES_TANYA_T2D_RSQ05_02CM	XU_GH1_EXOGENOUS_TARGETS_UP
0.554016620499%	2	361	85	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEIN_CEREBELLUM_MARKERS
0.554016620499%	2	361	85	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
0.554016620499%	2	361	85	T2D_GENES_TANYA_T2D_RSQ05_02CM	COLDREN_GEFITINIB_RESISTANCE_UP
0.554016620499%	2	361	84	T2D_GENES_TANYA_T2D_RSQ05_02CM	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP
0.554016620499%	2	361	84	T2D_GENES_TANYA_T2D_RSQ05_02CM	SMID_BREAST_CANCER_LUMINAL_A_UP
0.554016620499%	2	361	84	T2D_GENES_TANYA_T2D_RSQ05_02CM	RUAN_RESPONSE_TO_TNF_DN
0.554016620499%	2	361	84	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_ECM_RECEPTOR_INTERACTION
0.554016620499%	2	361	84	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHANG_IMMORTALIZED_BY_HPV31_UP
0.554016620499%	2	361	83	T2D_GENES_TANYA_T2D_RSQ05_02CM	WARTERS_RESPONSE_TO_IR_SKIN
0.554016620499%	2	361	83	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
0.554016620499%	2	361	82	T2D_GENES_TANYA_T2D_RSQ05_02CM	ST_INTEGRIN_SIGNALING_PATHWAY
0.554016620499%	2	361	81	T2D_GENES_TANYA_T2D_RSQ05_02CM	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
0.554016620499%	2	361	80	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_UNFOLDED_PROTEIN_RESPONSE
0.554016620499%	2	361	80	T2D_GENES_TANYA_T2D_RSQ05_02CM	MORI_PRE_BI_LYMPHOCYTE_UP
0.554016620499%	2	361	80	T2D_GENES_TANYA_T2D_RSQ05_02CM	FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.554016620499%	2	361	8	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN
0.554016620499%	2	361	8	T2D_GENES_TANYA_T2D_RSQ05_02CM	OHM_EMBRYONIC_CARCINOMA_DN
0.554016620499%	2	361	8	T2D_GENES_TANYA_T2D_RSQ05_02CM	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3
0.554016620499%	2	361	79	T2D_GENES_TANYA_T2D_RSQ05_02CM	TOOKER_GEMCITABINE_RESISTANCE_UP
0.554016620499%	2	361	79	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_MYC_ACTIVPATHWAY
0.554016620499%	2	361	79	T2D_GENES_TANYA_T2D_RSQ05_02CM	MEISSNER_NPC_HCP_WITH_H3K27ME3
0.554016620499%	2	361	79	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIU_COMMON_CANCER_GENES
0.554016620499%	2	361	783	T2D_GENES_TANYA_T2D_RSQ05_02CM	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
0.554016620499%	2	361	78	T2D_GENES_TANYA_T2D_RSQ05_02CM	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
0.554016620499%	2	361	78	T2D_GENES_TANYA_T2D_RSQ05_02CM	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.554016620499%	2	361	77	T2D_GENES_TANYA_T2D_RSQ05_02CM	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
0.554016620499%	2	361	77	T2D_GENES_TANYA_T2D_RSQ05_02CM	RIZ_ERYTHROID_DIFFERENTIATION
0.554016620499%	2	361	77	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM
0.554016620499%	2	361	77	T2D_GENES_TANYA_T2D_RSQ05_02CM	FRIDMAN_SENESCENCE_UP
0.554016620499%	2	361	77	T2D_GENES_TANYA_T2D_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
0.554016620499%	2	361	76	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
0.554016620499%	2	361	76	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
0.554016620499%	2	361	76	T2D_GENES_TANYA_T2D_RSQ05_02CM	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
0.554016620499%	2	361	76	T2D_GENES_TANYA_T2D_RSQ05_02CM	PEART_HDAC_PROLIFERATION_CLUSTER_DN
0.554016620499%	2	361	76	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
0.554016620499%	2	361	75	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
0.554016620499%	2	361	74	T2D_GENES_TANYA_T2D_RSQ05_02CM	VANASSE_BCL2_TARGETS_DN
0.554016620499%	2	361	74	T2D_GENES_TANYA_T2D_RSQ05_02CM	DER_IFN_ALPHA_RESPONSE_UP
0.554016620499%	2	361	74	T2D_GENES_TANYA_T2D_RSQ05_02CM	DARWICHE_PAPILLOMA_PROGRESSION_RISK
0.554016620499%	2	361	74	T2D_GENES_TANYA_T2D_RSQ05_02CM	CORRE_MULTIPLE_MYELOMA_UP
0.554016620499%	2	361	73	T2D_GENES_TANYA_T2D_RSQ05_02CM	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
0.554016620499%	2	361	73	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIN_MELANOMA_COPY_NUMBER_UP
0.554016620499%	2	361	73	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_CHRONIC_MYELOID_LEUKEMIA
0.554016620499%	2	361	73	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOSHIDA_LIVER_CANCER_SURVIVAL_UP
0.554016620499%	2	361	72	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
0.554016620499%	2	361	72	T2D_GENES_TANYA_T2D_RSQ05_02CM	MATZUK_SPERMATOCYTE
0.554016620499%	2	361	71	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
0.554016620499%	2	361	70	T2D_GENES_TANYA_T2D_RSQ05_02CM	VERNELL_RETINOBLASTOMA_PATHWAY_UP
0.554016620499%	2	361	70	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_AP1_PATHWAY
0.554016620499%	2	361	70	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIU_NASOPHARYNGEAL_CARCINOMA
0.554016620499%	2	361	7	T2D_GENES_TANYA_T2D_RSQ05_02CM	MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN
0.554016620499%	2	361	69	T2D_GENES_TANYA_T2D_RSQ05_02CM	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.554016620499%	2	361	69	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_P53_SIGNALING_PATHWAY
0.554016620499%	2	361	69	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
0.554016620499%	2	361	68	T2D_GENES_TANYA_T2D_RSQ05_02CM	ROSS_AML_OF_FAB_M7_TYPE
0.554016620499%	2	361	67	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.554016620499%	2	361	67	T2D_GENES_TANYA_T2D_RSQ05_02CM	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
0.554016620499%	2	361	67	T2D_GENES_TANYA_T2D_RSQ05_02CM	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP
0.554016620499%	2	361	67	T2D_GENES_TANYA_T2D_RSQ05_02CM	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.554016620499%	2	361	66	T2D_GENES_TANYA_T2D_RSQ05_02CM	RAMASWAMY_METASTASIS_UP
0.554016620499%	2	361	66	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_HDAC_CLASSI_PATHWAY
0.554016620499%	2	361	66	T2D_GENES_TANYA_T2D_RSQ05_02CM	BRUNO_HEMATOPOIESIS
0.554016620499%	2	361	65	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
0.554016620499%	2	361	65	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
0.554016620499%	2	361	65	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_GLIOMA
0.554016620499%	2	361	65	T2D_GENES_TANYA_T2D_RSQ05_02CM	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP
0.554016620499%	2	361	64	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHANG_GATA6_TARGETS_DN
0.554016620499%	2	361	64	T2D_GENES_TANYA_T2D_RSQ05_02CM	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
0.554016620499%	2	361	64	T2D_GENES_TANYA_T2D_RSQ05_02CM	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
0.554016620499%	2	361	64	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
0.554016620499%	2	361	63	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_INTERFERON_GAMMA_SIGNALING
0.554016620499%	2	361	63	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_MYC_REPRESSPATHWAY
0.554016620499%	2	361	63	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_ENDOTHELINPATHWAY
0.554016620499%	2	361	63	T2D_GENES_TANYA_T2D_RSQ05_02CM	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
0.554016620499%	2	361	63	T2D_GENES_TANYA_T2D_RSQ05_02CM	JOHNSTONE_PARVB_TARGETS_1_DN
0.554016620499%	2	361	63	T2D_GENES_TANYA_T2D_RSQ05_02CM	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.554016620499%	2	361	62	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_LIVER_CANCER_E2F1_UP
0.554016620499%	2	361	62	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_COLORECTAL_CANCER
0.554016620499%	2	361	62	T2D_GENES_TANYA_T2D_RSQ05_02CM	GEORGES_CELL_CYCLE_MIR192_TARGETS
0.554016620499%	2	361	61	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_AR_PATHWAY
0.554016620499%	2	361	60	T2D_GENES_TANYA_T2D_RSQ05_02CM	OUILLETTE_CLL_13Q14_DELETION_DN
0.554016620499%	2	361	60	T2D_GENES_TANYA_T2D_RSQ05_02CM	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
0.554016620499%	2	361	60	T2D_GENES_TANYA_T2D_RSQ05_02CM	AMIT_EGF_RESPONSE_240_HELA
0.554016620499%	2	361	6	T2D_GENES_TANYA_T2D_RSQ05_02CM	WILLIAMS_ESR1_TARGETS_DN
0.554016620499%	2	361	59	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_P53REGULATIONPATHWAY
0.554016620499%	2	361	59	T2D_GENES_TANYA_T2D_RSQ05_02CM	ELVIDGE_HYPOXIA_BY_DMOG_DN
0.554016620499%	2	361	59	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1
0.554016620499%	2	361	58	T2D_GENES_TANYA_T2D_RSQ05_02CM	SANSOM_WNT_PATHWAY_REQUIRE_MYC
0.554016620499%	2	361	58	T2D_GENES_TANYA_T2D_RSQ05_02CM	MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.554016620499%	2	361	58	T2D_GENES_TANYA_T2D_RSQ05_02CM	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN
0.554016620499%	2	361	58	T2D_GENES_TANYA_T2D_RSQ05_02CM	BERNARD_PPAPDC1B_TARGETS_DN
0.554016620499%	2	361	57	T2D_GENES_TANYA_T2D_RSQ05_02CM	TANG_SENESCENCE_TP53_TARGETS_DN
0.554016620499%	2	361	57	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE
0.554016620499%	2	361	57	T2D_GENES_TANYA_T2D_RSQ05_02CM	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP
0.554016620499%	2	361	56	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.554016620499%	2	361	56	T2D_GENES_TANYA_T2D_RSQ05_02CM	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP
0.554016620499%	2	361	56	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOQUE_METHYLATED_IN_CANCER
0.554016620499%	2	361	55	T2D_GENES_TANYA_T2D_RSQ05_02CM	YU_MYC_TARGETS_DN
0.554016620499%	2	361	55	T2D_GENES_TANYA_T2D_RSQ05_02CM	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
0.554016620499%	2	361	54	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHOU_TNF_SIGNALING_30MIN
0.554016620499%	2	361	536	T2D_GENES_TANYA_T2D_RSQ05_02CM	SENESE_HDAC3_TARGETS_DN
0.554016620499%	2	361	53	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHU_CMV_8_HR_DN
0.554016620499%	2	361	53	T2D_GENES_TANYA_T2D_RSQ05_02CM	ISHIDA_E2F_TARGETS
0.554016620499%	2	361	53	T2D_GENES_TANYA_T2D_RSQ05_02CM	HENDRICKS_SMARCA4_TARGETS_DN
0.554016620499%	2	361	52	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_PTP1BPATHWAY
0.554016620499%	2	361	52	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHIBA_RESPONSE_TO_TSA_UP
0.554016620499%	2	361	52	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN
0.554016620499%	2	361	50	T2D_GENES_TANYA_T2D_RSQ05_02CM	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC
0.554016620499%	2	361	50	T2D_GENES_TANYA_T2D_RSQ05_02CM	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN
0.554016620499%	2	361	50	T2D_GENES_TANYA_T2D_RSQ05_02CM	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION
0.554016620499%	2	361	49	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_GLYCEROLIPID_METABOLISM
0.554016620499%	2	361	49	T2D_GENES_TANYA_T2D_RSQ05_02CM	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.554016620499%	2	361	487	T2D_GENES_TANYA_T2D_RSQ05_02CM	RODWELL_AGING_KIDNEY_UP
0.554016620499%	2	361	48	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_LB_UP
0.554016620499%	2	361	48	T2D_GENES_TANYA_T2D_RSQ05_02CM	RICKMAN_HEAD_AND_NECK_CANCER_B
0.554016620499%	2	361	48	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_HES_HEYPATHWAY
0.554016620499%	2	361	48	T2D_GENES_TANYA_T2D_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN
0.554016620499%	2	361	47	T2D_GENES_TANYA_T2D_RSQ05_02CM	WOOD_EBV_EBNA1_TARGETS_DN
0.554016620499%	2	361	47	T2D_GENES_TANYA_T2D_RSQ05_02CM	WARTERS_IR_RESPONSE_5GY
0.554016620499%	2	361	47	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_DELTANP63PATHWAY
0.554016620499%	2	361	47	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_NOTCH_SIGNALING_PATHWAY
0.554016620499%	2	361	47	T2D_GENES_TANYA_T2D_RSQ05_02CM	IRITANI_MAD1_TARGETS_DN
0.554016620499%	2	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6
0.554016620499%	2	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	SESTO_RESPONSE_TO_UV_C5
0.554016620499%	2	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
0.554016620499%	2	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
0.554016620499%	2	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_N_GLYCAN_BIOSYNTHESIS
0.554016620499%	2	361	457	T2D_GENES_TANYA_T2D_RSQ05_02CM	MILI_PSEUDOPODIA_CHEMOTAXIS_DN
0.554016620499%	2	361	450	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
0.554016620499%	2	361	45	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_PR_UP
0.554016620499%	2	361	45	T2D_GENES_TANYA_T2D_RSQ05_02CM	ST_T_CELL_SIGNAL_TRANSDUCTION
0.554016620499%	2	361	45	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHIPP_DLBCL_CURED_VS_FATAL_DN
0.554016620499%	2	361	45	T2D_GENES_TANYA_T2D_RSQ05_02CM	NUTT_GBM_VS_AO_GLIOMA_DN
0.554016620499%	2	361	45	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRADE_METASTASIS_DN
0.554016620499%	2	361	442	T2D_GENES_TANYA_T2D_RSQ05_02CM	HAN_SATB1_TARGETS_DN
0.554016620499%	2	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	WHITFIELD_CELL_CYCLE_LITERATURE
0.554016620499%	2	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARTIN_INTERACT_WITH_HDAC
0.554016620499%	2	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_ABC_TRANSPORTERS
0.554016620499%	2	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	GROSS_HYPOXIA_VIA_ELK3_ONLY_DN
0.554016620499%	2	361	439	T2D_GENES_TANYA_T2D_RSQ05_02CM	MITSIADES_RESPONSE_TO_APLIDIN_UP
0.554016620499%	2	361	431	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.554016620499%	2	361	43	T2D_GENES_TANYA_T2D_RSQ05_02CM	POTTI_5FU_SENSITIVITY
0.554016620499%	2	361	43	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
0.554016620499%	2	361	43	T2D_GENES_TANYA_T2D_RSQ05_02CM	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
0.554016620499%	2	361	43	T2D_GENES_TANYA_T2D_RSQ05_02CM	BURTON_ADIPOGENESIS_PEAK_AT_24HR
0.554016620499%	2	361	428	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
0.554016620499%	2	361	42	T2D_GENES_TANYA_T2D_RSQ05_02CM	WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN
0.554016620499%	2	361	42	T2D_GENES_TANYA_T2D_RSQ05_02CM	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
0.554016620499%	2	361	42	T2D_GENES_TANYA_T2D_RSQ05_02CM	LUI_THYROID_CANCER_CLUSTER_2
0.554016620499%	2	361	42	T2D_GENES_TANYA_T2D_RSQ05_02CM	HAHTOLA_SEZARY_SYNDROM_DN
0.554016620499%	2	361	42	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_CHREBP2_PATHWAY
0.554016620499%	2	361	408	T2D_GENES_TANYA_T2D_RSQ05_02CM	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
0.554016620499%	2	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	TOMLINS_PROSTATE_CANCER_UP
0.554016620499%	2	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	RIZ_ERYTHROID_DIFFERENTIATION_6HR
0.554016620499%	2	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	GENTILE_UV_RESPONSE_CLUSTER_D7
0.554016620499%	2	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHANGOLKAR_H2AFY_TARGETS_DN
0.554016620499%	2	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	BENPORATH_ES_2
0.554016620499%	2	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	AMUNDSON_GAMMA_RADIATION_RESPONSE
0.554016620499%	2	361	391	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN
0.554016620499%	2	361	39	T2D_GENES_TANYA_T2D_RSQ05_02CM	GU_PDEF_TARGETS_DN
0.554016620499%	2	361	384	T2D_GENES_TANYA_T2D_RSQ05_02CM	BASAKI_YBX1_TARGETS_DN
0.554016620499%	2	361	382	T2D_GENES_TANYA_T2D_RSQ05_02CM	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.554016620499%	2	361	38	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_GLUCOSE_TRANSPORT
0.554016620499%	2	361	37	T2D_GENES_TANYA_T2D_RSQ05_02CM	ROLEF_GLIS3_TARGETS
0.554016620499%	2	361	367	T2D_GENES_TANYA_T2D_RSQ05_02CM	DELACROIX_RARG_BOUND_MEF
0.554016620499%	2	361	36	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
0.554016620499%	2	361	36	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARZEC_IL2_SIGNALING_DN
0.554016620499%	2	361	36	T2D_GENES_TANYA_T2D_RSQ05_02CM	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP
0.554016620499%	2	361	351	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.554016620499%	2	361	35	T2D_GENES_TANYA_T2D_RSQ05_02CM	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.554016620499%	2	361	35	T2D_GENES_TANYA_T2D_RSQ05_02CM	HU_GENOTOXIC_DAMAGE_4HR
0.554016620499%	2	361	344	T2D_GENES_TANYA_T2D_RSQ05_02CM	RICKMAN_METASTASIS_UP
0.554016620499%	2	361	330	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_METABOLISM_OF_RNA
0.554016620499%	2	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_RNA_POL_III_TRANSCRIPTION
0.554016620499%	2	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	GREENBAUM_E2A_TARGETS_UP
0.554016620499%	2	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	FARMER_BREAST_CANCER_CLUSTER_2
0.554016620499%	2	361	32	T2D_GENES_TANYA_T2D_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM
0.554016620499%	2	361	32	T2D_GENES_TANYA_T2D_RSQ05_02CM	DORSAM_HOXA9_TARGETS_DN
0.554016620499%	2	361	311	T2D_GENES_TANYA_T2D_RSQ05_02CM	JIANG_HYPOXIA_NORMAL
0.554016620499%	2	361	31	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_INWARDLY_RECTIFYING_K_CHANNELS
0.554016620499%	2	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_RAS_PATHWAY
0.554016620499%	2	361	299	T2D_GENES_TANYA_T2D_RSQ05_02CM	MUELLER_PLURINET
0.554016620499%	2	361	298	T2D_GENES_TANYA_T2D_RSQ05_02CM	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
0.554016620499%	2	361	295	T2D_GENES_TANYA_T2D_RSQ05_02CM	LU_EZH2_TARGETS_UP
0.554016620499%	2	361	293	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHANG_TLX_TARGETS_60HR_UP
0.554016620499%	2	361	293	T2D_GENES_TANYA_T2D_RSQ05_02CM	ENK_UV_RESPONSE_EPIDERMIS_UP
0.554016620499%	2	361	29	T2D_GENES_TANYA_T2D_RSQ05_02CM	TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN
0.554016620499%	2	361	29	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX
0.554016620499%	2	361	29	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_THYROID_CANCER
0.554016620499%	2	361	284	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
0.554016620499%	2	361	284	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_METABOLISM_OF_MRNA
0.554016620499%	2	361	281	T2D_GENES_TANYA_T2D_RSQ05_02CM	MULLIGHAN_MLL_SIGNATURE_2_DN
0.554016620499%	2	361	281	T2D_GENES_TANYA_T2D_RSQ05_02CM	BHAT_ESR1_TARGETS_VIA_AKT1_UP
0.554016620499%	2	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	WEBER_METHYLATED_HCP_IN_SPERM_DN
0.554016620499%	2	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
0.554016620499%	2	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	MATZUK_MALE_REPRODUCTION_SERTOLI
0.554016620499%	2	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_G1_PATHWAY
0.554016620499%	2	361	279	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_INNATE_IMMUNE_SYSTEM
0.554016620499%	2	361	277	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHANG_TLX_TARGETS_60HR_DN
0.554016620499%	2	361	274	T2D_GENES_TANYA_T2D_RSQ05_02CM	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN
0.554016620499%	2	361	270	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM
0.554016620499%	2	361	27	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN
0.554016620499%	2	361	27	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING
0.554016620499%	2	361	27	T2D_GENES_TANYA_T2D_RSQ05_02CM	OHM_METHYLATED_IN_ADULT_CANCERS
0.554016620499%	2	361	269	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_CLIM2_TARGETS_UP
0.554016620499%	2	361	269	T2D_GENES_TANYA_T2D_RSQ05_02CM	MEISSNER_BRAIN_HCP_WITH_H3K27ME3
0.554016620499%	2	361	267	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_MAPK_SIGNALING_PATHWAY
0.554016620499%	2	361	267	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOLLMANN_APOPTOSIS_VIA_CD40_DN
0.554016620499%	2	361	266	T2D_GENES_TANYA_T2D_RSQ05_02CM	ROZANOV_MMP14_TARGETS_UP
0.554016620499%	2	361	262	T2D_GENES_TANYA_T2D_RSQ05_02CM	LU_AGING_BRAIN_UP
0.554016620499%	2	361	261	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
0.554016620499%	2	361	261	T2D_GENES_TANYA_T2D_RSQ05_02CM	RICKMAN_METASTASIS_DN
0.554016620499%	2	361	261	T2D_GENES_TANYA_T2D_RSQ05_02CM	BILD_HRAS_ONCOGENIC_SIGNATURE
0.554016620499%	2	361	260	T2D_GENES_TANYA_T2D_RSQ05_02CM	SENESE_HDAC1_TARGETS_DN
0.554016620499%	2	361	26	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_RXR_VDR_PATHWAY
0.554016620499%	2	361	26	T2D_GENES_TANYA_T2D_RSQ05_02CM	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
0.554016620499%	2	361	26	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_WNT_PATHWAY
0.554016620499%	2	361	259	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
0.554016620499%	2	361	254	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_4HR_DN
0.554016620499%	2	361	253	T2D_GENES_TANYA_T2D_RSQ05_02CM	DANG_REGULATED_BY_MYC_DN
0.554016620499%	2	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS
0.554016620499%	2	361	245	T2D_GENES_TANYA_T2D_RSQ05_02CM	PENG_RAPAMYCIN_RESPONSE_DN
0.554016620499%	2	361	244	T2D_GENES_TANYA_T2D_RSQ05_02CM	THUM_SYSTOLIC_HEART_FAILURE_DN
0.554016620499%	2	361	244	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAZARD_RESPONSE_TO_UV_NHEK_UP
0.554016620499%	2	361	243	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHICAS_RB1_TARGETS_GROWING
0.554016620499%	2	361	242	T2D_GENES_TANYA_T2D_RSQ05_02CM	WINTER_HYPOXIA_METAGENE
0.554016620499%	2	361	240	T2D_GENES_TANYA_T2D_RSQ05_02CM	UDAYAKUMAR_MED1_TARGETS_DN
0.554016620499%	2	361	239	T2D_GENES_TANYA_T2D_RSQ05_02CM	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.554016620499%	2	361	239	T2D_GENES_TANYA_T2D_RSQ05_02CM	ALFANO_MYC_TARGETS
0.554016620499%	2	361	238	T2D_GENES_TANYA_T2D_RSQ05_02CM	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
0.554016620499%	2	361	238	T2D_GENES_TANYA_T2D_RSQ05_02CM	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
0.554016620499%	2	361	237	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.554016620499%	2	361	236	T2D_GENES_TANYA_T2D_RSQ05_02CM	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
0.554016620499%	2	361	234	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
0.554016620499%	2	361	233	T2D_GENES_TANYA_T2D_RSQ05_02CM	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.554016620499%	2	361	232	T2D_GENES_TANYA_T2D_RSQ05_02CM	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
0.554016620499%	2	361	23	T2D_GENES_TANYA_T2D_RSQ05_02CM	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP
0.554016620499%	2	361	23	T2D_GENES_TANYA_T2D_RSQ05_02CM	EGUCHI_CELL_CYCLE_RB1_TARGETS
0.554016620499%	2	361	229	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
0.554016620499%	2	361	228	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
0.554016620499%	2	361	226	T2D_GENES_TANYA_T2D_RSQ05_02CM	KYNG_DNA_DAMAGE_UP
0.554016620499%	2	361	225	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_16HR_UP
0.554016620499%	2	361	222	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_TRANSLATION
0.554016620499%	2	361	221	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHANDRAN_METASTASIS_UP
0.554016620499%	2	361	220	T2D_GENES_TANYA_T2D_RSQ05_02CM	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
0.554016620499%	2	361	22	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_METAL_ION_SLC_TRANSPORTERS
0.554016620499%	2	361	22	T2D_GENES_TANYA_T2D_RSQ05_02CM	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN
0.554016620499%	2	361	217	T2D_GENES_TANYA_T2D_RSQ05_02CM	SANSOM_APC_MYC_TARGETS
0.554016620499%	2	361	216	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
0.554016620499%	2	361	216	T2D_GENES_TANYA_T2D_RSQ05_02CM	BOQUEST_STEM_CELL_DN
0.554016620499%	2	361	214	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZWANG_EGF_INTERVAL_DN
0.554016620499%	2	361	214	T2D_GENES_TANYA_T2D_RSQ05_02CM	TIEN_INTESTINE_PROBIOTICS_24HR_DN
0.554016620499%	2	361	214	T2D_GENES_TANYA_T2D_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
0.554016620499%	2	361	211	T2D_GENES_TANYA_T2D_RSQ05_02CM	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
0.554016620499%	2	361	210	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_TRANSCRIPTION
0.554016620499%	2	361	208	T2D_GENES_TANYA_T2D_RSQ05_02CM	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
0.554016620499%	2	361	206	T2D_GENES_TANYA_T2D_RSQ05_02CM	RAMALHO_STEMNESS_UP
0.554016620499%	2	361	205	T2D_GENES_TANYA_T2D_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
0.554016620499%	2	361	200	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
0.554016620499%	2	361	198	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_PHOSPHOLIPID_METABOLISM
0.554016620499%	2	361	197	T2D_GENES_TANYA_T2D_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
0.554016620499%	2	361	196	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
0.554016620499%	2	361	196	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
0.554016620499%	2	361	195	T2D_GENES_TANYA_T2D_RSQ05_02CM	KYNG_DNA_DAMAGE_DN
0.554016620499%	2	361	192	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_DNA_REPLICATION
0.554016620499%	2	361	191	T2D_GENES_TANYA_T2D_RSQ05_02CM	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
0.554016620499%	2	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	VERRECCHIA_RESPONSE_TO_TGFB1_C1
0.554016620499%	2	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	RUAN_RESPONSE_TO_TROGLITAZONE_DN
0.554016620499%	2	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	NAGY_TFTC_COMPONENTS_HUMAN
0.554016620499%	2	361	189	T2D_GENES_TANYA_T2D_RSQ05_02CM	BURTON_ADIPOGENESIS_6
0.554016620499%	2	361	188	T2D_GENES_TANYA_T2D_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
0.554016620499%	2	361	187	T2D_GENES_TANYA_T2D_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
0.554016620499%	2	361	187	T2D_GENES_TANYA_T2D_RSQ05_02CM	PENG_LEUCINE_DEPRIVATION_DN
0.554016620499%	2	361	187	T2D_GENES_TANYA_T2D_RSQ05_02CM	BAKKER_FOXO3_TARGETS_DN
0.554016620499%	2	361	186	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
0.554016620499%	2	361	185	T2D_GENES_TANYA_T2D_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.554016620499%	2	361	185	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_LIVER_CANCER_SURVIVAL_UP
0.554016620499%	2	361	184	T2D_GENES_TANYA_T2D_RSQ05_02CM	WU_CELL_MIGRATION
0.554016620499%	2	361	184	T2D_GENES_TANYA_T2D_RSQ05_02CM	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
0.554016620499%	2	361	183	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.554016620499%	2	361	183	T2D_GENES_TANYA_T2D_RSQ05_02CM	VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.554016620499%	2	361	183	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_ENDOCYTOSIS
0.554016620499%	2	361	182	T2D_GENES_TANYA_T2D_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.554016620499%	2	361	182	T2D_GENES_TANYA_T2D_RSQ05_02CM	FERNANDEZ_BOUND_BY_MYC
0.554016620499%	2	361	181	T2D_GENES_TANYA_T2D_RSQ05_02CM	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
0.554016620499%	2	361	181	T2D_GENES_TANYA_T2D_RSQ05_02CM	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
0.554016620499%	2	361	180	T2D_GENES_TANYA_T2D_RSQ05_02CM	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
0.554016620499%	2	361	18	T2D_GENES_TANYA_T2D_RSQ05_02CM	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
0.554016620499%	2	361	18	T2D_GENES_TANYA_T2D_RSQ05_02CM	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES
0.554016620499%	2	361	18	T2D_GENES_TANYA_T2D_RSQ05_02CM	AMIT_DELAYED_EARLY_GENES
0.554016620499%	2	361	179	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
0.554016620499%	2	361	178	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_CALCIUM_SIGNALING_PATHWAY
0.554016620499%	2	361	178	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_18HR_DN
0.554016620499%	2	361	176	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
0.554016620499%	2	361	176	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
0.554016620499%	2	361	176	T2D_GENES_TANYA_T2D_RSQ05_02CM	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
0.554016620499%	2	361	174	T2D_GENES_TANYA_T2D_RSQ05_02CM	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
0.554016620499%	2	361	173	T2D_GENES_TANYA_T2D_RSQ05_02CM	SENGUPTA_EBNA1_ANTICORRELATED
0.554016620499%	2	361	172	T2D_GENES_TANYA_T2D_RSQ05_02CM	SMID_BREAST_CANCER_LUMINAL_B_UP
0.554016620499%	2	361	170	T2D_GENES_TANYA_T2D_RSQ05_02CM	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
0.554016620499%	2	361	170	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.554016620499%	2	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_SYNDECAN_3_PATHWAY
0.554016620499%	2	361	169	T2D_GENES_TANYA_T2D_RSQ05_02CM	UEDA_PERIFERAL_CLOCK
0.554016620499%	2	361	168	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
0.554016620499%	2	361	166	T2D_GENES_TANYA_T2D_RSQ05_02CM	CAIRO_LIVER_DEVELOPMENT_UP
0.554016620499%	2	361	165	T2D_GENES_TANYA_T2D_RSQ05_02CM	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
0.554016620499%	2	361	164	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
0.554016620499%	2	361	164	T2D_GENES_TANYA_T2D_RSQ05_02CM	AMIT_EGF_RESPONSE_480_HELA
0.554016620499%	2	361	163	T2D_GENES_TANYA_T2D_RSQ05_02CM	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
0.554016620499%	2	361	162	T2D_GENES_TANYA_T2D_RSQ05_02CM	MULLIGHAN_NPM1_SIGNATURE_3_DN
0.554016620499%	2	361	162	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
0.554016620499%	2	361	16	T2D_GENES_TANYA_T2D_RSQ05_02CM	ABDELMOHSEN_ELAVL4_TARGETS
0.554016620499%	2	361	159	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_INTERFERON_SIGNALING
0.554016620499%	2	361	159	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_PURINE_METABOLISM
0.554016620499%	2	361	158	T2D_GENES_TANYA_T2D_RSQ05_02CM	RODRIGUES_NTN1_TARGETS_DN
0.554016620499%	2	361	157	T2D_GENES_TANYA_T2D_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.554016620499%	2	361	157	T2D_GENES_TANYA_T2D_RSQ05_02CM	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
0.554016620499%	2	361	154	T2D_GENES_TANYA_T2D_RSQ05_02CM	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
0.554016620499%	2	361	153	T2D_GENES_TANYA_T2D_RSQ05_02CM	DURAND_STROMA_MAX_DN
0.554016620499%	2	361	152	T2D_GENES_TANYA_T2D_RSQ05_02CM	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
0.554016620499%	2	361	151	T2D_GENES_TANYA_T2D_RSQ05_02CM	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
0.554016620499%	2	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ZINC_TRANSPORTERS
0.554016620499%	2	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	NAGY_STAGA_COMPONENTS_HUMAN
0.554016620499%	2	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	FERRANDO_LYL1_NEIGHBORS
0.554016620499%	2	361	149	T2D_GENES_TANYA_T2D_RSQ05_02CM	TSAI_RESPONSE_TO_IONIZING_RADIATION
0.554016620499%	2	361	148	T2D_GENES_TANYA_T2D_RSQ05_02CM	WEI_MIR34A_TARGETS
0.554016620499%	2	361	148	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_APOPTOSIS
0.554016620499%	2	361	148	T2D_GENES_TANYA_T2D_RSQ05_02CM	KATSANOU_ELAVL1_TARGETS_DN
0.554016620499%	2	361	148	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_24HR_UP
0.554016620499%	2	361	147	T2D_GENES_TANYA_T2D_RSQ05_02CM	SMID_BREAST_CANCER_ERBB2_UP
0.554016620499%	2	361	147	T2D_GENES_TANYA_T2D_RSQ05_02CM	DARWICHE_PAPILLOMA_RISK_HIGH_UP
0.554016620499%	2	361	146	T2D_GENES_TANYA_T2D_RSQ05_02CM	PECE_MAMMARY_STEM_CELL_UP
0.554016620499%	2	361	146	T2D_GENES_TANYA_T2D_RSQ05_02CM	KIM_ALL_DISORDERS_DURATION_CORR_DN
0.554016620499%	2	361	145	T2D_GENES_TANYA_T2D_RSQ05_02CM	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
0.554016620499%	2	361	145	T2D_GENES_TANYA_T2D_RSQ05_02CM	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
0.554016620499%	2	361	144	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.554016620499%	2	361	142	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
0.554016620499%	2	361	141	T2D_GENES_TANYA_T2D_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.554016620499%	2	361	14	T2D_GENES_TANYA_T2D_RSQ05_02CM	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP
0.554016620499%	2	361	14	T2D_GENES_TANYA_T2D_RSQ05_02CM	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
0.554016620499%	2	361	139	T2D_GENES_TANYA_T2D_RSQ05_02CM	ODONNELL_TFRC_TARGETS_DN
0.554016620499%	2	361	138	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
0.554016620499%	2	361	137	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
0.554016620499%	2	361	137	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_P53DOWNSTREAMPATHWAY
0.554016620499%	2	361	137	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.554016620499%	2	361	137	T2D_GENES_TANYA_T2D_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
0.554016620499%	2	361	135	T2D_GENES_TANYA_T2D_RSQ05_02CM	SERVITJA_LIVER_HNF1A_TARGETS_UP
0.554016620499%	2	361	134	T2D_GENES_TANYA_T2D_RSQ05_02CM	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
0.554016620499%	2	361	132	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
0.554016620499%	2	361	13	T2D_GENES_TANYA_T2D_RSQ05_02CM	SA_REG_CASCADE_OF_CYCLIN_EXPR
0.554016620499%	2	361	129	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAGI_AML_SURVIVAL
0.554016620499%	2	361	129	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_PDGFRBPATHWAY
0.554016620499%	2	361	129	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWN_MYELOID_CELL_DEVELOPMENT_DN
0.554016620499%	2	361	128	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
0.554016620499%	2	361	128	T2D_GENES_TANYA_T2D_RSQ05_02CM	YEGNASUBRAMANIAN_PROSTATE_CANCER
0.554016620499%	2	361	128	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_MEF_LCP_WITH_H3K4ME3
0.554016620499%	2	361	128	T2D_GENES_TANYA_T2D_RSQ05_02CM	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.554016620499%	2	361	128	T2D_GENES_TANYA_T2D_RSQ05_02CM	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS
0.554016620499%	2	361	127	T2D_GENES_TANYA_T2D_RSQ05_02CM	KARLSSON_TGFB1_TARGETS_UP
0.554016620499%	2	361	126	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
0.554016620499%	2	361	126	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
0.554016620499%	2	361	126	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
0.554016620499%	2	361	126	T2D_GENES_TANYA_T2D_RSQ05_02CM	GERY_CEBP_TARGETS
0.554016620499%	2	361	126	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
0.554016620499%	2	361	125	T2D_GENES_TANYA_T2D_RSQ05_02CM	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
0.554016620499%	2	361	125	T2D_GENES_TANYA_T2D_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_1_UP
0.554016620499%	2	361	124	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_CELL_CYCLE_CHECKPOINTS
0.554016620499%	2	361	124	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAIRKEE_TERT_TARGETS_DN
0.554016620499%	2	361	122	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SIGNALING_BY_PDGF
0.554016620499%	2	361	122	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
0.554016620499%	2	361	121	T2D_GENES_TANYA_T2D_RSQ05_02CM	VANTVEER_BREAST_CANCER_METASTASIS_DN
0.554016620499%	2	361	121	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS
0.554016620499%	2	361	121	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_LYSOSOME
0.554016620499%	2	361	121	T2D_GENES_TANYA_T2D_RSQ05_02CM	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
0.554016620499%	2	361	120	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHU_CMV_ALL_UP
0.554016620499%	2	361	120	T2D_GENES_TANYA_T2D_RSQ05_02CM	XU_GH1_EXOGENOUS_TARGETS_DN
0.554016620499%	2	361	12	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS
0.554016620499%	2	361	12	T2D_GENES_TANYA_T2D_RSQ05_02CM	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP
0.554016620499%	2	361	12	T2D_GENES_TANYA_T2D_RSQ05_02CM	BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1
0.554016620499%	2	361	118	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_NEURAL_CREST_STEM_CELL_DN
0.554016620499%	2	361	118	T2D_GENES_TANYA_T2D_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
0.554016620499%	2	361	116	T2D_GENES_TANYA_T2D_RSQ05_02CM	WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.554016620499%	2	361	116	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
0.554016620499%	2	361	116	T2D_GENES_TANYA_T2D_RSQ05_02CM	LI_INDUCED_T_TO_NATURAL_KILLER_DN
0.554016620499%	2	361	116	T2D_GENES_TANYA_T2D_RSQ05_02CM	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
0.554016620499%	2	361	116	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIM_MAMMARY_LUMINAL_MATURE_UP
0.554016620499%	2	361	116	T2D_GENES_TANYA_T2D_RSQ05_02CM	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
0.554016620499%	2	361	115	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
0.554016620499%	2	361	114	T2D_GENES_TANYA_T2D_RSQ05_02CM	LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.554016620499%	2	361	114	T2D_GENES_TANYA_T2D_RSQ05_02CM	CERVERA_SDHB_TARGETS_2
0.554016620499%	2	361	113	T2D_GENES_TANYA_T2D_RSQ05_02CM	RICKMAN_HEAD_AND_NECK_CANCER_C
0.554016620499%	2	361	113	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SIGNALING_BY_RHO_GTPASES
0.554016620499%	2	361	112	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_G1_S_TRANSITION
0.554016620499%	2	361	111	T2D_GENES_TANYA_T2D_RSQ05_02CM	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
0.554016620499%	2	361	111	T2D_GENES_TANYA_T2D_RSQ05_02CM	BOUDOUKHA_BOUND_BY_IGF2BP2
0.554016620499%	2	361	110	T2D_GENES_TANYA_T2D_RSQ05_02CM	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.554016620499%	2	361	11	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHOU_PANCREATIC_BETA_CELL
0.554016620499%	2	361	108	T2D_GENES_TANYA_T2D_RSQ05_02CM	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
0.554016620499%	2	361	108	T2D_GENES_TANYA_T2D_RSQ05_02CM	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
0.554016620499%	2	361	107	T2D_GENES_TANYA_T2D_RSQ05_02CM	ROESSLER_LIVER_CANCER_METASTASIS_UP
0.554016620499%	2	361	107	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_EARLY_T_LYMPHOCYTE_UP
0.554016620499%	2	361	105	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZWANG_EGF_INTERVAL_UP
0.554016620499%	2	361	104	T2D_GENES_TANYA_T2D_RSQ05_02CM	NAKAMURA_ADIPOGENESIS_LATE_UP
0.554016620499%	2	361	104	T2D_GENES_TANYA_T2D_RSQ05_02CM	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
0.554016620499%	2	361	103	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
0.554016620499%	2	361	103	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEIN_CHOROID_PLEXUS_MARKERS
0.554016620499%	2	361	102	T2D_GENES_TANYA_T2D_RSQ05_02CM	DER_IFN_BETA_RESPONSE_UP
0.554016620499%	2	361	102	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.554016620499%	2	361	101	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
0.554016620499%	2	361	101	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_GNRH_SIGNALING_PATHWAY
0.554016620499%	2	361	101	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_12HR_DN
0.554016620499%	2	361	100	T2D_GENES_TANYA_T2D_RSQ05_02CM	MCCLUNG_CREB1_TARGETS_UP
0.553505535055%	3	542	98	T2D_GENES_TANYA_ANTHROPOMETRIC	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
0.553505535055%	3	542	98	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
0.553505535055%	3	542	98	T2D_GENES_TANYA_ANTHROPOMETRIC	GAVIN_FOXP3_TARGETS_CLUSTER_T7
0.553505535055%	3	542	98	T2D_GENES_TANYA_ANTHROPOMETRIC	BRUINS_UVC_RESPONSE_MIDDLE
0.553505535055%	3	542	97	T2D_GENES_TANYA_ANTHROPOMETRIC	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
0.553505535055%	3	542	96	T2D_GENES_TANYA_ANTHROPOMETRIC	LIU_PROSTATE_CANCER_UP
0.553505535055%	3	542	95	T2D_GENES_TANYA_ANTHROPOMETRIC	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
0.553505535055%	3	542	94	T2D_GENES_TANYA_ANTHROPOMETRIC	LU_IL4_SIGNALING
0.553505535055%	3	542	93	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHU_CMV_24_HR_UP
0.553505535055%	3	542	92	T2D_GENES_TANYA_ANTHROPOMETRIC	WINTER_HYPOXIA_UP
0.553505535055%	3	542	92	T2D_GENES_TANYA_ANTHROPOMETRIC	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
0.553505535055%	3	542	92	T2D_GENES_TANYA_ANTHROPOMETRIC	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
0.553505535055%	3	542	91	T2D_GENES_TANYA_ANTHROPOMETRIC	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
0.553505535055%	3	542	90	T2D_GENES_TANYA_ANTHROPOMETRIC	IVANOVSKA_MIR106B_TARGETS
0.553505535055%	3	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
0.553505535055%	3	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	SWEET_KRAS_ONCOGENIC_SIGNATURE
0.553505535055%	3	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	LI_DCP2_BOUND_MRNA
0.553505535055%	3	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.553505535055%	3	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	LEIN_PONS_MARKERS
0.553505535055%	3	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_AGING_NEOCORTEX_UP
0.553505535055%	3	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
0.553505535055%	3	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.553505535055%	3	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_APOPTOSIS
0.553505535055%	3	542	87	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
0.553505535055%	3	542	87	T2D_GENES_TANYA_ANTHROPOMETRIC	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.553505535055%	3	542	87	T2D_GENES_TANYA_ANTHROPOMETRIC	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
0.553505535055%	3	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.553505535055%	3	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_AGING_CEREBELLUM_DN
0.553505535055%	3	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	BURTON_ADIPOGENESIS_8
0.553505535055%	3	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	BAELDE_DIABETIC_NEPHROPATHY_UP
0.553505535055%	3	542	85	T2D_GENES_TANYA_ANTHROPOMETRIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
0.553505535055%	3	542	85	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
0.553505535055%	3	542	85	T2D_GENES_TANYA_ANTHROPOMETRIC	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
0.553505535055%	3	542	85	T2D_GENES_TANYA_ANTHROPOMETRIC	COLDREN_GEFITINIB_RESISTANCE_UP
0.553505535055%	3	542	84	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
0.553505535055%	3	542	84	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_GLIS2_TARGETS_UP
0.553505535055%	3	542	84	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_SMALL_CELL_LUNG_CANCER
0.553505535055%	3	542	83	T2D_GENES_TANYA_ANTHROPOMETRIC	ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.553505535055%	3	542	83	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
0.553505535055%	3	542	82	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_INTEGRIN_SIGNALING_PATHWAY
0.553505535055%	3	542	82	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS
0.553505535055%	3	542	82	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_SMAD2_3NUCLEARPATHWAY
0.553505535055%	3	542	82	T2D_GENES_TANYA_ANTHROPOMETRIC	LEIN_MIDBRAIN_MARKERS
0.553505535055%	3	542	82	T2D_GENES_TANYA_ANTHROPOMETRIC	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
0.553505535055%	3	542	82	T2D_GENES_TANYA_ANTHROPOMETRIC	BHAT_ESR1_TARGETS_VIA_AKT1_DN
0.553505535055%	3	542	81	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_M_G1_TRANSITION
0.553505535055%	3	542	81	T2D_GENES_TANYA_ANTHROPOMETRIC	MUNSHI_MULTIPLE_MYELOMA_UP
0.553505535055%	3	542	81	T2D_GENES_TANYA_ANTHROPOMETRIC	LEIN_MEDULLA_MARKERS
0.553505535055%	3	542	81	T2D_GENES_TANYA_ANTHROPOMETRIC	HUANG_DASATINIB_RESISTANCE_UP
0.553505535055%	3	542	81	T2D_GENES_TANYA_ANTHROPOMETRIC	CROMER_METASTASIS_DN
0.553505535055%	3	542	80	T2D_GENES_TANYA_ANTHROPOMETRIC	WOO_LIVER_CANCER_RECURRENCE_DN
0.553505535055%	3	542	80	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
0.553505535055%	3	542	80	T2D_GENES_TANYA_ANTHROPOMETRIC	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN
0.553505535055%	3	542	79	T2D_GENES_TANYA_ANTHROPOMETRIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
0.553505535055%	3	542	79	T2D_GENES_TANYA_ANTHROPOMETRIC	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
0.553505535055%	3	542	79	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
0.553505535055%	3	542	79	T2D_GENES_TANYA_ANTHROPOMETRIC	DUAN_PRDM5_TARGETS
0.553505535055%	3	542	78	T2D_GENES_TANYA_ANTHROPOMETRIC	SANA_RESPONSE_TO_IFNG_UP
0.553505535055%	3	542	78	T2D_GENES_TANYA_ANTHROPOMETRIC	ROSS_AML_WITH_MLL_FUSIONS
0.553505535055%	3	542	78	T2D_GENES_TANYA_ANTHROPOMETRIC	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.553505535055%	3	542	78	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PLATELET_HOMEOSTASIS
0.553505535055%	3	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
0.553505535055%	3	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
0.553505535055%	3	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN
0.553505535055%	3	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	MORI_PRE_BI_LYMPHOCYTE_DN
0.553505535055%	3	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM
0.553505535055%	3	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	GROSS_HYPOXIA_VIA_HIF1A_UP
0.553505535055%	3	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	CARD_MIR302A_TARGETS
0.553505535055%	3	542	76	T2D_GENES_TANYA_ANTHROPOMETRIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.553505535055%	3	542	76	T2D_GENES_TANYA_ANTHROPOMETRIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
0.553505535055%	3	542	76	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION
0.553505535055%	3	542	76	T2D_GENES_TANYA_ANTHROPOMETRIC	PEART_HDAC_PROLIFERATION_CLUSTER_DN
0.553505535055%	3	542	75	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_AVB3_INTEGRIN_PATHWAY
0.553505535055%	3	542	75	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.553505535055%	3	542	75	T2D_GENES_TANYA_ANTHROPOMETRIC	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
0.553505535055%	3	542	75	T2D_GENES_TANYA_ANTHROPOMETRIC	BAE_BRCA1_TARGETS_UP
0.553505535055%	3	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	SHEPARD_BMYB_TARGETS
0.553505535055%	3	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
0.553505535055%	3	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	CAMPS_COLON_CANCER_COPY_NUMBER_DN
0.553505535055%	3	542	73	T2D_GENES_TANYA_ANTHROPOMETRIC	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
0.553505535055%	3	542	72	T2D_GENES_TANYA_ANTHROPOMETRIC	SESTO_RESPONSE_TO_UV_C1
0.553505535055%	3	542	72	T2D_GENES_TANYA_ANTHROPOMETRIC	MATZUK_SPERMATOCYTE
0.553505535055%	3	542	72	T2D_GENES_TANYA_ANTHROPOMETRIC	DANG_REGULATED_BY_MYC_UP
0.553505535055%	3	542	71	T2D_GENES_TANYA_ANTHROPOMETRIC	KUMAR_AUTOPHAGY_NETWORK
0.553505535055%	3	542	71	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.553505535055%	3	542	71	T2D_GENES_TANYA_ANTHROPOMETRIC	GU_PDEF_TARGETS_UP
0.553505535055%	3	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS
0.553505535055%	3	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	LANDIS_BREAST_CANCER_PROGRESSION_DN
0.553505535055%	3	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_LONG_TERM_DEPRESSION
0.553505535055%	3	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	ZAMORA_NOS2_TARGETS_UP
0.553505535055%	3	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.553505535055%	3	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.553505535055%	3	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	HUANG_DASATINIB_RESISTANCE_DN
0.553505535055%	3	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
0.553505535055%	3	542	68	T2D_GENES_TANYA_ANTHROPOMETRIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.553505535055%	3	542	68	T2D_GENES_TANYA_ANTHROPOMETRIC	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
0.553505535055%	3	542	68	T2D_GENES_TANYA_ANTHROPOMETRIC	SESTO_RESPONSE_TO_UV_C7
0.553505535055%	3	542	68	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
0.553505535055%	3	542	68	T2D_GENES_TANYA_ANTHROPOMETRIC	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
0.553505535055%	3	542	67	T2D_GENES_TANYA_ANTHROPOMETRIC	VANHARANTA_UTERINE_FIBROID_DN
0.553505535055%	3	542	67	T2D_GENES_TANYA_ANTHROPOMETRIC	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.553505535055%	3	542	67	T2D_GENES_TANYA_ANTHROPOMETRIC	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
0.553505535055%	3	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM
0.553505535055%	3	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
0.553505535055%	3	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_TCR_PATHWAY
0.553505535055%	3	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN
0.553505535055%	3	542	65	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX
0.553505535055%	3	542	65	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_CD8TCRDOWNSTREAMPATHWAY
0.553505535055%	3	542	65	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_LIVER_CANCER_ACOX1_DN
0.553505535055%	3	542	65	T2D_GENES_TANYA_ANTHROPOMETRIC	GUO_HEX_TARGETS_DN
0.553505535055%	3	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHANG_GATA6_TARGETS_DN
0.553505535055%	3	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
0.553505535055%	3	542	63	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_MYC_REPRESSPATHWAY
0.553505535055%	3	542	63	T2D_GENES_TANYA_ANTHROPOMETRIC	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
0.553505535055%	3	542	63	T2D_GENES_TANYA_ANTHROPOMETRIC	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
0.553505535055%	3	542	63	T2D_GENES_TANYA_ANTHROPOMETRIC	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.553505535055%	3	542	62	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_LIVER_CANCER_E2F1_UP
0.553505535055%	3	542	62	T2D_GENES_TANYA_ANTHROPOMETRIC	ISSAEVA_MLL2_TARGETS
0.553505535055%	3	542	61	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ER_PHAGOSOME_PATHWAY
0.553505535055%	3	542	61	T2D_GENES_TANYA_ANTHROPOMETRIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
0.553505535055%	3	542	60	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING
0.553505535055%	3	542	60	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_ACUTE_MYELOID_LEUKEMIA
0.553505535055%	3	542	60	T2D_GENES_TANYA_ANTHROPOMETRIC	AMIT_EGF_RESPONSE_240_HELA
0.553505535055%	3	542	59	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_P53REGULATIONPATHWAY
0.553505535055%	3	542	59	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_FAK_PATHWAY
0.553505535055%	3	542	59	T2D_GENES_TANYA_ANTHROPOMETRIC	ELVIDGE_HYPOXIA_BY_DMOG_DN
0.553505535055%	3	542	59	T2D_GENES_TANYA_ANTHROPOMETRIC	BARIS_THYROID_CANCER_DN
0.553505535055%	3	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHENG_GLIOBLASTOMA_PLASTICITY_DN
0.553505535055%	3	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.553505535055%	3	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_NPC_LCP_WITH_H3K4ME3
0.553505535055%	3	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	LUCAS_HNF4A_TARGETS_UP
0.553505535055%	3	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	JI_RESPONSE_TO_FSH_DN
0.553505535055%	3	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	DELASERNA_MYOD_TARGETS_DN
0.553505535055%	3	542	56	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_VIBRIO_CHOLERAE_INFECTION
0.553505535055%	3	542	56	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.553505535055%	3	542	56	T2D_GENES_TANYA_ANTHROPOMETRIC	GYORFFY_DOXORUBICIN_RESISTANCE
0.553505535055%	3	542	56	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_10HR_DN
0.553505535055%	3	542	55	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_STEROID_HORMONE_BIOSYNTHESIS
0.553505535055%	3	542	55	T2D_GENES_TANYA_ANTHROPOMETRIC	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR
0.553505535055%	3	542	55	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_4HR_UP
0.553505535055%	3	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	SU_PANCREAS
0.553505535055%	3	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE
0.553505535055%	3	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_RAC1_PATHWAY
0.553505535055%	3	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_IPS_ICP_WITH_H3K27ME3
0.553505535055%	3	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_LIVER_CANCER_MYC_UP
0.553505535055%	3	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	FIGUEROA_AML_METHYLATION_CLUSTER_2_UP
0.553505535055%	3	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP
0.553505535055%	3	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
0.553505535055%	3	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	SMIRNOV_RESPONSE_TO_IR_2HR_UP
0.553505535055%	3	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS
0.553505535055%	3	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0
0.553505535055%	3	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CIRCADIAN_CLOCK
0.553505535055%	3	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	MENSSEN_MYC_TARGETS
0.553505535055%	3	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GABA_RECEPTOR_ACTIVATION
0.553505535055%	3	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_CASPASE_PATHWAY
0.553505535055%	3	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	KENNY_CTNNB1_TARGETS_DN
0.553505535055%	3	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP
0.553505535055%	3	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF
0.553505535055%	3	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT
0.553505535055%	3	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_NUCLEOTIDE_EXCISION_REPAIR
0.553505535055%	3	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
0.553505535055%	3	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	BYSTROEM_CORRELATED_WITH_IL5_UP
0.553505535055%	3	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	BURTON_ADIPOGENESIS_PEAK_AT_2HR
0.553505535055%	3	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
0.553505535055%	3	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.553505535055%	3	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	MARTINEZ_RESPONSE_TO_TRABECTEDIN
0.553505535055%	3	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC
0.553505535055%	3	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
0.553505535055%	3	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_METABOLISM_OF_NON_CODING_RNA
0.553505535055%	3	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_FOXOPATHWAY
0.553505535055%	3	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.553505535055%	3	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	GERHOLD_ADIPOGENESIS_UP
0.553505535055%	3	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	FAELT_B_CLL_WITH_VH3_21_DN
0.553505535055%	3	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_HEDGEHOG_GLIPATHWAY
0.553505535055%	3	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	MCCLUNG_DELTA_FOSB_TARGETS_2WK
0.553505535055%	3	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	ENGELMANN_CANCER_PROGENITORS_UP
0.553505535055%	3	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
0.553505535055%	3	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	WARTERS_IR_RESPONSE_5GY
0.553505535055%	3	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	SILIGAN_BOUND_BY_EWS_FLT1_FUSION
0.553505535055%	3	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	SIG_BCR_SIGNALING_PATHWAY
0.553505535055%	3	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN
0.553505535055%	3	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_MULTIPLE_MYELOMA_CD2_UP
0.553505535055%	3	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP
0.553505535055%	3	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS
0.553505535055%	3	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
0.553505535055%	3	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS
0.553505535055%	3	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS
0.553505535055%	3	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION
0.553505535055%	3	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_NUCLEOTIDE_EXCISION_REPAIR
0.553505535055%	3	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	FAELT_B_CLL_WITH_VH3_21_UP
0.553505535055%	3	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	MILI_PSEUDOPODIA
0.553505535055%	3	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
0.553505535055%	3	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
0.553505535055%	3	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	DORN_ADENOVIRUS_INFECTION_24HR_DN
0.553505535055%	3	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
0.553505535055%	3	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRNA_AMINOACYLATION
0.553505535055%	3	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_ECADHERIN_STABILIZATION_PATHWAY
0.553505535055%	3	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP
0.553505535055%	3	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_GRAFT_VERSUS_HOST_DISEASE
0.553505535055%	3	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_BLADDER_CANCER
0.553505535055%	3	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	BILBAN_B_CLL_LPL_DN
0.553505535055%	3	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	WENG_POR_TARGETS_LIVER_UP
0.553505535055%	3	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_AMB2_NEUTROPHILS_PATHWAY
0.553505535055%	3	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS
0.553505535055%	3	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	GENTILE_UV_RESPONSE_CLUSTER_D2
0.553505535055%	3	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	DELPUECH_FOXO3_TARGETS_DN
0.553505535055%	3	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_FOXM1PATHWAY
0.553505535055%	3	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.553505535055%	3	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	BENPORATH_ES_2
0.553505535055%	3	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_LSD1_TARGETS_DN
0.553505535055%	3	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
0.553505535055%	3	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	MA_MYELOID_DIFFERENTIATION_UP
0.553505535055%	3	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	MATZUK_MEIOTIC_AND_DNA_REPAIR
0.553505535055%	3	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_FMLP_PATHWAY
0.553505535055%	3	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GABA_B_RECEPTOR_ACTIVATION
0.553505535055%	3	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_FASPATHWAY
0.553505535055%	3	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_ALLOGRAFT_REJECTION
0.553505535055%	3	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN
0.553505535055%	3	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN
0.553505535055%	3	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_TOLL_PATHWAY
0.553505535055%	3	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_MET_PATHWAY
0.553505535055%	3	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	BILANGES_SERUM_RESPONSE_TRANSLATION
0.553505535055%	3	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_ADRENERGIC
0.553505535055%	3	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
0.553505535055%	3	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION
0.553505535055%	3	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.553505535055%	3	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_G_ALPHA_I_PATHWAY
0.553505535055%	3	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GLOBAL_GENOMIC_NER_GG_NER
0.553505535055%	3	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_HIVNEFPATHWAY
0.553505535055%	3	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	HU_GENOTOXIC_DAMAGE_4HR
0.553505535055%	3	542	346	T2D_GENES_TANYA_ANTHROPOMETRIC	GOLDRATH_ANTIGEN_RESPONSE
0.553505535055%	3	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	SIG_CD40PATHWAYMAP
0.553505535055%	3	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_MAPKTRKPATHWAY
0.553505535055%	3	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	LUI_TARGETS_OF_PAX8_PPARG_FUSION
0.553505535055%	3	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_BUTANOATE_METABOLISM
0.553505535055%	3	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	JIANG_HYPOXIA_VIA_VHL
0.553505535055%	3	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_IL1R_PATHWAY
0.553505535055%	3	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	APPEL_IMATINIB_RESPONSE
0.553505535055%	3	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	TSAI_RESPONSE_TO_RADIATION_THERAPY
0.553505535055%	3	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_DAG_AND_IP3_SIGNALING
0.553505535055%	3	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_COMPLEMENT_CASCADE
0.553505535055%	3	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	DIRMEIER_LMP1_RESPONSE_LATE_DN
0.553505535055%	3	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.553505535055%	3	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	RIZ_ERYTHROID_DIFFERENTIATION_HEMGN
0.553505535055%	3	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS
0.553505535055%	3	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	CUI_TCF21_TARGETS_DN
0.553505535055%	3	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	YANAGIHARA_ESX1_TARGETS
0.553505535055%	3	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
0.553505535055%	3	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
0.553505535055%	3	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_IL2_STAT5PATHWAY
0.553505535055%	3	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_IGF1_PATHWAY
0.553505535055%	3	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_RESPONSE_TO_BEXAROTENE_DN
0.553505535055%	3	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.553505535055%	3	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	CHOW_RASSF1_TARGETS_DN
0.553505535055%	3	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_TNFR1_PATHWAY
0.553505535055%	3	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_INFLAM_PATHWAY
0.553505535055%	3	542	289	T2D_GENES_TANYA_ANTHROPOMETRIC	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
0.553505535055%	3	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	LUI_THYROID_CANCER_CLUSTER_3
0.553505535055%	3	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_G_PROTEIN_ACTIVATION
0.553505535055%	3	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	NICK_RESPONSE_TO_PROC_TREATMENT_DN
0.553505535055%	3	542	255	T2D_GENES_TANYA_ANTHROPOMETRIC	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.553505535055%	3	542	251	T2D_GENES_TANYA_ANTHROPOMETRIC	KOBAYASHI_EGFR_SIGNALING_24HR_DN
0.553505535055%	3	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG
0.553505535055%	3	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	YAN_ESCAPE_FROM_ANOIKIS
0.553505535055%	3	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	MATZUK_SPERMATOGONIA
0.553505535055%	3	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN
0.553505535055%	3	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	YANG_MUC2_TARGETS_DUODENUM_3MO_DN
0.553505535055%	3	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_GA12_PATHWAY
0.553505535055%	3	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GLUTATHIONE_CONJUGATION
0.553505535055%	3	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER
0.553505535055%	3	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_NFKB_PATHWAY
0.553505535055%	3	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	BILANGES_SERUM_SENSITIVE_VIA_TSC1
0.553505535055%	3	542	229	T2D_GENES_TANYA_ANTHROPOMETRIC	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
0.553505535055%	3	542	227	T2D_GENES_TANYA_ANTHROPOMETRIC	RAO_BOUND_BY_SALL4
0.553505535055%	3	542	226	T2D_GENES_TANYA_ANTHROPOMETRIC	KYNG_DNA_DAMAGE_UP
0.553505535055%	3	542	226	T2D_GENES_TANYA_ANTHROPOMETRIC	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.553505535055%	3	542	223	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.553505535055%	3	542	222	T2D_GENES_TANYA_ANTHROPOMETRIC	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
0.553505535055%	3	542	222	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_1HR_DN
0.553505535055%	3	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION
0.553505535055%	3	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
0.553505535055%	3	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
0.553505535055%	3	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_CERAMIDE_PATHWAY
0.553505535055%	3	542	217	T2D_GENES_TANYA_ANTHROPOMETRIC	WIERENGA_STAT5A_TARGETS_UP
0.553505535055%	3	542	216	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
0.553505535055%	3	542	214	T2D_GENES_TANYA_ANTHROPOMETRIC	BIDUS_METASTASIS_UP
0.553505535055%	3	542	210	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_TUMOR_INVASIVENESS_DN
0.553505535055%	3	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	YANG_MUC2_TARGETS_DUODENUM_6MO_DN
0.553505535055%	3	542	207	T2D_GENES_TANYA_ANTHROPOMETRIC	VERHAAK_GLIOBLASTOMA_CLASSICAL
0.553505535055%	3	542	205	T2D_GENES_TANYA_ANTHROPOMETRIC	PEREZ_TP53_AND_TP63_TARGETS
0.553505535055%	3	542	204	T2D_GENES_TANYA_ANTHROPOMETRIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
0.553505535055%	3	542	201	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_MYC_AMPLIFICATION_TARGETS_UP
0.553505535055%	3	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
0.553505535055%	3	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	PHESSE_TARGETS_OF_APC_AND_MBD2_UP
0.553505535055%	3	542	198	T2D_GENES_TANYA_ANTHROPOMETRIC	ALONSO_METASTASIS_UP
0.553505535055%	3	542	191	T2D_GENES_TANYA_ANTHROPOMETRIC	YAGI_AML_FAB_MARKERS
0.553505535055%	3	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	VERNOCHET_ADIPOGENESIS
0.553505535055%	3	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1
0.553505535055%	3	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_TID_PATHWAY
0.553505535055%	3	542	186	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_CLIM2_TARGETS_DN
0.553505535055%	3	542	185	T2D_GENES_TANYA_ANTHROPOMETRIC	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
0.553505535055%	3	542	185	T2D_GENES_TANYA_ANTHROPOMETRIC	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
0.553505535055%	3	542	184	T2D_GENES_TANYA_ANTHROPOMETRIC	WU_CELL_MIGRATION
0.553505535055%	3	542	184	T2D_GENES_TANYA_ANTHROPOMETRIC	DOANE_RESPONSE_TO_ANDROGEN_UP
0.553505535055%	3	542	182	T2D_GENES_TANYA_ANTHROPOMETRIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.553505535055%	3	542	181	T2D_GENES_TANYA_ANTHROPOMETRIC	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
0.553505535055%	3	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS
0.553505535055%	3	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_TNFR2_PATHWAY
0.553505535055%	3	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_ETS_PATHWAY
0.553505535055%	3	542	178	T2D_GENES_TANYA_ANTHROPOMETRIC	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
0.553505535055%	3	542	178	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_18HR_DN
0.553505535055%	3	542	175	T2D_GENES_TANYA_ANTHROPOMETRIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.553505535055%	3	542	175	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_LIVER_CANCER_SURVIVAL_DN
0.553505535055%	3	542	170	T2D_GENES_TANYA_ANTHROPOMETRIC	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
0.553505535055%	3	542	170	T2D_GENES_TANYA_ANTHROPOMETRIC	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.553505535055%	3	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	INGA_TP53_TARGETS
0.553505535055%	3	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_PML_PATHWAY
0.553505535055%	3	542	169	T2D_GENES_TANYA_ANTHROPOMETRIC	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
0.553505535055%	3	542	167	T2D_GENES_TANYA_ANTHROPOMETRIC	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
0.553505535055%	3	542	165	T2D_GENES_TANYA_ANTHROPOMETRIC	LIU_CMYB_TARGETS_UP
0.553505535055%	3	542	165	T2D_GENES_TANYA_ANTHROPOMETRIC	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
0.553505535055%	3	542	163	T2D_GENES_TANYA_ANTHROPOMETRIC	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
0.553505535055%	3	542	162	T2D_GENES_TANYA_ANTHROPOMETRIC	WINNEPENNINCKX_MELANOMA_METASTASIS_UP
0.553505535055%	3	542	162	T2D_GENES_TANYA_ANTHROPOMETRIC	DARWICHE_PAPILLOMA_RISK_LOW_UP
0.553505535055%	3	542	161	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MRNA_PROCESSING
0.553505535055%	3	542	160	T2D_GENES_TANYA_ANTHROPOMETRIC	GAVIN_FOXP3_TARGETS_CLUSTER_P3
0.553505535055%	3	542	160	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_6HR_DN
0.553505535055%	3	542	160	T2D_GENES_TANYA_ANTHROPOMETRIC	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
0.553505535055%	3	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	WU_HBX_TARGETS_2_DN
0.553505535055%	3	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT
0.553505535055%	3	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_RELA_PATHWAY
0.553505535055%	3	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_CDMAC_PATHWAY
0.553505535055%	3	542	159	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
0.553505535055%	3	542	159	T2D_GENES_TANYA_ANTHROPOMETRIC	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
0.553505535055%	3	542	157	T2D_GENES_TANYA_ANTHROPOMETRIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.553505535055%	3	542	155	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_JAK_STAT_SIGNALING_PATHWAY
0.553505535055%	3	542	151	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_WNT_SIGNALING_PATHWAY
0.553505535055%	3	542	150	T2D_GENES_TANYA_ANTHROPOMETRIC	LANDIS_ERBB2_BREAST_TUMORS_324_UP
0.553505535055%	3	542	146	T2D_GENES_TANYA_ANTHROPOMETRIC	PECE_MAMMARY_STEM_CELL_DN
0.553505535055%	3	542	145	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHANG_BREAST_CANCER_PROGENITORS_DN
0.553505535055%	3	542	145	T2D_GENES_TANYA_ANTHROPOMETRIC	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.553505535055%	3	542	143	T2D_GENES_TANYA_ANTHROPOMETRIC	BASSO_B_LYMPHOCYTE_NETWORK
0.553505535055%	3	542	142	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_ES_LCP_WITH_H3K4ME3
0.553505535055%	3	542	141	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
0.553505535055%	3	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP
0.553505535055%	3	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_REGULATION_OF_COMPLEMENT_CASCADE
0.553505535055%	3	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_CLASSIC_PATHWAY
0.553505535055%	3	542	138	T2D_GENES_TANYA_ANTHROPOMETRIC	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
0.553505535055%	3	542	134	T2D_GENES_TANYA_ANTHROPOMETRIC	POOLA_INVASIVE_BREAST_CANCER_DN
0.553505535055%	3	542	131	T2D_GENES_TANYA_ANTHROPOMETRIC	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
0.553505535055%	3	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	WU_HBX_TARGETS_3_DN
0.553505535055%	3	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY
0.553505535055%	3	542	128	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
0.553505535055%	3	542	128	T2D_GENES_TANYA_ANTHROPOMETRIC	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS
0.553505535055%	3	542	127	T2D_GENES_TANYA_ANTHROPOMETRIC	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.553505535055%	3	542	125	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_HIV_LIFE_CYCLE
0.553505535055%	3	542	125	T2D_GENES_TANYA_ANTHROPOMETRIC	FIGUEROA_AML_METHYLATION_CLUSTER_1_UP
0.553505535055%	3	542	125	T2D_GENES_TANYA_ANTHROPOMETRIC	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
0.553505535055%	3	542	124	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CELL_CYCLE_CHECKPOINTS
0.553505535055%	3	542	123	T2D_GENES_TANYA_ANTHROPOMETRIC	KAYO_AGING_MUSCLE_DN
0.553505535055%	3	542	123	T2D_GENES_TANYA_ANTHROPOMETRIC	DAZARD_RESPONSE_TO_UV_SCC_UP
0.553505535055%	3	542	122	T2D_GENES_TANYA_ANTHROPOMETRIC	TOOKER_GEMCITABINE_RESISTANCE_DN
0.553505535055%	3	542	121	T2D_GENES_TANYA_ANTHROPOMETRIC	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
0.553505535055%	3	542	121	T2D_GENES_TANYA_ANTHROPOMETRIC	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
0.553505535055%	3	542	120	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHU_CMV_ALL_UP
0.553505535055%	3	542	120	T2D_GENES_TANYA_ANTHROPOMETRIC	XU_GH1_EXOGENOUS_TARGETS_DN
0.553505535055%	3	542	120	T2D_GENES_TANYA_ANTHROPOMETRIC	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN
0.553505535055%	3	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_LECTIN_PATHWAY
0.553505535055%	3	542	118	T2D_GENES_TANYA_ANTHROPOMETRIC	MARKEY_RB1_CHRONIC_LOF_DN
0.553505535055%	3	542	118	T2D_GENES_TANYA_ANTHROPOMETRIC	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
0.553505535055%	3	542	118	T2D_GENES_TANYA_ANTHROPOMETRIC	CERVERA_SDHB_TARGETS_1_UP
0.553505535055%	3	542	117	T2D_GENES_TANYA_ANTHROPOMETRIC	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.553505535055%	3	542	116	T2D_GENES_TANYA_ANTHROPOMETRIC	MATTIOLI_MGUS_VS_PCL
0.553505535055%	3	542	116	T2D_GENES_TANYA_ANTHROPOMETRIC	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
0.553505535055%	3	542	115	T2D_GENES_TANYA_ANTHROPOMETRIC	MARKEY_RB1_CHRONIC_LOF_UP
0.553505535055%	3	542	115	T2D_GENES_TANYA_ANTHROPOMETRIC	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
0.553505535055%	3	542	114	T2D_GENES_TANYA_ANTHROPOMETRIC	SMIRNOV_RESPONSE_TO_IR_6HR_DN
0.553505535055%	3	542	114	T2D_GENES_TANYA_ANTHROPOMETRIC	MATZUK_SPERMATOZOA
0.553505535055%	3	542	114	T2D_GENES_TANYA_ANTHROPOMETRIC	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN
0.553505535055%	3	542	114	T2D_GENES_TANYA_ANTHROPOMETRIC	LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.553505535055%	3	542	114	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_OOCYTE_MEIOSIS
0.553505535055%	3	542	113	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_RHO_GTPASES
0.553505535055%	3	542	113	T2D_GENES_TANYA_ANTHROPOMETRIC	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
0.553505535055%	3	542	112	T2D_GENES_TANYA_ANTHROPOMETRIC	DITTMER_PTHLH_TARGETS_UP
0.553505535055%	3	542	111	T2D_GENES_TANYA_ANTHROPOMETRIC	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.553505535055%	3	542	110	T2D_GENES_TANYA_ANTHROPOMETRIC	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
0.553505535055%	3	542	110	T2D_GENES_TANYA_ANTHROPOMETRIC	GHANDHI_DIRECT_IRRADIATION_UP
0.553505535055%	3	542	110	T2D_GENES_TANYA_ANTHROPOMETRIC	CHENG_IMPRINTED_BY_ESTRADIOL
0.553505535055%	3	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS
0.553505535055%	3	542	109	T2D_GENES_TANYA_ANTHROPOMETRIC	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
0.553505535055%	3	542	108	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHANG_TLX_TARGETS_DN
0.553505535055%	3	542	105	T2D_GENES_TANYA_ANTHROPOMETRIC	WOO_LIVER_CANCER_RECURRENCE_UP
0.553505535055%	3	542	105	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_8HR_UP
0.553505535055%	3	542	104	T2D_GENES_TANYA_ANTHROPOMETRIC	NAKAMURA_ADIPOGENESIS_LATE_UP
0.553505535055%	3	542	104	T2D_GENES_TANYA_ANTHROPOMETRIC	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
0.553505535055%	3	542	103	T2D_GENES_TANYA_ANTHROPOMETRIC	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
0.553505535055%	3	542	103	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_NOTCH
0.553505535055%	3	542	103	T2D_GENES_TANYA_ANTHROPOMETRIC	LEIN_CHOROID_PLEXUS_MARKERS
0.553505535055%	3	542	102	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.553505535055%	3	542	102	T2D_GENES_TANYA_ANTHROPOMETRIC	DER_IFN_BETA_RESPONSE_UP
0.553505535055%	3	542	102	T2D_GENES_TANYA_ANTHROPOMETRIC	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.553505535055%	3	542	101	T2D_GENES_TANYA_ANTHROPOMETRIC	KOBAYASHI_EGFR_SIGNALING_24HR_UP
0.553505535055%	3	542	100	T2D_GENES_TANYA_ANTHROPOMETRIC	MCCLUNG_CREB1_TARGETS_UP
0.553505535055%	3	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ANDROGEN_BIOSYNTHESIS
0.551977920883%	12	2174	99	T2D_GENES_TANYA_LIPIDS	LIM_MAMMARY_LUMINAL_MATURE_DN
0.551977920883%	12	2174	98	T2D_GENES_TANYA_LIPIDS	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
0.551977920883%	12	2174	98	T2D_GENES_TANYA_LIPIDS	HAHTOLA_SEZARY_SYNDROM_UP
0.551977920883%	12	2174	97	T2D_GENES_TANYA_LIPIDS	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP
0.551977920883%	12	2174	96	T2D_GENES_TANYA_LIPIDS	ZAMORA_NOS2_TARGETS_DN
0.551977920883%	12	2174	94	T2D_GENES_TANYA_LIPIDS	LU_IL4_SIGNALING
0.551977920883%	12	2174	88	T2D_GENES_TANYA_LIPIDS	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
0.551977920883%	12	2174	87	T2D_GENES_TANYA_LIPIDS	MOOTHA_VOXPHOS
0.551977920883%	12	2174	87	T2D_GENES_TANYA_LIPIDS	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
0.551977920883%	12	2174	86	T2D_GENES_TANYA_LIPIDS	LEE_AGING_CEREBELLUM_DN
0.551977920883%	12	2174	85	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE
0.551977920883%	12	2174	84	T2D_GENES_TANYA_LIPIDS	HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.551977920883%	12	2174	83	T2D_GENES_TANYA_LIPIDS	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
0.551977920883%	12	2174	80	T2D_GENES_TANYA_LIPIDS	LEE_AGING_NEOCORTEX_DN
0.551977920883%	12	2174	78	T2D_GENES_TANYA_LIPIDS	SANA_RESPONSE_TO_IFNG_UP
0.551977920883%	12	2174	77	T2D_GENES_TANYA_LIPIDS	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN
0.551977920883%	12	2174	76	T2D_GENES_TANYA_LIPIDS	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
0.551977920883%	12	2174	76	T2D_GENES_TANYA_LIPIDS	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
0.551977920883%	12	2174	75	T2D_GENES_TANYA_LIPIDS	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
0.551977920883%	12	2174	74	T2D_GENES_TANYA_LIPIDS	VANASSE_BCL2_TARGETS_DN
0.551977920883%	12	2174	74	T2D_GENES_TANYA_LIPIDS	RAMALHO_STEMNESS_DN
0.551977920883%	12	2174	74	T2D_GENES_TANYA_LIPIDS	FURUKAWA_DUSP6_TARGETS_PCI35_UP
0.551977920883%	12	2174	73	T2D_GENES_TANYA_LIPIDS	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
0.551977920883%	12	2174	73	T2D_GENES_TANYA_LIPIDS	GAURNIER_PSMD4_TARGETS
0.551977920883%	12	2174	72	T2D_GENES_TANYA_LIPIDS	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1
0.551977920883%	12	2174	72	T2D_GENES_TANYA_LIPIDS	MATZUK_SPERMATOCYTE
0.551977920883%	12	2174	72	T2D_GENES_TANYA_LIPIDS	KEGG_LEISHMANIA_INFECTION
0.551977920883%	12	2174	71	T2D_GENES_TANYA_LIPIDS	KYNG_RESPONSE_TO_H2O2
0.551977920883%	12	2174	71	T2D_GENES_TANYA_LIPIDS	GEORGANTAS_HSC_MARKERS
0.551977920883%	12	2174	70	T2D_GENES_TANYA_LIPIDS	REACTOME_PHASE_II_CONJUGATION
0.551977920883%	12	2174	68	T2D_GENES_TANYA_LIPIDS	ROSS_AML_OF_FAB_M7_TYPE
0.551977920883%	12	2174	68	T2D_GENES_TANYA_LIPIDS	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
0.551977920883%	12	2174	66	T2D_GENES_TANYA_LIPIDS	PID_TCR_PATHWAY
0.551977920883%	12	2174	66	T2D_GENES_TANYA_LIPIDS	PID_LYSOPHOSPHOLIPID_PATHWAY
0.551977920883%	12	2174	65	T2D_GENES_TANYA_LIPIDS	ST_FAS_SIGNALING_PATHWAY
0.551977920883%	12	2174	65	T2D_GENES_TANYA_LIPIDS	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX
0.551977920883%	12	2174	65	T2D_GENES_TANYA_LIPIDS	KEGG_GLIOMA
0.551977920883%	12	2174	64	T2D_GENES_TANYA_LIPIDS	REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C
0.551977920883%	12	2174	63	T2D_GENES_TANYA_LIPIDS	BURTON_ADIPOGENESIS_PEAK_AT_0HR
0.551977920883%	12	2174	61	T2D_GENES_TANYA_LIPIDS	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.551977920883%	12	2174	60	T2D_GENES_TANYA_LIPIDS	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING
0.551977920883%	12	2174	59	T2D_GENES_TANYA_LIPIDS	PID_P53REGULATIONPATHWAY
0.551977920883%	12	2174	59	T2D_GENES_TANYA_LIPIDS	BARIS_THYROID_CANCER_DN
0.551977920883%	12	2174	58	T2D_GENES_TANYA_LIPIDS	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
0.551977920883%	12	2174	57	T2D_GENES_TANYA_LIPIDS	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
0.551977920883%	12	2174	56	T2D_GENES_TANYA_LIPIDS	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP
0.551977920883%	12	2174	54	T2D_GENES_TANYA_LIPIDS	KEGG_ARGININE_AND_PROLINE_METABOLISM
0.551977920883%	12	2174	51	T2D_GENES_TANYA_LIPIDS	KEGG_DRUG_METABOLISM_OTHER_ENZYMES
0.551977920883%	12	2174	49	T2D_GENES_TANYA_LIPIDS	OLSSON_E2F3_TARGETS_DN
0.551977920883%	12	2174	49	T2D_GENES_TANYA_LIPIDS	GERHOLD_ADIPOGENESIS_UP
0.551977920883%	12	2174	49	T2D_GENES_TANYA_LIPIDS	BIOCARTA_TCR_PATHWAY
0.551977920883%	12	2174	42	T2D_GENES_TANYA_LIPIDS	PID_UPA_UPAR_PATHWAY
0.551977920883%	12	2174	42	T2D_GENES_TANYA_LIPIDS	KEGG_TYROSINE_METABOLISM
0.551977920883%	12	2174	38	T2D_GENES_TANYA_LIPIDS	NIKOLSKY_BREAST_CANCER_7P22_AMPLICON
0.551977920883%	12	2174	193	T2D_GENES_TANYA_LIPIDS	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP
0.551977920883%	12	2174	193	T2D_GENES_TANYA_LIPIDS	MOHANKUMAR_TLX1_TARGETS_DN
0.551977920883%	12	2174	191	T2D_GENES_TANYA_LIPIDS	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
0.551977920883%	12	2174	181	T2D_GENES_TANYA_LIPIDS	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
0.551977920883%	12	2174	175	T2D_GENES_TANYA_LIPIDS	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.551977920883%	12	2174	171	T2D_GENES_TANYA_LIPIDS	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
0.551977920883%	12	2174	164	T2D_GENES_TANYA_LIPIDS	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
0.551977920883%	12	2174	148	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_24HR_UP
0.551977920883%	12	2174	141	T2D_GENES_TANYA_LIPIDS	SABATES_COLORECTAL_ADENOMA_UP
0.551977920883%	12	2174	141	T2D_GENES_TANYA_LIPIDS	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
0.551977920883%	12	2174	139	T2D_GENES_TANYA_LIPIDS	ODONNELL_TFRC_TARGETS_DN
0.551977920883%	12	2174	139	T2D_GENES_TANYA_LIPIDS	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
0.551977920883%	12	2174	137	T2D_GENES_TANYA_LIPIDS	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
0.551977920883%	12	2174	136	T2D_GENES_TANYA_LIPIDS	WIERENGA_STAT5A_TARGETS_GROUP1
0.551977920883%	12	2174	136	T2D_GENES_TANYA_LIPIDS	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.551977920883%	12	2174	133	T2D_GENES_TANYA_LIPIDS	KEGG_PARKINSONS_DISEASE
0.551977920883%	12	2174	128	T2D_GENES_TANYA_LIPIDS	ZHU_CMV_ALL_DN
0.551977920883%	12	2174	128	T2D_GENES_TANYA_LIPIDS	POTTI_TOPOTECAN_SENSITIVITY
0.551977920883%	12	2174	126	T2D_GENES_TANYA_LIPIDS	SANSOM_APC_TARGETS_UP
0.551977920883%	12	2174	122	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_PDGF
0.551977920883%	12	2174	121	T2D_GENES_TANYA_LIPIDS	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP
0.551977920883%	12	2174	120	T2D_GENES_TANYA_LIPIDS	REACTOME_CELL_CELL_COMMUNICATION
0.551977920883%	12	2174	120	T2D_GENES_TANYA_LIPIDS	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
0.551977920883%	12	2174	118	T2D_GENES_TANYA_LIPIDS	MARKEY_RB1_CHRONIC_LOF_DN
0.551977920883%	12	2174	115	T2D_GENES_TANYA_LIPIDS	MARZEC_IL2_SIGNALING_UP
0.551977920883%	12	2174	114	T2D_GENES_TANYA_LIPIDS	CERVERA_SDHB_TARGETS_2
0.551977920883%	12	2174	114	T2D_GENES_TANYA_LIPIDS	BOSCO_TH1_CYTOTOXIC_MODULE
0.551977920883%	12	2174	112	T2D_GENES_TANYA_LIPIDS	REACTOME_G1_S_TRANSITION
0.551977920883%	12	2174	112	T2D_GENES_TANYA_LIPIDS	DITTMER_PTHLH_TARGETS_UP
0.551977920883%	12	2174	111	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_12HR_UP
0.551977920883%	12	2174	110	T2D_GENES_TANYA_LIPIDS	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.551977920883%	12	2174	109	T2D_GENES_TANYA_LIPIDS	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
0.551977920883%	12	2174	109	T2D_GENES_TANYA_LIPIDS	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
0.551977920883%	12	2174	108	T2D_GENES_TANYA_LIPIDS	LE_EGR2_TARGETS_DN
0.551977920883%	12	2174	108	T2D_GENES_TANYA_LIPIDS	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
0.551977920883%	12	2174	108	T2D_GENES_TANYA_LIPIDS	JAZAG_TGFB1_SIGNALING_UP
0.551977920883%	12	2174	105	T2D_GENES_TANYA_LIPIDS	STEIN_ESRRA_TARGETS_DN
0.551977920883%	12	2174	105	T2D_GENES_TANYA_LIPIDS	PID_ERBB1_DOWNSTREAM_PATHWAY
0.551977920883%	12	2174	102	T2D_GENES_TANYA_LIPIDS	LABBE_TGFB1_TARGETS_UP
0.551977920883%	12	2174	101	T2D_GENES_TANYA_LIPIDS	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
0.551977920883%	12	2174	101	T2D_GENES_TANYA_LIPIDS	BURTON_ADIPOGENESIS_3
0.551615445232%	7	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEIN_PONS_MARKERS
0.551615445232%	7	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_MITOTIC_PROMETAPHASE
0.551615445232%	7	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOEBEKE_LYMPHOID_STEM_CELL_DN
0.551615445232%	7	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RUAN_RESPONSE_TO_TNF_DN
0.551615445232%	7	1269	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_INTEGRIN_SIGNALING_PATHWAY
0.551615445232%	7	1269	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEIN_MIDBRAIN_MARKERS
0.551615445232%	7	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OUILLETTE_CLL_13Q14_DELETION_UP
0.551615445232%	7	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
0.551615445232%	7	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C2
0.551615445232%	7	1269	398	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
0.551615445232%	7	1269	362	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
0.551615445232%	7	1269	337	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PENG_GLUTAMINE_DEPRIVATION_DN
0.551615445232%	7	1269	315	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PASINI_SUZ12_TARGETS_DN
0.551615445232%	7	1269	310	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HORIUCHI_WTAP_TARGETS_DN
0.551615445232%	7	1269	299	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MUELLER_PLURINET
0.551615445232%	7	1269	295	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LU_EZH2_TARGETS_UP
0.551615445232%	7	1269	294	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
0.551615445232%	7	1269	293	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZWANG_DOWN_BY_2ND_EGF_PULSE
0.551615445232%	7	1269	281	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BHAT_ESR1_TARGETS_VIA_AKT1_UP
0.551615445232%	7	1269	275	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.551615445232%	7	1269	270	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RIZKI_TUMOR_INVASIVENESS_3D_DN
0.551615445232%	7	1269	264	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DURCHDEWALD_SKIN_CARCINOGENESIS_DN
0.551615445232%	7	1269	261	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
0.551615445232%	7	1269	259	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	QI_PLASMACYTOMA_UP
0.551615445232%	7	1269	258	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JAEGER_METASTASIS_DN
0.551615445232%	7	1269	249	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MITSIADES_RESPONSE_TO_APLIDIN_DN
0.551615445232%	7	1269	245	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.551615445232%	7	1269	245	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCLACHLAN_DENTAL_CARIES_DN
0.551615445232%	7	1269	245	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BLUM_RESPONSE_TO_SALIRASIB_UP
0.551615445232%	7	1269	244	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	THUM_SYSTOLIC_HEART_FAILURE_DN
0.551615445232%	7	1269	244	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HSIAO_LIVER_SPECIFIC_GENES
0.551615445232%	7	1269	238	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.551615445232%	7	1269	234	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
0.551615445232%	7	1269	233	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.551615445232%	7	1269	232	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DELYS_THYROID_CANCER_DN
0.551615445232%	7	1269	230	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	COLDREN_GEFITINIB_RESISTANCE_DN
0.551615445232%	7	1269	229	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
0.551615445232%	7	1269	222	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
0.551615445232%	7	1269	221	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHANDRAN_METASTASIS_UP
0.551615445232%	7	1269	214	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AFFAR_YY1_TARGETS_UP
0.551615445232%	7	1269	212	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
0.551615445232%	7	1269	212	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHANG_CORE_SERUM_RESPONSE_UP
0.551615445232%	7	1269	211	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP
0.551615445232%	7	1269	211	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
0.551615445232%	7	1269	209	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_WT1_TARGETS_12HR_DN
0.551615445232%	7	1269	208	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
0.551615445232%	7	1269	206	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BILD_MYC_ONCOGENIC_SIGNATURE
0.551615445232%	7	1269	205	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
0.551615445232%	7	1269	205	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.551615445232%	7	1269	204	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
0.551615445232%	7	1269	203	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PENG_RAPAMYCIN_RESPONSE_UP
0.551615445232%	7	1269	202	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
0.551615445232%	7	1269	200	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
0.551615445232%	7	1269	196	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
0.551615445232%	7	1269	195	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_DN
0.551615445232%	7	1269	194	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.551615445232%	7	1269	193	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
0.551615445232%	7	1269	191	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAGI_AML_FAB_MARKERS
0.551615445232%	7	1269	190	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.551615445232%	7	1269	189	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_6
0.551615445232%	7	1269	185	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_36HR_DN
0.551615445232%	7	1269	185	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_HUNTINGTONS_DISEASE
0.551615445232%	7	1269	185	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DARWICHE_SKIN_TUMOR_PROMOTER_DN
0.551615445232%	7	1269	184	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WU_CELL_MIGRATION
0.551615445232%	7	1269	184	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DOANE_RESPONSE_TO_ANDROGEN_UP
0.551615445232%	7	1269	184	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
0.551615445232%	7	1269	180	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
0.551615445232%	7	1269	178	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_18HR_UP
0.551615445232%	7	1269	174	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
0.551615445232%	7	1269	172	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
0.551615445232%	7	1269	171	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GOLDRATH_HOMEOSTATIC_PROLIFERATION
0.551615445232%	7	1269	169	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	UEDA_PERIFERAL_CLOCK
0.551615445232%	7	1269	165	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.551615445232%	7	1269	165	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIU_CMYB_TARGETS_UP
0.551615445232%	7	1269	165	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DARWICHE_PAPILLOMA_RISK_LOW_DN
0.551615445232%	7	1269	160	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_6HR_DN
0.551615445232%	7	1269	154	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
0.551615445232%	7	1269	153	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN
0.551615445232%	7	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON
0.551615445232%	7	1269	148	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_APOPTOSIS
0.551615445232%	7	1269	147	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.551615445232%	7	1269	146	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_ALL_DISORDERS_DURATION_CORR_DN
0.551615445232%	7	1269	144	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.551615445232%	7	1269	143	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION
0.551615445232%	7	1269	142	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PENG_LEUCINE_DEPRIVATION_UP
0.551615445232%	7	1269	140	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ONDER_CDH1_TARGETS_1_UP
0.551615445232%	7	1269	140	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
0.551615445232%	7	1269	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_MITOTIC_G1_G1_S_PHASES
0.551615445232%	7	1269	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_INSULIN_SIGNALING_PATHWAY
0.551615445232%	7	1269	133	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_DIABETES_PATHWAYS
0.551615445232%	7	1269	129	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_PDGFRBPATHWAY
0.551615445232%	7	1269	127	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIU_VMYB_TARGETS_UP
0.551615445232%	7	1269	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
0.551615445232%	7	1269	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
0.551615445232%	7	1269	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GERY_CEBP_TARGETS
0.551615445232%	7	1269	123	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KAYO_AGING_MUSCLE_DN
0.551615445232%	7	1269	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
0.551615445232%	7	1269	120	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	XU_GH1_EXOGENOUS_TARGETS_DN
0.551615445232%	7	1269	120	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
0.551615445232%	7	1269	117	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PUJANA_BRCA_CENTERED_NETWORK
0.551615445232%	7	1269	115	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
0.551615445232%	7	1269	113	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TSENG_IRS1_TARGETS_UP
0.551615445232%	7	1269	113	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_RHO_GTPASES
0.551615445232%	7	1269	110	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SUNG_METASTASIS_STROMA_UP
0.551615445232%	7	1269	104	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
0.551615445232%	7	1269	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KOBAYASHI_EGFR_SIGNALING_24HR_UP
0.551615445232%	7	1269	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_10HR_UP
0.551615445232%	7	1269	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.551615445232%	7	1269	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
0.539772727273%	19	3520	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
0.539772727273%	19	3520	389	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_OLFACTORY_TRANSDUCTION
0.539772727273%	19	3520	291	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SABATES_COLORECTAL_ADENOMA_DN
0.539772727273%	19	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_LIPOPROTEIN_METABOLISM
0.539772727273%	19	3520	267	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.539772727273%	19	3520	259	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
0.539772727273%	19	3520	230	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAUFFMANN_DNA_REPAIR_GENES
0.539772727273%	19	3520	229	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
0.539772727273%	19	3520	226	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.539772727273%	19	3520	220	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RIGGINS_TAMOXIFEN_RESISTANCE_DN
0.539772727273%	19	3520	216	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
0.539772727273%	19	3520	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VERHAAK_GLIOBLASTOMA_PRONEURAL
0.539772727273%	19	3520	208	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
0.539772727273%	19	3520	203	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INFLUENZA_LIFE_CYCLE
0.539772727273%	19	3520	201	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_FOCAL_ADHESION
0.539772727273%	19	3520	200	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_DIFFERENTIATING_T_LYMPHOCYTE
0.539772727273%	19	3520	198	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ALONSO_METASTASIS_UP
0.539772727273%	19	3520	196	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
0.539772727273%	19	3520	193	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
0.539772727273%	19	3520	182	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
0.539772727273%	19	3520	178	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_18HR_DN
0.539772727273%	19	3520	176	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SASAKI_ADULT_T_CELL_LEUKEMIA
0.539772727273%	19	3520	176	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
0.539772727273%	19	3520	166	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMIRNOV_RESPONSE_TO_IR_6HR_UP
0.539772727273%	19	3520	165	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
0.539772727273%	19	3520	164	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_480_HELA
0.539772727273%	19	3520	163	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
0.539772727273%	19	3520	144	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.539772727273%	19	3520	140	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	QI_HYPOXIA
0.539772727273%	19	3520	138	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
0.539772727273%	19	3520	134	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHLOSSER_SERUM_RESPONSE_UP
0.539772727273%	19	3520	134	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_CELL_ADHESION_MOLECULES_CAMS
0.539772727273%	19	3520	129	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_AXON_GUIDANCE
0.539772727273%	19	3520	123	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.539772727273%	19	3520	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
0.539772727273%	19	3520	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.537221795856%	7	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VANLOO_SP3_TARGETS_DN
0.537221795856%	7	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP
0.537221795856%	7	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.537221795856%	7	1303	85	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	COLDREN_GEFITINIB_RESISTANCE_UP
0.537221795856%	7	1303	84	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMID_BREAST_CANCER_LUMINAL_A_UP
0.537221795856%	7	1303	78	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
0.537221795856%	7	1303	76	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
0.537221795856%	7	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHEPARD_BMYB_TARGETS
0.537221795856%	7	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_E2F_PATHWAY
0.537221795856%	7	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FURUKAWA_DUSP6_TARGETS_PCI35_DN
0.537221795856%	7	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
0.537221795856%	7	1303	59	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_NOTCH_PATHWAY
0.537221795856%	7	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON
0.537221795856%	7	1303	367	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DELACROIX_RARG_BOUND_MEF
0.537221795856%	7	1303	288	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	POOLA_INVASIVE_BREAST_CANCER_UP
0.537221795856%	7	1303	284	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
0.537221795856%	7	1303	277	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_60HR_DN
0.537221795856%	7	1303	267	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_MAPK_SIGNALING_PATHWAY
0.537221795856%	7	1303	266	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROZANOV_MMP14_TARGETS_UP
0.537221795856%	7	1303	261	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
0.537221795856%	7	1303	252	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.537221795856%	7	1303	246	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VERHAAK_AML_WITH_NPM1_MUTATED_DN
0.537221795856%	7	1303	244	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	THUM_SYSTOLIC_HEART_FAILURE_DN
0.537221795856%	7	1303	234	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN
0.537221795856%	7	1303	234	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AFFAR_YY1_TARGETS_DN
0.537221795856%	7	1303	228	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
0.537221795856%	7	1303	223	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHEN_HOXA5_TARGETS_9HR_UP
0.537221795856%	7	1303	222	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
0.537221795856%	7	1303	221	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PEDRIOLI_MIR31_TARGETS_UP
0.537221795856%	7	1303	217	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WONG_MITOCHONDRIA_GENE_MODULE
0.537221795856%	7	1303	217	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SANSOM_APC_MYC_TARGETS
0.537221795856%	7	1303	217	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALLING_BY_NGF
0.537221795856%	7	1303	211	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
0.537221795856%	7	1303	209	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHANG_CORE_SERUM_RESPONSE_DN
0.537221795856%	7	1303	206	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_MEF_ICP_WITH_H3K27ME3
0.537221795856%	7	1303	205	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.537221795856%	7	1303	204	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
0.537221795856%	7	1303	203	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PENG_RAPAMYCIN_RESPONSE_UP
0.537221795856%	7	1303	198	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WELCSH_BRCA1_TARGETS_UP
0.537221795856%	7	1303	198	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.537221795856%	7	1303	188	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
0.537221795856%	7	1303	185	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_36HR_DN
0.537221795856%	7	1303	183	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.537221795856%	7	1303	182	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
0.537221795856%	7	1303	181	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
0.537221795856%	7	1303	180	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
0.537221795856%	7	1303	180	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN
0.537221795856%	7	1303	178	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LI_AMPLIFIED_IN_LUNG_CANCER
0.537221795856%	7	1303	178	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_18HR_DN
0.537221795856%	7	1303	176	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
0.537221795856%	7	1303	175	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FIRESTEIN_PROLIFERATION
0.537221795856%	7	1303	170	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
0.537221795856%	7	1303	169	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ONDER_CDH1_TARGETS_1_DN
0.537221795856%	7	1303	168	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
0.537221795856%	7	1303	167	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
0.537221795856%	7	1303	166	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMIRNOV_RESPONSE_TO_IR_6HR_UP
0.537221795856%	7	1303	166	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAIRO_LIVER_DEVELOPMENT_UP
0.537221795856%	7	1303	165	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN
0.537221795856%	7	1303	162	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MULLIGHAN_NPM1_SIGNATURE_3_DN
0.537221795856%	7	1303	159	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INTERFERON_SIGNALING
0.537221795856%	7	1303	156	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FOSTER_TOLERANT_MACROPHAGE_UP
0.537221795856%	7	1303	153	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DURAND_STROMA_MAX_DN
0.537221795856%	7	1303	151	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_WNT_SIGNALING_PATHWAY
0.537221795856%	7	1303	149	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
0.537221795856%	7	1303	148	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WEI_MIR34A_TARGETS
0.537221795856%	7	1303	148	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KATSANOU_ELAVL1_TARGETS_DN
0.537221795856%	7	1303	147	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMID_BREAST_CANCER_ERBB2_UP
0.537221795856%	7	1303	147	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.537221795856%	7	1303	146	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ELVIDGE_HYPOXIA_DN
0.537221795856%	7	1303	145	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK
0.537221795856%	7	1303	142	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
0.537221795856%	7	1303	140	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
0.537221795856%	7	1303	137	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIU_SOX4_TARGETS_UP
0.537221795856%	7	1303	131	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
0.537221795856%	7	1303	128	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_MEF_LCP_WITH_H3K4ME3
0.537221795856%	7	1303	121	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_METASTASIS_DN
0.537221795856%	7	1303	121	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS
0.537221795856%	7	1303	118	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CERVERA_SDHB_TARGETS_1_UP
0.537221795856%	7	1303	114	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CERVERA_SDHB_TARGETS_2
0.537221795856%	7	1303	111	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
0.537221795856%	7	1303	109	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SERVITJA_ISLET_HNF1A_TARGETS_DN
0.537221795856%	7	1303	108	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JAZAG_TGFB1_SIGNALING_UP
0.537221795856%	7	1303	103	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN
0.537221795856%	7	1303	100	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
0.537221795856%	7	1303	100	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BENPORATH_ES_CORE_NINE_CORRELATED
0.53447354356%	10	1871	98	T2D_GENES_TANYA_HEIGHT	MENSE_HYPOXIA_UP
0.53447354356%	10	1871	98	T2D_GENES_TANYA_HEIGHT	GUO_TARGETS_OF_IRS1_AND_IRS2
0.53447354356%	10	1871	98	T2D_GENES_TANYA_HEIGHT	GAVIN_FOXP3_TARGETS_CLUSTER_T7
0.53447354356%	10	1871	98	T2D_GENES_TANYA_HEIGHT	BRUINS_UVC_RESPONSE_MIDDLE
0.53447354356%	10	1871	95	T2D_GENES_TANYA_HEIGHT	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
0.53447354356%	10	1871	92	T2D_GENES_TANYA_HEIGHT	WINTER_HYPOXIA_UP
0.53447354356%	10	1871	92	T2D_GENES_TANYA_HEIGHT	HILLION_HMGA1B_TARGETS
0.53447354356%	10	1871	91	T2D_GENES_TANYA_HEIGHT	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION
0.53447354356%	10	1871	91	T2D_GENES_TANYA_HEIGHT	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.53447354356%	10	1871	90	T2D_GENES_TANYA_HEIGHT	SASSON_RESPONSE_TO_FORSKOLIN_UP
0.53447354356%	10	1871	90	T2D_GENES_TANYA_HEIGHT	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN
0.53447354356%	10	1871	89	T2D_GENES_TANYA_HEIGHT	RICKMAN_HEAD_AND_NECK_CANCER_E
0.53447354356%	10	1871	89	T2D_GENES_TANYA_HEIGHT	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.53447354356%	10	1871	89	T2D_GENES_TANYA_HEIGHT	LEE_AGING_NEOCORTEX_UP
0.53447354356%	10	1871	86	T2D_GENES_TANYA_HEIGHT	TAKAO_RESPONSE_TO_UVB_RADIATION_UP
0.53447354356%	10	1871	86	T2D_GENES_TANYA_HEIGHT	NGUYEN_NOTCH1_TARGETS_DN
0.53447354356%	10	1871	86	T2D_GENES_TANYA_HEIGHT	LEE_AGING_CEREBELLUM_DN
0.53447354356%	10	1871	85	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
0.53447354356%	10	1871	85	T2D_GENES_TANYA_HEIGHT	COLDREN_GEFITINIB_RESISTANCE_UP
0.53447354356%	10	1871	84	T2D_GENES_TANYA_HEIGHT	SWEET_KRAS_TARGETS_UP
0.53447354356%	10	1871	84	T2D_GENES_TANYA_HEIGHT	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
0.53447354356%	10	1871	84	T2D_GENES_TANYA_HEIGHT	REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S
0.53447354356%	10	1871	84	T2D_GENES_TANYA_HEIGHT	RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.53447354356%	10	1871	84	T2D_GENES_TANYA_HEIGHT	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
0.53447354356%	10	1871	80	T2D_GENES_TANYA_HEIGHT	WOO_LIVER_CANCER_RECURRENCE_DN
0.53447354356%	10	1871	78	T2D_GENES_TANYA_HEIGHT	ROSS_AML_WITH_MLL_FUSIONS
0.53447354356%	10	1871	78	T2D_GENES_TANYA_HEIGHT	REACTOME_PLATELET_HOMEOSTASIS
0.53447354356%	10	1871	78	T2D_GENES_TANYA_HEIGHT	COATES_MACROPHAGE_M1_VS_M2_DN
0.53447354356%	10	1871	77	T2D_GENES_TANYA_HEIGHT	RODRIGUES_THYROID_CARCINOMA_DN
0.53447354356%	10	1871	76	T2D_GENES_TANYA_HEIGHT	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.53447354356%	10	1871	76	T2D_GENES_TANYA_HEIGHT	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
0.53447354356%	10	1871	75	T2D_GENES_TANYA_HEIGHT	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
0.53447354356%	10	1871	74	T2D_GENES_TANYA_HEIGHT	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.53447354356%	10	1871	74	T2D_GENES_TANYA_HEIGHT	REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX
0.53447354356%	10	1871	74	T2D_GENES_TANYA_HEIGHT	JI_RESPONSE_TO_FSH_UP
0.53447354356%	10	1871	74	T2D_GENES_TANYA_HEIGHT	CAMPS_COLON_CANCER_COPY_NUMBER_DN
0.53447354356%	10	1871	73	T2D_GENES_TANYA_HEIGHT	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
0.53447354356%	10	1871	73	T2D_GENES_TANYA_HEIGHT	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
0.53447354356%	10	1871	72	T2D_GENES_TANYA_HEIGHT	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
0.53447354356%	10	1871	72	T2D_GENES_TANYA_HEIGHT	BURTON_ADIPOGENESIS_2
0.53447354356%	10	1871	70	T2D_GENES_TANYA_HEIGHT	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5
0.53447354356%	10	1871	70	T2D_GENES_TANYA_HEIGHT	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS
0.53447354356%	10	1871	69	T2D_GENES_TANYA_HEIGHT	REACTOME_SPHINGOLIPID_METABOLISM
0.53447354356%	10	1871	69	T2D_GENES_TANYA_HEIGHT	PID_VEGFR1_2_PATHWAY
0.53447354356%	10	1871	68	T2D_GENES_TANYA_HEIGHT	PID_TELOMERASEPATHWAY
0.53447354356%	10	1871	68	T2D_GENES_TANYA_HEIGHT	BROWNE_INTERFERON_RESPONSIVE_GENES
0.53447354356%	10	1871	68	T2D_GENES_TANYA_HEIGHT	AKL_HTLV1_INFECTION_DN
0.53447354356%	10	1871	65	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_WNT
0.53447354356%	10	1871	64	T2D_GENES_TANYA_HEIGHT	PETROVA_PROX1_TARGETS_DN
0.53447354356%	10	1871	63	T2D_GENES_TANYA_HEIGHT	PID_ENDOTHELINPATHWAY
0.53447354356%	10	1871	62	T2D_GENES_TANYA_HEIGHT	CORRE_MULTIPLE_MYELOMA_DN
0.53447354356%	10	1871	60	T2D_GENES_TANYA_HEIGHT	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
0.53447354356%	10	1871	59	T2D_GENES_TANYA_HEIGHT	PID_ATF2_PATHWAY
0.53447354356%	10	1871	59	T2D_GENES_TANYA_HEIGHT	BARIS_THYROID_CANCER_DN
0.53447354356%	10	1871	58	T2D_GENES_TANYA_HEIGHT	BERNARD_PPAPDC1B_TARGETS_DN
0.53447354356%	10	1871	57	T2D_GENES_TANYA_HEIGHT	BURTON_ADIPOGENESIS_11
0.53447354356%	10	1871	57	T2D_GENES_TANYA_HEIGHT	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
0.53447354356%	10	1871	56	T2D_GENES_TANYA_HEIGHT	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.53447354356%	10	1871	56	T2D_GENES_TANYA_HEIGHT	REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX
0.53447354356%	10	1871	55	T2D_GENES_TANYA_HEIGHT	YU_MYC_TARGETS_DN
0.53447354356%	10	1871	55	T2D_GENES_TANYA_HEIGHT	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR
0.53447354356%	10	1871	55	T2D_GENES_TANYA_HEIGHT	DEMAGALHAES_AGING_UP
0.53447354356%	10	1871	48	T2D_GENES_TANYA_HEIGHT	REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6
0.53447354356%	10	1871	48	T2D_GENES_TANYA_HEIGHT	PID_HEDGEHOG_GLIPATHWAY
0.53447354356%	10	1871	47	T2D_GENES_TANYA_HEIGHT	KEGG_TYPE_II_DIABETES_MELLITUS
0.53447354356%	10	1871	44	T2D_GENES_TANYA_HEIGHT	KEGG_ABC_TRANSPORTERS
0.53447354356%	10	1871	33	T2D_GENES_TANYA_HEIGHT	PID_IL12_STAT4PATHWAY
0.53447354356%	10	1871	23	T2D_GENES_TANYA_HEIGHT	WU_HBX_TARGETS_1_DN
0.53447354356%	10	1871	214	T2D_GENES_TANYA_HEIGHT	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
0.53447354356%	10	1871	193	T2D_GENES_TANYA_HEIGHT	MOHANKUMAR_TLX1_TARGETS_DN
0.53447354356%	10	1871	184	T2D_GENES_TANYA_HEIGHT	WU_CELL_MIGRATION
0.53447354356%	10	1871	182	T2D_GENES_TANYA_HEIGHT	RAO_BOUND_BY_SALL4_ISOFORM_A
0.53447354356%	10	1871	175	T2D_GENES_TANYA_HEIGHT	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
0.53447354356%	10	1871	165	T2D_GENES_TANYA_HEIGHT	DARWICHE_PAPILLOMA_RISK_LOW_DN
0.53447354356%	10	1871	153	T2D_GENES_TANYA_HEIGHT	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
0.53447354356%	10	1871	150	T2D_GENES_TANYA_HEIGHT	LANDIS_ERBB2_BREAST_TUMORS_324_UP
0.53447354356%	10	1871	148	T2D_GENES_TANYA_HEIGHT	KATSANOU_ELAVL1_TARGETS_DN
0.53447354356%	10	1871	146	T2D_GENES_TANYA_HEIGHT	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
0.53447354356%	10	1871	141	T2D_GENES_TANYA_HEIGHT	KAAB_FAILED_HEART_ATRIUM_DN
0.53447354356%	10	1871	140	T2D_GENES_TANYA_HEIGHT	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
0.53447354356%	10	1871	139	T2D_GENES_TANYA_HEIGHT	REACTOME_BIOLOGICAL_OXIDATIONS
0.53447354356%	10	1871	134	T2D_GENES_TANYA_HEIGHT	POOLA_INVASIVE_BREAST_CANCER_DN
0.53447354356%	10	1871	134	T2D_GENES_TANYA_HEIGHT	CHUNG_BLISTER_CYTOTOXICITY_UP
0.53447354356%	10	1871	128	T2D_GENES_TANYA_HEIGHT	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.53447354356%	10	1871	127	T2D_GENES_TANYA_HEIGHT	KARLSSON_TGFB1_TARGETS_UP
0.53447354356%	10	1871	123	T2D_GENES_TANYA_HEIGHT	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.53447354356%	10	1871	123	T2D_GENES_TANYA_HEIGHT	DAZARD_RESPONSE_TO_UV_SCC_DN
0.53447354356%	10	1871	122	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_PDGF
0.53447354356%	10	1871	122	T2D_GENES_TANYA_HEIGHT	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
0.53447354356%	10	1871	120	T2D_GENES_TANYA_HEIGHT	XU_GH1_EXOGENOUS_TARGETS_DN
0.53447354356%	10	1871	120	T2D_GENES_TANYA_HEIGHT	CHEBOTAEV_GR_TARGETS_DN
0.53447354356%	10	1871	118	T2D_GENES_TANYA_HEIGHT	LEE_NEURAL_CREST_STEM_CELL_DN
0.53447354356%	10	1871	116	T2D_GENES_TANYA_HEIGHT	IKEDA_MIR30_TARGETS_UP
0.53447354356%	10	1871	116	T2D_GENES_TANYA_HEIGHT	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.53447354356%	10	1871	115	T2D_GENES_TANYA_HEIGHT	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
0.53447354356%	10	1871	115	T2D_GENES_TANYA_HEIGHT	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
0.53447354356%	10	1871	114	T2D_GENES_TANYA_HEIGHT	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN
0.53447354356%	10	1871	111	T2D_GENES_TANYA_HEIGHT	REACTOME_GLYCOSAMINOGLYCAN_METABOLISM
0.53447354356%	10	1871	109	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
0.53447354356%	10	1871	108	T2D_GENES_TANYA_HEIGHT	ZHANG_TLX_TARGETS_DN
0.53447354356%	10	1871	105	T2D_GENES_TANYA_HEIGHT	WOO_LIVER_CANCER_RECURRENCE_UP
0.53447354356%	10	1871	104	T2D_GENES_TANYA_HEIGHT	NAKAMURA_ADIPOGENESIS_LATE_UP
0.53447354356%	10	1871	103	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_NOTCH
0.53447354356%	10	1871	103	T2D_GENES_TANYA_HEIGHT	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
0.53447354356%	10	1871	101	T2D_GENES_TANYA_HEIGHT	KEGG_GNRH_SIGNALING_PATHWAY
0.53447354356%	10	1871	100	T2D_GENES_TANYA_HEIGHT	BENPORATH_ES_CORE_NINE_CORRELATED
0.513259195894%	6	1169	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
0.513259195894%	6	1169	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HAHTOLA_SEZARY_SYNDROM_UP
0.513259195894%	6	1169	97	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP
0.513259195894%	6	1169	95	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.513259195894%	6	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
0.513259195894%	6	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
0.513259195894%	6	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
0.513259195894%	6	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ERBB_SIGNALING_PATHWAY
0.513259195894%	6	1169	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
0.513259195894%	6	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
0.513259195894%	6	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.513259195894%	6	1169	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
0.513259195894%	6	1169	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
0.513259195894%	6	1169	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_REG_GR_PATHWAY
0.513259195894%	6	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
0.513259195894%	6	1169	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CROMER_METASTASIS_UP
0.513259195894%	6	1169	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SANA_RESPONSE_TO_IFNG_UP
0.513259195894%	6	1169	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_SCF_KIT
0.513259195894%	6	1169	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	COATES_MACROPHAGE_M1_VS_M2_DN
0.513259195894%	6	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROSS_AML_WITH_PML_RARA_FUSION
0.513259195894%	6	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM
0.513259195894%	6	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
0.513259195894%	6	1169	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_AVB3_INTEGRIN_PATHWAY
0.513259195894%	6	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JI_RESPONSE_TO_FSH_UP
0.513259195894%	6	1169	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
0.513259195894%	6	1169	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MATZUK_SPERMATOCYTE
0.513259195894%	6	1169	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KUMAR_AUTOPHAGY_NETWORK
0.513259195894%	6	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
0.513259195894%	6	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_RENAL_CELL_CARCINOMA
0.513259195894%	6	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PANCREATIC_CANCER
0.513259195894%	6	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZAMORA_NOS2_TARGETS_UP
0.513259195894%	6	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
0.513259195894%	6	1169	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
0.513259195894%	6	1169	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
0.513259195894%	6	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_TCR_PATHWAY
0.513259195894%	6	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_INTERFERON_GAMMA_SIGNALING
0.513259195894%	6	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_FCER1PATHWAY
0.513259195894%	6	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_P53REGULATIONPATHWAY
0.513259195894%	6	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BARIS_THYROID_CANCER_DN
0.513259195894%	6	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
0.513259195894%	6	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_NFAT_PATHWAY
0.513259195894%	6	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_NON_SMALL_CELL_LUNG_CANCER
0.513259195894%	6	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_AUTOIMMUNE_THYROID_DISEASE
0.513259195894%	6	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAUER_STAT3_TARGETS_UP
0.513259195894%	6	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_TCR_PATHWAY
0.513259195894%	6	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_HNF3BPATHWAY
0.513259195894%	6	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ERBB2ERBB3PATHWAY
0.513259195894%	6	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_LYSINE_DEGRADATION
0.513259195894%	6	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_UPA_UPAR_PATHWAY
0.513259195894%	6	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CERVERA_SDHB_TARGETS_1_DN
0.513259195894%	6	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STEARMAN_TUMOR_FIELD_EFFECT_UP
0.513259195894%	6	1169	335	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON
0.513259195894%	6	1169	330	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
0.513259195894%	6	1169	308	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
0.513259195894%	6	1169	305	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
0.513259195894%	6	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ASTHMA
0.513259195894%	6	1169	294	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
0.513259195894%	6	1169	290	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BENPORATH_OCT4_TARGETS
0.513259195894%	6	1169	289	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
0.513259195894%	6	1169	285	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRADE_COLON_AND_RECTAL_CANCER_UP
0.513259195894%	6	1169	280	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_SMARCE1_TARGETS_UP
0.513259195894%	6	1169	266	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROZANOV_MMP14_TARGETS_UP
0.513259195894%	6	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_RXR_VDR_PATHWAY
0.513259195894%	6	1169	258	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
0.513259195894%	6	1169	256	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ONDER_CDH1_TARGETS_2_UP
0.513259195894%	6	1169	255	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.513259195894%	6	1169	252	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.513259195894%	6	1169	247	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_METABOLISM_OF_CARBOHYDRATES
0.513259195894%	6	1169	244	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	THUM_SYSTOLIC_HEART_FAILURE_DN
0.513259195894%	6	1169	244	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PLASARI_TGFB1_TARGETS_10HR_DN
0.513259195894%	6	1169	243	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHICAS_RB1_TARGETS_GROWING
0.513259195894%	6	1169	232	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DELYS_THYROID_CANCER_DN
0.513259195894%	6	1169	229	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
0.513259195894%	6	1169	229	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
0.513259195894%	6	1169	227	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.513259195894%	6	1169	222	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
0.513259195894%	6	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP
0.513259195894%	6	1169	217	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WONG_MITOCHONDRIA_GENE_MODULE
0.513259195894%	6	1169	214	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_WT1_TARGETS_UP
0.513259195894%	6	1169	213	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WIERENGA_STAT5A_TARGETS_DN
0.513259195894%	6	1169	209	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHANG_CORE_SERUM_RESPONSE_DN
0.513259195894%	6	1169	205	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
0.513259195894%	6	1169	205	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
0.513259195894%	6	1169	204	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
0.513259195894%	6	1169	203	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PENG_RAPAMYCIN_RESPONSE_UP
0.513259195894%	6	1169	201	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOLLMANN_APOPTOSIS_VIA_CD40_UP
0.513259195894%	6	1169	196	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
0.513259195894%	6	1169	195	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
0.513259195894%	6	1169	190	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.513259195894%	6	1169	187	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PENG_LEUCINE_DEPRIVATION_DN
0.513259195894%	6	1169	187	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BAKKER_FOXO3_TARGETS_DN
0.513259195894%	6	1169	184	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DOANE_RESPONSE_TO_ANDROGEN_UP
0.513259195894%	6	1169	177	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
0.513259195894%	6	1169	176	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SASAKI_ADULT_T_CELL_LEUKEMIA
0.513259195894%	6	1169	174	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
0.513259195894%	6	1169	172	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMID_BREAST_CANCER_LUMINAL_B_UP
0.513259195894%	6	1169	170	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
0.513259195894%	6	1169	169	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
0.513259195894%	6	1169	167	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANTVEER_BREAST_CANCER_ESR1_UP
0.513259195894%	6	1169	167	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TIEN_INTESTINE_PROBIOTICS_6HR_DN
0.513259195894%	6	1169	163	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIN_NPAS4_TARGETS_UP
0.513259195894%	6	1169	160	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAVIN_FOXP3_TARGETS_CLUSTER_P3
0.513259195894%	6	1169	157	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.513259195894%	6	1169	157	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
0.513259195894%	6	1169	149	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
0.513259195894%	6	1169	149	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GOZGIT_ESR1_TARGETS_UP
0.513259195894%	6	1169	148	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEI_MIR34A_TARGETS
0.513259195894%	6	1169	145	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
0.513259195894%	6	1169	143	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
0.513259195894%	6	1169	143	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.513259195894%	6	1169	143	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BASSO_B_LYMPHOCYTE_NETWORK
0.513259195894%	6	1169	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PENG_LEUCINE_DEPRIVATION_UP
0.513259195894%	6	1169	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DARWICHE_SKIN_TUMOR_PROMOTER_UP
0.513259195894%	6	1169	140	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	QI_HYPOXIA
0.513259195894%	6	1169	140	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
0.513259195894%	6	1169	138	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
0.513259195894%	6	1169	138	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
0.513259195894%	6	1169	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
0.513259195894%	6	1169	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.513259195894%	6	1169	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
0.513259195894%	6	1169	136	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.513259195894%	6	1169	135	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SERVITJA_LIVER_HNF1A_TARGETS_UP
0.513259195894%	6	1169	133	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SENESE_HDAC2_TARGETS_DN
0.513259195894%	6	1169	123	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOOI_ST7_TARGETS_DN
0.513259195894%	6	1169	123	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAZARD_RESPONSE_TO_UV_SCC_DN
0.513259195894%	6	1169	122	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TOOKER_GEMCITABINE_RESISTANCE_DN
0.513259195894%	6	1169	122	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_PDGF
0.513259195894%	6	1169	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.513259195894%	6	1169	120	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	XU_GH1_EXOGENOUS_TARGETS_DN
0.513259195894%	6	1169	118	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
0.513259195894%	6	1169	118	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
0.513259195894%	6	1169	117	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PUJANA_BRCA_CENTERED_NETWORK
0.513259195894%	6	1169	115	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARZEC_IL2_SIGNALING_UP
0.513259195894%	6	1169	115	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
0.513259195894%	6	1169	115	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
0.513259195894%	6	1169	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DOANE_BREAST_CANCER_ESR1_UP
0.513259195894%	6	1169	111	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_HCP_PROSTATE_CANCER
0.513259195894%	6	1169	110	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WOOD_EBV_EBNA1_TARGETS_UP
0.513259195894%	6	1169	109	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
0.513259195894%	6	1169	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LE_EGR2_TARGETS_DN
0.513259195894%	6	1169	107	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SESTO_RESPONSE_TO_UV_C0
0.513259195894%	6	1169	106	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
0.513259195894%	6	1169	105	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ERBB1_DOWNSTREAM_PATHWAY
0.513259195894%	6	1169	105	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HELLER_SILENCED_BY_METHYLATION_DN
0.513259195894%	6	1169	105	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_8HR_UP
0.513259195894%	6	1169	104	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.513259195894%	6	1169	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
0.513259195894%	6	1169	102	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_CXCR4_PATHWAY
0.513259195894%	6	1169	102	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.513259195894%	6	1169	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_ERBB2
0.513259195894%	6	1169	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
0.513259195894%	6	1169	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRADE_COLON_AND_RECTAL_CANCER_DN
0.511363636364%	18	3520	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GUO_TARGETS_OF_IRS1_AND_IRS2
0.511363636364%	18	3520	97	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KONG_E2F3_TARGETS
0.511363636364%	18	3520	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MORI_MATURE_B_LYMPHOCYTE_UP
0.511363636364%	18	3520	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_VEGF_SIGNALING_PATHWAY
0.511363636364%	18	3520	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_VIRAL_MYOCARDITIS
0.511363636364%	18	3520	316	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
0.511363636364%	18	3520	290	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BENPORATH_OCT4_TARGETS
0.511363636364%	18	3520	244	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PLASARI_TGFB1_TARGETS_10HR_DN
0.511363636364%	18	3520	229	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
0.511363636364%	18	3520	228	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
0.511363636364%	18	3520	227	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAO_BOUND_BY_SALL4
0.511363636364%	18	3520	227	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_RECENT_THYMIC_EMIGRANT
0.511363636364%	18	3520	209	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHANG_CORE_SERUM_RESPONSE_DN
0.511363636364%	18	3520	199	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
0.511363636364%	18	3520	195	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.511363636364%	18	3520	185	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_HUNTINGTONS_DISEASE
0.511363636364%	18	3520	178	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_CALCIUM_SIGNALING_PATHWAY
0.511363636364%	18	3520	172	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
0.511363636364%	18	3520	170	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
0.511363636364%	18	3520	165	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.511363636364%	18	3520	161	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
0.511363636364%	18	3520	150	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_30MIN_DN
0.511363636364%	18	3520	149	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OHGUCHI_LIVER_HNF4A_TARGETS_DN
0.511363636364%	18	3520	148	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHANG_CYCLING_GENES
0.511363636364%	18	3520	147	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_G1_S
0.511363636364%	18	3520	147	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.511363636364%	18	3520	145	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_BREAST_CANCER_PROGENITORS_DN
0.511363636364%	18	3520	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RUIZ_TNC_TARGETS_DN
0.511363636364%	18	3520	141	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.511363636364%	18	3520	140	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JOHNSTONE_PARVB_TARGETS_2_UP
0.511363636364%	18	3520	133	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DIABETES_PATHWAYS
0.511363636364%	18	3520	129	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MEMBRANE_TRAFFICKING
0.511363636364%	18	3520	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.511363636364%	18	3520	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_SPLICEOSOME
0.511363636364%	18	3520	125	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_HIV_LIFE_CYCLE
0.511363636364%	18	3520	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_LYSOSOME
0.511363636364%	18	3520	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN
0.511363636364%	18	3520	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
0.511363636364%	18	3520	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WIELAND_UP_BY_HBV_INFECTION
0.506585612969%	10	1974	98	Mendelian_Nancy_Cox	GAVIN_FOXP3_TARGETS_CLUSTER_T7
0.506585612969%	10	1974	94	Mendelian_Nancy_Cox	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER
0.506585612969%	10	1974	94	Mendelian_Nancy_Cox	HOOI_ST7_TARGETS_UP
0.506585612969%	10	1974	92	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_OF_DNA
0.506585612969%	10	1974	88	Mendelian_Nancy_Cox	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
0.506585612969%	10	1974	88	Mendelian_Nancy_Cox	WALLACE_PROSTATE_CANCER_RACE_DN
0.506585612969%	10	1974	88	Mendelian_Nancy_Cox	TIEN_INTESTINE_PROBIOTICS_2HR_DN
0.506585612969%	10	1974	87	Mendelian_Nancy_Cox	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.506585612969%	10	1974	86	Mendelian_Nancy_Cox	REACTOME_MEIOTIC_RECOMBINATION
0.506585612969%	10	1974	85	Mendelian_Nancy_Cox	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
0.506585612969%	10	1974	85	Mendelian_Nancy_Cox	STEIN_ESR1_TARGETS
0.506585612969%	10	1974	85	Mendelian_Nancy_Cox	COLDREN_GEFITINIB_RESISTANCE_UP
0.506585612969%	10	1974	85	Mendelian_Nancy_Cox	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
0.506585612969%	10	1974	84	Mendelian_Nancy_Cox	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP
0.506585612969%	10	1974	84	Mendelian_Nancy_Cox	HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.506585612969%	10	1974	83	Mendelian_Nancy_Cox	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
0.506585612969%	10	1974	82	Mendelian_Nancy_Cox	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS
0.506585612969%	10	1974	81	Mendelian_Nancy_Cox	GRABARCZYK_BCL11B_TARGETS_UP
0.506585612969%	10	1974	79	Mendelian_Nancy_Cox	LIU_COMMON_CANCER_GENES
0.506585612969%	10	1974	78	Mendelian_Nancy_Cox	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.506585612969%	10	1974	77	Mendelian_Nancy_Cox	ROSS_AML_WITH_PML_RARA_FUSION
0.506585612969%	10	1974	75	Mendelian_Nancy_Cox	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
0.506585612969%	10	1974	75	Mendelian_Nancy_Cox	CHESLER_BRAIN_QTL_CIS
0.506585612969%	10	1974	74	Mendelian_Nancy_Cox	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS
0.506585612969%	10	1974	73	Mendelian_Nancy_Cox	REACTOME_MEIOTIC_SYNAPSIS
0.506585612969%	10	1974	73	Mendelian_Nancy_Cox	GAURNIER_PSMD4_TARGETS
0.506585612969%	10	1974	72	Mendelian_Nancy_Cox	HUANG_GATA2_TARGETS_DN
0.506585612969%	10	1974	70	Mendelian_Nancy_Cox	REACTOME_PHASE_II_CONJUGATION
0.506585612969%	10	1974	70	Mendelian_Nancy_Cox	CADWELL_ATG16L1_TARGETS_DN
0.506585612969%	10	1974	69	Mendelian_Nancy_Cox	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.506585612969%	10	1974	69	Mendelian_Nancy_Cox	PID_MTOR_4PATHWAY
0.506585612969%	10	1974	69	Mendelian_Nancy_Cox	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
0.506585612969%	10	1974	67	Mendelian_Nancy_Cox	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
0.506585612969%	10	1974	67	Mendelian_Nancy_Cox	DAZARD_UV_RESPONSE_CLUSTER_G1
0.506585612969%	10	1974	67	Mendelian_Nancy_Cox	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70
0.506585612969%	10	1974	66	Mendelian_Nancy_Cox	KIM_GERMINAL_CENTER_T_HELPER_UP
0.506585612969%	10	1974	64	Mendelian_Nancy_Cox	INGRAM_SHH_TARGETS_DN
0.506585612969%	10	1974	64	Mendelian_Nancy_Cox	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
0.506585612969%	10	1974	63	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
0.506585612969%	10	1974	63	Mendelian_Nancy_Cox	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
0.506585612969%	10	1974	63	Mendelian_Nancy_Cox	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
0.506585612969%	10	1974	62	Mendelian_Nancy_Cox	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.506585612969%	10	1974	61	Mendelian_Nancy_Cox	ZWANG_EGF_PERSISTENTLY_DN
0.506585612969%	10	1974	61	Mendelian_Nancy_Cox	REN_BOUND_BY_E2F
0.506585612969%	10	1974	61	Mendelian_Nancy_Cox	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
0.506585612969%	10	1974	61	Mendelian_Nancy_Cox	RAMASWAMY_METASTASIS_DN
0.506585612969%	10	1974	61	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_1HR_UP
0.506585612969%	10	1974	60	Mendelian_Nancy_Cox	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN
0.506585612969%	10	1974	59	Mendelian_Nancy_Cox	LIAN_LIPA_TARGETS_3M
0.506585612969%	10	1974	59	Mendelian_Nancy_Cox	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1
0.506585612969%	10	1974	59	Mendelian_Nancy_Cox	DASU_IL6_SIGNALING_UP
0.506585612969%	10	1974	59	Mendelian_Nancy_Cox	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
0.506585612969%	10	1974	58	Mendelian_Nancy_Cox	MIKKELSEN_NPC_LCP_WITH_H3K4ME3
0.506585612969%	10	1974	57	Mendelian_Nancy_Cox	PEART_HDAC_PROLIFERATION_CLUSTER_UP
0.506585612969%	10	1974	57	Mendelian_Nancy_Cox	AMIT_SERUM_RESPONSE_240_MCF10A
0.506585612969%	10	1974	56	Mendelian_Nancy_Cox	ZHENG_IL22_SIGNALING_UP
0.506585612969%	10	1974	56	Mendelian_Nancy_Cox	VANTVEER_BREAST_CANCER_METASTASIS_UP
0.506585612969%	10	1974	56	Mendelian_Nancy_Cox	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP
0.506585612969%	10	1974	56	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_10HR_DN
0.506585612969%	10	1974	54	Mendelian_Nancy_Cox	PID_RAC1_PATHWAY
0.506585612969%	10	1974	54	Mendelian_Nancy_Cox	KEGG_INOSITOL_PHOSPHATE_METABOLISM
0.506585612969%	10	1974	53	Mendelian_Nancy_Cox	PID_AR_TF_PATHWAY
0.506585612969%	10	1974	53	Mendelian_Nancy_Cox	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
0.506585612969%	10	1974	52	Mendelian_Nancy_Cox	ROSS_AML_WITH_CBFB_MYH11_FUSION
0.506585612969%	10	1974	51	Mendelian_Nancy_Cox	REACTOME_NUCLEOTIDE_EXCISION_REPAIR
0.506585612969%	10	1974	51	Mendelian_Nancy_Cox	PRAMOONJAGO_SOX4_TARGETS_DN
0.506585612969%	10	1974	50	Mendelian_Nancy_Cox	YANG_BREAST_CANCER_ESR1_LASER_DN
0.506585612969%	10	1974	50	Mendelian_Nancy_Cox	STOSSI_RESPONSE_TO_ESTRADIOL
0.506585612969%	10	1974	49	Mendelian_Nancy_Cox	PID_PI3KCIPATHWAY
0.506585612969%	10	1974	49	Mendelian_Nancy_Cox	PID_FOXOPATHWAY
0.506585612969%	10	1974	49	Mendelian_Nancy_Cox	MANTOVANI_VIRAL_GPCR_SIGNALING_DN
0.506585612969%	10	1974	48	Mendelian_Nancy_Cox	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
0.506585612969%	10	1974	48	Mendelian_Nancy_Cox	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
0.506585612969%	10	1974	47	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_8HR_DN
0.506585612969%	10	1974	46	Mendelian_Nancy_Cox	NAKAJIMA_MAST_CELL
0.506585612969%	10	1974	46	Mendelian_Nancy_Cox	ABBUD_LIF_SIGNALING_1_UP
0.506585612969%	10	1974	45	Mendelian_Nancy_Cox	MCDOWELL_ACUTE_LUNG_INJURY_UP
0.506585612969%	10	1974	44	Mendelian_Nancy_Cox	OHGUCHI_LIVER_HNF4A_TARGETS_UP
0.506585612969%	10	1974	44	Mendelian_Nancy_Cox	KEGG_TYPE_I_DIABETES_MELLITUS
0.506585612969%	10	1974	42	Mendelian_Nancy_Cox	REACTOME_TRNA_AMINOACYLATION
0.506585612969%	10	1974	42	Mendelian_Nancy_Cox	LUI_THYROID_CANCER_CLUSTER_2
0.506585612969%	10	1974	41	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_DN
0.506585612969%	10	1974	41	Mendelian_Nancy_Cox	LIN_MELANOMA_COPY_NUMBER_DN
0.506585612969%	10	1974	41	Mendelian_Nancy_Cox	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS
0.506585612969%	10	1974	41	Mendelian_Nancy_Cox	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
0.506585612969%	10	1974	40	Mendelian_Nancy_Cox	KEGG_SPHINGOLIPID_METABOLISM
0.506585612969%	10	1974	39	Mendelian_Nancy_Cox	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2
0.506585612969%	10	1974	39	Mendelian_Nancy_Cox	VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1
0.506585612969%	10	1974	39	Mendelian_Nancy_Cox	CONRAD_STEM_CELL
0.506585612969%	10	1974	38	Mendelian_Nancy_Cox	KEGG_ALLOGRAFT_REJECTION
0.506585612969%	10	1974	38	Mendelian_Nancy_Cox	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP
0.506585612969%	10	1974	37	Mendelian_Nancy_Cox	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
0.506585612969%	10	1974	37	Mendelian_Nancy_Cox	REACTOME_DOWNSTREAM_TCR_SIGNALING
0.506585612969%	10	1974	37	Mendelian_Nancy_Cox	CUI_TCF21_TARGETS_UP
0.506585612969%	10	1974	37	Mendelian_Nancy_Cox	BIOCARTA_BCR_PATHWAY
0.506585612969%	10	1974	36	Mendelian_Nancy_Cox	YANG_BREAST_CANCER_ESR1_UP
0.506585612969%	10	1974	36	Mendelian_Nancy_Cox	REACTOME_SIGNALLING_TO_ERKS
0.506585612969%	10	1974	35	Mendelian_Nancy_Cox	WEIGEL_OXIDATIVE_STRESS_RESPONSE
0.506585612969%	10	1974	35	Mendelian_Nancy_Cox	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.506585612969%	10	1974	35	Mendelian_Nancy_Cox	BIOCARTA_CARM_ER_PATHWAY
0.506585612969%	10	1974	34	Mendelian_Nancy_Cox	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES
0.506585612969%	10	1974	34	Mendelian_Nancy_Cox	POTTI_CYTOXAN_SENSITIVITY
0.506585612969%	10	1974	34	Mendelian_Nancy_Cox	PID_IL2_PI3KPATHWAY
0.506585612969%	10	1974	32	Mendelian_Nancy_Cox	TSAI_RESPONSE_TO_RADIATION_THERAPY
0.506585612969%	10	1974	32	Mendelian_Nancy_Cox	BIOCARTA_PDGF_PATHWAY
0.506585612969%	10	1974	31	Mendelian_Nancy_Cox	DORSEY_GAB2_TARGETS
0.506585612969%	10	1974	31	Mendelian_Nancy_Cox	BIOCARTA_EGF_PATHWAY
0.506585612969%	10	1974	30	Mendelian_Nancy_Cox	LI_PROSTATE_CANCER_EPIGENETIC
0.506585612969%	10	1974	30	Mendelian_Nancy_Cox	BIOCARTA_FAS_PATHWAY
0.506585612969%	10	1974	29	Mendelian_Nancy_Cox	PID_BARD1PATHWAY
0.506585612969%	10	1974	284	Mendelian_Nancy_Cox	REACTOME_METABOLISM_OF_MRNA
0.506585612969%	10	1974	28	Mendelian_Nancy_Cox	ST_GAQ_PATHWAY
0.506585612969%	10	1974	28	Mendelian_Nancy_Cox	DAIRKEE_CANCER_PRONE_RESPONSE_E2
0.506585612969%	10	1974	28	Mendelian_Nancy_Cox	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN
0.506585612969%	10	1974	28	Mendelian_Nancy_Cox	BIOCARTA_ERK_PATHWAY
0.506585612969%	10	1974	27	Mendelian_Nancy_Cox	ST_MYOCYTE_AD_PATHWAY
0.506585612969%	10	1974	27	Mendelian_Nancy_Cox	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
0.506585612969%	10	1974	27	Mendelian_Nancy_Cox	REACTOME_GAP_JUNCTION_TRAFFICKING
0.506585612969%	10	1974	27	Mendelian_Nancy_Cox	LI_WILMS_TUMOR
0.506585612969%	10	1974	26	Mendelian_Nancy_Cox	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
0.506585612969%	10	1974	24	Mendelian_Nancy_Cox	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN
0.506585612969%	10	1974	23	Mendelian_Nancy_Cox	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP
0.506585612969%	10	1974	22	Mendelian_Nancy_Cox	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER
0.506585612969%	10	1974	22	Mendelian_Nancy_Cox	BIOCARTA_HER2_PATHWAY
0.506585612969%	10	1974	21	Mendelian_Nancy_Cox	MOOTHA_GLYCOLYSIS
0.506585612969%	10	1974	21	Mendelian_Nancy_Cox	BIOCARTA_ATRBRCA_PATHWAY
0.506585612969%	10	1974	20	Mendelian_Nancy_Cox	REACTOME_HS_GAG_DEGRADATION
0.506585612969%	10	1974	18	Mendelian_Nancy_Cox	REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS
0.506585612969%	10	1974	17	Mendelian_Nancy_Cox	SA_TRKA_RECEPTOR
0.506585612969%	10	1974	156	Mendelian_Nancy_Cox	FOSTER_TOLERANT_MACROPHAGE_UP
0.506585612969%	10	1974	15	Mendelian_Nancy_Cox	REACTOME_ENDOGENOUS_STEROLS
0.506585612969%	10	1974	14	Mendelian_Nancy_Cox	REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION
0.506585612969%	10	1974	133	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON
0.506585612969%	10	1974	128	Mendelian_Nancy_Cox	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
0.506585612969%	10	1974	125	Mendelian_Nancy_Cox	FIGUEROA_AML_METHYLATION_CLUSTER_1_UP
0.506585612969%	10	1974	12	Mendelian_Nancy_Cox	BIOCARTA_LECTIN_PATHWAY
0.506585612969%	10	1974	110	Mendelian_Nancy_Cox	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.506585612969%	10	1974	107	Mendelian_Nancy_Cox	LEE_EARLY_T_LYMPHOCYTE_UP
0.506585612969%	10	1974	105	Mendelian_Nancy_Cox	ZWANG_EGF_INTERVAL_UP
0.506585612969%	10	1974	104	Mendelian_Nancy_Cox	REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE
0.506585612969%	10	1974	103	Mendelian_Nancy_Cox	KIM_MYCN_AMPLIFICATION_TARGETS_DN
0.506585612969%	10	1974	10	Mendelian_Nancy_Cox	BRUNEAU_SEPTATION_VENTRICULAR
0.50597976081%	11	2174	98	T2D_GENES_TANYA_LIPIDS	NIELSEN_GIST
0.50597976081%	11	2174	98	T2D_GENES_TANYA_LIPIDS	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
0.50597976081%	11	2174	97	T2D_GENES_TANYA_LIPIDS	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
0.50597976081%	11	2174	95	T2D_GENES_TANYA_LIPIDS	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
0.50597976081%	11	2174	95	T2D_GENES_TANYA_LIPIDS	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
0.50597976081%	11	2174	95	T2D_GENES_TANYA_LIPIDS	KAYO_CALORIE_RESTRICTION_MUSCLE_UP
0.50597976081%	11	2174	93	T2D_GENES_TANYA_LIPIDS	REACTOME_ACTIVATED_TLR4_SIGNALLING
0.50597976081%	11	2174	89	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
0.50597976081%	11	2174	89	T2D_GENES_TANYA_LIPIDS	SWEET_KRAS_ONCOGENIC_SIGNATURE
0.50597976081%	11	2174	89	T2D_GENES_TANYA_LIPIDS	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.50597976081%	11	2174	89	T2D_GENES_TANYA_LIPIDS	LEIN_PONS_MARKERS
0.50597976081%	11	2174	89	T2D_GENES_TANYA_LIPIDS	KEGG_PROSTATE_CANCER
0.50597976081%	11	2174	89	T2D_GENES_TANYA_LIPIDS	BOYLAN_MULTIPLE_MYELOMA_D_UP
0.50597976081%	11	2174	88	T2D_GENES_TANYA_LIPIDS	KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.50597976081%	11	2174	87	T2D_GENES_TANYA_LIPIDS	KEGG_ERBB_SIGNALING_PATHWAY
0.50597976081%	11	2174	87	T2D_GENES_TANYA_LIPIDS	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.50597976081%	11	2174	86	T2D_GENES_TANYA_LIPIDS	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
0.50597976081%	11	2174	86	T2D_GENES_TANYA_LIPIDS	BURTON_ADIPOGENESIS_8
0.50597976081%	11	2174	85	T2D_GENES_TANYA_LIPIDS	XU_GH1_EXOGENOUS_TARGETS_UP
0.50597976081%	11	2174	85	T2D_GENES_TANYA_LIPIDS	STEIN_ESR1_TARGETS
0.50597976081%	11	2174	84	T2D_GENES_TANYA_LIPIDS	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
0.50597976081%	11	2174	83	T2D_GENES_TANYA_LIPIDS	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
0.50597976081%	11	2174	83	T2D_GENES_TANYA_LIPIDS	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
0.50597976081%	11	2174	82	T2D_GENES_TANYA_LIPIDS	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
0.50597976081%	11	2174	81	T2D_GENES_TANYA_LIPIDS	MUNSHI_MULTIPLE_MYELOMA_UP
0.50597976081%	11	2174	81	T2D_GENES_TANYA_LIPIDS	HARRIS_HYPOXIA
0.50597976081%	11	2174	81	T2D_GENES_TANYA_LIPIDS	COATES_MACROPHAGE_M1_VS_M2_UP
0.50597976081%	11	2174	80	T2D_GENES_TANYA_LIPIDS	REACTOME_UNFOLDED_PROTEIN_RESPONSE
0.50597976081%	11	2174	79	T2D_GENES_TANYA_LIPIDS	MALONEY_RESPONSE_TO_17AAG_DN
0.50597976081%	11	2174	79	T2D_GENES_TANYA_LIPIDS	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
0.50597976081%	11	2174	79	T2D_GENES_TANYA_LIPIDS	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
0.50597976081%	11	2174	78	T2D_GENES_TANYA_LIPIDS	COATES_MACROPHAGE_M1_VS_M2_DN
0.50597976081%	11	2174	77	T2D_GENES_TANYA_LIPIDS	ROSS_AML_WITH_PML_RARA_FUSION
0.50597976081%	11	2174	77	T2D_GENES_TANYA_LIPIDS	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
0.50597976081%	11	2174	76	T2D_GENES_TANYA_LIPIDS	ROSS_AML_WITH_AML1_ETO_FUSION
0.50597976081%	11	2174	75	T2D_GENES_TANYA_LIPIDS	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
0.50597976081%	11	2174	75	T2D_GENES_TANYA_LIPIDS	PID_AVB3_INTEGRIN_PATHWAY
0.50597976081%	11	2174	75	T2D_GENES_TANYA_LIPIDS	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
0.50597976081%	11	2174	75	T2D_GENES_TANYA_LIPIDS	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.50597976081%	11	2174	75	T2D_GENES_TANYA_LIPIDS	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
0.50597976081%	11	2174	74	T2D_GENES_TANYA_LIPIDS	JI_RESPONSE_TO_FSH_UP
0.50597976081%	11	2174	74	T2D_GENES_TANYA_LIPIDS	CAMPS_COLON_CANCER_COPY_NUMBER_DN
0.50597976081%	11	2174	73	T2D_GENES_TANYA_LIPIDS	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
0.50597976081%	11	2174	70	T2D_GENES_TANYA_LIPIDS	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS
0.50597976081%	11	2174	69	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10
0.50597976081%	11	2174	69	T2D_GENES_TANYA_LIPIDS	RIZKI_TUMOR_INVASIVENESS_2D_UP
0.50597976081%	11	2174	69	T2D_GENES_TANYA_LIPIDS	REACTOME_SPHINGOLIPID_METABOLISM
0.50597976081%	11	2174	68	T2D_GENES_TANYA_LIPIDS	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
0.50597976081%	11	2174	67	T2D_GENES_TANYA_LIPIDS	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN
0.50597976081%	11	2174	66	T2D_GENES_TANYA_LIPIDS	DIRMEIER_LMP1_RESPONSE_EARLY
0.50597976081%	11	2174	65	T2D_GENES_TANYA_LIPIDS	GUO_HEX_TARGETS_DN
0.50597976081%	11	2174	64	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_UP
0.50597976081%	11	2174	64	T2D_GENES_TANYA_LIPIDS	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
0.50597976081%	11	2174	64	T2D_GENES_TANYA_LIPIDS	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
0.50597976081%	11	2174	62	T2D_GENES_TANYA_LIPIDS	PID_FCER1PATHWAY
0.50597976081%	11	2174	61	T2D_GENES_TANYA_LIPIDS	REN_BOUND_BY_E2F
0.50597976081%	11	2174	58	T2D_GENES_TANYA_LIPIDS	LUCAS_HNF4A_TARGETS_UP
0.50597976081%	11	2174	56	T2D_GENES_TANYA_LIPIDS	BIOCARTA_NFAT_PATHWAY
0.50597976081%	11	2174	55	T2D_GENES_TANYA_LIPIDS	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR
0.50597976081%	11	2174	54	T2D_GENES_TANYA_LIPIDS	REACTOME_TCR_SIGNALING
0.50597976081%	11	2174	54	T2D_GENES_TANYA_LIPIDS	KEGG_NON_SMALL_CELL_LUNG_CANCER
0.50597976081%	11	2174	50	T2D_GENES_TANYA_LIPIDS	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
0.50597976081%	11	2174	49	T2D_GENES_TANYA_LIPIDS	KEGG_GLYCEROLIPID_METABOLISM
0.50597976081%	11	2174	47	T2D_GENES_TANYA_LIPIDS	POTTI_DOCETAXEL_SENSITIVITY
0.50597976081%	11	2174	45	T2D_GENES_TANYA_LIPIDS	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN
0.50597976081%	11	2174	32	T2D_GENES_TANYA_LIPIDS	PID_SYNDECAN_4_PATHWAY
0.50597976081%	11	2174	191	T2D_GENES_TANYA_LIPIDS	RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.50597976081%	11	2174	185	T2D_GENES_TANYA_LIPIDS	ZHANG_TLX_TARGETS_36HR_DN
0.50597976081%	11	2174	176	T2D_GENES_TANYA_LIPIDS	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
0.50597976081%	11	2174	163	T2D_GENES_TANYA_LIPIDS	SERVITJA_ISLET_HNF1A_TARGETS_UP
0.50597976081%	11	2174	159	T2D_GENES_TANYA_LIPIDS	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
0.50597976081%	11	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_HDL_MEDIATED_LIPID_TRANSPORT
0.50597976081%	11	2174	146	T2D_GENES_TANYA_LIPIDS	PECE_MAMMARY_STEM_CELL_UP
0.50597976081%	11	2174	145	T2D_GENES_TANYA_LIPIDS	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
0.50597976081%	11	2174	142	T2D_GENES_TANYA_LIPIDS	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.50597976081%	11	2174	142	T2D_GENES_TANYA_LIPIDS	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.50597976081%	11	2174	136	T2D_GENES_TANYA_LIPIDS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.50597976081%	11	2174	129	T2D_GENES_TANYA_LIPIDS	KIM_WT1_TARGETS_8HR_DN
0.50597976081%	11	2174	128	T2D_GENES_TANYA_LIPIDS	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
0.50597976081%	11	2174	128	T2D_GENES_TANYA_LIPIDS	KEGG_CELL_CYCLE
0.50597976081%	11	2174	127	T2D_GENES_TANYA_LIPIDS	KARLSSON_TGFB1_TARGETS_UP
0.50597976081%	11	2174	125	T2D_GENES_TANYA_LIPIDS	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
0.50597976081%	11	2174	125	T2D_GENES_TANYA_LIPIDS	FIGUEROA_AML_METHYLATION_CLUSTER_1_UP
0.50597976081%	11	2174	124	T2D_GENES_TANYA_LIPIDS	DAIRKEE_TERT_TARGETS_DN
0.50597976081%	11	2174	123	T2D_GENES_TANYA_LIPIDS	DAZARD_RESPONSE_TO_UV_SCC_UP
0.50597976081%	11	2174	123	T2D_GENES_TANYA_LIPIDS	DAZARD_RESPONSE_TO_UV_SCC_DN
0.50597976081%	11	2174	121	T2D_GENES_TANYA_LIPIDS	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.50597976081%	11	2174	121	T2D_GENES_TANYA_LIPIDS	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
0.50597976081%	11	2174	120	T2D_GENES_TANYA_LIPIDS	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
0.50597976081%	11	2174	116	T2D_GENES_TANYA_LIPIDS	MATTIOLI_MGUS_VS_PCL
0.50597976081%	11	2174	114	T2D_GENES_TANYA_LIPIDS	SMIRNOV_RESPONSE_TO_IR_6HR_DN
0.50597976081%	11	2174	112	T2D_GENES_TANYA_LIPIDS	LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.50597976081%	11	2174	110	T2D_GENES_TANYA_LIPIDS	SUNG_METASTASIS_STROMA_UP
0.50597976081%	11	2174	110	T2D_GENES_TANYA_LIPIDS	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
0.50597976081%	11	2174	108	T2D_GENES_TANYA_LIPIDS	ZHANG_TLX_TARGETS_DN
0.50597976081%	11	2174	104	T2D_GENES_TANYA_LIPIDS	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
0.50597976081%	11	2174	104	T2D_GENES_TANYA_LIPIDS	NAKAMURA_ADIPOGENESIS_LATE_UP
0.50597976081%	11	2174	103	T2D_GENES_TANYA_LIPIDS	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
0.50597976081%	11	2174	103	T2D_GENES_TANYA_LIPIDS	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.50597976081%	11	2174	102	T2D_GENES_TANYA_LIPIDS	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.50597976081%	11	2174	101	T2D_GENES_TANYA_LIPIDS	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
0.50597976081%	11	2174	101	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_20HR_DN
0.50597976081%	11	2174	100	T2D_GENES_TANYA_LIPIDS	BENPORATH_ES_CORE_NINE_CORRELATED
0.489396411093%	3	613	98	T2D_GENES_TANYA_BIOMARKER	PYEON_HPV_POSITIVE_TUMORS_UP
0.489396411093%	3	613	98	T2D_GENES_TANYA_BIOMARKER	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
0.489396411093%	3	613	97	T2D_GENES_TANYA_BIOMARKER	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP
0.489396411093%	3	613	95	T2D_GENES_TANYA_BIOMARKER	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
0.489396411093%	3	613	95	T2D_GENES_TANYA_BIOMARKER	HOEBEKE_LYMPHOID_STEM_CELL_UP
0.489396411093%	3	613	95	T2D_GENES_TANYA_BIOMARKER	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
0.489396411093%	3	613	94	T2D_GENES_TANYA_BIOMARKER	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5
0.489396411093%	3	613	94	T2D_GENES_TANYA_BIOMARKER	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER
0.489396411093%	3	613	93	T2D_GENES_TANYA_BIOMARKER	ZHU_CMV_24_HR_UP
0.489396411093%	3	613	92	T2D_GENES_TANYA_BIOMARKER	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
0.489396411093%	3	613	92	T2D_GENES_TANYA_BIOMARKER	CAMPS_COLON_CANCER_COPY_NUMBER_UP
0.489396411093%	3	613	92	T2D_GENES_TANYA_BIOMARKER	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
0.489396411093%	3	613	91	T2D_GENES_TANYA_BIOMARKER	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.489396411093%	3	613	91	T2D_GENES_TANYA_BIOMARKER	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
0.489396411093%	3	613	90	T2D_GENES_TANYA_BIOMARKER	KEGG_GAP_JUNCTION
0.489396411093%	3	613	9	T2D_GENES_TANYA_BIOMARKER	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY
0.489396411093%	3	613	89	T2D_GENES_TANYA_BIOMARKER	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.489396411093%	3	613	89	T2D_GENES_TANYA_BIOMARKER	BHATTACHARYA_EMBRYONIC_STEM_CELL
0.489396411093%	3	613	88	T2D_GENES_TANYA_BIOMARKER	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
0.489396411093%	3	613	88	T2D_GENES_TANYA_BIOMARKER	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
0.489396411093%	3	613	88	T2D_GENES_TANYA_BIOMARKER	KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.489396411093%	3	613	88	T2D_GENES_TANYA_BIOMARKER	DURCHDEWALD_SKIN_CARCINOGENESIS_UP
0.489396411093%	3	613	87	T2D_GENES_TANYA_BIOMARKER	REACTOME_MITOTIC_PROMETAPHASE
0.489396411093%	3	613	87	T2D_GENES_TANYA_BIOMARKER	KEGG_ERBB_SIGNALING_PATHWAY
0.489396411093%	3	613	87	T2D_GENES_TANYA_BIOMARKER	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.489396411093%	3	613	87	T2D_GENES_TANYA_BIOMARKER	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
0.489396411093%	3	613	86	T2D_GENES_TANYA_BIOMARKER	NELSON_RESPONSE_TO_ANDROGEN_UP
0.489396411093%	3	613	86	T2D_GENES_TANYA_BIOMARKER	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
0.489396411093%	3	613	86	T2D_GENES_TANYA_BIOMARKER	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
0.489396411093%	3	613	86	T2D_GENES_TANYA_BIOMARKER	HOEBEKE_LYMPHOID_STEM_CELL_DN
0.489396411093%	3	613	86	T2D_GENES_TANYA_BIOMARKER	BURTON_ADIPOGENESIS_8
0.489396411093%	3	613	86	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_16HR_DN
0.489396411093%	3	613	85	T2D_GENES_TANYA_BIOMARKER	XU_GH1_EXOGENOUS_TARGETS_UP
0.489396411093%	3	613	85	T2D_GENES_TANYA_BIOMARKER	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
0.489396411093%	3	613	85	T2D_GENES_TANYA_BIOMARKER	STEIN_ESR1_TARGETS
0.489396411093%	3	613	85	T2D_GENES_TANYA_BIOMARKER	SANA_RESPONSE_TO_IFNG_DN
0.489396411093%	3	613	85	T2D_GENES_TANYA_BIOMARKER	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE
0.489396411093%	3	613	85	T2D_GENES_TANYA_BIOMARKER	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
0.489396411093%	3	613	84	T2D_GENES_TANYA_BIOMARKER	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP
0.489396411093%	3	613	84	T2D_GENES_TANYA_BIOMARKER	SMID_BREAST_CANCER_LUMINAL_A_UP
0.489396411093%	3	613	84	T2D_GENES_TANYA_BIOMARKER	HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.489396411093%	3	613	84	T2D_GENES_TANYA_BIOMARKER	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
0.489396411093%	3	613	83	T2D_GENES_TANYA_BIOMARKER	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.489396411093%	3	613	83	T2D_GENES_TANYA_BIOMARKER	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.489396411093%	3	613	83	T2D_GENES_TANYA_BIOMARKER	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
0.489396411093%	3	613	82	T2D_GENES_TANYA_BIOMARKER	WONG_ENDMETRIUM_CANCER_DN
0.489396411093%	3	613	82	T2D_GENES_TANYA_BIOMARKER	ST_INTEGRIN_SIGNALING_PATHWAY
0.489396411093%	3	613	82	T2D_GENES_TANYA_BIOMARKER	LEIN_MIDBRAIN_MARKERS
0.489396411093%	3	613	81	T2D_GENES_TANYA_BIOMARKER	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
0.489396411093%	3	613	81	T2D_GENES_TANYA_BIOMARKER	REACTOME_M_G1_TRANSITION
0.489396411093%	3	613	81	T2D_GENES_TANYA_BIOMARKER	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION
0.489396411093%	3	613	81	T2D_GENES_TANYA_BIOMARKER	GUO_HEX_TARGETS_UP
0.489396411093%	3	613	80	T2D_GENES_TANYA_BIOMARKER	LEE_AGING_NEOCORTEX_DN
0.489396411093%	3	613	80	T2D_GENES_TANYA_BIOMARKER	KEGG_CARDIAC_MUSCLE_CONTRACTION
0.489396411093%	3	613	80	T2D_GENES_TANYA_BIOMARKER	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN
0.489396411093%	3	613	79	T2D_GENES_TANYA_BIOMARKER	PID_P73PATHWAY
0.489396411093%	3	613	79	T2D_GENES_TANYA_BIOMARKER	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
0.489396411093%	3	613	79	T2D_GENES_TANYA_BIOMARKER	MALONEY_RESPONSE_TO_17AAG_DN
0.489396411093%	3	613	79	T2D_GENES_TANYA_BIOMARKER	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
0.489396411093%	3	613	79	T2D_GENES_TANYA_BIOMARKER	DUAN_PRDM5_TARGETS
0.489396411093%	3	613	79	T2D_GENES_TANYA_BIOMARKER	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
0.489396411093%	3	613	78	T2D_GENES_TANYA_BIOMARKER	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
0.489396411093%	3	613	77	T2D_GENES_TANYA_BIOMARKER	SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.489396411093%	3	613	77	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
0.489396411093%	3	613	77	T2D_GENES_TANYA_BIOMARKER	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.489396411093%	3	613	77	T2D_GENES_TANYA_BIOMARKER	GROSS_HYPOXIA_VIA_HIF1A_UP
0.489396411093%	3	613	77	T2D_GENES_TANYA_BIOMARKER	CARD_MIR302A_TARGETS
0.489396411093%	3	613	76	T2D_GENES_TANYA_BIOMARKER	KEGG_VEGF_SIGNALING_PATHWAY
0.489396411093%	3	613	75	T2D_GENES_TANYA_BIOMARKER	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
0.489396411093%	3	613	75	T2D_GENES_TANYA_BIOMARKER	PID_AVB3_INTEGRIN_PATHWAY
0.489396411093%	3	613	75	T2D_GENES_TANYA_BIOMARKER	KEGG_ADHERENS_JUNCTION
0.489396411093%	3	613	75	T2D_GENES_TANYA_BIOMARKER	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
0.489396411093%	3	613	75	T2D_GENES_TANYA_BIOMARKER	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
0.489396411093%	3	613	74	T2D_GENES_TANYA_BIOMARKER	RAMALHO_STEMNESS_DN
0.489396411093%	3	613	74	T2D_GENES_TANYA_BIOMARKER	PID_E2F_PATHWAY
0.489396411093%	3	613	74	T2D_GENES_TANYA_BIOMARKER	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
0.489396411093%	3	613	74	T2D_GENES_TANYA_BIOMARKER	FURUKAWA_DUSP6_TARGETS_PCI35_UP
0.489396411093%	3	613	74	T2D_GENES_TANYA_BIOMARKER	CORRE_MULTIPLE_MYELOMA_UP
0.489396411093%	3	613	73	T2D_GENES_TANYA_BIOMARKER	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
0.489396411093%	3	613	73	T2D_GENES_TANYA_BIOMARKER	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.489396411093%	3	613	73	T2D_GENES_TANYA_BIOMARKER	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
0.489396411093%	3	613	73	T2D_GENES_TANYA_BIOMARKER	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
0.489396411093%	3	613	73	T2D_GENES_TANYA_BIOMARKER	KEGG_VIRAL_MYOCARDITIS
0.489396411093%	3	613	73	T2D_GENES_TANYA_BIOMARKER	GAURNIER_PSMD4_TARGETS
0.489396411093%	3	613	73	T2D_GENES_TANYA_BIOMARKER	DITTMER_PTHLH_TARGETS_DN
0.489396411093%	3	613	73	T2D_GENES_TANYA_BIOMARKER	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
0.489396411093%	3	613	72	T2D_GENES_TANYA_BIOMARKER	REACTOME_METABOLISM_OF_NUCLEOTIDES
0.489396411093%	3	613	72	T2D_GENES_TANYA_BIOMARKER	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1
0.489396411093%	3	613	72	T2D_GENES_TANYA_BIOMARKER	MATZUK_SPERMATOCYTE
0.489396411093%	3	613	71	T2D_GENES_TANYA_BIOMARKER	KYNG_RESPONSE_TO_H2O2
0.489396411093%	3	613	71	T2D_GENES_TANYA_BIOMARKER	DER_IFN_GAMMA_RESPONSE_UP
0.489396411093%	3	613	70	T2D_GENES_TANYA_BIOMARKER	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
0.489396411093%	3	613	70	T2D_GENES_TANYA_BIOMARKER	KEGG_RENAL_CELL_CARCINOMA
0.489396411093%	3	613	70	T2D_GENES_TANYA_BIOMARKER	ENGELMANN_CANCER_PROGENITORS_DN
0.489396411093%	3	613	69	T2D_GENES_TANYA_BIOMARKER	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10
0.489396411093%	3	613	69	T2D_GENES_TANYA_BIOMARKER	PID_VEGFR1_2_PATHWAY
0.489396411093%	3	613	69	T2D_GENES_TANYA_BIOMARKER	PID_P75NTRPATHWAY
0.489396411093%	3	613	69	T2D_GENES_TANYA_BIOMARKER	PID_MTOR_4PATHWAY
0.489396411093%	3	613	69	T2D_GENES_TANYA_BIOMARKER	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES
0.489396411093%	3	613	69	T2D_GENES_TANYA_BIOMARKER	BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE
0.489396411093%	3	613	68	T2D_GENES_TANYA_BIOMARKER	REACTOME_SEMAPHORIN_INTERACTIONS
0.489396411093%	3	613	68	T2D_GENES_TANYA_BIOMARKER	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.489396411093%	3	613	68	T2D_GENES_TANYA_BIOMARKER	DELPUECH_FOXO3_TARGETS_UP
0.489396411093%	3	613	67	T2D_GENES_TANYA_BIOMARKER	VANHARANTA_UTERINE_FIBROID_DN
0.489396411093%	3	613	67	T2D_GENES_TANYA_BIOMARKER	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN
0.489396411093%	3	613	66	T2D_GENES_TANYA_BIOMARKER	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM
0.489396411093%	3	613	66	T2D_GENES_TANYA_BIOMARKER	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
0.489396411093%	3	613	66	T2D_GENES_TANYA_BIOMARKER	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT
0.489396411093%	3	613	66	T2D_GENES_TANYA_BIOMARKER	TENEDINI_MEGAKARYOCYTE_MARKERS
0.489396411093%	3	613	66	T2D_GENES_TANYA_BIOMARKER	RAMASWAMY_METASTASIS_UP
0.489396411093%	3	613	66	T2D_GENES_TANYA_BIOMARKER	PID_LYSOPHOSPHOLIPID_PATHWAY
0.489396411093%	3	613	66	T2D_GENES_TANYA_BIOMARKER	PID_HIF1_TFPATHWAY
0.489396411093%	3	613	66	T2D_GENES_TANYA_BIOMARKER	MARSON_FOXP3_TARGETS_UP
0.489396411093%	3	613	66	T2D_GENES_TANYA_BIOMARKER	BEIER_GLIOMA_STEM_CELL_DN
0.489396411093%	3	613	65	T2D_GENES_TANYA_BIOMARKER	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.489396411093%	3	613	65	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_WNT
0.489396411093%	3	613	65	T2D_GENES_TANYA_BIOMARKER	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
0.489396411093%	3	613	65	T2D_GENES_TANYA_BIOMARKER	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX
0.489396411093%	3	613	65	T2D_GENES_TANYA_BIOMARKER	PID_CD8TCRDOWNSTREAMPATHWAY
0.489396411093%	3	613	64	T2D_GENES_TANYA_BIOMARKER	RIZKI_TUMOR_INVASIVENESS_2D_DN
0.489396411093%	3	613	64	T2D_GENES_TANYA_BIOMARKER	REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C
0.489396411093%	3	613	64	T2D_GENES_TANYA_BIOMARKER	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
0.489396411093%	3	613	64	T2D_GENES_TANYA_BIOMARKER	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
0.489396411093%	3	613	63	T2D_GENES_TANYA_BIOMARKER	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP
0.489396411093%	3	613	63	T2D_GENES_TANYA_BIOMARKER	REACTOME_INTERFERON_GAMMA_SIGNALING
0.489396411093%	3	613	63	T2D_GENES_TANYA_BIOMARKER	JOHNSTONE_PARVB_TARGETS_1_DN
0.489396411093%	3	613	63	T2D_GENES_TANYA_BIOMARKER	BILBAN_B_CLL_LPL_UP
0.489396411093%	3	613	62	T2D_GENES_TANYA_BIOMARKER	PID_FCER1PATHWAY
0.489396411093%	3	613	62	T2D_GENES_TANYA_BIOMARKER	KYNG_DNA_DAMAGE_BY_UV
0.489396411093%	3	613	62	T2D_GENES_TANYA_BIOMARKER	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
0.489396411093%	3	613	62	T2D_GENES_TANYA_BIOMARKER	ISSAEVA_MLL2_TARGETS
0.489396411093%	3	613	62	T2D_GENES_TANYA_BIOMARKER	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.489396411093%	3	613	61	T2D_GENES_TANYA_BIOMARKER	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.489396411093%	3	613	61	T2D_GENES_TANYA_BIOMARKER	RAMASWAMY_METASTASIS_DN
0.489396411093%	3	613	61	T2D_GENES_TANYA_BIOMARKER	NADLER_OBESITY_UP
0.489396411093%	3	613	61	T2D_GENES_TANYA_BIOMARKER	LEE_LIVER_CANCER_MYC_TGFA_UP
0.489396411093%	3	613	61	T2D_GENES_TANYA_BIOMARKER	BAKKER_FOXO3_TARGETS_UP
0.489396411093%	3	613	60	T2D_GENES_TANYA_BIOMARKER	AMIT_EGF_RESPONSE_240_HELA
0.489396411093%	3	613	59	T2D_GENES_TANYA_BIOMARKER	PID_NOTCH_PATHWAY
0.489396411093%	3	613	59	T2D_GENES_TANYA_BIOMARKER	HUPER_BREAST_BASAL_VS_LUMINAL_DN
0.489396411093%	3	613	59	T2D_GENES_TANYA_BIOMARKER	ELVIDGE_HYPOXIA_BY_DMOG_DN
0.489396411093%	3	613	59	T2D_GENES_TANYA_BIOMARKER	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
0.489396411093%	3	613	58	T2D_GENES_TANYA_BIOMARKER	PID_SHP2_PATHWAY
0.489396411093%	3	613	58	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_NPC_LCP_WITH_H3K4ME3
0.489396411093%	3	613	57	T2D_GENES_TANYA_BIOMARKER	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
0.489396411093%	3	613	57	T2D_GENES_TANYA_BIOMARKER	REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE
0.489396411093%	3	613	57	T2D_GENES_TANYA_BIOMARKER	LEE_EARLY_T_LYMPHOCYTE_DN
0.489396411093%	3	613	57	T2D_GENES_TANYA_BIOMARKER	BORLAK_LIVER_CANCER_EGF_UP
0.489396411093%	3	613	56	T2D_GENES_TANYA_BIOMARKER	VANTVEER_BREAST_CANCER_METASTASIS_UP
0.489396411093%	3	613	56	T2D_GENES_TANYA_BIOMARKER	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.489396411093%	3	613	56	T2D_GENES_TANYA_BIOMARKER	REACTOME_PI_3K_CASCADE
0.489396411093%	3	613	56	T2D_GENES_TANYA_BIOMARKER	REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX
0.489396411093%	3	613	56	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_30MIN_UP
0.489396411093%	3	613	55	T2D_GENES_TANYA_BIOMARKER	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
0.489396411093%	3	613	54	T2D_GENES_TANYA_BIOMARKER	SU_PANCREAS
0.489396411093%	3	613	54	T2D_GENES_TANYA_BIOMARKER	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE
0.489396411093%	3	613	54	T2D_GENES_TANYA_BIOMARKER	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP
0.489396411093%	3	613	54	T2D_GENES_TANYA_BIOMARKER	KEGG_NON_SMALL_CELL_LUNG_CANCER
0.489396411093%	3	613	54	T2D_GENES_TANYA_BIOMARKER	KANG_DOXORUBICIN_RESISTANCE_UP
0.489396411093%	3	613	53	T2D_GENES_TANYA_BIOMARKER	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP
0.489396411093%	3	613	53	T2D_GENES_TANYA_BIOMARKER	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0
0.489396411093%	3	613	53	T2D_GENES_TANYA_BIOMARKER	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
0.489396411093%	3	613	53	T2D_GENES_TANYA_BIOMARKER	KEGG_AUTOIMMUNE_THYROID_DISEASE
0.489396411093%	3	613	52	T2D_GENES_TANYA_BIOMARKER	REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.489396411093%	3	613	52	T2D_GENES_TANYA_BIOMARKER	PID_KITPATHWAY
0.489396411093%	3	613	52	T2D_GENES_TANYA_BIOMARKER	KEGG_MTOR_SIGNALING_PATHWAY
0.489396411093%	3	613	51	T2D_GENES_TANYA_BIOMARKER	REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.489396411093%	3	613	51	T2D_GENES_TANYA_BIOMARKER	REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT
0.489396411093%	3	613	51	T2D_GENES_TANYA_BIOMARKER	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1
0.489396411093%	3	613	51	T2D_GENES_TANYA_BIOMARKER	MORI_PLASMA_CELL_UP
0.489396411093%	3	613	51	T2D_GENES_TANYA_BIOMARKER	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN
0.489396411093%	3	613	51	T2D_GENES_TANYA_BIOMARKER	LEE_CALORIE_RESTRICTION_MUSCLE_DN
0.489396411093%	3	613	51	T2D_GENES_TANYA_BIOMARKER	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
0.489396411093%	3	613	50	T2D_GENES_TANYA_BIOMARKER	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.489396411093%	3	613	50	T2D_GENES_TANYA_BIOMARKER	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC
0.489396411093%	3	613	49	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_HP_UP
0.489396411093%	3	613	49	T2D_GENES_TANYA_BIOMARKER	WONG_PROTEASOME_GENE_MODULE
0.489396411093%	3	613	49	T2D_GENES_TANYA_BIOMARKER	REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC
0.489396411093%	3	613	49	T2D_GENES_TANYA_BIOMARKER	MARCHINI_TRABECTEDIN_RESISTANCE_DN
0.489396411093%	3	613	49	T2D_GENES_TANYA_BIOMARKER	KEGG_GLYCEROLIPID_METABOLISM
0.489396411093%	3	613	49	T2D_GENES_TANYA_BIOMARKER	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN
0.489396411093%	3	613	49	T2D_GENES_TANYA_BIOMARKER	FAELT_B_CLL_WITH_VH3_21_DN
0.489396411093%	3	613	48	T2D_GENES_TANYA_BIOMARKER	TAVOR_CEBPA_TARGETS_UP
0.489396411093%	3	613	48	T2D_GENES_TANYA_BIOMARKER	REACTOME_MUSCLE_CONTRACTION
0.489396411093%	3	613	48	T2D_GENES_TANYA_BIOMARKER	REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY
0.489396411093%	3	613	48	T2D_GENES_TANYA_BIOMARKER	REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES
0.489396411093%	3	613	48	T2D_GENES_TANYA_BIOMARKER	REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6
0.489396411093%	3	613	48	T2D_GENES_TANYA_BIOMARKER	PID_HEDGEHOG_GLIPATHWAY
0.489396411093%	3	613	48	T2D_GENES_TANYA_BIOMARKER	PID_CERAMIDE_PATHWAY
0.489396411093%	3	613	48	T2D_GENES_TANYA_BIOMARKER	KEGG_PROTEASOME
0.489396411093%	3	613	47	T2D_GENES_TANYA_BIOMARKER	SILIGAN_BOUND_BY_EWS_FLT1_FUSION
0.489396411093%	3	613	47	T2D_GENES_TANYA_BIOMARKER	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
0.489396411093%	3	613	47	T2D_GENES_TANYA_BIOMARKER	PID_NFAT_TFPATHWAY
0.489396411093%	3	613	47	T2D_GENES_TANYA_BIOMARKER	PID_IL6_7PATHWAY
0.489396411093%	3	613	47	T2D_GENES_TANYA_BIOMARKER	KEGG_TYPE_II_DIABETES_MELLITUS
0.489396411093%	3	613	47	T2D_GENES_TANYA_BIOMARKER	BOYLAN_MULTIPLE_MYELOMA_C_UP
0.489396411093%	3	613	46	T2D_GENES_TANYA_BIOMARKER	WINNEPENNINCKX_MELANOMA_METASTASIS_DN
0.489396411093%	3	613	46	T2D_GENES_TANYA_BIOMARKER	SESTO_RESPONSE_TO_UV_C5
0.489396411093%	3	613	46	T2D_GENES_TANYA_BIOMARKER	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
0.489396411093%	3	613	46	T2D_GENES_TANYA_BIOMARKER	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1
0.489396411093%	3	613	46	T2D_GENES_TANYA_BIOMARKER	HALMOS_CEBPA_TARGETS_DN
0.489396411093%	3	613	46	T2D_GENES_TANYA_BIOMARKER	ABBUD_LIF_SIGNALING_1_UP
0.489396411093%	3	613	45	T2D_GENES_TANYA_BIOMARKER	PID_RHOA_PATHWAY
0.489396411093%	3	613	45	T2D_GENES_TANYA_BIOMARKER	NAKAMURA_METASTASIS_MODEL_UP
0.489396411093%	3	613	45	T2D_GENES_TANYA_BIOMARKER	LUI_THYROID_CANCER_PAX8_PPARG_DN
0.489396411093%	3	613	45	T2D_GENES_TANYA_BIOMARKER	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN
0.489396411093%	3	613	45	T2D_GENES_TANYA_BIOMARKER	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP
0.489396411093%	3	613	44	T2D_GENES_TANYA_BIOMARKER	ZUCCHI_METASTASIS_DN
0.489396411093%	3	613	44	T2D_GENES_TANYA_BIOMARKER	OHGUCHI_LIVER_HNF4A_TARGETS_UP
0.489396411093%	3	613	44	T2D_GENES_TANYA_BIOMARKER	MEDINA_SMARCA4_TARGETS
0.489396411093%	3	613	44	T2D_GENES_TANYA_BIOMARKER	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS
0.489396411093%	3	613	44	T2D_GENES_TANYA_BIOMARKER	GROSS_HYPOXIA_VIA_ELK3_ONLY_DN
0.489396411093%	3	613	43	T2D_GENES_TANYA_BIOMARKER	POTTI_ETOPOSIDE_SENSITIVITY
0.489396411093%	3	613	43	T2D_GENES_TANYA_BIOMARKER	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
0.489396411093%	3	613	43	T2D_GENES_TANYA_BIOMARKER	LEE_CALORIE_RESTRICTION_MUSCLE_UP
0.489396411093%	3	613	43	T2D_GENES_TANYA_BIOMARKER	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
0.489396411093%	3	613	43	T2D_GENES_TANYA_BIOMARKER	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
0.489396411093%	3	613	42	T2D_GENES_TANYA_BIOMARKER	ZHENG_IL22_SIGNALING_DN
0.489396411093%	3	613	42	T2D_GENES_TANYA_BIOMARKER	WIERENGA_PML_INTERACTOME
0.489396411093%	3	613	42	T2D_GENES_TANYA_BIOMARKER	KEGG_TYROSINE_METABOLISM
0.489396411093%	3	613	42	T2D_GENES_TANYA_BIOMARKER	KEGG_GRAFT_VERSUS_HOST_DISEASE
0.489396411093%	3	613	41	T2D_GENES_TANYA_BIOMARKER	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.489396411093%	3	613	41	T2D_GENES_TANYA_BIOMARKER	EHLERS_ANEUPLOIDY_UP
0.489396411093%	3	613	41	T2D_GENES_TANYA_BIOMARKER	DELPUECH_FOXO3_TARGETS_DN
0.489396411093%	3	613	40	T2D_GENES_TANYA_BIOMARKER	VANASSE_BCL2_TARGETS_UP
0.489396411093%	3	613	40	T2D_GENES_TANYA_BIOMARKER	ST_B_CELL_ANTIGEN_RECEPTOR
0.489396411093%	3	613	40	T2D_GENES_TANYA_BIOMARKER	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
0.489396411093%	3	613	40	T2D_GENES_TANYA_BIOMARKER	PID_IFNGPATHWAY
0.489396411093%	3	613	40	T2D_GENES_TANYA_BIOMARKER	ELLWOOD_MYC_TARGETS_DN
0.489396411093%	3	613	39	T2D_GENES_TANYA_BIOMARKER	PID_RET_PATHWAY
0.489396411093%	3	613	39	T2D_GENES_TANYA_BIOMARKER	PID_ATR_PATHWAY
0.489396411093%	3	613	39	T2D_GENES_TANYA_BIOMARKER	MA_MYELOID_DIFFERENTIATION_UP
0.489396411093%	3	613	39	T2D_GENES_TANYA_BIOMARKER	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP
0.489396411093%	3	613	38	T2D_GENES_TANYA_BIOMARKER	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
0.489396411093%	3	613	38	T2D_GENES_TANYA_BIOMARKER	NAKAMURA_ADIPOGENESIS_EARLY_DN
0.489396411093%	3	613	38	T2D_GENES_TANYA_BIOMARKER	KEGG_ALLOGRAFT_REJECTION
0.489396411093%	3	613	36	T2D_GENES_TANYA_BIOMARKER	VALK_AML_CLUSTER_11
0.489396411093%	3	613	352	T2D_GENES_TANYA_BIOMARKER	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
0.489396411093%	3	613	35	T2D_GENES_TANYA_BIOMARKER	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.489396411093%	3	613	35	T2D_GENES_TANYA_BIOMARKER	PID_HIVNEFPATHWAY
0.489396411093%	3	613	35	T2D_GENES_TANYA_BIOMARKER	LOPEZ_TRANSLATION_VIA_FN1_SIGNALING
0.489396411093%	3	613	34	T2D_GENES_TANYA_BIOMARKER	YANG_BREAST_CANCER_ESR1_LASER_UP
0.489396411093%	3	613	34	T2D_GENES_TANYA_BIOMARKER	PID_EPOPATHWAY
0.489396411093%	3	613	34	T2D_GENES_TANYA_BIOMARKER	LUI_TARGETS_OF_PAX8_PPARG_FUSION
0.489396411093%	3	613	34	T2D_GENES_TANYA_BIOMARKER	HONMA_DOCETAXEL_RESISTANCE
0.489396411093%	3	613	33	T2D_GENES_TANYA_BIOMARKER	TANG_SENESCENCE_TP53_TARGETS_UP
0.489396411093%	3	613	33	T2D_GENES_TANYA_BIOMARKER	SIMBULAN_UV_RESPONSE_NORMAL_DN
0.489396411093%	3	613	33	T2D_GENES_TANYA_BIOMARKER	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP
0.489396411093%	3	613	33	T2D_GENES_TANYA_BIOMARKER	JEPSEN_SMRT_TARGETS
0.489396411093%	3	613	33	T2D_GENES_TANYA_BIOMARKER	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN
0.489396411093%	3	613	32	T2D_GENES_TANYA_BIOMARKER	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN
0.489396411093%	3	613	32	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_RHO_PATHWAY
0.489396411093%	3	613	32	T2D_GENES_TANYA_BIOMARKER	BAE_BRCA1_TARGETS_DN
0.489396411093%	3	613	31	T2D_GENES_TANYA_BIOMARKER	REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE
0.489396411093%	3	613	31	T2D_GENES_TANYA_BIOMARKER	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM
0.489396411093%	3	613	305	T2D_GENES_TANYA_BIOMARKER	BORCZUK_MALIGNANT_MESOTHELIOMA_UP
0.489396411093%	3	613	30	T2D_GENES_TANYA_BIOMARKER	URS_ADIPOCYTE_DIFFERENTIATION_DN
0.489396411093%	3	613	30	T2D_GENES_TANYA_BIOMARKER	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN
0.489396411093%	3	613	30	T2D_GENES_TANYA_BIOMARKER	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.489396411093%	3	613	30	T2D_GENES_TANYA_BIOMARKER	REACTOME_BASIGIN_INTERACTIONS
0.489396411093%	3	613	30	T2D_GENES_TANYA_BIOMARKER	KIM_LRRC3B_TARGETS
0.489396411093%	3	613	294	T2D_GENES_TANYA_BIOMARKER	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
0.489396411093%	3	613	291	T2D_GENES_TANYA_BIOMARKER	SABATES_COLORECTAL_ADENOMA_DN
0.489396411093%	3	613	29	T2D_GENES_TANYA_BIOMARKER	KRIGE_AMINO_ACID_DEPRIVATION
0.489396411093%	3	613	29	T2D_GENES_TANYA_BIOMARKER	KEGG_HISTIDINE_METABOLISM
0.489396411093%	3	613	29	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_INFLAM_PATHWAY
0.489396411093%	3	613	28	T2D_GENES_TANYA_BIOMARKER	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN
0.489396411093%	3	613	26	T2D_GENES_TANYA_BIOMARKER	VALK_AML_CLUSTER_16
0.489396411093%	3	613	26	T2D_GENES_TANYA_BIOMARKER	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN
0.489396411093%	3	613	25	T2D_GENES_TANYA_BIOMARKER	PID_MYC_PATHWAY
0.489396411093%	3	613	25	T2D_GENES_TANYA_BIOMARKER	LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS
0.489396411093%	3	613	25	T2D_GENES_TANYA_BIOMARKER	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN
0.489396411093%	3	613	25	T2D_GENES_TANYA_BIOMARKER	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS
0.489396411093%	3	613	25	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_STRESS_PATHWAY
0.489396411093%	3	613	25	T2D_GENES_TANYA_BIOMARKER	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP
0.489396411093%	3	613	243	T2D_GENES_TANYA_BIOMARKER	CHICAS_RB1_TARGETS_GROWING
0.489396411093%	3	613	242	T2D_GENES_TANYA_BIOMARKER	WINTER_HYPOXIA_METAGENE
0.489396411093%	3	613	242	T2D_GENES_TANYA_BIOMARKER	MULLIGHAN_MLL_SIGNATURE_1_DN
0.489396411093%	3	613	24	T2D_GENES_TANYA_BIOMARKER	ODONNELL_METASTASIS_DN
0.489396411093%	3	613	238	T2D_GENES_TANYA_BIOMARKER	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
0.489396411093%	3	613	23	T2D_GENES_TANYA_BIOMARKER	YANG_MUC2_TARGETS_DUODENUM_3MO_DN
0.489396411093%	3	613	23	T2D_GENES_TANYA_BIOMARKER	REACTOME_GLUTATHIONE_CONJUGATION
0.489396411093%	3	613	23	T2D_GENES_TANYA_BIOMARKER	PID_CONE_PATHWAY
0.489396411093%	3	613	23	T2D_GENES_TANYA_BIOMARKER	BILANGES_SERUM_SENSITIVE_VIA_TSC1
0.489396411093%	3	613	22	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_SPIKED
0.489396411093%	3	613	22	T2D_GENES_TANYA_BIOMARKER	YUAN_ZNF143_PARTNERS
0.489396411093%	3	613	22	T2D_GENES_TANYA_BIOMARKER	SPIRA_SMOKERS_LUNG_CANCER_DN
0.489396411093%	3	613	21	T2D_GENES_TANYA_BIOMARKER	YANG_MUC2_TARGETS_DUODENUM_6MO_DN
0.489396411093%	3	613	21	T2D_GENES_TANYA_BIOMARKER	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN
0.489396411093%	3	613	207	T2D_GENES_TANYA_BIOMARKER	VERHAAK_GLIOBLASTOMA_CLASSICAL
0.489396411093%	3	613	206	T2D_GENES_TANYA_BIOMARKER	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.489396411093%	3	613	205	T2D_GENES_TANYA_BIOMARKER	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.489396411093%	3	613	203	T2D_GENES_TANYA_BIOMARKER	REACTOME_INFLUENZA_LIFE_CYCLE
0.489396411093%	3	613	20	T2D_GENES_TANYA_BIOMARKER	WENG_POR_TARGETS_GLOBAL_UP
0.489396411093%	3	613	20	T2D_GENES_TANYA_BIOMARKER	NIELSEN_SYNOVIAL_SARCOMA_DN
0.489396411093%	3	613	198	T2D_GENES_TANYA_BIOMARKER	REACTOME_PHOSPHOLIPID_METABOLISM
0.489396411093%	3	613	197	T2D_GENES_TANYA_BIOMARKER	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
0.489396411093%	3	613	196	T2D_GENES_TANYA_BIOMARKER	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
0.489396411093%	3	613	193	T2D_GENES_TANYA_BIOMARKER	MOHANKUMAR_TLX1_TARGETS_DN
0.489396411093%	3	613	193	T2D_GENES_TANYA_BIOMARKER	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
0.489396411093%	3	613	188	T2D_GENES_TANYA_BIOMARKER	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
0.489396411093%	3	613	188	T2D_GENES_TANYA_BIOMARKER	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.489396411093%	3	613	185	T2D_GENES_TANYA_BIOMARKER	KEGG_HUNTINGTONS_DISEASE
0.489396411093%	3	613	184	T2D_GENES_TANYA_BIOMARKER	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
0.489396411093%	3	613	184	T2D_GENES_TANYA_BIOMARKER	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
0.489396411093%	3	613	181	T2D_GENES_TANYA_BIOMARKER	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
0.489396411093%	3	613	18	T2D_GENES_TANYA_BIOMARKER	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN
0.489396411093%	3	613	179	T2D_GENES_TANYA_BIOMARKER	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE
0.489396411093%	3	613	178	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_18HR_UP
0.489396411093%	3	613	176	T2D_GENES_TANYA_BIOMARKER	REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION
0.489396411093%	3	613	175	T2D_GENES_TANYA_BIOMARKER	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.489396411093%	3	613	175	T2D_GENES_TANYA_BIOMARKER	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
0.489396411093%	3	613	171	T2D_GENES_TANYA_BIOMARKER	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
0.489396411093%	3	613	17	T2D_GENES_TANYA_BIOMARKER	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
0.489396411093%	3	613	17	T2D_GENES_TANYA_BIOMARKER	GALE_APL_WITH_FLT3_MUTATED_DN
0.489396411093%	3	613	168	T2D_GENES_TANYA_BIOMARKER	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
0.489396411093%	3	613	167	T2D_GENES_TANYA_BIOMARKER	VANTVEER_BREAST_CANCER_ESR1_UP
0.489396411093%	3	613	167	T2D_GENES_TANYA_BIOMARKER	TIEN_INTESTINE_PROBIOTICS_6HR_DN
0.489396411093%	3	613	166	T2D_GENES_TANYA_BIOMARKER	SMIRNOV_RESPONSE_TO_IR_6HR_UP
0.489396411093%	3	613	165	T2D_GENES_TANYA_BIOMARKER	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
0.489396411093%	3	613	165	T2D_GENES_TANYA_BIOMARKER	LIU_CMYB_TARGETS_UP
0.489396411093%	3	613	162	T2D_GENES_TANYA_BIOMARKER	DARWICHE_PAPILLOMA_RISK_LOW_UP
0.489396411093%	3	613	161	T2D_GENES_TANYA_BIOMARKER	REACTOME_MRNA_PROCESSING
0.489396411093%	3	613	160	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_6HR_DN
0.489396411093%	3	613	159	T2D_GENES_TANYA_BIOMARKER	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
0.489396411093%	3	613	159	T2D_GENES_TANYA_BIOMARKER	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
0.489396411093%	3	613	158	T2D_GENES_TANYA_BIOMARKER	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.489396411093%	3	613	155	T2D_GENES_TANYA_BIOMARKER	KEGG_JAK_STAT_SIGNALING_PATHWAY
0.489396411093%	3	613	154	T2D_GENES_TANYA_BIOMARKER	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
0.489396411093%	3	613	153	T2D_GENES_TANYA_BIOMARKER	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN
0.489396411093%	3	613	151	T2D_GENES_TANYA_BIOMARKER	KEGG_WNT_SIGNALING_PATHWAY
0.489396411093%	3	613	151	T2D_GENES_TANYA_BIOMARKER	IGLESIAS_E2F_TARGETS_UP
0.489396411093%	3	613	151	T2D_GENES_TANYA_BIOMARKER	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
0.489396411093%	3	613	149	T2D_GENES_TANYA_BIOMARKER	LANDIS_ERBB2_BREAST_TUMORS_324_DN
0.489396411093%	3	613	149	T2D_GENES_TANYA_BIOMARKER	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
0.489396411093%	3	613	148	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_24HR_UP
0.489396411093%	3	613	145	T2D_GENES_TANYA_BIOMARKER	RODWELL_AGING_KIDNEY_DN
0.489396411093%	3	613	143	T2D_GENES_TANYA_BIOMARKER	BASSO_B_LYMPHOCYTE_NETWORK
0.489396411093%	3	613	142	T2D_GENES_TANYA_BIOMARKER	XU_GH1_AUTOCRINE_TARGETS_DN
0.489396411093%	3	613	142	T2D_GENES_TANYA_BIOMARKER	RUIZ_TNC_TARGETS_DN
0.489396411093%	3	613	142	T2D_GENES_TANYA_BIOMARKER	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
0.489396411093%	3	613	141	T2D_GENES_TANYA_BIOMARKER	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.489396411093%	3	613	14	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR
0.489396411093%	3	613	137	T2D_GENES_TANYA_BIOMARKER	REACTOME_MITOTIC_G1_G1_S_PHASES
0.489396411093%	3	613	137	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.489396411093%	3	613	135	T2D_GENES_TANYA_BIOMARKER	KEGG_OXIDATIVE_PHOSPHORYLATION
0.489396411093%	3	613	132	T2D_GENES_TANYA_BIOMARKER	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
0.489396411093%	3	613	130	T2D_GENES_TANYA_BIOMARKER	ELVIDGE_HYPOXIA_BY_DMOG_UP
0.489396411093%	3	613	13	T2D_GENES_TANYA_BIOMARKER	REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT
0.489396411093%	3	613	129	T2D_GENES_TANYA_BIOMARKER	PID_PDGFRBPATHWAY
0.489396411093%	3	613	129	T2D_GENES_TANYA_BIOMARKER	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP
0.489396411093%	3	613	128	T2D_GENES_TANYA_BIOMARKER	POTTI_TOPOTECAN_SENSITIVITY
0.489396411093%	3	613	128	T2D_GENES_TANYA_BIOMARKER	KEGG_CELL_CYCLE
0.489396411093%	3	613	128	T2D_GENES_TANYA_BIOMARKER	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS
0.489396411093%	3	613	128	T2D_GENES_TANYA_BIOMARKER	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
0.489396411093%	3	613	127	T2D_GENES_TANYA_BIOMARKER	KARLSSON_TGFB1_TARGETS_UP
0.489396411093%	3	613	126	T2D_GENES_TANYA_BIOMARKER	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
0.489396411093%	3	613	125	T2D_GENES_TANYA_BIOMARKER	FIGUEROA_AML_METHYLATION_CLUSTER_1_UP
0.489396411093%	3	613	123	T2D_GENES_TANYA_BIOMARKER	DAZARD_RESPONSE_TO_UV_SCC_UP
0.489396411093%	3	613	122	T2D_GENES_TANYA_BIOMARKER	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
0.489396411093%	3	613	121	T2D_GENES_TANYA_BIOMARKER	VANTVEER_BREAST_CANCER_METASTASIS_DN
0.489396411093%	3	613	120	T2D_GENES_TANYA_BIOMARKER	ZHU_CMV_ALL_UP
0.489396411093%	3	613	120	T2D_GENES_TANYA_BIOMARKER	XU_GH1_EXOGENOUS_TARGETS_DN
0.489396411093%	3	613	120	T2D_GENES_TANYA_BIOMARKER	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
0.489396411093%	3	613	120	T2D_GENES_TANYA_BIOMARKER	CHEBOTAEV_GR_TARGETS_DN
0.489396411093%	3	613	116	T2D_GENES_TANYA_BIOMARKER	LIM_MAMMARY_LUMINAL_MATURE_UP
0.489396411093%	3	613	116	T2D_GENES_TANYA_BIOMARKER	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
0.489396411093%	3	613	115	T2D_GENES_TANYA_BIOMARKER	MARZEC_IL2_SIGNALING_UP
0.489396411093%	3	613	115	T2D_GENES_TANYA_BIOMARKER	MARKEY_RB1_CHRONIC_LOF_UP
0.489396411093%	3	613	115	T2D_GENES_TANYA_BIOMARKER	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
0.489396411093%	3	613	114	T2D_GENES_TANYA_BIOMARKER	MATZUK_SPERMATOZOA
0.489396411093%	3	613	112	T2D_GENES_TANYA_BIOMARKER	REACTOME_G1_S_TRANSITION
0.489396411093%	3	613	111	T2D_GENES_TANYA_BIOMARKER	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
0.489396411093%	3	613	110	T2D_GENES_TANYA_BIOMARKER	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
0.489396411093%	3	613	108	T2D_GENES_TANYA_BIOMARKER	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
0.489396411093%	3	613	108	T2D_GENES_TANYA_BIOMARKER	LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT
0.489396411093%	3	613	107	T2D_GENES_TANYA_BIOMARKER	ROESSLER_LIVER_CANCER_METASTASIS_UP
0.489396411093%	3	613	107	T2D_GENES_TANYA_BIOMARKER	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.489396411093%	3	613	105	T2D_GENES_TANYA_BIOMARKER	PID_ERBB1_DOWNSTREAM_PATHWAY
0.489396411093%	3	613	105	T2D_GENES_TANYA_BIOMARKER	HELLER_SILENCED_BY_METHYLATION_DN
0.489396411093%	3	613	104	T2D_GENES_TANYA_BIOMARKER	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
0.489396411093%	3	613	104	T2D_GENES_TANYA_BIOMARKER	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.489396411093%	3	613	104	T2D_GENES_TANYA_BIOMARKER	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
0.489396411093%	3	613	103	T2D_GENES_TANYA_BIOMARKER	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN
0.489396411093%	3	613	103	T2D_GENES_TANYA_BIOMARKER	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
0.489396411093%	3	613	103	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_NOTCH
0.489396411093%	3	613	103	T2D_GENES_TANYA_BIOMARKER	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
0.489396411093%	3	613	103	T2D_GENES_TANYA_BIOMARKER	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.489396411093%	3	613	101	T2D_GENES_TANYA_BIOMARKER	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
0.489396411093%	3	613	101	T2D_GENES_TANYA_BIOMARKER	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
0.489396411093%	3	613	101	T2D_GENES_TANYA_BIOMARKER	KEGG_GNRH_SIGNALING_PATHWAY
0.489396411093%	3	613	101	T2D_GENES_TANYA_BIOMARKER	BASSO_CD40_SIGNALING_UP
0.489396411093%	3	613	100	T2D_GENES_TANYA_BIOMARKER	MCCLUNG_CREB1_TARGETS_UP
0.489396411093%	3	613	100	T2D_GENES_TANYA_BIOMARKER	BENPORATH_ES_CORE_NINE_CORRELATED
0.489396411093%	3	613	10	T2D_GENES_TANYA_BIOMARKER	REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM
0.482954545455%	17	3520	93	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CADWELL_ATG16L1_TARGETS_UP
0.482954545455%	17	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_VEGFR1_2_PATHWAY
0.482954545455%	17	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BEIER_GLIOMA_STEM_CELL_DN
0.482954545455%	17	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_STEROID_HORMONE_BIOSYNTHESIS
0.482954545455%	17	3520	294	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
0.482954545455%	17	3520	289	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GABRIELY_MIR21_TARGETS
0.482954545455%	17	3520	260	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SENESE_HDAC1_TARGETS_DN
0.482954545455%	17	3520	256	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ONDER_CDH1_TARGETS_2_UP
0.482954545455%	17	3520	217	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WIERENGA_STAT5A_TARGETS_UP
0.482954545455%	17	3520	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.482954545455%	17	3520	206	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAMALHO_STEMNESS_UP
0.482954545455%	17	3520	205	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK
0.482954545455%	17	3520	202	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FUJII_YBX1_TARGETS_DN
0.482954545455%	17	3520	201	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOLLMANN_APOPTOSIS_VIA_CD40_UP
0.482954545455%	17	3520	196	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
0.482954545455%	17	3520	196	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
0.482954545455%	17	3520	195	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
0.482954545455%	17	3520	181	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
0.482954545455%	17	3520	177	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.482954545455%	17	3520	169	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	UEDA_PERIFERAL_CLOCK
0.482954545455%	17	3520	169	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
0.482954545455%	17	3520	162	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
0.482954545455%	17	3520	157	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
0.482954545455%	17	3520	157	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
0.482954545455%	17	3520	153	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RUIZ_TNC_TARGETS_UP
0.482954545455%	17	3520	151	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
0.482954545455%	17	3520	146	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
0.482954545455%	17	3520	138	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JIANG_VHL_TARGETS
0.482954545455%	17	3520	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
0.482954545455%	17	3520	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
0.482954545455%	17	3520	134	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHUNG_BLISTER_CYTOTOXICITY_UP
0.482954545455%	17	3520	132	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS
0.482954545455%	17	3520	129	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_PDGFRBPATHWAY
0.482954545455%	17	3520	127	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.482954545455%	17	3520	127	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
0.482954545455%	17	3520	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.482954545455%	17	3520	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN
0.482954545455%	17	3520	107	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C0
0.482954545455%	17	3520	104	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
0.482954545455%	17	3520	104	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.481026189204%	9	1871	99	T2D_GENES_TANYA_HEIGHT	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.481026189204%	9	1871	98	T2D_GENES_TANYA_HEIGHT	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
0.481026189204%	9	1871	98	T2D_GENES_TANYA_HEIGHT	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
0.481026189204%	9	1871	98	T2D_GENES_TANYA_HEIGHT	KEGG_PYRIMIDINE_METABOLISM
0.481026189204%	9	1871	97	T2D_GENES_TANYA_HEIGHT	LABBE_WNT3A_TARGETS_DN
0.481026189204%	9	1871	95	T2D_GENES_TANYA_HEIGHT	HOEBEKE_LYMPHOID_STEM_CELL_UP
0.481026189204%	9	1871	94	T2D_GENES_TANYA_HEIGHT	LU_IL4_SIGNALING
0.481026189204%	9	1871	94	T2D_GENES_TANYA_HEIGHT	HOOI_ST7_TARGETS_UP
0.481026189204%	9	1871	93	T2D_GENES_TANYA_HEIGHT	ZHU_CMV_24_HR_UP
0.481026189204%	9	1871	93	T2D_GENES_TANYA_HEIGHT	CADWELL_ATG16L1_TARGETS_UP
0.481026189204%	9	1871	92	T2D_GENES_TANYA_HEIGHT	KIM_MYCN_AMPLIFICATION_TARGETS_UP
0.481026189204%	9	1871	92	T2D_GENES_TANYA_HEIGHT	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
0.481026189204%	9	1871	91	T2D_GENES_TANYA_HEIGHT	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
0.481026189204%	9	1871	91	T2D_GENES_TANYA_HEIGHT	ELVIDGE_HIF1A_TARGETS_DN
0.481026189204%	9	1871	91	T2D_GENES_TANYA_HEIGHT	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
0.481026189204%	9	1871	90	T2D_GENES_TANYA_HEIGHT	HILLION_HMGA1_TARGETS
0.481026189204%	9	1871	90	T2D_GENES_TANYA_HEIGHT	BILANGES_SERUM_SENSITIVE_GENES
0.481026189204%	9	1871	89	T2D_GENES_TANYA_HEIGHT	WNT_SIGNALING
0.481026189204%	9	1871	89	T2D_GENES_TANYA_HEIGHT	VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP
0.481026189204%	9	1871	89	T2D_GENES_TANYA_HEIGHT	KEGG_PROSTATE_CANCER
0.481026189204%	9	1871	89	T2D_GENES_TANYA_HEIGHT	KANG_IMMORTALIZED_BY_TERT_UP
0.481026189204%	9	1871	89	T2D_GENES_TANYA_HEIGHT	BOYLAN_MULTIPLE_MYELOMA_D_UP
0.481026189204%	9	1871	87	T2D_GENES_TANYA_HEIGHT	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.481026189204%	9	1871	87	T2D_GENES_TANYA_HEIGHT	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.481026189204%	9	1871	87	T2D_GENES_TANYA_HEIGHT	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.481026189204%	9	1871	86	T2D_GENES_TANYA_HEIGHT	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
0.481026189204%	9	1871	86	T2D_GENES_TANYA_HEIGHT	LAIHO_COLORECTAL_CANCER_SERRATED_DN
0.481026189204%	9	1871	85	T2D_GENES_TANYA_HEIGHT	LEIN_CEREBELLUM_MARKERS
0.481026189204%	9	1871	83	T2D_GENES_TANYA_HEIGHT	WARTERS_RESPONSE_TO_IR_SKIN
0.481026189204%	9	1871	83	T2D_GENES_TANYA_HEIGHT	SANA_TNF_SIGNALING_UP
0.481026189204%	9	1871	82	T2D_GENES_TANYA_HEIGHT	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
0.481026189204%	9	1871	82	T2D_GENES_TANYA_HEIGHT	ODONNELL_METASTASIS_UP
0.481026189204%	9	1871	81	T2D_GENES_TANYA_HEIGHT	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
0.481026189204%	9	1871	81	T2D_GENES_TANYA_HEIGHT	LEIN_MEDULLA_MARKERS
0.481026189204%	9	1871	81	T2D_GENES_TANYA_HEIGHT	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
0.481026189204%	9	1871	80	T2D_GENES_TANYA_HEIGHT	SCHUHMACHER_MYC_TARGETS_UP
0.481026189204%	9	1871	80	T2D_GENES_TANYA_HEIGHT	FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.481026189204%	9	1871	79	T2D_GENES_TANYA_HEIGHT	PID_MYC_ACTIVPATHWAY
0.481026189204%	9	1871	79	T2D_GENES_TANYA_HEIGHT	GAVIN_FOXP3_TARGETS_CLUSTER_P2
0.481026189204%	9	1871	77	T2D_GENES_TANYA_HEIGHT	ROSS_AML_WITH_PML_RARA_FUSION
0.481026189204%	9	1871	77	T2D_GENES_TANYA_HEIGHT	MORI_PRE_BI_LYMPHOCYTE_DN
0.481026189204%	9	1871	77	T2D_GENES_TANYA_HEIGHT	LIN_APC_TARGETS
0.481026189204%	9	1871	76	T2D_GENES_TANYA_HEIGHT	SU_TESTIS
0.481026189204%	9	1871	75	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
0.481026189204%	9	1871	75	T2D_GENES_TANYA_HEIGHT	MORI_MATURE_B_LYMPHOCYTE_DN
0.481026189204%	9	1871	75	T2D_GENES_TANYA_HEIGHT	BAE_BRCA1_TARGETS_UP
0.481026189204%	9	1871	74	T2D_GENES_TANYA_HEIGHT	WESTON_VEGFA_TARGETS_3HR
0.481026189204%	9	1871	74	T2D_GENES_TANYA_HEIGHT	SHEPARD_BMYB_TARGETS
0.481026189204%	9	1871	74	T2D_GENES_TANYA_HEIGHT	POTTI_ADRIAMYCIN_SENSITIVITY
0.481026189204%	9	1871	74	T2D_GENES_TANYA_HEIGHT	DARWICHE_PAPILLOMA_PROGRESSION_RISK
0.481026189204%	9	1871	73	T2D_GENES_TANYA_HEIGHT	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
0.481026189204%	9	1871	72	T2D_GENES_TANYA_HEIGHT	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1
0.481026189204%	9	1871	72	T2D_GENES_TANYA_HEIGHT	MATZUK_SPERMATOCYTE
0.481026189204%	9	1871	70	T2D_GENES_TANYA_HEIGHT	KEGG_PANCREATIC_CANCER
0.481026189204%	9	1871	69	T2D_GENES_TANYA_HEIGHT	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.481026189204%	9	1871	67	T2D_GENES_TANYA_HEIGHT	VANHARANTA_UTERINE_FIBROID_DN
0.481026189204%	9	1871	67	T2D_GENES_TANYA_HEIGHT	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP
0.481026189204%	9	1871	66	T2D_GENES_TANYA_HEIGHT	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES
0.481026189204%	9	1871	65	T2D_GENES_TANYA_HEIGHT	GOLDRATH_IMMUNE_MEMORY
0.481026189204%	9	1871	65	T2D_GENES_TANYA_HEIGHT	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS
0.481026189204%	9	1871	65	T2D_GENES_TANYA_HEIGHT	AMIT_SERUM_RESPONSE_120_MCF10A
0.481026189204%	9	1871	64	T2D_GENES_TANYA_HEIGHT	REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C
0.481026189204%	9	1871	64	T2D_GENES_TANYA_HEIGHT	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
0.481026189204%	9	1871	58	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_APOPTOSIS
0.481026189204%	9	1871	58	T2D_GENES_TANYA_HEIGHT	NAGASHIMA_NRG1_SIGNALING_DN
0.481026189204%	9	1871	58	T2D_GENES_TANYA_HEIGHT	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
0.481026189204%	9	1871	57	T2D_GENES_TANYA_HEIGHT	TONG_INTERACT_WITH_PTTG1
0.481026189204%	9	1871	57	T2D_GENES_TANYA_HEIGHT	REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE
0.481026189204%	9	1871	57	T2D_GENES_TANYA_HEIGHT	PEART_HDAC_PROLIFERATION_CLUSTER_UP
0.481026189204%	9	1871	56	T2D_GENES_TANYA_HEIGHT	REACTOME_PI_3K_CASCADE
0.481026189204%	9	1871	56	T2D_GENES_TANYA_HEIGHT	KEGG_VIBRIO_CHOLERAE_INFECTION
0.481026189204%	9	1871	56	T2D_GENES_TANYA_HEIGHT	HOQUE_METHYLATED_IN_CANCER
0.481026189204%	9	1871	56	T2D_GENES_TANYA_HEIGHT	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.481026189204%	9	1871	54	T2D_GENES_TANYA_HEIGHT	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE
0.481026189204%	9	1871	53	T2D_GENES_TANYA_HEIGHT	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0
0.481026189204%	9	1871	53	T2D_GENES_TANYA_HEIGHT	MORI_IMMATURE_B_LYMPHOCYTE_UP
0.481026189204%	9	1871	53	T2D_GENES_TANYA_HEIGHT	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
0.481026189204%	9	1871	51	T2D_GENES_TANYA_HEIGHT	REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.481026189204%	9	1871	51	T2D_GENES_TANYA_HEIGHT	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE
0.481026189204%	9	1871	50	T2D_GENES_TANYA_HEIGHT	PARK_HSC_AND_MULTIPOTENT_PROGENITORS
0.481026189204%	9	1871	50	T2D_GENES_TANYA_HEIGHT	FIGUEROA_AML_METHYLATION_CLUSTER_5_DN
0.481026189204%	9	1871	49	T2D_GENES_TANYA_HEIGHT	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.481026189204%	9	1871	47	T2D_GENES_TANYA_HEIGHT	PID_NFAT_TFPATHWAY
0.481026189204%	9	1871	46	T2D_GENES_TANYA_HEIGHT	BIOCARTA_KERATINOCYTE_PATHWAY
0.481026189204%	9	1871	44	T2D_GENES_TANYA_HEIGHT	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS
0.481026189204%	9	1871	43	T2D_GENES_TANYA_HEIGHT	PID_THROMBIN_PAR1_PATHWAY
0.481026189204%	9	1871	42	T2D_GENES_TANYA_HEIGHT	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
0.481026189204%	9	1871	41	T2D_GENES_TANYA_HEIGHT	KAMMINGA_SENESCENCE
0.481026189204%	9	1871	40	T2D_GENES_TANYA_HEIGHT	BENPORATH_ES_2
0.481026189204%	9	1871	35	T2D_GENES_TANYA_HEIGHT	RODRIGUES_NTN1_AND_DCC_TARGETS
0.481026189204%	9	1871	34	T2D_GENES_TANYA_HEIGHT	PLASARI_TGFB1_TARGETS_1HR_UP
0.481026189204%	9	1871	33	T2D_GENES_TANYA_HEIGHT	BIOCARTA_IL1R_PATHWAY
0.481026189204%	9	1871	32	T2D_GENES_TANYA_HEIGHT	REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS
0.481026189204%	9	1871	31	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNAL_AMPLIFICATION
0.481026189204%	9	1871	29	T2D_GENES_TANYA_HEIGHT	GENTLES_LEUKEMIC_STEM_CELL_UP
0.481026189204%	9	1871	201	T2D_GENES_TANYA_HEIGHT	KIM_MYC_AMPLIFICATION_TARGETS_UP
0.481026189204%	9	1871	201	T2D_GENES_TANYA_HEIGHT	KEGG_FOCAL_ADHESION
0.481026189204%	9	1871	185	T2D_GENES_TANYA_HEIGHT	KEGG_HUNTINGTONS_DISEASE
0.481026189204%	9	1871	179	T2D_GENES_TANYA_HEIGHT	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
0.481026189204%	9	1871	170	T2D_GENES_TANYA_HEIGHT	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
0.481026189204%	9	1871	159	T2D_GENES_TANYA_HEIGHT	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
0.481026189204%	9	1871	153	T2D_GENES_TANYA_HEIGHT	DURAND_STROMA_MAX_DN
0.481026189204%	9	1871	147	T2D_GENES_TANYA_HEIGHT	KAUFFMANN_DNA_REPLICATION_GENES
0.481026189204%	9	1871	143	T2D_GENES_TANYA_HEIGHT	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.481026189204%	9	1871	141	T2D_GENES_TANYA_HEIGHT	SABATES_COLORECTAL_ADENOMA_UP
0.481026189204%	9	1871	141	T2D_GENES_TANYA_HEIGHT	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
0.481026189204%	9	1871	134	T2D_GENES_TANYA_HEIGHT	KEGG_TIGHT_JUNCTION
0.481026189204%	9	1871	129	T2D_GENES_TANYA_HEIGHT	PID_PDGFRBPATHWAY
0.481026189204%	9	1871	129	T2D_GENES_TANYA_HEIGHT	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP
0.481026189204%	9	1871	128	T2D_GENES_TANYA_HEIGHT	ZHU_CMV_ALL_DN
0.481026189204%	9	1871	120	T2D_GENES_TANYA_HEIGHT	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.481026189204%	9	1871	117	T2D_GENES_TANYA_HEIGHT	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.481026189204%	9	1871	114	T2D_GENES_TANYA_HEIGHT	LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.481026189204%	9	1871	112	T2D_GENES_TANYA_HEIGHT	PASINI_SUZ12_TARGETS_UP
0.481026189204%	9	1871	111	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_12HR_UP
0.481026189204%	9	1871	110	T2D_GENES_TANYA_HEIGHT	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
0.481026189204%	9	1871	109	T2D_GENES_TANYA_HEIGHT	SERVITJA_ISLET_HNF1A_TARGETS_DN
0.481026189204%	9	1871	109	T2D_GENES_TANYA_HEIGHT	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
0.481026189204%	9	1871	106	T2D_GENES_TANYA_HEIGHT	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
0.481026189204%	9	1871	105	T2D_GENES_TANYA_HEIGHT	HELLER_SILENCED_BY_METHYLATION_DN
0.481026189204%	9	1871	105	T2D_GENES_TANYA_HEIGHT	AMUNDSON_GENOTOXIC_SIGNATURE
0.481026189204%	9	1871	104	T2D_GENES_TANYA_HEIGHT	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.481026189204%	9	1871	103	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
0.481026189204%	9	1871	103	T2D_GENES_TANYA_HEIGHT	LEIN_CHOROID_PLEXUS_MARKERS
0.481026189204%	9	1871	100	T2D_GENES_TANYA_HEIGHT	GAVIN_FOXP3_TARGETS_CLUSTER_P4
0.472813238771%	6	1269	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
0.472813238771%	6	1269	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_T7
0.472813238771%	6	1269	95	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOEBEKE_LYMPHOID_STEM_CELL_UP
0.472813238771%	6	1269	93	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_REGULATION_OF_INSULIN_SECRETION
0.472813238771%	6	1269	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_DNA
0.472813238771%	6	1269	91	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHU_CMV_24_HR_DN
0.472813238771%	6	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
0.472813238771%	6	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.472813238771%	6	1269	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SANA_RESPONSE_TO_IFNG_DN
0.472813238771%	6	1269	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
0.472813238771%	6	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEIN_MEDULLA_MARKERS
0.472813238771%	6	1269	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_MET_PATHWAY
0.472813238771%	6	1269	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
0.472813238771%	6	1269	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MEISSNER_NPC_HCP_WITH_H3K27ME3
0.472813238771%	6	1269	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
0.472813238771%	6	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_E2F_PATHWAY
0.472813238771%	6	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
0.472813238771%	6	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_VEGFR1_2_PATHWAY
0.472813238771%	6	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RIGGINS_TAMOXIFEN_RESISTANCE_UP
0.472813238771%	6	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BRUNO_HEMATOPOIESIS
0.472813238771%	6	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_RB_1PATHWAY
0.472813238771%	6	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_GLIOMA
0.472813238771%	6	1269	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ACUTE_MYELOID_LEUKEMIA
0.472813238771%	6	1269	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_240_HELA
0.472813238771%	6	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHENG_GLIOBLASTOMA_PLASTICITY_DN
0.472813238771%	6	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON
0.472813238771%	6	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP
0.472813238771%	6	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_APOPTOTIC_EXECUTION_PHASE
0.472813238771%	6	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_BIOPEPTIDES_PATHWAY
0.472813238771%	6	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MATZUK_SPERMATID_DIFFERENTIATION
0.472813238771%	6	1269	353	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN
0.472813238771%	6	1269	352	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY
0.472813238771%	6	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_NCADHERINPATHWAY
0.472813238771%	6	1269	315	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.472813238771%	6	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
0.472813238771%	6	1269	290	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BASAKI_YBX1_TARGETS_UP
0.472813238771%	6	1269	281	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
0.472813238771%	6	1269	267	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_MAPK_SIGNALING_PATHWAY
0.472813238771%	6	1269	259	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
0.472813238771%	6	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG
0.472813238771%	6	1269	237	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.472813238771%	6	1269	235	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_HGF_DN
0.472813238771%	6	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FERRANDO_HOX11_NEIGHBORS
0.472813238771%	6	1269	229	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
0.472813238771%	6	1269	222	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CAIRO_LIVER_DEVELOPMENT_DN
0.472813238771%	6	1269	217	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALLING_BY_NGF
0.472813238771%	6	1269	215	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAMAZAKI_TCEB3_TARGETS_DN
0.472813238771%	6	1269	214	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZWANG_EGF_INTERVAL_DN
0.472813238771%	6	1269	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.472813238771%	6	1269	209	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHANG_CORE_SERUM_RESPONSE_DN
0.472813238771%	6	1269	207	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MANALO_HYPOXIA_UP
0.472813238771%	6	1269	206	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.472813238771%	6	1269	204	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
0.472813238771%	6	1269	203	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PAL_PRMT5_TARGETS_UP
0.472813238771%	6	1269	199	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
0.472813238771%	6	1269	199	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PLASARI_TGFB1_TARGETS_10HR_UP
0.472813238771%	6	1269	198	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PHOSPHOLIPID_METABOLISM
0.472813238771%	6	1269	198	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ALONSO_METASTASIS_UP
0.472813238771%	6	1269	197	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
0.472813238771%	6	1269	195	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
0.472813238771%	6	1269	193	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOHANKUMAR_TLX1_TARGETS_DN
0.472813238771%	6	1269	188	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
0.472813238771%	6	1269	185	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.472813238771%	6	1269	183	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.472813238771%	6	1269	181	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
0.472813238771%	6	1269	181	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
0.472813238771%	6	1269	181	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
0.472813238771%	6	1269	181	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
0.472813238771%	6	1269	180	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
0.472813238771%	6	1269	178	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LI_AMPLIFIED_IN_LUNG_CANCER
0.472813238771%	6	1269	176	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP
0.472813238771%	6	1269	175	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAMAZAKI_TCEB3_TARGETS_UP
0.472813238771%	6	1269	171	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
0.472813238771%	6	1269	170	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
0.472813238771%	6	1269	169	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ONDER_CDH1_TARGETS_1_DN
0.472813238771%	6	1269	169	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
0.472813238771%	6	1269	168	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM
0.472813238771%	6	1269	162	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WINNEPENNINCKX_MELANOMA_METASTASIS_UP
0.472813238771%	6	1269	162	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
0.472813238771%	6	1269	159	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
0.472813238771%	6	1269	158	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.472813238771%	6	1269	157	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SERVITJA_LIVER_HNF1A_TARGETS_DN
0.472813238771%	6	1269	157	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
0.472813238771%	6	1269	156	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_DN
0.472813238771%	6	1269	151	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
0.472813238771%	6	1269	151	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_WNT_SIGNALING_PATHWAY
0.472813238771%	6	1269	151	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
0.472813238771%	6	1269	149	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GOZGIT_ESR1_TARGETS_UP
0.472813238771%	6	1269	148	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_M_G1
0.472813238771%	6	1269	148	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KATSANOU_ELAVL1_TARGETS_DN
0.472813238771%	6	1269	148	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_24HR_UP
0.472813238771%	6	1269	143	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BASSO_B_LYMPHOCYTE_NETWORK
0.472813238771%	6	1269	142	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
0.472813238771%	6	1269	141	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WELCSH_BRCA1_TARGETS_DN
0.472813238771%	6	1269	141	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.472813238771%	6	1269	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.472813238771%	6	1269	133	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAL_LEUKEMIC_STEM_CELL_UP
0.472813238771%	6	1269	131	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
0.472813238771%	6	1269	129	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP
0.472813238771%	6	1269	129	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_AXON_GUIDANCE
0.472813238771%	6	1269	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
0.472813238771%	6	1269	123	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOOI_ST7_TARGETS_DN
0.472813238771%	6	1269	120	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
0.472813238771%	6	1269	120	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHEBOTAEV_GR_TARGETS_DN
0.472813238771%	6	1269	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
0.472813238771%	6	1269	114	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.472813238771%	6	1269	114	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CERVERA_SDHB_TARGETS_2
0.472813238771%	6	1269	112	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_DNA_REPAIR
0.472813238771%	6	1269	111	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOUDOUKHA_BOUND_BY_IGF2BP2
0.472813238771%	6	1269	109	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SERVITJA_ISLET_HNF1A_TARGETS_DN
0.472813238771%	6	1269	109	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_S_PHASE
0.472813238771%	6	1269	103	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
0.472813238771%	6	1269	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_3
0.460475825019%	6	1303	98	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PYEON_HPV_POSITIVE_TUMORS_UP
0.460475825019%	6	1303	98	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GUO_TARGETS_OF_IRS1_AND_IRS2
0.460475825019%	6	1303	97	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_MYC_AMPLIFICATION_TARGETS_DN
0.460475825019%	6	1303	95	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOEBEKE_LYMPHOID_STEM_CELL_UP
0.460475825019%	6	1303	91	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHU_CMV_24_HR_DN
0.460475825019%	6	1303	91	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
0.460475825019%	6	1303	90	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BILANGES_SERUM_SENSITIVE_GENES
0.460475825019%	6	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_PROSTATE_CANCER
0.460475825019%	6	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
0.460475825019%	6	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
0.460475825019%	6	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.460475825019%	6	1303	86	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
0.460475825019%	6	1303	84	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
0.460475825019%	6	1303	84	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_CMYB_PATHWAY
0.460475825019%	6	1303	84	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_AGING_CEREBELLUM_UP
0.460475825019%	6	1303	83	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WARTERS_RESPONSE_TO_IR_SKIN
0.460475825019%	6	1303	83	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
0.460475825019%	6	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DUAN_PRDM5_TARGETS
0.460475825019%	6	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
0.460475825019%	6	1303	76	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
0.460475825019%	6	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DER_IFN_ALPHA_RESPONSE_UP
0.460475825019%	6	1303	73	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIN_MELANOMA_COPY_NUMBER_UP
0.460475825019%	6	1303	73	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_SURVIVAL_UP
0.460475825019%	6	1303	73	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
0.460475825019%	6	1303	70	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
0.460475825019%	6	1303	67	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.460475825019%	6	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_RB_1PATHWAY
0.460475825019%	6	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
0.460475825019%	6	1303	60	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OUILLETTE_CLL_13Q14_DELETION_DN
0.460475825019%	6	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
0.460475825019%	6	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTINEZ_RESPONSE_TO_TRABECTEDIN
0.460475825019%	6	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
0.460475825019%	6	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WOOD_EBV_EBNA1_TARGETS_DN
0.460475825019%	6	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_TYPE_II_DIABETES_MELLITUS
0.460475825019%	6	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NUTT_GBM_VS_AO_GLIOMA_DN
0.460475825019%	6	1303	431	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.460475825019%	6	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
0.460475825019%	6	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHANGOLKAR_H2AFY_TARGETS_DN
0.460475825019%	6	1303	367	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VECCHI_GASTRIC_CANCER_EARLY_DN
0.460475825019%	6	1303	344	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RICKMAN_METASTASIS_UP
0.460475825019%	6	1303	338	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
0.460475825019%	6	1303	311	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JIANG_HYPOXIA_NORMAL
0.460475825019%	6	1303	269	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_CLIM2_TARGETS_UP
0.460475825019%	6	1303	261	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RICKMAN_METASTASIS_DN
0.460475825019%	6	1303	260	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SENESE_HDAC1_TARGETS_DN
0.460475825019%	6	1303	258	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JAEGER_METASTASIS_DN
0.460475825019%	6	1303	254	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_4HR_DN
0.460475825019%	6	1303	253	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCLACHLAN_DENTAL_CARIES_UP
0.460475825019%	6	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG
0.460475825019%	6	1303	245	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCLACHLAN_DENTAL_CARIES_DN
0.460475825019%	6	1303	229	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
0.460475825019%	6	1303	229	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
0.460475825019%	6	1303	228	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_CISPLATIN_RESPONSE_AND_XPC_DN
0.460475825019%	6	1303	227	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
0.460475825019%	6	1303	223	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.460475825019%	6	1303	214	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
0.460475825019%	6	1303	212	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION
0.460475825019%	6	1303	210	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VERHAAK_GLIOBLASTOMA_PRONEURAL
0.460475825019%	6	1303	210	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRANSCRIPTION
0.460475825019%	6	1303	205	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
0.460475825019%	6	1303	205	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHEPARD_BMYB_MORPHOLINO_UP
0.460475825019%	6	1303	205	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PEREZ_TP53_AND_TP63_TARGETS
0.460475825019%	6	1303	200	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
0.460475825019%	6	1303	198	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ALONSO_METASTASIS_UP
0.460475825019%	6	1303	196	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
0.460475825019%	6	1303	195	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.460475825019%	6	1303	193	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP
0.460475825019%	6	1303	188	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP
0.460475825019%	6	1303	187	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BAKKER_FOXO3_TARGETS_DN
0.460475825019%	6	1303	185	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
0.460475825019%	6	1303	181	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
0.460475825019%	6	1303	179	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
0.460475825019%	6	1303	178	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_CALCIUM_SIGNALING_PATHWAY
0.460475825019%	6	1303	176	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
0.460475825019%	6	1303	176	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAGASHIMA_NRG1_SIGNALING_UP
0.460475825019%	6	1303	176	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
0.460475825019%	6	1303	176	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
0.460475825019%	6	1303	175	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_LIVER_CANCER_SURVIVAL_DN
0.460475825019%	6	1303	173	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SENGUPTA_EBNA1_ANTICORRELATED
0.460475825019%	6	1303	172	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
0.460475825019%	6	1303	172	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMID_BREAST_CANCER_LUMINAL_B_UP
0.460475825019%	6	1303	172	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MITOTIC_M_M_G1_PHASES
0.460475825019%	6	1303	170	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
0.460475825019%	6	1303	169	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
0.460475825019%	6	1303	169	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KATSANOU_ELAVL1_TARGETS_UP
0.460475825019%	6	1303	167	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_ESR1_UP
0.460475825019%	6	1303	165	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIU_CMYB_TARGETS_UP
0.460475825019%	6	1303	164	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_480_HELA
0.460475825019%	6	1303	163	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIN_NPAS4_TARGETS_UP
0.460475825019%	6	1303	162	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WINNEPENNINCKX_MELANOMA_METASTASIS_UP
0.460475825019%	6	1303	162	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_WT1_TARGETS_12HR_UP
0.460475825019%	6	1303	162	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DARWICHE_PAPILLOMA_RISK_LOW_UP
0.460475825019%	6	1303	160	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_P3
0.460475825019%	6	1303	158	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RODRIGUES_NTN1_TARGETS_DN
0.460475825019%	6	1303	157	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
0.460475825019%	6	1303	152	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
0.460475825019%	6	1303	150	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
0.460475825019%	6	1303	149	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GOZGIT_ESR1_TARGETS_UP
0.460475825019%	6	1303	148	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_APOPTOSIS
0.460475825019%	6	1303	148	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_24HR_UP
0.460475825019%	6	1303	147	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
0.460475825019%	6	1303	147	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BENPORATH_PROLIFERATION
0.460475825019%	6	1303	146	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_NEURAL_CREST_STEM_CELL_UP
0.460475825019%	6	1303	144	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.460475825019%	6	1303	143	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BASSO_B_LYMPHOCYTE_NETWORK
0.460475825019%	6	1303	142	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PENG_LEUCINE_DEPRIVATION_UP
0.460475825019%	6	1303	142	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_ES_LCP_WITH_H3K4ME3
0.460475825019%	6	1303	141	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SABATES_COLORECTAL_ADENOMA_UP
0.460475825019%	6	1303	138	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
0.460475825019%	6	1303	138	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
0.460475825019%	6	1303	133	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON
0.460475825019%	6	1303	129	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_AXON_GUIDANCE
0.460475825019%	6	1303	129	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWN_MYELOID_CELL_DEVELOPMENT_DN
0.460475825019%	6	1303	128	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.460475825019%	6	1303	127	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KARLSSON_TGFB1_TARGETS_UP
0.460475825019%	6	1303	127	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
0.460475825019%	6	1303	126	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.460475825019%	6	1303	124	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CELL_CYCLE_CHECKPOINTS
0.460475825019%	6	1303	123	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KAYO_AGING_MUSCLE_DN
0.460475825019%	6	1303	123	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOOI_ST7_TARGETS_DN
0.460475825019%	6	1303	122	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
0.460475825019%	6	1303	117	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.460475825019%	6	1303	116	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.460475825019%	6	1303	115	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARZEC_IL2_SIGNALING_UP
0.460475825019%	6	1303	115	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
0.460475825019%	6	1303	115	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOELZEL_NF1_TARGETS_DN
0.460475825019%	6	1303	112	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
0.460475825019%	6	1303	109	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_S_PHASE
0.460475825019%	6	1303	108	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LE_EGR2_TARGETS_UP
0.460475825019%	6	1303	107	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROESSLER_LIVER_CANCER_METASTASIS_UP
0.460475825019%	6	1303	103	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY
0.460475825019%	6	1303	103	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
0.460475825019%	6	1303	102	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LABBE_TGFB1_TARGETS_UP
0.460475825019%	6	1303	102	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.460475825019%	6	1303	100	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RICKMAN_HEAD_AND_NECK_CANCER_A
0.460475825019%	6	1303	100	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_P4
0.459981600736%	10	2174	99	T2D_GENES_TANYA_LIPIDS	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.459981600736%	10	2174	98	T2D_GENES_TANYA_LIPIDS	BRUINS_UVC_RESPONSE_MIDDLE
0.459981600736%	10	2174	96	T2D_GENES_TANYA_LIPIDS	LIU_PROSTATE_CANCER_UP
0.459981600736%	10	2174	95	T2D_GENES_TANYA_LIPIDS	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.459981600736%	10	2174	92	T2D_GENES_TANYA_LIPIDS	HILLION_HMGA1B_TARGETS
0.459981600736%	10	2174	91	T2D_GENES_TANYA_LIPIDS	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.459981600736%	10	2174	91	T2D_GENES_TANYA_LIPIDS	GAVIN_FOXP3_TARGETS_CLUSTER_P6
0.459981600736%	10	2174	90	T2D_GENES_TANYA_LIPIDS	SANA_TNF_SIGNALING_DN
0.459981600736%	10	2174	90	T2D_GENES_TANYA_LIPIDS	MORI_IMMATURE_B_LYMPHOCYTE_DN
0.459981600736%	10	2174	89	T2D_GENES_TANYA_LIPIDS	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
0.459981600736%	10	2174	88	T2D_GENES_TANYA_LIPIDS	WALLACE_PROSTATE_CANCER_RACE_DN
0.459981600736%	10	2174	88	T2D_GENES_TANYA_LIPIDS	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
0.459981600736%	10	2174	88	T2D_GENES_TANYA_LIPIDS	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
0.459981600736%	10	2174	87	T2D_GENES_TANYA_LIPIDS	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.459981600736%	10	2174	86	T2D_GENES_TANYA_LIPIDS	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
0.459981600736%	10	2174	86	T2D_GENES_TANYA_LIPIDS	HOEBEKE_LYMPHOID_STEM_CELL_DN
0.459981600736%	10	2174	85	T2D_GENES_TANYA_LIPIDS	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
0.459981600736%	10	2174	84	T2D_GENES_TANYA_LIPIDS	LEE_AGING_CEREBELLUM_UP
0.459981600736%	10	2174	83	T2D_GENES_TANYA_LIPIDS	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
0.459981600736%	10	2174	81	T2D_GENES_TANYA_LIPIDS	SCIBETTA_KDM5B_TARGETS_DN
0.459981600736%	10	2174	81	T2D_GENES_TANYA_LIPIDS	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
0.459981600736%	10	2174	81	T2D_GENES_TANYA_LIPIDS	GUO_HEX_TARGETS_UP
0.459981600736%	10	2174	81	T2D_GENES_TANYA_LIPIDS	CROMER_METASTASIS_DN
0.459981600736%	10	2174	80	T2D_GENES_TANYA_LIPIDS	SCHUHMACHER_MYC_TARGETS_UP
0.459981600736%	10	2174	78	T2D_GENES_TANYA_LIPIDS	ROSS_LEUKEMIA_WITH_MLL_FUSIONS
0.459981600736%	10	2174	78	T2D_GENES_TANYA_LIPIDS	REACTOME_OPIOID_SIGNALLING
0.459981600736%	10	2174	77	T2D_GENES_TANYA_LIPIDS	FRIDMAN_SENESCENCE_UP
0.459981600736%	10	2174	76	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.459981600736%	10	2174	76	T2D_GENES_TANYA_LIPIDS	MAHAJAN_RESPONSE_TO_IL1A_DN
0.459981600736%	10	2174	76	T2D_GENES_TANYA_LIPIDS	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
0.459981600736%	10	2174	75	T2D_GENES_TANYA_LIPIDS	MCCLUNG_COCAIN_REWARD_4WK
0.459981600736%	10	2174	75	T2D_GENES_TANYA_LIPIDS	BAE_BRCA1_TARGETS_UP
0.459981600736%	10	2174	74	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
0.459981600736%	10	2174	73	T2D_GENES_TANYA_LIPIDS	KEGG_CHRONIC_MYELOID_LEUKEMIA
0.459981600736%	10	2174	72	T2D_GENES_TANYA_LIPIDS	SESTO_RESPONSE_TO_UV_C1
0.459981600736%	10	2174	72	T2D_GENES_TANYA_LIPIDS	REACTOME_METABOLISM_OF_NUCLEOTIDES
0.459981600736%	10	2174	71	T2D_GENES_TANYA_LIPIDS	KUMAR_AUTOPHAGY_NETWORK
0.459981600736%	10	2174	70	T2D_GENES_TANYA_LIPIDS	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
0.459981600736%	10	2174	70	T2D_GENES_TANYA_LIPIDS	PID_CDC42_PATHWAY
0.459981600736%	10	2174	69	T2D_GENES_TANYA_LIPIDS	HUANG_DASATINIB_RESISTANCE_DN
0.459981600736%	10	2174	68	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.459981600736%	10	2174	68	T2D_GENES_TANYA_LIPIDS	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES
0.459981600736%	10	2174	67	T2D_GENES_TANYA_LIPIDS	DAZARD_UV_RESPONSE_CLUSTER_G1
0.459981600736%	10	2174	66	T2D_GENES_TANYA_LIPIDS	RIGGINS_TAMOXIFEN_RESISTANCE_UP
0.459981600736%	10	2174	66	T2D_GENES_TANYA_LIPIDS	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES
0.459981600736%	10	2174	66	T2D_GENES_TANYA_LIPIDS	PID_HIF1_TFPATHWAY
0.459981600736%	10	2174	66	T2D_GENES_TANYA_LIPIDS	PID_HDAC_CLASSI_PATHWAY
0.459981600736%	10	2174	66	T2D_GENES_TANYA_LIPIDS	BRUNO_HEMATOPOIESIS
0.459981600736%	10	2174	65	T2D_GENES_TANYA_LIPIDS	PID_CD8TCRDOWNSTREAMPATHWAY
0.459981600736%	10	2174	65	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER_ACOX1_DN
0.459981600736%	10	2174	64	T2D_GENES_TANYA_LIPIDS	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS
0.459981600736%	10	2174	64	T2D_GENES_TANYA_LIPIDS	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.459981600736%	10	2174	64	T2D_GENES_TANYA_LIPIDS	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
0.459981600736%	10	2174	63	T2D_GENES_TANYA_LIPIDS	REACTOME_INTERFERON_GAMMA_SIGNALING
0.459981600736%	10	2174	63	T2D_GENES_TANYA_LIPIDS	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
0.459981600736%	10	2174	63	T2D_GENES_TANYA_LIPIDS	PID_ENDOTHELINPATHWAY
0.459981600736%	10	2174	63	T2D_GENES_TANYA_LIPIDS	BILBAN_B_CLL_LPL_UP
0.459981600736%	10	2174	62	T2D_GENES_TANYA_LIPIDS	KEGG_COLORECTAL_CANCER
0.459981600736%	10	2174	61	T2D_GENES_TANYA_LIPIDS	GENTILE_RESPONSE_CLUSTER_D3
0.459981600736%	10	2174	60	T2D_GENES_TANYA_LIPIDS	CUI_GLUCOSE_DEPRIVATION
0.459981600736%	10	2174	58	T2D_GENES_TANYA_LIPIDS	NAGASHIMA_EGF_SIGNALING_UP
0.459981600736%	10	2174	58	T2D_GENES_TANYA_LIPIDS	KANNAN_TP53_TARGETS_UP
0.459981600736%	10	2174	57	T2D_GENES_TANYA_LIPIDS	REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE
0.459981600736%	10	2174	56	T2D_GENES_TANYA_LIPIDS	KEGG_VIBRIO_CHOLERAE_INFECTION
0.459981600736%	10	2174	55	T2D_GENES_TANYA_LIPIDS	YU_MYC_TARGETS_DN
0.459981600736%	10	2174	53	T2D_GENES_TANYA_LIPIDS	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0
0.459981600736%	10	2174	51	T2D_GENES_TANYA_LIPIDS	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
0.459981600736%	10	2174	51	T2D_GENES_TANYA_LIPIDS	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1
0.459981600736%	10	2174	51	T2D_GENES_TANYA_LIPIDS	LEE_CALORIE_RESTRICTION_MUSCLE_DN
0.459981600736%	10	2174	51	T2D_GENES_TANYA_LIPIDS	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
0.459981600736%	10	2174	49	T2D_GENES_TANYA_LIPIDS	PID_PI3KCIPATHWAY
0.459981600736%	10	2174	49	T2D_GENES_TANYA_LIPIDS	MARCHINI_TRABECTEDIN_RESISTANCE_DN
0.459981600736%	10	2174	49	T2D_GENES_TANYA_LIPIDS	DAUER_STAT3_TARGETS_UP
0.459981600736%	10	2174	48	T2D_GENES_TANYA_LIPIDS	REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY
0.459981600736%	10	2174	47	T2D_GENES_TANYA_LIPIDS	IRITANI_MAD1_TARGETS_DN
0.459981600736%	10	2174	46	T2D_GENES_TANYA_LIPIDS	SAGIV_CD24_TARGETS_DN
0.459981600736%	10	2174	43	T2D_GENES_TANYA_LIPIDS	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
0.459981600736%	10	2174	43	T2D_GENES_TANYA_LIPIDS	LEE_CALORIE_RESTRICTION_MUSCLE_UP
0.459981600736%	10	2174	42	T2D_GENES_TANYA_LIPIDS	MODY_HIPPOCAMPUS_PRENATAL
0.459981600736%	10	2174	40	T2D_GENES_TANYA_LIPIDS	BURTON_ADIPOGENESIS_PEAK_AT_16HR
0.459981600736%	10	2174	28	T2D_GENES_TANYA_LIPIDS	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS
0.459981600736%	10	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES
0.459981600736%	10	2174	25	T2D_GENES_TANYA_LIPIDS	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM
0.459981600736%	10	2174	185	T2D_GENES_TANYA_LIPIDS	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
0.459981600736%	10	2174	181	T2D_GENES_TANYA_LIPIDS	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
0.459981600736%	10	2174	175	T2D_GENES_TANYA_LIPIDS	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
0.459981600736%	10	2174	162	T2D_GENES_TANYA_LIPIDS	WINNEPENNINCKX_MELANOMA_METASTASIS_UP
0.459981600736%	10	2174	16	T2D_GENES_TANYA_LIPIDS	REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT
0.459981600736%	10	2174	158	T2D_GENES_TANYA_LIPIDS	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON
0.459981600736%	10	2174	153	T2D_GENES_TANYA_LIPIDS	LU_AGING_BRAIN_DN
0.459981600736%	10	2174	150	T2D_GENES_TANYA_LIPIDS	LANDIS_ERBB2_BREAST_TUMORS_324_UP
0.459981600736%	10	2174	149	T2D_GENES_TANYA_LIPIDS	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
0.459981600736%	10	2174	145	T2D_GENES_TANYA_LIPIDS	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.459981600736%	10	2174	137	T2D_GENES_TANYA_LIPIDS	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
0.459981600736%	10	2174	135	T2D_GENES_TANYA_LIPIDS	SERVITJA_LIVER_HNF1A_TARGETS_UP
0.459981600736%	10	2174	134	T2D_GENES_TANYA_LIPIDS	POOLA_INVASIVE_BREAST_CANCER_DN
0.459981600736%	10	2174	132	T2D_GENES_TANYA_LIPIDS	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
0.459981600736%	10	2174	128	T2D_GENES_TANYA_LIPIDS	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS
0.459981600736%	10	2174	121	T2D_GENES_TANYA_LIPIDS	VANTVEER_BREAST_CANCER_METASTASIS_DN
0.459981600736%	10	2174	121	T2D_GENES_TANYA_LIPIDS	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
0.459981600736%	10	2174	118	T2D_GENES_TANYA_LIPIDS	LEE_NEURAL_CREST_STEM_CELL_DN
0.459981600736%	10	2174	116	T2D_GENES_TANYA_LIPIDS	LI_INDUCED_T_TO_NATURAL_KILLER_DN
0.459981600736%	10	2174	114	T2D_GENES_TANYA_LIPIDS	KEGG_OOCYTE_MEIOSIS
0.459981600736%	10	2174	113	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_RHO_GTPASES
0.459981600736%	10	2174	113	T2D_GENES_TANYA_LIPIDS	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
0.459981600736%	10	2174	110	T2D_GENES_TANYA_LIPIDS	GROSS_HYPOXIA_VIA_HIF1A_DN
0.459981600736%	10	2174	108	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
0.459981600736%	10	2174	106	T2D_GENES_TANYA_LIPIDS	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
0.459981600736%	10	2174	105	T2D_GENES_TANYA_LIPIDS	REACTOME_RNA_POL_II_TRANSCRIPTION
0.459981600736%	10	2174	105	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_8HR_UP
0.459981600736%	10	2174	105	T2D_GENES_TANYA_LIPIDS	AMUNDSON_GENOTOXIC_SIGNATURE
0.459981600736%	10	2174	103	T2D_GENES_TANYA_LIPIDS	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN
0.459981600736%	10	2174	103	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_NOTCH
0.459981600736%	10	2174	103	T2D_GENES_TANYA_LIPIDS	LEIN_CHOROID_PLEXUS_MARKERS
0.459981600736%	10	2174	103	T2D_GENES_TANYA_LIPIDS	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
0.459981600736%	10	2174	102	T2D_GENES_TANYA_LIPIDS	KANG_IMMORTALIZED_BY_TERT_DN
0.459981600736%	10	2174	101	T2D_GENES_TANYA_LIPIDS	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
0.459981600736%	10	2174	101	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_ERBB2
0.455927051672%	9	1974	92	Mendelian_Nancy_Cox	CAMPS_COLON_CANCER_COPY_NUMBER_UP
0.455927051672%	9	1974	90	Mendelian_Nancy_Cox	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN
0.455927051672%	9	1974	89	Mendelian_Nancy_Cox	RICKMAN_HEAD_AND_NECK_CANCER_E
0.455927051672%	9	1974	88	Mendelian_Nancy_Cox	UEDA_CENTRAL_CLOCK
0.455927051672%	9	1974	88	Mendelian_Nancy_Cox	SASSON_RESPONSE_TO_FORSKOLIN_DN
0.455927051672%	9	1974	86	Mendelian_Nancy_Cox	TAKAO_RESPONSE_TO_UVB_RADIATION_UP
0.455927051672%	9	1974	85	Mendelian_Nancy_Cox	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
0.455927051672%	9	1974	83	Mendelian_Nancy_Cox	WARTERS_RESPONSE_TO_IR_SKIN
0.455927051672%	9	1974	83	Mendelian_Nancy_Cox	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
0.455927051672%	9	1974	82	Mendelian_Nancy_Cox	BHAT_ESR1_TARGETS_VIA_AKT1_DN
0.455927051672%	9	1974	81	Mendelian_Nancy_Cox	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
0.455927051672%	9	1974	81	Mendelian_Nancy_Cox	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
0.455927051672%	9	1974	79	Mendelian_Nancy_Cox	MCCLUNG_COCAINE_REWARD_5D
0.455927051672%	9	1974	78	Mendelian_Nancy_Cox	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.455927051672%	9	1974	77	Mendelian_Nancy_Cox	MORI_PRE_BI_LYMPHOCYTE_DN
0.455927051672%	9	1974	76	Mendelian_Nancy_Cox	SU_TESTIS
0.455927051672%	9	1974	76	Mendelian_Nancy_Cox	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION
0.455927051672%	9	1974	74	Mendelian_Nancy_Cox	SHEPARD_BMYB_TARGETS
0.455927051672%	9	1974	74	Mendelian_Nancy_Cox	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
0.455927051672%	9	1974	74	Mendelian_Nancy_Cox	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
0.455927051672%	9	1974	72	Mendelian_Nancy_Cox	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
0.455927051672%	9	1974	72	Mendelian_Nancy_Cox	CROONQUIST_NRAS_SIGNALING_DN
0.455927051672%	9	1974	70	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_NOTCH1
0.455927051672%	9	1974	69	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10
0.455927051672%	9	1974	69	Mendelian_Nancy_Cox	RHODES_UNDIFFERENTIATED_CANCER
0.455927051672%	9	1974	69	Mendelian_Nancy_Cox	HUANG_DASATINIB_RESISTANCE_DN
0.455927051672%	9	1974	69	Mendelian_Nancy_Cox	AMIT_EGF_RESPONSE_120_HELA
0.455927051672%	9	1974	68	Mendelian_Nancy_Cox	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
0.455927051672%	9	1974	68	Mendelian_Nancy_Cox	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
0.455927051672%	9	1974	68	Mendelian_Nancy_Cox	BROWNE_INTERFERON_RESPONSIVE_GENES
0.455927051672%	9	1974	68	Mendelian_Nancy_Cox	AKL_HTLV1_INFECTION_DN
0.455927051672%	9	1974	67	Mendelian_Nancy_Cox	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.455927051672%	9	1974	67	Mendelian_Nancy_Cox	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN
0.455927051672%	9	1974	66	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
0.455927051672%	9	1974	66	Mendelian_Nancy_Cox	PID_LYSOPHOSPHOLIPID_PATHWAY
0.455927051672%	9	1974	65	Mendelian_Nancy_Cox	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
0.455927051672%	9	1974	64	Mendelian_Nancy_Cox	ZHANG_GATA6_TARGETS_DN
0.455927051672%	9	1974	64	Mendelian_Nancy_Cox	RHODES_CANCER_META_SIGNATURE
0.455927051672%	9	1974	63	Mendelian_Nancy_Cox	REACTOME_INTERFERON_GAMMA_SIGNALING
0.455927051672%	9	1974	63	Mendelian_Nancy_Cox	PHONG_TNF_TARGETS_UP
0.455927051672%	9	1974	63	Mendelian_Nancy_Cox	BILBAN_B_CLL_LPL_UP
0.455927051672%	9	1974	62	Mendelian_Nancy_Cox	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
0.455927051672%	9	1974	62	Mendelian_Nancy_Cox	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP
0.455927051672%	9	1974	62	Mendelian_Nancy_Cox	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.455927051672%	9	1974	61	Mendelian_Nancy_Cox	LEE_LIVER_CANCER_MYC_TGFA_UP
0.455927051672%	9	1974	60	Mendelian_Nancy_Cox	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
0.455927051672%	9	1974	60	Mendelian_Nancy_Cox	LEE_LIVER_CANCER_CIPROFIBRATE_UP
0.455927051672%	9	1974	59	Mendelian_Nancy_Cox	PID_P53REGULATIONPATHWAY
0.455927051672%	9	1974	59	Mendelian_Nancy_Cox	PID_FAK_PATHWAY
0.455927051672%	9	1974	59	Mendelian_Nancy_Cox	KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION
0.455927051672%	9	1974	59	Mendelian_Nancy_Cox	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
0.455927051672%	9	1974	59	Mendelian_Nancy_Cox	BOYLAN_MULTIPLE_MYELOMA_C_DN
0.455927051672%	9	1974	58	Mendelian_Nancy_Cox	SANSOM_WNT_PATHWAY_REQUIRE_MYC
0.455927051672%	9	1974	58	Mendelian_Nancy_Cox	REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT
0.455927051672%	9	1974	58	Mendelian_Nancy_Cox	LIM_MAMMARY_LUMINAL_PROGENITOR_UP
0.455927051672%	9	1974	58	Mendelian_Nancy_Cox	BERNARD_PPAPDC1B_TARGETS_DN
0.455927051672%	9	1974	57	Mendelian_Nancy_Cox	TANG_SENESCENCE_TP53_TARGETS_DN
0.455927051672%	9	1974	57	Mendelian_Nancy_Cox	BURTON_ADIPOGENESIS_11
0.455927051672%	9	1974	57	Mendelian_Nancy_Cox	BORLAK_LIVER_CANCER_EGF_UP
0.455927051672%	9	1974	56	Mendelian_Nancy_Cox	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION
0.455927051672%	9	1974	56	Mendelian_Nancy_Cox	LEE_LIVER_CANCER_MYC_E2F1_UP
0.455927051672%	9	1974	55	Mendelian_Nancy_Cox	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
0.455927051672%	9	1974	54	Mendelian_Nancy_Cox	ROVERSI_GLIOMA_COPY_NUMBER_DN
0.455927051672%	9	1974	53	Mendelian_Nancy_Cox	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP
0.455927051672%	9	1974	53	Mendelian_Nancy_Cox	MORI_IMMATURE_B_LYMPHOCYTE_UP
0.455927051672%	9	1974	52	Mendelian_Nancy_Cox	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP
0.455927051672%	9	1974	52	Mendelian_Nancy_Cox	BECKER_TAMOXIFEN_RESISTANCE_DN
0.455927051672%	9	1974	51	Mendelian_Nancy_Cox	ZHANG_PROLIFERATING_VS_QUIESCENT
0.455927051672%	9	1974	51	Mendelian_Nancy_Cox	GUILLAUMOND_KLF10_TARGETS_UP
0.455927051672%	9	1974	50	Mendelian_Nancy_Cox	HOFMANN_CELL_LYMPHOMA_UP
0.455927051672%	9	1974	50	Mendelian_Nancy_Cox	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
0.455927051672%	9	1974	49	Mendelian_Nancy_Cox	KEGG_GLYCEROLIPID_METABOLISM
0.455927051672%	9	1974	49	Mendelian_Nancy_Cox	DAUER_STAT3_TARGETS_UP
0.455927051672%	9	1974	49	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_2HR_DN
0.455927051672%	9	1974	49	Mendelian_Nancy_Cox	APRELIKOVA_BRCA1_TARGETS
0.455927051672%	9	1974	48	Mendelian_Nancy_Cox	RICKMAN_HEAD_AND_NECK_CANCER_B
0.455927051672%	9	1974	48	Mendelian_Nancy_Cox	GNATENKO_PLATELET_SIGNATURE
0.455927051672%	9	1974	48	Mendelian_Nancy_Cox	BURTON_ADIPOGENESIS_4
0.455927051672%	9	1974	47	Mendelian_Nancy_Cox	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
0.455927051672%	9	1974	47	Mendelian_Nancy_Cox	PID_LKB1_PATHWAY
0.455927051672%	9	1974	47	Mendelian_Nancy_Cox	PID_FANCONI_PATHWAY
0.455927051672%	9	1974	47	Mendelian_Nancy_Cox	LEONARD_HYPOXIA
0.455927051672%	9	1974	46	Mendelian_Nancy_Cox	SESTO_RESPONSE_TO_UV_C5
0.455927051672%	9	1974	46	Mendelian_Nancy_Cox	PID_PS1PATHWAY
0.455927051672%	9	1974	46	Mendelian_Nancy_Cox	HEIDENBLAD_AMPLICON_8Q24_DN
0.455927051672%	9	1974	45	Mendelian_Nancy_Cox	SHIPP_DLBCL_CURED_VS_FATAL_DN
0.455927051672%	9	1974	45	Mendelian_Nancy_Cox	ABRAMSON_INTERACT_WITH_AIRE
0.455927051672%	9	1974	44	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_PR_DN
0.455927051672%	9	1974	44	Mendelian_Nancy_Cox	XU_CREBBP_TARGETS_DN
0.455927051672%	9	1974	43	Mendelian_Nancy_Cox	REACTOME_PLC_BETA_MEDIATED_EVENTS
0.455927051672%	9	1974	43	Mendelian_Nancy_Cox	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
0.455927051672%	9	1974	42	Mendelian_Nancy_Cox	WIERENGA_PML_INTERACTOME
0.455927051672%	9	1974	42	Mendelian_Nancy_Cox	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
0.455927051672%	9	1974	42	Mendelian_Nancy_Cox	PID_ECADHERIN_STABILIZATION_PATHWAY
0.455927051672%	9	1974	42	Mendelian_Nancy_Cox	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER
0.455927051672%	9	1974	42	Mendelian_Nancy_Cox	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP
0.455927051672%	9	1974	41	Mendelian_Nancy_Cox	PID_ERBB1_INTERNALIZATION_PATHWAY
0.455927051672%	9	1974	41	Mendelian_Nancy_Cox	PID_AMB2_NEUTROPHILS_PATHWAY
0.455927051672%	9	1974	40	Mendelian_Nancy_Cox	BURTON_ADIPOGENESIS_PEAK_AT_16HR
0.455927051672%	9	1974	40	Mendelian_Nancy_Cox	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
0.455927051672%	9	1974	39	Mendelian_Nancy_Cox	PID_ECADHERIN_NASCENTAJ_PATHWAY
0.455927051672%	9	1974	39	Mendelian_Nancy_Cox	MATZUK_MEIOTIC_AND_DNA_REPAIR
0.455927051672%	9	1974	39	Mendelian_Nancy_Cox	HAN_JNK_SINGALING_DN
0.455927051672%	9	1974	39	Mendelian_Nancy_Cox	BIOCARTA_FMLP_PATHWAY
0.455927051672%	9	1974	38	Mendelian_Nancy_Cox	REACTOME_GAB1_SIGNALOSOME
0.455927051672%	9	1974	38	Mendelian_Nancy_Cox	PIONTEK_PKD1_TARGETS_UP
0.455927051672%	9	1974	38	Mendelian_Nancy_Cox	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN
0.455927051672%	9	1974	37	Mendelian_Nancy_Cox	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN
0.455927051672%	9	1974	37	Mendelian_Nancy_Cox	ST_GA13_PATHWAY
0.455927051672%	9	1974	37	Mendelian_Nancy_Cox	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
0.455927051672%	9	1974	37	Mendelian_Nancy_Cox	PID_IL23PATHWAY
0.455927051672%	9	1974	37	Mendelian_Nancy_Cox	MURAKAMI_UV_RESPONSE_6HR_UP
0.455927051672%	9	1974	37	Mendelian_Nancy_Cox	LANDIS_ERBB2_BREAST_TUMORS_65_DN
0.455927051672%	9	1974	37	Mendelian_Nancy_Cox	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR
0.455927051672%	9	1974	36	Mendelian_Nancy_Cox	STEARMAN_TUMOR_FIELD_EFFECT_UP
0.455927051672%	9	1974	36	Mendelian_Nancy_Cox	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
0.455927051672%	9	1974	36	Mendelian_Nancy_Cox	PID_PI3KPLCTRKPATHWAY
0.455927051672%	9	1974	36	Mendelian_Nancy_Cox	MARZEC_IL2_SIGNALING_DN
0.455927051672%	9	1974	36	Mendelian_Nancy_Cox	HUANG_FOXA2_TARGETS_DN
0.455927051672%	9	1974	36	Mendelian_Nancy_Cox	BIOCARTA_AT1R_PATHWAY
0.455927051672%	9	1974	35	Mendelian_Nancy_Cox	MODY_HIPPOCAMPUS_NEONATAL
0.455927051672%	9	1974	35	Mendelian_Nancy_Cox	AIGNER_ZEB1_TARGETS
0.455927051672%	9	1974	34	Mendelian_Nancy_Cox	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE
0.455927051672%	9	1974	34	Mendelian_Nancy_Cox	PID_HIF2PATHWAY
0.455927051672%	9	1974	34	Mendelian_Nancy_Cox	PID_EPOPATHWAY
0.455927051672%	9	1974	34	Mendelian_Nancy_Cox	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM
0.455927051672%	9	1974	34	Mendelian_Nancy_Cox	FRIDMAN_IMMORTALIZATION_DN
0.455927051672%	9	1974	34	Mendelian_Nancy_Cox	DOANE_BREAST_CANCER_CLASSES_DN
0.455927051672%	9	1974	33	Mendelian_Nancy_Cox	ZHAN_LATE_DIFFERENTIATION_GENES_UP
0.455927051672%	9	1974	33	Mendelian_Nancy_Cox	VALK_AML_CLUSTER_5
0.455927051672%	9	1974	32	Mendelian_Nancy_Cox	PID_SYNDECAN_4_PATHWAY
0.455927051672%	9	1974	32	Mendelian_Nancy_Cox	BAUS_TFF2_TARGETS_UP
0.455927051672%	9	1974	31	Mendelian_Nancy_Cox	SIMBULAN_PARP1_TARGETS_UP
0.455927051672%	9	1974	31	Mendelian_Nancy_Cox	PID_CD40_PATHWAY
0.455927051672%	9	1974	30	Mendelian_Nancy_Cox	TAVOR_CEBPA_TARGETS_DN
0.455927051672%	9	1974	30	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
0.455927051672%	9	1974	30	Mendelian_Nancy_Cox	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP
0.455927051672%	9	1974	30	Mendelian_Nancy_Cox	KIM_LRRC3B_TARGETS
0.455927051672%	9	1974	30	Mendelian_Nancy_Cox	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY
0.455927051672%	9	1974	29	Mendelian_Nancy_Cox	NGUYEN_NOTCH1_TARGETS_UP
0.455927051672%	9	1974	28	Mendelian_Nancy_Cox	MATZUK_MALE_REPRODUCTION_SERTOLI
0.455927051672%	9	1974	28	Mendelian_Nancy_Cox	HWANG_PROSTATE_CANCER_MARKERS
0.455927051672%	9	1974	27	Mendelian_Nancy_Cox	REACTOME_SIGNALLING_TO_RAS
0.455927051672%	9	1974	27	Mendelian_Nancy_Cox	REACTOME_IL_RECEPTOR_SHC_SIGNALING
0.455927051672%	9	1974	27	Mendelian_Nancy_Cox	PID_GLYPICAN_1PATHWAY
0.455927051672%	9	1974	27	Mendelian_Nancy_Cox	KEGG_PENTOSE_PHOSPHATE_PATHWAY
0.455927051672%	9	1974	26	Mendelian_Nancy_Cox	REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE
0.455927051672%	9	1974	26	Mendelian_Nancy_Cox	NAKAMURA_CANCER_MICROENVIRONMENT_UP
0.455927051672%	9	1974	26	Mendelian_Nancy_Cox	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN
0.455927051672%	9	1974	26	Mendelian_Nancy_Cox	BIOCARTA_RACCYCD_PATHWAY
0.455927051672%	9	1974	25	Mendelian_Nancy_Cox	PID_TOLL_ENDOGENOUS_PATHWAY
0.455927051672%	9	1974	25	Mendelian_Nancy_Cox	LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS
0.455927051672%	9	1974	24	Mendelian_Nancy_Cox	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN
0.455927051672%	9	1974	24	Mendelian_Nancy_Cox	REACTOME_SULFUR_AMINO_ACID_METABOLISM
0.455927051672%	9	1974	24	Mendelian_Nancy_Cox	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN
0.455927051672%	9	1974	24	Mendelian_Nancy_Cox	BIOCARTA_NTHI_PATHWAY
0.455927051672%	9	1974	23	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_BMP
0.455927051672%	9	1974	222	Mendelian_Nancy_Cox	REACTOME_TRANSLATION
0.455927051672%	9	1974	22	Mendelian_Nancy_Cox	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING
0.455927051672%	9	1974	22	Mendelian_Nancy_Cox	REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION
0.455927051672%	9	1974	22	Mendelian_Nancy_Cox	MATZUK_IMPLANTATION_AND_UTERINE
0.455927051672%	9	1974	22	Mendelian_Nancy_Cox	BIOCARTA_INSULIN_PATHWAY
0.455927051672%	9	1974	22	Mendelian_Nancy_Cox	BIOCARTA_IL6_PATHWAY
0.455927051672%	9	1974	20	Mendelian_Nancy_Cox	BIOCARTA_ATM_PATHWAY
0.455927051672%	9	1974	19	Mendelian_Nancy_Cox	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS
0.455927051672%	9	1974	19	Mendelian_Nancy_Cox	LAMB_CCND1_TARGETS
0.455927051672%	9	1974	19	Mendelian_Nancy_Cox	JEON_SMAD6_TARGETS_DN
0.455927051672%	9	1974	18	Mendelian_Nancy_Cox	MOREIRA_RESPONSE_TO_TSA_DN
0.455927051672%	9	1974	174	Mendelian_Nancy_Cox	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
0.455927051672%	9	1974	17	Mendelian_Nancy_Cox	REACTOME_SHC_RELATED_EVENTS
0.455927051672%	9	1974	17	Mendelian_Nancy_Cox	REACTOME_ARMS_MEDIATED_ACTIVATION
0.455927051672%	9	1974	17	Mendelian_Nancy_Cox	MURAKAMI_UV_RESPONSE_1HR_UP
0.455927051672%	9	1974	17	Mendelian_Nancy_Cox	BIOCARTA_PML_PATHWAY
0.455927051672%	9	1974	16	Mendelian_Nancy_Cox	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT
0.455927051672%	9	1974	16	Mendelian_Nancy_Cox	REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT
0.455927051672%	9	1974	16	Mendelian_Nancy_Cox	KEGG_OTHER_GLYCAN_DEGRADATION
0.455927051672%	9	1974	15	Mendelian_Nancy_Cox	REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN
0.455927051672%	9	1974	15	Mendelian_Nancy_Cox	REACTOME_HDL_MEDIATED_LIPID_TRANSPORT
0.455927051672%	9	1974	147	Mendelian_Nancy_Cox	BENPORATH_PROLIFERATION
0.455927051672%	9	1974	140	Mendelian_Nancy_Cox	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
0.455927051672%	9	1974	13	Mendelian_Nancy_Cox	BIOCARTA_EXTRINSIC_PATHWAY
0.455927051672%	9	1974	13	Mendelian_Nancy_Cox	BIOCARTA_ACE2_PATHWAY
0.455927051672%	9	1974	125	Mendelian_Nancy_Cox	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
0.455927051672%	9	1974	116	Mendelian_Nancy_Cox	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
0.455927051672%	9	1974	114	Mendelian_Nancy_Cox	KEGG_OOCYTE_MEIOSIS
0.455927051672%	9	1974	104	Mendelian_Nancy_Cox	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
0.455927051672%	9	1974	103	Mendelian_Nancy_Cox	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
0.455927051672%	9	1974	100	Mendelian_Nancy_Cox	WINZEN_DEGRADED_VIA_KHSRP
0.454545454545%	16	3520	97	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
0.454545454545%	16	3520	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION
0.454545454545%	16	3520	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ELVIDGE_HIF1A_TARGETS_DN
0.454545454545%	16	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_16HR_DN
0.454545454545%	16	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_GLIS2_TARGETS_UP
0.454545454545%	16	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
0.454545454545%	16	3520	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WOO_LIVER_CANCER_RECURRENCE_DN
0.454545454545%	16	3520	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
0.454545454545%	16	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_MYC_ACTIVPATHWAY
0.454545454545%	16	3520	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIN_MELANOMA_COPY_NUMBER_UP
0.454545454545%	16	3520	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_DRUG_METABOLISM_CYTOCHROME_P450
0.454545454545%	16	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
0.454545454545%	16	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PPAR_SIGNALING_PATHWAY
0.454545454545%	16	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.454545454545%	16	3520	238	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.454545454545%	16	3520	221	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PEDRIOLI_MIR31_TARGETS_UP
0.454545454545%	16	3520	207	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VERHAAK_GLIOBLASTOMA_CLASSICAL
0.454545454545%	16	3520	188	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
0.454545454545%	16	3520	184	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
0.454545454545%	16	3520	182	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_G2
0.454545454545%	16	3520	179	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE
0.454545454545%	16	3520	174	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_IPS_LCP_WITH_H3K4ME3
0.454545454545%	16	3520	172	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMID_BREAST_CANCER_LUMINAL_B_UP
0.454545454545%	16	3520	169	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION
0.454545454545%	16	3520	167	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TIEN_INTESTINE_PROBIOTICS_6HR_DN
0.454545454545%	16	3520	165	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_CMYB_TARGETS_UP
0.454545454545%	16	3520	165	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWN_MYELOID_CELL_DEVELOPMENT_UP
0.454545454545%	16	3520	163	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
0.454545454545%	16	3520	162	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_S
0.454545454545%	16	3520	162	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_WT1_TARGETS_12HR_UP
0.454545454545%	16	3520	160	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
0.454545454545%	16	3520	159	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PURINE_METABOLISM
0.454545454545%	16	3520	152	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
0.454545454545%	16	3520	151	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_WNT_SIGNALING_PATHWAY
0.454545454545%	16	3520	149	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOZGIT_ESR1_TARGETS_UP
0.454545454545%	16	3520	148	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEI_MIR34A_TARGETS
0.454545454545%	16	3520	147	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
0.454545454545%	16	3520	146	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_NEURAL_CREST_STEM_CELL_UP
0.454545454545%	16	3520	140	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
0.454545454545%	16	3520	140	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
0.454545454545%	16	3520	138	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
0.454545454545%	16	3520	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_SOX4_TARGETS_UP
0.454545454545%	16	3520	134	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
0.454545454545%	16	3520	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
0.454545454545%	16	3520	118	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TOLL_RECEPTOR_CASCADES
0.454545454545%	16	3520	118	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
0.454545454545%	16	3520	115	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARKEY_RB1_CHRONIC_LOF_UP
0.454545454545%	16	3520	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
0.454545454545%	16	3520	111	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_HCP_PROSTATE_CANCER
0.454545454545%	16	3520	109	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SERVITJA_ISLET_HNF1A_TARGETS_DN
0.454545454545%	16	3520	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY
0.454545454545%	16	3520	102	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_CXCR4_PATHWAY
0.453857791225%	3	661	98	T2D_GENES_TANYA_GLYCEMIC	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
0.453857791225%	3	661	98	T2D_GENES_TANYA_GLYCEMIC	PYEON_HPV_POSITIVE_TUMORS_UP
0.453857791225%	3	661	98	T2D_GENES_TANYA_GLYCEMIC	BRUINS_UVC_RESPONSE_MIDDLE
0.453857791225%	3	661	97	T2D_GENES_TANYA_GLYCEMIC	LABBE_WNT3A_TARGETS_DN
0.453857791225%	3	661	97	T2D_GENES_TANYA_GLYCEMIC	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP
0.453857791225%	3	661	96	T2D_GENES_TANYA_GLYCEMIC	LIU_PROSTATE_CANCER_UP
0.453857791225%	3	661	92	T2D_GENES_TANYA_GLYCEMIC	WINTER_HYPOXIA_UP
0.453857791225%	3	661	92	T2D_GENES_TANYA_GLYCEMIC	KIM_MYCN_AMPLIFICATION_TARGETS_UP
0.453857791225%	3	661	92	T2D_GENES_TANYA_GLYCEMIC	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
0.453857791225%	3	661	92	T2D_GENES_TANYA_GLYCEMIC	BURTON_ADIPOGENESIS_9
0.453857791225%	3	661	91	T2D_GENES_TANYA_GLYCEMIC	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
0.453857791225%	3	661	91	T2D_GENES_TANYA_GLYCEMIC	GAVIN_FOXP3_TARGETS_CLUSTER_P6
0.453857791225%	3	661	90	T2D_GENES_TANYA_GLYCEMIC	SASSON_RESPONSE_TO_FORSKOLIN_UP
0.453857791225%	3	661	90	T2D_GENES_TANYA_GLYCEMIC	SANA_TNF_SIGNALING_DN
0.453857791225%	3	661	90	T2D_GENES_TANYA_GLYCEMIC	MORI_IMMATURE_B_LYMPHOCYTE_DN
0.453857791225%	3	661	90	T2D_GENES_TANYA_GLYCEMIC	KEGG_GAP_JUNCTION
0.453857791225%	3	661	9	T2D_GENES_TANYA_GLYCEMIC	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1
0.453857791225%	3	661	88	T2D_GENES_TANYA_GLYCEMIC	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
0.453857791225%	3	661	88	T2D_GENES_TANYA_GLYCEMIC	SEIDEN_ONCOGENESIS_BY_MET
0.453857791225%	3	661	88	T2D_GENES_TANYA_GLYCEMIC	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
0.453857791225%	3	661	88	T2D_GENES_TANYA_GLYCEMIC	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.453857791225%	3	661	87	T2D_GENES_TANYA_GLYCEMIC	SMITH_TERT_TARGETS_DN
0.453857791225%	3	661	87	T2D_GENES_TANYA_GLYCEMIC	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
0.453857791225%	3	661	87	T2D_GENES_TANYA_GLYCEMIC	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
0.453857791225%	3	661	87	T2D_GENES_TANYA_GLYCEMIC	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
0.453857791225%	3	661	86	T2D_GENES_TANYA_GLYCEMIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
0.453857791225%	3	661	86	T2D_GENES_TANYA_GLYCEMIC	NGUYEN_NOTCH1_TARGETS_DN
0.453857791225%	3	661	86	T2D_GENES_TANYA_GLYCEMIC	NELSON_RESPONSE_TO_ANDROGEN_UP
0.453857791225%	3	661	86	T2D_GENES_TANYA_GLYCEMIC	LAIHO_COLORECTAL_CANCER_SERRATED_DN
0.453857791225%	3	661	86	T2D_GENES_TANYA_GLYCEMIC	KEGG_TGF_BETA_SIGNALING_PATHWAY
0.453857791225%	3	661	86	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_16HR_DN
0.453857791225%	3	661	86	T2D_GENES_TANYA_GLYCEMIC	BAELDE_DIABETIC_NEPHROPATHY_UP
0.453857791225%	3	661	85	T2D_GENES_TANYA_GLYCEMIC	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
0.453857791225%	3	661	85	T2D_GENES_TANYA_GLYCEMIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
0.453857791225%	3	661	85	T2D_GENES_TANYA_GLYCEMIC	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
0.453857791225%	3	661	85	T2D_GENES_TANYA_GLYCEMIC	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
0.453857791225%	3	661	85	T2D_GENES_TANYA_GLYCEMIC	COLDREN_GEFITINIB_RESISTANCE_UP
0.453857791225%	3	661	84	T2D_GENES_TANYA_GLYCEMIC	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
0.453857791225%	3	661	84	T2D_GENES_TANYA_GLYCEMIC	PID_CMYB_PATHWAY
0.453857791225%	3	661	84	T2D_GENES_TANYA_GLYCEMIC	KEGG_SMALL_CELL_LUNG_CANCER
0.453857791225%	3	661	84	T2D_GENES_TANYA_GLYCEMIC	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
0.453857791225%	3	661	82	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS
0.453857791225%	3	661	82	T2D_GENES_TANYA_GLYCEMIC	PID_REG_GR_PATHWAY
0.453857791225%	3	661	81	T2D_GENES_TANYA_GLYCEMIC	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
0.453857791225%	3	661	81	T2D_GENES_TANYA_GLYCEMIC	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
0.453857791225%	3	661	81	T2D_GENES_TANYA_GLYCEMIC	COATES_MACROPHAGE_M1_VS_M2_UP
0.453857791225%	3	661	80	T2D_GENES_TANYA_GLYCEMIC	SCHUHMACHER_MYC_TARGETS_UP
0.453857791225%	3	661	80	T2D_GENES_TANYA_GLYCEMIC	REACTOME_UNFOLDED_PROTEIN_RESPONSE
0.453857791225%	3	661	79	T2D_GENES_TANYA_GLYCEMIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16
0.453857791225%	3	661	79	T2D_GENES_TANYA_GLYCEMIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
0.453857791225%	3	661	79	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT
0.453857791225%	3	661	79	T2D_GENES_TANYA_GLYCEMIC	PID_MYC_ACTIVPATHWAY
0.453857791225%	3	661	79	T2D_GENES_TANYA_GLYCEMIC	CROMER_METASTASIS_UP
0.453857791225%	3	661	78	T2D_GENES_TANYA_GLYCEMIC	SANA_RESPONSE_TO_IFNG_UP
0.453857791225%	3	661	78	T2D_GENES_TANYA_GLYCEMIC	ROSS_AML_WITH_MLL_FUSIONS
0.453857791225%	3	661	78	T2D_GENES_TANYA_GLYCEMIC	KEGG_PEROXISOME
0.453857791225%	3	661	78	T2D_GENES_TANYA_GLYCEMIC	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP
0.453857791225%	3	661	78	T2D_GENES_TANYA_GLYCEMIC	BOYLAN_MULTIPLE_MYELOMA_D_DN
0.453857791225%	3	661	77	T2D_GENES_TANYA_GLYCEMIC	ROSS_AML_WITH_PML_RARA_FUSION
0.453857791225%	3	661	77	T2D_GENES_TANYA_GLYCEMIC	RODRIGUES_THYROID_CARCINOMA_DN
0.453857791225%	3	661	77	T2D_GENES_TANYA_GLYCEMIC	RIZ_ERYTHROID_DIFFERENTIATION
0.453857791225%	3	661	77	T2D_GENES_TANYA_GLYCEMIC	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN
0.453857791225%	3	661	77	T2D_GENES_TANYA_GLYCEMIC	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM
0.453857791225%	3	661	77	T2D_GENES_TANYA_GLYCEMIC	FRIDMAN_SENESCENCE_UP
0.453857791225%	3	661	77	T2D_GENES_TANYA_GLYCEMIC	CARD_MIR302A_TARGETS
0.453857791225%	3	661	76	T2D_GENES_TANYA_GLYCEMIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.453857791225%	3	661	76	T2D_GENES_TANYA_GLYCEMIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
0.453857791225%	3	661	76	T2D_GENES_TANYA_GLYCEMIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
0.453857791225%	3	661	76	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION
0.453857791225%	3	661	76	T2D_GENES_TANYA_GLYCEMIC	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
0.453857791225%	3	661	76	T2D_GENES_TANYA_GLYCEMIC	KEGG_VEGF_SIGNALING_PATHWAY
0.453857791225%	3	661	76	T2D_GENES_TANYA_GLYCEMIC	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
0.453857791225%	3	661	76	T2D_GENES_TANYA_GLYCEMIC	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
0.453857791225%	3	661	75	T2D_GENES_TANYA_GLYCEMIC	PID_AVB3_INTEGRIN_PATHWAY
0.453857791225%	3	661	75	T2D_GENES_TANYA_GLYCEMIC	MORI_MATURE_B_LYMPHOCYTE_DN
0.453857791225%	3	661	74	T2D_GENES_TANYA_GLYCEMIC	SHEPARD_BMYB_TARGETS
0.453857791225%	3	661	74	T2D_GENES_TANYA_GLYCEMIC	RAMALHO_STEMNESS_DN
0.453857791225%	3	661	74	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
0.453857791225%	3	661	74	T2D_GENES_TANYA_GLYCEMIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN
0.453857791225%	3	661	73	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
0.453857791225%	3	661	73	T2D_GENES_TANYA_GLYCEMIC	KEGG_CHRONIC_MYELOID_LEUKEMIA
0.453857791225%	3	661	73	T2D_GENES_TANYA_GLYCEMIC	DITTMER_PTHLH_TARGETS_DN
0.453857791225%	3	661	73	T2D_GENES_TANYA_GLYCEMIC	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.453857791225%	3	661	72	T2D_GENES_TANYA_GLYCEMIC	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
0.453857791225%	3	661	71	T2D_GENES_TANYA_GLYCEMIC	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.453857791225%	3	661	71	T2D_GENES_TANYA_GLYCEMIC	KYNG_RESPONSE_TO_H2O2
0.453857791225%	3	661	71	T2D_GENES_TANYA_GLYCEMIC	GU_PDEF_TARGETS_UP
0.453857791225%	3	661	70	T2D_GENES_TANYA_GLYCEMIC	PID_AP1_PATHWAY
0.453857791225%	3	661	70	T2D_GENES_TANYA_GLYCEMIC	LIU_NASOPHARYNGEAL_CARCINOMA
0.453857791225%	3	661	70	T2D_GENES_TANYA_GLYCEMIC	KEGG_LONG_TERM_POTENTIATION
0.453857791225%	3	661	70	T2D_GENES_TANYA_GLYCEMIC	KEGG_LONG_TERM_DEPRESSION
0.453857791225%	3	661	70	T2D_GENES_TANYA_GLYCEMIC	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
0.453857791225%	3	661	69	T2D_GENES_TANYA_GLYCEMIC	ZAMORA_NOS2_TARGETS_UP
0.453857791225%	3	661	69	T2D_GENES_TANYA_GLYCEMIC	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.453857791225%	3	661	69	T2D_GENES_TANYA_GLYCEMIC	RIZKI_TUMOR_INVASIVENESS_2D_UP
0.453857791225%	3	661	69	T2D_GENES_TANYA_GLYCEMIC	RHODES_UNDIFFERENTIATED_CANCER
0.453857791225%	3	661	69	T2D_GENES_TANYA_GLYCEMIC	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
0.453857791225%	3	661	69	T2D_GENES_TANYA_GLYCEMIC	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
0.453857791225%	3	661	69	T2D_GENES_TANYA_GLYCEMIC	AMIT_EGF_RESPONSE_120_HELA
0.453857791225%	3	661	68	T2D_GENES_TANYA_GLYCEMIC	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
0.453857791225%	3	661	68	T2D_GENES_TANYA_GLYCEMIC	ROSS_AML_OF_FAB_M7_TYPE
0.453857791225%	3	661	68	T2D_GENES_TANYA_GLYCEMIC	PID_TELOMERASEPATHWAY
0.453857791225%	3	661	68	T2D_GENES_TANYA_GLYCEMIC	LIN_NPAS4_TARGETS_DN
0.453857791225%	3	661	68	T2D_GENES_TANYA_GLYCEMIC	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
0.453857791225%	3	661	67	T2D_GENES_TANYA_GLYCEMIC	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.453857791225%	3	661	67	T2D_GENES_TANYA_GLYCEMIC	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP
0.453857791225%	3	661	66	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
0.453857791225%	3	661	66	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES
0.453857791225%	3	661	66	T2D_GENES_TANYA_GLYCEMIC	PID_LYSOPHOSPHOLIPID_PATHWAY
0.453857791225%	3	661	66	T2D_GENES_TANYA_GLYCEMIC	LEE_LIVER_CANCER_CIPROFIBRATE_DN
0.453857791225%	3	661	66	T2D_GENES_TANYA_GLYCEMIC	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP
0.453857791225%	3	661	66	T2D_GENES_TANYA_GLYCEMIC	BEIER_GLIOMA_STEM_CELL_DN
0.453857791225%	3	661	65	T2D_GENES_TANYA_GLYCEMIC	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP
0.453857791225%	3	661	64	T2D_GENES_TANYA_GLYCEMIC	ZHANG_GATA6_TARGETS_DN
0.453857791225%	3	661	64	T2D_GENES_TANYA_GLYCEMIC	LEE_LIVER_CANCER_MYC_E2F1_DN
0.453857791225%	3	661	64	T2D_GENES_TANYA_GLYCEMIC	LEE_LIVER_CANCER_E2F1_DN
0.453857791225%	3	661	64	T2D_GENES_TANYA_GLYCEMIC	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
0.453857791225%	3	661	64	T2D_GENES_TANYA_GLYCEMIC	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
0.453857791225%	3	661	63	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
0.453857791225%	3	661	63	T2D_GENES_TANYA_GLYCEMIC	PID_ENDOTHELINPATHWAY
0.453857791225%	3	661	63	T2D_GENES_TANYA_GLYCEMIC	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
0.453857791225%	3	661	63	T2D_GENES_TANYA_GLYCEMIC	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.453857791225%	3	661	62	T2D_GENES_TANYA_GLYCEMIC	PID_TRKRPATHWAY
0.453857791225%	3	661	61	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS
0.453857791225%	3	661	61	T2D_GENES_TANYA_GLYCEMIC	MASSARWEH_RESPONSE_TO_ESTRADIOL
0.453857791225%	3	661	61	T2D_GENES_TANYA_GLYCEMIC	GENTILE_RESPONSE_CLUSTER_D3
0.453857791225%	3	661	60	T2D_GENES_TANYA_GLYCEMIC	SONG_TARGETS_OF_IE86_CMV_PROTEIN
0.453857791225%	3	661	60	T2D_GENES_TANYA_GLYCEMIC	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN
0.453857791225%	3	661	59	T2D_GENES_TANYA_GLYCEMIC	PID_NOTCH_PATHWAY
0.453857791225%	3	661	59	T2D_GENES_TANYA_GLYCEMIC	PID_FAK_PATHWAY
0.453857791225%	3	661	59	T2D_GENES_TANYA_GLYCEMIC	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
0.453857791225%	3	661	58	T2D_GENES_TANYA_GLYCEMIC	WAKASUGI_HAVE_ZNF143_BINDING_SITES
0.453857791225%	3	661	58	T2D_GENES_TANYA_GLYCEMIC	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
0.453857791225%	3	661	58	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT
0.453857791225%	3	661	58	T2D_GENES_TANYA_GLYCEMIC	NADLER_HYPERGLYCEMIA_AT_OBESITY
0.453857791225%	3	661	58	T2D_GENES_TANYA_GLYCEMIC	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN
0.453857791225%	3	661	58	T2D_GENES_TANYA_GLYCEMIC	LUCAS_HNF4A_TARGETS_UP
0.453857791225%	3	661	57	T2D_GENES_TANYA_GLYCEMIC	TONG_INTERACT_WITH_PTTG1
0.453857791225%	3	661	57	T2D_GENES_TANYA_GLYCEMIC	LEE_EARLY_T_LYMPHOCYTE_DN
0.453857791225%	3	661	57	T2D_GENES_TANYA_GLYCEMIC	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
0.453857791225%	3	661	57	T2D_GENES_TANYA_GLYCEMIC	AMIT_SERUM_RESPONSE_60_MCF10A
0.453857791225%	3	661	56	T2D_GENES_TANYA_GLYCEMIC	MAYBURD_RESPONSE_TO_L663536_DN
0.453857791225%	3	661	56	T2D_GENES_TANYA_GLYCEMIC	LY_AGING_OLD_DN
0.453857791225%	3	661	55	T2D_GENES_TANYA_GLYCEMIC	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
0.453857791225%	3	661	55	T2D_GENES_TANYA_GLYCEMIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
0.453857791225%	3	661	55	T2D_GENES_TANYA_GLYCEMIC	SU_LIVER
0.453857791225%	3	661	55	T2D_GENES_TANYA_GLYCEMIC	SMIRNOV_RESPONSE_TO_IR_2HR_DN
0.453857791225%	3	661	55	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ION_CHANNEL_TRANSPORT
0.453857791225%	3	661	55	T2D_GENES_TANYA_GLYCEMIC	PID_IL2_1PATHWAY
0.453857791225%	3	661	55	T2D_GENES_TANYA_GLYCEMIC	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR
0.453857791225%	3	661	54	T2D_GENES_TANYA_GLYCEMIC	SU_PANCREAS
0.453857791225%	3	661	54	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TCR_SIGNALING
0.453857791225%	3	661	53	T2D_GENES_TANYA_GLYCEMIC	ZHU_CMV_8_HR_DN
0.453857791225%	3	661	53	T2D_GENES_TANYA_GLYCEMIC	ISHIDA_E2F_TARGETS
0.453857791225%	3	661	52	T2D_GENES_TANYA_GLYCEMIC	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN
0.453857791225%	3	661	52	T2D_GENES_TANYA_GLYCEMIC	ROSS_AML_WITH_CBFB_MYH11_FUSION
0.453857791225%	3	661	52	T2D_GENES_TANYA_GLYCEMIC	PID_CASPASE_PATHWAY
0.453857791225%	3	661	52	T2D_GENES_TANYA_GLYCEMIC	KEGG_STARCH_AND_SUCROSE_METABOLISM
0.453857791225%	3	661	52	T2D_GENES_TANYA_GLYCEMIC	CHIBA_RESPONSE_TO_TSA_UP
0.453857791225%	3	661	52	T2D_GENES_TANYA_GLYCEMIC	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN
0.453857791225%	3	661	52	T2D_GENES_TANYA_GLYCEMIC	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
0.453857791225%	3	661	51	T2D_GENES_TANYA_GLYCEMIC	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
0.453857791225%	3	661	51	T2D_GENES_TANYA_GLYCEMIC	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
0.453857791225%	3	661	51	T2D_GENES_TANYA_GLYCEMIC	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT
0.453857791225%	3	661	51	T2D_GENES_TANYA_GLYCEMIC	MORI_PLASMA_CELL_UP
0.453857791225%	3	661	51	T2D_GENES_TANYA_GLYCEMIC	LUI_THYROID_CANCER_CLUSTER_1
0.453857791225%	3	661	51	T2D_GENES_TANYA_GLYCEMIC	GUILLAUMOND_KLF10_TARGETS_UP
0.453857791225%	3	661	51	T2D_GENES_TANYA_GLYCEMIC	APPIERTO_RESPONSE_TO_FENRETINIDE_DN
0.453857791225%	3	661	50	T2D_GENES_TANYA_GLYCEMIC	MARTINEZ_RESPONSE_TO_TRABECTEDIN
0.453857791225%	3	661	50	T2D_GENES_TANYA_GLYCEMIC	KANG_GIST_WITH_PDGFRA_UP
0.453857791225%	3	661	50	T2D_GENES_TANYA_GLYCEMIC	CHIBA_RESPONSE_TO_TSA
0.453857791225%	3	661	49	T2D_GENES_TANYA_GLYCEMIC	ZHAN_MULTIPLE_MYELOMA_HP_UP
0.453857791225%	3	661	49	T2D_GENES_TANYA_GLYCEMIC	REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS
0.453857791225%	3	661	49	T2D_GENES_TANYA_GLYCEMIC	PID_FOXOPATHWAY
0.453857791225%	3	661	49	T2D_GENES_TANYA_GLYCEMIC	KEGG_GLYCEROLIPID_METABOLISM
0.453857791225%	3	661	49	T2D_GENES_TANYA_GLYCEMIC	GERHOLD_ADIPOGENESIS_UP
0.453857791225%	3	661	49	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_TCR_PATHWAY
0.453857791225%	3	661	48	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MUSCLE_CONTRACTION
0.453857791225%	3	661	48	T2D_GENES_TANYA_GLYCEMIC	RASHI_RESPONSE_TO_IONIZING_RADIATION_3
0.453857791225%	3	661	48	T2D_GENES_TANYA_GLYCEMIC	PID_HES_HEYPATHWAY
0.453857791225%	3	661	47	T2D_GENES_TANYA_GLYCEMIC	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP
0.453857791225%	3	661	47	T2D_GENES_TANYA_GLYCEMIC	MELLMAN_TUT1_TARGETS_DN
0.453857791225%	3	661	47	T2D_GENES_TANYA_GLYCEMIC	IRITANI_MAD1_TARGETS_DN
0.453857791225%	3	661	46	T2D_GENES_TANYA_GLYCEMIC	ZHAN_MULTIPLE_MYELOMA_MS_DN
0.453857791225%	3	661	46	T2D_GENES_TANYA_GLYCEMIC	SESTO_RESPONSE_TO_UV_C5
0.453857791225%	3	661	46	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
0.453857791225%	3	661	46	T2D_GENES_TANYA_GLYCEMIC	PID_TNFPATHWAY
0.453857791225%	3	661	46	T2D_GENES_TANYA_GLYCEMIC	PID_A6B1_A6B4_INTEGRIN_PATHWAY
0.453857791225%	3	661	46	T2D_GENES_TANYA_GLYCEMIC	NUTT_GBM_VS_AO_GLIOMA_UP
0.453857791225%	3	661	46	T2D_GENES_TANYA_GLYCEMIC	LEE_AGING_MUSCLE_DN
0.453857791225%	3	661	46	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_KERATINOCYTE_PATHWAY
0.453857791225%	3	661	45	T2D_GENES_TANYA_GLYCEMIC	ST_T_CELL_SIGNAL_TRANSDUCTION
0.453857791225%	3	661	45	T2D_GENES_TANYA_GLYCEMIC	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
0.453857791225%	3	661	45	T2D_GENES_TANYA_GLYCEMIC	NUTT_GBM_VS_AO_GLIOMA_DN
0.453857791225%	3	661	45	T2D_GENES_TANYA_GLYCEMIC	KLEIN_TARGETS_OF_BCR_ABL1_FUSION
0.453857791225%	3	661	45	T2D_GENES_TANYA_GLYCEMIC	GRADE_METASTASIS_DN
0.453857791225%	3	661	45	T2D_GENES_TANYA_GLYCEMIC	ABRAMSON_INTERACT_WITH_AIRE
0.453857791225%	3	661	44	T2D_GENES_TANYA_GLYCEMIC	STREICHER_LSM1_TARGETS_UP
0.453857791225%	3	661	44	T2D_GENES_TANYA_GLYCEMIC	PID_ERBB2ERBB3PATHWAY
0.453857791225%	3	661	44	T2D_GENES_TANYA_GLYCEMIC	MEDINA_SMARCA4_TARGETS
0.453857791225%	3	661	44	T2D_GENES_TANYA_GLYCEMIC	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM
0.453857791225%	3	661	44	T2D_GENES_TANYA_GLYCEMIC	HARRIS_BRAIN_CANCER_PROGENITORS
0.453857791225%	3	661	43	T2D_GENES_TANYA_GLYCEMIC	RIZ_ERYTHROID_DIFFERENTIATION_12HR
0.453857791225%	3	661	43	T2D_GENES_TANYA_GLYCEMIC	PID_THROMBIN_PAR1_PATHWAY
0.453857791225%	3	661	43	T2D_GENES_TANYA_GLYCEMIC	LEE_CALORIE_RESTRICTION_MUSCLE_UP
0.453857791225%	3	661	43	T2D_GENES_TANYA_GLYCEMIC	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
0.453857791225%	3	661	42	T2D_GENES_TANYA_GLYCEMIC	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
0.453857791225%	3	661	42	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRNA_AMINOACYLATION
0.453857791225%	3	661	42	T2D_GENES_TANYA_GLYCEMIC	PID_ECADHERIN_STABILIZATION_PATHWAY
0.453857791225%	3	661	42	T2D_GENES_TANYA_GLYCEMIC	LUI_THYROID_CANCER_CLUSTER_2
0.453857791225%	3	661	42	T2D_GENES_TANYA_GLYCEMIC	KEGG_BLADDER_CANCER
0.453857791225%	3	661	41	T2D_GENES_TANYA_GLYCEMIC	REACTOME_IL_2_SIGNALING
0.453857791225%	3	661	41	T2D_GENES_TANYA_GLYCEMIC	PID_AMB2_NEUTROPHILS_PATHWAY
0.453857791225%	3	661	41	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_FCER1_PATHWAY
0.453857791225%	3	661	40	T2D_GENES_TANYA_GLYCEMIC	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.453857791225%	3	661	40	T2D_GENES_TANYA_GLYCEMIC	TOMLINS_PROSTATE_CANCER_UP
0.453857791225%	3	661	40	T2D_GENES_TANYA_GLYCEMIC	KEGG_TRYPTOPHAN_METABOLISM
0.453857791225%	3	661	39	T2D_GENES_TANYA_GLYCEMIC	WANG_LSD1_TARGETS_DN
0.453857791225%	3	661	39	T2D_GENES_TANYA_GLYCEMIC	NEWMAN_ERCC6_TARGETS_DN
0.453857791225%	3	661	39	T2D_GENES_TANYA_GLYCEMIC	MA_MYELOID_DIFFERENTIATION_UP
0.453857791225%	3	661	38	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS
0.453857791225%	3	661	38	T2D_GENES_TANYA_GLYCEMIC	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN
0.453857791225%	3	661	38	T2D_GENES_TANYA_GLYCEMIC	CHANDRAN_METASTASIS_TOP50_UP
0.453857791225%	3	661	38	T2D_GENES_TANYA_GLYCEMIC	CERVERA_SDHB_TARGETS_1_DN
0.453857791225%	3	661	37	T2D_GENES_TANYA_GLYCEMIC	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN
0.453857791225%	3	661	37	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS
0.453857791225%	3	661	37	T2D_GENES_TANYA_GLYCEMIC	MURAKAMI_UV_RESPONSE_6HR_UP
0.453857791225%	3	661	37	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_PAR1_PATHWAY
0.453857791225%	3	661	37	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_GPCR_PATHWAY
0.453857791225%	3	661	37	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_BCR_PATHWAY
0.453857791225%	3	661	36	T2D_GENES_TANYA_GLYCEMIC	ST_ADRENERGIC
0.453857791225%	3	661	36	T2D_GENES_TANYA_GLYCEMIC	HOUSTIS_ROS
0.453857791225%	3	661	36	T2D_GENES_TANYA_GLYCEMIC	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP
0.453857791225%	3	661	35	T2D_GENES_TANYA_GLYCEMIC	KEGG_BASE_EXCISION_REPAIR
0.453857791225%	3	661	34	T2D_GENES_TANYA_GLYCEMIC	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE
0.453857791225%	3	661	33	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RNA_POL_III_TRANSCRIPTION
0.453857791225%	3	661	33	T2D_GENES_TANYA_GLYCEMIC	DORN_ADENOVIRUS_INFECTION_12HR_DN
0.453857791225%	3	661	32	T2D_GENES_TANYA_GLYCEMIC	REACTOME_DAG_AND_IP3_SIGNALING
0.453857791225%	3	661	32	T2D_GENES_TANYA_GLYCEMIC	PID_WNT_NONCANONICAL_PATHWAY
0.453857791225%	3	661	32	T2D_GENES_TANYA_GLYCEMIC	LIANG_SILENCED_BY_METHYLATION_UP
0.453857791225%	3	661	32	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_RHO_PATHWAY
0.453857791225%	3	661	31	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_PYK2_PATHWAY
0.453857791225%	3	661	31	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_MYOSIN_PATHWAY
0.453857791225%	3	661	30	T2D_GENES_TANYA_GLYCEMIC	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
0.453857791225%	3	661	30	T2D_GENES_TANYA_GLYCEMIC	URS_ADIPOCYTE_DIFFERENTIATION_DN
0.453857791225%	3	661	30	T2D_GENES_TANYA_GLYCEMIC	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN
0.453857791225%	3	661	30	T2D_GENES_TANYA_GLYCEMIC	PID_IGF1_PATHWAY
0.453857791225%	3	661	30	T2D_GENES_TANYA_GLYCEMIC	PID_CDC42_REG_PATHWAY
0.453857791225%	3	661	30	T2D_GENES_TANYA_GLYCEMIC	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.453857791225%	3	661	30	T2D_GENES_TANYA_GLYCEMIC	KYNG_NORMAL_AGING_DN
0.453857791225%	3	661	290	T2D_GENES_TANYA_GLYCEMIC	BENPORATH_OCT4_TARGETS
0.453857791225%	3	661	29	T2D_GENES_TANYA_GLYCEMIC	WATANABE_COLON_CANCER_MSI_VS_MSS_UP
0.453857791225%	3	661	29	T2D_GENES_TANYA_GLYCEMIC	KYNG_WERNER_SYNDROM_DN
0.453857791225%	3	661	29	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_VIP_PATHWAY
0.453857791225%	3	661	284	T2D_GENES_TANYA_GLYCEMIC	REACTOME_METABOLISM_OF_MRNA
0.453857791225%	3	661	281	T2D_GENES_TANYA_GLYCEMIC	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
0.453857791225%	3	661	28	T2D_GENES_TANYA_GLYCEMIC	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP
0.453857791225%	3	661	27	T2D_GENES_TANYA_GLYCEMIC	ST_GRANULE_CELL_SURVIVAL_PATHWAY
0.453857791225%	3	661	27	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES
0.453857791225%	3	661	27	T2D_GENES_TANYA_GLYCEMIC	OHM_METHYLATED_IN_ADULT_CANCERS
0.453857791225%	3	661	26	T2D_GENES_TANYA_GLYCEMIC	PID_RXR_VDR_PATHWAY
0.453857791225%	3	661	26	T2D_GENES_TANYA_GLYCEMIC	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.453857791225%	3	661	26	T2D_GENES_TANYA_GLYCEMIC	KEGG_GALACTOSE_METABOLISM
0.453857791225%	3	661	26	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_BAD_PATHWAY
0.453857791225%	3	661	26	T2D_GENES_TANYA_GLYCEMIC	ABBUD_LIF_SIGNALING_1_DN
0.453857791225%	3	661	25	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SMOOTH_MUSCLE_CONTRACTION
0.453857791225%	3	661	24	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_ECM_PATHWAY
0.453857791225%	3	661	23	T2D_GENES_TANYA_GLYCEMIC	ST_GA12_PATHWAY
0.453857791225%	3	661	23	T2D_GENES_TANYA_GLYCEMIC	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER
0.453857791225%	3	661	23	T2D_GENES_TANYA_GLYCEMIC	MAHADEVAN_IMATINIB_RESISTANCE_UP
0.453857791225%	3	661	23	T2D_GENES_TANYA_GLYCEMIC	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.453857791225%	3	661	23	T2D_GENES_TANYA_GLYCEMIC	CHIBA_RESPONSE_TO_TSA_DN
0.453857791225%	3	661	23	T2D_GENES_TANYA_GLYCEMIC	BILANGES_SERUM_SENSITIVE_VIA_TSC1
0.453857791225%	3	661	227	T2D_GENES_TANYA_GLYCEMIC	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.453857791225%	3	661	223	T2D_GENES_TANYA_GLYCEMIC	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.453857791225%	3	661	222	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRANSLATION
0.453857791225%	3	661	220	T2D_GENES_TANYA_GLYCEMIC	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
0.453857791225%	3	661	22	T2D_GENES_TANYA_GLYCEMIC	WEBER_METHYLATED_ICP_IN_FIBROBLAST
0.453857791225%	3	661	22	T2D_GENES_TANYA_GLYCEMIC	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP
0.453857791225%	3	661	22	T2D_GENES_TANYA_GLYCEMIC	TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.453857791225%	3	661	22	T2D_GENES_TANYA_GLYCEMIC	REACTOME_METAL_ION_SLC_TRANSPORTERS
0.453857791225%	3	661	22	T2D_GENES_TANYA_GLYCEMIC	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
0.453857791225%	3	661	22	T2D_GENES_TANYA_GLYCEMIC	NUMATA_CSF3_SIGNALING_VIA_STAT3
0.453857791225%	3	661	22	T2D_GENES_TANYA_GLYCEMIC	KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS
0.453857791225%	3	661	217	T2D_GENES_TANYA_GLYCEMIC	WONG_MITOCHONDRIA_GENE_MODULE
0.453857791225%	3	661	21	T2D_GENES_TANYA_GLYCEMIC	STEGER_ADIPOGENESIS_UP
0.453857791225%	3	661	21	T2D_GENES_TANYA_GLYCEMIC	PID_ECADHERIN_KERATINOCYTE_PATHWAY
0.453857791225%	3	661	201	T2D_GENES_TANYA_GLYCEMIC	HOLLMANN_APOPTOSIS_VIA_CD40_UP
0.453857791225%	3	661	198	T2D_GENES_TANYA_GLYCEMIC	WELCSH_BRCA1_TARGETS_UP
0.453857791225%	3	661	19	T2D_GENES_TANYA_GLYCEMIC	REACTOME_LAGGING_STRAND_SYNTHESIS
0.453857791225%	3	661	19	T2D_GENES_TANYA_GLYCEMIC	KANG_CISPLATIN_RESISTANCE_UP
0.453857791225%	3	661	19	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_MAL_PATHWAY
0.453857791225%	3	661	182	T2D_GENES_TANYA_GLYCEMIC	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
0.453857791225%	3	661	181	T2D_GENES_TANYA_GLYCEMIC	JISON_SICKLE_CELL_DISEASE_UP
0.453857791225%	3	661	178	T2D_GENES_TANYA_GLYCEMIC	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
0.453857791225%	3	661	176	T2D_GENES_TANYA_GLYCEMIC	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
0.453857791225%	3	661	175	T2D_GENES_TANYA_GLYCEMIC	LEE_LIVER_CANCER_SURVIVAL_DN
0.453857791225%	3	661	170	T2D_GENES_TANYA_GLYCEMIC	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
0.453857791225%	3	661	17	T2D_GENES_TANYA_GLYCEMIC	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
0.453857791225%	3	661	17	T2D_GENES_TANYA_GLYCEMIC	LIU_IL13_MEMORY_MODEL_UP
0.453857791225%	3	661	166	T2D_GENES_TANYA_GLYCEMIC	SMIRNOV_RESPONSE_TO_IR_6HR_UP
0.453857791225%	3	661	163	T2D_GENES_TANYA_GLYCEMIC	LIN_NPAS4_TARGETS_UP
0.453857791225%	3	661	163	T2D_GENES_TANYA_GLYCEMIC	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
0.453857791225%	3	661	161	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MRNA_PROCESSING
0.453857791225%	3	661	161	T2D_GENES_TANYA_GLYCEMIC	BIDUS_METASTASIS_DN
0.453857791225%	3	661	160	T2D_GENES_TANYA_GLYCEMIC	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
0.453857791225%	3	661	16	T2D_GENES_TANYA_GLYCEMIC	WANG_RECURRENT_LIVER_CANCER_DN
0.453857791225%	3	661	159	T2D_GENES_TANYA_GLYCEMIC	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
0.453857791225%	3	661	158	T2D_GENES_TANYA_GLYCEMIC	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON
0.453857791225%	3	661	157	T2D_GENES_TANYA_GLYCEMIC	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
0.453857791225%	3	661	156	T2D_GENES_TANYA_GLYCEMIC	FOSTER_TOLERANT_MACROPHAGE_UP
0.453857791225%	3	661	151	T2D_GENES_TANYA_GLYCEMIC	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
0.453857791225%	3	661	150	T2D_GENES_TANYA_GLYCEMIC	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
0.453857791225%	3	661	15	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ZINC_TRANSPORTERS
0.453857791225%	3	661	15	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND
0.453857791225%	3	661	15	T2D_GENES_TANYA_GLYCEMIC	EHRLICH_ICF_SYNDROM_DN
0.453857791225%	3	661	149	T2D_GENES_TANYA_GLYCEMIC	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
0.453857791225%	3	661	149	T2D_GENES_TANYA_GLYCEMIC	TSAI_RESPONSE_TO_IONIZING_RADIATION
0.453857791225%	3	661	149	T2D_GENES_TANYA_GLYCEMIC	OHGUCHI_LIVER_HNF4A_TARGETS_DN
0.453857791225%	3	661	147	T2D_GENES_TANYA_GLYCEMIC	WHITFIELD_CELL_CYCLE_G1_S
0.453857791225%	3	661	147	T2D_GENES_TANYA_GLYCEMIC	BENPORATH_PROLIFERATION
0.453857791225%	3	661	146	T2D_GENES_TANYA_GLYCEMIC	PECE_MAMMARY_STEM_CELL_UP
0.453857791225%	3	661	146	T2D_GENES_TANYA_GLYCEMIC	PECE_MAMMARY_STEM_CELL_DN
0.453857791225%	3	661	146	T2D_GENES_TANYA_GLYCEMIC	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
0.453857791225%	3	661	146	T2D_GENES_TANYA_GLYCEMIC	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
0.453857791225%	3	661	145	T2D_GENES_TANYA_GLYCEMIC	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
0.453857791225%	3	661	142	T2D_GENES_TANYA_GLYCEMIC	RUIZ_TNC_TARGETS_DN
0.453857791225%	3	661	142	T2D_GENES_TANYA_GLYCEMIC	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
0.453857791225%	3	661	141	T2D_GENES_TANYA_GLYCEMIC	KAAB_FAILED_HEART_ATRIUM_DN
0.453857791225%	3	661	140	T2D_GENES_TANYA_GLYCEMIC	JOHNSTONE_PARVB_TARGETS_2_UP
0.453857791225%	3	661	140	T2D_GENES_TANYA_GLYCEMIC	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
0.453857791225%	3	661	14	T2D_GENES_TANYA_GLYCEMIC	TOMLINS_METASTASIS_UP
0.453857791225%	3	661	14	T2D_GENES_TANYA_GLYCEMIC	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
0.453857791225%	3	661	139	T2D_GENES_TANYA_GLYCEMIC	HOELZEL_NF1_TARGETS_UP
0.453857791225%	3	661	138	T2D_GENES_TANYA_GLYCEMIC	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
0.453857791225%	3	661	138	T2D_GENES_TANYA_GLYCEMIC	JIANG_VHL_TARGETS
0.453857791225%	3	661	138	T2D_GENES_TANYA_GLYCEMIC	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
0.453857791225%	3	661	137	T2D_GENES_TANYA_GLYCEMIC	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
0.453857791225%	3	661	137	T2D_GENES_TANYA_GLYCEMIC	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
0.453857791225%	3	661	136	T2D_GENES_TANYA_GLYCEMIC	WIERENGA_STAT5A_TARGETS_GROUP1
0.453857791225%	3	661	136	T2D_GENES_TANYA_GLYCEMIC	PROVENZANI_METASTASIS_DN
0.453857791225%	3	661	135	T2D_GENES_TANYA_GLYCEMIC	TSENG_IRS1_TARGETS_DN
0.453857791225%	3	661	134	T2D_GENES_TANYA_GLYCEMIC	KEGG_TIGHT_JUNCTION
0.453857791225%	3	661	134	T2D_GENES_TANYA_GLYCEMIC	CHUNG_BLISTER_CYTOTOXICITY_UP
0.453857791225%	3	661	132	T2D_GENES_TANYA_GLYCEMIC	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
0.453857791225%	3	661	131	T2D_GENES_TANYA_GLYCEMIC	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.453857791225%	3	661	129	T2D_GENES_TANYA_GLYCEMIC	KIM_WT1_TARGETS_8HR_DN
0.453857791225%	3	661	128	T2D_GENES_TANYA_GLYCEMIC	POTTI_TOPOTECAN_SENSITIVITY
0.453857791225%	3	661	127	T2D_GENES_TANYA_GLYCEMIC	INGRAM_SHH_TARGETS_UP
0.453857791225%	3	661	126	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
0.453857791225%	3	661	126	T2D_GENES_TANYA_GLYCEMIC	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.453857791225%	3	661	125	T2D_GENES_TANYA_GLYCEMIC	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
0.453857791225%	3	661	121	T2D_GENES_TANYA_GLYCEMIC	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP
0.453857791225%	3	661	120	T2D_GENES_TANYA_GLYCEMIC	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.453857791225%	3	661	12	T2D_GENES_TANYA_GLYCEMIC	TAGHAVI_NEOPLASTIC_TRANSFORMATION
0.453857791225%	3	661	118	T2D_GENES_TANYA_GLYCEMIC	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
0.453857791225%	3	661	116	T2D_GENES_TANYA_GLYCEMIC	WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.453857791225%	3	661	116	T2D_GENES_TANYA_GLYCEMIC	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
0.453857791225%	3	661	115	T2D_GENES_TANYA_GLYCEMIC	MARZEC_IL2_SIGNALING_UP
0.453857791225%	3	661	115	T2D_GENES_TANYA_GLYCEMIC	MARKEY_RB1_CHRONIC_LOF_UP
0.453857791225%	3	661	115	T2D_GENES_TANYA_GLYCEMIC	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
0.453857791225%	3	661	114	T2D_GENES_TANYA_GLYCEMIC	ROPERO_HDAC2_TARGETS
0.453857791225%	3	661	113	T2D_GENES_TANYA_GLYCEMIC	RICKMAN_HEAD_AND_NECK_CANCER_C
0.453857791225%	3	661	112	T2D_GENES_TANYA_GLYCEMIC	REACTOME_G1_S_TRANSITION
0.453857791225%	3	661	111	T2D_GENES_TANYA_GLYCEMIC	WANG_HCP_PROSTATE_CANCER
0.453857791225%	3	661	111	T2D_GENES_TANYA_GLYCEMIC	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.453857791225%	3	661	11	T2D_GENES_TANYA_GLYCEMIC	ZHOU_PANCREATIC_EXOCRINE_PROGENITOR
0.453857791225%	3	661	108	T2D_GENES_TANYA_GLYCEMIC	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
0.453857791225%	3	661	108	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
0.453857791225%	3	661	108	T2D_GENES_TANYA_GLYCEMIC	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.453857791225%	3	661	107	T2D_GENES_TANYA_GLYCEMIC	ROESSLER_LIVER_CANCER_METASTASIS_UP
0.453857791225%	3	661	107	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_ILS
0.453857791225%	3	661	105	T2D_GENES_TANYA_GLYCEMIC	ZWANG_EGF_INTERVAL_UP
0.453857791225%	3	661	105	T2D_GENES_TANYA_GLYCEMIC	WOO_LIVER_CANCER_RECURRENCE_UP
0.453857791225%	3	661	105	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RNA_POL_II_TRANSCRIPTION
0.453857791225%	3	661	104	T2D_GENES_TANYA_GLYCEMIC	REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE
0.453857791225%	3	661	104	T2D_GENES_TANYA_GLYCEMIC	NAKAMURA_ADIPOGENESIS_LATE_UP
0.453857791225%	3	661	103	T2D_GENES_TANYA_GLYCEMIC	LEIN_CHOROID_PLEXUS_MARKERS
0.453857791225%	3	661	102	T2D_GENES_TANYA_GLYCEMIC	LABBE_TGFB1_TARGETS_UP
0.453857791225%	3	661	101	T2D_GENES_TANYA_GLYCEMIC	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
0.453857791225%	3	661	101	T2D_GENES_TANYA_GLYCEMIC	GRADE_COLON_AND_RECTAL_CANCER_DN
0.453857791225%	3	661	101	T2D_GENES_TANYA_GLYCEMIC	BASSO_CD40_SIGNALING_UP
0.448430493274%	2	446	99	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.448430493274%	2	446	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MENSE_HYPOXIA_UP
0.448430493274%	2	446	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HAHTOLA_SEZARY_SYNDROM_UP
0.448430493274%	2	446	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GUO_TARGETS_OF_IRS1_AND_IRS2
0.448430493274%	2	446	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CROONQUIST_IL6_DEPRIVATION_DN
0.448430493274%	2	446	97	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LABBE_WNT3A_TARGETS_DN
0.448430493274%	2	446	95	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.448430493274%	2	446	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SYNTHESIS_OF_DNA
0.448430493274%	2	446	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
0.448430493274%	2	446	91	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHU_CMV_24_HR_DN
0.448430493274%	2	446	91	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GAVIN_FOXP3_TARGETS_CLUSTER_P6
0.448430493274%	2	446	91	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
0.448430493274%	2	446	90	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_GAP_JUNCTION
0.448430493274%	2	446	90	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BILANGES_SERUM_SENSITIVE_GENES
0.448430493274%	2	446	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_FEEDER_PATHWAY
0.448430493274%	2	446	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
0.448430493274%	2	446	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LI_DCP2_BOUND_MRNA
0.448430493274%	2	446	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.448430493274%	2	446	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEIN_PONS_MARKERS
0.448430493274%	2	446	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KANG_IMMORTALIZED_BY_TERT_UP
0.448430493274%	2	446	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_RIBOSOME
0.448430493274%	2	446	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
0.448430493274%	2	446	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ALCALA_APOPTOSIS
0.448430493274%	2	446	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_ERBB_SIGNALING_PATHWAY
0.448430493274%	2	446	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.448430493274%	2	446	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
0.448430493274%	2	446	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TAKAO_RESPONSE_TO_UVB_RADIATION_UP
0.448430493274%	2	446	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_L1CAM_INTERACTIONS
0.448430493274%	2	446	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
0.448430493274%	2	446	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOEBEKE_LYMPHOID_STEM_CELL_DN
0.448430493274%	2	446	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GHANDHI_BYSTANDER_IRRADIATION_UP
0.448430493274%	2	446	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEIN_CEREBELLUM_MARKERS
0.448430493274%	2	446	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
0.448430493274%	2	446	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SMID_BREAST_CANCER_LUMINAL_A_UP
0.448430493274%	2	446	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RUAN_RESPONSE_TO_TNF_DN
0.448430493274%	2	446	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_ECM_RECEPTOR_INTERACTION
0.448430493274%	2	446	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHANG_IMMORTALIZED_BY_HPV31_UP
0.448430493274%	2	446	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.448430493274%	2	446	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ST_INTEGRIN_SIGNALING_PATHWAY
0.448430493274%	2	446	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.448430493274%	2	446	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HUANG_DASATINIB_RESISTANCE_UP
0.448430493274%	2	446	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCHUHMACHER_MYC_TARGETS_UP
0.448430493274%	2	446	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
0.448430493274%	2	446	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16
0.448430493274%	2	446	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_MYC_ACTIVPATHWAY
0.448430493274%	2	446	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MEISSNER_NPC_HCP_WITH_H3K27ME3
0.448430493274%	2	446	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MALONEY_RESPONSE_TO_17AAG_DN
0.448430493274%	2	446	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ROSS_LEUKEMIA_WITH_MLL_FUSIONS
0.448430493274%	2	446	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_OPIOID_SIGNALLING
0.448430493274%	2	446	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RADMACHER_AML_PROGNOSIS
0.448430493274%	2	446	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ROSS_AML_WITH_PML_RARA_FUSION
0.448430493274%	2	446	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RIZ_ERYTHROID_DIFFERENTIATION
0.448430493274%	2	446	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN
0.448430493274%	2	446	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION
0.448430493274%	2	446	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
0.448430493274%	2	446	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
0.448430493274%	2	446	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
0.448430493274%	2	446	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
0.448430493274%	2	446	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
0.448430493274%	2	446	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	URS_ADIPOCYTE_DIFFERENTIATION_UP
0.448430493274%	2	446	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
0.448430493274%	2	446	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_LIVER_CANCER_DENA_DN
0.448430493274%	2	446	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DER_IFN_ALPHA_RESPONSE_UP
0.448430493274%	2	446	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.448430493274%	2	446	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
0.448430493274%	2	446	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
0.448430493274%	2	446	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DANG_REGULATED_BY_MYC_UP
0.448430493274%	2	446	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CROONQUIST_NRAS_SIGNALING_DN
0.448430493274%	2	446	71	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
0.448430493274%	2	446	71	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_MELANOMA
0.448430493274%	2	446	71	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GU_PDEF_TARGETS_UP
0.448430493274%	2	446	71	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GEORGANTAS_HSC_MARKERS
0.448430493274%	2	446	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
0.448430493274%	2	446	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
0.448430493274%	2	446	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZAMORA_NOS2_TARGETS_UP
0.448430493274%	2	446	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.448430493274%	2	446	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEIN_NEURON_MARKERS
0.448430493274%	2	446	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_P53_SIGNALING_PATHWAY
0.448430493274%	2	446	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ROSS_AML_OF_FAB_M7_TYPE
0.448430493274%	2	446	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SEMAPHORIN_INTERACTIONS
0.448430493274%	2	446	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.448430493274%	2	446	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
0.448430493274%	2	446	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES
0.448430493274%	2	446	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
0.448430493274%	2	446	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.448430493274%	2	446	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ELVIDGE_HIF1A_TARGETS_UP
0.448430493274%	2	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RIGGINS_TAMOXIFEN_RESISTANCE_UP
0.448430493274%	2	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES
0.448430493274%	2	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_TCR_PATHWAY
0.448430493274%	2	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_HIF1_TFPATHWAY
0.448430493274%	2	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN
0.448430493274%	2	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.448430493274%	2	446	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.448430493274%	2	446	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ST_FAS_SIGNALING_PATHWAY
0.448430493274%	2	446	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
0.448430493274%	2	446	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_RB_1PATHWAY
0.448430493274%	2	446	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_LIVER_CANCER_ACOX1_DN
0.448430493274%	2	446	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_UP
0.448430493274%	2	446	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_LIVER_CANCER_MYC_E2F1_DN
0.448430493274%	2	446	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_LIVER_CANCER_E2F1_DN
0.448430493274%	2	446	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
0.448430493274%	2	446	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
0.448430493274%	2	446	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_ENDOTHELINPATHWAY
0.448430493274%	2	446	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
0.448430493274%	2	446	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JOHNSTONE_PARVB_TARGETS_1_DN
0.448430493274%	2	446	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.448430493274%	2	446	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_FCER1PATHWAY
0.448430493274%	2	446	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KYNG_DNA_DAMAGE_BY_UV
0.448430493274%	2	446	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KORKOLA_YOLK_SAC_TUMOR
0.448430493274%	2	446	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_COLORECTAL_CANCER
0.448430493274%	2	446	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REN_BOUND_BY_E2F
0.448430493274%	2	446	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS
0.448430493274%	2	446	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RAMASWAMY_METASTASIS_DN
0.448430493274%	2	446	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GENTILE_RESPONSE_CLUSTER_D3
0.448430493274%	2	446	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_ACUTE_MYELOID_LEUKEMIA
0.448430493274%	2	446	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN
0.448430493274%	2	446	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_FAK_PATHWAY
0.448430493274%	2	446	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ELVIDGE_HYPOXIA_BY_DMOG_DN
0.448430493274%	2	446	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DASU_IL6_SIGNALING_UP
0.448430493274%	2	446	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
0.448430493274%	2	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
0.448430493274%	2	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.448430493274%	2	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LUCAS_HNF4A_TARGETS_UP
0.448430493274%	2	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KANNAN_TP53_TARGETS_UP
0.448430493274%	2	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_PPARA_PATHWAY
0.448430493274%	2	446	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MCCLUNG_CREB1_TARGETS_DN
0.448430493274%	2	446	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DELASERNA_MYOD_TARGETS_DN
0.448430493274%	2	446	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MAYBURD_RESPONSE_TO_L663536_DN
0.448430493274%	2	446	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_NFAT_PATHWAY
0.448430493274%	2	446	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
0.448430493274%	2	446	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SU_LIVER
0.448430493274%	2	446	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_IL2_1PATHWAY
0.448430493274%	2	446	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_FGF_PATHWAY
0.448430493274%	2	446	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR
0.448430493274%	2	446	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SESTO_RESPONSE_TO_UV_C2
0.448430493274%	2	446	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_APOPTOTIC_EXECUTION_PHASE
0.448430493274%	2	446	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_INOSITOL_PHOSPHATE_METABOLISM
0.448430493274%	2	446	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_ARGININE_AND_PROLINE_METABOLISM
0.448430493274%	2	446	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHU_CMV_8_HR_DN
0.448430493274%	2	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN
0.448430493274%	2	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_KITPATHWAY
0.448430493274%	2	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_CASPASE_PATHWAY
0.448430493274%	2	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HALMOS_CEBPA_TARGETS_UP
0.448430493274%	2	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP
0.448430493274%	2	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP
0.448430493274%	2	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MORI_PLASMA_CELL_UP
0.448430493274%	2	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GUILLAUMOND_KLF10_TARGETS_UP
0.448430493274%	2	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
0.448430493274%	2	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	APPIERTO_RESPONSE_TO_FENRETINIDE_DN
0.448430493274%	2	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN
0.448430493274%	2	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.448430493274%	2	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NADERI_BREAST_CANCER_PROGNOSIS_UP
0.448430493274%	2	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KANG_GIST_WITH_PDGFRA_UP
0.448430493274%	2	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
0.448430493274%	2	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHIBA_RESPONSE_TO_TSA
0.448430493274%	2	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_HP_UP
0.448430493274%	2	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WONG_PROTEASOME_GENE_MODULE
0.448430493274%	2	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
0.448430493274%	2	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_PI3KCIPATHWAY
0.448430493274%	2	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.448430493274%	2	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	OLSSON_E2F3_TARGETS_DN
0.448430493274%	2	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MANTOVANI_VIRAL_GPCR_SIGNALING_DN
0.448430493274%	2	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.448430493274%	2	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_HEDGEHOG_GLIPATHWAY
0.448430493274%	2	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_CERAMIDE_PATHWAY
0.448430493274%	2	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PENG_GLUCOSE_DEPRIVATION_UP
0.448430493274%	2	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NADLER_OBESITY_DN
0.448430493274%	2	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GNATENKO_PLATELET_SIGNATURE
0.448430493274%	2	446	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
0.448430493274%	2	446	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP
0.448430493274%	2	446	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IRITANI_MAD1_TARGETS_DN
0.448430493274%	2	446	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_MS_DN
0.448430493274%	2	446	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_RHOA_REG_PATHWAY
0.448430493274%	2	446	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_A6B1_A6B4_INTEGRIN_PATHWAY
0.448430493274%	2	446	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_AGING_MUSCLE_DN
0.448430493274%	2	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_PR_UP
0.448430493274%	2	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ST_T_CELL_SIGNAL_TRANSDUCTION
0.448430493274%	2	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_INSULIN_PATHWAY
0.448430493274%	2	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRADE_METASTASIS_DN
0.448430493274%	2	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_BIOPEPTIDES_PATHWAY
0.448430493274%	2	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZUCCHI_METASTASIS_DN
0.448430493274%	2	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS
0.448430493274%	2	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHUNG_BLISTER_CYTOTOXICITY_DN
0.448430493274%	2	446	435	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SWEET_LUNG_CANCER_KRAS_DN
0.448430493274%	2	446	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1
0.448430493274%	2	446	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PLC_BETA_MEDIATED_EVENTS
0.448430493274%	2	446	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.448430493274%	2	446	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_CALORIE_RESTRICTION_MUSCLE_UP
0.448430493274%	2	446	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
0.448430493274%	2	446	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TRNA_AMINOACYLATION
0.448430493274%	2	446	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_ECADHERIN_STABILIZATION_PATHWAY
0.448430493274%	2	446	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LUI_THYROID_CANCER_CLUSTER_2
0.448430493274%	2	446	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_CHREBP2_PATHWAY
0.448430493274%	2	446	414	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LU_EZH2_TARGETS_DN
0.448430493274%	2	446	411	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KOYAMA_SEMA3B_TARGETS_DN
0.448430493274%	2	446	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_ER_NONGENOMIC_PATHWAY
0.448430493274%	2	446	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_AMB2_NEUTROPHILS_PATHWAY
0.448430493274%	2	446	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS
0.448430493274%	2	446	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
0.448430493274%	2	446	408	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_GPCR_LIGAND_BINDING
0.448430493274%	2	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VARELA_ZMPSTE24_TARGETS_UP
0.448430493274%	2	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
0.448430493274%	2	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_IFNGPATHWAY
0.448430493274%	2	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ELLWOOD_MYC_TARGETS_DN
0.448430493274%	2	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHANGOLKAR_H2AFY_TARGETS_DN
0.448430493274%	2	446	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	POTTI_PACLITAXEL_SENSITIVITY
0.448430493274%	2	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN
0.448430493274%	2	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHANDRAN_METASTASIS_TOP50_UP
0.448430493274%	2	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_GPCR_PATHWAY
0.448430493274%	2	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BILANGES_SERUM_RESPONSE_TRANSLATION
0.448430493274%	2	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARZEC_IL2_SIGNALING_DN
0.448430493274%	2	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_AGR_PATHWAY
0.448430493274%	2	446	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
0.448430493274%	2	446	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HU_GENOTOXIC_DAMAGE_4HR
0.448430493274%	2	446	349	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3
0.448430493274%	2	446	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SIG_CD40PATHWAYMAP
0.448430493274%	2	446	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION
0.448430493274%	2	446	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_EPOPATHWAY
0.448430493274%	2	446	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_EPHA_FWDPATHWAY
0.448430493274%	2	446	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JIANG_HYPOXIA_VIA_VHL
0.448430493274%	2	446	335	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WONG_EMBRYONIC_STEM_CELL_CORE
0.448430493274%	2	446	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_RNA_POL_III_TRANSCRIPTION
0.448430493274%	2	446	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PURINE_METABOLISM
0.448430493274%	2	446	321	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN
0.448430493274%	2	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_WNT_NONCANONICAL_PATHWAY
0.448430493274%	2	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_NETRIN_PATHWAY
0.448430493274%	2	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN
0.448430493274%	2	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM
0.448430493274%	2	446	317	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BRUINS_UVC_RESPONSE_EARLY_LATE
0.448430493274%	2	446	316	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
0.448430493274%	2	446	315	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.448430493274%	2	446	315	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PASINI_SUZ12_TARGETS_DN
0.448430493274%	2	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VALK_AML_CLUSTER_15
0.448430493274%	2	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	THEODOROU_MAMMARY_TUMORIGENESIS
0.448430493274%	2	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES
0.448430493274%	2	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MOSERLE_IFNA_RESPONSE
0.448430493274%	2	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.448430493274%	2	446	306	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHANDRAN_METASTASIS_DN
0.448430493274%	2	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN
0.448430493274%	2	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CA_DEPENDENT_EVENTS
0.448430493274%	2	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.448430493274%	2	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KYNG_NORMAL_AGING_DN
0.448430493274%	2	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP
0.448430493274%	2	446	298	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
0.448430493274%	2	446	296	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DURAND_STROMA_MAX_UP
0.448430493274%	2	446	290	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BENPORATH_OCT4_TARGETS
0.448430493274%	2	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WATANABE_COLON_CANCER_MSI_VS_MSS_UP
0.448430493274%	2	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KYNG_WERNER_SYNDROM_DN
0.448430493274%	2	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_THYROID_CANCER
0.448430493274%	2	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_VIP_PATHWAY
0.448430493274%	2	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_VEGF_PATHWAY
0.448430493274%	2	446	289	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GABRIELY_MIR21_TARGETS
0.448430493274%	2	446	289	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP
0.448430493274%	2	446	284	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_METABOLISM_OF_MRNA
0.448430493274%	2	446	281	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MULLIGHAN_MLL_SIGNATURE_2_DN
0.448430493274%	2	446	281	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
0.448430493274%	2	446	279	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_INNATE_IMMUNE_SYSTEM
0.448430493274%	2	446	272	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
0.448430493274%	2	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ST_GRANULE_CELL_SURVIVAL_PATHWAY
0.448430493274%	2	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN
0.448430493274%	2	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GROSS_ELK3_TARGETS_UP
0.448430493274%	2	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.448430493274%	2	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_CREB_PATHWAY
0.448430493274%	2	446	268	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	XU_GH1_AUTOCRINE_TARGETS_UP
0.448430493274%	2	446	267	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_MAPK_SIGNALING_PATHWAY
0.448430493274%	2	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_VEGFR1_PATHWAY
0.448430493274%	2	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_RXR_VDR_PATHWAY
0.448430493274%	2	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BRACHAT_RESPONSE_TO_METHOTREXATE_UP
0.448430493274%	2	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_BAD_PATHWAY
0.448430493274%	2	446	258	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JAEGER_METASTASIS_DN
0.448430493274%	2	446	256	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ONDER_CDH1_TARGETS_2_UP
0.448430493274%	2	446	252	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.448430493274%	2	446	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP
0.448430493274%	2	446	249	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP
0.448430493274%	2	446	246	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VERHAAK_AML_WITH_NPM1_MUTATED_DN
0.448430493274%	2	446	242	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WINTER_HYPOXIA_METAGENE
0.448430493274%	2	446	242	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MULLIGHAN_MLL_SIGNATURE_1_DN
0.448430493274%	2	446	242	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
0.448430493274%	2	446	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION
0.448430493274%	2	446	239	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ALFANO_MYC_TARGETS
0.448430493274%	2	446	237	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.448430493274%	2	446	235	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RUTELLA_RESPONSE_TO_HGF_DN
0.448430493274%	2	446	232	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DELYS_THYROID_CANCER_DN
0.448430493274%	2	446	230	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	COLDREN_GEFITINIB_RESISTANCE_DN
0.448430493274%	2	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS
0.448430493274%	2	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_NITROGEN_METABOLISM
0.448430493274%	2	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHIBA_RESPONSE_TO_TSA_DN
0.448430493274%	2	446	229	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
0.448430493274%	2	446	229	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
0.448430493274%	2	446	229	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
0.448430493274%	2	446	226	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KYNG_DNA_DAMAGE_UP
0.448430493274%	2	446	225	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_16HR_UP
0.448430493274%	2	446	222	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TRANSLATION
0.448430493274%	2	446	221	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PEDRIOLI_MIR31_TARGETS_UP
0.448430493274%	2	446	220	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RIGGINS_TAMOXIFEN_RESISTANCE_DN
0.448430493274%	2	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WEBER_METHYLATED_ICP_IN_FIBROBLAST
0.448430493274%	2	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP
0.448430493274%	2	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_METAL_ION_SLC_TRANSPORTERS
0.448430493274%	2	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
0.448430493274%	2	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS
0.448430493274%	2	446	217	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AMUNDSON_RESPONSE_TO_ARSENITE
0.448430493274%	2	446	216	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WHITFIELD_CELL_CYCLE_G2_M
0.448430493274%	2	446	216	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
0.448430493274%	2	446	214	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_WT1_TARGETS_UP
0.448430493274%	2	446	211	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
0.448430493274%	2	446	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_TUMOR_INVASIVENESS_DN
0.448430493274%	2	446	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.448430493274%	2	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP
0.448430493274%	2	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	STEGER_ADIPOGENESIS_UP
0.448430493274%	2	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING
0.448430493274%	2	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_S1P_S1P1_PATHWAY
0.448430493274%	2	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_ECADHERIN_KERATINOCYTE_PATHWAY
0.448430493274%	2	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	OUYANG_PROSTATE_CANCER_PROGRESSION_DN
0.448430493274%	2	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MACLACHLAN_BRCA1_TARGETS_UP
0.448430493274%	2	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_IGF1_PATHWAY
0.448430493274%	2	446	209	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_WT1_TARGETS_12HR_DN
0.448430493274%	2	446	209	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GROSS_HYPOXIA_VIA_ELK3_UP
0.448430493274%	2	446	208	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
0.448430493274%	2	446	207	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KARLSSON_TGFB1_TARGETS_DN
0.448430493274%	2	446	206	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RAMALHO_STEMNESS_UP
0.448430493274%	2	446	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WENG_POR_TARGETS_GLOBAL_UP
0.448430493274%	2	446	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ST_WNT_CA2_CYCLIC_GMP_PATHWAY
0.448430493274%	2	446	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MAHADEVAN_RESPONSE_TO_MP470_UP
0.448430493274%	2	446	198	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WELCSH_BRCA1_TARGETS_UP
0.448430493274%	2	446	198	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PHOSPHOLIPID_METABOLISM
0.448430493274%	2	446	196	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP
0.448430493274%	2	446	196	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
0.448430493274%	2	446	195	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
0.448430493274%	2	446	195	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.448430493274%	2	446	194	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KASLER_HDAC7_TARGETS_1_UP
0.448430493274%	2	446	191	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAGI_AML_FAB_MARKERS
0.448430493274%	2	446	190	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.448430493274%	2	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_STATHMIN_PATHWAY
0.448430493274%	2	446	189	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BURTON_ADIPOGENESIS_6
0.448430493274%	2	446	188	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
0.448430493274%	2	446	185	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHANG_TLX_TARGETS_36HR_DN
0.448430493274%	2	446	185	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.448430493274%	2	446	185	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
0.448430493274%	2	446	185	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DARWICHE_SKIN_TUMOR_PROMOTER_DN
0.448430493274%	2	446	185	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
0.448430493274%	2	446	183	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_ENDOCYTOSIS
0.448430493274%	2	446	182	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WHITFIELD_CELL_CYCLE_G2
0.448430493274%	2	446	182	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
0.448430493274%	2	446	181	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
0.448430493274%	2	446	181	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
0.448430493274%	2	446	180	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN
0.448430493274%	2	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB
0.448430493274%	2	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOWIE_RESPONSE_TO_TAMOXIFEN
0.448430493274%	2	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_CARDIACEGF_PATHWAY
0.448430493274%	2	446	178	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_CALCIUM_SIGNALING_PATHWAY
0.448430493274%	2	446	178	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
0.448430493274%	2	446	178	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_18HR_UP
0.448430493274%	2	446	176	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
0.448430493274%	2	446	175	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.448430493274%	2	446	172	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
0.448430493274%	2	446	172	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SMID_BREAST_CANCER_LUMINAL_B_UP
0.448430493274%	2	446	172	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_MITOTIC_M_M_G1_PHASES
0.448430493274%	2	446	170	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.448430493274%	2	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
0.448430493274%	2	446	169	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ONDER_CDH1_TARGETS_1_DN
0.448430493274%	2	446	169	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
0.448430493274%	2	446	167	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
0.448430493274%	2	446	166	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SMIRNOV_RESPONSE_TO_IR_6HR_UP
0.448430493274%	2	446	166	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CAIRO_LIVER_DEVELOPMENT_UP
0.448430493274%	2	446	165	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.448430493274%	2	446	163	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
0.448430493274%	2	446	162	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_WT1_TARGETS_12HR_UP
0.448430493274%	2	446	161	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
0.448430493274%	2	446	160	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GAVIN_FOXP3_TARGETS_CLUSTER_P3
0.448430493274%	2	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_CIRCADIANPATHWAY
0.448430493274%	2	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IGLESIAS_E2F_TARGETS_DN
0.448430493274%	2	446	159	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_PURINE_METABOLISM
0.448430493274%	2	446	157	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.448430493274%	2	446	157	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
0.448430493274%	2	446	154	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
0.448430493274%	2	446	153	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LU_AGING_BRAIN_DN
0.448430493274%	2	446	150	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_30MIN_DN
0.448430493274%	2	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN
0.448430493274%	2	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	STEINER_ERYTHROCYTE_MEMBRANE_GENES
0.448430493274%	2	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ZINC_TRANSPORTERS
0.448430493274%	2	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN
0.448430493274%	2	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_AKAPCENTROSOME_PATHWAY
0.448430493274%	2	446	149	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TSAI_RESPONSE_TO_IONIZING_RADIATION
0.448430493274%	2	446	149	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LANDIS_ERBB2_BREAST_TUMORS_324_DN
0.448430493274%	2	446	149	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
0.448430493274%	2	446	148	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WHITFIELD_CELL_CYCLE_M_G1
0.448430493274%	2	446	148	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WEI_MIR34A_TARGETS
0.448430493274%	2	446	148	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHANG_CYCLING_GENES
0.448430493274%	2	446	148	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_24HR_UP
0.448430493274%	2	446	147	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
0.448430493274%	2	446	147	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KAUFFMANN_DNA_REPLICATION_GENES
0.448430493274%	2	446	145	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.448430493274%	2	446	143	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
0.448430493274%	2	446	143	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DANG_MYC_TARGETS_UP
0.448430493274%	2	446	142	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RUIZ_TNC_TARGETS_DN
0.448430493274%	2	446	141	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.448430493274%	2	446	140	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	QI_HYPOXIA
0.448430493274%	2	446	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WEBER_METHYLATED_ICP_IN_SPERM_DN
0.448430493274%	2	446	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_S1P_S1P4_PATHWAY
0.448430493274%	2	446	138	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
0.448430493274%	2	446	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
0.448430493274%	2	446	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_P53DOWNSTREAMPATHWAY
0.448430493274%	2	446	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.448430493274%	2	446	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIU_SOX4_TARGETS_UP
0.448430493274%	2	446	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
0.448430493274%	2	446	135	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SERVITJA_LIVER_HNF1A_TARGETS_UP
0.448430493274%	2	446	134	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCHLOSSER_SERUM_RESPONSE_UP
0.448430493274%	2	446	134	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_TIGHT_JUNCTION
0.448430493274%	2	446	133	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_PARKINSONS_DISEASE
0.448430493274%	2	446	133	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GAL_LEUKEMIC_STEM_CELL_UP
0.448430493274%	2	446	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION
0.448430493274%	2	446	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN
0.448430493274%	2	446	129	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAGI_AML_SURVIVAL
0.448430493274%	2	446	129	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_AXON_GUIDANCE
0.448430493274%	2	446	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
0.448430493274%	2	446	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.448430493274%	2	446	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_SPLICEOSOME
0.448430493274%	2	446	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
0.448430493274%	2	446	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
0.448430493274%	2	446	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GERY_CEBP_TARGETS
0.448430493274%	2	446	122	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
0.448430493274%	2	446	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RODRIGUES_DCC_TARGETS_DN
0.448430493274%	2	446	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS
0.448430493274%	2	446	120	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
0.448430493274%	2	446	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM
0.448430493274%	2	446	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP
0.448430493274%	2	446	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_AKAP13_PATHWAY
0.448430493274%	2	446	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
0.448430493274%	2	446	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
0.448430493274%	2	446	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
0.448430493274%	2	446	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIM_MAMMARY_LUMINAL_MATURE_UP
0.448430493274%	2	446	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
0.448430493274%	2	446	115	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
0.448430493274%	2	446	115	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
0.448430493274%	2	446	115	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOELZEL_NF1_TARGETS_DN
0.448430493274%	2	446	114	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ROPERO_HDAC2_TARGETS
0.448430493274%	2	446	114	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.448430493274%	2	446	113	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TSENG_IRS1_TARGETS_UP
0.448430493274%	2	446	113	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RICKMAN_HEAD_AND_NECK_CANCER_C
0.448430493274%	2	446	113	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
0.448430493274%	2	446	112	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_DNA_REPAIR
0.448430493274%	2	446	112	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PASINI_SUZ12_TARGETS_UP
0.448430493274%	2	446	112	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LABBE_WNT3A_TARGETS_UP
0.448430493274%	2	446	111	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
0.448430493274%	2	446	111	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.448430493274%	2	446	111	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_12HR_UP
0.448430493274%	2	446	111	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOUDOUKHA_BOUND_BY_IGF2BP2
0.448430493274%	2	446	110	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
0.448430493274%	2	446	109	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_S_PHASE
0.448430493274%	2	446	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TAVAZOIE_METASTASIS
0.448430493274%	2	446	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.448430493274%	2	446	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JAZAG_TGFB1_SIGNALING_UP
0.448430493274%	2	446	107	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ROESSLER_LIVER_CANCER_METASTASIS_UP
0.448430493274%	2	446	105	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_RNA_POL_II_TRANSCRIPTION
0.448430493274%	2	446	105	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AMUNDSON_GENOTOXIC_SIGNATURE
0.448430493274%	2	446	104	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
0.448430493274%	2	446	104	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE
0.448430493274%	2	446	104	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NAKAMURA_ADIPOGENESIS_LATE_UP
0.448430493274%	2	446	103	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEIN_CHOROID_PLEXUS_MARKERS
0.448430493274%	2	446	103	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY
0.448430493274%	2	446	102	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_CXCR4_PATHWAY
0.448430493274%	2	446	102	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LABBE_TGFB1_TARGETS_UP
0.448430493274%	2	446	102	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.448430493274%	2	446	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_GNRH_SIGNALING_PATHWAY
0.448430493274%	2	446	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRADE_COLON_AND_RECTAL_CANCER_DN
0.448430493274%	2	446	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RICKMAN_HEAD_AND_NECK_CANCER_A
0.448430493274%	2	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP
0.43956043956%	2	455	98	T2D_GENES_TANYA_BLOODPRESSURE	GUO_TARGETS_OF_IRS1_AND_IRS2
0.43956043956%	2	455	98	T2D_GENES_TANYA_BLOODPRESSURE	GAVIN_FOXP3_TARGETS_CLUSTER_T7
0.43956043956%	2	455	97	T2D_GENES_TANYA_BLOODPRESSURE	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
0.43956043956%	2	455	97	T2D_GENES_TANYA_BLOODPRESSURE	KIM_MYC_AMPLIFICATION_TARGETS_DN
0.43956043956%	2	455	95	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
0.43956043956%	2	455	95	T2D_GENES_TANYA_BLOODPRESSURE	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
0.43956043956%	2	455	94	T2D_GENES_TANYA_BLOODPRESSURE	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5
0.43956043956%	2	455	93	T2D_GENES_TANYA_BLOODPRESSURE	ZHU_CMV_24_HR_UP
0.43956043956%	2	455	92	T2D_GENES_TANYA_BLOODPRESSURE	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
0.43956043956%	2	455	92	T2D_GENES_TANYA_BLOODPRESSURE	KIM_MYCN_AMPLIFICATION_TARGETS_UP
0.43956043956%	2	455	92	T2D_GENES_TANYA_BLOODPRESSURE	BURTON_ADIPOGENESIS_9
0.43956043956%	2	455	91	T2D_GENES_TANYA_BLOODPRESSURE	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.43956043956%	2	455	91	T2D_GENES_TANYA_BLOODPRESSURE	ELVIDGE_HIF1A_TARGETS_DN
0.43956043956%	2	455	91	T2D_GENES_TANYA_BLOODPRESSURE	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
0.43956043956%	2	455	90	T2D_GENES_TANYA_BLOODPRESSURE	SANA_TNF_SIGNALING_DN
0.43956043956%	2	455	90	T2D_GENES_TANYA_BLOODPRESSURE	GAVIN_FOXP3_TARGETS_CLUSTER_P7
0.43956043956%	2	455	89	T2D_GENES_TANYA_BLOODPRESSURE	ZHANG_TLX_TARGETS_UP
0.43956043956%	2	455	89	T2D_GENES_TANYA_BLOODPRESSURE	RICKMAN_HEAD_AND_NECK_CANCER_E
0.43956043956%	2	455	89	T2D_GENES_TANYA_BLOODPRESSURE	LEIN_PONS_MARKERS
0.43956043956%	2	455	89	T2D_GENES_TANYA_BLOODPRESSURE	KANG_IMMORTALIZED_BY_TERT_UP
0.43956043956%	2	455	88	T2D_GENES_TANYA_BLOODPRESSURE	SEIDEN_ONCOGENESIS_BY_MET
0.43956043956%	2	455	88	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.43956043956%	2	455	88	T2D_GENES_TANYA_BLOODPRESSURE	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
0.43956043956%	2	455	88	T2D_GENES_TANYA_BLOODPRESSURE	ALCALA_APOPTOSIS
0.43956043956%	2	455	87	T2D_GENES_TANYA_BLOODPRESSURE	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
0.43956043956%	2	455	87	T2D_GENES_TANYA_BLOODPRESSURE	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
0.43956043956%	2	455	87	T2D_GENES_TANYA_BLOODPRESSURE	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.43956043956%	2	455	86	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_L1CAM_INTERACTIONS
0.43956043956%	2	455	86	T2D_GENES_TANYA_BLOODPRESSURE	NGUYEN_NOTCH1_TARGETS_DN
0.43956043956%	2	455	86	T2D_GENES_TANYA_BLOODPRESSURE	NELSON_RESPONSE_TO_ANDROGEN_UP
0.43956043956%	2	455	86	T2D_GENES_TANYA_BLOODPRESSURE	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.43956043956%	2	455	86	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_TGF_BETA_SIGNALING_PATHWAY
0.43956043956%	2	455	85	T2D_GENES_TANYA_BLOODPRESSURE	XU_GH1_EXOGENOUS_TARGETS_UP
0.43956043956%	2	455	85	T2D_GENES_TANYA_BLOODPRESSURE	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
0.43956043956%	2	455	85	T2D_GENES_TANYA_BLOODPRESSURE	SANA_RESPONSE_TO_IFNG_DN
0.43956043956%	2	455	85	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE
0.43956043956%	2	455	85	T2D_GENES_TANYA_BLOODPRESSURE	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
0.43956043956%	2	455	84	T2D_GENES_TANYA_BLOODPRESSURE	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP
0.43956043956%	2	455	84	T2D_GENES_TANYA_BLOODPRESSURE	SMID_BREAST_CANCER_LUMINAL_A_UP
0.43956043956%	2	455	84	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
0.43956043956%	2	455	84	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S
0.43956043956%	2	455	84	T2D_GENES_TANYA_BLOODPRESSURE	RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.43956043956%	2	455	84	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_SMALL_CELL_LUNG_CANCER
0.43956043956%	2	455	83	T2D_GENES_TANYA_BLOODPRESSURE	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
0.43956043956%	2	455	82	T2D_GENES_TANYA_BLOODPRESSURE	PID_REG_GR_PATHWAY
0.43956043956%	2	455	82	T2D_GENES_TANYA_BLOODPRESSURE	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
0.43956043956%	2	455	82	T2D_GENES_TANYA_BLOODPRESSURE	BHAT_ESR1_TARGETS_VIA_AKT1_DN
0.43956043956%	2	455	81	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
0.43956043956%	2	455	81	T2D_GENES_TANYA_BLOODPRESSURE	LEIN_MEDULLA_MARKERS
0.43956043956%	2	455	81	T2D_GENES_TANYA_BLOODPRESSURE	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
0.43956043956%	2	455	81	T2D_GENES_TANYA_BLOODPRESSURE	GRABARCZYK_BCL11B_TARGETS_UP
0.43956043956%	2	455	81	T2D_GENES_TANYA_BLOODPRESSURE	COATES_MACROPHAGE_M1_VS_M2_UP
0.43956043956%	2	455	80	T2D_GENES_TANYA_BLOODPRESSURE	SCHUHMACHER_MYC_TARGETS_UP
0.43956043956%	2	455	80	T2D_GENES_TANYA_BLOODPRESSURE	PID_BETACATENIN_NUC_PATHWAY
0.43956043956%	2	455	80	T2D_GENES_TANYA_BLOODPRESSURE	LEE_AGING_NEOCORTEX_DN
0.43956043956%	2	455	8	T2D_GENES_TANYA_BLOODPRESSURE	STANHILL_HRAS_TRANSFROMATION_UP
0.43956043956%	2	455	8	T2D_GENES_TANYA_BLOODPRESSURE	BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS
0.43956043956%	2	455	79	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT
0.43956043956%	2	455	79	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
0.43956043956%	2	455	79	T2D_GENES_TANYA_BLOODPRESSURE	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
0.43956043956%	2	455	79	T2D_GENES_TANYA_BLOODPRESSURE	MALONEY_RESPONSE_TO_17AAG_DN
0.43956043956%	2	455	79	T2D_GENES_TANYA_BLOODPRESSURE	LIU_COMMON_CANCER_GENES
0.43956043956%	2	455	79	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
0.43956043956%	2	455	79	T2D_GENES_TANYA_BLOODPRESSURE	GAVIN_FOXP3_TARGETS_CLUSTER_P2
0.43956043956%	2	455	79	T2D_GENES_TANYA_BLOODPRESSURE	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.43956043956%	2	455	79	T2D_GENES_TANYA_BLOODPRESSURE	CROMER_METASTASIS_UP
0.43956043956%	2	455	78	T2D_GENES_TANYA_BLOODPRESSURE	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
0.43956043956%	2	455	78	T2D_GENES_TANYA_BLOODPRESSURE	ROSS_AML_WITH_MLL_FUSIONS
0.43956043956%	2	455	78	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_SCF_KIT
0.43956043956%	2	455	78	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_OPIOID_SIGNALLING
0.43956043956%	2	455	77	T2D_GENES_TANYA_BLOODPRESSURE	ROSS_AML_WITH_PML_RARA_FUSION
0.43956043956%	2	455	77	T2D_GENES_TANYA_BLOODPRESSURE	RIZ_ERYTHROID_DIFFERENTIATION
0.43956043956%	2	455	77	T2D_GENES_TANYA_BLOODPRESSURE	LIN_APC_TARGETS
0.43956043956%	2	455	77	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM
0.43956043956%	2	455	77	T2D_GENES_TANYA_BLOODPRESSURE	JACKSON_DNMT1_TARGETS_UP
0.43956043956%	2	455	77	T2D_GENES_TANYA_BLOODPRESSURE	GROSS_HYPOXIA_VIA_HIF1A_UP
0.43956043956%	2	455	77	T2D_GENES_TANYA_BLOODPRESSURE	CARD_MIR302A_TARGETS
0.43956043956%	2	455	76	T2D_GENES_TANYA_BLOODPRESSURE	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
0.43956043956%	2	455	76	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
0.43956043956%	2	455	75	T2D_GENES_TANYA_BLOODPRESSURE	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
0.43956043956%	2	455	75	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.43956043956%	2	455	75	T2D_GENES_TANYA_BLOODPRESSURE	BAE_BRCA1_TARGETS_UP
0.43956043956%	2	455	74	T2D_GENES_TANYA_BLOODPRESSURE	URS_ADIPOCYTE_DIFFERENTIATION_UP
0.43956043956%	2	455	74	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX
0.43956043956%	2	455	74	T2D_GENES_TANYA_BLOODPRESSURE	PID_E2F_PATHWAY
0.43956043956%	2	455	74	T2D_GENES_TANYA_BLOODPRESSURE	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
0.43956043956%	2	455	74	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
0.43956043956%	2	455	74	T2D_GENES_TANYA_BLOODPRESSURE	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
0.43956043956%	2	455	74	T2D_GENES_TANYA_BLOODPRESSURE	FURUKAWA_DUSP6_TARGETS_PCI35_DN
0.43956043956%	2	455	74	T2D_GENES_TANYA_BLOODPRESSURE	DARWICHE_PAPILLOMA_PROGRESSION_RISK
0.43956043956%	2	455	73	T2D_GENES_TANYA_BLOODPRESSURE	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.43956043956%	2	455	73	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
0.43956043956%	2	455	73	T2D_GENES_TANYA_BLOODPRESSURE	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.43956043956%	2	455	72	T2D_GENES_TANYA_BLOODPRESSURE	SESTO_RESPONSE_TO_UV_C1
0.43956043956%	2	455	72	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
0.43956043956%	2	455	72	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_METABOLISM_OF_NUCLEOTIDES
0.43956043956%	2	455	72	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1
0.43956043956%	2	455	72	T2D_GENES_TANYA_BLOODPRESSURE	MATZUK_SPERMATOCYTE
0.43956043956%	2	455	72	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_LEISHMANIA_INFECTION
0.43956043956%	2	455	71	T2D_GENES_TANYA_BLOODPRESSURE	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
0.43956043956%	2	455	71	T2D_GENES_TANYA_BLOODPRESSURE	KYNG_RESPONSE_TO_H2O2
0.43956043956%	2	455	71	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.43956043956%	2	455	70	T2D_GENES_TANYA_BLOODPRESSURE	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
0.43956043956%	2	455	70	T2D_GENES_TANYA_BLOODPRESSURE	VERNELL_RETINOBLASTOMA_PATHWAY_UP
0.43956043956%	2	455	70	T2D_GENES_TANYA_BLOODPRESSURE	PID_AP1_PATHWAY
0.43956043956%	2	455	70	T2D_GENES_TANYA_BLOODPRESSURE	LANDIS_BREAST_CANCER_PROGRESSION_DN
0.43956043956%	2	455	70	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_RENAL_CELL_CARCINOMA
0.43956043956%	2	455	70	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_PANCREATIC_CANCER
0.43956043956%	2	455	70	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450
0.43956043956%	2	455	70	T2D_GENES_TANYA_BLOODPRESSURE	ENGELMANN_CANCER_PROGENITORS_DN
0.43956043956%	2	455	69	T2D_GENES_TANYA_BLOODPRESSURE	ZAMORA_NOS2_TARGETS_UP
0.43956043956%	2	455	69	T2D_GENES_TANYA_BLOODPRESSURE	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.43956043956%	2	455	69	T2D_GENES_TANYA_BLOODPRESSURE	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
0.43956043956%	2	455	69	T2D_GENES_TANYA_BLOODPRESSURE	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
0.43956043956%	2	455	69	T2D_GENES_TANYA_BLOODPRESSURE	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
0.43956043956%	2	455	68	T2D_GENES_TANYA_BLOODPRESSURE	PID_TELOMERASEPATHWAY
0.43956043956%	2	455	68	T2D_GENES_TANYA_BLOODPRESSURE	CASTELLANO_NRAS_TARGETS_UP
0.43956043956%	2	455	68	T2D_GENES_TANYA_BLOODPRESSURE	AKL_HTLV1_INFECTION_DN
0.43956043956%	2	455	67	T2D_GENES_TANYA_BLOODPRESSURE	VANHARANTA_UTERINE_FIBROID_DN
0.43956043956%	2	455	67	T2D_GENES_TANYA_BLOODPRESSURE	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
0.43956043956%	2	455	67	T2D_GENES_TANYA_BLOODPRESSURE	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP
0.43956043956%	2	455	66	T2D_GENES_TANYA_BLOODPRESSURE	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
0.43956043956%	2	455	66	T2D_GENES_TANYA_BLOODPRESSURE	TENEDINI_MEGAKARYOCYTE_MARKERS
0.43956043956%	2	455	66	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
0.43956043956%	2	455	66	T2D_GENES_TANYA_BLOODPRESSURE	PID_HIF1_TFPATHWAY
0.43956043956%	2	455	66	T2D_GENES_TANYA_BLOODPRESSURE	PID_HDAC_CLASSI_PATHWAY
0.43956043956%	2	455	66	T2D_GENES_TANYA_BLOODPRESSURE	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.43956043956%	2	455	65	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
0.43956043956%	2	455	65	T2D_GENES_TANYA_BLOODPRESSURE	PID_CD8TCRDOWNSTREAMPATHWAY
0.43956043956%	2	455	65	T2D_GENES_TANYA_BLOODPRESSURE	PID_BCR_5PATHWAY
0.43956043956%	2	455	65	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_GLIOMA
0.43956043956%	2	455	65	T2D_GENES_TANYA_BLOODPRESSURE	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS
0.43956043956%	2	455	64	T2D_GENES_TANYA_BLOODPRESSURE	RIZKI_TUMOR_INVASIVENESS_2D_DN
0.43956043956%	2	455	64	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C
0.43956043956%	2	455	64	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_RETINOL_METABOLISM
0.43956043956%	2	455	64	T2D_GENES_TANYA_BLOODPRESSURE	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.43956043956%	2	455	63	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
0.43956043956%	2	455	63	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
0.43956043956%	2	455	63	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED
0.43956043956%	2	455	63	T2D_GENES_TANYA_BLOODPRESSURE	LEE_LIVER_CANCER_MYC_DN
0.43956043956%	2	455	63	T2D_GENES_TANYA_BLOODPRESSURE	JOHNSTONE_PARVB_TARGETS_1_DN
0.43956043956%	2	455	63	T2D_GENES_TANYA_BLOODPRESSURE	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
0.43956043956%	2	455	63	T2D_GENES_TANYA_BLOODPRESSURE	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.43956043956%	2	455	62	T2D_GENES_TANYA_BLOODPRESSURE	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
0.43956043956%	2	455	62	T2D_GENES_TANYA_BLOODPRESSURE	PID_TRKRPATHWAY
0.43956043956%	2	455	62	T2D_GENES_TANYA_BLOODPRESSURE	PID_FCER1PATHWAY
0.43956043956%	2	455	62	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.43956043956%	2	455	62	T2D_GENES_TANYA_BLOODPRESSURE	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.43956043956%	2	455	62	T2D_GENES_TANYA_BLOODPRESSURE	CORRE_MULTIPLE_MYELOMA_DN
0.43956043956%	2	455	61	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ER_PHAGOSOME_PATHWAY
0.43956043956%	2	455	61	T2D_GENES_TANYA_BLOODPRESSURE	KAUFFMANN_MELANOMA_RELAPSE_UP
0.43956043956%	2	455	60	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE
0.43956043956%	2	455	60	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_ACUTE_MYELOID_LEUKEMIA
0.43956043956%	2	455	60	T2D_GENES_TANYA_BLOODPRESSURE	CUI_GLUCOSE_DEPRIVATION
0.43956043956%	2	455	60	T2D_GENES_TANYA_BLOODPRESSURE	AMIT_EGF_RESPONSE_240_HELA
0.43956043956%	2	455	59	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
0.43956043956%	2	455	59	T2D_GENES_TANYA_BLOODPRESSURE	HUPER_BREAST_BASAL_VS_LUMINAL_DN
0.43956043956%	2	455	59	T2D_GENES_TANYA_BLOODPRESSURE	BARIS_THYROID_CANCER_DN
0.43956043956%	2	455	58	T2D_GENES_TANYA_BLOODPRESSURE	WAKASUGI_HAVE_ZNF143_BINDING_SITES
0.43956043956%	2	455	58	T2D_GENES_TANYA_BLOODPRESSURE	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
0.43956043956%	2	455	58	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_COLLAGEN_FORMATION
0.43956043956%	2	455	58	T2D_GENES_TANYA_BLOODPRESSURE	MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.43956043956%	2	455	58	T2D_GENES_TANYA_BLOODPRESSURE	BERNARD_PPAPDC1B_TARGETS_DN
0.43956043956%	2	455	57	T2D_GENES_TANYA_BLOODPRESSURE	YAMASHITA_METHYLATED_IN_PROSTATE_CANCER
0.43956043956%	2	455	57	T2D_GENES_TANYA_BLOODPRESSURE	TANG_SENESCENCE_TP53_TARGETS_DN
0.43956043956%	2	455	57	T2D_GENES_TANYA_BLOODPRESSURE	PID_TXA2PATHWAY
0.43956043956%	2	455	57	T2D_GENES_TANYA_BLOODPRESSURE	PEART_HDAC_PROLIFERATION_CLUSTER_UP
0.43956043956%	2	455	57	T2D_GENES_TANYA_BLOODPRESSURE	MCCLUNG_CREB1_TARGETS_DN
0.43956043956%	2	455	57	T2D_GENES_TANYA_BLOODPRESSURE	LEE_EARLY_T_LYMPHOCYTE_DN
0.43956043956%	2	455	57	T2D_GENES_TANYA_BLOODPRESSURE	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP
0.43956043956%	2	455	57	T2D_GENES_TANYA_BLOODPRESSURE	BORLAK_LIVER_CANCER_EGF_UP
0.43956043956%	2	455	56	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_VIBRIO_CHOLERAE_INFECTION
0.43956043956%	2	455	56	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.43956043956%	2	455	56	T2D_GENES_TANYA_BLOODPRESSURE	HOQUE_METHYLATED_IN_CANCER
0.43956043956%	2	455	56	T2D_GENES_TANYA_BLOODPRESSURE	HENDRICKS_SMARCA4_TARGETS_UP
0.43956043956%	2	455	56	T2D_GENES_TANYA_BLOODPRESSURE	GRADE_COLON_VS_RECTAL_CANCER_DN
0.43956043956%	2	455	55	T2D_GENES_TANYA_BLOODPRESSURE	SU_LIVER
0.43956043956%	2	455	55	T2D_GENES_TANYA_BLOODPRESSURE	SMIRNOV_RESPONSE_TO_IR_2HR_DN
0.43956043956%	2	455	55	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_4HR_UP
0.43956043956%	2	455	54	T2D_GENES_TANYA_BLOODPRESSURE	ZHOU_TNF_SIGNALING_4HR
0.43956043956%	2	455	54	T2D_GENES_TANYA_BLOODPRESSURE	ZHOU_TNF_SIGNALING_30MIN
0.43956043956%	2	455	54	T2D_GENES_TANYA_BLOODPRESSURE	SU_PANCREAS
0.43956043956%	2	455	54	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE
0.43956043956%	2	455	54	T2D_GENES_TANYA_BLOODPRESSURE	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP
0.43956043956%	2	455	54	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_IPS_ICP_WITH_H3K27ME3
0.43956043956%	2	455	54	T2D_GENES_TANYA_BLOODPRESSURE	LEE_LIVER_CANCER_MYC_UP
0.43956043956%	2	455	54	T2D_GENES_TANYA_BLOODPRESSURE	KANG_DOXORUBICIN_RESISTANCE_UP
0.43956043956%	2	455	54	T2D_GENES_TANYA_BLOODPRESSURE	JIANG_AGING_CEREBRAL_CORTEX_DN
0.43956043956%	2	455	54	T2D_GENES_TANYA_BLOODPRESSURE	FIGUEROA_AML_METHYLATION_CLUSTER_2_UP
0.43956043956%	2	455	53	T2D_GENES_TANYA_BLOODPRESSURE	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
0.43956043956%	2	455	53	T2D_GENES_TANYA_BLOODPRESSURE	SMIRNOV_RESPONSE_TO_IR_2HR_UP
0.43956043956%	2	455	53	T2D_GENES_TANYA_BLOODPRESSURE	ROESSLER_LIVER_CANCER_METASTASIS_DN
0.43956043956%	2	455	53	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PROTEIN_FOLDING
0.43956043956%	2	455	53	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0
0.43956043956%	2	455	53	T2D_GENES_TANYA_BLOODPRESSURE	PID_CD8TCRPATHWAY
0.43956043956%	2	455	53	T2D_GENES_TANYA_BLOODPRESSURE	PID_AR_TF_PATHWAY
0.43956043956%	2	455	53	T2D_GENES_TANYA_BLOODPRESSURE	LIANG_SILENCED_BY_METHYLATION_2
0.43956043956%	2	455	53	T2D_GENES_TANYA_BLOODPRESSURE	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
0.43956043956%	2	455	52	T2D_GENES_TANYA_BLOODPRESSURE	RADAEVA_RESPONSE_TO_IFNA1_UP
0.43956043956%	2	455	52	T2D_GENES_TANYA_BLOODPRESSURE	PID_KITPATHWAY
0.43956043956%	2	455	52	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_MTOR_SIGNALING_PATHWAY
0.43956043956%	2	455	52	T2D_GENES_TANYA_BLOODPRESSURE	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP
0.43956043956%	2	455	51	T2D_GENES_TANYA_BLOODPRESSURE	ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF
0.43956043956%	2	455	51	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT
0.43956043956%	2	455	51	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
0.43956043956%	2	455	51	T2D_GENES_TANYA_BLOODPRESSURE	PRAMOONJAGO_SOX4_TARGETS_DN
0.43956043956%	2	455	51	T2D_GENES_TANYA_BLOODPRESSURE	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
0.43956043956%	2	455	51	T2D_GENES_TANYA_BLOODPRESSURE	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP
0.43956043956%	2	455	51	T2D_GENES_TANYA_BLOODPRESSURE	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
0.43956043956%	2	455	50	T2D_GENES_TANYA_BLOODPRESSURE	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.43956043956%	2	455	50	T2D_GENES_TANYA_BLOODPRESSURE	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
0.43956043956%	2	455	50	T2D_GENES_TANYA_BLOODPRESSURE	KOHOUTEK_CCNT1_TARGETS
0.43956043956%	2	455	50	T2D_GENES_TANYA_BLOODPRESSURE	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
0.43956043956%	2	455	5	T2D_GENES_TANYA_BLOODPRESSURE	REN_MIF_TARGETS_DN
0.43956043956%	2	455	49	T2D_GENES_TANYA_BLOODPRESSURE	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
0.43956043956%	2	455	49	T2D_GENES_TANYA_BLOODPRESSURE	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
0.43956043956%	2	455	49	T2D_GENES_TANYA_BLOODPRESSURE	PID_PI3KCIPATHWAY
0.43956043956%	2	455	49	T2D_GENES_TANYA_BLOODPRESSURE	MARCHINI_TRABECTEDIN_RESISTANCE_DN
0.43956043956%	2	455	49	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_GLYCEROLIPID_METABOLISM
0.43956043956%	2	455	49	T2D_GENES_TANYA_BLOODPRESSURE	GERHOLD_ADIPOGENESIS_UP
0.43956043956%	2	455	49	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_2HR_DN
0.43956043956%	2	455	49	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_TCR_PATHWAY
0.43956043956%	2	455	48	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_LB_UP
0.43956043956%	2	455	48	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PI_METABOLISM
0.43956043956%	2	455	48	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY
0.43956043956%	2	455	48	T2D_GENES_TANYA_BLOODPRESSURE	PID_HEDGEHOG_GLIPATHWAY
0.43956043956%	2	455	48	T2D_GENES_TANYA_BLOODPRESSURE	PID_CERAMIDE_PATHWAY
0.43956043956%	2	455	48	T2D_GENES_TANYA_BLOODPRESSURE	PENG_GLUCOSE_DEPRIVATION_UP
0.43956043956%	2	455	48	T2D_GENES_TANYA_BLOODPRESSURE	GNATENKO_PLATELET_SIGNATURE
0.43956043956%	2	455	48	T2D_GENES_TANYA_BLOODPRESSURE	ENGELMANN_CANCER_PROGENITORS_UP
0.43956043956%	2	455	47	T2D_GENES_TANYA_BLOODPRESSURE	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP
0.43956043956%	2	455	47	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_TYPE_II_DIABETES_MELLITUS
0.43956043956%	2	455	47	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_NOTCH_SIGNALING_PATHWAY
0.43956043956%	2	455	47	T2D_GENES_TANYA_BLOODPRESSURE	JIANG_AGING_HYPOTHALAMUS_UP
0.43956043956%	2	455	47	T2D_GENES_TANYA_BLOODPRESSURE	IRITANI_MAD1_TARGETS_DN
0.43956043956%	2	455	47	T2D_GENES_TANYA_BLOODPRESSURE	BOYLAN_MULTIPLE_MYELOMA_C_UP
0.43956043956%	2	455	46	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_MS_DN
0.43956043956%	2	455	46	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_CD2_DN
0.43956043956%	2	455	46	T2D_GENES_TANYA_BLOODPRESSURE	SAGIV_CD24_TARGETS_DN
0.43956043956%	2	455	46	T2D_GENES_TANYA_BLOODPRESSURE	PID_TNFPATHWAY
0.43956043956%	2	455	46	T2D_GENES_TANYA_BLOODPRESSURE	PARENT_MTOR_SIGNALING_DN
0.43956043956%	2	455	46	T2D_GENES_TANYA_BLOODPRESSURE	OSADA_ASCL1_TARGETS_UP
0.43956043956%	2	455	46	T2D_GENES_TANYA_BLOODPRESSURE	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN
0.43956043956%	2	455	45	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_PR_UP
0.43956043956%	2	455	45	T2D_GENES_TANYA_BLOODPRESSURE	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
0.43956043956%	2	455	45	T2D_GENES_TANYA_BLOODPRESSURE	SIG_CHEMOTAXIS
0.43956043956%	2	455	45	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MRNA_SPLICING_MINOR_PATHWAY
0.43956043956%	2	455	45	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_G2_M_CHECKPOINTS
0.43956043956%	2	455	45	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_
0.43956043956%	2	455	45	T2D_GENES_TANYA_BLOODPRESSURE	PID_INSULIN_PATHWAY
0.43956043956%	2	455	45	T2D_GENES_TANYA_BLOODPRESSURE	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN
0.43956043956%	2	455	45	T2D_GENES_TANYA_BLOODPRESSURE	ABRAMSON_INTERACT_WITH_AIRE
0.43956043956%	2	455	44	T2D_GENES_TANYA_BLOODPRESSURE	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.43956043956%	2	455	44	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS
0.43956043956%	2	455	44	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION
0.43956043956%	2	455	44	T2D_GENES_TANYA_BLOODPRESSURE	FAELT_B_CLL_WITH_VH3_21_UP
0.43956043956%	2	455	43	T2D_GENES_TANYA_BLOODPRESSURE	ULE_SPLICING_VIA_NOVA2
0.43956043956%	2	455	43	T2D_GENES_TANYA_BLOODPRESSURE	POTTI_ETOPOSIDE_SENSITIVITY
0.43956043956%	2	455	43	T2D_GENES_TANYA_BLOODPRESSURE	LEE_CALORIE_RESTRICTION_MUSCLE_UP
0.43956043956%	2	455	43	T2D_GENES_TANYA_BLOODPRESSURE	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
0.43956043956%	2	455	43	T2D_GENES_TANYA_BLOODPRESSURE	DORN_ADENOVIRUS_INFECTION_24HR_DN
0.43956043956%	2	455	43	T2D_GENES_TANYA_BLOODPRESSURE	BURTON_ADIPOGENESIS_PEAK_AT_24HR
0.43956043956%	2	455	42	T2D_GENES_TANYA_BLOODPRESSURE	ZHENG_IL22_SIGNALING_DN
0.43956043956%	2	455	42	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_ES_ICP_WITH_H3K27ME3
0.43956043956%	2	455	42	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_GRAFT_VERSUS_HOST_DISEASE
0.43956043956%	2	455	42	T2D_GENES_TANYA_BLOODPRESSURE	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN
0.43956043956%	2	455	42	T2D_GENES_TANYA_BLOODPRESSURE	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
0.43956043956%	2	455	41	T2D_GENES_TANYA_BLOODPRESSURE	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN
0.43956043956%	2	455	41	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_ES_HCP_WITH_H3K27ME3
0.43956043956%	2	455	41	T2D_GENES_TANYA_BLOODPRESSURE	LI_LUNG_CANCER
0.43956043956%	2	455	41	T2D_GENES_TANYA_BLOODPRESSURE	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN
0.43956043956%	2	455	41	T2D_GENES_TANYA_BLOODPRESSURE	KAMMINGA_SENESCENCE
0.43956043956%	2	455	41	T2D_GENES_TANYA_BLOODPRESSURE	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
0.43956043956%	2	455	41	T2D_GENES_TANYA_BLOODPRESSURE	CROONQUIST_NRAS_SIGNALING_UP
0.43956043956%	2	455	40	T2D_GENES_TANYA_BLOODPRESSURE	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.43956043956%	2	455	40	T2D_GENES_TANYA_BLOODPRESSURE	VALK_AML_WITH_FLT3_ITD
0.43956043956%	2	455	40	T2D_GENES_TANYA_BLOODPRESSURE	TOMLINS_PROSTATE_CANCER_UP
0.43956043956%	2	455	40	T2D_GENES_TANYA_BLOODPRESSURE	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
0.43956043956%	2	455	40	T2D_GENES_TANYA_BLOODPRESSURE	LIAO_HAVE_SOX4_BINDING_SITES
0.43956043956%	2	455	40	T2D_GENES_TANYA_BLOODPRESSURE	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP
0.43956043956%	2	455	40	T2D_GENES_TANYA_BLOODPRESSURE	HEIDENBLAD_AMPLICON_8Q24_UP
0.43956043956%	2	455	40	T2D_GENES_TANYA_BLOODPRESSURE	GENTILE_UV_RESPONSE_CLUSTER_D7
0.43956043956%	2	455	40	T2D_GENES_TANYA_BLOODPRESSURE	ELLWOOD_MYC_TARGETS_DN
0.43956043956%	2	455	40	T2D_GENES_TANYA_BLOODPRESSURE	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.43956043956%	2	455	39	T2D_GENES_TANYA_BLOODPRESSURE	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2
0.43956043956%	2	455	39	T2D_GENES_TANYA_BLOODPRESSURE	SHIPP_DLBCL_CURED_VS_FATAL_UP
0.43956043956%	2	455	39	T2D_GENES_TANYA_BLOODPRESSURE	PID_ATR_PATHWAY
0.43956043956%	2	455	39	T2D_GENES_TANYA_BLOODPRESSURE	MA_MYELOID_DIFFERENTIATION_UP
0.43956043956%	2	455	39	T2D_GENES_TANYA_BLOODPRESSURE	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
0.43956043956%	2	455	39	T2D_GENES_TANYA_BLOODPRESSURE	DORN_ADENOVIRUS_INFECTION_32HR_DN
0.43956043956%	2	455	39	T2D_GENES_TANYA_BLOODPRESSURE	BILANGES_RAPAMYCIN_SENSITIVE_GENES
0.43956043956%	2	455	38	T2D_GENES_TANYA_BLOODPRESSURE	TERAO_AOX4_TARGETS_SKIN_UP
0.43956043956%	2	455	38	T2D_GENES_TANYA_BLOODPRESSURE	SPIRA_SMOKERS_LUNG_CANCER_UP
0.43956043956%	2	455	38	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS
0.43956043956%	2	455	38	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4
0.43956043956%	2	455	38	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS
0.43956043956%	2	455	38	T2D_GENES_TANYA_BLOODPRESSURE	PIONTEK_PKD1_TARGETS_UP
0.43956043956%	2	455	38	T2D_GENES_TANYA_BLOODPRESSURE	PID_P38ALPHABETADOWNSTREAMPATHWAY
0.43956043956%	2	455	38	T2D_GENES_TANYA_BLOODPRESSURE	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP
0.43956043956%	2	455	38	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_ALLOGRAFT_REJECTION
0.43956043956%	2	455	38	T2D_GENES_TANYA_BLOODPRESSURE	KAAB_FAILED_HEART_ATRIUM_UP
0.43956043956%	2	455	38	T2D_GENES_TANYA_BLOODPRESSURE	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN
0.43956043956%	2	455	38	T2D_GENES_TANYA_BLOODPRESSURE	CERVERA_SDHB_TARGETS_1_DN
0.43956043956%	2	455	38	T2D_GENES_TANYA_BLOODPRESSURE	CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN
0.43956043956%	2	455	37	T2D_GENES_TANYA_BLOODPRESSURE	VALK_AML_WITH_CEBPA
0.43956043956%	2	455	37	T2D_GENES_TANYA_BLOODPRESSURE	ST_P38_MAPK_PATHWAY
0.43956043956%	2	455	37	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING
0.43956043956%	2	455	37	T2D_GENES_TANYA_BLOODPRESSURE	PID_IL23PATHWAY
0.43956043956%	2	455	37	T2D_GENES_TANYA_BLOODPRESSURE	LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES
0.43956043956%	2	455	37	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_TOLL_PATHWAY
0.43956043956%	2	455	37	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_MET_PATHWAY
0.43956043956%	2	455	37	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_GPCR_PATHWAY
0.43956043956%	2	455	36	T2D_GENES_TANYA_BLOODPRESSURE	STEARMAN_TUMOR_FIELD_EFFECT_UP
0.43956043956%	2	455	36	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
0.43956043956%	2	455	36	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_BASAL_TRANSCRIPTION_FACTORS
0.43956043956%	2	455	36	T2D_GENES_TANYA_BLOODPRESSURE	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN
0.43956043956%	2	455	36	T2D_GENES_TANYA_BLOODPRESSURE	ALONSO_METASTASIS_EMT_UP
0.43956043956%	2	455	35	T2D_GENES_TANYA_BLOODPRESSURE	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.43956043956%	2	455	35	T2D_GENES_TANYA_BLOODPRESSURE	WEIGEL_OXIDATIVE_STRESS_RESPONSE
0.43956043956%	2	455	35	T2D_GENES_TANYA_BLOODPRESSURE	ST_G_ALPHA_I_PATHWAY
0.43956043956%	2	455	35	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_BASE_EXCISION_REPAIR
0.43956043956%	2	455	35	T2D_GENES_TANYA_BLOODPRESSURE	JAZAG_TGFB1_SIGNALING_DN
0.43956043956%	2	455	35	T2D_GENES_TANYA_BLOODPRESSURE	DORSAM_HOXA9_TARGETS_UP
0.43956043956%	2	455	34	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNAL_TRANSDUCTION_BY_L1
0.43956043956%	2	455	34	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION
0.43956043956%	2	455	34	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX
0.43956043956%	2	455	34	T2D_GENES_TANYA_BLOODPRESSURE	PID_IL2_PI3KPATHWAY
0.43956043956%	2	455	34	T2D_GENES_TANYA_BLOODPRESSURE	PID_EPHA_FWDPATHWAY
0.43956043956%	2	455	34	T2D_GENES_TANYA_BLOODPRESSURE	PID_ATM_PATHWAY
0.43956043956%	2	455	34	T2D_GENES_TANYA_BLOODPRESSURE	MEISSNER_ES_ICP_WITH_H3K4ME3
0.43956043956%	2	455	34	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM
0.43956043956%	2	455	34	T2D_GENES_TANYA_BLOODPRESSURE	HONMA_DOCETAXEL_RESISTANCE
0.43956043956%	2	455	34	T2D_GENES_TANYA_BLOODPRESSURE	ABE_VEGFA_TARGETS_2HR
0.43956043956%	2	455	33	T2D_GENES_TANYA_BLOODPRESSURE	STAEGE_EWING_FAMILY_TUMOR
0.43956043956%	2	455	33	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PURINE_METABOLISM
0.43956043956%	2	455	33	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS
0.43956043956%	2	455	33	T2D_GENES_TANYA_BLOODPRESSURE	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.43956043956%	2	455	32	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.43956043956%	2	455	32	T2D_GENES_TANYA_BLOODPRESSURE	ST_ERK1_ERK2_MAPK_PATHWAY
0.43956043956%	2	455	32	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING
0.43956043956%	2	455	32	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ELONGATION_ARREST_AND_RECOVERY
0.43956043956%	2	455	32	T2D_GENES_TANYA_BLOODPRESSURE	MEISSNER_BRAIN_ICP_WITH_H3K4ME3
0.43956043956%	2	455	32	T2D_GENES_TANYA_BLOODPRESSURE	LIANG_SILENCED_BY_METHYLATION_UP
0.43956043956%	2	455	32	T2D_GENES_TANYA_BLOODPRESSURE	FARDIN_HYPOXIA_11
0.43956043956%	2	455	32	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_PDGF_PATHWAY
0.43956043956%	2	455	315	T2D_GENES_TANYA_BLOODPRESSURE	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
0.43956043956%	2	455	31	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE
0.43956043956%	2	455	31	T2D_GENES_TANYA_BLOODPRESSURE	PID_CD40_PATHWAY
0.43956043956%	2	455	31	T2D_GENES_TANYA_BLOODPRESSURE	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.43956043956%	2	455	31	T2D_GENES_TANYA_BLOODPRESSURE	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.43956043956%	2	455	30	T2D_GENES_TANYA_BLOODPRESSURE	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.43956043956%	2	455	30	T2D_GENES_TANYA_BLOODPRESSURE	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.43956043956%	2	455	30	T2D_GENES_TANYA_BLOODPRESSURE	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.43956043956%	2	455	30	T2D_GENES_TANYA_BLOODPRESSURE	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN
0.43956043956%	2	455	30	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
0.43956043956%	2	455	30	T2D_GENES_TANYA_BLOODPRESSURE	PID_IL2_STAT5PATHWAY
0.43956043956%	2	455	30	T2D_GENES_TANYA_BLOODPRESSURE	PID_EPHRINBREVPATHWAY
0.43956043956%	2	455	30	T2D_GENES_TANYA_BLOODPRESSURE	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP
0.43956043956%	2	455	30	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_FAS_PATHWAY
0.43956043956%	2	455	29	T2D_GENES_TANYA_BLOODPRESSURE	VALK_AML_CLUSTER_2
0.43956043956%	2	455	29	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION
0.43956043956%	2	455	29	T2D_GENES_TANYA_BLOODPRESSURE	GENTLES_LEUKEMIC_STEM_CELL_UP
0.43956043956%	2	455	29	T2D_GENES_TANYA_BLOODPRESSURE	DALESSIO_TSA_RESPONSE
0.43956043956%	2	455	29	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_VIP_PATHWAY
0.43956043956%	2	455	29	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_TNFR1_PATHWAY
0.43956043956%	2	455	29	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_INFLAM_PATHWAY
0.43956043956%	2	455	29	T2D_GENES_TANYA_BLOODPRESSURE	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.43956043956%	2	455	29	T2D_GENES_TANYA_BLOODPRESSURE	ABE_VEGFA_TARGETS_30MIN
0.43956043956%	2	455	28	T2D_GENES_TANYA_BLOODPRESSURE	TIAN_TNF_SIGNALING_VIA_NFKB
0.43956043956%	2	455	28	T2D_GENES_TANYA_BLOODPRESSURE	TERAO_AOX4_TARGETS_HG_UP
0.43956043956%	2	455	28	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING
0.43956043956%	2	455	28	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A
0.43956043956%	2	455	28	T2D_GENES_TANYA_BLOODPRESSURE	OLSSON_E2F3_TARGETS_UP
0.43956043956%	2	455	28	T2D_GENES_TANYA_BLOODPRESSURE	MOREIRA_RESPONSE_TO_TSA_UP
0.43956043956%	2	455	28	T2D_GENES_TANYA_BLOODPRESSURE	MATZUK_MALE_REPRODUCTION_SERTOLI
0.43956043956%	2	455	28	T2D_GENES_TANYA_BLOODPRESSURE	KAMIKUBO_MYELOID_CEBPA_NETWORK
0.43956043956%	2	455	28	T2D_GENES_TANYA_BLOODPRESSURE	HWANG_PROSTATE_CANCER_MARKERS
0.43956043956%	2	455	28	T2D_GENES_TANYA_BLOODPRESSURE	GENTILE_UV_RESPONSE_CLUSTER_D9
0.43956043956%	2	455	27	T2D_GENES_TANYA_BLOODPRESSURE	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP
0.43956043956%	2	455	27	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE
0.43956043956%	2	455	27	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING
0.43956043956%	2	455	27	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT
0.43956043956%	2	455	27	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CREB_PATHWAY
0.43956043956%	2	455	26	T2D_GENES_TANYA_BLOODPRESSURE	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP
0.43956043956%	2	455	26	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS
0.43956043956%	2	455	26	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B
0.43956043956%	2	455	26	T2D_GENES_TANYA_BLOODPRESSURE	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
0.43956043956%	2	455	26	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_BAD_PATHWAY
0.43956043956%	2	455	26	T2D_GENES_TANYA_BLOODPRESSURE	ABBUD_LIF_SIGNALING_1_DN
0.43956043956%	2	455	25	T2D_GENES_TANYA_BLOODPRESSURE	WANG_NFKB_TARGETS
0.43956043956%	2	455	25	T2D_GENES_TANYA_BLOODPRESSURE	VERRECCHIA_RESPONSE_TO_TGFB1_C2
0.43956043956%	2	455	25	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE
0.43956043956%	2	455	25	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
0.43956043956%	2	455	25	T2D_GENES_TANYA_BLOODPRESSURE	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN
0.43956043956%	2	455	25	T2D_GENES_TANYA_BLOODPRESSURE	HORTON_SREBF_TARGETS
0.43956043956%	2	455	25	T2D_GENES_TANYA_BLOODPRESSURE	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN
0.43956043956%	2	455	25	T2D_GENES_TANYA_BLOODPRESSURE	GENTILE_UV_HIGH_DOSE_UP
0.43956043956%	2	455	25	T2D_GENES_TANYA_BLOODPRESSURE	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP
0.43956043956%	2	455	25	T2D_GENES_TANYA_BLOODPRESSURE	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN
0.43956043956%	2	455	25	T2D_GENES_TANYA_BLOODPRESSURE	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS
0.43956043956%	2	455	247	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_METABOLISM_OF_CARBOHYDRATES
0.43956043956%	2	455	23	T2D_GENES_TANYA_BLOODPRESSURE	UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.43956043956%	2	455	23	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX
0.43956043956%	2	455	23	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT
0.43956043956%	2	455	23	T2D_GENES_TANYA_BLOODPRESSURE	PID_PRLSIGNALINGEVENTSPATHWAY
0.43956043956%	2	455	23	T2D_GENES_TANYA_BLOODPRESSURE	PID_NFKAPPABCANONICALPATHWAY
0.43956043956%	2	455	23	T2D_GENES_TANYA_BLOODPRESSURE	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP
0.43956043956%	2	455	23	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_RAS_PATHWAY
0.43956043956%	2	455	23	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_RAC1_PATHWAY
0.43956043956%	2	455	23	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CASPASE_PATHWAY
0.43956043956%	2	455	23	T2D_GENES_TANYA_BLOODPRESSURE	BILANGES_SERUM_SENSITIVE_VIA_TSC1
0.43956043956%	2	455	226	T2D_GENES_TANYA_BLOODPRESSURE	KYNG_DNA_DAMAGE_UP
0.43956043956%	2	455	22	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
0.43956043956%	2	455	22	T2D_GENES_TANYA_BLOODPRESSURE	KANG_FLUOROURACIL_RESISTANCE_UP
0.43956043956%	2	455	22	T2D_GENES_TANYA_BLOODPRESSURE	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN
0.43956043956%	2	455	22	T2D_GENES_TANYA_BLOODPRESSURE	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN
0.43956043956%	2	455	22	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_INSULIN_PATHWAY
0.43956043956%	2	455	22	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CYTOKINE_PATHWAY
0.43956043956%	2	455	22	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_AKT_PATHWAY
0.43956043956%	2	455	214	T2D_GENES_TANYA_BLOODPRESSURE	TIEN_INTESTINE_PROBIOTICS_24HR_DN
0.43956043956%	2	455	214	T2D_GENES_TANYA_BLOODPRESSURE	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
0.43956043956%	2	455	211	T2D_GENES_TANYA_BLOODPRESSURE	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
0.43956043956%	2	455	21	T2D_GENES_TANYA_BLOODPRESSURE	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP
0.43956043956%	2	455	21	T2D_GENES_TANYA_BLOODPRESSURE	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP
0.43956043956%	2	455	21	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION
0.43956043956%	2	455	21	T2D_GENES_TANYA_BLOODPRESSURE	OUYANG_PROSTATE_CANCER_PROGRESSION_DN
0.43956043956%	2	455	21	T2D_GENES_TANYA_BLOODPRESSURE	MURAKAMI_UV_RESPONSE_6HR_DN
0.43956043956%	2	455	21	T2D_GENES_TANYA_BLOODPRESSURE	LEE_INTRATHYMIC_T_PROGENITOR
0.43956043956%	2	455	21	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_MITOCHONDRIA_PATHWAY
0.43956043956%	2	455	21	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_IGF1_PATHWAY
0.43956043956%	2	455	209	T2D_GENES_TANYA_BLOODPRESSURE	KIM_WT1_TARGETS_12HR_DN
0.43956043956%	2	455	206	T2D_GENES_TANYA_BLOODPRESSURE	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.43956043956%	2	455	201	T2D_GENES_TANYA_BLOODPRESSURE	KIM_MYC_AMPLIFICATION_TARGETS_UP
0.43956043956%	2	455	20	T2D_GENES_TANYA_BLOODPRESSURE	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN
0.43956043956%	2	455	20	T2D_GENES_TANYA_BLOODPRESSURE	WANG_RECURRENT_LIVER_CANCER_UP
0.43956043956%	2	455	20	T2D_GENES_TANYA_BLOODPRESSURE	NIELSEN_SYNOVIAL_SARCOMA_DN
0.43956043956%	2	455	20	T2D_GENES_TANYA_BLOODPRESSURE	NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN
0.43956043956%	2	455	20	T2D_GENES_TANYA_BLOODPRESSURE	MURAKAMI_UV_RESPONSE_24HR
0.43956043956%	2	455	20	T2D_GENES_TANYA_BLOODPRESSURE	MEISSNER_NPC_ICP_WITH_H3K4ME3
0.43956043956%	2	455	20	T2D_GENES_TANYA_BLOODPRESSURE	HEDENFALK_BREAST_CANCER_BRACX_UP
0.43956043956%	2	455	194	T2D_GENES_TANYA_BLOODPRESSURE	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.43956043956%	2	455	194	T2D_GENES_TANYA_BLOODPRESSURE	PROVENZANI_METASTASIS_UP
0.43956043956%	2	455	193	T2D_GENES_TANYA_BLOODPRESSURE	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP
0.43956043956%	2	455	192	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_DNA_REPLICATION
0.43956043956%	2	455	19	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR
0.43956043956%	2	455	19	T2D_GENES_TANYA_BLOODPRESSURE	RASHI_NFKB1_TARGETS
0.43956043956%	2	455	19	T2D_GENES_TANYA_BLOODPRESSURE	PID_ARF_3PATHWAY
0.43956043956%	2	455	19	T2D_GENES_TANYA_BLOODPRESSURE	NAGY_TFTC_COMPONENTS_HUMAN
0.43956043956%	2	455	19	T2D_GENES_TANYA_BLOODPRESSURE	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN
0.43956043956%	2	455	19	T2D_GENES_TANYA_BLOODPRESSURE	GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP
0.43956043956%	2	455	189	T2D_GENES_TANYA_BLOODPRESSURE	BURTON_ADIPOGENESIS_6
0.43956043956%	2	455	188	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
0.43956043956%	2	455	187	T2D_GENES_TANYA_BLOODPRESSURE	PENG_LEUCINE_DEPRIVATION_DN
0.43956043956%	2	455	187	T2D_GENES_TANYA_BLOODPRESSURE	BAKKER_FOXO3_TARGETS_DN
0.43956043956%	2	455	182	T2D_GENES_TANYA_BLOODPRESSURE	RAO_BOUND_BY_SALL4_ISOFORM_A
0.43956043956%	2	455	18	T2D_GENES_TANYA_BLOODPRESSURE	SCHEIDEREIT_IKK_TARGETS
0.43956043956%	2	455	18	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SYNTHESIS_OF_PC
0.43956043956%	2	455	18	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI
0.43956043956%	2	455	18	T2D_GENES_TANYA_BLOODPRESSURE	NIELSEN_SCHWANNOMA_UP
0.43956043956%	2	455	18	T2D_GENES_TANYA_BLOODPRESSURE	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN
0.43956043956%	2	455	18	T2D_GENES_TANYA_BLOODPRESSURE	NIELSEN_LEIOMYOSARCOMA_UP
0.43956043956%	2	455	18	T2D_GENES_TANYA_BLOODPRESSURE	LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK
0.43956043956%	2	455	18	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_NGF_PATHWAY
0.43956043956%	2	455	18	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CARDIACEGF_PATHWAY
0.43956043956%	2	455	18	T2D_GENES_TANYA_BLOODPRESSURE	ALONSO_METASTASIS_NEURAL_UP
0.43956043956%	2	455	176	T2D_GENES_TANYA_BLOODPRESSURE	NAGASHIMA_NRG1_SIGNALING_UP
0.43956043956%	2	455	175	T2D_GENES_TANYA_BLOODPRESSURE	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
0.43956043956%	2	455	172	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MITOTIC_M_M_G1_PHASES
0.43956043956%	2	455	171	T2D_GENES_TANYA_BLOODPRESSURE	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
0.43956043956%	2	455	17	T2D_GENES_TANYA_BLOODPRESSURE	TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN
0.43956043956%	2	455	17	T2D_GENES_TANYA_BLOODPRESSURE	PID_NFKAPPABATYPICALPATHWAY
0.43956043956%	2	455	17	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_RENIN_ANGIOTENSIN_SYSTEM
0.43956043956%	2	455	17	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_HCMV_PATHWAY
0.43956043956%	2	455	168	T2D_GENES_TANYA_BLOODPRESSURE	PUJANA_XPRSS_INT_NETWORK
0.43956043956%	2	455	164	T2D_GENES_TANYA_BLOODPRESSURE	AMIT_EGF_RESPONSE_480_HELA
0.43956043956%	2	455	163	T2D_GENES_TANYA_BLOODPRESSURE	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
0.43956043956%	2	455	161	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MRNA_PROCESSING
0.43956043956%	2	455	16	T2D_GENES_TANYA_BLOODPRESSURE	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN
0.43956043956%	2	455	16	T2D_GENES_TANYA_BLOODPRESSURE	ST_G_ALPHA_S_PATHWAY
0.43956043956%	2	455	16	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_XENOBIOTICS
0.43956043956%	2	455	16	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI
0.43956043956%	2	455	16	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_OTHER_GLYCAN_DEGRADATION
0.43956043956%	2	455	16	T2D_GENES_TANYA_BLOODPRESSURE	FUKUSHIMA_TNFSF11_TARGETS
0.43956043956%	2	455	16	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_SHH_PATHWAY
0.43956043956%	2	455	16	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_RELA_PATHWAY
0.43956043956%	2	455	16	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CDMAC_PATHWAY
0.43956043956%	2	455	16	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_BCELLSURVIVAL_PATHWAY
0.43956043956%	2	455	159	T2D_GENES_TANYA_BLOODPRESSURE	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
0.43956043956%	2	455	159	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INTERFERON_SIGNALING
0.43956043956%	2	455	157	T2D_GENES_TANYA_BLOODPRESSURE	SERVITJA_LIVER_HNF1A_TARGETS_DN
0.43956043956%	2	455	156	T2D_GENES_TANYA_BLOODPRESSURE	FOSTER_TOLERANT_MACROPHAGE_UP
0.43956043956%	2	455	155	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_JAK_STAT_SIGNALING_PATHWAY
0.43956043956%	2	455	150	T2D_GENES_TANYA_BLOODPRESSURE	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
0.43956043956%	2	455	15	T2D_GENES_TANYA_BLOODPRESSURE	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP
0.43956043956%	2	455	15	T2D_GENES_TANYA_BLOODPRESSURE	TSUNODA_CISPLATIN_RESISTANCE_UP
0.43956043956%	2	455	15	T2D_GENES_TANYA_BLOODPRESSURE	SU_KIDNEY
0.43956043956%	2	455	15	T2D_GENES_TANYA_BLOODPRESSURE	SA_MMP_CYTOKINE_CONNECTION
0.43956043956%	2	455	15	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS
0.43956043956%	2	455	15	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE
0.43956043956%	2	455	15	T2D_GENES_TANYA_BLOODPRESSURE	FIGUEROA_AML_METHYLATION_CLUSTER_4_DN
0.43956043956%	2	455	15	T2D_GENES_TANYA_BLOODPRESSURE	EHRLICH_ICF_SYNDROM_DN
0.43956043956%	2	455	15	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_TALL1_PATHWAY
0.43956043956%	2	455	15	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CD40_PATHWAY
0.43956043956%	2	455	149	T2D_GENES_TANYA_BLOODPRESSURE	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
0.43956043956%	2	455	148	T2D_GENES_TANYA_BLOODPRESSURE	WHITFIELD_CELL_CYCLE_M_G1
0.43956043956%	2	455	148	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_24HR_UP
0.43956043956%	2	455	147	T2D_GENES_TANYA_BLOODPRESSURE	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
0.43956043956%	2	455	147	T2D_GENES_TANYA_BLOODPRESSURE	KAUFFMANN_DNA_REPLICATION_GENES
0.43956043956%	2	455	147	T2D_GENES_TANYA_BLOODPRESSURE	BENPORATH_PROLIFERATION
0.43956043956%	2	455	143	T2D_GENES_TANYA_BLOODPRESSURE	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.43956043956%	2	455	142	T2D_GENES_TANYA_BLOODPRESSURE	XU_GH1_AUTOCRINE_TARGETS_DN
0.43956043956%	2	455	142	T2D_GENES_TANYA_BLOODPRESSURE	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.43956043956%	2	455	142	T2D_GENES_TANYA_BLOODPRESSURE	DARWICHE_SKIN_TUMOR_PROMOTER_UP
0.43956043956%	2	455	141	T2D_GENES_TANYA_BLOODPRESSURE	SABATES_COLORECTAL_ADENOMA_UP
0.43956043956%	2	455	140	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
0.43956043956%	2	455	14	T2D_GENES_TANYA_BLOODPRESSURE	ZHANG_ADIPOGENESIS_BY_BMP7
0.43956043956%	2	455	14	T2D_GENES_TANYA_BLOODPRESSURE	WEBER_METHYLATED_ICP_IN_SPERM_DN
0.43956043956%	2	455	14	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP
0.43956043956%	2	455	14	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_P75NTR_SIGNALS_VIA_NFKB
0.43956043956%	2	455	14	T2D_GENES_TANYA_BLOODPRESSURE	INAMURA_LUNG_CANCER_SCC_DN
0.43956043956%	2	455	14	T2D_GENES_TANYA_BLOODPRESSURE	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION
0.43956043956%	2	455	14	T2D_GENES_TANYA_BLOODPRESSURE	GILMORE_CORE_NFKB_PATHWAY
0.43956043956%	2	455	14	T2D_GENES_TANYA_BLOODPRESSURE	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
0.43956043956%	2	455	138	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
0.43956043956%	2	455	138	T2D_GENES_TANYA_BLOODPRESSURE	JIANG_VHL_TARGETS
0.43956043956%	2	455	137	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
0.43956043956%	2	455	137	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
0.43956043956%	2	455	137	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MITOTIC_G1_G1_S_PHASES
0.43956043956%	2	455	137	T2D_GENES_TANYA_BLOODPRESSURE	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
0.43956043956%	2	455	137	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_INSULIN_SIGNALING_PATHWAY
0.43956043956%	2	455	136	T2D_GENES_TANYA_BLOODPRESSURE	PROVENZANI_METASTASIS_DN
0.43956043956%	2	455	136	T2D_GENES_TANYA_BLOODPRESSURE	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.43956043956%	2	455	135	T2D_GENES_TANYA_BLOODPRESSURE	SERVITJA_LIVER_HNF1A_TARGETS_UP
0.43956043956%	2	455	133	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_DIABETES_PATHWAYS
0.43956043956%	2	455	13	T2D_GENES_TANYA_BLOODPRESSURE	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
0.43956043956%	2	455	13	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING
0.43956043956%	2	455	13	T2D_GENES_TANYA_BLOODPRESSURE	PHESSE_TARGETS_OF_APC_AND_MBD2_DN
0.43956043956%	2	455	13	T2D_GENES_TANYA_BLOODPRESSURE	ONGUSAHA_BRCA1_TARGETS_UP
0.43956043956%	2	455	13	T2D_GENES_TANYA_BLOODPRESSURE	IRITANI_MAD1_TARGETS_UP
0.43956043956%	2	455	13	T2D_GENES_TANYA_BLOODPRESSURE	HO_LIVER_CANCER_VASCULAR_INVASION
0.43956043956%	2	455	13	T2D_GENES_TANYA_BLOODPRESSURE	EHRLICH_ICF_SYNDROM_UP
0.43956043956%	2	455	13	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_AGPCR_PATHWAY
0.43956043956%	2	455	13	T2D_GENES_TANYA_BLOODPRESSURE	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN
0.43956043956%	2	455	129	T2D_GENES_TANYA_BLOODPRESSURE	KIM_WT1_TARGETS_8HR_DN
0.43956043956%	2	455	127	T2D_GENES_TANYA_BLOODPRESSURE	KARLSSON_TGFB1_TARGETS_UP
0.43956043956%	2	455	127	T2D_GENES_TANYA_BLOODPRESSURE	INGRAM_SHH_TARGETS_UP
0.43956043956%	2	455	126	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
0.43956043956%	2	455	126	T2D_GENES_TANYA_BLOODPRESSURE	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
0.43956043956%	2	455	125	T2D_GENES_TANYA_BLOODPRESSURE	FIGUEROA_AML_METHYLATION_CLUSTER_1_UP
0.43956043956%	2	455	124	T2D_GENES_TANYA_BLOODPRESSURE	DAIRKEE_TERT_TARGETS_DN
0.43956043956%	2	455	123	T2D_GENES_TANYA_BLOODPRESSURE	HOOI_ST7_TARGETS_DN
0.43956043956%	2	455	121	T2D_GENES_TANYA_BLOODPRESSURE	VANTVEER_BREAST_CANCER_METASTASIS_DN
0.43956043956%	2	455	121	T2D_GENES_TANYA_BLOODPRESSURE	RODRIGUES_DCC_TARGETS_DN
0.43956043956%	2	455	121	T2D_GENES_TANYA_BLOODPRESSURE	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP
0.43956043956%	2	455	121	T2D_GENES_TANYA_BLOODPRESSURE	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
0.43956043956%	2	455	120	T2D_GENES_TANYA_BLOODPRESSURE	ZHU_CMV_ALL_UP
0.43956043956%	2	455	120	T2D_GENES_TANYA_BLOODPRESSURE	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.43956043956%	2	455	12	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_NOTCH4
0.43956043956%	2	455	12	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES
0.43956043956%	2	455	12	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CFTR_PATHWAY
0.43956043956%	2	455	119	T2D_GENES_TANYA_BLOODPRESSURE	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
0.43956043956%	2	455	118	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
0.43956043956%	2	455	117	T2D_GENES_TANYA_BLOODPRESSURE	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.43956043956%	2	455	116	T2D_GENES_TANYA_BLOODPRESSURE	MATTIOLI_MGUS_VS_PCL
0.43956043956%	2	455	116	T2D_GENES_TANYA_BLOODPRESSURE	IKEDA_MIR30_TARGETS_UP
0.43956043956%	2	455	114	T2D_GENES_TANYA_BLOODPRESSURE	LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.43956043956%	2	455	113	T2D_GENES_TANYA_BLOODPRESSURE	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
0.43956043956%	2	455	112	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_G1_S_TRANSITION
0.43956043956%	2	455	112	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_DNA_REPAIR
0.43956043956%	2	455	111	T2D_GENES_TANYA_BLOODPRESSURE	WANG_HCP_PROSTATE_CANCER
0.43956043956%	2	455	111	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MRNA_SPLICING
0.43956043956%	2	455	111	T2D_GENES_TANYA_BLOODPRESSURE	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
0.43956043956%	2	455	111	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_12HR_UP
0.43956043956%	2	455	110	T2D_GENES_TANYA_BLOODPRESSURE	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.43956043956%	2	455	11	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL
0.43956043956%	2	455	11	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_SRCRPTP_PATHWAY
0.43956043956%	2	455	109	T2D_GENES_TANYA_BLOODPRESSURE	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
0.43956043956%	2	455	109	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_S_PHASE
0.43956043956%	2	455	109	T2D_GENES_TANYA_BLOODPRESSURE	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.43956043956%	2	455	108	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
0.43956043956%	2	455	108	T2D_GENES_TANYA_BLOODPRESSURE	LE_EGR2_TARGETS_DN
0.43956043956%	2	455	108	T2D_GENES_TANYA_BLOODPRESSURE	JAZAG_TGFB1_SIGNALING_UP
0.43956043956%	2	455	107	T2D_GENES_TANYA_BLOODPRESSURE	ROESSLER_LIVER_CANCER_METASTASIS_UP
0.43956043956%	2	455	106	T2D_GENES_TANYA_BLOODPRESSURE	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
0.43956043956%	2	455	105	T2D_GENES_TANYA_BLOODPRESSURE	ZWANG_EGF_INTERVAL_UP
0.43956043956%	2	455	104	T2D_GENES_TANYA_BLOODPRESSURE	NAKAMURA_ADIPOGENESIS_LATE_UP
0.43956043956%	2	455	103	T2D_GENES_TANYA_BLOODPRESSURE	LEIN_CHOROID_PLEXUS_MARKERS
0.43956043956%	2	455	102	T2D_GENES_TANYA_BLOODPRESSURE	DER_IFN_BETA_RESPONSE_UP
0.43956043956%	2	455	101	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_ERBB2
0.43956043956%	2	455	101	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_20HR_DN
0.43956043956%	2	455	101	T2D_GENES_TANYA_BLOODPRESSURE	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.43956043956%	2	455	100	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
0.43956043956%	2	455	100	T2D_GENES_TANYA_BLOODPRESSURE	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
0.43956043956%	2	455	10	T2D_GENES_TANYA_BLOODPRESSURE	BRUNEAU_SEPTATION_VENTRICULAR
0.43956043956%	2	455	10	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_RNA_PATHWAY
0.43956043956%	2	455	10	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_FREE_PATHWAY
0.43956043956%	2	455	10	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_DNAFRAGMENT_PATHWAY
0.427715996578%	5	1169	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MENSE_HYPOXIA_UP
0.427715996578%	5	1169	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BRUINS_UVC_RESPONSE_MIDDLE
0.427715996578%	5	1169	95	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
0.427715996578%	5	1169	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION
0.427715996578%	5	1169	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.427715996578%	5	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
0.427715996578%	5	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.427715996578%	5	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PROSTATE_CANCER
0.427715996578%	5	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.427715996578%	5	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_APOPTOSIS
0.427715996578%	5	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DURCHDEWALD_SKIN_CARCINOGENESIS_UP
0.427715996578%	5	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
0.427715996578%	5	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.427715996578%	5	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_MAPK_PATHWAY
0.427715996578%	5	1169	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_L1CAM_INTERACTIONS
0.427715996578%	5	1169	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_AGING_CEREBELLUM_DN
0.427715996578%	5	1169	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_TGF_BETA_SIGNALING_PATHWAY
0.427715996578%	5	1169	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BAELDE_DIABETIC_NEPHROPATHY_UP
0.427715996578%	5	1169	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STEIN_ESR1_TARGETS
0.427715996578%	5	1169	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SANA_RESPONSE_TO_IFNG_DN
0.427715996578%	5	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
0.427715996578%	5	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
0.427715996578%	5	1169	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
0.427715996578%	5	1169	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.427715996578%	5	1169	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.427715996578%	5	1169	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_INTEGRIN_SIGNALING_PATHWAY
0.427715996578%	5	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CROMER_METASTASIS_DN
0.427715996578%	5	1169	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_CARDIAC_MUSCLE_CONTRACTION
0.427715996578%	5	1169	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_P73PATHWAY
0.427715996578%	5	1169	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_MYC_ACTIVPATHWAY
0.427715996578%	5	1169	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
0.427715996578%	5	1169	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROSS_LEUKEMIA_WITH_MLL_FUSIONS
0.427715996578%	5	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.427715996578%	5	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIN_APC_TARGETS
0.427715996578%	5	1169	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
0.427715996578%	5	1169	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.427715996578%	5	1169	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JAIN_NFKB_SIGNALING
0.427715996578%	5	1169	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BAE_BRCA1_TARGETS_UP
0.427715996578%	5	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	URS_ADIPOCYTE_DIFFERENTIATION_UP
0.427715996578%	5	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CAMPS_COLON_CANCER_COPY_NUMBER_DN
0.427715996578%	5	1169	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIN_MELANOMA_COPY_NUMBER_UP
0.427715996578%	5	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_CDC42_PATHWAY
0.427715996578%	5	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RIZKI_TUMOR_INVASIVENESS_2D_UP
0.427715996578%	5	1169	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
0.427715996578%	5	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RIGGINS_TAMOXIFEN_RESISTANCE_UP
0.427715996578%	5	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN
0.427715996578%	5	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_FAS_SIGNALING_PATHWAY
0.427715996578%	5	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_IL4_2PATHWAY
0.427715996578%	5	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_LIVER_CANCER_ACOX1_DN
0.427715996578%	5	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GUO_HEX_TARGETS_DN
0.427715996578%	5	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_UP
0.427715996578%	5	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
0.427715996578%	5	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
0.427715996578%	5	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_IL12_2PATHWAY
0.427715996578%	5	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ENDOTHELINPATHWAY
0.427715996578%	5	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BURTON_ADIPOGENESIS_PEAK_AT_0HR
0.427715996578%	5	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BRIDEAU_IMPRINTED_GENES
0.427715996578%	5	1169	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ACUTE_MYELOID_LEUKEMIA
0.427715996578%	5	1169	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CUI_GLUCOSE_DEPRIVATION
0.427715996578%	5	1169	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN
0.427715996578%	5	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KANNAN_TP53_TARGETS_UP
0.427715996578%	5	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.427715996578%	5	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP
0.427715996578%	5	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_30MIN_UP
0.427715996578%	5	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
0.427715996578%	5	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TCR_SIGNALING
0.427715996578%	5	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_APOPTOTIC_EXECUTION_PHASE
0.427715996578%	5	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_NFAT_3PATHWAY
0.427715996578%	5	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_LIVER_CANCER_MYC_UP
0.427715996578%	5	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROESSLER_LIVER_CANCER_METASTASIS_DN
0.427715996578%	5	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_KITPATHWAY
0.427715996578%	5	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
0.427715996578%	5	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TSUNODA_CISPLATIN_RESISTANCE_DN
0.427715996578%	5	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
0.427715996578%	5	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_CALORIE_RESTRICTION_MUSCLE_DN
0.427715996578%	5	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
0.427715996578%	5	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
0.427715996578%	5	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MUSCLE_CONTRACTION
0.427715996578%	5	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_HEDGEHOG_GLIPATHWAY
0.427715996578%	5	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.427715996578%	5	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MELLMAN_TUT1_TARGETS_DN
0.427715996578%	5	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6
0.427715996578%	5	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SESTO_RESPONSE_TO_UV_C5
0.427715996578%	5	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_INSULIN_PATHWAY
0.427715996578%	5	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN
0.427715996578%	5	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ABC_TRANSPORTERS
0.427715996578%	5	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
0.427715996578%	5	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS
0.427715996578%	5	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GENTILE_UV_RESPONSE_CLUSTER_D8
0.427715996578%	5	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AIYAR_COBRA1_TARGETS_UP
0.427715996578%	5	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KAAB_FAILED_HEART_ATRIUM_UP
0.427715996578%	5	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN
0.427715996578%	5	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_BCR_PATHWAY
0.427715996578%	5	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_PI3KPLCTRKPATHWAY
0.427715996578%	5	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_AR_NONGENOMIC_PATHWAY
0.427715996578%	5	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_GH_PATHWAY
0.427715996578%	5	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_STRIATED_MUSCLE_CONTRACTION
0.427715996578%	5	1169	261	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4
0.427715996578%	5	1169	258	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JAEGER_METASTASIS_DN
0.427715996578%	5	1169	250	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
0.427715996578%	5	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP
0.427715996578%	5	1169	246	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VERHAAK_AML_WITH_NPM1_MUTATED_DN
0.427715996578%	5	1169	229	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1
0.427715996578%	5	1169	228	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
0.427715996578%	5	1169	221	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PEDRIOLI_MIR31_TARGETS_UP
0.427715996578%	5	1169	220	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RIGGINS_TAMOXIFEN_RESISTANCE_DN
0.427715996578%	5	1169	214	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TIEN_INTESTINE_PROBIOTICS_24HR_DN
0.427715996578%	5	1169	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VERHAAK_GLIOBLASTOMA_PRONEURAL
0.427715996578%	5	1169	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.427715996578%	5	1169	208	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
0.427715996578%	5	1169	206	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.427715996578%	5	1169	199	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
0.427715996578%	5	1169	195	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.427715996578%	5	1169	186	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_CLIM2_TARGETS_DN
0.427715996578%	5	1169	186	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
0.427715996578%	5	1169	185	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHANG_TLX_TARGETS_36HR_DN
0.427715996578%	5	1169	184	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
0.427715996578%	5	1169	183	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.427715996578%	5	1169	182	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WHITFIELD_CELL_CYCLE_G2
0.427715996578%	5	1169	182	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
0.427715996578%	5	1169	181	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
0.427715996578%	5	1169	180	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
0.427715996578%	5	1169	178	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LI_AMPLIFIED_IN_LUNG_CANCER
0.427715996578%	5	1169	178	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
0.427715996578%	5	1169	175	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.427715996578%	5	1169	175	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_LIVER_CANCER_SURVIVAL_DN
0.427715996578%	5	1169	170	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP
0.427715996578%	5	1169	170	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
0.427715996578%	5	1169	163	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
0.427715996578%	5	1169	161	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MRNA_PROCESSING
0.427715996578%	5	1169	160	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
0.427715996578%	5	1169	158	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.427715996578%	5	1169	156	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GROSS_HYPOXIA_VIA_ELK3_DN
0.427715996578%	5	1169	155	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_JAK_STAT_SIGNALING_PATHWAY
0.427715996578%	5	1169	154	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
0.427715996578%	5	1169	153	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RUIZ_TNC_TARGETS_UP
0.427715996578%	5	1169	153	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LU_AGING_BRAIN_DN
0.427715996578%	5	1169	153	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DURAND_STROMA_MAX_DN
0.427715996578%	5	1169	153	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN
0.427715996578%	5	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_NUCLEARRS_PATHWAY
0.427715996578%	5	1169	149	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TSAI_RESPONSE_TO_IONIZING_RADIATION
0.427715996578%	5	1169	148	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WHITFIELD_CELL_CYCLE_M_G1
0.427715996578%	5	1169	147	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
0.427715996578%	5	1169	147	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.427715996578%	5	1169	146	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PECE_MAMMARY_STEM_CELL_UP
0.427715996578%	5	1169	146	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ELVIDGE_HYPOXIA_DN
0.427715996578%	5	1169	146	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
0.427715996578%	5	1169	145	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.427715996578%	5	1169	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	XU_GH1_AUTOCRINE_TARGETS_DN
0.427715996578%	5	1169	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.427715996578%	5	1169	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RUIZ_TNC_TARGETS_DN
0.427715996578%	5	1169	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
0.427715996578%	5	1169	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
0.427715996578%	5	1169	140	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
0.427715996578%	5	1169	138	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
0.427715996578%	5	1169	138	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JIANG_VHL_TARGETS
0.427715996578%	5	1169	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_P53DOWNSTREAMPATHWAY
0.427715996578%	5	1169	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIU_SOX4_TARGETS_UP
0.427715996578%	5	1169	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_INSULIN_SIGNALING_PATHWAY
0.427715996578%	5	1169	136	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WIERENGA_STAT5A_TARGETS_GROUP1
0.427715996578%	5	1169	136	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.427715996578%	5	1169	134	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_TIGHT_JUNCTION
0.427715996578%	5	1169	134	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHUNG_BLISTER_CYTOTOXICITY_UP
0.427715996578%	5	1169	133	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DIABETES_PATHWAYS
0.427715996578%	5	1169	133	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PARKINSONS_DISEASE
0.427715996578%	5	1169	130	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAGI_AML_WITH_T_9_11_TRANSLOCATION
0.427715996578%	5	1169	129	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP
0.427715996578%	5	1169	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHU_CMV_ALL_DN
0.427715996578%	5	1169	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YEGNASUBRAMANIAN_PROSTATE_CANCER
0.427715996578%	5	1169	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	POTTI_TOPOTECAN_SENSITIVITY
0.427715996578%	5	1169	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS
0.427715996578%	5	1169	127	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KARLSSON_TGFB1_TARGETS_UP
0.427715996578%	5	1169	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
0.427715996578%	5	1169	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
0.427715996578%	5	1169	125	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
0.427715996578%	5	1169	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
0.427715996578%	5	1169	118	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TOLL_RECEPTOR_CASCADES
0.427715996578%	5	1169	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LI_INDUCED_T_TO_NATURAL_KILLER_DN
0.427715996578%	5	1169	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIM_MAMMARY_LUMINAL_MATURE_UP
0.427715996578%	5	1169	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SENESE_HDAC2_TARGETS_UP
0.427715996578%	5	1169	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DITTMER_PTHLH_TARGETS_UP
0.427715996578%	5	1169	111	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MRNA_SPLICING
0.427715996578%	5	1169	110	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GROSS_HYPOXIA_VIA_HIF1A_DN
0.427715996578%	5	1169	109	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.427715996578%	5	1169	107	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROESSLER_LIVER_CANCER_METASTASIS_UP
0.427715996578%	5	1169	104	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
0.427715996578%	5	1169	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_MYCN_AMPLIFICATION_TARGETS_DN
0.427715996578%	5	1169	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
0.427715996578%	5	1169	102	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LABBE_TGFB1_TARGETS_UP
0.427715996578%	5	1169	102	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_MELANOGENESIS
0.427715996578%	5	1169	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WIELAND_UP_BY_HBV_INFECTION
0.427715996578%	5	1169	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BURTON_ADIPOGENESIS_3
0.427715996578%	5	1169	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BASSO_CD40_SIGNALING_UP
0.427715996578%	5	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ETHANOL_OXIDATION
0.427578834848%	8	1871	98	T2D_GENES_TANYA_HEIGHT	NIELSEN_GIST
0.427578834848%	8	1871	97	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP
0.427578834848%	8	1871	97	T2D_GENES_TANYA_HEIGHT	KIM_MYC_AMPLIFICATION_TARGETS_DN
0.427578834848%	8	1871	97	T2D_GENES_TANYA_HEIGHT	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP
0.427578834848%	8	1871	95	T2D_GENES_TANYA_HEIGHT	KAYO_CALORIE_RESTRICTION_MUSCLE_UP
0.427578834848%	8	1871	95	T2D_GENES_TANYA_HEIGHT	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
0.427578834848%	8	1871	92	T2D_GENES_TANYA_HEIGHT	CAMPS_COLON_CANCER_COPY_NUMBER_UP
0.427578834848%	8	1871	91	T2D_GENES_TANYA_HEIGHT	GAVIN_FOXP3_TARGETS_CLUSTER_P6
0.427578834848%	8	1871	90	T2D_GENES_TANYA_HEIGHT	KEGG_GAP_JUNCTION
0.427578834848%	8	1871	89	T2D_GENES_TANYA_HEIGHT	ZHANG_TLX_TARGETS_UP
0.427578834848%	8	1871	89	T2D_GENES_TANYA_HEIGHT	SWEET_KRAS_ONCOGENIC_SIGNATURE
0.427578834848%	8	1871	89	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
0.427578834848%	8	1871	89	T2D_GENES_TANYA_HEIGHT	LI_DCP2_BOUND_MRNA
0.427578834848%	8	1871	89	T2D_GENES_TANYA_HEIGHT	DELASERNA_MYOD_TARGETS_UP
0.427578834848%	8	1871	89	T2D_GENES_TANYA_HEIGHT	BHATTACHARYA_EMBRYONIC_STEM_CELL
0.427578834848%	8	1871	88	T2D_GENES_TANYA_HEIGHT	UEDA_CENTRAL_CLOCK
0.427578834848%	8	1871	88	T2D_GENES_TANYA_HEIGHT	TIEN_INTESTINE_PROBIOTICS_2HR_DN
0.427578834848%	8	1871	88	T2D_GENES_TANYA_HEIGHT	SASSON_RESPONSE_TO_FORSKOLIN_DN
0.427578834848%	8	1871	88	T2D_GENES_TANYA_HEIGHT	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
0.427578834848%	8	1871	88	T2D_GENES_TANYA_HEIGHT	KEGG_APOPTOSIS
0.427578834848%	8	1871	88	T2D_GENES_TANYA_HEIGHT	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.427578834848%	8	1871	87	T2D_GENES_TANYA_HEIGHT	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
0.427578834848%	8	1871	87	T2D_GENES_TANYA_HEIGHT	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
0.427578834848%	8	1871	86	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
0.427578834848%	8	1871	86	T2D_GENES_TANYA_HEIGHT	GHANDHI_BYSTANDER_IRRADIATION_UP
0.427578834848%	8	1871	86	T2D_GENES_TANYA_HEIGHT	BURTON_ADIPOGENESIS_8
0.427578834848%	8	1871	85	T2D_GENES_TANYA_HEIGHT	STEIN_ESR1_TARGETS
0.427578834848%	8	1871	84	T2D_GENES_TANYA_HEIGHT	HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.427578834848%	8	1871	83	T2D_GENES_TANYA_HEIGHT	ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.427578834848%	8	1871	81	T2D_GENES_TANYA_HEIGHT	MUNSHI_MULTIPLE_MYELOMA_UP
0.427578834848%	8	1871	81	T2D_GENES_TANYA_HEIGHT	COATES_MACROPHAGE_M1_VS_M2_UP
0.427578834848%	8	1871	80	T2D_GENES_TANYA_HEIGHT	MORI_PRE_BI_LYMPHOCYTE_UP
0.427578834848%	8	1871	79	T2D_GENES_TANYA_HEIGHT	MALONEY_RESPONSE_TO_17AAG_DN
0.427578834848%	8	1871	78	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_SCF_KIT
0.427578834848%	8	1871	78	T2D_GENES_TANYA_HEIGHT	LINDVALL_IMMORTALIZED_BY_TERT_UP
0.427578834848%	8	1871	78	T2D_GENES_TANYA_HEIGHT	KEGG_PEROXISOME
0.427578834848%	8	1871	78	T2D_GENES_TANYA_HEIGHT	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE
0.427578834848%	8	1871	77	T2D_GENES_TANYA_HEIGHT	RIZ_ERYTHROID_DIFFERENTIATION
0.427578834848%	8	1871	77	T2D_GENES_TANYA_HEIGHT	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN
0.427578834848%	8	1871	77	T2D_GENES_TANYA_HEIGHT	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM
0.427578834848%	8	1871	77	T2D_GENES_TANYA_HEIGHT	FRIDMAN_SENESCENCE_UP
0.427578834848%	8	1871	76	T2D_GENES_TANYA_HEIGHT	MAHAJAN_RESPONSE_TO_IL1A_DN
0.427578834848%	8	1871	74	T2D_GENES_TANYA_HEIGHT	FURUKAWA_DUSP6_TARGETS_PCI35_UP
0.427578834848%	8	1871	73	T2D_GENES_TANYA_HEIGHT	KEGG_CHRONIC_MYELOID_LEUKEMIA
0.427578834848%	8	1871	73	T2D_GENES_TANYA_HEIGHT	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
0.427578834848%	8	1871	73	T2D_GENES_TANYA_HEIGHT	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.427578834848%	8	1871	71	T2D_GENES_TANYA_HEIGHT	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.427578834848%	8	1871	70	T2D_GENES_TANYA_HEIGHT	VERNELL_RETINOBLASTOMA_PATHWAY_UP
0.427578834848%	8	1871	70	T2D_GENES_TANYA_HEIGHT	PID_CDC42_PATHWAY
0.427578834848%	8	1871	70	T2D_GENES_TANYA_HEIGHT	PID_AP1_PATHWAY
0.427578834848%	8	1871	70	T2D_GENES_TANYA_HEIGHT	KEGG_LONG_TERM_DEPRESSION
0.427578834848%	8	1871	69	T2D_GENES_TANYA_HEIGHT	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
0.427578834848%	8	1871	69	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10
0.427578834848%	8	1871	69	T2D_GENES_TANYA_HEIGHT	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.427578834848%	8	1871	69	T2D_GENES_TANYA_HEIGHT	RIZKI_TUMOR_INVASIVENESS_2D_UP
0.427578834848%	8	1871	69	T2D_GENES_TANYA_HEIGHT	PID_P75NTRPATHWAY
0.427578834848%	8	1871	69	T2D_GENES_TANYA_HEIGHT	PID_MTOR_4PATHWAY
0.427578834848%	8	1871	69	T2D_GENES_TANYA_HEIGHT	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.427578834848%	8	1871	69	T2D_GENES_TANYA_HEIGHT	KEGG_PPAR_SIGNALING_PATHWAY
0.427578834848%	8	1871	69	T2D_GENES_TANYA_HEIGHT	KEGG_P53_SIGNALING_PATHWAY
0.427578834848%	8	1871	68	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.427578834848%	8	1871	68	T2D_GENES_TANYA_HEIGHT	CASTELLANO_NRAS_TARGETS_UP
0.427578834848%	8	1871	68	T2D_GENES_TANYA_HEIGHT	BASSO_CD40_SIGNALING_DN
0.427578834848%	8	1871	67	T2D_GENES_TANYA_HEIGHT	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
0.427578834848%	8	1871	67	T2D_GENES_TANYA_HEIGHT	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.427578834848%	8	1871	67	T2D_GENES_TANYA_HEIGHT	ELVIDGE_HIF1A_TARGETS_UP
0.427578834848%	8	1871	66	T2D_GENES_TANYA_HEIGHT	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
0.427578834848%	8	1871	66	T2D_GENES_TANYA_HEIGHT	TENEDINI_MEGAKARYOCYTE_MARKERS
0.427578834848%	8	1871	66	T2D_GENES_TANYA_HEIGHT	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.427578834848%	8	1871	66	T2D_GENES_TANYA_HEIGHT	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.427578834848%	8	1871	66	T2D_GENES_TANYA_HEIGHT	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP
0.427578834848%	8	1871	65	T2D_GENES_TANYA_HEIGHT	PID_CD8TCRDOWNSTREAMPATHWAY
0.427578834848%	8	1871	65	T2D_GENES_TANYA_HEIGHT	PID_BCR_5PATHWAY
0.427578834848%	8	1871	64	T2D_GENES_TANYA_HEIGHT	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
0.427578834848%	8	1871	63	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
0.427578834848%	8	1871	63	T2D_GENES_TANYA_HEIGHT	BILBAN_B_CLL_LPL_UP
0.427578834848%	8	1871	62	T2D_GENES_TANYA_HEIGHT	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.427578834848%	8	1871	61	T2D_GENES_TANYA_HEIGHT	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
0.427578834848%	8	1871	61	T2D_GENES_TANYA_HEIGHT	GENTILE_RESPONSE_CLUSTER_D3
0.427578834848%	8	1871	60	T2D_GENES_TANYA_HEIGHT	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE
0.427578834848%	8	1871	60	T2D_GENES_TANYA_HEIGHT	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
0.427578834848%	8	1871	60	T2D_GENES_TANYA_HEIGHT	CUI_GLUCOSE_DEPRIVATION
0.427578834848%	8	1871	59	T2D_GENES_TANYA_HEIGHT	PID_NOTCH_PATHWAY
0.427578834848%	8	1871	58	T2D_GENES_TANYA_HEIGHT	KANNAN_TP53_TARGETS_UP
0.427578834848%	8	1871	57	T2D_GENES_TANYA_HEIGHT	GYORFFY_MITOXANTRONE_RESISTANCE
0.427578834848%	8	1871	57	T2D_GENES_TANYA_HEIGHT	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.427578834848%	8	1871	57	T2D_GENES_TANYA_HEIGHT	AMIT_SERUM_RESPONSE_240_MCF10A
0.427578834848%	8	1871	55	T2D_GENES_TANYA_HEIGHT	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN
0.427578834848%	8	1871	55	T2D_GENES_TANYA_HEIGHT	KEGG_BASAL_CELL_CARCINOMA
0.427578834848%	8	1871	54	T2D_GENES_TANYA_HEIGHT	PID_TAP63PATHWAY
0.427578834848%	8	1871	54	T2D_GENES_TANYA_HEIGHT	PID_RAC1_PATHWAY
0.427578834848%	8	1871	53	T2D_GENES_TANYA_HEIGHT	SMIRNOV_RESPONSE_TO_IR_2HR_UP
0.427578834848%	8	1871	53	T2D_GENES_TANYA_HEIGHT	PID_CD8TCRPATHWAY
0.427578834848%	8	1871	52	T2D_GENES_TANYA_HEIGHT	WINTER_HYPOXIA_DN
0.427578834848%	8	1871	52	T2D_GENES_TANYA_HEIGHT	REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.427578834848%	8	1871	52	T2D_GENES_TANYA_HEIGHT	RADAEVA_RESPONSE_TO_IFNA1_UP
0.427578834848%	8	1871	52	T2D_GENES_TANYA_HEIGHT	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
0.427578834848%	8	1871	51	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
0.427578834848%	8	1871	51	T2D_GENES_TANYA_HEIGHT	REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT
0.427578834848%	8	1871	51	T2D_GENES_TANYA_HEIGHT	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1
0.427578834848%	8	1871	51	T2D_GENES_TANYA_HEIGHT	BYSTROEM_CORRELATED_WITH_IL5_UP
0.427578834848%	8	1871	51	T2D_GENES_TANYA_HEIGHT	APPIERTO_RESPONSE_TO_FENRETINIDE_DN
0.427578834848%	8	1871	50	T2D_GENES_TANYA_HEIGHT	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
0.427578834848%	8	1871	50	T2D_GENES_TANYA_HEIGHT	PARK_APL_PATHOGENESIS_DN
0.427578834848%	8	1871	50	T2D_GENES_TANYA_HEIGHT	KENNY_CTNNB1_TARGETS_UP
0.427578834848%	8	1871	50	T2D_GENES_TANYA_HEIGHT	BECKER_TAMOXIFEN_RESISTANCE_UP
0.427578834848%	8	1871	49	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC
0.427578834848%	8	1871	49	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER
0.427578834848%	8	1871	48	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_MS_UP
0.427578834848%	8	1871	48	T2D_GENES_TANYA_HEIGHT	REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES
0.427578834848%	8	1871	47	T2D_GENES_TANYA_HEIGHT	PID_FANCONI_PATHWAY
0.427578834848%	8	1871	47	T2D_GENES_TANYA_HEIGHT	IRITANI_MAD1_TARGETS_DN
0.427578834848%	8	1871	46	T2D_GENES_TANYA_HEIGHT	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON
0.427578834848%	8	1871	46	T2D_GENES_TANYA_HEIGHT	LEE_AGING_MUSCLE_DN
0.427578834848%	8	1871	44	T2D_GENES_TANYA_HEIGHT	GROSS_HYPOXIA_VIA_ELK3_ONLY_DN
0.427578834848%	8	1871	43	T2D_GENES_TANYA_HEIGHT	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
0.427578834848%	8	1871	43	T2D_GENES_TANYA_HEIGHT	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
0.427578834848%	8	1871	41	T2D_GENES_TANYA_HEIGHT	PID_ER_NONGENOMIC_PATHWAY
0.427578834848%	8	1871	40	T2D_GENES_TANYA_HEIGHT	BURTON_ADIPOGENESIS_PEAK_AT_16HR
0.427578834848%	8	1871	40	T2D_GENES_TANYA_HEIGHT	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN
0.427578834848%	8	1871	40	T2D_GENES_TANYA_HEIGHT	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
0.427578834848%	8	1871	39	T2D_GENES_TANYA_HEIGHT	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
0.427578834848%	8	1871	295	T2D_GENES_TANYA_HEIGHT	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
0.427578834848%	8	1871	28	T2D_GENES_TANYA_HEIGHT	PID_IL8CXCR1_PATHWAY
0.427578834848%	8	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES
0.427578834848%	8	1871	25	T2D_GENES_TANYA_HEIGHT	REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS
0.427578834848%	8	1871	25	T2D_GENES_TANYA_HEIGHT	BIOCARTA_STRESS_PATHWAY
0.427578834848%	8	1871	21	T2D_GENES_TANYA_HEIGHT	MURAKAMI_UV_RESPONSE_6HR_DN
0.427578834848%	8	1871	150	T2D_GENES_TANYA_HEIGHT	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
0.427578834848%	8	1871	145	T2D_GENES_TANYA_HEIGHT	RODWELL_AGING_KIDNEY_DN
0.427578834848%	8	1871	139	T2D_GENES_TANYA_HEIGHT	HOELZEL_NF1_TARGETS_UP
0.427578834848%	8	1871	137	T2D_GENES_TANYA_HEIGHT	LIU_SOX4_TARGETS_UP
0.427578834848%	8	1871	136	T2D_GENES_TANYA_HEIGHT	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.427578834848%	8	1871	130	T2D_GENES_TANYA_HEIGHT	ELVIDGE_HYPOXIA_BY_DMOG_UP
0.427578834848%	8	1871	128	T2D_GENES_TANYA_HEIGHT	YEGNASUBRAMANIAN_PROSTATE_CANCER
0.427578834848%	8	1871	125	T2D_GENES_TANYA_HEIGHT	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
0.427578834848%	8	1871	121	T2D_GENES_TANYA_HEIGHT	VANTVEER_BREAST_CANCER_METASTASIS_DN
0.427578834848%	8	1871	121	T2D_GENES_TANYA_HEIGHT	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
0.427578834848%	8	1871	121	T2D_GENES_TANYA_HEIGHT	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
0.427578834848%	8	1871	118	T2D_GENES_TANYA_HEIGHT	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
0.427578834848%	8	1871	116	T2D_GENES_TANYA_HEIGHT	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
0.427578834848%	8	1871	114	T2D_GENES_TANYA_HEIGHT	SMIRNOV_RESPONSE_TO_IR_6HR_DN
0.427578834848%	8	1871	113	T2D_GENES_TANYA_HEIGHT	RICKMAN_HEAD_AND_NECK_CANCER_C
0.427578834848%	8	1871	111	T2D_GENES_TANYA_HEIGHT	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
0.427578834848%	8	1871	110	T2D_GENES_TANYA_HEIGHT	GHANDHI_DIRECT_IRRADIATION_UP
0.427578834848%	8	1871	109	T2D_GENES_TANYA_HEIGHT	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.427578834848%	8	1871	108	T2D_GENES_TANYA_HEIGHT	LE_EGR2_TARGETS_DN
0.427578834848%	8	1871	105	T2D_GENES_TANYA_HEIGHT	ZWANG_EGF_INTERVAL_UP
0.427578834848%	8	1871	105	T2D_GENES_TANYA_HEIGHT	PID_ERBB1_DOWNSTREAM_PATHWAY
0.427578834848%	8	1871	104	T2D_GENES_TANYA_HEIGHT	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
0.427578834848%	8	1871	102	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_IPS_WITH_HCP_H3K27ME3
0.427578834848%	8	1871	102	T2D_GENES_TANYA_HEIGHT	LABBE_TGFB1_TARGETS_UP
0.427578834848%	8	1871	101	T2D_GENES_TANYA_HEIGHT	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
0.427578834848%	8	1871	101	T2D_GENES_TANYA_HEIGHT	GRADE_COLON_AND_RECTAL_CANCER_DN
0.427578834848%	8	1871	100	T2D_GENES_TANYA_HEIGHT	MCCLUNG_CREB1_TARGETS_UP
0.427578834848%	8	1871	100	T2D_GENES_TANYA_HEIGHT	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
0.427578834848%	8	1871	100	T2D_GENES_TANYA_HEIGHT	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
0.426136363636%	15	3520	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
0.426136363636%	15	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
0.426136363636%	15	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
0.426136363636%	15	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_RIBOSOME
0.426136363636%	15	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DURCHDEWALD_SKIN_CARCINOGENESIS_UP
0.426136363636%	15	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ALCALA_APOPTOSIS
0.426136363636%	15	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
0.426136363636%	15	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BAELDE_DIABETIC_NEPHROPATHY_UP
0.426136363636%	15	3520	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
0.426136363636%	15	3520	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_REG_GR_PATHWAY
0.426136363636%	15	3520	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_MET_PATHWAY
0.426136363636%	15	3520	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.426136363636%	15	3520	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION
0.426136363636%	15	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZAMORA_NOS2_TARGETS_UP
0.426136363636%	15	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
0.426136363636%	15	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
0.426136363636%	15	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_PPARA_PATHWAY
0.426136363636%	15	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_TYPE_I_DIABETES_MELLITUS
0.426136363636%	15	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ALLOGRAFT_REJECTION
0.426136363636%	15	3520	214	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_WT1_TARGETS_UP
0.426136363636%	15	3520	210	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
0.426136363636%	15	3520	190	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.426136363636%	15	3520	188	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.426136363636%	15	3520	185	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
0.426136363636%	15	3520	182	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAO_BOUND_BY_SALL4_ISOFORM_A
0.426136363636%	15	3520	178	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_18HR_UP
0.426136363636%	15	3520	176	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX
0.426136363636%	15	3520	176	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION
0.426136363636%	15	3520	175	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.426136363636%	15	3520	167	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
0.426136363636%	15	3520	161	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MRNA_PROCESSING
0.426136363636%	15	3520	156	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_DN
0.426136363636%	15	3520	154	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
0.426136363636%	15	3520	149	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TSAI_RESPONSE_TO_IONIZING_RADIATION
0.426136363636%	15	3520	148	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_24HR_DN
0.426136363636%	15	3520	146	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ELVIDGE_HYPOXIA_DN
0.426136363636%	15	3520	143	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
0.426136363636%	15	3520	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_ES_LCP_WITH_H3K4ME3
0.426136363636%	15	3520	138	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
0.426136363636%	15	3520	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MITOTIC_G1_G1_S_PHASES
0.426136363636%	15	3520	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_P53DOWNSTREAMPATHWAY
0.426136363636%	15	3520	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
0.426136363636%	15	3520	136	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PROVENZANI_METASTASIS_DN
0.426136363636%	15	3520	134	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_TIGHT_JUNCTION
0.426136363636%	15	3520	130	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAGI_AML_WITH_T_9_11_TRANSLOCATION
0.426136363636%	15	3520	129	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAGI_AML_SURVIVAL
0.426136363636%	15	3520	129	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP
0.426136363636%	15	3520	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YEGNASUBRAMANIAN_PROSTATE_CANCER
0.426136363636%	15	3520	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
0.426136363636%	15	3520	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_5
0.426136363636%	15	3520	125	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
0.426136363636%	15	3520	123	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAYO_AGING_MUSCLE_DN
0.426136363636%	15	3520	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
0.426136363636%	15	3520	120	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_GH1_EXOGENOUS_TARGETS_DN
0.426136363636%	15	3520	120	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN
0.426136363636%	15	3520	118	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
0.426136363636%	15	3520	117	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PUJANA_BRCA_CENTERED_NETWORK
0.426136363636%	15	3520	115	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
0.426136363636%	15	3520	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.426136363636%	15	3520	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
0.426136363636%	15	3520	107	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROESSLER_LIVER_CANCER_METASTASIS_UP
0.426136363636%	15	3520	104	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
0.426136363636%	15	3520	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.426136363636%	15	3520	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRADE_COLON_AND_RECTAL_CANCER_DN
0.413983440662%	9	2174	98	T2D_GENES_TANYA_LIPIDS	REACTOME_POTASSIUM_CHANNELS
0.413983440662%	9	2174	98	T2D_GENES_TANYA_LIPIDS	PYEON_HPV_POSITIVE_TUMORS_UP
0.413983440662%	9	2174	98	T2D_GENES_TANYA_LIPIDS	MENSE_HYPOXIA_UP
0.413983440662%	9	2174	97	T2D_GENES_TANYA_LIPIDS	KIM_MYC_AMPLIFICATION_TARGETS_DN
0.413983440662%	9	2174	94	T2D_GENES_TANYA_LIPIDS	REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES
0.413983440662%	9	2174	92	T2D_GENES_TANYA_LIPIDS	DE_YY1_TARGETS_DN
0.413983440662%	9	2174	92	T2D_GENES_TANYA_LIPIDS	BURTON_ADIPOGENESIS_9
0.413983440662%	9	2174	91	T2D_GENES_TANYA_LIPIDS	ZHU_CMV_24_HR_DN
0.413983440662%	9	2174	91	T2D_GENES_TANYA_LIPIDS	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
0.413983440662%	9	2174	90	T2D_GENES_TANYA_LIPIDS	SASSON_RESPONSE_TO_FORSKOLIN_UP
0.413983440662%	9	2174	90	T2D_GENES_TANYA_LIPIDS	IVANOVSKA_MIR106B_TARGETS
0.413983440662%	9	2174	89	T2D_GENES_TANYA_LIPIDS	RICKMAN_HEAD_AND_NECK_CANCER_E
0.413983440662%	9	2174	89	T2D_GENES_TANYA_LIPIDS	LI_DCP2_BOUND_MRNA
0.413983440662%	9	2174	88	T2D_GENES_TANYA_LIPIDS	UEDA_CENTRAL_CLOCK
0.413983440662%	9	2174	88	T2D_GENES_TANYA_LIPIDS	KEGG_APOPTOSIS
0.413983440662%	9	2174	87	T2D_GENES_TANYA_LIPIDS	SMITH_TERT_TARGETS_DN
0.413983440662%	9	2174	87	T2D_GENES_TANYA_LIPIDS	REACTOME_MITOTIC_PROMETAPHASE
0.413983440662%	9	2174	86	T2D_GENES_TANYA_LIPIDS	REACTOME_L1CAM_INTERACTIONS
0.413983440662%	9	2174	86	T2D_GENES_TANYA_LIPIDS	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
0.413983440662%	9	2174	84	T2D_GENES_TANYA_LIPIDS	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
0.413983440662%	9	2174	83	T2D_GENES_TANYA_LIPIDS	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.413983440662%	9	2174	83	T2D_GENES_TANYA_LIPIDS	JIANG_HYPOXIA_CANCER
0.413983440662%	9	2174	82	T2D_GENES_TANYA_LIPIDS	ST_INTEGRIN_SIGNALING_PATHWAY
0.413983440662%	9	2174	82	T2D_GENES_TANYA_LIPIDS	ODONNELL_METASTASIS_UP
0.413983440662%	9	2174	82	T2D_GENES_TANYA_LIPIDS	LEIN_MIDBRAIN_MARKERS
0.413983440662%	9	2174	82	T2D_GENES_TANYA_LIPIDS	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
0.413983440662%	9	2174	81	T2D_GENES_TANYA_LIPIDS	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.413983440662%	9	2174	81	T2D_GENES_TANYA_LIPIDS	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION
0.413983440662%	9	2174	81	T2D_GENES_TANYA_LIPIDS	LEIN_MEDULLA_MARKERS
0.413983440662%	9	2174	81	T2D_GENES_TANYA_LIPIDS	HUANG_DASATINIB_RESISTANCE_UP
0.413983440662%	9	2174	80	T2D_GENES_TANYA_LIPIDS	MORI_PRE_BI_LYMPHOCYTE_UP
0.413983440662%	9	2174	80	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
0.413983440662%	9	2174	79	T2D_GENES_TANYA_LIPIDS	MCCLUNG_COCAINE_REWARD_5D
0.413983440662%	9	2174	79	T2D_GENES_TANYA_LIPIDS	DUAN_PRDM5_TARGETS
0.413983440662%	9	2174	79	T2D_GENES_TANYA_LIPIDS	CROMER_METASTASIS_UP
0.413983440662%	9	2174	78	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_SCF_KIT
0.413983440662%	9	2174	78	T2D_GENES_TANYA_LIPIDS	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE
0.413983440662%	9	2174	77	T2D_GENES_TANYA_LIPIDS	MORI_PRE_BI_LYMPHOCYTE_DN
0.413983440662%	9	2174	75	T2D_GENES_TANYA_LIPIDS	KEGG_ADHERENS_JUNCTION
0.413983440662%	9	2174	74	T2D_GENES_TANYA_LIPIDS	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
0.413983440662%	9	2174	73	T2D_GENES_TANYA_LIPIDS	DITTMER_PTHLH_TARGETS_DN
0.413983440662%	9	2174	72	T2D_GENES_TANYA_LIPIDS	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
0.413983440662%	9	2174	72	T2D_GENES_TANYA_LIPIDS	DOANE_BREAST_CANCER_CLASSES_UP
0.413983440662%	9	2174	72	T2D_GENES_TANYA_LIPIDS	BURTON_ADIPOGENESIS_2
0.413983440662%	9	2174	71	T2D_GENES_TANYA_LIPIDS	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
0.413983440662%	9	2174	71	T2D_GENES_TANYA_LIPIDS	KEGG_MELANOMA
0.413983440662%	9	2174	71	T2D_GENES_TANYA_LIPIDS	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
0.413983440662%	9	2174	70	T2D_GENES_TANYA_LIPIDS	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
0.413983440662%	9	2174	70	T2D_GENES_TANYA_LIPIDS	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5
0.413983440662%	9	2174	70	T2D_GENES_TANYA_LIPIDS	LIU_NASOPHARYNGEAL_CARCINOMA
0.413983440662%	9	2174	70	T2D_GENES_TANYA_LIPIDS	KEGG_LONG_TERM_POTENTIATION
0.413983440662%	9	2174	69	T2D_GENES_TANYA_LIPIDS	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
0.413983440662%	9	2174	69	T2D_GENES_TANYA_LIPIDS	PID_P75NTRPATHWAY
0.413983440662%	9	2174	69	T2D_GENES_TANYA_LIPIDS	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.413983440662%	9	2174	68	T2D_GENES_TANYA_LIPIDS	SESTO_RESPONSE_TO_UV_C7
0.413983440662%	9	2174	68	T2D_GENES_TANYA_LIPIDS	REACTOME_SEMAPHORIN_INTERACTIONS
0.413983440662%	9	2174	67	T2D_GENES_TANYA_LIPIDS	VANHARANTA_UTERINE_FIBROID_DN
0.413983440662%	9	2174	67	T2D_GENES_TANYA_LIPIDS	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
0.413983440662%	9	2174	66	T2D_GENES_TANYA_LIPIDS	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM
0.413983440662%	9	2174	66	T2D_GENES_TANYA_LIPIDS	MARSON_FOXP3_TARGETS_UP
0.413983440662%	9	2174	65	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_WNT
0.413983440662%	9	2174	65	T2D_GENES_TANYA_LIPIDS	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
0.413983440662%	9	2174	65	T2D_GENES_TANYA_LIPIDS	PID_RB_1PATHWAY
0.413983440662%	9	2174	65	T2D_GENES_TANYA_LIPIDS	PID_IL4_2PATHWAY
0.413983440662%	9	2174	65	T2D_GENES_TANYA_LIPIDS	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP
0.413983440662%	9	2174	65	T2D_GENES_TANYA_LIPIDS	CHANG_IMMORTALIZED_BY_HPV31_DN
0.413983440662%	9	2174	64	T2D_GENES_TANYA_LIPIDS	RHODES_CANCER_META_SIGNATURE
0.413983440662%	9	2174	64	T2D_GENES_TANYA_LIPIDS	BYSTROEM_CORRELATED_WITH_IL5_DN
0.413983440662%	9	2174	63	T2D_GENES_TANYA_LIPIDS	BRIDEAU_IMPRINTED_GENES
0.413983440662%	9	2174	62	T2D_GENES_TANYA_LIPIDS	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP
0.413983440662%	9	2174	61	T2D_GENES_TANYA_LIPIDS	REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS
0.413983440662%	9	2174	61	T2D_GENES_TANYA_LIPIDS	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
0.413983440662%	9	2174	61	T2D_GENES_TANYA_LIPIDS	RAMASWAMY_METASTASIS_DN
0.413983440662%	9	2174	60	T2D_GENES_TANYA_LIPIDS	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN
0.413983440662%	9	2174	59	T2D_GENES_TANYA_LIPIDS	PID_FAK_PATHWAY
0.413983440662%	9	2174	59	T2D_GENES_TANYA_LIPIDS	HUPER_BREAST_BASAL_VS_LUMINAL_DN
0.413983440662%	9	2174	58	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_APOPTOSIS
0.413983440662%	9	2174	57	T2D_GENES_TANYA_LIPIDS	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
0.413983440662%	9	2174	57	T2D_GENES_TANYA_LIPIDS	TONG_INTERACT_WITH_PTTG1
0.413983440662%	9	2174	57	T2D_GENES_TANYA_LIPIDS	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.413983440662%	9	2174	57	T2D_GENES_TANYA_LIPIDS	AMIT_SERUM_RESPONSE_240_MCF10A
0.413983440662%	9	2174	56	T2D_GENES_TANYA_LIPIDS	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.413983440662%	9	2174	56	T2D_GENES_TANYA_LIPIDS	REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX
0.413983440662%	9	2174	56	T2D_GENES_TANYA_LIPIDS	KEGG_HEDGEHOG_SIGNALING_PATHWAY
0.413983440662%	9	2174	56	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_30MIN_UP
0.413983440662%	9	2174	55	T2D_GENES_TANYA_LIPIDS	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER
0.413983440662%	9	2174	54	T2D_GENES_TANYA_LIPIDS	RICKMAN_HEAD_AND_NECK_CANCER_F
0.413983440662%	9	2174	54	T2D_GENES_TANYA_LIPIDS	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN
0.413983440662%	9	2174	54	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER_MYC_UP
0.413983440662%	9	2174	53	T2D_GENES_TANYA_LIPIDS	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS
0.413983440662%	9	2174	53	T2D_GENES_TANYA_LIPIDS	MENSSEN_MYC_TARGETS
0.413983440662%	9	2174	53	T2D_GENES_TANYA_LIPIDS	LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.413983440662%	9	2174	53	T2D_GENES_TANYA_LIPIDS	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP
0.413983440662%	9	2174	52	T2D_GENES_TANYA_LIPIDS	REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.413983440662%	9	2174	51	T2D_GENES_TANYA_LIPIDS	REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.413983440662%	9	2174	51	T2D_GENES_TANYA_LIPIDS	REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT
0.413983440662%	9	2174	51	T2D_GENES_TANYA_LIPIDS	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
0.413983440662%	9	2174	51	T2D_GENES_TANYA_LIPIDS	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
0.413983440662%	9	2174	50	T2D_GENES_TANYA_LIPIDS	KOHOUTEK_CCNT1_TARGETS
0.413983440662%	9	2174	49	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC
0.413983440662%	9	2174	49	T2D_GENES_TANYA_LIPIDS	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.413983440662%	9	2174	48	T2D_GENES_TANYA_LIPIDS	REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES
0.413983440662%	9	2174	48	T2D_GENES_TANYA_LIPIDS	REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6
0.413983440662%	9	2174	48	T2D_GENES_TANYA_LIPIDS	PID_HEDGEHOG_GLIPATHWAY
0.413983440662%	9	2174	48	T2D_GENES_TANYA_LIPIDS	KEGG_PROTEASOME
0.413983440662%	9	2174	47	T2D_GENES_TANYA_LIPIDS	MELLMAN_TUT1_TARGETS_DN
0.413983440662%	9	2174	46	T2D_GENES_TANYA_LIPIDS	LEE_AGING_MUSCLE_DN
0.413983440662%	9	2174	45	T2D_GENES_TANYA_LIPIDS	ST_T_CELL_SIGNAL_TRANSDUCTION
0.413983440662%	9	2174	45	T2D_GENES_TANYA_LIPIDS	ABRAMSON_INTERACT_WITH_AIRE
0.413983440662%	9	2174	44	T2D_GENES_TANYA_LIPIDS	PID_ERBB2ERBB3PATHWAY
0.413983440662%	9	2174	43	T2D_GENES_TANYA_LIPIDS	LASTOWSKA_COAMPLIFIED_WITH_MYCN
0.413983440662%	9	2174	43	T2D_GENES_TANYA_LIPIDS	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
0.413983440662%	9	2174	43	T2D_GENES_TANYA_LIPIDS	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
0.413983440662%	9	2174	42	T2D_GENES_TANYA_LIPIDS	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
0.413983440662%	9	2174	42	T2D_GENES_TANYA_LIPIDS	WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN
0.413983440662%	9	2174	42	T2D_GENES_TANYA_LIPIDS	KEGG_BLADDER_CANCER
0.413983440662%	9	2174	42	T2D_GENES_TANYA_LIPIDS	BILBAN_B_CLL_LPL_DN
0.413983440662%	9	2174	40	T2D_GENES_TANYA_LIPIDS	BENPORATH_ES_2
0.413983440662%	9	2174	39	T2D_GENES_TANYA_LIPIDS	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
0.413983440662%	9	2174	39	T2D_GENES_TANYA_LIPIDS	BIOCARTA_FMLP_PATHWAY
0.413983440662%	9	2174	37	T2D_GENES_TANYA_LIPIDS	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR
0.413983440662%	9	2174	36	T2D_GENES_TANYA_LIPIDS	STEARMAN_TUMOR_FIELD_EFFECT_UP
0.413983440662%	9	2174	35	T2D_GENES_TANYA_LIPIDS	KEGG_PRIMARY_IMMUNODEFICIENCY
0.413983440662%	9	2174	34	T2D_GENES_TANYA_LIPIDS	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT
0.413983440662%	9	2174	32	T2D_GENES_TANYA_LIPIDS	BAUS_TFF2_TARGETS_UP
0.413983440662%	9	2174	31	T2D_GENES_TANYA_LIPIDS	PID_AVB3_OPN_PATHWAY
0.413983440662%	9	2174	31	T2D_GENES_TANYA_LIPIDS	PID_AR_NONGENOMIC_PATHWAY
0.413983440662%	9	2174	30	T2D_GENES_TANYA_LIPIDS	KEGG_ASTHMA
0.413983440662%	9	2174	295	T2D_GENES_TANYA_LIPIDS	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
0.413983440662%	9	2174	29	T2D_GENES_TANYA_LIPIDS	PID_S1P_S1P3_PATHWAY
0.413983440662%	9	2174	26	T2D_GENES_TANYA_LIPIDS	PID_VEGFR1_PATHWAY
0.413983440662%	9	2174	26	T2D_GENES_TANYA_LIPIDS	PID_RXR_VDR_PATHWAY
0.413983440662%	9	2174	198	T2D_GENES_TANYA_LIPIDS	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.413983440662%	9	2174	170	T2D_GENES_TANYA_LIPIDS	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.413983440662%	9	2174	127	T2D_GENES_TANYA_LIPIDS	INGRAM_SHH_TARGETS_UP
0.413983440662%	9	2174	126	T2D_GENES_TANYA_LIPIDS	MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.413983440662%	9	2174	121	T2D_GENES_TANYA_LIPIDS	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS
0.413983440662%	9	2174	118	T2D_GENES_TANYA_LIPIDS	CERVERA_SDHB_TARGETS_1_UP
0.413983440662%	9	2174	116	T2D_GENES_TANYA_LIPIDS	WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.413983440662%	9	2174	116	T2D_GENES_TANYA_LIPIDS	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
0.413983440662%	9	2174	116	T2D_GENES_TANYA_LIPIDS	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
0.413983440662%	9	2174	114	T2D_GENES_TANYA_LIPIDS	SENESE_HDAC2_TARGETS_UP
0.413983440662%	9	2174	111	T2D_GENES_TANYA_LIPIDS	REACTOME_GLYCOSAMINOGLYCAN_METABOLISM
0.413983440662%	9	2174	111	T2D_GENES_TANYA_LIPIDS	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.413983440662%	9	2174	110	T2D_GENES_TANYA_LIPIDS	GHANDHI_DIRECT_IRRADIATION_UP
0.413983440662%	9	2174	109	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
0.405268490375%	8	1974	95	Mendelian_Nancy_Cox	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
0.405268490375%	8	1974	9	Mendelian_Nancy_Cox	BIOCARTA_FEEDER_PATHWAY
0.405268490375%	8	1974	87	Mendelian_Nancy_Cox	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
0.405268490375%	8	1974	86	Mendelian_Nancy_Cox	GHANDHI_BYSTANDER_IRRADIATION_UP
0.405268490375%	8	1974	85	Mendelian_Nancy_Cox	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
0.405268490375%	8	1974	84	Mendelian_Nancy_Cox	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
0.405268490375%	8	1974	83	Mendelian_Nancy_Cox	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.405268490375%	8	1974	81	Mendelian_Nancy_Cox	REACTOME_M_G1_TRANSITION
0.405268490375%	8	1974	80	Mendelian_Nancy_Cox	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
0.405268490375%	8	1974	77	Mendelian_Nancy_Cox	CHEBOTAEV_GR_TARGETS_UP
0.405268490375%	8	1974	74	Mendelian_Nancy_Cox	FURUKAWA_DUSP6_TARGETS_PCI35_UP
0.405268490375%	8	1974	74	Mendelian_Nancy_Cox	FURUKAWA_DUSP6_TARGETS_PCI35_DN
0.405268490375%	8	1974	74	Mendelian_Nancy_Cox	CORRE_MULTIPLE_MYELOMA_UP
0.405268490375%	8	1974	73	Mendelian_Nancy_Cox	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.405268490375%	8	1974	71	Mendelian_Nancy_Cox	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.405268490375%	8	1974	69	Mendelian_Nancy_Cox	LEIN_NEURON_MARKERS
0.405268490375%	8	1974	68	Mendelian_Nancy_Cox	NOUZOVA_METHYLATED_IN_APL
0.405268490375%	8	1974	67	Mendelian_Nancy_Cox	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP
0.405268490375%	8	1974	66	Mendelian_Nancy_Cox	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT
0.405268490375%	8	1974	66	Mendelian_Nancy_Cox	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP
0.405268490375%	8	1974	64	Mendelian_Nancy_Cox	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
0.405268490375%	8	1974	60	Mendelian_Nancy_Cox	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.405268490375%	8	1974	60	Mendelian_Nancy_Cox	AMIT_EGF_RESPONSE_240_HELA
0.405268490375%	8	1974	59	Mendelian_Nancy_Cox	HUPER_BREAST_BASAL_VS_LUMINAL_DN
0.405268490375%	8	1974	57	Mendelian_Nancy_Cox	DELASERNA_MYOD_TARGETS_DN
0.405268490375%	8	1974	56	Mendelian_Nancy_Cox	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.405268490375%	8	1974	55	Mendelian_Nancy_Cox	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
0.405268490375%	8	1974	55	Mendelian_Nancy_Cox	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR
0.405268490375%	8	1974	54	Mendelian_Nancy_Cox	MIKKELSEN_IPS_ICP_WITH_H3K27ME3
0.405268490375%	8	1974	54	Mendelian_Nancy_Cox	MARSON_FOXP3_TARGETS_DN
0.405268490375%	8	1974	54	Mendelian_Nancy_Cox	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN
0.405268490375%	8	1974	54	Mendelian_Nancy_Cox	LEE_LIVER_CANCER_MYC_UP
0.405268490375%	8	1974	54	Mendelian_Nancy_Cox	JIANG_AGING_CEREBRAL_CORTEX_DN
0.405268490375%	8	1974	53	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON
0.405268490375%	8	1974	53	Mendelian_Nancy_Cox	LIANG_SILENCED_BY_METHYLATION_2
0.405268490375%	8	1974	52	Mendelian_Nancy_Cox	WINTER_HYPOXIA_DN
0.405268490375%	8	1974	52	Mendelian_Nancy_Cox	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
0.405268490375%	8	1974	52	Mendelian_Nancy_Cox	KENNY_CTNNB1_TARGETS_DN
0.405268490375%	8	1974	51	Mendelian_Nancy_Cox	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP
0.405268490375%	8	1974	51	Mendelian_Nancy_Cox	APPIERTO_RESPONSE_TO_FENRETINIDE_DN
0.405268490375%	8	1974	50	Mendelian_Nancy_Cox	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN
0.405268490375%	8	1974	50	Mendelian_Nancy_Cox	CHIBA_RESPONSE_TO_TSA
0.405268490375%	8	1974	50	Mendelian_Nancy_Cox	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS
0.405268490375%	8	1974	49	Mendelian_Nancy_Cox	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP
0.405268490375%	8	1974	49	Mendelian_Nancy_Cox	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN
0.405268490375%	8	1974	48	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_MS_UP
0.405268490375%	8	1974	48	Mendelian_Nancy_Cox	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.405268490375%	8	1974	47	Mendelian_Nancy_Cox	KEGG_NOTCH_SIGNALING_PATHWAY
0.405268490375%	8	1974	46	Mendelian_Nancy_Cox	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
0.405268490375%	8	1974	46	Mendelian_Nancy_Cox	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
0.405268490375%	8	1974	46	Mendelian_Nancy_Cox	NUTT_GBM_VS_AO_GLIOMA_UP
0.405268490375%	8	1974	46	Mendelian_Nancy_Cox	JIANG_TIP30_TARGETS_UP
0.405268490375%	8	1974	46	Mendelian_Nancy_Cox	HALMOS_CEBPA_TARGETS_DN
0.405268490375%	8	1974	45	Mendelian_Nancy_Cox	REACTOME_G2_M_CHECKPOINTS
0.405268490375%	8	1974	45	Mendelian_Nancy_Cox	LEE_AGING_MUSCLE_UP
0.405268490375%	8	1974	45	Mendelian_Nancy_Cox	CHENG_RESPONSE_TO_NICKEL_ACETATE
0.405268490375%	8	1974	44	Mendelian_Nancy_Cox	MEDINA_SMARCA4_TARGETS
0.405268490375%	8	1974	44	Mendelian_Nancy_Cox	KERLEY_RESPONSE_TO_CISPLATIN_UP
0.405268490375%	8	1974	43	Mendelian_Nancy_Cox	ZUCCHI_METASTASIS_UP
0.405268490375%	8	1974	43	Mendelian_Nancy_Cox	POTTI_ETOPOSIDE_SENSITIVITY
0.405268490375%	8	1974	43	Mendelian_Nancy_Cox	POTTI_5FU_SENSITIVITY
0.405268490375%	8	1974	43	Mendelian_Nancy_Cox	NAKAMURA_METASTASIS_MODEL_DN
0.405268490375%	8	1974	43	Mendelian_Nancy_Cox	MANTOVANI_NFKB_TARGETS_UP
0.405268490375%	8	1974	43	Mendelian_Nancy_Cox	HUMMEL_BURKITTS_LYMPHOMA_UP
0.405268490375%	8	1974	43	Mendelian_Nancy_Cox	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
0.405268490375%	8	1974	42	Mendelian_Nancy_Cox	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
0.405268490375%	8	1974	42	Mendelian_Nancy_Cox	KEGG_GRAFT_VERSUS_HOST_DISEASE
0.405268490375%	8	1974	41	Mendelian_Nancy_Cox	KAAB_FAILED_HEART_VENTRICLE_DN
0.405268490375%	8	1974	41	Mendelian_Nancy_Cox	BIOCARTA_FCER1_PATHWAY
0.405268490375%	8	1974	40	Mendelian_Nancy_Cox	RIZ_ERYTHROID_DIFFERENTIATION_6HR
0.405268490375%	8	1974	40	Mendelian_Nancy_Cox	PID_EPHBFWDPATHWAY
0.405268490375%	8	1974	40	Mendelian_Nancy_Cox	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP
0.405268490375%	8	1974	40	Mendelian_Nancy_Cox	HEIDENBLAD_AMPLICON_8Q24_UP
0.405268490375%	8	1974	40	Mendelian_Nancy_Cox	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN
0.405268490375%	8	1974	40	Mendelian_Nancy_Cox	BIOCARTA_P38MAPK_PATHWAY
0.405268490375%	8	1974	39	Mendelian_Nancy_Cox	SESTO_RESPONSE_TO_UV_C6
0.405268490375%	8	1974	39	Mendelian_Nancy_Cox	PID_RET_PATHWAY
0.405268490375%	8	1974	38	Mendelian_Nancy_Cox	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
0.405268490375%	8	1974	38	Mendelian_Nancy_Cox	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
0.405268490375%	8	1974	38	Mendelian_Nancy_Cox	KAAB_FAILED_HEART_ATRIUM_UP
0.405268490375%	8	1974	38	Mendelian_Nancy_Cox	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN
0.405268490375%	8	1974	38	Mendelian_Nancy_Cox	GEISS_RESPONSE_TO_DSRNA_UP
0.405268490375%	8	1974	38	Mendelian_Nancy_Cox	CERVERA_SDHB_TARGETS_1_DN
0.405268490375%	8	1974	38	Mendelian_Nancy_Cox	CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN
0.405268490375%	8	1974	38	Mendelian_Nancy_Cox	BIOCARTA_INTEGRIN_PATHWAY
0.405268490375%	8	1974	37	Mendelian_Nancy_Cox	ROLEF_GLIS3_TARGETS
0.405268490375%	8	1974	37	Mendelian_Nancy_Cox	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2
0.405268490375%	8	1974	37	Mendelian_Nancy_Cox	KIM_ALL_DISORDERS_CALB1_CORR_DN
0.405268490375%	8	1974	36	Mendelian_Nancy_Cox	REACTOME_IRON_UPTAKE_AND_TRANSPORT
0.405268490375%	8	1974	35	Mendelian_Nancy_Cox	REACTOME_GLOBAL_GENOMIC_NER_GG_NER
0.405268490375%	8	1974	35	Mendelian_Nancy_Cox	REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION
0.405268490375%	8	1974	35	Mendelian_Nancy_Cox	LIEN_BREAST_CARCINOMA_METAPLASTIC
0.405268490375%	8	1974	35	Mendelian_Nancy_Cox	HOWLIN_CITED1_TARGETS_1_UP
0.405268490375%	8	1974	34	Mendelian_Nancy_Cox	ST_WNT_BETA_CATENIN_PATHWAY
0.405268490375%	8	1974	34	Mendelian_Nancy_Cox	SCHOEN_NFKB_SIGNALING
0.405268490375%	8	1974	34	Mendelian_Nancy_Cox	REACTOME_SIGNAL_TRANSDUCTION_BY_L1
0.405268490375%	8	1974	34	Mendelian_Nancy_Cox	PETRETTO_CARDIAC_HYPERTROPHY
0.405268490375%	8	1974	33	Mendelian_Nancy_Cox	SIMBULAN_UV_RESPONSE_NORMAL_DN
0.405268490375%	8	1974	33	Mendelian_Nancy_Cox	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.405268490375%	8	1974	33	Mendelian_Nancy_Cox	DUTTA_APOPTOSIS_VIA_NFKB
0.405268490375%	8	1974	33	Mendelian_Nancy_Cox	BIOCARTA_NO1_PATHWAY
0.405268490375%	8	1974	32	Mendelian_Nancy_Cox	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN
0.405268490375%	8	1974	31	Mendelian_Nancy_Cox	THEODOROU_MAMMARY_TUMORIGENESIS
0.405268490375%	8	1974	31	Mendelian_Nancy_Cox	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES
0.405268490375%	8	1974	31	Mendelian_Nancy_Cox	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
0.405268490375%	8	1974	31	Mendelian_Nancy_Cox	PID_AVB3_OPN_PATHWAY
0.405268490375%	8	1974	31	Mendelian_Nancy_Cox	MCCABE_HOXC6_TARGETS_CANCER_UP
0.405268490375%	8	1974	30	Mendelian_Nancy_Cox	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.405268490375%	8	1974	30	Mendelian_Nancy_Cox	TSENG_ADIPOGENIC_POTENTIAL_UP
0.405268490375%	8	1974	30	Mendelian_Nancy_Cox	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
0.405268490375%	8	1974	30	Mendelian_Nancy_Cox	REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM
0.405268490375%	8	1974	30	Mendelian_Nancy_Cox	PID_NECTIN_PATHWAY
0.405268490375%	8	1974	30	Mendelian_Nancy_Cox	PID_EPHRINBREVPATHWAY
0.405268490375%	8	1974	30	Mendelian_Nancy_Cox	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.405268490375%	8	1974	29	Mendelian_Nancy_Cox	REACTOME_GLYCOLYSIS
0.405268490375%	8	1974	29	Mendelian_Nancy_Cox	PID_S1P_S1P3_PATHWAY
0.405268490375%	8	1974	29	Mendelian_Nancy_Cox	KEGG_HISTIDINE_METABOLISM
0.405268490375%	8	1974	29	Mendelian_Nancy_Cox	BIOCARTA_VEGF_PATHWAY
0.405268490375%	8	1974	29	Mendelian_Nancy_Cox	BIOCARTA_TNFR1_PATHWAY
0.405268490375%	8	1974	28	Mendelian_Nancy_Cox	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
0.405268490375%	8	1974	28	Mendelian_Nancy_Cox	PID_WNT_SIGNALING_PATHWAY
0.405268490375%	8	1974	28	Mendelian_Nancy_Cox	PID_TRAIL_PATHWAY
0.405268490375%	8	1974	28	Mendelian_Nancy_Cox	CHEN_LUNG_CANCER_SURVIVAL
0.405268490375%	8	1974	27	Mendelian_Nancy_Cox	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP
0.405268490375%	8	1974	27	Mendelian_Nancy_Cox	REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING
0.405268490375%	8	1974	27	Mendelian_Nancy_Cox	OHM_METHYLATED_IN_ADULT_CANCERS
0.405268490375%	8	1974	27	Mendelian_Nancy_Cox	BIOCARTA_GSK3_PATHWAY
0.405268490375%	8	1974	26	Mendelian_Nancy_Cox	ST_INTERLEUKIN_4_PATHWAY
0.405268490375%	8	1974	26	Mendelian_Nancy_Cox	REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS
0.405268490375%	8	1974	26	Mendelian_Nancy_Cox	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
0.405268490375%	8	1974	26	Mendelian_Nancy_Cox	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP
0.405268490375%	8	1974	25	Mendelian_Nancy_Cox	VERRECCHIA_RESPONSE_TO_TGFB1_C2
0.405268490375%	8	1974	25	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17
0.405268490375%	8	1974	25	Mendelian_Nancy_Cox	KIM_HYPOXIA
0.405268490375%	8	1974	24	Mendelian_Nancy_Cox	YIH_RESPONSE_TO_ARSENITE_C1
0.405268490375%	8	1974	24	Mendelian_Nancy_Cox	WILLERT_WNT_SIGNALING
0.405268490375%	8	1974	24	Mendelian_Nancy_Cox	REACTOME_PYRIMIDINE_METABOLISM
0.405268490375%	8	1974	24	Mendelian_Nancy_Cox	GOLUB_ALL_VS_AML_DN
0.405268490375%	8	1974	24	Mendelian_Nancy_Cox	BIOCARTA_CSK_PATHWAY
0.405268490375%	8	1974	23	Mendelian_Nancy_Cox	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER
0.405268490375%	8	1974	23	Mendelian_Nancy_Cox	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION
0.405268490375%	8	1974	23	Mendelian_Nancy_Cox	KEGG_NITROGEN_METABOLISM
0.405268490375%	8	1974	22	Mendelian_Nancy_Cox	WELCH_GATA1_TARGETS
0.405268490375%	8	1974	22	Mendelian_Nancy_Cox	BIOCARTA_IL2_PATHWAY
0.405268490375%	8	1974	22	Mendelian_Nancy_Cox	BIOCARTA_AKT_PATHWAY
0.405268490375%	8	1974	21	Mendelian_Nancy_Cox	REACTOME_PEROXISOMAL_LIPID_METABOLISM
0.405268490375%	8	1974	21	Mendelian_Nancy_Cox	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN
0.405268490375%	8	1974	21	Mendelian_Nancy_Cox	BIOCARTA_IGF1_PATHWAY
0.405268490375%	8	1974	19	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS
0.405268490375%	8	1974	19	Mendelian_Nancy_Cox	REACTOME_PYRUVATE_METABOLISM
0.405268490375%	8	1974	19	Mendelian_Nancy_Cox	FARMER_BREAST_CANCER_CLUSTER_5
0.405268490375%	8	1974	19	Mendelian_Nancy_Cox	BIOCARTA_TID_PATHWAY
0.405268490375%	8	1974	19	Mendelian_Nancy_Cox	BIOCARTA_MAL_PATHWAY
0.405268490375%	8	1974	18	Mendelian_Nancy_Cox	REACTOME_GAP_JUNCTION_ASSEMBLY
0.405268490375%	8	1974	18	Mendelian_Nancy_Cox	NIELSEN_SCHWANNOMA_UP
0.405268490375%	8	1974	18	Mendelian_Nancy_Cox	BIOCARTA_MCM_PATHWAY
0.405268490375%	8	1974	17	Mendelian_Nancy_Cox	LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED
0.405268490375%	8	1974	17	Mendelian_Nancy_Cox	KEGG_STEROID_BIOSYNTHESIS
0.405268490375%	8	1974	17	Mendelian_Nancy_Cox	BIOCARTA_ARF_PATHWAY
0.405268490375%	8	1974	15	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3
0.405268490375%	8	1974	15	Mendelian_Nancy_Cox	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING
0.405268490375%	8	1974	15	Mendelian_Nancy_Cox	BIOCARTA_CTL_PATHWAY
0.405268490375%	8	1974	14	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_COMPLEMENT_CASCADE
0.405268490375%	8	1974	122	Mendelian_Nancy_Cox	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
0.405268490375%	8	1974	120	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_16P13_AMPLICON
0.405268490375%	8	1974	114	Mendelian_Nancy_Cox	SMIRNOV_RESPONSE_TO_IR_6HR_DN
0.405268490375%	8	1974	11	Mendelian_Nancy_Cox	REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS
0.405268490375%	8	1974	105	Mendelian_Nancy_Cox	REACTOME_RNA_POL_II_TRANSCRIPTION
0.397727272727%	14	3520	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_DILATED_CARDIOMYOPATHY
0.397727272727%	14	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
0.397727272727%	14	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_MAPK_PATHWAY
0.397727272727%	14	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
0.397727272727%	14	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
0.397727272727%	14	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
0.397727272727%	14	3520	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN
0.397727272727%	14	3520	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
0.397727272727%	14	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	URS_ADIPOCYTE_DIFFERENTIATION_UP
0.397727272727%	14	3520	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAURNIER_PSMD4_TARGETS
0.397727272727%	14	3520	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
0.397727272727%	14	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.397727272727%	14	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ENGELMANN_CANCER_PROGENITORS_DN
0.397727272727%	14	3520	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
0.397727272727%	14	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
0.397727272727%	14	3520	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ER_PHAGOSOME_PATHWAY
0.397727272727%	14	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
0.397727272727%	14	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_AUTOIMMUNE_THYROID_DISEASE
0.397727272727%	14	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ANGIOPOIETINRECEPTOR_PATHWAY
0.397727272727%	14	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.397727272727%	14	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ABC_TRANSPORTERS
0.397727272727%	14	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_GRAFT_VERSUS_HOST_DISEASE
0.397727272727%	14	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM
0.397727272727%	14	3520	209	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_WT1_TARGETS_12HR_DN
0.397727272727%	14	3520	205	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
0.397727272727%	14	3520	194	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.397727272727%	14	3520	183	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.397727272727%	14	3520	182	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.397727272727%	14	3520	175	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER_SURVIVAL_DN
0.397727272727%	14	3520	169	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ONDER_CDH1_TARGETS_1_DN
0.397727272727%	14	3520	163	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIN_NPAS4_TARGETS_UP
0.397727272727%	14	3520	161	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIDUS_METASTASIS_DN
0.397727272727%	14	3520	158	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.397727272727%	14	3520	153	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PEPTIDE_CHAIN_ELONGATION
0.397727272727%	14	3520	153	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DURAND_STROMA_MAX_DN
0.397727272727%	14	3520	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
0.397727272727%	14	3520	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
0.397727272727%	14	3520	135	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_OXIDATIVE_PHOSPHORYLATION
0.397727272727%	14	3520	124	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CELL_CYCLE_CHECKPOINTS
0.397727272727%	14	3520	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
0.397727272727%	14	3520	120	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHU_CMV_ALL_UP
0.397727272727%	14	3520	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIM_MAMMARY_LUMINAL_MATURE_UP
0.397727272727%	14	3520	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.397727272727%	14	3520	115	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
0.397727272727%	14	3520	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CERVERA_SDHB_TARGETS_2
0.397727272727%	14	3520	110	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WOOD_EBV_EBNA1_TARGETS_UP
0.397727272727%	14	3520	110	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GHANDHI_DIRECT_IRRADIATION_UP
0.397727272727%	14	3520	110	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHENG_IMPRINTED_BY_ESTRADIOL
0.397727272727%	14	3520	109	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_S_PHASE
0.397727272727%	14	3520	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LE_EGR2_TARGETS_DN
0.397727272727%	14	3520	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
0.397727272727%	14	3520	105	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HELLER_SILENCED_BY_METHYLATION_DN
0.397727272727%	14	3520	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
0.397727272727%	14	3520	102	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_MELANOGENESIS
0.397727272727%	14	3520	102	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.397727272727%	14	3520	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KOBAYASHI_EGFR_SIGNALING_24HR_UP
0.397727272727%	14	3520	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BASSO_CD40_SIGNALING_UP
0.397727272727%	14	3520	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	QI_PLASMACYTOMA_DN
0.395256916996%	1	253	98	Diabetes_McGill_CREBBP_coTF	REACTOME_POTASSIUM_CHANNELS
0.395256916996%	1	253	98	Diabetes_McGill_CREBBP_coTF	KEGG_PYRIMIDINE_METABOLISM
0.395256916996%	1	253	98	Diabetes_McGill_CREBBP_coTF	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
0.395256916996%	1	253	98	Diabetes_McGill_CREBBP_coTF	BRUINS_UVC_RESPONSE_MIDDLE
0.395256916996%	1	253	97	Diabetes_McGill_CREBBP_coTF	LABBE_WNT3A_TARGETS_DN
0.395256916996%	1	253	97	Diabetes_McGill_CREBBP_coTF	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
0.395256916996%	1	253	95	Diabetes_McGill_CREBBP_coTF	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
0.395256916996%	1	253	94	Diabetes_McGill_CREBBP_coTF	HOOI_ST7_TARGETS_UP
0.395256916996%	1	253	92	Diabetes_McGill_CREBBP_coTF	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
0.395256916996%	1	253	92	Diabetes_McGill_CREBBP_coTF	KIM_MYCN_AMPLIFICATION_TARGETS_UP
0.395256916996%	1	253	92	Diabetes_McGill_CREBBP_coTF	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
0.395256916996%	1	253	91	Diabetes_McGill_CREBBP_coTF	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
0.395256916996%	1	253	91	Diabetes_McGill_CREBBP_coTF	GAVIN_FOXP3_TARGETS_CLUSTER_P6
0.395256916996%	1	253	90	Diabetes_McGill_CREBBP_coTF	SANA_TNF_SIGNALING_DN
0.395256916996%	1	253	9	Diabetes_McGill_CREBBP_coTF	YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN
0.395256916996%	1	253	9	Diabetes_McGill_CREBBP_coTF	XU_AKT1_TARGETS_48HR
0.395256916996%	1	253	9	Diabetes_McGill_CREBBP_coTF	OXFORD_RALB_TARGETS_DN
0.395256916996%	1	253	9	Diabetes_McGill_CREBBP_coTF	NAGY_PCAF_COMPONENTS_HUMAN
0.395256916996%	1	253	9	Diabetes_McGill_CREBBP_coTF	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30
0.395256916996%	1	253	9	Diabetes_McGill_CREBBP_coTF	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21
0.395256916996%	1	253	9	Diabetes_McGill_CREBBP_coTF	MATZUK_MATERNAL_EFFECT
0.395256916996%	1	253	9	Diabetes_McGill_CREBBP_coTF	KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP
0.395256916996%	1	253	9	Diabetes_McGill_CREBBP_coTF	HAEGERSTRAND_RESPONSE_TO_IMATINIB
0.395256916996%	1	253	9	Diabetes_McGill_CREBBP_coTF	FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1
0.395256916996%	1	253	9	Diabetes_McGill_CREBBP_coTF	COLLER_MYC_TARGETS_DN
0.395256916996%	1	253	89	Diabetes_McGill_CREBBP_coTF	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
0.395256916996%	1	253	89	Diabetes_McGill_CREBBP_coTF	ZHANG_TLX_TARGETS_UP
0.395256916996%	1	253	89	Diabetes_McGill_CREBBP_coTF	RICKMAN_HEAD_AND_NECK_CANCER_E
0.395256916996%	1	253	89	Diabetes_McGill_CREBBP_coTF	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION
0.395256916996%	1	253	88	Diabetes_McGill_CREBBP_coTF	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
0.395256916996%	1	253	88	Diabetes_McGill_CREBBP_coTF	ALCALA_APOPTOSIS
0.395256916996%	1	253	87	Diabetes_McGill_CREBBP_coTF	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
0.395256916996%	1	253	87	Diabetes_McGill_CREBBP_coTF	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.395256916996%	1	253	86	Diabetes_McGill_CREBBP_coTF	TAKAO_RESPONSE_TO_UVB_RADIATION_UP
0.395256916996%	1	253	86	Diabetes_McGill_CREBBP_coTF	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.395256916996%	1	253	85	Diabetes_McGill_CREBBP_coTF	STEIN_ESR1_TARGETS
0.395256916996%	1	253	85	Diabetes_McGill_CREBBP_coTF	SANA_RESPONSE_TO_IFNG_DN
0.395256916996%	1	253	84	Diabetes_McGill_CREBBP_coTF	SWEET_KRAS_TARGETS_UP
0.395256916996%	1	253	84	Diabetes_McGill_CREBBP_coTF	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
0.395256916996%	1	253	84	Diabetes_McGill_CREBBP_coTF	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
0.395256916996%	1	253	84	Diabetes_McGill_CREBBP_coTF	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
0.395256916996%	1	253	83	Diabetes_McGill_CREBBP_coTF	SANA_TNF_SIGNALING_UP
0.395256916996%	1	253	82	Diabetes_McGill_CREBBP_coTF	WONG_ENDMETRIUM_CANCER_DN
0.395256916996%	1	253	82	Diabetes_McGill_CREBBP_coTF	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
0.395256916996%	1	253	82	Diabetes_McGill_CREBBP_coTF	FRASOR_RESPONSE_TO_ESTRADIOL_DN
0.395256916996%	1	253	82	Diabetes_McGill_CREBBP_coTF	BHAT_ESR1_TARGETS_VIA_AKT1_DN
0.395256916996%	1	253	81	Diabetes_McGill_CREBBP_coTF	HUANG_DASATINIB_RESISTANCE_UP
0.395256916996%	1	253	81	Diabetes_McGill_CREBBP_coTF	COATES_MACROPHAGE_M1_VS_M2_UP
0.395256916996%	1	253	805	Diabetes_McGill_CREBBP_coTF	REACTOME_GPCR_DOWNSTREAM_SIGNALING
0.395256916996%	1	253	80	Diabetes_McGill_CREBBP_coTF	SCHUHMACHER_MYC_TARGETS_UP
0.395256916996%	1	253	80	Diabetes_McGill_CREBBP_coTF	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
0.395256916996%	1	253	80	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
0.395256916996%	1	253	80	Diabetes_McGill_CREBBP_coTF	LINDVALL_IMMORTALIZED_BY_TERT_DN
0.395256916996%	1	253	8	Diabetes_McGill_CREBBP_coTF	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR
0.395256916996%	1	253	8	Diabetes_McGill_CREBBP_coTF	TCGA_GLIOBLASTOMA_MUTATED
0.395256916996%	1	253	8	Diabetes_McGill_CREBBP_coTF	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN
0.395256916996%	1	253	8	Diabetes_McGill_CREBBP_coTF	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN
0.395256916996%	1	253	8	Diabetes_McGill_CREBBP_coTF	REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS
0.395256916996%	1	253	8	Diabetes_McGill_CREBBP_coTF	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN
0.395256916996%	1	253	8	Diabetes_McGill_CREBBP_coTF	PHONG_TNF_TARGETS_DN
0.395256916996%	1	253	8	Diabetes_McGill_CREBBP_coTF	OHM_EMBRYONIC_CARCINOMA_DN
0.395256916996%	1	253	8	Diabetes_McGill_CREBBP_coTF	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9
0.395256916996%	1	253	8	Diabetes_McGill_CREBBP_coTF	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7
0.395256916996%	1	253	8	Diabetes_McGill_CREBBP_coTF	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18
0.395256916996%	1	253	8	Diabetes_McGill_CREBBP_coTF	KHETCHOUMIAN_TRIM24_TARGETS_DN
0.395256916996%	1	253	8	Diabetes_McGill_CREBBP_coTF	HOLLEMAN_DAUNORUBICIN_ALL_DN
0.395256916996%	1	253	8	Diabetes_McGill_CREBBP_coTF	GROSS_HYPOXIA_VIA_HIF1A_ONLY
0.395256916996%	1	253	79	Diabetes_McGill_CREBBP_coTF	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16
0.395256916996%	1	253	79	Diabetes_McGill_CREBBP_coTF	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
0.395256916996%	1	253	79	Diabetes_McGill_CREBBP_coTF	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
0.395256916996%	1	253	79	Diabetes_McGill_CREBBP_coTF	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
0.395256916996%	1	253	79	Diabetes_McGill_CREBBP_coTF	MALONEY_RESPONSE_TO_17AAG_DN
0.395256916996%	1	253	79	Diabetes_McGill_CREBBP_coTF	LIU_COMMON_CANCER_GENES
0.395256916996%	1	253	79	Diabetes_McGill_CREBBP_coTF	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
0.395256916996%	1	253	79	Diabetes_McGill_CREBBP_coTF	GAVIN_FOXP3_TARGETS_CLUSTER_P2
0.395256916996%	1	253	78	Diabetes_McGill_CREBBP_coTF	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.395256916996%	1	253	78	Diabetes_McGill_CREBBP_coTF	BOYLAN_MULTIPLE_MYELOMA_D_DN
0.395256916996%	1	253	77	Diabetes_McGill_CREBBP_coTF	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
0.395256916996%	1	253	77	Diabetes_McGill_CREBBP_coTF	SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.395256916996%	1	253	76	Diabetes_McGill_CREBBP_coTF	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
0.395256916996%	1	253	76	Diabetes_McGill_CREBBP_coTF	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
0.395256916996%	1	253	76	Diabetes_McGill_CREBBP_coTF	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.395256916996%	1	253	76	Diabetes_McGill_CREBBP_coTF	MAHAJAN_RESPONSE_TO_IL1A_DN
0.395256916996%	1	253	75	Diabetes_McGill_CREBBP_coTF	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
0.395256916996%	1	253	74	Diabetes_McGill_CREBBP_coTF	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.395256916996%	1	253	74	Diabetes_McGill_CREBBP_coTF	RAMALHO_STEMNESS_DN
0.395256916996%	1	253	74	Diabetes_McGill_CREBBP_coTF	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
0.395256916996%	1	253	74	Diabetes_McGill_CREBBP_coTF	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
0.395256916996%	1	253	74	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
0.395256916996%	1	253	74	Diabetes_McGill_CREBBP_coTF	JI_RESPONSE_TO_FSH_UP
0.395256916996%	1	253	74	Diabetes_McGill_CREBBP_coTF	FURUKAWA_DUSP6_TARGETS_PCI35_DN
0.395256916996%	1	253	73	Diabetes_McGill_CREBBP_coTF	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
0.395256916996%	1	253	73	Diabetes_McGill_CREBBP_coTF	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.395256916996%	1	253	73	Diabetes_McGill_CREBBP_coTF	REACTOME_MEIOTIC_SYNAPSIS
0.395256916996%	1	253	73	Diabetes_McGill_CREBBP_coTF	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
0.395256916996%	1	253	73	Diabetes_McGill_CREBBP_coTF	HOSHIDA_LIVER_CANCER_SURVIVAL_UP
0.395256916996%	1	253	73	Diabetes_McGill_CREBBP_coTF	DITTMER_PTHLH_TARGETS_DN
0.395256916996%	1	253	73	Diabetes_McGill_CREBBP_coTF	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
0.395256916996%	1	253	72	Diabetes_McGill_CREBBP_coTF	DOANE_BREAST_CANCER_CLASSES_UP
0.395256916996%	1	253	72	Diabetes_McGill_CREBBP_coTF	BURTON_ADIPOGENESIS_2
0.395256916996%	1	253	71	Diabetes_McGill_CREBBP_coTF	REACTOME_PI3K_CASCADE
0.395256916996%	1	253	71	Diabetes_McGill_CREBBP_coTF	KUMAR_AUTOPHAGY_NETWORK
0.395256916996%	1	253	70	Diabetes_McGill_CREBBP_coTF	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
0.395256916996%	1	253	70	Diabetes_McGill_CREBBP_coTF	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5
0.395256916996%	1	253	70	Diabetes_McGill_CREBBP_coTF	RAGHAVACHARI_PLATELET_SPECIFIC_GENES
0.395256916996%	1	253	70	Diabetes_McGill_CREBBP_coTF	LANDIS_BREAST_CANCER_PROGRESSION_DN
0.395256916996%	1	253	70	Diabetes_McGill_CREBBP_coTF	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
0.395256916996%	1	253	70	Diabetes_McGill_CREBBP_coTF	ENGELMANN_CANCER_PROGENITORS_DN
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	ZEILSTRA_CD44_TARGETS_DN
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	TESAR_ALK_TARGETS_HUMAN_ES_5D_DN
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	TESAR_ALK_TARGETS_EPISC_4D_UP
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	TESAR_ALK_TARGETS_EPISC_3D_UP
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	MCBRYAN_TERMINAL_END_BUD_DN
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	MATZUK_STEROIDOGENESIS
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	MARSHALL_VIRAL_INFECTION_RESPONSE_UP
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	FARMER_BREAST_CANCER_CLUSTER_8
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	BUSA_SAM68_TARGETS_UP
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	BAKER_HEMATOPOESIS_STAT5_TARGETS
0.395256916996%	1	253	7	Diabetes_McGill_CREBBP_coTF	ABBUD_LIF_SIGNALING_2_DN
0.395256916996%	1	253	69	Diabetes_McGill_CREBBP_coTF	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10
0.395256916996%	1	253	69	Diabetes_McGill_CREBBP_coTF	LEIN_NEURON_MARKERS
0.395256916996%	1	253	682	Diabetes_McGill_CREBBP_coTF	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP
0.395256916996%	1	253	68	Diabetes_McGill_CREBBP_coTF	SESTO_RESPONSE_TO_UV_C7
0.395256916996%	1	253	68	Diabetes_McGill_CREBBP_coTF	DELPUECH_FOXO3_TARGETS_UP
0.395256916996%	1	253	68	Diabetes_McGill_CREBBP_coTF	CASTELLANO_NRAS_TARGETS_UP
0.395256916996%	1	253	68	Diabetes_McGill_CREBBP_coTF	BASSO_CD40_SIGNALING_DN
0.395256916996%	1	253	67	Diabetes_McGill_CREBBP_coTF	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
0.395256916996%	1	253	67	Diabetes_McGill_CREBBP_coTF	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP
0.395256916996%	1	253	67	Diabetes_McGill_CREBBP_coTF	ELVIDGE_HIF1A_TARGETS_UP
0.395256916996%	1	253	67	Diabetes_McGill_CREBBP_coTF	DAZARD_UV_RESPONSE_CLUSTER_G1
0.395256916996%	1	253	67	Diabetes_McGill_CREBBP_coTF	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70
0.395256916996%	1	253	66	Diabetes_McGill_CREBBP_coTF	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
0.395256916996%	1	253	66	Diabetes_McGill_CREBBP_coTF	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT
0.395256916996%	1	253	66	Diabetes_McGill_CREBBP_coTF	SWEET_KRAS_TARGETS_DN
0.395256916996%	1	253	66	Diabetes_McGill_CREBBP_coTF	RIGGINS_TAMOXIFEN_RESISTANCE_UP
0.395256916996%	1	253	66	Diabetes_McGill_CREBBP_coTF	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
0.395256916996%	1	253	66	Diabetes_McGill_CREBBP_coTF	MARSON_FOXP3_TARGETS_UP
0.395256916996%	1	253	66	Diabetes_McGill_CREBBP_coTF	LEE_LIVER_CANCER_CIPROFIBRATE_DN
0.395256916996%	1	253	66	Diabetes_McGill_CREBBP_coTF	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN
0.395256916996%	1	253	65	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_WNT
0.395256916996%	1	253	64	Diabetes_McGill_CREBBP_coTF	ZHANG_GATA6_TARGETS_DN
0.395256916996%	1	253	64	Diabetes_McGill_CREBBP_coTF	ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE
0.395256916996%	1	253	63	Diabetes_McGill_CREBBP_coTF	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP
0.395256916996%	1	253	63	Diabetes_McGill_CREBBP_coTF	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
0.395256916996%	1	253	63	Diabetes_McGill_CREBBP_coTF	MODY_HIPPOCAMPUS_POSTNATAL
0.395256916996%	1	253	63	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED
0.395256916996%	1	253	63	Diabetes_McGill_CREBBP_coTF	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
0.395256916996%	1	253	63	Diabetes_McGill_CREBBP_coTF	JOHNSTONE_PARVB_TARGETS_1_DN
0.395256916996%	1	253	63	Diabetes_McGill_CREBBP_coTF	BURTON_ADIPOGENESIS_PEAK_AT_0HR
0.395256916996%	1	253	63	Diabetes_McGill_CREBBP_coTF	BILBAN_B_CLL_LPL_UP
0.395256916996%	1	253	62	Diabetes_McGill_CREBBP_coTF	PID_TRKRPATHWAY
0.395256916996%	1	253	62	Diabetes_McGill_CREBBP_coTF	LEE_LIVER_CANCER_E2F1_UP
0.395256916996%	1	253	61	Diabetes_McGill_CREBBP_coTF	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.395256916996%	1	253	61	Diabetes_McGill_CREBBP_coTF	RAMASWAMY_METASTASIS_DN
0.395256916996%	1	253	61	Diabetes_McGill_CREBBP_coTF	BAKKER_FOXO3_TARGETS_UP
0.395256916996%	1	253	60	Diabetes_McGill_CREBBP_coTF	WIERENGA_STAT5A_TARGETS_GROUP2
0.395256916996%	1	253	60	Diabetes_McGill_CREBBP_coTF	OUILLETTE_CLL_13Q14_DELETION_DN
0.395256916996%	1	253	60	Diabetes_McGill_CREBBP_coTF	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN
0.395256916996%	1	253	6	Diabetes_McGill_CREBBP_coTF	ZERBINI_RESPONSE_TO_SULINDAC_DN
0.395256916996%	1	253	6	Diabetes_McGill_CREBBP_coTF	WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN
0.395256916996%	1	253	6	Diabetes_McGill_CREBBP_coTF	TESAR_ALK_TARGETS_HUMAN_ES_4D_DN
0.395256916996%	1	253	6	Diabetes_McGill_CREBBP_coTF	TERAO_AOX4_TARGETS_HG_DN
0.395256916996%	1	253	6	Diabetes_McGill_CREBBP_coTF	OHM_EMBRYONIC_CARCINOMA_UP
0.395256916996%	1	253	6	Diabetes_McGill_CREBBP_coTF	OHASHI_AURKA_TARGETS
0.395256916996%	1	253	6	Diabetes_McGill_CREBBP_coTF	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6
0.395256916996%	1	253	6	Diabetes_McGill_CREBBP_coTF	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_14
0.395256916996%	1	253	6	Diabetes_McGill_CREBBP_coTF	IGARASHI_ATF4_TARGETS_UP
0.395256916996%	1	253	6	Diabetes_McGill_CREBBP_coTF	DING_LUNG_CANCER_MUTATED_RECURRENTLY
0.395256916996%	1	253	6	Diabetes_McGill_CREBBP_coTF	BUSA_SAM68_TARGETS_DN
0.395256916996%	1	253	59	Diabetes_McGill_CREBBP_coTF	WESTON_VEGFA_TARGETS_6HR
0.395256916996%	1	253	59	Diabetes_McGill_CREBBP_coTF	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
0.395256916996%	1	253	59	Diabetes_McGill_CREBBP_coTF	ONDER_CDH1_TARGETS_3_DN
0.395256916996%	1	253	59	Diabetes_McGill_CREBBP_coTF	KEGG_RNA_DEGRADATION
0.395256916996%	1	253	59	Diabetes_McGill_CREBBP_coTF	KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION
0.395256916996%	1	253	59	Diabetes_McGill_CREBBP_coTF	HUPER_BREAST_BASAL_VS_LUMINAL_DN
0.395256916996%	1	253	59	Diabetes_McGill_CREBBP_coTF	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1
0.395256916996%	1	253	59	Diabetes_McGill_CREBBP_coTF	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
0.395256916996%	1	253	58	Diabetes_McGill_CREBBP_coTF	ZHENG_GLIOBLASTOMA_PLASTICITY_DN
0.395256916996%	1	253	58	Diabetes_McGill_CREBBP_coTF	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
0.395256916996%	1	253	58	Diabetes_McGill_CREBBP_coTF	PID_SHP2_PATHWAY
0.395256916996%	1	253	58	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_NPC_LCP_WITH_H3K4ME3
0.395256916996%	1	253	58	Diabetes_McGill_CREBBP_coTF	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
0.395256916996%	1	253	58	Diabetes_McGill_CREBBP_coTF	BERNARD_PPAPDC1B_TARGETS_DN
0.395256916996%	1	253	57	Diabetes_McGill_CREBBP_coTF	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
0.395256916996%	1	253	57	Diabetes_McGill_CREBBP_coTF	TANG_SENESCENCE_TP53_TARGETS_DN
0.395256916996%	1	253	57	Diabetes_McGill_CREBBP_coTF	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN
0.395256916996%	1	253	57	Diabetes_McGill_CREBBP_coTF	PID_TXA2PATHWAY
0.395256916996%	1	253	57	Diabetes_McGill_CREBBP_coTF	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP
0.395256916996%	1	253	56	Diabetes_McGill_CREBBP_coTF	ZHENG_IL22_SIGNALING_UP
0.395256916996%	1	253	56	Diabetes_McGill_CREBBP_coTF	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.395256916996%	1	253	56	Diabetes_McGill_CREBBP_coTF	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP
0.395256916996%	1	253	56	Diabetes_McGill_CREBBP_coTF	KEGG_HEDGEHOG_SIGNALING_PATHWAY
0.395256916996%	1	253	56	Diabetes_McGill_CREBBP_coTF	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.395256916996%	1	253	56	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_30MIN_UP
0.395256916996%	1	253	55	Diabetes_McGill_CREBBP_coTF	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.395256916996%	1	253	55	Diabetes_McGill_CREBBP_coTF	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
0.395256916996%	1	253	55	Diabetes_McGill_CREBBP_coTF	SU_LIVER
0.395256916996%	1	253	54	Diabetes_McGill_CREBBP_coTF	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
0.395256916996%	1	253	54	Diabetes_McGill_CREBBP_coTF	MARSON_FOXP3_TARGETS_DN
0.395256916996%	1	253	54	Diabetes_McGill_CREBBP_coTF	KANG_DOXORUBICIN_RESISTANCE_UP
0.395256916996%	1	253	54	Diabetes_McGill_CREBBP_coTF	FIGUEROA_AML_METHYLATION_CLUSTER_2_UP
0.395256916996%	1	253	53	Diabetes_McGill_CREBBP_coTF	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
0.395256916996%	1	253	53	Diabetes_McGill_CREBBP_coTF	MORI_IMMATURE_B_LYMPHOCYTE_UP
0.395256916996%	1	253	53	Diabetes_McGill_CREBBP_coTF	LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.395256916996%	1	253	53	Diabetes_McGill_CREBBP_coTF	HENDRICKS_SMARCA4_TARGETS_DN
0.395256916996%	1	253	52	Diabetes_McGill_CREBBP_coTF	PID_CASPASE_PATHWAY
0.395256916996%	1	253	52	Diabetes_McGill_CREBBP_coTF	KENNY_CTNNB1_TARGETS_DN
0.395256916996%	1	253	52	Diabetes_McGill_CREBBP_coTF	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP
0.395256916996%	1	253	52	Diabetes_McGill_CREBBP_coTF	CHIBA_RESPONSE_TO_TSA_UP
0.395256916996%	1	253	52	Diabetes_McGill_CREBBP_coTF	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN
0.395256916996%	1	253	518	Diabetes_McGill_CREBBP_coTF	REACTOME_METABOLISM_OF_PROTEINS
0.395256916996%	1	253	51	Diabetes_McGill_CREBBP_coTF	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1
0.395256916996%	1	253	51	Diabetes_McGill_CREBBP_coTF	MORI_PLASMA_CELL_UP
0.395256916996%	1	253	51	Diabetes_McGill_CREBBP_coTF	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN
0.395256916996%	1	253	51	Diabetes_McGill_CREBBP_coTF	LEE_CALORIE_RESTRICTION_MUSCLE_DN
0.395256916996%	1	253	51	Diabetes_McGill_CREBBP_coTF	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
0.395256916996%	1	253	51	Diabetes_McGill_CREBBP_coTF	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
0.395256916996%	1	253	51	Diabetes_McGill_CREBBP_coTF	BURTON_ADIPOGENESIS_7
0.395256916996%	1	253	51	Diabetes_McGill_CREBBP_coTF	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
0.395256916996%	1	253	50	Diabetes_McGill_CREBBP_coTF	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.395256916996%	1	253	50	Diabetes_McGill_CREBBP_coTF	ROY_WOUND_BLOOD_VESSEL_UP
0.395256916996%	1	253	50	Diabetes_McGill_CREBBP_coTF	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
0.395256916996%	1	253	50	Diabetes_McGill_CREBBP_coTF	KOHOUTEK_CCNT1_TARGETS
0.395256916996%	1	253	50	Diabetes_McGill_CREBBP_coTF	KENNY_CTNNB1_TARGETS_UP
0.395256916996%	1	253	50	Diabetes_McGill_CREBBP_coTF	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
0.395256916996%	1	253	50	Diabetes_McGill_CREBBP_coTF	FIGUEROA_AML_METHYLATION_CLUSTER_5_DN
0.395256916996%	1	253	50	Diabetes_McGill_CREBBP_coTF	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION
0.395256916996%	1	253	50	Diabetes_McGill_CREBBP_coTF	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS
0.395256916996%	1	253	5	Diabetes_McGill_CREBBP_coTF	TESAR_ALK_TARGETS_HUMAN_ES_5D_UP
0.395256916996%	1	253	5	Diabetes_McGill_CREBBP_coTF	TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP
0.395256916996%	1	253	5	Diabetes_McGill_CREBBP_coTF	TERAMOTO_OPN_TARGETS_CLUSTER_3
0.395256916996%	1	253	5	Diabetes_McGill_CREBBP_coTF	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN
0.395256916996%	1	253	5	Diabetes_McGill_CREBBP_coTF	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3
0.395256916996%	1	253	5	Diabetes_McGill_CREBBP_coTF	LI_WILMS_TUMOR_ANAPLASTIC_DN
0.395256916996%	1	253	5	Diabetes_McGill_CREBBP_coTF	KERLEY_RESPONSE_TO_CISPLATIN_DN
0.395256916996%	1	253	5	Diabetes_McGill_CREBBP_coTF	KANG_GIST_WITH_PDGFRA_DN
0.395256916996%	1	253	5	Diabetes_McGill_CREBBP_coTF	IM_SREBF1A_TARGETS
0.395256916996%	1	253	5	Diabetes_McGill_CREBBP_coTF	CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_DN
0.395256916996%	1	253	5	Diabetes_McGill_CREBBP_coTF	BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.395256916996%	1	253	49	Diabetes_McGill_CREBBP_coTF	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
0.395256916996%	1	253	49	Diabetes_McGill_CREBBP_coTF	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
0.395256916996%	1	253	49	Diabetes_McGill_CREBBP_coTF	REACTOME_METABOLISM_OF_NON_CODING_RNA
0.395256916996%	1	253	49	Diabetes_McGill_CREBBP_coTF	PID_ARF6_TRAFFICKINGPATHWAY
0.395256916996%	1	253	49	Diabetes_McGill_CREBBP_coTF	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.395256916996%	1	253	49	Diabetes_McGill_CREBBP_coTF	LEE_LIVER_CANCER
0.395256916996%	1	253	49	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_2HR_DN
0.395256916996%	1	253	49	Diabetes_McGill_CREBBP_coTF	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.395256916996%	1	253	48	Diabetes_McGill_CREBBP_coTF	ZHAN_MULTIPLE_MYELOMA_LB_UP
0.395256916996%	1	253	48	Diabetes_McGill_CREBBP_coTF	REACTOME_MUSCLE_CONTRACTION
0.395256916996%	1	253	48	Diabetes_McGill_CREBBP_coTF	REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY
0.395256916996%	1	253	48	Diabetes_McGill_CREBBP_coTF	NADLER_OBESITY_DN
0.395256916996%	1	253	47	Diabetes_McGill_CREBBP_coTF	SILIGAN_BOUND_BY_EWS_FLT1_FUSION
0.395256916996%	1	253	47	Diabetes_McGill_CREBBP_coTF	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
0.395256916996%	1	253	47	Diabetes_McGill_CREBBP_coTF	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN
0.395256916996%	1	253	47	Diabetes_McGill_CREBBP_coTF	MELLMAN_TUT1_TARGETS_DN
0.395256916996%	1	253	47	Diabetes_McGill_CREBBP_coTF	MCCLUNG_DELTA_FOSB_TARGETS_8WK
0.395256916996%	1	253	47	Diabetes_McGill_CREBBP_coTF	LEONARD_HYPOXIA
0.395256916996%	1	253	47	Diabetes_McGill_CREBBP_coTF	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.395256916996%	1	253	47	Diabetes_McGill_CREBBP_coTF	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP
0.395256916996%	1	253	46	Diabetes_McGill_CREBBP_coTF	ZHAN_MULTIPLE_MYELOMA_MS_DN
0.395256916996%	1	253	46	Diabetes_McGill_CREBBP_coTF	WINNEPENNINCKX_MELANOMA_METASTASIS_DN
0.395256916996%	1	253	46	Diabetes_McGill_CREBBP_coTF	REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT
0.395256916996%	1	253	46	Diabetes_McGill_CREBBP_coTF	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
0.395256916996%	1	253	46	Diabetes_McGill_CREBBP_coTF	PID_PLK1_PATHWAY
0.395256916996%	1	253	46	Diabetes_McGill_CREBBP_coTF	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1
0.395256916996%	1	253	46	Diabetes_McGill_CREBBP_coTF	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON
0.395256916996%	1	253	46	Diabetes_McGill_CREBBP_coTF	LEE_AGING_MUSCLE_DN
0.395256916996%	1	253	46	Diabetes_McGill_CREBBP_coTF	JIANG_TIP30_TARGETS_UP
0.395256916996%	1	253	46	Diabetes_McGill_CREBBP_coTF	HEIDENBLAD_AMPLICON_8Q24_DN
0.395256916996%	1	253	46	Diabetes_McGill_CREBBP_coTF	HALMOS_CEBPA_TARGETS_DN
0.395256916996%	1	253	45	Diabetes_McGill_CREBBP_coTF	ZHAN_MULTIPLE_MYELOMA_CD2_UP
0.395256916996%	1	253	45	Diabetes_McGill_CREBBP_coTF	ZHAN_MULTIPLE_MYELOMA_CD1_UP
0.395256916996%	1	253	45	Diabetes_McGill_CREBBP_coTF	TRAYNOR_RETT_SYNDROM_UP
0.395256916996%	1	253	45	Diabetes_McGill_CREBBP_coTF	ST_T_CELL_SIGNAL_TRANSDUCTION
0.395256916996%	1	253	45	Diabetes_McGill_CREBBP_coTF	SMITH_LIVER_CANCER
0.395256916996%	1	253	45	Diabetes_McGill_CREBBP_coTF	REACTOME_MRNA_SPLICING_MINOR_PATHWAY
0.395256916996%	1	253	45	Diabetes_McGill_CREBBP_coTF	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_
0.395256916996%	1	253	45	Diabetes_McGill_CREBBP_coTF	PID_INSULIN_PATHWAY
0.395256916996%	1	253	45	Diabetes_McGill_CREBBP_coTF	GRADE_METASTASIS_DN
0.395256916996%	1	253	45	Diabetes_McGill_CREBBP_coTF	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP
0.395256916996%	1	253	44	Diabetes_McGill_CREBBP_coTF	ZUCCHI_METASTASIS_DN
0.395256916996%	1	253	44	Diabetes_McGill_CREBBP_coTF	ZHAN_MULTIPLE_MYELOMA_PR_DN
0.395256916996%	1	253	44	Diabetes_McGill_CREBBP_coTF	XU_CREBBP_TARGETS_DN
0.395256916996%	1	253	44	Diabetes_McGill_CREBBP_coTF	WANG_TARGETS_OF_MLL_CBP_FUSION_UP
0.395256916996%	1	253	44	Diabetes_McGill_CREBBP_coTF	ROVERSI_GLIOMA_LOH_REGIONS
0.395256916996%	1	253	44	Diabetes_McGill_CREBBP_coTF	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS
0.395256916996%	1	253	44	Diabetes_McGill_CREBBP_coTF	LUI_THYROID_CANCER_PAX8_PPARG_UP
0.395256916996%	1	253	44	Diabetes_McGill_CREBBP_coTF	LANDIS_BREAST_CANCER_PROGRESSION_UP
0.395256916996%	1	253	44	Diabetes_McGill_CREBBP_coTF	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION
0.395256916996%	1	253	44	Diabetes_McGill_CREBBP_coTF	KEGG_NUCLEOTIDE_EXCISION_REPAIR
0.395256916996%	1	253	44	Diabetes_McGill_CREBBP_coTF	KEGG_LYSINE_DEGRADATION
0.395256916996%	1	253	44	Diabetes_McGill_CREBBP_coTF	CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY
0.395256916996%	1	253	43	Diabetes_McGill_CREBBP_coTF	ULE_SPLICING_VIA_NOVA2
0.395256916996%	1	253	43	Diabetes_McGill_CREBBP_coTF	POTTI_ETOPOSIDE_SENSITIVITY
0.395256916996%	1	253	43	Diabetes_McGill_CREBBP_coTF	PID_THROMBIN_PAR1_PATHWAY
0.395256916996%	1	253	43	Diabetes_McGill_CREBBP_coTF	NAKAMURA_METASTASIS_MODEL_DN
0.395256916996%	1	253	43	Diabetes_McGill_CREBBP_coTF	MANTOVANI_NFKB_TARGETS_UP
0.395256916996%	1	253	43	Diabetes_McGill_CREBBP_coTF	LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.395256916996%	1	253	43	Diabetes_McGill_CREBBP_coTF	LEE_CALORIE_RESTRICTION_MUSCLE_UP
0.395256916996%	1	253	43	Diabetes_McGill_CREBBP_coTF	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
0.395256916996%	1	253	43	Diabetes_McGill_CREBBP_coTF	BURTON_ADIPOGENESIS_PEAK_AT_24HR
0.395256916996%	1	253	43	Diabetes_McGill_CREBBP_coTF	AMIT_EGF_RESPONSE_480_MCF10A
0.395256916996%	1	253	43	Diabetes_McGill_CREBBP_coTF	AMIT_EGF_RESPONSE_120_MCF10A
0.395256916996%	1	253	42	Diabetes_McGill_CREBBP_coTF	YU_MYC_TARGETS_UP
0.395256916996%	1	253	42	Diabetes_McGill_CREBBP_coTF	WIERENGA_PML_INTERACTOME
0.395256916996%	1	253	42	Diabetes_McGill_CREBBP_coTF	PID_ECADHERIN_STABILIZATION_PATHWAY
0.395256916996%	1	253	42	Diabetes_McGill_CREBBP_coTF	LUI_THYROID_CANCER_CLUSTER_2
0.395256916996%	1	253	42	Diabetes_McGill_CREBBP_coTF	HAHTOLA_SEZARY_SYNDROM_DN
0.395256916996%	1	253	42	Diabetes_McGill_CREBBP_coTF	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN
0.395256916996%	1	253	42	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CHREBP2_PATHWAY
0.395256916996%	1	253	42	Diabetes_McGill_CREBBP_coTF	BARRIER_COLON_CANCER_RECURRENCE_UP
0.395256916996%	1	253	413	Diabetes_McGill_CREBBP_coTF	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES
0.395256916996%	1	253	41	Diabetes_McGill_CREBBP_coTF	ZHAN_MULTIPLE_MYELOMA_MF_DN
0.395256916996%	1	253	41	Diabetes_McGill_CREBBP_coTF	ZHAN_MULTIPLE_MYELOMA_DN
0.395256916996%	1	253	41	Diabetes_McGill_CREBBP_coTF	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.395256916996%	1	253	41	Diabetes_McGill_CREBBP_coTF	PID_ER_NONGENOMIC_PATHWAY
0.395256916996%	1	253	41	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_ES_HCP_WITH_H3K27ME3
0.395256916996%	1	253	41	Diabetes_McGill_CREBBP_coTF	MALONEY_RESPONSE_TO_17AAG_UP
0.395256916996%	1	253	41	Diabetes_McGill_CREBBP_coTF	LIN_MELANOMA_COPY_NUMBER_DN
0.395256916996%	1	253	41	Diabetes_McGill_CREBBP_coTF	KAAB_FAILED_HEART_VENTRICLE_DN
0.395256916996%	1	253	41	Diabetes_McGill_CREBBP_coTF	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.395256916996%	1	253	41	Diabetes_McGill_CREBBP_coTF	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
0.395256916996%	1	253	41	Diabetes_McGill_CREBBP_coTF	DELPUECH_FOXO3_TARGETS_DN
0.395256916996%	1	253	41	Diabetes_McGill_CREBBP_coTF	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
0.395256916996%	1	253	41	Diabetes_McGill_CREBBP_coTF	CHEN_HOXA5_TARGETS_9HR_DN
0.395256916996%	1	253	40	Diabetes_McGill_CREBBP_coTF	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.395256916996%	1	253	40	Diabetes_McGill_CREBBP_coTF	TOMLINS_PROSTATE_CANCER_UP
0.395256916996%	1	253	40	Diabetes_McGill_CREBBP_coTF	ST_B_CELL_ANTIGEN_RECEPTOR
0.395256916996%	1	253	40	Diabetes_McGill_CREBBP_coTF	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS
0.395256916996%	1	253	40	Diabetes_McGill_CREBBP_coTF	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER
0.395256916996%	1	253	40	Diabetes_McGill_CREBBP_coTF	GENTILE_UV_RESPONSE_CLUSTER_D8
0.395256916996%	1	253	40	Diabetes_McGill_CREBBP_coTF	CHESLER_BRAIN_HIGHEST_EXPRESSION
0.395256916996%	1	253	40	Diabetes_McGill_CREBBP_coTF	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
0.395256916996%	1	253	40	Diabetes_McGill_CREBBP_coTF	BENPORATH_ES_2
0.395256916996%	1	253	39	Diabetes_McGill_CREBBP_coTF	STONER_ESOPHAGEAL_CARCINOGENESIS_UP
0.395256916996%	1	253	39	Diabetes_McGill_CREBBP_coTF	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP
0.395256916996%	1	253	39	Diabetes_McGill_CREBBP_coTF	SHIPP_DLBCL_CURED_VS_FATAL_UP
0.395256916996%	1	253	39	Diabetes_McGill_CREBBP_coTF	NEWMAN_ERCC6_TARGETS_DN
0.395256916996%	1	253	39	Diabetes_McGill_CREBBP_coTF	BILANGES_SERUM_SENSITIVE_VIA_TSC2
0.395256916996%	1	253	39	Diabetes_McGill_CREBBP_coTF	BEIER_GLIOMA_STEM_CELL_UP
0.395256916996%	1	253	39	Diabetes_McGill_CREBBP_coTF	AMIT_SERUM_RESPONSE_480_MCF10A
0.395256916996%	1	253	39	Diabetes_McGill_CREBBP_coTF	AIYAR_COBRA1_TARGETS_UP
0.395256916996%	1	253	38	Diabetes_McGill_CREBBP_coTF	NAKAMURA_ADIPOGENESIS_LATE_DN
0.395256916996%	1	253	38	Diabetes_McGill_CREBBP_coTF	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP
0.395256916996%	1	253	38	Diabetes_McGill_CREBBP_coTF	KRASNOSELSKAYA_ILF3_TARGETS_UP
0.395256916996%	1	253	38	Diabetes_McGill_CREBBP_coTF	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP
0.395256916996%	1	253	38	Diabetes_McGill_CREBBP_coTF	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP
0.395256916996%	1	253	38	Diabetes_McGill_CREBBP_coTF	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN
0.395256916996%	1	253	38	Diabetes_McGill_CREBBP_coTF	CHANDRAN_METASTASIS_TOP50_UP
0.395256916996%	1	253	38	Diabetes_McGill_CREBBP_coTF	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN
0.395256916996%	1	253	38	Diabetes_McGill_CREBBP_coTF	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
0.395256916996%	1	253	37	Diabetes_McGill_CREBBP_coTF	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN
0.395256916996%	1	253	37	Diabetes_McGill_CREBBP_coTF	ROLEF_GLIS3_TARGETS
0.395256916996%	1	253	37	Diabetes_McGill_CREBBP_coTF	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING
0.395256916996%	1	253	37	Diabetes_McGill_CREBBP_coTF	MURAKAMI_UV_RESPONSE_6HR_UP
0.395256916996%	1	253	37	Diabetes_McGill_CREBBP_coTF	MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED
0.395256916996%	1	253	37	Diabetes_McGill_CREBBP_coTF	KIM_ALL_DISORDERS_CALB1_CORR_DN
0.395256916996%	1	253	37	Diabetes_McGill_CREBBP_coTF	GENTILE_UV_RESPONSE_CLUSTER_D6
0.395256916996%	1	253	37	Diabetes_McGill_CREBBP_coTF	BILANGES_SERUM_RESPONSE_TRANSLATION
0.395256916996%	1	253	36	Diabetes_McGill_CREBBP_coTF	YANG_BREAST_CANCER_ESR1_UP
0.395256916996%	1	253	36	Diabetes_McGill_CREBBP_coTF	ST_ADRENERGIC
0.395256916996%	1	253	36	Diabetes_McGill_CREBBP_coTF	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
0.395256916996%	1	253	36	Diabetes_McGill_CREBBP_coTF	REACTOME_FRS2_MEDIATED_CASCADE
0.395256916996%	1	253	36	Diabetes_McGill_CREBBP_coTF	MMS_MOUSE_LYMPH_HIGH_4HRS_UP
0.395256916996%	1	253	36	Diabetes_McGill_CREBBP_coTF	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN
0.395256916996%	1	253	36	Diabetes_McGill_CREBBP_coTF	HUANG_FOXA2_TARGETS_DN
0.395256916996%	1	253	36	Diabetes_McGill_CREBBP_coTF	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP
0.395256916996%	1	253	36	Diabetes_McGill_CREBBP_coTF	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN
0.395256916996%	1	253	36	Diabetes_McGill_CREBBP_coTF	BIOCARTA_AGR_PATHWAY
0.395256916996%	1	253	36	Diabetes_McGill_CREBBP_coTF	ALONSO_METASTASIS_EMT_UP
0.395256916996%	1	253	351	Diabetes_McGill_CREBBP_coTF	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.395256916996%	1	253	35	Diabetes_McGill_CREBBP_coTF	YAGI_AML_RELAPSE_PROGNOSIS
0.395256916996%	1	253	35	Diabetes_McGill_CREBBP_coTF	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.395256916996%	1	253	35	Diabetes_McGill_CREBBP_coTF	VALK_AML_CLUSTER_9
0.395256916996%	1	253	35	Diabetes_McGill_CREBBP_coTF	ST_G_ALPHA_I_PATHWAY
0.395256916996%	1	253	35	Diabetes_McGill_CREBBP_coTF	ROZANOV_MMP14_TARGETS_DN
0.395256916996%	1	253	35	Diabetes_McGill_CREBBP_coTF	REACTOME_GLOBAL_GENOMIC_NER_GG_NER
0.395256916996%	1	253	35	Diabetes_McGill_CREBBP_coTF	REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION
0.395256916996%	1	253	35	Diabetes_McGill_CREBBP_coTF	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
0.395256916996%	1	253	35	Diabetes_McGill_CREBBP_coTF	MODY_HIPPOCAMPUS_NEONATAL
0.395256916996%	1	253	35	Diabetes_McGill_CREBBP_coTF	LIEN_BREAST_CARCINOMA_METAPLASTIC
0.395256916996%	1	253	35	Diabetes_McGill_CREBBP_coTF	KEGG_BASE_EXCISION_REPAIR
0.395256916996%	1	253	35	Diabetes_McGill_CREBBP_coTF	HU_GENOTOXIC_DAMAGE_24HR
0.395256916996%	1	253	35	Diabetes_McGill_CREBBP_coTF	HOWLIN_CITED1_TARGETS_1_UP
0.395256916996%	1	253	35	Diabetes_McGill_CREBBP_coTF	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN
0.395256916996%	1	253	34	Diabetes_McGill_CREBBP_coTF	ST_WNT_BETA_CATENIN_PATHWAY
0.395256916996%	1	253	34	Diabetes_McGill_CREBBP_coTF	SIG_CD40PATHWAYMAP
0.395256916996%	1	253	34	Diabetes_McGill_CREBBP_coTF	SCHOEN_NFKB_SIGNALING
0.395256916996%	1	253	34	Diabetes_McGill_CREBBP_coTF	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP
0.395256916996%	1	253	34	Diabetes_McGill_CREBBP_coTF	REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX
0.395256916996%	1	253	34	Diabetes_McGill_CREBBP_coTF	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT
0.395256916996%	1	253	34	Diabetes_McGill_CREBBP_coTF	PETRETTO_CARDIAC_HYPERTROPHY
0.395256916996%	1	253	34	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.395256916996%	1	253	34	Diabetes_McGill_CREBBP_coTF	KORKOLA_CORRELATED_WITH_POU5F1
0.395256916996%	1	253	34	Diabetes_McGill_CREBBP_coTF	JIANG_HYPOXIA_VIA_VHL
0.395256916996%	1	253	34	Diabetes_McGill_CREBBP_coTF	HONMA_DOCETAXEL_RESISTANCE
0.395256916996%	1	253	34	Diabetes_McGill_CREBBP_coTF	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP
0.395256916996%	1	253	34	Diabetes_McGill_CREBBP_coTF	BIOCARTA_MPR_PATHWAY
0.395256916996%	1	253	33	Diabetes_McGill_CREBBP_coTF	VALK_AML_CLUSTER_6
0.395256916996%	1	253	33	Diabetes_McGill_CREBBP_coTF	VALK_AML_CLUSTER_5
0.395256916996%	1	253	33	Diabetes_McGill_CREBBP_coTF	TANG_SENESCENCE_TP53_TARGETS_UP
0.395256916996%	1	253	33	Diabetes_McGill_CREBBP_coTF	SCHRAETS_MLL_TARGETS_DN
0.395256916996%	1	253	33	Diabetes_McGill_CREBBP_coTF	REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS
0.395256916996%	1	253	33	Diabetes_McGill_CREBBP_coTF	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP
0.395256916996%	1	253	33	Diabetes_McGill_CREBBP_coTF	PID_SYNDECAN_2_PATHWAY
0.395256916996%	1	253	33	Diabetes_McGill_CREBBP_coTF	PID_ALPHASYNUCLEIN_PATHWAY
0.395256916996%	1	253	33	Diabetes_McGill_CREBBP_coTF	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS
0.395256916996%	1	253	33	Diabetes_McGill_CREBBP_coTF	GRADE_COLON_CANCER_DN
0.395256916996%	1	253	33	Diabetes_McGill_CREBBP_coTF	CAFFAREL_RESPONSE_TO_THC_UP
0.395256916996%	1	253	33	Diabetes_McGill_CREBBP_coTF	APPEL_IMATINIB_RESPONSE
0.395256916996%	1	253	32	Diabetes_McGill_CREBBP_coTF	TRACEY_RESISTANCE_TO_IFNA2_DN
0.395256916996%	1	253	32	Diabetes_McGill_CREBBP_coTF	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN
0.395256916996%	1	253	32	Diabetes_McGill_CREBBP_coTF	REACTOME_ELONGATION_ARREST_AND_RECOVERY
0.395256916996%	1	253	32	Diabetes_McGill_CREBBP_coTF	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN
0.395256916996%	1	253	32	Diabetes_McGill_CREBBP_coTF	LIANG_SILENCED_BY_METHYLATION_UP
0.395256916996%	1	253	32	Diabetes_McGill_CREBBP_coTF	KIM_TIAL1_TARGETS
0.395256916996%	1	253	32	Diabetes_McGill_CREBBP_coTF	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM
0.395256916996%	1	253	32	Diabetes_McGill_CREBBP_coTF	GROSS_ELK3_TARGETS_DN
0.395256916996%	1	253	32	Diabetes_McGill_CREBBP_coTF	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP
0.395256916996%	1	253	32	Diabetes_McGill_CREBBP_coTF	BAUS_TFF2_TARGETS_UP
0.395256916996%	1	253	32	Diabetes_McGill_CREBBP_coTF	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN
0.395256916996%	1	253	32	Diabetes_McGill_CREBBP_coTF	BAE_BRCA1_TARGETS_DN
0.395256916996%	1	253	31	Diabetes_McGill_CREBBP_coTF	TING_SILENCED_BY_DICER
0.395256916996%	1	253	31	Diabetes_McGill_CREBBP_coTF	THEODOROU_MAMMARY_TUMORIGENESIS
0.395256916996%	1	253	31	Diabetes_McGill_CREBBP_coTF	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.395256916996%	1	253	31	Diabetes_McGill_CREBBP_coTF	REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING
0.395256916996%	1	253	31	Diabetes_McGill_CREBBP_coTF	REACTOME_INWARDLY_RECTIFYING_K_CHANNELS
0.395256916996%	1	253	31	Diabetes_McGill_CREBBP_coTF	PID_NEPHRIN_NEPH1_PATHWAY
0.395256916996%	1	253	31	Diabetes_McGill_CREBBP_coTF	NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON
0.395256916996%	1	253	31	Diabetes_McGill_CREBBP_coTF	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.395256916996%	1	253	31	Diabetes_McGill_CREBBP_coTF	MOSERLE_IFNA_RESPONSE
0.395256916996%	1	253	31	Diabetes_McGill_CREBBP_coTF	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP
0.395256916996%	1	253	31	Diabetes_McGill_CREBBP_coTF	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER
0.395256916996%	1	253	31	Diabetes_McGill_CREBBP_coTF	DORSEY_GAB2_TARGETS
0.395256916996%	1	253	31	Diabetes_McGill_CREBBP_coTF	BIOCARTA_PYK2_PATHWAY
0.395256916996%	1	253	31	Diabetes_McGill_CREBBP_coTF	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN
0.395256916996%	1	253	30	Diabetes_McGill_CREBBP_coTF	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN
0.395256916996%	1	253	30	Diabetes_McGill_CREBBP_coTF	URS_ADIPOCYTE_DIFFERENTIATION_DN
0.395256916996%	1	253	30	Diabetes_McGill_CREBBP_coTF	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN
0.395256916996%	1	253	30	Diabetes_McGill_CREBBP_coTF	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.395256916996%	1	253	30	Diabetes_McGill_CREBBP_coTF	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN
0.395256916996%	1	253	30	Diabetes_McGill_CREBBP_coTF	REACTOME_MRNA_CAPPING
0.395256916996%	1	253	30	Diabetes_McGill_CREBBP_coTF	REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX
0.395256916996%	1	253	30	Diabetes_McGill_CREBBP_coTF	PID_NECTIN_PATHWAY
0.395256916996%	1	253	30	Diabetes_McGill_CREBBP_coTF	PID_IGF1_PATHWAY
0.395256916996%	1	253	30	Diabetes_McGill_CREBBP_coTF	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.395256916996%	1	253	30	Diabetes_McGill_CREBBP_coTF	NAKAJIMA_EOSINOPHIL
0.395256916996%	1	253	30	Diabetes_McGill_CREBBP_coTF	GUILLAUMOND_KLF10_TARGETS_DN
0.395256916996%	1	253	30	Diabetes_McGill_CREBBP_coTF	GILDEA_METASTASIS
0.395256916996%	1	253	30	Diabetes_McGill_CREBBP_coTF	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP
0.395256916996%	1	253	295	Diabetes_McGill_CREBBP_coTF	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
0.395256916996%	1	253	293	Diabetes_McGill_CREBBP_coTF	ZWANG_DOWN_BY_2ND_EGF_PULSE
0.395256916996%	1	253	29	Diabetes_McGill_CREBBP_coTF	WOTTON_RUNX_TARGETS_DN
0.395256916996%	1	253	29	Diabetes_McGill_CREBBP_coTF	VALK_AML_CLUSTER_2
0.395256916996%	1	253	29	Diabetes_McGill_CREBBP_coTF	STANELLE_E2F1_TARGETS
0.395256916996%	1	253	29	Diabetes_McGill_CREBBP_coTF	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN
0.395256916996%	1	253	29	Diabetes_McGill_CREBBP_coTF	NAKAYAMA_FGF2_TARGETS
0.395256916996%	1	253	29	Diabetes_McGill_CREBBP_coTF	MAYBURD_RESPONSE_TO_L663536_UP
0.395256916996%	1	253	29	Diabetes_McGill_CREBBP_coTF	MARSHALL_VIRAL_INFECTION_RESPONSE_DN
0.395256916996%	1	253	29	Diabetes_McGill_CREBBP_coTF	KEGG_RNA_POLYMERASE
0.395256916996%	1	253	29	Diabetes_McGill_CREBBP_coTF	GENTLES_LEUKEMIC_STEM_CELL_UP
0.395256916996%	1	253	29	Diabetes_McGill_CREBBP_coTF	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN
0.395256916996%	1	253	29	Diabetes_McGill_CREBBP_coTF	DORN_ADENOVIRUS_INFECTION_12HR_UP
0.395256916996%	1	253	29	Diabetes_McGill_CREBBP_coTF	CHOW_RASSF1_TARGETS_DN
0.395256916996%	1	253	29	Diabetes_McGill_CREBBP_coTF	BIOCARTA_TNFR1_PATHWAY
0.395256916996%	1	253	29	Diabetes_McGill_CREBBP_coTF	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.395256916996%	1	253	29	Diabetes_McGill_CREBBP_coTF	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP
0.395256916996%	1	253	29	Diabetes_McGill_CREBBP_coTF	ABE_VEGFA_TARGETS_30MIN
0.395256916996%	1	253	288	Diabetes_McGill_CREBBP_coTF	POOLA_INVASIVE_BREAST_CANCER_UP
0.395256916996%	1	253	28	Diabetes_McGill_CREBBP_coTF	WIKMAN_ASBESTOS_LUNG_CANCER_DN
0.395256916996%	1	253	28	Diabetes_McGill_CREBBP_coTF	ST_GAQ_PATHWAY
0.395256916996%	1	253	28	Diabetes_McGill_CREBBP_coTF	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
0.395256916996%	1	253	28	Diabetes_McGill_CREBBP_coTF	SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER
0.395256916996%	1	253	28	Diabetes_McGill_CREBBP_coTF	REACTOME_SHC_MEDIATED_CASCADE
0.395256916996%	1	253	28	Diabetes_McGill_CREBBP_coTF	REACTOME_LIPOPROTEIN_METABOLISM
0.395256916996%	1	253	28	Diabetes_McGill_CREBBP_coTF	LI_CISPLATIN_RESISTANCE_UP
0.395256916996%	1	253	28	Diabetes_McGill_CREBBP_coTF	KEGG_HOMOLOGOUS_RECOMBINATION
0.395256916996%	1	253	28	Diabetes_McGill_CREBBP_coTF	HWANG_PROSTATE_CANCER_MARKERS
0.395256916996%	1	253	28	Diabetes_McGill_CREBBP_coTF	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.395256916996%	1	253	28	Diabetes_McGill_CREBBP_coTF	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN
0.395256916996%	1	253	28	Diabetes_McGill_CREBBP_coTF	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN
0.395256916996%	1	253	27	Diabetes_McGill_CREBBP_coTF	ST_MYOCYTE_AD_PATHWAY
0.395256916996%	1	253	27	Diabetes_McGill_CREBBP_coTF	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
0.395256916996%	1	253	27	Diabetes_McGill_CREBBP_coTF	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP
0.395256916996%	1	253	27	Diabetes_McGill_CREBBP_coTF	REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING
0.395256916996%	1	253	27	Diabetes_McGill_CREBBP_coTF	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP
0.395256916996%	1	253	27	Diabetes_McGill_CREBBP_coTF	GENTILE_UV_LOW_DOSE_UP
0.395256916996%	1	253	27	Diabetes_McGill_CREBBP_coTF	BRACHAT_RESPONSE_TO_METHOTREXATE_DN
0.395256916996%	1	253	27	Diabetes_McGill_CREBBP_coTF	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP
0.395256916996%	1	253	266	Diabetes_McGill_CREBBP_coTF	FOSTER_KDM1A_TARGETS_UP
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	ZHENG_FOXP3_TARGETS_UP
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	WALLACE_JAK2_TARGETS_UP
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	VALK_AML_CLUSTER_16
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	ST_INTERLEUKIN_4_PATHWAY
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	REACTOME_REGULATORY_RNA_PATHWAYS
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	PID_VEGFR1_PATHWAY
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	NEWMAN_ERCC6_TARGETS_UP
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	NAKAMURA_CANCER_MICROENVIRONMENT_UP
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	HAHTOLA_CTCL_CUTANEOUS
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	GAZIN_EPIGENETIC_SILENCING_BY_KRAS
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	FINAK_BREAST_CANCER_SDPP_SIGNATURE
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP
0.395256916996%	1	253	26	Diabetes_McGill_CREBBP_coTF	ALONSO_METASTASIS_DN
0.395256916996%	1	253	250	Diabetes_McGill_CREBBP_coTF	ZHENG_GLIOBLASTOMA_PLASTICITY_UP
0.395256916996%	1	253	25	Diabetes_McGill_CREBBP_coTF	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP
0.395256916996%	1	253	25	Diabetes_McGill_CREBBP_coTF	WANG_NFKB_TARGETS
0.395256916996%	1	253	25	Diabetes_McGill_CREBBP_coTF	REACTOME_SMOOTH_MUSCLE_CONTRACTION
0.395256916996%	1	253	25	Diabetes_McGill_CREBBP_coTF	REACTOME_FANCONI_ANEMIA_PATHWAY
0.395256916996%	1	253	25	Diabetes_McGill_CREBBP_coTF	REACTOME_EGFR_DOWNREGULATION
0.395256916996%	1	253	25	Diabetes_McGill_CREBBP_coTF	REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS
0.395256916996%	1	253	25	Diabetes_McGill_CREBBP_coTF	OZEN_MIR125B1_TARGETS
0.395256916996%	1	253	25	Diabetes_McGill_CREBBP_coTF	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP
0.395256916996%	1	253	25	Diabetes_McGill_CREBBP_coTF	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD
0.395256916996%	1	253	25	Diabetes_McGill_CREBBP_coTF	KIM_HYPOXIA
0.395256916996%	1	253	25	Diabetes_McGill_CREBBP_coTF	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN
0.395256916996%	1	253	25	Diabetes_McGill_CREBBP_coTF	GENTILE_UV_HIGH_DOSE_UP
0.395256916996%	1	253	25	Diabetes_McGill_CREBBP_coTF	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN
0.395256916996%	1	253	244	Diabetes_McGill_CREBBP_coTF	THUM_SYSTOLIC_HEART_FAILURE_DN
0.395256916996%	1	253	244	Diabetes_McGill_CREBBP_coTF	HSIAO_LIVER_SPECIFIC_GENES
0.395256916996%	1	253	24	Diabetes_McGill_CREBBP_coTF	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN
0.395256916996%	1	253	24	Diabetes_McGill_CREBBP_coTF	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN
0.395256916996%	1	253	24	Diabetes_McGill_CREBBP_coTF	SHI_SPARC_TARGETS_UP
0.395256916996%	1	253	24	Diabetes_McGill_CREBBP_coTF	SCHRAMM_INHBA_TARGETS_DN
0.395256916996%	1	253	24	Diabetes_McGill_CREBBP_coTF	ODONNELL_METASTASIS_DN
0.395256916996%	1	253	24	Diabetes_McGill_CREBBP_coTF	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN
0.395256916996%	1	253	24	Diabetes_McGill_CREBBP_coTF	JIANG_TIP30_TARGETS_DN
0.395256916996%	1	253	24	Diabetes_McGill_CREBBP_coTF	JEON_SMAD6_TARGETS_UP
0.395256916996%	1	253	24	Diabetes_McGill_CREBBP_coTF	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP
0.395256916996%	1	253	24	Diabetes_McGill_CREBBP_coTF	HASLINGER_B_CLL_WITH_13Q14_DELETION
0.395256916996%	1	253	24	Diabetes_McGill_CREBBP_coTF	GOLUB_ALL_VS_AML_DN
0.395256916996%	1	253	24	Diabetes_McGill_CREBBP_coTF	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP
0.395256916996%	1	253	24	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CXCR4_PATHWAY
0.395256916996%	1	253	24	Diabetes_McGill_CREBBP_coTF	AZARE_STAT3_TARGETS
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	ZIRN_TRETINOIN_RESPONSE_WT1_UP
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	YANG_MUC2_TARGETS_DUODENUM_3MO_DN
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	YANG_BREAST_CANCER_ESR1_BULK_DN
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	WENG_POR_TARGETS_GLOBAL_DN
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	VIETOR_IFRD1_TARGETS
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	ST_GA12_PATHWAY
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	REACTOME_MICRORNA_MIRNA_BIOGENESIS
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	REACTOME_LYSOSOME_VESICLE_BIOGENESIS
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	MARKS_HDAC_TARGETS_UP
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	HINATA_NFKB_TARGETS_KERATINOCYTE_DN
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	EGUCHI_CELL_CYCLE_RB1_TARGETS
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	CHIBA_RESPONSE_TO_TSA_DN
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	BILANGES_SERUM_SENSITIVE_VIA_TSC1
0.395256916996%	1	253	23	Diabetes_McGill_CREBBP_coTF	BARIS_THYROID_CANCER_UP
0.395256916996%	1	253	228	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
0.395256916996%	1	253	222	Diabetes_McGill_CREBBP_coTF	REACTOME_TRANSLATION
0.395256916996%	1	253	22	Diabetes_McGill_CREBBP_coTF	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP
0.395256916996%	1	253	22	Diabetes_McGill_CREBBP_coTF	VERNELL_RETINOBLASTOMA_PATHWAY_DN
0.395256916996%	1	253	22	Diabetes_McGill_CREBBP_coTF	REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION
0.395256916996%	1	253	22	Diabetes_McGill_CREBBP_coTF	REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION
0.395256916996%	1	253	22	Diabetes_McGill_CREBBP_coTF	REACTOME_DEADENYLATION_OF_MRNA
0.395256916996%	1	253	22	Diabetes_McGill_CREBBP_coTF	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP
0.395256916996%	1	253	22	Diabetes_McGill_CREBBP_coTF	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP
0.395256916996%	1	253	22	Diabetes_McGill_CREBBP_coTF	FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.395256916996%	1	253	22	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CERAMIDE_PATHWAY
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	YANG_MUC2_TARGETS_DUODENUM_6MO_DN
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	VERRECCHIA_RESPONSE_TO_TGFB1_C5
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	STEGER_ADIPOGENESIS_UP
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	PID_ECADHERIN_KERATINOCYTE_PATHWAY
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	OUYANG_PROSTATE_CANCER_PROGRESSION_DN
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	MARCHINI_TRABECTEDIN_RESISTANCE_UP
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	KANNAN_TP53_TARGETS_DN
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	HU_ANGIOGENESIS_UP
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	HUI_MAPK14_TARGETS_UP
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	HASLINGER_B_CLL_WITH_17P13_DELETION
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	GREENBAUM_E2A_TARGETS_DN
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	GESERICK_TERT_TARGETS_DN
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	FOURNIER_ACINAR_DEVELOPMENT_LATE_DN
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	BIOCARTA_TFF_PATHWAY
0.395256916996%	1	253	21	Diabetes_McGill_CREBBP_coTF	AMIT_SERUM_RESPONSE_20_MCF10A
0.395256916996%	1	253	205	Diabetes_McGill_CREBBP_coTF	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.395256916996%	1	253	203	Diabetes_McGill_CREBBP_coTF	REACTOME_INFLUENZA_LIFE_CYCLE
0.395256916996%	1	253	20	Diabetes_McGill_CREBBP_coTF	ZHU_SKIL_TARGETS_UP
0.395256916996%	1	253	20	Diabetes_McGill_CREBBP_coTF	WALLACE_PROSTATE_CANCER_UP
0.395256916996%	1	253	20	Diabetes_McGill_CREBBP_coTF	PID_WNT_CANONICAL_PATHWAY
0.395256916996%	1	253	20	Diabetes_McGill_CREBBP_coTF	PHESSE_TARGETS_OF_APC_AND_MBD2_UP
0.395256916996%	1	253	20	Diabetes_McGill_CREBBP_coTF	NIELSEN_LEIOMYOSARCOMA_CNN1_DN
0.395256916996%	1	253	20	Diabetes_McGill_CREBBP_coTF	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN
0.395256916996%	1	253	20	Diabetes_McGill_CREBBP_coTF	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP
0.395256916996%	1	253	20	Diabetes_McGill_CREBBP_coTF	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN
0.395256916996%	1	253	20	Diabetes_McGill_CREBBP_coTF	KIM_MYCL1_AMPLIFICATION_TARGETS_DN
0.395256916996%	1	253	20	Diabetes_McGill_CREBBP_coTF	HASLINGER_B_CLL_WITH_6Q21_DELETION
0.395256916996%	1	253	196	Diabetes_McGill_CREBBP_coTF	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	WU_ALZHEIMER_DISEASE_DN
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	VERNOCHET_ADIPOGENESIS
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	STREICHER_LSM1_TARGETS_DN
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	RUAN_RESPONSE_TO_TROGLITAZONE_DN
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	REACTOME_LAGGING_STRAND_SYNTHESIS
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	REACTOME_G1_S_SPECIFIC_TRANSCRIPTION
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	REACTOME_BASE_EXCISION_REPAIR
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	RASHI_NFKB1_TARGETS
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	NIELSEN_LEIOMYOSARCOMA_CNN1_UP
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	NAGY_TFTC_COMPONENTS_HUMAN
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	MELLMAN_TUT1_TARGETS_UP
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	MARSON_FOXP3_CORE_DIRECT_TARGETS
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	LE_NEURONAL_DIFFERENTIATION_DN
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	KANG_DOXORUBICIN_RESISTANCE_DN
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	KANG_CISPLATIN_RESISTANCE_UP
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	KANG_AR_TARGETS_DN
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	JEON_SMAD6_TARGETS_DN
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	HAHTOLA_MYCOSIS_FUNGOIDES_UP
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	BIOCARTA_STATHMIN_PATHWAY
0.395256916996%	1	253	19	Diabetes_McGill_CREBBP_coTF	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP
0.395256916996%	1	253	187	Diabetes_McGill_CREBBP_coTF	BAKKER_FOXO3_TARGETS_DN
0.395256916996%	1	253	185	Diabetes_McGill_CREBBP_coTF	LEE_LIVER_CANCER_SURVIVAL_UP
0.395256916996%	1	253	184	Diabetes_McGill_CREBBP_coTF	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	ZHENG_RESPONSE_TO_ARSENITE_DN
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	SMID_BREAST_CANCER_LUMINAL_A_DN
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	REACTOME_PD1_SIGNALING
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	PID_BETACATENIN_DEG_PATHWAY
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	NIELSEN_SCHWANNOMA_UP
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	MAINA_VHL_TARGETS_DN
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	KIM_PTEN_TARGETS_UP
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	KAPOSI_LIVER_CANCER_MET_UP
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	GENTILE_UV_RESPONSE_CLUSTER_D1
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	CHOI_ATL_CHRONIC_VS_ACUTE_DN
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	BIOCARTA_MCM_PATHWAY
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP
0.395256916996%	1	253	18	Diabetes_McGill_CREBBP_coTF	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP
0.395256916996%	1	253	178	Diabetes_McGill_CREBBP_coTF	LI_AMPLIFIED_IN_LUNG_CANCER
0.395256916996%	1	253	178	Diabetes_McGill_CREBBP_coTF	KEGG_CALCIUM_SIGNALING_PATHWAY
0.395256916996%	1	253	174	Diabetes_McGill_CREBBP_coTF	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP
0.395256916996%	1	253	17	Diabetes_McGill_CREBBP_coTF	ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL
0.395256916996%	1	253	17	Diabetes_McGill_CREBBP_coTF	RODRIGUES_NTN1_TARGETS_UP
0.395256916996%	1	253	17	Diabetes_McGill_CREBBP_coTF	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY
0.395256916996%	1	253	17	Diabetes_McGill_CREBBP_coTF	MATTHEWS_AP1_TARGETS
0.395256916996%	1	253	17	Diabetes_McGill_CREBBP_coTF	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
0.395256916996%	1	253	17	Diabetes_McGill_CREBBP_coTF	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN
0.395256916996%	1	253	17	Diabetes_McGill_CREBBP_coTF	KASLER_HDAC7_TARGETS_1_DN
0.395256916996%	1	253	17	Diabetes_McGill_CREBBP_coTF	KANG_AR_TARGETS_UP
0.395256916996%	1	253	17	Diabetes_McGill_CREBBP_coTF	JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN
0.395256916996%	1	253	17	Diabetes_McGill_CREBBP_coTF	HOWLIN_CITED1_TARGETS_2_DN
0.395256916996%	1	253	17	Diabetes_McGill_CREBBP_coTF	BIOCARTA_NO2IL12_PATHWAY
0.395256916996%	1	253	169	Diabetes_McGill_CREBBP_coTF	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION
0.395256916996%	1	253	165	Diabetes_McGill_CREBBP_coTF	BROWN_MYELOID_CELL_DEVELOPMENT_UP
0.395256916996%	1	253	160	Diabetes_McGill_CREBBP_coTF	GAVIN_FOXP3_TARGETS_CLUSTER_P3
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	ZHAN_LATE_DIFFERENTIATION_GENES_DN
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	WANG_RECURRENT_LIVER_CANCER_DN
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	ST_G_ALPHA_S_PATHWAY
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	PID_CIRCADIANPATHWAY
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	LUI_THYROID_CANCER_CLUSTER_4
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	LEE_LIVER_CANCER_HEPATOBLAST
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	KOINUMA_COLON_CANCER_MSI_DN
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	GHO_ATF5_TARGETS_DN
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	GEISS_RESPONSE_TO_DSRNA_DN
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	BIOCARTA_SHH_PATHWAY
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	BIOCARTA_BCELLSURVIVAL_PATHWAY
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	BIOCARTA_ACH_PATHWAY
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP
0.395256916996%	1	253	16	Diabetes_McGill_CREBBP_coTF	ABDELMOHSEN_ELAVL4_TARGETS
0.395256916996%	1	253	159	Diabetes_McGill_CREBBP_coTF	KEGG_PURINE_METABOLISM
0.395256916996%	1	253	153	Diabetes_McGill_CREBBP_coTF	RUIZ_TNC_TARGETS_UP
0.395256916996%	1	253	153	Diabetes_McGill_CREBBP_coTF	DURAND_STROMA_MAX_DN
0.395256916996%	1	253	150	Diabetes_McGill_CREBBP_coTF	LANDIS_ERBB2_BREAST_TUMORS_324_UP
0.395256916996%	1	253	15	Diabetes_McGill_CREBBP_coTF	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP
0.395256916996%	1	253	15	Diabetes_McGill_CREBBP_coTF	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3
0.395256916996%	1	253	15	Diabetes_McGill_CREBBP_coTF	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN
0.395256916996%	1	253	15	Diabetes_McGill_CREBBP_coTF	SU_KIDNEY
0.395256916996%	1	253	15	Diabetes_McGill_CREBBP_coTF	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP
0.395256916996%	1	253	15	Diabetes_McGill_CREBBP_coTF	SANCHEZ_MDM2_TARGETS
0.395256916996%	1	253	15	Diabetes_McGill_CREBBP_coTF	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND
0.395256916996%	1	253	15	Diabetes_McGill_CREBBP_coTF	REACTOME_HDL_MEDIATED_LIPID_TRANSPORT
0.395256916996%	1	253	15	Diabetes_McGill_CREBBP_coTF	REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION
0.395256916996%	1	253	15	Diabetes_McGill_CREBBP_coTF	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII
0.395256916996%	1	253	15	Diabetes_McGill_CREBBP_coTF	NAGY_STAGA_COMPONENTS_HUMAN
0.395256916996%	1	253	15	Diabetes_McGill_CREBBP_coTF	LI_CYTIDINE_ANALOGS_CYCTOTOXICITY
0.395256916996%	1	253	15	Diabetes_McGill_CREBBP_coTF	KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION
0.395256916996%	1	253	15	Diabetes_McGill_CREBBP_coTF	GRANDVAUX_IRF3_TARGETS_UP
0.395256916996%	1	253	15	Diabetes_McGill_CREBBP_coTF	FINETTI_BREAST_CANCERS_KINOME_GRAY
0.395256916996%	1	253	15	Diabetes_McGill_CREBBP_coTF	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN
0.395256916996%	1	253	15	Diabetes_McGill_CREBBP_coTF	BIOCARTA_HSP27_PATHWAY
0.395256916996%	1	253	149	Diabetes_McGill_CREBBP_coTF	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
0.395256916996%	1	253	146	Diabetes_McGill_CREBBP_coTF	PECE_MAMMARY_STEM_CELL_DN
0.395256916996%	1	253	146	Diabetes_McGill_CREBBP_coTF	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
0.395256916996%	1	253	145	Diabetes_McGill_CREBBP_coTF	RODWELL_AGING_KIDNEY_DN
0.395256916996%	1	253	142	Diabetes_McGill_CREBBP_coTF	XU_GH1_AUTOCRINE_TARGETS_DN
0.395256916996%	1	253	141	Diabetes_McGill_CREBBP_coTF	SABATES_COLORECTAL_ADENOMA_UP
0.395256916996%	1	253	141	Diabetes_McGill_CREBBP_coTF	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.395256916996%	1	253	14	Diabetes_McGill_CREBBP_coTF	ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR
0.395256916996%	1	253	14	Diabetes_McGill_CREBBP_coTF	WU_ALZHEIMER_DISEASE_UP
0.395256916996%	1	253	14	Diabetes_McGill_CREBBP_coTF	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN
0.395256916996%	1	253	14	Diabetes_McGill_CREBBP_coTF	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN
0.395256916996%	1	253	14	Diabetes_McGill_CREBBP_coTF	REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS
0.395256916996%	1	253	14	Diabetes_McGill_CREBBP_coTF	REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER
0.395256916996%	1	253	14	Diabetes_McGill_CREBBP_coTF	REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION
0.395256916996%	1	253	14	Diabetes_McGill_CREBBP_coTF	PID_TCRJNKPATHWAY
0.395256916996%	1	253	14	Diabetes_McGill_CREBBP_coTF	ONGUSAHA_BRCA1_TARGETS_DN
0.395256916996%	1	253	14	Diabetes_McGill_CREBBP_coTF	MATZUK_OVULATION
0.395256916996%	1	253	14	Diabetes_McGill_CREBBP_coTF	LIM_MAMMARY_LUMINAL_PROGENITOR_DN
0.395256916996%	1	253	14	Diabetes_McGill_CREBBP_coTF	KEGG_NON_HOMOLOGOUS_END_JOINING
0.395256916996%	1	253	14	Diabetes_McGill_CREBBP_coTF	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION
0.395256916996%	1	253	14	Diabetes_McGill_CREBBP_coTF	CASTELLANO_NRAS_TARGETS_DN
0.395256916996%	1	253	14	Diabetes_McGill_CREBBP_coTF	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP
0.395256916996%	1	253	14	Diabetes_McGill_CREBBP_coTF	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN
0.395256916996%	1	253	14	Diabetes_McGill_CREBBP_coTF	ABBUD_LIF_SIGNALING_2_UP
0.395256916996%	1	253	137	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.395256916996%	1	253	136	Diabetes_McGill_CREBBP_coTF	WIERENGA_STAT5A_TARGETS_GROUP1
0.395256916996%	1	253	135	Diabetes_McGill_CREBBP_coTF	SERVITJA_LIVER_HNF1A_TARGETS_UP
0.395256916996%	1	253	134	Diabetes_McGill_CREBBP_coTF	KEGG_CELL_ADHESION_MOLECULES_CAMS
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	YAGUE_PRETUMOR_DRUG_RESISTANCE_DN
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	WAGSCHAL_EHMT2_TARGETS_UP
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	VERRECCHIA_RESPONSE_TO_TGFB1_C4
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	SA_REG_CASCADE_OF_CYCLIN_EXPR
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6_ALPHA
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	PHESSE_TARGETS_OF_APC_AND_MBD2_DN
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	KEGG_CIRCADIAN_RHYTHM_MAMMAL
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	HASINA_NOL7_TARGETS_UP
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	GERHOLD_RESPONSE_TO_TZD_DN
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	BIOCARTA_P27_PATHWAY
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	BIOCARTA_D4GDI_PATHWAY
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	BIOCARTA_AHSP_PATHWAY
0.395256916996%	1	253	13	Diabetes_McGill_CREBBP_coTF	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN
0.395256916996%	1	253	128	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_MEF_LCP_WITH_H3K4ME3
0.395256916996%	1	253	127	Diabetes_McGill_CREBBP_coTF	KARLSSON_TGFB1_TARGETS_UP
0.395256916996%	1	253	126	Diabetes_McGill_CREBBP_coTF	BURTON_ADIPOGENESIS_5
0.395256916996%	1	253	124	Diabetes_McGill_CREBBP_coTF	DAIRKEE_TERT_TARGETS_DN
0.395256916996%	1	253	121	Diabetes_McGill_CREBBP_coTF	RODRIGUES_DCC_TARGETS_DN
0.395256916996%	1	253	121	Diabetes_McGill_CREBBP_coTF	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP
0.395256916996%	1	253	121	Diabetes_McGill_CREBBP_coTF	KEGG_LYSOSOME
0.395256916996%	1	253	121	Diabetes_McGill_CREBBP_coTF	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
0.395256916996%	1	253	121	Diabetes_McGill_CREBBP_coTF	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
0.395256916996%	1	253	120	Diabetes_McGill_CREBBP_coTF	XU_GH1_EXOGENOUS_TARGETS_DN
0.395256916996%	1	253	120	Diabetes_McGill_CREBBP_coTF	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
0.395256916996%	1	253	120	Diabetes_McGill_CREBBP_coTF	CHEBOTAEV_GR_TARGETS_DN
0.395256916996%	1	253	120	Diabetes_McGill_CREBBP_coTF	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN
0.395256916996%	1	253	12	Diabetes_McGill_CREBBP_coTF	WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53
0.395256916996%	1	253	12	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_NOTCH4
0.395256916996%	1	253	12	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_NOTCH3
0.395256916996%	1	253	12	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_NOTCH2
0.395256916996%	1	253	12	Diabetes_McGill_CREBBP_coTF	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY
0.395256916996%	1	253	12	Diabetes_McGill_CREBBP_coTF	REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES
0.395256916996%	1	253	12	Diabetes_McGill_CREBBP_coTF	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS
0.395256916996%	1	253	12	Diabetes_McGill_CREBBP_coTF	REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION
0.395256916996%	1	253	12	Diabetes_McGill_CREBBP_coTF	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP
0.395256916996%	1	253	12	Diabetes_McGill_CREBBP_coTF	HOLLEMAN_DAUNORUBICIN_B_ALL_DN
0.395256916996%	1	253	12	Diabetes_McGill_CREBBP_coTF	HEDVAT_ELF4_TARGETS_UP
0.395256916996%	1	253	12	Diabetes_McGill_CREBBP_coTF	FUNG_IL2_SIGNALING_2
0.395256916996%	1	253	12	Diabetes_McGill_CREBBP_coTF	BIOCARTA_AKAP95_PATHWAY
0.395256916996%	1	253	118	Diabetes_McGill_CREBBP_coTF	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
0.395256916996%	1	253	116	Diabetes_McGill_CREBBP_coTF	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
0.395256916996%	1	253	115	Diabetes_McGill_CREBBP_coTF	HOELZEL_NF1_TARGETS_DN
0.395256916996%	1	253	113	Diabetes_McGill_CREBBP_coTF	RICKMAN_HEAD_AND_NECK_CANCER_C
0.395256916996%	1	253	112	Diabetes_McGill_CREBBP_coTF	LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.395256916996%	1	253	110	Diabetes_McGill_CREBBP_coTF	CHENG_IMPRINTED_BY_ESTRADIOL
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	WHITESIDE_CISPLATIN_RESISTANCE_UP
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	ROZANOV_MMP14_CORRELATED
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	REACTOME_UNWINDING_OF_DNA
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	LIANG_SILENCED_BY_METHYLATION_DN
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	HOFFMAN_CLOCK_TARGETS_UP
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	HASEGAWA_TUMORIGENESIS_BY_RET_C634R
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	FRASOR_TAMOXIFEN_RESPONSE_DN
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	BIOCARTA_SET_PATHWAY
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	BIOCARTA_PTC1_PATHWAY
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	BIOCARTA_IL4_PATHWAY
0.395256916996%	1	253	11	Diabetes_McGill_CREBBP_coTF	BIOCARTA_CDK5_PATHWAY
0.395256916996%	1	253	109	Diabetes_McGill_CREBBP_coTF	SERVITJA_ISLET_HNF1A_TARGETS_DN
0.395256916996%	1	253	109	Diabetes_McGill_CREBBP_coTF	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
0.395256916996%	1	253	108	Diabetes_McGill_CREBBP_coTF	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
0.395256916996%	1	253	108	Diabetes_McGill_CREBBP_coTF	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
0.395256916996%	1	253	108	Diabetes_McGill_CREBBP_coTF	LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT
0.395256916996%	1	253	107	Diabetes_McGill_CREBBP_coTF	LEE_EARLY_T_LYMPHOCYTE_UP
0.395256916996%	1	253	105	Diabetes_McGill_CREBBP_coTF	ZWANG_EGF_INTERVAL_UP
0.395256916996%	1	253	103	Diabetes_McGill_CREBBP_coTF	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY
0.395256916996%	1	253	101	Diabetes_McGill_CREBBP_coTF	KOBAYASHI_EGFR_SIGNALING_24HR_UP
0.395256916996%	1	253	101	Diabetes_McGill_CREBBP_coTF	BROWNE_HCMV_INFECTION_20HR_DN
0.395256916996%	1	253	101	Diabetes_McGill_CREBBP_coTF	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.395256916996%	1	253	100	Diabetes_McGill_CREBBP_coTF	MCCLUNG_CREB1_TARGETS_UP
0.395256916996%	1	253	100	Diabetes_McGill_CREBBP_coTF	GAVIN_FOXP3_TARGETS_CLUSTER_P4
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	YIH_RESPONSE_TO_ARSENITE_C5
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	VISALA_AGING_LYMPHOCYTE_UP
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	TAKAYAMA_BOUND_BY_AR
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	ST_INTERFERON_GAMMA_PATHWAY
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	OXFORD_RALA_AND_RALB_TARGETS_UP
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	MURAKAMI_UV_RESPONSE_1HR_DN
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	MATZUK_PREOVULATORY_FOLLICLE
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	KONG_E2F1_TARGETS
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	HOLLEMAN_DAUNORUBICIN_B_ALL_UP
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	CHEN_HOXA5_TARGETS_6HR_UP
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	BIOCARTA_SKP2E2F_PATHWAY
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	BIOCARTA_RANMS_PATHWAY
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	BIOCARTA_FREE_PATHWAY
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	BIOCARTA_BARRESTIN_PATHWAY
0.395256916996%	1	253	10	Diabetes_McGill_CREBBP_coTF	BAKER_HEMATOPOESIS_STAT1_TARGETS
0.394011032309%	5	1269	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
0.394011032309%	5	1269	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MENSE_HYPOXIA_UP
0.394011032309%	5	1269	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PYRIMIDINE_METABOLISM
0.394011032309%	5	1269	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GUO_TARGETS_OF_IRS1_AND_IRS2
0.394011032309%	5	1269	95	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.394011032309%	5	1269	95	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
0.394011032309%	5	1269	94	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES
0.394011032309%	5	1269	93	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
0.394011032309%	5	1269	93	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHEN_LIVER_METABOLISM_QTL_CIS
0.394011032309%	5	1269	93	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CADWELL_ATG16L1_TARGETS_UP
0.394011032309%	5	1269	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_DILATED_CARDIOMYOPATHY
0.394011032309%	5	1269	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CAMPS_COLON_CANCER_COPY_NUMBER_UP
0.394011032309%	5	1269	91	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
0.394011032309%	5	1269	90	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BILANGES_SERUM_SENSITIVE_GENES
0.394011032309%	5	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_UP
0.394011032309%	5	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LI_DCP2_BOUND_MRNA
0.394011032309%	5	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PROSTATE_CANCER
0.394011032309%	5	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DELASERNA_MYOD_TARGETS_UP
0.394011032309%	5	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
0.394011032309%	5	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ALCALA_APOPTOSIS
0.394011032309%	5	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
0.394011032309%	5	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_MAPK_PATHWAY
0.394011032309%	5	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.394011032309%	5	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_AGING_CEREBELLUM_DN
0.394011032309%	5	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMID_BREAST_CANCER_LUMINAL_A_UP
0.394011032309%	5	1269	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
0.394011032309%	5	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MAHAJAN_RESPONSE_TO_IL1A_UP
0.394011032309%	5	1269	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BASSO_HAIRY_CELL_LEUKEMIA_DN
0.394011032309%	5	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RADMACHER_AML_PROGNOSIS
0.394011032309%	5	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE
0.394011032309%	5	1269	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
0.394011032309%	5	1269	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
0.394011032309%	5	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	URS_ADIPOCYTE_DIFFERENTIATION_UP
0.394011032309%	5	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JI_RESPONSE_TO_FSH_UP
0.394011032309%	5	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CORRE_MULTIPLE_MYELOMA_UP
0.394011032309%	5	1269	71	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_MELANOMA
0.394011032309%	5	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ENGELMANN_CANCER_PROGENITORS_DN
0.394011032309%	5	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEIN_NEURON_MARKERS
0.394011032309%	5	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
0.394011032309%	5	1269	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SEMAPHORIN_INTERACTIONS
0.394011032309%	5	1269	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.394011032309%	5	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.394011032309%	5	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_UP
0.394011032309%	5	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
0.394011032309%	5	1269	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BRIDEAU_IMPRINTED_GENES
0.394011032309%	5	1269	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
0.394011032309%	5	1269	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REN_BOUND_BY_E2F
0.394011032309%	5	1269	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RAMASWAMY_METASTASIS_DN
0.394011032309%	5	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_SHP2_PATHWAY
0.394011032309%	5	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER
0.394011032309%	5	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
0.394011032309%	5	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_NUCLEOTIDE_EXCISION_REPAIR
0.394011032309%	5	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAUER_STAT3_TARGETS_DN
0.394011032309%	5	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OLSSON_E2F3_TARGETS_DN
0.394011032309%	5	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_GLYCEROLIPID_METABOLISM
0.394011032309%	5	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_C_UP
0.394011032309%	5	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_RHOA_REG_PATHWAY
0.394011032309%	5	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_NUCLEOTIDE_EXCISION_REPAIR
0.394011032309%	5	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
0.394011032309%	5	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHENG_IL22_SIGNALING_DN
0.394011032309%	5	1269	411	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KOYAMA_SEMA3B_TARGETS_DN
0.394011032309%	5	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_AURORA_B_PATHWAY
0.394011032309%	5	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GLUCOSE_TRANSPORT
0.394011032309%	5	1269	373	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN
0.394011032309%	5	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROLEF_GLIS3_TARGETS
0.394011032309%	5	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GLOBAL_GENOMIC_NER_GG_NER
0.394011032309%	5	1269	335	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WONG_EMBRYONIC_STEM_CELL_CORE
0.394011032309%	5	1269	330	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_RNA
0.394011032309%	5	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TSENG_ADIPOGENIC_POTENTIAL_UP
0.394011032309%	5	1269	295	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
0.394011032309%	5	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAKAYAMA_FGF2_TARGETS
0.394011032309%	5	1269	285	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
0.394011032309%	5	1269	285	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRADE_COLON_AND_RECTAL_CANCER_UP
0.394011032309%	5	1269	280	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
0.394011032309%	5	1269	265	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
0.394011032309%	5	1269	261	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BILD_HRAS_ONCOGENIC_SIGNATURE
0.394011032309%	5	1269	260	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOQUEST_STEM_CELL_UP
0.394011032309%	5	1269	255	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.394011032309%	5	1269	245	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PENG_RAPAMYCIN_RESPONSE_DN
0.394011032309%	5	1269	228	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARKEY_RB1_ACUTE_LOF_DN
0.394011032309%	5	1269	227	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
0.394011032309%	5	1269	226	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.394011032309%	5	1269	225	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_16HR_UP
0.394011032309%	5	1269	217	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WIERENGA_STAT5A_TARGETS_UP
0.394011032309%	5	1269	214	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
0.394011032309%	5	1269	207	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_HIV_INFECTION
0.394011032309%	5	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
0.394011032309%	5	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HASLINGER_B_CLL_WITH_6Q21_DELETION
0.394011032309%	5	1269	195	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.394011032309%	5	1269	188	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.394011032309%	5	1269	187	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PENG_LEUCINE_DEPRIVATION_DN
0.394011032309%	5	1269	185	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS
0.394011032309%	5	1269	181	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
0.394011032309%	5	1269	179	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
0.394011032309%	5	1269	178	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_CALCIUM_SIGNALING_PATHWAY
0.394011032309%	5	1269	172	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
0.394011032309%	5	1269	169	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KATSANOU_ELAVL1_TARGETS_UP
0.394011032309%	5	1269	167	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
0.394011032309%	5	1269	166	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CAIRO_LIVER_DEVELOPMENT_UP
0.394011032309%	5	1269	164	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_WT1_TARGETS_8HR_UP
0.394011032309%	5	1269	163	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
0.394011032309%	5	1269	162	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
0.394011032309%	5	1269	162	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_WT1_TARGETS_12HR_UP
0.394011032309%	5	1269	160	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_P3
0.394011032309%	5	1269	155	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_JAK_STAT_SIGNALING_PATHWAY
0.394011032309%	5	1269	153	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RUIZ_TNC_TARGETS_UP
0.394011032309%	5	1269	153	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G6
0.394011032309%	5	1269	150	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_30MIN_DN
0.394011032309%	5	1269	148	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHANG_CYCLING_GENES
0.394011032309%	5	1269	147	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KAUFFMANN_DNA_REPLICATION_GENES
0.394011032309%	5	1269	146	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ELVIDGE_HYPOXIA_DN
0.394011032309%	5	1269	143	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14
0.394011032309%	5	1269	142	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.394011032309%	5	1269	141	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
0.394011032309%	5	1269	140	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
0.394011032309%	5	1269	138	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
0.394011032309%	5	1269	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
0.394011032309%	5	1269	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
0.394011032309%	5	1269	135	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_OXIDATIVE_PHOSPHORYLATION
0.394011032309%	5	1269	134	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHLOSSER_SERUM_RESPONSE_UP
0.394011032309%	5	1269	134	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
0.394011032309%	5	1269	134	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_TIGHT_JUNCTION
0.394011032309%	5	1269	133	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PARKINSONS_DISEASE
0.394011032309%	5	1269	129	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAGI_AML_SURVIVAL
0.394011032309%	5	1269	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YEGNASUBRAMANIAN_PROSTATE_CANCER
0.394011032309%	5	1269	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_CELL_CYCLE
0.394011032309%	5	1269	127	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
0.394011032309%	5	1269	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
0.394011032309%	5	1269	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_5
0.394011032309%	5	1269	124	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAIRKEE_TERT_TARGETS_DN
0.394011032309%	5	1269	123	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAZARD_RESPONSE_TO_UV_SCC_DN
0.394011032309%	5	1269	122	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TOOKER_GEMCITABINE_RESISTANCE_DN
0.394011032309%	5	1269	122	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_PDGF
0.394011032309%	5	1269	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_METASTASIS_DN
0.394011032309%	5	1269	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RODRIGUES_DCC_TARGETS_DN
0.394011032309%	5	1269	117	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.394011032309%	5	1269	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIM_MAMMARY_LUMINAL_MATURE_UP
0.394011032309%	5	1269	112	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_FGFR
0.394011032309%	5	1269	112	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
0.394011032309%	5	1269	112	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DITTMER_PTHLH_TARGETS_UP
0.394011032309%	5	1269	110	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
0.394011032309%	5	1269	109	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
0.394011032309%	5	1269	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_DN
0.394011032309%	5	1269	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LE_EGR2_TARGETS_DN
0.394011032309%	5	1269	107	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_EARLY_T_LYMPHOCYTE_UP
0.394011032309%	5	1269	107	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.394011032309%	5	1269	105	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_8HR_UP
0.394011032309%	5	1269	103	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY
0.394011032309%	5	1269	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_ERBB2
0.394011032309%	5	1269	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
0.394011032309%	5	1269	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BENPORATH_ES_CORE_NINE_CORRELATED
0.383729854183%	5	1303	99	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIM_MAMMARY_LUMINAL_MATURE_DN
0.383729854183%	5	1303	98	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_POTASSIUM_CHANNELS
0.383729854183%	5	1303	95	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
0.383729854183%	5	1303	95	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.383729854183%	5	1303	93	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_REGULATION_OF_INSULIN_SECRETION
0.383729854183%	5	1303	92	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_DNA
0.383729854183%	5	1303	92	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
0.383729854183%	5	1303	92	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DE_YY1_TARGETS_DN
0.383729854183%	5	1303	90	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SANA_TNF_SIGNALING_DN
0.383729854183%	5	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WNT_SIGNALING
0.383729854183%	5	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WALLACE_PROSTATE_CANCER_RACE_DN
0.383729854183%	5	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TIEN_INTESTINE_PROBIOTICS_2HR_DN
0.383729854183%	5	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMITH_TERT_TARGETS_DN
0.383729854183%	5	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.383729854183%	5	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.383729854183%	5	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
0.383729854183%	5	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_MAPK_PATHWAY
0.383729854183%	5	1303	86	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_16HR_DN
0.383729854183%	5	1303	84	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_SMALL_CELL_LUNG_CANCER
0.383729854183%	5	1303	84	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
0.383729854183%	5	1303	82	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_INTEGRIN_SIGNALING_PATHWAY
0.383729854183%	5	1303	82	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FRASOR_RESPONSE_TO_ESTRADIOL_DN
0.383729854183%	5	1303	80	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_UNFOLDED_PROTEIN_RESPONSE
0.383729854183%	5	1303	80	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_BETACATENIN_NUC_PATHWAY
0.383729854183%	5	1303	80	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BASSO_HAIRY_CELL_LEUKEMIA_DN
0.383729854183%	5	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
0.383729854183%	5	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TOOKER_GEMCITABINE_RESISTANCE_UP
0.383729854183%	5	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_MYC_ACTIVPATHWAY
0.383729854183%	5	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_P2
0.383729854183%	5	1303	78	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LINDVALL_IMMORTALIZED_BY_TERT_UP
0.383729854183%	5	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIN_APC_TARGETS
0.383729854183%	5	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM
0.383729854183%	5	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
0.383729854183%	5	1303	76	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
0.383729854183%	5	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	URS_ADIPOCYTE_DIFFERENTIATION_UP
0.383729854183%	5	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	POTTI_ADRIAMYCIN_SENSITIVITY
0.383729854183%	5	1303	72	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
0.383729854183%	5	1303	71	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_RESPONSE_TO_H2O2
0.383729854183%	5	1303	71	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DER_IFN_GAMMA_RESPONSE_UP
0.383729854183%	5	1303	70	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VERNELL_RETINOBLASTOMA_PATHWAY_UP
0.383729854183%	5	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_HIF1_TFPATHWAY
0.383729854183%	5	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP
0.383729854183%	5	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.383729854183%	5	1303	63	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_MYC_REPRESSPATHWAY
0.383729854183%	5	1303	60	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SONG_TARGETS_OF_IE86_CMV_PROTEIN
0.383729854183%	5	1303	60	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN
0.383729854183%	5	1303	59	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HUPER_BREAST_BASAL_VS_LUMINAL_DN
0.383729854183%	5	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LUCAS_HNF4A_TARGETS_UP
0.383729854183%	5	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_EARLY_T_LYMPHOCYTE_DN
0.383729854183%	5	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP
0.383729854183%	5	1303	55	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
0.383729854183%	5	1303	55	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
0.383729854183%	5	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMIRNOV_RESPONSE_TO_IR_2HR_UP
0.383729854183%	5	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN
0.383729854183%	5	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NUCLEOTIDE_EXCISION_REPAIR
0.383729854183%	5	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_GLYCEROLIPID_METABOLISM
0.383729854183%	5	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GERHOLD_ADIPOGENESIS_UP
0.383729854183%	5	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_LB_UP
0.383729854183%	5	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
0.383729854183%	5	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER
0.383729854183%	5	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.383729854183%	5	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_NUCLEOTIDE_EXCISION_REPAIR
0.383729854183%	5	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_ABC_TRANSPORTERS
0.383729854183%	5	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_G1_PHASE
0.383729854183%	5	1303	374	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_TUMOR_INVASIVENESS_UP
0.383729854183%	5	1303	358	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRUETZMANN_PANCREATIC_CANCER_UP
0.383729854183%	5	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GLOBAL_GENOMIC_NER_GG_NER
0.383729854183%	5	1303	330	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_RNA
0.383729854183%	5	1303	310	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HORIUCHI_WTAP_TARGETS_DN
0.383729854183%	5	1303	306	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HORIUCHI_WTAP_TARGETS_UP
0.383729854183%	5	1303	293	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_60HR_UP
0.383729854183%	5	1303	293	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_MATURE_CELL
0.383729854183%	5	1303	290	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BASAKI_YBX1_TARGETS_UP
0.383729854183%	5	1303	285	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRADE_COLON_AND_RECTAL_CANCER_UP
0.383729854183%	5	1303	284	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_MRNA
0.383729854183%	5	1303	280	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_SMARCE1_TARGETS_UP
0.383729854183%	5	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN
0.383729854183%	5	1303	259	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	QI_PLASMACYTOMA_UP
0.383729854183%	5	1303	258	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
0.383729854183%	5	1303	255	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.383729854183%	5	1303	244	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAL_LEUKEMIC_STEM_CELL_DN
0.383729854183%	5	1303	242	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WINTER_HYPOXIA_METAGENE
0.383729854183%	5	1303	242	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
0.383729854183%	5	1303	226	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_UP
0.383729854183%	5	1303	226	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.383729854183%	5	1303	222	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
0.383729854183%	5	1303	220	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
0.383729854183%	5	1303	220	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RIGGINS_TAMOXIFEN_RESISTANCE_DN
0.383729854183%	5	1303	216	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
0.383729854183%	5	1303	210	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VERHAAK_GLIOBLASTOMA_NEURAL
0.383729854183%	5	1303	210	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.383729854183%	5	1303	207	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_HIV_INFECTION
0.383729854183%	5	1303	207	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KARLSSON_TGFB1_TARGETS_DN
0.383729854183%	5	1303	206	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BILD_MYC_ONCOGENIC_SIGNATURE
0.383729854183%	5	1303	202	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
0.383729854183%	5	1303	198	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PHOSPHOLIPID_METABOLISM
0.383729854183%	5	1303	195	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_DN
0.383729854183%	5	1303	188	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.383729854183%	5	1303	187	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
0.383729854183%	5	1303	186	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES
0.383729854183%	5	1303	185	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_HUNTINGTONS_DISEASE
0.383729854183%	5	1303	185	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
0.383729854183%	5	1303	182	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_G2
0.383729854183%	5	1303	182	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.383729854183%	5	1303	178	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
0.383729854183%	5	1303	177	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
0.383729854183%	5	1303	172	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
0.383729854183%	5	1303	170	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.383729854183%	5	1303	167	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TIEN_INTESTINE_PROBIOTICS_6HR_DN
0.383729854183%	5	1303	165	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.383729854183%	5	1303	164	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_WT1_TARGETS_8HR_UP
0.383729854183%	5	1303	163	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
0.383729854183%	5	1303	161	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
0.383729854183%	5	1303	159	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
0.383729854183%	5	1303	158	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.383729854183%	5	1303	156	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_14HR_UP
0.383729854183%	5	1303	154	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
0.383729854183%	5	1303	153	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RUIZ_TNC_TARGETS_UP
0.383729854183%	5	1303	151	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
0.383729854183%	5	1303	147	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_G1_S
0.383729854183%	5	1303	146	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PECE_MAMMARY_STEM_CELL_UP
0.383729854183%	5	1303	146	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PECE_MAMMARY_STEM_CELL_DN
0.383729854183%	5	1303	146	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_ALL_DISORDERS_DURATION_CORR_DN
0.383729854183%	5	1303	146	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
0.383729854183%	5	1303	145	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RODWELL_AGING_KIDNEY_DN
0.383729854183%	5	1303	145	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
0.383729854183%	5	1303	143	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DANG_MYC_TARGETS_UP
0.383729854183%	5	1303	142	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
0.383729854183%	5	1303	141	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
0.383729854183%	5	1303	141	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.383729854183%	5	1303	140	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
0.383729854183%	5	1303	140	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ONDER_CDH1_TARGETS_1_UP
0.383729854183%	5	1303	137	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
0.383729854183%	5	1303	137	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.383729854183%	5	1303	137	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
0.383729854183%	5	1303	137	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_INSULIN_SIGNALING_PATHWAY
0.383729854183%	5	1303	135	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SERVITJA_LIVER_HNF1A_TARGETS_UP
0.383729854183%	5	1303	132	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
0.383729854183%	5	1303	129	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP
0.383729854183%	5	1303	127	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIU_VMYB_TARGETS_UP
0.383729854183%	5	1303	126	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
0.383729854183%	5	1303	126	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
0.383729854183%	5	1303	126	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
0.383729854183%	5	1303	125	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_1_UP
0.383729854183%	5	1303	124	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAIRKEE_TERT_TARGETS_DN
0.383729854183%	5	1303	123	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAZARD_RESPONSE_TO_UV_SCC_DN
0.383729854183%	5	1303	122	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_PDGF
0.383729854183%	5	1303	121	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
0.383729854183%	5	1303	120	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
0.383729854183%	5	1303	118	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
0.383729854183%	5	1303	117	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PUJANA_BRCA_CENTERED_NETWORK
0.383729854183%	5	1303	116	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
0.383729854183%	5	1303	116	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
0.383729854183%	5	1303	115	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
0.383729854183%	5	1303	114	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SENESE_HDAC2_TARGETS_UP
0.383729854183%	5	1303	114	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN
0.383729854183%	5	1303	113	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_RHO_GTPASES
0.383729854183%	5	1303	112	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_DNA_REPAIR
0.383729854183%	5	1303	112	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PASINI_SUZ12_TARGETS_UP
0.383729854183%	5	1303	111	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GLYCOSAMINOGLYCAN_METABOLISM
0.383729854183%	5	1303	110	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SUNG_METASTASIS_STROMA_UP
0.383729854183%	5	1303	109	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
0.383729854183%	5	1303	109	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
0.383729854183%	5	1303	108	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TAVAZOIE_METASTASIS
0.383729854183%	5	1303	108	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
0.383729854183%	5	1303	106	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
0.383729854183%	5	1303	103	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_MYCN_AMPLIFICATION_TARGETS_DN
0.383729854183%	5	1303	102	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_MELANOGENESIS
0.383729854183%	5	1303	101	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
0.383729854183%	5	1303	101	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRADE_COLON_AND_RECTAL_CANCER_DN
0.383729854183%	5	1303	101	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_3
0.383729854183%	5	1303	101	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_10HR_UP
0.374131480492%	7	1871	96	T2D_GENES_TANYA_HEIGHT	ZAMORA_NOS2_TARGETS_DN
0.374131480492%	7	1871	92	T2D_GENES_TANYA_HEIGHT	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
0.374131480492%	7	1871	91	T2D_GENES_TANYA_HEIGHT	ZHU_CMV_24_HR_DN
0.374131480492%	7	1871	91	T2D_GENES_TANYA_HEIGHT	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.374131480492%	7	1871	90	T2D_GENES_TANYA_HEIGHT	IGARASHI_ATF4_TARGETS_DN
0.374131480492%	7	1871	89	T2D_GENES_TANYA_HEIGHT	VANLOO_SP3_TARGETS_DN
0.374131480492%	7	1871	88	T2D_GENES_TANYA_HEIGHT	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
0.374131480492%	7	1871	87	T2D_GENES_TANYA_HEIGHT	SAFFORD_T_LYMPHOCYTE_ANERGY
0.374131480492%	7	1871	87	T2D_GENES_TANYA_HEIGHT	REACTOME_MITOTIC_PROMETAPHASE
0.374131480492%	7	1871	87	T2D_GENES_TANYA_HEIGHT	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION
0.374131480492%	7	1871	87	T2D_GENES_TANYA_HEIGHT	MOOTHA_VOXPHOS
0.374131480492%	7	1871	87	T2D_GENES_TANYA_HEIGHT	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.374131480492%	7	1871	87	T2D_GENES_TANYA_HEIGHT	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
0.374131480492%	7	1871	86	T2D_GENES_TANYA_HEIGHT	NELSON_RESPONSE_TO_ANDROGEN_UP
0.374131480492%	7	1871	86	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_16HR_DN
0.374131480492%	7	1871	85	T2D_GENES_TANYA_HEIGHT	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
0.374131480492%	7	1871	84	T2D_GENES_TANYA_HEIGHT	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP
0.374131480492%	7	1871	84	T2D_GENES_TANYA_HEIGHT	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
0.374131480492%	7	1871	83	T2D_GENES_TANYA_HEIGHT	JIANG_HYPOXIA_CANCER
0.374131480492%	7	1871	82	T2D_GENES_TANYA_HEIGHT	WONG_ENDMETRIUM_CANCER_DN
0.374131480492%	7	1871	82	T2D_GENES_TANYA_HEIGHT	ST_INTEGRIN_SIGNALING_PATHWAY
0.374131480492%	7	1871	82	T2D_GENES_TANYA_HEIGHT	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS
0.374131480492%	7	1871	82	T2D_GENES_TANYA_HEIGHT	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
0.374131480492%	7	1871	82	T2D_GENES_TANYA_HEIGHT	FRASOR_RESPONSE_TO_ESTRADIOL_DN
0.374131480492%	7	1871	81	T2D_GENES_TANYA_HEIGHT	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
0.374131480492%	7	1871	81	T2D_GENES_TANYA_HEIGHT	GRABARCZYK_BCL11B_TARGETS_UP
0.374131480492%	7	1871	80	T2D_GENES_TANYA_HEIGHT	REACTOME_UNFOLDED_PROTEIN_RESPONSE
0.374131480492%	7	1871	80	T2D_GENES_TANYA_HEIGHT	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.374131480492%	7	1871	79	T2D_GENES_TANYA_HEIGHT	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
0.374131480492%	7	1871	79	T2D_GENES_TANYA_HEIGHT	TOOKER_GEMCITABINE_RESISTANCE_UP
0.374131480492%	7	1871	79	T2D_GENES_TANYA_HEIGHT	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
0.374131480492%	7	1871	78	T2D_GENES_TANYA_HEIGHT	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
0.374131480492%	7	1871	78	T2D_GENES_TANYA_HEIGHT	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.374131480492%	7	1871	78	T2D_GENES_TANYA_HEIGHT	BOYLAN_MULTIPLE_MYELOMA_D_DN
0.374131480492%	7	1871	77	T2D_GENES_TANYA_HEIGHT	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
0.374131480492%	7	1871	77	T2D_GENES_TANYA_HEIGHT	SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.374131480492%	7	1871	77	T2D_GENES_TANYA_HEIGHT	JACKSON_DNMT1_TARGETS_UP
0.374131480492%	7	1871	77	T2D_GENES_TANYA_HEIGHT	GROSS_HYPOXIA_VIA_HIF1A_UP
0.374131480492%	7	1871	77	T2D_GENES_TANYA_HEIGHT	CARD_MIR302A_TARGETS
0.374131480492%	7	1871	76	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
0.374131480492%	7	1871	75	T2D_GENES_TANYA_HEIGHT	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.374131480492%	7	1871	74	T2D_GENES_TANYA_HEIGHT	URS_ADIPOCYTE_DIFFERENTIATION_UP
0.374131480492%	7	1871	74	T2D_GENES_TANYA_HEIGHT	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN
0.374131480492%	7	1871	72	T2D_GENES_TANYA_HEIGHT	SESTO_RESPONSE_TO_UV_C8
0.374131480492%	7	1871	72	T2D_GENES_TANYA_HEIGHT	REACTOME_METABOLISM_OF_NUCLEOTIDES
0.374131480492%	7	1871	71	T2D_GENES_TANYA_HEIGHT	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.374131480492%	7	1871	70	T2D_GENES_TANYA_HEIGHT	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
0.374131480492%	7	1871	70	T2D_GENES_TANYA_HEIGHT	CADWELL_ATG16L1_TARGETS_DN
0.374131480492%	7	1871	7	T2D_GENES_TANYA_HEIGHT	HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3
0.374131480492%	7	1871	69	T2D_GENES_TANYA_HEIGHT	ZAMORA_NOS2_TARGETS_UP
0.374131480492%	7	1871	69	T2D_GENES_TANYA_HEIGHT	RHODES_UNDIFFERENTIATED_CANCER
0.374131480492%	7	1871	69	T2D_GENES_TANYA_HEIGHT	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
0.374131480492%	7	1871	68	T2D_GENES_TANYA_HEIGHT	REACTOME_SEMAPHORIN_INTERACTIONS
0.374131480492%	7	1871	67	T2D_GENES_TANYA_HEIGHT	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
0.374131480492%	7	1871	67	T2D_GENES_TANYA_HEIGHT	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
0.374131480492%	7	1871	67	T2D_GENES_TANYA_HEIGHT	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70
0.374131480492%	7	1871	66	T2D_GENES_TANYA_HEIGHT	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM
0.374131480492%	7	1871	66	T2D_GENES_TANYA_HEIGHT	SWEET_KRAS_TARGETS_DN
0.374131480492%	7	1871	66	T2D_GENES_TANYA_HEIGHT	PID_HDAC_CLASSI_PATHWAY
0.374131480492%	7	1871	65	T2D_GENES_TANYA_HEIGHT	PID_IL4_2PATHWAY
0.374131480492%	7	1871	65	T2D_GENES_TANYA_HEIGHT	KEGG_GLIOMA
0.374131480492%	7	1871	64	T2D_GENES_TANYA_HEIGHT	RIZKI_TUMOR_INVASIVENESS_2D_DN
0.374131480492%	7	1871	64	T2D_GENES_TANYA_HEIGHT	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
0.374131480492%	7	1871	64	T2D_GENES_TANYA_HEIGHT	LIU_SMARCA4_TARGETS
0.374131480492%	7	1871	63	T2D_GENES_TANYA_HEIGHT	BURTON_ADIPOGENESIS_PEAK_AT_0HR
0.374131480492%	7	1871	61	T2D_GENES_TANYA_HEIGHT	ZWANG_EGF_PERSISTENTLY_DN
0.374131480492%	7	1871	61	T2D_GENES_TANYA_HEIGHT	REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS
0.374131480492%	7	1871	60	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING
0.374131480492%	7	1871	60	T2D_GENES_TANYA_HEIGHT	OUILLETTE_CLL_13Q14_DELETION_DN
0.374131480492%	7	1871	60	T2D_GENES_TANYA_HEIGHT	AMIT_EGF_RESPONSE_240_HELA
0.374131480492%	7	1871	59	T2D_GENES_TANYA_HEIGHT	MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3
0.374131480492%	7	1871	58	T2D_GENES_TANYA_HEIGHT	LUCAS_HNF4A_TARGETS_UP
0.374131480492%	7	1871	58	T2D_GENES_TANYA_HEIGHT	KOHOUTEK_CCNT2_TARGETS
0.374131480492%	7	1871	58	T2D_GENES_TANYA_HEIGHT	BIOCARTA_HIVNEF_PATHWAY
0.374131480492%	7	1871	57	T2D_GENES_TANYA_HEIGHT	DELASERNA_MYOD_TARGETS_DN
0.374131480492%	7	1871	56	T2D_GENES_TANYA_HEIGHT	GRADE_COLON_VS_RECTAL_CANCER_DN
0.374131480492%	7	1871	55	T2D_GENES_TANYA_HEIGHT	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
0.374131480492%	7	1871	55	T2D_GENES_TANYA_HEIGHT	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
0.374131480492%	7	1871	55	T2D_GENES_TANYA_HEIGHT	TIEN_INTESTINE_PROBIOTICS_6HR_UP
0.374131480492%	7	1871	55	T2D_GENES_TANYA_HEIGHT	PID_FGF_PATHWAY
0.374131480492%	7	1871	55	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_4HR_UP
0.374131480492%	7	1871	54	T2D_GENES_TANYA_HEIGHT	SUNG_METASTASIS_STROMA_DN
0.374131480492%	7	1871	54	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM
0.374131480492%	7	1871	54	T2D_GENES_TANYA_HEIGHT	KEGG_INOSITOL_PHOSPHATE_METABOLISM
0.374131480492%	7	1871	54	T2D_GENES_TANYA_HEIGHT	KEGG_ARGININE_AND_PROLINE_METABOLISM
0.374131480492%	7	1871	53	T2D_GENES_TANYA_HEIGHT	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP
0.374131480492%	7	1871	53	T2D_GENES_TANYA_HEIGHT	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS
0.374131480492%	7	1871	53	T2D_GENES_TANYA_HEIGHT	MENSSEN_MYC_TARGETS
0.374131480492%	7	1871	53	T2D_GENES_TANYA_HEIGHT	IKEDA_MIR1_TARGETS_UP
0.374131480492%	7	1871	53	T2D_GENES_TANYA_HEIGHT	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP
0.374131480492%	7	1871	52	T2D_GENES_TANYA_HEIGHT	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN
0.374131480492%	7	1871	52	T2D_GENES_TANYA_HEIGHT	KEGG_MTOR_SIGNALING_PATHWAY
0.374131480492%	7	1871	52	T2D_GENES_TANYA_HEIGHT	CHIBA_RESPONSE_TO_TSA_UP
0.374131480492%	7	1871	51	T2D_GENES_TANYA_HEIGHT	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT
0.374131480492%	7	1871	51	T2D_GENES_TANYA_HEIGHT	LEE_CALORIE_RESTRICTION_MUSCLE_DN
0.374131480492%	7	1871	50	T2D_GENES_TANYA_HEIGHT	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.374131480492%	7	1871	50	T2D_GENES_TANYA_HEIGHT	HOFMANN_CELL_LYMPHOMA_UP
0.374131480492%	7	1871	50	T2D_GENES_TANYA_HEIGHT	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
0.374131480492%	7	1871	50	T2D_GENES_TANYA_HEIGHT	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
0.374131480492%	7	1871	50	T2D_GENES_TANYA_HEIGHT	DAUER_STAT3_TARGETS_DN
0.374131480492%	7	1871	49	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_HP_UP
0.374131480492%	7	1871	49	T2D_GENES_TANYA_HEIGHT	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
0.374131480492%	7	1871	49	T2D_GENES_TANYA_HEIGHT	KEGG_GLYCEROLIPID_METABOLISM
0.374131480492%	7	1871	48	T2D_GENES_TANYA_HEIGHT	REACTOME_PI_METABOLISM
0.374131480492%	7	1871	48	T2D_GENES_TANYA_HEIGHT	REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY
0.374131480492%	7	1871	48	T2D_GENES_TANYA_HEIGHT	PID_HES_HEYPATHWAY
0.374131480492%	7	1871	48	T2D_GENES_TANYA_HEIGHT	PID_CERAMIDE_PATHWAY
0.374131480492%	7	1871	48	T2D_GENES_TANYA_HEIGHT	KEGG_PROTEASOME
0.374131480492%	7	1871	48	T2D_GENES_TANYA_HEIGHT	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN
0.374131480492%	7	1871	48	T2D_GENES_TANYA_HEIGHT	BURTON_ADIPOGENESIS_4
0.374131480492%	7	1871	47	T2D_GENES_TANYA_HEIGHT	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN
0.374131480492%	7	1871	46	T2D_GENES_TANYA_HEIGHT	PID_TNFPATHWAY
0.374131480492%	7	1871	46	T2D_GENES_TANYA_HEIGHT	KRASNOSELSKAYA_ILF3_TARGETS_DN
0.374131480492%	7	1871	46	T2D_GENES_TANYA_HEIGHT	ABBUD_LIF_SIGNALING_1_UP
0.374131480492%	7	1871	45	T2D_GENES_TANYA_HEIGHT	ZHAN_V2_LATE_DIFFERENTIATION_GENES
0.374131480492%	7	1871	45	T2D_GENES_TANYA_HEIGHT	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN
0.374131480492%	7	1871	45	T2D_GENES_TANYA_HEIGHT	LUI_THYROID_CANCER_PAX8_PPARG_DN
0.374131480492%	7	1871	45	T2D_GENES_TANYA_HEIGHT	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN
0.374131480492%	7	1871	44	T2D_GENES_TANYA_HEIGHT	XU_CREBBP_TARGETS_DN
0.374131480492%	7	1871	44	T2D_GENES_TANYA_HEIGHT	MARTIN_INTERACT_WITH_HDAC
0.374131480492%	7	1871	44	T2D_GENES_TANYA_HEIGHT	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP
0.374131480492%	7	1871	43	T2D_GENES_TANYA_HEIGHT	POTTI_5FU_SENSITIVITY
0.374131480492%	7	1871	43	T2D_GENES_TANYA_HEIGHT	PID_CXCR3PATHWAY
0.374131480492%	7	1871	43	T2D_GENES_TANYA_HEIGHT	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
0.374131480492%	7	1871	42	T2D_GENES_TANYA_HEIGHT	PID_ECADHERIN_STABILIZATION_PATHWAY
0.374131480492%	7	1871	42	T2D_GENES_TANYA_HEIGHT	ONO_FOXP3_TARGETS_DN
0.374131480492%	7	1871	42	T2D_GENES_TANYA_HEIGHT	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
0.374131480492%	7	1871	42	T2D_GENES_TANYA_HEIGHT	HAHTOLA_SEZARY_SYNDROM_DN
0.374131480492%	7	1871	42	T2D_GENES_TANYA_HEIGHT	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN
0.374131480492%	7	1871	41	T2D_GENES_TANYA_HEIGHT	ONO_AML1_TARGETS_DN
0.374131480492%	7	1871	41	T2D_GENES_TANYA_HEIGHT	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.374131480492%	7	1871	40	T2D_GENES_TANYA_HEIGHT	GENTILE_UV_RESPONSE_CLUSTER_D7
0.374131480492%	7	1871	39	T2D_GENES_TANYA_HEIGHT	MATZUK_MEIOTIC_AND_DNA_REPAIR
0.374131480492%	7	1871	39	T2D_GENES_TANYA_HEIGHT	CONRAD_STEM_CELL
0.374131480492%	7	1871	38	T2D_GENES_TANYA_HEIGHT	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4
0.374131480492%	7	1871	38	T2D_GENES_TANYA_HEIGHT	REACTOME_G1_PHASE
0.374131480492%	7	1871	38	T2D_GENES_TANYA_HEIGHT	NIKOLSKY_BREAST_CANCER_7P22_AMPLICON
0.374131480492%	7	1871	38	T2D_GENES_TANYA_HEIGHT	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN
0.374131480492%	7	1871	38	T2D_GENES_TANYA_HEIGHT	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN
0.374131480492%	7	1871	37	T2D_GENES_TANYA_HEIGHT	BIOCARTA_ALK_PATHWAY
0.374131480492%	7	1871	35	T2D_GENES_TANYA_HEIGHT	HU_GENOTOXIC_DAMAGE_4HR
0.374131480492%	7	1871	34	T2D_GENES_TANYA_HEIGHT	PID_IL8CXCR2_PATHWAY
0.374131480492%	7	1871	34	T2D_GENES_TANYA_HEIGHT	PID_ATM_PATHWAY
0.374131480492%	7	1871	34	T2D_GENES_TANYA_HEIGHT	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP
0.374131480492%	7	1871	33	T2D_GENES_TANYA_HEIGHT	PID_SYNDECAN_2_PATHWAY
0.374131480492%	7	1871	32	T2D_GENES_TANYA_HEIGHT	DIRMEIER_LMP1_RESPONSE_LATE_DN
0.374131480492%	7	1871	30	T2D_GENES_TANYA_HEIGHT	KIM_LRRC3B_TARGETS
0.374131480492%	7	1871	29	T2D_GENES_TANYA_HEIGHT	WANG_RESPONSE_TO_BEXAROTENE_DN
0.374131480492%	7	1871	28	T2D_GENES_TANYA_HEIGHT	MOREIRA_RESPONSE_TO_TSA_UP
0.374131480492%	7	1871	28	T2D_GENES_TANYA_HEIGHT	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN
0.374131480492%	7	1871	27	T2D_GENES_TANYA_HEIGHT	GENTILE_UV_LOW_DOSE_UP
0.374131480492%	7	1871	25	T2D_GENES_TANYA_HEIGHT	REACTOME_ADP_SIGNALLING_THROUGH_P2RY1
0.374131480492%	7	1871	23	T2D_GENES_TANYA_HEIGHT	WU_HBX_TARGETS_2_UP
0.374131480492%	7	1871	23	T2D_GENES_TANYA_HEIGHT	REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR
0.374131480492%	7	1871	21	T2D_GENES_TANYA_HEIGHT	BIOCARTA_TOB1_PATHWAY
0.374131480492%	7	1871	198	T2D_GENES_TANYA_HEIGHT	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.374131480492%	7	1871	19	T2D_GENES_TANYA_HEIGHT	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN
0.374131480492%	7	1871	18	T2D_GENES_TANYA_HEIGHT	REACTOME_PD1_SIGNALING
0.374131480492%	7	1871	164	T2D_GENES_TANYA_HEIGHT	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
0.374131480492%	7	1871	16	T2D_GENES_TANYA_HEIGHT	REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS
0.374131480492%	7	1871	143	T2D_GENES_TANYA_HEIGHT	BASSO_B_LYMPHOCYTE_NETWORK
0.374131480492%	7	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE
0.374131480492%	7	1871	136	T2D_GENES_TANYA_HEIGHT	PROVENZANI_METASTASIS_DN
0.374131480492%	7	1871	126	T2D_GENES_TANYA_HEIGHT	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
0.374131480492%	7	1871	123	T2D_GENES_TANYA_HEIGHT	HOOI_ST7_TARGETS_DN
0.374131480492%	7	1871	120	T2D_GENES_TANYA_HEIGHT	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
0.374131480492%	7	1871	114	T2D_GENES_TANYA_HEIGHT	MATZUK_SPERMATOZOA
0.374131480492%	7	1871	113	T2D_GENES_TANYA_HEIGHT	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
0.374131480492%	7	1871	112	T2D_GENES_TANYA_HEIGHT	LABBE_WNT3A_TARGETS_UP
0.374131480492%	7	1871	112	T2D_GENES_TANYA_HEIGHT	DITTMER_PTHLH_TARGETS_UP
0.374131480492%	7	1871	110	T2D_GENES_TANYA_HEIGHT	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
0.374131480492%	7	1871	107	T2D_GENES_TANYA_HEIGHT	ROESSLER_LIVER_CANCER_METASTASIS_UP
0.374131480492%	7	1871	104	T2D_GENES_TANYA_HEIGHT	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
0.374131480492%	7	1871	103	T2D_GENES_TANYA_HEIGHT	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.369318181818%	13	3520	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_T7
0.369318181818%	13	3520	95	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOEBEKE_LYMPHOID_STEM_CELL_UP
0.369318181818%	13	3520	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WINTER_HYPOXIA_UP
0.369318181818%	13	3520	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_DNA
0.369318181818%	13	3520	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
0.369318181818%	13	3520	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HILLION_HMGA1_TARGETS
0.369318181818%	13	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
0.369318181818%	13	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_AGING_NEOCORTEX_UP
0.369318181818%	13	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
0.369318181818%	13	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAKAO_RESPONSE_TO_UVB_RADIATION_UP
0.369318181818%	13	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_AGING_CEREBELLUM_DN
0.369318181818%	13	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_TGF_BETA_SIGNALING_PATHWAY
0.369318181818%	13	3520	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
0.369318181818%	13	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RUAN_RESPONSE_TO_TNF_DN
0.369318181818%	13	3520	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS
0.369318181818%	13	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_M_G1_TRANSITION
0.369318181818%	13	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM
0.369318181818%	13	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DER_IFN_ALPHA_RESPONSE_UP
0.369318181818%	13	3520	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.369318181818%	13	3520	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_LEISHMANIA_INFECTION
0.369318181818%	13	3520	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.369318181818%	13	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_MEF_LCP_WITH_H3K27ME3
0.369318181818%	13	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PANCREATIC_CANCER
0.369318181818%	13	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_120_HELA
0.369318181818%	13	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP
0.369318181818%	13	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_IL12_2PATHWAY
0.369318181818%	13	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SU_LIVER
0.369318181818%	13	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR
0.369318181818%	13	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_STARCH_AND_SUCROSE_METABOLISM
0.369318181818%	13	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
0.369318181818%	13	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.369318181818%	13	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER
0.369318181818%	13	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_CERAMIDE_PATHWAY
0.369318181818%	13	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_FATTY_ACID_METABOLISM
0.369318181818%	13	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_AMB2_NEUTROPHILS_PATHWAY
0.369318181818%	13	3520	229	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN
0.369318181818%	13	3520	206	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.369318181818%	13	3520	201	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_MYC_AMPLIFICATION_TARGETS_UP
0.369318181818%	13	3520	186	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_CLIM2_TARGETS_DN
0.369318181818%	13	3520	184	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
0.369318181818%	13	3520	180	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
0.369318181818%	13	3520	178	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
0.369318181818%	13	3520	171	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOLDRATH_HOMEOSTATIC_PROLIFERATION
0.369318181818%	13	3520	170	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
0.369318181818%	13	3520	166	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAIRO_LIVER_DEVELOPMENT_UP
0.369318181818%	13	3520	160	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_6HR_DN
0.369318181818%	13	3520	153	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN
0.369318181818%	13	3520	151	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
0.369318181818%	13	3520	149	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LANDIS_ERBB2_BREAST_TUMORS_324_DN
0.369318181818%	13	3520	148	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_M_G1
0.369318181818%	13	3520	148	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KATSANOU_ELAVL1_TARGETS_DN
0.369318181818%	13	3520	143	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.369318181818%	13	3520	143	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BASSO_B_LYMPHOCYTE_NETWORK
0.369318181818%	13	3520	141	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAAB_FAILED_HEART_ATRIUM_DN
0.369318181818%	13	3520	140	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
0.369318181818%	13	3520	138	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
0.369318181818%	13	3520	136	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WIERENGA_STAT5A_TARGETS_GROUP1
0.369318181818%	13	3520	135	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TSENG_IRS1_TARGETS_DN
0.369318181818%	13	3520	133	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SENESE_HDAC2_TARGETS_DN
0.369318181818%	13	3520	133	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAL_LEUKEMIC_STEM_CELL_UP
0.369318181818%	13	3520	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_MEF_LCP_WITH_H3K4ME3
0.369318181818%	13	3520	122	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
0.369318181818%	13	3520	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
0.369318181818%	13	3520	119	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
0.369318181818%	13	3520	115	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
0.369318181818%	13	3520	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROPERO_HDAC2_TARGETS
0.369318181818%	13	3520	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATZUK_SPERMATOZOA
0.369318181818%	13	3520	113	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
0.369318181818%	13	3520	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DOANE_BREAST_CANCER_ESR1_UP
0.369318181818%	13	3520	111	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOUDOUKHA_BOUND_BY_IGF2BP2
0.369318181818%	13	3520	110	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.369318181818%	13	3520	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LE_EGR2_TARGETS_UP
0.369318181818%	13	3520	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JAZAG_TGFB1_SIGNALING_UP
0.369318181818%	13	3520	104	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE
0.369318181818%	13	3520	102	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DER_IFN_BETA_RESPONSE_UP
0.369318181818%	13	3520	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_GNRH_SIGNALING_PATHWAY
0.369003690037%	2	542	99	T2D_GENES_TANYA_ANTHROPOMETRIC	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.369003690037%	2	542	98	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_POTASSIUM_CHANNELS
0.369003690037%	2	542	98	T2D_GENES_TANYA_ANTHROPOMETRIC	MENSE_HYPOXIA_UP
0.369003690037%	2	542	98	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PYRIMIDINE_METABOLISM
0.369003690037%	2	542	98	T2D_GENES_TANYA_ANTHROPOMETRIC	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
0.369003690037%	2	542	97	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
0.369003690037%	2	542	97	T2D_GENES_TANYA_ANTHROPOMETRIC	KONG_E2F3_TARGETS
0.369003690037%	2	542	97	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_MYC_AMPLIFICATION_TARGETS_DN
0.369003690037%	2	542	96	T2D_GENES_TANYA_ANTHROPOMETRIC	ZAMORA_NOS2_TARGETS_DN
0.369003690037%	2	542	94	T2D_GENES_TANYA_ANTHROPOMETRIC	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.369003690037%	2	542	94	T2D_GENES_TANYA_ANTHROPOMETRIC	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5
0.369003690037%	2	542	94	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES
0.369003690037%	2	542	94	T2D_GENES_TANYA_ANTHROPOMETRIC	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER
0.369003690037%	2	542	94	T2D_GENES_TANYA_ANTHROPOMETRIC	HOOI_ST7_TARGETS_UP
0.369003690037%	2	542	93	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ACTIVATED_TLR4_SIGNALLING
0.369003690037%	2	542	93	T2D_GENES_TANYA_ANTHROPOMETRIC	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
0.369003690037%	2	542	93	T2D_GENES_TANYA_ANTHROPOMETRIC	CADWELL_ATG16L1_TARGETS_UP
0.369003690037%	2	542	92	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SYNTHESIS_OF_DNA
0.369003690037%	2	542	92	T2D_GENES_TANYA_ANTHROPOMETRIC	DE_YY1_TARGETS_DN
0.369003690037%	2	542	91	T2D_GENES_TANYA_ANTHROPOMETRIC	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
0.369003690037%	2	542	90	T2D_GENES_TANYA_ANTHROPOMETRIC	SANA_TNF_SIGNALING_DN
0.369003690037%	2	542	90	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_ERBB4
0.369003690037%	2	542	90	T2D_GENES_TANYA_ANTHROPOMETRIC	MORI_MATURE_B_LYMPHOCYTE_UP
0.369003690037%	2	542	90	T2D_GENES_TANYA_ANTHROPOMETRIC	GAVIN_FOXP3_TARGETS_CLUSTER_P7
0.369003690037%	2	542	90	T2D_GENES_TANYA_ANTHROPOMETRIC	BILANGES_SERUM_SENSITIVE_GENES
0.369003690037%	2	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_RESPONSE_TO_FORSKOLIN_DN
0.369003690037%	2	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	SASSON_FSH_RESPONSE
0.369003690037%	2	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21
0.369003690037%	2	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	BENPORATH_ES_CORE_NINE
0.369003690037%	2	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP
0.369003690037%	2	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
0.369003690037%	2	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	KANG_IMMORTALIZED_BY_TERT_UP
0.369003690037%	2	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	BOYLAN_MULTIPLE_MYELOMA_D_UP
0.369003690037%	2	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	SEIDEN_ONCOGENESIS_BY_MET
0.369003690037%	2	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	DURCHDEWALD_SKIN_CARCINOGENESIS_UP
0.369003690037%	2	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	ALCALA_APOPTOSIS
0.369003690037%	2	542	87	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MITOTIC_PROMETAPHASE
0.369003690037%	2	542	87	T2D_GENES_TANYA_ANTHROPOMETRIC	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
0.369003690037%	2	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_L1CAM_INTERACTIONS
0.369003690037%	2	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	NGUYEN_NOTCH1_TARGETS_DN
0.369003690037%	2	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
0.369003690037%	2	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	GHANDHI_BYSTANDER_IRRADIATION_UP
0.369003690037%	2	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_16HR_DN
0.369003690037%	2	542	85	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
0.369003690037%	2	542	85	T2D_GENES_TANYA_ANTHROPOMETRIC	XU_GH1_EXOGENOUS_TARGETS_UP
0.369003690037%	2	542	85	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE
0.369003690037%	2	542	85	T2D_GENES_TANYA_ANTHROPOMETRIC	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
0.369003690037%	2	542	84	T2D_GENES_TANYA_ANTHROPOMETRIC	SWEET_KRAS_TARGETS_UP
0.369003690037%	2	542	84	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S
0.369003690037%	2	542	84	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_AGING_CEREBELLUM_UP
0.369003690037%	2	542	84	T2D_GENES_TANYA_ANTHROPOMETRIC	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
0.369003690037%	2	542	83	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
0.369003690037%	2	542	83	T2D_GENES_TANYA_ANTHROPOMETRIC	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.369003690037%	2	542	82	T2D_GENES_TANYA_ANTHROPOMETRIC	ODONNELL_METASTASIS_UP
0.369003690037%	2	542	82	T2D_GENES_TANYA_ANTHROPOMETRIC	FRASOR_RESPONSE_TO_ESTRADIOL_DN
0.369003690037%	2	542	81	T2D_GENES_TANYA_ANTHROPOMETRIC	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
0.369003690037%	2	542	81	T2D_GENES_TANYA_ANTHROPOMETRIC	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.369003690037%	2	542	81	T2D_GENES_TANYA_ANTHROPOMETRIC	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
0.369003690037%	2	542	81	T2D_GENES_TANYA_ANTHROPOMETRIC	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
0.369003690037%	2	542	81	T2D_GENES_TANYA_ANTHROPOMETRIC	HARRIS_HYPOXIA
0.369003690037%	2	542	80	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHUHMACHER_MYC_TARGETS_UP
0.369003690037%	2	542	8	T2D_GENES_TANYA_ANTHROPOMETRIC	STANHILL_HRAS_TRANSFROMATION_UP
0.369003690037%	2	542	8	T2D_GENES_TANYA_ANTHROPOMETRIC	BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS
0.369003690037%	2	542	79	T2D_GENES_TANYA_ANTHROPOMETRIC	MALONEY_RESPONSE_TO_17AAG_DN
0.369003690037%	2	542	78	T2D_GENES_TANYA_ANTHROPOMETRIC	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
0.369003690037%	2	542	78	T2D_GENES_TANYA_ANTHROPOMETRIC	ROSS_LEUKEMIA_WITH_MLL_FUSIONS
0.369003690037%	2	542	78	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_SCF_KIT
0.369003690037%	2	542	78	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CELL_JUNCTION_ORGANIZATION
0.369003690037%	2	542	78	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PEROXISOME
0.369003690037%	2	542	78	T2D_GENES_TANYA_ANTHROPOMETRIC	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.369003690037%	2	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
0.369003690037%	2	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	LIN_APC_TARGETS
0.369003690037%	2	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	JACKSON_DNMT1_TARGETS_UP
0.369003690037%	2	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	CHEBOTAEV_GR_TARGETS_UP
0.369003690037%	2	542	76	T2D_GENES_TANYA_ANTHROPOMETRIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
0.369003690037%	2	542	76	T2D_GENES_TANYA_ANTHROPOMETRIC	ROSS_AML_WITH_AML1_ETO_FUSION
0.369003690037%	2	542	76	T2D_GENES_TANYA_ANTHROPOMETRIC	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.369003690037%	2	542	76	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_VEGF_SIGNALING_PATHWAY
0.369003690037%	2	542	76	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
0.369003690037%	2	542	75	T2D_GENES_TANYA_ANTHROPOMETRIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
0.369003690037%	2	542	75	T2D_GENES_TANYA_ANTHROPOMETRIC	MORI_MATURE_B_LYMPHOCYTE_DN
0.369003690037%	2	542	75	T2D_GENES_TANYA_ANTHROPOMETRIC	MCCLUNG_COCAIN_REWARD_4WK
0.369003690037%	2	542	75	T2D_GENES_TANYA_ANTHROPOMETRIC	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
0.369003690037%	2	542	75	T2D_GENES_TANYA_ANTHROPOMETRIC	CHESLER_BRAIN_QTL_CIS
0.369003690037%	2	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.369003690037%	2	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX
0.369003690037%	2	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	RAMALHO_STEMNESS_DN
0.369003690037%	2	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	POTTI_ADRIAMYCIN_SENSITIVITY
0.369003690037%	2	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
0.369003690037%	2	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	LIAN_LIPA_TARGETS_6M
0.369003690037%	2	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	LEIN_OLIGODENDROCYTE_MARKERS
0.369003690037%	2	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_LIVER_CANCER_DENA_DN
0.369003690037%	2	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	DER_IFN_ALPHA_RESPONSE_UP
0.369003690037%	2	542	73	T2D_GENES_TANYA_ANTHROPOMETRIC	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.369003690037%	2	542	73	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
0.369003690037%	2	542	73	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
0.369003690037%	2	542	73	T2D_GENES_TANYA_ANTHROPOMETRIC	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
0.369003690037%	2	542	73	T2D_GENES_TANYA_ANTHROPOMETRIC	LIN_MELANOMA_COPY_NUMBER_UP
0.369003690037%	2	542	72	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_METABOLISM_OF_NUCLEOTIDES
0.369003690037%	2	542	72	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1
0.369003690037%	2	542	72	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_LEISHMANIA_INFECTION
0.369003690037%	2	542	72	T2D_GENES_TANYA_ANTHROPOMETRIC	CROONQUIST_NRAS_SIGNALING_DN
0.369003690037%	2	542	71	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PI3K_CASCADE
0.369003690037%	2	542	71	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_MELANOMA
0.369003690037%	2	542	71	T2D_GENES_TANYA_ANTHROPOMETRIC	GEORGANTAS_HSC_MARKERS
0.369003690037%	2	542	71	T2D_GENES_TANYA_ANTHROPOMETRIC	DER_IFN_GAMMA_RESPONSE_UP
0.369003690037%	2	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
0.369003690037%	2	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.369003690037%	2	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_AP1_PATHWAY
0.369003690037%	2	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	LIU_NASOPHARYNGEAL_CARCINOMA
0.369003690037%	2	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	CADWELL_ATG16L1_TARGETS_DN
0.369003690037%	2	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.369003690037%	2	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_P75NTRPATHWAY
0.369003690037%	2	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_MTOR_4PATHWAY
0.369003690037%	2	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PPAR_SIGNALING_PATHWAY
0.369003690037%	2	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
0.369003690037%	2	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	AMIT_EGF_RESPONSE_120_HELA
0.369003690037%	2	542	68	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_TELOMERASEPATHWAY
0.369003690037%	2	542	68	T2D_GENES_TANYA_ANTHROPOMETRIC	DELPUECH_FOXO3_TARGETS_UP
0.369003690037%	2	542	67	T2D_GENES_TANYA_ANTHROPOMETRIC	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
0.369003690037%	2	542	67	T2D_GENES_TANYA_ANTHROPOMETRIC	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP
0.369003690037%	2	542	67	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN
0.369003690037%	2	542	67	T2D_GENES_TANYA_ANTHROPOMETRIC	LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.369003690037%	2	542	67	T2D_GENES_TANYA_ANTHROPOMETRIC	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.369003690037%	2	542	67	T2D_GENES_TANYA_ANTHROPOMETRIC	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70
0.369003690037%	2	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	SWEET_KRAS_TARGETS_DN
0.369003690037%	2	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_LIVER_CANCER_CIPROFIBRATE_DN
0.369003690037%	2	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	BEIER_GLIOMA_STEM_CELL_DN
0.369003690037%	2	542	65	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_WNT
0.369003690037%	2	542	65	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
0.369003690037%	2	542	65	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_GLIOMA
0.369003690037%	2	542	65	T2D_GENES_TANYA_ANTHROPOMETRIC	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP
0.369003690037%	2	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_MULTIPLE_MYELOMA_UP
0.369003690037%	2	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	RIZKI_TUMOR_INVASIVENESS_2D_DN
0.369003690037%	2	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C
0.369003690037%	2	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS
0.369003690037%	2	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
0.369003690037%	2	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_LIVER_CANCER_ACOX1_UP
0.369003690037%	2	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
0.369003690037%	2	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.369003690037%	2	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	GERHOLD_ADIPOGENESIS_DN
0.369003690037%	2	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	BYSTROEM_CORRELATED_WITH_IL5_DN
0.369003690037%	2	542	63	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_INTERFERON_GAMMA_SIGNALING
0.369003690037%	2	542	63	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_IL12_2PATHWAY
0.369003690037%	2	542	63	T2D_GENES_TANYA_ANTHROPOMETRIC	BURTON_ADIPOGENESIS_PEAK_AT_0HR
0.369003690037%	2	542	62	T2D_GENES_TANYA_ANTHROPOMETRIC	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
0.369003690037%	2	542	62	T2D_GENES_TANYA_ANTHROPOMETRIC	KYNG_DNA_DAMAGE_BY_UV
0.369003690037%	2	542	62	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.369003690037%	2	542	62	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_COLORECTAL_CANCER
0.369003690037%	2	542	62	T2D_GENES_TANYA_ANTHROPOMETRIC	CORRE_MULTIPLE_MYELOMA_DN
0.369003690037%	2	542	62	T2D_GENES_TANYA_ANTHROPOMETRIC	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP
0.369003690037%	2	542	62	T2D_GENES_TANYA_ANTHROPOMETRIC	BILD_SRC_ONCOGENIC_SIGNATURE
0.369003690037%	2	542	61	T2D_GENES_TANYA_ANTHROPOMETRIC	REN_BOUND_BY_E2F
0.369003690037%	2	542	61	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS
0.369003690037%	2	542	61	T2D_GENES_TANYA_ANTHROPOMETRIC	MASSARWEH_RESPONSE_TO_ESTRADIOL
0.369003690037%	2	542	61	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_1HR_UP
0.369003690037%	2	542	60	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_LIVER_CANCER_CIPROFIBRATE_UP
0.369003690037%	2	542	60	T2D_GENES_TANYA_ANTHROPOMETRIC	CUI_GLUCOSE_DEPRIVATION
0.369003690037%	2	542	60	T2D_GENES_TANYA_ANTHROPOMETRIC	CROONQUIST_STROMAL_STIMULATION_UP
0.369003690037%	2	542	59	T2D_GENES_TANYA_ANTHROPOMETRIC	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
0.369003690037%	2	542	59	T2D_GENES_TANYA_ANTHROPOMETRIC	LIAN_LIPA_TARGETS_3M
0.369003690037%	2	542	59	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_RNA_DEGRADATION
0.369003690037%	2	542	59	T2D_GENES_TANYA_ANTHROPOMETRIC	HUPER_BREAST_BASAL_VS_LUMINAL_DN
0.369003690037%	2	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
0.369003690037%	2	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	SANSOM_WNT_PATHWAY_REQUIRE_MYC
0.369003690037%	2	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_REGULATION_OF_APOPTOSIS
0.369003690037%	2	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT
0.369003690037%	2	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	NADLER_HYPERGLYCEMIA_AT_OBESITY
0.369003690037%	2	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	LIM_MAMMARY_LUMINAL_PROGENITOR_UP
0.369003690037%	2	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
0.369003690037%	2	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	TONG_INTERACT_WITH_PTTG1
0.369003690037%	2	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	TANG_SENESCENCE_TP53_TARGETS_DN
0.369003690037%	2	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE
0.369003690037%	2	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	PEART_HDAC_PROLIFERATION_CLUSTER_UP
0.369003690037%	2	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	MCCLUNG_CREB1_TARGETS_DN
0.369003690037%	2	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.369003690037%	2	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	GRABARCZYK_BCL11B_TARGETS_DN
0.369003690037%	2	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP
0.369003690037%	2	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	BORLAK_LIVER_CANCER_EGF_UP
0.369003690037%	2	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	AMIT_SERUM_RESPONSE_60_MCF10A
0.369003690037%	2	542	56	T2D_GENES_TANYA_ANTHROPOMETRIC	VANTVEER_BREAST_CANCER_METASTASIS_UP
0.369003690037%	2	542	56	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.369003690037%	2	542	56	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX
0.369003690037%	2	542	56	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_NFAT_PATHWAY
0.369003690037%	2	542	55	T2D_GENES_TANYA_ANTHROPOMETRIC	YU_MYC_TARGETS_DN
0.369003690037%	2	542	55	T2D_GENES_TANYA_ANTHROPOMETRIC	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53
0.369003690037%	2	542	55	T2D_GENES_TANYA_ANTHROPOMETRIC	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
0.369003690037%	2	542	55	T2D_GENES_TANYA_ANTHROPOMETRIC	TIEN_INTESTINE_PROBIOTICS_6HR_UP
0.369003690037%	2	542	55	T2D_GENES_TANYA_ANTHROPOMETRIC	SMIRNOV_RESPONSE_TO_IR_2HR_DN
0.369003690037%	2	542	55	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_IL2_1PATHWAY
0.369003690037%	2	542	55	T2D_GENES_TANYA_ANTHROPOMETRIC	DEMAGALHAES_AGING_UP
0.369003690037%	2	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHOU_TNF_SIGNALING_4HR
0.369003690037%	2	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	SESTO_RESPONSE_TO_UV_C2
0.369003690037%	2	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	ROVERSI_GLIOMA_COPY_NUMBER_DN
0.369003690037%	2	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	RICKMAN_HEAD_AND_NECK_CANCER_F
0.369003690037%	2	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TCR_SIGNALING
0.369003690037%	2	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_TAP63PATHWAY
0.369003690037%	2	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_NFAT_3PATHWAY
0.369003690037%	2	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN
0.369003690037%	2	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_NON_SMALL_CELL_LUNG_CANCER
0.369003690037%	2	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_ARGININE_AND_PROLINE_METABOLISM
0.369003690037%	2	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	JIANG_AGING_CEREBRAL_CORTEX_DN
0.369003690037%	2	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	ROESSLER_LIVER_CANCER_METASTASIS_DN
0.369003690037%	2	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_CD8TCRPATHWAY
0.369003690037%	2	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.369003690037%	2	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_AUTOIMMUNE_THYROID_DISEASE
0.369003690037%	2	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	IKEDA_MIR1_TARGETS_UP
0.369003690037%	2	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.369003690037%	2	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_PTP1BPATHWAY
0.369003690037%	2	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_MTOR_SIGNALING_PATHWAY
0.369003690037%	2	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	HALMOS_CEBPA_TARGETS_UP
0.369003690037%	2	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHANG_PROLIFERATING_VS_QUIESCENT
0.369003690037%	2	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.369003690037%	2	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE
0.369003690037%	2	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1
0.369003690037%	2	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	PRAMOONJAGO_SOX4_TARGETS_DN
0.369003690037%	2	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	MORI_PLASMA_CELL_UP
0.369003690037%	2	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	LUI_THYROID_CANCER_CLUSTER_1
0.369003690037%	2	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
0.369003690037%	2	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	APPIERTO_RESPONSE_TO_FENRETINIDE_DN
0.369003690037%	2	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	PARK_APL_PATHOGENESIS_DN
0.369003690037%	2	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	NADERI_BREAST_CANCER_PROGNOSIS_UP
0.369003690037%	2	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	KOHOUTEK_CCNT1_TARGETS
0.369003690037%	2	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
0.369003690037%	2	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	WONG_PROTEASOME_GENE_MODULE
0.369003690037%	2	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
0.369003690037%	2	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
0.369003690037%	2	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC
0.369003690037%	2	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_PI3KCIPATHWAY
0.369003690037%	2	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	MARCHINI_TRABECTEDIN_RESISTANCE_DN
0.369003690037%	2	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP
0.369003690037%	2	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN
0.369003690037%	2	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.369003690037%	2	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP
0.369003690037%	2	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	APRELIKOVA_BRCA1_TARGETS
0.369003690037%	2	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES
0.369003690037%	2	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6
0.369003690037%	2	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_HES_HEYPATHWAY
0.369003690037%	2	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_AJDISS_2PATHWAY
0.369003690037%	2	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	OXFORD_RALA_OR_RALB_TARGETS_UP
0.369003690037%	2	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	NADLER_OBESITY_DN
0.369003690037%	2	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PROTEASOME
0.369003690037%	2	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
0.369003690037%	2	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
0.369003690037%	2	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN
0.369003690037%	2	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.369003690037%	2	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	DELACROIX_RAR_TARGETS_UP
0.369003690037%	2	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	WOOD_EBV_EBNA1_TARGETS_DN
0.369003690037%	2	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
0.369003690037%	2	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP
0.369003690037%	2	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_IL6_7PATHWAY
0.369003690037%	2	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	SAGIV_CD24_TARGETS_DN
0.369003690037%	2	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	PARENT_MTOR_SIGNALING_DN
0.369003690037%	2	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	HALMOS_CEBPA_TARGETS_DN
0.369003690037%	2	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN
0.369003690037%	2	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	ABBUD_LIF_SIGNALING_1_UP
0.369003690037%	2	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_MULTIPLE_MYELOMA_PR_UP
0.369003690037%	2	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_MULTIPLE_MYELOMA_CD1_DN
0.369003690037%	2	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
0.369003690037%	2	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	SIG_CHEMOTAXIS
0.369003690037%	2	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN
0.369003690037%	2	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	SHIPP_DLBCL_CURED_VS_FATAL_DN
0.369003690037%	2	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER
0.369003690037%	2	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MRNA_SPLICING_MINOR_PATHWAY
0.369003690037%	2	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_
0.369003690037%	2	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_INSULIN_PATHWAY
0.369003690037%	2	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_HNF3BPATHWAY
0.369003690037%	2	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	NUTT_GBM_VS_AO_GLIOMA_DN
0.369003690037%	2	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN
0.369003690037%	2	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP
0.369003690037%	2	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	XU_CREBBP_TARGETS_DN
0.369003690037%	2	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	WHITFIELD_CELL_CYCLE_LITERATURE
0.369003690037%	2	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_TARGETS_OF_MLL_CBP_FUSION_UP
0.369003690037%	2	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	THILLAINADESAN_ZNF217_TARGETS_UP
0.369003690037%	2	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_ERBB2ERBB3PATHWAY
0.369003690037%	2	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	PARK_HSC_MARKERS
0.369003690037%	2	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	OHGUCHI_LIVER_HNF4A_TARGETS_UP
0.369003690037%	2	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	MA_MYELOID_DIFFERENTIATION_DN
0.369003690037%	2	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_LYSINE_DEGRADATION
0.369003690037%	2	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM
0.369003690037%	2	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	GROSS_HYPOXIA_VIA_ELK3_ONLY_DN
0.369003690037%	2	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	ULE_SPLICING_VIA_NOVA2
0.369003690037%	2	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	RIZ_ERYTHROID_DIFFERENTIATION_12HR
0.369003690037%	2	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS
0.369003690037%	2	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1
0.369003690037%	2	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_THROMBIN_PAR1_PATHWAY
0.369003690037%	2	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_CXCR3PATHWAY
0.369003690037%	2	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	NAKAMURA_METASTASIS_MODEL_DN
0.369003690037%	2	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	AMIT_EGF_RESPONSE_480_MCF10A
0.369003690037%	2	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
0.369003690037%	2	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	ONO_FOXP3_TARGETS_DN
0.369003690037%	2	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_ES_ICP_WITH_H3K27ME3
0.369003690037%	2	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER
0.369003690037%	2	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	LUI_THYROID_CANCER_CLUSTER_2
0.369003690037%	2	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_MULTIPLE_MYELOMA_MF_DN
0.369003690037%	2	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_MULTIPLE_MYELOMA_DN
0.369003690037%	2	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN
0.369003690037%	2	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	RIZ_ERYTHROID_DIFFERENTIATION_HBZ
0.369003690037%	2	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_ES_HCP_WITH_H3K27ME3
0.369003690037%	2	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	MALONEY_RESPONSE_TO_17AAG_UP
0.369003690037%	2	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	LI_LUNG_CANCER
0.369003690037%	2	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	LIN_MELANOMA_COPY_NUMBER_DN
0.369003690037%	2	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	KAAB_FAILED_HEART_VENTRICLE_DN
0.369003690037%	2	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	EHLERS_ANEUPLOIDY_UP
0.369003690037%	2	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_FCER1_PATHWAY
0.369003690037%	2	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	VARELA_ZMPSTE24_TARGETS_UP
0.369003690037%	2	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	VANASSE_BCL2_TARGETS_UP
0.369003690037%	2	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_JNK_MAPK_PATHWAY
0.369003690037%	2	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP
0.369003690037%	2	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_TRYPTOPHAN_METABOLISM
0.369003690037%	2	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	JIANG_AGING_HYPOTHALAMUS_DN
0.369003690037%	2	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	GENTILE_UV_RESPONSE_CLUSTER_D7
0.369003690037%	2	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	DORN_ADENOVIRUS_INFECTION_48HR_DN
0.369003690037%	2	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	CHANGOLKAR_H2AFY_TARGETS_DN
0.369003690037%	2	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
0.369003690037%	2	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_P38MAPK_PATHWAY
0.369003690037%	2	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	SHIPP_DLBCL_CURED_VS_FATAL_UP
0.369003690037%	2	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	SESTO_RESPONSE_TO_UV_C6
0.369003690037%	2	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_RET_PATHWAY
0.369003690037%	2	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_ECADHERIN_NASCENTAJ_PATHWAY
0.369003690037%	2	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_AURORA_B_PATHWAY
0.369003690037%	2	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	GENTILE_UV_RESPONSE_CLUSTER_D5
0.369003690037%	2	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
0.369003690037%	2	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	DORN_ADENOVIRUS_INFECTION_32HR_DN
0.369003690037%	2	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	BILANGES_RAPAMYCIN_SENSITIVE_GENES
0.369003690037%	2	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	AIYAR_COBRA1_TARGETS_UP
0.369003690037%	2	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
0.369003690037%	2	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS
0.369003690037%	2	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_G1_PHASE
0.369003690037%	2	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	PIONTEK_PKD1_TARGETS_UP
0.369003690037%	2	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_P38ALPHABETADOWNSTREAMPATHWAY
0.369003690037%	2	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	CERVERA_SDHB_TARGETS_1_DN
0.369003690037%	2	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_INTEGRIN_PATHWAY
0.369003690037%	2	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_IL2RB_PATHWAY
0.369003690037%	2	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	VALK_AML_WITH_CEBPA
0.369003690037%	2	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_P38_MAPK_PATHWAY
0.369003690037%	2	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN
0.369003690037%	2	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	RICKMAN_HEAD_AND_NECK_CANCER_D
0.369003690037%	2	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS
0.369003690037%	2	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_IL23PATHWAY
0.369003690037%	2	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_GMCSF_PATHWAY
0.369003690037%	2	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	MATZUK_SPERMATID_DIFFERENTIATION
0.369003690037%	2	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES
0.369003690037%	2	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	FRASOR_RESPONSE_TO_ESTRADIOL_UP
0.369003690037%	2	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_BCR_PATHWAY
0.369003690037%	2	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	YANG_BREAST_CANCER_ESR1_UP
0.369003690037%	2	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	VANTVEER_BREAST_CANCER_BRCA1_UP
0.369003690037%	2	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
0.369003690037%	2	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALLING_TO_ERKS
0.369003690037%	2	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
0.369003690037%	2	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_AT1R_PATHWAY
0.369003690037%	2	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	VALK_AML_CLUSTER_9
0.369003690037%	2	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
0.369003690037%	2	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PRION_DISEASES
0.369003690037%	2	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_BASE_EXCISION_REPAIR
0.369003690037%	2	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	HOWLIN_CITED1_TARGETS_1_UP
0.369003690037%	2	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	DORSAM_HOXA9_TARGETS_UP
0.369003690037%	2	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP
0.369003690037%	2	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNAL_TRANSDUCTION_BY_L1
0.369003690037%	2	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION
0.369003690037%	2	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX
0.369003690037%	2	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_IL2_PI3KPATHWAY
0.369003690037%	2	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_HIF2PATHWAY
0.369003690037%	2	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	ABE_VEGFA_TARGETS_2HR
0.369003690037%	2	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	VALK_AML_CLUSTER_6
0.369003690037%	2	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	SIMBULAN_UV_RESPONSE_NORMAL_DN
0.369003690037%	2	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RNA_POL_III_TRANSCRIPTION
0.369003690037%	2	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS
0.369003690037%	2	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_NCADHERINPATHWAY
0.369003690037%	2	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_IL12_STAT4PATHWAY
0.369003690037%	2	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	HEIDENBLAD_AMPLICON_12P11_12_UP
0.369003690037%	2	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	GHANDHI_DIRECT_IRRADIATION_DN
0.369003690037%	2	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	DUTTA_APOPTOSIS_VIA_NFKB
0.369003690037%	2	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	DORN_ADENOVIRUS_INFECTION_12HR_DN
0.369003690037%	2	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	CAFFAREL_RESPONSE_TO_THC_UP
0.369003690037%	2	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	BURTON_ADIPOGENESIS_1
0.369003690037%	2	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	TRACEY_RESISTANCE_TO_IFNA2_DN
0.369003690037%	2	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_ERK1_ERK2_MAPK_PATHWAY
0.369003690037%	2	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	KASLER_HDAC7_TARGETS_2_DN
0.369003690037%	2	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN
0.369003690037%	2	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_PDGF_PATHWAY
0.369003690037%	2	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	BAUS_TFF2_TARGETS_UP
0.369003690037%	2	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP
0.369003690037%	2	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_CD40_PATHWAY
0.369003690037%	2	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_AVB3_OPN_PATHWAY
0.369003690037%	2	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_AR_NONGENOMIC_PATHWAY
0.369003690037%	2	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	NOJIMA_SFRP2_TARGETS_UP
0.369003690037%	2	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM
0.369003690037%	2	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_PYK2_PATHWAY
0.369003690037%	2	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_EGF_PATHWAY
0.369003690037%	2	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
0.369003690037%	2	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.369003690037%	2	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.369003690037%	2	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	SU_PLACENTA
0.369003690037%	2	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
0.369003690037%	2	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX
0.369003690037%	2	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CA_DEPENDENT_EVENTS
0.369003690037%	2	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_RETINOIC_ACID_PATHWAY
0.369003690037%	2	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	DASU_IL6_SIGNALING_SCAR_UP
0.369003690037%	2	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_FAS_PATHWAY
0.369003690037%	2	542	295	T2D_GENES_TANYA_ANTHROPOMETRIC	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
0.369003690037%	2	542	290	T2D_GENES_TANYA_ANTHROPOMETRIC	BENPORATH_OCT4_TARGETS
0.369003690037%	2	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION
0.369003690037%	2	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
0.369003690037%	2	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_S1P_S1P3_PATHWAY
0.369003690037%	2	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
0.369003690037%	2	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	MA_PITUITARY_FETAL_VS_ADULT_UP
0.369003690037%	2	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	LU_TUMOR_VASCULATURE_UP
0.369003690037%	2	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	KRIGE_AMINO_ACID_DEPRIVATION
0.369003690037%	2	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_RNA_POLYMERASE
0.369003690037%	2	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN
0.369003690037%	2	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_VIP_PATHWAY
0.369003690037%	2	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP
0.369003690037%	2	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	ABE_VEGFA_TARGETS_30MIN
0.369003690037%	2	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	VALK_AML_CLUSTER_1
0.369003690037%	2	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS
0.369003690037%	2	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	MOREIRA_RESPONSE_TO_TSA_UP
0.369003690037%	2	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	LOPES_METHYLATED_IN_COLON_CANCER_DN
0.369003690037%	2	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
0.369003690037%	2	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	GENTILE_UV_RESPONSE_CLUSTER_D9
0.369003690037%	2	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_PROTEASOME_PATHWAY
0.369003690037%	2	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	TERAO_AOX4_TARGETS_SKIN_DN
0.369003690037%	2	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_MYOCYTE_AD_PATHWAY
0.369003690037%	2	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
0.369003690037%	2	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SYNTHESIS_OF_PA
0.369003690037%	2	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES
0.369003690037%	2	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT
0.369003690037%	2	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	GENTILE_UV_LOW_DOSE_UP
0.369003690037%	2	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	XU_CREBBP_TARGETS_UP
0.369003690037%	2	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
0.369003690037%	2	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER
0.369003690037%	2	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_VEGFR1_PATHWAY
0.369003690037%	2	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_IL27PATHWAY
0.369003690037%	2	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_RACCYCD_PATHWAY
0.369003690037%	2	542	252	T2D_GENES_TANYA_ANTHROPOMETRIC	BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.369003690037%	2	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_NFKB_TARGETS
0.369003690037%	2	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN
0.369003690037%	2	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS
0.369003690037%	2	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	LU_TUMOR_ANGIOGENESIS_UP
0.369003690037%	2	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN
0.369003690037%	2	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	GENTILE_UV_HIGH_DOSE_UP
0.369003690037%	2	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP
0.369003690037%	2	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN
0.369003690037%	2	542	242	T2D_GENES_TANYA_ANTHROPOMETRIC	CHYLA_CBFA2T3_TARGETS_DN
0.369003690037%	2	542	240	T2D_GENES_TANYA_ANTHROPOMETRIC	VANTVEER_BREAST_CANCER_ESR1_DN
0.369003690037%	2	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	WILLERT_WNT_SIGNALING
0.369003690037%	2	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHRAMM_INHBA_TARGETS_DN
0.369003690037%	2	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION
0.369003690037%	2	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION
0.369003690037%	2	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION
0.369003690037%	2	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN
0.369003690037%	2	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	MAEKAWA_ATF2_TARGETS
0.369003690037%	2	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	LA_MEN1_TARGETS
0.369003690037%	2	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_GERMINAL_CENTER_T_HELPER_DN
0.369003690037%	2	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP
0.369003690037%	2	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	DELACROIX_RAR_TARGETS_DN
0.369003690037%	2	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN
0.369003690037%	2	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_CXCR4_PATHWAY
0.369003690037%	2	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	ZIRN_TRETINOIN_RESPONSE_WT1_UP
0.369003690037%	2	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	WU_HBX_TARGETS_1_DN
0.369003690037%	2	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_RESPONSE_TO_FORSKOLIN_UP
0.369003690037%	2	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.369003690037%	2	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER
0.369003690037%	2	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA
0.369003690037%	2	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_NFKAPPABCANONICALPATHWAY
0.369003690037%	2	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP
0.369003690037%	2	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP
0.369003690037%	2	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_RAS_PATHWAY
0.369003690037%	2	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_GLEEVEC_PATHWAY
0.369003690037%	2	542	228	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
0.369003690037%	2	542	228	T2D_GENES_TANYA_ANTHROPOMETRIC	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
0.369003690037%	2	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.369003690037%	2	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	SUZUKI_RESPONSE_TO_TSA
0.369003690037%	2	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
0.369003690037%	2	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	MATZUK_IMPLANTATION_AND_UTERINE
0.369003690037%	2	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	LU_TUMOR_ENDOTHELIAL_MARKERS_UP
0.369003690037%	2	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	KANG_FLUOROURACIL_RESISTANCE_UP
0.369003690037%	2	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN
0.369003690037%	2	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN
0.369003690037%	2	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_INSULIN_PATHWAY
0.369003690037%	2	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_IL6_PATHWAY
0.369003690037%	2	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_CYTOKINE_PATHWAY
0.369003690037%	2	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_AKT_PATHWAY
0.369003690037%	2	542	214	T2D_GENES_TANYA_ANTHROPOMETRIC	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
0.369003690037%	2	542	210	T2D_GENES_TANYA_ANTHROPOMETRIC	VERHAAK_GLIOBLASTOMA_PRONEURAL
0.369003690037%	2	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	WENG_POR_DOSAGE
0.369003690037%	2	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	STEGER_ADIPOGENESIS_UP
0.369003690037%	2	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHURINGA_STAT5A_TARGETS_UP
0.369003690037%	2	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP
0.369003690037%	2	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS
0.369003690037%	2	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING
0.369003690037%	2	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC
0.369003690037%	2	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_S1P_S1P1_PATHWAY
0.369003690037%	2	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	OUYANG_PROSTATE_CANCER_PROGRESSION_DN
0.369003690037%	2	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN
0.369003690037%	2	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	HUI_MAPK14_TARGETS_UP
0.369003690037%	2	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	GESERICK_TERT_TARGETS_DN
0.369003690037%	2	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_IGF1_PATHWAY
0.369003690037%	2	542	202	T2D_GENES_TANYA_ANTHROPOMETRIC	FUJII_YBX1_TARGETS_DN
0.369003690037%	2	542	201	T2D_GENES_TANYA_ANTHROPOMETRIC	HOLLMANN_APOPTOSIS_VIA_CD40_UP
0.369003690037%	2	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHU_SKIL_TARGETS_UP
0.369003690037%	2	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN
0.369003690037%	2	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	WENG_POR_TARGETS_GLOBAL_UP
0.369003690037%	2	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_RECURRENT_LIVER_CANCER_UP
0.369003690037%	2	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_WNT_CA2_CYCLIC_GMP_PATHWAY
0.369003690037%	2	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	SESTO_RESPONSE_TO_UV_C3
0.369003690037%	2	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3
0.369003690037%	2	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	NIELSEN_SYNOVIAL_SARCOMA_DN
0.369003690037%	2	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	NIELSEN_LEIOMYOSARCOMA_CNN1_DN
0.369003690037%	2	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	MANN_RESPONSE_TO_AMIFOSTINE_UP
0.369003690037%	2	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_ATM_PATHWAY
0.369003690037%	2	542	199	T2D_GENES_TANYA_ANTHROPOMETRIC	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
0.369003690037%	2	542	196	T2D_GENES_TANYA_ANTHROPOMETRIC	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
0.369003690037%	2	542	196	T2D_GENES_TANYA_ANTHROPOMETRIC	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
0.369003690037%	2	542	195	T2D_GENES_TANYA_ANTHROPOMETRIC	KYNG_DNA_DAMAGE_DN
0.369003690037%	2	542	191	T2D_GENES_TANYA_ANTHROPOMETRIC	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
0.369003690037%	2	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	WU_ALZHEIMER_DISEASE_DN
0.369003690037%	2	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	SYED_ESTRADIOL_RESPONSE
0.369003690037%	2	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION
0.369003690037%	2	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS
0.369003690037%	2	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_NAIVE_T_LYMPHOCYTE
0.369003690037%	2	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	LAMB_CCND1_TARGETS
0.369003690037%	2	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN
0.369003690037%	2	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_TGFB_PATHWAY
0.369003690037%	2	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_MAL_PATHWAY
0.369003690037%	2	542	188	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
0.369003690037%	2	542	187	T2D_GENES_TANYA_ANTHROPOMETRIC	PENG_LEUCINE_DEPRIVATION_DN
0.369003690037%	2	542	181	T2D_GENES_TANYA_ANTHROPOMETRIC	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
0.369003690037%	2	542	181	T2D_GENES_TANYA_ANTHROPOMETRIC	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
0.369003690037%	2	542	180	T2D_GENES_TANYA_ANTHROPOMETRIC	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
0.369003690037%	2	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHENG_RESPONSE_TO_ARSENITE_DN
0.369003690037%	2	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	WU_HBX_TARGETS_3_UP
0.369003690037%	2	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	WEBER_METHYLATED_IN_COLON_CANCER
0.369003690037%	2	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	TOMIDA_METASTASIS_DN
0.369003690037%	2	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA
0.369003690037%	2	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN
0.369003690037%	2	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB
0.369003690037%	2	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	NIELSEN_SCHWANNOMA_UP
0.369003690037%	2	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	NIELSEN_LIPOSARCOMA_UP
0.369003690037%	2	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	MAINA_VHL_TARGETS_DN
0.369003690037%	2	542	176	T2D_GENES_TANYA_ANTHROPOMETRIC	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN
0.369003690037%	2	542	175	T2D_GENES_TANYA_ANTHROPOMETRIC	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.369003690037%	2	542	175	T2D_GENES_TANYA_ANTHROPOMETRIC	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
0.369003690037%	2	542	173	T2D_GENES_TANYA_ANTHROPOMETRIC	SENGUPTA_EBNA1_ANTICORRELATED
0.369003690037%	2	542	171	T2D_GENES_TANYA_ANTHROPOMETRIC	ELVIDGE_HYPOXIA_UP
0.369003690037%	2	542	171	T2D_GENES_TANYA_ANTHROPOMETRIC	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
0.369003690037%	2	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	RODRIGUES_NTN1_TARGETS_UP
0.369003690037%	2	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RNA_POL_III_CHAIN_ELONGATION
0.369003690037%	2	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RAP1_SIGNALLING
0.369003690037%	2	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ARMS_MEDIATED_ACTIVATION
0.369003690037%	2	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS
0.369003690037%	2	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_SYNDECAN_3_PATHWAY
0.369003690037%	2	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_SMAD2_3PATHWAY
0.369003690037%	2	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_NFKAPPABATYPICALPATHWAY
0.369003690037%	2	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	ONDER_CDH1_TARGETS_3_UP
0.369003690037%	2	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
0.369003690037%	2	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL
0.369003690037%	2	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
0.369003690037%	2	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_HCMV_PATHWAY
0.369003690037%	2	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_ARF_PATHWAY
0.369003690037%	2	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_41BB_PATHWAY
0.369003690037%	2	542	169	T2D_GENES_TANYA_ANTHROPOMETRIC	ONDER_CDH1_TARGETS_1_DN
0.369003690037%	2	542	162	T2D_GENES_TANYA_ANTHROPOMETRIC	WHITFIELD_CELL_CYCLE_S
0.369003690037%	2	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN
0.369003690037%	2	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	WU_HBX_TARGETS_1_UP
0.369003690037%	2	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	TIAN_BHLHA15_TARGETS
0.369003690037%	2	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_G_ALPHA_S_PATHWAY
0.369003690037%	2	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
0.369003690037%	2	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING
0.369003690037%	2	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS
0.369003690037%	2	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN
0.369003690037%	2	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM
0.369003690037%	2	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	GEISS_RESPONSE_TO_DSRNA_DN
0.369003690037%	2	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_ACH_PATHWAY
0.369003690037%	2	542	159	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_INTERFERON_SIGNALING
0.369003690037%	2	542	158	T2D_GENES_TANYA_ANTHROPOMETRIC	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.369003690037%	2	542	156	T2D_GENES_TANYA_ANTHROPOMETRIC	FOSTER_TOLERANT_MACROPHAGE_UP
0.369003690037%	2	542	154	T2D_GENES_TANYA_ANTHROPOMETRIC	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
0.369003690037%	2	542	153	T2D_GENES_TANYA_ANTHROPOMETRIC	RUIZ_TNC_TARGETS_UP
0.369003690037%	2	542	152	T2D_GENES_TANYA_ANTHROPOMETRIC	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
0.369003690037%	2	542	152	T2D_GENES_TANYA_ANTHROPOMETRIC	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
0.369003690037%	2	542	150	T2D_GENES_TANYA_ANTHROPOMETRIC	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
0.369003690037%	2	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP
0.369003690037%	2	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN
0.369003690037%	2	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	SA_MMP_CYTOKINE_CONNECTION
0.369003690037%	2	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ENDOGENOUS_STEROLS
0.369003690037%	2	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_LPA4_PATHWAY
0.369003690037%	2	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	MARKS_HDAC_TARGETS_DN
0.369003690037%	2	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_NUCLEARRS_PATHWAY
0.369003690037%	2	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_HSP27_PATHWAY
0.369003690037%	2	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_CD40_PATHWAY
0.369003690037%	2	542	149	T2D_GENES_TANYA_ANTHROPOMETRIC	OHGUCHI_LIVER_HNF4A_TARGETS_DN
0.369003690037%	2	542	148	T2D_GENES_TANYA_ANTHROPOMETRIC	WEI_MIR34A_TARGETS
0.369003690037%	2	542	148	T2D_GENES_TANYA_ANTHROPOMETRIC	CHANG_CYCLING_GENES
0.369003690037%	2	542	147	T2D_GENES_TANYA_ANTHROPOMETRIC	WHITFIELD_CELL_CYCLE_G1_S
0.369003690037%	2	542	147	T2D_GENES_TANYA_ANTHROPOMETRIC	BENPORATH_PROLIFERATION
0.369003690037%	2	542	146	T2D_GENES_TANYA_ANTHROPOMETRIC	PECE_MAMMARY_STEM_CELL_UP
0.369003690037%	2	542	144	T2D_GENES_TANYA_ANTHROPOMETRIC	BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.369003690037%	2	542	141	T2D_GENES_TANYA_ANTHROPOMETRIC	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.369003690037%	2	542	140	T2D_GENES_TANYA_ANTHROPOMETRIC	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
0.369003690037%	2	542	140	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
0.369003690037%	2	542	140	T2D_GENES_TANYA_ANTHROPOMETRIC	QI_HYPOXIA
0.369003690037%	2	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS
0.369003690037%	2	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES
0.369003690037%	2	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_TCRJNKPATHWAY
0.369003690037%	2	542	139	T2D_GENES_TANYA_ANTHROPOMETRIC	HOELZEL_NF1_TARGETS_UP
0.369003690037%	2	542	138	T2D_GENES_TANYA_ANTHROPOMETRIC	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
0.369003690037%	2	542	137	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_INSULIN_SIGNALING_PATHWAY
0.369003690037%	2	542	136	T2D_GENES_TANYA_ANTHROPOMETRIC	WIERENGA_STAT5A_TARGETS_GROUP1
0.369003690037%	2	542	135	T2D_GENES_TANYA_ANTHROPOMETRIC	TSENG_IRS1_TARGETS_DN
0.369003690037%	2	542	134	T2D_GENES_TANYA_ANTHROPOMETRIC	CHUNG_BLISTER_CYTOTOXICITY_UP
0.369003690037%	2	542	133	T2D_GENES_TANYA_ANTHROPOMETRIC	GAL_LEUKEMIC_STEM_CELL_UP
0.369003690037%	2	542	131	T2D_GENES_TANYA_ANTHROPOMETRIC	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.369003690037%	2	542	130	T2D_GENES_TANYA_ANTHROPOMETRIC	ELVIDGE_HYPOXIA_BY_DMOG_UP
0.369003690037%	2	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS
0.369003690037%	2	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_SULFUR_METABOLISM
0.369003690037%	2	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION
0.369003690037%	2	542	129	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_WT1_TARGETS_8HR_DN
0.369003690037%	2	542	129	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_AXON_GUIDANCE
0.369003690037%	2	542	128	T2D_GENES_TANYA_ANTHROPOMETRIC	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
0.369003690037%	2	542	127	T2D_GENES_TANYA_ANTHROPOMETRIC	LIU_VMYB_TARGETS_UP
0.369003690037%	2	542	126	T2D_GENES_TANYA_ANTHROPOMETRIC	SANSOM_APC_TARGETS_UP
0.369003690037%	2	542	126	T2D_GENES_TANYA_ANTHROPOMETRIC	MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.369003690037%	2	542	123	T2D_GENES_TANYA_ANTHROPOMETRIC	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.369003690037%	2	542	123	T2D_GENES_TANYA_ANTHROPOMETRIC	HOOI_ST7_TARGETS_DN
0.369003690037%	2	542	120	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CELL_CELL_COMMUNICATION
0.369003690037%	2	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53
0.369003690037%	2	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	TAGHAVI_NEOPLASTIC_TRANSFORMATION
0.369003690037%	2	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_NPC_ICP_WITH_H3K27ME3
0.369003690037%	2	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.369003690037%	2	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_VDR_PATHWAY
0.369003690037%	2	542	119	T2D_GENES_TANYA_ANTHROPOMETRIC	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
0.369003690037%	2	542	116	T2D_GENES_TANYA_ANTHROPOMETRIC	WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.369003690037%	2	542	116	T2D_GENES_TANYA_ANTHROPOMETRIC	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
0.369003690037%	2	542	116	T2D_GENES_TANYA_ANTHROPOMETRIC	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
0.369003690037%	2	542	116	T2D_GENES_TANYA_ANTHROPOMETRIC	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.369003690037%	2	542	114	T2D_GENES_TANYA_ANTHROPOMETRIC	SENESE_HDAC2_TARGETS_UP
0.369003690037%	2	542	114	T2D_GENES_TANYA_ANTHROPOMETRIC	ROPERO_HDAC2_TARGETS
0.369003690037%	2	542	114	T2D_GENES_TANYA_ANTHROPOMETRIC	BOSCO_TH1_CYTOTOXIC_MODULE
0.369003690037%	2	542	112	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_G1_S_TRANSITION
0.369003690037%	2	542	111	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_HCP_PROSTATE_CANCER
0.369003690037%	2	542	111	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MRNA_SPLICING
0.369003690037%	2	542	111	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_12HR_UP
0.369003690037%	2	542	110	T2D_GENES_TANYA_ANTHROPOMETRIC	SUNG_METASTASIS_STROMA_UP
0.369003690037%	2	542	110	T2D_GENES_TANYA_ANTHROPOMETRIC	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
0.369003690037%	2	542	110	T2D_GENES_TANYA_ANTHROPOMETRIC	GROSS_HYPOXIA_VIA_HIF1A_DN
0.369003690037%	2	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	WILLIAMS_ESR2_TARGETS_DN
0.369003690037%	2	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.369003690037%	2	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	MARSON_FOXP3_TARGETS_STIMULATED_DN
0.369003690037%	2	542	109	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_S_PHASE
0.369003690037%	2	542	108	T2D_GENES_TANYA_ANTHROPOMETRIC	TAVAZOIE_METASTASIS
0.369003690037%	2	542	108	T2D_GENES_TANYA_ANTHROPOMETRIC	LE_EGR2_TARGETS_UP
0.369003690037%	2	542	108	T2D_GENES_TANYA_ANTHROPOMETRIC	LABBE_TGFB1_TARGETS_DN
0.369003690037%	2	542	108	T2D_GENES_TANYA_ANTHROPOMETRIC	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
0.369003690037%	2	542	108	T2D_GENES_TANYA_ANTHROPOMETRIC	JAZAG_TGFB1_SIGNALING_UP
0.369003690037%	2	542	107	T2D_GENES_TANYA_ANTHROPOMETRIC	SESTO_RESPONSE_TO_UV_C0
0.369003690037%	2	542	106	T2D_GENES_TANYA_ANTHROPOMETRIC	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
0.369003690037%	2	542	105	T2D_GENES_TANYA_ANTHROPOMETRIC	ZWANG_EGF_INTERVAL_UP
0.369003690037%	2	542	105	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RNA_POL_II_TRANSCRIPTION
0.369003690037%	2	542	104	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE
0.369003690037%	2	542	103	T2D_GENES_TANYA_ANTHROPOMETRIC	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
0.369003690037%	2	542	103	T2D_GENES_TANYA_ANTHROPOMETRIC	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
0.369003690037%	2	542	103	T2D_GENES_TANYA_ANTHROPOMETRIC	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.369003690037%	2	542	102	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_CXCR4_PATHWAY
0.369003690037%	2	542	102	T2D_GENES_TANYA_ANTHROPOMETRIC	KANG_IMMORTALIZED_BY_TERT_DN
0.369003690037%	2	542	101	T2D_GENES_TANYA_ANTHROPOMETRIC	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
0.369003690037%	2	542	101	T2D_GENES_TANYA_ANTHROPOMETRIC	BURTON_ADIPOGENESIS_3
0.369003690037%	2	542	101	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_20HR_DN
0.369003690037%	2	542	101	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_12HR_DN
0.369003690037%	2	542	101	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_10HR_UP
0.369003690037%	2	542	100	T2D_GENES_TANYA_ANTHROPOMETRIC	QI_PLASMACYTOMA_DN
0.369003690037%	2	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	YEMELYANOV_GR_TARGETS_DN
0.369003690037%	2	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY
0.369003690037%	2	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	BRUNEAU_SEPTATION_VENTRICULAR
0.369003690037%	2	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_FREE_PATHWAY
0.367985280589%	8	2174	98	T2D_GENES_TANYA_LIPIDS	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
0.367985280589%	8	2174	98	T2D_GENES_TANYA_LIPIDS	KEGG_PYRIMIDINE_METABOLISM
0.367985280589%	8	2174	97	T2D_GENES_TANYA_LIPIDS	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP
0.367985280589%	8	2174	94	T2D_GENES_TANYA_LIPIDS	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER
0.367985280589%	8	2174	92	T2D_GENES_TANYA_LIPIDS	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
0.367985280589%	8	2174	90	T2D_GENES_TANYA_LIPIDS	KEGG_GAP_JUNCTION
0.367985280589%	8	2174	89	T2D_GENES_TANYA_LIPIDS	VANLOO_SP3_TARGETS_DN
0.367985280589%	8	2174	88	T2D_GENES_TANYA_LIPIDS	SASSON_RESPONSE_TO_FORSKOLIN_DN
0.367985280589%	8	2174	88	T2D_GENES_TANYA_LIPIDS	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
0.367985280589%	8	2174	88	T2D_GENES_TANYA_LIPIDS	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.367985280589%	8	2174	87	T2D_GENES_TANYA_LIPIDS	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
0.367985280589%	8	2174	87	T2D_GENES_TANYA_LIPIDS	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.367985280589%	8	2174	87	T2D_GENES_TANYA_LIPIDS	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
0.367985280589%	8	2174	86	T2D_GENES_TANYA_LIPIDS	NGUYEN_NOTCH1_TARGETS_DN
0.367985280589%	8	2174	86	T2D_GENES_TANYA_LIPIDS	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.367985280589%	8	2174	86	T2D_GENES_TANYA_LIPIDS	LAIHO_COLORECTAL_CANCER_SERRATED_DN
0.367985280589%	8	2174	85	T2D_GENES_TANYA_LIPIDS	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
0.367985280589%	8	2174	85	T2D_GENES_TANYA_LIPIDS	LEIN_CEREBELLUM_MARKERS
0.367985280589%	8	2174	85	T2D_GENES_TANYA_LIPIDS	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
0.367985280589%	8	2174	84	T2D_GENES_TANYA_LIPIDS	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
0.367985280589%	8	2174	84	T2D_GENES_TANYA_LIPIDS	CHANG_IMMORTALIZED_BY_HPV31_UP
0.367985280589%	8	2174	82	T2D_GENES_TANYA_LIPIDS	FRASOR_RESPONSE_TO_ESTRADIOL_DN
0.367985280589%	8	2174	81	T2D_GENES_TANYA_LIPIDS	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
0.367985280589%	8	2174	81	T2D_GENES_TANYA_LIPIDS	REACTOME_MITOTIC_G2_G2_M_PHASES
0.367985280589%	8	2174	79	T2D_GENES_TANYA_LIPIDS	PID_P73PATHWAY
0.367985280589%	8	2174	78	T2D_GENES_TANYA_LIPIDS	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
0.367985280589%	8	2174	78	T2D_GENES_TANYA_LIPIDS	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.367985280589%	8	2174	78	T2D_GENES_TANYA_LIPIDS	REACTOME_CELL_JUNCTION_ORGANIZATION
0.367985280589%	8	2174	78	T2D_GENES_TANYA_LIPIDS	RADMACHER_AML_PROGNOSIS
0.367985280589%	8	2174	78	T2D_GENES_TANYA_LIPIDS	LINDVALL_IMMORTALIZED_BY_TERT_UP
0.367985280589%	8	2174	78	T2D_GENES_TANYA_LIPIDS	KEGG_PEROXISOME
0.367985280589%	8	2174	78	T2D_GENES_TANYA_LIPIDS	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.367985280589%	8	2174	77	T2D_GENES_TANYA_LIPIDS	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
0.367985280589%	8	2174	77	T2D_GENES_TANYA_LIPIDS	JACKSON_DNMT1_TARGETS_UP
0.367985280589%	8	2174	77	T2D_GENES_TANYA_LIPIDS	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.367985280589%	8	2174	77	T2D_GENES_TANYA_LIPIDS	GROSS_HYPOXIA_VIA_HIF1A_UP
0.367985280589%	8	2174	76	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
0.367985280589%	8	2174	76	T2D_GENES_TANYA_LIPIDS	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.367985280589%	8	2174	74	T2D_GENES_TANYA_LIPIDS	SHEPARD_BMYB_TARGETS
0.367985280589%	8	2174	74	T2D_GENES_TANYA_LIPIDS	POTTI_ADRIAMYCIN_SENSITIVITY
0.367985280589%	8	2174	74	T2D_GENES_TANYA_LIPIDS	DARWICHE_PAPILLOMA_PROGRESSION_RISK
0.367985280589%	8	2174	74	T2D_GENES_TANYA_LIPIDS	CORRE_MULTIPLE_MYELOMA_UP
0.367985280589%	8	2174	72	T2D_GENES_TANYA_LIPIDS	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
0.367985280589%	8	2174	70	T2D_GENES_TANYA_LIPIDS	KEGG_RENAL_CELL_CARCINOMA
0.367985280589%	8	2174	70	T2D_GENES_TANYA_LIPIDS	KEGG_LONG_TERM_DEPRESSION
0.367985280589%	8	2174	70	T2D_GENES_TANYA_LIPIDS	CADWELL_ATG16L1_TARGETS_DN
0.367985280589%	8	2174	68	T2D_GENES_TANYA_LIPIDS	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.367985280589%	8	2174	68	T2D_GENES_TANYA_LIPIDS	AKL_HTLV1_INFECTION_DN
0.367985280589%	8	2174	67	T2D_GENES_TANYA_LIPIDS	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP
0.367985280589%	8	2174	66	T2D_GENES_TANYA_LIPIDS	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT
0.367985280589%	8	2174	66	T2D_GENES_TANYA_LIPIDS	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
0.367985280589%	8	2174	66	T2D_GENES_TANYA_LIPIDS	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN
0.367985280589%	8	2174	66	T2D_GENES_TANYA_LIPIDS	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.367985280589%	8	2174	66	T2D_GENES_TANYA_LIPIDS	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
0.367985280589%	8	2174	66	T2D_GENES_TANYA_LIPIDS	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP
0.367985280589%	8	2174	65	T2D_GENES_TANYA_LIPIDS	PID_BCR_5PATHWAY
0.367985280589%	8	2174	64	T2D_GENES_TANYA_LIPIDS	PETROVA_PROX1_TARGETS_DN
0.367985280589%	8	2174	64	T2D_GENES_TANYA_LIPIDS	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
0.367985280589%	8	2174	63	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
0.367985280589%	8	2174	62	T2D_GENES_TANYA_LIPIDS	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.367985280589%	8	2174	62	T2D_GENES_TANYA_LIPIDS	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP
0.367985280589%	8	2174	61	T2D_GENES_TANYA_LIPIDS	NADLER_OBESITY_UP
0.367985280589%	8	2174	60	T2D_GENES_TANYA_LIPIDS	SONG_TARGETS_OF_IE86_CMV_PROTEIN
0.367985280589%	8	2174	60	T2D_GENES_TANYA_LIPIDS	KEGG_ACUTE_MYELOID_LEUKEMIA
0.367985280589%	8	2174	59	T2D_GENES_TANYA_LIPIDS	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
0.367985280589%	8	2174	59	T2D_GENES_TANYA_LIPIDS	KEGG_RNA_DEGRADATION
0.367985280589%	8	2174	59	T2D_GENES_TANYA_LIPIDS	DASU_IL6_SIGNALING_UP
0.367985280589%	8	2174	58	T2D_GENES_TANYA_LIPIDS	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
0.367985280589%	8	2174	58	T2D_GENES_TANYA_LIPIDS	KEGG_ARACHIDONIC_ACID_METABOLISM
0.367985280589%	8	2174	56	T2D_GENES_TANYA_LIPIDS	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.367985280589%	8	2174	55	T2D_GENES_TANYA_LIPIDS	SMIRNOV_RESPONSE_TO_IR_2HR_DN
0.367985280589%	8	2174	54	T2D_GENES_TANYA_LIPIDS	SUNG_METASTASIS_STROMA_DN
0.367985280589%	8	2174	54	T2D_GENES_TANYA_LIPIDS	PID_NFAT_3PATHWAY
0.367985280589%	8	2174	53	T2D_GENES_TANYA_LIPIDS	ROESSLER_LIVER_CANCER_METASTASIS_DN
0.367985280589%	8	2174	53	T2D_GENES_TANYA_LIPIDS	MORI_IMMATURE_B_LYMPHOCYTE_UP
0.367985280589%	8	2174	52	T2D_GENES_TANYA_LIPIDS	VILIMAS_NOTCH1_TARGETS_UP
0.367985280589%	8	2174	52	T2D_GENES_TANYA_LIPIDS	RADAEVA_RESPONSE_TO_IFNA1_UP
0.367985280589%	8	2174	52	T2D_GENES_TANYA_LIPIDS	PRAMOONJAGO_SOX4_TARGETS_UP
0.367985280589%	8	2174	52	T2D_GENES_TANYA_LIPIDS	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP
0.367985280589%	8	2174	51	T2D_GENES_TANYA_LIPIDS	ZHANG_PROLIFERATING_VS_QUIESCENT
0.367985280589%	8	2174	51	T2D_GENES_TANYA_LIPIDS	GUILLAUMOND_KLF10_TARGETS_UP
0.367985280589%	8	2174	51	T2D_GENES_TANYA_LIPIDS	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
0.367985280589%	8	2174	50	T2D_GENES_TANYA_LIPIDS	PARK_HSC_AND_MULTIPOTENT_PROGENITORS
0.367985280589%	8	2174	50	T2D_GENES_TANYA_LIPIDS	PARK_APL_PATHOGENESIS_DN
0.367985280589%	8	2174	50	T2D_GENES_TANYA_LIPIDS	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC
0.367985280589%	8	2174	50	T2D_GENES_TANYA_LIPIDS	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN
0.367985280589%	8	2174	50	T2D_GENES_TANYA_LIPIDS	CHIBA_RESPONSE_TO_TSA
0.367985280589%	8	2174	49	T2D_GENES_TANYA_LIPIDS	WONG_PROTEASOME_GENE_MODULE
0.367985280589%	8	2174	49	T2D_GENES_TANYA_LIPIDS	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
0.367985280589%	8	2174	49	T2D_GENES_TANYA_LIPIDS	MANTOVANI_VIRAL_GPCR_SIGNALING_DN
0.367985280589%	8	2174	48	T2D_GENES_TANYA_LIPIDS	REACTOME_MUSCLE_CONTRACTION
0.367985280589%	8	2174	48	T2D_GENES_TANYA_LIPIDS	PENG_GLUCOSE_DEPRIVATION_UP
0.367985280589%	8	2174	48	T2D_GENES_TANYA_LIPIDS	OXFORD_RALA_OR_RALB_TARGETS_UP
0.367985280589%	8	2174	48	T2D_GENES_TANYA_LIPIDS	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN
0.367985280589%	8	2174	48	T2D_GENES_TANYA_LIPIDS	BURTON_ADIPOGENESIS_4
0.367985280589%	8	2174	47	T2D_GENES_TANYA_LIPIDS	WOOD_EBV_EBNA1_TARGETS_DN
0.367985280589%	8	2174	47	T2D_GENES_TANYA_LIPIDS	PID_NFAT_TFPATHWAY
0.367985280589%	8	2174	46	T2D_GENES_TANYA_LIPIDS	WINNEPENNINCKX_MELANOMA_METASTASIS_DN
0.367985280589%	8	2174	46	T2D_GENES_TANYA_LIPIDS	SIG_BCR_SIGNALING_PATHWAY
0.367985280589%	8	2174	46	T2D_GENES_TANYA_LIPIDS	SESTO_RESPONSE_TO_UV_C5
0.367985280589%	8	2174	46	T2D_GENES_TANYA_LIPIDS	PID_A6B1_A6B4_INTEGRIN_PATHWAY
0.367985280589%	8	2174	46	T2D_GENES_TANYA_LIPIDS	HALMOS_CEBPA_TARGETS_DN
0.367985280589%	8	2174	46	T2D_GENES_TANYA_LIPIDS	BIOCARTA_KERATINOCYTE_PATHWAY
0.367985280589%	8	2174	46	T2D_GENES_TANYA_LIPIDS	AMIT_EGF_RESPONSE_60_HELA
0.367985280589%	8	2174	45	T2D_GENES_TANYA_LIPIDS	PID_INSULIN_PATHWAY
0.367985280589%	8	2174	45	T2D_GENES_TANYA_LIPIDS	PID_HNF3BPATHWAY
0.367985280589%	8	2174	45	T2D_GENES_TANYA_LIPIDS	BIOCARTA_BIOPEPTIDES_PATHWAY
0.367985280589%	8	2174	44	T2D_GENES_TANYA_LIPIDS	ZUCCHI_METASTASIS_DN
0.367985280589%	8	2174	44	T2D_GENES_TANYA_LIPIDS	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
0.367985280589%	8	2174	43	T2D_GENES_TANYA_LIPIDS	REACTOME_PLC_BETA_MEDIATED_EVENTS
0.367985280589%	8	2174	43	T2D_GENES_TANYA_LIPIDS	PID_THROMBIN_PAR1_PATHWAY
0.367985280589%	8	2174	42	T2D_GENES_TANYA_LIPIDS	LEIN_ASTROCYTE_MARKERS
0.367985280589%	8	2174	42	T2D_GENES_TANYA_LIPIDS	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN
0.367985280589%	8	2174	41	T2D_GENES_TANYA_LIPIDS	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.367985280589%	8	2174	41	T2D_GENES_TANYA_LIPIDS	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN
0.367985280589%	8	2174	40	T2D_GENES_TANYA_LIPIDS	PID_IFNGPATHWAY
0.367985280589%	8	2174	40	T2D_GENES_TANYA_LIPIDS	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS
0.367985280589%	8	2174	40	T2D_GENES_TANYA_LIPIDS	KEGG_PYRUVATE_METABOLISM
0.367985280589%	8	2174	39	T2D_GENES_TANYA_LIPIDS	MA_MYELOID_DIFFERENTIATION_UP
0.367985280589%	8	2174	38	T2D_GENES_TANYA_LIPIDS	PIONTEK_PKD1_TARGETS_UP
0.367985280589%	8	2174	38	T2D_GENES_TANYA_LIPIDS	KRASNOSELSKAYA_ILF3_TARGETS_UP
0.367985280589%	8	2174	38	T2D_GENES_TANYA_LIPIDS	CERVERA_SDHB_TARGETS_1_DN
0.367985280589%	8	2174	37	T2D_GENES_TANYA_LIPIDS	ROLEF_GLIS3_TARGETS
0.367985280589%	8	2174	37	T2D_GENES_TANYA_LIPIDS	REACTOME_DOWNSTREAM_TCR_SIGNALING
0.367985280589%	8	2174	37	T2D_GENES_TANYA_LIPIDS	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2
0.367985280589%	8	2174	35	T2D_GENES_TANYA_LIPIDS	PID_ARF6_PATHWAY
0.367985280589%	8	2174	34	T2D_GENES_TANYA_LIPIDS	PETRETTO_CARDIAC_HYPERTROPHY
0.367985280589%	8	2174	33	T2D_GENES_TANYA_LIPIDS	APPEL_IMATINIB_RESPONSE
0.367985280589%	8	2174	30	T2D_GENES_TANYA_LIPIDS	KIM_LRRC3B_TARGETS
0.367985280589%	8	2174	29	T2D_GENES_TANYA_LIPIDS	CHOW_RASSF1_TARGETS_DN
0.367985280589%	8	2174	28	T2D_GENES_TANYA_LIPIDS	WILLIAMS_ESR2_TARGETS_UP
0.367985280589%	8	2174	28	T2D_GENES_TANYA_LIPIDS	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.367985280589%	8	2174	28	T2D_GENES_TANYA_LIPIDS	BIOCARTA_GH_PATHWAY
0.367985280589%	8	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_STRIATED_MUSCLE_CONTRACTION
0.367985280589%	8	2174	27	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CREB_PATHWAY
0.367985280589%	8	2174	26	T2D_GENES_TANYA_LIPIDS	PID_INSULIN_GLUCOSE_PATHWAY
0.367985280589%	8	2174	26	T2D_GENES_TANYA_LIPIDS	BIOCARTA_RACCYCD_PATHWAY
0.367985280589%	8	2174	22	T2D_GENES_TANYA_LIPIDS	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP
0.367985280589%	8	2174	21	T2D_GENES_TANYA_LIPIDS	PID_S1P_S1P1_PATHWAY
0.367985280589%	8	2174	21	T2D_GENES_TANYA_LIPIDS	HASLINGER_B_CLL_WITH_17P13_DELETION
0.367985280589%	8	2174	21	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CTLA4_PATHWAY
0.367985280589%	8	2174	18	T2D_GENES_TANYA_LIPIDS	REACTOME_GLUCURONIDATION
0.367985280589%	8	2174	18	T2D_GENES_TANYA_LIPIDS	REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS
0.367985280589%	8	2174	159	T2D_GENES_TANYA_LIPIDS	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
0.367985280589%	8	2174	157	T2D_GENES_TANYA_LIPIDS	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.367985280589%	8	2174	147	T2D_GENES_TANYA_LIPIDS	KAUFFMANN_DNA_REPLICATION_GENES
0.367985280589%	8	2174	147	T2D_GENES_TANYA_LIPIDS	BENPORATH_PROLIFERATION
0.367985280589%	8	2174	145	T2D_GENES_TANYA_LIPIDS	RODWELL_AGING_KIDNEY_DN
0.367985280589%	8	2174	142	T2D_GENES_TANYA_LIPIDS	XU_GH1_AUTOCRINE_TARGETS_DN
0.367985280589%	8	2174	140	T2D_GENES_TANYA_LIPIDS	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
0.367985280589%	8	2174	135	T2D_GENES_TANYA_LIPIDS	UDAYAKUMAR_MED1_TARGETS_UP
0.367985280589%	8	2174	131	T2D_GENES_TANYA_LIPIDS	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
0.367985280589%	8	2174	128	T2D_GENES_TANYA_LIPIDS	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
0.367985280589%	8	2174	127	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
0.367985280589%	8	2174	126	T2D_GENES_TANYA_LIPIDS	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
0.367985280589%	8	2174	113	T2D_GENES_TANYA_LIPIDS	TSENG_IRS1_TARGETS_UP
0.367985280589%	8	2174	113	T2D_GENES_TANYA_LIPIDS	RICKMAN_HEAD_AND_NECK_CANCER_C
0.367985280589%	8	2174	112	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_FGFR
0.367985280589%	8	2174	108	T2D_GENES_TANYA_LIPIDS	WESTON_VEGFA_TARGETS
0.367985280589%	8	2174	106	T2D_GENES_TANYA_LIPIDS	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
0.367985280589%	8	2174	100	T2D_GENES_TANYA_LIPIDS	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
0.367985280589%	8	2174	100	T2D_GENES_TANYA_LIPIDS	GAVIN_FOXP3_TARGETS_CLUSTER_P4
0.354609929078%	7	1974	98	Mendelian_Nancy_Cox	BRUINS_UVC_RESPONSE_MIDDLE
0.354609929078%	7	1974	91	Mendelian_Nancy_Cox	GAVIN_FOXP3_TARGETS_CLUSTER_P6
0.354609929078%	7	1974	90	Mendelian_Nancy_Cox	IVANOVSKA_MIR106B_TARGETS
0.354609929078%	7	1974	87	Mendelian_Nancy_Cox	REACTOME_MITOTIC_PROMETAPHASE
0.354609929078%	7	1974	86	Mendelian_Nancy_Cox	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
0.354609929078%	7	1974	82	Mendelian_Nancy_Cox	LEIN_MIDBRAIN_MARKERS
0.354609929078%	7	1974	80	Mendelian_Nancy_Cox	MORI_PRE_BI_LYMPHOCYTE_UP
0.354609929078%	7	1974	80	Mendelian_Nancy_Cox	FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.354609929078%	7	1974	80	Mendelian_Nancy_Cox	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
0.354609929078%	7	1974	79	Mendelian_Nancy_Cox	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
0.354609929078%	7	1974	78	Mendelian_Nancy_Cox	SANA_RESPONSE_TO_IFNG_UP
0.354609929078%	7	1974	78	Mendelian_Nancy_Cox	REACTOME_PLATELET_HOMEOSTASIS
0.354609929078%	7	1974	77	Mendelian_Nancy_Cox	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.354609929078%	7	1974	77	Mendelian_Nancy_Cox	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM
0.354609929078%	7	1974	77	Mendelian_Nancy_Cox	GROSS_HYPOXIA_VIA_HIF1A_UP
0.354609929078%	7	1974	76	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.354609929078%	7	1974	74	Mendelian_Nancy_Cox	JI_RESPONSE_TO_FSH_UP
0.354609929078%	7	1974	70	Mendelian_Nancy_Cox	VERNELL_RETINOBLASTOMA_PATHWAY_UP
0.354609929078%	7	1974	69	Mendelian_Nancy_Cox	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.354609929078%	7	1974	65	Mendelian_Nancy_Cox	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.354609929078%	7	1974	65	Mendelian_Nancy_Cox	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX
0.354609929078%	7	1974	65	Mendelian_Nancy_Cox	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS
0.354609929078%	7	1974	64	Mendelian_Nancy_Cox	RIZKI_TUMOR_INVASIVENESS_2D_DN
0.354609929078%	7	1974	64	Mendelian_Nancy_Cox	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
0.354609929078%	7	1974	64	Mendelian_Nancy_Cox	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
0.354609929078%	7	1974	64	Mendelian_Nancy_Cox	KEGG_RETINOL_METABOLISM
0.354609929078%	7	1974	63	Mendelian_Nancy_Cox	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.354609929078%	7	1974	62	Mendelian_Nancy_Cox	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP
0.354609929078%	7	1974	61	Mendelian_Nancy_Cox	MASSARWEH_RESPONSE_TO_ESTRADIOL
0.354609929078%	7	1974	60	Mendelian_Nancy_Cox	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE
0.354609929078%	7	1974	59	Mendelian_Nancy_Cox	ASTIER_INTEGRIN_SIGNALING
0.354609929078%	7	1974	58	Mendelian_Nancy_Cox	NAGASHIMA_NRG1_SIGNALING_DN
0.354609929078%	7	1974	58	Mendelian_Nancy_Cox	KOHOUTEK_CCNT2_TARGETS
0.354609929078%	7	1974	58	Mendelian_Nancy_Cox	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
0.354609929078%	7	1974	57	Mendelian_Nancy_Cox	LEE_EARLY_T_LYMPHOCYTE_DN
0.354609929078%	7	1974	57	Mendelian_Nancy_Cox	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
0.354609929078%	7	1974	56	Mendelian_Nancy_Cox	WORSCHECH_TUMOR_REJECTION_UP
0.354609929078%	7	1974	56	Mendelian_Nancy_Cox	LY_AGING_OLD_DN
0.354609929078%	7	1974	56	Mendelian_Nancy_Cox	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP
0.354609929078%	7	1974	56	Mendelian_Nancy_Cox	KEGG_VIBRIO_CHOLERAE_INFECTION
0.354609929078%	7	1974	56	Mendelian_Nancy_Cox	HENDRICKS_SMARCA4_TARGETS_UP
0.354609929078%	7	1974	56	Mendelian_Nancy_Cox	GYORFFY_DOXORUBICIN_RESISTANCE
0.354609929078%	7	1974	56	Mendelian_Nancy_Cox	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.354609929078%	7	1974	56	Mendelian_Nancy_Cox	GRADE_COLON_VS_RECTAL_CANCER_DN
0.354609929078%	7	1974	56	Mendelian_Nancy_Cox	GALE_APL_WITH_FLT3_MUTATED_UP
0.354609929078%	7	1974	55	Mendelian_Nancy_Cox	TIEN_INTESTINE_PROBIOTICS_6HR_UP
0.354609929078%	7	1974	55	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_4HR_UP
0.354609929078%	7	1974	54	Mendelian_Nancy_Cox	ZHOU_TNF_SIGNALING_30MIN
0.354609929078%	7	1974	54	Mendelian_Nancy_Cox	SESTO_RESPONSE_TO_UV_C2
0.354609929078%	7	1974	54	Mendelian_Nancy_Cox	FIGUEROA_AML_METHYLATION_CLUSTER_2_UP
0.354609929078%	7	1974	52	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN
0.354609929078%	7	1974	52	Mendelian_Nancy_Cox	VILIMAS_NOTCH1_TARGETS_UP
0.354609929078%	7	1974	51	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
0.354609929078%	7	1974	51	Mendelian_Nancy_Cox	LUI_THYROID_CANCER_CLUSTER_1
0.354609929078%	7	1974	51	Mendelian_Nancy_Cox	LEE_CALORIE_RESTRICTION_MUSCLE_DN
0.354609929078%	7	1974	51	Mendelian_Nancy_Cox	FRASOR_TAMOXIFEN_RESPONSE_UP
0.354609929078%	7	1974	51	Mendelian_Nancy_Cox	BYSTROEM_CORRELATED_WITH_IL5_UP
0.354609929078%	7	1974	50	Mendelian_Nancy_Cox	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
0.354609929078%	7	1974	50	Mendelian_Nancy_Cox	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN
0.354609929078%	7	1974	49	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8
0.354609929078%	7	1974	49	Mendelian_Nancy_Cox	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
0.354609929078%	7	1974	48	Mendelian_Nancy_Cox	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN
0.354609929078%	7	1974	48	Mendelian_Nancy_Cox	DELACROIX_RAR_TARGETS_UP
0.354609929078%	7	1974	48	Mendelian_Nancy_Cox	ABE_INNER_EAR
0.354609929078%	7	1974	47	Mendelian_Nancy_Cox	MCCLUNG_DELTA_FOSB_TARGETS_8WK
0.354609929078%	7	1974	46	Mendelian_Nancy_Cox	SAGIV_CD24_TARGETS_DN
0.354609929078%	7	1974	46	Mendelian_Nancy_Cox	PID_TNFPATHWAY
0.354609929078%	7	1974	46	Mendelian_Nancy_Cox	PARENT_MTOR_SIGNALING_DN
0.354609929078%	7	1974	46	Mendelian_Nancy_Cox	OSADA_ASCL1_TARGETS_UP
0.354609929078%	7	1974	46	Mendelian_Nancy_Cox	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN
0.354609929078%	7	1974	46	Mendelian_Nancy_Cox	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN
0.354609929078%	7	1974	46	Mendelian_Nancy_Cox	AMIT_EGF_RESPONSE_60_HELA
0.354609929078%	7	1974	45	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_CD1_UP
0.354609929078%	7	1974	45	Mendelian_Nancy_Cox	WANG_TARGETS_OF_MLL_CBP_FUSION_DN
0.354609929078%	7	1974	45	Mendelian_Nancy_Cox	ST_T_CELL_SIGNAL_TRANSDUCTION
0.354609929078%	7	1974	45	Mendelian_Nancy_Cox	SMITH_LIVER_CANCER
0.354609929078%	7	1974	45	Mendelian_Nancy_Cox	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN
0.354609929078%	7	1974	45	Mendelian_Nancy_Cox	REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER
0.354609929078%	7	1974	45	Mendelian_Nancy_Cox	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
0.354609929078%	7	1974	45	Mendelian_Nancy_Cox	CHANDRAN_METASTASIS_TOP50_DN
0.354609929078%	7	1974	44	Mendelian_Nancy_Cox	PARK_HSC_MARKERS
0.354609929078%	7	1974	44	Mendelian_Nancy_Cox	LUI_THYROID_CANCER_PAX8_PPARG_UP
0.354609929078%	7	1974	44	Mendelian_Nancy_Cox	LANDIS_BREAST_CANCER_PROGRESSION_UP
0.354609929078%	7	1974	44	Mendelian_Nancy_Cox	FAELT_B_CLL_WITH_VH3_21_UP
0.354609929078%	7	1974	43	Mendelian_Nancy_Cox	ULE_SPLICING_VIA_NOVA2
0.354609929078%	7	1974	43	Mendelian_Nancy_Cox	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS
0.354609929078%	7	1974	43	Mendelian_Nancy_Cox	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK
0.354609929078%	7	1974	43	Mendelian_Nancy_Cox	PID_THROMBIN_PAR1_PATHWAY
0.354609929078%	7	1974	43	Mendelian_Nancy_Cox	MILI_PSEUDOPODIA
0.354609929078%	7	1974	43	Mendelian_Nancy_Cox	IKEDA_MIR133_TARGETS_UP
0.354609929078%	7	1974	43	Mendelian_Nancy_Cox	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
0.354609929078%	7	1974	43	Mendelian_Nancy_Cox	FUJII_YBX1_TARGETS_UP
0.354609929078%	7	1974	42	Mendelian_Nancy_Cox	MIKKELSEN_ES_ICP_WITH_H3K27ME3
0.354609929078%	7	1974	41	Mendelian_Nancy_Cox	WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.354609929078%	7	1974	41	Mendelian_Nancy_Cox	RIZ_ERYTHROID_DIFFERENTIATION_HBZ
0.354609929078%	7	1974	41	Mendelian_Nancy_Cox	MIKKELSEN_ES_HCP_WITH_H3K27ME3
0.354609929078%	7	1974	41	Mendelian_Nancy_Cox	CROONQUIST_NRAS_SIGNALING_UP
0.354609929078%	7	1974	40	Mendelian_Nancy_Cox	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.354609929078%	7	1974	40	Mendelian_Nancy_Cox	TOMLINS_PROSTATE_CANCER_UP
0.354609929078%	7	1974	40	Mendelian_Nancy_Cox	LIAO_HAVE_SOX4_BINDING_SITES
0.354609929078%	7	1974	40	Mendelian_Nancy_Cox	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
0.354609929078%	7	1974	40	Mendelian_Nancy_Cox	ELLWOOD_MYC_TARGETS_DN
0.354609929078%	7	1974	40	Mendelian_Nancy_Cox	DORN_ADENOVIRUS_INFECTION_48HR_DN
0.354609929078%	7	1974	40	Mendelian_Nancy_Cox	CHANGOLKAR_H2AFY_TARGETS_DN
0.354609929078%	7	1974	39	Mendelian_Nancy_Cox	POTTI_PACLITAXEL_SENSITIVITY
0.354609929078%	7	1974	39	Mendelian_Nancy_Cox	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
0.354609929078%	7	1974	39	Mendelian_Nancy_Cox	HOFMANN_CELL_LYMPHOMA_DN
0.354609929078%	7	1974	39	Mendelian_Nancy_Cox	BROWNE_HCMV_INFECTION_2HR_UP
0.354609929078%	7	1974	38	Mendelian_Nancy_Cox	VARELA_ZMPSTE24_TARGETS_DN
0.354609929078%	7	1974	38	Mendelian_Nancy_Cox	SPIRA_SMOKERS_LUNG_CANCER_UP
0.354609929078%	7	1974	38	Mendelian_Nancy_Cox	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER
0.354609929078%	7	1974	38	Mendelian_Nancy_Cox	PENG_GLUTAMINE_DEPRIVATION_UP
0.354609929078%	7	1974	38	Mendelian_Nancy_Cox	ONGUSAHA_TP53_TARGETS
0.354609929078%	7	1974	38	Mendelian_Nancy_Cox	NAKAMURA_ADIPOGENESIS_LATE_DN
0.354609929078%	7	1974	37	Mendelian_Nancy_Cox	VALK_AML_WITH_CEBPA
0.354609929078%	7	1974	37	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN
0.354609929078%	7	1974	37	Mendelian_Nancy_Cox	BIOCARTA_GPCR_PATHWAY
0.354609929078%	7	1974	36	Mendelian_Nancy_Cox	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2
0.354609929078%	7	1974	36	Mendelian_Nancy_Cox	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN
0.354609929078%	7	1974	36	Mendelian_Nancy_Cox	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
0.354609929078%	7	1974	36	Mendelian_Nancy_Cox	LIU_CDX2_TARGETS_UP
0.354609929078%	7	1974	36	Mendelian_Nancy_Cox	JIANG_AGING_CEREBRAL_CORTEX_UP
0.354609929078%	7	1974	36	Mendelian_Nancy_Cox	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN
0.354609929078%	7	1974	36	Mendelian_Nancy_Cox	BIOCARTA_AGR_PATHWAY
0.354609929078%	7	1974	35	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15
0.354609929078%	7	1974	35	Mendelian_Nancy_Cox	VALK_AML_CLUSTER_9
0.354609929078%	7	1974	35	Mendelian_Nancy_Cox	SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES
0.354609929078%	7	1974	35	Mendelian_Nancy_Cox	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
0.354609929078%	7	1974	35	Mendelian_Nancy_Cox	LI_CISPLATIN_RESISTANCE_DN
0.354609929078%	7	1974	35	Mendelian_Nancy_Cox	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN
0.354609929078%	7	1974	35	Mendelian_Nancy_Cox	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP
0.354609929078%	7	1974	34	Mendelian_Nancy_Cox	YANG_BREAST_CANCER_ESR1_LASER_UP
0.354609929078%	7	1974	34	Mendelian_Nancy_Cox	WONG_IFNA2_RESISTANCE_DN
0.354609929078%	7	1974	34	Mendelian_Nancy_Cox	PID_IL8CXCR2_PATHWAY
0.354609929078%	7	1974	34	Mendelian_Nancy_Cox	PID_HDAC_CLASSII_PATHWAY
0.354609929078%	7	1974	33	Mendelian_Nancy_Cox	TANG_SENESCENCE_TP53_TARGETS_UP
0.354609929078%	7	1974	33	Mendelian_Nancy_Cox	HEIDENBLAD_AMPLICON_12P11_12_UP
0.354609929078%	7	1974	33	Mendelian_Nancy_Cox	BIOCARTA_IL1R_PATHWAY
0.354609929078%	7	1974	33	Mendelian_Nancy_Cox	BIOCARTA_DEATH_PATHWAY
0.354609929078%	7	1974	32	Mendelian_Nancy_Cox	TRACEY_RESISTANCE_TO_IFNA2_DN
0.354609929078%	7	1974	32	Mendelian_Nancy_Cox	ST_ERK1_ERK2_MAPK_PATHWAY
0.354609929078%	7	1974	32	Mendelian_Nancy_Cox	REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING
0.354609929078%	7	1974	31	Mendelian_Nancy_Cox	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP
0.354609929078%	7	1974	31	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE
0.354609929078%	7	1974	31	Mendelian_Nancy_Cox	REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX
0.354609929078%	7	1974	31	Mendelian_Nancy_Cox	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP
0.354609929078%	7	1974	31	Mendelian_Nancy_Cox	BIOCARTA_PYK2_PATHWAY
0.354609929078%	7	1974	30	Mendelian_Nancy_Cox	VALK_AML_CLUSTER_12
0.354609929078%	7	1974	30	Mendelian_Nancy_Cox	URS_ADIPOCYTE_DIFFERENTIATION_DN
0.354609929078%	7	1974	30	Mendelian_Nancy_Cox	REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX
0.354609929078%	7	1974	30	Mendelian_Nancy_Cox	PID_IGF1_PATHWAY
0.354609929078%	7	1974	30	Mendelian_Nancy_Cox	GILDEA_METASTASIS
0.354609929078%	7	1974	29	Mendelian_Nancy_Cox	TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN
0.354609929078%	7	1974	29	Mendelian_Nancy_Cox	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN
0.354609929078%	7	1974	29	Mendelian_Nancy_Cox	REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION
0.354609929078%	7	1974	29	Mendelian_Nancy_Cox	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
0.354609929078%	7	1974	29	Mendelian_Nancy_Cox	PID_REELINPATHWAY
0.354609929078%	7	1974	29	Mendelian_Nancy_Cox	NAKAYAMA_FGF2_TARGETS
0.354609929078%	7	1974	29	Mendelian_Nancy_Cox	MAYBURD_RESPONSE_TO_L663536_UP
0.354609929078%	7	1974	29	Mendelian_Nancy_Cox	BIOCARTA_INFLAM_PATHWAY
0.354609929078%	7	1974	29	Mendelian_Nancy_Cox	AIYAR_COBRA1_TARGETS_DN
0.354609929078%	7	1974	29	Mendelian_Nancy_Cox	ABE_VEGFA_TARGETS_30MIN
0.354609929078%	7	1974	28	Mendelian_Nancy_Cox	WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1
0.354609929078%	7	1974	28	Mendelian_Nancy_Cox	VALK_AML_CLUSTER_1
0.354609929078%	7	1974	28	Mendelian_Nancy_Cox	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN
0.354609929078%	7	1974	27	Mendelian_Nancy_Cox	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
0.354609929078%	7	1974	27	Mendelian_Nancy_Cox	LOPES_METHYLATED_IN_COLON_CANCER_UP
0.354609929078%	7	1974	27	Mendelian_Nancy_Cox	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN
0.354609929078%	7	1974	27	Mendelian_Nancy_Cox	BIOCARTA_EDG1_PATHWAY
0.354609929078%	7	1974	26	Mendelian_Nancy_Cox	PID_INTEGRIN_CS_PATHWAY
0.354609929078%	7	1974	26	Mendelian_Nancy_Cox	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE
0.354609929078%	7	1974	26	Mendelian_Nancy_Cox	BIOCARTA_WNT_PATHWAY
0.354609929078%	7	1974	25	Mendelian_Nancy_Cox	YANG_BREAST_CANCER_ESR1_DN
0.354609929078%	7	1974	25	Mendelian_Nancy_Cox	WANG_NFKB_TARGETS
0.354609929078%	7	1974	25	Mendelian_Nancy_Cox	PID_LYMPHANGIOGENESIS_PATHWAY
0.354609929078%	7	1974	25	Mendelian_Nancy_Cox	LU_TUMOR_ANGIOGENESIS_UP
0.354609929078%	7	1974	24	Mendelian_Nancy_Cox	SA_B_CELL_RECEPTOR_COMPLEXES
0.354609929078%	7	1974	24	Mendelian_Nancy_Cox	REACTOME_DOUBLE_STRAND_BREAK_REPAIR
0.354609929078%	7	1974	24	Mendelian_Nancy_Cox	REACTOME_CHOLESTEROL_BIOSYNTHESIS
0.354609929078%	7	1974	24	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23
0.354609929078%	7	1974	24	Mendelian_Nancy_Cox	MURATA_VIRULENCE_OF_H_PILORI
0.354609929078%	7	1974	23	Mendelian_Nancy_Cox	PID_NFKAPPABCANONICALPATHWAY
0.354609929078%	7	1974	23	Mendelian_Nancy_Cox	BIOCARTA_IGF1R_PATHWAY
0.354609929078%	7	1974	23	Mendelian_Nancy_Cox	BIOCARTA_CASPASE_PATHWAY
0.354609929078%	7	1974	22	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_SPIKED
0.354609929078%	7	1974	22	Mendelian_Nancy_Cox	ROY_WOUND_BLOOD_VESSEL_DN
0.354609929078%	7	1974	22	Mendelian_Nancy_Cox	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
0.354609929078%	7	1974	22	Mendelian_Nancy_Cox	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP
0.354609929078%	7	1974	22	Mendelian_Nancy_Cox	BIOCARTA_CERAMIDE_PATHWAY
0.354609929078%	7	1974	21	Mendelian_Nancy_Cox	STEGER_ADIPOGENESIS_UP
0.354609929078%	7	1974	21	Mendelian_Nancy_Cox	PID_ECADHERIN_KERATINOCYTE_PATHWAY
0.354609929078%	7	1974	21	Mendelian_Nancy_Cox	MURAKAMI_UV_RESPONSE_6HR_DN
0.354609929078%	7	1974	21	Mendelian_Nancy_Cox	BIOCARTA_TFF_PATHWAY
0.354609929078%	7	1974	21	Mendelian_Nancy_Cox	BIOCARTA_CTLA4_PATHWAY
0.354609929078%	7	1974	203	Mendelian_Nancy_Cox	REACTOME_INFLUENZA_LIFE_CYCLE
0.354609929078%	7	1974	20	Mendelian_Nancy_Cox	ST_WNT_CA2_CYCLIC_GMP_PATHWAY
0.354609929078%	7	1974	20	Mendelian_Nancy_Cox	REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING
0.354609929078%	7	1974	20	Mendelian_Nancy_Cox	REACTOME_ENOS_ACTIVATION_AND_REGULATION
0.354609929078%	7	1974	20	Mendelian_Nancy_Cox	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN
0.354609929078%	7	1974	20	Mendelian_Nancy_Cox	MURAKAMI_UV_RESPONSE_24HR
0.354609929078%	7	1974	19	Mendelian_Nancy_Cox	VERRECCHIA_RESPONSE_TO_TGFB1_C1
0.354609929078%	7	1974	19	Mendelian_Nancy_Cox	BIOCARTA_MTA3_PATHWAY
0.354609929078%	7	1974	19	Mendelian_Nancy_Cox	BIOCARTA_EPO_PATHWAY
0.354609929078%	7	1974	18	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR
0.354609929078%	7	1974	18	Mendelian_Nancy_Cox	REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS
0.354609929078%	7	1974	18	Mendelian_Nancy_Cox	BIOCARTA_SPRY_PATHWAY
0.354609929078%	7	1974	17	Mendelian_Nancy_Cox	THUM_MIR21_TARGETS_HEART_DISEASE_UP
0.354609929078%	7	1974	17	Mendelian_Nancy_Cox	REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION
0.354609929078%	7	1974	17	Mendelian_Nancy_Cox	BIOCARTA_LAIR_PATHWAY
0.354609929078%	7	1974	17	Mendelian_Nancy_Cox	BIOCARTA_IL7_PATHWAY
0.354609929078%	7	1974	16	Mendelian_Nancy_Cox	WU_HBX_TARGETS_2_DN
0.354609929078%	7	1974	16	Mendelian_Nancy_Cox	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI
0.354609929078%	7	1974	16	Mendelian_Nancy_Cox	MOOTHA_TCA
0.354609929078%	7	1974	16	Mendelian_Nancy_Cox	KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS
0.354609929078%	7	1974	16	Mendelian_Nancy_Cox	HE_PTEN_TARGETS_UP
0.354609929078%	7	1974	15	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL
0.354609929078%	7	1974	15	Mendelian_Nancy_Cox	REACTOME_SHC_MEDIATED_SIGNALLING
0.354609929078%	7	1974	15	Mendelian_Nancy_Cox	REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_
0.354609929078%	7	1974	15	Mendelian_Nancy_Cox	REACTOME_AMINE_DERIVED_HORMONES
0.354609929078%	7	1974	15	Mendelian_Nancy_Cox	CHANG_POU5F1_TARGETS_UP
0.354609929078%	7	1974	15	Mendelian_Nancy_Cox	BIOCARTA_LONGEVITY_PATHWAY
0.354609929078%	7	1974	15	Mendelian_Nancy_Cox	BIOCARTA_CD40_PATHWAY
0.354609929078%	7	1974	14	Mendelian_Nancy_Cox	ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR
0.354609929078%	7	1974	14	Mendelian_Nancy_Cox	REACTOME_SOS_MEDIATED_SIGNALLING
0.354609929078%	7	1974	13	Mendelian_Nancy_Cox	REACTOME_PURINE_SALVAGE
0.354609929078%	7	1974	13	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22
0.354609929078%	7	1974	13	Mendelian_Nancy_Cox	GERHOLD_RESPONSE_TO_TZD_DN
0.354609929078%	7	1974	13	Mendelian_Nancy_Cox	BIOCARTA_AHSP_PATHWAY
0.354609929078%	7	1974	12	Mendelian_Nancy_Cox	REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN
0.354609929078%	7	1974	12	Mendelian_Nancy_Cox	REACTOME_CS_DS_DEGRADATION
0.354609929078%	7	1974	12	Mendelian_Nancy_Cox	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS
0.354609929078%	7	1974	12	Mendelian_Nancy_Cox	DING_LUNG_CANCER_MUTATED_FREQUENTLY
0.354609929078%	7	1974	12	Mendelian_Nancy_Cox	BIOCARTA_FIBRINOLYSIS_PATHWAY
0.342172797263%	4	1169	99	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIM_MAMMARY_LUMINAL_MATURE_DN
0.342172797263%	4	1169	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
0.342172797263%	4	1169	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAVIN_FOXP3_TARGETS_CLUSTER_T7
0.342172797263%	4	1169	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
0.342172797263%	4	1169	97	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
0.342172797263%	4	1169	97	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KONG_E2F3_TARGETS
0.342172797263%	4	1169	97	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_MYC_AMPLIFICATION_TARGETS_DN
0.342172797263%	4	1169	96	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZAMORA_NOS2_TARGETS_DN
0.342172797263%	4	1169	95	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
0.342172797263%	4	1169	95	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOEBEKE_LYMPHOID_STEM_CELL_UP
0.342172797263%	4	1169	94	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES
0.342172797263%	4	1169	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WINTER_HYPOXIA_UP
0.342172797263%	4	1169	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
0.342172797263%	4	1169	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SYNTHESIS_OF_DNA
0.342172797263%	4	1169	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_MYCN_AMPLIFICATION_TARGETS_UP
0.342172797263%	4	1169	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BURTON_ADIPOGENESIS_9
0.342172797263%	4	1169	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
0.342172797263%	4	1169	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HILLION_HMGA1_TARGETS
0.342172797263%	4	1169	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BILANGES_SERUM_SENSITIVE_GENES
0.342172797263%	4	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP
0.342172797263%	4	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEIN_PONS_MARKERS
0.342172797263%	4	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_AGING_NEOCORTEX_UP
0.342172797263%	4	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
0.342172797263%	4	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MITOTIC_PROMETAPHASE
0.342172797263%	4	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
0.342172797263%	4	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOOTHA_VOXPHOS
0.342172797263%	4	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.342172797263%	4	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
0.342172797263%	4	1169	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LAIHO_COLORECTAL_CANCER_SERRATED_DN
0.342172797263%	4	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_AGING_CEREBELLUM_UP
0.342172797263%	4	1169	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEIN_MIDBRAIN_MARKERS
0.342172797263%	4	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.342172797263%	4	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MUNSHI_MULTIPLE_MYELOMA_UP
0.342172797263%	4	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GUO_HEX_TARGETS_UP
0.342172797263%	4	1169	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_AGING_NEOCORTEX_DN
0.342172797263%	4	1169	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.342172797263%	4	1169	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.342172797263%	4	1169	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
0.342172797263%	4	1169	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIU_COMMON_CANCER_GENES
0.342172797263%	4	1169	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_OPIOID_SIGNALLING
0.342172797263%	4	1169	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP
0.342172797263%	4	1169	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.342172797263%	4	1169	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE
0.342172797263%	4	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GROSS_HYPOXIA_VIA_HIF1A_UP
0.342172797263%	4	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FRIDMAN_SENESCENCE_UP
0.342172797263%	4	1169	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROSS_AML_WITH_AML1_ETO_FUSION
0.342172797263%	4	1169	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION
0.342172797263%	4	1169	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCCLUNG_COCAIN_REWARD_4WK
0.342172797263%	4	1169	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
0.342172797263%	4	1169	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
0.342172797263%	4	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANASSE_BCL2_TARGETS_DN
0.342172797263%	4	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
0.342172797263%	4	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FURUKAWA_DUSP6_TARGETS_PCI35_UP
0.342172797263%	4	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DER_IFN_ALPHA_RESPONSE_UP
0.342172797263%	4	1169	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_CHRONIC_MYELOID_LEUKEMIA
0.342172797263%	4	1169	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.342172797263%	4	1169	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
0.342172797263%	4	1169	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_MELANOMA
0.342172797263%	4	1169	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GU_PDEF_TARGETS_UP
0.342172797263%	4	1169	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GEORGANTAS_HSC_MARKERS
0.342172797263%	4	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RAGHAVACHARI_PLATELET_SPECIFIC_GENES
0.342172797263%	4	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_MEF_LCP_WITH_H3K27ME3
0.342172797263%	4	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_LONG_TERM_DEPRESSION
0.342172797263%	4	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SPHINGOLIPID_METABOLISM
0.342172797263%	4	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_P75NTRPATHWAY
0.342172797263%	4	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.342172797263%	4	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.342172797263%	4	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES
0.342172797263%	4	1169	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANHARANTA_UTERINE_FIBROID_DN
0.342172797263%	4	1169	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GENTILE_UV_LOW_DOSE_DN
0.342172797263%	4	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM
0.342172797263%	4	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
0.342172797263%	4	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_LIVER_CANCER_CIPROFIBRATE_DN
0.342172797263%	4	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_CD8TCRDOWNSTREAMPATHWAY
0.342172797263%	4	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_BCR_5PATHWAY
0.342172797263%	4	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_GLIOMA
0.342172797263%	4	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHANG_IMMORTALIZED_BY_HPV31_DN
0.342172797263%	4	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
0.342172797263%	4	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
0.342172797263%	4	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP
0.342172797263%	4	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
0.342172797263%	4	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_TRKRPATHWAY
0.342172797263%	4	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_COLORECTAL_CANCER
0.342172797263%	4	1169	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
0.342172797263%	4	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_FAK_PATHWAY
0.342172797263%	4	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_RNA_DEGRADATION
0.342172797263%	4	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DASU_IL6_SIGNALING_UP
0.342172797263%	4	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
0.342172797263%	4	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JI_RESPONSE_TO_FSH_DN
0.342172797263%	4	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_TXA2PATHWAY
0.342172797263%	4	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_EARLY_T_LYMPHOCYTE_DN
0.342172797263%	4	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP
0.342172797263%	4	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_VIBRIO_CHOLERAE_INFECTION
0.342172797263%	4	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOQUE_METHYLATED_IN_CANCER
0.342172797263%	4	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMIRNOV_RESPONSE_TO_IR_2HR_DN
0.342172797263%	4	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_IL2_1PATHWAY
0.342172797263%	4	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_FGF_PATHWAY
0.342172797263%	4	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN
0.342172797263%	4	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR
0.342172797263%	4	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHOU_TNF_SIGNALING_30MIN
0.342172797263%	4	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AUNG_GASTRIC_CANCER
0.342172797263%	4	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
0.342172797263%	4	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
0.342172797263%	4	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_PTP1BPATHWAY
0.342172797263%	4	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_CASPASE_PATHWAY
0.342172797263%	4	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ENDOMETRIAL_CANCER
0.342172797263%	4	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHANG_PROLIFERATING_VS_QUIESCENT
0.342172797263%	4	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE
0.342172797263%	4	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MORI_PLASMA_CELL_UP
0.342172797263%	4	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GUILLAUMOND_KLF10_TARGETS_UP
0.342172797263%	4	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PARK_APL_PATHOGENESIS_DN
0.342172797263%	4	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
0.342172797263%	4	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_FOXOPATHWAY
0.342172797263%	4	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.342172797263%	4	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OLSSON_E2F3_TARGETS_DN
0.342172797263%	4	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARCHINI_TRABECTEDIN_RESISTANCE_DN
0.342172797263%	4	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GERHOLD_ADIPOGENESIS_UP
0.342172797263%	4	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NADLER_OBESITY_DN
0.342172797263%	4	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN
0.342172797263%	4	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WOOD_EBV_EBNA1_TARGETS_DN
0.342172797263%	4	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	POTTI_DOCETAXEL_SENSITIVITY
0.342172797263%	4	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_IL6_7PATHWAY
0.342172797263%	4	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IRITANI_MAD1_TARGETS_DN
0.342172797263%	4	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.342172797263%	4	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYLAN_MULTIPLE_MYELOMA_C_UP
0.342172797263%	4	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SIG_BCR_SIGNALING_PATHWAY
0.342172797263%	4	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_TNFPATHWAY
0.342172797263%	4	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_AGING_MUSCLE_DN
0.342172797263%	4	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_KERATINOCYTE_PATHWAY
0.342172797263%	4	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ILK_PATHWAY
0.342172797263%	4	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_BIOPEPTIDES_PATHWAY
0.342172797263%	4	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZUCCHI_METASTASIS_DN
0.342172797263%	4	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MA_MYELOID_DIFFERENTIATION_DN
0.342172797263%	4	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAMURA_METASTASIS_MODEL_DN
0.342172797263%	4	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_CALORIE_RESTRICTION_MUSCLE_UP
0.342172797263%	4	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
0.342172797263%	4	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHENG_IL22_SIGNALING_DN
0.342172797263%	4	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
0.342172797263%	4	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_DN
0.342172797263%	4	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WENG_POR_TARGETS_LIVER_UP
0.342172797263%	4	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN
0.342172797263%	4	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KAMMINGA_SENESCENCE
0.342172797263%	4	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.342172797263%	4	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANASSE_BCL2_TARGETS_UP
0.342172797263%	4	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1
0.342172797263%	4	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STONER_ESOPHAGEAL_CARCINOGENESIS_UP
0.342172797263%	4	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_RET_PATHWAY
0.342172797263%	4	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_2HR_UP
0.342172797263%	4	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_FMLP_PATHWAY
0.342172797263%	4	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BILANGES_RAPAMYCIN_SENSITIVE_GENES
0.342172797263%	4	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YOKOE_CANCER_TESTIS_ANTIGENS
0.342172797263%	4	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_RAC1_REG_PATHWAY
0.342172797263%	4	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_IL2RB_PATHWAY
0.342172797263%	4	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_GA13_PATHWAY
0.342172797263%	4	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROLEF_GLIS3_TARGETS
0.342172797263%	4	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DOWNSTREAM_TCR_SIGNALING
0.342172797263%	4	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2
0.342172797263%	4	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_GPCR_PATHWAY
0.342172797263%	4	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANTVEER_BREAST_CANCER_BRCA1_UP
0.342172797263%	4	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
0.342172797263%	4	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_PI3KCIAKTPATHWAY
0.342172797263%	4	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HU_GENOTOXIC_DAMAGE_4HR
0.342172797263%	4	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT
0.342172797263%	4	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_IL2_PI3KPATHWAY
0.342172797263%	4	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_EPOPATHWAY
0.342172797263%	4	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP
0.342172797263%	4	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_NCADHERINPATHWAY
0.342172797263%	4	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZWANG_EGF_PERSISTENTLY_UP
0.342172797263%	4	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GROSS_ELK3_TARGETS_DN
0.342172797263%	4	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BAUS_TFF2_TARGETS_UP
0.342172797263%	4	1169	315	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
0.342172797263%	4	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_NEPHRIN_NEPH1_PATHWAY
0.342172797263%	4	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_PYK2_PATHWAY
0.342172797263%	4	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VALK_AML_CLUSTER_13
0.342172797263%	4	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_RESPONSE_TO_ANDROGEN_UP
0.342172797263%	4	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_S1P_S1P3_PATHWAY
0.342172797263%	4	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_REELINPATHWAY
0.342172797263%	4	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_VEGF_PATHWAY
0.342172797263%	4	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_INFLAM_PATHWAY
0.342172797263%	4	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ABE_VEGFA_TARGETS_30MIN
0.342172797263%	4	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_LIS1PATHWAY
0.342172797263%	4	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_MYOCYTE_AD_PATHWAY
0.342172797263%	4	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES
0.342172797263%	4	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM
0.342172797263%	4	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_EDG1_PATHWAY
0.342172797263%	4	1169	268	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	XU_GH1_AUTOCRINE_TARGETS_UP
0.342172797263%	4	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_VEGFR1_PATHWAY
0.342172797263%	4	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_INSULIN_GLUCOSE_PATHWAY
0.342172797263%	4	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES
0.342172797263%	4	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DEN_INTERACT_WITH_LCA5
0.342172797263%	4	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_RACCYCD_PATHWAY
0.342172797263%	4	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN
0.342172797263%	4	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CXCR4_PATHWAY
0.342172797263%	4	1169	238	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP
0.342172797263%	4	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_RESPONSE_TO_FORSKOLIN_UP
0.342172797263%	4	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_RAS_PATHWAY
0.342172797263%	4	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_PTDINS_PATHWAY
0.342172797263%	4	1169	228	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARKEY_RB1_ACUTE_LOF_DN
0.342172797263%	4	1169	226	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.342172797263%	4	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEBER_METHYLATED_ICP_IN_FIBROBLAST
0.342172797263%	4	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_S1P_S1P1_PATHWAY
0.342172797263%	4	1169	209	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_WT1_TARGETS_12HR_DN
0.342172797263%	4	1169	202	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FUJII_YBX1_TARGETS_DN
0.342172797263%	4	1169	201	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_MYC_AMPLIFICATION_TARGETS_UP
0.342172797263%	4	1169	200	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_DIFFERENTIATING_T_LYMPHOCYTE
0.342172797263%	4	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN
0.342172797263%	4	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP
0.342172797263%	4	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS
0.342172797263%	4	1169	188	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
0.342172797263%	4	1169	188	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.342172797263%	4	1169	185	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_HUNTINGTONS_DISEASE
0.342172797263%	4	1169	184	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WU_CELL_MIGRATION
0.342172797263%	4	1169	184	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS
0.342172797263%	4	1169	182	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.342172797263%	4	1169	181	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP
0.342172797263%	4	1169	176	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
0.342172797263%	4	1169	170	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.342172797263%	4	1169	167	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
0.342172797263%	4	1169	166	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CAIRO_LIVER_DEVELOPMENT_UP
0.342172797263%	4	1169	164	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMIT_EGF_RESPONSE_480_HELA
0.342172797263%	4	1169	162	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WINNEPENNINCKX_MELANOMA_METASTASIS_UP
0.342172797263%	4	1169	162	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
0.342172797263%	4	1169	160	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_6HR_DN
0.342172797263%	4	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CDMAC_PATHWAY
0.342172797263%	4	1169	159	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
0.342172797263%	4	1169	156	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FOSTER_TOLERANT_MACROPHAGE_UP
0.342172797263%	4	1169	153	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAZARD_UV_RESPONSE_CLUSTER_G6
0.342172797263%	4	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL
0.342172797263%	4	1169	148	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_24HR_UP
0.342172797263%	4	1169	146	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PECE_MAMMARY_STEM_CELL_DN
0.342172797263%	4	1169	145	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RODWELL_AGING_KIDNEY_DN
0.342172797263%	4	1169	143	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DANG_MYC_TARGETS_UP
0.342172797263%	4	1169	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_ES_LCP_WITH_H3K4ME3
0.342172797263%	4	1169	141	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
0.342172797263%	4	1169	141	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.342172797263%	4	1169	141	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KAAB_FAILED_HEART_ATRIUM_DN
0.342172797263%	4	1169	141	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP
0.342172797263%	4	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEBER_METHYLATED_ICP_IN_SPERM_DN
0.342172797263%	4	1169	139	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ODONNELL_TFRC_TARGETS_DN
0.342172797263%	4	1169	139	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
0.342172797263%	4	1169	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
0.342172797263%	4	1169	135	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	UDAYAKUMAR_MED1_TARGETS_UP
0.342172797263%	4	1169	135	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_OXIDATIVE_PHOSPHORYLATION
0.342172797263%	4	1169	134	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	POOLA_INVASIVE_BREAST_CANCER_DN
0.342172797263%	4	1169	132	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
0.342172797263%	4	1169	132	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS
0.342172797263%	4	1169	132	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
0.342172797263%	4	1169	131	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
0.342172797263%	4	1169	129	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_WT1_TARGETS_8HR_DN
0.342172797263%	4	1169	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_MEF_LCP_WITH_H3K4ME3
0.342172797263%	4	1169	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.342172797263%	4	1169	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_CELL_CYCLE
0.342172797263%	4	1169	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
0.342172797263%	4	1169	127	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
0.342172797263%	4	1169	127	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.342172797263%	4	1169	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
0.342172797263%	4	1169	125	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_HIV_LIFE_CYCLE
0.342172797263%	4	1169	124	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAIRKEE_TERT_TARGETS_DN
0.342172797263%	4	1169	123	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAZARD_RESPONSE_TO_UV_SCC_UP
0.342172797263%	4	1169	120	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHU_CMV_ALL_UP
0.342172797263%	4	1169	120	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
0.342172797263%	4	1169	120	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CELL_CELL_COMMUNICATION
0.342172797263%	4	1169	120	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
0.342172797263%	4	1169	120	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHEBOTAEV_GR_TARGETS_DN
0.342172797263%	4	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_TRKA_PATHWAY
0.342172797263%	4	1169	118	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_NEURAL_CREST_STEM_CELL_DN
0.342172797263%	4	1169	118	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
0.342172797263%	4	1169	117	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.342172797263%	4	1169	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
0.342172797263%	4	1169	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MATTIOLI_MGUS_VS_PCL
0.342172797263%	4	1169	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.342172797263%	4	1169	115	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOELZEL_NF1_TARGETS_DN
0.342172797263%	4	1169	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN
0.342172797263%	4	1169	113	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_RHO_GTPASES
0.342172797263%	4	1169	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_FGFR
0.342172797263%	4	1169	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DNA_REPAIR
0.342172797263%	4	1169	111	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.342172797263%	4	1169	110	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.342172797263%	4	1169	110	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHENG_IMPRINTED_BY_ESTRADIOL
0.342172797263%	4	1169	109	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_S_PHASE
0.342172797263%	4	1169	109	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
0.342172797263%	4	1169	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
0.342172797263%	4	1169	105	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZWANG_EGF_INTERVAL_UP
0.342172797263%	4	1169	105	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMUNDSON_GENOTOXIC_SIGNATURE
0.342172797263%	4	1169	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN
0.342172797263%	4	1169	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEIN_CHOROID_PLEXUS_MARKERS
0.342172797263%	4	1169	102	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DER_IFN_BETA_RESPONSE_UP
0.342172797263%	4	1169	102	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.342172797263%	4	1169	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
0.342172797263%	4	1169	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KOBAYASHI_EGFR_SIGNALING_24HR_UP
0.342172797263%	4	1169	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_10HR_UP
0.342172797263%	4	1169	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
0.342172797263%	4	1169	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BENPORATH_ES_CORE_NINE_CORRELATED
0.342172797263%	4	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM
0.340909090909%	12	3520	99	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIM_MAMMARY_LUMINAL_MATURE_DN
0.340909090909%	12	3520	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HAHTOLA_SEZARY_SYNDROM_UP
0.340909090909%	12	3520	97	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP
0.340909090909%	12	3520	96	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZAMORA_NOS2_TARGETS_DN
0.340909090909%	12	3520	94	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5
0.340909090909%	12	3520	93	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHU_CMV_24_HR_UP
0.340909090909%	12	3520	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.340909090909%	12	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.340909090909%	12	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
0.340909090909%	12	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
0.340909090909%	12	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
0.340909090909%	12	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
0.340909090909%	12	3520	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE
0.340909090909%	12	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.340909090909%	12	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.340909090909%	12	3520	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
0.340909090909%	12	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HARRIS_HYPOXIA
0.340909090909%	12	3520	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_UNFOLDED_PROTEIN_RESPONSE
0.340909090909%	12	3520	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_AGING_NEOCORTEX_DN
0.340909090909%	12	3520	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.340909090909%	12	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
0.340909090909%	12	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SANA_RESPONSE_TO_IFNG_UP
0.340909090909%	12	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN
0.340909090909%	12	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIN_APC_TARGETS
0.340909090909%	12	3520	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
0.340909090909%	12	3520	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PEART_HDAC_PROLIFERATION_CLUSTER_DN
0.340909090909%	12	3520	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.340909090909%	12	3520	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JAIN_NFKB_SIGNALING
0.340909090909%	12	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANASSE_BCL2_TARGETS_DN
0.340909090909%	12	3520	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
0.340909090909%	12	3520	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1
0.340909090909%	12	3520	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DER_IFN_GAMMA_RESPONSE_UP
0.340909090909%	12	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PHASE_II_CONJUGATION
0.340909090909%	12	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS
0.340909090909%	12	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROSS_AML_OF_FAB_M7_TYPE
0.340909090909%	12	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
0.340909090909%	12	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_TCR_PATHWAY
0.340909090909%	12	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_LYSOPHOSPHOLIPID_PATHWAY
0.340909090909%	12	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX
0.340909090909%	12	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C
0.340909090909%	12	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
0.340909090909%	12	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_EARLY_T_LYMPHOCYTE_DN
0.340909090909%	12	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
0.340909090909%	12	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YU_MYC_TARGETS_DN
0.340909090909%	12	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_DRUG_METABOLISM_OTHER_ENZYMES
0.340909090909%	12	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION
0.340909090909%	12	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OLSSON_E2F3_TARGETS_DN
0.340909090909%	12	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GERHOLD_ADIPOGENESIS_UP
0.340909090909%	12	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_TCR_PATHWAY
0.340909090909%	12	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_TYROSINE_METABOLISM
0.340909090909%	12	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_7P22_AMPLICON
0.340909090909%	12	3520	245	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KONDO_EZH2_TARGETS
0.340909090909%	12	3520	193	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP
0.340909090909%	12	3520	193	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOHANKUMAR_TLX1_TARGETS_DN
0.340909090909%	12	3520	181	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
0.340909090909%	12	3520	177	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
0.340909090909%	12	3520	171	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
0.340909090909%	12	3520	165	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
0.340909090909%	12	3520	164	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
0.340909090909%	12	3520	160	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
0.340909090909%	12	3520	159	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
0.340909090909%	12	3520	155	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_JAK_STAT_SIGNALING_PATHWAY
0.340909090909%	12	3520	151	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IGLESIAS_E2F_TARGETS_UP
0.340909090909%	12	3520	141	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SABATES_COLORECTAL_ADENOMA_UP
0.340909090909%	12	3520	141	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
0.340909090909%	12	3520	139	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
0.340909090909%	12	3520	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
0.340909090909%	12	3520	132	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
0.340909090909%	12	3520	129	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_WT1_TARGETS_8HR_DN
0.340909090909%	12	3520	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHU_CMV_ALL_DN
0.340909090909%	12	3520	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	POTTI_TOPOTECAN_SENSITIVITY
0.340909090909%	12	3520	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SANSOM_APC_TARGETS_UP
0.340909090909%	12	3520	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
0.340909090909%	12	3520	123	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOOI_ST7_TARGETS_DN
0.340909090909%	12	3520	123	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAZARD_RESPONSE_TO_UV_SCC_UP
0.340909090909%	12	3520	123	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAZARD_RESPONSE_TO_UV_SCC_DN
0.340909090909%	12	3520	122	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TOOKER_GEMCITABINE_RESISTANCE_DN
0.340909090909%	12	3520	122	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_PDGF
0.340909090909%	12	3520	120	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CELL_CELL_COMMUNICATION
0.340909090909%	12	3520	120	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
0.340909090909%	12	3520	118	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
0.340909090909%	12	3520	117	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.340909090909%	12	3520	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_G1_S_TRANSITION
0.340909090909%	12	3520	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DNA_REPAIR
0.340909090909%	12	3520	109	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.340909090909%	12	3520	109	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
0.340909090909%	12	3520	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LABBE_TGFB1_TARGETS_DN
0.340909090909%	12	3520	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_3
0.340909090909%	12	3520	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.340909090909%	12	3520	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
0.326264274062%	2	613	99	T2D_GENES_TANYA_BIOMARKER	LIM_MAMMARY_LUMINAL_MATURE_DN
0.326264274062%	2	613	98	T2D_GENES_TANYA_BIOMARKER	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
0.326264274062%	2	613	98	T2D_GENES_TANYA_BIOMARKER	NIELSEN_GIST
0.326264274062%	2	613	98	T2D_GENES_TANYA_BIOMARKER	KEGG_PYRIMIDINE_METABOLISM
0.326264274062%	2	613	97	T2D_GENES_TANYA_BIOMARKER	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
0.326264274062%	2	613	95	T2D_GENES_TANYA_BIOMARKER	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.326264274062%	2	613	94	T2D_GENES_TANYA_BIOMARKER	GAVIN_FOXP3_TARGETS_CLUSTER_T4
0.326264274062%	2	613	93	T2D_GENES_TANYA_BIOMARKER	REACTOME_REGULATION_OF_INSULIN_SECRETION
0.326264274062%	2	613	93	T2D_GENES_TANYA_BIOMARKER	REACTOME_ACTIVATED_TLR4_SIGNALLING
0.326264274062%	2	613	92	T2D_GENES_TANYA_BIOMARKER	BURTON_ADIPOGENESIS_9
0.326264274062%	2	613	91	T2D_GENES_TANYA_BIOMARKER	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
0.326264274062%	2	613	91	T2D_GENES_TANYA_BIOMARKER	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION
0.326264274062%	2	613	91	T2D_GENES_TANYA_BIOMARKER	GAVIN_FOXP3_TARGETS_CLUSTER_P6
0.326264274062%	2	613	91	T2D_GENES_TANYA_BIOMARKER	ELVIDGE_HIF1A_TARGETS_DN
0.326264274062%	2	613	90	T2D_GENES_TANYA_BIOMARKER	SASSON_RESPONSE_TO_FORSKOLIN_UP
0.326264274062%	2	613	90	T2D_GENES_TANYA_BIOMARKER	MORI_IMMATURE_B_LYMPHOCYTE_DN
0.326264274062%	2	613	90	T2D_GENES_TANYA_BIOMARKER	GAVIN_FOXP3_TARGETS_CLUSTER_P7
0.326264274062%	2	613	9	T2D_GENES_TANYA_BIOMARKER	NOUSHMEHR_GBM_SOMATIC_MUTATED
0.326264274062%	2	613	89	T2D_GENES_TANYA_BIOMARKER	VANLOO_SP3_TARGETS_DN
0.326264274062%	2	613	89	T2D_GENES_TANYA_BIOMARKER	RICKMAN_HEAD_AND_NECK_CANCER_E
0.326264274062%	2	613	89	T2D_GENES_TANYA_BIOMARKER	REACTOME_RNA_POL_I_TRANSCRIPTION
0.326264274062%	2	613	89	T2D_GENES_TANYA_BIOMARKER	LI_DCP2_BOUND_MRNA
0.326264274062%	2	613	89	T2D_GENES_TANYA_BIOMARKER	KANG_IMMORTALIZED_BY_TERT_UP
0.326264274062%	2	613	89	T2D_GENES_TANYA_BIOMARKER	BOYLAN_MULTIPLE_MYELOMA_D_UP
0.326264274062%	2	613	88	T2D_GENES_TANYA_BIOMARKER	TIEN_INTESTINE_PROBIOTICS_2HR_DN
0.326264274062%	2	613	88	T2D_GENES_TANYA_BIOMARKER	KEGG_RIBOSOME
0.326264274062%	2	613	88	T2D_GENES_TANYA_BIOMARKER	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.326264274062%	2	613	87	T2D_GENES_TANYA_BIOMARKER	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
0.326264274062%	2	613	87	T2D_GENES_TANYA_BIOMARKER	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
0.326264274062%	2	613	87	T2D_GENES_TANYA_BIOMARKER	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
0.326264274062%	2	613	87	T2D_GENES_TANYA_BIOMARKER	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.326264274062%	2	613	87	T2D_GENES_TANYA_BIOMARKER	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.326264274062%	2	613	86	T2D_GENES_TANYA_BIOMARKER	TAKAO_RESPONSE_TO_UVB_RADIATION_UP
0.326264274062%	2	613	86	T2D_GENES_TANYA_BIOMARKER	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.326264274062%	2	613	86	T2D_GENES_TANYA_BIOMARKER	BAELDE_DIABETIC_NEPHROPATHY_UP
0.326264274062%	2	613	84	T2D_GENES_TANYA_BIOMARKER	RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.326264274062%	2	613	84	T2D_GENES_TANYA_BIOMARKER	PID_CMYB_PATHWAY
0.326264274062%	2	613	84	T2D_GENES_TANYA_BIOMARKER	KEGG_SMALL_CELL_LUNG_CANCER
0.326264274062%	2	613	84	T2D_GENES_TANYA_BIOMARKER	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
0.326264274062%	2	613	83	T2D_GENES_TANYA_BIOMARKER	SANA_TNF_SIGNALING_UP
0.326264274062%	2	613	83	T2D_GENES_TANYA_BIOMARKER	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
0.326264274062%	2	613	83	T2D_GENES_TANYA_BIOMARKER	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
0.326264274062%	2	613	83	T2D_GENES_TANYA_BIOMARKER	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
0.326264274062%	2	613	83	T2D_GENES_TANYA_BIOMARKER	JIANG_HYPOXIA_CANCER
0.326264274062%	2	613	82	T2D_GENES_TANYA_BIOMARKER	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
0.326264274062%	2	613	82	T2D_GENES_TANYA_BIOMARKER	PID_REG_GR_PATHWAY
0.326264274062%	2	613	82	T2D_GENES_TANYA_BIOMARKER	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
0.326264274062%	2	613	81	T2D_GENES_TANYA_BIOMARKER	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
0.326264274062%	2	613	81	T2D_GENES_TANYA_BIOMARKER	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
0.326264274062%	2	613	81	T2D_GENES_TANYA_BIOMARKER	REACTOME_MITOTIC_G2_G2_M_PHASES
0.326264274062%	2	613	81	T2D_GENES_TANYA_BIOMARKER	MUNSHI_MULTIPLE_MYELOMA_UP
0.326264274062%	2	613	81	T2D_GENES_TANYA_BIOMARKER	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
0.326264274062%	2	613	81	T2D_GENES_TANYA_BIOMARKER	HARRIS_HYPOXIA
0.326264274062%	2	613	80	T2D_GENES_TANYA_BIOMARKER	MORI_PRE_BI_LYMPHOCYTE_UP
0.326264274062%	2	613	80	T2D_GENES_TANYA_BIOMARKER	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.326264274062%	2	613	79	T2D_GENES_TANYA_BIOMARKER	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
0.326264274062%	2	613	79	T2D_GENES_TANYA_BIOMARKER	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT
0.326264274062%	2	613	79	T2D_GENES_TANYA_BIOMARKER	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.326264274062%	2	613	78	T2D_GENES_TANYA_BIOMARKER	SANA_RESPONSE_TO_IFNG_UP
0.326264274062%	2	613	78	T2D_GENES_TANYA_BIOMARKER	REACTOME_CELL_JUNCTION_ORGANIZATION
0.326264274062%	2	613	78	T2D_GENES_TANYA_BIOMARKER	RADMACHER_AML_PROGNOSIS
0.326264274062%	2	613	78	T2D_GENES_TANYA_BIOMARKER	KEGG_PEROXISOME
0.326264274062%	2	613	78	T2D_GENES_TANYA_BIOMARKER	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
0.326264274062%	2	613	78	T2D_GENES_TANYA_BIOMARKER	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP
0.326264274062%	2	613	77	T2D_GENES_TANYA_BIOMARKER	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
0.326264274062%	2	613	77	T2D_GENES_TANYA_BIOMARKER	CHEBOTAEV_GR_TARGETS_UP
0.326264274062%	2	613	76	T2D_GENES_TANYA_BIOMARKER	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
0.326264274062%	2	613	76	T2D_GENES_TANYA_BIOMARKER	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.326264274062%	2	613	76	T2D_GENES_TANYA_BIOMARKER	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
0.326264274062%	2	613	75	T2D_GENES_TANYA_BIOMARKER	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
0.326264274062%	2	613	75	T2D_GENES_TANYA_BIOMARKER	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.326264274062%	2	613	74	T2D_GENES_TANYA_BIOMARKER	URS_ADIPOCYTE_DIFFERENTIATION_UP
0.326264274062%	2	613	74	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
0.326264274062%	2	613	74	T2D_GENES_TANYA_BIOMARKER	POTTI_ADRIAMYCIN_SENSITIVITY
0.326264274062%	2	613	74	T2D_GENES_TANYA_BIOMARKER	OUILLETTE_CLL_13Q14_DELETION_UP
0.326264274062%	2	613	74	T2D_GENES_TANYA_BIOMARKER	LEIN_OLIGODENDROCYTE_MARKERS
0.326264274062%	2	613	74	T2D_GENES_TANYA_BIOMARKER	LEE_LIVER_CANCER_DENA_DN
0.326264274062%	2	613	74	T2D_GENES_TANYA_BIOMARKER	FURUKAWA_DUSP6_TARGETS_PCI35_DN
0.326264274062%	2	613	74	T2D_GENES_TANYA_BIOMARKER	DER_IFN_ALPHA_RESPONSE_UP
0.326264274062%	2	613	73	T2D_GENES_TANYA_BIOMARKER	KEGG_CHRONIC_MYELOID_LEUKEMIA
0.326264274062%	2	613	73	T2D_GENES_TANYA_BIOMARKER	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.326264274062%	2	613	72	T2D_GENES_TANYA_BIOMARKER	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
0.326264274062%	2	613	72	T2D_GENES_TANYA_BIOMARKER	KEGG_LEISHMANIA_INFECTION
0.326264274062%	2	613	72	T2D_GENES_TANYA_BIOMARKER	HUANG_GATA2_TARGETS_DN
0.326264274062%	2	613	72	T2D_GENES_TANYA_BIOMARKER	DOANE_BREAST_CANCER_CLASSES_UP
0.326264274062%	2	613	72	T2D_GENES_TANYA_BIOMARKER	CROONQUIST_NRAS_SIGNALING_DN
0.326264274062%	2	613	71	T2D_GENES_TANYA_BIOMARKER	REACTOME_PI3K_CASCADE
0.326264274062%	2	613	71	T2D_GENES_TANYA_BIOMARKER	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.326264274062%	2	613	71	T2D_GENES_TANYA_BIOMARKER	GEORGANTAS_HSC_MARKERS
0.326264274062%	2	613	71	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_6HR_UP
0.326264274062%	2	613	70	T2D_GENES_TANYA_BIOMARKER	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
0.326264274062%	2	613	70	T2D_GENES_TANYA_BIOMARKER	VERNELL_RETINOBLASTOMA_PATHWAY_UP
0.326264274062%	2	613	70	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_NOTCH1
0.326264274062%	2	613	70	T2D_GENES_TANYA_BIOMARKER	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS
0.326264274062%	2	613	70	T2D_GENES_TANYA_BIOMARKER	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.326264274062%	2	613	70	T2D_GENES_TANYA_BIOMARKER	RAGHAVACHARI_PLATELET_SPECIFIC_GENES
0.326264274062%	2	613	70	T2D_GENES_TANYA_BIOMARKER	PID_CDC42_PATHWAY
0.326264274062%	2	613	70	T2D_GENES_TANYA_BIOMARKER	LANDIS_BREAST_CANCER_PROGRESSION_DN
0.326264274062%	2	613	7	T2D_GENES_TANYA_BIOMARKER	PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN
0.326264274062%	2	613	7	T2D_GENES_TANYA_BIOMARKER	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN
0.326264274062%	2	613	7	T2D_GENES_TANYA_BIOMARKER	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.326264274062%	2	613	69	T2D_GENES_TANYA_BIOMARKER	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
0.326264274062%	2	613	69	T2D_GENES_TANYA_BIOMARKER	RHODES_UNDIFFERENTIATED_CANCER
0.326264274062%	2	613	69	T2D_GENES_TANYA_BIOMARKER	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.326264274062%	2	613	69	T2D_GENES_TANYA_BIOMARKER	KEGG_P53_SIGNALING_PATHWAY
0.326264274062%	2	613	69	T2D_GENES_TANYA_BIOMARKER	HUANG_DASATINIB_RESISTANCE_DN
0.326264274062%	2	613	69	T2D_GENES_TANYA_BIOMARKER	HOWLIN_PUBERTAL_MAMMARY_GLAND
0.326264274062%	2	613	68	T2D_GENES_TANYA_BIOMARKER	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.326264274062%	2	613	67	T2D_GENES_TANYA_BIOMARKER	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
0.326264274062%	2	613	67	T2D_GENES_TANYA_BIOMARKER	LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.326264274062%	2	613	67	T2D_GENES_TANYA_BIOMARKER	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.326264274062%	2	613	67	T2D_GENES_TANYA_BIOMARKER	ELVIDGE_HIF1A_TARGETS_UP
0.326264274062%	2	613	66	T2D_GENES_TANYA_BIOMARKER	SWEET_KRAS_TARGETS_DN
0.326264274062%	2	613	66	T2D_GENES_TANYA_BIOMARKER	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
0.326264274062%	2	613	66	T2D_GENES_TANYA_BIOMARKER	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES
0.326264274062%	2	613	66	T2D_GENES_TANYA_BIOMARKER	PID_TCR_PATHWAY
0.326264274062%	2	613	66	T2D_GENES_TANYA_BIOMARKER	PID_INTEGRIN1_PATHWAY
0.326264274062%	2	613	66	T2D_GENES_TANYA_BIOMARKER	PID_HDAC_CLASSI_PATHWAY
0.326264274062%	2	613	66	T2D_GENES_TANYA_BIOMARKER	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN
0.326264274062%	2	613	66	T2D_GENES_TANYA_BIOMARKER	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP
0.326264274062%	2	613	66	T2D_GENES_TANYA_BIOMARKER	BRUNO_HEMATOPOIESIS
0.326264274062%	2	613	65	T2D_GENES_TANYA_BIOMARKER	ST_FAS_SIGNALING_PATHWAY
0.326264274062%	2	613	65	T2D_GENES_TANYA_BIOMARKER	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
0.326264274062%	2	613	65	T2D_GENES_TANYA_BIOMARKER	PID_ERA_GENOMIC_PATHWAY
0.326264274062%	2	613	65	T2D_GENES_TANYA_BIOMARKER	PID_BCR_5PATHWAY
0.326264274062%	2	613	65	T2D_GENES_TANYA_BIOMARKER	LEE_LIVER_CANCER_ACOX1_DN
0.326264274062%	2	613	65	T2D_GENES_TANYA_BIOMARKER	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP
0.326264274062%	2	613	65	T2D_GENES_TANYA_BIOMARKER	CHANG_IMMORTALIZED_BY_HPV31_DN
0.326264274062%	2	613	65	T2D_GENES_TANYA_BIOMARKER	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP
0.326264274062%	2	613	65	T2D_GENES_TANYA_BIOMARKER	AMIT_SERUM_RESPONSE_120_MCF10A
0.326264274062%	2	613	64	T2D_GENES_TANYA_BIOMARKER	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
0.326264274062%	2	613	64	T2D_GENES_TANYA_BIOMARKER	REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE
0.326264274062%	2	613	64	T2D_GENES_TANYA_BIOMARKER	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
0.326264274062%	2	613	63	T2D_GENES_TANYA_BIOMARKER	PID_ENDOTHELINPATHWAY
0.326264274062%	2	613	63	T2D_GENES_TANYA_BIOMARKER	PHONG_TNF_TARGETS_UP
0.326264274062%	2	613	63	T2D_GENES_TANYA_BIOMARKER	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
0.326264274062%	2	613	62	T2D_GENES_TANYA_BIOMARKER	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.326264274062%	2	613	62	T2D_GENES_TANYA_BIOMARKER	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP
0.326264274062%	2	613	61	T2D_GENES_TANYA_BIOMARKER	ZWANG_EGF_PERSISTENTLY_DN
0.326264274062%	2	613	61	T2D_GENES_TANYA_BIOMARKER	REN_BOUND_BY_E2F
0.326264274062%	2	613	61	T2D_GENES_TANYA_BIOMARKER	REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS
0.326264274062%	2	613	61	T2D_GENES_TANYA_BIOMARKER	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
0.326264274062%	2	613	61	T2D_GENES_TANYA_BIOMARKER	PID_AR_PATHWAY
0.326264274062%	2	613	61	T2D_GENES_TANYA_BIOMARKER	MASSARWEH_RESPONSE_TO_ESTRADIOL
0.326264274062%	2	613	61	T2D_GENES_TANYA_BIOMARKER	GENTILE_RESPONSE_CLUSTER_D3
0.326264274062%	2	613	60	T2D_GENES_TANYA_BIOMARKER	OUILLETTE_CLL_13Q14_DELETION_DN
0.326264274062%	2	613	60	T2D_GENES_TANYA_BIOMARKER	LEE_LIVER_CANCER_DENA_UP
0.326264274062%	2	613	60	T2D_GENES_TANYA_BIOMARKER	LEE_LIVER_CANCER_CIPROFIBRATE_UP
0.326264274062%	2	613	60	T2D_GENES_TANYA_BIOMARKER	KEGG_ACUTE_MYELOID_LEUKEMIA
0.326264274062%	2	613	60	T2D_GENES_TANYA_BIOMARKER	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN
0.326264274062%	2	613	59	T2D_GENES_TANYA_BIOMARKER	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
0.326264274062%	2	613	59	T2D_GENES_TANYA_BIOMARKER	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
0.326264274062%	2	613	59	T2D_GENES_TANYA_BIOMARKER	KEGG_RNA_DEGRADATION
0.326264274062%	2	613	59	T2D_GENES_TANYA_BIOMARKER	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
0.326264274062%	2	613	59	T2D_GENES_TANYA_BIOMARKER	ASTIER_INTEGRIN_SIGNALING
0.326264274062%	2	613	58	T2D_GENES_TANYA_BIOMARKER	WAKASUGI_HAVE_ZNF143_BINDING_SITES
0.326264274062%	2	613	58	T2D_GENES_TANYA_BIOMARKER	KOHOUTEK_CCNT2_TARGETS
0.326264274062%	2	613	58	T2D_GENES_TANYA_BIOMARKER	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
0.326264274062%	2	613	57	T2D_GENES_TANYA_BIOMARKER	MCCLUNG_CREB1_TARGETS_DN
0.326264274062%	2	613	57	T2D_GENES_TANYA_BIOMARKER	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP
0.326264274062%	2	613	57	T2D_GENES_TANYA_BIOMARKER	DELASERNA_MYOD_TARGETS_DN
0.326264274062%	2	613	57	T2D_GENES_TANYA_BIOMARKER	BURTON_ADIPOGENESIS_11
0.326264274062%	2	613	57	T2D_GENES_TANYA_BIOMARKER	AMIT_SERUM_RESPONSE_60_MCF10A
0.326264274062%	2	613	57	T2D_GENES_TANYA_BIOMARKER	AMIT_SERUM_RESPONSE_240_MCF10A
0.326264274062%	2	613	56	T2D_GENES_TANYA_BIOMARKER	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP
0.326264274062%	2	613	56	T2D_GENES_TANYA_BIOMARKER	LEE_LIVER_CANCER_MYC_E2F1_UP
0.326264274062%	2	613	56	T2D_GENES_TANYA_BIOMARKER	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP
0.326264274062%	2	613	56	T2D_GENES_TANYA_BIOMARKER	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.326264274062%	2	613	56	T2D_GENES_TANYA_BIOMARKER	HOQUE_METHYLATED_IN_CANCER
0.326264274062%	2	613	56	T2D_GENES_TANYA_BIOMARKER	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.326264274062%	2	613	56	T2D_GENES_TANYA_BIOMARKER	GALE_APL_WITH_FLT3_MUTATED_UP
0.326264274062%	2	613	56	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_10HR_DN
0.326264274062%	2	613	55	T2D_GENES_TANYA_BIOMARKER	YU_MYC_TARGETS_DN
0.326264274062%	2	613	55	T2D_GENES_TANYA_BIOMARKER	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53
0.326264274062%	2	613	55	T2D_GENES_TANYA_BIOMARKER	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.326264274062%	2	613	55	T2D_GENES_TANYA_BIOMARKER	SMIRNOV_RESPONSE_TO_IR_2HR_DN
0.326264274062%	2	613	55	T2D_GENES_TANYA_BIOMARKER	PID_IL2_1PATHWAY
0.326264274062%	2	613	55	T2D_GENES_TANYA_BIOMARKER	PID_FGF_PATHWAY
0.326264274062%	2	613	55	T2D_GENES_TANYA_BIOMARKER	DEMAGALHAES_AGING_UP
0.326264274062%	2	613	54	T2D_GENES_TANYA_BIOMARKER	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
0.326264274062%	2	613	54	T2D_GENES_TANYA_BIOMARKER	RICKMAN_HEAD_AND_NECK_CANCER_F
0.326264274062%	2	613	54	T2D_GENES_TANYA_BIOMARKER	REACTOME_TCR_SIGNALING
0.326264274062%	2	613	54	T2D_GENES_TANYA_BIOMARKER	REACTOME_APOPTOTIC_EXECUTION_PHASE
0.326264274062%	2	613	54	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_IPS_ICP_WITH_H3K27ME3
0.326264274062%	2	613	54	T2D_GENES_TANYA_BIOMARKER	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN
0.326264274062%	2	613	54	T2D_GENES_TANYA_BIOMARKER	FIGUEROA_AML_METHYLATION_CLUSTER_2_UP
0.326264274062%	2	613	53	T2D_GENES_TANYA_BIOMARKER	SMIRNOV_RESPONSE_TO_IR_2HR_UP
0.326264274062%	2	613	53	T2D_GENES_TANYA_BIOMARKER	PID_AR_TF_PATHWAY
0.326264274062%	2	613	53	T2D_GENES_TANYA_BIOMARKER	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
0.326264274062%	2	613	53	T2D_GENES_TANYA_BIOMARKER	ISHIDA_E2F_TARGETS
0.326264274062%	2	613	53	T2D_GENES_TANYA_BIOMARKER	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP
0.326264274062%	2	613	52	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN
0.326264274062%	2	613	52	T2D_GENES_TANYA_BIOMARKER	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN
0.326264274062%	2	613	52	T2D_GENES_TANYA_BIOMARKER	ROSS_AML_WITH_CBFB_MYH11_FUSION
0.326264274062%	2	613	52	T2D_GENES_TANYA_BIOMARKER	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM
0.326264274062%	2	613	52	T2D_GENES_TANYA_BIOMARKER	PRAMOONJAGO_SOX4_TARGETS_UP
0.326264274062%	2	613	52	T2D_GENES_TANYA_BIOMARKER	PID_CASPASE_PATHWAY
0.326264274062%	2	613	52	T2D_GENES_TANYA_BIOMARKER	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP
0.326264274062%	2	613	52	T2D_GENES_TANYA_BIOMARKER	KENNY_CTNNB1_TARGETS_DN
0.326264274062%	2	613	52	T2D_GENES_TANYA_BIOMARKER	KEGG_ENDOMETRIAL_CANCER
0.326264274062%	2	613	52	T2D_GENES_TANYA_BIOMARKER	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP
0.326264274062%	2	613	52	T2D_GENES_TANYA_BIOMARKER	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP
0.326264274062%	2	613	52	T2D_GENES_TANYA_BIOMARKER	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN
0.326264274062%	2	613	51	T2D_GENES_TANYA_BIOMARKER	REACTOME_NUCLEOTIDE_EXCISION_REPAIR
0.326264274062%	2	613	51	T2D_GENES_TANYA_BIOMARKER	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
0.326264274062%	2	613	51	T2D_GENES_TANYA_BIOMARKER	CROMER_TUMORIGENESIS_DN
0.326264274062%	2	613	50	T2D_GENES_TANYA_BIOMARKER	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.326264274062%	2	613	50	T2D_GENES_TANYA_BIOMARKER	ROY_WOUND_BLOOD_VESSEL_UP
0.326264274062%	2	613	50	T2D_GENES_TANYA_BIOMARKER	KENNY_CTNNB1_TARGETS_UP
0.326264274062%	2	613	50	T2D_GENES_TANYA_BIOMARKER	KANG_GIST_WITH_PDGFRA_UP
0.326264274062%	2	613	50	T2D_GENES_TANYA_BIOMARKER	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
0.326264274062%	2	613	50	T2D_GENES_TANYA_BIOMARKER	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION
0.326264274062%	2	613	50	T2D_GENES_TANYA_BIOMARKER	CHIBA_RESPONSE_TO_TSA
0.326264274062%	2	613	5	T2D_GENES_TANYA_BIOMARKER	IM_SREBF1A_TARGETS
0.326264274062%	2	613	49	T2D_GENES_TANYA_BIOMARKER	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
0.326264274062%	2	613	49	T2D_GENES_TANYA_BIOMARKER	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
0.326264274062%	2	613	49	T2D_GENES_TANYA_BIOMARKER	REACTOME_METABOLISM_OF_NON_CODING_RNA
0.326264274062%	2	613	49	T2D_GENES_TANYA_BIOMARKER	REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM
0.326264274062%	2	613	49	T2D_GENES_TANYA_BIOMARKER	PID_PI3KCIPATHWAY
0.326264274062%	2	613	49	T2D_GENES_TANYA_BIOMARKER	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.326264274062%	2	613	49	T2D_GENES_TANYA_BIOMARKER	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP
0.326264274062%	2	613	49	T2D_GENES_TANYA_BIOMARKER	DAUER_STAT3_TARGETS_UP
0.326264274062%	2	613	49	T2D_GENES_TANYA_BIOMARKER	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.326264274062%	2	613	49	T2D_GENES_TANYA_BIOMARKER	APRELIKOVA_BRCA1_TARGETS
0.326264274062%	2	613	48	T2D_GENES_TANYA_BIOMARKER	REACTOME_PI_METABOLISM
0.326264274062%	2	613	48	T2D_GENES_TANYA_BIOMARKER	PID_HES_HEYPATHWAY
0.326264274062%	2	613	48	T2D_GENES_TANYA_BIOMARKER	MCDOWELL_ACUTE_LUNG_INJURY_DN
0.326264274062%	2	613	48	T2D_GENES_TANYA_BIOMARKER	GNATENKO_PLATELET_SIGNATURE
0.326264274062%	2	613	48	T2D_GENES_TANYA_BIOMARKER	ENGELMANN_CANCER_PROGENITORS_UP
0.326264274062%	2	613	48	T2D_GENES_TANYA_BIOMARKER	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.326264274062%	2	613	48	T2D_GENES_TANYA_BIOMARKER	BURTON_ADIPOGENESIS_4
0.326264274062%	2	613	48	T2D_GENES_TANYA_BIOMARKER	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
0.326264274062%	2	613	47	T2D_GENES_TANYA_BIOMARKER	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
0.326264274062%	2	613	47	T2D_GENES_TANYA_BIOMARKER	NAKAMURA_METASTASIS
0.326264274062%	2	613	47	T2D_GENES_TANYA_BIOMARKER	KEGG_NOTCH_SIGNALING_PATHWAY
0.326264274062%	2	613	47	T2D_GENES_TANYA_BIOMARKER	IRITANI_MAD1_TARGETS_DN
0.326264274062%	2	613	47	T2D_GENES_TANYA_BIOMARKER	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP
0.326264274062%	2	613	46	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_MS_DN
0.326264274062%	2	613	46	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_CD2_DN
0.326264274062%	2	613	46	T2D_GENES_TANYA_BIOMARKER	REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT
0.326264274062%	2	613	46	T2D_GENES_TANYA_BIOMARKER	PID_TNFPATHWAY
0.326264274062%	2	613	46	T2D_GENES_TANYA_BIOMARKER	PARENT_MTOR_SIGNALING_DN
0.326264274062%	2	613	46	T2D_GENES_TANYA_BIOMARKER	NUTT_GBM_VS_AO_GLIOMA_UP
0.326264274062%	2	613	46	T2D_GENES_TANYA_BIOMARKER	NAKAMURA_CANCER_MICROENVIRONMENT_DN
0.326264274062%	2	613	46	T2D_GENES_TANYA_BIOMARKER	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN
0.326264274062%	2	613	46	T2D_GENES_TANYA_BIOMARKER	KRASNOSELSKAYA_ILF3_TARGETS_DN
0.326264274062%	2	613	46	T2D_GENES_TANYA_BIOMARKER	KEGG_N_GLYCAN_BIOSYNTHESIS
0.326264274062%	2	613	46	T2D_GENES_TANYA_BIOMARKER	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN
0.326264274062%	2	613	46	T2D_GENES_TANYA_BIOMARKER	AMIT_EGF_RESPONSE_60_HELA
0.326264274062%	2	613	45	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_PR_UP
0.326264274062%	2	613	45	T2D_GENES_TANYA_BIOMARKER	ST_T_CELL_SIGNAL_TRANSDUCTION
0.326264274062%	2	613	45	T2D_GENES_TANYA_BIOMARKER	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
0.326264274062%	2	613	45	T2D_GENES_TANYA_BIOMARKER	SMITH_LIVER_CANCER
0.326264274062%	2	613	45	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER
0.326264274062%	2	613	45	T2D_GENES_TANYA_BIOMARKER	REACTOME_G2_M_CHECKPOINTS
0.326264274062%	2	613	45	T2D_GENES_TANYA_BIOMARKER	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
0.326264274062%	2	613	45	T2D_GENES_TANYA_BIOMARKER	PID_HNF3BPATHWAY
0.326264274062%	2	613	45	T2D_GENES_TANYA_BIOMARKER	LEE_AGING_MUSCLE_UP
0.326264274062%	2	613	45	T2D_GENES_TANYA_BIOMARKER	CHANDRAN_METASTASIS_TOP50_DN
0.326264274062%	2	613	45	T2D_GENES_TANYA_BIOMARKER	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.326264274062%	2	613	44	T2D_GENES_TANYA_BIOMARKER	XU_CREBBP_TARGETS_DN
0.326264274062%	2	613	44	T2D_GENES_TANYA_BIOMARKER	VANTVEER_BREAST_CANCER_BRCA1_DN
0.326264274062%	2	613	44	T2D_GENES_TANYA_BIOMARKER	THILLAINADESAN_ZNF217_TARGETS_UP
0.326264274062%	2	613	44	T2D_GENES_TANYA_BIOMARKER	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS
0.326264274062%	2	613	44	T2D_GENES_TANYA_BIOMARKER	PID_ERBB2ERBB3PATHWAY
0.326264274062%	2	613	44	T2D_GENES_TANYA_BIOMARKER	MA_MYELOID_DIFFERENTIATION_DN
0.326264274062%	2	613	44	T2D_GENES_TANYA_BIOMARKER	LANDIS_BREAST_CANCER_PROGRESSION_UP
0.326264274062%	2	613	44	T2D_GENES_TANYA_BIOMARKER	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
0.326264274062%	2	613	44	T2D_GENES_TANYA_BIOMARKER	KEGG_NUCLEOTIDE_EXCISION_REPAIR
0.326264274062%	2	613	43	T2D_GENES_TANYA_BIOMARKER	POTTI_5FU_SENSITIVITY
0.326264274062%	2	613	43	T2D_GENES_TANYA_BIOMARKER	PID_THROMBIN_PAR1_PATHWAY
0.326264274062%	2	613	43	T2D_GENES_TANYA_BIOMARKER	PID_TCPTP_PATHWAY
0.326264274062%	2	613	43	T2D_GENES_TANYA_BIOMARKER	PID_CXCR3PATHWAY
0.326264274062%	2	613	43	T2D_GENES_TANYA_BIOMARKER	MANTOVANI_NFKB_TARGETS_UP
0.326264274062%	2	613	43	T2D_GENES_TANYA_BIOMARKER	IKEDA_MIR133_TARGETS_UP
0.326264274062%	2	613	43	T2D_GENES_TANYA_BIOMARKER	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
0.326264274062%	2	613	43	T2D_GENES_TANYA_BIOMARKER	FUJII_YBX1_TARGETS_UP
0.326264274062%	2	613	43	T2D_GENES_TANYA_BIOMARKER	BURTON_ADIPOGENESIS_PEAK_AT_24HR
0.326264274062%	2	613	43	T2D_GENES_TANYA_BIOMARKER	AMIT_EGF_RESPONSE_480_MCF10A
0.326264274062%	2	613	42	T2D_GENES_TANYA_BIOMARKER	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
0.326264274062%	2	613	42	T2D_GENES_TANYA_BIOMARKER	YU_MYC_TARGETS_UP
0.326264274062%	2	613	42	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRNA_AMINOACYLATION
0.326264274062%	2	613	42	T2D_GENES_TANYA_BIOMARKER	MODY_HIPPOCAMPUS_PRENATAL
0.326264274062%	2	613	42	T2D_GENES_TANYA_BIOMARKER	LUI_THYROID_CANCER_CLUSTER_2
0.326264274062%	2	613	42	T2D_GENES_TANYA_BIOMARKER	KEGG_FATTY_ACID_METABOLISM
0.326264274062%	2	613	42	T2D_GENES_TANYA_BIOMARKER	KEGG_BLADDER_CANCER
0.326264274062%	2	613	41	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_MF_DN
0.326264274062%	2	613	41	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_DN
0.326264274062%	2	613	41	T2D_GENES_TANYA_BIOMARKER	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN
0.326264274062%	2	613	41	T2D_GENES_TANYA_BIOMARKER	RIZ_ERYTHROID_DIFFERENTIATION_HBZ
0.326264274062%	2	613	41	T2D_GENES_TANYA_BIOMARKER	REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING
0.326264274062%	2	613	41	T2D_GENES_TANYA_BIOMARKER	PID_AMB2_NEUTROPHILS_PATHWAY
0.326264274062%	2	613	41	T2D_GENES_TANYA_BIOMARKER	LI_LUNG_CANCER
0.326264274062%	2	613	41	T2D_GENES_TANYA_BIOMARKER	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS
0.326264274062%	2	613	41	T2D_GENES_TANYA_BIOMARKER	KAMMINGA_EZH2_TARGETS
0.326264274062%	2	613	41	T2D_GENES_TANYA_BIOMARKER	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.326264274062%	2	613	41	T2D_GENES_TANYA_BIOMARKER	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
0.326264274062%	2	613	41	T2D_GENES_TANYA_BIOMARKER	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
0.326264274062%	2	613	40	T2D_GENES_TANYA_BIOMARKER	ST_JNK_MAPK_PATHWAY
0.326264274062%	2	613	40	T2D_GENES_TANYA_BIOMARKER	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
0.326264274062%	2	613	40	T2D_GENES_TANYA_BIOMARKER	KEGG_TRYPTOPHAN_METABOLISM
0.326264274062%	2	613	40	T2D_GENES_TANYA_BIOMARKER	KEGG_PYRUVATE_METABOLISM
0.326264274062%	2	613	40	T2D_GENES_TANYA_BIOMARKER	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER
0.326264274062%	2	613	40	T2D_GENES_TANYA_BIOMARKER	BURTON_ADIPOGENESIS_PEAK_AT_16HR
0.326264274062%	2	613	40	T2D_GENES_TANYA_BIOMARKER	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.326264274062%	2	613	40	T2D_GENES_TANYA_BIOMARKER	BERNARD_PPAPDC1B_TARGETS_UP
0.326264274062%	2	613	40	T2D_GENES_TANYA_BIOMARKER	BENPORATH_ES_2
0.326264274062%	2	613	39	T2D_GENES_TANYA_BIOMARKER	WHITEHURST_PACLITAXEL_SENSITIVITY
0.326264274062%	2	613	39	T2D_GENES_TANYA_BIOMARKER	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2
0.326264274062%	2	613	39	T2D_GENES_TANYA_BIOMARKER	KORKOLA_TERATOMA
0.326264274062%	2	613	39	T2D_GENES_TANYA_BIOMARKER	HOFMANN_CELL_LYMPHOMA_DN
0.326264274062%	2	613	39	T2D_GENES_TANYA_BIOMARKER	CONRAD_STEM_CELL
0.326264274062%	2	613	39	T2D_GENES_TANYA_BIOMARKER	BURTON_ADIPOGENESIS_PEAK_AT_8HR
0.326264274062%	2	613	39	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_2HR_UP
0.326264274062%	2	613	39	T2D_GENES_TANYA_BIOMARKER	AMIT_EGF_RESPONSE_60_MCF10A
0.326264274062%	2	613	39	T2D_GENES_TANYA_BIOMARKER	AIYAR_COBRA1_TARGETS_UP
0.326264274062%	2	613	38	T2D_GENES_TANYA_BIOMARKER	VARELA_ZMPSTE24_TARGETS_DN
0.326264274062%	2	613	38	T2D_GENES_TANYA_BIOMARKER	REACTOME_PI3K_AKT_ACTIVATION
0.326264274062%	2	613	38	T2D_GENES_TANYA_BIOMARKER	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4
0.326264274062%	2	613	38	T2D_GENES_TANYA_BIOMARKER	REACTOME_GLUCOSE_TRANSPORT
0.326264274062%	2	613	38	T2D_GENES_TANYA_BIOMARKER	REACTOME_GAB1_SIGNALOSOME
0.326264274062%	2	613	38	T2D_GENES_TANYA_BIOMARKER	REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS
0.326264274062%	2	613	38	T2D_GENES_TANYA_BIOMARKER	PIONTEK_PKD1_TARGETS_UP
0.326264274062%	2	613	38	T2D_GENES_TANYA_BIOMARKER	PID_P38ALPHABETADOWNSTREAMPATHWAY
0.326264274062%	2	613	38	T2D_GENES_TANYA_BIOMARKER	PID_ERBB4_PATHWAY
0.326264274062%	2	613	38	T2D_GENES_TANYA_BIOMARKER	NAKAMURA_ADIPOGENESIS_LATE_DN
0.326264274062%	2	613	38	T2D_GENES_TANYA_BIOMARKER	KAAB_FAILED_HEART_ATRIUM_UP
0.326264274062%	2	613	38	T2D_GENES_TANYA_BIOMARKER	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN
0.326264274062%	2	613	37	T2D_GENES_TANYA_BIOMARKER	VALK_AML_WITH_CEBPA
0.326264274062%	2	613	37	T2D_GENES_TANYA_BIOMARKER	ST_GA13_PATHWAY
0.326264274062%	2	613	37	T2D_GENES_TANYA_BIOMARKER	PID_IL23PATHWAY
0.326264274062%	2	613	37	T2D_GENES_TANYA_BIOMARKER	PID_GMCSF_PATHWAY
0.326264274062%	2	613	37	T2D_GENES_TANYA_BIOMARKER	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR
0.326264274062%	2	613	37	T2D_GENES_TANYA_BIOMARKER	FRASOR_RESPONSE_TO_ESTRADIOL_UP
0.326264274062%	2	613	37	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_TOLL_PATHWAY
0.326264274062%	2	613	36	T2D_GENES_TANYA_BIOMARKER	YIH_RESPONSE_TO_ARSENITE_C3
0.326264274062%	2	613	36	T2D_GENES_TANYA_BIOMARKER	YANG_BREAST_CANCER_ESR1_UP
0.326264274062%	2	613	36	T2D_GENES_TANYA_BIOMARKER	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN
0.326264274062%	2	613	36	T2D_GENES_TANYA_BIOMARKER	REACTOME_IRON_UPTAKE_AND_TRANSPORT
0.326264274062%	2	613	36	T2D_GENES_TANYA_BIOMARKER	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
0.326264274062%	2	613	36	T2D_GENES_TANYA_BIOMARKER	KEGG_DNA_REPLICATION
0.326264274062%	2	613	36	T2D_GENES_TANYA_BIOMARKER	KEGG_BASAL_TRANSCRIPTION_FACTORS
0.326264274062%	2	613	36	T2D_GENES_TANYA_BIOMARKER	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP
0.326264274062%	2	613	35	T2D_GENES_TANYA_BIOMARKER	YAGI_AML_RELAPSE_PROGNOSIS
0.326264274062%	2	613	35	T2D_GENES_TANYA_BIOMARKER	SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES
0.326264274062%	2	613	35	T2D_GENES_TANYA_BIOMARKER	RODRIGUES_NTN1_AND_DCC_TARGETS
0.326264274062%	2	613	35	T2D_GENES_TANYA_BIOMARKER	REACTOME_GLOBAL_GENOMIC_NER_GG_NER
0.326264274062%	2	613	35	T2D_GENES_TANYA_BIOMARKER	PID_PI3KCIAKTPATHWAY
0.326264274062%	2	613	35	T2D_GENES_TANYA_BIOMARKER	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
0.326264274062%	2	613	35	T2D_GENES_TANYA_BIOMARKER	MODY_HIPPOCAMPUS_NEONATAL
0.326264274062%	2	613	35	T2D_GENES_TANYA_BIOMARKER	KEGG_PRION_DISEASES
0.326264274062%	2	613	35	T2D_GENES_TANYA_BIOMARKER	HU_GENOTOXIC_DAMAGE_24HR
0.326264274062%	2	613	35	T2D_GENES_TANYA_BIOMARKER	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.326264274062%	2	613	35	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CARM_ER_PATHWAY
0.326264274062%	2	613	34	T2D_GENES_TANYA_BIOMARKER	SUMI_HNF4A_TARGETS
0.326264274062%	2	613	34	T2D_GENES_TANYA_BIOMARKER	SIG_CD40PATHWAYMAP
0.326264274062%	2	613	34	T2D_GENES_TANYA_BIOMARKER	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE
0.326264274062%	2	613	34	T2D_GENES_TANYA_BIOMARKER	PID_MAPKTRKPATHWAY
0.326264274062%	2	613	34	T2D_GENES_TANYA_BIOMARKER	PID_IL2_PI3KPATHWAY
0.326264274062%	2	613	34	T2D_GENES_TANYA_BIOMARKER	MEISSNER_ES_ICP_WITH_H3K4ME3
0.326264274062%	2	613	34	T2D_GENES_TANYA_BIOMARKER	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM
0.326264274062%	2	613	34	T2D_GENES_TANYA_BIOMARKER	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP
0.326264274062%	2	613	33	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION
0.326264274062%	2	613	33	T2D_GENES_TANYA_BIOMARKER	REACTOME_RNA_POL_III_TRANSCRIPTION
0.326264274062%	2	613	33	T2D_GENES_TANYA_BIOMARKER	REACTOME_PURINE_METABOLISM
0.326264274062%	2	613	33	T2D_GENES_TANYA_BIOMARKER	REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS
0.326264274062%	2	613	33	T2D_GENES_TANYA_BIOMARKER	REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS
0.326264274062%	2	613	33	T2D_GENES_TANYA_BIOMARKER	PID_SYNDECAN_2_PATHWAY
0.326264274062%	2	613	33	T2D_GENES_TANYA_BIOMARKER	PID_NCADHERINPATHWAY
0.326264274062%	2	613	33	T2D_GENES_TANYA_BIOMARKER	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN
0.326264274062%	2	613	33	T2D_GENES_TANYA_BIOMARKER	KEGG_PROPANOATE_METABOLISM
0.326264274062%	2	613	33	T2D_GENES_TANYA_BIOMARKER	FIRESTEIN_CTNNB1_PATHWAY
0.326264274062%	2	613	33	T2D_GENES_TANYA_BIOMARKER	CAFFAREL_RESPONSE_TO_THC_UP
0.326264274062%	2	613	33	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_IL1R_PATHWAY
0.326264274062%	2	613	33	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_DEATH_PATHWAY
0.326264274062%	2	613	32	T2D_GENES_TANYA_BIOMARKER	TRACEY_RESISTANCE_TO_IFNA2_DN
0.326264274062%	2	613	32	T2D_GENES_TANYA_BIOMARKER	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN
0.326264274062%	2	613	32	T2D_GENES_TANYA_BIOMARKER	REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE
0.326264274062%	2	613	32	T2D_GENES_TANYA_BIOMARKER	REACTOME_DAG_AND_IP3_SIGNALING
0.326264274062%	2	613	32	T2D_GENES_TANYA_BIOMARKER	POS_HISTAMINE_RESPONSE_NETWORK
0.326264274062%	2	613	32	T2D_GENES_TANYA_BIOMARKER	MEISSNER_BRAIN_ICP_WITH_H3K4ME3
0.326264274062%	2	613	32	T2D_GENES_TANYA_BIOMARKER	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM
0.326264274062%	2	613	32	T2D_GENES_TANYA_BIOMARKER	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN
0.326264274062%	2	613	32	T2D_GENES_TANYA_BIOMARKER	AMIT_SERUM_RESPONSE_40_MCF10A
0.326264274062%	2	613	31	T2D_GENES_TANYA_BIOMARKER	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP
0.326264274062%	2	613	31	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES
0.326264274062%	2	613	31	T2D_GENES_TANYA_BIOMARKER	PID_AVB3_OPN_PATHWAY
0.326264274062%	2	613	31	T2D_GENES_TANYA_BIOMARKER	PID_AR_NONGENOMIC_PATHWAY
0.326264274062%	2	613	31	T2D_GENES_TANYA_BIOMARKER	HUNSBERGER_EXERCISE_REGULATED_GENES
0.326264274062%	2	613	31	T2D_GENES_TANYA_BIOMARKER	DANG_MYC_TARGETS_DN
0.326264274062%	2	613	31	T2D_GENES_TANYA_BIOMARKER	CUI_TCF21_TARGETS_DN
0.326264274062%	2	613	30	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
0.326264274062%	2	613	30	T2D_GENES_TANYA_BIOMARKER	YANAGIHARA_ESX1_TARGETS
0.326264274062%	2	613	30	T2D_GENES_TANYA_BIOMARKER	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN
0.326264274062%	2	613	30	T2D_GENES_TANYA_BIOMARKER	REACTOME_CA_DEPENDENT_EVENTS
0.326264274062%	2	613	30	T2D_GENES_TANYA_BIOMARKER	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN
0.326264274062%	2	613	30	T2D_GENES_TANYA_BIOMARKER	PID_IL2_STAT5PATHWAY
0.326264274062%	2	613	30	T2D_GENES_TANYA_BIOMARKER	PID_IGF1_PATHWAY
0.326264274062%	2	613	30	T2D_GENES_TANYA_BIOMARKER	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP
0.326264274062%	2	613	30	T2D_GENES_TANYA_BIOMARKER	HEIDENBLAD_AMPLICON_12P11_12_DN
0.326264274062%	2	613	30	T2D_GENES_TANYA_BIOMARKER	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY
0.326264274062%	2	613	29	T2D_GENES_TANYA_BIOMARKER	YU_BAP1_TARGETS
0.326264274062%	2	613	29	T2D_GENES_TANYA_BIOMARKER	ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.326264274062%	2	613	29	T2D_GENES_TANYA_BIOMARKER	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN
0.326264274062%	2	613	29	T2D_GENES_TANYA_BIOMARKER	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
0.326264274062%	2	613	29	T2D_GENES_TANYA_BIOMARKER	PID_S1P_S1P3_PATHWAY
0.326264274062%	2	613	29	T2D_GENES_TANYA_BIOMARKER	PID_BARD1PATHWAY
0.326264274062%	2	613	29	T2D_GENES_TANYA_BIOMARKER	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
0.326264274062%	2	613	29	T2D_GENES_TANYA_BIOMARKER	MA_PITUITARY_FETAL_VS_ADULT_UP
0.326264274062%	2	613	29	T2D_GENES_TANYA_BIOMARKER	LU_TUMOR_VASCULATURE_UP
0.326264274062%	2	613	29	T2D_GENES_TANYA_BIOMARKER	GENTLES_LEUKEMIC_STEM_CELL_UP
0.326264274062%	2	613	29	T2D_GENES_TANYA_BIOMARKER	CHOW_RASSF1_TARGETS_DN
0.326264274062%	2	613	29	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_VIP_PATHWAY
0.326264274062%	2	613	29	T2D_GENES_TANYA_BIOMARKER	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP
0.326264274062%	2	613	28	T2D_GENES_TANYA_BIOMARKER	WILLIAMS_ESR2_TARGETS_UP
0.326264274062%	2	613	28	T2D_GENES_TANYA_BIOMARKER	ST_GAQ_PATHWAY
0.326264274062%	2	613	28	T2D_GENES_TANYA_BIOMARKER	REICHERT_MITOSIS_LIN9_TARGETS
0.326264274062%	2	613	28	T2D_GENES_TANYA_BIOMARKER	OLSSON_E2F3_TARGETS_UP
0.326264274062%	2	613	28	T2D_GENES_TANYA_BIOMARKER	LUI_THYROID_CANCER_CLUSTER_3
0.326264274062%	2	613	28	T2D_GENES_TANYA_BIOMARKER	KEGG_HOMOLOGOUS_RECOMBINATION
0.326264274062%	2	613	28	T2D_GENES_TANYA_BIOMARKER	KAMIKUBO_MYELOID_CEBPA_NETWORK
0.326264274062%	2	613	28	T2D_GENES_TANYA_BIOMARKER	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
0.326264274062%	2	613	272	T2D_GENES_TANYA_BIOMARKER	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
0.326264274062%	2	613	27	T2D_GENES_TANYA_BIOMARKER	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN
0.326264274062%	2	613	27	T2D_GENES_TANYA_BIOMARKER	REACTOME_STRIATED_MUSCLE_CONTRACTION
0.326264274062%	2	613	27	T2D_GENES_TANYA_BIOMARKER	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN
0.326264274062%	2	613	27	T2D_GENES_TANYA_BIOMARKER	REACTOME_G_PROTEIN_ACTIVATION
0.326264274062%	2	613	27	T2D_GENES_TANYA_BIOMARKER	REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS
0.326264274062%	2	613	27	T2D_GENES_TANYA_BIOMARKER	REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS
0.326264274062%	2	613	27	T2D_GENES_TANYA_BIOMARKER	PLASARI_NFIC_TARGETS_BASAL_UP
0.326264274062%	2	613	27	T2D_GENES_TANYA_BIOMARKER	PID_IL3_PATHWAY
0.326264274062%	2	613	27	T2D_GENES_TANYA_BIOMARKER	NICK_RESPONSE_TO_PROC_TREATMENT_DN
0.326264274062%	2	613	27	T2D_GENES_TANYA_BIOMARKER	KEGG_PENTOSE_PHOSPHATE_PATHWAY
0.326264274062%	2	613	27	T2D_GENES_TANYA_BIOMARKER	IKEDA_MIR30_TARGETS_DN
0.326264274062%	2	613	27	T2D_GENES_TANYA_BIOMARKER	CHOW_RASSF1_TARGETS_UP
0.326264274062%	2	613	27	T2D_GENES_TANYA_BIOMARKER	CHIN_BREAST_CANCER_COPY_NUMBER_UP
0.326264274062%	2	613	262	T2D_GENES_TANYA_BIOMARKER	LU_AGING_BRAIN_UP
0.326264274062%	2	613	26	T2D_GENES_TANYA_BIOMARKER	PID_VEGFR1_PATHWAY
0.326264274062%	2	613	26	T2D_GENES_TANYA_BIOMARKER	PID_RXR_VDR_PATHWAY
0.326264274062%	2	613	26	T2D_GENES_TANYA_BIOMARKER	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
0.326264274062%	2	613	26	T2D_GENES_TANYA_BIOMARKER	BRACHAT_RESPONSE_TO_METHOTREXATE_UP
0.326264274062%	2	613	256	T2D_GENES_TANYA_BIOMARKER	ONDER_CDH1_TARGETS_2_UP
0.326264274062%	2	613	25	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING
0.326264274062%	2	613	25	T2D_GENES_TANYA_BIOMARKER	REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION
0.326264274062%	2	613	25	T2D_GENES_TANYA_BIOMARKER	REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN
0.326264274062%	2	613	25	T2D_GENES_TANYA_BIOMARKER	REACTOME_FANCONI_ANEMIA_PATHWAY
0.326264274062%	2	613	25	T2D_GENES_TANYA_BIOMARKER	REACTOME_DARPP_32_EVENTS
0.326264274062%	2	613	25	T2D_GENES_TANYA_BIOMARKER	REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS
0.326264274062%	2	613	25	T2D_GENES_TANYA_BIOMARKER	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17
0.326264274062%	2	613	25	T2D_GENES_TANYA_BIOMARKER	LU_TUMOR_ANGIOGENESIS_UP
0.326264274062%	2	613	25	T2D_GENES_TANYA_BIOMARKER	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM
0.326264274062%	2	613	25	T2D_GENES_TANYA_BIOMARKER	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN
0.326264274062%	2	613	24	T2D_GENES_TANYA_BIOMARKER	YAN_ESCAPE_FROM_ANOIKIS
0.326264274062%	2	613	24	T2D_GENES_TANYA_BIOMARKER	REACTOME_DOUBLE_STRAND_BREAK_REPAIR
0.326264274062%	2	613	24	T2D_GENES_TANYA_BIOMARKER	REACTOME_CHOLESTEROL_BIOSYNTHESIS
0.326264274062%	2	613	24	T2D_GENES_TANYA_BIOMARKER	PETRETTO_HEART_MASS_QTL_CIS_DN
0.326264274062%	2	613	24	T2D_GENES_TANYA_BIOMARKER	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN
0.326264274062%	2	613	24	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_NTHI_PATHWAY
0.326264274062%	2	613	238	T2D_GENES_TANYA_BIOMARKER	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
0.326264274062%	2	613	23	T2D_GENES_TANYA_BIOMARKER	UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.326264274062%	2	613	23	T2D_GENES_TANYA_BIOMARKER	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER
0.326264274062%	2	613	23	T2D_GENES_TANYA_BIOMARKER	REACTOME_INSULIN_RECEPTOR_RECYCLING
0.326264274062%	2	613	23	T2D_GENES_TANYA_BIOMARKER	PID_NFKAPPABCANONICALPATHWAY
0.326264274062%	2	613	23	T2D_GENES_TANYA_BIOMARKER	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP
0.326264274062%	2	613	23	T2D_GENES_TANYA_BIOMARKER	KEGG_NITROGEN_METABOLISM
0.326264274062%	2	613	23	T2D_GENES_TANYA_BIOMARKER	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP
0.326264274062%	2	613	23	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_RAS_PATHWAY
0.326264274062%	2	613	23	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_NFKB_PATHWAY
0.326264274062%	2	613	23	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_INTRINSIC_PATHWAY
0.326264274062%	2	613	23	T2D_GENES_TANYA_BIOMARKER	BARIS_THYROID_CANCER_UP
0.326264274062%	2	613	228	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
0.326264274062%	2	613	227	T2D_GENES_TANYA_BIOMARKER	RAO_BOUND_BY_SALL4
0.326264274062%	2	613	22	T2D_GENES_TANYA_BIOMARKER	VALK_AML_WITH_11Q23_REARRANGED
0.326264274062%	2	613	22	T2D_GENES_TANYA_BIOMARKER	REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION
0.326264274062%	2	613	22	T2D_GENES_TANYA_BIOMARKER	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING
0.326264274062%	2	613	22	T2D_GENES_TANYA_BIOMARKER	LU_TUMOR_ENDOTHELIAL_MARKERS_UP
0.326264274062%	2	613	22	T2D_GENES_TANYA_BIOMARKER	KEGG_BETA_ALANINE_METABOLISM
0.326264274062%	2	613	22	T2D_GENES_TANYA_BIOMARKER	HANSON_HRAS_SIGNALING_VIA_NFKB
0.326264274062%	2	613	22	T2D_GENES_TANYA_BIOMARKER	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN
0.326264274062%	2	613	22	T2D_GENES_TANYA_BIOMARKER	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN
0.326264274062%	2	613	22	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CYTOKINE_PATHWAY
0.326264274062%	2	613	22	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_AKT_PATHWAY
0.326264274062%	2	613	210	T2D_GENES_TANYA_BIOMARKER	RIZKI_TUMOR_INVASIVENESS_3D_UP
0.326264274062%	2	613	21	T2D_GENES_TANYA_BIOMARKER	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP
0.326264274062%	2	613	21	T2D_GENES_TANYA_BIOMARKER	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP
0.326264274062%	2	613	21	T2D_GENES_TANYA_BIOMARKER	WENG_POR_DOSAGE
0.326264274062%	2	613	21	T2D_GENES_TANYA_BIOMARKER	STEGER_ADIPOGENESIS_UP
0.326264274062%	2	613	21	T2D_GENES_TANYA_BIOMARKER	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC
0.326264274062%	2	613	21	T2D_GENES_TANYA_BIOMARKER	PID_S1P_S1P1_PATHWAY
0.326264274062%	2	613	21	T2D_GENES_TANYA_BIOMARKER	OUYANG_PROSTATE_CANCER_PROGRESSION_DN
0.326264274062%	2	613	21	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_ATRBRCA_PATHWAY
0.326264274062%	2	613	201	T2D_GENES_TANYA_BIOMARKER	KEGG_FOCAL_ADHESION
0.326264274062%	2	613	20	T2D_GENES_TANYA_BIOMARKER	ST_WNT_CA2_CYCLIC_GMP_PATHWAY
0.326264274062%	2	613	20	T2D_GENES_TANYA_BIOMARKER	MEISSNER_NPC_ICP_WITH_H3K4ME3
0.326264274062%	2	613	20	T2D_GENES_TANYA_BIOMARKER	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN
0.326264274062%	2	613	20	T2D_GENES_TANYA_BIOMARKER	MANN_RESPONSE_TO_AMIFOSTINE_UP
0.326264274062%	2	613	20	T2D_GENES_TANYA_BIOMARKER	MAHADEVAN_IMATINIB_RESISTANCE_DN
0.326264274062%	2	613	20	T2D_GENES_TANYA_BIOMARKER	LIU_TARGETS_OF_VMYB_VS_CMYB_UP
0.326264274062%	2	613	20	T2D_GENES_TANYA_BIOMARKER	KIM_MYCL1_AMPLIFICATION_TARGETS_DN
0.326264274062%	2	613	20	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_ATM_PATHWAY
0.326264274062%	2	613	198	T2D_GENES_TANYA_BIOMARKER	ALONSO_METASTASIS_UP
0.326264274062%	2	613	197	T2D_GENES_TANYA_BIOMARKER	SHEPARD_CRUSH_AND_BURN_MUTANT_UP
0.326264274062%	2	613	195	T2D_GENES_TANYA_BIOMARKER	KYNG_DNA_DAMAGE_DN
0.326264274062%	2	613	19	T2D_GENES_TANYA_BIOMARKER	VERNOCHET_ADIPOGENESIS
0.326264274062%	2	613	19	T2D_GENES_TANYA_BIOMARKER	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP
0.326264274062%	2	613	19	T2D_GENES_TANYA_BIOMARKER	MELLMAN_TUT1_TARGETS_UP
0.326264274062%	2	613	19	T2D_GENES_TANYA_BIOMARKER	LI_WILMS_TUMOR_ANAPLASTIC_UP
0.326264274062%	2	613	19	T2D_GENES_TANYA_BIOMARKER	KANG_AR_TARGETS_DN
0.326264274062%	2	613	19	T2D_GENES_TANYA_BIOMARKER	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN
0.326264274062%	2	613	19	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_TID_PATHWAY
0.326264274062%	2	613	185	T2D_GENES_TANYA_BIOMARKER	ZHANG_TLX_TARGETS_36HR_DN
0.326264274062%	2	613	182	T2D_GENES_TANYA_BIOMARKER	RAO_BOUND_BY_SALL4_ISOFORM_A
0.326264274062%	2	613	181	T2D_GENES_TANYA_BIOMARKER	JISON_SICKLE_CELL_DISEASE_UP
0.326264274062%	2	613	18	T2D_GENES_TANYA_BIOMARKER	TOMIDA_METASTASIS_DN
0.326264274062%	2	613	18	T2D_GENES_TANYA_BIOMARKER	SCHURINGA_STAT5A_TARGETS_DN
0.326264274062%	2	613	18	T2D_GENES_TANYA_BIOMARKER	PLASARI_NFIC_TARGETS_BASAL_DN
0.326264274062%	2	613	18	T2D_GENES_TANYA_BIOMARKER	NIELSEN_LIPOSARCOMA_UP
0.326264274062%	2	613	18	T2D_GENES_TANYA_BIOMARKER	KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.326264274062%	2	613	18	T2D_GENES_TANYA_BIOMARKER	GENTILE_UV_RESPONSE_CLUSTER_D1
0.326264274062%	2	613	18	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_TNFR2_PATHWAY
0.326264274062%	2	613	176	T2D_GENES_TANYA_BIOMARKER	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX
0.326264274062%	2	613	170	T2D_GENES_TANYA_BIOMARKER	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
0.326264274062%	2	613	17	T2D_GENES_TANYA_BIOMARKER	REACTOME_RAP1_SIGNALLING
0.326264274062%	2	613	17	T2D_GENES_TANYA_BIOMARKER	REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS
0.326264274062%	2	613	17	T2D_GENES_TANYA_BIOMARKER	REACTOME_INTRINSIC_PATHWAY
0.326264274062%	2	613	17	T2D_GENES_TANYA_BIOMARKER	REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS
0.326264274062%	2	613	17	T2D_GENES_TANYA_BIOMARKER	REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP
0.326264274062%	2	613	17	T2D_GENES_TANYA_BIOMARKER	REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1
0.326264274062%	2	613	17	T2D_GENES_TANYA_BIOMARKER	PID_NFKAPPABATYPICALPATHWAY
0.326264274062%	2	613	17	T2D_GENES_TANYA_BIOMARKER	LOPEZ_EPITHELIOID_MESOTHELIOMA
0.326264274062%	2	613	17	T2D_GENES_TANYA_BIOMARKER	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
0.326264274062%	2	613	17	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_LAIR_PATHWAY
0.326264274062%	2	613	17	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CK1_PATHWAY
0.326264274062%	2	613	17	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_ARF_PATHWAY
0.326264274062%	2	613	169	T2D_GENES_TANYA_BIOMARKER	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION
0.326264274062%	2	613	160	T2D_GENES_TANYA_BIOMARKER	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
0.326264274062%	2	613	16	T2D_GENES_TANYA_BIOMARKER	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN
0.326264274062%	2	613	16	T2D_GENES_TANYA_BIOMARKER	IGLESIAS_E2F_TARGETS_DN
0.326264274062%	2	613	16	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_RELA_PATHWAY
0.326264274062%	2	613	16	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CDMAC_PATHWAY
0.326264274062%	2	613	16	T2D_GENES_TANYA_BIOMARKER	BAKER_HEMATOPOIESIS_STAT3_TARGETS
0.326264274062%	2	613	157	T2D_GENES_TANYA_BIOMARKER	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
0.326264274062%	2	613	156	T2D_GENES_TANYA_BIOMARKER	GROSS_HYPOXIA_VIA_ELK3_DN
0.326264274062%	2	613	153	T2D_GENES_TANYA_BIOMARKER	REACTOME_PEPTIDE_CHAIN_ELONGATION
0.326264274062%	2	613	153	T2D_GENES_TANYA_BIOMARKER	DAZARD_UV_RESPONSE_CLUSTER_G6
0.326264274062%	2	613	15	T2D_GENES_TANYA_BIOMARKER	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP
0.326264274062%	2	613	15	T2D_GENES_TANYA_BIOMARKER	SU_KIDNEY
0.326264274062%	2	613	15	T2D_GENES_TANYA_BIOMARKER	SINGH_NFE2L2_TARGETS
0.326264274062%	2	613	15	T2D_GENES_TANYA_BIOMARKER	REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE
0.326264274062%	2	613	15	T2D_GENES_TANYA_BIOMARKER	REACTOME_AMINE_DERIVED_HORMONES
0.326264274062%	2	613	15	T2D_GENES_TANYA_BIOMARKER	PID_ERBB_NETWORK_PATHWAY
0.326264274062%	2	613	15	T2D_GENES_TANYA_BIOMARKER	MARKS_HDAC_TARGETS_DN
0.326264274062%	2	613	15	T2D_GENES_TANYA_BIOMARKER	KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS
0.326264274062%	2	613	15	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_HSP27_PATHWAY
0.326264274062%	2	613	15	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_HIF_PATHWAY
0.326264274062%	2	613	147	T2D_GENES_TANYA_BIOMARKER	KAUFFMANN_DNA_REPLICATION_GENES
0.326264274062%	2	613	146	T2D_GENES_TANYA_BIOMARKER	PECE_MAMMARY_STEM_CELL_UP
0.326264274062%	2	613	146	T2D_GENES_TANYA_BIOMARKER	PECE_MAMMARY_STEM_CELL_DN
0.326264274062%	2	613	145	T2D_GENES_TANYA_BIOMARKER	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
0.326264274062%	2	613	143	T2D_GENES_TANYA_BIOMARKER	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.326264274062%	2	613	142	T2D_GENES_TANYA_BIOMARKER	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
0.326264274062%	2	613	141	T2D_GENES_TANYA_BIOMARKER	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
0.326264274062%	2	613	141	T2D_GENES_TANYA_BIOMARKER	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP
0.326264274062%	2	613	140	T2D_GENES_TANYA_BIOMARKER	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
0.326264274062%	2	613	140	T2D_GENES_TANYA_BIOMARKER	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
0.326264274062%	2	613	140	T2D_GENES_TANYA_BIOMARKER	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.326264274062%	2	613	14	T2D_GENES_TANYA_BIOMARKER	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24
0.326264274062%	2	613	14	T2D_GENES_TANYA_BIOMARKER	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION
0.326264274062%	2	613	14	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_RANKL_PATHWAY
0.326264274062%	2	613	14	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_GRANULOCYTES_PATHWAY
0.326264274062%	2	613	139	T2D_GENES_TANYA_BIOMARKER	HOELZEL_NF1_TARGETS_UP
0.326264274062%	2	613	138	T2D_GENES_TANYA_BIOMARKER	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS
0.326264274062%	2	613	138	T2D_GENES_TANYA_BIOMARKER	JIANG_VHL_TARGETS
0.326264274062%	2	613	137	T2D_GENES_TANYA_BIOMARKER	KEGG_INSULIN_SIGNALING_PATHWAY
0.326264274062%	2	613	136	T2D_GENES_TANYA_BIOMARKER	PROVENZANI_METASTASIS_DN
0.326264274062%	2	613	135	T2D_GENES_TANYA_BIOMARKER	UDAYAKUMAR_MED1_TARGETS_UP
0.326264274062%	2	613	134	T2D_GENES_TANYA_BIOMARKER	KEGG_CELL_ADHESION_MOLECULES_CAMS
0.326264274062%	2	613	134	T2D_GENES_TANYA_BIOMARKER	CHUNG_BLISTER_CYTOTOXICITY_UP
0.326264274062%	2	613	133	T2D_GENES_TANYA_BIOMARKER	KEGG_PARKINSONS_DISEASE
0.326264274062%	2	613	13	T2D_GENES_TANYA_BIOMARKER	WU_HBX_TARGETS_3_DN
0.326264274062%	2	613	13	T2D_GENES_TANYA_BIOMARKER	REACTOME_PURINE_SALVAGE
0.326264274062%	2	613	13	T2D_GENES_TANYA_BIOMARKER	IRITANI_MAD1_TARGETS_UP
0.326264274062%	2	613	13	T2D_GENES_TANYA_BIOMARKER	HO_LIVER_CANCER_VASCULAR_INVASION
0.326264274062%	2	613	13	T2D_GENES_TANYA_BIOMARKER	HOEGERKORP_CD44_TARGETS_TEMPORAL_UP
0.326264274062%	2	613	126	T2D_GENES_TANYA_BIOMARKER	SANSOM_APC_TARGETS_UP
0.326264274062%	2	613	125	T2D_GENES_TANYA_BIOMARKER	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
0.326264274062%	2	613	123	T2D_GENES_TANYA_BIOMARKER	HOOI_ST7_TARGETS_DN
0.326264274062%	2	613	121	T2D_GENES_TANYA_BIOMARKER	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.326264274062%	2	613	121	T2D_GENES_TANYA_BIOMARKER	RODRIGUES_DCC_TARGETS_DN
0.326264274062%	2	613	121	T2D_GENES_TANYA_BIOMARKER	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS
0.326264274062%	2	613	121	T2D_GENES_TANYA_BIOMARKER	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
0.326264274062%	2	613	121	T2D_GENES_TANYA_BIOMARKER	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
0.326264274062%	2	613	12	T2D_GENES_TANYA_BIOMARKER	ZHENG_FOXP3_TARGETS_IN_THYMUS_DN
0.326264274062%	2	613	12	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_NOTCH4
0.326264274062%	2	613	12	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_NOTCH3
0.326264274062%	2	613	12	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_NOTCH2
0.326264274062%	2	613	12	T2D_GENES_TANYA_BIOMARKER	MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP
0.326264274062%	2	613	12	T2D_GENES_TANYA_BIOMARKER	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN
0.326264274062%	2	613	12	T2D_GENES_TANYA_BIOMARKER	DING_LUNG_CANCER_MUTATED_FREQUENTLY
0.326264274062%	2	613	118	T2D_GENES_TANYA_BIOMARKER	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
0.326264274062%	2	613	118	T2D_GENES_TANYA_BIOMARKER	CERVERA_SDHB_TARGETS_1_UP
0.326264274062%	2	613	116	T2D_GENES_TANYA_BIOMARKER	REACTOME_MEIOSIS
0.326264274062%	2	613	114	T2D_GENES_TANYA_BIOMARKER	CERVERA_SDHB_TARGETS_2
0.326264274062%	2	613	114	T2D_GENES_TANYA_BIOMARKER	BOSCO_TH1_CYTOTOXIC_MODULE
0.326264274062%	2	613	113	T2D_GENES_TANYA_BIOMARKER	TSENG_IRS1_TARGETS_UP
0.326264274062%	2	613	113	T2D_GENES_TANYA_BIOMARKER	RICKMAN_HEAD_AND_NECK_CANCER_C
0.326264274062%	2	613	113	T2D_GENES_TANYA_BIOMARKER	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
0.326264274062%	2	613	112	T2D_GENES_TANYA_BIOMARKER	LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.326264274062%	2	613	111	T2D_GENES_TANYA_BIOMARKER	WANG_HCP_PROSTATE_CANCER
0.326264274062%	2	613	111	T2D_GENES_TANYA_BIOMARKER	REACTOME_GLYCOSAMINOGLYCAN_METABOLISM
0.326264274062%	2	613	110	T2D_GENES_TANYA_BIOMARKER	SUNG_METASTASIS_STROMA_UP
0.326264274062%	2	613	110	T2D_GENES_TANYA_BIOMARKER	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
0.326264274062%	2	613	110	T2D_GENES_TANYA_BIOMARKER	GHANDHI_DIRECT_IRRADIATION_UP
0.326264274062%	2	613	110	T2D_GENES_TANYA_BIOMARKER	CHENG_IMPRINTED_BY_ESTRADIOL
0.326264274062%	2	613	11	T2D_GENES_TANYA_BIOMARKER	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP
0.326264274062%	2	613	11	T2D_GENES_TANYA_BIOMARKER	REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS
0.326264274062%	2	613	11	T2D_GENES_TANYA_BIOMARKER	HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP
0.326264274062%	2	613	11	T2D_GENES_TANYA_BIOMARKER	DER_IFN_GAMMA_RESPONSE_DN
0.326264274062%	2	613	11	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_EPONFKB_PATHWAY
0.326264274062%	2	613	11	T2D_GENES_TANYA_BIOMARKER	AUJLA_IL22_AND_IL17A_SIGNALING
0.326264274062%	2	613	109	T2D_GENES_TANYA_BIOMARKER	SERVITJA_ISLET_HNF1A_TARGETS_DN
0.326264274062%	2	613	108	T2D_GENES_TANYA_BIOMARKER	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.326264274062%	2	613	108	T2D_GENES_TANYA_BIOMARKER	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
0.326264274062%	2	613	107	T2D_GENES_TANYA_BIOMARKER	SESTO_RESPONSE_TO_UV_C0
0.326264274062%	2	613	105	T2D_GENES_TANYA_BIOMARKER	WOO_LIVER_CANCER_RECURRENCE_UP
0.326264274062%	2	613	105	T2D_GENES_TANYA_BIOMARKER	STEIN_ESRRA_TARGETS_DN
0.326264274062%	2	613	105	T2D_GENES_TANYA_BIOMARKER	REACTOME_RNA_POL_II_TRANSCRIPTION
0.326264274062%	2	613	105	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_8HR_UP
0.326264274062%	2	613	105	T2D_GENES_TANYA_BIOMARKER	AMUNDSON_GENOTOXIC_SIGNATURE
0.326264274062%	2	613	104	T2D_GENES_TANYA_BIOMARKER	NAKAMURA_ADIPOGENESIS_LATE_UP
0.326264274062%	2	613	103	T2D_GENES_TANYA_BIOMARKER	LEIN_CHOROID_PLEXUS_MARKERS
0.326264274062%	2	613	103	T2D_GENES_TANYA_BIOMARKER	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
0.326264274062%	2	613	102	T2D_GENES_TANYA_BIOMARKER	KEGG_MELANOGENESIS
0.326264274062%	2	613	102	T2D_GENES_TANYA_BIOMARKER	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.326264274062%	2	613	100	T2D_GENES_TANYA_BIOMARKER	CHICAS_RB1_TARGETS_LOW_SERUM
0.326264274062%	2	613	10	T2D_GENES_TANYA_BIOMARKER	REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR
0.326264274062%	2	613	10	T2D_GENES_TANYA_BIOMARKER	KEGG_LIMONENE_AND_PINENE_DEGRADATION
0.326264274062%	2	613	10	T2D_GENES_TANYA_BIOMARKER	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP
0.326264274062%	2	613	10	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_FREE_PATHWAY
0.321987120515%	7	2174	95	T2D_GENES_TANYA_LIPIDS	HECKER_IFNB1_TARGETS
0.321987120515%	7	2174	93	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_INSULIN_SECRETION
0.321987120515%	7	2174	92	T2D_GENES_TANYA_LIPIDS	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
0.321987120515%	7	2174	92	T2D_GENES_TANYA_LIPIDS	KIM_MYCN_AMPLIFICATION_TARGETS_UP
0.321987120515%	7	2174	91	T2D_GENES_TANYA_LIPIDS	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
0.321987120515%	7	2174	91	T2D_GENES_TANYA_LIPIDS	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
0.321987120515%	7	2174	90	T2D_GENES_TANYA_LIPIDS	GAVIN_FOXP3_TARGETS_CLUSTER_P7
0.321987120515%	7	2174	90	T2D_GENES_TANYA_LIPIDS	BILANGES_SERUM_SENSITIVE_GENES
0.321987120515%	7	2174	88	T2D_GENES_TANYA_LIPIDS	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
0.321987120515%	7	2174	87	T2D_GENES_TANYA_LIPIDS	SAFFORD_T_LYMPHOCYTE_ANERGY
0.321987120515%	7	2174	87	T2D_GENES_TANYA_LIPIDS	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION
0.321987120515%	7	2174	86	T2D_GENES_TANYA_LIPIDS	GHANDHI_BYSTANDER_IRRADIATION_UP
0.321987120515%	7	2174	85	T2D_GENES_TANYA_LIPIDS	SANA_RESPONSE_TO_IFNG_DN
0.321987120515%	7	2174	85	T2D_GENES_TANYA_LIPIDS	COLDREN_GEFITINIB_RESISTANCE_UP
0.321987120515%	7	2174	84	T2D_GENES_TANYA_LIPIDS	SMID_BREAST_CANCER_LUMINAL_A_UP
0.321987120515%	7	2174	84	T2D_GENES_TANYA_LIPIDS	KEGG_SMALL_CELL_LUNG_CANCER
0.321987120515%	7	2174	84	T2D_GENES_TANYA_LIPIDS	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
0.321987120515%	7	2174	83	T2D_GENES_TANYA_LIPIDS	WARTERS_RESPONSE_TO_IR_SKIN
0.321987120515%	7	2174	83	T2D_GENES_TANYA_LIPIDS	SANA_TNF_SIGNALING_UP
0.321987120515%	7	2174	83	T2D_GENES_TANYA_LIPIDS	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.321987120515%	7	2174	82	T2D_GENES_TANYA_LIPIDS	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
0.321987120515%	7	2174	81	T2D_GENES_TANYA_LIPIDS	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
0.321987120515%	7	2174	80	T2D_GENES_TANYA_LIPIDS	LINDVALL_IMMORTALIZED_BY_TERT_DN
0.321987120515%	7	2174	80	T2D_GENES_TANYA_LIPIDS	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
0.321987120515%	7	2174	79	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16
0.321987120515%	7	2174	79	T2D_GENES_TANYA_LIPIDS	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT
0.321987120515%	7	2174	79	T2D_GENES_TANYA_LIPIDS	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
0.321987120515%	7	2174	79	T2D_GENES_TANYA_LIPIDS	LIU_COMMON_CANCER_GENES
0.321987120515%	7	2174	78	T2D_GENES_TANYA_LIPIDS	ROSS_AML_WITH_MLL_FUSIONS
0.321987120515%	7	2174	78	T2D_GENES_TANYA_LIPIDS	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP
0.321987120515%	7	2174	76	T2D_GENES_TANYA_LIPIDS	SU_TESTIS
0.321987120515%	7	2174	76	T2D_GENES_TANYA_LIPIDS	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
0.321987120515%	7	2174	75	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
0.321987120515%	7	2174	75	T2D_GENES_TANYA_LIPIDS	MORI_MATURE_B_LYMPHOCYTE_DN
0.321987120515%	7	2174	74	T2D_GENES_TANYA_LIPIDS	OUILLETTE_CLL_13Q14_DELETION_UP
0.321987120515%	7	2174	74	T2D_GENES_TANYA_LIPIDS	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
0.321987120515%	7	2174	74	T2D_GENES_TANYA_LIPIDS	LEIN_OLIGODENDROCYTE_MARKERS
0.321987120515%	7	2174	74	T2D_GENES_TANYA_LIPIDS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN
0.321987120515%	7	2174	73	T2D_GENES_TANYA_LIPIDS	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
0.321987120515%	7	2174	73	T2D_GENES_TANYA_LIPIDS	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
0.321987120515%	7	2174	72	T2D_GENES_TANYA_LIPIDS	CROONQUIST_NRAS_SIGNALING_DN
0.321987120515%	7	2174	70	T2D_GENES_TANYA_LIPIDS	RAGHAVACHARI_PLATELET_SPECIFIC_GENES
0.321987120515%	7	2174	7	T2D_GENES_TANYA_LIPIDS	NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON
0.321987120515%	7	2174	7	T2D_GENES_TANYA_LIPIDS	HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3
0.321987120515%	7	2174	7	T2D_GENES_TANYA_LIPIDS	FARMER_BREAST_CANCER_CLUSTER_8
0.321987120515%	7	2174	69	T2D_GENES_TANYA_LIPIDS	RHODES_UNDIFFERENTIATED_CANCER
0.321987120515%	7	2174	69	T2D_GENES_TANYA_LIPIDS	LEIN_NEURON_MARKERS
0.321987120515%	7	2174	69	T2D_GENES_TANYA_LIPIDS	KEGG_P53_SIGNALING_PATHWAY
0.321987120515%	7	2174	69	T2D_GENES_TANYA_LIPIDS	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
0.321987120515%	7	2174	68	T2D_GENES_TANYA_LIPIDS	PID_TELOMERASEPATHWAY
0.321987120515%	7	2174	68	T2D_GENES_TANYA_LIPIDS	DELPUECH_FOXO3_TARGETS_UP
0.321987120515%	7	2174	68	T2D_GENES_TANYA_LIPIDS	CASTELLANO_NRAS_TARGETS_UP
0.321987120515%	7	2174	68	T2D_GENES_TANYA_LIPIDS	BROWNE_INTERFERON_RESPONSIVE_GENES
0.321987120515%	7	2174	67	T2D_GENES_TANYA_LIPIDS	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.321987120515%	7	2174	67	T2D_GENES_TANYA_LIPIDS	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.321987120515%	7	2174	66	T2D_GENES_TANYA_LIPIDS	NAKAMURA_ADIPOGENESIS_EARLY_UP
0.321987120515%	7	2174	66	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER_CIPROFIBRATE_DN
0.321987120515%	7	2174	65	T2D_GENES_TANYA_LIPIDS	AMIT_SERUM_RESPONSE_120_MCF10A
0.321987120515%	7	2174	64	T2D_GENES_TANYA_LIPIDS	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
0.321987120515%	7	2174	64	T2D_GENES_TANYA_LIPIDS	LIU_SMARCA4_TARGETS
0.321987120515%	7	2174	64	T2D_GENES_TANYA_LIPIDS	GERHOLD_ADIPOGENESIS_DN
0.321987120515%	7	2174	63	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED
0.321987120515%	7	2174	63	T2D_GENES_TANYA_LIPIDS	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
0.321987120515%	7	2174	63	T2D_GENES_TANYA_LIPIDS	JOHNSTONE_PARVB_TARGETS_1_DN
0.321987120515%	7	2174	63	T2D_GENES_TANYA_LIPIDS	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
0.321987120515%	7	2174	62	T2D_GENES_TANYA_LIPIDS	PID_TRKRPATHWAY
0.321987120515%	7	2174	62	T2D_GENES_TANYA_LIPIDS	GEORGES_CELL_CYCLE_MIR192_TARGETS
0.321987120515%	7	2174	62	T2D_GENES_TANYA_LIPIDS	BILD_SRC_ONCOGENIC_SIGNATURE
0.321987120515%	7	2174	61	T2D_GENES_TANYA_LIPIDS	BAKKER_FOXO3_TARGETS_UP
0.321987120515%	7	2174	59	T2D_GENES_TANYA_LIPIDS	PID_ATF2_PATHWAY
0.321987120515%	7	2174	58	T2D_GENES_TANYA_LIPIDS	WAKASUGI_HAVE_ZNF143_BINDING_SITES
0.321987120515%	7	2174	58	T2D_GENES_TANYA_LIPIDS	PID_SHP2_PATHWAY
0.321987120515%	7	2174	58	T2D_GENES_TANYA_LIPIDS	KOHOUTEK_CCNT2_TARGETS
0.321987120515%	7	2174	58	T2D_GENES_TANYA_LIPIDS	BERNARD_PPAPDC1B_TARGETS_DN
0.321987120515%	7	2174	57	T2D_GENES_TANYA_LIPIDS	PID_TXA2PATHWAY
0.321987120515%	7	2174	57	T2D_GENES_TANYA_LIPIDS	AMIT_SERUM_RESPONSE_60_MCF10A
0.321987120515%	7	2174	56	T2D_GENES_TANYA_LIPIDS	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION
0.321987120515%	7	2174	56	T2D_GENES_TANYA_LIPIDS	HENDRICKS_SMARCA4_TARGETS_UP
0.321987120515%	7	2174	56	T2D_GENES_TANYA_LIPIDS	GRADE_COLON_VS_RECTAL_CANCER_DN
0.321987120515%	7	2174	55	T2D_GENES_TANYA_LIPIDS	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
0.321987120515%	7	2174	55	T2D_GENES_TANYA_LIPIDS	TIEN_INTESTINE_PROBIOTICS_6HR_UP
0.321987120515%	7	2174	55	T2D_GENES_TANYA_LIPIDS	PID_IL2_1PATHWAY
0.321987120515%	7	2174	55	T2D_GENES_TANYA_LIPIDS	PID_FGF_PATHWAY
0.321987120515%	7	2174	55	T2D_GENES_TANYA_LIPIDS	KEGG_BASAL_CELL_CARCINOMA
0.321987120515%	7	2174	54	T2D_GENES_TANYA_LIPIDS	REACTOME_APOPTOTIC_EXECUTION_PHASE
0.321987120515%	7	2174	54	T2D_GENES_TANYA_LIPIDS	PID_RAC1_PATHWAY
0.321987120515%	7	2174	54	T2D_GENES_TANYA_LIPIDS	AUNG_GASTRIC_CANCER
0.321987120515%	7	2174	53	T2D_GENES_TANYA_LIPIDS	ZHU_CMV_8_HR_DN
0.321987120515%	7	2174	53	T2D_GENES_TANYA_LIPIDS	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP
0.321987120515%	7	2174	53	T2D_GENES_TANYA_LIPIDS	PID_CD8TCRPATHWAY
0.321987120515%	7	2174	53	T2D_GENES_TANYA_LIPIDS	PID_AR_TF_PATHWAY
0.321987120515%	7	2174	53	T2D_GENES_TANYA_LIPIDS	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
0.321987120515%	7	2174	53	T2D_GENES_TANYA_LIPIDS	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
0.321987120515%	7	2174	52	T2D_GENES_TANYA_LIPIDS	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN
0.321987120515%	7	2174	52	T2D_GENES_TANYA_LIPIDS	PID_PTP1BPATHWAY
0.321987120515%	7	2174	52	T2D_GENES_TANYA_LIPIDS	PID_CASPASE_PATHWAY
0.321987120515%	7	2174	52	T2D_GENES_TANYA_LIPIDS	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP
0.321987120515%	7	2174	52	T2D_GENES_TANYA_LIPIDS	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN
0.321987120515%	7	2174	51	T2D_GENES_TANYA_LIPIDS	MORI_PLASMA_CELL_UP
0.321987120515%	7	2174	51	T2D_GENES_TANYA_LIPIDS	CROMER_TUMORIGENESIS_DN
0.321987120515%	7	2174	51	T2D_GENES_TANYA_LIPIDS	APPIERTO_RESPONSE_TO_FENRETINIDE_DN
0.321987120515%	7	2174	50	T2D_GENES_TANYA_LIPIDS	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
0.321987120515%	7	2174	50	T2D_GENES_TANYA_LIPIDS	HOFMANN_CELL_LYMPHOMA_UP
0.321987120515%	7	2174	50	T2D_GENES_TANYA_LIPIDS	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
0.321987120515%	7	2174	49	T2D_GENES_TANYA_LIPIDS	PID_FOXOPATHWAY
0.321987120515%	7	2174	49	T2D_GENES_TANYA_LIPIDS	APRELIKOVA_BRCA1_TARGETS
0.321987120515%	7	2174	48	T2D_GENES_TANYA_LIPIDS	GNATENKO_PLATELET_SIGNATURE
0.321987120515%	7	2174	47	T2D_GENES_TANYA_LIPIDS	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP
0.321987120515%	7	2174	47	T2D_GENES_TANYA_LIPIDS	PID_LKB1_PATHWAY
0.321987120515%	7	2174	47	T2D_GENES_TANYA_LIPIDS	BOYLAN_MULTIPLE_MYELOMA_C_UP
0.321987120515%	7	2174	46	T2D_GENES_TANYA_LIPIDS	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
0.321987120515%	7	2174	46	T2D_GENES_TANYA_LIPIDS	PID_TNFPATHWAY
0.321987120515%	7	2174	46	T2D_GENES_TANYA_LIPIDS	PID_RHOA_REG_PATHWAY
0.321987120515%	7	2174	46	T2D_GENES_TANYA_LIPIDS	PID_PS1PATHWAY
0.321987120515%	7	2174	46	T2D_GENES_TANYA_LIPIDS	PARENT_MTOR_SIGNALING_DN
0.321987120515%	7	2174	46	T2D_GENES_TANYA_LIPIDS	NUTT_GBM_VS_AO_GLIOMA_UP
0.321987120515%	7	2174	46	T2D_GENES_TANYA_LIPIDS	ABBUD_LIF_SIGNALING_1_UP
0.321987120515%	7	2174	45	T2D_GENES_TANYA_LIPIDS	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
0.321987120515%	7	2174	45	T2D_GENES_TANYA_LIPIDS	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_
0.321987120515%	7	2174	45	T2D_GENES_TANYA_LIPIDS	CHANDRAN_METASTASIS_TOP50_DN
0.321987120515%	7	2174	44	T2D_GENES_TANYA_LIPIDS	MEDINA_SMARCA4_TARGETS
0.321987120515%	7	2174	44	T2D_GENES_TANYA_LIPIDS	KERLEY_RESPONSE_TO_CISPLATIN_UP
0.321987120515%	7	2174	44	T2D_GENES_TANYA_LIPIDS	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION
0.321987120515%	7	2174	44	T2D_GENES_TANYA_LIPIDS	KEGG_LYSINE_DEGRADATION
0.321987120515%	7	2174	44	T2D_GENES_TANYA_LIPIDS	FAELT_B_CLL_WITH_VH3_21_UP
0.321987120515%	7	2174	43	T2D_GENES_TANYA_LIPIDS	POTTI_ETOPOSIDE_SENSITIVITY
0.321987120515%	7	2174	43	T2D_GENES_TANYA_LIPIDS	AMIT_EGF_RESPONSE_480_MCF10A
0.321987120515%	7	2174	42	T2D_GENES_TANYA_LIPIDS	REACTOME_TRNA_AMINOACYLATION
0.321987120515%	7	2174	42	T2D_GENES_TANYA_LIPIDS	PID_ECADHERIN_STABILIZATION_PATHWAY
0.321987120515%	7	2174	42	T2D_GENES_TANYA_LIPIDS	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
0.321987120515%	7	2174	41	T2D_GENES_TANYA_LIPIDS	WENG_POR_TARGETS_LIVER_UP
0.321987120515%	7	2174	41	T2D_GENES_TANYA_LIPIDS	REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING
0.321987120515%	7	2174	41	T2D_GENES_TANYA_LIPIDS	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS
0.321987120515%	7	2174	41	T2D_GENES_TANYA_LIPIDS	DELPUECH_FOXO3_TARGETS_DN
0.321987120515%	7	2174	40	T2D_GENES_TANYA_LIPIDS	ST_B_CELL_ANTIGEN_RECEPTOR
0.321987120515%	7	2174	40	T2D_GENES_TANYA_LIPIDS	KEGG_TRYPTOPHAN_METABOLISM
0.321987120515%	7	2174	40	T2D_GENES_TANYA_LIPIDS	JIANG_AGING_HYPOTHALAMUS_DN
0.321987120515%	7	2174	40	T2D_GENES_TANYA_LIPIDS	GENTILE_UV_RESPONSE_CLUSTER_D8
0.321987120515%	7	2174	39	T2D_GENES_TANYA_LIPIDS	STONER_ESOPHAGEAL_CARCINOGENESIS_UP
0.321987120515%	7	2174	39	T2D_GENES_TANYA_LIPIDS	SHIPP_DLBCL_CURED_VS_FATAL_UP
0.321987120515%	7	2174	39	T2D_GENES_TANYA_LIPIDS	PID_RET_PATHWAY
0.321987120515%	7	2174	39	T2D_GENES_TANYA_LIPIDS	PID_AURORA_B_PATHWAY
0.321987120515%	7	2174	39	T2D_GENES_TANYA_LIPIDS	BILANGES_RAPAMYCIN_SENSITIVE_GENES
0.321987120515%	7	2174	38	T2D_GENES_TANYA_LIPIDS	REACTOME_GLUCOSE_TRANSPORT
0.321987120515%	7	2174	38	T2D_GENES_TANYA_LIPIDS	PID_P38ALPHABETADOWNSTREAMPATHWAY
0.321987120515%	7	2174	38	T2D_GENES_TANYA_LIPIDS	KYNG_DNA_DAMAGE_BY_4NQO
0.321987120515%	7	2174	38	T2D_GENES_TANYA_LIPIDS	CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN
0.321987120515%	7	2174	37	T2D_GENES_TANYA_LIPIDS	ST_GA13_PATHWAY
0.321987120515%	7	2174	37	T2D_GENES_TANYA_LIPIDS	BIOCARTA_TOLL_PATHWAY
0.321987120515%	7	2174	37	T2D_GENES_TANYA_LIPIDS	BIOCARTA_GPCR_PATHWAY
0.321987120515%	7	2174	37	T2D_GENES_TANYA_LIPIDS	BIOCARTA_BCR_PATHWAY
0.321987120515%	7	2174	36	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALLING_TO_ERKS
0.321987120515%	7	2174	36	T2D_GENES_TANYA_LIPIDS	REACTOME_IRON_UPTAKE_AND_TRANSPORT
0.321987120515%	7	2174	36	T2D_GENES_TANYA_LIPIDS	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP
0.321987120515%	7	2174	35	T2D_GENES_TANYA_LIPIDS	RODRIGUES_NTN1_AND_DCC_TARGETS
0.321987120515%	7	2174	35	T2D_GENES_TANYA_LIPIDS	HU_GENOTOXIC_DAMAGE_24HR
0.321987120515%	7	2174	35	T2D_GENES_TANYA_LIPIDS	HOWLIN_CITED1_TARGETS_1_UP
0.321987120515%	7	2174	34	T2D_GENES_TANYA_LIPIDS	PID_EPOPATHWAY
0.321987120515%	7	2174	34	T2D_GENES_TANYA_LIPIDS	KEGG_BUTANOATE_METABOLISM
0.321987120515%	7	2174	34	T2D_GENES_TANYA_LIPIDS	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP
0.321987120515%	7	2174	33	T2D_GENES_TANYA_LIPIDS	REACTOME_PURINE_METABOLISM
0.321987120515%	7	2174	33	T2D_GENES_TANYA_LIPIDS	PID_SYNDECAN_2_PATHWAY
0.321987120515%	7	2174	33	T2D_GENES_TANYA_LIPIDS	PID_NCADHERINPATHWAY
0.321987120515%	7	2174	33	T2D_GENES_TANYA_LIPIDS	PID_IL12_STAT4PATHWAY
0.321987120515%	7	2174	33	T2D_GENES_TANYA_LIPIDS	KEGG_PROPANOATE_METABOLISM
0.321987120515%	7	2174	33	T2D_GENES_TANYA_LIPIDS	JEPSEN_SMRT_TARGETS
0.321987120515%	7	2174	33	T2D_GENES_TANYA_LIPIDS	BIOCARTA_NO1_PATHWAY
0.321987120515%	7	2174	328	T2D_GENES_TANYA_LIPIDS	REACTOME_OLFACTORY_SIGNALING_PATHWAY
0.321987120515%	7	2174	32	T2D_GENES_TANYA_LIPIDS	SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY
0.321987120515%	7	2174	32	T2D_GENES_TANYA_LIPIDS	KIM_TIAL1_TARGETS
0.321987120515%	7	2174	32	T2D_GENES_TANYA_LIPIDS	DIRMEIER_LMP1_RESPONSE_LATE_DN
0.321987120515%	7	2174	32	T2D_GENES_TANYA_LIPIDS	AMIT_SERUM_RESPONSE_40_MCF10A
0.321987120515%	7	2174	31	T2D_GENES_TANYA_LIPIDS	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
0.321987120515%	7	2174	30	T2D_GENES_TANYA_LIPIDS	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN
0.321987120515%	7	2174	30	T2D_GENES_TANYA_LIPIDS	VALK_AML_CLUSTER_13
0.321987120515%	7	2174	30	T2D_GENES_TANYA_LIPIDS	REACTOME_BASIGIN_INTERACTIONS
0.321987120515%	7	2174	30	T2D_GENES_TANYA_LIPIDS	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP
0.321987120515%	7	2174	29	T2D_GENES_TANYA_LIPIDS	BIOCARTA_VIP_PATHWAY
0.321987120515%	7	2174	29	T2D_GENES_TANYA_LIPIDS	BIOCARTA_VEGF_PATHWAY
0.321987120515%	7	2174	28	T2D_GENES_TANYA_LIPIDS	PID_LIS1PATHWAY
0.321987120515%	7	2174	28	T2D_GENES_TANYA_LIPIDS	OLSSON_E2F3_TARGETS_UP
0.321987120515%	7	2174	27	T2D_GENES_TANYA_LIPIDS	ST_MYOCYTE_AD_PATHWAY
0.321987120515%	7	2174	27	T2D_GENES_TANYA_LIPIDS	BIOCARTA_EDG1_PATHWAY
0.321987120515%	7	2174	25	T2D_GENES_TANYA_LIPIDS	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP
0.321987120515%	7	2174	25	T2D_GENES_TANYA_LIPIDS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN
0.321987120515%	7	2174	25	T2D_GENES_TANYA_LIPIDS	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP
0.321987120515%	7	2174	24	T2D_GENES_TANYA_LIPIDS	PETRETTO_HEART_MASS_QTL_CIS_DN
0.321987120515%	7	2174	24	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CXCR4_PATHWAY
0.321987120515%	7	2174	24	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CSK_PATHWAY
0.321987120515%	7	2174	23	T2D_GENES_TANYA_LIPIDS	HASLINGER_B_CLL_WITH_11Q23_DELETION
0.321987120515%	7	2174	23	T2D_GENES_TANYA_LIPIDS	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
0.321987120515%	7	2174	23	T2D_GENES_TANYA_LIPIDS	BIOCARTA_RAS_PATHWAY
0.321987120515%	7	2174	22	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CERAMIDE_PATHWAY
0.321987120515%	7	2174	18	T2D_GENES_TANYA_LIPIDS	REACTOME_PD1_SIGNALING
0.321987120515%	7	2174	179	T2D_GENES_TANYA_LIPIDS	BENPORATH_NOS_TARGETS
0.321987120515%	7	2174	16	T2D_GENES_TANYA_LIPIDS	REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS
0.321987120515%	7	2174	153	T2D_GENES_TANYA_LIPIDS	DAZARD_UV_RESPONSE_CLUSTER_G6
0.321987120515%	7	2174	141	T2D_GENES_TANYA_LIPIDS	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP
0.321987120515%	7	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE
0.321987120515%	7	2174	139	T2D_GENES_TANYA_LIPIDS	HOELZEL_NF1_TARGETS_UP
0.321987120515%	7	2174	127	T2D_GENES_TANYA_LIPIDS	LIU_VMYB_TARGETS_UP
0.321987120515%	7	2174	121	T2D_GENES_TANYA_LIPIDS	RODRIGUES_DCC_TARGETS_DN
0.321987120515%	7	2174	112	T2D_GENES_TANYA_LIPIDS	PASINI_SUZ12_TARGETS_UP
0.321987120515%	7	2174	112	T2D_GENES_TANYA_LIPIDS	LABBE_WNT3A_TARGETS_UP
0.321987120515%	7	2174	107	T2D_GENES_TANYA_LIPIDS	LEE_EARLY_T_LYMPHOCYTE_UP
0.321987120515%	7	2174	102	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_IPS_WITH_HCP_H3K27ME3
0.321987120515%	7	2174	101	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_12HR_DN
0.321987120515%	7	2174	100	T2D_GENES_TANYA_LIPIDS	MCCLUNG_CREB1_TARGETS_UP
0.321987120515%	7	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_ETHANOL_OXIDATION
0.320684126136%	6	1871	98	T2D_GENES_TANYA_HEIGHT	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
0.320684126136%	6	1871	98	T2D_GENES_TANYA_HEIGHT	CROONQUIST_IL6_DEPRIVATION_DN
0.320684126136%	6	1871	97	T2D_GENES_TANYA_HEIGHT	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
0.320684126136%	6	1871	94	T2D_GENES_TANYA_HEIGHT	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.320684126136%	6	1871	94	T2D_GENES_TANYA_HEIGHT	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5
0.320684126136%	6	1871	94	T2D_GENES_TANYA_HEIGHT	GAVIN_FOXP3_TARGETS_CLUSTER_T4
0.320684126136%	6	1871	92	T2D_GENES_TANYA_HEIGHT	BURTON_ADIPOGENESIS_9
0.320684126136%	6	1871	90	T2D_GENES_TANYA_HEIGHT	IVANOVSKA_MIR106B_TARGETS
0.320684126136%	6	1871	90	T2D_GENES_TANYA_HEIGHT	GAVIN_FOXP3_TARGETS_CLUSTER_P7
0.320684126136%	6	1871	88	T2D_GENES_TANYA_HEIGHT	ALCALA_APOPTOSIS
0.320684126136%	6	1871	87	T2D_GENES_TANYA_HEIGHT	SMITH_TERT_TARGETS_DN
0.320684126136%	6	1871	86	T2D_GENES_TANYA_HEIGHT	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
0.320684126136%	6	1871	84	T2D_GENES_TANYA_HEIGHT	RUAN_RESPONSE_TO_TNF_DN
0.320684126136%	6	1871	84	T2D_GENES_TANYA_HEIGHT	PID_CMYB_PATHWAY
0.320684126136%	6	1871	84	T2D_GENES_TANYA_HEIGHT	KEGG_SMALL_CELL_LUNG_CANCER
0.320684126136%	6	1871	83	T2D_GENES_TANYA_HEIGHT	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.320684126136%	6	1871	82	T2D_GENES_TANYA_HEIGHT	BILD_CTNNB1_ONCOGENIC_SIGNATURE
0.320684126136%	6	1871	81	T2D_GENES_TANYA_HEIGHT	REACTOME_MITOTIC_G2_G2_M_PHASES
0.320684126136%	6	1871	81	T2D_GENES_TANYA_HEIGHT	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION
0.320684126136%	6	1871	81	T2D_GENES_TANYA_HEIGHT	MAHAJAN_RESPONSE_TO_IL1A_UP
0.320684126136%	6	1871	81	T2D_GENES_TANYA_HEIGHT	CROMER_METASTASIS_DN
0.320684126136%	6	1871	80	T2D_GENES_TANYA_HEIGHT	PID_MET_PATHWAY
0.320684126136%	6	1871	80	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
0.320684126136%	6	1871	80	T2D_GENES_TANYA_HEIGHT	LINDVALL_IMMORTALIZED_BY_TERT_DN
0.320684126136%	6	1871	80	T2D_GENES_TANYA_HEIGHT	LEE_AGING_NEOCORTEX_DN
0.320684126136%	6	1871	80	T2D_GENES_TANYA_HEIGHT	KEGG_CARDIAC_MUSCLE_CONTRACTION
0.320684126136%	6	1871	79	T2D_GENES_TANYA_HEIGHT	MCCLUNG_COCAINE_REWARD_5D
0.320684126136%	6	1871	79	T2D_GENES_TANYA_HEIGHT	CROMER_METASTASIS_UP
0.320684126136%	6	1871	78	T2D_GENES_TANYA_HEIGHT	ROSS_LEUKEMIA_WITH_MLL_FUSIONS
0.320684126136%	6	1871	77	T2D_GENES_TANYA_HEIGHT	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
0.320684126136%	6	1871	77	T2D_GENES_TANYA_HEIGHT	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.320684126136%	6	1871	76	T2D_GENES_TANYA_HEIGHT	NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON
0.320684126136%	6	1871	76	T2D_GENES_TANYA_HEIGHT	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
0.320684126136%	6	1871	75	T2D_GENES_TANYA_HEIGHT	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
0.320684126136%	6	1871	75	T2D_GENES_TANYA_HEIGHT	MCCLUNG_COCAIN_REWARD_4WK
0.320684126136%	6	1871	75	T2D_GENES_TANYA_HEIGHT	KEGG_ADHERENS_JUNCTION
0.320684126136%	6	1871	75	T2D_GENES_TANYA_HEIGHT	CHESLER_BRAIN_QTL_CIS
0.320684126136%	6	1871	74	T2D_GENES_TANYA_HEIGHT	RAMALHO_STEMNESS_DN
0.320684126136%	6	1871	74	T2D_GENES_TANYA_HEIGHT	PID_E2F_PATHWAY
0.320684126136%	6	1871	74	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
0.320684126136%	6	1871	74	T2D_GENES_TANYA_HEIGHT	LIAN_LIPA_TARGETS_6M
0.320684126136%	6	1871	73	T2D_GENES_TANYA_HEIGHT	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
0.320684126136%	6	1871	73	T2D_GENES_TANYA_HEIGHT	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.320684126136%	6	1871	72	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
0.320684126136%	6	1871	72	T2D_GENES_TANYA_HEIGHT	HUANG_GATA2_TARGETS_DN
0.320684126136%	6	1871	72	T2D_GENES_TANYA_HEIGHT	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
0.320684126136%	6	1871	72	T2D_GENES_TANYA_HEIGHT	DANG_REGULATED_BY_MYC_UP
0.320684126136%	6	1871	71	T2D_GENES_TANYA_HEIGHT	KEGG_MELANOMA
0.320684126136%	6	1871	71	T2D_GENES_TANYA_HEIGHT	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
0.320684126136%	6	1871	70	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_NOTCH1
0.320684126136%	6	1871	70	T2D_GENES_TANYA_HEIGHT	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.320684126136%	6	1871	70	T2D_GENES_TANYA_HEIGHT	RAGHAVACHARI_PLATELET_SPECIFIC_GENES
0.320684126136%	6	1871	69	T2D_GENES_TANYA_HEIGHT	HUANG_DASATINIB_RESISTANCE_DN
0.320684126136%	6	1871	69	T2D_GENES_TANYA_HEIGHT	HOWLIN_PUBERTAL_MAMMARY_GLAND
0.320684126136%	6	1871	68	T2D_GENES_TANYA_HEIGHT	ROSS_AML_OF_FAB_M7_TYPE
0.320684126136%	6	1871	68	T2D_GENES_TANYA_HEIGHT	NOUZOVA_METHYLATED_IN_APL
0.320684126136%	6	1871	68	T2D_GENES_TANYA_HEIGHT	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
0.320684126136%	6	1871	68	T2D_GENES_TANYA_HEIGHT	DELPUECH_FOXO3_TARGETS_UP
0.320684126136%	6	1871	67	T2D_GENES_TANYA_HEIGHT	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
0.320684126136%	6	1871	67	T2D_GENES_TANYA_HEIGHT	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.320684126136%	6	1871	67	T2D_GENES_TANYA_HEIGHT	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
0.320684126136%	6	1871	66	T2D_GENES_TANYA_HEIGHT	NAKAMURA_ADIPOGENESIS_EARLY_UP
0.320684126136%	6	1871	66	T2D_GENES_TANYA_HEIGHT	MARSON_FOXP3_TARGETS_UP
0.320684126136%	6	1871	66	T2D_GENES_TANYA_HEIGHT	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN
0.320684126136%	6	1871	66	T2D_GENES_TANYA_HEIGHT	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
0.320684126136%	6	1871	66	T2D_GENES_TANYA_HEIGHT	BRUNO_HEMATOPOIESIS
0.320684126136%	6	1871	65	T2D_GENES_TANYA_HEIGHT	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP
0.320684126136%	6	1871	65	T2D_GENES_TANYA_HEIGHT	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP
0.320684126136%	6	1871	64	T2D_GENES_TANYA_HEIGHT	ZHANG_GATA6_TARGETS_DN
0.320684126136%	6	1871	64	T2D_GENES_TANYA_HEIGHT	RHODES_CANCER_META_SIGNATURE
0.320684126136%	6	1871	64	T2D_GENES_TANYA_HEIGHT	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.320684126136%	6	1871	64	T2D_GENES_TANYA_HEIGHT	BYSTROEM_CORRELATED_WITH_IL5_DN
0.320684126136%	6	1871	63	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER_MYC_DN
0.320684126136%	6	1871	63	T2D_GENES_TANYA_HEIGHT	JOHNSTONE_PARVB_TARGETS_1_DN
0.320684126136%	6	1871	63	T2D_GENES_TANYA_HEIGHT	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
0.320684126136%	6	1871	63	T2D_GENES_TANYA_HEIGHT	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
0.320684126136%	6	1871	63	T2D_GENES_TANYA_HEIGHT	BRIDEAU_IMPRINTED_GENES
0.320684126136%	6	1871	62	T2D_GENES_TANYA_HEIGHT	PID_TRKRPATHWAY
0.320684126136%	6	1871	62	T2D_GENES_TANYA_HEIGHT	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.320684126136%	6	1871	62	T2D_GENES_TANYA_HEIGHT	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP
0.320684126136%	6	1871	62	T2D_GENES_TANYA_HEIGHT	BILD_SRC_ONCOGENIC_SIGNATURE
0.320684126136%	6	1871	61	T2D_GENES_TANYA_HEIGHT	RAMASWAMY_METASTASIS_DN
0.320684126136%	6	1871	61	T2D_GENES_TANYA_HEIGHT	MASSARWEH_RESPONSE_TO_ESTRADIOL
0.320684126136%	6	1871	61	T2D_GENES_TANYA_HEIGHT	BAKKER_FOXO3_TARGETS_UP
0.320684126136%	6	1871	59	T2D_GENES_TANYA_HEIGHT	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
0.320684126136%	6	1871	59	T2D_GENES_TANYA_HEIGHT	DASU_IL6_SIGNALING_UP
0.320684126136%	6	1871	58	T2D_GENES_TANYA_HEIGHT	WAKASUGI_HAVE_ZNF143_BINDING_SITES
0.320684126136%	6	1871	58	T2D_GENES_TANYA_HEIGHT	SANSOM_WNT_PATHWAY_REQUIRE_MYC
0.320684126136%	6	1871	58	T2D_GENES_TANYA_HEIGHT	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
0.320684126136%	6	1871	57	T2D_GENES_TANYA_HEIGHT	MCCLUNG_CREB1_TARGETS_DN
0.320684126136%	6	1871	56	T2D_GENES_TANYA_HEIGHT	HENDRICKS_SMARCA4_TARGETS_UP
0.320684126136%	6	1871	56	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_10HR_DN
0.320684126136%	6	1871	55	T2D_GENES_TANYA_HEIGHT	PID_TGFBRPATHWAY
0.320684126136%	6	1871	54	T2D_GENES_TANYA_HEIGHT	ZHOU_TNF_SIGNALING_4HR
0.320684126136%	6	1871	54	T2D_GENES_TANYA_HEIGHT	ZHOU_TNF_SIGNALING_30MIN
0.320684126136%	6	1871	54	T2D_GENES_TANYA_HEIGHT	RICKMAN_HEAD_AND_NECK_CANCER_F
0.320684126136%	6	1871	54	T2D_GENES_TANYA_HEIGHT	REACTOME_APOPTOTIC_EXECUTION_PHASE
0.320684126136%	6	1871	54	T2D_GENES_TANYA_HEIGHT	PID_NFAT_3PATHWAY
0.320684126136%	6	1871	54	T2D_GENES_TANYA_HEIGHT	KEGG_NON_SMALL_CELL_LUNG_CANCER
0.320684126136%	6	1871	54	T2D_GENES_TANYA_HEIGHT	KANG_DOXORUBICIN_RESISTANCE_UP
0.320684126136%	6	1871	54	T2D_GENES_TANYA_HEIGHT	FIGUEROA_AML_METHYLATION_CLUSTER_2_UP
0.320684126136%	6	1871	53	T2D_GENES_TANYA_HEIGHT	PID_AR_TF_PATHWAY
0.320684126136%	6	1871	53	T2D_GENES_TANYA_HEIGHT	LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.320684126136%	6	1871	53	T2D_GENES_TANYA_HEIGHT	KRIEG_HYPOXIA_VIA_KDM3A
0.320684126136%	6	1871	53	T2D_GENES_TANYA_HEIGHT	HENDRICKS_SMARCA4_TARGETS_DN
0.320684126136%	6	1871	52	T2D_GENES_TANYA_HEIGHT	ROSS_AML_WITH_CBFB_MYH11_FUSION
0.320684126136%	6	1871	52	T2D_GENES_TANYA_HEIGHT	KENNY_CTNNB1_TARGETS_DN
0.320684126136%	6	1871	52	T2D_GENES_TANYA_HEIGHT	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP
0.320684126136%	6	1871	51	T2D_GENES_TANYA_HEIGHT	ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF
0.320684126136%	6	1871	51	T2D_GENES_TANYA_HEIGHT	ZHANG_PROLIFERATING_VS_QUIESCENT
0.320684126136%	6	1871	51	T2D_GENES_TANYA_HEIGHT	TSUNODA_CISPLATIN_RESISTANCE_DN
0.320684126136%	6	1871	51	T2D_GENES_TANYA_HEIGHT	PRAMOONJAGO_SOX4_TARGETS_DN
0.320684126136%	6	1871	51	T2D_GENES_TANYA_HEIGHT	MORI_PLASMA_CELL_UP
0.320684126136%	6	1871	51	T2D_GENES_TANYA_HEIGHT	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
0.320684126136%	6	1871	51	T2D_GENES_TANYA_HEIGHT	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
0.320684126136%	6	1871	51	T2D_GENES_TANYA_HEIGHT	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
0.320684126136%	6	1871	50	T2D_GENES_TANYA_HEIGHT	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN
0.320684126136%	6	1871	50	T2D_GENES_TANYA_HEIGHT	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
0.320684126136%	6	1871	50	T2D_GENES_TANYA_HEIGHT	PID_ANGIOPOIETINRECEPTOR_PATHWAY
0.320684126136%	6	1871	50	T2D_GENES_TANYA_HEIGHT	NADERI_BREAST_CANCER_PROGNOSIS_UP
0.320684126136%	6	1871	50	T2D_GENES_TANYA_HEIGHT	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN
0.320684126136%	6	1871	50	T2D_GENES_TANYA_HEIGHT	CHIBA_RESPONSE_TO_TSA
0.320684126136%	6	1871	49	T2D_GENES_TANYA_HEIGHT	WONG_PROTEASOME_GENE_MODULE
0.320684126136%	6	1871	49	T2D_GENES_TANYA_HEIGHT	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
0.320684126136%	6	1871	49	T2D_GENES_TANYA_HEIGHT	OLSSON_E2F3_TARGETS_DN
0.320684126136%	6	1871	49	T2D_GENES_TANYA_HEIGHT	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP
0.320684126136%	6	1871	49	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_2HR_DN
0.320684126136%	6	1871	49	T2D_GENES_TANYA_HEIGHT	BIOCARTA_TCR_PATHWAY
0.320684126136%	6	1871	48	T2D_GENES_TANYA_HEIGHT	PID_AJDISS_2PATHWAY
0.320684126136%	6	1871	48	T2D_GENES_TANYA_HEIGHT	MCDOWELL_ACUTE_LUNG_INJURY_DN
0.320684126136%	6	1871	48	T2D_GENES_TANYA_HEIGHT	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
0.320684126136%	6	1871	48	T2D_GENES_TANYA_HEIGHT	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
0.320684126136%	6	1871	48	T2D_GENES_TANYA_HEIGHT	CHANGOLKAR_H2AFY_TARGETS_UP
0.320684126136%	6	1871	47	T2D_GENES_TANYA_HEIGHT	ZHU_CMV_8_HR_UP
0.320684126136%	6	1871	47	T2D_GENES_TANYA_HEIGHT	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
0.320684126136%	6	1871	47	T2D_GENES_TANYA_HEIGHT	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
0.320684126136%	6	1871	45	T2D_GENES_TANYA_HEIGHT	ST_T_CELL_SIGNAL_TRANSDUCTION
0.320684126136%	6	1871	45	T2D_GENES_TANYA_HEIGHT	SHIPP_DLBCL_CURED_VS_FATAL_DN
0.320684126136%	6	1871	45	T2D_GENES_TANYA_HEIGHT	PID_RHOA_PATHWAY
0.320684126136%	6	1871	45	T2D_GENES_TANYA_HEIGHT	NUTT_GBM_VS_AO_GLIOMA_DN
0.320684126136%	6	1871	45	T2D_GENES_TANYA_HEIGHT	BIOCARTA_BIOPEPTIDES_PATHWAY
0.320684126136%	6	1871	44	T2D_GENES_TANYA_HEIGHT	WHITFIELD_CELL_CYCLE_LITERATURE
0.320684126136%	6	1871	44	T2D_GENES_TANYA_HEIGHT	WANG_TARGETS_OF_MLL_CBP_FUSION_UP
0.320684126136%	6	1871	44	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS
0.320684126136%	6	1871	44	T2D_GENES_TANYA_HEIGHT	MEDINA_SMARCA4_TARGETS
0.320684126136%	6	1871	44	T2D_GENES_TANYA_HEIGHT	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS
0.320684126136%	6	1871	44	T2D_GENES_TANYA_HEIGHT	KERLEY_RESPONSE_TO_CISPLATIN_UP
0.320684126136%	6	1871	43	T2D_GENES_TANYA_HEIGHT	REACTOME_PLC_BETA_MEDIATED_EVENTS
0.320684126136%	6	1871	43	T2D_GENES_TANYA_HEIGHT	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK
0.320684126136%	6	1871	43	T2D_GENES_TANYA_HEIGHT	POTTI_ETOPOSIDE_SENSITIVITY
0.320684126136%	6	1871	43	T2D_GENES_TANYA_HEIGHT	AMIT_EGF_RESPONSE_480_MCF10A
0.320684126136%	6	1871	42	T2D_GENES_TANYA_HEIGHT	PID_BMPPATHWAY
0.320684126136%	6	1871	41	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_DN
0.320684126136%	6	1871	41	T2D_GENES_TANYA_HEIGHT	MALONEY_RESPONSE_TO_17AAG_UP
0.320684126136%	6	1871	41	T2D_GENES_TANYA_HEIGHT	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
0.320684126136%	6	1871	41	T2D_GENES_TANYA_HEIGHT	DELPUECH_FOXO3_TARGETS_DN
0.320684126136%	6	1871	40	T2D_GENES_TANYA_HEIGHT	TOMLINS_PROSTATE_CANCER_UP
0.320684126136%	6	1871	40	T2D_GENES_TANYA_HEIGHT	HEIDENBLAD_AMPLICON_8Q24_UP
0.320684126136%	6	1871	40	T2D_GENES_TANYA_HEIGHT	GENTILE_UV_RESPONSE_CLUSTER_D8
0.320684126136%	6	1871	40	T2D_GENES_TANYA_HEIGHT	AMUNDSON_GAMMA_RADIATION_RESPONSE
0.320684126136%	6	1871	39	T2D_GENES_TANYA_HEIGHT	SESTO_RESPONSE_TO_UV_C6
0.320684126136%	6	1871	39	T2D_GENES_TANYA_HEIGHT	BIOCARTA_FMLP_PATHWAY
0.320684126136%	6	1871	38	T2D_GENES_TANYA_HEIGHT	REACTOME_GLYCOSPHINGOLIPID_METABOLISM
0.320684126136%	6	1871	38	T2D_GENES_TANYA_HEIGHT	PENG_GLUTAMINE_DEPRIVATION_UP
0.320684126136%	6	1871	38	T2D_GENES_TANYA_HEIGHT	KRASNOSELSKAYA_ILF3_TARGETS_UP
0.320684126136%	6	1871	38	T2D_GENES_TANYA_HEIGHT	GEISS_RESPONSE_TO_DSRNA_UP
0.320684126136%	6	1871	38	T2D_GENES_TANYA_HEIGHT	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN
0.320684126136%	6	1871	37	T2D_GENES_TANYA_HEIGHT	RICKMAN_HEAD_AND_NECK_CANCER_D
0.320684126136%	6	1871	37	T2D_GENES_TANYA_HEIGHT	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING
0.320684126136%	6	1871	37	T2D_GENES_TANYA_HEIGHT	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR
0.320684126136%	6	1871	37	T2D_GENES_TANYA_HEIGHT	CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE
0.320684126136%	6	1871	37	T2D_GENES_TANYA_HEIGHT	BIOCARTA_PAR1_PATHWAY
0.320684126136%	6	1871	36	T2D_GENES_TANYA_HEIGHT	VALK_AML_CLUSTER_11
0.320684126136%	6	1871	36	T2D_GENES_TANYA_HEIGHT	SUBTIL_PROGESTIN_TARGETS
0.320684126136%	6	1871	36	T2D_GENES_TANYA_HEIGHT	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.320684126136%	6	1871	36	T2D_GENES_TANYA_HEIGHT	JIANG_AGING_CEREBRAL_CORTEX_UP
0.320684126136%	6	1871	34	T2D_GENES_TANYA_HEIGHT	PID_MAPKTRKPATHWAY
0.320684126136%	6	1871	34	T2D_GENES_TANYA_HEIGHT	PID_IL1PATHWAY
0.320684126136%	6	1871	34	T2D_GENES_TANYA_HEIGHT	PETRETTO_CARDIAC_HYPERTROPHY
0.320684126136%	6	1871	33	T2D_GENES_TANYA_HEIGHT	REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS
0.320684126136%	6	1871	33	T2D_GENES_TANYA_HEIGHT	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.320684126136%	6	1871	33	T2D_GENES_TANYA_HEIGHT	FIRESTEIN_CTNNB1_PATHWAY
0.320684126136%	6	1871	32	T2D_GENES_TANYA_HEIGHT	POS_HISTAMINE_RESPONSE_NETWORK
0.320684126136%	6	1871	32	T2D_GENES_TANYA_HEIGHT	BAUS_TFF2_TARGETS_UP
0.320684126136%	6	1871	32	T2D_GENES_TANYA_HEIGHT	BAE_BRCA1_TARGETS_DN
0.320684126136%	6	1871	31	T2D_GENES_TANYA_HEIGHT	VALK_AML_CLUSTER_15
0.320684126136%	6	1871	31	T2D_GENES_TANYA_HEIGHT	REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING
0.320684126136%	6	1871	31	T2D_GENES_TANYA_HEIGHT	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN
0.320684126136%	6	1871	30	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
0.320684126136%	6	1871	30	T2D_GENES_TANYA_HEIGHT	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP
0.320684126136%	6	1871	30	T2D_GENES_TANYA_HEIGHT	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP
0.320684126136%	6	1871	29	T2D_GENES_TANYA_HEIGHT	BIOCARTA_NKT_PATHWAY
0.320684126136%	6	1871	28	T2D_GENES_TANYA_HEIGHT	PETRETTO_HEART_MASS_QTL_CIS_UP
0.320684126136%	6	1871	28	T2D_GENES_TANYA_HEIGHT	BIOCARTA_G1_PATHWAY
0.320684126136%	6	1871	27	T2D_GENES_TANYA_HEIGHT	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
0.320684126136%	6	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_G_PROTEIN_ACTIVATION
0.320684126136%	6	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT
0.320684126136%	6	1871	26	T2D_GENES_TANYA_HEIGHT	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
0.320684126136%	6	1871	26	T2D_GENES_TANYA_HEIGHT	PID_RXR_VDR_PATHWAY
0.320684126136%	6	1871	26	T2D_GENES_TANYA_HEIGHT	ALONSO_METASTASIS_DN
0.320684126136%	6	1871	25	T2D_GENES_TANYA_HEIGHT	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP
0.320684126136%	6	1871	25	T2D_GENES_TANYA_HEIGHT	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP
0.320684126136%	6	1871	25	T2D_GENES_TANYA_HEIGHT	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP
0.320684126136%	6	1871	24	T2D_GENES_TANYA_HEIGHT	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING
0.320684126136%	6	1871	24	T2D_GENES_TANYA_HEIGHT	BIOCARTA_NTHI_PATHWAY
0.320684126136%	6	1871	24	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CSK_PATHWAY
0.320684126136%	6	1871	22	T2D_GENES_TANYA_HEIGHT	PID_HEDGEHOG_2PATHWAY
0.320684126136%	6	1871	22	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CYTOKINE_PATHWAY
0.320684126136%	6	1871	21	T2D_GENES_TANYA_HEIGHT	REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION
0.320684126136%	6	1871	21	T2D_GENES_TANYA_HEIGHT	DAZARD_UV_RESPONSE_CLUSTER_G4
0.320684126136%	6	1871	20	T2D_GENES_TANYA_HEIGHT	MURAKAMI_UV_RESPONSE_24HR
0.320684126136%	6	1871	15	T2D_GENES_TANYA_HEIGHT	BIOCARTA_ERYTH_PATHWAY
0.320684126136%	6	1871	141	T2D_GENES_TANYA_HEIGHT	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP
0.320684126136%	6	1871	14	T2D_GENES_TANYA_HEIGHT	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN
0.320684126136%	6	1871	138	T2D_GENES_TANYA_HEIGHT	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
0.320684126136%	6	1871	133	T2D_GENES_TANYA_HEIGHT	KEGG_PARKINSONS_DISEASE
0.320684126136%	6	1871	125	T2D_GENES_TANYA_HEIGHT	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
0.320684126136%	6	1871	121	T2D_GENES_TANYA_HEIGHT	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
0.320684126136%	6	1871	118	T2D_GENES_TANYA_HEIGHT	MARKEY_RB1_CHRONIC_LOF_DN
0.320684126136%	6	1871	108	T2D_GENES_TANYA_HEIGHT	TAVAZOIE_METASTASIS
0.320684126136%	6	1871	108	T2D_GENES_TANYA_HEIGHT	LABBE_TGFB1_TARGETS_DN
0.320684126136%	6	1871	102	T2D_GENES_TANYA_HEIGHT	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.320684126136%	6	1871	100	T2D_GENES_TANYA_HEIGHT	ROVERSI_GLIOMA_COPY_NUMBER_UP
0.315208825847%	4	1269	99	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.315208825847%	4	1269	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
0.315208825847%	4	1269	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CROONQUIST_IL6_DEPRIVATION_DN
0.315208825847%	4	1269	97	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP
0.315208825847%	4	1269	97	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LABBE_WNT3A_TARGETS_DN
0.315208825847%	4	1269	97	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
0.315208825847%	4	1269	95	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
0.315208825847%	4	1269	95	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
0.315208825847%	4	1269	95	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HECKER_IFNB1_TARGETS
0.315208825847%	4	1269	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
0.315208825847%	4	1269	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DE_YY1_TARGETS_DN
0.315208825847%	4	1269	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
0.315208825847%	4	1269	91	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
0.315208825847%	4	1269	91	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
0.315208825847%	4	1269	90	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IVANOVSKA_MIR106B_TARGETS
0.315208825847%	4	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VANLOO_SP3_TARGETS_DN
0.315208825847%	4	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP
0.315208825847%	4	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
0.315208825847%	4	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.315208825847%	4	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KANG_IMMORTALIZED_BY_TERT_UP
0.315208825847%	4	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BHATTACHARYA_EMBRYONIC_STEM_CELL
0.315208825847%	4	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
0.315208825847%	4	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
0.315208825847%	4	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
0.315208825847%	4	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
0.315208825847%	4	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SAFFORD_T_LYMPHOCYTE_ANERGY
0.315208825847%	4	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOOTHA_VOXPHOS
0.315208825847%	4	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.315208825847%	4	1269	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEIN_CEREBELLUM_MARKERS
0.315208825847%	4	1269	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
0.315208825847%	4	1269	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
0.315208825847%	4	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_AGING_CEREBELLUM_UP
0.315208825847%	4	1269	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SANA_TNF_SIGNALING_UP
0.315208825847%	4	1269	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
0.315208825847%	4	1269	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FRASOR_RESPONSE_TO_ESTRADIOL_DN
0.315208825847%	4	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
0.315208825847%	4	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.315208825847%	4	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_M_G1_TRANSITION
0.315208825847%	4	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_MITOTIC_G2_G2_M_PHASES
0.315208825847%	4	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
0.315208825847%	4	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
0.315208825847%	4	1269	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_BETACATENIN_NUC_PATHWAY
0.315208825847%	4	1269	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
0.315208825847%	4	1269	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MALONEY_RESPONSE_TO_17AAG_DN
0.315208825847%	4	1269	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DUAN_PRDM5_TARGETS
0.315208825847%	4	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
0.315208825847%	4	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SANA_RESPONSE_TO_IFNG_UP
0.315208825847%	4	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROSS_LEUKEMIA_WITH_MLL_FUSIONS
0.315208825847%	4	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
0.315208825847%	4	1269	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION
0.315208825847%	4	1269	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM
0.315208825847%	4	1269	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FRIDMAN_SENESCENCE_UP
0.315208825847%	4	1269	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
0.315208825847%	4	1269	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_AVB3_INTEGRIN_PATHWAY
0.315208825847%	4	1269	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ADHERENS_JUNCTION
0.315208825847%	4	1269	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
0.315208825847%	4	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS
0.315208825847%	4	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
0.315208825847%	4	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FURUKAWA_DUSP6_TARGETS_PCI35_DN
0.315208825847%	4	1269	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_CHRONIC_MYELOID_LEUKEMIA
0.315208825847%	4	1269	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
0.315208825847%	4	1269	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_NUCLEOTIDES
0.315208825847%	4	1269	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DANG_REGULATED_BY_MYC_UP
0.315208825847%	4	1269	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CROONQUIST_NRAS_SIGNALING_DN
0.315208825847%	4	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
0.315208825847%	4	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_AP1_PATHWAY
0.315208825847%	4	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PANCREATIC_CANCER
0.315208825847%	4	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_LONG_TERM_POTENTIATION
0.315208825847%	4	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_MTOR_4PATHWAY
0.315208825847%	4	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PPAR_SIGNALING_PATHWAY
0.315208825847%	4	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_P53_SIGNALING_PATHWAY
0.315208825847%	4	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HUANG_DASATINIB_RESISTANCE_DN
0.315208825847%	4	1269	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN
0.315208825847%	4	1269	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_INTERFERON_RESPONSIVE_GENES
0.315208825847%	4	1269	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.315208825847%	4	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN
0.315208825847%	4	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
0.315208825847%	4	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_LIVER_CANCER_MYC_TGFA_DN
0.315208825847%	4	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP
0.315208825847%	4	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
0.315208825847%	4	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BYSTROEM_CORRELATED_WITH_IL5_DN
0.315208825847%	4	1269	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP
0.315208825847%	4	1269	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
0.315208825847%	4	1269	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_INTERFERON_GAMMA_SIGNALING
0.315208825847%	4	1269	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_MYC_REPRESSPATHWAY
0.315208825847%	4	1269	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
0.315208825847%	4	1269	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_TRKRPATHWAY
0.315208825847%	4	1269	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_FCER1PATHWAY
0.315208825847%	4	1269	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_BY_UV
0.315208825847%	4	1269	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_COLORECTAL_CANCER
0.315208825847%	4	1269	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GEORGES_CELL_CYCLE_MIR192_TARGETS
0.315208825847%	4	1269	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN
0.315208825847%	4	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_P53REGULATIONPATHWAY
0.315208825847%	4	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_NOTCH_PATHWAY
0.315208825847%	4	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ELVIDGE_HYPOXIA_BY_DMOG_DN
0.315208825847%	4	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAGASHIMA_NRG1_SIGNALING_DN
0.315208825847%	4	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_NPC_LCP_WITH_H3K4ME3
0.315208825847%	4	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KANNAN_TP53_TARGETS_UP
0.315208825847%	4	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.315208825847%	4	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
0.315208825847%	4	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LY_AGING_OLD_DN
0.315208825847%	4	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOQUE_METHYLATED_IN_CANCER
0.315208825847%	4	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_NFAT_PATHWAY
0.315208825847%	4	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
0.315208825847%	4	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_IL2_1PATHWAY
0.315208825847%	4	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SU_PANCREAS
0.315208825847%	4	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE
0.315208825847%	4	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN
0.315208825847%	4	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_NON_SMALL_CELL_LUNG_CANCER
0.315208825847%	4	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIANG_SILENCED_BY_METHYLATION_2
0.315208825847%	4	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_KITPATHWAY
0.315208825847%	4	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HALMOS_CEBPA_TARGETS_UP
0.315208825847%	4	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
0.315208825847%	4	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
0.315208825847%	4	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	APPIERTO_RESPONSE_TO_FENRETINIDE_DN
0.315208825847%	4	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PARK_APL_PATHOGENESIS_DN
0.315208825847%	4	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KANG_GIST_WITH_PDGFRA_UP
0.315208825847%	4	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN
0.315208825847%	4	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_HP_UP
0.315208825847%	4	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
0.315208825847%	4	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.315208825847%	4	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GERHOLD_ADIPOGENESIS_UP
0.315208825847%	4	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_MUSCLE_CONTRACTION
0.315208825847%	4	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_CERAMIDE_PATHWAY
0.315208825847%	4	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GNATENKO_PLATELET_SIGNATURE
0.315208825847%	4	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
0.315208825847%	4	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MELLMAN_TUT1_TARGETS_DN
0.315208825847%	4	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_TYPE_II_DIABETES_MELLITUS
0.315208825847%	4	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_MS_DN
0.315208825847%	4	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WINNEPENNINCKX_MELANOMA_METASTASIS_DN
0.315208825847%	4	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VANHARANTA_UTERINE_FIBROID_UP
0.315208825847%	4	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER
0.315208825847%	4	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN
0.315208825847%	4	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KERLEY_RESPONSE_TO_CISPLATIN_UP
0.315208825847%	4	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FARMER_BREAST_CANCER_CLUSTER_1
0.315208825847%	4	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHUNG_BLISTER_CYTOTOXICITY_DN
0.315208825847%	4	1269	435	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SWEET_LUNG_CANCER_KRAS_DN
0.315208825847%	4	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_THROMBIN_PAR1_PATHWAY
0.315208825847%	4	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAKAMURA_METASTASIS_MODEL_DN
0.315208825847%	4	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.315208825847%	4	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
0.315208825847%	4	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_ECADHERIN_STABILIZATION_PATHWAY
0.315208825847%	4	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BILBAN_B_CLL_LPL_DN
0.315208825847%	4	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
0.315208825847%	4	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_FOXM1PATHWAY
0.315208825847%	4	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_TRYPTOPHAN_METABOLISM
0.315208825847%	4	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHANGOLKAR_H2AFY_TARGETS_DN
0.315208825847%	4	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1
0.315208825847%	4	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MA_MYELOID_DIFFERENTIATION_UP
0.315208825847%	4	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_G1_PHASE
0.315208825847%	4	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KRASNOSELSKAYA_ILF3_TARGETS_UP
0.315208825847%	4	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2
0.315208825847%	4	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_DNA_REPLICATION
0.315208825847%	4	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JIANG_AGING_CEREBRAL_CORTEX_UP
0.315208825847%	4	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM
0.315208825847%	4	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING
0.315208825847%	4	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_RHO_PATHWAY
0.315208825847%	4	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_PDGF_PATHWAY
0.315208825847%	4	1269	317	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
0.315208825847%	4	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOSERLE_IFNA_RESPONSE
0.315208825847%	4	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_MYOSIN_PATHWAY
0.315208825847%	4	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_EGF_PATHWAY
0.315208825847%	4	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_DNA_STRAND_ELONGATION
0.315208825847%	4	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_IGF1_PATHWAY
0.315208825847%	4	1269	290	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BENPORATH_OCT4_TARGETS
0.315208825847%	4	1269	284	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_MRNA
0.315208825847%	4	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP
0.315208825847%	4	1269	279	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_INNATE_IMMUNE_SYSTEM
0.315208825847%	4	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN
0.315208825847%	4	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE
0.315208825847%	4	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_EXTENSION_OF_TELOMERES
0.315208825847%	4	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_ECM_PATHWAY
0.315208825847%	4	1269	238	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
0.315208825847%	4	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHANG_INTERFERON_RESPONSE
0.315208825847%	4	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_GA12_PATHWAY
0.315208825847%	4	1269	229	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP
0.315208825847%	4	1269	222	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRANSLATION
0.315208825847%	4	1269	220	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
0.315208825847%	4	1269	220	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RIGGINS_TAMOXIFEN_RESISTANCE_DN
0.315208825847%	4	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP
0.315208825847%	4	1269	216	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_G2_M
0.315208825847%	4	1269	209	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_UP
0.315208825847%	4	1269	201	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOLLMANN_APOPTOSIS_VIA_CD40_UP
0.315208825847%	4	1269	200	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_DIFFERENTIATING_T_LYMPHOCYTE
0.315208825847%	4	1269	196	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
0.315208825847%	4	1269	193	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP
0.315208825847%	4	1269	186	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_CLIM2_TARGETS_DN
0.315208825847%	4	1269	185	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
0.315208825847%	4	1269	185	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
0.315208825847%	4	1269	183	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ENDOCYTOSIS
0.315208825847%	4	1269	176	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAGASHIMA_NRG1_SIGNALING_UP
0.315208825847%	4	1269	172	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
0.315208825847%	4	1269	170	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IWANAGA_CARCINOGENESIS_BY_KRAS_UP
0.315208825847%	4	1269	170	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.315208825847%	4	1269	169	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PENG_GLUCOSE_DEPRIVATION_DN
0.315208825847%	4	1269	169	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ALZHEIMERS_DISEASE
0.315208825847%	4	1269	167	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TIEN_INTESTINE_PROBIOTICS_6HR_DN
0.315208825847%	4	1269	164	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
0.315208825847%	4	1269	164	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_480_HELA
0.315208825847%	4	1269	161	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN
0.315208825847%	4	1269	160	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
0.315208825847%	4	1269	160	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
0.315208825847%	4	1269	156	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FOSTER_TOLERANT_MACROPHAGE_UP
0.315208825847%	4	1269	153	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LU_AGING_BRAIN_DN
0.315208825847%	4	1269	152	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
0.315208825847%	4	1269	151	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
0.315208825847%	4	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_NUCLEARRS_PATHWAY
0.315208825847%	4	1269	149	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
0.315208825847%	4	1269	148	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_24HR_DN
0.315208825847%	4	1269	147	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
0.315208825847%	4	1269	145	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMITH_TERT_TARGETS_UP
0.315208825847%	4	1269	145	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RODWELL_AGING_KIDNEY_DN
0.315208825847%	4	1269	145	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.315208825847%	4	1269	145	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
0.315208825847%	4	1269	143	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DANG_MYC_TARGETS_UP
0.315208825847%	4	1269	142	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	XU_GH1_AUTOCRINE_TARGETS_DN
0.315208825847%	4	1269	141	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KAAB_FAILED_HEART_ATRIUM_DN
0.315208825847%	4	1269	141	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP
0.315208825847%	4	1269	140	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	QI_HYPOXIA
0.315208825847%	4	1269	139	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ODONNELL_TFRC_TARGETS_DN
0.315208825847%	4	1269	139	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOELZEL_NF1_TARGETS_UP
0.315208825847%	4	1269	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
0.315208825847%	4	1269	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_P53DOWNSTREAMPATHWAY
0.315208825847%	4	1269	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
0.315208825847%	4	1269	136	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WIERENGA_STAT5A_TARGETS_GROUP1
0.315208825847%	4	1269	134	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	POOLA_INVASIVE_BREAST_CANCER_DN
0.315208825847%	4	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION
0.315208825847%	4	1269	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
0.315208825847%	4	1269	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.315208825847%	4	1269	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.315208825847%	4	1269	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SANSOM_APC_TARGETS_UP
0.315208825847%	4	1269	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.315208825847%	4	1269	125	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
0.315208825847%	4	1269	125	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_HIV_LIFE_CYCLE
0.315208825847%	4	1269	122	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
0.315208825847%	4	1269	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.315208825847%	4	1269	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS
0.315208825847%	4	1269	120	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHU_CMV_ALL_UP
0.315208825847%	4	1269	120	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.315208825847%	4	1269	118	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARKEY_RB1_CHRONIC_LOF_DN
0.315208825847%	4	1269	118	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
0.315208825847%	4	1269	118	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CERVERA_SDHB_TARGETS_1_UP
0.315208825847%	4	1269	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
0.315208825847%	4	1269	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
0.315208825847%	4	1269	115	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOELZEL_NF1_TARGETS_DN
0.315208825847%	4	1269	114	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_OOCYTE_MEIOSIS
0.315208825847%	4	1269	112	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PASINI_SUZ12_TARGETS_UP
0.315208825847%	4	1269	112	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LABBE_WNT3A_TARGETS_UP
0.315208825847%	4	1269	109	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
0.315208825847%	4	1269	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
0.315208825847%	4	1269	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TAVAZOIE_METASTASIS
0.315208825847%	4	1269	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JAZAG_TGFB1_SIGNALING_UP
0.315208825847%	4	1269	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN
0.315208825847%	4	1269	106	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
0.315208825847%	4	1269	105	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STEIN_ESRRA_TARGETS_DN
0.315208825847%	4	1269	105	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMUNDSON_GENOTOXIC_SIGNATURE
0.315208825847%	4	1269	104	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAKAMURA_ADIPOGENESIS_LATE_UP
0.315208825847%	4	1269	104	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
0.315208825847%	4	1269	102	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_MELANOGENESIS
0.315208825847%	4	1269	102	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DER_IFN_BETA_RESPONSE_UP
0.315208825847%	4	1269	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WIELAND_UP_BY_HBV_INFECTION
0.315208825847%	4	1269	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
0.315208825847%	4	1269	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_GNRH_SIGNALING_PATHWAY
0.315208825847%	4	1269	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRADE_COLON_AND_RECTAL_CANCER_DN
0.315208825847%	4	1269	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_20HR_DN
0.315208825847%	4	1269	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BASSO_CD40_SIGNALING_UP
0.315208825847%	4	1269	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	QI_PLASMACYTOMA_DN
0.315208825847%	4	1269	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHICAS_RB1_TARGETS_LOW_SERUM
0.3125%	11	3520	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
0.3125%	11	3520	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIELSEN_GIST
0.3125%	11	3520	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MENSE_HYPOXIA_UP
0.3125%	11	3520	97	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
0.3125%	11	3520	95	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
0.3125%	11	3520	95	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
0.3125%	11	3520	95	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.3125%	11	3520	94	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LU_IL4_SIGNALING
0.3125%	11	3520	93	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACTIVATED_TLR4_SIGNALLING
0.3125%	11	3520	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
0.3125%	11	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
0.3125%	11	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP
0.3125%	11	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEIN_PONS_MARKERS
0.3125%	11	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BHATTACHARYA_EMBRYONIC_STEM_CELL
0.3125%	11	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
0.3125%	11	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOOTHA_VOXPHOS
0.3125%	11	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ERBB_SIGNALING_PATHWAY
0.3125%	11	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.3125%	11	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_8
0.3125%	11	3520	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STEIN_ESR1_TARGETS
0.3125%	11	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
0.3125%	11	3520	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
0.3125%	11	3520	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
0.3125%	11	3520	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
0.3125%	11	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
0.3125%	11	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	COATES_MACROPHAGE_M1_VS_M2_UP
0.3125%	11	3520	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_CARDIAC_MUSCLE_CONTRACTION
0.3125%	11	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
0.3125%	11	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	COATES_MACROPHAGE_M1_VS_M2_DN
0.3125%	11	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROSS_AML_WITH_PML_RARA_FUSION
0.3125%	11	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
0.3125%	11	3520	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROSS_AML_WITH_AML1_ETO_FUSION
0.3125%	11	3520	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
0.3125%	11	3520	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_AVB3_INTEGRIN_PATHWAY
0.3125%	11	3520	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCCLUNG_COCAIN_REWARD_4WK
0.3125%	11	3520	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
0.3125%	11	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAMALHO_STEMNESS_DN
0.3125%	11	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JI_RESPONSE_TO_FSH_UP
0.3125%	11	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FURUKAWA_DUSP6_TARGETS_PCI35_UP
0.3125%	11	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAMPS_COLON_CANCER_COPY_NUMBER_DN
0.3125%	11	3520	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C1
0.3125%	11	3520	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATZUK_SPERMATOCYTE
0.3125%	11	3520	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DANG_REGULATED_BY_MYC_UP
0.3125%	11	3520	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_RESPONSE_TO_H2O2
0.3125%	11	3520	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GEORGANTAS_HSC_MARKERS
0.3125%	11	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10
0.3125%	11	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RIZKI_TUMOR_INVASIVENESS_2D_UP
0.3125%	11	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SPHINGOLIPID_METABOLISM
0.3125%	11	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_MTOR_4PATHWAY
0.3125%	11	3520	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN
0.3125%	11	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAMURA_ADIPOGENESIS_EARLY_UP
0.3125%	11	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_FAS_SIGNALING_PATHWAY
0.3125%	11	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER_ACOX1_DN
0.3125%	11	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_GLIOMA
0.3125%	11	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GUO_HEX_TARGETS_DN
0.3125%	11	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INTERFERON_GAMMA_SIGNALING
0.3125%	11	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_PEAK_AT_0HR
0.3125%	11	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_FCER1PATHWAY
0.3125%	11	3520	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING
0.3125%	11	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BARIS_THYROID_CANCER_DN
0.3125%	11	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LUCAS_HNF4A_TARGETS_UP
0.3125%	11	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
0.3125%	11	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TCR_SIGNALING
0.3125%	11	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ARGININE_AND_PROLINE_METABOLISM
0.3125%	11	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_GLYCEROLIPID_METABOLISM
0.3125%	11	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAUER_STAT3_TARGETS_UP
0.3125%	11	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN
0.3125%	11	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_UPA_UPAR_PATHWAY
0.3125%	11	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_SYNDECAN_4_PATHWAY
0.3125%	11	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ASTHMA
0.3125%	11	3520	191	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.3125%	11	3520	185	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_36HR_DN
0.3125%	11	3520	181	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
0.3125%	11	3520	176	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
0.3125%	11	3520	175	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.3125%	11	3520	163	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SERVITJA_ISLET_HNF1A_TARGETS_UP
0.3125%	11	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT
0.3125%	11	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_HDL_MEDIATED_LIPID_TRANSPORT
0.3125%	11	3520	146	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PECE_MAMMARY_STEM_CELL_UP
0.3125%	11	3520	145	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
0.3125%	11	3520	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.3125%	11	3520	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.3125%	11	3520	139	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ODONNELL_TFRC_TARGETS_DN
0.3125%	11	3520	139	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
0.3125%	11	3520	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.3125%	11	3520	136	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.3125%	11	3520	136	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.3125%	11	3520	133	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PARKINSONS_DISEASE
0.3125%	11	3520	127	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KARLSSON_TGFB1_TARGETS_UP
0.3125%	11	3520	125	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
0.3125%	11	3520	125	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_1_UP
0.3125%	11	3520	124	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAIRKEE_TERT_TARGETS_DN
0.3125%	11	3520	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.3125%	11	3520	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP
0.3125%	11	3520	120	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
0.3125%	11	3520	118	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARKEY_RB1_CHRONIC_LOF_DN
0.3125%	11	3520	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATTIOLI_MGUS_VS_PCL
0.3125%	11	3520	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMIRNOV_RESPONSE_TO_IR_6HR_DN
0.3125%	11	3520	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_OOCYTE_MEIOSIS
0.3125%	11	3520	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOSCO_TH1_CYTOTOXIC_MODULE
0.3125%	11	3520	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.3125%	11	3520	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DITTMER_PTHLH_TARGETS_UP
0.3125%	11	3520	111	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MRNA_SPLICING
0.3125%	11	3520	110	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SUNG_METASTASIS_STROMA_UP
0.3125%	11	3520	110	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
0.3125%	11	3520	110	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_HIF1A_DN
0.3125%	11	3520	109	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP
0.3125%	11	3520	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_DN
0.3125%	11	3520	105	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STEIN_ESRRA_TARGETS_DN
0.3125%	11	3520	105	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ERBB1_DOWNSTREAM_PATHWAY
0.3125%	11	3520	104	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
0.3125%	11	3520	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
0.3125%	11	3520	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_MYCN_AMPLIFICATION_TARGETS_DN
0.3125%	11	3520	102	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.3125%	11	3520	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
0.3125%	11	3520	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_20HR_DN
0.3125%	11	3520	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_10HR_UP
0.306983883346%	4	1303	99	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.306983883346%	4	1303	98	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
0.306983883346%	4	1303	98	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
0.306983883346%	4	1303	98	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CROONQUIST_IL6_DEPRIVATION_DN
0.306983883346%	4	1303	97	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KONG_E2F3_TARGETS
0.306983883346%	4	1303	97	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP
0.306983883346%	4	1303	96	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZAMORA_NOS2_TARGETS_DN
0.306983883346%	4	1303	96	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIU_PROSTATE_CANCER_UP
0.306983883346%	4	1303	95	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION
0.306983883346%	4	1303	95	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KAYO_CALORIE_RESTRICTION_MUSCLE_UP
0.306983883346%	4	1303	94	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER
0.306983883346%	4	1303	94	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_T4
0.306983883346%	4	1303	93	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CADWELL_ATG16L1_TARGETS_UP
0.306983883346%	4	1303	92	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WINTER_HYPOXIA_UP
0.306983883346%	4	1303	90	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN
0.306983883346%	4	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON
0.306983883346%	4	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS
0.306983883346%	4	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LI_DCP2_BOUND_MRNA
0.306983883346%	4	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
0.306983883346%	4	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
0.306983883346%	4	1303	86	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TAKAO_RESPONSE_TO_UVB_RADIATION_UP
0.306983883346%	4	1303	86	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_L1CAM_INTERACTIONS
0.306983883346%	4	1303	86	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_AGING_CEREBELLUM_DN
0.306983883346%	4	1303	86	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_TGF_BETA_SIGNALING_PATHWAY
0.306983883346%	4	1303	86	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOEBEKE_LYMPHOID_STEM_CELL_DN
0.306983883346%	4	1303	86	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GHANDHI_BYSTANDER_IRRADIATION_UP
0.306983883346%	4	1303	85	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STEIN_ESR1_TARGETS
0.306983883346%	4	1303	85	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
0.306983883346%	4	1303	84	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.306983883346%	4	1303	84	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.306983883346%	4	1303	83	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
0.306983883346%	4	1303	82	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WONG_ENDMETRIUM_CANCER_DN
0.306983883346%	4	1303	81	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
0.306983883346%	4	1303	81	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION
0.306983883346%	4	1303	80	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHUHMACHER_MYC_TARGETS_UP
0.306983883346%	4	1303	80	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_MET_PATHWAY
0.306983883346%	4	1303	80	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_AGING_NEOCORTEX_DN
0.306983883346%	4	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
0.306983883346%	4	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
0.306983883346%	4	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIU_COMMON_CANCER_GENES
0.306983883346%	4	1303	78	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
0.306983883346%	4	1303	78	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROSS_AML_WITH_MLL_FUSIONS
0.306983883346%	4	1303	78	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_PEROXISOME
0.306983883346%	4	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.306983883346%	4	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FRIDMAN_SENESCENCE_UP
0.306983883346%	4	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CARD_MIR302A_TARGETS
0.306983883346%	4	1303	76	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.306983883346%	4	1303	76	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SU_TESTIS
0.306983883346%	4	1303	76	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION
0.306983883346%	4	1303	76	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PEART_HDAC_PROLIFERATION_CLUSTER_DN
0.306983883346%	4	1303	76	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
0.306983883346%	4	1303	75	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
0.306983883346%	4	1303	75	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
0.306983883346%	4	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OUILLETTE_CLL_13Q14_DELETION_UP
0.306983883346%	4	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
0.306983883346%	4	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
0.306983883346%	4	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CORRE_MULTIPLE_MYELOMA_UP
0.306983883346%	4	1303	73	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
0.306983883346%	4	1303	73	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_CHRONIC_MYELOID_LEUKEMIA
0.306983883346%	4	1303	73	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DITTMER_PTHLH_TARGETS_DN
0.306983883346%	4	1303	73	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.306983883346%	4	1303	72	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_NUCLEOTIDES
0.306983883346%	4	1303	71	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.306983883346%	4	1303	70	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_NOTCH1
0.306983883346%	4	1303	70	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_MEF_LCP_WITH_H3K27ME3
0.306983883346%	4	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.306983883346%	4	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RIZKI_TUMOR_INVASIVENESS_2D_UP
0.306983883346%	4	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_PPAR_SIGNALING_PATHWAY
0.306983883346%	4	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_P53_SIGNALING_PATHWAY
0.306983883346%	4	1303	68	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIN_NPAS4_TARGETS_DN
0.306983883346%	4	1303	67	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP
0.306983883346%	4	1303	67	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
0.306983883346%	4	1303	67	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP
0.306983883346%	4	1303	67	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
0.306983883346%	4	1303	67	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GENTILE_UV_LOW_DOSE_DN
0.306983883346%	4	1303	67	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ELVIDGE_HIF1A_TARGETS_UP
0.306983883346%	4	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRUNO_HEMATOPOIESIS
0.306983883346%	4	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_FAS_SIGNALING_PATHWAY
0.306983883346%	4	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_GLIOMA
0.306983883346%	4	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP
0.306983883346%	4	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP
0.306983883346%	4	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_UP
0.306983883346%	4	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
0.306983883346%	4	1303	63	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP
0.306983883346%	4	1303	63	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INTERFERON_GAMMA_SIGNALING
0.306983883346%	4	1303	63	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
0.306983883346%	4	1303	63	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.306983883346%	4	1303	62	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GEORGES_CELL_CYCLE_MIR192_TARGETS
0.306983883346%	4	1303	61	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ER_PHAGOSOME_PATHWAY
0.306983883346%	4	1303	59	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WESTON_VEGFA_TARGETS_6HR
0.306983883346%	4	1303	59	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3
0.306983883346%	4	1303	59	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ELVIDGE_HYPOXIA_BY_DMOG_DN
0.306983883346%	4	1303	59	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DASU_IL6_SIGNALING_UP
0.306983883346%	4	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
0.306983883346%	4	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
0.306983883346%	4	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SANSOM_WNT_PATHWAY_REQUIRE_MYC
0.306983883346%	4	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.306983883346%	4	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_NPC_LCP_WITH_H3K4ME3
0.306983883346%	4	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
0.306983883346%	4	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN
0.306983883346%	4	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BORLAK_LIVER_CANCER_EGF_UP
0.306983883346%	4	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMIT_SERUM_RESPONSE_240_MCF10A
0.306983883346%	4	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOQUE_METHYLATED_IN_CANCER
0.306983883346%	4	1303	55	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
0.306983883346%	4	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C2
0.306983883346%	4	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_TAP63PATHWAY
0.306983883346%	4	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MENSSEN_MYC_TARGETS
0.306983883346%	4	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ISHIDA_E2F_TARGETS
0.306983883346%	4	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP
0.306983883346%	4	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
0.306983883346%	4	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
0.306983883346%	4	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION
0.306983883346%	4	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
0.306983883346%	4	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
0.306983883346%	4	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_ARF6_TRAFFICKINGPATHWAY
0.306983883346%	4	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARCHINI_TRABECTEDIN_RESISTANCE_DN
0.306983883346%	4	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_DELTANP63PATHWAY
0.306983883346%	4	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_NOTCH_SIGNALING_PATHWAY
0.306983883346%	4	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_C_UP
0.306983883346%	4	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SIG_BCR_SIGNALING_PATHWAY
0.306983883346%	4	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C5
0.306983883346%	4	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SAGIV_CD24_TARGETS_DN
0.306983883346%	4	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
0.306983883346%	4	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION
0.306983883346%	4	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_PS1PATHWAY
0.306983883346%	4	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JIANG_TIP30_TARGETS_UP
0.306983883346%	4	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_KERATINOCYTE_PATHWAY
0.306983883346%	4	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHIPP_DLBCL_CURED_VS_FATAL_DN
0.306983883346%	4	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN
0.306983883346%	4	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_AGING_MUSCLE_UP
0.306983883346%	4	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_BIOPEPTIDES_PATHWAY
0.306983883346%	4	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
0.306983883346%	4	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MEDINA_SMARCA4_TARGETS
0.306983883346%	4	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MA_MYELOID_DIFFERENTIATION_DN
0.306983883346%	4	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
0.306983883346%	4	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_480_MCF10A
0.306983883346%	4	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHENG_IL22_SIGNALING_DN
0.306983883346%	4	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LUI_THYROID_CANCER_CLUSTER_2
0.306983883346%	4	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BILBAN_B_CLL_LPL_DN
0.306983883346%	4	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_MF_DN
0.306983883346%	4	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GLUCOSE_TRANSPORT
0.306983883346%	4	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN
0.306983883346%	4	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR
0.306983883346%	4	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JIANG_AGING_CEREBRAL_CORTEX_UP
0.306983883346%	4	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WESTON_VEGFA_TARGETS_12HR
0.306983883346%	4	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT
0.306983883346%	4	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HEIDENBLAD_AMPLICON_12P11_12_UP
0.306983883346%	4	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN
0.306983883346%	4	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
0.306983883346%	4	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_DNA_STRAND_ELONGATION
0.306983883346%	4	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OHM_METHYLATED_IN_ADULT_CANCERS
0.306983883346%	4	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS
0.306983883346%	4	1303	245	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.306983883346%	4	1303	232	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SENESE_HDAC1_AND_HDAC2_TARGETS_DN
0.306983883346%	4	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BILANGES_SERUM_SENSITIVE_VIA_TSC1
0.306983883346%	4	1303	217	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WIERENGA_STAT5A_TARGETS_UP
0.306983883346%	4	1303	212	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHANG_CORE_SERUM_RESPONSE_UP
0.306983883346%	4	1303	200	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_DIFFERENTIATING_T_LYMPHOCYTE
0.306983883346%	4	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C3
0.306983883346%	4	1303	196	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
0.306983883346%	4	1303	194	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.306983883346%	4	1303	191	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
0.306983883346%	4	1303	190	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.306983883346%	4	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RUAN_RESPONSE_TO_TROGLITAZONE_DN
0.306983883346%	4	1303	187	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PENG_LEUCINE_DEPRIVATION_DN
0.306983883346%	4	1303	182	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
0.306983883346%	4	1303	181	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
0.306983883346%	4	1303	181	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JISON_SICKLE_CELL_DISEASE_UP
0.306983883346%	4	1303	179	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE
0.306983883346%	4	1303	172	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
0.306983883346%	4	1303	164	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
0.306983883346%	4	1303	163	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SERVITJA_ISLET_HNF1A_TARGETS_UP
0.306983883346%	4	1303	163	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
0.306983883346%	4	1303	162	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3
0.306983883346%	4	1303	161	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MRNA_PROCESSING
0.306983883346%	4	1303	160	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
0.306983883346%	4	1303	159	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
0.306983883346%	4	1303	153	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
0.306983883346%	4	1303	152	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WILCOX_PRESPONSE_TO_ROGESTERONE_UP
0.306983883346%	4	1303	151	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
0.306983883346%	4	1303	149	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LANDIS_ERBB2_BREAST_TUMORS_324_DN
0.306983883346%	4	1303	148	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_M_G1
0.306983883346%	4	1303	147	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DARWICHE_PAPILLOMA_RISK_HIGH_UP
0.306983883346%	4	1303	142	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RUIZ_TNC_TARGETS_DN
0.306983883346%	4	1303	142	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.306983883346%	4	1303	141	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KAAB_FAILED_HEART_ATRIUM_DN
0.306983883346%	4	1303	140	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	QI_HYPOXIA
0.306983883346%	4	1303	140	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JOHNSTONE_PARVB_TARGETS_2_UP
0.306983883346%	4	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TOMLINS_METASTASIS_UP
0.306983883346%	4	1303	139	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ODONNELL_TFRC_TARGETS_DN
0.306983883346%	4	1303	136	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.306983883346%	4	1303	134	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	POOLA_INVASIVE_BREAST_CANCER_DN
0.306983883346%	4	1303	134	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
0.306983883346%	4	1303	134	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_CELL_ADHESION_MOLECULES_CAMS
0.306983883346%	4	1303	130	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAGI_AML_WITH_T_9_11_TRANSLOCATION
0.306983883346%	4	1303	128	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
0.306983883346%	4	1303	128	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	POTTI_TOPOTECAN_SENSITIVITY
0.306983883346%	4	1303	128	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS
0.306983883346%	4	1303	127	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
0.306983883346%	4	1303	127	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.306983883346%	4	1303	126	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SANSOM_APC_TARGETS_UP
0.306983883346%	4	1303	126	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GERY_CEBP_TARGETS
0.306983883346%	4	1303	126	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
0.306983883346%	4	1303	125	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_HIV_LIFE_CYCLE
0.306983883346%	4	1303	125	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
0.306983883346%	4	1303	123	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.306983883346%	4	1303	122	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION
0.306983883346%	4	1303	122	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CHROMOSOME_MAINTENANCE
0.306983883346%	4	1303	121	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RODRIGUES_DCC_TARGETS_DN
0.306983883346%	4	1303	121	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP
0.306983883346%	4	1303	121	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
0.306983883346%	4	1303	121	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_LYSOSOME
0.306983883346%	4	1303	121	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN
0.306983883346%	4	1303	118	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARKEY_RB1_CHRONIC_LOF_DN
0.306983883346%	4	1303	118	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
0.306983883346%	4	1303	117	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.306983883346%	4	1303	116	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MATTIOLI_MGUS_VS_PCL
0.306983883346%	4	1303	116	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LI_INDUCED_T_TO_NATURAL_KILLER_DN
0.306983883346%	4	1303	116	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIM_MAMMARY_LUMINAL_MATURE_UP
0.306983883346%	4	1303	114	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_OOCYTE_MEIOSIS
0.306983883346%	4	1303	113	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TSENG_IRS1_TARGETS_UP
0.306983883346%	4	1303	113	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
0.306983883346%	4	1303	112	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_FGFR
0.306983883346%	4	1303	112	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DITTMER_PTHLH_TARGETS_UP
0.306983883346%	4	1303	111	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_12HR_UP
0.306983883346%	4	1303	110	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WOOD_EBV_EBNA1_TARGETS_UP
0.306983883346%	4	1303	110	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.306983883346%	4	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHOU_PANCREATIC_EXOCRINE_PROGENITOR
0.306983883346%	4	1303	108	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WESTON_VEGFA_TARGETS
0.306983883346%	4	1303	108	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
0.306983883346%	4	1303	108	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT
0.306983883346%	4	1303	107	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_EARLY_T_LYMPHOCYTE_UP
0.306983883346%	4	1303	105	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RNA_POL_II_TRANSCRIPTION
0.306983883346%	4	1303	105	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HELLER_SILENCED_BY_METHYLATION_DN
0.306983883346%	4	1303	104	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE
0.306983883346%	4	1303	103	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
0.306983883346%	4	1303	103	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
0.306983883346%	4	1303	101	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WIELAND_UP_BY_HBV_INFECTION
0.306983883346%	4	1303	101	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
0.306983883346%	4	1303	101	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_GNRH_SIGNALING_PATHWAY
0.306983883346%	4	1303	101	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_20HR_DN
0.306983883346%	4	1303	101	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_12HR_DN
0.306983883346%	4	1303	101	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BASSO_CD40_SIGNALING_UP
0.306983883346%	4	1303	100	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WINZEN_DEGRADED_VIA_KHSRP
0.303951367781%	6	1974	95	Mendelian_Nancy_Cox	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.303951367781%	6	1974	92	Mendelian_Nancy_Cox	BURTON_ADIPOGENESIS_9
0.303951367781%	6	1974	89	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
0.303951367781%	6	1974	89	Mendelian_Nancy_Cox	REACTOME_RNA_POL_I_TRANSCRIPTION
0.303951367781%	6	1974	84	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
0.303951367781%	6	1974	83	Mendelian_Nancy_Cox	JIANG_HYPOXIA_CANCER
0.303951367781%	6	1974	8	Mendelian_Nancy_Cox	TCGA_GLIOBLASTOMA_MUTATED
0.303951367781%	6	1974	8	Mendelian_Nancy_Cox	BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS
0.303951367781%	6	1974	79	Mendelian_Nancy_Cox	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.303951367781%	6	1974	78	Mendelian_Nancy_Cox	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE
0.303951367781%	6	1974	75	Mendelian_Nancy_Cox	REACTOME_TELOMERE_MAINTENANCE
0.303951367781%	6	1974	73	Mendelian_Nancy_Cox	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
0.303951367781%	6	1974	68	Mendelian_Nancy_Cox	LIN_NPAS4_TARGETS_DN
0.303951367781%	6	1974	68	Mendelian_Nancy_Cox	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
0.303951367781%	6	1974	67	Mendelian_Nancy_Cox	ELVIDGE_HIF1A_TARGETS_UP
0.303951367781%	6	1974	66	Mendelian_Nancy_Cox	SWEET_KRAS_TARGETS_DN
0.303951367781%	6	1974	66	Mendelian_Nancy_Cox	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES
0.303951367781%	6	1974	66	Mendelian_Nancy_Cox	BEIER_GLIOMA_STEM_CELL_DN
0.303951367781%	6	1974	65	Mendelian_Nancy_Cox	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP
0.303951367781%	6	1974	65	Mendelian_Nancy_Cox	AMIT_SERUM_RESPONSE_120_MCF10A
0.303951367781%	6	1974	64	Mendelian_Nancy_Cox	LIU_SMARCA4_TARGETS
0.303951367781%	6	1974	63	Mendelian_Nancy_Cox	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP
0.303951367781%	6	1974	63	Mendelian_Nancy_Cox	MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED
0.303951367781%	6	1974	63	Mendelian_Nancy_Cox	JOHNSTONE_PARVB_TARGETS_1_DN
0.303951367781%	6	1974	61	Mendelian_Nancy_Cox	REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS
0.303951367781%	6	1974	61	Mendelian_Nancy_Cox	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
0.303951367781%	6	1974	60	Mendelian_Nancy_Cox	OUILLETTE_CLL_13Q14_DELETION_DN
0.303951367781%	6	1974	57	Mendelian_Nancy_Cox	YAMASHITA_METHYLATED_IN_PROSTATE_CANCER
0.303951367781%	6	1974	57	Mendelian_Nancy_Cox	PID_TXA2PATHWAY
0.303951367781%	6	1974	57	Mendelian_Nancy_Cox	GYORFFY_MITOXANTRONE_RESISTANCE
0.303951367781%	6	1974	57	Mendelian_Nancy_Cox	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.303951367781%	6	1974	57	Mendelian_Nancy_Cox	DIRMEIER_LMP1_RESPONSE_LATE_UP
0.303951367781%	6	1974	56	Mendelian_Nancy_Cox	REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX
0.303951367781%	6	1974	55	Mendelian_Nancy_Cox	SMIRNOV_RESPONSE_TO_IR_2HR_DN
0.303951367781%	6	1974	55	Mendelian_Nancy_Cox	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER
0.303951367781%	6	1974	55	Mendelian_Nancy_Cox	GENTILE_UV_RESPONSE_CLUSTER_D4
0.303951367781%	6	1974	54	Mendelian_Nancy_Cox	ZHOU_TNF_SIGNALING_4HR
0.303951367781%	6	1974	54	Mendelian_Nancy_Cox	SUNG_METASTASIS_STROMA_DN
0.303951367781%	6	1974	53	Mendelian_Nancy_Cox	ROESSLER_LIVER_CANCER_METASTASIS_DN
0.303951367781%	6	1974	53	Mendelian_Nancy_Cox	LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.303951367781%	6	1974	53	Mendelian_Nancy_Cox	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
0.303951367781%	6	1974	52	Mendelian_Nancy_Cox	REACTOME_GABA_RECEPTOR_ACTIVATION
0.303951367781%	6	1974	52	Mendelian_Nancy_Cox	PRAMOONJAGO_SOX4_TARGETS_UP
0.303951367781%	6	1974	52	Mendelian_Nancy_Cox	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN
0.303951367781%	6	1974	52	Mendelian_Nancy_Cox	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
0.303951367781%	6	1974	51	Mendelian_Nancy_Cox	ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF
0.303951367781%	6	1974	51	Mendelian_Nancy_Cox	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.303951367781%	6	1974	51	Mendelian_Nancy_Cox	BURTON_ADIPOGENESIS_PEAK_AT_2HR
0.303951367781%	6	1974	51	Mendelian_Nancy_Cox	BURTON_ADIPOGENESIS_7
0.303951367781%	6	1974	50	Mendelian_Nancy_Cox	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.303951367781%	6	1974	50	Mendelian_Nancy_Cox	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
0.303951367781%	6	1974	50	Mendelian_Nancy_Cox	PARK_HSC_AND_MULTIPOTENT_PROGENITORS
0.303951367781%	6	1974	50	Mendelian_Nancy_Cox	KENNY_CTNNB1_TARGETS_UP
0.303951367781%	6	1974	50	Mendelian_Nancy_Cox	KEGG_GLUTATHIONE_METABOLISM
0.303951367781%	6	1974	50	Mendelian_Nancy_Cox	KANG_GIST_WITH_PDGFRA_UP
0.303951367781%	6	1974	50	Mendelian_Nancy_Cox	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC
0.303951367781%	6	1974	50	Mendelian_Nancy_Cox	FIGUEROA_AML_METHYLATION_CLUSTER_5_DN
0.303951367781%	6	1974	49	Mendelian_Nancy_Cox	REACTOME_METABOLISM_OF_NON_CODING_RNA
0.303951367781%	6	1974	49	Mendelian_Nancy_Cox	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.303951367781%	6	1974	49	Mendelian_Nancy_Cox	OLSSON_E2F3_TARGETS_DN
0.303951367781%	6	1974	49	Mendelian_Nancy_Cox	FAELT_B_CLL_WITH_VH3_21_DN
0.303951367781%	6	1974	48	Mendelian_Nancy_Cox	MCCLUNG_DELTA_FOSB_TARGETS_2WK
0.303951367781%	6	1974	48	Mendelian_Nancy_Cox	CHANGOLKAR_H2AFY_TARGETS_UP
0.303951367781%	6	1974	47	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_MF_UP
0.303951367781%	6	1974	47	Mendelian_Nancy_Cox	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
0.303951367781%	6	1974	47	Mendelian_Nancy_Cox	NAKAMURA_METASTASIS
0.303951367781%	6	1974	47	Mendelian_Nancy_Cox	IRITANI_MAD1_TARGETS_DN
0.303951367781%	6	1974	47	Mendelian_Nancy_Cox	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP
0.303951367781%	6	1974	46	Mendelian_Nancy_Cox	WINNEPENNINCKX_MELANOMA_METASTASIS_DN
0.303951367781%	6	1974	46	Mendelian_Nancy_Cox	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION
0.303951367781%	6	1974	46	Mendelian_Nancy_Cox	NAKAMURA_CANCER_MICROENVIRONMENT_DN
0.303951367781%	6	1974	46	Mendelian_Nancy_Cox	KUNINGER_IGF1_VS_PDGFB_TARGETS_DN
0.303951367781%	6	1974	45	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_CD2_UP
0.303951367781%	6	1974	45	Mendelian_Nancy_Cox	TRAYNOR_RETT_SYNDROM_UP
0.303951367781%	6	1974	45	Mendelian_Nancy_Cox	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN
0.303951367781%	6	1974	45	Mendelian_Nancy_Cox	NAKAMURA_METASTASIS_MODEL_UP
0.303951367781%	6	1974	45	Mendelian_Nancy_Cox	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN
0.303951367781%	6	1974	45	Mendelian_Nancy_Cox	GRADE_METASTASIS_DN
0.303951367781%	6	1974	44	Mendelian_Nancy_Cox	ZUCCHI_METASTASIS_DN
0.303951367781%	6	1974	44	Mendelian_Nancy_Cox	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.303951367781%	6	1974	44	Mendelian_Nancy_Cox	ROVERSI_GLIOMA_LOH_REGIONS
0.303951367781%	6	1974	44	Mendelian_Nancy_Cox	MA_MYELOID_DIFFERENTIATION_DN
0.303951367781%	6	1974	44	Mendelian_Nancy_Cox	KORKOLA_SEMINOMA_UP
0.303951367781%	6	1974	43	Mendelian_Nancy_Cox	DORN_ADENOVIRUS_INFECTION_24HR_DN
0.303951367781%	6	1974	43	Mendelian_Nancy_Cox	COWLING_MYCN_TARGETS
0.303951367781%	6	1974	42	Mendelian_Nancy_Cox	BARRIER_COLON_CANCER_RECURRENCE_UP
0.303951367781%	6	1974	41	Mendelian_Nancy_Cox	WENG_POR_TARGETS_LIVER_UP
0.303951367781%	6	1974	41	Mendelian_Nancy_Cox	DELPUECH_FOXO3_TARGETS_DN
0.303951367781%	6	1974	40	Mendelian_Nancy_Cox	ST_JNK_MAPK_PATHWAY
0.303951367781%	6	1974	40	Mendelian_Nancy_Cox	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
0.303951367781%	6	1974	40	Mendelian_Nancy_Cox	MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.303951367781%	6	1974	40	Mendelian_Nancy_Cox	GENTILE_UV_RESPONSE_CLUSTER_D7
0.303951367781%	6	1974	40	Mendelian_Nancy_Cox	CHESLER_BRAIN_HIGHEST_EXPRESSION
0.303951367781%	6	1974	39	Mendelian_Nancy_Cox	WANG_LSD1_TARGETS_DN
0.303951367781%	6	1974	39	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP
0.303951367781%	6	1974	39	Mendelian_Nancy_Cox	REACTOME_IL1_SIGNALING
0.303951367781%	6	1974	39	Mendelian_Nancy_Cox	PID_ATR_PATHWAY
0.303951367781%	6	1974	39	Mendelian_Nancy_Cox	MA_MYELOID_DIFFERENTIATION_UP
0.303951367781%	6	1974	39	Mendelian_Nancy_Cox	AMIT_SERUM_RESPONSE_480_MCF10A
0.303951367781%	6	1974	38	Mendelian_Nancy_Cox	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4
0.303951367781%	6	1974	38	Mendelian_Nancy_Cox	REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS
0.303951367781%	6	1974	38	Mendelian_Nancy_Cox	PID_ERBB4_PATHWAY
0.303951367781%	6	1974	38	Mendelian_Nancy_Cox	KRASNOSELSKAYA_ILF3_TARGETS_UP
0.303951367781%	6	1974	38	Mendelian_Nancy_Cox	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN
0.303951367781%	6	1974	38	Mendelian_Nancy_Cox	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
0.303951367781%	6	1974	37	Mendelian_Nancy_Cox	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN
0.303951367781%	6	1974	37	Mendelian_Nancy_Cox	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS
0.303951367781%	6	1974	37	Mendelian_Nancy_Cox	HOWLIN_CITED1_TARGETS_1_DN
0.303951367781%	6	1974	37	Mendelian_Nancy_Cox	FRASOR_RESPONSE_TO_ESTRADIOL_UP
0.303951367781%	6	1974	37	Mendelian_Nancy_Cox	BIOCARTA_TOLL_PATHWAY
0.303951367781%	6	1974	36	Mendelian_Nancy_Cox	SUBTIL_PROGESTIN_TARGETS
0.303951367781%	6	1974	36	Mendelian_Nancy_Cox	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.303951367781%	6	1974	36	Mendelian_Nancy_Cox	BURTON_ADIPOGENESIS_12
0.303951367781%	6	1974	35	Mendelian_Nancy_Cox	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.303951367781%	6	1974	35	Mendelian_Nancy_Cox	WANG_METHYLATED_IN_BREAST_CANCER
0.303951367781%	6	1974	35	Mendelian_Nancy_Cox	PID_PI3KCIAKTPATHWAY
0.303951367781%	6	1974	35	Mendelian_Nancy_Cox	PID_HIVNEFPATHWAY
0.303951367781%	6	1974	35	Mendelian_Nancy_Cox	PID_ARF6_PATHWAY
0.303951367781%	6	1974	34	Mendelian_Nancy_Cox	WANG_RESPONSE_TO_BEXAROTENE_UP
0.303951367781%	6	1974	34	Mendelian_Nancy_Cox	SIG_CD40PATHWAYMAP
0.303951367781%	6	1974	34	Mendelian_Nancy_Cox	PID_MAPKTRKPATHWAY
0.303951367781%	6	1974	34	Mendelian_Nancy_Cox	MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.303951367781%	6	1974	33	Mendelian_Nancy_Cox	VALK_AML_CLUSTER_10
0.303951367781%	6	1974	33	Mendelian_Nancy_Cox	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION
0.303951367781%	6	1974	33	Mendelian_Nancy_Cox	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS
0.303951367781%	6	1974	33	Mendelian_Nancy_Cox	REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS
0.303951367781%	6	1974	33	Mendelian_Nancy_Cox	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP
0.303951367781%	6	1974	33	Mendelian_Nancy_Cox	PID_ALPHASYNUCLEIN_PATHWAY
0.303951367781%	6	1974	33	Mendelian_Nancy_Cox	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS
0.303951367781%	6	1974	33	Mendelian_Nancy_Cox	DORN_ADENOVIRUS_INFECTION_12HR_DN
0.303951367781%	6	1974	33	Mendelian_Nancy_Cox	CHO_NR4A1_TARGETS
0.303951367781%	6	1974	32	Mendelian_Nancy_Cox	PID_WNT_NONCANONICAL_PATHWAY
0.303951367781%	6	1974	32	Mendelian_Nancy_Cox	LIANG_SILENCED_BY_METHYLATION_UP
0.303951367781%	6	1974	32	Mendelian_Nancy_Cox	KASLER_HDAC7_TARGETS_2_DN
0.303951367781%	6	1974	32	Mendelian_Nancy_Cox	GROSS_ELK3_TARGETS_DN
0.303951367781%	6	1974	32	Mendelian_Nancy_Cox	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP
0.303951367781%	6	1974	32	Mendelian_Nancy_Cox	FARDIN_HYPOXIA_11
0.303951367781%	6	1974	32	Mendelian_Nancy_Cox	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN
0.303951367781%	6	1974	32	Mendelian_Nancy_Cox	BIOCARTA_HDAC_PATHWAY
0.303951367781%	6	1974	31	Mendelian_Nancy_Cox	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.303951367781%	6	1974	31	Mendelian_Nancy_Cox	REACTOME_INWARDLY_RECTIFYING_K_CHANNELS
0.303951367781%	6	1974	31	Mendelian_Nancy_Cox	REACTOME_HS_GAG_BIOSYNTHESIS
0.303951367781%	6	1974	31	Mendelian_Nancy_Cox	REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE
0.303951367781%	6	1974	31	Mendelian_Nancy_Cox	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP
0.303951367781%	6	1974	31	Mendelian_Nancy_Cox	CUI_TCF21_TARGETS_DN
0.303951367781%	6	1974	30	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.303951367781%	6	1974	30	Mendelian_Nancy_Cox	VALK_AML_CLUSTER_13
0.303951367781%	6	1974	30	Mendelian_Nancy_Cox	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.303951367781%	6	1974	30	Mendelian_Nancy_Cox	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN
0.303951367781%	6	1974	30	Mendelian_Nancy_Cox	REACTOME_BASIGIN_INTERACTIONS
0.303951367781%	6	1974	30	Mendelian_Nancy_Cox	PID_RETINOIC_ACID_PATHWAY
0.303951367781%	6	1974	30	Mendelian_Nancy_Cox	PID_RAS_PATHWAY
0.303951367781%	6	1974	30	Mendelian_Nancy_Cox	KYNG_NORMAL_AGING_DN
0.303951367781%	6	1974	30	Mendelian_Nancy_Cox	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP
0.303951367781%	6	1974	29	Mendelian_Nancy_Cox	YU_BAP1_TARGETS
0.303951367781%	6	1974	29	Mendelian_Nancy_Cox	WOTTON_RUNX_TARGETS_DN
0.303951367781%	6	1974	29	Mendelian_Nancy_Cox	WEINMANN_ADAPTATION_TO_HYPOXIA_UP
0.303951367781%	6	1974	29	Mendelian_Nancy_Cox	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX
0.303951367781%	6	1974	29	Mendelian_Nancy_Cox	MIKKELSEN_MCV6_LCP_WITH_H3K27ME3
0.303951367781%	6	1974	29	Mendelian_Nancy_Cox	KRIGE_AMINO_ACID_DEPRIVATION
0.303951367781%	6	1974	29	Mendelian_Nancy_Cox	CHOW_RASSF1_TARGETS_DN
0.303951367781%	6	1974	29	Mendelian_Nancy_Cox	BIOCARTA_VIP_PATHWAY
0.303951367781%	6	1974	29	Mendelian_Nancy_Cox	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP
0.303951367781%	6	1974	28	Mendelian_Nancy_Cox	WIKMAN_ASBESTOS_LUNG_CANCER_DN
0.303951367781%	6	1974	28	Mendelian_Nancy_Cox	SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER
0.303951367781%	6	1974	28	Mendelian_Nancy_Cox	PETROVA_PROX1_TARGETS_UP
0.303951367781%	6	1974	28	Mendelian_Nancy_Cox	LI_CISPLATIN_RESISTANCE_UP
0.303951367781%	6	1974	28	Mendelian_Nancy_Cox	KEGG_HOMOLOGOUS_RECOMBINATION
0.303951367781%	6	1974	28	Mendelian_Nancy_Cox	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP
0.303951367781%	6	1974	28	Mendelian_Nancy_Cox	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN
0.303951367781%	6	1974	27	Mendelian_Nancy_Cox	REACTOME_G_PROTEIN_ACTIVATION
0.303951367781%	6	1974	27	Mendelian_Nancy_Cox	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS
0.303951367781%	6	1974	27	Mendelian_Nancy_Cox	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS
0.303951367781%	6	1974	27	Mendelian_Nancy_Cox	LEE_DOUBLE_POLAR_THYMOCYTE
0.303951367781%	6	1974	27	Mendelian_Nancy_Cox	CHOW_RASSF1_TARGETS_UP
0.303951367781%	6	1974	27	Mendelian_Nancy_Cox	BIOCARTA_CREB_PATHWAY
0.303951367781%	6	1974	26	Mendelian_Nancy_Cox	VALK_AML_CLUSTER_8
0.303951367781%	6	1974	26	Mendelian_Nancy_Cox	TOMIDA_METASTASIS_UP
0.303951367781%	6	1974	26	Mendelian_Nancy_Cox	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP
0.303951367781%	6	1974	26	Mendelian_Nancy_Cox	PID_VEGFR1_PATHWAY
0.303951367781%	6	1974	26	Mendelian_Nancy_Cox	PID_RXR_VDR_PATHWAY
0.303951367781%	6	1974	26	Mendelian_Nancy_Cox	PID_INSULIN_GLUCOSE_PATHWAY
0.303951367781%	6	1974	26	Mendelian_Nancy_Cox	PID_IL27PATHWAY
0.303951367781%	6	1974	26	Mendelian_Nancy_Cox	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN
0.303951367781%	6	1974	26	Mendelian_Nancy_Cox	BIOCARTA_BAD_PATHWAY
0.303951367781%	6	1974	26	Mendelian_Nancy_Cox	ALONSO_METASTASIS_DN
0.303951367781%	6	1974	25	Mendelian_Nancy_Cox	RUAN_RESPONSE_TO_TROGLITAZONE_UP
0.303951367781%	6	1974	25	Mendelian_Nancy_Cox	REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS
0.303951367781%	6	1974	25	Mendelian_Nancy_Cox	NOJIMA_SFRP2_TARGETS_DN
0.303951367781%	6	1974	25	Mendelian_Nancy_Cox	KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS
0.303951367781%	6	1974	25	Mendelian_Nancy_Cox	KEGG_DORSO_VENTRAL_AXIS_FORMATION
0.303951367781%	6	1974	25	Mendelian_Nancy_Cox	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN
0.303951367781%	6	1974	25	Mendelian_Nancy_Cox	HOEGERKORP_CD44_TARGETS_TEMPORAL_DN
0.303951367781%	6	1974	25	Mendelian_Nancy_Cox	COLLER_MYC_TARGETS_UP
0.303951367781%	6	1974	24	Mendelian_Nancy_Cox	WANG_LSD1_TARGETS_UP
0.303951367781%	6	1974	24	Mendelian_Nancy_Cox	REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION
0.303951367781%	6	1974	24	Mendelian_Nancy_Cox	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
0.303951367781%	6	1974	24	Mendelian_Nancy_Cox	MATZUK_SPERMATOGONIA
0.303951367781%	6	1974	24	Mendelian_Nancy_Cox	JIANG_TIP30_TARGETS_DN
0.303951367781%	6	1974	24	Mendelian_Nancy_Cox	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN
0.303951367781%	6	1974	24	Mendelian_Nancy_Cox	BIOCARTA_G2_PATHWAY
0.303951367781%	6	1974	24	Mendelian_Nancy_Cox	BIOCARTA_ECM_PATHWAY
0.303951367781%	6	1974	23	Mendelian_Nancy_Cox	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B
0.303951367781%	6	1974	23	Mendelian_Nancy_Cox	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A
0.303951367781%	6	1974	23	Mendelian_Nancy_Cox	MARKS_HDAC_TARGETS_UP
0.303951367781%	6	1974	23	Mendelian_Nancy_Cox	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP
0.303951367781%	6	1974	23	Mendelian_Nancy_Cox	BIOCARTA_MTOR_PATHWAY
0.303951367781%	6	1974	22	Mendelian_Nancy_Cox	PID_PDGFRAPATHWAY
0.303951367781%	6	1974	22	Mendelian_Nancy_Cox	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP
0.303951367781%	6	1974	22	Mendelian_Nancy_Cox	GAVIN_PDE3B_TARGETS
0.303951367781%	6	1974	22	Mendelian_Nancy_Cox	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN
0.303951367781%	6	1974	22	Mendelian_Nancy_Cox	BIOCARTA_SPPA_PATHWAY
0.303951367781%	6	1974	21	Mendelian_Nancy_Cox	REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION
0.303951367781%	6	1974	21	Mendelian_Nancy_Cox	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC
0.303951367781%	6	1974	21	Mendelian_Nancy_Cox	RAHMAN_TP53_TARGETS_PHOSPHORYLATED
0.303951367781%	6	1974	21	Mendelian_Nancy_Cox	HU_ANGIOGENESIS_UP
0.303951367781%	6	1974	20	Mendelian_Nancy_Cox	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN
0.303951367781%	6	1974	20	Mendelian_Nancy_Cox	VILIMAS_NOTCH1_TARGETS_DN
0.303951367781%	6	1974	20	Mendelian_Nancy_Cox	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN
0.303951367781%	6	1974	20	Mendelian_Nancy_Cox	PID_WNT_CANONICAL_PATHWAY
0.303951367781%	6	1974	20	Mendelian_Nancy_Cox	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP
0.303951367781%	6	1974	20	Mendelian_Nancy_Cox	MANN_RESPONSE_TO_AMIFOSTINE_UP
0.303951367781%	6	1974	20	Mendelian_Nancy_Cox	BIOCARTA_IGF1MTOR_PATHWAY
0.303951367781%	6	1974	19	Mendelian_Nancy_Cox	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN
0.303951367781%	6	1974	19	Mendelian_Nancy_Cox	VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP
0.303951367781%	6	1974	19	Mendelian_Nancy_Cox	SHIN_B_CELL_LYMPHOMA_CLUSTER_9
0.303951367781%	6	1974	19	Mendelian_Nancy_Cox	SA_CASPASE_CASCADE
0.303951367781%	6	1974	19	Mendelian_Nancy_Cox	OUYANG_PROSTATE_CANCER_MARKERS
0.303951367781%	6	1974	19	Mendelian_Nancy_Cox	MATZUK_EMBRYONIC_GERM_CELL
0.303951367781%	6	1974	19	Mendelian_Nancy_Cox	KANG_AR_TARGETS_DN
0.303951367781%	6	1974	18	Mendelian_Nancy_Cox	ZHENG_RESPONSE_TO_ARSENITE_DN
0.303951367781%	6	1974	18	Mendelian_Nancy_Cox	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP
0.303951367781%	6	1974	18	Mendelian_Nancy_Cox	SCHEIDEREIT_IKK_TARGETS
0.303951367781%	6	1974	18	Mendelian_Nancy_Cox	NIELSEN_SYNOVIAL_SARCOMA_UP
0.303951367781%	6	1974	18	Mendelian_Nancy_Cox	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN
0.303951367781%	6	1974	18	Mendelian_Nancy_Cox	MCGOWAN_RSP6_TARGETS_UP
0.303951367781%	6	1974	18	Mendelian_Nancy_Cox	LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK
0.303951367781%	6	1974	18	Mendelian_Nancy_Cox	KEGG_PHENYLALANINE_METABOLISM
0.303951367781%	6	1974	18	Mendelian_Nancy_Cox	HUMMERICH_MALIGNANT_SKIN_TUMOR_DN
0.303951367781%	6	1974	18	Mendelian_Nancy_Cox	HUMMERICH_BENIGN_SKIN_TUMOR_DN
0.303951367781%	6	1974	18	Mendelian_Nancy_Cox	BIOCARTA_TNFR2_PATHWAY
0.303951367781%	6	1974	18	Mendelian_Nancy_Cox	BIOCARTA_TEL_PATHWAY
0.303951367781%	6	1974	18	Mendelian_Nancy_Cox	BIOCARTA_PTEN_PATHWAY
0.303951367781%	6	1974	18	Mendelian_Nancy_Cox	BIOCARTA_NGF_PATHWAY
0.303951367781%	6	1974	18	Mendelian_Nancy_Cox	BIOCARTA_CARDIACEGF_PATHWAY
0.303951367781%	6	1974	18	Mendelian_Nancy_Cox	ALONSO_METASTASIS_NEURAL_UP
0.303951367781%	6	1974	17	Mendelian_Nancy_Cox	SA_PTEN_PATHWAY
0.303951367781%	6	1974	17	Mendelian_Nancy_Cox	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP
0.303951367781%	6	1974	17	Mendelian_Nancy_Cox	REACTOME_TIE2_SIGNALING
0.303951367781%	6	1974	17	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI
0.303951367781%	6	1974	17	Mendelian_Nancy_Cox	REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS
0.303951367781%	6	1974	17	Mendelian_Nancy_Cox	KASLER_HDAC7_TARGETS_1_DN
0.303951367781%	6	1974	17	Mendelian_Nancy_Cox	BIOCARTA_IL17_PATHWAY
0.303951367781%	6	1974	17	Mendelian_Nancy_Cox	BIOCARTA_HCMV_PATHWAY
0.303951367781%	6	1974	16	Mendelian_Nancy_Cox	REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2
0.303951367781%	6	1974	16	Mendelian_Nancy_Cox	REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS
0.303951367781%	6	1974	16	Mendelian_Nancy_Cox	HUMMERICH_MALIGNANT_SKIN_TUMOR_UP
0.303951367781%	6	1974	16	Mendelian_Nancy_Cox	CHIN_BREAST_CANCER_COPY_NUMBER_DN
0.303951367781%	6	1974	16	Mendelian_Nancy_Cox	BIOCARTA_SHH_PATHWAY
0.303951367781%	6	1974	16	Mendelian_Nancy_Cox	BIOCARTA_CDMAC_PATHWAY
0.303951367781%	6	1974	16	Mendelian_Nancy_Cox	BIOCARTA_ACH_PATHWAY
0.303951367781%	6	1974	16	Mendelian_Nancy_Cox	BAKER_HEMATOPOIESIS_STAT3_TARGETS
0.303951367781%	6	1974	15	Mendelian_Nancy_Cox	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP
0.303951367781%	6	1974	15	Mendelian_Nancy_Cox	SU_KIDNEY
0.303951367781%	6	1974	15	Mendelian_Nancy_Cox	STEINER_ERYTHROCYTE_MEMBRANE_GENES
0.303951367781%	6	1974	15	Mendelian_Nancy_Cox	SANDERSON_PPARA_TARGETS
0.303951367781%	6	1974	15	Mendelian_Nancy_Cox	REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS
0.303951367781%	6	1974	15	Mendelian_Nancy_Cox	BIOCARTA_PITX2_PATHWAY
0.303951367781%	6	1974	15	Mendelian_Nancy_Cox	BIOCARTA_IL3_PATHWAY
0.303951367781%	6	1974	15	Mendelian_Nancy_Cox	BIOCARTA_ERYTH_PATHWAY
0.303951367781%	6	1974	15	Mendelian_Nancy_Cox	BIOCARTA_BARRESTIN_SRC_PATHWAY
0.303951367781%	6	1974	14	Mendelian_Nancy_Cox	ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS
0.303951367781%	6	1974	14	Mendelian_Nancy_Cox	REACTOME_METABOLISM_OF_PORPHYRINS
0.303951367781%	6	1974	14	Mendelian_Nancy_Cox	REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION
0.303951367781%	6	1974	14	Mendelian_Nancy_Cox	PID_TCRRASPATHWAY
0.303951367781%	6	1974	14	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24
0.303951367781%	6	1974	14	Mendelian_Nancy_Cox	BIOCARTA_TCYTOTOXIC_PATHWAY
0.303951367781%	6	1974	13	Mendelian_Nancy_Cox	REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS
0.303951367781%	6	1974	13	Mendelian_Nancy_Cox	ONGUSAHA_BRCA1_TARGETS_UP
0.303951367781%	6	1974	13	Mendelian_Nancy_Cox	BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION
0.303951367781%	6	1974	12	Mendelian_Nancy_Cox	REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS
0.303951367781%	6	1974	12	Mendelian_Nancy_Cox	BIOCARTA_TRKA_PATHWAY
0.303951367781%	6	1974	12	Mendelian_Nancy_Cox	BIOCARTA_ETC_PATHWAY
0.303951367781%	6	1974	12	Mendelian_Nancy_Cox	BIOCARTA_ASBCELL_PATHWAY
0.303951367781%	6	1974	11	Mendelian_Nancy_Cox	PID_INTEGRIN4_PATHWAY
0.303951367781%	6	1974	11	Mendelian_Nancy_Cox	DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4
0.303951367781%	6	1974	11	Mendelian_Nancy_Cox	BIOCARTA_VITCB_PATHWAY
0.303951367781%	6	1974	10	Mendelian_Nancy_Cox	REACTOME_RAF_MAP_KINASE_CASCADE
0.303951367781%	6	1974	10	Mendelian_Nancy_Cox	REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS
0.303951367781%	6	1974	10	Mendelian_Nancy_Cox	REACTOME_ANDROGEN_BIOSYNTHESIS
0.302571860817%	2	661	99	T2D_GENES_TANYA_GLYCEMIC	LIM_MAMMARY_LUMINAL_MATURE_DN
0.302571860817%	2	661	98	T2D_GENES_TANYA_GLYCEMIC	NIELSEN_GIST
0.302571860817%	2	661	98	T2D_GENES_TANYA_GLYCEMIC	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
0.302571860817%	2	661	95	T2D_GENES_TANYA_GLYCEMIC	KAYO_CALORIE_RESTRICTION_MUSCLE_UP
0.302571860817%	2	661	94	T2D_GENES_TANYA_GLYCEMIC	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.302571860817%	2	661	94	T2D_GENES_TANYA_GLYCEMIC	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER
0.302571860817%	2	661	93	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ACTIVATED_TLR4_SIGNALLING
0.302571860817%	2	661	91	T2D_GENES_TANYA_GLYCEMIC	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.302571860817%	2	661	91	T2D_GENES_TANYA_GLYCEMIC	ELVIDGE_HIF1A_TARGETS_DN
0.302571860817%	2	661	9	T2D_GENES_TANYA_GLYCEMIC	ITO_PTTG1_TARGETS_DN
0.302571860817%	2	661	9	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_FEEDER_PATHWAY
0.302571860817%	2	661	89	T2D_GENES_TANYA_GLYCEMIC	SWEET_KRAS_ONCOGENIC_SIGNATURE
0.302571860817%	2	661	88	T2D_GENES_TANYA_GLYCEMIC	WALLACE_PROSTATE_CANCER_RACE_DN
0.302571860817%	2	661	88	T2D_GENES_TANYA_GLYCEMIC	TIEN_INTESTINE_PROBIOTICS_2HR_DN
0.302571860817%	2	661	88	T2D_GENES_TANYA_GLYCEMIC	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
0.302571860817%	2	661	88	T2D_GENES_TANYA_GLYCEMIC	KEGG_RIBOSOME
0.302571860817%	2	661	88	T2D_GENES_TANYA_GLYCEMIC	KEGG_APOPTOSIS
0.302571860817%	2	661	88	T2D_GENES_TANYA_GLYCEMIC	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
0.302571860817%	2	661	88	T2D_GENES_TANYA_GLYCEMIC	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
0.302571860817%	2	661	87	T2D_GENES_TANYA_GLYCEMIC	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.302571860817%	2	661	87	T2D_GENES_TANYA_GLYCEMIC	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.302571860817%	2	661	87	T2D_GENES_TANYA_GLYCEMIC	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
0.302571860817%	2	661	86	T2D_GENES_TANYA_GLYCEMIC	TAKAO_RESPONSE_TO_UVB_RADIATION_UP
0.302571860817%	2	661	86	T2D_GENES_TANYA_GLYCEMIC	REACTOME_L1CAM_INTERACTIONS
0.302571860817%	2	661	86	T2D_GENES_TANYA_GLYCEMIC	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
0.302571860817%	2	661	86	T2D_GENES_TANYA_GLYCEMIC	GHANDHI_BYSTANDER_IRRADIATION_UP
0.302571860817%	2	661	85	T2D_GENES_TANYA_GLYCEMIC	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE
0.302571860817%	2	661	84	T2D_GENES_TANYA_GLYCEMIC	SWEET_KRAS_TARGETS_UP
0.302571860817%	2	661	84	T2D_GENES_TANYA_GLYCEMIC	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP
0.302571860817%	2	661	84	T2D_GENES_TANYA_GLYCEMIC	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
0.302571860817%	2	661	84	T2D_GENES_TANYA_GLYCEMIC	RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.302571860817%	2	661	84	T2D_GENES_TANYA_GLYCEMIC	KEGG_ECM_RECEPTOR_INTERACTION
0.302571860817%	2	661	84	T2D_GENES_TANYA_GLYCEMIC	HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.302571860817%	2	661	84	T2D_GENES_TANYA_GLYCEMIC	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
0.302571860817%	2	661	84	T2D_GENES_TANYA_GLYCEMIC	CHANG_IMMORTALIZED_BY_HPV31_UP
0.302571860817%	2	661	83	T2D_GENES_TANYA_GLYCEMIC	WARTERS_RESPONSE_TO_IR_SKIN
0.302571860817%	2	661	83	T2D_GENES_TANYA_GLYCEMIC	SANA_TNF_SIGNALING_UP
0.302571860817%	2	661	83	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
0.302571860817%	2	661	83	T2D_GENES_TANYA_GLYCEMIC	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.302571860817%	2	661	83	T2D_GENES_TANYA_GLYCEMIC	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
0.302571860817%	2	661	82	T2D_GENES_TANYA_GLYCEMIC	WONG_ENDMETRIUM_CANCER_DN
0.302571860817%	2	661	82	T2D_GENES_TANYA_GLYCEMIC	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
0.302571860817%	2	661	82	T2D_GENES_TANYA_GLYCEMIC	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
0.302571860817%	2	661	81	T2D_GENES_TANYA_GLYCEMIC	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
0.302571860817%	2	661	81	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION
0.302571860817%	2	661	81	T2D_GENES_TANYA_GLYCEMIC	MUNSHI_MULTIPLE_MYELOMA_UP
0.302571860817%	2	661	81	T2D_GENES_TANYA_GLYCEMIC	GUO_HEX_TARGETS_UP
0.302571860817%	2	661	80	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
0.302571860817%	2	661	80	T2D_GENES_TANYA_GLYCEMIC	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.302571860817%	2	661	80	T2D_GENES_TANYA_GLYCEMIC	FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.302571860817%	2	661	8	T2D_GENES_TANYA_GLYCEMIC	OHM_EMBRYONIC_CARCINOMA_DN
0.302571860817%	2	661	8	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_DEDIFFERENTIATED_STATE_UP
0.302571860817%	2	661	79	T2D_GENES_TANYA_GLYCEMIC	TOOKER_GEMCITABINE_RESISTANCE_UP
0.302571860817%	2	661	79	T2D_GENES_TANYA_GLYCEMIC	LIU_COMMON_CANCER_GENES
0.302571860817%	2	661	79	T2D_GENES_TANYA_GLYCEMIC	GAVIN_FOXP3_TARGETS_CLUSTER_P2
0.302571860817%	2	661	78	T2D_GENES_TANYA_GLYCEMIC	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.302571860817%	2	661	78	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_SCF_KIT
0.302571860817%	2	661	78	T2D_GENES_TANYA_GLYCEMIC	REACTOME_OPIOID_SIGNALLING
0.302571860817%	2	661	78	T2D_GENES_TANYA_GLYCEMIC	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE
0.302571860817%	2	661	77	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
0.302571860817%	2	661	77	T2D_GENES_TANYA_GLYCEMIC	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
0.302571860817%	2	661	76	T2D_GENES_TANYA_GLYCEMIC	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
0.302571860817%	2	661	76	T2D_GENES_TANYA_GLYCEMIC	PEART_HDAC_PROLIFERATION_CLUSTER_DN
0.302571860817%	2	661	75	T2D_GENES_TANYA_GLYCEMIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
0.302571860817%	2	661	75	T2D_GENES_TANYA_GLYCEMIC	MCCLUNG_COCAIN_REWARD_4WK
0.302571860817%	2	661	75	T2D_GENES_TANYA_GLYCEMIC	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.302571860817%	2	661	75	T2D_GENES_TANYA_GLYCEMIC	CHESLER_BRAIN_QTL_CIS
0.302571860817%	2	661	75	T2D_GENES_TANYA_GLYCEMIC	BAE_BRCA1_TARGETS_UP
0.302571860817%	2	661	74	T2D_GENES_TANYA_GLYCEMIC	VANASSE_BCL2_TARGETS_DN
0.302571860817%	2	661	74	T2D_GENES_TANYA_GLYCEMIC	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.302571860817%	2	661	74	T2D_GENES_TANYA_GLYCEMIC	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
0.302571860817%	2	661	74	T2D_GENES_TANYA_GLYCEMIC	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
0.302571860817%	2	661	74	T2D_GENES_TANYA_GLYCEMIC	LEE_LIVER_CANCER_DENA_DN
0.302571860817%	2	661	73	T2D_GENES_TANYA_GLYCEMIC	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
0.302571860817%	2	661	73	T2D_GENES_TANYA_GLYCEMIC	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
0.302571860817%	2	661	73	T2D_GENES_TANYA_GLYCEMIC	KEGG_VIRAL_MYOCARDITIS
0.302571860817%	2	661	72	T2D_GENES_TANYA_GLYCEMIC	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1
0.302571860817%	2	661	72	T2D_GENES_TANYA_GLYCEMIC	MATZUK_SPERMATOCYTE
0.302571860817%	2	661	72	T2D_GENES_TANYA_GLYCEMIC	DOANE_BREAST_CANCER_CLASSES_UP
0.302571860817%	2	661	71	T2D_GENES_TANYA_GLYCEMIC	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
0.302571860817%	2	661	71	T2D_GENES_TANYA_GLYCEMIC	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.302571860817%	2	661	70	T2D_GENES_TANYA_GLYCEMIC	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
0.302571860817%	2	661	70	T2D_GENES_TANYA_GLYCEMIC	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5
0.302571860817%	2	661	70	T2D_GENES_TANYA_GLYCEMIC	RAGHAVACHARI_PLATELET_SPECIFIC_GENES
0.302571860817%	2	661	70	T2D_GENES_TANYA_GLYCEMIC	PID_CDC42_PATHWAY
0.302571860817%	2	661	69	T2D_GENES_TANYA_GLYCEMIC	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.302571860817%	2	661	69	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SPHINGOLIPID_METABOLISM
0.302571860817%	2	661	69	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GLUCOSE_METABOLISM
0.302571860817%	2	661	69	T2D_GENES_TANYA_GLYCEMIC	PID_P75NTRPATHWAY
0.302571860817%	2	661	69	T2D_GENES_TANYA_GLYCEMIC	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.302571860817%	2	661	68	T2D_GENES_TANYA_GLYCEMIC	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
0.302571860817%	2	661	68	T2D_GENES_TANYA_GLYCEMIC	BROWNE_INTERFERON_RESPONSIVE_GENES
0.302571860817%	2	661	68	T2D_GENES_TANYA_GLYCEMIC	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES
0.302571860817%	2	661	68	T2D_GENES_TANYA_GLYCEMIC	BASSO_CD40_SIGNALING_DN
0.302571860817%	2	661	68	T2D_GENES_TANYA_GLYCEMIC	AKL_HTLV1_INFECTION_DN
0.302571860817%	2	661	67	T2D_GENES_TANYA_GLYCEMIC	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
0.302571860817%	2	661	67	T2D_GENES_TANYA_GLYCEMIC	VANHARANTA_UTERINE_FIBROID_DN
0.302571860817%	2	661	67	T2D_GENES_TANYA_GLYCEMIC	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
0.302571860817%	2	661	67	T2D_GENES_TANYA_GLYCEMIC	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
0.302571860817%	2	661	67	T2D_GENES_TANYA_GLYCEMIC	GENTILE_UV_LOW_DOSE_DN
0.302571860817%	2	661	67	T2D_GENES_TANYA_GLYCEMIC	ELVIDGE_HIF1A_TARGETS_UP
0.302571860817%	2	661	67	T2D_GENES_TANYA_GLYCEMIC	DAZARD_UV_RESPONSE_CLUSTER_G1
0.302571860817%	2	661	66	T2D_GENES_TANYA_GLYCEMIC	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
0.302571860817%	2	661	66	T2D_GENES_TANYA_GLYCEMIC	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT
0.302571860817%	2	661	66	T2D_GENES_TANYA_GLYCEMIC	TENEDINI_MEGAKARYOCYTE_MARKERS
0.302571860817%	2	661	66	T2D_GENES_TANYA_GLYCEMIC	SWEET_KRAS_TARGETS_DN
0.302571860817%	2	661	66	T2D_GENES_TANYA_GLYCEMIC	RAMASWAMY_METASTASIS_UP
0.302571860817%	2	661	66	T2D_GENES_TANYA_GLYCEMIC	PID_TCR_PATHWAY
0.302571860817%	2	661	66	T2D_GENES_TANYA_GLYCEMIC	PID_INTEGRIN1_PATHWAY
0.302571860817%	2	661	66	T2D_GENES_TANYA_GLYCEMIC	PID_HIF1_TFPATHWAY
0.302571860817%	2	661	66	T2D_GENES_TANYA_GLYCEMIC	PID_HDAC_CLASSI_PATHWAY
0.302571860817%	2	661	66	T2D_GENES_TANYA_GLYCEMIC	MARSON_FOXP3_TARGETS_UP
0.302571860817%	2	661	66	T2D_GENES_TANYA_GLYCEMIC	DIRMEIER_LMP1_RESPONSE_EARLY
0.302571860817%	2	661	65	T2D_GENES_TANYA_GLYCEMIC	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.302571860817%	2	661	65	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX
0.302571860817%	2	661	65	T2D_GENES_TANYA_GLYCEMIC	PID_IL4_2PATHWAY
0.302571860817%	2	661	65	T2D_GENES_TANYA_GLYCEMIC	PID_CD8TCRDOWNSTREAMPATHWAY
0.302571860817%	2	661	65	T2D_GENES_TANYA_GLYCEMIC	PID_BCR_5PATHWAY
0.302571860817%	2	661	65	T2D_GENES_TANYA_GLYCEMIC	LEE_LIVER_CANCER_ACOX1_DN
0.302571860817%	2	661	65	T2D_GENES_TANYA_GLYCEMIC	GUO_HEX_TARGETS_DN
0.302571860817%	2	661	65	T2D_GENES_TANYA_GLYCEMIC	CHANG_IMMORTALIZED_BY_HPV31_DN
0.302571860817%	2	661	64	T2D_GENES_TANYA_GLYCEMIC	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
0.302571860817%	2	661	64	T2D_GENES_TANYA_GLYCEMIC	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
0.302571860817%	2	661	64	T2D_GENES_TANYA_GLYCEMIC	PETROVA_PROX1_TARGETS_DN
0.302571860817%	2	661	64	T2D_GENES_TANYA_GLYCEMIC	INGRAM_SHH_TARGETS_DN
0.302571860817%	2	661	64	T2D_GENES_TANYA_GLYCEMIC	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
0.302571860817%	2	661	63	T2D_GENES_TANYA_GLYCEMIC	JOHNSTONE_PARVB_TARGETS_1_DN
0.302571860817%	2	661	62	T2D_GENES_TANYA_GLYCEMIC	MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN
0.302571860817%	2	661	62	T2D_GENES_TANYA_GLYCEMIC	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.302571860817%	2	661	62	T2D_GENES_TANYA_GLYCEMIC	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.302571860817%	2	661	61	T2D_GENES_TANYA_GLYCEMIC	PID_AR_PATHWAY
0.302571860817%	2	661	61	T2D_GENES_TANYA_GLYCEMIC	KAUFFMANN_MELANOMA_RELAPSE_UP
0.302571860817%	2	661	61	T2D_GENES_TANYA_GLYCEMIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
0.302571860817%	2	661	61	T2D_GENES_TANYA_GLYCEMIC	BAKKER_FOXO3_TARGETS_UP
0.302571860817%	2	661	60	T2D_GENES_TANYA_GLYCEMIC	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
0.302571860817%	2	661	6	T2D_GENES_TANYA_GLYCEMIC	TRACEY_RESISTANCE_TO_IFNA2_UP
0.302571860817%	2	661	59	T2D_GENES_TANYA_GLYCEMIC	WESTON_VEGFA_TARGETS_6HR
0.302571860817%	2	661	59	T2D_GENES_TANYA_GLYCEMIC	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS
0.302571860817%	2	661	59	T2D_GENES_TANYA_GLYCEMIC	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
0.302571860817%	2	661	59	T2D_GENES_TANYA_GLYCEMIC	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1
0.302571860817%	2	661	59	T2D_GENES_TANYA_GLYCEMIC	DASU_IL6_SIGNALING_UP
0.302571860817%	2	661	58	T2D_GENES_TANYA_GLYCEMIC	NAGASHIMA_EGF_SIGNALING_UP
0.302571860817%	2	661	58	T2D_GENES_TANYA_GLYCEMIC	KOHOUTEK_CCNT2_TARGETS
0.302571860817%	2	661	58	T2D_GENES_TANYA_GLYCEMIC	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
0.302571860817%	2	661	58	T2D_GENES_TANYA_GLYCEMIC	JI_RESPONSE_TO_FSH_DN
0.302571860817%	2	661	58	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_PPARA_PATHWAY
0.302571860817%	2	661	57	T2D_GENES_TANYA_GLYCEMIC	TANG_SENESCENCE_TP53_TARGETS_DN
0.302571860817%	2	661	57	T2D_GENES_TANYA_GLYCEMIC	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN
0.302571860817%	2	661	57	T2D_GENES_TANYA_GLYCEMIC	MCCLUNG_CREB1_TARGETS_DN
0.302571860817%	2	661	57	T2D_GENES_TANYA_GLYCEMIC	GRABARCZYK_BCL11B_TARGETS_DN
0.302571860817%	2	661	57	T2D_GENES_TANYA_GLYCEMIC	DELASERNA_MYOD_TARGETS_DN
0.302571860817%	2	661	57	T2D_GENES_TANYA_GLYCEMIC	BURTON_ADIPOGENESIS_11
0.302571860817%	2	661	57	T2D_GENES_TANYA_GLYCEMIC	BORLAK_LIVER_CANCER_EGF_UP
0.302571860817%	2	661	56	T2D_GENES_TANYA_GLYCEMIC	VANTVEER_BREAST_CANCER_METASTASIS_UP
0.302571860817%	2	661	56	T2D_GENES_TANYA_GLYCEMIC	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP
0.302571860817%	2	661	56	T2D_GENES_TANYA_GLYCEMIC	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.302571860817%	2	661	56	T2D_GENES_TANYA_GLYCEMIC	HENDRICKS_SMARCA4_TARGETS_UP
0.302571860817%	2	661	56	T2D_GENES_TANYA_GLYCEMIC	GYORFFY_DOXORUBICIN_RESISTANCE
0.302571860817%	2	661	55	T2D_GENES_TANYA_GLYCEMIC	YU_MYC_TARGETS_DN
0.302571860817%	2	661	55	T2D_GENES_TANYA_GLYCEMIC	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
0.302571860817%	2	661	55	T2D_GENES_TANYA_GLYCEMIC	GENTILE_UV_RESPONSE_CLUSTER_D4
0.302571860817%	2	661	55	T2D_GENES_TANYA_GLYCEMIC	DEMAGALHAES_AGING_UP
0.302571860817%	2	661	54	T2D_GENES_TANYA_GLYCEMIC	ROVERSI_GLIOMA_COPY_NUMBER_DN
0.302571860817%	2	661	54	T2D_GENES_TANYA_GLYCEMIC	LEE_LIVER_CANCER_MYC_UP
0.302571860817%	2	661	54	T2D_GENES_TANYA_GLYCEMIC	KEGG_INOSITOL_PHOSPHATE_METABOLISM
0.302571860817%	2	661	54	T2D_GENES_TANYA_GLYCEMIC	KANG_DOXORUBICIN_RESISTANCE_UP
0.302571860817%	2	661	53	T2D_GENES_TANYA_GLYCEMIC	SMIRNOV_RESPONSE_TO_IR_2HR_UP
0.302571860817%	2	661	53	T2D_GENES_TANYA_GLYCEMIC	PID_AR_TF_PATHWAY
0.302571860817%	2	661	53	T2D_GENES_TANYA_GLYCEMIC	MENSSEN_MYC_TARGETS
0.302571860817%	2	661	53	T2D_GENES_TANYA_GLYCEMIC	LIANG_SILENCED_BY_METHYLATION_2
0.302571860817%	2	661	53	T2D_GENES_TANYA_GLYCEMIC	KRIEG_HYPOXIA_VIA_KDM3A
0.302571860817%	2	661	53	T2D_GENES_TANYA_GLYCEMIC	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
0.302571860817%	2	661	53	T2D_GENES_TANYA_GLYCEMIC	HENDRICKS_SMARCA4_TARGETS_DN
0.302571860817%	2	661	53	T2D_GENES_TANYA_GLYCEMIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN
0.302571860817%	2	661	52	T2D_GENES_TANYA_GLYCEMIC	WINTER_HYPOXIA_DN
0.302571860817%	2	661	52	T2D_GENES_TANYA_GLYCEMIC	PID_KITPATHWAY
0.302571860817%	2	661	52	T2D_GENES_TANYA_GLYCEMIC	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP
0.302571860817%	2	661	52	T2D_GENES_TANYA_GLYCEMIC	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
0.302571860817%	2	661	52	T2D_GENES_TANYA_GLYCEMIC	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6
0.302571860817%	2	661	52	T2D_GENES_TANYA_GLYCEMIC	KENNY_CTNNB1_TARGETS_DN
0.302571860817%	2	661	52	T2D_GENES_TANYA_GLYCEMIC	KEGG_ENDOMETRIAL_CANCER
0.302571860817%	2	661	52	T2D_GENES_TANYA_GLYCEMIC	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP
0.302571860817%	2	661	52	T2D_GENES_TANYA_GLYCEMIC	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP
0.302571860817%	2	661	51	T2D_GENES_TANYA_GLYCEMIC	ZHANG_PROLIFERATING_VS_QUIESCENT
0.302571860817%	2	661	51	T2D_GENES_TANYA_GLYCEMIC	WANG_BARRETTS_ESOPHAGUS_UP
0.302571860817%	2	661	51	T2D_GENES_TANYA_GLYCEMIC	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
0.302571860817%	2	661	51	T2D_GENES_TANYA_GLYCEMIC	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
0.302571860817%	2	661	51	T2D_GENES_TANYA_GLYCEMIC	BURTON_ADIPOGENESIS_7
0.302571860817%	2	661	50	T2D_GENES_TANYA_GLYCEMIC	STOSSI_RESPONSE_TO_ESTRADIOL
0.302571860817%	2	661	50	T2D_GENES_TANYA_GLYCEMIC	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.302571860817%	2	661	50	T2D_GENES_TANYA_GLYCEMIC	PID_ANGIOPOIETINRECEPTOR_PATHWAY
0.302571860817%	2	661	50	T2D_GENES_TANYA_GLYCEMIC	HOFMANN_CELL_LYMPHOMA_UP
0.302571860817%	2	661	50	T2D_GENES_TANYA_GLYCEMIC	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
0.302571860817%	2	661	50	T2D_GENES_TANYA_GLYCEMIC	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
0.302571860817%	2	661	50	T2D_GENES_TANYA_GLYCEMIC	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC
0.302571860817%	2	661	50	T2D_GENES_TANYA_GLYCEMIC	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION
0.302571860817%	2	661	50	T2D_GENES_TANYA_GLYCEMIC	DAUER_STAT3_TARGETS_DN
0.302571860817%	2	661	5	T2D_GENES_TANYA_GLYCEMIC	PASTURAL_RIZ1_TARGETS_DN
0.302571860817%	2	661	49	T2D_GENES_TANYA_GLYCEMIC	WONG_PROTEASOME_GENE_MODULE
0.302571860817%	2	661	49	T2D_GENES_TANYA_GLYCEMIC	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
0.302571860817%	2	661	49	T2D_GENES_TANYA_GLYCEMIC	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
0.302571860817%	2	661	49	T2D_GENES_TANYA_GLYCEMIC	PID_PI3KCIPATHWAY
0.302571860817%	2	661	49	T2D_GENES_TANYA_GLYCEMIC	MANTOVANI_VIRAL_GPCR_SIGNALING_DN
0.302571860817%	2	661	49	T2D_GENES_TANYA_GLYCEMIC	LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE
0.302571860817%	2	661	49	T2D_GENES_TANYA_GLYCEMIC	LEE_LIVER_CANCER
0.302571860817%	2	661	49	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_2HR_DN
0.302571860817%	2	661	49	T2D_GENES_TANYA_GLYCEMIC	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.302571860817%	2	661	48	T2D_GENES_TANYA_GLYCEMIC	ZHAN_MULTIPLE_MYELOMA_LB_UP
0.302571860817%	2	661	48	T2D_GENES_TANYA_GLYCEMIC	RICKMAN_HEAD_AND_NECK_CANCER_B
0.302571860817%	2	661	48	T2D_GENES_TANYA_GLYCEMIC	PID_HEDGEHOG_GLIPATHWAY
0.302571860817%	2	661	48	T2D_GENES_TANYA_GLYCEMIC	PENG_GLUCOSE_DEPRIVATION_UP
0.302571860817%	2	661	48	T2D_GENES_TANYA_GLYCEMIC	OXFORD_RALA_OR_RALB_TARGETS_UP
0.302571860817%	2	661	48	T2D_GENES_TANYA_GLYCEMIC	NADLER_OBESITY_DN
0.302571860817%	2	661	48	T2D_GENES_TANYA_GLYCEMIC	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
0.302571860817%	2	661	48	T2D_GENES_TANYA_GLYCEMIC	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN
0.302571860817%	2	661	48	T2D_GENES_TANYA_GLYCEMIC	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
0.302571860817%	2	661	48	T2D_GENES_TANYA_GLYCEMIC	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN
0.302571860817%	2	661	48	T2D_GENES_TANYA_GLYCEMIC	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.302571860817%	2	661	48	T2D_GENES_TANYA_GLYCEMIC	CHANGOLKAR_H2AFY_TARGETS_UP
0.302571860817%	2	661	47	T2D_GENES_TANYA_GLYCEMIC	WOOD_EBV_EBNA1_TARGETS_DN
0.302571860817%	2	661	47	T2D_GENES_TANYA_GLYCEMIC	WARTERS_IR_RESPONSE_5GY
0.302571860817%	2	661	47	T2D_GENES_TANYA_GLYCEMIC	PID_NFAT_TFPATHWAY
0.302571860817%	2	661	47	T2D_GENES_TANYA_GLYCEMIC	PID_DELTANP63PATHWAY
0.302571860817%	2	661	47	T2D_GENES_TANYA_GLYCEMIC	MCCLUNG_DELTA_FOSB_TARGETS_8WK
0.302571860817%	2	661	47	T2D_GENES_TANYA_GLYCEMIC	JIANG_AGING_HYPOTHALAMUS_UP
0.302571860817%	2	661	47	T2D_GENES_TANYA_GLYCEMIC	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.302571860817%	2	661	46	T2D_GENES_TANYA_GLYCEMIC	SIG_BCR_SIGNALING_PATHWAY
0.302571860817%	2	661	46	T2D_GENES_TANYA_GLYCEMIC	SAGIV_CD24_TARGETS_DN
0.302571860817%	2	661	46	T2D_GENES_TANYA_GLYCEMIC	PID_PS1PATHWAY
0.302571860817%	2	661	46	T2D_GENES_TANYA_GLYCEMIC	PID_PLK1_PATHWAY
0.302571860817%	2	661	46	T2D_GENES_TANYA_GLYCEMIC	JIANG_TIP30_TARGETS_UP
0.302571860817%	2	661	46	T2D_GENES_TANYA_GLYCEMIC	HALMOS_CEBPA_TARGETS_DN
0.302571860817%	2	661	45	T2D_GENES_TANYA_GLYCEMIC	ZHAN_MULTIPLE_MYELOMA_PR_UP
0.302571860817%	2	661	45	T2D_GENES_TANYA_GLYCEMIC	ZHAN_MULTIPLE_MYELOMA_CD2_UP
0.302571860817%	2	661	45	T2D_GENES_TANYA_GLYCEMIC	SMITH_LIVER_CANCER
0.302571860817%	2	661	45	T2D_GENES_TANYA_GLYCEMIC	SIG_CHEMOTAXIS
0.302571860817%	2	661	45	T2D_GENES_TANYA_GLYCEMIC	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP
0.302571860817%	2	661	45	T2D_GENES_TANYA_GLYCEMIC	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN
0.302571860817%	2	661	45	T2D_GENES_TANYA_GLYCEMIC	SHIPP_DLBCL_CURED_VS_FATAL_DN
0.302571860817%	2	661	45	T2D_GENES_TANYA_GLYCEMIC	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_
0.302571860817%	2	661	45	T2D_GENES_TANYA_GLYCEMIC	PID_INSULIN_PATHWAY
0.302571860817%	2	661	45	T2D_GENES_TANYA_GLYCEMIC	PID_ILK_PATHWAY
0.302571860817%	2	661	45	T2D_GENES_TANYA_GLYCEMIC	CHENG_RESPONSE_TO_NICKEL_ACETATE
0.302571860817%	2	661	45	T2D_GENES_TANYA_GLYCEMIC	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.302571860817%	2	661	44	T2D_GENES_TANYA_GLYCEMIC	ZUCCHI_METASTASIS_DN
0.302571860817%	2	661	44	T2D_GENES_TANYA_GLYCEMIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.302571860817%	2	661	44	T2D_GENES_TANYA_GLYCEMIC	REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS
0.302571860817%	2	661	44	T2D_GENES_TANYA_GLYCEMIC	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS
0.302571860817%	2	661	44	T2D_GENES_TANYA_GLYCEMIC	PID_HNF3APATHWAY
0.302571860817%	2	661	44	T2D_GENES_TANYA_GLYCEMIC	MA_MYELOID_DIFFERENTIATION_DN
0.302571860817%	2	661	44	T2D_GENES_TANYA_GLYCEMIC	LUI_THYROID_CANCER_PAX8_PPARG_UP
0.302571860817%	2	661	44	T2D_GENES_TANYA_GLYCEMIC	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP
0.302571860817%	2	661	44	T2D_GENES_TANYA_GLYCEMIC	GROSS_HYPOXIA_VIA_ELK3_ONLY_DN
0.302571860817%	2	661	43	T2D_GENES_TANYA_GLYCEMIC	ZUCCHI_METASTASIS_UP
0.302571860817%	2	661	43	T2D_GENES_TANYA_GLYCEMIC	ULE_SPLICING_VIA_NOVA2
0.302571860817%	2	661	43	T2D_GENES_TANYA_GLYCEMIC	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1
0.302571860817%	2	661	43	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PLC_BETA_MEDIATED_EVENTS
0.302571860817%	2	661	43	T2D_GENES_TANYA_GLYCEMIC	REACTOME_IL_3_5_AND_GM_CSF_SIGNALING
0.302571860817%	2	661	43	T2D_GENES_TANYA_GLYCEMIC	POTTI_ETOPOSIDE_SENSITIVITY
0.302571860817%	2	661	43	T2D_GENES_TANYA_GLYCEMIC	POTTI_5FU_SENSITIVITY
0.302571860817%	2	661	43	T2D_GENES_TANYA_GLYCEMIC	DORN_ADENOVIRUS_INFECTION_24HR_DN
0.302571860817%	2	661	43	T2D_GENES_TANYA_GLYCEMIC	COWLING_MYCN_TARGETS
0.302571860817%	2	661	43	T2D_GENES_TANYA_GLYCEMIC	BURTON_ADIPOGENESIS_PEAK_AT_24HR
0.302571860817%	2	661	42	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CHREBP2_PATHWAY
0.302571860817%	2	661	41	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING
0.302571860817%	2	661	41	T2D_GENES_TANYA_GLYCEMIC	PID_ER_NONGENOMIC_PATHWAY
0.302571860817%	2	661	41	T2D_GENES_TANYA_GLYCEMIC	MALONEY_RESPONSE_TO_17AAG_UP
0.302571860817%	2	661	41	T2D_GENES_TANYA_GLYCEMIC	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS
0.302571860817%	2	661	41	T2D_GENES_TANYA_GLYCEMIC	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
0.302571860817%	2	661	41	T2D_GENES_TANYA_GLYCEMIC	EHLERS_ANEUPLOIDY_UP
0.302571860817%	2	661	41	T2D_GENES_TANYA_GLYCEMIC	DELPUECH_FOXO3_TARGETS_DN
0.302571860817%	2	661	41	T2D_GENES_TANYA_GLYCEMIC	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
0.302571860817%	2	661	40	T2D_GENES_TANYA_GLYCEMIC	ST_B_CELL_ANTIGEN_RECEPTOR
0.302571860817%	2	661	40	T2D_GENES_TANYA_GLYCEMIC	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
0.302571860817%	2	661	40	T2D_GENES_TANYA_GLYCEMIC	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
0.302571860817%	2	661	40	T2D_GENES_TANYA_GLYCEMIC	PID_IFNGPATHWAY
0.302571860817%	2	661	40	T2D_GENES_TANYA_GLYCEMIC	JIANG_AGING_HYPOTHALAMUS_DN
0.302571860817%	2	661	40	T2D_GENES_TANYA_GLYCEMIC	GENTILE_UV_RESPONSE_CLUSTER_D8
0.302571860817%	2	661	40	T2D_GENES_TANYA_GLYCEMIC	DORN_ADENOVIRUS_INFECTION_48HR_DN
0.302571860817%	2	661	40	T2D_GENES_TANYA_GLYCEMIC	CHESLER_BRAIN_HIGHEST_EXPRESSION
0.302571860817%	2	661	40	T2D_GENES_TANYA_GLYCEMIC	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
0.302571860817%	2	661	40	T2D_GENES_TANYA_GLYCEMIC	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.302571860817%	2	661	40	T2D_GENES_TANYA_GLYCEMIC	BERNARD_PPAPDC1B_TARGETS_UP
0.302571860817%	2	661	40	T2D_GENES_TANYA_GLYCEMIC	BENPORATH_ES_2
0.302571860817%	2	661	40	T2D_GENES_TANYA_GLYCEMIC	AMUNDSON_GAMMA_RADIATION_RESPONSE
0.302571860817%	2	661	39	T2D_GENES_TANYA_GLYCEMIC	PID_RET_PATHWAY
0.302571860817%	2	661	39	T2D_GENES_TANYA_GLYCEMIC	PID_ATR_PATHWAY
0.302571860817%	2	661	39	T2D_GENES_TANYA_GLYCEMIC	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
0.302571860817%	2	661	39	T2D_GENES_TANYA_GLYCEMIC	MATZUK_MEIOTIC_AND_DNA_REPAIR
0.302571860817%	2	661	39	T2D_GENES_TANYA_GLYCEMIC	KORKOLA_TERATOMA
0.302571860817%	2	661	39	T2D_GENES_TANYA_GLYCEMIC	GENTILE_UV_RESPONSE_CLUSTER_D5
0.302571860817%	2	661	39	T2D_GENES_TANYA_GLYCEMIC	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
0.302571860817%	2	661	39	T2D_GENES_TANYA_GLYCEMIC	DORN_ADENOVIRUS_INFECTION_32HR_DN
0.302571860817%	2	661	39	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_FMLP_PATHWAY
0.302571860817%	2	661	39	T2D_GENES_TANYA_GLYCEMIC	BILANGES_SERUM_SENSITIVE_VIA_TSC2
0.302571860817%	2	661	38	T2D_GENES_TANYA_GLYCEMIC	TERAO_AOX4_TARGETS_SKIN_UP
0.302571860817%	2	661	38	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER
0.302571860817%	2	661	38	T2D_GENES_TANYA_GLYCEMIC	PID_RAC1_REG_PATHWAY
0.302571860817%	2	661	38	T2D_GENES_TANYA_GLYCEMIC	PID_FASPATHWAY
0.302571860817%	2	661	38	T2D_GENES_TANYA_GLYCEMIC	PENG_GLUTAMINE_DEPRIVATION_UP
0.302571860817%	2	661	38	T2D_GENES_TANYA_GLYCEMIC	LIU_LIVER_CANCER
0.302571860817%	2	661	38	T2D_GENES_TANYA_GLYCEMIC	KRASNOSELSKAYA_ILF3_TARGETS_UP
0.302571860817%	2	661	38	T2D_GENES_TANYA_GLYCEMIC	KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT
0.302571860817%	2	661	38	T2D_GENES_TANYA_GLYCEMIC	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP
0.302571860817%	2	661	38	T2D_GENES_TANYA_GLYCEMIC	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN
0.302571860817%	2	661	38	T2D_GENES_TANYA_GLYCEMIC	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
0.302571860817%	2	661	38	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_INTEGRIN_PATHWAY
0.302571860817%	2	661	38	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_IL2RB_PATHWAY
0.302571860817%	2	661	38	T2D_GENES_TANYA_GLYCEMIC	APPIERTO_RESPONSE_TO_FENRETINIDE_UP
0.302571860817%	2	661	37	T2D_GENES_TANYA_GLYCEMIC	VALK_AML_WITH_CEBPA
0.302571860817%	2	661	37	T2D_GENES_TANYA_GLYCEMIC	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
0.302571860817%	2	661	37	T2D_GENES_TANYA_GLYCEMIC	PID_GMCSF_PATHWAY
0.302571860817%	2	661	37	T2D_GENES_TANYA_GLYCEMIC	LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES
0.302571860817%	2	661	37	T2D_GENES_TANYA_GLYCEMIC	KIM_ALL_DISORDERS_CALB1_CORR_DN
0.302571860817%	2	661	37	T2D_GENES_TANYA_GLYCEMIC	CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE
0.302571860817%	2	661	36	T2D_GENES_TANYA_GLYCEMIC	YIH_RESPONSE_TO_ARSENITE_C3
0.302571860817%	2	661	36	T2D_GENES_TANYA_GLYCEMIC	VALK_AML_CLUSTER_11
0.302571860817%	2	661	36	T2D_GENES_TANYA_GLYCEMIC	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
0.302571860817%	2	661	36	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALLING_TO_ERKS
0.302571860817%	2	661	36	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
0.302571860817%	2	661	36	T2D_GENES_TANYA_GLYCEMIC	REACTOME_FRS2_MEDIATED_CASCADE
0.302571860817%	2	661	36	T2D_GENES_TANYA_GLYCEMIC	MARZEC_IL2_SIGNALING_DN
0.302571860817%	2	661	36	T2D_GENES_TANYA_GLYCEMIC	LIU_CDX2_TARGETS_UP
0.302571860817%	2	661	36	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_AT1R_PATHWAY
0.302571860817%	2	661	36	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_AGR_PATHWAY
0.302571860817%	2	661	35	T2D_GENES_TANYA_GLYCEMIC	ST_G_ALPHA_I_PATHWAY
0.302571860817%	2	661	35	T2D_GENES_TANYA_GLYCEMIC	SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES
0.302571860817%	2	661	35	T2D_GENES_TANYA_GLYCEMIC	HU_GENOTOXIC_DAMAGE_4HR
0.302571860817%	2	661	35	T2D_GENES_TANYA_GLYCEMIC	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP
0.302571860817%	2	661	35	T2D_GENES_TANYA_GLYCEMIC	AIGNER_ZEB1_TARGETS
0.302571860817%	2	661	34	T2D_GENES_TANYA_GLYCEMIC	YANG_BREAST_CANCER_ESR1_LASER_UP
0.302571860817%	2	661	34	T2D_GENES_TANYA_GLYCEMIC	SIG_CD40PATHWAYMAP
0.302571860817%	2	661	34	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES
0.302571860817%	2	661	34	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION
0.302571860817%	2	661	34	T2D_GENES_TANYA_GLYCEMIC	PID_IL8CXCR2_PATHWAY
0.302571860817%	2	661	34	T2D_GENES_TANYA_GLYCEMIC	PID_EPHA_FWDPATHWAY
0.302571860817%	2	661	34	T2D_GENES_TANYA_GLYCEMIC	KEGG_CYSTEINE_AND_METHIONINE_METABOLISM
0.302571860817%	2	661	34	T2D_GENES_TANYA_GLYCEMIC	JIANG_HYPOXIA_VIA_VHL
0.302571860817%	2	661	34	T2D_GENES_TANYA_GLYCEMIC	HONMA_DOCETAXEL_RESISTANCE
0.302571860817%	2	661	34	T2D_GENES_TANYA_GLYCEMIC	ABE_VEGFA_TARGETS_2HR
0.302571860817%	2	661	33	T2D_GENES_TANYA_GLYCEMIC	VALK_AML_CLUSTER_6
0.302571860817%	2	661	33	T2D_GENES_TANYA_GLYCEMIC	VALK_AML_CLUSTER_10
0.302571860817%	2	661	33	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PURINE_METABOLISM
0.302571860817%	2	661	33	T2D_GENES_TANYA_GLYCEMIC	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS
0.302571860817%	2	661	33	T2D_GENES_TANYA_GLYCEMIC	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN
0.302571860817%	2	661	33	T2D_GENES_TANYA_GLYCEMIC	FARMER_BREAST_CANCER_CLUSTER_2
0.302571860817%	2	661	33	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_NO1_PATHWAY
0.302571860817%	2	661	32	T2D_GENES_TANYA_GLYCEMIC	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN
0.302571860817%	2	661	32	T2D_GENES_TANYA_GLYCEMIC	PID_SYNDECAN_4_PATHWAY
0.302571860817%	2	661	32	T2D_GENES_TANYA_GLYCEMIC	PID_NETRIN_PATHWAY
0.302571860817%	2	661	32	T2D_GENES_TANYA_GLYCEMIC	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN
0.302571860817%	2	661	32	T2D_GENES_TANYA_GLYCEMIC	MOOTHA_GLUCONEOGENESIS
0.302571860817%	2	661	32	T2D_GENES_TANYA_GLYCEMIC	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM
0.302571860817%	2	661	32	T2D_GENES_TANYA_GLYCEMIC	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN
0.302571860817%	2	661	31	T2D_GENES_TANYA_GLYCEMIC	VALK_AML_CLUSTER_15
0.302571860817%	2	661	31	T2D_GENES_TANYA_GLYCEMIC	THEODOROU_MAMMARY_TUMORIGENESIS
0.302571860817%	2	661	31	T2D_GENES_TANYA_GLYCEMIC	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN
0.302571860817%	2	661	31	T2D_GENES_TANYA_GLYCEMIC	RIZ_ERYTHROID_DIFFERENTIATION_HEMGN
0.302571860817%	2	661	31	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES
0.302571860817%	2	661	31	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS
0.302571860817%	2	661	31	T2D_GENES_TANYA_GLYCEMIC	REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING
0.302571860817%	2	661	31	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
0.302571860817%	2	661	31	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX
0.302571860817%	2	661	31	T2D_GENES_TANYA_GLYCEMIC	PID_NEPHRIN_NEPH1_PATHWAY
0.302571860817%	2	661	31	T2D_GENES_TANYA_GLYCEMIC	PID_CD40_PATHWAY
0.302571860817%	2	661	31	T2D_GENES_TANYA_GLYCEMIC	PID_AVB3_OPN_PATHWAY
0.302571860817%	2	661	31	T2D_GENES_TANYA_GLYCEMIC	PID_AURORA_A_PATHWAY
0.302571860817%	2	661	31	T2D_GENES_TANYA_GLYCEMIC	PID_AR_NONGENOMIC_PATHWAY
0.302571860817%	2	661	31	T2D_GENES_TANYA_GLYCEMIC	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM
0.302571860817%	2	661	31	T2D_GENES_TANYA_GLYCEMIC	DANG_MYC_TARGETS_DN
0.302571860817%	2	661	31	T2D_GENES_TANYA_GLYCEMIC	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
0.302571860817%	2	661	30	T2D_GENES_TANYA_GLYCEMIC	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN
0.302571860817%	2	661	30	T2D_GENES_TANYA_GLYCEMIC	VALK_AML_CLUSTER_12
0.302571860817%	2	661	30	T2D_GENES_TANYA_GLYCEMIC	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN
0.302571860817%	2	661	30	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_ROBO_RECEPTOR
0.302571860817%	2	661	30	T2D_GENES_TANYA_GLYCEMIC	REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX
0.302571860817%	2	661	30	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CA_DEPENDENT_EVENTS
0.302571860817%	2	661	30	T2D_GENES_TANYA_GLYCEMIC	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP
0.302571860817%	2	661	30	T2D_GENES_TANYA_GLYCEMIC	LI_PROSTATE_CANCER_EPIGENETIC
0.302571860817%	2	661	30	T2D_GENES_TANYA_GLYCEMIC	GILDEA_METASTASIS
0.302571860817%	2	661	30	T2D_GENES_TANYA_GLYCEMIC	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP
0.302571860817%	2	661	30	T2D_GENES_TANYA_GLYCEMIC	BURTON_ADIPOGENESIS_10
0.302571860817%	2	661	30	T2D_GENES_TANYA_GLYCEMIC	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP
0.302571860817%	2	661	30	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_FAS_PATHWAY
0.302571860817%	2	661	292	T2D_GENES_TANYA_GLYCEMIC	HELLER_HDAC_TARGETS_DN
0.302571860817%	2	661	29	T2D_GENES_TANYA_GLYCEMIC	WANG_RESPONSE_TO_BEXAROTENE_DN
0.302571860817%	2	661	29	T2D_GENES_TANYA_GLYCEMIC	TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN
0.302571860817%	2	661	29	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GLYCOLYSIS
0.302571860817%	2	661	29	T2D_GENES_TANYA_GLYCEMIC	PID_REELINPATHWAY
0.302571860817%	2	661	29	T2D_GENES_TANYA_GLYCEMIC	KEGG_THYROID_CANCER
0.302571860817%	2	661	29	T2D_GENES_TANYA_GLYCEMIC	DORN_ADENOVIRUS_INFECTION_12HR_UP
0.302571860817%	2	661	29	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_VEGF_PATHWAY
0.302571860817%	2	661	29	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_TNFR1_PATHWAY
0.302571860817%	2	661	28	T2D_GENES_TANYA_GLYCEMIC	WIKMAN_ASBESTOS_LUNG_CANCER_DN
0.302571860817%	2	661	28	T2D_GENES_TANYA_GLYCEMIC	TERAO_AOX4_TARGETS_HG_UP
0.302571860817%	2	661	28	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS
0.302571860817%	2	661	28	T2D_GENES_TANYA_GLYCEMIC	PID_LIS1PATHWAY
0.302571860817%	2	661	28	T2D_GENES_TANYA_GLYCEMIC	PETRETTO_HEART_MASS_QTL_CIS_UP
0.302571860817%	2	661	28	T2D_GENES_TANYA_GLYCEMIC	OLSSON_E2F3_TARGETS_UP
0.302571860817%	2	661	28	T2D_GENES_TANYA_GLYCEMIC	LOPES_METHYLATED_IN_COLON_CANCER_DN
0.302571860817%	2	661	28	T2D_GENES_TANYA_GLYCEMIC	KAMIKUBO_MYELOID_CEBPA_NETWORK
0.302571860817%	2	661	28	T2D_GENES_TANYA_GLYCEMIC	DAIRKEE_CANCER_PRONE_RESPONSE_E2
0.302571860817%	2	661	28	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_GH_PATHWAY
0.302571860817%	2	661	28	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_G1_PATHWAY
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	YE_METASTATIC_LIVER_CANCER
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	YANG_BREAST_CANCER_ESR1_BULK_UP
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	TERAO_AOX4_TARGETS_SKIN_DN
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SYNTHESIS_OF_PA
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	REACTOME_IL_RECEPTOR_SHC_SIGNALING
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	NICK_RESPONSE_TO_PROC_TREATMENT_DN
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	LOPES_METHYLATED_IN_COLON_CANCER_UP
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	LEE_DOUBLE_POLAR_THYMOCYTE
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	JI_METASTASIS_REPRESSED_BY_STK11
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	GROSS_ELK3_TARGETS_UP
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	BOYAULT_LIVER_CANCER_SUBCLASS_G2
0.302571860817%	2	661	27	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CREB_PATHWAY
0.302571860817%	2	661	26	T2D_GENES_TANYA_GLYCEMIC	WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG
0.302571860817%	2	661	26	T2D_GENES_TANYA_GLYCEMIC	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP
0.302571860817%	2	661	26	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER
0.302571860817%	2	661	26	T2D_GENES_TANYA_GLYCEMIC	PID_P38_MKK3_6PATHWAY
0.302571860817%	2	661	26	T2D_GENES_TANYA_GLYCEMIC	GAZIN_EPIGENETIC_SILENCING_BY_KRAS
0.302571860817%	2	661	26	T2D_GENES_TANYA_GLYCEMIC	BRACHAT_RESPONSE_TO_METHOTREXATE_UP
0.302571860817%	2	661	26	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_RACCYCD_PATHWAY
0.302571860817%	2	661	25	T2D_GENES_TANYA_GLYCEMIC	WANG_NFKB_TARGETS
0.302571860817%	2	661	25	T2D_GENES_TANYA_GLYCEMIC	STEGER_ADIPOGENESIS_DN
0.302571860817%	2	661	25	T2D_GENES_TANYA_GLYCEMIC	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP
0.302571860817%	2	661	25	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION
0.302571860817%	2	661	25	T2D_GENES_TANYA_GLYCEMIC	REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE
0.302571860817%	2	661	25	T2D_GENES_TANYA_GLYCEMIC	REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS
0.302571860817%	2	661	25	T2D_GENES_TANYA_GLYCEMIC	PID_MYC_PATHWAY
0.302571860817%	2	661	25	T2D_GENES_TANYA_GLYCEMIC	LU_TUMOR_ANGIOGENESIS_UP
0.302571860817%	2	661	25	T2D_GENES_TANYA_GLYCEMIC	JACKSON_DNMT1_TARGETS_DN
0.302571860817%	2	661	25	T2D_GENES_TANYA_GLYCEMIC	GENTILE_UV_HIGH_DOSE_UP
0.302571860817%	2	661	25	T2D_GENES_TANYA_GLYCEMIC	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP
0.302571860817%	2	661	25	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_MCALPAIN_PATHWAY
0.302571860817%	2	661	24	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SULFUR_AMINO_ACID_METABOLISM
0.302571860817%	2	661	24	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION
0.302571860817%	2	661	24	T2D_GENES_TANYA_GLYCEMIC	MATZUK_SPERMATOGONIA
0.302571860817%	2	661	24	T2D_GENES_TANYA_GLYCEMIC	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN
0.302571860817%	2	661	24	T2D_GENES_TANYA_GLYCEMIC	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY
0.302571860817%	2	661	24	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_TPO_PATHWAY
0.302571860817%	2	661	24	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CXCR4_PATHWAY
0.302571860817%	2	661	23	T2D_GENES_TANYA_GLYCEMIC	WU_HBX_TARGETS_2_UP
0.302571860817%	2	661	23	T2D_GENES_TANYA_GLYCEMIC	WU_HBX_TARGETS_1_DN
0.302571860817%	2	661	23	T2D_GENES_TANYA_GLYCEMIC	WENG_POR_TARGETS_GLOBAL_DN
0.302571860817%	2	661	23	T2D_GENES_TANYA_GLYCEMIC	VIETOR_IFRD1_TARGETS
0.302571860817%	2	661	23	T2D_GENES_TANYA_GLYCEMIC	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B
0.302571860817%	2	661	23	T2D_GENES_TANYA_GLYCEMIC	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A
0.302571860817%	2	661	23	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER
0.302571860817%	2	661	23	T2D_GENES_TANYA_GLYCEMIC	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS
0.302571860817%	2	661	23	T2D_GENES_TANYA_GLYCEMIC	KEGG_NITROGEN_METABOLISM
0.302571860817%	2	661	23	T2D_GENES_TANYA_GLYCEMIC	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN
0.302571860817%	2	661	23	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_RAS_PATHWAY
0.302571860817%	2	661	23	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_RAC1_PATHWAY
0.302571860817%	2	661	23	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_IGF1R_PATHWAY
0.302571860817%	2	661	23	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_GLEEVEC_PATHWAY
0.302571860817%	2	661	23	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CELLCYCLE_PATHWAY
0.302571860817%	2	661	23	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CCR3_PATHWAY
0.302571860817%	2	661	228	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
0.302571860817%	2	661	221	T2D_GENES_TANYA_GLYCEMIC	PEDRIOLI_MIR31_TARGETS_UP
0.302571860817%	2	661	220	T2D_GENES_TANYA_GLYCEMIC	RIGGINS_TAMOXIFEN_RESISTANCE_DN
0.302571860817%	2	661	22	T2D_GENES_TANYA_GLYCEMIC	YUAN_ZNF143_PARTNERS
0.302571860817%	2	661	22	T2D_GENES_TANYA_GLYCEMIC	SPIRA_SMOKERS_LUNG_CANCER_DN
0.302571860817%	2	661	22	T2D_GENES_TANYA_GLYCEMIC	ROY_WOUND_BLOOD_VESSEL_DN
0.302571860817%	2	661	22	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION
0.302571860817%	2	661	22	T2D_GENES_TANYA_GLYCEMIC	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
0.302571860817%	2	661	22	T2D_GENES_TANYA_GLYCEMIC	HANSON_HRAS_SIGNALING_VIA_NFKB
0.302571860817%	2	661	22	T2D_GENES_TANYA_GLYCEMIC	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN
0.302571860817%	2	661	22	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_SPPA_PATHWAY
0.302571860817%	2	661	22	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_IL2_PATHWAY
0.302571860817%	2	661	22	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CERAMIDE_PATHWAY
0.302571860817%	2	661	21	T2D_GENES_TANYA_GLYCEMIC	WOTTON_RUNX_TARGETS_UP
0.302571860817%	2	661	21	T2D_GENES_TANYA_GLYCEMIC	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP
0.302571860817%	2	661	21	T2D_GENES_TANYA_GLYCEMIC	VERRECCHIA_RESPONSE_TO_TGFB1_C5
0.302571860817%	2	661	21	T2D_GENES_TANYA_GLYCEMIC	SCHURINGA_STAT5A_TARGETS_UP
0.302571860817%	2	661	21	T2D_GENES_TANYA_GLYCEMIC	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN
0.302571860817%	2	661	21	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION
0.302571860817%	2	661	21	T2D_GENES_TANYA_GLYCEMIC	REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING
0.302571860817%	2	661	21	T2D_GENES_TANYA_GLYCEMIC	PID_S1P_S1P1_PATHWAY
0.302571860817%	2	661	21	T2D_GENES_TANYA_GLYCEMIC	MOOTHA_GLYCOLYSIS
0.302571860817%	2	661	21	T2D_GENES_TANYA_GLYCEMIC	MACLACHLAN_BRCA1_TARGETS_UP
0.302571860817%	2	661	21	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_IGF1_PATHWAY
0.302571860817%	2	661	206	T2D_GENES_TANYA_GLYCEMIC	RAMALHO_STEMNESS_UP
0.302571860817%	2	661	205	T2D_GENES_TANYA_GLYCEMIC	SHEPARD_BMYB_MORPHOLINO_UP
0.302571860817%	2	661	20	T2D_GENES_TANYA_GLYCEMIC	WENG_POR_TARGETS_LIVER_DN
0.302571860817%	2	661	20	T2D_GENES_TANYA_GLYCEMIC	WENG_POR_TARGETS_GLOBAL_UP
0.302571860817%	2	661	20	T2D_GENES_TANYA_GLYCEMIC	SU_THYMUS
0.302571860817%	2	661	20	T2D_GENES_TANYA_GLYCEMIC	ST_WNT_CA2_CYCLIC_GMP_PATHWAY
0.302571860817%	2	661	20	T2D_GENES_TANYA_GLYCEMIC	PHESSE_TARGETS_OF_APC_AND_MBD2_UP
0.302571860817%	2	661	20	T2D_GENES_TANYA_GLYCEMIC	NIELSEN_LEIOMYOSARCOMA_CNN1_DN
0.302571860817%	2	661	20	T2D_GENES_TANYA_GLYCEMIC	MURAKAMI_UV_RESPONSE_24HR
0.302571860817%	2	661	20	T2D_GENES_TANYA_GLYCEMIC	MANN_RESPONSE_TO_AMIFOSTINE_UP
0.302571860817%	2	661	20	T2D_GENES_TANYA_GLYCEMIC	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN
0.302571860817%	2	661	198	T2D_GENES_TANYA_GLYCEMIC	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.302571860817%	2	661	191	T2D_GENES_TANYA_GLYCEMIC	RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.302571860817%	2	661	19	T2D_GENES_TANYA_GLYCEMIC	VERNOCHET_ADIPOGENESIS
0.302571860817%	2	661	19	T2D_GENES_TANYA_GLYCEMIC	RUAN_RESPONSE_TO_TROGLITAZONE_DN
0.302571860817%	2	661	19	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1
0.302571860817%	2	661	19	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS
0.302571860817%	2	661	19	T2D_GENES_TANYA_GLYCEMIC	REACTOME_BASE_EXCISION_REPAIR
0.302571860817%	2	661	19	T2D_GENES_TANYA_GLYCEMIC	NELSON_RESPONSE_TO_ANDROGEN_DN
0.302571860817%	2	661	19	T2D_GENES_TANYA_GLYCEMIC	MIZUSHIMA_AUTOPHAGOSOME_FORMATION
0.302571860817%	2	661	19	T2D_GENES_TANYA_GLYCEMIC	MELLMAN_TUT1_TARGETS_UP
0.302571860817%	2	661	19	T2D_GENES_TANYA_GLYCEMIC	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP
0.302571860817%	2	661	19	T2D_GENES_TANYA_GLYCEMIC	JEON_SMAD6_TARGETS_DN
0.302571860817%	2	661	19	T2D_GENES_TANYA_GLYCEMIC	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN
0.302571860817%	2	661	19	T2D_GENES_TANYA_GLYCEMIC	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN
0.302571860817%	2	661	19	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_STATHMIN_PATHWAY
0.302571860817%	2	661	19	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_EPO_PATHWAY
0.302571860817%	2	661	182	T2D_GENES_TANYA_GLYCEMIC	WHITFIELD_CELL_CYCLE_G2
0.302571860817%	2	661	18	T2D_GENES_TANYA_GLYCEMIC	TOMIDA_METASTASIS_DN
0.302571860817%	2	661	18	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB
0.302571860817%	2	661	18	T2D_GENES_TANYA_GLYCEMIC	HUMMERICH_MALIGNANT_SKIN_TUMOR_DN
0.302571860817%	2	661	18	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_TNFR2_PATHWAY
0.302571860817%	2	661	18	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_NGF_PATHWAY
0.302571860817%	2	661	18	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CARDIACEGF_PATHWAY
0.302571860817%	2	661	179	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE
0.302571860817%	2	661	177	T2D_GENES_TANYA_GLYCEMIC	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
0.302571860817%	2	661	176	T2D_GENES_TANYA_GLYCEMIC	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
0.302571860817%	2	661	176	T2D_GENES_TANYA_GLYCEMIC	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX
0.302571860817%	2	661	171	T2D_GENES_TANYA_GLYCEMIC	ELVIDGE_HYPOXIA_UP
0.302571860817%	2	661	17	T2D_GENES_TANYA_GLYCEMIC	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN
0.302571860817%	2	661	17	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY
0.302571860817%	2	661	17	T2D_GENES_TANYA_GLYCEMIC	MEISSNER_BRAIN_HCP_WITH_H3K4ME2
0.302571860817%	2	661	17	T2D_GENES_TANYA_GLYCEMIC	LOPEZ_EPITHELIOID_MESOTHELIOMA
0.302571860817%	2	661	17	T2D_GENES_TANYA_GLYCEMIC	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL
0.302571860817%	2	661	17	T2D_GENES_TANYA_GLYCEMIC	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.302571860817%	2	661	17	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_ARF_PATHWAY
0.302571860817%	2	661	169	T2D_GENES_TANYA_GLYCEMIC	PENG_GLUCOSE_DEPRIVATION_DN
0.302571860817%	2	661	165	T2D_GENES_TANYA_GLYCEMIC	BROWN_MYELOID_CELL_DEVELOPMENT_UP
0.302571860817%	2	661	163	T2D_GENES_TANYA_GLYCEMIC	SERVITJA_ISLET_HNF1A_TARGETS_UP
0.302571860817%	2	661	162	T2D_GENES_TANYA_GLYCEMIC	DARWICHE_PAPILLOMA_RISK_LOW_UP
0.302571860817%	2	661	16	T2D_GENES_TANYA_GLYCEMIC	WU_HBX_TARGETS_2_DN
0.302571860817%	2	661	16	T2D_GENES_TANYA_GLYCEMIC	WU_HBX_TARGETS_1_UP
0.302571860817%	2	661	16	T2D_GENES_TANYA_GLYCEMIC	REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS
0.302571860817%	2	661	16	T2D_GENES_TANYA_GLYCEMIC	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN
0.302571860817%	2	661	16	T2D_GENES_TANYA_GLYCEMIC	PID_CIRCADIANPATHWAY
0.302571860817%	2	661	16	T2D_GENES_TANYA_GLYCEMIC	LUI_THYROID_CANCER_CLUSTER_4
0.302571860817%	2	661	16	T2D_GENES_TANYA_GLYCEMIC	IGLESIAS_E2F_TARGETS_DN
0.302571860817%	2	661	157	T2D_GENES_TANYA_GLYCEMIC	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
0.302571860817%	2	661	153	T2D_GENES_TANYA_GLYCEMIC	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
0.302571860817%	2	661	150	T2D_GENES_TANYA_GLYCEMIC	LANDIS_ERBB2_BREAST_TUMORS_324_UP
0.302571860817%	2	661	15	T2D_GENES_TANYA_GLYCEMIC	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN
0.302571860817%	2	661	15	T2D_GENES_TANYA_GLYCEMIC	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN
0.302571860817%	2	661	15	T2D_GENES_TANYA_GLYCEMIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP
0.302571860817%	2	661	15	T2D_GENES_TANYA_GLYCEMIC	SU_KIDNEY
0.302571860817%	2	661	15	T2D_GENES_TANYA_GLYCEMIC	STEINER_ERYTHROCYTE_MEMBRANE_GENES
0.302571860817%	2	661	15	T2D_GENES_TANYA_GLYCEMIC	REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION
0.302571860817%	2	661	15	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE
0.302571860817%	2	661	15	T2D_GENES_TANYA_GLYCEMIC	PID_THROMBIN_PAR4_PATHWAY
0.302571860817%	2	661	15	T2D_GENES_TANYA_GLYCEMIC	LIU_IL13_PRIMING_MODEL
0.302571860817%	2	661	15	T2D_GENES_TANYA_GLYCEMIC	DAZARD_UV_RESPONSE_CLUSTER_G3
0.302571860817%	2	661	15	T2D_GENES_TANYA_GLYCEMIC	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN
0.302571860817%	2	661	15	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_IL3_PATHWAY
0.302571860817%	2	661	15	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_ERYTH_PATHWAY
0.302571860817%	2	661	15	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CD40_PATHWAY
0.302571860817%	2	661	15	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_AKAPCENTROSOME_PATHWAY
0.302571860817%	2	661	149	T2D_GENES_TANYA_GLYCEMIC	LANDIS_ERBB2_BREAST_TUMORS_324_DN
0.302571860817%	2	661	147	T2D_GENES_TANYA_GLYCEMIC	SMID_BREAST_CANCER_ERBB2_UP
0.302571860817%	2	661	146	T2D_GENES_TANYA_GLYCEMIC	LEE_NEURAL_CREST_STEM_CELL_UP
0.302571860817%	2	661	142	T2D_GENES_TANYA_GLYCEMIC	DARWICHE_SKIN_TUMOR_PROMOTER_UP
0.302571860817%	2	661	140	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
0.302571860817%	2	661	14	T2D_GENES_TANYA_GLYCEMIC	ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR
0.302571860817%	2	661	14	T2D_GENES_TANYA_GLYCEMIC	ZHANG_ADIPOGENESIS_BY_BMP7
0.302571860817%	2	661	14	T2D_GENES_TANYA_GLYCEMIC	WEBER_METHYLATED_ICP_IN_SPERM_DN
0.302571860817%	2	661	14	T2D_GENES_TANYA_GLYCEMIC	REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER
0.302571860817%	2	661	14	T2D_GENES_TANYA_GLYCEMIC	PID_TCRJNKPATHWAY
0.302571860817%	2	661	14	T2D_GENES_TANYA_GLYCEMIC	PID_S1P_S1P4_PATHWAY
0.302571860817%	2	661	14	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_ES_LCP_WITH_H3K27ME3
0.302571860817%	2	661	14	T2D_GENES_TANYA_GLYCEMIC	LIM_MAMMARY_LUMINAL_PROGENITOR_DN
0.302571860817%	2	661	14	T2D_GENES_TANYA_GLYCEMIC	KEGG_NON_HOMOLOGOUS_END_JOINING
0.302571860817%	2	661	14	T2D_GENES_TANYA_GLYCEMIC	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION
0.302571860817%	2	661	14	T2D_GENES_TANYA_GLYCEMIC	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS
0.302571860817%	2	661	137	T2D_GENES_TANYA_GLYCEMIC	LIU_SOX4_TARGETS_UP
0.302571860817%	2	661	136	T2D_GENES_TANYA_GLYCEMIC	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.302571860817%	2	661	135	T2D_GENES_TANYA_GLYCEMIC	UDAYAKUMAR_MED1_TARGETS_UP
0.302571860817%	2	661	135	T2D_GENES_TANYA_GLYCEMIC	SERVITJA_LIVER_HNF1A_TARGETS_UP
0.302571860817%	2	661	133	T2D_GENES_TANYA_GLYCEMIC	SENESE_HDAC2_TARGETS_DN
0.302571860817%	2	661	130	T2D_GENES_TANYA_GLYCEMIC	ELVIDGE_HYPOXIA_BY_DMOG_UP
0.302571860817%	2	661	13	T2D_GENES_TANYA_GLYCEMIC	REACTOME_POL_SWITCHING
0.302571860817%	2	661	13	T2D_GENES_TANYA_GLYCEMIC	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN
0.302571860817%	2	661	13	T2D_GENES_TANYA_GLYCEMIC	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS
0.302571860817%	2	661	13	T2D_GENES_TANYA_GLYCEMIC	GERHOLD_RESPONSE_TO_TZD_DN
0.302571860817%	2	661	13	T2D_GENES_TANYA_GLYCEMIC	CROONQUIST_STROMAL_STIMULATION_DN
0.302571860817%	2	661	129	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MEMBRANE_TRAFFICKING
0.302571860817%	2	661	126	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
0.302571860817%	2	661	126	T2D_GENES_TANYA_GLYCEMIC	MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.302571860817%	2	661	125	T2D_GENES_TANYA_GLYCEMIC	FIGUEROA_AML_METHYLATION_CLUSTER_1_UP
0.302571860817%	2	661	124	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CELL_CYCLE_CHECKPOINTS
0.302571860817%	2	661	123	T2D_GENES_TANYA_GLYCEMIC	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.302571860817%	2	661	123	T2D_GENES_TANYA_GLYCEMIC	DAZARD_RESPONSE_TO_UV_SCC_UP
0.302571860817%	2	661	121	T2D_GENES_TANYA_GLYCEMIC	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
0.302571860817%	2	661	121	T2D_GENES_TANYA_GLYCEMIC	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
0.302571860817%	2	661	120	T2D_GENES_TANYA_GLYCEMIC	ZHU_CMV_ALL_UP
0.302571860817%	2	661	12	T2D_GENES_TANYA_GLYCEMIC	REACTOME_P2Y_RECEPTORS
0.302571860817%	2	661	12	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM
0.302571860817%	2	661	12	T2D_GENES_TANYA_GLYCEMIC	LOPEZ_MESOTHELIOMA_SURVIVAL_DN
0.302571860817%	2	661	12	T2D_GENES_TANYA_GLYCEMIC	HOLLEMAN_DAUNORUBICIN_B_ALL_DN
0.302571860817%	2	661	12	T2D_GENES_TANYA_GLYCEMIC	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.302571860817%	2	661	12	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_AKAP13_PATHWAY
0.302571860817%	2	661	118	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TOLL_RECEPTOR_CASCADES
0.302571860817%	2	661	117	T2D_GENES_TANYA_GLYCEMIC	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.302571860817%	2	661	116	T2D_GENES_TANYA_GLYCEMIC	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
0.302571860817%	2	661	116	T2D_GENES_TANYA_GLYCEMIC	MATTIOLI_MGUS_VS_PCL
0.302571860817%	2	661	114	T2D_GENES_TANYA_GLYCEMIC	SMIRNOV_RESPONSE_TO_IR_6HR_DN
0.302571860817%	2	661	114	T2D_GENES_TANYA_GLYCEMIC	SENESE_HDAC2_TARGETS_UP
0.302571860817%	2	661	114	T2D_GENES_TANYA_GLYCEMIC	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN
0.302571860817%	2	661	113	T2D_GENES_TANYA_GLYCEMIC	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
0.302571860817%	2	661	113	T2D_GENES_TANYA_GLYCEMIC	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
0.302571860817%	2	661	112	T2D_GENES_TANYA_GLYCEMIC	LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.302571860817%	2	661	112	T2D_GENES_TANYA_GLYCEMIC	DOANE_BREAST_CANCER_ESR1_UP
0.302571860817%	2	661	111	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MRNA_SPLICING
0.302571860817%	2	661	111	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GLYCOSAMINOGLYCAN_METABOLISM
0.302571860817%	2	661	111	T2D_GENES_TANYA_GLYCEMIC	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
0.302571860817%	2	661	111	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_12HR_UP
0.302571860817%	2	661	110	T2D_GENES_TANYA_GLYCEMIC	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.302571860817%	2	661	110	T2D_GENES_TANYA_GLYCEMIC	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
0.302571860817%	2	661	110	T2D_GENES_TANYA_GLYCEMIC	GROSS_HYPOXIA_VIA_HIF1A_DN
0.302571860817%	2	661	110	T2D_GENES_TANYA_GLYCEMIC	CHENG_IMPRINTED_BY_ESTRADIOL
0.302571860817%	2	661	11	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS
0.302571860817%	2	661	108	T2D_GENES_TANYA_GLYCEMIC	WESTON_VEGFA_TARGETS
0.302571860817%	2	661	108	T2D_GENES_TANYA_GLYCEMIC	LE_EGR2_TARGETS_UP
0.302571860817%	2	661	108	T2D_GENES_TANYA_GLYCEMIC	LABBE_TGFB1_TARGETS_DN
0.302571860817%	2	661	108	T2D_GENES_TANYA_GLYCEMIC	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
0.302571860817%	2	661	108	T2D_GENES_TANYA_GLYCEMIC	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
0.302571860817%	2	661	106	T2D_GENES_TANYA_GLYCEMIC	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
0.302571860817%	2	661	105	T2D_GENES_TANYA_GLYCEMIC	PID_ERBB1_DOWNSTREAM_PATHWAY
0.302571860817%	2	661	105	T2D_GENES_TANYA_GLYCEMIC	HELLER_SILENCED_BY_METHYLATION_DN
0.302571860817%	2	661	105	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_8HR_UP
0.302571860817%	2	661	104	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
0.302571860817%	2	661	104	T2D_GENES_TANYA_GLYCEMIC	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.302571860817%	2	661	103	T2D_GENES_TANYA_GLYCEMIC	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN
0.302571860817%	2	661	103	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_NOTCH
0.302571860817%	2	661	103	T2D_GENES_TANYA_GLYCEMIC	KIM_MYCN_AMPLIFICATION_TARGETS_DN
0.302571860817%	2	661	103	T2D_GENES_TANYA_GLYCEMIC	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
0.302571860817%	2	661	103	T2D_GENES_TANYA_GLYCEMIC	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.302571860817%	2	661	102	T2D_GENES_TANYA_GLYCEMIC	PID_CXCR4_PATHWAY
0.302571860817%	2	661	102	T2D_GENES_TANYA_GLYCEMIC	KANG_IMMORTALIZED_BY_TERT_DN
0.302571860817%	2	661	102	T2D_GENES_TANYA_GLYCEMIC	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.302571860817%	2	661	101	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_12HR_DN
0.302571860817%	2	661	100	T2D_GENES_TANYA_GLYCEMIC	WINZEN_DEGRADED_VIA_KHSRP
0.302571860817%	2	661	100	T2D_GENES_TANYA_GLYCEMIC	RICKMAN_HEAD_AND_NECK_CANCER_A
0.302571860817%	2	661	100	T2D_GENES_TANYA_GLYCEMIC	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
0.302571860817%	2	661	10	T2D_GENES_TANYA_GLYCEMIC	WORSCHECH_TUMOR_REJECTION_DN
0.302571860817%	2	661	10	T2D_GENES_TANYA_GLYCEMIC	VISALA_AGING_LYMPHOCYTE_UP
0.302571860817%	2	661	10	T2D_GENES_TANYA_GLYCEMIC	REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND
0.302571860817%	2	661	10	T2D_GENES_TANYA_GLYCEMIC	OHASHI_AURKB_TARGETS
0.302571860817%	2	661	10	T2D_GENES_TANYA_GLYCEMIC	MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP
0.302571860817%	2	661	10	T2D_GENES_TANYA_GLYCEMIC	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP
0.302571860817%	2	661	10	T2D_GENES_TANYA_GLYCEMIC	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP
0.302571860817%	2	661	10	T2D_GENES_TANYA_GLYCEMIC	BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN
0.284090909091%	10	3520	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
0.284090909091%	10	3520	97	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_MYC_AMPLIFICATION_TARGETS_DN
0.284090909091%	10	3520	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HILLION_HMGA1B_TARGETS
0.284090909091%	10	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SWEET_KRAS_ONCOGENIC_SIGNATURE
0.284090909091%	10	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PROSTATE_CANCER
0.284090909091%	10	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DELASERNA_MYOD_TARGETS_UP
0.284090909091%	10	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_D_UP
0.284090909091%	10	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WALLACE_PROSTATE_CANCER_RACE_DN
0.284090909091%	10	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.284090909091%	10	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.284090909091%	10	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
0.284090909091%	10	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
0.284090909091%	10	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOEBEKE_LYMPHOID_STEM_CELL_DN
0.284090909091%	10	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GHANDHI_BYSTANDER_IRRADIATION_UP
0.284090909091%	10	3520	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
0.284090909091%	10	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
0.284090909091%	10	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCIBETTA_KDM5B_TARGETS_DN
0.284090909091%	10	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MUNSHI_MULTIPLE_MYELOMA_UP
0.284090909091%	10	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CROMER_METASTASIS_DN
0.284090909091%	10	3520	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHUHMACHER_MYC_TARGETS_UP
0.284090909091%	10	3520	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
0.284090909091%	10	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MALONEY_RESPONSE_TO_17AAG_DN
0.284090909091%	10	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
0.284090909091%	10	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROSS_LEUKEMIA_WITH_MLL_FUSIONS
0.284090909091%	10	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_OPIOID_SIGNALLING
0.284090909091%	10	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PEROXISOME
0.284090909091%	10	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.284090909091%	10	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
0.284090909091%	10	3520	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.284090909091%	10	3520	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MAHAJAN_RESPONSE_TO_IL1A_DN
0.284090909091%	10	3520	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
0.284090909091%	10	3520	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
0.284090909091%	10	3520	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
0.284090909091%	10	3520	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BAE_BRCA1_TARGETS_UP
0.284090909091%	10	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
0.284090909091%	10	3520	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DITTMER_PTHLH_TARGETS_DN
0.284090909091%	10	3520	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
0.284090909091%	10	3520	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_NUCLEOTIDES
0.284090909091%	10	3520	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KUMAR_AUTOPHAGY_NETWORK
0.284090909091%	10	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_CDC42_PATHWAY
0.284090909091%	10	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_LONG_TERM_POTENTIATION
0.284090909091%	10	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.284090909091%	10	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C7
0.284090909091%	10	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
0.284090909091%	10	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES
0.284090909091%	10	3520	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G1
0.284090909091%	10	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM
0.284090909091%	10	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RIGGINS_TAMOXIFEN_RESISTANCE_UP
0.284090909091%	10	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_HIF1_TFPATHWAY
0.284090909091%	10	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DIRMEIER_LMP1_RESPONSE_EARLY
0.284090909091%	10	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRUNO_HEMATOPOIESIS
0.284090909091%	10	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_CD8TCRDOWNSTREAMPATHWAY
0.284090909091%	10	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_UP
0.284090909091%	10	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS
0.284090909091%	10	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
0.284090909091%	10	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
0.284090909091%	10	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ENDOTHELINPATHWAY
0.284090909091%	10	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BILBAN_B_CLL_LPL_UP
0.284090909091%	10	3520	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.284090909091%	10	3520	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REN_BOUND_BY_E2F
0.284090909091%	10	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_P53REGULATIONPATHWAY
0.284090909091%	10	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
0.284090909091%	10	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.284090909091%	10	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP
0.284090909091%	10	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_VIBRIO_CHOLERAE_INFECTION
0.284090909091%	10	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_NFAT_PATHWAY
0.284090909091%	10	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_NON_SMALL_CELL_LUNG_CANCER
0.284090909091%	10	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0
0.284090909091%	10	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_CALORIE_RESTRICTION_MUSCLE_DN
0.284090909091%	10	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GUILLAUMOND_KLF10_TARGETS_UP
0.284090909091%	10	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
0.284090909091%	10	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
0.284090909091%	10	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_PI3KCIPATHWAY
0.284090909091%	10	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PROTEASOME
0.284090909091%	10	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	POTTI_DOCETAXEL_SENSITIVITY
0.284090909091%	10	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SAGIV_CD24_TARGETS_DN
0.284090909091%	10	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
0.284090909091%	10	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_CALORIE_RESTRICTION_MUSCLE_UP
0.284090909091%	10	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PIONTEK_PKD1_TARGETS_UP
0.284090909091%	10	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS
0.284090909091%	10	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES
0.284090909091%	10	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM
0.284090909091%	10	3520	198	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.284090909091%	10	3520	191	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
0.284090909091%	10	3520	185	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
0.284090909091%	10	3520	175	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
0.284090909091%	10	3520	162	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WINNEPENNINCKX_MELANOMA_METASTASIS_UP
0.284090909091%	10	3520	158	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON
0.284090909091%	10	3520	156	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FOSTER_TOLERANT_MACROPHAGE_UP
0.284090909091%	10	3520	153	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LU_AGING_BRAIN_DN
0.284090909091%	10	3520	149	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
0.284090909091%	10	3520	148	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_24HR_UP
0.284090909091%	10	3520	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
0.284090909091%	10	3520	135	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SERVITJA_LIVER_HNF1A_TARGETS_UP
0.284090909091%	10	3520	134	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	POOLA_INVASIVE_BREAST_CANCER_DN
0.284090909091%	10	3520	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.284090909091%	10	3520	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_CELL_CYCLE
0.284090909091%	10	3520	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
0.284090909091%	10	3520	118	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_NEURAL_CREST_STEM_CELL_DN
0.284090909091%	10	3520	118	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CERVERA_SDHB_TARGETS_1_UP
0.284090909091%	10	3520	117	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.284090909091%	10	3520	115	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARZEC_IL2_SIGNALING_UP
0.284090909091%	10	3520	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SENESE_HDAC2_TARGETS_UP
0.284090909091%	10	3520	106	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
0.284090909091%	10	3520	105	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RNA_POL_II_TRANSCRIPTION
0.284090909091%	10	3520	105	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_8HR_UP
0.284090909091%	10	3520	104	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAMURA_ADIPOGENESIS_LATE_UP
0.284090909091%	10	3520	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_NOTCH
0.284090909091%	10	3520	102	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LABBE_TGFB1_TARGETS_UP
0.284090909091%	10	3520	102	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KANG_IMMORTALIZED_BY_TERT_DN
0.284090909091%	10	3520	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_ERBB2
0.284090909091%	10	3520	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
0.284090909091%	10	3520	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BENPORATH_ES_CORE_NINE_CORRELATED
0.277008310249%	1	361	99	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIM_MAMMARY_LUMINAL_MATURE_DN
0.277008310249%	1	361	99	T2D_GENES_TANYA_T2D_RSQ05_02CM	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.277008310249%	1	361	98	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
0.277008310249%	1	361	98	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_PYRIMIDINE_METABOLISM
0.277008310249%	1	361	98	T2D_GENES_TANYA_T2D_RSQ05_02CM	HAHTOLA_SEZARY_SYNDROM_UP
0.277008310249%	1	361	96	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZAMORA_NOS2_TARGETS_DN
0.277008310249%	1	361	96	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIU_PROSTATE_CANCER_UP
0.277008310249%	1	361	95	T2D_GENES_TANYA_T2D_RSQ05_02CM	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
0.277008310249%	1	361	95	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOEBEKE_LYMPHOID_STEM_CELL_UP
0.277008310249%	1	361	95	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.277008310249%	1	361	94	T2D_GENES_TANYA_T2D_RSQ05_02CM	GAVIN_FOXP3_TARGETS_CLUSTER_T4
0.277008310249%	1	361	92	T2D_GENES_TANYA_T2D_RSQ05_02CM	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
0.277008310249%	1	361	92	T2D_GENES_TANYA_T2D_RSQ05_02CM	KIM_MYCN_AMPLIFICATION_TARGETS_UP
0.277008310249%	1	361	92	T2D_GENES_TANYA_T2D_RSQ05_02CM	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
0.277008310249%	1	361	92	T2D_GENES_TANYA_T2D_RSQ05_02CM	HILLION_HMGA1B_TARGETS
0.277008310249%	1	361	91	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION
0.277008310249%	1	361	91	T2D_GENES_TANYA_T2D_RSQ05_02CM	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.277008310249%	1	361	91	T2D_GENES_TANYA_T2D_RSQ05_02CM	GAVIN_FOXP3_TARGETS_CLUSTER_P6
0.277008310249%	1	361	90	T2D_GENES_TANYA_T2D_RSQ05_02CM	SANA_TNF_SIGNALING_DN
0.277008310249%	1	361	90	T2D_GENES_TANYA_T2D_RSQ05_02CM	MORI_MATURE_B_LYMPHOCYTE_UP
0.277008310249%	1	361	90	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_GAP_JUNCTION
0.277008310249%	1	361	9	T2D_GENES_TANYA_T2D_RSQ05_02CM	THILLAINADESAN_ZNF217_TARGETS_DN
0.277008310249%	1	361	9	T2D_GENES_TANYA_T2D_RSQ05_02CM	SA_FAS_SIGNALING
0.277008310249%	1	361	9	T2D_GENES_TANYA_T2D_RSQ05_02CM	NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON
0.277008310249%	1	361	9	T2D_GENES_TANYA_T2D_RSQ05_02CM	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30
0.277008310249%	1	361	9	T2D_GENES_TANYA_T2D_RSQ05_02CM	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21
0.277008310249%	1	361	9	T2D_GENES_TANYA_T2D_RSQ05_02CM	MATZUK_MATERNAL_EFFECT
0.277008310249%	1	361	89	T2D_GENES_TANYA_T2D_RSQ05_02CM	VANLOO_SP3_TARGETS_DN
0.277008310249%	1	361	89	T2D_GENES_TANYA_T2D_RSQ05_02CM	LI_DCP2_BOUND_MRNA
0.277008310249%	1	361	89	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEIN_PONS_MARKERS
0.277008310249%	1	361	89	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION
0.277008310249%	1	361	89	T2D_GENES_TANYA_T2D_RSQ05_02CM	KANG_IMMORTALIZED_BY_TERT_UP
0.277008310249%	1	361	88	T2D_GENES_TANYA_T2D_RSQ05_02CM	WALLACE_PROSTATE_CANCER_RACE_DN
0.277008310249%	1	361	88	T2D_GENES_TANYA_T2D_RSQ05_02CM	SEIDEN_ONCOGENESIS_BY_MET
0.277008310249%	1	361	88	T2D_GENES_TANYA_T2D_RSQ05_02CM	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
0.277008310249%	1	361	88	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_APOPTOSIS
0.277008310249%	1	361	87	T2D_GENES_TANYA_T2D_RSQ05_02CM	SAFFORD_T_LYMPHOCYTE_ANERGY
0.277008310249%	1	361	87	T2D_GENES_TANYA_T2D_RSQ05_02CM	MOOTHA_VOXPHOS
0.277008310249%	1	361	87	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_ERBB_SIGNALING_PATHWAY
0.277008310249%	1	361	87	T2D_GENES_TANYA_T2D_RSQ05_02CM	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.277008310249%	1	361	87	T2D_GENES_TANYA_T2D_RSQ05_02CM	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
0.277008310249%	1	361	86	T2D_GENES_TANYA_T2D_RSQ05_02CM	TAKAO_RESPONSE_TO_UVB_RADIATION_UP
0.277008310249%	1	361	86	T2D_GENES_TANYA_T2D_RSQ05_02CM	NGUYEN_NOTCH1_TARGETS_DN
0.277008310249%	1	361	86	T2D_GENES_TANYA_T2D_RSQ05_02CM	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
0.277008310249%	1	361	86	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
0.277008310249%	1	361	86	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOEBEKE_LYMPHOID_STEM_CELL_DN
0.277008310249%	1	361	86	T2D_GENES_TANYA_T2D_RSQ05_02CM	BURTON_ADIPOGENESIS_8
0.277008310249%	1	361	85	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
0.277008310249%	1	361	85	T2D_GENES_TANYA_T2D_RSQ05_02CM	STEIN_ESR1_TARGETS
0.277008310249%	1	361	85	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE
0.277008310249%	1	361	85	T2D_GENES_TANYA_T2D_RSQ05_02CM	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
0.277008310249%	1	361	84	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
0.277008310249%	1	361	84	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
0.277008310249%	1	361	84	T2D_GENES_TANYA_T2D_RSQ05_02CM	RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.277008310249%	1	361	84	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_AGING_CEREBELLUM_UP
0.277008310249%	1	361	84	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
0.277008310249%	1	361	84	T2D_GENES_TANYA_T2D_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
0.277008310249%	1	361	84	T2D_GENES_TANYA_T2D_RSQ05_02CM	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
0.277008310249%	1	361	83	T2D_GENES_TANYA_T2D_RSQ05_02CM	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.277008310249%	1	361	83	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.277008310249%	1	361	82	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS
0.277008310249%	1	361	82	T2D_GENES_TANYA_T2D_RSQ05_02CM	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
0.277008310249%	1	361	82	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEIN_MIDBRAIN_MARKERS
0.277008310249%	1	361	82	T2D_GENES_TANYA_T2D_RSQ05_02CM	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
0.277008310249%	1	361	82	T2D_GENES_TANYA_T2D_RSQ05_02CM	BHAT_ESR1_TARGETS_VIA_AKT1_DN
0.277008310249%	1	361	81	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.277008310249%	1	361	81	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_M_G1_TRANSITION
0.277008310249%	1	361	81	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION
0.277008310249%	1	361	81	T2D_GENES_TANYA_T2D_RSQ05_02CM	MAHAJAN_RESPONSE_TO_IL1A_UP
0.277008310249%	1	361	81	T2D_GENES_TANYA_T2D_RSQ05_02CM	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
0.277008310249%	1	361	81	T2D_GENES_TANYA_T2D_RSQ05_02CM	COATES_MACROPHAGE_M1_VS_M2_UP
0.277008310249%	1	361	80	T2D_GENES_TANYA_T2D_RSQ05_02CM	WOO_LIVER_CANCER_RECURRENCE_DN
0.277008310249%	1	361	80	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHUHMACHER_MYC_TARGETS_UP
0.277008310249%	1	361	80	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_MET_PATHWAY
0.277008310249%	1	361	80	T2D_GENES_TANYA_T2D_RSQ05_02CM	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
0.277008310249%	1	361	80	T2D_GENES_TANYA_T2D_RSQ05_02CM	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN
0.277008310249%	1	361	80	T2D_GENES_TANYA_T2D_RSQ05_02CM	BASSO_HAIRY_CELL_LEUKEMIA_DN
0.277008310249%	1	361	8	T2D_GENES_TANYA_T2D_RSQ05_02CM	REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS
0.277008310249%	1	361	8	T2D_GENES_TANYA_T2D_RSQ05_02CM	NADELLA_PRKAR1A_TARGETS_DN
0.277008310249%	1	361	8	T2D_GENES_TANYA_T2D_RSQ05_02CM	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18
0.277008310249%	1	361	8	T2D_GENES_TANYA_T2D_RSQ05_02CM	DER_IFN_BETA_RESPONSE_DN
0.277008310249%	1	361	8	T2D_GENES_TANYA_T2D_RSQ05_02CM	BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS
0.277008310249%	1	361	79	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
0.277008310249%	1	361	79	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT
0.277008310249%	1	361	79	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_P73PATHWAY
0.277008310249%	1	361	79	T2D_GENES_TANYA_T2D_RSQ05_02CM	MCCLUNG_COCAINE_REWARD_5D
0.277008310249%	1	361	79	T2D_GENES_TANYA_T2D_RSQ05_02CM	GAVIN_FOXP3_TARGETS_CLUSTER_P2
0.277008310249%	1	361	78	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_PLATELET_HOMEOSTASIS
0.277008310249%	1	361	78	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_OPIOID_SIGNALLING
0.277008310249%	1	361	78	T2D_GENES_TANYA_T2D_RSQ05_02CM	LINDVALL_IMMORTALIZED_BY_TERT_UP
0.277008310249%	1	361	78	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_PEROXISOME
0.277008310249%	1	361	78	T2D_GENES_TANYA_T2D_RSQ05_02CM	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.277008310249%	1	361	78	T2D_GENES_TANYA_T2D_RSQ05_02CM	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE
0.277008310249%	1	361	77	T2D_GENES_TANYA_T2D_RSQ05_02CM	ROSS_AML_WITH_PML_RARA_FUSION
0.277008310249%	1	361	77	T2D_GENES_TANYA_T2D_RSQ05_02CM	RODRIGUES_THYROID_CARCINOMA_DN
0.277008310249%	1	361	77	T2D_GENES_TANYA_T2D_RSQ05_02CM	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN
0.277008310249%	1	361	77	T2D_GENES_TANYA_T2D_RSQ05_02CM	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.277008310249%	1	361	77	T2D_GENES_TANYA_T2D_RSQ05_02CM	GROSS_HYPOXIA_VIA_HIF1A_UP
0.277008310249%	1	361	77	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHEBOTAEV_GR_TARGETS_UP
0.277008310249%	1	361	77	T2D_GENES_TANYA_T2D_RSQ05_02CM	CARD_MIR302A_TARGETS
0.277008310249%	1	361	76	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.277008310249%	1	361	76	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
0.277008310249%	1	361	76	T2D_GENES_TANYA_T2D_RSQ05_02CM	SU_TESTIS
0.277008310249%	1	361	76	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION
0.277008310249%	1	361	76	T2D_GENES_TANYA_T2D_RSQ05_02CM	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
0.277008310249%	1	361	75	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_AVB3_INTEGRIN_PATHWAY
0.277008310249%	1	361	75	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_ADHERENS_JUNCTION
0.277008310249%	1	361	75	T2D_GENES_TANYA_T2D_RSQ05_02CM	JAIN_NFKB_SIGNALING
0.277008310249%	1	361	75	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
0.277008310249%	1	361	75	T2D_GENES_TANYA_T2D_RSQ05_02CM	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP
0.277008310249%	1	361	75	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHESLER_BRAIN_QTL_CIS
0.277008310249%	1	361	74	T2D_GENES_TANYA_T2D_RSQ05_02CM	URS_ADIPOCYTE_DIFFERENTIATION_UP
0.277008310249%	1	361	74	T2D_GENES_TANYA_T2D_RSQ05_02CM	OUILLETTE_CLL_13Q14_DELETION_UP
0.277008310249%	1	361	74	T2D_GENES_TANYA_T2D_RSQ05_02CM	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
0.277008310249%	1	361	74	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
0.277008310249%	1	361	73	T2D_GENES_TANYA_T2D_RSQ05_02CM	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.277008310249%	1	361	73	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
0.277008310249%	1	361	73	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_VIRAL_MYOCARDITIS
0.277008310249%	1	361	73	T2D_GENES_TANYA_T2D_RSQ05_02CM	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
0.277008310249%	1	361	72	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_METABOLISM_OF_NUCLEOTIDES
0.277008310249%	1	361	72	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1
0.277008310249%	1	361	72	T2D_GENES_TANYA_T2D_RSQ05_02CM	HUANG_GATA2_TARGETS_DN
0.277008310249%	1	361	72	T2D_GENES_TANYA_T2D_RSQ05_02CM	CROONQUIST_NRAS_SIGNALING_DN
0.277008310249%	1	361	71	T2D_GENES_TANYA_T2D_RSQ05_02CM	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.277008310249%	1	361	71	T2D_GENES_TANYA_T2D_RSQ05_02CM	KYNG_RESPONSE_TO_H2O2
0.277008310249%	1	361	71	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_MELANOMA
0.277008310249%	1	361	71	T2D_GENES_TANYA_T2D_RSQ05_02CM	DER_IFN_GAMMA_RESPONSE_UP
0.277008310249%	1	361	71	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_6HR_UP
0.277008310249%	1	361	70	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
0.277008310249%	1	361	70	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_CDC42_PATHWAY
0.277008310249%	1	361	70	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_MEF_LCP_WITH_H3K27ME3
0.277008310249%	1	361	70	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_PANCREATIC_CANCER
0.277008310249%	1	361	70	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_LONG_TERM_POTENTIATION
0.277008310249%	1	361	70	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
0.277008310249%	1	361	70	T2D_GENES_TANYA_T2D_RSQ05_02CM	CADWELL_ATG16L1_TARGETS_DN
0.277008310249%	1	361	7	T2D_GENES_TANYA_T2D_RSQ05_02CM	TESAR_JAK_TARGETS_MOUSE_ES_D3_UP
0.277008310249%	1	361	7	T2D_GENES_TANYA_T2D_RSQ05_02CM	TESAR_ALK_TARGETS_HUMAN_ES_5D_DN
0.277008310249%	1	361	7	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN
0.277008310249%	1	361	7	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKI_COEXPRESSED_WITH_CYP19A1
0.277008310249%	1	361	7	T2D_GENES_TANYA_T2D_RSQ05_02CM	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN
0.277008310249%	1	361	7	T2D_GENES_TANYA_T2D_RSQ05_02CM	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP
0.277008310249%	1	361	7	T2D_GENES_TANYA_T2D_RSQ05_02CM	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN
0.277008310249%	1	361	7	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOLLEMAN_DAUNORUBICIN_ALL_UP
0.277008310249%	1	361	7	T2D_GENES_TANYA_T2D_RSQ05_02CM	BUSA_SAM68_TARGETS_UP
0.277008310249%	1	361	7	T2D_GENES_TANYA_T2D_RSQ05_02CM	BAKER_HEMATOPOESIS_STAT5_TARGETS
0.277008310249%	1	361	69	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZAMORA_NOS2_TARGETS_UP
0.277008310249%	1	361	69	T2D_GENES_TANYA_T2D_RSQ05_02CM	RIZKI_TUMOR_INVASIVENESS_2D_UP
0.277008310249%	1	361	69	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEIN_NEURON_MARKERS
0.277008310249%	1	361	69	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_PPAR_SIGNALING_PATHWAY
0.277008310249%	1	361	69	T2D_GENES_TANYA_T2D_RSQ05_02CM	HUANG_DASATINIB_RESISTANCE_DN
0.277008310249%	1	361	69	T2D_GENES_TANYA_T2D_RSQ05_02CM	AMIT_EGF_RESPONSE_120_HELA
0.277008310249%	1	361	68	T2D_GENES_TANYA_T2D_RSQ05_02CM	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
0.277008310249%	1	361	68	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_TELOMERASEPATHWAY
0.277008310249%	1	361	68	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN
0.277008310249%	1	361	68	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_INTERFERON_RESPONSIVE_GENES
0.277008310249%	1	361	68	T2D_GENES_TANYA_T2D_RSQ05_02CM	BASSO_CD40_SIGNALING_DN
0.277008310249%	1	361	67	T2D_GENES_TANYA_T2D_RSQ05_02CM	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP
0.277008310249%	1	361	67	T2D_GENES_TANYA_T2D_RSQ05_02CM	VANHARANTA_UTERINE_FIBROID_DN
0.277008310249%	1	361	67	T2D_GENES_TANYA_T2D_RSQ05_02CM	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
0.277008310249%	1	361	67	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN
0.277008310249%	1	361	67	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
0.277008310249%	1	361	66	T2D_GENES_TANYA_T2D_RSQ05_02CM	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
0.277008310249%	1	361	66	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT
0.277008310249%	1	361	66	T2D_GENES_TANYA_T2D_RSQ05_02CM	SWEET_KRAS_TARGETS_DN
0.277008310249%	1	361	66	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_TCR_PATHWAY
0.277008310249%	1	361	66	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_INTEGRIN1_PATHWAY
0.277008310249%	1	361	66	T2D_GENES_TANYA_T2D_RSQ05_02CM	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.277008310249%	1	361	66	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.277008310249%	1	361	66	T2D_GENES_TANYA_T2D_RSQ05_02CM	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP
0.277008310249%	1	361	65	T2D_GENES_TANYA_T2D_RSQ05_02CM	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.277008310249%	1	361	65	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SIGNALING_BY_WNT
0.277008310249%	1	361	65	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX
0.277008310249%	1	361	65	T2D_GENES_TANYA_T2D_RSQ05_02CM	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS
0.277008310249%	1	361	65	T2D_GENES_TANYA_T2D_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP
0.277008310249%	1	361	64	T2D_GENES_TANYA_T2D_RSQ05_02CM	RIZKI_TUMOR_INVASIVENESS_2D_DN
0.277008310249%	1	361	64	T2D_GENES_TANYA_T2D_RSQ05_02CM	RHODES_CANCER_META_SIGNATURE
0.277008310249%	1	361	64	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
0.277008310249%	1	361	64	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
0.277008310249%	1	361	64	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C
0.277008310249%	1	361	64	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS
0.277008310249%	1	361	64	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_LIVER_CANCER_ACOX1_UP
0.277008310249%	1	361	64	T2D_GENES_TANYA_T2D_RSQ05_02CM	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
0.277008310249%	1	361	64	T2D_GENES_TANYA_T2D_RSQ05_02CM	INGRAM_SHH_TARGETS_DN
0.277008310249%	1	361	64	T2D_GENES_TANYA_T2D_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
0.277008310249%	1	361	64	T2D_GENES_TANYA_T2D_RSQ05_02CM	BYSTROEM_CORRELATED_WITH_IL5_DN
0.277008310249%	1	361	63	T2D_GENES_TANYA_T2D_RSQ05_02CM	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP
0.277008310249%	1	361	63	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
0.277008310249%	1	361	63	T2D_GENES_TANYA_T2D_RSQ05_02CM	PHONG_TNF_TARGETS_UP
0.277008310249%	1	361	63	T2D_GENES_TANYA_T2D_RSQ05_02CM	MODY_HIPPOCAMPUS_POSTNATAL
0.277008310249%	1	361	63	T2D_GENES_TANYA_T2D_RSQ05_02CM	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
0.277008310249%	1	361	63	T2D_GENES_TANYA_T2D_RSQ05_02CM	CROMER_TUMORIGENESIS_UP
0.277008310249%	1	361	63	T2D_GENES_TANYA_T2D_RSQ05_02CM	BRIDEAU_IMPRINTED_GENES
0.277008310249%	1	361	63	T2D_GENES_TANYA_T2D_RSQ05_02CM	BILBAN_B_CLL_LPL_UP
0.277008310249%	1	361	62	T2D_GENES_TANYA_T2D_RSQ05_02CM	KYNG_DNA_DAMAGE_BY_UV
0.277008310249%	1	361	62	T2D_GENES_TANYA_T2D_RSQ05_02CM	KORKOLA_YOLK_SAC_TUMOR
0.277008310249%	1	361	62	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.277008310249%	1	361	62	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
0.277008310249%	1	361	62	T2D_GENES_TANYA_T2D_RSQ05_02CM	ISSAEVA_MLL2_TARGETS
0.277008310249%	1	361	62	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.277008310249%	1	361	62	T2D_GENES_TANYA_T2D_RSQ05_02CM	CORRE_MULTIPLE_MYELOMA_DN
0.277008310249%	1	361	62	T2D_GENES_TANYA_T2D_RSQ05_02CM	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP
0.277008310249%	1	361	61	T2D_GENES_TANYA_T2D_RSQ05_02CM	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.277008310249%	1	361	61	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ER_PHAGOSOME_PATHWAY
0.277008310249%	1	361	61	T2D_GENES_TANYA_T2D_RSQ05_02CM	RAMASWAMY_METASTASIS_DN
0.277008310249%	1	361	61	T2D_GENES_TANYA_T2D_RSQ05_02CM	NADLER_OBESITY_UP
0.277008310249%	1	361	61	T2D_GENES_TANYA_T2D_RSQ05_02CM	GENTILE_RESPONSE_CLUSTER_D3
0.277008310249%	1	361	61	T2D_GENES_TANYA_T2D_RSQ05_02CM	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
0.277008310249%	1	361	61	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_1HR_UP
0.277008310249%	1	361	61	T2D_GENES_TANYA_T2D_RSQ05_02CM	BAKKER_FOXO3_TARGETS_UP
0.277008310249%	1	361	60	T2D_GENES_TANYA_T2D_RSQ05_02CM	SONG_TARGETS_OF_IE86_CMV_PROTEIN
0.277008310249%	1	361	60	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_LIVER_CANCER_DENA_UP
0.277008310249%	1	361	60	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_LIVER_CANCER_CIPROFIBRATE_UP
0.277008310249%	1	361	60	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_ACUTE_MYELOID_LEUKEMIA
0.277008310249%	1	361	60	T2D_GENES_TANYA_T2D_RSQ05_02CM	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN
0.277008310249%	1	361	6	T2D_GENES_TANYA_T2D_RSQ05_02CM	TSAI_DNAJB4_TARGETS_DN
0.277008310249%	1	361	6	T2D_GENES_TANYA_T2D_RSQ05_02CM	TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN
0.277008310249%	1	361	6	T2D_GENES_TANYA_T2D_RSQ05_02CM	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP
0.277008310249%	1	361	6	T2D_GENES_TANYA_T2D_RSQ05_02CM	MOTAMED_RESPONSE_TO_ANDROGEN_DN
0.277008310249%	1	361	6	T2D_GENES_TANYA_T2D_RSQ05_02CM	KORKOLA_CHORIOCARCINOMA
0.277008310249%	1	361	59	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS
0.277008310249%	1	361	59	T2D_GENES_TANYA_T2D_RSQ05_02CM	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
0.277008310249%	1	361	59	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_FAK_PATHWAY
0.277008310249%	1	361	59	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_ATF2_PATHWAY
0.277008310249%	1	361	59	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
0.277008310249%	1	361	59	T2D_GENES_TANYA_T2D_RSQ05_02CM	DASU_IL6_SIGNALING_UP
0.277008310249%	1	361	59	T2D_GENES_TANYA_T2D_RSQ05_02CM	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
0.277008310249%	1	361	58	T2D_GENES_TANYA_T2D_RSQ05_02CM	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
0.277008310249%	1	361	58	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_REGULATION_OF_APOPTOSIS
0.277008310249%	1	361	58	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT
0.277008310249%	1	361	58	T2D_GENES_TANYA_T2D_RSQ05_02CM	LUCAS_HNF4A_TARGETS_UP
0.277008310249%	1	361	58	T2D_GENES_TANYA_T2D_RSQ05_02CM	KOHOUTEK_CCNT2_TARGETS
0.277008310249%	1	361	58	T2D_GENES_TANYA_T2D_RSQ05_02CM	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
0.277008310249%	1	361	58	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
0.277008310249%	1	361	58	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_HIVNEF_PATHWAY
0.277008310249%	1	361	57	T2D_GENES_TANYA_T2D_RSQ05_02CM	TONG_INTERACT_WITH_PTTG1
0.277008310249%	1	361	57	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN
0.277008310249%	1	361	57	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.277008310249%	1	361	57	T2D_GENES_TANYA_T2D_RSQ05_02CM	BURTON_ADIPOGENESIS_11
0.277008310249%	1	361	57	T2D_GENES_TANYA_T2D_RSQ05_02CM	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
0.277008310249%	1	361	57	T2D_GENES_TANYA_T2D_RSQ05_02CM	AMIT_SERUM_RESPONSE_60_MCF10A
0.277008310249%	1	361	57	T2D_GENES_TANYA_T2D_RSQ05_02CM	AMIT_SERUM_RESPONSE_240_MCF10A
0.277008310249%	1	361	56	T2D_GENES_TANYA_T2D_RSQ05_02CM	VANTVEER_BREAST_CANCER_METASTASIS_UP
0.277008310249%	1	361	56	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX
0.277008310249%	1	361	56	T2D_GENES_TANYA_T2D_RSQ05_02CM	MAYBURD_RESPONSE_TO_L663536_DN
0.277008310249%	1	361	56	T2D_GENES_TANYA_T2D_RSQ05_02CM	LY_AGING_OLD_DN
0.277008310249%	1	361	56	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_LIVER_CANCER_MYC_E2F1_UP
0.277008310249%	1	361	56	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_VIBRIO_CHOLERAE_INFECTION
0.277008310249%	1	361	56	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_HEDGEHOG_SIGNALING_PATHWAY
0.277008310249%	1	361	56	T2D_GENES_TANYA_T2D_RSQ05_02CM	HENDRICKS_SMARCA4_TARGETS_UP
0.277008310249%	1	361	55	T2D_GENES_TANYA_T2D_RSQ05_02CM	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
0.277008310249%	1	361	55	T2D_GENES_TANYA_T2D_RSQ05_02CM	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53
0.277008310249%	1	361	55	T2D_GENES_TANYA_T2D_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
0.277008310249%	1	361	55	T2D_GENES_TANYA_T2D_RSQ05_02CM	SU_LIVER
0.277008310249%	1	361	55	T2D_GENES_TANYA_T2D_RSQ05_02CM	SMIRNOV_RESPONSE_TO_IR_2HR_DN
0.277008310249%	1	361	55	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ION_CHANNEL_TRANSPORT
0.277008310249%	1	361	55	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_IL2_1PATHWAY
0.277008310249%	1	361	55	T2D_GENES_TANYA_T2D_RSQ05_02CM	LAU_APOPTOSIS_CDKN2A_UP
0.277008310249%	1	361	55	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_BASAL_CELL_CARCINOMA
0.277008310249%	1	361	55	T2D_GENES_TANYA_T2D_RSQ05_02CM	GENTILE_UV_RESPONSE_CLUSTER_D4
0.277008310249%	1	361	55	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_4HR_UP
0.277008310249%	1	361	54	T2D_GENES_TANYA_T2D_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
0.277008310249%	1	361	54	T2D_GENES_TANYA_T2D_RSQ05_02CM	ROVERSI_GLIOMA_COPY_NUMBER_DN
0.277008310249%	1	361	54	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE
0.277008310249%	1	361	54	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_TAP63PATHWAY
0.277008310249%	1	361	54	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_RAC1_PATHWAY
0.277008310249%	1	361	54	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_NFAT_3PATHWAY
0.277008310249%	1	361	54	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARSON_FOXP3_TARGETS_DN
0.277008310249%	1	361	54	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN
0.277008310249%	1	361	54	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_NON_SMALL_CELL_LUNG_CANCER
0.277008310249%	1	361	54	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_INOSITOL_PHOSPHATE_METABOLISM
0.277008310249%	1	361	54	T2D_GENES_TANYA_T2D_RSQ05_02CM	KANG_DOXORUBICIN_RESISTANCE_UP
0.277008310249%	1	361	54	T2D_GENES_TANYA_T2D_RSQ05_02CM	AUNG_GASTRIC_CANCER
0.277008310249%	1	361	53	T2D_GENES_TANYA_T2D_RSQ05_02CM	SMIRNOV_RESPONSE_TO_IR_2HR_UP
0.277008310249%	1	361	53	T2D_GENES_TANYA_T2D_RSQ05_02CM	ROESSLER_LIVER_CANCER_METASTASIS_DN
0.277008310249%	1	361	53	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_PROTEIN_FOLDING
0.277008310249%	1	361	53	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0
0.277008310249%	1	361	53	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_CD8TCRPATHWAY
0.277008310249%	1	361	53	T2D_GENES_TANYA_T2D_RSQ05_02CM	MORI_IMMATURE_B_LYMPHOCYTE_UP
0.277008310249%	1	361	53	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
0.277008310249%	1	361	53	T2D_GENES_TANYA_T2D_RSQ05_02CM	KRIEG_HYPOXIA_VIA_KDM3A
0.277008310249%	1	361	53	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
0.277008310249%	1	361	53	T2D_GENES_TANYA_T2D_RSQ05_02CM	IKEDA_MIR1_TARGETS_UP
0.277008310249%	1	361	53	T2D_GENES_TANYA_T2D_RSQ05_02CM	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN
0.277008310249%	1	361	52	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN
0.277008310249%	1	361	52	T2D_GENES_TANYA_T2D_RSQ05_02CM	WINTER_HYPOXIA_DN
0.277008310249%	1	361	52	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.277008310249%	1	361	52	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM
0.277008310249%	1	361	52	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_GABA_RECEPTOR_ACTIVATION
0.277008310249%	1	361	52	T2D_GENES_TANYA_T2D_RSQ05_02CM	RADAEVA_RESPONSE_TO_IFNA1_UP
0.277008310249%	1	361	52	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_KITPATHWAY
0.277008310249%	1	361	52	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_CASPASE_PATHWAY
0.277008310249%	1	361	52	T2D_GENES_TANYA_T2D_RSQ05_02CM	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP
0.277008310249%	1	361	52	T2D_GENES_TANYA_T2D_RSQ05_02CM	KENNY_CTNNB1_TARGETS_DN
0.277008310249%	1	361	52	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_STARCH_AND_SUCROSE_METABOLISM
0.277008310249%	1	361	52	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_ENDOMETRIAL_CANCER
0.277008310249%	1	361	52	T2D_GENES_TANYA_T2D_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
0.277008310249%	1	361	51	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
0.277008310249%	1	361	51	T2D_GENES_TANYA_T2D_RSQ05_02CM	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
0.277008310249%	1	361	51	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.277008310249%	1	361	51	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT
0.277008310249%	1	361	51	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
0.277008310249%	1	361	51	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1
0.277008310249%	1	361	51	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT
0.277008310249%	1	361	51	T2D_GENES_TANYA_T2D_RSQ05_02CM	LUI_THYROID_CANCER_CLUSTER_1
0.277008310249%	1	361	51	T2D_GENES_TANYA_T2D_RSQ05_02CM	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
0.277008310249%	1	361	51	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
0.277008310249%	1	361	51	T2D_GENES_TANYA_T2D_RSQ05_02CM	CROMER_TUMORIGENESIS_DN
0.277008310249%	1	361	51	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.277008310249%	1	361	51	T2D_GENES_TANYA_T2D_RSQ05_02CM	BYSTROEM_CORRELATED_WITH_IL5_UP
0.277008310249%	1	361	51	T2D_GENES_TANYA_T2D_RSQ05_02CM	BURTON_ADIPOGENESIS_7
0.277008310249%	1	361	50	T2D_GENES_TANYA_T2D_RSQ05_02CM	YANG_BREAST_CANCER_ESR1_LASER_DN
0.277008310249%	1	361	50	T2D_GENES_TANYA_T2D_RSQ05_02CM	STOSSI_RESPONSE_TO_ESTRADIOL
0.277008310249%	1	361	50	T2D_GENES_TANYA_T2D_RSQ05_02CM	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.277008310249%	1	361	50	T2D_GENES_TANYA_T2D_RSQ05_02CM	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
0.277008310249%	1	361	50	T2D_GENES_TANYA_T2D_RSQ05_02CM	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
0.277008310249%	1	361	50	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
0.277008310249%	1	361	50	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAUER_STAT3_TARGETS_DN
0.277008310249%	1	361	50	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN
0.277008310249%	1	361	50	T2D_GENES_TANYA_T2D_RSQ05_02CM	BECKER_TAMOXIFEN_RESISTANCE_UP
0.277008310249%	1	361	5	T2D_GENES_TANYA_T2D_RSQ05_02CM	JONES_TCOF1_TARGETS
0.277008310249%	1	361	49	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_HP_UP
0.277008310249%	1	361	49	T2D_GENES_TANYA_T2D_RSQ05_02CM	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
0.277008310249%	1	361	49	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC
0.277008310249%	1	361	49	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM
0.277008310249%	1	361	49	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_PI3KCIPATHWAY
0.277008310249%	1	361	49	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARCHINI_TRABECTEDIN_RESISTANCE_DN
0.277008310249%	1	361	49	T2D_GENES_TANYA_T2D_RSQ05_02CM	GERHOLD_ADIPOGENESIS_UP
0.277008310249%	1	361	49	T2D_GENES_TANYA_T2D_RSQ05_02CM	APRELIKOVA_BRCA1_TARGETS
0.277008310249%	1	361	48	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_PI_METABOLISM
0.277008310249%	1	361	48	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES
0.277008310249%	1	361	48	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6
0.277008310249%	1	361	48	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_HEDGEHOG_GLIPATHWAY
0.277008310249%	1	361	48	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_CERAMIDE_PATHWAY
0.277008310249%	1	361	48	T2D_GENES_TANYA_T2D_RSQ05_02CM	OXFORD_RALA_OR_RALB_TARGETS_UP
0.277008310249%	1	361	48	T2D_GENES_TANYA_T2D_RSQ05_02CM	NADLER_OBESITY_DN
0.277008310249%	1	361	48	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_PROTEASOME
0.277008310249%	1	361	48	T2D_GENES_TANYA_T2D_RSQ05_02CM	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.277008310249%	1	361	48	T2D_GENES_TANYA_T2D_RSQ05_02CM	BURTON_ADIPOGENESIS_4
0.277008310249%	1	361	47	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_HP_DN
0.277008310249%	1	361	47	T2D_GENES_TANYA_T2D_RSQ05_02CM	SILIGAN_BOUND_BY_EWS_FLT1_FUSION
0.277008310249%	1	361	47	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
0.277008310249%	1	361	47	T2D_GENES_TANYA_T2D_RSQ05_02CM	POTTI_DOCETAXEL_SENSITIVITY
0.277008310249%	1	361	47	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_NFAT_TFPATHWAY
0.277008310249%	1	361	47	T2D_GENES_TANYA_T2D_RSQ05_02CM	MELLMAN_TUT1_TARGETS_DN
0.277008310249%	1	361	47	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEONARD_HYPOXIA
0.277008310249%	1	361	47	T2D_GENES_TANYA_T2D_RSQ05_02CM	KHETCHOUMIAN_TRIM24_TARGETS_UP
0.277008310249%	1	361	47	T2D_GENES_TANYA_T2D_RSQ05_02CM	BOYLAN_MULTIPLE_MYELOMA_C_UP
0.277008310249%	1	361	461	T2D_GENES_TANYA_T2D_RSQ05_02CM	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
0.277008310249%	1	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_CD2_DN
0.277008310249%	1	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	TSENG_ADIPOGENIC_POTENTIAL_DN
0.277008310249%	1	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	SIG_BCR_SIGNALING_PATHWAY
0.277008310249%	1	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	SAGIV_CD24_TARGETS_DN
0.277008310249%	1	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_RHOA_REG_PATHWAY
0.277008310249%	1	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_PLK1_PATHWAY
0.277008310249%	1	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_A6B1_A6B4_INTEGRIN_PATHWAY
0.277008310249%	1	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON
0.277008310249%	1	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN
0.277008310249%	1	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	KUNINGER_IGF1_VS_PDGFB_TARGETS_DN
0.277008310249%	1	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	JIANG_TIP30_TARGETS_UP
0.277008310249%	1	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	HEIDENBLAD_AMPLICON_8Q24_DN
0.277008310249%	1	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN
0.277008310249%	1	361	46	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_KERATINOCYTE_PATHWAY
0.277008310249%	1	361	45	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_CD1_DN
0.277008310249%	1	361	45	T2D_GENES_TANYA_T2D_RSQ05_02CM	TRAYNOR_RETT_SYNDROM_UP
0.277008310249%	1	361	45	T2D_GENES_TANYA_T2D_RSQ05_02CM	NAKAMURA_METASTASIS_MODEL_UP
0.277008310249%	1	361	45	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHENG_RESPONSE_TO_NICKEL_ACETATE
0.277008310249%	1	361	45	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_BIOPEPTIDES_PATHWAY
0.277008310249%	1	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZUCCHI_METASTASIS_DN
0.277008310249%	1	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_LB_DN
0.277008310249%	1	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	XU_CREBBP_TARGETS_DN
0.277008310249%	1	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.277008310249%	1	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS
0.277008310249%	1	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
0.277008310249%	1	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS
0.277008310249%	1	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	MEDINA_SMARCA4_TARGETS
0.277008310249%	1	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	LANDIS_BREAST_CANCER_PROGRESSION_UP
0.277008310249%	1	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	KERLEY_RESPONSE_TO_CISPLATIN_UP
0.277008310249%	1	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_LYSINE_DEGRADATION
0.277008310249%	1	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM
0.277008310249%	1	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	JAEGER_METASTASIS_UP
0.277008310249%	1	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	FARMER_BREAST_CANCER_CLUSTER_1
0.277008310249%	1	361	44	T2D_GENES_TANYA_T2D_RSQ05_02CM	FAELT_B_CLL_WITH_VH3_21_UP
0.277008310249%	1	361	43	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZUCCHI_METASTASIS_UP
0.277008310249%	1	361	43	T2D_GENES_TANYA_T2D_RSQ05_02CM	ULE_SPLICING_VIA_NOVA2
0.277008310249%	1	361	43	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS
0.277008310249%	1	361	43	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1
0.277008310249%	1	361	43	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_PLC_BETA_MEDIATED_EVENTS
0.277008310249%	1	361	43	T2D_GENES_TANYA_T2D_RSQ05_02CM	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
0.277008310249%	1	361	43	T2D_GENES_TANYA_T2D_RSQ05_02CM	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN
0.277008310249%	1	361	43	T2D_GENES_TANYA_T2D_RSQ05_02CM	NAKAYAMA_FRA2_TARGETS
0.277008310249%	1	361	43	T2D_GENES_TANYA_T2D_RSQ05_02CM	MANTOVANI_NFKB_TARGETS_UP
0.277008310249%	1	361	43	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_CALORIE_RESTRICTION_MUSCLE_UP
0.277008310249%	1	361	43	T2D_GENES_TANYA_T2D_RSQ05_02CM	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
0.277008310249%	1	361	43	T2D_GENES_TANYA_T2D_RSQ05_02CM	IKEDA_MIR133_TARGETS_UP
0.277008310249%	1	361	425	T2D_GENES_TANYA_T2D_RSQ05_02CM	BOCHKIS_FOXA2_TARGETS
0.277008310249%	1	361	42	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHENG_IL22_SIGNALING_DN
0.277008310249%	1	361	42	T2D_GENES_TANYA_T2D_RSQ05_02CM	WIERENGA_PML_INTERACTOME
0.277008310249%	1	361	42	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP
0.277008310249%	1	361	42	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_UPA_UPAR_PATHWAY
0.277008310249%	1	361	42	T2D_GENES_TANYA_T2D_RSQ05_02CM	ONO_FOXP3_TARGETS_DN
0.277008310249%	1	361	42	T2D_GENES_TANYA_T2D_RSQ05_02CM	MODY_HIPPOCAMPUS_PRENATAL
0.277008310249%	1	361	42	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_ES_ICP_WITH_H3K27ME3
0.277008310249%	1	361	42	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEIN_ASTROCYTE_MARKERS
0.277008310249%	1	361	42	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_BLADDER_CANCER
0.277008310249%	1	361	418	T2D_GENES_TANYA_T2D_RSQ05_02CM	MULLIGHAN_MLL_SIGNATURE_2_UP
0.277008310249%	1	361	41	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_MF_DN
0.277008310249%	1	361	41	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_DN
0.277008310249%	1	361	41	T2D_GENES_TANYA_T2D_RSQ05_02CM	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN
0.277008310249%	1	361	41	T2D_GENES_TANYA_T2D_RSQ05_02CM	RIZ_ERYTHROID_DIFFERENTIATION_HBZ
0.277008310249%	1	361	41	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_ER_NONGENOMIC_PATHWAY
0.277008310249%	1	361	41	T2D_GENES_TANYA_T2D_RSQ05_02CM	LI_LUNG_CANCER
0.277008310249%	1	361	41	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIN_MELANOMA_COPY_NUMBER_DN
0.277008310249%	1	361	41	T2D_GENES_TANYA_T2D_RSQ05_02CM	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN
0.277008310249%	1	361	41	T2D_GENES_TANYA_T2D_RSQ05_02CM	KAMMINGA_EZH2_TARGETS
0.277008310249%	1	361	41	T2D_GENES_TANYA_T2D_RSQ05_02CM	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
0.277008310249%	1	361	41	T2D_GENES_TANYA_T2D_RSQ05_02CM	DELPUECH_FOXO3_TARGETS_DN
0.277008310249%	1	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.277008310249%	1	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	VARELA_ZMPSTE24_TARGETS_UP
0.277008310249%	1	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	VANASSE_BCL2_TARGETS_UP
0.277008310249%	1	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	ST_JNK_MAPK_PATHWAY
0.277008310249%	1	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_IFNGPATHWAY
0.277008310249%	1	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_FOXM1PATHWAY
0.277008310249%	1	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIAO_HAVE_SOX4_BINDING_SITES
0.277008310249%	1	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP
0.277008310249%	1	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
0.277008310249%	1	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	GENTILE_UV_RESPONSE_CLUSTER_D8
0.277008310249%	1	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	ELLWOOD_MYC_TARGETS_DN
0.277008310249%	1	361	40	T2D_GENES_TANYA_T2D_RSQ05_02CM	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.277008310249%	1	361	39	T2D_GENES_TANYA_T2D_RSQ05_02CM	WHITEHURST_PACLITAXEL_SENSITIVITY
0.277008310249%	1	361	39	T2D_GENES_TANYA_T2D_RSQ05_02CM	VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1
0.277008310249%	1	361	39	T2D_GENES_TANYA_T2D_RSQ05_02CM	VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN
0.277008310249%	1	361	39	T2D_GENES_TANYA_T2D_RSQ05_02CM	SESTO_RESPONSE_TO_UV_C6
0.277008310249%	1	361	39	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_NCAM1_INTERACTIONS
0.277008310249%	1	361	39	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_RET_PATHWAY
0.277008310249%	1	361	39	T2D_GENES_TANYA_T2D_RSQ05_02CM	MA_MYELOID_DIFFERENTIATION_UP
0.277008310249%	1	361	39	T2D_GENES_TANYA_T2D_RSQ05_02CM	KORKOLA_TERATOMA
0.277008310249%	1	361	39	T2D_GENES_TANYA_T2D_RSQ05_02CM	GENTILE_UV_RESPONSE_CLUSTER_D5
0.277008310249%	1	361	39	T2D_GENES_TANYA_T2D_RSQ05_02CM	CONRAD_STEM_CELL
0.277008310249%	1	361	39	T2D_GENES_TANYA_T2D_RSQ05_02CM	BURTON_ADIPOGENESIS_PEAK_AT_8HR
0.277008310249%	1	361	39	T2D_GENES_TANYA_T2D_RSQ05_02CM	BILANGES_SERUM_SENSITIVE_VIA_TSC2
0.277008310249%	1	361	39	T2D_GENES_TANYA_T2D_RSQ05_02CM	BEIER_GLIOMA_STEM_CELL_UP
0.277008310249%	1	361	39	T2D_GENES_TANYA_T2D_RSQ05_02CM	AMIT_EGF_RESPONSE_60_MCF10A
0.277008310249%	1	361	389	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_OLFACTORY_TRANSDUCTION
0.277008310249%	1	361	380	T2D_GENES_TANYA_T2D_RSQ05_02CM	MULLIGHAN_MLL_SIGNATURE_1_UP
0.277008310249%	1	361	38	T2D_GENES_TANYA_T2D_RSQ05_02CM	YOKOE_CANCER_TESTIS_ANTIGENS
0.277008310249%	1	361	38	T2D_GENES_TANYA_T2D_RSQ05_02CM	TERAO_AOX4_TARGETS_SKIN_UP
0.277008310249%	1	361	38	T2D_GENES_TANYA_T2D_RSQ05_02CM	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
0.277008310249%	1	361	38	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS
0.277008310249%	1	361	38	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER
0.277008310249%	1	361	38	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_GABA_B_RECEPTOR_ACTIVATION
0.277008310249%	1	361	38	T2D_GENES_TANYA_T2D_RSQ05_02CM	KRASNOSELSKAYA_ILF3_TARGETS_UP
0.277008310249%	1	361	38	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT
0.277008310249%	1	361	38	T2D_GENES_TANYA_T2D_RSQ05_02CM	KAAB_FAILED_HEART_ATRIUM_UP
0.277008310249%	1	361	38	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP
0.277008310249%	1	361	38	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHANDRAN_METASTASIS_TOP50_UP
0.277008310249%	1	361	38	T2D_GENES_TANYA_T2D_RSQ05_02CM	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
0.277008310249%	1	361	38	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_INTEGRIN_PATHWAY
0.277008310249%	1	361	38	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_IL2RB_PATHWAY
0.277008310249%	1	361	38	T2D_GENES_TANYA_T2D_RSQ05_02CM	APPIERTO_RESPONSE_TO_FENRETINIDE_UP
0.277008310249%	1	361	37	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN
0.277008310249%	1	361	37	T2D_GENES_TANYA_T2D_RSQ05_02CM	VALK_AML_WITH_CEBPA
0.277008310249%	1	361	37	T2D_GENES_TANYA_T2D_RSQ05_02CM	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
0.277008310249%	1	361	37	T2D_GENES_TANYA_T2D_RSQ05_02CM	ST_GA13_PATHWAY
0.277008310249%	1	361	37	T2D_GENES_TANYA_T2D_RSQ05_02CM	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
0.277008310249%	1	361	37	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS
0.277008310249%	1	361	37	T2D_GENES_TANYA_T2D_RSQ05_02CM	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2
0.277008310249%	1	361	37	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_FRA_PATHWAY
0.277008310249%	1	361	37	T2D_GENES_TANYA_T2D_RSQ05_02CM	KIM_ALL_DISORDERS_CALB1_CORR_DN
0.277008310249%	1	361	37	T2D_GENES_TANYA_T2D_RSQ05_02CM	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR
0.277008310249%	1	361	37	T2D_GENES_TANYA_T2D_RSQ05_02CM	HU_ANGIOGENESIS_DN
0.277008310249%	1	361	37	T2D_GENES_TANYA_T2D_RSQ05_02CM	FRASOR_RESPONSE_TO_ESTRADIOL_UP
0.277008310249%	1	361	37	T2D_GENES_TANYA_T2D_RSQ05_02CM	CUI_TCF21_TARGETS_UP
0.277008310249%	1	361	37	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_ALK_PATHWAY
0.277008310249%	1	361	37	T2D_GENES_TANYA_T2D_RSQ05_02CM	BILANGES_SERUM_RESPONSE_TRANSLATION
0.277008310249%	1	361	36	T2D_GENES_TANYA_T2D_RSQ05_02CM	YIH_RESPONSE_TO_ARSENITE_C3
0.277008310249%	1	361	36	T2D_GENES_TANYA_T2D_RSQ05_02CM	YANG_BREAST_CANCER_ESR1_UP
0.277008310249%	1	361	36	T2D_GENES_TANYA_T2D_RSQ05_02CM	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2
0.277008310249%	1	361	36	T2D_GENES_TANYA_T2D_RSQ05_02CM	SUBTIL_PROGESTIN_TARGETS
0.277008310249%	1	361	36	T2D_GENES_TANYA_T2D_RSQ05_02CM	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
0.277008310249%	1	361	36	T2D_GENES_TANYA_T2D_RSQ05_02CM	HUANG_FOXA2_TARGETS_DN
0.277008310249%	1	361	36	T2D_GENES_TANYA_T2D_RSQ05_02CM	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP
0.277008310249%	1	361	35	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15
0.277008310249%	1	361	35	T2D_GENES_TANYA_T2D_RSQ05_02CM	WEIGEL_OXIDATIVE_STRESS_RESPONSE
0.277008310249%	1	361	35	T2D_GENES_TANYA_T2D_RSQ05_02CM	SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES
0.277008310249%	1	361	35	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_HIVNEFPATHWAY
0.277008310249%	1	361	35	T2D_GENES_TANYA_T2D_RSQ05_02CM	LOPEZ_TRANSLATION_VIA_FN1_SIGNALING
0.277008310249%	1	361	35	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_PRIMARY_IMMUNODEFICIENCY
0.277008310249%	1	361	35	T2D_GENES_TANYA_T2D_RSQ05_02CM	GUTIERREZ_MULTIPLE_MYELOMA_DN
0.277008310249%	1	361	35	T2D_GENES_TANYA_T2D_RSQ05_02CM	DORSAM_HOXA9_TARGETS_UP
0.277008310249%	1	361	349	T2D_GENES_TANYA_T2D_RSQ05_02CM	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
0.277008310249%	1	361	34	T2D_GENES_TANYA_T2D_RSQ05_02CM	WONG_IFNA2_RESISTANCE_DN
0.277008310249%	1	361	34	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHOEN_NFKB_SIGNALING
0.277008310249%	1	361	34	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES
0.277008310249%	1	361	34	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION
0.277008310249%	1	361	34	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT
0.277008310249%	1	361	34	T2D_GENES_TANYA_T2D_RSQ05_02CM	PLASARI_TGFB1_TARGETS_1HR_UP
0.277008310249%	1	361	34	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_IL2_PI3KPATHWAY
0.277008310249%	1	361	34	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_HIF2PATHWAY
0.277008310249%	1	361	34	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_HDAC_CLASSII_PATHWAY
0.277008310249%	1	361	34	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_EPOPATHWAY
0.277008310249%	1	361	34	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_ATM_PATHWAY
0.277008310249%	1	361	34	T2D_GENES_TANYA_T2D_RSQ05_02CM	MEISSNER_ES_ICP_WITH_H3K4ME3
0.277008310249%	1	361	34	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_CYSTEINE_AND_METHIONINE_METABOLISM
0.277008310249%	1	361	34	T2D_GENES_TANYA_T2D_RSQ05_02CM	FRIDMAN_IMMORTALIZATION_DN
0.277008310249%	1	361	34	T2D_GENES_TANYA_T2D_RSQ05_02CM	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP
0.277008310249%	1	361	34	T2D_GENES_TANYA_T2D_RSQ05_02CM	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP
0.277008310249%	1	361	338	T2D_GENES_TANYA_T2D_RSQ05_02CM	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHAN_LATE_DIFFERENTIATION_GENES_UP
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	VALK_AML_CLUSTER_6
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	VALK_AML_CLUSTER_5
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	SIMBULAN_UV_RESPONSE_NORMAL_DN
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHRAETS_MLL_TARGETS_DN
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_SYNDECAN_2_PATHWAY
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_INTEGRIN_A4B1_PATHWAY
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_ALPHASYNUCLEIN_PATHWAY
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	HEIDENBLAD_AMPLICON_12P11_12_UP
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	DUTTA_APOPTOSIS_VIA_NFKB
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHO_NR4A1_TARGETS
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	CAFFAREL_RESPONSE_TO_THC_UP
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	BURTON_ADIPOGENESIS_1
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_DEATH_PATHWAY
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN
0.277008310249%	1	361	33	T2D_GENES_TANYA_T2D_RSQ05_02CM	APPEL_IMATINIB_RESPONSE
0.277008310249%	1	361	32	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZWANG_EGF_PERSISTENTLY_UP
0.277008310249%	1	361	32	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.277008310249%	1	361	32	T2D_GENES_TANYA_T2D_RSQ05_02CM	ST_ERK1_ERK2_MAPK_PATHWAY
0.277008310249%	1	361	32	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN
0.277008310249%	1	361	32	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_DAG_AND_IP3_SIGNALING
0.277008310249%	1	361	32	T2D_GENES_TANYA_T2D_RSQ05_02CM	POS_HISTAMINE_RESPONSE_NETWORK
0.277008310249%	1	361	32	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_WNT_NONCANONICAL_PATHWAY
0.277008310249%	1	361	32	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_SYNDECAN_4_PATHWAY
0.277008310249%	1	361	32	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_NETRIN_PATHWAY
0.277008310249%	1	361	32	T2D_GENES_TANYA_T2D_RSQ05_02CM	MEISSNER_BRAIN_ICP_WITH_H3K4ME3
0.277008310249%	1	361	32	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM
0.277008310249%	1	361	32	T2D_GENES_TANYA_T2D_RSQ05_02CM	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP
0.277008310249%	1	361	32	T2D_GENES_TANYA_T2D_RSQ05_02CM	DIRMEIER_LMP1_RESPONSE_LATE_DN
0.277008310249%	1	361	32	T2D_GENES_TANYA_T2D_RSQ05_02CM	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN
0.277008310249%	1	361	32	T2D_GENES_TANYA_T2D_RSQ05_02CM	BAE_BRCA1_TARGETS_DN
0.277008310249%	1	361	318	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEI_MYB_TARGETS
0.277008310249%	1	361	317	T2D_GENES_TANYA_T2D_RSQ05_02CM	HELLER_HDAC_TARGETS_UP
0.277008310249%	1	361	31	T2D_GENES_TANYA_T2D_RSQ05_02CM	VALK_AML_CLUSTER_15
0.277008310249%	1	361	31	T2D_GENES_TANYA_T2D_RSQ05_02CM	TING_SILENCED_BY_DICER
0.277008310249%	1	361	31	T2D_GENES_TANYA_T2D_RSQ05_02CM	THEODOROU_MAMMARY_TUMORIGENESIS
0.277008310249%	1	361	31	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.277008310249%	1	361	31	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES
0.277008310249%	1	361	31	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_AVB3_OPN_PATHWAY
0.277008310249%	1	361	31	T2D_GENES_TANYA_T2D_RSQ05_02CM	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.277008310249%	1	361	31	T2D_GENES_TANYA_T2D_RSQ05_02CM	MOSERLE_IFNA_RESPONSE
0.277008310249%	1	361	31	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM
0.277008310249%	1	361	31	T2D_GENES_TANYA_T2D_RSQ05_02CM	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER
0.277008310249%	1	361	31	T2D_GENES_TANYA_T2D_RSQ05_02CM	DANG_MYC_TARGETS_DN
0.277008310249%	1	361	31	T2D_GENES_TANYA_T2D_RSQ05_02CM	CAFFAREL_RESPONSE_TO_THC_DN
0.277008310249%	1	361	31	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_PYK2_PATHWAY
0.277008310249%	1	361	31	T2D_GENES_TANYA_T2D_RSQ05_02CM	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.277008310249%	1	361	308	T2D_GENES_TANYA_T2D_RSQ05_02CM	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN
0.277008310249%	1	361	306	T2D_GENES_TANYA_T2D_RSQ05_02CM	HORIUCHI_WTAP_TARGETS_UP
0.277008310249%	1	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.277008310249%	1	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN
0.277008310249%	1	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	VALK_AML_CLUSTER_13
0.277008310249%	1	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	TSENG_ADIPOGENIC_POTENTIAL_UP
0.277008310249%	1	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_NOD1_2_SIGNALING_PATHWAY
0.277008310249%	1	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
0.277008310249%	1	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_DNA_STRAND_ELONGATION
0.277008310249%	1	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_CA_DEPENDENT_EVENTS
0.277008310249%	1	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_IL2_STAT5PATHWAY
0.277008310249%	1	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_IGF1_PATHWAY
0.277008310249%	1	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP
0.277008310249%	1	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	LI_PROSTATE_CANCER_EPIGENETIC
0.277008310249%	1	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	KYNG_NORMAL_AGING_DN
0.277008310249%	1	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
0.277008310249%	1	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	DASU_IL6_SIGNALING_SCAR_UP
0.277008310249%	1	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	BURTON_ADIPOGENESIS_10
0.277008310249%	1	361	30	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_FAS_PATHWAY
0.277008310249%	1	361	299	T2D_GENES_TANYA_T2D_RSQ05_02CM	WALLACE_PROSTATE_CANCER_RACE_UP
0.277008310249%	1	361	29	T2D_GENES_TANYA_T2D_RSQ05_02CM	YU_BAP1_TARGETS
0.277008310249%	1	361	29	T2D_GENES_TANYA_T2D_RSQ05_02CM	STANELLE_E2F1_TARGETS
0.277008310249%	1	361	29	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION
0.277008310249%	1	361	29	T2D_GENES_TANYA_T2D_RSQ05_02CM	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN
0.277008310249%	1	361	29	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_INTEGRIN2_PATHWAY
0.277008310249%	1	361	29	T2D_GENES_TANYA_T2D_RSQ05_02CM	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
0.277008310249%	1	361	29	T2D_GENES_TANYA_T2D_RSQ05_02CM	NGUYEN_NOTCH1_TARGETS_UP
0.277008310249%	1	361	29	T2D_GENES_TANYA_T2D_RSQ05_02CM	NAKAYAMA_FGF2_TARGETS
0.277008310249%	1	361	29	T2D_GENES_TANYA_T2D_RSQ05_02CM	MA_PITUITARY_FETAL_VS_ADULT_UP
0.277008310249%	1	361	29	T2D_GENES_TANYA_T2D_RSQ05_02CM	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
0.277008310249%	1	361	29	T2D_GENES_TANYA_T2D_RSQ05_02CM	KYNG_WERNER_SYNDROM_DN
0.277008310249%	1	361	29	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_VEGF_PATHWAY
0.277008310249%	1	361	29	T2D_GENES_TANYA_T2D_RSQ05_02CM	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP
0.277008310249%	1	361	282	T2D_GENES_TANYA_T2D_RSQ05_02CM	HELLER_SILENCED_BY_METHYLATION_UP
0.277008310249%	1	361	280	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_SMARCE1_TARGETS_UP
0.277008310249%	1	361	280	T2D_GENES_TANYA_T2D_RSQ05_02CM	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D
0.277008310249%	1	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	VALK_AML_CLUSTER_7
0.277008310249%	1	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	VALK_AML_CLUSTER_1
0.277008310249%	1	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS
0.277008310249%	1	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	PETROVA_PROX1_TARGETS_UP
0.277008310249%	1	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	PETRETTO_HEART_MASS_QTL_CIS_UP
0.277008310249%	1	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	OLSSON_E2F3_TARGETS_UP
0.277008310249%	1	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	LOPES_METHYLATED_IN_COLON_CANCER_DN
0.277008310249%	1	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
0.277008310249%	1	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAIRKEE_CANCER_PRONE_RESPONSE_E2
0.277008310249%	1	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN
0.277008310249%	1	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN
0.277008310249%	1	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP
0.277008310249%	1	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_PROTEASOME_PATHWAY
0.277008310249%	1	361	28	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_GH_PATHWAY
0.277008310249%	1	361	27	T2D_GENES_TANYA_T2D_RSQ05_02CM	YE_METASTATIC_LIVER_CANCER
0.277008310249%	1	361	27	T2D_GENES_TANYA_T2D_RSQ05_02CM	TERAO_AOX4_TARGETS_SKIN_DN
0.277008310249%	1	361	27	T2D_GENES_TANYA_T2D_RSQ05_02CM	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
0.277008310249%	1	361	27	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SYNTHESIS_OF_PA
0.277008310249%	1	361	27	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION
0.277008310249%	1	361	27	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS
0.277008310249%	1	361	27	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS
0.277008310249%	1	361	27	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_GLYPICAN_1PATHWAY
0.277008310249%	1	361	27	T2D_GENES_TANYA_T2D_RSQ05_02CM	LOPES_METHYLATED_IN_COLON_CANCER_UP
0.277008310249%	1	361	27	T2D_GENES_TANYA_T2D_RSQ05_02CM	LI_WILMS_TUMOR
0.277008310249%	1	361	27	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP
0.277008310249%	1	361	27	T2D_GENES_TANYA_T2D_RSQ05_02CM	BRACHAT_RESPONSE_TO_METHOTREXATE_DN
0.277008310249%	1	361	27	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_CREB_PATHWAY
0.277008310249%	1	361	267	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.277008310249%	1	361	266	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOSHIDA_LIVER_CANCER_SUBCLASS_S3
0.277008310249%	1	361	261	T2D_GENES_TANYA_T2D_RSQ05_02CM	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN
0.277008310249%	1	361	26	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHENG_FOXP3_TARGETS_UP
0.277008310249%	1	361	26	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
0.277008310249%	1	361	26	T2D_GENES_TANYA_T2D_RSQ05_02CM	VALK_AML_CLUSTER_8
0.277008310249%	1	361	26	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER
0.277008310249%	1	361	26	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_P38_MKK3_6PATHWAY
0.277008310249%	1	361	26	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_INTEGRIN_CS_PATHWAY
0.277008310249%	1	361	26	T2D_GENES_TANYA_T2D_RSQ05_02CM	NAKAMURA_CANCER_MICROENVIRONMENT_UP
0.277008310249%	1	361	26	T2D_GENES_TANYA_T2D_RSQ05_02CM	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.277008310249%	1	361	26	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_GALACTOSE_METABOLISM
0.277008310249%	1	361	26	T2D_GENES_TANYA_T2D_RSQ05_02CM	BRACHAT_RESPONSE_TO_METHOTREXATE_UP
0.277008310249%	1	361	26	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_PGC1A_PATHWAY
0.277008310249%	1	361	26	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_BAD_PATHWAY
0.277008310249%	1	361	258	T2D_GENES_TANYA_T2D_RSQ05_02CM	MASSARWEH_TAMOXIFEN_RESISTANCE_DN
0.277008310249%	1	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_BARRETTS_ESOPHAGUS_DN
0.277008310249%	1	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	VERRECCHIA_RESPONSE_TO_TGFB1_C2
0.277008310249%	1	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP
0.277008310249%	1	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE
0.277008310249%	1	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_G0_AND_EARLY_G1
0.277008310249%	1	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS
0.277008310249%	1	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_INTEGRIN_A9B1_PATHWAY
0.277008310249%	1	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	OZEN_MIR125B1_TARGETS
0.277008310249%	1	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP
0.277008310249%	1	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP
0.277008310249%	1	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_DORSO_VENTRAL_AXIS_FORMATION
0.277008310249%	1	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOEGERKORP_CD44_TARGETS_TEMPORAL_DN
0.277008310249%	1	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN
0.277008310249%	1	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.277008310249%	1	361	25	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN
0.277008310249%	1	361	245	T2D_GENES_TANYA_T2D_RSQ05_02CM	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.277008310249%	1	361	245	T2D_GENES_TANYA_T2D_RSQ05_02CM	KONDO_EZH2_TARGETS
0.277008310249%	1	361	244	T2D_GENES_TANYA_T2D_RSQ05_02CM	GAL_LEUKEMIC_STEM_CELL_DN
0.277008310249%	1	361	24	T2D_GENES_TANYA_T2D_RSQ05_02CM	WILLERT_WNT_SIGNALING
0.277008310249%	1	361	24	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS
0.277008310249%	1	361	24	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SULFUR_AMINO_ACID_METABOLISM
0.277008310249%	1	361	24	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_PYRIMIDINE_METABOLISM
0.277008310249%	1	361	24	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_KINESINS
0.277008310249%	1	361	24	T2D_GENES_TANYA_T2D_RSQ05_02CM	MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED
0.277008310249%	1	361	24	T2D_GENES_TANYA_T2D_RSQ05_02CM	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN
0.277008310249%	1	361	24	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP
0.277008310249%	1	361	24	T2D_GENES_TANYA_T2D_RSQ05_02CM	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN
0.277008310249%	1	361	24	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_CXCR4_PATHWAY
0.277008310249%	1	361	24	T2D_GENES_TANYA_T2D_RSQ05_02CM	AZARE_STAT3_TARGETS
0.277008310249%	1	361	238	T2D_GENES_TANYA_T2D_RSQ05_02CM	SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.277008310249%	1	361	23	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHANG_INTERFERON_RESPONSE
0.277008310249%	1	361	23	T2D_GENES_TANYA_T2D_RSQ05_02CM	WENG_POR_TARGETS_GLOBAL_DN
0.277008310249%	1	361	23	T2D_GENES_TANYA_T2D_RSQ05_02CM	UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.277008310249%	1	361	23	T2D_GENES_TANYA_T2D_RSQ05_02CM	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B
0.277008310249%	1	361	23	T2D_GENES_TANYA_T2D_RSQ05_02CM	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A
0.277008310249%	1	361	23	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER
0.277008310249%	1	361	23	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS
0.277008310249%	1	361	23	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_PRLSIGNALINGEVENTSPATHWAY
0.277008310249%	1	361	23	T2D_GENES_TANYA_T2D_RSQ05_02CM	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP
0.277008310249%	1	361	23	T2D_GENES_TANYA_T2D_RSQ05_02CM	HASLINGER_B_CLL_WITH_11Q23_DELETION
0.277008310249%	1	361	23	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHEN_ETV5_TARGETS_TESTIS
0.277008310249%	1	361	23	T2D_GENES_TANYA_T2D_RSQ05_02CM	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
0.277008310249%	1	361	23	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_CTCF_PATHWAY
0.277008310249%	1	361	23	T2D_GENES_TANYA_T2D_RSQ05_02CM	BILANGES_SERUM_SENSITIVE_VIA_TSC1
0.277008310249%	1	361	229	T2D_GENES_TANYA_T2D_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN
0.277008310249%	1	361	227	T2D_GENES_TANYA_T2D_RSQ05_02CM	RAO_BOUND_BY_SALL4
0.277008310249%	1	361	227	T2D_GENES_TANYA_T2D_RSQ05_02CM	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
0.277008310249%	1	361	227	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_RECENT_THYMIC_EMIGRANT
0.277008310249%	1	361	223	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.277008310249%	1	361	222	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF
0.277008310249%	1	361	222	T2D_GENES_TANYA_T2D_RSQ05_02CM	RODWELL_AGING_KIDNEY_NO_BLOOD_UP
0.277008310249%	1	361	222	T2D_GENES_TANYA_T2D_RSQ05_02CM	CAIRO_LIVER_DEVELOPMENT_DN
0.277008310249%	1	361	221	T2D_GENES_TANYA_T2D_RSQ05_02CM	PEDRIOLI_MIR31_TARGETS_UP
0.277008310249%	1	361	220	T2D_GENES_TANYA_T2D_RSQ05_02CM	RIGGINS_TAMOXIFEN_RESISTANCE_DN
0.277008310249%	1	361	22	T2D_GENES_TANYA_T2D_RSQ05_02CM	WELCH_GATA1_TARGETS
0.277008310249%	1	361	22	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP
0.277008310249%	1	361	22	T2D_GENES_TANYA_T2D_RSQ05_02CM	SPIRA_SMOKERS_LUNG_CANCER_DN
0.277008310249%	1	361	22	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
0.277008310249%	1	361	22	T2D_GENES_TANYA_T2D_RSQ05_02CM	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
0.277008310249%	1	361	22	T2D_GENES_TANYA_T2D_RSQ05_02CM	NUMATA_CSF3_SIGNALING_VIA_STAT3
0.277008310249%	1	361	22	T2D_GENES_TANYA_T2D_RSQ05_02CM	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
0.277008310249%	1	361	22	T2D_GENES_TANYA_T2D_RSQ05_02CM	MATZUK_IMPLANTATION_AND_UTERINE
0.277008310249%	1	361	22	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP
0.277008310249%	1	361	22	T2D_GENES_TANYA_T2D_RSQ05_02CM	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN
0.277008310249%	1	361	22	T2D_GENES_TANYA_T2D_RSQ05_02CM	GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION
0.277008310249%	1	361	22	T2D_GENES_TANYA_T2D_RSQ05_02CM	BRACHAT_RESPONSE_TO_CISPLATIN
0.277008310249%	1	361	22	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_CHEMICAL_PATHWAY
0.277008310249%	1	361	22	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_CERAMIDE_PATHWAY
0.277008310249%	1	361	217	T2D_GENES_TANYA_T2D_RSQ05_02CM	WONG_MITOCHONDRIA_GENE_MODULE
0.277008310249%	1	361	217	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SIGNALLING_BY_NGF
0.277008310249%	1	361	216	T2D_GENES_TANYA_T2D_RSQ05_02CM	WHITFIELD_CELL_CYCLE_G2_M
0.277008310249%	1	361	214	T2D_GENES_TANYA_T2D_RSQ05_02CM	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
0.277008310249%	1	361	213	T2D_GENES_TANYA_T2D_RSQ05_02CM	WIERENGA_STAT5A_TARGETS_DN
0.277008310249%	1	361	212	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHANG_CORE_SERUM_RESPONSE_UP
0.277008310249%	1	361	210	T2D_GENES_TANYA_T2D_RSQ05_02CM	VERHAAK_GLIOBLASTOMA_PRONEURAL
0.277008310249%	1	361	210	T2D_GENES_TANYA_T2D_RSQ05_02CM	VERHAAK_GLIOBLASTOMA_NEURAL
0.277008310249%	1	361	21	T2D_GENES_TANYA_T2D_RSQ05_02CM	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP
0.277008310249%	1	361	21	T2D_GENES_TANYA_T2D_RSQ05_02CM	STEGER_ADIPOGENESIS_UP
0.277008310249%	1	361	21	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHURINGA_STAT5A_TARGETS_UP
0.277008310249%	1	361	21	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP
0.277008310249%	1	361	21	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS
0.277008310249%	1	361	21	T2D_GENES_TANYA_T2D_RSQ05_02CM	MOOTHA_GLYCOGEN_METABOLISM
0.277008310249%	1	361	21	T2D_GENES_TANYA_T2D_RSQ05_02CM	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN
0.277008310249%	1	361	21	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_MITOCHONDRIA_PATHWAY
0.277008310249%	1	361	209	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHANG_CORE_SERUM_RESPONSE_DN
0.277008310249%	1	361	207	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_HIV_INFECTION
0.277008310249%	1	361	207	T2D_GENES_TANYA_T2D_RSQ05_02CM	KARLSSON_TGFB1_TARGETS_DN
0.277008310249%	1	361	206	T2D_GENES_TANYA_T2D_RSQ05_02CM	BILD_MYC_ONCOGENIC_SIGNATURE
0.277008310249%	1	361	205	T2D_GENES_TANYA_T2D_RSQ05_02CM	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.277008310249%	1	361	204	T2D_GENES_TANYA_T2D_RSQ05_02CM	ROME_INSULIN_TARGETS_IN_MUSCLE_DN
0.277008310249%	1	361	202	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_CISPLATIN_RESPONSE_AND_XPC_UP
0.277008310249%	1	361	201	T2D_GENES_TANYA_T2D_RSQ05_02CM	KIM_MYC_AMPLIFICATION_TARGETS_UP
0.277008310249%	1	361	20	T2D_GENES_TANYA_T2D_RSQ05_02CM	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN
0.277008310249%	1	361	20	T2D_GENES_TANYA_T2D_RSQ05_02CM	WENG_POR_TARGETS_GLOBAL_UP
0.277008310249%	1	361	20	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_RECURRENT_LIVER_CANCER_UP
0.277008310249%	1	361	20	T2D_GENES_TANYA_T2D_RSQ05_02CM	ST_WNT_CA2_CYCLIC_GMP_PATHWAY
0.277008310249%	1	361	20	T2D_GENES_TANYA_T2D_RSQ05_02CM	NIELSEN_LEIOMYOSARCOMA_CNN1_DN
0.277008310249%	1	361	20	T2D_GENES_TANYA_T2D_RSQ05_02CM	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN
0.277008310249%	1	361	20	T2D_GENES_TANYA_T2D_RSQ05_02CM	KORKOLA_YOLK_SAC_TUMOR_UP
0.277008310249%	1	361	20	T2D_GENES_TANYA_T2D_RSQ05_02CM	KIM_MYCL1_AMPLIFICATION_TARGETS_DN
0.277008310249%	1	361	20	T2D_GENES_TANYA_T2D_RSQ05_02CM	DING_LUNG_CANCER_BY_MUTATION_RATE
0.277008310249%	1	361	20	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN
0.277008310249%	1	361	199	T2D_GENES_TANYA_T2D_RSQ05_02CM	PLASARI_TGFB1_TARGETS_10HR_UP
0.277008310249%	1	361	196	T2D_GENES_TANYA_T2D_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN
0.277008310249%	1	361	196	T2D_GENES_TANYA_T2D_RSQ05_02CM	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
0.277008310249%	1	361	195	T2D_GENES_TANYA_T2D_RSQ05_02CM	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP
0.277008310249%	1	361	194	T2D_GENES_TANYA_T2D_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.277008310249%	1	361	193	T2D_GENES_TANYA_T2D_RSQ05_02CM	MOHANKUMAR_TLX1_TARGETS_DN
0.277008310249%	1	361	191	T2D_GENES_TANYA_T2D_RSQ05_02CM	RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.277008310249%	1	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE
0.277008310249%	1	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN
0.277008310249%	1	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	VERNOCHET_ADIPOGENESIS
0.277008310249%	1	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	STREICHER_LSM1_TARGETS_DN
0.277008310249%	1	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1
0.277008310249%	1	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_HIF1APATHWAY
0.277008310249%	1	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_EPHA2_FWDPATHWAY
0.277008310249%	1	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	OUYANG_PROSTATE_CANCER_MARKERS
0.277008310249%	1	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	NELSON_RESPONSE_TO_ANDROGEN_DN
0.277008310249%	1	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	MELLMAN_TUT1_TARGETS_UP
0.277008310249%	1	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	MA_PITUITARY_FETAL_VS_ADULT_DN
0.277008310249%	1	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	MATZUK_EMBRYONIC_GERM_CELL
0.277008310249%	1	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	JEON_SMAD6_TARGETS_DN
0.277008310249%	1	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_STATHMIN_PATHWAY
0.277008310249%	1	361	19	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_MAL_PATHWAY
0.277008310249%	1	361	188	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
0.277008310249%	1	361	188	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.277008310249%	1	361	186	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_CLIM2_TARGETS_DN
0.277008310249%	1	361	185	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_HUNTINGTONS_DISEASE
0.277008310249%	1	361	185	T2D_GENES_TANYA_T2D_RSQ05_02CM	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
0.277008310249%	1	361	184	T2D_GENES_TANYA_T2D_RSQ05_02CM	DOANE_RESPONSE_TO_ANDROGEN_UP
0.277008310249%	1	361	182	T2D_GENES_TANYA_T2D_RSQ05_02CM	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
0.277008310249%	1	361	181	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17
0.277008310249%	1	361	181	T2D_GENES_TANYA_T2D_RSQ05_02CM	JISON_SICKLE_CELL_DISEASE_UP
0.277008310249%	1	361	18	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHENG_RESPONSE_TO_ARSENITE_UP
0.277008310249%	1	361	18	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE
0.277008310249%	1	361	18	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS
0.277008310249%	1	361	18	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB
0.277008310249%	1	361	18	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI
0.277008310249%	1	361	18	T2D_GENES_TANYA_T2D_RSQ05_02CM	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN
0.277008310249%	1	361	18	T2D_GENES_TANYA_T2D_RSQ05_02CM	MOREIRA_RESPONSE_TO_TSA_DN
0.277008310249%	1	361	18	T2D_GENES_TANYA_T2D_RSQ05_02CM	KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.277008310249%	1	361	18	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_TEL_PATHWAY
0.277008310249%	1	361	18	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_PTEN_PATHWAY
0.277008310249%	1	361	18	T2D_GENES_TANYA_T2D_RSQ05_02CM	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP
0.277008310249%	1	361	179	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE
0.277008310249%	1	361	178	T2D_GENES_TANYA_T2D_RSQ05_02CM	LI_AMPLIFIED_IN_LUNG_CANCER
0.277008310249%	1	361	176	T2D_GENES_TANYA_T2D_RSQ05_02CM	SASAKI_ADULT_T_CELL_LEUKEMIA
0.277008310249%	1	361	176	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX
0.277008310249%	1	361	175	T2D_GENES_TANYA_T2D_RSQ05_02CM	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.277008310249%	1	361	175	T2D_GENES_TANYA_T2D_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.277008310249%	1	361	175	T2D_GENES_TANYA_T2D_RSQ05_02CM	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
0.277008310249%	1	361	172	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_MITOTIC_M_M_G1_PHASES
0.277008310249%	1	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	WIKMAN_ASBESTOS_LUNG_CANCER_UP
0.277008310249%	1	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN
0.277008310249%	1	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE
0.277008310249%	1	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR
0.277008310249%	1	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_RAP1_SIGNALLING
0.277008310249%	1	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_INFLAMMASOMES
0.277008310249%	1	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS
0.277008310249%	1	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_INTEGRIN5_PATHWAY
0.277008310249%	1	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	MEISSNER_BRAIN_HCP_WITH_H3K4ME2
0.277008310249%	1	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN
0.277008310249%	1	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
0.277008310249%	1	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN
0.277008310249%	1	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	LE_SKI_TARGETS_UP
0.277008310249%	1	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOWLIN_CITED1_TARGETS_2_UP
0.277008310249%	1	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	GALE_APL_WITH_FLT3_MUTATED_DN
0.277008310249%	1	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_IL7_PATHWAY
0.277008310249%	1	361	17	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_ARF_PATHWAY
0.277008310249%	1	361	169	T2D_GENES_TANYA_T2D_RSQ05_02CM	ONDER_CDH1_TARGETS_1_DN
0.277008310249%	1	361	169	T2D_GENES_TANYA_T2D_RSQ05_02CM	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP
0.277008310249%	1	361	169	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_ALZHEIMERS_DISEASE
0.277008310249%	1	361	169	T2D_GENES_TANYA_T2D_RSQ05_02CM	KATSANOU_ELAVL1_TARGETS_UP
0.277008310249%	1	361	167	T2D_GENES_TANYA_T2D_RSQ05_02CM	TIEN_INTESTINE_PROBIOTICS_6HR_DN
0.277008310249%	1	361	166	T2D_GENES_TANYA_T2D_RSQ05_02CM	SMIRNOV_RESPONSE_TO_IR_6HR_UP
0.277008310249%	1	361	165	T2D_GENES_TANYA_T2D_RSQ05_02CM	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.277008310249%	1	361	165	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWN_MYELOID_CELL_DEVELOPMENT_UP
0.277008310249%	1	361	164	T2D_GENES_TANYA_T2D_RSQ05_02CM	KIM_WT1_TARGETS_8HR_UP
0.277008310249%	1	361	163	T2D_GENES_TANYA_T2D_RSQ05_02CM	SERVITJA_ISLET_HNF1A_TARGETS_UP
0.277008310249%	1	361	163	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIN_NPAS4_TARGETS_UP
0.277008310249%	1	361	162	T2D_GENES_TANYA_T2D_RSQ05_02CM	KIM_WT1_TARGETS_12HR_UP
0.277008310249%	1	361	162	T2D_GENES_TANYA_T2D_RSQ05_02CM	DARWICHE_PAPILLOMA_RISK_LOW_UP
0.277008310249%	1	361	161	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_MRNA_PROCESSING
0.277008310249%	1	361	161	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIDUS_METASTASIS_DN
0.277008310249%	1	361	160	T2D_GENES_TANYA_T2D_RSQ05_02CM	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
0.277008310249%	1	361	160	T2D_GENES_TANYA_T2D_RSQ05_02CM	GAVIN_FOXP3_TARGETS_CLUSTER_P3
0.277008310249%	1	361	160	T2D_GENES_TANYA_T2D_RSQ05_02CM	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
0.277008310249%	1	361	16	T2D_GENES_TANYA_T2D_RSQ05_02CM	XU_RESPONSE_TO_TRETINOIN_UP
0.277008310249%	1	361	16	T2D_GENES_TANYA_T2D_RSQ05_02CM	WONG_IFNA2_RESISTANCE_UP
0.277008310249%	1	361	16	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
0.277008310249%	1	361	16	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI
0.277008310249%	1	361	16	T2D_GENES_TANYA_T2D_RSQ05_02CM	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS
0.277008310249%	1	361	16	T2D_GENES_TANYA_T2D_RSQ05_02CM	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA
0.277008310249%	1	361	16	T2D_GENES_TANYA_T2D_RSQ05_02CM	LY_AGING_MIDDLE_DN
0.277008310249%	1	361	16	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIU_TOPBP1_TARGETS
0.277008310249%	1	361	16	T2D_GENES_TANYA_T2D_RSQ05_02CM	HAHTOLA_MYCOSIS_FUNGOIDES_DN
0.277008310249%	1	361	16	T2D_GENES_TANYA_T2D_RSQ05_02CM	FUKUSHIMA_TNFSF11_TARGETS
0.277008310249%	1	361	16	T2D_GENES_TANYA_T2D_RSQ05_02CM	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL
0.277008310249%	1	361	16	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_P53_PATHWAY
0.277008310249%	1	361	16	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_CACAM_PATHWAY
0.277008310249%	1	361	16	T2D_GENES_TANYA_T2D_RSQ05_02CM	BAKER_HEMATOPOIESIS_STAT3_TARGETS
0.277008310249%	1	361	159	T2D_GENES_TANYA_T2D_RSQ05_02CM	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
0.277008310249%	1	361	157	T2D_GENES_TANYA_T2D_RSQ05_02CM	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
0.277008310249%	1	361	156	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_14HR_UP
0.277008310249%	1	361	155	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_JAK_STAT_SIGNALING_PATHWAY
0.277008310249%	1	361	153	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
0.277008310249%	1	361	152	T2D_GENES_TANYA_T2D_RSQ05_02CM	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
0.277008310249%	1	361	151	T2D_GENES_TANYA_T2D_RSQ05_02CM	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
0.277008310249%	1	361	150	T2D_GENES_TANYA_T2D_RSQ05_02CM	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
0.277008310249%	1	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN
0.277008310249%	1	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	WEBER_METHYLATED_LCP_IN_SPERM_UP
0.277008310249%	1	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	SU_KIDNEY
0.277008310249%	1	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	STEINER_ERYTHROCYTE_MEMBRANE_GENES
0.277008310249%	1	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP
0.277008310249%	1	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	SA_G1_AND_S_PHASES
0.277008310249%	1	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION
0.277008310249%	1	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS
0.277008310249%	1	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_METABOLISM_OF_POLYAMINES
0.277008310249%	1	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII
0.277008310249%	1	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_LPA4_PATHWAY
0.277008310249%	1	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	MARKS_HDAC_TARGETS_DN
0.277008310249%	1	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN
0.277008310249%	1	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN
0.277008310249%	1	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_NUCLEARRS_PATHWAY
0.277008310249%	1	361	15	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_HSP27_PATHWAY
0.277008310249%	1	361	149	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
0.277008310249%	1	361	148	T2D_GENES_TANYA_T2D_RSQ05_02CM	WHITFIELD_CELL_CYCLE_M_G1
0.277008310249%	1	361	148	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_24HR_DN
0.277008310249%	1	361	147	T2D_GENES_TANYA_T2D_RSQ05_02CM	RASHI_RESPONSE_TO_IONIZING_RADIATION_5
0.277008310249%	1	361	146	T2D_GENES_TANYA_T2D_RSQ05_02CM	PECE_MAMMARY_STEM_CELL_DN
0.277008310249%	1	361	146	T2D_GENES_TANYA_T2D_RSQ05_02CM	LEE_NEURAL_CREST_STEM_CELL_UP
0.277008310249%	1	361	146	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
0.277008310249%	1	361	145	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHANG_BREAST_CANCER_PROGENITORS_DN
0.277008310249%	1	361	145	T2D_GENES_TANYA_T2D_RSQ05_02CM	SMITH_TERT_TARGETS_UP
0.277008310249%	1	361	145	T2D_GENES_TANYA_T2D_RSQ05_02CM	RODWELL_AGING_KIDNEY_DN
0.277008310249%	1	361	143	T2D_GENES_TANYA_T2D_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.277008310249%	1	361	143	T2D_GENES_TANYA_T2D_RSQ05_02CM	DANG_MYC_TARGETS_UP
0.277008310249%	1	361	143	T2D_GENES_TANYA_T2D_RSQ05_02CM	BASSO_B_LYMPHOCYTE_NETWORK
0.277008310249%	1	361	142	T2D_GENES_TANYA_T2D_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.277008310249%	1	361	142	T2D_GENES_TANYA_T2D_RSQ05_02CM	RUIZ_TNC_TARGETS_DN
0.277008310249%	1	361	142	T2D_GENES_TANYA_T2D_RSQ05_02CM	PENG_LEUCINE_DEPRIVATION_UP
0.277008310249%	1	361	142	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_ES_LCP_WITH_H3K4ME3
0.277008310249%	1	361	142	T2D_GENES_TANYA_T2D_RSQ05_02CM	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.277008310249%	1	361	141	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
0.277008310249%	1	361	141	T2D_GENES_TANYA_T2D_RSQ05_02CM	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP
0.277008310249%	1	361	140	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
0.277008310249%	1	361	140	T2D_GENES_TANYA_T2D_RSQ05_02CM	JOHNSTONE_PARVB_TARGETS_2_UP
0.277008310249%	1	361	140	T2D_GENES_TANYA_T2D_RSQ05_02CM	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
0.277008310249%	1	361	14	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR
0.277008310249%	1	361	14	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP
0.277008310249%	1	361	14	T2D_GENES_TANYA_T2D_RSQ05_02CM	ROETH_TERT_TARGETS_UP
0.277008310249%	1	361	14	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_N_GLYCAN_ANTENNAE_ELONGATION
0.277008310249%	1	361	14	T2D_GENES_TANYA_T2D_RSQ05_02CM	KINNEY_DNMT1_METHYLATION_TARGETS
0.277008310249%	1	361	14	T2D_GENES_TANYA_T2D_RSQ05_02CM	CASTELLANO_NRAS_TARGETS_DN
0.277008310249%	1	361	14	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_PS1_PATHWAY
0.277008310249%	1	361	14	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_CELL2CELL_PATHWAY
0.277008310249%	1	361	138	T2D_GENES_TANYA_T2D_RSQ05_02CM	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
0.277008310249%	1	361	137	T2D_GENES_TANYA_T2D_RSQ05_02CM	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
0.277008310249%	1	361	137	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
0.277008310249%	1	361	137	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_INSULIN_SIGNALING_PATHWAY
0.277008310249%	1	361	136	T2D_GENES_TANYA_T2D_RSQ05_02CM	PROVENZANI_METASTASIS_DN
0.277008310249%	1	361	135	T2D_GENES_TANYA_T2D_RSQ05_02CM	TSENG_IRS1_TARGETS_DN
0.277008310249%	1	361	134	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHLOSSER_SERUM_RESPONSE_UP
0.277008310249%	1	361	134	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_TIGHT_JUNCTION
0.277008310249%	1	361	133	T2D_GENES_TANYA_T2D_RSQ05_02CM	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON
0.277008310249%	1	361	133	T2D_GENES_TANYA_T2D_RSQ05_02CM	GAL_LEUKEMIC_STEM_CELL_UP
0.277008310249%	1	361	132	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS
0.277008310249%	1	361	132	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
0.277008310249%	1	361	130	T2D_GENES_TANYA_T2D_RSQ05_02CM	YAGI_AML_WITH_T_9_11_TRANSLOCATION
0.277008310249%	1	361	13	T2D_GENES_TANYA_T2D_RSQ05_02CM	VERRECCHIA_RESPONSE_TO_TGFB1_C4
0.277008310249%	1	361	13	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
0.277008310249%	1	361	13	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY
0.277008310249%	1	361	13	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY
0.277008310249%	1	361	13	T2D_GENES_TANYA_T2D_RSQ05_02CM	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
0.277008310249%	1	361	13	T2D_GENES_TANYA_T2D_RSQ05_02CM	GERHOLD_RESPONSE_TO_TZD_DN
0.277008310249%	1	361	13	T2D_GENES_TANYA_T2D_RSQ05_02CM	FRIDMAN_SENESCENCE_DN
0.277008310249%	1	361	13	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_PARKIN_PATHWAY
0.277008310249%	1	361	129	T2D_GENES_TANYA_T2D_RSQ05_02CM	KIM_WT1_TARGETS_8HR_DN
0.277008310249%	1	361	127	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
0.277008310249%	1	361	126	T2D_GENES_TANYA_T2D_RSQ05_02CM	SANSOM_APC_TARGETS_UP
0.277008310249%	1	361	126	T2D_GENES_TANYA_T2D_RSQ05_02CM	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN
0.277008310249%	1	361	126	T2D_GENES_TANYA_T2D_RSQ05_02CM	MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.277008310249%	1	361	126	T2D_GENES_TANYA_T2D_RSQ05_02CM	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.277008310249%	1	361	123	T2D_GENES_TANYA_T2D_RSQ05_02CM	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.277008310249%	1	361	123	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAZARD_RESPONSE_TO_UV_SCC_UP
0.277008310249%	1	361	123	T2D_GENES_TANYA_T2D_RSQ05_02CM	DAZARD_RESPONSE_TO_UV_SCC_DN
0.277008310249%	1	361	122	T2D_GENES_TANYA_T2D_RSQ05_02CM	TOOKER_GEMCITABINE_RESISTANCE_DN
0.277008310249%	1	361	121	T2D_GENES_TANYA_T2D_RSQ05_02CM	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.277008310249%	1	361	121	T2D_GENES_TANYA_T2D_RSQ05_02CM	RODRIGUES_DCC_TARGETS_DN
0.277008310249%	1	361	121	T2D_GENES_TANYA_T2D_RSQ05_02CM	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
0.277008310249%	1	361	121	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
0.277008310249%	1	361	120	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.277008310249%	1	361	120	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHEBOTAEV_GR_TARGETS_DN
0.277008310249%	1	361	12	T2D_GENES_TANYA_T2D_RSQ05_02CM	WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP
0.277008310249%	1	361	12	T2D_GENES_TANYA_T2D_RSQ05_02CM	WAESCH_ANAPHASE_PROMOTING_COMPLEX
0.277008310249%	1	361	12	T2D_GENES_TANYA_T2D_RSQ05_02CM	TAGHAVI_NEOPLASTIC_TRANSFORMATION
0.277008310249%	1	361	12	T2D_GENES_TANYA_T2D_RSQ05_02CM	SA_PROGRAMMED_CELL_DEATH
0.277008310249%	1	361	12	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SIGNALING_BY_NOTCH2
0.277008310249%	1	361	12	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR
0.277008310249%	1	361	12	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_CS_DS_DEGRADATION
0.277008310249%	1	361	12	T2D_GENES_TANYA_T2D_RSQ05_02CM	MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP
0.277008310249%	1	361	12	T2D_GENES_TANYA_T2D_RSQ05_02CM	FUNG_IL2_SIGNALING_2
0.277008310249%	1	361	12	T2D_GENES_TANYA_T2D_RSQ05_02CM	EHLERS_ANEUPLOIDY_DN
0.277008310249%	1	361	12	T2D_GENES_TANYA_T2D_RSQ05_02CM	CLAUS_PGR_POSITIVE_MENINGIOMA_DN
0.277008310249%	1	361	12	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_AKAP13_PATHWAY
0.277008310249%	1	361	119	T2D_GENES_TANYA_T2D_RSQ05_02CM	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
0.277008310249%	1	361	118	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
0.277008310249%	1	361	118	T2D_GENES_TANYA_T2D_RSQ05_02CM	CERVERA_SDHB_TARGETS_1_UP
0.277008310249%	1	361	117	T2D_GENES_TANYA_T2D_RSQ05_02CM	PUJANA_BRCA_CENTERED_NETWORK
0.277008310249%	1	361	117	T2D_GENES_TANYA_T2D_RSQ05_02CM	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.277008310249%	1	361	116	T2D_GENES_TANYA_T2D_RSQ05_02CM	MATTIOLI_MGUS_VS_PCL
0.277008310249%	1	361	116	T2D_GENES_TANYA_T2D_RSQ05_02CM	IKEDA_MIR30_TARGETS_UP
0.277008310249%	1	361	116	T2D_GENES_TANYA_T2D_RSQ05_02CM	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
0.277008310249%	1	361	115	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
0.277008310249%	1	361	115	T2D_GENES_TANYA_T2D_RSQ05_02CM	JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP
0.277008310249%	1	361	115	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOELZEL_NF1_TARGETS_DN
0.277008310249%	1	361	114	T2D_GENES_TANYA_T2D_RSQ05_02CM	SMIRNOV_RESPONSE_TO_IR_6HR_DN
0.277008310249%	1	361	114	T2D_GENES_TANYA_T2D_RSQ05_02CM	ROPERO_HDAC2_TARGETS
0.277008310249%	1	361	114	T2D_GENES_TANYA_T2D_RSQ05_02CM	MATZUK_SPERMATOZOA
0.277008310249%	1	361	114	T2D_GENES_TANYA_T2D_RSQ05_02CM	BOSCO_TH1_CYTOTOXIC_MODULE
0.277008310249%	1	361	113	T2D_GENES_TANYA_T2D_RSQ05_02CM	TSENG_IRS1_TARGETS_UP
0.277008310249%	1	361	113	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
0.277008310249%	1	361	112	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SIGNALING_BY_FGFR
0.277008310249%	1	361	112	T2D_GENES_TANYA_T2D_RSQ05_02CM	PASINI_SUZ12_TARGETS_UP
0.277008310249%	1	361	112	T2D_GENES_TANYA_T2D_RSQ05_02CM	LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.277008310249%	1	361	112	T2D_GENES_TANYA_T2D_RSQ05_02CM	LABBE_WNT3A_TARGETS_UP
0.277008310249%	1	361	112	T2D_GENES_TANYA_T2D_RSQ05_02CM	DOANE_BREAST_CANCER_ESR1_UP
0.277008310249%	1	361	112	T2D_GENES_TANYA_T2D_RSQ05_02CM	DITTMER_PTHLH_TARGETS_UP
0.277008310249%	1	361	111	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_MRNA_SPLICING
0.277008310249%	1	361	111	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_GLYCOSAMINOGLYCAN_METABOLISM
0.277008310249%	1	361	111	T2D_GENES_TANYA_T2D_RSQ05_02CM	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.277008310249%	1	361	110	T2D_GENES_TANYA_T2D_RSQ05_02CM	WOOD_EBV_EBNA1_TARGETS_UP
0.277008310249%	1	361	110	T2D_GENES_TANYA_T2D_RSQ05_02CM	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
0.277008310249%	1	361	110	T2D_GENES_TANYA_T2D_RSQ05_02CM	GHANDHI_DIRECT_IRRADIATION_UP
0.277008310249%	1	361	11	T2D_GENES_TANYA_T2D_RSQ05_02CM	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP
0.277008310249%	1	361	11	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM
0.277008310249%	1	361	11	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_UNWINDING_OF_DNA
0.277008310249%	1	361	11	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_INTEGRIN4_PATHWAY
0.277008310249%	1	361	11	T2D_GENES_TANYA_T2D_RSQ05_02CM	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29
0.277008310249%	1	361	11	T2D_GENES_TANYA_T2D_RSQ05_02CM	LIANG_SILENCED_BY_METHYLATION_DN
0.277008310249%	1	361	11	T2D_GENES_TANYA_T2D_RSQ05_02CM	CAFFAREL_RESPONSE_TO_THC_8HR_5_DN
0.277008310249%	1	361	11	T2D_GENES_TANYA_T2D_RSQ05_02CM	BIOCARTA_LEPTIN_PATHWAY
0.277008310249%	1	361	109	T2D_GENES_TANYA_T2D_RSQ05_02CM	SERVITJA_ISLET_HNF1A_TARGETS_DN
0.277008310249%	1	361	109	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
0.277008310249%	1	361	109	T2D_GENES_TANYA_T2D_RSQ05_02CM	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
0.277008310249%	1	361	108	T2D_GENES_TANYA_T2D_RSQ05_02CM	ZHANG_TLX_TARGETS_DN
0.277008310249%	1	361	108	T2D_GENES_TANYA_T2D_RSQ05_02CM	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.277008310249%	1	361	108	T2D_GENES_TANYA_T2D_RSQ05_02CM	JAZAG_TGFB1_SIGNALING_UP
0.277008310249%	1	361	108	T2D_GENES_TANYA_T2D_RSQ05_02CM	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN
0.277008310249%	1	361	107	T2D_GENES_TANYA_T2D_RSQ05_02CM	SESTO_RESPONSE_TO_UV_C0
0.277008310249%	1	361	106	T2D_GENES_TANYA_T2D_RSQ05_02CM	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
0.277008310249%	1	361	105	T2D_GENES_TANYA_T2D_RSQ05_02CM	STEIN_ESRRA_TARGETS_DN
0.277008310249%	1	361	105	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_8HR_UP
0.277008310249%	1	361	105	T2D_GENES_TANYA_T2D_RSQ05_02CM	AMUNDSON_GENOTOXIC_SIGNATURE
0.277008310249%	1	361	104	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
0.277008310249%	1	361	103	T2D_GENES_TANYA_T2D_RSQ05_02CM	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
0.277008310249%	1	361	103	T2D_GENES_TANYA_T2D_RSQ05_02CM	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
0.277008310249%	1	361	102	T2D_GENES_TANYA_T2D_RSQ05_02CM	PID_CXCR4_PATHWAY
0.277008310249%	1	361	102	T2D_GENES_TANYA_T2D_RSQ05_02CM	LABBE_TGFB1_TARGETS_UP
0.277008310249%	1	361	101	T2D_GENES_TANYA_T2D_RSQ05_02CM	WIELAND_UP_BY_HBV_INFECTION
0.277008310249%	1	361	101	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_SIGNALING_BY_ERBB2
0.277008310249%	1	361	101	T2D_GENES_TANYA_T2D_RSQ05_02CM	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
0.277008310249%	1	361	101	T2D_GENES_TANYA_T2D_RSQ05_02CM	GRADE_COLON_AND_RECTAL_CANCER_DN
0.277008310249%	1	361	101	T2D_GENES_TANYA_T2D_RSQ05_02CM	BROWNE_HCMV_INFECTION_20HR_DN
0.277008310249%	1	361	101	T2D_GENES_TANYA_T2D_RSQ05_02CM	BASSO_CD40_SIGNALING_UP
0.277008310249%	1	361	100	T2D_GENES_TANYA_T2D_RSQ05_02CM	WINZEN_DEGRADED_VIA_KHSRP
0.277008310249%	1	361	100	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
0.277008310249%	1	361	100	T2D_GENES_TANYA_T2D_RSQ05_02CM	QI_PLASMACYTOMA_DN
0.277008310249%	1	361	100	T2D_GENES_TANYA_T2D_RSQ05_02CM	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
0.277008310249%	1	361	100	T2D_GENES_TANYA_T2D_RSQ05_02CM	CHICAS_RB1_TARGETS_LOW_SERUM
0.277008310249%	1	361	10	T2D_GENES_TANYA_T2D_RSQ05_02CM	SHANK_TAL1_TARGETS_DN
0.277008310249%	1	361	10	T2D_GENES_TANYA_T2D_RSQ05_02CM	REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY
0.277008310249%	1	361	10	T2D_GENES_TANYA_T2D_RSQ05_02CM	OXFORD_RALA_AND_RALB_TARGETS_UP
0.277008310249%	1	361	10	T2D_GENES_TANYA_T2D_RSQ05_02CM	OSAWA_TNF_TARGETS
0.277008310249%	1	361	10	T2D_GENES_TANYA_T2D_RSQ05_02CM	MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY
0.277008310249%	1	361	10	T2D_GENES_TANYA_T2D_RSQ05_02CM	KONG_E2F1_TARGETS
0.277008310249%	1	361	10	T2D_GENES_TANYA_T2D_RSQ05_02CM	IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.277008310249%	1	361	10	T2D_GENES_TANYA_T2D_RSQ05_02CM	HOLLEMAN_DAUNORUBICIN_B_ALL_UP
0.277008310249%	1	361	10	T2D_GENES_TANYA_T2D_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN
0.277008310249%	1	361	10	T2D_GENES_TANYA_T2D_RSQ05_02CM	BAKER_HEMATOPOESIS_STAT1_TARGETS
0.275988960442%	6	2174	98	T2D_GENES_TANYA_LIPIDS	CROONQUIST_IL6_DEPRIVATION_DN
0.275988960442%	6	2174	97	T2D_GENES_TANYA_LIPIDS	LABBE_WNT3A_TARGETS_DN
0.275988960442%	6	2174	95	T2D_GENES_TANYA_LIPIDS	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
0.275988960442%	6	2174	94	T2D_GENES_TANYA_LIPIDS	GAVIN_FOXP3_TARGETS_CLUSTER_T4
0.275988960442%	6	2174	89	T2D_GENES_TANYA_LIPIDS	ZHANG_TLX_TARGETS_UP
0.275988960442%	6	2174	88	T2D_GENES_TANYA_LIPIDS	TIEN_INTESTINE_PROBIOTICS_2HR_DN
0.275988960442%	6	2174	88	T2D_GENES_TANYA_LIPIDS	REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS
0.275988960442%	6	2174	87	T2D_GENES_TANYA_LIPIDS	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
0.275988960442%	6	2174	87	T2D_GENES_TANYA_LIPIDS	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.275988960442%	6	2174	86	T2D_GENES_TANYA_LIPIDS	NELSON_RESPONSE_TO_ANDROGEN_UP
0.275988960442%	6	2174	84	T2D_GENES_TANYA_LIPIDS	REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S
0.275988960442%	6	2174	82	T2D_GENES_TANYA_LIPIDS	BHAT_ESR1_TARGETS_VIA_AKT1_DN
0.275988960442%	6	2174	81	T2D_GENES_TANYA_LIPIDS	MAHAJAN_RESPONSE_TO_IL1A_UP
0.275988960442%	6	2174	80	T2D_GENES_TANYA_LIPIDS	BASSO_HAIRY_CELL_LEUKEMIA_DN
0.275988960442%	6	2174	79	T2D_GENES_TANYA_LIPIDS	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
0.275988960442%	6	2174	79	T2D_GENES_TANYA_LIPIDS	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
0.275988960442%	6	2174	78	T2D_GENES_TANYA_LIPIDS	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
0.275988960442%	6	2174	77	T2D_GENES_TANYA_LIPIDS	SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.275988960442%	6	2174	77	T2D_GENES_TANYA_LIPIDS	RIZ_ERYTHROID_DIFFERENTIATION
0.275988960442%	6	2174	76	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
0.275988960442%	6	2174	74	T2D_GENES_TANYA_LIPIDS	WESTON_VEGFA_TARGETS_3HR
0.275988960442%	6	2174	74	T2D_GENES_TANYA_LIPIDS	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS
0.275988960442%	6	2174	74	T2D_GENES_TANYA_LIPIDS	LIAN_LIPA_TARGETS_6M
0.275988960442%	6	2174	74	T2D_GENES_TANYA_LIPIDS	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
0.275988960442%	6	2174	74	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER_DENA_DN
0.275988960442%	6	2174	73	T2D_GENES_TANYA_LIPIDS	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.275988960442%	6	2174	70	T2D_GENES_TANYA_LIPIDS	VERNELL_RETINOBLASTOMA_PATHWAY_UP
0.275988960442%	6	2174	70	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_NOTCH1
0.275988960442%	6	2174	69	T2D_GENES_TANYA_LIPIDS	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.275988960442%	6	2174	69	T2D_GENES_TANYA_LIPIDS	BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE
0.275988960442%	6	2174	68	T2D_GENES_TANYA_LIPIDS	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
0.275988960442%	6	2174	67	T2D_GENES_TANYA_LIPIDS	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP
0.275988960442%	6	2174	66	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
0.275988960442%	6	2174	66	T2D_GENES_TANYA_LIPIDS	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
0.275988960442%	6	2174	65	T2D_GENES_TANYA_LIPIDS	GOLDRATH_IMMUNE_MEMORY
0.275988960442%	6	2174	65	T2D_GENES_TANYA_LIPIDS	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS
0.275988960442%	6	2174	64	T2D_GENES_TANYA_LIPIDS	RIZKI_TUMOR_INVASIVENESS_2D_DN
0.275988960442%	6	2174	63	T2D_GENES_TANYA_LIPIDS	PID_MYC_REPRESSPATHWAY
0.275988960442%	6	2174	63	T2D_GENES_TANYA_LIPIDS	MODY_HIPPOCAMPUS_POSTNATAL
0.275988960442%	6	2174	62	T2D_GENES_TANYA_LIPIDS	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
0.275988960442%	6	2174	62	T2D_GENES_TANYA_LIPIDS	MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN
0.275988960442%	6	2174	62	T2D_GENES_TANYA_LIPIDS	KORKOLA_YOLK_SAC_TUMOR
0.275988960442%	6	2174	62	T2D_GENES_TANYA_LIPIDS	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.275988960442%	6	2174	61	T2D_GENES_TANYA_LIPIDS	MASSARWEH_RESPONSE_TO_ESTRADIOL
0.275988960442%	6	2174	60	T2D_GENES_TANYA_LIPIDS	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
0.275988960442%	6	2174	60	T2D_GENES_TANYA_LIPIDS	OUILLETTE_CLL_13Q14_DELETION_DN
0.275988960442%	6	2174	60	T2D_GENES_TANYA_LIPIDS	AMIT_EGF_RESPONSE_240_HELA
0.275988960442%	6	2174	59	T2D_GENES_TANYA_LIPIDS	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
0.275988960442%	6	2174	59	T2D_GENES_TANYA_LIPIDS	PID_NOTCH_PATHWAY
0.275988960442%	6	2174	59	T2D_GENES_TANYA_LIPIDS	ELVIDGE_HYPOXIA_BY_DMOG_DN
0.275988960442%	6	2174	59	T2D_GENES_TANYA_LIPIDS	ASTIER_INTEGRIN_SIGNALING
0.275988960442%	6	2174	58	T2D_GENES_TANYA_LIPIDS	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
0.275988960442%	6	2174	58	T2D_GENES_TANYA_LIPIDS	SCHEIDEREIT_IKK_INTERACTING_PROTEINS
0.275988960442%	6	2174	58	T2D_GENES_TANYA_LIPIDS	NAGASHIMA_NRG1_SIGNALING_DN
0.275988960442%	6	2174	58	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_NPC_LCP_WITH_H3K4ME3
0.275988960442%	6	2174	57	T2D_GENES_TANYA_LIPIDS	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP
0.275988960442%	6	2174	57	T2D_GENES_TANYA_LIPIDS	DIRMEIER_LMP1_RESPONSE_LATE_UP
0.275988960442%	6	2174	57	T2D_GENES_TANYA_LIPIDS	BORLAK_LIVER_CANCER_EGF_UP
0.275988960442%	6	2174	56	T2D_GENES_TANYA_LIPIDS	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP
0.275988960442%	6	2174	56	T2D_GENES_TANYA_LIPIDS	LY_AGING_OLD_DN
0.275988960442%	6	2174	56	T2D_GENES_TANYA_LIPIDS	GALE_APL_WITH_FLT3_MUTATED_UP
0.275988960442%	6	2174	55	T2D_GENES_TANYA_LIPIDS	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.275988960442%	6	2174	55	T2D_GENES_TANYA_LIPIDS	PID_TGFBRPATHWAY
0.275988960442%	6	2174	54	T2D_GENES_TANYA_LIPIDS	ZHOU_TNF_SIGNALING_30MIN
0.275988960442%	6	2174	54	T2D_GENES_TANYA_LIPIDS	KANG_DOXORUBICIN_RESISTANCE_UP
0.275988960442%	6	2174	53	T2D_GENES_TANYA_LIPIDS	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
0.275988960442%	6	2174	53	T2D_GENES_TANYA_LIPIDS	SMIRNOV_RESPONSE_TO_IR_2HR_UP
0.275988960442%	6	2174	53	T2D_GENES_TANYA_LIPIDS	REACTOME_CIRCADIAN_CLOCK
0.275988960442%	6	2174	53	T2D_GENES_TANYA_LIPIDS	HENDRICKS_SMARCA4_TARGETS_DN
0.275988960442%	6	2174	53	T2D_GENES_TANYA_LIPIDS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN
0.275988960442%	6	2174	52	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN
0.275988960442%	6	2174	52	T2D_GENES_TANYA_LIPIDS	PID_KITPATHWAY
0.275988960442%	6	2174	52	T2D_GENES_TANYA_LIPIDS	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP
0.275988960442%	6	2174	52	T2D_GENES_TANYA_LIPIDS	KENNY_CTNNB1_TARGETS_DN
0.275988960442%	6	2174	52	T2D_GENES_TANYA_LIPIDS	KEGG_MTOR_SIGNALING_PATHWAY
0.275988960442%	6	2174	52	T2D_GENES_TANYA_LIPIDS	KEGG_ENDOMETRIAL_CANCER
0.275988960442%	6	2174	52	T2D_GENES_TANYA_LIPIDS	CHIBA_RESPONSE_TO_TSA_UP
0.275988960442%	6	2174	52	T2D_GENES_TANYA_LIPIDS	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
0.275988960442%	6	2174	51	T2D_GENES_TANYA_LIPIDS	ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF
0.275988960442%	6	2174	51	T2D_GENES_TANYA_LIPIDS	WANG_BARRETTS_ESOPHAGUS_UP
0.275988960442%	6	2174	51	T2D_GENES_TANYA_LIPIDS	TSUNODA_CISPLATIN_RESISTANCE_DN
0.275988960442%	6	2174	51	T2D_GENES_TANYA_LIPIDS	REACTOME_NUCLEOTIDE_EXCISION_REPAIR
0.275988960442%	6	2174	51	T2D_GENES_TANYA_LIPIDS	PRAMOONJAGO_SOX4_TARGETS_DN
0.275988960442%	6	2174	51	T2D_GENES_TANYA_LIPIDS	LUI_THYROID_CANCER_CLUSTER_1
0.275988960442%	6	2174	51	T2D_GENES_TANYA_LIPIDS	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
0.275988960442%	6	2174	51	T2D_GENES_TANYA_LIPIDS	BYSTROEM_CORRELATED_WITH_IL5_UP
0.275988960442%	6	2174	51	T2D_GENES_TANYA_LIPIDS	BURTON_ADIPOGENESIS_PEAK_AT_2HR
0.275988960442%	6	2174	50	T2D_GENES_TANYA_LIPIDS	STOSSI_RESPONSE_TO_ESTRADIOL
0.275988960442%	6	2174	50	T2D_GENES_TANYA_LIPIDS	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN
0.275988960442%	6	2174	50	T2D_GENES_TANYA_LIPIDS	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.275988960442%	6	2174	50	T2D_GENES_TANYA_LIPIDS	ROY_WOUND_BLOOD_VESSEL_UP
0.275988960442%	6	2174	50	T2D_GENES_TANYA_LIPIDS	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
0.275988960442%	6	2174	50	T2D_GENES_TANYA_LIPIDS	DAUER_STAT3_TARGETS_DN
0.275988960442%	6	2174	49	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8
0.275988960442%	6	2174	49	T2D_GENES_TANYA_LIPIDS	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
0.275988960442%	6	2174	48	T2D_GENES_TANYA_LIPIDS	MCDOWELL_ACUTE_LUNG_INJURY_DN
0.275988960442%	6	2174	48	T2D_GENES_TANYA_LIPIDS	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
0.275988960442%	6	2174	48	T2D_GENES_TANYA_LIPIDS	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
0.275988960442%	6	2174	48	T2D_GENES_TANYA_LIPIDS	ENGELMANN_CANCER_PROGENITORS_UP
0.275988960442%	6	2174	48	T2D_GENES_TANYA_LIPIDS	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.275988960442%	6	2174	48	T2D_GENES_TANYA_LIPIDS	CHANGOLKAR_H2AFY_TARGETS_UP
0.275988960442%	6	2174	47	T2D_GENES_TANYA_LIPIDS	ZHU_CMV_8_HR_UP
0.275988960442%	6	2174	47	T2D_GENES_TANYA_LIPIDS	PID_IL6_7PATHWAY
0.275988960442%	6	2174	47	T2D_GENES_TANYA_LIPIDS	NAKAMURA_METASTASIS
0.275988960442%	6	2174	47	T2D_GENES_TANYA_LIPIDS	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP
0.275988960442%	6	2174	45	T2D_GENES_TANYA_LIPIDS	SHIPP_DLBCL_CURED_VS_FATAL_DN
0.275988960442%	6	2174	45	T2D_GENES_TANYA_LIPIDS	PID_RHOA_PATHWAY
0.275988960442%	6	2174	45	T2D_GENES_TANYA_LIPIDS	PID_ILK_PATHWAY
0.275988960442%	6	2174	45	T2D_GENES_TANYA_LIPIDS	NAKAMURA_METASTASIS_MODEL_UP
0.275988960442%	6	2174	45	T2D_GENES_TANYA_LIPIDS	LUI_THYROID_CANCER_PAX8_PPARG_DN
0.275988960442%	6	2174	45	T2D_GENES_TANYA_LIPIDS	HUANG_FOXA2_TARGETS_UP
0.275988960442%	6	2174	44	T2D_GENES_TANYA_LIPIDS	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.275988960442%	6	2174	44	T2D_GENES_TANYA_LIPIDS	MA_MYELOID_DIFFERENTIATION_DN
0.275988960442%	6	2174	44	T2D_GENES_TANYA_LIPIDS	FARMER_BREAST_CANCER_CLUSTER_1
0.275988960442%	6	2174	43	T2D_GENES_TANYA_LIPIDS	PID_CXCR3PATHWAY
0.275988960442%	6	2174	43	T2D_GENES_TANYA_LIPIDS	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
0.275988960442%	6	2174	43	T2D_GENES_TANYA_LIPIDS	BURTON_ADIPOGENESIS_PEAK_AT_24HR
0.275988960442%	6	2174	43	T2D_GENES_TANYA_LIPIDS	AMIT_EGF_RESPONSE_120_MCF10A
0.275988960442%	6	2174	42	T2D_GENES_TANYA_LIPIDS	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
0.275988960442%	6	2174	42	T2D_GENES_TANYA_LIPIDS	AMIT_EGF_RESPONSE_40_HELA
0.275988960442%	6	2174	41	T2D_GENES_TANYA_LIPIDS	WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.275988960442%	6	2174	41	T2D_GENES_TANYA_LIPIDS	PID_ER_NONGENOMIC_PATHWAY
0.275988960442%	6	2174	41	T2D_GENES_TANYA_LIPIDS	LI_LUNG_CANCER
0.275988960442%	6	2174	41	T2D_GENES_TANYA_LIPIDS	CHEN_HOXA5_TARGETS_9HR_DN
0.275988960442%	6	2174	41	T2D_GENES_TANYA_LIPIDS	BIOCARTA_FCER1_PATHWAY
0.275988960442%	6	2174	40	T2D_GENES_TANYA_LIPIDS	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.275988960442%	6	2174	40	T2D_GENES_TANYA_LIPIDS	VANASSE_BCL2_TARGETS_UP
0.275988960442%	6	2174	40	T2D_GENES_TANYA_LIPIDS	ST_JNK_MAPK_PATHWAY
0.275988960442%	6	2174	40	T2D_GENES_TANYA_LIPIDS	KEGG_SPHINGOLIPID_METABOLISM
0.275988960442%	6	2174	40	T2D_GENES_TANYA_LIPIDS	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.275988960442%	6	2174	39	T2D_GENES_TANYA_LIPIDS	SESTO_RESPONSE_TO_UV_C6
0.275988960442%	6	2174	39	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_2HR_UP
0.275988960442%	6	2174	38	T2D_GENES_TANYA_LIPIDS	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS
0.275988960442%	6	2174	38	T2D_GENES_TANYA_LIPIDS	REACTOME_GLYCOSPHINGOLIPID_METABOLISM
0.275988960442%	6	2174	38	T2D_GENES_TANYA_LIPIDS	PID_RAC1_REG_PATHWAY
0.275988960442%	6	2174	38	T2D_GENES_TANYA_LIPIDS	LIU_LIVER_CANCER
0.275988960442%	6	2174	38	T2D_GENES_TANYA_LIPIDS	KAAB_FAILED_HEART_ATRIUM_UP
0.275988960442%	6	2174	38	T2D_GENES_TANYA_LIPIDS	FIGUEROA_AML_METHYLATION_CLUSTER_6_DN
0.275988960442%	6	2174	38	T2D_GENES_TANYA_LIPIDS	BIOCARTA_IL2RB_PATHWAY
0.275988960442%	6	2174	37	T2D_GENES_TANYA_LIPIDS	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN
0.275988960442%	6	2174	37	T2D_GENES_TANYA_LIPIDS	ST_P38_MAPK_PATHWAY
0.275988960442%	6	2174	37	T2D_GENES_TANYA_LIPIDS	PID_IL23PATHWAY
0.275988960442%	6	2174	37	T2D_GENES_TANYA_LIPIDS	PID_FRA_PATHWAY
0.275988960442%	6	2174	37	T2D_GENES_TANYA_LIPIDS	MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED
0.275988960442%	6	2174	37	T2D_GENES_TANYA_LIPIDS	HU_ANGIOGENESIS_DN
0.275988960442%	6	2174	36	T2D_GENES_TANYA_LIPIDS	VANTVEER_BREAST_CANCER_BRCA1_UP
0.275988960442%	6	2174	36	T2D_GENES_TANYA_LIPIDS	VALK_AML_CLUSTER_11
0.275988960442%	6	2174	36	T2D_GENES_TANYA_LIPIDS	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
0.275988960442%	6	2174	36	T2D_GENES_TANYA_LIPIDS	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
0.275988960442%	6	2174	36	T2D_GENES_TANYA_LIPIDS	PID_PI3KPLCTRKPATHWAY
0.275988960442%	6	2174	36	T2D_GENES_TANYA_LIPIDS	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN
0.275988960442%	6	2174	36	T2D_GENES_TANYA_LIPIDS	BIOCARTA_AT1R_PATHWAY
0.275988960442%	6	2174	35	T2D_GENES_TANYA_LIPIDS	WEIGEL_OXIDATIVE_STRESS_RESPONSE
0.275988960442%	6	2174	35	T2D_GENES_TANYA_LIPIDS	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
0.275988960442%	6	2174	35	T2D_GENES_TANYA_LIPIDS	JAZAG_TGFB1_SIGNALING_DN
0.275988960442%	6	2174	35	T2D_GENES_TANYA_LIPIDS	HU_GENOTOXIC_DAMAGE_4HR
0.275988960442%	6	2174	34	T2D_GENES_TANYA_LIPIDS	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP
0.275988960442%	6	2174	34	T2D_GENES_TANYA_LIPIDS	PID_IL2_PI3KPATHWAY
0.275988960442%	6	2174	34	T2D_GENES_TANYA_LIPIDS	LUI_TARGETS_OF_PAX8_PPARG_FUSION
0.275988960442%	6	2174	34	T2D_GENES_TANYA_LIPIDS	KORKOLA_CORRELATED_WITH_POU5F1
0.275988960442%	6	2174	33	T2D_GENES_TANYA_LIPIDS	SIMBULAN_UV_RESPONSE_NORMAL_DN
0.275988960442%	6	2174	33	T2D_GENES_TANYA_LIPIDS	REACTOME_RNA_POL_III_TRANSCRIPTION
0.275988960442%	6	2174	33	T2D_GENES_TANYA_LIPIDS	DUTTA_APOPTOSIS_VIA_NFKB
0.275988960442%	6	2174	33	T2D_GENES_TANYA_LIPIDS	CHO_NR4A1_TARGETS
0.275988960442%	6	2174	33	T2D_GENES_TANYA_LIPIDS	CAFFAREL_RESPONSE_TO_THC_UP
0.275988960442%	6	2174	33	T2D_GENES_TANYA_LIPIDS	BURTON_ADIPOGENESIS_1
0.275988960442%	6	2174	32	T2D_GENES_TANYA_LIPIDS	REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING
0.275988960442%	6	2174	32	T2D_GENES_TANYA_LIPIDS	PID_NETRIN_PATHWAY
0.275988960442%	6	2174	32	T2D_GENES_TANYA_LIPIDS	GROSS_ELK3_TARGETS_DN
0.275988960442%	6	2174	32	T2D_GENES_TANYA_LIPIDS	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN
0.275988960442%	6	2174	32	T2D_GENES_TANYA_LIPIDS	BIOCARTA_RHO_PATHWAY
0.275988960442%	6	2174	31	T2D_GENES_TANYA_LIPIDS	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP
0.275988960442%	6	2174	31	T2D_GENES_TANYA_LIPIDS	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.275988960442%	6	2174	31	T2D_GENES_TANYA_LIPIDS	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD
0.275988960442%	6	2174	31	T2D_GENES_TANYA_LIPIDS	BIOCARTA_PYK2_PATHWAY
0.275988960442%	6	2174	30	T2D_GENES_TANYA_LIPIDS	URS_ADIPOCYTE_DIFFERENTIATION_DN
0.275988960442%	6	2174	30	T2D_GENES_TANYA_LIPIDS	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
0.275988960442%	6	2174	30	T2D_GENES_TANYA_LIPIDS	DAZARD_UV_RESPONSE_CLUSTER_G2
0.275988960442%	6	2174	29	T2D_GENES_TANYA_LIPIDS	WEINMANN_ADAPTATION_TO_HYPOXIA_UP
0.275988960442%	6	2174	29	T2D_GENES_TANYA_LIPIDS	WANG_RESPONSE_TO_ANDROGEN_UP
0.275988960442%	6	2174	29	T2D_GENES_TANYA_LIPIDS	PID_REELINPATHWAY
0.275988960442%	6	2174	28	T2D_GENES_TANYA_LIPIDS	PETRETTO_HEART_MASS_QTL_CIS_UP
0.275988960442%	6	2174	28	T2D_GENES_TANYA_LIPIDS	LUI_THYROID_CANCER_CLUSTER_3
0.275988960442%	6	2174	28	T2D_GENES_TANYA_LIPIDS	KAMIKUBO_MYELOID_CEBPA_NETWORK
0.275988960442%	6	2174	27	T2D_GENES_TANYA_LIPIDS	TIEN_INTESTINE_PROBIOTICS_2HR_UP
0.275988960442%	6	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALLING_TO_RAS
0.275988960442%	6	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM
0.275988960442%	6	2174	26	T2D_GENES_TANYA_LIPIDS	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
0.275988960442%	6	2174	26	T2D_GENES_TANYA_LIPIDS	DEN_INTERACT_WITH_LCA5
0.275988960442%	6	2174	26	T2D_GENES_TANYA_LIPIDS	BIOCARTA_BAD_PATHWAY
0.275988960442%	6	2174	25	T2D_GENES_TANYA_LIPIDS	OZEN_MIR125B1_TARGETS
0.275988960442%	6	2174	25	T2D_GENES_TANYA_LIPIDS	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP
0.275988960442%	6	2174	25	T2D_GENES_TANYA_LIPIDS	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD
0.275988960442%	6	2174	24	T2D_GENES_TANYA_LIPIDS	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN
0.275988960442%	6	2174	23	T2D_GENES_TANYA_LIPIDS	WANG_RESPONSE_TO_FORSKOLIN_UP
0.275988960442%	6	2174	23	T2D_GENES_TANYA_LIPIDS	BIOCARTA_IGF1R_PATHWAY
0.275988960442%	6	2174	23	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CCR3_PATHWAY
0.275988960442%	6	2174	22	T2D_GENES_TANYA_LIPIDS	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP
0.275988960442%	6	2174	21	T2D_GENES_TANYA_LIPIDS	WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP
0.275988960442%	6	2174	21	T2D_GENES_TANYA_LIPIDS	MACLACHLAN_BRCA1_TARGETS_UP
0.275988960442%	6	2174	20	T2D_GENES_TANYA_LIPIDS	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN
0.275988960442%	6	2174	19	T2D_GENES_TANYA_LIPIDS	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS
0.275988960442%	6	2174	19	T2D_GENES_TANYA_LIPIDS	BIOCARTA_STATHMIN_PATHWAY
0.275988960442%	6	2174	19	T2D_GENES_TANYA_LIPIDS	BIOCARTA_MAL_PATHWAY
0.275988960442%	6	2174	18	T2D_GENES_TANYA_LIPIDS	ZHENG_RESPONSE_TO_ARSENITE_UP
0.275988960442%	6	2174	18	T2D_GENES_TANYA_LIPIDS	BIOCARTA_ERK5_PATHWAY
0.275988960442%	6	2174	18	T2D_GENES_TANYA_LIPIDS	BIOCARTA_ARAP_PATHWAY
0.275988960442%	6	2174	16	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CDMAC_PATHWAY
0.275988960442%	6	2174	150	T2D_GENES_TANYA_LIPIDS	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
0.275988960442%	6	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL
0.275988960442%	6	2174	15	T2D_GENES_TANYA_LIPIDS	BIOCARTA_NUCLEARRS_PATHWAY
0.275988960442%	6	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS
0.275988960442%	6	2174	14	T2D_GENES_TANYA_LIPIDS	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION
0.275988960442%	6	2174	14	T2D_GENES_TANYA_LIPIDS	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
0.275988960442%	6	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_GLYCOPROTEIN_HORMONES
0.275988960442%	6	2174	116	T2D_GENES_TANYA_LIPIDS	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
0.275988960442%	6	2174	115	T2D_GENES_TANYA_LIPIDS	HOELZEL_NF1_TARGETS_DN
0.275988960442%	6	2174	111	T2D_GENES_TANYA_LIPIDS	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
0.275988960442%	6	2174	103	T2D_GENES_TANYA_LIPIDS	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
0.275988960442%	6	2174	10	T2D_GENES_TANYA_LIPIDS	RADAEVA_RESPONSE_TO_IFNA1_DN
0.26723677178%	5	1871	98	T2D_GENES_TANYA_HEIGHT	HAHTOLA_SEZARY_SYNDROM_UP
0.26723677178%	5	1871	96	T2D_GENES_TANYA_HEIGHT	LIU_PROSTATE_CANCER_UP
0.26723677178%	5	1871	95	T2D_GENES_TANYA_HEIGHT	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
0.26723677178%	5	1871	95	T2D_GENES_TANYA_HEIGHT	HECKER_IFNB1_TARGETS
0.26723677178%	5	1871	94	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES
0.26723677178%	5	1871	89	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
0.26723677178%	5	1871	89	T2D_GENES_TANYA_HEIGHT	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
0.26723677178%	5	1871	88	T2D_GENES_TANYA_HEIGHT	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
0.26723677178%	5	1871	88	T2D_GENES_TANYA_HEIGHT	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
0.26723677178%	5	1871	88	T2D_GENES_TANYA_HEIGHT	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
0.26723677178%	5	1871	87	T2D_GENES_TANYA_HEIGHT	KEGG_ERBB_SIGNALING_PATHWAY
0.26723677178%	5	1871	86	T2D_GENES_TANYA_HEIGHT	REACTOME_L1CAM_INTERACTIONS
0.26723677178%	5	1871	85	T2D_GENES_TANYA_HEIGHT	XU_GH1_EXOGENOUS_TARGETS_UP
0.26723677178%	5	1871	84	T2D_GENES_TANYA_HEIGHT	CHANG_IMMORTALIZED_BY_HPV31_UP
0.26723677178%	5	1871	83	T2D_GENES_TANYA_HEIGHT	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.26723677178%	5	1871	81	T2D_GENES_TANYA_HEIGHT	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.26723677178%	5	1871	81	T2D_GENES_TANYA_HEIGHT	HARRIS_HYPOXIA
0.26723677178%	5	1871	80	T2D_GENES_TANYA_HEIGHT	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
0.26723677178%	5	1871	80	T2D_GENES_TANYA_HEIGHT	BASSO_HAIRY_CELL_LEUKEMIA_DN
0.26723677178%	5	1871	78	T2D_GENES_TANYA_HEIGHT	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.26723677178%	5	1871	78	T2D_GENES_TANYA_HEIGHT	RADMACHER_AML_PROGNOSIS
0.26723677178%	5	1871	76	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
0.26723677178%	5	1871	76	T2D_GENES_TANYA_HEIGHT	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
0.26723677178%	5	1871	76	T2D_GENES_TANYA_HEIGHT	KEGG_VEGF_SIGNALING_PATHWAY
0.26723677178%	5	1871	75	T2D_GENES_TANYA_HEIGHT	PID_AVB3_INTEGRIN_PATHWAY
0.26723677178%	5	1871	74	T2D_GENES_TANYA_HEIGHT	VANASSE_BCL2_TARGETS_DN
0.26723677178%	5	1871	74	T2D_GENES_TANYA_HEIGHT	OUILLETTE_CLL_13Q14_DELETION_UP
0.26723677178%	5	1871	74	T2D_GENES_TANYA_HEIGHT	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
0.26723677178%	5	1871	74	T2D_GENES_TANYA_HEIGHT	FURUKAWA_DUSP6_TARGETS_PCI35_DN
0.26723677178%	5	1871	73	T2D_GENES_TANYA_HEIGHT	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.26723677178%	5	1871	73	T2D_GENES_TANYA_HEIGHT	DITTMER_PTHLH_TARGETS_DN
0.26723677178%	5	1871	72	T2D_GENES_TANYA_HEIGHT	SESTO_RESPONSE_TO_UV_C1
0.26723677178%	5	1871	72	T2D_GENES_TANYA_HEIGHT	CROONQUIST_NRAS_SIGNALING_DN
0.26723677178%	5	1871	71	T2D_GENES_TANYA_HEIGHT	KYNG_RESPONSE_TO_H2O2
0.26723677178%	5	1871	70	T2D_GENES_TANYA_HEIGHT	LIU_NASOPHARYNGEAL_CARCINOMA
0.26723677178%	5	1871	70	T2D_GENES_TANYA_HEIGHT	ENGELMANN_CANCER_PROGENITORS_DN
0.26723677178%	5	1871	69	T2D_GENES_TANYA_HEIGHT	LEIN_NEURON_MARKERS
0.26723677178%	5	1871	69	T2D_GENES_TANYA_HEIGHT	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES
0.26723677178%	5	1871	69	T2D_GENES_TANYA_HEIGHT	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
0.26723677178%	5	1871	68	T2D_GENES_TANYA_HEIGHT	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.26723677178%	5	1871	67	T2D_GENES_TANYA_HEIGHT	LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.26723677178%	5	1871	66	T2D_GENES_TANYA_HEIGHT	DIRMEIER_LMP1_RESPONSE_EARLY
0.26723677178%	5	1871	65	T2D_GENES_TANYA_HEIGHT	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.26723677178%	5	1871	65	T2D_GENES_TANYA_HEIGHT	ST_FAS_SIGNALING_PATHWAY
0.26723677178%	5	1871	65	T2D_GENES_TANYA_HEIGHT	PID_ERA_GENOMIC_PATHWAY
0.26723677178%	5	1871	65	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER_MYC_TGFA_DN
0.26723677178%	5	1871	65	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER_ACOX1_DN
0.26723677178%	5	1871	65	T2D_GENES_TANYA_HEIGHT	GUO_HEX_TARGETS_DN
0.26723677178%	5	1871	64	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER_ACOX1_UP
0.26723677178%	5	1871	64	T2D_GENES_TANYA_HEIGHT	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
0.26723677178%	5	1871	64	T2D_GENES_TANYA_HEIGHT	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
0.26723677178%	5	1871	64	T2D_GENES_TANYA_HEIGHT	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
0.26723677178%	5	1871	64	T2D_GENES_TANYA_HEIGHT	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
0.26723677178%	5	1871	62	T2D_GENES_TANYA_HEIGHT	PID_FCER1PATHWAY
0.26723677178%	5	1871	62	T2D_GENES_TANYA_HEIGHT	MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN
0.26723677178%	5	1871	62	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER_E2F1_UP
0.26723677178%	5	1871	62	T2D_GENES_TANYA_HEIGHT	KORKOLA_YOLK_SAC_TUMOR
0.26723677178%	5	1871	62	T2D_GENES_TANYA_HEIGHT	GEORGES_CELL_CYCLE_MIR192_TARGETS
0.26723677178%	5	1871	61	T2D_GENES_TANYA_HEIGHT	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.26723677178%	5	1871	61	T2D_GENES_TANYA_HEIGHT	NADLER_OBESITY_UP
0.26723677178%	5	1871	61	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_1HR_UP
0.26723677178%	5	1871	60	T2D_GENES_TANYA_HEIGHT	WIERENGA_STAT5A_TARGETS_GROUP2
0.26723677178%	5	1871	60	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER_DENA_UP
0.26723677178%	5	1871	60	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER_CIPROFIBRATE_UP
0.26723677178%	5	1871	60	T2D_GENES_TANYA_HEIGHT	KEGG_ACUTE_MYELOID_LEUKEMIA
0.26723677178%	5	1871	59	T2D_GENES_TANYA_HEIGHT	LIAN_LIPA_TARGETS_3M
0.26723677178%	5	1871	59	T2D_GENES_TANYA_HEIGHT	KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION
0.26723677178%	5	1871	59	T2D_GENES_TANYA_HEIGHT	ELVIDGE_HYPOXIA_BY_DMOG_DN
0.26723677178%	5	1871	59	T2D_GENES_TANYA_HEIGHT	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
0.26723677178%	5	1871	59	T2D_GENES_TANYA_HEIGHT	ASTIER_INTEGRIN_SIGNALING
0.26723677178%	5	1871	58	T2D_GENES_TANYA_HEIGHT	ZHENG_GLIOBLASTOMA_PLASTICITY_DN
0.26723677178%	5	1871	58	T2D_GENES_TANYA_HEIGHT	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
0.26723677178%	5	1871	58	T2D_GENES_TANYA_HEIGHT	REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT
0.26723677178%	5	1871	58	T2D_GENES_TANYA_HEIGHT	PID_SHP2_PATHWAY
0.26723677178%	5	1871	58	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_NPC_LCP_WITH_H3K4ME3
0.26723677178%	5	1871	58	T2D_GENES_TANYA_HEIGHT	LIM_MAMMARY_LUMINAL_PROGENITOR_UP
0.26723677178%	5	1871	58	T2D_GENES_TANYA_HEIGHT	BIOCARTA_PPARA_PATHWAY
0.26723677178%	5	1871	57	T2D_GENES_TANYA_HEIGHT	TANG_SENESCENCE_TP53_TARGETS_DN
0.26723677178%	5	1871	57	T2D_GENES_TANYA_HEIGHT	GRABARCZYK_BCL11B_TARGETS_DN
0.26723677178%	5	1871	57	T2D_GENES_TANYA_HEIGHT	DIRMEIER_LMP1_RESPONSE_LATE_UP
0.26723677178%	5	1871	56	T2D_GENES_TANYA_HEIGHT	VANTVEER_BREAST_CANCER_METASTASIS_UP
0.26723677178%	5	1871	56	T2D_GENES_TANYA_HEIGHT	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP
0.26723677178%	5	1871	56	T2D_GENES_TANYA_HEIGHT	MAYBURD_RESPONSE_TO_L663536_DN
0.26723677178%	5	1871	56	T2D_GENES_TANYA_HEIGHT	LY_AGING_OLD_DN
0.26723677178%	5	1871	56	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER_MYC_E2F1_UP
0.26723677178%	5	1871	56	T2D_GENES_TANYA_HEIGHT	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP
0.26723677178%	5	1871	56	T2D_GENES_TANYA_HEIGHT	GYORFFY_DOXORUBICIN_RESISTANCE
0.26723677178%	5	1871	56	T2D_GENES_TANYA_HEIGHT	BIOCARTA_NFAT_PATHWAY
0.26723677178%	5	1871	55	T2D_GENES_TANYA_HEIGHT	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.26723677178%	5	1871	55	T2D_GENES_TANYA_HEIGHT	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
0.26723677178%	5	1871	55	T2D_GENES_TANYA_HEIGHT	PID_IL2_1PATHWAY
0.26723677178%	5	1871	54	T2D_GENES_TANYA_HEIGHT	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
0.26723677178%	5	1871	54	T2D_GENES_TANYA_HEIGHT	SESTO_RESPONSE_TO_UV_C2
0.26723677178%	5	1871	54	T2D_GENES_TANYA_HEIGHT	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN
0.26723677178%	5	1871	53	T2D_GENES_TANYA_HEIGHT	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
0.26723677178%	5	1871	53	T2D_GENES_TANYA_HEIGHT	REACTOME_CIRCADIAN_CLOCK
0.26723677178%	5	1871	53	T2D_GENES_TANYA_HEIGHT	ISHIDA_E2F_TARGETS
0.26723677178%	5	1871	52	T2D_GENES_TANYA_HEIGHT	VILIMAS_NOTCH1_TARGETS_UP
0.26723677178%	5	1871	52	T2D_GENES_TANYA_HEIGHT	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
0.26723677178%	5	1871	52	T2D_GENES_TANYA_HEIGHT	KEGG_TASTE_TRANSDUCTION
0.26723677178%	5	1871	52	T2D_GENES_TANYA_HEIGHT	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP
0.26723677178%	5	1871	51	T2D_GENES_TANYA_HEIGHT	WANG_BARRETTS_ESOPHAGUS_UP
0.26723677178%	5	1871	51	T2D_GENES_TANYA_HEIGHT	GUILLAUMOND_KLF10_TARGETS_UP
0.26723677178%	5	1871	51	T2D_GENES_TANYA_HEIGHT	FRASOR_TAMOXIFEN_RESPONSE_UP
0.26723677178%	5	1871	51	T2D_GENES_TANYA_HEIGHT	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.26723677178%	5	1871	51	T2D_GENES_TANYA_HEIGHT	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP
0.26723677178%	5	1871	51	T2D_GENES_TANYA_HEIGHT	BURTON_ADIPOGENESIS_7
0.26723677178%	5	1871	51	T2D_GENES_TANYA_HEIGHT	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
0.26723677178%	5	1871	50	T2D_GENES_TANYA_HEIGHT	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.26723677178%	5	1871	50	T2D_GENES_TANYA_HEIGHT	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN
0.26723677178%	5	1871	5	T2D_GENES_TANYA_HEIGHT	NIKOLSKY_BREAST_CANCER_19P13_AMPLICON
0.26723677178%	5	1871	49	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8
0.26723677178%	5	1871	49	T2D_GENES_TANYA_HEIGHT	PID_FOXOPATHWAY
0.26723677178%	5	1871	49	T2D_GENES_TANYA_HEIGHT	LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE
0.26723677178%	5	1871	49	T2D_GENES_TANYA_HEIGHT	FAELT_B_CLL_WITH_VH3_21_DN
0.26723677178%	5	1871	49	T2D_GENES_TANYA_HEIGHT	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP
0.26723677178%	5	1871	48	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_LB_UP
0.26723677178%	5	1871	48	T2D_GENES_TANYA_HEIGHT	PENG_GLUCOSE_DEPRIVATION_UP
0.26723677178%	5	1871	48	T2D_GENES_TANYA_HEIGHT	MCCLUNG_DELTA_FOSB_TARGETS_2WK
0.26723677178%	5	1871	48	T2D_GENES_TANYA_HEIGHT	DOANE_BREAST_CANCER_ESR1_DN
0.26723677178%	5	1871	48	T2D_GENES_TANYA_HEIGHT	DELACROIX_RAR_TARGETS_UP
0.26723677178%	5	1871	47	T2D_GENES_TANYA_HEIGHT	WOOD_EBV_EBNA1_TARGETS_DN
0.26723677178%	5	1871	47	T2D_GENES_TANYA_HEIGHT	PID_LKB1_PATHWAY
0.26723677178%	5	1871	47	T2D_GENES_TANYA_HEIGHT	PID_DELTANP63PATHWAY
0.26723677178%	5	1871	47	T2D_GENES_TANYA_HEIGHT	NAKAMURA_METASTASIS
0.26723677178%	5	1871	46	T2D_GENES_TANYA_HEIGHT	WINNEPENNINCKX_MELANOMA_METASTASIS_DN
0.26723677178%	5	1871	46	T2D_GENES_TANYA_HEIGHT	TSENG_ADIPOGENIC_POTENTIAL_DN
0.26723677178%	5	1871	46	T2D_GENES_TANYA_HEIGHT	PID_RHOA_REG_PATHWAY
0.26723677178%	5	1871	46	T2D_GENES_TANYA_HEIGHT	NUTT_GBM_VS_AO_GLIOMA_UP
0.26723677178%	5	1871	46	T2D_GENES_TANYA_HEIGHT	NAKAMURA_CANCER_MICROENVIRONMENT_DN
0.26723677178%	5	1871	46	T2D_GENES_TANYA_HEIGHT	KUNINGER_IGF1_VS_PDGFB_TARGETS_DN
0.26723677178%	5	1871	46	T2D_GENES_TANYA_HEIGHT	HALMOS_CEBPA_TARGETS_DN
0.26723677178%	5	1871	46	T2D_GENES_TANYA_HEIGHT	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN
0.26723677178%	5	1871	45	T2D_GENES_TANYA_HEIGHT	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN
0.26723677178%	5	1871	45	T2D_GENES_TANYA_HEIGHT	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN
0.26723677178%	5	1871	45	T2D_GENES_TANYA_HEIGHT	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_
0.26723677178%	5	1871	45	T2D_GENES_TANYA_HEIGHT	PID_INSULIN_PATHWAY
0.26723677178%	5	1871	45	T2D_GENES_TANYA_HEIGHT	NAKAMURA_METASTASIS_MODEL_UP
0.26723677178%	5	1871	45	T2D_GENES_TANYA_HEIGHT	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN
0.26723677178%	5	1871	45	T2D_GENES_TANYA_HEIGHT	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.26723677178%	5	1871	44	T2D_GENES_TANYA_HEIGHT	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.26723677178%	5	1871	44	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_FGFR_MUTANTS
0.26723677178%	5	1871	44	T2D_GENES_TANYA_HEIGHT	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
0.26723677178%	5	1871	44	T2D_GENES_TANYA_HEIGHT	KEGG_LYSINE_DEGRADATION
0.26723677178%	5	1871	44	T2D_GENES_TANYA_HEIGHT	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM
0.26723677178%	5	1871	44	T2D_GENES_TANYA_HEIGHT	CHUNG_BLISTER_CYTOTOXICITY_DN
0.26723677178%	5	1871	43	T2D_GENES_TANYA_HEIGHT	ZUCCHI_METASTASIS_UP
0.26723677178%	5	1871	43	T2D_GENES_TANYA_HEIGHT	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS
0.26723677178%	5	1871	43	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1
0.26723677178%	5	1871	43	T2D_GENES_TANYA_HEIGHT	LEE_CALORIE_RESTRICTION_MUSCLE_UP
0.26723677178%	5	1871	43	T2D_GENES_TANYA_HEIGHT	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
0.26723677178%	5	1871	43	T2D_GENES_TANYA_HEIGHT	DORN_ADENOVIRUS_INFECTION_24HR_DN
0.26723677178%	5	1871	43	T2D_GENES_TANYA_HEIGHT	COWLING_MYCN_TARGETS
0.26723677178%	5	1871	42	T2D_GENES_TANYA_HEIGHT	YU_MYC_TARGETS_UP
0.26723677178%	5	1871	42	T2D_GENES_TANYA_HEIGHT	REACTOME_TRNA_AMINOACYLATION
0.26723677178%	5	1871	42	T2D_GENES_TANYA_HEIGHT	MODY_HIPPOCAMPUS_PRENATAL
0.26723677178%	5	1871	42	T2D_GENES_TANYA_HEIGHT	LEIN_ASTROCYTE_MARKERS
0.26723677178%	5	1871	42	T2D_GENES_TANYA_HEIGHT	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
0.26723677178%	5	1871	41	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_MF_DN
0.26723677178%	5	1871	41	T2D_GENES_TANYA_HEIGHT	REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING
0.26723677178%	5	1871	41	T2D_GENES_TANYA_HEIGHT	KAMMINGA_EZH2_TARGETS
0.26723677178%	5	1871	40	T2D_GENES_TANYA_HEIGHT	VARELA_ZMPSTE24_TARGETS_UP
0.26723677178%	5	1871	40	T2D_GENES_TANYA_HEIGHT	ST_JNK_MAPK_PATHWAY
0.26723677178%	5	1871	40	T2D_GENES_TANYA_HEIGHT	PID_IFNGPATHWAY
0.26723677178%	5	1871	40	T2D_GENES_TANYA_HEIGHT	PID_FOXM1PATHWAY
0.26723677178%	5	1871	39	T2D_GENES_TANYA_HEIGHT	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2
0.26723677178%	5	1871	39	T2D_GENES_TANYA_HEIGHT	STONER_ESOPHAGEAL_CARCINOGENESIS_UP
0.26723677178%	5	1871	39	T2D_GENES_TANYA_HEIGHT	REACTOME_IL1_SIGNALING
0.26723677178%	5	1871	39	T2D_GENES_TANYA_HEIGHT	POTTI_PACLITAXEL_SENSITIVITY
0.26723677178%	5	1871	39	T2D_GENES_TANYA_HEIGHT	PID_AURORA_B_PATHWAY
0.26723677178%	5	1871	39	T2D_GENES_TANYA_HEIGHT	PID_ATR_PATHWAY
0.26723677178%	5	1871	39	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_2HR_UP
0.26723677178%	5	1871	39	T2D_GENES_TANYA_HEIGHT	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP
0.26723677178%	5	1871	39	T2D_GENES_TANYA_HEIGHT	AIYAR_COBRA1_TARGETS_UP
0.26723677178%	5	1871	38	T2D_GENES_TANYA_HEIGHT	TERAO_AOX4_TARGETS_SKIN_UP
0.26723677178%	5	1871	38	T2D_GENES_TANYA_HEIGHT	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
0.26723677178%	5	1871	38	T2D_GENES_TANYA_HEIGHT	REACTOME_GLUCOSE_TRANSPORT
0.26723677178%	5	1871	38	T2D_GENES_TANYA_HEIGHT	PID_P38ALPHABETADOWNSTREAMPATHWAY
0.26723677178%	5	1871	38	T2D_GENES_TANYA_HEIGHT	PID_FASPATHWAY
0.26723677178%	5	1871	38	T2D_GENES_TANYA_HEIGHT	KAAB_FAILED_HEART_ATRIUM_UP
0.26723677178%	5	1871	37	T2D_GENES_TANYA_HEIGHT	MURAKAMI_UV_RESPONSE_6HR_UP
0.26723677178%	5	1871	37	T2D_GENES_TANYA_HEIGHT	LANDIS_ERBB2_BREAST_TUMORS_65_DN
0.26723677178%	5	1871	37	T2D_GENES_TANYA_HEIGHT	KIM_ALL_DISORDERS_CALB1_CORR_DN
0.26723677178%	5	1871	37	T2D_GENES_TANYA_HEIGHT	BIOCARTA_TOLL_PATHWAY
0.26723677178%	5	1871	37	T2D_GENES_TANYA_HEIGHT	BIOCARTA_BCR_PATHWAY
0.26723677178%	5	1871	36	T2D_GENES_TANYA_HEIGHT	ST_ADRENERGIC
0.26723677178%	5	1871	36	T2D_GENES_TANYA_HEIGHT	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
0.26723677178%	5	1871	36	T2D_GENES_TANYA_HEIGHT	REACTOME_FRS2_MEDIATED_CASCADE
0.26723677178%	5	1871	36	T2D_GENES_TANYA_HEIGHT	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
0.26723677178%	5	1871	36	T2D_GENES_TANYA_HEIGHT	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP
0.26723677178%	5	1871	35	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15
0.26723677178%	5	1871	35	T2D_GENES_TANYA_HEIGHT	YAGI_AML_RELAPSE_PROGNOSIS
0.26723677178%	5	1871	35	T2D_GENES_TANYA_HEIGHT	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.26723677178%	5	1871	35	T2D_GENES_TANYA_HEIGHT	REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D
0.26723677178%	5	1871	35	T2D_GENES_TANYA_HEIGHT	PID_HIVNEFPATHWAY
0.26723677178%	5	1871	35	T2D_GENES_TANYA_HEIGHT	PID_ARF6_PATHWAY
0.26723677178%	5	1871	35	T2D_GENES_TANYA_HEIGHT	HU_GENOTOXIC_DAMAGE_24HR
0.26723677178%	5	1871	35	T2D_GENES_TANYA_HEIGHT	HOWLIN_CITED1_TARGETS_1_UP
0.26723677178%	5	1871	34	T2D_GENES_TANYA_HEIGHT	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION
0.26723677178%	5	1871	34	T2D_GENES_TANYA_HEIGHT	REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX
0.26723677178%	5	1871	34	T2D_GENES_TANYA_HEIGHT	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT
0.26723677178%	5	1871	34	T2D_GENES_TANYA_HEIGHT	PID_HDAC_CLASSII_PATHWAY
0.26723677178%	5	1871	34	T2D_GENES_TANYA_HEIGHT	MEISSNER_ES_ICP_WITH_H3K4ME3
0.26723677178%	5	1871	34	T2D_GENES_TANYA_HEIGHT	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP
0.26723677178%	5	1871	33	T2D_GENES_TANYA_HEIGHT	SIMBULAN_UV_RESPONSE_NORMAL_DN
0.26723677178%	5	1871	33	T2D_GENES_TANYA_HEIGHT	ROZANOV_MMP14_TARGETS_SUBSET
0.26723677178%	5	1871	33	T2D_GENES_TANYA_HEIGHT	REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS
0.26723677178%	5	1871	33	T2D_GENES_TANYA_HEIGHT	DORN_ADENOVIRUS_INFECTION_12HR_DN
0.26723677178%	5	1871	33	T2D_GENES_TANYA_HEIGHT	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN
0.26723677178%	5	1871	32	T2D_GENES_TANYA_HEIGHT	ST_ERK1_ERK2_MAPK_PATHWAY
0.26723677178%	5	1871	32	T2D_GENES_TANYA_HEIGHT	REACTOME_DAG_AND_IP3_SIGNALING
0.26723677178%	5	1871	32	T2D_GENES_TANYA_HEIGHT	LIANG_SILENCED_BY_METHYLATION_UP
0.26723677178%	5	1871	32	T2D_GENES_TANYA_HEIGHT	KEGG_CITRATE_CYCLE_TCA_CYCLE
0.26723677178%	5	1871	32	T2D_GENES_TANYA_HEIGHT	BIOCARTA_HDAC_PATHWAY
0.26723677178%	5	1871	31	T2D_GENES_TANYA_HEIGHT	RIZ_ERYTHROID_DIFFERENTIATION_HEMGN
0.26723677178%	5	1871	31	T2D_GENES_TANYA_HEIGHT	REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX
0.26723677178%	5	1871	31	T2D_GENES_TANYA_HEIGHT	PID_CD40_PATHWAY
0.26723677178%	5	1871	31	T2D_GENES_TANYA_HEIGHT	BIOCARTA_MYOSIN_PATHWAY
0.26723677178%	5	1871	30	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.26723677178%	5	1871	30	T2D_GENES_TANYA_HEIGHT	TAVOR_CEBPA_TARGETS_DN
0.26723677178%	5	1871	30	T2D_GENES_TANYA_HEIGHT	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.26723677178%	5	1871	30	T2D_GENES_TANYA_HEIGHT	REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM
0.26723677178%	5	1871	30	T2D_GENES_TANYA_HEIGHT	REACTOME_CA_DEPENDENT_EVENTS
0.26723677178%	5	1871	30	T2D_GENES_TANYA_HEIGHT	PID_RETINOIC_ACID_PATHWAY
0.26723677178%	5	1871	30	T2D_GENES_TANYA_HEIGHT	PID_RAS_PATHWAY
0.26723677178%	5	1871	30	T2D_GENES_TANYA_HEIGHT	PID_IGF1_PATHWAY
0.26723677178%	5	1871	30	T2D_GENES_TANYA_HEIGHT	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP
0.26723677178%	5	1871	30	T2D_GENES_TANYA_HEIGHT	DAZARD_UV_RESPONSE_CLUSTER_G2
0.26723677178%	5	1871	29	T2D_GENES_TANYA_HEIGHT	REACTOME_PKB_MEDIATED_EVENTS
0.26723677178%	5	1871	29	T2D_GENES_TANYA_HEIGHT	PID_TCRCALCIUMPATHWAY
0.26723677178%	5	1871	29	T2D_GENES_TANYA_HEIGHT	PID_BARD1PATHWAY
0.26723677178%	5	1871	29	T2D_GENES_TANYA_HEIGHT	MAYBURD_RESPONSE_TO_L663536_UP
0.26723677178%	5	1871	29	T2D_GENES_TANYA_HEIGHT	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP
0.26723677178%	5	1871	28	T2D_GENES_TANYA_HEIGHT	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING
0.26723677178%	5	1871	28	T2D_GENES_TANYA_HEIGHT	PETROVA_PROX1_TARGETS_UP
0.26723677178%	5	1871	28	T2D_GENES_TANYA_HEIGHT	LUI_THYROID_CANCER_CLUSTER_3
0.26723677178%	5	1871	28	T2D_GENES_TANYA_HEIGHT	KEGG_HOMOLOGOUS_RECOMBINATION
0.26723677178%	5	1871	28	T2D_GENES_TANYA_HEIGHT	HWANG_PROSTATE_CANCER_MARKERS
0.26723677178%	5	1871	28	T2D_GENES_TANYA_HEIGHT	BIOCARTA_ERK_PATHWAY
0.26723677178%	5	1871	27	T2D_GENES_TANYA_HEIGHT	ST_MYOCYTE_AD_PATHWAY
0.26723677178%	5	1871	27	T2D_GENES_TANYA_HEIGHT	CHIN_BREAST_CANCER_COPY_NUMBER_UP
0.26723677178%	5	1871	26	T2D_GENES_TANYA_HEIGHT	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.26723677178%	5	1871	26	T2D_GENES_TANYA_HEIGHT	PID_P38_MKK3_6PATHWAY
0.26723677178%	5	1871	26	T2D_GENES_TANYA_HEIGHT	GAZIN_EPIGENETIC_SILENCING_BY_KRAS
0.26723677178%	5	1871	26	T2D_GENES_TANYA_HEIGHT	BIOCARTA_RACCYCD_PATHWAY
0.26723677178%	5	1871	25	T2D_GENES_TANYA_HEIGHT	WONG_ENDMETRIUM_CANCER_UP
0.26723677178%	5	1871	25	T2D_GENES_TANYA_HEIGHT	REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE
0.26723677178%	5	1871	25	T2D_GENES_TANYA_HEIGHT	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
0.26723677178%	5	1871	25	T2D_GENES_TANYA_HEIGHT	GENTILE_UV_HIGH_DOSE_UP
0.26723677178%	5	1871	25	T2D_GENES_TANYA_HEIGHT	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN
0.26723677178%	5	1871	25	T2D_GENES_TANYA_HEIGHT	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.26723677178%	5	1871	24	T2D_GENES_TANYA_HEIGHT	YAN_ESCAPE_FROM_ANOIKIS
0.26723677178%	5	1871	24	T2D_GENES_TANYA_HEIGHT	PID_S1P_S1P2_PATHWAY
0.26723677178%	5	1871	24	T2D_GENES_TANYA_HEIGHT	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN
0.26723677178%	5	1871	24	T2D_GENES_TANYA_HEIGHT	DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.26723677178%	5	1871	23	T2D_GENES_TANYA_HEIGHT	REACTOME_INSULIN_RECEPTOR_RECYCLING
0.26723677178%	5	1871	23	T2D_GENES_TANYA_HEIGHT	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN
0.26723677178%	5	1871	23	T2D_GENES_TANYA_HEIGHT	BIOCARTA_IL12_PATHWAY
0.26723677178%	5	1871	22	T2D_GENES_TANYA_HEIGHT	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP
0.26723677178%	5	1871	22	T2D_GENES_TANYA_HEIGHT	BIOCARTA_DC_PATHWAY
0.26723677178%	5	1871	21	T2D_GENES_TANYA_HEIGHT	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP
0.26723677178%	5	1871	21	T2D_GENES_TANYA_HEIGHT	REACTOME_ADP_SIGNALLING_THROUGH_P2RY12
0.26723677178%	5	1871	21	T2D_GENES_TANYA_HEIGHT	PID_S1P_META_PATHWAY
0.26723677178%	5	1871	21	T2D_GENES_TANYA_HEIGHT	KEGG_GLYCOSAMINOGLYCAN_DEGRADATION
0.26723677178%	5	1871	21	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CTLA4_PATHWAY
0.26723677178%	5	1871	20	T2D_GENES_TANYA_HEIGHT	WANG_RECURRENT_LIVER_CANCER_UP
0.26723677178%	5	1871	20	T2D_GENES_TANYA_HEIGHT	SESTO_RESPONSE_TO_UV_C3
0.26723677178%	5	1871	20	T2D_GENES_TANYA_HEIGHT	DAZARD_UV_RESPONSE_CLUSTER_G28
0.26723677178%	5	1871	19	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES
0.26723677178%	5	1871	19	T2D_GENES_TANYA_HEIGHT	LAMB_CCND1_TARGETS
0.26723677178%	5	1871	19	T2D_GENES_TANYA_HEIGHT	JEON_SMAD6_TARGETS_DN
0.26723677178%	5	1871	19	T2D_GENES_TANYA_HEIGHT	GAJATE_RESPONSE_TO_TRABECTEDIN_DN
0.26723677178%	5	1871	19	T2D_GENES_TANYA_HEIGHT	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP
0.26723677178%	5	1871	18	T2D_GENES_TANYA_HEIGHT	MOREIRA_RESPONSE_TO_TSA_DN
0.26723677178%	5	1871	17	T2D_GENES_TANYA_HEIGHT	ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN
0.26723677178%	5	1871	17	T2D_GENES_TANYA_HEIGHT	BIOCARTA_IL17_PATHWAY
0.26723677178%	5	1871	16	T2D_GENES_TANYA_HEIGHT	KOINUMA_COLON_CANCER_MSI_DN
0.26723677178%	5	1871	16	T2D_GENES_TANYA_HEIGHT	FARMER_BREAST_CANCER_CLUSTER_6
0.26723677178%	5	1871	16	T2D_GENES_TANYA_HEIGHT	BIOCARTA_GATA3_PATHWAY
0.26723677178%	5	1871	15	T2D_GENES_TANYA_HEIGHT	SA_G1_AND_S_PHASES
0.26723677178%	5	1871	15	T2D_GENES_TANYA_HEIGHT	REACTOME_ENDOGENOUS_STEROLS
0.26723677178%	5	1871	15	T2D_GENES_TANYA_HEIGHT	BIOCARTA_STEM_PATHWAY
0.26723677178%	5	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX
0.26723677178%	5	1871	13	T2D_GENES_TANYA_HEIGHT	BIOCARTA_TCRA_PATHWAY
0.26723677178%	5	1871	12	T2D_GENES_TANYA_HEIGHT	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.26723677178%	5	1871	113	T2D_GENES_TANYA_HEIGHT	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
0.26723677178%	5	1871	110	T2D_GENES_TANYA_HEIGHT	GROSS_HYPOXIA_VIA_HIF1A_DN
0.26723677178%	5	1871	108	T2D_GENES_TANYA_HEIGHT	LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT
0.26723677178%	5	1871	102	T2D_GENES_TANYA_HEIGHT	KANG_IMMORTALIZED_BY_TERT_DN
0.256629597947%	3	1169	99	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.256629597947%	3	1169	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PYEON_HPV_POSITIVE_TUMORS_UP
0.256629597947%	3	1169	97	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LABBE_WNT3A_TARGETS_DN
0.256629597947%	3	1169	97	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP
0.256629597947%	3	1169	95	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
0.256629597947%	3	1169	94	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LU_IL4_SIGNALING
0.256629597947%	3	1169	93	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHU_CMV_24_HR_UP
0.256629597947%	3	1169	93	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_INSULIN_SECRETION
0.256629597947%	3	1169	93	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
0.256629597947%	3	1169	93	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHEN_LIVER_METABOLISM_QTL_CIS
0.256629597947%	3	1169	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CAMPS_COLON_CANCER_COPY_NUMBER_UP
0.256629597947%	3	1169	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHU_CMV_24_HR_DN
0.256629597947%	3	1169	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
0.256629597947%	3	1169	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
0.256629597947%	3	1169	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SASSON_RESPONSE_TO_FORSKOLIN_UP
0.256629597947%	3	1169	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_GAP_JUNCTION
0.256629597947%	3	1169	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IGARASHI_ATF4_TARGETS_DN
0.256629597947%	3	1169	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAVIN_FOXP3_TARGETS_CLUSTER_P7
0.256629597947%	3	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
0.256629597947%	3	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SWEET_KRAS_ONCOGENIC_SIGNATURE
0.256629597947%	3	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LI_DCP2_BOUND_MRNA
0.256629597947%	3	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DELASERNA_MYOD_TARGETS_UP
0.256629597947%	3	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BHATTACHARYA_EMBRYONIC_STEM_CELL
0.256629597947%	3	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WALLACE_PROSTATE_CANCER_RACE_DN
0.256629597947%	3	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TIEN_INTESTINE_PROBIOTICS_2HR_DN
0.256629597947%	3	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SASSON_RESPONSE_TO_FORSKOLIN_DN
0.256629597947%	3	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
0.256629597947%	3	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.256629597947%	3	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
0.256629597947%	3	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ALCALA_APOPTOSIS
0.256629597947%	3	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.256629597947%	3	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
0.256629597947%	3	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
0.256629597947%	3	1169	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
0.256629597947%	3	1169	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
0.256629597947%	3	1169	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GHANDHI_BYSTANDER_IRRADIATION_UP
0.256629597947%	3	1169	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BURTON_ADIPOGENESIS_8
0.256629597947%	3	1169	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
0.256629597947%	3	1169	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
0.256629597947%	3	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.256629597947%	3	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_SMALL_CELL_LUNG_CANCER
0.256629597947%	3	1169	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WARTERS_RESPONSE_TO_IR_SKIN
0.256629597947%	3	1169	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JIANG_HYPOXIA_CANCER
0.256629597947%	3	1169	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ODONNELL_METASTASIS_UP
0.256629597947%	3	1169	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FRASOR_RESPONSE_TO_ESTRADIOL_DN
0.256629597947%	3	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
0.256629597947%	3	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_M_G1_TRANSITION
0.256629597947%	3	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MAHAJAN_RESPONSE_TO_IL1A_UP
0.256629597947%	3	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEIN_MEDULLA_MARKERS
0.256629597947%	3	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	COATES_MACROPHAGE_M1_VS_M2_UP
0.256629597947%	3	1169	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHUHMACHER_MYC_TARGETS_UP
0.256629597947%	3	1169	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
0.256629597947%	3	1169	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LINDVALL_IMMORTALIZED_BY_TERT_DN
0.256629597947%	3	1169	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
0.256629597947%	3	1169	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DUAN_PRDM5_TARGETS
0.256629597947%	3	1169	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
0.256629597947%	3	1169	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CELL_JUNCTION_ORGANIZATION
0.256629597947%	3	1169	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RADMACHER_AML_PROGNOSIS
0.256629597947%	3	1169	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PEROXISOME
0.256629597947%	3	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
0.256629597947%	3	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RODRIGUES_THYROID_CARCINOMA_DN
0.256629597947%	3	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RIZ_ERYTHROID_DIFFERENTIATION
0.256629597947%	3	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
0.256629597947%	3	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN
0.256629597947%	3	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JACKSON_DNMT1_TARGETS_UP
0.256629597947%	3	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.256629597947%	3	1169	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
0.256629597947%	3	1169	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MAHAJAN_RESPONSE_TO_IL1A_DN
0.256629597947%	3	1169	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM
0.256629597947%	3	1169	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHESLER_BRAIN_QTL_CIS
0.256629597947%	3	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OUILLETTE_CLL_13Q14_DELETION_UP
0.256629597947%	3	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
0.256629597947%	3	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_LIVER_CANCER_DENA_DN
0.256629597947%	3	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CORRE_MULTIPLE_MYELOMA_UP
0.256629597947%	3	1169	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
0.256629597947%	3	1169	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.256629597947%	3	1169	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
0.256629597947%	3	1169	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DITTMER_PTHLH_TARGETS_DN
0.256629597947%	3	1169	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
0.256629597947%	3	1169	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SESTO_RESPONSE_TO_UV_C1
0.256629597947%	3	1169	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_METABOLISM_OF_NUCLEOTIDES
0.256629597947%	3	1169	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
0.256629597947%	3	1169	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DANG_REGULATED_BY_MYC_UP
0.256629597947%	3	1169	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BURTON_ADIPOGENESIS_2
0.256629597947%	3	1169	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_RESPONSE_TO_H2O2
0.256629597947%	3	1169	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DER_IFN_GAMMA_RESPONSE_UP
0.256629597947%	3	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.256629597947%	3	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LANDIS_BREAST_CANCER_PROGRESSION_DN
0.256629597947%	3	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_LONG_TERM_POTENTIATION
0.256629597947%	3	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ENGELMANN_CANCER_PROGENITORS_DN
0.256629597947%	3	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CADWELL_ATG16L1_TARGETS_DN
0.256629597947%	3	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_P53_SIGNALING_PATHWAY
0.256629597947%	3	1169	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.256629597947%	3	1169	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SEMAPHORIN_INTERACTIONS
0.256629597947%	3	1169	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_TELOMERASEPATHWAY
0.256629597947%	3	1169	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.256629597947%	3	1169	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
0.256629597947%	3	1169	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BASSO_CD40_SIGNALING_DN
0.256629597947%	3	1169	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.256629597947%	3	1169	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN
0.256629597947%	3	1169	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.256629597947%	3	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT
0.256629597947%	3	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES
0.256629597947%	3	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_HIF1_TFPATHWAY
0.256629597947%	3	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_HDAC_CLASSI_PATHWAY
0.256629597947%	3	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.256629597947%	3	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
0.256629597947%	3	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BRUNO_HEMATOPOIESIS
0.256629597947%	3	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX
0.256629597947%	3	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_RB_1PATHWAY
0.256629597947%	3	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP
0.256629597947%	3	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS
0.256629597947%	3	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMIT_SERUM_RESPONSE_120_MCF10A
0.256629597947%	3	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
0.256629597947%	3	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS
0.256629597947%	3	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
0.256629597947%	3	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIU_SMARCA4_TARGETS
0.256629597947%	3	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
0.256629597947%	3	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BYSTROEM_CORRELATED_WITH_IL5_DN
0.256629597947%	3	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_MYC_REPRESSPATHWAY
0.256629597947%	3	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
0.256629597947%	3	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
0.256629597947%	3	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.256629597947%	3	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BILBAN_B_CLL_LPL_UP
0.256629597947%	3	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN
0.256629597947%	3	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KORKOLA_YOLK_SAC_TUMOR
0.256629597947%	3	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.256629597947%	3	1169	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REN_BOUND_BY_E2F
0.256629597947%	3	1169	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ER_PHAGOSOME_PATHWAY
0.256629597947%	3	1169	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NADLER_OBESITY_UP
0.256629597947%	3	1169	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GENTILE_RESPONSE_CLUSTER_D3
0.256629597947%	3	1169	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_1HR_UP
0.256629597947%	3	1169	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_LIVER_CANCER_DENA_UP
0.256629597947%	3	1169	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMIT_EGF_RESPONSE_240_HELA
0.256629597947%	3	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ATF2_PATHWAY
0.256629597947%	3	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3
0.256629597947%	3	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WAKASUGI_HAVE_ZNF143_BINDING_SITES
0.256629597947%	3	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_SHP2_PATHWAY
0.256629597947%	3	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAGASHIMA_EGF_SIGNALING_UP
0.256629597947%	3	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KOHOUTEK_CCNT2_TARGETS
0.256629597947%	3	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ARACHIDONIC_ACID_METABOLISM
0.256629597947%	3	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
0.256629597947%	3	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BURTON_ADIPOGENESIS_11
0.256629597947%	3	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BORLAK_LIVER_CANCER_EGF_UP
0.256629597947%	3	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMIT_SERUM_RESPONSE_60_MCF10A
0.256629597947%	3	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMIT_SERUM_RESPONSE_240_MCF10A
0.256629597947%	3	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHENG_IL22_SIGNALING_UP
0.256629597947%	3	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_LIVER_CANCER_MYC_E2F1_UP
0.256629597947%	3	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_HEDGEHOG_SIGNALING_PATHWAY
0.256629597947%	3	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER
0.256629597947%	3	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_4HR_UP
0.256629597947%	3	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RICKMAN_HEAD_AND_NECK_CANCER_F
0.256629597947%	3	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ARGININE_AND_PROLINE_METABOLISM
0.256629597947%	3	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHU_CMV_8_HR_DN
0.256629597947%	3	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0
0.256629597947%	3	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CIRCADIAN_CLOCK
0.256629597947%	3	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_CD8TCRPATHWAY
0.256629597947%	3	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_AR_TF_PATHWAY
0.256629597947%	3	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MORI_IMMATURE_B_LYMPHOCYTE_UP
0.256629597947%	3	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MENSSEN_MYC_TARGETS
0.256629597947%	3	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP
0.256629597947%	3	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN
0.256629597947%	3	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN
0.256629597947%	3	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RADAEVA_RESPONSE_TO_IFNA1_UP
0.256629597947%	3	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PRAMOONJAGO_SOX4_TARGETS_UP
0.256629597947%	3	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN
0.256629597947%	3	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_BARRETTS_ESOPHAGUS_UP
0.256629597947%	3	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LUI_THYROID_CANCER_CLUSTER_1
0.256629597947%	3	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
0.256629597947%	3	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
0.256629597947%	3	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CROMER_TUMORIGENESIS_DN
0.256629597947%	3	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BYSTROEM_CORRELATED_WITH_IL5_UP
0.256629597947%	3	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	APPIERTO_RESPONSE_TO_FENRETINIDE_DN
0.256629597947%	3	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STOSSI_RESPONSE_TO_ESTRADIOL
0.256629597947%	3	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.256629597947%	3	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PARK_HSC_AND_MULTIPOTENT_PROGENITORS
0.256629597947%	3	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
0.256629597947%	3	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC
0.256629597947%	3	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION
0.256629597947%	3	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAUER_STAT3_TARGETS_DN
0.256629597947%	3	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WONG_PROTEASOME_GENE_MODULE
0.256629597947%	3	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS
0.256629597947%	3	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_PI3KCIPATHWAY
0.256629597947%	3	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN
0.256629597947%	3	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.256629597947%	3	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP
0.256629597947%	3	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	APRELIKOVA_BRCA1_TARGETS
0.256629597947%	3	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY
0.256629597947%	3	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCDOWELL_ACUTE_LUNG_INJURY_DN
0.256629597947%	3	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ENGELMANN_CANCER_PROGENITORS_UP
0.256629597947%	3	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BURTON_ADIPOGENESIS_4
0.256629597947%	3	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHU_CMV_8_HR_UP
0.256629597947%	3	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_LKB1_PATHWAY
0.256629597947%	3	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_DELTANP63PATHWAY
0.256629597947%	3	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_TYPE_II_DIABETES_MELLITUS
0.256629597947%	3	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP
0.256629597947%	3	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SAGIV_CD24_TARGETS_DN
0.256629597947%	3	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_PS1PATHWAY
0.256629597947%	3	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1
0.256629597947%	3	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NUTT_GBM_VS_AO_GLIOMA_UP
0.256629597947%	3	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMIT_EGF_RESPONSE_60_HELA
0.256629597947%	3	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ABBUD_LIF_SIGNALING_1_UP
0.256629597947%	3	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_TARGETS_OF_MLL_CBP_FUSION_DN
0.256629597947%	3	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANHARANTA_UTERINE_FIBROID_UP
0.256629597947%	3	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_T_CELL_SIGNAL_TRANSDUCTION
0.256629597947%	3	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
0.256629597947%	3	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAMURA_METASTASIS_MODEL_UP
0.256629597947%	3	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCDOWELL_ACUTE_LUNG_INJURY_UP
0.256629597947%	3	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HUANG_FOXA2_TARGETS_UP
0.256629597947%	3	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ABRAMSON_INTERACT_WITH_AIRE
0.256629597947%	3	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WHITFIELD_CELL_CYCLE_LITERATURE
0.256629597947%	3	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MEDINA_SMARCA4_TARGETS
0.256629597947%	3	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS
0.256629597947%	3	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
0.256629597947%	3	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FAELT_B_CLL_WITH_VH3_21_UP
0.256629597947%	3	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PLC_BETA_MEDIATED_EVENTS
0.256629597947%	3	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	POTTI_ETOPOSIDE_SENSITIVITY
0.256629597947%	3	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_THROMBIN_PAR1_PATHWAY
0.256629597947%	3	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_TCPTP_PATHWAY
0.256629597947%	3	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_CXCR3PATHWAY
0.256629597947%	3	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MILI_PSEUDOPODIA
0.256629597947%	3	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
0.256629597947%	3	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FUJII_YBX1_TARGETS_UP
0.256629597947%	3	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMIT_EGF_RESPONSE_120_MCF10A
0.256629597947%	3	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WIERENGA_PML_INTERACTOME
0.256629597947%	3	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN
0.256629597947%	3	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEIN_ASTROCYTE_MARKERS
0.256629597947%	3	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_BLADDER_CANCER
0.256629597947%	3	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
0.256629597947%	3	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN
0.256629597947%	3	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.256629597947%	3	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_FCER1_PATHWAY
0.256629597947%	3	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VARELA_ZMPSTE24_TARGETS_UP
0.256629597947%	3	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_JNK_MAPK_PATHWAY
0.256629597947%	3	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_B_CELL_ANTIGEN_RECEPTOR
0.256629597947%	3	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
0.256629597947%	3	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_IFNGPATHWAY
0.256629597947%	3	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_FOXM1PATHWAY
0.256629597947%	3	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_TRYPTOPHAN_METABOLISM
0.256629597947%	3	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GENTILE_UV_RESPONSE_CLUSTER_D7
0.256629597947%	3	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ELLWOOD_MYC_TARGETS_DN
0.256629597947%	3	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BURTON_ADIPOGENESIS_PEAK_AT_16HR
0.256629597947%	3	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.256629597947%	3	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BERNARD_PPAPDC1B_TARGETS_UP
0.256629597947%	3	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHIPP_DLBCL_CURED_VS_FATAL_UP
0.256629597947%	3	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ECADHERIN_NASCENTAJ_PATHWAY
0.256629597947%	3	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MA_MYELOID_DIFFERENTIATION_UP
0.256629597947%	3	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HAN_JNK_SINGALING_DN
0.256629597947%	3	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
0.256629597947%	3	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS
0.256629597947%	3	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PIONTEK_PKD1_TARGETS_UP
0.256629597947%	3	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_DNA_DAMAGE_BY_4NQO
0.256629597947%	3	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KRASNOSELSKAYA_ILF3_TARGETS_UP
0.256629597947%	3	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP
0.256629597947%	3	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN
0.256629597947%	3	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
0.256629597947%	3	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_IL23PATHWAY
0.256629597947%	3	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_GMCSF_PATHWAY
0.256629597947%	3	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LANDIS_ERBB2_BREAST_TUMORS_65_DN
0.256629597947%	3	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR
0.256629597947%	3	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HU_ANGIOGENESIS_DN
0.256629597947%	3	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE
0.256629597947%	3	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_TOLL_PATHWAY
0.256629597947%	3	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_MET_PATHWAY
0.256629597947%	3	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_ADRENERGIC
0.256629597947%	3	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALLING_TO_ERKS
0.256629597947%	3	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION
0.256629597947%	3	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_DNA_REPLICATION
0.256629597947%	3	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BURTON_ADIPOGENESIS_12
0.256629597947%	3	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_AT1R_PATHWAY
0.256629597947%	3	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_G_ALPHA_I_PATHWAY
0.256629597947%	3	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ARF6_PATHWAY
0.256629597947%	3	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JAZAG_TGFB1_SIGNALING_DN
0.256629597947%	3	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP
0.256629597947%	3	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNAL_TRANSDUCTION_BY_L1
0.256629597947%	3	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_IL8CXCR2_PATHWAY
0.256629597947%	3	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ABE_VEGFA_TARGETS_2HR
0.256629597947%	3	1169	330	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
0.256629597947%	3	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WENDT_COHESIN_TARGETS_UP
0.256629597947%	3	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_INTEGRIN_A4B1_PATHWAY
0.256629597947%	3	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS
0.256629597947%	3	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JEPSEN_SMRT_TARGETS
0.256629597947%	3	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN
0.256629597947%	3	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	APPEL_IMATINIB_RESPONSE
0.256629597947%	3	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING
0.256629597947%	3	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_PDGF_PATHWAY
0.256629597947%	3	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.256629597947%	3	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.256629597947%	3	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS
0.256629597947%	3	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_AVB3_OPN_PATHWAY
0.256629597947%	3	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_AURORA_A_PATHWAY
0.256629597947%	3	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD
0.256629597947%	3	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM
0.256629597947%	3	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
0.256629597947%	3	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_EGF_PATHWAY
0.256629597947%	3	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.256629597947%	3	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN
0.256629597947%	3	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	URS_ADIPOCYTE_DIFFERENTIATION_DN
0.256629597947%	3	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
0.256629597947%	3	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_NECTIN_PATHWAY
0.256629597947%	3	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_IGF1_PATHWAY
0.256629597947%	3	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_CDC42_REG_PATHWAY
0.256629597947%	3	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_NORMAL_AGING_DN
0.256629597947%	3	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_LRRC3B_TARGETS
0.256629597947%	3	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEINMANN_ADAPTATION_TO_HYPOXIA_UP
0.256629597947%	3	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN
0.256629597947%	3	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NGUYEN_NOTCH1_TARGETS_UP
0.256629597947%	3	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_WERNER_SYNDROM_DN
0.256629597947%	3	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WILLIAMS_ESR2_TARGETS_UP
0.256629597947%	3	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_GAQ_PATHWAY
0.256629597947%	3	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_IL8CXCR1_PATHWAY
0.256629597947%	3	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PETRETTO_HEART_MASS_QTL_CIS_UP
0.256629597947%	3	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KAMIKUBO_MYELOID_CEBPA_NETWORK
0.256629597947%	3	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
0.256629597947%	3	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
0.256629597947%	3	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING
0.256629597947%	3	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NICK_RESPONSE_TO_PROC_TREATMENT_DN
0.256629597947%	3	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_GSK3_PATHWAY
0.256629597947%	3	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CREB_PATHWAY
0.256629597947%	3	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
0.256629597947%	3	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VALK_AML_CLUSTER_8
0.256629597947%	3	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP
0.256629597947%	3	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
0.256629597947%	3	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_MYC_PATHWAY
0.256629597947%	3	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17
0.256629597947%	3	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP
0.256629597947%	3	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD
0.256629597947%	3	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP
0.256629597947%	3	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN
0.256629597947%	3	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_STRESS_PATHWAY
0.256629597947%	3	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_TPO_PATHWAY
0.256629597947%	3	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.256629597947%	3	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_GA12_PATHWAY
0.256629597947%	3	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_NFKAPPABCANONICALPATHWAY
0.256629597947%	3	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP
0.256629597947%	3	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HASLINGER_B_CLL_WITH_11Q23_DELETION
0.256629597947%	3	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BILANGES_SERUM_SENSITIVE_VIA_TSC1
0.256629597947%	3	1169	222	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRANSLATION
0.256629597947%	3	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP
0.256629597947%	3	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN
0.256629597947%	3	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_SPPA_PATHWAY
0.256629597947%	3	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_INSULIN_PATHWAY
0.256629597947%	3	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CERAMIDE_PATHWAY
0.256629597947%	3	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VERRECCHIA_RESPONSE_TO_TGFB1_C5
0.256629597947%	3	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ECADHERIN_KERATINOCYTE_PATHWAY
0.256629597947%	3	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MACLACHLAN_BRCA1_TARGETS_UP
0.256629597947%	3	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_GLYCOSAMINOGLYCAN_DEGRADATION
0.256629597947%	3	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CTLA4_PATHWAY
0.256629597947%	3	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CALCINEURIN_PATHWAY
0.256629597947%	3	1169	207	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VERHAAK_GLIOBLASTOMA_CLASSICAL
0.256629597947%	3	1169	203	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_INFLUENZA_LIFE_CYCLE
0.256629597947%	3	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_RECURRENT_LIVER_CANCER_UP
0.256629597947%	3	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
0.256629597947%	3	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIELSEN_SYNOVIAL_SARCOMA_DN
0.256629597947%	3	1169	194	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.256629597947%	3	1169	193	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOHANKUMAR_TLX1_TARGETS_DN
0.256629597947%	3	1169	191	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
0.256629597947%	3	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN
0.256629597947%	3	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS
0.256629597947%	3	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OUYANG_PROSTATE_CANCER_MARKERS
0.256629597947%	3	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIZUSHIMA_AUTOPHAGOSOME_FORMATION
0.256629597947%	3	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_TID_PATHWAY
0.256629597947%	3	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_MAL_PATHWAY
0.256629597947%	3	1169	185	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
0.256629597947%	3	1169	185	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
0.256629597947%	3	1169	181	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP
0.256629597947%	3	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHIN_B_CELL_LYMPHOMA_CLUSTER_5
0.256629597947%	3	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PD1_SIGNALING
0.256629597947%	3	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS
0.256629597947%	3	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_ERK5_PATHWAY
0.256629597947%	3	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CARDIACEGF_PATHWAY
0.256629597947%	3	1169	175	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.256629597947%	3	1169	169	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN
0.256629597947%	3	1169	166	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMIRNOV_RESPONSE_TO_IR_6HR_UP
0.256629597947%	3	1169	165	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
0.256629597947%	3	1169	165	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIU_CMYB_TARGETS_UP
0.256629597947%	3	1169	164	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
0.256629597947%	3	1169	163	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SERVITJA_ISLET_HNF1A_TARGETS_UP
0.256629597947%	3	1169	162	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_WT1_TARGETS_12HR_UP
0.256629597947%	3	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_G_ALPHA_S_PATHWAY
0.256629597947%	3	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS
0.256629597947%	3	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LUI_THYROID_CANCER_CLUSTER_4
0.256629597947%	3	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS
0.256629597947%	3	1169	158	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON
0.256629597947%	3	1169	150	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LANDIS_ERBB2_BREAST_TUMORS_324_UP
0.256629597947%	3	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE
0.256629597947%	3	1169	147	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KAUFFMANN_DNA_REPLICATION_GENES
0.256629597947%	3	1169	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.256629597947%	3	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE
0.256629597947%	3	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR
0.256629597947%	3	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24
0.256629597947%	3	1169	139	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
0.256629597947%	3	1169	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
0.256629597947%	3	1169	137	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MITOTIC_G1_G1_S_PHASES
0.256629597947%	3	1169	136	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PROVENZANI_METASTASIS_DN
0.256629597947%	3	1169	134	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
0.256629597947%	3	1169	133	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAL_LEUKEMIC_STEM_CELL_UP
0.256629597947%	3	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT
0.256629597947%	3	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION
0.256629597947%	3	1169	129	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAGI_AML_SURVIVAL
0.256629597947%	3	1169	129	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MEMBRANE_TRAFFICKING
0.256629597947%	3	1169	127	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIU_VMYB_TARGETS_UP
0.256629597947%	3	1169	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SANSOM_APC_TARGETS_UP
0.256629597947%	3	1169	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.256629597947%	3	1169	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.256629597947%	3	1169	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
0.256629597947%	3	1169	125	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_1_UP
0.256629597947%	3	1169	125	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
0.256629597947%	3	1169	124	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CELL_CYCLE_CHECKPOINTS
0.256629597947%	3	1169	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RODRIGUES_DCC_TARGETS_DN
0.256629597947%	3	1169	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
0.256629597947%	3	1169	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
0.256629597947%	3	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.256629597947%	3	1169	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
0.256629597947%	3	1169	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
0.256629597947%	3	1169	115	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
0.256629597947%	3	1169	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOSCO_TH1_CYTOTOXIC_MODULE
0.256629597947%	3	1169	113	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TSENG_IRS1_TARGETS_UP
0.256629597947%	3	1169	113	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
0.256629597947%	3	1169	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_G1_S_TRANSITION
0.256629597947%	3	1169	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.256629597947%	3	1169	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LABBE_WNT3A_TARGETS_UP
0.256629597947%	3	1169	111	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GLYCOSAMINOGLYCAN_METABOLISM
0.256629597947%	3	1169	111	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_12HR_UP
0.256629597947%	3	1169	110	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SUNG_METASTASIS_STROMA_UP
0.256629597947%	3	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP
0.256629597947%	3	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LOPEZ_MESOTHELIOMA_SURVIVAL_UP
0.256629597947%	3	1169	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHANG_TLX_TARGETS_DN
0.256629597947%	3	1169	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LE_EGR2_TARGETS_UP
0.256629597947%	3	1169	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LABBE_TGFB1_TARGETS_DN
0.256629597947%	3	1169	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
0.256629597947%	3	1169	107	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_ILS
0.256629597947%	3	1169	106	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
0.256629597947%	3	1169	105	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STEIN_ESRRA_TARGETS_DN
0.256629597947%	3	1169	105	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RNA_POL_II_TRANSCRIPTION
0.256629597947%	3	1169	104	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE
0.256629597947%	3	1169	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.256629597947%	3	1169	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_GNRH_SIGNALING_PATHWAY
0.256629597947%	3	1169	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.256629597947%	3	1169	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCCLUNG_CREB1_TARGETS_UP
0.256629597947%	3	1169	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
0.256629597947%	3	1169	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAVIN_FOXP3_TARGETS_CLUSTER_P4
0.256629597947%	3	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN
0.256629597947%	3	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN
0.255681818182%	9	3520	99	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.255681818182%	9	3520	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PYEON_HPV_POSITIVE_TUMORS_UP
0.255681818182%	9	3520	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_MIDDLE
0.255681818182%	9	3520	97	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP
0.255681818182%	9	3520	94	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES
0.255681818182%	9	3520	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DE_YY1_TARGETS_DN
0.255681818182%	9	3520	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_9
0.255681818182%	9	3520	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHU_CMV_24_HR_DN
0.255681818182%	9	3520	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_P6
0.255681818182%	9	3520	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SANA_TNF_SIGNALING_DN
0.255681818182%	9	3520	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MORI_IMMATURE_B_LYMPHOCYTE_DN
0.255681818182%	9	3520	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IVANOVSKA_MIR106B_TARGETS
0.255681818182%	9	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANLOO_SP3_TARGETS_DN
0.255681818182%	9	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
0.255681818182%	9	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LI_DCP2_BOUND_MRNA
0.255681818182%	9	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	UEDA_CENTRAL_CLOCK
0.255681818182%	9	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_APOPTOSIS
0.255681818182%	9	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
0.255681818182%	9	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMITH_TERT_TARGETS_DN
0.255681818182%	9	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MITOTIC_PROMETAPHASE
0.255681818182%	9	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_L1CAM_INTERACTIONS
0.255681818182%	9	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
0.255681818182%	9	3520	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_GH1_EXOGENOUS_TARGETS_UP
0.255681818182%	9	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_AGING_CEREBELLUM_UP
0.255681818182%	9	3520	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
0.255681818182%	9	3520	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_INTEGRIN_SIGNALING_PATHWAY
0.255681818182%	9	3520	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ODONNELL_METASTASIS_UP
0.255681818182%	9	3520	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEIN_MIDBRAIN_MARKERS
0.255681818182%	9	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.255681818182%	9	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION
0.255681818182%	9	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEIN_MEDULLA_MARKERS
0.255681818182%	9	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GUO_HEX_TARGETS_UP
0.255681818182%	9	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_SCF_KIT
0.255681818182%	9	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.255681818182%	9	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE
0.255681818182%	9	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MORI_PRE_BI_LYMPHOCYTE_DN
0.255681818182%	9	3520	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.255681818182%	9	3520	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ADHERENS_JUNCTION
0.255681818182%	9	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHEPARD_BMYB_TARGETS
0.255681818182%	9	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
0.255681818182%	9	3520	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_CHRONIC_MYELOID_LEUKEMIA
0.255681818182%	9	3520	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_2
0.255681818182%	9	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
0.255681818182%	9	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_NASOPHARYNGEAL_CARCINOMA
0.255681818182%	9	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUANG_DASATINIB_RESISTANCE_DN
0.255681818182%	9	3520	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP
0.255681818182%	9	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_HDAC_CLASSI_PATHWAY
0.255681818182%	9	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARSON_FOXP3_TARGETS_UP
0.255681818182%	9	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.255681818182%	9	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_WNT
0.255681818182%	9	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
0.255681818182%	9	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_RB_1PATHWAY
0.255681818182%	9	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_IL4_2PATHWAY
0.255681818182%	9	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHANG_IMMORTALIZED_BY_HPV31_DN
0.255681818182%	9	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.255681818182%	9	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRIDEAU_IMPRINTED_GENES
0.255681818182%	9	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_COLORECTAL_CANCER
0.255681818182%	9	3520	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS
0.255681818182%	9	3520	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CUI_GLUCOSE_DEPRIVATION
0.255681818182%	9	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_FAK_PATHWAY
0.255681818182%	9	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_RNA_DEGRADATION
0.255681818182%	9	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUPER_BREAST_BASAL_VS_LUMINAL_DN
0.255681818182%	9	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_APOPTOSIS
0.255681818182%	9	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KANNAN_TP53_TARGETS_UP
0.255681818182%	9	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
0.255681818182%	9	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE
0.255681818182%	9	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.255681818182%	9	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX
0.255681818182%	9	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_HEDGEHOG_SIGNALING_PATHWAY
0.255681818182%	9	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER
0.255681818182%	9	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SUNG_METASTASIS_STROMA_DN
0.255681818182%	9	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER_MYC_UP
0.255681818182%	9	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS
0.255681818182%	9	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MORI_IMMATURE_B_LYMPHOCYTE_UP
0.255681818182%	9	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MENSSEN_MYC_TARGETS
0.255681818182%	9	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.255681818182%	9	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP
0.255681818182%	9	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.255681818182%	9	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
0.255681818182%	9	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.255681818182%	9	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT
0.255681818182%	9	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1
0.255681818182%	9	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC
0.255681818182%	9	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARCHINI_TRABECTEDIN_RESISTANCE_DN
0.255681818182%	9	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.255681818182%	9	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY
0.255681818182%	9	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES
0.255681818182%	9	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6
0.255681818182%	9	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_HEDGEHOG_GLIPATHWAY
0.255681818182%	9	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MELLMAN_TUT1_TARGETS_DN
0.255681818182%	9	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_AGING_MUSCLE_DN
0.255681818182%	9	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_T_CELL_SIGNAL_TRANSDUCTION
0.255681818182%	9	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_HNF3BPATHWAY
0.255681818182%	9	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ABRAMSON_INTERACT_WITH_AIRE
0.255681818182%	9	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ERBB2ERBB3PATHWAY
0.255681818182%	9	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LASTOWSKA_COAMPLIFIED_WITH_MYCN
0.255681818182%	9	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
0.255681818182%	9	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
0.255681818182%	9	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
0.255681818182%	9	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN
0.255681818182%	9	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MODY_HIPPOCAMPUS_PRENATAL
0.255681818182%	9	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_PEAK_AT_16HR
0.255681818182%	9	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MA_MYELOID_DIFFERENTIATION_UP
0.255681818182%	9	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_FMLP_PATHWAY
0.255681818182%	9	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR
0.255681818182%	9	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RODRIGUES_NTN1_AND_DCC_TARGETS
0.255681818182%	9	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PRIMARY_IMMUNODEFICIENCY
0.255681818182%	9	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT
0.255681818182%	9	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BAUS_TFF2_TARGETS_UP
0.255681818182%	9	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_AVB3_OPN_PATHWAY
0.255681818182%	9	3520	295	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
0.255681818182%	9	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_S1P_S1P3_PATHWAY
0.255681818182%	9	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_VEGFR1_PATHWAY
0.255681818182%	9	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_RXR_VDR_PATHWAY
0.255681818182%	9	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHENG_RESPONSE_TO_ARSENITE_UP
0.255681818182%	9	3520	170	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.255681818182%	9	3520	150	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LANDIS_ERBB2_BREAST_TUMORS_324_UP
0.255681818182%	9	3520	145	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.255681818182%	9	3520	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS
0.255681818182%	9	3520	127	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	INGRAM_SHH_TARGETS_UP
0.255681818182%	9	3520	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_METASTASIS_DN
0.255681818182%	9	3520	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS
0.255681818182%	9	3520	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
0.255681818182%	9	3520	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
0.255681818182%	9	3520	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
0.255681818182%	9	3520	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LI_INDUCED_T_TO_NATURAL_KILLER_DN
0.255681818182%	9	3520	113	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RICKMAN_HEAD_AND_NECK_CANCER_C
0.255681818182%	9	3520	113	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_RHO_GTPASES
0.255681818182%	9	3520	113	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
0.255681818182%	9	3520	111	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GLYCOSAMINOGLYCAN_METABOLISM
0.255681818182%	9	3520	111	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.255681818182%	9	3520	111	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_12HR_UP
0.255681818182%	9	3520	109	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_EGFR_IN_CANCER
0.255681818182%	9	3520	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
0.255681818182%	9	3520	105	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMUNDSON_GENOTOXIC_SIGNATURE
0.255681818182%	9	3520	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN
0.255681818182%	9	3520	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEIN_CHOROID_PLEXUS_MARKERS
0.255681818182%	9	3520	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
0.255681818182%	9	3520	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
0.253292806484%	5	1974	98	Mendelian_Nancy_Cox	PYEON_HPV_POSITIVE_TUMORS_UP
0.253292806484%	5	1974	90	Mendelian_Nancy_Cox	SANA_TNF_SIGNALING_DN
0.253292806484%	5	1974	79	Mendelian_Nancy_Cox	MALONEY_RESPONSE_TO_17AAG_DN
0.253292806484%	5	1974	77	Mendelian_Nancy_Cox	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
0.253292806484%	5	1974	76	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON
0.253292806484%	5	1974	74	Mendelian_Nancy_Cox	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN
0.253292806484%	5	1974	74	Mendelian_Nancy_Cox	CAMPS_COLON_CANCER_COPY_NUMBER_DN
0.253292806484%	5	1974	73	Mendelian_Nancy_Cox	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.253292806484%	5	1974	71	Mendelian_Nancy_Cox	GEORGANTAS_HSC_MARKERS
0.253292806484%	5	1974	70	Mendelian_Nancy_Cox	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
0.253292806484%	5	1974	70	Mendelian_Nancy_Cox	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5
0.253292806484%	5	1974	67	Mendelian_Nancy_Cox	LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.253292806484%	5	1974	65	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_WNT
0.253292806484%	5	1974	64	Mendelian_Nancy_Cox	LEE_LIVER_CANCER_ACOX1_UP
0.253292806484%	5	1974	63	Mendelian_Nancy_Cox	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
0.253292806484%	5	1974	61	Mendelian_Nancy_Cox	REACTOME_ER_PHAGOSOME_PATHWAY
0.253292806484%	5	1974	6	Mendelian_Nancy_Cox	GALIE_TUMOR_STEMNESS_GENES
0.253292806484%	5	1974	59	Mendelian_Nancy_Cox	ONDER_CDH1_TARGETS_3_DN
0.253292806484%	5	1974	59	Mendelian_Nancy_Cox	KEGG_RNA_DEGRADATION
0.253292806484%	5	1974	57	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON
0.253292806484%	5	1974	57	Mendelian_Nancy_Cox	AMIT_SERUM_RESPONSE_60_MCF10A
0.253292806484%	5	1974	54	Mendelian_Nancy_Cox	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
0.253292806484%	5	1974	54	Mendelian_Nancy_Cox	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM
0.253292806484%	5	1974	54	Mendelian_Nancy_Cox	PID_NFAT_3PATHWAY
0.253292806484%	5	1974	54	Mendelian_Nancy_Cox	KANG_DOXORUBICIN_RESISTANCE_UP
0.253292806484%	5	1974	53	Mendelian_Nancy_Cox	REACTOME_PROTEIN_FOLDING
0.253292806484%	5	1974	53	Mendelian_Nancy_Cox	REACTOME_CIRCADIAN_CLOCK
0.253292806484%	5	1974	53	Mendelian_Nancy_Cox	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP
0.253292806484%	5	1974	52	Mendelian_Nancy_Cox	RADAEVA_RESPONSE_TO_IFNA1_UP
0.253292806484%	5	1974	52	Mendelian_Nancy_Cox	KEGG_TASTE_TRANSDUCTION
0.253292806484%	5	1974	52	Mendelian_Nancy_Cox	HALMOS_CEBPA_TARGETS_UP
0.253292806484%	5	1974	52	Mendelian_Nancy_Cox	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP
0.253292806484%	5	1974	50	Mendelian_Nancy_Cox	NADERI_BREAST_CANCER_PROGNOSIS_UP
0.253292806484%	5	1974	50	Mendelian_Nancy_Cox	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN
0.253292806484%	5	1974	5	Mendelian_Nancy_Cox	BRUNEAU_SEPTATION_ATRIAL
0.253292806484%	5	1974	49	Mendelian_Nancy_Cox	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.253292806484%	5	1974	48	Mendelian_Nancy_Cox	OXFORD_RALA_OR_RALB_TARGETS_UP
0.253292806484%	5	1974	48	Mendelian_Nancy_Cox	ENGELMANN_CANCER_PROGENITORS_UP
0.253292806484%	5	1974	47	Mendelian_Nancy_Cox	ZHU_CMV_8_HR_UP
0.253292806484%	5	1974	47	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_HP_DN
0.253292806484%	5	1974	47	Mendelian_Nancy_Cox	WARTERS_IR_RESPONSE_5GY
0.253292806484%	5	1974	47	Mendelian_Nancy_Cox	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN
0.253292806484%	5	1974	47	Mendelian_Nancy_Cox	MELLMAN_TUT1_TARGETS_DN
0.253292806484%	5	1974	46	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_MS_DN
0.253292806484%	5	1974	46	Mendelian_Nancy_Cox	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6
0.253292806484%	5	1974	46	Mendelian_Nancy_Cox	PID_RHOA_REG_PATHWAY
0.253292806484%	5	1974	46	Mendelian_Nancy_Cox	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1
0.253292806484%	5	1974	46	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON
0.253292806484%	5	1974	45	Mendelian_Nancy_Cox	PID_RHOA_PATHWAY
0.253292806484%	5	1974	45	Mendelian_Nancy_Cox	PID_ILK_PATHWAY
0.253292806484%	5	1974	45	Mendelian_Nancy_Cox	NUTT_GBM_VS_AO_GLIOMA_DN
0.253292806484%	5	1974	45	Mendelian_Nancy_Cox	LUI_THYROID_CANCER_PAX8_PPARG_DN
0.253292806484%	5	1974	45	Mendelian_Nancy_Cox	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN
0.253292806484%	5	1974	44	Mendelian_Nancy_Cox	WHITFIELD_CELL_CYCLE_LITERATURE
0.253292806484%	5	1974	44	Mendelian_Nancy_Cox	VANTVEER_BREAST_CANCER_BRCA1_DN
0.253292806484%	5	1974	44	Mendelian_Nancy_Cox	THILLAINADESAN_ZNF217_TARGETS_UP
0.253292806484%	5	1974	44	Mendelian_Nancy_Cox	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS
0.253292806484%	5	1974	44	Mendelian_Nancy_Cox	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION
0.253292806484%	5	1974	43	Mendelian_Nancy_Cox	LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.253292806484%	5	1974	43	Mendelian_Nancy_Cox	AMIT_EGF_RESPONSE_120_MCF10A
0.253292806484%	5	1974	42	Mendelian_Nancy_Cox	ZHENG_IL22_SIGNALING_DN
0.253292806484%	5	1974	42	Mendelian_Nancy_Cox	ONO_FOXP3_TARGETS_DN
0.253292806484%	5	1974	41	Mendelian_Nancy_Cox	ONO_AML1_TARGETS_DN
0.253292806484%	5	1974	41	Mendelian_Nancy_Cox	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
0.253292806484%	5	1974	41	Mendelian_Nancy_Cox	EHLERS_ANEUPLOIDY_UP
0.253292806484%	5	1974	40	Mendelian_Nancy_Cox	VALK_AML_WITH_FLT3_ITD
0.253292806484%	5	1974	40	Mendelian_Nancy_Cox	JIANG_AGING_HYPOTHALAMUS_DN
0.253292806484%	5	1974	40	Mendelian_Nancy_Cox	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.253292806484%	5	1974	40	Mendelian_Nancy_Cox	BERNARD_PPAPDC1B_TARGETS_UP
0.253292806484%	5	1974	40	Mendelian_Nancy_Cox	BENPORATH_ES_2
0.253292806484%	5	1974	39	Mendelian_Nancy_Cox	PID_AURORA_B_PATHWAY
0.253292806484%	5	1974	39	Mendelian_Nancy_Cox	NEWMAN_ERCC6_TARGETS_DN
0.253292806484%	5	1974	39	Mendelian_Nancy_Cox	DORN_ADENOVIRUS_INFECTION_32HR_DN
0.253292806484%	5	1974	39	Mendelian_Nancy_Cox	BURTON_ADIPOGENESIS_PEAK_AT_8HR
0.253292806484%	5	1974	39	Mendelian_Nancy_Cox	BILANGES_SERUM_SENSITIVE_VIA_TSC2
0.253292806484%	5	1974	38	Mendelian_Nancy_Cox	YOKOE_CANCER_TESTIS_ANTIGENS
0.253292806484%	5	1974	38	Mendelian_Nancy_Cox	TERAO_AOX4_TARGETS_SKIN_UP
0.253292806484%	5	1974	38	Mendelian_Nancy_Cox	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS
0.253292806484%	5	1974	38	Mendelian_Nancy_Cox	PID_P38ALPHABETADOWNSTREAMPATHWAY
0.253292806484%	5	1974	38	Mendelian_Nancy_Cox	NAKAMURA_ADIPOGENESIS_EARLY_DN
0.253292806484%	5	1974	38	Mendelian_Nancy_Cox	MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.253292806484%	5	1974	38	Mendelian_Nancy_Cox	LIU_LIVER_CANCER
0.253292806484%	5	1974	38	Mendelian_Nancy_Cox	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP
0.253292806484%	5	1974	38	Mendelian_Nancy_Cox	FIGUEROA_AML_METHYLATION_CLUSTER_6_DN
0.253292806484%	5	1974	37	Mendelian_Nancy_Cox	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.253292806484%	5	1974	37	Mendelian_Nancy_Cox	RICKMAN_HEAD_AND_NECK_CANCER_D
0.253292806484%	5	1974	37	Mendelian_Nancy_Cox	GENTILE_UV_RESPONSE_CLUSTER_D6
0.253292806484%	5	1974	37	Mendelian_Nancy_Cox	CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE
0.253292806484%	5	1974	37	Mendelian_Nancy_Cox	BIOCARTA_PAR1_PATHWAY
0.253292806484%	5	1974	36	Mendelian_Nancy_Cox	YIH_RESPONSE_TO_ARSENITE_C3
0.253292806484%	5	1974	36	Mendelian_Nancy_Cox	VANTVEER_BREAST_CANCER_BRCA1_UP
0.253292806484%	5	1974	36	Mendelian_Nancy_Cox	VALK_AML_CLUSTER_11
0.253292806484%	5	1974	36	Mendelian_Nancy_Cox	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
0.253292806484%	5	1974	36	Mendelian_Nancy_Cox	MMS_MOUSE_LYMPH_HIGH_4HRS_UP
0.253292806484%	5	1974	36	Mendelian_Nancy_Cox	KEGG_DNA_REPLICATION
0.253292806484%	5	1974	36	Mendelian_Nancy_Cox	HOUSTIS_ROS
0.253292806484%	5	1974	36	Mendelian_Nancy_Cox	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP
0.253292806484%	5	1974	36	Mendelian_Nancy_Cox	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP
0.253292806484%	5	1974	36	Mendelian_Nancy_Cox	ALONSO_METASTASIS_EMT_UP
0.253292806484%	5	1974	35	Mendelian_Nancy_Cox	YAGI_AML_RELAPSE_PROGNOSIS
0.253292806484%	5	1974	35	Mendelian_Nancy_Cox	RODRIGUES_NTN1_AND_DCC_TARGETS
0.253292806484%	5	1974	34	Mendelian_Nancy_Cox	PID_IL1PATHWAY
0.253292806484%	5	1974	33	Mendelian_Nancy_Cox	REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS
0.253292806484%	5	1974	33	Mendelian_Nancy_Cox	GREENBAUM_E2A_TARGETS_UP
0.253292806484%	5	1974	33	Mendelian_Nancy_Cox	GRADE_COLON_CANCER_DN
0.253292806484%	5	1974	33	Mendelian_Nancy_Cox	BURTON_ADIPOGENESIS_1
0.253292806484%	5	1974	32	Mendelian_Nancy_Cox	REACTOME_CD28_CO_STIMULATION
0.253292806484%	5	1974	32	Mendelian_Nancy_Cox	KIM_TIAL1_TARGETS
0.253292806484%	5	1974	32	Mendelian_Nancy_Cox	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM
0.253292806484%	5	1974	32	Mendelian_Nancy_Cox	DORSAM_HOXA9_TARGETS_DN
0.253292806484%	5	1974	32	Mendelian_Nancy_Cox	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN
0.253292806484%	5	1974	32	Mendelian_Nancy_Cox	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP
0.253292806484%	5	1974	32	Mendelian_Nancy_Cox	BAE_BRCA1_TARGETS_DN
0.253292806484%	5	1974	32	Mendelian_Nancy_Cox	AMIT_SERUM_RESPONSE_40_MCF10A
0.253292806484%	5	1974	31	Mendelian_Nancy_Cox	VALK_AML_CLUSTER_15
0.253292806484%	5	1974	31	Mendelian_Nancy_Cox	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN
0.253292806484%	5	1974	31	Mendelian_Nancy_Cox	PID_AURORA_A_PATHWAY
0.253292806484%	5	1974	31	Mendelian_Nancy_Cox	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.253292806484%	5	1974	30	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
0.253292806484%	5	1974	30	Mendelian_Nancy_Cox	SU_PLACENTA
0.253292806484%	5	1974	30	Mendelian_Nancy_Cox	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN
0.253292806484%	5	1974	30	Mendelian_Nancy_Cox	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
0.253292806484%	5	1974	30	Mendelian_Nancy_Cox	PID_CDC42_REG_PATHWAY
0.253292806484%	5	1974	30	Mendelian_Nancy_Cox	GUILLAUMOND_KLF10_TARGETS_DN
0.253292806484%	5	1974	30	Mendelian_Nancy_Cox	BURTON_ADIPOGENESIS_10
0.253292806484%	5	1974	29	Mendelian_Nancy_Cox	REACTOME_PKB_MEDIATED_EVENTS
0.253292806484%	5	1974	29	Mendelian_Nancy_Cox	BIOCARTA_NKT_PATHWAY
0.253292806484%	5	1974	29	Mendelian_Nancy_Cox	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.253292806484%	5	1974	28	Mendelian_Nancy_Cox	VALK_AML_CLUSTER_7
0.253292806484%	5	1974	28	Mendelian_Nancy_Cox	TIAN_TNF_SIGNALING_VIA_NFKB
0.253292806484%	5	1974	28	Mendelian_Nancy_Cox	TERAO_AOX4_TARGETS_HG_UP
0.253292806484%	5	1974	28	Mendelian_Nancy_Cox	REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS
0.253292806484%	5	1974	28	Mendelian_Nancy_Cox	PID_LIS1PATHWAY
0.253292806484%	5	1974	28	Mendelian_Nancy_Cox	PID_IL8CXCR1_PATHWAY
0.253292806484%	5	1974	28	Mendelian_Nancy_Cox	MOREIRA_RESPONSE_TO_TSA_UP
0.253292806484%	5	1974	28	Mendelian_Nancy_Cox	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
0.253292806484%	5	1974	28	Mendelian_Nancy_Cox	GENTILE_UV_RESPONSE_CLUSTER_D9
0.253292806484%	5	1974	28	Mendelian_Nancy_Cox	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.253292806484%	5	1974	27	Mendelian_Nancy_Cox	YE_METASTATIC_LIVER_CANCER
0.253292806484%	5	1974	27	Mendelian_Nancy_Cox	XU_AKT1_TARGETS_6HR
0.253292806484%	5	1974	27	Mendelian_Nancy_Cox	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
0.253292806484%	5	1974	27	Mendelian_Nancy_Cox	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION
0.253292806484%	5	1974	27	Mendelian_Nancy_Cox	REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE
0.253292806484%	5	1974	27	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN
0.253292806484%	5	1974	27	Mendelian_Nancy_Cox	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES
0.253292806484%	5	1974	27	Mendelian_Nancy_Cox	REACTOME_EXTENSION_OF_TELOMERES
0.253292806484%	5	1974	27	Mendelian_Nancy_Cox	REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS
0.253292806484%	5	1974	27	Mendelian_Nancy_Cox	IKEDA_MIR30_TARGETS_DN
0.253292806484%	5	1974	27	Mendelian_Nancy_Cox	GROSS_ELK3_TARGETS_UP
0.253292806484%	5	1974	27	Mendelian_Nancy_Cox	CHIN_BREAST_CANCER_COPY_NUMBER_UP
0.253292806484%	5	1974	26	Mendelian_Nancy_Cox	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN
0.253292806484%	5	1974	26	Mendelian_Nancy_Cox	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS
0.253292806484%	5	1974	26	Mendelian_Nancy_Cox	KEGG_SELENOAMINO_ACID_METABOLISM
0.253292806484%	5	1974	26	Mendelian_Nancy_Cox	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP
0.253292806484%	5	1974	25	Mendelian_Nancy_Cox	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP
0.253292806484%	5	1974	25	Mendelian_Nancy_Cox	REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION
0.253292806484%	5	1974	25	Mendelian_Nancy_Cox	REACTOME_FANCONI_ANEMIA_PATHWAY
0.253292806484%	5	1974	25	Mendelian_Nancy_Cox	PID_HDAC_CLASSIII_PATHWAY
0.253292806484%	5	1974	25	Mendelian_Nancy_Cox	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP
0.253292806484%	5	1974	25	Mendelian_Nancy_Cox	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN
0.253292806484%	5	1974	25	Mendelian_Nancy_Cox	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP
0.253292806484%	5	1974	25	Mendelian_Nancy_Cox	GROSS_HIF1A_TARGETS_DN
0.253292806484%	5	1974	25	Mendelian_Nancy_Cox	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP
0.253292806484%	5	1974	25	Mendelian_Nancy_Cox	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN
0.253292806484%	5	1974	25	Mendelian_Nancy_Cox	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS
0.253292806484%	5	1974	25	Mendelian_Nancy_Cox	BIOCARTA_STRESS_PATHWAY
0.253292806484%	5	1974	25	Mendelian_Nancy_Cox	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP
0.253292806484%	5	1974	24	Mendelian_Nancy_Cox	YAN_ESCAPE_FROM_ANOIKIS
0.253292806484%	5	1974	24	Mendelian_Nancy_Cox	SHI_SPARC_TARGETS_UP
0.253292806484%	5	1974	24	Mendelian_Nancy_Cox	SCHRAMM_INHBA_TARGETS_DN
0.253292806484%	5	1974	24	Mendelian_Nancy_Cox	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING
0.253292806484%	5	1974	24	Mendelian_Nancy_Cox	MAEKAWA_ATF2_TARGETS
0.253292806484%	5	1974	24	Mendelian_Nancy_Cox	KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM
0.253292806484%	5	1974	24	Mendelian_Nancy_Cox	JEON_SMAD6_TARGETS_UP
0.253292806484%	5	1974	24	Mendelian_Nancy_Cox	GOLUB_ALL_VS_AML_UP
0.253292806484%	5	1974	24	Mendelian_Nancy_Cox	DELACROIX_RAR_TARGETS_DN
0.253292806484%	5	1974	24	Mendelian_Nancy_Cox	BIOCARTA_EIF4_PATHWAY
0.253292806484%	5	1974	24	Mendelian_Nancy_Cox	BIOCARTA_CXCR4_PATHWAY
0.253292806484%	5	1974	23	Mendelian_Nancy_Cox	WENG_POR_TARGETS_GLOBAL_DN
0.253292806484%	5	1974	23	Mendelian_Nancy_Cox	VIETOR_IFRD1_TARGETS
0.253292806484%	5	1974	23	Mendelian_Nancy_Cox	KEGG_MISMATCH_REPAIR
0.253292806484%	5	1974	23	Mendelian_Nancy_Cox	FERRANDO_HOX11_NEIGHBORS
0.253292806484%	5	1974	23	Mendelian_Nancy_Cox	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN
0.253292806484%	5	1974	23	Mendelian_Nancy_Cox	CHIBA_RESPONSE_TO_TSA_DN
0.253292806484%	5	1974	23	Mendelian_Nancy_Cox	CHEOK_RESPONSE_TO_HD_MTX_UP
0.253292806484%	5	1974	23	Mendelian_Nancy_Cox	BIOCARTA_RAS_PATHWAY
0.253292806484%	5	1974	23	Mendelian_Nancy_Cox	BIOCARTA_RAC1_PATHWAY
0.253292806484%	5	1974	23	Mendelian_Nancy_Cox	BIOCARTA_P53HYPOXIA_PATHWAY
0.253292806484%	5	1974	23	Mendelian_Nancy_Cox	BIOCARTA_NFKB_PATHWAY
0.253292806484%	5	1974	23	Mendelian_Nancy_Cox	BIOCARTA_IL12_PATHWAY
0.253292806484%	5	1974	23	Mendelian_Nancy_Cox	BIOCARTA_CCR3_PATHWAY
0.253292806484%	5	1974	22	Mendelian_Nancy_Cox	REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION
0.253292806484%	5	1974	22	Mendelian_Nancy_Cox	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
0.253292806484%	5	1974	22	Mendelian_Nancy_Cox	REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING
0.253292806484%	5	1974	22	Mendelian_Nancy_Cox	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
0.253292806484%	5	1974	22	Mendelian_Nancy_Cox	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE
0.253292806484%	5	1974	22	Mendelian_Nancy_Cox	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP
0.253292806484%	5	1974	22	Mendelian_Nancy_Cox	BIOCARTA_GCR_PATHWAY
0.253292806484%	5	1974	21	Mendelian_Nancy_Cox	WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP
0.253292806484%	5	1974	21	Mendelian_Nancy_Cox	VERRECCHIA_RESPONSE_TO_TGFB1_C5
0.253292806484%	5	1974	21	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP
0.253292806484%	5	1974	21	Mendelian_Nancy_Cox	SCHURINGA_STAT5A_TARGETS_UP
0.253292806484%	5	1974	21	Mendelian_Nancy_Cox	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP
0.253292806484%	5	1974	21	Mendelian_Nancy_Cox	LANDEMAINE_LUNG_METASTASIS
0.253292806484%	5	1974	21	Mendelian_Nancy_Cox	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP
0.253292806484%	5	1974	21	Mendelian_Nancy_Cox	FINETTI_BREAST_CANCERS_KINOME_BLUE
0.253292806484%	5	1974	20	Mendelian_Nancy_Cox	OUYANG_PROSTATE_CANCER_PROGRESSION_UP
0.253292806484%	5	1974	20	Mendelian_Nancy_Cox	NIELSEN_LEIOMYOSARCOMA_CNN1_DN
0.253292806484%	5	1974	20	Mendelian_Nancy_Cox	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP
0.253292806484%	5	1974	20	Mendelian_Nancy_Cox	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN
0.253292806484%	5	1974	20	Mendelian_Nancy_Cox	KYNG_WERNER_SYNDROM_UP
0.253292806484%	5	1974	20	Mendelian_Nancy_Cox	KIM_MYCL1_AMPLIFICATION_TARGETS_DN
0.253292806484%	5	1974	20	Mendelian_Nancy_Cox	CHEN_ETV5_TARGETS_SERTOLI
0.253292806484%	5	1974	19	Mendelian_Nancy_Cox	VERNOCHET_ADIPOGENESIS
0.253292806484%	5	1974	19	Mendelian_Nancy_Cox	TRAYNOR_RETT_SYNDROM_DN
0.253292806484%	5	1974	19	Mendelian_Nancy_Cox	SCIBETTA_KDM5B_TARGETS_UP
0.253292806484%	5	1974	19	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS
0.253292806484%	5	1974	19	Mendelian_Nancy_Cox	REACTOME_G1_S_SPECIFIC_TRANSCRIPTION
0.253292806484%	5	1974	19	Mendelian_Nancy_Cox	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN
0.253292806484%	5	1974	19	Mendelian_Nancy_Cox	GRANDVAUX_IRF3_TARGETS_DN
0.253292806484%	5	1974	19	Mendelian_Nancy_Cox	BIOCARTA_TH1TH2_PATHWAY
0.253292806484%	5	1974	19	Mendelian_Nancy_Cox	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP
0.253292806484%	5	1974	18	Mendelian_Nancy_Cox	WEBER_METHYLATED_IN_COLON_CANCER
0.253292806484%	5	1974	18	Mendelian_Nancy_Cox	SCHURINGA_STAT5A_TARGETS_DN
0.253292806484%	5	1974	18	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_NODAL
0.253292806484%	5	1974	18	Mendelian_Nancy_Cox	PODAR_RESPONSE_TO_ADAPHOSTIN_DN
0.253292806484%	5	1974	18	Mendelian_Nancy_Cox	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN
0.253292806484%	5	1974	18	Mendelian_Nancy_Cox	NIELSEN_SCHWANNOMA_DN
0.253292806484%	5	1974	18	Mendelian_Nancy_Cox	NIELSEN_LEIOMYOSARCOMA_UP
0.253292806484%	5	1974	18	Mendelian_Nancy_Cox	NAM_FXYD5_TARGETS_DN
0.253292806484%	5	1974	18	Mendelian_Nancy_Cox	KARAKAS_TGFB1_SIGNALING
0.253292806484%	5	1974	18	Mendelian_Nancy_Cox	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
0.253292806484%	5	1974	18	Mendelian_Nancy_Cox	DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP
0.253292806484%	5	1974	176	Mendelian_Nancy_Cox	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX
0.253292806484%	5	1974	17	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_KIT_SIGNALING
0.253292806484%	5	1974	17	Mendelian_Nancy_Cox	REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION
0.253292806484%	5	1974	17	Mendelian_Nancy_Cox	ONDER_CDH1_TARGETS_3_UP
0.253292806484%	5	1974	17	Mendelian_Nancy_Cox	KEGG_RENIN_ANGIOTENSIN_SYSTEM
0.253292806484%	5	1974	17	Mendelian_Nancy_Cox	KEGG_ONE_CARBON_POOL_BY_FOLATE
0.253292806484%	5	1974	17	Mendelian_Nancy_Cox	HOWLIN_CITED1_TARGETS_2_DN
0.253292806484%	5	1974	17	Mendelian_Nancy_Cox	BIOCARTA_NO2IL12_PATHWAY
0.253292806484%	5	1974	17	Mendelian_Nancy_Cox	BIOCARTA_IL10_PATHWAY
0.253292806484%	5	1974	16	Mendelian_Nancy_Cox	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN
0.253292806484%	5	1974	16	Mendelian_Nancy_Cox	WU_HBX_TARGETS_1_UP
0.253292806484%	5	1974	16	Mendelian_Nancy_Cox	VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN
0.253292806484%	5	1974	16	Mendelian_Nancy_Cox	SUZUKI_AMPLIFIED_IN_ORAL_CANCER
0.253292806484%	5	1974	16	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS
0.253292806484%	5	1974	16	Mendelian_Nancy_Cox	REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS
0.253292806484%	5	1974	16	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON
0.253292806484%	5	1974	16	Mendelian_Nancy_Cox	KORKOLA_TERATOMA_UP
0.253292806484%	5	1974	16	Mendelian_Nancy_Cox	KEGG_RIBOFLAVIN_METABOLISM
0.253292806484%	5	1974	16	Mendelian_Nancy_Cox	KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS
0.253292806484%	5	1974	16	Mendelian_Nancy_Cox	KANG_FLUOROURACIL_RESISTANCE_DN
0.253292806484%	5	1974	16	Mendelian_Nancy_Cox	FUKUSHIMA_TNFSF11_TARGETS
0.253292806484%	5	1974	16	Mendelian_Nancy_Cox	DEMAGALHAES_AGING_DN
0.253292806484%	5	1974	16	Mendelian_Nancy_Cox	BIOCARTA_RELA_PATHWAY
0.253292806484%	5	1974	16	Mendelian_Nancy_Cox	BIOCARTA_P53_PATHWAY
0.253292806484%	5	1974	15	Mendelian_Nancy_Cox	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP
0.253292806484%	5	1974	15	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25
0.253292806484%	5	1974	15	Mendelian_Nancy_Cox	MARKS_ACETYLATED_NON_HISTONE_PROTEINS
0.253292806484%	5	1974	15	Mendelian_Nancy_Cox	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES
0.253292806484%	5	1974	15	Mendelian_Nancy_Cox	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN
0.253292806484%	5	1974	14	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS
0.253292806484%	5	1974	14	Mendelian_Nancy_Cox	KEGG_NON_HOMOLOGOUS_END_JOINING
0.253292806484%	5	1974	14	Mendelian_Nancy_Cox	HOEGERKORP_CD44_TARGETS_DIRECT_DN
0.253292806484%	5	1974	14	Mendelian_Nancy_Cox	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
0.253292806484%	5	1974	14	Mendelian_Nancy_Cox	BIOCARTA_THELPER_PATHWAY
0.253292806484%	5	1974	14	Mendelian_Nancy_Cox	BIOCARTA_PS1_PATHWAY
0.253292806484%	5	1974	13	Mendelian_Nancy_Cox	WU_HBX_TARGETS_3_DN
0.253292806484%	5	1974	13	Mendelian_Nancy_Cox	SHIN_B_CELL_LYMPHOMA_CLUSTER_1
0.253292806484%	5	1974	13	Mendelian_Nancy_Cox	REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION
0.253292806484%	5	1974	13	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX
0.253292806484%	5	1974	13	Mendelian_Nancy_Cox	REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS
0.253292806484%	5	1974	13	Mendelian_Nancy_Cox	BIOCARTA_TCRA_PATHWAY
0.253292806484%	5	1974	12	Mendelian_Nancy_Cox	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN
0.253292806484%	5	1974	12	Mendelian_Nancy_Cox	REACTOME_PYRIMIDINE_CATABOLISM
0.253292806484%	5	1974	12	Mendelian_Nancy_Cox	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING
0.253292806484%	5	1974	12	Mendelian_Nancy_Cox	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
0.253292806484%	5	1974	12	Mendelian_Nancy_Cox	MALIK_REPRESSED_BY_ESTROGEN
0.253292806484%	5	1974	12	Mendelian_Nancy_Cox	JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP
0.253292806484%	5	1974	12	Mendelian_Nancy_Cox	BIOCARTA_BARR_MAPK_PATHWAY
0.253292806484%	5	1974	111	Mendelian_Nancy_Cox	REACTOME_MRNA_SPLICING
0.253292806484%	5	1974	11	Mendelian_Nancy_Cox	ZHOU_PANCREATIC_BETA_CELL
0.253292806484%	5	1974	11	Mendelian_Nancy_Cox	REACTOME_KERATAN_SULFATE_DEGRADATION
0.253292806484%	5	1974	11	Mendelian_Nancy_Cox	REACTOME_IL_7_SIGNALING
0.253292806484%	5	1974	11	Mendelian_Nancy_Cox	PID_ALK2PATHWAY
0.253292806484%	5	1974	11	Mendelian_Nancy_Cox	KEGG_FOLATE_BIOSYNTHESIS
0.253292806484%	5	1974	11	Mendelian_Nancy_Cox	FOURNIER_ACINAR_DEVELOPMENT_LATE_UP
0.253292806484%	5	1974	11	Mendelian_Nancy_Cox	BIOCARTA_TCAPOPTOSIS_PATHWAY
0.253292806484%	5	1974	11	Mendelian_Nancy_Cox	BIOCARTA_EGFR_SMRTE_PATHWAY
0.253292806484%	5	1974	11	Mendelian_Nancy_Cox	BIOCARTA_CDK5_PATHWAY
0.253292806484%	5	1974	11	Mendelian_Nancy_Cox	BIOCARTA_BLYMPHOCYTE_PATHWAY
0.253292806484%	5	1974	10	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL
0.253292806484%	5	1974	10	Mendelian_Nancy_Cox	REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS
0.253292806484%	5	1974	10	Mendelian_Nancy_Cox	MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP
0.253292806484%	5	1974	10	Mendelian_Nancy_Cox	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1
0.253292806484%	5	1974	10	Mendelian_Nancy_Cox	BIOCARTA_GLYCOLYSIS_PATHWAY
0.236406619385%	3	1269	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PYEON_HPV_POSITIVE_TUMORS_UP
0.236406619385%	3	1269	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HAHTOLA_SEZARY_SYNDROM_UP
0.236406619385%	3	1269	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN
0.236406619385%	3	1269	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_MIDDLE
0.236406619385%	3	1269	97	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP
0.236406619385%	3	1269	96	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIU_PROSTATE_CANCER_UP
0.236406619385%	3	1269	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WINTER_HYPOXIA_UP
0.236406619385%	3	1269	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_MYCN_AMPLIFICATION_TARGETS_UP
0.236406619385%	3	1269	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
0.236406619385%	3	1269	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_9
0.236406619385%	3	1269	91	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
0.236406619385%	3	1269	91	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_P6
0.236406619385%	3	1269	90	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SASSON_RESPONSE_TO_FORSKOLIN_UP
0.236406619385%	3	1269	90	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SANA_TNF_SIGNALING_DN
0.236406619385%	3	1269	90	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MORI_IMMATURE_B_LYMPHOCYTE_DN
0.236406619385%	3	1269	90	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_GAP_JUNCTION
0.236406619385%	3	1269	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1
0.236406619385%	3	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SWEET_KRAS_ONCOGENIC_SIGNATURE
0.236406619385%	3	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SEIDEN_ONCOGENESIS_BY_MET
0.236406619385%	3	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_RIBOSOME
0.236406619385%	3	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DURCHDEWALD_SKIN_CARCINOGENESIS_UP
0.236406619385%	3	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.236406619385%	3	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMITH_TERT_TARGETS_DN
0.236406619385%	3	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
0.236406619385%	3	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ERBB_SIGNALING_PATHWAY
0.236406619385%	3	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
0.236406619385%	3	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
0.236406619385%	3	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
0.236406619385%	3	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TAKAO_RESPONSE_TO_UVB_RADIATION_UP
0.236406619385%	3	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NELSON_RESPONSE_TO_ANDROGEN_UP
0.236406619385%	3	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LAIHO_COLORECTAL_CANCER_SERRATED_DN
0.236406619385%	3	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_TGF_BETA_SIGNALING_PATHWAY
0.236406619385%	3	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
0.236406619385%	3	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_16HR_DN
0.236406619385%	3	1269	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
0.236406619385%	3	1269	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
0.236406619385%	3	1269	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	COLDREN_GEFITINIB_RESISTANCE_UP
0.236406619385%	3	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
0.236406619385%	3	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_CMYB_PATHWAY
0.236406619385%	3	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_SMALL_CELL_LUNG_CANCER
0.236406619385%	3	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
0.236406619385%	3	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHANG_IMMORTALIZED_BY_HPV31_UP
0.236406619385%	3	1269	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS
0.236406619385%	3	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
0.236406619385%	3	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	COATES_MACROPHAGE_M1_VS_M2_UP
0.236406619385%	3	1269	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHUHMACHER_MYC_TARGETS_UP
0.236406619385%	3	1269	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_UNFOLDED_PROTEIN_RESPONSE
0.236406619385%	3	1269	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16
0.236406619385%	3	1269	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT
0.236406619385%	3	1269	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_MYC_ACTIVPATHWAY
0.236406619385%	3	1269	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
0.236406619385%	3	1269	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
0.236406619385%	3	1269	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CROMER_METASTASIS_UP
0.236406619385%	3	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROSS_AML_WITH_MLL_FUSIONS
0.236406619385%	3	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.236406619385%	3	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_SCF_KIT
0.236406619385%	3	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PEROXISOME
0.236406619385%	3	1269	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROSS_AML_WITH_PML_RARA_FUSION
0.236406619385%	3	1269	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RODRIGUES_THYROID_CARCINOMA_DN
0.236406619385%	3	1269	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN
0.236406619385%	3	1269	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CARD_MIR302A_TARGETS
0.236406619385%	3	1269	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.236406619385%	3	1269	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
0.236406619385%	3	1269	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION
0.236406619385%	3	1269	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
0.236406619385%	3	1269	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PEART_HDAC_PROLIFERATION_CLUSTER_DN
0.236406619385%	3	1269	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_VEGF_SIGNALING_PATHWAY
0.236406619385%	3	1269	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
0.236406619385%	3	1269	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MORI_MATURE_B_LYMPHOCYTE_DN
0.236406619385%	3	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHEPARD_BMYB_TARGETS
0.236406619385%	3	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RAMALHO_STEMNESS_DN
0.236406619385%	3	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
0.236406619385%	3	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN
0.236406619385%	3	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DER_IFN_ALPHA_RESPONSE_UP
0.236406619385%	3	1269	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.236406619385%	3	1269	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
0.236406619385%	3	1269	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DITTMER_PTHLH_TARGETS_DN
0.236406619385%	3	1269	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.236406619385%	3	1269	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
0.236406619385%	3	1269	71	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.236406619385%	3	1269	71	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
0.236406619385%	3	1269	71	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KYNG_RESPONSE_TO_H2O2
0.236406619385%	3	1269	71	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GU_PDEF_TARGETS_UP
0.236406619385%	3	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_CDC42_PATHWAY
0.236406619385%	3	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIU_NASOPHARYNGEAL_CARCINOMA
0.236406619385%	3	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_LONG_TERM_DEPRESSION
0.236406619385%	3	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
0.236406619385%	3	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZAMORA_NOS2_TARGETS_UP
0.236406619385%	3	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.236406619385%	3	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RIZKI_TUMOR_INVASIVENESS_2D_UP
0.236406619385%	3	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RHODES_UNDIFFERENTIATED_CANCER
0.236406619385%	3	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.236406619385%	3	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
0.236406619385%	3	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_120_HELA
0.236406619385%	3	1269	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
0.236406619385%	3	1269	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROSS_AML_OF_FAB_M7_TYPE
0.236406619385%	3	1269	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_TELOMERASEPATHWAY
0.236406619385%	3	1269	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIN_NPAS4_TARGETS_DN
0.236406619385%	3	1269	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
0.236406619385%	3	1269	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES
0.236406619385%	3	1269	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.236406619385%	3	1269	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP
0.236406619385%	3	1269	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G1
0.236406619385%	3	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
0.236406619385%	3	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES
0.236406619385%	3	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_TCR_PATHWAY
0.236406619385%	3	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_LYSOPHOSPHOLIPID_PATHWAY
0.236406619385%	3	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_LIVER_CANCER_CIPROFIBRATE_DN
0.236406619385%	3	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP
0.236406619385%	3	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BEIER_GLIOMA_STEM_CELL_DN
0.236406619385%	3	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_FAS_SIGNALING_PATHWAY
0.236406619385%	3	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHANG_IMMORTALIZED_BY_HPV31_DN
0.236406619385%	3	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP
0.236406619385%	3	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHANG_GATA6_TARGETS_DN
0.236406619385%	3	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_LIVER_CANCER_MYC_E2F1_DN
0.236406619385%	3	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_LIVER_CANCER_E2F1_DN
0.236406619385%	3	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
0.236406619385%	3	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
0.236406619385%	3	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
0.236406619385%	3	1269	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_ENDOTHELINPATHWAY
0.236406619385%	3	1269	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
0.236406619385%	3	1269	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.236406619385%	3	1269	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BILBAN_B_CLL_LPL_UP
0.236406619385%	3	1269	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KORKOLA_YOLK_SAC_TUMOR
0.236406619385%	3	1269	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS
0.236406619385%	3	1269	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MASSARWEH_RESPONSE_TO_ESTRADIOL
0.236406619385%	3	1269	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GENTILE_RESPONSE_CLUSTER_D3
0.236406619385%	3	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_FAK_PATHWAY
0.236406619385%	3	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
0.236406619385%	3	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WAKASUGI_HAVE_ZNF143_BINDING_SITES
0.236406619385%	3	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
0.236406619385%	3	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT
0.236406619385%	3	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NADLER_HYPERGLYCEMIA_AT_OBESITY
0.236406619385%	3	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.236406619385%	3	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LUCAS_HNF4A_TARGETS_UP
0.236406619385%	3	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TONG_INTERACT_WITH_PTTG1
0.236406619385%	3	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCCLUNG_CREB1_TARGETS_DN
0.236406619385%	3	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_EARLY_T_LYMPHOCYTE_DN
0.236406619385%	3	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMIT_SERUM_RESPONSE_60_MCF10A
0.236406619385%	3	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MAYBURD_RESPONSE_TO_L663536_DN
0.236406619385%	3	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HENDRICKS_SMARCA4_TARGETS_UP
0.236406619385%	3	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
0.236406619385%	3	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SU_LIVER
0.236406619385%	3	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR
0.236406619385%	3	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TCR_SIGNALING
0.236406619385%	3	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHU_CMV_8_HR_DN
0.236406619385%	3	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN
0.236406619385%	3	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROSS_AML_WITH_CBFB_MYH11_FUSION
0.236406619385%	3	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_CASPASE_PATHWAY
0.236406619385%	3	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_STARCH_AND_SUCROSE_METABOLISM
0.236406619385%	3	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIBA_RESPONSE_TO_TSA_UP
0.236406619385%	3	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN
0.236406619385%	3	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
0.236406619385%	3	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHANG_PROLIFERATING_VS_QUIESCENT
0.236406619385%	3	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
0.236406619385%	3	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT
0.236406619385%	3	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MORI_PLASMA_CELL_UP
0.236406619385%	3	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LUI_THYROID_CANCER_CLUSTER_1
0.236406619385%	3	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GUILLAUMOND_KLF10_TARGETS_UP
0.236406619385%	3	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_ANGIOPOIETINRECEPTOR_PATHWAY
0.236406619385%	3	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NADERI_BREAST_CANCER_PROGNOSIS_UP
0.236406619385%	3	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARTINEZ_RESPONSE_TO_TRABECTEDIN
0.236406619385%	3	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIBA_RESPONSE_TO_TSA
0.236406619385%	3	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS
0.236406619385%	3	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_TCR_PATHWAY
0.236406619385%	3	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RASHI_RESPONSE_TO_IONIZING_RADIATION_3
0.236406619385%	3	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_HES_HEYPATHWAY
0.236406619385%	3	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NADLER_OBESITY_DN
0.236406619385%	3	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
0.236406619385%	3	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
0.236406619385%	3	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHU_CMV_8_HR_UP
0.236406619385%	3	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP
0.236406619385%	3	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_DELTANP63PATHWAY
0.236406619385%	3	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IRITANI_MAD1_TARGETS_DN
0.236406619385%	3	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C5
0.236406619385%	3	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SAGIV_CD24_TARGETS_DN
0.236406619385%	3	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
0.236406619385%	3	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_TNFPATHWAY
0.236406619385%	3	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_PS1PATHWAY
0.236406619385%	3	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_A6B1_A6B4_INTEGRIN_PATHWAY
0.236406619385%	3	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NUTT_GBM_VS_AO_GLIOMA_UP
0.236406619385%	3	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_AGING_MUSCLE_DN
0.236406619385%	3	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_KERATINOCYTE_PATHWAY
0.236406619385%	3	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_60_HELA
0.236406619385%	3	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD2_UP
0.236406619385%	3	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_T_CELL_SIGNAL_TRANSDUCTION
0.236406619385%	3	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
0.236406619385%	3	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_INSULIN_PATHWAY
0.236406619385%	3	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NUTT_GBM_VS_AO_GLIOMA_DN
0.236406619385%	3	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KLEIN_TARGETS_OF_BCR_ABL1_FUSION
0.236406619385%	3	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRADE_METASTASIS_DN
0.236406619385%	3	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ABRAMSON_INTERACT_WITH_AIRE
0.236406619385%	3	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.236406619385%	3	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STREICHER_LSM1_TARGETS_UP
0.236406619385%	3	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_ERBB2ERBB3PATHWAY
0.236406619385%	3	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MA_MYELOID_DIFFERENTIATION_DN
0.236406619385%	3	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM
0.236406619385%	3	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HARRIS_BRAIN_CANCER_PROGENITORS
0.236406619385%	3	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION_12HR
0.236406619385%	3	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	POTTI_ETOPOSIDE_SENSITIVITY
0.236406619385%	3	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_CALORIE_RESTRICTION_MUSCLE_UP
0.236406619385%	3	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
0.236406619385%	3	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
0.236406619385%	3	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRNA_AMINOACYLATION
0.236406619385%	3	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LUI_THYROID_CANCER_CLUSTER_2
0.236406619385%	3	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_BLADDER_CANCER
0.236406619385%	3	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION_HBZ
0.236406619385%	3	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_IL_2_SIGNALING
0.236406619385%	3	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_AMB2_NEUTROPHILS_PATHWAY
0.236406619385%	3	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_FCER1_PATHWAY
0.236406619385%	3	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.236406619385%	3	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TOMLINS_PROSTATE_CANCER_UP
0.236406619385%	3	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_JNK_MAPK_PATHWAY
0.236406619385%	3	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_IFNGPATHWAY
0.236406619385%	3	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_LSD1_TARGETS_DN
0.236406619385%	3	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_RET_PATHWAY
0.236406619385%	3	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NEWMAN_ERCC6_TARGETS_DN
0.236406619385%	3	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D5
0.236406619385%	3	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS
0.236406619385%	3	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN
0.236406619385%	3	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHANDRAN_METASTASIS_TOP50_UP
0.236406619385%	3	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CERVERA_SDHB_TARGETS_1_DN
0.236406619385%	3	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN
0.236406619385%	3	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS
0.236406619385%	3	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_GMCSF_PATHWAY
0.236406619385%	3	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MURAKAMI_UV_RESPONSE_6HR_UP
0.236406619385%	3	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES
0.236406619385%	3	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_PAR1_PATHWAY
0.236406619385%	3	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_GPCR_PATHWAY
0.236406619385%	3	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_BCR_PATHWAY
0.236406619385%	3	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VALK_AML_CLUSTER_11
0.236406619385%	3	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOUSTIS_ROS
0.236406619385%	3	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP
0.236406619385%	3	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_BASE_EXCISION_REPAIR
0.236406619385%	3	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE
0.236406619385%	3	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_EPOPATHWAY
0.236406619385%	3	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RNA_POL_III_TRANSCRIPTION
0.236406619385%	3	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_12HR_DN
0.236406619385%	3	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_DAG_AND_IP3_SIGNALING
0.236406619385%	3	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIANG_SILENCED_BY_METHYLATION_UP
0.236406619385%	3	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_PYK2_PATHWAY
0.236406619385%	3	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
0.236406619385%	3	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	URS_ADIPOCYTE_DIFFERENTIATION_DN
0.236406619385%	3	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN
0.236406619385%	3	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_CDC42_REG_PATHWAY
0.236406619385%	3	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.236406619385%	3	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_LRRC3B_TARGETS
0.236406619385%	3	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GILDEA_METASTASIS
0.236406619385%	3	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP
0.236406619385%	3	1269	292	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HELLER_HDAC_TARGETS_DN
0.236406619385%	3	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WATANABE_COLON_CANCER_MSI_VS_MSS_UP
0.236406619385%	3	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_VIP_PATHWAY
0.236406619385%	3	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KAMIKUBO_MYELOID_CEBPA_NETWORK
0.236406619385%	3	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES
0.236406619385%	3	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OHM_METHYLATED_IN_ADULT_CANCERS
0.236406619385%	3	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_RXR_VDR_PATHWAY
0.236406619385%	3	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.236406619385%	3	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_GALACTOSE_METABOLISM
0.236406619385%	3	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BRACHAT_RESPONSE_TO_METHOTREXATE_UP
0.236406619385%	3	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_BAD_PATHWAY
0.236406619385%	3	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ABBUD_LIF_SIGNALING_1_DN
0.236406619385%	3	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SMOOTH_MUSCLE_CONTRACTION
0.236406619385%	3	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS
0.236406619385%	3	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_MCALPAIN_PATHWAY
0.236406619385%	3	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.236406619385%	3	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER
0.236406619385%	3	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MAHADEVAN_IMATINIB_RESISTANCE_UP
0.236406619385%	3	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.236406619385%	3	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIBA_RESPONSE_TO_TSA_DN
0.236406619385%	3	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_RAC1_PATHWAY
0.236406619385%	3	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CCR3_PATHWAY
0.236406619385%	3	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BILANGES_SERUM_SENSITIVE_VIA_TSC1
0.236406619385%	3	1269	228	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
0.236406619385%	3	1269	227	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.236406619385%	3	1269	223	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.236406619385%	3	1269	221	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PEDRIOLI_MIR31_TARGETS_UP
0.236406619385%	3	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WEBER_METHYLATED_ICP_IN_FIBROBLAST
0.236406619385%	3	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.236406619385%	3	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_METAL_ION_SLC_TRANSPORTERS
0.236406619385%	3	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
0.236406619385%	3	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS
0.236406619385%	3	1269	217	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WONG_MITOCHONDRIA_GENE_MODULE
0.236406619385%	3	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STEGER_ADIPOGENESIS_UP
0.236406619385%	3	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_ECADHERIN_KERATINOCYTE_PATHWAY
0.236406619385%	3	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_IGF1_PATHWAY
0.236406619385%	3	1269	207	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KARLSSON_TGFB1_TARGETS_DN
0.236406619385%	3	1269	198	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WELCSH_BRCA1_TARGETS_UP
0.236406619385%	3	1269	198	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.236406619385%	3	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_LAGGING_STRAND_SYNTHESIS
0.236406619385%	3	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KANG_CISPLATIN_RESISTANCE_UP
0.236406619385%	3	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_MAL_PATHWAY
0.236406619385%	3	1269	182	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
0.236406619385%	3	1269	182	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
0.236406619385%	3	1269	181	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JISON_SICKLE_CELL_DISEASE_UP
0.236406619385%	3	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOWIE_RESPONSE_TO_TAMOXIFEN
0.236406619385%	3	1269	179	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE
0.236406619385%	3	1269	176	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX
0.236406619385%	3	1269	176	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
0.236406619385%	3	1269	175	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.236406619385%	3	1269	175	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_LIVER_CANCER_SURVIVAL_DN
0.236406619385%	3	1269	170	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
0.236406619385%	3	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
0.236406619385%	3	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIU_IL13_MEMORY_MODEL_UP
0.236406619385%	3	1269	166	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMIRNOV_RESPONSE_TO_IR_6HR_UP
0.236406619385%	3	1269	163	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIN_NPAS4_TARGETS_UP
0.236406619385%	3	1269	163	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2
0.236406619385%	3	1269	161	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_MRNA_PROCESSING
0.236406619385%	3	1269	161	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIDUS_METASTASIS_DN
0.236406619385%	3	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_RECURRENT_LIVER_CANCER_DN
0.236406619385%	3	1269	159	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
0.236406619385%	3	1269	158	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON
0.236406619385%	3	1269	157	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN
0.236406619385%	3	1269	157	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
0.236406619385%	3	1269	153	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DURAND_STROMA_MAX_DN
0.236406619385%	3	1269	150	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
0.236406619385%	3	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP
0.236406619385%	3	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ZINC_TRANSPORTERS
0.236406619385%	3	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND
0.236406619385%	3	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_THROMBIN_PAR4_PATHWAY
0.236406619385%	3	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	EHRLICH_ICF_SYNDROM_DN
0.236406619385%	3	1269	149	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
0.236406619385%	3	1269	149	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TSAI_RESPONSE_TO_IONIZING_RADIATION
0.236406619385%	3	1269	149	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OHGUCHI_LIVER_HNF4A_TARGETS_DN
0.236406619385%	3	1269	147	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_G1_S
0.236406619385%	3	1269	146	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PECE_MAMMARY_STEM_CELL_UP
0.236406619385%	3	1269	146	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PECE_MAMMARY_STEM_CELL_DN
0.236406619385%	3	1269	146	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_NEURAL_CREST_STEM_CELL_UP
0.236406619385%	3	1269	146	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
0.236406619385%	3	1269	142	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RUIZ_TNC_TARGETS_DN
0.236406619385%	3	1269	142	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP
0.236406619385%	3	1269	141	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SABATES_COLORECTAL_ADENOMA_UP
0.236406619385%	3	1269	140	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JOHNSTONE_PARVB_TARGETS_2_UP
0.236406619385%	3	1269	140	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP
0.236406619385%	3	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TOMLINS_METASTASIS_UP
0.236406619385%	3	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_ES_LCP_WITH_H3K27ME3
0.236406619385%	3	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
0.236406619385%	3	1269	138	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JIANG_VHL_TARGETS
0.236406619385%	3	1269	138	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
0.236406619385%	3	1269	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
0.236406619385%	3	1269	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIU_SOX4_TARGETS_UP
0.236406619385%	3	1269	136	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PROVENZANI_METASTASIS_DN
0.236406619385%	3	1269	136	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.236406619385%	3	1269	135	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SERVITJA_LIVER_HNF1A_TARGETS_UP
0.236406619385%	3	1269	134	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHUNG_BLISTER_CYTOTOXICITY_UP
0.236406619385%	3	1269	133	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SENESE_HDAC2_TARGETS_DN
0.236406619385%	3	1269	132	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
0.236406619385%	3	1269	131	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.236406619385%	3	1269	129	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_WT1_TARGETS_8HR_DN
0.236406619385%	3	1269	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	POTTI_TOPOTECAN_SENSITIVITY
0.236406619385%	3	1269	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_SPLICEOSOME
0.236406619385%	3	1269	127	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	INGRAM_SHH_TARGETS_UP
0.236406619385%	3	1269	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
0.236406619385%	3	1269	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.236406619385%	3	1269	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP
0.236406619385%	3	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TAGHAVI_NEOPLASTIC_TRANSFORMATION
0.236406619385%	3	1269	118	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP
0.236406619385%	3	1269	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
0.236406619385%	3	1269	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LI_INDUCED_T_TO_NATURAL_KILLER_DN
0.236406619385%	3	1269	115	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARZEC_IL2_SIGNALING_UP
0.236406619385%	3	1269	115	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARKEY_RB1_CHRONIC_LOF_UP
0.236406619385%	3	1269	115	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_SUBCLASS_S2
0.236406619385%	3	1269	114	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMIRNOV_RESPONSE_TO_IR_6HR_DN
0.236406619385%	3	1269	114	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROPERO_HDAC2_TARGETS
0.236406619385%	3	1269	113	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RICKMAN_HEAD_AND_NECK_CANCER_C
0.236406619385%	3	1269	113	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
0.236406619385%	3	1269	112	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_G1_S_TRANSITION
0.236406619385%	3	1269	111	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_HCP_PROSTATE_CANCER
0.236406619385%	3	1269	111	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
0.236406619385%	3	1269	111	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.236406619385%	3	1269	111	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_12HR_UP
0.236406619385%	3	1269	110	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHENG_IMPRINTED_BY_ESTRADIOL
0.236406619385%	3	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHOU_PANCREATIC_EXOCRINE_PROGENITOR
0.236406619385%	3	1269	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
0.236406619385%	3	1269	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
0.236406619385%	3	1269	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.236406619385%	3	1269	107	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROESSLER_LIVER_CANCER_METASTASIS_UP
0.236406619385%	3	1269	107	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_ILS
0.236406619385%	3	1269	105	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZWANG_EGF_INTERVAL_UP
0.236406619385%	3	1269	105	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WOO_LIVER_CANCER_RECURRENCE_UP
0.236406619385%	3	1269	105	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RNA_POL_II_TRANSCRIPTION
0.236406619385%	3	1269	104	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE
0.236406619385%	3	1269	103	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_NOTCH
0.236406619385%	3	1269	103	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEIN_CHOROID_PLEXUS_MARKERS
0.236406619385%	3	1269	103	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.236406619385%	3	1269	102	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_CXCR4_PATHWAY
0.236406619385%	3	1269	102	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LABBE_TGFB1_TARGETS_UP
0.236406619385%	3	1269	102	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.23023791251%	3	1303	98	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
0.23023791251%	3	1303	98	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_PYRIMIDINE_METABOLISM
0.23023791251%	3	1303	98	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_MIDDLE
0.23023791251%	3	1303	97	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP
0.23023791251%	3	1303	97	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
0.23023791251%	3	1303	95	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HECKER_IFNB1_TARGETS
0.23023791251%	3	1303	95	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
0.23023791251%	3	1303	94	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5
0.23023791251%	3	1303	94	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES
0.23023791251%	3	1303	93	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHU_CMV_24_HR_UP
0.23023791251%	3	1303	93	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
0.23023791251%	3	1303	93	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHEN_LIVER_METABOLISM_QTL_CIS
0.23023791251%	3	1303	92	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
0.23023791251%	3	1303	92	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_MYCN_AMPLIFICATION_TARGETS_UP
0.23023791251%	3	1303	92	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_DILATED_CARDIOMYOPATHY
0.23023791251%	3	1303	92	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
0.23023791251%	3	1303	92	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_9
0.23023791251%	3	1303	92	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
0.23023791251%	3	1303	91	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
0.23023791251%	3	1303	91	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.23023791251%	3	1303	90	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MORI_MATURE_B_LYMPHOCYTE_UP
0.23023791251%	3	1303	90	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MORI_IMMATURE_B_LYMPHOCYTE_DN
0.23023791251%	3	1303	90	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IVANOVSKA_MIR106B_TARGETS
0.23023791251%	3	1303	90	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IGARASHI_ATF4_TARGETS_DN
0.23023791251%	3	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_UP
0.23023791251%	3	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SWEET_KRAS_ONCOGENIC_SIGNATURE
0.23023791251%	3	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
0.23023791251%	3	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION
0.23023791251%	3	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KANG_IMMORTALIZED_BY_TERT_UP
0.23023791251%	3	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DELASERNA_MYOD_TARGETS_UP
0.23023791251%	3	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BHATTACHARYA_EMBRYONIC_STEM_CELL
0.23023791251%	3	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SASSON_RESPONSE_TO_FORSKOLIN_DN
0.23023791251%	3	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.23023791251%	3	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MITOTIC_PROMETAPHASE
0.23023791251%	3	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION
0.23023791251%	3	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
0.23023791251%	3	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
0.23023791251%	3	1303	86	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.23023791251%	3	1303	86	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
0.23023791251%	3	1303	86	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
0.23023791251%	3	1303	86	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BAELDE_DIABETIC_NEPHROPATHY_UP
0.23023791251%	3	1303	85	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
0.23023791251%	3	1303	85	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	XU_GH1_EXOGENOUS_TARGETS_UP
0.23023791251%	3	1303	85	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SANA_RESPONSE_TO_IFNG_DN
0.23023791251%	3	1303	85	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE
0.23023791251%	3	1303	85	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEIN_CEREBELLUM_MARKERS
0.23023791251%	3	1303	84	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP
0.23023791251%	3	1303	84	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
0.23023791251%	3	1303	84	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S
0.23023791251%	3	1303	84	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_ECM_RECEPTOR_INTERACTION
0.23023791251%	3	1303	84	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
0.23023791251%	3	1303	83	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP
0.23023791251%	3	1303	82	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_SMAD2_3NUCLEARPATHWAY
0.23023791251%	3	1303	82	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEIN_MIDBRAIN_MARKERS
0.23023791251%	3	1303	82	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BILD_CTNNB1_ONCOGENIC_SIGNATURE
0.23023791251%	3	1303	81	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
0.23023791251%	3	1303	81	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
0.23023791251%	3	1303	81	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_M_G1_TRANSITION
0.23023791251%	3	1303	81	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	COATES_MACROPHAGE_M1_VS_M2_UP
0.23023791251%	3	1303	80	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MORI_PRE_BI_LYMPHOCYTE_UP
0.23023791251%	3	1303	80	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LINDVALL_IMMORTALIZED_BY_TERT_DN
0.23023791251%	3	1303	80	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.23023791251%	3	1303	80	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN
0.23023791251%	3	1303	80	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.23023791251%	3	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7
0.23023791251%	3	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3
0.23023791251%	3	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT
0.23023791251%	3	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MEISSNER_NPC_HCP_WITH_H3K27ME3
0.23023791251%	3	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCCLUNG_COCAINE_REWARD_5D
0.23023791251%	3	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.23023791251%	3	1303	78	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SANA_RESPONSE_TO_IFNG_UP
0.23023791251%	3	1303	78	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.23023791251%	3	1303	78	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_SCF_KIT
0.23023791251%	3	1303	78	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.23023791251%	3	1303	78	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE
0.23023791251%	3	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
0.23023791251%	3	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROSS_AML_WITH_PML_RARA_FUSION
0.23023791251%	3	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RODRIGUES_THYROID_CARCINOMA_DN
0.23023791251%	3	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION
0.23023791251%	3	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JACKSON_DNMT1_TARGETS_UP
0.23023791251%	3	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_HIF1A_UP
0.23023791251%	3	1303	76	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MAHAJAN_RESPONSE_TO_IL1A_DN
0.23023791251%	3	1303	75	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TELOMERE_MAINTENANCE
0.23023791251%	3	1303	75	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MORI_MATURE_B_LYMPHOCYTE_DN
0.23023791251%	3	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WESTON_VEGFA_TARGETS_3HR
0.23023791251%	3	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
0.23023791251%	3	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
0.23023791251%	3	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DARWICHE_PAPILLOMA_PROGRESSION_RISK
0.23023791251%	3	1303	73	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.23023791251%	3	1303	73	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
0.23023791251%	3	1303	73	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
0.23023791251%	3	1303	73	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_VIRAL_MYOCARDITIS
0.23023791251%	3	1303	72	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1
0.23023791251%	3	1303	72	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MATZUK_SPERMATOCYTE
0.23023791251%	3	1303	72	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_2
0.23023791251%	3	1303	71	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_MELANOMA
0.23023791251%	3	1303	71	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
0.23023791251%	3	1303	70	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.23023791251%	3	1303	70	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RAGHAVACHARI_PLATELET_SPECIFIC_GENES
0.23023791251%	3	1303	70	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_CDC42_PATHWAY
0.23023791251%	3	1303	70	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_PANCREATIC_CANCER
0.23023791251%	3	1303	70	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
0.23023791251%	3	1303	70	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CADWELL_ATG16L1_TARGETS_DN
0.23023791251%	3	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.23023791251%	3	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RHODES_UNDIFFERENTIATED_CANCER
0.23023791251%	3	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_VEGFR1_2_PATHWAY
0.23023791251%	3	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
0.23023791251%	3	1303	68	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROSS_AML_OF_FAB_M7_TYPE
0.23023791251%	3	1303	68	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SEMAPHORIN_INTERACTIONS
0.23023791251%	3	1303	68	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
0.23023791251%	3	1303	68	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DELPUECH_FOXO3_TARGETS_UP
0.23023791251%	3	1303	67	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
0.23023791251%	3	1303	67	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.23023791251%	3	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TENEDINI_MEGAKARYOCYTE_MARKERS
0.23023791251%	3	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SWEET_KRAS_TARGETS_DN
0.23023791251%	3	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RAMASWAMY_METASTASIS_UP
0.23023791251%	3	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_LYSOPHOSPHOLIPID_PATHWAY
0.23023791251%	3	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_GERMINAL_CENTER_T_HELPER_UP
0.23023791251%	3	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.23023791251%	3	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.23023791251%	3	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
0.23023791251%	3	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_BCR_5PATHWAY
0.23023791251%	3	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMIT_SERUM_RESPONSE_120_MCF10A
0.23023791251%	3	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C
0.23023791251%	3	1303	63	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
0.23023791251%	3	1303	63	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_ENDOTHELINPATHWAY
0.23023791251%	3	1303	63	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PHONG_TNF_TARGETS_UP
0.23023791251%	3	1303	63	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
0.23023791251%	3	1303	63	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_PEAK_AT_0HR
0.23023791251%	3	1303	62	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_LIVER_CANCER_E2F1_UP
0.23023791251%	3	1303	62	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
0.23023791251%	3	1303	62	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_COLORECTAL_CANCER
0.23023791251%	3	1303	62	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CORRE_MULTIPLE_MYELOMA_DN
0.23023791251%	3	1303	62	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP
0.23023791251%	3	1303	61	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REN_BOUND_BY_E2F
0.23023791251%	3	1303	61	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS
0.23023791251%	3	1303	61	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RAMASWAMY_METASTASIS_DN
0.23023791251%	3	1303	61	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KAUFFMANN_MELANOMA_RELAPSE_UP
0.23023791251%	3	1303	61	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GENTILE_RESPONSE_CLUSTER_D3
0.23023791251%	3	1303	60	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
0.23023791251%	3	1303	60	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING
0.23023791251%	3	1303	60	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_ACUTE_MYELOID_LEUKEMIA
0.23023791251%	3	1303	60	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
0.23023791251%	3	1303	59	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
0.23023791251%	3	1303	59	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_P53REGULATIONPATHWAY
0.23023791251%	3	1303	59	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1
0.23023791251%	3	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT
0.23023791251%	3	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
0.23023791251%	3	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BERNARD_PPAPDC1B_TARGETS_DN
0.23023791251%	3	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TONG_INTERACT_WITH_PTTG1
0.23023791251%	3	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.23023791251%	3	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP
0.23023791251%	3	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_METASTASIS_UP
0.23023791251%	3	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_VIBRIO_CHOLERAE_INFECTION
0.23023791251%	3	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRADE_COLON_VS_RECTAL_CANCER_DN
0.23023791251%	3	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_10HR_DN
0.23023791251%	3	1303	55	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YU_MYC_TARGETS_DN
0.23023791251%	3	1303	55	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LAU_APOPTOSIS_CDKN2A_UP
0.23023791251%	3	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_APOPTOTIC_EXECUTION_PHASE
0.23023791251%	3	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN
0.23023791251%	3	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_NON_SMALL_CELL_LUNG_CANCER
0.23023791251%	3	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROESSLER_LIVER_CANCER_METASTASIS_DN
0.23023791251%	3	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS
0.23023791251%	3	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
0.23023791251%	3	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IKEDA_MIR1_TARGETS_UP
0.23023791251%	3	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HENDRICKS_SMARCA4_TARGETS_DN
0.23023791251%	3	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN
0.23023791251%	3	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM
0.23023791251%	3	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_PTP1BPATHWAY
0.23023791251%	3	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_KITPATHWAY
0.23023791251%	3	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP
0.23023791251%	3	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
0.23023791251%	3	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PRAMOONJAGO_SOX4_TARGETS_DN
0.23023791251%	3	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BYSTROEM_CORRELATED_WITH_IL5_UP
0.23023791251%	3	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.23023791251%	3	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC
0.23023791251%	3	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN
0.23023791251%	3	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN
0.23023791251%	3	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_HP_UP
0.23023791251%	3	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM
0.23023791251%	3	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.23023791251%	3	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_LIVER_CANCER
0.23023791251%	3	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.23023791251%	3	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_HES_HEYPATHWAY
0.23023791251%	3	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_CERAMIDE_PATHWAY
0.23023791251%	3	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OXFORD_RALA_OR_RALB_TARGETS_UP
0.23023791251%	3	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN
0.23023791251%	3	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
0.23023791251%	3	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ENGELMANN_CANCER_PROGENITORS_UP
0.23023791251%	3	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.23023791251%	3	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DOANE_BREAST_CANCER_ESR1_DN
0.23023791251%	3	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_4
0.23023791251%	3	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WARTERS_IR_RESPONSE_5GY
0.23023791251%	3	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	POTTI_DOCETAXEL_SENSITIVITY
0.23023791251%	3	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP
0.23023791251%	3	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_FANCONI_PATHWAY
0.23023791251%	3	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MELLMAN_TUT1_TARGETS_DN
0.23023791251%	3	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP
0.23023791251%	3	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WINNEPENNINCKX_MELANOMA_METASTASIS_DN
0.23023791251%	3	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT
0.23023791251%	3	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_RHOA_REG_PATHWAY
0.23023791251%	3	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON
0.23023791251%	3	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAKAJIMA_MAST_CELL
0.23023791251%	3	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KRASNOSELSKAYA_ILF3_TARGETS_DN
0.23023791251%	3	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_N_GLYCAN_BIOSYNTHESIS
0.23023791251%	3	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN
0.23023791251%	3	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_PR_UP
0.23023791251%	3	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_T_CELL_SIGNAL_TRANSDUCTION
0.23023791251%	3	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_
0.23023791251%	3	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN
0.23023791251%	3	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRADE_METASTASIS_DN
0.23023791251%	3	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHENG_RESPONSE_TO_NICKEL_ACETATE
0.23023791251%	3	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_LITERATURE
0.23023791251%	3	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STREICHER_LSM1_TARGETS_UP
0.23023791251%	3	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTIN_INTERACT_WITH_HDAC
0.23023791251%	3	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION
0.23023791251%	3	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
0.23023791251%	3	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM
0.23023791251%	3	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FAELT_B_CLL_WITH_VH3_21_UP
0.23023791251%	3	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION_12HR
0.23023791251%	3	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN
0.23023791251%	3	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAKAMURA_METASTASIS_MODEL_DN
0.23023791251%	3	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_CALORIE_RESTRICTION_MUSCLE_UP
0.23023791251%	3	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
0.23023791251%	3	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
0.23023791251%	3	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP
0.23023791251%	3	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_BLADDER_CANCER
0.23023791251%	3	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN
0.23023791251%	3	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_ERBB1_INTERNALIZATION_PATHWAY
0.23023791251%	3	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DELPUECH_FOXO3_TARGETS_DN
0.23023791251%	3	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TOMLINS_PROSTATE_CANCER_UP
0.23023791251%	3	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_JNK_MAPK_PATHWAY
0.23023791251%	3	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION_6HR
0.23023791251%	3	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
0.23023791251%	3	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN
0.23023791251%	3	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D8
0.23023791251%	3	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_48HR_DN
0.23023791251%	3	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.23023791251%	3	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BENPORATH_ES_2
0.23023791251%	3	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1
0.23023791251%	3	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP
0.23023791251%	3	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MA_MYELOID_DIFFERENTIATION_UP
0.23023791251%	3	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_32HR_DN
0.23023791251%	3	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BILANGES_SERUM_SENSITIVE_VIA_TSC2
0.23023791251%	3	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_60_MCF10A
0.23023791251%	3	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VALK_AML_WITH_CEBPA
0.23023791251%	3	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_GA13_PATHWAY
0.23023791251%	3	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2
0.23023791251%	3	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2
0.23023791251%	3	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MMS_MOUSE_LYMPH_HIGH_4HRS_UP
0.23023791251%	3	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARZEC_IL2_SIGNALING_DN
0.23023791251%	3	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_DNA_REPLICATION
0.23023791251%	3	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP
0.23023791251%	3	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP
0.23023791251%	3	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_AT1R_PATHWAY
0.23023791251%	3	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAGI_AML_RELAPSE_PROGNOSIS
0.23023791251%	3	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.23023791251%	3	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WEIGEL_OXIDATIVE_STRESS_RESPONSE
0.23023791251%	3	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AIGNER_ZEB1_TARGETS
0.23023791251%	3	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_BUTANOATE_METABOLISM
0.23023791251%	3	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION
0.23023791251%	3	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PURINE_METABOLISM
0.23023791251%	3	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FARMER_BREAST_CANCER_CLUSTER_2
0.23023791251%	3	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DUTTA_APOPTOSIS_VIA_NFKB
0.23023791251%	3	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_1
0.23023791251%	3	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN
0.23023791251%	3	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KASLER_HDAC7_TARGETS_2_DN
0.23023791251%	3	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER
0.23023791251%	3	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_PYK2_PATHWAY
0.23023791251%	3	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_MYOSIN_PATHWAY
0.23023791251%	3	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TSENG_ADIPOGENIC_POTENTIAL_UP
0.23023791251%	3	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.23023791251%	3	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
0.23023791251%	3	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G2
0.23023791251%	3	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WATANABE_COLON_CANCER_MSI_VS_MSS_UP
0.23023791251%	3	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX
0.23023791251%	3	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NGUYEN_NOTCH1_TARGETS_UP
0.23023791251%	3	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MA_PITUITARY_FETAL_VS_ADULT_UP
0.23023791251%	3	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_12HR_UP
0.23023791251%	3	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PETROVA_PROX1_TARGETS_UP
0.23023791251%	3	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_HOMOLOGOUS_RECOMBINATION
0.23023791251%	3	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_GH_PATHWAY
0.23023791251%	3	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YE_METASTATIC_LIVER_CANCER
0.23023791251%	3	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_EXTENSION_OF_TELOMERES
0.23023791251%	3	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LOPES_METHYLATED_IN_COLON_CANCER_UP
0.23023791251%	3	1303	267	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.23023791251%	3	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.23023791251%	3	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_PGC1A_PATHWAY
0.23023791251%	3	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YANG_BREAST_CANCER_ESR1_DN
0.23023791251%	3	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_MYC_PATHWAY
0.23023791251%	3	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OXFORD_RALA_OR_RALB_TARGETS_DN
0.23023791251%	3	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP
0.23023791251%	3	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GOLUB_ALL_VS_AML_DN
0.23023791251%	3	1303	238	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
0.23023791251%	3	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B
0.23023791251%	3	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_GA12_PATHWAY
0.23023791251%	3	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER
0.23023791251%	3	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_MISMATCH_REPAIR
0.23023791251%	3	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_CELLCYCLE_PATHWAY
0.23023791251%	3	1303	221	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHANDRAN_METASTASIS_UP
0.23023791251%	3	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.23023791251%	3	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
0.23023791251%	3	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_CERAMIDE_PATHWAY
0.23023791251%	3	1303	217	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMUNDSON_RESPONSE_TO_ARSENITE
0.23023791251%	3	1303	216	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_G2_M
0.23023791251%	3	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WOTTON_RUNX_TARGETS_UP
0.23023791251%	3	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP
0.23023791251%	3	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STEGER_ADIPOGENESIS_UP
0.23023791251%	3	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HASLINGER_B_CLL_WITH_17P13_DELETION
0.23023791251%	3	1303	201	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOLLMANN_APOPTOSIS_VIA_CD40_UP
0.23023791251%	3	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP
0.23023791251%	3	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
0.23023791251%	3	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NIELSEN_LEIOMYOSARCOMA_CNN1_DN
0.23023791251%	3	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G28
0.23023791251%	3	1303	199	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
0.23023791251%	3	1303	197	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
0.23023791251%	3	1303	196	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
0.23023791251%	3	1303	193	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOHANKUMAR_TLX1_TARGETS_DN
0.23023791251%	3	1303	193	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
0.23023791251%	3	1303	191	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAGI_AML_FAB_MARKERS
0.23023791251%	3	1303	191	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.23023791251%	3	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_LAGGING_STRAND_SYNTHESIS
0.23023791251%	3	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAGY_TFTC_COMPONENTS_HUMAN
0.23023791251%	3	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MA_PITUITARY_FETAL_VS_ADULT_DN
0.23023791251%	3	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MATZUK_EMBRYONIC_GERM_CELL
0.23023791251%	3	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_MAL_PATHWAY
0.23023791251%	3	1303	184	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DOANE_RESPONSE_TO_ANDROGEN_UP
0.23023791251%	3	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS
0.23023791251%	3	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.23023791251%	3	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D1
0.23023791251%	3	1303	176	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX
0.23023791251%	3	1303	176	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION
0.23023791251%	3	1303	175	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.23023791251%	3	1303	175	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
0.23023791251%	3	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN
0.23023791251%	3	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INFLAMMASOMES
0.23023791251%	3	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MEISSNER_BRAIN_HCP_WITH_H3K4ME2
0.23023791251%	3	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
0.23023791251%	3	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GALE_APL_WITH_FLT3_MUTATED_DN
0.23023791251%	3	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.23023791251%	3	1303	169	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	UEDA_PERIFERAL_CLOCK
0.23023791251%	3	1303	169	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_ALZHEIMERS_DISEASE
0.23023791251%	3	1303	165	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWN_MYELOID_CELL_DEVELOPMENT_UP
0.23023791251%	3	1303	162	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_S
0.23023791251%	3	1303	161	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIDUS_METASTASIS_DN
0.23023791251%	3	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI
0.23023791251%	3	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ABDELMOHSEN_ELAVL4_TARGETS
0.23023791251%	3	1303	157	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
0.23023791251%	3	1303	155	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_JAK_STAT_SIGNALING_PATHWAY
0.23023791251%	3	1303	153	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LU_AGING_BRAIN_DN
0.23023791251%	3	1303	151	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
0.23023791251%	3	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FERRANDO_LYL1_NEIGHBORS
0.23023791251%	3	1303	149	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TSAI_RESPONSE_TO_IONIZING_RADIATION
0.23023791251%	3	1303	149	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OHGUCHI_LIVER_HNF4A_TARGETS_DN
0.23023791251%	3	1303	148	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHANG_CYCLING_GENES
0.23023791251%	3	1303	145	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.23023791251%	3	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER
0.23023791251%	3	1303	139	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP
0.23023791251%	3	1303	139	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOELZEL_NF1_TARGETS_UP
0.23023791251%	3	1303	139	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
0.23023791251%	3	1303	138	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
0.23023791251%	3	1303	137	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
0.23023791251%	3	1303	137	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
0.23023791251%	3	1303	137	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN
0.23023791251%	3	1303	136	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WIERENGA_STAT5A_TARGETS_GROUP1
0.23023791251%	3	1303	136	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.23023791251%	3	1303	135	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	UDAYAKUMAR_MED1_TARGETS_UP
0.23023791251%	3	1303	135	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TSENG_IRS1_TARGETS_DN
0.23023791251%	3	1303	135	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_OXIDATIVE_PHOSPHORYLATION
0.23023791251%	3	1303	134	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHLOSSER_SERUM_RESPONSE_UP
0.23023791251%	3	1303	134	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_TIGHT_JUNCTION
0.23023791251%	3	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GERHOLD_RESPONSE_TO_TZD_DN
0.23023791251%	3	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN
0.23023791251%	3	1303	129	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_PDGFRBPATHWAY
0.23023791251%	3	1303	129	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_WT1_TARGETS_8HR_DN
0.23023791251%	3	1303	128	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_SPLICEOSOME
0.23023791251%	3	1303	126	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
0.23023791251%	3	1303	126	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.23023791251%	3	1303	122	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TOOKER_GEMCITABINE_RESISTANCE_DN
0.23023791251%	3	1303	121	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.23023791251%	3	1303	121	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
0.23023791251%	3	1303	120	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHU_CMV_ALL_UP
0.23023791251%	3	1303	120	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IWANAGA_CARCINOGENESIS_BY_KRAS_DN
0.23023791251%	3	1303	120	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.23023791251%	3	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CS_DS_DEGRADATION
0.23023791251%	3	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_24HR_UP
0.23023791251%	3	1303	119	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
0.23023791251%	3	1303	118	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
0.23023791251%	3	1303	116	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.23023791251%	3	1303	116	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MEIOSIS
0.23023791251%	3	1303	116	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
0.23023791251%	3	1303	116	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
0.23023791251%	3	1303	115	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARKEY_RB1_CHRONIC_LOF_UP
0.23023791251%	3	1303	115	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION
0.23023791251%	3	1303	114	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMIRNOV_RESPONSE_TO_IR_6HR_DN
0.23023791251%	3	1303	114	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROPERO_HDAC2_TARGETS
0.23023791251%	3	1303	114	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.23023791251%	3	1303	114	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOSCO_TH1_CYTOTOXIC_MODULE
0.23023791251%	3	1303	113	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RICKMAN_HEAD_AND_NECK_CANCER_C
0.23023791251%	3	1303	112	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_G1_S_TRANSITION
0.23023791251%	3	1303	112	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LABBE_WNT3A_TARGETS_UP
0.23023791251%	3	1303	112	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DOANE_BREAST_CANCER_ESR1_UP
0.23023791251%	3	1303	111	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOUDOUKHA_BOUND_BY_IGF2BP2
0.23023791251%	3	1303	110	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
0.23023791251%	3	1303	110	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GHANDHI_DIRECT_IRRADIATION_UP
0.23023791251%	3	1303	110	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHENG_IMPRINTED_BY_ESTRADIOL
0.23023791251%	3	1303	109	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.23023791251%	3	1303	109	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
0.23023791251%	3	1303	108	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_DN
0.23023791251%	3	1303	108	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LE_EGR2_TARGETS_DN
0.23023791251%	3	1303	108	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LABBE_TGFB1_TARGETS_DN
0.23023791251%	3	1303	108	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
0.23023791251%	3	1303	107	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C0
0.23023791251%	3	1303	106	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
0.23023791251%	3	1303	105	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZWANG_EGF_INTERVAL_UP
0.23023791251%	3	1303	104	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
0.23023791251%	3	1303	104	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAKAMURA_ADIPOGENESIS_LATE_UP
0.23023791251%	3	1303	104	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
0.23023791251%	3	1303	103	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.23023791251%	3	1303	101	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_ERBB2
0.23023791251%	3	1303	100	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
0.23023791251%	3	1303	100	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	QI_PLASMACYTOMA_DN
0.23023791251%	3	1303	100	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCCLUNG_CREB1_TARGETS_UP
0.23023791251%	3	1303	100	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
0.229990800368%	5	2174	94	T2D_GENES_TANYA_LIPIDS	HOOI_ST7_TARGETS_UP
0.229990800368%	5	2174	93	T2D_GENES_TANYA_LIPIDS	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
0.229990800368%	5	2174	90	T2D_GENES_TANYA_LIPIDS	IGARASHI_ATF4_TARGETS_DN
0.229990800368%	5	2174	90	T2D_GENES_TANYA_LIPIDS	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN
0.229990800368%	5	2174	89	T2D_GENES_TANYA_LIPIDS	WNT_SIGNALING
0.229990800368%	5	2174	84	T2D_GENES_TANYA_LIPIDS	PID_CMYB_PATHWAY
0.229990800368%	5	2174	83	T2D_GENES_TANYA_LIPIDS	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
0.229990800368%	5	2174	82	T2D_GENES_TANYA_LIPIDS	PID_SMAD2_3NUCLEARPATHWAY
0.229990800368%	5	2174	82	T2D_GENES_TANYA_LIPIDS	BILD_CTNNB1_ONCOGENIC_SIGNATURE
0.229990800368%	5	2174	80	T2D_GENES_TANYA_LIPIDS	PID_BETACATENIN_NUC_PATHWAY
0.229990800368%	5	2174	79	T2D_GENES_TANYA_LIPIDS	MEISSNER_NPC_HCP_WITH_H3K27ME3
0.229990800368%	5	2174	79	T2D_GENES_TANYA_LIPIDS	GAVIN_FOXP3_TARGETS_CLUSTER_P2
0.229990800368%	5	2174	78	T2D_GENES_TANYA_LIPIDS	BOYLAN_MULTIPLE_MYELOMA_D_DN
0.229990800368%	5	2174	77	T2D_GENES_TANYA_LIPIDS	CARD_MIR302A_TARGETS
0.229990800368%	5	2174	75	T2D_GENES_TANYA_LIPIDS	CHESLER_BRAIN_QTL_CIS
0.229990800368%	5	2174	74	T2D_GENES_TANYA_LIPIDS	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.229990800368%	5	2174	74	T2D_GENES_TANYA_LIPIDS	PID_E2F_PATHWAY
0.229990800368%	5	2174	74	T2D_GENES_TANYA_LIPIDS	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
0.229990800368%	5	2174	74	T2D_GENES_TANYA_LIPIDS	FURUKAWA_DUSP6_TARGETS_PCI35_DN
0.229990800368%	5	2174	73	T2D_GENES_TANYA_LIPIDS	HOSHIDA_LIVER_CANCER_SURVIVAL_UP
0.229990800368%	5	2174	72	T2D_GENES_TANYA_LIPIDS	HUANG_GATA2_TARGETS_DN
0.229990800368%	5	2174	71	T2D_GENES_TANYA_LIPIDS	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.229990800368%	5	2174	71	T2D_GENES_TANYA_LIPIDS	GU_PDEF_TARGETS_UP
0.229990800368%	5	2174	71	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_6HR_UP
0.229990800368%	5	2174	70	T2D_GENES_TANYA_LIPIDS	PID_AP1_PATHWAY
0.229990800368%	5	2174	7	T2D_GENES_TANYA_LIPIDS	MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP
0.229990800368%	5	2174	69	T2D_GENES_TANYA_LIPIDS	HOWLIN_PUBERTAL_MAMMARY_GLAND
0.229990800368%	5	2174	68	T2D_GENES_TANYA_LIPIDS	BASSO_CD40_SIGNALING_DN
0.229990800368%	5	2174	67	T2D_GENES_TANYA_LIPIDS	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
0.229990800368%	5	2174	67	T2D_GENES_TANYA_LIPIDS	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
0.229990800368%	5	2174	67	T2D_GENES_TANYA_LIPIDS	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
0.229990800368%	5	2174	67	T2D_GENES_TANYA_LIPIDS	LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.229990800368%	5	2174	67	T2D_GENES_TANYA_LIPIDS	GENTILE_UV_LOW_DOSE_DN
0.229990800368%	5	2174	66	T2D_GENES_TANYA_LIPIDS	TENEDINI_MEGAKARYOCYTE_MARKERS
0.229990800368%	5	2174	66	T2D_GENES_TANYA_LIPIDS	KIM_GERMINAL_CENTER_T_HELPER_UP
0.229990800368%	5	2174	65	T2D_GENES_TANYA_LIPIDS	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.229990800368%	5	2174	65	T2D_GENES_TANYA_LIPIDS	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
0.229990800368%	5	2174	65	T2D_GENES_TANYA_LIPIDS	PID_ERA_GENOMIC_PATHWAY
0.229990800368%	5	2174	65	T2D_GENES_TANYA_LIPIDS	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP
0.229990800368%	5	2174	64	T2D_GENES_TANYA_LIPIDS	ZHANG_GATA6_TARGETS_DN
0.229990800368%	5	2174	64	T2D_GENES_TANYA_LIPIDS	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
0.229990800368%	5	2174	63	T2D_GENES_TANYA_LIPIDS	PHONG_TNF_TARGETS_UP
0.229990800368%	5	2174	63	T2D_GENES_TANYA_LIPIDS	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.229990800368%	5	2174	62	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER_E2F1_UP
0.229990800368%	5	2174	62	T2D_GENES_TANYA_LIPIDS	ISSAEVA_MLL2_TARGETS
0.229990800368%	5	2174	61	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER_MYC_TGFA_UP
0.229990800368%	5	2174	61	T2D_GENES_TANYA_LIPIDS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
0.229990800368%	5	2174	61	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_1HR_UP
0.229990800368%	5	2174	60	T2D_GENES_TANYA_LIPIDS	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE
0.229990800368%	5	2174	59	T2D_GENES_TANYA_LIPIDS	LIAN_LIPA_TARGETS_3M
0.229990800368%	5	2174	59	T2D_GENES_TANYA_LIPIDS	KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION
0.229990800368%	5	2174	59	T2D_GENES_TANYA_LIPIDS	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
0.229990800368%	5	2174	59	T2D_GENES_TANYA_LIPIDS	BOYLAN_MULTIPLE_MYELOMA_C_DN
0.229990800368%	5	2174	58	T2D_GENES_TANYA_LIPIDS	ZHENG_GLIOBLASTOMA_PLASTICITY_DN
0.229990800368%	5	2174	58	T2D_GENES_TANYA_LIPIDS	NADLER_HYPERGLYCEMIA_AT_OBESITY
0.229990800368%	5	2174	58	T2D_GENES_TANYA_LIPIDS	JI_RESPONSE_TO_FSH_DN
0.229990800368%	5	2174	57	T2D_GENES_TANYA_LIPIDS	BURTON_ADIPOGENESIS_11
0.229990800368%	5	2174	56	T2D_GENES_TANYA_LIPIDS	VANTVEER_BREAST_CANCER_METASTASIS_UP
0.229990800368%	5	2174	56	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER_MYC_E2F1_UP
0.229990800368%	5	2174	56	T2D_GENES_TANYA_LIPIDS	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.229990800368%	5	2174	56	T2D_GENES_TANYA_LIPIDS	HOQUE_METHYLATED_IN_CANCER
0.229990800368%	5	2174	55	T2D_GENES_TANYA_LIPIDS	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN
0.229990800368%	5	2174	55	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_4HR_UP
0.229990800368%	5	2174	54	T2D_GENES_TANYA_LIPIDS	SU_PANCREAS
0.229990800368%	5	2174	54	T2D_GENES_TANYA_LIPIDS	ROVERSI_GLIOMA_COPY_NUMBER_DN
0.229990800368%	5	2174	54	T2D_GENES_TANYA_LIPIDS	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE
0.229990800368%	5	2174	54	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_IPS_ICP_WITH_H3K27ME3
0.229990800368%	5	2174	54	T2D_GENES_TANYA_LIPIDS	KEGG_INOSITOL_PHOSPHATE_METABOLISM
0.229990800368%	5	2174	54	T2D_GENES_TANYA_LIPIDS	HUPER_BREAST_BASAL_VS_LUMINAL_UP
0.229990800368%	5	2174	53	T2D_GENES_TANYA_LIPIDS	KRIEG_HYPOXIA_VIA_KDM3A
0.229990800368%	5	2174	52	T2D_GENES_TANYA_LIPIDS	HALMOS_CEBPA_TARGETS_UP
0.229990800368%	5	2174	51	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
0.229990800368%	5	2174	51	T2D_GENES_TANYA_LIPIDS	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT
0.229990800368%	5	2174	51	T2D_GENES_TANYA_LIPIDS	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN
0.229990800368%	5	2174	50	T2D_GENES_TANYA_LIPIDS	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
0.229990800368%	5	2174	50	T2D_GENES_TANYA_LIPIDS	NADERI_BREAST_CANCER_PROGNOSIS_UP
0.229990800368%	5	2174	50	T2D_GENES_TANYA_LIPIDS	MARTINEZ_RESPONSE_TO_TRABECTEDIN
0.229990800368%	5	2174	50	T2D_GENES_TANYA_LIPIDS	KENNY_CTNNB1_TARGETS_UP
0.229990800368%	5	2174	50	T2D_GENES_TANYA_LIPIDS	FIGUEROA_AML_METHYLATION_CLUSTER_5_DN
0.229990800368%	5	2174	50	T2D_GENES_TANYA_LIPIDS	BECKER_TAMOXIFEN_RESISTANCE_UP
0.229990800368%	5	2174	49	T2D_GENES_TANYA_LIPIDS	REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM
0.229990800368%	5	2174	49	T2D_GENES_TANYA_LIPIDS	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN
0.229990800368%	5	2174	49	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_2HR_DN
0.229990800368%	5	2174	49	T2D_GENES_TANYA_LIPIDS	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP
0.229990800368%	5	2174	48	T2D_GENES_TANYA_LIPIDS	NADLER_OBESITY_DN
0.229990800368%	5	2174	47	T2D_GENES_TANYA_LIPIDS	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
0.229990800368%	5	2174	47	T2D_GENES_TANYA_LIPIDS	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
0.229990800368%	5	2174	47	T2D_GENES_TANYA_LIPIDS	PID_DELTANP63PATHWAY
0.229990800368%	5	2174	47	T2D_GENES_TANYA_LIPIDS	KEGG_TYPE_II_DIABETES_MELLITUS
0.229990800368%	5	2174	47	T2D_GENES_TANYA_LIPIDS	KEGG_NOTCH_SIGNALING_PATHWAY
0.229990800368%	5	2174	47	T2D_GENES_TANYA_LIPIDS	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.229990800368%	5	2174	46	T2D_GENES_TANYA_LIPIDS	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6
0.229990800368%	5	2174	46	T2D_GENES_TANYA_LIPIDS	PID_SYNDECAN_1_PATHWAY
0.229990800368%	5	2174	46	T2D_GENES_TANYA_LIPIDS	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1
0.229990800368%	5	2174	46	T2D_GENES_TANYA_LIPIDS	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON
0.229990800368%	5	2174	46	T2D_GENES_TANYA_LIPIDS	NAKAJIMA_MAST_CELL
0.229990800368%	5	2174	46	T2D_GENES_TANYA_LIPIDS	MADAN_DPPA4_TARGETS
0.229990800368%	5	2174	46	T2D_GENES_TANYA_LIPIDS	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN
0.229990800368%	5	2174	45	T2D_GENES_TANYA_LIPIDS	ZHAN_V2_LATE_DIFFERENTIATION_GENES
0.229990800368%	5	2174	45	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_CD2_UP
0.229990800368%	5	2174	45	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_CD1_UP
0.229990800368%	5	2174	45	T2D_GENES_TANYA_LIPIDS	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN
0.229990800368%	5	2174	45	T2D_GENES_TANYA_LIPIDS	REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER
0.229990800368%	5	2174	45	T2D_GENES_TANYA_LIPIDS	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
0.229990800368%	5	2174	45	T2D_GENES_TANYA_LIPIDS	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN
0.229990800368%	5	2174	45	T2D_GENES_TANYA_LIPIDS	LEE_AGING_MUSCLE_UP
0.229990800368%	5	2174	45	T2D_GENES_TANYA_LIPIDS	KLEIN_TARGETS_OF_BCR_ABL1_FUSION
0.229990800368%	5	2174	45	T2D_GENES_TANYA_LIPIDS	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.229990800368%	5	2174	44	T2D_GENES_TANYA_LIPIDS	XU_CREBBP_TARGETS_DN
0.229990800368%	5	2174	44	T2D_GENES_TANYA_LIPIDS	THILLAINADESAN_ZNF217_TARGETS_UP
0.229990800368%	5	2174	44	T2D_GENES_TANYA_LIPIDS	STREICHER_LSM1_TARGETS_UP
0.229990800368%	5	2174	44	T2D_GENES_TANYA_LIPIDS	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
0.229990800368%	5	2174	44	T2D_GENES_TANYA_LIPIDS	MARTIN_INTERACT_WITH_HDAC
0.229990800368%	5	2174	44	T2D_GENES_TANYA_LIPIDS	LUI_THYROID_CANCER_PAX8_PPARG_UP
0.229990800368%	5	2174	44	T2D_GENES_TANYA_LIPIDS	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS
0.229990800368%	5	2174	44	T2D_GENES_TANYA_LIPIDS	CHUNG_BLISTER_CYTOTOXICITY_DN
0.229990800368%	5	2174	43	T2D_GENES_TANYA_LIPIDS	POTTI_5FU_SENSITIVITY
0.229990800368%	5	2174	43	T2D_GENES_TANYA_LIPIDS	PID_TCPTP_PATHWAY
0.229990800368%	5	2174	43	T2D_GENES_TANYA_LIPIDS	MANTOVANI_NFKB_TARGETS_UP
0.229990800368%	5	2174	43	T2D_GENES_TANYA_LIPIDS	DORN_ADENOVIRUS_INFECTION_24HR_DN
0.229990800368%	5	2174	42	T2D_GENES_TANYA_LIPIDS	ZHENG_IL22_SIGNALING_DN
0.229990800368%	5	2174	42	T2D_GENES_TANYA_LIPIDS	WIERENGA_PML_INTERACTOME
0.229990800368%	5	2174	42	T2D_GENES_TANYA_LIPIDS	PID_BMPPATHWAY
0.229990800368%	5	2174	42	T2D_GENES_TANYA_LIPIDS	ONO_FOXP3_TARGETS_DN
0.229990800368%	5	2174	42	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_ES_ICP_WITH_H3K27ME3
0.229990800368%	5	2174	42	T2D_GENES_TANYA_LIPIDS	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP
0.229990800368%	5	2174	42	T2D_GENES_TANYA_LIPIDS	LUI_THYROID_CANCER_CLUSTER_2
0.229990800368%	5	2174	41	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_DN
0.229990800368%	5	2174	40	T2D_GENES_TANYA_LIPIDS	PID_FOXM1PATHWAY
0.229990800368%	5	2174	40	T2D_GENES_TANYA_LIPIDS	PID_EPHBFWDPATHWAY
0.229990800368%	5	2174	40	T2D_GENES_TANYA_LIPIDS	ELLWOOD_MYC_TARGETS_DN
0.229990800368%	5	2174	40	T2D_GENES_TANYA_LIPIDS	DORN_ADENOVIRUS_INFECTION_48HR_DN
0.229990800368%	5	2174	40	T2D_GENES_TANYA_LIPIDS	CHANGOLKAR_H2AFY_TARGETS_DN
0.229990800368%	5	2174	40	T2D_GENES_TANYA_LIPIDS	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
0.229990800368%	5	2174	40	T2D_GENES_TANYA_LIPIDS	BIOCARTA_P38MAPK_PATHWAY
0.229990800368%	5	2174	39	T2D_GENES_TANYA_LIPIDS	WANG_LSD1_TARGETS_DN
0.229990800368%	5	2174	39	T2D_GENES_TANYA_LIPIDS	VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1
0.229990800368%	5	2174	39	T2D_GENES_TANYA_LIPIDS	POTTI_PACLITAXEL_SENSITIVITY
0.229990800368%	5	2174	39	T2D_GENES_TANYA_LIPIDS	PID_ECADHERIN_NASCENTAJ_PATHWAY
0.229990800368%	5	2174	39	T2D_GENES_TANYA_LIPIDS	DORN_ADENOVIRUS_INFECTION_32HR_DN
0.229990800368%	5	2174	39	T2D_GENES_TANYA_LIPIDS	CONRAD_STEM_CELL
0.229990800368%	5	2174	39	T2D_GENES_TANYA_LIPIDS	AIYAR_COBRA1_TARGETS_UP
0.229990800368%	5	2174	38	T2D_GENES_TANYA_LIPIDS	YOKOE_CANCER_TESTIS_ANTIGENS
0.229990800368%	5	2174	38	T2D_GENES_TANYA_LIPIDS	TERAO_AOX4_TARGETS_SKIN_UP
0.229990800368%	5	2174	38	T2D_GENES_TANYA_LIPIDS	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
0.229990800368%	5	2174	38	T2D_GENES_TANYA_LIPIDS	KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT
0.229990800368%	5	2174	38	T2D_GENES_TANYA_LIPIDS	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP
0.229990800368%	5	2174	38	T2D_GENES_TANYA_LIPIDS	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP
0.229990800368%	5	2174	38	T2D_GENES_TANYA_LIPIDS	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN
0.229990800368%	5	2174	38	T2D_GENES_TANYA_LIPIDS	CHANDRAN_METASTASIS_TOP50_UP
0.229990800368%	5	2174	37	T2D_GENES_TANYA_LIPIDS	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
0.229990800368%	5	2174	37	T2D_GENES_TANYA_LIPIDS	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS
0.229990800368%	5	2174	37	T2D_GENES_TANYA_LIPIDS	PID_GMCSF_PATHWAY
0.229990800368%	5	2174	37	T2D_GENES_TANYA_LIPIDS	MATZUK_SPERMATID_DIFFERENTIATION
0.229990800368%	5	2174	37	T2D_GENES_TANYA_LIPIDS	BIOCARTA_PAR1_PATHWAY
0.229990800368%	5	2174	37	T2D_GENES_TANYA_LIPIDS	BIOCARTA_ALK_PATHWAY
0.229990800368%	5	2174	36	T2D_GENES_TANYA_LIPIDS	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2
0.229990800368%	5	2174	36	T2D_GENES_TANYA_LIPIDS	ST_ADRENERGIC
0.229990800368%	5	2174	36	T2D_GENES_TANYA_LIPIDS	SEMENZA_HIF1_TARGETS
0.229990800368%	5	2174	36	T2D_GENES_TANYA_LIPIDS	KEGG_DNA_REPLICATION
0.229990800368%	5	2174	36	T2D_GENES_TANYA_LIPIDS	KEGG_BASAL_TRANSCRIPTION_FACTORS
0.229990800368%	5	2174	36	T2D_GENES_TANYA_LIPIDS	BIOCARTA_AGR_PATHWAY
0.229990800368%	5	2174	35	T2D_GENES_TANYA_LIPIDS	YAGI_AML_RELAPSE_PROGNOSIS
0.229990800368%	5	2174	35	T2D_GENES_TANYA_LIPIDS	WANG_METHYLATED_IN_BREAST_CANCER
0.229990800368%	5	2174	35	T2D_GENES_TANYA_LIPIDS	ST_G_ALPHA_I_PATHWAY
0.229990800368%	5	2174	35	T2D_GENES_TANYA_LIPIDS	PID_PI3KCIAKTPATHWAY
0.229990800368%	5	2174	35	T2D_GENES_TANYA_LIPIDS	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
0.229990800368%	5	2174	35	T2D_GENES_TANYA_LIPIDS	LOPEZ_TRANSLATION_VIA_FN1_SIGNALING
0.229990800368%	5	2174	35	T2D_GENES_TANYA_LIPIDS	LI_CISPLATIN_RESISTANCE_DN
0.229990800368%	5	2174	35	T2D_GENES_TANYA_LIPIDS	DORSAM_HOXA9_TARGETS_UP
0.229990800368%	5	2174	35	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CARM_ER_PATHWAY
0.229990800368%	5	2174	35	T2D_GENES_TANYA_LIPIDS	BALDWIN_PRKCI_TARGETS_UP
0.229990800368%	5	2174	34	T2D_GENES_TANYA_LIPIDS	SIG_CD40PATHWAYMAP
0.229990800368%	5	2174	34	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNAL_TRANSDUCTION_BY_L1
0.229990800368%	5	2174	34	T2D_GENES_TANYA_LIPIDS	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE
0.229990800368%	5	2174	34	T2D_GENES_TANYA_LIPIDS	REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX
0.229990800368%	5	2174	34	T2D_GENES_TANYA_LIPIDS	POTTI_CYTOXAN_SENSITIVITY
0.229990800368%	5	2174	34	T2D_GENES_TANYA_LIPIDS	PID_MAPKTRKPATHWAY
0.229990800368%	5	2174	34	T2D_GENES_TANYA_LIPIDS	MEISSNER_ES_ICP_WITH_H3K4ME3
0.229990800368%	5	2174	33	T2D_GENES_TANYA_LIPIDS	VALK_AML_CLUSTER_5
0.229990800368%	5	2174	33	T2D_GENES_TANYA_LIPIDS	TANG_SENESCENCE_TP53_TARGETS_UP
0.229990800368%	5	2174	33	T2D_GENES_TANYA_LIPIDS	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS
0.229990800368%	5	2174	33	T2D_GENES_TANYA_LIPIDS	REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS
0.229990800368%	5	2174	33	T2D_GENES_TANYA_LIPIDS	PID_INTEGRIN_A4B1_PATHWAY
0.229990800368%	5	2174	33	T2D_GENES_TANYA_LIPIDS	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP
0.229990800368%	5	2174	33	T2D_GENES_TANYA_LIPIDS	DORN_ADENOVIRUS_INFECTION_12HR_DN
0.229990800368%	5	2174	33	T2D_GENES_TANYA_LIPIDS	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN
0.229990800368%	5	2174	33	T2D_GENES_TANYA_LIPIDS	BIOCARTA_IL1R_PATHWAY
0.229990800368%	5	2174	33	T2D_GENES_TANYA_LIPIDS	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN
0.229990800368%	5	2174	32	T2D_GENES_TANYA_LIPIDS	ZWANG_EGF_PERSISTENTLY_UP
0.229990800368%	5	2174	32	T2D_GENES_TANYA_LIPIDS	ST_ERK1_ERK2_MAPK_PATHWAY
0.229990800368%	5	2174	32	T2D_GENES_TANYA_LIPIDS	REACTOME_DAG_AND_IP3_SIGNALING
0.229990800368%	5	2174	32	T2D_GENES_TANYA_LIPIDS	POS_HISTAMINE_RESPONSE_NETWORK
0.229990800368%	5	2174	32	T2D_GENES_TANYA_LIPIDS	PID_WNT_NONCANONICAL_PATHWAY
0.229990800368%	5	2174	32	T2D_GENES_TANYA_LIPIDS	BIOCARTA_PDGF_PATHWAY
0.229990800368%	5	2174	32	T2D_GENES_TANYA_LIPIDS	BAE_BRCA1_TARGETS_DN
0.229990800368%	5	2174	31	T2D_GENES_TANYA_LIPIDS	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP
0.229990800368%	5	2174	31	T2D_GENES_TANYA_LIPIDS	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.229990800368%	5	2174	31	T2D_GENES_TANYA_LIPIDS	REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS
0.229990800368%	5	2174	31	T2D_GENES_TANYA_LIPIDS	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
0.229990800368%	5	2174	31	T2D_GENES_TANYA_LIPIDS	PID_NEPHRIN_NEPH1_PATHWAY
0.229990800368%	5	2174	31	T2D_GENES_TANYA_LIPIDS	PID_CD40_PATHWAY
0.229990800368%	5	2174	31	T2D_GENES_TANYA_LIPIDS	PID_AURORA_A_PATHWAY
0.229990800368%	5	2174	31	T2D_GENES_TANYA_LIPIDS	MCCABE_HOXC6_TARGETS_CANCER_UP
0.229990800368%	5	2174	31	T2D_GENES_TANYA_LIPIDS	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM
0.229990800368%	5	2174	31	T2D_GENES_TANYA_LIPIDS	HUNSBERGER_EXERCISE_REGULATED_GENES
0.229990800368%	5	2174	31	T2D_GENES_TANYA_LIPIDS	BIOCARTA_EGF_PATHWAY
0.229990800368%	5	2174	30	T2D_GENES_TANYA_LIPIDS	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN
0.229990800368%	5	2174	30	T2D_GENES_TANYA_LIPIDS	REACTOME_MRNA_CAPPING
0.229990800368%	5	2174	30	T2D_GENES_TANYA_LIPIDS	REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX
0.229990800368%	5	2174	30	T2D_GENES_TANYA_LIPIDS	REACTOME_CA_DEPENDENT_EVENTS
0.229990800368%	5	2174	30	T2D_GENES_TANYA_LIPIDS	PID_EPHRINBREVPATHWAY
0.229990800368%	5	2174	30	T2D_GENES_TANYA_LIPIDS	PID_CDC42_REG_PATHWAY
0.229990800368%	5	2174	30	T2D_GENES_TANYA_LIPIDS	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP
0.229990800368%	5	2174	29	T2D_GENES_TANYA_LIPIDS	WILENSKY_RESPONSE_TO_DARAPLADIB
0.229990800368%	5	2174	29	T2D_GENES_TANYA_LIPIDS	WANG_RESPONSE_TO_BEXAROTENE_DN
0.229990800368%	5	2174	29	T2D_GENES_TANYA_LIPIDS	REACTOME_TIGHT_JUNCTION_INTERACTIONS
0.229990800368%	5	2174	29	T2D_GENES_TANYA_LIPIDS	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX
0.229990800368%	5	2174	29	T2D_GENES_TANYA_LIPIDS	NGUYEN_NOTCH1_TARGETS_UP
0.229990800368%	5	2174	29	T2D_GENES_TANYA_LIPIDS	KRIGE_AMINO_ACID_DEPRIVATION
0.229990800368%	5	2174	29	T2D_GENES_TANYA_LIPIDS	KEGG_HISTIDINE_METABOLISM
0.229990800368%	5	2174	29	T2D_GENES_TANYA_LIPIDS	BIOCARTA_INFLAM_PATHWAY
0.229990800368%	5	2174	29	T2D_GENES_TANYA_LIPIDS	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP
0.229990800368%	5	2174	29	T2D_GENES_TANYA_LIPIDS	ABE_VEGFA_TARGETS_30MIN
0.229990800368%	5	2174	28	T2D_GENES_TANYA_LIPIDS	WIKMAN_ASBESTOS_LUNG_CANCER_DN
0.229990800368%	5	2174	28	T2D_GENES_TANYA_LIPIDS	WEBER_METHYLATED_HCP_IN_SPERM_DN
0.229990800368%	5	2174	28	T2D_GENES_TANYA_LIPIDS	MOREIRA_RESPONSE_TO_TSA_UP
0.229990800368%	5	2174	28	T2D_GENES_TANYA_LIPIDS	GENTILE_UV_RESPONSE_CLUSTER_D9
0.229990800368%	5	2174	28	T2D_GENES_TANYA_LIPIDS	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP
0.229990800368%	5	2174	27	T2D_GENES_TANYA_LIPIDS	YE_METASTATIC_LIVER_CANCER
0.229990800368%	5	2174	27	T2D_GENES_TANYA_LIPIDS	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
0.229990800368%	5	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_SYNTHESIS_OF_PA
0.229990800368%	5	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE
0.229990800368%	5	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS
0.229990800368%	5	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS
0.229990800368%	5	2174	27	T2D_GENES_TANYA_LIPIDS	LI_WILMS_TUMOR
0.229990800368%	5	2174	27	T2D_GENES_TANYA_LIPIDS	GENTILE_UV_LOW_DOSE_UP
0.229990800368%	5	2174	27	T2D_GENES_TANYA_LIPIDS	BIOCARTA_GSK3_PATHWAY
0.229990800368%	5	2174	26	T2D_GENES_TANYA_LIPIDS	PID_INTEGRIN_CS_PATHWAY
0.229990800368%	5	2174	26	T2D_GENES_TANYA_LIPIDS	PID_ALK1PATHWAY
0.229990800368%	5	2174	26	T2D_GENES_TANYA_LIPIDS	HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP
0.229990800368%	5	2174	26	T2D_GENES_TANYA_LIPIDS	HAHTOLA_CTCL_CUTANEOUS
0.229990800368%	5	2174	26	T2D_GENES_TANYA_LIPIDS	BIOCARTA_PGC1A_PATHWAY
0.229990800368%	5	2174	25	T2D_GENES_TANYA_LIPIDS	REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION
0.229990800368%	5	2174	25	T2D_GENES_TANYA_LIPIDS	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17
0.229990800368%	5	2174	25	T2D_GENES_TANYA_LIPIDS	KIM_HYPOXIA
0.229990800368%	5	2174	25	T2D_GENES_TANYA_LIPIDS	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS
0.229990800368%	5	2174	25	T2D_GENES_TANYA_LIPIDS	BIOCARTA_STRESS_PATHWAY
0.229990800368%	5	2174	24	T2D_GENES_TANYA_LIPIDS	PID_S1P_S1P2_PATHWAY
0.229990800368%	5	2174	24	T2D_GENES_TANYA_LIPIDS	OXFORD_RALA_OR_RALB_TARGETS_DN
0.229990800368%	5	2174	24	T2D_GENES_TANYA_LIPIDS	GOLUB_ALL_VS_AML_UP
0.229990800368%	5	2174	24	T2D_GENES_TANYA_LIPIDS	BIOCARTA_NOS1_PATHWAY
0.229990800368%	5	2174	24	T2D_GENES_TANYA_LIPIDS	BIOCARTA_EIF4_PATHWAY
0.229990800368%	5	2174	23	T2D_GENES_TANYA_LIPIDS	VIETOR_IFRD1_TARGETS
0.229990800368%	5	2174	23	T2D_GENES_TANYA_LIPIDS	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER
0.229990800368%	5	2174	23	T2D_GENES_TANYA_LIPIDS	REACTOME_INSULIN_RECEPTOR_RECYCLING
0.229990800368%	5	2174	23	T2D_GENES_TANYA_LIPIDS	BIOCARTA_RAC1_PATHWAY
0.229990800368%	5	2174	23	T2D_GENES_TANYA_LIPIDS	BILANGES_SERUM_SENSITIVE_VIA_TSC1
0.229990800368%	5	2174	22	T2D_GENES_TANYA_LIPIDS	REACTOME_DEADENYLATION_OF_MRNA
0.229990800368%	5	2174	22	T2D_GENES_TANYA_LIPIDS	PID_HEDGEHOG_2PATHWAY
0.229990800368%	5	2174	22	T2D_GENES_TANYA_LIPIDS	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
0.229990800368%	5	2174	22	T2D_GENES_TANYA_LIPIDS	NUMATA_CSF3_SIGNALING_VIA_STAT3
0.229990800368%	5	2174	21	T2D_GENES_TANYA_LIPIDS	REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE
0.229990800368%	5	2174	21	T2D_GENES_TANYA_LIPIDS	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC
0.229990800368%	5	2174	21	T2D_GENES_TANYA_LIPIDS	PID_ECADHERIN_KERATINOCYTE_PATHWAY
0.229990800368%	5	2174	21	T2D_GENES_TANYA_LIPIDS	MOOTHA_GLYCOGEN_METABOLISM
0.229990800368%	5	2174	21	T2D_GENES_TANYA_LIPIDS	GREENBAUM_E2A_TARGETS_DN
0.229990800368%	5	2174	21	T2D_GENES_TANYA_LIPIDS	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE
0.229990800368%	5	2174	20	T2D_GENES_TANYA_LIPIDS	WEBER_METHYLATED_HCP_IN_SPERM_UP
0.229990800368%	5	2174	20	T2D_GENES_TANYA_LIPIDS	WANG_RECURRENT_LIVER_CANCER_UP
0.229990800368%	5	2174	20	T2D_GENES_TANYA_LIPIDS	VILIMAS_NOTCH1_TARGETS_DN
0.229990800368%	5	2174	20	T2D_GENES_TANYA_LIPIDS	SESTO_RESPONSE_TO_UV_C3
0.229990800368%	5	2174	20	T2D_GENES_TANYA_LIPIDS	REACTOME_ENOS_ACTIVATION_AND_REGULATION
0.229990800368%	5	2174	20	T2D_GENES_TANYA_LIPIDS	PHESSE_TARGETS_OF_APC_AND_MBD2_UP
0.229990800368%	5	2174	20	T2D_GENES_TANYA_LIPIDS	HASLINGER_B_CLL_WITH_6Q21_DELETION
0.229990800368%	5	2174	20	T2D_GENES_TANYA_LIPIDS	DING_LUNG_CANCER_BY_MUTATION_RATE
0.229990800368%	5	2174	20	T2D_GENES_TANYA_LIPIDS	DAZARD_UV_RESPONSE_CLUSTER_G28
0.229990800368%	5	2174	20	T2D_GENES_TANYA_LIPIDS	BARRIER_COLON_CANCER_RECURRENCE_DN
0.229990800368%	5	2174	19	T2D_GENES_TANYA_LIPIDS	BIOCARTA_TID_PATHWAY
0.229990800368%	5	2174	18	T2D_GENES_TANYA_LIPIDS	SHIN_B_CELL_LYMPHOMA_CLUSTER_5
0.229990800368%	5	2174	18	T2D_GENES_TANYA_LIPIDS	HUMMERICH_MALIGNANT_SKIN_TUMOR_DN
0.229990800368%	5	2174	18	T2D_GENES_TANYA_LIPIDS	BIOCARTA_TEL_PATHWAY
0.229990800368%	5	2174	18	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CARDIACEGF_PATHWAY
0.229990800368%	5	2174	17	T2D_GENES_TANYA_LIPIDS	BIOCARTA_HCMV_PATHWAY
0.229990800368%	5	2174	16	T2D_GENES_TANYA_LIPIDS	ST_G_ALPHA_S_PATHWAY
0.229990800368%	5	2174	16	T2D_GENES_TANYA_LIPIDS	KANG_FLUOROURACIL_RESISTANCE_DN
0.229990800368%	5	2174	16	T2D_GENES_TANYA_LIPIDS	GEISS_RESPONSE_TO_DSRNA_DN
0.229990800368%	5	2174	16	T2D_GENES_TANYA_LIPIDS	BIOCARTA_SHH_PATHWAY
0.229990800368%	5	2174	15	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CTL_PATHWAY
0.229990800368%	5	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_HYALURONAN_METABOLISM
0.229990800368%	5	2174	14	T2D_GENES_TANYA_LIPIDS	PID_S1P_S1P4_PATHWAY
0.229990800368%	5	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION
0.229990800368%	5	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING
0.229990800368%	5	2174	13	T2D_GENES_TANYA_LIPIDS	HOEGERKORP_CD44_TARGETS_TEMPORAL_UP
0.229990800368%	5	2174	13	T2D_GENES_TANYA_LIPIDS	BIOCARTA_TCRA_PATHWAY
0.229990800368%	5	2174	120	T2D_GENES_TANYA_LIPIDS	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.229990800368%	5	2174	120	T2D_GENES_TANYA_LIPIDS	CHEBOTAEV_GR_TARGETS_DN
0.229990800368%	5	2174	110	T2D_GENES_TANYA_LIPIDS	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
0.229990800368%	5	2174	11	T2D_GENES_TANYA_LIPIDS	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP
0.229990800368%	5	2174	11	T2D_GENES_TANYA_LIPIDS	BIOCARTA_BLYMPHOCYTE_PATHWAY
0.229990800368%	5	2174	108	T2D_GENES_TANYA_LIPIDS	LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT
0.229990800368%	5	2174	105	T2D_GENES_TANYA_LIPIDS	ZWANG_EGF_INTERVAL_UP
0.229990800368%	5	2174	100	T2D_GENES_TANYA_LIPIDS	WINZEN_DEGRADED_VIA_KHSRP
0.227272727273%	8	3520	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
0.227272727273%	8	3520	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PYRIMIDINE_METABOLISM
0.227272727273%	8	3520	96	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_PROSTATE_CANCER_UP
0.227272727273%	8	3520	95	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAYO_CALORIE_RESTRICTION_MUSCLE_UP
0.227272727273%	8	3520	94	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER
0.227272727273%	8	3520	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
0.227272727273%	8	3520	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SASSON_RESPONSE_TO_FORSKOLIN_UP
0.227272727273%	8	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RICKMAN_HEAD_AND_NECK_CANCER_E
0.227272727273%	8	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
0.227272727273%	8	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
0.227272727273%	8	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.227272727273%	8	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LAIHO_COLORECTAL_CANCER_SERRATED_DN
0.227272727273%	8	3520	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEIN_CEREBELLUM_MARKERS
0.227272727273%	8	3520	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
0.227272727273%	8	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
0.227272727273%	8	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHANG_IMMORTALIZED_BY_HPV31_UP
0.227272727273%	8	3520	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.227272727273%	8	3520	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.227272727273%	8	3520	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JIANG_HYPOXIA_CANCER
0.227272727273%	8	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
0.227272727273%	8	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUANG_DASATINIB_RESISTANCE_UP
0.227272727273%	8	3520	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MORI_PRE_BI_LYMPHOCYTE_UP
0.227272727273%	8	3520	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LINDVALL_IMMORTALIZED_BY_TERT_DN
0.227272727273%	8	3520	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
0.227272727273%	8	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_P73PATHWAY
0.227272727273%	8	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
0.227272727273%	8	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CROMER_METASTASIS_UP
0.227272727273%	8	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
0.227272727273%	8	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CELL_JUNCTION_ORGANIZATION
0.227272727273%	8	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RADMACHER_AML_PROGNOSIS
0.227272727273%	8	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LINDVALL_IMMORTALIZED_BY_TERT_UP
0.227272727273%	8	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
0.227272727273%	8	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JACKSON_DNMT1_TARGETS_UP
0.227272727273%	8	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.227272727273%	8	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_HIF1A_UP
0.227272727273%	8	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FRIDMAN_SENESCENCE_UP
0.227272727273%	8	3520	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
0.227272727273%	8	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DARWICHE_PAPILLOMA_PROGRESSION_RISK
0.227272727273%	8	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CORRE_MULTIPLE_MYELOMA_UP
0.227272727273%	8	3520	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
0.227272727273%	8	3520	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
0.227272727273%	8	3520	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DOANE_BREAST_CANCER_CLASSES_UP
0.227272727273%	8	3520	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
0.227272727273%	8	3520	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_MELANOMA
0.227272727273%	8	3520	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
0.227272727273%	8	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
0.227272727273%	8	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5
0.227272727273%	8	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_RENAL_CELL_CARCINOMA
0.227272727273%	8	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_LONG_TERM_DEPRESSION
0.227272727273%	8	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
0.227272727273%	8	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.227272727273%	8	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SEMAPHORIN_INTERACTIONS
0.227272727273%	8	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.227272727273%	8	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AKL_HTLV1_INFECTION_DN
0.227272727273%	8	3520	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANHARANTA_UTERINE_FIBROID_DN
0.227272727273%	8	3520	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
0.227272727273%	8	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT
0.227272727273%	8	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES
0.227272727273%	8	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER_CIPROFIBRATE_DN
0.227272727273%	8	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN
0.227272727273%	8	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
0.227272727273%	8	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP
0.227272727273%	8	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_BCR_5PATHWAY
0.227272727273%	8	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP
0.227272727273%	8	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RHODES_CANCER_META_SIGNATURE
0.227272727273%	8	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PETROVA_PROX1_TARGETS_DN
0.227272727273%	8	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
0.227272727273%	8	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP
0.227272727273%	8	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN
0.227272727273%	8	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.227272727273%	8	3520	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
0.227272727273%	8	3520	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAMASWAMY_METASTASIS_DN
0.227272727273%	8	3520	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NADLER_OBESITY_UP
0.227272727273%	8	3520	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GENTILE_RESPONSE_CLUSTER_D3
0.227272727273%	8	3520	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SONG_TARGETS_OF_IE86_CMV_PROTEIN
0.227272727273%	8	3520	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ACUTE_MYELOID_LEUKEMIA
0.227272727273%	8	3520	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN
0.227272727273%	8	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DASU_IL6_SIGNALING_UP
0.227272727273%	8	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAGASHIMA_EGF_SIGNALING_UP
0.227272727273%	8	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_SERUM_RESPONSE_240_MCF10A
0.227272727273%	8	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HENDRICKS_SMARCA4_TARGETS_UP
0.227272727273%	8	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.227272727273%	8	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_30MIN_UP
0.227272727273%	8	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMIRNOV_RESPONSE_TO_IR_2HR_DN
0.227272727273%	8	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RICKMAN_HEAD_AND_NECK_CANCER_F
0.227272727273%	8	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_NFAT_3PATHWAY
0.227272727273%	8	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN
0.227272727273%	8	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROESSLER_LIVER_CANCER_METASTASIS_DN
0.227272727273%	8	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_AR_TF_PATHWAY
0.227272727273%	8	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
0.227272727273%	8	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PRAMOONJAGO_SOX4_TARGETS_UP
0.227272727273%	8	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_PROLIFERATING_VS_QUIESCENT
0.227272727273%	8	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
0.227272727273%	8	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PARK_APL_PATHOGENESIS_DN
0.227272727273%	8	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC
0.227272727273%	8	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN
0.227272727273%	8	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WONG_PROTEASOME_GENE_MODULE
0.227272727273%	8	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_FOXOPATHWAY
0.227272727273%	8	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MUSCLE_CONTRACTION
0.227272727273%	8	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PENG_GLUCOSE_DEPRIVATION_UP
0.227272727273%	8	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OXFORD_RALA_OR_RALB_TARGETS_UP
0.227272727273%	8	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_4
0.227272727273%	8	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WOOD_EBV_EBNA1_TARGETS_DN
0.227272727273%	8	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_NFAT_TFPATHWAY
0.227272727273%	8	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IRITANI_MAD1_TARGETS_DN
0.227272727273%	8	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WINNEPENNINCKX_MELANOMA_METASTASIS_DN
0.227272727273%	8	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C5
0.227272727273%	8	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
0.227272727273%	8	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_A6B1_A6B4_INTEGRIN_PATHWAY
0.227272727273%	8	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_KERATINOCYTE_PATHWAY
0.227272727273%	8	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_60_HELA
0.227272727273%	8	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_INSULIN_PATHWAY
0.227272727273%	8	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_BIOPEPTIDES_PATHWAY
0.227272727273%	8	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
0.227272727273%	8	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PLC_BETA_MEDIATED_EVENTS
0.227272727273%	8	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_THROMBIN_PAR1_PATHWAY
0.227272727273%	8	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEIN_ASTROCYTE_MARKERS
0.227272727273%	8	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_BLADDER_CANCER
0.227272727273%	8	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN
0.227272727273%	8	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN
0.227272727273%	8	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PYRUVATE_METABOLISM
0.227272727273%	8	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BENPORATH_ES_2
0.227272727273%	8	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
0.227272727273%	8	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CERVERA_SDHB_TARGETS_1_DN
0.227272727273%	8	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_GA13_PATHWAY
0.227272727273%	8	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROLEF_GLIS3_TARGETS
0.227272727273%	8	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DOWNSTREAM_TCR_SIGNALING
0.227272727273%	8	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2
0.227272727273%	8	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ARF6_PATHWAY
0.227272727273%	8	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PETRETTO_CARDIAC_HYPERTROPHY
0.227272727273%	8	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DIRMEIER_LMP1_RESPONSE_LATE_DN
0.227272727273%	8	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_AR_NONGENOMIC_PATHWAY
0.227272727273%	8	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHOW_RASSF1_TARGETS_DN
0.227272727273%	8	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.227272727273%	8	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_GH_PATHWAY
0.227272727273%	8	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_MYOCYTE_AD_PATHWAY
0.227272727273%	8	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_STRIATED_MUSCLE_CONTRACTION
0.227272727273%	8	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CREB_PATHWAY
0.227272727273%	8	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_RACCYCD_PATHWAY
0.227272727273%	8	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP
0.227272727273%	8	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_S1P_S1P1_PATHWAY
0.227272727273%	8	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CTLA4_PATHWAY
0.227272727273%	8	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GLUCURONIDATION
0.227272727273%	8	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS
0.227272727273%	8	3520	159	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
0.227272727273%	8	3520	147	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAUFFMANN_DNA_REPLICATION_GENES
0.227272727273%	8	3520	147	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BENPORATH_PROLIFERATION
0.227272727273%	8	3520	145	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RODWELL_AGING_KIDNEY_DN
0.227272727273%	8	3520	142	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_GH1_AUTOCRINE_TARGETS_DN
0.227272727273%	8	3520	140	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
0.227272727273%	8	3520	135	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	UDAYAKUMAR_MED1_TARGETS_UP
0.227272727273%	8	3520	131	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP
0.227272727273%	8	3520	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
0.227272727273%	8	3520	127	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
0.227272727273%	8	3520	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.227272727273%	8	3520	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.227272727273%	8	3520	113	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TSENG_IRS1_TARGETS_UP
0.227272727273%	8	3520	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_FGFR
0.227272727273%	8	3520	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PASINI_SUZ12_TARGETS_UP
0.227272727273%	8	3520	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
0.227272727273%	8	3520	106	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
0.227272727273%	8	3520	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
0.227272727273%	8	3520	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_P4
0.224215246637%	1	446	99	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIM_MAMMARY_LUMINAL_MATURE_DN
0.224215246637%	1	446	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
0.224215246637%	1	446	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
0.224215246637%	1	446	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
0.224215246637%	1	446	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PYEON_HPV_POSITIVE_TUMORS_UP
0.224215246637%	1	446	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NIELSEN_GIST
0.224215246637%	1	446	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_PYRIMIDINE_METABOLISM
0.224215246637%	1	446	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GAVIN_FOXP3_TARGETS_CLUSTER_T7
0.224215246637%	1	446	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BRUINS_UVC_RESPONSE_MIDDLE
0.224215246637%	1	446	97	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
0.224215246637%	1	446	97	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_MYC_AMPLIFICATION_TARGETS_DN
0.224215246637%	1	446	97	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
0.224215246637%	1	446	96	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZAMORA_NOS2_TARGETS_DN
0.224215246637%	1	446	96	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIU_PROSTATE_CANCER_UP
0.224215246637%	1	446	95	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN
0.224215246637%	1	446	95	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOEBEKE_LYMPHOID_STEM_CELL_UP
0.224215246637%	1	446	94	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES
0.224215246637%	1	446	94	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER
0.224215246637%	1	446	93	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHU_CMV_24_HR_UP
0.224215246637%	1	446	93	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHEN_LIVER_METABOLISM_QTL_CIS
0.224215246637%	1	446	93	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CADWELL_ATG16L1_TARGETS_UP
0.224215246637%	1	446	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WINTER_HYPOXIA_UP
0.224215246637%	1	446	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
0.224215246637%	1	446	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_MYCN_AMPLIFICATION_TARGETS_UP
0.224215246637%	1	446	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BURTON_ADIPOGENESIS_9
0.224215246637%	1	446	91	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
0.224215246637%	1	446	91	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ELVIDGE_HIF1A_TARGETS_DN
0.224215246637%	1	446	91	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
0.224215246637%	1	446	90	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SANA_TNF_SIGNALING_DN
0.224215246637%	1	446	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY
0.224215246637%	1	446	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN
0.224215246637%	1	446	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30
0.224215246637%	1	446	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GOUYER_TUMOR_INVASIVENESS
0.224215246637%	1	446	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHANG_TLX_TARGETS_UP
0.224215246637%	1	446	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VANLOO_SP3_TARGETS_DN
0.224215246637%	1	446	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP
0.224215246637%	1	446	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SWEET_KRAS_ONCOGENIC_SIGNATURE
0.224215246637%	1	446	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_AGING_NEOCORTEX_UP
0.224215246637%	1	446	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
0.224215246637%	1	446	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WALLACE_PROSTATE_CANCER_RACE_DN
0.224215246637%	1	446	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SEIDEN_ONCOGENESIS_BY_MET
0.224215246637%	1	446	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
0.224215246637%	1	446	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS
0.224215246637%	1	446	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP
0.224215246637%	1	446	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
0.224215246637%	1	446	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
0.224215246637%	1	446	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_APOPTOSIS
0.224215246637%	1	446	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
0.224215246637%	1	446	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DURCHDEWALD_SKIN_CARCINOGENESIS_UP
0.224215246637%	1	446	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_MITOTIC_PROMETAPHASE
0.224215246637%	1	446	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
0.224215246637%	1	446	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP
0.224215246637%	1	446	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MOOTHA_VOXPHOS
0.224215246637%	1	446	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KAYO_CALORIE_RESTRICTION_MUSCLE_DN
0.224215246637%	1	446	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.224215246637%	1	446	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.224215246637%	1	446	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
0.224215246637%	1	446	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_MAPK_PATHWAY
0.224215246637%	1	446	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.224215246637%	1	446	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
0.224215246637%	1	446	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_TGF_BETA_SIGNALING_PATHWAY
0.224215246637%	1	446	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BURTON_ADIPOGENESIS_8
0.224215246637%	1	446	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_16HR_DN
0.224215246637%	1	446	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
0.224215246637%	1	446	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	STEIN_ESR1_TARGETS
0.224215246637%	1	446	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE
0.224215246637%	1	446	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN
0.224215246637%	1	446	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
0.224215246637%	1	446	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
0.224215246637%	1	446	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_CMYB_PATHWAY
0.224215246637%	1	446	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_AGING_CEREBELLUM_UP
0.224215246637%	1	446	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_SMALL_CELL_LUNG_CANCER
0.224215246637%	1	446	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.224215246637%	1	446	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
0.224215246637%	1	446	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
0.224215246637%	1	446	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
0.224215246637%	1	446	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WARTERS_RESPONSE_TO_IR_SKIN
0.224215246637%	1	446	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.224215246637%	1	446	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.224215246637%	1	446	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
0.224215246637%	1	446	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JIANG_HYPOXIA_CANCER
0.224215246637%	1	446	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WONG_ENDMETRIUM_CANCER_DN
0.224215246637%	1	446	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS
0.224215246637%	1	446	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_REG_GR_PATHWAY
0.224215246637%	1	446	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FRASOR_RESPONSE_TO_ESTRADIOL_DN
0.224215246637%	1	446	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BILD_CTNNB1_ONCOGENIC_SIGNATURE
0.224215246637%	1	446	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
0.224215246637%	1	446	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
0.224215246637%	1	446	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
0.224215246637%	1	446	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_M_G1_TRANSITION
0.224215246637%	1	446	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION
0.224215246637%	1	446	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MAHAJAN_RESPONSE_TO_IL1A_UP
0.224215246637%	1	446	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEIN_MEDULLA_MARKERS
0.224215246637%	1	446	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
0.224215246637%	1	446	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
0.224215246637%	1	446	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HARRIS_HYPOXIA
0.224215246637%	1	446	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CROMER_METASTASIS_DN
0.224215246637%	1	446	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	COATES_MACROPHAGE_M1_VS_M2_UP
0.224215246637%	1	446	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WOO_LIVER_CANCER_RECURRENCE_DN
0.224215246637%	1	446	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_BETACATENIN_NUC_PATHWAY
0.224215246637%	1	446	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
0.224215246637%	1	446	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.224215246637%	1	446	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN
0.224215246637%	1	446	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.224215246637%	1	446	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BASSO_HAIRY_CELL_LEUKEMIA_DN
0.224215246637%	1	446	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP
0.224215246637%	1	446	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN
0.224215246637%	1	446	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GALIE_TUMOR_ANGIOGENESIS
0.224215246637%	1	446	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN
0.224215246637%	1	446	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DER_IFN_BETA_RESPONSE_DN
0.224215246637%	1	446	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS
0.224215246637%	1	446	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TOOKER_GEMCITABINE_RESISTANCE_UP
0.224215246637%	1	446	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT
0.224215246637%	1	446	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
0.224215246637%	1	446	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MCCLUNG_COCAINE_REWARD_5D
0.224215246637%	1	446	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
0.224215246637%	1	446	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIU_COMMON_CANCER_GENES
0.224215246637%	1	446	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
0.224215246637%	1	446	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GAVIN_FOXP3_TARGETS_CLUSTER_P2
0.224215246637%	1	446	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DUAN_PRDM5_TARGETS
0.224215246637%	1	446	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ROSS_AML_WITH_MLL_FUSIONS
0.224215246637%	1	446	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALING_BY_SCF_KIT
0.224215246637%	1	446	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CELL_JUNCTION_ORGANIZATION
0.224215246637%	1	446	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_PEROXISOME
0.224215246637%	1	446	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP
0.224215246637%	1	446	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	COATES_MACROPHAGE_M1_VS_M2_DN
0.224215246637%	1	446	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.224215246637%	1	446	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOYLAN_MULTIPLE_MYELOMA_D_DN
0.224215246637%	1	446	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RODRIGUES_THYROID_CARCINOMA_DN
0.224215246637%	1	446	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MORI_PRE_BI_LYMPHOCYTE_DN
0.224215246637%	1	446	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.224215246637%	1	446	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GROSS_HYPOXIA_VIA_HIF1A_UP
0.224215246637%	1	446	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
0.224215246637%	1	446	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
0.224215246637%	1	446	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SU_TESTIS
0.224215246637%	1	446	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ROSS_AML_WITH_AML1_ETO_FUSION
0.224215246637%	1	446	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
0.224215246637%	1	446	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MAHAJAN_RESPONSE_TO_IL1A_DN
0.224215246637%	1	446	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_VEGF_SIGNALING_PATHWAY
0.224215246637%	1	446	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MORI_MATURE_B_LYMPHOCYTE_DN
0.224215246637%	1	446	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BAE_BRCA1_TARGETS_UP
0.224215246637%	1	446	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHEPARD_BMYB_TARGETS
0.224215246637%	1	446	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS
0.224215246637%	1	446	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	OUILLETTE_CLL_13Q14_DELETION_UP
0.224215246637%	1	446	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3
0.224215246637%	1	446	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEIN_OLIGODENDROCYTE_MARKERS
0.224215246637%	1	446	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
0.224215246637%	1	446	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FURUKAWA_DUSP6_TARGETS_PCI35_DN
0.224215246637%	1	446	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.224215246637%	1	446	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
0.224215246637%	1	446	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
0.224215246637%	1	446	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_VIRAL_MYOCARDITIS
0.224215246637%	1	446	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_CHRONIC_MYELOID_LEUKEMIA
0.224215246637%	1	446	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DITTMER_PTHLH_TARGETS_DN
0.224215246637%	1	446	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SESTO_RESPONSE_TO_UV_C8
0.224215246637%	1	446	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
0.224215246637%	1	446	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1
0.224215246637%	1	446	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MATZUK_SPERMATOCYTE
0.224215246637%	1	446	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
0.224215246637%	1	446	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BURTON_ADIPOGENESIS_2
0.224215246637%	1	446	71	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.224215246637%	1	446	71	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KYNG_RESPONSE_TO_H2O2
0.224215246637%	1	446	71	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_6HR_UP
0.224215246637%	1	446	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VERNELL_RETINOBLASTOMA_PATHWAY_UP
0.224215246637%	1	446	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5
0.224215246637%	1	446	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS
0.224215246637%	1	446	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RAGHAVACHARI_PLATELET_SPECIFIC_GENES
0.224215246637%	1	446	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_AP1_PATHWAY
0.224215246637%	1	446	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LANDIS_BREAST_CANCER_PROGRESSION_DN
0.224215246637%	1	446	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_RENAL_CELL_CARCINOMA
0.224215246637%	1	446	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_LONG_TERM_POTENTIATION
0.224215246637%	1	446	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_LONG_TERM_DEPRESSION
0.224215246637%	1	446	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ENGELMANN_CANCER_PROGENITORS_DN
0.224215246637%	1	446	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TESAR_JAK_TARGETS_MOUSE_ES_D3_UP
0.224215246637%	1	446	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ST_PAC1_RECEPTOR_PATHWAY
0.224215246637%	1	446	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MOOTHA_ROS
0.224215246637%	1	446	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN
0.224215246637%	1	446	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOLLEMAN_DAUNORUBICIN_ALL_UP
0.224215246637%	1	446	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.224215246637%	1	446	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RIZKI_TUMOR_INVASIVENESS_2D_UP
0.224215246637%	1	446	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_P75NTRPATHWAY
0.224215246637%	1	446	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_MTOR_4PATHWAY
0.224215246637%	1	446	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.224215246637%	1	446	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HUANG_DASATINIB_RESISTANCE_DN
0.224215246637%	1	446	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
0.224215246637%	1	446	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
0.224215246637%	1	446	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AMIT_EGF_RESPONSE_120_HELA
0.224215246637%	1	446	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
0.224215246637%	1	446	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
0.224215246637%	1	446	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
0.224215246637%	1	446	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN
0.224215246637%	1	446	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP
0.224215246637%	1	446	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GENTILE_UV_LOW_DOSE_DN
0.224215246637%	1	446	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DAZARD_UV_RESPONSE_CLUSTER_G1
0.224215246637%	1	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
0.224215246637%	1	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
0.224215246637%	1	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT
0.224215246637%	1	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TENEDINI_MEGAKARYOCYTE_MARKERS
0.224215246637%	1	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RAMASWAMY_METASTASIS_UP
0.224215246637%	1	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_INTEGRIN1_PATHWAY
0.224215246637%	1	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_HDAC_CLASSI_PATHWAY
0.224215246637%	1	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NAKAMURA_ADIPOGENESIS_EARLY_UP
0.224215246637%	1	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP
0.224215246637%	1	446	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BEIER_GLIOMA_STEM_CELL_DN
0.224215246637%	1	446	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALING_BY_WNT
0.224215246637%	1	446	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
0.224215246637%	1	446	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX
0.224215246637%	1	446	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_IL4_2PATHWAY
0.224215246637%	1	446	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GUO_HEX_TARGETS_DN
0.224215246637%	1	446	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHANG_IMMORTALIZED_BY_HPV31_DN
0.224215246637%	1	446	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP
0.224215246637%	1	446	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RIZKI_TUMOR_INVASIVENESS_2D_DN
0.224215246637%	1	446	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
0.224215246637%	1	446	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C
0.224215246637%	1	446	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS
0.224215246637%	1	446	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIU_SMARCA4_TARGETS
0.224215246637%	1	446	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
0.224215246637%	1	446	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BYSTROEM_CORRELATED_WITH_IL5_DN
0.224215246637%	1	446	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP
0.224215246637%	1	446	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_MYC_REPRESSPATHWAY
0.224215246637%	1	446	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_LIVER_CANCER_MYC_DN
0.224215246637%	1	446	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
0.224215246637%	1	446	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BURTON_ADIPOGENESIS_PEAK_AT_0HR
0.224215246637%	1	446	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BRIDEAU_IMPRINTED_GENES
0.224215246637%	1	446	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_LIVER_CANCER_E2F1_UP
0.224215246637%	1	446	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.224215246637%	1	446	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ISSAEVA_MLL2_TARGETS
0.224215246637%	1	446	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.224215246637%	1	446	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GEORGES_CELL_CYCLE_MIR192_TARGETS
0.224215246637%	1	446	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CORRE_MULTIPLE_MYELOMA_DN
0.224215246637%	1	446	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BILD_SRC_ONCOGENIC_SIGNATURE
0.224215246637%	1	446	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZWANG_EGF_PERSISTENTLY_DN
0.224215246637%	1	446	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ER_PHAGOSOME_PATHWAY
0.224215246637%	1	446	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
0.224215246637%	1	446	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_AR_PATHWAY
0.224215246637%	1	446	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KAUFFMANN_MELANOMA_RELAPSE_UP
0.224215246637%	1	446	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_1HR_UP
0.224215246637%	1	446	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
0.224215246637%	1	446	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SONG_TARGETS_OF_IE86_CMV_PROTEIN
0.224215246637%	1	446	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_LIVER_CANCER_DENA_UP
0.224215246637%	1	446	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
0.224215246637%	1	446	6	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TRACEY_RESISTANCE_TO_IFNA2_UP
0.224215246637%	1	446	6	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KAUFFMANN_MELANOMA_RELAPSE_DN
0.224215246637%	1	446	6	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BUSA_SAM68_TARGETS_DN
0.224215246637%	1	446	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION
0.224215246637%	1	446	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
0.224215246637%	1	446	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ASTIER_INTEGRIN_SIGNALING
0.224215246637%	1	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHENG_GLIOBLASTOMA_PLASTICITY_DN
0.224215246637%	1	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
0.224215246637%	1	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WAKASUGI_HAVE_ZNF143_BINDING_SITES
0.224215246637%	1	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_REGULATION_OF_APOPTOSIS
0.224215246637%	1	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT
0.224215246637%	1	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NAGASHIMA_NRG1_SIGNALING_DN
0.224215246637%	1	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN
0.224215246637%	1	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_NPC_LCP_WITH_H3K4ME3
0.224215246637%	1	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KOHOUTEK_CCNT2_TARGETS
0.224215246637%	1	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_ARACHIDONIC_ACID_METABOLISM
0.224215246637%	1	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
0.224215246637%	1	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JI_RESPONSE_TO_FSH_DN
0.224215246637%	1	446	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BERNARD_PPAPDC1B_TARGETS_DN
0.224215246637%	1	446	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE
0.224215246637%	1	446	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_TXA2PATHWAY
0.224215246637%	1	446	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON
0.224215246637%	1	446	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_EARLY_T_LYMPHOCYTE_DN
0.224215246637%	1	446	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BURTON_ADIPOGENESIS_11
0.224215246637%	1	446	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
0.224215246637%	1	446	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BORLAK_LIVER_CANCER_EGF_UP
0.224215246637%	1	446	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AMIT_SERUM_RESPONSE_60_MCF10A
0.224215246637%	1	446	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AMIT_SERUM_RESPONSE_240_MCF10A
0.224215246637%	1	446	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VANTVEER_BREAST_CANCER_METASTASIS_UP
0.224215246637%	1	446	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.224215246637%	1	446	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION
0.224215246637%	1	446	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX
0.224215246637%	1	446	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP
0.224215246637%	1	446	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_VIBRIO_CHOLERAE_INFECTION
0.224215246637%	1	446	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.224215246637%	1	446	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_30MIN_UP
0.224215246637%	1	446	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_10HR_DN
0.224215246637%	1	446	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
0.224215246637%	1	446	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SMIRNOV_RESPONSE_TO_IR_2HR_DN
0.224215246637%	1	446	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ION_CHANNEL_TRANSPORT
0.224215246637%	1	446	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_TGFBRPATHWAY
0.224215246637%	1	446	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER
0.224215246637%	1	446	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN
0.224215246637%	1	446	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_BASAL_CELL_CARCINOMA
0.224215246637%	1	446	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DEMAGALHAES_AGING_UP
0.224215246637%	1	446	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_4HR_UP
0.224215246637%	1	446	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
0.224215246637%	1	446	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SU_PANCREAS
0.224215246637%	1	446	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RICKMAN_HEAD_AND_NECK_CANCER_F
0.224215246637%	1	446	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TCR_SIGNALING
0.224215246637%	1	446	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN
0.224215246637%	1	446	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_LIVER_CANCER_MYC_UP
0.224215246637%	1	446	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_NON_SMALL_CELL_LUNG_CANCER
0.224215246637%	1	446	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP
0.224215246637%	1	446	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
0.224215246637%	1	446	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SMIRNOV_RESPONSE_TO_IR_2HR_UP
0.224215246637%	1	446	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ROESSLER_LIVER_CANCER_METASTASIS_DN
0.224215246637%	1	446	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PROTEIN_FOLDING
0.224215246637%	1	446	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0
0.224215246637%	1	446	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CIRCADIAN_CLOCK
0.224215246637%	1	446	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_CD8TCRPATHWAY
0.224215246637%	1	446	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
0.224215246637%	1	446	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ISHIDA_E2F_TARGETS
0.224215246637%	1	446	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IKEDA_MIR1_TARGETS_UP
0.224215246637%	1	446	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HENDRICKS_SMARCA4_TARGETS_DN
0.224215246637%	1	446	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP
0.224215246637%	1	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WINTER_HYPOXIA_DN
0.224215246637%	1	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.224215246637%	1	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_GABA_RECEPTOR_ACTIVATION
0.224215246637%	1	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RADAEVA_RESPONSE_TO_IFNA1_UP
0.224215246637%	1	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PRAMOONJAGO_SOX4_TARGETS_UP
0.224215246637%	1	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_PTP1BPATHWAY
0.224215246637%	1	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_MTOR_SIGNALING_PATHWAY
0.224215246637%	1	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_ENDOMETRIAL_CANCER
0.224215246637%	1	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHIBA_RESPONSE_TO_TSA_UP
0.224215246637%	1	446	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
0.224215246637%	1	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
0.224215246637%	1	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
0.224215246637%	1	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.224215246637%	1	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT
0.224215246637%	1	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_NUCLEOTIDE_EXCISION_REPAIR
0.224215246637%	1	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
0.224215246637%	1	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1
0.224215246637%	1	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LUI_THYROID_CANCER_CLUSTER_1
0.224215246637%	1	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_DRUG_METABOLISM_OTHER_ENZYMES
0.224215246637%	1	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BURTON_ADIPOGENESIS_7
0.224215246637%	1	446	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
0.224215246637%	1	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YANG_BREAST_CANCER_ESR1_LASER_DN
0.224215246637%	1	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
0.224215246637%	1	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_ANGIOPOIETINRECEPTOR_PATHWAY
0.224215246637%	1	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PARK_APL_PATHOGENESIS_DN
0.224215246637%	1	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
0.224215246637%	1	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_GLUTATHIONE_METABOLISM
0.224215246637%	1	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC
0.224215246637%	1	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN
0.224215246637%	1	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN
0.224215246637%	1	446	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BECKER_TAMOXIFEN_RESISTANCE_UP
0.224215246637%	1	446	5	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PASTURAL_RIZ1_TARGETS_DN
0.224215246637%	1	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC
0.224215246637%	1	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_METABOLISM_OF_NON_CODING_RNA
0.224215246637%	1	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS
0.224215246637%	1	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_FOXOPATHWAY
0.224215246637%	1	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_ARF6_TRAFFICKINGPATHWAY
0.224215246637%	1	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARCHINI_TRABECTEDIN_RESISTANCE_DN
0.224215246637%	1	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_LIVER_CANCER
0.224215246637%	1	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_GLYCEROLIPID_METABOLISM
0.224215246637%	1	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_2HR_DN
0.224215246637%	1	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_TCR_PATHWAY
0.224215246637%	1	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP
0.224215246637%	1	446	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	APRELIKOVA_BRCA1_TARGETS
0.224215246637%	1	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_MS_UP
0.224215246637%	1	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_LB_UP
0.224215246637%	1	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PI_METABOLISM
0.224215246637%	1	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES
0.224215246637%	1	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6
0.224215246637%	1	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RASHI_RESPONSE_TO_IONIZING_RADIATION_3
0.224215246637%	1	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	OXFORD_RALA_OR_RALB_TARGETS_UP
0.224215246637%	1	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_PROTEASOME
0.224215246637%	1	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
0.224215246637%	1	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN
0.224215246637%	1	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ENGELMANN_CANCER_PROGENITORS_UP
0.224215246637%	1	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DELACROIX_RAR_TARGETS_UP
0.224215246637%	1	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHANGOLKAR_H2AFY_TARGETS_UP
0.224215246637%	1	446	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BURTON_ADIPOGENESIS_4
0.224215246637%	1	446	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_MF_UP
0.224215246637%	1	446	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_HP_DN
0.224215246637%	1	446	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WARTERS_IR_RESPONSE_5GY
0.224215246637%	1	446	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
0.224215246637%	1	446	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_NFAT_TFPATHWAY
0.224215246637%	1	446	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_IL6_7PATHWAY
0.224215246637%	1	446	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MCCLUNG_DELTA_FOSB_TARGETS_8WK
0.224215246637%	1	446	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JIANG_AGING_HYPOTHALAMUS_UP
0.224215246637%	1	446	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_CD2_DN
0.224215246637%	1	446	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WINNEPENNINCKX_MELANOMA_METASTASIS_DN
0.224215246637%	1	446	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SIG_BCR_SIGNALING_PATHWAY
0.224215246637%	1	446	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6
0.224215246637%	1	446	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SESTO_RESPONSE_TO_UV_C5
0.224215246637%	1	446	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SAGIV_CD24_TARGETS_DN
0.224215246637%	1	446	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
0.224215246637%	1	446	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_TNFPATHWAY
0.224215246637%	1	446	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_PLK1_PATHWAY
0.224215246637%	1	446	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NUTT_GBM_VS_AO_GLIOMA_UP
0.224215246637%	1	446	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN
0.224215246637%	1	446	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AMIT_EGF_RESPONSE_60_HELA
0.224215246637%	1	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_CD2_UP
0.224215246637%	1	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VANHARANTA_UTERINE_FIBROID_UP
0.224215246637%	1	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP
0.224215246637%	1	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN
0.224215246637%	1	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN
0.224215246637%	1	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_MRNA_SPLICING_MINOR_PATHWAY
0.224215246637%	1	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_
0.224215246637%	1	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_RHOA_PATHWAY
0.224215246637%	1	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN
0.224215246637%	1	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NUTT_GBM_VS_AO_GLIOMA_DN
0.224215246637%	1	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN
0.224215246637%	1	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHENG_RESPONSE_TO_NICKEL_ACETATE
0.224215246637%	1	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY
0.224215246637%	1	446	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ABRAMSON_INTERACT_WITH_AIRE
0.224215246637%	1	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.224215246637%	1	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALING_BY_FGFR_MUTANTS
0.224215246637%	1	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS
0.224215246637%	1	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_HNF3APATHWAY
0.224215246637%	1	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_ERBB2ERBB3PATHWAY
0.224215246637%	1	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MEDINA_SMARCA4_TARGETS
0.224215246637%	1	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MA_MYELOID_DIFFERENTIATION_DN
0.224215246637%	1	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP
0.224215246637%	1	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
0.224215246637%	1	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_TYPE_I_DIABETES_MELLITUS
0.224215246637%	1	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_NUCLEOTIDE_EXCISION_REPAIR
0.224215246637%	1	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_LYSINE_DEGRADATION
0.224215246637%	1	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_ABC_TRANSPORTERS
0.224215246637%	1	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HARRIS_BRAIN_CANCER_PROGENITORS
0.224215246637%	1	446	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FAELT_B_CLL_WITH_VH3_21_UP
0.224215246637%	1	446	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZUCCHI_METASTASIS_UP
0.224215246637%	1	446	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ULE_SPLICING_VIA_NOVA2
0.224215246637%	1	446	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RIZ_ERYTHROID_DIFFERENTIATION_12HR
0.224215246637%	1	446	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_THROMBIN_PAR1_PATHWAY
0.224215246637%	1	446	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NAKAMURA_METASTASIS_MODEL_DN
0.224215246637%	1	446	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
0.224215246637%	1	446	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
0.224215246637%	1	446	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FUJII_YBX1_TARGETS_UP
0.224215246637%	1	446	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BURTON_ADIPOGENESIS_PEAK_AT_24HR
0.224215246637%	1	446	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AMIT_EGF_RESPONSE_480_MCF10A
0.224215246637%	1	446	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WIERENGA_PML_INTERACTOME
0.224215246637%	1	446	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
0.224215246637%	1	446	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_FATTY_ACID_METABOLISM
0.224215246637%	1	446	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
0.224215246637%	1	446	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BILBAN_B_CLL_LPL_DN
0.224215246637%	1	446	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_MF_DN
0.224215246637%	1	446	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WENG_POR_TARGETS_LIVER_UP
0.224215246637%	1	446	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN
0.224215246637%	1	446	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RIZ_ERYTHROID_DIFFERENTIATION_HBZ
0.224215246637%	1	446	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING
0.224215246637%	1	446	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_NETRIN1_SIGNALING
0.224215246637%	1	446	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LI_LUNG_CANCER
0.224215246637%	1	446	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KAAB_FAILED_HEART_VENTRICLE_DN
0.224215246637%	1	446	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DELPUECH_FOXO3_TARGETS_DN
0.224215246637%	1	446	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
0.224215246637%	1	446	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHEN_HOXA5_TARGETS_9HR_DN
0.224215246637%	1	446	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_FCER1_PATHWAY
0.224215246637%	1	446	405	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KUMAR_TARGETS_OF_MLL_AF9_FUSION
0.224215246637%	1	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.224215246637%	1	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VANASSE_BCL2_TARGETS_UP
0.224215246637%	1	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ST_JNK_MAPK_PATHWAY
0.224215246637%	1	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ST_B_CELL_ANTIGEN_RECEPTOR
0.224215246637%	1	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_FOXM1PATHWAY
0.224215246637%	1	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_PYRUVATE_METABOLISM
0.224215246637%	1	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JIANG_AGING_HYPOTHALAMUS_DN
0.224215246637%	1	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHESLER_BRAIN_HIGHEST_EXPRESSION
0.224215246637%	1	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BURTON_ADIPOGENESIS_PEAK_AT_16HR
0.224215246637%	1	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.224215246637%	1	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_P38MAPK_PATHWAY
0.224215246637%	1	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BERNARD_PPAPDC1B_TARGETS_UP
0.224215246637%	1	446	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BENPORATH_ES_2
0.224215246637%	1	446	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WHITEHURST_PACLITAXEL_SENSITIVITY
0.224215246637%	1	446	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_LSD1_TARGETS_DN
0.224215246637%	1	446	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_ECADHERIN_NASCENTAJ_PATHWAY
0.224215246637%	1	446	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_AURORA_B_PATHWAY
0.224215246637%	1	446	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_ATR_PATHWAY
0.224215246637%	1	446	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KORKOLA_TERATOMA
0.224215246637%	1	446	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GENTILE_UV_RESPONSE_CLUSTER_D5
0.224215246637%	1	446	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BURTON_ADIPOGENESIS_PEAK_AT_8HR
0.224215246637%	1	446	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BILANGES_RAPAMYCIN_SENSITIVE_GENES
0.224215246637%	1	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS
0.224215246637%	1	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER
0.224215246637%	1	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PI3K_AKT_ACTIVATION
0.224215246637%	1	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_GABA_B_RECEPTOR_ACTIVATION
0.224215246637%	1	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PIONTEK_PKD1_TARGETS_UP
0.224215246637%	1	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_P38ALPHABETADOWNSTREAMPATHWAY
0.224215246637%	1	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PENG_GLUTAMINE_DEPRIVATION_UP
0.224215246637%	1	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.224215246637%	1	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP
0.224215246637%	1	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT
0.224215246637%	1	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP
0.224215246637%	1	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN
0.224215246637%	1	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CERVERA_SDHB_TARGETS_1_DN
0.224215246637%	1	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN
0.224215246637%	1	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN
0.224215246637%	1	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
0.224215246637%	1	446	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_INTEGRIN_PATHWAY
0.224215246637%	1	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN
0.224215246637%	1	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VALK_AML_WITH_CEBPA
0.224215246637%	1	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ST_P38_MAPK_PATHWAY
0.224215246637%	1	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
0.224215246637%	1	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN
0.224215246637%	1	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS
0.224215246637%	1	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_GMCSF_PATHWAY
0.224215246637%	1	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MURAKAMI_UV_RESPONSE_6HR_UP
0.224215246637%	1	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES
0.224215246637%	1	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_ALL_DISORDERS_CALB1_CORR_DN
0.224215246637%	1	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CUI_TCF21_TARGETS_UP
0.224215246637%	1	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_PAR1_PATHWAY
0.224215246637%	1	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_MET_PATHWAY
0.224215246637%	1	446	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_BCR_PATHWAY
0.224215246637%	1	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YANG_BREAST_CANCER_ESR1_UP
0.224215246637%	1	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VANTVEER_BREAST_CANCER_BRCA1_UP
0.224215246637%	1	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN
0.224215246637%	1	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VALK_AML_CLUSTER_11
0.224215246637%	1	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ST_ADRENERGIC
0.224215246637%	1	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
0.224215246637%	1	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SEMENZA_HIF1_TARGETS
0.224215246637%	1	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALLING_TO_ERKS
0.224215246637%	1	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION
0.224215246637%	1	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_PI3KPLCTRKPATHWAY
0.224215246637%	1	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MMS_MOUSE_LYMPH_HIGH_4HRS_UP
0.224215246637%	1	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_DNA_REPLICATION
0.224215246637%	1	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_BASAL_TRANSCRIPTION_FACTORS
0.224215246637%	1	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JIANG_AGING_CEREBRAL_CORTEX_UP
0.224215246637%	1	446	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOUSTIS_ROS
0.224215246637%	1	446	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ST_G_ALPHA_I_PATHWAY
0.224215246637%	1	446	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ROZANOV_MMP14_TARGETS_DN
0.224215246637%	1	446	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_GLOBAL_GENOMIC_NER_GG_NER
0.224215246637%	1	446	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
0.224215246637%	1	446	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_BASE_EXCISION_REPAIR
0.224215246637%	1	446	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JAZAG_TGFB1_SIGNALING_DN
0.224215246637%	1	446	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HU_GENOTOXIC_DAMAGE_24HR
0.224215246637%	1	446	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GUTIERREZ_MULTIPLE_MYELOMA_DN
0.224215246637%	1	446	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DORSAM_HOXA9_TARGETS_UP
0.224215246637%	1	446	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP
0.224215246637%	1	446	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BALDWIN_PRKCI_TARGETS_UP
0.224215246637%	1	446	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE
0.224215246637%	1	446	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES
0.224215246637%	1	446	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_IL2_PI3KPATHWAY
0.224215246637%	1	446	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.224215246637%	1	446	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_BUTANOATE_METABOLISM
0.224215246637%	1	446	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HONMA_DOCETAXEL_RESISTANCE
0.224215246637%	1	446	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DOANE_BREAST_CANCER_CLASSES_DN
0.224215246637%	1	446	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP
0.224215246637%	1	446	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_MPR_PATHWAY
0.224215246637%	1	446	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_LATE_DIFFERENTIATION_GENES_UP
0.224215246637%	1	446	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VALK_AML_CLUSTER_6
0.224215246637%	1	446	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS
0.224215246637%	1	446	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS
0.224215246637%	1	446	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_SYNDECAN_2_PATHWAY
0.224215246637%	1	446	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.224215246637%	1	446	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_PROPANOATE_METABOLISM
0.224215246637%	1	446	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JEPSEN_SMRT_TARGETS
0.224215246637%	1	446	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DORN_ADENOVIRUS_INFECTION_12HR_DN
0.224215246637%	1	446	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CAFFAREL_RESPONSE_TO_THC_UP
0.224215246637%	1	446	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_NO1_PATHWAY
0.224215246637%	1	446	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN
0.224215246637%	1	446	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	APPEL_IMATINIB_RESPONSE
0.224215246637%	1	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZWANG_EGF_PERSISTENTLY_UP
0.224215246637%	1	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.224215246637%	1	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TSAI_RESPONSE_TO_RADIATION_THERAPY
0.224215246637%	1	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING
0.224215246637%	1	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ELONGATION_ARREST_AND_RECOVERY
0.224215246637%	1	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	POS_HISTAMINE_RESPONSE_NETWORK
0.224215246637%	1	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_SYNDECAN_4_PATHWAY
0.224215246637%	1	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIANG_SILENCED_BY_METHYLATION_UP
0.224215246637%	1	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GROSS_ELK3_TARGETS_DN
0.224215246637%	1	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_RHO_PATHWAY
0.224215246637%	1	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_PDGF_PATHWAY
0.224215246637%	1	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_HDAC_PATHWAY
0.224215246637%	1	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BAUS_TFF2_TARGETS_UP
0.224215246637%	1	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP
0.224215246637%	1	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN
0.224215246637%	1	446	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BAE_BRCA1_TARGETS_DN
0.224215246637%	1	446	318	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DAZARD_RESPONSE_TO_UV_NHEK_DN
0.224215246637%	1	446	317	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12
0.224215246637%	1	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VALK_AML_CLUSTER_4
0.224215246637%	1	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.224215246637%	1	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING
0.224215246637%	1	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
0.224215246637%	1	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_NEPHRIN_NEPH1_PATHWAY
0.224215246637%	1	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_AVB3_OPN_PATHWAY
0.224215246637%	1	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_AR_NONGENOMIC_PATHWAY
0.224215246637%	1	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NOJIMA_SFRP2_TARGETS_UP
0.224215246637%	1	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM
0.224215246637%	1	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP
0.224215246637%	1	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
0.224215246637%	1	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_PYK2_PATHWAY
0.224215246637%	1	446	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_EGF_PATHWAY
0.224215246637%	1	446	307	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LI_INDUCED_T_TO_NATURAL_KILLER_UP
0.224215246637%	1	446	305	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
0.224215246637%	1	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
0.224215246637%	1	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.224215246637%	1	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VALK_AML_CLUSTER_13
0.224215246637%	1	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VALK_AML_CLUSTER_12
0.224215246637%	1	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TAVOR_CEBPA_TARGETS_DN
0.224215246637%	1	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
0.224215246637%	1	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_NOD1_2_SIGNALING_PATHWAY
0.224215246637%	1	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_DNA_STRAND_ELONGATION
0.224215246637%	1	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_RAS_PATHWAY
0.224215246637%	1	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_IL2_STAT5PATHWAY
0.224215246637%	1	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_CDC42_REG_PATHWAY
0.224215246637%	1	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP
0.224215246637%	1	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_LRRC3B_TARGETS
0.224215246637%	1	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GUILLAUMOND_KLF10_TARGETS_DN
0.224215246637%	1	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY
0.224215246637%	1	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BURTON_ADIPOGENESIS_10
0.224215246637%	1	446	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP
0.224215246637%	1	446	299	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WALLACE_PROSTATE_CANCER_RACE_UP
0.224215246637%	1	446	295	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LU_EZH2_TARGETS_UP
0.224215246637%	1	446	294	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
0.224215246637%	1	446	293	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZWANG_DOWN_BY_2ND_EGF_PULSE
0.224215246637%	1	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_RESPONSE_TO_BEXAROTENE_DN
0.224215246637%	1	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_RESPONSE_TO_ANDROGEN_UP
0.224215246637%	1	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VALK_AML_CLUSTER_2
0.224215246637%	1	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TIGHT_JUNCTION_INTERACTIONS
0.224215246637%	1	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN
0.224215246637%	1	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
0.224215246637%	1	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_S1P_S1P3_PATHWAY
0.224215246637%	1	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_REELINPATHWAY
0.224215246637%	1	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PATTERSON_DOCETAXEL_RESISTANCE
0.224215246637%	1	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NGUYEN_NOTCH1_TARGETS_UP
0.224215246637%	1	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MA_PITUITARY_FETAL_VS_ADULT_UP
0.224215246637%	1	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
0.224215246637%	1	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KRIGE_AMINO_ACID_DEPRIVATION
0.224215246637%	1	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_HISTIDINE_METABOLISM
0.224215246637%	1	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHOW_RASSF1_TARGETS_DN
0.224215246637%	1	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_TNFR1_PATHWAY
0.224215246637%	1	446	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP
0.224215246637%	1	446	288	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	POOLA_INVASIVE_BREAST_CANCER_UP
0.224215246637%	1	446	285	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRADE_COLON_AND_RECTAL_CANCER_UP
0.224215246637%	1	446	284	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
0.224215246637%	1	446	282	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HELLER_SILENCED_BY_METHYLATION_UP
0.224215246637%	1	446	281	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BHAT_ESR1_TARGETS_VIA_AKT1_UP
0.224215246637%	1	446	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VALK_AML_CLUSTER_7
0.224215246637%	1	446	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VALK_AML_CLUSTER_1
0.224215246637%	1	446	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ST_GAQ_PATHWAY
0.224215246637%	1	446	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS
0.224215246637%	1	446	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING
0.224215246637%	1	446	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_LIS1PATHWAY
0.224215246637%	1	446	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PETRETTO_HEART_MASS_QTL_CIS_UP
0.224215246637%	1	446	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	OLSSON_E2F3_TARGETS_UP
0.224215246637%	1	446	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MATZUK_MALE_REPRODUCTION_SERTOLI
0.224215246637%	1	446	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LI_CISPLATIN_RESISTANCE_UP
0.224215246637%	1	446	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KAMIKUBO_MYELOID_CEBPA_NETWORK
0.224215246637%	1	446	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
0.224215246637%	1	446	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP
0.224215246637%	1	446	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_PROTEASOME_PATHWAY
0.224215246637%	1	446	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_GH_PATHWAY
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YE_METASTATIC_LIVER_CANCER
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YANG_BREAST_CANCER_ESR1_BULK_UP
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	XU_AKT1_TARGETS_6HR
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TERAO_AOX4_TARGETS_SKIN_DN
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ST_MYOCYTE_AD_PATHWAY
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_EXTENSION_OF_TELOMERES
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PLASARI_NFIC_TARGETS_BASAL_UP
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_IL3_PATHWAY
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NICK_RESPONSE_TO_PROC_TREATMENT_DN
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_PENTOSE_PHOSPHATE_PATHWAY
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G2
0.224215246637%	1	446	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_EDG1_PATHWAY
0.224215246637%	1	446	267	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.224215246637%	1	446	260	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOQUEST_STEM_CELL_UP
0.224215246637%	1	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHENG_FOXP3_TARGETS_UP
0.224215246637%	1	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG
0.224215246637%	1	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VALK_AML_CLUSTER_8
0.224215246637%	1	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VALK_AML_CLUSTER_16
0.224215246637%	1	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP
0.224215246637%	1	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER
0.224215246637%	1	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_P38_MKK3_6PATHWAY
0.224215246637%	1	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_INSULIN_GLUCOSE_PATHWAY
0.224215246637%	1	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP
0.224215246637%	1	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HAHTOLA_CTCL_CUTANEOUS
0.224215246637%	1	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_RACCYCD_PATHWAY
0.224215246637%	1	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_PGC1A_PATHWAY
0.224215246637%	1	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP
0.224215246637%	1	446	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ABBUD_LIF_SIGNALING_1_DN
0.224215246637%	1	446	259	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP
0.224215246637%	1	446	253	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MCLACHLAN_DENTAL_CARIES_UP
0.224215246637%	1	446	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_NFKB_TARGETS
0.224215246637%	1	446	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE
0.224215246637%	1	446	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
0.224215246637%	1	446	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_DARPP_32_EVENTS
0.224215246637%	1	446	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_TOLL_ENDOGENOUS_PATHWAY
0.224215246637%	1	446	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_MYC_PATHWAY
0.224215246637%	1	446	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM
0.224215246637%	1	446	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JACKSON_DNMT1_TARGETS_DN
0.224215246637%	1	446	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_MCALPAIN_PATHWAY
0.224215246637%	1	446	245	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.224215246637%	1	446	245	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MCLACHLAN_DENTAL_CARIES_DN
0.224215246637%	1	446	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YIH_RESPONSE_TO_ARSENITE_C1
0.224215246637%	1	446	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PYRIMIDINE_METABOLISM
0.224215246637%	1	446	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CHOLESTEROL_BIOSYNTHESIS
0.224215246637%	1	446	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_S1P_S1P2_PATHWAY
0.224215246637%	1	446	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	OSADA_ASCL1_TARGETS_DN
0.224215246637%	1	446	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN
0.224215246637%	1	446	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MAEKAWA_ATF2_TARGETS
0.224215246637%	1	446	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY
0.224215246637%	1	446	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HASLINGER_B_CLL_WITH_13Q14_DELETION
0.224215246637%	1	446	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_TPO_PATHWAY
0.224215246637%	1	446	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_NOS1_PATHWAY
0.224215246637%	1	446	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_ECM_PATHWAY
0.224215246637%	1	446	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_CXCR4_PATHWAY
0.224215246637%	1	446	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_CSK_PATHWAY
0.224215246637%	1	446	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AZARE_STAT3_TARGETS
0.224215246637%	1	446	238	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZIRN_TRETINOIN_RESPONSE_WT1_UP
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_RESPONSE_TO_FORSKOLIN_UP
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VIETOR_IFRD1_TARGETS
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SAGIV_CD24_TARGETS_UP
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_PRLSIGNALINGEVENTSPATHWAY
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MAHADEVAN_IMATINIB_RESISTANCE_UP
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	EGUCHI_CELL_CYCLE_RB1_TARGETS
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_RAS_PATHWAY
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_PTDINS_PATHWAY
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_IGF1R_PATHWAY
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_CCR3_PATHWAY
0.224215246637%	1	446	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BILANGES_SERUM_SENSITIVE_VIA_TSC1
0.224215246637%	1	446	228	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED
0.224215246637%	1	446	227	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE
0.224215246637%	1	446	227	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.224215246637%	1	446	223	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.224215246637%	1	446	222	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CAIRO_LIVER_DEVELOPMENT_DN
0.224215246637%	1	446	220	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
0.224215246637%	1	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YUAN_ZNF143_PARTNERS
0.224215246637%	1	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WELCH_GATA1_TARGETS
0.224215246637%	1	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SPIRA_SMOKERS_LUNG_CANCER_DN
0.224215246637%	1	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ROY_WOUND_BLOOD_VESSEL_DN
0.224215246637%	1	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
0.224215246637%	1	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_PDGFRAPATHWAY
0.224215246637%	1	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_BETA_ALANINE_METABOLISM
0.224215246637%	1	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KANG_FLUOROURACIL_RESISTANCE_UP
0.224215246637%	1	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP
0.224215246637%	1	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HANSON_HRAS_SIGNALING_VIA_NFKB
0.224215246637%	1	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION
0.224215246637%	1	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN
0.224215246637%	1	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_INSULIN_PATHWAY
0.224215246637%	1	446	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_IL6_PATHWAY
0.224215246637%	1	446	217	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WONG_MITOCHONDRIA_GENE_MODULE
0.224215246637%	1	446	217	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WIERENGA_STAT5A_TARGETS_UP
0.224215246637%	1	446	216	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOQUEST_STEM_CELL_DN
0.224215246637%	1	446	214	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
0.224215246637%	1	446	210	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VERHAAK_GLIOBLASTOMA_NEURAL
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZIRN_TRETINOIN_RESPONSE_UP
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WOTTON_RUNX_TARGETS_UP
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCHURINGA_STAT5A_TARGETS_UP
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MOOTHA_GLYCOLYSIS
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MOOTHA_GLYCOGEN_METABOLISM
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HUI_MAPK14_TARGETS_UP
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HASLINGER_B_CLL_WITH_17P13_DELETION
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_TFF_PATHWAY
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_CTLA4_PATHWAY
0.224215246637%	1	446	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_CALCINEURIN_PATHWAY
0.224215246637%	1	446	208	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION
0.224215246637%	1	446	206	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BILD_MYC_ONCOGENIC_SIGNATURE
0.224215246637%	1	446	205	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
0.224215246637%	1	446	205	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHEPARD_BMYB_MORPHOLINO_UP
0.224215246637%	1	446	203	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_INFLUENZA_LIFE_CYCLE
0.224215246637%	1	446	203	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PENG_RAPAMYCIN_RESPONSE_UP
0.224215246637%	1	446	203	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PAL_PRMT5_TARGETS_UP
0.224215246637%	1	446	200	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHEPARD_BMYB_MORPHOLINO_DN
0.224215246637%	1	446	200	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_DIFFERENTIATING_T_LYMPHOCYTE
0.224215246637%	1	446	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WENG_POR_TARGETS_LIVER_DN
0.224215246637%	1	446	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_THOC1_TARGETS_DN
0.224215246637%	1	446	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_RECURRENT_LIVER_CANCER_UP
0.224215246637%	1	446	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NIELSEN_SYNOVIAL_SARCOMA_DN
0.224215246637%	1	446	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NIELSEN_LEIOMYOSARCOMA_CNN1_DN
0.224215246637%	1	446	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MURAKAMI_UV_RESPONSE_24HR
0.224215246637%	1	446	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MANN_RESPONSE_TO_AMIFOSTINE_UP
0.224215246637%	1	446	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_MYCL1_AMPLIFICATION_TARGETS_DN
0.224215246637%	1	446	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HASLINGER_B_CLL_WITH_6Q21_DELETION
0.224215246637%	1	446	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_IGF1MTOR_PATHWAY
0.224215246637%	1	446	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_CCR5_PATHWAY
0.224215246637%	1	446	198	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.224215246637%	1	446	193	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MOHANKUMAR_TLX1_TARGETS_DN
0.224215246637%	1	446	191	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.224215246637%	1	446	191	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WU_ALZHEIMER_DISEASE_DN
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VERRECCHIA_RESPONSE_TO_TGFB1_C1
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VERNOCHET_ADIPOGENESIS
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TERAMOTO_OPN_TARGETS_CLUSTER_7
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RUAN_RESPONSE_TO_TROGLITAZONE_DN
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_LAGGING_STRAND_SYNTHESIS
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_BASE_EXCISION_REPAIR
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_EPHA2_FWDPATHWAY
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NAGY_TFTC_COMPONENTS_HUMAN
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MELLMAN_TUT1_TARGETS_UP
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_ALPHA_LINOLENIC_ACID_METABOLISM
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KANG_CISPLATIN_RESISTANCE_UP
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HAHTOLA_MYCOSIS_FUNGOIDES_UP
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GAJATE_RESPONSE_TO_TRABECTEDIN_DN
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHEN_PDGF_TARGETS
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_MAL_PATHWAY
0.224215246637%	1	446	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_EPO_PATHWAY
0.224215246637%	1	446	185	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
0.224215246637%	1	446	184	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DOANE_RESPONSE_TO_ANDROGEN_UP
0.224215246637%	1	446	184	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
0.224215246637%	1	446	182	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
0.224215246637%	1	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHENG_RESPONSE_TO_ARSENITE_DN
0.224215246637%	1	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN
0.224215246637%	1	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TOMIDA_METASTASIS_DN
0.224215246637%	1	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SYNTHESIS_OF_PC
0.224215246637%	1	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR
0.224215246637%	1	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PODAR_RESPONSE_TO_ADAPHOSTIN_DN
0.224215246637%	1	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PIONTEK_PKD1_TARGETS_DN
0.224215246637%	1	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN
0.224215246637%	1	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES
0.224215246637%	1	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB
0.224215246637%	1	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_UCALPAIN_PATHWAY
0.224215246637%	1	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_TNFR2_PATHWAY
0.224215246637%	1	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_NGF_PATHWAY
0.224215246637%	1	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_ERK5_PATHWAY
0.224215246637%	1	446	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP
0.224215246637%	1	446	179	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE
0.224215246637%	1	446	177	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
0.224215246637%	1	446	176	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX
0.224215246637%	1	446	176	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION
0.224215246637%	1	446	176	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NAGASHIMA_NRG1_SIGNALING_UP
0.224215246637%	1	446	173	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SENGUPTA_EBNA1_ANTICORRELATED
0.224215246637%	1	446	171	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ELVIDGE_HYPOXIA_UP
0.224215246637%	1	446	170	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SA_TRKA_RECEPTOR
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MEISSNER_BRAIN_HCP_WITH_H3K4ME2
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIU_IL13_MEMORY_MODEL_UP
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_STEROID_BIOSYNTHESIS
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_RENIN_ANGIOTENSIN_SYSTEM
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_ONE_CARBON_POOL_BY_FOLATE
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_CK1_PATHWAY
0.224215246637%	1	446	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP
0.224215246637%	1	446	169	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION
0.224215246637%	1	446	169	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PENG_GLUCOSE_DEPRIVATION_DN
0.224215246637%	1	446	169	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_ALZHEIMERS_DISEASE
0.224215246637%	1	446	169	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KATSANOU_ELAVL1_TARGETS_UP
0.224215246637%	1	446	167	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TIEN_INTESTINE_PROBIOTICS_6HR_DN
0.224215246637%	1	446	163	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LIN_NPAS4_TARGETS_UP
0.224215246637%	1	446	162	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN
0.224215246637%	1	446	161	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_MRNA_PROCESSING
0.224215246637%	1	446	161	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIDUS_METASTASIS_DN
0.224215246637%	1	446	160	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL
0.224215246637%	1	446	160	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_6HR_DN
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WU_HBX_TARGETS_2_DN
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WU_HBX_TARGETS_1_UP
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TIAN_BHLHA15_TARGETS
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LUI_THYROID_CANCER_CLUSTER_4
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KOINUMA_COLON_CANCER_MSI_DN
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_RIBOFLAVIN_METABOLISM
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_SHH_PATHWAY
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_GATA3_PATHWAY
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_CDC42RAC_PATHWAY
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_CACAM_PATHWAY
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_ACH_PATHWAY
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
0.224215246637%	1	446	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ABDELMOHSEN_ELAVL4_TARGETS
0.224215246637%	1	446	158	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RODRIGUES_NTN1_TARGETS_DN
0.224215246637%	1	446	157	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON
0.224215246637%	1	446	156	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GROSS_HYPOXIA_VIA_ELK3_DN
0.224215246637%	1	446	156	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FOSTER_TOLERANT_MACROPHAGE_UP
0.224215246637%	1	446	155	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_JAK_STAT_SIGNALING_PATHWAY
0.224215246637%	1	446	153	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
0.224215246637%	1	446	153	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PEPTIDE_CHAIN_ELONGATION
0.224215246637%	1	446	153	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DURAND_STROMA_MAX_DN
0.224215246637%	1	446	151	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE
0.224215246637%	1	446	150	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
0.224215246637%	1	446	150	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LANDIS_ERBB2_BREAST_TUMORS_324_UP
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TSUNODA_CISPLATIN_RESISTANCE_UP
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SU_KIDNEY
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_THROMBIN_PAR4_PATHWAY
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_LPA4_PATHWAY
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_ARF6DOWNSTREAMPATHWAY
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	NAGY_STAGA_COMPONENTS_HUMAN
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRANDVAUX_IRF3_TARGETS_UP
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FERRANDO_LYL1_NEIGHBORS
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DAZARD_UV_RESPONSE_CLUSTER_G3
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_LONGEVITY_PATHWAY
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_ERYTH_PATHWAY
0.224215246637%	1	446	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_CD40_PATHWAY
0.224215246637%	1	446	149	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
0.224215246637%	1	446	149	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	OHGUCHI_LIVER_HNF4A_TARGETS_DN
0.224215246637%	1	446	148	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KATSANOU_ELAVL1_TARGETS_DN
0.224215246637%	1	446	147	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WHITFIELD_CELL_CYCLE_G1_S
0.224215246637%	1	446	147	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.224215246637%	1	446	146	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PECE_MAMMARY_STEM_CELL_UP
0.224215246637%	1	446	146	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_NEURAL_CREST_STEM_CELL_UP
0.224215246637%	1	446	146	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP
0.224215246637%	1	446	145	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHANG_BREAST_CANCER_PROGENITORS_DN
0.224215246637%	1	446	145	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SMITH_TERT_TARGETS_UP
0.224215246637%	1	446	145	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RODWELL_AGING_KIDNEY_DN
0.224215246637%	1	446	145	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB
0.224215246637%	1	446	142	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3
0.224215246637%	1	446	142	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DARWICHE_SKIN_TUMOR_PROMOTER_UP
0.224215246637%	1	446	141	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
0.224215246637%	1	446	141	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KAAB_FAILED_HEART_ATRIUM_DN
0.224215246637%	1	446	141	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP
0.224215246637%	1	446	140	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
0.224215246637%	1	446	140	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
0.224215246637%	1	446	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHANG_ADIPOGENESIS_BY_BMP7
0.224215246637%	1	446	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VERRECCHIA_RESPONSE_TO_TGFB1_C3
0.224215246637%	1	446	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP
0.224215246637%	1	446	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS
0.224215246637%	1	446	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNAL_ATTENUATION
0.224215246637%	1	446	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS
0.224215246637%	1	446	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CRMPS_IN_SEMA3A_SIGNALING
0.224215246637%	1	446	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_IL5_PATHWAY
0.224215246637%	1	446	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP
0.224215246637%	1	446	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_NON_HOMOLOGOUS_END_JOINING
0.224215246637%	1	446	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS
0.224215246637%	1	446	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_DREAM_PATHWAY
0.224215246637%	1	446	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ABBUD_LIF_SIGNALING_2_UP
0.224215246637%	1	446	139	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_BIOLOGICAL_OXIDATIONS
0.224215246637%	1	446	139	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ODONNELL_TFRC_TARGETS_DN
0.224215246637%	1	446	139	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOELZEL_NF1_TARGETS_UP
0.224215246637%	1	446	138	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
0.224215246637%	1	446	137	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_MITOTIC_G1_G1_S_PHASES
0.224215246637%	1	446	136	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WIERENGA_STAT5A_TARGETS_GROUP1
0.224215246637%	1	446	136	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PROVENZANI_METASTASIS_DN
0.224215246637%	1	446	135	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	UDAYAKUMAR_MED1_TARGETS_UP
0.224215246637%	1	446	135	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_OXIDATIVE_PHOSPHORYLATION
0.224215246637%	1	446	134	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	POOLA_INVASIVE_BREAST_CANCER_DN
0.224215246637%	1	446	134	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_CELL_ADHESION_MOLECULES_CAMS
0.224215246637%	1	446	134	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHUNG_BLISTER_CYTOTOXICITY_UP
0.224215246637%	1	446	133	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SENESE_HDAC2_TARGETS_DN
0.224215246637%	1	446	132	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST
0.224215246637%	1	446	132	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS
0.224215246637%	1	446	131	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.224215246637%	1	446	130	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ELVIDGE_HYPOXIA_BY_DMOG_UP
0.224215246637%	1	446	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	TSAI_DNAJB4_TARGETS_UP
0.224215246637%	1	446	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	STARK_BRAIN_22Q11_DELETION
0.224215246637%	1	446	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
0.224215246637%	1	446	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY
0.224215246637%	1	446	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ONGUSAHA_BRCA1_TARGETS_UP
0.224215246637%	1	446	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MATZUK_EARLY_ANTRAL_FOLLICLE
0.224215246637%	1	446	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_CIRCADIAN_RHYTHM_MAMMAL
0.224215246637%	1	446	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER
0.224215246637%	1	446	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP
0.224215246637%	1	446	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GHO_ATF5_TARGETS_UP
0.224215246637%	1	446	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GERHOLD_RESPONSE_TO_TZD_DN
0.224215246637%	1	446	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_CARM1_PATHWAY
0.224215246637%	1	446	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_AGPCR_PATHWAY
0.224215246637%	1	446	129	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP
0.224215246637%	1	446	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	YEGNASUBRAMANIAN_PROSTATE_CANCER
0.224215246637%	1	446	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	POTTI_TOPOTECAN_SENSITIVITY
0.224215246637%	1	446	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.224215246637%	1	446	127	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KARLSSON_TGFB1_TARGETS_UP
0.224215246637%	1	446	127	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	INGRAM_SHH_TARGETS_UP
0.224215246637%	1	446	127	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
0.224215246637%	1	446	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SANSOM_APC_TARGETS_UP
0.224215246637%	1	446	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3
0.224215246637%	1	446	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.224215246637%	1	446	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
0.224215246637%	1	446	125	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
0.224215246637%	1	446	124	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CELL_CYCLE_CHECKPOINTS
0.224215246637%	1	446	124	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DAIRKEE_TERT_TARGETS_DN
0.224215246637%	1	446	123	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.224215246637%	1	446	123	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DAZARD_RESPONSE_TO_UV_SCC_DN
0.224215246637%	1	446	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.224215246637%	1	446	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VANTVEER_BREAST_CANCER_METASTASIS_DN
0.224215246637%	1	446	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP
0.224215246637%	1	446	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_LYSOSOME
0.224215246637%	1	446	120	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_CELL_CELL_COMMUNICATION
0.224215246637%	1	446	120	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.224215246637%	1	446	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS
0.224215246637%	1	446	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOLLEMAN_DAUNORUBICIN_B_ALL_DN
0.224215246637%	1	446	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FUNG_IL2_SIGNALING_2
0.224215246637%	1	446	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1
0.224215246637%	1	446	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_TRKA_PATHWAY
0.224215246637%	1	446	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_PLCE_PATHWAY
0.224215246637%	1	446	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_CFTR_PATHWAY
0.224215246637%	1	446	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_AKAP95_PATHWAY
0.224215246637%	1	446	119	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
0.224215246637%	1	446	118	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LEE_NEURAL_CREST_STEM_CELL_DN
0.224215246637%	1	446	118	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2
0.224215246637%	1	446	118	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CERVERA_SDHB_TARGETS_1_UP
0.224215246637%	1	446	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.224215246637%	1	446	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MATTIOLI_MGUS_VS_PCL
0.224215246637%	1	446	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LI_INDUCED_T_TO_NATURAL_KILLER_DN
0.224215246637%	1	446	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
0.224215246637%	1	446	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.224215246637%	1	446	115	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARZEC_IL2_SIGNALING_UP
0.224215246637%	1	446	115	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MARKEY_RB1_CHRONIC_LOF_UP
0.224215246637%	1	446	114	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SMIRNOV_RESPONSE_TO_IR_6HR_DN
0.224215246637%	1	446	114	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CERVERA_SDHB_TARGETS_2
0.224215246637%	1	446	112	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_G1_S_TRANSITION
0.224215246637%	1	446	112	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.224215246637%	1	446	112	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP
0.224215246637%	1	446	111	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_HCP_PROSTATE_CANCER
0.224215246637%	1	446	111	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_MRNA_SPLICING
0.224215246637%	1	446	110	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.224215246637%	1	446	110	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GROSS_HYPOXIA_VIA_HIF1A_DN
0.224215246637%	1	446	110	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GHANDHI_DIRECT_IRRADIATION_UP
0.224215246637%	1	446	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ZHOU_PANCREATIC_BETA_CELL
0.224215246637%	1	446	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SEMBA_FHIT_TARGETS_UP
0.224215246637%	1	446	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP
0.224215246637%	1	446	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM
0.224215246637%	1	446	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_TRYPTOPHAN_CATABOLISM
0.224215246637%	1	446	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SYNTHESIS_OF_PE
0.224215246637%	1	446	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING
0.224215246637%	1	446	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS
0.224215246637%	1	446	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS
0.224215246637%	1	446	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS
0.224215246637%	1	446	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PID_INTEGRIN4_PATHWAY
0.224215246637%	1	446	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LOPEZ_MESOTHELIOMA_SURVIVAL_UP
0.224215246637%	1	446	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KALMA_E2F1_TARGETS
0.224215246637%	1	446	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN
0.224215246637%	1	446	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHUANG_OXIDATIVE_STRESS_RESPONSE_DN
0.224215246637%	1	446	109	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
0.224215246637%	1	446	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
0.224215246637%	1	446	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
0.224215246637%	1	446	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
0.224215246637%	1	446	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LABBE_TGFB1_TARGETS_DN
0.224215246637%	1	446	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
0.224215246637%	1	446	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
0.224215246637%	1	446	106	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
0.224215246637%	1	446	105	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	STEIN_ESRRA_TARGETS_DN
0.224215246637%	1	446	105	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HELLER_SILENCED_BY_METHYLATION_DN
0.224215246637%	1	446	104	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
0.224215246637%	1	446	104	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.224215246637%	1	446	104	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BORCZUK_MALIGNANT_MESOTHELIOMA_DN
0.224215246637%	1	446	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WIELAND_UP_BY_HBV_INFECTION
0.224215246637%	1	446	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
0.224215246637%	1	446	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
0.224215246637%	1	446	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BROWNE_HCMV_INFECTION_20HR_DN
0.224215246637%	1	446	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.224215246637%	1	446	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WINZEN_DEGRADED_VIA_KHSRP
0.224215246637%	1	446	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
0.224215246637%	1	446	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
0.224215246637%	1	446	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BENPORATH_ES_CORE_NINE_CORRELATED
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	WORSCHECH_TUMOR_REJECTION_DN
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	VISALA_AGING_LYMPHOCYTE_UP
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	SHIRAISHI_PLZF_TARGETS_UP
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PURINE_CATABOLISM
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_PECAM1_INTERACTIONS
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ETHANOL_OXIDATION
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	KEGG_LIMONENE_AND_PINENE_DEGRADATION
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	HOLLEMAN_DAUNORUBICIN_B_ALL_UP
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BRUNEAU_SEPTATION_VENTRICULAR
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_GLYCOLYSIS_PATHWAY
0.224215246637%	1	446	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM	BIOCARTA_FREE_PATHWAY
0.21978021978%	1	455	99	T2D_GENES_TANYA_BLOODPRESSURE	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.21978021978%	1	455	98	T2D_GENES_TANYA_BLOODPRESSURE	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP
0.21978021978%	1	455	98	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_POTASSIUM_CHANNELS
0.21978021978%	1	455	98	T2D_GENES_TANYA_BLOODPRESSURE	PYEON_HPV_POSITIVE_TUMORS_UP
0.21978021978%	1	455	98	T2D_GENES_TANYA_BLOODPRESSURE	CROONQUIST_IL6_DEPRIVATION_DN
0.21978021978%	1	455	97	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
0.21978021978%	1	455	97	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
0.21978021978%	1	455	96	T2D_GENES_TANYA_BLOODPRESSURE	ZAMORA_NOS2_TARGETS_DN
0.21978021978%	1	455	95	T2D_GENES_TANYA_BLOODPRESSURE	HECKER_IFNB1_TARGETS
0.21978021978%	1	455	94	T2D_GENES_TANYA_BLOODPRESSURE	GAVIN_FOXP3_TARGETS_CLUSTER_T4
0.21978021978%	1	455	92	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SYNTHESIS_OF_DNA
0.21978021978%	1	455	92	T2D_GENES_TANYA_BLOODPRESSURE	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
0.21978021978%	1	455	92	T2D_GENES_TANYA_BLOODPRESSURE	HILLION_HMGA1B_TARGETS
0.21978021978%	1	455	92	T2D_GENES_TANYA_BLOODPRESSURE	DE_YY1_TARGETS_DN
0.21978021978%	1	455	92	T2D_GENES_TANYA_BLOODPRESSURE	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C
0.21978021978%	1	455	91	T2D_GENES_TANYA_BLOODPRESSURE	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.21978021978%	1	455	90	T2D_GENES_TANYA_BLOODPRESSURE	MORI_MATURE_B_LYMPHOCYTE_UP
0.21978021978%	1	455	90	T2D_GENES_TANYA_BLOODPRESSURE	IVANOVSKA_MIR106B_TARGETS
0.21978021978%	1	455	90	T2D_GENES_TANYA_BLOODPRESSURE	HILLION_HMGA1_TARGETS
0.21978021978%	1	455	9	T2D_GENES_TANYA_BLOODPRESSURE	YANAGISAWA_LUNG_CANCER_RECURRENCE
0.21978021978%	1	455	9	T2D_GENES_TANYA_BLOODPRESSURE	TESAR_JAK_TARGETS_MOUSE_ES_D3_DN
0.21978021978%	1	455	9	T2D_GENES_TANYA_BLOODPRESSURE	SCHMAHL_PDGF_SIGNALING
0.21978021978%	1	455	9	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION
0.21978021978%	1	455	9	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY
0.21978021978%	1	455	9	T2D_GENES_TANYA_BLOODPRESSURE	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN
0.21978021978%	1	455	9	T2D_GENES_TANYA_BLOODPRESSURE	OXFORD_RALB_TARGETS_DN
0.21978021978%	1	455	9	T2D_GENES_TANYA_BLOODPRESSURE	OXFORD_RALA_TARGETS_UP
0.21978021978%	1	455	9	T2D_GENES_TANYA_BLOODPRESSURE	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30
0.21978021978%	1	455	9	T2D_GENES_TANYA_BLOODPRESSURE	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP
0.21978021978%	1	455	9	T2D_GENES_TANYA_BLOODPRESSURE	FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION
0.21978021978%	1	455	9	T2D_GENES_TANYA_BLOODPRESSURE	FIGUEROA_AML_METHYLATION_CLUSTER_2_DN
0.21978021978%	1	455	9	T2D_GENES_TANYA_BLOODPRESSURE	COLLER_MYC_TARGETS_DN
0.21978021978%	1	455	9	T2D_GENES_TANYA_BLOODPRESSURE	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1
0.21978021978%	1	455	9	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_FEEDER_PATHWAY
0.21978021978%	1	455	89	T2D_GENES_TANYA_BLOODPRESSURE	VANLOO_SP3_TARGETS_DN
0.21978021978%	1	455	89	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
0.21978021978%	1	455	89	T2D_GENES_TANYA_BLOODPRESSURE	BOYLAN_MULTIPLE_MYELOMA_D_UP
0.21978021978%	1	455	88	T2D_GENES_TANYA_BLOODPRESSURE	TIEN_INTESTINE_PROBIOTICS_2HR_DN
0.21978021978%	1	455	88	T2D_GENES_TANYA_BLOODPRESSURE	SASSON_RESPONSE_TO_FORSKOLIN_DN
0.21978021978%	1	455	88	T2D_GENES_TANYA_BLOODPRESSURE	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
0.21978021978%	1	455	88	T2D_GENES_TANYA_BLOODPRESSURE	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
0.21978021978%	1	455	87	T2D_GENES_TANYA_BLOODPRESSURE	SMITH_TERT_TARGETS_DN
0.21978021978%	1	455	87	T2D_GENES_TANYA_BLOODPRESSURE	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.21978021978%	1	455	87	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MITOTIC_PROMETAPHASE
0.21978021978%	1	455	87	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
0.21978021978%	1	455	87	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_ERBB_SIGNALING_PATHWAY
0.21978021978%	1	455	87	T2D_GENES_TANYA_BLOODPRESSURE	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
0.21978021978%	1	455	86	T2D_GENES_TANYA_BLOODPRESSURE	TAKAO_RESPONSE_TO_UVB_RADIATION_UP
0.21978021978%	1	455	86	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_16HR_DN
0.21978021978%	1	455	85	T2D_GENES_TANYA_BLOODPRESSURE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
0.21978021978%	1	455	85	T2D_GENES_TANYA_BLOODPRESSURE	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
0.21978021978%	1	455	85	T2D_GENES_TANYA_BLOODPRESSURE	LEIN_CEREBELLUM_MARKERS
0.21978021978%	1	455	84	T2D_GENES_TANYA_BLOODPRESSURE	SWEET_KRAS_TARGETS_UP
0.21978021978%	1	455	84	T2D_GENES_TANYA_BLOODPRESSURE	SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
0.21978021978%	1	455	84	T2D_GENES_TANYA_BLOODPRESSURE	RUAN_RESPONSE_TO_TNF_DN
0.21978021978%	1	455	84	T2D_GENES_TANYA_BLOODPRESSURE	PID_CMYB_PATHWAY
0.21978021978%	1	455	84	T2D_GENES_TANYA_BLOODPRESSURE	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
0.21978021978%	1	455	84	T2D_GENES_TANYA_BLOODPRESSURE	CHANG_IMMORTALIZED_BY_HPV31_UP
0.21978021978%	1	455	84	T2D_GENES_TANYA_BLOODPRESSURE	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
0.21978021978%	1	455	83	T2D_GENES_TANYA_BLOODPRESSURE	SANA_TNF_SIGNALING_UP
0.21978021978%	1	455	83	T2D_GENES_TANYA_BLOODPRESSURE	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.21978021978%	1	455	83	T2D_GENES_TANYA_BLOODPRESSURE	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP
0.21978021978%	1	455	82	T2D_GENES_TANYA_BLOODPRESSURE	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
0.21978021978%	1	455	82	T2D_GENES_TANYA_BLOODPRESSURE	LEIN_MIDBRAIN_MARKERS
0.21978021978%	1	455	82	T2D_GENES_TANYA_BLOODPRESSURE	BILD_CTNNB1_ONCOGENIC_SIGNATURE
0.21978021978%	1	455	81	T2D_GENES_TANYA_BLOODPRESSURE	WATANABE_COLON_CANCER_MSI_VS_MSS_DN
0.21978021978%	1	455	81	T2D_GENES_TANYA_BLOODPRESSURE	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.21978021978%	1	455	81	T2D_GENES_TANYA_BLOODPRESSURE	SCIBETTA_KDM5B_TARGETS_DN
0.21978021978%	1	455	81	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_M_G1_TRANSITION
0.21978021978%	1	455	81	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION
0.21978021978%	1	455	81	T2D_GENES_TANYA_BLOODPRESSURE	MUNSHI_MULTIPLE_MYELOMA_UP
0.21978021978%	1	455	80	T2D_GENES_TANYA_BLOODPRESSURE	WOO_LIVER_CANCER_RECURRENCE_DN
0.21978021978%	1	455	80	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_UNFOLDED_PROTEIN_RESPONSE
0.21978021978%	1	455	80	T2D_GENES_TANYA_BLOODPRESSURE	PID_MET_PATHWAY
0.21978021978%	1	455	80	T2D_GENES_TANYA_BLOODPRESSURE	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
0.21978021978%	1	455	80	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
0.21978021978%	1	455	80	T2D_GENES_TANYA_BLOODPRESSURE	FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.21978021978%	1	455	80	T2D_GENES_TANYA_BLOODPRESSURE	BASSO_HAIRY_CELL_LEUKEMIA_DN
0.21978021978%	1	455	8	T2D_GENES_TANYA_BLOODPRESSURE	WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP
0.21978021978%	1	455	8	T2D_GENES_TANYA_BLOODPRESSURE	WEBER_METHYLATED_ICP_IN_SPERM_UP
0.21978021978%	1	455	8	T2D_GENES_TANYA_BLOODPRESSURE	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN
0.21978021978%	1	455	8	T2D_GENES_TANYA_BLOODPRESSURE	THUM_MIR21_TARGETS_HEART_DISEASE_DN
0.21978021978%	1	455	8	T2D_GENES_TANYA_BLOODPRESSURE	SA_G2_AND_M_PHASES
0.21978021978%	1	455	8	T2D_GENES_TANYA_BLOODPRESSURE	REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS
0.21978021978%	1	455	8	T2D_GENES_TANYA_BLOODPRESSURE	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN
0.21978021978%	1	455	8	T2D_GENES_TANYA_BLOODPRESSURE	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7
0.21978021978%	1	455	8	T2D_GENES_TANYA_BLOODPRESSURE	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2
0.21978021978%	1	455	8	T2D_GENES_TANYA_BLOODPRESSURE	LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP
0.21978021978%	1	455	8	T2D_GENES_TANYA_BLOODPRESSURE	LE_SKI_TARGETS_DN
0.21978021978%	1	455	8	T2D_GENES_TANYA_BLOODPRESSURE	KREPPEL_CD99_TARGETS_DN
0.21978021978%	1	455	8	T2D_GENES_TANYA_BLOODPRESSURE	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN
0.21978021978%	1	455	79	T2D_GENES_TANYA_BLOODPRESSURE	TOOKER_GEMCITABINE_RESISTANCE_UP
0.21978021978%	1	455	79	T2D_GENES_TANYA_BLOODPRESSURE	PID_MYC_ACTIVPATHWAY
0.21978021978%	1	455	79	T2D_GENES_TANYA_BLOODPRESSURE	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
0.21978021978%	1	455	78	T2D_GENES_TANYA_BLOODPRESSURE	SANA_RESPONSE_TO_IFNG_UP
0.21978021978%	1	455	78	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_PEROXISOME
0.21978021978%	1	455	78	T2D_GENES_TANYA_BLOODPRESSURE	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.21978021978%	1	455	76	T2D_GENES_TANYA_BLOODPRESSURE	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
0.21978021978%	1	455	76	T2D_GENES_TANYA_BLOODPRESSURE	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
0.21978021978%	1	455	76	T2D_GENES_TANYA_BLOODPRESSURE	SU_TESTIS
0.21978021978%	1	455	76	T2D_GENES_TANYA_BLOODPRESSURE	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
0.21978021978%	1	455	76	T2D_GENES_TANYA_BLOODPRESSURE	MAHAJAN_RESPONSE_TO_IL1A_DN
0.21978021978%	1	455	76	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_VEGF_SIGNALING_PATHWAY
0.21978021978%	1	455	75	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_ADHERENS_JUNCTION
0.21978021978%	1	455	75	T2D_GENES_TANYA_BLOODPRESSURE	CHESLER_BRAIN_QTL_CIS
0.21978021978%	1	455	74	T2D_GENES_TANYA_BLOODPRESSURE	WESTON_VEGFA_TARGETS_3HR
0.21978021978%	1	455	74	T2D_GENES_TANYA_BLOODPRESSURE	RAMALHO_STEMNESS_DN
0.21978021978%	1	455	74	T2D_GENES_TANYA_BLOODPRESSURE	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
0.21978021978%	1	455	74	T2D_GENES_TANYA_BLOODPRESSURE	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN
0.21978021978%	1	455	74	T2D_GENES_TANYA_BLOODPRESSURE	DER_IFN_ALPHA_RESPONSE_UP
0.21978021978%	1	455	74	T2D_GENES_TANYA_BLOODPRESSURE	CORRE_MULTIPLE_MYELOMA_UP
0.21978021978%	1	455	74	T2D_GENES_TANYA_BLOODPRESSURE	CAMPS_COLON_CANCER_COPY_NUMBER_DN
0.21978021978%	1	455	73	T2D_GENES_TANYA_BLOODPRESSURE	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
0.21978021978%	1	455	73	T2D_GENES_TANYA_BLOODPRESSURE	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.21978021978%	1	455	73	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_VIRAL_MYOCARDITIS
0.21978021978%	1	455	73	T2D_GENES_TANYA_BLOODPRESSURE	HOSHIDA_LIVER_CANCER_SURVIVAL_UP
0.21978021978%	1	455	73	T2D_GENES_TANYA_BLOODPRESSURE	DITTMER_PTHLH_TARGETS_DN
0.21978021978%	1	455	73	T2D_GENES_TANYA_BLOODPRESSURE	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2
0.21978021978%	1	455	72	T2D_GENES_TANYA_BLOODPRESSURE	SESTO_RESPONSE_TO_UV_C8
0.21978021978%	1	455	72	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_DRUG_METABOLISM_CYTOCHROME_P450
0.21978021978%	1	455	72	T2D_GENES_TANYA_BLOODPRESSURE	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
0.21978021978%	1	455	72	T2D_GENES_TANYA_BLOODPRESSURE	DOANE_BREAST_CANCER_CLASSES_UP
0.21978021978%	1	455	71	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PI3K_CASCADE
0.21978021978%	1	455	71	T2D_GENES_TANYA_BLOODPRESSURE	GU_PDEF_TARGETS_UP
0.21978021978%	1	455	71	T2D_GENES_TANYA_BLOODPRESSURE	DER_IFN_GAMMA_RESPONSE_UP
0.21978021978%	1	455	70	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.21978021978%	1	455	70	T2D_GENES_TANYA_BLOODPRESSURE	LIU_NASOPHARYNGEAL_CARCINOMA
0.21978021978%	1	455	7	T2D_GENES_TANYA_BLOODPRESSURE	ZEILSTRA_CD44_TARGETS_UP
0.21978021978%	1	455	7	T2D_GENES_TANYA_BLOODPRESSURE	TESAR_JAK_TARGETS_MOUSE_ES_D3_UP
0.21978021978%	1	455	7	T2D_GENES_TANYA_BLOODPRESSURE	ST_PAC1_RECEPTOR_PATHWAY
0.21978021978%	1	455	7	T2D_GENES_TANYA_BLOODPRESSURE	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN
0.21978021978%	1	455	7	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_NPC_WITH_LCP_H3K27ME3
0.21978021978%	1	455	7	T2D_GENES_TANYA_BLOODPRESSURE	MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP
0.21978021978%	1	455	7	T2D_GENES_TANYA_BLOODPRESSURE	MATZUK_STEROIDOGENESIS
0.21978021978%	1	455	7	T2D_GENES_TANYA_BLOODPRESSURE	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN
0.21978021978%	1	455	7	T2D_GENES_TANYA_BLOODPRESSURE	KUWANO_RNA_STABILIZED_BY_NO
0.21978021978%	1	455	7	T2D_GENES_TANYA_BLOODPRESSURE	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.21978021978%	1	455	7	T2D_GENES_TANYA_BLOODPRESSURE	JOHNSTONE_PARVB_TARGETS_1_UP
0.21978021978%	1	455	7	T2D_GENES_TANYA_BLOODPRESSURE	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP
0.21978021978%	1	455	7	T2D_GENES_TANYA_BLOODPRESSURE	FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES
0.21978021978%	1	455	7	T2D_GENES_TANYA_BLOODPRESSURE	BUDHU_LIVER_CANCER_METASTASIS_DN
0.21978021978%	1	455	7	T2D_GENES_TANYA_BLOODPRESSURE	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3
0.21978021978%	1	455	7	T2D_GENES_TANYA_BLOODPRESSURE	ABBUD_LIF_SIGNALING_2_DN
0.21978021978%	1	455	69	T2D_GENES_TANYA_BLOODPRESSURE	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
0.21978021978%	1	455	69	T2D_GENES_TANYA_BLOODPRESSURE	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.21978021978%	1	455	69	T2D_GENES_TANYA_BLOODPRESSURE	RIZKI_TUMOR_INVASIVENESS_2D_UP
0.21978021978%	1	455	69	T2D_GENES_TANYA_BLOODPRESSURE	RHODES_UNDIFFERENTIATED_CANCER
0.21978021978%	1	455	69	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SPHINGOLIPID_METABOLISM
0.21978021978%	1	455	69	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GLUCOSE_METABOLISM
0.21978021978%	1	455	69	T2D_GENES_TANYA_BLOODPRESSURE	LEIN_NEURON_MARKERS
0.21978021978%	1	455	69	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_P53_SIGNALING_PATHWAY
0.21978021978%	1	455	68	T2D_GENES_TANYA_BLOODPRESSURE	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
0.21978021978%	1	455	68	T2D_GENES_TANYA_BLOODPRESSURE	ROSS_AML_OF_FAB_M7_TYPE
0.21978021978%	1	455	68	T2D_GENES_TANYA_BLOODPRESSURE	NOUZOVA_METHYLATED_IN_APL
0.21978021978%	1	455	68	T2D_GENES_TANYA_BLOODPRESSURE	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.21978021978%	1	455	68	T2D_GENES_TANYA_BLOODPRESSURE	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN
0.21978021978%	1	455	68	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_INTERFERON_RESPONSIVE_GENES
0.21978021978%	1	455	67	T2D_GENES_TANYA_BLOODPRESSURE	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP
0.21978021978%	1	455	67	T2D_GENES_TANYA_BLOODPRESSURE	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.21978021978%	1	455	67	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN
0.21978021978%	1	455	67	T2D_GENES_TANYA_BLOODPRESSURE	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
0.21978021978%	1	455	67	T2D_GENES_TANYA_BLOODPRESSURE	LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.21978021978%	1	455	67	T2D_GENES_TANYA_BLOODPRESSURE	GENTILE_UV_LOW_DOSE_DN
0.21978021978%	1	455	67	T2D_GENES_TANYA_BLOODPRESSURE	ELVIDGE_HIF1A_TARGETS_UP
0.21978021978%	1	455	67	T2D_GENES_TANYA_BLOODPRESSURE	DAZARD_UV_RESPONSE_CLUSTER_G1
0.21978021978%	1	455	66	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
0.21978021978%	1	455	66	T2D_GENES_TANYA_BLOODPRESSURE	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT
0.21978021978%	1	455	66	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES
0.21978021978%	1	455	66	T2D_GENES_TANYA_BLOODPRESSURE	PID_LYSOPHOSPHOLIPID_PATHWAY
0.21978021978%	1	455	66	T2D_GENES_TANYA_BLOODPRESSURE	PID_INTEGRIN1_PATHWAY
0.21978021978%	1	455	66	T2D_GENES_TANYA_BLOODPRESSURE	MARSON_FOXP3_TARGETS_UP
0.21978021978%	1	455	66	T2D_GENES_TANYA_BLOODPRESSURE	LEE_LIVER_CANCER_CIPROFIBRATE_DN
0.21978021978%	1	455	66	T2D_GENES_TANYA_BLOODPRESSURE	KIM_GERMINAL_CENTER_T_HELPER_UP
0.21978021978%	1	455	66	T2D_GENES_TANYA_BLOODPRESSURE	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN
0.21978021978%	1	455	66	T2D_GENES_TANYA_BLOODPRESSURE	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP
0.21978021978%	1	455	65	T2D_GENES_TANYA_BLOODPRESSURE	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.21978021978%	1	455	65	T2D_GENES_TANYA_BLOODPRESSURE	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
0.21978021978%	1	455	65	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_WNT
0.21978021978%	1	455	65	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX
0.21978021978%	1	455	65	T2D_GENES_TANYA_BLOODPRESSURE	PID_ERA_GENOMIC_PATHWAY
0.21978021978%	1	455	65	T2D_GENES_TANYA_BLOODPRESSURE	LEE_LIVER_CANCER_MYC_TGFA_DN
0.21978021978%	1	455	65	T2D_GENES_TANYA_BLOODPRESSURE	LEE_LIVER_CANCER_ACOX1_DN
0.21978021978%	1	455	65	T2D_GENES_TANYA_BLOODPRESSURE	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP
0.21978021978%	1	455	65	T2D_GENES_TANYA_BLOODPRESSURE	GUO_HEX_TARGETS_DN
0.21978021978%	1	455	65	T2D_GENES_TANYA_BLOODPRESSURE	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP
0.21978021978%	1	455	65	T2D_GENES_TANYA_BLOODPRESSURE	AMIT_SERUM_RESPONSE_120_MCF10A
0.21978021978%	1	455	64	T2D_GENES_TANYA_BLOODPRESSURE	ZHANG_GATA6_TARGETS_DN
0.21978021978%	1	455	64	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
0.21978021978%	1	455	64	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
0.21978021978%	1	455	64	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS
0.21978021978%	1	455	64	T2D_GENES_TANYA_BLOODPRESSURE	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
0.21978021978%	1	455	64	T2D_GENES_TANYA_BLOODPRESSURE	LIU_SMARCA4_TARGETS
0.21978021978%	1	455	64	T2D_GENES_TANYA_BLOODPRESSURE	LEE_LIVER_CANCER_MYC_E2F1_DN
0.21978021978%	1	455	64	T2D_GENES_TANYA_BLOODPRESSURE	LEE_LIVER_CANCER_E2F1_DN
0.21978021978%	1	455	64	T2D_GENES_TANYA_BLOODPRESSURE	LEE_LIVER_CANCER_ACOX1_UP
0.21978021978%	1	455	64	T2D_GENES_TANYA_BLOODPRESSURE	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
0.21978021978%	1	455	64	T2D_GENES_TANYA_BLOODPRESSURE	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
0.21978021978%	1	455	64	T2D_GENES_TANYA_BLOODPRESSURE	BYSTROEM_CORRELATED_WITH_IL5_DN
0.21978021978%	1	455	63	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INTERFERON_GAMMA_SIGNALING
0.21978021978%	1	455	63	T2D_GENES_TANYA_BLOODPRESSURE	PID_ENDOTHELINPATHWAY
0.21978021978%	1	455	63	T2D_GENES_TANYA_BLOODPRESSURE	PHONG_TNF_TARGETS_UP
0.21978021978%	1	455	63	T2D_GENES_TANYA_BLOODPRESSURE	MODY_HIPPOCAMPUS_POSTNATAL
0.21978021978%	1	455	63	T2D_GENES_TANYA_BLOODPRESSURE	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
0.21978021978%	1	455	63	T2D_GENES_TANYA_BLOODPRESSURE	BRIDEAU_IMPRINTED_GENES
0.21978021978%	1	455	63	T2D_GENES_TANYA_BLOODPRESSURE	BILBAN_B_CLL_LPL_UP
0.21978021978%	1	455	62	T2D_GENES_TANYA_BLOODPRESSURE	KYNG_DNA_DAMAGE_BY_UV
0.21978021978%	1	455	62	T2D_GENES_TANYA_BLOODPRESSURE	KORKOLA_YOLK_SAC_TUMOR
0.21978021978%	1	455	62	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
0.21978021978%	1	455	62	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_COLORECTAL_CANCER
0.21978021978%	1	455	62	T2D_GENES_TANYA_BLOODPRESSURE	ISSAEVA_MLL2_TARGETS
0.21978021978%	1	455	62	T2D_GENES_TANYA_BLOODPRESSURE	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP
0.21978021978%	1	455	61	T2D_GENES_TANYA_BLOODPRESSURE	RAMASWAMY_METASTASIS_DN
0.21978021978%	1	455	61	T2D_GENES_TANYA_BLOODPRESSURE	MASSARWEH_RESPONSE_TO_ESTRADIOL
0.21978021978%	1	455	61	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_1HR_UP
0.21978021978%	1	455	60	T2D_GENES_TANYA_BLOODPRESSURE	OUILLETTE_CLL_13Q14_DELETION_DN
0.21978021978%	1	455	60	T2D_GENES_TANYA_BLOODPRESSURE	LEE_LIVER_CANCER_CIPROFIBRATE_UP
0.21978021978%	1	455	60	T2D_GENES_TANYA_BLOODPRESSURE	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN
0.21978021978%	1	455	6	T2D_GENES_TANYA_BLOODPRESSURE	WILLIAMS_ESR1_TARGETS_DN
0.21978021978%	1	455	6	T2D_GENES_TANYA_BLOODPRESSURE	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP
0.21978021978%	1	455	6	T2D_GENES_TANYA_BLOODPRESSURE	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_DN
0.21978021978%	1	455	6	T2D_GENES_TANYA_BLOODPRESSURE	GALIE_TUMOR_STEMNESS_GENES
0.21978021978%	1	455	6	T2D_GENES_TANYA_BLOODPRESSURE	CASTELLANO_HRAS_TARGETS_DN
0.21978021978%	1	455	59	T2D_GENES_TANYA_BLOODPRESSURE	PID_ATF2_PATHWAY
0.21978021978%	1	455	59	T2D_GENES_TANYA_BLOODPRESSURE	ONDER_CDH1_TARGETS_3_DN
0.21978021978%	1	455	59	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION
0.21978021978%	1	455	59	T2D_GENES_TANYA_BLOODPRESSURE	ELVIDGE_HYPOXIA_BY_DMOG_DN
0.21978021978%	1	455	59	T2D_GENES_TANYA_BLOODPRESSURE	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1
0.21978021978%	1	455	59	T2D_GENES_TANYA_BLOODPRESSURE	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
0.21978021978%	1	455	59	T2D_GENES_TANYA_BLOODPRESSURE	ASTIER_INTEGRIN_SIGNALING
0.21978021978%	1	455	58	T2D_GENES_TANYA_BLOODPRESSURE	ZHENG_GLIOBLASTOMA_PLASTICITY_DN
0.21978021978%	1	455	58	T2D_GENES_TANYA_BLOODPRESSURE	SCHEIDEREIT_IKK_INTERACTING_PROTEINS
0.21978021978%	1	455	58	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_REGULATION_OF_APOPTOSIS
0.21978021978%	1	455	58	T2D_GENES_TANYA_BLOODPRESSURE	PID_SHP2_PATHWAY
0.21978021978%	1	455	58	T2D_GENES_TANYA_BLOODPRESSURE	NAGASHIMA_NRG1_SIGNALING_DN
0.21978021978%	1	455	58	T2D_GENES_TANYA_BLOODPRESSURE	NADLER_HYPERGLYCEMIA_AT_OBESITY
0.21978021978%	1	455	58	T2D_GENES_TANYA_BLOODPRESSURE	LUCAS_HNF4A_TARGETS_UP
0.21978021978%	1	455	58	T2D_GENES_TANYA_BLOODPRESSURE	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
0.21978021978%	1	455	58	T2D_GENES_TANYA_BLOODPRESSURE	KANNAN_TP53_TARGETS_UP
0.21978021978%	1	455	58	T2D_GENES_TANYA_BLOODPRESSURE	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
0.21978021978%	1	455	58	T2D_GENES_TANYA_BLOODPRESSURE	JI_RESPONSE_TO_FSH_DN
0.21978021978%	1	455	58	T2D_GENES_TANYA_BLOODPRESSURE	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
0.21978021978%	1	455	57	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE
0.21978021978%	1	455	57	T2D_GENES_TANYA_BLOODPRESSURE	BURTON_ADIPOGENESIS_11
0.21978021978%	1	455	57	T2D_GENES_TANYA_BLOODPRESSURE	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
0.21978021978%	1	455	56	T2D_GENES_TANYA_BLOODPRESSURE	ZHENG_IL22_SIGNALING_UP
0.21978021978%	1	455	56	T2D_GENES_TANYA_BLOODPRESSURE	VANTVEER_BREAST_CANCER_METASTASIS_UP
0.21978021978%	1	455	56	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.21978021978%	1	455	56	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PI_3K_CASCADE
0.21978021978%	1	455	56	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX
0.21978021978%	1	455	56	T2D_GENES_TANYA_BLOODPRESSURE	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP
0.21978021978%	1	455	56	T2D_GENES_TANYA_BLOODPRESSURE	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.21978021978%	1	455	56	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_30MIN_UP
0.21978021978%	1	455	56	T2D_GENES_TANYA_BLOODPRESSURE	BROWNE_HCMV_INFECTION_10HR_DN
0.21978021978%	1	455	55	T2D_GENES_TANYA_BLOODPRESSURE	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
0.21978021978%	1	455	55	T2D_GENES_TANYA_BLOODPRESSURE	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53
0.21978021978%	1	455	55	T2D_GENES_TANYA_BLOODPRESSURE	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.21978021978%	1	455	55	T2D_GENES_TANYA_BLOODPRESSURE	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
0.21978021978%	1	455	55	T2D_GENES_TANYA_BLOODPRESSURE	PID_IL2_1PATHWAY
0.21978021978%	1	455	55	T2D_GENES_TANYA_BLOODPRESSURE	PID_FGF_PATHWAY
0.21978021978%	1	455	55	T2D_GENES_TANYA_BLOODPRESSURE	LAU_APOPTOSIS_CDKN2A_UP
0.21978021978%	1	455	55	T2D_GENES_TANYA_BLOODPRESSURE	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN
0.21978021978%	1	455	55	T2D_GENES_TANYA_BLOODPRESSURE	GENTILE_UV_RESPONSE_CLUSTER_D4
0.21978021978%	1	455	54	T2D_GENES_TANYA_BLOODPRESSURE	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
0.21978021978%	1	455	54	T2D_GENES_TANYA_BLOODPRESSURE	SUNG_METASTASIS_STROMA_DN
0.21978021978%	1	455	54	T2D_GENES_TANYA_BLOODPRESSURE	SESTO_RESPONSE_TO_UV_C2
0.21978021978%	1	455	54	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TCR_SIGNALING
0.21978021978%	1	455	54	T2D_GENES_TANYA_BLOODPRESSURE	PID_TAP63PATHWAY
0.21978021978%	1	455	54	T2D_GENES_TANYA_BLOODPRESSURE	MARSON_FOXP3_TARGETS_DN
0.21978021978%	1	455	54	T2D_GENES_TANYA_BLOODPRESSURE	MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN
0.21978021978%	1	455	54	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_NON_SMALL_CELL_LUNG_CANCER
0.21978021978%	1	455	54	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_ARGININE_AND_PROLINE_METABOLISM
0.21978021978%	1	455	54	T2D_GENES_TANYA_BLOODPRESSURE	HUPER_BREAST_BASAL_VS_LUMINAL_UP
0.21978021978%	1	455	53	T2D_GENES_TANYA_BLOODPRESSURE	ZHU_CMV_8_HR_DN
0.21978021978%	1	455	53	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS
0.21978021978%	1	455	53	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CIRCADIAN_CLOCK
0.21978021978%	1	455	53	T2D_GENES_TANYA_BLOODPRESSURE	MORI_IMMATURE_B_LYMPHOCYTE_UP
0.21978021978%	1	455	53	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_AUTOIMMUNE_THYROID_DISEASE
0.21978021978%	1	455	53	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
0.21978021978%	1	455	53	T2D_GENES_TANYA_BLOODPRESSURE	ISHIDA_E2F_TARGETS
0.21978021978%	1	455	53	T2D_GENES_TANYA_BLOODPRESSURE	IKEDA_MIR1_TARGETS_UP
0.21978021978%	1	455	53	T2D_GENES_TANYA_BLOODPRESSURE	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP
0.21978021978%	1	455	52	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN
0.21978021978%	1	455	52	T2D_GENES_TANYA_BLOODPRESSURE	WINTER_HYPOXIA_DN
0.21978021978%	1	455	52	T2D_GENES_TANYA_BLOODPRESSURE	VILIMAS_NOTCH1_TARGETS_UP
0.21978021978%	1	455	52	T2D_GENES_TANYA_BLOODPRESSURE	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN
0.21978021978%	1	455	52	T2D_GENES_TANYA_BLOODPRESSURE	ROSS_AML_WITH_CBFB_MYH11_FUSION
0.21978021978%	1	455	52	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.21978021978%	1	455	52	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GABA_RECEPTOR_ACTIVATION
0.21978021978%	1	455	52	T2D_GENES_TANYA_BLOODPRESSURE	KENNY_CTNNB1_TARGETS_DN
0.21978021978%	1	455	52	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_TASTE_TRANSDUCTION
0.21978021978%	1	455	52	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_ENDOMETRIAL_CANCER
0.21978021978%	1	455	52	T2D_GENES_TANYA_BLOODPRESSURE	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP
0.21978021978%	1	455	52	T2D_GENES_TANYA_BLOODPRESSURE	CHIBA_RESPONSE_TO_TSA_UP
0.21978021978%	1	455	52	T2D_GENES_TANYA_BLOODPRESSURE	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN
0.21978021978%	1	455	52	T2D_GENES_TANYA_BLOODPRESSURE	BECKER_TAMOXIFEN_RESISTANCE_DN
0.21978021978%	1	455	51	T2D_GENES_TANYA_BLOODPRESSURE	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.21978021978%	1	455	51	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.21978021978%	1	455	51	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1
0.21978021978%	1	455	51	T2D_GENES_TANYA_BLOODPRESSURE	MORI_PLASMA_CELL_UP
0.21978021978%	1	455	51	T2D_GENES_TANYA_BLOODPRESSURE	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN
0.21978021978%	1	455	51	T2D_GENES_TANYA_BLOODPRESSURE	GUILLAUMOND_KLF10_TARGETS_UP
0.21978021978%	1	455	51	T2D_GENES_TANYA_BLOODPRESSURE	FRASOR_TAMOXIFEN_RESPONSE_UP
0.21978021978%	1	455	51	T2D_GENES_TANYA_BLOODPRESSURE	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
0.21978021978%	1	455	51	T2D_GENES_TANYA_BLOODPRESSURE	BURTON_ADIPOGENESIS_PEAK_AT_2HR
0.21978021978%	1	455	51	T2D_GENES_TANYA_BLOODPRESSURE	BURTON_ADIPOGENESIS_7
0.21978021978%	1	455	51	T2D_GENES_TANYA_BLOODPRESSURE	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
0.21978021978%	1	455	50	T2D_GENES_TANYA_BLOODPRESSURE	STOSSI_RESPONSE_TO_ESTRADIOL
0.21978021978%	1	455	50	T2D_GENES_TANYA_BLOODPRESSURE	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN
0.21978021978%	1	455	50	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
0.21978021978%	1	455	50	T2D_GENES_TANYA_BLOODPRESSURE	PARK_APL_PATHOGENESIS_DN
0.21978021978%	1	455	50	T2D_GENES_TANYA_BLOODPRESSURE	NADERI_BREAST_CANCER_PROGNOSIS_UP
0.21978021978%	1	455	50	T2D_GENES_TANYA_BLOODPRESSURE	KANG_GIST_WITH_PDGFRA_UP
0.21978021978%	1	455	50	T2D_GENES_TANYA_BLOODPRESSURE	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
0.21978021978%	1	455	50	T2D_GENES_TANYA_BLOODPRESSURE	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC
0.21978021978%	1	455	50	T2D_GENES_TANYA_BLOODPRESSURE	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN
0.21978021978%	1	455	50	T2D_GENES_TANYA_BLOODPRESSURE	FIGUEROA_AML_METHYLATION_CLUSTER_5_DN
0.21978021978%	1	455	50	T2D_GENES_TANYA_BLOODPRESSURE	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION
0.21978021978%	1	455	50	T2D_GENES_TANYA_BLOODPRESSURE	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN
0.21978021978%	1	455	50	T2D_GENES_TANYA_BLOODPRESSURE	BECKER_TAMOXIFEN_RESISTANCE_UP
0.21978021978%	1	455	5	T2D_GENES_TANYA_BLOODPRESSURE	WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN
0.21978021978%	1	455	5	T2D_GENES_TANYA_BLOODPRESSURE	WANG_THOC1_TARGETS_UP
0.21978021978%	1	455	5	T2D_GENES_TANYA_BLOODPRESSURE	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN
0.21978021978%	1	455	5	T2D_GENES_TANYA_BLOODPRESSURE	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3
0.21978021978%	1	455	5	T2D_GENES_TANYA_BLOODPRESSURE	PASTURAL_RIZ1_TARGETS_DN
0.21978021978%	1	455	5	T2D_GENES_TANYA_BLOODPRESSURE	NAKAMURA_ALVEOLAR_EPITHELIUM
0.21978021978%	1	455	5	T2D_GENES_TANYA_BLOODPRESSURE	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_3
0.21978021978%	1	455	5	T2D_GENES_TANYA_BLOODPRESSURE	BRUNEAU_SEPTATION_ATRIAL
0.21978021978%	1	455	49	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_HP_UP
0.21978021978%	1	455	49	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY
0.21978021978%	1	455	49	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS
0.21978021978%	1	455	49	T2D_GENES_TANYA_BLOODPRESSURE	PID_ARF6_TRAFFICKINGPATHWAY
0.21978021978%	1	455	49	T2D_GENES_TANYA_BLOODPRESSURE	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.21978021978%	1	455	49	T2D_GENES_TANYA_BLOODPRESSURE	LEE_LIVER_CANCER
0.21978021978%	1	455	49	T2D_GENES_TANYA_BLOODPRESSURE	FAELT_B_CLL_WITH_VH3_21_DN
0.21978021978%	1	455	49	T2D_GENES_TANYA_BLOODPRESSURE	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.21978021978%	1	455	49	T2D_GENES_TANYA_BLOODPRESSURE	APRELIKOVA_BRCA1_TARGETS
0.21978021978%	1	455	48	T2D_GENES_TANYA_BLOODPRESSURE	TAVOR_CEBPA_TARGETS_UP
0.21978021978%	1	455	48	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE
0.21978021978%	1	455	48	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MUSCLE_CONTRACTION
0.21978021978%	1	455	48	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES
0.21978021978%	1	455	48	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6
0.21978021978%	1	455	48	T2D_GENES_TANYA_BLOODPRESSURE	PID_HES_HEYPATHWAY
0.21978021978%	1	455	48	T2D_GENES_TANYA_BLOODPRESSURE	OXFORD_RALA_OR_RALB_TARGETS_UP
0.21978021978%	1	455	48	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.21978021978%	1	455	48	T2D_GENES_TANYA_BLOODPRESSURE	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
0.21978021978%	1	455	48	T2D_GENES_TANYA_BLOODPRESSURE	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
0.21978021978%	1	455	48	T2D_GENES_TANYA_BLOODPRESSURE	DELACROIX_RAR_TARGETS_UP
0.21978021978%	1	455	48	T2D_GENES_TANYA_BLOODPRESSURE	CHANGOLKAR_H2AFY_TARGETS_UP
0.21978021978%	1	455	48	T2D_GENES_TANYA_BLOODPRESSURE	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
0.21978021978%	1	455	47	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_HP_DN
0.21978021978%	1	455	47	T2D_GENES_TANYA_BLOODPRESSURE	PID_NFAT_TFPATHWAY
0.21978021978%	1	455	47	T2D_GENES_TANYA_BLOODPRESSURE	PID_IL6_7PATHWAY
0.21978021978%	1	455	47	T2D_GENES_TANYA_BLOODPRESSURE	MELLMAN_TUT1_TARGETS_DN
0.21978021978%	1	455	47	T2D_GENES_TANYA_BLOODPRESSURE	MCCLUNG_DELTA_FOSB_TARGETS_8WK
0.21978021978%	1	455	47	T2D_GENES_TANYA_BLOODPRESSURE	LEONARD_HYPOXIA
0.21978021978%	1	455	47	T2D_GENES_TANYA_BLOODPRESSURE	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	WINNEPENNINCKX_MELANOMA_METASTASIS_DN
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	SIG_BCR_SIGNALING_PATHWAY
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	SESTO_RESPONSE_TO_UV_C5
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	PID_SYNDECAN_1_PATHWAY
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	PID_PLK1_PATHWAY
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	PID_A6B1_A6B4_INTEGRIN_PATHWAY
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	NAKAJIMA_MAST_CELL
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	LEE_AGING_MUSCLE_DN
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	KUNINGER_IGF1_VS_PDGFB_TARGETS_DN
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	KRASNOSELSKAYA_ILF3_TARGETS_DN
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_N_GLYCAN_BIOSYNTHESIS
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	JIANG_TIP30_TARGETS_UP
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	HEIDENBLAD_AMPLICON_8Q24_DN
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	HALMOS_CEBPA_TARGETS_DN
0.21978021978%	1	455	46	T2D_GENES_TANYA_BLOODPRESSURE	AMIT_EGF_RESPONSE_60_HELA
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_V2_LATE_DIFFERENTIATION_GENES
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_CD2_UP
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_CD1_UP
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_CD1_DN
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	WANG_TARGETS_OF_MLL_CBP_FUSION_DN
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	SMITH_LIVER_CANCER
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	SHIPP_DLBCL_CURED_VS_FATAL_DN
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	NUTT_GBM_VS_AO_GLIOMA_DN
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	KLEIN_TARGETS_OF_BCR_ABL1_FUSION
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	HUANG_FOXA2_TARGETS_UP
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	CHENG_RESPONSE_TO_NICKEL_ACETATE
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY
0.21978021978%	1	455	45	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_BIOPEPTIDES_PATHWAY
0.21978021978%	1	455	44	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_PR_DN
0.21978021978%	1	455	44	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_LB_DN
0.21978021978%	1	455	44	T2D_GENES_TANYA_BLOODPRESSURE	XU_CREBBP_TARGETS_DN
0.21978021978%	1	455	44	T2D_GENES_TANYA_BLOODPRESSURE	WHITFIELD_CELL_CYCLE_LITERATURE
0.21978021978%	1	455	44	T2D_GENES_TANYA_BLOODPRESSURE	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.21978021978%	1	455	44	T2D_GENES_TANYA_BLOODPRESSURE	STREICHER_LSM1_TARGETS_UP
0.21978021978%	1	455	44	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_FGFR_MUTANTS
0.21978021978%	1	455	44	T2D_GENES_TANYA_BLOODPRESSURE	PID_ERBB2ERBB3PATHWAY
0.21978021978%	1	455	44	T2D_GENES_TANYA_BLOODPRESSURE	PARK_HSC_MARKERS
0.21978021978%	1	455	44	T2D_GENES_TANYA_BLOODPRESSURE	MEDINA_SMARCA4_TARGETS
0.21978021978%	1	455	44	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
0.21978021978%	1	455	44	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM
0.21978021978%	1	455	44	T2D_GENES_TANYA_BLOODPRESSURE	GROSS_HYPOXIA_VIA_ELK3_ONLY_DN
0.21978021978%	1	455	44	T2D_GENES_TANYA_BLOODPRESSURE	CHUNG_BLISTER_CYTOTOXICITY_DN
0.21978021978%	1	455	44	T2D_GENES_TANYA_BLOODPRESSURE	CHOI_ATL_STAGE_PREDICTOR
0.21978021978%	1	455	44	T2D_GENES_TANYA_BLOODPRESSURE	CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY
0.21978021978%	1	455	43	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PLC_BETA_MEDIATED_EVENTS
0.21978021978%	1	455	43	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK
0.21978021978%	1	455	43	T2D_GENES_TANYA_BLOODPRESSURE	POTTI_5FU_SENSITIVITY
0.21978021978%	1	455	43	T2D_GENES_TANYA_BLOODPRESSURE	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
0.21978021978%	1	455	43	T2D_GENES_TANYA_BLOODPRESSURE	PID_INTEGRIN3_PATHWAY
0.21978021978%	1	455	43	T2D_GENES_TANYA_BLOODPRESSURE	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN
0.21978021978%	1	455	43	T2D_GENES_TANYA_BLOODPRESSURE	NAKAMURA_METASTASIS_MODEL_DN
0.21978021978%	1	455	43	T2D_GENES_TANYA_BLOODPRESSURE	MILI_PSEUDOPODIA
0.21978021978%	1	455	43	T2D_GENES_TANYA_BLOODPRESSURE	MANTOVANI_NFKB_TARGETS_UP
0.21978021978%	1	455	43	T2D_GENES_TANYA_BLOODPRESSURE	HUMMEL_BURKITTS_LYMPHOMA_UP
0.21978021978%	1	455	43	T2D_GENES_TANYA_BLOODPRESSURE	GALLUZZI_PERMEABILIZE_MITOCHONDRIA
0.21978021978%	1	455	43	T2D_GENES_TANYA_BLOODPRESSURE	FUJII_YBX1_TARGETS_UP
0.21978021978%	1	455	43	T2D_GENES_TANYA_BLOODPRESSURE	COWLING_MYCN_TARGETS
0.21978021978%	1	455	43	T2D_GENES_TANYA_BLOODPRESSURE	AMIT_EGF_RESPONSE_120_MCF10A
0.21978021978%	1	455	42	T2D_GENES_TANYA_BLOODPRESSURE	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP
0.21978021978%	1	455	42	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRNA_AMINOACYLATION
0.21978021978%	1	455	42	T2D_GENES_TANYA_BLOODPRESSURE	PID_UPA_UPAR_PATHWAY
0.21978021978%	1	455	42	T2D_GENES_TANYA_BLOODPRESSURE	PID_ECADHERIN_STABILIZATION_PATHWAY
0.21978021978%	1	455	42	T2D_GENES_TANYA_BLOODPRESSURE	ONO_FOXP3_TARGETS_DN
0.21978021978%	1	455	42	T2D_GENES_TANYA_BLOODPRESSURE	MODY_HIPPOCAMPUS_PRENATAL
0.21978021978%	1	455	42	T2D_GENES_TANYA_BLOODPRESSURE	LUI_THYROID_CANCER_CLUSTER_2
0.21978021978%	1	455	42	T2D_GENES_TANYA_BLOODPRESSURE	LEIN_ASTROCYTE_MARKERS
0.21978021978%	1	455	42	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_FATTY_ACID_METABOLISM
0.21978021978%	1	455	42	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
0.21978021978%	1	455	42	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CHREBP2_PATHWAY
0.21978021978%	1	455	42	T2D_GENES_TANYA_BLOODPRESSURE	BILBAN_B_CLL_LPL_DN
0.21978021978%	1	455	42	T2D_GENES_TANYA_BLOODPRESSURE	AMIT_EGF_RESPONSE_40_HELA
0.21978021978%	1	455	41	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_MF_DN
0.21978021978%	1	455	41	T2D_GENES_TANYA_BLOODPRESSURE	WENG_POR_TARGETS_LIVER_UP
0.21978021978%	1	455	41	T2D_GENES_TANYA_BLOODPRESSURE	WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.21978021978%	1	455	41	T2D_GENES_TANYA_BLOODPRESSURE	RIZ_ERYTHROID_DIFFERENTIATION_HBZ
0.21978021978%	1	455	41	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING
0.21978021978%	1	455	41	T2D_GENES_TANYA_BLOODPRESSURE	MALONEY_RESPONSE_TO_17AAG_UP
0.21978021978%	1	455	41	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS
0.21978021978%	1	455	41	T2D_GENES_TANYA_BLOODPRESSURE	KAMMINGA_EZH2_TARGETS
0.21978021978%	1	455	41	T2D_GENES_TANYA_BLOODPRESSURE	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
0.21978021978%	1	455	41	T2D_GENES_TANYA_BLOODPRESSURE	EHLERS_ANEUPLOIDY_UP
0.21978021978%	1	455	41	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_FCER1_PATHWAY
0.21978021978%	1	455	40	T2D_GENES_TANYA_BLOODPRESSURE	RIZ_ERYTHROID_DIFFERENTIATION_6HR
0.21978021978%	1	455	40	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
0.21978021978%	1	455	40	T2D_GENES_TANYA_BLOODPRESSURE	PID_IFNGPATHWAY
0.21978021978%	1	455	40	T2D_GENES_TANYA_BLOODPRESSURE	PID_FOXM1PATHWAY
0.21978021978%	1	455	40	T2D_GENES_TANYA_BLOODPRESSURE	MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.21978021978%	1	455	40	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_SPHINGOLIPID_METABOLISM
0.21978021978%	1	455	40	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_PYRUVATE_METABOLISM
0.21978021978%	1	455	40	T2D_GENES_TANYA_BLOODPRESSURE	JIANG_AGING_HYPOTHALAMUS_DN
0.21978021978%	1	455	40	T2D_GENES_TANYA_BLOODPRESSURE	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN
0.21978021978%	1	455	40	T2D_GENES_TANYA_BLOODPRESSURE	DORN_ADENOVIRUS_INFECTION_48HR_DN
0.21978021978%	1	455	40	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_P38MAPK_PATHWAY
0.21978021978%	1	455	40	T2D_GENES_TANYA_BLOODPRESSURE	BERNARD_PPAPDC1B_TARGETS_UP
0.21978021978%	1	455	40	T2D_GENES_TANYA_BLOODPRESSURE	AMUNDSON_GAMMA_RADIATION_RESPONSE
0.21978021978%	1	455	39	T2D_GENES_TANYA_BLOODPRESSURE	WHITEHURST_PACLITAXEL_SENSITIVITY
0.21978021978%	1	455	39	T2D_GENES_TANYA_BLOODPRESSURE	VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1
0.21978021978%	1	455	39	T2D_GENES_TANYA_BLOODPRESSURE	VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN
0.21978021978%	1	455	39	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NCAM1_INTERACTIONS
0.21978021978%	1	455	39	T2D_GENES_TANYA_BLOODPRESSURE	PID_RET_PATHWAY
0.21978021978%	1	455	39	T2D_GENES_TANYA_BLOODPRESSURE	PID_ECADHERIN_NASCENTAJ_PATHWAY
0.21978021978%	1	455	39	T2D_GENES_TANYA_BLOODPRESSURE	NEWMAN_ERCC6_TARGETS_DN
0.21978021978%	1	455	39	T2D_GENES_TANYA_BLOODPRESSURE	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
0.21978021978%	1	455	39	T2D_GENES_TANYA_BLOODPRESSURE	MATZUK_MEIOTIC_AND_DNA_REPAIR
0.21978021978%	1	455	39	T2D_GENES_TANYA_BLOODPRESSURE	HOFMANN_CELL_LYMPHOMA_DN
0.21978021978%	1	455	39	T2D_GENES_TANYA_BLOODPRESSURE	HAN_JNK_SINGALING_DN
0.21978021978%	1	455	39	T2D_GENES_TANYA_BLOODPRESSURE	CONRAD_STEM_CELL
0.21978021978%	1	455	39	T2D_GENES_TANYA_BLOODPRESSURE	BURTON_ADIPOGENESIS_PEAK_AT_8HR
0.21978021978%	1	455	39	T2D_GENES_TANYA_BLOODPRESSURE	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP
0.21978021978%	1	455	39	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_FMLP_PATHWAY
0.21978021978%	1	455	39	T2D_GENES_TANYA_BLOODPRESSURE	AMIT_EGF_RESPONSE_60_MCF10A
0.21978021978%	1	455	39	T2D_GENES_TANYA_BLOODPRESSURE	AIYAR_COBRA1_TARGETS_UP
0.21978021978%	1	455	38	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER
0.21978021978%	1	455	38	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GLYCOSPHINGOLIPID_METABOLISM
0.21978021978%	1	455	38	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GABA_B_RECEPTOR_ACTIVATION
0.21978021978%	1	455	38	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GAB1_SIGNALOSOME
0.21978021978%	1	455	38	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_G1_PHASE
0.21978021978%	1	455	38	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS
0.21978021978%	1	455	38	T2D_GENES_TANYA_BLOODPRESSURE	PENG_GLUTAMINE_DEPRIVATION_UP
0.21978021978%	1	455	38	T2D_GENES_TANYA_BLOODPRESSURE	ONGUSAHA_TP53_TARGETS
0.21978021978%	1	455	38	T2D_GENES_TANYA_BLOODPRESSURE	LIU_LIVER_CANCER
0.21978021978%	1	455	38	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT
0.21978021978%	1	455	38	T2D_GENES_TANYA_BLOODPRESSURE	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP
0.21978021978%	1	455	38	T2D_GENES_TANYA_BLOODPRESSURE	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP
0.21978021978%	1	455	38	T2D_GENES_TANYA_BLOODPRESSURE	FIGUEROA_AML_METHYLATION_CLUSTER_6_DN
0.21978021978%	1	455	38	T2D_GENES_TANYA_BLOODPRESSURE	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN
0.21978021978%	1	455	38	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_INTEGRIN_PATHWAY
0.21978021978%	1	455	38	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_IL2RB_PATHWAY
0.21978021978%	1	455	37	T2D_GENES_TANYA_BLOODPRESSURE	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN
0.21978021978%	1	455	37	T2D_GENES_TANYA_BLOODPRESSURE	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.21978021978%	1	455	37	T2D_GENES_TANYA_BLOODPRESSURE	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
0.21978021978%	1	455	37	T2D_GENES_TANYA_BLOODPRESSURE	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN
0.21978021978%	1	455	37	T2D_GENES_TANYA_BLOODPRESSURE	ROLEF_GLIS3_TARGETS
0.21978021978%	1	455	37	T2D_GENES_TANYA_BLOODPRESSURE	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2
0.21978021978%	1	455	37	T2D_GENES_TANYA_BLOODPRESSURE	PID_GMCSF_PATHWAY
0.21978021978%	1	455	37	T2D_GENES_TANYA_BLOODPRESSURE	MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED
0.21978021978%	1	455	37	T2D_GENES_TANYA_BLOODPRESSURE	MATZUK_SPERMATID_DIFFERENTIATION
0.21978021978%	1	455	37	T2D_GENES_TANYA_BLOODPRESSURE	LANDIS_ERBB2_BREAST_TUMORS_65_DN
0.21978021978%	1	455	37	T2D_GENES_TANYA_BLOODPRESSURE	KIM_ALL_DISORDERS_CALB1_CORR_DN
0.21978021978%	1	455	37	T2D_GENES_TANYA_BLOODPRESSURE	GENTILE_UV_RESPONSE_CLUSTER_D6
0.21978021978%	1	455	37	T2D_GENES_TANYA_BLOODPRESSURE	FRASOR_RESPONSE_TO_ESTRADIOL_UP
0.21978021978%	1	455	37	T2D_GENES_TANYA_BLOODPRESSURE	CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE
0.21978021978%	1	455	37	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_PAR1_PATHWAY
0.21978021978%	1	455	36	T2D_GENES_TANYA_BLOODPRESSURE	VALK_AML_CLUSTER_11
0.21978021978%	1	455	36	T2D_GENES_TANYA_BLOODPRESSURE	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
0.21978021978%	1	455	36	T2D_GENES_TANYA_BLOODPRESSURE	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
0.21978021978%	1	455	36	T2D_GENES_TANYA_BLOODPRESSURE	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.21978021978%	1	455	36	T2D_GENES_TANYA_BLOODPRESSURE	SEMENZA_HIF1_TARGETS
0.21978021978%	1	455	36	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_IRON_UPTAKE_AND_TRANSPORT
0.21978021978%	1	455	36	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_FRS2_MEDIATED_CASCADE
0.21978021978%	1	455	36	T2D_GENES_TANYA_BLOODPRESSURE	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
0.21978021978%	1	455	36	T2D_GENES_TANYA_BLOODPRESSURE	MARZEC_IL2_SIGNALING_DN
0.21978021978%	1	455	36	T2D_GENES_TANYA_BLOODPRESSURE	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN
0.21978021978%	1	455	36	T2D_GENES_TANYA_BLOODPRESSURE	HUANG_FOXA2_TARGETS_DN
0.21978021978%	1	455	36	T2D_GENES_TANYA_BLOODPRESSURE	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP
0.21978021978%	1	455	36	T2D_GENES_TANYA_BLOODPRESSURE	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP
0.21978021978%	1	455	36	T2D_GENES_TANYA_BLOODPRESSURE	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP
0.21978021978%	1	455	36	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_AT1R_PATHWAY
0.21978021978%	1	455	35	T2D_GENES_TANYA_BLOODPRESSURE	YAGI_AML_RELAPSE_PROGNOSIS
0.21978021978%	1	455	35	T2D_GENES_TANYA_BLOODPRESSURE	WANG_METHYLATED_IN_BREAST_CANCER
0.21978021978%	1	455	35	T2D_GENES_TANYA_BLOODPRESSURE	SCHRAETS_MLL_TARGETS_UP
0.21978021978%	1	455	35	T2D_GENES_TANYA_BLOODPRESSURE	ROZANOV_MMP14_TARGETS_DN
0.21978021978%	1	455	35	T2D_GENES_TANYA_BLOODPRESSURE	RODRIGUES_NTN1_AND_DCC_TARGETS
0.21978021978%	1	455	35	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION
0.21978021978%	1	455	35	T2D_GENES_TANYA_BLOODPRESSURE	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
0.21978021978%	1	455	35	T2D_GENES_TANYA_BLOODPRESSURE	PID_ARF6_PATHWAY
0.21978021978%	1	455	35	T2D_GENES_TANYA_BLOODPRESSURE	LIEN_BREAST_CARCINOMA_METAPLASTIC
0.21978021978%	1	455	35	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_REGULATION_OF_AUTOPHAGY
0.21978021978%	1	455	35	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_PRION_DISEASES
0.21978021978%	1	455	35	T2D_GENES_TANYA_BLOODPRESSURE	HU_GENOTOXIC_DAMAGE_24HR
0.21978021978%	1	455	35	T2D_GENES_TANYA_BLOODPRESSURE	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP
0.21978021978%	1	455	35	T2D_GENES_TANYA_BLOODPRESSURE	AIGNER_ZEB1_TARGETS
0.21978021978%	1	455	34	T2D_GENES_TANYA_BLOODPRESSURE	SUMI_HNF4A_TARGETS
0.21978021978%	1	455	34	T2D_GENES_TANYA_BLOODPRESSURE	SCHOEN_NFKB_SIGNALING
0.21978021978%	1	455	34	T2D_GENES_TANYA_BLOODPRESSURE	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP
0.21978021978%	1	455	34	T2D_GENES_TANYA_BLOODPRESSURE	PLASARI_TGFB1_TARGETS_1HR_UP
0.21978021978%	1	455	34	T2D_GENES_TANYA_BLOODPRESSURE	PID_IL8CXCR2_PATHWAY
0.21978021978%	1	455	34	T2D_GENES_TANYA_BLOODPRESSURE	PID_IL1PATHWAY
0.21978021978%	1	455	34	T2D_GENES_TANYA_BLOODPRESSURE	DOANE_BREAST_CANCER_CLASSES_DN
0.21978021978%	1	455	34	T2D_GENES_TANYA_BLOODPRESSURE	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP
0.21978021978%	1	455	33	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_LATE_DIFFERENTIATION_GENES_UP
0.21978021978%	1	455	33	T2D_GENES_TANYA_BLOODPRESSURE	VALK_AML_CLUSTER_6
0.21978021978%	1	455	33	T2D_GENES_TANYA_BLOODPRESSURE	ROZANOV_MMP14_TARGETS_SUBSET
0.21978021978%	1	455	33	T2D_GENES_TANYA_BLOODPRESSURE	PID_NCADHERINPATHWAY
0.21978021978%	1	455	33	T2D_GENES_TANYA_BLOODPRESSURE	PID_ALPHASYNUCLEIN_PATHWAY
0.21978021978%	1	455	33	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_PROPANOATE_METABOLISM
0.21978021978%	1	455	33	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_ETHER_LIPID_METABOLISM
0.21978021978%	1	455	33	T2D_GENES_TANYA_BLOODPRESSURE	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP
0.21978021978%	1	455	33	T2D_GENES_TANYA_BLOODPRESSURE	GHANDHI_DIRECT_IRRADIATION_DN
0.21978021978%	1	455	33	T2D_GENES_TANYA_BLOODPRESSURE	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN
0.21978021978%	1	455	33	T2D_GENES_TANYA_BLOODPRESSURE	FIRESTEIN_CTNNB1_PATHWAY
0.21978021978%	1	455	33	T2D_GENES_TANYA_BLOODPRESSURE	FARMER_BREAST_CANCER_CLUSTER_2
0.21978021978%	1	455	33	T2D_GENES_TANYA_BLOODPRESSURE	DUTTA_APOPTOSIS_VIA_NFKB
0.21978021978%	1	455	33	T2D_GENES_TANYA_BLOODPRESSURE	CAFFAREL_RESPONSE_TO_THC_UP
0.21978021978%	1	455	33	T2D_GENES_TANYA_BLOODPRESSURE	BURTON_ADIPOGENESIS_1
0.21978021978%	1	455	33	T2D_GENES_TANYA_BLOODPRESSURE	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN
0.21978021978%	1	455	33	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_NO1_PATHWAY
0.21978021978%	1	455	32	T2D_GENES_TANYA_BLOODPRESSURE	TSAI_RESPONSE_TO_RADIATION_THERAPY
0.21978021978%	1	455	32	T2D_GENES_TANYA_BLOODPRESSURE	SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY
0.21978021978%	1	455	32	T2D_GENES_TANYA_BLOODPRESSURE	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN
0.21978021978%	1	455	32	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS
0.21978021978%	1	455	32	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_DAG_AND_IP3_SIGNALING
0.21978021978%	1	455	32	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CD28_CO_STIMULATION
0.21978021978%	1	455	32	T2D_GENES_TANYA_BLOODPRESSURE	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN
0.21978021978%	1	455	32	T2D_GENES_TANYA_BLOODPRESSURE	KIM_TIAL1_TARGETS
0.21978021978%	1	455	32	T2D_GENES_TANYA_BLOODPRESSURE	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP
0.21978021978%	1	455	32	T2D_GENES_TANYA_BLOODPRESSURE	DORSAM_HOXA9_TARGETS_DN
0.21978021978%	1	455	32	T2D_GENES_TANYA_BLOODPRESSURE	DIRMEIER_LMP1_RESPONSE_LATE_DN
0.21978021978%	1	455	32	T2D_GENES_TANYA_BLOODPRESSURE	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
0.21978021978%	1	455	32	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_HDAC_PATHWAY
0.21978021978%	1	455	32	T2D_GENES_TANYA_BLOODPRESSURE	BAUS_TFF2_TARGETS_UP
0.21978021978%	1	455	32	T2D_GENES_TANYA_BLOODPRESSURE	AMIT_SERUM_RESPONSE_40_MCF10A
0.21978021978%	1	455	31	T2D_GENES_TANYA_BLOODPRESSURE	VALK_AML_CLUSTER_15
0.21978021978%	1	455	31	T2D_GENES_TANYA_BLOODPRESSURE	SIMBULAN_PARP1_TARGETS_UP
0.21978021978%	1	455	31	T2D_GENES_TANYA_BLOODPRESSURE	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.21978021978%	1	455	31	T2D_GENES_TANYA_BLOODPRESSURE	RIZ_ERYTHROID_DIFFERENTIATION_HEMGN
0.21978021978%	1	455	31	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNAL_AMPLIFICATION
0.21978021978%	1	455	31	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING
0.21978021978%	1	455	31	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INWARDLY_RECTIFYING_K_CHANNELS
0.21978021978%	1	455	31	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
0.21978021978%	1	455	31	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING
0.21978021978%	1	455	31	T2D_GENES_TANYA_BLOODPRESSURE	PID_P38ALPHABETAPATHWAY
0.21978021978%	1	455	31	T2D_GENES_TANYA_BLOODPRESSURE	NOJIMA_SFRP2_TARGETS_UP
0.21978021978%	1	455	31	T2D_GENES_TANYA_BLOODPRESSURE	MCCABE_HOXC6_TARGETS_CANCER_UP
0.21978021978%	1	455	31	T2D_GENES_TANYA_BLOODPRESSURE	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP
0.21978021978%	1	455	31	T2D_GENES_TANYA_BLOODPRESSURE	HUNSBERGER_EXERCISE_REGULATED_GENES
0.21978021978%	1	455	31	T2D_GENES_TANYA_BLOODPRESSURE	DORSEY_GAB2_TARGETS
0.21978021978%	1	455	31	T2D_GENES_TANYA_BLOODPRESSURE	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP
0.21978021978%	1	455	31	T2D_GENES_TANYA_BLOODPRESSURE	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	VALK_AML_CLUSTER_13
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	URS_ADIPOCYTE_DIFFERENTIATION_DN
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	TSENG_ADIPOGENIC_POTENTIAL_UP
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	SU_PLACENTA
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CA_DEPENDENT_EVENTS
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_BASIGIN_INTERACTIONS
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	PID_RAS_PATHWAY
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	PID_NECTIN_PATHWAY
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	PID_IGF1_PATHWAY
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	LY_AGING_PREMATURE_DN
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	LIU_BREAST_CANCER
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	KYNG_NORMAL_AGING_DN
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	KIM_LRRC3B_TARGETS
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_O_GLYCAN_BIOSYNTHESIS
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_ASTHMA
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	HEIDENBLAD_AMPLICON_12P11_12_DN
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	GUILLAUMOND_KLF10_TARGETS_DN
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	DAZARD_UV_RESPONSE_CLUSTER_G2
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY
0.21978021978%	1	455	30	T2D_GENES_TANYA_BLOODPRESSURE	BURTON_ADIPOGENESIS_10
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	WEINMANN_ADAPTATION_TO_HYPOXIA_UP
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	WANG_RESPONSE_TO_BEXAROTENE_DN
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	STANELLE_E2F1_TARGETS
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GLYCOLYSIS
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	PID_S1P_S1P3_PATHWAY
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	PAL_PRMT5_TARGETS_DN
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	MIKKELSEN_MCV6_LCP_WITH_H3K27ME3
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	MAYBURD_RESPONSE_TO_L663536_UP
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	KYNG_WERNER_SYNDROM_DN
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_LINOLEIC_ACID_METABOLISM
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_HISTIDINE_METABOLISM
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	DORN_ADENOVIRUS_INFECTION_12HR_UP
0.21978021978%	1	455	29	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_VEGF_PATHWAY
0.21978021978%	1	455	28	T2D_GENES_TANYA_BLOODPRESSURE	VALK_AML_CLUSTER_7
0.21978021978%	1	455	28	T2D_GENES_TANYA_BLOODPRESSURE	VALK_AML_CLUSTER_1
0.21978021978%	1	455	28	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS
0.21978021978%	1	455	28	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SHC_MEDIATED_CASCADE
0.21978021978%	1	455	28	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC
0.21978021978%	1	455	28	T2D_GENES_TANYA_BLOODPRESSURE	PID_WNT_SIGNALING_PATHWAY
0.21978021978%	1	455	28	T2D_GENES_TANYA_BLOODPRESSURE	PID_IL8CXCR1_PATHWAY
0.21978021978%	1	455	28	T2D_GENES_TANYA_BLOODPRESSURE	PETRETTO_HEART_MASS_QTL_CIS_UP
0.21978021978%	1	455	28	T2D_GENES_TANYA_BLOODPRESSURE	LOPES_METHYLATED_IN_COLON_CANCER_DN
0.21978021978%	1	455	28	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_HOMOLOGOUS_RECOMBINATION
0.21978021978%	1	455	28	T2D_GENES_TANYA_BLOODPRESSURE	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
0.21978021978%	1	455	28	T2D_GENES_TANYA_BLOODPRESSURE	DAZARD_UV_RESPONSE_CLUSTER_G24
0.21978021978%	1	455	28	T2D_GENES_TANYA_BLOODPRESSURE	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.21978021978%	1	455	28	T2D_GENES_TANYA_BLOODPRESSURE	CHEN_LUNG_CANCER_SURVIVAL
0.21978021978%	1	455	28	T2D_GENES_TANYA_BLOODPRESSURE	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP
0.21978021978%	1	455	28	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_GH_PATHWAY
0.21978021978%	1	455	28	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_G1_PATHWAY
0.21978021978%	1	455	272	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	TIEN_INTESTINE_PROBIOTICS_2HR_UP
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	TERAO_AOX4_TARGETS_SKIN_DN
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	ST_GRANULE_CELL_SURVIVAL_PATHWAY
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SYNTHESIS_OF_PA
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_STRIATED_MUSCLE_CONTRACTION
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_G_PROTEIN_ACTIVATION
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GAP_JUNCTION_TRAFFICKING
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	PID_IL3_PATHWAY
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	PID_GLYPICAN_1PATHWAY
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	OHM_METHYLATED_IN_ADULT_CANCERS
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	GENTILE_UV_LOW_DOSE_UP
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	BOYAULT_LIVER_CANCER_SUBCLASS_G2
0.21978021978%	1	455	27	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_GSK3_PATHWAY
0.21978021978%	1	455	26	T2D_GENES_TANYA_BLOODPRESSURE	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
0.21978021978%	1	455	26	T2D_GENES_TANYA_BLOODPRESSURE	VALK_AML_CLUSTER_16
0.21978021978%	1	455	26	T2D_GENES_TANYA_BLOODPRESSURE	TOMIDA_METASTASIS_UP
0.21978021978%	1	455	26	T2D_GENES_TANYA_BLOODPRESSURE	PID_VEGFR1_PATHWAY
0.21978021978%	1	455	26	T2D_GENES_TANYA_BLOODPRESSURE	PID_RXR_VDR_PATHWAY
0.21978021978%	1	455	26	T2D_GENES_TANYA_BLOODPRESSURE	PID_INTEGRIN_CS_PATHWAY
0.21978021978%	1	455	26	T2D_GENES_TANYA_BLOODPRESSURE	PID_IL27PATHWAY
0.21978021978%	1	455	26	T2D_GENES_TANYA_BLOODPRESSURE	PID_ALK1PATHWAY
0.21978021978%	1	455	26	T2D_GENES_TANYA_BLOODPRESSURE	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.21978021978%	1	455	26	T2D_GENES_TANYA_BLOODPRESSURE	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN
0.21978021978%	1	455	26	T2D_GENES_TANYA_BLOODPRESSURE	HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP
0.21978021978%	1	455	26	T2D_GENES_TANYA_BLOODPRESSURE	FINAK_BREAST_CANCER_SDPP_SIGNATURE
0.21978021978%	1	455	26	T2D_GENES_TANYA_BLOODPRESSURE	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP
0.21978021978%	1	455	26	T2D_GENES_TANYA_BLOODPRESSURE	BRACHAT_RESPONSE_TO_METHOTREXATE_UP
0.21978021978%	1	455	26	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_RACCYCD_PATHWAY
0.21978021978%	1	455	26	T2D_GENES_TANYA_BLOODPRESSURE	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	WANG_BARRETTS_ESOPHAGUS_DN
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_G0_AND_EARLY_G1
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_FANCONI_ANEMIA_PATHWAY
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_EGFR_DOWNREGULATION
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_DARPP_32_EVENTS
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ADP_SIGNALLING_THROUGH_P2RY1
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	PID_HDAC_CLASSIII_PATHWAY
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	OZEN_MIR125B1_TARGETS
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	LU_TUMOR_ANGIOGENESIS_UP
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	KIM_HYPOXIA
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_DORSO_VENTRAL_AXIS_FORMATION
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	GROSS_HIF1A_TARGETS_DN
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	COLLER_MYC_TARGETS_UP
0.21978021978%	1	455	25	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_MCALPAIN_PATHWAY
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	YIH_RESPONSE_TO_ARSENITE_C1
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_KINESINS
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CHOLESTEROL_BIOSYNTHESIS
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	ONO_AML1_TARGETS_UP
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	MAEKAWA_ATF2_TARGETS
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	KIM_GERMINAL_CENTER_T_HELPER_DN
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	DELACROIX_RAR_TARGETS_DN
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_TPO_PATHWAY
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_NOS1_PATHWAY
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_G2_PATHWAY
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_ECM_PATHWAY
0.21978021978%	1	455	24	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CXCR4_PATHWAY
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	ZIRN_TRETINOIN_RESPONSE_WT1_UP
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	YANG_MUC2_TARGETS_DUODENUM_3MO_DN
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	WU_HBX_TARGETS_2_UP
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	WU_HBX_TARGETS_1_DN
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	VIETOR_IFRD1_TARGETS
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	ST_GA12_PATHWAY
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	SAGIV_CD24_TARGETS_UP
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PHOSPHORYLATION_OF_THE_APC_C
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_LYSOSOME_VESICLE_BIOGENESIS
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_INSULIN_RECEPTOR_RECYCLING
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	PID_CONE_PATHWAY
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	MARKS_HDAC_TARGETS_UP
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	CHEOK_RESPONSE_TO_HD_MTX_UP
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_PTDINS_PATHWAY
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_P53HYPOXIA_PATHWAY
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_IGF1R_PATHWAY
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_GLEEVEC_PATHWAY
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CTCF_PATHWAY
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CELLCYCLE_PATHWAY
0.21978021978%	1	455	23	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CCR3_PATHWAY
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	ZHAN_MULTIPLE_MYELOMA_SPIKED
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	YUAN_ZNF143_PARTNERS
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	SPIRA_SMOKERS_LUNG_CANCER_DN
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_METAL_ION_SLC_TRANSPORTERS
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	PID_PDGFRAPATHWAY
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	NUMATA_CSF3_SIGNALING_VIA_STAT3
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	MATZUK_IMPLANTATION_AND_UTERINE
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	LANDIS_ERBB2_BREAST_TUMORS_65_UP
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_BETA_ALANINE_METABOLISM
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	HANSON_HRAS_SIGNALING_VIA_NFKB
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_IL6_PATHWAY
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_HER2_PATHWAY
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CHEMICAL_PATHWAY
0.21978021978%	1	455	22	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CERAMIDE_PATHWAY
0.21978021978%	1	455	210	T2D_GENES_TANYA_BLOODPRESSURE	VERHAAK_GLIOBLASTOMA_MESENCHYMAL
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	WENG_POR_DOSAGE
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	VERRECCHIA_RESPONSE_TO_TGFB1_C5
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	STEGER_ADIPOGENESIS_UP
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ERK_MAPK_TARGETS
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ADP_SIGNALLING_THROUGH_P2RY12
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	PID_S1P_S1P1_PATHWAY
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	MCCABE_HOXC6_TARGETS_DN
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	MARCHINI_TRABECTEDIN_RESISTANCE_UP
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	KANNAN_TP53_TARGETS_DN
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	HU_ANGIOGENESIS_UP
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	GREENBAUM_E2A_TARGETS_DN
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	GESERICK_TERT_TARGETS_DN
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	FINETTI_BREAST_CANCERS_KINOME_BLUE
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_TFF_PATHWAY
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CTLA4_PATHWAY
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_ATRBRCA_PATHWAY
0.21978021978%	1	455	21	T2D_GENES_TANYA_BLOODPRESSURE	AMIT_SERUM_RESPONSE_20_MCF10A
0.21978021978%	1	455	200	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	ZHU_SKIL_TARGETS_UP
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	ZEMBUTSU_SENSITIVITY_TO_CISPLATIN
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	WANG_THOC1_TARGETS_DN
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	WALLACE_PROSTATE_CANCER_UP
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	VILIMAS_NOTCH1_TARGETS_DN
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	TOMLINS_METASTASIS_DN
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	ST_WNT_CA2_CYCLIC_GMP_PATHWAY
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	SESTO_RESPONSE_TO_UV_C4
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	OUYANG_PROSTATE_CANCER_PROGRESSION_UP
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	DING_LUNG_CANCER_BY_MUTATION_RATE
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	DE_YY1_TARGETS_UP
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	CHEN_ETV5_TARGETS_SERTOLI
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_ATM_PATHWAY
0.21978021978%	1	455	20	T2D_GENES_TANYA_BLOODPRESSURE	ABE_VEGFA_TARGETS
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	VISALA_AGING_LYMPHOCYTE_DN
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	VERNOCHET_ADIPOGENESIS
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	SYED_ESTRADIOL_RESPONSE
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PYRUVATE_METABOLISM
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_G1_S_SPECIFIC_TRANSCRIPTION
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CGMP_EFFECTS
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	OUYANG_PROSTATE_CANCER_MARKERS
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	MARSON_FOXP3_CORE_DIRECT_TARGETS
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	MAHADEVAN_RESPONSE_TO_MP470_DN
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	LE_NEURONAL_DIFFERENTIATION_DN
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	LAMB_CCND1_TARGETS
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	KANG_DOXORUBICIN_RESISTANCE_DN
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	GAJATE_RESPONSE_TO_TRABECTEDIN_DN
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	CHEN_PDGF_TARGETS
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_STATHMIN_PATHWAY
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP
0.21978021978%	1	455	19	T2D_GENES_TANYA_BLOODPRESSURE	AMIT_EGF_RESPONSE_40_MCF10A
0.21978021978%	1	455	182	T2D_GENES_TANYA_BLOODPRESSURE	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	ZHENG_RESPONSE_TO_ARSENITE_DN
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	SHIN_B_CELL_LYMPHOMA_CLUSTER_5
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_NODAL
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PD1_SIGNALING
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GAP_JUNCTION_ASSEMBLY
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	PODAR_RESPONSE_TO_ADAPHOSTIN_DN
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	OZANNE_AP1_TARGETS_UP
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	NIELSEN_SCHWANNOMA_DN
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	NIELSEN_LIPOSARCOMA_UP
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	KAPOSI_LIVER_CANCER_MET_UP
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_UCALPAIN_PATHWAY
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_ERK5_PATHWAY
0.21978021978%	1	455	18	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_ARAP_PATHWAY
0.21978021978%	1	455	177	T2D_GENES_TANYA_BLOODPRESSURE	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.21978021978%	1	455	171	T2D_GENES_TANYA_BLOODPRESSURE	ELVIDGE_HYPOXIA_UP
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	WIKMAN_ASBESTOS_LUNG_CANCER_UP
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	SA_TRKA_RECEPTOR
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TIE2_SIGNALING
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_REGULATION_OF_KIT_SIGNALING
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	MURAKAMI_UV_RESPONSE_1HR_UP
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	LI_CYTIDINE_ANALOG_PATHWAY
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	LIU_IL13_MEMORY_MODEL_UP
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	LE_SKI_TARGETS_UP
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_STEROID_BIOSYNTHESIS
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_ONE_CARBON_POOL_BY_FOLATE
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	GALE_APL_WITH_FLT3_MUTATED_DN
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	DORMOY_ELAVL1_TARGETS
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_PML_PATHWAY
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_LAIR_PATHWAY
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_IL7_PATHWAY
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_IL10_PATHWAY
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CK1_PATHWAY
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_ARF_PATHWAY
0.21978021978%	1	455	17	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_41BB_PATHWAY
0.21978021978%	1	455	161	T2D_GENES_TANYA_BLOODPRESSURE	BIDUS_METASTASIS_DN
0.21978021978%	1	455	160	T2D_GENES_TANYA_BLOODPRESSURE	GAVIN_FOXP3_TARGETS_CLUSTER_P3
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	TIAN_BHLHA15_TARGETS
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	SUZUKI_AMPLIFIED_IN_ORAL_CANCER
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	PID_DNAPK_PATHWAY
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	IGLESIAS_E2F_TARGETS_DN
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	GHO_ATF5_TARGETS_DN
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	FARMER_BREAST_CANCER_CLUSTER_4
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	DASU_IL6_SIGNALING_SCAR_DN
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	CHIN_BREAST_CANCER_COPY_NUMBER_DN
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_GATA3_PATHWAY
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CDC42RAC_PATHWAY
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_ACH_PATHWAY
0.21978021978%	1	455	16	T2D_GENES_TANYA_BLOODPRESSURE	AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
0.21978021978%	1	455	159	T2D_GENES_TANYA_BLOODPRESSURE	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
0.21978021978%	1	455	152	T2D_GENES_TANYA_BLOODPRESSURE	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
0.21978021978%	1	455	150	T2D_GENES_TANYA_BLOODPRESSURE	LANDIS_ERBB2_BREAST_TUMORS_324_UP
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ZINC_TRANSPORTERS
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_OTHER_SEMAPHORIN_INTERACTIONS
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	MARKS_HDAC_TARGETS_DN
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	LIU_IL13_PRIMING_MODEL
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	FERRANDO_LYL1_NEIGHBORS
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	DAZARD_UV_RESPONSE_CLUSTER_G3
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_PITX2_PATHWAY
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_NUCLEARRS_PATHWAY
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_LONGEVITY_PATHWAY
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_HSP27_PATHWAY
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_BARRESTIN_SRC_PATHWAY
0.21978021978%	1	455	15	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_AKAPCENTROSOME_PATHWAY
0.21978021978%	1	455	146	T2D_GENES_TANYA_BLOODPRESSURE	ELVIDGE_HYPOXIA_DN
0.21978021978%	1	455	141	T2D_GENES_TANYA_BLOODPRESSURE	KAAB_FAILED_HEART_ATRIUM_DN
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	WU_ALZHEIMER_DISEASE_UP
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_HYALURONAN_METABOLISM
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CRMPS_IN_SEMA3A_SIGNALING
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	PID_IL5_PATHWAY
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	MATZUK_OVULATION
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	DORN_ADENOVIRUS_INFECTION_48HR_UP
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_RANKL_PATHWAY
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_GRANULOCYTES_PATHWAY
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_DREAM_PATHWAY
0.21978021978%	1	455	14	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CELL2CELL_PATHWAY
0.21978021978%	1	455	137	T2D_GENES_TANYA_BLOODPRESSURE	PID_P53DOWNSTREAMPATHWAY
0.21978021978%	1	455	136	T2D_GENES_TANYA_BLOODPRESSURE	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.21978021978%	1	455	134	T2D_GENES_TANYA_BLOODPRESSURE	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
0.21978021978%	1	455	134	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_TIGHT_JUNCTION
0.21978021978%	1	455	134	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_CELL_ADHESION_MOLECULES_CAMS
0.21978021978%	1	455	132	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS
0.21978021978%	1	455	130	T2D_GENES_TANYA_BLOODPRESSURE	YAGI_AML_WITH_T_9_11_TRANSLOCATION
0.21978021978%	1	455	130	T2D_GENES_TANYA_BLOODPRESSURE	ELVIDGE_HYPOXIA_BY_DMOG_UP
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	WAGSCHAL_EHMT2_TARGETS_UP
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	WACKER_HYPOXIA_TARGETS_OF_VHL
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	TERAMOTO_OPN_TARGETS_CLUSTER_1
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	STARK_BRAIN_22Q11_DELETION
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PURINE_SALVAGE
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	RAY_ALZHEIMERS_DISEASE
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	LU_TUMOR_VASCULATURE_DN
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	KORKOLA_EMBRYONAL_CARCINOMA
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	JIANG_CORE_DUPLICON_GENES
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	IVANOV_MUTATED_IN_COLON_CANCER
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	HOEGERKORP_CD44_TARGETS_TEMPORAL_UP
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	HASINA_NOL7_TARGETS_UP
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	HASINA_NOL7_TARGETS_DN
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	GERHOLD_RESPONSE_TO_TZD_DN
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	CROONQUIST_STROMAL_STIMULATION_DN
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CBL_PATHWAY
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CARM1_PATHWAY
0.21978021978%	1	455	13	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_ACE2_PATHWAY
0.21978021978%	1	455	128	T2D_GENES_TANYA_BLOODPRESSURE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
0.21978021978%	1	455	127	T2D_GENES_TANYA_BLOODPRESSURE	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
0.21978021978%	1	455	123	T2D_GENES_TANYA_BLOODPRESSURE	DAZARD_RESPONSE_TO_UV_SCC_DN
0.21978021978%	1	455	121	T2D_GENES_TANYA_BLOODPRESSURE	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP
0.21978021978%	1	455	120	T2D_GENES_TANYA_BLOODPRESSURE	CHEBOTAEV_GR_TARGETS_DN
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	WAESCH_ANAPHASE_PROMOTING_COMPLEX
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_NOTCH3
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_NOTCH2
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ERKS_ARE_INACTIVATED
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	PARK_TRETINOIN_RESPONSE
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	MIZUKAMI_HYPOXIA_UP
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	MALIK_REPRESSED_BY_ESTROGEN
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	KRISHNAN_FURIN_TARGETS_UP
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	DING_LUNG_CANCER_MUTATED_FREQUENTLY
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	DAZARD_UV_RESPONSE_CLUSTER_G5
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_ETC_PATHWAY
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_BARR_MAPK_PATHWAY
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_AKAP95_PATHWAY
0.21978021978%	1	455	12	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_AKAP13_PATHWAY
0.21978021978%	1	455	118	T2D_GENES_TANYA_BLOODPRESSURE	CERVERA_SDHB_TARGETS_1_UP
0.21978021978%	1	455	117	T2D_GENES_TANYA_BLOODPRESSURE	PUJANA_BRCA_CENTERED_NETWORK
0.21978021978%	1	455	116	T2D_GENES_TANYA_BLOODPRESSURE	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
0.21978021978%	1	455	116	T2D_GENES_TANYA_BLOODPRESSURE	LI_INDUCED_T_TO_NATURAL_KILLER_DN
0.21978021978%	1	455	116	T2D_GENES_TANYA_BLOODPRESSURE	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
0.21978021978%	1	455	116	T2D_GENES_TANYA_BLOODPRESSURE	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.21978021978%	1	455	114	T2D_GENES_TANYA_BLOODPRESSURE	MATZUK_SPERMATOZOA
0.21978021978%	1	455	114	T2D_GENES_TANYA_BLOODPRESSURE	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN
0.21978021978%	1	455	114	T2D_GENES_TANYA_BLOODPRESSURE	BOSCO_TH1_CYTOTOXIC_MODULE
0.21978021978%	1	455	113	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_RHO_GTPASES
0.21978021978%	1	455	111	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GLYCOSAMINOGLYCAN_METABOLISM
0.21978021978%	1	455	110	T2D_GENES_TANYA_BLOODPRESSURE	GROSS_HYPOXIA_VIA_HIF1A_DN
0.21978021978%	1	455	110	T2D_GENES_TANYA_BLOODPRESSURE	GHANDHI_DIRECT_IRRADIATION_UP
0.21978021978%	1	455	110	T2D_GENES_TANYA_BLOODPRESSURE	CHENG_IMPRINTED_BY_ESTRADIOL
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	WILLIAMS_ESR2_TARGETS_DN
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	SASAKI_TARGETS_OF_TP73_AND_TP63
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	ROZANOV_MMP14_CORRELATED
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_TRYPTOPHAN_CATABOLISM
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SYNTHESIS_OF_PE
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_FGFR3_MUTANTS
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	MARTINELLI_IMMATURE_NEUTROPHIL_UP
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	MARSON_FOXP3_TARGETS_STIMULATED_DN
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	IIZUKA_LIVER_CANCER_EARLY_RECURRENCE
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	FUNG_IL2_SIGNALING_1
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	CHUANG_OXIDATIVE_STRESS_RESPONSE_DN
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	CAFFAREL_RESPONSE_TO_THC_8HR_5_DN
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_SET_PATHWAY
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_PTC1_PATHWAY
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_EPONFKB_PATHWAY
0.21978021978%	1	455	11	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_CDK5_PATHWAY
0.21978021978%	1	455	109	T2D_GENES_TANYA_BLOODPRESSURE	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
0.21978021978%	1	455	108	T2D_GENES_TANYA_BLOODPRESSURE	WESTON_VEGFA_TARGETS
0.21978021978%	1	455	108	T2D_GENES_TANYA_BLOODPRESSURE	LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT
0.21978021978%	1	455	108	T2D_GENES_TANYA_BLOODPRESSURE	LABBE_TGFB1_TARGETS_DN
0.21978021978%	1	455	107	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SIGNALING_BY_ILS
0.21978021978%	1	455	107	T2D_GENES_TANYA_BLOODPRESSURE	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.21978021978%	1	455	106	T2D_GENES_TANYA_BLOODPRESSURE	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
0.21978021978%	1	455	105	T2D_GENES_TANYA_BLOODPRESSURE	PID_ERBB1_DOWNSTREAM_PATHWAY
0.21978021978%	1	455	104	T2D_GENES_TANYA_BLOODPRESSURE	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.21978021978%	1	455	103	T2D_GENES_TANYA_BLOODPRESSURE	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
0.21978021978%	1	455	101	T2D_GENES_TANYA_BLOODPRESSURE	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
0.21978021978%	1	455	101	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_GNRH_SIGNALING_PATHWAY
0.21978021978%	1	455	101	T2D_GENES_TANYA_BLOODPRESSURE	GRADE_COLON_AND_RECTAL_CANCER_DN
0.21978021978%	1	455	100	T2D_GENES_TANYA_BLOODPRESSURE	ROVERSI_GLIOMA_COPY_NUMBER_UP
0.21978021978%	1	455	100	T2D_GENES_TANYA_BLOODPRESSURE	RICKMAN_HEAD_AND_NECK_CANCER_A
0.21978021978%	1	455	100	T2D_GENES_TANYA_BLOODPRESSURE	CHICAS_RB1_TARGETS_LOW_SERUM
0.21978021978%	1	455	100	T2D_GENES_TANYA_BLOODPRESSURE	BENPORATH_ES_CORE_NINE_CORRELATED
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	YEMELYANOV_GR_TARGETS_DN
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PURINE_CATABOLISM
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_PECAM1_INTERACTIONS
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ETHANOL_OXIDATION
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_COPI_MEDIATED_TRANSPORT
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ANDROGEN_BIOSYNTHESIS
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	PYEON_HPV_POSITIVE_TUMORS_DN
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	OXFORD_RALA_TARGETS_DN
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	OXFORD_RALA_AND_RALB_TARGETS_UP
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	KEGG_LIMONENE_AND_PINENE_DEGRADATION
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	HOLLEMAN_DAUNORUBICIN_B_ALL_UP
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	GOUYER_TATI_TARGETS_UP
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	CAFFAREL_RESPONSE_TO_THC_8HR_3_DN
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_SODD_PATHWAY
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	BIOCARTA_BARRESTIN_PATHWAY
0.21978021978%	1	455	10	T2D_GENES_TANYA_BLOODPRESSURE	BAKER_HEMATOPOESIS_STAT1_TARGETS
0.213789417424%	4	1871	92	T2D_GENES_TANYA_HEIGHT	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
0.213789417424%	4	1871	9	T2D_GENES_TANYA_HEIGHT	NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON
0.213789417424%	4	1871	88	T2D_GENES_TANYA_HEIGHT	SEIDEN_ONCOGENESIS_BY_MET
0.213789417424%	4	1871	88	T2D_GENES_TANYA_HEIGHT	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
0.213789417424%	4	1871	86	T2D_GENES_TANYA_HEIGHT	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.213789417424%	4	1871	82	T2D_GENES_TANYA_HEIGHT	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
0.213789417424%	4	1871	82	T2D_GENES_TANYA_HEIGHT	BHAT_ESR1_TARGETS_VIA_AKT1_DN
0.213789417424%	4	1871	80	T2D_GENES_TANYA_HEIGHT	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN
0.213789417424%	4	1871	80	T2D_GENES_TANYA_HEIGHT	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN
0.213789417424%	4	1871	8	T2D_GENES_TANYA_HEIGHT	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR
0.213789417424%	4	1871	8	T2D_GENES_TANYA_HEIGHT	LE_SKI_TARGETS_DN
0.213789417424%	4	1871	8	T2D_GENES_TANYA_HEIGHT	GAUTSCHI_SRC_SIGNALING
0.213789417424%	4	1871	79	T2D_GENES_TANYA_HEIGHT	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT
0.213789417424%	4	1871	79	T2D_GENES_TANYA_HEIGHT	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
0.213789417424%	4	1871	76	T2D_GENES_TANYA_HEIGHT	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
0.213789417424%	4	1871	74	T2D_GENES_TANYA_HEIGHT	LEIN_OLIGODENDROCYTE_MARKERS
0.213789417424%	4	1871	74	T2D_GENES_TANYA_HEIGHT	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
0.213789417424%	4	1871	74	T2D_GENES_TANYA_HEIGHT	CORRE_MULTIPLE_MYELOMA_UP
0.213789417424%	4	1871	73	T2D_GENES_TANYA_HEIGHT	HOSHIDA_LIVER_CANCER_SURVIVAL_UP
0.213789417424%	4	1871	72	T2D_GENES_TANYA_HEIGHT	DOANE_BREAST_CANCER_CLASSES_UP
0.213789417424%	4	1871	71	T2D_GENES_TANYA_HEIGHT	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
0.213789417424%	4	1871	71	T2D_GENES_TANYA_HEIGHT	KUMAR_AUTOPHAGY_NETWORK
0.213789417424%	4	1871	71	T2D_GENES_TANYA_HEIGHT	GU_PDEF_TARGETS_UP
0.213789417424%	4	1871	71	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_6HR_UP
0.213789417424%	4	1871	70	T2D_GENES_TANYA_HEIGHT	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
0.213789417424%	4	1871	70	T2D_GENES_TANYA_HEIGHT	LANDIS_BREAST_CANCER_PROGRESSION_DN
0.213789417424%	4	1871	69	T2D_GENES_TANYA_HEIGHT	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.213789417424%	4	1871	69	T2D_GENES_TANYA_HEIGHT	REACTOME_GLUCOSE_METABOLISM
0.213789417424%	4	1871	69	T2D_GENES_TANYA_HEIGHT	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
0.213789417424%	4	1871	68	T2D_GENES_TANYA_HEIGHT	SESTO_RESPONSE_TO_UV_C7
0.213789417424%	4	1871	67	T2D_GENES_TANYA_HEIGHT	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP
0.213789417424%	4	1871	67	T2D_GENES_TANYA_HEIGHT	GENTILE_UV_LOW_DOSE_DN
0.213789417424%	4	1871	67	T2D_GENES_TANYA_HEIGHT	DAZARD_UV_RESPONSE_CLUSTER_G1
0.213789417424%	4	1871	66	T2D_GENES_TANYA_HEIGHT	RIGGINS_TAMOXIFEN_RESISTANCE_UP
0.213789417424%	4	1871	66	T2D_GENES_TANYA_HEIGHT	RAMASWAMY_METASTASIS_UP
0.213789417424%	4	1871	66	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER_CIPROFIBRATE_DN
0.213789417424%	4	1871	66	T2D_GENES_TANYA_HEIGHT	KIM_GERMINAL_CENTER_T_HELPER_UP
0.213789417424%	4	1871	65	T2D_GENES_TANYA_HEIGHT	CHANG_IMMORTALIZED_BY_HPV31_DN
0.213789417424%	4	1871	64	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER_MYC_E2F1_DN
0.213789417424%	4	1871	64	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER_E2F1_DN
0.213789417424%	4	1871	63	T2D_GENES_TANYA_HEIGHT	PID_MYC_REPRESSPATHWAY
0.213789417424%	4	1871	62	T2D_GENES_TANYA_HEIGHT	ISSAEVA_MLL2_TARGETS
0.213789417424%	4	1871	61	T2D_GENES_TANYA_HEIGHT	PID_AR_PATHWAY
0.213789417424%	4	1871	61	T2D_GENES_TANYA_HEIGHT	KAUFFMANN_MELANOMA_RELAPSE_UP
0.213789417424%	4	1871	61	T2D_GENES_TANYA_HEIGHT	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
0.213789417424%	4	1871	60	T2D_GENES_TANYA_HEIGHT	SONG_TARGETS_OF_IE86_CMV_PROTEIN
0.213789417424%	4	1871	60	T2D_GENES_TANYA_HEIGHT	CROONQUIST_STROMAL_STIMULATION_UP
0.213789417424%	4	1871	60	T2D_GENES_TANYA_HEIGHT	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.213789417424%	4	1871	59	T2D_GENES_TANYA_HEIGHT	WESTON_VEGFA_TARGETS_6HR
0.213789417424%	4	1871	59	T2D_GENES_TANYA_HEIGHT	PID_FAK_PATHWAY
0.213789417424%	4	1871	59	T2D_GENES_TANYA_HEIGHT	ONDER_CDH1_TARGETS_3_DN
0.213789417424%	4	1871	59	T2D_GENES_TANYA_HEIGHT	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1
0.213789417424%	4	1871	59	T2D_GENES_TANYA_HEIGHT	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
0.213789417424%	4	1871	58	T2D_GENES_TANYA_HEIGHT	REACTOME_COLLAGEN_FORMATION
0.213789417424%	4	1871	58	T2D_GENES_TANYA_HEIGHT	NAGASHIMA_EGF_SIGNALING_UP
0.213789417424%	4	1871	57	T2D_GENES_TANYA_HEIGHT	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN
0.213789417424%	4	1871	57	T2D_GENES_TANYA_HEIGHT	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP
0.213789417424%	4	1871	57	T2D_GENES_TANYA_HEIGHT	AMIT_SERUM_RESPONSE_60_MCF10A
0.213789417424%	4	1871	56	T2D_GENES_TANYA_HEIGHT	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.213789417424%	4	1871	56	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_30MIN_UP
0.213789417424%	4	1871	55	T2D_GENES_TANYA_HEIGHT	SU_LIVER
0.213789417424%	4	1871	55	T2D_GENES_TANYA_HEIGHT	SMIRNOV_RESPONSE_TO_IR_2HR_DN
0.213789417424%	4	1871	54	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_IPS_ICP_WITH_H3K27ME3
0.213789417424%	4	1871	53	T2D_GENES_TANYA_HEIGHT	ROESSLER_LIVER_CANCER_METASTASIS_DN
0.213789417424%	4	1871	53	T2D_GENES_TANYA_HEIGHT	LIANG_SILENCED_BY_METHYLATION_2
0.213789417424%	4	1871	53	T2D_GENES_TANYA_HEIGHT	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN
0.213789417424%	4	1871	52	T2D_GENES_TANYA_HEIGHT	PID_PTP1BPATHWAY
0.213789417424%	4	1871	52	T2D_GENES_TANYA_HEIGHT	PID_CASPASE_PATHWAY
0.213789417424%	4	1871	52	T2D_GENES_TANYA_HEIGHT	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6
0.213789417424%	4	1871	52	T2D_GENES_TANYA_HEIGHT	HALMOS_CEBPA_TARGETS_UP
0.213789417424%	4	1871	52	T2D_GENES_TANYA_HEIGHT	BECKER_TAMOXIFEN_RESISTANCE_DN
0.213789417424%	4	1871	51	T2D_GENES_TANYA_HEIGHT	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.213789417424%	4	1871	51	T2D_GENES_TANYA_HEIGHT	REACTOME_NUCLEOTIDE_EXCISION_REPAIR
0.213789417424%	4	1871	51	T2D_GENES_TANYA_HEIGHT	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
0.213789417424%	4	1871	51	T2D_GENES_TANYA_HEIGHT	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN
0.213789417424%	4	1871	51	T2D_GENES_TANYA_HEIGHT	CROMER_TUMORIGENESIS_DN
0.213789417424%	4	1871	51	T2D_GENES_TANYA_HEIGHT	BURTON_ADIPOGENESIS_PEAK_AT_2HR
0.213789417424%	4	1871	50	T2D_GENES_TANYA_HEIGHT	STOSSI_RESPONSE_TO_ESTRADIOL
0.213789417424%	4	1871	50	T2D_GENES_TANYA_HEIGHT	ROY_WOUND_BLOOD_VESSEL_UP
0.213789417424%	4	1871	50	T2D_GENES_TANYA_HEIGHT	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
0.213789417424%	4	1871	50	T2D_GENES_TANYA_HEIGHT	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC
0.213789417424%	4	1871	50	T2D_GENES_TANYA_HEIGHT	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION
0.213789417424%	4	1871	49	T2D_GENES_TANYA_HEIGHT	REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM
0.213789417424%	4	1871	49	T2D_GENES_TANYA_HEIGHT	MARCHINI_TRABECTEDIN_RESISTANCE_DN
0.213789417424%	4	1871	49	T2D_GENES_TANYA_HEIGHT	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN
0.213789417424%	4	1871	49	T2D_GENES_TANYA_HEIGHT	GERHOLD_ADIPOGENESIS_UP
0.213789417424%	4	1871	49	T2D_GENES_TANYA_HEIGHT	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.213789417424%	4	1871	49	T2D_GENES_TANYA_HEIGHT	APRELIKOVA_BRCA1_TARGETS
0.213789417424%	4	1871	48	T2D_GENES_TANYA_HEIGHT	TAVOR_CEBPA_TARGETS_UP
0.213789417424%	4	1871	48	T2D_GENES_TANYA_HEIGHT	RICKMAN_HEAD_AND_NECK_CANCER_B
0.213789417424%	4	1871	48	T2D_GENES_TANYA_HEIGHT	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE
0.213789417424%	4	1871	48	T2D_GENES_TANYA_HEIGHT	REACTOME_MUSCLE_CONTRACTION
0.213789417424%	4	1871	48	T2D_GENES_TANYA_HEIGHT	NADLER_OBESITY_DN
0.213789417424%	4	1871	47	T2D_GENES_TANYA_HEIGHT	WARTERS_IR_RESPONSE_5GY
0.213789417424%	4	1871	47	T2D_GENES_TANYA_HEIGHT	POTTI_DOCETAXEL_SENSITIVITY
0.213789417424%	4	1871	47	T2D_GENES_TANYA_HEIGHT	PID_IL6_7PATHWAY
0.213789417424%	4	1871	47	T2D_GENES_TANYA_HEIGHT	KEGG_NOTCH_SIGNALING_PATHWAY
0.213789417424%	4	1871	47	T2D_GENES_TANYA_HEIGHT	BOYLAN_MULTIPLE_MYELOMA_C_UP
0.213789417424%	4	1871	46	T2D_GENES_TANYA_HEIGHT	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6
0.213789417424%	4	1871	46	T2D_GENES_TANYA_HEIGHT	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
0.213789417424%	4	1871	46	T2D_GENES_TANYA_HEIGHT	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION
0.213789417424%	4	1871	46	T2D_GENES_TANYA_HEIGHT	PID_PS1PATHWAY
0.213789417424%	4	1871	46	T2D_GENES_TANYA_HEIGHT	OSADA_ASCL1_TARGETS_UP
0.213789417424%	4	1871	46	T2D_GENES_TANYA_HEIGHT	NAKAJIMA_MAST_CELL
0.213789417424%	4	1871	46	T2D_GENES_TANYA_HEIGHT	MADAN_DPPA4_TARGETS
0.213789417424%	4	1871	46	T2D_GENES_TANYA_HEIGHT	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN
0.213789417424%	4	1871	46	T2D_GENES_TANYA_HEIGHT	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN
0.213789417424%	4	1871	45	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_PR_UP
0.213789417424%	4	1871	45	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_CD2_UP
0.213789417424%	4	1871	45	T2D_GENES_TANYA_HEIGHT	WANG_TARGETS_OF_MLL_CBP_FUSION_DN
0.213789417424%	4	1871	45	T2D_GENES_TANYA_HEIGHT	SMITH_LIVER_CANCER
0.213789417424%	4	1871	45	T2D_GENES_TANYA_HEIGHT	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP
0.213789417424%	4	1871	45	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER
0.213789417424%	4	1871	45	T2D_GENES_TANYA_HEIGHT	REACTOME_MRNA_SPLICING_MINOR_PATHWAY
0.213789417424%	4	1871	45	T2D_GENES_TANYA_HEIGHT	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
0.213789417424%	4	1871	45	T2D_GENES_TANYA_HEIGHT	LEE_AGING_MUSCLE_UP
0.213789417424%	4	1871	45	T2D_GENES_TANYA_HEIGHT	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP
0.213789417424%	4	1871	45	T2D_GENES_TANYA_HEIGHT	ABRAMSON_INTERACT_WITH_AIRE
0.213789417424%	4	1871	44	T2D_GENES_TANYA_HEIGHT	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
0.213789417424%	4	1871	44	T2D_GENES_TANYA_HEIGHT	REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_
0.213789417424%	4	1871	44	T2D_GENES_TANYA_HEIGHT	PID_HNF3APATHWAY
0.213789417424%	4	1871	44	T2D_GENES_TANYA_HEIGHT	PID_ERBB2ERBB3PATHWAY
0.213789417424%	4	1871	44	T2D_GENES_TANYA_HEIGHT	PARK_HSC_MARKERS
0.213789417424%	4	1871	44	T2D_GENES_TANYA_HEIGHT	OHGUCHI_LIVER_HNF4A_TARGETS_UP
0.213789417424%	4	1871	44	T2D_GENES_TANYA_HEIGHT	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION
0.213789417424%	4	1871	44	T2D_GENES_TANYA_HEIGHT	JAEGER_METASTASIS_UP
0.213789417424%	4	1871	44	T2D_GENES_TANYA_HEIGHT	FAELT_B_CLL_WITH_VH3_21_UP
0.213789417424%	4	1871	43	T2D_GENES_TANYA_HEIGHT	RIZ_ERYTHROID_DIFFERENTIATION_12HR
0.213789417424%	4	1871	43	T2D_GENES_TANYA_HEIGHT	REACTOME_IL_3_5_AND_GM_CSF_SIGNALING
0.213789417424%	4	1871	42	T2D_GENES_TANYA_HEIGHT	WIERENGA_PML_INTERACTOME
0.213789417424%	4	1871	42	T2D_GENES_TANYA_HEIGHT	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER
0.213789417424%	4	1871	42	T2D_GENES_TANYA_HEIGHT	LUI_THYROID_CANCER_CLUSTER_2
0.213789417424%	4	1871	42	T2D_GENES_TANYA_HEIGHT	KEGG_BLADDER_CANCER
0.213789417424%	4	1871	42	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CHREBP2_PATHWAY
0.213789417424%	4	1871	42	T2D_GENES_TANYA_HEIGHT	BILBAN_B_CLL_LPL_DN
0.213789417424%	4	1871	41	T2D_GENES_TANYA_HEIGHT	WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.213789417424%	4	1871	41	T2D_GENES_TANYA_HEIGHT	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.213789417424%	4	1871	41	T2D_GENES_TANYA_HEIGHT	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN
0.213789417424%	4	1871	41	T2D_GENES_TANYA_HEIGHT	RIZ_ERYTHROID_DIFFERENTIATION_HBZ
0.213789417424%	4	1871	41	T2D_GENES_TANYA_HEIGHT	REACTOME_NETRIN1_SIGNALING
0.213789417424%	4	1871	41	T2D_GENES_TANYA_HEIGHT	PID_AMB2_NEUTROPHILS_PATHWAY
0.213789417424%	4	1871	41	T2D_GENES_TANYA_HEIGHT	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN
0.213789417424%	4	1871	41	T2D_GENES_TANYA_HEIGHT	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS
0.213789417424%	4	1871	41	T2D_GENES_TANYA_HEIGHT	CHEN_HOXA5_TARGETS_9HR_DN
0.213789417424%	4	1871	40	T2D_GENES_TANYA_HEIGHT	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.213789417424%	4	1871	40	T2D_GENES_TANYA_HEIGHT	RIZ_ERYTHROID_DIFFERENTIATION_6HR
0.213789417424%	4	1871	40	T2D_GENES_TANYA_HEIGHT	KEGG_SPHINGOLIPID_METABOLISM
0.213789417424%	4	1871	40	T2D_GENES_TANYA_HEIGHT	KEGG_PYRUVATE_METABOLISM
0.213789417424%	4	1871	40	T2D_GENES_TANYA_HEIGHT	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER
0.213789417424%	4	1871	40	T2D_GENES_TANYA_HEIGHT	ELLWOOD_MYC_TARGETS_DN
0.213789417424%	4	1871	40	T2D_GENES_TANYA_HEIGHT	CHANGOLKAR_H2AFY_TARGETS_DN
0.213789417424%	4	1871	40	T2D_GENES_TANYA_HEIGHT	BIOCARTA_P38MAPK_PATHWAY
0.213789417424%	4	1871	39	T2D_GENES_TANYA_HEIGHT	WANG_LSD1_TARGETS_DN
0.213789417424%	4	1871	39	T2D_GENES_TANYA_HEIGHT	VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1
0.213789417424%	4	1871	39	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP
0.213789417424%	4	1871	39	T2D_GENES_TANYA_HEIGHT	MA_MYELOID_DIFFERENTIATION_UP
0.213789417424%	4	1871	39	T2D_GENES_TANYA_HEIGHT	HOFMANN_CELL_LYMPHOMA_DN
0.213789417424%	4	1871	39	T2D_GENES_TANYA_HEIGHT	HAN_JNK_SINGALING_DN
0.213789417424%	4	1871	39	T2D_GENES_TANYA_HEIGHT	DORN_ADENOVIRUS_INFECTION_32HR_DN
0.213789417424%	4	1871	38	T2D_GENES_TANYA_HEIGHT	SPIRA_SMOKERS_LUNG_CANCER_UP
0.213789417424%	4	1871	38	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER
0.213789417424%	4	1871	38	T2D_GENES_TANYA_HEIGHT	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
0.213789417424%	4	1871	38	T2D_GENES_TANYA_HEIGHT	REACTOME_PI3K_AKT_ACTIVATION
0.213789417424%	4	1871	38	T2D_GENES_TANYA_HEIGHT	REACTOME_GAB1_SIGNALOSOME
0.213789417424%	4	1871	38	T2D_GENES_TANYA_HEIGHT	ONGUSAHA_TP53_TARGETS
0.213789417424%	4	1871	38	T2D_GENES_TANYA_HEIGHT	KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT
0.213789417424%	4	1871	38	T2D_GENES_TANYA_HEIGHT	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP
0.213789417424%	4	1871	38	T2D_GENES_TANYA_HEIGHT	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP
0.213789417424%	4	1871	38	T2D_GENES_TANYA_HEIGHT	FIGUEROA_AML_METHYLATION_CLUSTER_6_DN
0.213789417424%	4	1871	38	T2D_GENES_TANYA_HEIGHT	CHANDRAN_METASTASIS_TOP50_UP
0.213789417424%	4	1871	37	T2D_GENES_TANYA_HEIGHT	VALK_AML_WITH_CEBPA
0.213789417424%	4	1871	37	T2D_GENES_TANYA_HEIGHT	ST_P38_MAPK_PATHWAY
0.213789417424%	4	1871	37	T2D_GENES_TANYA_HEIGHT	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2
0.213789417424%	4	1871	37	T2D_GENES_TANYA_HEIGHT	PID_IL23PATHWAY
0.213789417424%	4	1871	37	T2D_GENES_TANYA_HEIGHT	MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED
0.213789417424%	4	1871	37	T2D_GENES_TANYA_HEIGHT	FRASOR_RESPONSE_TO_ESTRADIOL_UP
0.213789417424%	4	1871	36	T2D_GENES_TANYA_HEIGHT	YIH_RESPONSE_TO_ARSENITE_C3
0.213789417424%	4	1871	36	T2D_GENES_TANYA_HEIGHT	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
0.213789417424%	4	1871	36	T2D_GENES_TANYA_HEIGHT	REACTOME_IRON_UPTAKE_AND_TRANSPORT
0.213789417424%	4	1871	36	T2D_GENES_TANYA_HEIGHT	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN
0.213789417424%	4	1871	36	T2D_GENES_TANYA_HEIGHT	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP
0.213789417424%	4	1871	36	T2D_GENES_TANYA_HEIGHT	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN
0.213789417424%	4	1871	35	T2D_GENES_TANYA_HEIGHT	VALK_AML_CLUSTER_9
0.213789417424%	4	1871	35	T2D_GENES_TANYA_HEIGHT	REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION
0.213789417424%	4	1871	35	T2D_GENES_TANYA_HEIGHT	LIEN_BREAST_CARCINOMA_METAPLASTIC
0.213789417424%	4	1871	35	T2D_GENES_TANYA_HEIGHT	KEGG_PRIMARY_IMMUNODEFICIENCY
0.213789417424%	4	1871	35	T2D_GENES_TANYA_HEIGHT	KEGG_BASE_EXCISION_REPAIR
0.213789417424%	4	1871	35	T2D_GENES_TANYA_HEIGHT	HAN_JNK_SINGALING_UP
0.213789417424%	4	1871	35	T2D_GENES_TANYA_HEIGHT	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN
0.213789417424%	4	1871	35	T2D_GENES_TANYA_HEIGHT	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP
0.213789417424%	4	1871	35	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CARM_ER_PATHWAY
0.213789417424%	4	1871	34	T2D_GENES_TANYA_HEIGHT	SUMI_HNF4A_TARGETS
0.213789417424%	4	1871	34	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.213789417424%	4	1871	34	T2D_GENES_TANYA_HEIGHT	LUI_TARGETS_OF_PAX8_PPARG_FUSION
0.213789417424%	4	1871	34	T2D_GENES_TANYA_HEIGHT	FRIDMAN_IMMORTALIZATION_DN
0.213789417424%	4	1871	34	T2D_GENES_TANYA_HEIGHT	ABE_VEGFA_TARGETS_2HR
0.213789417424%	4	1871	33	T2D_GENES_TANYA_HEIGHT	ZHAN_LATE_DIFFERENTIATION_GENES_UP
0.213789417424%	4	1871	33	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT
0.213789417424%	4	1871	33	T2D_GENES_TANYA_HEIGHT	REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS
0.213789417424%	4	1871	33	T2D_GENES_TANYA_HEIGHT	JEPSEN_SMRT_TARGETS
0.213789417424%	4	1871	33	T2D_GENES_TANYA_HEIGHT	HEIDENBLAD_AMPLICON_12P11_12_UP
0.213789417424%	4	1871	33	T2D_GENES_TANYA_HEIGHT	GHANDHI_DIRECT_IRRADIATION_DN
0.213789417424%	4	1871	33	T2D_GENES_TANYA_HEIGHT	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN
0.213789417424%	4	1871	33	T2D_GENES_TANYA_HEIGHT	CAFFAREL_RESPONSE_TO_THC_UP
0.213789417424%	4	1871	33	T2D_GENES_TANYA_HEIGHT	BIOCARTA_NO1_PATHWAY
0.213789417424%	4	1871	33	T2D_GENES_TANYA_HEIGHT	BIOCARTA_DEATH_PATHWAY
0.213789417424%	4	1871	32	T2D_GENES_TANYA_HEIGHT	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN
0.213789417424%	4	1871	32	T2D_GENES_TANYA_HEIGHT	REACTOME_CD28_CO_STIMULATION
0.213789417424%	4	1871	32	T2D_GENES_TANYA_HEIGHT	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN
0.213789417424%	4	1871	32	T2D_GENES_TANYA_HEIGHT	MEISSNER_BRAIN_ICP_WITH_H3K4ME3
0.213789417424%	4	1871	32	T2D_GENES_TANYA_HEIGHT	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM
0.213789417424%	4	1871	32	T2D_GENES_TANYA_HEIGHT	KASLER_HDAC7_TARGETS_2_DN
0.213789417424%	4	1871	32	T2D_GENES_TANYA_HEIGHT	FARDIN_HYPOXIA_11
0.213789417424%	4	1871	32	T2D_GENES_TANYA_HEIGHT	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN
0.213789417424%	4	1871	32	T2D_GENES_TANYA_HEIGHT	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN
0.213789417424%	4	1871	31	T2D_GENES_TANYA_HEIGHT	TING_SILENCED_BY_DICER
0.213789417424%	4	1871	31	T2D_GENES_TANYA_HEIGHT	THEODOROU_MAMMARY_TUMORIGENESIS
0.213789417424%	4	1871	31	T2D_GENES_TANYA_HEIGHT	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN
0.213789417424%	4	1871	31	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES
0.213789417424%	4	1871	31	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE
0.213789417424%	4	1871	31	T2D_GENES_TANYA_HEIGHT	REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS
0.213789417424%	4	1871	31	T2D_GENES_TANYA_HEIGHT	REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING
0.213789417424%	4	1871	31	T2D_GENES_TANYA_HEIGHT	PID_P38ALPHABETAPATHWAY
0.213789417424%	4	1871	31	T2D_GENES_TANYA_HEIGHT	PID_AURORA_A_PATHWAY
0.213789417424%	4	1871	31	T2D_GENES_TANYA_HEIGHT	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.213789417424%	4	1871	31	T2D_GENES_TANYA_HEIGHT	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD
0.213789417424%	4	1871	31	T2D_GENES_TANYA_HEIGHT	CUI_TCF21_TARGETS_DN
0.213789417424%	4	1871	31	T2D_GENES_TANYA_HEIGHT	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
0.213789417424%	4	1871	30	T2D_GENES_TANYA_HEIGHT	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP
0.213789417424%	4	1871	30	T2D_GENES_TANYA_HEIGHT	URS_ADIPOCYTE_DIFFERENTIATION_DN
0.213789417424%	4	1871	30	T2D_GENES_TANYA_HEIGHT	SU_PLACENTA
0.213789417424%	4	1871	30	T2D_GENES_TANYA_HEIGHT	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
0.213789417424%	4	1871	30	T2D_GENES_TANYA_HEIGHT	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION
0.213789417424%	4	1871	30	T2D_GENES_TANYA_HEIGHT	REACTOME_NOD1_2_SIGNALING_PATHWAY
0.213789417424%	4	1871	30	T2D_GENES_TANYA_HEIGHT	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES
0.213789417424%	4	1871	30	T2D_GENES_TANYA_HEIGHT	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
0.213789417424%	4	1871	30	T2D_GENES_TANYA_HEIGHT	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN
0.213789417424%	4	1871	30	T2D_GENES_TANYA_HEIGHT	PID_CDC42_REG_PATHWAY
0.213789417424%	4	1871	30	T2D_GENES_TANYA_HEIGHT	LI_PROSTATE_CANCER_EPIGENETIC
0.213789417424%	4	1871	30	T2D_GENES_TANYA_HEIGHT	GUILLAUMOND_KLF10_TARGETS_DN
0.213789417424%	4	1871	30	T2D_GENES_TANYA_HEIGHT	GILDEA_METASTASIS
0.213789417424%	4	1871	29	T2D_GENES_TANYA_HEIGHT	YU_BAP1_TARGETS
0.213789417424%	4	1871	29	T2D_GENES_TANYA_HEIGHT	WOTTON_RUNX_TARGETS_DN
0.213789417424%	4	1871	29	T2D_GENES_TANYA_HEIGHT	WANG_RESPONSE_TO_ANDROGEN_UP
0.213789417424%	4	1871	29	T2D_GENES_TANYA_HEIGHT	REACTOME_STEROID_HORMONES
0.213789417424%	4	1871	29	T2D_GENES_TANYA_HEIGHT	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
0.213789417424%	4	1871	29	T2D_GENES_TANYA_HEIGHT	REACTOME_PERK_REGULATED_GENE_EXPRESSION
0.213789417424%	4	1871	29	T2D_GENES_TANYA_HEIGHT	PID_S1P_S1P3_PATHWAY
0.213789417424%	4	1871	29	T2D_GENES_TANYA_HEIGHT	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6
0.213789417424%	4	1871	29	T2D_GENES_TANYA_HEIGHT	PATTERSON_DOCETAXEL_RESISTANCE
0.213789417424%	4	1871	29	T2D_GENES_TANYA_HEIGHT	MA_PITUITARY_FETAL_VS_ADULT_UP
0.213789417424%	4	1871	29	T2D_GENES_TANYA_HEIGHT	MARSHALL_VIRAL_INFECTION_RESPONSE_DN
0.213789417424%	4	1871	29	T2D_GENES_TANYA_HEIGHT	LU_TUMOR_VASCULATURE_UP
0.213789417424%	4	1871	29	T2D_GENES_TANYA_HEIGHT	DALESSIO_TSA_RESPONSE
0.213789417424%	4	1871	29	T2D_GENES_TANYA_HEIGHT	BIOCARTA_VEGF_PATHWAY
0.213789417424%	4	1871	28	T2D_GENES_TANYA_HEIGHT	VALK_AML_CLUSTER_1
0.213789417424%	4	1871	28	T2D_GENES_TANYA_HEIGHT	TERAO_AOX4_TARGETS_HG_UP
0.213789417424%	4	1871	28	T2D_GENES_TANYA_HEIGHT	SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER
0.213789417424%	4	1871	28	T2D_GENES_TANYA_HEIGHT	REICHERT_MITOSIS_LIN9_TARGETS
0.213789417424%	4	1871	28	T2D_GENES_TANYA_HEIGHT	REACTOME_SHC_MEDIATED_CASCADE
0.213789417424%	4	1871	28	T2D_GENES_TANYA_HEIGHT	REACTOME_MYOGENESIS
0.213789417424%	4	1871	28	T2D_GENES_TANYA_HEIGHT	PID_WNT_SIGNALING_PATHWAY
0.213789417424%	4	1871	28	T2D_GENES_TANYA_HEIGHT	PID_LIS1PATHWAY
0.213789417424%	4	1871	28	T2D_GENES_TANYA_HEIGHT	DAZARD_UV_RESPONSE_CLUSTER_G24
0.213789417424%	4	1871	28	T2D_GENES_TANYA_HEIGHT	BIOCARTA_GH_PATHWAY
0.213789417424%	4	1871	27	T2D_GENES_TANYA_HEIGHT	TERAO_AOX4_TARGETS_SKIN_DN
0.213789417424%	4	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION
0.213789417424%	4	1871	27	T2D_GENES_TANYA_HEIGHT	OHM_METHYLATED_IN_ADULT_CANCERS
0.213789417424%	4	1871	27	T2D_GENES_TANYA_HEIGHT	LOPES_METHYLATED_IN_COLON_CANCER_UP
0.213789417424%	4	1871	27	T2D_GENES_TANYA_HEIGHT	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP
0.213789417424%	4	1871	27	T2D_GENES_TANYA_HEIGHT	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN
0.213789417424%	4	1871	26	T2D_GENES_TANYA_HEIGHT	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS
0.213789417424%	4	1871	26	T2D_GENES_TANYA_HEIGHT	REACTOME_KERATAN_SULFATE_BIOSYNTHESIS
0.213789417424%	4	1871	26	T2D_GENES_TANYA_HEIGHT	PID_VEGFR1_PATHWAY
0.213789417424%	4	1871	26	T2D_GENES_TANYA_HEIGHT	PID_IL27PATHWAY
0.213789417424%	4	1871	26	T2D_GENES_TANYA_HEIGHT	FINAK_BREAST_CANCER_SDPP_SIGNATURE
0.213789417424%	4	1871	26	T2D_GENES_TANYA_HEIGHT	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
0.213789417424%	4	1871	26	T2D_GENES_TANYA_HEIGHT	DEN_INTERACT_WITH_LCA5
0.213789417424%	4	1871	26	T2D_GENES_TANYA_HEIGHT	BIOCARTA_BAD_PATHWAY
0.213789417424%	4	1871	25	T2D_GENES_TANYA_HEIGHT	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP
0.213789417424%	4	1871	25	T2D_GENES_TANYA_HEIGHT	WANG_NFKB_TARGETS
0.213789417424%	4	1871	25	T2D_GENES_TANYA_HEIGHT	WANG_BARRETTS_ESOPHAGUS_DN
0.213789417424%	4	1871	25	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING
0.213789417424%	4	1871	25	T2D_GENES_TANYA_HEIGHT	REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE
0.213789417424%	4	1871	25	T2D_GENES_TANYA_HEIGHT	REACTOME_FANCONI_ANEMIA_PATHWAY
0.213789417424%	4	1871	25	T2D_GENES_TANYA_HEIGHT	PID_MYC_PATHWAY
0.213789417424%	4	1871	25	T2D_GENES_TANYA_HEIGHT	OZEN_MIR125B1_TARGETS
0.213789417424%	4	1871	25	T2D_GENES_TANYA_HEIGHT	KEGG_DORSO_VENTRAL_AXIS_FORMATION
0.213789417424%	4	1871	25	T2D_GENES_TANYA_HEIGHT	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN
0.213789417424%	4	1871	25	T2D_GENES_TANYA_HEIGHT	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS
0.213789417424%	4	1871	24	T2D_GENES_TANYA_HEIGHT	WANG_LSD1_TARGETS_UP
0.213789417424%	4	1871	24	T2D_GENES_TANYA_HEIGHT	REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION
0.213789417424%	4	1871	24	T2D_GENES_TANYA_HEIGHT	REACTOME_DOUBLE_STRAND_BREAK_REPAIR
0.213789417424%	4	1871	24	T2D_GENES_TANYA_HEIGHT	REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION
0.213789417424%	4	1871	24	T2D_GENES_TANYA_HEIGHT	PETRETTO_HEART_MASS_QTL_CIS_DN
0.213789417424%	4	1871	24	T2D_GENES_TANYA_HEIGHT	JIANG_TIP30_TARGETS_DN
0.213789417424%	4	1871	24	T2D_GENES_TANYA_HEIGHT	JEON_SMAD6_TARGETS_UP
0.213789417424%	4	1871	24	T2D_GENES_TANYA_HEIGHT	GOLUB_ALL_VS_AML_DN
0.213789417424%	4	1871	23	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_BMP
0.213789417424%	4	1871	23	T2D_GENES_TANYA_HEIGHT	REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING
0.213789417424%	4	1871	23	T2D_GENES_TANYA_HEIGHT	PID_NFKAPPABCANONICALPATHWAY
0.213789417424%	4	1871	23	T2D_GENES_TANYA_HEIGHT	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION
0.213789417424%	4	1871	23	T2D_GENES_TANYA_HEIGHT	HINATA_NFKB_TARGETS_KERATINOCYTE_DN
0.213789417424%	4	1871	23	T2D_GENES_TANYA_HEIGHT	BIOCARTA_PTDINS_PATHWAY
0.213789417424%	4	1871	23	T2D_GENES_TANYA_HEIGHT	BIOCARTA_NFKB_PATHWAY
0.213789417424%	4	1871	22	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_SPIKED
0.213789417424%	4	1871	22	T2D_GENES_TANYA_HEIGHT	VALK_AML_WITH_11Q23_REARRANGED
0.213789417424%	4	1871	22	T2D_GENES_TANYA_HEIGHT	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN
0.213789417424%	4	1871	22	T2D_GENES_TANYA_HEIGHT	REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION
0.213789417424%	4	1871	22	T2D_GENES_TANYA_HEIGHT	NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON
0.213789417424%	4	1871	22	T2D_GENES_TANYA_HEIGHT	LU_TUMOR_ENDOTHELIAL_MARKERS_UP
0.213789417424%	4	1871	22	T2D_GENES_TANYA_HEIGHT	BIOCARTA_AKT_PATHWAY
0.213789417424%	4	1871	21	T2D_GENES_TANYA_HEIGHT	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP
0.213789417424%	4	1871	21	T2D_GENES_TANYA_HEIGHT	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC
0.213789417424%	4	1871	21	T2D_GENES_TANYA_HEIGHT	BIOCARTA_NDKDYNAMIN_PATHWAY
0.213789417424%	4	1871	21	T2D_GENES_TANYA_HEIGHT	BIOCARTA_ATRBRCA_PATHWAY
0.213789417424%	4	1871	20	T2D_GENES_TANYA_HEIGHT	ZEMBUTSU_SENSITIVITY_TO_CISPLATIN
0.213789417424%	4	1871	20	T2D_GENES_TANYA_HEIGHT	SESTO_RESPONSE_TO_UV_C4
0.213789417424%	4	1871	20	T2D_GENES_TANYA_HEIGHT	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA
0.213789417424%	4	1871	20	T2D_GENES_TANYA_HEIGHT	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP
0.213789417424%	4	1871	20	T2D_GENES_TANYA_HEIGHT	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN
0.213789417424%	4	1871	20	T2D_GENES_TANYA_HEIGHT	MCCABE_HOXC6_TARGETS_CANCER_DN
0.213789417424%	4	1871	20	T2D_GENES_TANYA_HEIGHT	HASLINGER_B_CLL_WITH_6Q21_DELETION
0.213789417424%	4	1871	20	T2D_GENES_TANYA_HEIGHT	DE_YY1_TARGETS_UP
0.213789417424%	4	1871	20	T2D_GENES_TANYA_HEIGHT	BIOCARTA_ATM_PATHWAY
0.213789417424%	4	1871	19	T2D_GENES_TANYA_HEIGHT	SYED_ESTRADIOL_RESPONSE
0.213789417424%	4	1871	19	T2D_GENES_TANYA_HEIGHT	REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR
0.213789417424%	4	1871	19	T2D_GENES_TANYA_HEIGHT	REACTOME_BASE_EXCISION_REPAIR
0.213789417424%	4	1871	19	T2D_GENES_TANYA_HEIGHT	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP
0.213789417424%	4	1871	19	T2D_GENES_TANYA_HEIGHT	LEE_NAIVE_T_LYMPHOCYTE
0.213789417424%	4	1871	19	T2D_GENES_TANYA_HEIGHT	HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN
0.213789417424%	4	1871	19	T2D_GENES_TANYA_HEIGHT	BIOCARTA_TID_PATHWAY
0.213789417424%	4	1871	19	T2D_GENES_TANYA_HEIGHT	BIOCARTA_COMP_PATHWAY
0.213789417424%	4	1871	19	T2D_GENES_TANYA_HEIGHT	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
0.213789417424%	4	1871	18	T2D_GENES_TANYA_HEIGHT	YIH_RESPONSE_TO_ARSENITE_C4
0.213789417424%	4	1871	18	T2D_GENES_TANYA_HEIGHT	REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI
0.213789417424%	4	1871	18	T2D_GENES_TANYA_HEIGHT	REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK
0.213789417424%	4	1871	18	T2D_GENES_TANYA_HEIGHT	LE_NEURONAL_DIFFERENTIATION_UP
0.213789417424%	4	1871	18	T2D_GENES_TANYA_HEIGHT	BIOCARTA_TNFR2_PATHWAY
0.213789417424%	4	1871	17	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE
0.213789417424%	4	1871	17	T2D_GENES_TANYA_HEIGHT	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY
0.213789417424%	4	1871	17	T2D_GENES_TANYA_HEIGHT	REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS
0.213789417424%	4	1871	17	T2D_GENES_TANYA_HEIGHT	REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP
0.213789417424%	4	1871	17	T2D_GENES_TANYA_HEIGHT	BIOCARTA_PML_PATHWAY
0.213789417424%	4	1871	17	T2D_GENES_TANYA_HEIGHT	BIOCARTA_41BB_PATHWAY
0.213789417424%	4	1871	16	T2D_GENES_TANYA_HEIGHT	WU_HBX_TARGETS_2_DN
0.213789417424%	4	1871	16	T2D_GENES_TANYA_HEIGHT	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION
0.213789417424%	4	1871	16	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS
0.213789417424%	4	1871	16	T2D_GENES_TANYA_HEIGHT	REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS
0.213789417424%	4	1871	16	T2D_GENES_TANYA_HEIGHT	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA
0.213789417424%	4	1871	16	T2D_GENES_TANYA_HEIGHT	LY_AGING_MIDDLE_DN
0.213789417424%	4	1871	15	T2D_GENES_TANYA_HEIGHT	SA_MMP_CYTOKINE_CONNECTION
0.213789417424%	4	1871	15	T2D_GENES_TANYA_HEIGHT	REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS
0.213789417424%	4	1871	15	T2D_GENES_TANYA_HEIGHT	PID_THROMBIN_PAR4_PATHWAY
0.213789417424%	4	1871	15	T2D_GENES_TANYA_HEIGHT	MARKS_ACETYLATED_NON_HISTONE_PROTEINS
0.213789417424%	4	1871	15	T2D_GENES_TANYA_HEIGHT	KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION
0.213789417424%	4	1871	15	T2D_GENES_TANYA_HEIGHT	EHRLICH_ICF_SYNDROM_DN
0.213789417424%	4	1871	15	T2D_GENES_TANYA_HEIGHT	BIOCARTA_TALL1_PATHWAY
0.213789417424%	4	1871	15	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CTL_PATHWAY
0.213789417424%	4	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_PROLACTIN_RECEPTOR_SIGNALING
0.213789417424%	4	1871	14	T2D_GENES_TANYA_HEIGHT	PARK_APL_PATHOGENESIS_UP
0.213789417424%	4	1871	14	T2D_GENES_TANYA_HEIGHT	MATZUK_OVULATION
0.213789417424%	4	1871	14	T2D_GENES_TANYA_HEIGHT	GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.213789417424%	4	1871	13	T2D_GENES_TANYA_HEIGHT	REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION
0.213789417424%	4	1871	13	T2D_GENES_TANYA_HEIGHT	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS
0.213789417424%	4	1871	13	T2D_GENES_TANYA_HEIGHT	BIOCARTA_P27_PATHWAY
0.213789417424%	4	1871	120	T2D_GENES_TANYA_HEIGHT	REACTOME_CELL_CELL_COMMUNICATION
0.213789417424%	4	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10
0.213789417424%	4	1871	12	T2D_GENES_TANYA_HEIGHT	FIGUEROA_AML_METHYLATION_CLUSTER_5_UP
0.213789417424%	4	1871	12	T2D_GENES_TANYA_HEIGHT	DAZARD_UV_RESPONSE_CLUSTER_G5
0.213789417424%	4	1871	12	T2D_GENES_TANYA_HEIGHT	BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1
0.213789417424%	4	1871	115	T2D_GENES_TANYA_HEIGHT	HOELZEL_NF1_TARGETS_DN
0.213789417424%	4	1871	111	T2D_GENES_TANYA_HEIGHT	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.213789417424%	4	1871	110	T2D_GENES_TANYA_HEIGHT	CHENG_IMPRINTED_BY_ESTRADIOL
0.213789417424%	4	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_KERATAN_SULFATE_DEGRADATION
0.213789417424%	4	1871	11	T2D_GENES_TANYA_HEIGHT	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12
0.213789417424%	4	1871	11	T2D_GENES_TANYA_HEIGHT	MATHEW_FANCONI_ANEMIA_GENES
0.213789417424%	4	1871	11	T2D_GENES_TANYA_HEIGHT	KEGG_FOLATE_BIOSYNTHESIS
0.213789417424%	4	1871	102	T2D_GENES_TANYA_HEIGHT	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.213789417424%	4	1871	10	T2D_GENES_TANYA_HEIGHT	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN
0.213789417424%	4	1871	10	T2D_GENES_TANYA_HEIGHT	BIOCARTA_IL5_PATHWAY
0.202634245187%	4	1974	9	Mendelian_Nancy_Cox	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP
0.202634245187%	4	1974	9	Mendelian_Nancy_Cox	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK
0.202634245187%	4	1974	9	Mendelian_Nancy_Cox	OXFORD_RALA_AND_RALB_TARGETS_DN
0.202634245187%	4	1974	84	Mendelian_Nancy_Cox	REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S
0.202634245187%	4	1974	8	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9
0.202634245187%	4	1974	8	Mendelian_Nancy_Cox	LE_SKI_TARGETS_DN
0.202634245187%	4	1974	8	Mendelian_Nancy_Cox	GROSS_HYPOXIA_VIA_HIF1A_ONLY
0.202634245187%	4	1974	8	Mendelian_Nancy_Cox	GROSS_HIF1A_TARGETS_UP
0.202634245187%	4	1974	8	Mendelian_Nancy_Cox	BIOCARTA_KREB_PATHWAY
0.202634245187%	4	1974	76	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
0.202634245187%	4	1974	72	Mendelian_Nancy_Cox	SESTO_RESPONSE_TO_UV_C1
0.202634245187%	4	1974	70	Mendelian_Nancy_Cox	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450
0.202634245187%	4	1974	7	Mendelian_Nancy_Cox	TESAR_ALK_TARGETS_EPISC_4D_UP
0.202634245187%	4	1974	7	Mendelian_Nancy_Cox	TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP
0.202634245187%	4	1974	7	Mendelian_Nancy_Cox	MIKKELSEN_DEDIFFERENTIATED_STATE_DN
0.202634245187%	4	1974	7	Mendelian_Nancy_Cox	MATZUK_STEROIDOGENESIS
0.202634245187%	4	1974	7	Mendelian_Nancy_Cox	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.202634245187%	4	1974	7	Mendelian_Nancy_Cox	ABBUD_LIF_SIGNALING_2_DN
0.202634245187%	4	1974	68	Mendelian_Nancy_Cox	BASSO_CD40_SIGNALING_DN
0.202634245187%	4	1974	67	Mendelian_Nancy_Cox	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP
0.202634245187%	4	1974	65	Mendelian_Nancy_Cox	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
0.202634245187%	4	1974	64	Mendelian_Nancy_Cox	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS
0.202634245187%	4	1974	61	Mendelian_Nancy_Cox	GENTILE_RESPONSE_CLUSTER_D3
0.202634245187%	4	1974	60	Mendelian_Nancy_Cox	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
0.202634245187%	4	1974	6	Mendelian_Nancy_Cox	DING_LUNG_CANCER_MUTATED_RECURRENTLY
0.202634245187%	4	1974	58	Mendelian_Nancy_Cox	NAGASHIMA_EGF_SIGNALING_UP
0.202634245187%	4	1974	58	Mendelian_Nancy_Cox	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN
0.202634245187%	4	1974	58	Mendelian_Nancy_Cox	KEGG_ARACHIDONIC_ACID_METABOLISM
0.202634245187%	4	1974	57	Mendelian_Nancy_Cox	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN
0.202634245187%	4	1974	57	Mendelian_Nancy_Cox	REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE
0.202634245187%	4	1974	57	Mendelian_Nancy_Cox	GRABARCZYK_BCL11B_TARGETS_DN
0.202634245187%	4	1974	56	Mendelian_Nancy_Cox	MAYBURD_RESPONSE_TO_L663536_DN
0.202634245187%	4	1974	55	Mendelian_Nancy_Cox	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53
0.202634245187%	4	1974	54	Mendelian_Nancy_Cox	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP
0.202634245187%	4	1974	53	Mendelian_Nancy_Cox	ISHIDA_E2F_TARGETS
0.202634245187%	4	1974	53	Mendelian_Nancy_Cox	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN
0.202634245187%	4	1974	52	Mendelian_Nancy_Cox	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6
0.202634245187%	4	1974	52	Mendelian_Nancy_Cox	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP
0.202634245187%	4	1974	51	Mendelian_Nancy_Cox	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT
0.202634245187%	4	1974	51	Mendelian_Nancy_Cox	MORI_PLASMA_CELL_UP
0.202634245187%	4	1974	50	Mendelian_Nancy_Cox	DAUER_STAT3_TARGETS_DN
0.202634245187%	4	1974	47	Mendelian_Nancy_Cox	SILIGAN_BOUND_BY_EWS_FLT1_FUSION
0.202634245187%	4	1974	47	Mendelian_Nancy_Cox	POTTI_DOCETAXEL_SENSITIVITY
0.202634245187%	4	1974	47	Mendelian_Nancy_Cox	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.202634245187%	4	1974	46	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_CD2_DN
0.202634245187%	4	1974	46	Mendelian_Nancy_Cox	MADAN_DPPA4_TARGETS
0.202634245187%	4	1974	46	Mendelian_Nancy_Cox	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN
0.202634245187%	4	1974	45	Mendelian_Nancy_Cox	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_
0.202634245187%	4	1974	45	Mendelian_Nancy_Cox	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN
0.202634245187%	4	1974	45	Mendelian_Nancy_Cox	CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY
0.202634245187%	4	1974	44	Mendelian_Nancy_Cox	WANG_TARGETS_OF_MLL_CBP_FUSION_UP
0.202634245187%	4	1974	44	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS
0.202634245187%	4	1974	44	Mendelian_Nancy_Cox	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS
0.202634245187%	4	1974	44	Mendelian_Nancy_Cox	GROSS_HYPOXIA_VIA_ELK3_ONLY_DN
0.202634245187%	4	1974	44	Mendelian_Nancy_Cox	FARMER_BREAST_CANCER_CLUSTER_1
0.202634245187%	4	1974	44	Mendelian_Nancy_Cox	CHUNG_BLISTER_CYTOTOXICITY_DN
0.202634245187%	4	1974	44	Mendelian_Nancy_Cox	CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY
0.202634245187%	4	1974	43	Mendelian_Nancy_Cox	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN
0.202634245187%	4	1974	43	Mendelian_Nancy_Cox	AMIT_EGF_RESPONSE_480_MCF10A
0.202634245187%	4	1974	42	Mendelian_Nancy_Cox	BIOCARTA_CHREBP2_PATHWAY
0.202634245187%	4	1974	42	Mendelian_Nancy_Cox	BILBAN_B_CLL_LPL_DN
0.202634245187%	4	1974	41	Mendelian_Nancy_Cox	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.202634245187%	4	1974	41	Mendelian_Nancy_Cox	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN
0.202634245187%	4	1974	41	Mendelian_Nancy_Cox	REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING
0.202634245187%	4	1974	41	Mendelian_Nancy_Cox	LI_LUNG_CANCER
0.202634245187%	4	1974	41	Mendelian_Nancy_Cox	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN
0.202634245187%	4	1974	40	Mendelian_Nancy_Cox	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS
0.202634245187%	4	1974	40	Mendelian_Nancy_Cox	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER
0.202634245187%	4	1974	40	Mendelian_Nancy_Cox	AMUNDSON_GAMMA_RADIATION_RESPONSE
0.202634245187%	4	1974	39	Mendelian_Nancy_Cox	VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN
0.202634245187%	4	1974	39	Mendelian_Nancy_Cox	KORKOLA_TERATOMA
0.202634245187%	4	1974	39	Mendelian_Nancy_Cox	GENTILE_UV_RESPONSE_CLUSTER_D5
0.202634245187%	4	1974	39	Mendelian_Nancy_Cox	CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP
0.202634245187%	4	1974	39	Mendelian_Nancy_Cox	BILANGES_RAPAMYCIN_SENSITIVE_GENES
0.202634245187%	4	1974	389	Mendelian_Nancy_Cox	KEGG_OLFACTORY_TRANSDUCTION
0.202634245187%	4	1974	38	Mendelian_Nancy_Cox	REACTOME_GABA_B_RECEPTOR_ACTIVATION
0.202634245187%	4	1974	38	Mendelian_Nancy_Cox	REACTOME_G1_PHASE
0.202634245187%	4	1974	38	Mendelian_Nancy_Cox	PID_RAC1_REG_PATHWAY
0.202634245187%	4	1974	38	Mendelian_Nancy_Cox	KYNG_DNA_DAMAGE_BY_4NQO
0.202634245187%	4	1974	38	Mendelian_Nancy_Cox	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP
0.202634245187%	4	1974	38	Mendelian_Nancy_Cox	APPIERTO_RESPONSE_TO_FENRETINIDE_UP
0.202634245187%	4	1974	37	Mendelian_Nancy_Cox	MATZUK_SPERMATID_DIFFERENTIATION
0.202634245187%	4	1974	36	Mendelian_Nancy_Cox	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION
0.202634245187%	4	1974	36	Mendelian_Nancy_Cox	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN
0.202634245187%	4	1974	35	Mendelian_Nancy_Cox	JAZAG_TGFB1_SIGNALING_DN
0.202634245187%	4	1974	35	Mendelian_Nancy_Cox	HU_GENOTOXIC_DAMAGE_24HR
0.202634245187%	4	1974	34	Mendelian_Nancy_Cox	SUMI_HNF4A_TARGETS
0.202634245187%	4	1974	34	Mendelian_Nancy_Cox	JIANG_HYPOXIA_VIA_VHL
0.202634245187%	4	1974	34	Mendelian_Nancy_Cox	HONMA_DOCETAXEL_RESISTANCE
0.202634245187%	4	1974	34	Mendelian_Nancy_Cox	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP
0.202634245187%	4	1974	34	Mendelian_Nancy_Cox	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP
0.202634245187%	4	1974	34	Mendelian_Nancy_Cox	BIOCARTA_MPR_PATHWAY
0.202634245187%	4	1974	33	Mendelian_Nancy_Cox	VALK_AML_CLUSTER_6
0.202634245187%	4	1974	33	Mendelian_Nancy_Cox	VALK_AML_CLUSTER_3
0.202634245187%	4	1974	33	Mendelian_Nancy_Cox	REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT
0.202634245187%	4	1974	33	Mendelian_Nancy_Cox	REACTOME_RNA_POL_III_TRANSCRIPTION
0.202634245187%	4	1974	33	Mendelian_Nancy_Cox	PID_INTEGRIN_A4B1_PATHWAY
0.202634245187%	4	1974	33	Mendelian_Nancy_Cox	MORI_PLASMA_CELL_DN
0.202634245187%	4	1974	33	Mendelian_Nancy_Cox	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN
0.202634245187%	4	1974	33	Mendelian_Nancy_Cox	GHANDHI_DIRECT_IRRADIATION_DN
0.202634245187%	4	1974	33	Mendelian_Nancy_Cox	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN
0.202634245187%	4	1974	33	Mendelian_Nancy_Cox	FIRESTEIN_CTNNB1_PATHWAY
0.202634245187%	4	1974	33	Mendelian_Nancy_Cox	CAFFAREL_RESPONSE_TO_THC_UP
0.202634245187%	4	1974	33	Mendelian_Nancy_Cox	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN
0.202634245187%	4	1974	32	Mendelian_Nancy_Cox	PID_NETRIN_PATHWAY
0.202634245187%	4	1974	32	Mendelian_Nancy_Cox	DIRMEIER_LMP1_RESPONSE_LATE_DN
0.202634245187%	4	1974	31	Mendelian_Nancy_Cox	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP
0.202634245187%	4	1974	31	Mendelian_Nancy_Cox	TING_SILENCED_BY_DICER
0.202634245187%	4	1974	31	Mendelian_Nancy_Cox	RIZ_ERYTHROID_DIFFERENTIATION_HEMGN
0.202634245187%	4	1974	31	Mendelian_Nancy_Cox	REACTOME_SIGNAL_AMPLIFICATION
0.202634245187%	4	1974	31	Mendelian_Nancy_Cox	PID_NEPHRIN_NEPH1_PATHWAY
0.202634245187%	4	1974	31	Mendelian_Nancy_Cox	NOJIMA_SFRP2_TARGETS_UP
0.202634245187%	4	1974	31	Mendelian_Nancy_Cox	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.202634245187%	4	1974	31	Mendelian_Nancy_Cox	IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM
0.202634245187%	4	1974	31	Mendelian_Nancy_Cox	HUNSBERGER_EXERCISE_REGULATED_GENES
0.202634245187%	4	1974	31	Mendelian_Nancy_Cox	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
0.202634245187%	4	1974	30	Mendelian_Nancy_Cox	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN
0.202634245187%	4	1974	30	Mendelian_Nancy_Cox	YANAGIHARA_ESX1_TARGETS
0.202634245187%	4	1974	30	Mendelian_Nancy_Cox	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP
0.202634245187%	4	1974	30	Mendelian_Nancy_Cox	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN
0.202634245187%	4	1974	30	Mendelian_Nancy_Cox	REACTOME_NOD1_2_SIGNALING_PATHWAY
0.202634245187%	4	1974	30	Mendelian_Nancy_Cox	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN
0.202634245187%	4	1974	30	Mendelian_Nancy_Cox	KEGG_ASTHMA
0.202634245187%	4	1974	30	Mendelian_Nancy_Cox	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP
0.202634245187%	4	1974	29	Mendelian_Nancy_Cox	WILENSKY_RESPONSE_TO_DARAPLADIB
0.202634245187%	4	1974	29	Mendelian_Nancy_Cox	WANG_RESPONSE_TO_ANDROGEN_UP
0.202634245187%	4	1974	29	Mendelian_Nancy_Cox	VALK_AML_CLUSTER_2
0.202634245187%	4	1974	29	Mendelian_Nancy_Cox	ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.202634245187%	4	1974	29	Mendelian_Nancy_Cox	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN
0.202634245187%	4	1974	29	Mendelian_Nancy_Cox	PID_TCRCALCIUMPATHWAY
0.202634245187%	4	1974	29	Mendelian_Nancy_Cox	PAL_PRMT5_TARGETS_DN
0.202634245187%	4	1974	29	Mendelian_Nancy_Cox	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
0.202634245187%	4	1974	29	Mendelian_Nancy_Cox	LU_TUMOR_VASCULATURE_UP
0.202634245187%	4	1974	28	Mendelian_Nancy_Cox	REACTOME_MYOGENESIS
0.202634245187%	4	1974	28	Mendelian_Nancy_Cox	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING
0.202634245187%	4	1974	28	Mendelian_Nancy_Cox	OLSSON_E2F3_TARGETS_UP
0.202634245187%	4	1974	28	Mendelian_Nancy_Cox	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP
0.202634245187%	4	1974	27	Mendelian_Nancy_Cox	ST_GRANULE_CELL_SURVIVAL_PATHWAY
0.202634245187%	4	1974	27	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN
0.202634245187%	4	1974	27	Mendelian_Nancy_Cox	REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS
0.202634245187%	4	1974	27	Mendelian_Nancy_Cox	REACTOME_RECYCLING_PATHWAY_OF_L1
0.202634245187%	4	1974	27	Mendelian_Nancy_Cox	REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY
0.202634245187%	4	1974	27	Mendelian_Nancy_Cox	PID_IL3_PATHWAY
0.202634245187%	4	1974	27	Mendelian_Nancy_Cox	AKL_HTLV1_INFECTION_UP
0.202634245187%	4	1974	26	Mendelian_Nancy_Cox	ZHENG_FOXP3_TARGETS_UP
0.202634245187%	4	1974	26	Mendelian_Nancy_Cox	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.202634245187%	4	1974	26	Mendelian_Nancy_Cox	WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG
0.202634245187%	4	1974	26	Mendelian_Nancy_Cox	VALK_AML_CLUSTER_16
0.202634245187%	4	1974	26	Mendelian_Nancy_Cox	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER
0.202634245187%	4	1974	26	Mendelian_Nancy_Cox	REACTOME_KERATAN_SULFATE_BIOSYNTHESIS
0.202634245187%	4	1974	26	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_5P15_AMPLICON
0.202634245187%	4	1974	26	Mendelian_Nancy_Cox	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.202634245187%	4	1974	26	Mendelian_Nancy_Cox	HAHTOLA_CTCL_CUTANEOUS
0.202634245187%	4	1974	26	Mendelian_Nancy_Cox	ABBUD_LIF_SIGNALING_1_DN
0.202634245187%	4	1974	25	Mendelian_Nancy_Cox	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP
0.202634245187%	4	1974	25	Mendelian_Nancy_Cox	WANG_BARRETTS_ESOPHAGUS_DN
0.202634245187%	4	1974	25	Mendelian_Nancy_Cox	VANDESLUIS_NORMAL_EMBRYOS_DN
0.202634245187%	4	1974	25	Mendelian_Nancy_Cox	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP
0.202634245187%	4	1974	25	Mendelian_Nancy_Cox	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN
0.202634245187%	4	1974	25	Mendelian_Nancy_Cox	BIOCARTA_MCALPAIN_PATHWAY
0.202634245187%	4	1974	24	Mendelian_Nancy_Cox	WANG_TNF_TARGETS
0.202634245187%	4	1974	24	Mendelian_Nancy_Cox	REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION
0.202634245187%	4	1974	24	Mendelian_Nancy_Cox	OSADA_ASCL1_TARGETS_DN
0.202634245187%	4	1974	24	Mendelian_Nancy_Cox	ONO_AML1_TARGETS_UP
0.202634245187%	4	1974	24	Mendelian_Nancy_Cox	HASLINGER_B_CLL_WITH_13Q14_DELETION
0.202634245187%	4	1974	24	Mendelian_Nancy_Cox	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP
0.202634245187%	4	1974	23	Mendelian_Nancy_Cox	ST_GA12_PATHWAY
0.202634245187%	4	1974	23	Mendelian_Nancy_Cox	REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX
0.202634245187%	4	1974	23	Mendelian_Nancy_Cox	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER
0.202634245187%	4	1974	23	Mendelian_Nancy_Cox	REACTOME_LYSOSOME_VESICLE_BIOGENESIS
0.202634245187%	4	1974	23	Mendelian_Nancy_Cox	REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING
0.202634245187%	4	1974	23	Mendelian_Nancy_Cox	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5
0.202634245187%	4	1974	23	Mendelian_Nancy_Cox	BIOCARTA_PTDINS_PATHWAY
0.202634245187%	4	1974	23	Mendelian_Nancy_Cox	BIOCARTA_CELLCYCLE_PATHWAY
0.202634245187%	4	1974	23	Mendelian_Nancy_Cox	BARIS_THYROID_CANCER_UP
0.202634245187%	4	1974	22	Mendelian_Nancy_Cox	TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.202634245187%	4	1974	22	Mendelian_Nancy_Cox	LU_TUMOR_ENDOTHELIAL_MARKERS_UP
0.202634245187%	4	1974	22	Mendelian_Nancy_Cox	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP
0.202634245187%	4	1974	22	Mendelian_Nancy_Cox	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN
0.202634245187%	4	1974	22	Mendelian_Nancy_Cox	FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.202634245187%	4	1974	22	Mendelian_Nancy_Cox	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN
0.202634245187%	4	1974	22	Mendelian_Nancy_Cox	BIOCARTA_DC_PATHWAY
0.202634245187%	4	1974	22	Mendelian_Nancy_Cox	BIOCARTA_CYTOKINE_PATHWAY
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	WOTTON_RUNX_TARGETS_UP
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	PID_S1P_S1P1_PATHWAY
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	PID_P38_MK2PATHWAY
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	OUYANG_PROSTATE_CANCER_PROGRESSION_DN
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	MARCHINI_TRABECTEDIN_RESISTANCE_UP
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	MACLACHLAN_BRCA1_TARGETS_UP
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	KANNAN_TP53_TARGETS_DN
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	BIOCARTA_NDKDYNAMIN_PATHWAY
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	BIOCARTA_MITOCHONDRIA_PATHWAY
0.202634245187%	4	1974	21	Mendelian_Nancy_Cox	AMIT_SERUM_RESPONSE_20_MCF10A
0.202634245187%	4	1974	20	Mendelian_Nancy_Cox	ZHU_SKIL_TARGETS_UP
0.202634245187%	4	1974	20	Mendelian_Nancy_Cox	WALLACE_PROSTATE_CANCER_UP
0.202634245187%	4	1974	20	Mendelian_Nancy_Cox	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP
0.202634245187%	4	1974	20	Mendelian_Nancy_Cox	REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY
0.202634245187%	4	1974	20	Mendelian_Nancy_Cox	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP
0.202634245187%	4	1974	20	Mendelian_Nancy_Cox	KORKOLA_YOLK_SAC_TUMOR_UP
0.202634245187%	4	1974	20	Mendelian_Nancy_Cox	FARMER_BREAST_CANCER_CLUSTER_7
0.202634245187%	4	1974	20	Mendelian_Nancy_Cox	CROONQUIST_IL6_DEPRIVATION_UP
0.202634245187%	4	1974	20	Mendelian_Nancy_Cox	COLLIS_PRKDC_SUBSTRATES
0.202634245187%	4	1974	20	Mendelian_Nancy_Cox	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
0.202634245187%	4	1974	20	Mendelian_Nancy_Cox	BIOCARTA_ACTINY_PATHWAY
0.202634245187%	4	1974	20	Mendelian_Nancy_Cox	AMUNDSON_GAMMA_RADIATION_RESISTANCE
0.202634245187%	4	1974	20	Mendelian_Nancy_Cox	ABE_VEGFA_TARGETS
0.202634245187%	4	1974	19	Mendelian_Nancy_Cox	ZHANG_RESPONSE_TO_CANTHARIDIN_UP
0.202634245187%	4	1974	19	Mendelian_Nancy_Cox	WU_ALZHEIMER_DISEASE_DN
0.202634245187%	4	1974	19	Mendelian_Nancy_Cox	VISALA_AGING_LYMPHOCYTE_DN
0.202634245187%	4	1974	19	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1
0.202634245187%	4	1974	19	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES
0.202634245187%	4	1974	19	Mendelian_Nancy_Cox	REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE
0.202634245187%	4	1974	19	Mendelian_Nancy_Cox	PID_HIF1APATHWAY
0.202634245187%	4	1974	19	Mendelian_Nancy_Cox	NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP
0.202634245187%	4	1974	19	Mendelian_Nancy_Cox	NELSON_RESPONSE_TO_ANDROGEN_DN
0.202634245187%	4	1974	19	Mendelian_Nancy_Cox	KANG_CISPLATIN_RESISTANCE_UP
0.202634245187%	4	1974	19	Mendelian_Nancy_Cox	KAMIKUBO_MYELOID_MN1_NETWORK
0.202634245187%	4	1974	19	Mendelian_Nancy_Cox	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN
0.202634245187%	4	1974	19	Mendelian_Nancy_Cox	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS
0.202634245187%	4	1974	19	Mendelian_Nancy_Cox	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN
0.202634245187%	4	1974	19	Mendelian_Nancy_Cox	BIOCARTA_STATHMIN_PATHWAY
0.202634245187%	4	1974	19	Mendelian_Nancy_Cox	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
0.202634245187%	4	1974	18	Mendelian_Nancy_Cox	TOMIDA_METASTASIS_DN
0.202634245187%	4	1974	18	Mendelian_Nancy_Cox	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN
0.202634245187%	4	1974	18	Mendelian_Nancy_Cox	SHIN_B_CELL_LYMPHOMA_CLUSTER_5
0.202634245187%	4	1974	18	Mendelian_Nancy_Cox	REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI
0.202634245187%	4	1974	18	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_SIGNALING_BY_CBL
0.202634245187%	4	1974	18	Mendelian_Nancy_Cox	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS
0.202634245187%	4	1974	18	Mendelian_Nancy_Cox	REACTOME_PD1_SIGNALING
0.202634245187%	4	1974	18	Mendelian_Nancy_Cox	PIONTEK_PKD1_TARGETS_DN
0.202634245187%	4	1974	18	Mendelian_Nancy_Cox	PID_BETACATENIN_DEG_PATHWAY
0.202634245187%	4	1974	18	Mendelian_Nancy_Cox	OZANNE_AP1_TARGETS_UP
0.202634245187%	4	1974	18	Mendelian_Nancy_Cox	NIELSEN_LIPOSARCOMA_UP
0.202634245187%	4	1974	18	Mendelian_Nancy_Cox	NADERI_BREAST_CANCER_PROGNOSIS_DN
0.202634245187%	4	1974	18	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8
0.202634245187%	4	1974	18	Mendelian_Nancy_Cox	MAINA_VHL_TARGETS_DN
0.202634245187%	4	1974	18	Mendelian_Nancy_Cox	BIOCARTA_ERK5_PATHWAY
0.202634245187%	4	1974	176	Mendelian_Nancy_Cox	REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION
0.202634245187%	4	1974	17	Mendelian_Nancy_Cox	REACTOME_INFLAMMASOMES
0.202634245187%	4	1974	17	Mendelian_Nancy_Cox	PID_SMAD2_3PATHWAY
0.202634245187%	4	1974	17	Mendelian_Nancy_Cox	PID_INTEGRIN5_PATHWAY
0.202634245187%	4	1974	17	Mendelian_Nancy_Cox	NGO_MALIGNANT_GLIOMA_1P_LOH
0.202634245187%	4	1974	17	Mendelian_Nancy_Cox	MEISSNER_BRAIN_HCP_WITH_H3K4ME2
0.202634245187%	4	1974	17	Mendelian_Nancy_Cox	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
0.202634245187%	4	1974	17	Mendelian_Nancy_Cox	JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN
0.202634245187%	4	1974	17	Mendelian_Nancy_Cox	GALE_APL_WITH_FLT3_MUTATED_DN
0.202634245187%	4	1974	17	Mendelian_Nancy_Cox	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP
0.202634245187%	4	1974	16	Mendelian_Nancy_Cox	XU_RESPONSE_TO_TRETINOIN_UP
0.202634245187%	4	1974	16	Mendelian_Nancy_Cox	ST_G_ALPHA_S_PATHWAY
0.202634245187%	4	1974	16	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
0.202634245187%	4	1974	16	Mendelian_Nancy_Cox	REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE
0.202634245187%	4	1974	16	Mendelian_Nancy_Cox	PID_DNAPK_PATHWAY
0.202634245187%	4	1974	16	Mendelian_Nancy_Cox	MACLACHLAN_BRCA1_TARGETS_DN
0.202634245187%	4	1974	16	Mendelian_Nancy_Cox	IGLESIAS_E2F_TARGETS_DN
0.202634245187%	4	1974	16	Mendelian_Nancy_Cox	GEISS_RESPONSE_TO_DSRNA_DN
0.202634245187%	4	1974	16	Mendelian_Nancy_Cox	FARMER_BREAST_CANCER_CLUSTER_4
0.202634245187%	4	1974	16	Mendelian_Nancy_Cox	DASU_IL6_SIGNALING_SCAR_DN
0.202634245187%	4	1974	16	Mendelian_Nancy_Cox	BIOCARTA_IL22BP_PATHWAY
0.202634245187%	4	1974	16	Mendelian_Nancy_Cox	AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
0.202634245187%	4	1974	15	Mendelian_Nancy_Cox	SA_G1_AND_S_PHASES
0.202634245187%	4	1974	15	Mendelian_Nancy_Cox	REACTOME_OTHER_SEMAPHORIN_INTERACTIONS
0.202634245187%	4	1974	15	Mendelian_Nancy_Cox	PIEPOLI_LGI1_TARGETS_UP
0.202634245187%	4	1974	15	Mendelian_Nancy_Cox	PID_ERB_GENOMIC_PATHWAY
0.202634245187%	4	1974	15	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27
0.202634245187%	4	1974	15	Mendelian_Nancy_Cox	MARKS_HDAC_TARGETS_DN
0.202634245187%	4	1974	15	Mendelian_Nancy_Cox	KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS
0.202634245187%	4	1974	15	Mendelian_Nancy_Cox	FIGUEROA_AML_METHYLATION_CLUSTER_4_DN
0.202634245187%	4	1974	15	Mendelian_Nancy_Cox	BIOCARTA_NUCLEARRS_PATHWAY
0.202634245187%	4	1974	15	Mendelian_Nancy_Cox	BIOCARTA_HSP27_PATHWAY
0.202634245187%	4	1974	14	Mendelian_Nancy_Cox	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.202634245187%	4	1974	14	Mendelian_Nancy_Cox	REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE
0.202634245187%	4	1974	14	Mendelian_Nancy_Cox	REACTOME_PROLACTIN_RECEPTOR_SIGNALING
0.202634245187%	4	1974	14	Mendelian_Nancy_Cox	REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS
0.202634245187%	4	1974	14	Mendelian_Nancy_Cox	REACTOME_HYALURONAN_METABOLISM
0.202634245187%	4	1974	14	Mendelian_Nancy_Cox	REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX
0.202634245187%	4	1974	14	Mendelian_Nancy_Cox	PID_IL5_PATHWAY
0.202634245187%	4	1974	14	Mendelian_Nancy_Cox	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP
0.202634245187%	4	1974	14	Mendelian_Nancy_Cox	MIKKELSEN_ES_LCP_WITH_H3K27ME3
0.202634245187%	4	1974	14	Mendelian_Nancy_Cox	KINNEY_DNMT1_METHYLATION_TARGETS
0.202634245187%	4	1974	14	Mendelian_Nancy_Cox	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES
0.202634245187%	4	1974	14	Mendelian_Nancy_Cox	INAMURA_LUNG_CANCER_SCC_UP
0.202634245187%	4	1974	13	Mendelian_Nancy_Cox	YAGUE_PRETUMOR_DRUG_RESISTANCE_DN
0.202634245187%	4	1974	13	Mendelian_Nancy_Cox	VERRECCHIA_RESPONSE_TO_TGFB1_C4
0.202634245187%	4	1974	13	Mendelian_Nancy_Cox	SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP
0.202634245187%	4	1974	13	Mendelian_Nancy_Cox	REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING
0.202634245187%	4	1974	13	Mendelian_Nancy_Cox	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY
0.202634245187%	4	1974	13	Mendelian_Nancy_Cox	REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS
0.202634245187%	4	1974	13	Mendelian_Nancy_Cox	PHESSE_TARGETS_OF_APC_AND_MBD2_DN
0.202634245187%	4	1974	13	Mendelian_Nancy_Cox	MATZUK_EARLY_ANTRAL_FOLLICLE
0.202634245187%	4	1974	13	Mendelian_Nancy_Cox	LUI_THYROID_CANCER_CLUSTER_5
0.202634245187%	4	1974	13	Mendelian_Nancy_Cox	HO_LIVER_CANCER_VASCULAR_INVASION
0.202634245187%	4	1974	13	Mendelian_Nancy_Cox	HASINA_NOL7_TARGETS_DN
0.202634245187%	4	1974	13	Mendelian_Nancy_Cox	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP
0.202634245187%	4	1974	13	Mendelian_Nancy_Cox	DISTECHE_ESCAPED_FROM_X_INACTIVATION
0.202634245187%	4	1974	13	Mendelian_Nancy_Cox	BIOCARTA_CBL_PATHWAY
0.202634245187%	4	1974	13	Mendelian_Nancy_Cox	BIOCARTA_CARM1_PATHWAY
0.202634245187%	4	1974	128	Mendelian_Nancy_Cox	KEGG_SPLICEOSOME
0.202634245187%	4	1974	12	Mendelian_Nancy_Cox	TURJANSKI_MAPK1_AND_MAPK2_TARGETS
0.202634245187%	4	1974	12	Mendelian_Nancy_Cox	REACTOME_THE_NLRP3_INFLAMMASOME
0.202634245187%	4	1974	12	Mendelian_Nancy_Cox	REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES
0.202634245187%	4	1974	12	Mendelian_Nancy_Cox	REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION
0.202634245187%	4	1974	12	Mendelian_Nancy_Cox	REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS
0.202634245187%	4	1974	11	Mendelian_Nancy_Cox	ZHOU_PANCREATIC_EXOCRINE_PROGENITOR
0.202634245187%	4	1974	11	Mendelian_Nancy_Cox	ST_STAT3_PATHWAY
0.202634245187%	4	1974	11	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_FGFR3_MUTANTS
0.202634245187%	4	1974	11	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1
0.202634245187%	4	1974	11	Mendelian_Nancy_Cox	REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS
0.202634245187%	4	1974	11	Mendelian_Nancy_Cox	REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS
0.202634245187%	4	1974	11	Mendelian_Nancy_Cox	REACTOME_IL_6_SIGNALING
0.202634245187%	4	1974	11	Mendelian_Nancy_Cox	REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX
0.202634245187%	4	1974	11	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29
0.202634245187%	4	1974	11	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12
0.202634245187%	4	1974	11	Mendelian_Nancy_Cox	FUNG_IL2_SIGNALING_1
0.202634245187%	4	1974	11	Mendelian_Nancy_Cox	FRASOR_TAMOXIFEN_RESPONSE_DN
0.202634245187%	4	1974	100	Mendelian_Nancy_Cox	MCCLUNG_CREB1_TARGETS_UP
0.202634245187%	4	1974	10	Mendelian_Nancy_Cox	REACTOME_OPSINS
0.202634245187%	4	1974	10	Mendelian_Nancy_Cox	REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION
0.202634245187%	4	1974	10	Mendelian_Nancy_Cox	REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE
0.202634245187%	4	1974	10	Mendelian_Nancy_Cox	MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY
0.202634245187%	4	1974	10	Mendelian_Nancy_Cox	IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.202634245187%	4	1974	10	Mendelian_Nancy_Cox	BAKER_HEMATOPOESIS_STAT1_TARGETS
0.198863636364%	7	3520	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_POTASSIUM_CHANNELS
0.198863636364%	7	3520	93	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_INSULIN_SECRETION
0.198863636364%	7	3520	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
0.198863636364%	7	3520	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_MYCN_AMPLIFICATION_TARGETS_UP
0.198863636364%	7	3520	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
0.198863636364%	7	3520	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
0.198863636364%	7	3520	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_GAP_JUNCTION
0.198863636364%	7	3520	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_P7
0.198863636364%	7	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SASSON_RESPONSE_TO_FORSKOLIN_DN
0.198863636364%	7	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.198863636364%	7	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
0.198863636364%	7	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.198863636364%	7	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION
0.198863636364%	7	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NGUYEN_NOTCH1_TARGETS_DN
0.198863636364%	7	3520	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SANA_RESPONSE_TO_IFNG_DN
0.198863636364%	7	3520	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	COLDREN_GEFITINIB_RESISTANCE_UP
0.198863636364%	7	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMID_BREAST_CANCER_LUMINAL_A_UP
0.198863636364%	7	3520	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WARTERS_RESPONSE_TO_IR_SKIN
0.198863636364%	7	3520	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SANA_TNF_SIGNALING_UP
0.198863636364%	7	3520	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
0.198863636364%	7	3520	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
0.198863636364%	7	3520	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FRASOR_RESPONSE_TO_ESTRADIOL_DN
0.198863636364%	7	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
0.198863636364%	7	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MITOTIC_G2_G2_M_PHASES
0.198863636364%	7	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT
0.198863636364%	7	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCCLUNG_COCAINE_REWARD_5D
0.198863636364%	7	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DUAN_PRDM5_TARGETS
0.198863636364%	7	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.198863636364%	7	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP
0.198863636364%	7	3520	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
0.198863636364%	7	3520	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
0.198863636364%	7	3520	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
0.198863636364%	7	3520	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MORI_MATURE_B_LYMPHOCYTE_DN
0.198863636364%	7	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	POTTI_ADRIAMYCIN_SENSITIVITY
0.198863636364%	7	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OUILLETTE_CLL_13Q14_DELETION_UP
0.198863636364%	7	3520	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
0.198863636364%	7	3520	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
0.198863636364%	7	3520	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CROONQUIST_NRAS_SIGNALING_DN
0.198863636364%	7	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_NOTCH1
0.198863636364%	7	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAGHAVACHARI_PLATELET_SPECIFIC_GENES
0.198863636364%	7	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CADWELL_ATG16L1_TARGETS_DN
0.198863636364%	7	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON
0.198863636364%	7	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3
0.198863636364%	7	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FARMER_BREAST_CANCER_CLUSTER_8
0.198863636364%	7	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_P75NTRPATHWAY
0.198863636364%	7	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEIN_NEURON_MARKERS
0.198863636364%	7	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES
0.198863636364%	7	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN
0.198863636364%	7	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_TELOMERASEPATHWAY
0.198863636364%	7	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DELPUECH_FOXO3_TARGETS_UP
0.198863636364%	7	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CASTELLANO_NRAS_TARGETS_UP
0.198863636364%	7	3520	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.198863636364%	7	3520	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.198863636364%	7	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
0.198863636364%	7	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_SERUM_RESPONSE_120_MCF10A
0.198863636364%	7	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_SMARCA4_TARGETS
0.198863636364%	7	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
0.198863636364%	7	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BYSTROEM_CORRELATED_WITH_IL5_DN
0.198863636364%	7	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
0.198863636364%	7	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_TRKRPATHWAY
0.198863636364%	7	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GEORGES_CELL_CYCLE_MIR192_TARGETS
0.198863636364%	7	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP
0.198863636364%	7	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BILD_SRC_ONCOGENIC_SIGNATURE
0.198863636364%	7	3520	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER_MYC_TGFA_UP
0.198863636364%	7	3520	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BAKKER_FOXO3_TARGETS_UP
0.198863636364%	7	3520	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
0.198863636364%	7	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
0.198863636364%	7	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ATF2_PATHWAY
0.198863636364%	7	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_SHP2_PATHWAY
0.198863636364%	7	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KOHOUTEK_CCNT2_TARGETS
0.198863636364%	7	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_TXA2PATHWAY
0.198863636364%	7	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION
0.198863636364%	7	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRADE_COLON_VS_RECTAL_CANCER_DN
0.198863636364%	7	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
0.198863636364%	7	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TIEN_INTESTINE_PROBIOTICS_6HR_UP
0.198863636364%	7	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_IL2_1PATHWAY
0.198863636364%	7	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_FGF_PATHWAY
0.198863636364%	7	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_APOPTOTIC_EXECUTION_PHASE
0.198863636364%	7	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_RAC1_PATHWAY
0.198863636364%	7	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AUNG_GASTRIC_CANCER
0.198863636364%	7	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHU_CMV_8_HR_DN
0.198863636364%	7	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP
0.198863636364%	7	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_CD8TCRPATHWAY
0.198863636364%	7	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
0.198863636364%	7	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VILIMAS_NOTCH1_TARGETS_UP
0.198863636364%	7	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN
0.198863636364%	7	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_PTP1BPATHWAY
0.198863636364%	7	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_CASPASE_PATHWAY
0.198863636364%	7	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP
0.198863636364%	7	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP
0.198863636364%	7	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP
0.198863636364%	7	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN
0.198863636364%	7	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF
0.198863636364%	7	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_BARRETTS_ESOPHAGUS_UP
0.198863636364%	7	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TSUNODA_CISPLATIN_RESISTANCE_DN
0.198863636364%	7	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MORI_PLASMA_CELL_UP
0.198863636364%	7	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
0.198863636364%	7	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CROMER_TUMORIGENESIS_DN
0.198863636364%	7	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BYSTROEM_CORRELATED_WITH_IL5_UP
0.198863636364%	7	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
0.198863636364%	7	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	APPIERTO_RESPONSE_TO_FENRETINIDE_DN
0.198863636364%	7	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PARK_HSC_AND_MULTIPOTENT_PROGENITORS
0.198863636364%	7	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KOHOUTEK_CCNT1_TARGETS
0.198863636364%	7	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOFMANN_CELL_LYMPHOMA_UP
0.198863636364%	7	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
0.198863636364%	7	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIBA_RESPONSE_TO_TSA
0.198863636364%	7	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
0.198863636364%	7	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MANTOVANI_VIRAL_GPCR_SIGNALING_DN
0.198863636364%	7	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	APRELIKOVA_BRCA1_TARGETS
0.198863636364%	7	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP
0.198863636364%	7	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.198863636364%	7	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_C_UP
0.198863636364%	7	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SIG_BCR_SIGNALING_PATHWAY
0.198863636364%	7	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_TNFPATHWAY
0.198863636364%	7	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_RHOA_REG_PATHWAY
0.198863636364%	7	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_PS1PATHWAY
0.198863636364%	7	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NUTT_GBM_VS_AO_GLIOMA_UP
0.198863636364%	7	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAJIMA_MAST_CELL
0.198863636364%	7	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ABBUD_LIF_SIGNALING_1_UP
0.198863636364%	7	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
0.198863636364%	7	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_
0.198863636364%	7	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZUCCHI_METASTASIS_DN
0.198863636364%	7	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_LYSINE_DEGRADATION
0.198863636364%	7	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FAELT_B_CLL_WITH_VH3_21_UP
0.198863636364%	7	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	POTTI_ETOPOSIDE_SENSITIVITY
0.198863636364%	7	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_480_MCF10A
0.198863636364%	7	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BILBAN_B_CLL_LPL_DN
0.198863636364%	7	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WENG_POR_TARGETS_LIVER_UP
0.198863636364%	7	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DELPUECH_FOXO3_TARGETS_DN
0.198863636364%	7	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_B_CELL_ANTIGEN_RECEPTOR
0.198863636364%	7	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_IFNGPATHWAY
0.198863636364%	7	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_TRYPTOPHAN_METABOLISM
0.198863636364%	7	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D8
0.198863636364%	7	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STONER_ESOPHAGEAL_CARCINOGENESIS_UP
0.198863636364%	7	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_RET_PATHWAY
0.198863636364%	7	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BILANGES_RAPAMYCIN_SENSITIVE_GENES
0.198863636364%	7	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_BY_4NQO
0.198863636364%	7	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_TOLL_PATHWAY
0.198863636364%	7	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_GPCR_PATHWAY
0.198863636364%	7	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_BCR_PATHWAY
0.198863636364%	7	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STEARMAN_TUMOR_FIELD_EFFECT_UP
0.198863636364%	7	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALLING_TO_ERKS
0.198863636364%	7	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_IRON_UPTAKE_AND_TRANSPORT
0.198863636364%	7	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOUSTIS_ROS
0.198863636364%	7	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP
0.198863636364%	7	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_AT1R_PATHWAY
0.198863636364%	7	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_EPOPATHWAY
0.198863636364%	7	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_BUTANOATE_METABOLISM
0.198863636364%	7	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PURINE_METABOLISM
0.198863636364%	7	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_SYNDECAN_2_PATHWAY
0.198863636364%	7	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_NCADHERINPATHWAY
0.198863636364%	7	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_IL12_STAT4PATHWAY
0.198863636364%	7	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PROPANOATE_METABOLISM
0.198863636364%	7	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_NO1_PATHWAY
0.198863636364%	7	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	APPEL_IMATINIB_RESPONSE
0.198863636364%	7	3520	328	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_OLFACTORY_SIGNALING_PATHWAY
0.198863636364%	7	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_TIAL1_TARGETS
0.198863636364%	7	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_SERUM_RESPONSE_40_MCF10A
0.198863636364%	7	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
0.198863636364%	7	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN
0.198863636364%	7	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_CLUSTER_13
0.198863636364%	7	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_LRRC3B_TARGETS
0.198863636364%	7	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP
0.198863636364%	7	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_VIP_PATHWAY
0.198863636364%	7	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_VEGF_PATHWAY
0.198863636364%	7	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WILLIAMS_ESR2_TARGETS_UP
0.198863636364%	7	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_LIS1PATHWAY
0.198863636364%	7	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OLSSON_E2F3_TARGETS_UP
0.198863636364%	7	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_EDG1_PATHWAY
0.198863636364%	7	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_INSULIN_GLUCOSE_PATHWAY
0.198863636364%	7	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN
0.198863636364%	7	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP
0.198863636364%	7	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PETRETTO_HEART_MASS_QTL_CIS_DN
0.198863636364%	7	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CXCR4_PATHWAY
0.198863636364%	7	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CSK_PATHWAY
0.198863636364%	7	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HASLINGER_B_CLL_WITH_11Q23_DELETION
0.198863636364%	7	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_RAS_PATHWAY
0.198863636364%	7	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CERAMIDE_PATHWAY
0.198863636364%	7	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PD1_SIGNALING
0.198863636364%	7	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_ERK5_PATHWAY
0.198863636364%	7	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS
0.198863636364%	7	3520	157	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.198863636364%	7	3520	153	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G6
0.198863636364%	7	3520	150	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
0.198863636364%	7	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE
0.198863636364%	7	3520	139	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOELZEL_NF1_TARGETS_UP
0.198863636364%	7	3520	127	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_VMYB_TARGETS_UP
0.198863636364%	7	3520	126	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
0.198863636364%	7	3520	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RODRIGUES_DCC_TARGETS_DN
0.198863636364%	7	3520	115	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOELZEL_NF1_TARGETS_DN
0.198863636364%	7	3520	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LABBE_WNT3A_TARGETS_UP
0.198863636364%	7	3520	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WESTON_VEGFA_TARGETS
0.198863636364%	7	3520	102	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_IPS_WITH_HCP_H3K27ME3
0.198863636364%	7	3520	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCCLUNG_CREB1_TARGETS_UP
0.198863636364%	7	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ETHANOL_OXIDATION
0.184501845018%	1	542	98	T2D_GENES_TANYA_ANTHROPOMETRIC	PYEON_HPV_POSITIVE_TUMORS_UP
0.184501845018%	1	542	98	T2D_GENES_TANYA_ANTHROPOMETRIC	NIELSEN_GIST
0.184501845018%	1	542	98	T2D_GENES_TANYA_ANTHROPOMETRIC	CROONQUIST_IL6_DEPRIVATION_DN
0.184501845018%	1	542	95	T2D_GENES_TANYA_ANTHROPOMETRIC	KAYO_CALORIE_RESTRICTION_MUSCLE_UP
0.184501845018%	1	542	95	T2D_GENES_TANYA_ANTHROPOMETRIC	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.184501845018%	1	542	94	T2D_GENES_TANYA_ANTHROPOMETRIC	GAVIN_FOXP3_TARGETS_CLUSTER_T4
0.184501845018%	1	542	92	T2D_GENES_TANYA_ANTHROPOMETRIC	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN
0.184501845018%	1	542	92	T2D_GENES_TANYA_ANTHROPOMETRIC	CAMPS_COLON_CANCER_COPY_NUMBER_UP
0.184501845018%	1	542	91	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHU_CMV_24_HR_DN
0.184501845018%	1	542	91	T2D_GENES_TANYA_ANTHROPOMETRIC	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.184501845018%	1	542	91	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
0.184501845018%	1	542	90	T2D_GENES_TANYA_ANTHROPOMETRIC	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN
0.184501845018%	1	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	XU_AKT1_TARGETS_48HR
0.184501845018%	1	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	VANLOO_SP3_TARGETS_UP
0.184501845018%	1	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	TSUTSUMI_FBXW8_TARGETS
0.184501845018%	1	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	ST_JAK_STAT_PATHWAY
0.184501845018%	1	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP
0.184501845018%	1	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	SA_FAS_SIGNALING
0.184501845018%	1	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY
0.184501845018%	1	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	RAFFEL_VEGFA_TARGETS_UP
0.184501845018%	1	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN
0.184501845018%	1	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	OXFORD_RALA_TARGETS_UP
0.184501845018%	1	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	NOUSHMEHR_GBM_SOMATIC_MUTATED
0.184501845018%	1	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON
0.184501845018%	1	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30
0.184501845018%	1	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.184501845018%	1	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN
0.184501845018%	1	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN
0.184501845018%	1	542	9	T2D_GENES_TANYA_ANTHROPOMETRIC	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN
0.184501845018%	1	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	WNT_SIGNALING
0.184501845018%	1	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	VANLOO_SP3_TARGETS_DN
0.184501845018%	1	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP
0.184501845018%	1	542	89	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
0.184501845018%	1	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
0.184501845018%	1	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	WALLACE_PROSTATE_CANCER_RACE_DN
0.184501845018%	1	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	TIEN_INTESTINE_PROBIOTICS_2HR_DN
0.184501845018%	1	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS
0.184501845018%	1	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
0.184501845018%	1	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	KESHELAVA_MULTIPLE_DRUG_RESISTANCE
0.184501845018%	1	542	88	T2D_GENES_TANYA_ANTHROPOMETRIC	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
0.184501845018%	1	542	87	T2D_GENES_TANYA_ANTHROPOMETRIC	SMITH_TERT_TARGETS_DN
0.184501845018%	1	542	87	T2D_GENES_TANYA_ANTHROPOMETRIC	SAFFORD_T_LYMPHOCYTE_ANERGY
0.184501845018%	1	542	87	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_ERBB_SIGNALING_PATHWAY
0.184501845018%	1	542	87	T2D_GENES_TANYA_ANTHROPOMETRIC	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.184501845018%	1	542	87	T2D_GENES_TANYA_ANTHROPOMETRIC	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.184501845018%	1	542	87	T2D_GENES_TANYA_ANTHROPOMETRIC	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
0.184501845018%	1	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MEIOTIC_RECOMBINATION
0.184501845018%	1	542	86	T2D_GENES_TANYA_ANTHROPOMETRIC	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
0.184501845018%	1	542	85	T2D_GENES_TANYA_ANTHROPOMETRIC	LEIN_CEREBELLUM_MARKERS
0.184501845018%	1	542	84	T2D_GENES_TANYA_ANTHROPOMETRIC	RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.184501845018%	1	542	84	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_ECM_RECEPTOR_INTERACTION
0.184501845018%	1	542	84	T2D_GENES_TANYA_ANTHROPOMETRIC	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
0.184501845018%	1	542	83	T2D_GENES_TANYA_ANTHROPOMETRIC	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.184501845018%	1	542	82	T2D_GENES_TANYA_ANTHROPOMETRIC	WONG_ENDMETRIUM_CANCER_DN
0.184501845018%	1	542	82	T2D_GENES_TANYA_ANTHROPOMETRIC	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
0.184501845018%	1	542	82	T2D_GENES_TANYA_ANTHROPOMETRIC	BILD_CTNNB1_ONCOGENIC_SIGNATURE
0.184501845018%	1	542	81	T2D_GENES_TANYA_ANTHROPOMETRIC	SCIBETTA_KDM5B_TARGETS_DN
0.184501845018%	1	542	81	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MITOTIC_G2_G2_M_PHASES
0.184501845018%	1	542	81	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION
0.184501845018%	1	542	80	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_UNFOLDED_PROTEIN_RESPONSE
0.184501845018%	1	542	80	T2D_GENES_TANYA_ANTHROPOMETRIC	MORI_PRE_BI_LYMPHOCYTE_UP
0.184501845018%	1	542	80	T2D_GENES_TANYA_ANTHROPOMETRIC	LINDVALL_IMMORTALIZED_BY_TERT_DN
0.184501845018%	1	542	80	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_CARDIAC_MUSCLE_CONTRACTION
0.184501845018%	1	542	80	T2D_GENES_TANYA_ANTHROPOMETRIC	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.184501845018%	1	542	80	T2D_GENES_TANYA_ANTHROPOMETRIC	FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.184501845018%	1	542	8	T2D_GENES_TANYA_ANTHROPOMETRIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN
0.184501845018%	1	542	8	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN
0.184501845018%	1	542	8	T2D_GENES_TANYA_ANTHROPOMETRIC	RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN
0.184501845018%	1	542	8	T2D_GENES_TANYA_ANTHROPOMETRIC	NEBEN_AML_WITH_FLT3_OR_NRAS_UP
0.184501845018%	1	542	8	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_DEDIFFERENTIATED_STATE_UP
0.184501845018%	1	542	8	T2D_GENES_TANYA_ANTHROPOMETRIC	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2
0.184501845018%	1	542	8	T2D_GENES_TANYA_ANTHROPOMETRIC	KONDO_HYPOXIA
0.184501845018%	1	542	8	T2D_GENES_TANYA_ANTHROPOMETRIC	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN
0.184501845018%	1	542	8	T2D_GENES_TANYA_ANTHROPOMETRIC	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN
0.184501845018%	1	542	79	T2D_GENES_TANYA_ANTHROPOMETRIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16
0.184501845018%	1	542	79	T2D_GENES_TANYA_ANTHROPOMETRIC	TOOKER_GEMCITABINE_RESISTANCE_UP
0.184501845018%	1	542	79	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT
0.184501845018%	1	542	79	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
0.184501845018%	1	542	79	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_P73PATHWAY
0.184501845018%	1	542	79	T2D_GENES_TANYA_ANTHROPOMETRIC	MCCLUNG_COCAINE_REWARD_5D
0.184501845018%	1	542	79	T2D_GENES_TANYA_ANTHROPOMETRIC	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
0.184501845018%	1	542	79	T2D_GENES_TANYA_ANTHROPOMETRIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.184501845018%	1	542	79	T2D_GENES_TANYA_ANTHROPOMETRIC	CROMER_METASTASIS_UP
0.184501845018%	1	542	79	T2D_GENES_TANYA_ANTHROPOMETRIC	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP
0.184501845018%	1	542	78	T2D_GENES_TANYA_ANTHROPOMETRIC	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
0.184501845018%	1	542	78	T2D_GENES_TANYA_ANTHROPOMETRIC	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP
0.184501845018%	1	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.184501845018%	1	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.184501845018%	1	542	77	T2D_GENES_TANYA_ANTHROPOMETRIC	FRIDMAN_SENESCENCE_UP
0.184501845018%	1	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	VANASSE_BCL2_TARGETS_DN
0.184501845018%	1	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
0.184501845018%	1	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	OUILLETTE_CLL_13Q14_DELETION_UP
0.184501845018%	1	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
0.184501845018%	1	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	JI_RESPONSE_TO_FSH_UP
0.184501845018%	1	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN
0.184501845018%	1	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	FURUKAWA_DUSP6_TARGETS_PCI35_UP
0.184501845018%	1	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	FURUKAWA_DUSP6_TARGETS_PCI35_DN
0.184501845018%	1	542	74	T2D_GENES_TANYA_ANTHROPOMETRIC	CORRE_MULTIPLE_MYELOMA_UP
0.184501845018%	1	542	73	T2D_GENES_TANYA_ANTHROPOMETRIC	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP
0.184501845018%	1	542	73	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_VIRAL_MYOCARDITIS
0.184501845018%	1	542	73	T2D_GENES_TANYA_ANTHROPOMETRIC	HOSHIDA_LIVER_CANCER_SURVIVAL_UP
0.184501845018%	1	542	72	T2D_GENES_TANYA_ANTHROPOMETRIC	SESTO_RESPONSE_TO_UV_C8
0.184501845018%	1	542	72	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
0.184501845018%	1	542	72	T2D_GENES_TANYA_ANTHROPOMETRIC	HUANG_GATA2_TARGETS_DN
0.184501845018%	1	542	72	T2D_GENES_TANYA_ANTHROPOMETRIC	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
0.184501845018%	1	542	71	T2D_GENES_TANYA_ANTHROPOMETRIC	KYNG_RESPONSE_TO_H2O2
0.184501845018%	1	542	71	T2D_GENES_TANYA_ANTHROPOMETRIC	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
0.184501845018%	1	542	71	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_6HR_UP
0.184501845018%	1	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5
0.184501845018%	1	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_NOTCH1
0.184501845018%	1	542	70	T2D_GENES_TANYA_ANTHROPOMETRIC	ENGELMANN_CANCER_PROGENITORS_DN
0.184501845018%	1	542	7	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_EARLY_DIFFERENTIATION_GENES_UP
0.184501845018%	1	542	7	T2D_GENES_TANYA_ANTHROPOMETRIC	TESAR_ALK_TARGETS_EPISC_4D_UP
0.184501845018%	1	542	7	T2D_GENES_TANYA_ANTHROPOMETRIC	TERAMOTO_OPN_TARGETS_CLUSTER_5
0.184501845018%	1	542	7	T2D_GENES_TANYA_ANTHROPOMETRIC	TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP
0.184501845018%	1	542	7	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN
0.184501845018%	1	542	7	T2D_GENES_TANYA_ANTHROPOMETRIC	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5
0.184501845018%	1	542	7	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP
0.184501845018%	1	542	7	T2D_GENES_TANYA_ANTHROPOMETRIC	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN
0.184501845018%	1	542	7	T2D_GENES_TANYA_ANTHROPOMETRIC	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.184501845018%	1	542	7	T2D_GENES_TANYA_ANTHROPOMETRIC	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP
0.184501845018%	1	542	7	T2D_GENES_TANYA_ANTHROPOMETRIC	HE_PTEN_TARGETS_DN
0.184501845018%	1	542	7	T2D_GENES_TANYA_ANTHROPOMETRIC	FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES
0.184501845018%	1	542	7	T2D_GENES_TANYA_ANTHROPOMETRIC	FARDIN_HYPOXIA_9
0.184501845018%	1	542	7	T2D_GENES_TANYA_ANTHROPOMETRIC	DASU_IL6_SIGNALING_DN
0.184501845018%	1	542	7	T2D_GENES_TANYA_ANTHROPOMETRIC	BUDHU_LIVER_CANCER_METASTASIS_DN
0.184501845018%	1	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	RIZKI_TUMOR_INVASIVENESS_2D_UP
0.184501845018%	1	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.184501845018%	1	542	69	T2D_GENES_TANYA_ANTHROPOMETRIC	HOWLIN_PUBERTAL_MAMMARY_GLAND
0.184501845018%	1	542	68	T2D_GENES_TANYA_ANTHROPOMETRIC	ROSS_AML_OF_FAB_M7_TYPE
0.184501845018%	1	542	68	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SEMAPHORIN_INTERACTIONS
0.184501845018%	1	542	68	T2D_GENES_TANYA_ANTHROPOMETRIC	NOUZOVA_METHYLATED_IN_APL
0.184501845018%	1	542	68	T2D_GENES_TANYA_ANTHROPOMETRIC	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN
0.184501845018%	1	542	67	T2D_GENES_TANYA_ANTHROPOMETRIC	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP
0.184501845018%	1	542	67	T2D_GENES_TANYA_ANTHROPOMETRIC	GENTILE_UV_LOW_DOSE_DN
0.184501845018%	1	542	67	T2D_GENES_TANYA_ANTHROPOMETRIC	ELVIDGE_HIF1A_TARGETS_UP
0.184501845018%	1	542	67	T2D_GENES_TANYA_ANTHROPOMETRIC	DAZARD_UV_RESPONSE_CLUSTER_G1
0.184501845018%	1	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT
0.184501845018%	1	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	TENEDINI_MEGAKARYOCYTE_MARKERS
0.184501845018%	1	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_INTEGRIN1_PATHWAY
0.184501845018%	1	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.184501845018%	1	542	66	T2D_GENES_TANYA_ANTHROPOMETRIC	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP
0.184501845018%	1	542	65	T2D_GENES_TANYA_ANTHROPOMETRIC	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.184501845018%	1	542	65	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_LIVER_CANCER_MYC_TGFA_DN
0.184501845018%	1	542	65	T2D_GENES_TANYA_ANTHROPOMETRIC	CHANG_IMMORTALIZED_BY_HPV31_DN
0.184501845018%	1	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
0.184501845018%	1	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
0.184501845018%	1	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE
0.184501845018%	1	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	LIU_SMARCA4_TARGETS
0.184501845018%	1	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_LIVER_CANCER_MYC_E2F1_DN
0.184501845018%	1	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_LIVER_CANCER_E2F1_DN
0.184501845018%	1	542	64	T2D_GENES_TANYA_ANTHROPOMETRIC	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
0.184501845018%	1	542	63	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
0.184501845018%	1	542	63	T2D_GENES_TANYA_ANTHROPOMETRIC	PHONG_TNF_TARGETS_UP
0.184501845018%	1	542	63	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED
0.184501845018%	1	542	63	T2D_GENES_TANYA_ANTHROPOMETRIC	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
0.184501845018%	1	542	63	T2D_GENES_TANYA_ANTHROPOMETRIC	JOHNSTONE_PARVB_TARGETS_1_DN
0.184501845018%	1	542	63	T2D_GENES_TANYA_ANTHROPOMETRIC	BILBAN_B_CLL_LPL_UP
0.184501845018%	1	542	62	T2D_GENES_TANYA_ANTHROPOMETRIC	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP
0.184501845018%	1	542	62	T2D_GENES_TANYA_ANTHROPOMETRIC	MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN
0.184501845018%	1	542	62	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
0.184501845018%	1	542	62	T2D_GENES_TANYA_ANTHROPOMETRIC	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.184501845018%	1	542	62	T2D_GENES_TANYA_ANTHROPOMETRIC	GEORGES_CELL_CYCLE_MIR192_TARGETS
0.184501845018%	1	542	61	T2D_GENES_TANYA_ANTHROPOMETRIC	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.184501845018%	1	542	61	T2D_GENES_TANYA_ANTHROPOMETRIC	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
0.184501845018%	1	542	61	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_AR_PATHWAY
0.184501845018%	1	542	61	T2D_GENES_TANYA_ANTHROPOMETRIC	KAUFFMANN_MELANOMA_RELAPSE_UP
0.184501845018%	1	542	61	T2D_GENES_TANYA_ANTHROPOMETRIC	GENTILE_RESPONSE_CLUSTER_D3
0.184501845018%	1	542	60	T2D_GENES_TANYA_ANTHROPOMETRIC	WIERENGA_STAT5A_TARGETS_GROUP2
0.184501845018%	1	542	60	T2D_GENES_TANYA_ANTHROPOMETRIC	OUILLETTE_CLL_13Q14_DELETION_DN
0.184501845018%	1	542	60	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_LIVER_CANCER_DENA_UP
0.184501845018%	1	542	60	T2D_GENES_TANYA_ANTHROPOMETRIC	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.184501845018%	1	542	6	T2D_GENES_TANYA_ANTHROPOMETRIC	WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN
0.184501845018%	1	542	6	T2D_GENES_TANYA_ANTHROPOMETRIC	WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP
0.184501845018%	1	542	6	T2D_GENES_TANYA_ANTHROPOMETRIC	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP
0.184501845018%	1	542	6	T2D_GENES_TANYA_ANTHROPOMETRIC	KORKOLA_CHORIOCARCINOMA
0.184501845018%	1	542	6	T2D_GENES_TANYA_ANTHROPOMETRIC	KAUFFMANN_MELANOMA_RELAPSE_DN
0.184501845018%	1	542	6	T2D_GENES_TANYA_ANTHROPOMETRIC	ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS
0.184501845018%	1	542	6	T2D_GENES_TANYA_ANTHROPOMETRIC	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP
0.184501845018%	1	542	6	T2D_GENES_TANYA_ANTHROPOMETRIC	COURTOIS_SENESCENCE_TRIGGERS
0.184501845018%	1	542	6	T2D_GENES_TANYA_ANTHROPOMETRIC	CORRADETTI_MTOR_PATHWAY_REGULATORS_DN
0.184501845018%	1	542	6	T2D_GENES_TANYA_ANTHROPOMETRIC	CHESLER_BRAIN_QTL_TRANS
0.184501845018%	1	542	6	T2D_GENES_TANYA_ANTHROPOMETRIC	CASTELLANO_HRAS_TARGETS_DN
0.184501845018%	1	542	6	T2D_GENES_TANYA_ANTHROPOMETRIC	BASSO_HAIRY_CELL_LEUKEMIA_UP
0.184501845018%	1	542	59	T2D_GENES_TANYA_ANTHROPOMETRIC	WESTON_VEGFA_TARGETS_6HR
0.184501845018%	1	542	59	T2D_GENES_TANYA_ANTHROPOMETRIC	MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3
0.184501845018%	1	542	59	T2D_GENES_TANYA_ANTHROPOMETRIC	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1
0.184501845018%	1	542	59	T2D_GENES_TANYA_ANTHROPOMETRIC	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
0.184501845018%	1	542	59	T2D_GENES_TANYA_ANTHROPOMETRIC	DASU_IL6_SIGNALING_UP
0.184501845018%	1	542	59	T2D_GENES_TANYA_ANTHROPOMETRIC	BOYLAN_MULTIPLE_MYELOMA_C_DN
0.184501845018%	1	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHEIDEREIT_IKK_INTERACTING_PROTEINS
0.184501845018%	1	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	NAGASHIMA_EGF_SIGNALING_UP
0.184501845018%	1	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
0.184501845018%	1	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
0.184501845018%	1	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
0.184501845018%	1	542	58	T2D_GENES_TANYA_ANTHROPOMETRIC	BERNARD_PPAPDC1B_TARGETS_DN
0.184501845018%	1	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	GYORFFY_MITOXANTRONE_RESISTANCE
0.184501845018%	1	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	DIRMEIER_LMP1_RESPONSE_LATE_UP
0.184501845018%	1	542	57	T2D_GENES_TANYA_ANTHROPOMETRIC	AMIT_SERUM_RESPONSE_240_MCF10A
0.184501845018%	1	542	56	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHENG_IL22_SIGNALING_UP
0.184501845018%	1	542	56	T2D_GENES_TANYA_ANTHROPOMETRIC	WORSCHECH_TUMOR_REJECTION_UP
0.184501845018%	1	542	56	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION
0.184501845018%	1	542	56	T2D_GENES_TANYA_ANTHROPOMETRIC	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.184501845018%	1	542	56	T2D_GENES_TANYA_ANTHROPOMETRIC	GRADE_COLON_VS_RECTAL_CANCER_DN
0.184501845018%	1	542	56	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_30MIN_UP
0.184501845018%	1	542	55	T2D_GENES_TANYA_ANTHROPOMETRIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
0.184501845018%	1	542	55	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ION_CHANNEL_TRANSPORT
0.184501845018%	1	542	55	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_TGFBRPATHWAY
0.184501845018%	1	542	55	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_FGF_PATHWAY
0.184501845018%	1	542	55	T2D_GENES_TANYA_ANTHROPOMETRIC	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN
0.184501845018%	1	542	55	T2D_GENES_TANYA_ANTHROPOMETRIC	GENTILE_UV_RESPONSE_CLUSTER_D4
0.184501845018%	1	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
0.184501845018%	1	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	SUNG_METASTASIS_STROMA_DN
0.184501845018%	1	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP
0.184501845018%	1	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	MARSON_FOXP3_TARGETS_DN
0.184501845018%	1	542	54	T2D_GENES_TANYA_ANTHROPOMETRIC	KANG_DOXORUBICIN_RESISTANCE_UP
0.184501845018%	1	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHU_CMV_8_HR_DN
0.184501845018%	1	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	MORI_IMMATURE_B_LYMPHOCYTE_UP
0.184501845018%	1	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
0.184501845018%	1	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
0.184501845018%	1	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	HENDRICKS_SMARCA4_TARGETS_DN
0.184501845018%	1	542	53	T2D_GENES_TANYA_ANTHROPOMETRIC	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP
0.184501845018%	1	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN
0.184501845018%	1	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	VILIMAS_NOTCH1_TARGETS_UP
0.184501845018%	1	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	ROSS_AML_WITH_CBFB_MYH11_FUSION
0.184501845018%	1	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM
0.184501845018%	1	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	PRAMOONJAGO_SOX4_TARGETS_UP
0.184501845018%	1	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP
0.184501845018%	1	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6
0.184501845018%	1	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_TASTE_TRANSDUCTION
0.184501845018%	1	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_ENDOMETRIAL_CANCER
0.184501845018%	1	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP
0.184501845018%	1	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	CHIBA_RESPONSE_TO_TSA_UP
0.184501845018%	1	542	52	T2D_GENES_TANYA_ANTHROPOMETRIC	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN
0.184501845018%	1	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
0.184501845018%	1	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_BARRETTS_ESOPHAGUS_UP
0.184501845018%	1	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	TSUNODA_CISPLATIN_RESISTANCE_DN
0.184501845018%	1	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
0.184501845018%	1	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN
0.184501845018%	1	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_CALORIE_RESTRICTION_MUSCLE_DN
0.184501845018%	1	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	GUILLAUMOND_KLF10_TARGETS_UP
0.184501845018%	1	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	CROMER_TUMORIGENESIS_DN
0.184501845018%	1	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP
0.184501845018%	1	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	BURTON_ADIPOGENESIS_7
0.184501845018%	1	542	51	T2D_GENES_TANYA_ANTHROPOMETRIC	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
0.184501845018%	1	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN
0.184501845018%	1	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
0.184501845018%	1	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
0.184501845018%	1	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	FIGUEROA_AML_METHYLATION_CLUSTER_5_DN
0.184501845018%	1	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION
0.184501845018%	1	542	50	T2D_GENES_TANYA_ANTHROPOMETRIC	BECKER_TAMOXIFEN_RESISTANCE_UP
0.184501845018%	1	542	5	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_THOC1_TARGETS_UP
0.184501845018%	1	542	5	T2D_GENES_TANYA_ANTHROPOMETRIC	TESAR_ALK_TARGETS_HUMAN_ES_5D_UP
0.184501845018%	1	542	5	T2D_GENES_TANYA_ANTHROPOMETRIC	TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP
0.184501845018%	1	542	5	T2D_GENES_TANYA_ANTHROPOMETRIC	SMID_BREAST_CANCER_ERBB2_DN
0.184501845018%	1	542	5	T2D_GENES_TANYA_ANTHROPOMETRIC	JONES_TCOF1_TARGETS
0.184501845018%	1	542	5	T2D_GENES_TANYA_ANTHROPOMETRIC	CASTELLANO_HRAS_TARGETS_UP
0.184501845018%	1	542	5	T2D_GENES_TANYA_ANTHROPOMETRIC	CAFFAREL_RESPONSE_TO_THC_8HR_3_UP
0.184501845018%	1	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_MULTIPLE_MYELOMA_HP_UP
0.184501845018%	1	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS
0.184501845018%	1	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	OLSSON_E2F3_TARGETS_DN
0.184501845018%	1	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	MANTOVANI_VIRAL_GPCR_SIGNALING_DN
0.184501845018%	1	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_LIVER_CANCER
0.184501845018%	1	542	49	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_2HR_DN
0.184501845018%	1	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	TAVOR_CEBPA_TARGETS_UP
0.184501845018%	1	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	RICKMAN_HEAD_AND_NECK_CANCER_B
0.184501845018%	1	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MUSCLE_CONTRACTION
0.184501845018%	1	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY
0.184501845018%	1	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	RASHI_RESPONSE_TO_IONIZING_RADIATION_3
0.184501845018%	1	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	MCDOWELL_ACUTE_LUNG_INJURY_DN
0.184501845018%	1	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN
0.184501845018%	1	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	DOANE_BREAST_CANCER_ESR1_DN
0.184501845018%	1	542	48	T2D_GENES_TANYA_ANTHROPOMETRIC	ABE_INNER_EAR
0.184501845018%	1	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHU_CMV_8_HR_UP
0.184501845018%	1	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_MULTIPLE_MYELOMA_HP_DN
0.184501845018%	1	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN
0.184501845018%	1	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_LKB1_PATHWAY
0.184501845018%	1	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	MCCLUNG_DELTA_FOSB_TARGETS_8WK
0.184501845018%	1	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	LEONARD_HYPOXIA
0.184501845018%	1	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_TYPE_II_DIABETES_MELLITUS
0.184501845018%	1	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_NOTCH_SIGNALING_PATHWAY
0.184501845018%	1	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	JIANG_AGING_HYPOTHALAMUS_UP
0.184501845018%	1	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	IRITANI_MAD1_TARGETS_DN
0.184501845018%	1	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.184501845018%	1	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWNE_HCMV_INFECTION_8HR_DN
0.184501845018%	1	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	BOYLAN_MULTIPLE_MYELOMA_C_UP
0.184501845018%	1	542	47	T2D_GENES_TANYA_ANTHROPOMETRIC	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP
0.184501845018%	1	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_MULTIPLE_MYELOMA_MS_DN
0.184501845018%	1	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_MULTIPLE_MYELOMA_CD2_DN
0.184501845018%	1	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	WINNEPENNINCKX_MELANOMA_METASTASIS_DN
0.184501845018%	1	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6
0.184501845018%	1	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION
0.184501845018%	1	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
0.184501845018%	1	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_RHOA_REG_PATHWAY
0.184501845018%	1	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_PS1PATHWAY
0.184501845018%	1	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	OSADA_ASCL1_TARGETS_UP
0.184501845018%	1	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	NUTT_GBM_VS_AO_GLIOMA_UP
0.184501845018%	1	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	NAKAJIMA_MAST_CELL
0.184501845018%	1	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_AGING_MUSCLE_DN
0.184501845018%	1	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	KRASNOSELSKAYA_ILF3_TARGETS_DN
0.184501845018%	1	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN
0.184501845018%	1	542	46	T2D_GENES_TANYA_ANTHROPOMETRIC	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN
0.184501845018%	1	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_V2_LATE_DIFFERENTIATION_GENES
0.184501845018%	1	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	VANHARANTA_UTERINE_FIBROID_UP
0.184501845018%	1	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	SMITH_LIVER_CANCER
0.184501845018%	1	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_G2_M_CHECKPOINTS
0.184501845018%	1	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
0.184501845018%	1	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_ILK_PATHWAY
0.184501845018%	1	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	NAKAMURA_METASTASIS_MODEL_UP
0.184501845018%	1	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	LEE_AGING_MUSCLE_UP
0.184501845018%	1	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	KLEIN_TARGETS_OF_BCR_ABL1_FUSION
0.184501845018%	1	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN
0.184501845018%	1	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY
0.184501845018%	1	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_BIOPEPTIDES_PATHWAY
0.184501845018%	1	542	45	T2D_GENES_TANYA_ANTHROPOMETRIC	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.184501845018%	1	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	ZUCCHI_METASTASIS_DN
0.184501845018%	1	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	VANTVEER_BREAST_CANCER_BRCA1_DN
0.184501845018%	1	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	STREICHER_LSM1_TARGETS_UP
0.184501845018%	1	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	MEDINA_SMARCA4_TARGETS
0.184501845018%	1	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	MARTIN_INTERACT_WITH_HDAC
0.184501845018%	1	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	LUI_THYROID_CANCER_PAX8_PPARG_UP
0.184501845018%	1	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP
0.184501845018%	1	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	LANDIS_BREAST_CANCER_PROGRESSION_UP
0.184501845018%	1	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	KERLEY_RESPONSE_TO_CISPLATIN_UP
0.184501845018%	1	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
0.184501845018%	1	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	HARRIS_BRAIN_CANCER_PROGENITORS
0.184501845018%	1	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	CHUNG_BLISTER_CYTOTOXICITY_DN
0.184501845018%	1	542	44	T2D_GENES_TANYA_ANTHROPOMETRIC	CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY
0.184501845018%	1	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	ZUCCHI_METASTASIS_UP
0.184501845018%	1	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_INTEGRIN3_PATHWAY
0.184501845018%	1	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN
0.184501845018%	1	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	NAKAYAMA_FRA2_TARGETS
0.184501845018%	1	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	MANTOVANI_NFKB_TARGETS_UP
0.184501845018%	1	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.184501845018%	1	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	LASTOWSKA_COAMPLIFIED_WITH_MYCN
0.184501845018%	1	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
0.184501845018%	1	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	IKEDA_MIR133_TARGETS_UP
0.184501845018%	1	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	HUMMEL_BURKITTS_LYMPHOMA_UP
0.184501845018%	1	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	FUJII_YBX1_TARGETS_UP
0.184501845018%	1	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	COWLING_MYCN_TARGETS
0.184501845018%	1	542	43	T2D_GENES_TANYA_ANTHROPOMETRIC	BURTON_ADIPOGENESIS_PEAK_AT_24HR
0.184501845018%	1	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHENG_IL22_SIGNALING_DN
0.184501845018%	1	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	YU_MYC_TARGETS_UP
0.184501845018%	1	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	MODY_HIPPOCAMPUS_PRENATAL
0.184501845018%	1	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	LEIN_ASTROCYTE_MARKERS
0.184501845018%	1	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_FATTY_ACID_METABOLISM
0.184501845018%	1	542	42	T2D_GENES_TANYA_ANTHROPOMETRIC	AMIT_EGF_RESPONSE_40_HELA
0.184501845018%	1	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.184501845018%	1	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.184501845018%	1	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING
0.184501845018%	1	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_IL_2_SIGNALING
0.184501845018%	1	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_ER_NONGENOMIC_PATHWAY
0.184501845018%	1	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_ERBB1_INTERNALIZATION_PATHWAY
0.184501845018%	1	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN
0.184501845018%	1	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM
0.184501845018%	1	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
0.184501845018%	1	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
0.184501845018%	1	542	41	T2D_GENES_TANYA_ANTHROPOMETRIC	CROONQUIST_NRAS_SIGNALING_UP
0.184501845018%	1	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.184501845018%	1	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	TOMLINS_PROSTATE_CANCER_UP
0.184501845018%	1	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	TOMLINS_PROSTATE_CANCER_DN
0.184501845018%	1	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
0.184501845018%	1	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_EPHBFWDPATHWAY
0.184501845018%	1	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	LIAO_HAVE_SOX4_BINDING_SITES
0.184501845018%	1	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_SPHINGOLIPID_METABOLISM
0.184501845018%	1	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PYRUVATE_METABOLISM
0.184501845018%	1	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	GENTILE_UV_RESPONSE_CLUSTER_D8
0.184501845018%	1	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	ELLWOOD_MYC_TARGETS_DN
0.184501845018%	1	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	CHESLER_BRAIN_HIGHEST_EXPRESSION
0.184501845018%	1	542	40	T2D_GENES_TANYA_ANTHROPOMETRIC	BURTON_ADIPOGENESIS_PEAK_AT_16HR
0.184501845018%	1	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	WHITEHURST_PACLITAXEL_SENSITIVITY
0.184501845018%	1	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	KORKOLA_TERATOMA
0.184501845018%	1	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	HOFMANN_CELL_LYMPHOMA_DN
0.184501845018%	1	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	GU_PDEF_TARGETS_DN
0.184501845018%	1	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP
0.184501845018%	1	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP
0.184501845018%	1	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	BILANGES_SERUM_SENSITIVE_VIA_TSC2
0.184501845018%	1	542	39	T2D_GENES_TANYA_ANTHROPOMETRIC	AMIT_SERUM_RESPONSE_480_MCF10A
0.184501845018%	1	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	YOKOE_CANCER_TESTIS_ANTIGENS
0.184501845018%	1	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	SPIRA_SMOKERS_LUNG_CANCER_UP
0.184501845018%	1	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER
0.184501845018%	1	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4
0.184501845018%	1	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GLYCOSPHINGOLIPID_METABOLISM
0.184501845018%	1	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_RAC1_REG_PATHWAY
0.184501845018%	1	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	NAKAMURA_ADIPOGENESIS_LATE_DN
0.184501845018%	1	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.184501845018%	1	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	LIU_LIVER_CANCER
0.184501845018%	1	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP
0.184501845018%	1	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP
0.184501845018%	1	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	KAAB_FAILED_HEART_ATRIUM_UP
0.184501845018%	1	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN
0.184501845018%	1	542	38	T2D_GENES_TANYA_ANTHROPOMETRIC	CHANDRAN_METASTASIS_TOP50_UP
0.184501845018%	1	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN
0.184501845018%	1	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	ROLEF_GLIS3_TARGETS
0.184501845018%	1	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2
0.184501845018%	1	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	MURAKAMI_UV_RESPONSE_6HR_UP
0.184501845018%	1	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED
0.184501845018%	1	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_ALL_DISORDERS_CALB1_CORR_DN
0.184501845018%	1	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	HOWLIN_CITED1_TARGETS_1_DN
0.184501845018%	1	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	GENTILE_UV_RESPONSE_CLUSTER_D6
0.184501845018%	1	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	CUI_TCF21_TARGETS_UP
0.184501845018%	1	542	37	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_GPCR_PATHWAY
0.184501845018%	1	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	YIH_RESPONSE_TO_ARSENITE_C3
0.184501845018%	1	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN
0.184501845018%	1	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	SUBTIL_PROGESTIN_TARGETS
0.184501845018%	1	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	SEMENZA_HIF1_TARGETS
0.184501845018%	1	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
0.184501845018%	1	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_IRON_UPTAKE_AND_TRANSPORT
0.184501845018%	1	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_FRS2_MEDIATED_CASCADE
0.184501845018%	1	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	MMS_MOUSE_LYMPH_HIGH_4HRS_UP
0.184501845018%	1	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN
0.184501845018%	1	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	JIANG_AGING_CEREBRAL_CORTEX_UP
0.184501845018%	1	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	HUANG_FOXA2_TARGETS_DN
0.184501845018%	1	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP
0.184501845018%	1	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP
0.184501845018%	1	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP
0.184501845018%	1	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN
0.184501845018%	1	542	36	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_AGR_PATHWAY
0.184501845018%	1	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15
0.184501845018%	1	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	WESTON_VEGFA_TARGETS_12HR
0.184501845018%	1	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_METHYLATED_IN_BREAST_CANCER
0.184501845018%	1	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES
0.184501845018%	1	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	ROZANOV_MMP14_TARGETS_DN
0.184501845018%	1	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	RODRIGUES_NTN1_AND_DCC_TARGETS
0.184501845018%	1	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_PI3KCIAKTPATHWAY
0.184501845018%	1	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
0.184501845018%	1	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	LI_CISPLATIN_RESISTANCE_DN
0.184501845018%	1	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PRIMARY_IMMUNODEFICIENCY
0.184501845018%	1	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	JAZAG_TGFB1_SIGNALING_DN
0.184501845018%	1	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.184501845018%	1	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP
0.184501845018%	1	542	35	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_CARM_ER_PATHWAY
0.184501845018%	1	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	SUMI_HNF4A_TARGETS
0.184501845018%	1	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP
0.184501845018%	1	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE
0.184501845018%	1	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES
0.184501845018%	1	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	POTTI_CYTOXAN_SENSITIVITY
0.184501845018%	1	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_IL8CXCR2_PATHWAY
0.184501845018%	1	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_IL1PATHWAY
0.184501845018%	1	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_ATM_PATHWAY
0.184501845018%	1	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	MEISSNER_ES_ICP_WITH_H3K4ME3
0.184501845018%	1	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM
0.184501845018%	1	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_CYSTEINE_AND_METHIONINE_METABOLISM
0.184501845018%	1	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	HONMA_DOCETAXEL_RESISTANCE
0.184501845018%	1	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	DOANE_BREAST_CANCER_CLASSES_DN
0.184501845018%	1	542	34	T2D_GENES_TANYA_ANTHROPOMETRIC	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	WENDT_COHESIN_TARGETS_UP
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	TANG_SENESCENCE_TP53_TARGETS_UP
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHRAETS_MLL_TARGETS_DN
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PURINE_METABOLISM
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PROPANOATE_METABOLISM
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	JEPSEN_SMRT_TARGETS
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	GREENBAUM_E2A_TARGETS_UP
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	GRADE_COLON_CANCER_DN
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	FIRESTEIN_CTNNB1_PATHWAY
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_NO1_PATHWAY
0.184501845018%	1	542	33	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_DEATH_PATHWAY
0.184501845018%	1	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	ZWANG_EGF_PERSISTENTLY_UP
0.184501845018%	1	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN
0.184501845018%	1	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING
0.184501845018%	1	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ELONGATION_ARREST_AND_RECOVERY
0.184501845018%	1	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	POS_HISTAMINE_RESPONSE_NETWORK
0.184501845018%	1	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_WNT_NONCANONICAL_PATHWAY
0.184501845018%	1	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	MOOTHA_GLUCONEOGENESIS
0.184501845018%	1	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	MEISSNER_BRAIN_ICP_WITH_H3K4ME3
0.184501845018%	1	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM
0.184501845018%	1	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	GROSS_ELK3_TARGETS_DN
0.184501845018%	1	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	FARDIN_HYPOXIA_11
0.184501845018%	1	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_RHO_PATHWAY
0.184501845018%	1	542	32	T2D_GENES_TANYA_ANTHROPOMETRIC	AMIT_SERUM_RESPONSE_40_MCF10A
0.184501845018%	1	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	TING_SILENCED_BY_DICER
0.184501845018%	1	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	THEODOROU_MAMMARY_TUMORIGENESIS
0.184501845018%	1	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.184501845018%	1	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP
0.184501845018%	1	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN
0.184501845018%	1	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNAL_AMPLIFICATION
0.184501845018%	1	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_HS_GAG_BIOSYNTHESIS
0.184501845018%	1	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
0.184501845018%	1	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE
0.184501845018%	1	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	MCCABE_HOXC6_TARGETS_CANCER_UP
0.184501845018%	1	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
0.184501845018%	1	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.184501845018%	1	542	31	T2D_GENES_TANYA_ANTHROPOMETRIC	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_ROBO_RECEPTOR
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MRNA_CAPPING
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_NECTIN_PATHWAY
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_CDC42_REG_PATHWAY
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	NAKAJIMA_EOSINOPHIL
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	KYNG_NORMAL_AGING_DN
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_LRRC3B_TARGETS
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_ASTHMA
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	HEIDENBLAD_AMPLICON_12P11_12_DN
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	GUILLAUMOND_KLF10_TARGETS_DN
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	DAZARD_UV_RESPONSE_CLUSTER_G2
0.184501845018%	1	542	30	T2D_GENES_TANYA_ANTHROPOMETRIC	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	YU_BAP1_TARGETS
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	WEINMANN_ADAPTATION_TO_HYPOXIA_UP
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	WATANABE_COLON_CANCER_MSI_VS_MSS_UP
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	VALK_AML_CLUSTER_2
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PKB_MEDIATED_EVENTS
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_TCRCALCIUMPATHWAY
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_REELINPATHWAY
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_BARD1PATHWAY
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	PAL_PRMT5_TARGETS_DN
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	NGUYEN_NOTCH1_TARGETS_UP
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	NAKAYAMA_FGF2_TARGETS
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	LANG_MYB_FAMILY_TARGETS
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	KYNG_WERNER_SYNDROM_DN
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_THYROID_CANCER
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_HISTIDINE_METABOLISM
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	GENTLES_LEUKEMIC_STEM_CELL_UP
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	DORN_ADENOVIRUS_INFECTION_12HR_UP
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	DALESSIO_TSA_RESPONSE
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_VEGF_PATHWAY
0.184501845018%	1	542	29	T2D_GENES_TANYA_ANTHROPOMETRIC	AIYAR_COBRA1_TARGETS_DN
0.184501845018%	1	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	WILLIAMS_ESR2_TARGETS_UP
0.184501845018%	1	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	TIAN_TNF_SIGNALING_VIA_NFKB
0.184501845018%	1	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	TERAO_AOX4_TARGETS_HG_UP
0.184501845018%	1	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER
0.184501845018%	1	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS
0.184501845018%	1	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_WNT_SIGNALING_PATHWAY
0.184501845018%	1	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_TRAIL_PATHWAY
0.184501845018%	1	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	PETROVA_PROX1_TARGETS_UP
0.184501845018%	1	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	PETRETTO_HEART_MASS_QTL_CIS_UP
0.184501845018%	1	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	MATZUK_MALE_REPRODUCTION_SERTOLI
0.184501845018%	1	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	KAMIKUBO_MYELOID_CEBPA_NETWORK
0.184501845018%	1	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.184501845018%	1	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.184501845018%	1	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP
0.184501845018%	1	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_GH_PATHWAY
0.184501845018%	1	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_G1_PATHWAY
0.184501845018%	1	542	28	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_ERK_PATHWAY
0.184501845018%	1	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	YANG_BREAST_CANCER_ESR1_BULK_UP
0.184501845018%	1	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN
0.184501845018%	1	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	XU_AKT1_TARGETS_6HR
0.184501845018%	1	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
0.184501845018%	1	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_STRIATED_MUSCLE_CONTRACTION
0.184501845018%	1	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION
0.184501845018%	1	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALLING_TO_RAS
0.184501845018%	1	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RECYCLING_PATHWAY_OF_L1
0.184501845018%	1	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING
0.184501845018%	1	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS
0.184501845018%	1	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM
0.184501845018%	1	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS
0.184501845018%	1	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS
0.184501845018%	1	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_IL3_PATHWAY
0.184501845018%	1	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_GLYPICAN_1PATHWAY
0.184501845018%	1	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	JI_METASTASIS_REPRESSED_BY_STK11
0.184501845018%	1	542	27	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_GSK3_PATHWAY
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHENG_FOXP3_TARGETS_UP
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	VALK_AML_CLUSTER_16
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_REGULATORY_RNA_PATHWAYS
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_P38_MKK3_6PATHWAY
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_ALK1PATHWAY
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	NEWMAN_ERCC6_TARGETS_UP
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	GAZIN_EPIGENETIC_SILENCING_BY_KRAS
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	FINAK_BREAST_CANCER_SDPP_SIGNATURE
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	BRACHAT_RESPONSE_TO_METHOTREXATE_UP
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_WNT_PATHWAY
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
0.184501845018%	1	542	26	T2D_GENES_TANYA_ANTHROPOMETRIC	ABBUD_LIF_SIGNALING_1_DN
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	VANDESLUIS_NORMAL_EMBRYOS_DN
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	RUAN_RESPONSE_TO_TROGLITAZONE_UP
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_G0_AND_EARLY_G1
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_EGFR_DOWNREGULATION
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_INTEGRIN_A9B1_PATHWAY
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_HDAC_CLASSIII_PATHWAY
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	OZEN_MIR125B1_TARGETS
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	NOJIMA_SFRP2_TARGETS_DN
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_HYPOXIA
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	COLLER_MYC_TARGETS_UP
0.184501845018%	1	542	25	T2D_GENES_TANYA_ANTHROPOMETRIC	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS
0.184501845018%	1	542	247	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_METABOLISM_OF_CARBOHYDRATES
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	YIH_RESPONSE_TO_ARSENITE_C1
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	SA_B_CELL_RECEPTOR_COMPLEXES
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CHOLESTEROL_BIOSYNTHESIS
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_S1P_S1P2_PATHWAY
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	OXFORD_RALA_OR_RALB_TARGETS_DN
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	OSADA_ASCL1_TARGETS_DN
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	ONO_AML1_TARGETS_UP
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PROTEIN_EXPORT
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	JEON_SMAD6_TARGETS_UP
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	CHEOK_RESPONSE_TO_HD_MTX_DN
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_TPO_PATHWAY
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_G2_PATHWAY
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_ECM_PATHWAY
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_CSK_PATHWAY
0.184501845018%	1	542	24	T2D_GENES_TANYA_ANTHROPOMETRIC	AZARE_STAT3_TARGETS
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	WU_HBX_TARGETS_2_UP
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	SABATES_COLORECTAL_ADENOMA_SIZE_UP
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MICRORNA_MIRNA_BIOGENESIS
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_LYSOSOME_VESICLE_BIOGENESIS
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_INSULIN_RECEPTOR_RECYCLING
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_CONE_PATHWAY
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	MARKS_HDAC_TARGETS_UP
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	FERRANDO_HOX11_NEIGHBORS
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	EGUCHI_CELL_CYCLE_RB1_TARGETS
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_RAC1_PATHWAY
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_P53HYPOXIA_PATHWAY
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_IL12_PATHWAY
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_IGF1R_PATHWAY
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_CCR3_PATHWAY
0.184501845018%	1	542	23	T2D_GENES_TANYA_ANTHROPOMETRIC	BARIS_THYROID_CANCER_UP
0.184501845018%	1	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHAN_MULTIPLE_MYELOMA_SPIKED
0.184501845018%	1	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_METAL_ION_SLC_TRANSPORTERS
0.184501845018%	1	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING
0.184501845018%	1	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP
0.184501845018%	1	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP
0.184501845018%	1	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	LANDIS_ERBB2_BREAST_TUMORS_65_UP
0.184501845018%	1	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP
0.184501845018%	1	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_BETA_ALANINE_METABOLISM
0.184501845018%	1	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP
0.184501845018%	1	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP
0.184501845018%	1	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_SPPA_PATHWAY
0.184501845018%	1	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_IL2_PATHWAY
0.184501845018%	1	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_HER2_PATHWAY
0.184501845018%	1	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_GCR_PATHWAY
0.184501845018%	1	542	22	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_DC_PATHWAY
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	ZIRN_TRETINOIN_RESPONSE_UP
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	WOTTON_RUNX_TARGETS_UP
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PEROXISOMAL_LIPID_METABOLISM
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ERK_MAPK_TARGETS
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ADP_SIGNALLING_THROUGH_P2RY12
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_S1P_META_PATHWAY
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_P38_MK2PATHWAY
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_ECADHERIN_KERATINOCYTE_PATHWAY
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	MCCABE_HOXC6_TARGETS_DN
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	DAZARD_UV_RESPONSE_CLUSTER_G4
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_TOB1_PATHWAY
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_CTLA4_PATHWAY
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_ATRBRCA_PATHWAY
0.184501845018%	1	542	21	T2D_GENES_TANYA_ANTHROPOMETRIC	AMIT_SERUM_RESPONSE_20_MCF10A
0.184501845018%	1	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	WEBER_METHYLATED_HCP_IN_SPERM_UP
0.184501845018%	1	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN
0.184501845018%	1	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING
0.184501845018%	1	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY
0.184501845018%	1	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	OUYANG_PROSTATE_CANCER_PROGRESSION_UP
0.184501845018%	1	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN
0.184501845018%	1	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN
0.184501845018%	1	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP
0.184501845018%	1	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	MEISSNER_NPC_ICP_WITH_H3K4ME3
0.184501845018%	1	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN
0.184501845018%	1	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	LIU_TARGETS_OF_VMYB_VS_CMYB_UP
0.184501845018%	1	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_MYCL1_AMPLIFICATION_TARGETS_DN
0.184501845018%	1	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	DING_LUNG_CANCER_BY_MUTATION_RATE
0.184501845018%	1	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	DAZARD_UV_RESPONSE_CLUSTER_G28
0.184501845018%	1	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN
0.184501845018%	1	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
0.184501845018%	1	542	20	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_NKCELLS_PATHWAY
0.184501845018%	1	542	191	T2D_GENES_TANYA_ANTHROPOMETRIC	RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHANG_RESPONSE_TO_CANTHARIDIN_UP
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	STREICHER_LSM1_TARGETS_DN
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	SHIN_B_CELL_LYMPHOMA_CLUSTER_9
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	SA_CASPASE_CASCADE
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	RUAN_RESPONSE_TO_TROGLITAZONE_DN
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_BASE_EXCISION_REPAIR
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	RASHI_NFKB1_TARGETS
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_EPHA2_FWDPATHWAY
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	NIELSEN_LIPOSARCOMA_DN
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	NELSON_RESPONSE_TO_ANDROGEN_DN
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	NAGY_TFTC_COMPONENTS_HUMAN
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	MAHADEVAN_RESPONSE_TO_MP470_DN
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	KANG_AR_TARGETS_DN
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	KAMIKUBO_MYELOID_MN1_NETWORK
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	CHEN_PDGF_TARGETS
0.184501845018%	1	542	19	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_EPO_PATHWAY
0.184501845018%	1	542	185	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHANG_TLX_TARGETS_36HR_DN
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	YIH_RESPONSE_TO_ARSENITE_C2
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	SHIN_B_CELL_LYMPHOMA_CLUSTER_5
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHEIDEREIT_IKK_TARGETS
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SYNTHESIS_OF_PC
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_NODAL
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	MOREIRA_RESPONSE_TO_TSA_DN
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	LE_NEURONAL_DIFFERENTIATION_UP
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	KAPOSI_LIVER_CANCER_MET_UP
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	HUMMERICH_MALIGNANT_SKIN_TUMOR_DN
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	HUMMERICH_BENIGN_SKIN_TUMOR_DN
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	GENTILE_UV_RESPONSE_CLUSTER_D1
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	CHOI_ATL_CHRONIC_VS_ACUTE_DN
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_SPRY_PATHWAY
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_PTEN_PATHWAY
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_NGF_PATHWAY
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_CARDIACEGF_PATHWAY
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP
0.184501845018%	1	542	18	T2D_GENES_TANYA_ANTHROPOMETRIC	AMIT_DELAYED_EARLY_GENES
0.184501845018%	1	542	179	T2D_GENES_TANYA_ANTHROPOMETRIC	BENPORATH_NOS_TARGETS
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	WIKMAN_ASBESTOS_LUNG_CANCER_UP
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	SA_PTEN_PATHWAY
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TIE2_SIGNALING
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SHC_RELATED_EVENTS
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_REGULATION_OF_KIT_SIGNALING
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_ANTHRAXPATHWAY
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	HOWLIN_CITED1_TARGETS_2_UP
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	GOUYER_TATI_TARGETS_DN
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	GALE_APL_WITH_FLT3_MUTATED_DN
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_LAIR_PATHWAY
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_IL7_PATHWAY
0.184501845018%	1	542	17	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_IL10_PATHWAY
0.184501845018%	1	542	163	T2D_GENES_TANYA_ANTHROPOMETRIC	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	XU_RESPONSE_TO_TRETINOIN_UP
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	WONG_IFNA2_RESISTANCE_UP
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_INTEGRATION_OF_PROVIRUS
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_DNAPK_PATHWAY
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	LUI_THYROID_CANCER_CLUSTER_4
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	KOINUMA_COLON_CANCER_MSI_DN
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_RIBOFLAVIN_METABOLISM
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_OTHER_GLYCAN_DEGRADATION
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	HE_PTEN_TARGETS_UP
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	DASU_IL6_SIGNALING_SCAR_DN
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_GATA3_PATHWAY
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	BAKER_HEMATOPOIESIS_STAT3_TARGETS
0.184501845018%	1	542	16	T2D_GENES_TANYA_ANTHROPOMETRIC	AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
0.184501845018%	1	542	157	T2D_GENES_TANYA_ANTHROPOMETRIC	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP
0.184501845018%	1	542	151	T2D_GENES_TANYA_ANTHROPOMETRIC	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
0.184501845018%	1	542	151	T2D_GENES_TANYA_ANTHROPOMETRIC	IGLESIAS_E2F_TARGETS_UP
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	TSUNODA_CISPLATIN_RESISTANCE_UP
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	SU_KIDNEY
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	SINGH_NFE2L2_TARGETS
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	SANDERSON_PPARA_TARGETS
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ZINC_TRANSPORTERS
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SHC_MEDIATED_SIGNALLING
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	PIEPOLI_LGI1_TARGETS_UP
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_ERB_GENOMIC_PATHWAY
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	NAGY_STAGA_COMPONENTS_HUMAN
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	MARKS_ACETYLATED_NON_HISTONE_PROTEINS
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	LIU_IL13_PRIMING_MODEL
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	GRANDVAUX_IRF3_TARGETS_UP
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	FINETTI_BREAST_CANCERS_KINOME_GRAY
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	DAZARD_UV_RESPONSE_CLUSTER_G3
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	CHANG_POU5F1_TARGETS_UP
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_TALL1_PATHWAY
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_STEM_PATHWAY
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_RARRXR_PATHWAY
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_PITX2_PATHWAY
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_IL3_PATHWAY
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_HIF_PATHWAY
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_CTL_PATHWAY
0.184501845018%	1	542	15	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_BARRESTIN_SRC_PATHWAY
0.184501845018%	1	542	149	T2D_GENES_TANYA_ANTHROPOMETRIC	NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON
0.184501845018%	1	542	147	T2D_GENES_TANYA_ANTHROPOMETRIC	KAUFFMANN_DNA_REPLICATION_GENES
0.184501845018%	1	542	145	T2D_GENES_TANYA_ANTHROPOMETRIC	RODWELL_AGING_KIDNEY_DN
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHANG_ADIPOGENESIS_BY_BMP7
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	TOMLINS_METASTASIS_UP
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SOS_MEDIATED_SIGNALLING
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_REGULATION_OF_IFNG_SIGNALING
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PROLACTIN_RECEPTOR_SIGNALING
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_METABOLISM_OF_PORPHYRINS
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_TCRRASPATHWAY
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_S1P_S1P4_PATHWAY
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_IL5_PATHWAY
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	MATZUK_POST-IMPLANTATION_AND_POST-PARTUM
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	KINNEY_DNMT1_METHYLATION_TARGETS
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	GILMORE_CORE_NFKB_PATHWAY
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_RANKL_PATHWAY
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_GRANULOCYTES_PATHWAY
0.184501845018%	1	542	14	T2D_GENES_TANYA_ANTHROPOMETRIC	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP
0.184501845018%	1	542	137	T2D_GENES_TANYA_ANTHROPOMETRIC	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
0.184501845018%	1	542	134	T2D_GENES_TANYA_ANTHROPOMETRIC	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
0.184501845018%	1	542	132	T2D_GENES_TANYA_ANTHROPOMETRIC	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	WACKER_HYPOXIA_TARGETS_OF_VHL
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	TERAMOTO_OPN_TARGETS_CLUSTER_1
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	SHI_SPARC_TARGETS_DN
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_PURINE_SALVAGE
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6_ALPHA
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	RAY_ALZHEIMERS_DISEASE
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	MATZUK_EARLY_ANTRAL_FOLLICLE
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	KORKOLA_SEMINOMA_DN
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	KORKOLA_EMBRYONAL_CARCINOMA_DN
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	KORKOLA_EMBRYONAL_CARCINOMA
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_MYCL1_AMPLIFICATION_TARGETS_UP
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_CIRCADIAN_RHYTHM_MAMMAL
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	IVANOV_MUTATED_IN_COLON_CANCER
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	IRITANI_MAD1_TARGETS_UP
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	HASINA_NOL7_TARGETS_DN
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	GHO_ATF5_TARGETS_UP
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	GERHOLD_RESPONSE_TO_TZD_DN
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	ELLWOOD_MYC_TARGETS_UP
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	EHRLICH_ICF_SYNDROM_UP
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	CAFFAREL_RESPONSE_TO_THC_24HR_3_DN
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_CARM1_PATHWAY
0.184501845018%	1	542	13	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_AHSP_PATHWAY
0.184501845018%	1	542	129	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP
0.184501845018%	1	542	129	T2D_GENES_TANYA_ANTHROPOMETRIC	BROWN_MYELOID_CELL_DEVELOPMENT_DN
0.184501845018%	1	542	128	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHU_CMV_ALL_DN
0.184501845018%	1	542	124	T2D_GENES_TANYA_ANTHROPOMETRIC	DAIRKEE_TERT_TARGETS_DN
0.184501845018%	1	542	122	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CHROMOSOME_MAINTENANCE
0.184501845018%	1	542	122	T2D_GENES_TANYA_ANTHROPOMETRIC	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
0.184501845018%	1	542	121	T2D_GENES_TANYA_ANTHROPOMETRIC	VANTVEER_BREAST_CANCER_METASTASIS_DN
0.184501845018%	1	542	121	T2D_GENES_TANYA_ANTHROPOMETRIC	RODRIGUES_DCC_TARGETS_DN
0.184501845018%	1	542	120	T2D_GENES_TANYA_ANTHROPOMETRIC	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	TURJANSKI_MAPK1_AND_MAPK2_TARGETS
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ERKS_ARE_INACTIVATED
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	MIZUKAMI_HYPOXIA_UP
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	KRISHNAN_FURIN_TARGETS_UP
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	FIGUEROA_AML_METHYLATION_CLUSTER_5_UP
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	DING_LUNG_CANCER_MUTATED_FREQUENTLY
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	CLAUS_PGR_POSITIVE_MENINGIOMA_DN
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_BARR_MAPK_PATHWAY
0.184501845018%	1	542	12	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_ASBCELL_PATHWAY
0.184501845018%	1	542	117	T2D_GENES_TANYA_ANTHROPOMETRIC	PUJANA_BRCA_CENTERED_NETWORK
0.184501845018%	1	542	116	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MEIOSIS
0.184501845018%	1	542	113	T2D_GENES_TANYA_ANTHROPOMETRIC	TSENG_IRS1_TARGETS_UP
0.184501845018%	1	542	111	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_GLYCOSAMINOGLYCAN_METABOLISM
0.184501845018%	1	542	111	T2D_GENES_TANYA_ANTHROPOMETRIC	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
0.184501845018%	1	542	110	T2D_GENES_TANYA_ANTHROPOMETRIC	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	ZHOU_PANCREATIC_BETA_CELL
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	SASAKI_TARGETS_OF_TP73_AND_TP63
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_MTORC1_MEDIATED_SIGNALLING
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_CALNEXIN_CALRETICULIN_CYCLE
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	POS_RESPONSE_TO_HISTAMINE_DN
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_RANBP2PATHWAY
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	KORKOLA_CHORIOCARCINOMA_DN
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	FUNG_IL2_SIGNALING_1
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	CHUANG_OXIDATIVE_STRESS_RESPONSE_DN
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	CAFFAREL_RESPONSE_TO_THC_8HR_5_DN
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_TCAPOPTOSIS_PATHWAY
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_SET_PATHWAY
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_EPONFKB_PATHWAY
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_EGFR_SMRTE_PATHWAY
0.184501845018%	1	542	11	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_CDK5_PATHWAY
0.184501845018%	1	542	109	T2D_GENES_TANYA_ANTHROPOMETRIC	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.184501845018%	1	542	108	T2D_GENES_TANYA_ANTHROPOMETRIC	WESTON_VEGFA_TARGETS
0.184501845018%	1	542	108	T2D_GENES_TANYA_ANTHROPOMETRIC	LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT
0.184501845018%	1	542	107	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_SIGNALING_BY_ILS
0.184501845018%	1	542	107	T2D_GENES_TANYA_ANTHROPOMETRIC	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.184501845018%	1	542	106	T2D_GENES_TANYA_ANTHROPOMETRIC	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
0.184501845018%	1	542	105	T2D_GENES_TANYA_ANTHROPOMETRIC	STEIN_ESRRA_TARGETS_DN
0.184501845018%	1	542	104	T2D_GENES_TANYA_ANTHROPOMETRIC	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.184501845018%	1	542	103	T2D_GENES_TANYA_ANTHROPOMETRIC	KIM_MYCN_AMPLIFICATION_TARGETS_DN
0.184501845018%	1	542	101	T2D_GENES_TANYA_ANTHROPOMETRIC	WIELAND_UP_BY_HBV_INFECTION
0.184501845018%	1	542	101	T2D_GENES_TANYA_ANTHROPOMETRIC	GRADE_COLON_AND_RECTAL_CANCER_DN
0.184501845018%	1	542	101	T2D_GENES_TANYA_ANTHROPOMETRIC	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.184501845018%	1	542	100	T2D_GENES_TANYA_ANTHROPOMETRIC	RICKMAN_HEAD_AND_NECK_CANCER_A
0.184501845018%	1	542	100	T2D_GENES_TANYA_ANTHROPOMETRIC	CHICAS_RB1_TARGETS_LOW_SERUM
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	WORSCHECH_TUMOR_REJECTION_DN
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	SHIRAISHI_PLZF_TARGETS_UP
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	SEMBA_FHIT_TARGETS_DN
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_RAF_MAP_KINASE_CASCADE
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ETHANOL_OXIDATION
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	PID_VEGF_VEGFR_PATHWAY
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	OHASHI_AURKB_TARGETS
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	MATZUK_PREOVULATORY_FOLLICLE
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	KEGG_LIMONENE_AND_PINENE_DEGRADATION
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	GOUYER_TATI_TARGETS_UP
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	CHASSOT_SKIN_WOUND
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	CAFFAREL_RESPONSE_TO_THC_8HR_3_DN
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	BUDHU_LIVER_CANCER_METASTASIS_UP
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_SODD_PATHWAY
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	BIOCARTA_RNA_PATHWAY
0.184501845018%	1	542	10	T2D_GENES_TANYA_ANTHROPOMETRIC	AGARWAL_AKT_PATHWAY_TARGETS
0.183992640294%	4	2174	93	T2D_GENES_TANYA_LIPIDS	CHEN_LIVER_METABOLISM_QTL_CIS
0.183992640294%	4	2174	92	T2D_GENES_TANYA_LIPIDS	CAMPS_COLON_CANCER_COPY_NUMBER_UP
0.183992640294%	4	2174	90	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_ERBB4
0.183992640294%	4	2174	9	T2D_GENES_TANYA_LIPIDS	FIGUEROA_AML_METHYLATION_CLUSTER_2_DN
0.183992640294%	4	2174	85	T2D_GENES_TANYA_LIPIDS	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
0.183992640294%	4	2174	84	T2D_GENES_TANYA_LIPIDS	SWEET_KRAS_TARGETS_UP
0.183992640294%	4	2174	84	T2D_GENES_TANYA_LIPIDS	KEGG_ECM_RECEPTOR_INTERACTION
0.183992640294%	4	2174	84	T2D_GENES_TANYA_LIPIDS	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
0.183992640294%	4	2174	83	T2D_GENES_TANYA_LIPIDS	ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.183992640294%	4	2174	8	T2D_GENES_TANYA_LIPIDS	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3
0.183992640294%	4	2174	79	T2D_GENES_TANYA_LIPIDS	TOOKER_GEMCITABINE_RESISTANCE_UP
0.183992640294%	4	2174	78	T2D_GENES_TANYA_LIPIDS	REACTOME_PLATELET_HOMEOSTASIS
0.183992640294%	4	2174	77	T2D_GENES_TANYA_LIPIDS	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
0.183992640294%	4	2174	77	T2D_GENES_TANYA_LIPIDS	RODRIGUES_THYROID_CARCINOMA_DN
0.183992640294%	4	2174	76	T2D_GENES_TANYA_LIPIDS	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
0.183992640294%	4	2174	74	T2D_GENES_TANYA_LIPIDS	REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX
0.183992640294%	4	2174	73	T2D_GENES_TANYA_LIPIDS	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.183992640294%	4	2174	73	T2D_GENES_TANYA_LIPIDS	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
0.183992640294%	4	2174	72	T2D_GENES_TANYA_LIPIDS	SESTO_RESPONSE_TO_UV_C8
0.183992640294%	4	2174	71	T2D_GENES_TANYA_LIPIDS	REACTOME_PI3K_CASCADE
0.183992640294%	4	2174	70	T2D_GENES_TANYA_LIPIDS	LANDIS_BREAST_CANCER_PROGRESSION_DN
0.183992640294%	4	2174	69	T2D_GENES_TANYA_LIPIDS	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.183992640294%	4	2174	69	T2D_GENES_TANYA_LIPIDS	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
0.183992640294%	4	2174	68	T2D_GENES_TANYA_LIPIDS	LIN_NPAS4_TARGETS_DN
0.183992640294%	4	2174	68	T2D_GENES_TANYA_LIPIDS	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN
0.183992640294%	4	2174	67	T2D_GENES_TANYA_LIPIDS	ELVIDGE_HIF1A_TARGETS_UP
0.183992640294%	4	2174	67	T2D_GENES_TANYA_LIPIDS	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70
0.183992640294%	4	2174	66	T2D_GENES_TANYA_LIPIDS	SWEET_KRAS_TARGETS_DN
0.183992640294%	4	2174	66	T2D_GENES_TANYA_LIPIDS	RAMASWAMY_METASTASIS_UP
0.183992640294%	4	2174	65	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER_MYC_TGFA_DN
0.183992640294%	4	2174	64	T2D_GENES_TANYA_LIPIDS	ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE
0.183992640294%	4	2174	62	T2D_GENES_TANYA_LIPIDS	KYNG_DNA_DAMAGE_BY_UV
0.183992640294%	4	2174	61	T2D_GENES_TANYA_LIPIDS	ZWANG_EGF_PERSISTENTLY_DN
0.183992640294%	4	2174	60	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER_DENA_UP
0.183992640294%	4	2174	60	T2D_GENES_TANYA_LIPIDS	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
0.183992640294%	4	2174	60	T2D_GENES_TANYA_LIPIDS	CROONQUIST_STROMAL_STIMULATION_UP
0.183992640294%	4	2174	59	T2D_GENES_TANYA_LIPIDS	WESTON_VEGFA_TARGETS_6HR
0.183992640294%	4	2174	59	T2D_GENES_TANYA_LIPIDS	MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3
0.183992640294%	4	2174	59	T2D_GENES_TANYA_LIPIDS	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1
0.183992640294%	4	2174	59	T2D_GENES_TANYA_LIPIDS	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
0.183992640294%	4	2174	58	T2D_GENES_TANYA_LIPIDS	SANSOM_WNT_PATHWAY_REQUIRE_MYC
0.183992640294%	4	2174	58	T2D_GENES_TANYA_LIPIDS	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN
0.183992640294%	4	2174	58	T2D_GENES_TANYA_LIPIDS	BIOCARTA_HIVNEF_PATHWAY
0.183992640294%	4	2174	57	T2D_GENES_TANYA_LIPIDS	TANG_SENESCENCE_TP53_TARGETS_DN
0.183992640294%	4	2174	57	T2D_GENES_TANYA_LIPIDS	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN
0.183992640294%	4	2174	57	T2D_GENES_TANYA_LIPIDS	REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.183992640294%	4	2174	57	T2D_GENES_TANYA_LIPIDS	PEART_HDAC_PROLIFERATION_CLUSTER_UP
0.183992640294%	4	2174	57	T2D_GENES_TANYA_LIPIDS	GYORFFY_MITOXANTRONE_RESISTANCE
0.183992640294%	4	2174	57	T2D_GENES_TANYA_LIPIDS	DELASERNA_MYOD_TARGETS_DN
0.183992640294%	4	2174	56	T2D_GENES_TANYA_LIPIDS	ZHENG_IL22_SIGNALING_UP
0.183992640294%	4	2174	56	T2D_GENES_TANYA_LIPIDS	WORSCHECH_TUMOR_REJECTION_UP
0.183992640294%	4	2174	55	T2D_GENES_TANYA_LIPIDS	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53
0.183992640294%	4	2174	55	T2D_GENES_TANYA_LIPIDS	GENTILE_UV_RESPONSE_CLUSTER_D4
0.183992640294%	4	2174	54	T2D_GENES_TANYA_LIPIDS	ZHOU_TNF_SIGNALING_4HR
0.183992640294%	4	2174	54	T2D_GENES_TANYA_LIPIDS	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM
0.183992640294%	4	2174	54	T2D_GENES_TANYA_LIPIDS	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP
0.183992640294%	4	2174	54	T2D_GENES_TANYA_LIPIDS	PID_TAP63PATHWAY
0.183992640294%	4	2174	54	T2D_GENES_TANYA_LIPIDS	FIGUEROA_AML_METHYLATION_CLUSTER_2_UP
0.183992640294%	4	2174	53	T2D_GENES_TANYA_LIPIDS	IKEDA_MIR1_TARGETS_UP
0.183992640294%	4	2174	52	T2D_GENES_TANYA_LIPIDS	WINTER_HYPOXIA_DN
0.183992640294%	4	2174	52	T2D_GENES_TANYA_LIPIDS	ROSS_AML_WITH_CBFB_MYH11_FUSION
0.183992640294%	4	2174	52	T2D_GENES_TANYA_LIPIDS	REACTOME_GABA_RECEPTOR_ACTIVATION
0.183992640294%	4	2174	52	T2D_GENES_TANYA_LIPIDS	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6
0.183992640294%	4	2174	51	T2D_GENES_TANYA_LIPIDS	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE
0.183992640294%	4	2174	51	T2D_GENES_TANYA_LIPIDS	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.183992640294%	4	2174	51	T2D_GENES_TANYA_LIPIDS	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP
0.183992640294%	4	2174	50	T2D_GENES_TANYA_LIPIDS	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS
0.183992640294%	4	2174	49	T2D_GENES_TANYA_LIPIDS	REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS
0.183992640294%	4	2174	49	T2D_GENES_TANYA_LIPIDS	PID_ARF6_TRAFFICKINGPATHWAY
0.183992640294%	4	2174	49	T2D_GENES_TANYA_LIPIDS	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP
0.183992640294%	4	2174	48	T2D_GENES_TANYA_LIPIDS	TAVOR_CEBPA_TARGETS_UP
0.183992640294%	4	2174	48	T2D_GENES_TANYA_LIPIDS	RICKMAN_HEAD_AND_NECK_CANCER_B
0.183992640294%	4	2174	48	T2D_GENES_TANYA_LIPIDS	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE
0.183992640294%	4	2174	48	T2D_GENES_TANYA_LIPIDS	RASHI_RESPONSE_TO_IONIZING_RADIATION_3
0.183992640294%	4	2174	48	T2D_GENES_TANYA_LIPIDS	PID_HES_HEYPATHWAY
0.183992640294%	4	2174	48	T2D_GENES_TANYA_LIPIDS	PID_AJDISS_2PATHWAY
0.183992640294%	4	2174	47	T2D_GENES_TANYA_LIPIDS	PID_FANCONI_PATHWAY
0.183992640294%	4	2174	46	T2D_GENES_TANYA_LIPIDS	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION
0.183992640294%	4	2174	46	T2D_GENES_TANYA_LIPIDS	PID_PLK1_PATHWAY
0.183992640294%	4	2174	46	T2D_GENES_TANYA_LIPIDS	KUNINGER_IGF1_VS_PDGFB_TARGETS_DN
0.183992640294%	4	2174	46	T2D_GENES_TANYA_LIPIDS	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN
0.183992640294%	4	2174	46	T2D_GENES_TANYA_LIPIDS	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN
0.183992640294%	4	2174	45	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_PR_UP
0.183992640294%	4	2174	45	T2D_GENES_TANYA_LIPIDS	WANG_TARGETS_OF_MLL_CBP_FUSION_DN
0.183992640294%	4	2174	45	T2D_GENES_TANYA_LIPIDS	VANHARANTA_UTERINE_FIBROID_UP
0.183992640294%	4	2174	45	T2D_GENES_TANYA_LIPIDS	SIG_CHEMOTAXIS
0.183992640294%	4	2174	45	T2D_GENES_TANYA_LIPIDS	REACTOME_MRNA_SPLICING_MINOR_PATHWAY
0.183992640294%	4	2174	45	T2D_GENES_TANYA_LIPIDS	MCDOWELL_ACUTE_LUNG_INJURY_UP
0.183992640294%	4	2174	45	T2D_GENES_TANYA_LIPIDS	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN
0.183992640294%	4	2174	45	T2D_GENES_TANYA_LIPIDS	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN
0.183992640294%	4	2174	45	T2D_GENES_TANYA_LIPIDS	GRADE_METASTASIS_DN
0.183992640294%	4	2174	44	T2D_GENES_TANYA_LIPIDS	WHITFIELD_CELL_CYCLE_LITERATURE
0.183992640294%	4	2174	44	T2D_GENES_TANYA_LIPIDS	VANTVEER_BREAST_CANCER_BRCA1_DN
0.183992640294%	4	2174	44	T2D_GENES_TANYA_LIPIDS	ROVERSI_GLIOMA_LOH_REGIONS
0.183992640294%	4	2174	44	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS
0.183992640294%	4	2174	44	T2D_GENES_TANYA_LIPIDS	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS
0.183992640294%	4	2174	44	T2D_GENES_TANYA_LIPIDS	OHGUCHI_LIVER_HNF4A_TARGETS_UP
0.183992640294%	4	2174	44	T2D_GENES_TANYA_LIPIDS	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP
0.183992640294%	4	2174	44	T2D_GENES_TANYA_LIPIDS	KEGG_NUCLEOTIDE_EXCISION_REPAIR
0.183992640294%	4	2174	44	T2D_GENES_TANYA_LIPIDS	JAEGER_METASTASIS_UP
0.183992640294%	4	2174	44	T2D_GENES_TANYA_LIPIDS	GROSS_HYPOXIA_VIA_ELK3_ONLY_DN
0.183992640294%	4	2174	43	T2D_GENES_TANYA_LIPIDS	ZUCCHI_METASTASIS_UP
0.183992640294%	4	2174	43	T2D_GENES_TANYA_LIPIDS	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS
0.183992640294%	4	2174	43	T2D_GENES_TANYA_LIPIDS	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK
0.183992640294%	4	2174	43	T2D_GENES_TANYA_LIPIDS	PID_INTEGRIN3_PATHWAY
0.183992640294%	4	2174	43	T2D_GENES_TANYA_LIPIDS	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN
0.183992640294%	4	2174	43	T2D_GENES_TANYA_LIPIDS	NAKAYAMA_FRA2_TARGETS
0.183992640294%	4	2174	43	T2D_GENES_TANYA_LIPIDS	NAKAMURA_METASTASIS_MODEL_DN
0.183992640294%	4	2174	43	T2D_GENES_TANYA_LIPIDS	LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.183992640294%	4	2174	43	T2D_GENES_TANYA_LIPIDS	HUMMEL_BURKITTS_LYMPHOMA_UP
0.183992640294%	4	2174	43	T2D_GENES_TANYA_LIPIDS	COWLING_MYCN_TARGETS
0.183992640294%	4	2174	42	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CHREBP2_PATHWAY
0.183992640294%	4	2174	42	T2D_GENES_TANYA_LIPIDS	BARRIER_COLON_CANCER_RECURRENCE_UP
0.183992640294%	4	2174	41	T2D_GENES_TANYA_LIPIDS	RIZ_ERYTHROID_DIFFERENTIATION_HBZ
0.183992640294%	4	2174	41	T2D_GENES_TANYA_LIPIDS	MALONEY_RESPONSE_TO_17AAG_UP
0.183992640294%	4	2174	41	T2D_GENES_TANYA_LIPIDS	LIN_MELANOMA_COPY_NUMBER_DN
0.183992640294%	4	2174	41	T2D_GENES_TANYA_LIPIDS	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN
0.183992640294%	4	2174	41	T2D_GENES_TANYA_LIPIDS	KAMMINGA_SENESCENCE
0.183992640294%	4	2174	41	T2D_GENES_TANYA_LIPIDS	GENTILE_UV_RESPONSE_CLUSTER_D2
0.183992640294%	4	2174	41	T2D_GENES_TANYA_LIPIDS	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
0.183992640294%	4	2174	40	T2D_GENES_TANYA_LIPIDS	VARELA_ZMPSTE24_TARGETS_UP
0.183992640294%	4	2174	40	T2D_GENES_TANYA_LIPIDS	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
0.183992640294%	4	2174	40	T2D_GENES_TANYA_LIPIDS	MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.183992640294%	4	2174	40	T2D_GENES_TANYA_LIPIDS	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN
0.183992640294%	4	2174	40	T2D_GENES_TANYA_LIPIDS	BERNARD_PPAPDC1B_TARGETS_UP
0.183992640294%	4	2174	39	T2D_GENES_TANYA_LIPIDS	NEWMAN_ERCC6_TARGETS_DN
0.183992640294%	4	2174	39	T2D_GENES_TANYA_LIPIDS	KORKOLA_TERATOMA
0.183992640294%	4	2174	39	T2D_GENES_TANYA_LIPIDS	HOFMANN_CELL_LYMPHOMA_DN
0.183992640294%	4	2174	39	T2D_GENES_TANYA_LIPIDS	HAN_JNK_SINGALING_DN
0.183992640294%	4	2174	39	T2D_GENES_TANYA_LIPIDS	GU_PDEF_TARGETS_DN
0.183992640294%	4	2174	39	T2D_GENES_TANYA_LIPIDS	GENTILE_UV_RESPONSE_CLUSTER_D5
0.183992640294%	4	2174	39	T2D_GENES_TANYA_LIPIDS	BURTON_ADIPOGENESIS_PEAK_AT_8HR
0.183992640294%	4	2174	39	T2D_GENES_TANYA_LIPIDS	AMIT_SERUM_RESPONSE_480_MCF10A
0.183992640294%	4	2174	39	T2D_GENES_TANYA_LIPIDS	AMIT_EGF_RESPONSE_60_MCF10A
0.183992640294%	4	2174	38	T2D_GENES_TANYA_LIPIDS	REACTOME_GABA_B_RECEPTOR_ACTIVATION
0.183992640294%	4	2174	38	T2D_GENES_TANYA_LIPIDS	PENG_GLUTAMINE_DEPRIVATION_UP
0.183992640294%	4	2174	38	T2D_GENES_TANYA_LIPIDS	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN
0.183992640294%	4	2174	38	T2D_GENES_TANYA_LIPIDS	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN
0.183992640294%	4	2174	38	T2D_GENES_TANYA_LIPIDS	BIOCARTA_INTEGRIN_PATHWAY
0.183992640294%	4	2174	37	T2D_GENES_TANYA_LIPIDS	VALK_AML_WITH_CEBPA
0.183992640294%	4	2174	37	T2D_GENES_TANYA_LIPIDS	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.183992640294%	4	2174	37	T2D_GENES_TANYA_LIPIDS	MURAKAMI_UV_RESPONSE_6HR_UP
0.183992640294%	4	2174	37	T2D_GENES_TANYA_LIPIDS	LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES
0.183992640294%	4	2174	37	T2D_GENES_TANYA_LIPIDS	GENTILE_UV_RESPONSE_CLUSTER_D6
0.183992640294%	4	2174	37	T2D_GENES_TANYA_LIPIDS	CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE
0.183992640294%	4	2174	37	T2D_GENES_TANYA_LIPIDS	BIOCARTA_MET_PATHWAY
0.183992640294%	4	2174	37	T2D_GENES_TANYA_LIPIDS	BILANGES_SERUM_RESPONSE_TRANSLATION
0.183992640294%	4	2174	36	T2D_GENES_TANYA_LIPIDS	YIH_RESPONSE_TO_ARSENITE_C3
0.183992640294%	4	2174	36	T2D_GENES_TANYA_LIPIDS	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
0.183992640294%	4	2174	36	T2D_GENES_TANYA_LIPIDS	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
0.183992640294%	4	2174	36	T2D_GENES_TANYA_LIPIDS	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION
0.183992640294%	4	2174	36	T2D_GENES_TANYA_LIPIDS	JIANG_AGING_CEREBRAL_CORTEX_UP
0.183992640294%	4	2174	36	T2D_GENES_TANYA_LIPIDS	HOUSTIS_ROS
0.183992640294%	4	2174	36	T2D_GENES_TANYA_LIPIDS	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP
0.183992640294%	4	2174	36	T2D_GENES_TANYA_LIPIDS	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP
0.183992640294%	4	2174	35	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15
0.183992640294%	4	2174	35	T2D_GENES_TANYA_LIPIDS	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.183992640294%	4	2174	35	T2D_GENES_TANYA_LIPIDS	REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D
0.183992640294%	4	2174	35	T2D_GENES_TANYA_LIPIDS	REACTOME_GLOBAL_GENOMIC_NER_GG_NER
0.183992640294%	4	2174	35	T2D_GENES_TANYA_LIPIDS	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP
0.183992640294%	4	2174	35	T2D_GENES_TANYA_LIPIDS	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP
0.183992640294%	4	2174	35	T2D_GENES_TANYA_LIPIDS	AIGNER_ZEB1_TARGETS
0.183992640294%	4	2174	34	T2D_GENES_TANYA_LIPIDS	YANG_BREAST_CANCER_ESR1_LASER_UP
0.183992640294%	4	2174	34	T2D_GENES_TANYA_LIPIDS	ST_WNT_BETA_CATENIN_PATHWAY
0.183992640294%	4	2174	34	T2D_GENES_TANYA_LIPIDS	PLASARI_TGFB1_TARGETS_1HR_UP
0.183992640294%	4	2174	34	T2D_GENES_TANYA_LIPIDS	PID_HIF2PATHWAY
0.183992640294%	4	2174	34	T2D_GENES_TANYA_LIPIDS	PID_EPHA_FWDPATHWAY
0.183992640294%	4	2174	34	T2D_GENES_TANYA_LIPIDS	KEGG_CYSTEINE_AND_METHIONINE_METABOLISM
0.183992640294%	4	2174	34	T2D_GENES_TANYA_LIPIDS	HONMA_DOCETAXEL_RESISTANCE
0.183992640294%	4	2174	34	T2D_GENES_TANYA_LIPIDS	BIOCARTA_MPR_PATHWAY
0.183992640294%	4	2174	34	T2D_GENES_TANYA_LIPIDS	ABE_VEGFA_TARGETS_2HR
0.183992640294%	4	2174	33	T2D_GENES_TANYA_LIPIDS	REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS
0.183992640294%	4	2174	33	T2D_GENES_TANYA_LIPIDS	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS
0.183992640294%	4	2174	33	T2D_GENES_TANYA_LIPIDS	KEGG_ETHER_LIPID_METABOLISM
0.183992640294%	4	2174	33	T2D_GENES_TANYA_LIPIDS	HEIDENBLAD_AMPLICON_12P11_12_UP
0.183992640294%	4	2174	33	T2D_GENES_TANYA_LIPIDS	GHANDHI_DIRECT_IRRADIATION_DN
0.183992640294%	4	2174	33	T2D_GENES_TANYA_LIPIDS	FIRESTEIN_CTNNB1_PATHWAY
0.183992640294%	4	2174	32	T2D_GENES_TANYA_LIPIDS	TSAI_RESPONSE_TO_RADIATION_THERAPY
0.183992640294%	4	2174	32	T2D_GENES_TANYA_LIPIDS	TRACEY_RESISTANCE_TO_IFNA2_DN
0.183992640294%	4	2174	32	T2D_GENES_TANYA_LIPIDS	REACTOME_ELONGATION_ARREST_AND_RECOVERY
0.183992640294%	4	2174	32	T2D_GENES_TANYA_LIPIDS	MEISSNER_BRAIN_ICP_WITH_H3K4ME3
0.183992640294%	4	2174	32	T2D_GENES_TANYA_LIPIDS	LIANG_SILENCED_BY_METHYLATION_UP
0.183992640294%	4	2174	32	T2D_GENES_TANYA_LIPIDS	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM
0.183992640294%	4	2174	32	T2D_GENES_TANYA_LIPIDS	KASLER_HDAC7_TARGETS_2_DN
0.183992640294%	4	2174	32	T2D_GENES_TANYA_LIPIDS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP
0.183992640294%	4	2174	32	T2D_GENES_TANYA_LIPIDS	BIOCARTA_HDAC_PATHWAY
0.183992640294%	4	2174	31	T2D_GENES_TANYA_LIPIDS	SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN
0.183992640294%	4	2174	31	T2D_GENES_TANYA_LIPIDS	NOJIMA_SFRP2_TARGETS_UP
0.183992640294%	4	2174	31	T2D_GENES_TANYA_LIPIDS	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.183992640294%	4	2174	31	T2D_GENES_TANYA_LIPIDS	DANG_MYC_TARGETS_DN
0.183992640294%	4	2174	31	T2D_GENES_TANYA_LIPIDS	BIOCARTA_MYOSIN_PATHWAY
0.183992640294%	4	2174	31	T2D_GENES_TANYA_LIPIDS	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.183992640294%	4	2174	31	T2D_GENES_TANYA_LIPIDS	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN
0.183992640294%	4	2174	30	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.183992640294%	4	2174	30	T2D_GENES_TANYA_LIPIDS	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN
0.183992640294%	4	2174	30	T2D_GENES_TANYA_LIPIDS	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.183992640294%	4	2174	30	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
0.183992640294%	4	2174	30	T2D_GENES_TANYA_LIPIDS	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES
0.183992640294%	4	2174	30	T2D_GENES_TANYA_LIPIDS	REACTOME_DNA_STRAND_ELONGATION
0.183992640294%	4	2174	30	T2D_GENES_TANYA_LIPIDS	PID_RETINOIC_ACID_PATHWAY
0.183992640294%	4	2174	30	T2D_GENES_TANYA_LIPIDS	PID_NECTIN_PATHWAY
0.183992640294%	4	2174	30	T2D_GENES_TANYA_LIPIDS	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.183992640294%	4	2174	30	T2D_GENES_TANYA_LIPIDS	KYNG_NORMAL_AGING_DN
0.183992640294%	4	2174	30	T2D_GENES_TANYA_LIPIDS	GILDEA_METASTASIS
0.183992640294%	4	2174	30	T2D_GENES_TANYA_LIPIDS	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP
0.183992640294%	4	2174	30	T2D_GENES_TANYA_LIPIDS	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY
0.183992640294%	4	2174	29	T2D_GENES_TANYA_LIPIDS	WATANABE_COLON_CANCER_MSI_VS_MSS_UP
0.183992640294%	4	2174	29	T2D_GENES_TANYA_LIPIDS	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR
0.183992640294%	4	2174	29	T2D_GENES_TANYA_LIPIDS	TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN
0.183992640294%	4	2174	29	T2D_GENES_TANYA_LIPIDS	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN
0.183992640294%	4	2174	29	T2D_GENES_TANYA_LIPIDS	REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION
0.183992640294%	4	2174	29	T2D_GENES_TANYA_LIPIDS	REACTOME_PERK_REGULATED_GENE_EXPRESSION
0.183992640294%	4	2174	29	T2D_GENES_TANYA_LIPIDS	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
0.183992640294%	4	2174	29	T2D_GENES_TANYA_LIPIDS	PID_INTEGRIN2_PATHWAY
0.183992640294%	4	2174	29	T2D_GENES_TANYA_LIPIDS	PAL_PRMT5_TARGETS_DN
0.183992640294%	4	2174	29	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_MCV6_LCP_WITH_H3K27ME3
0.183992640294%	4	2174	29	T2D_GENES_TANYA_LIPIDS	MARSHALL_VIRAL_INFECTION_RESPONSE_DN
0.183992640294%	4	2174	29	T2D_GENES_TANYA_LIPIDS	LU_TUMOR_VASCULATURE_UP
0.183992640294%	4	2174	29	T2D_GENES_TANYA_LIPIDS	KYNG_WERNER_SYNDROM_DN
0.183992640294%	4	2174	29	T2D_GENES_TANYA_LIPIDS	KEGG_THYROID_CANCER
0.183992640294%	4	2174	29	T2D_GENES_TANYA_LIPIDS	GENTLES_LEUKEMIC_STEM_CELL_UP
0.183992640294%	4	2174	29	T2D_GENES_TANYA_LIPIDS	DALESSIO_TSA_RESPONSE
0.183992640294%	4	2174	28	T2D_GENES_TANYA_LIPIDS	VALK_AML_CLUSTER_7
0.183992640294%	4	2174	28	T2D_GENES_TANYA_LIPIDS	TERAO_AOX4_TARGETS_HG_UP
0.183992640294%	4	2174	28	T2D_GENES_TANYA_LIPIDS	ST_GAQ_PATHWAY
0.183992640294%	4	2174	28	T2D_GENES_TANYA_LIPIDS	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS
0.183992640294%	4	2174	28	T2D_GENES_TANYA_LIPIDS	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
0.183992640294%	4	2174	28	T2D_GENES_TANYA_LIPIDS	DAZARD_UV_RESPONSE_CLUSTER_G24
0.183992640294%	4	2174	27	T2D_GENES_TANYA_LIPIDS	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN
0.183992640294%	4	2174	27	T2D_GENES_TANYA_LIPIDS	XU_AKT1_TARGETS_6HR
0.183992640294%	4	2174	27	T2D_GENES_TANYA_LIPIDS	TERAMOTO_OPN_TARGETS_CLUSTER_6
0.183992640294%	4	2174	27	T2D_GENES_TANYA_LIPIDS	ST_GRANULE_CELL_SURVIVAL_PATHWAY
0.183992640294%	4	2174	27	T2D_GENES_TANYA_LIPIDS	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
0.183992640294%	4	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_EXTENSION_OF_TELOMERES
0.183992640294%	4	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT
0.183992640294%	4	2174	27	T2D_GENES_TANYA_LIPIDS	NICK_RESPONSE_TO_PROC_TREATMENT_DN
0.183992640294%	4	2174	27	T2D_GENES_TANYA_LIPIDS	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN
0.183992640294%	4	2174	27	T2D_GENES_TANYA_LIPIDS	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP
0.183992640294%	4	2174	27	T2D_GENES_TANYA_LIPIDS	BOYAULT_LIVER_CANCER_SUBCLASS_G2
0.183992640294%	4	2174	26	T2D_GENES_TANYA_LIPIDS	VALK_AML_CLUSTER_8
0.183992640294%	4	2174	26	T2D_GENES_TANYA_LIPIDS	ST_INTERLEUKIN_4_PATHWAY
0.183992640294%	4	2174	26	T2D_GENES_TANYA_LIPIDS	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP
0.183992640294%	4	2174	26	T2D_GENES_TANYA_LIPIDS	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER
0.183992640294%	4	2174	26	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATORY_RNA_PATHWAYS
0.183992640294%	4	2174	26	T2D_GENES_TANYA_LIPIDS	REACTOME_ACTIVATION_OF_GENES_BY_ATF4
0.183992640294%	4	2174	26	T2D_GENES_TANYA_LIPIDS	PID_P38_MKK3_6PATHWAY
0.183992640294%	4	2174	26	T2D_GENES_TANYA_LIPIDS	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1
0.183992640294%	4	2174	26	T2D_GENES_TANYA_LIPIDS	KEGG_SELENOAMINO_ACID_METABOLISM
0.183992640294%	4	2174	26	T2D_GENES_TANYA_LIPIDS	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES
0.183992640294%	4	2174	26	T2D_GENES_TANYA_LIPIDS	KEGG_GALACTOSE_METABOLISM
0.183992640294%	4	2174	26	T2D_GENES_TANYA_LIPIDS	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
0.183992640294%	4	2174	26	T2D_GENES_TANYA_LIPIDS	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP
0.183992640294%	4	2174	26	T2D_GENES_TANYA_LIPIDS	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
0.183992640294%	4	2174	25	T2D_GENES_TANYA_LIPIDS	WONG_ENDMETRIUM_CANCER_UP
0.183992640294%	4	2174	25	T2D_GENES_TANYA_LIPIDS	WANG_NFKB_TARGETS
0.183992640294%	4	2174	25	T2D_GENES_TANYA_LIPIDS	REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING
0.183992640294%	4	2174	25	T2D_GENES_TANYA_LIPIDS	REACTOME_DARPP_32_EVENTS
0.183992640294%	4	2174	25	T2D_GENES_TANYA_LIPIDS	PID_MYC_PATHWAY
0.183992640294%	4	2174	25	T2D_GENES_TANYA_LIPIDS	PID_LYMPHANGIOGENESIS_PATHWAY
0.183992640294%	4	2174	25	T2D_GENES_TANYA_LIPIDS	PID_HDAC_CLASSIII_PATHWAY
0.183992640294%	4	2174	25	T2D_GENES_TANYA_LIPIDS	LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS
0.183992640294%	4	2174	25	T2D_GENES_TANYA_LIPIDS	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP
0.183992640294%	4	2174	25	T2D_GENES_TANYA_LIPIDS	GENTILE_UV_HIGH_DOSE_UP
0.183992640294%	4	2174	25	T2D_GENES_TANYA_LIPIDS	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.183992640294%	4	2174	25	T2D_GENES_TANYA_LIPIDS	BIOCARTA_MCALPAIN_PATHWAY
0.183992640294%	4	2174	24	T2D_GENES_TANYA_LIPIDS	YIH_RESPONSE_TO_ARSENITE_C1
0.183992640294%	4	2174	24	T2D_GENES_TANYA_LIPIDS	YAN_ESCAPE_FROM_ANOIKIS
0.183992640294%	4	2174	24	T2D_GENES_TANYA_LIPIDS	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN
0.183992640294%	4	2174	24	T2D_GENES_TANYA_LIPIDS	SA_B_CELL_RECEPTOR_COMPLEXES
0.183992640294%	4	2174	24	T2D_GENES_TANYA_LIPIDS	REACTOME_PYRIMIDINE_METABOLISM
0.183992640294%	4	2174	24	T2D_GENES_TANYA_LIPIDS	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION
0.183992640294%	4	2174	24	T2D_GENES_TANYA_LIPIDS	REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION
0.183992640294%	4	2174	24	T2D_GENES_TANYA_LIPIDS	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23
0.183992640294%	4	2174	24	T2D_GENES_TANYA_LIPIDS	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN
0.183992640294%	4	2174	24	T2D_GENES_TANYA_LIPIDS	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY
0.183992640294%	4	2174	24	T2D_GENES_TANYA_LIPIDS	HASLINGER_B_CLL_WITH_13Q14_DELETION
0.183992640294%	4	2174	24	T2D_GENES_TANYA_LIPIDS	BIOCARTA_ECM_PATHWAY
0.183992640294%	4	2174	23	T2D_GENES_TANYA_LIPIDS	ST_GA12_PATHWAY
0.183992640294%	4	2174	23	T2D_GENES_TANYA_LIPIDS	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER
0.183992640294%	4	2174	23	T2D_GENES_TANYA_LIPIDS	PID_PRLSIGNALINGEVENTSPATHWAY
0.183992640294%	4	2174	23	T2D_GENES_TANYA_LIPIDS	PID_NFKAPPABCANONICALPATHWAY
0.183992640294%	4	2174	23	T2D_GENES_TANYA_LIPIDS	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION
0.183992640294%	4	2174	23	T2D_GENES_TANYA_LIPIDS	KEGG_NITROGEN_METABOLISM
0.183992640294%	4	2174	23	T2D_GENES_TANYA_LIPIDS	FERRANDO_HOX11_NEIGHBORS
0.183992640294%	4	2174	23	T2D_GENES_TANYA_LIPIDS	BIOCARTA_PTDINS_PATHWAY
0.183992640294%	4	2174	23	T2D_GENES_TANYA_LIPIDS	BIOCARTA_P53HYPOXIA_PATHWAY
0.183992640294%	4	2174	23	T2D_GENES_TANYA_LIPIDS	BIOCARTA_NFKB_PATHWAY
0.183992640294%	4	2174	23	T2D_GENES_TANYA_LIPIDS	BIOCARTA_MTOR_PATHWAY
0.183992640294%	4	2174	22	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_SPIKED
0.183992640294%	4	2174	22	T2D_GENES_TANYA_LIPIDS	WEBER_METHYLATED_ICP_IN_FIBROBLAST
0.183992640294%	4	2174	22	T2D_GENES_TANYA_LIPIDS	TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.183992640294%	4	2174	22	T2D_GENES_TANYA_LIPIDS	REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION
0.183992640294%	4	2174	22	T2D_GENES_TANYA_LIPIDS	REACTOME_ACYL_CHAIN_REMODELLING_OF_PC
0.183992640294%	4	2174	22	T2D_GENES_TANYA_LIPIDS	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
0.183992640294%	4	2174	22	T2D_GENES_TANYA_LIPIDS	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP
0.183992640294%	4	2174	22	T2D_GENES_TANYA_LIPIDS	HANSON_HRAS_SIGNALING_VIA_NFKB
0.183992640294%	4	2174	22	T2D_GENES_TANYA_LIPIDS	BIOCARTA_SPPA_PATHWAY
0.183992640294%	4	2174	22	T2D_GENES_TANYA_LIPIDS	BIOCARTA_INSULIN_PATHWAY
0.183992640294%	4	2174	22	T2D_GENES_TANYA_LIPIDS	BIOCARTA_GCR_PATHWAY
0.183992640294%	4	2174	22	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CHEMICAL_PATHWAY
0.183992640294%	4	2174	21	T2D_GENES_TANYA_LIPIDS	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP
0.183992640294%	4	2174	21	T2D_GENES_TANYA_LIPIDS	VERRECCHIA_RESPONSE_TO_TGFB1_C5
0.183992640294%	4	2174	21	T2D_GENES_TANYA_LIPIDS	STEGER_ADIPOGENESIS_UP
0.183992640294%	4	2174	21	T2D_GENES_TANYA_LIPIDS	REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION
0.183992640294%	4	2174	21	T2D_GENES_TANYA_LIPIDS	REACTOME_ERK_MAPK_TARGETS
0.183992640294%	4	2174	21	T2D_GENES_TANYA_LIPIDS	REACTOME_ACYL_CHAIN_REMODELLING_OF_PE
0.183992640294%	4	2174	21	T2D_GENES_TANYA_LIPIDS	BIOCARTA_TOB1_PATHWAY
0.183992640294%	4	2174	21	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CALCINEURIN_PATHWAY
0.183992640294%	4	2174	21	T2D_GENES_TANYA_LIPIDS	AMIT_SERUM_RESPONSE_20_MCF10A
0.183992640294%	4	2174	20	T2D_GENES_TANYA_LIPIDS	ZHU_SKIL_TARGETS_UP
0.183992640294%	4	2174	20	T2D_GENES_TANYA_LIPIDS	ZEMBUTSU_SENSITIVITY_TO_CISPLATIN
0.183992640294%	4	2174	20	T2D_GENES_TANYA_LIPIDS	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN
0.183992640294%	4	2174	20	T2D_GENES_TANYA_LIPIDS	NIELSEN_SYNOVIAL_SARCOMA_DN
0.183992640294%	4	2174	20	T2D_GENES_TANYA_LIPIDS	KIM_MYCL1_AMPLIFICATION_TARGETS_DN
0.183992640294%	4	2174	20	T2D_GENES_TANYA_LIPIDS	ABE_VEGFA_TARGETS
0.183992640294%	4	2174	19	T2D_GENES_TANYA_LIPIDS	VERNOCHET_ADIPOGENESIS
0.183992640294%	4	2174	19	T2D_GENES_TANYA_LIPIDS	VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP
0.183992640294%	4	2174	19	T2D_GENES_TANYA_LIPIDS	SCIBETTA_KDM5B_TARGETS_UP
0.183992640294%	4	2174	19	T2D_GENES_TANYA_LIPIDS	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS
0.183992640294%	4	2174	19	T2D_GENES_TANYA_LIPIDS	PID_ARF_3PATHWAY
0.183992640294%	4	2174	19	T2D_GENES_TANYA_LIPIDS	NIELSEN_LIPOSARCOMA_DN
0.183992640294%	4	2174	19	T2D_GENES_TANYA_LIPIDS	MIZUSHIMA_AUTOPHAGOSOME_FORMATION
0.183992640294%	4	2174	19	T2D_GENES_TANYA_LIPIDS	MAHADEVAN_RESPONSE_TO_MP470_DN
0.183992640294%	4	2174	19	T2D_GENES_TANYA_LIPIDS	LE_NEURONAL_DIFFERENTIATION_DN
0.183992640294%	4	2174	19	T2D_GENES_TANYA_LIPIDS	KEGG_ALPHA_LINOLENIC_ACID_METABOLISM
0.183992640294%	4	2174	19	T2D_GENES_TANYA_LIPIDS	KANG_CISPLATIN_RESISTANCE_UP
0.183992640294%	4	2174	19	T2D_GENES_TANYA_LIPIDS	HAHTOLA_MYCOSIS_FUNGOIDES_UP
0.183992640294%	4	2174	19	T2D_GENES_TANYA_LIPIDS	GAJATE_RESPONSE_TO_TRABECTEDIN_DN
0.183992640294%	4	2174	19	T2D_GENES_TANYA_LIPIDS	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP
0.183992640294%	4	2174	18	T2D_GENES_TANYA_LIPIDS	ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE
0.183992640294%	4	2174	18	T2D_GENES_TANYA_LIPIDS	SCHURINGA_STAT5A_TARGETS_DN
0.183992640294%	4	2174	18	T2D_GENES_TANYA_LIPIDS	REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI
0.183992640294%	4	2174	18	T2D_GENES_TANYA_LIPIDS	KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.183992640294%	4	2174	18	T2D_GENES_TANYA_LIPIDS	HUMMERICH_BENIGN_SKIN_TUMOR_DN
0.183992640294%	4	2174	18	T2D_GENES_TANYA_LIPIDS	CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB
0.183992640294%	4	2174	18	T2D_GENES_TANYA_LIPIDS	BIOCARTA_TNFR2_PATHWAY
0.183992640294%	4	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS
0.183992640294%	4	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS
0.183992640294%	4	2174	17	T2D_GENES_TANYA_LIPIDS	PID_SYNDECAN_3_PATHWAY
0.183992640294%	4	2174	17	T2D_GENES_TANYA_LIPIDS	PID_NFKAPPABATYPICALPATHWAY
0.183992640294%	4	2174	17	T2D_GENES_TANYA_LIPIDS	LOPEZ_EPITHELIOID_MESOTHELIOMA
0.183992640294%	4	2174	17	T2D_GENES_TANYA_LIPIDS	KEGG_RENIN_ANGIOTENSIN_SYSTEM
0.183992640294%	4	2174	17	T2D_GENES_TANYA_LIPIDS	INGA_TP53_TARGETS
0.183992640294%	4	2174	17	T2D_GENES_TANYA_LIPIDS	GALE_APL_WITH_FLT3_MUTATED_DN
0.183992640294%	4	2174	17	T2D_GENES_TANYA_LIPIDS	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.183992640294%	4	2174	17	T2D_GENES_TANYA_LIPIDS	BIOCARTA_IL17_PATHWAY
0.183992640294%	4	2174	17	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CK1_PATHWAY
0.183992640294%	4	2174	16	T2D_GENES_TANYA_LIPIDS	WANG_RECURRENT_LIVER_CANCER_DN
0.183992640294%	4	2174	16	T2D_GENES_TANYA_LIPIDS	KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS
0.183992640294%	4	2174	16	T2D_GENES_TANYA_LIPIDS	HAHTOLA_CTCL_PATHOGENESIS
0.183992640294%	4	2174	16	T2D_GENES_TANYA_LIPIDS	DASU_IL6_SIGNALING_SCAR_DN
0.183992640294%	4	2174	16	T2D_GENES_TANYA_LIPIDS	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL
0.183992640294%	4	2174	16	T2D_GENES_TANYA_LIPIDS	BAKER_HEMATOPOIESIS_STAT3_TARGETS
0.183992640294%	4	2174	15	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4
0.183992640294%	4	2174	15	T2D_GENES_TANYA_LIPIDS	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN
0.183992640294%	4	2174	15	T2D_GENES_TANYA_LIPIDS	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP
0.183992640294%	4	2174	15	T2D_GENES_TANYA_LIPIDS	SA_G1_AND_S_PHASES
0.183992640294%	4	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_ACYL_CHAIN_REMODELLING_OF_PI
0.183992640294%	4	2174	15	T2D_GENES_TANYA_LIPIDS	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP
0.183992640294%	4	2174	15	T2D_GENES_TANYA_LIPIDS	PID_ERB_GENOMIC_PATHWAY
0.183992640294%	4	2174	15	T2D_GENES_TANYA_LIPIDS	PID_ARF6DOWNSTREAMPATHWAY
0.183992640294%	4	2174	15	T2D_GENES_TANYA_LIPIDS	KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS
0.183992640294%	4	2174	15	T2D_GENES_TANYA_LIPIDS	EHRLICH_ICF_SYNDROM_DN
0.183992640294%	4	2174	15	T2D_GENES_TANYA_LIPIDS	DAZARD_UV_RESPONSE_CLUSTER_G3
0.183992640294%	4	2174	15	T2D_GENES_TANYA_LIPIDS	BIOCARTA_HIF_PATHWAY
0.183992640294%	4	2174	15	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CD40_PATHWAY
0.183992640294%	4	2174	14	T2D_GENES_TANYA_LIPIDS	WEBER_METHYLATED_ICP_IN_SPERM_DN
0.183992640294%	4	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_METABOLISM_OF_PORPHYRINS
0.183992640294%	4	2174	14	T2D_GENES_TANYA_LIPIDS	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24
0.183992640294%	4	2174	14	T2D_GENES_TANYA_LIPIDS	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP
0.183992640294%	4	2174	14	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_ES_LCP_WITH_H3K27ME3
0.183992640294%	4	2174	14	T2D_GENES_TANYA_LIPIDS	MATZUK_OVULATION
0.183992640294%	4	2174	14	T2D_GENES_TANYA_LIPIDS	GILMORE_CORE_NFKB_PATHWAY
0.183992640294%	4	2174	14	T2D_GENES_TANYA_LIPIDS	BIOCARTA_THELPER_PATHWAY
0.183992640294%	4	2174	14	T2D_GENES_TANYA_LIPIDS	BIOCARTA_TCYTOTOXIC_PATHWAY
0.183992640294%	4	2174	14	T2D_GENES_TANYA_LIPIDS	BIOCARTA_RANKL_PATHWAY
0.183992640294%	4	2174	14	T2D_GENES_TANYA_LIPIDS	BIOCARTA_GRANULOCYTES_PATHWAY
0.183992640294%	4	2174	14	T2D_GENES_TANYA_LIPIDS	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP
0.183992640294%	4	2174	132	T2D_GENES_TANYA_LIPIDS	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
0.183992640294%	4	2174	13	T2D_GENES_TANYA_LIPIDS	TERAMOTO_OPN_TARGETS_CLUSTER_4
0.183992640294%	4	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_PURINE_SALVAGE
0.183992640294%	4	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE
0.183992640294%	4	2174	13	T2D_GENES_TANYA_LIPIDS	ONGUSAHA_BRCA1_TARGETS_UP
0.183992640294%	4	2174	13	T2D_GENES_TANYA_LIPIDS	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
0.183992640294%	4	2174	13	T2D_GENES_TANYA_LIPIDS	BIOCARTA_ARENRF2_PATHWAY
0.183992640294%	4	2174	12	T2D_GENES_TANYA_LIPIDS	SUZUKI_CTCFL_TARGETS_UP
0.183992640294%	4	2174	12	T2D_GENES_TANYA_LIPIDS	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP
0.183992640294%	4	2174	12	T2D_GENES_TANYA_LIPIDS	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.183992640294%	4	2174	12	T2D_GENES_TANYA_LIPIDS	DAZARD_UV_RESPONSE_CLUSTER_G5
0.183992640294%	4	2174	12	T2D_GENES_TANYA_LIPIDS	BIOCARTA_TRKA_PATHWAY
0.183992640294%	4	2174	12	T2D_GENES_TANYA_LIPIDS	BIOCARTA_ASBCELL_PATHWAY
0.183992640294%	4	2174	11	T2D_GENES_TANYA_LIPIDS	SASAKI_TARGETS_OF_TP73_AND_TP63
0.183992640294%	4	2174	11	T2D_GENES_TANYA_LIPIDS	LOPEZ_MESOTHELIOMA_SURVIVAL_UP
0.183992640294%	4	2174	11	T2D_GENES_TANYA_LIPIDS	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS
0.183992640294%	4	2174	11	T2D_GENES_TANYA_LIPIDS	CHUANG_OXIDATIVE_STRESS_RESPONSE_DN
0.183992640294%	4	2174	11	T2D_GENES_TANYA_LIPIDS	BIOCARTA_EPONFKB_PATHWAY
0.183992640294%	4	2174	107	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_ILS
0.183992640294%	4	2174	100	T2D_GENES_TANYA_LIPIDS	RICKMAN_HEAD_AND_NECK_CANCER_A
0.183992640294%	4	2174	10	T2D_GENES_TANYA_LIPIDS	TAKAYAMA_BOUND_BY_AR
0.183992640294%	4	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION
0.183992640294%	4	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM
0.183992640294%	4	2174	10	T2D_GENES_TANYA_LIPIDS	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN
0.183992640294%	4	2174	10	T2D_GENES_TANYA_LIPIDS	BIOCARTA_SARS_PATHWAY
0.171086398631%	2	1169	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_
0.171086398631%	2	1169	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_POTASSIUM_CHANNELS
0.171086398631%	2	1169	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PYRIMIDINE_METABOLISM
0.171086398631%	2	1169	96	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIU_PROSTATE_CANCER_UP
0.171086398631%	2	1169	95	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KAYO_CALORIE_RESTRICTION_MUSCLE_UP
0.171086398631%	2	1169	95	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HECKER_IFNB1_TARGETS
0.171086398631%	2	1169	94	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5
0.171086398631%	2	1169	94	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER
0.171086398631%	2	1169	93	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ACTIVATED_TLR4_SIGNALLING
0.171086398631%	2	1169	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
0.171086398631%	2	1169	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN
0.171086398631%	2	1169	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SANA_TNF_SIGNALING_DN
0.171086398631%	2	1169	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_ERBB4
0.171086398631%	2	1169	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MORI_IMMATURE_B_LYMPHOCYTE_DN
0.171086398631%	2	1169	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IVANOVSKA_MIR106B_TARGETS
0.171086398631%	2	1169	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY
0.171086398631%	2	1169	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN
0.171086398631%	2	1169	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30
0.171086398631%	2	1169	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_FEEDER_PATHWAY
0.171086398631%	2	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHANG_TLX_TARGETS_UP
0.171086398631%	2	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYLAN_MULTIPLE_MYELOMA_D_UP
0.171086398631%	2	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION
0.171086398631%	2	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS
0.171086398631%	2	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_RIBOSOME
0.171086398631%	2	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMITH_TERT_TARGETS_DN
0.171086398631%	2	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
0.171086398631%	2	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.171086398631%	2	1169	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NGUYEN_NOTCH1_TARGETS_DN
0.171086398631%	2	1169	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
0.171086398631%	2	1169	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	XU_GH1_EXOGENOUS_TARGETS_UP
0.171086398631%	2	1169	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
0.171086398631%	2	1169	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE
0.171086398631%	2	1169	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEIN_CEREBELLUM_MARKERS
0.171086398631%	2	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP
0.171086398631%	2	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMID_BREAST_CANCER_LUMINAL_A_UP
0.171086398631%	2	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_CMYB_PATHWAY
0.171086398631%	2	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ECM_RECEPTOR_INTERACTION
0.171086398631%	2	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
0.171086398631%	2	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
0.171086398631%	2	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHANG_IMMORTALIZED_BY_HPV31_UP
0.171086398631%	2	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
0.171086398631%	2	1169	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
0.171086398631%	2	1169	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
0.171086398631%	2	1169	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_SMAD2_3NUCLEARPATHWAY
0.171086398631%	2	1169	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
0.171086398631%	2	1169	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BHAT_ESR1_TARGETS_VIA_AKT1_DN
0.171086398631%	2	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
0.171086398631%	2	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
0.171086398631%	2	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MITOTIC_G2_G2_M_PHASES
0.171086398631%	2	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HUANG_DASATINIB_RESISTANCE_UP
0.171086398631%	2	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HARRIS_HYPOXIA
0.171086398631%	2	1169	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MORI_PRE_BI_LYMPHOCYTE_UP
0.171086398631%	2	1169	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BASSO_HAIRY_CELL_LEUKEMIA_DN
0.171086398631%	2	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STANHILL_HRAS_TRANSFROMATION_UP
0.171086398631%	2	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN
0.171086398631%	2	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN
0.171086398631%	2	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KHETCHOUMIAN_TRIM24_TARGETS_DN
0.171086398631%	2	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GROSS_HYPOXIA_VIA_HIF1A_ONLY
0.171086398631%	2	1169	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT
0.171086398631%	2	1169	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MEISSNER_NPC_HCP_WITH_H3K27ME3
0.171086398631%	2	1169	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MALONEY_RESPONSE_TO_17AAG_DN
0.171086398631%	2	1169	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROSS_AML_WITH_MLL_FUSIONS
0.171086398631%	2	1169	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.171086398631%	2	1169	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LINDVALL_IMMORTALIZED_BY_TERT_UP
0.171086398631%	2	1169	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
0.171086398631%	2	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
0.171086398631%	2	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.171086398631%	2	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MORI_PRE_BI_LYMPHOCYTE_DN
0.171086398631%	2	1169	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
0.171086398631%	2	1169	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
0.171086398631%	2	1169	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
0.171086398631%	2	1169	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
0.171086398631%	2	1169	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP
0.171086398631%	2	1169	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MORI_MATURE_B_LYMPHOCYTE_DN
0.171086398631%	2	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHEPARD_BMYB_TARGETS
0.171086398631%	2	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
0.171086398631%	2	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RAMALHO_STEMNESS_DN
0.171086398631%	2	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
0.171086398631%	2	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIAN_LIPA_TARGETS_6M
0.171086398631%	2	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEIN_OLIGODENDROCYTE_MARKERS
0.171086398631%	2	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
0.171086398631%	2	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN
0.171086398631%	2	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FURUKAWA_DUSP6_TARGETS_PCI35_DN
0.171086398631%	2	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DARWICHE_PAPILLOMA_PROGRESSION_RISK
0.171086398631%	2	1169	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.171086398631%	2	1169	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
0.171086398631%	2	1169	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
0.171086398631%	2	1169	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.171086398631%	2	1169	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
0.171086398631%	2	1169	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1
0.171086398631%	2	1169	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HUANG_GATA2_TARGETS_DN
0.171086398631%	2	1169	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DOANE_BREAST_CANCER_CLASSES_UP
0.171086398631%	2	1169	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PI3K_CASCADE
0.171086398631%	2	1169	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.171086398631%	2	1169	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
0.171086398631%	2	1169	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_6HR_UP
0.171086398631%	2	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VERNELL_RETINOBLASTOMA_PATHWAY_UP
0.171086398631%	2	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIU_NASOPHARYNGEAL_CARCINOMA
0.171086398631%	2	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP
0.171086398631%	2	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP
0.171086398631%	2	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN
0.171086398631%	2	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES
0.171086398631%	2	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
0.171086398631%	2	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEIN_NEURON_MARKERS
0.171086398631%	2	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HUANG_DASATINIB_RESISTANCE_DN
0.171086398631%	2	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOWLIN_PUBERTAL_MAMMARY_GLAND
0.171086398631%	2	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
0.171086398631%	2	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMIT_EGF_RESPONSE_120_HELA
0.171086398631%	2	1169	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
0.171086398631%	2	1169	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NOUZOVA_METHYLATED_IN_APL
0.171086398631%	2	1169	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DELPUECH_FOXO3_TARGETS_UP
0.171086398631%	2	1169	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP
0.171086398631%	2	1169	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
0.171086398631%	2	1169	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ELVIDGE_HIF1A_TARGETS_UP
0.171086398631%	2	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
0.171086398631%	2	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
0.171086398631%	2	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RAMASWAMY_METASTASIS_UP
0.171086398631%	2	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_INTEGRIN1_PATHWAY
0.171086398631%	2	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARSON_FOXP3_TARGETS_UP
0.171086398631%	2	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP
0.171086398631%	2	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DIRMEIER_LMP1_RESPONSE_EARLY
0.171086398631%	2	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.171086398631%	2	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_WNT
0.171086398631%	2	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
0.171086398631%	2	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ERA_GENOMIC_PATHWAY
0.171086398631%	2	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_LIVER_CANCER_MYC_TGFA_DN
0.171086398631%	2	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP
0.171086398631%	2	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
0.171086398631%	2	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C
0.171086398631%	2	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_LIVER_CANCER_MYC_E2F1_DN
0.171086398631%	2	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_LIVER_CANCER_ACOX1_UP
0.171086398631%	2	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.171086398631%	2	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
0.171086398631%	2	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE
0.171086398631%	2	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PHONG_TNF_TARGETS_UP
0.171086398631%	2	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MODY_HIPPOCAMPUS_POSTNATAL
0.171086398631%	2	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JOHNSTONE_PARVB_TARGETS_1_DN
0.171086398631%	2	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
0.171086398631%	2	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CROMER_TUMORIGENESIS_UP
0.171086398631%	2	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP
0.171086398631%	2	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_LIVER_CANCER_E2F1_UP
0.171086398631%	2	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.171086398631%	2	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ISSAEVA_MLL2_TARGETS
0.171086398631%	2	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CORRE_MULTIPLE_MYELOMA_DN
0.171086398631%	2	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP
0.171086398631%	2	1169	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZWANG_EGF_PERSISTENTLY_DN
0.171086398631%	2	1169	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS
0.171086398631%	2	1169	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
0.171086398631%	2	1169	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RAMASWAMY_METASTASIS_DN
0.171086398631%	2	1169	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_AR_PATHWAY
0.171086398631%	2	1169	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_LIVER_CANCER_MYC_TGFA_UP
0.171086398631%	2	1169	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WIERENGA_STAT5A_TARGETS_GROUP2
0.171086398631%	2	1169	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SONG_TARGETS_OF_IE86_CMV_PROTEIN
0.171086398631%	2	1169	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING
0.171086398631%	2	1169	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OUILLETTE_CLL_13Q14_DELETION_DN
0.171086398631%	2	1169	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_LIVER_CANCER_CIPROFIBRATE_UP
0.171086398631%	2	1169	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
0.171086398631%	2	1169	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TRACEY_RESISTANCE_TO_IFNA2_UP
0.171086398631%	2	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
0.171086398631%	2	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HUPER_BREAST_BASAL_VS_LUMINAL_DN
0.171086398631%	2	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ELVIDGE_HYPOXIA_BY_DMOG_DN
0.171086398631%	2	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
0.171086398631%	2	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
0.171086398631%	2	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
0.171086398631%	2	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_APOPTOSIS
0.171086398631%	2	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_NPC_LCP_WITH_H3K4ME3
0.171086398631%	2	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LUCAS_HNF4A_TARGETS_UP
0.171086398631%	2	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_HIVNEF_PATHWAY
0.171086398631%	2	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE
0.171086398631%	2	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRABARCZYK_BCL11B_TARGETS_DN
0.171086398631%	2	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DELASERNA_MYOD_TARGETS_DN
0.171086398631%	2	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANTVEER_BREAST_CANCER_METASTASIS_UP
0.171086398631%	2	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.171086398631%	2	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION
0.171086398631%	2	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX
0.171086398631%	2	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HENDRICKS_SMARCA4_TARGETS_UP
0.171086398631%	2	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.171086398631%	2	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRADE_COLON_VS_RECTAL_CANCER_DN
0.171086398631%	2	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_BASAL_CELL_CARCINOMA
0.171086398631%	2	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GENTILE_UV_RESPONSE_CLUSTER_D4
0.171086398631%	2	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DEMAGALHAES_AGING_UP
0.171086398631%	2	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
0.171086398631%	2	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SU_PANCREAS
0.171086398631%	2	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SUNG_METASTASIS_STROMA_DN
0.171086398631%	2	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SESTO_RESPONSE_TO_UV_C2
0.171086398631%	2	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE
0.171086398631%	2	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_RAC1_PATHWAY
0.171086398631%	2	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_IPS_ICP_WITH_H3K27ME3
0.171086398631%	2	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARSON_FOXP3_TARGETS_DN
0.171086398631%	2	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP
0.171086398631%	2	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.171086398631%	2	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.171086398631%	2	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP
0.171086398631%	2	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HALMOS_CEBPA_TARGETS_UP
0.171086398631%	2	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP
0.171086398631%	2	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.171086398631%	2	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT
0.171086398631%	2	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
0.171086398631%	2	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1
0.171086398631%	2	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN
0.171086398631%	2	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
0.171086398631%	2	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP
0.171086398631%	2	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
0.171086398631%	2	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.171086398631%	2	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROY_WOUND_BLOOD_VESSEL_UP
0.171086398631%	2	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NADERI_BREAST_CANCER_PROGNOSIS_UP
0.171086398631%	2	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARTINEZ_RESPONSE_TO_TRABECTEDIN
0.171086398631%	2	1169	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP
0.171086398631%	2	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
0.171086398631%	2	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC
0.171086398631%	2	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM
0.171086398631%	2	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP
0.171086398631%	2	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FAELT_B_CLL_WITH_VH3_21_DN
0.171086398631%	2	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TAVOR_CEBPA_TARGETS_UP
0.171086398631%	2	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RICKMAN_HEAD_AND_NECK_CANCER_B
0.171086398631%	2	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE
0.171086398631%	2	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES
0.171086398631%	2	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6
0.171086398631%	2	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_AJDISS_2PATHWAY
0.171086398631%	2	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PENG_GLUCOSE_DEPRIVATION_UP
0.171086398631%	2	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PROTEASOME
0.171086398631%	2	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
0.171086398631%	2	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GNATENKO_PLATELET_SIGNATURE
0.171086398631%	2	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
0.171086398631%	2	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.171086398631%	2	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHANGOLKAR_H2AFY_TARGETS_UP
0.171086398631%	2	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
0.171086398631%	2	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
0.171086398631%	2	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WARTERS_IR_RESPONSE_5GY
0.171086398631%	2	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_NFAT_TFPATHWAY
0.171086398631%	2	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_FANCONI_PATHWAY
0.171086398631%	2	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAMURA_METASTASIS
0.171086398631%	2	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JIANG_AGING_HYPOTHALAMUS_UP
0.171086398631%	2	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WINNEPENNINCKX_MELANOMA_METASTASIS_DN
0.171086398631%	2	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_SYNDECAN_1_PATHWAY
0.171086398631%	2	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MADAN_DPPA4_TARGETS
0.171086398631%	2	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN
0.171086398631%	2	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HEIDENBLAD_AMPLICON_8Q24_DN
0.171086398631%	2	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_CD2_UP
0.171086398631%	2	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SIG_CHEMOTAXIS
0.171086398631%	2	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN
0.171086398631%	2	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHIPP_DLBCL_CURED_VS_FATAL_DN
0.171086398631%	2	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LUI_THYROID_CANCER_PAX8_PPARG_DN
0.171086398631%	2	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRADE_METASTASIS_DN
0.171086398631%	2	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHANDRAN_METASTASIS_TOP50_DN
0.171086398631%	2	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP
0.171086398631%	2	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	XU_CREBBP_TARGETS_DN
0.171086398631%	2	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
0.171086398631%	2	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS
0.171086398631%	2	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARTIN_INTERACT_WITH_HDAC
0.171086398631%	2	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KORKOLA_SEMINOMA_UP
0.171086398631%	2	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KERLEY_RESPONSE_TO_CISPLATIN_UP
0.171086398631%	2	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION
0.171086398631%	2	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JAEGER_METASTASIS_UP
0.171086398631%	2	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GROSS_HYPOXIA_VIA_ELK3_ONLY_DN
0.171086398631%	2	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHUNG_BLISTER_CYTOTOXICITY_DN
0.171086398631%	2	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHOI_ATL_STAGE_PREDICTOR
0.171086398631%	2	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	POTTI_5FU_SENSITIVITY
0.171086398631%	2	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
0.171086398631%	2	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_INTEGRIN3_PATHWAY
0.171086398631%	2	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN
0.171086398631%	2	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAYAMA_FRA2_TARGETS
0.171086398631%	2	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.171086398631%	2	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRNA_AMINOACYLATION
0.171086398631%	2	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ECADHERIN_STABILIZATION_PATHWAY
0.171086398631%	2	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_ES_ICP_WITH_H3K27ME3
0.171086398631%	2	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CHREBP2_PATHWAY
0.171086398631%	2	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BILBAN_B_CLL_LPL_DN
0.171086398631%	2	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_MF_DN
0.171086398631%	2	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NETRIN1_SIGNALING
0.171086398631%	2	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ER_NONGENOMIC_PATHWAY
0.171086398631%	2	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ERBB1_INTERNALIZATION_PATHWAY
0.171086398631%	2	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MALONEY_RESPONSE_TO_17AAG_UP
0.171086398631%	2	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LI_LUNG_CANCER
0.171086398631%	2	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN
0.171086398631%	2	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS
0.171086398631%	2	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DELPUECH_FOXO3_TARGETS_DN
0.171086398631%	2	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
0.171086398631%	2	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
0.171086398631%	2	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_EPHBFWDPATHWAY
0.171086398631%	2	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP
0.171086398631%	2	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_SPHINGOLIPID_METABOLISM
0.171086398631%	2	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PYRUVATE_METABOLISM
0.171086398631%	2	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JIANG_AGING_HYPOTHALAMUS_DN
0.171086398631%	2	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHANGOLKAR_H2AFY_TARGETS_DN
0.171086398631%	2	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
0.171086398631%	2	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_P38MAPK_PATHWAY
0.171086398631%	2	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BENPORATH_ES_2
0.171086398631%	2	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WHITEHURST_PACLITAXEL_SENSITIVITY
0.171086398631%	2	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	POTTI_PACLITAXEL_SENSITIVITY
0.171086398631%	2	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_AURORA_B_PATHWAY
0.171086398631%	2	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
0.171086398631%	2	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GENTILE_UV_RESPONSE_CLUSTER_D5
0.171086398631%	2	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BURTON_ADIPOGENESIS_PEAK_AT_8HR
0.171086398631%	2	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMIT_EGF_RESPONSE_60_MCF10A
0.171086398631%	2	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TERAO_AOX4_TARGETS_SKIN_UP
0.171086398631%	2	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SPIRA_SMOKERS_LUNG_CANCER_UP
0.171086398631%	2	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PI3K_AKT_ACTIVATION
0.171086398631%	2	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_P38ALPHABETADOWNSTREAMPATHWAY
0.171086398631%	2	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PENG_GLUTAMINE_DEPRIVATION_UP
0.171086398631%	2	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP
0.171086398631%	2	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN
0.171086398631%	2	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_6_DN
0.171086398631%	2	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHANDRAN_METASTASIS_TOP50_UP
0.171086398631%	2	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN
0.171086398631%	2	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_P38_MAPK_PATHWAY
0.171086398631%	2	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN
0.171086398631%	2	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RICKMAN_HEAD_AND_NECK_CANCER_D
0.171086398631%	2	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_FRA_PATHWAY
0.171086398631%	2	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MURAKAMI_UV_RESPONSE_6HR_UP
0.171086398631%	2	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED
0.171086398631%	2	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MATZUK_SPERMATID_DIFFERENTIATION
0.171086398631%	2	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_PAR1_PATHWAY
0.171086398631%	2	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_ALK_PATHWAY
0.171086398631%	2	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BILANGES_SERUM_RESPONSE_TRANSLATION
0.171086398631%	2	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
0.171086398631%	2	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP
0.171086398631%	2	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN
0.171086398631%	2	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_AGR_PATHWAY
0.171086398631%	2	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ALONSO_METASTASIS_EMT_UP
0.171086398631%	2	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.171086398631%	2	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_HIVNEFPATHWAY
0.171086398631%	2	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
0.171086398631%	2	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
0.171086398631%	2	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.171086398631%	2	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MODY_HIPPOCAMPUS_NEONATAL
0.171086398631%	2	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOWLIN_CITED1_TARGETS_1_UP
0.171086398631%	2	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DORSAM_HOXA9_TARGETS_UP
0.171086398631%	2	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_WNT_BETA_CATENIN_PATHWAY
0.171086398631%	2	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SIG_CD40PATHWAYMAP
0.171086398631%	2	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHOEN_NFKB_SIGNALING
0.171086398631%	2	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP
0.171086398631%	2	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	POTTI_CYTOXAN_SENSITIVITY
0.171086398631%	2	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PETRETTO_CARDIAC_HYPERTROPHY
0.171086398631%	2	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LUI_TARGETS_OF_PAX8_PPARG_FUSION
0.171086398631%	2	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KORKOLA_CORRELATED_WITH_POU5F1
0.171086398631%	2	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_BUTANOATE_METABOLISM
0.171086398631%	2	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VALK_AML_CLUSTER_6
0.171086398631%	2	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TANG_SENESCENCE_TP53_TARGETS_UP
0.171086398631%	2	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SIMBULAN_UV_RESPONSE_NORMAL_DN
0.171086398631%	2	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROZANOV_MMP14_TARGETS_SUBSET
0.171086398631%	2	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_SYNDECAN_2_PATHWAY
0.171086398631%	2	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_IL12_STAT4PATHWAY
0.171086398631%	2	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PROPANOATE_METABOLISM
0.171086398631%	2	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ETHER_LIPID_METABOLISM
0.171086398631%	2	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HEIDENBLAD_AMPLICON_12P11_12_UP
0.171086398631%	2	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN
0.171086398631%	2	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DORN_ADENOVIRUS_INFECTION_12HR_DN
0.171086398631%	2	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CAFFAREL_RESPONSE_TO_THC_UP
0.171086398631%	2	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_IL1R_PATHWAY
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TSAI_RESPONSE_TO_RADIATION_THERAPY
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DAG_AND_IP3_SIGNALING
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_COMPLEMENT_CASCADE
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CD28_CO_STIMULATION
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	POS_HISTAMINE_RESPONSE_NETWORK
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_WNT_NONCANONICAL_PATHWAY
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_NETRIN_PATHWAY
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_CITRATE_CYCLE_TCA_CYCLE
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KASLER_HDAC7_TARGETS_2_DN
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DORSAM_HOXA9_TARGETS_DN
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DIRMEIER_LMP1_RESPONSE_LATE_DN
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_HDAC_PATHWAY
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN
0.171086398631%	2	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BAE_BRCA1_TARGETS_DN
0.171086398631%	2	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	THEODOROU_MAMMARY_TUMORIGENESIS
0.171086398631%	2	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP
0.171086398631%	2	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN
0.171086398631%	2	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING
0.171086398631%	2	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
0.171086398631%	2	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE
0.171086398631%	2	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_CD40_PATHWAY
0.171086398631%	2	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NOJIMA_SFRP2_TARGETS_UP
0.171086398631%	2	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.171086398631%	2	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CUI_TCF21_TARGETS_DN
0.171086398631%	2	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CAFFAREL_RESPONSE_TO_THC_DN
0.171086398631%	2	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.171086398631%	2	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN
0.171086398631%	2	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
0.171086398631%	2	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VALK_AML_CLUSTER_12
0.171086398631%	2	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.171086398631%	2	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DNA_STRAND_ELONGATION
0.171086398631%	2	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_RETINOIC_ACID_PATHWAY
0.171086398631%	2	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_IL2_STAT5PATHWAY
0.171086398631%	2	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_EPHRINBREVPATHWAY
0.171086398631%	2	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.171086398631%	2	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GILDEA_METASTASIS
0.171086398631%	2	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP
0.171086398631%	2	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY
0.171086398631%	2	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP
0.171086398631%	2	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YU_BAP1_TARGETS
0.171086398631%	2	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WATANABE_COLON_CANCER_MSI_VS_MSS_UP
0.171086398631%	2	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_RESPONSE_TO_BEXAROTENE_DN
0.171086398631%	2	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.171086398631%	2	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARSHALL_VIRAL_INFECTION_RESPONSE_DN
0.171086398631%	2	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_HISTIDINE_METABOLISM
0.171086398631%	2	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DALESSIO_TSA_RESPONSE
0.171086398631%	2	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHOW_RASSF1_TARGETS_DN
0.171086398631%	2	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_VIP_PATHWAY
0.171086398631%	2	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_TNFR1_PATHWAY
0.171086398631%	2	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP
0.171086398631%	2	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEBER_METHYLATED_HCP_IN_SPERM_DN
0.171086398631%	2	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VALK_AML_CLUSTER_7
0.171086398631%	2	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VALK_AML_CLUSTER_1
0.171086398631%	2	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOREIRA_RESPONSE_TO_TSA_UP
0.171086398631%	2	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.171086398631%	2	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALLING_TO_RAS
0.171086398631%	2	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE
0.171086398631%	2	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_G_PROTEIN_ACTIVATION
0.171086398631%	2	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS
0.171086398631%	2	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_IL3_PATHWAY
0.171086398631%	2	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN
0.171086398631%	2	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GENTILE_UV_LOW_DOSE_UP
0.171086398631%	2	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIN_BREAST_CANCER_COPY_NUMBER_UP
0.171086398631%	2	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHENG_FOXP3_TARGETS_UP
0.171086398631%	2	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VALK_AML_CLUSTER_16
0.171086398631%	2	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_INTERLEUKIN_4_PATHWAY
0.171086398631%	2	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1
0.171086398631%	2	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_GALACTOSE_METABOLISM
0.171086398631%	2	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HAHTOLA_CTCL_CUTANEOUS
0.171086398631%	2	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
0.171086398631%	2	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_WNT_PATHWAY
0.171086398631%	2	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP
0.171086398631%	2	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WAGNER_APO2_SENSITIVITY
0.171086398631%	2	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RUAN_RESPONSE_TO_TROGLITAZONE_UP
0.171086398631%	2	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION
0.171086398631%	2	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_FANCONI_ANEMIA_PATHWAY
0.171086398631%	2	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_LYMPHANGIOGENESIS_PATHWAY
0.171086398631%	2	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_INTEGRIN_A9B1_PATHWAY
0.171086398631%	2	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OZEN_MIR125B1_TARGETS
0.171086398631%	2	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_HYPOXIA
0.171086398631%	2	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG
0.171086398631%	2	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HORTON_SREBF_TARGETS
0.171086398631%	2	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN
0.171086398631%	2	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS
0.171086398631%	2	1169	245	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KONDO_EZH2_TARGETS
0.171086398631%	2	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAN_ESCAPE_FROM_ANOIKIS
0.171086398631%	2	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN
0.171086398631%	2	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION
0.171086398631%	2	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION
0.171086398631%	2	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PYRIMIDINE_METABOLISM
0.171086398631%	2	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION
0.171086398631%	2	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CHOLESTEROL_BIOSYNTHESIS
0.171086398631%	2	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_S1P_S1P2_PATHWAY
0.171086398631%	2	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PETRETTO_HEART_MASS_QTL_CIS_DN
0.171086398631%	2	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OSADA_ASCL1_TARGETS_DN
0.171086398631%	2	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23
0.171086398631%	2	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN
0.171086398631%	2	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HASLINGER_B_CLL_WITH_13Q14_DELETION
0.171086398631%	2	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN
0.171086398631%	2	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_NTHI_PATHWAY
0.171086398631%	2	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_EIF4_PATHWAY
0.171086398631%	2	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CSK_PATHWAY
0.171086398631%	2	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WENG_POR_TARGETS_GLOBAL_DN
0.171086398631%	2	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_INSULIN_RECEPTOR_RECYCLING
0.171086398631%	2	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA
0.171086398631%	2	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	EGUCHI_CELL_CYCLE_RB1_TARGETS
0.171086398631%	2	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIBA_RESPONSE_TO_TSA_DN
0.171086398631%	2	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
0.171086398631%	2	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_P53HYPOXIA_PATHWAY
0.171086398631%	2	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_NFKB_PATHWAY
0.171086398631%	2	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_IGF1R_PATHWAY
0.171086398631%	2	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_GLEEVEC_PATHWAY
0.171086398631%	2	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CCR3_PATHWAY
0.171086398631%	2	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_SPIKED
0.171086398631%	2	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VALK_AML_WITH_11Q23_REARRANGED
0.171086398631%	2	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.171086398631%	2	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN
0.171086398631%	2	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_METAL_ION_SLC_TRANSPORTERS
0.171086398631%	2	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING
0.171086398631%	2	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ACYL_CHAIN_REMODELLING_OF_PC
0.171086398631%	2	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS
0.171086398631%	2	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KANG_FLUOROURACIL_RESISTANCE_UP
0.171086398631%	2	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN
0.171086398631%	2	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER
0.171086398631%	2	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_IL6_PATHWAY
0.171086398631%	2	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_GCR_PATHWAY
0.171086398631%	2	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CYTOKINE_PATHWAY
0.171086398631%	2	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CHEMICAL_PATHWAY
0.171086398631%	2	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_AKT_PATHWAY
0.171086398631%	2	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP
0.171086398631%	2	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP
0.171086398631%	2	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STEGER_ADIPOGENESIS_UP
0.171086398631%	2	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP
0.171086398631%	2	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN
0.171086398631%	2	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ACYL_CHAIN_REMODELLING_OF_PE
0.171086398631%	2	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_S1P_META_PATHWAY
0.171086398631%	2	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_P38_MK2PATHWAY
0.171086398631%	2	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOOTHA_GLYCOGEN_METABOLISM
0.171086398631%	2	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN
0.171086398631%	2	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN
0.171086398631%	2	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_IGF1_PATHWAY
0.171086398631%	2	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZEMBUTSU_SENSITIVITY_TO_CISPLATIN
0.171086398631%	2	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WENG_POR_TARGETS_GLOBAL_UP
0.171086398631%	2	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEBER_METHYLATED_HCP_IN_SPERM_UP
0.171086398631%	2	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP
0.171086398631%	2	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PHESSE_TARGETS_OF_APC_AND_MBD2_UP
0.171086398631%	2	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIELSEN_LEIOMYOSARCOMA_CNN1_DN
0.171086398631%	2	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP
0.171086398631%	2	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_MYCL1_AMPLIFICATION_TARGETS_DN
0.171086398631%	2	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HASLINGER_B_CLL_WITH_6Q21_DELETION
0.171086398631%	2	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_IGF1MTOR_PATHWAY
0.171086398631%	2	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CCR5_PATHWAY
0.171086398631%	2	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_AMI_PATHWAY
0.171086398631%	2	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_ACTINY_PATHWAY
0.171086398631%	2	1169	198	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.171086398631%	2	1169	196	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
0.171086398631%	2	1169	191	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.171086398631%	2	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WU_ALZHEIMER_DISEASE_DN
0.171086398631%	2	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MELLMAN_TUT1_TARGETS_UP
0.171086398631%	2	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MAHADEVAN_RESPONSE_TO_MP470_DN
0.171086398631%	2	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LAMB_CCND1_TARGETS
0.171086398631%	2	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ALPHA_LINOLENIC_ACID_METABOLISM
0.171086398631%	2	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KANG_CISPLATIN_RESISTANCE_UP
0.171086398631%	2	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HAHTOLA_MYCOSIS_FUNGOIDES_UP
0.171086398631%	2	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAJATE_RESPONSE_TO_TRABECTEDIN_DN
0.171086398631%	2	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN
0.171086398631%	2	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_TH1TH2_PATHWAY
0.171086398631%	2	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_EPO_PATHWAY
0.171086398631%	2	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_COMP_PATHWAY
0.171086398631%	2	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE
0.171086398631%	2	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SYNTHESIS_OF_PC
0.171086398631%	2	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN
0.171086398631%	2	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIELSEN_SCHWANNOMA_UP
0.171086398631%	2	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIELSEN_LEIOMYOSARCOMA_UP
0.171086398631%	2	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES
0.171086398631%	2	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB
0.171086398631%	2	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_UCALPAIN_PATHWAY
0.171086398631%	2	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_TNFR2_PATHWAY
0.171086398631%	2	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_TEL_PATHWAY
0.171086398631%	2	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_NGF_PATHWAY
0.171086398631%	2	1169	179	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE
0.171086398631%	2	1169	179	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BENPORATH_NOS_TARGETS
0.171086398631%	2	1169	172	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
0.171086398631%	2	1169	171	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
0.171086398631%	2	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SA_TRKA_RECEPTOR
0.171086398631%	2	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP
0.171086398631%	2	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SHC_RELATED_EVENTS
0.171086398631%	2	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_KIT_SIGNALING
0.171086398631%	2	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RAP1_SIGNALLING
0.171086398631%	2	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ARMS_MEDIATED_ACTIVATION
0.171086398631%	2	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_NFKAPPABATYPICALPATHWAY
0.171086398631%	2	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LOPEZ_EPITHELIOID_MESOTHELIOMA
0.171086398631%	2	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN
0.171086398631%	2	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP
0.171086398631%	2	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GALE_APL_WITH_FLT3_MUTATED_DN
0.171086398631%	2	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.171086398631%	2	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_HCMV_PATHWAY
0.171086398631%	2	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN
0.171086398631%	2	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TIAN_BHLHA15_TARGETS
0.171086398631%	2	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS
0.171086398631%	2	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT
0.171086398631%	2	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KANG_FLUOROURACIL_RESISTANCE_DN
0.171086398631%	2	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL
0.171086398631%	2	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_RELA_PATHWAY
0.171086398631%	2	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_ACH_PATHWAY
0.171086398631%	2	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
0.171086398631%	2	1169	159	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PURINE_METABOLISM
0.171086398631%	2	1169	150	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RODWELL_AGING_KIDNEY_NO_BLOOD_DN
0.171086398631%	2	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN
0.171086398631%	2	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP
0.171086398631%	2	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TSUNODA_CISPLATIN_RESISTANCE_UP
0.171086398631%	2	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SU_KIDNEY
0.171086398631%	2	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP
0.171086398631%	2	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ZINC_TRANSPORTERS
0.171086398631%	2	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN
0.171086398631%	2	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS
0.171086398631%	2	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_
0.171086398631%	2	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS
0.171086398631%	2	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FINETTI_BREAST_CANCERS_KINOME_GRAY
0.171086398631%	2	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN
0.171086398631%	2	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_PITX2_PATHWAY
0.171086398631%	2	1169	149	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP
0.171086398631%	2	1169	146	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_NEURAL_CREST_STEM_CELL_UP
0.171086398631%	2	1169	140	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
0.171086398631%	2	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_COMPLEMENT_CASCADE
0.171086398631%	2	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS
0.171086398631%	2	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_METABOLISM_OF_PORPHYRINS
0.171086398631%	2	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_HYALURONAN_METABOLISM
0.171086398631%	2	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_TCRRASPATHWAY
0.171086398631%	2	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_S1P_S1P4_PATHWAY
0.171086398631%	2	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_IL5_PATHWAY
0.171086398631%	2	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP
0.171086398631%	2	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES
0.171086398631%	2	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION
0.171086398631%	2	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GILMORE_CORE_NFKB_PATHWAY
0.171086398631%	2	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_PS1_PATHWAY
0.171086398631%	2	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_PLATELETAPP_PATHWAY
0.171086398631%	2	1169	139	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOELZEL_NF1_TARGETS_UP
0.171086398631%	2	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TERAMOTO_OPN_TARGETS_CLUSTER_1
0.171086398631%	2	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
0.171086398631%	2	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS
0.171086398631%	2	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ONGUSAHA_BRCA1_TARGETS_UP
0.171086398631%	2	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
0.171086398631%	2	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN
0.171086398631%	2	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOEGERKORP_CD44_TARGETS_TEMPORAL_UP
0.171086398631%	2	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_TCRA_PATHWAY
0.171086398631%	2	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CBL_PATHWAY
0.171086398631%	2	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_ARENRF2_PATHWAY
0.171086398631%	2	1169	128	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
0.171086398631%	2	1169	127	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	INGRAM_SHH_TARGETS_UP
0.171086398631%	2	1169	127	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN
0.171086398631%	2	1169	123	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.171086398631%	2	1169	122	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MISSIAGLIA_REGULATED_BY_METHYLATION_DN
0.171086398631%	2	1169	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS
0.171086398631%	2	1169	120	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.171086398631%	2	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TAGHAVI_NEOPLASTIC_TRANSFORMATION
0.171086398631%	2	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RUAN_RESPONSE_TO_TNF_UP
0.171086398631%	2	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS
0.171086398631%	2	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GLYCOPROTEIN_HORMONES
0.171086398631%	2	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING
0.171086398631%	2	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE
0.171086398631%	2	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CS_DS_DEGRADATION
0.171086398631%	2	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM
0.171086398631%	2	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS
0.171086398631%	2	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.171086398631%	2	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP
0.171086398631%	2	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ITO_PTTG1_TARGETS_UP
0.171086398631%	2	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP
0.171086398631%	2	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN
0.171086398631%	2	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOLLEMAN_DAUNORUBICIN_B_ALL_DN
0.171086398631%	2	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_FIBRINOLYSIS_PATHWAY
0.171086398631%	2	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_ASBCELL_PATHWAY
0.171086398631%	2	1169	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROPERO_HDAC2_TARGETS
0.171086398631%	2	1169	113	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RICKMAN_HEAD_AND_NECK_CANCER_C
0.171086398631%	2	1169	112	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PASINI_SUZ12_TARGETS_UP
0.171086398631%	2	1169	110	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4
0.171086398631%	2	1169	110	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GHANDHI_DIRECT_IRRADIATION_UP
0.171086398631%	2	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHOU_PANCREATIC_BETA_CELL
0.171086398631%	2	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS
0.171086398631%	2	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KALMA_E2F1_TARGETS
0.171086398631%	2	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IIZUKA_LIVER_CANCER_EARLY_RECURRENCE
0.171086398631%	2	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FUNG_IL2_SIGNALING_1
0.171086398631%	2	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CAFFAREL_RESPONSE_TO_THC_8HR_5_DN
0.171086398631%	2	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_EPONFKB_PATHWAY
0.171086398631%	2	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_BLYMPHOCYTE_PATHWAY
0.171086398631%	2	1169	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT
0.171086398631%	2	1169	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JAZAG_TGFB1_SIGNALING_UP
0.171086398631%	2	1169	104	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAMURA_ADIPOGENESIS_LATE_UP
0.171086398631%	2	1169	102	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_IPS_WITH_HCP_H3K27ME3
0.171086398631%	2	1169	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
0.171086398631%	2	1169	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_20HR_DN
0.171086398631%	2	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP
0.171086398631%	2	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TAKAYAMA_BOUND_BY_AR
0.171086398631%	2	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PECAM1_INTERACTIONS
0.171086398631%	2	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION
0.171086398631%	2	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RADAEVA_RESPONSE_TO_IFNA1_DN
0.171086398631%	2	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_LIMONENE_AND_PINENE_DEGRADATION
0.171086398631%	2	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP
0.171086398631%	2	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GOUYER_TATI_TARGETS_UP
0.171086398631%	2	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP
0.171086398631%	2	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BRUNEAU_SEPTATION_VENTRICULAR
0.171086398631%	2	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_IL5_PATHWAY
0.171086398631%	2	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_FREE_PATHWAY
0.170454545455%	6	3520	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CROONQUIST_IL6_DEPRIVATION_DN
0.170454545455%	6	3520	97	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LABBE_WNT3A_TARGETS_DN
0.170454545455%	6	3520	95	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HECKER_IFNB1_TARGETS
0.170454545455%	6	3520	95	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
0.170454545455%	6	3520	94	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_T4
0.170454545455%	6	3520	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
0.170454545455%	6	3520	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN
0.170454545455%	6	3520	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BILANGES_SERUM_SENSITIVE_GENES
0.170454545455%	6	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_TLX_TARGETS_UP
0.170454545455%	6	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TIEN_INTESTINE_PROBIOTICS_2HR_DN
0.170454545455%	6	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS
0.170454545455%	6	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.170454545455%	6	3520	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NELSON_RESPONSE_TO_ANDROGEN_UP
0.170454545455%	6	3520	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
0.170454545455%	6	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_SMALL_CELL_LUNG_CANCER
0.170454545455%	6	3520	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BHAT_ESR1_TARGETS_VIA_AKT1_DN
0.170454545455%	6	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MAHAJAN_RESPONSE_TO_IL1A_UP
0.170454545455%	6	3520	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BASSO_HAIRY_CELL_LEUKEMIA_DN
0.170454545455%	6	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
0.170454545455%	6	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_COMMON_CANCER_GENES
0.170454545455%	6	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROSS_AML_WITH_MLL_FUSIONS
0.170454545455%	6	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
0.170454545455%	6	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.170454545455%	6	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION
0.170454545455%	6	3520	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SU_TESTIS
0.170454545455%	6	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN
0.170454545455%	6	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEIN_OLIGODENDROCYTE_MARKERS
0.170454545455%	6	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER_DENA_DN
0.170454545455%	6	3520	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.170454545455%	6	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VERNELL_RETINOBLASTOMA_PATHWAY_UP
0.170454545455%	6	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RHODES_UNDIFFERENTIATED_CANCER
0.170454545455%	6	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_P53_SIGNALING_PATHWAY
0.170454545455%	6	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE
0.170454545455%	6	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
0.170454545455%	6	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_INTERFERON_RESPONSIVE_GENES
0.170454545455%	6	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BASSO_CD40_SIGNALING_DN
0.170454545455%	6	3520	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.170454545455%	6	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
0.170454545455%	6	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.170454545455%	6	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER_MYC_TGFA_DN
0.170454545455%	6	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS
0.170454545455%	6	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RIZKI_TUMOR_INVASIVENESS_2D_DN
0.170454545455%	6	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING
0.170454545455%	6	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_MYC_REPRESSPATHWAY
0.170454545455%	6	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED
0.170454545455%	6	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
0.170454545455%	6	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
0.170454545455%	6	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KORKOLA_YOLK_SAC_TUMOR
0.170454545455%	6	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ISSAEVA_MLL2_TARGETS
0.170454545455%	6	3520	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MASSARWEH_RESPONSE_TO_ESTRADIOL
0.170454545455%	6	3520	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_240_HELA
0.170454545455%	6	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
0.170454545455%	6	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_NOTCH_PATHWAY
0.170454545455%	6	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ELVIDGE_HYPOXIA_BY_DMOG_DN
0.170454545455%	6	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
0.170454545455%	6	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ASTIER_INTEGRIN_SIGNALING
0.170454545455%	6	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHEIDEREIT_IKK_INTERACTING_PROTEINS
0.170454545455%	6	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAGASHIMA_NRG1_SIGNALING_DN
0.170454545455%	6	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ARACHIDONIC_ACID_METABOLISM
0.170454545455%	6	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BERNARD_PPAPDC1B_TARGETS_DN
0.170454545455%	6	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TONG_INTERACT_WITH_PTTG1
0.170454545455%	6	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_SERUM_RESPONSE_60_MCF10A
0.170454545455%	6	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP
0.170454545455%	6	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LY_AGING_OLD_DN
0.170454545455%	6	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.170454545455%	6	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_BASAL_CELL_CARCINOMA
0.170454545455%	6	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_4HR_UP
0.170454545455%	6	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHOU_TNF_SIGNALING_30MIN
0.170454545455%	6	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KANG_DOXORUBICIN_RESISTANCE_UP
0.170454545455%	6	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
0.170454545455%	6	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CIRCADIAN_CLOCK
0.170454545455%	6	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HENDRICKS_SMARCA4_TARGETS_DN
0.170454545455%	6	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN
0.170454545455%	6	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RADAEVA_RESPONSE_TO_IFNA1_UP
0.170454545455%	6	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_KITPATHWAY
0.170454545455%	6	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KENNY_CTNNB1_TARGETS_DN
0.170454545455%	6	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
0.170454545455%	6	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PRAMOONJAGO_SOX4_TARGETS_DN
0.170454545455%	6	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LUI_THYROID_CANCER_CLUSTER_1
0.170454545455%	6	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STOSSI_RESPONSE_TO_ESTRADIOL
0.170454545455%	6	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.170454545455%	6	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
0.170454545455%	6	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
0.170454545455%	6	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAUER_STAT3_TARGETS_DN
0.170454545455%	6	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
0.170454545455%	6	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NADLER_OBESITY_DN
0.170454545455%	6	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
0.170454545455%	6	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GNATENKO_PLATELET_SIGNATURE
0.170454545455%	6	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN
0.170454545455%	6	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
0.170454545455%	6	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ENGELMANN_CANCER_PROGENITORS_UP
0.170454545455%	6	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.170454545455%	6	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHANGOLKAR_H2AFY_TARGETS_UP
0.170454545455%	6	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_IL6_7PATHWAY
0.170454545455%	6	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP
0.170454545455%	6	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6
0.170454545455%	6	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PARENT_MTOR_SIGNALING_DN
0.170454545455%	6	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HALMOS_CEBPA_TARGETS_DN
0.170454545455%	6	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHIPP_DLBCL_CURED_VS_FATAL_DN
0.170454545455%	6	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_RHOA_PATHWAY
0.170454545455%	6	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ILK_PATHWAY
0.170454545455%	6	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LUI_THYROID_CANCER_PAX8_PPARG_DN
0.170454545455%	6	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUANG_FOXA2_TARGETS_UP
0.170454545455%	6	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHANDRAN_METASTASIS_TOP50_DN
0.170454545455%	6	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.170454545455%	6	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MEDINA_SMARCA4_TARGETS
0.170454545455%	6	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MA_MYELOID_DIFFERENTIATION_DN
0.170454545455%	6	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KERLEY_RESPONSE_TO_CISPLATIN_UP
0.170454545455%	6	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION
0.170454545455%	6	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
0.170454545455%	6	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_120_MCF10A
0.170454545455%	6	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
0.170454545455%	6	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRNA_AMINOACYLATION
0.170454545455%	6	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ECADHERIN_STABILIZATION_PATHWAY
0.170454545455%	6	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.170454545455%	6	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.170454545455%	6	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING
0.170454545455%	6	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ER_NONGENOMIC_PATHWAY
0.170454545455%	6	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS
0.170454545455%	6	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEN_HOXA5_TARGETS_9HR_DN
0.170454545455%	6	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_FCER1_PATHWAY
0.170454545455%	6	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.170454545455%	6	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS
0.170454545455%	6	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_SPHINGOLIPID_METABOLISM
0.170454545455%	6	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JIANG_AGING_HYPOTHALAMUS_DN
0.170454545455%	6	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.170454545455%	6	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_P38MAPK_PATHWAY
0.170454545455%	6	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C6
0.170454545455%	6	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_AURORA_B_PATHWAY
0.170454545455%	6	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
0.170454545455%	6	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS
0.170454545455%	6	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GLYCOSPHINGOLIPID_METABOLISM
0.170454545455%	6	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GLUCOSE_TRANSPORT
0.170454545455%	6	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_RAC1_REG_PATHWAY
0.170454545455%	6	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_P38ALPHABETADOWNSTREAMPATHWAY
0.170454545455%	6	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_LIVER_CANCER
0.170454545455%	6	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAAB_FAILED_HEART_ATRIUM_UP
0.170454545455%	6	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_6_DN
0.170454545455%	6	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN
0.170454545455%	6	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_IL2RB_PATHWAY
0.170454545455%	6	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN
0.170454545455%	6	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_P38_MAPK_PATHWAY
0.170454545455%	6	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_FRA_PATHWAY
0.170454545455%	6	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED
0.170454545455%	6	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HU_ANGIOGENESIS_DN
0.170454545455%	6	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_BRCA1_UP
0.170454545455%	6	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_CLUSTER_11
0.170454545455%	6	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_ADRENERGIC
0.170454545455%	6	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_PI3KPLCTRKPATHWAY
0.170454545455%	6	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN
0.170454545455%	6	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_G_ALPHA_I_PATHWAY
0.170454545455%	6	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
0.170454545455%	6	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HU_GENOTOXIC_DAMAGE_4HR
0.170454545455%	6	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HU_GENOTOXIC_DAMAGE_24HR
0.170454545455%	6	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOWLIN_CITED1_TARGETS_1_UP
0.170454545455%	6	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CARM_ER_PATHWAY
0.170454545455%	6	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP
0.170454545455%	6	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_IL2_PI3KPATHWAY
0.170454545455%	6	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LUI_TARGETS_OF_PAX8_PPARG_FUSION
0.170454545455%	6	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP
0.170454545455%	6	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_CLUSTER_5
0.170454545455%	6	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SIMBULAN_UV_RESPONSE_NORMAL_DN
0.170454545455%	6	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RNA_POL_III_TRANSCRIPTION
0.170454545455%	6	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JEPSEN_SMRT_TARGETS
0.170454545455%	6	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHO_NR4A1_TARGETS
0.170454545455%	6	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAFFAREL_RESPONSE_TO_THC_UP
0.170454545455%	6	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY
0.170454545455%	6	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_NETRIN_PATHWAY
0.170454545455%	6	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GROSS_ELK3_TARGETS_DN
0.170454545455%	6	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN
0.170454545455%	6	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_RHO_PATHWAY
0.170454545455%	6	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.170454545455%	6	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_PYK2_PATHWAY
0.170454545455%	6	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	URS_ADIPOCYTE_DIFFERENTIATION_DN
0.170454545455%	6	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_BASIGIN_INTERACTIONS
0.170454545455%	6	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEINMANN_ADAPTATION_TO_HYPOXIA_UP
0.170454545455%	6	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_RESPONSE_TO_ANDROGEN_UP
0.170454545455%	6	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_REELINPATHWAY
0.170454545455%	6	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ABE_VEGFA_TARGETS_30MIN
0.170454545455%	6	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PETRETTO_HEART_MASS_QTL_CIS_UP
0.170454545455%	6	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LUI_THYROID_CANCER_CLUSTER_3
0.170454545455%	6	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TIEN_INTESTINE_PROBIOTICS_2HR_UP
0.170454545455%	6	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALLING_TO_RAS
0.170454545455%	6	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM
0.170454545455%	6	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
0.170454545455%	6	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DEN_INTERACT_WITH_LCA5
0.170454545455%	6	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_PGC1A_PATHWAY
0.170454545455%	6	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_BAD_PATHWAY
0.170454545455%	6	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP
0.170454545455%	6	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OZEN_MIR125B1_TARGETS
0.170454545455%	6	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP
0.170454545455%	6	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN
0.170454545455%	6	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_RESPONSE_TO_FORSKOLIN_UP
0.170454545455%	6	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
0.170454545455%	6	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_IGF1R_PATHWAY
0.170454545455%	6	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CCR3_PATHWAY
0.170454545455%	6	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BILANGES_SERUM_SENSITIVE_VIA_TSC1
0.170454545455%	6	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP
0.170454545455%	6	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP
0.170454545455%	6	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MACLACHLAN_BRCA1_TARGETS_UP
0.170454545455%	6	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN
0.170454545455%	6	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS
0.170454545455%	6	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_STATHMIN_PATHWAY
0.170454545455%	6	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_MAL_PATHWAY
0.170454545455%	6	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_ARAP_PATHWAY
0.170454545455%	6	3520	179	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BENPORATH_NOS_TARGETS
0.170454545455%	6	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_G_ALPHA_S_PATHWAY
0.170454545455%	6	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CDMAC_PATHWAY
0.170454545455%	6	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL
0.170454545455%	6	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_NUCLEARRS_PATHWAY
0.170454545455%	6	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS
0.170454545455%	6	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
0.170454545455%	6	3520	120	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEBOTAEV_GR_TARGETS_DN
0.170454545455%	6	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GLYCOPROTEIN_HORMONES
0.170454545455%	6	3520	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
0.170454545455%	6	3520	111	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
0.170454545455%	6	3520	107	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_EARLY_T_LYMPHOCYTE_UP
0.170454545455%	6	3520	105	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZWANG_EGF_INTERVAL_UP
0.170454545455%	6	3520	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
0.170454545455%	6	3520	101	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_12HR_DN
0.170454545455%	6	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RADAEVA_RESPONSE_TO_IFNA1_DN
0.163132137031%	1	613	98	T2D_GENES_TANYA_BIOMARKER	REACTOME_POTASSIUM_CHANNELS
0.163132137031%	1	613	98	T2D_GENES_TANYA_BIOMARKER	MENSE_HYPOXIA_UP
0.163132137031%	1	613	98	T2D_GENES_TANYA_BIOMARKER	GUO_TARGETS_OF_IRS1_AND_IRS2
0.163132137031%	1	613	98	T2D_GENES_TANYA_BIOMARKER	GAVIN_FOXP3_TARGETS_CLUSTER_T7
0.163132137031%	1	613	96	T2D_GENES_TANYA_BIOMARKER	LIU_PROSTATE_CANCER_UP
0.163132137031%	1	613	95	T2D_GENES_TANYA_BIOMARKER	KAYO_CALORIE_RESTRICTION_MUSCLE_UP
0.163132137031%	1	613	94	T2D_GENES_TANYA_BIOMARKER	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.163132137031%	1	613	94	T2D_GENES_TANYA_BIOMARKER	LU_IL4_SIGNALING
0.163132137031%	1	613	91	T2D_GENES_TANYA_BIOMARKER	ZHU_CMV_24_HR_DN
0.163132137031%	1	613	91	T2D_GENES_TANYA_BIOMARKER	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.163132137031%	1	613	91	T2D_GENES_TANYA_BIOMARKER	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
0.163132137031%	1	613	90	T2D_GENES_TANYA_BIOMARKER	SANA_TNF_SIGNALING_DN
0.163132137031%	1	613	90	T2D_GENES_TANYA_BIOMARKER	IVANOVSKA_MIR106B_TARGETS
0.163132137031%	1	613	90	T2D_GENES_TANYA_BIOMARKER	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN
0.163132137031%	1	613	90	T2D_GENES_TANYA_BIOMARKER	BILANGES_SERUM_SENSITIVE_GENES
0.163132137031%	1	613	9	T2D_GENES_TANYA_BIOMARKER	ZHU_SKIL_TARGETS_DN
0.163132137031%	1	613	9	T2D_GENES_TANYA_BIOMARKER	ZERBINI_RESPONSE_TO_SULINDAC_UP
0.163132137031%	1	613	9	T2D_GENES_TANYA_BIOMARKER	XU_AKT1_TARGETS_48HR
0.163132137031%	1	613	9	T2D_GENES_TANYA_BIOMARKER	THILLAINADESAN_ZNF217_TARGETS_DN
0.163132137031%	1	613	9	T2D_GENES_TANYA_BIOMARKER	SA_FAS_SIGNALING
0.163132137031%	1	613	9	T2D_GENES_TANYA_BIOMARKER	SASSON_FSH_RESPONSE
0.163132137031%	1	613	9	T2D_GENES_TANYA_BIOMARKER	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN
0.163132137031%	1	613	9	T2D_GENES_TANYA_BIOMARKER	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30
0.163132137031%	1	613	9	T2D_GENES_TANYA_BIOMARKER	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN
0.163132137031%	1	613	9	T2D_GENES_TANYA_BIOMARKER	GOUYER_TUMOR_INVASIVENESS
0.163132137031%	1	613	9	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_FEEDER_PATHWAY
0.163132137031%	1	613	89	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
0.163132137031%	1	613	89	T2D_GENES_TANYA_BIOMARKER	ZHANG_TLX_TARGETS_UP
0.163132137031%	1	613	89	T2D_GENES_TANYA_BIOMARKER	WNT_SIGNALING
0.163132137031%	1	613	89	T2D_GENES_TANYA_BIOMARKER	VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP
0.163132137031%	1	613	89	T2D_GENES_TANYA_BIOMARKER	LEIN_PONS_MARKERS
0.163132137031%	1	613	89	T2D_GENES_TANYA_BIOMARKER	DELASERNA_MYOD_TARGETS_UP
0.163132137031%	1	613	88	T2D_GENES_TANYA_BIOMARKER	UEDA_CENTRAL_CLOCK
0.163132137031%	1	613	88	T2D_GENES_TANYA_BIOMARKER	SEIDEN_ONCOGENESIS_BY_MET
0.163132137031%	1	613	88	T2D_GENES_TANYA_BIOMARKER	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
0.163132137031%	1	613	88	T2D_GENES_TANYA_BIOMARKER	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
0.163132137031%	1	613	88	T2D_GENES_TANYA_BIOMARKER	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
0.163132137031%	1	613	87	T2D_GENES_TANYA_BIOMARKER	MOOTHA_VOXPHOS
0.163132137031%	1	613	86	T2D_GENES_TANYA_BIOMARKER	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2
0.163132137031%	1	613	86	T2D_GENES_TANYA_BIOMARKER	REACTOME_MEIOTIC_RECOMBINATION
0.163132137031%	1	613	86	T2D_GENES_TANYA_BIOMARKER	REACTOME_L1CAM_INTERACTIONS
0.163132137031%	1	613	86	T2D_GENES_TANYA_BIOMARKER	LAIHO_COLORECTAL_CANCER_SERRATED_DN
0.163132137031%	1	613	86	T2D_GENES_TANYA_BIOMARKER	KEGG_TGF_BETA_SIGNALING_PATHWAY
0.163132137031%	1	613	86	T2D_GENES_TANYA_BIOMARKER	GHANDHI_BYSTANDER_IRRADIATION_UP
0.163132137031%	1	613	84	T2D_GENES_TANYA_BIOMARKER	REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S
0.163132137031%	1	613	84	T2D_GENES_TANYA_BIOMARKER	LEE_AGING_CEREBELLUM_UP
0.163132137031%	1	613	83	T2D_GENES_TANYA_BIOMARKER	ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.163132137031%	1	613	82	T2D_GENES_TANYA_BIOMARKER	PID_SMAD2_3NUCLEARPATHWAY
0.163132137031%	1	613	82	T2D_GENES_TANYA_BIOMARKER	BILD_CTNNB1_ONCOGENIC_SIGNATURE
0.163132137031%	1	613	82	T2D_GENES_TANYA_BIOMARKER	BHAT_ESR1_TARGETS_VIA_AKT1_DN
0.163132137031%	1	613	81	T2D_GENES_TANYA_BIOMARKER	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.163132137031%	1	613	81	T2D_GENES_TANYA_BIOMARKER	SCIBETTA_KDM5B_TARGETS_DN
0.163132137031%	1	613	81	T2D_GENES_TANYA_BIOMARKER	MAHAJAN_RESPONSE_TO_IL1A_UP
0.163132137031%	1	613	81	T2D_GENES_TANYA_BIOMARKER	LEIN_MEDULLA_MARKERS
0.163132137031%	1	613	81	T2D_GENES_TANYA_BIOMARKER	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
0.163132137031%	1	613	80	T2D_GENES_TANYA_BIOMARKER	PID_MET_PATHWAY
0.163132137031%	1	613	80	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
0.163132137031%	1	613	80	T2D_GENES_TANYA_BIOMARKER	LINDVALL_IMMORTALIZED_BY_TERT_DN
0.163132137031%	1	613	80	T2D_GENES_TANYA_BIOMARKER	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
0.163132137031%	1	613	80	T2D_GENES_TANYA_BIOMARKER	BASSO_HAIRY_CELL_LEUKEMIA_DN
0.163132137031%	1	613	8	T2D_GENES_TANYA_BIOMARKER	TURJANSKI_MAPK7_TARGETS
0.163132137031%	1	613	8	T2D_GENES_TANYA_BIOMARKER	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN
0.163132137031%	1	613	8	T2D_GENES_TANYA_BIOMARKER	TCGA_GLIOBLASTOMA_MUTATED
0.163132137031%	1	613	8	T2D_GENES_TANYA_BIOMARKER	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP
0.163132137031%	1	613	8	T2D_GENES_TANYA_BIOMARKER	SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN
0.163132137031%	1	613	8	T2D_GENES_TANYA_BIOMARKER	RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN
0.163132137031%	1	613	8	T2D_GENES_TANYA_BIOMARKER	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7
0.163132137031%	1	613	8	T2D_GENES_TANYA_BIOMARKER	KONDO_HYPOXIA
0.163132137031%	1	613	8	T2D_GENES_TANYA_BIOMARKER	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN
0.163132137031%	1	613	8	T2D_GENES_TANYA_BIOMARKER	DER_IFN_BETA_RESPONSE_DN
0.163132137031%	1	613	8	T2D_GENES_TANYA_BIOMARKER	CLIMENT_BREAST_CANCER_COPY_NUMBER_DN
0.163132137031%	1	613	8	T2D_GENES_TANYA_BIOMARKER	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3
0.163132137031%	1	613	8	T2D_GENES_TANYA_BIOMARKER	BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS
0.163132137031%	1	613	79	T2D_GENES_TANYA_BIOMARKER	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
0.163132137031%	1	613	79	T2D_GENES_TANYA_BIOMARKER	MEISSNER_NPC_HCP_WITH_H3K27ME3
0.163132137031%	1	613	79	T2D_GENES_TANYA_BIOMARKER	MCCLUNG_COCAINE_REWARD_5D
0.163132137031%	1	613	79	T2D_GENES_TANYA_BIOMARKER	CROMER_METASTASIS_UP
0.163132137031%	1	613	78	T2D_GENES_TANYA_BIOMARKER	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.163132137031%	1	613	78	T2D_GENES_TANYA_BIOMARKER	REACTOME_PLATELET_HOMEOSTASIS
0.163132137031%	1	613	78	T2D_GENES_TANYA_BIOMARKER	BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE
0.163132137031%	1	613	77	T2D_GENES_TANYA_BIOMARKER	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
0.163132137031%	1	613	77	T2D_GENES_TANYA_BIOMARKER	RIZ_ERYTHROID_DIFFERENTIATION
0.163132137031%	1	613	77	T2D_GENES_TANYA_BIOMARKER	JACKSON_DNMT1_TARGETS_UP
0.163132137031%	1	613	76	T2D_GENES_TANYA_BIOMARKER	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.163132137031%	1	613	76	T2D_GENES_TANYA_BIOMARKER	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
0.163132137031%	1	613	76	T2D_GENES_TANYA_BIOMARKER	ROSS_AML_WITH_AML1_ETO_FUSION
0.163132137031%	1	613	76	T2D_GENES_TANYA_BIOMARKER	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
0.163132137031%	1	613	76	T2D_GENES_TANYA_BIOMARKER	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC
0.163132137031%	1	613	75	T2D_GENES_TANYA_BIOMARKER	REACTOME_TELOMERE_MAINTENANCE
0.163132137031%	1	613	75	T2D_GENES_TANYA_BIOMARKER	MCCLUNG_COCAIN_REWARD_4WK
0.163132137031%	1	613	75	T2D_GENES_TANYA_BIOMARKER	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
0.163132137031%	1	613	75	T2D_GENES_TANYA_BIOMARKER	CHESLER_BRAIN_QTL_CIS
0.163132137031%	1	613	74	T2D_GENES_TANYA_BIOMARKER	WESTON_VEGFA_TARGETS_3HR
0.163132137031%	1	613	74	T2D_GENES_TANYA_BIOMARKER	VANASSE_BCL2_TARGETS_DN
0.163132137031%	1	613	74	T2D_GENES_TANYA_BIOMARKER	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.163132137031%	1	613	74	T2D_GENES_TANYA_BIOMARKER	SHEPARD_BMYB_TARGETS
0.163132137031%	1	613	74	T2D_GENES_TANYA_BIOMARKER	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
0.163132137031%	1	613	74	T2D_GENES_TANYA_BIOMARKER	JI_RESPONSE_TO_FSH_UP
0.163132137031%	1	613	73	T2D_GENES_TANYA_BIOMARKER	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.163132137031%	1	613	73	T2D_GENES_TANYA_BIOMARKER	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
0.163132137031%	1	613	73	T2D_GENES_TANYA_BIOMARKER	REACTOME_MEIOTIC_SYNAPSIS
0.163132137031%	1	613	73	T2D_GENES_TANYA_BIOMARKER	HOSHIDA_LIVER_CANCER_SURVIVAL_UP
0.163132137031%	1	613	72	T2D_GENES_TANYA_BIOMARKER	SESTO_RESPONSE_TO_UV_C8
0.163132137031%	1	613	71	T2D_GENES_TANYA_BIOMARKER	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
0.163132137031%	1	613	71	T2D_GENES_TANYA_BIOMARKER	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
0.163132137031%	1	613	71	T2D_GENES_TANYA_BIOMARKER	GU_PDEF_TARGETS_UP
0.163132137031%	1	613	70	T2D_GENES_TANYA_BIOMARKER	PID_AP1_PATHWAY
0.163132137031%	1	613	70	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_MEF_LCP_WITH_H3K27ME3
0.163132137031%	1	613	70	T2D_GENES_TANYA_BIOMARKER	LIU_NASOPHARYNGEAL_CARCINOMA
0.163132137031%	1	613	70	T2D_GENES_TANYA_BIOMARKER	KEGG_LONG_TERM_POTENTIATION
0.163132137031%	1	613	70	T2D_GENES_TANYA_BIOMARKER	KEGG_LONG_TERM_DEPRESSION
0.163132137031%	1	613	7	T2D_GENES_TANYA_BIOMARKER	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN
0.163132137031%	1	613	7	T2D_GENES_TANYA_BIOMARKER	TESAR_ALK_TARGETS_HUMAN_ES_5D_DN
0.163132137031%	1	613	7	T2D_GENES_TANYA_BIOMARKER	TERAMOTO_OPN_TARGETS_CLUSTER_5
0.163132137031%	1	613	7	T2D_GENES_TANYA_BIOMARKER	ST_PAC1_RECEPTOR_PATHWAY
0.163132137031%	1	613	7	T2D_GENES_TANYA_BIOMARKER	PETRETTO_BLOOD_PRESSURE_DN
0.163132137031%	1	613	7	T2D_GENES_TANYA_BIOMARKER	MARSHALL_VIRAL_INFECTION_RESPONSE_UP
0.163132137031%	1	613	7	T2D_GENES_TANYA_BIOMARKER	LY_AGING_OLD_UP
0.163132137031%	1	613	7	T2D_GENES_TANYA_BIOMARKER	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN
0.163132137031%	1	613	7	T2D_GENES_TANYA_BIOMARKER	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP
0.163132137031%	1	613	7	T2D_GENES_TANYA_BIOMARKER	JOHNSTONE_PARVB_TARGETS_1_UP
0.163132137031%	1	613	7	T2D_GENES_TANYA_BIOMARKER	HOLLEMAN_DAUNORUBICIN_ALL_UP
0.163132137031%	1	613	7	T2D_GENES_TANYA_BIOMARKER	HE_PTEN_TARGETS_DN
0.163132137031%	1	613	7	T2D_GENES_TANYA_BIOMARKER	FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES
0.163132137031%	1	613	7	T2D_GENES_TANYA_BIOMARKER	FARDIN_HYPOXIA_9
0.163132137031%	1	613	7	T2D_GENES_TANYA_BIOMARKER	DER_IFN_ALPHA_RESPONSE_DN
0.163132137031%	1	613	7	T2D_GENES_TANYA_BIOMARKER	BUDHU_LIVER_CANCER_METASTASIS_DN
0.163132137031%	1	613	7	T2D_GENES_TANYA_BIOMARKER	BERGER_MBD2_TARGETS
0.163132137031%	1	613	69	T2D_GENES_TANYA_BIOMARKER	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.163132137031%	1	613	69	T2D_GENES_TANYA_BIOMARKER	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.163132137031%	1	613	69	T2D_GENES_TANYA_BIOMARKER	REACTOME_SPHINGOLIPID_METABOLISM
0.163132137031%	1	613	69	T2D_GENES_TANYA_BIOMARKER	REACTOME_GLUCOSE_METABOLISM
0.163132137031%	1	613	69	T2D_GENES_TANYA_BIOMARKER	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.163132137031%	1	613	69	T2D_GENES_TANYA_BIOMARKER	LEIN_NEURON_MARKERS
0.163132137031%	1	613	69	T2D_GENES_TANYA_BIOMARKER	KEGG_PPAR_SIGNALING_PATHWAY
0.163132137031%	1	613	69	T2D_GENES_TANYA_BIOMARKER	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
0.163132137031%	1	613	68	T2D_GENES_TANYA_BIOMARKER	SESTO_RESPONSE_TO_UV_C7
0.163132137031%	1	613	68	T2D_GENES_TANYA_BIOMARKER	NOUZOVA_METHYLATED_IN_APL
0.163132137031%	1	613	68	T2D_GENES_TANYA_BIOMARKER	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES
0.163132137031%	1	613	68	T2D_GENES_TANYA_BIOMARKER	AKL_HTLV1_INFECTION_DN
0.163132137031%	1	613	67	T2D_GENES_TANYA_BIOMARKER	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP
0.163132137031%	1	613	67	T2D_GENES_TANYA_BIOMARKER	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
0.163132137031%	1	613	67	T2D_GENES_TANYA_BIOMARKER	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP
0.163132137031%	1	613	67	T2D_GENES_TANYA_BIOMARKER	DAZARD_UV_RESPONSE_CLUSTER_G1
0.163132137031%	1	613	67	T2D_GENES_TANYA_BIOMARKER	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70
0.163132137031%	1	613	66	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
0.163132137031%	1	613	66	T2D_GENES_TANYA_BIOMARKER	LEE_LIVER_CANCER_CIPROFIBRATE_DN
0.163132137031%	1	613	66	T2D_GENES_TANYA_BIOMARKER	KIM_GERMINAL_CENTER_T_HELPER_UP
0.163132137031%	1	613	66	T2D_GENES_TANYA_BIOMARKER	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.163132137031%	1	613	66	T2D_GENES_TANYA_BIOMARKER	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.163132137031%	1	613	65	T2D_GENES_TANYA_BIOMARKER	PID_RB_1PATHWAY
0.163132137031%	1	613	65	T2D_GENES_TANYA_BIOMARKER	PID_IL4_2PATHWAY
0.163132137031%	1	613	65	T2D_GENES_TANYA_BIOMARKER	LEE_LIVER_CANCER_MYC_TGFA_DN
0.163132137031%	1	613	65	T2D_GENES_TANYA_BIOMARKER	KEGG_GLIOMA
0.163132137031%	1	613	65	T2D_GENES_TANYA_BIOMARKER	GOLDRATH_IMMUNE_MEMORY
0.163132137031%	1	613	65	T2D_GENES_TANYA_BIOMARKER	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS
0.163132137031%	1	613	64	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_UP
0.163132137031%	1	613	64	T2D_GENES_TANYA_BIOMARKER	ZHANG_GATA6_TARGETS_DN
0.163132137031%	1	613	64	T2D_GENES_TANYA_BIOMARKER	RHODES_CANCER_META_SIGNATURE
0.163132137031%	1	613	64	T2D_GENES_TANYA_BIOMARKER	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
0.163132137031%	1	613	64	T2D_GENES_TANYA_BIOMARKER	PETROVA_PROX1_TARGETS_DN
0.163132137031%	1	613	64	T2D_GENES_TANYA_BIOMARKER	LIU_SMARCA4_TARGETS
0.163132137031%	1	613	64	T2D_GENES_TANYA_BIOMARKER	LEE_LIVER_CANCER_MYC_E2F1_DN
0.163132137031%	1	613	64	T2D_GENES_TANYA_BIOMARKER	LEE_LIVER_CANCER_E2F1_DN
0.163132137031%	1	613	64	T2D_GENES_TANYA_BIOMARKER	KEGG_RETINOL_METABOLISM
0.163132137031%	1	613	64	T2D_GENES_TANYA_BIOMARKER	INGRAM_SHH_TARGETS_DN
0.163132137031%	1	613	64	T2D_GENES_TANYA_BIOMARKER	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
0.163132137031%	1	613	64	T2D_GENES_TANYA_BIOMARKER	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.163132137031%	1	613	64	T2D_GENES_TANYA_BIOMARKER	GERHOLD_ADIPOGENESIS_DN
0.163132137031%	1	613	64	T2D_GENES_TANYA_BIOMARKER	BYSTROEM_CORRELATED_WITH_IL5_DN
0.163132137031%	1	613	64	T2D_GENES_TANYA_BIOMARKER	ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE
0.163132137031%	1	613	63	T2D_GENES_TANYA_BIOMARKER	REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
0.163132137031%	1	613	63	T2D_GENES_TANYA_BIOMARKER	PID_IL12_2PATHWAY
0.163132137031%	1	613	63	T2D_GENES_TANYA_BIOMARKER	MODY_HIPPOCAMPUS_POSTNATAL
0.163132137031%	1	613	63	T2D_GENES_TANYA_BIOMARKER	LEE_LIVER_CANCER_MYC_DN
0.163132137031%	1	613	63	T2D_GENES_TANYA_BIOMARKER	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
0.163132137031%	1	613	63	T2D_GENES_TANYA_BIOMARKER	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11
0.163132137031%	1	613	63	T2D_GENES_TANYA_BIOMARKER	CROMER_TUMORIGENESIS_UP
0.163132137031%	1	613	62	T2D_GENES_TANYA_BIOMARKER	PID_TRKRPATHWAY
0.163132137031%	1	613	62	T2D_GENES_TANYA_BIOMARKER	KEGG_COLORECTAL_CANCER
0.163132137031%	1	613	62	T2D_GENES_TANYA_BIOMARKER	GEORGES_CELL_CYCLE_MIR192_TARGETS
0.163132137031%	1	613	62	T2D_GENES_TANYA_BIOMARKER	CORRE_MULTIPLE_MYELOMA_DN
0.163132137031%	1	613	62	T2D_GENES_TANYA_BIOMARKER	BILD_SRC_ONCOGENIC_SIGNATURE
0.163132137031%	1	613	61	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_1HR_UP
0.163132137031%	1	613	60	T2D_GENES_TANYA_BIOMARKER	WIERENGA_STAT5A_TARGETS_GROUP2
0.163132137031%	1	613	60	T2D_GENES_TANYA_BIOMARKER	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
0.163132137031%	1	613	60	T2D_GENES_TANYA_BIOMARKER	SONG_TARGETS_OF_IE86_CMV_PROTEIN
0.163132137031%	1	613	60	T2D_GENES_TANYA_BIOMARKER	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE
0.163132137031%	1	613	60	T2D_GENES_TANYA_BIOMARKER	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
0.163132137031%	1	613	60	T2D_GENES_TANYA_BIOMARKER	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.163132137031%	1	613	6	T2D_GENES_TANYA_BIOMARKER	WILLIAMS_ESR1_TARGETS_DN
0.163132137031%	1	613	6	T2D_GENES_TANYA_BIOMARKER	WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP
0.163132137031%	1	613	6	T2D_GENES_TANYA_BIOMARKER	TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN
0.163132137031%	1	613	6	T2D_GENES_TANYA_BIOMARKER	KREPPEL_CD99_TARGETS_UP
0.163132137031%	1	613	6	T2D_GENES_TANYA_BIOMARKER	KIM_PTEN_TARGETS_DN
0.163132137031%	1	613	6	T2D_GENES_TANYA_BIOMARKER	DONATO_CELL_CYCLE_TRETINOIN
0.163132137031%	1	613	6	T2D_GENES_TANYA_BIOMARKER	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP
0.163132137031%	1	613	6	T2D_GENES_TANYA_BIOMARKER	CHESLER_BRAIN_QTL_TRANS
0.163132137031%	1	613	6	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_NEUROTRANSMITTERS_PATHWAY
0.163132137031%	1	613	59	T2D_GENES_TANYA_BIOMARKER	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS
0.163132137031%	1	613	59	T2D_GENES_TANYA_BIOMARKER	PID_FAK_PATHWAY
0.163132137031%	1	613	59	T2D_GENES_TANYA_BIOMARKER	PID_ATF2_PATHWAY
0.163132137031%	1	613	59	T2D_GENES_TANYA_BIOMARKER	ONDER_CDH1_TARGETS_3_DN
0.163132137031%	1	613	59	T2D_GENES_TANYA_BIOMARKER	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1
0.163132137031%	1	613	59	T2D_GENES_TANYA_BIOMARKER	DASU_IL6_SIGNALING_UP
0.163132137031%	1	613	58	T2D_GENES_TANYA_BIOMARKER	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
0.163132137031%	1	613	58	T2D_GENES_TANYA_BIOMARKER	SCHEIDEREIT_IKK_INTERACTING_PROTEINS
0.163132137031%	1	613	58	T2D_GENES_TANYA_BIOMARKER	SANSOM_WNT_PATHWAY_REQUIRE_MYC
0.163132137031%	1	613	58	T2D_GENES_TANYA_BIOMARKER	REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT
0.163132137031%	1	613	58	T2D_GENES_TANYA_BIOMARKER	NAGASHIMA_NRG1_SIGNALING_DN
0.163132137031%	1	613	58	T2D_GENES_TANYA_BIOMARKER	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN
0.163132137031%	1	613	58	T2D_GENES_TANYA_BIOMARKER	LUCAS_HNF4A_TARGETS_UP
0.163132137031%	1	613	58	T2D_GENES_TANYA_BIOMARKER	JI_RESPONSE_TO_FSH_DN
0.163132137031%	1	613	58	T2D_GENES_TANYA_BIOMARKER	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
0.163132137031%	1	613	57	T2D_GENES_TANYA_BIOMARKER	TANG_SENESCENCE_TP53_TARGETS_DN
0.163132137031%	1	613	57	T2D_GENES_TANYA_BIOMARKER	PID_TXA2PATHWAY
0.163132137031%	1	613	57	T2D_GENES_TANYA_BIOMARKER	PEART_HDAC_PROLIFERATION_CLUSTER_UP
0.163132137031%	1	613	57	T2D_GENES_TANYA_BIOMARKER	GYORFFY_MITOXANTRONE_RESISTANCE
0.163132137031%	1	613	57	T2D_GENES_TANYA_BIOMARKER	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.163132137031%	1	613	57	T2D_GENES_TANYA_BIOMARKER	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
0.163132137031%	1	613	56	T2D_GENES_TANYA_BIOMARKER	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION
0.163132137031%	1	613	56	T2D_GENES_TANYA_BIOMARKER	LY_AGING_OLD_DN
0.163132137031%	1	613	56	T2D_GENES_TANYA_BIOMARKER	KEGG_HEDGEHOG_SIGNALING_PATHWAY
0.163132137031%	1	613	56	T2D_GENES_TANYA_BIOMARKER	HENDRICKS_SMARCA4_TARGETS_UP
0.163132137031%	1	613	56	T2D_GENES_TANYA_BIOMARKER	GRADE_COLON_VS_RECTAL_CANCER_DN
0.163132137031%	1	613	56	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_NFAT_PATHWAY
0.163132137031%	1	613	55	T2D_GENES_TANYA_BIOMARKER	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
0.163132137031%	1	613	55	T2D_GENES_TANYA_BIOMARKER	REACTOME_ION_CHANNEL_TRANSPORT
0.163132137031%	1	613	55	T2D_GENES_TANYA_BIOMARKER	PID_TGFBRPATHWAY
0.163132137031%	1	613	55	T2D_GENES_TANYA_BIOMARKER	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN
0.163132137031%	1	613	55	T2D_GENES_TANYA_BIOMARKER	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR
0.163132137031%	1	613	55	T2D_GENES_TANYA_BIOMARKER	GENTILE_UV_RESPONSE_CLUSTER_D4
0.163132137031%	1	613	55	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_4HR_UP
0.163132137031%	1	613	54	T2D_GENES_TANYA_BIOMARKER	ZHOU_TNF_SIGNALING_30MIN
0.163132137031%	1	613	54	T2D_GENES_TANYA_BIOMARKER	SUNG_METASTASIS_STROMA_DN
0.163132137031%	1	613	54	T2D_GENES_TANYA_BIOMARKER	SESTO_RESPONSE_TO_UV_C2
0.163132137031%	1	613	54	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM
0.163132137031%	1	613	54	T2D_GENES_TANYA_BIOMARKER	PID_TAP63PATHWAY
0.163132137031%	1	613	54	T2D_GENES_TANYA_BIOMARKER	PID_NFAT_3PATHWAY
0.163132137031%	1	613	54	T2D_GENES_TANYA_BIOMARKER	JIANG_AGING_CEREBRAL_CORTEX_DN
0.163132137031%	1	613	53	T2D_GENES_TANYA_BIOMARKER	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
0.163132137031%	1	613	53	T2D_GENES_TANYA_BIOMARKER	REACTOME_PROTEIN_FOLDING
0.163132137031%	1	613	53	T2D_GENES_TANYA_BIOMARKER	REACTOME_CIRCADIAN_CLOCK
0.163132137031%	1	613	53	T2D_GENES_TANYA_BIOMARKER	LIANG_SILENCED_BY_METHYLATION_2
0.163132137031%	1	613	53	T2D_GENES_TANYA_BIOMARKER	KRIEG_HYPOXIA_VIA_KDM3A
0.163132137031%	1	613	52	T2D_GENES_TANYA_BIOMARKER	REACTOME_GABA_RECEPTOR_ACTIVATION
0.163132137031%	1	613	52	T2D_GENES_TANYA_BIOMARKER	RADAEVA_RESPONSE_TO_IFNA1_UP
0.163132137031%	1	613	52	T2D_GENES_TANYA_BIOMARKER	PID_PTP1BPATHWAY
0.163132137031%	1	613	52	T2D_GENES_TANYA_BIOMARKER	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
0.163132137031%	1	613	52	T2D_GENES_TANYA_BIOMARKER	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6
0.163132137031%	1	613	52	T2D_GENES_TANYA_BIOMARKER	KEGG_TASTE_TRANSDUCTION
0.163132137031%	1	613	52	T2D_GENES_TANYA_BIOMARKER	HALMOS_CEBPA_TARGETS_UP
0.163132137031%	1	613	52	T2D_GENES_TANYA_BIOMARKER	CHIBA_RESPONSE_TO_TSA_UP
0.163132137031%	1	613	52	T2D_GENES_TANYA_BIOMARKER	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
0.163132137031%	1	613	51	T2D_GENES_TANYA_BIOMARKER	ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF
0.163132137031%	1	613	51	T2D_GENES_TANYA_BIOMARKER	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
0.163132137031%	1	613	51	T2D_GENES_TANYA_BIOMARKER	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE
0.163132137031%	1	613	51	T2D_GENES_TANYA_BIOMARKER	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT
0.163132137031%	1	613	51	T2D_GENES_TANYA_BIOMARKER	PRAMOONJAGO_SOX4_TARGETS_DN
0.163132137031%	1	613	51	T2D_GENES_TANYA_BIOMARKER	GUILLAUMOND_KLF10_TARGETS_UP
0.163132137031%	1	613	51	T2D_GENES_TANYA_BIOMARKER	FRASOR_TAMOXIFEN_RESPONSE_UP
0.163132137031%	1	613	51	T2D_GENES_TANYA_BIOMARKER	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
0.163132137031%	1	613	51	T2D_GENES_TANYA_BIOMARKER	BYSTROEM_CORRELATED_WITH_IL5_UP
0.163132137031%	1	613	51	T2D_GENES_TANYA_BIOMARKER	BURTON_ADIPOGENESIS_PEAK_AT_2HR
0.163132137031%	1	613	51	T2D_GENES_TANYA_BIOMARKER	BURTON_ADIPOGENESIS_7
0.163132137031%	1	613	51	T2D_GENES_TANYA_BIOMARKER	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
0.163132137031%	1	613	51	T2D_GENES_TANYA_BIOMARKER	APPIERTO_RESPONSE_TO_FENRETINIDE_DN
0.163132137031%	1	613	50	T2D_GENES_TANYA_BIOMARKER	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN
0.163132137031%	1	613	50	T2D_GENES_TANYA_BIOMARKER	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
0.163132137031%	1	613	50	T2D_GENES_TANYA_BIOMARKER	PARK_APL_PATHOGENESIS_DN
0.163132137031%	1	613	50	T2D_GENES_TANYA_BIOMARKER	MARTINEZ_RESPONSE_TO_TRABECTEDIN
0.163132137031%	1	613	50	T2D_GENES_TANYA_BIOMARKER	KOHOUTEK_CCNT1_TARGETS
0.163132137031%	1	613	50	T2D_GENES_TANYA_BIOMARKER	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
0.163132137031%	1	613	50	T2D_GENES_TANYA_BIOMARKER	FIGUEROA_AML_METHYLATION_CLUSTER_5_DN
0.163132137031%	1	613	50	T2D_GENES_TANYA_BIOMARKER	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN
0.163132137031%	1	613	50	T2D_GENES_TANYA_BIOMARKER	BECKER_TAMOXIFEN_RESISTANCE_UP
0.163132137031%	1	613	5	T2D_GENES_TANYA_BIOMARKER	NICK_RESPONSE_TO_PROC_TREATMENT_UP
0.163132137031%	1	613	5	T2D_GENES_TANYA_BIOMARKER	MCGOWAN_RSP6_TARGETS_DN
0.163132137031%	1	613	5	T2D_GENES_TANYA_BIOMARKER	LAU_APOPTOSIS_CDKN2A_DN
0.163132137031%	1	613	5	T2D_GENES_TANYA_BIOMARKER	FUJIWARA_PARK2_IN_LIVER_CANCER_DN
0.163132137031%	1	613	49	T2D_GENES_TANYA_BIOMARKER	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8
0.163132137031%	1	613	49	T2D_GENES_TANYA_BIOMARKER	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
0.163132137031%	1	613	49	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_2HR_DN
0.163132137031%	1	613	49	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_TCR_PATHWAY
0.163132137031%	1	613	49	T2D_GENES_TANYA_BIOMARKER	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP
0.163132137031%	1	613	48	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_LB_UP
0.163132137031%	1	613	48	T2D_GENES_TANYA_BIOMARKER	PENG_GLUCOSE_DEPRIVATION_UP
0.163132137031%	1	613	48	T2D_GENES_TANYA_BIOMARKER	OXFORD_RALA_OR_RALB_TARGETS_UP
0.163132137031%	1	613	48	T2D_GENES_TANYA_BIOMARKER	NADLER_OBESITY_DN
0.163132137031%	1	613	48	T2D_GENES_TANYA_BIOMARKER	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN
0.163132137031%	1	613	48	T2D_GENES_TANYA_BIOMARKER	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN
0.163132137031%	1	613	48	T2D_GENES_TANYA_BIOMARKER	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN
0.163132137031%	1	613	48	T2D_GENES_TANYA_BIOMARKER	DOANE_BREAST_CANCER_ESR1_DN
0.163132137031%	1	613	48	T2D_GENES_TANYA_BIOMARKER	ABE_INNER_EAR
0.163132137031%	1	613	47	T2D_GENES_TANYA_BIOMARKER	ZHU_CMV_8_HR_UP
0.163132137031%	1	613	47	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_MF_UP
0.163132137031%	1	613	47	T2D_GENES_TANYA_BIOMARKER	WOOD_EBV_EBNA1_TARGETS_DN
0.163132137031%	1	613	47	T2D_GENES_TANYA_BIOMARKER	WARTERS_IR_RESPONSE_5GY
0.163132137031%	1	613	47	T2D_GENES_TANYA_BIOMARKER	MELLMAN_TUT1_TARGETS_DN
0.163132137031%	1	613	47	T2D_GENES_TANYA_BIOMARKER	MCCLUNG_DELTA_FOSB_TARGETS_8WK
0.163132137031%	1	613	47	T2D_GENES_TANYA_BIOMARKER	LEONARD_HYPOXIA
0.163132137031%	1	613	47	T2D_GENES_TANYA_BIOMARKER	JIANG_AGING_HYPOTHALAMUS_UP
0.163132137031%	1	613	47	T2D_GENES_TANYA_BIOMARKER	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.163132137031%	1	613	46	T2D_GENES_TANYA_BIOMARKER	TSENG_ADIPOGENIC_POTENTIAL_DN
0.163132137031%	1	613	46	T2D_GENES_TANYA_BIOMARKER	SIG_BCR_SIGNALING_PATHWAY
0.163132137031%	1	613	46	T2D_GENES_TANYA_BIOMARKER	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
0.163132137031%	1	613	46	T2D_GENES_TANYA_BIOMARKER	PID_PS1PATHWAY
0.163132137031%	1	613	46	T2D_GENES_TANYA_BIOMARKER	PID_A6B1_A6B4_INTEGRIN_PATHWAY
0.163132137031%	1	613	46	T2D_GENES_TANYA_BIOMARKER	OSADA_ASCL1_TARGETS_UP
0.163132137031%	1	613	46	T2D_GENES_TANYA_BIOMARKER	NAKAJIMA_MAST_CELL
0.163132137031%	1	613	46	T2D_GENES_TANYA_BIOMARKER	MADAN_DPPA4_TARGETS
0.163132137031%	1	613	46	T2D_GENES_TANYA_BIOMARKER	KUNINGER_IGF1_VS_PDGFB_TARGETS_DN
0.163132137031%	1	613	45	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_CD2_UP
0.163132137031%	1	613	45	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_CD1_UP
0.163132137031%	1	613	45	T2D_GENES_TANYA_BIOMARKER	WANG_TARGETS_OF_MLL_CBP_FUSION_DN
0.163132137031%	1	613	45	T2D_GENES_TANYA_BIOMARKER	TRAYNOR_RETT_SYNDROM_UP
0.163132137031%	1	613	45	T2D_GENES_TANYA_BIOMARKER	SIG_CHEMOTAXIS
0.163132137031%	1	613	45	T2D_GENES_TANYA_BIOMARKER	SHIPP_DLBCL_CURED_VS_FATAL_DN
0.163132137031%	1	613	45	T2D_GENES_TANYA_BIOMARKER	REACTOME_MRNA_SPLICING_MINOR_PATHWAY
0.163132137031%	1	613	45	T2D_GENES_TANYA_BIOMARKER	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_
0.163132137031%	1	613	45	T2D_GENES_TANYA_BIOMARKER	PID_INSULIN_PATHWAY
0.163132137031%	1	613	45	T2D_GENES_TANYA_BIOMARKER	PID_ILK_PATHWAY
0.163132137031%	1	613	45	T2D_GENES_TANYA_BIOMARKER	NUTT_GBM_VS_AO_GLIOMA_DN
0.163132137031%	1	613	45	T2D_GENES_TANYA_BIOMARKER	MCDOWELL_ACUTE_LUNG_INJURY_UP
0.163132137031%	1	613	45	T2D_GENES_TANYA_BIOMARKER	KLEIN_TARGETS_OF_BCR_ABL1_FUSION
0.163132137031%	1	613	45	T2D_GENES_TANYA_BIOMARKER	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN
0.163132137031%	1	613	45	T2D_GENES_TANYA_BIOMARKER	CHENG_RESPONSE_TO_NICKEL_ACETATE
0.163132137031%	1	613	45	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_BIOPEPTIDES_PATHWAY
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	ZHAN_MULTIPLE_MYELOMA_PR_DN
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	WHITFIELD_CELL_CYCLE_LITERATURE
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	WANG_TARGETS_OF_MLL_CBP_FUSION_UP
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	STREICHER_LSM1_TARGETS_UP
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_FGFR_MUTANTS
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	PID_HNF3APATHWAY
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	PARK_HSC_MARKERS
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	MARTIN_INTERACT_WITH_HDAC
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	LUI_THYROID_CANCER_PAX8_PPARG_UP
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	KERLEY_RESPONSE_TO_CISPLATIN_UP
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	KEGG_ABC_TRANSPORTERS
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	JAEGER_METASTASIS_UP
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	HARRIS_BRAIN_CANCER_PROGENITORS
0.163132137031%	1	613	44	T2D_GENES_TANYA_BIOMARKER	FAELT_B_CLL_WITH_VH3_21_UP
0.163132137031%	1	613	43	T2D_GENES_TANYA_BIOMARKER	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1
0.163132137031%	1	613	43	T2D_GENES_TANYA_BIOMARKER	PID_INTEGRIN3_PATHWAY
0.163132137031%	1	613	43	T2D_GENES_TANYA_BIOMARKER	NAKAMURA_METASTASIS_MODEL_DN
0.163132137031%	1	613	43	T2D_GENES_TANYA_BIOMARKER	LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.163132137031%	1	613	43	T2D_GENES_TANYA_BIOMARKER	HUMMEL_BURKITTS_LYMPHOMA_UP
0.163132137031%	1	613	43	T2D_GENES_TANYA_BIOMARKER	DORN_ADENOVIRUS_INFECTION_24HR_DN
0.163132137031%	1	613	43	T2D_GENES_TANYA_BIOMARKER	AMIT_EGF_RESPONSE_120_MCF10A
0.163132137031%	1	613	42	T2D_GENES_TANYA_BIOMARKER	WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN
0.163132137031%	1	613	42	T2D_GENES_TANYA_BIOMARKER	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
0.163132137031%	1	613	42	T2D_GENES_TANYA_BIOMARKER	PID_UPA_UPAR_PATHWAY
0.163132137031%	1	613	42	T2D_GENES_TANYA_BIOMARKER	PID_BMPPATHWAY
0.163132137031%	1	613	42	T2D_GENES_TANYA_BIOMARKER	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER
0.163132137031%	1	613	42	T2D_GENES_TANYA_BIOMARKER	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP
0.163132137031%	1	613	42	T2D_GENES_TANYA_BIOMARKER	LEIN_ASTROCYTE_MARKERS
0.163132137031%	1	613	42	T2D_GENES_TANYA_BIOMARKER	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
0.163132137031%	1	613	42	T2D_GENES_TANYA_BIOMARKER	HAHTOLA_SEZARY_SYNDROM_DN
0.163132137031%	1	613	42	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CHREBP2_PATHWAY
0.163132137031%	1	613	42	T2D_GENES_TANYA_BIOMARKER	BILBAN_B_CLL_LPL_DN
0.163132137031%	1	613	42	T2D_GENES_TANYA_BIOMARKER	AMIT_EGF_RESPONSE_40_HELA
0.163132137031%	1	613	41	T2D_GENES_TANYA_BIOMARKER	WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.163132137031%	1	613	41	T2D_GENES_TANYA_BIOMARKER	PID_ER_NONGENOMIC_PATHWAY
0.163132137031%	1	613	41	T2D_GENES_TANYA_BIOMARKER	PID_ERBB1_INTERNALIZATION_PATHWAY
0.163132137031%	1	613	41	T2D_GENES_TANYA_BIOMARKER	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM
0.163132137031%	1	613	41	T2D_GENES_TANYA_BIOMARKER	KAMMINGA_SENESCENCE
0.163132137031%	1	613	41	T2D_GENES_TANYA_BIOMARKER	GENTILE_UV_RESPONSE_CLUSTER_D2
0.163132137031%	1	613	41	T2D_GENES_TANYA_BIOMARKER	CROONQUIST_NRAS_SIGNALING_UP
0.163132137031%	1	613	40	T2D_GENES_TANYA_BIOMARKER	VARELA_ZMPSTE24_TARGETS_UP
0.163132137031%	1	613	40	T2D_GENES_TANYA_BIOMARKER	TOMLINS_PROSTATE_CANCER_DN
0.163132137031%	1	613	40	T2D_GENES_TANYA_BIOMARKER	PID_EPHBFWDPATHWAY
0.163132137031%	1	613	40	T2D_GENES_TANYA_BIOMARKER	MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.163132137031%	1	613	40	T2D_GENES_TANYA_BIOMARKER	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS
0.163132137031%	1	613	40	T2D_GENES_TANYA_BIOMARKER	JIANG_AGING_HYPOTHALAMUS_DN
0.163132137031%	1	613	40	T2D_GENES_TANYA_BIOMARKER	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
0.163132137031%	1	613	40	T2D_GENES_TANYA_BIOMARKER	GENTILE_UV_RESPONSE_CLUSTER_D7
0.163132137031%	1	613	40	T2D_GENES_TANYA_BIOMARKER	DORN_ADENOVIRUS_INFECTION_48HR_DN
0.163132137031%	1	613	40	T2D_GENES_TANYA_BIOMARKER	CHESLER_BRAIN_HIGHEST_EXPRESSION
0.163132137031%	1	613	40	T2D_GENES_TANYA_BIOMARKER	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
0.163132137031%	1	613	40	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_P38MAPK_PATHWAY
0.163132137031%	1	613	39	T2D_GENES_TANYA_BIOMARKER	WANG_LSD1_TARGETS_DN
0.163132137031%	1	613	39	T2D_GENES_TANYA_BIOMARKER	VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN
0.163132137031%	1	613	39	T2D_GENES_TANYA_BIOMARKER	STONER_ESOPHAGEAL_CARCINOGENESIS_UP
0.163132137031%	1	613	39	T2D_GENES_TANYA_BIOMARKER	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP
0.163132137031%	1	613	39	T2D_GENES_TANYA_BIOMARKER	SHIPP_DLBCL_CURED_VS_FATAL_UP
0.163132137031%	1	613	39	T2D_GENES_TANYA_BIOMARKER	SESTO_RESPONSE_TO_UV_C6
0.163132137031%	1	613	39	T2D_GENES_TANYA_BIOMARKER	REACTOME_NCAM1_INTERACTIONS
0.163132137031%	1	613	39	T2D_GENES_TANYA_BIOMARKER	PID_ECADHERIN_NASCENTAJ_PATHWAY
0.163132137031%	1	613	39	T2D_GENES_TANYA_BIOMARKER	NEWMAN_ERCC6_TARGETS_DN
0.163132137031%	1	613	39	T2D_GENES_TANYA_BIOMARKER	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
0.163132137031%	1	613	39	T2D_GENES_TANYA_BIOMARKER	GU_PDEF_TARGETS_DN
0.163132137031%	1	613	39	T2D_GENES_TANYA_BIOMARKER	GENTILE_UV_RESPONSE_CLUSTER_D5
0.163132137031%	1	613	39	T2D_GENES_TANYA_BIOMARKER	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
0.163132137031%	1	613	39	T2D_GENES_TANYA_BIOMARKER	DORN_ADENOVIRUS_INFECTION_32HR_DN
0.163132137031%	1	613	39	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_FMLP_PATHWAY
0.163132137031%	1	613	39	T2D_GENES_TANYA_BIOMARKER	BILANGES_RAPAMYCIN_SENSITIVE_GENES
0.163132137031%	1	613	39	T2D_GENES_TANYA_BIOMARKER	AMIT_SERUM_RESPONSE_480_MCF10A
0.163132137031%	1	613	389	T2D_GENES_TANYA_BIOMARKER	KEGG_OLFACTORY_TRANSDUCTION
0.163132137031%	1	613	38	T2D_GENES_TANYA_BIOMARKER	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
0.163132137031%	1	613	38	T2D_GENES_TANYA_BIOMARKER	SPIRA_SMOKERS_LUNG_CANCER_UP
0.163132137031%	1	613	38	T2D_GENES_TANYA_BIOMARKER	REACTOME_GABA_B_RECEPTOR_ACTIVATION
0.163132137031%	1	613	38	T2D_GENES_TANYA_BIOMARKER	PENG_GLUTAMINE_DEPRIVATION_UP
0.163132137031%	1	613	38	T2D_GENES_TANYA_BIOMARKER	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN
0.163132137031%	1	613	38	T2D_GENES_TANYA_BIOMARKER	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN
0.163132137031%	1	613	38	T2D_GENES_TANYA_BIOMARKER	CERVERA_SDHB_TARGETS_1_DN
0.163132137031%	1	613	38	T2D_GENES_TANYA_BIOMARKER	CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN
0.163132137031%	1	613	38	T2D_GENES_TANYA_BIOMARKER	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
0.163132137031%	1	613	38	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_IL2RB_PATHWAY
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	ST_P38_MAPK_PATHWAY
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	RICKMAN_HEAD_AND_NECK_CANCER_D
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	REACTOME_DOWNSTREAM_TCR_SIGNALING
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	PID_FRA_PATHWAY
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	MURAKAMI_UV_RESPONSE_6HR_UP
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	LANDIS_ERBB2_BREAST_TUMORS_65_DN
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	KIM_ALL_DISORDERS_CALB1_CORR_DN
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_MET_PATHWAY
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_GPCR_PATHWAY
0.163132137031%	1	613	37	T2D_GENES_TANYA_BIOMARKER	BILANGES_SERUM_RESPONSE_TRANSLATION
0.163132137031%	1	613	36	T2D_GENES_TANYA_BIOMARKER	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2
0.163132137031%	1	613	36	T2D_GENES_TANYA_BIOMARKER	VANTVEER_BREAST_CANCER_BRCA1_UP
0.163132137031%	1	613	36	T2D_GENES_TANYA_BIOMARKER	SUBTIL_PROGESTIN_TARGETS
0.163132137031%	1	613	36	T2D_GENES_TANYA_BIOMARKER	ST_ADRENERGIC
0.163132137031%	1	613	36	T2D_GENES_TANYA_BIOMARKER	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
0.163132137031%	1	613	36	T2D_GENES_TANYA_BIOMARKER	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
0.163132137031%	1	613	36	T2D_GENES_TANYA_BIOMARKER	SEMENZA_HIF1_TARGETS
0.163132137031%	1	613	36	T2D_GENES_TANYA_BIOMARKER	REACTOME_FRS2_MEDIATED_CASCADE
0.163132137031%	1	613	36	T2D_GENES_TANYA_BIOMARKER	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION
0.163132137031%	1	613	36	T2D_GENES_TANYA_BIOMARKER	PID_PI3KPLCTRKPATHWAY
0.163132137031%	1	613	36	T2D_GENES_TANYA_BIOMARKER	MMS_MOUSE_LYMPH_HIGH_4HRS_UP
0.163132137031%	1	613	36	T2D_GENES_TANYA_BIOMARKER	MARZEC_IL2_SIGNALING_DN
0.163132137031%	1	613	36	T2D_GENES_TANYA_BIOMARKER	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN
0.163132137031%	1	613	36	T2D_GENES_TANYA_BIOMARKER	HUANG_FOXA2_TARGETS_DN
0.163132137031%	1	613	36	T2D_GENES_TANYA_BIOMARKER	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP
0.163132137031%	1	613	36	T2D_GENES_TANYA_BIOMARKER	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN
0.163132137031%	1	613	35	T2D_GENES_TANYA_BIOMARKER	WANG_METHYLATED_IN_BREAST_CANCER
0.163132137031%	1	613	35	T2D_GENES_TANYA_BIOMARKER	ST_G_ALPHA_I_PATHWAY
0.163132137031%	1	613	35	T2D_GENES_TANYA_BIOMARKER	ROZANOV_MMP14_TARGETS_DN
0.163132137031%	1	613	35	T2D_GENES_TANYA_BIOMARKER	REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D
0.163132137031%	1	613	35	T2D_GENES_TANYA_BIOMARKER	PID_ARF6_PATHWAY
0.163132137031%	1	613	35	T2D_GENES_TANYA_BIOMARKER	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
0.163132137031%	1	613	35	T2D_GENES_TANYA_BIOMARKER	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.163132137031%	1	613	35	T2D_GENES_TANYA_BIOMARKER	LIEN_BREAST_CARCINOMA_METAPLASTIC
0.163132137031%	1	613	35	T2D_GENES_TANYA_BIOMARKER	KEGG_REGULATION_OF_AUTOPHAGY
0.163132137031%	1	613	35	T2D_GENES_TANYA_BIOMARKER	HOWLIN_CITED1_TARGETS_1_UP
0.163132137031%	1	613	35	T2D_GENES_TANYA_BIOMARKER	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN
0.163132137031%	1	613	35	T2D_GENES_TANYA_BIOMARKER	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP
0.163132137031%	1	613	35	T2D_GENES_TANYA_BIOMARKER	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP
0.163132137031%	1	613	35	T2D_GENES_TANYA_BIOMARKER	BALDWIN_PRKCI_TARGETS_UP
0.163132137031%	1	613	35	T2D_GENES_TANYA_BIOMARKER	AIGNER_ZEB1_TARGETS
0.163132137031%	1	613	34	T2D_GENES_TANYA_BIOMARKER	WONG_IFNA2_RESISTANCE_DN
0.163132137031%	1	613	34	T2D_GENES_TANYA_BIOMARKER	WANG_RESPONSE_TO_BEXAROTENE_UP
0.163132137031%	1	613	34	T2D_GENES_TANYA_BIOMARKER	SCHOEN_NFKB_SIGNALING
0.163132137031%	1	613	34	T2D_GENES_TANYA_BIOMARKER	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP
0.163132137031%	1	613	34	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNAL_TRANSDUCTION_BY_L1
0.163132137031%	1	613	34	T2D_GENES_TANYA_BIOMARKER	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES
0.163132137031%	1	613	34	T2D_GENES_TANYA_BIOMARKER	REACTOME_GLUCONEOGENESIS
0.163132137031%	1	613	34	T2D_GENES_TANYA_BIOMARKER	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION
0.163132137031%	1	613	34	T2D_GENES_TANYA_BIOMARKER	REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX
0.163132137031%	1	613	34	T2D_GENES_TANYA_BIOMARKER	PID_IL1PATHWAY
0.163132137031%	1	613	34	T2D_GENES_TANYA_BIOMARKER	PID_ATM_PATHWAY
0.163132137031%	1	613	34	T2D_GENES_TANYA_BIOMARKER	PETRETTO_CARDIAC_HYPERTROPHY
0.163132137031%	1	613	34	T2D_GENES_TANYA_BIOMARKER	JIANG_HYPOXIA_VIA_VHL
0.163132137031%	1	613	34	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_MPR_PATHWAY
0.163132137031%	1	613	34	T2D_GENES_TANYA_BIOMARKER	ABE_VEGFA_TARGETS_2HR
0.163132137031%	1	613	33	T2D_GENES_TANYA_BIOMARKER	ZHAN_LATE_DIFFERENTIATION_GENES_UP
0.163132137031%	1	613	33	T2D_GENES_TANYA_BIOMARKER	VALK_AML_CLUSTER_6
0.163132137031%	1	613	33	T2D_GENES_TANYA_BIOMARKER	VALK_AML_CLUSTER_5
0.163132137031%	1	613	33	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT
0.163132137031%	1	613	33	T2D_GENES_TANYA_BIOMARKER	PID_ALPHASYNUCLEIN_PATHWAY
0.163132137031%	1	613	33	T2D_GENES_TANYA_BIOMARKER	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.163132137031%	1	613	33	T2D_GENES_TANYA_BIOMARKER	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS
0.163132137031%	1	613	33	T2D_GENES_TANYA_BIOMARKER	GREENBAUM_E2A_TARGETS_UP
0.163132137031%	1	613	33	T2D_GENES_TANYA_BIOMARKER	GHANDHI_DIRECT_IRRADIATION_DN
0.163132137031%	1	613	33	T2D_GENES_TANYA_BIOMARKER	FARMER_BREAST_CANCER_CLUSTER_2
0.163132137031%	1	613	33	T2D_GENES_TANYA_BIOMARKER	DUTTA_APOPTOSIS_VIA_NFKB
0.163132137031%	1	613	33	T2D_GENES_TANYA_BIOMARKER	DORN_ADENOVIRUS_INFECTION_12HR_DN
0.163132137031%	1	613	33	T2D_GENES_TANYA_BIOMARKER	CHO_NR4A1_TARGETS
0.163132137031%	1	613	33	T2D_GENES_TANYA_BIOMARKER	BURTON_ADIPOGENESIS_1
0.163132137031%	1	613	32	T2D_GENES_TANYA_BIOMARKER	ZWANG_EGF_PERSISTENTLY_UP
0.163132137031%	1	613	32	T2D_GENES_TANYA_BIOMARKER	TSAI_RESPONSE_TO_RADIATION_THERAPY
0.163132137031%	1	613	32	T2D_GENES_TANYA_BIOMARKER	ST_ERK1_ERK2_MAPK_PATHWAY
0.163132137031%	1	613	32	T2D_GENES_TANYA_BIOMARKER	SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY
0.163132137031%	1	613	32	T2D_GENES_TANYA_BIOMARKER	REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING
0.163132137031%	1	613	32	T2D_GENES_TANYA_BIOMARKER	REACTOME_COMPLEMENT_CASCADE
0.163132137031%	1	613	32	T2D_GENES_TANYA_BIOMARKER	REACTOME_CD28_CO_STIMULATION
0.163132137031%	1	613	32	T2D_GENES_TANYA_BIOMARKER	PID_WNT_NONCANONICAL_PATHWAY
0.163132137031%	1	613	32	T2D_GENES_TANYA_BIOMARKER	PID_SYNDECAN_4_PATHWAY
0.163132137031%	1	613	32	T2D_GENES_TANYA_BIOMARKER	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN
0.163132137031%	1	613	32	T2D_GENES_TANYA_BIOMARKER	KASLER_HDAC7_TARGETS_2_DN
0.163132137031%	1	613	32	T2D_GENES_TANYA_BIOMARKER	FARDIN_HYPOXIA_11
0.163132137031%	1	613	32	T2D_GENES_TANYA_BIOMARKER	DORSAM_HOXA9_TARGETS_DN
0.163132137031%	1	613	32	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_HDAC_PATHWAY
0.163132137031%	1	613	32	T2D_GENES_TANYA_BIOMARKER	BAUS_TFF2_TARGETS_UP
0.163132137031%	1	613	32	T2D_GENES_TANYA_BIOMARKER	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP
0.163132137031%	1	613	32	T2D_GENES_TANYA_BIOMARKER	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN
0.163132137031%	1	613	31	T2D_GENES_TANYA_BIOMARKER	VALK_AML_CLUSTER_4
0.163132137031%	1	613	31	T2D_GENES_TANYA_BIOMARKER	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP
0.163132137031%	1	613	31	T2D_GENES_TANYA_BIOMARKER	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.163132137031%	1	613	31	T2D_GENES_TANYA_BIOMARKER	RIZ_ERYTHROID_DIFFERENTIATION_HEMGN
0.163132137031%	1	613	31	T2D_GENES_TANYA_BIOMARKER	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE
0.163132137031%	1	613	31	T2D_GENES_TANYA_BIOMARKER	REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS
0.163132137031%	1	613	31	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNAL_AMPLIFICATION
0.163132137031%	1	613	31	T2D_GENES_TANYA_BIOMARKER	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
0.163132137031%	1	613	31	T2D_GENES_TANYA_BIOMARKER	PID_CD40_PATHWAY
0.163132137031%	1	613	31	T2D_GENES_TANYA_BIOMARKER	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.163132137031%	1	613	31	T2D_GENES_TANYA_BIOMARKER	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD
0.163132137031%	1	613	31	T2D_GENES_TANYA_BIOMARKER	IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM
0.163132137031%	1	613	31	T2D_GENES_TANYA_BIOMARKER	DORSEY_GAB2_TARGETS
0.163132137031%	1	613	31	T2D_GENES_TANYA_BIOMARKER	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	VALK_AML_CLUSTER_13
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	REACTOME_NOD1_2_SIGNALING_PATHWAY
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	REACTOME_MRNA_CAPPING
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	REACTOME_DNA_STRAND_ELONGATION
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	PID_RAS_PATHWAY
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	LY_AGING_PREMATURE_DN
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	LI_PROSTATE_CANCER_EPIGENETIC
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	KEGG_ASTHMA
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	GUILLAUMOND_KLF10_TARGETS_DN
0.163132137031%	1	613	30	T2D_GENES_TANYA_BIOMARKER	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	WILENSKY_RESPONSE_TO_DARAPLADIB
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	WEINMANN_ADAPTATION_TO_HYPOXIA_UP
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	WANG_RESPONSE_TO_BEXAROTENE_DN
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	WANG_RESPONSE_TO_ANDROGEN_UP
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	REACTOME_PERK_REGULATED_GENE_EXPRESSION
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	PID_TCRCALCIUMPATHWAY
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	PID_REELINPATHWAY
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	PID_INTEGRIN2_PATHWAY
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	PAL_PRMT5_TARGETS_DN
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	NGUYEN_NOTCH1_TARGETS_UP
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	NAKAYAMA_FGF2_TARGETS
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_MCV6_LCP_WITH_H3K27ME3
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	MAYBURD_RESPONSE_TO_L663536_UP
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	KEGG_RNA_POLYMERASE
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_TNFR1_PATHWAY
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.163132137031%	1	613	29	T2D_GENES_TANYA_BIOMARKER	ABE_VEGFA_TARGETS_30MIN
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	WIKMAN_ASBESTOS_LUNG_CANCER_DN
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	WEBER_METHYLATED_HCP_IN_SPERM_DN
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	VALK_AML_CLUSTER_7
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	VALK_AML_CLUSTER_1
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	TERAO_AOX4_TARGETS_HG_UP
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	REACTOME_SHC_MEDIATED_CASCADE
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	REACTOME_LIPOPROTEIN_METABOLISM
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	PID_LIS1PATHWAY
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	PETRETTO_HEART_MASS_QTL_CIS_UP
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	GENTILE_UV_RESPONSE_CLUSTER_D9
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	DAZARD_UV_RESPONSE_CLUSTER_G24
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	DAIRKEE_CANCER_PRONE_RESPONSE_E2
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	CHEN_LUNG_CANCER_SURVIVAL
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_PROTEASOME_PATHWAY
0.163132137031%	1	613	28	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_G1_PATHWAY
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	YE_METASTATIC_LIVER_CANCER
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	XU_AKT1_TARGETS_6HR
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	ST_MYOCYTE_AD_PATHWAY
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	ST_GRANULE_CELL_SURVIVAL_PATHWAY
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	REACTOME_GAP_JUNCTION_TRAFFICKING
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	REACTOME_EXTENSION_OF_TELOMERES
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	PID_GLYPICAN_1PATHWAY
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	BOYAULT_LIVER_CANCER_SUBCLASS_G2
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_GSK3_PATHWAY
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CREB_PATHWAY
0.163132137031%	1	613	27	T2D_GENES_TANYA_BIOMARKER	AKL_HTLV1_INFECTION_UP
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	ZHENG_FOXP3_TARGETS_UP
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	XU_CREBBP_TARGETS_UP
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	WALLACE_JAK2_TARGETS_UP
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	REACTOME_REGULATORY_RNA_PATHWAYS
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	REACTOME_ACTIVATION_OF_GENES_BY_ATF4
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	PID_IL27PATHWAY
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	PID_ALK1PATHWAY
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	HAHTOLA_CTCL_CUTANEOUS
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	FINAK_BREAST_CANCER_SDPP_SIGNATURE
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	DEN_INTERACT_WITH_LCA5
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_RACCYCD_PATHWAY
0.163132137031%	1	613	26	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_BAD_PATHWAY
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	YANG_BREAST_CANCER_ESR1_DN
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	WANG_NFKB_TARGETS
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	WANG_BARRETTS_ESOPHAGUS_DN
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	VALK_AML_WITH_EVI1
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	RUAN_RESPONSE_TO_TROGLITAZONE_UP
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	REACTOME_SMOOTH_MUSCLE_CONTRACTION
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	PID_INTEGRIN_A9B1_PATHWAY
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	OZEN_MIR125B1_TARGETS
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	KIM_HYPOXIA
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	HORTON_SREBF_TARGETS
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	HOEGERKORP_CD44_TARGETS_TEMPORAL_DN
0.163132137031%	1	613	25	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_MCALPAIN_PATHWAY
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	WILLERT_WNT_SIGNALING
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	WANG_TNF_TARGETS
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	REACTOME_SULFUR_AMINO_ACID_METABOLISM
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	REACTOME_PYRIMIDINE_METABOLISM
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	PID_S1P_S1P2_PATHWAY
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	PID_RHODOPSIN_PATHWAY
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	OXFORD_RALA_OR_RALB_TARGETS_DN
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	KIM_GERMINAL_CENTER_T_HELPER_DN
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	KEGG_PROTEIN_EXPORT
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	JIANG_TIP30_TARGETS_DN
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	JEON_SMAD6_TARGETS_UP
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	GOLUB_ALL_VS_AML_DN
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_NOS1_PATHWAY
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_G2_PATHWAY
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_EIF4_PATHWAY
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CXCR4_PATHWAY
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CSK_PATHWAY
0.163132137031%	1	613	24	T2D_GENES_TANYA_BIOMARKER	AZARE_STAT3_TARGETS
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	YANG_BREAST_CANCER_ESR1_BULK_DN
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	WU_HBX_TARGETS_1_DN
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	WANG_RESPONSE_TO_FORSKOLIN_UP
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	ST_GA12_PATHWAY
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	SABATES_COLORECTAL_ADENOMA_SIZE_UP
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	REACTOME_MICRORNA_MIRNA_BIOGENESIS
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	MARKS_HDAC_TARGETS_UP
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	KEGG_MISMATCH_REPAIR
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	HASLINGER_B_CLL_WITH_11Q23_DELETION
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	CHEN_ETV5_TARGETS_TESTIS
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_RAC1_PATHWAY
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_MTOR_PATHWAY
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_IGF1R_PATHWAY
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CCR3_PATHWAY
0.163132137031%	1	613	23	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CASPASE_PATHWAY
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	WELCH_GATA1_TARGETS
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	WEBER_METHYLATED_ICP_IN_FIBROBLAST
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_HIPPO
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	REACTOME_METAL_ION_SLC_TRANSPORTERS
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	REACTOME_DEADENYLATION_OF_MRNA
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	PID_PDGFRAPATHWAY
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	OKAWA_NEUROBLASTOMA_1P36_31_DELETION
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	NUMATA_CSF3_SIGNALING_VIA_STAT3
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	MATZUK_IMPLANTATION_AND_UTERINE
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	LANDIS_ERBB2_BREAST_TUMORS_65_UP
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	KANG_FLUOROURACIL_RESISTANCE_UP
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	GAVIN_PDE3B_TARGETS
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	BRACHAT_RESPONSE_TO_CISPLATIN
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_INSULIN_PATHWAY
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_IL6_PATHWAY
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_GCR_PATHWAY
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_DC_PATHWAY
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CHEMICAL_PATHWAY
0.163132137031%	1	613	22	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CERAMIDE_PATHWAY
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	WOTTON_RUNX_TARGETS_UP
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	SCHURINGA_STAT5A_TARGETS_UP
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	REACTOME_ERK_MAPK_TARGETS
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	REACTOME_ADP_SIGNALLING_THROUGH_P2RY12
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	PID_S1P_META_PATHWAY
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	PID_ECADHERIN_KERATINOCYTE_PATHWAY
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	MOOTHA_GLYCOGEN_METABOLISM
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	MCCABE_HOXC6_TARGETS_DN
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	MARCHINI_TRABECTEDIN_RESISTANCE_UP
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	LANDEMAINE_LUNG_METASTASIS
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	HUI_MAPK14_TARGETS_UP
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	HASLINGER_B_CLL_WITH_17P13_DELETION
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_TFF_PATHWAY
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_MITOCHONDRIA_PATHWAY
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_IGF1_PATHWAY
0.163132137031%	1	613	21	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CTLA4_PATHWAY
0.163132137031%	1	613	205	T2D_GENES_TANYA_BIOMARKER	PEREZ_TP53_AND_TP63_TARGETS
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	ZHU_SKIL_TARGETS_UP
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	WEBER_METHYLATED_HCP_IN_SPERM_UP
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	WANG_RECURRENT_LIVER_CANCER_UP
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	SESTO_RESPONSE_TO_UV_C3
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	REACTOME_NEPHRIN_INTERACTIONS
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	REACTOME_ENOS_ACTIVATION_AND_REGULATION
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	PID_WNT_CANONICAL_PATHWAY
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	NIELSEN_LEIOMYOSARCOMA_CNN1_DN
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	MCCABE_HOXC6_TARGETS_CANCER_DN
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	HEDENFALK_BREAST_CANCER_BRACX_UP
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	DING_LUNG_CANCER_BY_MUTATION_RATE
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	DAZARD_UV_RESPONSE_CLUSTER_G28
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	BARRIER_COLON_CANCER_RECURRENCE_DN
0.163132137031%	1	613	20	T2D_GENES_TANYA_BIOMARKER	AMUNDSON_GAMMA_RADIATION_RESISTANCE
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	VISALA_AGING_LYMPHOCYTE_DN
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	TRAYNOR_RETT_SYNDROM_DN
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	TERAMOTO_OPN_TARGETS_CLUSTER_7
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	SYED_ESTRADIOL_RESPONSE
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	SHIN_B_CELL_LYMPHOMA_CLUSTER_9
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	SA_CASPASE_CASCADE
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	RUAN_RESPONSE_TO_TROGLITAZONE_DN
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	REACTOME_LAGGING_STRAND_SYNTHESIS
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	REACTOME_CGMP_EFFECTS
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	PID_HIF1APATHWAY
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	PID_ARF_3PATHWAY
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	NAGY_TFTC_COMPONENTS_HUMAN
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	MIZUSHIMA_AUTOPHAGOSOME_FORMATION
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	MA_PITUITARY_FETAL_VS_ADULT_DN
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	FARMER_BREAST_CANCER_CLUSTER_5
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	CHEN_PDGF_TARGETS
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_STATHMIN_PATHWAY
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_COMP_PATHWAY
0.163132137031%	1	613	19	T2D_GENES_TANYA_BIOMARKER	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	ZHENG_RESPONSE_TO_ARSENITE_UP
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	ZHENG_RESPONSE_TO_ARSENITE_DN
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	YIH_RESPONSE_TO_ARSENITE_C4
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	YIH_RESPONSE_TO_ARSENITE_C2
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	WU_HBX_TARGETS_3_UP
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	SHIN_B_CELL_LYMPHOMA_CLUSTER_5
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	SCHEIDEREIT_IKK_TARGETS
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_NODAL
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	PODAR_RESPONSE_TO_ADAPHOSTIN_DN
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	MAINA_VHL_TARGETS_DN
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	KEGG_PHENYLALANINE_METABOLISM
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	KARAKAS_TGFB1_SIGNALING
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	KAPOSI_LIVER_CANCER_MET_UP
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_ERK5_PATHWAY
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CARDIACEGF_PATHWAY
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP
0.163132137031%	1	613	18	T2D_GENES_TANYA_BIOMARKER	AMIT_DELAYED_EARLY_GENES
0.163132137031%	1	613	179	T2D_GENES_TANYA_BIOMARKER	BENPORATH_NOS_TARGETS
0.163132137031%	1	613	175	T2D_GENES_TANYA_BIOMARKER	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	REACTOME_TIE2_SIGNALING
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	REACTOME_RNA_POL_III_CHAIN_ELONGATION
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	REACTOME_REGULATION_OF_KIT_SIGNALING
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	PID_SYNDECAN_3_PATHWAY
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	PID_ANTHRAXPATHWAY
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	LI_CYTIDINE_ANALOG_PATHWAY
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	LIU_IL13_MEMORY_MODEL_UP
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	KEGG_RENIN_ANGIOTENSIN_SYSTEM
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	KASLER_HDAC7_TARGETS_1_DN
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	KANG_AR_TARGETS_UP
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	HOWLIN_CITED1_TARGETS_2_UP
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	GOUYER_TATI_TARGETS_DN
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_PML_PATHWAY
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_IL17_PATHWAY
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_IL10_PATHWAY
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_HCMV_PATHWAY
0.163132137031%	1	613	17	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_41BB_PATHWAY
0.163132137031%	1	613	163	T2D_GENES_TANYA_BIOMARKER	SERVITJA_ISLET_HNF1A_TARGETS_UP
0.163132137031%	1	613	162	T2D_GENES_TANYA_BIOMARKER	MULLIGHAN_NPM1_SIGNATURE_3_DN
0.163132137031%	1	613	160	T2D_GENES_TANYA_BIOMARKER	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	XU_RESPONSE_TO_TRETINOIN_UP
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	WU_HBX_TARGETS_2_DN
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	WANG_RECURRENT_LIVER_CANCER_DN
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	TIAN_BHLHA15_TARGETS
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	REACTOME_INTEGRATION_OF_PROVIRUS
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	PID_DNAPK_PATHWAY
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	PID_CIRCADIANPATHWAY
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	HUMMERICH_MALIGNANT_SKIN_TUMOR_UP
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	HE_PTEN_TARGETS_UP
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	GHO_ATF5_TARGETS_DN
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	GEISS_RESPONSE_TO_DSRNA_DN
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	FUKUSHIMA_TNFSF11_TARGETS
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	CHIN_BREAST_CANCER_COPY_NUMBER_DN
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	CAFFAREL_RESPONSE_TO_THC_8HR_5_UP
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_SHH_PATHWAY
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_GATA3_PATHWAY
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_EIF_PATHWAY
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_BCELLSURVIVAL_PATHWAY
0.163132137031%	1	613	16	T2D_GENES_TANYA_BIOMARKER	ABDELMOHSEN_ELAVL4_TARGETS
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	WEBER_METHYLATED_LCP_IN_SPERM_UP
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	TSUNODA_CISPLATIN_RESISTANCE_UP
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	SA_MMP_CYTOKINE_CONNECTION
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	SA_G1_AND_S_PHASES
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	SANDERSON_PPARA_TARGETS
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	REACTOME_ZINC_TRANSPORTERS
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	REACTOME_METABOLISM_OF_POLYAMINES
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	PIEPOLI_LGI1_TARGETS_UP
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	PID_ARF6DOWNSTREAMPATHWAY
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	NAGY_STAGA_COMPONENTS_HUMAN
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	MARKS_ACETYLATED_NON_HISTONE_PROTEINS
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	LIU_IL13_PRIMING_MODEL
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	HUMMEL_BURKITTS_LYMPHOMA_DN
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	GRANDVAUX_IRF3_TARGETS_UP
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	FINETTI_BREAST_CANCERS_KINOME_GRAY
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	FERRANDO_LYL1_NEIGHBORS
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	COLLIS_PRKDC_REGULATORS
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_TALL1_PATHWAY
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_STEM_PATHWAY
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_PITX2_PATHWAY
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_ERYTH_PATHWAY
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CD40_PATHWAY
0.163132137031%	1	613	15	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_AKAPCENTROSOME_PATHWAY
0.163132137031%	1	613	148	T2D_GENES_TANYA_BIOMARKER	WHITFIELD_CELL_CYCLE_M_G1
0.163132137031%	1	613	146	T2D_GENES_TANYA_BIOMARKER	LEE_NEURAL_CREST_STEM_CELL_UP
0.163132137031%	1	613	145	T2D_GENES_TANYA_BIOMARKER	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	WEBER_METHYLATED_ICP_IN_SPERM_DN
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	VERRECCHIA_RESPONSE_TO_TGFB1_C3
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	TOMLINS_METASTASIS_UP
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	REACTOME_P75NTR_SIGNALS_VIA_NFKB
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	REACTOME_N_GLYCAN_ANTENNAE_ELONGATION
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	REACTOME_METABOLISM_OF_PORPHYRINS
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	REACTOME_CRMPS_IN_SEMA3A_SIGNALING
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	PID_S1P_S1P4_PATHWAY
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	PID_IL5_PATHWAY
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	PARK_APL_PATHOGENESIS_UP
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	MATZUK_OVULATION
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	LY_AGING_MIDDLE_UP
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	INAMURA_LUNG_CANCER_SCC_DN
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	GILMORE_CORE_NFKB_PATHWAY
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_DREAM_PATHWAY
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CLASSIC_PATHWAY
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP
0.163132137031%	1	613	14	T2D_GENES_TANYA_BIOMARKER	AMIT_EGF_RESPONSE_20_MCF10A
0.163132137031%	1	613	137	T2D_GENES_TANYA_BIOMARKER	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
0.163132137031%	1	613	137	T2D_GENES_TANYA_BIOMARKER	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL
0.163132137031%	1	613	137	T2D_GENES_TANYA_BIOMARKER	PID_P53DOWNSTREAMPATHWAY
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	WACKER_HYPOXIA_TARGETS_OF_VHL
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	REACTOME_POL_SWITCHING
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	RAY_ALZHEIMERS_DISEASE
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	POS_RESPONSE_TO_HISTAMINE_UP
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	ONGUSAHA_BRCA1_TARGETS_UP
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	MARTINELLI_IMMATURE_NEUTROPHIL_DN
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	KORKOLA_EMBRYONAL_CARCINOMA
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	IVANOV_MUTATED_IN_COLON_CANCER
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	HASINA_NOL7_TARGETS_DN
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	GHO_ATF5_TARGETS_UP
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	GERHOLD_RESPONSE_TO_TZD_DN
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	FU_INTERACT_WITH_ALKBH8
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	CROONQUIST_STROMAL_STIMULATION_DN
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	CAFFAREL_RESPONSE_TO_THC_24HR_3_DN
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_D4GDI_PATHWAY
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CARM1_PATHWAY
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_ARENRF2_PATHWAY
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_AHSP_PATHWAY
0.163132137031%	1	613	13	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_AGPCR_PATHWAY
0.163132137031%	1	613	128	T2D_GENES_TANYA_BIOMARKER	ZHU_CMV_ALL_DN
0.163132137031%	1	613	127	T2D_GENES_TANYA_BIOMARKER	INGRAM_SHH_TARGETS_UP
0.163132137031%	1	613	126	T2D_GENES_TANYA_BIOMARKER	MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.163132137031%	1	613	123	T2D_GENES_TANYA_BIOMARKER	DAZARD_RESPONSE_TO_UV_SCC_DN
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	SA_PROGRAMMED_CELL_DEATH
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	REACTOME_ERKS_ARE_INACTIVATED
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	REACTOME_CS_DS_DEGRADATION
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	PETRETTO_BLOOD_PRESSURE_UP
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	MIZUKAMI_HYPOXIA_UP
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	FIGUEROA_AML_METHYLATION_CLUSTER_5_UP
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	EHLERS_ANEUPLOIDY_DN
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_VDR_PATHWAY
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_PLCE_PATHWAY
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_LECTIN_PATHWAY
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_CFTR_PATHWAY
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_AKAP95_PATHWAY
0.163132137031%	1	613	12	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_AKAP13_PATHWAY
0.163132137031%	1	613	116	T2D_GENES_TANYA_BIOMARKER	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP
0.163132137031%	1	613	116	T2D_GENES_TANYA_BIOMARKER	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
0.163132137031%	1	613	116	T2D_GENES_TANYA_BIOMARKER	IKEDA_MIR30_TARGETS_UP
0.163132137031%	1	613	114	T2D_GENES_TANYA_BIOMARKER	KEGG_OOCYTE_MEIOSIS
0.163132137031%	1	613	113	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_RHO_GTPASES
0.163132137031%	1	613	111	T2D_GENES_TANYA_BIOMARKER	REACTOME_MRNA_SPLICING
0.163132137031%	1	613	111	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_12HR_UP
0.163132137031%	1	613	110	T2D_GENES_TANYA_BIOMARKER	GROSS_HYPOXIA_VIA_HIF1A_DN
0.163132137031%	1	613	11	T2D_GENES_TANYA_BIOMARKER	SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.163132137031%	1	613	11	T2D_GENES_TANYA_BIOMARKER	REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM
0.163132137031%	1	613	11	T2D_GENES_TANYA_BIOMARKER	REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY
0.163132137031%	1	613	11	T2D_GENES_TANYA_BIOMARKER	REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL
0.163132137031%	1	613	11	T2D_GENES_TANYA_BIOMARKER	POS_RESPONSE_TO_HISTAMINE_DN
0.163132137031%	1	613	11	T2D_GENES_TANYA_BIOMARKER	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12
0.163132137031%	1	613	11	T2D_GENES_TANYA_BIOMARKER	MUNSHI_MULTIPLE_MYELOMA_DN
0.163132137031%	1	613	11	T2D_GENES_TANYA_BIOMARKER	MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN
0.163132137031%	1	613	11	T2D_GENES_TANYA_BIOMARKER	MATHEW_FANCONI_ANEMIA_GENES
0.163132137031%	1	613	11	T2D_GENES_TANYA_BIOMARKER	MARSON_FOXP3_TARGETS_STIMULATED_DN
0.163132137031%	1	613	11	T2D_GENES_TANYA_BIOMARKER	KALMA_E2F1_TARGETS
0.163132137031%	1	613	11	T2D_GENES_TANYA_BIOMARKER	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN
0.163132137031%	1	613	11	T2D_GENES_TANYA_BIOMARKER	FUNG_IL2_SIGNALING_1
0.163132137031%	1	613	11	T2D_GENES_TANYA_BIOMARKER	BAUS_TFF2_TARGETS_DN
0.163132137031%	1	613	108	T2D_GENES_TANYA_BIOMARKER	WESTON_VEGFA_TARGETS
0.163132137031%	1	613	108	T2D_GENES_TANYA_BIOMARKER	LABBE_TGFB1_TARGETS_DN
0.163132137031%	1	613	107	T2D_GENES_TANYA_BIOMARKER	REACTOME_SIGNALING_BY_ILS
0.163132137031%	1	613	106	T2D_GENES_TANYA_BIOMARKER	KEEN_RESPONSE_TO_ROSIGLITAZONE_DN
0.163132137031%	1	613	105	T2D_GENES_TANYA_BIOMARKER	ZWANG_EGF_INTERVAL_UP
0.163132137031%	1	613	102	T2D_GENES_TANYA_BIOMARKER	LABBE_TGFB1_TARGETS_UP
0.163132137031%	1	613	102	T2D_GENES_TANYA_BIOMARKER	KANG_IMMORTALIZED_BY_TERT_DN
0.163132137031%	1	613	101	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_12HR_DN
0.163132137031%	1	613	101	T2D_GENES_TANYA_BIOMARKER	BROWNE_HCMV_INFECTION_10HR_UP
0.163132137031%	1	613	100	T2D_GENES_TANYA_BIOMARKER	WINZEN_DEGRADED_VIA_KHSRP
0.163132137031%	1	613	100	T2D_GENES_TANYA_BIOMARKER	RICKMAN_HEAD_AND_NECK_CANCER_A
0.163132137031%	1	613	100	T2D_GENES_TANYA_BIOMARKER	GAVIN_FOXP3_TARGETS_CLUSTER_P4
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	REACTOME_GAP_JUNCTION_DEGRADATION
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	REACTOME_ETHANOL_OXIDATION
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	PID_VEGF_VEGFR_PATHWAY
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	OXFORD_RALA_TARGETS_DN
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	MAINA_VHL_TARGETS_UP
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	KONG_E2F1_TARGETS
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	HOLLEMAN_DAUNORUBICIN_B_ALL_UP
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	GOUYER_TATI_TARGETS_UP
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	FREDERICK_PRKCI_TARGETS
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	CLAUS_PGR_POSITIVE_MENINGIOMA_UP
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	BRUNEAU_SEPTATION_VENTRICULAR
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_SODD_PATHWAY
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	BIOCARTA_RNA_PATHWAY
0.163132137031%	1	613	10	T2D_GENES_TANYA_BIOMARKER	AGARWAL_AKT_PATHWAY_TARGETS
0.160342063068%	3	1871	99	T2D_GENES_TANYA_HEIGHT	LIM_MAMMARY_LUMINAL_MATURE_DN
0.160342063068%	3	1871	93	T2D_GENES_TANYA_HEIGHT	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
0.160342063068%	3	1871	9	T2D_GENES_TANYA_HEIGHT	WANG_RESPONSE_TO_FORSKOLIN_DN
0.160342063068%	3	1871	9	T2D_GENES_TANYA_HEIGHT	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN
0.160342063068%	3	1871	9	T2D_GENES_TANYA_HEIGHT	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP
0.160342063068%	3	1871	9	T2D_GENES_TANYA_HEIGHT	FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION
0.160342063068%	3	1871	84	T2D_GENES_TANYA_HEIGHT	KEGG_ECM_RECEPTOR_INTERACTION
0.160342063068%	3	1871	84	T2D_GENES_TANYA_HEIGHT	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
0.160342063068%	3	1871	81	T2D_GENES_TANYA_HEIGHT	SCIBETTA_KDM5B_TARGETS_DN
0.160342063068%	3	1871	8	T2D_GENES_TANYA_HEIGHT	TURJANSKI_MAPK7_TARGETS
0.160342063068%	3	1871	79	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16
0.160342063068%	3	1871	79	T2D_GENES_TANYA_HEIGHT	LIU_COMMON_CANCER_GENES
0.160342063068%	3	1871	78	T2D_GENES_TANYA_HEIGHT	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP
0.160342063068%	3	1871	74	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER_DENA_DN
0.160342063068%	3	1871	70	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_MEF_LCP_WITH_H3K27ME3
0.160342063068%	3	1871	70	T2D_GENES_TANYA_HEIGHT	KEGG_RENAL_CELL_CARCINOMA
0.160342063068%	3	1871	70	T2D_GENES_TANYA_HEIGHT	KEGG_LONG_TERM_POTENTIATION
0.160342063068%	3	1871	7	T2D_GENES_TANYA_HEIGHT	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN
0.160342063068%	3	1871	7	T2D_GENES_TANYA_HEIGHT	PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN
0.160342063068%	3	1871	7	T2D_GENES_TANYA_HEIGHT	MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP
0.160342063068%	3	1871	69	T2D_GENES_TANYA_HEIGHT	BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE
0.160342063068%	3	1871	66	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
0.160342063068%	3	1871	66	T2D_GENES_TANYA_HEIGHT	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
0.160342063068%	3	1871	66	T2D_GENES_TANYA_HEIGHT	PID_HIF1_TFPATHWAY
0.160342063068%	3	1871	64	T2D_GENES_TANYA_HEIGHT	INGRAM_SHH_TARGETS_DN
0.160342063068%	3	1871	64	T2D_GENES_TANYA_HEIGHT	ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE
0.160342063068%	3	1871	63	T2D_GENES_TANYA_HEIGHT	PHONG_TNF_TARGETS_UP
0.160342063068%	3	1871	63	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED
0.160342063068%	3	1871	63	T2D_GENES_TANYA_HEIGHT	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
0.160342063068%	3	1871	62	T2D_GENES_TANYA_HEIGHT	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP
0.160342063068%	3	1871	62	T2D_GENES_TANYA_HEIGHT	KEGG_GLYCOLYSIS_GLUCONEOGENESIS
0.160342063068%	3	1871	62	T2D_GENES_TANYA_HEIGHT	KEGG_COLORECTAL_CANCER
0.160342063068%	3	1871	61	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER_MYC_TGFA_UP
0.160342063068%	3	1871	6	T2D_GENES_TANYA_HEIGHT	TERAO_AOX4_TARGETS_HG_DN
0.160342063068%	3	1871	6	T2D_GENES_TANYA_HEIGHT	PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP
0.160342063068%	3	1871	59	T2D_GENES_TANYA_HEIGHT	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS
0.160342063068%	3	1871	59	T2D_GENES_TANYA_HEIGHT	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
0.160342063068%	3	1871	58	T2D_GENES_TANYA_HEIGHT	NADLER_HYPERGLYCEMIA_AT_OBESITY
0.160342063068%	3	1871	58	T2D_GENES_TANYA_HEIGHT	KEGG_ARACHIDONIC_ACID_METABOLISM
0.160342063068%	3	1871	58	T2D_GENES_TANYA_HEIGHT	JI_RESPONSE_TO_FSH_DN
0.160342063068%	3	1871	57	T2D_GENES_TANYA_HEIGHT	BORLAK_LIVER_CANCER_EGF_UP
0.160342063068%	3	1871	56	T2D_GENES_TANYA_HEIGHT	ZHENG_IL22_SIGNALING_UP
0.160342063068%	3	1871	56	T2D_GENES_TANYA_HEIGHT	WORSCHECH_TUMOR_REJECTION_UP
0.160342063068%	3	1871	56	T2D_GENES_TANYA_HEIGHT	GALE_APL_WITH_FLT3_MUTATED_UP
0.160342063068%	3	1871	55	T2D_GENES_TANYA_HEIGHT	KEGG_STEROID_HORMONE_BIOSYNTHESIS
0.160342063068%	3	1871	54	T2D_GENES_TANYA_HEIGHT	SU_PANCREAS
0.160342063068%	3	1871	54	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER_MYC_UP
0.160342063068%	3	1871	54	T2D_GENES_TANYA_HEIGHT	JIANG_AGING_CEREBRAL_CORTEX_DN
0.160342063068%	3	1871	53	T2D_GENES_TANYA_HEIGHT	ZHU_CMV_8_HR_DN
0.160342063068%	3	1871	53	T2D_GENES_TANYA_HEIGHT	REACTOME_PROTEIN_FOLDING
0.160342063068%	3	1871	53	T2D_GENES_TANYA_HEIGHT	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
0.160342063068%	3	1871	52	T2D_GENES_TANYA_HEIGHT	PRAMOONJAGO_SOX4_TARGETS_UP
0.160342063068%	3	1871	52	T2D_GENES_TANYA_HEIGHT	PID_KITPATHWAY
0.160342063068%	3	1871	50	T2D_GENES_TANYA_HEIGHT	YANG_BREAST_CANCER_ESR1_LASER_DN
0.160342063068%	3	1871	50	T2D_GENES_TANYA_HEIGHT	MARTINEZ_RESPONSE_TO_TRABECTEDIN
0.160342063068%	3	1871	50	T2D_GENES_TANYA_HEIGHT	KEGG_GLUTATHIONE_METABOLISM
0.160342063068%	3	1871	50	T2D_GENES_TANYA_HEIGHT	KANG_GIST_WITH_PDGFRA_UP
0.160342063068%	3	1871	49	T2D_GENES_TANYA_HEIGHT	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
0.160342063068%	3	1871	49	T2D_GENES_TANYA_HEIGHT	REACTOME_METABOLISM_OF_NON_CODING_RNA
0.160342063068%	3	1871	49	T2D_GENES_TANYA_HEIGHT	PID_PI3KCIPATHWAY
0.160342063068%	3	1871	49	T2D_GENES_TANYA_HEIGHT	PID_ARF6_TRAFFICKINGPATHWAY
0.160342063068%	3	1871	49	T2D_GENES_TANYA_HEIGHT	MANTOVANI_VIRAL_GPCR_SIGNALING_DN
0.160342063068%	3	1871	49	T2D_GENES_TANYA_HEIGHT	DAUER_STAT3_TARGETS_UP
0.160342063068%	3	1871	48	T2D_GENES_TANYA_HEIGHT	RASHI_RESPONSE_TO_IONIZING_RADIATION_3
0.160342063068%	3	1871	48	T2D_GENES_TANYA_HEIGHT	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.160342063068%	3	1871	48	T2D_GENES_TANYA_HEIGHT	ABE_INNER_EAR
0.160342063068%	3	1871	47	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_MF_UP
0.160342063068%	3	1871	47	T2D_GENES_TANYA_HEIGHT	SILIGAN_BOUND_BY_EWS_FLT1_FUSION
0.160342063068%	3	1871	47	T2D_GENES_TANYA_HEIGHT	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP
0.160342063068%	3	1871	47	T2D_GENES_TANYA_HEIGHT	MELLMAN_TUT1_TARGETS_DN
0.160342063068%	3	1871	47	T2D_GENES_TANYA_HEIGHT	MCCLUNG_DELTA_FOSB_TARGETS_8WK
0.160342063068%	3	1871	47	T2D_GENES_TANYA_HEIGHT	LEONARD_HYPOXIA
0.160342063068%	3	1871	47	T2D_GENES_TANYA_HEIGHT	JIANG_AGING_HYPOTHALAMUS_UP
0.160342063068%	3	1871	46	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_MS_DN
0.160342063068%	3	1871	46	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_CD2_DN
0.160342063068%	3	1871	46	T2D_GENES_TANYA_HEIGHT	SESTO_RESPONSE_TO_UV_C5
0.160342063068%	3	1871	46	T2D_GENES_TANYA_HEIGHT	PID_PLK1_PATHWAY
0.160342063068%	3	1871	46	T2D_GENES_TANYA_HEIGHT	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1
0.160342063068%	3	1871	46	T2D_GENES_TANYA_HEIGHT	HEIDENBLAD_AMPLICON_8Q24_DN
0.160342063068%	3	1871	45	T2D_GENES_TANYA_HEIGHT	VANHARANTA_UTERINE_FIBROID_UP
0.160342063068%	3	1871	45	T2D_GENES_TANYA_HEIGHT	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
0.160342063068%	3	1871	45	T2D_GENES_TANYA_HEIGHT	REACTOME_G2_M_CHECKPOINTS
0.160342063068%	3	1871	45	T2D_GENES_TANYA_HEIGHT	PID_HNF3BPATHWAY
0.160342063068%	3	1871	45	T2D_GENES_TANYA_HEIGHT	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN
0.160342063068%	3	1871	45	T2D_GENES_TANYA_HEIGHT	HUANG_FOXA2_TARGETS_UP
0.160342063068%	3	1871	45	T2D_GENES_TANYA_HEIGHT	GRADE_METASTASIS_DN
0.160342063068%	3	1871	45	T2D_GENES_TANYA_HEIGHT	CHENG_RESPONSE_TO_NICKEL_ACETATE
0.160342063068%	3	1871	44	T2D_GENES_TANYA_HEIGHT	ZUCCHI_METASTASIS_DN
0.160342063068%	3	1871	44	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_LB_DN
0.160342063068%	3	1871	44	T2D_GENES_TANYA_HEIGHT	STREICHER_LSM1_TARGETS_UP
0.160342063068%	3	1871	44	T2D_GENES_TANYA_HEIGHT	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
0.160342063068%	3	1871	44	T2D_GENES_TANYA_HEIGHT	KEGG_NUCLEOTIDE_EXCISION_REPAIR
0.160342063068%	3	1871	44	T2D_GENES_TANYA_HEIGHT	CHOI_ATL_STAGE_PREDICTOR
0.160342063068%	3	1871	43	T2D_GENES_TANYA_HEIGHT	NAKAMURA_METASTASIS_MODEL_DN
0.160342063068%	3	1871	43	T2D_GENES_TANYA_HEIGHT	MANTOVANI_NFKB_TARGETS_UP
0.160342063068%	3	1871	43	T2D_GENES_TANYA_HEIGHT	LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.160342063068%	3	1871	43	T2D_GENES_TANYA_HEIGHT	BURTON_ADIPOGENESIS_PEAK_AT_24HR
0.160342063068%	3	1871	43	T2D_GENES_TANYA_HEIGHT	AMIT_EGF_RESPONSE_120_MCF10A
0.160342063068%	3	1871	42	T2D_GENES_TANYA_HEIGHT	WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN
0.160342063068%	3	1871	42	T2D_GENES_TANYA_HEIGHT	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP
0.160342063068%	3	1871	42	T2D_GENES_TANYA_HEIGHT	KEGG_TYROSINE_METABOLISM
0.160342063068%	3	1871	42	T2D_GENES_TANYA_HEIGHT	KEGG_FATTY_ACID_METABOLISM
0.160342063068%	3	1871	42	T2D_GENES_TANYA_HEIGHT	AMIT_EGF_RESPONSE_40_HELA
0.160342063068%	3	1871	41	T2D_GENES_TANYA_HEIGHT	WENG_POR_TARGETS_LIVER_UP
0.160342063068%	3	1871	41	T2D_GENES_TANYA_HEIGHT	REACTOME_IL_2_SIGNALING
0.160342063068%	3	1871	41	T2D_GENES_TANYA_HEIGHT	KAAB_FAILED_HEART_VENTRICLE_DN
0.160342063068%	3	1871	41	T2D_GENES_TANYA_HEIGHT	GENTILE_UV_RESPONSE_CLUSTER_D2
0.160342063068%	3	1871	41	T2D_GENES_TANYA_HEIGHT	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
0.160342063068%	3	1871	40	T2D_GENES_TANYA_HEIGHT	VANASSE_BCL2_TARGETS_UP
0.160342063068%	3	1871	40	T2D_GENES_TANYA_HEIGHT	ST_B_CELL_ANTIGEN_RECEPTOR
0.160342063068%	3	1871	40	T2D_GENES_TANYA_HEIGHT	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
0.160342063068%	3	1871	40	T2D_GENES_TANYA_HEIGHT	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP
0.160342063068%	3	1871	40	T2D_GENES_TANYA_HEIGHT	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS
0.160342063068%	3	1871	40	T2D_GENES_TANYA_HEIGHT	JIANG_AGING_HYPOTHALAMUS_DN
0.160342063068%	3	1871	40	T2D_GENES_TANYA_HEIGHT	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
0.160342063068%	3	1871	40	T2D_GENES_TANYA_HEIGHT	DORN_ADENOVIRUS_INFECTION_48HR_DN
0.160342063068%	3	1871	40	T2D_GENES_TANYA_HEIGHT	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.160342063068%	3	1871	40	T2D_GENES_TANYA_HEIGHT	BERNARD_PPAPDC1B_TARGETS_UP
0.160342063068%	3	1871	39	T2D_GENES_TANYA_HEIGHT	WHITEHURST_PACLITAXEL_SENSITIVITY
0.160342063068%	3	1871	39	T2D_GENES_TANYA_HEIGHT	VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN
0.160342063068%	3	1871	39	T2D_GENES_TANYA_HEIGHT	SHIPP_DLBCL_CURED_VS_FATAL_UP
0.160342063068%	3	1871	39	T2D_GENES_TANYA_HEIGHT	PID_RET_PATHWAY
0.160342063068%	3	1871	39	T2D_GENES_TANYA_HEIGHT	PID_ECADHERIN_NASCENTAJ_PATHWAY
0.160342063068%	3	1871	39	T2D_GENES_TANYA_HEIGHT	GU_PDEF_TARGETS_DN
0.160342063068%	3	1871	39	T2D_GENES_TANYA_HEIGHT	BILANGES_SERUM_SENSITIVE_VIA_TSC2
0.160342063068%	3	1871	39	T2D_GENES_TANYA_HEIGHT	BEIER_GLIOMA_STEM_CELL_UP
0.160342063068%	3	1871	39	T2D_GENES_TANYA_HEIGHT	AMIT_SERUM_RESPONSE_480_MCF10A
0.160342063068%	3	1871	38	T2D_GENES_TANYA_HEIGHT	YOKOE_CANCER_TESTIS_ANTIGENS
0.160342063068%	3	1871	38	T2D_GENES_TANYA_HEIGHT	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS
0.160342063068%	3	1871	38	T2D_GENES_TANYA_HEIGHT	REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS
0.160342063068%	3	1871	38	T2D_GENES_TANYA_HEIGHT	NAKAMURA_ADIPOGENESIS_LATE_DN
0.160342063068%	3	1871	38	T2D_GENES_TANYA_HEIGHT	NAKAMURA_ADIPOGENESIS_EARLY_DN
0.160342063068%	3	1871	38	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.160342063068%	3	1871	38	T2D_GENES_TANYA_HEIGHT	LIU_LIVER_CANCER
0.160342063068%	3	1871	38	T2D_GENES_TANYA_HEIGHT	KYNG_DNA_DAMAGE_BY_4NQO
0.160342063068%	3	1871	38	T2D_GENES_TANYA_HEIGHT	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP
0.160342063068%	3	1871	38	T2D_GENES_TANYA_HEIGHT	GRADE_COLON_VS_RECTAL_CANCER_UP
0.160342063068%	3	1871	38	T2D_GENES_TANYA_HEIGHT	CERVERA_SDHB_TARGETS_1_DN
0.160342063068%	3	1871	38	T2D_GENES_TANYA_HEIGHT	CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN
0.160342063068%	3	1871	38	T2D_GENES_TANYA_HEIGHT	APPIERTO_RESPONSE_TO_FENRETINIDE_UP
0.160342063068%	3	1871	37	T2D_GENES_TANYA_HEIGHT	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN
0.160342063068%	3	1871	37	T2D_GENES_TANYA_HEIGHT	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.160342063068%	3	1871	37	T2D_GENES_TANYA_HEIGHT	ST_GA13_PATHWAY
0.160342063068%	3	1871	37	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN
0.160342063068%	3	1871	37	T2D_GENES_TANYA_HEIGHT	ROLEF_GLIS3_TARGETS
0.160342063068%	3	1871	37	T2D_GENES_TANYA_HEIGHT	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS
0.160342063068%	3	1871	37	T2D_GENES_TANYA_HEIGHT	PID_GMCSF_PATHWAY
0.160342063068%	3	1871	37	T2D_GENES_TANYA_HEIGHT	GENTILE_UV_RESPONSE_CLUSTER_D6
0.160342063068%	3	1871	37	T2D_GENES_TANYA_HEIGHT	CUI_TCF21_TARGETS_UP
0.160342063068%	3	1871	37	T2D_GENES_TANYA_HEIGHT	BIOCARTA_GPCR_PATHWAY
0.160342063068%	3	1871	36	T2D_GENES_TANYA_HEIGHT	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN
0.160342063068%	3	1871	36	T2D_GENES_TANYA_HEIGHT	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
0.160342063068%	3	1871	36	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALLING_TO_ERKS
0.160342063068%	3	1871	36	T2D_GENES_TANYA_HEIGHT	LIU_CDX2_TARGETS_UP
0.160342063068%	3	1871	36	T2D_GENES_TANYA_HEIGHT	KEGG_DNA_REPLICATION
0.160342063068%	3	1871	36	T2D_GENES_TANYA_HEIGHT	KEGG_BASAL_TRANSCRIPTION_FACTORS
0.160342063068%	3	1871	36	T2D_GENES_TANYA_HEIGHT	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP
0.160342063068%	3	1871	36	T2D_GENES_TANYA_HEIGHT	ALONSO_METASTASIS_EMT_UP
0.160342063068%	3	1871	35	T2D_GENES_TANYA_HEIGHT	WEIGEL_OXIDATIVE_STRESS_RESPONSE
0.160342063068%	3	1871	35	T2D_GENES_TANYA_HEIGHT	ST_G_ALPHA_I_PATHWAY
0.160342063068%	3	1871	35	T2D_GENES_TANYA_HEIGHT	SCHRAETS_MLL_TARGETS_UP
0.160342063068%	3	1871	35	T2D_GENES_TANYA_HEIGHT	REACTOME_MRNA_3_END_PROCESSING
0.160342063068%	3	1871	35	T2D_GENES_TANYA_HEIGHT	REACTOME_GLOBAL_GENOMIC_NER_GG_NER
0.160342063068%	3	1871	35	T2D_GENES_TANYA_HEIGHT	PID_PI3KCIAKTPATHWAY
0.160342063068%	3	1871	35	T2D_GENES_TANYA_HEIGHT	LOPEZ_TRANSLATION_VIA_FN1_SIGNALING
0.160342063068%	3	1871	35	T2D_GENES_TANYA_HEIGHT	JAZAG_TGFB1_SIGNALING_DN
0.160342063068%	3	1871	35	T2D_GENES_TANYA_HEIGHT	GUTIERREZ_MULTIPLE_MYELOMA_DN
0.160342063068%	3	1871	34	T2D_GENES_TANYA_HEIGHT	YANG_BREAST_CANCER_ESR1_LASER_UP
0.160342063068%	3	1871	34	T2D_GENES_TANYA_HEIGHT	WONG_IFNA2_RESISTANCE_DN
0.160342063068%	3	1871	34	T2D_GENES_TANYA_HEIGHT	SIG_CD40PATHWAYMAP
0.160342063068%	3	1871	34	T2D_GENES_TANYA_HEIGHT	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP
0.160342063068%	3	1871	34	T2D_GENES_TANYA_HEIGHT	POTTI_CYTOXAN_SENSITIVITY
0.160342063068%	3	1871	34	T2D_GENES_TANYA_HEIGHT	PID_IL2_PI3KPATHWAY
0.160342063068%	3	1871	34	T2D_GENES_TANYA_HEIGHT	JIANG_HYPOXIA_VIA_VHL
0.160342063068%	3	1871	34	T2D_GENES_TANYA_HEIGHT	HONMA_DOCETAXEL_RESISTANCE
0.160342063068%	3	1871	34	T2D_GENES_TANYA_HEIGHT	DOANE_BREAST_CANCER_CLASSES_DN
0.160342063068%	3	1871	34	T2D_GENES_TANYA_HEIGHT	BIOCARTA_MPR_PATHWAY
0.160342063068%	3	1871	33	T2D_GENES_TANYA_HEIGHT	VALK_AML_CLUSTER_6
0.160342063068%	3	1871	33	T2D_GENES_TANYA_HEIGHT	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS
0.160342063068%	3	1871	33	T2D_GENES_TANYA_HEIGHT	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP
0.160342063068%	3	1871	33	T2D_GENES_TANYA_HEIGHT	PID_ALPHASYNUCLEIN_PATHWAY
0.160342063068%	3	1871	33	T2D_GENES_TANYA_HEIGHT	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS
0.160342063068%	3	1871	33	T2D_GENES_TANYA_HEIGHT	KEGG_ETHER_LIPID_METABOLISM
0.160342063068%	3	1871	33	T2D_GENES_TANYA_HEIGHT	GREENBAUM_E2A_TARGETS_UP
0.160342063068%	3	1871	33	T2D_GENES_TANYA_HEIGHT	DUTTA_APOPTOSIS_VIA_NFKB
0.160342063068%	3	1871	33	T2D_GENES_TANYA_HEIGHT	BURTON_ADIPOGENESIS_1
0.160342063068%	3	1871	33	T2D_GENES_TANYA_HEIGHT	APPEL_IMATINIB_RESPONSE
0.160342063068%	3	1871	32	T2D_GENES_TANYA_HEIGHT	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.160342063068%	3	1871	32	T2D_GENES_TANYA_HEIGHT	TSAI_RESPONSE_TO_RADIATION_THERAPY
0.160342063068%	3	1871	32	T2D_GENES_TANYA_HEIGHT	TRACEY_RESISTANCE_TO_IFNA2_DN
0.160342063068%	3	1871	32	T2D_GENES_TANYA_HEIGHT	SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY
0.160342063068%	3	1871	32	T2D_GENES_TANYA_HEIGHT	REACTOME_ELONGATION_ARREST_AND_RECOVERY
0.160342063068%	3	1871	32	T2D_GENES_TANYA_HEIGHT	REACTOME_COMPLEMENT_CASCADE
0.160342063068%	3	1871	32	T2D_GENES_TANYA_HEIGHT	PID_WNT_NONCANONICAL_PATHWAY
0.160342063068%	3	1871	32	T2D_GENES_TANYA_HEIGHT	KIM_TIAL1_TARGETS
0.160342063068%	3	1871	32	T2D_GENES_TANYA_HEIGHT	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM
0.160342063068%	3	1871	32	T2D_GENES_TANYA_HEIGHT	DORSAM_HOXA9_TARGETS_DN
0.160342063068%	3	1871	32	T2D_GENES_TANYA_HEIGHT	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN
0.160342063068%	3	1871	31	T2D_GENES_TANYA_HEIGHT	SIMBULAN_PARP1_TARGETS_UP
0.160342063068%	3	1871	31	T2D_GENES_TANYA_HEIGHT	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
0.160342063068%	3	1871	31	T2D_GENES_TANYA_HEIGHT	PID_NEPHRIN_NEPH1_PATHWAY
0.160342063068%	3	1871	31	T2D_GENES_TANYA_HEIGHT	PID_AVB3_OPN_PATHWAY
0.160342063068%	3	1871	31	T2D_GENES_TANYA_HEIGHT	NOJIMA_SFRP2_TARGETS_UP
0.160342063068%	3	1871	31	T2D_GENES_TANYA_HEIGHT	MCCABE_HOXC6_TARGETS_CANCER_UP
0.160342063068%	3	1871	31	T2D_GENES_TANYA_HEIGHT	HUNSBERGER_EXERCISE_REGULATED_GENES
0.160342063068%	3	1871	31	T2D_GENES_TANYA_HEIGHT	DORSEY_GAB2_TARGETS
0.160342063068%	3	1871	31	T2D_GENES_TANYA_HEIGHT	DANG_MYC_TARGETS_DN
0.160342063068%	3	1871	31	T2D_GENES_TANYA_HEIGHT	CAFFAREL_RESPONSE_TO_THC_DN
0.160342063068%	3	1871	31	T2D_GENES_TANYA_HEIGHT	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP
0.160342063068%	3	1871	31	T2D_GENES_TANYA_HEIGHT	BIOCARTA_PYK2_PATHWAY
0.160342063068%	3	1871	31	T2D_GENES_TANYA_HEIGHT	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.160342063068%	3	1871	30	T2D_GENES_TANYA_HEIGHT	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN
0.160342063068%	3	1871	30	T2D_GENES_TANYA_HEIGHT	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.160342063068%	3	1871	30	T2D_GENES_TANYA_HEIGHT	YANAGIHARA_ESX1_TARGETS
0.160342063068%	3	1871	30	T2D_GENES_TANYA_HEIGHT	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN
0.160342063068%	3	1871	30	T2D_GENES_TANYA_HEIGHT	VALK_AML_CLUSTER_13
0.160342063068%	3	1871	30	T2D_GENES_TANYA_HEIGHT	VALK_AML_CLUSTER_12
0.160342063068%	3	1871	30	T2D_GENES_TANYA_HEIGHT	TSENG_ADIPOGENIC_POTENTIAL_UP
0.160342063068%	3	1871	30	T2D_GENES_TANYA_HEIGHT	REACTOME_MRNA_CAPPING
0.160342063068%	3	1871	30	T2D_GENES_TANYA_HEIGHT	REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX
0.160342063068%	3	1871	30	T2D_GENES_TANYA_HEIGHT	PID_IL2_STAT5PATHWAY
0.160342063068%	3	1871	30	T2D_GENES_TANYA_HEIGHT	NAKAJIMA_EOSINOPHIL
0.160342063068%	3	1871	30	T2D_GENES_TANYA_HEIGHT	LY_AGING_PREMATURE_DN
0.160342063068%	3	1871	30	T2D_GENES_TANYA_HEIGHT	LIU_BREAST_CANCER
0.160342063068%	3	1871	29	T2D_GENES_TANYA_HEIGHT	WEINMANN_ADAPTATION_TO_HYPOXIA_UP
0.160342063068%	3	1871	29	T2D_GENES_TANYA_HEIGHT	WATANABE_COLON_CANCER_MSI_VS_MSS_UP
0.160342063068%	3	1871	29	T2D_GENES_TANYA_HEIGHT	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR
0.160342063068%	3	1871	29	T2D_GENES_TANYA_HEIGHT	ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.160342063068%	3	1871	29	T2D_GENES_TANYA_HEIGHT	STANELLE_E2F1_TARGETS
0.160342063068%	3	1871	29	T2D_GENES_TANYA_HEIGHT	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX
0.160342063068%	3	1871	29	T2D_GENES_TANYA_HEIGHT	REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN
0.160342063068%	3	1871	29	T2D_GENES_TANYA_HEIGHT	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
0.160342063068%	3	1871	29	T2D_GENES_TANYA_HEIGHT	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
0.160342063068%	3	1871	29	T2D_GENES_TANYA_HEIGHT	NGUYEN_NOTCH1_TARGETS_UP
0.160342063068%	3	1871	29	T2D_GENES_TANYA_HEIGHT	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
0.160342063068%	3	1871	29	T2D_GENES_TANYA_HEIGHT	KRIGE_AMINO_ACID_DEPRIVATION
0.160342063068%	3	1871	29	T2D_GENES_TANYA_HEIGHT	KEGG_HISTIDINE_METABOLISM
0.160342063068%	3	1871	29	T2D_GENES_TANYA_HEIGHT	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN
0.160342063068%	3	1871	29	T2D_GENES_TANYA_HEIGHT	CHOW_RASSF1_TARGETS_DN
0.160342063068%	3	1871	29	T2D_GENES_TANYA_HEIGHT	BIOCARTA_TNFR1_PATHWAY
0.160342063068%	3	1871	29	T2D_GENES_TANYA_HEIGHT	ABE_VEGFA_TARGETS_30MIN
0.160342063068%	3	1871	28	T2D_GENES_TANYA_HEIGHT	WIKMAN_ASBESTOS_LUNG_CANCER_DN
0.160342063068%	3	1871	28	T2D_GENES_TANYA_HEIGHT	ST_GAQ_PATHWAY
0.160342063068%	3	1871	28	T2D_GENES_TANYA_HEIGHT	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
0.160342063068%	3	1871	28	T2D_GENES_TANYA_HEIGHT	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS
0.160342063068%	3	1871	28	T2D_GENES_TANYA_HEIGHT	REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A
0.160342063068%	3	1871	28	T2D_GENES_TANYA_HEIGHT	OLSSON_E2F3_TARGETS_UP
0.160342063068%	3	1871	28	T2D_GENES_TANYA_HEIGHT	MATZUK_MALE_REPRODUCTION_SERTOLI
0.160342063068%	3	1871	28	T2D_GENES_TANYA_HEIGHT	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
0.160342063068%	3	1871	28	T2D_GENES_TANYA_HEIGHT	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN
0.160342063068%	3	1871	28	T2D_GENES_TANYA_HEIGHT	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN
0.160342063068%	3	1871	27	T2D_GENES_TANYA_HEIGHT	ST_GRANULE_CELL_SURVIVAL_PATHWAY
0.160342063068%	3	1871	27	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN
0.160342063068%	3	1871	27	T2D_GENES_TANYA_HEIGHT	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP
0.160342063068%	3	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS
0.160342063068%	3	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN
0.160342063068%	3	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_RECYCLING_PATHWAY_OF_L1
0.160342063068%	3	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY
0.160342063068%	3	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_IL_RECEPTOR_SHC_SIGNALING
0.160342063068%	3	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS
0.160342063068%	3	1871	27	T2D_GENES_TANYA_HEIGHT	PID_IL3_PATHWAY
0.160342063068%	3	1871	27	T2D_GENES_TANYA_HEIGHT	PID_GLYPICAN_1PATHWAY
0.160342063068%	3	1871	27	T2D_GENES_TANYA_HEIGHT	KEGG_PENTOSE_PHOSPHATE_PATHWAY
0.160342063068%	3	1871	27	T2D_GENES_TANYA_HEIGHT	JI_METASTASIS_REPRESSED_BY_STK11
0.160342063068%	3	1871	27	T2D_GENES_TANYA_HEIGHT	GROSS_ELK3_TARGETS_UP
0.160342063068%	3	1871	27	T2D_GENES_TANYA_HEIGHT	BOYAULT_LIVER_CANCER_SUBCLASS_G2
0.160342063068%	3	1871	27	T2D_GENES_TANYA_HEIGHT	BIOCARTA_EDG1_PATHWAY
0.160342063068%	3	1871	27	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CREB_PATHWAY
0.160342063068%	3	1871	26	T2D_GENES_TANYA_HEIGHT	XU_CREBBP_TARGETS_UP
0.160342063068%	3	1871	26	T2D_GENES_TANYA_HEIGHT	VALK_AML_CLUSTER_8
0.160342063068%	3	1871	26	T2D_GENES_TANYA_HEIGHT	VALK_AML_CLUSTER_16
0.160342063068%	3	1871	26	T2D_GENES_TANYA_HEIGHT	TOMIDA_METASTASIS_UP
0.160342063068%	3	1871	26	T2D_GENES_TANYA_HEIGHT	ST_INTERLEUKIN_4_PATHWAY
0.160342063068%	3	1871	26	T2D_GENES_TANYA_HEIGHT	REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS
0.160342063068%	3	1871	26	T2D_GENES_TANYA_HEIGHT	REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE
0.160342063068%	3	1871	26	T2D_GENES_TANYA_HEIGHT	REACTOME_ACTIVATION_OF_GENES_BY_ATF4
0.160342063068%	3	1871	26	T2D_GENES_TANYA_HEIGHT	PID_INSULIN_GLUCOSE_PATHWAY
0.160342063068%	3	1871	26	T2D_GENES_TANYA_HEIGHT	PID_ALK1PATHWAY
0.160342063068%	3	1871	26	T2D_GENES_TANYA_HEIGHT	HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP
0.160342063068%	3	1871	26	T2D_GENES_TANYA_HEIGHT	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP
0.160342063068%	3	1871	26	T2D_GENES_TANYA_HEIGHT	BRACHAT_RESPONSE_TO_METHOTREXATE_UP
0.160342063068%	3	1871	26	T2D_GENES_TANYA_HEIGHT	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP
0.160342063068%	3	1871	25	T2D_GENES_TANYA_HEIGHT	REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION
0.160342063068%	3	1871	25	T2D_GENES_TANYA_HEIGHT	REACTOME_G0_AND_EARLY_G1
0.160342063068%	3	1871	25	T2D_GENES_TANYA_HEIGHT	REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS
0.160342063068%	3	1871	25	T2D_GENES_TANYA_HEIGHT	PID_LYMPHANGIOGENESIS_PATHWAY
0.160342063068%	3	1871	25	T2D_GENES_TANYA_HEIGHT	LU_TUMOR_ANGIOGENESIS_UP
0.160342063068%	3	1871	25	T2D_GENES_TANYA_HEIGHT	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD
0.160342063068%	3	1871	25	T2D_GENES_TANYA_HEIGHT	KIM_HYPOXIA
0.160342063068%	3	1871	25	T2D_GENES_TANYA_HEIGHT	KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS
0.160342063068%	3	1871	25	T2D_GENES_TANYA_HEIGHT	HOEGERKORP_CD44_TARGETS_TEMPORAL_DN
0.160342063068%	3	1871	25	T2D_GENES_TANYA_HEIGHT	COLLER_MYC_TARGETS_UP
0.160342063068%	3	1871	24	T2D_GENES_TANYA_HEIGHT	YIH_RESPONSE_TO_ARSENITE_C1
0.160342063068%	3	1871	24	T2D_GENES_TANYA_HEIGHT	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN
0.160342063068%	3	1871	24	T2D_GENES_TANYA_HEIGHT	SA_B_CELL_RECEPTOR_COMPLEXES
0.160342063068%	3	1871	24	T2D_GENES_TANYA_HEIGHT	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION
0.160342063068%	3	1871	24	T2D_GENES_TANYA_HEIGHT	ONO_AML1_TARGETS_UP
0.160342063068%	3	1871	24	T2D_GENES_TANYA_HEIGHT	ODONNELL_METASTASIS_DN
0.160342063068%	3	1871	24	T2D_GENES_TANYA_HEIGHT	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23
0.160342063068%	3	1871	24	T2D_GENES_TANYA_HEIGHT	MATZUK_SPERMATOGONIA
0.160342063068%	3	1871	24	T2D_GENES_TANYA_HEIGHT	HASLINGER_B_CLL_WITH_13Q14_DELETION
0.160342063068%	3	1871	24	T2D_GENES_TANYA_HEIGHT	DELACROIX_RAR_TARGETS_DN
0.160342063068%	3	1871	24	T2D_GENES_TANYA_HEIGHT	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN
0.160342063068%	3	1871	24	T2D_GENES_TANYA_HEIGHT	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP
0.160342063068%	3	1871	24	T2D_GENES_TANYA_HEIGHT	BIOCARTA_EIF4_PATHWAY
0.160342063068%	3	1871	24	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CXCR4_PATHWAY
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	ZHANG_INTERFERON_RESPONSE
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	WENG_POR_TARGETS_GLOBAL_DN
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	ST_GA12_PATHWAY
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	REACTOME_LYSOSOME_VESICLE_BIOGENESIS
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	ONO_FOXP3_TARGETS_UP
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	KEGG_NITROGEN_METABOLISM
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	HASLINGER_B_CLL_WITH_11Q23_DELETION
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	EGUCHI_CELL_CYCLE_RB1_TARGETS
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	CHIBA_RESPONSE_TO_TSA_DN
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CTCF_PATHWAY
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CELLCYCLE_PATHWAY
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CCR3_PATHWAY
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	BILANGES_SERUM_SENSITIVE_VIA_TSC1
0.160342063068%	3	1871	23	T2D_GENES_TANYA_HEIGHT	BARIS_THYROID_CANCER_UP
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	SUZUKI_RESPONSE_TO_TSA
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	NUMATA_CSF3_SIGNALING_VIA_STAT3
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	MATZUK_IMPLANTATION_AND_UTERINE
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	LANDIS_ERBB2_BREAST_TUMORS_65_UP
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	GAVIN_PDE3B_TARGETS
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	BRACHAT_RESPONSE_TO_CISPLATIN
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	BIOCARTA_SPPA_PATHWAY
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	BIOCARTA_HER2_PATHWAY
0.160342063068%	3	1871	22	T2D_GENES_TANYA_HEIGHT	BIOCARTA_GCR_PATHWAY
0.160342063068%	3	1871	21	T2D_GENES_TANYA_HEIGHT	WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP
0.160342063068%	3	1871	21	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP
0.160342063068%	3	1871	21	T2D_GENES_TANYA_HEIGHT	REACTOME_ERK_MAPK_TARGETS
0.160342063068%	3	1871	21	T2D_GENES_TANYA_HEIGHT	REACTOME_CTLA4_INHIBITORY_SIGNALING
0.160342063068%	3	1871	21	T2D_GENES_TANYA_HEIGHT	PID_P38_MK2PATHWAY
0.160342063068%	3	1871	21	T2D_GENES_TANYA_HEIGHT	MACLACHLAN_BRCA1_TARGETS_UP
0.160342063068%	3	1871	21	T2D_GENES_TANYA_HEIGHT	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP
0.160342063068%	3	1871	21	T2D_GENES_TANYA_HEIGHT	FINETTI_BREAST_CANCERS_KINOME_BLUE
0.160342063068%	3	1871	21	T2D_GENES_TANYA_HEIGHT	FERRANDO_TAL1_NEIGHBORS
0.160342063068%	3	1871	21	T2D_GENES_TANYA_HEIGHT	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE
0.160342063068%	3	1871	21	T2D_GENES_TANYA_HEIGHT	AMIT_SERUM_RESPONSE_20_MCF10A
0.160342063068%	3	1871	20	T2D_GENES_TANYA_HEIGHT	ZHU_SKIL_TARGETS_UP
0.160342063068%	3	1871	20	T2D_GENES_TANYA_HEIGHT	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN
0.160342063068%	3	1871	20	T2D_GENES_TANYA_HEIGHT	VILIMAS_NOTCH1_TARGETS_DN
0.160342063068%	3	1871	20	T2D_GENES_TANYA_HEIGHT	REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY
0.160342063068%	3	1871	20	T2D_GENES_TANYA_HEIGHT	PID_WNT_CANONICAL_PATHWAY
0.160342063068%	3	1871	20	T2D_GENES_TANYA_HEIGHT	NIELSEN_SYNOVIAL_SARCOMA_DN
0.160342063068%	3	1871	20	T2D_GENES_TANYA_HEIGHT	NIELSEN_LEIOMYOSARCOMA_CNN1_DN
0.160342063068%	3	1871	20	T2D_GENES_TANYA_HEIGHT	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN
0.160342063068%	3	1871	20	T2D_GENES_TANYA_HEIGHT	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN
0.160342063068%	3	1871	20	T2D_GENES_TANYA_HEIGHT	CROONQUIST_IL6_DEPRIVATION_UP
0.160342063068%	3	1871	20	T2D_GENES_TANYA_HEIGHT	BIOCARTA_IGF1MTOR_PATHWAY
0.160342063068%	3	1871	20	T2D_GENES_TANYA_HEIGHT	BARRIER_COLON_CANCER_RECURRENCE_DN
0.160342063068%	3	1871	20	T2D_GENES_TANYA_HEIGHT	AMIT_EGF_RESPONSE_240_MCF10A
0.160342063068%	3	1871	20	T2D_GENES_TANYA_HEIGHT	ABE_VEGFA_TARGETS
0.160342063068%	3	1871	19	T2D_GENES_TANYA_HEIGHT	REACTOME_G1_S_SPECIFIC_TRANSCRIPTION
0.160342063068%	3	1871	19	T2D_GENES_TANYA_HEIGHT	REACTOME_CGMP_EFFECTS
0.160342063068%	3	1871	19	T2D_GENES_TANYA_HEIGHT	OUYANG_PROSTATE_CANCER_MARKERS
0.160342063068%	3	1871	19	T2D_GENES_TANYA_HEIGHT	MELLMAN_TUT1_TARGETS_UP
0.160342063068%	3	1871	19	T2D_GENES_TANYA_HEIGHT	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN
0.160342063068%	3	1871	19	T2D_GENES_TANYA_HEIGHT	GRANDVAUX_IRF3_TARGETS_DN
0.160342063068%	3	1871	19	T2D_GENES_TANYA_HEIGHT	BIOCARTA_TH1TH2_PATHWAY
0.160342063068%	3	1871	19	T2D_GENES_TANYA_HEIGHT	BIOCARTA_TGFB_PATHWAY
0.160342063068%	3	1871	19	T2D_GENES_TANYA_HEIGHT	BIOCARTA_STATHMIN_PATHWAY
0.160342063068%	3	1871	19	T2D_GENES_TANYA_HEIGHT	BIOCARTA_MTA3_PATHWAY
0.160342063068%	3	1871	18	T2D_GENES_TANYA_HEIGHT	ZHENG_RESPONSE_TO_ARSENITE_UP
0.160342063068%	3	1871	18	T2D_GENES_TANYA_HEIGHT	TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP
0.160342063068%	3	1871	18	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_LUMINAL_A_DN
0.160342063068%	3	1871	18	T2D_GENES_TANYA_HEIGHT	SCHEIDEREIT_IKK_TARGETS
0.160342063068%	3	1871	18	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_OF_PC
0.160342063068%	3	1871	18	T2D_GENES_TANYA_HEIGHT	REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION
0.160342063068%	3	1871	18	T2D_GENES_TANYA_HEIGHT	NIELSEN_SYNOVIAL_SARCOMA_UP
0.160342063068%	3	1871	18	T2D_GENES_TANYA_HEIGHT	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.160342063068%	3	1871	18	T2D_GENES_TANYA_HEIGHT	NIELSEN_LEIOMYOSARCOMA_UP
0.160342063068%	3	1871	18	T2D_GENES_TANYA_HEIGHT	NAM_FXYD5_TARGETS_DN
0.160342063068%	3	1871	18	T2D_GENES_TANYA_HEIGHT	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8
0.160342063068%	3	1871	18	T2D_GENES_TANYA_HEIGHT	KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.160342063068%	3	1871	18	T2D_GENES_TANYA_HEIGHT	KAPOSI_LIVER_CANCER_MET_UP
0.160342063068%	3	1871	18	T2D_GENES_TANYA_HEIGHT	BIOCARTA_MCM_PATHWAY
0.160342063068%	3	1871	18	T2D_GENES_TANYA_HEIGHT	BIOCARTA_ETS_PATHWAY
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	WIKMAN_ASBESTOS_LUNG_CANCER_UP
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	THUM_MIR21_TARGETS_HEART_DISEASE_UP
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	PID_SYNDECAN_3_PATHWAY
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	PID_NFKAPPABATYPICALPATHWAY
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	PID_ANTHRAXPATHWAY
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	MURAKAMI_UV_RESPONSE_1HR_UP
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	LEE_METASTASIS_AND_RNA_PROCESSING_UP
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	KEGG_RENIN_ANGIOTENSIN_SYSTEM
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	INGA_TP53_TARGETS
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	HOWLIN_CITED1_TARGETS_2_UP
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	GRATIAS_RETINOBLASTOMA_16Q24
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	GALE_APL_WITH_FLT3_MUTATED_DN
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	BIOCARTA_NO2IL12_PATHWAY
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	BIOCARTA_HCMV_PATHWAY
0.160342063068%	3	1871	17	T2D_GENES_TANYA_HEIGHT	BIOCARTA_ARF_PATHWAY
0.160342063068%	3	1871	16	T2D_GENES_TANYA_HEIGHT	VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN
0.160342063068%	3	1871	16	T2D_GENES_TANYA_HEIGHT	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI
0.160342063068%	3	1871	16	T2D_GENES_TANYA_HEIGHT	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT
0.160342063068%	3	1871	16	T2D_GENES_TANYA_HEIGHT	LUI_THYROID_CANCER_CLUSTER_4
0.160342063068%	3	1871	16	T2D_GENES_TANYA_HEIGHT	KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS
0.160342063068%	3	1871	16	T2D_GENES_TANYA_HEIGHT	IGLESIAS_E2F_TARGETS_DN
0.160342063068%	3	1871	16	T2D_GENES_TANYA_HEIGHT	HE_PTEN_TARGETS_UP
0.160342063068%	3	1871	16	T2D_GENES_TANYA_HEIGHT	GEISS_RESPONSE_TO_DSRNA_DN
0.160342063068%	3	1871	16	T2D_GENES_TANYA_HEIGHT	BIOCARTA_RELA_PATHWAY
0.160342063068%	3	1871	16	T2D_GENES_TANYA_HEIGHT	BIOCARTA_P53_PATHWAY
0.160342063068%	3	1871	16	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CDMAC_PATHWAY
0.160342063068%	3	1871	15	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3
0.160342063068%	3	1871	15	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1
0.160342063068%	3	1871	15	T2D_GENES_TANYA_HEIGHT	REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS
0.160342063068%	3	1871	15	T2D_GENES_TANYA_HEIGHT	REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE
0.160342063068%	3	1871	15	T2D_GENES_TANYA_HEIGHT	PID_ERB_GENOMIC_PATHWAY
0.160342063068%	3	1871	15	T2D_GENES_TANYA_HEIGHT	PID_ARF6DOWNSTREAMPATHWAY
0.160342063068%	3	1871	15	T2D_GENES_TANYA_HEIGHT	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27
0.160342063068%	3	1871	15	T2D_GENES_TANYA_HEIGHT	LIU_IL13_PRIMING_MODEL
0.160342063068%	3	1871	15	T2D_GENES_TANYA_HEIGHT	GRANDVAUX_IRF3_TARGETS_UP
0.160342063068%	3	1871	15	T2D_GENES_TANYA_HEIGHT	FINETTI_BREAST_CANCERS_KINOME_GRAY
0.160342063068%	3	1871	15	T2D_GENES_TANYA_HEIGHT	FIGUEROA_AML_METHYLATION_CLUSTER_4_DN
0.160342063068%	3	1871	15	T2D_GENES_TANYA_HEIGHT	BIOCARTA_RARRXR_PATHWAY
0.160342063068%	3	1871	15	T2D_GENES_TANYA_HEIGHT	BIOCARTA_LONGEVITY_PATHWAY
0.160342063068%	3	1871	15	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CD40_PATHWAY
0.160342063068%	3	1871	14	T2D_GENES_TANYA_HEIGHT	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.160342063068%	3	1871	14	T2D_GENES_TANYA_HEIGHT	VERRECCHIA_RESPONSE_TO_TGFB1_C3
0.160342063068%	3	1871	14	T2D_GENES_TANYA_HEIGHT	SABATES_COLORECTAL_ADENOMA_SIZE_DN
0.160342063068%	3	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY
0.160342063068%	3	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_COMPLEMENT_CASCADE
0.160342063068%	3	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_P75NTR_SIGNALS_VIA_NFKB
0.160342063068%	3	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_HYALURONAN_METABOLISM
0.160342063068%	3	1871	14	T2D_GENES_TANYA_HEIGHT	PID_S1P_S1P4_PATHWAY
0.160342063068%	3	1871	14	T2D_GENES_TANYA_HEIGHT	PID_IL5_PATHWAY
0.160342063068%	3	1871	14	T2D_GENES_TANYA_HEIGHT	INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP
0.160342063068%	3	1871	14	T2D_GENES_TANYA_HEIGHT	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION
0.160342063068%	3	1871	14	T2D_GENES_TANYA_HEIGHT	BIOCARTA_THELPER_PATHWAY
0.160342063068%	3	1871	14	T2D_GENES_TANYA_HEIGHT	BIOCARTA_TCYTOTOXIC_PATHWAY
0.160342063068%	3	1871	14	T2D_GENES_TANYA_HEIGHT	BIOCARTA_RANKL_PATHWAY
0.160342063068%	3	1871	14	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CLASSIC_PATHWAY
0.160342063068%	3	1871	14	T2D_GENES_TANYA_HEIGHT	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP
0.160342063068%	3	1871	13	T2D_GENES_TANYA_HEIGHT	SA_REG_CASCADE_OF_CYCLIN_EXPR
0.160342063068%	3	1871	13	T2D_GENES_TANYA_HEIGHT	REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT
0.160342063068%	3	1871	13	T2D_GENES_TANYA_HEIGHT	REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY
0.160342063068%	3	1871	13	T2D_GENES_TANYA_HEIGHT	POS_RESPONSE_TO_HISTAMINE_UP
0.160342063068%	3	1871	13	T2D_GENES_TANYA_HEIGHT	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN
0.160342063068%	3	1871	13	T2D_GENES_TANYA_HEIGHT	IRITANI_MAD1_TARGETS_UP
0.160342063068%	3	1871	13	T2D_GENES_TANYA_HEIGHT	BIOCARTA_AGPCR_PATHWAY
0.160342063068%	3	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES
0.160342063068%	3	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY
0.160342063068%	3	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING
0.160342063068%	3	1871	12	T2D_GENES_TANYA_HEIGHT	NEBEN_AML_WITH_FLT3_OR_NRAS_DN
0.160342063068%	3	1871	12	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_NPC_ICP_WITH_H3K27ME3
0.160342063068%	3	1871	12	T2D_GENES_TANYA_HEIGHT	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.160342063068%	3	1871	12	T2D_GENES_TANYA_HEIGHT	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP
0.160342063068%	3	1871	12	T2D_GENES_TANYA_HEIGHT	FUNG_IL2_SIGNALING_2
0.160342063068%	3	1871	12	T2D_GENES_TANYA_HEIGHT	BIOCARTA_LECTIN_PATHWAY
0.160342063068%	3	1871	12	T2D_GENES_TANYA_HEIGHT	BIOCARTA_ASBCELL_PATHWAY
0.160342063068%	3	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM
0.160342063068%	3	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE
0.160342063068%	3	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL
0.160342063068%	3	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX
0.160342063068%	3	1871	11	T2D_GENES_TANYA_HEIGHT	MARSON_FOXP3_TARGETS_STIMULATED_DN
0.160342063068%	3	1871	11	T2D_GENES_TANYA_HEIGHT	CHUANG_OXIDATIVE_STRESS_RESPONSE_DN
0.160342063068%	3	1871	11	T2D_GENES_TANYA_HEIGHT	BIOCARTA_TCAPOPTOSIS_PATHWAY
0.160342063068%	3	1871	11	T2D_GENES_TANYA_HEIGHT	BIOCARTA_EGFR_SMRTE_PATHWAY
0.160342063068%	3	1871	101	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_12HR_DN
0.160342063068%	3	1871	100	T2D_GENES_TANYA_HEIGHT	RICKMAN_HEAD_AND_NECK_CANCER_A
0.160342063068%	3	1871	10	T2D_GENES_TANYA_HEIGHT	WONG_ENDOMETRIAL_CANCER_LATE
0.160342063068%	3	1871	10	T2D_GENES_TANYA_HEIGHT	TSUDA_ALVEOLAR_SOFT_PART_SARCOMA
0.160342063068%	3	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR
0.160342063068%	3	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION
0.160342063068%	3	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_COPI_MEDIATED_TRANSPORT
0.160342063068%	3	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY
0.160342063068%	3	1871	10	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_IPS_LCP_WITH_H3K27ME3
0.160342063068%	3	1871	10	T2D_GENES_TANYA_HEIGHT	KONG_E2F1_TARGETS
0.160342063068%	3	1871	10	T2D_GENES_TANYA_HEIGHT	BUDHU_LIVER_CANCER_METASTASIS_UP
0.160342063068%	3	1871	10	T2D_GENES_TANYA_HEIGHT	BIOCARTA_SKP2E2F_PATHWAY
0.160342063068%	3	1871	10	T2D_GENES_TANYA_HEIGHT	BIOCARTA_RNA_PATHWAY
0.157604412924%	2	1269	99	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIM_MAMMARY_LUMINAL_MATURE_DN
0.157604412924%	2	1269	96	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZAMORA_NOS2_TARGETS_DN
0.157604412924%	2	1269	95	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KAYO_CALORIE_RESTRICTION_MUSCLE_UP
0.157604412924%	2	1269	94	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.157604412924%	2	1269	94	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER
0.157604412924%	2	1269	93	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHU_CMV_24_HR_UP
0.157604412924%	2	1269	91	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.157604412924%	2	1269	91	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ELVIDGE_HIF1A_TARGETS_DN
0.157604412924%	2	1269	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30
0.157604412924%	2	1269	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_FEEDER_PATHWAY
0.157604412924%	2	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_D_UP
0.157604412924%	2	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WALLACE_PROSTATE_CANCER_RACE_DN
0.157604412924%	2	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TIEN_INTESTINE_PROBIOTICS_2HR_DN
0.157604412924%	2	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
0.157604412924%	2	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_APOPTOSIS
0.157604412924%	2	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
0.157604412924%	2	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN
0.157604412924%	2	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.157604412924%	2	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.157604412924%	2	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
0.157604412924%	2	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_L1CAM_INTERACTIONS
0.157604412924%	2	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NGUYEN_NOTCH1_TARGETS_DN
0.157604412924%	2	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
0.157604412924%	2	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GHANDHI_BYSTANDER_IRRADIATION_UP
0.157604412924%	2	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BAELDE_DIABETIC_NEPHROPATHY_UP
0.157604412924%	2	1269	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
0.157604412924%	2	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SWEET_KRAS_TARGETS_UP
0.157604412924%	2	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP
0.157604412924%	2	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN
0.157604412924%	2	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.157604412924%	2	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ECM_RECEPTOR_INTERACTION
0.157604412924%	2	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.157604412924%	2	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
0.157604412924%	2	1269	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WARTERS_RESPONSE_TO_IR_SKIN
0.157604412924%	2	1269	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.157604412924%	2	1269	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.157604412924%	2	1269	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
0.157604412924%	2	1269	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WONG_ENDMETRIUM_CANCER_DN
0.157604412924%	2	1269	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
0.157604412924%	2	1269	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_REG_GR_PATHWAY
0.157604412924%	2	1269	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
0.157604412924%	2	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING
0.157604412924%	2	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION
0.157604412924%	2	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MUNSHI_MULTIPLE_MYELOMA_UP
0.157604412924%	2	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GUO_HEX_TARGETS_UP
0.157604412924%	2	1269	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
0.157604412924%	2	1269	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_CARDIAC_MUSCLE_CONTRACTION
0.157604412924%	2	1269	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.157604412924%	2	1269	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.157604412924%	2	1269	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
0.157604412924%	2	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OHM_EMBRYONIC_CARCINOMA_DN
0.157604412924%	2	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_DEDIFFERENTIATED_STATE_UP
0.157604412924%	2	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS
0.157604412924%	2	1269	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TOOKER_GEMCITABINE_RESISTANCE_UP
0.157604412924%	2	1269	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIU_COMMON_CANCER_GENES
0.157604412924%	2	1269	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_P2
0.157604412924%	2	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_OPIOID_SIGNALLING
0.157604412924%	2	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CELL_JUNCTION_ORGANIZATION
0.157604412924%	2	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_D_DN
0.157604412924%	2	1269	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MORI_PRE_BI_LYMPHOCYTE_DN
0.157604412924%	2	1269	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP
0.157604412924%	2	1269	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
0.157604412924%	2	1269	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAMASHITA_LIVER_CANCER_STEM_CELL_DN
0.157604412924%	2	1269	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
0.157604412924%	2	1269	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCCLUNG_COCAIN_REWARD_4WK
0.157604412924%	2	1269	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.157604412924%	2	1269	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BAE_BRCA1_TARGETS_UP
0.157604412924%	2	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VANASSE_BCL2_TARGETS_DN
0.157604412924%	2	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.157604412924%	2	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
0.157604412924%	2	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_LIVER_CANCER_DENA_DN
0.157604412924%	2	1269	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
0.157604412924%	2	1269	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_VIRAL_MYOCARDITIS
0.157604412924%	2	1269	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MATZUK_SPERMATOCYTE
0.157604412924%	2	1269	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DOANE_BREAST_CANCER_CLASSES_UP
0.157604412924%	2	1269	71	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_6HR_UP
0.157604412924%	2	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3
0.157604412924%	2	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5
0.157604412924%	2	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_NOTCH1
0.157604412924%	2	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RAGHAVACHARI_PLATELET_SPECIFIC_GENES
0.157604412924%	2	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_RENAL_CELL_CARCINOMA
0.157604412924%	2	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.157604412924%	2	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SPHINGOLIPID_METABOLISM
0.157604412924%	2	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GLUCOSE_METABOLISM
0.157604412924%	2	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.157604412924%	2	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
0.157604412924%	2	1269	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
0.157604412924%	2	1269	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BASSO_CD40_SIGNALING_DN
0.157604412924%	2	1269	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AKL_HTLV1_INFECTION_DN
0.157604412924%	2	1269	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
0.157604412924%	2	1269	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VANHARANTA_UTERINE_FIBROID_DN
0.157604412924%	2	1269	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES
0.157604412924%	2	1269	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY
0.157604412924%	2	1269	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GENTILE_UV_LOW_DOSE_DN
0.157604412924%	2	1269	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ELVIDGE_HIF1A_TARGETS_UP
0.157604412924%	2	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
0.157604412924%	2	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
0.157604412924%	2	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT
0.157604412924%	2	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TENEDINI_MEGAKARYOCYTE_MARKERS
0.157604412924%	2	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SWEET_KRAS_TARGETS_DN
0.157604412924%	2	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_INTEGRIN1_PATHWAY
0.157604412924%	2	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_HIF1_TFPATHWAY
0.157604412924%	2	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_HDAC_CLASSI_PATHWAY
0.157604412924%	2	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARSON_FOXP3_TARGETS_UP
0.157604412924%	2	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DIRMEIER_LMP1_RESPONSE_EARLY
0.157604412924%	2	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.157604412924%	2	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX
0.157604412924%	2	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_IL4_2PATHWAY
0.157604412924%	2	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_CD8TCRDOWNSTREAMPATHWAY
0.157604412924%	2	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_BCR_5PATHWAY
0.157604412924%	2	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_LIVER_CANCER_ACOX1_DN
0.157604412924%	2	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
0.157604412924%	2	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PETROVA_PROX1_TARGETS_DN
0.157604412924%	2	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	INGRAM_SHH_TARGETS_DN
0.157604412924%	2	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
0.157604412924%	2	1269	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JOHNSTONE_PARVB_TARGETS_1_DN
0.157604412924%	2	1269	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
0.157604412924%	2	1269	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.157604412924%	2	1269	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
0.157604412924%	2	1269	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_AR_PATHWAY
0.157604412924%	2	1269	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
0.157604412924%	2	1269	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_1HR_UP
0.157604412924%	2	1269	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BAKKER_FOXO3_TARGETS_UP
0.157604412924%	2	1269	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
0.157604412924%	2	1269	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SONG_TARGETS_OF_IE86_CMV_PROTEIN
0.157604412924%	2	1269	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
0.157604412924%	2	1269	6	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TRACEY_RESISTANCE_TO_IFNA2_UP
0.157604412924%	2	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WESTON_VEGFA_TARGETS_6HR
0.157604412924%	2	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS
0.157604412924%	2	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
0.157604412924%	2	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1
0.157604412924%	2	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DASU_IL6_SIGNALING_UP
0.157604412924%	2	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAGASHIMA_EGF_SIGNALING_UP
0.157604412924%	2	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN
0.157604412924%	2	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KOHOUTEK_CCNT2_TARGETS
0.157604412924%	2	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
0.157604412924%	2	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JI_RESPONSE_TO_FSH_DN
0.157604412924%	2	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_PPARA_PATHWAY
0.157604412924%	2	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TANG_SENESCENCE_TP53_TARGETS_DN
0.157604412924%	2	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN
0.157604412924%	2	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PEART_HDAC_PROLIFERATION_CLUSTER_UP
0.157604412924%	2	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRABARCZYK_BCL11B_TARGETS_DN
0.157604412924%	2	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DELASERNA_MYOD_TARGETS_DN
0.157604412924%	2	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_11
0.157604412924%	2	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BORLAK_LIVER_CANCER_EGF_UP
0.157604412924%	2	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WORSCHECH_TUMOR_REJECTION_UP
0.157604412924%	2	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_METASTASIS_UP
0.157604412924%	2	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP
0.157604412924%	2	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.157604412924%	2	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GYORFFY_DOXORUBICIN_RESISTANCE
0.157604412924%	2	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YU_MYC_TARGETS_DN
0.157604412924%	2	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
0.157604412924%	2	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMIRNOV_RESPONSE_TO_IR_2HR_DN
0.157604412924%	2	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ION_CHANNEL_TRANSPORT
0.157604412924%	2	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_FGF_PATHWAY
0.157604412924%	2	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D4
0.157604412924%	2	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DEMAGALHAES_AGING_UP
0.157604412924%	2	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROVERSI_GLIOMA_COPY_NUMBER_DN
0.157604412924%	2	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RICKMAN_HEAD_AND_NECK_CANCER_F
0.157604412924%	2	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_LIVER_CANCER_MYC_UP
0.157604412924%	2	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_INOSITOL_PHOSPHATE_METABOLISM
0.157604412924%	2	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ARGININE_AND_PROLINE_METABOLISM
0.157604412924%	2	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KANG_DOXORUBICIN_RESISTANCE_UP
0.157604412924%	2	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP
0.157604412924%	2	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
0.157604412924%	2	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMIRNOV_RESPONSE_TO_IR_2HR_UP
0.157604412924%	2	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_AR_TF_PATHWAY
0.157604412924%	2	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MENSSEN_MYC_TARGETS
0.157604412924%	2	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
0.157604412924%	2	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ISHIDA_E2F_TARGETS
0.157604412924%	2	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HENDRICKS_SMARCA4_TARGETS_DN
0.157604412924%	2	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN
0.157604412924%	2	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WINTER_HYPOXIA_DN
0.157604412924%	2	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP
0.157604412924%	2	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
0.157604412924%	2	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6
0.157604412924%	2	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KENNY_CTNNB1_TARGETS_DN
0.157604412924%	2	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ENDOMETRIAL_CANCER
0.157604412924%	2	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP
0.157604412924%	2	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP
0.157604412924%	2	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_BARRETTS_ESOPHAGUS_UP
0.157604412924%	2	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
0.157604412924%	2	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
0.157604412924%	2	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_7
0.157604412924%	2	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STOSSI_RESPONSE_TO_ESTRADIOL
0.157604412924%	2	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN
0.157604412924%	2	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.157604412924%	2	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOFMANN_CELL_LYMPHOMA_UP
0.157604412924%	2	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
0.157604412924%	2	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
0.157604412924%	2	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC
0.157604412924%	2	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION
0.157604412924%	2	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN
0.157604412924%	2	1269	5	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PASTURAL_RIZ1_TARGETS_DN
0.157604412924%	2	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WONG_PROTEASOME_GENE_MODULE
0.157604412924%	2	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP
0.157604412924%	2	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
0.157604412924%	2	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_PI3KCIPATHWAY
0.157604412924%	2	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_FOXOPATHWAY
0.157604412924%	2	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MANTOVANI_VIRAL_GPCR_SIGNALING_DN
0.157604412924%	2	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE
0.157604412924%	2	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_LIVER_CANCER
0.157604412924%	2	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_2HR_DN
0.157604412924%	2	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.157604412924%	2	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_LB_UP
0.157604412924%	2	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RICKMAN_HEAD_AND_NECK_CANCER_B
0.157604412924%	2	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_HEDGEHOG_GLIPATHWAY
0.157604412924%	2	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PENG_GLUCOSE_DEPRIVATION_UP
0.157604412924%	2	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OXFORD_RALA_OR_RALB_TARGETS_UP
0.157604412924%	2	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PROTEASOME
0.157604412924%	2	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN
0.157604412924%	2	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN
0.157604412924%	2	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.157604412924%	2	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHANGOLKAR_H2AFY_TARGETS_UP
0.157604412924%	2	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WOOD_EBV_EBNA1_TARGETS_DN
0.157604412924%	2	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WARTERS_IR_RESPONSE_5GY
0.157604412924%	2	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_NFAT_TFPATHWAY
0.157604412924%	2	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCCLUNG_DELTA_FOSB_TARGETS_8WK
0.157604412924%	2	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEONARD_HYPOXIA
0.157604412924%	2	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_NOTCH_SIGNALING_PATHWAY
0.157604412924%	2	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JIANG_AGING_HYPOTHALAMUS_UP
0.157604412924%	2	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.157604412924%	2	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SIG_BCR_SIGNALING_PATHWAY
0.157604412924%	2	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_PLK1_PATHWAY
0.157604412924%	2	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HALMOS_CEBPA_TARGETS_DN
0.157604412924%	2	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_PR_UP
0.157604412924%	2	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMITH_LIVER_CANCER
0.157604412924%	2	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SIG_CHEMOTAXIS
0.157604412924%	2	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP
0.157604412924%	2	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN
0.157604412924%	2	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHIPP_DLBCL_CURED_VS_FATAL_DN
0.157604412924%	2	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_
0.157604412924%	2	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_RHOA_PATHWAY
0.157604412924%	2	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_ILK_PATHWAY
0.157604412924%	2	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHENG_RESPONSE_TO_NICKEL_ACETATE
0.157604412924%	2	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.157604412924%	2	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZUCCHI_METASTASIS_DN
0.157604412924%	2	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS
0.157604412924%	2	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS
0.157604412924%	2	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_HNF3APATHWAY
0.157604412924%	2	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MEDINA_SMARCA4_TARGETS
0.157604412924%	2	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_ONLY_DN
0.157604412924%	2	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZUCCHI_METASTASIS_UP
0.157604412924%	2	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ULE_SPLICING_VIA_NOVA2
0.157604412924%	2	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1
0.157604412924%	2	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PLC_BETA_MEDIATED_EVENTS
0.157604412924%	2	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_IL_3_5_AND_GM_CSF_SIGNALING
0.157604412924%	2	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	POTTI_5FU_SENSITIVITY
0.157604412924%	2	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
0.157604412924%	2	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_24HR_DN
0.157604412924%	2	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	COWLING_MYCN_TARGETS
0.157604412924%	2	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CHREBP2_PATHWAY
0.157604412924%	2	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING
0.157604412924%	2	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_ER_NONGENOMIC_PATHWAY
0.157604412924%	2	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MALONEY_RESPONSE_TO_17AAG_UP
0.157604412924%	2	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS
0.157604412924%	2	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KAMMINGA_EZH2_TARGETS
0.157604412924%	2	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
0.157604412924%	2	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	EHLERS_ANEUPLOIDY_UP
0.157604412924%	2	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DELPUECH_FOXO3_TARGETS_DN
0.157604412924%	2	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
0.157604412924%	2	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VARELA_ZMPSTE24_TARGETS_UP
0.157604412924%	2	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_B_CELL_ANTIGEN_RECEPTOR
0.157604412924%	2	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
0.157604412924%	2	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JIANG_AGING_HYPOTHALAMUS_DN
0.157604412924%	2	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D8
0.157604412924%	2	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ELLWOOD_MYC_TARGETS_DN
0.157604412924%	2	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_48HR_DN
0.157604412924%	2	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHESLER_BRAIN_HIGHEST_EXPRESSION
0.157604412924%	2	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_PEAK_AT_16HR
0.157604412924%	2	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
0.157604412924%	2	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.157604412924%	2	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_P38MAPK_PATHWAY
0.157604412924%	2	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BERNARD_PPAPDC1B_TARGETS_UP
0.157604412924%	2	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BENPORATH_ES_2
0.157604412924%	2	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	POTTI_PACLITAXEL_SENSITIVITY
0.157604412924%	2	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_ATR_PATHWAY
0.157604412924%	2	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
0.157604412924%	2	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MATZUK_MEIOTIC_AND_DNA_REPAIR
0.157604412924%	2	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KORKOLA_TERATOMA
0.157604412924%	2	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
0.157604412924%	2	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_32HR_DN
0.157604412924%	2	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_PEAK_AT_8HR
0.157604412924%	2	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_FMLP_PATHWAY
0.157604412924%	2	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BILANGES_SERUM_SENSITIVE_VIA_TSC2
0.157604412924%	2	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TERAO_AOX4_TARGETS_SKIN_UP
0.157604412924%	2	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER
0.157604412924%	2	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_RAC1_REG_PATHWAY
0.157604412924%	2	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PENG_GLUTAMINE_DEPRIVATION_UP
0.157604412924%	2	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIU_LIVER_CANCER
0.157604412924%	2	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT
0.157604412924%	2	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP
0.157604412924%	2	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN
0.157604412924%	2	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
0.157604412924%	2	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_INTEGRIN_PATHWAY
0.157604412924%	2	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_IL2RB_PATHWAY
0.157604412924%	2	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VALK_AML_WITH_CEBPA
0.157604412924%	2	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.157604412924%	2	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
0.157604412924%	2	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_FRA_PATHWAY
0.157604412924%	2	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_ALL_DISORDERS_CALB1_CORR_DN
0.157604412924%	2	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_MET_PATHWAY
0.157604412924%	2	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BILANGES_SERUM_RESPONSE_TRANSLATION
0.157604412924%	2	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YIH_RESPONSE_TO_ARSENITE_C3
0.157604412924%	2	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN
0.157604412924%	2	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_ADRENERGIC
0.157604412924%	2	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
0.157604412924%	2	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALLING_TO_ERKS
0.157604412924%	2	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
0.157604412924%	2	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_FRS2_MEDIATED_CASCADE
0.157604412924%	2	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARZEC_IL2_SIGNALING_DN
0.157604412924%	2	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_AT1R_PATHWAY
0.157604412924%	2	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_AGR_PATHWAY
0.157604412924%	2	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_G_ALPHA_I_PATHWAY
0.157604412924%	2	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES
0.157604412924%	2	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
0.157604412924%	2	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HU_GENOTOXIC_DAMAGE_4HR
0.157604412924%	2	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP
0.157604412924%	2	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BALDWIN_PRKCI_TARGETS_UP
0.157604412924%	2	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AIGNER_ZEB1_TARGETS
0.157604412924%	2	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YANG_BREAST_CANCER_ESR1_LASER_UP
0.157604412924%	2	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SIG_CD40PATHWAYMAP
0.157604412924%	2	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION
0.157604412924%	2	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_IL8CXCR2_PATHWAY
0.157604412924%	2	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_IL2_PI3KPATHWAY
0.157604412924%	2	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_EPHA_FWDPATHWAY
0.157604412924%	2	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_CYSTEINE_AND_METHIONINE_METABOLISM
0.157604412924%	2	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JIANG_HYPOXIA_VIA_VHL
0.157604412924%	2	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HONMA_DOCETAXEL_RESISTANCE
0.157604412924%	2	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FRIDMAN_IMMORTALIZATION_DN
0.157604412924%	2	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ABE_VEGFA_TARGETS_2HR
0.157604412924%	2	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VALK_AML_CLUSTER_6
0.157604412924%	2	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VALK_AML_CLUSTER_10
0.157604412924%	2	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PURINE_METABOLISM
0.157604412924%	2	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS
0.157604412924%	2	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_NO1_PATHWAY
0.157604412924%	2	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN
0.157604412924%	2	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_WNT_NONCANONICAL_PATHWAY
0.157604412924%	2	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_SYNDECAN_4_PATHWAY
0.157604412924%	2	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_NETRIN_PATHWAY
0.157604412924%	2	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN
0.157604412924%	2	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOOTHA_GLUCONEOGENESIS
0.157604412924%	2	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM
0.157604412924%	2	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GROSS_ELK3_TARGETS_DN
0.157604412924%	2	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN
0.157604412924%	2	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VALK_AML_CLUSTER_15
0.157604412924%	2	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	THEODOROU_MAMMARY_TUMORIGENESIS
0.157604412924%	2	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN
0.157604412924%	2	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION_HEMGN
0.157604412924%	2	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES
0.157604412924%	2	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS
0.157604412924%	2	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING
0.157604412924%	2	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
0.157604412924%	2	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX
0.157604412924%	2	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_AVB3_OPN_PATHWAY
0.157604412924%	2	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_AURORA_A_PATHWAY
0.157604412924%	2	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_AR_NONGENOMIC_PATHWAY
0.157604412924%	2	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM
0.157604412924%	2	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DANG_MYC_TARGETS_DN
0.157604412924%	2	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
0.157604412924%	2	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.157604412924%	2	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN
0.157604412924%	2	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VALK_AML_CLUSTER_12
0.157604412924%	2	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN
0.157604412924%	2	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_ROBO_RECEPTOR
0.157604412924%	2	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX
0.157604412924%	2	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CA_DEPENDENT_EVENTS
0.157604412924%	2	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_RAS_PATHWAY
0.157604412924%	2	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_IL2_STAT5PATHWAY
0.157604412924%	2	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP
0.157604412924%	2	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LI_PROSTATE_CANCER_EPIGENETIC
0.157604412924%	2	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KYNG_NORMAL_AGING_DN
0.157604412924%	2	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_10
0.157604412924%	2	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP
0.157604412924%	2	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_RESPONSE_TO_BEXAROTENE_DN
0.157604412924%	2	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN
0.157604412924%	2	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GLYCOLYSIS
0.157604412924%	2	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_REELINPATHWAY
0.157604412924%	2	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PATTERSON_DOCETAXEL_RESISTANCE
0.157604412924%	2	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KYNG_WERNER_SYNDROM_DN
0.157604412924%	2	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_THYROID_CANCER
0.157604412924%	2	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_HISTIDINE_METABOLISM
0.157604412924%	2	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_12HR_UP
0.157604412924%	2	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DALESSIO_TSA_RESPONSE
0.157604412924%	2	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_VEGF_PATHWAY
0.157604412924%	2	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_TNFR1_PATHWAY
0.157604412924%	2	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WIKMAN_ASBESTOS_LUNG_CANCER_DN
0.157604412924%	2	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TERAO_AOX4_TARGETS_HG_UP
0.157604412924%	2	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS
0.157604412924%	2	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_LIS1PATHWAY
0.157604412924%	2	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PETRETTO_HEART_MASS_QTL_CIS_UP
0.157604412924%	2	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OLSSON_E2F3_TARGETS_UP
0.157604412924%	2	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LOPES_METHYLATED_IN_COLON_CANCER_DN
0.157604412924%	2	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAIRKEE_CANCER_PRONE_RESPONSE_E2
0.157604412924%	2	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_GH_PATHWAY
0.157604412924%	2	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_G1_PATHWAY
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YE_METASTATIC_LIVER_CANCER
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YANG_BREAST_CANCER_ESR1_BULK_UP
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	XU_AKT1_TARGETS_6HR
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TERAO_AOX4_TARGETS_SKIN_DN
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_GRANULE_CELL_SURVIVAL_PATHWAY
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_PA
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_IL_RECEPTOR_SHC_SIGNALING
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_IL3_PATHWAY
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NICK_RESPONSE_TO_PROC_TREATMENT_DN
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LOPES_METHYLATED_IN_COLON_CANCER_UP
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_DOUBLE_POLAR_THYMOCYTE
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JI_METASTASIS_REPRESSED_BY_STK11
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GROSS_ELK3_TARGETS_UP
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G2
0.157604412924%	2	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CREB_PATHWAY
0.157604412924%	2	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG
0.157604412924%	2	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER
0.157604412924%	2	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_VEGFR1_PATHWAY
0.157604412924%	2	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_P38_MKK3_6PATHWAY
0.157604412924%	2	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_INSULIN_GLUCOSE_PATHWAY
0.157604412924%	2	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAZIN_EPIGENETIC_SILENCING_BY_KRAS
0.157604412924%	2	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_RACCYCD_PATHWAY
0.157604412924%	2	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_NFKB_TARGETS
0.157604412924%	2	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STEGER_ADIPOGENESIS_DN
0.157604412924%	2	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION
0.157604412924%	2	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE
0.157604412924%	2	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_MYC_PATHWAY
0.157604412924%	2	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LU_TUMOR_ANGIOGENESIS_UP
0.157604412924%	2	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JACKSON_DNMT1_TARGETS_DN
0.157604412924%	2	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GENTILE_UV_HIGH_DOSE_UP
0.157604412924%	2	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP
0.157604412924%	2	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS
0.157604412924%	2	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SULFUR_AMINO_ACID_METABOLISM
0.157604412924%	2	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION
0.157604412924%	2	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MATZUK_SPERMATOGONIA
0.157604412924%	2	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN
0.157604412924%	2	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY
0.157604412924%	2	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_TPO_PATHWAY
0.157604412924%	2	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CXCR4_PATHWAY
0.157604412924%	2	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WU_HBX_TARGETS_2_UP
0.157604412924%	2	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WU_HBX_TARGETS_1_DN
0.157604412924%	2	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B
0.157604412924%	2	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A
0.157604412924%	2	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER
0.157604412924%	2	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS
0.157604412924%	2	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_NITROGEN_METABOLISM
0.157604412924%	2	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN
0.157604412924%	2	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_RAS_PATHWAY
0.157604412924%	2	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_IGF1R_PATHWAY
0.157604412924%	2	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_GLEEVEC_PATHWAY
0.157604412924%	2	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CELLCYCLE_PATHWAY
0.157604412924%	2	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YUAN_ZNF143_PARTNERS
0.157604412924%	2	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SPIRA_SMOKERS_LUNG_CANCER_DN
0.157604412924%	2	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROY_WOUND_BLOOD_VESSEL_DN
0.157604412924%	2	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION
0.157604412924%	2	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
0.157604412924%	2	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NUMATA_CSF3_SIGNALING_VIA_STAT3
0.157604412924%	2	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HANSON_HRAS_SIGNALING_VIA_NFKB
0.157604412924%	2	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN
0.157604412924%	2	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_SPPA_PATHWAY
0.157604412924%	2	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_INSULIN_PATHWAY
0.157604412924%	2	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_IL6_PATHWAY
0.157604412924%	2	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_IL2_PATHWAY
0.157604412924%	2	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CERAMIDE_PATHWAY
0.157604412924%	2	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WOTTON_RUNX_TARGETS_UP
0.157604412924%	2	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP
0.157604412924%	2	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VERRECCHIA_RESPONSE_TO_TGFB1_C5
0.157604412924%	2	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHURINGA_STAT5A_TARGETS_UP
0.157604412924%	2	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN
0.157604412924%	2	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION
0.157604412924%	2	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING
0.157604412924%	2	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_S1P_S1P1_PATHWAY
0.157604412924%	2	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OUYANG_PROSTATE_CANCER_PROGRESSION_DN
0.157604412924%	2	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOOTHA_GLYCOLYSIS
0.157604412924%	2	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOOTHA_GLYCOGEN_METABOLISM
0.157604412924%	2	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MACLACHLAN_BRCA1_TARGETS_UP
0.157604412924%	2	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN
0.157604412924%	2	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP
0.157604412924%	2	1269	206	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RAMALHO_STEMNESS_UP
0.157604412924%	2	1269	205	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHEPARD_BMYB_MORPHOLINO_UP
0.157604412924%	2	1269	203	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_INFLUENZA_LIFE_CYCLE
0.157604412924%	2	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WENG_POR_TARGETS_GLOBAL_UP
0.157604412924%	2	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_THOC1_TARGETS_DN
0.157604412924%	2	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SU_THYMUS
0.157604412924%	2	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_WNT_CA2_CYCLIC_GMP_PATHWAY
0.157604412924%	2	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PHESSE_TARGETS_OF_APC_AND_MBD2_UP
0.157604412924%	2	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NIELSEN_LEIOMYOSARCOMA_CNN1_DN
0.157604412924%	2	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MURAKAMI_UV_RESPONSE_24HR
0.157604412924%	2	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MANN_RESPONSE_TO_AMIFOSTINE_UP
0.157604412924%	2	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MAHADEVAN_RESPONSE_TO_MP470_UP
0.157604412924%	2	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN
0.157604412924%	2	1269	191	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.157604412924%	2	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VERNOCHET_ADIPOGENESIS
0.157604412924%	2	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RUAN_RESPONSE_TO_TROGLITAZONE_DN
0.157604412924%	2	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1
0.157604412924%	2	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS
0.157604412924%	2	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_BASE_EXCISION_REPAIR
0.157604412924%	2	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NELSON_RESPONSE_TO_ANDROGEN_DN
0.157604412924%	2	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIZUSHIMA_AUTOPHAGOSOME_FORMATION
0.157604412924%	2	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP
0.157604412924%	2	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JEON_SMAD6_TARGETS_DN
0.157604412924%	2	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN
0.157604412924%	2	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN
0.157604412924%	2	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN
0.157604412924%	2	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_STATHMIN_PATHWAY
0.157604412924%	2	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_EPO_PATHWAY
0.157604412924%	2	1269	182	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_G2
0.157604412924%	2	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TOMIDA_METASTASIS_DN
0.157604412924%	2	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHURINGA_STAT5A_TARGETS_DN
0.157604412924%	2	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB
0.157604412924%	2	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN
0.157604412924%	2	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_TNFR2_PATHWAY
0.157604412924%	2	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_NGF_PATHWAY
0.157604412924%	2	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CARDIACEGF_PATHWAY
0.157604412924%	2	1269	179	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BENPORATH_NOS_TARGETS
0.157604412924%	2	1269	178	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
0.157604412924%	2	1269	177	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP
0.157604412924%	2	1269	176	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP
0.157604412924%	2	1269	176	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION
0.157604412924%	2	1269	171	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ELVIDGE_HYPOXIA_UP
0.157604412924%	2	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN
0.157604412924%	2	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY
0.157604412924%	2	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MEISSNER_BRAIN_HCP_WITH_H3K4ME2
0.157604412924%	2	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LOPEZ_EPITHELIOID_MESOTHELIOMA
0.157604412924%	2	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.157604412924%	2	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.157604412924%	2	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_ARF_PATHWAY
0.157604412924%	2	1269	169	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION
0.157604412924%	2	1269	165	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWN_MYELOID_CELL_DEVELOPMENT_UP
0.157604412924%	2	1269	163	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SERVITJA_ISLET_HNF1A_TARGETS_UP
0.157604412924%	2	1269	162	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DARWICHE_PAPILLOMA_RISK_LOW_UP
0.157604412924%	2	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WU_HBX_TARGETS_2_DN
0.157604412924%	2	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WU_HBX_TARGETS_1_UP
0.157604412924%	2	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS
0.157604412924%	2	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN
0.157604412924%	2	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_CIRCADIANPATHWAY
0.157604412924%	2	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LUI_THYROID_CANCER_CLUSTER_4
0.157604412924%	2	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IGLESIAS_E2F_TARGETS_DN
0.157604412924%	2	1269	153	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PEPTIDE_CHAIN_ELONGATION
0.157604412924%	2	1269	150	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LANDIS_ERBB2_BREAST_TUMORS_324_UP
0.157604412924%	2	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN
0.157604412924%	2	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN
0.157604412924%	2	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SU_KIDNEY
0.157604412924%	2	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STEINER_ERYTHROCYTE_MEMBRANE_GENES
0.157604412924%	2	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION
0.157604412924%	2	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE
0.157604412924%	2	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIU_IL13_PRIMING_MODEL
0.157604412924%	2	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G3
0.157604412924%	2	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN
0.157604412924%	2	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_IL3_PATHWAY
0.157604412924%	2	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_ERYTH_PATHWAY
0.157604412924%	2	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CD40_PATHWAY
0.157604412924%	2	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_AKAPCENTROSOME_PATHWAY
0.157604412924%	2	1269	149	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LANDIS_ERBB2_BREAST_TUMORS_324_DN
0.157604412924%	2	1269	147	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMID_BREAST_CANCER_ERBB2_UP
0.157604412924%	2	1269	147	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BENPORATH_PROLIFERATION
0.157604412924%	2	1269	142	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DARWICHE_SKIN_TUMOR_PROMOTER_UP
0.157604412924%	2	1269	140	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
0.157604412924%	2	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR
0.157604412924%	2	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHANG_ADIPOGENESIS_BY_BMP7
0.157604412924%	2	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WEBER_METHYLATED_ICP_IN_SPERM_DN
0.157604412924%	2	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER
0.157604412924%	2	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_TCRJNKPATHWAY
0.157604412924%	2	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_S1P_S1P4_PATHWAY
0.157604412924%	2	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_IL5_PATHWAY
0.157604412924%	2	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIM_MAMMARY_LUMINAL_PROGENITOR_DN
0.157604412924%	2	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_NON_HOMOLOGOUS_END_JOINING
0.157604412924%	2	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION
0.157604412924%	2	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS
0.157604412924%	2	1269	138	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
0.157604412924%	2	1269	135	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	UDAYAKUMAR_MED1_TARGETS_UP
0.157604412924%	2	1269	135	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TSENG_IRS1_TARGETS_DN
0.157604412924%	2	1269	130	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ELVIDGE_HYPOXIA_BY_DMOG_UP
0.157604412924%	2	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_POL_SWITCHING
0.157604412924%	2	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN
0.157604412924%	2	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS
0.157604412924%	2	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GERHOLD_RESPONSE_TO_TZD_DN
0.157604412924%	2	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CROONQUIST_STROMAL_STIMULATION_DN
0.157604412924%	2	1269	129	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_MEMBRANE_TRAFFICKING
0.157604412924%	2	1269	126	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR
0.157604412924%	2	1269	125	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_1_UP
0.157604412924%	2	1269	124	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CELL_CYCLE_CHECKPOINTS
0.157604412924%	2	1269	123	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.157604412924%	2	1269	123	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAZARD_RESPONSE_TO_UV_SCC_UP
0.157604412924%	2	1269	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
0.157604412924%	2	1269	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
0.157604412924%	2	1269	120	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CELL_CELL_COMMUNICATION
0.157604412924%	2	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_P2Y_RECEPTORS
0.157604412924%	2	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM
0.157604412924%	2	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LOPEZ_MESOTHELIOMA_SURVIVAL_DN
0.157604412924%	2	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP
0.157604412924%	2	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOLLEMAN_DAUNORUBICIN_B_ALL_DN
0.157604412924%	2	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.157604412924%	2	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_AKAP13_PATHWAY
0.157604412924%	2	1269	119	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
0.157604412924%	2	1269	117	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.157604412924%	2	1269	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.157604412924%	2	1269	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
0.157604412924%	2	1269	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MATTIOLI_MGUS_VS_PCL
0.157604412924%	2	1269	114	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SENESE_HDAC2_TARGETS_UP
0.157604412924%	2	1269	114	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN
0.157604412924%	2	1269	113	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP
0.157604412924%	2	1269	112	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.157604412924%	2	1269	112	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DOANE_BREAST_CANCER_ESR1_UP
0.157604412924%	2	1269	111	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_MRNA_SPLICING
0.157604412924%	2	1269	110	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.157604412924%	2	1269	110	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
0.157604412924%	2	1269	110	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_HIF1A_DN
0.157604412924%	2	1269	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WESTON_VEGFA_TARGETS
0.157604412924%	2	1269	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LE_EGR2_TARGETS_UP
0.157604412924%	2	1269	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LABBE_TGFB1_TARGETS_DN
0.157604412924%	2	1269	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP
0.157604412924%	2	1269	105	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_ERBB1_DOWNSTREAM_PATHWAY
0.157604412924%	2	1269	105	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HELLER_SILENCED_BY_METHYLATION_DN
0.157604412924%	2	1269	104	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION
0.157604412924%	2	1269	104	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.157604412924%	2	1269	103	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN
0.157604412924%	2	1269	103	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_MYCN_AMPLIFICATION_TARGETS_DN
0.157604412924%	2	1269	103	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
0.157604412924%	2	1269	102	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_IPS_WITH_HCP_H3K27ME3
0.157604412924%	2	1269	102	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KANG_IMMORTALIZED_BY_TERT_DN
0.157604412924%	2	1269	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_12HR_DN
0.157604412924%	2	1269	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WINZEN_DEGRADED_VIA_KHSRP
0.157604412924%	2	1269	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RICKMAN_HEAD_AND_NECK_CANCER_A
0.157604412924%	2	1269	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HUMMERICH_SKIN_CANCER_PROGRESSION_DN
0.157604412924%	2	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WORSCHECH_TUMOR_REJECTION_DN
0.157604412924%	2	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VISALA_AGING_LYMPHOCYTE_UP
0.157604412924%	2	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND
0.157604412924%	2	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OHASHI_AURKB_TARGETS
0.157604412924%	2	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP
0.157604412924%	2	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP
0.157604412924%	2	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP
0.157604412924%	2	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BRUNEAU_SEPTATION_VENTRICULAR
0.157604412924%	2	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN
0.153491941673%	2	1303	97	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
0.153491941673%	2	1303	94	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.153491941673%	2	1303	94	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LU_IL4_SIGNALING
0.153491941673%	2	1303	93	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ACTIVATED_TLR4_SIGNALLING
0.153491941673%	2	1303	92	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HILLION_HMGA1B_TARGETS
0.153491941673%	2	1303	91	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.153491941673%	2	1303	91	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SASSON_RESPONSE_TO_GONADOTROPHINS_UP
0.153491941673%	2	1303	91	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION
0.153491941673%	2	1303	91	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_P6
0.153491941673%	2	1303	90	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SASSON_RESPONSE_TO_FORSKOLIN_UP
0.153491941673%	2	1303	90	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_ERBB4
0.153491941673%	2	1303	90	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_GAP_JUNCTION
0.153491941673%	2	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHU_SKIL_TARGETS_DN
0.153491941673%	2	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY
0.153491941673%	2	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_FEEDER_PATHWAY
0.153491941673%	2	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP
0.153491941673%	2	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RNA_POL_I_TRANSCRIPTION
0.153491941673%	2	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEIN_PONS_MARKERS
0.153491941673%	2	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_AGING_NEOCORTEX_UP
0.153491941673%	2	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SEIDEN_ONCOGENESIS_BY_MET
0.153491941673%	2	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS
0.153491941673%	2	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
0.153491941673%	2	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_APOPTOSIS
0.153491941673%	2	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HUMMERICH_SKIN_CANCER_PROGRESSION_UP
0.153491941673%	2	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ALCALA_APOPTOSIS
0.153491941673%	2	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
0.153491941673%	2	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
0.153491941673%	2	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOOTHA_VOXPHOS
0.153491941673%	2	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_ERBB_SIGNALING_PATHWAY
0.153491941673%	2	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.153491941673%	2	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN
0.153491941673%	2	1303	86	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MEIOTIC_RECOMBINATION
0.153491941673%	2	1303	86	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NGUYEN_NOTCH1_TARGETS_DN
0.153491941673%	2	1303	85	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
0.153491941673%	2	1303	84	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN
0.153491941673%	2	1303	84	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHANG_IMMORTALIZED_BY_HPV31_UP
0.153491941673%	2	1303	83	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SANA_TNF_SIGNALING_UP
0.153491941673%	2	1303	83	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
0.153491941673%	2	1303	83	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.153491941673%	2	1303	83	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP
0.153491941673%	2	1303	82	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
0.153491941673%	2	1303	82	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS
0.153491941673%	2	1303	82	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KUNINGER_IGF1_VS_PDGFB_TARGETS_UP
0.153491941673%	2	1303	82	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BHAT_ESR1_TARGETS_VIA_AKT1_DN
0.153491941673%	2	1303	81	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.153491941673%	2	1303	81	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MITOTIC_G2_G2_M_PHASES
0.153491941673%	2	1303	81	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MAHAJAN_RESPONSE_TO_IL1A_UP
0.153491941673%	2	1303	81	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION
0.153491941673%	2	1303	81	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP
0.153491941673%	2	1303	81	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HARRIS_HYPOXIA
0.153491941673%	2	1303	81	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CROMER_METASTASIS_DN
0.153491941673%	2	1303	80	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WOO_LIVER_CANCER_RECURRENCE_DN
0.153491941673%	2	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN
0.153491941673%	2	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OHM_EMBRYONIC_CARCINOMA_DN
0.153491941673%	2	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18
0.153491941673%	2	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DER_IFN_BETA_RESPONSE_DN
0.153491941673%	2	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS
0.153491941673%	2	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16
0.153491941673%	2	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_P73PATHWAY
0.153491941673%	2	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MALONEY_RESPONSE_TO_17AAG_DN
0.153491941673%	2	1303	78	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROSS_LEUKEMIA_WITH_MLL_FUSIONS
0.153491941673%	2	1303	78	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PLATELET_HOMEOSTASIS
0.153491941673%	2	1303	78	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RADMACHER_AML_PROGNOSIS
0.153491941673%	2	1303	78	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP
0.153491941673%	2	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA
0.153491941673%	2	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHEBOTAEV_GR_TARGETS_UP
0.153491941673%	2	1303	76	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
0.153491941673%	2	1303	76	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
0.153491941673%	2	1303	76	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROSS_AML_WITH_AML1_ETO_FUSION
0.153491941673%	2	1303	76	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
0.153491941673%	2	1303	75	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_AVB3_INTEGRIN_PATHWAY
0.153491941673%	2	1303	75	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCCLUNG_COCAIN_REWARD_4WK
0.153491941673%	2	1303	75	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.153491941673%	2	1303	75	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JAIN_NFKB_SIGNALING
0.153491941673%	2	1303	75	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
0.153491941673%	2	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VANASSE_BCL2_TARGETS_DN
0.153491941673%	2	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.153491941673%	2	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS
0.153491941673%	2	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX
0.153491941673%	2	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RAMALHO_STEMNESS_DN
0.153491941673%	2	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAMPS_COLON_CANCER_COPY_NUMBER_DN
0.153491941673%	2	1303	73	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS
0.153491941673%	2	1303	73	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAURNIER_PSMD4_TARGETS
0.153491941673%	2	1303	72	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HUANG_GATA2_TARGETS_DN
0.153491941673%	2	1303	72	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
0.153491941673%	2	1303	72	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DOANE_BREAST_CANCER_CLASSES_UP
0.153491941673%	2	1303	72	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DANG_REGULATED_BY_MYC_UP
0.153491941673%	2	1303	72	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CROONQUIST_NRAS_SIGNALING_DN
0.153491941673%	2	1303	71	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
0.153491941673%	2	1303	71	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KUMAR_AUTOPHAGY_NETWORK
0.153491941673%	2	1303	71	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_6HR_UP
0.153491941673%	2	1303	70	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
0.153491941673%	2	1303	70	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_AP1_PATHWAY
0.153491941673%	2	1303	70	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIU_NASOPHARYNGEAL_CARCINOMA
0.153491941673%	2	1303	70	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_RENAL_CELL_CARCINOMA
0.153491941673%	2	1303	70	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_LONG_TERM_POTENTIATION
0.153491941673%	2	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN
0.153491941673%	2	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KONDO_COLON_CANCER_HCP_WITH_H3K27ME3
0.153491941673%	2	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_RESPONSE_TO_CANTHARIDIN_DN
0.153491941673%	2	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10
0.153491941673%	2	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_P75NTRPATHWAY
0.153491941673%	2	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_MTOR_4PATHWAY
0.153491941673%	2	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.153491941673%	2	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEIN_NEURON_MARKERS
0.153491941673%	2	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES
0.153491941673%	2	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOWLIN_PUBERTAL_MAMMARY_GLAND
0.153491941673%	2	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
0.153491941673%	2	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE
0.153491941673%	2	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_120_HELA
0.153491941673%	2	1303	68	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_TELOMERASEPATHWAY
0.153491941673%	2	1303	68	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.153491941673%	2	1303	68	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_INTERFERON_RESPONSIVE_GENES
0.153491941673%	2	1303	68	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES
0.153491941673%	2	1303	68	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BASSO_CD40_SIGNALING_DN
0.153491941673%	2	1303	67	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VANHARANTA_UTERINE_FIBROID_DN
0.153491941673%	2	1303	67	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.153491941673%	2	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
0.153491941673%	2	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
0.153491941673%	2	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT
0.153491941673%	2	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RIGGINS_TAMOXIFEN_RESISTANCE_UP
0.153491941673%	2	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES
0.153491941673%	2	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_TCR_PATHWAY
0.153491941673%	2	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_INTEGRIN1_PATHWAY
0.153491941673%	2	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_HDAC_CLASSI_PATHWAY
0.153491941673%	2	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARSON_FOXP3_TARGETS_UP
0.153491941673%	2	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
0.153491941673%	2	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX
0.153491941673%	2	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_IL4_2PATHWAY
0.153491941673%	2	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_LIVER_CANCER_ACOX1_DN
0.153491941673%	2	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHANG_IMMORTALIZED_BY_HPV31_DN
0.153491941673%	2	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_GATA6_TARGETS_DN
0.153491941673%	2	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RIZKI_TUMOR_INVASIVENESS_2D_DN
0.153491941673%	2	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RHODES_CANCER_META_SIGNATURE
0.153491941673%	2	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
0.153491941673%	2	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_LIVER_CANCER_ACOX1_UP
0.153491941673%	2	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN
0.153491941673%	2	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	INGRAM_SHH_TARGETS_DN
0.153491941673%	2	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP
0.153491941673%	2	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GERHOLD_ADIPOGENESIS_DN
0.153491941673%	2	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP
0.153491941673%	2	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP
0.153491941673%	2	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BYSTROEM_CORRELATED_WITH_IL5_DN
0.153491941673%	2	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE
0.153491941673%	2	1303	63	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED
0.153491941673%	2	1303	63	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JOHNSTONE_PARVB_TARGETS_1_DN
0.153491941673%	2	1303	63	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BILBAN_B_CLL_LPL_UP
0.153491941673%	2	1303	62	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_FCER1PATHWAY
0.153491941673%	2	1303	62	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN
0.153491941673%	2	1303	62	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_BY_UV
0.153491941673%	2	1303	62	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KORKOLA_YOLK_SAC_TUMOR
0.153491941673%	2	1303	62	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.153491941673%	2	1303	62	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ISSAEVA_MLL2_TARGETS
0.153491941673%	2	1303	62	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.153491941673%	2	1303	62	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BILD_SRC_ONCOGENIC_SIGNATURE
0.153491941673%	2	1303	61	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_AR_PATHWAY
0.153491941673%	2	1303	61	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NADLER_OBESITY_UP
0.153491941673%	2	1303	61	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
0.153491941673%	2	1303	61	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BAKKER_FOXO3_TARGETS_UP
0.153491941673%	2	1303	60	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE
0.153491941673%	2	1303	60	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_LIVER_CANCER_DENA_UP
0.153491941673%	2	1303	60	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_LIVER_CANCER_CIPROFIBRATE_UP
0.153491941673%	2	1303	60	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_240_HELA
0.153491941673%	2	1303	6	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WILLIAMS_ESR1_TARGETS_DN
0.153491941673%	2	1303	59	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS
0.153491941673%	2	1303	59	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_FAK_PATHWAY
0.153491941673%	2	1303	59	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_ATF2_PATHWAY
0.153491941673%	2	1303	59	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ONDER_CDH1_TARGETS_3_DN
0.153491941673%	2	1303	59	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BARIS_THYROID_CANCER_DN
0.153491941673%	2	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHENG_GLIOBLASTOMA_PLASTICITY_DN
0.153491941673%	2	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAGASHIMA_NRG1_SIGNALING_DN
0.153491941673%	2	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAGASHIMA_EGF_SIGNALING_UP
0.153491941673%	2	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NADLER_HYPERGLYCEMIA_AT_OBESITY
0.153491941673%	2	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN
0.153491941673%	2	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KOHOUTEK_CCNT2_TARGETS
0.153491941673%	2	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KANNAN_TP53_TARGETS_UP
0.153491941673%	2	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
0.153491941673%	2	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_HIVNEF_PATHWAY
0.153491941673%	2	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TANG_SENESCENCE_TP53_TARGETS_DN
0.153491941673%	2	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE
0.153491941673%	2	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GYORFFY_MITOXANTRONE_RESISTANCE
0.153491941673%	2	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRABARCZYK_BCL11B_TARGETS_DN
0.153491941673%	2	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_11
0.153491941673%	2	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN
0.153491941673%	2	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMIT_SERUM_RESPONSE_60_MCF10A
0.153491941673%	2	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.153491941673%	2	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LY_AGING_OLD_DN
0.153491941673%	2	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_LIVER_CANCER_MYC_E2F1_UP
0.153491941673%	2	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_HEDGEHOG_SIGNALING_PATHWAY
0.153491941673%	2	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.153491941673%	2	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GALE_APL_WITH_FLT3_MUTATED_UP
0.153491941673%	2	1303	55	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53
0.153491941673%	2	1303	55	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMIRNOV_RESPONSE_TO_IR_2HR_DN
0.153491941673%	2	1303	55	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_IL2_1PATHWAY
0.153491941673%	2	1303	55	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_BASAL_CELL_CARCINOMA
0.153491941673%	2	1303	55	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR
0.153491941673%	2	1303	55	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D4
0.153491941673%	2	1303	55	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_4HR_UP
0.153491941673%	2	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHOU_TNF_SIGNALING_30MIN
0.153491941673%	2	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_RAC1_PATHWAY
0.153491941673%	2	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_NFAT_3PATHWAY
0.153491941673%	2	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_INOSITOL_PHOSPHATE_METABOLISM
0.153491941673%	2	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KANG_DOXORUBICIN_RESISTANCE_UP
0.153491941673%	2	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HUPER_BREAST_BASAL_VS_LUMINAL_UP
0.153491941673%	2	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_2_UP
0.153491941673%	2	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AUNG_GASTRIC_CANCER
0.153491941673%	2	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHU_CMV_8_HR_DN
0.153491941673%	2	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KRIEG_HYPOXIA_VIA_KDM3A
0.153491941673%	2	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_AUTOIMMUNE_THYROID_DISEASE
0.153491941673%	2	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN
0.153491941673%	2	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WINTER_HYPOXIA_DN
0.153491941673%	2	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VILIMAS_NOTCH1_TARGETS_UP
0.153491941673%	2	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROSS_AML_WITH_CBFB_MYH11_FUSION
0.153491941673%	2	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RADAEVA_RESPONSE_TO_IFNA1_UP
0.153491941673%	2	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PRAMOONJAGO_SOX4_TARGETS_UP
0.153491941673%	2	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_CASPASE_PATHWAY
0.153491941673%	2	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
0.153491941673%	2	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_STARCH_AND_SUCROSE_METABOLISM
0.153491941673%	2	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_ENDOMETRIAL_CANCER
0.153491941673%	2	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP
0.153491941673%	2	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIBA_RESPONSE_TO_TSA_UP
0.153491941673%	2	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
0.153491941673%	2	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT
0.153491941673%	2	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MORI_PLASMA_CELL_UP
0.153491941673%	2	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LUI_THYROID_CANCER_CLUSTER_1
0.153491941673%	2	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
0.153491941673%	2	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FRASOR_TAMOXIFEN_RESPONSE_UP
0.153491941673%	2	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CROMER_TUMORIGENESIS_DN
0.153491941673%	2	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.153491941673%	2	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP
0.153491941673%	2	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_PEAK_AT_2HR
0.153491941673%	2	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_7
0.153491941673%	2	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STOSSI_RESPONSE_TO_ESTRADIOL
0.153491941673%	2	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN
0.153491941673%	2	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.153491941673%	2	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_ANGIOPOIETINRECEPTOR_PATHWAY
0.153491941673%	2	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PARK_APL_PATHOGENESIS_DN
0.153491941673%	2	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
0.153491941673%	2	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_GLUTATHIONE_METABOLISM
0.153491941673%	2	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN
0.153491941673%	2	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN
0.153491941673%	2	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAUER_STAT3_TARGETS_DN
0.153491941673%	2	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BECKER_TAMOXIFEN_RESISTANCE_UP
0.153491941673%	2	1303	5	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PASTURAL_RIZ1_TARGETS_DN
0.153491941673%	2	1303	5	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JONES_TCOF1_TARGETS
0.153491941673%	2	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS
0.153491941673%	2	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_FOXOPATHWAY
0.153491941673%	2	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE
0.153491941673%	2	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_TCR_PATHWAY
0.153491941673%	2	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP
0.153491941673%	2	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	APRELIKOVA_BRCA1_TARGETS
0.153491941673%	2	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TAVOR_CEBPA_TARGETS_UP
0.153491941673%	2	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RICKMAN_HEAD_AND_NECK_CANCER_B
0.153491941673%	2	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE
0.153491941673%	2	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PI_METABOLISM
0.153491941673%	2	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PENG_GLUCOSE_DEPRIVATION_UP
0.153491941673%	2	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NADLER_OBESITY_DN
0.153491941673%	2	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_PROTEASOME
0.153491941673%	2	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GNATENKO_PLATELET_SIGNATURE
0.153491941673%	2	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHANGOLKAR_H2AFY_TARGETS_UP
0.153491941673%	2	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_HP_DN
0.153491941673%	2	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SILIGAN_BOUND_BY_EWS_FLT1_FUSION
0.153491941673%	2	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
0.153491941673%	2	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN
0.153491941673%	2	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_NFAT_TFPATHWAY
0.153491941673%	2	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEONARD_HYPOXIA
0.153491941673%	2	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JIANG_AGING_HYPOTHALAMUS_UP
0.153491941673%	2	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IRITANI_MAD1_TARGETS_DN
0.153491941673%	2	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.153491941673%	2	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD2_DN
0.153491941673%	2	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6
0.153491941673%	2	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAKAMURA_CANCER_MICROENVIRONMENT_DN
0.153491941673%	2	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_AGING_MUSCLE_DN
0.153491941673%	2	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN
0.153491941673%	2	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HEIDENBLAD_AMPLICON_8Q24_DN
0.153491941673%	2	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HALMOS_CEBPA_TARGETS_DN
0.153491941673%	2	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN
0.153491941673%	2	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN
0.153491941673%	2	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD1_UP
0.153491941673%	2	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VANHARANTA_UTERINE_FIBROID_UP
0.153491941673%	2	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TRAYNOR_RETT_SYNDROM_UP
0.153491941673%	2	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SIG_CHEMOTAXIS
0.153491941673%	2	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP
0.153491941673%	2	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_G2_M_CHECKPOINTS
0.153491941673%	2	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
0.153491941673%	2	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_INSULIN_PATHWAY
0.153491941673%	2	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HUANG_FOXA2_TARGETS_UP
0.153491941673%	2	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHANDRAN_METASTASIS_TOP50_DN
0.153491941673%	2	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_LB_DN
0.153491941673%	2	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_TARGETS_OF_MLL_CBP_FUSION_UP
0.153491941673%	2	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	THILLAINADESAN_ZNF217_TARGETS_UP
0.153491941673%	2	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS
0.153491941673%	2	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PARK_HSC_MARKERS
0.153491941673%	2	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OHGUCHI_LIVER_HNF4A_TARGETS_UP
0.153491941673%	2	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LUI_THYROID_CANCER_PAX8_PPARG_UP
0.153491941673%	2	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LANDIS_BREAST_CANCER_PROGRESSION_UP
0.153491941673%	2	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KERLEY_RESPONSE_TO_CISPLATIN_UP
0.153491941673%	2	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_TYPE_I_DIABETES_MELLITUS
0.153491941673%	2	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JAEGER_METASTASIS_UP
0.153491941673%	2	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_ONLY_DN
0.153491941673%	2	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FARMER_BREAST_CANCER_CLUSTER_1
0.153491941673%	2	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHUNG_BLISTER_CYTOTOXICITY_DN
0.153491941673%	2	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHOI_ATL_STAGE_PREDICTOR
0.153491941673%	2	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZUCCHI_METASTASIS_UP
0.153491941673%	2	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1
0.153491941673%	2	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK
0.153491941673%	2	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	POTTI_ETOPOSIDE_SENSITIVITY
0.153491941673%	2	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	POTTI_5FU_SENSITIVITY
0.153491941673%	2	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAKAYAMA_FRA2_TARGETS
0.153491941673%	2	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_24HR_DN
0.153491941673%	2	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_PEAK_AT_24HR
0.153491941673%	2	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN
0.153491941673%	2	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRNA_AMINOACYLATION
0.153491941673%	2	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_ECADHERIN_STABILIZATION_PATHWAY
0.153491941673%	2	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ONO_FOXP3_TARGETS_DN
0.153491941673%	2	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_TYROSINE_METABOLISM
0.153491941673%	2	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_GRAFT_VERSUS_HOST_DISEASE
0.153491941673%	2	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_FATTY_ACID_METABOLISM
0.153491941673%	2	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HAHTOLA_SEZARY_SYNDROM_DN
0.153491941673%	2	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN
0.153491941673%	2	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_CHREBP2_PATHWAY
0.153491941673%	2	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.153491941673%	2	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING
0.153491941673%	2	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LI_LUNG_CANCER
0.153491941673%	2	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN
0.153491941673%	2	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS
0.153491941673%	2	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KAMMINGA_SENESCENCE
0.153491941673%	2	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
0.153491941673%	2	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CROONQUIST_NRAS_SIGNALING_UP
0.153491941673%	2	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_FCER1_PATHWAY
0.153491941673%	2	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VANASSE_BCL2_TARGETS_UP
0.153491941673%	2	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_IFNGPATHWAY
0.153491941673%	2	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_FOXM1PATHWAY
0.153491941673%	2	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.153491941673%	2	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP
0.153491941673%	2	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HEIDENBLAD_AMPLICON_8Q24_UP
0.153491941673%	2	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D7
0.153491941673%	2	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_PEAK_AT_16HR
0.153491941673%	2	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_P38MAPK_PATHWAY
0.153491941673%	2	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMUNDSON_GAMMA_RADIATION_RESPONSE
0.153491941673%	2	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_LSD1_TARGETS_DN
0.153491941673%	2	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STONER_ESOPHAGEAL_CARCINOGENESIS_UP
0.153491941673%	2	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C6
0.153491941673%	2	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_ATR_PATHWAY
0.153491941673%	2	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NEWMAN_ERCC6_TARGETS_DN
0.153491941673%	2	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
0.153491941673%	2	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GU_PDEF_TARGETS_DN
0.153491941673%	2	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D5
0.153491941673%	2	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CONRAD_STEM_CELL
0.153491941673%	2	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_FMLP_PATHWAY
0.153491941673%	2	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS
0.153491941673%	2	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER
0.153491941673%	2	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS
0.153491941673%	2	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.153491941673%	2	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KRASNOSELSKAYA_ILF3_TARGETS_UP
0.153491941673%	2	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT
0.153491941673%	2	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_ALLOGRAFT_REJECTION
0.153491941673%	2	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KAAB_FAILED_HEART_ATRIUM_UP
0.153491941673%	2	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_INTEGRIN_PATHWAY
0.153491941673%	2	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_IL2RB_PATHWAY
0.153491941673%	2	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
0.153491941673%	2	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROLEF_GLIS3_TARGETS
0.153491941673%	2	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS
0.153491941673%	2	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MURAKAMI_UV_RESPONSE_6HR_UP
0.153491941673%	2	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MATZUK_SPERMATID_DIFFERENTIATION
0.153491941673%	2	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_ALL_DISORDERS_CALB1_CORR_DN
0.153491941673%	2	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HU_ANGIOGENESIS_DN
0.153491941673%	2	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D6
0.153491941673%	2	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FRASOR_RESPONSE_TO_ESTRADIOL_UP
0.153491941673%	2	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CUI_TCF21_TARGETS_UP
0.153491941673%	2	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_BCR_PATHWAY
0.153491941673%	2	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YIH_RESPONSE_TO_ARSENITE_C3
0.153491941673%	2	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SUBTIL_PROGESTIN_TARGETS
0.153491941673%	2	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
0.153491941673%	2	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
0.153491941673%	2	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
0.153491941673%	2	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_BASAL_TRANSCRIPTION_FACTORS
0.153491941673%	2	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VALK_AML_CLUSTER_9
0.153491941673%	2	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES
0.153491941673%	2	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RODRIGUES_NTN1_AND_DCC_TARGETS
0.153491941673%	2	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_PI3KCIAKTPATHWAY
0.153491941673%	2	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LOPEZ_TRANSLATION_VIA_FN1_SIGNALING
0.153491941673%	2	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_REGULATION_OF_AUTOPHAGY
0.153491941673%	2	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_PRIMARY_IMMUNODEFICIENCY
0.153491941673%	2	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HU_GENOTOXIC_DAMAGE_4HR
0.153491941673%	2	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HU_GENOTOXIC_DAMAGE_24HR
0.153491941673%	2	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.153491941673%	2	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WONG_IFNA2_RESISTANCE_DN
0.153491941673%	2	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_WNT_BETA_CATENIN_PATHWAY
0.153491941673%	2	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHOEN_NFKB_SIGNALING
0.153491941673%	2	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE
0.153491941673%	2	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX
0.153491941673%	2	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	POTTI_CYTOXAN_SENSITIVITY
0.153491941673%	2	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PLASARI_TGFB1_TARGETS_1HR_UP
0.153491941673%	2	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_IL2_PI3KPATHWAY
0.153491941673%	2	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_HDAC_CLASSII_PATHWAY
0.153491941673%	2	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_ATM_PATHWAY
0.153491941673%	2	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM
0.153491941673%	2	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DOANE_BREAST_CANCER_CLASSES_DN
0.153491941673%	2	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP
0.153491941673%	2	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ABE_VEGFA_TARGETS_2HR
0.153491941673%	2	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_LATE_DIFFERENTIATION_GENES_UP
0.153491941673%	2	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WENDT_COHESIN_TARGETS_UP
0.153491941673%	2	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VALK_AML_CLUSTER_6
0.153491941673%	2	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VALK_AML_CLUSTER_10
0.153491941673%	2	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STAEGE_EWING_FAMILY_TUMOR
0.153491941673%	2	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RNA_POL_III_TRANSCRIPTION
0.153491941673%	2	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS
0.153491941673%	2	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_SYNDECAN_2_PATHWAY
0.153491941673%	2	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_INTEGRIN_A4B1_PATHWAY
0.153491941673%	2	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MORI_PLASMA_CELL_DN
0.153491941673%	2	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GREENBAUM_E2A_TARGETS_UP
0.153491941673%	2	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FIRESTEIN_CTNNB1_PATHWAY
0.153491941673%	2	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_12HR_DN
0.153491941673%	2	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_NO1_PATHWAY
0.153491941673%	2	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_IL1R_PATHWAY
0.153491941673%	2	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_ERK1_ERK2_MAPK_PATHWAY
0.153491941673%	2	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY
0.153491941673%	2	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	POS_HISTAMINE_RESPONSE_NETWORK
0.153491941673%	2	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_WNT_NONCANONICAL_PATHWAY
0.153491941673%	2	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_CITRATE_CYCLE_TCA_CYCLE
0.153491941673%	2	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM
0.153491941673%	2	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DORSAM_HOXA9_TARGETS_DN
0.153491941673%	2	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_RHO_PATHWAY
0.153491941673%	2	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_PDGF_PATHWAY
0.153491941673%	2	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP
0.153491941673%	2	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INWARDLY_RECTIFYING_K_CHANNELS
0.153491941673%	2	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_AVB3_OPN_PATHWAY
0.153491941673%	2	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCCABE_HOXC6_TARGETS_CANCER_UP
0.153491941673%	2	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM
0.153491941673%	2	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DANG_MYC_TARGETS_DN
0.153491941673%	2	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAFFAREL_RESPONSE_TO_THC_DN
0.153491941673%	2	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_EGF_PATHWAY
0.153491941673%	2	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	URS_ADIPOCYTE_DIFFERENTIATION_DN
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MRNA_CAPPING
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_BASIGIN_INTERACTIONS
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_RAS_PATHWAY
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_IGF1_PATHWAY
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LI_PROSTATE_CANCER_EPIGENETIC
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_NORMAL_AGING_DN
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_LRRC3B_TARGETS
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DASU_IL6_SIGNALING_SCAR_UP
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_10
0.153491941673%	2	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_FAS_PATHWAY
0.153491941673%	2	1303	298	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP
0.153491941673%	2	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YU_BAP1_TARGETS
0.153491941673%	2	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR
0.153491941673%	2	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN
0.153491941673%	2	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STANELLE_E2F1_TARGETS
0.153491941673%	2	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION
0.153491941673%	2	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_INTEGRIN2_PATHWAY
0.153491941673%	2	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PATTERSON_DOCETAXEL_RESISTANCE
0.153491941673%	2	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
0.153491941673%	2	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
0.153491941673%	2	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_WERNER_SYNDROM_DN
0.153491941673%	2	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_THYROID_CANCER
0.153491941673%	2	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_VEGF_PATHWAY
0.153491941673%	2	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WILLIAMS_ESR2_TARGETS_UP
0.153491941673%	2	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WEBER_METHYLATED_HCP_IN_SPERM_DN
0.153491941673%	2	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VALK_AML_CLUSTER_7
0.153491941673%	2	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TERAO_AOX4_TARGETS_HG_UP
0.153491941673%	2	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
0.153491941673%	2	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MYOGENESIS
0.153491941673%	2	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A
0.153491941673%	2	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MATZUK_MALE_REPRODUCTION_SERTOLI
0.153491941673%	2	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LOPES_METHYLATED_IN_COLON_CANCER_DN
0.153491941673%	2	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
0.153491941673%	2	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAIRKEE_CANCER_PRONE_RESPONSE_E2
0.153491941673%	2	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP
0.153491941673%	2	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.153491941673%	2	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_G1_PATHWAY
0.153491941673%	2	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_ERK_PATHWAY
0.153491941673%	2	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
0.153491941673%	2	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
0.153491941673%	2	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
0.153491941673%	2	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_PA
0.153491941673%	2	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION
0.153491941673%	2	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN
0.153491941673%	2	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION
0.153491941673%	2	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING
0.153491941673%	2	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT
0.153491941673%	2	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS
0.153491941673%	2	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GENTILE_UV_LOW_DOSE_UP
0.153491941673%	2	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG
0.153491941673%	2	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VALK_AML_CLUSTER_8
0.153491941673%	2	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_KERATAN_SULFATE_BIOSYNTHESIS
0.153491941673%	2	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE
0.153491941673%	2	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B
0.153491941673%	2	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_RXR_VDR_PATHWAY
0.153491941673%	2	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_P38_MKK3_6PATHWAY
0.153491941673%	2	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_GALACTOSE_METABOLISM
0.153491941673%	2	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
0.153491941673%	2	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_WNT_PATHWAY
0.153491941673%	2	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_NFKB_TARGETS
0.153491941673%	2	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION
0.153491941673%	2	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_G0_AND_EARLY_G1
0.153491941673%	2	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_EGFR_DOWNREGULATION
0.153491941673%	2	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS
0.153491941673%	2	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OZEN_MIR125B1_TARGETS
0.153491941673%	2	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LU_TUMOR_ANGIOGENESIS_UP
0.153491941673%	2	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_DORSO_VENTRAL_AXIS_FORMATION
0.153491941673%	2	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	COLLER_MYC_TARGETS_UP
0.153491941673%	2	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN
0.153491941673%	2	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_LSD1_TARGETS_UP
0.153491941673%	2	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS
0.153491941673%	2	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PYRIMIDINE_METABOLISM
0.153491941673%	2	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS
0.153491941673%	2	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MURATA_VIRULENCE_OF_H_PILORI
0.153491941673%	2	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MATZUK_SPERMATOGONIA
0.153491941673%	2	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN
0.153491941673%	2	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY
0.153491941673%	2	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_ECM_PATHWAY
0.153491941673%	2	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_CXCR4_PATHWAY
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YANG_BREAST_CANCER_ESR1_BULK_DN
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WU_HBX_TARGETS_1_DN
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SAGIV_CD24_TARGETS_UP
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SABATES_COLORECTAL_ADENOMA_SIZE_UP
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PHOSPHORYLATION_OF_THE_APC_C
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MAHADEVAN_IMATINIB_RESISTANCE_UP
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FERRANDO_HOX11_NEIGHBORS
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	EGUCHI_CELL_CYCLE_RB1_TARGETS
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_RAC1_PATHWAY
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_P53HYPOXIA_PATHWAY
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_MTOR_PATHWAY
0.153491941673%	2	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_GLEEVEC_PATHWAY
0.153491941673%	2	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SPIRA_SMOKERS_LUNG_CANCER_DN
0.153491941673%	2	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROY_WOUND_BLOOD_VESSEL_DN
0.153491941673%	2	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION
0.153491941673%	2	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_METAL_ION_SLC_TRANSPORTERS
0.153491941673%	2	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE
0.153491941673%	2	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NUMATA_CSF3_SIGNALING_VIA_STAT3
0.153491941673%	2	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
0.153491941673%	2	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOOTHA_FFA_OXYDATION
0.153491941673%	2	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP
0.153491941673%	2	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION
0.153491941673%	2	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN
0.153491941673%	2	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_INSULIN_PATHWAY
0.153491941673%	2	1303	214	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER
0.153491941673%	2	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP
0.153491941673%	2	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS
0.153491941673%	2	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC
0.153491941673%	2	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RAHMAN_TP53_TARGETS_PHOSPHORYLATED
0.153491941673%	2	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOOTHA_GLYCOLYSIS
0.153491941673%	2	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HU_ANGIOGENESIS_UP
0.153491941673%	2	1303	206	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RAMALHO_STEMNESS_UP
0.153491941673%	2	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_RECURRENT_LIVER_CANCER_UP
0.153491941673%	2	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3
0.153491941673%	2	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OUYANG_PROSTATE_CANCER_PROGRESSION_UP
0.153491941673%	2	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP
0.153491941673%	2	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN
0.153491941673%	2	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MANN_RESPONSE_TO_AMIFOSTINE_UP
0.153491941673%	2	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DING_LUNG_CANCER_BY_MUTATION_RATE
0.153491941673%	2	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CROONQUIST_IL6_DEPRIVATION_UP
0.153491941673%	2	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VERRECCHIA_RESPONSE_TO_TGFB1_C1
0.153491941673%	2	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VERNOCHET_ADIPOGENESIS
0.153491941673%	2	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TERAMOTO_OPN_TARGETS_CLUSTER_7
0.153491941673%	2	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STREICHER_LSM1_TARGETS_DN
0.153491941673%	2	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_HIF1APATHWAY
0.153491941673%	2	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NELSON_RESPONSE_TO_ANDROGEN_DN
0.153491941673%	2	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIZUSHIMA_AUTOPHAGOSOME_FORMATION
0.153491941673%	2	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MELLMAN_TUT1_TARGETS_UP
0.153491941673%	2	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7
0.153491941673%	2	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JEON_SMAD6_TARGETS_DN
0.153491941673%	2	1303	186	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_CLIM2_TARGETS_DN
0.153491941673%	2	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE
0.153491941673%	2	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHURINGA_STAT5A_TARGETS_DN
0.153491941673%	2	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI
0.153491941673%	2	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN
0.153491941673%	2	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOREIRA_RESPONSE_TO_TSA_DN
0.153491941673%	2	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
0.153491941673%	2	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES
0.153491941673%	2	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_SPRY_PATHWAY
0.153491941673%	2	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMIT_DELAYED_EARLY_GENES
0.153491941673%	2	1303	175	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.153491941673%	2	1303	171	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
0.153491941673%	2	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WIKMAN_ASBESTOS_LUNG_CANCER_UP
0.153491941673%	2	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE
0.153491941673%	2	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RAP1_SIGNALLING
0.153491941673%	2	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS
0.153491941673%	2	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_SYNDECAN_3_PATHWAY
0.153491941673%	2	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED
0.153491941673%	2	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES
0.153491941673%	2	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	INGA_TP53_TARGETS
0.153491941673%	2	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_LATE_DIFFERENTIATION_GENES_DN
0.153491941673%	2	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN
0.153491941673%	2	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WU_HBX_TARGETS_2_DN
0.153491941673%	2	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_G_ALPHA_S_PATHWAY
0.153491941673%	2	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.153491941673%	2	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS
0.153491941673%	2	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOOTHA_TCA
0.153491941673%	2	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA
0.153491941673%	2	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIU_TOPBP1_TARGETS
0.153491941673%	2	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FUKUSHIMA_TNFSF11_TARGETS
0.153491941673%	2	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_EIF_PATHWAY
0.153491941673%	2	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_CACAM_PATHWAY
0.153491941673%	2	1303	157	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.153491941673%	2	1303	157	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SERVITJA_LIVER_HNF1A_TARGETS_DN
0.153491941673%	2	1303	151	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IGLESIAS_E2F_TARGETS_UP
0.153491941673%	2	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP
0.153491941673%	2	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ZINC_TRANSPORTERS
0.153491941673%	2	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND
0.153491941673%	2	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAGY_STAGA_COMPONENTS_HUMAN
0.153491941673%	2	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LI_CYTIDINE_ANALOGS_CYCTOTOXICITY
0.153491941673%	2	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIU_IL13_PRIMING_MODEL
0.153491941673%	2	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN
0.153491941673%	2	1303	148	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_24HR_DN
0.153491941673%	2	1303	145	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMITH_TERT_TARGETS_UP
0.153491941673%	2	1303	143	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.153491941673%	2	1303	141	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP
0.153491941673%	2	1303	140	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
0.153491941673%	2	1303	140	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
0.153491941673%	2	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_ADIPOGENESIS_BY_BMP7
0.153491941673%	2	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP
0.153491941673%	2	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_N_GLYCAN_ANTENNAE_ELONGATION
0.153491941673%	2	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION
0.153491941673%	2	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CRMPS_IN_SEMA3A_SIGNALING
0.153491941673%	2	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_TCRJNKPATHWAY
0.153491941673%	2	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP
0.153491941673%	2	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_SP4_THYMOCYTE
0.153491941673%	2	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_48HR_UP
0.153491941673%	2	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
0.153491941673%	2	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_PS1_PATHWAY
0.153491941673%	2	1303	138	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JIANG_VHL_TARGETS
0.153491941673%	2	1303	136	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PROVENZANI_METASTASIS_DN
0.153491941673%	2	1303	134	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHUNG_BLISTER_CYTOTOXICITY_UP
0.153491941673%	2	1303	133	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_PARKINSONS_DISEASE
0.153491941673%	2	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SA_REG_CASCADE_OF_CYCLIN_EXPR
0.153491941673%	2	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_POL_SWITCHING
0.153491941673%	2	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_MYCL1_AMPLIFICATION_TARGETS_UP
0.153491941673%	2	1303	128	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YEGNASUBRAMANIAN_PROSTATE_CANCER
0.153491941673%	2	1303	128	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION
0.153491941673%	2	1303	127	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	INGRAM_SHH_TARGETS_UP
0.153491941673%	2	1303	125	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP
0.153491941673%	2	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHENG_FOXP3_TARGETS_IN_THYMUS_DN
0.153491941673%	2	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN
0.153491941673%	2	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WAESCH_ANAPHASE_PROMOTING_COMPLEX
0.153491941673%	2	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TAGHAVI_NEOPLASTIC_TRANSFORMATION
0.153491941673%	2	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_THE_NLRP3_INFLAMMASOME
0.153491941673%	2	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS
0.153491941673%	2	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_P2Y_RECEPTORS
0.153491941673%	2	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP
0.153491941673%	2	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FUNG_IL2_SIGNALING_2
0.153491941673%	2	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_5_UP
0.153491941673%	2	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1
0.153491941673%	2	1303	118	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TOLL_RECEPTOR_CASCADES
0.153491941673%	2	1303	114	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MATZUK_SPERMATOZOA
0.153491941673%	2	1303	113	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_SURVIVAL_DN
0.153491941673%	2	1303	110	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
0.153491941673%	2	1303	110	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_HIF1A_DN
0.153491941673%	2	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHOU_PANCREATIC_BETA_CELL
0.153491941673%	2	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_32HR_UP
0.153491941673%	2	1303	108	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR
0.153491941673%	2	1303	108	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
0.153491941673%	2	1303	108	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.153491941673%	2	1303	108	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN
0.153491941673%	2	1303	107	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_ILS
0.153491941673%	2	1303	105	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_ERBB1_DOWNSTREAM_PATHWAY
0.153491941673%	2	1303	105	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMUNDSON_GENOTOXIC_SIGNATURE
0.153491941673%	2	1303	104	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP
0.153491941673%	2	1303	103	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEIN_CHOROID_PLEXUS_MARKERS
0.153491941673%	2	1303	102	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_CXCR4_PATHWAY
0.153491941673%	2	1303	101	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
0.153491941673%	2	1303	101	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KOBAYASHI_EGFR_SIGNALING_24HR_UP
0.153491941673%	2	1303	101	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.153491941673%	2	1303	100	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHICAS_RB1_TARGETS_LOW_SERUM
0.153491941673%	2	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND
0.153491941673%	2	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RADAEVA_RESPONSE_TO_IFNA1_DN
0.153491941673%	2	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OXFORD_RALA_AND_RALB_TARGETS_UP
0.153491941673%	2	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OSAWA_TNF_TARGETS
0.153491941673%	2	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN
0.151975683891%	3	1974	9	Mendelian_Nancy_Cox	SA_FAS_SIGNALING
0.151975683891%	3	1974	9	Mendelian_Nancy_Cox	RAFFEL_VEGFA_TARGETS_UP
0.151975683891%	3	1974	9	Mendelian_Nancy_Cox	NADELLA_PRKAR1A_TARGETS_UP
0.151975683891%	3	1974	9	Mendelian_Nancy_Cox	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN
0.151975683891%	3	1974	9	Mendelian_Nancy_Cox	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1
0.151975683891%	3	1974	8	Mendelian_Nancy_Cox	NADELLA_PRKAR1A_TARGETS_DN
0.151975683891%	3	1974	8	Mendelian_Nancy_Cox	MOOTHA_PYR
0.151975683891%	3	1974	8	Mendelian_Nancy_Cox	MIKKELSEN_PLURIPOTENT_STATE_DN
0.151975683891%	3	1974	8	Mendelian_Nancy_Cox	MATZUK_FERTILIZATION
0.151975683891%	3	1974	8	Mendelian_Nancy_Cox	LIU_CDX2_TARGETS_DN
0.151975683891%	3	1974	8	Mendelian_Nancy_Cox	ISHIKAWA_STING_SIGNALING
0.151975683891%	3	1974	8	Mendelian_Nancy_Cox	GALI_TP53_TARGETS_APOPTOTIC_UP
0.151975683891%	3	1974	8	Mendelian_Nancy_Cox	DER_IFN_BETA_RESPONSE_DN
0.151975683891%	3	1974	74	Mendelian_Nancy_Cox	REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX
0.151975683891%	3	1974	72	Mendelian_Nancy_Cox	KEGG_DRUG_METABOLISM_CYTOCHROME_P450
0.151975683891%	3	1974	7	Mendelian_Nancy_Cox	ZHAN_EARLY_DIFFERENTIATION_GENES_UP
0.151975683891%	3	1974	7	Mendelian_Nancy_Cox	SCHRAMM_INHBA_TARGETS_UP
0.151975683891%	3	1974	7	Mendelian_Nancy_Cox	MCBRYAN_TERMINAL_END_BUD_DN
0.151975683891%	3	1974	7	Mendelian_Nancy_Cox	LY_AGING_OLD_UP
0.151975683891%	3	1974	7	Mendelian_Nancy_Cox	LUDWICZEK_TREATING_IRON_OVERLOAD
0.151975683891%	3	1974	7	Mendelian_Nancy_Cox	INGRAM_SHH_TARGETS
0.151975683891%	3	1974	7	Mendelian_Nancy_Cox	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN
0.151975683891%	3	1974	7	Mendelian_Nancy_Cox	FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES
0.151975683891%	3	1974	7	Mendelian_Nancy_Cox	CHESLER_BRAIN_D6MIT150_QTL_CIS
0.151975683891%	3	1974	7	Mendelian_Nancy_Cox	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3
0.151975683891%	3	1974	65	Mendelian_Nancy_Cox	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP
0.151975683891%	3	1974	6	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_14
0.151975683891%	3	1974	6	Mendelian_Nancy_Cox	MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN
0.151975683891%	3	1974	6	Mendelian_Nancy_Cox	COURTOIS_SENESCENCE_TRIGGERS
0.151975683891%	3	1974	6	Mendelian_Nancy_Cox	BUSA_SAM68_TARGETS_DN
0.151975683891%	3	1974	59	Mendelian_Nancy_Cox	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS
0.151975683891%	3	1974	57	Mendelian_Nancy_Cox	TONG_INTERACT_WITH_PTTG1
0.151975683891%	3	1974	53	Mendelian_Nancy_Cox	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
0.151975683891%	3	1974	53	Mendelian_Nancy_Cox	SMIRNOV_RESPONSE_TO_IR_2HR_UP
0.151975683891%	3	1974	53	Mendelian_Nancy_Cox	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0
0.151975683891%	3	1974	53	Mendelian_Nancy_Cox	KRIEG_HYPOXIA_VIA_KDM3A
0.151975683891%	3	1974	51	Mendelian_Nancy_Cox	REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT
0.151975683891%	3	1974	51	Mendelian_Nancy_Cox	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1
0.151975683891%	3	1974	51	Mendelian_Nancy_Cox	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
0.151975683891%	3	1974	5	Mendelian_Nancy_Cox	TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP
0.151975683891%	3	1974	5	Mendelian_Nancy_Cox	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN
0.151975683891%	3	1974	5	Mendelian_Nancy_Cox	RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP
0.151975683891%	3	1974	48	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_LB_UP
0.151975683891%	3	1974	48	Mendelian_Nancy_Cox	KEGG_PROTEASOME
0.151975683891%	3	1974	48	Mendelian_Nancy_Cox	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN
0.151975683891%	3	1974	47	Mendelian_Nancy_Cox	WOOD_EBV_EBNA1_TARGETS_DN
0.151975683891%	3	1974	46	Mendelian_Nancy_Cox	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN
0.151975683891%	3	1974	45	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_CD1_DN
0.151975683891%	3	1974	44	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_LB_DN
0.151975683891%	3	1974	43	Mendelian_Nancy_Cox	LASTOWSKA_COAMPLIFIED_WITH_MYCN
0.151975683891%	3	1974	43	Mendelian_Nancy_Cox	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
0.151975683891%	3	1974	43	Mendelian_Nancy_Cox	BURTON_ADIPOGENESIS_PEAK_AT_24HR
0.151975683891%	3	1974	42	Mendelian_Nancy_Cox	YU_MYC_TARGETS_UP
0.151975683891%	3	1974	42	Mendelian_Nancy_Cox	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP
0.151975683891%	3	1974	42	Mendelian_Nancy_Cox	MODY_HIPPOCAMPUS_PRENATAL
0.151975683891%	3	1974	42	Mendelian_Nancy_Cox	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN
0.151975683891%	3	1974	42	Mendelian_Nancy_Cox	AMIT_EGF_RESPONSE_40_HELA
0.151975683891%	3	1974	41	Mendelian_Nancy_Cox	MALONEY_RESPONSE_TO_17AAG_UP
0.151975683891%	3	1974	41	Mendelian_Nancy_Cox	KAMMINGA_SENESCENCE
0.151975683891%	3	1974	41	Mendelian_Nancy_Cox	KAMMINGA_EZH2_TARGETS
0.151975683891%	3	1974	41	Mendelian_Nancy_Cox	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.151975683891%	3	1974	41	Mendelian_Nancy_Cox	CHEN_HOXA5_TARGETS_9HR_DN
0.151975683891%	3	1974	40	Mendelian_Nancy_Cox	GENTILE_UV_RESPONSE_CLUSTER_D8
0.151975683891%	3	1974	39	Mendelian_Nancy_Cox	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
0.151975683891%	3	1974	39	Mendelian_Nancy_Cox	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP
0.151975683891%	3	1974	39	Mendelian_Nancy_Cox	AIYAR_COBRA1_TARGETS_UP
0.151975683891%	3	1974	38	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_7P22_AMPLICON
0.151975683891%	3	1974	38	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON
0.151975683891%	3	1974	38	Mendelian_Nancy_Cox	KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT
0.151975683891%	3	1974	38	Mendelian_Nancy_Cox	HATADA_METHYLATED_IN_LUNG_CANCER_DN
0.151975683891%	3	1974	37	Mendelian_Nancy_Cox	HU_ANGIOGENESIS_DN
0.151975683891%	3	1974	36	Mendelian_Nancy_Cox	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP
0.151975683891%	3	1974	36	Mendelian_Nancy_Cox	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP
0.151975683891%	3	1974	35	Mendelian_Nancy_Cox	ROZANOV_MMP14_TARGETS_DN
0.151975683891%	3	1974	35	Mendelian_Nancy_Cox	KEGG_BASE_EXCISION_REPAIR
0.151975683891%	3	1974	35	Mendelian_Nancy_Cox	HU_GENOTOXIC_DAMAGE_4HR
0.151975683891%	3	1974	35	Mendelian_Nancy_Cox	HAN_JNK_SINGALING_UP
0.151975683891%	3	1974	35	Mendelian_Nancy_Cox	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.151975683891%	3	1974	34	Mendelian_Nancy_Cox	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP
0.151975683891%	3	1974	34	Mendelian_Nancy_Cox	REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX
0.151975683891%	3	1974	34	Mendelian_Nancy_Cox	PLASARI_TGFB1_TARGETS_1HR_UP
0.151975683891%	3	1974	34	Mendelian_Nancy_Cox	MEISSNER_ES_ICP_WITH_H3K4ME3
0.151975683891%	3	1974	34	Mendelian_Nancy_Cox	LUI_TARGETS_OF_PAX8_PPARG_FUSION
0.151975683891%	3	1974	33	Mendelian_Nancy_Cox	STAEGE_EWING_FAMILY_TUMOR
0.151975683891%	3	1974	33	Mendelian_Nancy_Cox	KEGG_ETHER_LIPID_METABOLISM
0.151975683891%	3	1974	33	Mendelian_Nancy_Cox	JEPSEN_SMRT_TARGETS
0.151975683891%	3	1974	33	Mendelian_Nancy_Cox	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP
0.151975683891%	3	1974	33	Mendelian_Nancy_Cox	FARMER_BREAST_CANCER_CLUSTER_2
0.151975683891%	3	1974	33	Mendelian_Nancy_Cox	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN
0.151975683891%	3	1974	32	Mendelian_Nancy_Cox	ZWANG_EGF_PERSISTENTLY_UP
0.151975683891%	3	1974	32	Mendelian_Nancy_Cox	REACTOME_DAG_AND_IP3_SIGNALING
0.151975683891%	3	1974	32	Mendelian_Nancy_Cox	POS_HISTAMINE_RESPONSE_NETWORK
0.151975683891%	3	1974	32	Mendelian_Nancy_Cox	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN
0.151975683891%	3	1974	32	Mendelian_Nancy_Cox	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
0.151975683891%	3	1974	32	Mendelian_Nancy_Cox	BIOCARTA_RHO_PATHWAY
0.151975683891%	3	1974	31	Mendelian_Nancy_Cox	REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS
0.151975683891%	3	1974	31	Mendelian_Nancy_Cox	CAFFAREL_RESPONSE_TO_THC_DN
0.151975683891%	3	1974	31	Mendelian_Nancy_Cox	BIOCARTA_MYOSIN_PATHWAY
0.151975683891%	3	1974	31	Mendelian_Nancy_Cox	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.151975683891%	3	1974	31	Mendelian_Nancy_Cox	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN
0.151975683891%	3	1974	30	Mendelian_Nancy_Cox	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION
0.151975683891%	3	1974	30	Mendelian_Nancy_Cox	REACTOME_CA_DEPENDENT_EVENTS
0.151975683891%	3	1974	30	Mendelian_Nancy_Cox	NAKAJIMA_EOSINOPHIL
0.151975683891%	3	1974	29	Mendelian_Nancy_Cox	WATANABE_COLON_CANCER_MSI_VS_MSS_UP
0.151975683891%	3	1974	29	Mendelian_Nancy_Cox	WANG_RESPONSE_TO_BEXAROTENE_DN
0.151975683891%	3	1974	29	Mendelian_Nancy_Cox	STANELLE_E2F1_TARGETS
0.151975683891%	3	1974	29	Mendelian_Nancy_Cox	REACTOME_TIGHT_JUNCTION_INTERACTIONS
0.151975683891%	3	1974	29	Mendelian_Nancy_Cox	REACTOME_PERK_REGULATED_GENE_EXPRESSION
0.151975683891%	3	1974	29	Mendelian_Nancy_Cox	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6
0.151975683891%	3	1974	29	Mendelian_Nancy_Cox	MARSON_FOXP3_TARGETS_STIMULATED_UP
0.151975683891%	3	1974	29	Mendelian_Nancy_Cox	KYNG_WERNER_SYNDROM_DN
0.151975683891%	3	1974	29	Mendelian_Nancy_Cox	KEGG_RNA_POLYMERASE
0.151975683891%	3	1974	28	Mendelian_Nancy_Cox	WILLIAMS_ESR2_TARGETS_UP
0.151975683891%	3	1974	28	Mendelian_Nancy_Cox	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS
0.151975683891%	3	1974	28	Mendelian_Nancy_Cox	REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC
0.151975683891%	3	1974	28	Mendelian_Nancy_Cox	LUI_THYROID_CANCER_CLUSTER_3
0.151975683891%	3	1974	28	Mendelian_Nancy_Cox	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS
0.151975683891%	3	1974	28	Mendelian_Nancy_Cox	KAMIKUBO_MYELOID_CEBPA_NETWORK
0.151975683891%	3	1974	28	Mendelian_Nancy_Cox	BIOCARTA_PROTEASOME_PATHWAY
0.151975683891%	3	1974	27	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_OF_PA
0.151975683891%	3	1974	27	Mendelian_Nancy_Cox	REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS
0.151975683891%	3	1974	27	Mendelian_Nancy_Cox	JI_METASTASIS_REPRESSED_BY_STK11
0.151975683891%	3	1974	27	Mendelian_Nancy_Cox	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP
0.151975683891%	3	1974	27	Mendelian_Nancy_Cox	GENTILE_UV_LOW_DOSE_UP
0.151975683891%	3	1974	27	Mendelian_Nancy_Cox	BRACHAT_RESPONSE_TO_METHOTREXATE_DN
0.151975683891%	3	1974	27	Mendelian_Nancy_Cox	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP
0.151975683891%	3	1974	26	Mendelian_Nancy_Cox	XU_CREBBP_TARGETS_UP
0.151975683891%	3	1974	26	Mendelian_Nancy_Cox	WILLIAMS_ESR1_TARGETS_UP
0.151975683891%	3	1974	26	Mendelian_Nancy_Cox	HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP
0.151975683891%	3	1974	26	Mendelian_Nancy_Cox	GAZIN_EPIGENETIC_SILENCING_BY_KRAS
0.151975683891%	3	1974	26	Mendelian_Nancy_Cox	FINAK_BREAST_CANCER_SDPP_SIGNATURE
0.151975683891%	3	1974	25	Mendelian_Nancy_Cox	WONG_ENDMETRIUM_CANCER_UP
0.151975683891%	3	1974	25	Mendelian_Nancy_Cox	STEGER_ADIPOGENESIS_DN
0.151975683891%	3	1974	25	Mendelian_Nancy_Cox	REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING
0.151975683891%	3	1974	25	Mendelian_Nancy_Cox	REACTOME_SMOOTH_MUSCLE_CONTRACTION
0.151975683891%	3	1974	25	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN
0.151975683891%	3	1974	25	Mendelian_Nancy_Cox	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
0.151975683891%	3	1974	25	Mendelian_Nancy_Cox	REACTOME_EGFR_DOWNREGULATION
0.151975683891%	3	1974	25	Mendelian_Nancy_Cox	REACTOME_DARPP_32_EVENTS
0.151975683891%	3	1974	25	Mendelian_Nancy_Cox	PID_MYC_PATHWAY
0.151975683891%	3	1974	25	Mendelian_Nancy_Cox	PID_INTEGRIN_A9B1_PATHWAY
0.151975683891%	3	1974	25	Mendelian_Nancy_Cox	OZEN_MIR125B1_TARGETS
0.151975683891%	3	1974	25	Mendelian_Nancy_Cox	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM
0.151975683891%	3	1974	25	Mendelian_Nancy_Cox	HORTON_SREBF_TARGETS
0.151975683891%	3	1974	25	Mendelian_Nancy_Cox	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN
0.151975683891%	3	1974	25	Mendelian_Nancy_Cox	GENTILE_UV_HIGH_DOSE_UP
0.151975683891%	3	1974	25	Mendelian_Nancy_Cox	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN
0.151975683891%	3	1974	25	Mendelian_Nancy_Cox	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.151975683891%	3	1974	24	Mendelian_Nancy_Cox	REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION
0.151975683891%	3	1974	24	Mendelian_Nancy_Cox	REACTOME_KINESINS
0.151975683891%	3	1974	24	Mendelian_Nancy_Cox	PETRETTO_HEART_MASS_QTL_CIS_DN
0.151975683891%	3	1974	24	Mendelian_Nancy_Cox	OXFORD_RALA_OR_RALB_TARGETS_DN
0.151975683891%	3	1974	24	Mendelian_Nancy_Cox	ODONNELL_METASTASIS_DN
0.151975683891%	3	1974	24	Mendelian_Nancy_Cox	MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED
0.151975683891%	3	1974	24	Mendelian_Nancy_Cox	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP
0.151975683891%	3	1974	24	Mendelian_Nancy_Cox	AZARE_STAT3_TARGETS
0.151975683891%	3	1974	23	Mendelian_Nancy_Cox	ZIRN_TRETINOIN_RESPONSE_WT1_UP
0.151975683891%	3	1974	23	Mendelian_Nancy_Cox	YANG_MUC2_TARGETS_DUODENUM_3MO_DN
0.151975683891%	3	1974	23	Mendelian_Nancy_Cox	WU_HBX_TARGETS_1_DN
0.151975683891%	3	1974	23	Mendelian_Nancy_Cox	SABATES_COLORECTAL_ADENOMA_SIZE_UP
0.151975683891%	3	1974	23	Mendelian_Nancy_Cox	REACTOME_INSULIN_RECEPTOR_RECYCLING
0.151975683891%	3	1974	23	Mendelian_Nancy_Cox	REACTOME_GLUTATHIONE_CONJUGATION
0.151975683891%	3	1974	23	Mendelian_Nancy_Cox	HINATA_NFKB_TARGETS_KERATINOCYTE_DN
0.151975683891%	3	1974	23	Mendelian_Nancy_Cox	HASLINGER_B_CLL_WITH_11Q23_DELETION
0.151975683891%	3	1974	23	Mendelian_Nancy_Cox	EGUCHI_CELL_CYCLE_RB1_TARGETS
0.151975683891%	3	1974	22	Mendelian_Nancy_Cox	VERNELL_RETINOBLASTOMA_PATHWAY_DN
0.151975683891%	3	1974	22	Mendelian_Nancy_Cox	VALK_AML_WITH_11Q23_REARRANGED
0.151975683891%	3	1974	22	Mendelian_Nancy_Cox	SUZUKI_RESPONSE_TO_TSA
0.151975683891%	3	1974	22	Mendelian_Nancy_Cox	SPIRA_SMOKERS_LUNG_CANCER_DN
0.151975683891%	3	1974	22	Mendelian_Nancy_Cox	REACTOME_METAL_ION_SLC_TRANSPORTERS
0.151975683891%	3	1974	22	Mendelian_Nancy_Cox	NUMATA_CSF3_SIGNALING_VIA_STAT3
0.151975683891%	3	1974	22	Mendelian_Nancy_Cox	HANSON_HRAS_SIGNALING_VIA_NFKB
0.151975683891%	3	1974	22	Mendelian_Nancy_Cox	BIOCARTA_CHEMICAL_PATHWAY
0.151975683891%	3	1974	21	Mendelian_Nancy_Cox	YANG_MUC2_TARGETS_DUODENUM_6MO_DN
0.151975683891%	3	1974	21	Mendelian_Nancy_Cox	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP
0.151975683891%	3	1974	21	Mendelian_Nancy_Cox	REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE
0.151975683891%	3	1974	21	Mendelian_Nancy_Cox	REACTOME_CTLA4_INHIBITORY_SIGNALING
0.151975683891%	3	1974	21	Mendelian_Nancy_Cox	REACTOME_ADP_SIGNALLING_THROUGH_P2RY12
0.151975683891%	3	1974	21	Mendelian_Nancy_Cox	MCCABE_HOXC6_TARGETS_DN
0.151975683891%	3	1974	21	Mendelian_Nancy_Cox	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN
0.151975683891%	3	1974	21	Mendelian_Nancy_Cox	HUI_MAPK14_TARGETS_UP
0.151975683891%	3	1974	21	Mendelian_Nancy_Cox	HASLINGER_B_CLL_WITH_17P13_DELETION
0.151975683891%	3	1974	21	Mendelian_Nancy_Cox	GREENBAUM_E2A_TARGETS_DN
0.151975683891%	3	1974	21	Mendelian_Nancy_Cox	FERRANDO_TAL1_NEIGHBORS
0.151975683891%	3	1974	21	Mendelian_Nancy_Cox	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN
0.151975683891%	3	1974	20	Mendelian_Nancy_Cox	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN
0.151975683891%	3	1974	20	Mendelian_Nancy_Cox	WENG_POR_TARGETS_GLOBAL_UP
0.151975683891%	3	1974	20	Mendelian_Nancy_Cox	WANG_RECURRENT_LIVER_CANCER_UP
0.151975683891%	3	1974	20	Mendelian_Nancy_Cox	REACTOME_NEPHRIN_INTERACTIONS
0.151975683891%	3	1974	20	Mendelian_Nancy_Cox	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3
0.151975683891%	3	1974	20	Mendelian_Nancy_Cox	NIELSEN_SYNOVIAL_SARCOMA_DN
0.151975683891%	3	1974	20	Mendelian_Nancy_Cox	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN
0.151975683891%	3	1974	20	Mendelian_Nancy_Cox	MCCABE_HOXC6_TARGETS_CANCER_DN
0.151975683891%	3	1974	20	Mendelian_Nancy_Cox	MAHADEVAN_IMATINIB_RESISTANCE_DN
0.151975683891%	3	1974	20	Mendelian_Nancy_Cox	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN
0.151975683891%	3	1974	20	Mendelian_Nancy_Cox	HEDENFALK_BREAST_CANCER_BRACX_DN
0.151975683891%	3	1974	20	Mendelian_Nancy_Cox	HASLINGER_B_CLL_WITH_6Q21_DELETION
0.151975683891%	3	1974	20	Mendelian_Nancy_Cox	DING_LUNG_CANCER_BY_MUTATION_RATE
0.151975683891%	3	1974	20	Mendelian_Nancy_Cox	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN
0.151975683891%	3	1974	20	Mendelian_Nancy_Cox	BIOCARTA_NKCELLS_PATHWAY
0.151975683891%	3	1974	20	Mendelian_Nancy_Cox	AMIT_EGF_RESPONSE_240_MCF10A
0.151975683891%	3	1974	19	Mendelian_Nancy_Cox	TERAMOTO_OPN_TARGETS_CLUSTER_7
0.151975683891%	3	1974	19	Mendelian_Nancy_Cox	SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP
0.151975683891%	3	1974	19	Mendelian_Nancy_Cox	STREICHER_LSM1_TARGETS_DN
0.151975683891%	3	1974	19	Mendelian_Nancy_Cox	RUAN_RESPONSE_TO_TROGLITAZONE_DN
0.151975683891%	3	1974	19	Mendelian_Nancy_Cox	REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION
0.151975683891%	3	1974	19	Mendelian_Nancy_Cox	PID_EPHA2_FWDPATHWAY
0.151975683891%	3	1974	19	Mendelian_Nancy_Cox	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP
0.151975683891%	3	1974	19	Mendelian_Nancy_Cox	NIELSEN_LEIOMYOSARCOMA_CNN1_UP
0.151975683891%	3	1974	19	Mendelian_Nancy_Cox	MAHADEVAN_RESPONSE_TO_MP470_DN
0.151975683891%	3	1974	19	Mendelian_Nancy_Cox	HAHTOLA_MYCOSIS_FUNGOIDES_UP
0.151975683891%	3	1974	19	Mendelian_Nancy_Cox	GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP
0.151975683891%	3	1974	19	Mendelian_Nancy_Cox	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN
0.151975683891%	3	1974	19	Mendelian_Nancy_Cox	AMIT_EGF_RESPONSE_40_MCF10A
0.151975683891%	3	1974	18	Mendelian_Nancy_Cox	ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE
0.151975683891%	3	1974	18	Mendelian_Nancy_Cox	ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE
0.151975683891%	3	1974	18	Mendelian_Nancy_Cox	YIH_RESPONSE_TO_ARSENITE_C4
0.151975683891%	3	1974	18	Mendelian_Nancy_Cox	YIH_RESPONSE_TO_ARSENITE_C2
0.151975683891%	3	1974	18	Mendelian_Nancy_Cox	TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP
0.151975683891%	3	1974	18	Mendelian_Nancy_Cox	REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK
0.151975683891%	3	1974	18	Mendelian_Nancy_Cox	NIELSEN_LEIOMYOSARCOMA_DN
0.151975683891%	3	1974	18	Mendelian_Nancy_Cox	BIOCARTA_UCALPAIN_PATHWAY
0.151975683891%	3	1974	179	Mendelian_Nancy_Cox	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	SIMBULAN_PARP1_TARGETS_DN
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	REACTOME_RNA_POL_III_CHAIN_ELONGATION
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	PID_SYNDECAN_3_PATHWAY
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	PID_ANTHRAXPATHWAY
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	LE_SKI_TARGETS_UP
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	LEI_HOXC8_TARGETS_DN
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	GRATIAS_RETINOBLASTOMA_16Q24
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	DORMOY_ELAVL1_TARGETS
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	BIOCARTA_CK1_PATHWAY
0.151975683891%	3	1974	17	Mendelian_Nancy_Cox	BIOCARTA_41BB_PATHWAY
0.151975683891%	3	1974	169	Mendelian_Nancy_Cox	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION
0.151975683891%	3	1974	16	Mendelian_Nancy_Cox	WONG_IFNA2_RESISTANCE_UP
0.151975683891%	3	1974	16	Mendelian_Nancy_Cox	WANG_RECURRENT_LIVER_CANCER_DN
0.151975683891%	3	1974	16	Mendelian_Nancy_Cox	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP
0.151975683891%	3	1974	16	Mendelian_Nancy_Cox	SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.151975683891%	3	1974	16	Mendelian_Nancy_Cox	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION
0.151975683891%	3	1974	16	Mendelian_Nancy_Cox	REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1
0.151975683891%	3	1974	16	Mendelian_Nancy_Cox	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN
0.151975683891%	3	1974	16	Mendelian_Nancy_Cox	LEE_LIVER_CANCER_HEPATOBLAST
0.151975683891%	3	1974	16	Mendelian_Nancy_Cox	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL
0.151975683891%	3	1974	16	Mendelian_Nancy_Cox	BIOCARTA_GATA3_PATHWAY
0.151975683891%	3	1974	16	Mendelian_Nancy_Cox	BIOCARTA_BCELLSURVIVAL_PATHWAY
0.151975683891%	3	1974	153	Mendelian_Nancy_Cox	REACTOME_PEPTIDE_CHAIN_ELONGATION
0.151975683891%	3	1974	15	Mendelian_Nancy_Cox	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4
0.151975683891%	3	1974	15	Mendelian_Nancy_Cox	WANG_METASTASIS_OF_BREAST_CANCER
0.151975683891%	3	1974	15	Mendelian_Nancy_Cox	TSUNODA_CISPLATIN_RESISTANCE_UP
0.151975683891%	3	1974	15	Mendelian_Nancy_Cox	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP
0.151975683891%	3	1974	15	Mendelian_Nancy_Cox	SA_MMP_CYTOKINE_CONNECTION
0.151975683891%	3	1974	15	Mendelian_Nancy_Cox	REACTOME_METABOLISM_OF_POLYAMINES
0.151975683891%	3	1974	15	Mendelian_Nancy_Cox	REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE
0.151975683891%	3	1974	15	Mendelian_Nancy_Cox	PID_ERBB_NETWORK_PATHWAY
0.151975683891%	3	1974	15	Mendelian_Nancy_Cox	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE
0.151975683891%	3	1974	15	Mendelian_Nancy_Cox	HUMMEL_BURKITTS_LYMPHOMA_DN
0.151975683891%	3	1974	15	Mendelian_Nancy_Cox	DAZARD_UV_RESPONSE_CLUSTER_G3
0.151975683891%	3	1974	15	Mendelian_Nancy_Cox	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN
0.151975683891%	3	1974	15	Mendelian_Nancy_Cox	BIOCARTA_TALL1_PATHWAY
0.151975683891%	3	1974	15	Mendelian_Nancy_Cox	BIOCARTA_RARRXR_PATHWAY
0.151975683891%	3	1974	15	Mendelian_Nancy_Cox	BIOCARTA_HIF_PATHWAY
0.151975683891%	3	1974	14	Mendelian_Nancy_Cox	ZHANG_ADIPOGENESIS_BY_BMP7
0.151975683891%	3	1974	14	Mendelian_Nancy_Cox	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN
0.151975683891%	3	1974	14	Mendelian_Nancy_Cox	SABATES_COLORECTAL_ADENOMA_SIZE_DN
0.151975683891%	3	1974	14	Mendelian_Nancy_Cox	REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY
0.151975683891%	3	1974	14	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP
0.151975683891%	3	1974	14	Mendelian_Nancy_Cox	REACTOME_SIGNAL_ATTENUATION
0.151975683891%	3	1974	14	Mendelian_Nancy_Cox	REACTOME_P75NTR_SIGNALS_VIA_NFKB
0.151975683891%	3	1974	14	Mendelian_Nancy_Cox	PIEPOLI_LGI1_TARGETS_DN
0.151975683891%	3	1974	14	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16
0.151975683891%	3	1974	14	Mendelian_Nancy_Cox	MATZUK_POST-IMPLANTATION_AND_POST-PARTUM
0.151975683891%	3	1974	14	Mendelian_Nancy_Cox	LY_AGING_MIDDLE_UP
0.151975683891%	3	1974	14	Mendelian_Nancy_Cox	CASTELLANO_NRAS_TARGETS_DN
0.151975683891%	3	1974	14	Mendelian_Nancy_Cox	BIOCARTA_GRANULOCYTES_PATHWAY
0.151975683891%	3	1974	14	Mendelian_Nancy_Cox	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP
0.151975683891%	3	1974	14	Mendelian_Nancy_Cox	ABBUD_LIF_SIGNALING_2_UP
0.151975683891%	3	1974	13	Mendelian_Nancy_Cox	TERAMOTO_OPN_TARGETS_CLUSTER_4
0.151975683891%	3	1974	13	Mendelian_Nancy_Cox	TERAMOTO_OPN_TARGETS_CLUSTER_1
0.151975683891%	3	1974	13	Mendelian_Nancy_Cox	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
0.151975683891%	3	1974	13	Mendelian_Nancy_Cox	SA_REG_CASCADE_OF_CYCLIN_EXPR
0.151975683891%	3	1974	13	Mendelian_Nancy_Cox	REACTOME_P38MAPK_EVENTS
0.151975683891%	3	1974	13	Mendelian_Nancy_Cox	REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT
0.151975683891%	3	1974	13	Mendelian_Nancy_Cox	HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER
0.151975683891%	3	1974	13	Mendelian_Nancy_Cox	EHRLICH_ICF_SYNDROM_UP
0.151975683891%	3	1974	13	Mendelian_Nancy_Cox	CROONQUIST_STROMAL_STIMULATION_DN
0.151975683891%	3	1974	13	Mendelian_Nancy_Cox	CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP
0.151975683891%	3	1974	13	Mendelian_Nancy_Cox	BIOCARTA_RB_PATHWAY
0.151975683891%	3	1974	13	Mendelian_Nancy_Cox	BIOCARTA_D4GDI_PATHWAY
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	TAGHAVI_NEOPLASTIC_TRANSFORMATION
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	RUAN_RESPONSE_TO_TNF_UP
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	PARK_TRETINOIN_RESPONSE
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	NEBEN_AML_WITH_FLT3_OR_NRAS_DN
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	HEDVAT_ELF4_TARGETS_UP
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	FIGUEROA_AML_METHYLATION_CLUSTER_5_UP
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	DAZARD_UV_RESPONSE_CLUSTER_G5
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	BIOCARTA_VDR_PATHWAY
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	BIOCARTA_RAB_PATHWAY
0.151975683891%	3	1974	12	Mendelian_Nancy_Cox	BIOCARTA_CFTR_PATHWAY
0.151975683891%	3	1974	11	Mendelian_Nancy_Cox	WHITESIDE_CISPLATIN_RESISTANCE_UP
0.151975683891%	3	1974	11	Mendelian_Nancy_Cox	SEMBA_FHIT_TARGETS_UP
0.151975683891%	3	1974	11	Mendelian_Nancy_Cox	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP
0.151975683891%	3	1974	11	Mendelian_Nancy_Cox	REACTOME_TRANSPORT_OF_ORGANIC_ANIONS
0.151975683891%	3	1974	11	Mendelian_Nancy_Cox	POS_RESPONSE_TO_HISTAMINE_DN
0.151975683891%	3	1974	11	Mendelian_Nancy_Cox	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.151975683891%	3	1974	11	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_7P15_AMPLICON
0.151975683891%	3	1974	11	Mendelian_Nancy_Cox	MUNSHI_MULTIPLE_MYELOMA_DN
0.151975683891%	3	1974	11	Mendelian_Nancy_Cox	BIOCARTA_SET_PATHWAY
0.151975683891%	3	1974	11	Mendelian_Nancy_Cox	BIOCARTA_LEPTIN_PATHWAY
0.151975683891%	3	1974	11	Mendelian_Nancy_Cox	BIOCARTA_IL4_PATHWAY
0.151975683891%	3	1974	11	Mendelian_Nancy_Cox	BIOCARTA_EPONFKB_PATHWAY
0.151975683891%	3	1974	10	Mendelian_Nancy_Cox	YIH_RESPONSE_TO_ARSENITE_C5
0.151975683891%	3	1974	10	Mendelian_Nancy_Cox	YEMELYANOV_GR_TARGETS_DN
0.151975683891%	3	1974	10	Mendelian_Nancy_Cox	WONG_ENDOMETRIAL_CANCER_LATE
0.151975683891%	3	1974	10	Mendelian_Nancy_Cox	TSUDA_ALVEOLAR_SOFT_PART_SARCOMA
0.151975683891%	3	1974	10	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE
0.151975683891%	3	1974	10	Mendelian_Nancy_Cox	REACTOME_PURINE_CATABOLISM
0.151975683891%	3	1974	10	Mendelian_Nancy_Cox	REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE
0.151975683891%	3	1974	10	Mendelian_Nancy_Cox	REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION
0.151975683891%	3	1974	10	Mendelian_Nancy_Cox	REACTOME_GAP_JUNCTION_DEGRADATION
0.151975683891%	3	1974	10	Mendelian_Nancy_Cox	REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION
0.151975683891%	3	1974	10	Mendelian_Nancy_Cox	RADAEVA_RESPONSE_TO_IFNA1_DN
0.151975683891%	3	1974	10	Mendelian_Nancy_Cox	PYEON_HPV_POSITIVE_TUMORS_DN
0.151975683891%	3	1974	10	Mendelian_Nancy_Cox	MCCABE_HOXC6_TARGETS_UP
0.151975683891%	3	1974	10	Mendelian_Nancy_Cox	MATZUK_PREOVULATORY_FOLLICLE
0.151975683891%	3	1974	10	Mendelian_Nancy_Cox	KEGG_LIMONENE_AND_PINENE_DEGRADATION
0.151975683891%	3	1974	10	Mendelian_Nancy_Cox	AGARWAL_AKT_PATHWAY_TARGETS
0.151285930408%	1	661	98	T2D_GENES_TANYA_GLYCEMIC	REACTOME_POTASSIUM_CHANNELS
0.151285930408%	1	661	97	T2D_GENES_TANYA_GLYCEMIC	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
0.151285930408%	1	661	97	T2D_GENES_TANYA_GLYCEMIC	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
0.151285930408%	1	661	97	T2D_GENES_TANYA_GLYCEMIC	KIM_MYC_AMPLIFICATION_TARGETS_DN
0.151285930408%	1	661	96	T2D_GENES_TANYA_GLYCEMIC	ZAMORA_NOS2_TARGETS_DN
0.151285930408%	1	661	95	T2D_GENES_TANYA_GLYCEMIC	HECKER_IFNB1_TARGETS
0.151285930408%	1	661	94	T2D_GENES_TANYA_GLYCEMIC	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5
0.151285930408%	1	661	94	T2D_GENES_TANYA_GLYCEMIC	GAVIN_FOXP3_TARGETS_CLUSTER_T4
0.151285930408%	1	661	93	T2D_GENES_TANYA_GLYCEMIC	ZHU_CMV_24_HR_UP
0.151285930408%	1	661	92	T2D_GENES_TANYA_GLYCEMIC	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
0.151285930408%	1	661	92	T2D_GENES_TANYA_GLYCEMIC	HILLION_HMGA1B_TARGETS
0.151285930408%	1	661	91	T2D_GENES_TANYA_GLYCEMIC	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.151285930408%	1	661	90	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_ERBB4
0.151285930408%	1	661	90	T2D_GENES_TANYA_GLYCEMIC	MORI_MATURE_B_LYMPHOCYTE_UP
0.151285930408%	1	661	90	T2D_GENES_TANYA_GLYCEMIC	IGARASHI_ATF4_TARGETS_DN
0.151285930408%	1	661	90	T2D_GENES_TANYA_GLYCEMIC	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN
0.151285930408%	1	661	9	T2D_GENES_TANYA_GLYCEMIC	ZERBINI_RESPONSE_TO_SULINDAC_UP
0.151285930408%	1	661	9	T2D_GENES_TANYA_GLYCEMIC	YANAGISAWA_LUNG_CANCER_RECURRENCE
0.151285930408%	1	661	9	T2D_GENES_TANYA_GLYCEMIC	THILLAINADESAN_ZNF217_TARGETS_DN
0.151285930408%	1	661	9	T2D_GENES_TANYA_GLYCEMIC	ST_TYPE_I_INTERFERON_PATHWAY
0.151285930408%	1	661	9	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY
0.151285930408%	1	661	9	T2D_GENES_TANYA_GLYCEMIC	RAFFEL_VEGFA_TARGETS_UP
0.151285930408%	1	661	9	T2D_GENES_TANYA_GLYCEMIC	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN
0.151285930408%	1	661	9	T2D_GENES_TANYA_GLYCEMIC	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30
0.151285930408%	1	661	9	T2D_GENES_TANYA_GLYCEMIC	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN
0.151285930408%	1	661	9	T2D_GENES_TANYA_GLYCEMIC	HAEGERSTRAND_RESPONSE_TO_IMATINIB
0.151285930408%	1	661	9	T2D_GENES_TANYA_GLYCEMIC	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.151285930408%	1	661	9	T2D_GENES_TANYA_GLYCEMIC	GOUYER_TUMOR_INVASIVENESS
0.151285930408%	1	661	9	T2D_GENES_TANYA_GLYCEMIC	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN
0.151285930408%	1	661	9	T2D_GENES_TANYA_GLYCEMIC	FIGUEROA_AML_METHYLATION_CLUSTER_2_DN
0.151285930408%	1	661	89	T2D_GENES_TANYA_GLYCEMIC	WNT_SIGNALING
0.151285930408%	1	661	89	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
0.151285930408%	1	661	89	T2D_GENES_TANYA_GLYCEMIC	LEE_AGING_NEOCORTEX_UP
0.151285930408%	1	661	88	T2D_GENES_TANYA_GLYCEMIC	UEDA_CENTRAL_CLOCK
0.151285930408%	1	661	88	T2D_GENES_TANYA_GLYCEMIC	SASSON_RESPONSE_TO_FORSKOLIN_DN
0.151285930408%	1	661	88	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS
0.151285930408%	1	661	88	T2D_GENES_TANYA_GLYCEMIC	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
0.151285930408%	1	661	87	T2D_GENES_TANYA_GLYCEMIC	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
0.151285930408%	1	661	87	T2D_GENES_TANYA_GLYCEMIC	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.151285930408%	1	661	87	T2D_GENES_TANYA_GLYCEMIC	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION
0.151285930408%	1	661	87	T2D_GENES_TANYA_GLYCEMIC	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
0.151285930408%	1	661	86	T2D_GENES_TANYA_GLYCEMIC	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
0.151285930408%	1	661	86	T2D_GENES_TANYA_GLYCEMIC	BURTON_ADIPOGENESIS_8
0.151285930408%	1	661	85	T2D_GENES_TANYA_GLYCEMIC	XU_GH1_EXOGENOUS_TARGETS_UP
0.151285930408%	1	661	85	T2D_GENES_TANYA_GLYCEMIC	STEIN_ESR1_TARGETS
0.151285930408%	1	661	84	T2D_GENES_TANYA_GLYCEMIC	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
0.151285930408%	1	661	84	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S
0.151285930408%	1	661	84	T2D_GENES_TANYA_GLYCEMIC	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
0.151285930408%	1	661	83	T2D_GENES_TANYA_GLYCEMIC	ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.151285930408%	1	661	83	T2D_GENES_TANYA_GLYCEMIC	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.151285930408%	1	661	83	T2D_GENES_TANYA_GLYCEMIC	JIANG_HYPOXIA_CANCER
0.151285930408%	1	661	82	T2D_GENES_TANYA_GLYCEMIC	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
0.151285930408%	1	661	82	T2D_GENES_TANYA_GLYCEMIC	PID_SMAD2_3NUCLEARPATHWAY
0.151285930408%	1	661	82	T2D_GENES_TANYA_GLYCEMIC	ODONNELL_METASTASIS_UP
0.151285930408%	1	661	82	T2D_GENES_TANYA_GLYCEMIC	BILD_CTNNB1_ONCOGENIC_SIGNATURE
0.151285930408%	1	661	82	T2D_GENES_TANYA_GLYCEMIC	BHAT_ESR1_TARGETS_VIA_AKT1_DN
0.151285930408%	1	661	81	T2D_GENES_TANYA_GLYCEMIC	HARRIS_HYPOXIA
0.151285930408%	1	661	81	T2D_GENES_TANYA_GLYCEMIC	GRABARCZYK_BCL11B_TARGETS_UP
0.151285930408%	1	661	81	T2D_GENES_TANYA_GLYCEMIC	CROMER_METASTASIS_DN
0.151285930408%	1	661	80	T2D_GENES_TANYA_GLYCEMIC	WOO_LIVER_CANCER_RECURRENCE_DN
0.151285930408%	1	661	80	T2D_GENES_TANYA_GLYCEMIC	LEE_AGING_NEOCORTEX_DN
0.151285930408%	1	661	80	T2D_GENES_TANYA_GLYCEMIC	KEGG_CARDIAC_MUSCLE_CONTRACTION
0.151285930408%	1	661	80	T2D_GENES_TANYA_GLYCEMIC	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN
0.151285930408%	1	661	80	T2D_GENES_TANYA_GLYCEMIC	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
0.151285930408%	1	661	8	T2D_GENES_TANYA_GLYCEMIC	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR
0.151285930408%	1	661	8	T2D_GENES_TANYA_GLYCEMIC	WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP
0.151285930408%	1	661	8	T2D_GENES_TANYA_GLYCEMIC	WEBER_METHYLATED_ICP_IN_SPERM_UP
0.151285930408%	1	661	8	T2D_GENES_TANYA_GLYCEMIC	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN
0.151285930408%	1	661	8	T2D_GENES_TANYA_GLYCEMIC	RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN
0.151285930408%	1	661	8	T2D_GENES_TANYA_GLYCEMIC	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN
0.151285930408%	1	661	8	T2D_GENES_TANYA_GLYCEMIC	NAKAMURA_LUNG_CANCER
0.151285930408%	1	661	8	T2D_GENES_TANYA_GLYCEMIC	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9
0.151285930408%	1	661	8	T2D_GENES_TANYA_GLYCEMIC	HOLLEMAN_DAUNORUBICIN_ALL_DN
0.151285930408%	1	661	8	T2D_GENES_TANYA_GLYCEMIC	GROSS_HIF1A_TARGETS_UP
0.151285930408%	1	661	8	T2D_GENES_TANYA_GLYCEMIC	GALIE_TUMOR_ANGIOGENESIS
0.151285930408%	1	661	8	T2D_GENES_TANYA_GLYCEMIC	FUJIWARA_PARK2_IN_LIVER_CANCER_UP
0.151285930408%	1	661	8	T2D_GENES_TANYA_GLYCEMIC	DER_IFN_BETA_RESPONSE_DN
0.151285930408%	1	661	8	T2D_GENES_TANYA_GLYCEMIC	BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS
0.151285930408%	1	661	8	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_KREB_PATHWAY
0.151285930408%	1	661	79	T2D_GENES_TANYA_GLYCEMIC	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
0.151285930408%	1	661	79	T2D_GENES_TANYA_GLYCEMIC	MCCLUNG_COCAINE_REWARD_5D
0.151285930408%	1	661	78	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PLATELET_HOMEOSTASIS
0.151285930408%	1	661	78	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CELL_JUNCTION_ORGANIZATION
0.151285930408%	1	661	78	T2D_GENES_TANYA_GLYCEMIC	LINDVALL_IMMORTALIZED_BY_TERT_UP
0.151285930408%	1	661	78	T2D_GENES_TANYA_GLYCEMIC	COATES_MACROPHAGE_M1_VS_M2_DN
0.151285930408%	1	661	78	T2D_GENES_TANYA_GLYCEMIC	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.151285930408%	1	661	77	T2D_GENES_TANYA_GLYCEMIC	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
0.151285930408%	1	661	77	T2D_GENES_TANYA_GLYCEMIC	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.151285930408%	1	661	77	T2D_GENES_TANYA_GLYCEMIC	GROSS_HYPOXIA_VIA_HIF1A_UP
0.151285930408%	1	661	77	T2D_GENES_TANYA_GLYCEMIC	CHEBOTAEV_GR_TARGETS_UP
0.151285930408%	1	661	76	T2D_GENES_TANYA_GLYCEMIC	SU_TESTIS
0.151285930408%	1	661	76	T2D_GENES_TANYA_GLYCEMIC	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.151285930408%	1	661	76	T2D_GENES_TANYA_GLYCEMIC	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
0.151285930408%	1	661	76	T2D_GENES_TANYA_GLYCEMIC	MAHAJAN_RESPONSE_TO_IL1A_DN
0.151285930408%	1	661	75	T2D_GENES_TANYA_GLYCEMIC	JAIN_NFKB_SIGNALING
0.151285930408%	1	661	74	T2D_GENES_TANYA_GLYCEMIC	WESTON_VEGFA_TARGETS_3HR
0.151285930408%	1	661	74	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING
0.151285930408%	1	661	74	T2D_GENES_TANYA_GLYCEMIC	REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX
0.151285930408%	1	661	74	T2D_GENES_TANYA_GLYCEMIC	POTTI_ADRIAMYCIN_SENSITIVITY
0.151285930408%	1	661	74	T2D_GENES_TANYA_GLYCEMIC	LIAN_LIPA_TARGETS_6M
0.151285930408%	1	661	74	T2D_GENES_TANYA_GLYCEMIC	LEIN_OLIGODENDROCYTE_MARKERS
0.151285930408%	1	661	74	T2D_GENES_TANYA_GLYCEMIC	FURUKAWA_DUSP6_TARGETS_PCI35_UP
0.151285930408%	1	661	73	T2D_GENES_TANYA_GLYCEMIC	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.151285930408%	1	661	73	T2D_GENES_TANYA_GLYCEMIC	HOSHIDA_LIVER_CANCER_SURVIVAL_UP
0.151285930408%	1	661	72	T2D_GENES_TANYA_GLYCEMIC	SESTO_RESPONSE_TO_UV_C8
0.151285930408%	1	661	72	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
0.151285930408%	1	661	72	T2D_GENES_TANYA_GLYCEMIC	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE
0.151285930408%	1	661	72	T2D_GENES_TANYA_GLYCEMIC	KEGG_LEISHMANIA_INFECTION
0.151285930408%	1	661	72	T2D_GENES_TANYA_GLYCEMIC	HUANG_GATA2_TARGETS_DN
0.151285930408%	1	661	72	T2D_GENES_TANYA_GLYCEMIC	BURTON_ADIPOGENESIS_2
0.151285930408%	1	661	71	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PI3K_CASCADE
0.151285930408%	1	661	71	T2D_GENES_TANYA_GLYCEMIC	KUMAR_AUTOPHAGY_NETWORK
0.151285930408%	1	661	71	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_6HR_UP
0.151285930408%	1	661	70	T2D_GENES_TANYA_GLYCEMIC	VERNELL_RETINOBLASTOMA_PATHWAY_UP
0.151285930408%	1	661	70	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_NOTCH1
0.151285930408%	1	661	70	T2D_GENES_TANYA_GLYCEMIC	LANDIS_BREAST_CANCER_PROGRESSION_DN
0.151285930408%	1	661	70	T2D_GENES_TANYA_GLYCEMIC	KEGG_RENAL_CELL_CARCINOMA
0.151285930408%	1	661	7	T2D_GENES_TANYA_GLYCEMIC	ZEILSTRA_CD44_TARGETS_UP
0.151285930408%	1	661	7	T2D_GENES_TANYA_GLYCEMIC	YAMASHITA_SILENCED_BY_METHYLATION
0.151285930408%	1	661	7	T2D_GENES_TANYA_GLYCEMIC	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN
0.151285930408%	1	661	7	T2D_GENES_TANYA_GLYCEMIC	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN
0.151285930408%	1	661	7	T2D_GENES_TANYA_GLYCEMIC	TESAR_JAK_TARGETS_MOUSE_ES_D3_UP
0.151285930408%	1	661	7	T2D_GENES_TANYA_GLYCEMIC	ST_PAC1_RECEPTOR_PATHWAY
0.151285930408%	1	661	7	T2D_GENES_TANYA_GLYCEMIC	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN
0.151285930408%	1	661	7	T2D_GENES_TANYA_GLYCEMIC	PETRETTO_BLOOD_PRESSURE_DN
0.151285930408%	1	661	7	T2D_GENES_TANYA_GLYCEMIC	NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA
0.151285930408%	1	661	7	T2D_GENES_TANYA_GLYCEMIC	MOOTHA_ROS
0.151285930408%	1	661	7	T2D_GENES_TANYA_GLYCEMIC	MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP
0.151285930408%	1	661	7	T2D_GENES_TANYA_GLYCEMIC	LIU_CMYB_TARGETS_DN
0.151285930408%	1	661	7	T2D_GENES_TANYA_GLYCEMIC	HOLLEMAN_DAUNORUBICIN_ALL_UP
0.151285930408%	1	661	7	T2D_GENES_TANYA_GLYCEMIC	BUSA_SAM68_TARGETS_UP
0.151285930408%	1	661	69	T2D_GENES_TANYA_GLYCEMIC	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.151285930408%	1	661	69	T2D_GENES_TANYA_GLYCEMIC	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES
0.151285930408%	1	661	69	T2D_GENES_TANYA_GLYCEMIC	BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE
0.151285930408%	1	661	68	T2D_GENES_TANYA_GLYCEMIC	NOUZOVA_METHYLATED_IN_APL
0.151285930408%	1	661	68	T2D_GENES_TANYA_GLYCEMIC	DELPUECH_FOXO3_TARGETS_UP
0.151285930408%	1	661	67	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN
0.151285930408%	1	661	67	T2D_GENES_TANYA_GLYCEMIC	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
0.151285930408%	1	661	67	T2D_GENES_TANYA_GLYCEMIC	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70
0.151285930408%	1	661	66	T2D_GENES_TANYA_GLYCEMIC	WILCOX_PRESPONSE_TO_ROGESTERONE_DN
0.151285930408%	1	661	66	T2D_GENES_TANYA_GLYCEMIC	NAKAMURA_ADIPOGENESIS_EARLY_UP
0.151285930408%	1	661	66	T2D_GENES_TANYA_GLYCEMIC	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.151285930408%	1	661	65	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_WNT
0.151285930408%	1	661	65	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
0.151285930408%	1	661	65	T2D_GENES_TANYA_GLYCEMIC	AMIT_SERUM_RESPONSE_120_MCF10A
0.151285930408%	1	661	64	T2D_GENES_TANYA_GLYCEMIC	RIZKI_TUMOR_INVASIVENESS_2D_DN
0.151285930408%	1	661	64	T2D_GENES_TANYA_GLYCEMIC	RHODES_CANCER_META_SIGNATURE
0.151285930408%	1	661	64	T2D_GENES_TANYA_GLYCEMIC	REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C
0.151285930408%	1	661	64	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS
0.151285930408%	1	661	64	T2D_GENES_TANYA_GLYCEMIC	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
0.151285930408%	1	661	64	T2D_GENES_TANYA_GLYCEMIC	LIU_SMARCA4_TARGETS
0.151285930408%	1	661	64	T2D_GENES_TANYA_GLYCEMIC	KEGG_RETINOL_METABOLISM
0.151285930408%	1	661	64	T2D_GENES_TANYA_GLYCEMIC	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.151285930408%	1	661	64	T2D_GENES_TANYA_GLYCEMIC	ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE
0.151285930408%	1	661	63	T2D_GENES_TANYA_GLYCEMIC	REACTOME_INTERFERON_GAMMA_SIGNALING
0.151285930408%	1	661	63	T2D_GENES_TANYA_GLYCEMIC	PID_IL12_2PATHWAY
0.151285930408%	1	661	63	T2D_GENES_TANYA_GLYCEMIC	MODY_HIPPOCAMPUS_POSTNATAL
0.151285930408%	1	661	63	T2D_GENES_TANYA_GLYCEMIC	LEE_LIVER_CANCER_MYC_DN
0.151285930408%	1	661	63	T2D_GENES_TANYA_GLYCEMIC	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
0.151285930408%	1	661	63	T2D_GENES_TANYA_GLYCEMIC	BURTON_ADIPOGENESIS_PEAK_AT_0HR
0.151285930408%	1	661	63	T2D_GENES_TANYA_GLYCEMIC	BILBAN_B_CLL_LPL_UP
0.151285930408%	1	661	62	T2D_GENES_TANYA_GLYCEMIC	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
0.151285930408%	1	661	62	T2D_GENES_TANYA_GLYCEMIC	LEE_LIVER_CANCER_E2F1_UP
0.151285930408%	1	661	62	T2D_GENES_TANYA_GLYCEMIC	CORRE_MULTIPLE_MYELOMA_DN
0.151285930408%	1	661	62	T2D_GENES_TANYA_GLYCEMIC	BILD_SRC_ONCOGENIC_SIGNATURE
0.151285930408%	1	661	61	T2D_GENES_TANYA_GLYCEMIC	ZWANG_EGF_PERSISTENTLY_DN
0.151285930408%	1	661	61	T2D_GENES_TANYA_GLYCEMIC	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.151285930408%	1	661	61	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ER_PHAGOSOME_PATHWAY
0.151285930408%	1	661	61	T2D_GENES_TANYA_GLYCEMIC	RASHI_RESPONSE_TO_IONIZING_RADIATION_4
0.151285930408%	1	661	61	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_1HR_UP
0.151285930408%	1	661	60	T2D_GENES_TANYA_GLYCEMIC	WIERENGA_STAT5A_TARGETS_GROUP2
0.151285930408%	1	661	60	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING
0.151285930408%	1	661	60	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE
0.151285930408%	1	661	60	T2D_GENES_TANYA_GLYCEMIC	OUILLETTE_CLL_13Q14_DELETION_DN
0.151285930408%	1	661	60	T2D_GENES_TANYA_GLYCEMIC	LEE_LIVER_CANCER_DENA_UP
0.151285930408%	1	661	60	T2D_GENES_TANYA_GLYCEMIC	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
0.151285930408%	1	661	60	T2D_GENES_TANYA_GLYCEMIC	CUI_GLUCOSE_DEPRIVATION
0.151285930408%	1	661	60	T2D_GENES_TANYA_GLYCEMIC	CROONQUIST_STROMAL_STIMULATION_UP
0.151285930408%	1	661	6	T2D_GENES_TANYA_GLYCEMIC	ZIRN_TRETINOIN_RESPONSE_DN
0.151285930408%	1	661	6	T2D_GENES_TANYA_GLYCEMIC	PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN
0.151285930408%	1	661	6	T2D_GENES_TANYA_GLYCEMIC	OHASHI_AURKA_TARGETS
0.151285930408%	1	661	6	T2D_GENES_TANYA_GLYCEMIC	KAUFFMANN_MELANOMA_RELAPSE_DN
0.151285930408%	1	661	6	T2D_GENES_TANYA_GLYCEMIC	DONATO_CELL_CYCLE_TRETINOIN
0.151285930408%	1	661	6	T2D_GENES_TANYA_GLYCEMIC	DIERICK_SEROTONIN_FUNCTION_GENES
0.151285930408%	1	661	6	T2D_GENES_TANYA_GLYCEMIC	CROSBY_E2F4_TARGETS
0.151285930408%	1	661	6	T2D_GENES_TANYA_GLYCEMIC	COURTOIS_SENESCENCE_TRIGGERS
0.151285930408%	1	661	6	T2D_GENES_TANYA_GLYCEMIC	CHEN_HOXA5_TARGETS_6HR_DN
0.151285930408%	1	661	6	T2D_GENES_TANYA_GLYCEMIC	BUSA_SAM68_TARGETS_DN
0.151285930408%	1	661	59	T2D_GENES_TANYA_GLYCEMIC	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
0.151285930408%	1	661	59	T2D_GENES_TANYA_GLYCEMIC	PID_ATF2_PATHWAY
0.151285930408%	1	661	59	T2D_GENES_TANYA_GLYCEMIC	ONDER_CDH1_TARGETS_3_DN
0.151285930408%	1	661	59	T2D_GENES_TANYA_GLYCEMIC	MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3
0.151285930408%	1	661	59	T2D_GENES_TANYA_GLYCEMIC	LIAN_LIPA_TARGETS_3M
0.151285930408%	1	661	59	T2D_GENES_TANYA_GLYCEMIC	KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION
0.151285930408%	1	661	59	T2D_GENES_TANYA_GLYCEMIC	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
0.151285930408%	1	661	59	T2D_GENES_TANYA_GLYCEMIC	BOYLAN_MULTIPLE_MYELOMA_C_DN
0.151285930408%	1	661	59	T2D_GENES_TANYA_GLYCEMIC	BARIS_THYROID_CANCER_DN
0.151285930408%	1	661	59	T2D_GENES_TANYA_GLYCEMIC	ASTIER_INTEGRIN_SIGNALING
0.151285930408%	1	661	58	T2D_GENES_TANYA_GLYCEMIC	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
0.151285930408%	1	661	58	T2D_GENES_TANYA_GLYCEMIC	SANSOM_WNT_PATHWAY_REQUIRE_MYC
0.151285930408%	1	661	58	T2D_GENES_TANYA_GLYCEMIC	REACTOME_REGULATION_OF_APOPTOSIS
0.151285930408%	1	661	58	T2D_GENES_TANYA_GLYCEMIC	REACTOME_COLLAGEN_FORMATION
0.151285930408%	1	661	58	T2D_GENES_TANYA_GLYCEMIC	MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.151285930408%	1	661	58	T2D_GENES_TANYA_GLYCEMIC	KEGG_ARACHIDONIC_ACID_METABOLISM
0.151285930408%	1	661	58	T2D_GENES_TANYA_GLYCEMIC	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
0.151285930408%	1	661	58	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_HIVNEF_PATHWAY
0.151285930408%	1	661	58	T2D_GENES_TANYA_GLYCEMIC	BERNARD_PPAPDC1B_TARGETS_DN
0.151285930408%	1	661	57	T2D_GENES_TANYA_GLYCEMIC	YAMASHITA_METHYLATED_IN_PROSTATE_CANCER
0.151285930408%	1	661	57	T2D_GENES_TANYA_GLYCEMIC	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
0.151285930408%	1	661	57	T2D_GENES_TANYA_GLYCEMIC	REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE
0.151285930408%	1	661	57	T2D_GENES_TANYA_GLYCEMIC	PID_TXA2PATHWAY
0.151285930408%	1	661	57	T2D_GENES_TANYA_GLYCEMIC	PEART_HDAC_PROLIFERATION_CLUSTER_UP
0.151285930408%	1	661	57	T2D_GENES_TANYA_GLYCEMIC	AMIT_SERUM_RESPONSE_240_MCF10A
0.151285930408%	1	661	56	T2D_GENES_TANYA_GLYCEMIC	WORSCHECH_TUMOR_REJECTION_UP
0.151285930408%	1	661	56	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.151285930408%	1	661	56	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PI_3K_CASCADE
0.151285930408%	1	661	56	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX
0.151285930408%	1	661	56	T2D_GENES_TANYA_GLYCEMIC	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP
0.151285930408%	1	661	56	T2D_GENES_TANYA_GLYCEMIC	KEGG_VIBRIO_CHOLERAE_INFECTION
0.151285930408%	1	661	56	T2D_GENES_TANYA_GLYCEMIC	KEGG_HEDGEHOG_SIGNALING_PATHWAY
0.151285930408%	1	661	56	T2D_GENES_TANYA_GLYCEMIC	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.151285930408%	1	661	56	T2D_GENES_TANYA_GLYCEMIC	GRADE_COLON_VS_RECTAL_CANCER_DN
0.151285930408%	1	661	56	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_30MIN_UP
0.151285930408%	1	661	56	T2D_GENES_TANYA_GLYCEMIC	BROWNE_HCMV_INFECTION_10HR_DN
0.151285930408%	1	661	55	T2D_GENES_TANYA_GLYCEMIC	PID_TGFBRPATHWAY
0.151285930408%	1	661	55	T2D_GENES_TANYA_GLYCEMIC	PID_FGF_PATHWAY
0.151285930408%	1	661	55	T2D_GENES_TANYA_GLYCEMIC	LAU_APOPTOSIS_CDKN2A_UP
0.151285930408%	1	661	55	T2D_GENES_TANYA_GLYCEMIC	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN
0.151285930408%	1	661	55	T2D_GENES_TANYA_GLYCEMIC	KEGG_STEROID_HORMONE_BIOSYNTHESIS
0.151285930408%	1	661	55	T2D_GENES_TANYA_GLYCEMIC	KEGG_BASAL_CELL_CARCINOMA
0.151285930408%	1	661	54	T2D_GENES_TANYA_GLYCEMIC	ZHOU_TNF_SIGNALING_4HR
0.151285930408%	1	661	54	T2D_GENES_TANYA_GLYCEMIC	RICKMAN_HEAD_AND_NECK_CANCER_F
0.151285930408%	1	661	54	T2D_GENES_TANYA_GLYCEMIC	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP
0.151285930408%	1	661	54	T2D_GENES_TANYA_GLYCEMIC	PID_TAP63PATHWAY
0.151285930408%	1	661	54	T2D_GENES_TANYA_GLYCEMIC	PID_RAC1_PATHWAY
0.151285930408%	1	661	54	T2D_GENES_TANYA_GLYCEMIC	PID_NFAT_3PATHWAY
0.151285930408%	1	661	54	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_IPS_ICP_WITH_H3K27ME3
0.151285930408%	1	661	54	T2D_GENES_TANYA_GLYCEMIC	MARSON_FOXP3_TARGETS_DN
0.151285930408%	1	661	54	T2D_GENES_TANYA_GLYCEMIC	KEGG_ARGININE_AND_PROLINE_METABOLISM
0.151285930408%	1	661	54	T2D_GENES_TANYA_GLYCEMIC	JIANG_AGING_CEREBRAL_CORTEX_DN
0.151285930408%	1	661	54	T2D_GENES_TANYA_GLYCEMIC	FIGUEROA_AML_METHYLATION_CLUSTER_2_UP
0.151285930408%	1	661	54	T2D_GENES_TANYA_GLYCEMIC	AUNG_GASTRIC_CANCER
0.151285930408%	1	661	53	T2D_GENES_TANYA_GLYCEMIC	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP
0.151285930408%	1	661	53	T2D_GENES_TANYA_GLYCEMIC	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
0.151285930408%	1	661	53	T2D_GENES_TANYA_GLYCEMIC	ROESSLER_LIVER_CANCER_METASTASIS_DN
0.151285930408%	1	661	53	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PROTEIN_FOLDING
0.151285930408%	1	661	53	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS
0.151285930408%	1	661	53	T2D_GENES_TANYA_GLYCEMIC	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0
0.151285930408%	1	661	53	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CIRCADIAN_CLOCK
0.151285930408%	1	661	53	T2D_GENES_TANYA_GLYCEMIC	PID_CD8TCRPATHWAY
0.151285930408%	1	661	53	T2D_GENES_TANYA_GLYCEMIC	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
0.151285930408%	1	661	53	T2D_GENES_TANYA_GLYCEMIC	IKEDA_MIR1_TARGETS_UP
0.151285930408%	1	661	52	T2D_GENES_TANYA_GLYCEMIC	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN
0.151285930408%	1	661	52	T2D_GENES_TANYA_GLYCEMIC	REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.151285930408%	1	661	52	T2D_GENES_TANYA_GLYCEMIC	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM
0.151285930408%	1	661	52	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GABA_RECEPTOR_ACTIVATION
0.151285930408%	1	661	52	T2D_GENES_TANYA_GLYCEMIC	PRAMOONJAGO_SOX4_TARGETS_UP
0.151285930408%	1	661	52	T2D_GENES_TANYA_GLYCEMIC	PID_PTP1BPATHWAY
0.151285930408%	1	661	52	T2D_GENES_TANYA_GLYCEMIC	KEGG_MTOR_SIGNALING_PATHWAY
0.151285930408%	1	661	52	T2D_GENES_TANYA_GLYCEMIC	BECKER_TAMOXIFEN_RESISTANCE_DN
0.151285930408%	1	661	51	T2D_GENES_TANYA_GLYCEMIC	TSUNODA_CISPLATIN_RESISTANCE_DN
0.151285930408%	1	661	51	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.151285930408%	1	661	51	T2D_GENES_TANYA_GLYCEMIC	REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT
0.151285930408%	1	661	51	T2D_GENES_TANYA_GLYCEMIC	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
0.151285930408%	1	661	51	T2D_GENES_TANYA_GLYCEMIC	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1
0.151285930408%	1	661	51	T2D_GENES_TANYA_GLYCEMIC	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN
0.151285930408%	1	661	51	T2D_GENES_TANYA_GLYCEMIC	KEGG_DRUG_METABOLISM_OTHER_ENZYMES
0.151285930408%	1	661	51	T2D_GENES_TANYA_GLYCEMIC	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
0.151285930408%	1	661	51	T2D_GENES_TANYA_GLYCEMIC	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP
0.151285930408%	1	661	51	T2D_GENES_TANYA_GLYCEMIC	BYSTROEM_CORRELATED_WITH_IL5_UP
0.151285930408%	1	661	51	T2D_GENES_TANYA_GLYCEMIC	BURTON_ADIPOGENESIS_PEAK_AT_2HR
0.151285930408%	1	661	50	T2D_GENES_TANYA_GLYCEMIC	YANG_BREAST_CANCER_ESR1_LASER_DN
0.151285930408%	1	661	50	T2D_GENES_TANYA_GLYCEMIC	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
0.151285930408%	1	661	50	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
0.151285930408%	1	661	50	T2D_GENES_TANYA_GLYCEMIC	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
0.151285930408%	1	661	50	T2D_GENES_TANYA_GLYCEMIC	KOHOUTEK_CCNT1_TARGETS
0.151285930408%	1	661	50	T2D_GENES_TANYA_GLYCEMIC	KEGG_GLUTATHIONE_METABOLISM
0.151285930408%	1	661	50	T2D_GENES_TANYA_GLYCEMIC	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN
0.151285930408%	1	661	50	T2D_GENES_TANYA_GLYCEMIC	BECKER_TAMOXIFEN_RESISTANCE_UP
0.151285930408%	1	661	5	T2D_GENES_TANYA_GLYCEMIC	VERRECCHIA_RESPONSE_TO_TGFB1_C6
0.151285930408%	1	661	5	T2D_GENES_TANYA_GLYCEMIC	ABDULRAHMAN_KIDNEY_CANCER_VHL_UP
0.151285930408%	1	661	49	T2D_GENES_TANYA_GLYCEMIC	REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC
0.151285930408%	1	661	49	T2D_GENES_TANYA_GLYCEMIC	REACTOME_METABOLISM_OF_NON_CODING_RNA
0.151285930408%	1	661	49	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM
0.151285930408%	1	661	49	T2D_GENES_TANYA_GLYCEMIC	PID_ARF6_TRAFFICKINGPATHWAY
0.151285930408%	1	661	49	T2D_GENES_TANYA_GLYCEMIC	MARCHINI_TRABECTEDIN_RESISTANCE_DN
0.151285930408%	1	661	49	T2D_GENES_TANYA_GLYCEMIC	DAUER_STAT3_TARGETS_UP
0.151285930408%	1	661	49	T2D_GENES_TANYA_GLYCEMIC	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP
0.151285930408%	1	661	49	T2D_GENES_TANYA_GLYCEMIC	APRELIKOVA_BRCA1_TARGETS
0.151285930408%	1	661	48	T2D_GENES_TANYA_GLYCEMIC	ZHAN_MULTIPLE_MYELOMA_MS_UP
0.151285930408%	1	661	48	T2D_GENES_TANYA_GLYCEMIC	TAVOR_CEBPA_TARGETS_UP
0.151285930408%	1	661	48	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE
0.151285930408%	1	661	48	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PI_METABOLISM
0.151285930408%	1	661	48	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES
0.151285930408%	1	661	48	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6
0.151285930408%	1	661	48	T2D_GENES_TANYA_GLYCEMIC	PID_AJDISS_2PATHWAY
0.151285930408%	1	661	48	T2D_GENES_TANYA_GLYCEMIC	MCDOWELL_ACUTE_LUNG_INJURY_DN
0.151285930408%	1	661	48	T2D_GENES_TANYA_GLYCEMIC	KEGG_PROTEASOME
0.151285930408%	1	661	48	T2D_GENES_TANYA_GLYCEMIC	ENGELMANN_CANCER_PROGENITORS_UP
0.151285930408%	1	661	48	T2D_GENES_TANYA_GLYCEMIC	DELACROIX_RAR_TARGETS_UP
0.151285930408%	1	661	48	T2D_GENES_TANYA_GLYCEMIC	BURTON_ADIPOGENESIS_4
0.151285930408%	1	661	47	T2D_GENES_TANYA_GLYCEMIC	ZHU_CMV_8_HR_UP
0.151285930408%	1	661	47	T2D_GENES_TANYA_GLYCEMIC	ZHAN_MULTIPLE_MYELOMA_MF_UP
0.151285930408%	1	661	47	T2D_GENES_TANYA_GLYCEMIC	ZHAN_MULTIPLE_MYELOMA_HP_DN
0.151285930408%	1	661	47	T2D_GENES_TANYA_GLYCEMIC	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
0.151285930408%	1	661	47	T2D_GENES_TANYA_GLYCEMIC	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN
0.151285930408%	1	661	47	T2D_GENES_TANYA_GLYCEMIC	POTTI_DOCETAXEL_SENSITIVITY
0.151285930408%	1	661	47	T2D_GENES_TANYA_GLYCEMIC	PID_FANCONI_PATHWAY
0.151285930408%	1	661	47	T2D_GENES_TANYA_GLYCEMIC	LEONARD_HYPOXIA
0.151285930408%	1	661	47	T2D_GENES_TANYA_GLYCEMIC	KHETCHOUMIAN_TRIM24_TARGETS_UP
0.151285930408%	1	661	47	T2D_GENES_TANYA_GLYCEMIC	KEGG_NOTCH_SIGNALING_PATHWAY
0.151285930408%	1	661	46	T2D_GENES_TANYA_GLYCEMIC	ZHAN_MULTIPLE_MYELOMA_CD2_DN
0.151285930408%	1	661	46	T2D_GENES_TANYA_GLYCEMIC	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6
0.151285930408%	1	661	46	T2D_GENES_TANYA_GLYCEMIC	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
0.151285930408%	1	661	46	T2D_GENES_TANYA_GLYCEMIC	PID_SYNDECAN_1_PATHWAY
0.151285930408%	1	661	46	T2D_GENES_TANYA_GLYCEMIC	OSADA_ASCL1_TARGETS_UP
0.151285930408%	1	661	46	T2D_GENES_TANYA_GLYCEMIC	MADAN_DPPA4_TARGETS
0.151285930408%	1	661	46	T2D_GENES_TANYA_GLYCEMIC	KRASNOSELSKAYA_ILF3_TARGETS_DN
0.151285930408%	1	661	46	T2D_GENES_TANYA_GLYCEMIC	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN
0.151285930408%	1	661	46	T2D_GENES_TANYA_GLYCEMIC	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN
0.151285930408%	1	661	46	T2D_GENES_TANYA_GLYCEMIC	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN
0.151285930408%	1	661	46	T2D_GENES_TANYA_GLYCEMIC	AMIT_EGF_RESPONSE_60_HELA
0.151285930408%	1	661	45	T2D_GENES_TANYA_GLYCEMIC	ZHAN_V2_LATE_DIFFERENTIATION_GENES
0.151285930408%	1	661	45	T2D_GENES_TANYA_GLYCEMIC	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN
0.151285930408%	1	661	45	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MRNA_SPLICING_MINOR_PATHWAY
0.151285930408%	1	661	45	T2D_GENES_TANYA_GLYCEMIC	REACTOME_G2_M_CHECKPOINTS
0.151285930408%	1	661	45	T2D_GENES_TANYA_GLYCEMIC	PID_RHOA_PATHWAY
0.151285930408%	1	661	45	T2D_GENES_TANYA_GLYCEMIC	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN
0.151285930408%	1	661	45	T2D_GENES_TANYA_GLYCEMIC	NAKAMURA_METASTASIS_MODEL_UP
0.151285930408%	1	661	45	T2D_GENES_TANYA_GLYCEMIC	MCDOWELL_ACUTE_LUNG_INJURY_UP
0.151285930408%	1	661	45	T2D_GENES_TANYA_GLYCEMIC	LEE_AGING_MUSCLE_UP
0.151285930408%	1	661	45	T2D_GENES_TANYA_GLYCEMIC	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN
0.151285930408%	1	661	45	T2D_GENES_TANYA_GLYCEMIC	CHANDRAN_METASTASIS_TOP50_DN
0.151285930408%	1	661	45	T2D_GENES_TANYA_GLYCEMIC	CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY
0.151285930408%	1	661	44	T2D_GENES_TANYA_GLYCEMIC	ZHAN_MULTIPLE_MYELOMA_LB_DN
0.151285930408%	1	661	44	T2D_GENES_TANYA_GLYCEMIC	XU_CREBBP_TARGETS_DN
0.151285930408%	1	661	44	T2D_GENES_TANYA_GLYCEMIC	WHITFIELD_CELL_CYCLE_LITERATURE
0.151285930408%	1	661	44	T2D_GENES_TANYA_GLYCEMIC	VANTVEER_BREAST_CANCER_BRCA1_DN
0.151285930408%	1	661	44	T2D_GENES_TANYA_GLYCEMIC	THILLAINADESAN_ZNF217_TARGETS_UP
0.151285930408%	1	661	44	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_FGFR_MUTANTS
0.151285930408%	1	661	44	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
0.151285930408%	1	661	44	T2D_GENES_TANYA_GLYCEMIC	PARK_HSC_MARKERS
0.151285930408%	1	661	44	T2D_GENES_TANYA_GLYCEMIC	LANDIS_BREAST_CANCER_PROGRESSION_UP
0.151285930408%	1	661	44	T2D_GENES_TANYA_GLYCEMIC	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS
0.151285930408%	1	661	44	T2D_GENES_TANYA_GLYCEMIC	KEGG_TYPE_I_DIABETES_MELLITUS
0.151285930408%	1	661	44	T2D_GENES_TANYA_GLYCEMIC	KEGG_ABC_TRANSPORTERS
0.151285930408%	1	661	44	T2D_GENES_TANYA_GLYCEMIC	JAEGER_METASTASIS_UP
0.151285930408%	1	661	44	T2D_GENES_TANYA_GLYCEMIC	FARMER_BREAST_CANCER_CLUSTER_1
0.151285930408%	1	661	44	T2D_GENES_TANYA_GLYCEMIC	FAELT_B_CLL_WITH_VH3_21_UP
0.151285930408%	1	661	44	T2D_GENES_TANYA_GLYCEMIC	CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY
0.151285930408%	1	661	43	T2D_GENES_TANYA_GLYCEMIC	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK
0.151285930408%	1	661	43	T2D_GENES_TANYA_GLYCEMIC	PID_CXCR3PATHWAY
0.151285930408%	1	661	43	T2D_GENES_TANYA_GLYCEMIC	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN
0.151285930408%	1	661	43	T2D_GENES_TANYA_GLYCEMIC	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
0.151285930408%	1	661	43	T2D_GENES_TANYA_GLYCEMIC	IKEDA_MIR133_TARGETS_UP
0.151285930408%	1	661	43	T2D_GENES_TANYA_GLYCEMIC	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
0.151285930408%	1	661	43	T2D_GENES_TANYA_GLYCEMIC	FUJII_YBX1_TARGETS_UP
0.151285930408%	1	661	43	T2D_GENES_TANYA_GLYCEMIC	AMIT_EGF_RESPONSE_480_MCF10A
0.151285930408%	1	661	42	T2D_GENES_TANYA_GLYCEMIC	WIERENGA_PML_INTERACTOME
0.151285930408%	1	661	42	T2D_GENES_TANYA_GLYCEMIC	WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN
0.151285930408%	1	661	42	T2D_GENES_TANYA_GLYCEMIC	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP
0.151285930408%	1	661	42	T2D_GENES_TANYA_GLYCEMIC	ONO_FOXP3_TARGETS_DN
0.151285930408%	1	661	42	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_ES_ICP_WITH_H3K27ME3
0.151285930408%	1	661	42	T2D_GENES_TANYA_GLYCEMIC	KEGG_TYROSINE_METABOLISM
0.151285930408%	1	661	42	T2D_GENES_TANYA_GLYCEMIC	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
0.151285930408%	1	661	42	T2D_GENES_TANYA_GLYCEMIC	HAHTOLA_SEZARY_SYNDROM_DN
0.151285930408%	1	661	42	T2D_GENES_TANYA_GLYCEMIC	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN
0.151285930408%	1	661	42	T2D_GENES_TANYA_GLYCEMIC	BARRIER_COLON_CANCER_RECURRENCE_UP
0.151285930408%	1	661	42	T2D_GENES_TANYA_GLYCEMIC	AMIT_EGF_RESPONSE_40_HELA
0.151285930408%	1	661	41	T2D_GENES_TANYA_GLYCEMIC	WENG_POR_TARGETS_LIVER_UP
0.151285930408%	1	661	41	T2D_GENES_TANYA_GLYCEMIC	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN
0.151285930408%	1	661	41	T2D_GENES_TANYA_GLYCEMIC	REACTOME_NETRIN1_SIGNALING
0.151285930408%	1	661	41	T2D_GENES_TANYA_GLYCEMIC	PID_ERBB1_INTERNALIZATION_PATHWAY
0.151285930408%	1	661	41	T2D_GENES_TANYA_GLYCEMIC	LI_LUNG_CANCER
0.151285930408%	1	661	41	T2D_GENES_TANYA_GLYCEMIC	LIN_MELANOMA_COPY_NUMBER_DN
0.151285930408%	1	661	41	T2D_GENES_TANYA_GLYCEMIC	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM
0.151285930408%	1	661	41	T2D_GENES_TANYA_GLYCEMIC	KAMMINGA_EZH2_TARGETS
0.151285930408%	1	661	41	T2D_GENES_TANYA_GLYCEMIC	KAAB_FAILED_HEART_VENTRICLE_DN
0.151285930408%	1	661	41	T2D_GENES_TANYA_GLYCEMIC	GENTILE_UV_RESPONSE_CLUSTER_D2
0.151285930408%	1	661	41	T2D_GENES_TANYA_GLYCEMIC	CHEN_HOXA5_TARGETS_9HR_DN
0.151285930408%	1	661	40	T2D_GENES_TANYA_GLYCEMIC	VARELA_ZMPSTE24_TARGETS_UP
0.151285930408%	1	661	40	T2D_GENES_TANYA_GLYCEMIC	VANASSE_BCL2_TARGETS_UP
0.151285930408%	1	661	40	T2D_GENES_TANYA_GLYCEMIC	TOMLINS_PROSTATE_CANCER_DN
0.151285930408%	1	661	40	T2D_GENES_TANYA_GLYCEMIC	MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.151285930408%	1	661	40	T2D_GENES_TANYA_GLYCEMIC	LIAO_HAVE_SOX4_BINDING_SITES
0.151285930408%	1	661	40	T2D_GENES_TANYA_GLYCEMIC	KEGG_SPHINGOLIPID_METABOLISM
0.151285930408%	1	661	40	T2D_GENES_TANYA_GLYCEMIC	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN
0.151285930408%	1	661	40	T2D_GENES_TANYA_GLYCEMIC	HEIDENBLAD_AMPLICON_8Q24_UP
0.151285930408%	1	661	40	T2D_GENES_TANYA_GLYCEMIC	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
0.151285930408%	1	661	40	T2D_GENES_TANYA_GLYCEMIC	GENTILE_UV_RESPONSE_CLUSTER_D7
0.151285930408%	1	661	40	T2D_GENES_TANYA_GLYCEMIC	ELLWOOD_MYC_TARGETS_DN
0.151285930408%	1	661	40	T2D_GENES_TANYA_GLYCEMIC	BURTON_ADIPOGENESIS_PEAK_AT_16HR
0.151285930408%	1	661	40	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_P38MAPK_PATHWAY
0.151285930408%	1	661	39	T2D_GENES_TANYA_GLYCEMIC	WHITEHURST_PACLITAXEL_SENSITIVITY
0.151285930408%	1	661	39	T2D_GENES_TANYA_GLYCEMIC	STONER_ESOPHAGEAL_CARCINOGENESIS_UP
0.151285930408%	1	661	39	T2D_GENES_TANYA_GLYCEMIC	SESTO_RESPONSE_TO_UV_C6
0.151285930408%	1	661	39	T2D_GENES_TANYA_GLYCEMIC	PID_ECADHERIN_NASCENTAJ_PATHWAY
0.151285930408%	1	661	39	T2D_GENES_TANYA_GLYCEMIC	HOFMANN_CELL_LYMPHOMA_DN
0.151285930408%	1	661	39	T2D_GENES_TANYA_GLYCEMIC	HAN_JNK_SINGALING_DN
0.151285930408%	1	661	39	T2D_GENES_TANYA_GLYCEMIC	CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP
0.151285930408%	1	661	39	T2D_GENES_TANYA_GLYCEMIC	BURTON_ADIPOGENESIS_PEAK_AT_8HR
0.151285930408%	1	661	39	T2D_GENES_TANYA_GLYCEMIC	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP
0.151285930408%	1	661	39	T2D_GENES_TANYA_GLYCEMIC	AMIT_SERUM_RESPONSE_480_MCF10A
0.151285930408%	1	661	38	T2D_GENES_TANYA_GLYCEMIC	YOKOE_CANCER_TESTIS_ANTIGENS
0.151285930408%	1	661	38	T2D_GENES_TANYA_GLYCEMIC	VARELA_ZMPSTE24_TARGETS_DN
0.151285930408%	1	661	38	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PI3K_AKT_ACTIVATION
0.151285930408%	1	661	38	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GABA_B_RECEPTOR_ACTIVATION
0.151285930408%	1	661	38	T2D_GENES_TANYA_GLYCEMIC	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS
0.151285930408%	1	661	38	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS
0.151285930408%	1	661	38	T2D_GENES_TANYA_GLYCEMIC	PIONTEK_PKD1_TARGETS_UP
0.151285930408%	1	661	38	T2D_GENES_TANYA_GLYCEMIC	NAKAMURA_ADIPOGENESIS_LATE_DN
0.151285930408%	1	661	38	T2D_GENES_TANYA_GLYCEMIC	NAKAMURA_ADIPOGENESIS_EARLY_DN
0.151285930408%	1	661	38	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.151285930408%	1	661	38	T2D_GENES_TANYA_GLYCEMIC	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP
0.151285930408%	1	661	38	T2D_GENES_TANYA_GLYCEMIC	KYNG_DNA_DAMAGE_BY_4NQO
0.151285930408%	1	661	38	T2D_GENES_TANYA_GLYCEMIC	FIGUEROA_AML_METHYLATION_CLUSTER_6_DN
0.151285930408%	1	661	38	T2D_GENES_TANYA_GLYCEMIC	CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN
0.151285930408%	1	661	37	T2D_GENES_TANYA_GLYCEMIC	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN
0.151285930408%	1	661	37	T2D_GENES_TANYA_GLYCEMIC	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.151285930408%	1	661	37	T2D_GENES_TANYA_GLYCEMIC	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
0.151285930408%	1	661	37	T2D_GENES_TANYA_GLYCEMIC	ST_GA13_PATHWAY
0.151285930408%	1	661	37	T2D_GENES_TANYA_GLYCEMIC	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING
0.151285930408%	1	661	37	T2D_GENES_TANYA_GLYCEMIC	PID_IL23PATHWAY
0.151285930408%	1	661	37	T2D_GENES_TANYA_GLYCEMIC	PID_FRA_PATHWAY
0.151285930408%	1	661	37	T2D_GENES_TANYA_GLYCEMIC	MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED
0.151285930408%	1	661	37	T2D_GENES_TANYA_GLYCEMIC	HU_ANGIOGENESIS_DN
0.151285930408%	1	661	37	T2D_GENES_TANYA_GLYCEMIC	GENTILE_UV_RESPONSE_CLUSTER_D6
0.151285930408%	1	661	37	T2D_GENES_TANYA_GLYCEMIC	FRASOR_RESPONSE_TO_ESTRADIOL_UP
0.151285930408%	1	661	37	T2D_GENES_TANYA_GLYCEMIC	CUI_TCF21_TARGETS_UP
0.151285930408%	1	661	37	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_TOLL_PATHWAY
0.151285930408%	1	661	37	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_MET_PATHWAY
0.151285930408%	1	661	37	T2D_GENES_TANYA_GLYCEMIC	BILANGES_SERUM_RESPONSE_TRANSLATION
0.151285930408%	1	661	36	T2D_GENES_TANYA_GLYCEMIC	YANG_BREAST_CANCER_ESR1_UP
0.151285930408%	1	661	36	T2D_GENES_TANYA_GLYCEMIC	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2
0.151285930408%	1	661	36	T2D_GENES_TANYA_GLYCEMIC	VANTVEER_BREAST_CANCER_BRCA1_UP
0.151285930408%	1	661	36	T2D_GENES_TANYA_GLYCEMIC	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN
0.151285930408%	1	661	36	T2D_GENES_TANYA_GLYCEMIC	STEARMAN_TUMOR_FIELD_EFFECT_UP
0.151285930408%	1	661	36	T2D_GENES_TANYA_GLYCEMIC	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
0.151285930408%	1	661	36	T2D_GENES_TANYA_GLYCEMIC	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.151285930408%	1	661	36	T2D_GENES_TANYA_GLYCEMIC	SEMENZA_HIF1_TARGETS
0.151285930408%	1	661	36	T2D_GENES_TANYA_GLYCEMIC	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
0.151285930408%	1	661	36	T2D_GENES_TANYA_GLYCEMIC	REACTOME_IRON_UPTAKE_AND_TRANSPORT
0.151285930408%	1	661	36	T2D_GENES_TANYA_GLYCEMIC	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION
0.151285930408%	1	661	36	T2D_GENES_TANYA_GLYCEMIC	PID_PI3KPLCTRKPATHWAY
0.151285930408%	1	661	36	T2D_GENES_TANYA_GLYCEMIC	MMS_MOUSE_LYMPH_HIGH_4HRS_UP
0.151285930408%	1	661	36	T2D_GENES_TANYA_GLYCEMIC	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
0.151285930408%	1	661	36	T2D_GENES_TANYA_GLYCEMIC	KEGG_BASAL_TRANSCRIPTION_FACTORS
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	WESTON_VEGFA_TARGETS_12HR
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	WEIGEL_OXIDATIVE_STRESS_RESPONSE
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	WANG_METHYLATED_IN_BREAST_CANCER
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	VALK_AML_CLUSTER_9
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	ROZANOV_MMP14_TARGETS_DN
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	PID_PI3KCIAKTPATHWAY
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	KEGG_PRION_DISEASES
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	JAZAG_TGFB1_SIGNALING_DN
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	HU_GENOTOXIC_DAMAGE_24HR
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	HOWLIN_CITED1_TARGETS_1_UP
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	GUTIERREZ_MULTIPLE_MYELOMA_DN
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	DORSAM_HOXA9_TARGETS_UP
0.151285930408%	1	661	35	T2D_GENES_TANYA_GLYCEMIC	BALDWIN_PRKCI_TARGETS_UP
0.151285930408%	1	661	34	T2D_GENES_TANYA_GLYCEMIC	WONG_IFNA2_RESISTANCE_DN
0.151285930408%	1	661	34	T2D_GENES_TANYA_GLYCEMIC	ST_WNT_BETA_CATENIN_PATHWAY
0.151285930408%	1	661	34	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GLUCONEOGENESIS
0.151285930408%	1	661	34	T2D_GENES_TANYA_GLYCEMIC	REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX
0.151285930408%	1	661	34	T2D_GENES_TANYA_GLYCEMIC	PID_MAPKTRKPATHWAY
0.151285930408%	1	661	34	T2D_GENES_TANYA_GLYCEMIC	PID_IL2_PI3KPATHWAY
0.151285930408%	1	661	34	T2D_GENES_TANYA_GLYCEMIC	PID_EPOPATHWAY
0.151285930408%	1	661	34	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.151285930408%	1	661	34	T2D_GENES_TANYA_GLYCEMIC	FRIDMAN_IMMORTALIZATION_DN
0.151285930408%	1	661	34	T2D_GENES_TANYA_GLYCEMIC	DOANE_BREAST_CANCER_CLASSES_DN
0.151285930408%	1	661	34	T2D_GENES_TANYA_GLYCEMIC	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP
0.151285930408%	1	661	34	T2D_GENES_TANYA_GLYCEMIC	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP
0.151285930408%	1	661	34	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_MPR_PATHWAY
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	ZHAN_LATE_DIFFERENTIATION_GENES_UP
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	WENDT_COHESIN_TARGETS_UP
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	VALK_AML_CLUSTER_5
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	PID_SYNDECAN_2_PATHWAY
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	PID_IL12_STAT4PATHWAY
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	KEGG_ETHER_LIPID_METABOLISM
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	JEPSEN_SMRT_TARGETS
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	DUTTA_APOPTOSIS_VIA_NFKB
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	CAFFAREL_RESPONSE_TO_THC_UP
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_IL1R_PATHWAY
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN
0.151285930408%	1	661	33	T2D_GENES_TANYA_GLYCEMIC	APPEL_IMATINIB_RESPONSE
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	ZWANG_EGF_PERSISTENTLY_UP
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	TRACEY_RESISTANCE_TO_IFNA2_DN
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ELONGATION_ARREST_AND_RECOVERY
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	POS_HISTAMINE_RESPONSE_NETWORK
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	KEGG_CITRATE_CYCLE_TCA_CYCLE
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	GROSS_ELK3_TARGETS_DN
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	FARDIN_HYPOXIA_11
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	DORSAM_HOXA9_TARGETS_DN
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_HDAC_PATHWAY
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	BAUS_TFF2_TARGETS_UP
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	BAE_BRCA1_TARGETS_DN
0.151285930408%	1	661	32	T2D_GENES_TANYA_GLYCEMIC	AMIT_SERUM_RESPONSE_40_MCF10A
0.151285930408%	1	661	31	T2D_GENES_TANYA_GLYCEMIC	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP
0.151285930408%	1	661	31	T2D_GENES_TANYA_GLYCEMIC	VALK_AML_CLUSTER_4
0.151285930408%	1	661	31	T2D_GENES_TANYA_GLYCEMIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.151285930408%	1	661	31	T2D_GENES_TANYA_GLYCEMIC	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.151285930408%	1	661	31	T2D_GENES_TANYA_GLYCEMIC	REACTOME_HS_GAG_BIOSYNTHESIS
0.151285930408%	1	661	31	T2D_GENES_TANYA_GLYCEMIC	REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE
0.151285930408%	1	661	31	T2D_GENES_TANYA_GLYCEMIC	NOJIMA_SFRP2_TARGETS_UP
0.151285930408%	1	661	31	T2D_GENES_TANYA_GLYCEMIC	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.151285930408%	1	661	31	T2D_GENES_TANYA_GLYCEMIC	MOSERLE_IFNA_RESPONSE
0.151285930408%	1	661	31	T2D_GENES_TANYA_GLYCEMIC	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD
0.151285930408%	1	661	31	T2D_GENES_TANYA_GLYCEMIC	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP
0.151285930408%	1	661	31	T2D_GENES_TANYA_GLYCEMIC	IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM
0.151285930408%	1	661	31	T2D_GENES_TANYA_GLYCEMIC	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	YANAGIHARA_ESX1_TARGETS
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	VALK_AML_CLUSTER_13
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	REACTOME_NOD1_2_SIGNALING_PATHWAY
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MRNA_CAPPING
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	REACTOME_BASIGIN_INTERACTIONS
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	PID_RAS_PATHWAY
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	PID_IL2_STAT5PATHWAY
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	PID_EPHRINBREVPATHWAY
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	LY_AGING_PREMATURE_DN
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	KIM_LRRC3B_TARGETS
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	KEGG_O_GLYCAN_BIOSYNTHESIS
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	GUILLAUMOND_KLF10_TARGETS_DN
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	DAZARD_UV_RESPONSE_CLUSTER_G2
0.151285930408%	1	661	30	T2D_GENES_TANYA_GLYCEMIC	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	WOTTON_RUNX_TARGETS_DN
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	WANG_RESPONSE_TO_ANDROGEN_UP
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	VALK_AML_CLUSTER_2
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	REACTOME_STEROID_HORMONES
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	PID_S1P_S1P3_PATHWAY
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	PATTERSON_DOCETAXEL_RESISTANCE
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	PAL_PRMT5_TARGETS_DN
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	NGUYEN_NOTCH1_TARGETS_UP
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	MA_PITUITARY_FETAL_VS_ADULT_UP
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	MAYBURD_RESPONSE_TO_L663536_UP
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	KRIGE_AMINO_ACID_DEPRIVATION
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	KEGG_RNA_POLYMERASE
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	KEGG_HISTIDINE_METABOLISM
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	DALESSIO_TSA_RESPONSE
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	CHOW_RASSF1_TARGETS_DN
0.151285930408%	1	661	29	T2D_GENES_TANYA_GLYCEMIC	ABE_VEGFA_TARGETS_30MIN
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	WILLIAMS_ESR2_TARGETS_UP
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	VALK_AML_CLUSTER_7
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	VALK_AML_CLUSTER_1
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	ST_GAQ_PATHWAY
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	REICHERT_MITOSIS_LIN9_TARGETS
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SHC_MEDIATED_CASCADE
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	PID_TRAIL_PATHWAY
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	PETROVA_PROX1_TARGETS_UP
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	LI_CISPLATIN_RESISTANCE_UP
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	KEGG_HOMOLOGOUS_RECOMBINATION
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	DAZARD_UV_RESPONSE_CLUSTER_G24
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_PROTEASOME_PATHWAY
0.151285930408%	1	661	28	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_ERK_PATHWAY
0.151285930408%	1	661	27	T2D_GENES_TANYA_GLYCEMIC	XU_AKT1_TARGETS_6HR
0.151285930408%	1	661	27	T2D_GENES_TANYA_GLYCEMIC	ST_MYOCYTE_AD_PATHWAY
0.151285930408%	1	661	27	T2D_GENES_TANYA_GLYCEMIC	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
0.151285930408%	1	661	27	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALLING_TO_RAS
0.151285930408%	1	661	27	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS
0.151285930408%	1	661	27	T2D_GENES_TANYA_GLYCEMIC	PLASARI_NFIC_TARGETS_BASAL_UP
0.151285930408%	1	661	27	T2D_GENES_TANYA_GLYCEMIC	PID_IL3_PATHWAY
0.151285930408%	1	661	27	T2D_GENES_TANYA_GLYCEMIC	LI_WILMS_TUMOR
0.151285930408%	1	661	27	T2D_GENES_TANYA_GLYCEMIC	KEGG_PENTOSE_PHOSPHATE_PATHWAY
0.151285930408%	1	661	27	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_EDG1_PATHWAY
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	ZHENG_FOXP3_TARGETS_UP
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	WALLACE_JAK2_TARGETS_UP
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	VALK_AML_CLUSTER_8
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	VALK_AML_CLUSTER_16
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	TOMIDA_METASTASIS_UP
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	REACTOME_KERATAN_SULFATE_BIOSYNTHESIS
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	PID_VEGFR1_PATHWAY
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	PID_INSULIN_GLUCOSE_PATHWAY
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	PID_IL27PATHWAY
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	NEWMAN_ERCC6_TARGETS_UP
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	HAHTOLA_CTCL_CUTANEOUS
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	FINAK_BREAST_CANCER_SDPP_SIGNATURE
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_WNT_PATHWAY
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_PGC1A_PATHWAY
0.151285930408%	1	661	26	T2D_GENES_TANYA_GLYCEMIC	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	WAGNER_APO2_SENSITIVITY
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	VERRECCHIA_RESPONSE_TO_TGFB1_C2
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	VALK_AML_WITH_EVI1
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	RUAN_RESPONSE_TO_TROGLITAZONE_UP
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	REACTOME_G0_AND_EARLY_G1
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	REACTOME_DARPP_32_EVENTS
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	PID_TOLL_ENDOGENOUS_PATHWAY
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	PID_HDAC_CLASSIII_PATHWAY
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	OZEN_MIR125B1_TARGETS
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	NOJIMA_SFRP2_TARGETS_DN
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	KEGG_DORSO_VENTRAL_AXIS_FORMATION
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS
0.151285930408%	1	661	25	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_STRESS_PATHWAY
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	YIH_RESPONSE_TO_ARSENITE_C1
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	YAN_ESCAPE_FROM_ANOIKIS
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	WANG_TNF_TARGETS
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	WANG_LSD1_TARGETS_UP
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	SA_B_CELL_RECEPTOR_COMPLEXES
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	REACTOME_REGULATION_OF_IFNA_SIGNALING
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PYRIMIDINE_METABOLISM
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CHOLESTEROL_BIOSYNTHESIS
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	PID_S1P_S1P2_PATHWAY
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	OXFORD_RALA_OR_RALB_TARGETS_DN
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	OSADA_ASCL1_TARGETS_DN
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	ONO_AML1_TARGETS_UP
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	MAEKAWA_ATF2_TARGETS
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	LA_MEN1_TARGETS
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	KIM_GERMINAL_CENTER_T_HELPER_DN
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	HASLINGER_B_CLL_WITH_13Q14_DELETION
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	GOLUB_ALL_VS_AML_UP
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	GOLUB_ALL_VS_AML_DN
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_NOS1_PATHWAY
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CSK_PATHWAY
0.151285930408%	1	661	24	T2D_GENES_TANYA_GLYCEMIC	AZARE_STAT3_TARGETS
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	YANG_MUC2_TARGETS_DUODENUM_3MO_DN
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	YANG_BREAST_CANCER_ESR1_BULK_DN
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	WANG_RESPONSE_TO_FORSKOLIN_UP
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	SEKI_INFLAMMATORY_RESPONSE_LPS_DN
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	SAGIV_CD24_TARGETS_UP
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	PID_PRLSIGNALINGEVENTSPATHWAY
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	ONO_FOXP3_TARGETS_UP
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	MARKS_HDAC_TARGETS_UP
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	KEGG_MISMATCH_REPAIR
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	HINATA_NFKB_TARGETS_KERATINOCYTE_DN
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	HASLINGER_B_CLL_WITH_11Q23_DELETION
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	EGUCHI_CELL_CYCLE_RB1_TARGETS
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	CHEOK_RESPONSE_TO_HD_MTX_UP
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_PTDINS_PATHWAY
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_P53HYPOXIA_PATHWAY
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_NFKB_PATHWAY
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_INTRINSIC_PATHWAY
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_IL12_PATHWAY
0.151285930408%	1	661	23	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CTCF_PATHWAY
0.151285930408%	1	661	22	T2D_GENES_TANYA_GLYCEMIC	WELCH_GATA1_TARGETS
0.151285930408%	1	661	22	T2D_GENES_TANYA_GLYCEMIC	VALK_AML_WITH_11Q23_REARRANGED
0.151285930408%	1	661	22	T2D_GENES_TANYA_GLYCEMIC	SUZUKI_RESPONSE_TO_TSA
0.151285930408%	1	661	22	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING
0.151285930408%	1	661	22	T2D_GENES_TANYA_GLYCEMIC	REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION
0.151285930408%	1	661	22	T2D_GENES_TANYA_GLYCEMIC	PID_PDGFRAPATHWAY
0.151285930408%	1	661	22	T2D_GENES_TANYA_GLYCEMIC	PID_HEDGEHOG_2PATHWAY
0.151285930408%	1	661	22	T2D_GENES_TANYA_GLYCEMIC	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
0.151285930408%	1	661	22	T2D_GENES_TANYA_GLYCEMIC	KANG_FLUOROURACIL_RESISTANCE_UP
0.151285930408%	1	661	22	T2D_GENES_TANYA_GLYCEMIC	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP
0.151285930408%	1	661	22	T2D_GENES_TANYA_GLYCEMIC	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP
0.151285930408%	1	661	22	T2D_GENES_TANYA_GLYCEMIC	GAVIN_PDE3B_TARGETS
0.151285930408%	1	661	22	T2D_GENES_TANYA_GLYCEMIC	GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION
0.151285930408%	1	661	22	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_INSULIN_PATHWAY
0.151285930408%	1	661	22	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_IL6_PATHWAY
0.151285930408%	1	661	22	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_HER2_PATHWAY
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	ZIRN_TRETINOIN_RESPONSE_UP
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	PID_P38_MK2PATHWAY
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	OUYANG_PROSTATE_CANCER_PROGRESSION_DN
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	MOOTHA_GLYCOGEN_METABOLISM
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	LANDEMAINE_LUNG_METASTASIS
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	HU_ANGIOGENESIS_UP
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	HUI_MAPK14_TARGETS_UP
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	HASLINGER_B_CLL_WITH_17P13_DELETION
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	GREENBAUM_E2A_TARGETS_DN
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	GESERICK_TERT_TARGETS_DN
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	FERRANDO_TAL1_NEIGHBORS
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_TFF_PATHWAY
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CALCINEURIN_PATHWAY
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_ATRBRCA_PATHWAY
0.151285930408%	1	661	21	T2D_GENES_TANYA_GLYCEMIC	AMIT_SERUM_RESPONSE_20_MCF10A
0.151285930408%	1	661	203	T2D_GENES_TANYA_GLYCEMIC	REACTOME_INFLUENZA_LIFE_CYCLE
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	WEBER_METHYLATED_HCP_IN_SPERM_UP
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	WANG_THOC1_TARGETS_DN
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	WALLACE_PROSTATE_CANCER_UP
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	VILIMAS_NOTCH1_TARGETS_DN
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	REACTOME_HS_GAG_DEGRADATION
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ENOS_ACTIVATION_AND_REGULATION
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	OUYANG_PROSTATE_CANCER_PROGRESSION_UP
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	NIELSEN_SYNOVIAL_SARCOMA_DN
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	MCCABE_HOXC6_TARGETS_CANCER_DN
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	KIM_MYCL1_AMPLIFICATION_TARGETS_DN
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	HEDENFALK_BREAST_CANCER_BRACX_UP
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_IGF1MTOR_PATHWAY
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CCR5_PATHWAY
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_AMI_PATHWAY
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	BARRIER_COLON_CANCER_RECURRENCE_DN
0.151285930408%	1	661	20	T2D_GENES_TANYA_GLYCEMIC	ABE_VEGFA_TARGETS
0.151285930408%	1	661	191	T2D_GENES_TANYA_GLYCEMIC	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	WU_ALZHEIMER_DISEASE_DN
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	VISALA_AGING_LYMPHOCYTE_DN
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	VERRECCHIA_RESPONSE_TO_TGFB1_C1
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	TERAMOTO_OPN_TARGETS_CLUSTER_7
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CGMP_EFFECTS
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	PID_HIF1APATHWAY
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	PID_EPHA2_FWDPATHWAY
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	NIELSEN_LIPOSARCOMA_DN
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	NIELSEN_LEIOMYOSARCOMA_CNN1_UP
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	NAGY_TFTC_COMPONENTS_HUMAN
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	LI_WILMS_TUMOR_ANAPLASTIC_UP
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	KEGG_ALPHA_LINOLENIC_ACID_METABOLISM
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	HAHTOLA_MYCOSIS_FUNGOIDES_UP
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	GRANDVAUX_IRF3_TARGETS_DN
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	GAJATE_RESPONSE_TO_TRABECTEDIN_DN
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	FARMER_BREAST_CANCER_CLUSTER_5
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	CHEN_PDGF_TARGETS
0.151285930408%	1	661	19	T2D_GENES_TANYA_GLYCEMIC	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	ZHENG_RESPONSE_TO_ARSENITE_UP
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	YIH_RESPONSE_TO_ARSENITE_C2
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	SCHURINGA_STAT5A_TARGETS_DN
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SYNTHESIS_OF_PC
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	PODAR_RESPONSE_TO_ADAPHOSTIN_DN
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	NIELSEN_LEIOMYOSARCOMA_UP
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	NAM_FXYD5_TARGETS_DN
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	MOREIRA_RESPONSE_TO_TSA_DN
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	KIM_PTEN_TARGETS_UP
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	KEGG_PHENYLALANINE_METABOLISM
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	HUMMERICH_BENIGN_SKIN_TUMOR_UP
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	HUMMERICH_BENIGN_SKIN_TUMOR_DN
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	GENTILE_UV_RESPONSE_CLUSTER_D1
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_UCALPAIN_PATHWAY
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_TEL_PATHWAY
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_SPRY_PATHWAY
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_ETS_PATHWAY
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_ERK5_PATHWAY
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_ARAP_PATHWAY
0.151285930408%	1	661	18	T2D_GENES_TANYA_GLYCEMIC	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP
0.151285930408%	1	661	179	T2D_GENES_TANYA_GLYCEMIC	BENPORATH_NOS_TARGETS
0.151285930408%	1	661	176	T2D_GENES_TANYA_GLYCEMIC	REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION
0.151285930408%	1	661	175	T2D_GENES_TANYA_GLYCEMIC	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	SIMBULAN_PARP1_TARGETS_DN
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	SA_TRKA_RECEPTOR
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	SA_PTEN_PATHWAY
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TIE2_SIGNALING
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SHC_RELATED_EVENTS
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RNA_POL_III_CHAIN_ELONGATION
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RAP1_SIGNALLING
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	REACTOME_INTRINSIC_PATHWAY
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ARMS_MEDIATED_ACTIVATION
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	PID_SMAD2_3PATHWAY
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	KEGG_STEROID_BIOSYNTHESIS
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	KEGG_RENIN_ANGIOTENSIN_SYSTEM
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	KEGG_ONE_CARBON_POOL_BY_FOLATE
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	GOUYER_TATI_TARGETS_DN
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_IL10_PATHWAY
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_HCMV_PATHWAY
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CK1_PATHWAY
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_41BB_PATHWAY
0.151285930408%	1	661	17	T2D_GENES_TANYA_GLYCEMIC	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP
0.151285930408%	1	661	169	T2D_GENES_TANYA_GLYCEMIC	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION
0.151285930408%	1	661	165	T2D_GENES_TANYA_GLYCEMIC	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	TIAN_BHLHA15_TARGETS
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	ST_G_ALPHA_S_PATHWAY
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	PID_DNAPK_PATHWAY
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	MOOTHA_TCA
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	LY_AGING_MIDDLE_DN
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	LUND_SILENCED_BY_METHYLATION
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	LIU_TOPBP1_TARGETS
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	KOINUMA_COLON_CANCER_MSI_DN
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	KEGG_RIBOFLAVIN_METABOLISM
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	KANG_FLUOROURACIL_RESISTANCE_DN
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	HAHTOLA_MYCOSIS_FUNGOIDES_DN
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	HAHTOLA_CTCL_PATHOGENESIS
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	GHO_ATF5_TARGETS_DN
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	FUKUSHIMA_TNFSF11_TARGETS
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_SHH_PATHWAY
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_IL22BP_PATHWAY
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_GATA3_PATHWAY
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CDMAC_PATHWAY
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CDC42RAC_PATHWAY
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CACAM_PATHWAY
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_ACH_PATHWAY
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
0.151285930408%	1	661	16	T2D_GENES_TANYA_GLYCEMIC	ABDELMOHSEN_ELAVL4_TARGETS
0.151285930408%	1	661	153	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PEPTIDE_CHAIN_ELONGATION
0.151285930408%	1	661	152	T2D_GENES_TANYA_GLYCEMIC	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
0.151285930408%	1	661	151	T2D_GENES_TANYA_GLYCEMIC	IGLESIAS_E2F_TARGETS_UP
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	SA_G1_AND_S_PHASES
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SHC_MEDIATED_SIGNALLING
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	REACTOME_METABOLISM_OF_POLYAMINES
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	REACTOME_AMINE_DERIVED_HORMONES
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	PID_LPA4_PATHWAY
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	PID_ARF6DOWNSTREAMPATHWAY
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	NAGY_STAGA_COMPONENTS_HUMAN
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	FERRANDO_LYL1_NEIGHBORS
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	CHANG_POU5F1_TARGETS_UP
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_LONGEVITY_PATHWAY
0.151285930408%	1	661	15	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_BARRESTIN_SRC_PATHWAY
0.151285930408%	1	661	147	T2D_GENES_TANYA_GLYCEMIC	DARWICHE_PAPILLOMA_RISK_HIGH_UP
0.151285930408%	1	661	143	T2D_GENES_TANYA_GLYCEMIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.151285930408%	1	661	142	T2D_GENES_TANYA_GLYCEMIC	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	WU_ALZHEIMER_DISEASE_UP
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	VERRECCHIA_RESPONSE_TO_TGFB1_C3
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	ROETH_TERT_TARGETS_UP
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SOS_MEDIATED_SIGNALLING
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SIGNAL_ATTENUATION
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CRMPS_IN_SEMA3A_SIGNALING
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	REACTOME_COMMON_PATHWAY
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	PID_TCRRASPATHWAY
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	PID_IL5_PATHWAY
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	KINNEY_DNMT1_METHYLATION_TARGETS
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	DORN_ADENOVIRUS_INFECTION_48HR_UP
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	CASTELLANO_NRAS_TARGETS_DN
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_PS1_PATHWAY
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_PLATELETAPP_PATHWAY
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_DREAM_PATHWAY
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	AMIT_EGF_RESPONSE_20_MCF10A
0.151285930408%	1	661	14	T2D_GENES_TANYA_GLYCEMIC	ABBUD_LIF_SIGNALING_2_UP
0.151285930408%	1	661	139	T2D_GENES_TANYA_GLYCEMIC	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
0.151285930408%	1	661	136	T2D_GENES_TANYA_GLYCEMIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.151285930408%	1	661	132	T2D_GENES_TANYA_GLYCEMIC	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	VERRECCHIA_RESPONSE_TO_TGFB1_C4
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	STARK_BRAIN_22Q11_DELETION
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	SHI_SPARC_TARGETS_DN
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	SA_REG_CASCADE_OF_CYCLIN_EXPR
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	ONGUSAHA_BRCA1_TARGETS_UP
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	MATZUK_EARLY_ANTRAL_FOLLICLE
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	KORKOLA_EMBRYONAL_CARCINOMA
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	KIM_MYCL1_AMPLIFICATION_TARGETS_UP
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	KEGG_CIRCADIAN_RHYTHM_MAMMAL
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	GHO_ATF5_TARGETS_UP
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_EXTRINSIC_PATHWAY
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CARM1_PATHWAY
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_AGPCR_PATHWAY
0.151285930408%	1	661	13	T2D_GENES_TANYA_GLYCEMIC	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN
0.151285930408%	1	661	129	T2D_GENES_TANYA_GLYCEMIC	BROWN_MYELOID_CELL_DEVELOPMENT_DN
0.151285930408%	1	661	127	T2D_GENES_TANYA_GLYCEMIC	KARLSSON_TGFB1_TARGETS_UP
0.151285930408%	1	661	121	T2D_GENES_TANYA_GLYCEMIC	KEGG_LYSOSOME
0.151285930408%	1	661	120	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CELL_CELL_COMMUNICATION
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	ZHENG_FOXP3_TARGETS_IN_THYMUS_DN
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	NEBEN_AML_WITH_FLT3_OR_NRAS_DN
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_NPC_ICP_WITH_H3K27ME3
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	FUNG_IL2_SIGNALING_2
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	FIGUEROA_AML_METHYLATION_CLUSTER_5_UP
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	EHLERS_ANEUPLOIDY_DN
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	DORN_ADENOVIRUS_INFECTION_24HR_UP
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	DAZARD_UV_RESPONSE_CLUSTER_G5
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_TRKA_PATHWAY
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_PLCE_PATHWAY
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_FIBRINOLYSIS_PATHWAY
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_ETC_PATHWAY
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CFTR_PATHWAY
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_BARR_MAPK_PATHWAY
0.151285930408%	1	661	12	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_AKAP95_PATHWAY
0.151285930408%	1	661	116	T2D_GENES_TANYA_GLYCEMIC	IKEDA_MIR30_TARGETS_UP
0.151285930408%	1	661	114	T2D_GENES_TANYA_GLYCEMIC	BOSCO_TH1_CYTOTOXIC_MODULE
0.151285930408%	1	661	110	T2D_GENES_TANYA_GLYCEMIC	WOOD_EBV_EBNA1_TARGETS_UP
0.151285930408%	1	661	110	T2D_GENES_TANYA_GLYCEMIC	GHANDHI_DIRECT_IRRADIATION_UP
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	ZHOU_PANCREATIC_BETA_CELL
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	SHIN_B_CELL_LYMPHOMA_CLUSTER_6
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	REACTOME_UNWINDING_OF_DNA
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	REACTOME_TRYPTOPHAN_CATABOLISM
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	REACTOME_SYNTHESIS_OF_PE
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	PID_INTEGRIN4_PATHWAY
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	LOPEZ_MESOTHELIOMA_SURVIVAL_UP
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	KALMA_E2F1_TARGETS
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	FOURNIER_ACINAR_DEVELOPMENT_LATE_UP
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	DORN_ADENOVIRUS_INFECTION_32HR_UP
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	CHUANG_OXIDATIVE_STRESS_RESPONSE_DN
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_EGFR_SMRTE_PATHWAY
0.151285930408%	1	661	11	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_CDK5_PATHWAY
0.151285930408%	1	661	109	T2D_GENES_TANYA_GLYCEMIC	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
0.151285930408%	1	661	103	T2D_GENES_TANYA_GLYCEMIC	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
0.151285930408%	1	661	102	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_IPS_WITH_HCP_H3K27ME3
0.151285930408%	1	661	102	T2D_GENES_TANYA_GLYCEMIC	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.151285930408%	1	661	101	T2D_GENES_TANYA_GLYCEMIC	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
0.151285930408%	1	661	100	T2D_GENES_TANYA_GLYCEMIC	MCCLUNG_CREB1_TARGETS_UP
0.151285930408%	1	661	100	T2D_GENES_TANYA_GLYCEMIC	GAVIN_FOXP3_TARGETS_CLUSTER_P4
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	WONG_ENDOMETRIAL_CANCER_LATE
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	SCHLESINGER_METHYLATED_IN_COLON_CANCER
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	REACTOME_RAF_MAP_KINASE_CASCADE
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PURINE_CATABOLISM
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	REACTOME_PECAM1_INTERACTIONS
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	OXFORD_RALA_TARGETS_DN
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	HOLLEMAN_DAUNORUBICIN_B_ALL_UP
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	CHASSOT_SKIN_WOUND
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	BUDHU_LIVER_CANCER_METASTASIS_UP
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	BRUNEAU_SEPTATION_VENTRICULAR
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_GLYCOLYSIS_PATHWAY
0.151285930408%	1	661	10	T2D_GENES_TANYA_GLYCEMIC	BIOCARTA_FREE_PATHWAY
0.142045454545%	5	3520	94	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOOI_ST7_TARGETS_UP
0.142045454545%	5	3520	93	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP
0.142045454545%	5	3520	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IGARASHI_ATF4_TARGETS_DN
0.142045454545%	5	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WNT_SIGNALING
0.142045454545%	5	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
0.142045454545%	5	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S
0.142045454545%	5	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_CMYB_PATHWAY
0.142045454545%	5	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
0.142045454545%	5	3520	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
0.142045454545%	5	3520	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_BETACATENIN_NUC_PATHWAY
0.142045454545%	5	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MEISSNER_NPC_HCP_WITH_H3K27ME3
0.142045454545%	5	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_P2
0.142045454545%	5	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP
0.142045454545%	5	3520	75	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHESLER_BRAIN_QTL_CIS
0.142045454545%	5	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WESTON_VEGFA_TARGETS_3HR
0.142045454545%	5	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.142045454545%	5	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS
0.142045454545%	5	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_E2F_PATHWAY
0.142045454545%	5	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
0.142045454545%	5	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIAN_LIPA_TARGETS_6M
0.142045454545%	5	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP
0.142045454545%	5	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN
0.142045454545%	5	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FURUKAWA_DUSP6_TARGETS_PCI35_DN
0.142045454545%	5	3520	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C8
0.142045454545%	5	3520	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUANG_GATA2_TARGETS_DN
0.142045454545%	5	3520	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.142045454545%	5	3520	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GU_PDEF_TARGETS_UP
0.142045454545%	5	3520	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_6HR_UP
0.142045454545%	5	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_AP1_PATHWAY
0.142045454545%	5	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP
0.142045454545%	5	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.142045454545%	5	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOWLIN_PUBERTAL_MAMMARY_GLAND
0.142045454545%	5	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIN_NPAS4_TARGETS_DN
0.142045454545%	5	3520	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
0.142045454545%	5	3520	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
0.142045454545%	5	3520	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP
0.142045454545%	5	3520	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
0.142045454545%	5	3520	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GENTILE_UV_LOW_DOSE_DN
0.142045454545%	5	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
0.142045454545%	5	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TENEDINI_MEGAKARYOCYTE_MARKERS
0.142045454545%	5	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_GERMINAL_CENTER_T_HELPER_UP
0.142045454545%	5	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
0.142045454545%	5	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ERA_GENOMIC_PATHWAY
0.142045454545%	5	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOLDRATH_IMMUNE_MEMORY
0.142045454545%	5	3520	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP
0.142045454545%	5	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_GATA6_TARGETS_DN
0.142045454545%	5	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH
0.142045454545%	5	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GERHOLD_ADIPOGENESIS_DN
0.142045454545%	5	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MODY_HIPPOCAMPUS_POSTNATAL
0.142045454545%	5	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
0.142045454545%	5	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JOHNSTONE_PARVB_TARGETS_1_DN
0.142045454545%	5	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.142045454545%	5	3520	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN
0.142045454545%	5	3520	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_1HR_UP
0.142045454545%	5	3520	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE
0.142045454545%	5	3520	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OUILLETTE_CLL_13Q14_DELETION_DN
0.142045454545%	5	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_C_DN
0.142045454545%	5	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHENG_GLIOBLASTOMA_PLASTICITY_DN
0.142045454545%	5	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WAKASUGI_HAVE_ZNF143_BINDING_SITES
0.142045454545%	5	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
0.142045454545%	5	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_NPC_LCP_WITH_H3K4ME3
0.142045454545%	5	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JI_RESPONSE_TO_FSH_DN
0.142045454545%	5	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP
0.142045454545%	5	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DIRMEIER_LMP1_RESPONSE_LATE_UP
0.142045454545%	5	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_11
0.142045454545%	5	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BORLAK_LIVER_CANCER_EGF_UP
0.142045454545%	5	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHENG_IL22_SIGNALING_UP
0.142045454545%	5	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_METASTASIS_UP
0.142045454545%	5	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER_MYC_E2F1_UP
0.142045454545%	5	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOQUE_METHYLATED_IN_CANCER
0.142045454545%	5	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GALE_APL_WITH_FLT3_MUTATED_UP
0.142045454545%	5	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_TGFBRPATHWAY
0.142045454545%	5	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN
0.142045454545%	5	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SU_PANCREAS
0.142045454545%	5	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROVERSI_GLIOMA_COPY_NUMBER_DN
0.142045454545%	5	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE
0.142045454545%	5	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_IPS_ICP_WITH_H3K27ME3
0.142045454545%	5	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_INOSITOL_PHOSPHATE_METABOLISM
0.142045454545%	5	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUPER_BREAST_BASAL_VS_LUMINAL_UP
0.142045454545%	5	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMIRNOV_RESPONSE_TO_IR_2HR_UP
0.142045454545%	5	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN
0.142045454545%	5	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_MTOR_SIGNALING_PATHWAY
0.142045454545%	5	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ENDOMETRIAL_CANCER
0.142045454545%	5	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HALMOS_CEBPA_TARGETS_UP
0.142045454545%	5	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIBA_RESPONSE_TO_TSA_UP
0.142045454545%	5	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
0.142045454545%	5	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NUCLEOTIDE_EXCISION_REPAIR
0.142045454545%	5	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE
0.142045454545%	5	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT
0.142045454545%	5	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN
0.142045454545%	5	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
0.142045454545%	5	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN
0.142045454545%	5	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROY_WOUND_BLOOD_VESSEL_UP
0.142045454545%	5	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
0.142045454545%	5	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NADERI_BREAST_CANCER_PROGNOSIS_UP
0.142045454545%	5	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTINEZ_RESPONSE_TO_TRABECTEDIN
0.142045454545%	5	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_5_DN
0.142045454545%	5	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8
0.142045454545%	5	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM
0.142045454545%	5	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN
0.142045454545%	5	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_2HR_DN
0.142045454545%	5	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAVOR_CEBPA_TARGETS_UP
0.142045454545%	5	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCDOWELL_ACUTE_LUNG_INJURY_DN
0.142045454545%	5	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHU_CMV_8_HR_UP
0.142045454545%	5	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_LKB1_PATHWAY
0.142045454545%	5	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_DELTANP63PATHWAY
0.142045454545%	5	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAMURA_METASTASIS
0.142045454545%	5	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_TYPE_II_DIABETES_MELLITUS
0.142045454545%	5	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_NOTCH_SIGNALING_PATHWAY
0.142045454545%	5	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION
0.142045454545%	5	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_SYNDECAN_1_PATHWAY
0.142045454545%	5	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1
0.142045454545%	5	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON
0.142045454545%	5	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MADAN_DPPA4_TARGETS
0.142045454545%	5	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_V2_LATE_DIFFERENTIATION_GENES
0.142045454545%	5	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD2_UP
0.142045454545%	5	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN
0.142045454545%	5	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAMURA_METASTASIS_MODEL_UP
0.142045454545%	5	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.142045454545%	5	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_CREBBP_TARGETS_DN
0.142045454545%	5	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	THILLAINADESAN_ZNF217_TARGETS_UP
0.142045454545%	5	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STREICHER_LSM1_TARGETS_UP
0.142045454545%	5	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTIN_INTERACT_WITH_HDAC
0.142045454545%	5	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LUI_THYROID_CANCER_PAX8_PPARG_UP
0.142045454545%	5	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP
0.142045454545%	5	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FARMER_BREAST_CANCER_CLUSTER_1
0.142045454545%	5	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHUNG_BLISTER_CYTOTOXICITY_DN
0.142045454545%	5	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_TCPTP_PATHWAY
0.142045454545%	5	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_CXCR3PATHWAY
0.142045454545%	5	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAYAMA_FRA2_TARGETS
0.142045454545%	5	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MANTOVANI_NFKB_TARGETS_UP
0.142045454545%	5	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FUJII_YBX1_TARGETS_UP
0.142045454545%	5	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHENG_IL22_SIGNALING_DN
0.142045454545%	5	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WIERENGA_PML_INTERACTOME
0.142045454545%	5	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP
0.142045454545%	5	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ONO_FOXP3_TARGETS_DN
0.142045454545%	5	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_ES_ICP_WITH_H3K27ME3
0.142045454545%	5	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LUI_THYROID_CANCER_CLUSTER_2
0.142045454545%	5	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
0.142045454545%	5	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_40_HELA
0.142045454545%	5	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_DN
0.142045454545%	5	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LI_LUNG_CANCER
0.142045454545%	5	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANASSE_BCL2_TARGETS_UP
0.142045454545%	5	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_JNK_MAPK_PATHWAY
0.142045454545%	5	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_FOXM1PATHWAY
0.142045454545%	5	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ELLWOOD_MYC_TARGETS_DN
0.142045454545%	5	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHANGOLKAR_H2AFY_TARGETS_DN
0.142045454545%	5	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_LSD1_TARGETS_DN
0.142045454545%	5	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHIPP_DLBCL_CURED_VS_FATAL_UP
0.142045454545%	5	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	POTTI_PACLITAXEL_SENSITIVITY
0.142045454545%	5	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ECADHERIN_NASCENTAJ_PATHWAY
0.142045454545%	5	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CONRAD_STEM_CELL
0.142045454545%	5	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_2HR_UP
0.142045454545%	5	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AIYAR_COBRA1_TARGETS_UP
0.142045454545%	5	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YOKOE_CANCER_TESTIS_ANTIGENS
0.142045454545%	5	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TERAO_AOX4_TARGETS_SKIN_UP
0.142045454545%	5	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KRASNOSELSKAYA_ILF3_TARGETS_UP
0.142045454545%	5	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP
0.142045454545%	5	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP
0.142045454545%	5	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN
0.142045454545%	5	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHANDRAN_METASTASIS_TOP50_UP
0.142045454545%	5	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
0.142045454545%	5	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS
0.142045454545%	5	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_IL23PATHWAY
0.142045454545%	5	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_GMCSF_PATHWAY
0.142045454545%	5	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATZUK_SPERMATID_DIFFERENTIATION
0.142045454545%	5	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES
0.142045454545%	5	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_PAR1_PATHWAY
0.142045454545%	5	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_ALK_PATHWAY
0.142045454545%	5	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
0.142045454545%	5	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SEMENZA_HIF1_TARGETS
0.142045454545%	5	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
0.142045454545%	5	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_DNA_REPLICATION
0.142045454545%	5	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_AGR_PATHWAY
0.142045454545%	5	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEIGEL_OXIDATIVE_STRESS_RESPONSE
0.142045454545%	5	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D
0.142045454545%	5	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_PI3KCIAKTPATHWAY
0.142045454545%	5	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
0.142045454545%	5	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LOPEZ_TRANSLATION_VIA_FN1_SIGNALING
0.142045454545%	5	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LI_CISPLATIN_RESISTANCE_DN
0.142045454545%	5	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JAZAG_TGFB1_SIGNALING_DN
0.142045454545%	5	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DORSAM_HOXA9_TARGETS_UP
0.142045454545%	5	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP
0.142045454545%	5	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SIG_CD40PATHWAYMAP
0.142045454545%	5	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNAL_TRANSDUCTION_BY_L1
0.142045454545%	5	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE
0.142045454545%	5	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX
0.142045454545%	5	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	POTTI_CYTOXAN_SENSITIVITY
0.142045454545%	5	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_MAPKTRKPATHWAY
0.142045454545%	5	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MEISSNER_ES_ICP_WITH_H3K4ME3
0.142045454545%	5	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KORKOLA_CORRELATED_WITH_POU5F1
0.142045454545%	5	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ABE_VEGFA_TARGETS_2HR
0.142045454545%	5	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TANG_SENESCENCE_TP53_TARGETS_UP
0.142045454545%	5	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS
0.142045454545%	5	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS
0.142045454545%	5	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_INTEGRIN_A4B1_PATHWAY
0.142045454545%	5	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP
0.142045454545%	5	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DUTTA_APOPTOSIS_VIA_NFKB
0.142045454545%	5	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_IL1R_PATHWAY
0.142045454545%	5	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZWANG_EGF_PERSISTENTLY_UP
0.142045454545%	5	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TSAI_RESPONSE_TO_RADIATION_THERAPY
0.142045454545%	5	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_ERK1_ERK2_MAPK_PATHWAY
0.142045454545%	5	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING
0.142045454545%	5	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ELONGATION_ARREST_AND_RECOVERY
0.142045454545%	5	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DAG_AND_IP3_SIGNALING
0.142045454545%	5	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	POS_HISTAMINE_RESPONSE_NETWORK
0.142045454545%	5	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_WNT_NONCANONICAL_PATHWAY
0.142045454545%	5	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_PDGF_PATHWAY
0.142045454545%	5	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_HDAC_PATHWAY
0.142045454545%	5	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BAE_BRCA1_TARGETS_DN
0.142045454545%	5	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP
0.142045454545%	5	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.142045454545%	5	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS
0.142045454545%	5	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_NEPHRIN_NEPH1_PATHWAY
0.142045454545%	5	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_CD40_PATHWAY
0.142045454545%	5	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM
0.142045454545%	5	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUNSBERGER_EXERCISE_REGULATED_GENES
0.142045454545%	5	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_EGF_PATHWAY
0.142045454545%	5	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
0.142045454545%	5	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CA_DEPENDENT_EVENTS
0.142045454545%	5	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_EPHRINBREVPATHWAY
0.142045454545%	5	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_CDC42_REG_PATHWAY
0.142045454545%	5	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G2
0.142045454545%	5	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WILENSKY_RESPONSE_TO_DARAPLADIB
0.142045454545%	5	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WATANABE_COLON_CANCER_MSI_VS_MSS_UP
0.142045454545%	5	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_RESPONSE_TO_BEXAROTENE_DN
0.142045454545%	5	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TIGHT_JUNCTION_INTERACTIONS
0.142045454545%	5	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX
0.142045454545%	5	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KRIGE_AMINO_ACID_DEPRIVATION
0.142045454545%	5	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_HISTIDINE_METABOLISM
0.142045454545%	5	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_INFLAM_PATHWAY
0.142045454545%	5	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP
0.142045454545%	5	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WIKMAN_ASBESTOS_LUNG_CANCER_DN
0.142045454545%	5	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEBER_METHYLATED_HCP_IN_SPERM_DN
0.142045454545%	5	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_GAQ_PATHWAY
0.142045454545%	5	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAMIKUBO_MYELOID_CEBPA_NETWORK
0.142045454545%	5	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
0.142045454545%	5	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D9
0.142045454545%	5	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
0.142045454545%	5	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_PA
0.142045454545%	5	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS
0.142045454545%	5	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS
0.142045454545%	5	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LI_WILMS_TUMOR
0.142045454545%	5	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_GSK3_PATHWAY
0.142045454545%	5	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP
0.142045454545%	5	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HAHTOLA_CTCL_CUTANEOUS
0.142045454545%	5	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_NFKB_TARGETS
0.142045454545%	5	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION
0.142045454545%	5	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17
0.142045454545%	5	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_HYPOXIA
0.142045454545%	5	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP
0.142045454545%	5	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP
0.142045454545%	5	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS
0.142045454545%	5	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_STRESS_PATHWAY
0.142045454545%	5	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAN_ESCAPE_FROM_ANOIKIS
0.142045454545%	5	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_S1P_S1P2_PATHWAY
0.142045454545%	5	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OXFORD_RALA_OR_RALB_TARGETS_DN
0.142045454545%	5	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOLUB_ALL_VS_AML_UP
0.142045454545%	5	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_NOS1_PATHWAY
0.142045454545%	5	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VIETOR_IFRD1_TARGETS
0.142045454545%	5	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_GA12_PATHWAY
0.142045454545%	5	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER
0.142045454545%	5	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INSULIN_RECEPTOR_RECYCLING
0.142045454545%	5	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_RAC1_PATHWAY
0.142045454545%	5	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEBER_METHYLATED_ICP_IN_FIBROBLAST
0.142045454545%	5	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_HEDGEHOG_2PATHWAY
0.142045454545%	5	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE
0.142045454545%	5	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC
0.142045454545%	5	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ECADHERIN_KERATINOCYTE_PATHWAY
0.142045454545%	5	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOOTHA_GLYCOGEN_METABOLISM
0.142045454545%	5	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GREENBAUM_E2A_TARGETS_DN
0.142045454545%	5	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEBER_METHYLATED_HCP_IN_SPERM_UP
0.142045454545%	5	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_RECURRENT_LIVER_CANCER_UP
0.142045454545%	5	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ENOS_ACTIVATION_AND_REGULATION
0.142045454545%	5	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIELSEN_SYNOVIAL_SARCOMA_DN
0.142045454545%	5	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HASLINGER_B_CLL_WITH_6Q21_DELETION
0.142045454545%	5	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BARRIER_COLON_CANCER_RECURRENCE_DN
0.142045454545%	5	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ARF_3PATHWAY
0.142045454545%	5	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MAHADEVAN_RESPONSE_TO_MP470_DN
0.142045454545%	5	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HAHTOLA_MYCOSIS_FUNGOIDES_UP
0.142045454545%	5	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP
0.142045454545%	5	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHIN_B_CELL_LYMPHOMA_CLUSTER_5
0.142045454545%	5	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CARDIACEGF_PATHWAY
0.142045454545%	5	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_HCMV_PATHWAY
0.142045454545%	5	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KANG_FLUOROURACIL_RESISTANCE_DN
0.142045454545%	5	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IGLESIAS_E2F_TARGETS_DN
0.142045454545%	5	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_SHH_PATHWAY
0.142045454545%	5	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEBER_METHYLATED_ICP_IN_SPERM_DN
0.142045454545%	5	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_HYALURONAN_METABOLISM
0.142045454545%	5	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_S1P_S1P4_PATHWAY
0.142045454545%	5	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION
0.142045454545%	5	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING
0.142045454545%	5	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOEGERKORP_CD44_TARGETS_TEMPORAL_UP
0.142045454545%	5	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_TCRA_PATHWAY
0.142045454545%	5	3520	110	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
0.142045454545%	5	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SASAKI_TARGETS_OF_TP73_AND_TP63
0.142045454545%	5	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_EPONFKB_PATHWAY
0.142045454545%	5	3520	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT
0.142045454545%	5	3520	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WINZEN_DEGRADED_VIA_KHSRP
0.137994480221%	3	2174	97	T2D_GENES_TANYA_LIPIDS	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
0.137994480221%	3	2174	94	T2D_GENES_TANYA_LIPIDS	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.137994480221%	3	2174	9	T2D_GENES_TANYA_LIPIDS	YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN
0.137994480221%	3	2174	9	T2D_GENES_TANYA_LIPIDS	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY
0.137994480221%	3	2174	9	T2D_GENES_TANYA_LIPIDS	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN
0.137994480221%	3	2174	9	T2D_GENES_TANYA_LIPIDS	CHESLER_BRAIN_D6MIT150_QTL_TRANS
0.137994480221%	3	2174	9	T2D_GENES_TANYA_LIPIDS	BIOCARTA_FEEDER_PATHWAY
0.137994480221%	3	2174	89	T2D_GENES_TANYA_LIPIDS	KANG_IMMORTALIZED_BY_TERT_UP
0.137994480221%	3	2174	88	T2D_GENES_TANYA_LIPIDS	SEIDEN_ONCOGENESIS_BY_MET
0.137994480221%	3	2174	88	T2D_GENES_TANYA_LIPIDS	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
0.137994480221%	3	2174	84	T2D_GENES_TANYA_LIPIDS	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP
0.137994480221%	3	2174	82	T2D_GENES_TANYA_LIPIDS	WONG_ENDMETRIUM_CANCER_DN
0.137994480221%	3	2174	8	T2D_GENES_TANYA_LIPIDS	STANHILL_HRAS_TRANSFROMATION_UP
0.137994480221%	3	2174	8	T2D_GENES_TANYA_LIPIDS	SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN
0.137994480221%	3	2174	8	T2D_GENES_TANYA_LIPIDS	RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN
0.137994480221%	3	2174	8	T2D_GENES_TANYA_LIPIDS	GROSS_HYPOXIA_VIA_HIF1A_ONLY
0.137994480221%	3	2174	79	T2D_GENES_TANYA_LIPIDS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.137994480221%	3	2174	77	T2D_GENES_TANYA_LIPIDS	CHEBOTAEV_GR_TARGETS_UP
0.137994480221%	3	2174	7	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_NPC_WITH_LCP_H3K27ME3
0.137994480221%	3	2174	7	T2D_GENES_TANYA_LIPIDS	MARSHALL_VIRAL_INFECTION_RESPONSE_UP
0.137994480221%	3	2174	7	T2D_GENES_TANYA_LIPIDS	CHESLER_BRAIN_D6MIT150_QTL_CIS
0.137994480221%	3	2174	69	T2D_GENES_TANYA_LIPIDS	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.137994480221%	3	2174	69	T2D_GENES_TANYA_LIPIDS	REACTOME_GLUCOSE_METABOLISM
0.137994480221%	3	2174	69	T2D_GENES_TANYA_LIPIDS	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES
0.137994480221%	3	2174	69	T2D_GENES_TANYA_LIPIDS	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
0.137994480221%	3	2174	68	T2D_GENES_TANYA_LIPIDS	NOUZOVA_METHYLATED_IN_APL
0.137994480221%	3	2174	66	T2D_GENES_TANYA_LIPIDS	PID_INTEGRIN1_PATHWAY
0.137994480221%	3	2174	66	T2D_GENES_TANYA_LIPIDS	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.137994480221%	3	2174	64	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER_MYC_E2F1_DN
0.137994480221%	3	2174	64	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER_E2F1_DN
0.137994480221%	3	2174	64	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER_ACOX1_UP
0.137994480221%	3	2174	64	T2D_GENES_TANYA_LIPIDS	INGRAM_SHH_TARGETS_DN
0.137994480221%	3	2174	63	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER_MYC_DN
0.137994480221%	3	2174	63	T2D_GENES_TANYA_LIPIDS	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
0.137994480221%	3	2174	63	T2D_GENES_TANYA_LIPIDS	CROMER_TUMORIGENESIS_UP
0.137994480221%	3	2174	61	T2D_GENES_TANYA_LIPIDS	PID_AR_PATHWAY
0.137994480221%	3	2174	61	T2D_GENES_TANYA_LIPIDS	KAUFFMANN_MELANOMA_RELAPSE_UP
0.137994480221%	3	2174	6	T2D_GENES_TANYA_LIPIDS	ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS
0.137994480221%	3	2174	59	T2D_GENES_TANYA_LIPIDS	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS
0.137994480221%	3	2174	58	T2D_GENES_TANYA_LIPIDS	REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT
0.137994480221%	3	2174	58	T2D_GENES_TANYA_LIPIDS	LIM_MAMMARY_LUMINAL_PROGENITOR_UP
0.137994480221%	3	2174	57	T2D_GENES_TANYA_LIPIDS	YAMASHITA_METHYLATED_IN_PROSTATE_CANCER
0.137994480221%	3	2174	57	T2D_GENES_TANYA_LIPIDS	GRABARCZYK_BCL11B_TARGETS_DN
0.137994480221%	3	2174	56	T2D_GENES_TANYA_LIPIDS	GYORFFY_DOXORUBICIN_RESISTANCE
0.137994480221%	3	2174	55	T2D_GENES_TANYA_LIPIDS	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
0.137994480221%	3	2174	55	T2D_GENES_TANYA_LIPIDS	LAU_APOPTOSIS_CDKN2A_UP
0.137994480221%	3	2174	55	T2D_GENES_TANYA_LIPIDS	DEMAGALHAES_AGING_UP
0.137994480221%	3	2174	54	T2D_GENES_TANYA_LIPIDS	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
0.137994480221%	3	2174	54	T2D_GENES_TANYA_LIPIDS	SESTO_RESPONSE_TO_UV_C2
0.137994480221%	3	2174	54	T2D_GENES_TANYA_LIPIDS	MARSON_FOXP3_TARGETS_DN
0.137994480221%	3	2174	53	T2D_GENES_TANYA_LIPIDS	LIANG_SILENCED_BY_METHYLATION_2
0.137994480221%	3	2174	53	T2D_GENES_TANYA_LIPIDS	ISHIDA_E2F_TARGETS
0.137994480221%	3	2174	52	T2D_GENES_TANYA_LIPIDS	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
0.137994480221%	3	2174	52	T2D_GENES_TANYA_LIPIDS	BECKER_TAMOXIFEN_RESISTANCE_DN
0.137994480221%	3	2174	51	T2D_GENES_TANYA_LIPIDS	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
0.137994480221%	3	2174	51	T2D_GENES_TANYA_LIPIDS	BURTON_ADIPOGENESIS_7
0.137994480221%	3	2174	50	T2D_GENES_TANYA_LIPIDS	YANG_BREAST_CANCER_ESR1_LASER_DN
0.137994480221%	3	2174	50	T2D_GENES_TANYA_LIPIDS	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.137994480221%	3	2174	49	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_HP_UP
0.137994480221%	3	2174	49	T2D_GENES_TANYA_LIPIDS	REACTOME_METABOLISM_OF_NON_CODING_RNA
0.137994480221%	3	2174	49	T2D_GENES_TANYA_LIPIDS	FAELT_B_CLL_WITH_VH3_21_DN
0.137994480221%	3	2174	48	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_MS_UP
0.137994480221%	3	2174	48	T2D_GENES_TANYA_LIPIDS	MCCLUNG_DELTA_FOSB_TARGETS_2WK
0.137994480221%	3	2174	48	T2D_GENES_TANYA_LIPIDS	DELACROIX_RAR_TARGETS_UP
0.137994480221%	3	2174	47	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_HP_DN
0.137994480221%	3	2174	47	T2D_GENES_TANYA_LIPIDS	WARTERS_IR_RESPONSE_5GY
0.137994480221%	3	2174	47	T2D_GENES_TANYA_LIPIDS	SILIGAN_BOUND_BY_EWS_FLT1_FUSION
0.137994480221%	3	2174	47	T2D_GENES_TANYA_LIPIDS	KHETCHOUMIAN_TRIM24_TARGETS_UP
0.137994480221%	3	2174	46	T2D_GENES_TANYA_LIPIDS	HEIDENBLAD_AMPLICON_8Q24_DN
0.137994480221%	3	2174	46	T2D_GENES_TANYA_LIPIDS	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN
0.137994480221%	3	2174	45	T2D_GENES_TANYA_LIPIDS	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP
0.137994480221%	3	2174	45	T2D_GENES_TANYA_LIPIDS	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN
0.137994480221%	3	2174	44	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_PR_DN
0.137994480221%	3	2174	44	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_LB_DN
0.137994480221%	3	2174	44	T2D_GENES_TANYA_LIPIDS	WANG_TARGETS_OF_MLL_CBP_FUSION_UP
0.137994480221%	3	2174	44	T2D_GENES_TANYA_LIPIDS	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.137994480221%	3	2174	44	T2D_GENES_TANYA_LIPIDS	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM
0.137994480221%	3	2174	44	T2D_GENES_TANYA_LIPIDS	CHOI_ATL_STAGE_PREDICTOR
0.137994480221%	3	2174	43	T2D_GENES_TANYA_LIPIDS	RIZ_ERYTHROID_DIFFERENTIATION_12HR
0.137994480221%	3	2174	43	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1
0.137994480221%	3	2174	43	T2D_GENES_TANYA_LIPIDS	MILI_PSEUDOPODIA
0.137994480221%	3	2174	43	T2D_GENES_TANYA_LIPIDS	FUJII_YBX1_TARGETS_UP
0.137994480221%	3	2174	42	T2D_GENES_TANYA_LIPIDS	YU_MYC_TARGETS_UP
0.137994480221%	3	2174	42	T2D_GENES_TANYA_LIPIDS	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP
0.137994480221%	3	2174	41	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_MF_DN
0.137994480221%	3	2174	41	T2D_GENES_TANYA_LIPIDS	REACTOME_NETRIN1_SIGNALING
0.137994480221%	3	2174	41	T2D_GENES_TANYA_LIPIDS	ONO_AML1_TARGETS_DN
0.137994480221%	3	2174	41	T2D_GENES_TANYA_LIPIDS	KAAB_FAILED_HEART_VENTRICLE_DN
0.137994480221%	3	2174	41	T2D_GENES_TANYA_LIPIDS	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
0.137994480221%	3	2174	40	T2D_GENES_TANYA_LIPIDS	LIAO_HAVE_SOX4_BINDING_SITES
0.137994480221%	3	2174	40	T2D_GENES_TANYA_LIPIDS	HEIDENBLAD_AMPLICON_8Q24_UP
0.137994480221%	3	2174	40	T2D_GENES_TANYA_LIPIDS	GENTILE_UV_RESPONSE_CLUSTER_D7
0.137994480221%	3	2174	39	T2D_GENES_TANYA_LIPIDS	WHITEHURST_PACLITAXEL_SENSITIVITY
0.137994480221%	3	2174	39	T2D_GENES_TANYA_LIPIDS	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP
0.137994480221%	3	2174	39	T2D_GENES_TANYA_LIPIDS	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
0.137994480221%	3	2174	39	T2D_GENES_TANYA_LIPIDS	MATZUK_MEIOTIC_AND_DNA_REPAIR
0.137994480221%	3	2174	39	T2D_GENES_TANYA_LIPIDS	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP
0.137994480221%	3	2174	39	T2D_GENES_TANYA_LIPIDS	BILANGES_SERUM_SENSITIVE_VIA_TSC2
0.137994480221%	3	2174	38	T2D_GENES_TANYA_LIPIDS	SPIRA_SMOKERS_LUNG_CANCER_UP
0.137994480221%	3	2174	38	T2D_GENES_TANYA_LIPIDS	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER
0.137994480221%	3	2174	38	T2D_GENES_TANYA_LIPIDS	REACTOME_PI3K_AKT_ACTIVATION
0.137994480221%	3	2174	38	T2D_GENES_TANYA_LIPIDS	REACTOME_G1_PHASE
0.137994480221%	3	2174	38	T2D_GENES_TANYA_LIPIDS	PID_ERBB4_PATHWAY
0.137994480221%	3	2174	38	T2D_GENES_TANYA_LIPIDS	ONGUSAHA_TP53_TARGETS
0.137994480221%	3	2174	38	T2D_GENES_TANYA_LIPIDS	NAKAMURA_ADIPOGENESIS_LATE_DN
0.137994480221%	3	2174	38	T2D_GENES_TANYA_LIPIDS	NAKAMURA_ADIPOGENESIS_EARLY_DN
0.137994480221%	3	2174	38	T2D_GENES_TANYA_LIPIDS	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP
0.137994480221%	3	2174	37	T2D_GENES_TANYA_LIPIDS	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
0.137994480221%	3	2174	37	T2D_GENES_TANYA_LIPIDS	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN
0.137994480221%	3	2174	37	T2D_GENES_TANYA_LIPIDS	RICKMAN_HEAD_AND_NECK_CANCER_D
0.137994480221%	3	2174	37	T2D_GENES_TANYA_LIPIDS	LANDIS_ERBB2_BREAST_TUMORS_65_DN
0.137994480221%	3	2174	37	T2D_GENES_TANYA_LIPIDS	KIM_ALL_DISORDERS_CALB1_CORR_DN
0.137994480221%	3	2174	36	T2D_GENES_TANYA_LIPIDS	YANG_BREAST_CANCER_ESR1_UP
0.137994480221%	3	2174	36	T2D_GENES_TANYA_LIPIDS	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN
0.137994480221%	3	2174	36	T2D_GENES_TANYA_LIPIDS	MMS_MOUSE_LYMPH_HIGH_4HRS_UP
0.137994480221%	3	2174	36	T2D_GENES_TANYA_LIPIDS	BURTON_ADIPOGENESIS_12
0.137994480221%	3	2174	36	T2D_GENES_TANYA_LIPIDS	ALONSO_METASTASIS_EMT_UP
0.137994480221%	3	2174	35	T2D_GENES_TANYA_LIPIDS	WESTON_VEGFA_TARGETS_12HR
0.137994480221%	3	2174	35	T2D_GENES_TANYA_LIPIDS	VALK_AML_CLUSTER_9
0.137994480221%	3	2174	35	T2D_GENES_TANYA_LIPIDS	PID_HIVNEFPATHWAY
0.137994480221%	3	2174	35	T2D_GENES_TANYA_LIPIDS	MODY_HIPPOCAMPUS_NEONATAL
0.137994480221%	3	2174	35	T2D_GENES_TANYA_LIPIDS	KEGG_REGULATION_OF_AUTOPHAGY
0.137994480221%	3	2174	35	T2D_GENES_TANYA_LIPIDS	KEGG_PRION_DISEASES
0.137994480221%	3	2174	35	T2D_GENES_TANYA_LIPIDS	KEGG_BASE_EXCISION_REPAIR
0.137994480221%	3	2174	34	T2D_GENES_TANYA_LIPIDS	WONG_IFNA2_RESISTANCE_DN
0.137994480221%	3	2174	34	T2D_GENES_TANYA_LIPIDS	SUMI_HNF4A_TARGETS
0.137994480221%	3	2174	34	T2D_GENES_TANYA_LIPIDS	SCHOEN_NFKB_SIGNALING
0.137994480221%	3	2174	34	T2D_GENES_TANYA_LIPIDS	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION
0.137994480221%	3	2174	34	T2D_GENES_TANYA_LIPIDS	PID_IL8CXCR2_PATHWAY
0.137994480221%	3	2174	34	T2D_GENES_TANYA_LIPIDS	PID_HDAC_CLASSII_PATHWAY
0.137994480221%	3	2174	34	T2D_GENES_TANYA_LIPIDS	PID_ATM_PATHWAY
0.137994480221%	3	2174	34	T2D_GENES_TANYA_LIPIDS	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM
0.137994480221%	3	2174	34	T2D_GENES_TANYA_LIPIDS	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP
0.137994480221%	3	2174	33	T2D_GENES_TANYA_LIPIDS	ZHAN_LATE_DIFFERENTIATION_GENES_UP
0.137994480221%	3	2174	33	T2D_GENES_TANYA_LIPIDS	WENDT_COHESIN_TARGETS_UP
0.137994480221%	3	2174	33	T2D_GENES_TANYA_LIPIDS	VALK_AML_CLUSTER_6
0.137994480221%	3	2174	33	T2D_GENES_TANYA_LIPIDS	STAEGE_EWING_FAMILY_TUMOR
0.137994480221%	3	2174	33	T2D_GENES_TANYA_LIPIDS	ROZANOV_MMP14_TARGETS_SUBSET
0.137994480221%	3	2174	33	T2D_GENES_TANYA_LIPIDS	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION
0.137994480221%	3	2174	33	T2D_GENES_TANYA_LIPIDS	REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT
0.137994480221%	3	2174	33	T2D_GENES_TANYA_LIPIDS	PID_ALPHASYNUCLEIN_PATHWAY
0.137994480221%	3	2174	33	T2D_GENES_TANYA_LIPIDS	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.137994480221%	3	2174	33	T2D_GENES_TANYA_LIPIDS	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN
0.137994480221%	3	2174	33	T2D_GENES_TANYA_LIPIDS	BIOCARTA_DEATH_PATHWAY
0.137994480221%	3	2174	32	T2D_GENES_TANYA_LIPIDS	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.137994480221%	3	2174	32	T2D_GENES_TANYA_LIPIDS	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN
0.137994480221%	3	2174	32	T2D_GENES_TANYA_LIPIDS	REACTOME_CD28_CO_STIMULATION
0.137994480221%	3	2174	32	T2D_GENES_TANYA_LIPIDS	MOOTHA_GLUCONEOGENESIS
0.137994480221%	3	2174	32	T2D_GENES_TANYA_LIPIDS	KEGG_CITRATE_CYCLE_TCA_CYCLE
0.137994480221%	3	2174	32	T2D_GENES_TANYA_LIPIDS	FARDIN_HYPOXIA_11
0.137994480221%	3	2174	32	T2D_GENES_TANYA_LIPIDS	DORSAM_HOXA9_TARGETS_DN
0.137994480221%	3	2174	32	T2D_GENES_TANYA_LIPIDS	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN
0.137994480221%	3	2174	31	T2D_GENES_TANYA_LIPIDS	TING_SILENCED_BY_DICER
0.137994480221%	3	2174	31	T2D_GENES_TANYA_LIPIDS	THEODOROU_MAMMARY_TUMORIGENESIS
0.137994480221%	3	2174	31	T2D_GENES_TANYA_LIPIDS	RIZ_ERYTHROID_DIFFERENTIATION_HEMGN
0.137994480221%	3	2174	31	T2D_GENES_TANYA_LIPIDS	REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING
0.137994480221%	3	2174	31	T2D_GENES_TANYA_LIPIDS	REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE
0.137994480221%	3	2174	31	T2D_GENES_TANYA_LIPIDS	REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX
0.137994480221%	3	2174	31	T2D_GENES_TANYA_LIPIDS	PID_P38ALPHABETAPATHWAY
0.137994480221%	3	2174	31	T2D_GENES_TANYA_LIPIDS	IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM
0.137994480221%	3	2174	31	T2D_GENES_TANYA_LIPIDS	CUI_TCF21_TARGETS_DN
0.137994480221%	3	2174	31	T2D_GENES_TANYA_LIPIDS	CAFFAREL_RESPONSE_TO_THC_DN
0.137994480221%	3	2174	31	T2D_GENES_TANYA_LIPIDS	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.137994480221%	3	2174	30	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
0.137994480221%	3	2174	30	T2D_GENES_TANYA_LIPIDS	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.137994480221%	3	2174	30	T2D_GENES_TANYA_LIPIDS	YANAGIHARA_ESX1_TARGETS
0.137994480221%	3	2174	30	T2D_GENES_TANYA_LIPIDS	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN
0.137994480221%	3	2174	30	T2D_GENES_TANYA_LIPIDS	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN
0.137994480221%	3	2174	30	T2D_GENES_TANYA_LIPIDS	PID_IGF1_PATHWAY
0.137994480221%	3	2174	30	T2D_GENES_TANYA_LIPIDS	LY_AGING_PREMATURE_DN
0.137994480221%	3	2174	30	T2D_GENES_TANYA_LIPIDS	LIU_BREAST_CANCER
0.137994480221%	3	2174	30	T2D_GENES_TANYA_LIPIDS	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
0.137994480221%	3	2174	30	T2D_GENES_TANYA_LIPIDS	GUILLAUMOND_KLF10_TARGETS_DN
0.137994480221%	3	2174	30	T2D_GENES_TANYA_LIPIDS	BURTON_ADIPOGENESIS_10
0.137994480221%	3	2174	29	T2D_GENES_TANYA_LIPIDS	YU_BAP1_TARGETS
0.137994480221%	3	2174	29	T2D_GENES_TANYA_LIPIDS	ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.137994480221%	3	2174	29	T2D_GENES_TANYA_LIPIDS	REACTOME_STEROID_HORMONES
0.137994480221%	3	2174	29	T2D_GENES_TANYA_LIPIDS	PID_BARD1PATHWAY
0.137994480221%	3	2174	29	T2D_GENES_TANYA_LIPIDS	PATTERSON_DOCETAXEL_RESISTANCE
0.137994480221%	3	2174	29	T2D_GENES_TANYA_LIPIDS	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
0.137994480221%	3	2174	29	T2D_GENES_TANYA_LIPIDS	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
0.137994480221%	3	2174	29	T2D_GENES_TANYA_LIPIDS	MARSON_FOXP3_TARGETS_STIMULATED_UP
0.137994480221%	3	2174	29	T2D_GENES_TANYA_LIPIDS	KEGG_RNA_POLYMERASE
0.137994480221%	3	2174	29	T2D_GENES_TANYA_LIPIDS	KEGG_LINOLEIC_ACID_METABOLISM
0.137994480221%	3	2174	29	T2D_GENES_TANYA_LIPIDS	BIOCARTA_TNFR1_PATHWAY
0.137994480221%	3	2174	29	T2D_GENES_TANYA_LIPIDS	AIYAR_COBRA1_TARGETS_DN
0.137994480221%	3	2174	28	T2D_GENES_TANYA_LIPIDS	VALK_AML_CLUSTER_1
0.137994480221%	3	2174	28	T2D_GENES_TANYA_LIPIDS	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
0.137994480221%	3	2174	28	T2D_GENES_TANYA_LIPIDS	REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS
0.137994480221%	3	2174	28	T2D_GENES_TANYA_LIPIDS	REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A
0.137994480221%	3	2174	28	T2D_GENES_TANYA_LIPIDS	PID_IL8CXCR1_PATHWAY
0.137994480221%	3	2174	28	T2D_GENES_TANYA_LIPIDS	PETROVA_PROX1_TARGETS_UP
0.137994480221%	3	2174	28	T2D_GENES_TANYA_LIPIDS	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN
0.137994480221%	3	2174	28	T2D_GENES_TANYA_LIPIDS	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN
0.137994480221%	3	2174	28	T2D_GENES_TANYA_LIPIDS	BIOCARTA_G1_PATHWAY
0.137994480221%	3	2174	28	T2D_GENES_TANYA_LIPIDS	BIOCARTA_ERK_PATHWAY
0.137994480221%	3	2174	27	T2D_GENES_TANYA_LIPIDS	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP
0.137994480221%	3	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS
0.137994480221%	3	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN
0.137994480221%	3	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_RECYCLING_PATHWAY_OF_L1
0.137994480221%	3	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION
0.137994480221%	3	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING
0.137994480221%	3	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_G_PROTEIN_ACTIVATION
0.137994480221%	3	2174	27	T2D_GENES_TANYA_LIPIDS	PID_IL3_PATHWAY
0.137994480221%	3	2174	27	T2D_GENES_TANYA_LIPIDS	PID_GLYPICAN_1PATHWAY
0.137994480221%	3	2174	27	T2D_GENES_TANYA_LIPIDS	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP
0.137994480221%	3	2174	27	T2D_GENES_TANYA_LIPIDS	CHIN_BREAST_CANCER_COPY_NUMBER_UP
0.137994480221%	3	2174	27	T2D_GENES_TANYA_LIPIDS	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN
0.137994480221%	3	2174	26	T2D_GENES_TANYA_LIPIDS	XU_CREBBP_TARGETS_UP
0.137994480221%	3	2174	26	T2D_GENES_TANYA_LIPIDS	WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG
0.137994480221%	3	2174	26	T2D_GENES_TANYA_LIPIDS	VALK_AML_CLUSTER_16
0.137994480221%	3	2174	26	T2D_GENES_TANYA_LIPIDS	TOMIDA_METASTASIS_UP
0.137994480221%	3	2174	26	T2D_GENES_TANYA_LIPIDS	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS
0.137994480221%	3	2174	26	T2D_GENES_TANYA_LIPIDS	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B
0.137994480221%	3	2174	26	T2D_GENES_TANYA_LIPIDS	NEWMAN_ERCC6_TARGETS_UP
0.137994480221%	3	2174	26	T2D_GENES_TANYA_LIPIDS	NAKAMURA_CANCER_MICROENVIRONMENT_UP
0.137994480221%	3	2174	26	T2D_GENES_TANYA_LIPIDS	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
0.137994480221%	3	2174	26	T2D_GENES_TANYA_LIPIDS	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN
0.137994480221%	3	2174	26	T2D_GENES_TANYA_LIPIDS	FINAK_BREAST_CANCER_SDPP_SIGNATURE
0.137994480221%	3	2174	26	T2D_GENES_TANYA_LIPIDS	BRACHAT_RESPONSE_TO_METHOTREXATE_UP
0.137994480221%	3	2174	25	T2D_GENES_TANYA_LIPIDS	VERRECCHIA_RESPONSE_TO_TGFB1_C2
0.137994480221%	3	2174	25	T2D_GENES_TANYA_LIPIDS	VANDESLUIS_NORMAL_EMBRYOS_DN
0.137994480221%	3	2174	25	T2D_GENES_TANYA_LIPIDS	RUAN_RESPONSE_TO_TROGLITAZONE_UP
0.137994480221%	3	2174	25	T2D_GENES_TANYA_LIPIDS	REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE
0.137994480221%	3	2174	25	T2D_GENES_TANYA_LIPIDS	REACTOME_FANCONI_ANEMIA_PATHWAY
0.137994480221%	3	2174	25	T2D_GENES_TANYA_LIPIDS	REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS
0.137994480221%	3	2174	25	T2D_GENES_TANYA_LIPIDS	PID_TOLL_ENDOGENOUS_PATHWAY
0.137994480221%	3	2174	25	T2D_GENES_TANYA_LIPIDS	PID_INTEGRIN_A9B1_PATHWAY
0.137994480221%	3	2174	25	T2D_GENES_TANYA_LIPIDS	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP
0.137994480221%	3	2174	25	T2D_GENES_TANYA_LIPIDS	LU_TUMOR_ANGIOGENESIS_UP
0.137994480221%	3	2174	25	T2D_GENES_TANYA_LIPIDS	KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS
0.137994480221%	3	2174	25	T2D_GENES_TANYA_LIPIDS	HORTON_SREBF_TARGETS
0.137994480221%	3	2174	25	T2D_GENES_TANYA_LIPIDS	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	WANG_LSD1_TARGETS_UP
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	SHI_SPARC_TARGETS_UP
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	REACTOME_DOUBLE_STRAND_BREAK_REPAIR
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	REACTOME_CHOLESTEROL_BIOSYNTHESIS
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	OSADA_ASCL1_TARGETS_DN
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	LA_MEN1_TARGETS
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	JIANG_TIP30_TARGETS_DN
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	JEON_SMAD6_TARGETS_UP
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	BIOCARTA_TPO_PATHWAY
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	BIOCARTA_NTHI_PATHWAY
0.137994480221%	3	2174	24	T2D_GENES_TANYA_LIPIDS	AZARE_STAT3_TARGETS
0.137994480221%	3	2174	23	T2D_GENES_TANYA_LIPIDS	YANG_BREAST_CANCER_ESR1_BULK_DN
0.137994480221%	3	2174	23	T2D_GENES_TANYA_LIPIDS	WU_HBX_TARGETS_1_DN
0.137994480221%	3	2174	23	T2D_GENES_TANYA_LIPIDS	WENG_POR_TARGETS_GLOBAL_DN
0.137994480221%	3	2174	23	T2D_GENES_TANYA_LIPIDS	UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.137994480221%	3	2174	23	T2D_GENES_TANYA_LIPIDS	SAGIV_CD24_TARGETS_UP
0.137994480221%	3	2174	23	T2D_GENES_TANYA_LIPIDS	REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX
0.137994480221%	3	2174	23	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_BMP
0.137994480221%	3	2174	23	T2D_GENES_TANYA_LIPIDS	REACTOME_PHOSPHORYLATION_OF_THE_APC_C
0.137994480221%	3	2174	23	T2D_GENES_TANYA_LIPIDS	REACTOME_MICRORNA_MIRNA_BIOGENESIS
0.137994480221%	3	2174	23	T2D_GENES_TANYA_LIPIDS	REACTOME_LYSOSOME_VESICLE_BIOGENESIS
0.137994480221%	3	2174	23	T2D_GENES_TANYA_LIPIDS	REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING
0.137994480221%	3	2174	23	T2D_GENES_TANYA_LIPIDS	REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA
0.137994480221%	3	2174	23	T2D_GENES_TANYA_LIPIDS	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP
0.137994480221%	3	2174	23	T2D_GENES_TANYA_LIPIDS	EGUCHI_CELL_CYCLE_RB1_TARGETS
0.137994480221%	3	2174	23	T2D_GENES_TANYA_LIPIDS	BIOCARTA_IL12_PATHWAY
0.137994480221%	3	2174	23	T2D_GENES_TANYA_LIPIDS	BIOCARTA_GLEEVEC_PATHWAY
0.137994480221%	3	2174	23	T2D_GENES_TANYA_LIPIDS	BARIS_THYROID_CANCER_UP
0.137994480221%	3	2174	22	T2D_GENES_TANYA_LIPIDS	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN
0.137994480221%	3	2174	22	T2D_GENES_TANYA_LIPIDS	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING
0.137994480221%	3	2174	22	T2D_GENES_TANYA_LIPIDS	REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE
0.137994480221%	3	2174	22	T2D_GENES_TANYA_LIPIDS	MOOTHA_FFA_OXYDATION
0.137994480221%	3	2174	22	T2D_GENES_TANYA_LIPIDS	LU_TUMOR_ENDOTHELIAL_MARKERS_UP
0.137994480221%	3	2174	22	T2D_GENES_TANYA_LIPIDS	KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS
0.137994480221%	3	2174	22	T2D_GENES_TANYA_LIPIDS	GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION
0.137994480221%	3	2174	22	T2D_GENES_TANYA_LIPIDS	FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.137994480221%	3	2174	22	T2D_GENES_TANYA_LIPIDS	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN
0.137994480221%	3	2174	22	T2D_GENES_TANYA_LIPIDS	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER
0.137994480221%	3	2174	22	T2D_GENES_TANYA_LIPIDS	BIOCARTA_HER2_PATHWAY
0.137994480221%	3	2174	22	T2D_GENES_TANYA_LIPIDS	BIOCARTA_DC_PATHWAY
0.137994480221%	3	2174	22	T2D_GENES_TANYA_LIPIDS	BIOCARTA_AKT_PATHWAY
0.137994480221%	3	2174	21	T2D_GENES_TANYA_LIPIDS	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP
0.137994480221%	3	2174	21	T2D_GENES_TANYA_LIPIDS	SCHURINGA_STAT5A_TARGETS_UP
0.137994480221%	3	2174	21	T2D_GENES_TANYA_LIPIDS	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN
0.137994480221%	3	2174	21	T2D_GENES_TANYA_LIPIDS	REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION
0.137994480221%	3	2174	21	T2D_GENES_TANYA_LIPIDS	REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS
0.137994480221%	3	2174	21	T2D_GENES_TANYA_LIPIDS	PID_S1P_META_PATHWAY
0.137994480221%	3	2174	21	T2D_GENES_TANYA_LIPIDS	PID_P38_MK2PATHWAY
0.137994480221%	3	2174	21	T2D_GENES_TANYA_LIPIDS	MARCHINI_TRABECTEDIN_RESISTANCE_UP
0.137994480221%	3	2174	21	T2D_GENES_TANYA_LIPIDS	KEGG_GLYCOSAMINOGLYCAN_DEGRADATION
0.137994480221%	3	2174	21	T2D_GENES_TANYA_LIPIDS	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN
0.137994480221%	3	2174	21	T2D_GENES_TANYA_LIPIDS	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP
0.137994480221%	3	2174	21	T2D_GENES_TANYA_LIPIDS	BIOCARTA_TFF_PATHWAY
0.137994480221%	3	2174	21	T2D_GENES_TANYA_LIPIDS	BIOCARTA_ATRBRCA_PATHWAY
0.137994480221%	3	2174	20	T2D_GENES_TANYA_LIPIDS	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP
0.137994480221%	3	2174	20	T2D_GENES_TANYA_LIPIDS	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN
0.137994480221%	3	2174	20	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
0.137994480221%	3	2174	20	T2D_GENES_TANYA_LIPIDS	PID_WNT_CANONICAL_PATHWAY
0.137994480221%	3	2174	20	T2D_GENES_TANYA_LIPIDS	NIELSEN_LEIOMYOSARCOMA_CNN1_DN
0.137994480221%	3	2174	20	T2D_GENES_TANYA_LIPIDS	MEISSNER_NPC_ICP_WITH_H3K4ME3
0.137994480221%	3	2174	20	T2D_GENES_TANYA_LIPIDS	MCCABE_HOXC6_TARGETS_CANCER_DN
0.137994480221%	3	2174	20	T2D_GENES_TANYA_LIPIDS	MANN_RESPONSE_TO_AMIFOSTINE_UP
0.137994480221%	3	2174	20	T2D_GENES_TANYA_LIPIDS	BIOCARTA_IGF1MTOR_PATHWAY
0.137994480221%	3	2174	20	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CCR5_PATHWAY
0.137994480221%	3	2174	20	T2D_GENES_TANYA_LIPIDS	BIOCARTA_ATM_PATHWAY
0.137994480221%	3	2174	20	T2D_GENES_TANYA_LIPIDS	BIOCARTA_ACTINY_PATHWAY
0.137994480221%	3	2174	20	T2D_GENES_TANYA_LIPIDS	AMIT_EGF_RESPONSE_240_MCF10A
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	WU_ALZHEIMER_DISEASE_DN
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	TERAMOTO_OPN_TARGETS_CLUSTER_7
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	SHIN_B_CELL_LYMPHOMA_CLUSTER_9
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	REACTOME_PYRUVATE_METABOLISM
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	REACTOME_BOTULINUM_NEUROTOXICITY
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	PID_HIF1APATHWAY
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	OUYANG_PROSTATE_CANCER_MARKERS
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	NIELSEN_LEIOMYOSARCOMA_CNN1_UP
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	NELSON_RESPONSE_TO_ANDROGEN_DN
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	MA_PITUITARY_FETAL_VS_ADULT_DN
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	LEE_NAIVE_T_LYMPHOCYTE
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	LAMB_CCND1_TARGETS
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	BIOCARTA_TH1TH2_PATHWAY
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	BIOCARTA_EPO_PATHWAY
0.137994480221%	3	2174	19	T2D_GENES_TANYA_LIPIDS	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
0.137994480221%	3	2174	18	T2D_GENES_TANYA_LIPIDS	SCHEIDEREIT_IKK_TARGETS
0.137994480221%	3	2174	18	T2D_GENES_TANYA_LIPIDS	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN
0.137994480221%	3	2174	18	T2D_GENES_TANYA_LIPIDS	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB
0.137994480221%	3	2174	18	T2D_GENES_TANYA_LIPIDS	PID_BETACATENIN_DEG_PATHWAY
0.137994480221%	3	2174	18	T2D_GENES_TANYA_LIPIDS	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN
0.137994480221%	3	2174	18	T2D_GENES_TANYA_LIPIDS	NIELSEN_LIPOSARCOMA_UP
0.137994480221%	3	2174	18	T2D_GENES_TANYA_LIPIDS	MOREIRA_RESPONSE_TO_TSA_DN
0.137994480221%	3	2174	18	T2D_GENES_TANYA_LIPIDS	MAINA_VHL_TARGETS_DN
0.137994480221%	3	2174	18	T2D_GENES_TANYA_LIPIDS	KARAKAS_TGFB1_SIGNALING
0.137994480221%	3	2174	18	T2D_GENES_TANYA_LIPIDS	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
0.137994480221%	3	2174	18	T2D_GENES_TANYA_LIPIDS	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES
0.137994480221%	3	2174	18	T2D_GENES_TANYA_LIPIDS	BIOCARTA_UCALPAIN_PATHWAY
0.137994480221%	3	2174	18	T2D_GENES_TANYA_LIPIDS	BIOCARTA_ETS_PATHWAY
0.137994480221%	3	2174	18	T2D_GENES_TANYA_LIPIDS	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP
0.137994480221%	3	2174	18	T2D_GENES_TANYA_LIPIDS	AMIT_DELAYED_EARLY_GENES
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	WIKMAN_ASBESTOS_LUNG_CANCER_UP
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	SA_TRKA_RECEPTOR
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	SA_PTEN_PATHWAY
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_SHC_RELATED_EVENTS
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_RNA_POL_III_CHAIN_ELONGATION
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_ARMS_MEDIATED_ACTIVATION
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	PID_SMAD2_3PATHWAY
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	ONDER_CDH1_TARGETS_3_UP
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	MEISSNER_BRAIN_HCP_WITH_H3K4ME2
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	MATTHEWS_AP1_TARGETS
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	LEE_METASTASIS_AND_RNA_PROCESSING_UP
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	KEGG_ONE_CARBON_POOL_BY_FOLATE
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	HOWLIN_CITED1_TARGETS_2_UP
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	BIOCARTA_PML_PATHWAY
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	BIOCARTA_NO2IL12_PATHWAY
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	BIOCARTA_IL10_PATHWAY
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	BIOCARTA_ARF_PATHWAY
0.137994480221%	3	2174	17	T2D_GENES_TANYA_LIPIDS	BIOCARTA_41BB_PATHWAY
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	WU_HBX_TARGETS_2_DN
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	TIAN_BHLHA15_TARGETS
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	REACTOME_INTEGRATION_OF_PROVIRUS
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	REACTOME_ACYL_CHAIN_REMODELLING_OF_PG
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	LY_AGING_MIDDLE_DN
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	LUI_THYROID_CANCER_CLUSTER_4
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	IGLESIAS_E2F_TARGETS_DN
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	CAFFAREL_RESPONSE_TO_THC_8HR_5_UP
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	BIOCARTA_RELA_PATHWAY
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	BIOCARTA_P53_PATHWAY
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	BIOCARTA_EIF_PATHWAY
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	BIOCARTA_BCELLSURVIVAL_PATHWAY
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	BIOCARTA_ACH_PATHWAY
0.137994480221%	3	2174	16	T2D_GENES_TANYA_LIPIDS	ABDELMOHSEN_ELAVL4_TARGETS
0.137994480221%	3	2174	15	T2D_GENES_TANYA_LIPIDS	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN
0.137994480221%	3	2174	15	T2D_GENES_TANYA_LIPIDS	VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP
0.137994480221%	3	2174	15	T2D_GENES_TANYA_LIPIDS	SU_KIDNEY
0.137994480221%	3	2174	15	T2D_GENES_TANYA_LIPIDS	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP
0.137994480221%	3	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN
0.137994480221%	3	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE
0.137994480221%	3	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_ACYL_CHAIN_REMODELLING_OF_PS
0.137994480221%	3	2174	15	T2D_GENES_TANYA_LIPIDS	PID_THROMBIN_PAR4_PATHWAY
0.137994480221%	3	2174	15	T2D_GENES_TANYA_LIPIDS	MARKS_HDAC_TARGETS_DN
0.137994480221%	3	2174	15	T2D_GENES_TANYA_LIPIDS	MARKS_ACETYLATED_NON_HISTONE_PROTEINS
0.137994480221%	3	2174	15	T2D_GENES_TANYA_LIPIDS	LI_CYTIDINE_ANALOGS_CYCTOTOXICITY
0.137994480221%	3	2174	15	T2D_GENES_TANYA_LIPIDS	LIU_IL13_PRIMING_MODEL
0.137994480221%	3	2174	15	T2D_GENES_TANYA_LIPIDS	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN
0.137994480221%	3	2174	15	T2D_GENES_TANYA_LIPIDS	BIOCARTA_TALL1_PATHWAY
0.137994480221%	3	2174	14	T2D_GENES_TANYA_LIPIDS	TOMLINS_METASTASIS_UP
0.137994480221%	3	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR
0.137994480221%	3	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION
0.137994480221%	3	2174	14	T2D_GENES_TANYA_LIPIDS	PID_TCRRASPATHWAY
0.137994480221%	3	2174	14	T2D_GENES_TANYA_LIPIDS	PID_IL5_PATHWAY
0.137994480221%	3	2174	14	T2D_GENES_TANYA_LIPIDS	PARK_APL_PATHOGENESIS_UP
0.137994480221%	3	2174	14	T2D_GENES_TANYA_LIPIDS	MATZUK_POST-IMPLANTATION_AND_POST-PARTUM
0.137994480221%	3	2174	14	T2D_GENES_TANYA_LIPIDS	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP
0.137994480221%	3	2174	14	T2D_GENES_TANYA_LIPIDS	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES
0.137994480221%	3	2174	14	T2D_GENES_TANYA_LIPIDS	INAMURA_LUNG_CANCER_SCC_DN
0.137994480221%	3	2174	14	T2D_GENES_TANYA_LIPIDS	BIOCARTA_PS1_PATHWAY
0.137994480221%	3	2174	14	T2D_GENES_TANYA_LIPIDS	BIOCARTA_DREAM_PATHWAY
0.137994480221%	3	2174	13	T2D_GENES_TANYA_LIPIDS	WACKER_HYPOXIA_TARGETS_OF_VHL
0.137994480221%	3	2174	13	T2D_GENES_TANYA_LIPIDS	SHI_SPARC_TARGETS_DN
0.137994480221%	3	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_P38MAPK_EVENTS
0.137994480221%	3	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT
0.137994480221%	3	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY
0.137994480221%	3	2174	13	T2D_GENES_TANYA_LIPIDS	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS
0.137994480221%	3	2174	13	T2D_GENES_TANYA_LIPIDS	GERHOLD_RESPONSE_TO_TZD_DN
0.137994480221%	3	2174	13	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CARM1_PATHWAY
0.137994480221%	3	2174	13	T2D_GENES_TANYA_LIPIDS	BIOCARTA_AGPCR_PATHWAY
0.137994480221%	3	2174	13	T2D_GENES_TANYA_LIPIDS	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN
0.137994480221%	3	2174	12	T2D_GENES_TANYA_LIPIDS	WAESCH_ANAPHASE_PROMOTING_COMPLEX
0.137994480221%	3	2174	12	T2D_GENES_TANYA_LIPIDS	RUAN_RESPONSE_TO_TNF_UP
0.137994480221%	3	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS
0.137994480221%	3	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_NOTCH4
0.137994480221%	3	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_ERKS_ARE_INACTIVATED
0.137994480221%	3	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_CS_DS_DEGRADATION
0.137994480221%	3	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION
0.137994480221%	3	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM
0.137994480221%	3	2174	12	T2D_GENES_TANYA_LIPIDS	MALIK_REPRESSED_BY_ESTROGEN
0.137994480221%	3	2174	12	T2D_GENES_TANYA_LIPIDS	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS
0.137994480221%	3	2174	12	T2D_GENES_TANYA_LIPIDS	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.137994480221%	3	2174	12	T2D_GENES_TANYA_LIPIDS	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP
0.137994480221%	3	2174	12	T2D_GENES_TANYA_LIPIDS	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN
0.137994480221%	3	2174	12	T2D_GENES_TANYA_LIPIDS	HOLLEMAN_DAUNORUBICIN_B_ALL_DN
0.137994480221%	3	2174	12	T2D_GENES_TANYA_LIPIDS	DING_LUNG_CANCER_MUTATED_FREQUENTLY
0.137994480221%	3	2174	116	T2D_GENES_TANYA_LIPIDS	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
0.137994480221%	3	2174	116	T2D_GENES_TANYA_LIPIDS	IKEDA_MIR30_TARGETS_UP
0.137994480221%	3	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_CALNEXIN_CALRETICULIN_CYCLE
0.137994480221%	3	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS
0.137994480221%	3	2174	11	T2D_GENES_TANYA_LIPIDS	KALMA_E2F1_TARGETS
0.137994480221%	3	2174	11	T2D_GENES_TANYA_LIPIDS	IIZUKA_LIVER_CANCER_EARLY_RECURRENCE
0.137994480221%	3	2174	11	T2D_GENES_TANYA_LIPIDS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_DN
0.137994480221%	3	2174	11	T2D_GENES_TANYA_LIPIDS	DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4
0.137994480221%	3	2174	11	T2D_GENES_TANYA_LIPIDS	BIOCARTA_TCAPOPTOSIS_PATHWAY
0.137994480221%	3	2174	11	T2D_GENES_TANYA_LIPIDS	BIOCARTA_EGFR_SMRTE_PATHWAY
0.137994480221%	3	2174	11	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CDK5_PATHWAY
0.137994480221%	3	2174	108	T2D_GENES_TANYA_LIPIDS	TAVAZOIE_METASTASIS
0.137994480221%	3	2174	105	T2D_GENES_TANYA_LIPIDS	WOO_LIVER_CANCER_RECURRENCE_UP
0.137994480221%	3	2174	100	T2D_GENES_TANYA_LIPIDS	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
0.137994480221%	3	2174	10	T2D_GENES_TANYA_LIPIDS	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN
0.137994480221%	3	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS
0.137994480221%	3	2174	10	T2D_GENES_TANYA_LIPIDS	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP
0.137994480221%	3	2174	10	T2D_GENES_TANYA_LIPIDS	BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN
0.137994480221%	3	2174	10	T2D_GENES_TANYA_LIPIDS	BIOCARTA_RNA_PATHWAY
0.137994480221%	3	2174	10	T2D_GENES_TANYA_LIPIDS	BIOCARTA_FREE_PATHWAY
0.113636363636%	4	3520	93	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEN_LIVER_METABOLISM_QTL_CIS
0.113636363636%	4	3520	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAMPS_COLON_CANCER_COPY_NUMBER_UP
0.113636363636%	4	3520	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_ERBB4
0.113636363636%	4	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_2_DN
0.113636363636%	4	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
0.113636363636%	4	3520	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SAFFORD_T_LYMPHOCYTE_ANERGY
0.113636363636%	4	3520	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
0.113636363636%	4	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SWEET_KRAS_TARGETS_UP
0.113636363636%	4	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ECM_RECEPTOR_INTERACTION
0.113636363636%	4	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
0.113636363636%	4	3520	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.113636363636%	4	3520	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WONG_ENDMETRIUM_CANCER_DN
0.113636363636%	4	3520	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_SMAD2_3NUCLEARPATHWAY
0.113636363636%	4	3520	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BILD_CTNNB1_ONCOGENIC_SIGNATURE
0.113636363636%	4	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16
0.113636363636%	4	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TOOKER_GEMCITABINE_RESISTANCE_UP
0.113636363636%	4	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PLATELET_HOMEOSTASIS
0.113636363636%	4	3520	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_D_DN
0.113636363636%	4	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RODRIGUES_THYROID_CARCINOMA_DN
0.113636363636%	4	3520	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX
0.113636363636%	4	3520	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.113636363636%	4	3520	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
0.113636363636%	4	3520	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_SURVIVAL_UP
0.113636363636%	4	3520	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LANDIS_BREAST_CANCER_PROGRESSION_DN
0.113636363636%	4	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.113636363636%	4	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP
0.113636363636%	4	3520	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ELVIDGE_HIF1A_TARGETS_UP
0.113636363636%	4	3520	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70
0.113636363636%	4	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SWEET_KRAS_TARGETS_DN
0.113636363636%	4	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER_MYC_E2F1_DN
0.113636363636%	4	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER_E2F1_DN
0.113636363636%	4	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER_ACOX1_UP
0.113636363636%	4	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE
0.113636363636%	4	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PHONG_TNF_TARGETS_UP
0.113636363636%	4	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER_MYC_DN
0.113636363636%	4	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER_E2F1_UP
0.113636363636%	4	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.113636363636%	4	3520	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZWANG_EGF_PERSISTENTLY_DN
0.113636363636%	4	3520	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER_DENA_UP
0.113636363636%	4	3520	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUTTMANN_B_CLL_POOR_SURVIVAL_DN
0.113636363636%	4	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3
0.113636363636%	4	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIAN_LIPA_TARGETS_3M
0.113636363636%	4	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION
0.113636363636%	4	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1
0.113636363636%	4	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
0.113636363636%	4	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NADLER_HYPERGLYCEMIA_AT_OBESITY
0.113636363636%	4	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN
0.113636363636%	4	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_HIVNEF_PATHWAY
0.113636363636%	4	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TANG_SENESCENCE_TP53_TARGETS_DN
0.113636363636%	4	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.113636363636%	4	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PEART_HDAC_PROLIFERATION_CLUSTER_UP
0.113636363636%	4	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GYORFFY_MITOXANTRONE_RESISTANCE
0.113636363636%	4	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRABARCZYK_BCL11B_TARGETS_DN
0.113636363636%	4	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DELASERNA_MYOD_TARGETS_DN
0.113636363636%	4	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WORSCHECH_TUMOR_REJECTION_UP
0.113636363636%	4	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.113636363636%	4	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53
0.113636363636%	4	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D4
0.113636363636%	4	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DEMAGALHAES_AGING_UP
0.113636363636%	4	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHOU_TNF_SIGNALING_4HR
0.113636363636%	4	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C2
0.113636363636%	4	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP
0.113636363636%	4	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_TAP63PATHWAY
0.113636363636%	4	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_2_UP
0.113636363636%	4	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KRIEG_HYPOXIA_VIA_KDM3A
0.113636363636%	4	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IKEDA_MIR1_TARGETS_UP
0.113636363636%	4	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WINTER_HYPOXIA_DN
0.113636363636%	4	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GABA_RECEPTOR_ACTIVATION
0.113636363636%	4	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP
0.113636363636%	4	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_PEAK_AT_2HR
0.113636363636%	4	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KENNY_CTNNB1_TARGETS_UP
0.113636363636%	4	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS
0.113636363636%	4	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BECKER_TAMOXIFEN_RESISTANCE_UP
0.113636363636%	4	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS
0.113636363636%	4	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ARF6_TRAFFICKINGPATHWAY
0.113636363636%	4	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP
0.113636363636%	4	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP
0.113636363636%	4	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RICKMAN_HEAD_AND_NECK_CANCER_B
0.113636363636%	4	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE
0.113636363636%	4	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_HES_HEYPATHWAY
0.113636363636%	4	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_AJDISS_2PATHWAY
0.113636363636%	4	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAMASHITA_LIVER_CANCER_STEM_CELL_UP
0.113636363636%	4	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
0.113636363636%	4	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_FANCONI_PATHWAY
0.113636363636%	4	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_PLK1_PATHWAY
0.113636363636%	4	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN
0.113636363636%	4	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KUNINGER_IGF1_VS_PDGFB_TARGETS_DN
0.113636363636%	4	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN
0.113636363636%	4	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_PR_UP
0.113636363636%	4	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD1_UP
0.113636363636%	4	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_TARGETS_OF_MLL_CBP_FUSION_DN
0.113636363636%	4	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANHARANTA_UTERINE_FIBROID_UP
0.113636363636%	4	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SIG_CHEMOTAXIS
0.113636363636%	4	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER
0.113636363636%	4	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MRNA_SPLICING_MINOR_PATHWAY
0.113636363636%	4	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
0.113636363636%	4	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN
0.113636363636%	4	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCDOWELL_ACUTE_LUNG_INJURY_UP
0.113636363636%	4	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN
0.113636363636%	4	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_AGING_MUSCLE_UP
0.113636363636%	4	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KLEIN_TARGETS_OF_BCR_ABL1_FUSION
0.113636363636%	4	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN
0.113636363636%	4	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRADE_METASTASIS_DN
0.113636363636%	4	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_LITERATURE
0.113636363636%	4	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_TARGETS_OF_MLL_CBP_FUSION_UP
0.113636363636%	4	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_BRCA1_DN
0.113636363636%	4	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROVERSI_GLIOMA_LOH_REGIONS
0.113636363636%	4	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS
0.113636363636%	4	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
0.113636363636%	4	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS
0.113636363636%	4	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS
0.113636363636%	4	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JAEGER_METASTASIS_UP
0.113636363636%	4	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_ONLY_DN
0.113636363636%	4	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK
0.113636363636%	4	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	POTTI_5FU_SENSITIVITY
0.113636363636%	4	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_INTEGRIN3_PATHWAY
0.113636363636%	4	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN
0.113636363636%	4	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAMURA_METASTASIS_MODEL_DN
0.113636363636%	4	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.113636363636%	4	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUMMEL_BURKITTS_LYMPHOMA_UP
0.113636363636%	4	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_24HR_DN
0.113636363636%	4	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	COWLING_MYCN_TARGETS
0.113636363636%	4	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_PEAK_AT_24HR
0.113636363636%	4	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_BMPPATHWAY
0.113636363636%	4	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP
0.113636363636%	4	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CHREBP2_PATHWAY
0.113636363636%	4	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BARRIER_COLON_CANCER_RECURRENCE_UP
0.113636363636%	4	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION_HBZ
0.113636363636%	4	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MALONEY_RESPONSE_TO_17AAG_UP
0.113636363636%	4	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIN_MELANOMA_COPY_NUMBER_DN
0.113636363636%	4	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN
0.113636363636%	4	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAMMINGA_SENESCENCE
0.113636363636%	4	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
0.113636363636%	4	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VARELA_ZMPSTE24_TARGETS_UP
0.113636363636%	4	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
0.113636363636%	4	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_EPHBFWDPATHWAY
0.113636363636%	4	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_48HR_DN
0.113636363636%	4	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN
0.113636363636%	4	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BERNARD_PPAPDC1B_TARGETS_UP
0.113636363636%	4	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1
0.113636363636%	4	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NEWMAN_ERCC6_TARGETS_DN
0.113636363636%	4	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KORKOLA_TERATOMA
0.113636363636%	4	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOFMANN_CELL_LYMPHOMA_DN
0.113636363636%	4	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HAN_JNK_SINGALING_DN
0.113636363636%	4	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GU_PDEF_TARGETS_DN
0.113636363636%	4	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D5
0.113636363636%	4	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_32HR_DN
0.113636363636%	4	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_PEAK_AT_8HR
0.113636363636%	4	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_SERUM_RESPONSE_480_MCF10A
0.113636363636%	4	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GABA_B_RECEPTOR_ACTIVATION
0.113636363636%	4	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PENG_GLUTAMINE_DEPRIVATION_UP
0.113636363636%	4	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT
0.113636363636%	4	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN
0.113636363636%	4	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_INTEGRIN_PATHWAY
0.113636363636%	4	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_WITH_CEBPA
0.113636363636%	4	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.113636363636%	4	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MURAKAMI_UV_RESPONSE_6HR_UP
0.113636363636%	4	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D6
0.113636363636%	4	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE
0.113636363636%	4	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_MET_PATHWAY
0.113636363636%	4	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BILANGES_SERUM_RESPONSE_TRANSLATION
0.113636363636%	4	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
0.113636363636%	4	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
0.113636363636%	4	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION
0.113636363636%	4	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_BASAL_TRANSCRIPTION_FACTORS
0.113636363636%	4	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JIANG_AGING_CEREBRAL_CORTEX_UP
0.113636363636%	4	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP
0.113636363636%	4	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP
0.113636363636%	4	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15
0.113636363636%	4	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAGI_AML_RELAPSE_PROGNOSIS
0.113636363636%	4	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.113636363636%	4	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_METHYLATED_IN_BREAST_CANCER
0.113636363636%	4	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP
0.113636363636%	4	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BALDWIN_PRKCI_TARGETS_UP
0.113636363636%	4	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AIGNER_ZEB1_TARGETS
0.113636363636%	4	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YANG_BREAST_CANCER_ESR1_LASER_UP
0.113636363636%	4	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_WNT_BETA_CATENIN_PATHWAY
0.113636363636%	4	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_HIF2PATHWAY
0.113636363636%	4	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_HDAC_CLASSII_PATHWAY
0.113636363636%	4	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_EPHA_FWDPATHWAY
0.113636363636%	4	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM
0.113636363636%	4	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_CYSTEINE_AND_METHIONINE_METABOLISM
0.113636363636%	4	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_MPR_PATHWAY
0.113636363636%	4	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ETHER_LIPID_METABOLISM
0.113636363636%	4	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HEIDENBLAD_AMPLICON_12P11_12_UP
0.113636363636%	4	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GHANDHI_DIRECT_IRRADIATION_DN
0.113636363636%	4	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FIRESTEIN_CTNNB1_PATHWAY
0.113636363636%	4	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_12HR_DN
0.113636363636%	4	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_1
0.113636363636%	4	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN
0.113636363636%	4	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN
0.113636363636%	4	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TRACEY_RESISTANCE_TO_IFNA2_DN
0.113636363636%	4	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOOTHA_GLUCONEOGENESIS
0.113636363636%	4	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MEISSNER_BRAIN_ICP_WITH_H3K4ME3
0.113636363636%	4	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIANG_SILENCED_BY_METHYLATION_UP
0.113636363636%	4	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM
0.113636363636%	4	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KASLER_HDAC7_TARGETS_2_DN
0.113636363636%	4	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP
0.113636363636%	4	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN
0.113636363636%	4	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE
0.113636363636%	4	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_AURORA_A_PATHWAY
0.113636363636%	4	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NOJIMA_SFRP2_TARGETS_UP
0.113636363636%	4	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.113636363636%	4	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCCABE_HOXC6_TARGETS_CANCER_UP
0.113636363636%	4	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD
0.113636363636%	4	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DANG_MYC_TARGETS_DN
0.113636363636%	4	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_MYOSIN_PATHWAY
0.113636363636%	4	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.113636363636%	4	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN
0.113636363636%	4	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN
0.113636363636%	4	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN
0.113636363636%	4	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT
0.113636363636%	4	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MRNA_CAPPING
0.113636363636%	4	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES
0.113636363636%	4	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX
0.113636363636%	4	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DNA_STRAND_ELONGATION
0.113636363636%	4	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_RETINOIC_ACID_PATHWAY
0.113636363636%	4	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_NECTIN_PATHWAY
0.113636363636%	4	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP
0.113636363636%	4	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_NORMAL_AGING_DN
0.113636363636%	4	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GILDEA_METASTASIS
0.113636363636%	4	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP
0.113636363636%	4	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY
0.113636363636%	4	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR
0.113636363636%	4	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN
0.113636363636%	4	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN
0.113636363636%	4	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_STEROID_HORMONES
0.113636363636%	4	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PERK_REGULATED_GENE_EXPRESSION
0.113636363636%	4	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
0.113636363636%	4	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NGUYEN_NOTCH1_TARGETS_UP
0.113636363636%	4	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARSHALL_VIRAL_INFECTION_RESPONSE_DN
0.113636363636%	4	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LU_TUMOR_VASCULATURE_UP
0.113636363636%	4	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_WERNER_SYNDROM_DN
0.113636363636%	4	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GENTLES_LEUKEMIC_STEM_CELL_UP
0.113636363636%	4	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DALESSIO_TSA_RESPONSE
0.113636363636%	4	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_CLUSTER_7
0.113636363636%	4	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TERAO_AOX4_TARGETS_HG_UP
0.113636363636%	4	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS
0.113636363636%	4	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MYOGENESIS
0.113636363636%	4	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G24
0.113636363636%	4	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN
0.113636363636%	4	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YE_METASTATIC_LIVER_CANCER
0.113636363636%	4	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN
0.113636363636%	4	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_AKT1_TARGETS_6HR
0.113636363636%	4	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TERAMOTO_OPN_TARGETS_CLUSTER_6
0.113636363636%	4	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_GRANULE_CELL_SURVIVAL_PATHWAY
0.113636363636%	4	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
0.113636363636%	4	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE
0.113636363636%	4	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT
0.113636363636%	4	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN
0.113636363636%	4	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GENTILE_UV_LOW_DOSE_UP
0.113636363636%	4	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP
0.113636363636%	4	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G2
0.113636363636%	4	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_CLUSTER_8
0.113636363636%	4	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_INTERLEUKIN_4_PATHWAY
0.113636363636%	4	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP
0.113636363636%	4	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER
0.113636363636%	4	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATORY_RNA_PATHWAYS
0.113636363636%	4	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_GENES_BY_ATF4
0.113636363636%	4	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_P38_MKK3_6PATHWAY
0.113636363636%	4	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ALK1PATHWAY
0.113636363636%	4	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1
0.113636363636%	4	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES
0.113636363636%	4	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_GALACTOSE_METABOLISM
0.113636363636%	4	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRACHAT_RESPONSE_TO_METHOTREXATE_UP
0.113636363636%	4	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
0.113636363636%	4	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WONG_ENDMETRIUM_CANCER_UP
0.113636363636%	4	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING
0.113636363636%	4	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DARPP_32_EVENTS
0.113636363636%	4	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_MYC_PATHWAY
0.113636363636%	4	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_LYMPHANGIOGENESIS_PATHWAY
0.113636363636%	4	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS
0.113636363636%	4	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD
0.113636363636%	4	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GENTILE_UV_HIGH_DOSE_UP
0.113636363636%	4	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.113636363636%	4	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_MCALPAIN_PATHWAY
0.113636363636%	4	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YIH_RESPONSE_TO_ARSENITE_C1
0.113636363636%	4	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN
0.113636363636%	4	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SA_B_CELL_RECEPTOR_COMPLEXES
0.113636363636%	4	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PYRIMIDINE_METABOLISM
0.113636363636%	4	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION
0.113636363636%	4	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION
0.113636363636%	4	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23
0.113636363636%	4	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN
0.113636363636%	4	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY
0.113636363636%	4	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_EIF4_PATHWAY
0.113636363636%	4	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_ECM_PATHWAY
0.113636363636%	4	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_PRLSIGNALINGEVENTSPATHWAY
0.113636363636%	4	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_NFKAPPABCANONICALPATHWAY
0.113636363636%	4	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_NITROGEN_METABOLISM
0.113636363636%	4	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FERRANDO_HOX11_NEIGHBORS
0.113636363636%	4	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_PTDINS_PATHWAY
0.113636363636%	4	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_NFKB_PATHWAY
0.113636363636%	4	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_SPIKED
0.113636363636%	4	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DEADENYLATION_OF_MRNA
0.113636363636%	4	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACYL_CHAIN_REMODELLING_OF_PC
0.113636363636%	4	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
0.113636363636%	4	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NUMATA_CSF3_SIGNALING_VIA_STAT3
0.113636363636%	4	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS
0.113636363636%	4	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP
0.113636363636%	4	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HANSON_HRAS_SIGNALING_VIA_NFKB
0.113636363636%	4	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION
0.113636363636%	4	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_SPPA_PATHWAY
0.113636363636%	4	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_INSULIN_PATHWAY
0.113636363636%	4	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_GCR_PATHWAY
0.113636363636%	4	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP
0.113636363636%	4	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STEGER_ADIPOGENESIS_UP
0.113636363636%	4	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION
0.113636363636%	4	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ERK_MAPK_TARGETS
0.113636363636%	4	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACYL_CHAIN_REMODELLING_OF_PE
0.113636363636%	4	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HASLINGER_B_CLL_WITH_17P13_DELETION
0.113636363636%	4	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE
0.113636363636%	4	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_TOB1_PATHWAY
0.113636363636%	4	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CALCINEURIN_PATHWAY
0.113636363636%	4	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_SERUM_RESPONSE_20_MCF10A
0.113636363636%	4	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHU_SKIL_TARGETS_UP
0.113636363636%	4	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZEMBUTSU_SENSITIVITY_TO_CISPLATIN
0.113636363636%	4	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VILIMAS_NOTCH1_TARGETS_DN
0.113636363636%	4	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C3
0.113636363636%	4	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PHESSE_TARGETS_OF_APC_AND_MBD2_UP
0.113636363636%	4	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_MYCL1_AMPLIFICATION_TARGETS_DN
0.113636363636%	4	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G28
0.113636363636%	4	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ABE_VEGFA_TARGETS
0.113636363636%	4	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN
0.113636363636%	4	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VERNOCHET_ADIPOGENESIS
0.113636363636%	4	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP
0.113636363636%	4	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP
0.113636363636%	4	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS
0.113636363636%	4	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIELSEN_LIPOSARCOMA_DN
0.113636363636%	4	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIZUSHIMA_AUTOPHAGOSOME_FORMATION
0.113636363636%	4	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LE_NEURONAL_DIFFERENTIATION_DN
0.113636363636%	4	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ALPHA_LINOLENIC_ACID_METABOLISM
0.113636363636%	4	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KANG_CISPLATIN_RESISTANCE_UP
0.113636363636%	4	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAJATE_RESPONSE_TO_TRABECTEDIN_DN
0.113636363636%	4	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_TID_PATHWAY
0.113636363636%	4	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_COMP_PATHWAY
0.113636363636%	4	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE
0.113636363636%	4	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP
0.113636363636%	4	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHURINGA_STAT5A_TARGETS_DN
0.113636363636%	4	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI
0.113636363636%	4	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KARAKAS_TGFB1_SIGNALING
0.113636363636%	4	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUMMERICH_MALIGNANT_SKIN_TUMOR_DN
0.113636363636%	4	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_TNFR2_PATHWAY
0.113636363636%	4	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_TEL_PATHWAY
0.113636363636%	4	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_ETS_PATHWAY
0.113636363636%	4	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP
0.113636363636%	4	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS
0.113636363636%	4	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_SYNDECAN_3_PATHWAY
0.113636363636%	4	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_NFKAPPABATYPICALPATHWAY
0.113636363636%	4	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LOPEZ_EPITHELIOID_MESOTHELIOMA
0.113636363636%	4	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_RENIN_ANGIOTENSIN_SYSTEM
0.113636363636%	4	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GALE_APL_WITH_FLT3_MUTATED_DN
0.113636363636%	4	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_IL17_PATHWAY
0.113636363636%	4	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CK1_PATHWAY
0.113636363636%	4	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_RECURRENT_LIVER_CANCER_DN
0.113636363636%	4	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS
0.113636363636%	4	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HAHTOLA_CTCL_PATHOGENESIS
0.113636363636%	4	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DASU_IL6_SIGNALING_SCAR_DN
0.113636363636%	4	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL
0.113636363636%	4	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BAKER_HEMATOPOIESIS_STAT3_TARGETS
0.113636363636%	4	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4
0.113636363636%	4	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN
0.113636363636%	4	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP
0.113636363636%	4	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP
0.113636363636%	4	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACYL_CHAIN_REMODELLING_OF_PI
0.113636363636%	4	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP
0.113636363636%	4	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ERB_GENOMIC_PATHWAY
0.113636363636%	4	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ARF6DOWNSTREAMPATHWAY
0.113636363636%	4	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS
0.113636363636%	4	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	EHRLICH_ICF_SYNDROM_DN
0.113636363636%	4	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G3
0.113636363636%	4	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_HIF_PATHWAY
0.113636363636%	4	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CTL_PATHWAY
0.113636363636%	4	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CD40_PATHWAY
0.113636363636%	4	3520	141	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP
0.113636363636%	4	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_PORPHYRINS
0.113636363636%	4	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24
0.113636363636%	4	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP
0.113636363636%	4	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_ES_LCP_WITH_H3K27ME3
0.113636363636%	4	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATZUK_OVULATION
0.113636363636%	4	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION
0.113636363636%	4	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GILMORE_CORE_NFKB_PATHWAY
0.113636363636%	4	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_RANKL_PATHWAY
0.113636363636%	4	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP
0.113636363636%	4	3520	132	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
0.113636363636%	4	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TERAMOTO_OPN_TARGETS_CLUSTER_4
0.113636363636%	4	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PURINE_SALVAGE
0.113636363636%	4	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE
0.113636363636%	4	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ONGUSAHA_BRCA1_TARGETS_UP
0.113636363636%	4	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
0.113636363636%	4	3520	120	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.113636363636%	4	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RUAN_RESPONSE_TO_TNF_UP
0.113636363636%	4	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP
0.113636363636%	4	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.113636363636%	4	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G5
0.113636363636%	4	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_TRKA_PATHWAY
0.113636363636%	4	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_ASBCELL_PATHWAY
0.113636363636%	4	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP
0.113636363636%	4	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LOPEZ_MESOTHELIOMA_SURVIVAL_UP
0.113636363636%	4	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHUANG_OXIDATIVE_STRESS_RESPONSE_DN
0.113636363636%	4	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_BLYMPHOCYTE_PATHWAY
0.113636363636%	4	3520	107	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_ILS
0.113636363636%	4	3520	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RICKMAN_HEAD_AND_NECK_CANCER_A
0.113636363636%	4	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAKAYAMA_BOUND_BY_AR
0.113636363636%	4	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION
0.113636363636%	4	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM
0.113636363636%	4	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN
0.113636363636%	4	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_SARS_PATHWAY
0.106894708712%	2	1871	93	T2D_GENES_TANYA_HEIGHT	CHEN_LIVER_METABOLISM_QTL_CIS
0.106894708712%	2	1871	91	T2D_GENES_TANYA_HEIGHT	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
0.106894708712%	2	1871	9	T2D_GENES_TANYA_HEIGHT	YANAGISAWA_LUNG_CANCER_RECURRENCE
0.106894708712%	2	1871	9	T2D_GENES_TANYA_HEIGHT	ST_TYPE_I_INTERFERON_PATHWAY
0.106894708712%	2	1871	9	T2D_GENES_TANYA_HEIGHT	SA_FAS_SIGNALING
0.106894708712%	2	1871	9	T2D_GENES_TANYA_HEIGHT	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY
0.106894708712%	2	1871	9	T2D_GENES_TANYA_HEIGHT	KIM_ALL_DISORDERS_DURATION_CORR_UP
0.106894708712%	2	1871	9	T2D_GENES_TANYA_HEIGHT	FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1
0.106894708712%	2	1871	9	T2D_GENES_TANYA_HEIGHT	FIGUEROA_AML_METHYLATION_CLUSTER_2_DN
0.106894708712%	2	1871	9	T2D_GENES_TANYA_HEIGHT	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1
0.106894708712%	2	1871	9	T2D_GENES_TANYA_HEIGHT	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP
0.106894708712%	2	1871	88	T2D_GENES_TANYA_HEIGHT	WALLACE_PROSTATE_CANCER_RACE_DN
0.106894708712%	2	1871	85	T2D_GENES_TANYA_HEIGHT	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
0.106894708712%	2	1871	85	T2D_GENES_TANYA_HEIGHT	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
0.106894708712%	2	1871	83	T2D_GENES_TANYA_HEIGHT	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
0.106894708712%	2	1871	80	T2D_GENES_TANYA_HEIGHT	PID_BETACATENIN_NUC_PATHWAY
0.106894708712%	2	1871	8	T2D_GENES_TANYA_HEIGHT	STANHILL_HRAS_TRANSFROMATION_UP
0.106894708712%	2	1871	8	T2D_GENES_TANYA_HEIGHT	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP
0.106894708712%	2	1871	8	T2D_GENES_TANYA_HEIGHT	OHM_EMBRYONIC_CARCINOMA_DN
0.106894708712%	2	1871	8	T2D_GENES_TANYA_HEIGHT	NEBEN_AML_WITH_FLT3_OR_NRAS_UP
0.106894708712%	2	1871	8	T2D_GENES_TANYA_HEIGHT	NADELLA_PRKAR1A_TARGETS_DN
0.106894708712%	2	1871	8	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_PLURIPOTENT_STATE_DN
0.106894708712%	2	1871	8	T2D_GENES_TANYA_HEIGHT	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2
0.106894708712%	2	1871	8	T2D_GENES_TANYA_HEIGHT	ISHIKAWA_STING_SIGNALING
0.106894708712%	2	1871	8	T2D_GENES_TANYA_HEIGHT	HOLLEMAN_DAUNORUBICIN_ALL_DN
0.106894708712%	2	1871	8	T2D_GENES_TANYA_HEIGHT	GALIE_TUMOR_ANGIOGENESIS
0.106894708712%	2	1871	8	T2D_GENES_TANYA_HEIGHT	CAFFAREL_RESPONSE_TO_THC_24HR_3_UP
0.106894708712%	2	1871	8	T2D_GENES_TANYA_HEIGHT	BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS
0.106894708712%	2	1871	79	T2D_GENES_TANYA_HEIGHT	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
0.106894708712%	2	1871	79	T2D_GENES_TANYA_HEIGHT	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.106894708712%	2	1871	78	T2D_GENES_TANYA_HEIGHT	REACTOME_CELL_JUNCTION_ORGANIZATION
0.106894708712%	2	1871	77	T2D_GENES_TANYA_HEIGHT	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.106894708712%	2	1871	70	T2D_GENES_TANYA_HEIGHT	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450
0.106894708712%	2	1871	7	T2D_GENES_TANYA_HEIGHT	TERAMOTO_OPN_TARGETS_CLUSTER_5
0.106894708712%	2	1871	7	T2D_GENES_TANYA_HEIGHT	MIKI_COEXPRESSED_WITH_CYP19A1
0.106894708712%	2	1871	7	T2D_GENES_TANYA_HEIGHT	MATZUK_STEROIDOGENESIS
0.106894708712%	2	1871	7	T2D_GENES_TANYA_HEIGHT	MARSHALL_VIRAL_INFECTION_RESPONSE_UP
0.106894708712%	2	1871	7	T2D_GENES_TANYA_HEIGHT	KUWANO_RNA_STABILIZED_BY_NO
0.106894708712%	2	1871	7	T2D_GENES_TANYA_HEIGHT	FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES
0.106894708712%	2	1871	7	T2D_GENES_TANYA_HEIGHT	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3
0.106894708712%	2	1871	66	T2D_GENES_TANYA_HEIGHT	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT
0.106894708712%	2	1871	64	T2D_GENES_TANYA_HEIGHT	KEGG_RETINOL_METABOLISM
0.106894708712%	2	1871	64	T2D_GENES_TANYA_HEIGHT	GERHOLD_ADIPOGENESIS_DN
0.106894708712%	2	1871	63	T2D_GENES_TANYA_HEIGHT	MODY_HIPPOCAMPUS_POSTNATAL
0.106894708712%	2	1871	63	T2D_GENES_TANYA_HEIGHT	CROMER_TUMORIGENESIS_UP
0.106894708712%	2	1871	62	T2D_GENES_TANYA_HEIGHT	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
0.106894708712%	2	1871	62	T2D_GENES_TANYA_HEIGHT	KYNG_DNA_DAMAGE_BY_UV
0.106894708712%	2	1871	60	T2D_GENES_TANYA_HEIGHT	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN
0.106894708712%	2	1871	6	T2D_GENES_TANYA_HEIGHT	COURTOIS_SENESCENCE_TRIGGERS
0.106894708712%	2	1871	6	T2D_GENES_TANYA_HEIGHT	BUSA_SAM68_TARGETS_DN
0.106894708712%	2	1871	59	T2D_GENES_TANYA_HEIGHT	BOYLAN_MULTIPLE_MYELOMA_C_DN
0.106894708712%	2	1871	58	T2D_GENES_TANYA_HEIGHT	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN
0.106894708712%	2	1871	58	T2D_GENES_TANYA_HEIGHT	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
0.106894708712%	2	1871	57	T2D_GENES_TANYA_HEIGHT	YAMASHITA_METHYLATED_IN_PROSTATE_CANCER
0.106894708712%	2	1871	57	T2D_GENES_TANYA_HEIGHT	REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.106894708712%	2	1871	55	T2D_GENES_TANYA_HEIGHT	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53
0.106894708712%	2	1871	55	T2D_GENES_TANYA_HEIGHT	REACTOME_ION_CHANNEL_TRANSPORT
0.106894708712%	2	1871	55	T2D_GENES_TANYA_HEIGHT	GENTILE_UV_RESPONSE_CLUSTER_D4
0.106894708712%	2	1871	54	T2D_GENES_TANYA_HEIGHT	ROVERSI_GLIOMA_COPY_NUMBER_DN
0.106894708712%	2	1871	54	T2D_GENES_TANYA_HEIGHT	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP
0.106894708712%	2	1871	54	T2D_GENES_TANYA_HEIGHT	MARSON_FOXP3_TARGETS_DN
0.106894708712%	2	1871	54	T2D_GENES_TANYA_HEIGHT	HUPER_BREAST_BASAL_VS_LUMINAL_UP
0.106894708712%	2	1871	54	T2D_GENES_TANYA_HEIGHT	AUNG_GASTRIC_CANCER
0.106894708712%	2	1871	52	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN
0.106894708712%	2	1871	52	T2D_GENES_TANYA_HEIGHT	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM
0.106894708712%	2	1871	52	T2D_GENES_TANYA_HEIGHT	KEGG_STARCH_AND_SUCROSE_METABOLISM
0.106894708712%	2	1871	52	T2D_GENES_TANYA_HEIGHT	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN
0.106894708712%	2	1871	51	T2D_GENES_TANYA_HEIGHT	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP
0.106894708712%	2	1871	5	T2D_GENES_TANYA_HEIGHT	VERRECCHIA_RESPONSE_TO_TGFB1_C6
0.106894708712%	2	1871	5	T2D_GENES_TANYA_HEIGHT	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN
0.106894708712%	2	1871	5	T2D_GENES_TANYA_HEIGHT	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3
0.106894708712%	2	1871	5	T2D_GENES_TANYA_HEIGHT	PASTURAL_RIZ1_TARGETS_DN
0.106894708712%	2	1871	5	T2D_GENES_TANYA_HEIGHT	CASTELLANO_HRAS_TARGETS_UP
0.106894708712%	2	1871	5	T2D_GENES_TANYA_HEIGHT	ALONSO_METASTASIS_EMT_DN
0.106894708712%	2	1871	49	T2D_GENES_TANYA_HEIGHT	REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS
0.106894708712%	2	1871	48	T2D_GENES_TANYA_HEIGHT	ENGELMANN_CANCER_PROGENITORS_UP
0.106894708712%	2	1871	48	T2D_GENES_TANYA_HEIGHT	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
0.106894708712%	2	1871	47	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_HP_DN
0.106894708712%	2	1871	47	T2D_GENES_TANYA_HEIGHT	BROWNE_HCMV_INFECTION_8HR_DN
0.106894708712%	2	1871	47	T2D_GENES_TANYA_HEIGHT	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP
0.106894708712%	2	1871	46	T2D_GENES_TANYA_HEIGHT	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
0.106894708712%	2	1871	46	T2D_GENES_TANYA_HEIGHT	PID_SYNDECAN_1_PATHWAY
0.106894708712%	2	1871	46	T2D_GENES_TANYA_HEIGHT	PID_A6B1_A6B4_INTEGRIN_PATHWAY
0.106894708712%	2	1871	46	T2D_GENES_TANYA_HEIGHT	PARENT_MTOR_SIGNALING_DN
0.106894708712%	2	1871	46	T2D_GENES_TANYA_HEIGHT	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN
0.106894708712%	2	1871	46	T2D_GENES_TANYA_HEIGHT	KEGG_N_GLYCAN_BIOSYNTHESIS
0.106894708712%	2	1871	46	T2D_GENES_TANYA_HEIGHT	AMIT_EGF_RESPONSE_60_HELA
0.106894708712%	2	1871	45	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_CD1_UP
0.106894708712%	2	1871	45	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_CD1_DN
0.106894708712%	2	1871	45	T2D_GENES_TANYA_HEIGHT	TRAYNOR_RETT_SYNDROM_UP
0.106894708712%	2	1871	45	T2D_GENES_TANYA_HEIGHT	SIG_CHEMOTAXIS
0.106894708712%	2	1871	45	T2D_GENES_TANYA_HEIGHT	PID_ILK_PATHWAY
0.106894708712%	2	1871	45	T2D_GENES_TANYA_HEIGHT	MCDOWELL_ACUTE_LUNG_INJURY_UP
0.106894708712%	2	1871	45	T2D_GENES_TANYA_HEIGHT	KLEIN_TARGETS_OF_BCR_ABL1_FUSION
0.106894708712%	2	1871	45	T2D_GENES_TANYA_HEIGHT	CHANDRAN_METASTASIS_TOP50_DN
0.106894708712%	2	1871	44	T2D_GENES_TANYA_HEIGHT	ZHAN_MULTIPLE_MYELOMA_PR_DN
0.106894708712%	2	1871	44	T2D_GENES_TANYA_HEIGHT	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.106894708712%	2	1871	44	T2D_GENES_TANYA_HEIGHT	LANDIS_BREAST_CANCER_PROGRESSION_UP
0.106894708712%	2	1871	44	T2D_GENES_TANYA_HEIGHT	FARMER_BREAST_CANCER_CLUSTER_1
0.106894708712%	2	1871	43	T2D_GENES_TANYA_HEIGHT	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN
0.106894708712%	2	1871	43	T2D_GENES_TANYA_HEIGHT	HUMMEL_BURKITTS_LYMPHOMA_UP
0.106894708712%	2	1871	43	T2D_GENES_TANYA_HEIGHT	FUJII_YBX1_TARGETS_UP
0.106894708712%	2	1871	42	T2D_GENES_TANYA_HEIGHT	ZHENG_IL22_SIGNALING_DN
0.106894708712%	2	1871	42	T2D_GENES_TANYA_HEIGHT	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP
0.106894708712%	2	1871	42	T2D_GENES_TANYA_HEIGHT	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN
0.106894708712%	2	1871	42	T2D_GENES_TANYA_HEIGHT	PID_UPA_UPAR_PATHWAY
0.106894708712%	2	1871	41	T2D_GENES_TANYA_HEIGHT	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM
0.106894708712%	2	1871	41	T2D_GENES_TANYA_HEIGHT	CROONQUIST_NRAS_SIGNALING_UP
0.106894708712%	2	1871	41	T2D_GENES_TANYA_HEIGHT	BIOCARTA_FCER1_PATHWAY
0.106894708712%	2	1871	40	T2D_GENES_TANYA_HEIGHT	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
0.106894708712%	2	1871	40	T2D_GENES_TANYA_HEIGHT	PID_EPHBFWDPATHWAY
0.106894708712%	2	1871	40	T2D_GENES_TANYA_HEIGHT	MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.106894708712%	2	1871	40	T2D_GENES_TANYA_HEIGHT	LIAO_HAVE_SOX4_BINDING_SITES
0.106894708712%	2	1871	40	T2D_GENES_TANYA_HEIGHT	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN
0.106894708712%	2	1871	39	T2D_GENES_TANYA_HEIGHT	NEWMAN_ERCC6_TARGETS_DN
0.106894708712%	2	1871	39	T2D_GENES_TANYA_HEIGHT	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
0.106894708712%	2	1871	39	T2D_GENES_TANYA_HEIGHT	CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP
0.106894708712%	2	1871	39	T2D_GENES_TANYA_HEIGHT	BURTON_ADIPOGENESIS_PEAK_AT_8HR
0.106894708712%	2	1871	38	T2D_GENES_TANYA_HEIGHT	VARELA_ZMPSTE24_TARGETS_DN
0.106894708712%	2	1871	38	T2D_GENES_TANYA_HEIGHT	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS
0.106894708712%	2	1871	38	T2D_GENES_TANYA_HEIGHT	PIONTEK_PKD1_TARGETS_UP
0.106894708712%	2	1871	38	T2D_GENES_TANYA_HEIGHT	PID_RAC1_REG_PATHWAY
0.106894708712%	2	1871	38	T2D_GENES_TANYA_HEIGHT	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP
0.106894708712%	2	1871	38	T2D_GENES_TANYA_HEIGHT	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
0.106894708712%	2	1871	37	T2D_GENES_TANYA_HEIGHT	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
0.106894708712%	2	1871	37	T2D_GENES_TANYA_HEIGHT	PID_FRA_PATHWAY
0.106894708712%	2	1871	37	T2D_GENES_TANYA_HEIGHT	MATZUK_SPERMATID_DIFFERENTIATION
0.106894708712%	2	1871	37	T2D_GENES_TANYA_HEIGHT	LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES
0.106894708712%	2	1871	37	T2D_GENES_TANYA_HEIGHT	HU_ANGIOGENESIS_DN
0.106894708712%	2	1871	37	T2D_GENES_TANYA_HEIGHT	BILANGES_SERUM_RESPONSE_TRANSLATION
0.106894708712%	2	1871	36	T2D_GENES_TANYA_HEIGHT	VANTVEER_BREAST_CANCER_BRCA1_UP
0.106894708712%	2	1871	36	T2D_GENES_TANYA_HEIGHT	SEMENZA_HIF1_TARGETS
0.106894708712%	2	1871	36	T2D_GENES_TANYA_HEIGHT	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
0.106894708712%	2	1871	36	T2D_GENES_TANYA_HEIGHT	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION
0.106894708712%	2	1871	36	T2D_GENES_TANYA_HEIGHT	PID_PI3KPLCTRKPATHWAY
0.106894708712%	2	1871	36	T2D_GENES_TANYA_HEIGHT	MMS_MOUSE_LYMPH_HIGH_4HRS_UP
0.106894708712%	2	1871	36	T2D_GENES_TANYA_HEIGHT	MARZEC_IL2_SIGNALING_DN
0.106894708712%	2	1871	36	T2D_GENES_TANYA_HEIGHT	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP
0.106894708712%	2	1871	36	T2D_GENES_TANYA_HEIGHT	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN
0.106894708712%	2	1871	36	T2D_GENES_TANYA_HEIGHT	BURTON_ADIPOGENESIS_12
0.106894708712%	2	1871	36	T2D_GENES_TANYA_HEIGHT	BIOCARTA_AT1R_PATHWAY
0.106894708712%	2	1871	35	T2D_GENES_TANYA_HEIGHT	WANG_METHYLATED_IN_BREAST_CANCER
0.106894708712%	2	1871	35	T2D_GENES_TANYA_HEIGHT	SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES
0.106894708712%	2	1871	35	T2D_GENES_TANYA_HEIGHT	PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY
0.106894708712%	2	1871	35	T2D_GENES_TANYA_HEIGHT	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
0.106894708712%	2	1871	35	T2D_GENES_TANYA_HEIGHT	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.106894708712%	2	1871	35	T2D_GENES_TANYA_HEIGHT	LI_CISPLATIN_RESISTANCE_DN
0.106894708712%	2	1871	35	T2D_GENES_TANYA_HEIGHT	KEGG_PRION_DISEASES
0.106894708712%	2	1871	35	T2D_GENES_TANYA_HEIGHT	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.106894708712%	2	1871	34	T2D_GENES_TANYA_HEIGHT	SCHOEN_NFKB_SIGNALING
0.106894708712%	2	1871	34	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNAL_TRANSDUCTION_BY_L1
0.106894708712%	2	1871	34	T2D_GENES_TANYA_HEIGHT	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE
0.106894708712%	2	1871	34	T2D_GENES_TANYA_HEIGHT	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES
0.106894708712%	2	1871	34	T2D_GENES_TANYA_HEIGHT	REACTOME_GLUCONEOGENESIS
0.106894708712%	2	1871	34	T2D_GENES_TANYA_HEIGHT	PID_HIF2PATHWAY
0.106894708712%	2	1871	34	T2D_GENES_TANYA_HEIGHT	PID_EPOPATHWAY
0.106894708712%	2	1871	34	T2D_GENES_TANYA_HEIGHT	PID_EPHA_FWDPATHWAY
0.106894708712%	2	1871	33	T2D_GENES_TANYA_HEIGHT	WENDT_COHESIN_TARGETS_UP
0.106894708712%	2	1871	33	T2D_GENES_TANYA_HEIGHT	STAEGE_EWING_FAMILY_TUMOR
0.106894708712%	2	1871	33	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION
0.106894708712%	2	1871	33	T2D_GENES_TANYA_HEIGHT	REACTOME_PURINE_METABOLISM
0.106894708712%	2	1871	33	T2D_GENES_TANYA_HEIGHT	PID_NCADHERINPATHWAY
0.106894708712%	2	1871	33	T2D_GENES_TANYA_HEIGHT	PID_INTEGRIN_A4B1_PATHWAY
0.106894708712%	2	1871	33	T2D_GENES_TANYA_HEIGHT	MORI_PLASMA_CELL_DN
0.106894708712%	2	1871	33	T2D_GENES_TANYA_HEIGHT	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN
0.106894708712%	2	1871	33	T2D_GENES_TANYA_HEIGHT	KEGG_PROPANOATE_METABOLISM
0.106894708712%	2	1871	33	T2D_GENES_TANYA_HEIGHT	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP
0.106894708712%	2	1871	33	T2D_GENES_TANYA_HEIGHT	GRADE_COLON_CANCER_DN
0.106894708712%	2	1871	33	T2D_GENES_TANYA_HEIGHT	FARMER_BREAST_CANCER_CLUSTER_2
0.106894708712%	2	1871	33	T2D_GENES_TANYA_HEIGHT	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN
0.106894708712%	2	1871	32	T2D_GENES_TANYA_HEIGHT	REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE
0.106894708712%	2	1871	32	T2D_GENES_TANYA_HEIGHT	PID_SYNDECAN_4_PATHWAY
0.106894708712%	2	1871	32	T2D_GENES_TANYA_HEIGHT	PID_NETRIN_PATHWAY
0.106894708712%	2	1871	32	T2D_GENES_TANYA_HEIGHT	MOOTHA_GLUCONEOGENESIS
0.106894708712%	2	1871	32	T2D_GENES_TANYA_HEIGHT	BIOCARTA_PDGF_PATHWAY
0.106894708712%	2	1871	32	T2D_GENES_TANYA_HEIGHT	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP
0.106894708712%	2	1871	32	T2D_GENES_TANYA_HEIGHT	AMIT_SERUM_RESPONSE_40_MCF10A
0.106894708712%	2	1871	31	T2D_GENES_TANYA_HEIGHT	VALK_AML_CLUSTER_4
0.106894708712%	2	1871	31	T2D_GENES_TANYA_HEIGHT	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.106894708712%	2	1871	31	T2D_GENES_TANYA_HEIGHT	SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN
0.106894708712%	2	1871	31	T2D_GENES_TANYA_HEIGHT	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.106894708712%	2	1871	31	T2D_GENES_TANYA_HEIGHT	REACTOME_HS_GAG_BIOSYNTHESIS
0.106894708712%	2	1871	31	T2D_GENES_TANYA_HEIGHT	REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE
0.106894708712%	2	1871	31	T2D_GENES_TANYA_HEIGHT	PID_AR_NONGENOMIC_PATHWAY
0.106894708712%	2	1871	31	T2D_GENES_TANYA_HEIGHT	MOSERLE_IFNA_RESPONSE
0.106894708712%	2	1871	31	T2D_GENES_TANYA_HEIGHT	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER
0.106894708712%	2	1871	31	T2D_GENES_TANYA_HEIGHT	BIOCARTA_EGF_PATHWAY
0.106894708712%	2	1871	30	T2D_GENES_TANYA_HEIGHT	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN
0.106894708712%	2	1871	30	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_ROBO_RECEPTOR
0.106894708712%	2	1871	30	T2D_GENES_TANYA_HEIGHT	REACTOME_DNA_STRAND_ELONGATION
0.106894708712%	2	1871	30	T2D_GENES_TANYA_HEIGHT	PID_NECTIN_PATHWAY
0.106894708712%	2	1871	30	T2D_GENES_TANYA_HEIGHT	PID_EPHRINBREVPATHWAY
0.106894708712%	2	1871	30	T2D_GENES_TANYA_HEIGHT	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.106894708712%	2	1871	30	T2D_GENES_TANYA_HEIGHT	KYNG_NORMAL_AGING_DN
0.106894708712%	2	1871	30	T2D_GENES_TANYA_HEIGHT	HEIDENBLAD_AMPLICON_12P11_12_DN
0.106894708712%	2	1871	30	T2D_GENES_TANYA_HEIGHT	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY
0.106894708712%	2	1871	29	T2D_GENES_TANYA_HEIGHT	REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION
0.106894708712%	2	1871	29	T2D_GENES_TANYA_HEIGHT	PID_REELINPATHWAY
0.106894708712%	2	1871	29	T2D_GENES_TANYA_HEIGHT	NAKAYAMA_FGF2_TARGETS
0.106894708712%	2	1871	29	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_MCV6_LCP_WITH_H3K27ME3
0.106894708712%	2	1871	29	T2D_GENES_TANYA_HEIGHT	KYNG_WERNER_SYNDROM_DN
0.106894708712%	2	1871	29	T2D_GENES_TANYA_HEIGHT	DORN_ADENOVIRUS_INFECTION_12HR_UP
0.106894708712%	2	1871	29	T2D_GENES_TANYA_HEIGHT	BIOCARTA_VIP_PATHWAY
0.106894708712%	2	1871	29	T2D_GENES_TANYA_HEIGHT	AIYAR_COBRA1_TARGETS_DN
0.106894708712%	2	1871	28	T2D_GENES_TANYA_HEIGHT	WILLIAMS_ESR2_TARGETS_UP
0.106894708712%	2	1871	28	T2D_GENES_TANYA_HEIGHT	TIAN_TNF_SIGNALING_VIA_NFKB
0.106894708712%	2	1871	28	T2D_GENES_TANYA_HEIGHT	REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC
0.106894708712%	2	1871	28	T2D_GENES_TANYA_HEIGHT	PID_TRAIL_PATHWAY
0.106894708712%	2	1871	28	T2D_GENES_TANYA_HEIGHT	LOPES_METHYLATED_IN_COLON_CANCER_DN
0.106894708712%	2	1871	28	T2D_GENES_TANYA_HEIGHT	KAMIKUBO_MYELOID_CEBPA_NETWORK
0.106894708712%	2	1871	28	T2D_GENES_TANYA_HEIGHT	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP
0.106894708712%	2	1871	28	T2D_GENES_TANYA_HEIGHT	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.106894708712%	2	1871	28	T2D_GENES_TANYA_HEIGHT	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.106894708712%	2	1871	28	T2D_GENES_TANYA_HEIGHT	CHEN_LUNG_CANCER_SURVIVAL
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	XU_AKT1_TARGETS_6HR
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	TIEN_INTESTINE_PROBIOTICS_2HR_UP
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	TERAMOTO_OPN_TARGETS_CLUSTER_6
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_STRIATED_MUSCLE_CONTRACTION
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALLING_TO_RAS
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_GAP_JUNCTION_TRAFFICKING
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_EXTENSION_OF_TELOMERES
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	PLASARI_NFIC_TARGETS_BASAL_UP
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	NICK_RESPONSE_TO_PROC_TREATMENT_DN
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	LI_WILMS_TUMOR
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	IKEDA_MIR30_TARGETS_DN
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	BIOCARTA_GSK3_PATHWAY
0.106894708712%	2	1871	27	T2D_GENES_TANYA_HEIGHT	AKL_HTLV1_INFECTION_UP
0.106894708712%	2	1871	26	T2D_GENES_TANYA_HEIGHT	WILLIAMS_ESR1_TARGETS_UP
0.106894708712%	2	1871	26	T2D_GENES_TANYA_HEIGHT	WALLACE_JAK2_TARGETS_UP
0.106894708712%	2	1871	26	T2D_GENES_TANYA_HEIGHT	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN
0.106894708712%	2	1871	26	T2D_GENES_TANYA_HEIGHT	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP
0.106894708712%	2	1871	26	T2D_GENES_TANYA_HEIGHT	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B
0.106894708712%	2	1871	26	T2D_GENES_TANYA_HEIGHT	NEWMAN_ERCC6_TARGETS_UP
0.106894708712%	2	1871	26	T2D_GENES_TANYA_HEIGHT	KEGG_SELENOAMINO_ACID_METABOLISM
0.106894708712%	2	1871	26	T2D_GENES_TANYA_HEIGHT	HAHTOLA_CTCL_CUTANEOUS
0.106894708712%	2	1871	26	T2D_GENES_TANYA_HEIGHT	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
0.106894708712%	2	1871	26	T2D_GENES_TANYA_HEIGHT	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
0.106894708712%	2	1871	25	T2D_GENES_TANYA_HEIGHT	YANG_BREAST_CANCER_ESR1_DN
0.106894708712%	2	1871	25	T2D_GENES_TANYA_HEIGHT	VANDESLUIS_NORMAL_EMBRYOS_DN
0.106894708712%	2	1871	25	T2D_GENES_TANYA_HEIGHT	VALK_AML_WITH_EVI1
0.106894708712%	2	1871	25	T2D_GENES_TANYA_HEIGHT	STEGER_ADIPOGENESIS_DN
0.106894708712%	2	1871	25	T2D_GENES_TANYA_HEIGHT	REACTOME_SMOOTH_MUSCLE_CONTRACTION
0.106894708712%	2	1871	25	T2D_GENES_TANYA_HEIGHT	PID_TOLL_ENDOGENOUS_PATHWAY
0.106894708712%	2	1871	25	T2D_GENES_TANYA_HEIGHT	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP
0.106894708712%	2	1871	25	T2D_GENES_TANYA_HEIGHT	NOJIMA_SFRP2_TARGETS_DN
0.106894708712%	2	1871	25	T2D_GENES_TANYA_HEIGHT	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP
0.106894708712%	2	1871	25	T2D_GENES_TANYA_HEIGHT	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN
0.106894708712%	2	1871	25	T2D_GENES_TANYA_HEIGHT	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP
0.106894708712%	2	1871	25	T2D_GENES_TANYA_HEIGHT	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN
0.106894708712%	2	1871	25	T2D_GENES_TANYA_HEIGHT	BIOCARTA_MCALPAIN_PATHWAY
0.106894708712%	2	1871	24	T2D_GENES_TANYA_HEIGHT	WANG_TNF_TARGETS
0.106894708712%	2	1871	24	T2D_GENES_TANYA_HEIGHT	SHI_SPARC_TARGETS_UP
0.106894708712%	2	1871	24	T2D_GENES_TANYA_HEIGHT	SCHRAMM_INHBA_TARGETS_DN
0.106894708712%	2	1871	24	T2D_GENES_TANYA_HEIGHT	REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION
0.106894708712%	2	1871	24	T2D_GENES_TANYA_HEIGHT	REACTOME_CHOLESTEROL_BIOSYNTHESIS
0.106894708712%	2	1871	24	T2D_GENES_TANYA_HEIGHT	PID_RHODOPSIN_PATHWAY
0.106894708712%	2	1871	24	T2D_GENES_TANYA_HEIGHT	OXFORD_RALA_OR_RALB_TARGETS_DN
0.106894708712%	2	1871	24	T2D_GENES_TANYA_HEIGHT	OSADA_ASCL1_TARGETS_DN
0.106894708712%	2	1871	24	T2D_GENES_TANYA_HEIGHT	MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED
0.106894708712%	2	1871	24	T2D_GENES_TANYA_HEIGHT	MAEKAWA_ATF2_TARGETS
0.106894708712%	2	1871	24	T2D_GENES_TANYA_HEIGHT	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY
0.106894708712%	2	1871	24	T2D_GENES_TANYA_HEIGHT	CHEOK_RESPONSE_TO_HD_MTX_DN
0.106894708712%	2	1871	24	T2D_GENES_TANYA_HEIGHT	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN
0.106894708712%	2	1871	24	T2D_GENES_TANYA_HEIGHT	AZARE_STAT3_TARGETS
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	YANG_BREAST_CANCER_ESR1_BULK_DN
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	WANG_RESPONSE_TO_FORSKOLIN_UP
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	VIETOR_IFRD1_TARGETS
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	SAGIV_CD24_TARGETS_UP
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	SABATES_COLORECTAL_ADENOMA_SIZE_UP
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	PID_PRLSIGNALINGEVENTSPATHWAY
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	PID_CONE_PATHWAY
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	MARKS_HDAC_TARGETS_UP
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	MAHADEVAN_IMATINIB_RESISTANCE_UP
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	CHEOK_RESPONSE_TO_HD_MTX_UP
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	BIOCARTA_RAS_PATHWAY
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	BIOCARTA_RAC1_PATHWAY
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	BIOCARTA_MTOR_PATHWAY
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	BIOCARTA_IGF1R_PATHWAY
0.106894708712%	2	1871	23	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CASPASE_PATHWAY
0.106894708712%	2	1871	22	T2D_GENES_TANYA_HEIGHT	WELCH_GATA1_TARGETS
0.106894708712%	2	1871	22	T2D_GENES_TANYA_HEIGHT	WEBER_METHYLATED_ICP_IN_FIBROBLAST
0.106894708712%	2	1871	22	T2D_GENES_TANYA_HEIGHT	ROY_WOUND_BLOOD_VESSEL_DN
0.106894708712%	2	1871	22	T2D_GENES_TANYA_HEIGHT	REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION
0.106894708712%	2	1871	22	T2D_GENES_TANYA_HEIGHT	REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC
0.106894708712%	2	1871	22	T2D_GENES_TANYA_HEIGHT	REACTOME_DEADENYLATION_OF_MRNA
0.106894708712%	2	1871	22	T2D_GENES_TANYA_HEIGHT	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP
0.106894708712%	2	1871	22	T2D_GENES_TANYA_HEIGHT	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
0.106894708712%	2	1871	22	T2D_GENES_TANYA_HEIGHT	MOOTHA_FFA_OXYDATION
0.106894708712%	2	1871	22	T2D_GENES_TANYA_HEIGHT	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP
0.106894708712%	2	1871	22	T2D_GENES_TANYA_HEIGHT	HANSON_HRAS_SIGNALING_VIA_NFKB
0.106894708712%	2	1871	21	T2D_GENES_TANYA_HEIGHT	ZIRN_TRETINOIN_RESPONSE_UP
0.106894708712%	2	1871	21	T2D_GENES_TANYA_HEIGHT	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP
0.106894708712%	2	1871	21	T2D_GENES_TANYA_HEIGHT	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN
0.106894708712%	2	1871	21	T2D_GENES_TANYA_HEIGHT	OUYANG_PROSTATE_CANCER_PROGRESSION_DN
0.106894708712%	2	1871	21	T2D_GENES_TANYA_HEIGHT	NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON
0.106894708712%	2	1871	21	T2D_GENES_TANYA_HEIGHT	MOOTHA_GLYCOGEN_METABOLISM
0.106894708712%	2	1871	21	T2D_GENES_TANYA_HEIGHT	MCCABE_HOXC6_TARGETS_DN
0.106894708712%	2	1871	21	T2D_GENES_TANYA_HEIGHT	LEE_INTRATHYMIC_T_PROGENITOR
0.106894708712%	2	1871	21	T2D_GENES_TANYA_HEIGHT	LANDEMAINE_LUNG_METASTASIS
0.106894708712%	2	1871	21	T2D_GENES_TANYA_HEIGHT	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN
0.106894708712%	2	1871	21	T2D_GENES_TANYA_HEIGHT	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD
0.106894708712%	2	1871	21	T2D_GENES_TANYA_HEIGHT	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN
0.106894708712%	2	1871	21	T2D_GENES_TANYA_HEIGHT	GREENBAUM_E2A_TARGETS_DN
0.106894708712%	2	1871	21	T2D_GENES_TANYA_HEIGHT	FOURNIER_ACINAR_DEVELOPMENT_LATE_DN
0.106894708712%	2	1871	21	T2D_GENES_TANYA_HEIGHT	BIOCARTA_IGF1_PATHWAY
0.106894708712%	2	1871	21	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CALCINEURIN_PATHWAY
0.106894708712%	2	1871	20	T2D_GENES_TANYA_HEIGHT	WENG_POR_TARGETS_LIVER_DN
0.106894708712%	2	1871	20	T2D_GENES_TANYA_HEIGHT	WENG_POR_TARGETS_GLOBAL_UP
0.106894708712%	2	1871	20	T2D_GENES_TANYA_HEIGHT	WEBER_METHYLATED_HCP_IN_SPERM_UP
0.106894708712%	2	1871	20	T2D_GENES_TANYA_HEIGHT	WANG_THOC1_TARGETS_DN
0.106894708712%	2	1871	20	T2D_GENES_TANYA_HEIGHT	SU_THYMUS
0.106894708712%	2	1871	20	T2D_GENES_TANYA_HEIGHT	ST_WNT_CA2_CYCLIC_GMP_PATHWAY
0.106894708712%	2	1871	20	T2D_GENES_TANYA_HEIGHT	REACTOME_ENOS_ACTIVATION_AND_REGULATION
0.106894708712%	2	1871	20	T2D_GENES_TANYA_HEIGHT	PHESSE_TARGETS_OF_APC_AND_MBD2_UP
0.106894708712%	2	1871	20	T2D_GENES_TANYA_HEIGHT	MEISSNER_NPC_ICP_WITH_H3K4ME3
0.106894708712%	2	1871	20	T2D_GENES_TANYA_HEIGHT	MANN_RESPONSE_TO_AMIFOSTINE_UP
0.106894708712%	2	1871	20	T2D_GENES_TANYA_HEIGHT	LIU_TARGETS_OF_VMYB_VS_CMYB_UP
0.106894708712%	2	1871	20	T2D_GENES_TANYA_HEIGHT	KYNG_WERNER_SYNDROM_UP
0.106894708712%	2	1871	20	T2D_GENES_TANYA_HEIGHT	HEDENFALK_BREAST_CANCER_BRACX_UP
0.106894708712%	2	1871	20	T2D_GENES_TANYA_HEIGHT	COLLIS_PRKDC_SUBSTRATES
0.106894708712%	2	1871	20	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CCR5_PATHWAY
0.106894708712%	2	1871	20	T2D_GENES_TANYA_HEIGHT	AMUNDSON_GAMMA_RADIATION_RESISTANCE
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	ZHANG_RESPONSE_TO_CANTHARIDIN_UP
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	VISALA_AGING_LYMPHOCYTE_DN
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	VERNOCHET_ADIPOGENESIS
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	STREICHER_LSM1_TARGETS_DN
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	SEIDEN_MET_SIGNALING
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	SCIBETTA_KDM5B_TARGETS_UP
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	REACTOME_LAGGING_STRAND_SYNTHESIS
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	PID_ARF_3PATHWAY
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	MAHADEVAN_RESPONSE_TO_MP470_DN
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	LE_NEURONAL_DIFFERENTIATION_DN
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	KYNG_NORMAL_AGING_UP
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	KAMIKUBO_MYELOID_MN1_NETWORK
0.106894708712%	2	1871	19	T2D_GENES_TANYA_HEIGHT	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	STAMBOLSKY_BOUND_BY_MUTATED_TP53
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	SHIN_B_CELL_LYMPHOMA_CLUSTER_5
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	PODAR_RESPONSE_TO_ADAPHOSTIN_DN
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	PLASARI_NFIC_TARGETS_BASAL_DN
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	PID_BETACATENIN_DEG_PATHWAY
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	NIELSEN_SCHWANNOMA_UP
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	NIELSEN_SCHWANNOMA_DN
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	NADERI_BREAST_CANCER_PROGNOSIS_DN
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	KARAKAS_TGFB1_SIGNALING
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	GENTILE_UV_RESPONSE_CLUSTER_D1
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	BOWIE_RESPONSE_TO_TAMOXIFEN
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	BIOCARTA_UCALPAIN_PATHWAY
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	BIOCARTA_TEL_PATHWAY
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	BIOCARTA_ERK5_PATHWAY
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CARDIACEGF_PATHWAY
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	BIOCARTA_ARAP_PATHWAY
0.106894708712%	2	1871	18	T2D_GENES_TANYA_HEIGHT	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_KIT_SIGNALING
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	REACTOME_INTRINSIC_PATHWAY
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	ONDER_CDH1_TARGETS_3_UP
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	NGO_MALIGNANT_GLIOMA_1P_LOH
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	MEISSNER_BRAIN_HCP_WITH_H3K4ME2
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	LIU_IL13_MEMORY_MODEL_UP
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	LE_SKI_TARGETS_UP
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	DORMOY_ELAVL1_TARGETS
0.106894708712%	2	1871	17	T2D_GENES_TANYA_HEIGHT	BIOCARTA_IL10_PATHWAY
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	ST_G_ALPHA_S_PATHWAY
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	RODRIGUES_THYROID_CARCINOMA_UP
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	REACTOME_XENOBIOTICS
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	REACTOME_PLATELET_SENSITIZATION_BY_LDL
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	PID_DNAPK_PATHWAY
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	PID_CIRCADIANPATHWAY
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	MOOTHA_TCA
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	LUND_SILENCED_BY_METHYLATION
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	KEGG_OTHER_GLYCAN_DEGRADATION
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	HAHTOLA_CTCL_PATHOGENESIS
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	FUKUSHIMA_TNFSF11_TARGETS
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	FINETTI_BREAST_CANCER_KINOME_RED
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	FINETTI_BREAST_CANCER_KINOME_GREEN
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	CHIN_BREAST_CANCER_COPY_NUMBER_DN
0.106894708712%	2	1871	16	T2D_GENES_TANYA_HEIGHT	BIOCARTA_ACH_PATHWAY
0.106894708712%	2	1871	15	T2D_GENES_TANYA_HEIGHT	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP
0.106894708712%	2	1871	15	T2D_GENES_TANYA_HEIGHT	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN
0.106894708712%	2	1871	15	T2D_GENES_TANYA_HEIGHT	WEBER_METHYLATED_LCP_IN_SPERM_UP
0.106894708712%	2	1871	15	T2D_GENES_TANYA_HEIGHT	SU_KIDNEY
0.106894708712%	2	1871	15	T2D_GENES_TANYA_HEIGHT	SINGH_NFE2L2_TARGETS
0.106894708712%	2	1871	15	T2D_GENES_TANYA_HEIGHT	SANDERSON_PPARA_TARGETS
0.106894708712%	2	1871	15	T2D_GENES_TANYA_HEIGHT	SANCHEZ_MDM2_TARGETS
0.106894708712%	2	1871	15	T2D_GENES_TANYA_HEIGHT	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND
0.106894708712%	2	1871	15	T2D_GENES_TANYA_HEIGHT	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP
0.106894708712%	2	1871	15	T2D_GENES_TANYA_HEIGHT	PID_LPA4_PATHWAY
0.106894708712%	2	1871	15	T2D_GENES_TANYA_HEIGHT	KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS
0.106894708712%	2	1871	15	T2D_GENES_TANYA_HEIGHT	DAZARD_UV_RESPONSE_CLUSTER_G3
0.106894708712%	2	1871	15	T2D_GENES_TANYA_HEIGHT	COLLIS_PRKDC_REGULATORS
0.106894708712%	2	1871	15	T2D_GENES_TANYA_HEIGHT	BIOCARTA_NUCLEARRS_PATHWAY
0.106894708712%	2	1871	15	T2D_GENES_TANYA_HEIGHT	BIOCARTA_HSP27_PATHWAY
0.106894708712%	2	1871	15	T2D_GENES_TANYA_HEIGHT	BIOCARTA_BARRESTIN_SRC_PATHWAY
0.106894708712%	2	1871	149	T2D_GENES_TANYA_HEIGHT	NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	WU_ALZHEIMER_DISEASE_UP
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	WEBER_METHYLATED_ICP_IN_SPERM_DN
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_CRMPS_IN_SEMA3A_SIGNALING
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	LIM_MAMMARY_LUMINAL_PROGENITOR_DN
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	KEGG_NON_HOMOLOGOUS_END_JOINING
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	INAMURA_LUNG_CANCER_SCC_UP
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	INAMURA_LUNG_CANCER_SCC_DN
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	GILMORE_CORE_NFKB_PATHWAY
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	DORN_ADENOVIRUS_INFECTION_48HR_UP
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	CASTELLANO_NRAS_TARGETS_DN
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	BIOCARTA_GRANULOCYTES_PATHWAY
0.106894708712%	2	1871	14	T2D_GENES_TANYA_HEIGHT	ABBUD_LIF_SIGNALING_2_UP
0.106894708712%	2	1871	132	T2D_GENES_TANYA_HEIGHT	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	YAGUE_PRETUMOR_DRUG_RESISTANCE_DN
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	XU_RESPONSE_TO_TRETINOIN_DN
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	WU_HBX_TARGETS_3_DN
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	TSAI_DNAJB4_TARGETS_UP
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	TERAMOTO_OPN_TARGETS_CLUSTER_4
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	TERAMOTO_OPN_TARGETS_CLUSTER_1
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	REACTOME_PURINE_SALVAGE
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	REACTOME_POL_SWITCHING
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	REACTOME_P38MAPK_EVENTS
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	RAY_ALZHEIMERS_DISEASE
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	LUI_THYROID_CANCER_CLUSTER_5
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	KRISHNAN_FURIN_TARGETS_DN
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	KEGG_SULFUR_METABOLISM
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	GHO_ATF5_TARGETS_UP
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	EHRLICH_ICF_SYNDROM_UP
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	CROONQUIST_STROMAL_STIMULATION_DN
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	CONRAD_GERMLINE_STEM_CELL
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	BIOCARTA_RB_PATHWAY
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	BIOCARTA_ARENRF2_PATHWAY
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	BIOCARTA_ACE2_PATHWAY
0.106894708712%	2	1871	13	T2D_GENES_TANYA_HEIGHT	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	ZHENG_FOXP3_TARGETS_IN_THYMUS_DN
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	RUAN_RESPONSE_TO_TNF_UP
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_NOTCH4
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_CS_DS_DEGRADATION
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	PARK_TRETINOIN_RESPONSE
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	LEI_HOXC8_TARGETS_UP
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	KRISHNAN_FURIN_TARGETS_UP
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	DING_LUNG_CANCER_MUTATED_FREQUENTLY
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	BIOCARTA_VDR_PATHWAY
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	BIOCARTA_BARR_MAPK_PATHWAY
0.106894708712%	2	1871	12	T2D_GENES_TANYA_HEIGHT	BIOCARTA_AKAP13_PATHWAY
0.106894708712%	2	1871	11	T2D_GENES_TANYA_HEIGHT	SHIN_B_CELL_LYMPHOMA_CLUSTER_6
0.106894708712%	2	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_TRANSPORT_OF_ORGANIC_ANIONS
0.106894708712%	2	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_FGFR3_MUTANTS
0.106894708712%	2	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE
0.106894708712%	2	1871	11	T2D_GENES_TANYA_HEIGHT	PID_P38GAMMADELTAPATHWAY
0.106894708712%	2	1871	11	T2D_GENES_TANYA_HEIGHT	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS
0.106894708712%	2	1871	11	T2D_GENES_TANYA_HEIGHT	KALMA_E2F1_TARGETS
0.106894708712%	2	1871	11	T2D_GENES_TANYA_HEIGHT	IIZUKA_LIVER_CANCER_EARLY_RECURRENCE
0.106894708712%	2	1871	11	T2D_GENES_TANYA_HEIGHT	FUNG_IL2_SIGNALING_1
0.106894708712%	2	1871	11	T2D_GENES_TANYA_HEIGHT	BIOCARTA_SET_PATHWAY
0.106894708712%	2	1871	11	T2D_GENES_TANYA_HEIGHT	BIOCARTA_PTC1_PATHWAY
0.106894708712%	2	1871	11	T2D_GENES_TANYA_HEIGHT	BIOCARTA_P35ALZHEIMERS_PATHWAY
0.106894708712%	2	1871	11	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CDK5_PATHWAY
0.106894708712%	2	1871	11	T2D_GENES_TANYA_HEIGHT	BIOCARTA_BLYMPHOCYTE_PATHWAY
0.106894708712%	2	1871	11	T2D_GENES_TANYA_HEIGHT	BAUS_TFF2_TARGETS_DN
0.106894708712%	2	1871	103	T2D_GENES_TANYA_HEIGHT	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
0.106894708712%	2	1871	10	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN
0.106894708712%	2	1871	10	T2D_GENES_TANYA_HEIGHT	SHIRAISHI_PLZF_TARGETS_UP
0.106894708712%	2	1871	10	T2D_GENES_TANYA_HEIGHT	SEMBA_FHIT_TARGETS_DN
0.106894708712%	2	1871	10	T2D_GENES_TANYA_HEIGHT	SCHLESINGER_METHYLATED_IN_COLON_CANCER
0.106894708712%	2	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE
0.106894708712%	2	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK
0.106894708712%	2	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_PROSTANOID_LIGAND_RECEPTORS
0.106894708712%	2	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS
0.106894708712%	2	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_IRAK1_RECRUITS_IKK_COMPLEX
0.106894708712%	2	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY
0.106894708712%	2	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS
0.106894708712%	2	1871	10	T2D_GENES_TANYA_HEIGHT	OHASHI_AURKB_TARGETS
0.106894708712%	2	1871	10	T2D_GENES_TANYA_HEIGHT	MANN_RESPONSE_TO_AMIFOSTINE_DN
0.106894708712%	2	1871	10	T2D_GENES_TANYA_HEIGHT	GOUYER_TATI_TARGETS_UP
0.106894708712%	2	1871	10	T2D_GENES_TANYA_HEIGHT	BIOCARTA_FREE_PATHWAY
0.106894708712%	2	1871	10	T2D_GENES_TANYA_HEIGHT	BIOCARTA_DNAFRAGMENT_PATHWAY
0.106894708712%	2	1871	10	T2D_GENES_TANYA_HEIGHT	BIOCARTA_BARRESTIN_PATHWAY
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	WANG_RESPONSE_TO_FORSKOLIN_DN
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	TSUTSUMI_FBXW8_TARGETS
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	TESAR_JAK_TARGETS_MOUSE_ES_D3_DN
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	ST_JAK_STAT_PATHWAY
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	NOUSHMEHR_GBM_SOMATIC_MUTATED
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	MATZUK_CUMULUS_EXPANSION
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	KOMMAGANI_TP63_GAMMA_TARGETS
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	GOUYER_TUMOR_INVASIVENESS
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	FIGUEROA_AML_METHYLATION_CLUSTER_2_DN
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	COLLER_MYC_TARGETS_DN
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	CHESLER_BRAIN_D6MIT150_QTL_TRANS
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA
0.101317122594%	2	1974	9	Mendelian_Nancy_Cox	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN
0.101317122594%	2	1974	88	Mendelian_Nancy_Cox	KEGG_RIBOSOME
0.101317122594%	2	1974	85	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	STANHILL_HRAS_TRANSFROMATION_UP
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	OXFORD_RALB_TARGETS_UP
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	OHM_EMBRYONIC_CARCINOMA_DN
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	NOUSHMEHR_GBM_GERMLINE_MUTATED
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	NEBEN_AML_WITH_FLT3_OR_NRAS_UP
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	MIKKELSEN_DEDIFFERENTIATED_STATE_UP
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	LUCAS_HNF4A_TARGETS_DN
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	KONDO_HYPOXIA
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	KANG_CISPLATIN_RESISTANCE_DN
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	IKEDA_MIR133_TARGETS_DN
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	GAUTSCHI_SRC_SIGNALING
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	GALIE_TUMOR_ANGIOGENESIS
0.101317122594%	2	1974	8	Mendelian_Nancy_Cox	CASTELLANO_HRAS_AND_NRAS_TARGETS_DN
0.101317122594%	2	1974	74	Mendelian_Nancy_Cox	OUILLETTE_CLL_13Q14_DELETION_UP
0.101317122594%	2	1974	73	Mendelian_Nancy_Cox	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	ZEILSTRA_CD44_TARGETS_UP
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	YAMASHITA_SILENCED_BY_METHYLATION
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	TESAR_ALK_TARGETS_HUMAN_ES_5D_DN
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	TESAR_ALK_TARGETS_EPISC_3D_UP
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	ST_PAC1_RECEPTOR_PATHWAY
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	SCHUHMACHER_MYC_TARGETS_DN
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	MIKI_COEXPRESSED_WITH_CYP19A1
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	DASU_IL6_SIGNALING_DN
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	BUSA_SAM68_TARGETS_UP
0.101317122594%	2	1974	7	Mendelian_Nancy_Cox	BAKER_HEMATOPOESIS_STAT5_TARGETS
0.101317122594%	2	1974	68	Mendelian_Nancy_Cox	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES
0.101317122594%	2	1974	6	Mendelian_Nancy_Cox	YANG_MUC2_TARGETS_COLON_3MO_DN
0.101317122594%	2	1974	6	Mendelian_Nancy_Cox	TESAR_ALK_TARGETS_HUMAN_ES_4D_DN
0.101317122594%	2	1974	6	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP
0.101317122594%	2	1974	6	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP
0.101317122594%	2	1974	6	Mendelian_Nancy_Cox	OHM_EMBRYONIC_CARCINOMA_UP
0.101317122594%	2	1974	6	Mendelian_Nancy_Cox	MAINA_HYPOXIA_VHL_TARGETS_UP
0.101317122594%	2	1974	6	Mendelian_Nancy_Cox	KIM_GLIS2_TARGETS_DN
0.101317122594%	2	1974	6	Mendelian_Nancy_Cox	IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM
0.101317122594%	2	1974	6	Mendelian_Nancy_Cox	ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS
0.101317122594%	2	1974	6	Mendelian_Nancy_Cox	GERHOLD_RESPONSE_TO_TZD_UP
0.101317122594%	2	1974	6	Mendelian_Nancy_Cox	ELVIDGE_HIF2A_TARGETS_UP
0.101317122594%	2	1974	6	Mendelian_Nancy_Cox	DIERICK_SEROTONIN_FUNCTION_GENES
0.101317122594%	2	1974	6	Mendelian_Nancy_Cox	CROSBY_E2F4_TARGETS
0.101317122594%	2	1974	6	Mendelian_Nancy_Cox	CASTELLANO_HRAS_TARGETS_DN
0.101317122594%	2	1974	6	Mendelian_Nancy_Cox	BIOCARTA_NEUROTRANSMITTERS_PATHWAY
0.101317122594%	2	1974	58	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_APOPTOSIS
0.101317122594%	2	1974	56	Mendelian_Nancy_Cox	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.101317122594%	2	1974	54	Mendelian_Nancy_Cox	AUNG_GASTRIC_CANCER
0.101317122594%	2	1974	51	Mendelian_Nancy_Cox	REACTOME_DEFENSINS
0.101317122594%	2	1974	50	Mendelian_Nancy_Cox	BECKER_TAMOXIFEN_RESISTANCE_UP
0.101317122594%	2	1974	5	Mendelian_Nancy_Cox	TESAR_ALK_TARGETS_HUMAN_ES_5D_UP
0.101317122594%	2	1974	5	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_ERBB2_DN
0.101317122594%	2	1974	5	Mendelian_Nancy_Cox	PASTURAL_RIZ1_TARGETS_DN
0.101317122594%	2	1974	5	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2
0.101317122594%	2	1974	5	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_11
0.101317122594%	2	1974	5	Mendelian_Nancy_Cox	LAU_APOPTOSIS_CDKN2A_DN
0.101317122594%	2	1974	5	Mendelian_Nancy_Cox	KERLEY_RESPONSE_TO_CISPLATIN_DN
0.101317122594%	2	1974	5	Mendelian_Nancy_Cox	GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN
0.101317122594%	2	1974	5	Mendelian_Nancy_Cox	CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP
0.101317122594%	2	1974	5	Mendelian_Nancy_Cox	CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_DN
0.101317122594%	2	1974	49	Mendelian_Nancy_Cox	WONG_PROTEASOME_GENE_MODULE
0.101317122594%	2	1974	48	Mendelian_Nancy_Cox	REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY
0.101317122594%	2	1974	48	Mendelian_Nancy_Cox	REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6
0.101317122594%	2	1974	46	Mendelian_Nancy_Cox	PID_PLK1_PATHWAY
0.101317122594%	2	1974	45	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_PR_UP
0.101317122594%	2	1974	45	Mendelian_Nancy_Cox	REACTOME_MRNA_SPLICING_MINOR_PATHWAY
0.101317122594%	2	1974	45	Mendelian_Nancy_Cox	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP
0.101317122594%	2	1974	44	Mendelian_Nancy_Cox	REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_
0.101317122594%	2	1974	44	Mendelian_Nancy_Cox	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP
0.101317122594%	2	1974	44	Mendelian_Nancy_Cox	CHOI_ATL_STAGE_PREDICTOR
0.101317122594%	2	1974	43	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1
0.101317122594%	2	1974	43	Mendelian_Nancy_Cox	NAKAYAMA_FRA2_TARGETS
0.101317122594%	2	1974	42	Mendelian_Nancy_Cox	REACTOME_BETA_DEFENSINS
0.101317122594%	2	1974	41	Mendelian_Nancy_Cox	REACTOME_NETRIN1_SIGNALING
0.101317122594%	2	1974	41	Mendelian_Nancy_Cox	GENTILE_UV_RESPONSE_CLUSTER_D2
0.101317122594%	2	1974	40	Mendelian_Nancy_Cox	VARELA_ZMPSTE24_TARGETS_UP
0.101317122594%	2	1974	39	Mendelian_Nancy_Cox	WHITEHURST_PACLITAXEL_SENSITIVITY
0.101317122594%	2	1974	39	Mendelian_Nancy_Cox	AMIT_EGF_RESPONSE_60_MCF10A
0.101317122594%	2	1974	38	Mendelian_Nancy_Cox	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS
0.101317122594%	2	1974	38	Mendelian_Nancy_Cox	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP
0.101317122594%	2	1974	38	Mendelian_Nancy_Cox	GRADE_COLON_VS_RECTAL_CANCER_UP
0.101317122594%	2	1974	38	Mendelian_Nancy_Cox	CHANDRAN_METASTASIS_TOP50_UP
0.101317122594%	2	1974	37	Mendelian_Nancy_Cox	ST_P38_MAPK_PATHWAY
0.101317122594%	2	1974	37	Mendelian_Nancy_Cox	MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED
0.101317122594%	2	1974	37	Mendelian_Nancy_Cox	LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES
0.101317122594%	2	1974	37	Mendelian_Nancy_Cox	BILANGES_SERUM_RESPONSE_TRANSLATION
0.101317122594%	2	1974	36	Mendelian_Nancy_Cox	KEGG_BASAL_TRANSCRIPTION_FACTORS
0.101317122594%	2	1974	35	Mendelian_Nancy_Cox	REACTOME_MRNA_3_END_PROCESSING
0.101317122594%	2	1974	35	Mendelian_Nancy_Cox	LOPEZ_TRANSLATION_VIA_FN1_SIGNALING
0.101317122594%	2	1974	35	Mendelian_Nancy_Cox	KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION
0.101317122594%	2	1974	35	Mendelian_Nancy_Cox	KEGG_REGULATION_OF_AUTOPHAGY
0.101317122594%	2	1974	35	Mendelian_Nancy_Cox	DORSAM_HOXA9_TARGETS_UP
0.101317122594%	2	1974	34	Mendelian_Nancy_Cox	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION
0.101317122594%	2	1974	34	Mendelian_Nancy_Cox	PID_EPHA_FWDPATHWAY
0.101317122594%	2	1974	34	Mendelian_Nancy_Cox	ABE_VEGFA_TARGETS_2HR
0.101317122594%	2	1974	33	Mendelian_Nancy_Cox	REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS
0.101317122594%	2	1974	32	Mendelian_Nancy_Cox	REACTOME_ELONGATION_ARREST_AND_RECOVERY
0.101317122594%	2	1974	32	Mendelian_Nancy_Cox	MEISSNER_BRAIN_ICP_WITH_H3K4ME3
0.101317122594%	2	1974	31	Mendelian_Nancy_Cox	VALK_AML_CLUSTER_4
0.101317122594%	2	1974	31	Mendelian_Nancy_Cox	REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING
0.101317122594%	2	1974	31	Mendelian_Nancy_Cox	REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING
0.101317122594%	2	1974	31	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON
0.101317122594%	2	1974	31	Mendelian_Nancy_Cox	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD
0.101317122594%	2	1974	31	Mendelian_Nancy_Cox	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER
0.101317122594%	2	1974	30	Mendelian_Nancy_Cox	REACTOME_MRNA_CAPPING
0.101317122594%	2	1974	30	Mendelian_Nancy_Cox	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES
0.101317122594%	2	1974	30	Mendelian_Nancy_Cox	REACTOME_DNA_STRAND_ELONGATION
0.101317122594%	2	1974	30	Mendelian_Nancy_Cox	LIU_BREAST_CANCER
0.101317122594%	2	1974	30	Mendelian_Nancy_Cox	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
0.101317122594%	2	1974	30	Mendelian_Nancy_Cox	DAZARD_UV_RESPONSE_CLUSTER_G2
0.101317122594%	2	1974	30	Mendelian_Nancy_Cox	DASU_IL6_SIGNALING_SCAR_UP
0.101317122594%	2	1974	29	Mendelian_Nancy_Cox	MA_PITUITARY_FETAL_VS_ADULT_UP
0.101317122594%	2	1974	29	Mendelian_Nancy_Cox	GENTLES_LEUKEMIC_STEM_CELL_UP
0.101317122594%	2	1974	29	Mendelian_Nancy_Cox	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN
0.101317122594%	2	1974	29	Mendelian_Nancy_Cox	DORN_ADENOVIRUS_INFECTION_12HR_UP
0.101317122594%	2	1974	28	Mendelian_Nancy_Cox	PETRETTO_HEART_MASS_QTL_CIS_UP
0.101317122594%	2	1974	28	Mendelian_Nancy_Cox	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.101317122594%	2	1974	28	Mendelian_Nancy_Cox	DAZARD_UV_RESPONSE_CLUSTER_G24
0.101317122594%	2	1974	27	Mendelian_Nancy_Cox	YANG_BREAST_CANCER_ESR1_BULK_UP
0.101317122594%	2	1974	27	Mendelian_Nancy_Cox	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN
0.101317122594%	2	1974	27	Mendelian_Nancy_Cox	TIEN_INTESTINE_PROBIOTICS_2HR_UP
0.101317122594%	2	1974	27	Mendelian_Nancy_Cox	TERAO_AOX4_TARGETS_SKIN_DN
0.101317122594%	2	1974	27	Mendelian_Nancy_Cox	REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS
0.101317122594%	2	1974	27	Mendelian_Nancy_Cox	PLASARI_NFIC_TARGETS_BASAL_UP
0.101317122594%	2	1974	27	Mendelian_Nancy_Cox	EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.101317122594%	2	1974	27	Mendelian_Nancy_Cox	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN
0.101317122594%	2	1974	26	Mendelian_Nancy_Cox	WALLACE_JAK2_TARGETS_UP
0.101317122594%	2	1974	26	Mendelian_Nancy_Cox	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN
0.101317122594%	2	1974	26	Mendelian_Nancy_Cox	REACTOME_ACTIVATION_OF_GENES_BY_ATF4
0.101317122594%	2	1974	26	Mendelian_Nancy_Cox	PID_P38_MKK3_6PATHWAY
0.101317122594%	2	1974	26	Mendelian_Nancy_Cox	NEWMAN_ERCC6_TARGETS_UP
0.101317122594%	2	1974	26	Mendelian_Nancy_Cox	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1
0.101317122594%	2	1974	26	Mendelian_Nancy_Cox	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES
0.101317122594%	2	1974	26	Mendelian_Nancy_Cox	DEN_INTERACT_WITH_LCA5
0.101317122594%	2	1974	26	Mendelian_Nancy_Cox	BRACHAT_RESPONSE_TO_METHOTREXATE_UP
0.101317122594%	2	1974	25	Mendelian_Nancy_Cox	VALK_AML_WITH_EVI1
0.101317122594%	2	1974	25	Mendelian_Nancy_Cox	REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE
0.101317122594%	2	1974	25	Mendelian_Nancy_Cox	REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS
0.101317122594%	2	1974	25	Mendelian_Nancy_Cox	REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE
0.101317122594%	2	1974	24	Mendelian_Nancy_Cox	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN
0.101317122594%	2	1974	24	Mendelian_Nancy_Cox	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS
0.101317122594%	2	1974	24	Mendelian_Nancy_Cox	PID_S1P_S1P2_PATHWAY
0.101317122594%	2	1974	24	Mendelian_Nancy_Cox	LA_MEN1_TARGETS
0.101317122594%	2	1974	24	Mendelian_Nancy_Cox	DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.101317122594%	2	1974	24	Mendelian_Nancy_Cox	CHEOK_RESPONSE_TO_HD_MTX_DN
0.101317122594%	2	1974	24	Mendelian_Nancy_Cox	BIOCARTA_NOS1_PATHWAY
0.101317122594%	2	1974	23	Mendelian_Nancy_Cox	ZHANG_INTERFERON_RESPONSE
0.101317122594%	2	1974	23	Mendelian_Nancy_Cox	WANG_RESPONSE_TO_FORSKOLIN_UP
0.101317122594%	2	1974	23	Mendelian_Nancy_Cox	UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.101317122594%	2	1974	23	Mendelian_Nancy_Cox	SAGIV_CD24_TARGETS_UP
0.101317122594%	2	1974	23	Mendelian_Nancy_Cox	REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA
0.101317122594%	2	1974	23	Mendelian_Nancy_Cox	ONO_FOXP3_TARGETS_UP
0.101317122594%	2	1974	23	Mendelian_Nancy_Cox	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP
0.101317122594%	2	1974	23	Mendelian_Nancy_Cox	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN
0.101317122594%	2	1974	23	Mendelian_Nancy_Cox	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP
0.101317122594%	2	1974	23	Mendelian_Nancy_Cox	CHEN_ETV5_TARGETS_TESTIS
0.101317122594%	2	1974	23	Mendelian_Nancy_Cox	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
0.101317122594%	2	1974	23	Mendelian_Nancy_Cox	BIOCARTA_MEF2D_PATHWAY
0.101317122594%	2	1974	22	Mendelian_Nancy_Cox	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN
0.101317122594%	2	1974	22	Mendelian_Nancy_Cox	REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC
0.101317122594%	2	1974	22	Mendelian_Nancy_Cox	LANDIS_ERBB2_BREAST_TUMORS_65_UP
0.101317122594%	2	1974	22	Mendelian_Nancy_Cox	KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS
0.101317122594%	2	1974	22	Mendelian_Nancy_Cox	KANG_FLUOROURACIL_RESISTANCE_UP
0.101317122594%	2	1974	22	Mendelian_Nancy_Cox	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP
0.101317122594%	2	1974	22	Mendelian_Nancy_Cox	GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION
0.101317122594%	2	1974	21	Mendelian_Nancy_Cox	WENG_POR_DOSAGE
0.101317122594%	2	1974	21	Mendelian_Nancy_Cox	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP
0.101317122594%	2	1974	21	Mendelian_Nancy_Cox	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN
0.101317122594%	2	1974	21	Mendelian_Nancy_Cox	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN
0.101317122594%	2	1974	21	Mendelian_Nancy_Cox	PID_S1P_META_PATHWAY
0.101317122594%	2	1974	21	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON
0.101317122594%	2	1974	21	Mendelian_Nancy_Cox	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4
0.101317122594%	2	1974	21	Mendelian_Nancy_Cox	LEE_INTRATHYMIC_T_PROGENITOR
0.101317122594%	2	1974	21	Mendelian_Nancy_Cox	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN
0.101317122594%	2	1974	21	Mendelian_Nancy_Cox	GESERICK_TERT_TARGETS_DN
0.101317122594%	2	1974	21	Mendelian_Nancy_Cox	FOURNIER_ACINAR_DEVELOPMENT_LATE_DN
0.101317122594%	2	1974	21	Mendelian_Nancy_Cox	DAZARD_UV_RESPONSE_CLUSTER_G4
0.101317122594%	2	1974	20	Mendelian_Nancy_Cox	ZEMBUTSU_SENSITIVITY_TO_CISPLATIN
0.101317122594%	2	1974	20	Mendelian_Nancy_Cox	WENG_POR_TARGETS_LIVER_DN
0.101317122594%	2	1974	20	Mendelian_Nancy_Cox	TOMLINS_METASTASIS_DN
0.101317122594%	2	1974	20	Mendelian_Nancy_Cox	SU_THYMUS
0.101317122594%	2	1974	20	Mendelian_Nancy_Cox	STARK_HYPPOCAMPUS_22Q11_DELETION_DN
0.101317122594%	2	1974	20	Mendelian_Nancy_Cox	SESTO_RESPONSE_TO_UV_C3
0.101317122594%	2	1974	20	Mendelian_Nancy_Cox	NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN
0.101317122594%	2	1974	20	Mendelian_Nancy_Cox	MEISSNER_NPC_ICP_WITH_H3K4ME3
0.101317122594%	2	1974	20	Mendelian_Nancy_Cox	LIU_TARGETS_OF_VMYB_VS_CMYB_UP
0.101317122594%	2	1974	20	Mendelian_Nancy_Cox	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP
0.101317122594%	2	1974	20	Mendelian_Nancy_Cox	HEDENFALK_BREAST_CANCER_BRACX_UP
0.101317122594%	2	1974	20	Mendelian_Nancy_Cox	DE_YY1_TARGETS_UP
0.101317122594%	2	1974	20	Mendelian_Nancy_Cox	DAZARD_UV_RESPONSE_CLUSTER_G28
0.101317122594%	2	1974	20	Mendelian_Nancy_Cox	BIOCARTA_CCR5_PATHWAY
0.101317122594%	2	1974	20	Mendelian_Nancy_Cox	BARRIER_COLON_CANCER_RECURRENCE_DN
0.101317122594%	2	1974	19	Mendelian_Nancy_Cox	SYED_ESTRADIOL_RESPONSE
0.101317122594%	2	1974	19	Mendelian_Nancy_Cox	REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY
0.101317122594%	2	1974	19	Mendelian_Nancy_Cox	REACTOME_CGMP_EFFECTS
0.101317122594%	2	1974	19	Mendelian_Nancy_Cox	REACTOME_BASE_EXCISION_REPAIR
0.101317122594%	2	1974	19	Mendelian_Nancy_Cox	RASHI_NFKB1_TARGETS
0.101317122594%	2	1974	19	Mendelian_Nancy_Cox	NAGY_TFTC_COMPONENTS_HUMAN
0.101317122594%	2	1974	19	Mendelian_Nancy_Cox	MA_PITUITARY_FETAL_VS_ADULT_DN
0.101317122594%	2	1974	19	Mendelian_Nancy_Cox	MARSON_FOXP3_CORE_DIRECT_TARGETS
0.101317122594%	2	1974	19	Mendelian_Nancy_Cox	LI_WILMS_TUMOR_ANAPLASTIC_UP
0.101317122594%	2	1974	19	Mendelian_Nancy_Cox	LEE_NAIVE_T_LYMPHOCYTE
0.101317122594%	2	1974	19	Mendelian_Nancy_Cox	KYNG_NORMAL_AGING_UP
0.101317122594%	2	1974	19	Mendelian_Nancy_Cox	KEGG_ALPHA_LINOLENIC_ACID_METABOLISM
0.101317122594%	2	1974	19	Mendelian_Nancy_Cox	GAJATE_RESPONSE_TO_TRABECTEDIN_DN
0.101317122594%	2	1974	19	Mendelian_Nancy_Cox	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN
0.101317122594%	2	1974	19	Mendelian_Nancy_Cox	CHEN_PDGF_TARGETS
0.101317122594%	2	1974	18	Mendelian_Nancy_Cox	ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE
0.101317122594%	2	1974	18	Mendelian_Nancy_Cox	WU_HBX_TARGETS_3_UP
0.101317122594%	2	1974	18	Mendelian_Nancy_Cox	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA
0.101317122594%	2	1974	18	Mendelian_Nancy_Cox	STAMBOLSKY_BOUND_BY_MUTATED_TP53
0.101317122594%	2	1974	18	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_LUMINAL_A_DN
0.101317122594%	2	1974	18	Mendelian_Nancy_Cox	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN
0.101317122594%	2	1974	18	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_OF_PC
0.101317122594%	2	1974	18	Mendelian_Nancy_Cox	REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI
0.101317122594%	2	1974	18	Mendelian_Nancy_Cox	REACTOME_GLUCURONIDATION
0.101317122594%	2	1974	18	Mendelian_Nancy_Cox	REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION
0.101317122594%	2	1974	18	Mendelian_Nancy_Cox	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP
0.101317122594%	2	1974	18	Mendelian_Nancy_Cox	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.101317122594%	2	1974	18	Mendelian_Nancy_Cox	KIM_PTEN_TARGETS_UP
0.101317122594%	2	1974	18	Mendelian_Nancy_Cox	HUMMERICH_BENIGN_SKIN_TUMOR_UP
0.101317122594%	2	1974	18	Mendelian_Nancy_Cox	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES
0.101317122594%	2	1974	18	Mendelian_Nancy_Cox	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP
0.101317122594%	2	1974	18	Mendelian_Nancy_Cox	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	WIKMAN_ASBESTOS_LUNG_CANCER_UP
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	RODRIGUES_NTN1_TARGETS_UP
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	PID_NFKAPPABATYPICALPATHWAY
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	MATTHEWS_AP1_TARGETS
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	LI_CYTIDINE_ANALOG_PATHWAY
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	LIU_IL13_MEMORY_MODEL_UP
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	INGA_TP53_TARGETS
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	HOWLIN_CITED1_TARGETS_2_UP
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	GOUYER_TATI_TARGETS_DN
0.101317122594%	2	1974	17	Mendelian_Nancy_Cox	BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.101317122594%	2	1974	16	Mendelian_Nancy_Cox	VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN
0.101317122594%	2	1974	16	Mendelian_Nancy_Cox	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN
0.101317122594%	2	1974	16	Mendelian_Nancy_Cox	TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN
0.101317122594%	2	1974	16	Mendelian_Nancy_Cox	REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS
0.101317122594%	2	1974	16	Mendelian_Nancy_Cox	REACTOME_INTEGRATION_OF_PROVIRUS
0.101317122594%	2	1974	16	Mendelian_Nancy_Cox	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN
0.101317122594%	2	1974	16	Mendelian_Nancy_Cox	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS
0.101317122594%	2	1974	16	Mendelian_Nancy_Cox	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA
0.101317122594%	2	1974	16	Mendelian_Nancy_Cox	KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM
0.101317122594%	2	1974	16	Mendelian_Nancy_Cox	HAHTOLA_MYCOSIS_FUNGOIDES_DN
0.101317122594%	2	1974	16	Mendelian_Nancy_Cox	HAHTOLA_CTCL_PATHOGENESIS
0.101317122594%	2	1974	16	Mendelian_Nancy_Cox	GHO_ATF5_TARGETS_DN
0.101317122594%	2	1974	16	Mendelian_Nancy_Cox	FINETTI_BREAST_CANCER_KINOME_RED
0.101317122594%	2	1974	16	Mendelian_Nancy_Cox	FINETTI_BREAST_CANCER_KINOME_GREEN
0.101317122594%	2	1974	16	Mendelian_Nancy_Cox	FARMER_BREAST_CANCER_CLUSTER_6
0.101317122594%	2	1974	16	Mendelian_Nancy_Cox	CAFFAREL_RESPONSE_TO_THC_8HR_5_UP
0.101317122594%	2	1974	16	Mendelian_Nancy_Cox	BIOCARTA_CDC42RAC_PATHWAY
0.101317122594%	2	1974	15	Mendelian_Nancy_Cox	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN
0.101317122594%	2	1974	15	Mendelian_Nancy_Cox	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP
0.101317122594%	2	1974	15	Mendelian_Nancy_Cox	SINGH_NFE2L2_TARGETS
0.101317122594%	2	1974	15	Mendelian_Nancy_Cox	SANCHEZ_MDM2_TARGETS
0.101317122594%	2	1974	15	Mendelian_Nancy_Cox	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII
0.101317122594%	2	1974	15	Mendelian_Nancy_Cox	REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS
0.101317122594%	2	1974	15	Mendelian_Nancy_Cox	MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH
0.101317122594%	2	1974	15	Mendelian_Nancy_Cox	LI_CYTIDINE_ANALOGS_CYCTOTOXICITY
0.101317122594%	2	1974	15	Mendelian_Nancy_Cox	KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION
0.101317122594%	2	1974	15	Mendelian_Nancy_Cox	FERRANDO_LYL1_NEIGHBORS
0.101317122594%	2	1974	15	Mendelian_Nancy_Cox	EHRLICH_ICF_SYNDROM_DN
0.101317122594%	2	1974	15	Mendelian_Nancy_Cox	BIOCARTA_STEM_PATHWAY
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	VICENT_METASTASIS_UP
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	VERRECCHIA_RESPONSE_TO_TGFB1_C3
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	TOMLINS_METASTASIS_UP
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_IFNG_SIGNALING
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	PID_S1P_S1P4_PATHWAY
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	MATZUK_OVULATION
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	LIM_MAMMARY_LUMINAL_PROGENITOR_DN
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	LEE_SP4_THYMOCYTE
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	INAMURA_LUNG_CANCER_SCC_DN
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	GILMORE_CORE_NFKB_PATHWAY
0.101317122594%	2	1974	14	Mendelian_Nancy_Cox	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	XU_RESPONSE_TO_TRETINOIN_DN
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	WACKER_HYPOXIA_TARGETS_OF_VHL
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	SHI_SPARC_TARGETS_DN
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6_ALPHA
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	RAY_ALZHEIMERS_DISEASE
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	MARTINELLI_IMMATURE_NEUTROPHIL_DN
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	KRISHNAN_FURIN_TARGETS_DN
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	KORKOLA_EMBRYONAL_CARCINOMA
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	KIM_MYCL1_AMPLIFICATION_TARGETS_UP
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	KEGG_SULFUR_METABOLISM
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	IRITANI_MAD1_TARGETS_UP
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	GHO_ATF5_TARGETS_UP
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	CAFFAREL_RESPONSE_TO_THC_24HR_3_DN
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	BIOCARTA_P27_PATHWAY
0.101317122594%	2	1974	13	Mendelian_Nancy_Cox	BIOCARTA_AGPCR_PATHWAY
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	SUZUKI_CTCFL_TARGETS_UP
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_NOTCH3
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_NOTCH2
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	REACTOME_GLYCOPROTEIN_HORMONES
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	REACTOME_GABA_A_RECEPTOR_ACTIVATION
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	MIZUKAMI_HYPOXIA_UP
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	LOPEZ_MESOTHELIOMA_SURVIVAL_DN
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	LEI_HOXC8_TARGETS_UP
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	ITO_PTTG1_TARGETS_UP
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	FUNG_IL2_SIGNALING_2
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	DORN_ADENOVIRUS_INFECTION_24HR_UP
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1
0.101317122594%	2	1974	12	Mendelian_Nancy_Cox	BIOCARTA_PLCE_PATHWAY
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	WILLIAMS_ESR2_TARGETS_DN
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	STEGMEIER_PRE-MITOTIC_CELL_CYCLE_REGULATORS
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	SHIN_B_CELL_LYMPHOMA_CLUSTER_6
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	SASAKI_TARGETS_OF_TP73_AND_TP63
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	ROZANOV_MMP14_CORRELATED
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	PID_RANBP2PATHWAY
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	PID_P38GAMMADELTAPATHWAY
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	MARTINELLI_IMMATURE_NEUTROPHIL_UP
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	LIANG_SILENCED_BY_METHYLATION_DN
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	HASEGAWA_TUMORIGENESIS_BY_RET_C634R
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	CHUANG_OXIDATIVE_STRESS_RESPONSE_DN
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	BIOCARTA_PTC1_PATHWAY
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	BIOCARTA_P35ALZHEIMERS_PATHWAY
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	BIOCARTA_EIF2_PATHWAY
0.101317122594%	2	1974	11	Mendelian_Nancy_Cox	BAUS_TFF2_TARGETS_DN
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	TURJANSKI_MAPK14_TARGETS
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	TAKAYAMA_BOUND_BY_AR
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	ST_INTERFERON_GAMMA_PATHWAY
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	SHANK_TAL1_TARGETS_DN
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	SEMBA_FHIT_TARGETS_DN
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	OXFORD_RALA_AND_RALB_TARGETS_UP
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_17P11_AMPLICON
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	MURAKAMI_UV_RESPONSE_1HR_DN
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	MIKKELSEN_IPS_LCP_WITH_H3K27ME3
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	KONG_E2F1_TARGETS
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	HOLLEMAN_DAUNORUBICIN_B_ALL_UP
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	CHEN_HOXA5_TARGETS_6HR_UP
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	CAFFAREL_RESPONSE_TO_THC_8HR_3_DN
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	BIOCARTA_SODD_PATHWAY
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	BIOCARTA_SARS_PATHWAY
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	BIOCARTA_RNA_PATHWAY
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	BIOCARTA_IL5_PATHWAY
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	BIOCARTA_FREE_PATHWAY
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	BIOCARTA_EPHA4_PATHWAY
0.101317122594%	2	1974	10	Mendelian_Nancy_Cox	BIOCARTA_BARRESTIN_PATHWAY
0.0919963201472%	2	2174	91	T2D_GENES_TANYA_LIPIDS	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.0919963201472%	2	2174	9	T2D_GENES_TANYA_LIPIDS	ZHU_SKIL_TARGETS_DN
0.0919963201472%	2	2174	9	T2D_GENES_TANYA_LIPIDS	THILLAINADESAN_ZNF217_TARGETS_DN
0.0919963201472%	2	2174	9	T2D_GENES_TANYA_LIPIDS	SHIRAISHI_PLZF_TARGETS_DN
0.0919963201472%	2	2174	9	T2D_GENES_TANYA_LIPIDS	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP
0.0919963201472%	2	2174	9	T2D_GENES_TANYA_LIPIDS	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30
0.0919963201472%	2	2174	9	T2D_GENES_TANYA_LIPIDS	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21
0.0919963201472%	2	2174	9	T2D_GENES_TANYA_LIPIDS	KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP
0.0919963201472%	2	2174	9	T2D_GENES_TANYA_LIPIDS	ITO_PTTG1_TARGETS_DN
0.0919963201472%	2	2174	9	T2D_GENES_TANYA_LIPIDS	FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION
0.0919963201472%	2	2174	9	T2D_GENES_TANYA_LIPIDS	DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.0919963201472%	2	2174	9	T2D_GENES_TANYA_LIPIDS	COLLER_MYC_TARGETS_DN
0.0919963201472%	2	2174	9	T2D_GENES_TANYA_LIPIDS	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA
0.0919963201472%	2	2174	81	T2D_GENES_TANYA_LIPIDS	GRABARCZYK_BCL11B_TARGETS_UP
0.0919963201472%	2	2174	8	T2D_GENES_TANYA_LIPIDS	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR
0.0919963201472%	2	2174	8	T2D_GENES_TANYA_LIPIDS	TURJANSKI_MAPK8_AND_MAPK9_TARGETS
0.0919963201472%	2	2174	8	T2D_GENES_TANYA_LIPIDS	TCGA_GLIOBLASTOMA_MUTATED
0.0919963201472%	2	2174	8	T2D_GENES_TANYA_LIPIDS	OXFORD_RALB_TARGETS_UP
0.0919963201472%	2	2174	8	T2D_GENES_TANYA_LIPIDS	NOUSHMEHR_GBM_GERMLINE_MUTATED
0.0919963201472%	2	2174	8	T2D_GENES_TANYA_LIPIDS	MATZUK_LUTEAL_GENES
0.0919963201472%	2	2174	8	T2D_GENES_TANYA_LIPIDS	KHETCHOUMIAN_TRIM24_TARGETS_DN
0.0919963201472%	2	2174	8	T2D_GENES_TANYA_LIPIDS	GAUTSCHI_SRC_SIGNALING
0.0919963201472%	2	2174	8	T2D_GENES_TANYA_LIPIDS	GALI_TP53_TARGETS_APOPTOTIC_UP
0.0919963201472%	2	2174	8	T2D_GENES_TANYA_LIPIDS	FUJIWARA_PARK2_IN_LIVER_CANCER_UP
0.0919963201472%	2	2174	8	T2D_GENES_TANYA_LIPIDS	CHANG_POU5F1_TARGETS_DN
0.0919963201472%	2	2174	7	T2D_GENES_TANYA_LIPIDS	TESAR_ALK_TARGETS_HUMAN_ES_5D_DN
0.0919963201472%	2	2174	7	T2D_GENES_TANYA_LIPIDS	ST_PAC1_RECEPTOR_PATHWAY
0.0919963201472%	2	2174	7	T2D_GENES_TANYA_LIPIDS	SCHRAMM_INHBA_TARGETS_UP
0.0919963201472%	2	2174	7	T2D_GENES_TANYA_LIPIDS	PETRETTO_BLOOD_PRESSURE_DN
0.0919963201472%	2	2174	7	T2D_GENES_TANYA_LIPIDS	MIKI_COEXPRESSED_WITH_CYP19A1
0.0919963201472%	2	2174	7	T2D_GENES_TANYA_LIPIDS	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP
0.0919963201472%	2	2174	7	T2D_GENES_TANYA_LIPIDS	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN
0.0919963201472%	2	2174	7	T2D_GENES_TANYA_LIPIDS	KUWANO_RNA_STABILIZED_BY_NO
0.0919963201472%	2	2174	7	T2D_GENES_TANYA_LIPIDS	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.0919963201472%	2	2174	7	T2D_GENES_TANYA_LIPIDS	FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES
0.0919963201472%	2	2174	7	T2D_GENES_TANYA_LIPIDS	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3
0.0919963201472%	2	2174	62	T2D_GENES_TANYA_LIPIDS	CORRE_MULTIPLE_MYELOMA_DN
0.0919963201472%	2	2174	60	T2D_GENES_TANYA_LIPIDS	WIERENGA_STAT5A_TARGETS_GROUP2
0.0919963201472%	2	2174	60	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER_CIPROFIBRATE_UP
0.0919963201472%	2	2174	6	T2D_GENES_TANYA_LIPIDS	TRACEY_RESISTANCE_TO_IFNA2_UP
0.0919963201472%	2	2174	6	T2D_GENES_TANYA_LIPIDS	TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN
0.0919963201472%	2	2174	59	T2D_GENES_TANYA_LIPIDS	ONDER_CDH1_TARGETS_3_DN
0.0919963201472%	2	2174	58	T2D_GENES_TANYA_LIPIDS	REACTOME_COLLAGEN_FORMATION
0.0919963201472%	2	2174	56	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_10HR_DN
0.0919963201472%	2	2174	55	T2D_GENES_TANYA_LIPIDS	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
0.0919963201472%	2	2174	55	T2D_GENES_TANYA_LIPIDS	REACTOME_ION_CHANNEL_TRANSPORT
0.0919963201472%	2	2174	54	T2D_GENES_TANYA_LIPIDS	JIANG_AGING_CEREBRAL_CORTEX_DN
0.0919963201472%	2	2174	52	T2D_GENES_TANYA_LIPIDS	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM
0.0919963201472%	2	2174	51	T2D_GENES_TANYA_LIPIDS	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.0919963201472%	2	2174	51	T2D_GENES_TANYA_LIPIDS	FRASOR_TAMOXIFEN_RESPONSE_UP
0.0919963201472%	2	2174	50	T2D_GENES_TANYA_LIPIDS	KANG_GIST_WITH_PDGFRA_UP
0.0919963201472%	2	2174	5	T2D_GENES_TANYA_LIPIDS	SMID_BREAST_CANCER_ERBB2_DN
0.0919963201472%	2	2174	5	T2D_GENES_TANYA_LIPIDS	RODRIGUES_DCC_TARGETS_UP
0.0919963201472%	2	2174	5	T2D_GENES_TANYA_LIPIDS	OZANNE_AP1_TARGETS_DN
0.0919963201472%	2	2174	5	T2D_GENES_TANYA_LIPIDS	NICK_RESPONSE_TO_PROC_TREATMENT_UP
0.0919963201472%	2	2174	5	T2D_GENES_TANYA_LIPIDS	MCGOWAN_RSP6_TARGETS_DN
0.0919963201472%	2	2174	5	T2D_GENES_TANYA_LIPIDS	LAU_APOPTOSIS_CDKN2A_DN
0.0919963201472%	2	2174	5	T2D_GENES_TANYA_LIPIDS	GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN
0.0919963201472%	2	2174	5	T2D_GENES_TANYA_LIPIDS	CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP
0.0919963201472%	2	2174	48	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_LB_UP
0.0919963201472%	2	2174	48	T2D_GENES_TANYA_LIPIDS	REACTOME_PI_METABOLISM
0.0919963201472%	2	2174	48	T2D_GENES_TANYA_LIPIDS	DOANE_BREAST_CANCER_ESR1_DN
0.0919963201472%	2	2174	48	T2D_GENES_TANYA_LIPIDS	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
0.0919963201472%	2	2174	48	T2D_GENES_TANYA_LIPIDS	ABE_INNER_EAR
0.0919963201472%	2	2174	47	T2D_GENES_TANYA_LIPIDS	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN
0.0919963201472%	2	2174	47	T2D_GENES_TANYA_LIPIDS	MCCLUNG_DELTA_FOSB_TARGETS_8WK
0.0919963201472%	2	2174	47	T2D_GENES_TANYA_LIPIDS	LEONARD_HYPOXIA
0.0919963201472%	2	2174	47	T2D_GENES_TANYA_LIPIDS	JIANG_AGING_HYPOTHALAMUS_UP
0.0919963201472%	2	2174	46	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_CD2_DN
0.0919963201472%	2	2174	46	T2D_GENES_TANYA_LIPIDS	TSENG_ADIPOGENIC_POTENTIAL_DN
0.0919963201472%	2	2174	46	T2D_GENES_TANYA_LIPIDS	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
0.0919963201472%	2	2174	46	T2D_GENES_TANYA_LIPIDS	OSADA_ASCL1_TARGETS_UP
0.0919963201472%	2	2174	46	T2D_GENES_TANYA_LIPIDS	NAKAMURA_CANCER_MICROENVIRONMENT_DN
0.0919963201472%	2	2174	46	T2D_GENES_TANYA_LIPIDS	KRASNOSELSKAYA_ILF3_TARGETS_DN
0.0919963201472%	2	2174	46	T2D_GENES_TANYA_LIPIDS	KEGG_N_GLYCAN_BIOSYNTHESIS
0.0919963201472%	2	2174	45	T2D_GENES_TANYA_LIPIDS	ZHAN_MULTIPLE_MYELOMA_CD1_DN
0.0919963201472%	2	2174	45	T2D_GENES_TANYA_LIPIDS	TRAYNOR_RETT_SYNDROM_UP
0.0919963201472%	2	2174	45	T2D_GENES_TANYA_LIPIDS	SMITH_LIVER_CANCER
0.0919963201472%	2	2174	45	T2D_GENES_TANYA_LIPIDS	REACTOME_G2_M_CHECKPOINTS
0.0919963201472%	2	2174	45	T2D_GENES_TANYA_LIPIDS	NUTT_GBM_VS_AO_GLIOMA_DN
0.0919963201472%	2	2174	45	T2D_GENES_TANYA_LIPIDS	CHENG_RESPONSE_TO_NICKEL_ACETATE
0.0919963201472%	2	2174	45	T2D_GENES_TANYA_LIPIDS	CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY
0.0919963201472%	2	2174	45	T2D_GENES_TANYA_LIPIDS	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP
0.0919963201472%	2	2174	44	T2D_GENES_TANYA_LIPIDS	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
0.0919963201472%	2	2174	44	T2D_GENES_TANYA_LIPIDS	LANDIS_BREAST_CANCER_PROGRESSION_UP
0.0919963201472%	2	2174	44	T2D_GENES_TANYA_LIPIDS	KORKOLA_SEMINOMA_UP
0.0919963201472%	2	2174	44	T2D_GENES_TANYA_LIPIDS	HARRIS_BRAIN_CANCER_PROGENITORS
0.0919963201472%	2	2174	44	T2D_GENES_TANYA_LIPIDS	CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY
0.0919963201472%	2	2174	43	T2D_GENES_TANYA_LIPIDS	IKEDA_MIR133_TARGETS_UP
0.0919963201472%	2	2174	42	T2D_GENES_TANYA_LIPIDS	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER
0.0919963201472%	2	2174	42	T2D_GENES_TANYA_LIPIDS	HAHTOLA_SEZARY_SYNDROM_DN
0.0919963201472%	2	2174	41	T2D_GENES_TANYA_LIPIDS	REACTOME_IL_2_SIGNALING
0.0919963201472%	2	2174	41	T2D_GENES_TANYA_LIPIDS	PID_ERBB1_INTERNALIZATION_PATHWAY
0.0919963201472%	2	2174	41	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_ES_HCP_WITH_H3K27ME3
0.0919963201472%	2	2174	41	T2D_GENES_TANYA_LIPIDS	KAMMINGA_EZH2_TARGETS
0.0919963201472%	2	2174	41	T2D_GENES_TANYA_LIPIDS	EHLERS_ANEUPLOIDY_UP
0.0919963201472%	2	2174	41	T2D_GENES_TANYA_LIPIDS	CROONQUIST_NRAS_SIGNALING_UP
0.0919963201472%	2	2174	40	T2D_GENES_TANYA_LIPIDS	VALK_AML_WITH_FLT3_ITD
0.0919963201472%	2	2174	40	T2D_GENES_TANYA_LIPIDS	TOMLINS_PROSTATE_CANCER_UP
0.0919963201472%	2	2174	40	T2D_GENES_TANYA_LIPIDS	TOMLINS_PROSTATE_CANCER_DN
0.0919963201472%	2	2174	40	T2D_GENES_TANYA_LIPIDS	RIZ_ERYTHROID_DIFFERENTIATION_6HR
0.0919963201472%	2	2174	40	T2D_GENES_TANYA_LIPIDS	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
0.0919963201472%	2	2174	40	T2D_GENES_TANYA_LIPIDS	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP
0.0919963201472%	2	2174	40	T2D_GENES_TANYA_LIPIDS	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER
0.0919963201472%	2	2174	40	T2D_GENES_TANYA_LIPIDS	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN
0.0919963201472%	2	2174	40	T2D_GENES_TANYA_LIPIDS	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
0.0919963201472%	2	2174	40	T2D_GENES_TANYA_LIPIDS	CHESLER_BRAIN_HIGHEST_EXPRESSION
0.0919963201472%	2	2174	40	T2D_GENES_TANYA_LIPIDS	AMUNDSON_GAMMA_RADIATION_RESPONSE
0.0919963201472%	2	2174	39	T2D_GENES_TANYA_LIPIDS	REACTOME_NCAM1_INTERACTIONS
0.0919963201472%	2	2174	39	T2D_GENES_TANYA_LIPIDS	PID_ATR_PATHWAY
0.0919963201472%	2	2174	39	T2D_GENES_TANYA_LIPIDS	CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP
0.0919963201472%	2	2174	39	T2D_GENES_TANYA_LIPIDS	BEIER_GLIOMA_STEM_CELL_UP
0.0919963201472%	2	2174	38	T2D_GENES_TANYA_LIPIDS	VARELA_ZMPSTE24_TARGETS_DN
0.0919963201472%	2	2174	38	T2D_GENES_TANYA_LIPIDS	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS
0.0919963201472%	2	2174	38	T2D_GENES_TANYA_LIPIDS	REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS
0.0919963201472%	2	2174	38	T2D_GENES_TANYA_LIPIDS	PID_FASPATHWAY
0.0919963201472%	2	2174	38	T2D_GENES_TANYA_LIPIDS	GRADE_COLON_VS_RECTAL_CANCER_UP
0.0919963201472%	2	2174	38	T2D_GENES_TANYA_LIPIDS	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
0.0919963201472%	2	2174	37	T2D_GENES_TANYA_LIPIDS	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN
0.0919963201472%	2	2174	37	T2D_GENES_TANYA_LIPIDS	FRASOR_RESPONSE_TO_ESTRADIOL_UP
0.0919963201472%	2	2174	37	T2D_GENES_TANYA_LIPIDS	CUI_TCF21_TARGETS_UP
0.0919963201472%	2	2174	36	T2D_GENES_TANYA_LIPIDS	SUBTIL_PROGESTIN_TARGETS
0.0919963201472%	2	2174	36	T2D_GENES_TANYA_LIPIDS	REACTOME_FRS2_MEDIATED_CASCADE
0.0919963201472%	2	2174	36	T2D_GENES_TANYA_LIPIDS	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
0.0919963201472%	2	2174	36	T2D_GENES_TANYA_LIPIDS	LIU_CDX2_TARGETS_UP
0.0919963201472%	2	2174	36	T2D_GENES_TANYA_LIPIDS	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP
0.0919963201472%	2	2174	35	T2D_GENES_TANYA_LIPIDS	SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES
0.0919963201472%	2	2174	35	T2D_GENES_TANYA_LIPIDS	ROZANOV_MMP14_TARGETS_DN
0.0919963201472%	2	2174	35	T2D_GENES_TANYA_LIPIDS	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.0919963201472%	2	2174	35	T2D_GENES_TANYA_LIPIDS	GUTIERREZ_MULTIPLE_MYELOMA_DN
0.0919963201472%	2	2174	35	T2D_GENES_TANYA_LIPIDS	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN
0.0919963201472%	2	2174	35	T2D_GENES_TANYA_LIPIDS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.0919963201472%	2	2174	34	T2D_GENES_TANYA_LIPIDS	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES
0.0919963201472%	2	2174	34	T2D_GENES_TANYA_LIPIDS	PID_IL1PATHWAY
0.0919963201472%	2	2174	34	T2D_GENES_TANYA_LIPIDS	FRIDMAN_IMMORTALIZATION_DN
0.0919963201472%	2	2174	34	T2D_GENES_TANYA_LIPIDS	DOANE_BREAST_CANCER_CLASSES_DN
0.0919963201472%	2	2174	33	T2D_GENES_TANYA_LIPIDS	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP
0.0919963201472%	2	2174	33	T2D_GENES_TANYA_LIPIDS	MORI_PLASMA_CELL_DN
0.0919963201472%	2	2174	33	T2D_GENES_TANYA_LIPIDS	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN
0.0919963201472%	2	2174	33	T2D_GENES_TANYA_LIPIDS	GRADE_COLON_CANCER_DN
0.0919963201472%	2	2174	32	T2D_GENES_TANYA_LIPIDS	REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS
0.0919963201472%	2	2174	32	T2D_GENES_TANYA_LIPIDS	REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE
0.0919963201472%	2	2174	32	T2D_GENES_TANYA_LIPIDS	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN
0.0919963201472%	2	2174	32	T2D_GENES_TANYA_LIPIDS	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM
0.0919963201472%	2	2174	32	T2D_GENES_TANYA_LIPIDS	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
0.0919963201472%	2	2174	32	T2D_GENES_TANYA_LIPIDS	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP
0.0919963201472%	2	2174	31	T2D_GENES_TANYA_LIPIDS	VALK_AML_CLUSTER_15
0.0919963201472%	2	2174	31	T2D_GENES_TANYA_LIPIDS	SIMBULAN_PARP1_TARGETS_UP
0.0919963201472%	2	2174	31	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNAL_AMPLIFICATION
0.0919963201472%	2	2174	31	T2D_GENES_TANYA_LIPIDS	REACTOME_INWARDLY_RECTIFYING_K_CHANNELS
0.0919963201472%	2	2174	31	T2D_GENES_TANYA_LIPIDS	MOSERLE_IFNA_RESPONSE
0.0919963201472%	2	2174	31	T2D_GENES_TANYA_LIPIDS	DORSEY_GAB2_TARGETS
0.0919963201472%	2	2174	31	T2D_GENES_TANYA_LIPIDS	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP
0.0919963201472%	2	2174	30	T2D_GENES_TANYA_LIPIDS	VALK_AML_CLUSTER_12
0.0919963201472%	2	2174	30	T2D_GENES_TANYA_LIPIDS	TAVOR_CEBPA_TARGETS_DN
0.0919963201472%	2	2174	30	T2D_GENES_TANYA_LIPIDS	SU_PLACENTA
0.0919963201472%	2	2174	30	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_ROBO_RECEPTOR
0.0919963201472%	2	2174	30	T2D_GENES_TANYA_LIPIDS	PID_RAS_PATHWAY
0.0919963201472%	2	2174	30	T2D_GENES_TANYA_LIPIDS	PID_IL2_STAT5PATHWAY
0.0919963201472%	2	2174	30	T2D_GENES_TANYA_LIPIDS	NAKAJIMA_EOSINOPHIL
0.0919963201472%	2	2174	30	T2D_GENES_TANYA_LIPIDS	LI_PROSTATE_CANCER_EPIGENETIC
0.0919963201472%	2	2174	30	T2D_GENES_TANYA_LIPIDS	KEGG_O_GLYCAN_BIOSYNTHESIS
0.0919963201472%	2	2174	30	T2D_GENES_TANYA_LIPIDS	HEIDENBLAD_AMPLICON_12P11_12_DN
0.0919963201472%	2	2174	30	T2D_GENES_TANYA_LIPIDS	DASU_IL6_SIGNALING_SCAR_UP
0.0919963201472%	2	2174	30	T2D_GENES_TANYA_LIPIDS	BIOCARTA_FAS_PATHWAY
0.0919963201472%	2	2174	29	T2D_GENES_TANYA_LIPIDS	VALK_AML_CLUSTER_2
0.0919963201472%	2	2174	29	T2D_GENES_TANYA_LIPIDS	REACTOME_PKB_MEDIATED_EVENTS
0.0919963201472%	2	2174	29	T2D_GENES_TANYA_LIPIDS	REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN
0.0919963201472%	2	2174	29	T2D_GENES_TANYA_LIPIDS	PID_TCRCALCIUMPATHWAY
0.0919963201472%	2	2174	29	T2D_GENES_TANYA_LIPIDS	NAKAYAMA_FGF2_TARGETS
0.0919963201472%	2	2174	29	T2D_GENES_TANYA_LIPIDS	MAYBURD_RESPONSE_TO_L663536_UP
0.0919963201472%	2	2174	29	T2D_GENES_TANYA_LIPIDS	DORN_ADENOVIRUS_INFECTION_12HR_UP
0.0919963201472%	2	2174	29	T2D_GENES_TANYA_LIPIDS	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.0919963201472%	2	2174	28	T2D_GENES_TANYA_LIPIDS	TIAN_TNF_SIGNALING_VIA_NFKB
0.0919963201472%	2	2174	28	T2D_GENES_TANYA_LIPIDS	REACTOME_MYOGENESIS
0.0919963201472%	2	2174	28	T2D_GENES_TANYA_LIPIDS	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING
0.0919963201472%	2	2174	28	T2D_GENES_TANYA_LIPIDS	PID_WNT_SIGNALING_PATHWAY
0.0919963201472%	2	2174	28	T2D_GENES_TANYA_LIPIDS	PID_TRAIL_PATHWAY
0.0919963201472%	2	2174	28	T2D_GENES_TANYA_LIPIDS	KEGG_HOMOLOGOUS_RECOMBINATION
0.0919963201472%	2	2174	28	T2D_GENES_TANYA_LIPIDS	HWANG_PROSTATE_CANCER_MARKERS
0.0919963201472%	2	2174	28	T2D_GENES_TANYA_LIPIDS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.0919963201472%	2	2174	28	T2D_GENES_TANYA_LIPIDS	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.0919963201472%	2	2174	28	T2D_GENES_TANYA_LIPIDS	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN
0.0919963201472%	2	2174	28	T2D_GENES_TANYA_LIPIDS	BIOCARTA_PROTEASOME_PATHWAY
0.0919963201472%	2	2174	27	T2D_GENES_TANYA_LIPIDS	TERAO_AOX4_TARGETS_SKIN_DN
0.0919963201472%	2	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION
0.0919963201472%	2	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY
0.0919963201472%	2	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS
0.0919963201472%	2	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS
0.0919963201472%	2	2174	27	T2D_GENES_TANYA_LIPIDS	OHM_METHYLATED_IN_ADULT_CANCERS
0.0919963201472%	2	2174	27	T2D_GENES_TANYA_LIPIDS	KEGG_PENTOSE_PHOSPHATE_PATHWAY
0.0919963201472%	2	2174	27	T2D_GENES_TANYA_LIPIDS	HOEGERKORP_CD44_TARGETS_DIRECT_UP
0.0919963201472%	2	2174	27	T2D_GENES_TANYA_LIPIDS	GROSS_ELK3_TARGETS_UP
0.0919963201472%	2	2174	27	T2D_GENES_TANYA_LIPIDS	CHOW_RASSF1_TARGETS_UP
0.0919963201472%	2	2174	26	T2D_GENES_TANYA_LIPIDS	ZHENG_FOXP3_TARGETS_UP
0.0919963201472%	2	2174	26	T2D_GENES_TANYA_LIPIDS	WALLACE_JAK2_TARGETS_UP
0.0919963201472%	2	2174	26	T2D_GENES_TANYA_LIPIDS	REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS
0.0919963201472%	2	2174	26	T2D_GENES_TANYA_LIPIDS	PID_IL27PATHWAY
0.0919963201472%	2	2174	26	T2D_GENES_TANYA_LIPIDS	GAZIN_EPIGENETIC_SILENCING_BY_KRAS
0.0919963201472%	2	2174	26	T2D_GENES_TANYA_LIPIDS	BIOCARTA_WNT_PATHWAY
0.0919963201472%	2	2174	26	T2D_GENES_TANYA_LIPIDS	ABBUD_LIF_SIGNALING_1_DN
0.0919963201472%	2	2174	25	T2D_GENES_TANYA_LIPIDS	WAGNER_APO2_SENSITIVITY
0.0919963201472%	2	2174	25	T2D_GENES_TANYA_LIPIDS	STEGER_ADIPOGENESIS_DN
0.0919963201472%	2	2174	25	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN
0.0919963201472%	2	2174	25	T2D_GENES_TANYA_LIPIDS	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
0.0919963201472%	2	2174	25	T2D_GENES_TANYA_LIPIDS	REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS
0.0919963201472%	2	2174	25	T2D_GENES_TANYA_LIPIDS	NOJIMA_SFRP2_TARGETS_DN
0.0919963201472%	2	2174	25	T2D_GENES_TANYA_LIPIDS	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN
0.0919963201472%	2	2174	25	T2D_GENES_TANYA_LIPIDS	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG
0.0919963201472%	2	2174	25	T2D_GENES_TANYA_LIPIDS	KEGG_DORSO_VENTRAL_AXIS_FORMATION
0.0919963201472%	2	2174	25	T2D_GENES_TANYA_LIPIDS	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN
0.0919963201472%	2	2174	25	T2D_GENES_TANYA_LIPIDS	HOEGERKORP_CD44_TARGETS_TEMPORAL_DN
0.0919963201472%	2	2174	25	T2D_GENES_TANYA_LIPIDS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN
0.0919963201472%	2	2174	25	T2D_GENES_TANYA_LIPIDS	COLLER_MYC_TARGETS_UP
0.0919963201472%	2	2174	25	T2D_GENES_TANYA_LIPIDS	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN
0.0919963201472%	2	2174	24	T2D_GENES_TANYA_LIPIDS	WILLERT_WNT_SIGNALING
0.0919963201472%	2	2174	24	T2D_GENES_TANYA_LIPIDS	WANG_TNF_TARGETS
0.0919963201472%	2	2174	24	T2D_GENES_TANYA_LIPIDS	REACTOME_KINESINS
0.0919963201472%	2	2174	24	T2D_GENES_TANYA_LIPIDS	PID_RHODOPSIN_PATHWAY
0.0919963201472%	2	2174	24	T2D_GENES_TANYA_LIPIDS	ODONNELL_METASTASIS_DN
0.0919963201472%	2	2174	24	T2D_GENES_TANYA_LIPIDS	MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED
0.0919963201472%	2	2174	24	T2D_GENES_TANYA_LIPIDS	MATZUK_SPERMATOGONIA
0.0919963201472%	2	2174	24	T2D_GENES_TANYA_LIPIDS	KEGG_PROTEIN_EXPORT
0.0919963201472%	2	2174	24	T2D_GENES_TANYA_LIPIDS	GOLUB_ALL_VS_AML_DN
0.0919963201472%	2	2174	24	T2D_GENES_TANYA_LIPIDS	DELACROIX_RAR_TARGETS_DN
0.0919963201472%	2	2174	24	T2D_GENES_TANYA_LIPIDS	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN
0.0919963201472%	2	2174	24	T2D_GENES_TANYA_LIPIDS	BIOCARTA_G2_PATHWAY
0.0919963201472%	2	2174	23	T2D_GENES_TANYA_LIPIDS	ZHANG_INTERFERON_RESPONSE
0.0919963201472%	2	2174	23	T2D_GENES_TANYA_LIPIDS	WU_HBX_TARGETS_2_UP
0.0919963201472%	2	2174	23	T2D_GENES_TANYA_LIPIDS	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A
0.0919963201472%	2	2174	23	T2D_GENES_TANYA_LIPIDS	SEKI_INFLAMMATORY_RESPONSE_LPS_DN
0.0919963201472%	2	2174	23	T2D_GENES_TANYA_LIPIDS	REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT
0.0919963201472%	2	2174	23	T2D_GENES_TANYA_LIPIDS	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5
0.0919963201472%	2	2174	23	T2D_GENES_TANYA_LIPIDS	HINATA_NFKB_TARGETS_KERATINOCYTE_DN
0.0919963201472%	2	2174	23	T2D_GENES_TANYA_LIPIDS	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN
0.0919963201472%	2	2174	23	T2D_GENES_TANYA_LIPIDS	CHIBA_RESPONSE_TO_TSA_DN
0.0919963201472%	2	2174	23	T2D_GENES_TANYA_LIPIDS	CHEOK_RESPONSE_TO_HD_MTX_UP
0.0919963201472%	2	2174	23	T2D_GENES_TANYA_LIPIDS	BIOCARTA_MEF2D_PATHWAY
0.0919963201472%	2	2174	23	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CTCF_PATHWAY
0.0919963201472%	2	2174	22	T2D_GENES_TANYA_LIPIDS	WELCH_GATA1_TARGETS
0.0919963201472%	2	2174	22	T2D_GENES_TANYA_LIPIDS	VERNELL_RETINOBLASTOMA_PATHWAY_DN
0.0919963201472%	2	2174	22	T2D_GENES_TANYA_LIPIDS	VALK_AML_WITH_11Q23_REARRANGED
0.0919963201472%	2	2174	22	T2D_GENES_TANYA_LIPIDS	SUZUKI_RESPONSE_TO_TSA
0.0919963201472%	2	2174	22	T2D_GENES_TANYA_LIPIDS	REACTOME_METAL_ION_SLC_TRANSPORTERS
0.0919963201472%	2	2174	22	T2D_GENES_TANYA_LIPIDS	REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING
0.0919963201472%	2	2174	22	T2D_GENES_TANYA_LIPIDS	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP
0.0919963201472%	2	2174	22	T2D_GENES_TANYA_LIPIDS	PID_PDGFRAPATHWAY
0.0919963201472%	2	2174	22	T2D_GENES_TANYA_LIPIDS	MATZUK_IMPLANTATION_AND_UTERINE
0.0919963201472%	2	2174	22	T2D_GENES_TANYA_LIPIDS	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE
0.0919963201472%	2	2174	22	T2D_GENES_TANYA_LIPIDS	KANG_FLUOROURACIL_RESISTANCE_UP
0.0919963201472%	2	2174	22	T2D_GENES_TANYA_LIPIDS	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP
0.0919963201472%	2	2174	22	T2D_GENES_TANYA_LIPIDS	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN
0.0919963201472%	2	2174	22	T2D_GENES_TANYA_LIPIDS	BRACHAT_RESPONSE_TO_CISPLATIN
0.0919963201472%	2	2174	22	T2D_GENES_TANYA_LIPIDS	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN
0.0919963201472%	2	2174	22	T2D_GENES_TANYA_LIPIDS	BIOCARTA_IL6_PATHWAY
0.0919963201472%	2	2174	22	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CYTOKINE_PATHWAY
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	WOTTON_RUNX_TARGETS_UP
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	WENG_POR_DOSAGE
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	REACTOME_PEROXISOMAL_LIPID_METABOLISM
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	REACTOME_CTLA4_INHIBITORY_SIGNALING
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	REACTOME_ADP_SIGNALLING_THROUGH_P2RY12
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	MURAKAMI_UV_RESPONSE_6HR_DN
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	MCCABE_HOXC6_TARGETS_DN
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	LEE_INTRATHYMIC_T_PROGENITOR
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	LANDEMAINE_LUNG_METASTASIS
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	GESERICK_TERT_TARGETS_DN
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	DAZARD_UV_RESPONSE_CLUSTER_G4
0.0919963201472%	2	2174	21	T2D_GENES_TANYA_LIPIDS	BIOCARTA_IGF1_PATHWAY
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	WENG_POR_TARGETS_LIVER_DN
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	WENG_POR_TARGETS_GLOBAL_UP
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	WALLACE_PROSTATE_CANCER_UP
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	TOMLINS_METASTASIS_DN
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	SU_THYMUS
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	ST_WNT_CA2_CYCLIC_GMP_PATHWAY
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	REACTOME_NEPHRIN_INTERACTIONS
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	OUYANG_PROSTATE_CANCER_PROGRESSION_UP
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	MURAKAMI_UV_RESPONSE_24HR
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	HEDENFALK_BREAST_CANCER_BRACX_DN
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	COLLIS_PRKDC_SUBSTRATES
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
0.0919963201472%	2	2174	20	T2D_GENES_TANYA_LIPIDS	BIOCARTA_AMI_PATHWAY
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	ZHANG_RESPONSE_TO_CANTHARIDIN_UP
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	VISALA_AGING_LYMPHOCYTE_DN
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	SYED_ESTRADIOL_RESPONSE
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	SA_CASPASE_CASCADE
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	RUAN_RESPONSE_TO_TROGLITAZONE_DN
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	REACTOME_LAGGING_STRAND_SYNTHESIS
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	REACTOME_CGMP_EFFECTS
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	PID_EPHA2_FWDPATHWAY
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	NAGY_TFTC_COMPONENTS_HUMAN
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	MELLMAN_TUT1_TARGETS_UP
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	LI_WILMS_TUMOR_ANAPLASTIC_UP
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	KANG_AR_TARGETS_DN
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	KAMIKUBO_MYELOID_MN1_NETWORK
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	GRANDVAUX_IRF3_TARGETS_DN
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN
0.0919963201472%	2	2174	19	T2D_GENES_TANYA_LIPIDS	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	ZHENG_RESPONSE_TO_ARSENITE_DN
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	YIH_RESPONSE_TO_ARSENITE_C4
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	WU_HBX_TARGETS_3_UP
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	TOMIDA_METASTASIS_DN
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	REACTOME_SYNTHESIS_OF_PC
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_NODAL
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	PODAR_RESPONSE_TO_ADAPHOSTIN_DN
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	OZANNE_AP1_TARGETS_UP
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	NIELSEN_SCHWANNOMA_UP
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	NIELSEN_LEIOMYOSARCOMA_UP
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	NADERI_BREAST_CANCER_PROGNOSIS_DN
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	KEGG_PHENYLALANINE_METABOLISM
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	CHOI_ATL_CHRONIC_VS_ACUTE_DN
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	BIOCARTA_SPRY_PATHWAY
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	BIOCARTA_PTEN_PATHWAY
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	BIOCARTA_NGF_PATHWAY
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	BIOCARTA_MCM_PATHWAY
0.0919963201472%	2	2174	18	T2D_GENES_TANYA_LIPIDS	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP
0.0919963201472%	2	2174	17	T2D_GENES_TANYA_LIPIDS	ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE
0.0919963201472%	2	2174	17	T2D_GENES_TANYA_LIPIDS	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN
0.0919963201472%	2	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_TIE2_SIGNALING
0.0919963201472%	2	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_KIT_SIGNALING
0.0919963201472%	2	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR
0.0919963201472%	2	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_RAP1_SIGNALLING
0.0919963201472%	2	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_INTRINSIC_PATHWAY
0.0919963201472%	2	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_INFLAMMASOMES
0.0919963201472%	2	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1
0.0919963201472%	2	2174	17	T2D_GENES_TANYA_LIPIDS	PID_ANTHRAXPATHWAY
0.0919963201472%	2	2174	17	T2D_GENES_TANYA_LIPIDS	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.0919963201472%	2	2174	17	T2D_GENES_TANYA_LIPIDS	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL
0.0919963201472%	2	2174	17	T2D_GENES_TANYA_LIPIDS	LEI_HOXC8_TARGETS_DN
0.0919963201472%	2	2174	17	T2D_GENES_TANYA_LIPIDS	KEGG_STEROID_BIOSYNTHESIS
0.0919963201472%	2	2174	17	T2D_GENES_TANYA_LIPIDS	GOUYER_TATI_TARGETS_DN
0.0919963201472%	2	2174	17	T2D_GENES_TANYA_LIPIDS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
0.0919963201472%	2	2174	17	T2D_GENES_TANYA_LIPIDS	BIOCARTA_LAIR_PATHWAY
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	XU_RESPONSE_TO_TRETINOIN_UP
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	WU_HBX_TARGETS_1_UP
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	PID_CIRCADIANPATHWAY
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	MACLACHLAN_BRCA1_TARGETS_DN
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	LUND_SILENCED_BY_METHYLATION
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	KEGG_RIBOFLAVIN_METABOLISM
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	HAHTOLA_MYCOSIS_FUNGOIDES_DN
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	FUKUSHIMA_TNFSF11_TARGETS
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	FARMER_BREAST_CANCER_CLUSTER_4
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	BIOCARTA_IL22BP_PATHWAY
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	BIOCARTA_GATA3_PATHWAY
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CDC42RAC_PATHWAY
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CACAM_PATHWAY
0.0919963201472%	2	2174	16	T2D_GENES_TANYA_LIPIDS	AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	WEBER_METHYLATED_LCP_IN_SPERM_UP
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	TSUNODA_CISPLATIN_RESISTANCE_UP
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	SANDERSON_PPARA_TARGETS
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_ZINC_TRANSPORTERS
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_SHC_MEDIATED_SIGNALLING
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_AMINE_DERIVED_HORMONES
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	HUMMEL_BURKITTS_LYMPHOMA_DN
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	GRANDVAUX_IRF3_TARGETS_UP
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	FINETTI_BREAST_CANCERS_KINOME_GRAY
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	FIGUEROA_AML_METHYLATION_CLUSTER_4_DN
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	COLLIS_PRKDC_REGULATORS
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	CHANG_POU5F1_TARGETS_UP
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	BIOCARTA_RARRXR_PATHWAY
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	BIOCARTA_PITX2_PATHWAY
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	BIOCARTA_HSP27_PATHWAY
0.0919963201472%	2	2174	15	T2D_GENES_TANYA_LIPIDS	BIOCARTA_BARRESTIN_SRC_PATHWAY
0.0919963201472%	2	2174	14	T2D_GENES_TANYA_LIPIDS	ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR
0.0919963201472%	2	2174	14	T2D_GENES_TANYA_LIPIDS	ZHANG_ADIPOGENESIS_BY_BMP7
0.0919963201472%	2	2174	14	T2D_GENES_TANYA_LIPIDS	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.0919963201472%	2	2174	14	T2D_GENES_TANYA_LIPIDS	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN
0.0919963201472%	2	2174	14	T2D_GENES_TANYA_LIPIDS	WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP
0.0919963201472%	2	2174	14	T2D_GENES_TANYA_LIPIDS	VERRECCHIA_RESPONSE_TO_TGFB1_C3
0.0919963201472%	2	2174	14	T2D_GENES_TANYA_LIPIDS	ROETH_TERT_TARGETS_UP
0.0919963201472%	2	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS
0.0919963201472%	2	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_SOS_MEDIATED_SIGNALLING
0.0919963201472%	2	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_CRMPS_IN_SEMA3A_SIGNALING
0.0919963201472%	2	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_ACTIVATION_OF_RAC
0.0919963201472%	2	2174	14	T2D_GENES_TANYA_LIPIDS	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP
0.0919963201472%	2	2174	14	T2D_GENES_TANYA_LIPIDS	LIM_MAMMARY_LUMINAL_PROGENITOR_DN
0.0919963201472%	2	2174	14	T2D_GENES_TANYA_LIPIDS	KINNEY_DNMT1_METHYLATION_TARGETS
0.0919963201472%	2	2174	14	T2D_GENES_TANYA_LIPIDS	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS
0.0919963201472%	2	2174	14	T2D_GENES_TANYA_LIPIDS	BIOCARTA_PLATELETAPP_PATHWAY
0.0919963201472%	2	2174	14	T2D_GENES_TANYA_LIPIDS	AMIT_EGF_RESPONSE_20_MCF10A
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	WU_HBX_TARGETS_3_DN
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	TERAMOTO_OPN_TARGETS_CLUSTER_1
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	SA_REG_CASCADE_OF_CYCLIN_EXPR
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	KORKOLA_EMBRYONAL_CARCINOMA
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	KIM_MYCL1_AMPLIFICATION_TARGETS_UP
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	KEGG_CIRCADIAN_RHYTHM_MAMMAL
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	HO_LIVER_CANCER_VASCULAR_INVASION
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	HASINA_NOL7_TARGETS_DN
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	GHO_ATF5_TARGETS_UP
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	FU_INTERACT_WITH_ALKBH8
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	ELLWOOD_MYC_TARGETS_UP
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	CONRAD_GERMLINE_STEM_CELL
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	BIOCARTA_RB_PATHWAY
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CBL_PATHWAY
0.0919963201472%	2	2174	13	T2D_GENES_TANYA_LIPIDS	BIOCARTA_AHSP_PATHWAY
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	TURJANSKI_MAPK1_AND_MAPK2_TARGETS
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	TAGHAVI_NEOPLASTIC_TRANSFORMATION
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_THE_NLRP3_INFLAMMASOME
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_NOTCH3
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_NOTCH2
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	PETRETTO_BLOOD_PRESSURE_UP
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	MIZUKAMI_HYPOXIA_UP
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	MCBRYAN_TERMINAL_END_BUD_UP
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	ITO_PTTG1_TARGETS_UP
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	FIGUEROA_AML_METHYLATION_CLUSTER_5_UP
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	EHLERS_ANEUPLOIDY_DN
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	BIOCARTA_VDR_PATHWAY
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	BIOCARTA_PLCE_PATHWAY
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	BIOCARTA_FIBRINOLYSIS_PATHWAY
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CFTR_PATHWAY
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	BIOCARTA_BARR_MAPK_PATHWAY
0.0919963201472%	2	2174	12	T2D_GENES_TANYA_LIPIDS	BIOCARTA_AKAP13_PATHWAY
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	ZHOU_PANCREATIC_BETA_CELL
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_UNWINDING_OF_DNA
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_TRYPTOPHAN_CATABOLISM
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_DSCAM_INTERACTIONS
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_CD28_DEPENDENT_VAV1_PATHWAY
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	MUNSHI_MULTIPLE_MYELOMA_DN
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_PLURIPOTENT_STATE_UP
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	MATHEW_FANCONI_ANEMIA_GENES
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	MARSON_FOXP3_TARGETS_STIMULATED_DN
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	MANTOVANI_NFKB_TARGETS_DN
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	FUNG_IL2_SIGNALING_1
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	FRASOR_TAMOXIFEN_RESPONSE_DN
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	FOURNIER_ACINAR_DEVELOPMENT_LATE_UP
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	CAFFAREL_RESPONSE_TO_THC_8HR_5_DN
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	BIOCARTA_P35ALZHEIMERS_PATHWAY
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	BIOCARTA_MONOCYTE_PATHWAY
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	BIOCARTA_IL4_PATHWAY
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	BIOCARTA_EIF2_PATHWAY
0.0919963201472%	2	2174	11	T2D_GENES_TANYA_LIPIDS	AMIT_EGF_RESPONSE_20_HELA
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	TURJANSKI_MAPK14_TARGETS
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	TSUDA_ALVEOLAR_SOFT_PART_SARCOMA
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_RAF_MAP_KINASE_CASCADE
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_PECAM1_INTERACTIONS
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_COPI_MEDIATED_TRANSPORT
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_BINDING_AND_ENTRY_OF_HIV_VIRION
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	OSAWA_TNF_TARGETS
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	OHASHI_AURKB_TARGETS
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	MAINA_VHL_TARGETS_UP
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	KEGG_LIMONENE_AND_PINENE_DEGRADATION
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	GOUYER_TATI_TARGETS_UP
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	CHASSOT_SKIN_WOUND
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	BRUNEAU_SEPTATION_VENTRICULAR
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	BIOCARTA_IL5_PATHWAY
0.0919963201472%	2	2174	10	T2D_GENES_TANYA_LIPIDS	AGARWAL_AKT_PATHWAY_TARGETS
0.0855431993157%	1	1169	98	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CROONQUIST_IL6_DEPRIVATION_DN
0.0855431993157%	1	1169	94	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.0855431993157%	1	1169	94	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOOI_ST7_TARGETS_UP
0.0855431993157%	1	1169	94	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAVIN_FOXP3_TARGETS_CLUSTER_T4
0.0855431993157%	1	1169	92	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HILLION_HMGA1B_TARGETS
0.0855431993157%	1	1169	90	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN
0.0855431993157%	1	1169	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	THILLAINADESAN_ZNF217_TARGETS_DN
0.0855431993157%	1	1169	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP
0.0855431993157%	1	1169	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK
0.0855431993157%	1	1169	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OXFORD_RALB_TARGETS_DN
0.0855431993157%	1	1169	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP
0.0855431993157%	1	1169	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ITO_PTTG1_TARGETS_DN
0.0855431993157%	1	1169	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION
0.0855431993157%	1	1169	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	COLLER_MYC_TARGETS_DN
0.0855431993157%	1	1169	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA
0.0855431993157%	1	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WNT_SIGNALING
0.0855431993157%	1	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANLOO_SP3_TARGETS_DN
0.0855431993157%	1	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RICKMAN_HEAD_AND_NECK_CANCER_E
0.0855431993157%	1	1169	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KANG_IMMORTALIZED_BY_TERT_UP
0.0855431993157%	1	1169	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
0.0855431993157%	1	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SAFFORD_T_LYMPHOCYTE_ANERGY
0.0855431993157%	1	1169	87	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION
0.0855431993157%	1	1169	86	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.0855431993157%	1	1169	85	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	COLDREN_GEFITINIB_RESISTANCE_UP
0.0855431993157%	1	1169	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SWEET_KRAS_TARGETS_UP
0.0855431993157%	1	1169	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SANA_TNF_SIGNALING_UP
0.0855431993157%	1	1169	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.0855431993157%	1	1169	83	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
0.0855431993157%	1	1169	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WONG_ENDMETRIUM_CANCER_DN
0.0855431993157%	1	1169	82	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BILD_CTNNB1_ONCOGENIC_SIGNATURE
0.0855431993157%	1	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION
0.0855431993157%	1	1169	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRABARCZYK_BCL11B_TARGETS_UP
0.0855431993157%	1	1169	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_UNFOLDED_PROTEIN_RESPONSE
0.0855431993157%	1	1169	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_BETACATENIN_NUC_PATHWAY
0.0855431993157%	1	1169	80	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TURJANSKI_MAPK8_AND_MAPK9_TARGETS
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TCGA_GLIOBLASTOMA_MUTATED
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OXFORD_RALB_TARGETS_UP
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NOUSHMEHR_GBM_GERMLINE_MUTATED
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAMURA_LUNG_CANCER
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOOTHA_PYR
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_DEDIFFERENTIATED_STATE_UP
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MATZUK_LUTEAL_GENES
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOLLEMAN_DAUNORUBICIN_ALL_DN
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FUJIWARA_PARK2_IN_LIVER_CANCER_UP
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DER_IFN_BETA_RESPONSE_DN
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CLIMENT_BREAST_CANCER_COPY_NUMBER_DN
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHANG_POU5F1_TARGETS_DN
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS
0.0855431993157%	1	1169	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_KREB_PATHWAY
0.0855431993157%	1	1169	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16
0.0855431993157%	1	1169	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCCLUNG_COCAINE_REWARD_5D
0.0855431993157%	1	1169	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
0.0855431993157%	1	1169	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.0855431993157%	1	1169	78	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PLATELET_HOMEOSTASIS
0.0855431993157%	1	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHEBOTAEV_GR_TARGETS_UP
0.0855431993157%	1	1169	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CARD_MIR302A_TARGETS
0.0855431993157%	1	1169	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.0855431993157%	1	1169	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SU_TESTIS
0.0855431993157%	1	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.0855431993157%	1	1169	74	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_G_ALPHA1213_SIGNALLING_EVENTS
0.0855431993157%	1	1169	73	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOSHIDA_LIVER_CANCER_SURVIVAL_UP
0.0855431993157%	1	1169	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SESTO_RESPONSE_TO_UV_C8
0.0855431993157%	1	1169	72	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CROONQUIST_NRAS_SIGNALING_DN
0.0855431993157%	1	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5
0.0855431993157%	1	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_NOTCH1
0.0855431993157%	1	1169	70	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_AP1_PATHWAY
0.0855431993157%	1	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN
0.0855431993157%	1	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TERAMOTO_OPN_TARGETS_CLUSTER_5
0.0855431993157%	1	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP
0.0855431993157%	1	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_NPC_WITH_LCP_H3K27ME3
0.0855431993157%	1	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKI_COEXPRESSED_WITH_CYP19A1
0.0855431993157%	1	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARSHALL_VIRAL_INFECTION_RESPONSE_UP
0.0855431993157%	1	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN
0.0855431993157%	1	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.0855431993157%	1	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOLLEMAN_DAUNORUBICIN_ALL_UP
0.0855431993157%	1	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DASU_IL6_SIGNALING_DN
0.0855431993157%	1	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHESLER_BRAIN_D6MIT150_QTL_CIS
0.0855431993157%	1	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BUDHU_LIVER_CANCER_METASTASIS_DN
0.0855431993157%	1	1169	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3
0.0855431993157%	1	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10
0.0855431993157%	1	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.0855431993157%	1	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.0855431993157%	1	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RHODES_UNDIFFERENTIATED_CANCER
0.0855431993157%	1	1169	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE
0.0855431993157%	1	1169	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SESTO_RESPONSE_TO_UV_C7
0.0855431993157%	1	1169	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIN_NPAS4_TARGETS_DN
0.0855431993157%	1	1169	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CASTELLANO_NRAS_TARGETS_UP
0.0855431993157%	1	1169	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_INTERFERON_RESPONSIVE_GENES
0.0855431993157%	1	1169	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES
0.0855431993157%	1	1169	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
0.0855431993157%	1	1169	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP
0.0855431993157%	1	1169	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.0855431993157%	1	1169	67	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAZARD_UV_RESPONSE_CLUSTER_G1
0.0855431993157%	1	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TENEDINI_MEGAKARYOCYTE_MARKERS
0.0855431993157%	1	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SWEET_KRAS_TARGETS_DN
0.0855431993157%	1	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAMURA_ADIPOGENESIS_EARLY_UP
0.0855431993157%	1	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_GERMINAL_CENTER_T_HELPER_UP
0.0855431993157%	1	1169	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.0855431993157%	1	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
0.0855431993157%	1	1169	65	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GOLDRATH_IMMUNE_MEMORY
0.0855431993157%	1	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHANG_GATA6_TARGETS_DN
0.0855431993157%	1	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RIZKI_TUMOR_INVASIVENESS_2D_DN
0.0855431993157%	1	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RHODES_CANCER_META_SIGNATURE
0.0855431993157%	1	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PETROVA_PROX1_TARGETS_DN
0.0855431993157%	1	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_LIVER_CANCER_E2F1_DN
0.0855431993157%	1	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	INGRAM_SHH_TARGETS_DN
0.0855431993157%	1	1169	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GERHOLD_ADIPOGENESIS_DN
0.0855431993157%	1	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX
0.0855431993157%	1	1169	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED
0.0855431993157%	1	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_DNA_DAMAGE_BY_UV
0.0855431993157%	1	1169	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BILD_SRC_ONCOGENIC_SIGNATURE
0.0855431993157%	1	1169	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MASSARWEH_RESPONSE_TO_ESTRADIOL
0.0855431993157%	1	1169	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KAUFFMANN_MELANOMA_RELAPSE_UP
0.0855431993157%	1	1169	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BAKKER_FOXO3_TARGETS_UP
0.0855431993157%	1	1169	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH
0.0855431993157%	1	1169	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE
0.0855431993157%	1	1169	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CROONQUIST_STROMAL_STIMULATION_UP
0.0855431993157%	1	1169	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WILLIAMS_ESR1_TARGETS_DN
0.0855431993157%	1	1169	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN
0.0855431993157%	1	1169	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP
0.0855431993157%	1	1169	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP
0.0855431993157%	1	1169	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOTAMED_RESPONSE_TO_ANDROGEN_DN
0.0855431993157%	1	1169	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP
0.0855431993157%	1	1169	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	COURTOIS_SENESCENCE_TRIGGERS
0.0855431993157%	1	1169	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CORRADETTI_MTOR_PATHWAY_REGULATORS_DN
0.0855431993157%	1	1169	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHOI_ATL_ACUTE_STAGE
0.0855431993157%	1	1169	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHESLER_BRAIN_QTL_TRANS
0.0855431993157%	1	1169	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHENG_TAF7L_TARGETS
0.0855431993157%	1	1169	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_NEUROTRANSMITTERS_PATHWAY
0.0855431993157%	1	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WESTON_VEGFA_TARGETS_6HR
0.0855431993157%	1	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS
0.0855431993157%	1	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
0.0855431993157%	1	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIAN_LIPA_TARGETS_3M
0.0855431993157%	1	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION
0.0855431993157%	1	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYLAN_MULTIPLE_MYELOMA_C_DN
0.0855431993157%	1	1169	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ASTIER_INTEGRIN_SIGNALING
0.0855431993157%	1	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHENG_GLIOBLASTOMA_PLASTICITY_DN
0.0855431993157%	1	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHEIDEREIT_IKK_INTERACTING_PROTEINS
0.0855431993157%	1	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT
0.0855431993157%	1	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAGASHIMA_NRG1_SIGNALING_DN
0.0855431993157%	1	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NADLER_HYPERGLYCEMIA_AT_OBESITY
0.0855431993157%	1	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
0.0855431993157%	1	1169	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BERNARD_PPAPDC1B_TARGETS_DN
0.0855431993157%	1	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAMASHITA_METHYLATED_IN_PROSTATE_CANCER
0.0855431993157%	1	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TONG_INTERACT_WITH_PTTG1
0.0855431993157%	1	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TANG_SENESCENCE_TP53_TARGETS_DN
0.0855431993157%	1	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.0855431993157%	1	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PEART_HDAC_PROLIFERATION_CLUSTER_UP
0.0855431993157%	1	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCCLUNG_CREB1_TARGETS_DN
0.0855431993157%	1	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GYORFFY_MITOXANTRONE_RESISTANCE
0.0855431993157%	1	1169	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP
0.0855431993157%	1	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PI_3K_CASCADE
0.0855431993157%	1	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LY_AGING_OLD_DN
0.0855431993157%	1	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.0855431993157%	1	1169	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GALE_APL_WITH_FLT3_MUTATED_UP
0.0855431993157%	1	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
0.0855431993157%	1	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53
0.0855431993157%	1	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
0.0855431993157%	1	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_TGFBRPATHWAY
0.0855431993157%	1	1169	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LAU_APOPTOSIS_CDKN2A_UP
0.0855431993157%	1	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROVERSI_GLIOMA_COPY_NUMBER_DN
0.0855431993157%	1	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM
0.0855431993157%	1	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_INOSITOL_PHOSPHATE_METABOLISM
0.0855431993157%	1	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KANG_DOXORUBICIN_RESISTANCE_UP
0.0855431993157%	1	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JIANG_AGING_CEREBRAL_CORTEX_DN
0.0855431993157%	1	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HUPER_BREAST_BASAL_VS_LUMINAL_UP
0.0855431993157%	1	1169	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FIGUEROA_AML_METHYLATION_CLUSTER_2_UP
0.0855431993157%	1	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
0.0855431993157%	1	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMIRNOV_RESPONSE_TO_IR_2HR_UP
0.0855431993157%	1	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS
0.0855431993157%	1	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIANG_SILENCED_BY_METHYLATION_2
0.0855431993157%	1	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ISHIDA_E2F_TARGETS
0.0855431993157%	1	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HENDRICKS_SMARCA4_TARGETS_DN
0.0855431993157%	1	1169	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN
0.0855431993157%	1	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VILIMAS_NOTCH1_TARGETS_UP
0.0855431993157%	1	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROSS_AML_WITH_CBFB_MYH11_FUSION
0.0855431993157%	1	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM
0.0855431993157%	1	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GABA_RECEPTOR_ACTIVATION
0.0855431993157%	1	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KENNY_CTNNB1_TARGETS_DN
0.0855431993157%	1	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_MTOR_SIGNALING_PATHWAY
0.0855431993157%	1	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP
0.0855431993157%	1	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIBA_RESPONSE_TO_TSA_UP
0.0855431993157%	1	1169	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BECKER_TAMOXIFEN_RESISTANCE_DN
0.0855431993157%	1	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF
0.0855431993157%	1	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
0.0855431993157%	1	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NUCLEOTIDE_EXCISION_REPAIR
0.0855431993157%	1	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT
0.0855431993157%	1	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PRAMOONJAGO_SOX4_TARGETS_DN
0.0855431993157%	1	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FRASOR_TAMOXIFEN_RESPONSE_UP
0.0855431993157%	1	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.0855431993157%	1	1169	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BURTON_ADIPOGENESIS_7
0.0855431993157%	1	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN
0.0855431993157%	1	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
0.0855431993157%	1	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE
0.0855431993157%	1	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KOHOUTEK_CCNT1_TARGETS
0.0855431993157%	1	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KENNY_CTNNB1_TARGETS_UP
0.0855431993157%	1	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN
0.0855431993157%	1	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIBA_RESPONSE_TO_TSA
0.0855431993157%	1	1169	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN
0.0855431993157%	1	1169	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN
0.0855431993157%	1	1169	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REN_MIF_TARGETS_DN
0.0855431993157%	1	1169	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP
0.0855431993157%	1	1169	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OZANNE_AP1_TARGETS_DN
0.0855431993157%	1	1169	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LAU_APOPTOSIS_CDKN2A_DN
0.0855431993157%	1	1169	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KERLEY_RESPONSE_TO_CISPLATIN_DN
0.0855431993157%	1	1169	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FERRARI_RESPONSE_TO_FENRETINIDE_DN
0.0855431993157%	1	1169	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ABDULRAHMAN_KIDNEY_CANCER_VHL_UP
0.0855431993157%	1	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_HP_UP
0.0855431993157%	1	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8
0.0855431993157%	1	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ARF6_TRAFFICKINGPATHWAY
0.0855431993157%	1	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MANTOVANI_VIRAL_GPCR_SIGNALING_DN
0.0855431993157%	1	1169	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BROWNE_HCMV_INFECTION_2HR_DN
0.0855431993157%	1	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_MS_UP
0.0855431993157%	1	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PI_METABOLISM
0.0855431993157%	1	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_HES_HEYPATHWAY
0.0855431993157%	1	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OXFORD_RALA_OR_RALB_TARGETS_UP
0.0855431993157%	1	1169	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCCLUNG_DELTA_FOSB_TARGETS_2WK
0.0855431993157%	1	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_HP_DN
0.0855431993157%	1	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SILIGAN_BOUND_BY_EWS_FLT1_FUSION
0.0855431993157%	1	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
0.0855431993157%	1	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN
0.0855431993157%	1	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCCLUNG_DELTA_FOSB_TARGETS_8WK
0.0855431993157%	1	1169	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KHETCHOUMIAN_TRIM24_TARGETS_UP
0.0855431993157%	1	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_CD2_DN
0.0855431993157%	1	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION
0.0855431993157%	1	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
0.0855431993157%	1	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_RHOA_REG_PATHWAY
0.0855431993157%	1	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_PLK1_PATHWAY
0.0855431993157%	1	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OSADA_ASCL1_TARGETS_UP
0.0855431993157%	1	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAJIMA_MAST_CELL
0.0855431993157%	1	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HALMOS_CEBPA_TARGETS_DN
0.0855431993157%	1	1169	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN
0.0855431993157%	1	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_V2_LATE_DIFFERENTIATION_GENES
0.0855431993157%	1	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_CD1_UP
0.0855431993157%	1	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_CD1_DN
0.0855431993157%	1	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TRAYNOR_RETT_SYNDROM_UP
0.0855431993157%	1	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN
0.0855431993157%	1	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MRNA_SPLICING_MINOR_PATHWAY
0.0855431993157%	1	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_G2_M_CHECKPOINTS
0.0855431993157%	1	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_
0.0855431993157%	1	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RASHI_RESPONSE_TO_IONIZING_RADIATION_1
0.0855431993157%	1	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_RHOA_PATHWAY
0.0855431993157%	1	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN
0.0855431993157%	1	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KLEIN_TARGETS_OF_BCR_ABL1_FUSION
0.0855431993157%	1	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN
0.0855431993157%	1	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHENG_RESPONSE_TO_NICKEL_ACETATE
0.0855431993157%	1	1169	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_PR_DN
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_MULTIPLE_MYELOMA_LB_DN
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_TARGETS_OF_MLL_CBP_FUSION_UP
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANTVEER_BREAST_CANCER_BRCA1_DN
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	THILLAINADESAN_ZNF217_TARGETS_UP
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STREICHER_LSM1_TARGETS_UP
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROVERSI_GLIOMA_LOH_REGIONS
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_FGFR_MUTANTS
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_HNF3APATHWAY
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OHGUCHI_LIVER_HNF4A_TARGETS_UP
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LUI_THYROID_CANCER_PAX8_PPARG_UP
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_NUCLEOTIDE_EXCISION_REPAIR
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM
0.0855431993157%	1	1169	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FARMER_BREAST_CANCER_CLUSTER_1
0.0855431993157%	1	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RIZ_ERYTHROID_DIFFERENTIATION_12HR
0.0855431993157%	1	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK
0.0855431993157%	1	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MANTOVANI_NFKB_TARGETS_UP
0.0855431993157%	1	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
0.0855431993157%	1	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DORN_ADENOVIRUS_INFECTION_24HR_DN
0.0855431993157%	1	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	COWLING_MYCN_TARGETS
0.0855431993157%	1	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BURTON_ADIPOGENESIS_PEAK_AT_24HR
0.0855431993157%	1	1169	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMIT_EGF_RESPONSE_480_MCF10A
0.0855431993157%	1	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YU_MYC_TARGETS_UP
0.0855431993157%	1	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP
0.0855431993157%	1	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_BMPPATHWAY
0.0855431993157%	1	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MODY_HIPPOCAMPUS_PRENATAL
0.0855431993157%	1	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LUI_THYROID_CANCER_CLUSTER_2
0.0855431993157%	1	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BARRIER_COLON_CANCER_RECURRENCE_UP
0.0855431993157%	1	1169	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMIT_EGF_RESPONSE_40_HELA
0.0855431993157%	1	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RIZ_ERYTHROID_DIFFERENTIATION_HBZ
0.0855431993157%	1	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING
0.0855431993157%	1	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_IL_2_SIGNALING
0.0855431993157%	1	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ONO_AML1_TARGETS_DN
0.0855431993157%	1	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KORKOLA_EMBRYONAL_CARCINOMA_UP
0.0855431993157%	1	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KAMMINGA_EZH2_TARGETS
0.0855431993157%	1	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GENTILE_UV_RESPONSE_CLUSTER_D2
0.0855431993157%	1	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
0.0855431993157%	1	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	EHLERS_ANEUPLOIDY_UP
0.0855431993157%	1	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CROONQUIST_NRAS_SIGNALING_UP
0.0855431993157%	1	1169	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHEN_HOXA5_TARGETS_9HR_DN
0.0855431993157%	1	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VALK_AML_WITH_FLT3_ITD
0.0855431993157%	1	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RIZ_ERYTHROID_DIFFERENTIATION_6HR
0.0855431993157%	1	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.0855431993157%	1	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER
0.0855431993157%	1	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN
0.0855431993157%	1	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HEIDENBLAD_AMPLICON_8Q24_UP
0.0855431993157%	1	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
0.0855431993157%	1	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DORN_ADENOVIRUS_INFECTION_48HR_DN
0.0855431993157%	1	1169	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN
0.0855431993157%	1	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2
0.0855431993157%	1	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP
0.0855431993157%	1	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SESTO_RESPONSE_TO_UV_C6
0.0855431993157%	1	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NCAM1_INTERACTIONS
0.0855431993157%	1	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ATR_PATHWAY
0.0855431993157%	1	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NEWMAN_ERCC6_TARGETS_DN
0.0855431993157%	1	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MATZUK_MEIOTIC_AND_DNA_REPAIR
0.0855431993157%	1	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KORKOLA_TERATOMA
0.0855431993157%	1	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GU_PDEF_TARGETS_DN
0.0855431993157%	1	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DORN_ADENOVIRUS_INFECTION_32HR_DN
0.0855431993157%	1	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CONRAD_STEM_CELL
0.0855431993157%	1	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP
0.0855431993157%	1	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP
0.0855431993157%	1	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BEIER_GLIOMA_STEM_CELL_UP
0.0855431993157%	1	1169	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMIT_SERUM_RESPONSE_480_MCF10A
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VARELA_ZMPSTE24_TARGETS_DN
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GLYCOSPHINGOLIPID_METABOLISM
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GLUCOSE_TRANSPORT
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GABA_B_RECEPTOR_ACTIVATION
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GAB1_SIGNALOSOME
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_FASPATHWAY
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ERBB4_PATHWAY
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ONGUSAHA_TP53_TARGETS
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAMURA_ADIPOGENESIS_LATE_DN
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAMURA_ADIPOGENESIS_EARLY_DN
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRADE_COLON_VS_RECTAL_CANCER_UP
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
0.0855431993157%	1	1169	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_INTEGRIN_PATHWAY
0.0855431993157%	1	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN
0.0855431993157%	1	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VALK_AML_WITH_CEBPA
0.0855431993157%	1	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS
0.0855431993157%	1	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_ALL_DISORDERS_CALB1_CORR_DN
0.0855431993157%	1	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GENTILE_UV_RESPONSE_CLUSTER_D6
0.0855431993157%	1	1169	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CUI_TCF21_TARGETS_UP
0.0855431993157%	1	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YIH_RESPONSE_TO_ARSENITE_C3
0.0855431993157%	1	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YANG_BREAST_CANCER_ESR1_UP
0.0855431993157%	1	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2
0.0855431993157%	1	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN
0.0855431993157%	1	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VALK_AML_CLUSTER_11
0.0855431993157%	1	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SUBTIL_PROGESTIN_TARGETS
0.0855431993157%	1	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHIN_B_CELL_LYMPHOMA_CLUSTER_8
0.0855431993157%	1	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
0.0855431993157%	1	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_IRON_UPTAKE_AND_TRANSPORT
0.0855431993157%	1	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_FRS2_MEDIATED_CASCADE
0.0855431993157%	1	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MMS_MOUSE_LYMPH_HIGH_4HRS_UP
0.0855431993157%	1	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_BASAL_TRANSCRIPTION_FACTORS
0.0855431993157%	1	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JIANG_AGING_CEREBRAL_CORTEX_UP
0.0855431993157%	1	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HUANG_FOXA2_TARGETS_DN
0.0855431993157%	1	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOUSTIS_ROS
0.0855431993157%	1	1169	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WESTON_VEGFA_TARGETS_12HR
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEIGEL_OXIDATIVE_STRESS_RESPONSE
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_METHYLATED_IN_BREAST_CANCER
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROZANOV_MMP14_TARGETS_DN
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RODRIGUES_NTN1_AND_DCC_TARGETS
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MRNA_3_END_PROCESSING
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GLOBAL_GENOMIC_NER_GG_NER
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LOPEZ_TRANSLATION_VIA_FN1_SIGNALING
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LI_CISPLATIN_RESISTANCE_DN
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_REGULATION_OF_AUTOPHAGY
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PRION_DISEASES
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PRIMARY_IMMUNODEFICIENCY
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_BASE_EXCISION_REPAIR
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HU_GENOTOXIC_DAMAGE_24HR
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CARM_ER_PATHWAY
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BALDWIN_PRKCI_TARGETS_UP
0.0855431993157%	1	1169	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AIGNER_ZEB1_TARGETS
0.0855431993157%	1	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WONG_IFNA2_RESISTANCE_DN
0.0855431993157%	1	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_RESPONSE_TO_BEXAROTENE_UP
0.0855431993157%	1	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SUMI_HNF4A_TARGETS
0.0855431993157%	1	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE
0.0855431993157%	1	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX
0.0855431993157%	1	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PLASARI_TGFB1_TARGETS_1HR_UP
0.0855431993157%	1	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_MAPKTRKPATHWAY
0.0855431993157%	1	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_IL1PATHWAY
0.0855431993157%	1	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_HIF2PATHWAY
0.0855431993157%	1	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_HDAC_CLASSII_PATHWAY
0.0855431993157%	1	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_EPHA_FWDPATHWAY
0.0855431993157%	1	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ATM_PATHWAY
0.0855431993157%	1	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MEISSNER_ES_ICP_WITH_H3K4ME3
0.0855431993157%	1	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM
0.0855431993157%	1	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JIANG_HYPOXIA_VIA_VHL
0.0855431993157%	1	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HONMA_DOCETAXEL_RESISTANCE
0.0855431993157%	1	1169	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DOANE_BREAST_CANCER_CLASSES_DN
0.0855431993157%	1	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VALK_AML_CLUSTER_5
0.0855431993157%	1	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHRAETS_MLL_TARGETS_DN
0.0855431993157%	1	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RNA_POL_III_TRANSCRIPTION
0.0855431993157%	1	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PURINE_METABOLISM
0.0855431993157%	1	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS
0.0855431993157%	1	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS
0.0855431993157%	1	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ALPHASYNUCLEIN_PATHWAY
0.0855431993157%	1	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.0855431993157%	1	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MORI_PLASMA_CELL_DN
0.0855431993157%	1	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP
0.0855431993157%	1	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FIRESTEIN_CTNNB1_PATHWAY
0.0855431993157%	1	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DUTTA_APOPTOSIS_VIA_NFKB
0.0855431993157%	1	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHO_NR4A1_TARGETS
0.0855431993157%	1	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BURTON_ADIPOGENESIS_1
0.0855431993157%	1	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN
0.0855431993157%	1	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_NO1_PATHWAY
0.0855431993157%	1	1169	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_DEATH_PATHWAY
0.0855431993157%	1	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.0855431993157%	1	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_ERK1_ERK2_MAPK_PATHWAY
0.0855431993157%	1	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN
0.0855431993157%	1	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS
0.0855431993157%	1	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE
0.0855431993157%	1	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ELONGATION_ARREST_AND_RECOVERY
0.0855431993157%	1	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MEISSNER_BRAIN_ICP_WITH_H3K4ME3
0.0855431993157%	1	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIANG_SILENCED_BY_METHYLATION_UP
0.0855431993157%	1	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KIM_TIAL1_TARGETS
0.0855431993157%	1	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FARDIN_HYPOXIA_11
0.0855431993157%	1	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN
0.0855431993157%	1	1169	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_RHO_PATHWAY
0.0855431993157%	1	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP
0.0855431993157%	1	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VALK_AML_CLUSTER_4
0.0855431993157%	1	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VALK_AML_CLUSTER_15
0.0855431993157%	1	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TING_SILENCED_BY_DICER
0.0855431993157%	1	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RIZ_ERYTHROID_DIFFERENTIATION_HEMGN
0.0855431993157%	1	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES
0.0855431993157%	1	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE
0.0855431993157%	1	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNAL_AMPLIFICATION
0.0855431993157%	1	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX
0.0855431993157%	1	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_P38ALPHABETAPATHWAY
0.0855431993157%	1	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOSERLE_IFNA_RESPONSE
0.0855431993157%	1	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DORSEY_GAB2_TARGETS
0.0855431993157%	1	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DANG_MYC_TARGETS_DN
0.0855431993157%	1	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_MYOSIN_PATHWAY
0.0855431993157%	1	1169	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YANAGIHARA_ESX1_TARGETS
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_ROBO_RECEPTOR
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CA_DEPENDENT_EVENTS
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_BASIGIN_INTERACTIONS
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_RAS_PATHWAY
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LI_PROSTATE_CANCER_EPIGENETIC
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIU_BREAST_CANCER
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_O_GLYCAN_BIOSYNTHESIS
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HEIDENBLAD_AMPLICON_12P11_12_DN
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GUILLAUMOND_KLF10_TARGETS_DN
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DASU_IL6_SIGNALING_SCAR_UP
0.0855431993157%	1	1169	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BURTON_ADIPOGENESIS_10
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WILENSKY_RESPONSE_TO_DARAPLADIB
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TIGHT_JUNCTION_INTERACTIONS
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_TCRCALCIUMPATHWAY
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_BARD1PATHWAY
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PATTERSON_DOCETAXEL_RESISTANCE
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAYAMA_FGF2_TARGETS
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_MCV6_LCP_WITH_H3K27ME3
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MA_PITUITARY_FETAL_VS_ADULT_UP
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_THYROID_CANCER
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_LINOLEIC_ACID_METABOLISM
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GENTLES_LEUKEMIC_STEM_CELL_UP
0.0855431993157%	1	1169	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WIKMAN_ASBESTOS_LUNG_CANCER_DN
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TIAN_TNF_SIGNALING_VIA_NFKB
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TERAO_AOX4_TARGETS_HG_UP
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_WNT_SIGNALING_PATHWAY
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PETROVA_PROX1_TARGETS_UP
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OLSSON_E2F3_TARGETS_UP
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LUI_THYROID_CANCER_CLUSTER_3
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_HOMOLOGOUS_RECOMBINATION
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HWANG_PROSTATE_CANCER_MARKERS
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GENTILE_UV_RESPONSE_CLUSTER_D9
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_PROTEASOME_PATHWAY
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_G1_PATHWAY
0.0855431993157%	1	1169	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_ERK_PATHWAY
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YE_METASTATIC_LIVER_CANCER
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YANG_BREAST_CANCER_ESR1_BULK_UP
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	XU_AKT1_TARGETS_6HR
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TERAO_AOX4_TARGETS_SKIN_DN
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHIN_B_CELL_LYMPHOMA_CLUSTER_7
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SYNTHESIS_OF_PA
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_EXTENSION_OF_TELOMERES
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OHM_METHYLATED_IN_ADULT_CANCERS
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LI_WILMS_TUMOR
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IKEDA_MIR30_TARGETS_DN
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOEGERKORP_CD44_TARGETS_DIRECT_UP
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GROSS_ELK3_TARGETS_UP
0.0855431993157%	1	1169	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOYAULT_LIVER_CANCER_SUBCLASS_G2
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	XU_CREBBP_TARGETS_UP
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TOMIDA_METASTASIS_UP
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_P38_MKK3_6PATHWAY
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_INTEGRIN_CS_PATHWAY
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_IL27PATHWAY
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ALK1PATHWAY
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NEWMAN_ERCC6_TARGETS_UP
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAKAMURA_CANCER_MICROENVIRONMENT_UP
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAZIN_EPIGENETIC_SILENCING_BY_KRAS
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BRACHAT_RESPONSE_TO_METHOTREXATE_UP
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_PGC1A_PATHWAY
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_BAD_PATHWAY
0.0855431993157%	1	1169	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WONG_ENDMETRIUM_CANCER_UP
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_NFKB_TARGETS
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VERRECCHIA_RESPONSE_TO_TGFB1_C2
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANDESLUIS_NORMAL_EMBRYOS_DN
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SMOOTH_MUSCLE_CONTRACTION
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DARPP_32_EVENTS
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NOJIMA_SFRP2_TARGETS_DN
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JACKSON_DNMT1_TARGETS_DN
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOEGERKORP_CD44_TARGETS_TEMPORAL_DN
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GENTILE_UV_HIGH_DOSE_UP
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	COLLER_MYC_TARGETS_UP
0.0855431993157%	1	1169	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YIH_RESPONSE_TO_ARSENITE_C1
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WILLERT_WNT_SIGNALING
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WANG_LSD1_TARGETS_UP
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SA_B_CELL_RECEPTOR_COMPLEXES
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_IFNA_SIGNALING
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_KINESINS
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DOUBLE_STRAND_BREAK_REPAIR
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_RHODOPSIN_PATHWAY
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OXFORD_RALA_OR_RALB_TARGETS_DN
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PROTEIN_EXPORT
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JIANG_TIP30_TARGETS_DN
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JEON_SMAD6_TARGETS_UP
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_NOS1_PATHWAY
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_ECM_PATHWAY
0.0855431993157%	1	1169	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AZARE_STAT3_TARGETS
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHANG_INTERFERON_RESPONSE
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WU_HBX_TARGETS_2_UP
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WU_HBX_TARGETS_1_DN
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VIETOR_IFRD1_TARGETS
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SEKI_INFLAMMATORY_RESPONSE_LPS_DN
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SAGIV_CD24_TARGETS_UP
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_LYSOSOME_VESICLE_BIOGENESIS
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_PRLSIGNALINGEVENTSPATHWAY
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_NITROGEN_METABOLISM
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HINATA_NFKB_TARGETS_KERATINOCYTE_DN
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_RAC1_PATHWAY
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_MTOR_PATHWAY
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_MEF2D_PATHWAY
0.0855431993157%	1	1169	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_INTRINSIC_PATHWAY
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YUAN_ZNF143_PARTNERS
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SUZUKI_RESPONSE_TO_TSA
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_PDGFRAPATHWAY
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_HEDGEHOG_2PATHWAY
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NUMATA_CSF3_SIGNALING_VIA_STAT3
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOOTHA_FFA_OXYDATION
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MATZUK_IMPLANTATION_AND_UTERINE
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LANDIS_ERBB2_BREAST_TUMORS_65_UP
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_BETA_ALANINE_METABOLISM
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_IL2_PATHWAY
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_HER2_PATHWAY
0.0855431993157%	1	1169	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_DC_PATHWAY
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WOTTON_RUNX_TARGETS_UP
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WENG_POR_DOSAGE
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHURINGA_STAT5A_TARGETS_UP
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PEROXISOMAL_LIPID_METABOLISM
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ERK_MAPK_TARGETS
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CTLA4_INHIBITORY_SIGNALING
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ADP_SIGNALLING_THROUGH_P2RY12
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OUYANG_PROSTATE_CANCER_PROGRESSION_DN
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LANDEMAINE_LUNG_METASTASIS
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HU_ANGIOGENESIS_UP
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HUI_MAPK14_TARGETS_UP
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HASLINGER_B_CLL_WITH_17P13_DELETION
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_TFF_PATHWAY
0.0855431993157%	1	1169	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_ATRBRCA_PATHWAY
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHU_SKIL_TARGETS_UP
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WENG_POR_TARGETS_LIVER_DN
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VILIMAS_NOTCH1_TARGETS_DN
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TOMLINS_METASTASIS_DN
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ST_WNT_CA2_CYCLIC_GMP_PATHWAY
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ENOS_ACTIVATION_AND_REGULATION
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_WNT_CANONICAL_PATHWAY
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MURAKAMI_UV_RESPONSE_24HR
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MEISSNER_NPC_ICP_WITH_H3K4ME3
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MANN_RESPONSE_TO_AMIFOSTINE_UP
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MAHADEVAN_IMATINIB_RESISTANCE_DN
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HEDENFALK_BREAST_CANCER_BRACX_DN
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FARMER_BREAST_CANCER_CLUSTER_7
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_NKCELLS_PATHWAY
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_ATM_PATHWAY
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BARRIER_COLON_CANCER_RECURRENCE_DN
0.0855431993157%	1	1169	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMIT_EGF_RESPONSE_240_MCF10A
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VERNOCHET_ADIPOGENESIS
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TERAMOTO_OPN_TARGETS_CLUSTER_7
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SYED_ESTRADIOL_RESPONSE
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHIN_B_CELL_LYMPHOMA_CLUSTER_9
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SA_CASPASE_CASCADE
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RUAN_RESPONSE_TO_TROGLITAZONE_DN
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PYRUVATE_METABOLISM
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_LAGGING_STRAND_SYNTHESIS
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_BASE_EXCISION_REPAIR
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RASHI_NFKB1_TARGETS
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_HIF1APATHWAY
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_EPHA2_FWDPATHWAY
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ARF_3PATHWAY
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIELSEN_LIPOSARCOMA_DN
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NELSON_RESPONSE_TO_ANDROGEN_DN
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAGY_TFTC_COMPONENTS_HUMAN
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MA_PITUITARY_FETAL_VS_ADULT_DN
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LI_WILMS_TUMOR_ANAPLASTIC_UP
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KANG_AR_TARGETS_DN
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRANDVAUX_IRF3_TARGETS_DN
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FARMER_BREAST_CANCER_CLUSTER_5
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP
0.0855431993157%	1	1169	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHENG_RESPONSE_TO_ARSENITE_DN
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WEBER_METHYLATED_IN_COLON_CANCER
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TOMIDA_METASTASIS_DN
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	STAMBOLSKY_BOUND_BY_MUTATED_TP53
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHEIDEREIT_IKK_TARGETS
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_BETACATENIN_DEG_PATHWAY
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NIELSEN_LIPOSARCOMA_UP
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOREIRA_RESPONSE_TO_TSA_DN
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_PHENYLALANINE_METABOLISM
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KARAKAS_TGFB1_SIGNALING
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KAPOSI_LIVER_CANCER_MET_UP
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HUMMERICH_MALIGNANT_SKIN_TUMOR_DN
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HUMMERICH_BENIGN_SKIN_TUMOR_DN
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHOI_ATL_CHRONIC_VS_ACUTE_DN
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_SPRY_PATHWAY
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_PTEN_PATHWAY
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_MCM_PATHWAY
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_ARAP_PATHWAY
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMIT_DELAYED_EARLY_GENES
0.0855431993157%	1	1169	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ALONSO_METASTASIS_NEURAL_UP
0.0855431993157%	1	1169	176	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX
0.0855431993157%	1	1169	176	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION
0.0855431993157%	1	1169	175	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WIKMAN_ASBESTOS_LUNG_CANCER_UP
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SA_PTEN_PATHWAY
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TIE2_SIGNALING
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_INTRINSIC_PATHWAY
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_SYNDECAN_3_PATHWAY
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_SMAD2_3PATHWAY
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_INTEGRIN5_PATHWAY
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ANTHRAXPATHWAY
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ONDER_CDH1_TARGETS_3_UP
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NGO_MALIGNANT_GLIOMA_1P_LOH
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MATTHEWS_AP1_TARGETS
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIU_IL13_MEMORY_MODEL_UP
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LE_SKI_TARGETS_UP
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_ONE_CARBON_POOL_BY_FOLATE
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KASLER_HDAC7_TARGETS_1_DN
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	INGA_TP53_TARGETS
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GOUYER_TATI_TARGETS_DN
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_PML_PATHWAY
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_LAIR_PATHWAY
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_IL10_PATHWAY
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CK1_PATHWAY
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_ARF_PATHWAY
0.0855431993157%	1	1169	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_41BB_PATHWAY
0.0855431993157%	1	1169	169	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	XU_RESPONSE_TO_TRETINOIN_UP
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WU_HBX_TARGETS_2_DN
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WU_HBX_TARGETS_1_UP
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RODRIGUES_THYROID_CARCINOMA_UP
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PLATELET_SENSITIZATION_BY_LDL
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ACYL_CHAIN_REMODELLING_OF_PG
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_DNAPK_PATHWAY
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MOOTHA_TCA
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MACLACHLAN_BRCA1_TARGETS_DN
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_LIVER_CANCER_HEPATOBLAST
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_RIBOFLAVIN_METABOLISM
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_OTHER_GLYCAN_DEGRADATION
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IGLESIAS_E2F_TARGETS_DN
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HAHTOLA_MYCOSIS_FUNGOIDES_DN
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GEISS_RESPONSE_TO_DSRNA_DN
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FARMER_BREAST_CANCER_CLUSTER_4
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DASU_IL6_SIGNALING_SCAR_DN
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_SHH_PATHWAY
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_IL22BP_PATHWAY
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CDC42RAC_PATHWAY
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_BCELLSURVIVAL_PATHWAY
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP
0.0855431993157%	1	1169	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ABDELMOHSEN_ELAVL4_TARGETS
0.0855431993157%	1	1169	159	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
0.0855431993157%	1	1169	157	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.0855431993157%	1	1169	153	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PEPTIDE_CHAIN_ELONGATION
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SA_MMP_CYTOKINE_CONNECTION
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SANDERSON_PPARA_TARGETS
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SHC_MEDIATED_SIGNALLING
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ENDOGENOUS_STEROLS
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_AMINE_DERIVED_HORMONES
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ACYL_CHAIN_REMODELLING_OF_PS
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ACYL_CHAIN_REMODELLING_OF_PI
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_THROMBIN_PAR4_PATHWAY
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ERB_GENOMIC_PATHWAY
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ERBB_NETWORK_PATHWAY
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PID_ARF6DOWNSTREAMPATHWAY
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	NAGY_STAGA_COMPONENTS_HUMAN
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARKS_HDAC_TARGETS_DN
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARKS_ACETYLATED_NON_HISTONE_PROTEINS
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHANG_POU5F1_TARGETS_UP
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_TALL1_PATHWAY
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_LONGEVITY_PATHWAY
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_IL3_PATHWAY
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_HSP27_PATHWAY
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_HIF_PATHWAY
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CD40_PATHWAY
0.0855431993157%	1	1169	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_BARRESTIN_SRC_PATHWAY
0.0855431993157%	1	1169	147	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BENPORATH_PROLIFERATION
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHANG_ADIPOGENESIS_BY_BMP7
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VERRECCHIA_RESPONSE_TO_TGFB1_C3
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TOMLINS_METASTASIS_UP
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ROETH_TERT_TARGETS_UP
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SOS_MEDIATED_SIGNALLING
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNAL_ATTENUATION
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_IFNG_SIGNALING
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_P75NTR_SIGNALS_VIA_NFKB
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_COMMON_PATHWAY
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ACTIVATION_OF_RAC
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_ES_LCP_WITH_H3K27ME3
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MATZUK_POST-IMPLANTATION_AND_POST-PARTUM
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MATZUK_OVULATION
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LIM_MAMMARY_LUMINAL_PROGENITOR_DN
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KINNEY_DNMT1_METHYLATION_TARGETS
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_NON_HOMOLOGOUS_END_JOINING
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	INAMURA_LUNG_CANCER_SCC_UP
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	INAMURA_LUNG_CANCER_SCC_DN
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOEGERKORP_CD44_TARGETS_DIRECT_DN
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CAIRO_PML_TARGETS_BOUND_BY_MYC_DN
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_RANKL_PATHWAY
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_GRANULOCYTES_PATHWAY
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CLASSIC_PATHWAY
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	AMIT_EGF_RESPONSE_20_MCF10A
0.0855431993157%	1	1169	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN
0.0855431993157%	1	1169	135	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TSENG_IRS1_TARGETS_DN
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VERRECCHIA_RESPONSE_TO_TGFB1_C4
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TERAMOTO_OPN_TARGETS_CLUSTER_4
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHI_SPARC_TARGETS_DN
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_PURINE_SALVAGE
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RAY_ALZHEIMERS_DISEASE
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	POS_RESPONSE_TO_HISTAMINE_UP
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KORKOLA_EMBRYONAL_CARCINOMA
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	JIANG_CORE_DUPLICON_GENES
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IVANOV_MUTATED_IN_COLON_CANCER
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IRITANI_MAD1_TARGETS_UP
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HO_LIVER_CANCER_VASCULAR_INVASION
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HASINA_NOL7_TARGETS_DN
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GERHOLD_RESPONSE_TO_TZD_DN
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ELLWOOD_MYC_TARGETS_UP
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_SALMONELLA_PATHWAY
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_PARKIN_PATHWAY
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_EXTRINSIC_PATHWAY
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_AHSP_PATHWAY
0.0855431993157%	1	1169	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_AGPCR_PATHWAY
0.0855431993157%	1	1169	121	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	VANTVEER_BREAST_CANCER_METASTASIS_DN
0.0855431993157%	1	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53
0.0855431993157%	1	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN
0.0855431993157%	1	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WAESCH_ANAPHASE_PROMOTING_COMPLEX
0.0855431993157%	1	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ERKS_ARE_INACTIVATED
0.0855431993157%	1	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
0.0855431993157%	1	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	PETRETTO_BLOOD_PRESSURE_UP
0.0855431993157%	1	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KRISHNAN_FURIN_TARGETS_UP
0.0855431993157%	1	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN
0.0855431993157%	1	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	EHLERS_ANEUPLOIDY_DN
0.0855431993157%	1	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DING_LUNG_CANCER_MUTATED_FREQUENTLY
0.0855431993157%	1	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DAZARD_UV_RESPONSE_CLUSTER_G5
0.0855431993157%	1	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL
0.0855431993157%	1	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_VDR_PATHWAY
0.0855431993157%	1	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_LECTIN_PATHWAY
0.0855431993157%	1	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_BARR_MAPK_PATHWAY
0.0855431993157%	1	1169	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_AKAP13_PATHWAY
0.0855431993157%	1	1169	118	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CERVERA_SDHB_TARGETS_1_UP
0.0855431993157%	1	1169	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.0855431993157%	1	1169	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	IKEDA_MIR30_TARGETS_UP
0.0855431993157%	1	1169	114	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	KEGG_OOCYTE_MEIOSIS
0.0855431993157%	1	1169	111	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	ZHOU_PANCREATIC_EXOCRINE_PROGENITOR
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WHITESIDE_CISPLATIN_RESISTANCE_UP
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_UNWINDING_OF_DNA
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SYNTHESIS_OF_PE
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_IL_6_SIGNALING
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_DSCAM_INTERACTIONS
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_CD28_DEPENDENT_VAV1_PATHWAY
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	POS_RESPONSE_TO_HISTAMINE_DN
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MUNSHI_MULTIPLE_MYELOMA_DN
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MATHEW_FANCONI_ANEMIA_GENES
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARSON_FOXP3_TARGETS_STIMULATED_DN
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FRASOR_TAMOXIFEN_RESPONSE_DN
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	FOURNIER_ACINAR_DEVELOPMENT_LATE_UP
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	CHUANG_OXIDATIVE_STRESS_RESPONSE_DN
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_SRCRPTP_PATHWAY
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_P35ALZHEIMERS_PATHWAY
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_IL4_PATHWAY
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_EIF2_PATHWAY
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_CDK5_PATHWAY
0.0855431993157%	1	1169	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BAUS_TFF2_TARGETS_DN
0.0855431993157%	1	1169	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WESTON_VEGFA_TARGETS
0.0855431993157%	1	1169	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TAVAZOIE_METASTASIS
0.0855431993157%	1	1169	107	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	LEE_EARLY_T_LYMPHOCYTE_UP
0.0855431993157%	1	1169	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SIGNALING_BY_NOTCH
0.0855431993157%	1	1169	103	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN
0.0855431993157%	1	1169	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	WINZEN_DEGRADED_VIA_KHSRP
0.0855431993157%	1	1169	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	RICKMAN_HEAD_AND_NECK_CANCER_A
0.0855431993157%	1	1169	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	QI_PLASMACYTOMA_DN
0.0855431993157%	1	1169	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	TSUDA_ALVEOLAR_SOFT_PART_SARCOMA
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	SHIRAISHI_PLZF_TARGETS_UP
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_RAF_MAP_KINASE_CASCADE
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OSAWA_TNF_TARGETS
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	OHASHI_AURKB_TARGETS
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MIKKELSEN_IPS_LCP_WITH_H3K27ME3
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	HOLLEMAN_DAUNORUBICIN_B_ALL_UP
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BUDHU_LIVER_CANCER_METASTASIS_UP
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_SODD_PATHWAY
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_RNA_PATHWAY
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_RANMS_PATHWAY
0.0855431993157%	1	1169	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM	BIOCARTA_BARRESTIN_PATHWAY
0.0852272727273%	3	3520	97	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
0.0852272727273%	3	3520	94	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.0852272727273%	3	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY
0.0852272727273%	3	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN
0.0852272727273%	3	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHESLER_BRAIN_D6MIT150_QTL_TRANS
0.0852272727273%	3	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_FEEDER_PATHWAY
0.0852272727273%	3	3520	89	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KANG_IMMORTALIZED_BY_TERT_UP
0.0852272727273%	3	3520	88	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SEIDEN_ONCOGENESIS_BY_MET
0.0852272727273%	3	3520	84	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP
0.0852272727273%	3	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STANHILL_HRAS_TRANSFROMATION_UP
0.0852272727273%	3	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN
0.0852272727273%	3	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_HIF1A_ONLY
0.0852272727273%	3	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3
0.0852272727273%	3	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
0.0852272727273%	3	3520	79	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.0852272727273%	3	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEBOTAEV_GR_TARGETS_UP
0.0852272727273%	3	3520	77	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CARD_MIR302A_TARGETS
0.0852272727273%	3	3520	76	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2
0.0852272727273%	3	3520	71	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PI3K_CASCADE
0.0852272727273%	3	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_NPC_WITH_LCP_H3K27ME3
0.0852272727273%	3	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARSHALL_VIRAL_INFECTION_RESPONSE_UP
0.0852272727273%	3	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHESLER_BRAIN_D6MIT150_QTL_CIS
0.0852272727273%	3	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.0852272727273%	3	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GLUCOSE_METABOLISM
0.0852272727273%	3	3520	69	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN
0.0852272727273%	3	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NOUZOVA_METHYLATED_IN_APL
0.0852272727273%	3	3520	68	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN
0.0852272727273%	3	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAMASWAMY_METASTASIS_UP
0.0852272727273%	3	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_INTEGRIN1_PATHWAY
0.0852272727273%	3	3520	66	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.0852272727273%	3	3520	64	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	INGRAM_SHH_TARGETS_DN
0.0852272727273%	3	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
0.0852272727273%	3	3520	63	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CROMER_TUMORIGENESIS_UP
0.0852272727273%	3	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_BY_UV
0.0852272727273%	3	3520	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_AR_PATHWAY
0.0852272727273%	3	3520	61	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAUFFMANN_MELANOMA_RELAPSE_UP
0.0852272727273%	3	3520	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER_CIPROFIBRATE_UP
0.0852272727273%	3	3520	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CROONQUIST_STROMAL_STIMULATION_UP
0.0852272727273%	3	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS
0.0852272727273%	3	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WESTON_VEGFA_TARGETS_6HR
0.0852272727273%	3	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS
0.0852272727273%	3	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SANSOM_WNT_PATHWAY_REQUIRE_MYC
0.0852272727273%	3	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT
0.0852272727273%	3	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIM_MAMMARY_LUMINAL_PROGENITOR_UP
0.0852272727273%	3	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAMASHITA_METHYLATED_IN_PROSTATE_CANCER
0.0852272727273%	3	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
0.0852272727273%	3	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
0.0852272727273%	3	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM
0.0852272727273%	3	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARSON_FOXP3_TARGETS_DN
0.0852272727273%	3	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIANG_SILENCED_BY_METHYLATION_2
0.0852272727273%	3	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROSS_AML_WITH_CBFB_MYH11_FUSION
0.0852272727273%	3	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN
0.0852272727273%	3	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6
0.0852272727273%	3	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BECKER_TAMOXIFEN_RESISTANCE_DN
0.0852272727273%	3	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
0.0852272727273%	3	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.0852272727273%	3	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_7
0.0852272727273%	3	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YANG_BREAST_CANCER_ESR1_LASER_DN
0.0852272727273%	3	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.0852272727273%	3	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_HP_UP
0.0852272727273%	3	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FAELT_B_CLL_WITH_VH3_21_DN
0.0852272727273%	3	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_MS_UP
0.0852272727273%	3	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RASHI_RESPONSE_TO_IONIZING_RADIATION_3
0.0852272727273%	3	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCCLUNG_DELTA_FOSB_TARGETS_2WK
0.0852272727273%	3	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DOANE_BREAST_CANCER_ESR1_DN
0.0852272727273%	3	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ABE_INNER_EAR
0.0852272727273%	3	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_HP_DN
0.0852272727273%	3	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WARTERS_IR_RESPONSE_5GY
0.0852272727273%	3	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SILIGAN_BOUND_BY_EWS_FLT1_FUSION
0.0852272727273%	3	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JIANG_AGING_HYPOTHALAMUS_UP
0.0852272727273%	3	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HEIDENBLAD_AMPLICON_8Q24_DN
0.0852272727273%	3	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN
0.0852272727273%	3	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN
0.0852272727273%	3	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP
0.0852272727273%	3	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN
0.0852272727273%	3	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_PR_DN
0.0852272727273%	3	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.0852272727273%	3	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OHGUCHI_LIVER_HNF4A_TARGETS_UP
0.0852272727273%	3	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_NUCLEOTIDE_EXCISION_REPAIR
0.0852272727273%	3	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM
0.0852272727273%	3	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHOI_ATL_STAGE_PREDICTOR
0.0852272727273%	3	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZUCCHI_METASTASIS_UP
0.0852272727273%	3	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION_12HR
0.0852272727273%	3	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1
0.0852272727273%	3	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MILI_PSEUDOPODIA
0.0852272727273%	3	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_MF_DN
0.0852272727273%	3	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NETRIN1_SIGNALING
0.0852272727273%	3	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ONO_AML1_TARGETS_DN
0.0852272727273%	3	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D2
0.0852272727273%	3	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP
0.0852272727273%	3	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_WITH_FLT3_ITD
0.0852272727273%	3	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION_6HR
0.0852272727273%	3	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.0852272727273%	3	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIAO_HAVE_SOX4_BINDING_SITES
0.0852272727273%	3	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HEIDENBLAD_AMPLICON_8Q24_UP
0.0852272727273%	3	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D7
0.0852272727273%	3	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
0.0852272727273%	3	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WHITEHURST_PACLITAXEL_SENSITIVITY
0.0852272727273%	3	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP
0.0852272727273%	3	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
0.0852272727273%	3	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATZUK_MEIOTIC_AND_DNA_REPAIR
0.0852272727273%	3	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP
0.0852272727273%	3	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BILANGES_SERUM_SENSITIVE_VIA_TSC2
0.0852272727273%	3	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_60_MCF10A
0.0852272727273%	3	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VARELA_ZMPSTE24_TARGETS_DN
0.0852272727273%	3	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SPIRA_SMOKERS_LUNG_CANCER_UP
0.0852272727273%	3	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PI3K_AKT_ACTIVATION
0.0852272727273%	3	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_G1_PHASE
0.0852272727273%	3	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ERBB4_PATHWAY
0.0852272727273%	3	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAMURA_ADIPOGENESIS_LATE_DN
0.0852272727273%	3	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAMURA_ADIPOGENESIS_EARLY_DN
0.0852272727273%	3	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP
0.0852272727273%	3	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN
0.0852272727273%	3	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
0.0852272727273%	3	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN
0.0852272727273%	3	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RICKMAN_HEAD_AND_NECK_CANCER_D
0.0852272727273%	3	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LANDIS_ERBB2_BREAST_TUMORS_65_DN
0.0852272727273%	3	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_ALL_DISORDERS_CALB1_CORR_DN
0.0852272727273%	3	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YIH_RESPONSE_TO_ARSENITE_C3
0.0852272727273%	3	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YANG_BREAST_CANCER_ESR1_UP
0.0852272727273%	3	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2
0.0852272727273%	3	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN
0.0852272727273%	3	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SUBTIL_PROGESTIN_TARGETS
0.0852272727273%	3	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MMS_MOUSE_LYMPH_HIGH_4HRS_UP
0.0852272727273%	3	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_12
0.0852272727273%	3	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ALONSO_METASTASIS_EMT_UP
0.0852272727273%	3	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_CLUSTER_9
0.0852272727273%	3	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROZANOV_MMP14_TARGETS_DN
0.0852272727273%	3	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GLOBAL_GENOMIC_NER_GG_NER
0.0852272727273%	3	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_HIVNEFPATHWAY
0.0852272727273%	3	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.0852272727273%	3	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_REGULATION_OF_AUTOPHAGY
0.0852272727273%	3	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PRION_DISEASES
0.0852272727273%	3	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_BASE_EXCISION_REPAIR
0.0852272727273%	3	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WONG_IFNA2_RESISTANCE_DN
0.0852272727273%	3	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHOEN_NFKB_SIGNALING
0.0852272727273%	3	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION
0.0852272727273%	3	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_IL8CXCR2_PATHWAY
0.0852272727273%	3	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HONMA_DOCETAXEL_RESISTANCE
0.0852272727273%	3	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_LATE_DIFFERENTIATION_GENES_UP
0.0852272727273%	3	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WENDT_COHESIN_TARGETS_UP
0.0852272727273%	3	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_CLUSTER_6
0.0852272727273%	3	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROZANOV_MMP14_TARGETS_SUBSET
0.0852272727273%	3	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION
0.0852272727273%	3	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS
0.0852272727273%	3	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ALPHASYNUCLEIN_PATHWAY
0.0852272727273%	3	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.0852272727273%	3	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS
0.0852272727273%	3	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN
0.0852272727273%	3	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.0852272727273%	3	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN
0.0852272727273%	3	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_COMPLEMENT_CASCADE
0.0852272727273%	3	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CD28_CO_STIMULATION
0.0852272727273%	3	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_CITRATE_CYCLE_TCA_CYCLE
0.0852272727273%	3	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FARDIN_HYPOXIA_11
0.0852272727273%	3	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DORSAM_HOXA9_TARGETS_DN
0.0852272727273%	3	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN
0.0852272727273%	3	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TING_SILENCED_BY_DICER
0.0852272727273%	3	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	THEODOROU_MAMMARY_TUMORIGENESIS
0.0852272727273%	3	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP
0.0852272727273%	3	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION_HEMGN
0.0852272727273%	3	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING
0.0852272727273%	3	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE
0.0852272727273%	3	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX
0.0852272727273%	3	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_P38ALPHABETAPATHWAY
0.0852272727273%	3	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM
0.0852272727273%	3	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CUI_TCF21_TARGETS_DN
0.0852272727273%	3	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
0.0852272727273%	3	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.0852272727273%	3	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.0852272727273%	3	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YANAGIHARA_ESX1_TARGETS
0.0852272727273%	3	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SU_PLACENTA
0.0852272727273%	3	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.0852272727273%	3	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN
0.0852272727273%	3	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN
0.0852272727273%	3	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_IGF1_PATHWAY
0.0852272727273%	3	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.0852272727273%	3	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LY_AGING_PREMATURE_DN
0.0852272727273%	3	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GUILLAUMOND_KLF10_TARGETS_DN
0.0852272727273%	3	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YU_BAP1_TARGETS
0.0852272727273%	3	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.0852272727273%	3	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION
0.0852272727273%	3	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PAL_PRMT5_TARGETS_DN
0.0852272727273%	3	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
0.0852272727273%	3	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_MCV6_LCP_WITH_H3K27ME3
0.0852272727273%	3	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
0.0852272727273%	3	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARSON_FOXP3_TARGETS_STIMULATED_UP
0.0852272727273%	3	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_THYROID_CANCER
0.0852272727273%	3	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_RNA_POLYMERASE
0.0852272727273%	3	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_LINOLEIC_ACID_METABOLISM
0.0852272727273%	3	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_TNFR1_PATHWAY
0.0852272727273%	3	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AIYAR_COBRA1_TARGETS_DN
0.0852272727273%	3	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_CLUSTER_1
0.0852272727273%	3	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS
0.0852272727273%	3	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A
0.0852272727273%	3	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_IL8CXCR1_PATHWAY
0.0852272727273%	3	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PETROVA_PROX1_TARGETS_UP
0.0852272727273%	3	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOREIRA_RESPONSE_TO_TSA_UP
0.0852272727273%	3	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP
0.0852272727273%	3	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN
0.0852272727273%	3	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_ERK_PATHWAY
0.0852272727273%	3	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP
0.0852272727273%	3	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RECYCLING_PATHWAY_OF_L1
0.0852272727273%	3	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING
0.0852272727273%	3	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_G_PROTEIN_ACTIVATION
0.0852272727273%	3	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_EXTENSION_OF_TELOMERES
0.0852272727273%	3	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_IL3_PATHWAY
0.0852272727273%	3	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_GLYPICAN_1PATHWAY
0.0852272727273%	3	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NICK_RESPONSE_TO_PROC_TREATMENT_DN
0.0852272727273%	3	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PENTOSE_PHOSPHATE_PATHWAY
0.0852272727273%	3	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP
0.0852272727273%	3	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIN_BREAST_CANCER_COPY_NUMBER_UP
0.0852272727273%	3	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN
0.0852272727273%	3	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_CREBBP_TARGETS_UP
0.0852272727273%	3	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG
0.0852272727273%	3	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_CLUSTER_16
0.0852272727273%	3	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B
0.0852272727273%	3	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NEWMAN_ERCC6_TARGETS_UP
0.0852272727273%	3	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_SELENOAMINO_ACID_METABOLISM
0.0852272727273%	3	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
0.0852272727273%	3	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAZIN_EPIGENETIC_SILENCING_BY_KRAS
0.0852272727273%	3	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN
0.0852272727273%	3	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FINAK_BREAST_CANCER_SDPP_SIGNATURE
0.0852272727273%	3	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
0.0852272727273%	3	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VERRECCHIA_RESPONSE_TO_TGFB1_C2
0.0852272727273%	3	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANDESLUIS_NORMAL_EMBRYOS_DN
0.0852272727273%	3	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RUAN_RESPONSE_TO_TROGLITAZONE_UP
0.0852272727273%	3	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE
0.0852272727273%	3	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_FANCONI_ANEMIA_PATHWAY
0.0852272727273%	3	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS
0.0852272727273%	3	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_TOLL_ENDOGENOUS_PATHWAY
0.0852272727273%	3	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_INTEGRIN_A9B1_PATHWAY
0.0852272727273%	3	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_HDAC_CLASSIII_PATHWAY
0.0852272727273%	3	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP
0.0852272727273%	3	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LU_TUMOR_ANGIOGENESIS_UP
0.0852272727273%	3	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS
0.0852272727273%	3	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HORTON_SREBF_TARGETS
0.0852272727273%	3	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN
0.0852272727273%	3	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN
0.0852272727273%	3	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHI_SPARC_TARGETS_UP
0.0852272727273%	3	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION
0.0852272727273%	3	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION
0.0852272727273%	3	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS
0.0852272727273%	3	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING
0.0852272727273%	3	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CHOLESTEROL_BIOSYNTHESIS
0.0852272727273%	3	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OSADA_ASCL1_TARGETS_DN
0.0852272727273%	3	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
0.0852272727273%	3	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LA_MEN1_TARGETS
0.0852272727273%	3	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JEON_SMAD6_TARGETS_UP
0.0852272727273%	3	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HASLINGER_B_CLL_WITH_13Q14_DELETION
0.0852272727273%	3	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN
0.0852272727273%	3	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_TPO_PATHWAY
0.0852272727273%	3	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_NTHI_PATHWAY
0.0852272727273%	3	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AZARE_STAT3_TARGETS
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YANG_BREAST_CANCER_ESR1_BULK_DN
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WU_HBX_TARGETS_1_DN
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WENG_POR_TARGETS_GLOBAL_DN
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SAGIV_CD24_TARGETS_UP
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PHOSPHORYLATION_OF_THE_APC_C
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MICRORNA_MIRNA_BIOGENESIS
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_LYSOSOME_VESICLE_BIOGENESIS
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	EGUCHI_CELL_CYCLE_RB1_TARGETS
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_P53HYPOXIA_PATHWAY
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_IL12_PATHWAY
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_GLEEVEC_PATHWAY
0.0852272727273%	3	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BARIS_THYROID_CANCER_UP
0.0852272727273%	3	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.0852272727273%	3	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN
0.0852272727273%	3	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION
0.0852272727273%	3	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING
0.0852272727273%	3	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE
0.0852272727273%	3	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOOTHA_FFA_OXYDATION
0.0852272727273%	3	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LU_TUMOR_ENDOTHELIAL_MARKERS_UP
0.0852272727273%	3	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.0852272727273%	3	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN
0.0852272727273%	3	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN
0.0852272727273%	3	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_HER2_PATHWAY
0.0852272727273%	3	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CHEMICAL_PATHWAY
0.0852272727273%	3	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_AKT_PATHWAY
0.0852272727273%	3	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP
0.0852272727273%	3	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VERRECCHIA_RESPONSE_TO_TGFB1_C5
0.0852272727273%	3	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP
0.0852272727273%	3	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHURINGA_STAT5A_TARGETS_UP
0.0852272727273%	3	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN
0.0852272727273%	3	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS
0.0852272727273%	3	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_S1P_META_PATHWAY
0.0852272727273%	3	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_P38_MK2PATHWAY
0.0852272727273%	3	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARCHINI_TRABECTEDIN_RESISTANCE_UP
0.0852272727273%	3	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_GLYCOSAMINOGLYCAN_DEGRADATION
0.0852272727273%	3	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN
0.0852272727273%	3	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP
0.0852272727273%	3	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_TFF_PATHWAY
0.0852272727273%	3	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN
0.0852272727273%	3	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP
0.0852272727273%	3	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_WNT_CA2_CYCLIC_GMP_PATHWAY
0.0852272727273%	3	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS
0.0852272727273%	3	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_WNT_CANONICAL_PATHWAY
0.0852272727273%	3	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIELSEN_LEIOMYOSARCOMA_CNN1_DN
0.0852272727273%	3	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP
0.0852272727273%	3	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MEISSNER_NPC_ICP_WITH_H3K4ME3
0.0852272727273%	3	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCCABE_HOXC6_TARGETS_CANCER_DN
0.0852272727273%	3	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MANN_RESPONSE_TO_AMIFOSTINE_UP
0.0852272727273%	3	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DING_LUNG_CANCER_BY_MUTATION_RATE
0.0852272727273%	3	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_IGF1MTOR_PATHWAY
0.0852272727273%	3	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CCR5_PATHWAY
0.0852272727273%	3	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_ACTINY_PATHWAY
0.0852272727273%	3	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_240_MCF10A
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TERAMOTO_OPN_TARGETS_CLUSTER_7
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHIN_B_CELL_LYMPHOMA_CLUSTER_9
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RUAN_RESPONSE_TO_TROGLITAZONE_DN
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PYRUVATE_METABOLISM
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OUYANG_PROSTATE_CANCER_MARKERS
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIELSEN_LEIOMYOSARCOMA_CNN1_UP
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NELSON_RESPONSE_TO_ANDROGEN_DN
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MA_PITUITARY_FETAL_VS_ADULT_DN
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_NAIVE_T_LYMPHOCYTE
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LAMB_CCND1_TARGETS
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_TH1TH2_PATHWAY
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_EPO_PATHWAY
0.0852272727273%	3	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN
0.0852272727273%	3	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHEIDEREIT_IKK_TARGETS
0.0852272727273%	3	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN
0.0852272727273%	3	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB
0.0852272727273%	3	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_BETACATENIN_DEG_PATHWAY
0.0852272727273%	3	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIELSEN_LIPOSARCOMA_UP
0.0852272727273%	3	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOREIRA_RESPONSE_TO_TSA_DN
0.0852272727273%	3	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MAINA_VHL_TARGETS_DN
0.0852272727273%	3	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.0852272727273%	3	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUMMERICH_BENIGN_SKIN_TUMOR_DN
0.0852272727273%	3	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES
0.0852272727273%	3	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB
0.0852272727273%	3	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_UCALPAIN_PATHWAY
0.0852272727273%	3	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP
0.0852272727273%	3	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_DELAYED_EARLY_GENES
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WIKMAN_ASBESTOS_LUNG_CANCER_UP
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SA_TRKA_RECEPTOR
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SA_PTEN_PATHWAY
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SHC_RELATED_EVENTS
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RNA_POL_III_CHAIN_ELONGATION
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ARMS_MEDIATED_ACTIVATION
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_SMAD2_3PATHWAY
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ONDER_CDH1_TARGETS_3_UP
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MEISSNER_BRAIN_HCP_WITH_H3K4ME2
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATTHEWS_AP1_TARGETS
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_ONE_CARBON_POOL_BY_FOLATE
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	INGA_TP53_TARGETS
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOWLIN_CITED1_TARGETS_2_UP
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_NO2IL12_PATHWAY
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_IL10_PATHWAY
0.0852272727273%	3	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_41BB_PATHWAY
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WU_HBX_TARGETS_2_DN
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TIAN_BHLHA15_TARGETS
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INTEGRATION_OF_PROVIRUS
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACYL_CHAIN_REMODELLING_OF_PG
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LY_AGING_MIDDLE_DN
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LUI_THYROID_CANCER_CLUSTER_4
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GEISS_RESPONSE_TO_DSRNA_DN
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAFFAREL_RESPONSE_TO_THC_8HR_5_UP
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_RELA_PATHWAY
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_BCELLSURVIVAL_PATHWAY
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_ACH_PATHWAY
0.0852272727273%	3	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ABDELMOHSEN_ELAVL4_TARGETS
0.0852272727273%	3	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN
0.0852272727273%	3	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SU_KIDNEY
0.0852272727273%	3	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP
0.0852272727273%	3	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SA_G1_AND_S_PHASES
0.0852272727273%	3	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN
0.0852272727273%	3	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE
0.0852272727273%	3	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACYL_CHAIN_REMODELLING_OF_PS
0.0852272727273%	3	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_THROMBIN_PAR4_PATHWAY
0.0852272727273%	3	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARKS_HDAC_TARGETS_DN
0.0852272727273%	3	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LI_CYTIDINE_ANALOGS_CYCTOTOXICITY
0.0852272727273%	3	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_IL13_PRIMING_MODEL
0.0852272727273%	3	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN
0.0852272727273%	3	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TOMLINS_METASTASIS_UP
0.0852272727273%	3	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR
0.0852272727273%	3	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_COMPLEMENT_CASCADE
0.0852272727273%	3	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION
0.0852272727273%	3	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_TCRRASPATHWAY
0.0852272727273%	3	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_IL5_PATHWAY
0.0852272727273%	3	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PARK_APL_PATHOGENESIS_UP
0.0852272727273%	3	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATZUK_POST-IMPLANTATION_AND_POST-PARTUM
0.0852272727273%	3	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES
0.0852272727273%	3	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	INAMURA_LUNG_CANCER_SCC_DN
0.0852272727273%	3	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_THELPER_PATHWAY
0.0852272727273%	3	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_TCYTOTOXIC_PATHWAY
0.0852272727273%	3	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_PS1_PATHWAY
0.0852272727273%	3	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_DREAM_PATHWAY
0.0852272727273%	3	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CLASSIC_PATHWAY
0.0852272727273%	3	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WACKER_HYPOXIA_TARGETS_OF_VHL
0.0852272727273%	3	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHI_SPARC_TARGETS_DN
0.0852272727273%	3	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_P38MAPK_EVENTS
0.0852272727273%	3	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT
0.0852272727273%	3	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY
0.0852272727273%	3	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2
0.0852272727273%	3	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS
0.0852272727273%	3	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GERHOLD_RESPONSE_TO_TZD_DN
0.0852272727273%	3	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CARM1_PATHWAY
0.0852272727273%	3	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_ARENRF2_PATHWAY
0.0852272727273%	3	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_AGPCR_PATHWAY
0.0852272727273%	3	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WAESCH_ANAPHASE_PROMOTING_COMPLEX
0.0852272727273%	3	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SUZUKI_CTCFL_TARGETS_UP
0.0852272727273%	3	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS
0.0852272727273%	3	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_NOTCH4
0.0852272727273%	3	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ERKS_ARE_INACTIVATED
0.0852272727273%	3	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CS_DS_DEGRADATION
0.0852272727273%	3	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION
0.0852272727273%	3	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM
0.0852272727273%	3	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PETRETTO_BLOOD_PRESSURE_UP
0.0852272727273%	3	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MALIK_REPRESSED_BY_ESTROGEN
0.0852272727273%	3	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.0852272727273%	3	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP
0.0852272727273%	3	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN
0.0852272727273%	3	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOLLEMAN_DAUNORUBICIN_B_ALL_DN
0.0852272727273%	3	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_LECTIN_PATHWAY
0.0852272727273%	3	3520	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
0.0852272727273%	3	3520	116	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IKEDA_MIR30_TARGETS_UP
0.0852272727273%	3	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CALNEXIN_CALRETICULIN_CYCLE
0.0852272727273%	3	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS
0.0852272727273%	3	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KALMA_E2F1_TARGETS
0.0852272727273%	3	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IIZUKA_LIVER_CANCER_EARLY_RECURRENCE
0.0852272727273%	3	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_DN
0.0852272727273%	3	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_TCAPOPTOSIS_PATHWAY
0.0852272727273%	3	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_EGFR_SMRTE_PATHWAY
0.0852272727273%	3	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CDK5_PATHWAY
0.0852272727273%	3	3520	108	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAVAZOIE_METASTASIS
0.0852272727273%	3	3520	100	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
0.0852272727273%	3	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP
0.0852272727273%	3	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS
0.0852272727273%	3	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1
0.0852272727273%	3	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP
0.0852272727273%	3	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN
0.0852272727273%	3	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_FREE_PATHWAY
0.0788022064618%	1	1269	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_POTASSIUM_CHANNELS
0.0788022064618%	1	1269	98	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NIELSEN_GIST
0.0788022064618%	1	1269	97	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR
0.0788022064618%	1	1269	97	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
0.0788022064618%	1	1269	97	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_MYC_AMPLIFICATION_TARGETS_DN
0.0788022064618%	1	1269	94	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5
0.0788022064618%	1	1269	94	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_T4
0.0788022064618%	1	1269	93	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ACTIVATED_TLR4_SIGNALLING
0.0788022064618%	1	1269	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP
0.0788022064618%	1	1269	92	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HILLION_HMGA1B_TARGETS
0.0788022064618%	1	1269	91	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.0788022064618%	1	1269	90	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_ERBB4
0.0788022064618%	1	1269	90	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MORI_MATURE_B_LYMPHOCYTE_UP
0.0788022064618%	1	1269	90	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IGARASHI_ATF4_TARGETS_DN
0.0788022064618%	1	1269	90	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN
0.0788022064618%	1	1269	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZERBINI_RESPONSE_TO_SULINDAC_UP
0.0788022064618%	1	1269	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YANAGISAWA_LUNG_CANCER_RECURRENCE
0.0788022064618%	1	1269	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	THILLAINADESAN_ZNF217_TARGETS_DN
0.0788022064618%	1	1269	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_TYPE_I_INTERFERON_PATHWAY
0.0788022064618%	1	1269	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SASSON_FSH_RESPONSE
0.0788022064618%	1	1269	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY
0.0788022064618%	1	1269	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RAFFEL_VEGFA_TARGETS_UP
0.0788022064618%	1	1269	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN
0.0788022064618%	1	1269	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ITO_PTTG1_TARGETS_DN
0.0788022064618%	1	1269	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN
0.0788022064618%	1	1269	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HAEGERSTRAND_RESPONSE_TO_IMATINIB
0.0788022064618%	1	1269	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.0788022064618%	1	1269	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GOUYER_TUMOR_INVASIVENESS
0.0788022064618%	1	1269	9	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_2_DN
0.0788022064618%	1	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WNT_SIGNALING
0.0788022064618%	1	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_
0.0788022064618%	1	1269	89	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_AGING_NEOCORTEX_UP
0.0788022064618%	1	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	UEDA_CENTRAL_CLOCK
0.0788022064618%	1	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SASSON_RESPONSE_TO_FORSKOLIN_DN
0.0788022064618%	1	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS
0.0788022064618%	1	1269	88	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
0.0788022064618%	1	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN
0.0788022064618%	1	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.0788022064618%	1	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION
0.0788022064618%	1	1269	87	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
0.0788022064618%	1	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MANTOVANI_VIRAL_GPCR_SIGNALING_UP
0.0788022064618%	1	1269	86	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_8
0.0788022064618%	1	1269	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	XU_GH1_EXOGENOUS_TARGETS_UP
0.0788022064618%	1	1269	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STEIN_ESR1_TARGETS
0.0788022064618%	1	1269	85	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE
0.0788022064618%	1	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
0.0788022064618%	1	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S
0.0788022064618%	1	1269	84	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP
0.0788022064618%	1	1269	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE
0.0788022064618%	1	1269	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.0788022064618%	1	1269	83	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JIANG_HYPOXIA_CANCER
0.0788022064618%	1	1269	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
0.0788022064618%	1	1269	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_SMAD2_3NUCLEARPATHWAY
0.0788022064618%	1	1269	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ODONNELL_METASTASIS_UP
0.0788022064618%	1	1269	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BILD_CTNNB1_ONCOGENIC_SIGNATURE
0.0788022064618%	1	1269	82	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BHAT_ESR1_TARGETS_VIA_AKT1_DN
0.0788022064618%	1	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HARRIS_HYPOXIA
0.0788022064618%	1	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRABARCZYK_BCL11B_TARGETS_UP
0.0788022064618%	1	1269	81	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CROMER_METASTASIS_DN
0.0788022064618%	1	1269	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WOO_LIVER_CANCER_RECURRENCE_DN
0.0788022064618%	1	1269	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_AGING_NEOCORTEX_DN
0.0788022064618%	1	1269	80	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN
0.0788022064618%	1	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR
0.0788022064618%	1	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP
0.0788022064618%	1	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WEBER_METHYLATED_ICP_IN_SPERM_UP
0.0788022064618%	1	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN
0.0788022064618%	1	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN
0.0788022064618%	1	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN
0.0788022064618%	1	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OXFORD_RALB_TARGETS_UP
0.0788022064618%	1	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9
0.0788022064618%	1	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOLLEMAN_DAUNORUBICIN_ALL_DN
0.0788022064618%	1	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GROSS_HIF1A_TARGETS_UP
0.0788022064618%	1	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GALIE_TUMOR_ANGIOGENESIS
0.0788022064618%	1	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FUJIWARA_PARK2_IN_LIVER_CANCER_UP
0.0788022064618%	1	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN
0.0788022064618%	1	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DER_IFN_BETA_RESPONSE_DN
0.0788022064618%	1	1269	8	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_KREB_PATHWAY
0.0788022064618%	1	1269	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
0.0788022064618%	1	1269	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCCLUNG_COCAINE_REWARD_5D
0.0788022064618%	1	1269	79	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.0788022064618%	1	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PLATELET_HOMEOSTASIS
0.0788022064618%	1	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LINDVALL_IMMORTALIZED_BY_TERT_UP
0.0788022064618%	1	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP
0.0788022064618%	1	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	COATES_MACROPHAGE_M1_VS_M2_DN
0.0788022064618%	1	1269	78	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.0788022064618%	1	1269	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE
0.0788022064618%	1	1269	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
0.0788022064618%	1	1269	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.0788022064618%	1	1269	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_HIF1A_UP
0.0788022064618%	1	1269	77	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHEBOTAEV_GR_TARGETS_UP
0.0788022064618%	1	1269	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SU_TESTIS
0.0788022064618%	1	1269	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.0788022064618%	1	1269	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
0.0788022064618%	1	1269	76	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MAHAJAN_RESPONSE_TO_IL1A_DN
0.0788022064618%	1	1269	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JAIN_NFKB_SIGNALING
0.0788022064618%	1	1269	75	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHESLER_BRAIN_QTL_CIS
0.0788022064618%	1	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WESTON_VEGFA_TARGETS_3HR
0.0788022064618%	1	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX
0.0788022064618%	1	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	POTTI_ADRIAMYCIN_SENSITIVITY
0.0788022064618%	1	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIAN_LIPA_TARGETS_6M
0.0788022064618%	1	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEIN_OLIGODENDROCYTE_MARKERS
0.0788022064618%	1	1269	74	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FURUKAWA_DUSP6_TARGETS_PCI35_UP
0.0788022064618%	1	1269	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.0788022064618%	1	1269	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
0.0788022064618%	1	1269	73	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOSHIDA_LIVER_CANCER_SURVIVAL_UP
0.0788022064618%	1	1269	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C8
0.0788022064618%	1	1269	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION
0.0788022064618%	1	1269	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1
0.0788022064618%	1	1269	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_LEISHMANIA_INFECTION
0.0788022064618%	1	1269	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HUANG_GATA2_TARGETS_DN
0.0788022064618%	1	1269	72	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_2
0.0788022064618%	1	1269	71	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PI3K_CASCADE
0.0788022064618%	1	1269	71	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.0788022064618%	1	1269	71	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DER_IFN_GAMMA_RESPONSE_UP
0.0788022064618%	1	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VERNELL_RETINOBLASTOMA_PATHWAY_UP
0.0788022064618%	1	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS
0.0788022064618%	1	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_MEF_LCP_WITH_H3K27ME3
0.0788022064618%	1	1269	70	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LANDIS_BREAST_CANCER_PROGRESSION_DN
0.0788022064618%	1	1269	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZEILSTRA_CD44_TARGETS_UP
0.0788022064618%	1	1269	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAMASHITA_SILENCED_BY_METHYLATION
0.0788022064618%	1	1269	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN
0.0788022064618%	1	1269	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TESAR_JAK_TARGETS_MOUSE_ES_D3_UP
0.0788022064618%	1	1269	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_PAC1_RECEPTOR_PATHWAY
0.0788022064618%	1	1269	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN
0.0788022064618%	1	1269	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PETRETTO_BLOOD_PRESSURE_DN
0.0788022064618%	1	1269	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOOTHA_ROS
0.0788022064618%	1	1269	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP
0.0788022064618%	1	1269	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN
0.0788022064618%	1	1269	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIU_CMYB_TARGETS_DN
0.0788022064618%	1	1269	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOLLEMAN_DAUNORUBICIN_ALL_UP
0.0788022064618%	1	1269	7	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BUSA_SAM68_TARGETS_UP
0.0788022064618%	1	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_P75NTRPATHWAY
0.0788022064618%	1	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES
0.0788022064618%	1	1269	69	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE
0.0788022064618%	1	1269	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NOUZOVA_METHYLATED_IN_APL
0.0788022064618%	1	1269	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DELPUECH_FOXO3_TARGETS_UP
0.0788022064618%	1	1269	68	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CASTELLANO_NRAS_TARGETS_UP
0.0788022064618%	1	1269	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN
0.0788022064618%	1	1269	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
0.0788022064618%	1	1269	67	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70
0.0788022064618%	1	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RAMASWAMY_METASTASIS_UP
0.0788022064618%	1	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAKAMURA_ADIPOGENESIS_EARLY_UP
0.0788022064618%	1	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_GERMINAL_CENTER_T_HELPER_UP
0.0788022064618%	1	1269	66	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN
0.0788022064618%	1	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_WNT
0.0788022064618%	1	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
0.0788022064618%	1	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_ERA_GENOMIC_PATHWAY
0.0788022064618%	1	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GUO_HEX_TARGETS_DN
0.0788022064618%	1	1269	65	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMIT_SERUM_RESPONSE_120_MCF10A
0.0788022064618%	1	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RIZKI_TUMOR_INVASIVENESS_2D_DN
0.0788022064618%	1	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RHODES_CANCER_META_SIGNATURE
0.0788022064618%	1	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C
0.0788022064618%	1	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS
0.0788022064618%	1	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
0.0788022064618%	1	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIU_SMARCA4_TARGETS
0.0788022064618%	1	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_RETINOL_METABOLISM
0.0788022064618%	1	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.0788022064618%	1	1269	64	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE
0.0788022064618%	1	1269	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_IL12_2PATHWAY
0.0788022064618%	1	1269	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MODY_HIPPOCAMPUS_POSTNATAL
0.0788022064618%	1	1269	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED
0.0788022064618%	1	1269	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_LIVER_CANCER_MYC_DN
0.0788022064618%	1	1269	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
0.0788022064618%	1	1269	63	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_PEAK_AT_0HR
0.0788022064618%	1	1269	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN
0.0788022064618%	1	1269	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_LIVER_CANCER_E2F1_UP
0.0788022064618%	1	1269	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.0788022064618%	1	1269	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ISSAEVA_MLL2_TARGETS
0.0788022064618%	1	1269	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CORRE_MULTIPLE_MYELOMA_DN
0.0788022064618%	1	1269	62	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BILD_SRC_ONCOGENIC_SIGNATURE
0.0788022064618%	1	1269	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZWANG_EGF_PERSISTENTLY_DN
0.0788022064618%	1	1269	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.0788022064618%	1	1269	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ER_PHAGOSOME_PATHWAY
0.0788022064618%	1	1269	61	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KAUFFMANN_MELANOMA_RELAPSE_UP
0.0788022064618%	1	1269	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WIERENGA_STAT5A_TARGETS_GROUP2
0.0788022064618%	1	1269	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING
0.0788022064618%	1	1269	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE
0.0788022064618%	1	1269	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OUILLETTE_CLL_13Q14_DELETION_DN
0.0788022064618%	1	1269	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_LIVER_CANCER_DENA_UP
0.0788022064618%	1	1269	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CUI_GLUCOSE_DEPRIVATION
0.0788022064618%	1	1269	60	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CROONQUIST_STROMAL_STIMULATION_UP
0.0788022064618%	1	1269	6	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZIRN_TRETINOIN_RESPONSE_DN
0.0788022064618%	1	1269	6	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN
0.0788022064618%	1	1269	6	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OHASHI_AURKA_TARGETS
0.0788022064618%	1	1269	6	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KAUFFMANN_MELANOMA_RELAPSE_DN
0.0788022064618%	1	1269	6	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DONATO_CELL_CYCLE_TRETINOIN
0.0788022064618%	1	1269	6	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DIERICK_SEROTONIN_FUNCTION_GENES
0.0788022064618%	1	1269	6	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	COURTOIS_SENESCENCE_TRIGGERS
0.0788022064618%	1	1269	6	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BUSA_SAM68_TARGETS_DN
0.0788022064618%	1	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN
0.0788022064618%	1	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_ATF2_PATHWAY
0.0788022064618%	1	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ONDER_CDH1_TARGETS_3_DN
0.0788022064618%	1	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3
0.0788022064618%	1	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIAN_LIPA_TARGETS_3M
0.0788022064618%	1	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION
0.0788022064618%	1	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
0.0788022064618%	1	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_C_DN
0.0788022064618%	1	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BARIS_THYROID_CANCER_DN
0.0788022064618%	1	1269	59	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ASTIER_INTEGRIN_SIGNALING
0.0788022064618%	1	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
0.0788022064618%	1	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SANSOM_WNT_PATHWAY_REQUIRE_MYC
0.0788022064618%	1	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_REGULATION_OF_APOPTOSIS
0.0788022064618%	1	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_COLLAGEN_FORMATION
0.0788022064618%	1	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIM_MAMMARY_LUMINAL_PROGENITOR_UP
0.0788022064618%	1	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ARACHIDONIC_ACID_METABOLISM
0.0788022064618%	1	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP
0.0788022064618%	1	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_HIVNEF_PATHWAY
0.0788022064618%	1	1269	58	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BERNARD_PPAPDC1B_TARGETS_DN
0.0788022064618%	1	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAMASHITA_METHYLATED_IN_PROSTATE_CANCER
0.0788022064618%	1	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2
0.0788022064618%	1	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE
0.0788022064618%	1	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_TXA2PATHWAY
0.0788022064618%	1	1269	57	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMIT_SERUM_RESPONSE_240_MCF10A
0.0788022064618%	1	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.0788022064618%	1	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PI_3K_CASCADE
0.0788022064618%	1	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION
0.0788022064618%	1	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX
0.0788022064618%	1	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP
0.0788022064618%	1	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_VIBRIO_CHOLERAE_INFECTION
0.0788022064618%	1	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_HEDGEHOG_SIGNALING_PATHWAY
0.0788022064618%	1	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.0788022064618%	1	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRADE_COLON_VS_RECTAL_CANCER_DN
0.0788022064618%	1	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GALE_APL_WITH_FLT3_MUTATED_UP
0.0788022064618%	1	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_30MIN_UP
0.0788022064618%	1	1269	56	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_10HR_DN
0.0788022064618%	1	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_TGFBRPATHWAY
0.0788022064618%	1	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LAU_APOPTOSIS_CDKN2A_UP
0.0788022064618%	1	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN
0.0788022064618%	1	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_STEROID_HORMONE_BIOSYNTHESIS
0.0788022064618%	1	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_BASAL_CELL_CARCINOMA
0.0788022064618%	1	1269	55	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_4HR_UP
0.0788022064618%	1	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHOU_TNF_SIGNALING_4HR
0.0788022064618%	1	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP
0.0788022064618%	1	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_TAP63PATHWAY
0.0788022064618%	1	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_RAC1_PATHWAY
0.0788022064618%	1	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_NFAT_3PATHWAY
0.0788022064618%	1	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_IPS_ICP_WITH_H3K27ME3
0.0788022064618%	1	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARSON_FOXP3_TARGETS_DN
0.0788022064618%	1	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JIANG_AGING_CEREBRAL_CORTEX_DN
0.0788022064618%	1	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_2_UP
0.0788022064618%	1	1269	54	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AUNG_GASTRIC_CANCER
0.0788022064618%	1	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROESSLER_LIVER_CANCER_METASTASIS_DN
0.0788022064618%	1	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PROTEIN_FOLDING
0.0788022064618%	1	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS
0.0788022064618%	1	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0
0.0788022064618%	1	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CIRCADIAN_CLOCK
0.0788022064618%	1	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_CD8TCRPATHWAY
0.0788022064618%	1	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MORI_IMMATURE_B_LYMPHOCYTE_UP
0.0788022064618%	1	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP
0.0788022064618%	1	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KRIEG_HYPOXIA_VIA_KDM3A
0.0788022064618%	1	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IKEDA_MIR1_TARGETS_UP
0.0788022064618%	1	1269	53	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP
0.0788022064618%	1	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN
0.0788022064618%	1	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VILIMAS_NOTCH1_TARGETS_UP
0.0788022064618%	1	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.0788022064618%	1	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GABA_RECEPTOR_ACTIVATION
0.0788022064618%	1	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RADAEVA_RESPONSE_TO_IFNA1_UP
0.0788022064618%	1	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PRAMOONJAGO_SOX4_TARGETS_UP
0.0788022064618%	1	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_PTP1BPATHWAY
0.0788022064618%	1	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_MTOR_SIGNALING_PATHWAY
0.0788022064618%	1	1269	52	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BECKER_TAMOXIFEN_RESISTANCE_DN
0.0788022064618%	1	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TSUNODA_CISPLATIN_RESISTANCE_DN
0.0788022064618%	1	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.0788022064618%	1	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT
0.0788022064618%	1	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
0.0788022064618%	1	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1
0.0788022064618%	1	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN
0.0788022064618%	1	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_DRUG_METABOLISM_OTHER_ENZYMES
0.0788022064618%	1	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
0.0788022064618%	1	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BYSTROEM_CORRELATED_WITH_IL5_UP
0.0788022064618%	1	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_PEAK_AT_2HR
0.0788022064618%	1	1269	51	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN
0.0788022064618%	1	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YANG_BREAST_CANCER_ESR1_LASER_DN
0.0788022064618%	1	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION
0.0788022064618%	1	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
0.0788022064618%	1	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KOHOUTEK_CCNT1_TARGETS
0.0788022064618%	1	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_GLUTATHIONE_METABOLISM
0.0788022064618%	1	1269	50	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BECKER_TAMOXIFEN_RESISTANCE_UP
0.0788022064618%	1	1269	5	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VERRECCHIA_RESPONSE_TO_TGFB1_C6
0.0788022064618%	1	1269	5	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LI_WILMS_TUMOR_ANAPLASTIC_DN
0.0788022064618%	1	1269	5	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ABDULRAHMAN_KIDNEY_CANCER_VHL_UP
0.0788022064618%	1	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC
0.0788022064618%	1	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_NON_CODING_RNA
0.0788022064618%	1	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_ARF6_TRAFFICKINGPATHWAY
0.0788022064618%	1	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARCHINI_TRABECTEDIN_RESISTANCE_DN
0.0788022064618%	1	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAUER_STAT3_TARGETS_UP
0.0788022064618%	1	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP
0.0788022064618%	1	1269	49	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	APRELIKOVA_BRCA1_TARGETS
0.0788022064618%	1	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_MS_UP
0.0788022064618%	1	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TAVOR_CEBPA_TARGETS_UP
0.0788022064618%	1	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE
0.0788022064618%	1	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PI_METABOLISM
0.0788022064618%	1	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES
0.0788022064618%	1	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6
0.0788022064618%	1	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_AJDISS_2PATHWAY
0.0788022064618%	1	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCDOWELL_ACUTE_LUNG_INJURY_DN
0.0788022064618%	1	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ENGELMANN_CANCER_PROGENITORS_UP
0.0788022064618%	1	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DELACROIX_RAR_TARGETS_UP
0.0788022064618%	1	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_4
0.0788022064618%	1	1269	48	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
0.0788022064618%	1	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_MF_UP
0.0788022064618%	1	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_HP_DN
0.0788022064618%	1	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP
0.0788022064618%	1	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN
0.0788022064618%	1	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	POTTI_DOCETAXEL_SENSITIVITY
0.0788022064618%	1	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_IL6_7PATHWAY
0.0788022064618%	1	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_FANCONI_PATHWAY
0.0788022064618%	1	1269	47	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KHETCHOUMIAN_TRIM24_TARGETS_UP
0.0788022064618%	1	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD2_DN
0.0788022064618%	1	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6
0.0788022064618%	1	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
0.0788022064618%	1	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT
0.0788022064618%	1	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_SYNDECAN_1_PATHWAY
0.0788022064618%	1	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OSADA_ASCL1_TARGETS_UP
0.0788022064618%	1	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MADAN_DPPA4_TARGETS
0.0788022064618%	1	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KRASNOSELSKAYA_ILF3_TARGETS_DN
0.0788022064618%	1	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JIANG_TIP30_TARGETS_UP
0.0788022064618%	1	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN
0.0788022064618%	1	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN
0.0788022064618%	1	1269	46	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN
0.0788022064618%	1	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_V2_LATE_DIFFERENTIATION_GENES
0.0788022064618%	1	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN
0.0788022064618%	1	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_MRNA_SPLICING_MINOR_PATHWAY
0.0788022064618%	1	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_G2_M_CHECKPOINTS
0.0788022064618%	1	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN
0.0788022064618%	1	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAKAMURA_METASTASIS_MODEL_UP
0.0788022064618%	1	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCDOWELL_ACUTE_LUNG_INJURY_UP
0.0788022064618%	1	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEE_AGING_MUSCLE_UP
0.0788022064618%	1	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN
0.0788022064618%	1	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHANDRAN_METASTASIS_TOP50_DN
0.0788022064618%	1	1269	45	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_LB_DN
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	XU_CREBBP_TARGETS_DN
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WHITFIELD_CELL_CYCLE_LITERATURE
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_BRCA1_DN
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	THILLAINADESAN_ZNF217_TARGETS_UP
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_FGFR_MUTANTS
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PARK_HSC_MARKERS
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LUI_THYROID_CANCER_PAX8_PPARG_UP
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LANDIS_BREAST_CANCER_PROGRESSION_UP
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_TYPE_I_DIABETES_MELLITUS
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_LYSINE_DEGRADATION
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ABC_TRANSPORTERS
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JAEGER_METASTASIS_UP
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FAELT_B_CLL_WITH_VH3_21_UP
0.0788022064618%	1	1269	44	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY
0.0788022064618%	1	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK
0.0788022064618%	1	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_CXCR3PATHWAY
0.0788022064618%	1	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN
0.0788022064618%	1	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN
0.0788022064618%	1	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FUJII_YBX1_TARGETS_UP
0.0788022064618%	1	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_PEAK_AT_24HR
0.0788022064618%	1	1269	43	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_480_MCF10A
0.0788022064618%	1	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WIERENGA_PML_INTERACTOME
0.0788022064618%	1	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN
0.0788022064618%	1	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP
0.0788022064618%	1	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ONO_FOXP3_TARGETS_DN
0.0788022064618%	1	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_ES_ICP_WITH_H3K27ME3
0.0788022064618%	1	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_TYROSINE_METABOLISM
0.0788022064618%	1	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_FATTY_ACID_METABOLISM
0.0788022064618%	1	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION
0.0788022064618%	1	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HAHTOLA_SEZARY_SYNDROM_DN
0.0788022064618%	1	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN
0.0788022064618%	1	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BARRIER_COLON_CANCER_RECURRENCE_UP
0.0788022064618%	1	1269	42	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_40_HELA
0.0788022064618%	1	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_MF_DN
0.0788022064618%	1	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WENG_POR_TARGETS_LIVER_UP
0.0788022064618%	1	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN
0.0788022064618%	1	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_NETRIN1_SIGNALING
0.0788022064618%	1	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_ERBB1_INTERNALIZATION_PATHWAY
0.0788022064618%	1	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LI_LUNG_CANCER
0.0788022064618%	1	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIN_MELANOMA_COPY_NUMBER_DN
0.0788022064618%	1	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM
0.0788022064618%	1	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KAMMINGA_SENESCENCE
0.0788022064618%	1	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KAAB_FAILED_HEART_VENTRICLE_DN
0.0788022064618%	1	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D2
0.0788022064618%	1	1269	41	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHEN_HOXA5_TARGETS_9HR_DN
0.0788022064618%	1	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VANASSE_BCL2_TARGETS_UP
0.0788022064618%	1	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TOMLINS_PROSTATE_CANCER_DN
0.0788022064618%	1	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.0788022064618%	1	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIAO_HAVE_SOX4_BINDING_SITES
0.0788022064618%	1	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_SPHINGOLIPID_METABOLISM
0.0788022064618%	1	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PYRUVATE_METABOLISM
0.0788022064618%	1	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN
0.0788022064618%	1	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HEIDENBLAD_AMPLICON_8Q24_UP
0.0788022064618%	1	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
0.0788022064618%	1	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D7
0.0788022064618%	1	1269	40	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMUNDSON_GAMMA_RADIATION_RESPONSE
0.0788022064618%	1	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WHITEHURST_PACLITAXEL_SENSITIVITY
0.0788022064618%	1	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STONER_ESOPHAGEAL_CARCINOGENESIS_UP
0.0788022064618%	1	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C6
0.0788022064618%	1	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_ECADHERIN_NASCENTAJ_PATHWAY
0.0788022064618%	1	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOFMANN_CELL_LYMPHOMA_DN
0.0788022064618%	1	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP
0.0788022064618%	1	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP
0.0788022064618%	1	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BILANGES_RAPAMYCIN_SENSITIVE_GENES
0.0788022064618%	1	1269	39	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMIT_SERUM_RESPONSE_480_MCF10A
0.0788022064618%	1	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VARELA_ZMPSTE24_TARGETS_DN
0.0788022064618%	1	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PI3K_AKT_ACTIVATION
0.0788022064618%	1	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GABA_B_RECEPTOR_ACTIVATION
0.0788022064618%	1	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS
0.0788022064618%	1	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS
0.0788022064618%	1	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PIONTEK_PKD1_TARGETS_UP
0.0788022064618%	1	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_P38ALPHABETADOWNSTREAMPATHWAY
0.0788022064618%	1	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_FASPATHWAY
0.0788022064618%	1	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAKAMURA_ADIPOGENESIS_LATE_DN
0.0788022064618%	1	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAKAMURA_ADIPOGENESIS_EARLY_DN
0.0788022064618%	1	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.0788022064618%	1	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP
0.0788022064618%	1	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_BY_4NQO
0.0788022064618%	1	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_6_DN
0.0788022064618%	1	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN
0.0788022064618%	1	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN
0.0788022064618%	1	1269	38	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	APPIERTO_RESPONSE_TO_FENRETINIDE_UP
0.0788022064618%	1	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN
0.0788022064618%	1	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
0.0788022064618%	1	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_P38_MAPK_PATHWAY
0.0788022064618%	1	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_GA13_PATHWAY
0.0788022064618%	1	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING
0.0788022064618%	1	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_IL23PATHWAY
0.0788022064618%	1	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED
0.0788022064618%	1	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HU_ANGIOGENESIS_DN
0.0788022064618%	1	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D6
0.0788022064618%	1	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FRASOR_RESPONSE_TO_ESTRADIOL_UP
0.0788022064618%	1	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CUI_TCF21_TARGETS_UP
0.0788022064618%	1	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE
0.0788022064618%	1	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_TOLL_PATHWAY
0.0788022064618%	1	1269	37	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_ALK_PATHWAY
0.0788022064618%	1	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YANG_BREAST_CANCER_ESR1_UP
0.0788022064618%	1	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2
0.0788022064618%	1	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_BRCA1_UP
0.0788022064618%	1	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STEARMAN_TUMOR_FIELD_EFFECT_UP
0.0788022064618%	1	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
0.0788022064618%	1	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.0788022064618%	1	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SEMENZA_HIF1_TARGETS
0.0788022064618%	1	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
0.0788022064618%	1	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_IRON_UPTAKE_AND_TRANSPORT
0.0788022064618%	1	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION
0.0788022064618%	1	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_PI3KPLCTRKPATHWAY
0.0788022064618%	1	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MMS_MOUSE_LYMPH_HIGH_4HRS_UP
0.0788022064618%	1	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
0.0788022064618%	1	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIU_CDX2_TARGETS_UP
0.0788022064618%	1	1269	36	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_BASAL_TRANSCRIPTION_FACTORS
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WESTON_VEGFA_TARGETS_12HR
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WEIGEL_OXIDATIVE_STRESS_RESPONSE
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_METHYLATED_IN_BREAST_CANCER
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VALK_AML_CLUSTER_9
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHRAETS_MLL_TARGETS_UP
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROZANOV_MMP14_TARGETS_DN
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_PI3KCIAKTPATHWAY
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PRION_DISEASES
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JAZAG_TGFB1_SIGNALING_DN
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HU_GENOTOXIC_DAMAGE_24HR
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOWLIN_CITED1_TARGETS_1_UP
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GUTIERREZ_MULTIPLE_MYELOMA_DN
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DORSAM_HOXA9_TARGETS_UP
0.0788022064618%	1	1269	35	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP
0.0788022064618%	1	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WONG_IFNA2_RESISTANCE_DN
0.0788022064618%	1	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_WNT_BETA_CATENIN_PATHWAY
0.0788022064618%	1	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES
0.0788022064618%	1	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GLUCONEOGENESIS
0.0788022064618%	1	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX
0.0788022064618%	1	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_MAPKTRKPATHWAY
0.0788022064618%	1	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.0788022064618%	1	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_BUTANOATE_METABOLISM
0.0788022064618%	1	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DOANE_BREAST_CANCER_CLASSES_DN
0.0788022064618%	1	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP
0.0788022064618%	1	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP
0.0788022064618%	1	1269	34	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_MPR_PATHWAY
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_LATE_DIFFERENTIATION_GENES_UP
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WENDT_COHESIN_TARGETS_UP
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VALK_AML_CLUSTER_5
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_SYNDECAN_2_PATHWAY
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_IL12_STAT4PATHWAY
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MORI_PLASMA_CELL_DN
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PROPANOATE_METABOLISM
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ETHER_LIPID_METABOLISM
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JEPSEN_SMRT_TARGETS
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FARMER_BREAST_CANCER_CLUSTER_2
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DUTTA_APOPTOSIS_VIA_NFKB
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CAFFAREL_RESPONSE_TO_THC_UP
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_1
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_IL1R_PATHWAY
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN
0.0788022064618%	1	1269	33	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	APPEL_IMATINIB_RESPONSE
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZWANG_EGF_PERSISTENTLY_UP
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TSAI_RESPONSE_TO_RADIATION_THERAPY
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ELONGATION_ARREST_AND_RECOVERY
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	POS_HISTAMINE_RESPONSE_NETWORK
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_CITRATE_CYCLE_TCA_CYCLE
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FARDIN_HYPOXIA_11
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DORSAM_HOXA9_TARGETS_DN
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_HDAC_PATHWAY
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BAUS_TFF2_TARGETS_UP
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BAE_BRCA1_TARGETS_DN
0.0788022064618%	1	1269	32	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMIT_SERUM_RESPONSE_40_MCF10A
0.0788022064618%	1	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP
0.0788022064618%	1	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VALK_AML_CLUSTER_4
0.0788022064618%	1	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.0788022064618%	1	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.0788022064618%	1	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE
0.0788022064618%	1	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_NEPHRIN_NEPH1_PATHWAY
0.0788022064618%	1	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_CD40_PATHWAY
0.0788022064618%	1	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NOJIMA_SFRP2_TARGETS_UP
0.0788022064618%	1	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.0788022064618%	1	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD
0.0788022064618%	1	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP
0.0788022064618%	1	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM
0.0788022064618%	1	1269	31	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP
0.0788022064618%	1	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.0788022064618%	1	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YANAGIHARA_ESX1_TARGETS
0.0788022064618%	1	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VALK_AML_CLUSTER_13
0.0788022064618%	1	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TAVOR_CEBPA_TARGETS_DN
0.0788022064618%	1	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
0.0788022064618%	1	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN
0.0788022064618%	1	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
0.0788022064618%	1	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_NOD1_2_SIGNALING_PATHWAY
0.0788022064618%	1	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_MRNA_CAPPING
0.0788022064618%	1	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM
0.0788022064618%	1	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_BASIGIN_INTERACTIONS
0.0788022064618%	1	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LY_AGING_PREMATURE_DN
0.0788022064618%	1	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_O_GLYCAN_BIOSYNTHESIS
0.0788022064618%	1	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GUILLAUMOND_KLF10_TARGETS_DN
0.0788022064618%	1	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G2
0.0788022064618%	1	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY
0.0788022064618%	1	1269	30	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_FAS_PATHWAY
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WOTTON_RUNX_TARGETS_DN
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_RESPONSE_TO_ANDROGEN_UP
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VALK_AML_CLUSTER_2
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TIGHT_JUNCTION_INTERACTIONS
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_STEROID_HORMONES
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_S1P_S1P3_PATHWAY
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PAL_PRMT5_TARGETS_DN
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NGUYEN_NOTCH1_TARGETS_UP
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_MCV6_LCP_WITH_H3K27ME3
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MA_PITUITARY_FETAL_VS_ADULT_UP
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MAYBURD_RESPONSE_TO_L663536_UP
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MATZUK_CENTRAL_FOR_FEMALE_FERTILITY
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARSHALL_VIRAL_INFECTION_RESPONSE_DN
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KRIGE_AMINO_ACID_DEPRIVATION
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_RNA_POLYMERASE
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHOW_RASSF1_TARGETS_DN
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP
0.0788022064618%	1	1269	29	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ABE_VEGFA_TARGETS_30MIN
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WILLIAMS_ESR2_TARGETS_UP
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VALK_AML_CLUSTER_7
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VALK_AML_CLUSTER_1
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_GAQ_PATHWAY
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REICHERT_MITOSIS_LIN9_TARGETS
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SHC_MEDIATED_CASCADE
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_TRAIL_PATHWAY
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PETROVA_PROX1_TARGETS_UP
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MATZUK_MALE_REPRODUCTION_SERTOLI
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LI_CISPLATIN_RESISTANCE_UP
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_HOMOLOGOUS_RECOMBINATION
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G24
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_PROTEASOME_PATHWAY
0.0788022064618%	1	1269	28	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_ERK_PATHWAY
0.0788022064618%	1	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TERAMOTO_OPN_TARGETS_CLUSTER_6
0.0788022064618%	1	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_MYOCYTE_AD_PATHWAY
0.0788022064618%	1	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
0.0788022064618%	1	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_STRIATED_MUSCLE_CONTRACTION
0.0788022064618%	1	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALLING_TO_RAS
0.0788022064618%	1	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM
0.0788022064618%	1	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PLASARI_NFIC_TARGETS_BASAL_UP
0.0788022064618%	1	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LI_WILMS_TUMOR
0.0788022064618%	1	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PENTOSE_PHOSPHATE_PATHWAY
0.0788022064618%	1	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN
0.0788022064618%	1	1269	27	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_EDG1_PATHWAY
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHENG_FOXP3_TARGETS_UP
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WALLACE_JAK2_TARGETS_UP
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VALK_AML_CLUSTER_8
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VALK_AML_CLUSTER_16
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_KERATAN_SULFATE_BIOSYNTHESIS
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_IL27PATHWAY
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NEWMAN_ERCC6_TARGETS_UP
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HAHTOLA_CTCL_CUTANEOUS
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FINAK_BREAST_CANCER_SDPP_SIGNATURE
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_WNT_PATHWAY
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_PGC1A_PATHWAY
0.0788022064618%	1	1269	26	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WAGNER_APO2_SENSITIVITY
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VERRECCHIA_RESPONSE_TO_TGFB1_C2
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VALK_AML_WITH_EVI1
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RUAN_RESPONSE_TO_TROGLITAZONE_UP
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_G0_AND_EARLY_G1
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_DARPP_32_EVENTS
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_TOLL_ENDOGENOUS_PATHWAY
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_HDAC_CLASSIII_PATHWAY
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OZEN_MIR125B1_TARGETS
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NOJIMA_SFRP2_TARGETS_DN
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_DORSO_VENTRAL_AXIS_FORMATION
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.0788022064618%	1	1269	25	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_STRESS_PATHWAY
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YIH_RESPONSE_TO_ARSENITE_C1
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAN_ESCAPE_FROM_ANOIKIS
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_TNF_TARGETS
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_LSD1_TARGETS_UP
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SA_B_CELL_RECEPTOR_COMPLEXES
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_REGULATION_OF_IFNA_SIGNALING
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PYRIMIDINE_METABOLISM
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CHOLESTEROL_BIOSYNTHESIS
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_S1P_S1P2_PATHWAY
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OXFORD_RALA_OR_RALB_TARGETS_DN
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OSADA_ASCL1_TARGETS_DN
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ONO_AML1_TARGETS_UP
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MAEKAWA_ATF2_TARGETS
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_GERMINAL_CENTER_T_HELPER_DN
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HASLINGER_B_CLL_WITH_13Q14_DELETION
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GOLUB_ALL_VS_AML_UP
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GOLUB_ALL_VS_AML_DN
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_NOS1_PATHWAY
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CSK_PATHWAY
0.0788022064618%	1	1269	24	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AZARE_STAT3_TARGETS
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZIRN_TRETINOIN_RESPONSE_WT1_UP
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YANG_MUC2_TARGETS_DUODENUM_3MO_DN
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YANG_BREAST_CANCER_ESR1_BULK_DN
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WENG_POR_TARGETS_GLOBAL_DN
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_RESPONSE_TO_FORSKOLIN_UP
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VIETOR_IFRD1_TARGETS
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SAGIV_CD24_TARGETS_UP
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_PRLSIGNALINGEVENTSPATHWAY
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ONO_FOXP3_TARGETS_UP
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARKS_HDAC_TARGETS_UP
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_MISMATCH_REPAIR
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HINATA_NFKB_TARGETS_KERATINOCYTE_DN
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HASLINGER_B_CLL_WITH_11Q23_DELETION
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	EGUCHI_CELL_CYCLE_RB1_TARGETS
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHEOK_RESPONSE_TO_HD_MTX_UP
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_PTDINS_PATHWAY
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_P53HYPOXIA_PATHWAY
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_NFKB_PATHWAY
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_INTRINSIC_PATHWAY
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_IL12_PATHWAY
0.0788022064618%	1	1269	23	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CTCF_PATHWAY
0.0788022064618%	1	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WELCH_GATA1_TARGETS
0.0788022064618%	1	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VALK_AML_WITH_11Q23_REARRANGED
0.0788022064618%	1	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SUZUKI_RESPONSE_TO_TSA
0.0788022064618%	1	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING
0.0788022064618%	1	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION
0.0788022064618%	1	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_PDGFRAPATHWAY
0.0788022064618%	1	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_HEDGEHOG_2PATHWAY
0.0788022064618%	1	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
0.0788022064618%	1	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_BETA_ALANINE_METABOLISM
0.0788022064618%	1	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KANG_FLUOROURACIL_RESISTANCE_UP
0.0788022064618%	1	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP
0.0788022064618%	1	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP
0.0788022064618%	1	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP
0.0788022064618%	1	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAVIN_PDE3B_TARGETS
0.0788022064618%	1	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION
0.0788022064618%	1	1269	22	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_HER2_PATHWAY
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZIRN_TRETINOIN_RESPONSE_UP
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_P38_MK2PATHWAY
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LANDEMAINE_LUNG_METASTASIS
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KANNAN_TP53_TARGETS_DN
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HU_ANGIOGENESIS_UP
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HUI_MAPK14_TARGETS_UP
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HASLINGER_B_CLL_WITH_17P13_DELETION
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GREENBAUM_E2A_TARGETS_DN
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GESERICK_TERT_TARGETS_DN
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FERRANDO_TAL1_NEIGHBORS
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_TFF_PATHWAY
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CTLA4_PATHWAY
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CALCINEURIN_PATHWAY
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_ATRBRCA_PATHWAY
0.0788022064618%	1	1269	21	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMIT_SERUM_RESPONSE_20_MCF10A
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WENG_POR_TARGETS_LIVER_DN
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WEBER_METHYLATED_HCP_IN_SPERM_UP
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WANG_RECURRENT_LIVER_CANCER_UP
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WALLACE_PROSTATE_CANCER_UP
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VILIMAS_NOTCH1_TARGETS_DN
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ENOS_ACTIVATION_AND_REGULATION
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OUYANG_PROSTATE_CANCER_PROGRESSION_UP
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NIELSEN_SYNOVIAL_SARCOMA_DN
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCCABE_HOXC6_TARGETS_CANCER_DN
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_MYCL1_AMPLIFICATION_TARGETS_DN
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HEDENFALK_BREAST_CANCER_BRACX_UP
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_IGF1MTOR_PATHWAY
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CCR5_PATHWAY
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_AMI_PATHWAY
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BARRIER_COLON_CANCER_RECURRENCE_DN
0.0788022064618%	1	1269	20	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ABE_VEGFA_TARGETS
0.0788022064618%	1	1269	191	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WU_ALZHEIMER_DISEASE_DN
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VISALA_AGING_LYMPHOCYTE_DN
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VERRECCHIA_RESPONSE_TO_TGFB1_C1
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TERAMOTO_OPN_TARGETS_CLUSTER_7
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CGMP_EFFECTS
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_HIF1APATHWAY
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_EPHA2_FWDPATHWAY
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NIELSEN_LIPOSARCOMA_DN
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NIELSEN_LEIOMYOSARCOMA_CNN1_UP
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAGY_TFTC_COMPONENTS_HUMAN
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MELLMAN_TUT1_TARGETS_UP
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LI_WILMS_TUMOR_ANAPLASTIC_UP
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ALPHA_LINOLENIC_ACID_METABOLISM
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HAHTOLA_MYCOSIS_FUNGOIDES_UP
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRANDVAUX_IRF3_TARGETS_DN
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAJATE_RESPONSE_TO_TRABECTEDIN_DN
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FARMER_BREAST_CANCER_CLUSTER_5
0.0788022064618%	1	1269	19	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHEN_PDGF_TARGETS
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHENG_RESPONSE_TO_ARSENITE_UP
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHENG_RESPONSE_TO_ARSENITE_DN
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YIH_RESPONSE_TO_ARSENITE_C2
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_PC
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PODAR_RESPONSE_TO_ADAPHOSTIN_DN
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PIONTEK_PKD1_TARGETS_DN
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NIELSEN_LEIOMYOSARCOMA_UP
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAM_FXYD5_TARGETS_DN
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOREIRA_RESPONSE_TO_TSA_DN
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_PTEN_TARGETS_UP
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_PHENYLALANINE_METABOLISM
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HUMMERICH_BENIGN_SKIN_TUMOR_UP
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D1
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHOI_ATL_CHRONIC_VS_ACUTE_DN
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_UCALPAIN_PATHWAY
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_TEL_PATHWAY
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_SPRY_PATHWAY
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_ETS_PATHWAY
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_ERK5_PATHWAY
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_ARAP_PATHWAY
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP
0.0788022064618%	1	1269	18	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMIT_DELAYED_EARLY_GENES
0.0788022064618%	1	1269	175	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SIMBULAN_PARP1_TARGETS_DN
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SA_TRKA_RECEPTOR
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SA_PTEN_PATHWAY
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TIE2_SIGNALING
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SHC_RELATED_EVENTS
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RNA_POL_III_CHAIN_ELONGATION
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_REGULATION_OF_KIT_SIGNALING
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RAP1_SIGNALLING
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_INTRINSIC_PATHWAY
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ARMS_MEDIATED_ACTIVATION
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_SMAD2_3PATHWAY
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_STEROID_BIOSYNTHESIS
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_RENIN_ANGIOTENSIN_SYSTEM
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_ONE_CARBON_POOL_BY_FOLATE
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GOUYER_TATI_TARGETS_DN
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_IL10_PATHWAY
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_HCMV_PATHWAY
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CK1_PATHWAY
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_41BB_PATHWAY
0.0788022064618%	1	1269	17	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP
0.0788022064618%	1	1269	165	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TIAN_BHLHA15_TARGETS
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ST_G_ALPHA_S_PATHWAY
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_DNAPK_PATHWAY
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MOOTHA_TCA
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LY_AGING_MIDDLE_DN
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LUND_SILENCED_BY_METHYLATION
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LIU_TOPBP1_TARGETS
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KOINUMA_COLON_CANCER_MSI_DN
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_RIBOFLAVIN_METABOLISM
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KANG_FLUOROURACIL_RESISTANCE_DN
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HAHTOLA_MYCOSIS_FUNGOIDES_DN
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HAHTOLA_CTCL_PATHOGENESIS
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GHO_ATF5_TARGETS_DN
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FUKUSHIMA_TNFSF11_TARGETS
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_SHH_PATHWAY
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_IL22BP_PATHWAY
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_GATA3_PATHWAY
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CDMAC_PATHWAY
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CDC42RAC_PATHWAY
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CACAM_PATHWAY
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_ACH_PATHWAY
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
0.0788022064618%	1	1269	16	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ABDELMOHSEN_ELAVL4_TARGETS
0.0788022064618%	1	1269	153	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2
0.0788022064618%	1	1269	152	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR
0.0788022064618%	1	1269	151	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IGLESIAS_E2F_TARGETS_UP
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TSUNODA_CISPLATIN_RESISTANCE_UP
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SA_G1_AND_S_PHASES
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SHC_MEDIATED_SIGNALLING
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_POLYAMINES
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_AMINE_DERIVED_HORMONES
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_LPA4_PATHWAY
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_ERB_GENOMIC_PATHWAY
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_ARF6DOWNSTREAMPATHWAY
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NAGY_STAGA_COMPONENTS_HUMAN
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRANDVAUX_IRF3_TARGETS_UP
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FERRANDO_LYL1_NEIGHBORS
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	COLLIS_PRKDC_REGULATORS
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHANG_POU5F1_TARGETS_UP
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_LONGEVITY_PATHWAY
0.0788022064618%	1	1269	15	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_BARRESTIN_SRC_PATHWAY
0.0788022064618%	1	1269	147	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DARWICHE_PAPILLOMA_RISK_HIGH_UP
0.0788022064618%	1	1269	146	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
0.0788022064618%	1	1269	143	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.0788022064618%	1	1269	142	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WU_ALZHEIMER_DISEASE_UP
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VERRECCHIA_RESPONSE_TO_TGFB1_C3
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ROETH_TERT_TARGETS_UP
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SOS_MEDIATED_SIGNALLING
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SIGNAL_ATTENUATION
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CRMPS_IN_SEMA3A_SIGNALING
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_COMMON_PATHWAY
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_TCRRASPATHWAY
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KINNEY_DNMT1_METHYLATION_TARGETS
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_48HR_UP
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CASTELLANO_NRAS_TARGETS_DN
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_RANKL_PATHWAY
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_PS1_PATHWAY
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_PLATELETAPP_PATHWAY
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_DREAM_PATHWAY
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_20_MCF10A
0.0788022064618%	1	1269	14	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ABBUD_LIF_SIGNALING_2_UP
0.0788022064618%	1	1269	139	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_BIOLOGICAL_OXIDATIONS
0.0788022064618%	1	1269	139	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_C_D_UP
0.0788022064618%	1	1269	136	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.0788022064618%	1	1269	134	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_CELL_ADHESION_MOLECULES_CAMS
0.0788022064618%	1	1269	132	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	VERRECCHIA_RESPONSE_TO_TGFB1_C4
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	TSAI_DNAJB4_TARGETS_UP
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	STARK_BRAIN_22Q11_DELETION
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHI_SPARC_TARGETS_DN
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SA_REG_CASCADE_OF_CYCLIN_EXPR
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ONGUSAHA_BRCA1_TARGETS_UP
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MATZUK_EARLY_ANTRAL_FOLLICLE
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KORKOLA_EMBRYONAL_CARCINOMA
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KIM_MYCL1_AMPLIFICATION_TARGETS_UP
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_CIRCADIAN_RHYTHM_MAMMAL
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GHO_ATF5_TARGETS_UP
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_EXTRINSIC_PATHWAY
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CARM1_PATHWAY
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_AGPCR_PATHWAY
0.0788022064618%	1	1269	13	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN
0.0788022064618%	1	1269	129	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BROWN_MYELOID_CELL_DEVELOPMENT_DN
0.0788022064618%	1	1269	128	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS
0.0788022064618%	1	1269	127	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KARLSSON_TGFB1_TARGETS_UP
0.0788022064618%	1	1269	121	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_LYSOSOME
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHENG_FOXP3_TARGETS_IN_THYMUS_DN
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	NEBEN_AML_WITH_FLT3_OR_NRAS_DN
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_NPC_ICP_WITH_H3K27ME3
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FUNG_IL2_SIGNALING_2
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_5_UP
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	EHLERS_ANEUPLOIDY_DN
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_24HR_UP
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G5
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_TRKA_PATHWAY
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_PLCE_PATHWAY
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_FIBRINOLYSIS_PATHWAY
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_ETC_PATHWAY
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CFTR_PATHWAY
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_BARR_MAPK_PATHWAY
0.0788022064618%	1	1269	12	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_AKAP95_PATHWAY
0.0788022064618%	1	1269	118	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TOLL_RECEPTOR_CASCADES
0.0788022064618%	1	1269	116	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	IKEDA_MIR30_TARGETS_UP
0.0788022064618%	1	1269	114	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BOSCO_TH1_CYTOTOXIC_MODULE
0.0788022064618%	1	1269	111	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GLYCOSAMINOGLYCAN_METABOLISM
0.0788022064618%	1	1269	110	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WOOD_EBV_EBNA1_TARGETS_UP
0.0788022064618%	1	1269	110	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GHANDHI_DIRECT_IRRADIATION_UP
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	ZHOU_PANCREATIC_BETA_CELL
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHIN_B_CELL_LYMPHOMA_CLUSTER_6
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SEMBA_FHIT_TARGETS_UP
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_UNWINDING_OF_DNA
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_TRYPTOPHAN_CATABOLISM
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_PE
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PID_INTEGRIN4_PATHWAY
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LOPEZ_MESOTHELIOMA_SURVIVAL_UP
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KALMA_E2F1_TARGETS
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FOURNIER_ACINAR_DEVELOPMENT_LATE_UP
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_32HR_UP
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHUANG_OXIDATIVE_STRESS_RESPONSE_DN
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_EGFR_SMRTE_PATHWAY
0.0788022064618%	1	1269	11	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_CDK5_PATHWAY
0.0788022064618%	1	1269	109	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.0788022064618%	1	1269	109	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53
0.0788022064618%	1	1269	108	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN
0.0788022064618%	1	1269	107	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C0
0.0788022064618%	1	1269	106	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN
0.0788022064618%	1	1269	103	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN
0.0788022064618%	1	1269	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
0.0788022064618%	1	1269	101	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	PUJANA_BREAST_CANCER_LIT_INT_NETWORK
0.0788022064618%	1	1269	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MCCLUNG_CREB1_TARGETS_UP
0.0788022064618%	1	1269	100	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_P4
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	WONG_ENDOMETRIAL_CANCER_LATE
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SHIRAISHI_PLZF_TARGETS_UP
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	SCHLESINGER_METHYLATED_IN_COLON_CANCER
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_RAF_MAP_KINASE_CASCADE
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PURINE_CATABOLISM
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_PECAM1_INTERACTIONS
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ETHANOL_OXIDATION
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	OXFORD_RALA_TARGETS_DN
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	KEGG_LIMONENE_AND_PINENE_DEGRADATION
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	HOLLEMAN_DAUNORUBICIN_B_ALL_UP
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	CHASSOT_SKIN_WOUND
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BUDHU_LIVER_CANCER_METASTASIS_UP
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_GLYCOLYSIS_PATHWAY
0.0788022064618%	1	1269	10	T2D_GENES_TANYA_GLYCEMIC_RSQ05_02CM_300K	BIOCARTA_FREE_PATHWAY
0.0767459708365%	1	1303	98	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TAKAO_RESPONSE_TO_UVB_RADIATION_DN
0.0767459708365%	1	1303	98	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NIELSEN_GIST
0.0767459708365%	1	1303	98	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MENSE_HYPOXIA_UP
0.0767459708365%	1	1303	98	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HAHTOLA_SEZARY_SYNDROM_UP
0.0767459708365%	1	1303	98	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAVIN_FOXP3_TARGETS_CLUSTER_T7
0.0767459708365%	1	1303	97	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
0.0767459708365%	1	1303	94	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOOI_ST7_TARGETS_UP
0.0767459708365%	1	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZERBINI_RESPONSE_TO_SULINDAC_UP
0.0767459708365%	1	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN
0.0767459708365%	1	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	THILLAINADESAN_ZNF217_TARGETS_DN
0.0767459708365%	1	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SA_FAS_SIGNALING
0.0767459708365%	1	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK
0.0767459708365%	1	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RAFFEL_VEGFA_TARGETS_UP
0.0767459708365%	1	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN
0.0767459708365%	1	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OXFORD_RALB_TARGETS_DN
0.0767459708365%	1	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OXFORD_RALA_TARGETS_UP
0.0767459708365%	1	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30
0.0767459708365%	1	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21
0.0767459708365%	1	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MATZUK_MATERNAL_EFFECT
0.0767459708365%	1	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HAEGERSTRAND_RESPONSE_TO_IMATINIB
0.0767459708365%	1	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA
0.0767459708365%	1	1303	9	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1
0.0767459708365%	1	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RICKMAN_HEAD_AND_NECK_CANCER_E
0.0767459708365%	1	1303	89	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_D_UP
0.0767459708365%	1	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_CALORIE_RESTRICTION_NEOCORTEX_DN
0.0767459708365%	1	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN
0.0767459708365%	1	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_RIBOSOME
0.0767459708365%	1	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.0767459708365%	1	1303	88	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DURCHDEWALD_SKIN_CARCINOGENESIS_UP
0.0767459708365%	1	1303	87	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE
0.0767459708365%	1	1303	86	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NELSON_RESPONSE_TO_ANDROGEN_UP
0.0767459708365%	1	1303	86	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_8
0.0767459708365%	1	1303	85	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
0.0767459708365%	1	1303	85	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN
0.0767459708365%	1	1303	85	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
0.0767459708365%	1	1303	84	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS
0.0767459708365%	1	1303	83	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.0767459708365%	1	1303	83	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.0767459708365%	1	1303	82	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
0.0767459708365%	1	1303	81	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MUNSHI_MULTIPLE_MYELOMA_UP
0.0767459708365%	1	1303	81	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEIN_MEDULLA_MARKERS
0.0767459708365%	1	1303	81	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HUANG_DASATINIB_RESISTANCE_UP
0.0767459708365%	1	1303	81	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GUO_HEX_TARGETS_UP
0.0767459708365%	1	1303	80	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED
0.0767459708365%	1	1303	80	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
0.0767459708365%	1	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP
0.0767459708365%	1	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS
0.0767459708365%	1	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN
0.0767459708365%	1	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OXFORD_RALB_TARGETS_UP
0.0767459708365%	1	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NADELLA_PRKAR1A_TARGETS_DN
0.0767459708365%	1	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9
0.0767459708365%	1	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_DEDIFFERENTIATED_STATE_UP
0.0767459708365%	1	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MATZUK_FERTILIZATION
0.0767459708365%	1	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LUCAS_HNF4A_TARGETS_DN
0.0767459708365%	1	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP
0.0767459708365%	1	1303	8	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_KREB_PATHWAY
0.0767459708365%	1	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
0.0767459708365%	1	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
0.0767459708365%	1	1303	79	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CROMER_METASTASIS_UP
0.0767459708365%	1	1303	78	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_OPIOID_SIGNALLING
0.0767459708365%	1	1303	78	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CELL_JUNCTION_ORGANIZATION
0.0767459708365%	1	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.0767459708365%	1	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION
0.0767459708365%	1	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN
0.0767459708365%	1	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MORI_PRE_BI_LYMPHOCYTE_DN
0.0767459708365%	1	1303	77	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.0767459708365%	1	1303	76	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_VEGF_SIGNALING_PATHWAY
0.0767459708365%	1	1303	75	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_ADHERENS_JUNCTION
0.0767459708365%	1	1303	75	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHESLER_BRAIN_QTL_CIS
0.0767459708365%	1	1303	75	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BAE_BRCA1_TARGETS_UP
0.0767459708365%	1	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEIN_OLIGODENDROCYTE_MARKERS
0.0767459708365%	1	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_LIVER_CANCER_DENA_DN
0.0767459708365%	1	1303	74	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JI_RESPONSE_TO_FSH_UP
0.0767459708365%	1	1303	73	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP
0.0767459708365%	1	1303	73	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MEIOTIC_SYNAPSIS
0.0767459708365%	1	1303	72	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C8
0.0767459708365%	1	1303	71	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.0767459708365%	1	1303	71	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GEORGANTAS_HSC_MARKERS
0.0767459708365%	1	1303	70	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_LONG_TERM_DEPRESSION
0.0767459708365%	1	1303	70	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ENGELMANN_CANCER_PROGENITORS_DN
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZEILSTRA_CD44_TARGETS_UP
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAMASHITA_SILENCED_BY_METHYLATION
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TESAR_JAK_TARGETS_MOUSE_ES_D3_UP
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TESAR_ALK_TARGETS_HUMAN_ES_5D_DN
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PETRETTO_BLOOD_PRESSURE_DN
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOOTHA_ROS
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKI_COEXPRESSED_WITH_CYP19A1
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCBRYAN_TERMINAL_END_BUD_DN
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIU_CMYB_TARGETS_DN
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOLLEMAN_DAUNORUBICIN_ALL_UP
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GLINSKY_CANCER_DEATH_UP
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BUSA_SAM68_TARGETS_UP
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BAKER_HEMATOPOESIS_STAT5_TARGETS
0.0767459708365%	1	1303	7	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ABBUD_LIF_SIGNALING_2_DN
0.0767459708365%	1	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZAMORA_NOS2_TARGETS_UP
0.0767459708365%	1	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SPHINGOLIPID_METABOLISM
0.0767459708365%	1	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GLUCOSE_METABOLISM
0.0767459708365%	1	1303	69	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HUANG_DASATINIB_RESISTANCE_DN
0.0767459708365%	1	1303	68	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.0767459708365%	1	1303	68	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
0.0767459708365%	1	1303	68	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C7
0.0767459708365%	1	1303	68	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NOUZOVA_METHYLATED_IN_APL
0.0767459708365%	1	1303	68	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
0.0767459708365%	1	1303	68	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN
0.0767459708365%	1	1303	68	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CASTELLANO_NRAS_TARGETS_UP
0.0767459708365%	1	1303	67	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN
0.0767459708365%	1	1303	67	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN
0.0767459708365%	1	1303	67	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G1
0.0767459708365%	1	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM
0.0767459708365%	1	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
0.0767459708365%	1	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_LIVER_CANCER_CIPROFIBRATE_DN
0.0767459708365%	1	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN
0.0767459708365%	1	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DIRMEIER_LMP1_RESPONSE_EARLY
0.0767459708365%	1	1303	66	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BEIER_GLIOMA_STEM_CELL_DN
0.0767459708365%	1	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_WNT
0.0767459708365%	1	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_CD8TCRDOWNSTREAMPATHWAY
0.0767459708365%	1	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_LIVER_CANCER_MYC_TGFA_DN
0.0767459708365%	1	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GUO_HEX_TARGETS_DN
0.0767459708365%	1	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GOLDRATH_IMMUNE_MEMORY
0.0767459708365%	1	1303	65	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS
0.0767459708365%	1	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS
0.0767459708365%	1	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PETROVA_PROX1_TARGETS_DN
0.0767459708365%	1	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN
0.0767459708365%	1	1303	64	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.0767459708365%	1	1303	63	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MODY_HIPPOCAMPUS_POSTNATAL
0.0767459708365%	1	1303	63	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
0.0767459708365%	1	1303	63	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CROMER_TUMORIGENESIS_UP
0.0767459708365%	1	1303	62	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
0.0767459708365%	1	1303	62	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP
0.0767459708365%	1	1303	61	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZWANG_EGF_PERSISTENTLY_DN
0.0767459708365%	1	1303	61	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.0767459708365%	1	1303	61	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MASSARWEH_RESPONSE_TO_ESTRADIOL
0.0767459708365%	1	1303	61	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_1HR_UP
0.0767459708365%	1	1303	60	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CUI_GLUCOSE_DEPRIVATION
0.0767459708365%	1	1303	60	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CROONQUIST_STROMAL_STIMULATION_UP
0.0767459708365%	1	1303	60	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.0767459708365%	1	1303	6	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZIRN_TRETINOIN_RESPONSE_DN
0.0767459708365%	1	1303	6	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TSAI_DNAJB4_TARGETS_DN
0.0767459708365%	1	1303	6	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN
0.0767459708365%	1	1303	6	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP
0.0767459708365%	1	1303	6	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_DN
0.0767459708365%	1	1303	6	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OHM_EMBRYONIC_CARCINOMA_UP
0.0767459708365%	1	1303	6	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOTAMED_RESPONSE_TO_ANDROGEN_DN
0.0767459708365%	1	1303	6	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MAINA_HYPOXIA_VHL_TARGETS_UP
0.0767459708365%	1	1303	6	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KORKOLA_CHORIOCARCINOMA
0.0767459708365%	1	1303	6	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IGARASHI_ATF4_TARGETS_UP
0.0767459708365%	1	1303	6	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DONATO_CELL_CYCLE_TRETINOIN
0.0767459708365%	1	1303	6	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	COURTOIS_SENESCENCE_TRIGGERS
0.0767459708365%	1	1303	59	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
0.0767459708365%	1	1303	59	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP
0.0767459708365%	1	1303	59	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
0.0767459708365%	1	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WAKASUGI_HAVE_ZNF143_BINDING_SITES
0.0767459708365%	1	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_REGULATION_OF_APOPTOSIS
0.0767459708365%	1	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_SHP2_PATHWAY
0.0767459708365%	1	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIM_MAMMARY_LUMINAL_PROGENITOR_UP
0.0767459708365%	1	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_ARACHIDONIC_ACID_METABOLISM
0.0767459708365%	1	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JI_RESPONSE_TO_FSH_DN
0.0767459708365%	1	1303	58	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
0.0767459708365%	1	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAMASHITA_METHYLATED_IN_PROSTATE_CANCER
0.0767459708365%	1	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PEART_HDAC_PROLIFERATION_CLUSTER_UP
0.0767459708365%	1	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCCLUNG_CREB1_TARGETS_DN
0.0767459708365%	1	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DIRMEIER_LMP1_RESPONSE_LATE_UP
0.0767459708365%	1	1303	57	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DELASERNA_MYOD_TARGETS_DN
0.0767459708365%	1	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WORSCHECH_TUMOR_REJECTION_UP
0.0767459708365%	1	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PI_3K_CASCADE
0.0767459708365%	1	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION
0.0767459708365%	1	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX
0.0767459708365%	1	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MAYBURD_RESPONSE_TO_L663536_DN
0.0767459708365%	1	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP
0.0767459708365%	1	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HENDRICKS_SMARCA4_TARGETS_UP
0.0767459708365%	1	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GYORFFY_DOXORUBICIN_RESISTANCE
0.0767459708365%	1	1303	56	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_NFAT_PATHWAY
0.0767459708365%	1	1303	55	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TIEN_INTESTINE_PROBIOTICS_6HR_UP
0.0767459708365%	1	1303	55	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SU_LIVER
0.0767459708365%	1	1303	55	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ION_CHANNEL_TRANSPORT
0.0767459708365%	1	1303	55	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_FGF_PATHWAY
0.0767459708365%	1	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHOU_TNF_SIGNALING_4HR
0.0767459708365%	1	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
0.0767459708365%	1	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SU_PANCREAS
0.0767459708365%	1	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SUNG_METASTASIS_STROMA_DN
0.0767459708365%	1	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROVERSI_GLIOMA_COPY_NUMBER_DN
0.0767459708365%	1	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM
0.0767459708365%	1	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE
0.0767459708365%	1	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP
0.0767459708365%	1	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_IPS_ICP_WITH_H3K27ME3
0.0767459708365%	1	1303	54	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARSON_FOXP3_TARGETS_DN
0.0767459708365%	1	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STARK_HYPPOCAMPUS_22Q11_DELETION_UP
0.0767459708365%	1	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PROTEIN_FOLDING
0.0767459708365%	1	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0
0.0767459708365%	1	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_CD8TCRPATHWAY
0.0767459708365%	1	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_AR_TF_PATHWAY
0.0767459708365%	1	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MORI_IMMATURE_B_LYMPHOCYTE_UP
0.0767459708365%	1	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIANG_SILENCED_BY_METHYLATION_2
0.0767459708365%	1	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
0.0767459708365%	1	1303	53	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP
0.0767459708365%	1	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN
0.0767459708365%	1	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.0767459708365%	1	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GABA_RECEPTOR_ACTIVATION
0.0767459708365%	1	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6
0.0767459708365%	1	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KENNY_CTNNB1_TARGETS_DN
0.0767459708365%	1	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_TASTE_TRANSDUCTION
0.0767459708365%	1	1303	52	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HALMOS_CEBPA_TARGETS_UP
0.0767459708365%	1	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF
0.0767459708365%	1	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.0767459708365%	1	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_BARRETTS_ESOPHAGUS_UP
0.0767459708365%	1	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.0767459708365%	1	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT
0.0767459708365%	1	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS
0.0767459708365%	1	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1
0.0767459708365%	1	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_DRUG_METABOLISM_OTHER_ENZYMES
0.0767459708365%	1	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
0.0767459708365%	1	1303	51	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAIRKEE_CANCER_PRONE_RESPONSE_BPA
0.0767459708365%	1	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YANG_BREAST_CANCER_ESR1_LASER_DN
0.0767459708365%	1	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROY_WOUND_BLOOD_VESSEL_UP
0.0767459708365%	1	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PARK_HSC_AND_MULTIPOTENT_PROGENITORS
0.0767459708365%	1	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KOHOUTEK_CCNT1_TARGETS
0.0767459708365%	1	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOFMANN_CELL_LYMPHOMA_UP
0.0767459708365%	1	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_5_DN
0.0767459708365%	1	1303	50	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIBA_RESPONSE_TO_TSA
0.0767459708365%	1	1303	5	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VERRECCHIA_RESPONSE_TO_TGFB1_C6
0.0767459708365%	1	1303	5	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMID_BREAST_CANCER_ERBB2_DN
0.0767459708365%	1	1303	5	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_3
0.0767459708365%	1	1303	5	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FUJIWARA_PARK2_IN_LIVER_CANCER_DN
0.0767459708365%	1	1303	5	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ABDULRAHMAN_KIDNEY_CANCER_VHL_UP
0.0767459708365%	1	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8
0.0767459708365%	1	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC
0.0767459708365%	1	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_PI3KCIPATHWAY
0.0767459708365%	1	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OLSSON_E2F3_TARGETS_DN
0.0767459708365%	1	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MANTOVANI_VIRAL_GPCR_SIGNALING_DN
0.0767459708365%	1	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN
0.0767459708365%	1	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FAELT_B_CLL_WITH_VH3_21_DN
0.0767459708365%	1	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAUER_STAT3_TARGETS_UP
0.0767459708365%	1	1303	49	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_2HR_DN
0.0767459708365%	1	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_MS_UP
0.0767459708365%	1	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MUSCLE_CONTRACTION
0.0767459708365%	1	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY
0.0767459708365%	1	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES
0.0767459708365%	1	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6
0.0767459708365%	1	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RASHI_RESPONSE_TO_IONIZING_RADIATION_3
0.0767459708365%	1	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_HEDGEHOG_GLIPATHWAY
0.0767459708365%	1	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_AJDISS_2PATHWAY
0.0767459708365%	1	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCDOWELL_ACUTE_LUNG_INJURY_DN
0.0767459708365%	1	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN
0.0767459708365%	1	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
0.0767459708365%	1	1303	48	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ABE_INNER_EAR
0.0767459708365%	1	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCCLUNG_DELTA_FOSB_TARGETS_8WK
0.0767459708365%	1	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KHETCHOUMIAN_TRIM24_TARGETS_UP
0.0767459708365%	1	1303	47	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_8HR_DN
0.0767459708365%	1	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TSENG_ADIPOGENIC_POTENTIAL_DN
0.0767459708365%	1	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_TNFPATHWAY
0.0767459708365%	1	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_PLK1_PATHWAY
0.0767459708365%	1	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_A6B1_A6B4_INTEGRIN_PATHWAY
0.0767459708365%	1	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MADAN_DPPA4_TARGETS
0.0767459708365%	1	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KUNINGER_IGF1_VS_PDGFB_TARGETS_DN
0.0767459708365%	1	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_60_HELA
0.0767459708365%	1	1303	46	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ABBUD_LIF_SIGNALING_1_UP
0.0767459708365%	1	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_V2_LATE_DIFFERENTIATION_GENES
0.0767459708365%	1	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD2_UP
0.0767459708365%	1	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD1_DN
0.0767459708365%	1	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_TARGETS_OF_MLL_CBP_FUSION_DN
0.0767459708365%	1	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS
0.0767459708365%	1	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAKAMURA_METASTASIS_MODEL_UP
0.0767459708365%	1	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LUI_THYROID_CANCER_PAX8_PPARG_DN
0.0767459708365%	1	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN
0.0767459708365%	1	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KLEIN_TARGETS_OF_BCR_ABL1_FUSION
0.0767459708365%	1	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP
0.0767459708365%	1	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.0767459708365%	1	1303	45	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ABRAMSON_INTERACT_WITH_AIRE
0.0767459708365%	1	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZUCCHI_METASTASIS_DN
0.0767459708365%	1	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_PR_DN
0.0767459708365%	1	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	XU_CREBBP_TARGETS_DN
0.0767459708365%	1	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROVERSI_GLIOMA_LOH_REGIONS
0.0767459708365%	1	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
0.0767459708365%	1	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS
0.0767459708365%	1	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_
0.0767459708365%	1	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_ERBB2ERBB3PATHWAY
0.0767459708365%	1	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_LYSINE_DEGRADATION
0.0767459708365%	1	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HARRIS_BRAIN_CANCER_PROGENITORS
0.0767459708365%	1	1303	44	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY
0.0767459708365%	1	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ULE_SPLICING_VIA_NOVA2
0.0767459708365%	1	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS
0.0767459708365%	1	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PLC_BETA_MEDIATED_EVENTS
0.0767459708365%	1	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
0.0767459708365%	1	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_INTEGRIN3_PATHWAY
0.0767459708365%	1	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_CXCR3PATHWAY
0.0767459708365%	1	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MILI_PSEUDOPODIA
0.0767459708365%	1	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MANTOVANI_NFKB_TARGETS_UP
0.0767459708365%	1	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.0767459708365%	1	1303	43	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IKEDA_MIR133_TARGETS_UP
0.0767459708365%	1	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_EARLY_DIFFERENTIATION_GENES_DN
0.0767459708365%	1	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WIERENGA_PML_INTERACTOME
0.0767459708365%	1	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP
0.0767459708365%	1	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_UPA_UPAR_PATHWAY
0.0767459708365%	1	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MODY_HIPPOCAMPUS_PRENATAL
0.0767459708365%	1	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_ES_ICP_WITH_H3K27ME3
0.0767459708365%	1	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER
0.0767459708365%	1	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEIN_ASTROCYTE_MARKERS
0.0767459708365%	1	1303	42	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_40_HELA
0.0767459708365%	1	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_DN
0.0767459708365%	1	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.0767459708365%	1	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION_HBZ
0.0767459708365%	1	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_IL_2_SIGNALING
0.0767459708365%	1	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_ER_NONGENOMIC_PATHWAY
0.0767459708365%	1	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ONO_AML1_TARGETS_DN
0.0767459708365%	1	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIN_MELANOMA_COPY_NUMBER_DN
0.0767459708365%	1	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KAMMINGA_EZH2_TARGETS
0.0767459708365%	1	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
0.0767459708365%	1	1303	41	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHEN_HOXA5_TARGETS_9HR_DN
0.0767459708365%	1	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.0767459708365%	1	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VARELA_ZMPSTE24_TARGETS_UP
0.0767459708365%	1	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VALK_AML_WITH_FLT3_ITD
0.0767459708365%	1	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TOMLINS_PROSTATE_CANCER_DN
0.0767459708365%	1	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_B_CELL_ANTIGEN_RECEPTOR
0.0767459708365%	1	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION_CCNE1
0.0767459708365%	1	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIAO_HAVE_SOX4_BINDING_SITES
0.0767459708365%	1	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS
0.0767459708365%	1	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_TRYPTOPHAN_METABOLISM
0.0767459708365%	1	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_SPHINGOLIPID_METABOLISM
0.0767459708365%	1	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_PYRUVATE_METABOLISM
0.0767459708365%	1	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JIANG_AGING_HYPOTHALAMUS_DN
0.0767459708365%	1	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
0.0767459708365%	1	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ELLWOOD_MYC_TARGETS_DN
0.0767459708365%	1	1303	40	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN
0.0767459708365%	1	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WHITEHURST_PACLITAXEL_SENSITIVITY
0.0767459708365%	1	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2
0.0767459708365%	1	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN
0.0767459708365%	1	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NCAM1_INTERACTIONS
0.0767459708365%	1	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_IL1_SIGNALING
0.0767459708365%	1	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_RET_PATHWAY
0.0767459708365%	1	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_AURORA_B_PATHWAY
0.0767459708365%	1	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KORKOLA_TERATOMA
0.0767459708365%	1	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOFMANN_CELL_LYMPHOMA_DN
0.0767459708365%	1	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
0.0767459708365%	1	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_PEAK_AT_8HR
0.0767459708365%	1	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP
0.0767459708365%	1	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BILANGES_RAPAMYCIN_SENSITIVE_GENES
0.0767459708365%	1	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BEIER_GLIOMA_STEM_CELL_UP
0.0767459708365%	1	1303	39	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMIT_SERUM_RESPONSE_480_MCF10A
0.0767459708365%	1	1303	389	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_OLFACTORY_TRANSDUCTION
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YOKOE_CANCER_TESTIS_ANTIGENS
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TERAO_AOX4_TARGETS_SKIN_UP
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SPIRA_SMOKERS_LUNG_CANCER_UP
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PI3K_AKT_ACTIVATION
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GABA_B_RECEPTOR_ACTIVATION
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GAB1_SIGNALOSOME
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_FASPATHWAY
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_ERBB4_PATHWAY
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PENG_GLUTAMINE_DEPRIVATION_UP
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAKAMURA_ADIPOGENESIS_LATE_DN
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAKAMURA_ADIPOGENESIS_EARLY_DN
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEEN_RESPONSE_TO_ROSIGLITAZONE_UP
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRADE_COLON_VS_RECTAL_CANCER_UP
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHANDRAN_METASTASIS_TOP50_UP
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CERVERA_SDHB_TARGETS_1_DN
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
0.0767459708365%	1	1303	38	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	APPIERTO_RESPONSE_TO_FENRETINIDE_UP
0.0767459708365%	1	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN
0.0767459708365%	1	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN
0.0767459708365%	1	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY
0.0767459708365%	1	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_P38_MAPK_PATHWAY
0.0767459708365%	1	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING
0.0767459708365%	1	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_GMCSF_PATHWAY
0.0767459708365%	1	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_FRA_PATHWAY
0.0767459708365%	1	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED
0.0767459708365%	1	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES
0.0767459708365%	1	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_TOLL_PATHWAY
0.0767459708365%	1	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_PAR1_PATHWAY
0.0767459708365%	1	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_MET_PATHWAY
0.0767459708365%	1	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_GPCR_PATHWAY
0.0767459708365%	1	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_ALK_PATHWAY
0.0767459708365%	1	1303	37	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BILANGES_SERUM_RESPONSE_TRANSLATION
0.0767459708365%	1	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YANG_BREAST_CANCER_ESR1_UP
0.0767459708365%	1	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VALK_AML_CLUSTER_11
0.0767459708365%	1	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_ADRENERGIC
0.0767459708365%	1	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SEMENZA_HIF1_TARGETS
0.0767459708365%	1	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALLING_TO_ERKS
0.0767459708365%	1	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_IRON_UPTAKE_AND_TRANSPORT
0.0767459708365%	1	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_FRS2_MEDIATED_CASCADE
0.0767459708365%	1	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIU_CDX2_TARGETS_UP
0.0767459708365%	1	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HUANG_FOXA2_TARGETS_DN
0.0767459708365%	1	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOUSTIS_ROS
0.0767459708365%	1	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP
0.0767459708365%	1	1303	36	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN
0.0767459708365%	1	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15
0.0767459708365%	1	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_METHYLATED_IN_BREAST_CANCER
0.0767459708365%	1	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_G_ALPHA_I_PATHWAY
0.0767459708365%	1	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_HIVNEFPATHWAY
0.0767459708365%	1	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_ARF6_PATHWAY
0.0767459708365%	1	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP
0.0767459708365%	1	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.0767459708365%	1	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MODY_HIPPOCAMPUS_NEONATAL
0.0767459708365%	1	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LI_CISPLATIN_RESISTANCE_DN
0.0767459708365%	1	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_PRION_DISEASES
0.0767459708365%	1	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_BASE_EXCISION_REPAIR
0.0767459708365%	1	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GUTIERREZ_MULTIPLE_MYELOMA_DN
0.0767459708365%	1	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN
0.0767459708365%	1	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DORSAM_HOXA9_TARGETS_UP
0.0767459708365%	1	1303	35	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BALDWIN_PRKCI_TARGETS_UP
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YANG_BREAST_CANCER_ESR1_LASER_UP
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SUMI_HNF4A_TARGETS
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNAL_TRANSDUCTION_BY_L1
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GLUCONEOGENESIS
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_MAPKTRKPATHWAY
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_IL1PATHWAY
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_HIF2PATHWAY
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_EPOPATHWAY
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PETRETTO_CARDIAC_HYPERTROPHY
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MEISSNER_ES_ICP_WITH_H3K4ME3
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LUI_TARGETS_OF_PAX8_PPARG_FUSION
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_CYSTEINE_AND_METHIONINE_METABOLISM
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HONMA_DOCETAXEL_RESISTANCE
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FRIDMAN_IMMORTALIZATION_DN
0.0767459708365%	1	1303	34	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VALK_AML_CLUSTER_5
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SIMBULAN_UV_RESPONSE_NORMAL_DN
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHRAETS_MLL_TARGETS_DN
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_IL12_STAT4PATHWAY
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_ALPHASYNUCLEIN_PATHWAY
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_ETHER_LIPID_METABOLISM
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JEPSEN_SMRT_TARGETS
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GHANDHI_DIRECT_IRRADIATION_DN
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHO_NR4A1_TARGETS
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAFFAREL_RESPONSE_TO_THC_UP
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_DEATH_PATHWAY
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN
0.0767459708365%	1	1303	33	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	APPEL_IMATINIB_RESPONSE
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZWANG_EGF_PERSISTENTLY_UP
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TRACEY_RESISTANCE_TO_IFNA2_DN
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ELONGATION_ARREST_AND_RECOVERY
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_DAG_AND_IP3_SIGNALING
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_COMPLEMENT_CASCADE
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_SYNDECAN_4_PATHWAY
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_NETRIN_PATHWAY
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOOTHA_GLUCONEOGENESIS
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MEISSNER_BRAIN_ICP_WITH_H3K4ME3
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIANG_SILENCED_BY_METHYLATION_UP
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GROSS_ELK3_TARGETS_DN
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DIRMEIER_LMP1_RESPONSE_LATE_DN
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_HDAC_PATHWAY
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BAUS_TFF2_TARGETS_UP
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BAE_BRCA1_TARGETS_DN
0.0767459708365%	1	1303	32	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMIT_SERUM_RESPONSE_40_MCF10A
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VALK_AML_CLUSTER_15
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TING_SILENCED_BY_DICER
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	THEODOROU_MAMMARY_TUMORIGENESIS
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SIMBULAN_PARP1_TARGETS_UP
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_CD40_PATHWAY
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_AR_NONGENOMIC_PATHWAY
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NOJIMA_SFRP2_TARGETS_UP
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOSERLE_IFNA_RESPONSE
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DORSEY_GAB2_TARGETS
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP
0.0767459708365%	1	1303	31	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.0767459708365%	1	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN
0.0767459708365%	1	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VALK_AML_CLUSTER_13
0.0767459708365%	1	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VALK_AML_CLUSTER_12
0.0767459708365%	1	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SU_PLACENTA
0.0767459708365%	1	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NOD1_2_SIGNALING_PATHWAY
0.0767459708365%	1	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CA_DEPENDENT_EVENTS
0.0767459708365%	1	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN
0.0767459708365%	1	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_IL2_STAT5PATHWAY
0.0767459708365%	1	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP
0.0767459708365%	1	1303	30	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GILDEA_METASTASIS
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WOTTON_RUNX_TARGETS_DN
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WEINMANN_ADAPTATION_TO_HYPOXIA_UP
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_RESPONSE_TO_BEXAROTENE_DN
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_RESPONSE_TO_ANDROGEN_UP
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VALK_AML_CLUSTER_2
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TIGHT_JUNCTION_INTERACTIONS
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GLYCOLYSIS
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_REELINPATHWAY
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PAL_PRMT5_TARGETS_DN
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAKAYAMA_FGF2_TARGETS
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARSON_FOXP3_TARGETS_STIMULATED_UP
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LU_TUMOR_VASCULATURE_UP
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KRIGE_AMINO_ACID_DEPRIVATION
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_HISTIDINE_METABOLISM
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_VIP_PATHWAY
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_TNFR1_PATHWAY
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AIYAR_COBRA1_TARGETS_DN
0.0767459708365%	1	1303	29	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ABE_VEGFA_TARGETS_30MIN
0.0767459708365%	1	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VALK_AML_CLUSTER_1
0.0767459708365%	1	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS
0.0767459708365%	1	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_TRAIL_PATHWAY
0.0767459708365%	1	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_LIS1PATHWAY
0.0767459708365%	1	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PETRETTO_HEART_MASS_QTL_CIS_UP
0.0767459708365%	1	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OLSSON_E2F3_TARGETS_UP
0.0767459708365%	1	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOREIRA_RESPONSE_TO_TSA_UP
0.0767459708365%	1	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LUI_THYROID_CANCER_CLUSTER_3
0.0767459708365%	1	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KAMIKUBO_MYELOID_CEBPA_NETWORK
0.0767459708365%	1	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G24
0.0767459708365%	1	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN
0.0767459708365%	1	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.0767459708365%	1	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP
0.0767459708365%	1	1303	28	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_PROTEASOME_PATHWAY
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YANG_BREAST_CANCER_ESR1_BULK_UP
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	XU_AKT1_TARGETS_6HR
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TIEN_INTESTINE_PROBIOTICS_2HR_UP
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TERAO_AOX4_TARGETS_SKIN_DN
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_MYOCYTE_AD_PATHWAY
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_GRANULE_CELL_SURVIVAL_PATHWAY
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALLING_TO_RAS
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RECYCLING_PATHWAY_OF_L1
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GAP_JUNCTION_TRAFFICKING
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_GLYPICAN_1PATHWAY
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NICK_RESPONSE_TO_PROC_TREATMENT_DN
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LI_WILMS_TUMOR
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_DOUBLE_POLAR_THYMOCYTE
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_PENTOSE_PHOSPHATE_PATHWAY
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JI_METASTASIS_REPRESSED_BY_STK11
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IKEDA_MIR30_TARGETS_DN
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHOW_RASSF1_TARGETS_UP
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRACHAT_RESPONSE_TO_METHOTREXATE_DN
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_CREB_PATHWAY
0.0767459708365%	1	1303	27	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AKL_HTLV1_INFECTION_UP
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHENG_FOXP3_TARGETS_UP
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WILLIAMS_ESR1_TARGETS_UP
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VALK_AML_CLUSTER_16
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TOMIDA_METASTASIS_UP
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_INTEGRIN_CS_PATHWAY
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_INSULIN_GLUCOSE_PATHWAY
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NEWMAN_ERCC6_TARGETS_UP
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAKAMURA_CANCER_MICROENVIRONMENT_UP
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_SELENOAMINO_ACID_METABOLISM
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAZIN_EPIGENETIC_SILENCING_BY_KRAS
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRACHAT_RESPONSE_TO_METHOTREXATE_UP
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_RACCYCD_PATHWAY
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_BAD_PATHWAY
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ALONSO_METASTASIS_DN
0.0767459708365%	1	1303	26	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_BARRETTS_ESOPHAGUS_DN
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VERRECCHIA_RESPONSE_TO_TGFB1_C2
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VANDESLUIS_NORMAL_EMBRYOS_DN
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VALK_AML_WITH_EVI1
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RUAN_RESPONSE_TO_TROGLITAZONE_UP
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SMOOTH_MUSCLE_CONTRACTION
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_TOLL_ENDOGENOUS_PATHWAY
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_INTEGRIN_A9B1_PATHWAY
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NOJIMA_SFRP2_TARGETS_DN
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOEGERKORP_CD44_TARGETS_TEMPORAL_DN
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GENTILE_UV_HIGH_DOSE_UP
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_STRESS_PATHWAY
0.0767459708365%	1	1303	25	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_MCALPAIN_PATHWAY
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YIH_RESPONSE_TO_ARSENITE_C1
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WILLERT_WNT_SIGNALING
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SA_B_CELL_RECEPTOR_COMPLEXES
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SULFUR_AMINO_ACID_METABOLISM
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_KINESINS
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_DOUBLE_STRAND_BREAK_REPAIR
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OSADA_ASCL1_TARGETS_DN
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MAEKAWA_ATF2_TARGETS
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LA_MEN1_TARGETS
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_PROTEIN_EXPORT
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HASLINGER_B_CLL_WITH_13Q14_DELETION
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GOLUB_ALL_VS_AML_UP
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_TPO_PATHWAY
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_NOS1_PATHWAY
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_EIF4_PATHWAY
0.0767459708365%	1	1303	24	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AZARE_STAT3_TARGETS
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_INTERFERON_RESPONSE
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WU_HBX_TARGETS_2_UP
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WENG_POR_TARGETS_GLOBAL_DN
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_RESPONSE_TO_FORSKOLIN_UP
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INSULIN_RECEPTOR_RECYCLING
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_PRLSIGNALINGEVENTSPATHWAY
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HINATA_NFKB_TARGETS_KERATINOCYTE_DN
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HASLINGER_B_CLL_WITH_11Q23_DELETION
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIBA_RESPONSE_TO_TSA_DN
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHEOK_RESPONSE_TO_HD_MTX_UP
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHEN_ETV5_TARGETS_TESTIS
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAIRO_PML_TARGETS_BOUND_BY_MYC_UP
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_RAS_PATHWAY
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_NFKB_PATHWAY
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_INTRINSIC_PATHWAY
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_IL12_PATHWAY
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_IGF1R_PATHWAY
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_CTCF_PATHWAY
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_CCR3_PATHWAY
0.0767459708365%	1	1303	23	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BARIS_THYROID_CANCER_UP
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YUAN_ZNF143_PARTNERS
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WELCH_GATA1_TARGETS
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VERNELL_RETINOBLASTOMA_PATHWAY_DN
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VALK_AML_WITH_11Q23_REARRANGED
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SUZUKI_RESPONSE_TO_TSA
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_HIPPO
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_DEADENYLATION_OF_MRNA
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_HEDGEHOG_2PATHWAY
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MATZUK_IMPLANTATION_AND_UTERINE
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LU_TUMOR_ENDOTHELIAL_MARKERS_UP
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HANSON_HRAS_SIGNALING_VIA_NFKB
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRACHAT_RESPONSE_TO_CISPLATIN
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_SPPA_PATHWAY
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_IL6_PATHWAY
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_IL2_PATHWAY
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_HER2_PATHWAY
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_DC_PATHWAY
0.0767459708365%	1	1303	22	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_CHEMICAL_PATHWAY
0.0767459708365%	1	1303	215	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARKEY_RB1_ACUTE_LOF_UP
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VERRECCHIA_RESPONSE_TO_TGFB1_C5
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHURINGA_STAT5A_TARGETS_UP
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PEROXISOMAL_LIPID_METABOLISM
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_P38_MK2PATHWAY
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OUYANG_PROSTATE_CANCER_PROGRESSION_DN
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MOOTHA_GLYCOGEN_METABOLISM
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_INTRATHYMIC_T_PROGENITOR
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_GLYCOSAMINOGLYCAN_DEGRADATION
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HUI_MAPK14_TARGETS_UP
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GREENBAUM_E2A_TARGETS_DN
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GESERICK_TERT_TARGETS_DN
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FINETTI_BREAST_CANCERS_KINOME_BLUE
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FERRANDO_TAL1_NEIGHBORS
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G4
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_NDKDYNAMIN_PATHWAY
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_MITOCHONDRIA_PATHWAY
0.0767459708365%	1	1303	21	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_IGF1_PATHWAY
0.0767459708365%	1	1303	203	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INFLUENZA_LIFE_CYCLE
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WENG_POR_TARGETS_GLOBAL_UP
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_THOC1_TARGETS_DN
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WALLACE_PROSTATE_CANCER_UP
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ST_WNT_CA2_CYCLIC_GMP_PATHWAY
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_HS_GAG_DEGRADATION
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_WNT_CANONICAL_PATHWAY
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PHESSE_TARGETS_OF_APC_AND_MBD2_UP
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MURAKAMI_UV_RESPONSE_24HR
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCCABE_HOXC6_TARGETS_CANCER_DN
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MAHADEVAN_RESPONSE_TO_MP470_UP
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KORKOLA_YOLK_SAC_TUMOR_UP
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_MYCL1_AMPLIFICATION_TARGETS_DN
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HEDENFALK_BREAST_CANCER_BRACX_UP
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DE_YY1_TARGETS_UP
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	COLLIS_PRKDC_SUBSTRATES
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BARRIER_COLON_CANCER_RECURRENCE_DN
0.0767459708365%	1	1303	20	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_240_MCF10A
0.0767459708365%	1	1303	196	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KONDO_PROSTATE_CANCER_WITH_H3K27ME3
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHANG_RESPONSE_TO_CANTHARIDIN_UP
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VISALA_AGING_LYMPHOCYTE_DN
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHIN_B_CELL_LYMPHOMA_CLUSTER_9
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCIBETTA_KDM5B_TARGETS_UP
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CGMP_EFFECTS
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_BASE_EXCISION_REPAIR
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_EPHA2_FWDPATHWAY
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	OUYANG_PROSTATE_CANCER_MARKERS
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NIELSEN_LEIOMYOSARCOMA_CNN1_UP
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LI_WILMS_TUMOR_ANAPLASTIC_UP
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FARMER_BREAST_CANCER_CLUSTER_5
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_TID_PATHWAY
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_STATHMIN_PATHWAY
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_EPO_PATHWAY
0.0767459708365%	1	1303	19	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_COMP_PATHWAY
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHENG_RESPONSE_TO_ARSENITE_UP
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YIH_RESPONSE_TO_ARSENITE_C2
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_NODAL
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GAP_JUNCTION_ASSEMBLY
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PLASARI_NFIC_TARGETS_BASAL_DN
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_BETACATENIN_DEG_PATHWAY
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NIELSEN_SCHWANNOMA_UP
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NIELSEN_LEIOMYOSARCOMA_DN
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NAM_FXYD5_TARGETS_DN
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KIM_PTEN_TARGETS_UP
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KAPOSI_LIVER_CANCER_MET_UP
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHOI_ATL_CHRONIC_VS_ACUTE_DN
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_TNFR2_PATHWAY
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_TEL_PATHWAY
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_PTEN_PATHWAY
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_NGF_PATHWAY
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_ETS_PATHWAY
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_ERK5_PATHWAY
0.0767459708365%	1	1303	18	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP
0.0767459708365%	1	1303	171	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ELVIDGE_HYPOXIA_UP
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	THUM_MIR21_TARGETS_HEART_DISEASE_UP
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SA_PTEN_PATHWAY
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TIE2_SIGNALING
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SHC_RELATED_EVENTS
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INTRINSIC_PATHWAY
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ARMS_MEDIATED_ACTIVATION
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_SMAD2_3PATHWAY
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_INTEGRIN5_PATHWAY
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LI_CYTIDINE_ANALOG_PATHWAY
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LE_SKI_TARGETS_UP
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LEE_METASTASIS_AND_RNA_PROCESSING_UP
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_RENIN_ANGIOTENSIN_SYSTEM
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_ONE_CARBON_POOL_BY_FOLATE
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOWLIN_CITED1_TARGETS_2_UP
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOWLIN_CITED1_TARGETS_2_DN
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GOUYER_TATI_TARGETS_DN
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_LAIR_PATHWAY
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_IL7_PATHWAY
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_HCMV_PATHWAY
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_ARF_PATHWAY
0.0767459708365%	1	1303	17	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_41BB_PATHWAY
0.0767459708365%	1	1303	169	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	XU_RESPONSE_TO_TRETINOIN_UP
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WU_HBX_TARGETS_1_UP
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WONG_IFNA2_RESISTANCE_UP
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_DNAPK_PATHWAY
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LY_AGING_MIDDLE_DN
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LUND_SILENCED_BY_METHYLATION
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_OTHER_GLYCAN_DEGRADATION
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HAHTOLA_MYCOSIS_FUNGOIDES_DN
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GHO_ATF5_TARGETS_DN
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHIN_BREAST_CANCER_COPY_NUMBER_DN
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAFFAREL_RESPONSE_TO_THC_8HR_5_UP
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_P53_PATHWAY
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_CDMAC_PATHWAY
0.0767459708365%	1	1303	16	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BAKER_HEMATOPOIESIS_STAT3_TARGETS
0.0767459708365%	1	1303	153	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PEPTIDE_CHAIN_ELONGATION
0.0767459708365%	1	1303	150	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_30MIN_DN
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WEBER_METHYLATED_LCP_IN_SPERM_UP
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SU_KIDNEY
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STEINER_ERYTHROCYTE_MEMBRANE_GENES
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SA_G1_AND_S_PHASES
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SANDERSON_PPARA_TARGETS
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SHC_MEDIATED_SIGNALLING
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_OTHER_SEMAPHORIN_INTERACTIONS
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_POLYAMINES
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_LPA4_PATHWAY
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_ERB_GENOMIC_PATHWAY
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARKS_HDAC_TARGETS_DN
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HUMMEL_BURKITTS_LYMPHOMA_DN
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRANDVAUX_IRF3_TARGETS_UP
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	EHRLICH_ICF_SYNDROM_DN
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G3
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_NUCLEARRS_PATHWAY
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_IL3_PATHWAY
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_HSP27_PATHWAY
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_CD40_PATHWAY
0.0767459708365%	1	1303	15	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_BARRESTIN_SRC_PATHWAY
0.0767459708365%	1	1303	146	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
0.0767459708365%	1	1303	142	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	XU_GH1_AUTOCRINE_TARGETS_DN
0.0767459708365%	1	1303	142	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VERRECCHIA_RESPONSE_TO_TGFB1_C3
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ROETH_TERT_TARGETS_UP
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SOS_MEDIATED_SIGNALLING
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_TCRRASPATHWAY
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_ES_LCP_WITH_H3K27ME3
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MATZUK_OVULATION
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KINNEY_DNMT1_METHYLATION_TARGETS
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_NON_HOMOLOGOUS_END_JOINING
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CASTELLANO_NRAS_TARGETS_DN
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_CELL2CELL_PATHWAY
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP
0.0767459708365%	1	1303	14	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ABBUD_LIF_SIGNALING_2_UP
0.0767459708365%	1	1303	133	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SENESE_HDAC2_TARGETS_DN
0.0767459708365%	1	1303	132	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS
0.0767459708365%	1	1303	132	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WU_HBX_TARGETS_3_DN
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VERRECCHIA_RESPONSE_TO_TGFB1_C4
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHIN_B_CELL_LYMPHOMA_CLUSTER_1
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PURINE_SALVAGE
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MARTINELLI_IMMATURE_NEUTROPHIL_DN
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LUI_THYROID_CANCER_CLUSTER_5
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KORKOLA_EMBRYONAL_CARCINOMA
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IVANOV_MUTATED_IN_COLON_CANCER
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FRIDMAN_SENESCENCE_DN
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CONRAD_GERMLINE_STEM_CELL
0.0767459708365%	1	1303	13	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_PARKIN_PATHWAY
0.0767459708365%	1	1303	120	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CELL_CELL_COMMUNICATION
0.0767459708365%	1	1303	120	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHEBOTAEV_GR_TARGETS_DN
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SA_PROGRAMMED_CELL_DEATH
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_NOTCH2
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PYRIMIDINE_CATABOLISM
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_NPC_ICP_WITH_H3K27ME3
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MCBRYAN_TERMINAL_END_BUD_UP
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LOPEZ_MESOTHELIOMA_SURVIVAL_DN
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	EHLERS_ANEUPLOIDY_DN
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CLAUS_PGR_POSITIVE_MENINGIOMA_DN
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_LECTIN_PATHWAY
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_BARR_MAPK_PATHWAY
0.0767459708365%	1	1303	12	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_AKAP13_PATHWAY
0.0767459708365%	1	1303	116	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IKEDA_MIR30_TARGETS_UP
0.0767459708365%	1	1303	116	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN
0.0767459708365%	1	1303	112	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.0767459708365%	1	1303	111	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WANG_HCP_PROSTATE_CANCER
0.0767459708365%	1	1303	111	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MRNA_SPLICING
0.0767459708365%	1	1303	111	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SASAKI_TARGETS_OF_TP73_AND_TP63
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_UNWINDING_OF_DNA
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_TRYPTOPHAN_CATABOLISM
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PID_INTEGRIN4_PATHWAY
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MANTOVANI_NFKB_TARGETS_DN
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	LIANG_SILENCED_BY_METHYLATION_DN
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KALMA_E2F1_TARGETS
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CAFFAREL_RESPONSE_TO_THC_8HR_5_DN
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_LEPTIN_PATHWAY
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_EGFR_SMRTE_PATHWAY
0.0767459708365%	1	1303	11	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_CDK5_PATHWAY
0.0767459708365%	1	1303	107	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.0767459708365%	1	1303	105	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	STEIN_ESRRA_TARGETS_DN
0.0767459708365%	1	1303	105	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_8HR_UP
0.0767459708365%	1	1303	104	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.0767459708365%	1	1303	102	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_IPS_WITH_HCP_H3K27ME3
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	YIH_RESPONSE_TO_ARSENITE_C5
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	WORSCHECH_TUMOR_REJECTION_DN
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	VISALA_AGING_LYMPHOCYTE_UP
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHIRAISHI_PLZF_TARGETS_UP
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SHANK_TAL1_TARGETS_DN
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHLESINGER_METHYLATED_IN_COLON_CANCER
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_RAF_MAP_KINASE_CASCADE
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_PURINE_CATABOLISM
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_COPI_MEDIATED_TRANSPORT
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	PYEON_HPV_POSITIVE_TUMORS_DN
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	MAINA_VHL_TARGETS_UP
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	KONG_E2F1_TARGETS
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	JU_AGING_TERC_TARGETS_UP
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	HOLLEMAN_DAUNORUBICIN_B_ALL_UP
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	GOUYER_TATI_TARGETS_UP
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CLAUS_PGR_POSITIVE_MENINGIOMA_UP
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BUDHU_LIVER_CANCER_METASTASIS_UP
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BRUNEAU_SEPTATION_VENTRICULAR
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_SARS_PATHWAY
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_GLYCOLYSIS_PATHWAY
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_GABA_PATHWAY
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BIOCARTA_EPHA4_PATHWAY
0.0767459708365%	1	1303	10	T2D_GENES_TANYA_T2D_RSQ05_02CM_300K	BAKER_HEMATOPOESIS_STAT1_TARGETS
0.0568181818182%	2	3520	91	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.0568181818182%	2	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHU_SKIL_TARGETS_DN
0.0568181818182%	2	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN
0.0568181818182%	2	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	THILLAINADESAN_ZNF217_TARGETS_DN
0.0568181818182%	2	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHIRAISHI_PLZF_TARGETS_DN
0.0568181818182%	2	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SASSON_FSH_RESPONSE
0.0568181818182%	2	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30
0.0568181818182%	2	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21
0.0568181818182%	2	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP
0.0568181818182%	2	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION
0.0568181818182%	2	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	COLLER_MYC_TARGETS_DN
0.0568181818182%	2	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA
0.0568181818182%	2	3520	81	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRABARCZYK_BCL11B_TARGETS_UP
0.0568181818182%	2	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR
0.0568181818182%	2	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN
0.0568181818182%	2	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN
0.0568181818182%	2	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OXFORD_RALB_TARGETS_UP
0.0568181818182%	2	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NOUSHMEHR_GBM_GERMLINE_MUTATED
0.0568181818182%	2	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATZUK_LUTEAL_GENES
0.0568181818182%	2	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KHETCHOUMIAN_TRIM24_TARGETS_DN
0.0568181818182%	2	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GALI_TP53_TARGETS_APOPTOTIC_UP
0.0568181818182%	2	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FUJIWARA_PARK2_IN_LIVER_CANCER_UP
0.0568181818182%	2	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TESAR_ALK_TARGETS_HUMAN_ES_5D_DN
0.0568181818182%	2	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_PAC1_RECEPTOR_PATHWAY
0.0568181818182%	2	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHRAMM_INHBA_TARGETS_UP
0.0568181818182%	2	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PETRETTO_BLOOD_PRESSURE_DN
0.0568181818182%	2	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKI_COEXPRESSED_WITH_CYP19A1
0.0568181818182%	2	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP
0.0568181818182%	2	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN
0.0568181818182%	2	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KUWANO_RNA_STABILIZED_BY_NO
0.0568181818182%	2	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.0568181818182%	2	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KONDO_COLON_CANCER_HCP_WITH_H3K27ME3
0.0568181818182%	2	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES
0.0568181818182%	2	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3
0.0568181818182%	2	3520	62	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CORRE_MULTIPLE_MYELOMA_DN
0.0568181818182%	2	3520	60	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WIERENGA_STAT5A_TARGETS_GROUP2
0.0568181818182%	2	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TRACEY_RESISTANCE_TO_IFNA2_UP
0.0568181818182%	2	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN
0.0568181818182%	2	3520	59	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ONDER_CDH1_TARGETS_3_DN
0.0568181818182%	2	3520	58	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_COLLAGEN_FORMATION
0.0568181818182%	2	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN
0.0568181818182%	2	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MAYBURD_RESPONSE_TO_L663536_DN
0.0568181818182%	2	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GYORFFY_DOXORUBICIN_RESISTANCE
0.0568181818182%	2	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_10HR_DN
0.0568181818182%	2	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
0.0568181818182%	2	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ISHIDA_E2F_TARGETS
0.0568181818182%	2	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM
0.0568181818182%	2	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.0568181818182%	2	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KANG_GIST_WITH_PDGFRA_UP
0.0568181818182%	2	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMID_BREAST_CANCER_ERBB2_DN
0.0568181818182%	2	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RODRIGUES_DCC_TARGETS_UP
0.0568181818182%	2	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OZANNE_AP1_TARGETS_DN
0.0568181818182%	2	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NICK_RESPONSE_TO_PROC_TREATMENT_UP
0.0568181818182%	2	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCGOWAN_RSP6_TARGETS_DN
0.0568181818182%	2	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LAU_APOPTOSIS_CDKN2A_DN
0.0568181818182%	2	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN
0.0568181818182%	2	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP
0.0568181818182%	2	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_METABOLISM_OF_NON_CODING_RNA
0.0568181818182%	2	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_LB_UP
0.0568181818182%	2	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PI_METABOLISM
0.0568181818182%	2	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DELACROIX_RAR_TARGETS_UP
0.0568181818182%	2	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
0.0568181818182%	2	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN
0.0568181818182%	2	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCCLUNG_DELTA_FOSB_TARGETS_8WK
0.0568181818182%	2	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEONARD_HYPOXIA
0.0568181818182%	2	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD2_DN
0.0568181818182%	2	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TSENG_ADIPOGENIC_POTENTIAL_DN
0.0568181818182%	2	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OSADA_ASCL1_TARGETS_UP
0.0568181818182%	2	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAMURA_CANCER_MICROENVIRONMENT_DN
0.0568181818182%	2	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KRASNOSELSKAYA_ILF3_TARGETS_DN
0.0568181818182%	2	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_N_GLYCAN_BIOSYNTHESIS
0.0568181818182%	2	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_CD1_DN
0.0568181818182%	2	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TRAYNOR_RETT_SYNDROM_UP
0.0568181818182%	2	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMITH_LIVER_CANCER
0.0568181818182%	2	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_G2_M_CHECKPOINTS
0.0568181818182%	2	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NUTT_GBM_VS_AO_GLIOMA_DN
0.0568181818182%	2	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY
0.0568181818182%	2	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP
0.0568181818182%	2	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_MULTIPLE_MYELOMA_LB_DN
0.0568181818182%	2	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING
0.0568181818182%	2	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LANDIS_BREAST_CANCER_PROGRESSION_UP
0.0568181818182%	2	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KORKOLA_SEMINOMA_UP
0.0568181818182%	2	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HARRIS_BRAIN_CANCER_PROGENITORS
0.0568181818182%	2	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY
0.0568181818182%	2	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS
0.0568181818182%	2	3520	43	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IKEDA_MIR133_TARGETS_UP
0.0568181818182%	2	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YU_MYC_TARGETS_UP
0.0568181818182%	2	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER
0.0568181818182%	2	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HAHTOLA_SEZARY_SYNDROM_DN
0.0568181818182%	2	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_IL_2_SIGNALING
0.0568181818182%	2	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ERBB1_INTERNALIZATION_PATHWAY
0.0568181818182%	2	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAMMINGA_EZH2_TARGETS
0.0568181818182%	2	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAAB_FAILED_HEART_VENTRICLE_DN
0.0568181818182%	2	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CROONQUIST_NRAS_SIGNALING_UP
0.0568181818182%	2	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TOMLINS_PROSTATE_CANCER_DN
0.0568181818182%	2	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
0.0568181818182%	2	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP
0.0568181818182%	2	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER
0.0568181818182%	2	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION
0.0568181818182%	2	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHESLER_BRAIN_HIGHEST_EXPRESSION
0.0568181818182%	2	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMUNDSON_GAMMA_RADIATION_RESPONSE
0.0568181818182%	2	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NCAM1_INTERACTIONS
0.0568181818182%	2	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ATR_PATHWAY
0.0568181818182%	2	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP
0.0568181818182%	2	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BEIER_GLIOMA_STEM_CELL_UP
0.0568181818182%	2	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER
0.0568181818182%	2	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS
0.0568181818182%	2	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS
0.0568181818182%	2	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_FASPATHWAY
0.0568181818182%	2	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ONGUSAHA_TP53_TARGETS
0.0568181818182%	2	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRADE_COLON_VS_RECTAL_CANCER_UP
0.0568181818182%	2	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP
0.0568181818182%	2	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN
0.0568181818182%	2	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FRASOR_RESPONSE_TO_ESTRADIOL_UP
0.0568181818182%	2	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CUI_TCF21_TARGETS_UP
0.0568181818182%	2	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_FRS2_MEDIATED_CASCADE
0.0568181818182%	2	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
0.0568181818182%	2	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_CDX2_TARGETS_UP
0.0568181818182%	2	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP
0.0568181818182%	2	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WESTON_VEGFA_TARGETS_12HR
0.0568181818182%	2	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES
0.0568181818182%	2	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MODY_HIPPOCAMPUS_NEONATAL
0.0568181818182%	2	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN
0.0568181818182%	2	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.0568181818182%	2	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SUMI_HNF4A_TARGETS
0.0568181818182%	2	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GLUCONEOGENESIS
0.0568181818182%	2	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PLASARI_TGFB1_TARGETS_1HR_UP
0.0568181818182%	2	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_IL1PATHWAY
0.0568181818182%	2	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ATM_PATHWAY
0.0568181818182%	2	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DOANE_BREAST_CANCER_CLASSES_DN
0.0568181818182%	2	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP
0.0568181818182%	2	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STAEGE_EWING_FAMILY_TUMOR
0.0568181818182%	2	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT
0.0568181818182%	2	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP
0.0568181818182%	2	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MORI_PLASMA_CELL_DN
0.0568181818182%	2	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN
0.0568181818182%	2	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRADE_COLON_CANCER_DN
0.0568181818182%	2	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_DEATH_PATHWAY
0.0568181818182%	2	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS
0.0568181818182%	2	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE
0.0568181818182%	2	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN
0.0568181818182%	2	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM
0.0568181818182%	2	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
0.0568181818182%	2	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP
0.0568181818182%	2	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_CLUSTER_15
0.0568181818182%	2	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SIMBULAN_PARP1_TARGETS_UP
0.0568181818182%	2	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNAL_AMPLIFICATION
0.0568181818182%	2	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INWARDLY_RECTIFYING_K_CHANNELS
0.0568181818182%	2	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOSERLE_IFNA_RESPONSE
0.0568181818182%	2	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP
0.0568181818182%	2	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAFFAREL_RESPONSE_TO_THC_DN
0.0568181818182%	2	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP
0.0568181818182%	2	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.0568181818182%	2	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_CLUSTER_12
0.0568181818182%	2	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_ROBO_RECEPTOR
0.0568181818182%	2	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_RAS_PATHWAY
0.0568181818182%	2	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_IL2_STAT5PATHWAY
0.0568181818182%	2	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LI_PROSTATE_CANCER_EPIGENETIC
0.0568181818182%	2	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_BREAST_CANCER
0.0568181818182%	2	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_O_GLYCAN_BIOSYNTHESIS
0.0568181818182%	2	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
0.0568181818182%	2	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HEIDENBLAD_AMPLICON_12P11_12_DN
0.0568181818182%	2	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DASU_IL6_SIGNALING_SCAR_UP
0.0568181818182%	2	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BURTON_ADIPOGENESIS_10
0.0568181818182%	2	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_FAS_PATHWAY
0.0568181818182%	2	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_CLUSTER_2
0.0568181818182%	2	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN
0.0568181818182%	2	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_TCRCALCIUMPATHWAY
0.0568181818182%	2	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_BARD1PATHWAY
0.0568181818182%	2	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PATTERSON_DOCETAXEL_RESISTANCE
0.0568181818182%	2	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAYAMA_FGF2_TARGETS
0.0568181818182%	2	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MAYBURD_RESPONSE_TO_L663536_UP
0.0568181818182%	2	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN
0.0568181818182%	2	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DORN_ADENOVIRUS_INFECTION_12HR_UP
0.0568181818182%	2	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.0568181818182%	2	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TIAN_TNF_SIGNALING_VIA_NFKB
0.0568181818182%	2	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHIN_B_CELL_LYMPHOMA_CLUSTER_3
0.0568181818182%	2	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING
0.0568181818182%	2	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_WNT_SIGNALING_PATHWAY
0.0568181818182%	2	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_TRAIL_PATHWAY
0.0568181818182%	2	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_HOMOLOGOUS_RECOMBINATION
0.0568181818182%	2	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HWANG_PROSTATE_CANCER_MARKERS
0.0568181818182%	2	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.0568181818182%	2	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.0568181818182%	2	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN
0.0568181818182%	2	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP
0.0568181818182%	2	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_PROTEASOME_PATHWAY
0.0568181818182%	2	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_G1_PATHWAY
0.0568181818182%	2	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TERAO_AOX4_TARGETS_SKIN_DN
0.0568181818182%	2	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS
0.0568181818182%	2	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN
0.0568181818182%	2	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION
0.0568181818182%	2	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS
0.0568181818182%	2	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS
0.0568181818182%	2	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LOPES_METHYLATED_IN_COLON_CANCER_UP
0.0568181818182%	2	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOEGERKORP_CD44_TARGETS_DIRECT_UP
0.0568181818182%	2	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GROSS_ELK3_TARGETS_UP
0.0568181818182%	2	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHOW_RASSF1_TARGETS_UP
0.0568181818182%	2	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRACHAT_RESPONSE_TO_METHOTREXATE_DN
0.0568181818182%	2	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHENG_FOXP3_TARGETS_UP
0.0568181818182%	2	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WALLACE_JAK2_TARGETS_UP
0.0568181818182%	2	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS
0.0568181818182%	2	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS
0.0568181818182%	2	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_IL27PATHWAY
0.0568181818182%	2	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_WNT_PATHWAY
0.0568181818182%	2	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ALONSO_METASTASIS_DN
0.0568181818182%	2	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ABBUD_LIF_SIGNALING_1_DN
0.0568181818182%	2	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WAGNER_APO2_SENSITIVITY
0.0568181818182%	2	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STEGER_ADIPOGENESIS_DN
0.0568181818182%	2	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN
0.0568181818182%	2	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
0.0568181818182%	2	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS
0.0568181818182%	2	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN
0.0568181818182%	2	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG
0.0568181818182%	2	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_DORSO_VENTRAL_AXIS_FORMATION
0.0568181818182%	2	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN
0.0568181818182%	2	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOEGERKORP_CD44_TARGETS_TEMPORAL_DN
0.0568181818182%	2	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	COLLER_MYC_TARGETS_UP
0.0568181818182%	2	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN
0.0568181818182%	2	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WILLERT_WNT_SIGNALING
0.0568181818182%	2	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_LSD1_TARGETS_UP
0.0568181818182%	2	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_KINESINS
0.0568181818182%	2	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DOUBLE_STRAND_BREAK_REPAIR
0.0568181818182%	2	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ODONNELL_METASTASIS_DN
0.0568181818182%	2	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED
0.0568181818182%	2	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATZUK_SPERMATOGONIA
0.0568181818182%	2	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PROTEIN_EXPORT
0.0568181818182%	2	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JIANG_TIP30_TARGETS_DN
0.0568181818182%	2	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP
0.0568181818182%	2	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DELACROIX_RAR_TARGETS_DN
0.0568181818182%	2	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN
0.0568181818182%	2	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_INTERFERON_RESPONSE
0.0568181818182%	2	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WU_HBX_TARGETS_2_UP
0.0568181818182%	2	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A
0.0568181818182%	2	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SEKI_INFLAMMATORY_RESPONSE_LPS_DN
0.0568181818182%	2	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_BMP
0.0568181818182%	2	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING
0.0568181818182%	2	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION
0.0568181818182%	2	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HINATA_NFKB_TARGETS_KERATINOCYTE_DN
0.0568181818182%	2	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.0568181818182%	2	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN
0.0568181818182%	2	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIBA_RESPONSE_TO_TSA_DN
0.0568181818182%	2	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEOK_RESPONSE_TO_HD_MTX_UP
0.0568181818182%	2	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_MTOR_PATHWAY
0.0568181818182%	2	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_MEF2D_PATHWAY
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WELCH_GATA1_TARGETS
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VERNELL_RETINOBLASTOMA_PATHWAY_DN
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_WITH_11Q23_REARRANGED
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SUZUKI_RESPONSE_TO_TSA
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_METAL_ION_SLC_TRANSPORTERS
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_PDGFRAPATHWAY
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATZUK_IMPLANTATION_AND_UTERINE
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KANG_FLUOROURACIL_RESISTANCE_UP
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRACHAT_RESPONSE_TO_CISPLATIN
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_IL6_PATHWAY
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_DC_PATHWAY
0.0568181818182%	2	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CYTOKINE_PATHWAY
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WOTTON_RUNX_TARGETS_UP
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WENG_POR_DOSAGE
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PEROXISOMAL_LIPID_METABOLISM
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CTLA4_INHIBITORY_SIGNALING
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ADP_SIGNALLING_THROUGH_P2RY12
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MURAKAMI_UV_RESPONSE_6HR_DN
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCCABE_HOXC6_TARGETS_DN
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LANDEMAINE_LUNG_METASTASIS
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_IGF1_PATHWAY
0.0568181818182%	2	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_ATRBRCA_PATHWAY
0.0568181818182%	2	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN
0.0568181818182%	2	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WENG_POR_TARGETS_LIVER_DN
0.0568181818182%	2	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WENG_POR_TARGETS_GLOBAL_UP
0.0568181818182%	2	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TOMLINS_METASTASIS_DN
0.0568181818182%	2	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SU_THYMUS
0.0568181818182%	2	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING
0.0568181818182%	2	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NEPHRIN_INTERACTIONS
0.0568181818182%	2	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OUYANG_PROSTATE_CANCER_PROGRESSION_UP
0.0568181818182%	2	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN
0.0568181818182%	2	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MURAKAMI_UV_RESPONSE_24HR
0.0568181818182%	2	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN
0.0568181818182%	2	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MAHADEVAN_IMATINIB_RESISTANCE_DN
0.0568181818182%	2	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HEDENFALK_BREAST_CANCER_BRACX_DN
0.0568181818182%	2	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	COLLIS_PRKDC_SUBSTRATES
0.0568181818182%	2	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
0.0568181818182%	2	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_ATM_PATHWAY
0.0568181818182%	2	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_AMI_PATHWAY
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_RESPONSE_TO_CANTHARIDIN_UP
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WU_ALZHEIMER_DISEASE_DN
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VISALA_AGING_LYMPHOCYTE_DN
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SYED_ESTRADIOL_RESPONSE
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCIBETTA_KDM5B_TARGETS_UP
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SA_CASPASE_CASCADE
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_LAGGING_STRAND_SYNTHESIS
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CGMP_EFFECTS
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_HIF1APATHWAY
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_EPHA2_FWDPATHWAY
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAGY_TFTC_COMPONENTS_HUMAN
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MELLMAN_TUT1_TARGETS_UP
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LI_WILMS_TUMOR_ANAPLASTIC_UP
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KANG_AR_TARGETS_DN
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAMIKUBO_MYELOID_MN1_NETWORK
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRANDVAUX_IRF3_TARGETS_DN
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN
0.0568181818182%	2	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHENG_RESPONSE_TO_ARSENITE_DN
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YIH_RESPONSE_TO_ARSENITE_C4
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WU_HBX_TARGETS_3_UP
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TOMIDA_METASTASIS_DN
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_PC
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_NODAL
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PODAR_RESPONSE_TO_ADAPHOSTIN_DN
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OZANNE_AP1_TARGETS_UP
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIELSEN_SCHWANNOMA_UP
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIELSEN_LEIOMYOSARCOMA_UP
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NADERI_BREAST_CANCER_PROGNOSIS_DN
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PHENYLALANINE_METABOLISM
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHOI_ATL_CHRONIC_VS_ACUTE_DN
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_SPRY_PATHWAY
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_PTEN_PATHWAY
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_NGF_PATHWAY
0.0568181818182%	2	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_MCM_PATHWAY
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TIE2_SIGNALING
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_KIT_SIGNALING
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RAP1_SIGNALLING
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INTRINSIC_PATHWAY
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ANTHRAXPATHWAY
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEI_HOXC8_TARGETS_DN
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_METASTASIS_AND_RNA_PROCESSING_UP
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_STEROID_BIOSYNTHESIS
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOUYER_TATI_TARGETS_DN
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_PML_PATHWAY
0.0568181818182%	2	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_ARF_PATHWAY
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_RESPONSE_TO_TRETINOIN_UP
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WU_HBX_TARGETS_1_UP
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_CIRCADIANPATHWAY
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MACLACHLAN_BRCA1_TARGETS_DN
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LUND_SILENCED_BY_METHYLATION
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_RIBOFLAVIN_METABOLISM
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HAHTOLA_MYCOSIS_FUNGOIDES_DN
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FUKUSHIMA_TNFSF11_TARGETS
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FARMER_BREAST_CANCER_CLUSTER_4
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_P53_PATHWAY
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_IL22BP_PATHWAY
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_GATA3_PATHWAY
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_EIF_PATHWAY
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CDC42RAC_PATHWAY
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CACAM_PATHWAY
0.0568181818182%	2	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEBER_METHYLATED_LCP_IN_SPERM_UP
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TSUNODA_CISPLATIN_RESISTANCE_UP
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SANDERSON_PPARA_TARGETS
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ZINC_TRANSPORTERS
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SHC_MEDIATED_SIGNALLING
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ENDOGENOUS_STEROLS
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_AMINE_DERIVED_HORMONES
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUMMEL_BURKITTS_LYMPHOMA_DN
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRANDVAUX_IRF3_TARGETS_UP
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FINETTI_BREAST_CANCERS_KINOME_GRAY
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_4_DN
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHANG_POU5F1_TARGETS_UP
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_TALL1_PATHWAY
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_RARRXR_PATHWAY
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_PITX2_PATHWAY
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_LONGEVITY_PATHWAY
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_HSP27_PATHWAY
0.0568181818182%	2	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_BARRESTIN_SRC_PATHWAY
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_ADIPOGENESIS_BY_BMP7
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VERRECCHIA_RESPONSE_TO_TGFB1_C3
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ROETH_TERT_TARGETS_UP
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SOS_MEDIATED_SIGNALLING
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CRMPS_IN_SEMA3A_SIGNALING
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_RAC
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIM_MAMMARY_LUMINAL_PROGENITOR_DN
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KINNEY_DNMT1_METHYLATION_TARGETS
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_PLATELETAPP_PATHWAY
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_GRANULOCYTES_PATHWAY
0.0568181818182%	2	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_20_MCF10A
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TERAMOTO_OPN_TARGETS_CLUSTER_1
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SA_REG_CASCADE_OF_CYCLIN_EXPR
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KORKOLA_EMBRYONAL_CARCINOMA
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_MYCL1_AMPLIFICATION_TARGETS_UP
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_CIRCADIAN_RHYTHM_MAMMAL
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HO_LIVER_CANCER_VASCULAR_INVASION
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HASINA_NOL7_TARGETS_DN
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GHO_ATF5_TARGETS_UP
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FU_INTERACT_WITH_ALKBH8
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CONRAD_GERMLINE_STEM_CELL
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CBL_PATHWAY
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_AHSP_PATHWAY
0.0568181818182%	2	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAGHAVI_NEOPLASTIC_TRANSFORMATION
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_NOTCH3
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_NOTCH2
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIZUKAMI_HYPOXIA_UP
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCBRYAN_TERMINAL_END_BUD_UP
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ITO_PTTG1_TARGETS_UP
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FIGUEROA_AML_METHYLATION_CLUSTER_5_UP
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	EHLERS_ANEUPLOIDY_DN
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DING_LUNG_CANCER_MUTATED_FREQUENTLY
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_VDR_PATHWAY
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_PLCE_PATHWAY
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_FIBRINOLYSIS_PATHWAY
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CFTR_PATHWAY
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_BARR_MAPK_PATHWAY
0.0568181818182%	2	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_AKAP13_PATHWAY
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHOU_PANCREATIC_BETA_CELL
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_UNWINDING_OF_DNA
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRYPTOPHAN_CATABOLISM
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DSCAM_INTERACTIONS
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CD28_DEPENDENT_VAV1_PATHWAY
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MUNSHI_MULTIPLE_MYELOMA_DN
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_PLURIPOTENT_STATE_UP
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATHEW_FANCONI_ANEMIA_GENES
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARSON_FOXP3_TARGETS_STIMULATED_DN
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FUNG_IL2_SIGNALING_1
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FRASOR_TAMOXIFEN_RESPONSE_DN
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FOURNIER_ACINAR_DEVELOPMENT_LATE_UP
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAFFAREL_RESPONSE_TO_THC_8HR_5_DN
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_P35ALZHEIMERS_PATHWAY
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_IL4_PATHWAY
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_EIF2_PATHWAY
0.0568181818182%	2	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_20_HELA
0.0568181818182%	2	3520	105	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WOO_LIVER_CANCER_RECURRENCE_UP
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TSUDA_ALVEOLAR_SOFT_PART_SARCOMA
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RAF_MAP_KINASE_CASCADE
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PECAM1_INTERACTIONS
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_COPI_MEDIATED_TRANSPORT
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_BINDING_AND_ENTRY_OF_HIV_VIRION
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OHASHI_AURKB_TARGETS
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MAINA_VHL_TARGETS_UP
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_LIMONENE_AND_PINENE_DEGRADATION
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOUYER_TATI_TARGETS_UP
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHASSOT_SKIN_WOUND
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRUNEAU_SEPTATION_VENTRICULAR
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_RNA_PATHWAY
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_IL5_PATHWAY
0.0568181818182%	2	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AGARWAL_AKT_PATHWAY_TARGETS
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	XU_AKT1_TARGETS_48HR
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	VANLOO_SP3_TARGETS_UP
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	ST_JAK_STAT_PATHWAY
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	SHIRAISHI_PLZF_TARGETS_DN
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	OXFORD_RALB_TARGETS_DN
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	NOUSHMEHR_GBM_SOMATIC_MUTATED
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	NAGY_PCAF_COMPONENTS_HUMAN
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	NADELLA_PRKAR1A_TARGETS_UP
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	MATZUK_MATERNAL_EFFECT
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	HAEGERSTRAND_RESPONSE_TO_IMATINIB
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	CHESLER_BRAIN_D6MIT150_QTL_TRANS
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	BIOCARTA_FEEDER_PATHWAY
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	BENPORATH_ES_CORE_NINE
0.053447354356%	1	1871	9	T2D_GENES_TANYA_HEIGHT	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	YANG_BCL3_TARGETS_DN
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	THUM_MIR21_TARGETS_HEART_DISEASE_DN
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	TCGA_GLIOBLASTOMA_MUTATED
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	OXFORD_RALB_TARGETS_UP
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	NAKAMURA_LUNG_CANCER
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_DEDIFFERENTIATED_STATE_UP
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	MATZUK_LUTEAL_GENES
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	KREPPEL_CD99_TARGETS_DN
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	KONDO_HYPOXIA
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	KOINUMA_COLON_CANCER_MSI_UP
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	IKEDA_MIR133_TARGETS_DN
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3
0.053447354356%	1	1871	8	T2D_GENES_TANYA_HEIGHT	BIOCARTA_KREB_PATHWAY
0.053447354356%	1	1871	74	T2D_GENES_TANYA_HEIGHT	MILI_PSEUDOPODIA_CHEMOTAXIS_UP
0.053447354356%	1	1871	72	T2D_GENES_TANYA_HEIGHT	KEGG_DRUG_METABOLISM_CYTOCHROME_P450
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	ZEILSTRA_CD44_TARGETS_UP
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	ZEILSTRA_CD44_TARGETS_DN
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	TESAR_ALK_TARGETS_HUMAN_ES_5D_DN
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	ST_INTERLEUKIN_13_PATHWAY
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	ST_IL_13_PATHWAY
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	STONER_ESOPHAGEAL_CARCINOGENESIS_DN
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	SCHUHMACHER_MYC_TARGETS_DN
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_DEDIFFERENTIATED_STATE_DN
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	MCBRYAN_TERMINAL_END_BUD_DN
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	INGRAM_SHH_TARGETS
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	IKEDA_MIR1_TARGETS_DN
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	CHESLER_BRAIN_D6MIT150_QTL_CIS
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	BUDHU_LIVER_CANCER_METASTASIS_DN
0.053447354356%	1	1871	7	T2D_GENES_TANYA_HEIGHT	ABBUD_LIF_SIGNALING_2_DN
0.053447354356%	1	1871	68	T2D_GENES_TANYA_HEIGHT	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
0.053447354356%	1	1871	68	T2D_GENES_TANYA_HEIGHT	LIN_NPAS4_TARGETS_DN
0.053447354356%	1	1871	68	T2D_GENES_TANYA_HEIGHT	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN
0.053447354356%	1	1871	63	T2D_GENES_TANYA_HEIGHT	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	TSAI_DNAJB4_TARGETS_DN
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	TRACEY_RESISTANCE_TO_IFNA2_UP
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_DN
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	MOTAMED_RESPONSE_TO_ANDROGEN_DN
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	MAINA_HYPOXIA_VHL_TARGETS_UP
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	GALIE_TUMOR_STEMNESS_GENES
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	ELVIDGE_HIF2A_TARGETS_UP
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	DONATO_CELL_CYCLE_TRETINOIN
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	DING_LUNG_CANCER_MUTATED_RECURRENTLY
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	DIERICK_SEROTONIN_FUNCTION_GENES
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	CROSBY_E2F4_TARGETS
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	CHESLER_BRAIN_QTL_TRANS
0.053447354356%	1	1871	6	T2D_GENES_TANYA_HEIGHT	BASSO_HAIRY_CELL_LEUKEMIA_UP
0.053447354356%	1	1871	56	T2D_GENES_TANYA_HEIGHT	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION
0.053447354356%	1	1871	55	T2D_GENES_TANYA_HEIGHT	LAU_APOPTOSIS_CDKN2A_UP
0.053447354356%	1	1871	52	T2D_GENES_TANYA_HEIGHT	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP
0.053447354356%	1	1871	52	T2D_GENES_TANYA_HEIGHT	KEGG_ENDOMETRIAL_CANCER
0.053447354356%	1	1871	51	T2D_GENES_TANYA_HEIGHT	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES
0.053447354356%	1	1871	51	T2D_GENES_TANYA_HEIGHT	LUI_THYROID_CANCER_CLUSTER_1
0.053447354356%	1	1871	51	T2D_GENES_TANYA_HEIGHT	KEGG_DRUG_METABOLISM_OTHER_ENZYMES
0.053447354356%	1	1871	50	T2D_GENES_TANYA_HEIGHT	KOHOUTEK_CCNT1_TARGETS
0.053447354356%	1	1871	5	T2D_GENES_TANYA_HEIGHT	WANG_THOC1_TARGETS_UP
0.053447354356%	1	1871	5	T2D_GENES_TANYA_HEIGHT	TURJANSKI_MAPK11_TARGETS
0.053447354356%	1	1871	5	T2D_GENES_TANYA_HEIGHT	SMID_BREAST_CANCER_ERBB2_DN
0.053447354356%	1	1871	5	T2D_GENES_TANYA_HEIGHT	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN
0.053447354356%	1	1871	5	T2D_GENES_TANYA_HEIGHT	RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP
0.053447354356%	1	1871	5	T2D_GENES_TANYA_HEIGHT	RAFFEL_VEGFA_TARGETS_DN
0.053447354356%	1	1871	5	T2D_GENES_TANYA_HEIGHT	OZANNE_AP1_TARGETS_DN
0.053447354356%	1	1871	5	T2D_GENES_TANYA_HEIGHT	NAKAMURA_ALVEOLAR_EPITHELIUM
0.053447354356%	1	1871	5	T2D_GENES_TANYA_HEIGHT	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_3
0.053447354356%	1	1871	5	T2D_GENES_TANYA_HEIGHT	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2
0.053447354356%	1	1871	5	T2D_GENES_TANYA_HEIGHT	LU_TUMOR_ENDOTHELIAL_MARKERS_DN
0.053447354356%	1	1871	5	T2D_GENES_TANYA_HEIGHT	LAU_APOPTOSIS_CDKN2A_DN
0.053447354356%	1	1871	5	T2D_GENES_TANYA_HEIGHT	KANG_GIST_WITH_PDGFRA_DN
0.053447354356%	1	1871	5	T2D_GENES_TANYA_HEIGHT	JONES_TCOF1_TARGETS
0.053447354356%	1	1871	5	T2D_GENES_TANYA_HEIGHT	GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN
0.053447354356%	1	1871	5	T2D_GENES_TANYA_HEIGHT	BRUNEAU_SEPTATION_ATRIAL
0.053447354356%	1	1871	5	T2D_GENES_TANYA_HEIGHT	ABDULRAHMAN_KIDNEY_CANCER_VHL_UP
0.053447354356%	1	1871	47	T2D_GENES_TANYA_HEIGHT	KHETCHOUMIAN_TRIM24_TARGETS_UP
0.053447354356%	1	1871	46	T2D_GENES_TANYA_HEIGHT	SIG_BCR_SIGNALING_PATHWAY
0.053447354356%	1	1871	46	T2D_GENES_TANYA_HEIGHT	SAGIV_CD24_TARGETS_DN
0.053447354356%	1	1871	46	T2D_GENES_TANYA_HEIGHT	REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT
0.053447354356%	1	1871	46	T2D_GENES_TANYA_HEIGHT	JIANG_TIP30_TARGETS_UP
0.053447354356%	1	1871	45	T2D_GENES_TANYA_HEIGHT	CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY
0.053447354356%	1	1871	44	T2D_GENES_TANYA_HEIGHT	VANTVEER_BREAST_CANCER_BRCA1_DN
0.053447354356%	1	1871	44	T2D_GENES_TANYA_HEIGHT	THILLAINADESAN_ZNF217_TARGETS_UP
0.053447354356%	1	1871	44	T2D_GENES_TANYA_HEIGHT	ROVERSI_GLIOMA_LOH_REGIONS
0.053447354356%	1	1871	44	T2D_GENES_TANYA_HEIGHT	MA_MYELOID_DIFFERENTIATION_DN
0.053447354356%	1	1871	44	T2D_GENES_TANYA_HEIGHT	LUI_THYROID_CANCER_PAX8_PPARG_UP
0.053447354356%	1	1871	44	T2D_GENES_TANYA_HEIGHT	HARRIS_BRAIN_CANCER_PROGENITORS
0.053447354356%	1	1871	43	T2D_GENES_TANYA_HEIGHT	PID_TCPTP_PATHWAY
0.053447354356%	1	1871	43	T2D_GENES_TANYA_HEIGHT	NAKAYAMA_FRA2_TARGETS
0.053447354356%	1	1871	43	T2D_GENES_TANYA_HEIGHT	MILI_PSEUDOPODIA
0.053447354356%	1	1871	43	T2D_GENES_TANYA_HEIGHT	IKEDA_MIR133_TARGETS_UP
0.053447354356%	1	1871	42	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_ES_ICP_WITH_H3K27ME3
0.053447354356%	1	1871	42	T2D_GENES_TANYA_HEIGHT	BARRIER_COLON_CANCER_RECURRENCE_UP
0.053447354356%	1	1871	41	T2D_GENES_TANYA_HEIGHT	PID_ERBB1_INTERNALIZATION_PATHWAY
0.053447354356%	1	1871	41	T2D_GENES_TANYA_HEIGHT	LI_LUNG_CANCER
0.053447354356%	1	1871	41	T2D_GENES_TANYA_HEIGHT	KORKOLA_EMBRYONAL_CARCINOMA_UP
0.053447354356%	1	1871	40	T2D_GENES_TANYA_HEIGHT	VALK_AML_WITH_FLT3_ITD
0.053447354356%	1	1871	40	T2D_GENES_TANYA_HEIGHT	TOMLINS_PROSTATE_CANCER_DN
0.053447354356%	1	1871	40	T2D_GENES_TANYA_HEIGHT	KEGG_TRYPTOPHAN_METABOLISM
0.053447354356%	1	1871	40	T2D_GENES_TANYA_HEIGHT	CHESLER_BRAIN_HIGHEST_EXPRESSION
0.053447354356%	1	1871	39	T2D_GENES_TANYA_HEIGHT	KORKOLA_TERATOMA
0.053447354356%	1	1871	39	T2D_GENES_TANYA_HEIGHT	GENTILE_UV_RESPONSE_CLUSTER_D5
0.053447354356%	1	1871	39	T2D_GENES_TANYA_HEIGHT	BILANGES_RAPAMYCIN_SENSITIVE_GENES
0.053447354356%	1	1871	39	T2D_GENES_TANYA_HEIGHT	AMIT_EGF_RESPONSE_60_MCF10A
0.053447354356%	1	1871	38	T2D_GENES_TANYA_HEIGHT	PID_ERBB4_PATHWAY
0.053447354356%	1	1871	38	T2D_GENES_TANYA_HEIGHT	HATADA_METHYLATED_IN_LUNG_CANCER_DN
0.053447354356%	1	1871	38	T2D_GENES_TANYA_HEIGHT	BIOCARTA_INTEGRIN_PATHWAY
0.053447354356%	1	1871	38	T2D_GENES_TANYA_HEIGHT	BIOCARTA_IL2RB_PATHWAY
0.053447354356%	1	1871	37	T2D_GENES_TANYA_HEIGHT	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN
0.053447354356%	1	1871	37	T2D_GENES_TANYA_HEIGHT	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
0.053447354356%	1	1871	36	T2D_GENES_TANYA_HEIGHT	YANG_BREAST_CANCER_ESR1_UP
0.053447354356%	1	1871	36	T2D_GENES_TANYA_HEIGHT	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2
0.053447354356%	1	1871	36	T2D_GENES_TANYA_HEIGHT	STEARMAN_TUMOR_FIELD_EFFECT_UP
0.053447354356%	1	1871	36	T2D_GENES_TANYA_HEIGHT	HOUSTIS_ROS
0.053447354356%	1	1871	36	T2D_GENES_TANYA_HEIGHT	BIOCARTA_AGR_PATHWAY
0.053447354356%	1	1871	35	T2D_GENES_TANYA_HEIGHT	WESTON_VEGFA_TARGETS_12HR
0.053447354356%	1	1871	35	T2D_GENES_TANYA_HEIGHT	ROZANOV_MMP14_TARGETS_DN
0.053447354356%	1	1871	35	T2D_GENES_TANYA_HEIGHT	MODY_HIPPOCAMPUS_NEONATAL
0.053447354356%	1	1871	35	T2D_GENES_TANYA_HEIGHT	KEGG_REGULATION_OF_AUTOPHAGY
0.053447354356%	1	1871	35	T2D_GENES_TANYA_HEIGHT	DORSAM_HOXA9_TARGETS_UP
0.053447354356%	1	1871	35	T2D_GENES_TANYA_HEIGHT	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP
0.053447354356%	1	1871	35	T2D_GENES_TANYA_HEIGHT	BALDWIN_PRKCI_TARGETS_UP
0.053447354356%	1	1871	35	T2D_GENES_TANYA_HEIGHT	AIGNER_ZEB1_TARGETS
0.053447354356%	1	1871	34	T2D_GENES_TANYA_HEIGHT	WANG_RESPONSE_TO_BEXAROTENE_UP
0.053447354356%	1	1871	34	T2D_GENES_TANYA_HEIGHT	ST_WNT_BETA_CATENIN_PATHWAY
0.053447354356%	1	1871	34	T2D_GENES_TANYA_HEIGHT	KORKOLA_CORRELATED_WITH_POU5F1
0.053447354356%	1	1871	34	T2D_GENES_TANYA_HEIGHT	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM
0.053447354356%	1	1871	34	T2D_GENES_TANYA_HEIGHT	KEGG_CYSTEINE_AND_METHIONINE_METABOLISM
0.053447354356%	1	1871	33	T2D_GENES_TANYA_HEIGHT	VALK_AML_CLUSTER_5
0.053447354356%	1	1871	33	T2D_GENES_TANYA_HEIGHT	VALK_AML_CLUSTER_3
0.053447354356%	1	1871	33	T2D_GENES_TANYA_HEIGHT	VALK_AML_CLUSTER_10
0.053447354356%	1	1871	33	T2D_GENES_TANYA_HEIGHT	TANG_SENESCENCE_TP53_TARGETS_UP
0.053447354356%	1	1871	33	T2D_GENES_TANYA_HEIGHT	REACTOME_RNA_POL_III_TRANSCRIPTION
0.053447354356%	1	1871	33	T2D_GENES_TANYA_HEIGHT	CHO_NR4A1_TARGETS
0.053447354356%	1	1871	32	T2D_GENES_TANYA_HEIGHT	ZWANG_EGF_PERSISTENTLY_UP
0.053447354356%	1	1871	32	T2D_GENES_TANYA_HEIGHT	REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING
0.053447354356%	1	1871	32	T2D_GENES_TANYA_HEIGHT	GROSS_ELK3_TARGETS_DN
0.053447354356%	1	1871	32	T2D_GENES_TANYA_HEIGHT	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP
0.053447354356%	1	1871	32	T2D_GENES_TANYA_HEIGHT	BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
0.053447354356%	1	1871	32	T2D_GENES_TANYA_HEIGHT	BIOCARTA_RHO_PATHWAY
0.053447354356%	1	1871	31	T2D_GENES_TANYA_HEIGHT	WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP
0.053447354356%	1	1871	31	T2D_GENES_TANYA_HEIGHT	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP
0.053447354356%	1	1871	31	T2D_GENES_TANYA_HEIGHT	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP
0.053447354356%	1	1871	31	T2D_GENES_TANYA_HEIGHT	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.053447354356%	1	1871	30	T2D_GENES_TANYA_HEIGHT	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN
0.053447354356%	1	1871	30	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
0.053447354356%	1	1871	30	T2D_GENES_TANYA_HEIGHT	REACTOME_BASIGIN_INTERACTIONS
0.053447354356%	1	1871	30	T2D_GENES_TANYA_HEIGHT	KEGG_O_GLYCAN_BIOSYNTHESIS
0.053447354356%	1	1871	30	T2D_GENES_TANYA_HEIGHT	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
0.053447354356%	1	1871	30	T2D_GENES_TANYA_HEIGHT	DASU_IL6_SIGNALING_SCAR_UP
0.053447354356%	1	1871	30	T2D_GENES_TANYA_HEIGHT	BIOCARTA_FAS_PATHWAY
0.053447354356%	1	1871	29	T2D_GENES_TANYA_HEIGHT	WILENSKY_RESPONSE_TO_DARAPLADIB
0.053447354356%	1	1871	29	T2D_GENES_TANYA_HEIGHT	VALK_AML_CLUSTER_2
0.053447354356%	1	1871	29	T2D_GENES_TANYA_HEIGHT	REACTOME_TIGHT_JUNCTION_INTERACTIONS
0.053447354356%	1	1871	29	T2D_GENES_TANYA_HEIGHT	REACTOME_GLYCOLYSIS
0.053447354356%	1	1871	29	T2D_GENES_TANYA_HEIGHT	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN
0.053447354356%	1	1871	29	T2D_GENES_TANYA_HEIGHT	PID_INTEGRIN2_PATHWAY
0.053447354356%	1	1871	29	T2D_GENES_TANYA_HEIGHT	PAL_PRMT5_TARGETS_DN
0.053447354356%	1	1871	29	T2D_GENES_TANYA_HEIGHT	LANG_MYB_FAMILY_TARGETS
0.053447354356%	1	1871	29	T2D_GENES_TANYA_HEIGHT	KEGG_RNA_POLYMERASE
0.053447354356%	1	1871	28	T2D_GENES_TANYA_HEIGHT	WEBER_METHYLATED_HCP_IN_SPERM_DN
0.053447354356%	1	1871	28	T2D_GENES_TANYA_HEIGHT	WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1
0.053447354356%	1	1871	28	T2D_GENES_TANYA_HEIGHT	VALK_AML_CLUSTER_7
0.053447354356%	1	1871	28	T2D_GENES_TANYA_HEIGHT	REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS
0.053447354356%	1	1871	28	T2D_GENES_TANYA_HEIGHT	LI_CISPLATIN_RESISTANCE_UP
0.053447354356%	1	1871	28	T2D_GENES_TANYA_HEIGHT	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.053447354356%	1	1871	28	T2D_GENES_TANYA_HEIGHT	DAIRKEE_CANCER_PRONE_RESPONSE_E2
0.053447354356%	1	1871	28	T2D_GENES_TANYA_HEIGHT	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP
0.053447354356%	1	1871	28	T2D_GENES_TANYA_HEIGHT	BIOCARTA_PROTEASOME_PATHWAY
0.053447354356%	1	1871	27	T2D_GENES_TANYA_HEIGHT	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN
0.053447354356%	1	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_OF_PA
0.053447354356%	1	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE
0.053447354356%	1	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING
0.053447354356%	1	1871	27	T2D_GENES_TANYA_HEIGHT	REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS
0.053447354356%	1	1871	27	T2D_GENES_TANYA_HEIGHT	LEE_DOUBLE_POLAR_THYMOCYTE
0.053447354356%	1	1871	27	T2D_GENES_TANYA_HEIGHT	HOEGERKORP_CD44_TARGETS_DIRECT_UP
0.053447354356%	1	1871	27	T2D_GENES_TANYA_HEIGHT	CHOW_RASSF1_TARGETS_UP
0.053447354356%	1	1871	27	T2D_GENES_TANYA_HEIGHT	BRACHAT_RESPONSE_TO_METHOTREXATE_DN
0.053447354356%	1	1871	26	T2D_GENES_TANYA_HEIGHT	REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER
0.053447354356%	1	1871	26	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATORY_RNA_PATHWAYS
0.053447354356%	1	1871	26	T2D_GENES_TANYA_HEIGHT	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.053447354356%	1	1871	26	T2D_GENES_TANYA_HEIGHT	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1
0.053447354356%	1	1871	26	T2D_GENES_TANYA_HEIGHT	KEGG_GALACTOSE_METABOLISM
0.053447354356%	1	1871	26	T2D_GENES_TANYA_HEIGHT	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP
0.053447354356%	1	1871	26	T2D_GENES_TANYA_HEIGHT	BIOCARTA_WNT_PATHWAY
0.053447354356%	1	1871	26	T2D_GENES_TANYA_HEIGHT	BIOCARTA_PGC1A_PATHWAY
0.053447354356%	1	1871	26	T2D_GENES_TANYA_HEIGHT	ABBUD_LIF_SIGNALING_1_DN
0.053447354356%	1	1871	25	T2D_GENES_TANYA_HEIGHT	VERRECCHIA_RESPONSE_TO_TGFB1_C2
0.053447354356%	1	1871	25	T2D_GENES_TANYA_HEIGHT	RUAN_RESPONSE_TO_TROGLITAZONE_UP
0.053447354356%	1	1871	25	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN
0.053447354356%	1	1871	25	T2D_GENES_TANYA_HEIGHT	REACTOME_EGFR_DOWNREGULATION
0.053447354356%	1	1871	25	T2D_GENES_TANYA_HEIGHT	REACTOME_DARPP_32_EVENTS
0.053447354356%	1	1871	25	T2D_GENES_TANYA_HEIGHT	REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS
0.053447354356%	1	1871	25	T2D_GENES_TANYA_HEIGHT	PID_INTEGRIN_A9B1_PATHWAY
0.053447354356%	1	1871	25	T2D_GENES_TANYA_HEIGHT	PID_HDAC_CLASSIII_PATHWAY
0.053447354356%	1	1871	25	T2D_GENES_TANYA_HEIGHT	LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS
0.053447354356%	1	1871	25	T2D_GENES_TANYA_HEIGHT	JACKSON_DNMT1_TARGETS_DN
0.053447354356%	1	1871	25	T2D_GENES_TANYA_HEIGHT	HORTON_SREBF_TARGETS
0.053447354356%	1	1871	25	T2D_GENES_TANYA_HEIGHT	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN
0.053447354356%	1	1871	25	T2D_GENES_TANYA_HEIGHT	HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN
0.053447354356%	1	1871	24	T2D_GENES_TANYA_HEIGHT	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS
0.053447354356%	1	1871	24	T2D_GENES_TANYA_HEIGHT	REACTOME_SULFUR_AMINO_ACID_METABOLISM
0.053447354356%	1	1871	24	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_IFNA_SIGNALING
0.053447354356%	1	1871	24	T2D_GENES_TANYA_HEIGHT	REACTOME_KINESINS
0.053447354356%	1	1871	24	T2D_GENES_TANYA_HEIGHT	REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS
0.053447354356%	1	1871	24	T2D_GENES_TANYA_HEIGHT	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN
0.053447354356%	1	1871	24	T2D_GENES_TANYA_HEIGHT	KIM_GERMINAL_CENTER_T_HELPER_DN
0.053447354356%	1	1871	24	T2D_GENES_TANYA_HEIGHT	KEGG_PROTEIN_EXPORT
0.053447354356%	1	1871	24	T2D_GENES_TANYA_HEIGHT	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP
0.053447354356%	1	1871	24	T2D_GENES_TANYA_HEIGHT	GOLUB_ALL_VS_AML_UP
0.053447354356%	1	1871	24	T2D_GENES_TANYA_HEIGHT	BIOCARTA_TPO_PATHWAY
0.053447354356%	1	1871	24	T2D_GENES_TANYA_HEIGHT	BIOCARTA_NOS1_PATHWAY
0.053447354356%	1	1871	24	T2D_GENES_TANYA_HEIGHT	BIOCARTA_G2_PATHWAY
0.053447354356%	1	1871	23	T2D_GENES_TANYA_HEIGHT	ZIRN_TRETINOIN_RESPONSE_WT1_UP
0.053447354356%	1	1871	23	T2D_GENES_TANYA_HEIGHT	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B
0.053447354356%	1	1871	23	T2D_GENES_TANYA_HEIGHT	REACTOME_PHOSPHORYLATION_OF_THE_APC_C
0.053447354356%	1	1871	23	T2D_GENES_TANYA_HEIGHT	REACTOME_MICRORNA_MIRNA_BIOGENESIS
0.053447354356%	1	1871	23	T2D_GENES_TANYA_HEIGHT	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS
0.053447354356%	1	1871	23	T2D_GENES_TANYA_HEIGHT	KEGG_MISMATCH_REPAIR
0.053447354356%	1	1871	23	T2D_GENES_TANYA_HEIGHT	FERRANDO_HOX11_NEIGHBORS
0.053447354356%	1	1871	23	T2D_GENES_TANYA_HEIGHT	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN
0.053447354356%	1	1871	23	T2D_GENES_TANYA_HEIGHT	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP
0.053447354356%	1	1871	23	T2D_GENES_TANYA_HEIGHT	CHEN_ETV5_TARGETS_TESTIS
0.053447354356%	1	1871	23	T2D_GENES_TANYA_HEIGHT	BIOCARTA_P53HYPOXIA_PATHWAY
0.053447354356%	1	1871	23	T2D_GENES_TANYA_HEIGHT	BIOCARTA_MEF2D_PATHWAY
0.053447354356%	1	1871	23	T2D_GENES_TANYA_HEIGHT	BIOCARTA_INTRINSIC_PATHWAY
0.053447354356%	1	1871	22	T2D_GENES_TANYA_HEIGHT	YUAN_ZNF143_PARTNERS
0.053447354356%	1	1871	22	T2D_GENES_TANYA_HEIGHT	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP
0.053447354356%	1	1871	22	T2D_GENES_TANYA_HEIGHT	VERNELL_RETINOBLASTOMA_PATHWAY_DN
0.053447354356%	1	1871	22	T2D_GENES_TANYA_HEIGHT	TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.053447354356%	1	1871	22	T2D_GENES_TANYA_HEIGHT	SPIRA_SMOKERS_LUNG_CANCER_DN
0.053447354356%	1	1871	22	T2D_GENES_TANYA_HEIGHT	REACTOME_METAL_ION_SLC_TRANSPORTERS
0.053447354356%	1	1871	22	T2D_GENES_TANYA_HEIGHT	REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE
0.053447354356%	1	1871	22	T2D_GENES_TANYA_HEIGHT	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE
0.053447354356%	1	1871	22	T2D_GENES_TANYA_HEIGHT	KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS
0.053447354356%	1	1871	22	T2D_GENES_TANYA_HEIGHT	KANG_FLUOROURACIL_RESISTANCE_UP
0.053447354356%	1	1871	22	T2D_GENES_TANYA_HEIGHT	GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION
0.053447354356%	1	1871	22	T2D_GENES_TANYA_HEIGHT	BIOCARTA_INSULIN_PATHWAY
0.053447354356%	1	1871	22	T2D_GENES_TANYA_HEIGHT	BIOCARTA_IL6_PATHWAY
0.053447354356%	1	1871	22	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CHEMICAL_PATHWAY
0.053447354356%	1	1871	22	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CERAMIDE_PATHWAY
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	WOTTON_RUNX_TARGETS_UP
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	WENG_POR_DOSAGE
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	VERRECCHIA_RESPONSE_TO_TGFB1_C5
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	STEGER_ADIPOGENESIS_UP
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	SCHURINGA_STAT5A_TARGETS_UP
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	REACTOME_PEROXISOMAL_LIPID_METABOLISM
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	REACTOME_ACYL_CHAIN_REMODELLING_OF_PE
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	RAHMAN_TP53_TARGETS_PHOSPHORYLATED
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	PID_S1P_S1P1_PATHWAY
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	MOOTHA_GLYCOLYSIS
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	MARCHINI_TRABECTEDIN_RESISTANCE_UP
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	KANNAN_TP53_TARGETS_DN
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	HU_ANGIOGENESIS_UP
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	HASLINGER_B_CLL_WITH_17P13_DELETION
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	GESERICK_TERT_TARGETS_DN
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP
0.053447354356%	1	1871	21	T2D_GENES_TANYA_HEIGHT	BIOCARTA_TFF_PATHWAY
0.053447354356%	1	1871	20	T2D_GENES_TANYA_HEIGHT	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN
0.053447354356%	1	1871	20	T2D_GENES_TANYA_HEIGHT	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP
0.053447354356%	1	1871	20	T2D_GENES_TANYA_HEIGHT	TOMLINS_METASTASIS_DN
0.053447354356%	1	1871	20	T2D_GENES_TANYA_HEIGHT	REACTOME_NEPHRIN_INTERACTIONS
0.053447354356%	1	1871	20	T2D_GENES_TANYA_HEIGHT	REACTOME_HS_GAG_DEGRADATION
0.053447354356%	1	1871	20	T2D_GENES_TANYA_HEIGHT	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3
0.053447354356%	1	1871	20	T2D_GENES_TANYA_HEIGHT	NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN
0.053447354356%	1	1871	20	T2D_GENES_TANYA_HEIGHT	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP
0.053447354356%	1	1871	20	T2D_GENES_TANYA_HEIGHT	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN
0.053447354356%	1	1871	20	T2D_GENES_TANYA_HEIGHT	MAHADEVAN_IMATINIB_RESISTANCE_DN
0.053447354356%	1	1871	20	T2D_GENES_TANYA_HEIGHT	KORKOLA_YOLK_SAC_TUMOR_UP
0.053447354356%	1	1871	20	T2D_GENES_TANYA_HEIGHT	HEDENFALK_BREAST_CANCER_BRACX_DN
0.053447354356%	1	1871	20	T2D_GENES_TANYA_HEIGHT	FARMER_BREAST_CANCER_CLUSTER_7
0.053447354356%	1	1871	20	T2D_GENES_TANYA_HEIGHT	DING_LUNG_CANCER_BY_MUTATION_RATE
0.053447354356%	1	1871	20	T2D_GENES_TANYA_HEIGHT	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
0.053447354356%	1	1871	20	T2D_GENES_TANYA_HEIGHT	CHEN_ETV5_TARGETS_SERTOLI
0.053447354356%	1	1871	20	T2D_GENES_TANYA_HEIGHT	BIOCARTA_ACTINY_PATHWAY
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	VERRECCHIA_RESPONSE_TO_TGFB1_C1
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	TRAYNOR_RETT_SYNDROM_DN
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	TERAMOTO_OPN_TARGETS_CLUSTER_7
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	SHIN_B_CELL_LYMPHOMA_CLUSTER_9
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	SA_CASPASE_CASCADE
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	RUAN_RESPONSE_TO_TROGLITAZONE_DN
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	RASHI_NFKB1_TARGETS
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	NIELSEN_LIPOSARCOMA_DN
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	NELSON_RESPONSE_TO_ANDROGEN_DN
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	NAGY_TFTC_COMPONENTS_HUMAN
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	MIZUSHIMA_AUTOPHAGOSOME_FORMATION
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	MA_PITUITARY_FETAL_VS_ADULT_DN
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	MARSON_FOXP3_CORE_DIRECT_TARGETS
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	KANG_DOXORUBICIN_RESISTANCE_DN
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	KANG_AR_TARGETS_DN
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	HAHTOLA_MYCOSIS_FUNGOIDES_UP
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS
0.053447354356%	1	1871	19	T2D_GENES_TANYA_HEIGHT	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	YIH_RESPONSE_TO_ARSENITE_C2
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	WU_HBX_TARGETS_3_UP
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	WEBER_METHYLATED_IN_COLON_CANCER
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	SCHURINGA_STAT5A_TARGETS_DN
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_SIGNALING_BY_CBL
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	REACTOME_GAP_JUNCTION_ASSEMBLY
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	OZANNE_AP1_TARGETS_UP
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	NIELSEN_LIPOSARCOMA_UP
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	NIELSEN_LEIOMYOSARCOMA_DN
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	MCGOWAN_RSP6_TARGETS_UP
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	MAINA_VHL_TARGETS_DN
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	KEGG_PHENYLALANINE_METABOLISM
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	CHOI_ATL_CHRONIC_VS_ACUTE_DN
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	BIOCARTA_PTEN_PATHWAY
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	BIOCARTA_NGF_PATHWAY
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP
0.053447354356%	1	1871	18	T2D_GENES_TANYA_HEIGHT	AMIT_DELAYED_EARLY_GENES
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	SIMBULAN_PARP1_TARGETS_DN
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	SA_TRKA_RECEPTOR
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	RODRIGUES_NTN1_TARGETS_UP
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	REACTOME_SHC_RELATED_EVENTS
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	REACTOME_RAP1_SIGNALLING
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	PID_SMAD2_3PATHWAY
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	MATTHEWS_AP1_TARGETS
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	LOPEZ_EPITHELIOID_MESOTHELIOMA
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	LI_CYTIDINE_ANALOG_PATHWAY
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	LI_ADIPOGENESIS_BY_ACTIVATED_PPARG
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	LEI_HOXC8_TARGETS_DN
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	KEGG_STEROID_BIOSYNTHESIS
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	KANG_AR_TARGETS_UP
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	HOWLIN_CITED1_TARGETS_2_DN
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	BIOCARTA_LAIR_PATHWAY
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CK1_PATHWAY
0.053447354356%	1	1871	17	T2D_GENES_TANYA_HEIGHT	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	ZHAN_LATE_DIFFERENTIATION_GENES_DN
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	XU_RESPONSE_TO_TRETINOIN_UP
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	WU_HBX_TARGETS_1_UP
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	TIAN_BHLHA15_TARGETS
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	SU_SALIVARY_GLAND
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	REACTOME_INTEGRATION_OF_PROVIRUS
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	REACTOME_ACYL_CHAIN_REMODELLING_OF_PG
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	MACLACHLAN_BRCA1_TARGETS_DN
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	LEE_LIVER_CANCER_HEPATOBLAST
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	KORKOLA_TERATOMA_UP
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	KANG_FLUOROURACIL_RESISTANCE_DN
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	HAHTOLA_MYCOSIS_FUNGOIDES_DN
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	GHO_ATF5_TARGETS_DN
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	DASU_IL6_SIGNALING_SCAR_DN
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	CAFFAREL_RESPONSE_TO_THC_8HR_5_UP
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	BIOCARTA_SHH_PATHWAY
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	BIOCARTA_IL22BP_PATHWAY
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	BIOCARTA_EIF_PATHWAY
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	BIOCARTA_BCELLSURVIVAL_PATHWAY
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP
0.053447354356%	1	1871	16	T2D_GENES_TANYA_HEIGHT	ABDELMOHSEN_ELAVL4_TARGETS
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	ZHANG_GATA6_TARGETS_UP
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	WANG_METASTASIS_OF_BREAST_CANCER
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	TSUNODA_CISPLATIN_RESISTANCE_UP
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	REACTOME_ZINC_TRANSPORTERS
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	REACTOME_OTHER_SEMAPHORIN_INTERACTIONS
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	REACTOME_METABOLISM_OF_POLYAMINES
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	REACTOME_ACYL_CHAIN_REMODELLING_OF_PS
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	PIEPOLI_LGI1_TARGETS_UP
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	PID_ERBB_NETWORK_PATHWAY
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	NAGY_STAGA_COMPONENTS_HUMAN
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	MARKS_HDAC_TARGETS_DN
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	LI_CYTIDINE_ANALOGS_CYCTOTOXICITY
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	HUMMEL_BURKITTS_LYMPHOMA_DN
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	CHANG_POU5F1_TARGETS_UP
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	BIOCARTA_IL3_PATHWAY
0.053447354356%	1	1871	15	T2D_GENES_TANYA_HEIGHT	BIOCARTA_HIF_PATHWAY
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	ZHANG_ADIPOGENESIS_BY_BMP7
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	TOMLINS_METASTASIS_UP
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNAL_ATTENUATION
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_N_GLYCAN_ANTENNAE_ELONGATION
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_METABOLISM_OF_PORPHYRINS
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_ACTIVATION_OF_RAC
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	PID_TCRRASPATHWAY
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_ES_LCP_WITH_H3K27ME3
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	LEE_SP4_THYMOCYTE
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	KINNEY_DNMT1_METHYLATION_TARGETS
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	BIOCARTA_PS1_PATHWAY
0.053447354356%	1	1871	14	T2D_GENES_TANYA_HEIGHT	AMIT_EGF_RESPONSE_20_MCF10A
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	VERRECCHIA_RESPONSE_TO_TGFB1_C4
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	SHI_SPARC_TARGETS_DN
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	SHIN_B_CELL_LYMPHOMA_CLUSTER_1
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	PHESSE_TARGETS_OF_APC_AND_MBD2_DN
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	ONGUSAHA_BRCA1_TARGETS_UP
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	MATZUK_EARLY_ANTRAL_FOLLICLE
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	MARTINELLI_IMMATURE_NEUTROPHIL_DN
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	LU_TUMOR_VASCULATURE_DN
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	KORKOLA_EMBRYONAL_CARCINOMA
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	KEGG_CIRCADIAN_RHYTHM_MAMMAL
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	IVANOV_MUTATED_IN_COLON_CANCER
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	HOEGERKORP_CD44_TARGETS_TEMPORAL_UP
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	HASINA_NOL7_TARGETS_UP
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	FU_INTERACT_WITH_ALKBH8
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	BIOCARTA_D4GDI_PATHWAY
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CBL_PATHWAY
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CARM1_PATHWAY
0.053447354356%	1	1871	13	T2D_GENES_TANYA_HEIGHT	BIOCARTA_AHSP_PATHWAY
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	WAESCH_ANAPHASE_PROMOTING_COMPLEX
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	TAGHAVI_NEOPLASTIC_TRANSFORMATION
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_NOTCH3
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_SIGNALING_BY_NOTCH2
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_SEROTONIN_RECEPTORS
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	PETRETTO_BLOOD_PRESSURE_UP
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	MALIK_REPRESSED_BY_ESTROGEN
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	LOPEZ_MESOTHELIOMA_SURVIVAL_DN
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	ITO_PTTG1_TARGETS_UP
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	HOLLEMAN_DAUNORUBICIN_B_ALL_DN
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	HEDVAT_ELF4_TARGETS_UP
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	GHANDHI_BYSTANDER_IRRADIATION_DN
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	EHLERS_ANEUPLOIDY_DN
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	BIOCARTA_TRKA_PATHWAY
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	BIOCARTA_ETC_PATHWAY
0.053447354356%	1	1871	12	T2D_GENES_TANYA_HEIGHT	BIOCARTA_CFTR_PATHWAY
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	WILLIAMS_ESR2_TARGETS_DN
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	WHITESIDE_CISPLATIN_RESISTANCE_UP
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	ST_STAT3_PATHWAY
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	STEGMEIER_PRE-MITOTIC_CELL_CYCLE_REGULATORS
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_TRYPTOPHAN_CATABOLISM
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_OF_PE
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_MTORC1_MEDIATED_SIGNALLING
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_IL_6_SIGNALING
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_DSCAM_INTERACTIONS
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	REACTOME_CALNEXIN_CALRETICULIN_CYCLE
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	POS_RESPONSE_TO_HISTAMINE_DN
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	PID_ALK2PATHWAY
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	MUNSHI_MULTIPLE_MYELOMA_DN
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	MIKKELSEN_PLURIPOTENT_STATE_UP
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	MARTINELLI_IMMATURE_NEUTROPHIL_UP
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	MANTOVANI_NFKB_TARGETS_DN
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	LOPEZ_MESOTHELIOMA_SURVIVAL_UP
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	LIANG_SILENCED_BY_METHYLATION_DN
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	HOFFMAN_CLOCK_TARGETS_UP
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_DN
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	FOURNIER_ACINAR_DEVELOPMENT_LATE_UP
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	DORN_ADENOVIRUS_INFECTION_32HR_UP
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	DER_IFN_GAMMA_RESPONSE_DN
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	CAFFAREL_RESPONSE_TO_THC_8HR_5_DN
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	BIOCARTA_SRCRPTP_PATHWAY
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	BIOCARTA_LEPTIN_PATHWAY
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	BIOCARTA_IL4_PATHWAY
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	BIOCARTA_EPONFKB_PATHWAY
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	BIOCARTA_EIF2_PATHWAY
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	AUJLA_IL22_AND_IL17A_SIGNALING
0.053447354356%	1	1871	11	T2D_GENES_TANYA_HEIGHT	AMIT_EGF_RESPONSE_20_HELA
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	YIH_RESPONSE_TO_ARSENITE_C5
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	VISALA_AGING_LYMPHOCYTE_UP
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	TURJANSKI_MAPK14_TARGETS
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	ST_INTERFERON_GAMMA_PATHWAY
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_PECAM1_INTERACTIONS
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_OPSINS
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_GAP_JUNCTION_DEGRADATION
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	REACTOME_ANDROGEN_BIOSYNTHESIS
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	RADAEVA_RESPONSE_TO_IFNA1_DN
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	PYEON_HPV_POSITIVE_TUMORS_DN
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	PID_VEGF_VEGFR_PATHWAY
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	MURAKAMI_UV_RESPONSE_1HR_DN
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	MATZUK_PREOVULATORY_FOLLICLE
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	MAINA_VHL_TARGETS_UP
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	KEGG_LIMONENE_AND_PINENE_DEGRADATION
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	JU_AGING_TERC_TARGETS_UP
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	FREDERICK_PRKCI_TARGETS
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	CHEN_HOXA5_TARGETS_6HR_UP
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	CHASSOT_SKIN_WOUND
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	CAFFAREL_RESPONSE_TO_THC_8HR_3_DN
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	BRUNEAU_SEPTATION_VENTRICULAR
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	BIOCARTA_SODD_PATHWAY
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	BIOCARTA_SARS_PATHWAY
0.053447354356%	1	1871	10	T2D_GENES_TANYA_HEIGHT	BIOCARTA_EPHA4_PATHWAY
0.0506585612969%	1	1974	9	Mendelian_Nancy_Cox	ZERBINI_RESPONSE_TO_SULINDAC_UP
0.0506585612969%	1	1974	9	Mendelian_Nancy_Cox	YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN
0.0506585612969%	1	1974	9	Mendelian_Nancy_Cox	XU_AKT1_TARGETS_48HR
0.0506585612969%	1	1974	9	Mendelian_Nancy_Cox	THILLAINADESAN_ZNF217_TARGETS_DN
0.0506585612969%	1	1974	9	Mendelian_Nancy_Cox	SIMBULAN_UV_RESPONSE_NORMAL_UP
0.0506585612969%	1	1974	9	Mendelian_Nancy_Cox	SHIRAISHI_PLZF_TARGETS_DN
0.0506585612969%	1	1974	9	Mendelian_Nancy_Cox	OXFORD_RALB_TARGETS_DN
0.0506585612969%	1	1974	9	Mendelian_Nancy_Cox	OXFORD_RALA_TARGETS_UP
0.0506585612969%	1	1974	9	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21
0.0506585612969%	1	1974	9	Mendelian_Nancy_Cox	MATZUK_MATERNAL_EFFECT
0.0506585612969%	1	1974	9	Mendelian_Nancy_Cox	KIM_ALL_DISORDERS_DURATION_CORR_UP
0.0506585612969%	1	1974	9	Mendelian_Nancy_Cox	HAEGERSTRAND_RESPONSE_TO_IMATINIB
0.0506585612969%	1	1974	9	Mendelian_Nancy_Cox	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN
0.0506585612969%	1	1974	9	Mendelian_Nancy_Cox	FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION
0.0506585612969%	1	1974	9	Mendelian_Nancy_Cox	CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	YAGUE_PRETUMOR_DRUG_RESISTANCE_UP
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	TURJANSKI_MAPK8_AND_MAPK9_TARGETS
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	TURJANSKI_MAPK7_TARGETS
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	THUM_MIR21_TARGETS_HEART_DISEASE_DN
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	TERAMOTO_OPN_TARGETS_CLUSTER_8
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	SOUCEK_MYC_TARGETS
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	SA_G2_AND_M_PHASES
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	PHONG_TNF_TARGETS_DN
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	NAKAMURA_LUNG_CANCER
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	MATZUK_LUTEAL_GENES
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	KOINUMA_COLON_CANCER_MSI_UP
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	KHETCHOUMIAN_TRIM24_TARGETS_DN
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	HOLLEMAN_DAUNORUBICIN_ALL_DN
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	FUJIWARA_PARK2_IN_LIVER_CANCER_UP
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	CHANG_POU5F1_TARGETS_DN
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	CAFFAREL_RESPONSE_TO_THC_24HR_3_UP
0.0506585612969%	1	1974	8	Mendelian_Nancy_Cox	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3
0.0506585612969%	1	1974	72	Mendelian_Nancy_Cox	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	TESAR_JAK_TARGETS_MOUSE_ES_D3_UP
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	TERAMOTO_OPN_TARGETS_CLUSTER_5
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	ST_INTERLEUKIN_13_PATHWAY
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	ST_IL_13_PATHWAY
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	STONER_ESOPHAGEAL_CARCINOGENESIS_DN
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	PETRETTO_BLOOD_PRESSURE_DN
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	PALOMERO_GSI_SENSITIVITY_UP
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	MIKKELSEN_NPC_WITH_LCP_H3K27ME3
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	MARSHALL_VIRAL_INFECTION_RESPONSE_UP
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	KUWANO_RNA_STABILIZED_BY_NO
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	JOHNSTONE_PARVB_TARGETS_1_UP
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	IKEDA_MIR1_TARGETS_DN
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	HOLLEMAN_DAUNORUBICIN_ALL_UP
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	FARMER_BREAST_CANCER_CLUSTER_8
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	BUDHU_LIVER_CANCER_METASTASIS_DN
0.0506585612969%	1	1974	7	Mendelian_Nancy_Cox	BERGER_MBD2_TARGETS
0.0506585612969%	1	1974	66	Mendelian_Nancy_Cox	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.0506585612969%	1	1974	64	Mendelian_Nancy_Cox	REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE
0.0506585612969%	1	1974	64	Mendelian_Nancy_Cox	REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	WILLIAMS_ESR1_TARGETS_DN
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	WALLACE_PROSTATE_CANCER_DN
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	TSAI_DNAJB4_TARGETS_DN
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	TRACEY_RESISTANCE_TO_IFNA2_UP
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	SMID_BREAST_CANCER_NORMAL_LIKE_DN
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	PLASARI_TGFB1_TARGETS_1HR_DN
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_DN
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	MOTAMED_RESPONSE_TO_ANDROGEN_UP
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	MOTAMED_RESPONSE_TO_ANDROGEN_DN
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	MIZUKAMI_HYPOXIA_DN
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	KORKOLA_CHORIOCARCINOMA
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	KIM_PTEN_TARGETS_DN
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	KAPOSI_LIVER_CANCER_MET_DN
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	IGARASHI_ATF4_TARGETS_UP
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	GALI_TP53_TARGETS_APOPTOTIC_DN
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	DONATO_CELL_CYCLE_TRETINOIN
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	CORRADETTI_MTOR_PATHWAY_REGULATORS_DN
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	CHOI_ATL_ACUTE_STAGE
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	CHESLER_BRAIN_QTL_TRANS
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	CHEN_HOXA5_TARGETS_6HR_DN
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	CASTELLANO_HRAS_AND_NRAS_TARGETS_UP
0.0506585612969%	1	1974	6	Mendelian_Nancy_Cox	BYSTRYKH_SCP2_QTL
0.0506585612969%	1	1974	57	Mendelian_Nancy_Cox	REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.0506585612969%	1	1974	52	Mendelian_Nancy_Cox	REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.0506585612969%	1	1974	51	Mendelian_Nancy_Cox	REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.0506585612969%	1	1974	5	Mendelian_Nancy_Cox	WANG_THOC1_TARGETS_UP
0.0506585612969%	1	1974	5	Mendelian_Nancy_Cox	VERRECCHIA_RESPONSE_TO_TGFB1_C6
0.0506585612969%	1	1974	5	Mendelian_Nancy_Cox	VANDESLUIS_NORMAL_EMBRYOS_UP
0.0506585612969%	1	1974	5	Mendelian_Nancy_Cox	TOMIDA_LUNG_CANCER_POOR_SURVIVAL
0.0506585612969%	1	1974	5	Mendelian_Nancy_Cox	SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM
0.0506585612969%	1	1974	5	Mendelian_Nancy_Cox	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3
0.0506585612969%	1	1974	5	Mendelian_Nancy_Cox	RODRIGUES_DCC_TARGETS_UP
0.0506585612969%	1	1974	5	Mendelian_Nancy_Cox	RAFFEL_VEGFA_TARGETS_DN
0.0506585612969%	1	1974	5	Mendelian_Nancy_Cox	OZANNE_AP1_TARGETS_DN
0.0506585612969%	1	1974	5	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_3
0.0506585612969%	1	1974	5	Mendelian_Nancy_Cox	LI_WILMS_TUMOR_ANAPLASTIC_DN
0.0506585612969%	1	1974	5	Mendelian_Nancy_Cox	LIU_IL13_MEMORY_MODEL_DN
0.0506585612969%	1	1974	5	Mendelian_Nancy_Cox	JU_AGING_TERC_TARGETS_DN
0.0506585612969%	1	1974	5	Mendelian_Nancy_Cox	INAMURA_LUNG_CANCER_SCC_SUBTYPES_DN
0.0506585612969%	1	1974	5	Mendelian_Nancy_Cox	FIGUEROA_AML_METHYLATION_CLUSTER_7_DN
0.0506585612969%	1	1974	5	Mendelian_Nancy_Cox	CAFFAREL_RESPONSE_TO_THC_8HR_3_UP
0.0506585612969%	1	1974	5	Mendelian_Nancy_Cox	BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.0506585612969%	1	1974	49	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_HP_UP
0.0506585612969%	1	1974	49	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC
0.0506585612969%	1	1974	48	Mendelian_Nancy_Cox	REACTOME_PACKAGING_OF_TELOMERE_ENDS
0.0506585612969%	1	1974	48	Mendelian_Nancy_Cox	REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES
0.0506585612969%	1	1974	42	Mendelian_Nancy_Cox	WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN
0.0506585612969%	1	1974	42	Mendelian_Nancy_Cox	HAHTOLA_SEZARY_SYNDROM_DN
0.0506585612969%	1	1974	41	Mendelian_Nancy_Cox	ZHAN_MULTIPLE_MYELOMA_MF_DN
0.0506585612969%	1	1974	35	Mendelian_Nancy_Cox	GUTIERREZ_MULTIPLE_MYELOMA_DN
0.0506585612969%	1	1974	35	Mendelian_Nancy_Cox	BALDWIN_PRKCI_TARGETS_UP
0.0506585612969%	1	1974	34	Mendelian_Nancy_Cox	KORKOLA_CORRELATED_WITH_POU5F1
0.0506585612969%	1	1974	32	Mendelian_Nancy_Cox	SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY
0.0506585612969%	1	1974	32	Mendelian_Nancy_Cox	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN
0.0506585612969%	1	1974	32	Mendelian_Nancy_Cox	REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS
0.0506585612969%	1	1974	31	Mendelian_Nancy_Cox	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.0506585612969%	1	1974	31	Mendelian_Nancy_Cox	PID_P38ALPHABETAPATHWAY
0.0506585612969%	1	1974	31	Mendelian_Nancy_Cox	MOSERLE_IFNA_RESPONSE
0.0506585612969%	1	1974	30	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_ROBO_RECEPTOR
0.0506585612969%	1	1974	30	Mendelian_Nancy_Cox	KEGG_O_GLYCAN_BIOSYNTHESIS
0.0506585612969%	1	1974	30	Mendelian_Nancy_Cox	HEIDENBLAD_AMPLICON_12P11_12_DN
0.0506585612969%	1	1974	29	Mendelian_Nancy_Cox	PATTERSON_DOCETAXEL_RESISTANCE
0.0506585612969%	1	1974	29	Mendelian_Nancy_Cox	MARSHALL_VIRAL_INFECTION_RESPONSE_DN
0.0506585612969%	1	1974	29	Mendelian_Nancy_Cox	KEGG_LINOLEIC_ACID_METABOLISM
0.0506585612969%	1	1974	29	Mendelian_Nancy_Cox	DALESSIO_TSA_RESPONSE
0.0506585612969%	1	1974	28	Mendelian_Nancy_Cox	WEBER_METHYLATED_HCP_IN_SPERM_DN
0.0506585612969%	1	1974	28	Mendelian_Nancy_Cox	REICHERT_MITOSIS_LIN9_TARGETS
0.0506585612969%	1	1974	28	Mendelian_Nancy_Cox	REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A
0.0506585612969%	1	1974	27	Mendelian_Nancy_Cox	TERAMOTO_OPN_TARGETS_CLUSTER_6
0.0506585612969%	1	1974	27	Mendelian_Nancy_Cox	NICK_RESPONSE_TO_PROC_TREATMENT_DN
0.0506585612969%	1	1974	26	Mendelian_Nancy_Cox	REACTOME_REGULATORY_RNA_PATHWAYS
0.0506585612969%	1	1974	26	Mendelian_Nancy_Cox	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP
0.0506585612969%	1	1974	26	Mendelian_Nancy_Cox	BIOCARTA_PGC1A_PATHWAY
0.0506585612969%	1	1974	25	Mendelian_Nancy_Cox	WAGNER_APO2_SENSITIVITY
0.0506585612969%	1	1974	25	Mendelian_Nancy_Cox	REACTOME_G0_AND_EARLY_G1
0.0506585612969%	1	1974	25	Mendelian_Nancy_Cox	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD
0.0506585612969%	1	1974	24	Mendelian_Nancy_Cox	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION
0.0506585612969%	1	1974	24	Mendelian_Nancy_Cox	REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS
0.0506585612969%	1	1974	24	Mendelian_Nancy_Cox	KEGG_PROTEIN_EXPORT
0.0506585612969%	1	1974	24	Mendelian_Nancy_Cox	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY
0.0506585612969%	1	1974	24	Mendelian_Nancy_Cox	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN
0.0506585612969%	1	1974	23	Mendelian_Nancy_Cox	YANG_BREAST_CANCER_ESR1_BULK_DN
0.0506585612969%	1	1974	23	Mendelian_Nancy_Cox	WU_HBX_TARGETS_2_UP
0.0506585612969%	1	1974	23	Mendelian_Nancy_Cox	SEKI_INFLAMMATORY_RESPONSE_LPS_DN
0.0506585612969%	1	1974	23	Mendelian_Nancy_Cox	REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR
0.0506585612969%	1	1974	23	Mendelian_Nancy_Cox	REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA
0.0506585612969%	1	1974	23	Mendelian_Nancy_Cox	REACTOME_MICRORNA_MIRNA_BIOGENESIS
0.0506585612969%	1	1974	23	Mendelian_Nancy_Cox	REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT
0.0506585612969%	1	1974	23	Mendelian_Nancy_Cox	PID_PRLSIGNALINGEVENTSPATHWAY
0.0506585612969%	1	1974	23	Mendelian_Nancy_Cox	MAHADEVAN_IMATINIB_RESISTANCE_UP
0.0506585612969%	1	1974	23	Mendelian_Nancy_Cox	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN
0.0506585612969%	1	1974	22	Mendelian_Nancy_Cox	YUAN_ZNF143_PARTNERS
0.0506585612969%	1	1974	22	Mendelian_Nancy_Cox	WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP
0.0506585612969%	1	1974	22	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_HIPPO
0.0506585612969%	1	1974	22	Mendelian_Nancy_Cox	REACTOME_DEADENYLATION_OF_MRNA
0.0506585612969%	1	1974	22	Mendelian_Nancy_Cox	REACTOME_ACYL_CHAIN_REMODELLING_OF_PC
0.0506585612969%	1	1974	22	Mendelian_Nancy_Cox	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP
0.0506585612969%	1	1974	22	Mendelian_Nancy_Cox	OKAWA_NEUROBLASTOMA_1P36_31_DELETION
0.0506585612969%	1	1974	22	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON
0.0506585612969%	1	1974	22	Mendelian_Nancy_Cox	BRACHAT_RESPONSE_TO_CISPLATIN
0.0506585612969%	1	1974	21	Mendelian_Nancy_Cox	ZIRN_TRETINOIN_RESPONSE_UP
0.0506585612969%	1	1974	21	Mendelian_Nancy_Cox	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP
0.0506585612969%	1	1974	21	Mendelian_Nancy_Cox	WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC
0.0506585612969%	1	1974	21	Mendelian_Nancy_Cox	REACTOME_ERK_MAPK_TARGETS
0.0506585612969%	1	1974	21	Mendelian_Nancy_Cox	REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS
0.0506585612969%	1	1974	21	Mendelian_Nancy_Cox	REACTOME_ACYL_CHAIN_REMODELLING_OF_PE
0.0506585612969%	1	1974	21	Mendelian_Nancy_Cox	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP
0.0506585612969%	1	1974	21	Mendelian_Nancy_Cox	BIOCARTA_CALCINEURIN_PATHWAY
0.0506585612969%	1	1974	20	Mendelian_Nancy_Cox	SESTO_RESPONSE_TO_UV_C4
0.0506585612969%	1	1974	20	Mendelian_Nancy_Cox	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA
0.0506585612969%	1	1974	20	Mendelian_Nancy_Cox	PHESSE_TARGETS_OF_APC_AND_MBD2_UP
0.0506585612969%	1	1974	20	Mendelian_Nancy_Cox	MAHADEVAN_RESPONSE_TO_MP470_UP
0.0506585612969%	1	1974	19	Mendelian_Nancy_Cox	ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE
0.0506585612969%	1	1974	19	Mendelian_Nancy_Cox	ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN
0.0506585612969%	1	1974	19	Mendelian_Nancy_Cox	XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.0506585612969%	1	1974	19	Mendelian_Nancy_Cox	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP
0.0506585612969%	1	1974	19	Mendelian_Nancy_Cox	REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR
0.0506585612969%	1	1974	19	Mendelian_Nancy_Cox	REACTOME_LAGGING_STRAND_SYNTHESIS
0.0506585612969%	1	1974	19	Mendelian_Nancy_Cox	REACTOME_BOTULINUM_NEUROTOXICITY
0.0506585612969%	1	1974	19	Mendelian_Nancy_Cox	PID_ARF_3PATHWAY
0.0506585612969%	1	1974	19	Mendelian_Nancy_Cox	NIELSEN_LIPOSARCOMA_DN
0.0506585612969%	1	1974	19	Mendelian_Nancy_Cox	MIZUSHIMA_AUTOPHAGOSOME_FORMATION
0.0506585612969%	1	1974	19	Mendelian_Nancy_Cox	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP
0.0506585612969%	1	1974	19	Mendelian_Nancy_Cox	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7
0.0506585612969%	1	1974	19	Mendelian_Nancy_Cox	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN
0.0506585612969%	1	1974	19	Mendelian_Nancy_Cox	KANG_DOXORUBICIN_RESISTANCE_DN
0.0506585612969%	1	1974	19	Mendelian_Nancy_Cox	HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN
0.0506585612969%	1	1974	19	Mendelian_Nancy_Cox	GENTLES_LEUKEMIC_STEM_CELL_DN
0.0506585612969%	1	1974	18	Mendelian_Nancy_Cox	ZHENG_RESPONSE_TO_ARSENITE_UP
0.0506585612969%	1	1974	18	Mendelian_Nancy_Cox	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN
0.0506585612969%	1	1974	18	Mendelian_Nancy_Cox	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB
0.0506585612969%	1	1974	18	Mendelian_Nancy_Cox	REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA
0.0506585612969%	1	1974	18	Mendelian_Nancy_Cox	REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS
0.0506585612969%	1	1974	18	Mendelian_Nancy_Cox	PLASARI_NFIC_TARGETS_BASAL_DN
0.0506585612969%	1	1974	18	Mendelian_Nancy_Cox	LE_NEURONAL_DIFFERENTIATION_UP
0.0506585612969%	1	1974	18	Mendelian_Nancy_Cox	KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.0506585612969%	1	1974	18	Mendelian_Nancy_Cox	GENTILE_UV_RESPONSE_CLUSTER_D1
0.0506585612969%	1	1974	18	Mendelian_Nancy_Cox	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP
0.0506585612969%	1	1974	18	Mendelian_Nancy_Cox	CHOI_ATL_CHRONIC_VS_ACUTE_DN
0.0506585612969%	1	1974	18	Mendelian_Nancy_Cox	CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB
0.0506585612969%	1	1974	18	Mendelian_Nancy_Cox	BOWIE_RESPONSE_TO_TAMOXIFEN
0.0506585612969%	1	1974	18	Mendelian_Nancy_Cox	BIOCARTA_ETS_PATHWAY
0.0506585612969%	1	1974	18	Mendelian_Nancy_Cox	AMIT_DELAYED_EARLY_GENES
0.0506585612969%	1	1974	17	Mendelian_Nancy_Cox	REACTOME_RAP1_SIGNALLING
0.0506585612969%	1	1974	17	Mendelian_Nancy_Cox	REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS
0.0506585612969%	1	1974	17	Mendelian_Nancy_Cox	REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP
0.0506585612969%	1	1974	17	Mendelian_Nancy_Cox	LOPEZ_EPITHELIOID_MESOTHELIOMA
0.0506585612969%	1	1974	17	Mendelian_Nancy_Cox	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL
0.0506585612969%	1	1974	16	Mendelian_Nancy_Cox	ZHAN_LATE_DIFFERENTIATION_GENES_DN
0.0506585612969%	1	1974	16	Mendelian_Nancy_Cox	TIAN_BHLHA15_TARGETS
0.0506585612969%	1	1974	16	Mendelian_Nancy_Cox	SU_SALIVARY_GLAND
0.0506585612969%	1	1974	16	Mendelian_Nancy_Cox	RODRIGUES_THYROID_CARCINOMA_UP
0.0506585612969%	1	1974	16	Mendelian_Nancy_Cox	REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS
0.0506585612969%	1	1974	16	Mendelian_Nancy_Cox	REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING
0.0506585612969%	1	1974	16	Mendelian_Nancy_Cox	REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS
0.0506585612969%	1	1974	16	Mendelian_Nancy_Cox	PID_CIRCADIANPATHWAY
0.0506585612969%	1	1974	16	Mendelian_Nancy_Cox	LY_AGING_MIDDLE_DN
0.0506585612969%	1	1974	16	Mendelian_Nancy_Cox	LUI_THYROID_CANCER_CLUSTER_4
0.0506585612969%	1	1974	16	Mendelian_Nancy_Cox	LIU_TOPBP1_TARGETS
0.0506585612969%	1	1974	16	Mendelian_Nancy_Cox	KOINUMA_COLON_CANCER_MSI_DN
0.0506585612969%	1	1974	16	Mendelian_Nancy_Cox	BIOCARTA_EIF_PATHWAY
0.0506585612969%	1	1974	16	Mendelian_Nancy_Cox	BIOCARTA_CACAM_PATHWAY
0.0506585612969%	1	1974	16	Mendelian_Nancy_Cox	ABDELMOHSEN_ELAVL4_TARGETS
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	ZHANG_GATA6_TARGETS_UP
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	REACTOME_ZINC_TRANSPORTERS
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	PID_THROMBIN_PAR4_PATHWAY
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	PID_ARF6DOWNSTREAMPATHWAY
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	NAGY_STAGA_COMPONENTS_HUMAN
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	LIU_IL13_PRIMING_MODEL
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	GRANDVAUX_IRF3_TARGETS_UP
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	FINETTI_BREAST_CANCERS_KINOME_GRAY
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	COLLIS_PRKDC_REGULATORS
0.0506585612969%	1	1974	15	Mendelian_Nancy_Cox	BIOCARTA_AKAPCENTROSOME_PATHWAY
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	WU_ALZHEIMER_DISEASE_UP
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	REACTOME_N_GLYCAN_ANTENNAE_ELONGATION
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	REACTOME_CRMPS_IN_SEMA3A_SIGNALING
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	REACTOME_ACTIVATION_OF_RAC
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	PID_TCRJNKPATHWAY
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	PARK_APL_PATHOGENESIS_UP
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	DORN_ADENOVIRUS_INFECTION_48HR_UP
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	BIOCARTA_DREAM_PATHWAY
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	BIOCARTA_CELL2CELL_PATHWAY
0.0506585612969%	1	1974	14	Mendelian_Nancy_Cox	AMIT_EGF_RESPONSE_20_MCF10A
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	WHITESIDE_CISPLATIN_RESISTANCE_DN
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	WAGSCHAL_EHMT2_TARGETS_UP
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	TSAI_DNAJB4_TARGETS_UP
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	REACTOME_POL_SWITCHING
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	POS_RESPONSE_TO_HISTAMINE_UP
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	LU_TUMOR_VASCULATURE_DN
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	HOEGERKORP_CD44_TARGETS_TEMPORAL_UP
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	HASINA_NOL7_TARGETS_UP
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	FU_INTERACT_WITH_ALKBH8
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	FRIDMAN_SENESCENCE_DN
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	ELLWOOD_MYC_TARGETS_UP
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	CONRAD_GERMLINE_STEM_CELL
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	BIOCARTA_SALMONELLA_PATHWAY
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	BIOCARTA_PARKIN_PATHWAY
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	BIOCARTA_ARENRF2_PATHWAY
0.0506585612969%	1	1974	13	Mendelian_Nancy_Cox	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	ZHENG_FOXP3_TARGETS_IN_THYMUS_DN
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	WAESCH_ANAPHASE_PROMOTING_COMPLEX
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	SA_PROGRAMMED_CELL_DEATH
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	REACTOME_SIGNALING_BY_NOTCH4
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	REACTOME_P2Y_RECEPTORS
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	PETRETTO_BLOOD_PRESSURE_UP
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	MIKKELSEN_NPC_ICP_WITH_H3K27ME3
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	MCBRYAN_TERMINAL_END_BUD_UP
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	KRISHNAN_FURIN_TARGETS_UP
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	HOLLEMAN_DAUNORUBICIN_B_ALL_DN
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	GHANDHI_BYSTANDER_IRRADIATION_DN
0.0506585612969%	1	1974	12	Mendelian_Nancy_Cox	EHLERS_ANEUPLOIDY_DN
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	REACTOME_UNWINDING_OF_DNA
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	REACTOME_SYNTHESIS_OF_PE
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	REACTOME_MTORC1_MEDIATED_SIGNALLING
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	REACTOME_DSCAM_INTERACTIONS
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	REACTOME_CALNEXIN_CALRETICULIN_CYCLE
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	MIKKELSEN_PLURIPOTENT_STATE_UP
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	MATHEW_FANCONI_ANEMIA_GENES
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	MANTOVANI_NFKB_TARGETS_DN
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	IIZUKA_LIVER_CANCER_EARLY_RECURRENCE
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	HOFFMAN_CLOCK_TARGETS_UP
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_DN
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	DORN_ADENOVIRUS_INFECTION_32HR_UP
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	DER_IFN_GAMMA_RESPONSE_DN
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	BIOCARTA_MONOCYTE_PATHWAY
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	BIOCARTA_LYM_PATHWAY
0.0506585612969%	1	1974	11	Mendelian_Nancy_Cox	AUJLA_IL22_AND_IL17A_SIGNALING
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	WORSCHECH_TUMOR_REJECTION_DN
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	VISALA_AGING_LYMPHOCYTE_UP
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	SHIRAISHI_PLZF_TARGETS_UP
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	SCHLESINGER_METHYLATED_IN_COLON_CANCER
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	REACTOME_PROSTANOID_LIGAND_RECEPTORS
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	REACTOME_PECAM1_INTERACTIONS
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	REACTOME_IRAK1_RECRUITS_IKK_COMPLEX
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	REACTOME_BINDING_AND_ENTRY_OF_HIV_VIRION
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	OXFORD_RALA_TARGETS_DN
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	OSAWA_TNF_TARGETS
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	OHASHI_AURKB_TARGETS
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	MANN_RESPONSE_TO_AMIFOSTINE_DN
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	MAINA_VHL_TARGETS_UP
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	JU_AGING_TERC_TARGETS_UP
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	CHASSOT_SKIN_WOUND
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	BUDHU_LIVER_CANCER_METASTASIS_UP
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	BIOCARTA_SKP2E2F_PATHWAY
0.0506585612969%	1	1974	10	Mendelian_Nancy_Cox	BIOCARTA_GABA_PATHWAY
0.0459981600736%	1	2174	9	T2D_GENES_TANYA_LIPIDS	ZERBINI_RESPONSE_TO_SULINDAC_UP
0.0459981600736%	1	2174	9	T2D_GENES_TANYA_LIPIDS	YANAGISAWA_LUNG_CANCER_RECURRENCE
0.0459981600736%	1	2174	9	T2D_GENES_TANYA_LIPIDS	XU_AKT1_TARGETS_48HR
0.0459981600736%	1	2174	9	T2D_GENES_TANYA_LIPIDS	ST_TYPE_I_INTERFERON_PATHWAY
0.0459981600736%	1	2174	9	T2D_GENES_TANYA_LIPIDS	ST_JAK_STAT_PATHWAY
0.0459981600736%	1	2174	9	T2D_GENES_TANYA_LIPIDS	SA_FAS_SIGNALING
0.0459981600736%	1	2174	9	T2D_GENES_TANYA_LIPIDS	SASSON_FSH_RESPONSE
0.0459981600736%	1	2174	9	T2D_GENES_TANYA_LIPIDS	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK
0.0459981600736%	1	2174	9	T2D_GENES_TANYA_LIPIDS	RAFFEL_VEGFA_TARGETS_UP
0.0459981600736%	1	2174	9	T2D_GENES_TANYA_LIPIDS	OXFORD_RALB_TARGETS_DN
0.0459981600736%	1	2174	9	T2D_GENES_TANYA_LIPIDS	GOUYER_TUMOR_INVASIVENESS
0.0459981600736%	1	2174	9	T2D_GENES_TANYA_LIPIDS	CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN
0.0459981600736%	1	2174	9	T2D_GENES_TANYA_LIPIDS	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1
0.0459981600736%	1	2174	9	T2D_GENES_TANYA_LIPIDS	BENPORATH_ES_CORE_NINE
0.0459981600736%	1	2174	9	T2D_GENES_TANYA_LIPIDS	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	YAGUE_PRETUMOR_DRUG_RESISTANCE_UP
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	TURJANSKI_MAPK7_TARGETS
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	TERAMOTO_OPN_TARGETS_CLUSTER_8
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	NAKAMURA_LUNG_CANCER
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	MOOTHA_PYR
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_PLURIPOTENT_STATE_DN
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_DEDIFFERENTIATED_STATE_UP
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	KREPPEL_CD99_TARGETS_DN
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	KONDO_HYPOXIA
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	ISHIKAWA_STING_SIGNALING
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	HOLLEMAN_DAUNORUBICIN_ALL_DN
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	GROSS_HIF1A_TARGETS_UP
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	DER_IFN_BETA_RESPONSE_DN
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	CLIMENT_BREAST_CANCER_COPY_NUMBER_DN
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	BOYLAN_MULTIPLE_MYELOMA_PCA1_DN
0.0459981600736%	1	2174	8	T2D_GENES_TANYA_LIPIDS	BIOCARTA_KREB_PATHWAY
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	ZEILSTRA_CD44_TARGETS_DN
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	TESAR_ALK_TARGETS_EPISC_4D_UP
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	TESAR_ALK_TARGETS_EPISC_3D_UP
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	TERAMOTO_OPN_TARGETS_CLUSTER_5
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_DEDIFFERENTIATED_STATE_DN
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	MATZUK_STEROIDOGENESIS
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	LY_AGING_OLD_UP
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	LIU_CMYB_TARGETS_DN
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	KONDO_COLON_CANCER_HCP_WITH_H3K27ME3
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	JOHNSTONE_PARVB_TARGETS_1_UP
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	IKEDA_MIR1_TARGETS_DN
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	HOLLEMAN_DAUNORUBICIN_ALL_UP
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	HE_PTEN_TARGETS_DN
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	FARDIN_HYPOXIA_9
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	DER_IFN_ALPHA_RESPONSE_DN
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	DASU_IL6_SIGNALING_DN
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	BUDHU_LIVER_CANCER_METASTASIS_DN
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	BERGER_MBD2_TARGETS
0.0459981600736%	1	2174	7	T2D_GENES_TANYA_LIPIDS	ABBUD_LIF_SIGNALING_2_DN
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	WILLIAMS_ESR1_TARGETS_DN
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	WALLACE_PROSTATE_CANCER_DN
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	TESAR_ALK_TARGETS_HUMAN_ES_4D_DN
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	PLASARI_TGFB1_TARGETS_1HR_DN
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_DN
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	MOTAMED_RESPONSE_TO_ANDROGEN_DN
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	MIZUKAMI_HYPOXIA_DN
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	MAINA_HYPOXIA_VHL_TARGETS_UP
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	KREPPEL_CD99_TARGETS_UP
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	KORKOLA_CHORIOCARCINOMA
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	KIM_GLIS2_TARGETS_DN
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	GERHOLD_RESPONSE_TO_TZD_UP
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	DING_LUNG_CANCER_MUTATED_RECURRENTLY
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	DIERICK_SEROTONIN_FUNCTION_GENES
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	COURTOIS_SENESCENCE_TRIGGERS
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	CORRADETTI_MTOR_PATHWAY_REGULATORS_DN
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	CHOI_ATL_ACUTE_STAGE
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	CHESLER_BRAIN_QTL_TRANS
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	CHEN_HOXA5_TARGETS_6HR_DN
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	CHENG_TAF7L_TARGETS
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	CASTELLANO_HRAS_TARGETS_DN
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	CASTELLANO_HRAS_AND_NRAS_TARGETS_UP
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	BIOCARTA_NEUROTRANSMITTERS_PATHWAY
0.0459981600736%	1	2174	6	T2D_GENES_TANYA_LIPIDS	BASSO_HAIRY_CELL_LEUKEMIA_UP
0.0459981600736%	1	2174	57	T2D_GENES_TANYA_LIPIDS	MCCLUNG_CREB1_TARGETS_DN
0.0459981600736%	1	2174	56	T2D_GENES_TANYA_LIPIDS	REACTOME_PI_3K_CASCADE
0.0459981600736%	1	2174	56	T2D_GENES_TANYA_LIPIDS	MAYBURD_RESPONSE_TO_L663536_DN
0.0459981600736%	1	2174	53	T2D_GENES_TANYA_LIPIDS	REACTOME_PROTEIN_FOLDING
0.0459981600736%	1	2174	52	T2D_GENES_TANYA_LIPIDS	KEGG_TASTE_TRANSDUCTION
0.0459981600736%	1	2174	50	T2D_GENES_TANYA_LIPIDS	KEGG_GLUTATHIONE_METABOLISM
0.0459981600736%	1	2174	50	T2D_GENES_TANYA_LIPIDS	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN
0.0459981600736%	1	2174	5	T2D_GENES_TANYA_LIPIDS	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN
0.0459981600736%	1	2174	5	T2D_GENES_TANYA_LIPIDS	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3
0.0459981600736%	1	2174	5	T2D_GENES_TANYA_LIPIDS	REN_MIF_TARGETS_DN
0.0459981600736%	1	2174	5	T2D_GENES_TANYA_LIPIDS	RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP
0.0459981600736%	1	2174	5	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3
0.0459981600736%	1	2174	5	T2D_GENES_TANYA_LIPIDS	KERLEY_RESPONSE_TO_CISPLATIN_DN
0.0459981600736%	1	2174	5	T2D_GENES_TANYA_LIPIDS	KANG_GIST_WITH_PDGFRA_DN
0.0459981600736%	1	2174	5	T2D_GENES_TANYA_LIPIDS	JONES_TCOF1_TARGETS
0.0459981600736%	1	2174	5	T2D_GENES_TANYA_LIPIDS	INAMURA_LUNG_CANCER_SCC_SUBTYPES_DN
0.0459981600736%	1	2174	5	T2D_GENES_TANYA_LIPIDS	IM_SREBF1A_TARGETS
0.0459981600736%	1	2174	5	T2D_GENES_TANYA_LIPIDS	FERRARI_RESPONSE_TO_FENRETINIDE_DN
0.0459981600736%	1	2174	5	T2D_GENES_TANYA_LIPIDS	CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN
0.0459981600736%	1	2174	5	T2D_GENES_TANYA_LIPIDS	CAFFAREL_RESPONSE_TO_THC_8HR_3_UP
0.0459981600736%	1	2174	5	T2D_GENES_TANYA_LIPIDS	ABDULRAHMAN_KIDNEY_CANCER_VHL_UP
0.0459981600736%	1	2174	49	T2D_GENES_TANYA_LIPIDS	LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE
0.0459981600736%	1	2174	48	T2D_GENES_TANYA_LIPIDS	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN
0.0459981600736%	1	2174	47	T2D_GENES_TANYA_LIPIDS	BROWNE_HCMV_INFECTION_8HR_DN
0.0459981600736%	1	2174	46	T2D_GENES_TANYA_LIPIDS	JIANG_TIP30_TARGETS_UP
0.0459981600736%	1	2174	44	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_FGFR_MUTANTS
0.0459981600736%	1	2174	44	T2D_GENES_TANYA_LIPIDS	REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_
0.0459981600736%	1	2174	44	T2D_GENES_TANYA_LIPIDS	PID_HNF3APATHWAY
0.0459981600736%	1	2174	44	T2D_GENES_TANYA_LIPIDS	PARK_HSC_MARKERS
0.0459981600736%	1	2174	42	T2D_GENES_TANYA_LIPIDS	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
0.0459981600736%	1	2174	41	T2D_GENES_TANYA_LIPIDS	KORKOLA_EMBRYONAL_CARCINOMA_UP
0.0459981600736%	1	2174	41	T2D_GENES_TANYA_LIPIDS	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.0459981600736%	1	2174	39	T2D_GENES_TANYA_LIPIDS	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2
0.0459981600736%	1	2174	39	T2D_GENES_TANYA_LIPIDS	VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN
0.0459981600736%	1	2174	38	T2D_GENES_TANYA_LIPIDS	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
0.0459981600736%	1	2174	38	T2D_GENES_TANYA_LIPIDS	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4
0.0459981600736%	1	2174	38	T2D_GENES_TANYA_LIPIDS	REACTOME_GAB1_SIGNALOSOME
0.0459981600736%	1	2174	38	T2D_GENES_TANYA_LIPIDS	HATADA_METHYLATED_IN_LUNG_CANCER_DN
0.0459981600736%	1	2174	38	T2D_GENES_TANYA_LIPIDS	GEISS_RESPONSE_TO_DSRNA_UP
0.0459981600736%	1	2174	38	T2D_GENES_TANYA_LIPIDS	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP
0.0459981600736%	1	2174	38	T2D_GENES_TANYA_LIPIDS	APPIERTO_RESPONSE_TO_FENRETINIDE_UP
0.0459981600736%	1	2174	37	T2D_GENES_TANYA_LIPIDS	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING
0.0459981600736%	1	2174	36	T2D_GENES_TANYA_LIPIDS	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.0459981600736%	1	2174	36	T2D_GENES_TANYA_LIPIDS	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN
0.0459981600736%	1	2174	36	T2D_GENES_TANYA_LIPIDS	HUANG_FOXA2_TARGETS_DN
0.0459981600736%	1	2174	35	T2D_GENES_TANYA_LIPIDS	SCHRAETS_MLL_TARGETS_UP
0.0459981600736%	1	2174	35	T2D_GENES_TANYA_LIPIDS	REACTOME_MRNA_3_END_PROCESSING
0.0459981600736%	1	2174	35	T2D_GENES_TANYA_LIPIDS	REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION
0.0459981600736%	1	2174	35	T2D_GENES_TANYA_LIPIDS	HAN_JNK_SINGALING_UP
0.0459981600736%	1	2174	34	T2D_GENES_TANYA_LIPIDS	WANG_RESPONSE_TO_BEXAROTENE_UP
0.0459981600736%	1	2174	34	T2D_GENES_TANYA_LIPIDS	REACTOME_GLUCONEOGENESIS
0.0459981600736%	1	2174	34	T2D_GENES_TANYA_LIPIDS	JIANG_HYPOXIA_VIA_VHL
0.0459981600736%	1	2174	33	T2D_GENES_TANYA_LIPIDS	VALK_AML_CLUSTER_3
0.0459981600736%	1	2174	33	T2D_GENES_TANYA_LIPIDS	VALK_AML_CLUSTER_10
0.0459981600736%	1	2174	33	T2D_GENES_TANYA_LIPIDS	SCHRAETS_MLL_TARGETS_DN
0.0459981600736%	1	2174	33	T2D_GENES_TANYA_LIPIDS	REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS
0.0459981600736%	1	2174	33	T2D_GENES_TANYA_LIPIDS	GREENBAUM_E2A_TARGETS_UP
0.0459981600736%	1	2174	32	T2D_GENES_TANYA_LIPIDS	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN
0.0459981600736%	1	2174	31	T2D_GENES_TANYA_LIPIDS	VALK_AML_CLUSTER_4
0.0459981600736%	1	2174	31	T2D_GENES_TANYA_LIPIDS	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES
0.0459981600736%	1	2174	31	T2D_GENES_TANYA_LIPIDS	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE
0.0459981600736%	1	2174	31	T2D_GENES_TANYA_LIPIDS	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP
0.0459981600736%	1	2174	30	T2D_GENES_TANYA_LIPIDS	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP
0.0459981600736%	1	2174	30	T2D_GENES_TANYA_LIPIDS	TSENG_ADIPOGENIC_POTENTIAL_UP
0.0459981600736%	1	2174	30	T2D_GENES_TANYA_LIPIDS	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
0.0459981600736%	1	2174	30	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
0.0459981600736%	1	2174	29	T2D_GENES_TANYA_LIPIDS	WOTTON_RUNX_TARGETS_DN
0.0459981600736%	1	2174	29	T2D_GENES_TANYA_LIPIDS	STANELLE_E2F1_TARGETS
0.0459981600736%	1	2174	29	T2D_GENES_TANYA_LIPIDS	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
0.0459981600736%	1	2174	29	T2D_GENES_TANYA_LIPIDS	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN
0.0459981600736%	1	2174	29	T2D_GENES_TANYA_LIPIDS	MA_PITUITARY_FETAL_VS_ADULT_UP
0.0459981600736%	1	2174	29	T2D_GENES_TANYA_LIPIDS	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN
0.0459981600736%	1	2174	29	T2D_GENES_TANYA_LIPIDS	BIOCARTA_NKT_PATHWAY
0.0459981600736%	1	2174	28	T2D_GENES_TANYA_LIPIDS	WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1
0.0459981600736%	1	2174	28	T2D_GENES_TANYA_LIPIDS	REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC
0.0459981600736%	1	2174	28	T2D_GENES_TANYA_LIPIDS	MATZUK_MALE_REPRODUCTION_SERTOLI
0.0459981600736%	1	2174	28	T2D_GENES_TANYA_LIPIDS	LOPES_METHYLATED_IN_COLON_CANCER_DN
0.0459981600736%	1	2174	28	T2D_GENES_TANYA_LIPIDS	LI_CISPLATIN_RESISTANCE_UP
0.0459981600736%	1	2174	28	T2D_GENES_TANYA_LIPIDS	DAIRKEE_CANCER_PRONE_RESPONSE_E2
0.0459981600736%	1	2174	28	T2D_GENES_TANYA_LIPIDS	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP
0.0459981600736%	1	2174	27	T2D_GENES_TANYA_LIPIDS	YANG_BREAST_CANCER_ESR1_BULK_UP
0.0459981600736%	1	2174	27	T2D_GENES_TANYA_LIPIDS	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN
0.0459981600736%	1	2174	27	T2D_GENES_TANYA_LIPIDS	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
0.0459981600736%	1	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_GAP_JUNCTION_TRAFFICKING
0.0459981600736%	1	2174	27	T2D_GENES_TANYA_LIPIDS	REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS
0.0459981600736%	1	2174	27	T2D_GENES_TANYA_LIPIDS	PLASARI_NFIC_TARGETS_BASAL_UP
0.0459981600736%	1	2174	27	T2D_GENES_TANYA_LIPIDS	LOPES_METHYLATED_IN_COLON_CANCER_UP
0.0459981600736%	1	2174	27	T2D_GENES_TANYA_LIPIDS	LEE_DOUBLE_POLAR_THYMOCYTE
0.0459981600736%	1	2174	27	T2D_GENES_TANYA_LIPIDS	IKEDA_MIR30_TARGETS_DN
0.0459981600736%	1	2174	27	T2D_GENES_TANYA_LIPIDS	EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.0459981600736%	1	2174	27	T2D_GENES_TANYA_LIPIDS	BRACHAT_RESPONSE_TO_METHOTREXATE_DN
0.0459981600736%	1	2174	27	T2D_GENES_TANYA_LIPIDS	AKL_HTLV1_INFECTION_UP
0.0459981600736%	1	2174	26	T2D_GENES_TANYA_LIPIDS	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.0459981600736%	1	2174	26	T2D_GENES_TANYA_LIPIDS	WILLIAMS_ESR1_TARGETS_UP
0.0459981600736%	1	2174	26	T2D_GENES_TANYA_LIPIDS	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN
0.0459981600736%	1	2174	26	T2D_GENES_TANYA_LIPIDS	REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE
0.0459981600736%	1	2174	26	T2D_GENES_TANYA_LIPIDS	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.0459981600736%	1	2174	26	T2D_GENES_TANYA_LIPIDS	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN
0.0459981600736%	1	2174	26	T2D_GENES_TANYA_LIPIDS	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP
0.0459981600736%	1	2174	26	T2D_GENES_TANYA_LIPIDS	ALONSO_METASTASIS_DN
0.0459981600736%	1	2174	25	T2D_GENES_TANYA_LIPIDS	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP
0.0459981600736%	1	2174	25	T2D_GENES_TANYA_LIPIDS	YANG_BREAST_CANCER_ESR1_DN
0.0459981600736%	1	2174	25	T2D_GENES_TANYA_LIPIDS	WANG_BARRETTS_ESOPHAGUS_DN
0.0459981600736%	1	2174	25	T2D_GENES_TANYA_LIPIDS	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP
0.0459981600736%	1	2174	25	T2D_GENES_TANYA_LIPIDS	REACTOME_SMOOTH_MUSCLE_CONTRACTION
0.0459981600736%	1	2174	25	T2D_GENES_TANYA_LIPIDS	REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS
0.0459981600736%	1	2174	25	T2D_GENES_TANYA_LIPIDS	REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE
0.0459981600736%	1	2174	25	T2D_GENES_TANYA_LIPIDS	REACTOME_G0_AND_EARLY_G1
0.0459981600736%	1	2174	25	T2D_GENES_TANYA_LIPIDS	JACKSON_DNMT1_TARGETS_DN
0.0459981600736%	1	2174	25	T2D_GENES_TANYA_LIPIDS	GROSS_HIF1A_TARGETS_DN
0.0459981600736%	1	2174	24	T2D_GENES_TANYA_LIPIDS	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS
0.0459981600736%	1	2174	24	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_IFNA_SIGNALING
0.0459981600736%	1	2174	24	T2D_GENES_TANYA_LIPIDS	ONO_AML1_TARGETS_UP
0.0459981600736%	1	2174	24	T2D_GENES_TANYA_LIPIDS	KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM
0.0459981600736%	1	2174	24	T2D_GENES_TANYA_LIPIDS	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP
0.0459981600736%	1	2174	24	T2D_GENES_TANYA_LIPIDS	DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.0459981600736%	1	2174	24	T2D_GENES_TANYA_LIPIDS	CHEOK_RESPONSE_TO_HD_MTX_DN
0.0459981600736%	1	2174	23	T2D_GENES_TANYA_LIPIDS	YANG_MUC2_TARGETS_DUODENUM_3MO_DN
0.0459981600736%	1	2174	23	T2D_GENES_TANYA_LIPIDS	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B
0.0459981600736%	1	2174	23	T2D_GENES_TANYA_LIPIDS	SABATES_COLORECTAL_ADENOMA_SIZE_UP
0.0459981600736%	1	2174	23	T2D_GENES_TANYA_LIPIDS	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS
0.0459981600736%	1	2174	23	T2D_GENES_TANYA_LIPIDS	REACTOME_GLUTATHIONE_CONJUGATION
0.0459981600736%	1	2174	23	T2D_GENES_TANYA_LIPIDS	PID_CONE_PATHWAY
0.0459981600736%	1	2174	23	T2D_GENES_TANYA_LIPIDS	MARKS_HDAC_TARGETS_UP
0.0459981600736%	1	2174	23	T2D_GENES_TANYA_LIPIDS	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.0459981600736%	1	2174	23	T2D_GENES_TANYA_LIPIDS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN
0.0459981600736%	1	2174	23	T2D_GENES_TANYA_LIPIDS	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP
0.0459981600736%	1	2174	23	T2D_GENES_TANYA_LIPIDS	BIOCARTA_INTRINSIC_PATHWAY
0.0459981600736%	1	2174	23	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CELLCYCLE_PATHWAY
0.0459981600736%	1	2174	23	T2D_GENES_TANYA_LIPIDS	BIOCARTA_CASPASE_PATHWAY
0.0459981600736%	1	2174	22	T2D_GENES_TANYA_LIPIDS	YUAN_ZNF143_PARTNERS
0.0459981600736%	1	2174	22	T2D_GENES_TANYA_LIPIDS	SPIRA_SMOKERS_LUNG_CANCER_DN
0.0459981600736%	1	2174	22	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_HIPPO
0.0459981600736%	1	2174	22	T2D_GENES_TANYA_LIPIDS	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
0.0459981600736%	1	2174	22	T2D_GENES_TANYA_LIPIDS	REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC
0.0459981600736%	1	2174	22	T2D_GENES_TANYA_LIPIDS	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP
0.0459981600736%	1	2174	22	T2D_GENES_TANYA_LIPIDS	LANDIS_ERBB2_BREAST_TUMORS_65_UP
0.0459981600736%	1	2174	22	T2D_GENES_TANYA_LIPIDS	KEGG_BETA_ALANINE_METABOLISM
0.0459981600736%	1	2174	22	T2D_GENES_TANYA_LIPIDS	GAVIN_PDE3B_TARGETS
0.0459981600736%	1	2174	22	T2D_GENES_TANYA_LIPIDS	BIOCARTA_IL2_PATHWAY
0.0459981600736%	1	2174	21	T2D_GENES_TANYA_LIPIDS	WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC
0.0459981600736%	1	2174	21	T2D_GENES_TANYA_LIPIDS	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP
0.0459981600736%	1	2174	21	T2D_GENES_TANYA_LIPIDS	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP
0.0459981600736%	1	2174	21	T2D_GENES_TANYA_LIPIDS	RAHMAN_TP53_TARGETS_PHOSPHORYLATED
0.0459981600736%	1	2174	21	T2D_GENES_TANYA_LIPIDS	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.0459981600736%	1	2174	21	T2D_GENES_TANYA_LIPIDS	OUYANG_PROSTATE_CANCER_PROGRESSION_DN
0.0459981600736%	1	2174	21	T2D_GENES_TANYA_LIPIDS	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD
0.0459981600736%	1	2174	21	T2D_GENES_TANYA_LIPIDS	KANNAN_TP53_TARGETS_DN
0.0459981600736%	1	2174	21	T2D_GENES_TANYA_LIPIDS	HU_ANGIOGENESIS_UP
0.0459981600736%	1	2174	21	T2D_GENES_TANYA_LIPIDS	HUI_MAPK14_TARGETS_UP
0.0459981600736%	1	2174	21	T2D_GENES_TANYA_LIPIDS	FOURNIER_ACINAR_DEVELOPMENT_LATE_DN
0.0459981600736%	1	2174	21	T2D_GENES_TANYA_LIPIDS	FERRANDO_TAL1_NEIGHBORS
0.0459981600736%	1	2174	21	T2D_GENES_TANYA_LIPIDS	BIOCARTA_MITOCHONDRIA_PATHWAY
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	WANG_THOC1_TARGETS_DN
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	SESTO_RESPONSE_TO_UV_C4
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	MAHADEVAN_RESPONSE_TO_MP470_UP
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	MAHADEVAN_IMATINIB_RESISTANCE_DN
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	LIU_TARGETS_OF_VMYB_VS_CMYB_UP
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	KYNG_WERNER_SYNDROM_UP
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	HEDENFALK_BREAST_CANCER_BRACX_UP
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	FARMER_BREAST_CANCER_CLUSTER_7
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	DE_YY1_TARGETS_UP
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	CROONQUIST_IL6_DEPRIVATION_UP
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	BIOCARTA_NKCELLS_PATHWAY
0.0459981600736%	1	2174	20	T2D_GENES_TANYA_LIPIDS	AMUNDSON_GAMMA_RADIATION_RESISTANCE
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	VERRECCHIA_RESPONSE_TO_TGFB1_C1
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	TRAYNOR_RETT_SYNDROM_DN
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	STREICHER_LSM1_TARGETS_DN
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	REACTOME_BASE_EXCISION_REPAIR
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	RASHI_NFKB1_TARGETS
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	MATZUK_EMBRYONIC_GERM_CELL
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	MARSON_FOXP3_CORE_DIRECT_TARGETS
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	KYNG_NORMAL_AGING_UP
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	JEON_SMAD6_TARGETS_DN
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	FARMER_BREAST_CANCER_CLUSTER_5
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	CHEN_PDGF_TARGETS
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	BIOCARTA_TGFB_PATHWAY
0.0459981600736%	1	2174	19	T2D_GENES_TANYA_LIPIDS	AMIT_EGF_RESPONSE_40_MCF10A
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	YIH_RESPONSE_TO_ARSENITE_C2
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	WEBER_METHYLATED_IN_COLON_CANCER
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	STAMBOLSKY_BOUND_BY_MUTATED_TP53
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	PLASARI_NFIC_TARGETS_BASAL_DN
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	PIONTEK_PKD1_TARGETS_DN
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	NAM_FXYD5_TARGETS_DN
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	MCGOWAN_RSP6_TARGETS_UP
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	LE_NEURONAL_DIFFERENTIATION_UP
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	KAPOSI_LIVER_CANCER_MET_UP
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	GENTILE_UV_RESPONSE_CLUSTER_D1
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	BOWIE_RESPONSE_TO_TAMOXIFEN
0.0459981600736%	1	2174	18	T2D_GENES_TANYA_LIPIDS	ALONSO_METASTASIS_NEURAL_UP
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	THUM_MIR21_TARGETS_HEART_DISEASE_UP
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	SIMBULAN_PARP1_TARGETS_DN
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	PID_INTEGRIN5_PATHWAY
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	NGO_MALIGNANT_GLIOMA_1P_LOH
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	LI_CYTIDINE_ANALOG_PATHWAY
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	LIU_IL13_MEMORY_MODEL_UP
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	LE_SKI_TARGETS_UP
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	KASLER_HDAC7_TARGETS_1_DN
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	KANG_AR_TARGETS_UP
0.0459981600736%	1	2174	17	T2D_GENES_TANYA_LIPIDS	JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	ZHAN_LATE_DIFFERENTIATION_GENES_DN
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	WONG_IFNA2_RESISTANCE_UP
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	RODRIGUES_THYROID_CARCINOMA_UP
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	REACTOME_PLATELET_SENSITIZATION_BY_LDL
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	PID_DNAPK_PATHWAY
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	MOOTHA_TCA
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	LEE_LIVER_CANCER_HEPATOBLAST
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	KORKOLA_TERATOMA_UP
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	KEGG_OTHER_GLYCAN_DEGRADATION
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	HUMMERICH_MALIGNANT_SKIN_TUMOR_UP
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	HE_PTEN_TARGETS_UP
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	GHO_ATF5_TARGETS_DN
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	FINETTI_BREAST_CANCER_KINOME_GREEN
0.0459981600736%	1	2174	16	T2D_GENES_TANYA_LIPIDS	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	ZHANG_GATA6_TARGETS_UP
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	SINGH_NFE2L2_TARGETS
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	SA_MMP_CYTOKINE_CONNECTION
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	SANCHEZ_MDM2_TARGETS
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	REACTOME_ENDOGENOUS_STEROLS
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	PID_LPA4_PATHWAY
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	PID_ERBB_NETWORK_PATHWAY
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	NAGY_STAGA_COMPONENTS_HUMAN
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	BIOCARTA_STEM_PATHWAY
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	BIOCARTA_LONGEVITY_PATHWAY
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	BIOCARTA_IL3_PATHWAY
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	BIOCARTA_ERYTH_PATHWAY
0.0459981600736%	1	2174	15	T2D_GENES_TANYA_LIPIDS	BIOCARTA_AKAPCENTROSOME_PATHWAY
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	WU_ALZHEIMER_DISEASE_UP
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_SIGNAL_ATTENUATION
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_IFNG_SIGNALING
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_P75NTR_SIGNALS_VIA_NFKB
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_N_GLYCAN_ANTENNAE_ELONGATION
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_COMMON_PATHWAY
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	PID_TCRJNKPATHWAY
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	LY_AGING_MIDDLE_UP
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	LEE_SP4_THYMOCYTE
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	KEGG_NON_HOMOLOGOUS_END_JOINING
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	INAMURA_LUNG_CANCER_SCC_UP
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	HOEGERKORP_CD44_TARGETS_DIRECT_DN
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.0459981600736%	1	2174	14	T2D_GENES_TANYA_LIPIDS	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	YAGUE_PRETUMOR_DRUG_RESISTANCE_DN
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	WHITESIDE_CISPLATIN_RESISTANCE_DN
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	VERRECCHIA_RESPONSE_TO_TGFB1_C4
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	TSAI_DNAJB4_TARGETS_UP
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	STARK_BRAIN_22Q11_DELETION
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	SHIN_B_CELL_LYMPHOMA_CLUSTER_1
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_POL_SWITCHING
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6_ALPHA
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	RAY_ALZHEIMERS_DISEASE
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	POS_RESPONSE_TO_HISTAMINE_UP
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	KRISHNAN_FURIN_TARGETS_DN
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	KEGG_SULFUR_METABOLISM
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	JIANG_CORE_DUPLICON_GENES
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	IVANOV_MUTATED_IN_COLON_CANCER
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	IRITANI_MAD1_TARGETS_UP
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	HASINA_NOL7_TARGETS_UP
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	BIOCARTA_SALMONELLA_PATHWAY
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	BIOCARTA_PARKIN_PATHWAY
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	BIOCARTA_P27_PATHWAY
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	BIOCARTA_EXTRINSIC_PATHWAY
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	BIOCARTA_D4GDI_PATHWAY
0.0459981600736%	1	2174	13	T2D_GENES_TANYA_LIPIDS	BIOCARTA_ACE2_PATHWAY
0.0459981600736%	1	2174	12	T2D_GENES_TANYA_LIPIDS	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN
0.0459981600736%	1	2174	12	T2D_GENES_TANYA_LIPIDS	SA_PROGRAMMED_CELL_DEATH
0.0459981600736%	1	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_SEROTONIN_RECEPTORS
0.0459981600736%	1	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE
0.0459981600736%	1	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_PYRIMIDINE_CATABOLISM
0.0459981600736%	1	2174	12	T2D_GENES_TANYA_LIPIDS	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
0.0459981600736%	1	2174	12	T2D_GENES_TANYA_LIPIDS	NEBEN_AML_WITH_FLT3_OR_NRAS_DN
0.0459981600736%	1	2174	12	T2D_GENES_TANYA_LIPIDS	KRISHNAN_FURIN_TARGETS_UP
0.0459981600736%	1	2174	12	T2D_GENES_TANYA_LIPIDS	HEDVAT_ELF4_TARGETS_UP
0.0459981600736%	1	2174	12	T2D_GENES_TANYA_LIPIDS	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.0459981600736%	1	2174	12	T2D_GENES_TANYA_LIPIDS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN
0.0459981600736%	1	2174	12	T2D_GENES_TANYA_LIPIDS	CLAUS_PGR_POSITIVE_MENINGIOMA_DN
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	ZHOU_PANCREATIC_EXOCRINE_PROGENITOR
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	WILLIAMS_ESR2_TARGETS_DN
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	WHITESIDE_CISPLATIN_RESISTANCE_UP
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	ST_STAT3_PATHWAY
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	SHIN_B_CELL_LYMPHOMA_CLUSTER_6
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	SEMBA_FHIT_TARGETS_UP
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_SYNTHESIS_OF_PE
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_MTORC1_MEDIATED_SIGNALLING
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_IL_6_SIGNALING
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	POS_RESPONSE_TO_HISTAMINE_DN
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	PID_ALK2PATHWAY
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	PASTURAL_RIZ1_TARGETS_UP
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	MARTINELLI_IMMATURE_NEUTROPHIL_UP
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	DER_IFN_GAMMA_RESPONSE_DN
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	BIOCARTA_SRCRPTP_PATHWAY
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	BIOCARTA_SET_PATHWAY
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	BIOCARTA_LYM_PATHWAY
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	BAUS_TFF2_TARGETS_DN
0.0459981600736%	1	2174	11	T2D_GENES_TANYA_LIPIDS	AUJLA_IL22_AND_IL17A_SIGNALING
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	YIH_RESPONSE_TO_ARSENITE_C5
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	ST_INTERFERON_GAMMA_PATHWAY
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	SHIRAISHI_PLZF_TARGETS_UP
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	SEMBA_FHIT_TARGETS_DN
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_PURINE_CATABOLISM
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_GAP_JUNCTION_DEGRADATION
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_ANDROGEN_BIOSYNTHESIS
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	PYEON_HPV_POSITIVE_TUMORS_DN
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	PID_VEGF_VEGFR_PATHWAY
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	OXFORD_RALA_AND_RALB_TARGETS_UP
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	MURAKAMI_UV_RESPONSE_1HR_DN
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	MIKKELSEN_IPS_LCP_WITH_H3K27ME3
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	MANN_RESPONSE_TO_AMIFOSTINE_DN
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	KONG_E2F1_TARGETS
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	HOLLEMAN_DAUNORUBICIN_B_ALL_UP
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	CAFFAREL_RESPONSE_TO_THC_8HR_3_DN
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	BUDHU_LIVER_CANCER_METASTASIS_UP
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	BIOCARTA_SODD_PATHWAY
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	BIOCARTA_RANMS_PATHWAY
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	BIOCARTA_GABA_PATHWAY
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	BIOCARTA_DNAFRAGMENT_PATHWAY
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	BIOCARTA_BARRESTIN_PATHWAY
0.0459981600736%	1	2174	10	T2D_GENES_TANYA_LIPIDS	BAKER_HEMATOPOESIS_STAT1_TARGETS
0.0284090909091%	1	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZERBINI_RESPONSE_TO_SULINDAC_UP
0.0284090909091%	1	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YANAGISAWA_LUNG_CANCER_RECURRENCE
0.0284090909091%	1	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_AKT1_TARGETS_48HR
0.0284090909091%	1	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_TYPE_I_INTERFERON_PATHWAY
0.0284090909091%	1	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_JAK_STAT_PATHWAY
0.0284090909091%	1	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP
0.0284090909091%	1	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SA_FAS_SIGNALING
0.0284090909091%	1	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK
0.0284090909091%	1	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAFFEL_VEGFA_TARGETS_UP
0.0284090909091%	1	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OXFORD_RALB_TARGETS_DN
0.0284090909091%	1	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ITO_PTTG1_TARGETS_DN
0.0284090909091%	1	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOUYER_TUMOR_INVASIVENESS
0.0284090909091%	1	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.0284090909091%	1	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN
0.0284090909091%	1	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1
0.0284090909091%	1	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BENPORATH_ES_CORE_NINE
0.0284090909091%	1	3520	9	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAGUE_PRETUMOR_DRUG_RESISTANCE_UP
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TURJANSKI_MAPK8_AND_MAPK9_TARGETS
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TURJANSKI_MAPK7_TARGETS
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TCGA_GLIOBLASTOMA_MUTATED
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAMURA_LUNG_CANCER
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOOTHA_PYR
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_PLURIPOTENT_STATE_DN
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_DEDIFFERENTIATED_STATE_UP
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KREPPEL_CD99_TARGETS_DN
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KONDO_HYPOXIA
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ISHIKAWA_STING_SIGNALING
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOLLEMAN_DAUNORUBICIN_ALL_DN
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GROSS_HIF1A_TARGETS_UP
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAUTSCHI_SRC_SIGNALING
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DER_IFN_BETA_RESPONSE_DN
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CLIMENT_BREAST_CANCER_COPY_NUMBER_DN
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHANG_POU5F1_TARGETS_DN
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOYLAN_MULTIPLE_MYELOMA_PCA1_DN
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_KREB_PATHWAY
0.0284090909091%	1	3520	8	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZEILSTRA_CD44_TARGETS_DN
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TESAR_ALK_TARGETS_EPISC_4D_UP
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TESAR_ALK_TARGETS_EPISC_3D_UP
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TERAMOTO_OPN_TARGETS_CLUSTER_5
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOOTHA_ROS
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_DEDIFFERENTIATED_STATE_DN
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATZUK_STEROIDOGENESIS
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LY_AGING_OLD_UP
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LUDWICZEK_TREATING_IRON_OVERLOAD
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_CMYB_TARGETS_DN
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JOHNSTONE_PARVB_TARGETS_1_UP
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IKEDA_MIR1_TARGETS_DN
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOLLEMAN_DAUNORUBICIN_ALL_UP
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HE_PTEN_TARGETS_DN
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FARDIN_HYPOXIA_9
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DER_IFN_ALPHA_RESPONSE_DN
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DASU_IL6_SIGNALING_DN
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BUDHU_LIVER_CANCER_METASTASIS_DN
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BERGER_MBD2_TARGETS
0.0284090909091%	1	3520	7	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ABBUD_LIF_SIGNALING_2_DN
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WILLIAMS_ESR1_TARGETS_DN
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WALLACE_PROSTATE_CANCER_DN
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TESAR_ALK_TARGETS_HUMAN_ES_4D_DN
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PLASARI_TGFB1_TARGETS_1HR_DN
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_DN
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOTAMED_RESPONSE_TO_ANDROGEN_DN
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIZUKAMI_HYPOXIA_DN
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MAINA_HYPOXIA_VHL_TARGETS_UP
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KREPPEL_CD99_TARGETS_UP
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KORKOLA_CHORIOCARCINOMA
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_GLIS2_TARGETS_DN
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GERHOLD_RESPONSE_TO_TZD_UP
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DIERICK_SEROTONIN_FUNCTION_GENES
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	COURTOIS_SENESCENCE_TRIGGERS
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CORRADETTI_MTOR_PATHWAY_REGULATORS_DN
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHOI_ATL_ACUTE_STAGE
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHESLER_BRAIN_QTL_TRANS
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEN_HOXA5_TARGETS_6HR_DN
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHENG_TAF7L_TARGETS
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CASTELLANO_HRAS_TARGETS_DN
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CASTELLANO_HRAS_AND_NRAS_TARGETS_UP
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_NEUROTRANSMITTERS_PATHWAY
0.0284090909091%	1	3520	6	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BASSO_HAIRY_CELL_LEUKEMIA_UP
0.0284090909091%	1	3520	57	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCCLUNG_CREB1_TARGETS_DN
0.0284090909091%	1	3520	56	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PI_3K_CASCADE
0.0284090909091%	1	3520	55	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LAU_APOPTOSIS_CDKN2A_UP
0.0284090909091%	1	3520	54	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JIANG_AGING_CEREBRAL_CORTEX_DN
0.0284090909091%	1	3520	53	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PROTEIN_FOLDING
0.0284090909091%	1	3520	52	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_TASTE_TRANSDUCTION
0.0284090909091%	1	3520	51	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FRASOR_TAMOXIFEN_RESPONSE_UP
0.0284090909091%	1	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_GLUTATHIONE_METABOLISM
0.0284090909091%	1	3520	50	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN
0.0284090909091%	1	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN
0.0284090909091%	1	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3
0.0284090909091%	1	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REN_MIF_TARGETS_DN
0.0284090909091%	1	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP
0.0284090909091%	1	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3
0.0284090909091%	1	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KERLEY_RESPONSE_TO_CISPLATIN_DN
0.0284090909091%	1	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KANG_GIST_WITH_PDGFRA_DN
0.0284090909091%	1	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JONES_TCOF1_TARGETS
0.0284090909091%	1	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	INAMURA_LUNG_CANCER_SCC_SUBTYPES_DN
0.0284090909091%	1	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IM_SREBF1A_TARGETS
0.0284090909091%	1	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FERRARI_RESPONSE_TO_FENRETINIDE_DN
0.0284090909091%	1	3520	5	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ABDULRAHMAN_KIDNEY_CANCER_VHL_UP
0.0284090909091%	1	3520	49	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE
0.0284090909091%	1	3520	48	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN
0.0284090909091%	1	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KHETCHOUMIAN_TRIM24_TARGETS_UP
0.0284090909091%	1	3520	47	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BROWNE_HCMV_INFECTION_8HR_DN
0.0284090909091%	1	3520	46	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS
0.0284090909091%	1	3520	45	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHENG_RESPONSE_TO_NICKEL_ACETATE
0.0284090909091%	1	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_FGFR_MUTANTS
0.0284090909091%	1	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_
0.0284090909091%	1	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_HNF3APATHWAY
0.0284090909091%	1	3520	44	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PARK_HSC_MARKERS
0.0284090909091%	1	3520	42	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
0.0284090909091%	1	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_ES_HCP_WITH_H3K27ME3
0.0284090909091%	1	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KORKOLA_EMBRYONAL_CARCINOMA_UP
0.0284090909091%	1	3520	41	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	EHLERS_ANEUPLOIDY_UP
0.0284090909091%	1	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TOMLINS_PROSTATE_CANCER_UP
0.0284090909091%	1	3520	40	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN
0.0284090909091%	1	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2
0.0284090909091%	1	3520	39	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN
0.0284090909091%	1	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING
0.0284090909091%	1	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4
0.0284090909091%	1	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GAB1_SIGNALOSOME
0.0284090909091%	1	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HATADA_METHYLATED_IN_LUNG_CANCER_DN
0.0284090909091%	1	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GEISS_RESPONSE_TO_DSRNA_UP
0.0284090909091%	1	3520	38	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP
0.0284090909091%	1	3520	37	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING
0.0284090909091%	1	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.0284090909091%	1	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN
0.0284090909091%	1	3520	36	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUANG_FOXA2_TARGETS_DN
0.0284090909091%	1	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHRAETS_MLL_TARGETS_UP
0.0284090909091%	1	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MRNA_3_END_PROCESSING
0.0284090909091%	1	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION
0.0284090909091%	1	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HAN_JNK_SINGALING_UP
0.0284090909091%	1	3520	35	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GUTIERREZ_MULTIPLE_MYELOMA_DN
0.0284090909091%	1	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_RESPONSE_TO_BEXAROTENE_UP
0.0284090909091%	1	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JIANG_HYPOXIA_VIA_VHL
0.0284090909091%	1	3520	34	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FRIDMAN_IMMORTALIZATION_DN
0.0284090909091%	1	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_CLUSTER_3
0.0284090909091%	1	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_CLUSTER_10
0.0284090909091%	1	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHRAETS_MLL_TARGETS_DN
0.0284090909091%	1	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS
0.0284090909091%	1	3520	33	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GREENBAUM_E2A_TARGETS_UP
0.0284090909091%	1	3520	32	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN
0.0284090909091%	1	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VALK_AML_CLUSTER_4
0.0284090909091%	1	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES
0.0284090909091%	1	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE
0.0284090909091%	1	3520	31	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DORSEY_GAB2_TARGETS
0.0284090909091%	1	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP
0.0284090909091%	1	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TSENG_ADIPOGENIC_POTENTIAL_UP
0.0284090909091%	1	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TAVOR_CEBPA_TARGETS_DN
0.0284090909091%	1	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHIN_B_CELL_LYMPHOMA_CLUSTER_2
0.0284090909091%	1	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_FGFR1_MUTANTS
0.0284090909091%	1	3520	30	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAJIMA_EOSINOPHIL
0.0284090909091%	1	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WOTTON_RUNX_TARGETS_DN
0.0284090909091%	1	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STANELLE_E2F1_TARGETS
0.0284090909091%	1	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PKB_MEDIATED_EVENTS
0.0284090909091%	1	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING
0.0284090909091%	1	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GLYCOLYSIS
0.0284090909091%	1	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN
0.0284090909091%	1	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MA_PITUITARY_FETAL_VS_ADULT_UP
0.0284090909091%	1	3520	29	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_NKT_PATHWAY
0.0284090909091%	1	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1
0.0284090909091%	1	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC
0.0284090909091%	1	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATZUK_MALE_REPRODUCTION_SERTOLI
0.0284090909091%	1	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LOPES_METHYLATED_IN_COLON_CANCER_DN
0.0284090909091%	1	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LI_CISPLATIN_RESISTANCE_UP
0.0284090909091%	1	3520	28	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEN_LUNG_CANCER_SURVIVAL
0.0284090909091%	1	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YANG_BREAST_CANCER_ESR1_BULK_UP
0.0284090909091%	1	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN
0.0284090909091%	1	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2
0.0284090909091%	1	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION
0.0284090909091%	1	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY
0.0284090909091%	1	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GAP_JUNCTION_TRAFFICKING
0.0284090909091%	1	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS
0.0284090909091%	1	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PLASARI_NFIC_TARGETS_BASAL_UP
0.0284090909091%	1	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OHM_METHYLATED_IN_ADULT_CANCERS
0.0284090909091%	1	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IKEDA_MIR30_TARGETS_DN
0.0284090909091%	1	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.0284090909091%	1	3520	27	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AKL_HTLV1_INFECTION_UP
0.0284090909091%	1	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.0284090909091%	1	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WILLIAMS_ESR1_TARGETS_UP
0.0284090909091%	1	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TOMIDA_METASTASIS_UP
0.0284090909091%	1	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN
0.0284090909091%	1	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE
0.0284090909091%	1	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_INTEGRIN_CS_PATHWAY
0.0284090909091%	1	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAKAMURA_CANCER_MICROENVIRONMENT_UP
0.0284090909091%	1	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.0284090909091%	1	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN
0.0284090909091%	1	3520	26	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP
0.0284090909091%	1	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP
0.0284090909091%	1	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YANG_BREAST_CANCER_ESR1_DN
0.0284090909091%	1	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_BARRETTS_ESOPHAGUS_DN
0.0284090909091%	1	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP
0.0284090909091%	1	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SMOOTH_MUSCLE_CONTRACTION
0.0284090909091%	1	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS
0.0284090909091%	1	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE
0.0284090909091%	1	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_G0_AND_EARLY_G1
0.0284090909091%	1	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NOJIMA_SFRP2_TARGETS_DN
0.0284090909091%	1	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JACKSON_DNMT1_TARGETS_DN
0.0284090909091%	1	3520	25	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GROSS_HIF1A_TARGETS_DN
0.0284090909091%	1	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_TNF_TARGETS
0.0284090909091%	1	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS
0.0284090909091%	1	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_IFNA_SIGNALING
0.0284090909091%	1	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_RHODOPSIN_PATHWAY
0.0284090909091%	1	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ONO_AML1_TARGETS_UP
0.0284090909091%	1	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MURATA_VIRULENCE_OF_H_PILORI
0.0284090909091%	1	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM
0.0284090909091%	1	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GOLUB_ALL_VS_AML_DN
0.0284090909091%	1	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP
0.0284090909091%	1	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.0284090909091%	1	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEOK_RESPONSE_TO_HD_MTX_DN
0.0284090909091%	1	3520	24	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_G2_PATHWAY
0.0284090909091%	1	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YANG_MUC2_TARGETS_DUODENUM_3MO_DN
0.0284090909091%	1	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B
0.0284090909091%	1	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SABATES_COLORECTAL_ADENOMA_SIZE_UP
0.0284090909091%	1	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS
0.0284090909091%	1	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GLUTATHIONE_CONJUGATION
0.0284090909091%	1	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARKS_HDAC_TARGETS_UP
0.0284090909091%	1	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5
0.0284090909091%	1	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN
0.0284090909091%	1	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP
0.0284090909091%	1	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP
0.0284090909091%	1	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_INTRINSIC_PATHWAY
0.0284090909091%	1	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CTCF_PATHWAY
0.0284090909091%	1	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CELLCYCLE_PATHWAY
0.0284090909091%	1	3520	23	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_CASPASE_PATHWAY
0.0284090909091%	1	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YUAN_ZNF143_PARTNERS
0.0284090909091%	1	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SPIRA_SMOKERS_LUNG_CANCER_DN
0.0284090909091%	1	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_HIPPO
0.0284090909091%	1	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION
0.0284090909091%	1	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC
0.0284090909091%	1	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP
0.0284090909091%	1	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LANDIS_ERBB2_BREAST_TUMORS_65_UP
0.0284090909091%	1	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_BETA_ALANINE_METABOLISM
0.0284090909091%	1	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GAVIN_PDE3B_TARGETS
0.0284090909091%	1	3520	22	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_IL2_PATHWAY
0.0284090909091%	1	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC
0.0284090909091%	1	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP
0.0284090909091%	1	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP
0.0284090909091%	1	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAHMAN_TP53_TARGETS_PHOSPHORYLATED
0.0284090909091%	1	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN
0.0284090909091%	1	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OUYANG_PROSTATE_CANCER_PROGRESSION_DN
0.0284090909091%	1	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOOTHA_GLYCOLYSIS
0.0284090909091%	1	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_INTRATHYMIC_T_PROGENITOR
0.0284090909091%	1	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD
0.0284090909091%	1	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HU_ANGIOGENESIS_UP
0.0284090909091%	1	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUI_MAPK14_TARGETS_UP
0.0284090909091%	1	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GESERICK_TERT_TARGETS_DN
0.0284090909091%	1	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP
0.0284090909091%	1	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FERRANDO_TAL1_NEIGHBORS
0.0284090909091%	1	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAZARD_UV_RESPONSE_CLUSTER_G4
0.0284090909091%	1	3520	21	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_MITOCHONDRIA_PATHWAY
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_THOC1_TARGETS_DN
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WALLACE_PROSTATE_CANCER_UP
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SESTO_RESPONSE_TO_UV_C4
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MAHADEVAN_RESPONSE_TO_MP470_UP
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_TARGETS_OF_VMYB_VS_CMYB_UP
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_WERNER_SYNDROM_UP
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HEDENFALK_BREAST_CANCER_BRACX_UP
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FARMER_BREAST_CANCER_CLUSTER_7
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DE_YY1_TARGETS_UP
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CROONQUIST_IL6_DEPRIVATION_UP
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_NKCELLS_PATHWAY
0.0284090909091%	1	3520	20	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMUNDSON_GAMMA_RADIATION_RESISTANCE
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TRAYNOR_RETT_SYNDROM_DN
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STREICHER_LSM1_TARGETS_DN
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_BOTULINUM_NEUROTOXICITY
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_BASE_EXCISION_REPAIR
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RASHI_NFKB1_TARGETS
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MATZUK_EMBRYONIC_GERM_CELL
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARSON_FOXP3_CORE_DIRECT_TARGETS
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_NORMAL_AGING_UP
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JEON_SMAD6_TARGETS_DN
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FARMER_BREAST_CANCER_CLUSTER_5
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEN_PDGF_TARGETS
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN
0.0284090909091%	1	3520	19	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AMIT_EGF_RESPONSE_40_MCF10A
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YIH_RESPONSE_TO_ARSENITE_C2
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WEBER_METHYLATED_IN_COLON_CANCER
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STAMBOLSKY_BOUND_BY_MUTATED_TP53
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PLASARI_NFIC_TARGETS_BASAL_DN
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAM_FXYD5_TARGETS_DN
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCGOWAN_RSP6_TARGETS_UP
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LE_NEURONAL_DIFFERENTIATION_UP
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KAPOSI_LIVER_CANCER_MET_UP
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GENTILE_UV_RESPONSE_CLUSTER_D1
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BOWIE_RESPONSE_TO_TAMOXIFEN
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP
0.0284090909091%	1	3520	18	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ALONSO_METASTASIS_NEURAL_UP
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	THUM_MIR21_TARGETS_HEART_DISEASE_UP
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SIMBULAN_PARP1_TARGETS_DN
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INFLAMMASOMES
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_INTEGRIN5_PATHWAY
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NGO_MALIGNANT_GLIOMA_1P_LOH
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LI_CYTIDINE_ANALOG_PATHWAY
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LIU_IL13_MEMORY_MODEL_UP
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LE_SKI_TARGETS_UP
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KASLER_HDAC7_TARGETS_1_DN
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KANG_AR_TARGETS_UP
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DORMOY_ELAVL1_TARGETS
0.0284090909091%	1	3520	17	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_LAIR_PATHWAY
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_LATE_DIFFERENTIATION_GENES_DN
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WONG_IFNA2_RESISTANCE_UP
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RODRIGUES_THYROID_CARCINOMA_UP
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PLATELET_SENSITIZATION_BY_LDL
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_DNAPK_PATHWAY
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MOOTHA_TCA
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LEE_LIVER_CANCER_HEPATOBLAST
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KORKOLA_TERATOMA_UP
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KOINUMA_COLON_CANCER_MSI_DN
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_OTHER_GLYCAN_DEGRADATION
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HUMMERICH_MALIGNANT_SKIN_TUMOR_UP
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GHO_ATF5_TARGETS_DN
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FINETTI_BREAST_CANCER_KINOME_GREEN
0.0284090909091%	1	3520	16	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHANG_GATA6_TARGETS_UP
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SINGH_NFE2L2_TARGETS
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SA_MMP_CYTOKINE_CONNECTION
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SANCHEZ_MDM2_TARGETS
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_LPA4_PATHWAY
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ERBB_NETWORK_PATHWAY
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NAGY_STAGA_COMPONENTS_HUMAN
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARKS_ACETYLATED_NON_HISTONE_PROTEINS
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	FERRANDO_LYL1_NEIGHBORS
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	COLLIS_PRKDC_REGULATORS
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_STEM_PATHWAY
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_IL3_PATHWAY
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_ERYTH_PATHWAY
0.0284090909091%	1	3520	15	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_AKAPCENTROSOME_PATHWAY
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WU_ALZHEIMER_DISEASE_UP
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SIGNAL_ATTENUATION
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_IFNG_SIGNALING
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_P75NTR_SIGNALS_VIA_NFKB
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_N_GLYCAN_ANTENNAE_ELONGATION
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_COMMON_PATHWAY
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_TCRJNKPATHWAY
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LY_AGING_MIDDLE_UP
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_NON_HOMOLOGOUS_END_JOINING
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	INAMURA_LUNG_CANCER_SCC_UP
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOEGERKORP_CD44_TARGETS_DIRECT_DN
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.0284090909091%	1	3520	14	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAGUE_PRETUMOR_DRUG_RESISTANCE_DN
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WU_HBX_TARGETS_3_DN
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WHITESIDE_CISPLATIN_RESISTANCE_DN
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	VERRECCHIA_RESPONSE_TO_TGFB1_C4
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TSAI_DNAJB4_TARGETS_UP
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	STARK_BRAIN_22Q11_DELETION
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHIN_B_CELL_LYMPHOMA_CLUSTER_1
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_POL_SWITCHING
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6_ALPHA
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	RAY_ALZHEIMERS_DISEASE
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	POS_RESPONSE_TO_HISTAMINE_UP
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTINELLI_IMMATURE_NEUTROPHIL_DN
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	LUI_THYROID_CANCER_CLUSTER_5
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KRISHNAN_FURIN_TARGETS_DN
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KEGG_SULFUR_METABOLISM
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	JIANG_CORE_DUPLICON_GENES
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IVANOV_MUTATED_IN_COLON_CANCER
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IRITANI_MAD1_TARGETS_UP
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HASINA_NOL7_TARGETS_UP
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ELLWOOD_MYC_TARGETS_UP
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAFFAREL_RESPONSE_TO_THC_24HR_3_DN
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_SALMONELLA_PATHWAY
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_RB_PATHWAY
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_PARKIN_PATHWAY
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_P27_PATHWAY
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_EXTRINSIC_PATHWAY
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_D4GDI_PATHWAY
0.0284090909091%	1	3520	13	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_ACE2_PATHWAY
0.0284090909091%	1	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53
0.0284090909091%	1	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN
0.0284090909091%	1	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TURJANSKI_MAPK1_AND_MAPK2_TARGETS
0.0284090909091%	1	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SA_PROGRAMMED_CELL_DEATH
0.0284090909091%	1	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_THE_NLRP3_INFLAMMASOME
0.0284090909091%	1	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SEROTONIN_RECEPTORS
0.0284090909091%	1	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE
0.0284090909091%	1	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PYRIMIDINE_CATABOLISM
0.0284090909091%	1	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
0.0284090909091%	1	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	NEBEN_AML_WITH_FLT3_OR_NRAS_DN
0.0284090909091%	1	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KRISHNAN_FURIN_TARGETS_UP
0.0284090909091%	1	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HEDVAT_ELF4_TARGETS_UP
0.0284090909091%	1	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.0284090909091%	1	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN
0.0284090909091%	1	3520	12	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CLAUS_PGR_POSITIVE_MENINGIOMA_DN
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ZHOU_PANCREATIC_EXOCRINE_PROGENITOR
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WILLIAMS_ESR2_TARGETS_DN
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	WHITESIDE_CISPLATIN_RESISTANCE_UP
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_STAT3_PATHWAY
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHIN_B_CELL_LYMPHOMA_CLUSTER_6
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SEMBA_FHIT_TARGETS_UP
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_PE
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_MTORC1_MEDIATED_SIGNALLING
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_IL_6_SIGNALING
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	POS_RESPONSE_TO_HISTAMINE_DN
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_ALK2PATHWAY
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MARTINELLI_IMMATURE_NEUTROPHIL_UP
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MANTOVANI_NFKB_TARGETS_DN
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	DER_IFN_GAMMA_RESPONSE_DN
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_SRCRPTP_PATHWAY
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_SET_PATHWAY
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BAUS_TFF2_TARGETS_DN
0.0284090909091%	1	3520	11	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	AUJLA_IL22_AND_IL17A_SIGNALING
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	YIH_RESPONSE_TO_ARSENITE_C5
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	TURJANSKI_MAPK14_TARGETS
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	ST_INTERFERON_GAMMA_PATHWAY
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SHIRAISHI_PLZF_TARGETS_UP
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	SEMBA_FHIT_TARGETS_DN
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_PURINE_CATABOLISM
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_GAP_JUNCTION_DEGRADATION
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ANDROGEN_BIOSYNTHESIS
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PYEON_HPV_POSITIVE_TUMORS_DN
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	PID_VEGF_VEGFR_PATHWAY
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OXFORD_RALA_AND_RALB_TARGETS_UP
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	OSAWA_TNF_TARGETS
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MURAKAMI_UV_RESPONSE_1HR_DN
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MIKKELSEN_IPS_LCP_WITH_H3K27ME3
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	MANN_RESPONSE_TO_AMIFOSTINE_DN
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	KONG_E2F1_TARGETS
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	HOLLEMAN_DAUNORUBICIN_B_ALL_UP
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	CAFFAREL_RESPONSE_TO_THC_8HR_3_DN
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BUDHU_LIVER_CANCER_METASTASIS_UP
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_SODD_PATHWAY
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_RANMS_PATHWAY
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_GLYCOLYSIS_PATHWAY
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_GABA_PATHWAY
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_DNAFRAGMENT_PATHWAY
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BIOCARTA_BARRESTIN_PATHWAY
0.0284090909091%	1	3520	10	T2D_GENES_TANYA_LIPIDS_RSQ05_02CM_300K	BAKER_HEMATOPOESIS_STAT1_TARGETS
overlap%%	overlap	size_1	size_2	Gene Set 1